content,labels,0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22
treating diabetes elderly special considerations management diabetes elderly patients generally follows lines younger patients improvement blood glucose status diet oral hypoglycemic insulin therapy required older patients fragile however caution must used therapeutic interventions,C19,0.004418851,0.003919741,0.008245117,0.0024827719,0.006160266,0.005702757,0.4282605,0.004155541,0.0031946322,0.00434178,0.021245468,0.009088731,0.052882552,0.010160303,0.0038858259,0.049663577,0.14178294,0.004550684,0.0050315117,0.14317395,0.081537545,0.0015689733,0.004545951
antidiabetic agents although either insulin oral hypoglycemics may used conjunction diet exercise management type ii diabetes drug therapy type diabetes involves insulin c peptide levels tested assess whether patient remaining pancreatic endocrine function patients started insulin first time receive single injection intermediate acting insulin human origin dose approximately u kg thereafter fasting mid morning mid afternoon bedtime possibly early morning blood sugars examined periodically determine insulin dose needs increased decreased split patient needs two insulin regimen intensive insulin therapy become commonplace control plasma glucose levels majority patients receiving insulin therapy proper patient education regarding insulin regimen injection techniques blood glucose monitoring well diet exercise foot care essential patient diabetes controlled adequately guidelines adequate glycemic control outlined table recent evidence suggests tight control plasma glucose levels may decrease macrovascular complications diabetes although also evidence suggest onset microvascular complications might delayed strict glycemic control data conflicting benefits strict control must weighted problems hypoglycemia experienced many patients attempt tight control blood glucose levels biguanide compounds available europe sulfonylureas comprise class oral agents united states commercially available treatment type ii diabetes two generations drugs reflect potency possible side effect profiles first generation agents tolbutamide chlorpropamide widely prescribed tolbutamide weakest sulfonylureas possibly making good drug initiating oral therapy elderly chlorpropamide becoming less popular agent long duration action increased incidence side effects second generation agents glyburide offers better dosing schedule daily compared twice daily glipizide however glyburide may produce greater incidence hypoglycemia particularly elderly patients significant renal impairment good studies comparing two drugs recommending one difficult drug interactions numerous first generation drugs less newer second generation agents abstract truncated words,C19,0.00090722897,0.026014037,0.001694826,0.03205912,0.0012632876,0.0066877822,0.39555556,0.013999632,0.0006558862,0.0052805725,0.029135637,0.021150382,0.04741604,0.0022355814,0.013952473,0.067290656,0.07407732,0.0009342954,0.005405159,0.05892613,0.1940994,0.00032212405,0.00093686744
effects repetitive administration corticotropin releasing hormone combined lysine vasopressin plasma adrenocorticotropin cortisol levels secondary adrenocortical insufficiency examine functioning hypothalamo pituitary adrenocortical axis secondary adrenocortical insufficiency administered micrograms synthetic human crh iv plus u lysine vasopressin lvp im three times daily consecutive days changes plasma acth cortisol levels administration response insulin tolerance test itt conducted administration determined three patients isolated acth deficiency basal plasma acth cortisol levels undetectablly low response noted itt crh lvp administration throughout observation period four patients adrenocortical insufficiency undergone successful transsphenoidal microadenomectomy cushing disease six patients undergone curative unilateral adrenalectomy cushing syndrome basal plasma acth levels low responded considerably stimulation tests along days crh lvp stimulation however neither peak time integrated acth response significantly enhanced variability responses among patients compared acth response last day crh lvp stimulation subsequent itt tended induce lower acth response post cushing disease patients higher response post cushing syndrome patients regarding plasma cortisol levels basal peak integrated responses tended increase daily crh lvp administration conversely itt repetitive crh lvp administration induced higher cortisol response test crh lvp administration post cushing disease patients serious complications noted patients treatment present findings indicate repetitive administration crh combination lvp safe valuable provocation test examine pituitary acth reserve integrity pituitary adrenocortical axis isolated acth deficiency usually due defect pituitary level respect adrenocortical responsiveness post cushing disease patients show better accumulation provocative effect post cushing syndrome patients hypothalamic pituitary dysfunction responsible adrenal hypofunction patients hypercortisolemia post cushing syndrome patients especially short period hypercortisolemia appeared less impairment hypothalamic acth releasing activity post cushing disease patients,C19,0.001040408,0.00092273456,0.0019409584,0.0055780453,0.006457719,0.001343282,0.11302202,0.011028154,0.0007520389,0.0010220855,0.024816899,0.0021434939,0.031223316,0.0024690032,0.005918416,0.021734381,0.11832934,0.0010712629,0.0011844531,0.047297437,0.5992614,0.00036934734,0.0010738301
minimal model analysis intravenous glucose tolerance test derived insulin sensitivity diabetic subjects although minimal model analysis frequently sampled iv glucose tolerance tests fsigts measure insulin sensitivity well recognized application limited need endogenous insulin secretion present study determined whether use exogenous insulin could permit minimal model assessment insulin sensitivity si extended diabetic subjects normal volunteers separate fsigt assessments supplemented tolbutamide insulin accelerate glucose disappearance diabetics fsigt supplemented insulin strong highly significant correlation two assessments normal subjects r p less rank order si generally maintained two assessments fold range si however insulin determined si lower vs x min microu microl p less diabetic subjects markedly lower insulin sensitivity controls si p less across subjects level fasting serum glucose correlated inversely insulin sensitivity r p less acute insulin responses r p less however insulin sensitivity diabetic subjects little insulin secretion comparable insulin sensitivity diabetic subjects near normal responses subjects fasting hyperglycemia significant correlations insulin sensitivity body mass index percent fat mass waist hip ratio p less among female subjects also strong correlation insulin sensitivity upper body obesity measured waist hip ratio r p less model parameters also permitted glucose uptake estimated diabetic vs normal subjects comparable hyperglycemia mmol l total glucose uptake decreased diabetic subjects vs mg min kg normals p less insulin dependent glucose uptake diminished greater extent vs noninsulin independent glucose uptake vs p less administration insulin permits minimal model fsigt analysis applied diabetic well normal subjects yielding information insulin noninsulin mediated glucose uptake well insulin sensitivity insulin secretion,C19,0.0009487826,0.0008416175,0.05885489,0.00053308223,0.0013211498,0.0012244533,0.10977436,0.00089261483,0.0006859276,0.00093223463,0.040667366,0.008553936,0.22383872,0.0022756334,0.00085691304,0.3323221,0.01585214,0.016880162,0.0010803286,0.041490678,0.1388536,0.00033687823,0.0009824452
advanced protein glycosylation induces transendothelial human monocyte chemotaxis secretion platelet derived growth factor role vascular disease diabetes aging diabetes aging commonly accompanied arterio atherosclerosis infiltration arterial subendothelial intima macrophages monocytes important early event preceding development atheromatous lesions macrophages known produce mitogenic factors early atherosclerotic lesions previously shown time vascular matrix accumulates proteins nonenzymatically modified advanced glycosylation end products ages view fact macrophages monocytes age specific receptors associated expression several growth factors investigated possibility ages mediate initial monocyte vessel wall interactions occur overt formation vascular lesions study demonstrates vitro vivo formed ages chemotactic human blood monocytes ii sub endothelial ages selectively induce monocyte migration across intact endothelial cell monolayer iii subsequent monocyte interaction age containing matrix results expression platelet derived growth factor results support existing hypothesis vivo forming glucose derived protein adducts act signals normal turnover senescent tissue protein means age specific receptor system time dependent glucose induced deposition ages matrix proteins may promote monocyte infiltration subendothelium subsequent age triggered macrophage activation consequent elaboration proliferative factors may normally coordinate remodeling may also lead diverse pathogenic changes typical arterio atherosclerosis diabetic aging populations,C19,0.0012961489,0.0010735363,0.0022869464,0.0006799801,0.019269813,0.0015618677,0.32288682,0.15016302,0.0067138793,0.0011891242,0.01920045,0.002571805,0.022037193,0.07885383,0.0010642476,0.037027836,0.028366871,0.06291479,0.013084514,0.0992082,0.112311326,0.00042970947,0.015808038
iodine selenium deficiency associated cretinism northern zaire selenium status determined endemic goiter area control area zaire compared reference values noniodine deficient area serum selenium subjects living core northern zaire endemic goiter belt karawa villages seven times lower school children similarly low cretins erythrocyte glutathione peroxidase rbc gpx five times lower schoolchildren still two times lower cretins p less severely iodine deficient city endemia businga selenium status moderately altered rbc gpx activity linearly associated serum selenium concentration value nmol l leveled approximately u g hb greater selenium concentration karawa villages selenium supplementation normalized serum selenium rbc gpx combined iodine selenium deficiency could associated elevated frequency endemic myxedematous cretinism central africa,C19,0.0023021617,0.0020421322,0.015407504,0.0012934906,0.003205687,0.0029710594,0.071560405,0.0021649806,0.0016643603,0.18595456,0.010692377,0.0047471877,0.19292074,0.0053700097,0.024293732,0.0035849444,0.02162538,0.0023708446,0.0026213496,0.10353823,0.2950059,0.0008174139,0.043845564
management primary hypothyroidism primary hypothyroidism common condition requiring lifelong treatment monitoring type amount thyroid hormone replacement selection laboratory tests timing office visits important optimizing patient well reducing costs medical care aim treatment bring patient euthyroid state currently defined normal serum concentration tsh recently developed sensitive specific immunometric assays accomplished titrating dose levothyroxine changing often week intervals indicator euthyroidism sensitive tsh assay advantages tests serum ft ft tsh ria independent tbg changes result pregnancy birth control pills estrogen replacement spuriously elevated levothyroxine treatment test detects subclinical hypothyroidism subclinical hyperthyroidism additional serum tests usually necessary advantages special circumstances optimal replacement dose determined monitoring done yearly even bi yearly depending adequacy patient education patient compliance,C19,0.01127285,0.011299271,0.020819942,0.0011087147,0.0027477003,0.0025465933,0.45056877,0.0018556764,0.0014265783,0.0019388426,0.07399331,0.013908303,0.017124288,0.030552382,0.0017352339,0.0030785115,0.10564974,0.0020330495,0.0022468453,0.05694342,0.18441698,0.0007006325,0.002032393
interrelationships age thyroid volume thyroid nodularity thyroid function patients sporadic nontoxic goiter purpose test hypothesis natural history sporadic nontoxic goiter sng diffuse goiter precedes multinodular goiter gradual development autonomous thyroid function patients methods cross sectional survey consecutive patients sng seven male female performed thyroid volume measured ultrasonography plasma thyroid stimulating hormone tsh sensitive assay tsh immunoradiometric assay results patients multinodular goiter older larger thyroid volume patients diffuse uninodular goiter plasma free thyroxine total triiodothyronine higher plasma tsh lower patients normal subjects free higher subgroup patients multinodular goiter decreased tsh response thyrotropin releasing hormone plasma tsh mu l negatively related thyroid volume x ml x r p less thyroid volume ml positively related age x years x r p less duration goiter x years x r p less annual increase thyroid volume calculated conclusion data suggest continuous growth sng provide support concept increasing thyroid nodularity autonomy thyroid function related increasing thyroid volume natural history disorder,C19,0.0018491208,0.0016402624,0.011530563,0.0010389456,0.002575596,0.022979422,0.11959018,0.0017389357,0.0013368321,0.0018168698,0.073122405,0.15433459,0.20556661,0.034774765,0.0016260959,0.0028794657,0.118547656,0.0019046575,0.011051784,0.08071673,0.14681962,0.00065655564,0.0019023074
structural abnormality ldl diabetic patients revealed resonance raman spectroscopy resonance raman spectra low density lipoprotein ldl isolated plasma diabetic patients age range yr mean age yr age sex matched control subjects recorded cm region function temperature degrees c nondiabetic diabetic ldl yield spectra characterized two major bands near cm due carotenoid component lipoproteins relative intensity cm bands assigned c c c c stretchings respectively e ratio plotted temperature nondiabetic control subjects plots showed inflection temperature range degrees c corresponded thermal transition ldl transition abolished ldl diabetic patients p less suggesting altered lipid structure transition degrees c also abolished vitro glycosylated nondiabetic ldl lipid analysis show appreciable change nondiabetic control subjects diabetic patients change thermal transition properties diabetic ldl attributed organizational change ldl protein,C19,0.0017718398,0.0015702657,0.09153685,0.0009946096,0.0024774906,0.0022845499,0.11095818,0.0016647282,0.0012797839,0.0017433657,0.020065617,0.003703882,0.17795287,0.0041220877,0.29000002,0.071303666,0.05928391,0.028717902,0.0020156458,0.029843504,0.07816616,0.00062853773,0.017914528
defective fasciculata zone function mechanism glucocorticoid remediable aldosteronism glucocorticoid remediable aldosteronism characterized unusual sensitivity aldosterone secretion acth suppressibility glucocorticoid continued stimulability exogenous acth provided basis diagnosis treatment disorder qualitative biochemical abnormality consisting marked overproduction products cortisol c oxidation pathway hydroxycortisol oxocortisol examined patients disorder compared normal c oxidation products corticosterone aldosterone hydroxycorticosterone technique based stable isotope dilution mass fragmentography measured tetrahydro urinary metabolites aldosterone hydroxycorticosterone oxocortisol unmetabolized hydroxycortisol c oxygenated corticosteroids markedly elevated untreated state showed rapid parallel suppression low doses glucocorticoid proportional changes c oxygenated cortisols together aldosterone hydroxycorticosterone suggested mechanism common catalytic site cytochrome p methyl oxidase serving cortisol corticosterone substrates acth dependent secretion c oxidation products corticosterone cortisol disorder attributed acquisition methyl oxidase activity fasciculata zone abundant pools precursors,C19,0.001954072,0.0017333593,0.26888356,0.0010979132,0.0027209832,0.01183729,0.3042792,0.0018376329,0.001412707,0.0019199904,0.027241629,0.013473172,0.026178358,0.014754491,0.0017183615,0.05033359,0.026515935,0.0020158624,0.0022249983,0.013371945,0.22177221,0.00069381995,0.0020289244
occurrence type vi collagen extracellular matrix renal glomeruli increase diabetes human bovine glomerular basement membrane gbm preparations representing extracellular matrix renal filtration units found contain type vi collagen protein solubilized guanidine guanidine dithiothreitol extractions characterized polyacrylamide gel electrophoretic resolution immunoblotting antiserum directed alpha vi alpha vi polypeptide chains insensitivity collagenase digestion nonreduced state contrast gbm product three distinct cells type vi collagen could detected extracts calf lens capsule epithelial cell derived basement membrane quantitation radioimmunoassay type vi collagen content gbm diabetic nondiabetic human subjects indicated fold higher level p less diabetic preparations glomerulus type vi collagen considered basis immunohistochemistry localized mesangium believe measurement protein gbm preparations provide valuable index mesangial expansion diabetic glomerulopathies,C19,0.002251755,0.0019974192,0.015096923,0.19655558,0.0031354977,0.0029060072,0.19870992,0.0021180338,0.0016279187,0.0022124816,0.011640006,0.00463143,0.0635089,0.03462793,0.012855221,0.039443374,0.046014976,0.036938157,0.0025639543,0.03571943,0.10733386,0.0007995164,0.17731172
aberrant splicing androgen receptor mrna results synthesis nonfunctional receptor protein patient androgen insensitivity androgen insensitivity disorder correct androgen response androgen target cell impaired clinical symptoms x chromosome linked syndrome presumed caused mutations androgen receptor gene report g mutation splice donor site intron androgen receptor gene xy subject lacking detectable androgen binding receptor complete form androgen insensitivity point mutation completely abolishes normal rna splicing exon intron boundary results activation cryptic splice donor site exon leads deletion nucleotides mrna translation mutant mrna results androgen receptor protein approximately kda smaller wild type mutated androgen receptor protein unable bind androgens unable activate transcription androgen regulated reporter gene construct mutation human androgen receptor gene demonstrates importance intact steroid binding domain proper androgen receptor functioning vivo,C19,0.0021602912,0.001895176,0.0041873874,0.011530492,0.0029754222,0.0027572557,0.17757171,0.0020091839,0.0015445894,0.0021057862,0.009996869,0.004394358,0.015028218,0.04148764,0.012619541,0.003326964,0.053451248,0.4172972,0.0024327117,0.035218965,0.08074657,0.00075859105,0.11450376
mutation signal peptide encoding region preproparathyroid hormone gene familial isolated hypoparathyroidism preproparathyroid hormone prepropth gene mutation proposed cause familial isolated hypoparathyroidism fih cloned prepropth alleles patient autosomal dominant fih sequenced coding regions flanking regions splice junctions putatively abnormal based previous linkage studies allele differed allele normal sequence one nucleotide c point mutation changes codon position amino acid prepro sequence cysteine arginine disrupting hydrophobic core signal sequence hydrophobic core required secreted proteins efficient translocation across endoplasmic reticulum mutant protein likely inefficiently processed indeed vitro studies demonstrated dramatically impaired processing mutant prepropth propth summary observed point mutation signal peptide encoding region prepropth gene one fih kindred demonstrated functional defect caused mutation mutation signal sequence constitutes novel pathophysiologic mechanism man study may yield important insights form hormone deficiency role signal sequences human physiology,C19,0.0018168128,0.0016116037,0.01218801,0.009802864,0.028911613,0.0023446917,0.11202088,0.019259928,0.010084973,0.0017851252,0.23557228,0.0037368368,0.013378688,0.0045475527,0.0015976593,0.0028291554,0.026036995,0.072381325,0.0020687087,0.028150378,0.20879625,0.0006450842,0.20043261
short term treatment acromegaly somatostatin analog octreotide first double blind randomized placebo controlled study effects several studies suggest somatostatin analog octreotide sms may effectively reduce gh hypersecretion however double blind placebo controlled study substantiated findings present results randomized double blind day clinical trial octreotide patients acromegaly drug given sc every h initial dose micrograms added another micrograms every day micrograms gh levels calculated mean values observations hourly intervals h insulin like growth factor igf levels significantly reduced octreotide treatment responses varied reduction basal mean gh level significant reduction patients good correlation reduction gh igf levels main side effects gastrointestinal well tolerated found spontaneous variation daily mean gh igf levels h placebo group ranging approximately gh igf levels noted day patients treated octreotide occurrence gh rises administration times suggests may desirable give octreotide every h patients,C19,0.0018325517,0.001625337,0.0034188724,0.0010294918,0.0025514127,0.0025650968,0.14959837,0.0017231123,0.0013246677,0.0018003373,0.020617967,0.023152031,0.076511376,0.004227551,0.001611274,0.011720135,0.10049289,0.00188696,0.17890812,0.021991096,0.38887566,0.0006505814,0.0018851109
genetic evidence equating sry testis determining factor testis determining factor gene tdf lies chromosome responsible initiating male sex determination sry gene located sex determining region human mouse chromosomes many properties expected tdf sex reversal xy females results failure testis determination differentiation pathways xy females gonadal dysgenesis lost sex determining region chromosome terminal exchange sex chromosomes deletions sry tdf would predicted sex reversed xy females without chromosome deletions suffered mutations sry tested human xy females normal xy males alterations sry using single strand conformation polymorphism assay subsequent dna sequencing de novo mutation found sry gene one xy female mutation present patient normal father brother second variant found sry gene another xy female case normal father shared alteration variant second case may fortuitously associated predisposing towards sex reversal de novo mutation associated sex reversal provides compelling evidence sry required male sex determination,C19,0.0016969093,0.009719058,0.0042987885,0.00095342414,0.018782046,0.0021899499,0.17120054,0.0015957941,0.0012267899,0.001667313,0.07368371,0.0034902182,0.019577183,0.05460909,0.0014922193,0.0026557632,0.025539754,0.0017518701,0.0019321808,0.27420816,0.037394404,0.0006025109,0.28973234
human xy female frame shift mutation candidate testis determining gene sry primary decision male female sexual development human embryo depends presence chromosome specifically gene chromosome encoding testis determining factor tdf human sex determining region delimited kilobase interval near pseudoautosomal boundary region candidate gene tdf termed sry conserved specific chromosome mammals tested corresponding gene mouse chromosome deleted line xy female mutant mice expressed expected stage male gonadal development identified mutation sry one sex inversed xy females gonadal dysgenesis lack large segments short arm chromosome four nucleotide deletion occurs sequence sry encoding conserved dna binding motif results frame shift presumably leading non functional protein mutation occurred de novo father sporadic xy female bears normal sequence corresponding position results provide strong evidence sry tdf,C19,0.0019361974,0.0017175038,0.0036127437,0.0010878703,0.02146044,0.0024987636,0.1877069,0.0018208235,0.010746022,0.0019024278,0.020989696,0.003982388,0.014594703,0.03965844,0.0017026432,0.0030319043,0.034727793,0.040158343,0.0022046457,0.26570073,0.107749306,0.00068747334,0.23032226
tumor necrosis factor putative mediator sick euthyroid syndrome man tumor necrosis factor alpha tnf believed important mediator many diseases associated sick euthyroid syndrome investigate effect tnf thyroid hormone metabolism performed controlled study six healthy postabsorptive males plasma thyroid hormones tsh sequentially measured iv bolus injections recombinant human tnf micrograms isotonic saline h study tnf produced characteristic changes circulating thyroid hormones tsh observed sick euthyroid syndrome compared control experiment tnf induced significant decreases saline p less tsh levels saline p less significant increase rt values saline p less free index affected tnf free showed mean transient increase five subjects nonsignificant occurred synchronically transient fold rise circulating ffa levels results suggest tnf involved either directly indirectly pathogenesis sick euthyroid syndrome,C19,0.010508454,0.0016256538,0.0034195385,0.0010296925,0.00255191,0.0023651328,0.13772458,0.0017234482,0.0013249258,0.0018006882,0.009582991,0.09500033,0.18183272,0.022601632,0.0016115879,0.003044838,0.035451,0.011640934,0.002086744,0.08673467,0.23149565,0.13372749,0.021115422
comparison hba fructosamine diagnosis glucose tolerance abnormalities total glycosylated hemoglobin hba fructosamine evaluated screening tools detection glucose tolerance abnormalities asymptomatic subjects undergoing g oral glucose tolerance test subjects classified according world health organization criteria normal n impaired n diabetic n glucose tolerance found good specificity hba fructosamine respectively low sensitivity respectively intersection curves sensitivity specificity drawn various thresholds normality sensitivity specificity hba fructosamine thus neither hba fructosamine seems suitable diagnosis mild abnormalities glucose tolerance,C19,0.0032406095,0.0028745823,0.021731654,0.0018207664,0.020174997,0.0041821753,0.123121224,0.0030475084,0.0023428164,0.0031840892,0.15657681,0.0066911057,0.39131942,0.007580163,0.0028497702,0.099110305,0.054434393,0.0033586978,0.019374013,0.021949487,0.046550985,0.0011506227,0.0033338196
vitro vivo testing electrocatalytic glucose sensor prerequisite development implantable artificial pancreas availability stable long life glucose sensor platinum pt catalyzed electrodes demonstrated vitro show high sensitivity glucose long cycle life sensitive co reactants compared enzymatic methods authors developed special data processing method compensated net charge ratio cncr measured electrode response sensitive glucose completely insensitive urea moderately sensitive amino acids endogenous exogenous co reactants show minor interferences cncr method involves determination ratio net oxidation charge total charge one complete cycle cyclic voltammogram prototype electrodes tested vitro spiked plasma shown typical sensitivities greater x cncr units per mg dl change glucose concentration linear response mg dl vivo testing modified f vascular catheter membrane covered surface mounted electrodes used vena cava site swine several sensor designs tested vivo sensitivities x cncr units mg dl,C19,0.0016830532,0.0014929522,0.38891137,0.000945639,0.0023438227,0.0021723586,0.120436475,0.014014767,0.0012167726,0.0016536986,0.10576618,0.0034617188,0.056900933,0.0038886638,0.034125607,0.06779898,0.027828649,0.0017621061,0.0019164036,0.053739138,0.097479805,0.00059759105,0.009863317
total serum glycosylated proteins detection monitoring gestational diabetes goal study determine whether serum glycosylated protein levels e fructosamine reliably screen gestational diabetes whether levels valid markers short term glycemic control third trimester pregnancy ninety seven pregnant women wk gestation evaluated mo hba c serum glycosylated protein serum fructosamine determined baseline venipuncture g oral glucose tolerance test performed detect gestational diabetes women studied tested positive gestational diabetes national diabetes data group criteria significant differences fasting h glucose values nondiabetic diabetic patients p less time point difference noted baseline serum glycosylated protein level vs mm ns hba c level vs ns gestational nondiabetic patients diabetic patients followed wk intervals serum glycosylated protein analysis hba c fasting glucose mean glucose determined outpatient monitoring serum glycosylated protein correlated significantly fasting blood glucose r p less mean outpatient glucose r p less wk follow visits correlation found hba c fasting blood glucose r ns mean outpatient glucose r ns follow period serum glycosylated protein level serum fructosamine useful screening test gestational diabetes however assay shows potential objective marker short term control evaluating maternal glycemic state,C19,0.0014275197,0.0012662811,0.0026893162,0.0008020651,0.001987776,0.0018422885,0.100872435,0.0013424568,0.0010320331,0.0014026219,0.20718493,0.017279163,0.15903923,0.010823696,0.06348227,0.098966785,0.07176076,0.049846306,0.0016254411,0.028790228,0.17455891,0.0005068604,0.0014706659
circadian rhythmicity rate normalized qt interval hypothyroidism significance development class iii antiarrhythmic agents lengthening repolarization refractoriness occurs hypothyroidism associated reduced probability arrhythmias converse occurring hyperthyroidism qt interval circadian rhythmicity relative heart rate poorly defined man used new computer assisted technique measure qt interval analysis hour holter tapes weeks thyroxine replacement patients hypothyroidism findings compared normal control subjects qtc interval prolonged p less heart rate decreased p less hypothyroid state data analyzed circadian rhythmicity repeated measures analysis circadian variation qtc heart rate statistically significant hypothyroid euthyroid states p less well control subjects circadian rhythmicity qtc interval heart rate phase maximum prolongation qtc occurred midnight time heart lowest qtc interval remained significantly prolonged weeks replacement biochemical indexes hypothyroidism returned normal values computer assisted qtc interval determination technique used data circadian rhythmicity qtc heart rate significant implications development new class iii antiarrhythmic agents,C19,0.0017425611,0.0015457387,0.0116845835,0.000979074,0.002426461,0.0022488658,0.1808705,0.0016387255,0.0012597941,0.052201983,0.03843433,0.0036264025,0.22747773,0.0040609115,0.009944223,0.011146002,0.36023837,0.0017953671,0.001984162,0.04592402,0.03634637,0.00061872014,0.0018050872
effects converting enzyme inhibition barrier function diabetic glomerulopathy differential solute clearances used examine effects day course enalapril glomerular barrier function proteinuric patients diabetic glomerulopathy day plasma renin prorenin became elevated arterial pressure declined transglomerular passage dextrans broad size distribution radii lowered significantly subset patients withdrawal enalapril followed additional days return renin levels arterial pressure pretreatment levels dextran sieving profile also returned baseline becoming uniformly elevated treated day levels theoretical analysis serial dextran sieving profiles indicated enalapril shifted glomerular pore size distribution smaller size changes barrier size selectivity associated reduction fractional albumin igg clearances enalapril therapy subsequent rise quantities withdrawal urinary protein excretion rate tended vary parallel conclude inhibition converting enzyme humans established diabetic glomerulopathy diminishes glomerular permeability proteins enhancing barrier size selectivity neither enalapril therapy withdrawal influenced glomerular filtration renal plasma flow rates significantly propose primary action enalapril may modulate intrinsic membrane properties glomerular barrier,C19,0.0014551295,0.0012666796,0.03026202,0.00080231746,0.0020274154,0.008750128,0.10331134,0.0013428793,0.0010323579,0.0014030633,0.0076262304,0.0029371085,0.047217824,0.003383009,0.0012557198,0.022956042,0.042550094,0.023196062,0.0016259525,0.0115455985,0.68206894,0.00050701987,0.0014770548
oral calcium load test diagnostic physiologic implications hyperparathyroidism oral calcium load test clt gm ca kg administered control subjects patients overt hyperparathyroidism assess efficacy diagnosis hyperparathyroidism participants placed low calcium diet days clt intact parathormone ionized calcium cai levels measured hours clt initial cai parathormone mean se mmol l pmol l control group compared mmol l pmol l group hyperparathyroidism groups similar percent increase cai values control hyperparathyroidism p greater decline parathormone levels patients hyperparathyroidism significantly less decline observed control subjects p less three hours clt parathormone suppressed control subjects whereas rebound occurred patients hyperparathyroidism postoperative clt demonstrated higher mean percent cai increase percent parathormone decline cai parathormone compared preoperative values cai pth p less hours calcium intake parathormone remained suppressed similar control subjects surgery three patients elevated parathormone low normal cai levels parathormone response clt confirmed diagnosis secondary hyperparathyroidism conclusion clt confirm diagnosis hyperparathyroidism successful parathyroidectomy distinguished postoperative secondary persistent primary hyperparathyroidism demonstrated nonautonomy abnormal parathyroid glands parathormone response calcium load characterized earlier nadir decreased suppressibility rapid recovery produced dynamic changes distinguish patients hyperparathyroidism control subjects hyperplasia adenoma,C19,0.0014610488,0.001292936,0.06939338,0.0008189483,0.002029888,0.0230331,0.08740788,0.017094785,0.0010537572,0.0014321466,0.061437972,0.026751379,0.21573102,0.05934791,0.001281749,0.0022697372,0.1729729,0.032466136,0.0016596562,0.024947692,0.19409156,0.0005175296,0.0015069209
reappraisal thyroxine treatment primary hypothyroidism optimum daily dose thyroxine calculated children aged years primary hypothyroidism titrating doses monthly intervals condition thyroid assessed sensitive assay thyroid stimulating hormone concentrations well measurement total free thyroid hormone concentrations systolic time interval ratios serum thyroid stimulating hormone concentration found responsive small changes thyroxine calculated optimum daily replacement dose thyroxine micrograms micrograms kg fractionally lower previously recommended closely related surface area coefficient variation body weight coefficient variation results suggest though monthly may optimal time interval increases dose thyroxine reduction dose made gradually,C19,0.0023814884,0.002112499,0.019810317,0.012858263,0.003316147,0.10592303,0.16083094,0.0022428462,0.0017217101,0.020021172,0.018447619,0.05099756,0.08248687,0.032175455,0.002094278,0.0037084727,0.04976898,0.002452538,0.002711675,0.023847671,0.3967945,0.00084558,0.002450396
tests thyroid function update diagnosis management thyroid disease current thyroid function tests give clinician powerful tools accurate assessment thyroid status majority patients encountered however small number clinical situations appear inconsistencies interrelationship thyroid function tests apparently inappropriate clinical status patient instances rational explanation observed alterations application information allow clinicians refine diagnostic accuracy thereby enable proceed appropriate therapeutic management program,C19,0.01704693,0.0025903643,0.0054487926,0.001640742,0.018177629,0.0037686718,0.24511984,0.0027461925,0.0021111756,0.002869269,0.09091026,0.08055095,0.024588443,0.0070347786,0.0025679513,0.23468478,0.063146845,0.003007323,0.014350725,0.0769093,0.096688,0.0010368574,0.0030041954
hyperparathyroidism cellular mechanisms gastric acid secretion patients hyperparathyroidism appear particular risk peptic ulcer disease test hypothesis hypercalcemia parathyroid hormone plays role promoting ulcer disease studied effect varying concentrations extracellular calcium acid secretion using vitro isolated rabbit gastric glands acid secretion assessed accumulation carbon labeled aminopyrine c ap glands incubated varying calcium concentrations unstimulated state histamine carbachol mol l mmol l calcium medium effect parathyroid hormone also examined identical conditions compared mmol l standard calcium medium unstimulated c ap accumulation significantly inhibited p less lower mmol l higher mmol l calcium concentrations accumulation c ap response histamine stimulation unaffected alteration extracellular calcium p greater carbachol stimulated c ap accumulation significantly augmented p less increase calcium concentration mmol l addition parathyroid hormone mmol l alone combination carbachol histamine mmol l incubation alter c ap accumulation data suggest elevations extracellular calcium play active role potentiation cholinergic mediated gastric gland acid secretion may thereby play role hyperparathyroid related ulcer disease,C19,0.0015683299,0.0013911868,0.002926341,0.0008811806,0.0021838497,0.0020240115,0.50788814,0.024242995,0.0011338327,0.0015409762,0.007315376,0.012335806,0.05831966,0.09971862,0.0013791497,0.032987315,0.019138256,0.0016246437,0.0017857742,0.021424528,0.19601972,0.000556857,0.00161344
cold follicles multinodular human goiter arise partly failing iodide pump partly deficient iodine organification investigate whether common cold follicles human multinodular goiters consequence functional defect apical membrane peroxidase failure iodide transport system deficiencies studied iodide accumulation iodine organification fragments large multinodular goiter transplanted nude mice labeled transplants frozen c immediately removal avoid diffusion inorganic iodide autoradiographic assessment cryosections exposed either c thawing washing unbound iodide showed two types cold follicles namely failed accumulate iodide therefore organify iodine readily accumulated iodide failed bind suggesting failure apical membrane peroxidase two types pathogenetically different cold follicles coexisted apparently randomly intermingled fashion throughout whole goiter,C19,0.0025593552,0.02705022,0.041935593,0.0014382041,0.014159588,0.0033029814,0.15077043,0.0024068486,0.0018502999,0.05201632,0.011863829,0.104341164,0.015953656,0.043442443,0.027019193,0.0039854483,0.054829504,0.015023289,0.0029142024,0.066833355,0.33644548,0.00090873404,0.018949812
rebound increase serum thyrotropin anti microsomal antibodies thyroglobulin discontinuation l thyroxine assayed serum thyrotropin tsh antimicrosomal antibodies msa antithyroglobulin antibodies thyroglobulin seven individuals subclinical autoimmune hypothyroidism two month periods l thyroxine substitution placebo respectively serum tsh decreased l thyroxine administration rebound increase serum tsh months duration placebo treatment parallel increase serum thyroglobulin agreement previous observations groups found decreased serum concentrations msa l thyroxine treatment three individuals addition slow significant transient increase serum msa recorded placebo administration four individuals showed pronounced increase serum tsh greater mu l association serum levels msa tsh probably related antigen presentation surface thyrocyte conclude changes serum tsh concentration taken account interpretation msa patients thyroid disease whether untreated treated l thyroxine,C19,0.0022517778,0.0019974392,0.004368179,0.001265182,0.003135529,0.0029060366,0.24856703,0.0021175991,0.0016279351,0.002212504,0.021477854,0.027066937,0.02471193,0.07425725,0.0019801564,0.0035064863,0.06611637,0.0023189578,0.0352668,0.03713965,0.4324883,0.0007995245,0.002420548
prevalence previously undiagnosed hypothyroidism residents midwestern nursing home published erratum appears south med j jul hypothyroidism elderly may associated nonspecific symptoms determine prevalence undiagnosed hypothyroidism residents skilled nursing facility screened male female residents aged years older thyroid dysfunction overt hypothyroidism found three men two women subclinical hypothyroidism diagnosed men women tests thyroid antibodies positive patients overt hypothyroidism men women subclinical hypothyroidism thyroid antibody testing residents newly diagnosed overt hypothyroidism subclinical hypothyroidism medical observation year longer institutionalized elderly screened hypothyroidism abnormality may otherwise remain undiagnosed detection subclinical hypothyroidism important affected individuals risk decline thyroid function,C19,0.0027273337,0.002419281,0.0050889216,0.0015323776,0.0037977258,0.016663406,0.16564856,0.0025648177,0.001971741,0.0026950953,0.1435553,0.05840626,0.031633247,0.033349082,0.0023983484,0.004247026,0.044143073,0.0028087015,0.0031054707,0.40150216,0.0659674,0.0009683771,0.002806354
lipoprotein apolipoprotein levels subclinical hypothyroidism effect levothyroxine therapy assess whether subclinical hypothyroidism associated changes lipoprotein fractions patients maintained stable state subclinical hypothyroidism least months studied prior months following restoration euthyroid state incremental levothyroxine sodium therapy thyrotropin levels sem decreased mu l mu l mu l months months months levothyroxine treatment led decrease levels total cholesterol mmol l mg dl mmol l mg dl low density lipoprotein cholesterol ldl c mmol l mg dl mmol l mg dl apolipoprotein b mg dl mg dl months levels ldl c apolipoprotein b remained significantly lower pretreatment values mmol l mg dl mg dl respectively high density lipoprotein cholesterol hdl c hdl c apolipoprotein significantly affected levothyroxine therapy slight trend increase hdl c levothyroxine substitution also tendency decrease triglyceride levels mmol l mg dl mmol l mg dl months levothyroxine therapy levels hdl c tended decrease mmol l mg dl mmol l mg dl months mmol l mg dl months ldl c hdl c ratio also decreased mmol l mg dl mmol l mg dl mmol l mg dl months months respectively results suggest long term levothyroxine therapy patients subclinical hypothyroidism associated decrease ldl c apolipoprotein b levels reflected trend decreases cholesterol hdl c ldl c hdl c ratios known relationship coronary artery disease,C19,0.0013889838,0.0078896005,0.0025916998,0.00078041333,0.001934116,0.001792556,0.2991404,0.0013062172,0.0010041735,0.008065291,0.0064424574,0.0028760675,0.07929764,0.0032264588,0.27049202,0.0021629366,0.1217337,0.0014304231,0.0015815625,0.029721154,0.15318993,0.0004931777,0.0014589949
interaction insulin glucose delivery route regulation net hepatic glucose uptake conscious dogs presence fixed basal levels insulin route intravenous glucose delivery protal vs peripheral determines whether net hepatic glucose uptake nhgu occurs aims determine route intravenous glucose delivery also plays role regulating nhgu presence hyperinsulinemia determine length fast vs h influences regulation nhgu five conscious dogs fasted h given somatostatin replacement insulin microu kg min glucagon ng kg min infusions intraportally min control period insulin infusion rate increased fourfold glucose infused h glucose given either peripheral vein portal vein min double glucose load reaching liver order infusions randomized nhgu measured arterial venous difference technique insulin glucagon levels microu ml pg ml control peripheral portal infusions respectively glucose infusion rate load glucose reaching liver arterial portal plasma glucose gradient mg kg min mg kg min mg dl periods,C19,0.011408542,0.0014932271,0.035677094,0.0009458131,0.0023440297,0.0021724678,0.103027016,0.01787547,0.025662262,0.0016540032,0.012402086,0.06669983,0.1377111,0.004904575,0.009622097,0.3299394,0.034881897,0.0017335849,0.011354467,0.029476361,0.15668519,0.00059770106,0.0017317819
intercellular propagation individually programmed growth bursts frtl cells implications interpreting growth factor actions five methods commonly used quantify frtl cells thyrocytes growth vitro impact growth inhibiting stimulating maneuvers total cell count mitotic index dna measurement total h thymidine incorporation fraction h thymidine labeled cells assess cell growth though cells homogeneous identical response growth factors demonstrate assumption valid rather intrinsically growth prone cells appear pass growth signal neighboring cells variably sized colonies synchronized cells within cluster growing monodispersed cells formed true frtl cells growing vitro monolayers three dimensional collagen embedded spheroids pattern cell suspensions collagen embedded spheroids implanted onto nude mice patches alternating high low growth become particularly prominent large tumor like organoids grown monodispersed cells nude mice pattern much reminds similar observations growing intact thyroids since significant correlation fraction h thymidine labeled cells size two three dimensional clusters experiment growth signal spreading cells assumed occur leaps bounds growth velocity subclone cell population depends mean interval bursts replications number cells synchronized cell cell diffusion growth signal emanating one dividing cell thus growth promoting growth inhibiting factors may act mean interval successive growth bursts may also change cell cell spreading growth signals,C19,0.0012704646,0.0011264534,0.0023739403,0.013004218,0.045427974,0.0016388557,0.097661175,0.0011942174,0.0009253144,0.0012477388,0.043569904,0.015158102,0.0685519,0.5164695,0.013564704,0.008107517,0.02553025,0.01359455,0.018105,0.01791455,0.08564046,0.00045089083,0.007472411
intraoperative parathormone level measurement management hyperparathyroidism investigate potential use intraoperative intact parathormone measurements predict curative parathyroidectomy measured ionized calcium cai levels parathormone levels patients hyperparathyroidism underwent exploratory bilateral neck surgery nineteen patients solitary adenoma patients hyperplasia one patient four normal parathyroid glands results compared results patients underwent either thyroid lobectomy tl n near total thyroidectomy ntt n control patients underwent miscellaneous operations parathormone decline curative parathyroidectomy mean se significantly greater decline three patients persistent postoperative hyperparathyroidism p less declines tl p less ntt p less p less control patients intraoperative cai decline curative parathyroidectomy differ significantly results tl ntt miscellaneous operations control patients patients persistent postoperative hyperparathyroidism greatest decline cai levels p less data conclude decline parathormone level minutes parathyroidectomy predictive cure thyroidectomy even unilaterally produces significant decline parathormone level affects interpretation intraoperative parathormone level changes cai level slow decline useful predicting effective parathyroidectomy measurement intraoperative parathormone level changes used substitute exploratory bilateral neck surgery,C19,0.0017240265,0.0014932912,0.018350678,0.057956733,0.0023441305,0.0021725611,0.12756068,0.06042317,0.0012170488,0.0016540742,0.03378662,0.0118476795,0.1647144,0.0048912796,0.0014803942,0.002621459,0.23395596,0.0017339734,0.0019168388,0.02000541,0.22952418,0.016893534,0.0017318563
selective serotonin reuptake inhibitor paroxetine effective treatment diabetic neuropathy symptoms effect selective serotonin reuptake inhibitor paroxetine diabetic neuropathy symptoms examined comparison imipramine placebo randomised double blind cross study paroxetine given fixed dose mg day dose imipramine adjusted yield optimal plasma levels imipramine plus desipramine nm paroxetine significantly reduced symptoms neuropathy measured observer self rating somewhat less effective imipramine however patients showing weaker response paroxetine imipramine lower plasma concentrations paroxetine patients similar response drugs imipramine patients dropped intolerable side effects patients completing study reported withdrawal symptoms discontinuing imipramine paroxetine patients dropped due side effects withdrawal symptoms reported self rating showed depressive symptoms baseline changes study neither paroxetine imipramine caused changes objective measures peripheral nerve function conclusion mg paroxetine day significantly reduced symptoms peripheral diabetic neuropathy suggested dose adjustment basis drug level monitoring paroxetine may become effective imipramine paroxetine devoid often disturbing autonomic side effects limiting use imipramine several patients,C19,0.0016309774,0.001445997,0.0030416332,0.0009160204,0.0022698892,0.0021037536,0.35603422,0.0015329837,0.0011785036,0.0016131508,0.015494486,0.0033712757,0.19662042,0.0037481473,0.0014334857,0.026206838,0.06799531,0.0016787524,0.017635345,0.022166384,0.26962304,0.0005787961,0.0016806192
hyperinsulinemia increases amount glut mrna white adipose tissue decreases muscles clue increased fat depot insulin resistance mimick state hyperinsulinemia normal rats infused insulin days via minipumps compared saline infused rats end experimental period abundance mrna increased white adipose tissue wat decreased muscles insulinized rats compared controls findings accompanied tissues considered except diaphragm parallel changes amount glucose transporter protein parallel changes vivo glucose utilization index hyperinsulinemia thus driving force stimulating adipose tissue metabolic activity bringing incipient muscle insulin resistance,C19,0.0028017552,0.0024852967,0.005229589,0.001574192,0.0039013554,0.030741699,0.110972404,0.0026348045,0.16474783,0.0027528892,0.026297092,0.0063946033,0.10107622,0.006609128,0.002463793,0.082316644,0.038935322,0.046356045,0.0031902106,0.027478281,0.3271637,0.0009948015,0.0028823426
metabolic effects kcal diet obese pregnant women gestational diabetes calorie restriction widely used primary therapy obese pregnant women gestational diabetes better understand metabolic consequences marked calorie restriction performed randomized prospective trial metabolic ward conditions obese gestationally diabetic women randomized control n calorie restricted n groups patients consumed approximately kcal day diet st wk study end st wk metabolic features two groups statistically indistinguishable nd wk control group continued consume approximately kcal day whereas calorie restricted group consumed approximately kcal day twenty four hour mean glucose levels remained unchanged control group mm wk vs mm wk although dropped dramatically calorie restricted group mm wk vs mm wk p less fasting plasma insulin also declined calorie restricted group pm wk vs pm wk resulting significant change groups p less surprisingly fasting plasma glucose glucose tolerance measured h oral glucose tolerance test change within groups fasting levels beta hydroxybutyrate rose calorie restricted group microm wk vs microm wk control group p less finally urine ketones increased significantly p less calorie restricted group whereas remained absent control group,C19,0.0017112173,0.0015179351,0.0693825,0.0009614632,0.0023828158,0.010478371,0.10954666,0.0016092495,0.0012371339,0.0016813715,0.028016029,0.1677139,0.11269275,0.003938616,0.0015048013,0.07720266,0.050843675,0.0017622701,0.011358424,0.026095271,0.3054733,0.00060759106,0.012282019
training obstetrics gynecology residents manage breast disease incorporation breast care clinic american board obstetricians gynecologists recently issued directive education breast disease incorporated residency training programs university michigan medical center comprehensive breast care center bcc provides vehicle education training residents area breast disease department obstetrics gynecology fully integrated participates actively care patients bcc,C19,0.0036406405,0.0032294297,0.0067930575,0.0020455273,0.0050694766,0.0046984362,0.1348622,0.0034237024,0.002632021,0.0035771432,0.0167429,0.0074881017,0.022536233,0.008370956,0.0032014872,0.0056692343,0.2593208,0.003749256,0.053342555,0.3678911,0.07667771,0.0012926592,0.0037453566
increased transcapillary escape rate albumin nondiabetic men response hyperinsulinemia diabetic patients manifest increased vascular permeability determine whether insulin per se might increase vascular permeability five nondiabetic men studied hyperinsulinemic euglycemic clamp technique subject received nmol kg body wt v insulin bolus followed pmol kg min insulin infusion h euglycemia maintained biostator glucose controller h study microci v labeled albumin injected bolus dose frequent blood samples drawn next min determination transcapillary escape rate ter albumin subjects returned wk later control study saline infused rate identical dextrose insulin infusion rates hyperinsulinemic clamp mean se serum insulin levels hyperinsulinemic clamp saline infusion pm respectively whereas serum glucose two sessions similar vs mm ns identical fluid volumes infused two sessions ml h urine outputs differ significantly vs ml h ter albumin greater five men hyperinsulinemia saline infusion vs h p,C19,0.0018997922,0.0016852105,0.0035448151,0.0010674158,0.0026454006,0.20339018,0.04827031,0.0017865876,0.0013734652,0.0018666574,0.047054134,0.034720324,0.24216618,0.014020043,0.020042932,0.092193715,0.044411875,0.001956471,0.002163193,0.058288682,0.17282367,0.00067454716,0.001954436
review iodine toxicity reports article summarizes case reports population studies experimental studies literature concerning adverse effects exposure iodine mid exposure excessive iodine foods dietary supplements topical medications iodinated contrast media resulted thyroiditis goiter hypothyroidism hyperthyroidism sensitivity reactions acute responses individuals reports maternal iodine exposure pregnancy lactation affecting newborn nursing infants cited susceptibility excess iodine discussed well relationship dose response concluded individuals tolerate high levels iodine apparent side effects iodine intakes less equal mg day probably safe majority population may cause adverse effects individuals determination maximum tolerable levels iodine intake require human experimental studies levels mg day normal subjects subjects autonomous thyroid tissue iodine sensitive subjects,C19,0.0018653739,0.0016546798,0.021240816,0.0010480775,0.002597474,0.0024073622,0.21357381,0.0017542202,0.0013485823,0.0018328395,0.035224885,0.012848533,0.058074046,0.00474915,0.0016403628,0.0029095542,0.020146126,0.0019216579,0.0021240027,0.39485347,0.21359292,0.0006623265,0.0019297245
thyroid hormones influences sex steroid binding protein levels infancy study congenital hypothyroidism order test hypothesis role thyroid hormones circulating levels sex steroid binding protein shbg children shbg levels determined infants congenital hypothyroidism diagnosis first months therapy separate group children congenital hypothyroidism yr mean sd treated month age adequate l therapy weeks withdrawing therapy shbg levels significantly lower hypothyroid infants controls vs nmol l p less significantly lower infants athyreosis compared ectopic eutopic glands p less patients low values diagnosis shbg increased rapidly remained normal lt therapy months treatment positive correlation p less found shbg ft ft levels older hypothyroid children weeks withdrawal therapy significant p less decrease shbg concentrations observed analysis results well previous reports adults indicates thyroid hormones influence shbg concentrations infants children study also indicates thyroid hormones may play role physiological postnatal increase shbg,C19,0.001725277,0.0015304069,0.003219188,0.0009693628,0.027449364,0.010568756,0.16165668,0.009962775,0.0012472986,0.035104964,0.03817223,0.05420477,0.097642675,0.0040305783,0.0015171651,0.002686615,0.056910392,0.035368547,0.0019644818,0.13362993,0.31804752,0.0006125832,0.0017784548
systemic amiloride inhibits experimentally induced neovascularization amiloride inhibitor urokinase type plasminogen activator might therefore inhibitory effect neovascularization neovascularization induced rabbit corneas via local implantation prostaglandin e pellets prepared slow release polymer animals received daily intraperitoneal injections mg amiloride equivalent volume saline solution days well tolerated without severe untoward effect neovascular response documented corneal photographs evaluated days injections area induced corneal neovascularization decreased animals receiving amiloride compared controls thus amiloride similar compounds may prove useful study management neovascularization,C22,0.10882169,0.0024527502,0.0051593236,0.0015537014,0.0038502647,0.004120158,0.15346277,0.0026003001,0.0019990185,0.0027168384,0.03173744,0.2148294,0.052526597,0.02099354,0.002431528,0.017681647,0.04110594,0.0028475581,0.016458279,0.018165132,0.29065976,0.000981774,0.0028445965
comparison phenytoin noncompetitive n methyl aspartate antagonists model focal brain ischemia rat recent vitro vivo experiments suggested excitatory amino acid antagonists particularly active n methyl aspartate receptor subtype effective ameliorating ischemic injury due antiexcitotoxic activity however drugs also potent effective vivo anticonvulsants present experiments compared noncompetitive n methyl aspartate antagonists phencyclidine mk anticonvulsant phenytoin model focal brain ischemia fisher f rats subjected tandem occlusion middle cerebral ipsilateral common carotid arteries halothane anesthesia compounds administered intravenously minutes hours arterial occlusion infarct size assessed hours occlusion phencyclidine effect infarct volume mg kg significantly reduced infarct volume mg kg produced nonsignificant decrease mg kg potent selective noncompetitive antagonist mk reduced infarct volume significantly mg kg produced nonsignificant decrease mg kg effect mg kg phenytoin glutamate antagonist reduced infarct volume mg kg single dose phenytoin mg kg administered minutes occlusion neuroprotective delaying drug administration hours ineffective data suggest blockade n methyl aspartate receptor effective reducing infarct size focal cerebral ischemia neuroprotective activity phenytoin suggests may related common anticonvulsant action,C22,0.2431881,0.001403799,0.01055471,0.00088916917,0.002203648,0.0020423606,0.15534952,0.0014882473,0.0011441117,0.0015549463,0.016677769,0.026078807,0.093630195,0.004655056,0.0013916527,0.010115683,0.022308731,0.04179195,0.0018019637,0.14944458,0.21009246,0.00056190527,0.0016306422
effects micron laser human atherosclerotic xenografts vivo thulium holmium chromium yttrium aluminum garnet thc yag laser tissue effect similar co laser advantage transmissibility flexible fibers authors used human rabbit xenograft model evaluate thrombotic healing responses atherosclerotic vessels subjected laser energy occluded atherosclerotic human coronary artery segments recanalized vitro use thc yag laser destruction plaque laser achieved minimal collateral thermal damage vascular segments transplanted rabbit abdominal aorta authors observed luminal surface lased vessels thrombogenic nonlased control vessels however occlusion lased vessels occur repair laser treated tissue progressed mature nonthrombogenic fibrin platelet aggregate adherent luminal wall overall lased vessels behaved fashion similar nonlased control vessels basis results authors believe thc yag laser may use human angioplasty,C22,0.012607779,0.0019160578,0.0040317937,0.0012136349,0.0030077791,0.0027876361,0.07128229,0.0020554576,0.0015616083,0.00212236,0.025718601,0.06726657,0.028538318,0.036003858,0.012347607,0.0033646557,0.39779007,0.002228922,0.0024595163,0.013935834,0.30474406,0.0007669495,0.002248643
isolation tete serogroup bunyaviruses ceratopogonidae collected colorado two viruses isolated ceratopogonid midges collected northern colorado electron microscopy indicated isolates bunyavirus like indirect fluorescent antibody serum dilution plaque reduction neutralization tests showed isolates members tete serogroup closely related antigenically tete batama viruses distinguishable suggest name weldona virus isolates antibody waterfowl passerine birds northern colorado indicates enzootic presence viruses northern colorado raises unanswered questions introduction establishment tete serogroup viruses americas,C22,0.003706544,0.0032878895,0.024834497,0.0020825558,0.005161245,0.004783488,0.35133055,0.003491044,0.0026796663,0.003641897,0.07136046,0.0076236525,0.023083346,0.061489858,0.0032594411,0.0057718595,0.05722227,0.021715038,0.093890905,0.024507377,0.11229197,0.001316059,0.11146837
increased activity calcium leak channels myotubes duchenne human mdx mouse origin elevated free ca concentrations found adult dystrophic muscle fibers result enhanced protein degradation since difference concentrations may reflect differences entry ca leak channels cultures normal duchenne human myotubes normal mdx murine myotubes identified characterized open probability leak channels markedly increased dystrophic myotubes channel properties mean open times single channel conductance ion selectivity behavior presence pharmacological agents similar among myotube types compared ca concentrations normal human normal mouse myotubes intracellular resting free ca concentrations ca myotubes duchenne mdx origin significantly higher time dystrophin first expressed normal tissue taken together findings suggest increased open probability ca leak channels contributes elevated free intracellular ca concentration duchenne human mdx mouse myotubes,C22,0.0018653888,0.0016546929,0.0035692654,0.0010481231,0.0025974947,0.011395593,0.104740135,0.0017542342,0.010378422,0.001832854,0.03567405,0.0038894156,0.09803122,0.42427558,0.0016403758,0.0029047984,0.018864326,0.011090464,0.0021240197,0.016855542,0.24122119,0.00066233176,0.0019305036
rat femoral artery model vasospasm new animal model vasospasm using rat femoral artery developed whole blood washed erythrocytes leukocytes platelet rich plasma selectively applied adventitial surface femoral artery days rats vessels perfusion fixed examined light transmission electron microscopy immunohistochemistry compared matched control arteries prominent reduction luminal cross sectional area days vessels exposed whole blood washed erythrocytes exposed leukocytes platelet rich plasma arteries luminal narrowing light transmission electron microscopy demonstrated marked morphological changes throughout vessel wall similar seen cerebral vasospasm subarachnoid hemorrhage immunohistochemistry disclosed prominent loss immunoreactive actin smooth muscle cells arteries exposed whole blood erythrocytes assess time course arterial narrowing model whole blood selectively applied adventitial surface femoral arteries rats periods days compared control arteries arterial narrowing variably present days progressively increased days maximal days returned near control levels days presence severity ultrastructural changes vessel wall corresponded degree arterial narrowing time results suggest chronic narrowing rat femoral artery exposed periadventitial blood analogous observed cerebral arterial vasospasm subarachnoid hemorrhage new model represents simple reliable means investigate pathogenic mechanisms potential therapies vasospasm,C22,0.085527346,0.0010797759,0.002946956,0.0065478105,0.0016950497,0.0015709454,0.09055744,0.0011491459,0.15403028,0.0011960355,0.012690284,0.002545952,0.062089495,0.022183044,0.007186181,0.0018955366,0.012901436,0.0012535823,0.0013860365,0.015119427,0.5127638,0.000432207,0.0012522786
evidence requisite role defective virus establishment persistent hepadnavirus infections factors involved establishment persistent hepadnavirus infection poorly understood recent findings demonstrate sequence genome hepatitis b virus hbv variable infected individuals cases virus mutants predominate objectives present study analyze variability woodchuck hepatitis virus whv genomes infected animal determine whether sequence heterogeneity played critical role ability whv induce chronic infection cloned determined complete nucleotide sequence three supercoiled genomes animal became infected inoculation standardized whv serum pool e whv virus pool found four nucleotide substitutions among three genome sequences well nucleotide deletion one recombinants dna transfection experiments revealed one three recombinants capable independent replication data suggest significant proportion replicative templates woodchucks infected whv defective virus genomes next compared outcome acute infection inoculation serum pool containing uniform population replication competent virus e whv r pool serum pool composed whv genomes variable sequence whv r serum pool originated woodchuck became chronic carrier vivo transfection liver infectious whv recombinant neonatal woodchucks inoculated x whv genome equivalents either whv pool whv r pool animals study became acutely infected whv animals infected whv serum pool became chronic carriers animals infected whv r serum pool developed chronic infection thus infection woodchucks serum pool containing defective virus resulted rate chronic whv infection similar even lower rate pool containing wild type virus suggests presence defective virus inoculum prerequisite establishment persistent hepadnavirus infections,C22,0.0011251891,0.0009980989,0.0072873356,0.0006321979,0.062358234,0.0014521152,0.23868626,0.0010594593,0.00081346167,0.0011055644,0.010252566,0.0039655785,0.008898129,0.007590618,0.000989463,0.0059339684,0.021499977,0.02959637,0.0012811933,0.14027818,0.24381064,0.0058356123,0.2045498
borna virus cdna encoding protein recognized antibodies humans behavioral diseases borna disease virus bdv causes rare neurological disease horses sheep virus classified neither infectious particle specific nucleic acid identified identify genome bdv subtractive complementary dna expression library constructed polyadenylate selected rna bdv infected mdck cell line clone b isolated specifically hybridized rna isolated bdv infected brain tissue bdv infected cell lines clone hybridized four bdv specific positive strand rnas kilobases one negative strand rna kilobases bdv infected rat brain nucleotide sequence analysis clone suggested represented full length messenger rna contained several open reading frames vitro transcription translation clone resulted synthesis kilodalton bdv specific proteins kilodalton protein translated vitro clone recognized antibodies sera patients three seven behavioral disorders bdv specific clone provide means isolate bdv specific nucleic acids identify virus responsible borna disease addition significance bdv bdv related virus human pathogen directly examined,C22,0.018283907,0.0015183887,0.0031939081,0.017526267,0.010664205,0.002209075,0.41276523,0.009891878,0.0012375036,0.0016818739,0.03302624,0.0035206988,0.015167285,0.043008223,0.001505251,0.0026655176,0.025422346,0.055957813,0.0019490549,0.020306421,0.12232393,0.0006077727,0.1955672
synergism hepatic injuries nonhepatotropic reovirus mice enhanced hepatic infection death reovirus type intravenous inoculation adult mouse secreted via bile intestine infectious form although reovirus type rapidly removed systemic circulation liver lung hepatocytes express reovirus antigen infection intestinal cells reovirus replicates selectively crypts site preference may due active cell proliferation crypts hypothesized state cell may affect virus replication tested hypothesis using chemical surgical means increase hepatic mitotic activity adult mice treated carbon tetrachloride surgical trauma inoculated reovirus type intravenously subsequently killed virus antigen identified using highly specific immunohistochemical technique liver sections stained using immunoperoxidase specific rabbit antireovirus antibody hepatotoxin surgical trauma increase reovirus antigen detection kupffer cells hepatocytes sequential administration ccl virus caused mortality doses sublethal alone data demonstrate synergism hepatic injury reovirus results significant increase magnitude viral infection contributes mortality synergism may important idiopathic liver disease,C22,0.017706584,0.0014465554,0.0030428078,0.00091629656,0.010157218,0.00999756,0.37315857,0.009422345,0.0011789587,0.0016023063,0.024494812,0.012047688,0.05194397,0.21049958,0.0014340392,0.057069167,0.050085068,0.0016809885,0.0018568472,0.049985744,0.0836873,0.0005790196,0.026006578
aortic atresia survival adulthood without surgery aortic atresia rare congenital cardiac defect usually leads death neonatal period patient aortic atresia survived age years without surgical procedure view uncertain results reconstructive surgery case may therapeutic implications,C16,0.0044192364,0.003920083,0.008245836,0.0024829886,0.04887463,0.0057032546,0.17953688,0.21790315,0.0031949112,0.0043421593,0.04143549,0.009089524,0.02768559,0.010349037,0.0038861649,0.0068816696,0.28342932,0.0045510805,0.0050319503,0.06795316,0.05496844,0.0015691102,0.004546347
persistent right umbilical vein ominous prenatal finding persistence right umbilical vein uncommon finding dozen cases reported since persistent right umbilical vein may replace normal left umbilical vein supernumerary anomaly associated numerous occasionally lethal malformations series three six fetuses another two literature associated anomalies others variety associated lesions ranging minor lethal appearance ultrasound easy recognize intrahepatic portion umbilical vein lateral gallbladder portal vein curves toward stomach instead parallel since recognition persistent right umbilical vein simple require additional scanning visible section used measure abdominal perimeter author suggests using indicator depth scanning,C16,0.0024102821,0.0021380405,0.0044973367,0.059686515,0.015318584,0.01475254,0.18028107,0.3261536,0.0133277895,0.0023682439,0.07293063,0.0049574897,0.04680997,0.0056734676,0.0021195414,0.0037533105,0.031125706,0.016209746,0.0027444607,0.11105825,0.07834803,0.0008558036,0.0024796093
placental histology fetuses weeks gestation abnormal karyotype placentas karyotypically abnormal fetuses weeks gestation analyzed prospectively light microscopic level group consisted control placentas group ii consisted placentas fetuses abnormal karyotype secondary tertiary stem villi counts small muscular artery counts total vessel counts determined per x field differences secondary tertiary stem villi counts groups significant decrease small muscular artery counts p less total vessel counts p less noted group ii placental fetal weights comparable groups undervascularization may represent placental immaturity result arrested delayed angiopoiesis appears abnormality established third trimester may enhanced late vascular obliteration reported others data substantiate concept structure function placenta determined great degree fetal karyotype may help explain morbidity mortality seen fetuses,C16,0.021271216,0.0017664892,0.003718484,0.0107508525,0.0027729897,0.0306876,0.16338424,0.0018936634,0.18450949,0.012300384,0.032394934,0.054316264,0.08178794,0.0046229623,0.0017512966,0.0031010555,0.042419765,0.0020508328,0.0023232785,0.035914436,0.292494,0.000707081,0.0130607765
association intrapartum asphyxia mature fetus newborn behavior matched cohort study mature newborns biochemically determined intrapartum fetal asphyxia mature newborns normal blood gas acid base assessments delivery studied demonstrate effect fetal asphyxia newborn behavior expressed brazelton newborn behavioral assessment scale newborn behavioral assessment scale administered days delivery weeks delivery lester newborn behavioral assessment scale summary scores group asphyxia order control group also true group newborns asphyxia severe metabolic acidosis low apgar scores findings support contention many newborns undergone intrapartum asphyxial insult evidence central nervous system injury threshold central nervous system injury severe end spectrum asphyxia expressed metabolic acidosis,C16,0.02556308,0.0019146054,0.004027344,0.0012127149,0.0030084297,0.021175634,0.22623648,0.0020297822,0.12692408,0.0021207512,0.010462585,0.13752638,0.050998513,0.070519455,0.0019004801,0.0033610722,0.035259306,0.002223871,0.0024576518,0.15190406,0.106122866,0.010820545,0.002230279
value transesophageal echocardiography repair congenital heart defects two dimensional transesophageal color doppler echocardiography employed intraoperatively children undergoing repair variety simple complex cardiac malformations female male patients mean age years range years mean weight kg range kg children weighing less kg standard commercially available transesophageal echocardiography probe mhz elements used patients without complications transesophageal echocardiography proved helpful selecting surgical approach assessing adequacy surgical repair detecting residual intracardiac shunts allowing uninterrupted monitoring ventricular performance throughout procedure initial experience suggests transesophageal echocardiography valuable tool used children congenital cardiac malformations particularly requiring complex intracardiac procedures amount information obtained surgeon favor routine use transesophageal echocardiography open heart procedures stimulate development probes safely used even infants newborns,C16,0.0109688705,0.0016705376,0.0036298535,0.055738807,0.0390656,0.0024304336,0.16360535,0.0017710321,0.010456254,0.029201997,0.045370057,0.003980602,0.038479842,0.0046414095,0.0016560835,0.0029326135,0.30226335,0.0019394363,0.0021443584,0.20025952,0.07518475,0.000668674,0.0019405887
norwood operation univentricular heart subaortic stenosis neonate setting single ventricle subaortic stenosis may enhanced pulmonary artery banding may later contraindicate fontan operation norwood operation may prove preferable alternative infants preparatory procedure successfully used procedure initial operation palliate newborn tricuspid atresia transposition great arteries coarctation severe arch hypoplasia secondary restrictive bulboventricular foramen,C16,0.03377668,0.0034127946,0.007178763,0.0021616712,0.005357318,0.19840083,0.13437113,0.021432105,0.0027814654,0.003780251,0.057566803,0.007913271,0.027227273,0.008846254,0.0033832656,0.0059911297,0.32838038,0.0039621363,0.0043901494,0.08156664,0.052780513,0.0013660555,0.0039731334
prenatal screening report discusses role prenatal screening preventing congenital abnormalities prevention possible avoiding conception birth would untreatable abnormalities women found screening immune rubella safely vaccinated prior pregnancy found risk children genetic disorders tay sachs disease thalassemia option avoiding conception affected offspring screening pregnancy permits primary prevention rh disease sequelae results prophylactic administration rh immune globulin unsensitized rh negative women maternal serum alpha fetoprotein screening identifies pregnant women increased risk carrying fetuses neural tube defects syndrome giving option avoiding birth affected fetuses abortion recombinant dna technology permit screening many genetic disorders disease related genes mutations identified many disorders ability predict risk disease antedate preventive therapeutic interventions many years lag phase issues concerning validity tests severity conditions screening offered safety interventions autonomy pregnant women deciding screened important,C16,0.0017258497,0.06836537,0.0032202564,0.0009696845,0.019082058,0.002227299,0.2630243,0.0016230099,0.017888341,0.018397475,0.15583958,0.012164274,0.011191381,0.00404314,0.009841425,0.0110390745,0.015518127,0.001777339,0.0103108045,0.27869225,0.052195366,0.0006127865,0.04025079
effect maternal smoking age congenital anomalies incidence congenital anomalies examined level maternal paternal smoking pregnancy infants multiple regression analysis used control possible confounding effects maternal age formal education ethnic origin religion marital status parity social class work outside home neither maternal paternal smoking habits significantly associated occurrence congenital malformations maternal age significantly p less related incidence major anomalies mothers aged years older smoked found significantly p less higher risk minor malformations nonsignificantly increased rate major malformations maternal cigarette smoking may important preventable risk factor congenital anomalies among mothers aged years older,C16,0.0023284885,0.0020654856,0.004344718,0.0013082827,0.014503215,0.014257246,0.096997395,0.013396765,0.0016833936,0.0022912098,0.028028069,0.004819116,0.074916765,0.0054479544,0.01331463,0.003625941,0.020375803,0.0023979573,0.0026513268,0.61246186,0.07556219,0.0008267617,0.0023954632
recombinant human dnase reduces viscosity cystic fibrosis sputum respiratory distress progressive lung destruction cystic fibrosis attributed bacterial persistence accumulation viscous purulent secretions airways yr ago suggested large amounts dna purulent secretions contribute viscosity bovine pancreatic dnase could reduce viscosity evaluate potential clinical utility recombinant human dnase rhdnase treatment cystic fibrosis cloned sequenced expressed rhdnase catalytic amounts rhdnase greatly reduce viscosity purulent cystic fibrosis sputum transforming within minutes nonflowing viscous gel flowing liquid reduction viscosity associated decrease size dna sputum inhalation rhdnase aerosol may simple direct approach help individuals cystic fibrosis patients pneumonia bronchitis clear airways purulent secretions,C16,0.0024983813,0.002214662,0.0046585086,0.0014027714,0.0035451434,0.2553777,0.19123165,0.0023478894,0.001804974,0.002459662,0.012631587,0.0051351525,0.045954723,0.007962118,0.0021954998,0.052220624,0.053919327,0.0025711458,0.052766386,0.031187102,0.1620673,0.0008864733,0.10296121
respiratory muscle function cystic fibrosis maximal static expiratory inspiratory mouth pressures pemax pimax quadriceps femoris muscle strength measured patients aged years cystic fibrosis mean fev predicted mean sd pemax predicted predicted patients pimax predicted predicted patients quadriceps muscle strength predicted predicted patients relatively small reduction respiratory muscle strength patients unlikely contributed appreciably respiratory problems,C16,0.0038430493,0.0034089766,0.0071707317,0.0021592528,0.0053513246,0.0049596555,0.10521773,0.00361405,0.03998662,0.3006712,0.1442431,0.007904418,0.08890865,0.0095350025,0.0033794807,0.005984427,0.14722769,0.0039577037,0.004375877,0.026515853,0.07626713,0.0013645272,0.0039535873
characteristics cholinergic neuroeffector transmission ganglionic aganglionic colon hirschsprung disease differences release content acetylcholine alpha adrenoceptor mediated interaction noradrenergic cholinergic neurons investigated neurochemical pharmacological methods aganglionic ganglionic segments isolated human colon taken children suffering hirschsprung disease rest transmural stimulation release acetylcholine significantly higher spastic aganglionic segment proximal dilated bowel significant differences found tissue concentration acetylcholine ganglionic aganglionic specimens pattern response transmural stimulation also different spastic dilated bowel transmural stimulation induced relaxation contraction ganglionic specimens contractions aganglionic specimens sensitivity smooth muscle aganglionic portion exogenous acetylcholine field stimulation found higher ganglionic portion noradrenaline added organ bath reduced stimulation evoked release acetylcholine spastic segments via alpha adrenoceptor mediated process yohimbine enhance release suggested hirschsprung disease increased acetylcholine release enhanced sensitivity smooth muscle cells acetylcholine lack alpha adrenoceptor mediated noradrenergic modulation acetylcholine release cholinergic interneurons might responsible spasm aganglionic segments,C16,0.0016973529,0.0015055764,0.02781111,0.00095363514,0.0023634157,0.0021904346,0.10630619,0.0015961472,0.0012270614,0.009884133,0.043100704,0.0035406796,0.021025324,0.053941317,0.0014925494,0.0026430255,0.014608617,0.0017725952,0.028000135,0.022837315,0.6491519,0.00060264417,0.0017480984
localization microsatellite probe dxs dxs dxs xp linkage x linked retinitis pigmentosa microsatellite marker dxs maps interval xp xp chromosomal region contains two loci x linked retinitis pigmentosa xlrp rp rp refined localization dxs physically mapping deletion spans interval xp xp genetically studying multiply informative crossovers indicate dxs lies dxs dxs e xp xp region contains rp gene rp families could identified basis linkage xlrp dxs multiply informative crossovers two rp families indicate likely location rp gene dxs dxs dxs therefore important highly informative marker purposes carrier detection early diagnosis rp localization disease gene,C16,0.0031422665,0.048407476,0.0058631436,0.0017655113,0.0043755067,0.004055259,0.5205086,0.0029550255,0.0022717188,0.0030874615,0.053233527,0.006463042,0.01957324,0.046266764,0.00276323,0.0048931623,0.027065735,0.0032393162,0.0035779327,0.038892984,0.07528685,0.0011157047,0.12119661
parenchymal vascular magnetic resonance imaging brain extracorporeal membrane oxygenation three dimensional volume magnetic resonance angiography new noninvasive method imaging intracranial vasculature combination magnetic resonance angiography conventional magnetic resonance imaging used evaluate brain parenchyma vessels survivors extracorporeal membrane oxygenation magnetic resonance imaging findings abnormal patients increased frequency right hemispheric lesions magnetic resonance angiography demonstrated good intracranial flow infants demonstrable right internal carotid arterial flow patients permanent carotid ligation abnormal magnetic resonance imaging study found often infants abnormal predischarge neurologic examination results techniques several advantages neuroimaging modalities including better definition deep structures myelin formation intracranial vasculature absence bone artifact elimination catheter contrast use,C16,0.031045858,0.0018019178,0.0037903073,0.0011413384,0.20565929,0.0026215762,0.15099204,0.040088635,0.021088349,0.0019959307,0.3015501,0.00417812,0.05131627,0.004687183,0.0017863269,0.0031632502,0.06646384,0.0020919642,0.0023130022,0.034770165,0.044994656,0.010543651,0.0119162835
longitudinal results first stage palliation hypoplastic left heart syndrome evaluate results palliative surgery hypoplastic left heart syndrome reviewed records infants underwent first stage reconstruction institution july april infants long term survivors died thirty one infants died within first days surgery twenty six early deaths occurred within first hours surgery causes early mortality low cardiac output sepsis two sudden death two pulmonary vein atresia three cardiac transplant one late death occurred infants due sepsis three sudden death four death reoperation seven three fontan procedure three shunt replacement one transplant patients survived hours complications noted echocardiography confirmed catheterization reoperation indicated significant arch obstruction branch pulmonary artery stenosis small atrial septal defect inadequate shunt neoaortic regurgitation tricuspid regurgitation ventricular dysfunction thrombus superior vena cava obstruction patients survived hours additional palliative surgical procedures performed eight patients procedures included arch reconstruction four additional shunt four glenn shunt three atrial septectomy two coarctation balloon angioplasty two pulmonary artery reconstruction reshunting one long term survivors four successful fontan procedure one transplant seven awaiting second stage procedure thus deaths occurred within first days surgery deaths occurred within first hours due cardiovascular collapse,C16,0.08965632,0.0012245971,0.0025759218,0.0007756623,0.008559097,0.008358118,0.05105864,0.01432039,0.0009980602,0.0013564498,0.006442498,0.0028394822,0.013452668,0.0032303147,0.0012140014,0.002149769,0.6619527,0.0014221944,0.0015719341,0.09576001,0.02917079,0.0004901753,0.0014202362
effects newborn screening cystic fibrosis reported maternal behaviour screening cystic fibrosis highly controversial concerns expressed newborn screening may cause mothers considered child healthy diagnosis overprotect child critics screening also suggest period delay onset symptoms diagnosis may help mother adjust reality child lethal condition study compared strength overprotective child rearing attitudes mothers whose children screened symptomatic children asymptomatic children attitudes mothers whose children diagnosed onset symptoms results indicate newborn screening increased mother tendency overprotect child cystic fibrosis cases tendency decreased delay diagnosis screening conducted usually caused mothers considerable personal distress,C16,0.0022515308,0.00199722,0.0042011226,0.012157382,0.0031351852,0.0029366873,0.15619083,0.0021173668,0.0016277565,0.29157984,0.15153658,0.0046309684,0.032039125,0.016307795,0.0019799394,0.0035061017,0.03419596,0.0023187033,0.002578058,0.17959246,0.089971125,0.00079943676,0.0023488367
relation genotype phenotype cystic fibrosis analysis common mutation delta f background methods clinical manifestations cystic fibrosis genotypes patients heterogeneous associations two known therefore studied blood samples patients cystic fibrosis presence common disease causing mutation delta f chromosome compared results clinical manifestations disease results prevalence delta f allele cohort percent percent patients homozygous mutation percent heterozygous percent undefined mutations patients homozygous mutation received diagnosis cystic fibrosis earlier age greater frequency pancreatic insufficiency pancreatic insufficiency present percent homozygous patients percent heterozygous patients percent patients genotypes patients pancreatic insufficiency three genotype groups similar clinical characteristics reflected early age diagnosis similar sweat chloride values diagnosis similar severity pulmonary disease similar percentiles weight contrast patients heterozygous genotype genotype groups pancreatic insufficiency older milder disease lower sweat chloride values diagnosis normal nutritional status better pulmonary function adjustment age conclusions variable clinical course patients cystic fibrosis attributed least part specific genotypes locus cystic fibrosis gene,C16,0.01660955,0.0013807155,0.0029043145,0.000874548,0.0021674118,0.0020243914,0.3400116,0.001463775,0.0011252984,0.0015293774,0.05504182,0.021638788,0.06391414,0.0037332124,0.001368769,0.0024238334,0.15870886,0.0016039643,0.0091530755,0.08672695,0.028282844,0.0005526655,0.19676007
elevated maternal serum alpha fetoprotein amniotic fluid alpha fetoprotein multifetal pregnancy reduction forty patients underwent fetal reduction approximately weeks gestation multiple pregnancy twenty two maternal serum alpha fetoprotein msafp determinations one elevated mean value multiples median mom total amniotic fluid specimens evaluated afp elevated mom one sample positive acetylcholinesterase none elevations associated neural tube defect although two neural tube defects detected means routine msafp recommended patients multifetal pregnancy reduction,C16,0.0032407828,0.002874736,0.0060469643,0.0018208637,0.035796702,0.004182399,0.06750248,0.0030476714,0.03365795,0.0031842594,0.37821224,0.006665671,0.06746578,0.007625085,0.002850006,0.0050465725,0.107209645,0.003337469,0.003690108,0.06584756,0.18620838,0.0011506842,0.0033359737
functional residual capacity anesthetized children normal values values children cardiac anomalies assess increase functional residual capacity frc growth frc measured induction anesthesia two groups children one group consisted children yr age without signs cardiorespiratory disease referred normal children children yr age cardiac malformations anesthesia maintained halothane normal children fentanyl droperidol nitrous oxide children cardiac anomalies patients paralyzed tracheas intubated lungs mechanically ventilated frc measured automated tracer gas washout technique patients measurements performed duplicate mean coefficient variation frc correlated significantly height weight age groups multiple regression analysis groups considered together indicated significant improvement factors sex child presence cardiac anomalies incorporated model normal children simple linear nonlinear regression equations frc milliliters versus height centimeters frc x height r frc x height r respectively corresponding equations frc milliliters versus weight kilograms frc x weight r frc x weight r,C16,0.009392306,0.0014583312,0.011002436,0.00092371,0.018023089,0.018034087,0.05820042,0.025369406,0.009127823,0.21463688,0.026914246,0.04361446,0.13355893,0.017538184,0.0014457131,0.11573222,0.09362945,0.0016950655,0.001871963,0.121349104,0.07420712,0.00058373314,0.0016913112
intraoperative echocardiography infants children congenital cardiac shunt lesions transesophageal versus epicardial echocardiography determine utility limitations intraoperative transesophageal echocardiography infants children congenital intracardiac shunts intraoperative transesophageal n epicardial n echocardiograms performed cardiopulmonary bypass children days years old kg body weight miniaturized transesophageal probe mm maximal diameter used patients weighting less equal kg epicardial imaging performed mhz precordial probe intraoperative transesophageal echocardiographic findings cardiopulmonary bypass correct complete patients transesophageal echocardiography correctly identified atrial septal defects types ventricular septal defects anomalous pulmonary veins atrioventricular septal defects tetralogy fallot truncus arteriosus double inlet ventricles failed provide correct diagnosis three patients doubly committed subarterial ventricular septal defects epicardial echocardiography identified cases doubly committed subarterial ventricular septal defect correct complete intraoperative diagnosis obtained use epicardial imaging cardiopulmonary bypass technique required interruption surgery could completed three patients induced arrhythmias hypotension results demonstrated intraoperative transesophageal echocardiography consistently defined important morphologic color pulsed doppler ultrasound features congenital shunt lesions lesions involved right ventricular outflow tract sometimes difficult image uniplane transesophageal echocardiography complications subjects,C16,0.03952923,0.0013919106,0.0029278633,0.040262796,0.07823651,0.0020278785,0.14143199,0.009064695,0.008726512,0.02433135,0.0704063,0.003333377,0.029143186,0.003656532,0.0013798672,0.0024434864,0.4341227,0.00161596,0.00937016,0.04046078,0.05396554,0.0005571467,0.0016142793
cardiac transplantation hypoplastic left heart syndrome modified technique see comment modified technique infant orthotopic cardiac transplantation arch reconstruction using bicaval cannulation described results infants hypoplastic left heart syndrome presented technique minimizes donor myocardial ischemic time recipient circulatory arrest time,C16,0.0043277014,0.003838887,0.008075042,0.002431559,0.006026187,0.005585124,0.12222057,0.004069823,0.0031287353,0.0042522205,0.047423605,0.008901254,0.13278843,0.009950722,0.0038056714,0.0067391307,0.38913405,0.025399517,0.0049277246,0.13861506,0.062370237,0.0015366095,0.0044521797
maternal serum alpha fetoprotein screening activities state health agencies survey maternal serum alpha fetoprotein msafp screening demonstrated cost effective population basis becoming standard practice american society human genetics twice published policy statements define essential elements quality screening program present study reviewed impact policy statements state public health agencies respect regulation provision msafp screening jurisdictions exceptions states elected play major role provision regulation test need address issues funding standards data collection collaborative effort policy statements genetic services translated effective state population screening,C16,0.002558668,0.002269666,0.0047742086,0.0014376111,0.0035632467,0.003302094,0.2679077,0.0024062023,0.0018498029,0.0025140415,0.11479779,0.0052626906,0.030120473,0.010541581,0.0022500278,0.028749133,0.02342679,0.0026350035,0.26219878,0.12947641,0.08189109,0.0132880565,0.002778933
natural modified history complete atrioventricular septal defect year study reviewed cases isolated complete atrioventricular septal defect cases represented cases congenital heart disease diagnosed hospital catheterisation angiography children n syndrome banding pulmonary artery performed seven cases complete repair cases period complete correction performed mean age months surgical mortality period mean age complete correction months mortality five year actuarial survival patients survived complete correction functional classes ii new york heart association classification mean follow years eight followed treated medically survived developed pulmonary vascular obstructive disease functional classes iii iv findings stress importance early complete surgical repair,C16,0.03313604,0.00189433,0.003984695,0.02183187,0.02363788,0.0027694795,0.102221206,0.0020186089,0.0015438999,0.012436461,0.08376373,0.004392396,0.018783584,0.0049169566,0.11558033,0.0033254789,0.39806098,0.0021992514,0.0024316257,0.10873225,0.049383752,0.00075825246,0.002196964
fontan operation patients tricuspid atresia results proposed new index patient selection march patients tricuspid atresia fontan procedure performed mayo clinic age range time surgery months years patients years old older hospital mortality rates nine late cardiovascular deaths postoperative follow survivors range months years mean years revealed excellent good condition fair poor condition patients fair poor condition poor stamina fluid retention intermittent pleural effusion ascites two factors clearly influence operative late results preoperative pulmonary arteriolar resistance rpa left ventricular diastolic function preoperative catheterization index devised adding rpa left ventricular end diastolic pressure divided qpi plus qsi may helpful selecting candidates likely survive benefit fontan operation experience index less postoperative right atrial mean pressure mm hg less circumstance associated early overall survival rates,C16,0.011060012,0.0015578965,0.0032856094,0.0009867748,0.0024593687,0.011513054,0.114226714,0.017954422,0.0012697028,0.0017256355,0.00880003,0.012103044,0.08574553,0.004265289,0.0015444169,0.002734873,0.48531818,0.0018119054,0.0019997684,0.09710048,0.113104194,0.017626287,0.0018067827
use palatal stabilizing device prevention palatal grooves premature infants prospective randomized study using acrylic palatal stabilizing device psd conducted evaluate effectiveness device preventing disruptions palatal architecture total premature infants birth weights g intubated orally period varying days randomized control experimental groups neonates control group developed palatal grooving ranging mm depth whereas experimental group psd showed evidence palatal grooving conclude psd effective preventive device premature orally intubated infants,C16,0.0029616412,0.34670016,0.005526115,0.015987296,0.004123992,0.0038221523,0.11756673,0.0027851632,0.0021411348,0.0029099865,0.016998017,0.06796038,0.02920731,0.0068097278,0.002604522,0.004611891,0.04973723,0.0030499995,0.0034366054,0.11592016,0.19104138,0.0010515712,0.0030468274
tolerance dependence neonates sedated fentanyl extracorporeal membrane oxygenation undertook retrospective chart review neonates received fentanyl continuous infusion undergoing extracorporeal membrane oxygenation ecmo may october quantified doses sedatives utilized determined incidence neonatal abstinence syndrome nas identified risk factors associated nas determined peak fentanyl infusion rate mean fentanyl infusion rate total fentanyl dose duration ecmo therapy nas observed neonates nas non nas neonates mean infusion rate increased steadily ecmo therapy mean sd micrograms kg h day mean sd micrograms kg h day total fentanyl dose duration ecmo significantly greater neonates nas found neonates total dose greater mg kg ecmo duration greater days significantly greater incidence nas chi squared test p less p less odds ratios respectively multiple logistic regression ecmo duration found powerful predictor occurrence nas also measured plasma fentanyl concentrations separate group neonates receiving fentanyl continuous infusion sedation fentanyl concentrations increased steadily period infusion suggesting development tolerance sedating effects conclude continuous administration fentanyl sedation associated uniform development tolerance significant incidence dependence alternative approaches sedation investigated,C16,0.0015027877,0.0013330476,0.002837551,0.0008443551,0.0020925843,0.0019394258,0.080452755,0.0014132397,0.022873478,0.0014765771,0.04732014,0.17051382,0.14474295,0.0034837166,0.0013215585,0.024964359,0.06687549,0.0015476221,0.0017111448,0.2429537,0.17572013,0.0005335853,0.0015460126
gut blood flow velocities newborn effects patent ductus arteriosus parenteral indomethacin effects gut blood flow velocities parenteral indomethacin mg kg given either quickly bolus slowly infusion compared consecutive studies two groups infants symptomatic patent ductus arteriosus presence patent ductus arteriosus range velocities superior mesenteric artery indomethacin given characterised pronounced abnormalities including absent cases even retrograde diastolic flow eight subjects first rapidly given bolus dose indomethacin duration seconds less caused pronounced sustained fall velocity superior mesenteric artery blood flow mean peak systolic velocity cm second median time maximum fall minutes median time recovery minutes subjects received first dose indomethacin slow infusion duration min percentage fall peak systolic velocity substantially less compared later median time maximum fall minutes rapid infusion qualitatively similar smaller changes seen coeliac axis return antegrade end diastolic flow superior mesenteric artery within one hour first dose indomethacin good predictor subsequent closure ductus data suggest profound disturbance mid gut perfusion infants patent ductus exacerbated indomethacin given rapidly intravenous bolus may also provide rational explanation well recognised association necrotising enterocolitis patent ductus arteriosus indomethacin administration,C16,0.02315108,0.0011869222,0.008912943,0.000751799,0.0018632002,0.008102053,0.09606532,0.0077106147,0.00096735475,0.0013147184,0.012522995,0.0123703275,0.35259268,0.0032185938,0.0011766525,0.015027334,0.13622409,0.0013779756,0.0015235733,0.06284441,0.24923912,0.00047509497,0.0013811464
ultrasonic forms posterior staphyloma frequent deformations globe encountered pediatric ophthalmology staphylomas colobomas paper reviewed ultrasonographically diagnosed staphylomas classified ultrasonographic patterns produced staphyloma cases four types staphylomas involving posterior pole optic nerve head staphylomas involving posterior pole optic nerve head peripapillary staphylomas giant peripapillary staphylomas morphologic ultrasonographic characteristics described,C16,0.28552666,0.0042861784,0.009015912,0.0027151287,0.0067283334,0.006358533,0.23641859,0.0045440216,0.0034932827,0.004747672,0.12678228,0.009938392,0.029910639,0.011553749,0.004249092,0.0075243465,0.111411445,0.0049761045,0.0055018826,0.03264369,0.08497964,0.0017156488,0.0049787583
partial anomalous pulmonary venous return anomalous pulmonary venous return left lung extremely rare condition reported sporadically general case reports identified patients condition underwent surgical correction represents single largest reported institutional experience anomaly patients ranged age months years seven asymptomatic six symptoms ranging recurrent pulmonary infection moderate congestive heart failure six anomalous venous return entire left lung seven anomalous return upper lobe eight patients associated cardiovascular anomalies four patients underwent surgical correction via sternotomy approach cardiopulmonary bypass allow correction coexisting intracardiac anomalies remaining patients underwent surgical repair left thoracotomy technique included high ligation division persistent left superior vena cava anastomosis left atrium site partial excision atrial appendage deaths one complication series,C16,0.028990004,0.04997658,0.003717553,0.0011194306,0.012419637,0.023797773,0.21573912,0.13352154,0.0014403939,0.0019622627,0.14318475,0.0040979213,0.039072424,0.004581071,0.0017520387,0.0031025324,0.24311623,0.0020560154,0.0022686047,0.04131364,0.030378155,0.010341036,0.0020512817
anterior fontanel pressure visual evoked potentials neonates infants undergoing profound hypothermic circulatory arrest determine effects cardiopulmonary bypass profound hypothermic circulatory arrest phca anterior fontanel pressure afp visual evoked potentials veps neonates infants undergoing cardiopulmonary bypass cpb phca surgical correction congenital heart defects studied mean sd minimum nasopharyngeal esophageal rectal temperatures degrees c respectively achieved mean duration phca min afp increased significantly pre cpb values first min rewarming duration increase afp related logarithmically directly product nasopharyngeal temperature npt end phca duration phca r p less nineteen patients simultaneous monitoring veps latency n p components veps increased temperature decreased cerebral perfusion pressure linearly inversely related afp r p less veps disappeared nasopharyngeal temperature npt degrees c reappeared min post phca npt degrees c significant difference duration increased afp min duration absence veps post phca period duration increased afp correlated linearly directly duration absence veps r p less data demonstrate transient neurophysiologic dysfunction occurs phca dysfunction related duration elevation afp cannot explained solely temperature effect,C16,0.009596832,0.0014579174,0.09078016,0.00092344783,0.018204743,0.0021210965,0.07503245,0.0015456212,0.0011882188,0.0016148916,0.0077521014,0.0033863392,0.59172297,0.0038007933,0.0014453029,0.0025624977,0.059811458,0.0016925916,0.0018714318,0.06219084,0.05902389,0.0005835675,0.0016908312
vasa aplasia cystic fibrosis bilateral vasa aplasia considered invariable finding cystic fibrosis patients rarely seen male infertility clinics improved survival beyond years age likely change clinical study group male cystics vasa absent boys epididymal abnormalities palpable majority main cause infertility appears mechanical obstruction whether absence due primary failure mesonephric duct development secondary luminal obstruction subsequent atrophy known,C16,0.003406438,0.019491466,0.006349429,0.0019119419,0.0047384086,0.0043915994,0.21083257,0.0032001135,0.0024601337,0.08569614,0.02650632,0.02347304,0.026614394,0.007865697,0.0029924107,0.0052989987,0.13257222,0.0035044067,0.0038746842,0.30432895,0.09930337,0.01767729,0.0035099844
macular dystrophy cornea systemic disorder keratan sulfate metabolism serum patients type macular corneal dystrophy mcd prevalent subtype lacks detectable antigenic keratan sulfate ks postulated individuals may lack antigenic ks cartilage well test hypothesis studied cornea serum nasal cartilage mcd patient using light electron microscopy immunohistochemistry quantitative enzyme linked immunosorbent assay elisa uses monoclonal antibody sulfated epitope ks chain measure ks content histologically corneal deposits seen characteristic mcd abnormal deposits noted cartilage lack immunoreactivity corneal sections antibodies sulfated epitope ks absence epitope serum showed patient type mcd cartilage specimen showed immunoreactivity chondrocytes extracellular matrix quantitative analysis elisa demonstrated antigenic ks content cornea cartilage least times lower normal controls provided direct evidence abnormality sulfation keratan type mcd involves cornea cartilage,C16,0.002180429,0.0019341492,0.0040684543,0.0012251867,0.003036405,0.002813957,0.38070577,0.012600441,0.012122252,0.0021423993,0.011519078,0.1455529,0.030679028,0.017003966,0.0019174141,0.0033953812,0.056775305,0.13712795,0.002482739,0.0283394,0.12839058,0.00077419105,0.013212604
early amniocentesis report cases neonatal follow amniocentesis performed prenatal diagnosis pregnancies gestational ages weeks safety accuracy procedure compared data obtained collaborative studies amniocentesis performed later second trimester differences observed respect accuracy pseudomosaicism maternal cell contamination related timing procedure fetal loss rate within weeks procedure fetal losses appeared related maternal complications bleeding leakage fluid occurred within day procedure major maternal complications noted information regarding neonatal outcome including pulmonary complications congenital orthopedic postural deformities found similar previous reports,C16,0.014551708,0.014294898,0.0046584224,0.0014027454,0.015551273,0.0032508443,0.13914694,0.0023478458,0.025967058,0.0024530697,0.07943391,0.005174918,0.03508619,0.018026816,0.002195459,0.0038877467,0.20446917,0.0025710983,0.002842762,0.33704713,0.08218515,0.0008864568,0.0025684242
teratogenically induced fetal anomalies variety infectious physical agents maternal diseases altered metabolic states drugs chemicals shown cause postnatal structural functional disabilities embryonic fetal exposure occurs human pregnancy disabilities potentially preventable public education awareness health care providers must equipped collect relevant data regarding exposures concern pregnant patients locate evaluate pertinent current teratology information resources sensitively counsel women regarding associated potential teratogenic risks comprehensive care patient exposed human teratogen may also include discussion prenatal diagnostic procedures pregnancy management options,C16,0.0024973564,0.0022152797,0.0046598082,0.0014031627,0.015522913,0.111918844,0.31030256,0.014373142,0.02597479,0.0024537994,0.066970035,0.005136585,0.029330725,0.009147089,0.014265312,0.015976,0.059055466,0.0025718631,0.014919879,0.16966558,0.09672779,0.00088672055,0.024025278
comparative value transthoracic transesophageal echocardiography assessment congenital abnormalities atrioventricular junction information obtained transthoracic transesophageal echocardiography two dimensional echocardiography spectral doppler color flow imaging compared patients major congenital abnormalities atrioventricular av junction discordant av connections criss cross connection absent right connections absent left connection findings either technique correlated findings cardiac catheterization patients surgery patients two six patients absent av connection defined transthoracic echocardiography transesophageal imaging demonstrated imperforate av valve patients discordant criss cross connection assessment av valve ventricular morphology defining chordal attachments av valves possible transesophageal echocardiography patients transthoracic echocardiography chordal straddling detected patient excluded others associated inlet ventricular septal defect anomalous pulmonary venous connection one patient atrial septal defect three patients subpulmonary stenosis five patients better assessed transesophageal imaging atrial appendage morphology could demonstrated transesophageal technique less useful demonstrating anterior subaortic infundibulum aortopulmonary shunt two patients although systemic ventricular function could assessed either method use short axis mode scans transesophageal pulsed doppler interrogation av valve pulmonary venous flow patterns provided clues diastolic dysfunction systemic ventricle,C16,0.022447318,0.0013043215,0.0027436207,0.18939796,0.04535348,0.008767526,0.16555546,0.03696839,0.0081590405,0.0014447579,0.097689405,0.0030243394,0.07365931,0.003391788,0.0012930359,0.0022897243,0.20819521,0.001514272,0.0016742708,0.023859315,0.030844953,0.0005220869,0.06990042
changes circulating alphafetoprotein following administration mifepristone first trimester pregnancy occurrence fetomaternal haemorrhage investigated women measuring maternal serum alphafetoprotein afp levels administration mifepristone ru termination first trimester pregnancy significant rise afp levels seen women increase ranging baseline levels apparent frequency fetomaternal haemorrhage similar reported previously surgical termination first trimester pregnancies,C16,0.004326294,0.003837639,0.008072416,0.0024307682,0.006024228,0.005583308,0.11033486,0.0040684994,0.003127718,0.0042508384,0.084719904,0.008914464,0.114250995,0.009973229,0.003804434,0.00673694,0.086353466,0.0044553657,0.0049261223,0.12386674,0.39395377,0.00153611,0.0044518844
increased birth prevalence cardiac defects yuma arizona systematic study undertaken estimate birth prevalence congenital heart disease clinical impression disproportionate number cases occurred yuma arizona control data obtained sierra vista arizona region similar demographic characteristics baltimore washington infant study patients chromosomal syndromal associations excluded baltimore washington infant study echocardiographic invasively documented cases included birth prevalence significantly higher yuma sierra vista p less assessed invasive echocardiographic diagnosis higher birth prevalence congenital heart disease study population compared baltimore washington infant study p sierra vista p families interviewed exclude cases mother spend month conception first trimester yuma sierra vista birth prevalence yuma remained significantly greater sierra vista p exclusion cases mother resided elsewhere suggests prove environmental influence may played role increased birth prevalence congenital heart disease community,C16,0.0019725496,0.00174975,0.032285802,0.0011082952,0.040831696,0.002545678,0.18005873,0.0018550096,0.010965645,0.001938146,0.1931824,0.004088651,0.097410455,0.014526629,0.0017346104,0.0030716702,0.08060333,0.0020313992,0.002246038,0.27880546,0.044250343,0.0007003807,0.0020373312
intraoperative transesophageal versus epicardial ultrasound surgery congenital heart disease twenty eight patients age range years median age years undergoing correction congenital heart disease entered prospective study intraoperative transesophageal epicardial ultrasound determine relative values techniques bypass surgery introduction transesophageal probe successful patients children studied use dedicated pediatric transducers epicardial studies performed patients epicardial studies allowed higher resolution imaging complete assessment bypass surgery intracardiac morphological condition ventricular septum right ventricular outflow tract assessment obtained transesophageal approach period immediately bypass surgery transesophageal technique allowed detailed insight atrioventricular valve function valvar regurgitation five patients ventricular inflow patterns continuous monitoring left ventricular function volume residual interventricular shunting three patients residual outflow tract obstruction four patients could reliably documented transesophageal studies concluded intraoperative transesophageal epicardial ultrasound surgery congenital heart disease complementary rather alternative techniques,C16,0.01917216,0.0014932231,0.027785115,0.04982268,0.043077946,0.0021724622,0.15933348,0.0015830509,0.0012169934,0.009803029,0.055153638,0.0034625244,0.0419281,0.0039011745,0.0014803031,0.0026213396,0.49202323,0.0017335804,0.0019167515,0.03761962,0.032223687,0.0087441625,0.0017317773
right ventricular growth transventricular pulmonary valvotomy central aortopulmonary shunt pulmonary atresia intact ventricular septum performed transventricular pulmonary valvotomy initial surgery consecutive patients pulmonary atresia intact ventricular septum patent infundibulum nineteen patients also placement central aortopulmonary shunt patients survived surgery patients preoperative later postoperative catheterizations purpose study determine response right ventricle transventricular pulmonary valvotomy regard relief right ventricular hypertension growth entire right ventricle including tricuspid valve right ventricular volume right ventricular outflow tract right ventricular systolic pressure decreased mm hg initial surgery mm hg right ventricular end diastolic volume increased predicted normal initial surgery late follow catheterization tricuspid valve anulus circumference also increased size predicted normal initial surgery late follow catheterization one patient required transanular right ventricular outflow tract patch time biventricular repair twenty patients either awaiting biventricular repair conclude transventricular pulmonary valvotomy central aortopulmonary shunt performed safely newborn infants pulmonary atresia intact ventricular septum patent infundibulum effective valvotomy relieves right ventricular hypertension allows excellent right ventricular tricuspid valve growth optimizes potential biventricular repair,C16,0.30818027,0.0013411609,0.00284446,0.000849494,0.009631517,0.0019533779,0.072617255,0.022714809,0.001093061,0.0014855639,0.019897861,0.0031097592,0.05470247,0.028880516,0.0013295566,0.0023543956,0.3376499,0.0015583641,0.0017215592,0.038444012,0.08554836,0.00053683284,0.001555422
analysis human dna excision repair gene involved group xeroderma pigmentosum containing zinc finger domain xeroderma pigmentosum xp autosomal recessive disease characterized high incidence sunlight induced skin cancer cells people condition hypersensitive ultraviolet defect dna repair nine genetic complementation groups xp groups h variant cloned mouse dna repair gene complements defect group xpac gene report molecular cloning human mouse xpac complementary dnas expression xpac cdna confers ultraviolet resistance several group cell lines lines xp groups almost group lines tested showed abnormality absence xpac messenger rnas results indicate defective xpac gene causes group xp human mouse xpac genes located chromosome q chromosome c respectively human xpac cdna encodes protein amino acids zinc finger motif,C16,0.0021136508,0.0018749136,0.003943853,0.0011875741,0.11830631,0.012958002,0.15792748,0.0019877027,0.0015280753,0.002076786,0.020350823,0.12183576,0.016975123,0.057683494,0.0018586911,0.0032913936,0.049697995,0.012408178,0.0228154,0.02911362,0.11167114,0.00075048057,0.24764352
core polypeptide cystic fibrosis tracheal mucin contains tandem repeat structure evidence common mucin airway gastrointestinal tissue cystic fibrosis trachea cdna library constructed probed synthetic oligonucleotide containing consensus sequence recently identified human intestinal mucin one isolated clones amn characterized extensively cdna sequence bp fragment determined revealed tandem repeat structure rich threonine proline residues repeating sequence amn similar identical determined gut mucin examined northern analysis mrna hybridizing amn extremely polydisperse cystic fibrosis cf trachea apparent message length varying approximately kb greater kb similar pattern observed less abundant message cf bronchiectatic lung parenchyma lung cdna hybridized similarly polydisperse message ulcerative colitis colon rna hybridize control rna u lymphoma cells stomach rna pedigree analysis restriction digests genomic dna revealed pattern indicating single polymorphic locus mucin gene expressed lung intestine southern analyses human mouse somatic cell hybrid cell lines allow chromosomal localization mucin gene human chromosome ii within region p pter taken together data demonstrate polymorphic gene encodes mucin core polypeptide expressed lung intestine,C16,0.0015126095,0.0013417602,0.0028223726,0.00084987364,0.0021216057,0.038552027,0.14993209,0.011709209,0.0010935494,0.0014862277,0.019280378,0.0031225872,0.018708093,0.03721166,0.0013301506,0.0023554477,0.013995702,0.009285525,0.008967564,0.010682038,0.4799866,0.0005370727,0.18311584
magnetic resonance imaging evaluation congenital dislocation hips magnetic resonance mr images obtained preoperatively postoperatively pediatric patients congenital dislocation hip cdh images compared arthrograms computed tomography scans mr images accurate defining soft tissue anatomy hip position obstructive factors relocation mr imaging efficient diagnostic tool cdh,C16,0.0044184336,0.003919371,0.008244338,0.0024825376,0.4222539,0.0057022185,0.0979651,0.0041551483,0.0031943307,0.0043413704,0.09696408,0.009087874,0.037726283,0.01793098,0.003885459,0.00688042,0.15093343,0.004550254,0.0050310367,0.04401209,0.060207017,0.0015688252,0.0045455215
prevalence additional cardiovascular anomalies patients referred transcatheter closure patent ductus arteriosus catheter closure patent ductus arteriosus reality purpose study establish prevalence associated cardiovascular defects accuracy echocardiography patients referred transvenous ductal closure study reviewed patients seen patent ductus arteriosus group additional cardiovascular anomalies group ii groups ii differ significantly age gender physical examination except presence continuous murmur group versus group ii p less left patent ductus arteriosus visualized two dimensional echocardiography patients evident doppler study patent ductus arteriosus seen six patients including patient found collateral network aorta main pulmonary artery patients noncardiovascular abnormalities syndrome likely overall group additional cardiovascular anomalies p cardiovascular anomalies encountered varied eight patients anomalies restrictive ventricular septal defect addition patent ductus arteriosus significant anomalies found catheterization included two thoracic arteriovenous malformations isolated right carotid artery draining right pulmonary artery way right ductus arteriosus study indicates echocardiography effective diagnostic technique patient group thorough cardiac catheterization angiography performed implantation ductal device,C16,0.042536676,0.00972319,0.0031805772,0.0009541236,0.018567774,0.010653835,0.15996245,0.07555358,0.058746252,0.0016685363,0.13116457,0.06928542,0.027702563,0.0040995516,0.001493314,0.0026443794,0.22846888,0.0017488174,0.0019335984,0.068567015,0.07899494,0.0006029529,0.0017469985
autosomal dominant retinitis pigmentosa absence rhodopsin proline histidine substitution codon pedigrees europe exon codon rhodopsin gene mutation resulting proline histidine substitution previously observed approximately american autosomal dominant retinitis pigmentosa adrp patients region around site mutation rhodopsin gene amplified analyzed affected individuals european adrp pedigrees codon mutation found absent cases including large irish pedigree disease gene previously shown closely linked rhodopsin locus indicates presence either allelic nonallelic heterogeneity adrp,C16,0.0034577604,0.003067206,0.0064518224,0.0019427745,0.004816059,0.00446242,0.27310005,0.1634565,0.002499807,0.0033974526,0.034375213,0.007111952,0.021669092,0.008879292,0.0030406672,0.005384452,0.053879082,0.021867553,0.02065887,0.030864263,0.10192792,0.017956546,0.20573328
cardiac teratogenesis trichloroethylene dichloroethylene mammalian model recent epidemiologic studies demonstrated greater expected number pediatric patients congenital heart disease areas drinking water contaminated halogenated aliphatic hydrocarbons trichloroethylene trichloroethane dichlorethylene principal contaminants groundwater previous study chick embryos demonstrated injected air sacs fertilized eggs trichloroethylene produced three times number cardiac defects found control embryos mammalian study demonstrates similar effects trichloroethylene dichloroethylene applied provocative circumstances solutions delivered catheter gravid uterus intraperitoneal osmotic pump developing rat fetus utero period organ differentiation development furthermore effect dose dependent agents although small number congenital heart anomalies found control group found lower dose trichloroethylene dichloroethylene groups higher dose groups respectively p less variety cardiac defects found dichloroethylene appears least great cardiac teratogen trichloroethylene even though administered fold lower concentration agents appear specific cardiac teratogens single noncardiac anomaly found study rat model demonstrates dose dependent relation fetal exposure trichloroethylene dichloroethylene utero period organogenesis appearance variety congenital cardiac defects,C16,0.001594749,0.0014146221,0.0030028922,0.016311178,0.049929734,0.0020581067,0.1783959,0.024623413,0.016553462,0.0015669346,0.018421562,0.080226615,0.04068644,0.0040268707,0.0014023822,0.0026845091,0.09811457,0.00914649,0.009451258,0.19601293,0.23407045,0.0005662375,0.009738659
impact intrauterine growth retardation body proportionality fetal neonatal outcome previous prognostic studies infants intrauterine growth retardation iugr adequately considered heterogeneity iugr terms cause severity body proportionality prone misclassification iugr errors estimation gestational age based cohort infants early ultrasound validated gestational ages indexes body proportionality standardized birth weight consequences severity cause specific iugr proportionality fetal neonatal morbidity mortality assessed progressive severity iugr significant p less linear trends increasing risks stillbirth fetal distress abnormal electronic fetal heart tracings parturition neonatal hypoglycemia minimum plasma glucose less mg dl hypocalcemia minimum ca less mg dl polycythemia maximum capillary hemoglobin greater equal g dl severe depression birth manual ventilation greater minutes minute minute apgar scores less equal minute apgar score less equal hospital death trends persisted common outcomes even restriction term weeks births convincing evidence outcome among infants given degree growth retardation varied function cause growth retardation among infants iugr increased length weight significant crude associations hypoglycemia polycythemia associations disappeared adjustment severity growth retardation gestational age,C16,0.0015462576,0.0013704762,0.010335964,0.00086806243,0.0021513386,0.03190566,0.14133778,0.0014529199,0.031025201,0.0015180357,0.033521637,0.018300394,0.15397863,0.020372063,0.10557016,0.017356575,0.060978632,0.0015910754,0.0018219943,0.20027088,0.08585187,0.07528398,0.0015903891
aberrant morphogenesis central nervous system overview congenital defects cns emphasized pathogenesis developmental pathways continue elucidated approach remains extent hypothetical however understanding features morphogenesis dysmorphogenesis helps indicate time onset elucidate causal factors important steps toward prevention birth defects taken,C16,0.004418734,0.025308643,0.008244899,0.0024827062,0.062289502,0.0059879217,0.262055,0.004155431,0.003194548,0.02850535,0.020321265,0.009088491,0.029231565,0.31366697,0.003885723,0.028267328,0.05026534,0.004550563,0.005152872,0.05111932,0.07169305,0.0015689319,0.0045458307
intrauterine growth retardation diagnosis based multiple parameters prospective study scoring system previously developed diagnose intrauterine growth retardation iugr based three parameters estimated fetal weight amniotic fluid volume maternal blood pressure status test iugr score prospectively authors computed score third trimester fetuses growth retarded normal scanned within weeks prior delivery iugr score identified three groups distinct probability iugr score virtually excludes iugr probability score allows confident diagnosis probability score indeterminate probability iugr score performed best patients accurate dating early ultrasound us even among patients lacking accurate dating performance iugr score superior previously reported single sonographic parameter iugr score used us facility diagnose exclude third trimester iugr,C16,0.0023304615,0.0020672355,0.004348399,0.0013095943,0.003246416,0.003007582,0.12236221,0.002191594,0.03550536,0.002289815,0.4381014,0.043554187,0.0534969,0.017230282,0.002049349,0.003629013,0.06440927,0.032199446,0.0026535732,0.08532959,0.07546148,0.0008274622,0.0023993843
neonatal ethics development consultative group experience neonatal ethics advisory group tertiary care setting reviewed identify aspects experience valuable development consultative group consultations requested patients seen august december review patients indicated infants born full term gestations infants seen beyond neonatal period type congenital anomaly principal diagnosis patients reasons seeking consultation primarily involved decisions regarding withdrawal withholding treatment patients consensus group supported decision health care team remaining consultations recommendation group information communication needed analysis neonatal ethics advisory group experience consultations characteristics neonatal patients identified value forum discussing difficult ethical issues facing members health care team validated,C16,0.0021809526,0.0019346137,0.004069431,0.0012254313,0.013583506,0.0028421262,0.27680573,0.012543725,0.0015767316,0.033786714,0.04861052,0.06783715,0.021152204,0.005031545,0.012439143,0.0033961965,0.16625355,0.0022460194,0.18190986,0.095109634,0.042443078,0.00077437697,0.0022477317
results year screening programme neonatal hip instability neonates screened congenital dislocation hip cdh primary physical examination performed junior paediatric staff persistent late diagnosis rate per live births primary examination undertaken experienced orthopaedic personnel late diagnosis rate fell fewer infants splinted,C16,0.0044193985,0.003920227,0.00824614,0.0024830797,0.027537504,0.005703464,0.096959725,0.0041649584,0.0031950285,0.0043423185,0.13097052,0.009089858,0.050510027,0.010161562,0.0038863076,0.0068819225,0.4421734,0.0045512477,0.005032135,0.115643546,0.054011945,0.0015691678,0.0045465142
total artificial heart neonates allowing bridging transplantation since early rapid increase successful pediatric heart transplantation improved chance survival many children suffering otherwise fatal cardiomyopathies congenital cardiac defects last years heart transplantation neonates infants days months respectively rapidly growing area within pediatric patient population adequate mechanical circulatory support system designed used bridge transplantation available many pediatric patients neonates smallest candidates potentially benefit heart transplantation often acute need either heart transplantation temporary circulatory support indicates new development pediatric bridging device focus youngest group subsequently device may modified weight age group innovative total artificial heart design developed attempt meet anatomic physiologic requirements neonates infants report discusses rapidly growing pediatric heart transplantation patient population well innovative total artificial heart design,C16,0.0016970248,0.026675815,0.010242217,0.000953489,0.018427154,0.19011466,0.20411432,0.0015959026,0.0012268734,0.009882618,0.008257163,0.02049728,0.036700264,0.02068007,0.0014924392,0.0026426204,0.22697161,0.009948478,0.0019323123,0.15688542,0.046713915,0.00060255185,0.0017458365
osmiophilic deposits cytosomes hallervorden spatz syndrome young child hallervorden spatz syndrome presented well years age lost interest activities school performance declined age years began episodes blepharospasm accompanied bilateral ptosis occasional episodes oculogyric crisis age years motor coordination declined began exhibit evidence dementia dystonia dysarthria tremor motor incoordination dystonia tremor progressed patient wheel chair bound multiple tests performed including metabolic studies magnetic resonance imaging bone marrow biopsy electron microscopy buffy coat bone marrow buffy coat revealed inclusions cytosomes granular osmiophilic knowledge third case report inclusion bodies found patients manifestations hallervorden spatz syndrome findings suggest obtaining buffy coat bone marrow biopsy may aid diagnosis hallervorden spatz syndrome ultimately provide information regarding etiology,C16,0.0022766725,0.002019522,0.048308227,0.0012791693,0.025883194,0.0029381644,0.1720856,0.013154936,0.0016459328,0.0242616,0.05987008,0.00468268,0.03715719,0.0054426123,0.012347617,0.047594026,0.06351686,0.12703465,0.002593938,0.25101244,0.080725774,0.011825084,0.0023440376
hypoplastic left heart syndrome outcome initial reconstruction modified fontan procedure outcome clinical course modified fontan procedure reviewed patients hypoplastic left heart syndrome underwent initial reconstructive surgery august march median age time initial reconstruction days range day months patients right modified blalock taussig shunt used patients central shunt placed additional procedures n performed patients median age months range days months revision systemic pulmonary shunt n arch reconstruction n balloon angioplasty arch obstruction n atrial septectomy n pulmonary artery angioplasty n tricuspid valve annuloplasty replacement n modified glenn shunt n significant difference frequency additional procedures performed postoperative days survivors compared nonsurvivors actuarial survival rates month months months seventy percent deaths occurred initial admission resulting acute cardiovascular collapse first postoperative day statistical difference actuarial survival assessed type shunt used anatomical subtype influence additional interventions considered substantial improvement outcome may possible immediate perioperative mortality reduced speculate intermediate mortality days year may related effects chronic exposure right ventricle volume overload systemic pressure,C16,0.08153728,0.001321231,0.00277919,0.00083690934,0.002074035,0.0019245617,0.14374664,0.015758734,0.001076818,0.0014634882,0.007380029,0.0030868633,0.07493381,0.0034389892,0.015539372,0.002319409,0.4272213,0.0015339035,0.0016959766,0.15035218,0.05791815,0.0005288554,0.0015323082
child abuse one pair twins japan nationwide survey japan child abuse neglect revealed victims products multiple births none victims singletons multiple birth siblings cases twins abused findings indicated one rather pair twins likely abused japan abuse twins likely serious parental family problems whereas abuse one twin associated child medical problems non home care instance abuse pair twins handicapped comparisons abused twin non abused co twin examination abuser attitude victim suggested difference twins development response parents increased stress child rearing encouraged favouritism resulted abuse one twin comparison parents children siblings may common factor general child abuse natural thing parents,C16,0.0032404044,0.0028744005,0.021723008,0.017497998,0.00453166,0.004181911,0.27260584,0.0030473156,0.0023426681,0.11299445,0.086576946,0.0067298645,0.031463046,0.037676796,0.01853431,0.041194428,0.033389974,0.0033416657,0.01937159,0.20021948,0.07197807,0.0011505499,0.0033336086
development new transvenous patent ductus arteriosus occlusion technique using shape memory polymer novel percutaneous patent ductus arteriosus pda occlusion technique without potential problems associated conventional techniques long awaited development novel transvenous pda occlusion technique using temperature shape changeable occluder device verification vitro performance demonstrated study principles technique bar form device inserted pda transvenously guide wire pushing catheter device dashed hot water catheters device expanded hot water pda pda occluded occluder device made shape memory polymer polynorbornene designed monobloc configuration thin disk hole guide wire center cone barlike device hot press fully expanded within sec upon immersion degrees c water mock circulation test great arteries specially designed pda showed introduction hot water degrees c catheters caused expansion device stayed pda without support aortic pressure distal aortic flow increased rapidly pulmonary flow reduced promptly resulted drastically reduced shunt ratio pda thus novel pda occlusion technique developed functioned well occlude pda great arteries model,C16,0.07935203,0.07746509,0.03684884,0.011990264,0.0031021943,0.0028903238,0.2371332,0.023654046,0.0016104825,0.0021887843,0.17528938,0.0477118,0.102566645,0.005196685,0.0019589278,0.0034688942,0.07217393,0.0022940969,0.0025364924,0.028422808,0.07906077,0.000790953,0.0022933325
atrial cardiomyoplasty fontan type procedures purpose right atrial cardiomyoplasty increase atrial pulmonary flow patients undergoing fontan type procedures developed two surgical techniques bypass right ventricle followed right atrial cardiomyoplasty stimulated latissimus dorsi muscle flap ldmf goats left ldmf transferred chest removal second rib sternotomy right atrial appendages five goats group connected distal main pulmonary artery polytetrafluoroethylene tubing proximal pulmonary trunks ligated five goats group cardiopulmonary bypass bioprosthetic valves implanted inferior venae cavae tricuspid orifice closed atriopulmonary connection performed left ldmf sutured right atrium stimulated using synchronous hz bursts impulses delivered medtronic cardiomyostimulator hemodynamic studies performed acute phase right atrial pulmonary arterial aortic pressures assessed cardiac output measured using ultrasonic flow studies ldmf stimulation restored pulsatile pressure patterns pulmonary artery increased cardiac output observations evident model caval valvular implant functional ventricularization right atrium could improve long term results fontan type procedures extend operative indications chronic experimental studies necessary evaluate diastolic systolic functions neo right ventricle,C16,0.12552425,0.0017503054,0.0036817414,0.011809031,0.0027475848,0.0025531151,0.13479005,0.030509088,0.0205263,0.0019387611,0.035963804,0.032706365,0.084057964,0.028710645,0.001735161,0.012621592,0.2104203,0.0020320439,0.002246751,0.013472723,0.23747186,0.000700603,0.0020299305
clinical approach prenatal detection human structural defects tremendous advances prenatal diagnosis allowed clinicians recognize variety structural defects developing fetus guidelines fetal ultrasonography approach fetal evaluation outlined developmental morphologic approach emphasized way categorizing congenital anomalies whether detected prenatal postnatal life use approach diagnosing managing fetal malformation syndromes illustrated,C16,0.0037765107,0.0033499536,0.0070465775,0.02039186,0.058566757,0.004873784,0.24713135,0.0035514764,0.07583917,0.0037106436,0.10772244,0.007767561,0.023377294,0.06394545,0.039869186,0.042433575,0.06693109,0.0039187996,0.004300113,0.15954593,0.04669267,0.0013409017,0.003916908
chromosomal region cystic fibrosis gene yeast artificial chromosomes model human genome mapping general strategy cloning mapping large regions human dna yeast artificial chromosomes yac described relies use polymerase chain reaction detect dna landmarks called sequence tagged sites sts within yac clones method applied region human chromosome containing cystic fibrosis cf gene thirty yac clones region analyzed contig map spans base pairs assembled individual yac large kilobase pairs containing entire cf gene constructed vivo meiotic recombination yeast pairs overlapping yac,C16,0.0032418952,0.0028757227,0.0417387,0.0018214886,0.004516428,0.0041838344,0.26619694,0.0030487175,0.002343746,0.0031853523,0.036815207,0.0066679586,0.020067926,0.0080825295,0.0028508408,0.005048305,0.043791436,0.0033644717,0.0036913746,0.038501877,0.18773265,0.0011510792,0.30908155
william glenn lecture cavopulmonary shunt evolution concept bold imaginative development cavopulmonary anastomosis appeared originate several centers almost simultaneously extensive research right heart bypass glenn first north america perform successful experimental cavopulmonary shunt became known name properly selected patients palliation success excellent mortality rates low used cavopulmonary anastomosis palliation infants children eight hospital deaths occurred early series palliation generally lasted years child outgrew blood supply contralateral lung palliation could restored increased flow lung another shunt six otherwise inoperable patients received benefit addition axillary arteriovenous fistula late pulmonary arteriovenous fistulas identified patients angiography sensitive testing incidence rate may high occurrence pulmonary arteriovenous fistulas caused general concern less frequent use shunt recent application end side anastomosis creating bidirectional shunt restored interest major legacy cavopulmonary anastomosis demonstration feasibility partial right heart bypass paved way fontan operation frequently constructed part operation currently glenn shunt often used temporary permanent alternative fontan repair appears significant risk risk factors usually encountered include small pulmonary arteries young age poor ventricular function atrioventricular valve incompetence myocardial hypertrophy sometimes alone often combination,C16,0.07919558,0.037108447,0.009226806,0.0008310941,0.016884552,0.045866776,0.24201357,0.015710272,0.0010693854,0.0157752,0.047153212,0.003154134,0.056848735,0.0034282887,0.0013007586,0.023777492,0.23579822,0.001523316,0.0016842704,0.10407163,0.05553062,0.0005252051,0.001522468
ischiopagus tetrapus twins urological aspects separation year followup conjoined twins occur births conjoined twins ischiopagus type twins joined symmetrically pelvis fusion begins level common umbilicus longitudinal axis extends straight line opposite directions genitourinary gastrointestinal tracts shared tetrapus subtype lower extremities present oriented right angles axis common trunk two sets female ischiopagus tetrapus twins born successfully separated st louis children hospital following year describe genitourinary associated anomalies surgical separation long term urological followup sets ischiopagus tetrapus twins,C16,0.0042375955,0.0037589585,0.007906914,0.0023811595,0.005914963,0.05990771,0.2038739,0.08602275,0.0030635928,0.024678519,0.024768824,0.008715924,0.028536277,0.009827741,0.0037264344,0.006598817,0.15283826,0.0043640207,0.032430418,0.23141553,0.08916763,0.0015046162,0.004359482
life threatening antiglobulin test negative acute autoimmune hemolytic anemia due non complement activating igg kappa cold antibody pra specificity year old man fulminant cold autoantibody hemolytic anemia caha hospitalized hemoglobinemia hemoglobinuria hemoglobin concentration gm per dl negative direct antiglobulin test dat polyspecific anti c reagents negative donath landsteiner test cold agglutinin titer failed respond corticosteroids multiple plasma exchanges cyclophosphamide required transfusions days maintain hemoglobin concentration g per dl improved dramatically splenectomy performed wide thermal amplitude cold agglutinin proved igg kappa antibody pra specificity patient serum exhibited normal complement activation dat carried degrees c result strongly positive igg indirect antiglobulin test degrees c positive patient serum diluted within months complete remission receiving therapy compared eight patients caha exclusively igg mediated patient remarkable requirement many transfusions dats consistently negative c,C15,0.0023833513,0.0021125474,0.0044572116,0.0013380918,0.003316223,0.0145925665,0.16329363,0.0022396317,0.0017217494,0.0023400057,0.12598565,0.08331851,0.03782207,0.031532187,0.036668364,0.003830602,0.10138036,0.06513058,0.0027117368,0.053429406,0.22255227,0.023883518,0.013959792
doppler umbilical artery studies twin twin transfusion syndrome eleven patients twin pregnancies identified twin twin transfusion syndrome basis like sex twins monochorionic placentation umbilical venous blood hemoglobin differences exceeding g l delivery umbilical artery velocity time waveform studies performed pregnancies part large series twin pregnancies cases systolic diastolic ratio differences twins less unit mean indicating twin twin transfusion umbilical artery ratios concordant even presence discordancy fetal size,C15,0.059659652,0.0034091384,0.025771275,0.0021593552,0.0054961154,0.004959891,0.20175417,0.022212204,0.058585566,0.003776201,0.135546,0.008023752,0.17099407,0.009414378,0.003379641,0.0059847115,0.07949752,0.0039578914,0.004376085,0.099841915,0.06730314,0.019943511,0.0039537754
parvovirus b induced perturbation human megakaryocytopoiesis vitro parvovirus b infection leads transient aplastic crises individuals chronic hemolytic anemias immunodeficiency states additional unexplained sequela b infection thrombocytopenia b known remarkable tropism human erythropoietic elements known replicate nonerythroid cells etiology thrombocytopenia uncertain sought define pathobiology b associated thrombocytopenia examining role b vitro megakaryocytopoiesis b infection normal human bone marrow cells significantly suppressed megakaryocyte mk colony formation compared mock infected cells inhibition observed nonpathogenic human parvovirus adeno associated virus aav b mk cell interaction also studied molecular level whereas low density bone marrow cells containing erythroid precursor cells supported b dna replication viral dna replication observed b infected mk enriched fractions determined presence viral dna replicative intermediates southern blots however analysis total cytoplasmic rna isolated b infected mk fractions showed low level expression b genome detected quantitative rna dot blots well northern analysis furthermore frame shift mutation recombinant aav b hybrid genome segment encodes viral nonstructural ns protein significantly reduced observed inhibition mk colony formation studies indicate tissue tropism b beyond erythroid progenitor cell lend support hypothesis b genome expression may toxic cell populations nonpermissive viral dna replication,C15,0.0016572126,0.0014698001,0.014095853,0.0009309744,0.04588118,0.0021383844,0.2681544,0.009551113,0.0011979034,0.0016280538,0.008441033,0.0034536584,0.0293639,0.154817,0.009960788,0.0025802206,0.014481334,0.044001855,0.0098895645,0.06429574,0.15689911,0.00058832386,0.15452261
constitutive antibody normal human serum directed rabbit bone marrow cells lack parturients neonates hematologic disorders normal human serum effectively inhibits bioassay erythropoietin based dna synthesis rabbit erythroid precursors heat sensitive inhibitory activity readily lost dilution serum revealing presence erythropoietin potentiating activity inhibitory activity caused rapid cytotoxic effect rabbit bone marrow cells mouse cells less sensitive cytotoxic activity removed serum adsorption protein expressed degrees c neutralized anti c c complement antibody cytotoxicity inhibited egta effect egta reversed addition ca ions findings show cytotoxicity exerted antibody via classical pathway complement dependent cell lysis although serum healthy adult human donors consistently contains cytotoxic activity activity observed serum samples neonates parturients patients severe anemia patients polycythemia chronic renal failure occasionally lack cytotoxic activity serum serum samples lacking cytotoxic activity found deficient antibody component cases examined results show antibody directed rabbit cells constitutively present normal human serum absent number pathologic situations well absent neonates parturients,C15,0.0016362754,0.009335311,0.048015244,0.00091578474,0.0022761654,0.00998567,0.1756072,0.0015327951,0.0011783586,0.0016014907,0.03304995,0.024584744,0.032276493,0.2820473,0.0014333092,0.026201747,0.02896591,0.04286891,0.0097251395,0.05781762,0.18244793,0.00057872484,0.025917917
treatment cis retinoic acid transfusion dependent patients myelodysplastic syndrome decreased toxicity addition alpha tocopherol purpose purpose study determine response tolerance long term treatment using cis retinoic acid cra transfusion dependent patients myelodysplastic syndrome mds determine effects therapy natural history disease patients methods sixty six consecutive patients transfusion dependent mds seen medical school hospital outpatient clinic studied first patients treated cra alone next patients cra plus alpha tocopherol compared responses toxicities therapy rates transformation survival onset therapy evaluable patients treated cra alone patients treated cra plus results four patients responded months cra alone response associated considerable toxicity resulted cessation therapy among responders one continued therapy currently remission whereas three discontinued therapy toxicity relapse died cra plus group observed one prolonged complete remission partial remissions decrease skin constitutional toxicities addition enabled continuation cra indefinitely although response rates similar groups fewer patients versus experienced progression acute leukemia cra plus group group receiving cra alone terminated treatment p twofold increase median survival ra rars raeb cmml patient groups observed cra plus significant p greater conclusion study shows response rate cra suggests cra given continuously decreases rate progression transformation acute leukemia patients mds addition ameliorates toxicity cra allows long term treatment cra since standard treatment mds currently unsatisfactory findings indicate longer treatment non marrow suppressive agent cra important trials determine role cra plus combination new recombinant growth factors therapy transfusion dependent mds offer new approach disease common elderly population,C15,0.0012851504,0.0011399926,0.0023979575,0.0007220736,0.008082444,0.00786333,0.40705597,0.001208571,0.00092910655,0.019911535,0.01937288,0.044037133,0.012454455,0.010169431,0.0011301289,0.008628729,0.19964279,0.0013234919,0.0076832073,0.08389277,0.14062847,0.00045631023,0.019984134
negative screening sickle cell diseases monoclonal immunoassay newborn blood eluted filter paper common method blood sample collection neonatal screening programs inherited diseases blood spots filter paper poorly suited screening sickle cell diseases conventional assays denaturing effects medium hemoglobins affect electrophoretic identifications monoclonal antibody beta specifically recognizes hemoglobin beta chain residue glutamic acid normal counterpart hemoglobins c recognition unaffected changes hemoglobins induced filter paper storage beta immunoassay analysis prescreened samples extracted filter paper permitted unambiguous group identification virtue nonreactivity pathologic sickle cell disease phenotypes ss sickle cell anemia sc sickle cell hemoglobin c disease along homozygous hemoglobin c phenotype hemoglobin cc disease phenotypes identified beta nonreactivity would include beta degrees thalassemia c beta degrees thalassemia beta degrees thalassemia cooley anemia systems collecting newborn blood specimens filter paper transmittal centralized laboratories already established many states assay sickle cell hemoglobin c diseases could rapidly combined mass screening programs inborn errors metabolism,C15,0.0020110244,0.0017838791,0.013649742,0.0011299127,0.002800288,0.0025953318,0.32309845,0.011617802,0.0014538812,0.0019759496,0.12519987,0.013871852,0.091419116,0.025797384,0.0017684442,0.0031315833,0.036651112,0.0021468375,0.019774048,0.057152618,0.04997795,0.0980584,0.11293451
deficiency glycosyl phosphatidylinositol linked membrane glycoproteins leukocytes paroxysmal nocturnal hemoglobinuria description new diagnostic cytofluorometric assay paroxysmal nocturnal hemoglobinuria pnh disease affects red cells blood cells well common defect supposed acquired deficiency glycosyl phosphatidylinositol gpi anchored membrane proteins may present already hematopoietic stem cell level recently panel monoclonal antibodies moabs become available directed various gpi linked membrane proteins makes possible study various cell lineages deficiency proteins pnh detail using cytofluorography could show granulocytes different pnh patients miss gpi linked fcriii cd antigen also three gpi linked proteins ie cd antigen cd antigen granulocyte specific kd antigen affected granulocytes neutrophils also eosinophils found detailed analysis three patients moreover pnh patients tested monocytes found deficient gpi linked cd antigen found cd cd daf antibodies lymphocytes may involved well however abnormal b lymphocytes detected subset patients tested uniform deficiency gpi linked proteins granulocytes allows introduction new diagnostic cytofluorometric assay pnh moabs gpi linked granulocytic antigens test positive pnh patients studied group control patients normal donors exception three aplastic anemia aa patients three aa patients subpopulations pnh granulocytes could detected whereas patients negative acidified serum ham test indicates new test sensitive ham test allows early diagnosis pnh aa advantage neutrophil assay contrast ham test influenced recent red cell transfusions moreover possible quantify number affected cells single cell analysis,C15,0.0015218308,0.00871442,0.031157453,0.008207992,0.0025258274,0.001964002,0.31378016,0.0014311482,0.001100216,0.0014952881,0.13223383,0.010701736,0.044767037,0.15834981,0.0013382597,0.009719589,0.078497715,0.046594184,0.0017328282,0.011676355,0.10481082,0.00054034684,0.027139112
autoimmune hemolytic anemia kawasaki disease case report year old boy presented fever conjunctivitis rash lymphadenopathy diagnostic kawasaki disease treatment antibiotics aspirin intravenous immunoglobulin instituted hematocrit decreased percent admission percent hospital day white cell count increased x per microl patient leukoerythroblastic blood smear direct antiglobulin test demonstrated igg complement red cell rbc surface acid eluate reacted titer panel cells antiglobulin phase intravenous immunoglobulin lot used treatment contain antibody reacted patient group rbcs panel group rbcs contain igg anti b titer patient received transfusion given methylprednisone direct antiglobulin test acid eluate negative days later patient uneventful recovery distinction antibody mediated hemolytic anemia autoimmune hemolytic anemia important treatment disease,C15,0.0028394635,0.0025187458,0.005461246,0.0015953787,0.0039542736,0.0036644754,0.24722405,0.016408836,0.015796911,0.030275106,0.0693065,0.08841299,0.035766777,0.11637994,0.0024969524,0.018164538,0.14677306,0.0029549056,0.0032331469,0.019122325,0.16368957,0.0010081903,0.002952676
antigenic recognition intravenous gamma globulin selected bacteria isolated throats patients kawasaki syndrome kawasaki syndrome ks mucocutaneous lymph node syndrome acute febrile exanthematous illness unknown etiology therapy intravenous gamma globulin ivgg results rapid defervescence disappearance signs symptoms inflammation prevention coronary artery aneurysms hypothesized ivgg might neutralize bacterial toxin produced staphylococcus streptococcus present nasopharynx speculated toxin might detectable serum urine patients goal work identify microbial antigens different materials taken patients clinical diagnosis ks tested aerobic bacterial isolates throat cultures patients ks acute serum patients acute urine specimens patients ks patients ranged age years specimens tested standard system counterimmunoelectrophoresis reacted ivgg prepared solution ten aerobic bacteria isolated throat cultures demonstrated precipitation reaction ivgg counterimmunoelectrophoresis testing ivgg acute serum acute urine specimens uniformly negative ivgg contains precipitating antibody limited number aerobic throat organisms possible antigenic products one bacteria may involved pathogenesis ks,C15,0.0021353525,0.012228641,0.003986199,0.0011997675,0.0029736685,0.0027557835,0.29346347,0.012336632,0.0015437647,0.002098109,0.09759538,0.10774184,0.013755085,0.081131585,0.0018777751,0.013628616,0.121481724,0.033962406,0.023104042,0.085574426,0.082461014,0.00075818604,0.0022065165
serum concentration soluble interleukin receptor sensitive parameter disease activity sarcoidosis investigated clinical value measuring serum concentrations soluble il r monitoring sarcoidosis serum concentrations soluble il r measured patients sarcoidosis mean value active untreated sarcoidosis u ml normal range healthy control subjects u ml mean value active untreated sarcoidosis significantly higher dormant disease u ml corticosteroid treated patients u ml serial changes serum soluble il r level studied cases spontaneous remission corticosteroid treated patients good correlation noted changes serum level soluble il r clinical status positive correlation noted serum concentration soluble il r serum ace activity data confirmed measurement serum concentration soluble il r could used monitoring disease activity sarcoidosis,C15,0.002251456,0.0019971537,0.014540015,0.0012650013,0.0031350811,0.0029056212,0.18863481,0.0021172964,0.0016277025,0.0022121877,0.036878314,0.0046407226,0.22331639,0.00550761,0.0019798735,0.0035059853,0.09620369,0.014227639,0.002563614,0.03024483,0.35712934,0.0007994102,0.0023162148
wiskott aldrich syndrome case report paper presents report child wiskott aldrich syndrome clinical picture laboratory findings characteristic disease prevailing symptoms included recurrent respiratory alimentary tract infections seborrhic dermatitis type skin lesions thrombocytopenia humoral cellular immunological disturbances noted pedigree pattern characteristic,C15,0.02958546,0.0044965805,0.00945849,0.0028482878,0.056139547,0.0065419897,0.4488001,0.029300204,0.0036647627,0.058206864,0.025125595,0.010426253,0.031378906,0.011708536,0.004457674,0.007893706,0.08148983,0.005220374,0.005771962,0.09001914,0.070450984,0.0017998675,0.0052149445
bioavailability iron hemodialysis patients treated erythropoietin evidence inhibitory role aluminum dose recombinant human erythropoietin r huepo required correct anemia end stage renal disease esrd varies among patients response r huepo impaired absolute relative iron deficiency exists aluminum may cause microcytic anemia patients esrd mechanism remains incompletely defined twenty two patients canadian multicentre epo trial studied months randomized double blind placebo controlled trial free erythrocyte protoporphyrin fep used indicator iron deficient deficient erythropoiesis relationship fep estimates iron availability serum iron transferrin saturation ferritin iron utilization corrected reticulocyte count hemoglobin evaluated multiple linear regression analysis effect aluminum fep evaluated adjusting statistical model variable patients iron replete assessed serum ferritin fep related serum aluminum administration r huepo significantly correlated aluminum treated group hemodialysis patients treated r huepo proportion variability explained parameters iron utilization iron availability effect aluminum increased hemodialysis patients receiving r huepo proportion variability fep explained model increased adjusting aluminum data support hypothesis aluminum interferes bioavailability stored iron erythropoiesis thus may result microcytic anemia patients esrd may blunt response r huepo therapy,C15,0.0020106635,0.0017835589,0.032933746,0.0011297098,0.0027997852,0.002594866,0.20032932,0.0018908523,0.0014536203,0.001975595,0.03342748,0.016255105,0.041800927,0.004824821,0.0017681267,0.012854595,0.18800306,0.011792047,0.02175082,0.050538808,0.32183164,0.010420699,0.035830136
social integration older thalassaemic patient social policy favours fullest possible social integration chronically ill patients evaluated facilities needed achieve patients beta thalassaemia major light therapeutic advances permit survive adulthood investigated social integration adolescent young adult thalassaemic patients greece ferrara italy patients areas show good level social integration favourable self image indicating may achieved providing psychosocial support part comprehensive approach treatment,C15,0.003640009,0.0032288698,0.0067918794,0.0020451725,0.022686826,0.0046976213,0.29377386,0.0034231085,0.0026315646,0.0035765227,0.017889965,0.007486803,0.023105323,0.008371835,0.0032009322,0.0056682513,0.18508975,0.0037486057,0.02175687,0.22681032,0.1277196,0.001292435,0.021363882
evaluation manual hexadimethrine bromide polybrene technique investigation autoimmune hemolytic anemia use direct manual hexadimethrine bromide polybrene test dpt investigation patients autoimmune hemolytic anemia aiha evaluated seventy nine blood samples patients tested direct antiglobulin test dat using monospecific reagents dpt performed concentrated ether eluate tested dat positive patients negative good correlation among dat eluate dpt demonstrating presence immunoglobulin red cell surface contrast dpt detect c often negative cases aiha c alone demonstrated dat dat negative cases dpt results correlated reactive eluates however four cases steroid responsive dat negative hemolytic anemia dpt supported diagnosis aiha eluate react dpt useful additional screening test investigation aiha recommended replacement either eluate testing dat,C15,0.0030948285,0.0027452672,0.0065896735,0.0017388578,0.019304374,0.018947598,0.23502219,0.002910414,0.002237423,0.0030408506,0.37409294,0.0063654706,0.04787176,0.040751036,0.032670084,0.004819291,0.10391937,0.00318716,0.0035239174,0.019784756,0.06309894,0.0010988611,0.0031849353
viral infections transfusion dependent patients beta thalassemia major predominant role cytomegalovirus months transfusion dependent patients beta thalassemia ranging age years observed serologic evidence viral infections collection serial serum samples seventy six age matched healthy subjects two patient followed controls samples taken beginning middle end study tested viral antigens complement fixation cf addition tests antibodies hiv epstein barr virus hepatitis virus markers hepatitis b virus performed changes antibody titer cf tests greater equal fold increase decrease persistently high titers greater equal revealed specific enzyme immunoassays eias igm iga antibodies performed concomitant cf tests sera symptomatic infections occurred viral cultures direct detection antigens carried immunofluorescence methods eia latex agglutination tests thalassemic patients controls similar p greater overall rates serologically confirmed viral infections versus former group higher p less incidence cytomegalovirus cmv infections versus cmv infections associated thalassemic patients hepatitis cases lymphadenitis cases upper respiratory tract infection case remaining cases cmv subclinical course moreover thalassemic patients lower p less incidence symptomatic infections versus controls therefore study showed symptomatic subclinical cmv infections may occur often thalassemic patients otherwise subclinical viral infections overall rate similar healthy subjects,C15,0.0015802159,0.0014017303,0.0029485188,0.00088785886,0.002206133,0.009629257,0.21322668,0.0014861223,0.0011424257,0.0091973,0.12044917,0.019564403,0.10020909,0.06958752,0.001389602,0.002646355,0.16164148,0.009454382,0.0017993082,0.10857499,0.097279444,0.023508707,0.040189315
hypergammaglobulinemic purpura waldenstrom hypergammaglobulinemic purpura waldenstrom characterized hypergammaglobulinemia recurring purpura elevated erythrocyte sedimentation rate presence rheumatoid factor indicative circulating immune complexes significant association autoimmune diseases especially sjogren syndrome lupus erythematosus hypergammaglobulinemic purpura considered primary associated disease secondary associated diseases usually autoimmune immune derangements fundamental pathogenesis although cause still unknown therapy unrewarding probably unnecessary usually benign condition three cases presented representative patients hypergammaglobulinemic purpura,C15,0.0044187,0.0039196075,0.008465031,0.0024826874,0.0061529,0.0057025626,0.40876675,0.004155399,0.0031945233,0.0043946146,0.040995397,0.009088421,0.058826067,0.042202964,0.0038856931,0.0068808347,0.085247025,0.0045505282,0.00503134,0.1594834,0.12602341,0.0015689199,0.0045631807
normal reticulin level iliac bone marrow level marrow reticulin may factor used presence hematologic disorder considered knowledge study graded amount reticulin present normal iliac bone marrow grading reticulin stains bone biopsy specimens hematologically normal patients documented normal amount reticulin marrow low twenty seven percent patients marrow reticulin grade using bauermeister scale grade n grade grade patient bauermeister grade reticulin level knowledge normal range reticulin essential reticulin level used factor evaluating possibility hematologic disorder,C15,0.0037052184,0.0032867137,0.0069135535,0.0020818112,0.0051593995,0.0047817775,0.2574041,0.0034844324,0.002678708,0.0036405947,0.04916817,0.025548482,0.04967404,0.024348166,0.0032582756,0.0057697957,0.15422998,0.042855844,0.004241543,0.10357043,0.2390716,0.0013155885,0.0038117922
improvement brain function hemodialysis patients treated erythropoietin evaluate effects recombinant human erythropoietin rhuepo brain function chronic hemodialysis patients studied event related p stimulus related evoked potentials trailmaking hematocrit rhuepo hematocrit p peak latency elicited tone discrimination paradigm improved vs ms cz vertex p less confirming beneficial effects cerebral cognitive processing p amplitude vs microv p trailmaking tended improve vs p measures influenced low hemoglobin levels rhuepo p less suggesting severe anemia may contribute uremic brain dysfunction furthermore decrease stimulus related auditory brainstem v interpeak latency vs ms p less increase somatosensory n p amplitude vs microv p less pointed improvement sensory pathways mechanisms unrelated cognition brain dysfunction chronic hemodialysis patients may beside factors part caused severe anemia improved rhuepo treatment,C15,0.07673796,0.0023877665,0.0050226315,0.0015124162,0.003823597,0.020646535,0.23284131,0.0025314072,0.0019460561,0.0026448579,0.027062248,0.005733567,0.21751566,0.03245011,0.0023671065,0.004191702,0.086573854,0.0027831604,0.0030650175,0.07426958,0.16245623,0.013960213,0.017477037
impaired thermoregulation thyroid function iron deficiency anemia ten women iron deficiency anemia depleted iron stores nonanemic control women similar body fatness exposed degrees c water bath test hypothesis iron deficiency anemia impairs thermoregulatory performance anemic women lower rectal temperatures control women vs degree c respectively p lower rate oxygen consumption vs ml min kg body wt respectively p min cold exposure plasma thyroxine triiodothyronine concentrations significantly p less lower anemic control women baseline cold exposure responses iron depleted subjects similar control subjects iron supplementation corrected anemia significantly p improved rectal temperature min partially normalized plasma thyroid hormone concentrations plasma catecholamines unaffected iron status experiment demonstrates functional consequence iron deficiency anemia balance heat production loss suggests thyroid hormone metabolism may responsible,C15,0.0023283735,0.0020653834,0.026975714,0.001308218,0.0032424934,0.0030048871,0.08472172,0.0021896306,0.0016833104,0.0022877636,0.0108196745,0.102360085,0.26760137,0.005491564,0.022452207,0.0036364151,0.023216229,0.017726058,0.0026511957,0.1403251,0.25948983,0.0008267208,0.013596007
alterations pulmonary mechanics transfusion anemic preterm infants pulmonary mechanics studied ten anemic preterm infants using esophageal balloon mask transfusion ml kg packed rbc mean birth weight g gestational age wk transfusions carried mean postnatal age days mean hct increased dynamic lung compliance decreased infants transfusion increase resistance work breathing increased transfusion changes might due volume overload increased lung water content,C15,0.03847689,0.02331211,0.02728867,0.0022869606,0.005667826,0.07067807,0.13269338,0.0038278014,0.002942678,0.023695856,0.020729633,0.008482048,0.20219114,0.00935898,0.0035793583,0.0063909325,0.042827617,0.00419178,0.0046346863,0.1575247,0.16419859,0.040832836,0.0041874205
hematopoietic defect aplastic anemia assessed long term marrow culture thirty two patients aplastic anemia aa studied using long term bone marrow culture ltbmc system patients treated immunosuppressive therapy including antilymphocyte globulin alg without androgens high dose methyl prednisolone remaining six patients either required treatment studied therapy begun thirty one patients defective hematopoiesis ltbmc little evidence generation primitive progenitor cells exception patient spontaneous recovery aplasia defect less marked crossover ltbmc experiments performed cases inoculating patient marrow hematopoietic cells depleted adherent cells onto preformed irradiated normal stromas assess proliferative capacity hematopoietic cells normal marrow hematopoietic cells depleted adherent cells onto preformed irradiated stromas patients aa assess stromal function results experiments demonstrated hematopoietic defect patients independent degree hematologic recovery alg therapy one patient probable stromal defect coexisted defect regenerative capacity hematopoietic cells conclude ltbmc sensitive method detecting defining hematopoietic failure aa suggest defective hematopoiesis present patients studied may important pathogenesis clonal evolution aa,C15,0.002032702,0.011642595,0.032122426,0.0011420924,0.04630717,0.002623308,0.2364348,0.0019115777,0.0014695531,0.0019972492,0.039127443,0.015712248,0.048894033,0.14370376,0.001787507,0.04288392,0.17975628,0.012082989,0.0023145303,0.039894167,0.13328747,0.0007217387,0.0021504401
molecular defect band protein southeast asian ovalocytosis background southeast asian ovalocytosis form hereditary elliptocytosis red cells rigid resistant malaria invasion underlying molecular defect unknown methods results studied red cells patients ovalocytosis normal controls found ovalocytes contain structurally functionally abnormal band protein principal transmembrane protein red cells structural lesion ovalocyte band revealed limited proteolytic cleavage protein produced fragments abnormal size derived cytoplasmic domain protein structural lesion present subjects ovalocytosis none controls region band serves principal binding site membrane skeleton submembrane protein network composed ankyrin spectrin actin protein structural defect dominantly inherited tightly linked inheritance ovalocytosis probability linkage excess million ovalocyte band bound considerably tightly normal band ankyrin connects membrane skeleton band protein tight binding ovalocyte band underlying skeleton containing ankyrin directly confirmed intact cells finding ovalocyte band markedly reduced lateral mobility membrane conclusions red cells southeast asian ovalocytosis carry structurally functionally abnormal band protein molecular defect may underlie increased rigidity red cells resistance invasion malaria parasites,C15,0.0019617176,0.0017331468,0.013896246,0.0010977788,0.11496248,0.011978021,0.17638676,0.011335821,0.01078213,0.0019197551,0.055373274,0.004102144,0.03709213,0.09528427,0.14358784,0.0030425235,0.027467687,0.14441784,0.021067202,0.034029655,0.08573083,0.0006937349,0.0020570406
pulse oximetry uses abuses pulse oximetry made significant contribution noninvasive monitoring wide variety clinical situations allows continuous reliable measurements oxygen saturation avoiding discomfort risks arterial puncture extent hypoxic episodes various procedures clinical settings better appreciated role continuous noninvasive monitoring undoubtedly expand understanding principles technology pulse oximetry allow physicians obtain maximal clinical benefit use,C15,0.023439864,0.025299488,0.008765729,0.0024829686,0.0061535966,0.0057032085,0.34282085,0.0041558696,0.0459772,0.004342124,0.092590965,0.009094659,0.086087964,0.031476866,0.0038861334,0.04966411,0.108732,0.0045510437,0.00503191,0.0723,0.061328024,0.0015690975,0.0045463108
cytokine production il alpha il beta tnf alpha endothelial cell activation elam hla dr reactive lymphadenitis hodgkin disease non hodgkin lymphomas immunocytochemical study cryostat sections lymph nodes immunostained polyclonal rabbit serum il alpha monoclonal antibodies directed il alpha vmp il beta vhp brhc tumor necrosis factor alpha tnf alpha b furthermore presence cytokine containing cells correlated expression endothelial leukocyte adhesion molecule elam f human leukocyte antigen hla dr okia endothelial cells cells containing il tnf alpha detected mainly pathologic conditions characterized reactive neoplastic expansion lymph node paracortex cells positive il detected cases hodgkin disease cases nhl cases diffuse mixed lymphadenitis interleukin alpha detected macrophages interdigitating reticulum cells idrcs endothelial cells neoplastic hodgkin reed sternberg h rs cells cells positive il beta much fewer consisted mainly macrophages hodgkin reed sternberg cells negative il beta even vitro stimulation bacterial endotoxin tumor necrosis factor alpha tnf alpha present macrophages h rs cells endothelial leukocyte adhesion molecule expression endothelial venules detected cases hodgkin disease cases nhl cases diffuse lymphadenitis pathologic conditions hla dr antigens also expressed frequently endothelial cells cytokine containing cells elam positive high endothelial venules hev extremely rare lymph nodes involved follicular lymphadenitis cases b nhl cases cases reactive neoplastic b cell proliferations hla dr positive hevs still present often results indicate il tnf alpha production tissue level often associated elam expression hevs less well correlated expression hla dr antigens endothelial cells,C15,0.001544643,0.0013701754,0.0029588807,0.008299835,0.0022452758,0.0019934422,0.1679463,0.11353608,0.001116708,0.0015270778,0.15071133,0.0035466317,0.036130965,0.21901068,0.00135832,0.009879222,0.02198103,0.009063908,0.0017588031,0.022484599,0.076386556,0.015500209,0.12964937
enhanced endogenous leukotriene biosynthesis patients treated granulocyte macrophage colony stimulating factor hematopoietic cytokine granulocyte macrophage colony stimulating factor gm csf used clinical trials potential treatment hematopoietic insufficiency due various causes involvement leukotrienes effects gm csf suggested analytical pharmacologic evidence obtained vitro however data support role leukotrienes gm csf action vivo presented present investigation question approached measurement endogenous cysteinyl leukotriene formation patients treated cytokine cytopenia induced cytostatic drugs refractory anemia excess blasts raeb endogenous cysteinyl leukotriene formation assessed determination urinary leukotriene metabolites using combined high performance liquid chromatography radioimmunoassay analysis gm csf administration distinct increase urinary cysteinyl leukotrienes found cytopenic raeb patients ranged fold fold respectively cytopenic patients increase leukotriene production correlated expansion peripheral blood leukocytes raeb patients responded gm csf enhanced leukotriene biosynthesis even peripheral leukocytes decreased possibly due abnormal number irritability leukotriene producing cells increase endogenous leukotriene production therapy gm csf may indicate leukotrienes play role gm csf action vivo,C15,0.0020525546,0.0018189221,0.03370887,0.011780513,0.0028552976,0.0026463154,0.3082683,0.0019529879,0.0014824417,0.0020147657,0.025285043,0.0042376067,0.067037396,0.030116102,0.001803184,0.0626557,0.09010567,0.0022220365,0.022183778,0.041574225,0.2813568,0.0007280686,0.0021133535
impact marrow cytogenetics morphology vitro hematopoiesis myelodysplastic syndromes comparison recombinant human granulocyte colony stimulating factor csf granulocyte monocyte csf marrow cells patients myelodysplastic syndromes mds refractory anemia ra refractory anemia excess blasts raeb raeb transformation raeb evaluated vitro proliferative differentiative responsiveness recombinant human granulocyte colony stimulating factor g csf granulocyte monocyte csf gm csf gm csf exerted stronger proliferative stimulus g csf marrow myeloid clonal growth cfu gm patients v colonies per nonadherent buoyant bone marrow cells nab respectively p less gm csf stimulated increased cfu gm growth patients abnormal marrow cytogenetics comparison patients normal cytogenetics colonies per nab respectively p less whereas difference could demonstrated g csf colonies per nab respectively contrast granulocytic differentiation marrow cells induced liquid culture g csf patients gm csf patients p less including raeb raeb patients versus respectively p less mds patients normal cytogenetics g csf gm csf induced marrow cell granulocytic differentiation versus respectively p less contrasted granulocytic induction patients abnormal cytogenetics respectively conclude g csf greater granulocytic differentiative less proliferative activity mds marrow cells gm csf vitro particularly raeb raeb patients normal cytogenetics,C15,0.0022273217,0.0019757454,0.004155951,0.0012514412,0.0031020022,0.013610842,0.1341201,0.0020946003,0.0016102544,0.0021884744,0.012999491,0.004666834,0.21022375,0.17950416,0.0019586505,0.05935284,0.14132155,0.013230795,0.0026276289,0.0641233,0.08315697,0.000790841,0.05970648
histiocytosis x protein peanut agglutinin transmission electron microscopy study twenty seven cases histiocytosis x hx paraffin blocks available studied use protein immunohistochemistry peanut agglutinin affinity histochemistry transmission electron microscopy results show techniques enable identification langerhans type histiocytes cases respectively techniques proved diagnostic value hx none able confirm diagnosis instances none could foretell prognosis patients study shows besides langerhans cells indeterminate cells skin interdigitating dendritic reticulum cells lymph node may also involved process moreover multinucleate giant cells foamy cells may derived langerhans related cells,C15,0.019849816,0.019476194,0.0063450155,0.0019107235,0.021196352,0.0043885466,0.2377203,0.0031993217,0.06826182,0.0033412094,0.2030977,0.00712079,0.044965595,0.09836755,0.0029903303,0.038203686,0.054744646,0.051947635,0.0038719908,0.026199393,0.06085847,0.0012074007,0.020735519
rheologic properties mixed hemoglobin gels deoxyhemoglobins obtain new information concerning behaviors turn structures gels formed mixtures hemoglobins physical properties characterized stress relaxation rotational rheometer variables manipulated initial total hemoglobin concentration mole fraction hemoglobin present mixture hemoglobin intact tetramer tetramer hybridized hemoglobin annealing time shear history temperature temperature time annealing characteristics monitored gain information effect variables gel properties lag time polymer mass polymer fraction polymer composition equilibrium total hemoglobin activity solidity total hemoglobin polymer mass total hemoglobin fraction expected mixed hemoglobin sa gels less solid pure similar initial hemoglobin concentrations lower polymer mass gel properties influenced shear history annealing time temperature temperature time annealing however solidities compared basis similar quantities gel present mixed hemoglobin sa gels found solid pure mole fraction hemoglobin decreased initial mixture explained predominant influence gel properties high hemoglobin activity incurred volume exclusion effect total hemoglobin concentration presence hemoglobin hemoglobin results polymers gels differ found pure hemoglobin pathophysiologic implications findings sickle cell disorders proposed,C15,0.0016596866,0.0014689467,0.11327773,0.0009304338,0.002305915,0.074273765,0.17970166,0.0015573141,0.0011972078,0.0016271084,0.009591826,0.003414056,0.054877155,0.046261765,0.047953434,0.0025787225,0.043162454,0.0017053962,0.0018855894,0.045925565,0.20935449,0.14487867,0.010411098
increased serum ige increased prevalence eosinophilia year old children smoking parents studied relationship serum ige levels eosinophil counts passive smoking year old nonselected children three italian towns near rome male children smoking parents significantly higher total count percentage eosinophils p higher ige levels p male children nonsmoking parents prevalence eosinophilia defined greater equal total white blood cell count significantly correlated number cigarettes smoked parents among boys p among girls p significant trend p prevalence eosinophilia increase increasing levels serum ige given level serum ige frequency eosinophilia higher among children smoking parents among children nonsmoking parents parental smoking studied multivariable analysis controlling variable still significantly associated eosinophilia children smoking parents serum ige levels conclude parental smoking associated significant enhancement expression important markers allergic sensitization children smoking parents particularly evident boys may explain least part increased frequency respiratory symptoms children smoking parents,C15,0.0020104127,0.0017833365,0.0037512218,0.001129569,0.0027994362,0.0025945425,0.13558249,0.0018906166,0.02091314,0.13017619,0.009645525,0.004190889,0.11462149,0.015182103,0.0017679611,0.0031306308,0.018355481,0.0020703918,0.0022891508,0.24865335,0.2546641,0.010444061,0.012353959
specific vitro bioassay measuring erythropoietin levels human serum plasma accurate measurement biologically active erythropoietin ep human serum plasma using present vivo vitro bioassays difficult presence inhibitors non ep stimulators erythropoiesis developed simple procedure quantitatively purify ep serum plasma subsequent testing phenylhydrazine treated mouse spleen cell assay method involves absorption ep immobilized high affinity anti ep monoclonal antibody acid elution antibody bound material neutralization eluted ep tested directly vitro bioassay without interference serum proteins using magnetic beads solid support antibody washing elution steps performed rapidly efficiently recoveries ep procedure show little sample sample variation consistently close maximum binding expected anti ep antibody coupled fold concentration procedure affords overall increase sensitivity three fourfold makes assay suitable accurately measuring ep levels patients average titers results magnetic bead assay indicate accurate reproducible estimates ep levels serum plasma healthy donors well patients hematologic disorders obtained titers biologically active ep sera group patients either leukemia lymphoma found elevated values correlated well titers immunoreactive ep measured ep radioimmunoassay specificity high sensitivity magnetic bead assay valuable alternative immunoassays measurement elevated normal even subnormal ep levels human serum plasma,C15,0.0015923269,0.0014124735,0.026110064,0.00089466356,0.0022172648,0.002054981,0.18720008,0.0014974435,0.0011511815,0.0015645548,0.08910282,0.010983636,0.10112104,0.12120716,0.0014002521,0.02174149,0.082577236,0.05235414,0.0018130984,0.034040652,0.25575435,0.0005653775,0.001643746
total differential leukocyte counts clinically well children information misinformation determine whether total differential leukocyte count value case finding test applied evaluation criteria developed us preventive services task force criteria comprise review current burden suffering disease prevented attributes intervention used quality evidence available literature search revealed evidence form data patients chart review complete blood cell counts ordered year period one group pediatricians undertaken least one value outside published normal ranges found tests performed clinically well children unsuspected illness discovered result abnormal total differential leukocyte count,C15,0.0025271247,0.026708368,0.0048046093,0.0014198882,0.016166579,0.003261386,0.24953298,0.0023765387,0.014029529,0.026951613,0.09864521,0.017431963,0.07999043,0.01931472,0.0022225033,0.016166473,0.0865318,0.0026064708,0.018269109,0.09041812,0.21712555,0.0008972901,0.0026017015
human neutrophil cytochrome b light chain p phox gene structure chromosomal location mutations cytochrome negative autosomal recessive chronic granulomatous disease membrane bound cytochrome b heterodimer formed kd glycoprotein heavy chain kd polypeptide light chain essential component phagocyte nadph oxidase responsible superoxide generation cytochrome b absent two subgroups chronic granulomatous disease cgd inherited disorder characterized lack oxidase activity mutations cytochrome heavy chain gene encoded cybb locus xp result x linked form cgd rare subgroup autosomal recessive cgd also lacks cytochrome b cgd genetic defect previously identified order search possible mutations cytochrome light chain locus cyba structure gene characterized cyba locus localized q approximately bp open reading frame determined encoded six exons span approximately kb three unrelated patients cgd studied evidence mutations light chain gene one patient whose parents first cousins homozygous large deletion removed extreme coding sequence gene two patients grossly normal light chain transcript northern blot mononuclear cell rna light chain transcript amplified polymerase chain reaction sequenced one patient compound heterozygote two alleles containing point mutations open reading frame predict frame shift nonconservative amino acid replacement respectively second patient whose parents second cousins homozygous different single base substitution resulting another nonconservative amino acid change results indicate cgd results defects gene encoding kd light chain phagocyte cytochrome b,C15,0.0014999707,0.0013305489,0.075356446,0.00084277237,0.01618014,0.0019357903,0.28091136,0.015919972,0.0010844121,0.015990436,0.032525986,0.03648505,0.016786307,0.013495205,0.0013190364,0.0023357663,0.059374582,0.016534153,0.0017079373,0.04644077,0.07030892,0.0005325851,0.29110187
incubation platelet concentrates transfusion improve posttransfusion recovery incubation stored platelet concentrates pcs degrees c hour reported result better morphology score improved platelet recovery study conducted adult patients leukemia determine whether incubation stored pcs results improved platelet recovery measured minute posttransfusion corrected count increments cci eligible patients platelet counts less per microl clinically stable patients transfused units pc stored days studies days studies platelets pooled split two equal volumes patient received two sequential half transfusions one incubated degrees c hour kept degrees c hour patients randomized half transfusion received first mean cci incubated half transfusions x given first x given second significantly different mean cci nonincubated half transfusions x given first x given second contrast earlier reports concluded incubation pooled pcs improve platelet recovery,C15,0.002276376,0.0020192591,0.015361663,0.0012790028,0.0031697813,0.0029377816,0.19498073,0.0021407316,0.0016457185,0.0022366731,0.010661175,0.04442209,0.11697101,0.005234091,0.0020017875,0.0035447907,0.14041273,0.0023442898,0.0026523403,0.01880052,0.41077852,0.00080825837,0.013320646
elevated serum procollagen iii aminopeptide levels sarcoidosis procollagen iii aminopeptide p iii p peptide released conversion type iii procollagen type iii collagen considered potential marker fibroblast activity variety pulmonary extrapulmonary diseases aim present article investigate levels p iii p serum samples sp iii p large number sarcoid patients particular looking relationship markers disease activity presumed role marker pulmonary fibrosis sp iii p radioimmunoassayed overall series patients levels higher ng ml age sex matched controls ng ml p less elevation neither sex related related obvious liver sarcoid localization although sp iii p levels slightly higher patients stage ii significant difference patients stage iii found positive relationship serum angiotensin converting enzyme ace levels p less markers disease activity ga uptake bronchoalveolar lavage bal lymphocyte percent vital capacity lung diffusing capacity relationship ace confirmed longitudinal follow study sp iii p strictly paralleled ace behavior finally initial sp iii p levels predict cases either disease relapse resistance corticosteroid treatment conclude study sp iii p levels failed characterize sarcoid patients radiologic fibrotic pattern stage iii addition unable predict patients would poor prognosis rather reflect metabolic activity sarcoid granuloma cells thus usefulness sp iii p treatment patients sarcoid may considered similar ace,C15,0.015720082,0.0014458835,0.018800594,0.009056329,0.0022699598,0.019574123,0.28747463,0.0015328634,0.0011784111,0.001601562,0.04947733,0.004795959,0.0430417,0.027847616,0.0014469649,0.017644003,0.15088902,0.01802647,0.0018559847,0.063283965,0.26077762,0.0005787506,0.0016801627
fluosol da treatment severe anemia randomized controlled study patients evaluated safety efficacy fluosol da fda blood substitute treatment severe anemia thirty six patients received either fda n crystalloid hydroxyethyl starch chs n part randomized controlled trial ten patients received fda part humanitarian protocol jehovah witnesses refused transfusion bled recently average hgb levels g dl pulmonary artery catheter insertion patient infused chs attain pulmonary artery wedge pressure wp mm hg fda given one time dose ml kg data collected baseline h none patients negative reactions ml test dose fda adverse reactions subsequent infusion plasma dissolved component oxygen content significantly higher fda group h fda group ml dl control group ml dl p less test nineteen patients died fda seven control difference significant conclude following fda given safely severely anemic patients doses ml kg b fda significantly increased dissolved component oxygen content h effect persist c severely anemic patients survive without transfusion although mortality high study inability fda sustain increased oxygen content due part rapid elimination fda also limited amount given,C15,0.042294987,0.0016399873,0.021393463,0.0010387714,0.0025744105,0.01627604,0.15392809,0.001738644,0.0013366078,0.0018165652,0.07240457,0.074077874,0.1924688,0.004256262,0.037412625,0.0030510656,0.13528919,0.0019039685,0.0021495454,0.034931727,0.19545834,0.0006564455,0.0019019883
prenatal diagnosis laryngeal atresia patient preeclampsia developed weeks gestation ultrasonographic examination fetus showed enlarged edematous lungs compressed fetal heart severe ascites fetal hydrops placental edema autopsy hydropic stillborn infant showed laryngeal atresia ultrasonographic appearance rare malformation presented,C15,0.005487282,0.004858984,0.010220801,0.0030776905,0.00762751,0.060095873,0.19015585,0.11090542,0.13650891,0.0053821523,0.0811966,0.011266561,0.050500665,0.012594901,0.0048169424,0.008529902,0.082138546,0.0056411126,0.0062371558,0.11379918,0.081377834,0.0019449287,0.0056352452
immunoglobulin g subclasses serum circulating immune complexes patients kawasaki syndrome igg subclass concentrations sera patients kawasaki syndrome determined significantly increased igg p less igg p less found patients compared age matched healthy children whereas igg igg normal slightly decreased igg immune complexes measured protein enzyme linked immunosorbent assay elisa combined polyethylene glycol precipitations eight patients found circulating immune complexes cic values normal control range geometric mean sd igg subclass composition cic analyzed subclasses cic predominantly igg igg antibody responses different antigens exhibit igg subclass restriction would suggest change serum cic igg subclasses kawasaki syndrome may relevance pathogenesis disease,C15,0.0029615483,0.0026270412,0.0056204493,0.0016639732,0.0041238624,0.0038220324,0.15212561,0.002785076,0.0021410675,0.017247012,0.014110498,0.006112873,0.15169609,0.05425519,0.0026043109,0.0046117464,0.09285335,0.032109797,0.0033721584,0.08947625,0.34957117,0.0010515382,0.0030573206
rheologic properties mixed hemoglobin gels deoxyhemoglobins f obtain new information concerning behaviors turn structures gels formed mixtures f hemoglobins rheologic properties characterized stress relaxation variables manipulated initial total hemoglobin concentration mole fraction hemoglobin present mixture hemoglobin f intact tetramer tetramers hybridized hemoglobin hemoglobin f predominantly g gamma gamma mixture gamma chain types annealing time shear history temperature temperature time annealing characteristics monitored gain information effect variables gel properties lag time polymer mass polymer fraction polymer composition equilibrium total hemoglobin activity solidity total hemoglobin polymer mass total hemoglobin fraction expected mixed hemoglobin f gels less solid pure hemoglobin gels similar initial total hemoglobin concentrations lower polymer mass gel properties influenced annealing time shear history temperature temperature time annealing however solidities compared basis similar quantities gel present mixed hemoglobin f gels found solid pure mole fraction hemoglobin decreased initial mixture explained predominant influence gel properties high hemoglobin activity incurred volume exclusion effect total hemoglobin concentration pathophysiologic implications findings various sickle cell disorders proposed,C15,0.0016868538,0.00149288,0.115792684,0.00094563456,0.002343485,0.07548418,0.16104317,0.0015826871,0.0012167137,0.0016536186,0.009884232,0.003469744,0.07642361,0.04192582,0.05002854,0.002620737,0.044725306,0.001733182,0.001916311,0.04738228,0.19785278,0.13909167,0.01970387
cardiac abnormalities children sickle cell anemia cardiac status children ages yr sickle cell anemia documented hemoglobin electrophoresis evaluated echocardiography left atrial left ventricular aortic root dimensions significantly increased percent children ages compared values normal black non sca control subjects left ventricular wall thickness increased percent older children sickle cell anemia estimated lv mass left ventricular cardiac index increased compared control subjects p less left heart abnormalities expressed single composite function derived multivariate regression analysis correlated well severity anemia expressed grams hemoglobin r p less percentage hemoglobin r p less extent age echocardiographically assessed left ventricular function rest comparable control subjects data suggest major cardiac abnormalities children related volume overload effects chronic anemia age group evidence distinct sickle cell cardiomyopathy cardiac dysfunction,C15,0.0021575638,0.0019138667,0.014466163,0.0012128003,0.0030043393,0.0027844484,0.13436581,0.012850437,0.0015598226,0.06010089,0.028294608,0.015221049,0.28570378,0.02615715,0.0018973071,0.019869203,0.12357459,0.0023461548,0.0024567037,0.10583434,0.07808229,0.073874734,0.0022719598
prognosis chronic granulomatous disease records patients chronic granulomatous disease born year period reviewed characteristics group frequency various clinical laboratory features recorded assessed nine patients known died cases progressive suppurative infection actuarial analysis showed survival third decade life long term survival patients developing symptoms end first year life significantly better patients whose illness started infancy data confirm severity chronic granulomatous disease uniform prognosis long term survival better suggested earlier reports early onset may poor prognostic sign invasive aspergillosis life threatening complication absence curative treatment trials assess effectiveness interferon gamma necessary early antenatal diagnosis offered many affected families possible,C15,0.0022037337,0.012619135,0.004111938,0.011864833,0.0030686292,0.013506081,0.41891715,0.0020724176,0.0015932013,0.03547695,0.049410958,0.015203093,0.036381554,0.015930437,0.012599457,0.0034316715,0.2150963,0.0022729104,0.013176279,0.08338542,0.04462418,0.00078246574,0.0022711963
iron nutrition monitoring nutrition status assessment majority anemias united states characterized low mean corpuscular volume thus classified microcytic iron deficiency chronic disease thalassemia traits three leading causes microcytic anemia true cause anemia must always sought prevalence estimates iron deficiency accurate appropriate treatment initiated anemic individual clinical setting surveys frequent differential diagnosis microcytic anemia involve distinguishing iron deficiency chronic disease erythrocyte sedimentation rate esr zeta sedimentation rate zsr c reactive protein crp elevated variety diseases indicators may help differentiate anemia chronic disease iron deficiency iron deficiency overestimated hospitalized aged populations red cell distribution width rdw appears elevated greater extent iron deficiency chronic disease thalassemia traits rdw crp two several indicators iron status third national health examination survey nhanes iii,C15,0.002656962,0.002356858,0.0049740826,0.0014928386,0.0037559129,0.028957099,0.4268336,0.0024986393,0.014714177,0.0026137414,0.09441471,0.0057849213,0.049692426,0.019429319,0.0023364653,0.029859163,0.026488338,0.015598027,0.07042108,0.11409003,0.07734882,0.00094339065,0.002739398
hla b dr dqw clozapine induced agranulocytosis jewish patients schizophrenia agranulocytosis develops approximately patients chronic schizophrenia treated atypical neuroleptic drug clozapine previous studies identified mechanism risk factors adverse reaction observed association jewish ethnic background development agranulocytosis patient sample treated clozapine refractory symptoms hla typing performed patients developed agranulocytosis hla b phenotype found patients developed agranulocytosis clozapine treated patients develop agranulocytosis b part haplotype known occur frequently ashkenazi jewish population frequencies combined alleles hla b dr dqw examined incidence hla b dr dqw significantly increased patients agranulocytosis five five patients compared control patients ashkenazi jewish ancestry two patients findings indicate genetic factors marked major histocompatibility complex haplotypes may associated susceptibility jewish schizophrenic patients treated clozapine develop agranulocytosis postulate gene products contained haplotype may involved mediating drug toxicity,C15,0.0023276324,0.002064726,0.012556423,0.0013078017,0.0032411544,0.003003931,0.39293614,0.0021889335,0.0016827746,0.0022904722,0.024975736,0.0048399745,0.033746004,0.0061403103,0.0020468612,0.014889185,0.18796705,0.02564909,0.0026503517,0.14052719,0.09814866,0.0008264577,0.033993144
disseminated intravascular coagulation due intravenous administration hetastarch disseminated intravascular coagulation occurred patient intravenous administration hetastarch onset acute within hours exposure agent course fulminating patient died hours clinical hematologic pathologic features presented possible pathophysiologic mechanism discussed view experience documented effects hetastarch coagulation use hetastarch avoided patient history coagulation disorder patient receiving agent closely monitored appropriate coagulation tests,C15,0.0039201654,0.003473683,0.0073557626,0.0022002377,0.005452899,0.0050537954,0.32287455,0.023172004,0.00283109,0.022803191,0.036849674,0.05591786,0.033029195,0.009267229,0.022399826,0.02505281,0.22325355,0.0040328256,0.0044589364,0.05143228,0.12974937,0.0013904275,0.0040286314
primary splenic lymphocyte depletion hodgkin disease case lymphocyte depletion hodgkin disease described purpose reviewing criteria currently used distinguish disease pleomorphic large cell malignancies year old man month history daily fevers underwent extensive evaluation exploratory laparotomy revealed two large separate splenic tumor nodules postoperatively patient remained asymptomatic histologically tumor composed giant cells including typical reed sternberg forms mononuclear variants inflammatory stromal response along borders immunoperoxidase showed tumor cells strongly reactive leu cd ber h cd leu cd cd weakly reactive leu cd nonreactive ema lca lysozyme leu leu leu immunoglobulin light chains southern blot analysis revealed isolated clonal band kappa light chain included discussion case primary splenic lymphocyte depletion hodgkin disease review clinical histologic immunohistochemical gene rearrangement characteristics defined lymphocyte depletion hodgkin disease,C15,0.016134975,0.0024523025,0.0051583815,0.0015532933,0.11669111,0.016940683,0.3520333,0.029059881,0.0019986536,0.0027163422,0.08196061,0.005686171,0.017173165,0.04795151,0.029190246,0.0043049944,0.08615719,0.016669286,0.003147858,0.034451917,0.09631015,0.0009815947,0.031276364
increased incidence monoclonal gammopathy undetermined significance blacks age related differences whites basis study men one woman hospital setting serum samples individuals whites blacks exhibiting quantitatively normal amounts five typically seen fractions albumin alpha globulin alpha globulin beta globulin gamma globulin serum protein electrophoresis showing evidence multiple myeloma immunoproliferative diseases diseases known produce monoclonal proteins tested monoclonal gammopathy undetermined significance mgus immunofixation electrophoresis individual study serum protein electrophoresis pattern suggestive monoclonal protein gammopathy except one year old woman subjects men subjects divided seven age groups years years ii years iii years iv years v years vi years vii age considering subjects given race blacks two times higher incidence mgus whites difference statistically significant increased incidence mgus blacks compared whites prevailed age group difference statistically significant age groups except group ii mgus found groups iii either race races showed threefold increase incidence mgus group ii group vii routine laboratory test erythrocyte sedimentation rate subjects mgus significantly different age race matched individuals without mgus results show incidence mgus higher group blacks also known higher prevalence multiple myeloma,C15,0.0016170412,0.0014343963,0.0030172311,0.00090854947,0.0022516786,0.017714584,0.13508657,0.0015206852,0.03248134,0.001588838,0.047004588,0.14843029,0.068865314,0.01216518,0.0014405132,0.0025180695,0.02960341,0.04118948,0.0018646547,0.2925317,0.13032615,0.00057415257,0.025865583
transfusion alloimmunization sickle cell disease cooperative study sickle cell disease patients sickle cell disease transfused overall rate alloimmunization erythrocyte antigens rate alloimmunization group appears explicit function number transfusions received increases exponentially increasing numbers transfusions alloimmunization usually occurred less transfusions although rate alloimmunization continued increase transfusions given rate alloimmunization less patients hemoglobin sc disease sickle beta thalassemia patients received fewer transfusions children less years old slightly lower rate alloimmunization patients age groups even correction number transfusions given women frequently alloimmunized men largely due fact women received transfusions men age group years increase may due part alloimmunization owing pregnancy forty five percent alloimmunized made antibodies one specificity made four antibodies reacting different antigens antibodies c e antigens rh group kell antigen lewis antigens commonly made findings may important formulating rational transfusion policy sickle cell disease,C15,0.002074004,0.0018372273,0.00386458,0.0011637034,0.0028840324,0.002672947,0.25185627,0.0019477492,0.0014973605,0.012061559,0.020966662,0.07120122,0.093346596,0.094085984,0.0018213307,0.023184035,0.13719876,0.0021545363,0.012375247,0.17649066,0.062425762,0.010735095,0.012154674
detection drug dependent platelet reactive antibodies antigen capture elisa flow cytometry effectiveness flow cytometry detection drug dependent platelet reactive antibodies investigated studies seven sera known contain quinine quinidine dependent platelet reactive antibodies flow cytometry times sensitive detecting drug dependent antibodies ddabs cr release assay antigen capture enzyme linked immunosorbent assay elisa indirect immunofluorescence microscopic assay flow cytometry ddabs could detected drug concentrations low microm less one tenth level required methods antigen capture elisa sensitive flow cytometry ddab detection allow identification ddabs target molecules assay five seven ddabs recognized glycoprotein ib ix gpib ix glycoprotein iib iiia gpiib iiia complexes remaining two sera reacted gpib ix consecutive patients developed thrombocytopenia taking quinidine ddabs detected flow cytometry twice number detected methods one patient developed thrombocytopenia taking trimethoprim sulfamethoxazole ddabs could detected flow cytometry concluded flow cytometry highly sensitive detecting ddabs allows detection pharmacologic concentrations drug quinidine dependent antibodies recognize least two different glycoprotein complexes platelet membrane,C15,0.0021133078,0.012101145,0.046478186,0.0011873815,0.0029427141,0.002727334,0.3569007,0.0019873802,0.0015278275,0.002076449,0.124458514,0.0043466706,0.025301758,0.13923094,0.0018583896,0.0032908597,0.058147676,0.013850047,0.012618468,0.015696201,0.16821772,0.00075035886,0.00218996
sickle erythrocytes inhibit human endothelial cell dna synthesis patients sickle cell anemia experience severe vascular occlusive phenomena including acute pain crisis cerebral infarction obstruction occurs microvascular arterial level clinical presentation vascular events heterogeneous suggesting complex etiology interaction sickle erythrocytes endothelium may contribute vascular occlusion due alteration endothelial function investigate hypothesis human vascular endothelial cells overlaid sickle normal erythrocytes stimulated synthesize dna erythrocytes sedimented onto replicate monolayers centrifugation minutes g insure contact endothelial cells incorporation h thymidine endothelial cell dna markedly inhibited contact sickle erythrocytes inhibitory effect enhanced twofold autologous sickle plasma present endothelial cell labeling normal erythrocytes without autologous plasma modest effect endothelial cell dna synthesis sickle erythrocytes autologous sickle plasma applied endothelial monolayers minute minutes hour removed subsequent dna synthesis endothelial cells inhibited although adherence sickle erythrocytes endothelial monolayers observed experimental conditions effect sickle erythrocytes endothelial dna synthesis occurred absence significant adherence hence human endothelial cell dna synthesis partially inhibited contact sickle erythrocytes inhibitory effect sickle erythrocytes occurs brief minute contact endothelial monolayers persists least hours h thymidine labeling results indicate interaction sickle erythrocytes endothelium may result altered endothelial function altered endothelial function may contribute development vascular occlusive phenomena patients sickle cell anemia,C15,0.026120981,0.0013701345,0.002954985,0.000867846,0.0021508022,0.0061454456,0.20871556,0.15447813,0.0011166749,0.0015176572,0.007111753,0.0031769406,0.09603099,0.19376531,0.0088268295,0.017559372,0.046073973,0.0015912033,0.0017587508,0.019112263,0.18155456,0.00054843025,0.017451417
intravenous immunoglobulin virus associated haemophagocytic syndrome year old boy virus associated haemophagocytic syndrome caused cytomegalovirus infection described persistent severe thrombocytopenia responded repeated intravenous infusions immunoglobulin,C15,0.006531194,0.0057709874,0.012139186,0.0036553552,0.009059149,0.03986494,0.19206524,0.0061303894,0.0047034184,0.037879493,0.029919544,0.08704817,0.06117776,0.01495889,0.005721054,0.010170813,0.10580172,0.0066999164,0.0074078334,0.1812172,0.10008476,0.0023099803,0.06968301
analysis platelet aggregation disorders based flow cytometric analysis membrane glycoprotein iib iiia conformation specific monoclonal antibodies normal primary platelet aggregation requires agonist mediated activation membrane gpiib iiia binding fibrinogen gpiib iiia cellular events ligand binding pac monoclonal antibody distinguishes resting activated states gpiib iiia antibodies preferentially recognize gpiib pmi iiia anti libs binding fibrinogen fibrinogen mimetic peptides grgdsp using antibodies platelet flow cytometry studied two distinct persistent platelet aggregation abnormalities platelets thrombasthenic variant contained near normal amounts gpiib iiia failed aggregate bind pac response agonists addition grgdsp binds normal gpiib iiia without prior cell activation failed increase binding pmi anti libs thrombasthenic platelets suggesting primary defect ligand binding chromatography detergent solubilized platelets kygrgds affinity column confirmed patient gpiib iiia lacked fibrinogen binding site another patient myelofibrosis defective aggregation pac failed bind adenosine diphosphate stimulated platelets bind protein kinase c directly activated phorbol myristate acetate furthermore binding pmi anti libs increased response grgdsp confirming defect agonist mediated fibrinogen receptor activation rather fibrinogen binding events distal binding studies indicate immunochemical approach useful classification clinical abnormalities platelet aggregation defects either fibrinogen receptor activation b fibrinogen binding c postoccupancy events,C15,0.0018161753,0.0016110381,0.020971604,0.0010204511,0.04224668,0.011125314,0.2637899,0.0017153637,0.0013130138,0.0017844989,0.009746571,0.0038296257,0.022294635,0.049908265,0.010382323,0.0028281626,0.046187457,0.25954586,0.0020679827,0.02577451,0.21749577,0.0006448579,0.0018999751
colony stimulating factors recombinant hematopoietic colony stimulating factors profound effects developing mature granulocytes macrophages lymphocytes use agents treatment disease may result variety adverse cutaneous reactions recent discovery colony stimulating factor production keratinocytes dermal cells suggests agents may also significant cutaneous homeostasis pathogenesis cutaneous diseases,C15,0.0049479995,0.0043891226,0.03311541,0.0027800791,0.006889933,0.0063856514,0.41271198,0.028604295,0.0035771835,0.0048617003,0.022755686,0.03409047,0.039844383,0.1163253,0.004351146,0.0077050645,0.046119753,0.0050956192,0.005634025,0.07264989,0.106369615,0.0017568548,0.029038854
prenatal identification potential donors umbilical cord blood transplantation fanconi anemia reported studies fanconi anemia fetal cells led first use umbilical cord blood hematopoietic reconstitution clinical trial prenatal diagnosis hla typing performed fetuses risk fanconi anemia fa identify prior birth unaffected syndrome hla identical affected siblings umbilical cord blood harvested delivery infants assays progenitor cells indicated presence colony forming units granulocyte macrophage cfu gm numbers similar bone marrow cfu gm associated successful engraftment hla matched allogeneic bone marrow transplantation possibility umbilical cord blood single individual used alternative bone marrow hematopoietic reconstitution demonstrated successful engraftment two patients fa progenitor cell assays umbilical cord blood collected birth child affected fa misdiagnosed basis chorionic villus sampling cvs studies indicated profound deficiency colony formation consistent previously reported abnormalities growth fa cells vitro results suggest hematopoietic disorder fa related underlying problem cell proliferation,C15,0.0022521561,0.001997775,0.025971008,0.0012653946,0.0031363785,0.0029065248,0.30028087,0.002117955,0.03431145,0.013115619,0.0509785,0.0060249628,0.07494099,0.13044076,0.0020087464,0.0035070754,0.09951816,0.04592775,0.013465843,0.113768525,0.06887792,0.0007996588,0.0023859339
effects recombinant human interleukin aplastic anemia phase ii study nine patients aplastic anemia treated recombinant human interleukin rhil assess toxicity biologic effects multipotential hematopoietic growth factor doses ranging micrograms micrograms administered subcutaneous bolus injections daily days increase platelet counts microl microl induced rhil one patient increase reticulocyte counts microl four patients blood leukocyte counts temporarily increased eight patients fold median fold mainly due increase number neutrophils eosinophils lymphocytes monocytes two patients bone marrow cellularity increased respectively without resulting substantial improvement peripheral blood counts mild side effects headache flushing observed patients low grade fever occurred patients transient thrombocytopenia necessitating discontinuation rhil treatment occurred one patient conclusion rhil stimulate hematopoiesis patients aplastic anemia however lasting effects obtained,C15,0.0024680344,0.0021881363,0.009432641,0.00138597,0.0034348809,0.0031913975,0.15831286,0.002319768,0.0017833554,0.0024237335,0.0122758215,0.017633136,0.10360934,0.0068490948,0.0021692037,0.01874048,0.19057435,0.042505134,0.014737966,0.01834516,0.35293004,0.00087585574,0.031813685
newborn screening sickle cell disease infant lost follow success programs screen newborns sickle cell disease depends timely follow education regarding fever splenic palpation initiation prophylactic penicillin therapy reduce morbidity mortality occur prior months age however contacting parents permit implementation care may difficult particularly large urban populations nine infants recently identified sickle cell disease arrived institution initial appointments medical providers must aware medical legal obligations related follow newborns sickle cell disease prevent untoward events missed cases,C15,0.0032950947,0.03479315,0.0061428626,0.0018497406,0.004585213,0.020123512,0.31809965,0.0030960042,0.0023800982,0.0032347583,0.06926619,0.006771381,0.021637961,0.007569734,0.0028950584,0.0051266057,0.12592176,0.0033903976,0.004351593,0.29390582,0.05700423,0.0011689328,0.0033902526
identification characterization middle ear vascular leakage sites experimental otitis media site leakage middle ear vessels determined characterized experimental otitis media rats middle ear effusion induced intravenous administration local application tympanic bulla substance p sp acetylcholine histamine another experiment degrees c airstream blown external auditory canal colloidal carbon used trace leakage sites light electron microscopic levels mediators tested degrees c airstream resulted increased number leaking vessels pars flaccida middle ear mucosa leakage sites restricted capillaries postcapillary venules increased numbers degranulated pars flaccida mast cells observed sp interendothelial gaps formed leakage vessels administration mediators stimulation external auditory canal degrees c airstream also cytoplasmic vesicle like structures within endothelial cells increased number following sp histamine treatment suggesting increased permeability experimental otitis media occur exclusively interendothelial gaps,C09,0.0026239322,0.0023275588,0.004916405,0.0014742804,0.0036537424,0.003386321,0.20186096,0.022126041,0.0018969862,0.0025781675,0.026164165,0.049146824,0.028016578,0.07089882,0.0023074197,0.01678452,0.05500712,0.0027309111,0.0029877326,0.102659725,0.3404885,0.03903475,0.01692855
nasolabial flap single stage procedure nasolabial flap useful reconstructive technique repair defects nose improved technique used patients presented allows use procedure single stage rather commonly seen two stage procedure alterations include following excision burow triangle superior edge defect toward inner canthus use periosteal suspension suture minimize tenting across concave junction nose cheek wide undermining skin surrounding defect create stabilizing platelike scar significant thinning donor flap adjust size flap recreate original preincisional skin tension flap suturing none patients presented required second stage procedure correct trapdoor defects recreate natural folds creases,C09,0.0032404247,0.018538436,0.006046296,0.03318654,0.13650319,0.004181937,0.16900915,0.0030473345,0.0023426828,0.0031839074,0.11966025,0.006664934,0.0225608,0.0076846965,0.0028495477,0.005228595,0.30804694,0.034547623,0.0036897,0.043645173,0.061647605,0.0011505571,0.0033436455
comparison propofol thiopental halothane short duration ent surgical procedures children experiences propofol pediatric anesthesia limited undertook study evaluate quality induction recovery anesthesia propofol compared thiopental halothane twenty children received mg kg min propofol loading dose followed maintenance dose mg kg min twenty children received mg kg thiopental maintenance provided halothane interval end administration propofol thiopental halothane extubation well discharge ward significantly shorter propofol versus min versus min respectively spontaneous movements pain injection seen significantly frequently propofol whereas laryngospasm hiccup observed thiopental first h surgical procedure analgesics needed significantly often thiopental group nausea vomiting also observed frequently thiopental group conclusion propofol used single anesthetic satisfactory technique ent surgery short duration children,C09,0.062794685,0.0022146516,0.0046584867,0.0014027648,0.0034765035,0.0032220546,0.12506993,0.0023478782,0.0018049655,0.050800607,0.023069909,0.070592776,0.17277277,0.0057523763,0.0021954896,0.06744674,0.16633557,0.002571134,0.0028634905,0.059381016,0.16576418,0.0008864691,0.0025755938
effects cyclophosphamide pathogenesis cytomegalovirus induced labyrinthitis cyclophosphamide used study define contribution inflammatory response relative direct cytopathic effects guinea pig cytomegalovirus gpcmv inducing sensorineural hearing loss guinea pig eighth nerve compound action potential cap threshold day inoculation gpcmv scala tympani average db greater control animals immunosuppressed daily intraperitoneal injections cyclophosphamide mg kg body weight amount gpcmv antigen cochlea detected immunohistochemically correlate cap threshold however greater inflammatory response gpcmv cochlea higher cap threshold thus greater hearing loss study demonstrates inflammatory response gpcmv may important direct cytopathic effects virus producing sensorineural hearing loss gpcmv induced labyrinthitis,C09,0.0033455833,0.0029676992,0.022436362,0.018067434,0.0046590427,0.0043176496,0.17717274,0.003146227,0.0024187078,0.003287232,0.027498024,0.057084464,0.14366385,0.043920025,0.0029420215,0.005209769,0.030513313,0.003445396,0.0038094386,0.06733824,0.35021502,0.0011878951,0.021353845
ligmaject system local anaesthesia otology ligmaject syringe local anaesthetic injection incorporates pistol grip handle ratchet system designed inject tiny aliquot anaesthetic per click instrument used provide local anaesthesia otological procedures consenting adults performance ligmaject syringe compared favourably conventional dental syringe terms patient acceptability user convenience,C09,0.0061203097,0.00542902,0.04099046,0.0034387524,0.008522337,0.007953985,0.23255569,0.0057556136,0.0044247117,0.006013564,0.065494545,0.160732,0.054131623,0.0140724825,0.005382046,0.0095305955,0.114746295,0.0063029043,0.006968873,0.15318902,0.07977576,0.0021730997,0.006296349
selective management early glottic cancer seventy patients stage ii glottic cancer treated university utah school medicine hospitals forty four patients stage cancer patients stage ii overall survival stage group primary site control three deaths due laryngeal cancer local control rates co laser excision co laser irradiation radiation alone stage ii glottic patients overall survival local control rate twenty one patients treated full course irradiation eight patients recurred primary site irradiation failures initial bulky disease impaired vocal cord mobility selective co laser excision highly effective whereas radiation therapy results somewhat disappointing open partial laryngectomy considered bulky stage ii disease patients,C09,0.0025601864,0.0146546895,0.0047739428,0.001437531,0.02832062,0.0033019101,0.25703788,0.0024060681,0.0018496998,0.014856414,0.012298956,0.10813179,0.029933535,0.0058828397,0.0022499026,0.0039841556,0.4113226,0.016369428,0.0029132573,0.022539003,0.04963504,0.00090843934,0.0026321164
sensorineural hearing loss bullous myringitis prospective study eighteen patients eighteen patients seen period years twenty ears diagnosed bullous myringitis pure tone audiograms stapedial reflexes performed within h referral six ears demonstrated sensorineural hearing loss ears mixed loss conductive loss recovery sensorineural hearing loss complete ears stapedial reflexes elicited patients showed recruitment findings study confirms fact sensorineural hearing loss common bullous myringitis previously thought temporary many cases stapedial reflex results suggest site lesion cochlea,C09,0.004237302,0.0037586982,0.007906366,0.0023807671,0.026444983,0.025940185,0.25521037,0.0039848103,0.0030633807,0.004163398,0.06427225,0.008717023,0.02790097,0.009742866,0.0037261765,0.0065983604,0.19685812,0.0043912474,0.0048247916,0.18853836,0.141474,0.0015045119,0.004361086
chondrogenic potential tragal perichondrium cause hearing loss following stapedectomy tragal perichondrium widely used tissue seal oval window following stapes surgery autogenous easily accessible suitable substance cover vestibule total stapedectomy seal around prosthesis small fenestra stapedotomy incidence complications use perichondrium manner exceedingly low report case tragal perichondrium oval window resulted proliferation cartilage cartilage displaced stapes prosthesis resulting conductive loss although chondrogenic potential perichondrium known aware reports implicating cause failure stapes surgery pertinent clinical experimental literature regarding chondrogenesis reviewed information suggests formation cartilage perichondrium oval window might influenced mechanical trauma tissue orientation,C09,0.0035772834,0.020490482,0.023972044,0.0020099296,0.0049812538,0.021894136,0.34446448,0.003397475,0.0025862167,0.0035148908,0.036862835,0.059299435,0.0489704,0.029378189,0.0031459527,0.005570574,0.12798637,0.0036840087,0.004073263,0.1246446,0.120542645,0.0012701633,0.00368334
controlled double blind study effect quazolast nasal challenge ragweed antigen quazolast potent mediator release inhibitor determined vitro vivo testing placebo controlled double blind two way crossover study compared safety efficacy quazolast mg bid orally placebo subjects ragweed rw allergy season subjects assigned two day treatments random sequence day washout subjects challenged days trial serial dilutions pnu ml rw using metered pump spray bottles two sprays delivered ml preceded saline control efficacy evaluation consisted nasal flow rates measured rhinomanometry sneeze counts nasal itchiness scores weight nasal secretions challenges quazolast treatment subjects significantly lower p less mean percent decreases nasal flow rate pnu nasal itchiness scores significantly lower p less quazolast treatment placebo pnu although sneeze counts lower treatment quazolast placebo results reach statistical significance significant improvement seen weight nasal secretions adverse experiences clinical laboratory results physical examinations unremarkable posttreatment quazolast superior placebo protecting nasal congestion nasal itchiness ragweed nasal challenge,C09,0.0018163167,0.01038957,0.03852822,0.0010205143,0.011320571,0.0023440514,0.16188864,0.0017080862,0.0013131162,0.0105306255,0.037695684,0.051943295,0.19545704,0.012966152,0.0015972231,0.020408044,0.035747144,0.098589525,0.072410926,0.03825305,0.1739905,0.009432325,0.010649348
bilateral semicircular canal aplasia near normal cochlear development two case reports congenital malformations vestibular labyrinth pars superior rare present two patients computed tomographic findings bilateral semicircular canal aplasia normal near normal cochleas initial bone conduction thresholds within normal limits although patients significant conductive hearing losses due congenital middle ear malformations bithermal caloric responses absent knowledge first reports vestibular aplasia concomitant normal near normal cochlear development findings conflict conventional hypotheses state inner ear malformations result arrested development normal stages inner ear embryogenesis,C09,0.0033005234,0.0029246323,0.0061519207,0.001852468,0.03650376,0.004254992,0.22656757,0.019057648,0.0023836077,0.003239528,0.08039784,0.0067813657,0.15859273,0.008515682,0.002899327,0.0051341653,0.09840695,0.0034077284,0.0037585672,0.19644578,0.09293232,0.03309026,0.0034006827
comparison electro chemical cautery treatment anterior epistaxis ent department royal victoria hospital belfast impression supported anecdotes electro cautery superior chemical cautery treatment simple anterior epistaxis since evaluation relative merits electro chemical cautery reported prospective randomized study conducted assess effectiveness electro cautery cautery silver nitrate results study showed statistically significant difference two methods either controlling epistaxis incidence complications concluded since cautery silver nitrate tipped applicator simpler equal effectiveness would appear treatment choice simple anterior epistaxis,C09,0.0037054212,0.05709673,0.04277202,0.002081925,0.023096802,0.004782039,0.28402984,0.003484623,0.0026788546,0.003640794,0.053925853,0.008096155,0.11191377,0.008519908,0.003258454,0.0057701115,0.14261742,0.0038159697,0.0042191674,0.1314127,0.09395375,0.0013156604,0.0038120009
dysequilibrium otitis media effusion association association non suppurative otitis media nsom symptoms dysequilibrium observed previously quantified children gates busis blayney coleman study compared incidence balance related problems children surgically proven glue ear children normal ear function symptoms ranging true vertigo mild ataxia discovered per cent children nsom none within control group p less periods dysequilibrium associated episodes otalgia per cent children increased unilateral compared bilateral effusions complete resolution symptoms occurred per cent children following insertion grommets history balance disturbance actively sought children otitis media effusion present provides strong indication early operative intervention,C09,0.0029200083,0.002590193,0.005448432,0.0016406334,0.004127758,0.0037684226,0.15075009,0.0027460111,0.016172279,0.1279618,0.042046174,0.02061369,0.093611546,0.0068054786,0.016702117,0.020252904,0.18857081,0.0030090348,0.017442616,0.15108842,0.10355829,0.015168091,0.0030051675
adenoid cystic carcinoma comparison ct mr gd mr imaging techniques nasopharyngeal carcinoma continues difficult diagnostic problem many patients well known amongst many varied manifestations disease unilateral middle ear effusion adult regarded suspicion case year old patient presented case benefit gadolinium enhanced magnetic resonance imaging computerized tomography demonstrated,C09,0.004722085,0.004188725,0.008810921,0.0026531469,0.07523044,0.0060940967,0.408813,0.0044407058,0.0034138572,0.027462937,0.11196898,0.009712426,0.034621023,0.010857532,0.0041524824,0.007353268,0.11393503,0.0048629646,0.0053767883,0.037528783,0.10726096,0.0016766408,0.0048631984
myogenic influences electrical auditory brainstem response eabr humans two cases demonstrating effects myogenic artifact electrical auditory brainstem response eabr using promontory stimulation site presented intensity response functions obtained unparalyzed condition repeated infusion neuromuscular paralyzing agent cases myogenic response observed lower stimulus intensities eabr components intensity increased myogenic responses grew extremely rapid rates made subsequent identification auditory responses virtually impossible alleviate adverse influence myogenic components general anesthesia paralyzing agent must incorporated test protocol acquiring eabr using promontory site stimulation,C09,0.0032926053,0.0029207051,0.038167648,0.0018499806,0.020376101,0.0042492785,0.22975472,0.0030964059,0.002380407,0.003235178,0.10015239,0.0069854124,0.046511866,0.027818844,0.05071196,0.005145454,0.032512892,0.0034106402,0.0037491154,0.07131844,0.3377876,0.0011690845,0.00340327
excitation thresholds nerves reinnervating paralyzed canine larynx electrical stimulation paralyzed laryngeal muscles implanted nerve muscle pedicles nmp resulted documented return motion study however yet determined nmp excitability correlates normal muscle nerve six anesthetized dogs one hemilarynx denervated paralyzed thyroarytenoid cricothyroid posterior cricoarytenoid muscles reinnervated via nmps originating ansa hypoglossi nerve months electric stimulator delivering biphasic pulses variable amplitude widths used test thresholds contraction nine stimulatable nmps six intact recurrent laryngeal nerves rln five normal cervical muscles one exception nmp rheobases varied mean sd n two nmps belonging animals stimulated several hours higher values rheobase varied control rlns mean sd muscles mean sd histologic correspondence reinnervation established implanted muscles type grouping atpase stains data suggest nerve pedicles may offer promise eventual construction implantable low energy consuming laryngeal devices appropriate charge injected time remains determined,C09,0.017310329,0.014835455,0.047638,0.0014556387,0.016099183,0.0033433095,0.19221926,0.0024362353,0.089665145,0.0025454205,0.026401244,0.05749717,0.22508205,0.0418875,0.0022781119,0.016572291,0.059210196,0.0026692443,0.0029497838,0.019361263,0.1549582,0.00091982936,0.0026651178
evaluation neonatal subglottic stenosis year prospective study subglottic stenosis common cause chronic airway obstruction results prolonged tracheal cannulation infants children following widespread adoption past years prolonged intubation respiratory support neonates incidence acquired subglottic stenosis increased dramatically january began year prospective study delineate potential etiologic factors involved development subglottic stenosis neonates present study analyzes data infants relationships birth weight gestational age endotracheal tube size duration intubation ventilation number difficulty intubations subsequent need medical surgical therapy discussed whole organ larynges autopsy specimens provide histological correlation,C09,0.0027637233,0.0024515605,0.005156821,0.0015528233,0.01818051,0.016934091,0.23486601,0.0025990389,0.001998049,0.029472783,0.031816535,0.0056855073,0.027594065,0.0067484505,0.0024303484,0.004303692,0.26259443,0.0028461767,0.0031469055,0.18623967,0.12005067,0.02771736,0.0028507668
epstein barr virus related antibody changes titers therapy nasopharyngeal carcinoma using long term follow data prospective collaborative study north american patients evaluated significance various serologic tests antibody epstein barr virus predicting outcome treatment patients nasopharyngeal carcinoma restudied patients examining repeated measurements titer various times diagnosis treatment looked associations trends titers measured slope log titer time titer level measured mean log titer outcome alive evidence disease alive recurrence dead nasopharyngeal carcinoma found posttreatment sequential measurements predict outcome,C09,0.0033452176,0.0029673749,0.006241829,0.0018795413,0.0046581095,0.0043171775,0.22994547,0.003145883,0.0024184433,0.0032868728,0.088274844,0.006881686,0.15331802,0.040751465,0.0029417,0.0052091996,0.17145202,0.0034450195,0.019985866,0.1251272,0.083390586,0.0011877653,0.03582869
aqueous beclomethasone diproprionate nasal spray regular versus required use treatment seasonal allergic rhinitis objective determine effect alternative regimens nasal steroid administration symptoms quality life design randomized double blind parallel group comparison subjects sixty ragweed sensitive adults recruited participants previous studies media advertising interventions micrograms aqueous beclomethasone diproprionate nasal spray twice daily week week ragweed pollen season regular micrograms spray taken required micrograms daily troublesome nasal symptoms treated groups increasing daily dose micrograms symptoms controlled treatment insufficient mg terfenadine daily added results one subject required treated group withdrew uncontrolled nasal symptoms remaining subjects sneezing stuffy nose rhinorrhea measured daily diary significantly better controlled regular treated group p less impairment quality life including sleep disturbance nonhay fever symptoms practical problems uncomfortable emotions greater required treated group p less subjects regular treated group required less additional terfenadine tablets per subject versus p eye symptoms eye drop use similar two treated groups conclusion patients seasonal allergic rhinitis regular use inhaled steroids results fewer symptoms better quality life spray taken required,C09,0.0018486221,0.00163982,0.030019414,0.0010386654,0.002574148,0.0023910399,0.30021593,0.0017384667,0.0013364715,0.0018372994,0.008525997,0.06829287,0.115961365,0.0042609996,0.0016256317,0.0028786892,0.11384743,0.046644643,0.019994525,0.013732007,0.2570378,0.0006563786,0.0019017943
distortion product otoacoustic emissions normal impaired adult ears distortion product otoacoustic emissions dpoes recorded group normally hearing subjects ears group subjects whose conditions diagnosed sensorineural hearing loss ears study correlation might exist dpoe characteristics hearing impairment different configurations three different dpoe paradigms used investigate influence different test parameters dpoe data normal hearing impaired ears normally hearing ears demonstrated detectable dpoes provided primary tone level certain value hearing impaired ears produced substantially reduced dpoes compared normally hearing subjects primary frequencies f f corresponded region hearing loss data also suggested general one f f ratio needed examine particular frequency region dpoes provide frequency specific information cochlear function development may form basis noninvasive objective method evaluating cochlear function,C09,0.0023020934,0.0020417687,0.0042948304,0.0012932605,0.003205299,0.0029705307,0.4160072,0.0021645953,0.0016640641,0.013397081,0.08377615,0.027020771,0.13767982,0.005522182,0.0020241025,0.0035843065,0.021533486,0.028266983,0.002620883,0.024963247,0.2104454,0.00081726845,0.0024047256
vestibular recruitment meniere disease aim study search vestibular recruitment sample patients meniere disease recruitment defined abnormal growth response increasing stimulus intensity twenty nine patients tested sinusoidal rotation three different magnitudes four different frequencies also searched auditory recruitment patient via tests auditory brain stem responses acoustic reflexes loudness balance discomfort level analysis vestibular responses indicated average linear relationship stimulus magnitude response magnitude ie doubling stimulus magnitude resulted twice response magnitude meniere patients yield results significantly different although variable normal subjects vestibular responses patients auditory recruitment differ systematically patients without auditory recruitment conclude vestibular recruitment exists patients meniere disease demonstrated sinusoidal rotational testing,C09,0.0029198667,0.0025900675,0.0054481686,0.001640554,0.004066115,0.00376824,0.3220902,0.002745878,0.0021109337,0.0028689406,0.09479026,0.006005779,0.04800392,0.021445354,0.01669763,0.018667687,0.12985854,0.003008312,0.017441677,0.020826647,0.26895848,0.0010367386,0.0030100057
effect vitamin c histamine bronchial responsiveness patients allergic rhinitis effect acute oral administration g vitamin c bronchial responsiveness inhaled histamine patients allergic rhinitis compared placebo two consecutive days double blind crossover design pc fev significantly increased one hour treatment vitamin c placebo,C09,0.0054719714,0.0048539117,0.036647797,0.0030744774,0.0076195467,0.007111398,0.24214952,0.005145908,0.0039559915,0.031857476,0.025164986,0.011255249,0.08021205,0.012581752,0.0048119132,0.008520997,0.13856296,0.005635223,0.08570191,0.03622414,0.23586854,0.0019428981,0.005629362
localized antigen challenge nasal mucosa describe localized nasal antigen challenge measurement mediators found site eight ragweed allergic subjects challenged days week apart challenges consisted six sequential provocations beginning two control challenges diluent antigen phenol buffered saline followed four increasing antigen doses protein nitrogen units antigen day additional four control challenges control day number sneezes symptom scores increased significantly increasing antigen doses levels histamine n alpha tosyl l arginine methyl ester esterase activity increased eluted secretions antigen day control day amount secretions collected also increased per unit time antigen day found significant increase concentration level either histamine n alpha tosyl l arginine methyl ester esterase nasal secretions either day conclude total amount histamine n alpha tosyl l arginine methyl ester esterase activity increased per unit time concentration,C09,0.0021357255,0.0018944951,0.06598476,0.0011999771,0.0029739302,0.002756265,0.11799064,0.002008462,0.0015440345,0.0020984758,0.052560497,0.031834804,0.07822434,0.102701634,0.0018781546,0.034337975,0.043034356,0.046508193,0.0024318376,0.02793324,0.33366236,0.011092091,0.03321375
small fenestra stapedotomy using fiberoptic hand held argon laser obliterative otosclerosis obliterative otosclerosis challenge since advent stapes surgery drill procedures generally poorer prognosis conventional stapes surgery excessive bleeding acoustic trauma burr reclosure oval window otosclerosis report describe early experience using hand held fiberoptic argon laser small fenestra stapedotomy cases obliterative otosclerosis closure air bone gap within db seen patients significant sensorineural hearing loss vertigo facial weakness argon laser stapedotomy using hand held fiberoptic system safe effective alternative drill stapedotomy cases obliterative otosclerosis,C09,0.0043260953,0.0038374623,0.008072045,0.0024306565,0.0060239504,0.005583051,0.23209275,0.0040683122,0.0031275742,0.004250643,0.13557807,0.008897951,0.030879898,0.009947029,0.003804259,0.00673663,0.34994772,0.004455161,0.004925896,0.09574759,0.06928067,0.0015360393,0.0044505275
lasers otosclerosis one laboratory stapedotomy stapedectomy revisions performed human temporal bones pyroelectric wave energy analyzers ultrasensitive thermocouples measured energy absorption stapes footplate vestibule analysis data shows visible lasers argon ktp possess ideal optical properties precision otosclerosis surgery conversely less ideal tissue characteristics co laser possesses ideal tissue characteristics recent advances optical engineering pulsing energy increased precision laser provide accuracy required delicate microsurgery two clinical studies analyze long term hearing results complications patients undergone co laser stapedectomy revision patients co laser stapedotomy patients advantages laser techniques provide conventional surgery methods discussed,C09,0.0032409558,0.0028748894,0.020306643,0.0018209609,0.0045129284,0.0041826223,0.21848528,0.018700652,0.0023430667,0.0031844294,0.09609003,0.053723313,0.04795593,0.014753563,0.0028500147,0.005046842,0.33849895,0.003337647,0.003690305,0.022451064,0.12739383,0.0011507457,0.003405354
analgesia removal nasal packing present prospective controlled trial comparing methods analgesia relief discomfort removing nasal packing including general discussion considerations methods nasal tamponade basis nasal packing likely continue used frequently nitrous oxide entonox advocated safe relatively cheap means pain relief statistically significant advantage papaveretum,C09,0.028886104,0.0043892832,0.009232792,0.002780181,0.03080104,0.006385885,0.33814177,0.004653329,0.0035773146,0.02881297,0.076390505,0.010984547,0.039857224,0.011377396,0.0043513053,0.055582356,0.10982261,0.10091034,0.005634232,0.03729524,0.08328618,0.0017569192,0.005090506
transtympanic endoscopic findings patients otitis media effusion using fine rigid endoscope olympus ses k examined middle ear including tympanic orifice eustachian tube children otitis media effusion ome active stage ears convalescent stage ears treatment ventilation tubes days months five ears myringotomy patients general anesthesia several color photographs representative ears shown active stage ome edema hyperemia characteristic features middle ear mucosa normal mucosa seen one ear tympanic orifice eustachian tube could examined ears stenosed edema four ears plugged effusion three ears group convalescent stage ome dilated vessels often seen rest patients normal mucosa middle ear none edema hyperemia tympanic orifice eustachian tube could examined five ears clearly patent patients group one ear treated ventilation tube month showed dilated vessels less severe inflammation ears active stage ome three ears treated months showed almost normal middle ear mucosa,C09,0.0025617094,0.002269815,0.004774522,0.0014377054,0.0035630977,0.04045556,0.23381048,0.002413013,0.0018499243,0.014901674,0.09656842,0.030038776,0.047940567,0.0061048074,0.0022501755,0.0039846394,0.2910091,0.0026395533,0.015224994,0.01721534,0.17544508,0.0009085496,0.0026324359
asymptomatic congenital cytomegalovirus infection audiologic neuroradiologic neurodevelopmental abnormalities first year twenty eight infants asymptomatic congenital cytomegalovirus infection control infants followed prospectively congenital sensorineural hearing loss documented auditory brain stem responses four infected infants two mild bilateral loss one mild unilateral loss one extreme unilateral loss controls four infected infants diffuse periventricular radiolucencies computed tomographic scan none calcifications ventriculomegaly differences groups noted neurologic examination results bayley mental developmental index however one infected infant severely delayed bayley psychomotor developmental index score addition mean mental developmental index score four infected infants diffuse periventricular radiolucencies significantly remaining infected infants vs data suggest asymptomatic congenital cytomegalovirus infection may associated broad range audiologic subtle neuroradiologic neurodevelopmental differences early infancy,C09,0.0024093923,0.0021372512,0.004495676,0.0013537392,0.050703347,0.0031094463,0.17124543,0.0022658217,0.0017418833,0.014028192,0.12857066,0.040950425,0.14234689,0.040449653,0.0021187586,0.0037519247,0.06447222,0.0024812745,0.0027434474,0.19795169,0.105679475,0.012514745,0.0024786938
efficacy oral steroids treatment persistent otitis media effusion one hundred thirty six children otitis media effusion least months duration investigated strict double blind randomized prospective study evaluate efficacy oral steroids treatment disease results study showed significant complete partial recovery otitis media effusion group treated combination antibiotics amoxicillin oral steroids prednisone compared amoxicillin treated group placebo treated group believe treatment mostly benefits children aged years without oversized adenoids findings study imply combined course antibiotics oral steroids deserves place routine conservative trial surgery,C09,0.002839706,0.0025189607,0.032791775,0.001595515,0.0039614453,0.0036647883,0.24993849,0.002679005,0.002052981,0.037040044,0.020844126,0.052400023,0.025022635,0.0065293605,0.0024971657,0.0044220127,0.2207193,0.0029244262,0.052928876,0.052368354,0.21633139,0.0010082764,0.0029213848
informed consent head neck surgery informed consent fastest growing problem medical negligence debate highlighted recently united kingdom sidaway case informed consent comprises advice would give patient consequences taking advice specific risks surgery treatment mind risks surgery general attempt identify present practice otolaryngology postal survey carried members scottish north england otolaryngological societies,C09,0.0047218474,0.0042512636,0.008810477,0.0026530134,0.006575023,0.028882155,0.2734501,0.0044404822,0.0034136854,0.0046394924,0.05277838,0.009949851,0.029236002,0.03896837,0.0041522733,0.030202892,0.13371378,0.0048627197,0.096805945,0.14388977,0.10706337,0.0016765564,0.0048625628
mucosal thickening sinus x rays significance mucosal thickening commonly seen x rays paranasal sinuses taken ent department sometimes leads sinus washout clear even though x rays strongly suggestive disease paper examines prevalence sinus x ray anomalies general population facial x rays conditions possible sinus disease study suggests per cent called normal population may sinus x ray appearances consistent sinus disease may partly explain clear returns sinus washout,C09,0.027557887,0.0041886787,0.008810823,0.0026531175,0.006575281,0.051808245,0.3841697,0.004440657,0.0034138195,0.05032025,0.022452826,0.009712319,0.033988923,0.011156289,0.0041524363,0.007353187,0.09797802,0.0048689577,0.0053767287,0.08348299,0.16900441,0.0016766222,0.004857853
hearing aids high frequency hearing loss cross study compares relative benefits standard nhs contracted hearing aid high frequency emphasis commercial aid subjects high frequency hearing loss disability questionnaires free field speech noise faaf ii tests used assess subjects unaided weeks wearing aid total faaf ii test scores showed significant difference either aid analysis frequency specific subscores demonstrated less use low frequency information using high frequency emphasis aid overall questionnaire responses relating conversation showed benefit high frequency emphasis aid subjects generally preferred aid possibly due less low tone gain standard nhs aid,C09,0.002693809,0.0023874235,0.13531853,0.0015126116,0.0037480986,0.0034734171,0.2927578,0.0025310435,0.0019457766,0.0026444779,0.061172068,0.017621145,0.26313728,0.006406238,0.0023668204,0.0041911,0.029873393,0.0027717159,0.0031672132,0.029714558,0.12682024,0.0009556253,0.0027895574
head stability gaze vertical whole body oscillations understand head eye stabilities upright locomotion investigated head eye movements vertical whole body oscillations various amplitudes cm frequencies hz normal subjects n patients bilateral labyrinthine loss n vertical oscillations produced pitching motions head amplitude markedly altered change oscillation frequency displacement vertical eye movements correlated pitching head movements scarcely modified gaze hz acquired bilateral lesions presented deteriorated head stability physically induced eye movements stronger stimulations however significant increase head movement upon stepping suppression pitching motion upon running characteristically found bilateral lesions reproduced passive oscillations thus features active locomotion may result imbalance produced alternate bipedal motions adaptation minimize oscillopsia respectively,C09,0.11131146,0.002830213,0.02138826,0.0017926627,0.035334606,0.0041176234,0.19297133,0.0030004699,0.0023066548,0.0031349426,0.014903383,0.0065911347,0.1462395,0.040603917,0.031190407,0.0050204196,0.042888045,0.0032869512,0.0036329567,0.052148774,0.22455521,0.047468707,0.003282362
artificial restoration voice experiments phonatory control reinnervated canine larynx coordinated electronic pacing implanted nerve pedicles paralyzed laryngeal muscles allowed selective dynamic control abduction adduction elongation vocal cords modifications original circuit cervical muscle model added fine tuning basic none pacing rehabilitation phonation illustrated sophisticated nature voice need restoration fine tuning five mongrel dogs received nerve muscle pedicles thyroarytenoideus cricothyroideus posterior cricothyroideus denervation one hemilarynx following appropriate reinnervation time pedicles intact recurrent laryngeal nerves injected currents variable amplitudes pulse widths achieve graded vocal fold control air blown intratracheally towards glottic chink videoscopic spectral analyses indicated artificial phonation could restored frequencies measured normal state experiments suggested rehabilitation impaired voice servocontrol might eventually feasible,C09,0.02239166,0.034742694,0.061426647,0.017749622,0.00458461,0.0042490577,0.21211104,0.003096245,0.050198324,0.00323501,0.034744814,0.060798552,0.15722391,0.040711183,0.0028952835,0.052796893,0.06678049,0.003559669,0.0037489205,0.040099587,0.11828601,0.0011690237,0.0034007279
vocal cord paralysis children bilateral vocal cord paralysis common cause stridor infants children significant differences entity children adults regard etiology diagnosis management outcome review years experience children hospital philadelphia identified children seen diagnosis vocal cord paralysis cases evaluated respect etiology paralysis whether unilateral bilateral delay diagnosis need tracheotomy abnormality voice surgical treatment outcome guidelines management child vocal cord paralysis presented emphasis flexible endoscopic evaluation conservative management,C09,0.003576954,0.0031729366,0.006674225,0.0020097445,0.022295965,0.004616245,0.26443362,0.0033638107,0.0025859785,0.12473322,0.10894125,0.007442294,0.031523086,0.008224522,0.0031454829,0.022868674,0.11153297,0.0036836695,0.0040728883,0.188726,0.05011482,0.01858182,0.0036798383
unterberger stepping test useful indicator peripheral vestibular dysfunction deviation gait stepping test proposed useful indicator peripheral labyrinthine dysfunction prospective study patients suspected uncompensated peripheral labyrinthine dysfunction normal patients normal labyrinthine dysfunction showed significant difference performance unterberger stepping test patients electronystagmographically significant canal paresis normal vestibular function,C09,0.0046159993,0.0040946216,0.008637195,0.0025935415,0.0064276326,0.005957187,0.17119363,0.0043409416,0.0033371618,0.00453549,0.1226357,0.009568461,0.22397749,0.010939725,0.004059193,0.0071880706,0.14802994,0.004760268,0.005255994,0.056134243,0.1853298,0.0016389736,0.0047487696
vivo assessment antimicrobial agents toxoplasma gondii quantification parasites blood lungs brain infected mice vivo effects antimicrobial agents toxoplasma gondii evaluated mice infected intraperitoneally tachyzoites rh strain determination survival rates study kinetics growth gondii infected mice various intervals infection subcultures serial dilutions blood lung brain homogenates performed fibroblast tissue cultures determination parasitic loads pyrimethamine mg kg per day sulfadiazine mg kg per day clindamycin mg kg per day administered days day day infection untreated control mice died within days showed early predominant lung involvement mice treated sulfadiazine administered day survived apparently healthy parasitic loads decreased early treatment relapse observed days cessation therapy pyrimethamine administered day mice died within days determination parasitic loads effect pyrimethamine demonstrable day relapse constantly observed cessation therapy pyrimethamine sulfadiazine administered combination mice survived therapy started day parasites remained undetectable mice treated day parasites eradicated day infection relapsed days cessation therapy mice treated clindamycin day day died within days parasitemia always undetectable,C03,0.037304517,0.0016252601,0.038978454,0.001029443,0.020390086,0.028973619,0.15568998,0.0017230307,0.001324605,0.0018002521,0.03830606,0.003866395,0.051339723,0.10312397,0.0016111976,0.002853129,0.12242694,0.0018921284,0.0020862385,0.012651816,0.3684677,0.00065055053,0.0018849082
quantitative vitro drug potency drug susceptibility evaluation leishmania ssp patients unresponsive pentavalent antimony therapy quantitative vitro drug sensitivity leishmania isolates patients failing pentavalent antimony sbv therapy determined using radiorespirometric microtechnique ram isolates histories ram tests agreed patient history remaining difference ram drug sensitivity clinical correlation isolates tested blindly known clinical history agree clinical history test sensitivity appeared limited sensitivity leishmania sbv could detected micrograms ml sb serum drug level isolate patient untreated self healing cutaneous disease drug resistant using ram parasite drug sensitivity quantified apart patient physiologic immunologic variables intrinsic clinical data potency differed maximum weight sb weight sb among drug lots also glucantime pentostam potency changes drug lots explainable based sb content test test variability microtest offers rapid method evaluating drug sensitivity patient isolates determining activity pentavalent antimonials candidate anti leishmanials prior initiation therapy,C03,0.0019722546,0.0017494883,0.06105575,0.029737627,0.012292651,0.0025452974,0.42287123,0.0018547322,0.0014258523,0.0019378561,0.08926725,0.00410378,0.039732285,0.004656317,0.039925568,0.012601645,0.08419902,0.011564398,0.002245702,0.04340871,0.12812081,0.000700276,0.002031462
activated eosinophils increase vascular permeability resistance isolated perfused rat lungs effects eosinophils activated phorbol myristate acetate pma isolated perfused rat lungs examined eosinophils obtained lungs rats infected toxocara canis bronchoalveolar lavage incubated pma administered isolated perfused rat lung preparation vascular endothelial permeability assessed measuring capillary filtration coefficient kf c perfused lungs lungs receiving either eosinophils control nonactivated eosinophils changes pulmonary hemodynamics kf c however lungs receiving x eosinophils activated pma transient fold increase pulmonary vascular resistance peaked min primarily due constriction small arteries veins initial pressor response kf c increased times control min resulted marked lung edema increased wet dry weight ratios edema histologic examination pulmonary arterial pressure kf c responses dose related eosinophil numbers x x cells peak airway pressure paw constant tidal volume ventilation also increased lungs receiving activated eosinophils compared control nonactivated eosinophil groups findings indicate activated eosinophils potent effector cells cause pulmonary vasoconstriction bronchoconstriction vascular endothelial injury without widespread plugging capillaries aggregated eosinophils,C03,0.058374338,0.0016546788,0.012500354,0.019092722,0.011624384,0.13536899,0.10433861,0.040065456,0.0013485815,0.0018328384,0.019451153,0.03854717,0.13439448,0.026920093,0.0016403619,0.0029352778,0.031222025,0.065108426,0.0021240015,0.017970197,0.25285488,0.01871196,0.0019190268
b cell responses paramyosin isotypic analysis epitope mapping filarial paramyosin patients onchocerciasis examine fine specificity human immune response filarial paramyosin antigenicity expressed rcdna kb dirofilaria immitis paramyosin detailed elisa using sera patients infected onchocerca volvulus analyzed entire paramyosin molecule six subcloned fragments igg igg subclasses ige responses patients guatemala positive ghana positive reacted paramyosin specific igg levels normal controls although anti paramyosin subclass restriction common patients igg response ghananians significantly greater guatemalans p less ige anti paramyosin responses showed positive correlations igg p less igg p less igg p less responses epitope mapping using igg response six subclones demonstrated preferential recognition amino terminal end molecule nucleotides igg reactivity clearly localized amino terminal amino acids igg antibodies recognized amino acids immediately adjacent fragment studies examining fine specificity anti filarial immune reactions provide method understanding parasites either evade induce host immune responses,C03,0.0020920725,0.0018557728,0.0039035904,0.011289116,0.013042726,0.0026999286,0.14463665,0.012086401,0.0015124753,0.0020555842,0.059583537,0.0043160585,0.09133251,0.040078297,0.0018397159,0.0032577922,0.06889634,0.049283747,0.0023821325,0.04803156,0.36670023,0.000742819,0.06838098
effects albendazole echinococcus multilocularis infection mongolian jird albendazole chemotherapy larval echinococcus multilocularis studied mongolian jird administration medicated feed various concentrations durations effects evaluated comparison treated control groups terms host mortality larval metastases lungs final weight histologic appearance larval tissue viability larval tissue necropsy animal tested inoculation two noninfected jirds albendazole medicated feed significantly inhibited larval growth effects drug included larval degeneration necrosis inhibition protoscolex formation decreased pulmonary metastases reduced mortality hosts adverse effects parasite correlated significantly serum albendazole metabolite levels duration therapy however serum albendazole levels jirds equal exceeding concentrations achieved humans receiving daily doses mg kg body weight kill parasite,C03,0.029815093,0.0025189572,0.019012809,0.01533407,0.003954195,0.018014546,0.12466588,0.023970231,0.0020529781,0.002790174,0.028462198,0.045458496,0.1101732,0.04132972,0.0024971622,0.0044220067,0.055575248,0.0029344931,0.0032334183,0.10234896,0.357497,0.001008275,0.0029309075
impact mass treatment onchocerciasis ivermectin transmission infection onchocerciasis major blinding disease recently essentially untreatable ivermectin safe effective drug mass treatment onchocerciasis used individual basis reduces ability treated person transmit onchocerca volvulus infection present study effect community based ivermectin treatment degree transmission within community assessed determining incidence new infection children ivermectin distributed annually three occasions eligible members population approximately people living rubber plantation forest area endemic onchocerciasis years prevalence infection year old children decreased annual incidence uninfected cohort children decreased age specific adjustment reduction incidence year old children thus community based distribution ivermectin led significant reduction incidence new infection findings suggest ivermectin important reducing transmission onchocerciasis,C03,0.0024674528,0.0021879135,0.028739454,0.0013858288,0.003434531,0.003183154,0.38016835,0.0023195317,0.0017831738,0.062127393,0.05390305,0.0050731306,0.024203995,0.005814668,0.0021689828,0.003840862,0.026227571,0.0025400918,0.0741923,0.117357224,0.19346663,0.0008757665,0.0025389055
variations malaria transmission rates related anopheline survivorship per feeding cycle anopheline survivorship vectorial capacity mosquito infection probability estimates mosquito infection rates determined times year papua new guinea village estimates survivorship length extrinsic incubation period differed significantly year however survivorship per feeding cycle individual mosquito vectorial capacity mosquito infection probability vary significantly estimates parameters compared estimates survivorship individual vectorial capacity mosquito infection probability mosquito populations villages study area since survivorship per feeding cycle vary significantly among mosquito populations villages changes malaria transmission potential better gauged estimates survivorship length extrinsic incubation period however measurements relative inoculation rates easier perform related parasite prevalences children area estimates inoculation rates preferred option estimating malaria transmission madang area papua new guinea,C03,0.002354266,0.0020883512,0.0499739,0.001322766,0.0032782406,0.0030383028,0.20237538,0.00221398,0.0017020294,0.013710292,0.14410743,0.0048424886,0.09141169,0.005413184,0.002070282,0.037853245,0.032024097,0.0024245034,0.036869325,0.17696634,0.18070199,0.0008359142,0.002421982
transmission indices loa loa chaillu mountains congo longitudinal entomological survey vectors loiasis conducted missama area lekoumou region congo september august principal catching site palm grove surrounded forest km village landing biting densities chrysops measured standardized fly catches lasting hr carried twice month vector landing densities also assessed bantu pygmy villages fields populations chrysops palm grove examined times month infection infective stage loa loa chrysops silacea predominate vector except beginning rainy season c dimidiata prevailing species chrysops caught throughout rainy season october june host seeking activity c silacea greatest middle season february occurred sooner october c dimidiata following variables associated transmission calculated observations palm grove first figure corresponds first year study figure parentheses corresponds second year calculated c silacea c dimidiata could bite person palm grove per year including average infective c silacea infective c dimidiata percentage dissected flies third stage larvae head mean number larvae head infective fly c silacea c dimidiata respectively estimated annual transmission potentials c silacea c dimidiata palm grove transmission ensured effective vectors rainy season october may although annual biting rate species twice low village forest data suggest effective transmission occurs also,C03,0.02405378,0.001997829,0.0042024036,0.001265429,0.003136141,0.042928167,0.20088345,0.0021180124,0.0016282528,0.0022129356,0.07170893,0.0046590264,0.0667541,0.005372152,0.001980543,0.0035071706,0.11663362,0.002324898,0.120459914,0.16389848,0.15513802,0.0007996805,0.0023370741
ascariasis ascaris lumbricoides common helminth infect humans infection occurs contaminated soil containing mature eggs swallowed clinically infection ranges asymptomatic carrier state life threatening pulmonary disease intestinal obstruction diagnosis frequently established identification eggs stool specimens treatment antiparasitic drugs effective preventing serious complications eradicating parasite members household,C03,0.026324797,0.025867304,0.008426571,0.0025374116,0.028148388,0.0058804164,0.33126417,0.004246994,0.0032649382,0.004437332,0.08993242,0.031111132,0.02947449,0.029631106,0.0039713434,0.050753888,0.10770475,0.004650833,0.026994243,0.11845116,0.060504366,0.0016035025,0.004818414
echinococcus infestation biceps brachii case report echinococcus genus tapeworm endemic certain parts world found rarely united states extremely unusual case intramuscular infestation involving extremity occurred year old man since infestation closely resembled soft tissue tumor clinical roentgenographic examination patient treated incisional biopsy mass consisted cystic cavity filled clear fluid diagnosis echinococcus cyst made permanent section analysis revealed numerous scoleces within cyst lining patient asymptomatic six months cyst excision still remains risk recurrence infestation present report serves alert reader rare potentially fatal condition preoperative diagnosis imperative avoid inadvertant rupture hydatid cyst releases viable scoleces systemic circulation may precipitate anaphylactic reaction,C03,0.0029618395,0.0026272994,0.034200322,0.0016641368,0.06396132,0.032494057,0.31761155,0.062828034,0.0021412782,0.035456814,0.10543422,0.006091938,0.081526965,0.0071116295,0.002604567,0.0046122,0.10949375,0.0030530696,0.00337249,0.06454161,0.05210633,0.0010516417,0.0030529457
comparison active passive case detection cutaneous leishmaniasis guatemala estimate degree passive case detection underestimates true incidence cutaneous leishmaniasis guatemala compared data passive surveillance system guatemalan ministry health cross sectional population based survey cutaneous leishmaniasis guatemala persons interviewed reported cutaneous leishmaniasis time past reported onset infection months survey active infections parasitologically confirmed infections calculated basis reports estimated population endemic area total number new cases leishmaniasis endemic area months survey approximately month period ministry health data based passive surveillance listed cases cutaneous leishmaniasis guatemala incidence estimates based passive surveillance may underestimate occurrence cutaneous leishmaniasis much factor,C03,0.0028394125,0.0025187007,0.005313269,0.0015953501,0.004013825,0.0036948568,0.2521209,0.002670218,0.015725527,0.01653333,0.20161007,0.0058401288,0.041145198,0.0073257782,0.00249702,0.004421556,0.1068568,0.0029318193,0.07196076,0.16141585,0.083039746,0.0010081722,0.0029216914
diffuse cutaneous leishmaniasis acquired peru case diffuse cutaneous leishmaniasis dcl acquired peru described causative agent leishmania mexicana amazonensis determined isoenzyme analysis species specific monoclonal antibody binding characteristics histological examination biopsy material showed large number intracellular extracellular amastigotes lymphocytes treatment meglumine antimoniate glucantime administered iv dosage mg antimony kg body weight day days resulted visible improvement lesions clinical parasitological cure,C03,0.004515421,0.0040054037,0.03028172,0.04625307,0.0282054,0.0058273864,0.31083333,0.026069356,0.0032644486,0.0044366666,0.11670714,0.009806264,0.03288278,0.046964537,0.0039707473,0.0070314496,0.07658216,0.04199795,0.005141471,0.035986163,0.15297039,0.001603262,0.0046635037
parasite antigenemia untreated treated lymphatic filarial infections evaluate merit antigen detection assays tool monitor efficacy chemotherapy lymphatic filariasis serially measured antigen levels sera jirds infected brugia malayi humans bancroftian filariasis antigenemia detected animals parasitologically proven infection present jirds prepatent occult filariasis antigen levels correlated worm burdens progressively declined drug cured animals treatment diethylcarbamazine dec triggered transient increase serum levels filarial antigens bearing epitope recognized monoclonal antibody hc patients bancroftian filariasis became amicrofilaremic within one week dec treatment antigenemia levels slowly declined period several months one treated individual forty two months treatment progressively rising antigen levels present patients six remain amicrofilaremic elevated antigenemia levels preceded detected time recurrent parasitemia periodic monitoring antigenemia levels treatment patients lymphatic filariasis used identify individuals likely develop recurrent microfilaremia parasites become detectable blood samples thereby allowing timely retreatment,C03,0.0021134296,0.0018747175,0.014338068,0.011416426,0.023392472,0.002727491,0.3576786,0.0019874948,0.0015279155,0.0020765688,0.06529941,0.0043738647,0.039089497,0.07482121,0.0018584967,0.0032910495,0.09342702,0.018653208,0.0024064505,0.027054885,0.24765795,0.00075040205,0.0021833917
geographical distribution plasmodium falciparum erythrocyte rosetting frequency rosetting antibodies human sera uninfected erythrocytes bind spontaneously infected certain strains plasmodium falciparum known spontaneous erythrocyte rosetting studied occurrence frequency rosetting fresh patient isolates identified rosetting strains africa south america asia rosetting present isolates tested frequency rosetting red blood cells rbc individual isolates scored first cycle vitro growth rosetting antibodies found liberian sera measured disruption rosettes vitro however antibodies able inhibit cd dependent cytoadherence p falciparum infected rbc detected sera erythrocyte rosetting geographically widespread phenomenon rosetting antibodies seem induced natural infection molecular mechanism rosette formation seems distinct endothelial cytoadherence,C03,0.0028398808,0.016253278,0.028771412,0.017349977,0.031444613,0.003665014,0.3093927,0.025030205,0.0020531074,0.030279674,0.040010914,0.018872565,0.13380443,0.12243059,0.0024973194,0.0044222847,0.038591027,0.022469271,0.0032336218,0.035642635,0.107000224,0.0010083384,0.002936924
immunization owl monkeys combination plasmodium falciparum asexual blood stage synthetic peptide antigens mixture synthetic peptides corresponding portions kda kda kda proteins asexual blood stages plasmodium falciparum polymer syntheic peptide incorporating individual peptides spf tested candidate malaria vaccine antigens aotus nancymai monkeys immunized combinations peptides separate sources centers disease control cdc atlanta ga colombia synthetic polymer animals immunized combination peptides cdc higher antibody titers peptides peptide monkeys immunized combination peptides produced colombia developed higher levels antibody peptides animals immunized polymer produced detectable antibodies peptide alone following challenge p falciparum differences observed vaccine groups control groups respect number animals parasitemias greater equal inconsistency serologic response peptides animals contrasted previous trials performed colombia monkeys developed high antibody titers peptides protected experimental infection,C03,0.0024409827,0.0021652735,0.0045546205,0.0013714886,0.0034091289,0.0031502154,0.13093734,0.0022955297,0.0017647218,0.002398409,0.025551466,0.031181565,0.053062744,0.057237417,0.0021465386,0.01419797,0.08602002,0.027678017,0.014595015,0.06815294,0.4504959,0.012681457,0.002511193
humoral cell mediated immune responses plasmodium falciparum antigens pf resa cs protein seasonal variations population recently reexposed endemic malaria resurgence falciparum malaria occurred central highlands madagascar disease currently hyperendemic determined humoral cellular responses synthetic peptides reproducing repeat sequences major plasmodium falciparum antigens pf resa circumsporozoite cs protein blood samples subjects living rural community near antananarivo obtained beginning end transmission season enrollment subjects presenting without blood parasites similar cell proliferative response antibody level antigens tested however p falciparum infected individuals exhibited decrease absolute number lymphocytes due diminished number cd natural killer lymphocytes number cd cells similar groups overall population subjects cell response least resa peptide responding given peptide cs protein peptide thirty two percent donors presented resa antibodies cs protein antibodies weeks end transmission season cellular proliferative responses antigens markedly decreased evidenced decrease number responders mean stimulation indexes humoral response resa detected erythrocyte membrane immunofluorescence number responders mean antibody titers markedly increased humoral responses cs protein resa peptides similar,C03,0.0018170989,0.0016109799,0.012178464,0.0010203979,0.0025288751,0.002343784,0.16751035,0.0017078915,0.0013129665,0.010570178,0.04951142,0.01297572,0.123124756,0.13454553,0.0015970409,0.020401925,0.04396695,0.06803847,0.019647941,0.060870122,0.25118253,0.00064483454,0.010891786
studies owl monkeys leading development synthetic vaccine asexual blood stages plasmodium falciparum development synthetic vaccine human use asexual blood stages plasmodium falciparum monkey trials performed assess safety immunogenicity protectivity determined minimal infective dose p falciparum fvo strain kinetics immune response induced vaccination synthetic peptide mixture synthetic hybrid polymeric protein spf induction protective immunity experimental challenge p falciparum strains clear boosting effect observed determined increased antibody titers synthetic peptides spf improvement protective immune response challenge studies suggest either peptide mixture synthetic hybrid polymeric protein excellent choices development vaccine p falciparum,C03,0.0034600664,0.019813897,0.006456125,0.0019440702,0.004818033,0.021208588,0.1588828,0.0032538883,0.002501474,0.0033997186,0.017205026,0.0071166954,0.066891536,0.008563764,0.003042695,0.022224491,0.10185108,0.037064504,0.020689078,0.06121649,0.4235893,0.0012285439,0.0035781828
diagnosis intestinal amebiasis using salivary iga antibody detection investigation sought determine whether detection salivary iga antibodies entamoeba histolytica could identify intestinal amebic infections among school children four groups children identified coproparasitoscopic examination e histolytica parasites parasite free diagnostic accuracy salivary iga antibodies e histolytica membrane extract sensitivity specificity maintaining high predictive value different prevalences also positive correlation r p less observed fecal e histolytica membrane antigen levels salivary iga antibody activity measurement iga antibodies saliva may useful diagnosing intestinal infections e histolytica within wide range prevalences moreover sampling saliva may useful non invasive test immunoepidemiologic surveys,C03,0.0030496095,0.0027051559,0.04997219,0.0017134512,0.004246485,0.00393568,0.21377465,0.0028678898,0.002204732,0.04727607,0.19669388,0.021036116,0.08217439,0.10390707,0.0026817496,0.01934687,0.026284333,0.003147032,0.03298954,0.055002145,0.10601873,0.0010828056,0.017889459
visceral leishmaniasis scottish child scottish girl acquired visceral leishmaniasis kala azar holiday majorca presented infection six months later scotland inexperience disease degree scepticism unnecessary investigations carried resulting delay treatment,C03,0.0077214316,0.006849295,0.014478744,0.0043383576,0.010751849,0.009964909,0.31685326,0.007261328,0.0055822516,0.082348265,0.03551111,0.015881509,0.08020385,0.017753957,0.006790032,0.012023875,0.13782687,0.007951794,0.008791986,0.09341068,0.10701949,0.0027416,0.007943524
ultrasonographical investigations onchocerciasis liberia efficiency ultrasonography us diagnosis clinical characterization onchocerciasis evaluated us performed probands liberia ninety two patients generalized onchocerciasis patients suffered chronic hyperreactive form onchocerciasis sowda probands served controls patients examined us linear mhz mhz sector mhz scanners us results evaluated examination extirpated nodules us structure nodules revealed typical pattern consisting homogeneous echogenicity small echodense particles lateral acoustic shadow differentiation lymph nodes lipoma fibroma achieved within onchocercomata calcifications fluid identified regarding estimation worm burden important note patients additional nodules previously palpated found us also number worm centers palpable conglomerate nodules determined exactly us palpation sowda patients impalpable nodules found us patients positive microfilaria counts nodules could detected highly characteristic ultrasonographical pattern onchocercomata may serve basis us investigations onchocerciasis,C03,0.0027275097,0.002419437,0.00508925,0.0015324764,0.0038095715,0.0035199933,0.32316348,0.028968452,0.001971868,0.0026799385,0.11064541,0.0056898594,0.03915731,0.006632825,0.028791193,0.017436879,0.21946727,0.0028116188,0.003105671,0.06221035,0.08231111,0.00096843956,0.04489012
vitro growth inhibition plasmodium falciparum sera different regions philippines sera different malaria endemic regions republic philippines compared ability inhibit growth plasmodium falciparum vitro dialyzed serum added synchronous cultures containing schizonts either total hr test period last hr order analyze effects erythrocytic invasion intraerythrocytic growth respectively reduction h hypoxanthine uptake used determine percent inhibition compared nonimmune serum one hundred seventy sera mindanao palawan south centrally located island mindoro luzon north tested p falciparum strains philippines africa indirect fluorescent antibody titers predictive inhibition inhibition merozoite invasion rather intraerythrocytic parasite growth suggested study generally sera inhibitory parasite strains geographical area remote areas,C03,0.0031421403,0.0027872352,0.005862908,0.0017654405,0.004375331,0.004067474,0.18957148,0.0029549068,0.0022716275,0.0030873374,0.055497777,0.006523285,0.037061,0.120436475,0.0027632439,0.03530884,0.05199982,0.003286739,0.018698249,0.04339041,0.36859637,0.0011156598,0.03543631
preoperative stabilisation congenital diaphragmatic hernia january november newborn infants congenital diaphragmatic hernia treated early operation mean hours age infants admitted december december stabilised mean period hours operation significant difference survival two groups delayed operation detrimental infants congenital diaphragmatic hernia,C06,0.0049482617,0.004389355,0.009232943,0.0027802265,0.078747556,0.0063859895,0.10574597,0.0046534054,0.003577373,0.028814208,0.022756506,0.035309587,0.09811585,0.011377582,0.0043513766,0.007705473,0.26352048,0.0050958893,0.05338297,0.17128883,0.070972666,0.001756948,0.005090589
exacerbation chronic active hepatitis type b short term corticosteroid therapy resulting fatal liver failure case yr old male chronic active type b hepatitis wk prednisone therapy resulted prolonged fatal exacerbation liver disease described thus short term corticosteroid therapy may patients disastrous effects course chronic active hepatitis b,C06,0.0041525075,0.023785567,0.0077481484,0.002333318,0.0057822354,0.045560107,0.4483427,0.0039050686,0.0030020783,0.0040800828,0.038691454,0.008540914,0.06649161,0.009637591,0.0036516106,0.04449479,0.08217108,0.0042763944,0.004728241,0.10821107,0.074667096,0.0014744046,0.004271947
enteroglucagon peptide response construction pelvic reservoir humans results investigation plasma levels gastrointestinal hormones patients construction pelvic reservoir reported enteroglucagon eg peptide tyrosine tyrosine pyy two hormones believed play relevant role adaptive response bowel resection investigated using specific radioimmunoassay basal conditions standard meal pouch patients showed statistically significant increase basal levels enteroglucagon pyy compared control subjects p less p less respectively response enteroglucagon food ingestion evaluated means total integrated response similar patients controls conversely response pyy significantly increased pouch patients compared control cases p less results investigation suggest gut hormones may involved mediating adaptive response intestine pouch construction changes gut peptides may explain least part functional results observed pouch construction,C06,0.002409649,0.002137479,0.0044961553,0.0013538835,0.0033553601,0.0031097778,0.1775106,0.0022660631,0.001742069,0.0023676218,0.025009435,0.005196908,0.14324793,0.006476975,0.0021190266,0.0037523247,0.10418207,0.002512073,0.0143780615,0.028986521,0.4600447,0.00085557887,0.0024897235
airway responsiveness inhaled methacholine patients irritable bowel syndrome examined whether patients irritable bowel syndrome increased airway responsiveness measuring forced expiratory volumes second fev inhalation increasing concentrations methacholine responses obtained ibs patients compared obtained normal subjects subjects organic disease gut related organs subjects selected factors might contribute increased airway responsiveness excluded methacholine concentration caused fall fev pc well reduction fev induced methacholine concentration used assess airway responsiveness geometric mean pc mg ml sem normal subjects mg ml sem subjects organic bowel disease p mg ml sem ibs patients p less decrease fev induced mg ml methacholine ibs patients significantly greater observed healthy subjects p contrast decrease fev observed patients organic disease different seen normal subjects p conclude ibs associated increased airway responsiveness following challenge methacholine,C06,0.0021579175,0.0019141805,0.00402645,0.0012124458,0.0030048317,0.013223504,0.18192193,0.0020293319,0.0015600784,0.05434739,0.013543384,0.0044384478,0.2441627,0.006052253,0.0018976182,0.0033603264,0.09604562,0.0022234183,0.012872701,0.05554842,0.2914709,0.0007661981,0.002219986
crohn disease city derby epidemiological survey crohn disease city derby showed incidence condition increased per year per year seemed reach plateau large bowel crohn disease common patients presenting aged years aged years increase incidence solely due detection milder disease evidence asian indian subcontinent population derby resistant development crohn disease,C06,0.0047301752,0.004188813,0.008811106,0.0026532027,0.006577884,0.0060942248,0.26664597,0.0044407994,0.003413929,0.06440179,0.045288265,0.03255995,0.09089045,0.01085776,0.0041525695,0.0073534227,0.07387855,0.0048630666,0.07390724,0.1856891,0.09206705,0.001676676,0.004858009
role ercp children adolescents diagnostic therapeutic role ercp patients ranging years age discussed ercp provided useful additional information patients biliary tract disease patients pancreatic disease patients abdominal pain appropriate duct cannulated cases mild pancreatitis occurred two patients ercp endoscopic papillotomy successful five patients ercp plays important part investigation unexplained biliary tract pancreatic disease rarely demonstrates abnormal pathology patients otherwise unexplained abdominal pain,C06,0.0037055141,0.003286976,0.006914105,0.0020819772,0.0051606484,0.022661608,0.35265106,0.03935376,0.0026789217,0.05744188,0.06488316,0.007621534,0.0419358,0.008520122,0.0032585356,0.02370605,0.21036975,0.0038160651,0.04008053,0.047412768,0.04733145,0.0013156934,0.0038120963
preliminary report antegrade continence enema principles antegrade colonic washout mitrofanoff non refluxing catheterisable channel combined produce continent catheterisable colonic stoma intention antegrade washouts delivered route would produce complete colonic emptying thereby prevent soiling procedure successfully carried five patients intractable faecal incontinence,C06,0.005638562,0.03229716,0.010520972,0.003168078,0.007851519,0.03456378,0.17997997,0.005302572,0.004076429,0.060095258,0.025931118,0.038865227,0.0367813,0.04019465,0.0049584094,0.04230146,0.20857143,0.005806784,0.0064203325,0.116590604,0.122281626,0.0020020485,0.0058007445
glucose disposal beta cell secretion hepatic insulin extraction cirrhosis minimal model assessment factors controlling glucose metabolism iv load studied nine patients compensated cirrhosis six age matched controls time courses glucose insulin c peptide analyzed means minimal model technique cirrhosis insulin sensitivity reduced approximately glucose dependent glucose uptake glucose effectiveness decreased glucose effectiveness explained variance glucose disappearance correlated ratio urinary creatinine height independent measure muscle mass r beta cell responsiveness glucose measured c peptide kinetics variable increased average first phase second phase respectively total amount insulin secreted beta cells course study nearly doubled whereas basal insulin secretion rate normal range time courses hepatic extraction insulin differ groups basal extraction average controls patients cirrhosis reduced single patient severe hepatocellular failure large spontaneous portosystemic shunting conclude alterations glucose metabolism cirrhosis include decreased insulin sensitivity reduced glucose effectiveness increased pancreatic responsiveness glucose leading hyperinsulinemia hepatic extraction insulin reduced advanced stages disease possibly large reserve capacity hepatic parenchyma,C06,0.0014534822,0.029307643,0.044729814,0.028830215,0.0089973295,0.008866477,0.14854212,0.0013610421,0.008051977,0.008419536,0.009418615,0.01042134,0.06272497,0.03278967,0.0012727351,0.23438083,0.07909111,0.0015027205,0.00863468,0.015109814,0.2306404,0.0005138775,0.024939584
azathioprine treatment children inflammatory bowel disease year period treated patients azathioprine mg kg day adjunct customary regimen nine patients ulcerative colitis patients crohn disease patients ages ranged years median duration disease start azathioprine therapy years median follow years sixteen patients seemed respond azathioprine therapy six patients disease group complete responses four patients one ulcerative colitis three crohn disease partial responses two patients ulcerative colitis three patients crohn disease respond median time patients responded less months patients ulcerative colitis months crohn disease reduction corticosteroid dose possible patients responded azathioprine therapy minimal side effects attributable drug conclude azathioprine effective adjunctive agent treatment inflammatory bowel disease childhood questions remain regarding long term safety use reserved children refractory disease severe unacceptable side effects corticosteroids,C06,0.002418471,0.013793449,0.004495085,0.0013535613,0.0033545613,0.014760303,0.34490985,0.002265524,0.0017416544,0.0256926,0.01107907,0.016617648,0.036706507,0.0055392087,0.0021184802,0.0037532356,0.37581387,0.0024809483,0.014395749,0.020050306,0.09332616,0.0008553752,0.002478368
ablation cystic duct gallbladder experimental basis initial clinical observations bipolar radiofrequency electrocoagulation cystic duct catheter performed safely reproducibly using fluoroscopic control induces endoluminal scar formation scar within cystic duct forms reliable barrier gallbladder biliary system avoids recanalization cystic duct later date sclerotherapy isolated gallbladder ethanol sts performed without toxic otherwise adverse effects suitable ablate porcine gallbladder initial clinical trials new technique small number patients promising demonstrated protocol applied safely humans electrocoagulation technique catheter appears suitable ablate human cystic duct follow evaluation first patients way must determine whether regimen appropriate ablate human gallbladder long term basis development new approach may eventually enable definitive nonoperative treatment cholecystolithiasis selected patients,C06,0.0024672765,0.0021885973,0.004712564,0.0013862621,0.015387613,0.015068733,0.27562332,0.06987465,0.013716471,0.002424244,0.08082114,0.0051138042,0.044282984,0.020625766,0.0021696608,0.027719915,0.14966701,0.0025408857,0.014752251,0.073499784,0.17248994,0.00087604026,0.00259103
pathogenesis ceftriaxone associated biliary sludge vitro studies calcium ceftriaxone binding solubility ceftriaxone semisynthetic third generation cephalosporin recently associated biliary sludge formation analysis biliary concretions induced agent shows calcium salt ceftriaxone present vitro studies undertaken provide insight pathogenesis ceftriaxone associated biliary sludge formation evaluating possible interactions may exist calcium bile salts ceftriaxone ceftriaxone possessed high calcium binding affinity formation constant calcium ceftriaxone salt degrees c l mol stoichiometry salt e calcium ceftriaxone calcium binding property ceftriaxone observed additive taurocholate mixed taurocholate ceftriaxone solutions although solubility product constant calcium ceftriaxone x mol l marked metastability observed neither visible microscopic precipitates developed ca x ceftriaxone ion product exceeded solubility product constant factor metastability calcium ceftriaxone salt also observed human gallbladder bile vitro estimates human biliary calcium ceftriaxone solubility vivo calculated previously reported values biliary ca ceftriaxone solubility product constant defined study calculated saturation indices calcium ceftriaxone human bile generally increased corresponding decrease solubility increasing ceftriaxone dose doses less equal g saturation index well within metastable range calcium salt however doses greater equal g saturation index surpassed metastable limit conditions precipitation ceftriaxone could occur concluded development ceftriaxone induced biliary sludge solubility problem occurs patients receiving high dose treatment greater equal g study proposes risk developing ceftriaxone associated biliary pseudolithiasis increases increasing ceftriaxone dose patients impaired gallbladder emptying,C06,0.0015562306,0.0013804542,0.020964617,0.0008743825,0.0021670018,0.0021258001,0.31039518,0.024626253,0.0011250854,0.001529088,0.0404078,0.014725616,0.06640195,0.1855492,0.00136851,0.0024233747,0.050363265,0.03335779,0.0017719974,0.028352,0.1913088,0.0156187145,0.0016068534
soluble interleukin receptor crohn disease relation serum concentrations disease activity serum concentrations soluble interleukin receptor sil r measured marker immune activation group patients crohn disease sil r concentrations determined enzyme linked immunosorbent assay periods active inactive disease correlated standard parameters disease activity serum concentrations sil r significantly raised patients active crohn disease compared patients inactive disease p less control subjects significant correlation serum sil r concentrations disease activity assessed harvey bradshaw index r p less platelet numbers r p less orosomucoid r p less alpha antitrypsin r p less c reactive protein concentrations r p less erythrocyte sedimentation rate measurement serum sil r concentration simple useful laboratory means assessing disease activity raised concentrations patients active crohn disease evidence vivo immune activation occurring disease,C06,0.002227143,0.0019755869,0.004156862,0.0012513407,0.003101226,0.002874244,0.2672122,0.002094432,0.0016101252,0.0021882986,0.011010114,0.015487178,0.18993676,0.005617033,0.0019584931,0.0034681247,0.07710193,0.059032116,0.0025359297,0.073342405,0.26873645,0.0007907775,0.0022912025
duodenal ulcer refined carbohydrate intake case control study assessing dietary fibre refined sugar intake association duodenal ulceration low fibre intake high refined carbohydrate diet reported therefore compared current diet smoking habits social class possible risk factors patients duodenal ulcer community control group matched age sex logistic regression matched sets used calculate relative risks successive quintiles dietary fibre sugar intake adjustment total calorie intake possible confounding effect known risk factors relative risks differ materially consistently total dietary fibre cereal moiety whether adjusted calorie intake contrast relative risks tended reduced high vegetable fibre intake low refined sugar intake controlling smoking social class associated ulcer disease relative weight quetelet index relation ulcer disease low refined sugar intake persisted high vegetable fibre intake reduced results study indicate lack cereal total fibre intake plays part duodenal ulcer development low refined sugar intake may protective factor,C06,0.0017554536,0.04399487,0.05997914,0.0009860566,0.0024437662,0.0138272485,0.20176013,0.0016504127,0.0012687787,0.0017243795,0.03133522,0.015922412,0.040250145,0.012704845,0.039404385,0.011225957,0.02345216,0.0018073474,0.0020386179,0.39455763,0.095481664,0.00062313274,0.0018062291
gallstone clearance randomized study extracorporeal shock wave lithotripsy chemical dissolution following extracorporeal shock wave lithotripsy known whether gallstone fragments cleared gallbladder without use oral dissolution therapy assess efficacy lithotripsy dissolution therapy alone combination patients randomized one three treatment groups lithotripsy alone dissolution therapy alone combined lithotripsy dissolution therapy patients symptomatic gallstones functioning gallbladders comparable stone profiles lithotripsy administered using piezoelectric lithotripter dissolution therapy consisted combined bile acid terpene clearance assessed months using ultrasound oral cholecystography patients less per cent stone clearance end months considered failures number patients total partial clearance combined group significantly greater lithotripsy alone group p less gallstone clearance following lithotripsy appears dependent upon dissolution therapy,C06,0.0025274442,0.014476646,0.016949465,0.0014200677,0.0035193858,0.015489877,0.36236063,0.02677016,0.0018272295,0.0024833623,0.025766805,0.06997056,0.06817401,0.019630421,0.0022226716,0.003935756,0.1769367,0.0026028485,0.0029760043,0.021723192,0.15473749,0.0008974036,0.0026018473
effects milk prostaglandin antacid experimentally induced duodenitis rat use myeloperoxidase index inflammation ulcerogenesis duodenal mucosa frequently involves inflammatory reaction infiltration leukocytes measurement neutrophil myeloperoxidase activity might thus sensitive indicator damage visible lesions occur test possibility rat model duodenal injury used fasted animals treated indomethacin histamine dihcl twenty four hours indomethacin treatment duodenal tissues collected histochemical staining biochemical assay myeloperoxidase activity indomethacin histamine challenged rats significantly elevated myeloperoxidase activity compared unchallenged controls p less histochemistry biochemistry also significant correlation two parameters r p less duodenal injury model used test effectiveness known gastric protective agents results indicated milk buttermilk aggravate protect duodenal injury antacid prostaglandin significantly protect inflammation p less concluded measurement myeloperoxidase activity sensitive potentially useful estimate duodenal injury valuable assessing ulcerogenesis healing,C06,0.07607368,0.012486424,0.024114331,0.0012251711,0.01359167,0.0028141344,0.2573949,0.02314251,0.0015764523,0.0021425344,0.063210666,0.0045115734,0.12668459,0.018066619,0.0019175349,0.024502499,0.035581227,0.0022456218,0.0024828953,0.01434149,0.28887418,0.00077423983,0.0022450876
requirement endogenous tumor necrosis factor cachectin recovery experimental peritonitis intrasplenic immunization raised rat mab mab v q igg kappa potent neutralizing activity natural mouse tnf microgram ml mab v q u ml tnf mab v q used study role endogenous tnf experimental peritonitis induced sublethal cecal ligation puncture mab v q persisted days serum mice injected micrograms antibody therefore proved useful vivo experiments little micrograms mab v q mouse prevented lethal shock animals micrograms lps mouse sublethal cecal ligation puncture p injection mab v q directly h induction experimental peritonitis lead death animals within days lethal effect mab v q compensated injection recombinant mouse tnf similar mab v q effects immunocompetent mice shown severe combined immune deficiency mice deficient mature functional b cells taken together data suggest early phase peritonitis endogenous tnf may stimulate nonlymphoid cells granulocytes macrophages platelets fibroblasts ingest bacteria localize inflammation respectively beneficial effects tnf may determine survival thus data may implications therapeutic management beginning peritonitis,C06,0.0018856335,0.010780206,0.0035133397,0.028389702,0.002621094,0.020645896,0.16908339,0.010879519,0.0013608455,0.0018495062,0.020098126,0.045058932,0.03907375,0.12517437,0.0016552792,0.057598677,0.031075204,0.0114435805,0.002143317,0.02210288,0.2816345,0.08267574,0.029256465
gallbladder motility cholesterol gallstone disease effect ursodeoxycholic acid administration gallstone dissolution gallbladder motility evaluated ultrasonography cholesterol gallstone patients matched control subjects gallstone patients candidates oral bile acid therapy radiolucent gallstones less cm diameter well opacified gallbladder also studied ursodeoxycholic acid administration additional gallstone patients studied year confirmed gallstone dissolution oral bile acids gallstone patients showed significantly greater fasting residual volumes decreased percent gallbladder emptying similar absolute emptying emptying rate compared control subjects greater fasting volumes reduced percents gallbladder emptying also found gallstone free patients achieved complete dissolution oral bile acids ursodeoxycholic acid administration fasting gallbladder volumes greater percents gallbladder emptying decreased untreated gallstone patients conclusion greater fasting volumes reduced gallbladder contractility account defective gallbladder function radiolucent cholesterol rich gallstone patients condition likely precede possibly promote gallstone formation persists gallstone dissolution ursodeoxycholic acid administration worsens defect observed gallstone patients finding also suggests although indirectly expected normalization cholesterol saturation oral bile acid administration paralleled improvement gallbladder function,C06,0.0017117616,0.0015180896,0.0114602195,0.000961561,0.009571594,0.0022086396,0.19646308,0.059535928,0.0012372597,0.0016815425,0.017192226,0.012678177,0.1472215,0.026426328,0.04687585,0.035797406,0.17694159,0.0017770285,0.0019486707,0.029163662,0.21524882,0.0006076529,0.0017714289
nonoperative management bile duct stones treatment choice retained bile duct stones nonoperative means tube place percutaneous techniques via tract indicated percutaneous access via puncture roux en loop also practical absence tube retrograde endoscopic techniques used techniques effective safe stones intrahepatic extrahepatic ducts also treated nonoperatively endoscopic sphincterotomy role treatment selected patients gallstone pancreatitis acute cholangitis choledocholithiasis situ gallbladders difficult cases endoscopic percutaneous techniques employed combination,C06,0.004515775,0.004005718,0.008425968,0.0025372298,0.0063348943,0.005827843,0.32753655,0.047912546,0.0032647045,0.026250532,0.16786122,0.009288087,0.03362639,0.010435719,0.003971059,0.007032001,0.1701849,0.0046504997,0.0051418743,0.050771706,0.09417572,0.0016033876,0.004645663
intrahepatic cholesterol stones rationale dissolution therapy case primary cholesterol hepatolithiasis reported stone composition documented infrared spectroscopy presence cholesterol saturated bile demonstrated using standard biochemical techniques patient treated operative stone extraction choledochoscopy biliary enteric anastomosis oral dissolution therapy administration oral dissolution agents altered composition patient bile may prevent stone formation advocate use stone biliary biochemical analysis patients primary hepatolithiasis facilitate optimal therapy,C06,0.003773662,0.039879028,0.025269767,0.020376444,0.005255444,0.0048701074,0.4040932,0.026849532,0.0027281896,0.0037078445,0.052636575,0.0077617015,0.024620894,0.0484792,0.05812099,0.0058763763,0.15620708,0.0038862461,0.004296869,0.024735812,0.07134305,0.0013398903,0.00389206
pancreatitis pancreatitis common rather poorly understood entity often associated alcohol abuse biliary tract disease despite availability variety diagnostic tests imaging techniques diagnosis pancreatitis continues primarily clinical one major concern emergency physician distinguishing pancreatitis potentially lethal causes abdominal pain identifying patients severe pancreatitis risk complicated course secondary remote systemic effects disease,C06,0.0043404913,0.0038435012,0.029031128,0.02340339,0.027006166,0.047531802,0.3556354,0.025040153,0.003132496,0.0042573316,0.111869715,0.008911953,0.034948386,0.011339499,0.0038102458,0.0067472314,0.1018462,0.004462172,0.0049336473,0.10066589,0.08124718,0.0015384564,0.004457531
effect race upon organ donation recipient survival liver transplantation effect race donor organ donation outcome clinical liver transplantation addressed previously aims study determine number organs donated major racial groups united states outcome transplantation organs across racial groups pattern liver disease required transplantation racial groups significantly higher proportion organs donated white non hispanic americans either black hispanic americans significant difference survival organ transplanted black white americans vice versa postnecrotic cirrhosis variety causes common indicator affecting black white recipients primary biliary cirrhosis primary sclerosing cholangitis uncommon black population number organs donated blacks low however proportional number black recipients study reasons low rate donation black white hispanic population discussed concluded race criteria used selection donors liver transplantation educational programs addressing issues organ donation transplantation directed towards black hispanic populations recommended,C06,0.0022038298,0.0019549069,0.014672083,0.001238242,0.003068763,0.002844157,0.23537514,0.012730891,0.012260086,0.002165392,0.030206501,0.037268937,0.07759985,0.005375209,0.0019379922,0.013597331,0.10649661,0.023600446,0.076532915,0.14621136,0.1896092,0.00078249985,0.002267695
pathogenesis biliary sludge increasing application ultrasonography biliary tract disease led frequent recognition old disorder biliary sludge sludge detected ultrasound low amplitude echoes without acoustic shadowing layers dependent part gallbladder shifts positioning particulate matter bile cholesterol monohydrate crystals shown echogenic agglomeration crystals biles high mucus content accounts layering characteristic appearance movement sludge alteration patient position within gallbladder stability vesicular form cholesterol protein lipid interactions important determinants cholesterol precipitation mixed pigment gallstones equilibrium ionized unionized calcium hydrolysis conjugated bilirubin also important factors although risk factors contributing formation gallbladder sludge critically examined known instances sludge produce biliary pain associated acalculous cholecystitis recurrent pancreatitis ultimately formation gallstones better appreciation pathogenesis sludge formation help understanding genesis gallstones also perhaps understanding documented poorly understood biliary pancreatic disorders,C06,0.0026601504,0.0023596862,0.0049635647,0.00149463,0.029455671,0.003737998,0.30749545,0.09411204,0.0019231703,0.0026241387,0.060592916,0.005471421,0.020673625,0.08671195,0.053848308,0.04339993,0.05260015,0.015616747,0.023830572,0.082383014,0.10035618,0.00094452273,0.0027441932
outpatient health care utilization patients inflammatory bowel disease basis normal life expectancy inflammatory bowel disease patients early onset disease variety symptoms inflammatory bowel disease patients anticipated frequent users outpatients services study assesses characteristics outpatient health care utilization degree satisfaction health care inflammatory bowel disease patients compared patients gastrointestinal disease study method secondary analysis data collected patients attending university calgary gastroenterology outpatient clinic inflammatory bowel disease patients significantly younger p less better educated p less patients past year inflammatory bowel disease patients consulted significantly often gastroenterologist p less spent time hospital p less patients inflammatory bowel disease patients also consulted frequently herbalists naturopaths lastly inflammatory bowel disease patients satisfied health care received patients results provide information useful health care planners well dealing directly inflammatory bowel disease patients,C06,0.0022274898,0.0019758944,0.0041607963,0.0012515356,0.0031017088,0.0029027893,0.33438233,0.0020947582,0.0016103759,0.01348208,0.1071735,0.0048422515,0.10663528,0.005190627,0.0019587982,0.014248423,0.23994945,0.002295248,0.0672287,0.04600507,0.034197208,0.00079090067,0.0022947928
motility changes primary achalasia following pneumatic dilatation changes esophageal motility pneumatic dilatation evaluated prospectively patients achalasia patients evaluated median months pneumatic dilatation led clinical improvement patients manometric evaluation significant decrease lower esophageal sphincter pressure observed mmhg vs mmhg p resting pressure esophageal body dropped mmhg gastric baseline mmhg gastric baseline therapy peristaltic activity present patients case complete relaxation lower esophageal sphincter recorded treatment induced motility changes could predicted clinical history lower esophageal sphincter pressure therapy however resting pressure esophageal body therapy significantly lower patients peristalsis recurred therapy patients unchanged motility pattern reappearance peristaltic activity pneumatic dilatation unrelated lower esophageal sphincter pressure conclusion motility disturbances esophageal body patients achalasia simply reflect functional obstruction lower esophageal sphincter findings support hypothesis achalasia distinct motility disturbance regarded part broad spectrum different interrelated esophageal motility disorders,C06,0.0021133337,0.0018746323,0.003943261,0.001187666,0.013172104,0.002727367,0.24818182,0.0019874044,0.011753269,0.0020764743,0.04413038,0.004346744,0.28236023,0.005047818,0.039436057,0.0032908998,0.16014591,0.0022094618,0.0024063413,0.015735596,0.14894874,0.000750368,0.0021741197
pathogenesis therapy peptic ulcer disease epithelial cells stomach duodenum normally protected damaging effects acid pepsin balancing mechanism mucosal resistance imbalance occurs peptic ulcer may result traditional teaching emphasized importance acid pepsin cause imbalance however clear acid pepsin important factors pathogenesis peptic ulcer recent investigative efforts directed constitutes mucosal resistance disrupted produce presence gastric acid peptic ulcer depletion endogenous prostaglandins helicobacter pylori gastritis emerged prominent theories evidence exists support refute theories humans definitive conclusions cannot made time acute management peptic ulcer disease directed relieving pain accelerating ulcer healing preventing complications peptic ulcers healed antisecretory agents e h receptor antagonists omeprazole antacids prostaglandins sucralfate effective safe convenient h receptor antagonists widely used agents management peptic ulcer disease h receptor antagonist agents equally effective indicated uses equally safe based scientifically valid data selection based primarily cost omeprazole newest antisecretory agent single morning dose mg suppresses acid secretion h agent offers little advantage h receptor antagonists majority patients peptic ulcer,C06,0.028451683,0.010504991,0.0034225986,0.018782841,0.0025541936,0.029004417,0.5479817,0.008388932,0.0013261115,0.0018022996,0.045153067,0.003772788,0.030403374,0.05026891,0.010488308,0.029488193,0.04480685,0.01963655,0.01096125,0.022253547,0.07799913,0.00065129047,0.0018970042
fluorescence assays monitor membrane fusion potential application biliary lipid secretion vesicle interactions membrane fusion constitutes essential intermediate step numerous cell biological processes occurring example endocytosis membrane recycling exocytosis also less desirable events infection cells animal viruses mediated membrane fusion viral envelope merges cellular membrane causing expulsion viral nucleocapsid cytoplasm cell initial step virus replication much current knowledge concerning mechanism membrane fusion derived studies using simple artificial membranes liposomes phospholipid vesicles model systems essential feature studies development membrane fusion assays register sensitive continuous fashion mixing membranes aqueous volumes initially enclosed membranes assays allow one readily detect quantify fusion also provide possibility relate kinetics fusion rate certain molecular changes membranes take place obviously insight relevance understanding mechanism membrane fusion principles applications representative assays rely use fluorescence spectroscopy discussed assays monitor membrane mixing commonly based detection changes resonance energy transfer efficiency relief fluorescence self quenching appropriate fluorescent lipid analogs contents mixing assays rely either formation aqueous soluble fluorescent complex quenching fluorophore encapsulated one vesicle population suitable quencher entrapped second population,C06,0.009580835,0.0014576353,0.16981415,0.00092326914,0.018187504,0.002120686,0.27436006,0.011073697,0.0011879889,0.0016145791,0.030765641,0.019975744,0.044117574,0.1423486,0.017351223,0.050285053,0.03233196,0.001710463,0.026459245,0.06459877,0.060266882,0.00058345456,0.018885003
sexual physical abuse women functional organic gastrointestinal disorders study objectives determine prevalence history sexual physical abuse women seen referral based gastroenterology practice determine whether patients functional gastrointestinal disorders report greater frequencies abuse patients organic gastrointestinal diseases determine whether history abuse associated symptom reporting health care utilization design consecutive sample women seen university based gastroenterology practice month period asked complete brief questionnaire measurements self administered questionnaire requested information demographics symptoms health care utilization history abuse physicians indicated primary diagnosis patient whether ever discussed sexually physically abused results patients reported history sexual physical abuse childhood later life physically abused patients sexually abused almost one third abused patients never discussed experiences anyone informed doctors patients functional disorders likely organic disease diagnoses report history forced intercourse odds ratio ci frequent physical abuse odds ratio ci chronic recurrent abdominal pain odds ratio ci lifetime surgeries compared surgeries p less abused patients likely nonabused patients report pelvic pain odds ratio ci multiple somatic symptoms compared symptoms p less lifetime surgeries compared surgeries p less conclusions found history sexual physical abuse frequent yet hidden experience women seen referral based gastroenterology practice particularly common functional gastrointestinal disorders history abuse regardless diagnosis associated greater risk symptom reporting lifetime surgeries,C06,0.0014473131,0.001283839,0.008917813,0.0008131862,0.0020153378,0.011468368,0.3300923,0.008356453,0.015053028,0.0014301216,0.06998465,0.0030341048,0.055313542,0.0033342394,0.05031902,0.0022537676,0.16734383,0.0014904926,0.043671895,0.13446407,0.085909784,0.0005138883,0.0014889424
effect leukotriene b receptor antagonist sc colonic inflammation rat guinea pig rabbit inflammatory bowel disease chronic inflammatory disorder gastrointestinal tract includes ulcerative colitis crohn disease leukotriene b thought prominent proinflammatory mediator diseases leukotriene b levels increased colonic mucosa inflammatory bowel disease patients increased polymorphonuclear leukocyte infiltration tissues evaluated efficacy acetyl methoxy propylphenoxy dihydro propyl h benzopyran carboxylic acid sc potent orally active leukotriene b receptor antagonist model inflammatory bowel disease colonic mucosal inflammation induced rats guinea pig rabbits rectal instillation dilute solution acetic acid twenty four hours later mucosal levels myeloperoxidase marker enzyme neutrophil infiltration extravasation v administered evans blue dye marker vascular disruption increased permeability measured tissues also evaluated histologically animals received either sc vehicle intrarectally min hr hr acetic acid given min acetic acid instillation sc prevented rise myeloperoxidase dye extravasation observed acetic acid inflammed tissue sc treated tissues less edematous fewer neutrophils within subepithelial space median effective dose ed values vascular protection approximately mg kg rat guinea pig ed values inhibition granulocyte accumulation mg kg rat mg kg guinea pig mg kg rabbit data indicate sc effective locally prevent acute colonic inflammation,C06,0.012991304,0.045102138,0.014936742,0.0012514626,0.003101528,0.0028745239,0.19994874,0.033257026,0.001610282,0.002188512,0.011330245,0.05930089,0.104848646,0.0057056067,0.001958684,0.0034856827,0.08360763,0.025278704,0.0025361767,0.015997821,0.35482776,0.011568255,0.0022915988
gastric lesions secondary long distance running gastrointestinal disorders reported long distance running purpose study evaluate effects prolonged exercise upper digestive tract seven subjects submitted standard endoscopic examination upper digestive tract long distance running range km mucosal biopsy specimens taken endoscopies running runners histologically pathological features stomach vascular lesions present chorion six subjects running intensity lesions ranging congestion hemorrhage postexercise histological examination also showed decrease mucosal secretion lesions secondary prolonged exercise indicate presence hemodynamic perturbations upper digestive tract,C06,0.0035771942,0.03780737,0.0066746734,0.0020098796,0.07425279,0.0046165553,0.26720765,0.026514394,0.0025861522,0.0035148032,0.110541105,0.007357605,0.06610754,0.008603832,0.020457992,0.022881271,0.16937281,0.020979434,0.0040731616,0.023581574,0.11233199,0.0012701317,0.0036800855
gastroesophageal reflux disease update management gastroesophageal reflux commonplace humans experience many patients gastroesophageal reflux disease gerd manageable condition others gerd progress severe symptoms inflammation disruption mucosal lining effective therapy calls clear understanding pathogenesis gerd final common denominator gerd lower esophageal sphincter mechanism relaxes incompetent allows gastroesophageal reflux occur key factors associated gerd gastric content b potency refluxate c esophageal clearance tissue resistance e disruption anatomic hiatus gerd generally chronic condition characterized recurrent symptoms treatment goals gerd patient need defined therapy directed toward eliminating symptoms therapy designed eliminate gastroesophageal reflux unfortunately effective therapy gerd usually affect mechanism underlying problem broad goals therapy gerd decrease gastroesophageal reflux neutralize enhance esophageal clearance protect esophageal mucosa therapeutic modalities related situations numerous overlap treatment strategies managing gerd patient used clinical stages clinical situation dictates h receptor antagonist therapy become keystone management gerd unfortunately gerd patients respond conventional h receptor antagonist dosage treatment high dose h receptor antagonist therapy recently demonstrated effective greater number gerd patients severe esophagitis,C06,0.001851035,0.019529125,0.007849869,0.018928524,0.0025756825,0.051680073,0.48897022,0.010679463,0.0013366343,0.0018218387,0.02768885,0.021686537,0.05054298,0.042832877,0.0016258296,0.029710703,0.09715613,0.0019040061,0.0021051846,0.018538345,0.09841807,0.0006564585,0.0019115348
surgical aspects sclerosing cholangitis results patients patients sclerosing cholangitis treated since patients associated inflammatory bowel disease history iatrogenic injury stone disease total biliary operations performed rate temporary improvement initial operation subsequent operations resulted lower success rate higher mortality rate radiologic findings included predominant extrahepatic intrahepatic diffuse disease patients respectively survival differences noted seventy five one hundred three deaths related liver failure bleeding sepsis patients undergoing portosystemic shunt died surgical complications related disease orthotopic liver transplantation performed patients resulted eight deaths mainly patients previously undergone extensive surgical treatment survival differences seen patients inflammatory bowel disease without condition colectomy surgical treatment patients sclerosing cholangitis minimized orthotopic liver transplantation offered treatment choice patients portal hypertension refractory cholangitis advanced cirrhosis progressive liver failure,C06,0.023525983,0.023290105,0.004111704,0.0012381175,0.0030684543,0.024158087,0.20715247,0.012695783,0.0015931105,0.0021651743,0.021922484,0.004677683,0.038879402,0.0050667753,0.012620667,0.023763105,0.42653975,0.002269351,0.01316324,0.108241655,0.036806215,0.00078242115,0.0022682287
technical aspects biliary extracorporeal shock wave lithotripsy radiologic imaging procedures play major role evaluation potential patient biliary extracorporeal shock wave lithotripsy procedure follow evaluation treating physician must thorough knowledge ultrasonography techniques lithotripsy requires continual monitoring frequent reassessment optimize targeting fragmentation gallstones maintaining patient comfort,C06,0.029331934,0.0044983155,0.009560638,0.0028492422,0.10516092,0.0067579797,0.27285233,0.00476892,0.0036661767,0.00498265,0.08819549,0.010430275,0.038554743,0.011660016,0.004459394,0.007896751,0.20686164,0.02976679,0.033600397,0.053804863,0.063323,0.001800562,0.0052169566
limitations evaluation therapy inflammatory bowel disease suggestions future research current treatment inflammatory bowel disease ibd though improved earlier therapies remains variable rather consistent supportive rather curative similar management ulcerative colitis uc crohn disease cd thought differing though related disorders suggests therapy nonspecific variation therapeutic practices results fact etiologies diseases obscure limited knowledge biological pharmacological actions drugs commonly prescribed sulfasalazine asa compounds steroids mp azathioprine inadequate understanding genetic differences influencing drug metabolism insufficient awareness factors influencing drug efficiency concurrent use antimotility drugs cigarette smoking food combinations variability patient groups studied extent severity disease incomplete documentation clinical status patients time therapeutic trial future advances treatment depend gaining new information nature ibd drug pharmacology bioavailability derived collaborative studies clinicians clinical investigators basic scientists important areas ibd research include biology intestinal epithelium nature ibd inflammatory reaction gut mucosal immune regulation via application new biotechnologies representative experimental animal models decisive multicenter therapeutic studies require agreement definitions ulcerative colitis crohn disease accurate characterization patient groups acceptable objective criteria ibd severity activity reliable indicators therapeutic response,C06,0.0017699624,0.0015700449,0.0033025662,0.018108787,0.019879907,0.010816315,0.44925928,0.0016649228,0.009836423,0.0017390919,0.026296861,0.030287087,0.025839137,0.0057788207,0.0015564603,0.045594428,0.060900316,0.0018319822,0.019483998,0.11510047,0.14691593,0.0006284493,0.0018387663
bile duct emptying response fat validation study fatty meal sonography suggested assess patients biliary pain cholecystectomy effects gallbladder removal biliary dynamics studied prospectively elective cholecystectomy patients common hepatic ducts diameter measured ultrasonography fat stimulus tests repeated month year years surgery preoperative studies patients showed dilatation fat stones common bile duct however another patients stones sludge duct show dilatation response fat poor indicator patients requiring common bile duct exploration patient major symptoms surgery month months response fat variable half tested showing decrease duct size consistent pattern emerged years patients tested showed decrease common hepatic duct fat unchanged increased mm response fat less consistent difficult measure common bile duct even years operation concluded patients indications exploration common bile duct operative cholangiography show dilatation response fat preoperative testing also fatty meal sonography used caution response fat asymptomatic patients soon operation unpredictable occasional patients showing dilation without apparent obstruction measurement common hepatic duct preferred common bile duct increases diameter mm probably significant,C06,0.0016430662,0.0014574818,0.018917397,0.0009231719,0.0022966717,0.0021204625,0.20856571,0.009408188,0.0011878638,0.043496072,0.07008626,0.0033794732,0.04202752,0.0037813906,0.001444871,0.09799572,0.27384016,0.0016920858,0.0018708726,0.012972013,0.19861986,0.0005833931,0.0016903259
hemodynamic changes splenic blood flow distal splenorenal shunt purpose study examine hemodynamic changes spleen subsequent influence numbers blood cells month distal splenorenal shunt dsrs splenopancreatic disconnection patients portal hypertension intraoperative splenic blood flow measured electromagnetic flowmeter significantly increased shunt insertion mean percentage increases within splenic vein artery p less p less respectively splenic venous blood flow measured pulsed doppler flowmeter changed significantly month postoperatively ml min wbc platelet counts significantly p less p less respectively increased month postoperatively whereas small significant p less decrease rbc count concluded splenic blood flow increases immediately dsrs splenopancreatic disconnection increase may short term influence postoperative hemodynamic changes blood cell count uncertain,C06,0.049638163,0.0021629648,0.0045497646,0.0013700264,0.02697857,0.0031468566,0.05846472,0.03769553,0.0017628403,0.014191506,0.011213839,0.005028285,0.42307952,0.032512266,0.00214425,0.0037994918,0.13351363,0.0025111274,0.0027764544,0.023380766,0.15670516,0.0008657802,0.0025085155
combined radiologic retrograde endoscopic biliary interventions methods treating complex biliary duct problems team composed endoscopist interventional radiologist described procedures two types manipulations performed endoscope antegrade transhepatic retrograde endoscopic approach combined,C06,0.0061266124,0.005434611,0.012295408,0.00344264,0.03812908,0.007906713,0.28043973,0.0057615405,0.0044292677,0.06529883,0.061634265,0.01260127,0.04089647,0.014215412,0.0053875884,0.00954041,0.2546746,0.0063093947,0.0069760494,0.049961757,0.100060195,0.0021753374,0.0063028326
acalculus lymphoeosinophilic cholecystitis associated interleukin lymphokine activated killer cell therapy case unusual cholecystitis developed completion interleukin lymphokine activated killer cell therapy described year old man treated interleukin lymphokine activated killer cells disseminated renal cell carcinoma course immunotherapy serum alkaline phosphatase level increased peripheral eosinophil count subsequently clinical radiologic evidence acute cholecystitis noted removed gallbladder showed acalculus cholecystitis extensive diffuse infiltrates numerous eosinophils lymphocytes sparse polymorphonuclear leukocytes authors name unusual cholecystitis acalculus lymphoeosinophilic cholecystitis believe associated interleukin lymphokine activated killer cell therapy pathogenic relationship discussed,C06,0.0036403087,0.0032291356,0.0067924387,0.002045341,0.0050690146,0.0046980083,0.34219483,0.038627375,0.020235553,0.0035768172,0.068205826,0.0074874195,0.023492021,0.097820066,0.0032011957,0.005668718,0.08990537,0.0037489145,0.004145027,0.054427125,0.20675193,0.0012925414,0.0037450155
pathogenesis gallstones many developments nonoperative methods treatment gallstone disease underscore importance understanding pathogenesis stones elucidation factors responsible nucleation crystals mechanism occurs would appear challenge define cascade events results gallstone formation,C06,0.006120235,0.005428954,0.011419724,0.0034387105,0.008522234,0.0078984825,0.4254318,0.0057555432,0.0044246577,0.0060134903,0.058609825,0.012588154,0.037966534,0.12630245,0.0350068,0.009530479,0.05649952,0.0063028275,0.006968788,0.077502884,0.07979855,0.0021730731,0.0062962724
rosacea ulcerative colitis possible association although rosacea formerly believed associated gastrointestinal upsets one longer finds significant association rosacea intestinal tract describe four patients combination ulcerative colitis rosacea four ulcerative colitis preceded onset severe papulopustular rosacea therefore feel severity rosacea could due associated bowel disorder one severity poor initial response rosacea treatment clearly related activity ulcerative colitis rosacea improved proctocolectomy possible purported association fortuitous report cases hope others may seen combination diseases knowledge previously unreported,C06,0.0036579117,0.0032289417,0.0067920308,0.019658897,0.0051020887,0.022303825,0.34625822,0.003423185,0.0026316233,0.021196362,0.034201812,0.00748697,0.02549252,0.008639332,0.0032010037,0.0056683775,0.14058681,0.0037486895,0.02224474,0.14854755,0.1608904,0.0012924639,0.0037462525
nonoperative management small bowel obstruction endoscopic long intestinal tube placement intestinal obstruction remains major cause morbidity mortality surgical patients reviewed records patients mechanical small bowel obstruction treated endoscopically fluoroscopically placed leonard long intestinal tube decompression patients failed trial nasogastric tube miller abbott tube decompression overall per cent patients able resolve obstruction leonard tube decompression alone subdivision patients basis etiology obstruction demonstrated much higher rate success tube decompression adhesive obstruction versus malignant obstruction inflammatory obstruction successes patients radiographic clinical evidence complete intestinal obstruction significantly less likely respond long intestinal tube treatment long intestinal tube easily passed patients complications intubation procedure series incidence tube related complications four per cent conclude initial period long intestinal tube decompression allows significant percentage patients mechanical small bowel obstruction treated nonoperatively particularly partial obstruction postoperative adhesions present patients failed trial nasogastric tube decompression poor operative risks also considered long intestinal tube placement,C06,0.020267,0.0016850721,0.0035445238,0.001067328,0.0026454688,0.0024515793,0.27005702,0.0017864408,0.0013733524,0.0018665041,0.06118787,0.003907315,0.03980629,0.004390398,0.0016704921,0.0029581285,0.44190538,0.0019563104,0.020554692,0.08530693,0.02698311,0.00067449175,0.0019542756
esophageal reflux isolated myotomy achalasia four patients achalasia underwent hour esophageal ph measurements ambulatory patients limited myotomy without fundoplication resting lower esophageal sphincter pressure reduced mm hg mm hg significant differences p greater found operation total hour ph data distribution ph vs fraction time ph vs mean duration reflux episodes greater minutes minutes vs minutes sd effective relief esophageal obstruction achalasia feasible isolated limited myotomy without producing gastroesophageal reflux,C06,0.050265674,0.0033470532,0.007040477,0.0021200303,0.0052541187,0.0048695644,0.14672428,0.0035484016,0.0027278855,0.003707431,0.021354005,0.0077912696,0.37164,0.027729465,0.0033596302,0.005875721,0.13070449,0.0038858128,0.0042963903,0.054982398,0.13355444,0.0013397408,0.0038817714
healing amelioration esophagitis result increased lower esophageal sphincter esophageal contractile pressure published erratum appears j gastroenterol feb conflicting evidence regarding whether lower esophageal sphincter esophageal contractile pressures affected changes severity gastroesophageal reflux disease compared manometric endoscopic findings patients treatment esophagitis treatment grade esophagitis iii significantly correlated r p less lower esophageal sphincter pressure esophageal contractile pressure treatment grade esophagitis change became worse patients became better patients seven healed group showed endoscopic improvement demonstrated change lower esophageal sphincter esophageal contractile pressures group show endoscopic improvement also demonstrated increase lower esophageal sphincter esophageal contractile pressures particularly evident whose esophagitis healed data suggest healing esophagitis result improvement esophageal motor function,C06,0.0026573979,0.0023572445,0.0049584284,0.0014930834,0.0037013085,0.0034295102,0.3257685,0.002499049,0.014774001,0.015468315,0.01273513,0.031196369,0.3809905,0.006119115,0.0023368485,0.004138121,0.08418005,0.002736679,0.0030258382,0.03705617,0.054700922,0.0009435454,0.002733833
towards true prevalence peptic ulcer sorreisa gastrointestinal disorder study study designed overcome methodological problems inherent earlier prevalence studies peptic ulcer carried municipality northern norway included total population aged years comprised questionnaire search previously diagnosed peptic ulcers local medical records subjects additional endoscopy subjects dyspepsia matched healthy controls n overall prevalence men women sex ratio close one higher duodenal gastric ratio previously reported region substantial prevalence asymptomatic ulcers also observed,C06,0.0034608296,0.0030699286,0.023176886,0.001944499,0.0048922626,0.0044977097,0.27182934,0.0032546062,0.01917013,0.0034101673,0.06929377,0.032982837,0.12983342,0.007972925,0.0030633756,0.0053892313,0.035621226,0.0035640807,0.0039406638,0.24019802,0.12458697,0.0012288148,0.003618305
binding human jejunum serum iga antibody children coeliac disease jejunal histology presence serum iga antibodies jab binding human jejunum vitro studied children severe malabsorptive symptoms among children confirmed coeliac disease espgan criteria sampled starting gluten free diet jab none sampled jab gluten free diet long duration sampled gluten challenge jab children severe jejunal villous atrophy probable coeliac disease younger years aged years jab gluten intake jab could detected disease control patients normal jejunal histology coeliac disease patients selective iga deficiency simultaneous determination antigliadin aga antiendomysium ema levels gliadin tissue absorption studies showed jab aga different whereas jab ema probably identical iga jab could target organ related autoantibodies coeliac disease,C06,0.0027369212,0.0024192343,0.018222835,0.001532348,0.0037976524,0.02991502,0.13109072,0.002597113,0.0019717028,0.084039904,0.10526051,0.005642183,0.03863464,0.057121363,0.002398302,0.0042469436,0.06867034,0.046856117,0.0031054106,0.075572155,0.3103567,0.00096835836,0.0028434962
extracorporeal cholecystolithotripsy without oral chemolitholysis one hundred thirty six patients completed extracorporeal biliary lithotripsy ebl symptomatic cholecystolithiasis sonographic evidence complete clearance stone fragments criterion treatment success occurred patients followed weeks patients followed weeks authors protocol varied protocols researchers primarily adjuvant chemolitholysis used however number treatment sessions total number shock waves maximum shock waves per treatment session shock waves patient demonstrating significant fragmentation shock waves patient whose stones responded well fragmentation higher reports results treatment complication rates study comparable centers using shock wave lithotripsy chemotherapy authors conclude ebl developing important alternative surgery obviated patients complete clearance fragments gallbladder,C06,0.0028793097,0.0025540914,0.0053724935,0.0016177667,0.004009754,0.03157975,0.25719053,0.016556181,0.0020816128,0.0167607,0.039843716,0.00592219,0.035685312,0.006958079,0.0025321194,0.004483684,0.33842024,0.0029652116,0.0032785176,0.02892709,0.1863972,0.0010223383,0.0029621278
collis gastroplasty origin evolution j leigh collis published innovative operation treating difficult problem irreducible hiatal hernia esophagitis stricture design operation based relatively primitive understanding hiatal hernia newly emerging concept reflux esophagitis variety antireflux operations different surgeons emerged years follow original collis gastroplasty subsequently modified addition partial complete fundoplication procedures place modified collis gastroplasty fundoplication operations today approach problems hiatal hernia gastroesophageal reflux disease remains unsettled,C06,0.004326645,0.0038379498,0.02505152,0.0024309652,0.006024716,0.051399913,0.2820602,0.004068829,0.0031279717,0.025193231,0.020929543,0.0088990815,0.03133306,0.03349543,0.0038047424,0.006737486,0.2569658,0.004455727,0.025850412,0.11387367,0.080145754,0.0015362344,0.004451093
combined electromyographic cineradiologic investigation patients defecation disorders records patients defecography electromyography performed simultaneously defecation disorders analyzed according electromyographic investigation patients could divided three main groups normal sphincter reaction paradoxical sphincter reaction combined reaction group characterized marked reduction muscular activity emptying pronounced closing reflex emptying followed return normal tonic activity patients group b relaxation sphincters emptying pronounced increased activity external sphincter puborectalis muscle also severe emptying difficulties defecography closing reflex seen group c electrical activity sphincters increased moderate straining emptying complete clear closing reflex seen study dynamic visualization defecation together registration electromyographic activity striated anal sphincters performed shown patients paradoxical sphincter reaction lacking closing reflex emptying complete reported previously important evidence paradoxical defecation pattern also shown patients rectoceles paradoxical sphincter reaction,C06,0.0025627296,0.014645013,0.04191401,0.0014373759,0.0035622811,0.028062811,0.28577206,0.0024058085,0.026614657,0.0025136303,0.016860275,0.067185335,0.034292355,0.0064544147,0.00224966,0.0039837263,0.1662495,0.002636891,0.0029129433,0.017817186,0.2663077,0.0009083414,0.002651314
corticosteroid treatment reduces mast cell numbers inflammatory bowel disease mast cell degranulation gut causes mucus secretion mucosal edema increased gut permeability may responsible symptoms signs inflammatory bowel disease used novel monoclonal antibody aai tryptase expressed exclusively granules mast cells enumerate mast cells rectal biopsies order study effect inflammatory bowel disease drug treatment upon rectal mast cell numbers rectal mast cell numbers significantly reduced inflammatory bowel disease patients taking corticosteroids mean cells mm compared control patients p less inflammatory bowel disease patients taking corticosteroids p less wilcoxon rank sum test reduction mast cell counts independent degree inflammation architectural distortion negative correlation dose corticosteroids mast cell count r p less spearman rank correlation mast cell count reduced within days treatment remained low throughout steroid therapy mucosal mast cell depletion may important mechanism action corticosteroids inflammatory bowel disease,C06,0.001992559,0.0017668103,0.013384387,0.0011191012,0.0027734938,0.0025704987,0.3000597,0.0018730962,0.00143997,0.0120505635,0.03702921,0.0041097566,0.13574986,0.14940286,0.0017515231,0.03228193,0.053128682,0.002109399,0.0022679372,0.031186692,0.20919384,0.0007072095,0.0020509271
relative frequencies portosystemic pathways renal shunt formation posterior gastric vein portographic study patients percutaneous transhepatic portography carried patients portal hypertension study various collateral routes besides left gastric vein frequent collateral route feeder esophageal varices distinct vein located left gastric vein short gastric vein constituted major collateral route patients terms frequency vein significant short gastric paraumbilical vein collateral route propose previously anonymous vein called posterior gastric vein runs posterior stomach vein also formed renal shunt common cause encephalopathy patients relative frequency renal shunt formation vein significantly greater left gastric vein short gastric vein,C06,0.068404436,0.0020198163,0.026658852,0.0012798395,0.0031706563,0.0030501594,0.20644604,0.19796689,0.0016461727,0.0022372904,0.03506392,0.0046834527,0.07324455,0.016942605,0.00200234,0.047618587,0.11207229,0.002407673,0.0025927043,0.07753157,0.09848493,0.0008084815,0.013666791
duodenal ulcer associated low dietary linoleic acid intake suggested falling incidence virulence duodenal ulcer related increased dietary polyunsaturated essential fatty acid intake adipose fatty acid profile closely reflects dietary intake measured men chronic duodenal ulcer matched control men mean percentage linoleic acid adipose tissue significantly lower ulcer group v p less difference found smokers non smokers finding suggests diets duodenal ulcer patients deficient linoleic acid could aetiological importance,C06,0.003640977,0.0032297284,0.0067936857,0.0020457164,0.0050699455,0.0046988707,0.20743781,0.0034334455,0.020057866,0.0035774738,0.017239453,0.032671824,0.17837128,0.009546327,0.026347065,0.005719581,0.06759374,0.0037496027,0.004145788,0.26320013,0.10880847,0.0012927786,0.021328397
effects short term pancreatic duct obstruction rats short term effects rat pancreatic duct obstruction evaluated compared recently reported follow obstruction rabbit pancreatic duct species pancreatic edema hyperamylasemia noted lysosomal hydrolase cathepsin b redistributed lysosome enriched zymogen granule enriched subcellular fraction theoretically redistribution phenomenon might lead digestive enzyme activation cathepsin b known capable activating trypsinogen hyperamylasemia pancreatic edema cathepsin b redistribution follow rat pancreatic duct obstruction increased infusion submaximally stimulating dose cholecystokinin analogue cerulein administration cholecystokinin receptor antagonist l reduced hyperamylasemia alter pancreatic edema cathepsin b redistribution observations indicate cholecystokinin may modulate effects duct obstruction secretin administration increased degree pancreatic edema demonstrable protective effect rat duct obstruction model described report may prove particularly useful future studies designed clarify early events underlying development acute pancreatitis,C06,0.0023547192,0.0020884986,0.015823781,0.0013228592,0.014632434,0.0030597153,0.20945734,0.0022141363,0.0017021494,0.070665665,0.025044246,0.010386328,0.066174105,0.024095744,0.0020867581,0.003672168,0.13157187,0.013818289,0.093852624,0.016599596,0.28611627,0.0008359732,0.0024247319
paf acether synthesis helicobacter pylori clinical studies suggest helicobacter pylori may play role pathogenesis gastroduodenal ulcers man direct evidence mucosal injury microorganism still lacking paf acether paf causes number disorders including ischaemic bowel necrosis gastroduodenal ulceration since paf produced escherichia coli investigated whether could synthesised h pylori five h pylori isolates collected antral biopsy specimens patients gastritis duodenal ulcer cultured selective antibiotics colonies obtained blood agar brucella broth medium used paf determined platelet aggregation assay ethanolic extraction subsequent purification high performance liquid chromatography paf detected h pylori blood agar plates pg paf x organisms bacteria cultured brucella broth medium supplementation latter medium lyso paf acetyl coa two paf precursors present high amounts mammalian intestine induced paf production three five isolates platelet aggregating material extracted h pylori exhibited biological physiochemical characteristics identical paf released eukaryotic cells findings suggest h pylori may add local production paf inflamed gastric mucosa,C06,0.015135392,0.0022985782,0.013231745,0.026527576,0.0036082494,0.0033441577,0.36207414,0.0024368535,0.0018733667,0.0025608833,0.03708493,0.017869765,0.06391257,0.09466134,0.0022786898,0.004035133,0.0349394,0.027750459,0.015464105,0.03906512,0.19997492,0.00092006277,0.028952526
vascular microvascular changes key factors development acetic acid induced gastric ulcers rats present study examined time sequence histologic ultrastructural features formation evolution experimental acetic acid induced gastric ulcerations rats one hundred percent acetic acid applied gastric serosa fasted male sprague dawley rats polyethylene tube gastric mucosal changes evaluated min h days acetic acid application visual inspection quantitative qualitative light microscopy transmission electron microscopy following exposure acetic acid earliest morphologic changes occurred min consisted dilatation large submucosal veins arteries mucosal collecting venules five minutes injury thrombi developed submucosal veins collecting venules leading microvascular stasis mucosal necrosis h necrotic masses started detach h necrotic changes penetrated submucosa h ulcers underwent transition chronic stage characterized histologically presence granulation tissue bottom appearance transitional healing zone margins days increased amount granulation tissue observed gastric glands transitional zones ulcer margin displayed cystic dilatation based study conclude key feature acetic acid induced ulcer formation early vascular microvascular injury precedes glandular cell necrosis,C06,0.029493492,0.0016853595,0.052344803,0.0010675101,0.0026459822,0.0024519977,0.28263432,0.09411828,0.028930355,0.011027025,0.042235613,0.003907855,0.051846195,0.021987384,0.010856021,0.022585155,0.07164459,0.011132087,0.002163384,0.028106084,0.21481341,0.0006746068,0.0116484845
unconjugated bilirubin cholesterol gallstone formation cholesterol gallstones usually small amounts pigment centers often diffuse pigmentation pigmented layers alternating cholesterol layers pigmented rims associated calcium carbonate eggshell calcification pigments primarily monomeric calcium salts unconjugated bilirubin anions insoluble black network polymer tetrapyrroles bilirubin presumably precipitate bile supersaturated calcium bilirubinates among various vitro model systems aqueous solubilities pk values unconjugated bilirubin differ greatly therefore known whether normal bile saturated unconjugated bilirubin however systems indicate unconjugated bilirubin solubilized binding bile salt monomers oligomers well micelles marked metastable supersaturation unconjugated bilirubin occur presence bile salt micelles pk values unconjugated bilirubin greater probably internal hydrogen bonding cooh groups lecithin decreases equilibrium solubilization unconjugated bilirubin crystals enhances metastable supersaturation unconjugated bilirubin calcium ions form insoluble salts unconjugated bilirubin monoanions dianions soluble complexes bilirubin conjugates solubility products calcium bilirubinate salts suggest normal hepatic bile saturated cab ca hb gallbladder bile may supersaturated ca hb,C06,0.0028016171,0.0024851742,0.005332489,0.0015741144,0.0039011633,0.017164987,0.26876324,0.016106965,0.029103585,0.0027527534,0.027757874,0.01932544,0.07419456,0.22710253,0.04314833,0.017912535,0.041541316,0.016655438,0.0031900534,0.021350428,0.1539544,0.0009947525,0.0028862644
esophageal motility adult congenital h type tracheoesophageal fistula congenital h type tracheoesophageal fistulas tef rare long standing respiratory symptoms common presenting complaints patients fistulas congenital esophageal motor abnormality characterized uncoordinated low amplitude peristalsis esophageal body low normal lower esophageal sphincter pressures described findings persist despite fistula repair case history adult patient congenital tef presented literature reviewed patient unusual esophageal symptoms dysphagia prominent usual respiratory symptoms,C06,0.0034578904,0.0030673214,0.006452065,0.001943049,0.07176709,0.0044625876,0.30006656,0.019987684,0.0024999008,0.047104288,0.03247011,0.00711222,0.18863419,0.008951113,0.052281205,0.0053846543,0.11641905,0.0035628767,0.003937317,0.053467706,0.062171064,0.0012277713,0.0035722966
computed tomography patients esophageal perforation contrast esophagram diagnostic procedure choice patients clinically suspected perforation esophagus patients usual clinical signs symptoms unrecognized diagnosis obscure diagnosis perforated esophagus may suggested finding mediastinal fluid air ct three patients reviewed perforations included one spontaneous one erosion esophageal carcinoma one iatrogenic two three patients diagnosis perforated esophagus made initially one patient initial esophagram interpreted normal computed tomography chest patient led suspected diagnosis perforated esophagus prompt appropriate surgical intervention followed findings mediastinal fluid importantly mediastinal air ct chest strongly suggestive esophageal perforation,C06,0.003705469,0.0032869359,0.0069140205,0.0020819518,0.05896081,0.0047821007,0.24216318,0.003484668,0.002678889,0.003640841,0.10990052,0.0076214415,0.12559037,0.008708963,0.0032584958,0.023705762,0.22667973,0.0038187571,0.0042192214,0.070318796,0.07935132,0.0013156774,0.0038120497
breast feeding diarrheal morbidity study used unique longitudinal survey mother infant pairs observed pregnancy infancy sample representative infants cebu region philippines sequencing breast feeding diarrheal morbidity events carefully examined longitudinal analysis allowed examination age specific effects feeding patterns work controlled wide range environmental causes diarrhea results generalized populations confidence addition breast milk diet even water teas nonnutritive liquids doubled tripled likelihood diarrhea supplementation breast feeding additional nutritive foods liquids increased significantly risk diarrhea benefits breast feeding alone combination nutritive foods liquids became small second half infancy benefits breast feeding slightly greater urban environments,C06,0.0028397485,0.0025189987,0.005298676,0.0015955388,0.0039542597,0.044868104,0.23871875,0.0026705337,0.0020530117,0.0027902196,0.08924819,0.020187661,0.032292854,0.0068158843,0.0024972032,0.004422079,0.028058574,0.00292447,0.016975686,0.3082505,0.14178078,0.0010082915,0.038229994
phospholipids rat human canine gastric mucosa composition metabolism molecular classes phosphatidylcholine validate recent proposal phospholipid lining high content dipalmitoylphosphatidylcholine may protect gastric mucosa luminal acid decided study composition metabolism phospholipids gastric mucosa phospholipids analyzed rat human dog gastric mucosal surface tissue chloroform methanol lavage rat canine stomach phosphatidylcholine phosphatidylethanolamine main components saturated fatty acids almost exclusively esterified sn position glycerol moiety phosphatidylcholine unsaturated fatty acids mainly sn position disaturated class phosphatidylcholine comprised total phosphatidylcholine precursors phosphatidylcholine e p orthophosphate methyl c choline preferentially incorporated disaturated molecular class hours iv administration speculated disaturated phosphatidylcholine although quantitatively minor component specifically triggered mucosal renewal processes,C06,0.003577834,0.0031737173,0.09164394,0.002010239,0.07561871,0.0046173814,0.20783968,0.0037248433,0.0025866148,0.0035154321,0.021727767,0.0073589208,0.027639298,0.01506739,0.07263031,0.0055714315,0.032682996,0.0037393118,0.0040738904,0.07253627,0.33363888,0.0012703589,0.0037547818
assessment functional gastrointestinal disease bowel disease questionnaire need exists self report questionnaire reliably accurately measures symptoms distinguishes patients functional gastrointestinal disease conditions developed instrument bowel disease questionnaire herein describe details discriminatory validity data subjects analyzed patients gastrointestinal symptoms ultimately diagnosed functional gastrointestinal disease irritable bowel syndrome functional dyspepsia organic gastrointestinal disease n healthy control subjects patients psychiatric disease somatoform disorder includes diagnosis hypochrondriasis psychogenic pain somatization conversion disorder subjects completed questionnaire undergoing independent diagnostic assessment experienced physicians functional gastrointestinal disease could distinguished organic disease somatoform disorder health using models derived logistic discriminant analysis use models estimated probability functional gastrointestinal disease calculated descriptive symptom scores less value scores derived data sets logistic discriminant analysis age significantly affect responses questionnaire items conclude population studied bowel disease questionnaire valid measure symptoms functional gastrointestinal disease instrument may clinical research applications,C06,0.001953579,0.001732922,0.0036451756,0.0010976363,0.0027202968,0.018056033,0.37194288,0.0018384379,0.0014123506,0.012521282,0.081422344,0.012016289,0.10319405,0.0045806807,0.001717928,0.022212494,0.1048077,0.002031026,0.045494292,0.06846199,0.13441798,0.0006936449,0.0020290203
alpha antitrypsin excretion stool normal subjects patients gastrointestinal disorders fecal clearance plasma alpha antitrypsin used measure protein leakage intestinal tract study alpha antitrypsin concentration stool plasma clearance alpha antitrypsin normal subjects consecutive series patients chronic diarrhea malabsorption unexplained hypoalbuminemia determined normal subjects studied usual state also diarrhea secondary ingestion lactulose sorbitol sodium sulfate phenolphthalein study first concluded induced diarrhea cause increase alpha antitrypsin clearance considered establishing normal values may overdiagnosis excess protein leakage patients diarrhea second highly significant statistical correlation p less alpha antitrypsin clearance serum albumin concentration average serum albumin falls g dl g l alpha antitrypsin clearance exceeds ml day value threefold higher upper limit normal third three nine patients microscopic collagenous colitis elevated clearance alpha antitrypsin contrast abnormal alpha antitrypsin clearance found patients idiopathic secretory diarrhea fourth fecal alpha antitrypsin concentration reliable index abnormal alpha antitrypsin clearance,C06,0.0022516688,0.0019973428,0.014971325,0.0012651209,0.0031353778,0.002905896,0.2181397,0.0021174967,0.0125167705,0.002212397,0.020100152,0.0046312525,0.1795611,0.00532771,0.001980061,0.0035063168,0.10242162,0.035946164,0.0025638563,0.06855606,0.31077668,0.00079948583,0.002316434
mallory weiss syndrome cardiopulmonary resuscitation report hematemesis mallory weiss tears successful cardiopulmonary resuscitation cpr computer search english language literature disclosed similar cases review complication cpr may occur frequently recognized prevented careful technique,C06,0.0067174034,0.038477134,0.012533979,0.003774235,0.009353772,0.008669159,0.2818364,0.0063171275,0.037350055,0.0066002435,0.08701642,0.013921568,0.04648597,0.015445385,0.005907115,0.042977165,0.13824362,0.0070066373,0.007648752,0.120432355,0.09398983,0.002385106,0.006910617
antimony glass ph electrodes used interchangeably hour studies gastric acidity antimony glass ph electrodes show almost identical experimental errors continuously measuring buffer solutions constant temperature hr errors lower nominal quantization error instruments properly described hr drift determination addition food particles solutions induce severe reading artifacts longer response time reported vitro antimony electrodes moving ph ph sec vs sec glass electrodes irrelevant vivo ph metry studies found greatest absolute difference raw fast acquired sec consecutive ph readings two commonly used devices ph units circadian profiles obtained subjects various clinical conditions vivo studies gastric acidity monitored continuously two side side minielectrodes variously combined antimony glass g antimony antimony glass glass g g applied groups subjects matched clinical condition hr ph means hr h means calculated acidity profiles obtained three electrode combinations lie identity line group using bland altman technique assessing measurement agreement differences hr ph means hr h means obtained three combined systems similar p p respectively confidence limits comprised within range reading error measuring systems namely ph units mmol liter terms h,C06,0.0018887649,0.02901569,0.07279029,0.0010579801,0.0117883235,0.013602687,0.214702,0.0017707946,0.0013613241,0.0108040245,0.05555115,0.057361003,0.16061072,0.0043716384,0.0016590722,0.012038456,0.048194613,0.0019510093,0.0021440708,0.046549775,0.17526984,0.03713055,0.038386263
biliary cholesterol transport precipitation introduction overview conference cholesterol secreted bile cholesterol phospholipid vesicles cholesterol phospholipid subsequently exposed bile salts contained bile leads process micellation two situations may arise depending whether enough bile salt proportion cholesterol complete maturation process cholesterol saturation low equilibrium bile salts completely micellized vesicles hand bile saturated cholesterol micellation process incomplete vesicles micelles present equilibrium residual vesicle latter situation may higher cholesterol phospholipid ratio greater propensity phospholipid micellized situation may result cholesterol nucleation mechanism nucleation vesicles possible role nucleating antinucleating proteins process discussed,C06,0.0034007395,0.0030166258,0.006345427,0.0019107369,0.0047354223,0.0043888316,0.29470935,0.0031980968,0.0024585833,0.0033414264,0.018900108,0.0069946717,0.05176818,0.1513102,0.15046257,0.054679766,0.06521413,0.020661185,0.0038722423,0.034874834,0.10903351,0.001207479,0.003515857
generation ammonia mucosal lesion formation following hydrolysis urea urease rat stomach examined morphological changes gastric mucosa generation ammonia exposure rat stomach urea presence urease attempts investigate pathophysiological role urea urease ammonia system gastric ulcer diseases exposure stomach min ml urea together urease iu induced histological damages concentration related manner either urea urease alone induce histological change mucosa instillation urea stomach generated ammonia presence urease amount ammonia increased depending concentration urea closely associated severity histological damage exposure stomach ammonia nh oh also produced histological damages gastric mucosa concentration related manner characteristics injury induced ammonia stasis microcirculation disruption surface epithelial cells necrosis mucosa results demonstrated ammonia generated hydrolysis urea urease stomach causes damages gastric mucosa,C06,0.014071328,0.025088482,0.11964688,0.024664685,0.015023639,0.0034702034,0.28403753,0.08009339,0.0017416715,0.0023670814,0.0111615155,0.0049550566,0.04525812,0.026315795,0.0021185009,0.0037769238,0.030273208,0.0024809728,0.0027431138,0.026632795,0.27074537,0.0008553836,0.0024783923
crypt cell proliferation hla dr expression pelvic ileal pouches investigate nature morphological changes occur ileal pouches biopsy specimens patients functioning ileo anal pouches eight pouchitis studied normal ileum n used control mucosal morphometry using linear measurements crypt cell proliferation ccp using monoclonal antibody ki epithelial hla dr expression monoclonal antibody cr assessed ccp expressed percentage ki positive nuclei crypt significantly higher pouches pouchitis compared without pouches without pouchitis compared normal ileum ccp values pouches without pouchitis approached values found pouchitis ccp related inversely villous height index villous atrophy vh tmt directly crypt depth presence pouchitis intense epithelial hla dr expression extended crypts pouches high ccp values without clinically important inflammation surface epithelial hla dr expression weak patchy concluded villous atrophy crypt hyperplasia ileal pouches associated high ccp values may increased even absence active inflammation increase may occur response new luminal environment,C06,0.00225269,0.0019982485,0.004276495,0.05578543,0.0031367994,0.0029072138,0.26122624,0.0130184,0.0016285946,0.034922987,0.018218743,0.0046487343,0.19821575,0.1539537,0.0019809587,0.025283532,0.033928957,0.0025875857,0.0025650188,0.020599114,0.108980976,0.00079984835,0.04708399
sphincter oddi manometry decreased risk clinical pancreatitis use modified aspirating catheter study undertaken determine whether routine use modified triple lumen five french sphincter oddi manometry catheter would reduce frequency severity post manometry pancreatitis pancreatic enzyme elevation seventy six patients alternately assigned undergo sphincter oddi manometry som standard perfusion infused group catheter newly developed aspiration aspirated group catheter som significantly patients infused group amylase lipase values elevated least two times upper limits normal p less p hours p procedure compared standard perfusion system aspiration catheter associated decreased frequency clinical pancreatitis vs p reduced hospital stay days mean se versus day p milder pancreatitis aspiration manometry catheter considered standard use som particularly pancreatic duct sphincter evaluated,C06,0.0025921937,0.0022980883,0.017332332,0.0014556138,0.0036074806,0.003343445,0.18589102,0.0024365168,0.0018729673,0.015038991,0.12318891,0.042956475,0.25052473,0.018759526,0.0022782043,0.0047707562,0.11822581,0.002668718,0.04052201,0.06315323,0.093497925,0.00091986667,0.002665226
primary sclerosing cholangitis primary sclerosing cholangitis rare disease unknown etiology sclerosis bile ducts may actually final result multiple factors autoimmune bacterial congenital drug viral injury commonly associated diseases ulcerative colitis chronic pancreatitis except earliest stages disease liver histologic findings specific patients present jaundice pain pruritus although increasing number asymptomatic patients inflammatory bowel disease abnormal liver function identified cholangiography key diagnosis usually pathognomonic except unusual case primary sclerosing cholangitis confused cholangiocarcinoma many forms medical therapy tried including antibiotics azathioprine cholestyramine colchicine cyclosporine penicillamine steroids ursodeoxycholic acid date none medications proved alter course disease recent reports ursodeoxycholic acid trials encouraging long term results ongoing randomized trials yet published recent years balloon dilatation biliary strictures accomplished via endoscopic percutaneous transhepatic approaches however patients primary sclerosing cholangitis nonoperative manipulations must done repeatedly may entail multiple general anesthetics difficult perform believe direct surgical approach biliary tree long term transhepatic stenting indicated selected patients severe hilar extrahepatic stricturing persistent jaundice recurrent cholangitis evidence cirrhosis hepatic transplantation reserved patients primary sclerosing cholangitis well established cirrhosis responded therapeutic measures,C06,0.0120665105,0.0016699609,0.003512738,0.0010577566,0.011723647,0.0104708895,0.46452755,0.01137308,0.0013610367,0.010914973,0.09039375,0.0038721503,0.02226648,0.030568587,0.0016555117,0.028826639,0.13369538,0.0019387668,0.038594197,0.063716866,0.053187244,0.00066844316,0.0019378014
absorption motility bypassed human ileum authors assessed absorption motility human ileum prolonged period disuse eight patients ulcerative colitis manometric catheter assembly placed via ileostomy unused portion distal ileum two months ileal pouch anal anastomosis temporary diverting loop ileostomy distal ileum perfused ml min isosmotic solution either sodium chloride ileal chyme diluted sodium chloride three hours three hours meal two consecutive days absorption measured single clustered pressure waves identified quantitated aid computer program motility index calculated mean absorption e perfusates poor day ml cm x min meal induced ileal motor response day however absorption perfusates much improved ml cm x min p less number discrete clustered contractions motility index clearly increased meal vs clustered waves hr vs motility units min p less conclusion absorption motility human ileum impaired two months disuse ileal absorption motility improved one day introduction isosmotic ileal perfusates,C06,0.0026570926,0.015206417,0.030681012,0.001492912,0.0036999173,0.019940738,0.07417874,0.002498762,0.0019209597,0.0026107496,0.061865617,0.018320668,0.26947308,0.022338592,0.0023365803,0.004156165,0.18985835,0.041318346,0.015270789,0.020472813,0.19596708,0.00094343704,0.0027911577
gallstone disease north india clinical ultrasound profile referral hospital studied prevalence gallstones patients upper abdominal pain heaviness discomfort ultrasound examination gallbladder actual ultrasound examination performed clinical gastroenterologist blinded symptoms consecutive dyspeptic patients gallstones gallbladder contracted normal size distended biliary colic frequently presenting complaint patients contracted gallbladder normal size gallbladder p less dyspepsia frequent presence normal size gallbladder contracted one p less conclude ultrasonography gallbladder clinician high diagnostic yield symptom complex excellent correlation sonographic appearance,C06,0.0031904033,0.002830047,0.006164012,0.0017925574,0.004604129,0.004147638,0.18543254,0.12680635,0.0023065195,0.0031640371,0.19995001,0.00656205,0.08869011,0.008271085,0.0028055601,0.03585255,0.16786848,0.0032927073,0.0036327434,0.04491656,0.09330501,0.0011327963,0.0032821693
calcium calcium binding human gallstone disease precipitation calcium salts bile important pigment gallstone formation may serve nidus cholesterol precipitation compared gallbladder bile patients symptomatic gallstone disease cholesterol gallstones pigment gallstones bile patients undergoing surgery non biliary tract disease bile patients gallstone disease less concentrated decreased sodium bile salt phospholipid concentrations elevated biliary calcium concentrations observed relationship free ionized calcium total calcium similar groups indicating difference calcium binding gallstone containing bile cannot exclude elevated biliary calcium level factor gallstone pathogenesis could transient event importance calcium precipitation supported finding half samples saturated supersaturated least one calcium salt calcium carbonate,C06,0.0024967375,0.002214731,0.0046586534,0.001402815,0.003476628,0.00322217,0.2429417,0.014344151,0.0018050302,0.0024531914,0.024873672,0.017857203,0.07880489,0.24639449,0.038538843,0.004109859,0.09459401,0.02673205,0.0028429031,0.036819804,0.14595214,0.0008865008,0.0025778674
oral dissolution therapy cholelithiasis mix match authors conducted prospective randomized trial chenodeoxycholic ursodeoxycholic acid versus ursodeoxycholic acid alone patients cholelithiasis determine efficacy dissolution gallstones one hundred twenty patients radiolucent gallstones less equal mm functioning gallbladder enrolled patients divided two groups based diameter largest stones seventy patients stones larger mm less mm whereas patients stones measured mm less patients randomly assigned treatment chenodeoxycholic acid plus ursodeoxycholic acid mm kg ursodeoxycholic acid mm kg alone oral cholecystography plain abdominal x rays ultrasonography gallbladder done months dissolution deemed complete stones visualized two examinations partial dissolution defined reduction stone size number stones detected cholecystography still detected ultrasonography considered partially dissolved plasma triglycerides serum cholesterol hdl serologic liver function tests determined months select group patients bile rich duodenal aspirates aspirated analyzed biliary lipid contents group small stones defined less equal mm complete stone dissolution occurred significantly often utilizing combination therapy months vs trend persisted although longer significant months combination therapy also achieved improved rate dissolution large stones within months however persist months although statistically significant stone calcification occurred less often combined therapy treatment regimens well tolerated minor changes bowel habits mild elevations serum transaminase levels serum lipid levels change either therapy authors concluded combination chenodeoxycholic acid ursodeoxycholic acid preferred therapy gallstone dissolution dissolves stones rapidly lower incidence stone calcifications thus might reduce long term cost treatment,C06,0.0013355666,0.0076323524,0.008954472,0.00075032987,0.0018728331,0.0017234562,0.23771292,0.014107261,0.00096546445,0.001314598,0.066159785,0.04268631,0.0942021,0.010033859,0.042231947,0.0072751204,0.19460613,0.0013752829,0.014436228,0.049707994,0.19906333,0.0004741666,0.001378478
colonoscopy critically ill patients conditions call indications colonoscopy intensive care unit include acute lower intestinal bleeding sigmoid volvulus pseudo obstruction colon suspicion pseudomembranous colitis although incidence cardiorespiratory complications may higher critically ill patients procedure done safely proper attention detail colonic dilatation endoscopy often done without bowel preparation,C06,0.0054727206,0.004854576,0.036700584,0.0560578,0.0076205903,0.007062831,0.31146777,0.005146613,0.0039565335,0.0053772693,0.025168432,0.01125634,0.042781647,0.012583475,0.004812572,0.008522164,0.18025938,0.005635995,0.03269528,0.12010901,0.1048851,0.0019431643,0.005630133
surgical management bile duct stones biliary surgeon must familiar available techniques treatment bile duct stones experience judgment important successful management individual patient intrahepatic extrahepatic stones knowledge nonsurgical methods stone removal important decision making process however biliary surgeon must resist temptation less thorough removal stones operation lest patient subjected additional procedures carry risks morbidity death goal clear stones biliary system fewest procedures offering lowest morbidity mortality risks patient,C06,0.003517957,0.020148922,0.0065641426,0.0019765964,0.021466227,0.021563565,0.25922436,0.020295117,0.0025433262,0.0034565993,0.050729364,0.024249332,0.05886278,0.008788337,0.0030936026,0.0054781907,0.217345,0.0036229123,0.0040115793,0.16996829,0.08822557,0.0012490987,0.0036191444
monitoring enzyme replacement treatment exocrine pancreatic insufficiency using cholesteryl octanoate breath test cholesteryl c octanoate breath test used monitor intraluminal enzymatic activity pancreatin preparations six patients severe pancreatic insufficiency conventional enzyme replacement cimetidine adjunct compared supplementation enteric coated microspheres healthy control subjects co excretion rose rapidly peaked minutes mean sd cumulative recovery four hours patients pancreatic insufficiency treatment mean sd cumulative recovery pancreatin previous administration cimetidine increased time course resembling controls mm enteric coated microspheres co excretion rise significantly minutes cumulative recovery four hours control study mm radio opaque microspheres empty stomach two hours ingestion results suggest cholesteryl octanoate breath test successfully used monitor intraluminal enzymatic activity treatment different forms enzyme replacement pancreatic insufficiency contrast treatment conventional pancreatin cimetidine adjunct mm enteric coated microspheres show vivo enzymatic activity two hours administration,C06,0.0023588962,0.0020888003,0.09085721,0.012718826,0.0032789453,0.025828991,0.168522,0.0023489827,0.0017023953,0.0023137017,0.079366475,0.0048888344,0.1505998,0.005687738,0.002070727,0.0036668696,0.09983755,0.002430465,0.0026812542,0.029623235,0.29225665,0.00083609397,0.014035589
extracorporeal shock wave lithotripsy biliary stones extracorporeal shock wave lithotripsy noninvasive technique treatment patients gallbladder bile duct stones selected patients gallbladder stones treated outpatient basis without general anesthesia may return full activity within days stone free rates months achieved reported series minimal morbidity bile duct stone lithotripsy achieved stone clearance patients conventional methods unsuccessful therefore constitutes valuable second line treatment patients,C06,0.0040707276,0.0036109383,0.007595555,0.0022871757,0.005677948,0.005253486,0.27465743,0.043164752,0.0029429547,0.0039997287,0.1417498,0.008372708,0.025931612,0.009699058,0.003579695,0.006345342,0.26735333,0.0041921744,0.004635122,0.02976303,0.13948424,0.0014453674,0.0041878144
advanced assessment abdomen gastrointestinal problems many unique physical assessment findings associated specific gastrointestinal disorders detection findings enables nurse manage gastrointestinal emergencies patient unit timely fashion preventing deterioration maintaining safety patient skills build well traditional detailed comprehensive assessments nurse makes using nursing process specific abdominal assessments include detection signs associated appendicitis rebound tenderness mcburney rosvig aaron signs nurse must always alert possibility peritonitis urgency early detection treatment patient cirrhosis liver presents distinct clinical picture need subtle evaluation mental status detect early signs hepatic coma another extra abdominal assessment complication asterixis finally assessment patient enhanced nurse able help identify location bleeding improving abdominal gastrointestinal system assessment leads early detection nursing problems appropriate interventions,C06,0.0022278896,0.023544097,0.025719292,0.01648394,0.01388622,0.003187572,0.4560853,0.034443278,0.0016106651,0.04468073,0.07621107,0.015343622,0.014483707,0.0059374436,0.00195915,0.04608643,0.082280084,0.0023613481,0.0026539143,0.07310401,0.054623257,0.0007910427,0.0022959334
microprocessor assisted solvent transfer system gallstone dissolution vitro vivo validation improve efficacy safety convenience contact dissolution gallbladder stones microprocessor assisted solvent transfer system developed system two pumps simultaneously infuse aspirate solvent gallbladder high flow rate multilumen catheter microprocessor controls pumps using closed feedback loop control algorithm regulate intragallbladder pressure prevent solvent escape duodenum turbulent solvent flow catheter end gallbladder designed induce rapid stone dissolution suspend insoluble residue thus promoting aspiration system response gallbladder emptying capacity fold faster natural gallbladder emptying rate rate gallstones dissolved methyl tert butyl ether using system compared achieved syringe pump pairs stones totally dissolved mean dissolution time system minutes compared minutes syringe pump stone pairs dissolved incompletely insoluble residue completely eliminated system minutes syringe pump even minutes system used gallstone patients solvent recovery concentration nonabsorbable marker change confirming lack appreciable absorption methyl tert butyl ether studies suggest microprocessor assisted solvent transfer system device capable safe complete fully automatic contact dissolution cholesterol gallbladder stones using methyl tert butyl ether similar solvents,C06,0.0022043537,0.02329625,0.025060719,0.011900033,0.0030694928,0.013696892,0.28275192,0.044687517,0.0015936496,0.0021659068,0.037550226,0.05973022,0.19066712,0.0056488705,0.023241157,0.03041464,0.09237776,0.0024328295,0.002509981,0.024521964,0.11742807,0.0007826859,0.0022677577
geographic variation inflammatory bowel disease within united states one approach learn possible environmental risks inflammatory bowel disease relates studying geographic pattern occurrence geographic variation inflammatory bowel disease within united states analyzed using accumulated million hospital discharges u medicare beneficiaries two consecutive years validate geographic pattern shown medicare data hospitalization compared mortality inflammatory bowel disease among different states mortality hospitalization statistics suggested occurrence inflammatory bowel disease determined environmental factors marked geographic variation within united states crohn disease ulcerative colitis appeared frequent northern parts united states southern urban rural parts trends observed men women blacks whites alike similar geographic patterns crohn disease ulcerative colitis suggested influence one identical risk factors diseases,C06,0.0028398638,0.002519101,0.005298891,0.0015956035,0.0039544203,0.0037814914,0.36994332,0.0026706422,0.015799139,0.002790333,0.049941167,0.0058516576,0.06956964,0.006559672,0.016208619,0.0044222586,0.05646816,0.0029245887,0.0032336025,0.20536476,0.16432288,0.0010083325,0.002931866
selective intestinal decontamination increases serum ascitic fluid c levels cirrhosis selective intestinal decontamination days norfloxacin performed cirrhotic patients ascites low ascitic fluid total protein variations serum ascitic fluid c c ascitic fluid total protein therapy compared control group untreated patients similar characteristics oral norfloxacin administration saw significant increase c serum p less ascitic fluid p significant increase also observed ascitic fluid total protein p less serum ascitic fluid c changes serum c ascitic fluid c ascitic fluid c ascitic fluid total protein group data demonstrate selective intestinal decontamination increases serum ascitic fluid c levels therefore might useful preventing spontaneous infections cirrhotic patients high risk infection,C06,0.0026567988,0.015216594,0.004957311,0.0014927469,0.003699747,0.0034287372,0.20925978,0.0024984858,0.0019207472,0.0026104609,0.014375871,0.031682044,0.12801117,0.006175385,0.002336553,0.004137188,0.0766192,0.0541843,0.0030251562,0.040509537,0.38752565,0.00094333274,0.0027332166
circadian esophageal motor function patients gastroesophageal reflux disease effective esophageal peristalsis major determinant esophageal clearance function may contribute development complications gastroesophageal reflux disease using hour ambulatory esophageal manometry compared circadian esophageal motor activity normal volunteers patients increased esophageal exposure gastric juice various grades mucosal injury mucosal injury esophagitis stricture barrett esophagus prevalence mechanically defective lower esophageal sphincter esophageal acid exposure time frequency nonperistaltic esophageal contractions supine upright meal periods increased increasing severity mucosal injury median amplitude esophageal contractions compromised patients mechanically defective sphincter particularly patients stricture barrett esophagus associated increased frequency ineffective contractions less mm hg data show esophageal motor function deteriorates increasing severity mucosal injury appears caused persistent reflux gastric juice across mechanically defective lower esophageal sphincter need surgical correction mechanically defective sphincter loss esophageal body function implicated,C06,0.042184364,0.0018374668,0.0038650841,0.0011638552,0.0028844087,0.0026732958,0.22415267,0.0019509138,0.0014975559,0.021951403,0.009844387,0.0042605475,0.32872427,0.004905282,0.0018976138,0.0032256562,0.086238526,0.0021335676,0.0023586343,0.07534817,0.17393404,0.0007354916,0.0022327714
circulating antibodies human colonic extract enriched kda protein patients ulcerative colitis previously described kda colonic protein specifically recognised tissue bound immunoglobulin g obtained colon patients ulcerative colitis report presence circulating antibodies antigen using enzyme linked immunosorbent assay highly enriched preparation kda protein normal colon extracts serum collected patients ulcerative colitis crohn disease specific diarrhoeal syndromes normal subjects twenty nine patients ulcerative colitis crohn disease patients diarrhoea symptomatic collection sera difference optical density values patients symptomatic ulcerative colitis groups including patients ulcerative colitis remission highly significant p less seventy nine per cent patients symptomatic ulcerative colitis optical density values means groups fifty five per cent sera patients symptomatic ulcerative colitis optical densities beyond two sds values groups two sera non ulcerative colitis patients one crohn disease one normal subject values range results show presence anti colon antibodies kda protein sera many patients symptomatic ulcerative colitis,C06,0.0021353066,0.0018941235,0.003984261,0.011533018,0.0029733467,0.0027557244,0.1972391,0.0020080681,0.0015437317,0.0020980642,0.027041603,0.03626668,0.106227905,0.07676641,0.0018777348,0.0034696825,0.21649742,0.09773245,0.0024313608,0.038482487,0.1289756,0.011088114,0.02497781
diarrhea diarrhea one manifestation gi disturbance symptoms may acute caused things infections drug reactions alterations diet heavy metal poisoning fecal impaction chronic diarrhea symptom gi diseases irritable bowel syndrome lactase deficiency cancer colon inflammatory bowel disease malabsorption diseases chronic diarrhea may also associated gi surgery radiation therapy laxative abuse alcohol abuse chemotherapeutic agents interventions required deal diarrhea may include things alteration tube feeding products methods administration fluid replacement oral rehydration procedures rapid return feeding education aimed health information clients need prevent control symptom diarrhea,C06,0.003190486,0.018273737,0.00595543,0.0017926039,0.004442651,0.0041174884,0.5141211,0.0030003716,0.0023065794,0.0031499173,0.04691417,0.022869566,0.04129028,0.007343599,0.0028056328,0.004983696,0.10119025,0.0032856716,0.019074278,0.058469895,0.12694371,0.0011328256,0.0033459926
free radical inhibition serial chemiluminescence evolving experimental pancreatitis oxygen free radical activity inhibition examined experimental pancreatitis twenty five rats randomized five groups controls received intravenous saline simulate pancreatitis one group received intravenous caerulein micrograms kg h three groups received sodium taurocholate via pancreatic duct ml per cent either alone following allopurinol immediately superoxide dismutase chemiluminescence phenomenon based emission light chemical reactions dependent oxygen free radical activity used index oxygen free radical activity measured tissue samples min intervals following induction pancreatitis control mean e serum amylase level h induction pancreatitis units significantly elevated caerulein induced pancreatitis units p less exceeded units taurocholate infused animals mean e chemiluminescence ranged mv mg time zero mv mg h controls caerulein induced pancreatitis mean e chemiluminescence peaked min mv mg p less taurocholate induced pancreatitis min mv mg p less superoxide dismutase significantly reduced chemiluminescence hyperamylasaemia taurocholate groups increasing oxygen free radical activity paralleled evolving pancreatitis superoxide dismutase may therapeutic role pancreatitis,C06,0.0021578085,0.0019139256,0.03535728,0.0012122843,0.0030044317,0.013190497,0.12949891,0.0020290616,0.0015598706,0.0125167435,0.023210859,0.116795175,0.18856376,0.005161773,0.0018973656,0.030780425,0.03090834,0.002233366,0.014102271,0.013983853,0.36693618,0.00076609605,0.0022196902
effect omeprazole high doses ranitidine gastric acidity gastroesophageal reflux patients moderate severe esophagitis thirty fifty percent patients reflux esophagitis fail heal treatment conventional doses h receptor antagonists whereas omeprazole administration induces healing investigate effect omeprazole higher presently recommended doses h blockers evaluated gastric acidity gastroesophageal reflux patients severe moderate esophagitis treatment mg ranitidine twice daily mg omeprazole daily three ph metric studies performed cross design days treatment omeprazole ranitidine drugs significantly reduced intragastric acidity p less night day hours median hourly h intragastric ph basal study ranitidine omeprazole intragastric acidity fell mmol l basal study mmol l inhibition ranitidine mmol l inhibition omeprazole patients esophagitis significantly exposed acid healthy subjects supine upright position p less time esophageal ph less dropped basal study ranitidine omeprazole p less drugs significantly reduced esophageal exposure acid supine upright positions p less whereas neither effect esophageal acid clearance,C06,0.0022605537,0.012891422,0.014170302,0.0012658009,0.024936773,0.01473043,0.20085831,0.002117926,0.0016281864,0.0022128455,0.032029733,0.026434414,0.19399095,0.005188572,0.0019804623,0.0035070276,0.111105375,0.0023339782,0.013229774,0.017149314,0.3128487,0.0007996479,0.0023295218
pharmacology pravadoline new analgesic agent pravadoline new chemical entity analgesic activity humans report describes pharmacology pravadoline compares activity pravadoline two major classes analgesics opioids nonsteroidal anti inflammatory drugs nsaids like nsaids pravadoline inhibited synthesis prostaglandins pgs mouse brain vitro ic microm ex vivo ed mg kg p displayed antinociceptive activity rodents subjected variety chemical thermal mechanical nociceptive stimuli administration pravadoline prevented writhing response induced p administration acetylcholine ed mg kg p pge ed mg kg p prolonged response latency induced tail immersion hot water temperature degrees c minimum effective dose mg kg c rat treatment pravadoline prevented acetic acid induced writhing ed mg kg p brewer yeast induced hyperalgesia randall selitto test minimum effective dose mg kg p nociceptive response induced paw flexion adjuvant arthritic rat ed mg kg p bradykinin induced head forepaw flexion ed mg kg p antinociceptive activity pravadoline cannot explained opioid mechanism pravadoline induced antinociception antagonized naloxone mg kg c pravadoline bind opioid receptors concentrations microm however like opioid analgesics pravadoline diminished electrically induced twitch response mouse vas deferens preparations contrast opioids action pravadoline attenuated naloxone possibility discussed effect pravadoline upon isolated tissues may contribute antinociceptive activity contrast nsaids pravadoline potent ex vivo inhibitor formation pgs brain vs stomach addition pravadoline failed produce gastrointestinal lesions administered p rats mice possess significant anti inflammatory activity antinociceptive doses also unlike nsaids pravadoline inhibited rat gastrointestinal transit administered doses similar antinociceptive overall pharmacologic profile pravadoline suggests compound may capable managing diverse severe pain achieved anti inflammatory analgesics without producing side effects commonly associated either opioid nonopioid analgesics,C06,0.054283503,0.016573044,0.010533307,0.008468782,0.009774245,0.002444051,0.18689102,0.016366277,0.0011337295,0.001540836,0.017987497,0.034730803,0.0656849,0.044287585,0.016556634,0.0024419934,0.034576256,0.03197784,0.0017856117,0.018604673,0.42118487,0.0005568063,0.0016157296
hour intragastric acidity plasma gastrin omeprazole treatment proximal gastric vagotomy duodenal ulcer patients relationship suppressed gastric acidity increase plasma gastrin levels pharmacological surgical treatment peptic ulcer disease compared study eight patients chronic duodenal ulcer referred proximal gastric vagotomy studied hour intragastric acidity plasma gastrin levels investigated patients three consecutive occasions preentry without treatment weeks administration mg omeprazole daily months proximal gastric vagotomy intragastric acidity slightly reduced omeprazole proximal gastric vagotomy difference found day night either plasma gastrin levels increased slightly proximal gastric vagotomy median pmol h l range pmol h l omeprazole administration median pmol h l range pmol h l strong evidence increased plasma gastrin concentration following omeprazole treatment caused reduced intragastric acidity slight increase plasma gastrin concentration following proximal gastric vagotomy despite lesser reduction intragastric acidity may result additional effects gastrin release vagotomy treatments resulted modest increase plasma levels gastrin far gastrin levels observed achlorhydric patients e g patients pernicious anemia,C06,0.0020931354,0.0018565923,0.0039053143,0.0011759693,0.0029144313,0.0432114,0.15833277,0.0019682792,0.0015131432,0.0020564918,0.02003516,0.0043427283,0.029688356,0.0048288843,0.0018405282,0.0032891785,0.18013312,0.012281857,0.0023831844,0.038220234,0.48103294,0.000743147,0.0021531975
use pudendo anal reflex treatment neurogenic faecal incontinence electrical stimulator devised treat neurogenic faecal incontinence caused pudendal nerve neuropathy works basis repeated stimulation pudendo anal reflex arc although conduction pudendo anal reflex arc may prolonged neurogenic faecal incontinence must shown present method used stimulation results immediate rise pressure anal canal significant increase electromyographic activity external anal sphincter maintenance stimulus two month period raised mean resting pressure significantly anal canal increased reflex voluntary responses external anal sphincter coughing squeezing actions respectively length sphincter affected widening mean motor unit potential duration though significant resting electromyogram enhanced course treatment indicating greater spontaneous activity external sphincter changes led seven eight patients studied becoming continent end treatment,C06,0.0029197617,0.0025899743,0.005447972,0.0016404949,0.0040656757,0.0037681044,0.27675086,0.0027457792,0.0021108577,0.0028688372,0.029095717,0.00602244,0.20975417,0.0069157076,0.0025675646,0.004546676,0.115870886,0.0030068704,0.003324578,0.03662972,0.2733169,0.0010367013,0.003003743
clinical importance drug interactions antiulcer therapy overall safety given drug determined toxicity side effects drug drug interactions thus clarification mechanisms importance clinical implications drug drug interaction antiulcer therapy critical use antiulcer medications drug drug interactions may occur result changes absorption metabolism distribution excretion fortunately drug distribution protein binding unchanged antiulcer therapy antiulcer drugs may affect absorption several mechanisms ionized medications may bind divalent cations antacids sucralfate result poorly absorbed complexes reduced gastric acid may decrease absorption medications weak bases enhancing absorption weak acids drug absorption may impaired delayed gastric emptying several h receptor antagonists including cimetidine lesser extent ranitidine proton pump inhibitor omeprazole may reduce hepatic degradation drugs metabolized cytochrome p system degree agents alter drug metabolism determined patient age genetics duration therapy degree cytochrome p binding regimen clinical importance interaction cannot always predicted caution recommended whenever drugs metabolized system used concurrently development understanding ways drug metabolism interactions occur may lead effective safe use medications,C06,0.001534236,0.00877776,0.026944377,0.0008616031,0.0021353303,0.0019790432,0.57184356,0.0014421087,0.001108642,0.008927037,0.013273746,0.010694842,0.056562405,0.024701795,0.023616536,0.01722685,0.03989125,0.041844018,0.0017460992,0.06260786,0.08013613,0.0005444851,0.001600258
xipamide disposition liver cirrhosis pharmacokinetics sulfonamide type diuretic xipamide studied patients liver cirrhosis ascites compared healthy control subjects oral administration mg xipamide diuretic rapidly distributed blood ascites ratio area concentration time curve auc plasma ascitic fluid protein content respective compartments auc plasma cirrhotic patients significantly greater control subjects p less striking finding increase amount ae parent drug main metabolite excreted urine p less renal clearance xipamide moderately reduced patients liver cirrhosis auc ae positively correlated plasma concentration direct bilirubin patients p less concluded nonrenal drug clearance patients liver cirrhosis reduced result blockade hepatobiliary excretion cholestatic conditions,C06,0.0028401962,0.0025187556,0.046475496,0.0015955112,0.0039538783,0.0036644896,0.16347437,0.0026702762,0.0020528135,0.0027899505,0.015334806,0.01996022,0.1979065,0.006608386,0.0024969622,0.058659516,0.10149061,0.030406663,0.0032331594,0.018896714,0.3090414,0.0010081942,0.0029211466
endoscopic appearance significance functional lymphangiectasia duodenal mucosa intestinal lymphangiectasia found wide variety pathologic conditions functional lymphangiectasia well characterized report patients followed months mean months incidental detection endoscopy lymphangiectasia study indicates functional lymphangiectasia pathologic warrant repeat endoscopy absence clinical indications,C06,0.0053306227,0.004728528,0.009946388,0.0029950594,0.007422723,0.006879446,0.38563734,0.030812507,0.0038538028,0.0052376497,0.051706266,0.010964071,0.041968133,0.012427248,0.0046876147,0.008300887,0.18008594,0.005489657,0.006069698,0.035811137,0.17224073,0.0018927103,0.005511862
systemic hemodynamic cardiac function changes patients undergoing orthotopic liver transplantation objective study determine changes systemic hemodynamics systemic vascular resistance svr cardiac output co systemic blood pressure sbp cardiac function pulmonary artery pressure pap pulmonary wedge pressure pwp hours following orthotopic liver transplantation olt correlate changes hepatic renal function patient outcome study took place bed medical respiratory intensive care unit large teaching hospital twenty one patients olt performed month period january october end stage liver disease esld variety causes flow directed right heart catheter indwelling arterial cannula inserted hemodynamic monitoring hour postoperative period liver renal function studies total serum calcium serum albumin fluid balance determined daily svr increased significantly u hours compared immediate less hours postoperative levels p less remained elevated hours co fell progressively significantly lower baseline values hours significant inverse correlation increase svr fall co r p less sbp stable except small significant fall hours postoperatively pwp increased significantly baseline value mm hg mm hg hours remained elevated hours p less serum bilirubin level fell progressively postoperatively prothrombin time partial thromboplastin time ptt shortened significantly bile flow increased progressively ml hours end first hours ml hours hours postoperatively five patients died nine days postoperatively patients hemodynamic parameters significantly different patients survived successful olt associated rapid increase svr fall co without changes sbp findings tend parallel improvement found results liver function tests however correlation improvement hemodynamic state long term survival,C06,0.027674071,0.0010084425,0.02966813,0.00063874957,0.023616232,0.0014714248,0.11604081,0.00656934,0.0008218918,0.0066151978,0.02261769,0.0023383063,0.36094284,0.013945175,0.0009997239,0.023377879,0.179368,0.0011707669,0.0012944707,0.017597737,0.1606499,0.00040365406,0.0011695492
expression leukocyte adhesion molecules mucosal mononuclear phagocytes inflammatory bowel disease leukocyte adhesion molecules important cell cell interactions immune system lymphocyte function associated antigen cluster designation mediates interactions cells mononuclear phagocytes ligand intercellular adhesion molecule cd whereas complement receptors cd b cd c involved complement mediated phagocytosis expression cd molecules intercellular adhesion molecule studied colonic biopsy specimens patients inflammatory bowel disease normal controls normal colon mononuclear phagocytes expressed lymphocyte function associated antigen intercellular adhesion molecule high densities major adhesion molecule cd c thus largest population normal colonic mononuclear phagocytes represented quiescent resident macrophages likely phagocytic function inflammatory bowel disease mononuclear phagocytes showed slight increase cd expression significant change expression cd b cd c contrast percentage mononuclear phagocytes expressing intercellular adhesion molecule increased controls ulcerative colitis p less crohn disease p less showing close relationship histological activity increased expression intercellular adhesion molecule inflammatory bowel disease indicates state immunological activation induced local release inflammatory cytokines induction intercellular adhesion molecule mononuclear phagocytes may important maintenance chronic inflammation facilitating interactions cells cell antigen recognition,C06,0.0021574635,0.0019137777,0.0040256027,0.0012121906,0.0030047111,0.0027843188,0.25054783,0.02291312,0.00155975,0.0021198345,0.010035552,0.036941145,0.09744823,0.1503357,0.0018972189,0.013797432,0.02831291,0.042557687,0.0024565894,0.069590345,0.19646214,0.00076603686,0.057160378
normal small bowel biopsy followed coeliac disease report four patients two children one adolescent one adult normal small bowel mucosa shown biopsy specimen taken initial diagnosis coeliac disease made first biopsy undertaken two cases suspected malabsorption third suspected dermatitis herpetiformis fourth part coeliac disease family study years diet containing gluten small bowel villous atrophy crypt hyperplasia compatible coeliac disease found second biopsy specimen hla type patients typical coeliac disease dr positive within families three patients coeliac disease diagnosed two earlier one time first biopsy undertaken four hla dr positive haploidentical first degree relatives found biopsies four normal small bowel villous architecture one increased intraepithelial cell count another positive reticulin endomysium antibodies coeliac disease may exist latent patients normal mucosa eating normal diet containing gluten,C06,0.002763781,0.015801266,0.058674116,0.0015529324,0.0038484777,0.0035668034,0.21560444,0.029352762,0.0019980907,0.029471412,0.106177315,0.0056845695,0.028369937,0.12554619,0.0024303994,0.004303782,0.17301732,0.0028533693,0.0031469713,0.027801422,0.15418053,0.0009813183,0.002872799
intracorporeal biliary lithotripsy bile duct calculi removed standard percutaneous endoscopic techniques large stones common cause failure intracorporeal lithotripsy ehl particular used safely either biliary tree gallbladder fragment large stones allow percutaneous removal passage intracorporeal ehl requires direct vision prevent damage bile duct mucosa intracorporeal laser lithotripsy may offer safety advantages laser requires much expensive equipment intracorporeal ehl additional studies needed determine technique better circumstance,C06,0.004071781,0.06274706,0.007597521,0.0022877676,0.0056721265,0.0052548456,0.40470648,0.023451008,0.0029437165,0.004000764,0.04367846,0.008374875,0.02744869,0.009633327,0.0035806214,0.00634061,0.15494315,0.0041932594,0.0046363217,0.047738228,0.16106471,0.0014457415,0.004188898
gallbladder mucin pronucleating agent cholesterol monohydrate crystals bile mucin densely glycosylated macromolecule secreted gallbladder epithelium principal constituent gallbladder mucus hypersecretion gallbladder mucus occurs response lithogenic diet experimental animals mucus accumulates viscous gel within gallbladder lumen gallstone formation animals man initial stage cholesterol gallstone formation nucleation cholesterol monohydrate crystals occurs within mucus gel inhibition mucus secretion aspirin prevents gallstone formation cholesterol fed prairie dog indicating importance mucus gallstone formation mucin contains domains bind cholesterol lecithin transported vesicles supersaturated bile furthermore mucin accelerates nucleation cholesterol crystals supersaturated model native biles binding cholesterol enriched vesicles hydrophobic domains mucin protein core appears critical acceleration cholesterol crystal nucleation mucin study structure function gallbladder mucin help elucidate pathogenesis cholesterol cholelithiasis,C06,0.002469917,0.014146071,0.0046086092,0.0013877456,0.03328431,0.03465452,0.09747466,0.07399698,0.0017856401,0.0024313554,0.034570467,0.005310128,0.016172698,0.07439694,0.14565559,0.015796345,0.04696569,0.05428543,0.017177848,0.035616495,0.27010483,0.0008769778,0.016830813
inhibition cell mediated cytotoxicity sulphasalazine effect vivo treatment aminosalicylic acid sulphasalazine vitro natural killer cell activity decreased cell mediated cytotoxicity occurs frequently inflammatory bowel disease particularly patients active disease clear however whether decrease caused disease consequence medical treatment study evaluated effect vivo treatment aminosalicylic acid sulphasalazine vitro natural killer cell activity five patients inflammatory bowel disease remission four healthy control subjects double blind randomised crossover trial preceded separated four weeks treatment placebo natural killer cell activity significantly impaired six nine subjects four weeks sulphasalazine treatment tended related subjects slow acetylator phenotype contrast aminosalicylic acid treatment caused marginal reaction natural killer cell activity two nine subjects inhibitory effects found reversible since decreased natural killer cell activity completely restored placebo treatment subjects conclusion vivo treatment sulphasalazine inhibits vitro natural killer cell activity seems mediated sulphapyridine moiety phenomenon may contribute low natural killer cell activity found patients active inflammatory bowel disease,C06,0.0019171565,0.0017006135,0.0035807989,0.001077172,0.0026695798,0.011747679,0.32603085,0.0018029172,0.0013860188,0.0018837189,0.009727656,0.003956986,0.10588964,0.13884938,0.0017015543,0.021541487,0.04643559,0.04062999,0.039306443,0.0176951,0.21781667,0.00068071263,0.0019723
clinical significance cholelithiasis patients decompensated cirrhosis general agreement prevalence gallstones cirrhotics high least twice general population pathogenetic link cirrhosis cholelithiasis still uncertain influence cholelithiasis survival cirrhotics also unknown year period observed patients affected decompensated cirrhosis turned cholecystographic cholangiographic ultrasonographic examination cholelithiasis able demonstrate correlation cholelithiasis sex age patients etiology cirrhosis severity illness degree portal hypertension previous gastrointestinal bleeding number pregnancies levels serum cholesterol bilirubin triglycerides follow observation range months patients died survival curves analyzed log rank test show difference patients without gallstones therefore confirm cirrhosis lithogenic condition able explain reasons close relationship cholelithiasis cirrhosis gallstones however affect survival patients,C06,0.0027636983,0.0024515383,0.0051644794,0.0015528094,0.0038487685,0.0035666968,0.26791218,0.015950073,0.001998031,0.002730193,0.05813295,0.005727151,0.0726727,0.006510248,0.015803238,0.0043036533,0.23199216,0.0028533188,0.016507795,0.13176371,0.14196129,0.0009812888,0.0028520622
pitfall azygos vein cannulation cirrhotic patients mistaken cannulation mammary vein azygos venous flow measured thermodilution catheter patients cirrhosis useful technique since azygos flow thought reflect superior portosystemic collateral flow patients authors report cases mistaken internal mammary vein cannulation mimicked azygos vein cannulation supine fluoroscopic view lateral fluoroscopic view confirmed internal mammary cannulation suggest azygos arch unpronounced flow measurements unexpectedly low patients portal hypertension due cirrhosis lateral view performed rule internal mammary vein cannulation,C06,0.003581444,0.0031730589,0.006674482,0.0020098218,0.004980987,0.004616423,0.10842346,0.19385356,0.002586078,0.0035147027,0.10778656,0.007357394,0.15488355,0.008224838,0.0031456042,0.0055702757,0.28784835,0.0036917957,0.0040730448,0.026064795,0.052989736,0.0012700952,0.00367998
bile sampling processing analysis clinical studies obtaining proper bile sample investigative purposes utmost importance obtain valid results bile collected direct aspiration gallbladder duodenal intubation tube drainage optimal method collection depends investigative question well resources available investigator procedures obtaining processing analyzing human bile gallbladder hepatic summarized pointing disadvantages pitfalls may occur,C06,0.0038441701,0.022017581,0.007172823,0.02075738,0.005352885,0.023537412,0.23313764,0.040757995,0.002779164,0.003777123,0.2431362,0.007906724,0.024183553,0.107870474,0.021986172,0.024583342,0.06364441,0.003958858,0.02297756,0.029986225,0.06258491,0.019968007,0.004079412
long term outcome surgery biliary atresia study patients surviving years define long term prognosis children underwent surgery biliary atresia retrospective study undertaken children underwent one kasai procedures forty children alive years firm hepatomegaly present splenomegaly children serum bilirubin liver function tests normal children respectively survival rate decreased age operation significant difference observed rate children surviving normal serum bilirubin whether underwent surgery age months months twenty four esophageal varices experienced gastrointestinal bleeding normal liver function tests absence portal hypertension observed children results indicate kasai procedures helpful significant proportion children biliary atresia underwent surgery period however children initially underwent surgery kasai procedures eventually undergo liver transplantation,C06,0.0022530193,0.0019985405,0.0042039,0.0012658796,0.0031372579,0.0029076387,0.111706056,0.034177065,0.0016288325,0.10038091,0.037717957,0.0046916422,0.07931525,0.005392051,0.0019812481,0.024793327,0.34869814,0.0023234838,0.0025653937,0.088022046,0.13772255,0.00079996523,0.002317823
update epidemiology anorexia nervosa defined region switzerland follow investigation authors studied swiss women canton zurich developed anorexia nervosa ages years hospitalized first time diagnosis data compared earlier study focused periods incidence anorexia nervosa increase significantly compared contrast constant increase found however frequent use vomiting abuse laxatives may indicate increase cases mixed features anorexia nervosa bulimia,C06,0.00423728,0.003758679,0.007906325,0.0023807548,0.005900278,0.02993961,0.24712309,0.0039847894,0.003063365,0.0041633765,0.11638438,0.008715544,0.07981198,0.009801979,0.0037261571,0.027061522,0.07821734,0.004363696,0.004824767,0.15081684,0.19790569,0.0015045042,0.0044080405
carcinoma gallbladder gallbladder cancer remains difficult diagnose preoperatively however recent work suggests ultrasound may effective gallbladder cancer remains highly lethal despite aggressive therapy extension disease beyond mucosa predicts poor chance long term survival,C06,0.004948456,0.0043895273,0.009233305,0.026729321,0.030768849,0.030320257,0.33643392,0.07644978,0.0035775134,0.0048621483,0.09004529,0.05809003,0.030968187,0.011378028,0.004351547,0.0077057746,0.12648955,0.005096089,0.005634545,0.058516067,0.06716399,0.0017570169,0.005090789
management acute abdomen complicating oral anticoagulation therapy acute abdominal pain patient receiving oral anticoagulants poses difficult diagnostic therapeutic challenge describe two cases peritonitis requiring laparotomy anticoagulated patients review similar case reports world literature patients usually explored signs bowel obstruction operation intestine often appeared infarcted pathologic examination commonly revealed intramural hematomata contrast present microscopic evidence hemorrhagic cecal infarction complicating oral anticoagulation therapy one patient intramural intestinal hemorrhage common cause acute abdominal pain anticoagulated patient undergoes laparotomy addition intramural hemorrhage per cent patients coexistent volvulus appendicitis intestinal wall disruption intestinal infarction conclude anticoagulated patients suspected intramural intestinal hemorrhage may severe intraabdominal pathology requiring operation therefore operation mandatory patients fail improve short course expectant management,C06,0.01581615,0.014125586,0.0046058726,0.0013869216,0.0034441855,0.013730419,0.43797734,0.03394007,0.0017845797,0.014369964,0.058979,0.005456859,0.02828821,0.00567573,0.002170693,0.0038438905,0.21832918,0.002543737,0.0147296935,0.04568384,0.0697022,0.000876457,0.0025394508
nsaid induced gastrointestinal damage critical review prophylaxis therapy nonsteroidal anti inflammatory drugs nsaids cause acute diffuse injury gastroduodenal mucosa also cause chronic focal ulcers may bleed perforate without warning symptoms acute chronic lesions distinct pathogenetically different respond differently drugs require different management strategies principal rationale antiulcer therapy nsaid users prevent reduce potentially fatal outcomes date evaluated drug meets criterion efficacy antacids h receptor antagonists based open uncontrolled studies appear heal gastric duodenal ulcers maintain healed continued nsaid use larger gastric ulcers show delayed healing conventional doses h receptor antagonists nsaid therapy delay occurs omeprazole therapy suggests nsaid associated gastric ulcers treated h receptor antagonists larger doses given longer periods patients pre existing ulcer disease h receptor antagonists given prophylactically prevent duodenal gastric ulcers sucralfate individuals without peptic ulcer disease taking nsaids misoprostol given prophylaxis reduces development gastric ulcers beneficial effects ulcer healing symptoms continued nsaid therapy ability prevent duodenal ulcers ulcer complications established diarrhea micrograms day dosage recommended especially elderly,C06,0.011175254,0.029278833,0.012741117,0.001067719,0.011855358,0.020841245,0.5116042,0.0017867886,0.0013736198,0.021366017,0.055433854,0.02354296,0.012811425,0.0043843854,0.0016708173,0.0029587045,0.04292507,0.0019786311,0.011276771,0.041213773,0.17608422,0.00067462306,0.001954656
immunohistochemical detection abnormal cell proliferation colonic mucosa subjects polyps previous studies shown presence increased proliferation large bowel epithelium high risk developing colon cancer vitro technique labelling large bowel mucosa thymidine analogue bromodeoxyuridine brdu therefore developed ability distinguish differences mucosal proliferation subjects colorectal adenomas normal controls assessed sigmoid biopsy specimens subjects polyps age sex matched controls labelled incorporated brdu visualised immunohistochemical technique mean labelling index li significantly higher polyps controls differences pattern labelling colonic crypts compared generation cumulative labelling distributions analysis showed significant expansion proliferative compartment colon crypts polyps concluded vitro labelling brdu provides useful method assessment mucosal proliferation subjects high risk developing colon cancer,C06,0.0024381564,0.0021627664,0.02809759,0.013127761,0.0033965562,0.014939221,0.2169033,0.0022928717,0.0017626785,0.0023956317,0.07384111,0.005787007,0.18959476,0.15714337,0.002176444,0.01558909,0.024870357,0.002511464,0.026355827,0.07434901,0.13688539,0.0008657008,0.0025139092
left retroperitoneal exposure distal mesenteric artery repair distal disease mesenteric arteries usually repaired transabdominally since believed proximal centimeter vessel accessible retroperitoneum treated five patients chronic visceral ischemia lesions extending beyond orifice using retroperitoneal approach exposure obtained left flank incision tenth interspace left crus diaphragm divided order control supraceliac aorta mesenteric vessels identified dissected entrance peritoneum difficulties exposing superior mesenteric artery sma coursed pancreas duodenum approximate length cm uncinate process pancreas limiting factor exposure sma region distal exposure could obtained incising peritoneum trifurcation celiac artery splenic artery accessible exposure however first centimeter hepatic gastric branches could reached revascularization performed endarterectomy patients bypass patients bowel viability assessed conclusion procedure incising peritoneum complications exposure patient required reoperation ischemic bowel conclude left retroperitoneal approach acceptable orifice lesions also applicable distal disease,C06,0.067730926,0.0019996343,0.004206201,0.0012665725,0.024964618,0.00290923,0.22891796,0.051414777,0.023399059,0.0022149354,0.058193903,0.027485926,0.030075125,0.0060253497,0.0019823327,0.035835106,0.21621914,0.0023215062,0.02436575,0.08306383,0.10226102,0.0008004031,0.0023466747
mechanical lithotripsy common duct stones past years utilized various types mechanical lithotriptors crush common bile duct stones procedure performed patients overall success rate however many accessories developmental stage entrapment stones always possible first attempt procedure repeated patients second third time interim awaiting another attempt lithotripsy cholangitis prevented leaving prosthesis place variety lithotriptor models different manufacturers proven effective recommend endoscopists use devices rid bile duct retained stones,C06,0.022249216,0.07727884,0.007173113,0.0021601317,0.005353102,0.00553041,0.22798853,0.022224125,0.0027792763,0.0037772758,0.09292974,0.008607883,0.044835433,0.02786263,0.003380603,0.005986415,0.23654947,0.0039590183,0.00437733,0.08700372,0.102673836,0.0013649804,0.0039549004
esophageal h ph monitoring prior manometry necessary correct positioning electrode h esophageal ph monitoring electrode usually positioned cm manometrically localized esophagogastric junction order replace esophageal manometry purpose tested whether esophagogastric junction identified correctly fluoroscopy determination ph step stomach esophagus compared esophageal manometry distance nares esophagogastric junction determined three times three methods patients volunteers fluoroscopy assumed esophagogastric junction cm mean se lower peak pressure point determined manometry ph step cm ph step one subject difference cm manometrically defined esophagogastric junction whether gastroesophageal reflux disease proven ph monitoring present conclude esophagogastric junction usually identified sufficient accuracy measurement ph step stomach esophagus fluoroscopy far less accurate ph step used,C06,0.0027275444,0.002419468,0.033691008,0.001532496,0.030202068,0.0035200382,0.17753457,0.04161572,0.0019718932,0.0026799727,0.133001,0.0056318818,0.2799224,0.089069,0.0023985337,0.004247354,0.08747052,0.0028089187,0.0031057107,0.034584645,0.04290272,0.00096845196,0.015994072
endoscopic retrograde cannulation gallbladder direct dissolution gallstones percutaneous transhepatic catheterization gallbladder dissolution cholesterol stones instillation methyl tert butyl ether mtbe invasive therapeutic procedure non invasive alternative available endoscopic retrograde cannulation cystic duct difficult cystic duct tortuosity spiral valves therefore developed catheter system using conventional duodenoscopes routine endoscopic retrograde cholangiography erc procedure permits reliable safe catheterization gallbladder without need endoscopic sphincterotomy patients able place cysto nasal catheter patients mtbe dissolution therapy performed eight patients completely free stones treatment six residual debris patients cannulation attempts failed patients due cystic duct blockage calculus endoscopic retrograde cannulation gallbladder ercg represents promising alternative invasive percutaneous transhepatic catheterization procedure,C06,0.0028421625,0.02955327,0.0052990722,0.0015956581,0.0039545554,0.0041205017,0.19380985,0.057593998,0.01579019,0.0027904282,0.10157418,0.0058412566,0.017782206,0.0065565393,0.02662291,0.0044224095,0.4097835,0.02002937,0.003233713,0.033424143,0.04945007,0.0010083669,0.002921647
pemoline associated hepatic injury among cases hepatic injury attributed administration pemoline sufficient accompanying information permit analysis two patients less years old less years old males predominated study injury appeared early week late greater year taking drug injury uniformly hepatocellular judged high values aminotransferases death massive necrosis one patient mechanism judged idiosyncratic idiosyncrasy probably metabolic rather immunologic,C06,0.07413329,0.0032290737,0.0067923083,0.002045302,0.0050689178,0.004697918,0.23748522,0.003423325,0.0026317309,0.0035767488,0.039098393,0.007487276,0.081209846,0.009057185,0.0032011343,0.040902767,0.12567843,0.021333816,0.0041449475,0.21215045,0.10760297,0.0012925166,0.0037564372
pharmacokinetics propofol infusions patients cirrhosis compared pharmacokinetics propofol infusion control patients cirrhosis anaesthesia induced within min administration infusion propofol mg kg h min infusion decreased stepwise manner mg kg h subsequently mg kg h mean recovery time discontinuation infusion significantly longer cirrhotic group however patients opened eyes blood concentrations propofol similar groups micrograms ml pharmacokinetic analysis performed beginning infusion h termination total body clearance reduced significantly cirrhotic sd litre min compared control litre min patients volume distribution steady state significantly greater patients cirrhosis control patients litre vs litre however difference change terminal elimination half life pharmacokinetics propofol given infusion maintain general anaesthesia affected markedly moderate cirrhosis,C06,0.027774502,0.014829777,0.0048336117,0.0014554985,0.0036071946,0.0033431803,0.11244481,0.0024361413,0.001872819,0.0025453223,0.013369755,0.03593203,0.38518158,0.0059803682,0.0023892634,0.0040542274,0.11455281,0.0026677896,0.0029496697,0.059542805,0.18047749,0.0009197938,0.016839592
serial prothrombin time prognostic indicator paracetamol induced fulminant hepatic failure objective find whether changes daily prothrombin time prognostic importance patients paracetamol induced fulminant hepatic failure design retrospective study setting liver unit king college hospital london patients consecutive patients paracetamol induced fulminant hepatic failure admitted october february main outcome measure death results patients died patients peak prothrombin time greater equal seconds died time seconds nine time seconds nine time less seconds patients continuing rise prothrombin time days overdose died compared prothrombin time fell conclusions data indicate continued increase prothrombin time day overdose peak prothrombin time greater equal seconds identify early stage patients less chance survival liver transplantation considered patients meeting either criteria,C06,0.0022517391,0.03470021,0.024628894,0.0012651604,0.0031354756,0.036949106,0.13964394,0.0021175628,0.0016279072,0.002212466,0.04580733,0.0046313973,0.112857714,0.0052672722,0.03467872,0.046943747,0.2515751,0.002318918,0.0025835675,0.04944021,0.17044705,0.022599982,0.002316506
frequency recovery blastocystis hominis clinical practice examined frequency isolation blastocystis hominis stools patients seen indigent care teaching hospital year period stool specimens examined prospectively b hominis found stools stool specimens positive specimens clinical data obtained patients stools positive b hominis b hominis parasite isolated adults compared children p patients without concomitant parasitic infection bacterial pathogens stool gastrointestinal symptoms abdominal pain diarrhea vomiting association seen fever peripheral leukocytosis stool occult blood fecal leukocytes endoscopic radiologic evidence colitis therefore b hominis frequently recovered stools examined hospital clinical parasitology laboratory clinical presentations patients series suggest b hominis invasive patients b hominis probably require treatment since either spontaneous resolution symptoms found alternative explanation problem,C06,0.0026231955,0.0023269053,0.004894611,0.0014738666,0.0036527168,0.0033853706,0.3613674,0.015155088,0.0018964537,0.016682426,0.12490136,0.005395412,0.04178453,0.006113376,0.002306772,0.029474279,0.16312891,0.0027014564,0.028375516,0.060889266,0.11784104,0.00093140145,0.0026986469
evaluation women possible appendicitis using technetium leukocyte scan authors evaluated use technetium albumin colloid white blood cell tac wbc scan women possible appendicitis one hundred nine women underwent tac wbc scans one woman second scan separate admission considered two individual patients analysis twenty six women appendicitis perforated appendix surgery tac wbc scan indeterminate abnormal nondiagnostic appendicitis women nine appendicitis fifty eight scans read positive negative appendiceal pathology true positives false positives true negatives false negative predictive value positive scan predictive value negative scan tac wbc scan positive patients appendicitis negative patients without appendicitis resulting overall accuracy women main value tac wbc scan women possible appendicitis high negative predictive value main problem tac wbc scan high indeterminate rate,C06,0.0025581704,0.0022692247,0.0047732806,0.0014373315,0.01763391,0.01568036,0.12121351,0.0024057343,0.0380012,0.0025135526,0.4131136,0.0052616675,0.034994107,0.018449303,0.0022495904,0.0039836033,0.08283965,0.0026344913,0.0029128531,0.17176883,0.049763262,0.0009083133,0.0026345004
comparison omeprazole cimetidine reflux oesophagitis symptomatic endoscopic histological evaluations symptomatic patients endoscopically verified reflux oesophagitis randomised double blind trial received either omeprazole mg daily cimetidine mg four times daily four necessary eight weeks intention treat analysis oesophagitis found healed four weeks omeprazole group cimetidine group p less eight weeks values respectively p less histological assessments available patients entry omeprazole group cimetidine group ns abnormal histology study proportions patients initially abnormal histology progressed normal omeprazole cimetidine respectively p less patients reflux symptoms entry four weeks omeprazole group p less cimetidine group asymptomatic diary cards completed first two weeks showed patients treated omeprazole experienced fewer reflux symptoms day night used fewer antacids omeprazole mg day four eight weeks healed greater proportion patients reflux oesophagitis cimetidine g per day assessed endoscopically histologically relieved patients symptoms,C06,0.013524424,0.013332291,0.0043437593,0.001307994,0.014510124,0.0030043726,0.14353122,0.0021892556,0.001683022,0.0023181462,0.032520145,0.08172628,0.114703804,0.005440211,0.002047162,0.0036251405,0.2501089,0.013722089,0.02518704,0.021097476,0.24684608,0.00082657917,0.002404495
biliary lithotripsy vitro analysis gallstone fragmentation equivalent stone volumes relationship gallstone fragmentation extracorporeal shock wave lithotripsy eswl gallstone volume poorly understood clinical results eswl show highest stone free rate months occurs radiolucent single gallstones mm less diameter vitro study individual gallstones cholecystectomy specimens divided size composition nine single nine multiple stone groups stones paired basis similar volume eswl performed phantom size largest fragment measured shock waves shock waves sandlike particles present six nine single stones versus two nine multiple stone groups mean size largest fragment shock waves mm single mm multiple diameter corrected volume authors data suggest single stones easily broken fragments smaller mm diameter multiple gallstones implication especially spark gap technology used shock wave energy ie increased number shock waves higher kilovoltage necessary achieve results treating patients multiple stones versus single gallstone similar stone volume,C06,0.0022808353,0.013050124,0.015233698,0.0012815082,0.0032374463,0.0029435367,0.13675745,0.0021719723,0.0016489424,0.0022410545,0.1599514,0.049398333,0.11614548,0.0054764063,0.0020057089,0.0035517348,0.19908518,0.0023488821,0.0025970663,0.038817283,0.22384228,0.00080984173,0.015123874
effect epidermal growth factor combination sucralfate omeprazole healing chronic gastric ulcers rat epidermal growth factor egf shown enhance healing experimental gastric ulcers given subcutaneously orally drinking water effect egf occurs without reducing gastric acid secretion hand egf reportedly excreted rapidly gastric lumen administered intragastric bolus suggests stimulation ulcer healing may expected egf given acid suppressive agent agent allowing egf remain rat gastric lumen high concentrations present study egf administered gastric intubation dose micrograms kg three times smaller reported previous studies evaluated effect acetic acid induced rat gastric ulcers combination sucralfate omeprazole sucralfate well known selectively bind proteins covering ulcer base omeprazole potent acid suppressive agent prior study combined egf sucralfate oral sucralfate confirmed allow endogenous gastric egf mouse egf given exogenously remain high concentrations gastric contents tissues egf sucralfate g kg day given alone failed stimulate ulcer healing submandibularectomized rats smr rat whose endogenous gastric egf depleted however combination drugs administered doses significantly accelerated ulcer healing smr rat omeprazole mg kg day significantly enhanced ulcer healing regardless removal submandibular glands combination egf omeprazole stimulated ulcer healing smr rat,C06,0.0016975027,0.009708336,0.011363179,0.0009536964,0.002369058,0.010368348,0.32621658,0.009801561,0.0012271402,0.009877378,0.008405244,0.022669582,0.0272085,0.023636654,0.0014926452,0.027283086,0.029887604,0.038478605,0.0019327325,0.033022355,0.40005046,0.0006026829,0.001747048
cellular immune response hepatitis b virus encoded antigens acute chronic hepatitis b virus infection proliferative response pbmc hepatitis b virus hbv envelope core e ag analyzed prospectively patients acute self limited hbv infection compared response patients chronic hbv infection different levels hbv replication e hepatitis e ag hbeag anti hbe positive liver damage e chronic active hepatitis chronic asymptomatic carriers results indicate hbv infected subjects develop self limited acute hepatitis show vigorous pbmc response hepatitis b core ag hbeag expression cell activation appearance detectable lymphocyte response hbv nucleocapsid ag temporally associated clearance hbv envelope ag patients chronic hbv infection level cell responsiveness hepatitis b core ag hbeag significantly lower observed acute infection cell sensitization hbv envelope ag acute chronic hbv infection usually undetectable measurable expressed transiently low levels results may reflect immune events pathogenetic relevance respect evolution disease viral clearance,C06,0.001756214,0.0015578493,0.010145164,0.000986745,0.010934728,0.0022664855,0.27822924,0.010146277,0.0012696645,0.0017255833,0.032190338,0.0036122887,0.027019247,0.054256078,0.0015443702,0.02780964,0.03887087,0.012145727,0.001999708,0.23484413,0.19746724,0.0006235677,0.04859886
piezoelectric lithotripsy stone disintegration follow results patients symptomatic gallbladder stones one hundred symptomatic patients radiolucent gallbladder stones treated new piezoelectric lithotripter oral chemolitholytic agents stone disintegration achieved patients mean sd maximum fragment size mm significant differences found mean sd fragment sizes single stones less equal mm mm compared single stones greater mm mm p less multiple stones mm p less respectively none patients required anesthesia analgesics sedatives treatment stone free rates patients followed months mean sd months month months months months months partly significant differences obtained stone free rates single stones less equal mm compared larger stones greater mm multiple stones p less respectively serious adverse reactions e cholestasis pancreatitis observed patients conditions induced fragment impaction common bile duct patients endoscopic retrograde cholangiopancreatography endoscopic sphincterotomy required concluded piezoelectrically generated shock waves suitable effective safe disintegration gallbladder stones humans anesthesia free analgesia free shock wave application opens possibility perform biliary lithotripsy outpatient procedure stone free rate achieved combination oral bile acids promising single stones less equal mm,C06,0.0017544812,0.0015563124,0.00327368,0.0009857714,0.0024636525,0.0022642494,0.12604828,0.027056672,0.0012684119,0.0017238809,0.07117134,0.0036594889,0.13731384,0.0043356307,0.0015428466,0.0367002,0.32292026,0.0018068248,0.0019977351,0.014277631,0.2334356,0.00062295253,0.0018202126
disposition aminosalicylic acid olsalazine three mesalazine preparations patients ulcerative colitis comparison intraluminal colonic concentrations serum values urinary excretion compare disposition aminosalicylic acid asa acetylated metabolite treatment olsalazine mesalazine patients inactive ulcerative colitis randomly assigned olsalazine g twice daily mesalazines asacol mg daily pentasa mg daily salofalk mg daily crossover design trial received drug seven days intraluminal colonic concentrations asa estimated five days method equilibrium vivo dialysis faeces predose serum sample hour urine collection obtained day seven asa acetyl aminosalicylic acid ac asa values determined high performance liquid chromatography olsalazine almost doubled colonic concentrations mean sem mmol l therapeutically active ingredient asa compared equimolar doses pentasa mmol l p less salofalk mmol l p less time olsalazine treatment associated lower serum concentrations urinary excretions p less asa ac asa compared mesalazine preparations low systemic load asa provided olsalazine reduces potential risk nephrotoxicity long term treatment,C06,0.0024668775,0.0021879936,0.064398676,0.025265332,0.0034346567,0.0031873928,0.20612136,0.0023196167,0.0017832391,0.0024235754,0.05302444,0.0376182,0.14543928,0.005703768,0.0021690622,0.003841003,0.06495694,0.002545909,0.01474818,0.034598447,0.3064189,0.012809617,0.002537543
cyclic pelvic pain cyclic pelvic pain common gynecologic problem caused relatively diseases usually diagnosed remedied quickly complaints reflect normal physiologic aspects menstrual cycle mittelschmerz menstrual awareness premenstrual syndrome diagnosed effective convenient treatment lacking dysmenorrhea commonest source cyclic pain diagnosed characteristic history rapid relief administration antiprostaglandin agents endometriosis diagnosed surgically best treated either surgically medically danazol gnrh agonists contrast adenomyosis problem commonly encountered later life hysterectomy usually needed definitive diagnosis treatment,C06,0.03957634,0.0032873359,0.060852557,0.0020822051,0.005160376,0.0406027,0.38202006,0.003485092,0.002679215,0.021578217,0.10491465,0.007622369,0.03261825,0.008792596,0.039124675,0.005770888,0.052153777,0.022363722,0.022147022,0.04787903,0.09016057,0.0013158375,0.0038125138
extracellular matrix gene expression increases preferentially rat lipocytes sinusoidal endothelial cells hepatic fibrosis vivo whether parenchymal nonparenchymal liver cells play predominant role pathophysiology hepatic fibrosis firmly established vivo addressed question quantitating relative abundance specific mrnas collagen types iii iv laminin purified populations hepatocytes sinusoidal endothelial cells lipocytes normal fibrotic rat liver normal liver type collagen gene expression minimal cell types mrna types iii iv collagen apparent endothelial cells lipocytes hepatocytes laminin mrna present cell types induction fibrogenesis either bile duct ligation carbon tetrachloride administration associated substantial increase mrna types iii collagen nonparenchymal cells lipocytes fibrotic animals exhibited greater fold increase type collagen mrna relative normal lipocytes greater fold relative hepatocytes type iii collagen mrna reached times normal lipocytes greater times hepatocytes endothelial cells exhibited isolated increase type collagen mrna reaching five times normal liver type iv collagen laminin gene expression significantly increased nonparenchymal cells fibrogenesis fact mrna type iv collagen laminin decreased endothelial cells despite pronounced changes occurred matrix gene expression nonparenchymal cells fibrogenesis change noted hepatocytes conclude nonparenchymal liver cells particularly lipocytes important effectors hepatic fibrosis vivo,C06,0.0014274386,0.0012662092,0.02346018,0.08323855,0.008858615,0.0018421838,0.14840493,0.04279286,0.007839181,0.0014025422,0.0067251776,0.024326911,0.033409797,0.15033436,0.0012552534,0.06750018,0.017400037,0.093690306,0.015434668,0.020503018,0.18443453,0.007405441,0.057047598
high fat semielemental diet treatment protracted diarrhea infancy capacity greater fat absorption relative carbohydrate absorption protracted diarrhea infancy studied developed developing country buffalo ny bangkok thailand fifty patients protracted diarrhea first year life defined liquid stools ml kg per day day duration randomly assigned receive either standard semielemental diet pregestimil high fat semielemental diet contained fat increased fat largely form medium chain triglycerides new diet providing fat medium chain triglycerides compared standard diet tolerance diets good studies groups showed adequate weight gain improvement anthropometric biochemical parameters patients receiving high fat diet showed initial weight loss however weight gain initiated earlier cumulative weight gain also higher group receiving high fat semielemental diet fecal fat analyses performed week therapy difference observed coefficient fat absorption groups receiving two formulas indicating infants protracted diarrhea may able tolerate higher fat intake normally provided carbohydrate intolerance known complicating factor using semielemental enteral feeds infants protracted diarrhea higher fat semielemental diet may appropriate way provide adequate caloric intake,C06,0.0017108949,0.001517649,0.011472191,0.000961282,0.002382367,0.035322808,0.27715015,0.0016089462,0.0012369008,0.0016810546,0.009148767,0.05724746,0.031722426,0.0041994657,0.0015045177,0.11032527,0.06413593,0.001761938,0.0019481054,0.15713029,0.20292695,0.00060747657,0.02229716
lipid peroxidation hepatic antioxidants alcoholic liver disease generation hepatic liver peroxidation free radicals proposed mechanism ethanol induced hepatotoxicity investigate hypothesis lipid extracts hepatic needle biopsy specimens alcoholic subjects examined evidence lipid peroxidation measuring total conjugated dienes derivative spectroscopy hydrolysis hepatic lipid extract reverse phase high performance liquid chromatography molar ratio diene conjugated linoleic acid isomer parent linoleic acid isomer changes related hepatic histology iron deposition glutathione vitamin e values derivative spectroscopy minima suggestive diene conjugation identified nm correlated weakly suggesting two minima may represent different classes lipid dienes weak relation inflammatory histological changes biopsy specimen correlation hepatic iron grade glutathione vitamin e lipid ratio proportion linoleic acid hepatic lipids correlated significantly inflammatory histological features inversely hepatic glutathione furthermore hepatic glutathione lower biopsy specimens greater iron staining ratio vitamin e lipid related histological group inflammation iron grade findings suggest excess alcohol consumption leads hepatic inflammation lipid peroxidation,C06,0.0022517266,0.0019973938,0.026347425,0.0012651533,0.0031829197,0.0029059704,0.21883506,0.002117551,0.0016278981,0.0022124536,0.0127897775,0.016892863,0.18210165,0.0053004576,0.12204964,0.15597102,0.019590316,0.002318905,0.002563922,0.07119642,0.11067052,0.0007995063,0.03501147
physicochemical determinants vitro shock wave biliary lithotripsy human gallstones studied visual inspection computerized tomographic imaging chemical analysis assess physicochemical characteristics may determine outcome vitro shock wave fragmentation eighty five stones mean diameter mm collected different patients fifty five calculi angular round oval shaped three easily obtained measures derived stone optimal computerized tomographic image including mean stone density measure corresponding standard deviation mean stone density value termed stone density distribution index may reflect physicochemical heterogeneity given gallstone well density range administration shock waves using electrohydraulic generator fragmentation noted calculi satisfactory largest resulting fragment diameters less equal mm strong determinants satisfactory fragmentation multivariate analysis included stone diameter less equal mm presence angular stone shape stone density distribution index greater equal hounsfield units parameters independently determine satisfactory fragmentation prospective clinical trials needed assess whether findings result better prediction success extracorporeal biliary lithotripsy broadening indications,C06,0.002437527,0.002162208,0.039924078,0.001369547,0.027031653,0.0031457557,0.27838722,0.0023024685,0.0017622235,0.0023950136,0.031012932,0.0050625475,0.13459769,0.006545314,0.0021434997,0.0038251118,0.16064157,0.0025301701,0.01457435,0.051592555,0.19955453,0.024461523,0.0025404945
albumin absorption protein secretion gallbladder man pig study albumin absorption gallbladder man vitro model first established pig compared vivo function species water electrolyte transport albumin absorption protein secretion vivo vitro compared similar vitro studies performed human gallbladders obtained surgery vivo study pig performed without disturbing gallbladder except tie cannula cystic duct end vitro model identical pig human gallbladders gallbladders excised using technique causing minimal injury anoxia oxygenated mucosal serosal surfaces temperature controlled environment luminal external bath test solutions consisted modified ringers bicarbonate added glucose luminal solutions also contained albumin different species depending study active absorption sodium water occurred types studies pig vivo absorption rates considerably greater vitro rates albumin absorption vivo substantial although present vitro absorption albumin diminished relatively electrolyte transport rates protein secretion rates gallbladder similar vitro vivo results studies human gallbladders vitro similar pig except albumin absorption greater human gallbladders obtained control patients patients cholesterol gallstones significant differences two groups variables studied however numbers small control gallbladders normal gallbladders,C06,0.009093993,0.0013811403,0.03502355,0.00087485876,0.002168079,0.054769747,0.14449064,0.08861618,0.0011256447,0.009063232,0.02916116,0.04420469,0.036679626,0.011983688,0.03151022,0.032685008,0.078577764,0.029514246,0.0017728781,0.06596652,0.28914255,0.0005528356,0.0016418158
schatzki ring long term results following dilation purpose study report long term results patients schatzki ring dilated relief dysphagia severity schatzki ring mild patients moderate severe indeterminate follow information available patients mean months follow patients developed recurrent dysphagia required repeated dilations patients one two dilations patients three seven dilations patients seven dilations patient underwent surgery resection schatzki ring mean range dilation free interval months months mild cases months months moderate cases months months severe cases significant correlation severity schatzki ring initial presentation subsequent dilation free interval data indicate recurrent dysphagia common among patients schatzki ring successful dilation severity schatzki ring good prognostic indicator need subsequent dilation,C06,0.015794937,0.026068939,0.004603007,0.0013860587,0.0034351004,0.013723862,0.22183737,0.0023199164,0.0017834695,0.0024238885,0.06695001,0.005073972,0.056235366,0.005673552,0.014105031,0.003841499,0.41976795,0.0025405132,0.0028089453,0.017514447,0.10869838,0.00087591173,0.0025378708
plasma fatty acid profile advanced cirrhosis unsaturation deficit lipid fractions fatty acid fa profile plasma total lipids phospholipids pl cholesteryl esters ce triglycerides tg measured patients advanced liver cirrhosis age sex matched healthy controls plasma levels lipidic phosphorus esterified cholesterol tg also measured unsaturation index ui calculated fraction total plasma concentrations saturated fa linoleate polyunsaturated fa pufa lower cirrhotics controls profile also found plasma levels pl ce associated fa detectable amounts c n found cirrhotic patients percent fa distribution lipid fractions showed lower percentage linoleate pufa higher relative amount saturated monoenoic fa cirrhotics controls consequence ui pl ce diminished liver cirrhosis linoleate pufa deficiency marked ce pl shown number patients values th percentile control group suggesting attempt maintain unsaturation pl important component cell membranes hepatic failure poor essential fa intake malnutrition possible etiologic factors pufa deficiency cirrhosis relative contribution plasma fa abnormalities well clinical pathophysiological consequences pufa deficit cirrhotic patients requires investigation,C06,0.0020711455,0.014551271,0.048736975,0.0011636921,0.0028840045,0.019945005,0.17064479,0.0019477302,0.001497346,0.002035022,0.009819611,0.01558467,0.11803469,0.03851156,0.07009689,0.032771554,0.08546135,0.0021365187,0.0023583036,0.038960878,0.31790158,0.0007353885,0.002150034
phase clinical pharmacologic study intraperitoneal cisplatin fluorouracil patients advanced intraabdominal cancer fluorouracil fu cisplatin display marked therapeutic synergy preclinical models effective treatment number solid tumors combined administered intravenously iv drug also administered intraperitoneally ip displays favorable pharmacologic profile acceptable clinical toxicity therefore undertook phase study determine feasibility toxicity combination ip chemotherapy agents thirty one patients histologically documented malignancy confined peritoneal space treated cisplatin mg mixed fu l lactated ringer solution given ip hours every days cohorts least three patients received starting fu concentrations ranging mmol l mg l mmol l dose limiting toxicity neutropenia median granulocyte nadir cells per microliter occurring fu dose mmol l intrapatient escalation fu dose permitted cycles chemotherapy delivered fu concentrations greater mmol l highest concentration mmol l g fu l toxicities included mild moderate nausea cycles therapy vomiting cycles diarrhea cycles abdominal pain renal dysfunction peripheral neuropathy oral mucositis occurred infrequently related fu dose peritoneal fluid plasma fu concentrations measured high performance liquid chromatography hplc selected patients mean peak plasma fu concentrations ranged mumol l greater mumol l peritoneal fluid plasma fu area curve auc ratios ranged nine patients nonbulky disease resolution malignant ascites least reduction peritoneal studding tumor repeat laparotomy conclude combination ip chemotherapy cisplatin fu technically feasible acceptable clinical toxicity favorable pharmacologic profile recommended starting fu dose phase ii trials mg mixed mg cisplatin l isotonic fluid,C06,0.001510983,0.0013403173,0.039287202,0.0008489597,0.016966943,0.0019500023,0.27658984,0.008724575,0.0010923734,0.0014846296,0.008601389,0.045511704,0.11247046,0.011451962,0.0013287204,0.02429478,0.12443473,0.008848329,0.0090336725,0.04100498,0.2611325,0.0005364952,0.0015544436
prevention pancreatic fistula modified pancreaticojejunal anastomosis major cause morbidity pancreatoduodenectomy leakage pancreaticojejunal anastomosis prevent complication employed mucosal stripping proximal jejunum prior end end anastomosis patients good results,C06,0.005944713,0.14916609,0.011092218,0.0033400918,0.008277825,0.007671962,0.21443778,0.0055904803,0.004297763,0.00584103,0.027447812,0.0122271385,0.045847014,0.013668732,0.005227631,0.009257155,0.18809709,0.006122069,0.035529252,0.13010319,0.10258649,0.0021107516,0.0061157015
feasibility digital teleradiology imaging evaluation patients acute right upper quadrant abdominal pain assess utility commercially available digital teleradiology system evaluating patients acute pain right upper quadrant hard copy images examinations hepatobiliary scintigrams sonograms right upper quadrant digitized transmitted via standard telephone lines viewed remotely video monitor video hard copy interpretations compared degree concordance scintigraphic studies hard copy video images equal demonstrating gallbladder bile duct activity video images failed depict presence bowel activity one case gallstones depicted equally well hard copy video sonographic images video interpreters overestimated presence abnormal hepatic parenchyma overlooked one case right hydronephrosis video interpretations scintigrams sonograms showed overall error rate comparable rate obtained radiographs interpreted remotely digital teleradiology systems,C06,0.0029198192,0.0025900253,0.0055020633,0.0016405273,0.11876634,0.0037681789,0.22419171,0.10247108,0.0021108994,0.0028688938,0.1652684,0.00600551,0.037214037,0.008114175,0.0025676154,0.018668855,0.098439194,0.0030069298,0.031576168,0.028232025,0.115905054,0.0151687255,0.0030038024
effects synthetic human secretin calcium carbonate solubility human bile study sought determine effects synthetic human secretin ionized calcium carbonate concentrations human hepatic bile five patients nasobiliary drain right hepatic duct studied three basal samples bile collected minute period synthetic human secretin infused iv micrograms kg h minutes followed micrograms kg h minutes bile sampled minute periods document return baseline conditions two samples bile obtained minute periods hours infusion terminated bile acid concentration determined enzymatic method ph pco measured automated analyzer total calcium determined inductively coupled plasma emission spectrometry ionized calcium ion specific electrode bicarbonate carbonate concentrations calculated using henry law henderson hasselbalch equation fraction bile sampled catheter determined indocyanin green recovery end experiment secretin caused increase bile flow bicarbonate output bicarbonate concentrations increased mmol l mmol l p less chloride concentrations decreased mean bile acid concentrations declined significantly mmol l mmol l p less ionized calcium concentrations decreased mmol l mmol l p less ph increased significantly p less carbonate concentrations increased significantly mmol l mmol l ion product calcium carbonate increased significantly mmol l mmol l p less synthetic human secretin augments ion product calcium carbonate human hepatic bile increasing tendency calcium carbonate precipitation,C06,0.0014177293,0.0012575967,0.016337652,0.0007965643,0.001974143,0.025082324,0.18213007,0.008193304,0.0010249552,0.015088525,0.057283025,0.0029598826,0.19571757,0.15633027,0.0012474228,0.040910468,0.038386874,0.0014600261,0.00845901,0.010172583,0.23179968,0.00050338416,0.001466944
incidence prevalence ulcerative colitis upper galilee northern israel epidemiological study ulcerative colitis performed upper galilee israel yr period average annual incidence ulcerative colitis per population prevalence december per considering fact strict steps taken include definite cases figures probably underestimation increase average annual incidence period found data stratified according ethnic groups highest average annual incidence highest point prevalence found israeli born jews per population respectively jewish residence patterns compared highest average annual incidence point prevalence found among kibbutz members respectively lowest among moshav inhabitants arab patients average annual incidence point prevalence women men female male ratio among jews female male ratio peak incidence found yr old range second peak noticed anemia demonstrated women men study suggest increase uc incidence prevalence israeli asia africa born jew arabs upper galilee points toward environmental factors etiology disease,C06,0.0022039458,0.0019550098,0.004112334,0.0012383072,0.003069339,0.0028443069,0.12548828,0.0020730246,0.0015933547,0.0021655061,0.119272254,0.015546607,0.11014321,0.016286107,0.0019380943,0.003432002,0.041658398,0.0022696988,0.02376222,0.44159594,0.07430221,0.00078254106,0.002267338
inter intraindividual variation pressure volume relations rectum normal subjects patients irritable bowel syndrome relation intrarectal volume pressure increasing rectal distension latex balloon studied repeated occasions healthy adult volunteers define variations within individuals wide intersubject variation maximum tolerable volume ml pressure cm h end point seen two values correlated r intrasubject variation maximum tolerable volume also occurred related study order progressively reduced repeated study unselected patients pain predominant irritable bowel syndrome similar intersubject variation noted virtually patients data fell within calculated confidence limits normal individuals differentiation patients normal subjects possible knowledge rectal responses noticeable inter intrasubject variations rectal responses distension need considered whenever similar techniques proposed use study rectal disease rectal response treatment,C06,0.00220452,0.0019552277,0.0041225753,0.0012384453,0.0030692667,0.013345094,0.13755666,0.0020728484,0.0015935323,0.0021657476,0.015318014,0.004541493,0.39247695,0.005125568,0.0019383103,0.0034323845,0.095928565,0.0022709628,0.00251254,0.14067951,0.15273945,0.0007826283,0.012929691
sterol dependence gastric protective activity unsaturated phospholipids major aim study investigate gastric protective effect unsaturated phospholipids determine ability neutral lipids enhance activity found although liposomal suspension unsaturated phosphatidylcholine pc administered intragastrically failed protect rats acid induced gastric ulcer formation addition cholesterol unsaturated pc induced dose dependent protective response maximally effective dose reducing lesion score greater effect also seen plant sterol beta sitosterol reducing lesion score blocked cholesterol esterified fatty acids varying chain length addition sterols liposomes saturated dipalmitoylphosphatidylcholine contrast attenuated gastric protective action saturated pc appears protective mechanism elicited sterols unsaturated pc mediated alterations gastric emptying rate prostaglandin biosynthesis although maintenance surface hydrophobicity may involved results suggest sterol may promote packing adjacent unsaturated phospholipid molecules either cell membrane putative extracellular hydrophobic lining gastric epithelium provide mucosa protection luminal acid,C06,0.013517234,0.0020441094,0.019871678,0.0012947432,0.036917478,0.0029739363,0.35328504,0.002180178,0.0016659718,0.002264199,0.021268938,0.05054253,0.017105157,0.03341473,0.03548986,0.0035942525,0.022644315,0.0024020683,0.0026238877,0.019428354,0.32997605,0.0008182054,0.024677081
clinicians accurately assess esophageal dilation without fluoroscopy study questioned whether clinicians could determine success esophageal dilation accurately without aid fluoroscopy twenty patients enrolled diagnosis distal esophageal stenosis including benign peptic stricture schatski ring squamous cell carcinoma esophagus dilation attempts using maloney dilators monitored fluoroscopically principle investigator physician patient unaware findings physicians predicted whether dilations successful examined various features determine usefulness predicting successful dilation able predict successful dilation accurately cases studied however predictions unsuccessful dilation correct time features helpful predicting passage included easy passage dilator patient feeling dilator stomach excessive resistance suggesting unsuccessful passage unreliable feature often due dilator curling stomach maloney dilators used dilate simple distal strictures physician predicts successful passage reliably accurate without use fluoroscopy however unsuccessful passage suspected fluoroscopy must used confirmation,C06,0.0025928502,0.0023110425,0.017713333,0.0014557907,0.003607919,0.028413855,0.24403866,0.023295607,0.001873195,0.0025458334,0.12338219,0.005329241,0.08103288,0.005957617,0.0022784811,0.029112644,0.1760456,0.002668325,0.015483794,0.047648218,0.17962742,0.0009199785,0.00266555
leningrad day care center ubiquitous giardia lamblia giardiasis recognized worldwide public health problem seroprevalence data developing developed world show high rates carriage populations risk fecal oral transmission children day care centers outbreak investigation expanded understanding reservoirs giardia lamblia routes transmission various host factors associated infection pathogenesis giardial infections elucidated particular role lectin activation producing disease three standard chemotherapeutic agents available united states institution community wide prevention measures equally important current areas investigation including antigenic composition enzymatic variants result effective forms immunotherapy effective forms chemoprophylaxis could assist eradicating pathogen institutional settings,C06,0.0028401143,0.030016154,0.018995266,0.0015957444,0.017692331,0.0036653155,0.3670934,0.0026708778,0.0020532762,0.016539799,0.0269254,0.0058415723,0.062632285,0.058400296,0.0024975247,0.018169139,0.07721329,0.032795656,0.044461288,0.10961447,0.094353616,0.0010084214,0.0029247783
increasing prevalence gallstones male veterans alcoholic cirrhosis cases alcoholic cirrhosis identified necropsy studied prevalence type gallstones compared age race matched autopsy controls data examined early sample cirrhotic patients gallstone disease contrasted controls among patients gallstone disease whereas present controls prevalence stones significantly greater patients controls time periods among patients significantly greater p less comparison cirrhotic patients without gallstones indicated significantly higher incidence ascites patients gallstones gallstones cirrhotics frequently pigmented controls time periods living patients advanced cirrhosis studied sonography prevalence gallstones almost autopsy sample cirrhotics ascites encephalopathy varices prevalent patients stones without conclude pigmented gallstones increasing cirrhosis liver related severity liver disease,C06,0.0026914286,0.0023874317,0.005021927,0.0015123005,0.0037477294,0.003473429,0.190954,0.002531052,0.0019457832,0.015667917,0.05815012,0.0064965384,0.16953026,0.0062255273,0.002386819,0.042688712,0.166062,0.0027717254,0.0030645875,0.16925852,0.1397077,0.0009556285,0.0027688427
primary biliary cirrhosis quantitation autoantibodies purified mitochondrial enzymes correlation disease progression primary biliary cirrhosis characterized presence antimitochondrial antibodies recently six autoantigens identified components oxo acid dehydrogenase multienzyme complexes located within mammalian mitochondria immunoblotting studies shown two components namely e protein x pyruvate dehydrogenase complex major antigenic polypeptides recognized autoantibodies study shows development enzyme linked immunosorbent assay detect quantitate antibodies two purified antigens coded serum samples patients primary biliary cirrhosis patients liver autoimmune disease normal women analyzed reactivity using immunoassay results indicate rapid simple method sensitivity specificity diagnosis primary biliary cirrhosis titer immunoglobulin g autoantibodies correlated antimitochondrial antibody titer measured indirect immunofluorescence p less also histological stage disease p less prognostic biochemical variables higher serum bilirubin lower serum albumin levels p respectively significant correlation titer autoantibodies serum globulin immunoglobulin g levels indicating positive correlation disease progression secondary hypergammaglobulinemia,C06,0.002113823,0.0018750665,0.027703462,0.011389306,0.0029434317,0.002727999,0.32304952,0.001987865,0.0015282,0.0020769553,0.085789986,0.02502791,0.116220914,0.05332847,0.012085108,0.011813309,0.06278014,0.024339985,0.0024068987,0.045310505,0.13179107,0.0007505418,0.05095955
loss duodenal folds allows diagnosis unsuspected coeliac disease report three patients coeliac disease presented without classic features malabsorption underwent biopsy diagnosed endoscopic finding disappearance kerckring folds descending duodenum sign constitutes new valid aid identification patients otherwise unsuspected coeliac disease,C06,0.005621384,0.0049864477,0.06491502,0.0031584261,0.007827599,0.03440971,0.24367686,0.0052864174,0.00406401,0.032732215,0.1529554,0.011562112,0.034797397,0.013044993,0.004943303,0.057666067,0.12978688,0.038488567,0.0064007724,0.063406505,0.07249093,0.001995949,0.005783072
sucralfate used adjunctive therapy patients severe erosive peptic esophagitis resulting gastroesophageal reflux total patients grade greater erosive esophagitis abnormal h ph monitor study treated randomized double blind fashion assess efficacy sucralfate suspension adjunctive therapy cimetidine severe esophagitis secondary gastroesophageal reflux treatment consisted cimetidine mg qid either sucralfate suspension g ml identical placebo suspension ml meals ml hs patients treated wk unless endoscopic healing occurred earlier initial evaluation monthly follow consisted symptom monitoring endoscopic evaluation pre post therapy esophageal manometry bernstein test h ph monitoring combination cimetidine sucralfate suspension superior cimetidine alone improving daytime heartburn symptoms p less nighttime heartburn dysphagia regurgitation sucralfate plus cimetidine improved overall endoscopic outcome esophagitis cimetidine alone p less patients exhibited endoscopic healing adjunctive sucralfate group cimetidine group endoscopic healing however statistically different groups conclude sucralfate used adjunctive therapy cimetidine resulted improvement symptoms reflux probably increases likelihood complete healing esophagitis compared cimetidine alone,C06,0.0020969065,0.0018558652,0.025245706,0.0011755088,0.06530016,0.033057615,0.29394934,0.0019675083,0.0015125507,0.0020670884,0.035529647,0.044812236,0.12441041,0.004830547,0.0018398617,0.0032579545,0.18396966,0.012276812,0.0327619,0.022738779,0.10244878,0.000742856,0.0021523545
interventional gallbladder procedures interventional radiologic procedures gallbladder influencing diagnosis therapy many gallbladder disorders current diagnostic therapeutic percutaneous techniques offer important alternatives management article highlights spectrum interventional radiologic techniques available gallbladder diseases,C06,0.0051968955,0.029766463,0.009696868,0.0029199237,0.0072365124,0.0067068646,0.32261634,0.10545331,0.028911008,0.005106255,0.11483659,0.010689021,0.032169737,0.011949268,0.004570019,0.033249013,0.12958813,0.0053519406,0.00591743,0.048111305,0.072765484,0.0018452288,0.0053463746
investigation mode action biofeedback treatment fecal incontinence study carried incontinent patients evaluate factors thought responsible success retraining fecal incontinence subjects initially allocated one two groups one group trained perceive small rectal volumes active retraining group carried maneuvers given information instruction active sensory retraining reduced sensory threshold ml p less corrected sensory delay present p less reduced frequency incontinence episodes per week p less sham retraining caused modest reduction sensory threshold p less significantly reduce frequency incontinence subsequent strength coordination training significantly improve continence although end study patients incontinent episodes patients reduced frequency incontinence episodes improvement continence associated change sphincter pressures continence rectally infused saline associated significant improvements rectal sensation functional improvement sustained period two years patients available follow conclusion results support use retraining management fecal incontinence suggest retraining may work enhancing rectal sensitivity instilling confidence,C06,0.0021363532,0.012228356,0.014317862,0.0011997158,0.0029732825,0.002755665,0.20346566,0.0020080248,0.0015436983,0.022766633,0.0106063085,0.03968246,0.2636761,0.017191533,0.0018776942,0.0034847762,0.10008302,0.0021989644,0.0024313082,0.13747333,0.14262286,0.00075815344,0.012518268
influence sclerotherapy gastric mucosal blood flow distribution hemodynamic events structural vascular changes gastric mucosa cirrhotics caught attention investigators recent past yet known whether therapeutic interruption variceal blood flow gastroesophageal level alters portal hypertensive mucosal features newly developed endoscopic laser doppler technique used assess whether variceal eradication means endoscopic sclerotherapy influences gastric mucosal congestion portal hypertension patients gastric mucosal blood flow determined ten defined sites stomach first session sclerotherapy complete variceal eradication achieved patients statistically significant decrease p less microcirculation found gastric antrum corpus increase pylorus p less change fundic area important question following findings consequences aggravation gastric congestion integrity gastric mucosa,C06,0.0029624524,0.002627843,0.005527629,0.0016644811,0.004125121,0.018148454,0.27066594,0.017409278,0.016458366,0.0029107835,0.018547544,0.0062444857,0.18748054,0.006844777,0.016925994,0.018823674,0.17194855,0.0030579448,0.017704923,0.026435675,0.17938288,0.0010518592,0.00305079
rectal prolapse infants children rectal prolapse intractable usual medical therapy successfully managed without significant complications patients simple subcutaneous encirclement anus heavy nonabsorbable suture place suture removed broke months four patients required two sutures one needed third insertion since procedure simple serious complications controls rectal prolapse recommended preferred initial surgical treatment condition,C06,0.0045156293,0.0040055886,0.008425696,0.002537148,0.006287871,0.027678108,0.19025418,0.0042465525,0.003264599,0.026297748,0.045386788,0.009394802,0.12286986,0.010382826,0.0039709304,0.028884392,0.29438984,0.0046503497,0.0051417085,0.1320293,0.059137233,0.001603336,0.004645513
gallstone dissolution many methods available gallstone dissolution including oral bile salts cholesterol solvents mono octanoin methyl tert butyl either calcium pigment solvents edta polysorbate approaches appropriate individual patient depends type stones whether gallbladder bile ducts whether access biliary tree available patient age general medical condition availability necessary expertise us chenodeoxycholate ursodeoxycholate available ursodeoxycholate expensive appears produce fewer side effects may efficacious agents effective thin women small floating radiolucent cholesterol stones functioning gallbladder half small subset patients experience partial complete dissolution stones within year stone recurrence potential toxicity long term therapy problems approach therefore patients cholecystectomy either traditional fashion using laparoscopic approach see article later issue gadacz et al cost effective perhaps safest option intragallbladder instillation methyl tert butyl ether probably applicable small subset patients treatment likely followed high recurrence rate patients retained common duct cholesterol stones access biliary tree mono octanoin therapy advantageous initiated soon cholangiography demonstrates extravasation properly selected patients success rate technique expected within days,C06,0.0020715033,0.031921208,0.01386333,0.0011639219,0.0028847372,0.0026733829,0.36691666,0.021926608,0.0014976047,0.022050248,0.024255186,0.014264845,0.014450235,0.025276069,0.0319022,0.013250819,0.20692828,0.002133305,0.022395333,0.09145571,0.0838522,0.00073551555,0.002131086
early results combined electrohydraulic shock wave lithotripsy oral litholytic therapy gallbladder stones university iowa one hundred thirty three patients entered randomized double blind placebo controlled trial extracorporeal shock wave lithotripsy symptomatic gallstones versus extracorporeal shock wave lithotripsy plus adjuvant litholytic therapy ursodeoxycholic acid udca six months lithotripsy patients receiving placebo crossed udca therapy without unblinding study one hundred sixteen patients completed months follow five patients dropped study nine percent required cholecystectomy patients biliary colic acute cholecystitis ninety one patients solitary stone patients stones less equal mm patients stones greater mm diameter patients two three stones fifty percent retreated cumulative stone free rates months respectively months significant advantage patients treated udca versus placebo vs stone free disappeared months placebo treated patients received months udca patients solitary stones equal less mm diameter treated udca stone free rates months respectively versus difference significant month follow stone free rates patients large solitary stones multiple stones low extracorporeal shock wave lithotripsy safe effective therapy treatment symptomatic gallstones patients solitary stone equal less mm diameter udca markedly improves efficiency procedure results stone free gallbladder sooner,C06,0.001848672,0.0016398643,0.0034494302,0.042563338,0.0025749595,0.0023858075,0.1265276,0.019559424,0.0013365076,0.0018164288,0.016727423,0.004055995,0.08559232,0.004250668,0.0016256755,0.0028787667,0.49203235,0.0019038257,0.03790066,0.0170992,0.12966803,0.00065639627,0.0019066522
study mucosal repair sofalcone experimental gastritis effect sofalcone glandular structure cell proliferation gastric mucosa rats gastritis induced administration sodium taurocholate tca months examined histoquantitative analysis h thymidine autoradiography morphometric observation revealed tca treatment mucosal thickness parietal cell mass ratios length glandular portion total length gastric gland decreased fundic pyloric glands inflammatory cell infiltration collagenous fiber proliferation present gastric mucosa following tca indicated presence atrophic gastritis atrophic changes inflammatory cell infiltration reversed week administration sofalcone cellular proliferative activity assessed labeling indices gastric mucosa increased tca induced gastritis rats administration sofalcone rats tca induced gastritis significantly increased labeling indices particularly pyloric glands results appears sofalcone stimulates compensatory increase proliferative activity generative cells may become available heal gastritis,C06,0.002437498,0.013959677,0.016343735,0.0013695307,0.0034097019,0.003145718,0.19558427,0.06128572,0.0017622025,0.0023949847,0.011657044,0.0050135483,0.071276054,0.13173546,0.0021435444,0.027386213,0.054281216,0.002513877,0.0027754498,0.016914915,0.34353754,0.00086546695,0.028206622
effect ulcerative colitis smoking rectal blood flow rectal blood flow measured laser doppler flowmetry minutes eight patients colitis remission eight healthy male non smokers ten smokers also examined two occasions one included smoking cigarette plasma nicotine concentrations measured smokers subjects showed pronounced fall rectal blood flow first minutes patients colitis significantly higher values compared smokers p less p less non smokers p less p less first second minutes respectively values smokers non smokers similar smoking cigarette associated significant fall blood flow p less change inversely related rise plasma nicotine concentration r p less findings may relevant association colitis smoking history,C06,0.0024666565,0.0021880474,0.0046025254,0.0013859137,0.0034347412,0.0031833488,0.097383626,0.0023196738,0.013699604,0.002423635,0.011462867,0.0050843265,0.4523276,0.0056864456,0.014108644,0.0039568874,0.06510662,0.0025402473,0.0028086514,0.16877583,0.13164064,0.0008758201,0.0025376054
crohn disease pancreas editorial crohn disease cd accepted systemic illness importance extraintestinal manifestations underlined fact complications prominent even difficult control intestinal disease lately evidence accidental association pancreatitis exocrine pancreatic insufficiency cd growing might significant impact treatment abdominal pain diarrhea cd symptoms far attributed exclusively intestinal rather extraintestinal manifestations disease,C06,0.004833203,0.0042872922,0.03234895,0.0027155797,0.006730082,0.0062375003,0.417735,0.027932756,0.0034941908,0.0047631427,0.022227362,0.010093265,0.07669776,0.05242276,0.027644109,0.0075263022,0.08294501,0.0049773976,0.02160214,0.059062816,0.117035076,0.0017160948,0.004972221
stasis syndromes following gastric surgery clinical motility features symptomatic patients retrospectively reviewed records patients referred gastrointestinal manometry stasis gastric surgery nausea vomiting bloating abdominal pain weight loss common symptoms two thirds patients well documented history peptic ulcer initial operations others surgery performed reasons obesity reflux esophagitis twelve patients undergone truncal vagotomy drainage operation received partial gastrectomy gastroenterostomy billroth n billroth ii n roux en n patients recordings gastrointestinal manometry also scintigraphic measurement gastric emptying measurements compared data healthy controls gastric manometry could assessed group intact antrum characterized antral hypomotility p less gastric emptying studies showed rapid early emptying liquids delayed emptying solids p less whole group fasting jejunal motility characterized absence phase ii presence bursts phasic activity abnormal propagation phase iii significantly increased frequency phase iii mmc noted patients billroth ii roux en operations postprandially patients failed develop fed pattern,C06,0.0021879165,0.0018753622,0.0047533307,0.011414016,0.0029438958,0.012916913,0.32383728,0.012211962,0.001528441,0.012785229,0.022521762,0.02882465,0.098801576,0.016972018,0.022262137,0.054457415,0.2494573,0.0021772305,0.0024072782,0.04334279,0.06938574,0.00075066014,0.0021851098
healed experimental gastric ulcers remain histologically ultrastructurally abnormal present study designed assess histologic ultrastructural features gastric mucosa areas grossly healed ulcers acetic acid induced gastric ulcers rats specific question studied whether structure cellular composition gastric mucosa area grossly healed ulcer fully restored eighty sprague dawley rats underwent laparotomy acetic acid applied lower gastric corpus serosa abdomen closed stomachs reopened weeks months standardized gastric wall specimens area grossly healed ulcers obtained processed evaluated light microscopy transmission electron microscopy gastric mucosa grossly healed ulcers demonstrated epithelialization study time mucosa beneath surface epithelium displayed prominent histologic ultrastructural abnormalities two different patterns scar could distinguished mucosa area healed ulcer thinner reduction vs normal increased connective tissue poor differentiation degenerative changes glandular cells b mucosa displayed ballooning dilatation gastric glands reduction microvascular network poor differentiation glandular cells conclude subepithelial mucosa grossly healed gastric ulcer displays disorganized restoration glandular vascular structures remains histologically ultrastructurally abnormal ii abnormalities may interfere oxygenation nutrient supply mucosal resistance defense therefore could basis ulcer recurrence,C06,0.0020110502,0.01145317,0.016062608,0.0011299271,0.0028004753,0.023275947,0.30979756,0.038557976,0.059831884,0.001975975,0.027319055,0.004136346,0.015728693,0.037408642,0.0017684668,0.0031316234,0.07985265,0.021701956,0.012015572,0.024713693,0.26320675,0.00071405084,0.041405927
reproducibility hour oesophageal ph studies infants thirteen infants undergone hour oesophageal ph monitoring diagnose gastro oesophageal reflux second study carried see results reproducible studies done without restricting babies activities appreciable differences found percentage total time ph less varying fold two tests differences largely result biological rather technical variability results estimates made reliability single diagnostic study size changes would necessary show effect treatment findings considerable impact diagnosis abnormal gastro oesophageal reflux response treatment whether using hour ph monitoring method measurement,C06,0.0029616775,0.0026271557,0.005526183,0.0016640458,0.0041779303,0.003822199,0.24783537,0.0027851975,0.0021411611,0.017235646,0.13300419,0.0061611687,0.1587942,0.007888565,0.0026044985,0.0049856943,0.09360736,0.016999355,0.0036354796,0.09351111,0.18393023,0.001051584,0.0030499925
relation helicobacter pylori human gastric mucosa chronic gastritis antrum spatial relations bacteria affected tissues indicate pathogenic mechanisms study undertaken define spatial relation helicobacter pylori human gastric mucosa antibodies gastric mucus ruthenium red used stabilise glycoprotein structure mucus glycocalyces antral biopsy specimens eight patients infected h pylori location organisms ultrastructural features assessed using systematic scanning transmission electron microscopy mean se h pylori pit mucus surface mucus h pylori close epithelial cells located near epithelial intercellular junctions fine filamentous strands extended organisms nearby epithelial cells organisms membrane membrane contact h pylori observed beneath within cells gastric mucosa preferred location h pylori gastric antrum within pit mucus close epithelial cell surface evidence direct toxic effect mucosa,C06,0.0031419923,0.0027871039,0.07943753,0.09302248,0.019582532,0.004054905,0.30312183,0.0029547676,0.063085265,0.003087192,0.016138732,0.0064624776,0.019888567,0.13375564,0.0027629887,0.0048927353,0.058617745,0.003239781,0.0035776205,0.049405146,0.0713496,0.0011156073,0.054517772
current concepts cholesterol transport crystal formation human bile presence vesicles human bile probably accounts almost entirely frequently observed hitherto unexplained phenomenon metastable cholesterol supersaturation turn largely explains prolonged stability cholesterol solubilized supersaturated human bile certain overall compositional conditions supersaturated native bile vesicular phase contribution total cholesterol transport also becomes supersaturated cholesterol vesicles also become unstable leading formation cholesterol crystals simple common example one factor affecting composition way concentration total solutes especially biliary lipids conversely dilution bile e g hepatic bile markedly reduces cholesterol saturation level biliary vesicles result vesicles become much stable conditions cholesterol crystal formation becomes unlikely rarely ever occurs,C06,0.0025913925,0.002298186,0.017351054,0.0014556758,0.003607634,0.015871428,0.27534306,0.002512764,0.0018730472,0.027616262,0.014380741,0.0053288206,0.019603314,0.13977776,0.14135389,0.05420046,0.052448485,0.0026681146,0.002950029,0.034401186,0.1787677,0.00091990584,0.002679067
outpatient laparoscopic laser cholecystectomy laparoscopic laser cholecystectomy performed clinically united states since refinement technique procedure offered outpatient basis eighty three patients underwent laparoscopic laser cholecystectomy study period thirty seven procedure outpatient younger patients suited outpatient procedure without previous surgery likely procedure done outpatient weight operating time gallbladder pathology similar although patients acute inflammation gallbladder likely require hospitalization primary reason patient admission patient preference,C06,0.0036404806,0.003229288,0.006792759,0.0020454375,0.005069254,0.00469823,0.25017238,0.03859416,0.0026319055,0.003576986,0.11976806,0.0075296285,0.025173733,0.008370589,0.0032013468,0.0056689857,0.35246462,0.0037490914,0.0041452227,0.08624877,0.0581913,0.0012926024,0.0037451922
witzel pneumatic dilation achalasia safety long term efficacy forceful dilation lower esophageal sphincter considered primary therapy achalasia witzel pneumatic balloon dilator unlike fluoroscopically placed dilators placed standard gastroscope allowing positioning dilation direct vision report experience witzel dilator patients achalasia year period patients least one major symptom score dysphagia regurgitation dilation witzel dilation symptomatic response graded excellent score good score fair score poor improvement symptom response assessed week month month year present mean period follow months range months passage balloon across gastroesophageal junction technically unsuccessful three patients esophageal perforation occurred two patients transient chest pain greater days three patients bleeding death symptomatic long term improvement excellent patients good patients fair patients poor patients repeat witzel dilation performed five patients resulted good excellent improvement one patient conclude pneumatic dilation witzel balloon safe effective procedure achalasia,C06,0.0021575773,0.012352778,0.014468697,0.011644076,0.0030043582,0.002784466,0.19921081,0.002029012,0.0015598324,0.0021319902,0.010274293,0.046096742,0.04126031,0.004975697,0.0018973191,0.0033597967,0.54263914,0.0022219468,0.0024567193,0.018444622,0.072044104,0.0007660773,0.002219636
freckle sign endoscopic feature cecum mucosal spots freckles surrounding appendiceal orifice endoscopic feature cecum clusters mm round oval slightly raised spots pale center erythematous border correlate microscopically subepithelial submucosal lymphoid follicles freckling pattern identified one third colonoscopies seen best videoendoscope identified commonly patients systemic illness recognition mucosal freckling around appendiceal orifice helps identify cecum may useful evaluation cecal appendiceal pathology,C06,0.0051968126,0.004609832,0.009696713,0.002919877,0.032393776,0.008125041,0.31656015,0.03003715,0.003757064,0.078240685,0.11736159,0.01068885,0.06234802,0.012431144,0.0045699454,0.008092518,0.11985918,0.03050095,0.0063177072,0.036212146,0.09288934,0.0018451993,0.005346289
cigarette smoking gastric acidity peptic ulceration relationships influence cigarette smoking intragastric acidity assessed duodenal ulcer patients symptomatic remission healthy volunteers retrospective study continuous hr ph recordings nonsmokers smokers receiving placebo treatment compared daytime intragastric acidity higher smokers median ph interquartile range nonsmokers median ph p less difference hr nighttime median ph two groups small difference daytime intragastric acidity smokers nonsmokers unlikely account increased prevalence peptic ulcer disease smokers analysis smoking status duodenal ulcer patients healthy controls males females supports general trend towards higher daytime acidity smokers differences ph hr night period found groups epidemiological clinical correlation smoking duodenal ulcer disease adequately explained increased intragastric acidity,C06,0.0032421018,0.002875906,0.0061059347,0.0018216047,0.004514524,0.0041841012,0.23034075,0.0030489117,0.0023438951,0.018860323,0.016472854,0.051200684,0.12506521,0.0074946987,0.0028510224,0.0050486266,0.18396239,0.0033388273,0.019385576,0.21180767,0.091537796,0.0011511525,0.0033454243
nonmucous glycoproteins pronucleating agents cholesterol crystallization promoting factors probably play important role pathogenesis gallstone disease isolated one factors involved using lectin affinity chromatography potent promoting activity binds concanavalin sepharose activity heat labile sensitive digestion glycosidase remarkably insensitive proteases concanavalin binding pronucleator affects cholesterol solubilization model bile two ways induces shift cholesterol phospholipid micellar vesicular phase also interacts directly cholesterol phospholipid vesicles concanavalin binding protein fraction contains least two different promoting factors gel permeation molecular weights kd kd respectively higher molecular weight activity could assigned protein apparent molecular weight kd concanavalin binding promoting activity present bile patients without stones indicating normal constituent bile however activity strongly increased bile patients multiple cholesterol gallstones suggesting could play key role gallstone formation patients,C06,0.002466859,0.0021882271,0.038498417,0.0013860276,0.0034350231,0.015105355,0.2811908,0.0023198642,0.0017834293,0.002423834,0.023392433,0.005148523,0.024898252,0.2018589,0.03935381,0.015780428,0.054124057,0.086983435,0.002808882,0.020841476,0.1578891,0.00087589206,0.015246995
increased cholecystectomy rates saudi arabia gallstones become increasingly prevalent saudi arabia cholecystectomy one commonest major abdominal operations people underwent cholecystectomy hospitals country eastern province years period overall frequency cholecystectomy increased finding explained increase population increase operations simultaneously average daily individual consumption total calories fat sugar increased respectively consumption high fibre grain fell striking increase frequency cholecystectomy presumably reflects incidence gallstones cannot explained demographic changes seems closely linked concomitant changes dietary habits,C06,0.0032931706,0.018808313,0.021891246,0.0018502983,0.004585636,0.004250008,0.15939862,0.019643659,0.034251526,0.0032357336,0.016843356,0.0067952545,0.21737982,0.0079429215,0.0028960032,0.02104928,0.13982947,0.0033975798,0.019678142,0.13003026,0.15839252,0.0011692853,0.0033878924
alcoholic liver disease alcoholic liver disease presents wide spectrum clinical manifestations ranging mild asymptomatic fatty liver alcoholic hepatitis severe life threatening liver failure ascites hemorrhaging esophageal varices encephalopathy although still poorly understood mechanism injury probably result numerous direct toxic metabolic effects alcohol hepatocyte therapy consists primarily abstinence supportive care however several newer treatments actively studied include prednisolone anabolic steroids glucagon insulin propylthiouracil cyanidanol colchicine promising agent inhibit fibrosis complications cirrhosis including ascites variceal hemorrhage result end stage disease return old techniques ascitic fluid management suggests therapeutic large volume paracentesis albumin infusion safe effective form therapy variceal hemorrhage best treated sclerotherapy vasoconstrictors balloon tamponade little done alter ultimately dismal prognosis long term survival alcoholic liver disease,C06,0.014471489,0.013658362,0.004449409,0.0013398073,0.0033208842,0.025619427,0.390224,0.013777018,0.013262645,0.002352707,0.028724305,0.004955573,0.07976505,0.029400982,0.0020969536,0.10765889,0.117301226,0.0024557386,0.0027152135,0.063183516,0.075965874,0.00084668346,0.0024542417
prospective randomized comparison brown mchardy microvasive balloon dilators treatment achalasia report results randomized prospective study comparing standard bougie rubber balloon dilator brown mchardy bmh newer polyethylene dilator passed guide wire microvasive rigiflex mvr twenty achalasia patients f mean age yr considered candidates either dilator randomized symptom assessment body weight upright radionuclide solid esophageal emptying study measured months pneumatic dilatation dilatations performed one three experienced gastroenterologists fluoroscopic guidance overall success occurred bmh mvr one patient improved mvr myotomy two successfully treated bmh complications occurred either dilator,C06,0.004070495,0.023299793,0.007595121,0.021984253,0.0056680352,0.0249486,0.24478246,0.0038279428,0.0029427866,0.00406307,0.02108485,0.011267852,0.100929044,0.009359324,0.0035794904,0.025979888,0.29325637,0.0041919346,0.041144535,0.06876097,0.071630344,0.0014452848,0.004187575
insulin resistance noncirrhotic idiopathic portal hypertension explore pathogenesis glucose intolerance insulin resistance observed patients cirrhosis portal hypertension studied year old woman presinusoidal portal hypertension without cirrhosis due nodular regenerative hyperplasia liver oral glucose ingestion glucose tolerance remained normal however occurred expense markedly hyperinsulinemic plasma response suggesting presence insulin resistance examine question directly performed stepwise euglycemic insulin clamp study combination infusion h glucose c palmitate indirect calorimetry ability insulin promote total body primarily muscle glucose uptake markedly impaired whereas effect suppress hepatic glucose production normal compared results obtained nine healthy subjects moreover insulin failed normally suppress plasma free fatty acid turnover oxidation patient informative case demonstrates portal hypertension alone without hepatic dysfunction cirrhosis associated impaired insulin mediated glucose plasma free fatty acid metabolism may also play predominant role development insulin resistance many cirrhotic patients,C06,0.0019185107,0.0017007535,0.0035775094,0.0010772607,0.002673277,0.0581409,0.22579497,0.011079353,0.010667349,0.0018838738,0.022646017,0.0039805816,0.06270963,0.019959733,0.0097147385,0.19965689,0.060210932,0.04948613,0.011455036,0.025084259,0.21392906,0.00068076863,0.0019724623
failure hepatitis b immunization liver transplant recipients results prospective trial twenty patients advanced liver disease need transplantation given three injections micrograms three injections micrograms hepatitis b vaccine see antibody response could obtained patients developed measurable anti hbs one failed develop anti hbs developed chronic hepatitis b exposure infected sexual partner type liver disease native liver age sex sexual preference timing immunization transplantation dosage hepatitis b vaccine seem explain lack immunologic response hepatitis b vaccine presumed immunosuppression underlying disease immunosuppressive medications best explains findings liver transplantation patients infrequently benefit hepatitis b vaccine possible vaccines given prevent viral bacterial illness may also fail elicit immunologic response patients,C06,0.0024380467,0.025767587,0.016306434,0.0013698885,0.0151943,0.0031464265,0.29469016,0.0022927688,0.0017625993,0.0023955242,0.013277841,0.030674974,0.026881661,0.029599475,0.0021752373,0.049631268,0.12447492,0.014210415,0.026380261,0.1446603,0.16929615,0.00086566183,0.0025081728
morphological study cholesterol hepatolithiasis report three cases three cases pure cholesterol intrahepatic stones compared morphologically calcium bilirubinate stones cholesterol stones found intrahepatic bile duct left lateral lobe two cases left lateral right posterior lobe one although chronic inflammatory reaction fibrous thickening bile duct wall similar types hepatolithiasis proliferation intrahepatic periductal glands production mucin rather mild compared liner containing calcium bilirubinate stones multiple intramural cholesterol calculi cholesterin granulomas cholesterin crystals surrounded foreign body giant cells found within cystically dilated small bile duct branches conduits periductal glands calculi granulomas characteristic cholesterol hepatolithiasis findings suggest formation cholesterol stones differs calcium bilirubinate stones perturbation factors influencing cholesterol nucleation hepatic bile may related changed microenvironment intrahepatic bile ducts followed formation cholesterol stones,C06,0.039226986,0.0022420613,0.0047161425,0.014041963,0.0035195306,0.0032619326,0.1803488,0.19416492,0.0018273048,0.014671143,0.06261138,0.00521329,0.043403257,0.1288642,0.100110106,0.016158896,0.0346635,0.0026029556,0.0028779854,0.026436081,0.1155275,0.0008974405,0.0026126502
ct diagnosis acquired small bowel volvulus small bowel volvulus uncommon important cause small bowel obstruction often results ischemia infarction clinical examination plain film radiography may nondiagnostic leading delay surgical intervention subsequent increase morbidity mortality present two patients diagnosis strangulating small bowel volvulus made computed tomography ct allowing rapid surgical correction potentially life threatening condition,C06,0.0047221733,0.0041888035,0.008817363,0.0026531967,0.029428717,0.006094211,0.41031674,0.02729127,0.0034139212,0.027497498,0.09301067,0.0097126085,0.059883844,0.010857735,0.00415256,0.007353406,0.120722055,0.004863056,0.005376889,0.07990171,0.073206894,0.0016766723,0.004857998
fibronectin related substance located chief cells human rat gastric mucosa novel substance located chief cells human rat gastric mucosa detected immunologically either polyclonal monoclonal antihuman fibronectin fn antibodies reported three polyclonal antihuman fn antibodies used study reacted immunohistologically exclusively chief cells monoclonal antibody c terminal peptide cell binding peptide reacted clearly human chief cells monoclonal antibodies fn n terminal midmolecule failed react cells western blot analysis rat gastric mucosal extract polyclonal antihuman fn antibody showed substance molecular weight da therefore substance appears fragment containing c terminal peptide whole molecule fn thus present study named fn related substance fnrs study ethanol induced ulcer model rat physiological significance fnrs examined fnrs decreased remarkably dose dependent manner fundic mucosa rats ingested ethanol fnrs appeared associated development mucosal damage repair subsequently playing part important role gastric mucosal protection mechanism,C06,0.0024375978,0.002162271,0.0045483047,0.0013695869,0.003394278,0.0031458472,0.32451516,0.0022923467,0.0017622748,0.0023950832,0.028799284,0.005013673,0.015657734,0.13899347,0.002143562,0.0037958468,0.035622478,0.02043805,0.0027755639,0.018594103,0.28417912,0.00086550246,0.09509888
interventional radiology biliary tract transcholecystic intervention diagnostic therapeutic biliary intervention percutaneous access gallbladder important new area interventional radiology anatomy gallbladder biliary tree surrounding viscera reviewed article preliminary discussion diagnostic techniques aspiration cholangiography biopsy therapeutic techniques gallbladder drainage cholelithotomy recently bewildering proliferation procedures aimed removal fragmentation dissolution gallbladder stones several discussed article removal common bile duct stones percutaneous cholecystostomy also discussed,C06,0.004326507,0.0038378276,0.029014634,0.0024308877,0.047883615,0.0055835824,0.4051895,0.08777943,0.003127872,0.004251047,0.101283714,0.008898797,0.026781872,0.031024596,0.003804621,0.006737271,0.06269155,0.004455585,0.0049263644,0.032618526,0.11736506,0.0015361854,0.004450951
pancreatic function crohn disease investigated exocrine pancreatic function population patients crohn disease order correlate pancreatic function clinical laboratory variables total patients affected crohn disease control subjects studied lundh meal test group patients crohn disease significantly decreased activity amylase p less lipase p less duodenal aspirates patients crohn disease enzyme activities correlated duration disease extent localisation previous bowel resection lowest enzyme values found patients extensive bowel involvement significantly lower p less patients disease confined terminal ileum differences enzyme values subgroups patients significant patient group whole correlation found disease activity enzyme values uniform group patients terminal ileitis pancreatic function significantly lower p less patients moderate severe disease compared patients mild disease thus least two factors seem responsible impaired pancreatic function crohn disease firstly disease activity secondly localisation extent disease,C06,0.0020302797,0.0018009593,0.0037882912,0.0011407313,0.0028271002,0.0026201818,0.19297895,0.0019092995,0.0014678019,0.001994869,0.021309726,0.042512275,0.25840786,0.0059752795,0.0017854038,0.022814315,0.12967882,0.011907218,0.061267346,0.0660897,0.14325167,0.00072087854,0.02172101
cirrhosis liver risk factor development cholelithiasis males ultrasonographic study prevalence cholelithiasis performed cirrhotic patients controls matched age sex gallstone disease found often cirrhotic patients controls p less female male ratio gallstones prevalence cirrhotic patients approached gallstone disease cirrhotic patients vs controls significantly higher vs p less males difference found gallstone disease prevalence cirrhosis different etiology prevalence cholelithiasis increased child child c significant trend p less difference significant males vs p less females study shows cirrhosis represents risk factor development cholelithiasis males suggest high levels estrogens could play role patients impairment gallbladder emptying similar observed pregnant women,C06,0.0024999538,0.0022175838,0.028836599,0.0014046221,0.0034811066,0.0032263207,0.22225392,0.002350987,0.0018073554,0.02666183,0.024709892,0.006336819,0.15636265,0.0061121834,0.0022381141,0.014840217,0.09436459,0.0025826169,0.0028465653,0.28685153,0.10455502,0.0008876428,0.0025718603
intermittent obstruction incarcerated hiatal hernia total thoracic stomach case intermittent obstruction sliding hiatal hernia presented obstruction occurred patient stomach totally diaphragm anatomy sliding hiatal hernias discussed well presenting signs symptoms obstruction sliding hiatal hernias,C06,0.0059448765,0.0052734017,0.011092522,0.0033401835,0.03703281,0.0076721725,0.24525942,0.060097225,0.061841484,0.00584119,0.055948544,0.012227475,0.044270124,0.013669107,0.0052284575,0.009257409,0.21068549,0.006122237,0.006769116,0.042231128,0.14196897,0.0021108096,0.0061158696
relation rectal sensation anal function normal subjects patients faecal incontinence relation sensory perception rapid balloon distension rectum motor responses rectum external internal anal sphincters normal subjects patients faecal incontinence impaired rectal sensation normal sphincter pressures studied patients normal subjects onset duration rectal sensation correlated closely external anal sphincter electrical activity r p less rectal contraction r p less internal sphincter relaxation normal subjects perceived rectal sensation within one second rapid inflation rectal balloon volumes ml less air six patients perceive rectal sensation ml introduced remaining nine patients sensation delayed least two seconds internal sphincter relaxation occurred sensation perceived three normal subjects patients p less could associated anal leakage stopped soon sensation perceived lowest rectal volumes required induce anal relaxation cause sustained relaxation elicit sensations desire defecate pain similar patients normal subjects conclusion results show close association rectal sensation external anal sphincter contraction show faecal incontinence may occur result delayed absent external anal sphincter contraction internal anal sphincter relaxed,C06,0.002180372,0.0019340988,0.004071992,0.0012250621,0.003036099,0.0028138836,0.15158124,0.0020521036,0.0015763119,0.03380688,0.0101536205,0.0044885036,0.33895144,0.0054034833,0.0019173641,0.0033952927,0.13017194,0.013065152,0.0024826743,0.08619064,0.19647558,0.00077417085,0.002252123
antibiotic use among children urban brazilian slum risk factor diarrhea published erratum appears j public health apr among cohort children poor urban setting brazil relative risk occurrence new episode diarrhea two weeks following antibiotic use vs weeks confidence interval ci among children ever corrected exposed antibiotics odds ratio ci stratifying individual child controlling previous diarrhea research needed confirm whether antibiotics risk factor diarrhea settings,C06,0.0047218343,0.0041885027,0.031667143,0.002653006,0.0065750047,0.006093773,0.15957959,0.00444047,0.0034136758,0.09607805,0.022624623,0.009887267,0.035377655,0.0121703,0.0041522617,0.007352878,0.12413894,0.0048775896,0.0281693,0.28545666,0.13984725,0.0016765518,0.004857649
prospective trial comparing combination ph probe nasogastric tube aspirated gastric ph intensive care unit patients upper gi bleeding related stress ulcer syndrome estimated affect much patients icu since occurrence bleeding icu admission may associated increased morbidity mortality many efforts directed defining optimal therapy stress ulcer prophylaxis titration intragastric ph antacids iv doses h receptor antagonists may prevent stress ulcer bleeding high risk icu patients evaluated recently developed ph probe incorporated ng tube compared aspiration gastric contents using ph paper means monitor ph surgical icu patients regression analysis comparing intragastric probe ph values aspirated ph values showed good correlation two methods r new technique intragastric ph measurement appears technically simple clinically applicable use patients risk stress ulcer bleeding may accurate ph paper patients receiving antacids,C06,0.023270214,0.0124874925,0.014789972,0.0012250657,0.0030494921,0.0028138917,0.3485296,0.0020506412,0.0015763164,0.0021423497,0.08611243,0.0049497765,0.08177405,0.00509345,0.04413839,0.0033953025,0.14365625,0.002245428,0.023590095,0.11744933,0.072643206,0.0007741731,0.0022430927
safety concerns available ulcer treatment influence drug selection identification parietal cell receptors gastric acid secretion coupled introduction cimetidine treatment acid peptic diseases transformed empiric therapy approach based clearer understanding human physiology today physicians confronted array antiulcer agents differ within drug class e g h receptor antagonists well mechanisms action e g neutralize acid alter mucosal defensive factors suppress acid secretion minor exceptions clinical efficacy available antiulcer drugs regarded comparable thus safety profile becomes next consideration choosing among similarly effective drug products available antiulcer agents h receptor antagonists class excellent safety profile indicated years cumulative clinical experience postmarketing surveillance important safety issues currently available antiulcer drugs e h receptor antagonists sucralfate prostaglandin e analogues newest antiulcer agent omeprazole reviewed place perspective clinician,C06,0.0132938735,0.07917472,0.015268436,0.0012792485,0.0031703901,0.03599382,0.4860056,0.0021411427,0.0016460345,0.0022371027,0.022006797,0.00468297,0.025750637,0.029495256,0.024042558,0.036605854,0.05136225,0.024386588,0.013605544,0.061039373,0.06364397,0.0008084136,0.0023594121
human oocyte preembryo donation evolving method treatment infertility utilization oocyte preembryo donation treatment infertility recently expanded since modifications retrieval donated female gametes enhanced safety efficacy procedure pregnancy rates women receiving donated preembryos remarkably high success occurring transfer cycles technology used preembryo donation continues evolve current future role ovum donation treatment infertility,C13,0.0051967036,0.02975332,0.034842864,0.0029198157,0.007236245,0.006706617,0.2896355,0.004887043,0.0037569853,0.0051060664,0.08124969,0.018795177,0.034711935,0.026347913,0.00456985,0.033247788,0.10114934,0.005351743,0.0059172115,0.19879642,0.09251787,0.0018451606,0.0054587303
expression rat prolactin like protein b deciduoma pseudopregnant rat decidua early pregnancy rat prl like protein b rplp b complementary dna cdna originally cloned late term placental library hybridizes transcripts deciduoma tissue artificially produced pseudopregnant rats expression rplp b deciduoma first observed h pseudopregnancy day deciduogenic stimulus increases maximum h pseudopregnancy day situ hybridization studies show rplp b hybridizes specifically antimesometrial cells deciduoma tissue day pseudopregnant rats homologous cells decidua surround embryo trophoblastic structure day pregnancy temporal study expression rplp b pregnancy shows rplp b concomitantly expressed decidual cells maternal origin cytotrophoblast fetal origin around day pregnancy,C13,0.0031446028,0.0027894196,0.0058675027,0.001766824,0.019561173,0.0040582735,0.09410373,0.0029572225,0.032689836,0.003089757,0.076838374,0.0064678467,0.025486704,0.07709272,0.0027652844,0.0048968005,0.049458396,0.033685118,0.0035805928,0.09189242,0.36901432,0.0011165342,0.087676555
direct ultrasonographic measurement fetal lung length normal pregnancies pregnancies complicated prolonged rupture membranes fetal lung length measured directly ultrasonography patients prolonged rupture membranes commencing weeks gestation measurements made weekly compared data collected normal pregnancies measurement fetal lung length ultrasonography good predictor pulmonary hypoplasia predicting greater cases good correlation lung size assessed last ultrasonographic examination lung weight postmortem r p less lung length measurements superior fetal chest circumference measurements identification pulmonary hypoplasia significant negative association amount amniotic fluid pulmonary hypoplasia p less fetuses pulmonary hypoplasia respiratory movements seen majority ultrasonographic examinations,C13,0.049351998,0.0020648944,0.02688035,0.0013079083,0.00327938,0.13090369,0.08629923,0.0021891121,0.0692664,0.013551257,0.17106655,0.004787885,0.15620247,0.0054732137,0.002047028,0.003624903,0.080983356,0.0023988558,0.0026505678,0.06366431,0.11878538,0.00082652504,0.0023947775
experience physiological steroid replacement regimen establishment receptive endometrium women premature ovarian failure eighteen women premature menopause underwent assessment serial serum oestradiol e progesterone levels endometrial histology function patients received continuous transdermal e progesterone either orally vaginally days physiological levels e attained significantly higher levels progesterone achieved vaginal progesterone p less endometrial biopsies obtained e replacement demonstrated normal proliferative features expression oestrogen related antigen er ag localized cytoplasm epithelium days progesterone replacement endometrium showed normal secretory features expression er ag stroma well glands days progesterone supplementation vaginal administration produced consistent physiological appearance oral administration thus transdermal e combined vaginal progesterone highly satisfactory combination establishing physiological endometrium women premature ovarian failure,C13,0.002590487,0.07753497,0.018075291,0.001455489,0.0036112287,0.0033431584,0.16191494,0.027510133,0.0018728068,0.0025453058,0.015928412,0.0061856788,0.039768815,0.01939846,0.002278009,0.01656378,0.12419791,0.0026696168,0.0029496506,0.06457729,0.33876356,0.00091978785,0.065345176
effect interleukin gamete interaction mouse embryo development early stages endometriosis shown associated infertility pathophysiology relationship unclear determine interleukin il peritoneal macrophage product effect gamete interaction early embryo development human recombinant il added coincubation gametes sperm penetration assay spa human zona pellucida assay zppa culture medium ham f used processing semen samples layering method analysis velocity motility hours il also added mouse embryos two cells cultured hours results showed il caused impairment spa zppa compared control medium without significant alterations sperm velocity motility also il demonstrated significant inhibition mouse embryo development results help explain subfertility associated early stages endometriosis,C13,0.0027314222,0.0024229079,0.0050965506,0.0015346748,0.0038037328,0.0038769105,0.3071357,0.015788686,0.0019746968,0.002702164,0.058498777,0.005650222,0.08647221,0.13376285,0.0024019438,0.0042629004,0.05763122,0.0028297121,0.003246265,0.07593423,0.20326087,0.0009698288,0.018011479
adenomyosis pakistani women four year experience aga khan university medical centre karachi part quality assurance programme aga khan university medical centre karachi pakistan hysterectomy specimens reviewed january december adenomyosis found specimens studied patients parous fourth fifth decades life high prevalence parous women aged years significant fibroids cervicitis endometrial hyperplasia common associated diagnoses associations studied endometrial hyperplasia significantly prevalent group adenomyosis adenomyosis stated indication surgery patients confirmed histopathology preoperative suspicion adenomyosis present patients ultimately found disease high prevalence adenomyosis population studied indicates condition may underdiagnosed past especially difficult diagnose without surgery hysterectomy currently treatment,C13,0.0029205997,0.0025907177,0.0054495363,0.0016409658,0.0040668426,0.003769186,0.270497,0.031020332,0.0021114636,0.0028763765,0.06920227,0.020148413,0.053006504,0.0067714765,0.0025683017,0.018665787,0.18329184,0.0030126253,0.0034435089,0.24490905,0.06399557,0.0010369988,0.0030046052
clinical evaluation clonidine added lidocaine solution epidural anesthesia effects clonidine added lidocaine solution used epidural anesthesia assessed women scheduled surgery premedicated diazepam mg po patients received ml lidocaine clonidine micrograms ml group c n clonidine micrograms ml group c n epinephrine micrograms ml group e n plain group p n significant difference number segments analgesia found observation period among four groups patients decreases mean blood pressure bp observed min epidural injection given clonidine c c mean sd similar given plain lidocaine significantly less given epinephrine p less vs c p response bp ephedrine given restoring bp anesthesia attenuated patients received epidural clonidine heart rate hr decreased significantly patients given clonidine micrograms ml p less given clonidine micrograms ml whereas hr increased significantly given lidocaine plain epinephrine respectively p less incidence sinus bradycardia similar among four groups patients significant differences also observed sedation score clonidine groups groups p e sedation appeared approximately min epidural injection clonidine groups,C13,0.0022033714,0.0019545003,0.004111262,0.011901057,0.013733394,0.0028435653,0.09182096,0.002072077,0.0015929394,0.0021649417,0.01093169,0.2509301,0.22156906,0.0053085797,0.0019375891,0.014260548,0.105939135,0.0022691071,0.0025088624,0.04926725,0.19763063,0.0007823371,0.0022670606
effect physical activity pregnancy preterm delivery birth weight relationship physical activity pregnancy preterm birth gestational age adjusted birth weight investigated prospectively cohort women study one evaluate employment non employment related physical activity prolonged periods standing associated modestly increased risk preterm delivery adjusted odds ratio greater equal hours day standing heavy work exercise associated preterm delivery adjusted odds ratio greater equal hours per day heavy work proportion infants born preterm differ among women working predominantly standing active sedentary occupations physical activity associated gestational age adjusted birth weight controlling confounding variables data suggest unmeasured socioeconomic differences among women reporting different levels activity may account previously described associations physical activity pregnancy outcome pregnant women report increased levels physical activity increased risk preterm delivery reduced intrauterine growth however data address role activity restriction management selected women high risk adverse pregnancy outcome,C13,0.0018661235,0.010686,0.0034816125,0.0010483841,0.002598234,0.0024080665,0.17394313,0.0017547334,0.0013489769,0.0018333757,0.07540132,0.0038702982,0.015806057,0.016051836,0.0016408426,0.0029162571,0.039460722,0.0019215879,0.011141599,0.31269595,0.2613562,0.054848917,0.0019197904
endocervical chlamydial deoxyribonucleic acid infertile women presence chlamydial deoxyribonucleic acid dna evaluated dna hybridization endocervical cells infertile normal fertile women chlamydial dna detected infertile patients significantly common fertile control individuals individuals among infertile patients tubal factors cause infertility nontubal factors found contain chlamydial dna endocervical cells results show chlamydial dna could found significantly frequently endocervical cells infertile patients tubal factor without tubal factors normal controls,C13,0.0037051064,0.0032866143,0.0069133444,0.002081748,0.0051592435,0.0047816327,0.26252443,0.0034843269,0.002678627,0.0036404845,0.024669498,0.007789501,0.10012445,0.15649632,0.003258177,0.023702962,0.09067412,0.003820018,0.004218809,0.106830195,0.06976376,0.0013155487,0.10908108
hyperemesis gravidarum conversion disorder psychosocial factors long believed important pathogenesis emesis gravidarum morning sickness hyperemesis gravidarum hg although confirmed extensive studies last years hg never described conversion reaction describe two women presenting hyperemesis clearly fulfill diagnostic criteria conversion suggest strong psychodynamic conflicts expressed potentially dangerous symptom subset individuals dynamic interventions role treating certain patients hg,C13,0.004418696,0.003919604,0.029625136,0.02386233,0.0061528943,0.0057898127,0.30424038,0.004155395,0.0031945205,0.0043581557,0.06347937,0.009088413,0.027650727,0.06426244,0.0038856897,0.0069244844,0.19142136,0.0045653437,0.005031335,0.1113362,0.116497986,0.0015689183,0.004570816
oocyte retention follicle luteinization indirect evidence supports existence luteinized unruptured follicle syndrome infertile women seek direct evidence oocyte retention infertile normal women studied early midluteal phase visual documentation ovulation stigma needle aspiration ovarian follicles peritoneal fluid collection estradiol progesterone assay luteal phase confirmed endometrial biopsy postovulation day normal control subjects n test cycles stigma negative oocytes recovered infertile group n test cycles stigma negative five oocytes recovered including one stigma bearing follicle peritoneal fluid steroid levels failed discriminate stigma positive stigma negative cycles either group oocyte retention luteinization occurs infertile women,C13,0.003190735,0.002830341,0.08317986,0.0017927438,0.0044429973,0.0041178097,0.19707268,0.0030006056,0.0023067594,0.06486355,0.10055749,0.038433038,0.08848662,0.024963282,0.0028058516,0.020412153,0.039116587,0.0033099141,0.019061556,0.11292983,0.16327053,0.01657251,0.0032825104
ovarian pregnancy report twenty cases one institution series cases primary ovarian pregnancy diagnosed treated one institution reported prevalence rate deliveries seems increasing past years comprises extrauterine pregnancies clinical presentation possible pathogenesis diagnostic steps preferred management future fertility detailed inasmuch fertile patients used intrauterine contraceptive device operation special emphasis made controversial relationship use intrauterine contraceptive devices ovarian pregnancy,C13,0.0037735137,0.03988086,0.007040985,0.0021201833,0.005254498,0.004869916,0.23878655,0.003548658,0.020992119,0.021938138,0.22236392,0.0077613965,0.047136195,0.045196872,0.0033183326,0.0058761453,0.14350043,0.0038860934,0.0042967005,0.07474712,0.088489495,0.0013398376,0.0038820517
measurement activity urea resistant neutrophil alkaline phosphatase antenatal screening test syndrome objective investigate value measuring maternal urea resistant neutrophil alkaline phosphatase activity antenatal screening test syndrome design case control study blood samples collected nine weeks pregnancy setting antenatal clinics london oxford patients women whose fetuses diagnosed amniocentesis chorionic villus sampling syndrome women whose fetuses syndrome singleton pregnancies studied main outcome measure activity urea resistant neutrophil alkaline phosphatase measured cytochemically results median enzyme activity index patients times expected median controls duration pregnancy p less confidence interval cut value identified control patients highest activities yielded rate detection syndrome confidence interval conclusion activity urea resistant neutrophil alkaline phosphatase effective maternal blood marker syndrome use antenatal screening could lead substantial improvement detection disorder introducing test routine medical practice automated used large scale less subjective,C13,0.0019174604,0.001700883,0.04997889,0.0010773428,0.002670795,0.0029220027,0.114702225,0.0018032029,0.01988219,0.020443028,0.20077924,0.013613333,0.1610734,0.0050646425,0.0016861663,0.012197058,0.06972189,0.0019746663,0.020299265,0.17416403,0.119674854,0.0006808205,0.0019726125
new method dressing free skin grafts using adhesive drapes disposable suction drain new method dressing free skin grafts devised graft compressed pressure equivalent negative pressure suction drain method apply uniform constant pressure graft moreover graft observed transparent drape existence hematomas detected easily,C13,0.0054724254,0.004854314,0.010661301,0.0030747326,0.06060585,0.0070624496,0.13677181,0.005146335,0.0039563198,0.0053769792,0.25255072,0.011255733,0.114256546,0.012615581,0.004812313,0.008521704,0.047017995,0.005635691,0.0062311613,0.03610117,0.25044066,0.0019430594,0.0056351284
maternal mortality united states understand better epidemiology describe causes maternal death reviewed identified maternal deaths united states puerto rico overall maternal mortality ratio period deaths per live births ratios increased age higher among women black minority races among white women age groups causes death varied different outcomes pregnancy pulmonary embolism leading cause death live birth unmarried women higher risk death married women risk death increased increasing live birth order except primiparas order develop strategies reduce risk maternal death united states future studies include expanded information death allow better understanding factors associated maternal mortality,C13,0.0024387285,0.0021625115,0.004548811,0.0013697392,0.0033946554,0.003146197,0.15856752,0.0022926016,0.01356234,0.025994496,0.034086097,0.01681627,0.045076612,0.017960165,0.0021438005,0.003796269,0.075105265,0.002510601,0.0027758726,0.47722897,0.10164886,0.00086559873,0.0025079898
comparison endometrial biopsy urinary pregnanediol glucuronide concentration diagnosis luteal phase defect determine pregnanediol glucuronide pg excretion useful luteal phase assessment compared daily first morning urinary pg concentrations luteal phase nine normal nine deficient cycles total luteal pregnanediol excretion versus area units sem different however significantly less pregnanediol excreted abnormal group st days luteal phase versus area units sem respectively thus delayed pg excretion may characteristic luteal phase defect measurement urinary pg may useful daily samples early luteal phase obtained,C13,0.0031421462,0.0027872405,0.1579514,0.016964903,0.034707192,0.0040551033,0.22151126,0.0029549124,0.0022716317,0.018295646,0.066676274,0.022030735,0.11517594,0.00738756,0.0027632392,0.004892975,0.03026179,0.0032371958,0.0035777956,0.022331458,0.23750775,0.0011156619,0.018400175
screening trisomy ultrasonographic determination biparietal diameter femur length ratio ultrasonographic determination biparietal diameter femur length ratios performed weeks gestation fetuses trisomy statistically different normal fetuses appears test could used screening trisomy,C13,0.0056212964,0.00498637,0.03767768,0.003158377,0.007827477,0.0072545754,0.1607181,0.005286335,0.085626885,0.0055232537,0.19475885,0.011561932,0.10289976,0.013190264,0.004943226,0.008753527,0.11512363,0.0057944376,0.0064006727,0.036699664,0.16841477,0.001995918,0.0057829823
relative risks caesarean section intrapartum elective vaginal delivery detailed analysis exclude effects medical disorders acute pre existing physiological disturbances objective compare maternal mortalities attributable vaginal delivery elective caesarean section cs intrapartum cs design number deaths associated method delivery ascertained among unselected among low risk women detailed retrospective review case notes women died delivery frequency method delivery throughout study period ascertained computer database enhanced analysis case notes unselected groups women setting peninsula maternity services cape town years inclusive subjects total maternal deaths arising maternities provided accurate information relative frequency vaginal abdominal delivery determined computer database ratio elective cs emergency prepartum cs intrapartum cs obtained review first operations years main outcome measures mortality rates associated different methods delivery unselected women women healthy surgery ii mortality rates apparently attributable method delivery results overall relative risk mortality associated caesarean section compared vaginal delivery decreasing exclusion women medical life threatening antenatal complications eg haemorrhage hypertension relative risk associated intrapartum compared elective sections decreasing exclusion women medical disorders life threatening complications relative risk maternal mortality apparently attributable intrapartum compared elective sections however confidence intervals values even large data set wide nevertheless rates broad agreement approximation derived british confidential enquiries maternal deaths conclusion attributable relative mortalities caesarean section compared vaginal delivery intrapartum compared elective caesarean section lower overall relative mortalities modes delivery approximately respectively data crucially important decision recommend elective caesarean section compared trial labour,C13,0.0073180622,0.0011123708,0.06303428,0.0007045779,0.0017465475,0.0018700481,0.10981388,0.038539,0.06768456,0.0012321399,0.08001753,0.008715834,0.088789634,0.0029141984,0.007154308,0.0019527567,0.07116651,0.0013018529,0.025452588,0.3118799,0.09902074,0.0004452539,0.008133468
subzonal insemination alleviation infertility methods developed facilitate use subzonal insemination achieve fertilization vitro clinical trial undertaken patients previously failed achieve fertilization vitro fertilization presenting severe oligospermia oligoasthenospermia patients oocytes obtained activated parthenogenetically vivo metaphase ii underwent subzonal insemination fertilized three pronuclei thirty eight percent patients fertilization replacement one conceptus replaced patients two conceptus patients three patients twin two singleton pregnancies established,C13,0.0048509613,0.004286328,0.009032747,0.0027149688,0.006728568,0.029608563,0.19335459,0.027925175,0.0034934045,0.0047478373,0.10733332,0.009938738,0.029911682,0.0111105265,0.0042492407,0.007524609,0.31537095,0.03664984,0.02889385,0.062038835,0.09354289,0.0017157088,0.004976672
heterologous transplantation activated murine peritoneal macrophages inhibits gamete interaction vivo paradigm endometriosis associated subfertility macrophage hyperactivation postulated pathologic aberration patients suffering endometriosis associated subfertility report vivo model macrophage mediated infertility described populations macrophages obtained inbred strain mice balb c follows vivo hyperactivated macrophages harvested donor mice treated intraperitoneal thioglycolate hyperactivated macrophages deactivated ex vivo protein synthesis inhibitor emetine basal state nonactivated macrophages obtained untreated mice recipient mice underwent ovarian hyperstimulation pregnant mare serum gonadotropins x macrophages transferred afternoon stimulation day injection human chorionic gonadotropin hcg mating unfertilized oocytes cell embryos counted day hcg reflection reproductive performance heterologous transfer vivo hyperactivated macrophages basal state macrophages significantly inhibited fertilization effect largely reversed pretreatment emetine experiments confirm relevance macrophage mediated interference early reproductive performance provide model development alternative therapies e g immunomodulation peritoneal fluid environment endometriosis associated subfertility,C13,0.0022063302,0.001957125,0.014820152,0.0012396469,0.003072245,0.012741125,0.122377425,0.11956842,0.0015950785,0.002167849,0.013048356,0.028120698,0.04178996,0.112790704,0.0019401911,0.003435715,0.09618753,0.09107361,0.0025122315,0.10490393,0.21939847,0.0007833877,0.0022697912
frequency costs diagnostic imaging office practice comparison self referring radiologist referring physicians background assess possible differences physicians practices respect diagnostic imaging compared frequency costs imaging examinations performed primary physicians used imaging equipment offices self referring ordered physicians always referred patients radiologists radiologist referring methods using large private insurance claims data base analyzed episodes outpatient care physicians acute upper respiratory symptoms pregnancy low back pain men difficulty urinating respective imaging procedures studied chest radiography obstetrical ultrasonography radiography lumbar spine excretory urography cystography ultrasonography results four clinical presentations self referring physicians obtained imaging examinations times often radiologist referring physicians p less four chest radiography obstetrical ultrasonography lumbar spine radiography self referring physicians charged significantly radiologists imaging examinations similar complexity p less three combination frequent imaging higher charges resulted mean imaging charges per episode care times higher self referring physicians p less results confirmed separate analysis controlled specialty physician conclusions physicians refer patients radiologists medical imaging use imaging examinations frequently physicians refer patients radiologists charges usually higher imaging done self referring physician results possible determine group physicians uses imaging appropriately,C13,0.0016693502,0.0014807968,0.03543176,0.00093793974,0.11154622,0.0021618963,0.23711006,0.0015699196,0.0012068659,0.010122864,0.21298838,0.011919477,0.10343183,0.0038383515,0.0014679844,0.010677163,0.08348181,0.0017227388,0.01806095,0.109060675,0.037794773,0.0005927256,0.0017254797
contraception ectopic pregnancy risk studies association ectopic pregnancy contraception generated conflicting array results methodologic differences studies estimated absolute incidence rates ectopic pregnancy various contraceptives multiplying pregnancy rate proportion pregnancies ectopic implantation method results indicated fold difference ectopic pregnancy incidence low ectopic pregnancies per women years oral contraception vasectomy high per women years contraception estimated incidence rates useful clinicians patients seeking better understand risks benefits contraceptives,C13,0.0037090725,0.021223461,0.0069207447,0.0020839765,0.0051647658,0.0047867512,0.16098832,0.0034880566,0.0026814942,0.0036443816,0.11782769,0.045203377,0.055045616,0.0085325055,0.0032616646,0.04139912,0.059809707,0.0040889285,0.022161208,0.33437997,0.08846649,0.0013169568,0.003815757
maternal genetic effects ethanol teratogenesis dominance relative embryonic resistance malformations maternal genetic factors fetal genetic factors contribute variations response prenatal alcohol exposure assess contribution maternal genotype ethanol teratogenesis reciprocal cross study conducted animal model using c bl j b long sleep ls mice b mice susceptible ls mice prenatal ethanol induced malformations mouse stocks susceptible fetal weight deficits following utero alcohol exposure b ls dams reciprocally mated b ls males producing four embryonic genotype groups true bred b b lsls genotypes genetically similar b ls lsb genotypes f genotype dams intubated either g kg ethanol e isocaloric amount sucrose day pregnancy fetuses removed gestation day weighed assessed soft tissue skeletal malformations results showed greater litter weight deficit increased total malformation rate ethanol exposed f litters carried b mothers compared ethanol exposed f litters carried ls mothers result would expected maternal genetic factors contribute significantly towards susceptibility ethanol teratogenesis influence ls mother decrease susceptibility ethanol teratogenesis compared b mother influence b mother increase susceptibility ethanol teratogenesis compared ls mother average malformation rate f litters significantly less predicted midparental value shows f genotype exhibited dominance towards resistance prenatal alcohol effects,C13,0.0016978307,0.009707166,0.011384568,0.0009541214,0.0107876975,0.035014022,0.07433129,0.0015966606,0.03387052,0.0016682184,0.031788673,0.011912197,0.07323151,0.028593503,0.0014930484,0.0026438755,0.022790061,0.00996155,0.0019332301,0.36622444,0.19852889,0.000602838,0.06928409
effect serum patients minimal mild endometriosis mouse embryo development vitro two cell mouse embryos cultured degrees c co air serum supplement patients minimal mild endometriosis group n tubal factor group ii n male factor group iii n fetal cord samples group iv n ham f medium gibco grand island ny without serum supplement group v n progression blastocyst stage mean percent se hours groups ii iii iv v respectively serum factors appear associated inhibition early embryogenesis may explain decreased fertility rates observed patients minimal mild endometriosis,C13,0.0030506484,0.0027060774,0.020536484,0.0017140348,0.0042479313,0.0039370204,0.12503299,0.0028688665,0.016960798,0.0029974412,0.028794711,0.109948024,0.10323501,0.07887334,0.0026826633,0.004847107,0.1354265,0.0031626867,0.003473612,0.1371431,0.2041394,0.0010831744,0.0031383946
initiating chorionic villus sampling program relying placental location primary determinant sampling route initiating chorionic villus sampling cvs protocol relied upon placental locations determinant choice technique anterior fundal location prompted transabdominal ta cvs transcervical tc approach reserved posterior placentas coaxial needle system used ta cvs gauge cm guide needle gauge cm sampling needle tc cvs accomplished french cm polyethylene catheter july february initial procedures performed consecutive pregnancies using protocol testing indications antenatal characteristics ta n tc n groups similar one procedure failure occurred tc group single aspiration sufficient cases ta tc tc procedures increased aggregate sample weight observed compared ta cases g vs g respectively p less difference attributable increased number placental aspirations tc cases one abnormal karyotype observed x four pregnancy losses occurred tc ta using placental location determine choice cvs technique appears feasible may associated lower failure rate facility initial experience compared reliance upon one technique alone trials comparing safety two methods consider placental location independent variable randomization,C13,0.0118570905,0.031291854,0.0037890095,0.0011409476,0.0028276362,0.0026206784,0.23571317,0.0019096616,0.06038427,0.0019952473,0.16748783,0.024714509,0.12536626,0.004864937,0.0017857152,0.013076901,0.10610933,0.0020912478,0.020553622,0.08642457,0.091184065,0.0007210152,0.002090399
aggressive evaluation atypical squamous cells papanicolaou smears retrospective study done women atypical papanicolaou smears referred immediate colposcopy smears obtained january march edwards air force base california excluded evaluation abnormal papanicolaou smears hyperkeratosis parakeratosis koilocytotic atypia suggestive human papillomavirus hpv infection evaluation included colposcopy colposcopically directed biopsies endocervical curettage repeat papanicolaou smears total patients included study cervical intraepithelial neoplasia cin seen patients cin cin ii cin iii carcinoma seen patients carcinoma situ invasive squamous cell carcinoma stage iib hpv dysplastic lesions seen together patients hpv seen alone twenty one patients apparent lesions colposcopy although one developed microinvasive keratinizing squamous cell carcinoma within months colposcopy many significant lesions go undetected extended periods time women atypical papanicolaou smears resulting delayed management referral immediate colposcopy advocated strongly,C13,0.0030049863,0.0026655728,0.034689255,0.0016883792,0.09147095,0.0038780912,0.2765848,0.0028259254,0.016713817,0.017496847,0.07387191,0.006180682,0.024712875,0.031133184,0.0026426786,0.019145729,0.20094824,0.0030946375,0.0034216188,0.09295926,0.08668509,0.0010669614,0.0031185606
neosalpingostomy distal tubal obstruction prognostic factors impact surgical technique reviewed clinical records women underwent microsurgical terminal neosalpingostomy distal tubal obstruction january june identified women whose preoperative evaluation revealed contributory factors infertility analyzed pregnancy outcome procedure pregnancy success inversely related extent tubal distortion dilation rugal integrity status fimbria degree adnexal adhesions using classification system distal tubal obstruction patients mild disease pregnancy rate whereas patients moderate severe disease success rate respectively found statistically significant difference pregnancy outcome compared series previous group reported contemporary microsurgical technique used although feel optimal surgical technique important maximize success conclude important prognostic factor pregnancy outcome neosalpingostomy distal tubal disease anatomical functional integrity tube,C13,0.0024093972,0.0021372554,0.0045018797,0.001353742,0.015486803,0.0031094525,0.19994898,0.0022658263,0.0017418868,0.014023993,0.13727218,0.01827265,0.082073316,0.0063925437,0.037106533,0.015410566,0.1746179,0.0024845921,0.0033046613,0.18508185,0.07523877,0.0008554894,0.014909706
preliminary characterization angiogenic activity media conditioned cells luteinized rat ovaries angiogenic activity detected media conditioned ovarian cells superovulated pseudopregnant pmsg human cg treated immature holtzman rats media conditioned cells luteinized rat ovaries stimulated directed migration rabbit endothelial cells mouse balb c cells mitogenic either cell type endotheliotropic activity associated steroid indicated finding chemoattractant activity detected fractions reversed phase c chromatography removes steroids present media chemoattractant activity precipitated ammonium sulfate ethanol full chemoattractant activity recovered boiling c min lyophilization dialysis sephadex g desalting columns ph changes sephadex g chromatography chemoattractant activity emerged elution volumes corresponding mol wt chemoattractant activity retained concanavalin sepharose gelatin sepharose partially retained heparin agarose chemoattractant activity also partially retained cation anion exchange columns collective findings indicate presence nonsteroidal heat stable pronase sensitive factor nominal mol wt media conditioned cells luteinized rat ovaries factor chemoattractive mitogenic endothelial cells ovarian derived chemoattractant activity appears distinct fibroblast growth factor lacked detectable mitogenic activity fibroblast growth factor active cell migration bioassay stimulation endothelial cell migration key event angiogenesis demonstration ovarian endotheliotropic chemoattractant consistent hypothesis angiogenesis factors play role paracrine regulation ovarian function,C13,0.001882322,0.0016697135,0.0050206636,0.0010577526,0.0026210737,0.0024292346,0.30016258,0.08476967,0.001360835,0.0018494918,0.011230652,0.0039538434,0.032963943,0.27663693,0.0016559501,0.022102835,0.0175057,0.0150584765,0.0021433004,0.013583596,0.17669109,0.00066834415,0.022981975
serum concentrations ca aminoterminal propeptide type iii procollagen piiinp patients endometrial carcinoma serum ca marker coelomic epithelial cells aminoterminal propeptide type iii procollagen piiinp indicator collagen metabolism concentrations measured patients endometrial carcinoma initial serum concentration ca pathologic patients frequency abnormal values higher p advanced early disease serum piiinp concentration increased patients often p less advanced early disease among patients least one tumor markers increased cases early disease patients contracted recurrent cancer accuracy pathologic ca piiinp concentrations prediction poor total material pathologic ca piiinp concentrations appeared simultaneously patients eight poor prognoses monitoring treatment response patients regression accompanied normal decreasing ca piiinp values persistence pathologic ca piiinp concentration predicted relapse malignancy progressive disease ca piiinp concentrations together separately remained pathologic level increased continuously clinically stable endometrial carcinoma ca gave false negative results determinations piiinp current results suggest use ca piiinp simultaneously monitoring clinical course advanced endometrial carcinoma,C13,0.0019911528,0.0017662519,0.01363679,0.021151109,0.012411459,0.02183383,0.33909702,0.0018725041,0.0014395148,0.0019564244,0.04967092,0.014010791,0.059905585,0.056385025,0.0017510288,0.022370685,0.13187398,0.0020559276,0.0022672203,0.0136488,0.22614855,0.000706986,0.0020484244
abnormal bleeding climacteric perimenopausal years encounter situation normal diminution reproductive capacity resulting disruption normal menstrual hormonal pattern coincides real risk pelvic pathology limitation ability diagnose treat patients conservatively past resulted high rate hysterectomy increased understanding normal physiology stage transition improved diagnostic tools able come definitive diagnosis patients ability assure diagnosis made much easier counsel patient confidently appropriate course action continue encounter problem hysterectomy bleeding histologic lesion found although reviewers letters may considered unnecessary thorn side improved practice resulted efforts gives strong support continued activities confidence treatment plan evolved logical manner offers patients high probability benefit justifiable risk,C13,0.027666237,0.027375365,0.004834035,0.0014556259,0.028679743,0.01577913,0.26275614,0.0024363545,0.001872983,0.002545545,0.097055346,0.005387256,0.02401037,0.006534433,0.01480771,0.042878367,0.12494117,0.002673113,0.028029732,0.08943392,0.18526226,0.00091987435,0.0026652482
preoperative evaluation serum ca tag ca patients endometrial carcinoma evaluated women endometrial carcinoma determine accuracy preoperative tumor associated antigen levels ca ca ca prediction extrauterine disease whether tag ca would improve predictive value ca alone eleven patients disease confined uterus positive cytologic findings ca values greater u ml versus patients extrauterine metastasis therefore ca values sensitivity specificity tag level elevated greater u ml patients localized disease metastasis ca elevated greater u ml categories respectively tag ca levels improve combination sensitivity specificity ca alone addition one patients microscopic metastasis three cases positive peritoneal cytology seven elevation tumor associated antigen levels failure detect occult metastasis high false positive rate limit role tumor associated antigen assays preoperative evaluation patients endometrial carcinoma,C13,0.0021801705,0.0124873435,0.0040679723,0.0012249489,0.057127524,0.0028136238,0.14790124,0.002050259,0.0015761663,0.0021421455,0.0655214,0.00449815,0.1484623,0.20890133,0.001917187,0.003394979,0.12220339,0.0022452143,0.002482445,0.07493085,0.11805068,0.0007740994,0.013046573
pregnancy liver transplantation define risks outcomes associated pregnancy liver transplantation reviewed experience managing eight pregnant women undergone orthotopic liver transplantation seven patients conceived transplantation interval transplantation conception ranged weeks months one patient received allograft weeks gestation hepatic failure secondary acute fulminant hepatitis b seven patients conceived transplantation six live births one electively terminated pregnancy five patients developed worsening hypertension preeclampsia three patients developed severe preeclampsia required delivery one patient suffered acute allograft rejection pregnancy successfully treated corticosteroids two patients persistent elevation serum transaminases two severe anemia mean gestational age delivery weeks six live births women conceived transplantation five infants survived well one infant died congenital anomalies mothers alive time pregnancy recipients hepatic allografts associated good perinatal outcome increased risk preeclampsia worsening hypertension preterm delivery pregnancy appear deleterious effect hepatic graft function survival joint management patients transplant specialist perinatologist essential,C13,0.02331661,0.011750962,0.00382811,0.0011527216,0.0028568157,0.031034764,0.14841188,0.0019307114,0.031241518,0.002015837,0.07974133,0.0043776636,0.03883072,0.0047453963,0.0018041427,0.032979786,0.32429534,0.0021128284,0.002336071,0.15404071,0.084466055,0.010619374,0.002110631
serum levels anticardiolipin antibodies pathologically increased active immunization patients recurrent spontaneous abortion although pathophysiological mechanisms leading recurrent spontaneous abortion still fully understood treatment schemes based immunological principles advocated recent years claiming production called blocking factor specifically stimulated investigated retrospectively whether active immunization affect production immunoglobulin ig g igm anticardiolipin antibodies group untreated recurrent spontaneous abortion patients n range variation cardiolipin antibodies consecutive controls taken time interval immunization statistically significant contrast significant increases igg igm antibodies occurred active immunization paternal leucocytes cases respectively mean basal posttransfusion levels u ml igg u ml igm respectively conclude active immunization human lymphocytes leads production antibodies cardiolipin effect exerted igm igg antibodies,C13,0.0026950545,0.0023906478,0.005028692,0.0015142412,0.003752778,0.0034781082,0.26769745,0.002534462,0.0019484044,0.0026559832,0.026379513,0.021302609,0.121482536,0.11176924,0.0023699629,0.0041967602,0.122075625,0.0027754593,0.003068716,0.03513818,0.25200924,0.0009569159,0.002779404
ectopic pregnancy ten common pitfalls diagnosis ectopic pregnancy ep common life threatening complication pregnancy modern technology ultrasonography improved pregnancy tests facilitate diagnosis ep however retrospective review cases confirmed ep managed months urban teaching hospital patients cl received prompt diagnosis treatment delays occurred patients delayed cases diagnosis ep even considered time first visit patients delayed diagnosis morbidity transfusions cardiovascular instability progression illness occur diagnostic pitfalls resulted delayed care reviewed delays commonly occurred patients benign examination atypical pain risk factors ep missed patients subtle clues blood loss often ignored patients passage tissue thought exclude ep patients ultrasound helpful half diagnoses misinterpreted dry serous culdocentesis occurred frequently five patients falling low quantitative human chorionic gonadotropin level believed indicate completed abortion authors conclude almost half eps still missed first physician visit errors pitfalls diagnosis still common,C13,0.0021575503,0.0123439,0.0040257648,0.0012122395,0.0030043202,0.002784431,0.17465082,0.0020289863,0.0015598127,0.06641991,0.2144389,0.0046563153,0.0484595,0.005062451,0.0018972952,0.0138009135,0.26595238,0.0022247818,0.0024566883,0.06021013,0.09722557,0.011207701,0.002219608
maternal hemodynamics normal preeclamptic pregnancies longitudinal study preeclampsia disease unique pregnancy contributes substantially maternal fetal morbidity mortality condition thought one hypoperfusion increased vascular resistance characterizes associated hypertension study designed test alternative hypothesis preeclampsia characterized high cardiac output blinded longitudinal study nulliparas uncomplicated pregnancies cardiac output measured serially doppler technique cardiac output elevated throughout pregnancy patients became preeclamptic p six weeks postpartum hypertension preeclamptic subjects resolved cardiac output remained elevated p peripheral resistance remained lower normotensive subjects p study demonstrates preeclampsia disease systemic hypoperfusion challenges current models disease based assumption,C13,0.08650897,0.0025541498,0.018116886,0.0016178037,0.00400987,0.018844934,0.21791932,0.0027077997,0.0159961,0.0028291557,0.10449432,0.0059223254,0.095407315,0.043918636,0.0025320502,0.018420354,0.061706793,0.0029666228,0.017210295,0.11416898,0.15813515,0.0010223617,0.002989857
correlation quantitative antibody titers sperm immobilizing antibodies pregnancy rates treatments immunological infertility women possessed sperm immobilizing si antibodies made difficult conceive using usual treatments examined si antibodies quantitative sperm immobilization test found antibody titers sperm immobilization unit si unit associated pregnancy rates patients high si titers greater units conceive ordinary repeated artificial inseminations husband semen aih except treated vitro fertilization ivf embryo replacement patients relatively low si titers less units could conceive either repeated ordinary aih though success rates lower ivf embryo replacement important assess si titers quantitative method select treatments infertile women si antibodies follow studies patients conceived successfully found si titers tended decline pregnancy proceeded,C13,0.002529878,0.002244128,0.06595014,0.0014214352,0.0035227747,0.01550174,0.23322463,0.0023791278,0.001828989,0.014729111,0.086524226,0.0052034752,0.04615895,0.056294654,0.0022247108,0.101477556,0.14259183,0.0026053546,0.002880638,0.14774978,0.05945591,0.0008982677,0.002602645
establishment pregnancies humans transcervical transfer gametes immediately oocyte retrieval study like veersema et al demonstrates feasibility direct intrauterine transfer gametes initiating pregnancy whether success procedure improved modification preincubation vitro insemination remains subject continued investigation notwithstanding uncertainty feel transcervical transfer gametes may alternative ivf patients ethical concerns regarding ivf,C13,0.005944919,0.0052734395,0.011092601,0.0033402073,0.0082799215,0.0076722275,0.25739768,0.0055906735,0.0042979117,0.005841232,0.11930637,0.012227561,0.037378408,0.017462661,0.0052278116,0.009257475,0.15804726,0.006122281,0.03553095,0.08926774,0.14557964,0.0021108247,0.047750186
serial section study visually normal pelvic peritoneum patients endometriosis defined criteria used select small samples visually normal study peritoneum serial section light microscopy patients biopsy proven endometriosis patients without endometriosis glandular element compatible possible endometriosis found patient visually normal peritoneum harbor high prevalence invisible microscopic endometriosis,C13,0.0049476163,0.0043887827,0.033180535,0.0027798638,0.0068893987,0.0063851564,0.19238488,0.05255319,0.0035769062,0.0048613236,0.114889644,0.010176301,0.054928344,0.012308105,0.004350809,0.0077044675,0.15821429,0.0051099584,0.005633589,0.102250196,0.20564,0.0017567187,0.005089925
diagnosis ectopic pregnancy vaginal ultrasonography combination discriminatory serum hcg level iu l irp diagnostic value vaginal sonography combination discriminatory serum hcg level iu l international reference preparation tested prospectively pregnant women suspected ectopic pregnancy ectopic pregnancy diagnosed women miscarriage normal pregnancy admission intrauterine sac seen intrauterine pregnancies none ectopic pregnancies detection adnexal mass separate ovaries diagnostic ectopic pregnancy sensitivity specificity positive predictive value negative predictive value patients initial sonogram non diagnostic final diagnosis obtained repeated scan within days five women ectopic pregnancy miscarriage two normal pregnancy admission hcg level exceeded iu l patients ectopic pregnancies patients initial level exceeding iu l intrauterine sac found intrauterine pregnancies none ectopic pregnancies use threshold combination sonographic detection adnexal mass diagnostic ectopic pregnancy sensitivity specificity positive predictive value negative predictive value,C13,0.0028011573,0.0024847663,0.032344222,0.015130716,0.0039258203,0.0036150394,0.057126187,0.0026342422,0.002025112,0.0027523015,0.34782225,0.005761445,0.11057159,0.0066278297,0.002463267,0.0044595385,0.09581191,0.0028869144,0.0031895295,0.08713212,0.20455778,0.0009945892,0.0028817272
sodium lauryl sulfate induced irritant contact dermatitis vulvar forearm skin premenopausal postmenopausal women reactivity skin forearm labia majora three concentrations sodium lauryl sulfate studied healthy women premenopausal postmenopausal patches irritant applied day hours skin changes monitored visual scoring measurement transepidermal water loss capacitance indicators stratum corneum hydration days forearm skin irritant dermatitis developed majority subjects indicated visual scoring increase transepidermal water loss changes significantly dependent concentration sodium lauryl sulfate labia majora skin irritant dermatitis developed women determined visual scoring however pigmentation visual scoring readings less reliable labia majora skin transepidermal water loss increase significant immediate decrease capacitance noted labia majora skin forearm skin postmenopausal women reacted less frequently slowly sodium lauryl sulfate premenopausal women whereas age related differences observed reaction vulvar skin concluded labia majora skin reactive sodium lauryl sulfate forearm skin capacitance sensitive transepidermal water loss monitoring vulvar irritant dermatitis age related differences irritant reaction apparent forearm vulva,C13,0.002092005,0.0018557128,0.06794591,0.0011754123,0.124445505,0.0026998415,0.14211278,0.0019673468,0.011628358,0.0020555179,0.009640733,0.046245195,0.12466532,0.0048334794,0.0018396564,0.013381522,0.021797631,0.09536724,0.0023820554,0.13971984,0.16914664,0.00074279495,0.012259513
triplet tubal pregnancy treated outpatient laparoscopic salpingostomy knowledge represents first case laparoscopically treated triplet ep first time double ep tube treated conservatively preservation tube multiple eps may common currently thought report offers alternative explanation least cases persistent ep conservative surgical therapy finally given substantial cost savings reduced postoperative recovery time associated operative laparoscopy patient stable surgeon experienced laparoscopic approach tried regardless number eps size,C13,0.0035791632,0.0031730956,0.023979131,0.0020098453,0.005032361,0.0046164766,0.30715606,0.0033707311,0.0025861082,0.0035147434,0.12078978,0.007480418,0.024342898,0.008443769,0.0031456407,0.022871424,0.24481316,0.0036838541,0.0040839436,0.09926201,0.097115286,0.00127011,0.0036800227
interobserver variation histopathological grading cervical dysplasia order assess variability among histopathologists grading cervical dysplasia four experienced histopathologists examined set biopsy specimens assigned one five diagnostic categories dysplasia mild dysplasia moderate dysplasia severe dysplasia carcinoma situ histopathologists discuss grading criteria beforehand considerable disagreement among pathologists unweighted group kappa weighted group kappa appeared grades dysplasia equally difficult distinguish adjacent categories various explanations interobserver variation put forward,C13,0.005202893,0.029761039,0.034813847,0.0029200122,0.007236732,0.08212908,0.20453231,0.004887372,0.0037572382,0.030254204,0.07421465,0.061009843,0.15543394,0.01194963,0.0045701573,0.033236545,0.061099257,0.005352103,0.005965028,0.09148712,0.082995184,0.0018452848,0.0053465366
ovarian response exogenous gonadotropins pregnancy multiple ovarian follicles successfully induced patient undergoing superovulation gamete intrafallopian transfer gift procedure despite presence undiagnosed ectopic pregnancy midluteal gonadotropin releasing hormone agonist gnrh treatment coupled mechanical contraception previous cycle patients patent tubes,C13,0.005947563,0.005275785,0.06867233,0.003341693,0.0082817925,0.036458533,0.17613709,0.00559316,0.004299823,0.03456329,0.14056404,0.012233,0.036816504,0.015953025,0.0052301367,0.009261592,0.20106056,0.0061250036,0.006772175,0.08096579,0.1282167,0.0021117635,0.0061186333
recall alcohol consumption pregnancy test retest reliability study self reported alcohol use pregnancy two groups women provided two reports first trimester drinking month interval group month interval group women group n queried first trimester alcohol consumption fourth month pregnancy seventh month month recall interval group women n provided first trimester drinking reports fourth month pregnancy delivery month recall interval test retest pearson correlation coefficient recall first trimester average daily volume adv p group p group adv scores grouped five ordinal categories group group remained category test retest leads conclusion self reported alcohol consumption moderately reliable month month time period,C13,0.003292092,0.0029202497,0.022047231,0.0018496921,0.0045841336,0.004248616,0.15980072,0.003095923,0.03424899,0.0032346735,0.07950133,0.18195401,0.04028799,0.0075695356,0.0028949825,0.0051264716,0.20389041,0.0033903087,0.0037485308,0.09510909,0.13264933,0.0011689021,0.0033867827
perinatal outcomes twin pregnancies term review two year experience community disclosed twin pregnancies deliver term little attention focused perinatal outcomes twin pregnancies remaining undelivered completed weeks therefore reviewed experience determine whether practice change maximize perinatal care nearly study pregnancies delivered estimated date confinement fetal malpresentation failure progress patient lack desire vaginal birth cesarean delivery common reasons high cesarean rate neonatal outcomes favorable regardless route interval deliveries discordant fetal growth found eight cases perinatal deaths occurred five minute apgar scores less rates anomalies different singleton pregnancies delivering period using principles obstetric practice used community would expect perinatal outcomes term twin gestations favorable,C13,0.0023555725,0.013492105,0.004395254,0.0013235001,0.00328006,0.014438055,0.13403639,0.013553361,0.047307566,0.0023144882,0.17316997,0.04960795,0.045202214,0.016997173,0.002071431,0.026462309,0.11449313,0.002425849,0.02548672,0.21699105,0.07632656,0.0118459985,0.002423326
epidural analgesia parturient herpes gestationis yr old parturient herpes gestationis spontaneously delivered normal healthy infant epidural analgesia received five injections bupivacaine per cent ten hour period infection lumbar region even though body covered vesicles bullae including face neck eight months delivery patient still vesicular eruption occurs mainly menses,C13,0.0057780524,0.0051254206,0.03873313,0.003246452,0.008045755,0.0074568777,0.17694558,0.033399805,0.032145884,0.03856126,0.04253539,0.088488884,0.13044089,0.0136043215,0.030555649,0.008997629,0.14785747,0.0059569404,0.0065791626,0.07102704,0.096127525,0.0020515765,0.006339306
effects intravascular fetal blood transfusion fetal intracardiac doppler velocity waveforms fetuses pregnancies red blood cell isoimmunization doppler velocity waveforms recorded level atrioventricular valves immediately minute intervals hours intravascular transfusion left right cardiac outputs ratio peak velocities early passive ventricular filling active atrial filling level ventricles well heart rate calculated transfusion left right cardiac outputs significantly higher reference ranges gestation constructed cross sectional study normal pregnancies transfusion significant temporary fall right left outputs associated increased ratios peak velocities early passive ventricular filling active atrial filling within hours transfusion parameters returned toward normal range addition significant changes found fetal heart rate values transfusion fall cardiac output significantly related amount expansion feto placental volume,C13,0.011733289,0.0017840791,0.003752784,0.010821061,0.002800602,0.04703659,0.12712745,0.050574087,0.06958836,0.0019761713,0.056482907,0.004136792,0.3046113,0.01486842,0.0017686426,0.0031319347,0.14362954,0.0020719664,0.002290104,0.019132094,0.11789862,0.00071412185,0.0020690998
repair uterine cavity hysteroscopic septal incision performed follow hysteroscopy multiple biopsies different intervals surgery women underwent hysteroscopic septal incision seven days operation sectioned areas evident epithelialized patients days incised zone depressed scattered epithelialization subjects month sectioned surfaces still depressed uniformly covered thin endometrium cases months uterine cavity almost normal minimal tendency central fundal adhesions women thus spontaneous healing processes hysteroscopic metroplasty progressed regularly completely probably reason delay attempts pregnancy longer two cycles surgery,C13,0.0032923254,0.0029574402,0.08541168,0.0018498234,0.0045844587,0.020142337,0.091273405,0.03496903,0.018306911,0.042138267,0.07111952,0.006771684,0.049996752,0.008497051,0.0029786483,0.0051308307,0.23505759,0.035694476,0.0037487969,0.07047345,0.20104954,0.0011689852,0.003387023
cryopreserved thawed semen vitro fertilization results fertile donors infertile patients evaluated vitro fertilization ivf outcome cycles using cryopreserved thawed semen fertile donors controls ivf patients matched time frame female age stimulation protocol number pre embryos transferred absence male factor using freshly ejaculated normal semen samples study group controls respectively post thaw swim motility fertilization rate preovulatory oocytes ongoing pregnancy rate pr per transfer similar excellent fertilization rate frozen thawed semen achieved high concentration insemination x motile sperm ml use frozen thawed samples infertile men normal subfertile samples pr similar fertilization rate lower cryopreserved semen valuable option infertile couples ivf therapy,C13,0.0031427313,0.0027877595,0.021066425,0.0017657725,0.004376154,0.0040558586,0.13038203,0.0029554626,0.0022720548,0.003087918,0.09623942,0.03109747,0.16658461,0.007840626,0.0027805066,0.004893886,0.11277726,0.034361582,0.003578462,0.23709205,0.12251295,0.0011158697,0.0032331261
use rectus abdominis myocutaneous flaps following excision vulvar cancer rectus abdominis myocutaneous flaps used women following radical excision extensive vulvar cancer two women procedure part primary surgery recurrence vulvar cancer three symptomatic palliation fifteen grafts took primary healing thirteen patients alive months median months surgery three died benefited symptomatic palliation simultaneous vulvar reconstruction allows good cosmetic rehabilitation important part armamentarium management patients advanced primary recurrent vulvar carcinoma technique offers excellent surgical clearance massive offensive painful vulvar tumors,C13,0.0035165958,0.003119396,0.006561603,0.0019758318,0.055961277,0.0045383503,0.24585584,0.0033070494,0.0025423423,0.003455262,0.0199006,0.05830574,0.03915796,0.00808574,0.0030924056,0.005476071,0.40629536,0.0036215107,0.004004162,0.056764558,0.059595995,0.0012486154,0.0036177442
effect maternal ethanol infusion placental blood flow fetal glucose metabolism sheep intravenous infusion g ethanol min hr seven catheterised pregnant ewes decreased blood flow sides placenta reductions blood flow maintained least hr infusion ethanol ceased although blood flow reduced fetal blood gases unchanged plasma glucose concentrations unchanged ethanol fetal glucose supply consumption decreased following maternal ethanol infusions maintained chronic alcohol consumption changes could contribute growth retardation seen fetal alcohol syndrome,C13,0.0032955038,0.018869713,0.006147548,0.017784745,0.00458775,0.019420618,0.13441896,0.0030983654,0.0980683,0.0032372256,0.015587419,0.023794465,0.32211423,0.0077519366,0.0028972665,0.05406878,0.036655385,0.0034287816,0.0037514882,0.06885917,0.14760308,0.0011698244,0.0033894547
alterations phospholipase activity luteal regression pseudopregnant pregnant rats activity phospholipase measured microsomes prepared ovaries superovulated pseudopregnant rats spontaneous prostaglandin f alpha induced regression regression pregnant rats microsome samples incubated c min tris buffer ph mm cacl added substrate radiolabeled phosphatidylcholine incorporated liposomes spontaneous regression significant fold increase phospholipase activity compared levels mid pseudopregnancy days elevation correlated significant decrease plasma progesterone concentration day pseudopregnancy treatment rats luteolytic doses prostaglandin f alpha also caused significant increase phospholipase activity remained elevated throughout h sampling period pregnant rats small significant rise phospholipase activity parturition results indicate activity phospholipase increases luteal regression pregnant pseudopregnant rats could involved mechanism causes loss progesterone secretion,C13,0.025161995,0.002089788,0.015784947,0.001323676,0.0032804958,0.047993805,0.0996323,0.0022155032,0.0017032003,0.0023147957,0.033641472,0.01624493,0.07354365,0.0056231525,0.002071706,0.08867548,0.025410352,0.00245538,0.0026825222,0.045533877,0.47654828,0.0008364893,0.025232183
progesterone induced blocking factor corrects high resorption rates mice treated antiprogesterone earlier showed presence functional progesterone receptors lymphocytes healthy pregnant women produced immunomodulatory protein presence progesterone whereas nonpregnant persons progesterone treated murine pregnancy lymphocytes release similar factor present study reveals biologic significance finding treatment balb c mice days pregnant progesterone receptor blocker ru resulted resorption fetuses simultaneous administration supernatant progesterone treated murine pregnancy spleen cells restored resorption rate original observed untreated control animals data suggest functional lymphocytic progesterone binding sites needed maintenance normal pregnancy blockage progesterone receptors consequent inability lymphocytes produce progesterone induced blocking factor abortion initiated immune factors fact administration preformed blocking factor counteracted effect antiprogesterone treatment suggests progesterone mediated immunosuppression needed maintenance normal gestation,C13,0.002412505,0.002140012,0.005570432,0.0013554881,0.0033705372,0.014006744,0.20511697,0.013908559,0.013340158,0.0023704278,0.07067608,0.0050115376,0.052643605,0.14168666,0.002121496,0.0037567718,0.044725545,0.08588257,0.0027469916,0.05117543,0.272643,0.00085659284,0.002481896
calcium supplementation pregnancy may reduce preterm delivery high risk populations results presented randomized double blinded controlled clinical trial calcium supplementation gm elemental calcium calcium carbonate placebo participants years age less clinically healthy patients enrolled twenty third week gestation mean duration calcium supplementation placebo approximately weeks treatment consisted tablets per day placebo group n tablets per day calcium group n dietary calcium intake similar groups mg day calcium group lower incidence preterm delivery less weeks vs p spontaneous labor preterm delivery vs p low birth weight vs p effect also present stratified analysis level treatment compliance urinary tract infection chlamydial infection life table analysis demonstrated overall shift higher gestational age calcium group compared placebo group log rank test p suggested previously observed effect could mediated reduction uterine smooth muscle contractibility confirmed future research results could represent important preventive intervention prematurity high risk populations,C13,0.001816512,0.01918468,0.020967694,0.0010204981,0.002529289,0.0023440144,0.18404387,0.0017080592,0.0013130953,0.0017846096,0.04696082,0.05766662,0.064866714,0.08017383,0.0015971978,0.0028283382,0.037985,0.0018907187,0.063616626,0.1412536,0.21526696,0.018207287,0.030973973
gamete intrafallopian transfer gift women bicornuate uteri fourteen women bicornuate uteri underwent total gamete intrafallopian transfer procedures patients responded adequately ovarian stimulation eight women conceived two twice five women delivered term three premature delivery one spontaneous abortion ectopic pregnancy neonatal deaths occurred series increase incidence spontaneous abortion noted appeared increase incidence premature labor findings suggest prospects conception infertile women bicornuate uteri treated gamete intrafallopian transfer similar rest infertile population treated center,C13,0.003992004,0.04217535,0.0074486653,0.0022429442,0.005558739,0.0051518893,0.21534762,0.003754129,0.022207856,0.003922378,0.024208846,0.027822984,0.056947198,0.00917885,0.003510617,0.0062163803,0.16138698,0.0041111023,0.023853041,0.2471092,0.11832895,0.0014174156,0.0041068266
ultrasound guided transcervical metroplasty new technique metroplasty described septum divided mm endoscopic scissors introduced uterine cavity cervix whole procedure monitored real time ultrasound scanner twenty four patients operated technique complication encountered fifteen patients third trimester deliveries ongoing pregnancies among patients suffered repetitive pregnancy losses desired pregnancy successfully pregnant beyond second trimester delivered living birth rate results equal obtained hysteroscopic metroplasty procedure short safe requires special equipment necessitate concomitant laparoscopy,C13,0.027904447,0.0033484998,0.0071439273,0.0021209465,0.0052563897,0.04106863,0.15128428,0.0035499353,0.020999677,0.021977745,0.17367317,0.044293832,0.02507755,0.008679597,0.003319527,0.0058782604,0.23904163,0.0038874922,0.004298247,0.10823605,0.09373639,0.0013403199,0.003883449
serum hcg beta core fragment masked associated macromolecules determine beta core fragment present serum individuals pregnancy choriocarcinoma samples analyzed gel filtration fractions assessed immunoassays mr agreement published reports minute amounts beta core fragment detected less hcg level small amount beta core fragment activity identified near void volume column mr greater high molecular weight material pooled dissociated ammonium thiocyanate gel filtration repeated much significant beta core fragment peak detected mr dissociation beta core fragment mol mol hcg level early pregnancy serum mid pregnancy serum term pregnancy serum choriocarcinoma serum pre therapy conclude major form beta core fragment found serum associated macromolecules mask beta core fragment epitope existing hcg beta antibodies measurements made dissociated beta core fragment complex much keeping pregnancy levels found urine,C13,0.0022037989,0.0019548796,0.0041500665,0.022546297,0.00306872,0.024163462,0.20019795,0.002072479,0.0015932485,0.0021653618,0.09837628,0.015190492,0.0946766,0.042205703,0.0019449749,0.003431773,0.0370397,0.012926991,0.013155805,0.056538075,0.237527,0.0007824889,0.122087896
peritoneal fluid fractions patients endometriosis promote two cell mouse embryo growth peritoneal fluid pf infertile patients endometriosis obtained follicular phase cycle laparoscopy promote two cell mouse embryo growth extent observed fluid obtained seven normal controls five molecular weight mw fractions obtained ultrafiltration used media supplement assay compared pf fractions normal controls fractions pf patients endometriosis inhibited mouse embryo growth greater extent normal controls however mw fractions greater daltons showed greater inhibition embryo development fractions less daltons study cell free pf suggests presence humoral factor greater daltons inhibitory mouse embryo growth,C13,0.0028830098,0.0025573736,0.019324416,0.0016198456,0.0040145,0.0037206744,0.11415028,0.0027112174,0.0020842878,0.0028327266,0.034736525,0.0060070795,0.1783428,0.2678549,0.0025437488,0.06682772,0.07083185,0.0029956163,0.003282731,0.046944298,0.15974478,0.001023652,0.0029659343
midtrimester tubal pregnancy markedly elevated maternal serum alpha fetoprotein case report elevated maternal serum alpha fetoprotein levels reported occur variety pathologic conditions including early tubal pregnancy case markedly elevated maternal serum alpha fetoprotein associated midtrimester tubal pregnancy breakdown normal fetomaternal circulatory barrier allowing transplacental exchange alpha fetoprotein likely etiology elevation,C13,0.0043278737,0.0038390402,0.008075364,0.0024316558,0.0060264273,0.005585347,0.22317003,0.02501441,0.0031288601,0.0042523905,0.13046646,0.008901609,0.05223907,0.080439225,0.0038058232,0.0067394,0.040551517,0.0044600386,0.004927921,0.1473893,0.20730662,0.0015366707,0.025384957
clinical review management ovulatory disorders pulsatile gonadotropin releasing hormone pulsatile gnrh therapy yet achieve widespread acceptance alternative exogenous gonadotropin therapy women hypothalamic amenorrhea complete gnrh deficiency however physiologically based replacement regimen pulsatile gnrh used high rate ovulation conception anticipated patients complete gnrh deficiency hypothalamic amenorrhea women polycystic ovarian syndrome may also benefit pulsatile gnrh although rates ovulation lower pretreatment gnrh agonist may improve rates considerably experience limited whether iv sc route administration chosen simplified clinical monitoring protocol created requires minimum patient monitoring assuring maximum safety seventy five nanograms per kg appears reasonable initiating dose subsequent increases respond frequency gnrh administration best based gnrh pulse frequency normal women however information needed determine whether variable frequency clearly superior fixed frequency regimen used appropriately pulsatile gnrh safe effective offers excellent alternative conventional gonadotropin therapy women disordered endogenous gnrh secretion importantly opposed exogenous gonadotropin therapy pulsatile gnrh administered physicians office setting without necessity line e monitoring feature enable patients receive treatment local physicians whereas exogenous gonadotropin therapy administered appropriately equipped referral centers future studies required determine categories patients might benefit pulsatile gnrh,C13,0.0017119104,0.009799838,0.028043987,0.00096185255,0.002384925,0.010427103,0.39513534,0.0016099012,0.0012376349,0.0016820524,0.03754177,0.015494531,0.039135095,0.0039714305,0.009760959,0.035801362,0.1482786,0.0017636723,0.0019492618,0.078024805,0.17288987,0.00060783717,0.001786221
c reactive protein assessing antimicrobial treatment acute pelvic inflammatory disease serial serum c reactive protein crp determinations used evaluation antimicrobial treatment acute pelvic inflammatory disease pid proven laparoscopy endometrial biopsy microbiologic findings upper genital tract women sixteen patients treated ciprofloxacin doxycycline plus metronidazole mean crp levels differ significantly patients severe moderate salpingitis comparison mild salpingitis admission treatment significant difference mean crp levels patients acute chlamydial gonococcal nonchlamydial nongonococcal pid mean crp levels decreased third day treatment treatment groups decrease sixth day treatment significant p less reflecting clinical response therapy faster serial esr determinations documentation acute pid serial serum crp determinations useful predictor short term response antimicrobial therapy,C13,0.002568136,0.014644495,0.01715398,0.0014373251,0.01594504,0.015673878,0.2589769,0.0024059664,0.001849435,0.0025135414,0.09190041,0.017977996,0.1320703,0.00591067,0.0022495803,0.0039835856,0.08401897,0.027402893,0.0029128403,0.04653733,0.2483267,0.0009083093,0.0026317395
comparative study changes insulin like growth factor procollagen iii n terminal extension peptide bone gla protein bone mineral content children turner syndrome treated recombinant growth hormone six girls yr old turner syndrome short stature treated yr recombinant human gh u kg day sc sequential determinations serum insulin like growth factor igf osteocalcin procollagen iii bone mineral content density spine radius measured treatment days two girls received small doses ethinyl estradiol micrograms kg addition gh height velocity increased months treatment igf normal ku l treatment increased day day procollagen iii low treatment peaked micrograms l baseline day decreased normal range serum osteocalcin increased slowly reach plateau day micrograms l baseline treatment bone mineral content spine lower children matched bone age bone mineral contents peripheral axial skeleton increased respectively yr treatment increase commensurate bone age four patients receive estrogen day however although radius mineral density already increased mineral density lumbar spine significantly decreased conclude treatment gh increases igf collagen turnover osteoblastic function height velocity turner syndrome however catch bone mineral content yr treatment early effect gh decrease spine mineral density,C13,0.001739705,0.0015432051,0.003246109,0.017813215,0.002422484,0.010627799,0.12369984,0.0016360396,0.0012577293,0.04095896,0.04185801,0.035726234,0.107245706,0.0041711484,0.0015321447,0.04766399,0.0600631,0.010282829,0.04407398,0.05787115,0.35505924,0.00061770604,0.028889654
serum estradiol aid diagnosis ectopic pregnancy value serum beta hcg measurement diagnosis ectopic pregnancy well established recent studies use serum progesterone levels however unable find reports potential application serum estradiol e assays diagnosis ectopic pregnancy therefore concurrently measured serum e progesterone beta hcg women ectopic pregnancies well controls normal intrauterine pregnancies women threatened abortion mean standard deviation e levels ectopic pregnancy patients normal controls women threatened abortion pg ml respectively mean levels ectopic group significantly different p less two groups one ectopic pregnancies values pg ml e ng ml progesterone one normal intrauterine pregnancies values levels data suggest addition estradiol assay without progesterone early evaluation patients suspected ectopic pregnancy may helpful diagnosis,C13,0.0027275407,0.0024194648,0.018291164,0.0015324939,0.017000925,0.0035200333,0.19084424,0.0025650123,0.0019718905,0.002679969,0.07237592,0.03323694,0.17657803,0.036665924,0.0023985305,0.01744746,0.06711184,0.016214833,0.0031057063,0.06301293,0.23811784,0.00096845056,0.029212842
objective tocodynamometry identifies labor onset earlier subjective maternal perception ability women instructed self detection uterine contractions identify abrupt rise uterine activity known precede onset labor evaluated study designed assess temporal relationship objective uterine activity monitoring subjective maternal perception uterine activity commonly used threshold value four contractions per hour progressive cervical change daily tocodynamometry recorded women preterm premature rupture membranes admission onset spontaneous labor days subjects bed rest received tocolytic therapy instructed signs labor uterine self palpation patients simultaneously provided subjective assessment uterine activity four contractions per hour majority uterine activity recordings revealed fewer four contractions per hour patients subjective reports agreed almost instances days four contractions per hour recorded objectively patients subjective reports agreed instances day labor onset significantly women objective assessment p less equal patients subjectively identified labor onset hours objective monitoring indicated increased uterine activity subjectively identified cervical dilatation cm effacement significantly advanced p less equal compared admission examination cm,C13,0.0018654232,0.010663938,0.021509511,0.0010481052,0.0026048871,0.011773457,0.23777871,0.0017542664,0.0013486178,0.05601646,0.045645356,0.004453238,0.16075678,0.0045328033,0.001640406,0.020952053,0.08760409,0.0019228098,0.0021240585,0.074474216,0.24694811,0.000662344,0.0019203401
evaluation stimulated menstrual cycle magnetic resonance imaging changes uterine zonal anatomy six women cycle treatment clomiphene citrate studied magnetic resonance imaging rapid rate increase endometrial thickness periovulatory period similar pattern seen prior study women normal nonstimulated cycles junctional zone thickness parallel endometrial pattern differed response seen nonstimulated cycles results large scale studies may help understand effects medications,C13,0.003772935,0.0033467815,0.08053838,0.0021198583,0.11525857,0.022432363,0.20548093,0.0035481136,0.002727664,0.0037411214,0.02023452,0.026192367,0.03394151,0.009470347,0.0033178239,0.0058752443,0.039867286,0.003887856,0.0045757177,0.10888826,0.29556125,0.0013396321,0.0038814563
prior cesarean delivery women secondary tubal infertility history cesarean delivery evaluated population based case control study secondary infertility king county washington sixty one married women diagnosed secondary infertility due tubal problems previous viable pregnancy compared married women previous viable pregnancy live birth conceived time infertile women began trying conceive risk tubal infertility substantially elevated women previous cesarean delivery recent viable pregnancy compared women vaginal delivery odds ratio confidence interval,C13,0.003581395,0.0031732037,0.0066747866,0.0020099136,0.004981214,0.004616634,0.13249317,0.0033640938,0.019900084,0.02082685,0.13721447,0.007448354,0.036538824,0.008225214,0.020462008,0.00557053,0.07279231,0.0036839794,0.004073231,0.35662824,0.14079124,0.0012701532,0.003680148
treatment tubal pregnancy local injection methotrexate adrenaline injection mesosalpinx report patients twenty five patients tubal pregnancy treated injection methotrexate mtx tubal swelling vasoconstriction mesosalpinx adrenaline twenty four patients uneventful clinical course one case tube ruptured despite falling serum human chorionic gonadotropin hcg concentrations patients dose mg locally injected sufficient seven patients given additional systemic injections patients high initial serum hcg levels greater miu ml clinical course uneventful side effects mtx adrenaline minimal whether way treatment guarantees better chances fertility future unknown therefore prospective case controlled study comparing fertility rates different ways treatment needed,C13,0.0030489978,0.0027046134,0.005689114,0.0017131076,0.004245633,0.018672977,0.255478,0.0028673145,0.0022042897,0.0029958196,0.058594473,0.10144908,0.08941432,0.0070680426,0.0026812118,0.0047516488,0.21961509,0.0031399624,0.0034717326,0.025609577,0.18036574,0.0010825883,0.0031366965
failure prevent preterm labour delivery twin pregnancy using prophylactic oral salbutamol double blind controlled study performed see whether use prophylactic oral salbutamol would reduce incidence preterm labour twin pregnancy women studied took salbutamol placebo difference found length gestation birthweight fetal outcome although fewer babies suffered respiratory distress syndrome salbutamol group women experience troublesome side effects salbutamol,C13,0.0039938865,0.08084292,0.0074486164,0.0022429295,0.0055587026,0.0051518553,0.18761452,0.0037541043,0.04153097,0.0039223526,0.103223056,0.029997401,0.035237998,0.009239121,0.0035104447,0.0062163398,0.071486,0.0041110753,0.06250779,0.19710815,0.12977758,0.0014174063,0.0041067996
perinatal impact cocaine amphetamine opiate use detected universal intrapartum screening universal urine testing cocaine amphetamines opiates performed women admitted obstetric service year period positive results patients positive toxicology results matched race discharge date patients negative toxicology drug history significant differences age prior obstetric history prenatal care alcohol history smoking noted groups significant decrease birth weight head circumference length gestational age drug positive group marked cocaine multiple drug users differences persisted controlled smoking prenatal care prior preterm births differences birth weight head circumference remained controlled gestational age rates congenital anomalies abruptio placental similar groups perinatal substance abuse independently associated growth retardation prematurity multiple risk factors frequently present necessitating comprehensive approach prenatal care,C13,0.046850707,0.002042531,0.0042964336,0.0012937433,0.0032063131,0.0029716396,0.13533108,0.0021654034,0.012750741,0.0022624505,0.12157581,0.06279531,0.041074634,0.005354627,0.05122562,0.014729087,0.09737177,0.0023713077,0.023381237,0.25569752,0.085801184,0.023080114,0.002370721
effect angiotensin ii infusion normal pregnancy flow velocity waveforms uteroplacental umbilical circulations women destined develop preeclampsia show increased systemic pressor response infused angiotensin ii angiotensin sensitivity test accepted appropriate means identifying women however effect angiotensin ii infusion uteroplacental blood flow unknown may deleterious patients undergoing angiotensin sensitivity tests part protocol examining effect aspirin incidence preeclampsia studied doppler velocimetry performed angiotensin ii infusion fetal well documented biophysical profiles performed infusions neither systolic diastolic ratios uterine umbilical arteries biophysical profile scores altered significantly p p wilcoxon signed rank median test p fisher exact test respectively findings suggest angiotensin sensitivity test increase resistance flow uterine umbilical circulation therefore may used safely screening preeclampsia,C13,0.014291114,0.0021706258,0.040102456,0.0013748788,0.0034073931,0.015002151,0.17895913,0.002301204,0.013602021,0.014245136,0.123972096,0.0152869355,0.24090919,0.005655988,0.0021518446,0.033931006,0.08091017,0.0025206504,0.0027862883,0.07526929,0.12776421,0.00086884666,0.0025174003
hypersecretion luteinising hormone infertility miscarriage relation prepregnancy follicular phase serum luteinising hormone lh concentrations outcome pregnancy investigated prospectively women regular spontaneous menstrual cycles group included nulliparous multiparous women various obstetric histories women lh concentrations less iu l normal lh group conceived whereas women lh values iu l high lh group high lh group pregnancies ended miscarriage whereas pregnancies normal lh group adverse effect high prepregnancy lh concentration fertility outcome pregnancy seen primigravidae women previously successful pregnancies women history recurrent miscarriage data indicate important role hypersecretion lh conception miscarriage finding offers possibility simple predictive test women pregnancy could also used identify patients endocrine abnormality remedied,C13,0.0023820377,0.0021129863,0.01596429,0.0013383698,0.003316912,0.0030741438,0.17906749,0.0022400972,0.0017221073,0.0023404919,0.122242175,0.062559694,0.062114608,0.0055964156,0.025157023,0.015237698,0.0629514,0.002455062,0.0027123003,0.20104183,0.2210761,0.00084577507,0.0024509972
home monitoring gonadotropin ovulation induction using ovarian monitor safe use gonadotropins relies close hormonal ultrasound monitoring assess response treatment requiring multiple hospital visits home monitoring ovarian monitor st michael research foundation macleod victoria australia minimizes hospital visits overcomes many logistic difficulties associated gonadotropin use utilizes system homogenous enzyme immunoassay using lysozyme conjugates measure quantitatively either urinary estrone pregnanediol glucuronide results obtained patients cycles using ovarian monitor home correlate closely results obtained laboratory estrone glucuronide r pregnanediol glucuronide r cycle outcomes ovulation cycle clinical pregnancy cycle multiple pregnancy pregnancy hyperstimulation cycle different achieved laboratory monitored patients home monitoring safe effective laboratory monitoring offers significant social benefits improves access form therapy,C13,0.0025270807,0.0022416466,0.086843275,0.0014198635,0.0035188799,0.0032613294,0.3667292,0.002379244,0.0018269669,0.0024830052,0.15556195,0.005347669,0.03909168,0.006122927,0.0022222511,0.016162435,0.10679066,0.0026024743,0.002877453,0.10062173,0.08586991,0.0008972746,0.002601109
value hysteroscopy elderly women prior vitro fertilization embryo transfer ivf et comparative study two hundred eighty four hysteroscopies performed candidates vitro fertilization embryo transfer ivf et divided two groups group consisted elderly women years group ii women age although visualization revealed uterine abnormalities patients abnormal findings significantly increased former group comparison latter p less difference attributed mainly uterine rather cervical pathology furthermore elderly women age related uterine pathology submucous myomata endometrial hyperplasia polyps prominent younger patients uterine lesions adhesions tubal ostia occlusion common moreover treatment prior ivf et resulted clinical pregnancies group clinical pregnancies group ii failed one three cycles previously seems hysteroscopic evaluation may reduce ivf et failure rate due intrauterine abnormalities elderly well young patients thus becomes absolute prerequisite patients scheduled ivf program,C13,0.013515329,0.012904356,0.025884889,0.023072183,0.026452942,0.0029075735,0.24437486,0.0130200125,0.0016287961,0.0022136741,0.049340982,0.08448946,0.07163117,0.005868214,0.001981204,0.0035083408,0.09969225,0.0023224666,0.0028396035,0.24873333,0.0605001,0.00079994736,0.0023183604
observations doubling time human chorionic gonadotropin early asymptomatic pregnancies doubling time dt human chorionic gonadotropin hcg serum investigated retrospectively using serial serum hcg values obtained asymptomatic pregnant women prior history infertility dt hcg increase significantly pregnancy advanced period gestation serum hcg concentration less miu ml international reference preparation serum hcg concentrations increased subnormally women normal intrauterine pregnancies women asymptomatic ectopic pregnancies eps asymptomatic women subsequently aborted pregnancies neither sensitivity specificity serial hcg testing ep enhanced adopting different test criteria different serum hcg concentrations,C13,0.00300546,0.0026659928,0.0056078765,0.016234597,0.004185008,0.0038787026,0.1421719,0.002826371,0.0021728138,0.0029530409,0.21155497,0.006181744,0.11525457,0.0070692543,0.017190961,0.004680126,0.033486694,0.0030960988,0.0034221583,0.08575844,0.32244417,0.0010671297,0.0030919064
prenatal diagnosis congenital cytomegalovirus infection virus isolation amniotic fluid cytomegalovirus isolated antenatally amniotic fluid two pregnant women cases prenatal diagnosis fetal virus infection aided subsequent management mother newborn infant,C13,0.00578153,0.0051285056,0.03877486,0.0032484059,0.036028743,0.007461366,0.21211766,0.005437021,0.032156184,0.005680693,0.19398122,0.011891503,0.035788734,0.013317578,0.005084132,0.009003045,0.05351965,0.0059540174,0.03455323,0.14880836,0.07230591,0.0020528112,0.06192489
congenital perinatal cytomegalovirus infections cytomegalovirus common cause congenital perinatal viral infections throughout world congenital infection occurs live births developed countries even higher percentage developing nations result transmission birth breast milk blood transfusion perinatal infections much prevalent congenital infections vast majority infections chronic subclinical forms symptomatic infections sufficiently prevalent dangerous represent major unsolved public health problem throughout world review epidemiologic clinical immunologic therapeutic facets cytomegaloviral infections pregnant women offspring discussed,C13,0.0035230175,0.0031250922,0.006573585,0.0019794398,0.07311897,0.0045466376,0.4866039,0.0033130883,0.0025469847,0.0034615716,0.031565256,0.0072461735,0.09512146,0.008568489,0.0030980527,0.0054860706,0.08337099,0.0036281238,0.038091227,0.086295076,0.043859582,0.0012508954,0.0036263166
ectopic pregnancy adolescents clinical review pediatricians pediatricians caring sexually active female adolescents young adults need aware history symptoms signs ectopic pregnancy thorough history physical examination including pelvic examination well specific diagnostic tests repeated quantitative hcg measurements ultrasonography indicated crucial proper early diagnosis nonruptured ectopic pregnancy manageable laparoscopy key early diagnosis include ectopic pregnancy differential diagnosis sexually active female patient abnormal vaginal bleeding abdominal pain early diagnosis close observation appropriate management outcome likely favorable minimal morbidity risk death,C13,0.0033469955,0.002968952,0.0062451465,0.01807106,0.020400196,0.0043194722,0.34848237,0.019339904,0.0024197288,0.020607922,0.13453344,0.00688413,0.03772582,0.007982609,0.035348862,0.021683492,0.08996007,0.0034468505,0.0038110467,0.14076851,0.06701937,0.0011883965,0.0034456823
small cell neuroendocrine carcinoma bartholin gland small cell neuroendocrine carcinoma arose bartholin gland year old woman reported tumor light electron microscopic immunohistochemical features typical pulmonary small cell carcinoma metastatic inguinal lymph nodes presentation first reported example tumor occurring bartholin gland,C13,0.031905774,0.0048552025,0.010212846,0.0030752951,0.06061763,0.007126954,0.23248819,0.11113176,0.003957044,0.0053779627,0.025171679,0.037455987,0.033987943,0.09207977,0.031289525,0.008523263,0.08809074,0.005636722,0.0062323012,0.07380485,0.11940426,0.0019434149,0.005630859
role tubal pathology parameters ectopic pregnancies occurring vitro fertilization embryo transfer contradictory findings reported concerning role tubal disease genesis ectopic pregnancy vitro fertilization embryo transfer ivf et report six ectopics occurred ivf et pregnancies six cases among patients tubal disease none occurred remaining patients etiological factors correlation found parameters including ovulation induction number embryos transferred luteal support comparison ectopics six matched controls demonstrated similar estradiol levels beta hcg levels day et lower homolateral salpingectomy performed six cases contralateral resection carried three comprehensive studies needed clarify whether tubal pathology really increases risk ectopic gestation ivf et,C13,0.003099963,0.0027498219,0.0057842094,0.0017417427,0.0043169786,0.0040006638,0.27204767,0.0029152427,0.0022411353,0.0030458958,0.11923075,0.007016253,0.031697474,0.0077547105,0.002742555,0.019828029,0.07874806,0.0031924478,0.0035297638,0.18069836,0.2243238,0.0011006843,0.018193778
current concepts beta endorphin physiology female reproductive dysfunction beta endorphin role regulation normal menstrual cycle possibly onset puberty reviewed evidence pointing alteration neuropeptide may contribute pathogenesis various reproductive dysfunctions elevated high levels beta endorphin associated exercise associated amenorrhea stress associated amenorrhea polycystic ovarian syndrome depressed low levels beta endorphin associated pms menopause alterations levels beta endorphin may change pulsatile release gnrh via noradrenergic dopaminergic pathways primarily focused beta endorphin representative endogenous opioid peptides opioid peptides may also contribute pathogenesis various types reproductive dysfunction perhaps become possible characterize hone understanding function beta endorphin substances composing endogenous opioid peptides better understanding role physiological well pathophysiological processes may allow development rational approaches treatment specific disorders pertaining reproduction many questions remain unanswered among relevant precise mechanism action beta endorphin exerts influence pulsatile gnrh release functional relationship cns peripheral serum levels beta endorphin detected changes beta endorphin levels merely associated cause particular disorder since took almost years time prostaglandins first discovered eventual realization clinical application may take time beta endorphin story complete,C13,0.009908521,0.009719853,0.0031669093,0.00095364015,0.0105168335,0.018614687,0.34494975,0.001596123,0.0012270428,0.009881594,0.030077843,0.0034909374,0.07790505,0.077291295,0.009706482,0.052839894,0.034619473,0.0017482773,0.018281233,0.05435847,0.22679158,0.00060263503,0.0017518887
reappraisal need autologous blood donation obstetric patient recent interest autologous blood donation obstetric patients little attention paid whether programs needed whether patients require transfusion accurately predicted university california san diego medical center july dec deliveries women received blood transfusions traditionally accepted risk factors identified patients four requiring transfusion among patients delivered repeat cesarean section one required blood one multiple gestations two eight patients placenta previa none grandmultiparous women transfusions data suggest autologous blood donation may beneficial cost effective low frequency blood transfusions high risk obstetric population difficulty accurately predicting likely require transfusions considered,C13,0.0030951141,0.0027455208,0.005775162,0.0017390185,0.0043098484,0.003994406,0.13051581,0.017888892,0.017217332,0.0030411314,0.093836844,0.025024202,0.13193731,0.0071166237,0.0027217653,0.03477563,0.2893408,0.0031874545,0.031094287,0.1452308,0.041128937,0.0010989626,0.0031841395
transplantable rat choriocarcinoma cells express placental lactogen identification placental lactogen immunoreactive protein messenger ribonucleic acid purpose investigation evaluate abilities transplantable rat choriocarcinoma rcho produce placental prls rcho tumor analyzed biochemically histologically expression placental prls expression placental prl mrnas determined northern blot situ hybridization analyses expression placental prl proteins determined western blot immunocytochemical analyses histologically rcho tumors characterized appearance giant cell surrounding hemorrhagic regions female rats bearing rcho tumor beneath kidney capsule showed extensive mammary gland development rcho tumors expressed placental lactogen pl mrna protein evidence placental lactogen ii pl ii prl like protein plp prl like protein b plp b rcho pl mrna proteins migrated kilobase species kda species similar expressed normal rat trophoblast tissues cell type responsible rcho pl production giant cell similar observed normal rat trophoblast tissues summary demonstrated production pl transplantable rat choriocarcinoma rcho rcho tumor resembles rat trophoblast tissue early postimplantation stages days gestation may useful tool studying placental prl expression trophoblast differentiation,C13,0.021060947,0.0017498282,0.0036807375,0.0011084082,0.060088113,0.002545792,0.13519622,0.02094671,0.0968853,0.0019382325,0.024002708,0.004069103,0.015204862,0.07061198,0.001734688,0.0030718073,0.028787553,0.11867324,0.0022461384,0.045335766,0.2491018,0.000700412,0.09125963
establishment ovum donation program using simple fixed dose estrogen progesterone replacement regimen ovum donation od programs involve cycle synchronization recipient donor normally cycling recipients complex estrogen progesterone replacement regimen recipients ovarian failure serhal craft suggested use fixed dose estrogen progesterone regimen recipients normally ovulatory ovarian failure following protocol simplifying still authors administered mg estradiol valerate e daily orally starting day induced withdrawal bleeding augmented mg progesterone ethyl oleate p intramuscularly daily starting time days prior day oocyte pickup recipients underwent embryo transfer pronuclei pn cell stage group patients underwent treatment cycles resulting pregnancies twelve patients gave birth one triplets two twins nine singletons four patients miscarried first trimester pregnancy,C13,0.0024993785,0.038512908,0.030075327,0.0014042989,0.0034803054,0.0032255782,0.2346775,0.0023504458,0.0018069395,0.002465179,0.047591496,0.018420305,0.089924365,0.017979763,0.0021978905,0.0038920522,0.14516585,0.0146651715,0.02517999,0.05527559,0.24372002,0.00088743854,0.014602238
menorrhagia excessive vaginal bleeding menorrhagia one common presenting symptoms gynecologic patients although disorder many possible etiologies generally possible approach diagnosis management orderly fashion evaluating menorrhagic patient important gear work toward differential diagnosis includes pregnancy related causes hormonal problems iatrogenic etiologies mechanical intrauterine disorders infections lower genital tract gynecologic cancers phimic differential approach guide types historical data obtained patient focus physical examination alert practitioner appropriate laboratory radiologic evaluation therapy differ widely depending cause bleeding types menorrhagia respond medical therapy oral contraceptives oral synthetic estrogens progestins long acting intramuscular progestins gnrh agonists surgical approaches dilatation curettage hysterectomy less less first line therapy innovative surgical techniques hysteroscopy laparoscopic surgery becoming increasingly important rapid goal directed diagnosis specific therapy medical complications anxiety discomfort suffered woman menorrhagia alleviated quickly,C13,0.0022038154,0.0019548943,0.004113302,0.0012382857,0.013788031,0.034795783,0.46717018,0.0020724947,0.0015932604,0.0021679576,0.072229676,0.0365262,0.035427287,0.0051825037,0.0019379796,0.01409742,0.116232306,0.0022695644,0.002509368,0.1245582,0.054881033,0.0007824948,0.002267982
genetic familial predisposition eclampsia pre eclampsia defined population familial predisposition patterns genetic inheritance eclampsia pre eclampsia investigated three four generations families homogenous island population iceland families descended index women delivered years either eclampsia n severe pre eclampsia n inheritance followed sons daughters prevalence pre eclampsia eclampsia daughters significantly higher daughters law difference noted prevalence diseases whether daughter born eclamptic pre eclamptic mother whether first later born daughter non significantly higher occurrence pre eclampsia among grand daughters grand daughters law difference seen whether grand daughters descended sons daughters increasing numbers affected daughters grand daughters probability rose finding affected women family hypotheses single recessive dominant gene inheritance compared maximum likelihood estimates gene frequency obtained single recessive gene model reflecting population prevalence whereas dominant model incomplete penetrance gave gene penetrance corresponding population prevalence homozygous expression severe disease heterozygous expression milder disease either genetic model could fit data,C13,0.0020996958,0.0018559746,0.0039040148,0.0011755781,0.0029134615,0.022949532,0.11677235,0.0019676243,0.0015126398,0.0020558077,0.07763917,0.015449207,0.16820562,0.03795353,0.0018399159,0.003273761,0.029106136,0.002154722,0.01235736,0.26992,0.118570015,0.0007428997,0.10558102
rate rise corticotrophin releasing factor endogenous digoxin like immunoreactivity normal abnormal pregnancy maternal plasma concentrations corticotrophin releasing factor crf endogenous digoxin like immunoreactivity edli estimated normal abnormal pregnancies sampled sequentially weeks gestation delivery slope fitted woman antenatal edli crf values rose significantly gestation mean slopes normal abnormal groups value compared evidence significant mean differences groups edli evidence significant mean difference crf p less adjustment variables may affect pregnancy outcome slopes crf found significantly related outcome,C13,0.0032406566,0.002874624,0.0060467287,0.0018207927,0.0045125117,0.004182236,0.19229387,0.0030475527,0.033660464,0.0031841353,0.13935463,0.039180662,0.2763729,0.0076542348,0.0028497516,0.036408093,0.031333797,0.0033405435,0.003689964,0.109387,0.09108037,0.0011506394,0.003333868
corpus luteum function early pregnancies primarily determined rate change human chorionic gonadotropin levels regulation human corpus luteum activity studied radioimmunoassays bioassays sera drawn serially women suspected ectopic pregnancies progesterone values exhibited considerable overlap pregnancies subsequently classified normal intrauterine n ectopic n spontaneous abortion n rate change human chorionic gonadotropin concentration significantly correlated progesterone levels ectopic r pregnancies r correlation r rate change human chorionic gonadotropin bioactivity produced per volume serum ectopic pregnancies normal intrauterine pregnancies differ ratio vivo bioactivity immunoactivity data conclude corpus luteum activity primarily regulated rate change human chorionic gonadotropin concentration without involvement serum factors also conclude reduced corpus luteum function ectopic pregnancies result biochemical modification human chorionic gonadotropin molecule finally discourage use single progesterone values screening ectopic pregnancies considerable overlap progesterone values among normal intrauterine pregnancies,C13,0.0026237422,0.0023273902,0.017608836,0.0014741737,0.0036534779,0.0033860758,0.14948061,0.002467399,0.0018968488,0.027971486,0.08769062,0.005396575,0.21426903,0.008454696,0.0023072527,0.016777622,0.027692365,0.030083954,0.0029875163,0.08380889,0.3039932,0.0009315955,0.0027165902
basal body temperature endometriosis investigation examined association pelvic endometriosis altered basal body temperature bbt study population consisted infertile women diagnosed endometriosis significant association found presence pelvic endometriosis without previous treatment appearance late decline bbt early follicular phase menstrual cycle temperature greater degrees f first days menses associated pelvic endometriosis findings study support early clinical diagnosis endometriosis infertile women basal body temperature chart analysis may useful clinical adjunct endometriosis suspected,C13,0.0033453791,0.002967518,0.07190498,0.001879632,0.0046583344,0.004317386,0.3165744,0.019334385,0.018582568,0.0032870313,0.050095476,0.0068808054,0.038699012,0.007985205,0.051000584,0.021401644,0.05358892,0.0034451857,0.0038092062,0.14997768,0.16162705,0.0011878225,0.003449823
morphological immunological study human placental bed biopsies miscarriage placental bed biopsies examined three groups pregnant women maternal vascular response placentation well presence cells associated local immunosuppression activity group women undergoing legal abortion histological appearance trophoblastic invasion normal one proportion immunosuppressor cells also normal missed miscarriage group histological appearances abnormal except one patient women history recurrent miscarriage miscarried immunization placentation normal defective others immunosuppressor cells appeared diminished number although correlation cytotoxic status sera pregnancy outcome,C13,0.003345613,0.0029677255,0.03863278,0.034258366,0.00465866,0.004317688,0.17086783,0.046741273,0.034761533,0.0032872611,0.041738454,0.07166809,0.039678536,0.106483705,0.019136861,0.0052098148,0.063748844,0.00345179,0.0038094723,0.13941555,0.15711659,0.0011879056,0.003515656
continuous interrupted fascial closure prospective evaluation maxon suture gynecologic procedures month period using long term absorbable suture maxon patients entered prospective randomized trial fascial closure patients randomized continuous closure patients interrupted en bloc patients technique patient subjected preoperative intraoperative protocol wound management acute wound failures wound infection rates risk hernia apparently affected closure technique,C13,0.00407038,0.043014333,0.007664977,0.0022869804,0.025371866,0.005253037,0.16375457,0.0038278345,0.0029427034,0.0039993874,0.027458314,0.009197421,0.0466759,0.00935906,0.0035793893,0.006338428,0.45919254,0.0041918163,0.043217544,0.050129212,0.07284164,0.001445244,0.004187457
intrapartum cocaine use case report use cocaine pregnancy appears reaching epidemic proportions first reported case intrapartum cocaine use fetal heart rate abnormalities detected,C13,0.007184657,0.0063731493,0.013405825,0.0040367655,0.010004408,0.009272174,0.24104995,0.041531533,0.039963577,0.0070593474,0.13409422,0.049546413,0.075606294,0.016628867,0.006318006,0.011188005,0.08799595,0.0073990053,0.008180789,0.113260336,0.09994084,0.0025510106,0.0074088946
twin pregnancy diagnosis treatment ectopic implantation retrograde selective salpingography intraluminal methotrexate injection case report patient right tubal pregnancy managed new procedure combining retrograde salpingography local mtx injection twin pregnancy occurred shortly treatment conclude retrograde tubal cannulation may provide alternative method diagnosis treatment selected eps,C13,0.004422122,0.003922643,0.008251221,0.00248461,0.006157665,0.005706979,0.24740247,0.04697113,0.0031969973,0.0043449947,0.13163935,0.094721995,0.028247066,0.010167824,0.0038887025,0.0068861637,0.25709543,0.0045540524,0.0050352365,0.028571183,0.09021278,0.0015701349,0.004549316
features near death experience relation whether patients near death medical records patients believed near death illness injury later remembered unusual experiences occurring time examined patients judged close death would died without medical intervention patients danger dying although thought patients groups reported closely similar experiences patients really close death likely report enhanced perception light enhanced cognitive powers claim enhancement cognitive functions despite likelihood brain function probably become disturbed possibly diminished deserves investigation,C23,0.036931362,0.0030667782,0.006450922,0.0019425036,0.0048141503,0.0044617974,0.2307991,0.003253104,0.0024994581,0.0033969788,0.015899638,0.024093732,0.026900014,0.008279983,0.0030402432,0.005383701,0.29263362,0.0035604234,0.00393662,0.17684689,0.13702469,0.0012275538,0.0035567202
premenstrual syndrome update clinician premenstrual syndrome complex disorder variety symptoms occur luteal phase menstrual cycle symptoms occur cycle time near ovulation soon onset menses least week follicular phase symptom free symptoms severe enough significantly interfere ability patient function within normal lifestyle diagnosis based clinical information prospective charting symptoms per cent patients think pms really suffer another type mental illness usually depressive disorder laboratory tests generally helpful diagnosis treatment based type symptom available treatments reviewed documentation results double blind placebo controlled experimental designs etiology pms known however good empiric therapies available help pms patients,C23,0.0026950624,0.02844632,0.032351807,0.001512379,0.003747942,0.037793852,0.4064534,0.0025311958,0.0019458936,0.022253014,0.05710901,0.0055375923,0.031710003,0.0063870433,0.0023669088,0.043263644,0.1082913,0.0027743224,0.034141827,0.046539478,0.11842162,0.0009556828,0.0027706774
muscle maximal uptake constant delivery without co blood present study investigated effects carboxyhemoglobinemia hbco muscle maximal uptake vo max hypoxia uptake vo measured isolated situ canine gastrocnemius n working maximally isometric twitch contractions hz min muscles pump perfused identical blood flow arterial po pao total hemoglobin concentration hb blood containing either control hbco conditions pao set torr produced arterial contents muscle blood flow set ml g min delivery conditions minimize co diffusion tissues perfusion hbco containing blood limited time contraction period vo max se ml min g n hypoxemia alone reduced ml min g hbco present n p less cases mean muscle effluent venous po pvo torr pao pvo conditions mean capillary po estimate mean driving pressure probably much different two conditions even though dissociation curve shifted left hbco consequently blood mitochondria diffusive conductance likely reduced hbco,C23,0.014809475,0.001855875,0.024150876,0.001175515,0.0029133053,0.022886584,0.12969771,0.012088154,0.10279778,0.0020556974,0.029890878,0.014504266,0.29265693,0.042993173,0.0018398451,0.034403488,0.026119707,0.0021546066,0.0024469304,0.029389651,0.18599,0.02098386,0.0021956982
liver transplantation shadow side relatively large number patients liver disease liver transplant always provide successful solution confrontation modern technology mean involved interviewed relatives patients died turned transplant shortly liver transplant operation performed groningen liver transplant programme quantitative data obtained means questionnaire one third respondents opinion patient would better entered programme half found loss difficult accept patient involved programme nevertheless many feeling satisfaction everything possible done however fruitful transplantation technology may specific group patients also involves undesirable side effects included careful judgement technology,C23,0.0028406954,0.0575206,0.01904998,0.0015960708,0.003956372,0.0036660654,0.28774172,0.0026714243,0.0020536962,0.01653927,0.047541503,0.03334376,0.01990288,0.0070089437,0.0024980358,0.058093563,0.3294386,0.0029254453,0.0032345494,0.05450613,0.039937556,0.0010086277,0.002924508
comparison ketorolac trometamol morphine sulphate pain relief cholecystectomy ketorolac trometamol mg compared morphine sulphate mg cholecystectomy double blind multiple dose randomized study patients assessments pain made immediately operation day next morning day pain intensity verbal response score visual analogue scale recorded injection h period pain relief assessed also effect ketorolac operative blood loss platelet function examined time commencing oral intake duration administration v fluids recorded adverse events noted ketorolac produced significantly less analgesia morphine day day two drugs produced similar effect blood loss increased ketorolac although platelet function impaired repeated administration ketorolac produce serious adverse effects,C23,0.0025903604,0.0022977788,0.004833344,0.013983507,0.0036069949,0.015866728,0.14656267,0.0024360062,0.0018727153,0.0025451812,0.020475844,0.051577825,0.10909158,0.005963112,0.014812631,0.01656552,0.08243503,0.015195539,0.019530814,0.072419025,0.3917532,0.00091974286,0.0026648673
surveillance situ infrainguinal bypass grafts conventional vs color flow duplex ultrasonography surveillance situ saphenous vein bypass grafts duplex scanning detects graft abnormalities may lead graft thrombosis correction defects grafts still patent potentially improves overall graft patency study compared color flow conventional duplex determine whether color flow provided additional information obtainable conventional duplex examination primary patency rate patency maintained without intervention cases secondary patency rate patency maintained identification correction graft defects failure duplex scanning reduced graft failure rate color flow conventional duplex examination provided information regarding incipient graft failure patients monitored techniques number proximal distal anastomoses imaged number graft defects three vein graft stenoses one proximal femoral artery stenosis identified velocity data obtained using two techniques peak systolic velocity area stenosis duplex velocity ratio always making calculation percent stenosis data inaccurate color flow duplex useful monitoring graft patency provides additional information provided conventional scanning,C23,0.012437238,0.042800386,0.003959778,0.011376139,0.04382111,0.0027276475,0.23837566,0.0019876088,0.0117565375,0.0020814342,0.18359305,0.0043471702,0.12294475,0.0051897774,0.0018586033,0.0032912383,0.18868223,0.002176607,0.0024065885,0.041078985,0.070181675,0.0007504451,0.0021753625
anatomical relationship renal venous arrangement kidney collecting system anatomical relationships renal venous arrangement pelviocaliceal system studied dimensional polyester resin corrosion endocasts cases large venous trunks venous trunks joining form main renal vein intrarenal veins demonstrated free anastomoses disposed systems longitudinal arcades stellate arcuate interlobar veins large venous collars around caliceal necks also horizontal arches crossing calices link anterior posterior veins cases upper caliceal group encircled anteriorly posteriorly venous plexuses coursed parallel infundibulum cases lower caliceal group also enriched venous plexuses close relationship existed large inferior tributary renal vein anterior aspect ureteropelvic junction cases cases posterior retropelvic vein vein close relationship junction pelvis upper calix crossed middle posterior surface renal pelvis,C23,0.038755555,0.014287976,0.009760005,0.037308946,0.0034794738,0.0032221999,0.19673502,0.18467574,0.0018050469,0.0024532143,0.13338204,0.029310053,0.044153303,0.013314072,0.0021955885,0.0038879758,0.035301074,0.0025740531,0.014916286,0.039833482,0.18517485,0.0008865091,0.0025875405
neurodevelopmental performance low birth weight infants mild periventricular intraventricular hemorrhage outcome years age neurodevelopmental outcome low birth weight neonates birth weight less g followed prospectively birth years age assess neurodevelopmental sequelae mild periventricular intraventricular hemorrhage grades ii neonates screened periventricular intraventricular hemorrhage days age eleven incurred mild periventricular intraventricular hemorrhage group periventricular intraventricular hemorrhage group infants neurodevelopmentally normal years age children matched race age sex socioeconomic status control children group born term outcome measurements years age groups scored significantly lower group combined test measurements three four individual measurements group scored significantly lower group combined test measurements data indicate low birth weight infants risk learning problems although children mild periventricular intraventricular hemorrhage demonstrate significant deficit individual test scores significant difference combined battery suggests mild periventricular intraventricular hemorrhage adverse effect global performance,C23,0.0020708812,0.001836975,0.013847422,0.0011635437,0.0028841372,0.00267258,0.09273125,0.0019474818,0.0014971549,0.032111473,0.061229404,0.115416124,0.2145205,0.0047901347,0.0018518902,0.0032247927,0.02817663,0.0021332281,0.0023580028,0.30121142,0.06936988,0.04082467,0.0021304463
nitrous oxide epinephrine induced arrhythmias asked whether sympathomimetic effect nitrous oxide n predisposed patients receiving n arrhythmias response epinephrine administration also asked whether aging contributed development arrhythmias without n one hundred patients transsphenoidal hypophysectomy randomly assigned receive anesthesia including n excluding n n patients given injection epinephrine lidocaine produce hemostasis using intermittent lead continuous lead ii electrocardiography determined incidence premature ventricular contraction isorhythmic atrioventricular av dissociation changes wave morphology patients given n significantly higher incidence isorhythmic av dissociation vs trend toward higher incidence multiple premature ventricular contractions vs statistically significant anesthetic groups high incidence postoperative changes wave morphology n group vs group given n aging alone affect incidence ventricular ectopic beats isorhythmic av dissociation changes electrocardiographic morphology correlated development ventricular ectopy n anesthesia conclude use n correlated higher incidence isorhythmic av dissociation response injection epinephrine lidocaine,C23,0.002159672,0.022808196,0.0040556956,0.0012134317,0.003007275,0.0027871693,0.15551913,0.0020309817,0.0015613468,0.0021220047,0.016075743,0.08465195,0.058837514,0.0051717297,0.0018991611,0.045149643,0.17377184,0.0022241042,0.0024591044,0.14532547,0.19171593,0.0007668211,0.07468612
long term echocardiographic follow patients tricuspid bioprosthesis clarify long term results bioprosthetic valve function tricuspid position consecutive patients underwent tricuspid valve replacement tvr evaluated girls women boys men ages ranging years mean years bioprosthetic valves included hancock carpentier edwards follow period ranged months mean months regurgitant flow tricuspid bioprosthesis studied color doppler echocardiography peak velocity vp pressure half time pht measured continuous wave doppler echocardiography operative mortality actuarial survival rate including operative deaths years valve thrombosis developed one patient years tvr color doppler showed regurgitation patients completely followed asymptomatic required special intervention cusp tear calcification requiring reoperation observed study including patients younger years age vp significantly slower pht significantly prolonged tricuspid rather mitral position data demonstrate bioprosthetic valves tricuspid position used safely doppler examination performed taking different flow dynamics account,C23,0.010690718,0.0016409857,0.021553267,0.0010394037,0.029488258,0.0023874391,0.12833968,0.0017397024,0.019228207,0.0107642235,0.03060313,0.0038051624,0.09908488,0.004296468,0.019417658,0.0028807353,0.42638427,0.0019298571,0.0021064244,0.13721369,0.042845882,0.0006568451,0.0019031462
profound digital collagen atrophy new cutaneous presentation adrenal dependent cushing syndrome year old caucasian housewife presented year history marked loss tissue substance finger toe pulps heel pads clinical evidence history urticaria inflammatory change investigations demonstrated raised plasma cortisol secondary left adrenal adenoma skin biopsies showed abnormalities dermal collagen evidence elastin destruction case presents unusual variant cutaneous atrophy associated cushing syndrome,C23,0.0036421567,0.0032307748,0.059645317,0.03730681,0.0580146,0.004700393,0.2895241,0.0034251283,0.0026331171,0.038835257,0.035770163,0.0074912203,0.037107233,0.008488278,0.03846634,0.0056715957,0.07295043,0.0037508176,0.0041471315,0.043607518,0.23655151,0.0012931975,0.0037469165
bilateral phrenic nerve palsy associated open heart surgery incidence phrenic nerve palsy open heart surgery estimated usually unilateral cause symptoms bilateral phrenic nerve injury coronary artery bypass surgery rare complication case report describes patient developed bilateral phrenic nerve palsies required prolonged ventilatory support denervation hemidiaphragms documented needle electromyography four weeks bypass surgery patient required total ventilatory support three months partial ventilatory support additional three months case demonstrates usefulness electromyographic screening documentation prognostication phrenic nerve injury cause lesion unclear hypothermia stretch leading hypotheses patient developed phrenic nerve palsies despite using cardiac insulation pad,C23,0.031637315,0.002627136,0.0055261413,0.0016640333,0.018479567,0.0038221702,0.28822458,0.031456046,0.0021411448,0.0029177105,0.061068982,0.006091559,0.03820708,0.007429567,0.0026045747,0.004611913,0.32634532,0.0030500137,0.0033722802,0.047527723,0.064085886,0.044062395,0.0030468416
late luteal phase dysphoric disorder young women authors determined prevalence late luteal phase dysphoric disorder university women aged years unaware focus premenstrual syndrome pms participants rated dsm iii r symptoms late luteal phase dysphoric disorder days using greater premenstrual change index luteal variation authors found women met symptom criteria two menstrual cycles compared young women seeking treatment pms met diagnostic criteria women university sample reported significantly less fatigue impaired concentration somewhat less severe depression overall symptoms,C23,0.0029634493,0.0026273103,0.03419264,0.0016641438,0.0041242847,0.08984905,0.19849443,0.0027853614,0.002141287,0.0029606652,0.11405645,0.006092059,0.12142773,0.006844011,0.0026045777,0.004612219,0.11592316,0.01737662,0.01769284,0.16366737,0.083801605,0.001051646,0.003047044
effects endotracheal suctioning mixed venous oxygen saturation heart rate critically ill adults purpose multisite study determine effects endotracheal suctioning mixed venous oxygen saturation svo heart rate critically ill adults one pass intermittent suction applied fewer seconds three prehyperoxygenation three posthyperoxygenation breaths oxygen subjects three hospitals n underwent suctioning using hyperoxygenation anesthesia bags traditional suction catheters open suction method subjects one hospital n underwent suctioning hyperoxygenation ventilator line suction catheters closed suction method subjects hospital sites combined svo decreased p change baseline returned baseline within minutes however subjects receiving open method suction svo dropped immediately suctioning returned baseline within minutes contrast closed suction method used svo rose immediately suctioning drifting upward next minutes dropping toward baseline minutes mean heart rate increased baseline beats min beats min immediately suctioning p change baseline gradually returned baseline next minutes significant differences seen heart rate subjects open versus closed suction method conclusion closed suction method showed higher svo endotracheal suctioning compared open suction method p form hyperoxygenation endotracheal suctioning recommended,C23,0.0019352783,0.0017166884,0.0037059598,0.0010873539,0.002700024,0.021217981,0.11489789,0.0205513,0.0013991201,0.0019015246,0.12117598,0.004423719,0.3973577,0.0045571593,0.001701835,0.012372636,0.12423363,0.0019999703,0.002203599,0.017598778,0.1385812,0.000687147,0.0019935078
high dietary fiber low saturated fat intake among oligomenorrheic undergraduates numerous functional risk factors associated occurrence secondary amenorrhea young women less known regarding factors associated prevalent problem oligomenorrhea evaluated nutrient intake body composition perceived psychological stress hour urinary cortisol urinary c peptide ucp eumenorrheic mildly oligomenorrheic oligomenorrheic nonathletic undergraduate women nutrient intake evaluated validated food frequency questionnaire oligomenorrheic women found consume significantly dietary fiber crude fiber polyunsaturated fat significantly less saturated fat eumenorrheic classmates oligomenorrheic women significantly lower hour ucp excretion mildly oligomenorrheic women groups differ aspect body composition body weight age menarche perceived psychological stress urinary cortisol excretion data suggest higher intake fiber lower intake saturated fat may associated oligomenorrhea among otherwise healthy undergraduate nonathletic women,C23,0.0024668165,0.0021881892,0.064296976,0.013319305,0.0034349638,0.003183555,0.1095188,0.014252393,0.0017833984,0.002423792,0.014415524,0.017018108,0.112642445,0.057312552,0.07325319,0.015761804,0.03155576,0.002540412,0.014737218,0.33757782,0.102901116,0.00087587687,0.0025399663
effects prostaglandin superoxide dismutase catalase ischemia reperfusion injury liver transplantation study evaluated effects prostaglandin analogue apgi superoxide dismutase sod catalase cat hepatic injury warm ischemia reperfusion terms survival mitochondrial function serum enzymes histology hepatic ischemia created rats clamping hepatoduodenal ligament min splenofemoral bypass reperfusion induced unclamping vessels disconnecting splenofemoral bypass apgi ng kg min infused min hepatic ischemia sod cat units kg administered immediately start reperfusion serum enzyme mitochondrial function assessments livers made ischemia hr reperfusion survival rate also assessed separate group rats liver enzymes sgot sgpt ldh showed correlation liver viability administration apgi alone showed effect ischemically injured mitochondria however free radical scavengers sod cat combination apgi showed significant improvement mitochondrial function together extension survival ultrastructure hepatocytes better preserved treated groups agents improved viability ischemic reperfused injured livers,C23,0.049063966,0.0021372067,0.027809508,0.0013537111,0.0033583469,0.014730047,0.13785377,0.0022682978,0.0017418471,0.0023673202,0.012897787,0.029490814,0.07646916,0.017482694,0.0021187149,0.10304226,0.11223492,0.002481223,0.0027433906,0.07007051,0.32495043,0.0008554699,0.0024786424
use jarvik total artificial heart symbion ventricular assist device bridge transplantation proliferation transplantation programs paralleled similar increase availability organ donors orthotopic heart transplantations performed loyola university medical center period patients died awaiting donor organ reduce mortality began using total artificial heart tah ventricular assist device vad bridge transplantation patients underwent transplantation patients required tah three patients required vad bridge underlying heart conditions ischemic cardiomyopathy patients dilated cardiomyopathy patients giant cell myocarditis patient allograft failure patient average duration mechanical support days range days patients successfully underwent transplantation patient died days acute rejection transplanted heart another patient died days cerebral vascular event fifteen patients long term survivors nine patients required reoperation bleeding mechanical device place activated clotting time maintained seconds heparin dipyridamole given conclude tah vad excellent mechanical bridges transplantation,C23,0.029951327,0.038849454,0.0128366025,0.0010778854,0.0026713477,0.06711588,0.10050699,0.0018107808,0.0013869368,0.0018849664,0.0093043735,0.0040303865,0.024723103,0.022978608,0.0016871233,0.0029873885,0.45771918,0.02983142,0.00847852,0.0693129,0.108200066,0.0006811634,0.0019736062
effects spermatic vascular division correction high undescended testis testicular function orchiopexy division spermatic artery veins commonly used technique correcting high undescended testis although longterm results clearly defined left spermatic artery veins adult wistar albino rats divided preserving vessels associated vas cremaster muscle dt sham operation performed left testicle six additional rats st weeks postoperatively testes rats removed testes viable bled incised although bleeding considerably reduced testes dt mean testicular weights dt mg compared mg st rats p less mg contralateral testes mean tubular diameter dt mu compared mu st testes p less testicular biopsy score based upon morphology spermatic tubules dt testes st testes p less compared contralateral testes absolute normal value morphologic abnormalities observed contralateral unoperated testes rats contralateral testes additional rats removed dt mean testosterone values rats one testicle ng ml three weeks dt testosterone values ng ml p less concluded division main spermatic artery vein rats produces testicular atrophy spermatogenic arrest interstitial cell dysfunction although collateral blood flow testis may demonstrated tissue perfusion inadequate normal spermatogenesis endocrine function,C23,0.025565786,0.0014575814,0.011017028,0.000923235,0.010218156,0.0021206075,0.12549935,0.047439516,0.009141989,0.0095594125,0.051374346,0.018794674,0.1674855,0.012095198,0.009367762,0.0025587708,0.08379305,0.0016927286,0.0018710005,0.024916198,0.28539336,0.000583433,0.09713131
acute hypervolaemia increases gastroduodenal resistance flow liquid rat effect volume expansion extracellular fluid gastroduodenal resistance flow isotonic saline assessed three groups rats using intravenous infusions isotonic isotonic isoncotic isotonic isoncotic isohaemic solutions gastroduodenal segment male wistar rats barostatically perfused constant pressure gradient cm h changes flow ml minute taken reflection changes gastroduodenal resistance isotonic expansion led drop gastroduodenal flow compared normovolaemic period animals p less extracellular fluid expansion isotonic isoncotic isotonic isoncotic isohaemic solutions associated reductions gastroduodenal flow p less p less respectively increase gastroduodenal resistance due hypervolaemia per se haemodilution decreases plasma oncotic pressure electrolyte imbalance effect hypervolaemia gastroduodenal resistance reversed small haemorrhages ml per g body weight may due changes tonus phasic motor activity may part homeostatic processes help organism minimise liquid volume excess,C23,0.0020948274,0.0018558205,0.003903691,0.04166269,0.0029132203,0.08368196,0.13170244,0.001967461,0.0015125143,0.0020575009,0.010813881,0.059445493,0.377312,0.005111024,0.0018397631,0.0032586085,0.02074449,0.0021545433,0.0023941759,0.03922087,0.19133697,0.0007428381,0.012273192
observations haemopoietic response critical illness peripheral blood cytopenias common patients receiving intensive care particularly multiple organ failure assess contribution bone marrow hypoplasia patients bone marrow samples patients intensive care studied standard morphological techniques granulocyte macrophage colony forming cell gm cfc assay frequently observed morphological abnormalities bone marrow included following reduction overall cellularity seven patients progressive decrease patients studied sequentially ii increase number actively phagocytic macrophages iii disruption normal bone marrow architecture accumulation intercellular hyaluronic acid glycosaminoglycan mean gm cfc growth significantly reduced compared group normal controls four five patients studied sequentially gm cfc growth became subnormal association reduction bone marrow cellularity inhibitory serum factors identified morphological abnormalities similar changes observed gelatinous degeneration bone marrow situations disruption haemopoietic microenvironment accumulation hyaluronic acid proteoglycan may important factor inhibition haemopoietic progenitor cell growth proliferation macrophages release variety cytokines reactive oxygen intermediates may also implicated impaired haemopoiesis development disordered erythropoiesis,C23,0.0018164302,0.03677003,0.003388851,0.027376518,0.0025290085,0.019895662,0.20926426,0.019290425,0.0013130357,0.0017845286,0.037486292,0.02028229,0.051212687,0.103673585,0.0015971253,0.029199416,0.10087257,0.084464155,0.0020680171,0.026294125,0.21690685,0.0006448686,0.0018692593
computerized laboratory alerting system computerized laboratory alerting system clas developed part ongoing effort improve quality care lds hospital system identifies potentially life threatening conditions basis laboratory findings generates appropriate warnings transmits clinicians use system led significant increase proportion patients life threatening situations received appropriate care implementation vs afterward p less among patients hypokalemia falling potassium levels hyperkalemia hypokalemia treatment digoxin hyponatremia falling sodium levels hypernatremia hypoglycemia hyperglycemia average length time spent life threatening situation decreased hours p less average length stay decreased days p less little change proportion patients findings indicating metabolic acidosis received appropriate care vs conclude clas important role patient care hospital,C23,0.002498519,0.002216311,0.0046619773,0.0014038159,0.0034791084,0.0032244688,0.29358375,0.0023496374,0.013773435,0.0024549416,0.025492134,0.007728667,0.11625137,0.0057458673,0.014256059,0.100652926,0.13226719,0.0025730603,0.017070197,0.08532224,0.15953676,0.0008871333,0.0025703842
retroperitoneal mobilization vas deferens complex vasovasostomy anatomic distances along retroperitoneal inguinal infrainguinal segments vas deferens measured formalin fixed cadavers recently postmortem males significant differences segment lengths two groups right left vasa data recent postmortem group reveals mean length cm gained retroperitoneal mobilization vas deferens information important surgical decisions cases microsurgical repair obstructive azoospermia resulting damage inguinal segment vas deferens data vasal segment lengths beneficial planning repair complex cases obstructive azoospermia well,C23,0.0037732732,0.0033470816,0.0072517,0.0021200483,0.04430233,0.023125112,0.18770312,0.021812374,0.0027279085,0.0037074627,0.057980403,0.04581423,0.10139172,0.008675921,0.0033181214,0.0058757714,0.12200085,0.003893862,0.0042964267,0.07859816,0.26306254,0.0013397522,0.0038818044
rhodopsin mutants bind fail activate transducin rhodopsin member family receptors contain seven transmembrane helices coupled g proteins nature interactions rhodopsin mutants g protein transduction gt investigated flash photolysis order monitor directly gt binding dissociation three mutant opsins alterations cytoplasmic loops bound cis retinal yield pigments native rhodopsin absorption spectra failed stimulate guanosine triphosphatase activity gt opsin mutations included reversal charged pair conserved g protein coupled receptors cytoplasmic border third transmembrane helix mutant cd replacement amino acids second cytoplasmic loop mutant cd deletion amino acids third cytoplasmic loop mutant ef whereas mutant cd failed bind gt mutants cd ef showed normal gt binding failed release gt presence guanosine triphosphate therefore appears least second third cytoplasmic loops rhodopsin required activation bound gt,C23,0.0027273684,0.0024193118,0.018743379,0.001532397,0.003797774,0.003519811,0.22068062,0.0025648503,0.001971766,0.0026797997,0.051615745,0.0056096753,0.018482678,0.036361493,0.015580546,0.0042604236,0.05803589,0.28506133,0.0162977,0.05979809,0.11035668,0.0009683894,0.07693429
flumazenil ketamine midazolam anaesthesia double blind parallel group study using flumazenil placebo carried determine whether patients received flumazenil would awake quickly whether drug would reverse protection conferred midazolam psychic sequelae ketamine fifty female patients studied results showed significant reduction awakening time p significant increase p incidence dreams flumazenil group,C23,0.004616557,0.026422443,0.008614017,0.0025938551,0.00642841,0.028206324,0.15793602,0.0043414664,0.0033375653,0.0045360387,0.02509344,0.07108715,0.044143766,0.010614891,0.004059684,0.0071889395,0.1092319,0.0047542886,0.07227256,0.15730053,0.21848917,0.0016391717,0.02709178
evaluation level blood warmer series level blood warmer series comprises three infusion sets two blood warmers different power outputs systems found extremely efficient larger series capable warming equivalent units blood hour almost body temperature,C23,0.0048322203,0.0042864205,0.055799436,0.0027150277,0.05373608,0.0529448,0.184133,0.0045442786,0.0034934804,0.00474794,0.08355319,0.0100502875,0.16469358,0.011212743,0.024301881,0.0075347214,0.04197371,0.0049763857,0.0055721747,0.031501133,0.23671053,0.0017157459,0.0049712104
reproducibility growth hormone testing procedures comparison hour integrated concentration pharmacological stimulation purpose study compare reproducibility two approaches evaluation gh secretion integrated concentration gh ic gh physiological test gh secretion pharmacological stimulation tests ic gh determined poorly growing children twice within weeks first second ic gh highly correlated r p less one hundred thirteen poorly growing children underwent pharmacological gh stimulation tests twice within weeks moderate correlation found first second pharmacological test r p less among three pharmacological stimuli studied clonidine n highest reproducibility followed arginine n insulin n conclude ic gh consistently reproducible gh response repeated pharmacological stimulation,C23,0.0027644401,0.015826147,0.0051581585,0.0015532261,0.017230947,0.003567654,0.107361846,0.002599713,0.001998567,0.029482616,0.10026738,0.005685925,0.08207826,0.033623513,0.0024309787,0.01768447,0.11187427,0.0028469148,0.02989777,0.020405218,0.40183648,0.0009815522,0.002843954
monitoring platelet interactions prosthetic graft implants canine model study shows prosthetic arterial grafts stimulate platelets long year implantation canine model carotid distal aorta dacron dupont wilmington de grafts x cm tunneled subcutaneously right dorsal side allowing percutaneous arterial sampling thromboxane b txb levels evaluated proximal anastomosis w x z cm distal w platelet counts mean platelet volumes monitored sites w z txb levels increased blood entered graft progressively increased blood exited distal anastomosis platelet counts significantly change across graft time systemic platelet counts decreased approximately dog pregraft baseline levels remained depressed year period mean platelet volumes peaked weeks implant remained greater pregraft levels examination graft luminal surface showed developed pseudointima characteristically similar develops mature human vascular grafts results suggest healed vascular grafts canines continue stimulate platelet release txb reduce systemic platelet counts increase mean platelet volumes year data suggest platelets stimulated graft consumed,C23,0.0021966016,0.03159651,0.014264754,0.0011522794,0.00285572,0.0026467068,0.1369151,0.017094156,0.011307873,0.002015064,0.0430907,0.03404393,0.19192722,0.03554806,0.0018034509,0.0031935736,0.0764563,0.0021178098,0.0023351752,0.02335317,0.36124253,0.0007281763,0.0021150957
postoperative bile duct strictures bile duct strictures uncommon serious complication primary operations gallbladder biliary tree strictures occur result injury bile duct cholecystectomy addition strictures occur site previous biliary anastomoses reconstruction biliary tree patients benign bile duct strictures present soon initial operation however cases presentation delayed years cholangiography essential defining anatomy biliary tree prior management many cases nonoperative biliary drainage useful treat sepsis biliary fistulas number alternatives exist elective repair bile duct strictures experience would suggest however choledochojejunostomy hepaticojejunostomy performed roux en limb jejunum preferable management cases postoperative biliary stenting may valuable optimizing results nonoperative management percutaneous transhepatic endoscopic balloon dilatation reported successful number small series long term results limited however comparative data suggest surgical repair benign postoperative strictures associated fewer long term problems similar overall morbidity costs,C23,0.013752096,0.013472755,0.004393156,0.012705386,0.014650716,0.014383837,0.3859603,0.02496714,0.0017021613,0.013708206,0.05253617,0.004858697,0.015700478,0.0056319465,0.0020704423,0.015056032,0.31977177,0.0024279496,0.0026808856,0.038225353,0.03808634,0.000835979,0.0024221695
filler dna associated spontaneous deletions maize determined structure five spontaneous deletions within maize waxy wx gene four found spontaneous wx mutants wx b wx b wx b wx c include exon sequences fifth restricted intron represents restriction fragment length polymorphism nonmutant allele wx w deletions range size base pairs bp cluster g c rich region approximately bp capable forming stable secondary structures striking finding alleles dna insertions filler dna bp deletion endpoints three five deletions filler dna sequences deletion termini appear derived sequences near one deletion endpoint previously reported spontaneous deletion maize bronze gene bz r also contains filler dna association filler dna maize deletion endpoints contrasts dramatically rarity similar events animal germ line bacterial mutations,C23,0.0026918335,0.0023877907,0.0050226822,0.0015124315,0.003825308,0.0034739515,0.17564838,0.0025318225,0.0019460758,0.0026448846,0.013069848,0.005572035,0.01849658,0.0063707554,0.0023671305,0.0041917446,0.040899698,0.05810513,0.0030650485,0.035487074,0.22786212,0.0009557723,0.38187194
cochlear implant flap complications series patients received cochlear implants patients suffered flap complications problems encountered involved postauricular flap usually minor nature none required explantation direct result complications flap ischemia patient cogan syndrome vasculitis two cases suture extrusion one exposure implant case receiver unit magnet extrusion repaired vascularized pericranial flap based upon temporalis muscle presented flap design patients postauricular incisions demands special consideration principles useful avoiding complications well management discussed,C23,0.021251608,0.0032288777,0.04201593,0.0020451776,0.00506861,0.004713401,0.3126576,0.003423117,0.020252898,0.0035765315,0.084835604,0.008383776,0.02253238,0.06186044,0.00320094,0.0056682653,0.21795219,0.003748615,0.004144696,0.12065095,0.04375122,0.0012924381,0.0037447163
antibodies nuclear lamin c chronic hepatitis delta virus infection sera patients chronic hepatitis delta virus infection stained nuclear periphery indirect immunofluorescence using proteins isolated nuclei isolated nuclear matrices nuclear pore complex lamina fraction purified lamins c antigen source immunoblotting experiments nuclear lamin c identified reactive antigen sera tested recognized nuclear lamin c exclusively nuclear lamins b antibodies reacting nuclear lamins c share extensive sequence homologies reported occur autoimmune hepatitis primary biliary cirrhosis present findings suggest novel autoantibody associated chronic hepatitis delta virus infection recognizes epitope localized short carboxyterminal region nuclear lamin c,C23,0.0031423606,0.0027874308,0.0061610145,0.0017655643,0.0043756375,0.00405538,0.40268677,0.018119352,0.0022717868,0.003087554,0.05400951,0.0067858584,0.019584432,0.09850873,0.0027690604,0.004893309,0.04182411,0.039508834,0.0035780398,0.07791121,0.04778187,0.0011157381,0.15327641
massive allografts salvage revisions failed total knee arthroplasties ten patients failed total knee arthroplasties severe bone loss treated massive whole distal femur proximal tibial allografts combination prosthetic implants fourteen allografts inserted either invaginated segmental grafts rigidly fixed host bone clinically roentgenographically grafts seemed united host bone average range motion degrees five patients developed complications two involved allograft nonunion fracture two caused inadequate healing ligament allograft junction one patient late infection careful planning improved surgical techniques complications avoided massive allograft prosthesis composite techniques viable reconstructive alternative worthy clinical trials,C23,0.0037878535,0.0033469617,0.0070554535,0.020373244,0.005270745,0.023119206,0.15975513,0.0035483046,0.0027278108,0.0037073295,0.094337925,0.0077606235,0.06389644,0.026936151,0.0033183396,0.0058755605,0.27346006,0.0038857064,0.022561224,0.09034941,0.16970512,0.0013397041,0.0038816652
psychosocial correlates temporomandibular joint pain dysfunction study examines psychological differences temporomandibular joint pain dysfunction tmjpd patients pain controls healthy controls two hundred two patients classified according diagnostic criteria eversole machado either myogenic facial pain n internal derangement type n internal derangement type ii n internal derangement type iii n patients completed basic personality inventory illness behavior questionnaire multidimensional health locus control perceived stress scale ways coping checklist subjects also answered question pertaining tmjpd symptomatology including chronicity severity conservative treatment simple jaw exercise ultrasound patients contacted months complete follow questionnaires similar previously completed comparison groups comprised patients attending outpatient physiotherapy clinics pain related injuries involving temporomandibular joint pain free healthy students data analyzed using multivariate statistics results indicate significant relationship pain intensity extent chronicity diverse measures personality among pain controls among tmjpd patients calls question validity assuming individual pain disorders subsets larger homogenous pain disorder population tmjpd patients pain controls score higher hypochondriasis anxiety pain free controls elevations clinically significant elevations decrease normal levels response positive treatment outcome differences tmjpd patients pain controls measures results suggests tmjpd patients appear significantly different pain patients healthy controls personality type response illness attitudes towards health care ways coping stress,C23,0.009520454,0.009334641,0.0030414336,0.0009159677,0.0022701006,0.0021036158,0.19968362,0.009365619,0.0011784263,0.017363233,0.057151623,0.02938179,0.20422041,0.020934556,0.025104245,0.010423662,0.14440422,0.0016789354,0.033413175,0.058750775,0.14905378,0.00057875813,0.010126945
myod induces growth arrest independent differentiation normal transformed cells myod gene involved control muscle differentiation show myod causes growth arrest expressed cell lines derived tumors transformed different oncogenes myod induced growth inhibition demonstrated reduction efficiency colony formation single cell level show myod growth inhibition occur cells induced activate muscle differentiation markers inhibitory activity myod mapped amino acid segment necessary sufficient induction muscle differentiation basic helix loop helix motif mutants alterations basic region myod fail bind activate muscle specific enhancer inhibited growth mutants deletions helix loop helix region failed inhibit growth thus inhibition cell growth myod seems occur means parallel pathway one leads myogenesis conclude myod prototypic gene capable functionally activating intracellular growth inhibitory pathways,C23,0.0020509693,0.0018193121,0.003826896,0.001152356,0.022495601,0.022488859,0.13275306,0.0019290937,0.041199293,0.0020151979,0.010730795,0.004241394,0.057194114,0.22169408,0.0018035707,0.03409537,0.027152376,0.08346426,0.0023353302,0.013979199,0.19307818,0.0007282247,0.117772445
alien hand sign localization lateralization recovery alien hand sign first described brion jedynak feeling estrangement patient one hands affected hand frequently shows grasp reflex instinctive grasp reaction well elements denny brown referred magnetic apraxia associated frontal lobe damage notably however affected hand observed perform apparently purposive behaviors perceived outside volitional control patient patients interpret behavior affected limb controlled external agent feel initiating controlling behavior hand often express dismay hand extravolitional activity patients attempt control behavior alien hand unimpaired hand forcibly restraining affected limb act may termed self restriction paper report additional four cases alien hand sign right handed subjects two involving right hand two involving left hand case clinical findings associated extensive unilateral damage medial frontal cortex hemisphere contralateral affected hand furthermore alien movement gradually disappears course months stroke clinical case studies presented discussed context dual premotoer systems hypothesis anatomicophysiological model proposes action organized two separate interactive premotor brain systems corresponding evolutionarily defined medial lateral cortical moieties hypothesized alien mode behavior results unconstrained activity lateral premotor system damaged hemisphere residual volitional control limb occurs activity intact medial premotor system ipsilateral hemisphere recovery may occur extension ipsilateral control mechanisms compensatory changes subcortical systems controlling hemispheric activation associated adaptive behavior observation may important understanding mechanisms involved motor recovery stroke,C23,0.017873414,0.0013883928,0.010875208,0.0008745852,0.019142173,0.017058713,0.30516535,0.03913853,0.0011253463,0.024132252,0.042627215,0.00337416,0.05573406,0.09093747,0.0013688272,0.0099556735,0.07896492,0.009134059,0.0017724083,0.05020295,0.20927207,0.000552689,0.009329504
demonstration area slow conduction human atrial flutter ten patients chronic atrial flutter studied prospectively using electrophysiologic mapping pacing techniques assess mechanism atrial flutter presence area slow conduction atria electrograms recorded greater equal right atrial sites patient atrial flutter demonstrated right atrial free wall activation craniocaudal interatrial septum activation caudocranial consistent reentrant circuit involving right atrium six patients slow conduction occurred atrial flutter inferior right atrium spatially associated fractionated electrographic recordings four patients missing interval electrical activity occurred inferior right atrium average atrial flutter cycle transient entrainment criteria demonstrated patient rapid high right atrial pacing mean activation time high right atrial pacing site coronary sinus inferior left atrial recording site long ms consistent activation area slow conduction rapid pacing atrial flutter coronary sinus site transient entrainment criteria could demonstrated mean activation time coronary sinus pacing site high right atrial recording site relatively short ms consistent orthodromic activation high right atrium area slow conduction high right atrial pacing sinus rhythm rates similar atrial flutter demonstrated short activation time coronary sinus low right atrial sites mean ms respectively indicating activation traverse area slow conduction coronary sinus pacing sinus rhythm demonstrated phenomena low right atrial electrograms recorded sinus rhythm rapid pacing sinus rhythm fractionated although atrial flutter thus atrial mapping pacing data complementary indicating human atrial flutter patients studied generated reentrant circuit right atrium area slow conduction low right atrium present atrial flutter,C23,0.0017455834,0.0015308171,0.011613798,0.0009696227,0.010733238,0.002227157,0.2630753,0.010684401,0.0012476329,0.010045924,0.04102114,0.0035703422,0.041880045,0.004576393,0.0015175719,0.0026873355,0.12745713,0.0849828,0.0019650084,0.05294373,0.31277218,0.008964797,0.0017880411
systolic wall stress ventricular arrhythmia role acute change blood pressure isolated working rat heart effect sudden acute change blood pressure upon arrhythmia provocation studied isolated working heart model wistar kyoto strain rat twenty four hearts studied perfused two different modified krebs henseleit solutions fixed left atrial pressure acute changes pressure increases decreases arrhythmogenic whilst ectopic activity predictably produced pressure reductions consisted simple ventricular ectopics pressure increases contrast capable provoking complex sustained arrhythmias effect pressure changes highly dependent upon electrolyte concentrations perfusate low potassium magnesium concentrations increased amount arrhythmia provoked pressure increases tended reduce provoked pressure reductions conclude direct effect acute change pressure upon myocardium arrhythmogenic however myocardial response pressure change interdependent upon prevailing electrolyte concentrations,C23,0.002071843,0.0018376894,0.0038875472,0.0011639962,0.0028847582,0.0026736197,0.14362916,0.012833472,0.0014977372,0.0020355538,0.009553359,0.014282469,0.2607607,0.004821612,0.01184846,0.003226047,0.09264629,0.0021334938,0.00235892,0.048314232,0.37267214,0.0007355807,0.002131275
constipation pathophysiology treatment although many physicians consider constipation trivial problem one frequent chronic digestive disorders united states affecting million people causing considerable morbidity million spent counter laxatives untold millions dollars spent prescription drugs medical services manage disorder successful management requires appreciation magnitude problem understanding colorectal function clear assessment causes careful examination patient anorectal anatomy improvement patient dietary habits first steps management therapeutic options include behavioral modification strategies diet lifestyle changes pharmacologic therapy rarely surgical intervention,C23,0.003242616,0.0028763623,0.006050385,0.0018218936,0.020187398,0.023579657,0.4278623,0.0030493953,0.002344267,0.03457148,0.073413976,0.0066694412,0.027575795,0.023133978,0.0028514746,0.0050494275,0.123015314,0.0033393567,0.03507757,0.10129539,0.06850531,0.0011513351,0.0033358838
influence postmortem time temperature osteoinductive activity demineralized microperforated ethylene oxide sterilized syngeneic bone implant rat bone morphogenetic protein labile easily inactivated many extracorporeal factors crucial establish whether delay retrieval donor bone ambient holding temperature donor body influence osteoinductivity bone left situ ten adult rats killed five kept degrees five room temperature femurs harvested hours processing segments implanted four week old syngeneic rats days level osteoinduction evaluated histologically excellent degrees group hour specimens less advanced hours bone taken room temperature group showed findings identical kept degrees hours osteoinduction less advanced hours absent hours bone formed hours either temperature group following observations made osteoinductivity demineralized bone left situ death unexpectedly stable retrieval time extended donor cooling microperforated demineralized bone actively induced new bone formation ethylene oxide inhibit osteoinduction correctly applied sterilization confirmed humans retrieval bone used osteoinduction could delayed hours particularly donor immediately refrigerated would increase effective number bone tissue donors utilize undeveloped resource,C23,0.001800521,0.001597152,0.031443864,0.0010116394,0.0025071688,0.011005896,0.15239206,0.023647713,0.0013016965,0.019199539,0.13997427,0.031927854,0.09977781,0.051377263,0.008110761,0.0028037857,0.06789088,0.066437684,0.002050158,0.06483729,0.21639928,0.0006392996,0.0018664048
effect motion artefact pulse oximeters evaluation four instruments finger probes ability ohmeda nellcor n datex satlite plus simed pulse oximeters detect induced hypoxaemia presence motion artefact assessed conditions controlled vibration using industrial vibration facility vibration hz hz induced increases detection time hypoxaemia spurious decreases displayed sao oximeters tested finger dependent differences oximeter performance pulse rate registration noted especially oximeters without ecg linkage ohmeda simed subsequently eight different pulse oximeter finger probes assessed characteristics may predispose motion artefact marked differences mass probes forces exerted test finger force required displace probes subject finger differences microprocessor programmes physical characteristics finger probes may explain observed differences function similar studies form part standard evaluation new pulse oximeters,C23,0.0025928733,0.002300008,0.02992966,0.0014568297,0.10400957,0.003346238,0.33362994,0.0024383694,0.02697464,0.0025476501,0.06300859,0.0056170556,0.047249615,0.006253157,0.0022801072,0.004037643,0.046518624,0.0026786008,0.0029523675,0.08776179,0.21882297,0.00092063507,0.002673045
effects stress gastric mucosal prostaglandin generation intact adrenalectomized sham operated rats study effects cold restraint stress b adrenalectomy association cold restraint stress gastric mucosal ulceration prostaglandin generation performed two experiments first rats divided four groups rats unstressed b stressed h c stressed h stressed h second experiment another rats divided four groups rats adrenalectomy plus cold restraint stress h b adrenalectomy plus stress c sham operated plus h stress sham operated plus stress experiments recorded ulcer index measured mucosal generation prostaglandin e pge prostaglandin keto pgf conclusion cold restraint stress associated time dependent decrease gastric mucosal pge generation change keto pgf generation increase mucosal injury maximal h b adrenalectomy augments effects stress mucosal injury effect prostaglandin generation thus ulcerogenic effect adrenalectomy appears independent effect prostaglandin generation,C23,0.10046768,0.0020043433,0.0042750677,0.0012695551,0.0031463671,0.002916081,0.20480388,0.0021249184,0.012568159,0.0022201512,0.012350446,0.124499805,0.037487872,0.006165885,0.13325503,0.0035321491,0.031051628,0.0023269732,0.0025728424,0.040847063,0.2669873,0.000802288,0.002324553
effect electrocautery wound healing midline laparotomy incisions effect electrocautery midline fascial wound healing studied sprague dawley rats midline wound tensile strength significantly reduced fascia incised coagulation current compared cutting current scalpel addition tissue necrosis inflammation well adhesion formation incision abdominal viscera extensive animals incisions made using coagulation current results study indicate use electrocautery coagulation current associated increased tissue damage significant reduction tensile strength healing wounds contribution electrocautery wound complications patients needs evaluation,C23,0.0039926567,0.0035410428,0.0074485308,0.0022429037,0.02488284,0.005151796,0.19567433,0.03300048,0.0028859891,0.04256538,0.019802762,0.008246457,0.04822089,0.009375862,0.0035104041,0.083517656,0.12519199,0.004111028,0.004545402,0.03039399,0.33617347,0.00141739,0.0041067526
isoenzymes aldehyde dehydrogenase human lymphocytes types isozymes aldehyde dehydrogenase aldh present human lymphocytes investigated using isoelectric focusing polyacrylamide gels followed substrate specific staining lymphocytes obtained individuals found contain types ii aldh group typical individuals reported develop marked facial flushing rapid heart rate drinking alcohol develop erythema cutaneously applied ethanol lymphocytes obtained atypical individuals suffer alcohol induced flushing rapid heart rate developed erythema cutaneous ethanol displayed type ii type aldh lymphocytes thus appear easily accessible suitable tissue determining type aldh phenotype,C23,0.0034004427,0.0030163624,0.025576422,0.0019109033,0.004735009,0.037301287,0.4281616,0.01965049,0.0024583687,0.0033411346,0.027273882,0.0234562,0.08008896,0.033312667,0.0029902635,0.0052951965,0.051580485,0.0035018923,0.0038719042,0.06266412,0.17162159,0.0012073737,0.0035834378
localization human angiogenin gene chromosome band q proximal cell receptor alpha delta locus gene encoding angiogenin potent inducer blood vessel formation localized within human genome present single copy per haploid genome located chromosome basis discordancy analysis human rodent hybrid cell lines localization refined q situ hybridization angiogenin probe metaphase chromosomes prepared normal human lymphocytes rpmi cells results rpmi cells also establish angiogenin gene resides proximal translocation breakpoint within cell receptor alpha delta locus therefore upstream locus avaii rflp present frequency unselected collection human placental dnas identified coding region gene results single silent transversion,C23,0.0026270647,0.0023303377,0.0049018306,0.0014760406,0.0036581045,0.0033903639,0.19736986,0.0025174594,0.014556143,0.0025812455,0.07078023,0.018104581,0.034280386,0.089644544,0.015010053,0.004090886,0.02464498,0.041522,0.0029912996,0.016929042,0.09671177,0.013643473,0.33623832
spreading depression like depolarization selective vulnerability neurons brief review oxygen withdrawn rat hippocampal slices spreading depression like response occurs earlier larger amplitude ca area dentate gyrus reoxygenation recovery synaptic transmission correlates inversely time spent spreading depression recovery occurs frequently dentate gyrus ca chlorpromazine gangliosides gm agf promote recovery hypoxic depression synaptic transmission ca prevention irreversible loss function correlates closely shortening time spent spreading depression ca withdrawn hypoxia synaptic function recovers upon restoration oxygen ca despite prolonged spreading depression spreading depression lasting minutes induced fully oxygenated slices superfusion high k solution transient recovery followed long lasting loss synaptic function intact brain anesthetized rats synaptic transmission ca recovers spreading depression like depolarization lasting minutes lost irreversibly minutes conclude entry ca neurons caused spreading depression like depolarization important selective vulnerability neurons duration depolarization critical cell survival presence normal blood supply neurons resist protracted spreading depression like depolarization,C23,0.013835382,0.02380725,0.015156293,0.0012671404,0.0031414873,0.014559964,0.11895852,0.002121666,0.0016304549,0.0022159286,0.03141489,0.015548801,0.11084819,0.17664696,0.0019832216,0.0253176,0.07867715,0.0023230116,0.035318695,0.042003818,0.2800901,0.00080076203,0.0023327125
magnetic resonance imaging idiopathic retroperitoneal fibrosis measurement relaxation time magnetic resonance imaging tesla performed nine patients proven idiopathic retroperitoneal fibrosis total scans performed three patients scanned diagnosis one also two follow scans six patients scanned variable time diagnosis treatment scan periaortic soft tissue mass readily identified distribution corresponding seen computed tomography difference mean relaxation time mass patients scanned diagnosis scanned treatment however patient followed serial scans showed progressive reduction value mass time comparison results obtained patients lymphoma suggests values retroperitoneal fibrosis lower lymphoma particularly non hodgkin lymphoma,C23,0.0024665822,0.0021879815,0.052357096,0.0013858719,0.08147869,0.0151178315,0.14557357,0.0023196037,0.0017832292,0.0024235619,0.18946014,0.005121148,0.084214605,0.005680812,0.0021691292,0.0038409815,0.16411674,0.0025401707,0.0028085667,0.018480783,0.21105959,0.00087579375,0.0025375288
mutations src homology regions activated chicken c src result preferential transformation mouse chicken cells src homology regions sh sh proteins encoded src closely related genes conserved domains believed modulate protein tyrosine kinase activity class proteins perhaps interactions proteins explore possibility using src mutants probes interactions compared mouse nih cells chicken embryo fibroblasts host cells previously described substitution deletion mutants lesions sh sh encoding regions transformation competent allele chicken c src although several mutants equally competent equally defective transformation two cell types four mutants three map within sh preferentially transform nih cells seven mutants map within sh preferentially transform chicken cells sh mutants least able transform mouse cells exhibit augmented transforming activity chicken cells general vitro protein tyrosine kinase activities mutants correlated transforming activities thus many cases catalytic activity mutant protein depended upon host cell protein made host dependent mutants may especially useful reagents biochemical genetic studies src gene family,C23,0.0019020647,0.0016872262,0.0035490554,0.0010687249,0.03945566,0.057672158,0.22650753,0.0017893713,0.0013751081,0.0018688902,0.021540545,0.0039121835,0.018706823,0.17838497,0.010875196,0.0029619103,0.03713567,0.16770485,0.0021657804,0.034971077,0.07620972,0.00067535404,0.1078801
spontaneous regression giant arteriovenous fistulae perinatal period case report unique case spontaneous regression giant arteriovenous fistulae infancy described report female infant product normal labor delivery demonstrated severe ventriculomegaly intracranial hemorrhage birth cerebral angiography days age revealed several large fistulae fed anterior middle cerebral arteries draining deep venous system dilated internal cerebral vein ectatic vein galen two days following angiogram second intracranial hemorrhage occurred active hydrocephalus developed next months treated ventriculoperitoneal shunting child months age angiography failed demonstrate fistulae postulated pressure effects intracranial hematoma long standing intracranial hypertension well stenosis anomalous venous outflow resulted vascular stasis venous thrombosis selective arterial occlusion hydrocephalus result compression intraventricular foramina dilated embryonic vessels anomaly predominantly involving anterior circulation may homologous vein galen aneurysm posterior circulation,C23,0.11415875,0.0018198758,0.0038280818,0.0011527131,0.002869414,0.02916564,0.18027918,0.08351348,0.011410978,0.011947637,0.13348933,0.004219759,0.06772026,0.0047622994,0.0018041295,0.02304383,0.099836454,0.012420109,0.0023360539,0.07705163,0.13033134,0.0007284503,0.0021106154
late postoperative episodic constant hypoxaemia associated ecg abnormalities twenty two patients without cardiopulmonary disease undergoing elective major abdominal surgery monitored continuously holter tape recorder pulse oximeter one night operation first two nights operation without oxygen therapy mean heart rate increased beat min p less mean oxygen saturation sao decreased p less operation episodic oxygen desaturation less occurred four patients operation patients operation p less ecg abnormalities observed patients operation patients operation ns individual maximum st depression pronounced operation p less episodic desaturation related closely tachycardia six patients operation one patient operation operation atrioventricular block one patient operation st depression two patients mean sao second night operation correlated total dose opioid pain relief rs p less postoperative decrease sao correlated postoperative increase heart rate rs p less patient postoperative cardiac complications indicating treatment,C23,0.0022776856,0.0020204207,0.004274004,0.0012797386,0.003171605,0.002939472,0.14221746,0.013240384,0.0016466654,0.00223796,0.0104748225,0.004684764,0.20111164,0.005278176,0.0020029796,0.0035513549,0.4784565,0.0023456386,0.0025934803,0.020714866,0.090328455,0.00080872345,0.002343199
response bitot spots preschool children vitamin treatment double masked placebo controlled clinical trial indonesia preschool children ages months bitot spots randomly assigned iu oral vitamin placebo followed five weeks baseline follow serum vitamin levels obtained children receiving vitamin showed complete cure disappearance bitot spots six disappearance bitot spots six unresponsive treatment nonresponsive children older male higher initial mean serum vitamin levels micrograms dl compared micrograms dl cured group p data suggest normal vitamin status may found approximately children bitot spots vitamin intervention one fourth bitot spots originally cured bitot spots intervention important factors consider using bitot spots prevalence surveys clinical sign vitamin deficiency,C23,0.0026915658,0.002387553,0.0050221826,0.040602133,0.00374792,0.0034736057,0.18421131,0.002531181,0.0019458822,0.08082734,0.015586144,0.024848346,0.044250265,0.0067673596,0.028408252,0.030220365,0.107471354,0.0027733091,0.055182315,0.13665192,0.2166504,0.0009556772,0.0027936043
inflammatory nodular reactions hepatitis b vaccination due aluminium sensitization patients pruritic nodules appeared revaccination hepatitis b aluminium found responsible side effect contact allergy aluminium present patients whereas controls negative,C23,0.00695781,0.03977144,0.012955875,0.0039012767,0.009668622,0.008960965,0.30613926,0.006529764,0.0050198506,0.006822409,0.05299558,0.014619161,0.056935485,0.016121332,0.00610595,0.010812494,0.13079959,0.0071506673,0.007906211,0.12215287,0.15806475,0.0024653892,0.00714323
persistence arrhythmia exercise response healthy young men study assesses persistence arrhythmia rest exercise tests mean follow period years young men mean age years without evidence organic heart disease exercise test performed using near maximal protocol based progressively increasing intermittent work loads minutes duration initial work load w electrocardiogram continuously registered throughout stages examination arrhythmia defined occurrence greater equal supraventricular ventricular premature beat stage examination follow examination rate persistence arrhythmia differ significantly among subgroups irrespective follow interval type arrhythmia arrhythmia patterns response exercise two dimensional echocardiography show structural abnormalities doppler examination demonstrate significant abnormal flow patterns data show almost patients continued present arrhythmia follow period without evidence development organic heart disease moreover arrhythmia pattern response exercise remained constant throughout years time arrhythmia without underlying heart disease seems benign natural course young men,C23,0.0016832415,0.05038297,0.019428296,0.009335603,0.00234405,0.026595859,0.1587795,0.0015829407,0.025650218,0.0016538836,0.09021875,0.003614024,0.092714645,0.0038862627,0.009607987,0.002621157,0.24024096,0.0017334596,0.0019166181,0.12381469,0.121719256,0.00874396,0.0017316567
effects medical surgical treatment cerebral perfusion cognition patients chronic cerebral ischemia effects medical treatment without cerebral revascularization procedures cognition cerebral blood flow compared among patients extracranial occlusive cerebrovascular disease cognitive impairments three comparable groups studied first group n received medical treatment control risk factors stroke including hypertension diabetes hyperlipidemia antiplatelet aggregant medication second group n medical treatment plus superficial temporal middle cerebral artery bypass third group medical treatment plus carotid endarterectomy regional cerebral blood flow cognition monitored three treatment groups year interval groups showed stabilization without expected rates decline cerebral blood flow cognition statistically significant differences emerged among treatment groups,C23,0.09036677,0.0022976922,0.0048591285,0.001455363,0.003606859,0.003342869,0.21816938,0.0024359145,0.0018726446,0.0025450853,0.013122603,0.11506896,0.13062426,0.005955814,0.0022778118,0.0040335776,0.10504138,0.0026675412,0.0029493952,0.17214744,0.11157499,0.00091970817,0.0026647667
functional metabolic effects bupivacaine lignocaine rat heart lung preparation examined effects bupivacaine lignocaine myocardial metabolism rat isolated heart lung preparation bupivacaine micrograms ml lignocaine micrograms ml administered min start perfusion bupivacaine micrograms ml lignocaine micrograms ml reduced heart rate significantly bupivacaine micrograms ml associated higher incidence arrhythmias groups three hearts bupivacaine micrograms ml group n two hearts lignocaine micrograms ml group n failed zero cardiac output end experiment although significant differences myocardial lactate glycogen concentrations groups atp content bupivacaine micrograms ml lignocaine micrograms ml groups significantly less control group results suggest myocardial depression subsequent metabolic deterioration occurred high doses local anaesthetics findings account apparent increased cardiotoxicity bupivacaine,C23,0.015550121,0.0023570508,0.0049580215,0.027217753,0.0037000382,0.0420192,0.12751526,0.0024988437,0.0019210225,0.002610835,0.012220288,0.12839378,0.23940974,0.0062514246,0.0023366567,0.0041429517,0.053322546,0.0027605575,0.0030255897,0.04261839,0.2714929,0.0009434679,0.0027336082
plasma norepinephrine chronic schizophrenia several lines evidence indicate altered noradrenergic function schizophrenia authors examined resting standing change standing minus resting plasma norepinephrine levels drug free patients chronic schizophrenia schizoaffective disorder age sex matched healthy volunteers schizophrenic patients significantly higher resting standing plasma norepinephrine levels significantly greater change resting standing levels significantly related positive negative symptoms significant positive correlation resting plasma csf norepinephrine levels significant negative correlation csf homovanillic acid resting standing change plasma norepinephrine levels,C23,0.003049104,0.0027047074,0.020394603,0.0017131672,0.004252763,0.0039350274,0.21139903,0.0028674144,0.0022043665,0.003007243,0.08582702,0.006628737,0.24397749,0.007095625,0.0027364292,0.0047480892,0.056839045,0.0031400716,0.0034718534,0.022096096,0.30369273,0.001082626,0.0031368057
effects intravenous immunoglobulin hemorrhage induced alterations plasma cell repertoires hemorrhage produces decreases serum immunoglobulin ig levels alterations number frequency b cells producing antibodies bacterial antigens abnormalities immune response may contribute increased susceptibility infection injury hemorrhage examine relationship serum ig levels bacterial antigen specific plasma cell numbers frequencies blood loss treated hemorrhaged mice intravenous ig ivig hemorrhaged mice given ivig increased total numbers splenic plasma cells compared normal hemorrhaged untreated mice immunization bacterial polysaccharide antigen levan immediately hemorrhage resulted approximately fewer levan specific splenic plasma cells seen normal unhemorrhaged mice treatment hemorrhaged mice ivig correct decrease levan specific plasma cells results demonstrate hemorrhage induced alterations numbers frequencies bacterial antigen specific b cells related changes serum ig levels cannot corrected administration ivig,C23,0.011629741,0.0017662152,0.0037152073,0.0011187244,0.0027727159,0.002569633,0.14514449,0.0018724652,0.0014394849,0.001956384,0.009299582,0.024018945,0.067046456,0.24081989,0.001750976,0.0031339703,0.040570013,0.0020511744,0.031182852,0.048770398,0.3546137,0.00070697133,0.0020500184
afferent nipple valve malfunction caused anchoring collar unexpected late complication kock continent ileal reservoir construction kock continent ileal reservoir urinary diversion significantly high rates late postoperative complications regarding nipple valves efferent limb particular reported reports afferent nipple valve malfunction total patients underwent kock pouch operation observed months mean months evaluated terms afferent nipple valve malfunction late afferent nipple valve complications observed patients complications included erosion polyester fiber fabric used collar patients stenosis afferent limb obstruction afferent nipple mucous plug fungus ball latter complications due mechanical dynamic obstruction urine flow caused nonabsorbable collar none patients problems efferent nipple valve function results suggest peristaltic direction intestine use nonabsorbable material collar primarily responsible late afferent nipple valve complications modifications needed produce stable nipple valve otherwise simpler reliable alternative techniques antireflux anastomosis considered,C23,0.0024116018,0.013792674,0.027827976,0.0013542471,0.003356261,0.014719329,0.17834382,0.0022666717,0.013399418,0.0023682574,0.02727292,0.016616544,0.046394218,0.017202219,0.0021196296,0.0037533324,0.4374696,0.0024822054,0.0027444768,0.07599628,0.10477286,0.00085580855,0.0024796238
mechanical deficit persists long term muscle hypertrophy hypotheses tested deficit maximum isometric force normalized muscle cross sectional area e specific po n cm hypertrophied muscle would return control value time rate magnitude adaptation specific force would differ soleus plantaris muscles ablation operations gastrocnemius plantaris muscles gastrocnemius soleus muscles done induce hypertrophy synergistic muscle left intact female wistar rats n wk age hypertrophied soleus plantaris muscles control muscles age matched rats n studied days thereafter po measured vitro degrees c oxygenated krebs ringer bicarbonate compared control values soleus muscle cross sectional area increased days ablation whereas po increased days compared control values plantaris muscle cross sectional area increased day days day plantaris muscle po increased days day different control value changes muscle architecture negligible ablation muscles specific po depressed muscles times time ablation synergistic muscle increased muscle cross sectional area contribute fully isometric force production,C23,0.0019955512,0.0112717,0.01565455,0.001108584,0.0027474286,0.0025463414,0.07741364,0.011405034,0.17336456,0.0019386509,0.058776643,0.0041101826,0.15392926,0.028348766,0.02082498,0.0030724704,0.056248132,0.0020319284,0.0022466232,0.07039701,0.29783124,0.0007005632,0.0020361852
underlying illness associated failure thrive breastfed infants four year period suburban pediatric practice infants aged six months less identified failure thrive ftt breast feeding seven cases associated organic illness diagnosed breast fed neonates found ftt associated another illness compared older infants breast fed infants ftt particularly presenting first month life considered high risk disease clinical evaluation include appropriate search organic illnesses,C23,0.0039158124,0.041387472,0.0073065,0.0022001353,0.024408331,0.0050535602,0.17237307,0.0036824776,0.0028309582,0.003847516,0.04624449,0.008054078,0.049004663,0.009060585,0.0034434667,0.025051644,0.10987035,0.004032638,0.023412438,0.39785662,0.051544383,0.0013903627,0.0040284437
recognising failure thrive early childhood maximum weight centile achieved child weeks age found better predictor centile months birth weight centile children whose weight deviated two major centiles maximum weight centile month showed significant anthropometric differences second year life showed deviation suggested leads logical practical definition failure thrive,C23,0.0045150337,0.04772102,0.008424585,0.0025368133,0.028132778,0.0058268863,0.21073402,0.0042459923,0.0032641685,0.070009515,0.021594672,0.009381256,0.08364147,0.010464337,0.003970407,0.0070308466,0.14272276,0.004649736,0.00514103,0.18648209,0.13326257,0.0016031244,0.0046449
comparison hospital costs morbidity octogenarians patients undergoing general surgical operations hospital costs clinical results patients years old underwent general surgical procedures evaluated mortality rate per cent per cent occurred patients admitted emergency conditions compared per cent occurred patients undergoing elective procedures p less seventy nine per cent patients discharged per cent required care skilled nursing facility survival rates good better standard life table survival rates year old patients costs higher admitted emergent conditions died hospital deaths result complications primary disease rather associated disease groups neither costs length stay could accurately predict survival individual patients concluded health resources directed treating problems cholelithiasis hernia carcinoma early complications develop,C23,0.0023543262,0.0020884047,0.0043929284,0.0013227998,0.0032783246,0.0144017935,0.31887954,0.0022140369,0.001702073,0.0023132637,0.017310278,0.016239982,0.028078968,0.005499681,0.002070335,0.0036661755,0.40126395,0.0024245656,0.014074085,0.10891477,0.044251695,0.0008359357,0.002422044
treatment chronic facial palsy transplantation neurovascularized free rectus abdominis muscle performed neurovascularized free rectus abdominis muscle transplantations two patients chronic facial palsy one patient postoperative course uneventful patient died rupture esophageal varices patient morphologic functional results satisfactory therefore rectus abdominis muscle considered suitable donor muscle transplantation treatment chronic facial palsy rectus abdominis muscle advantageous simultaneous operations two teams possible patient supine position supplied long nerves long large vessels flat consists segments appropriate lengths force distance contraction appropriate tendinous intersections suitable anchoring sutures,C23,0.0031906797,0.002830292,0.005953477,0.0017927127,0.019926986,0.0041177385,0.21469982,0.0030065274,0.09498726,0.018532895,0.015065939,0.006562618,0.097445205,0.0073363576,0.0028058032,0.035859104,0.2756878,0.018723901,0.0036330582,0.022204962,0.14122154,0.0011328944,0.0032824536
tracheotomy first year life much written concerning complications pediatric tracheotomies studies reviewed complication rates tracheotomies performed first months life reviewed records patients underwent tracheotomy first year life study includes full term infants premature infants low birth weight preterm infants less equal weeks gestation less g birth weight overall complication rates intraoperative early postoperative late postoperative early postoperative complication rate preterm infants nearly double full term infants late postoperative complication rate patients undergoing tracheotomy airway obstruction double patients requiring tracheotomy pulmonary indications duration tracheotomy however felt important factor development late postoperative complication,C23,0.014043073,0.013779857,0.0044956263,0.0013537243,0.0033549652,0.0031372383,0.14445393,0.0022657965,0.013265952,0.0023673433,0.011499324,0.0049556047,0.034740314,0.0057362053,0.0021187353,0.0037518833,0.4333835,0.002481247,0.0027434172,0.23558943,0.03383503,0.024169149,0.0024786666
hypoxic events surgical intensive care unit oxygen monitoring protocol established surgical intensive care unit sicu denver general hospital july month surveillance audit ending march prospectively documented consecutive hypoxic events sicu patients episodes occurred mechanical ventilation patients spontaneous ventilation patients artificial airways remaining occurred nonintubated patients hypoxemia recognized pulse oximetry arterial blood gas analysis mixed venous oximetry transcutaneous oxygen monitoring events due problems ventilator airway recent interventions new pulmonary process progression underlying disease unknown causes two thirds resulted mechanical problems amenable simple intervention two adverse outcomes conclusion acute hypoxia frequent potentially morbid sicu event advances continuous oxygen monitoring permit early identification thereby may limit adverse outcomes prompt expensive diagnostic work,C23,0.023547577,0.0021623317,0.041123096,0.0013696253,0.0033943732,0.0467741,0.37796894,0.014085616,0.013543886,0.0023951505,0.051825207,0.005014203,0.028907241,0.005987114,0.0021436224,0.0037959535,0.1872851,0.0025180618,0.0027756419,0.13108751,0.048918486,0.0008655268,0.002511598
plasma concentrations methadone postoperative patient controlled extradural analgesia plasma concentrations methadone measured gas chromatography patients receiving extradural methadone continuous infusion relief postoperative pain venous blood samples taken loading dose extradural methadone mg infusion mg h plus patient controlled increments mg mean sd plasma concentration methadone ng ml min change significantly first h increased gradually ng ml p less end h mean quantity extradural methadone required produce effective analgesia mg first h operation mg subsequent h mean amount methadone effective analgesia second day mg adverse effects detected days methadone therapy plasma concentration methadone increased significantly patient controlled infusion extradural methadone first h operation suggesting rapid vascular uptake systemic activity drug contributes analgesic effect extradural methadone,C23,0.014926229,0.0022693726,0.0047772517,0.0014374253,0.0035624034,0.0156645,0.12946264,0.017429788,0.014215335,0.0025137165,0.020468432,0.023073554,0.18793815,0.0062050926,0.002249737,0.016605081,0.18782598,0.0026346631,0.0029130431,0.023147117,0.31712627,0.0009083725,0.0026458376
site strand specificity uvb mutagenesis sup gene yeast published erratum appears proc natl acad sci u mar dna sequencing used characterize mutations induced sup trna gene yeast saccharomyces cerevisiae uvb nm radiation results compared analysis sup mutations induced nm uvc light case greater mutations single base pair changes g c transitions predominated accounted mutations induced uvb uvc double substitutions single base pair deletions complex events also recovered however uvb induced fold tandem substitutions uvc nontandem double events detected irradiation uvc virtually induced substitutions occurred sites pyrimidine base pair part dipyrimidine sequence although site specificities consistent roles cyclobutane dimers pyrimidine pyrimidone lesions mutation induction preliminary photoreactivation data implicated cyclobutane dimers major form premutational dna damage agents intriguingly preference uvb uvc induced mutations occur sites dipyrimidine transcribed strand,C23,0.0024098358,0.0021376447,0.0045559877,0.0013539885,0.015020883,0.0031100188,0.33279493,0.002266239,0.0017422041,0.0023678052,0.03589227,0.004956572,0.027108165,0.005745755,0.013772866,0.018074322,0.022739043,0.022257153,0.0027439527,0.046639666,0.184365,0.00085564516,0.24709007
hemodialysis associated febrile episodes surveillance major alteration water treatment system surveillance bacteremic pyrogenic episodes associated hemodialysis undertaken reconstruction water treatment system university medical center new water system included holding tank iodination treatment water delivered individual dialysis stations occasional positive bacterial cultures samples completion construction samples afterwards intermittent detection endotoxin samples completion construction samples afterwards monthly sampling among individual dialysis treatments patients reconstruction treatments patients febrile events identified respectively associated underlying infectious illness hemodialysis procedure overall conclude pyrogenic episodes associated directly hemodialysis treatment infrequent addition water storage tank iodination treatment appear increase risk bacteremia pyrogenic episodes,C23,0.0027276522,0.0024195637,0.018188447,0.0015325565,0.0037981693,0.016647305,0.34347177,0.002565117,0.0019719712,0.0026800784,0.10652847,0.08966504,0.023112401,0.019683616,0.0023986285,0.004255975,0.15564659,0.0028090295,0.01630772,0.11518311,0.064632185,0.0009684902,0.002806108
objective appraisal role computed tomographic ct guided drainage intra abdominal abscesses computed tomographic ct guided drainage important tool treatment intra abdominal abscess important role treatment small unilocular well placed abscesses success rates experience diminish considerably abscesses involving necrotic tumors infected yeast frequently characteristic new technologic procedures initial evaluation success rate procedure overly optimistic procedure carries considerable complication rate mortality rate importantly success usually evident early within first hours length time careful evaluation consider treatment contemplated,C23,0.0035162375,0.003119078,0.0065609342,0.0019756304,0.09000582,0.0045378874,0.2954066,0.0033067123,0.019552821,0.020465335,0.016427277,0.0072322283,0.028566437,0.008084916,0.020083068,0.022494484,0.2363756,0.0036211414,0.0040037534,0.10310114,0.09669699,0.0012484881,0.0036173754
effect race relationship fetal death altered fetal growth population study examines racial differences relationship birth weight fetal death earlier report showed birth weight results fourfold increased risk stillbirth constant birth weight percentile nd percentile weeks th percentile weeks analysis applied white black births illinois mean th percentile growth white black infants identical weeks gestation growth diverges gm term white infants larger race specific birth weights resulting quadrupling stillbirth rate determined exponential regression analysis relationship birth weight fetal death rate gestational age data indicate birth weights resulting quadrupling stillbirth rate substantially denver th percentile previously unpublished race specific illinois th percentiles term white infants demonstrate constant risk th percentile whereas black infants exhibit risk th percentile data conclude black fetuses sensitive white fetuses factors adversely affect growth continued use race neutral data clinical management racially heterogenous populations accurately predict risk stillbirth,C23,0.002030571,0.0018012178,0.012186036,0.001140895,0.0028284348,0.0026205576,0.18213679,0.0019095736,0.119412445,0.0019951551,0.012191622,0.0041764965,0.022585353,0.057927944,0.0017856328,0.012834972,0.02500516,0.011915116,0.0023121038,0.3409339,0.12831748,0.049857575,0.0020949643
reduction bleeding heart lung transplantation importance posterior mediastinal hemostasis reduce perioperative hemorrhage following heart lung transplantation several technical modifications introduced june secure better posterior mediastinal hemostasis intraoperative postoperative use blood blood products well chest tube drainage first hours postoperatively compared seven patients operated since june nine patients operated date significant p less reductions demonstrated intraoperative postoperative transfusion packed cells postoperative administration fresh frozen plasma chest tube drainage within first hours postoperatively one month total hospital mortality rates percent percent respectively concluded newer techniques obtain optimal posterior mediastinal hemostasis significantly reduced blood loss following heart lung transplantation experience contributed excellent early postoperative results,C23,0.002467821,0.0021880209,0.004602469,0.0013858968,0.027322352,0.03900658,0.14088675,0.0023196454,0.0017832612,0.0024236054,0.063535824,0.0050909184,0.15346847,0.018833512,0.014119237,0.0038410504,0.3361889,0.0025402163,0.0028086172,0.04091105,0.13086236,0.00087580946,0.0025375744
rejection multivisceral allografts rats sequential analysis comparison isolated orthotopic small bowel liver grafts multivisceral isografts allografts transplanted lewis rats histopathologic changes studied liver intestine constituent organs rats receiving isografts indefinite survival maintenance weight multivisceral allografts brown norway donors intestinal component rejected severely companion liver severity intestinal transplantation performed alone intestinal rejection either circumstance lethal event causing death days earliest day intense cellular rejection peyer patches mesenteric lymph nodes associated followed cryptitis epithelial cell necrosis focal abscess formation mural necrosis eventual perforation liver allografts transplanted alone part multivisceral grafts also histopathologic evidence rejection self limiting spontaneously reversible liver transplanted alone thus achille heel multivisceral grafts intestinal component protected presence liver organ complex better immunosuppression permit successful experimental clinical transplantation grafts,C23,0.0024686935,0.0021898544,0.030006345,0.02528383,0.015357184,0.0031859775,0.3420629,0.0023372006,0.0017847555,0.0024256364,0.012085226,0.0056224097,0.03460252,0.01873551,0.0021709066,0.07397362,0.15702602,0.014485015,0.0028109706,0.0662273,0.18173674,0.00087654334,0.0025449002
neurological phenomena emergence enflurane isoflurane anaesthesia emergence anaesthesia transient neurological signs would usually considered pathological may appear objective randomized patient n observer blinded study compare prospectively incidence duration post anaesthetic neurological abnormalities healthy patients undergoing minor elective procedures following thiopentone succinylcholine induction enflurane n isoflurane n anaesthesia patients studied min anaesthesia arousal state muscle tone deep tendon reflexes plantar reflex sustained clonus shivering intense muscular spasticity temperature assessed results neurological examination correlated patient state arousal transient emergent neurological abnormalities occurred frequently following enflurane n anaesthesia isoflurane n anaesthesia statistically significant p less quadriceps hyperreflexia upgoing toes positive babinski reflex intense muscular spasticity neurological abnormalities occurred commonly min anaesthesia abnormalities resolved within min following enflurane anaesthesia patients became alert incidence abnormalities declined arousal state affect incidence abnormalities isoflurane significant difference axillary temperatures patients shivered conclusion temporary emergent neurological abnormalities occurred often following enflurane n isoflurane n anaesthesia,C23,0.002092127,0.0018558211,0.024155986,0.072071314,0.0029132208,0.0127860755,0.2836168,0.0019674615,0.031891916,0.022284484,0.050443053,0.004398339,0.15405644,0.0048439372,0.0018397637,0.02423415,0.17039032,0.002154544,0.012502582,0.07634456,0.040261973,0.0007428383,0.0021523032
effect recombinant hirudin specific inhibitor thrombin endotoxin induced intravascular coagulation acute lung injury pigs hypothesized thrombin activation may play prominent role endotoxin induced secondary organ failure acute lung injury test hypothesis administered thrombin specific inhibitor recombinant hirudin endotoxemic pigs pigs anesthetized mechanically ventilated prepared swan ganz extravascular lung water evlw catheters total randomly selected animals received pretreatment u kg hirudin followed continuous infusion h u kg h given simultaneously infusion micrograms kg h salmonella abortus equi endotoxin another animals received continuous infusion h endotoxin receive hirudin animals fluid resuscitated ml kg h saline duration experiment data expressed mean confidence interval hirudin reduced endotoxin induced consumption plasma fibrinogen mg ml mg ml p endotoxin induced increases soluble fibrin plasma ng ml ng ml p data suggest effective inhibition endotoxin generated thrombin hirudin furthermore hirudin significantly reduced endotoxin induced increases pulmonary vascular resistance kdyn x x cm x kg kdyn x x cm x kg p increases evlw ml kg ml kg p,C23,0.031106165,0.011865462,0.0038654064,0.0011639523,0.024608279,0.043977547,0.09291892,0.0019481656,0.0014976807,0.002035477,0.019553712,0.11352579,0.14385375,0.035337344,0.0018217561,0.00322753,0.037759047,0.012717196,0.0023588308,0.016242746,0.37243843,0.00073555287,0.025441233
internal mammary artery saphenous vein graft patency effects aspirin part two department veterans affairs cooperative trials obtained angiographic patency data internal mammary artery ima saphenous vein grafts left anterior descending lad coronary artery year coronary artery bypass surgery patients received either aspirin mg q aspirin mg aspirin mg dipyridamole mg placebo aspirin initiated either hours hours operation patients stratified preoperatively extent disease randomized therapies outlined randomization ima versus saphenous vein grafts lad patients taking placebo compared taking aspirin differences ima versus p vein graft versus p patency rates patency rate irrespective treatment ima grafts versus vein grafts lad p thus ima vein grafts excellent patency rates year aspirin alter year differences ima vein graft patency lad,C23,0.030758651,0.0025542977,0.005372927,0.015545377,0.017871318,0.0037161992,0.17070502,0.044525143,0.002081781,0.0028293193,0.016154427,0.0070570265,0.05660149,0.006635119,0.0025321967,0.10198253,0.2515502,0.002965451,0.058702238,0.05471878,0.14115572,0.0010224208,0.002962367
effective adaptable transvenous defibrillation system using coronary sinus humans use coronary sinus catheter electrode right ventricular catheter electrode chest wall patch electrode system defibrillation threshold voltage current energy measured four distinct transvenous defibrillation techniques delivered random sequence survivors cardiac arrest immediately implantation standard epicardial patch defibrillation system four transvenous defibrillation techniques single pathway monophasic pulsing single pathway biphasic pulsing dual pathway sequential pulsing dual pathway simultaneous pulsing transvenous defibrillation method considered potentially useful defibrillation threshold less equal v less equal j delivered energy v value would allow defibrillation safety margin device maximal output j single transvenous pulsing technique uniformly superior efficacy however choosing best pulsing technique patient possible obtain average defibrillation threshold v leading edge voltage leading edge current j delivered energy group patients ability vary defibrillation technique transvenous antiarrhythmic device implantation would possible patients j defibrillation threshold cutoff point contrast one transvenous defibrillation method used patients would candidates transvenous defibrillation system given j defibrillation threshold cutoff point insertion,C23,0.011604917,0.030692281,0.042276017,0.0011193972,0.02203048,0.012199338,0.17393602,0.0018731735,0.011078628,0.0019571239,0.17787306,0.09466897,0.056201655,0.050253436,0.0017515954,0.022385007,0.14069757,0.016943105,0.0022680308,0.04696536,0.067451775,0.00070723874,0.0130658215
growth thermogenesis hyperphagia resting metabolic rate demonstrated function fat free mass growth variable related food energy input imbalance rate use obligatory energy expenditure terms two reservoir energy model applied hyperphagia shows growth fat free mass rapid whereas fat store slow growth bounded excess energy onset hyperphagia initially goes fat store decreases time greater fraction diverted fat free mass two reservoir model predicts weight gain per unit excess energy constant decreases monotonically ultimately reaching asymptotic value departure theory experiment long term suggests facultative considerations become increasingly important,C23,0.0029617194,0.0026271928,0.06800546,0.0016640692,0.004124597,0.003822253,0.16849639,0.0027852368,0.0021411912,0.017245626,0.02313418,0.08573995,0.064849004,0.08485939,0.0026104408,0.09062365,0.03895614,0.0030500798,0.003372353,0.121298395,0.20353414,0.0010515989,0.0030469077
indomethacin alter hemodynamic response magnesium sulfate infusion hemorrhage gravid ewes purpose study determine whether indomethacin alters maternal fetal hemodynamic response magnesium sulfate mgso infusion hemorrhage gravid ewes studied seven chronically instrumented animals timed gestation experimental sequence included time indomethacin mg kg vehicle intravenously iv minutes minutes mgso g iv minutes minutes mgso infusion g hour minutes maternal hemorrhage ml kg minutes minutes reinfusion maternal blood minutes animal studied without indomethacin indomethacin vehicle transiently increased maternal fetal mean arterial pressure map decreased maternal fetal heart rate decreased maternal cardiac output magnesium sulfate significantly decreased uterine vascular resistance increased uterine blood flow without indomethacin hemorrhage significantly decreased maternal map heart rate cardiac output uterine blood flow groups magnitude change similar groups example end hemorrhage maternal map baseline p indomethacin baseline p vehicle group p significant groups hemorrhage significantly decreased fetal heart rate ph po increased fetal map pco groups conclude indomethacin alter maternal fetal hemodynamic response mgso infusion hemorrhage gravid ewes,C23,0.025109686,0.0015702175,0.0033029292,0.000994579,0.0024648875,0.0022844798,0.09084165,0.001664677,0.018407868,0.0017392832,0.016840782,0.06445653,0.36581242,0.0040701376,0.0015566314,0.002758654,0.0515865,0.027513668,0.0020155841,0.06512741,0.23887448,0.0006285184,0.010378387
laryngomalacia children two hundred three percent children laryngomalacia associated respiratory disorders flexible fiberoptic bronchoscopy ffb associated disorders included congenital respiratory anomalies variety anatomic obstructions upper lower airways aspiration disorders mean age isolated laryngomalacia type weeks range weeks months children laryngomalacia associated respiratory disorders type mean age years range weeks years conclude following complete evaluation pediatric airways bronchoscopy recommended every symptomatic child diagnosis laryngomalacia confirmed laryngoscopy type laryngomalacia common early infancy type laryngomalacia associated older age although type laryngomalacia common endoscopic diagnosis experience majority cases associated lower airway dysfunction,C23,0.0024667922,0.0021881678,0.0046027782,0.001386316,0.02731344,0.05094835,0.23558469,0.014249765,0.0017833809,0.08601878,0.06841544,0.00507372,0.026545558,0.005796575,0.0021692347,0.0038413084,0.21950094,0.0025440103,0.0028088058,0.15929747,0.07405085,0.00087586825,0.0025377448
management premature removal percutaneous gastrostomy percutaneous endoscopic gastrostomy peg become preferred method enteral access nutritional support increased use modality complications encountered frequently premature withdrawal inadvertent removal gastrostomy tube within first seven days insertion adherence gastric serosa parietal peritoneum indication laparotomy report describes treatment premature withdrawal immediate endoscopic replacement month period patients underwent insertion peg five patients inadvertently removed gastrostomy tube within seven days insertion treated immediate replacement using retrograde string technique avoiding laparotomy five pegs successfully replaced gastrostomy site despite presence pneumoperitoneum patient developed peritonitis septic complications premature gastrostomy tube withdrawal safely managed endoscopic replacement observation laparotomy unnecessary potentially meddlesome,C23,0.018069426,0.06266831,0.0057754098,0.001739093,0.0043100333,0.01896851,0.21261768,0.017883066,0.0022377258,0.0030412618,0.10451536,0.006366331,0.020067481,0.007456134,0.002721882,0.019800773,0.2593268,0.0031974914,0.003524394,0.053399995,0.16802959,0.0010990098,0.003184276
comparison four pulse oximeters effects venous occlusion cold induced peripheral vasoconstriction ability four pulse oximeters ohmeda nellcor n n datex oscar detect hypoxaemia determined presence venous obstruction cold induced peripheral vasoconstriction significant increases detection time hypoxaemia found cases significant differences detection time instruments although ohmeda displayed smaller values sao certain conditions peripheral vasoconstriction induced using three differing methods gave differing results thus emphasizing importance methodology assessments pulse oximetry,C23,0.02125328,0.003228946,0.0067920396,0.002045221,0.005068717,0.004697732,0.16590405,0.038661577,0.0026316266,0.003576607,0.117100924,0.046833336,0.08345253,0.03234412,0.020818723,0.005668385,0.059540406,0.0037486942,0.0041447836,0.02608449,0.3413617,0.0012924655,0.0037496726
brachial jugular polytetrafluoroethylene fistulas hemodialysis retrospective analysis made patients received brachial jugular polytetrafluoroethylene ptfe graft hemodialysis four patients procedure used treat malfunctioning brachio axillary fistulas due long venous stenosis axillary vein patients operation chosen cases exhaustion veins upper extremity previous multiple failed fistulas two patients died functioning fistula months placement graft causes unrelated vascular access patients retained functioning fistulas months construction shunt three patients needed graft thrombectomy treat occlusive episodes venous stenosis found postoperative fistulography made patients one patient needed substitution graft segment due stenosis prosthesis crossing clavicle believe brachial jugular graft procedure considered vascular access hemodialysis cases use veins upper extremity axilla possible,C23,0.03340852,0.0026654876,0.0056068134,0.0016883252,0.0041842177,0.0038779674,0.1811883,0.09410724,0.0021724019,0.0029524812,0.06127611,0.0064449287,0.022038922,0.0069565717,0.0026424245,0.004679239,0.42084977,0.0030945386,0.0034215094,0.064440444,0.0676918,0.0010669273,0.003545088
bleeding complications associated cardiopulmonary bypass bleeding cpb difficult characterize treatment equally difficult standardize complexity problem related hemostatic process technical variations operative procedures many uncontrolled variables associated cpb including effects anesthetic pharmacologic agents nature priming solution hemodilution hypothermia type oxygenator use transfused blood products although multiple generally predictable complex changes hemostatic mechanism cpb temporary loss platelet function common clinically relevant transient platelet dysfunction occurs patients undergoing cpb however causes excessive bleeding small percentage patients unfortunately yet possible predict patients develop hemorrhagic complications although prolonged pump times contributing risk factor past decade extensive investigation management bleeding associated cpb provoked primarily increased awareness transfusion transmitted viral diseases inappropriately excessive use homologous blood products several approaches autotransfusion shed blood autologus blood donation developed minimize perioperative homologous blood transfusion pharmacologic agents desmopressin aprotinin topical fibrin glues also introduced improve hemostasis cpb protease inhibitor aprotinin particularly promising reduction bleeding associated cpb given prophylactically aprotinin may provide new insights mechanism cpb induced platelet dysfunction desmopressin indicated treatment bleeding cpb management bleeding associated cpb undoubtedly,C23,0.001604842,0.001423575,0.011188155,0.00090171106,0.0022346918,0.017574111,0.40117872,0.0015092129,0.0011602293,0.0015768516,0.016835418,0.019203488,0.19141057,0.015486418,0.0014112575,0.0024990728,0.10497339,0.0016527212,0.0018273487,0.09120624,0.11091883,0.0005698211,0.0016533171
cerebral blood flow acute mountain sickness changes cerebral blood flow cbf measured using radioactive xenon technique related development acute mountain sickness ams subjects ascending cbf increased h initial slope index isi units increased days isi units four subjects similar increases cbf ascending mo later indicating reproducibility measurements nine subjects ascending cbf increased isi units estimated sea level values cbf increases cbf similar subjects without ams six subjects cbf measured therapeutic intervention h cbf increased isi units pretreatment values three subjects given g acetazolamide three subjects given placebo showed change symptoms remained unaltered subjects h study overall results indicated increases cbf similar subjects without ams acetazolamide provoked increases cbf ams subjects caused acute change symptoms alterations cbf cannot directly implicated pathogenesis ams,C23,0.024861092,0.002064657,0.04941071,0.0013077579,0.0032410459,0.0030038303,0.23090522,0.0021888604,0.0016827183,0.002299006,0.0403174,0.0049151145,0.380715,0.016623663,0.0020467928,0.0036337054,0.03813113,0.0023969952,0.013916638,0.018264242,0.15485352,0.00082643004,0.0023945023
reoperations heart valve prostheses analysis operative risks late results evaluate risks complications reoperations heart valve prostheses reviewed data patients underwent reoperation prosthetic valve malfunction incremental effect redo procedure hospital mortality morbidity studied comparing primary reoperative procedures analyzing series possible predisposing factors late survival first second reoperations computed possible determinants late mortality examined overall operative mortality emergency operation p previous thromboembolism p advanced new york heart association functional class p independent determinants series patients primary secondary isolated valve replacement redo procedure significant risk factor univariate analysis p multivariate analysis except subset patients mitral valve replacement p postoperative course quite complicated evidenced long mean stay intensive care unit mean stay days longer days survivors nevertheless postoperative complications significantly greater redo procedure primary operation actuarial survival years comparison nonhomogeneous series institution demonstrate significant differences subset patients second reoperation late survival years advanced new york heart association class p double prosthetic valve dysfunction p indication primary tissue failure p determinants late mortality,C23,0.0016430841,0.00941073,0.011014447,0.00092318194,0.0022882426,0.0021204858,0.10207163,0.0015451763,0.0011878767,0.0016144267,0.026727479,0.0033954943,0.03785705,0.0041175974,0.041159082,0.0025601275,0.48220187,0.0016921043,0.0018708931,0.17576058,0.086558565,0.0005833995,0.0016964861
use gadolinium enhanced magnetic resonance imaging determine lesion site traumatic facial paralysis gadolinium enhanced magnetic resonance imaging used evaluate patients surgically confirmed facial nerve lesions nerve could seen gadolinium enhanced magnetic resonance imaging accurately revealed lesion site well known extent cases predicted topognostic testing technique appears provide accurate lesion site testing may importance surgical planning currently used topognostic tests facial nerve function frequently inaccurate determine proximal lesion site multiple extensive lesions focal nerve enhancement seen nerve injury globally increased signal intensity within temporal bone trauma increased signal intensity within dura surgery occasionally mask nerve lesions may confused tumors,C23,0.015518761,0.002356796,0.0049574855,0.0014927995,0.18845786,0.003428858,0.2525196,0.0024985739,0.001920815,0.0026105528,0.15437263,0.00546472,0.09809906,0.0061090738,0.01519414,0.029858157,0.07494973,0.0224805,0.0030252628,0.035306796,0.07569855,0.000943366,0.0027359514
detubularized right colonic segment urinary reservoir evolution technique continent diversion continent diversion urine via cecal right colonic reservoir performed university hospital since several modifications surgical technique devised prevent problems urinary leakage difficulties catheterization current technique used last years patients involves use detubularized right colonic segment reservoir ileal mesenteric exclusion fashioning intussuscepted ileal nipple valve staples anchoring fascia strip sling around nipple base anterior rectus sheath complication reservoir outlet occurred patient,C23,0.004238268,0.024275793,0.069442734,0.0023813099,0.00590166,0.0055379705,0.17627844,0.06553883,0.0030640792,0.0041643474,0.0671655,0.029224517,0.04732797,0.0097450875,0.003727026,0.027115233,0.2547392,0.0043647136,0.0048258915,0.05164514,0.13343127,0.001504855,0.004360174
hypothalamic glucocorticoid implants prevent fetal ovine adrenocorticotropin secretion response stress evaluated role hypothalamic paraventricular nucleus pvn control acth secretion fetal sheep dexamethasone dex micrograms n cholesterol chol micrograms n implants placed bilaterally mm lateral pvn fetal sheep days gestation dga days recovery fetuses challenged hypotension drop blood pressure hypoxemia fall greater mm hg fetal pao corticotropin releasing hormone crh micrograms iv single injection fetus hypotension hypoxemia repeated dga compared chol dex fetuses lower average concentrations acth plasma hypotension vs vs pg ml less dga respectively mean sem p less hypoxemia vs vs pg ml less dga respectively p less dex chol responses crh dga micrograms iv different vs pg ml respectively immunocytochemistry demonstrated crh decreased pvn eliminated median eminence dex chol fetuses arginine vasopressin avp immunostaining pvn dex chol fetuses similar however unlike chol dex fetuses showed avp immunostaining external zone median eminence results show fetal sheep high concentrations glucocorticoid near fetal pvn prevent increases plasma acth secretion seen controls response hypotension hypoxemia exert least part effect level crh avp producing neurons located pvn,C23,0.001804822,0.018586904,0.02881051,0.026518583,0.00244909,0.0022697197,0.0609469,0.010164725,0.103410006,0.0017280455,0.018993855,0.019302003,0.12971893,0.02957347,0.018571258,0.028275311,0.0917658,0.0018111899,0.0020025612,0.012144274,0.38001373,0.00062445755,0.010513877
getting sick means concepts health disease death intrigued man since beginning time continually evolving nonwestern societies models proposed etiology disease dichotomous view disease causation derived either natural supernatural forces western societies concepts well defined numerous advances fields genetics molecular biology added new dimension understanding various factors involved pathogenesis disease processes advances allowed greater understanding numerous disease processes including inborn errors metabolism endocrine disorders human neoplasia several recent advances areas molecular biology physiology allowing increased understanding human disease presented,C23,0.00300505,0.0026656294,0.0056235855,0.016226334,0.004184437,0.032961138,0.3109252,0.047540218,0.016714172,0.002952638,0.039951734,0.0061808135,0.05251536,0.061627794,0.0026425652,0.0046794876,0.03349461,0.0031329298,0.05670647,0.11275796,0.15017448,0.030154213,0.0031831586
use somatostatin complications occurring liver transplantation somatostatin helpful liver transplantation well defined indications uncontrolled digestive haemorrhage short course somatostatin therapy great help controlling acute bleeding avoid emergency laparotomy somatostatin could also helpful bilio pancreato intestinal fistula case advantage elective surgical treatment remains confirmed,C23,0.0048319926,0.0042862184,0.009015997,0.0027148994,0.0067283963,0.0063610836,0.3284937,0.004544064,0.0034933153,0.0047564367,0.045851436,0.010192772,0.04818832,0.0112211425,0.0042491322,0.007524417,0.1969076,0.0049945097,0.12223002,0.090879045,0.07584884,0.0017156649,0.0049709757
effect complement arachidonic acid pathway inhibition white blood cell count deposition vascular grafts determine role complement arachidonic acid metabolites decrease peripheral white blood cell count pwbc observed graft implantation dacron aortic grafts implanted control rabbits group n rabbits pretreated cobra venom factor u kg deplete complement group ii n indomethacin mg kg inhibit cyclooxygenase group iii n diethylcarbamazine dec mg kg inhibit leukotriene synthesis group iv n pwbc measured min hr graft implantation graft removal wbc count grafts gwbc determined light microscopy lm scanning electron microscopy sem one hr graft implantation pwbc decreased significantly groups iv preoperative pwbc respectively significant difference among groups lm revealed gwbc per x field groups iv respectively similarly sem showed gwbc per x field groups iv respectively sem gwbc significantly greater group ii p less significantly less group iii p less results suggested complement arachidonic acid pathways alone affect fall pwbc may influence gwbc,C23,0.002030647,0.0018012852,0.0135862585,0.0011409377,0.0028422042,0.0026206556,0.13925911,0.015304191,0.030956883,0.0019952299,0.009367215,0.23088616,0.17682396,0.08493272,0.0017856997,0.003166231,0.02914097,0.013325177,0.0023769247,0.015227895,0.21861956,0.0007210089,0.0020890548
nitrous oxide antagonizes cns stimulation laudanosine mice investigated whether nitrous oxide antagonizes augments cns stimulant action laudanosine mice comparing mean convulsive doses cd se control group following pretreatment nitrous oxide oxygen min nitrous oxide significantly increased cd mg kg control mg kg min mg kg min attenuation effect nitrous oxide min suggestive possible partial drug tolerance statistically significant findings indicate nitrous oxide antagonizes cns stimulating action laudanosine,C23,0.02202281,0.0033472797,0.0070409533,0.0021201738,0.0052544745,0.0048698937,0.168866,0.003548642,0.0027280701,0.003707682,0.01735389,0.057162017,0.14096782,0.10820382,0.0033183177,0.1230806,0.05456684,0.003886076,0.004296681,0.04438663,0.2140495,0.0013398315,0.0038820342
intrathoracic current flow transthoracic defibrillation dogs transcardiac current fraction achieve transcardiac threshold current transthoracic defibrillation considerably larger current must delivered thorax compensate shunting effect lungs thoracic cage elements torso shunting effect thus important determinant transthoracic defibrillation threshold quantified transcardiac current fraction fc ratio transcardiac transthoracic threshold currents previous estimates fc ranged low high purpose study quantify fc major intrathoracic current pathways transthoracic intrathoracic voltages currents simultaneously measured high voltage transthoracic shocks dogs correction factors determined another set dogs raw data corrected compensate field distortion caused presence intrathoracic electrodes adjusted data fit resistive network model results showed transthoracic current shunted thoracic cage shunted lungs remaining fc portion passed heart good agreement two independent methods used calculate fc analysis based model indicated fc whereas fc determined direct measurement calibrated electrodes therefore results study contrast earlier estimates fc show defibrillation dogs achieved total transthoracic current,C23,0.028422106,0.0016255778,0.03887826,0.07192949,0.0025522434,0.033676203,0.20333894,0.0017233676,0.027912593,0.001800604,0.045615226,0.0037692387,0.10130775,0.03699295,0.013678237,0.11046407,0.07931582,0.0018872395,0.0021480357,0.06301492,0.12740737,0.0006506777,0.0018890514
late results carpentier edwards porcine bioprosthesis patients underwent aortic valve replacement avr underwent mitral valve replacement mvr carpentier edwards bioprosthesis early mortality avr isolated avr mvr isolated mvr follow complete mean years actuarial event free rates years avr mvr respectively structural valve deterioration versus p less nonstructural dysfunction versus p ns thromboembolism versus p ns anticoagulant related bleeding versus p endocarditis versus p ns reoperation versus p less valve related mortality versus p permanent physical impairment versus p less combined operative mortality valve related mortality reoperation versus p structural valve dysfunction observed avr patient whose valve inserted age age operation factor predicted structural valve deterioration p less,C23,0.0028796862,0.0025544253,0.0053731957,0.0016179782,0.017934868,0.003716385,0.13990296,0.0027080916,0.002081885,0.016762894,0.024788344,0.0059570335,0.101709425,0.0069832127,0.044339254,0.0044842702,0.34708184,0.0029655993,0.0032789463,0.16345198,0.09544275,0.0010224719,0.002962515
cytomegalovirus infections pediatric liver transplantation consecutive pediatric liver transplant recipients followed hospital sick children toronto canada patients reviewed assess incidence infection cytomegalovirus severity disease relationship recipient donor serostatus cytomegalovirus disease overall incidence infection patients seropositive whose donors seropositive developed evidence cytomegalovirus infection transplantation forty three percent cytomegalovirus infections developed severe fatal cytomegalovirus disease despite treatment immunoglobulins ganciclovir syntex laboratories inc palo alto calif foscarnet sodium astra pharmaceutical products inc westborough mass posttransplant deaths two thirds associated severe cytomegalovirus infection cytomegalovirus related deaths occurred three four seronegative patients seropositive donors three six seropositive patients seropositive donors therefore seropositive donor appeared major risk factor severe cytomegalovirus disease,C23,0.0028079664,0.0024845994,0.018781608,0.0015737503,0.003900261,0.057846077,0.35275334,0.0026340652,0.002024976,0.029868992,0.013532919,0.005761058,0.030997293,0.0069386126,0.0024631016,0.01606741,0.20141809,0.0706788,0.0031893153,0.1200569,0.036804736,0.01453462,0.0028815337
longitudinal study diagnoses children women unipolar bipolar affective disorder school age children unipolar depressed bipolar chronically medically ill normal women diagnosed every months years offspring unipolar women highest rates disorder evaluations children bipolar medically ill mothers also experienced significant rates disorder observing diagnoses past lifetime prospective follow assessments appeared children diagnoses onsets preadolescence continued chronic intermittent course disorder thus risk offspring ill mothers transitory indicates pernicious course commonly includes effective disorders alone combination behavior anxiety disorders,C23,0.002961747,0.0026272174,0.005526313,0.001664085,0.018460913,0.003822289,0.31935823,0.002785263,0.0021412114,0.088935636,0.0684024,0.0060936073,0.0269781,0.022783061,0.03124955,0.0046120565,0.090603784,0.0030535238,0.003372385,0.19715516,0.09331489,0.0010516088,0.0030469364
functional heart replacement spindle pump first results spindle pump nonpulsatile blood pump double function e works centrifugally represses simultaneously first experiences type pump used biventricular assist device four short term animal experiments hours described demonstrated cases normally beating heart bvad decompresses ventricles aortic pressure slightly increased hand case ventricular fibrillation bvad two spindle pumps maintained entire circulation arterial pressure mmhg flow volume l min,C23,0.037690222,0.003287378,0.0069149504,0.0020824224,0.0051614675,0.0047827438,0.18584664,0.021415144,0.0026792495,0.0036413306,0.059251435,0.11999487,0.25519866,0.008916488,0.0032589342,0.0057804883,0.10874962,0.003816532,0.004219789,0.048464593,0.10371861,0.0013158544,0.0038125624
morphological biochemical changes gastric mucosa aging rats although previous data laboratory indicated aging associated increased gastric mucosal proliferative activity direct assessment proliferative potential tissue made aging order assess determine whether changes mucosal proliferative potential would reflected growth tissue examined labeling index li height morphology gastric mucosa young month old aged month old fischer rats addition tyrosine kinase tyr k activity levels phosphotyrosine proteins determined evaluate relationship mucosal proliferative activity histologic evaluation revealed marked atrophy mucosal glandular component reduction height aged rats compared young animals aged rats also decrease gland density resulting reduction number epithelial cells types evidence decreased secretory activity despite occurrence mucosal atrophy aged rats li animals significantly increased associated parallel rise mucosal tyr k activity two threefold increase relative concentrations seven phosphotyrosine membrane proteins mr kda conclude although aging associated increased gastric mucosal proliferative activity result mucosal growth tyr k tyrosine phosphorylation certain proteins play role regulation gastric mucosal cell proliferation aging,C23,0.0017694938,0.0015696293,0.028998606,0.018683344,0.011295963,0.002283624,0.16471623,0.010218424,0.0012792653,0.035997294,0.008584659,0.0036528292,0.03348321,0.058681846,0.0015560482,0.054145206,0.016679566,0.037139487,0.002014829,0.14852864,0.34774834,0.00062828296,0.010345159
intravenous diclofenac sodium administration operation suppress postoperative pain intravenous diclofenac sodium evaluated double blind randomised trial relative intramuscular diclofenac intravenous fentanyl intramuscular placebo patients undergoing extraction impacted lower third molar teeth test drug administered operation attempt alleviate postoperative pain cm visual analogue scale used assess pain minutes one day surgery patients stayed overnight patients received intravenous diclofenac significantly less pain groups minutes operation also significantly less pain one day surgery placebo opioid groups less intramuscular diclofenac group capillary bleeding time comparison placebo significantly prolonged use intramuscular diclofenac similar nonsignificant trend observed intravenous diclofenac group problems encountered excessive bleeding group,C23,0.02595273,0.0021898686,0.016347962,0.013158761,0.0033946168,0.014912362,0.12900928,0.0022925755,0.0017624508,0.0023953223,0.03373487,0.16547318,0.14779492,0.0056200223,0.0021437763,0.0037962259,0.19697201,0.014306491,0.07185039,0.045867525,0.08586405,0.012652688,0.0025079614
association anterior ectopic anus partial absence levator musculature woman impaired defecation report case year old nulliparous woman adult onset constipation slight anterior displacement anus underwent pelvic magnetic resonance imaging diagnosed congenital hemiabsence levator ani sling impaired defecation confirmed anorectal function studies defecography demonstrated anterior rectocele perineal descent upper limit normal partial obstruction defecation appeared related levator sling abnormality knowledge combination findings previously described cause adult onset constipation,C23,0.0038452893,0.0034109636,0.007174911,0.0021605112,0.063988194,0.0049625463,0.25753856,0.0036161568,0.0027799732,0.04100795,0.051771604,0.007909025,0.12710999,0.008966842,0.0033814504,0.005987915,0.09837518,0.029898152,0.004386138,0.15630257,0.110102944,0.0013653226,0.0039578606
cloggology revisited endoscopic surgical decompression malignant biliary obstruction study consecutive patients age obstructive jaundice secondary malignant stricture distal common bile duct identified endoscopic cholangiography patients randomized palliative therapy either endoscopic endoprosthesis bypass surgery prospective indices survival time complication rates hospitalization requirements quality life followed patients randomized endoprosthesis treated procedure whereas patients randomized bypass surgery underwent operative biliary digestive anastomosis difference indices found two groups authors concluded palliation obstructive jaundice due malignant bile duct stricture endoscopically placed biliary stent effective operative bypass,C23,0.0033482783,0.019150397,0.0062425267,0.0018797514,0.00465863,0.020503985,0.1435629,0.003146235,0.0024187136,0.0032872402,0.028478747,0.075091116,0.06477965,0.007774764,0.0029420287,0.0052097817,0.4985405,0.0034454046,0.004113027,0.04736546,0.049431182,0.001187898,0.003441821
transformed nontransformed cells differ stability cell cycle regulation binding activity murine thymidine kinase promoter dna binding activity upstream region murine thymidine kinase gene regulated differently transformed nontransformed cell line pair differences regulation observed serum levels reduced ii serum levels returned initial high levels iii protein synthesis inhibited reduction serum levels binding activity unstable nontransformed balb c clone cells significantly stable benzo pyrene transformed balb c cells serum concentration returned high levels kinetic pattern binding activity differed nontransformed transformed cells protein synthesis inhibited binding activity unstable nontransformed cells stable transformed cells partial inhibition protein synthesis stringent condition test instability prevented induction binding activity nontransformed cells previously labile protein hypothesis set forth criterion protein regulating onset dna synthesis unstable nontransformed cells stable transformed cells dna binding activity described satisfies criterion,C23,0.0018511856,0.010600608,0.0124023985,0.0010399924,0.0025828863,0.06509593,0.100965984,0.0017406879,0.0013381791,0.010776865,0.038567826,0.0049572266,0.019657211,0.19318126,0.0016277087,0.037468612,0.04299972,0.14157997,0.0021144096,0.015541734,0.2606386,0.00065721717,0.032613777
biologically inert synthetic dural substitutes appraisal medical grade aliphatic polyurethane polysiloxane carbonate block copolymer two types artificial membranes medical grade aliphatic polyurethane polysiloxane carbonate block copolymer tested substitutes dura rabbits respectively films placed either epidurally subdurally dural grafts equal subgroups animals postoperative course uneventful manifestations convulsive disorder cerebrospinal fluid leak animals sacrificed months implantation artificial membranes types artificial membranes easily removed underlying nervous surrounding tissues histological examination failed reveal adhesions neomembrane formations type foreign body reactions polyurethane film implantation polysiloxane carbonate film caused reaction applied epidurally dural graft polysiloxane carbonate copolymer induced formation thin neomembrane one two layers fibroblasts formed watertight seal dural defect similar thin neomembrane found encase artificial membrane group animals implanted subdurally foreign body reaction polysiloxane carbonate film authors conclude materials hold promise dural substitutes prevention spinal dural scarring evaluated clinically,C23,0.0030050296,0.017210454,0.1310994,0.0016886069,0.016759941,0.0038781473,0.32318187,0.002878928,0.0021725027,0.002952618,0.050566107,0.08606899,0.024442403,0.047402725,0.0026425472,0.004679456,0.08587695,0.0030946822,0.0034216682,0.03931932,0.14349723,0.0010669768,0.0030933851
neuropsychological assessment monozygotic twins discordant schizophrenia comparison monozygotic twins discordant schizophrenia controls genetic variance reduces variance due environmental circumstances thus serving highlight differences due phenotypic related variables study assessed twin pairs wide range neuropsychological tests affected twins tended perform worse unaffected counterparts tests deficits especially severe tests vigilance memory concept formation suggesting dysfunction greatest frontotemporal cortex manifest symptoms highly associated neuropsychological scores global level functioning address issue genetic liability also compared sample discordant unaffected twins sample seven pairs normal monozygotic twins significant differences groups found neuropsychological test fact results suggest neuropsychological dysfunction consistent feature schizophrenia related primarily clinical disease process genetic nonspecific environmental factors,C23,0.0025370514,0.002242106,0.0047162366,0.0014201545,0.0035196007,0.027723279,0.34380293,0.0023932797,0.0018273412,0.0024881698,0.1698829,0.030115737,0.105314806,0.006018147,0.0022227063,0.0039359964,0.028223777,0.0026041574,0.0273401,0.097797684,0.13022967,0.00089745835,0.002746756
effects tracheal irritation hypercapnia tracheal smooth muscle humans hypercapnia tracheal irritation known constrict airways animals see whether similar responses occur humans investigated tracheal smooth muscle tsm responses hypercapnia tracheal irritation water paralyzed anesthetized humans tsm tone monitored measuring pressure saline filled cuff endotracheal tube although tracheal irritation caused tsm constriction patients patients showed tsm response administration intravenous atropine attenuated tsm constriction response hypercapnia cause change tsm tone patients results indicate paralyzed anesthetized humans exist interindividual differences tsm responses tracheal irritation hypercapnia cannot effective stimulus tsm constriction,C23,0.0034003623,0.003016291,0.0064058863,0.0019105249,0.0047348966,0.020846764,0.15983404,0.003197742,0.0024583105,0.0033410557,0.015846783,0.050797604,0.11164007,0.012312258,0.0029901927,0.0052950713,0.08281874,0.0035018094,0.0038718127,0.023513552,0.47348598,0.001207345,0.0035729033
point mutation exoplasmic domain erythropoietin receptor resulting hormone independent activation tumorigenicity receptors erythropoietin cytokines constitute new superfamily tyrosine kinase enzyme motif signal transducing mechanism unclear describe two classes activating mutations erythropoietin receptor epor single point mutation exoplasmic domain enables induce hormone independent cell growth tumorigenesis expression nontumorigenic interleukin dependent haematopoietic cells c terminal truncation cytoplasmic domain epor renders receptor hyperresponsive erythropoietin insufficient induce hormone independent growth tumorigenicity activating point mutation retards intracellular transport turnover receptor alterations metabolism tumorigenicity caused epor activating point mutations similar observed erythropoietin independent activation wild type epor association gp friend spleen focus forming virus glycoprotein,C23,0.002764652,0.0024523842,0.005527815,0.0015533452,0.057259664,0.016946472,0.12374373,0.0025999122,0.0019987205,0.002716433,0.054319374,0.0057071256,0.018002281,0.11882769,0.029194565,0.033640426,0.038093433,0.22742625,0.003147963,0.056526028,0.12180324,0.0009816275,0.07476683
measurements right ventricular volumes fluid challenge effects fluid loading rv function studied acutely ill patients monitored modified pulmonary artery catheter equipped measuring rvef hemodynamic evaluation performed infusion ml percent albumin solution min changes si correlate pra ppao rvedvi entire group rvef unchanged vs percent eight patients initial rvedvi greater ml fluid challenge increased pra ppao reduced lvswi without significant effect significant correlation rvedvi pra weak correlation rvesvi ppa however highly linear correlation rvedvi rvesvi changes rvedvi rvesvi suggesting absence severe pulmonary hypertension rv output primarily dependent rv preload,C23,0.07198153,0.0025198117,0.005328574,0.001596054,0.017706115,0.058892265,0.16406949,0.0026713961,0.0020536745,0.0027911204,0.030778458,0.033722676,0.32216167,0.006531567,0.0024980092,0.03195074,0.104942635,0.0029254141,0.0032345152,0.035377674,0.092335634,0.001008617,0.0029223717
bleeding risk index estimating probability major bleeding hospitalized patients starting anticoagulant therapy purpose construct test prospectively bleeding risk index estimating probability major bleeding hospitalized patients starting long term anticoagulant therapy patients methods inception cohort patients starting long term anticoagulant therapy one hospital data gathered retrospectively bleeding classified using reliable explicit criteria constructed bleeding risk index identifying weighting independent predictors major bleeding using multivariate proportional hazards model bleeding risk index tested patients prospectively identified second hospital index compared physicians predictions results major bleeding developed discharge patients bleeding risk index included four independent risk factors major hospital bleeding number specific comorbid conditions heparin use patients aged years older maximal prothrombin partial thromboplastin time times control liver dysfunction worsening therapy testing group index predicted major bleeding occurred low risk patients middle risk patients high risk patients p less bleeding risk index performed well physicians predictions integration bleeding risk index physicians predictions led classification system sensitive p physicians predictions alone patients high risk major bleeding identified specific ways improving therapy e g avoiding overanticoagulation nonsteroidal anti inflammatory agents conclusion bleeding risk index provides valid estimates probability major bleeding hospitalized patients starting long term anticoagulant therapy complements physicians predictions possibility bleeding prevented high risk patients warrants prospective evaluation,C23,0.0012693992,0.00726909,0.0075642145,0.0007132236,0.007911217,0.0016382257,0.33296525,0.0011937583,0.013201784,0.0012489817,0.12041715,0.015097482,0.09959294,0.0030915306,0.0133931395,0.0063520772,0.14692034,0.0013072707,0.0014453977,0.17742592,0.038224302,0.00045071752,0.0013066354
observer reliability detecting surreptitious random occlusions monaural esophageal stethoscope esophageal stethoscope used often anesthesia monitor ventilation cardiac function deficiencies observer vigilance may limit effectiveness monitoring instrument aim study determine long took observer detect surreptitiously occluded monaural esophageal stethoscope setting clinical anesthesia routine anesthesia esophageal stethoscope use computer guided device would artificially silently random time intervals occlude stethoscope tubing personnel using stethoscope noted perceived absence stethoscope sounds studied stethoscope occlusions patients time stethoscope occlusion detection seconds mean sd eighty seven percent detections made less seconds however detections delayed seconds seconds anesthesia personnel using esophageal stethoscope could detect stethoscope occlusions failure appreciate episodes occurred small significant number cases suggests esophageal stethoscope definite limitations continuous monitor monitoring techniques oximetry capnography ventilator disconnect alarms well visual tactile inspection patient used well,C23,0.043938566,0.03325269,0.015455768,0.001212447,0.0030048348,0.023638839,0.29642808,0.0020293337,0.0015600797,0.012563651,0.12276824,0.0044387765,0.07739882,0.0051310146,0.00189762,0.045139544,0.17559385,0.0022222993,0.0024883617,0.041982267,0.06870297,0.00076619885,0.018385725
percutaneous balloon dilatation benign biliary strictures percutaneous biliary dilatation effective alternative surgical management benign biliary strictures low morbidity reported mortality reported success rates procedure range depending size series type patient treated length follow period procedure done fluoroscopy suite angioplasty balloon catheter transhepatic access common procedure may done via existing tube tracts specially created jejunal loops frequency radical liver surgery liver transplant radical trisegmentectomy rises rate biliary stricture likely rise making percutaneous balloon dilatation increasingly important tool interventional radiologist armamentarium,C23,0.0035770922,0.003173059,0.006674483,0.0020099194,0.023832094,0.0046164235,0.33210555,0.0033639406,0.0025860784,0.0035147031,0.056244284,0.007357395,0.05395234,0.008260453,0.0031456044,0.038597763,0.28070086,0.0036838118,0.0040730457,0.0676858,0.085895255,0.0012700955,0.0036799805
patients risk cardiac death late aortic valve replacement total patients aged years screened prospectively mean months aortic valve replacement presence left ventricular hypertrophy lvh ecg estes scores greater equal repetitive ventricular premature beats vpbs greater equal couplets hr hour holter monitoring subsequent month follow range months yearly cardiac mortality rate patients lvh patients vpbs patients lvh plus vpbs none factors present p less chi test patient groups differ regard age time elapsed since operation underlying valve lesion coronary artery disease lvh vpbs occurred frequently patients left ventricular dysfunction conclude aortic valve replacement cardiac mortality markedly increased patients lvh repetitive vpbs since noninvasive markers left ventricular dysfunction,C23,0.0024386265,0.013947474,0.0045502237,0.0013701647,0.015200355,0.0031471744,0.1163875,0.0022933139,0.0017630183,0.002406627,0.07085232,0.027956665,0.037840072,0.006594027,0.0021445435,0.027364071,0.3927497,0.002511381,0.0027767348,0.112639084,0.0906639,0.059894286,0.0025087688
blood loss reduced hip arthroplasty lumbar plexus block measured blood loss hip replacement two groups women consisting patients one group lumbar plexus infiltrated bupivacaine group plexus blocked significantly less blood loss,C23,0.0061245053,0.005428873,0.011419553,0.0034386592,0.008522106,0.007898364,0.14493243,0.0057554576,0.0044245915,0.006013401,0.028145859,0.10148321,0.22182211,0.014072101,0.0053819,0.009530337,0.14132483,0.0063027334,0.006968684,0.14980076,0.10274034,0.0021730408,0.0062961783
sudden unexpected nocturnal death syndrome mariana islands sudden unexpected nocturnal death syndrome sunds distinct clinical entity previously healthy young southeast asian males well known philippines recently recognized u nonspecific autopsy findings evidence underlying disease absence toxic drug alcohol levels cases apparent sunds came coroner autopsy commonwealth northern marianas cnmi guam cases exception one yapese previously healthy male filipinos aged either found dead bed described colleagues nocturnal seizure activity consisting gurgling frothing tongue biting immediately prior death autopsy findings showed anatomic findings account death comprehensive serum urine drug analyses negative decedents showed absence significant atherosclerosis grossly detectable structural cardiac anomaly four showed cardiomegaly migrants southeast asia carry pre disposition syndrome appears decline longer residence new country mechanism death sunds believed ventricular fibrillation possibly precipitated sudden sympathetic discharge studies suggest least deaths may associated abnormal cardiac conduction system acute pancreatitis finding series cases condition virtually limited males seemingly sleep triggered adequately explained stress depression believed predisposing factors,C23,0.0018825653,0.0016699294,0.0035126715,0.0010579696,0.0026214125,0.020649938,0.37762123,0.019949188,0.001361011,0.001849731,0.044247463,0.012974583,0.05389195,0.0045409957,0.019873183,0.0029315457,0.06645425,0.0019763673,0.0021435774,0.21938385,0.13680005,0.0006684305,0.0019381102
prolonged paralysis following suxamethonium use neostigmine case prolonged neuromuscular block following administration suxamethonium reported three hours administration suxamethonium well defined recovering phase ii block demonstrated ratio neostigmine administered although ratio improved remained control significant paralysis persisted responded administration cholinesterase concluded neuromuscular monitoring cannot reliably predict reversibility cases even h antagonism prolonged suxamethonium block commence cholinesterase followed neostigmine necessary,C23,0.0041522253,0.003683231,0.0077476217,0.002332966,0.005782701,0.005358663,0.20311344,0.003904803,0.003001874,0.004079805,0.08127428,0.008814423,0.1414332,0.009636157,0.023744253,0.026564252,0.2194837,0.0042761033,0.004727919,0.031153055,0.19998938,0.0014743044,0.0042716563
electrophysiologic effects exogenous phosphocreatine cardiac tissue potential antiarrhythmic actions cellular electrophysiologic effects exogenous phosphocreatine pcr analyzed ascertain purported antiarrhythmic properties myocardial ischemia reperfusion transmembrane potentials recorded isolated guinea pig papillary muscles purkinje fibers studied vitro control normoxic conditions mmol l pcr significantly increased action potential duration measured repolarization ventricular muscle msec effective refractory period msec p less ischemic like conditions hypoxia lactic acidosis elevated k zero substrate pcr effect phosphocreatinine related compound direct substrate creatine kinase reaction acted similarly pcr suggesting alterations induced pcr involve change energy state cells however pcr reduced free ca nearly electrical effects normoxic conditions could largely reversed concomitant increase ca purkinje fibers superfused low k tyrode solution elicit conditions ca overload delayed afterdepolarizations triggered responses reversibly inhibited pcr data suggest antiarrhythmic effects pcr situ may involve prolongation effective refractory period nonischemic tissue attenuation membrane changes elicited ca overload ischemic cells mechanism pcr produces effects may related part changes extracellular ca composition,C23,0.0019742046,0.0017510037,0.05871885,0.0011090894,0.002748681,0.002547502,0.28738403,0.0018563387,0.020539254,0.011492316,0.009091864,0.03327819,0.058973473,0.11009584,0.0017358533,0.003079142,0.12313241,0.0020328546,0.0022476471,0.016300097,0.23685622,0.0007008825,0.012354266
effects methoxamine epinephrine survival regional distribution cardiac output dogs prolonged ventricular fibrillation study compares effects methoxamine pure alpha agonist epinephrine cerebral myocardial blood flow central hemodynamics survival randomized placebo controlled fashion prolonged ventricular fibrillation vf canine model twenty four anesthetized ventilated adult mongrel dogs instrumented regional blood flow determinations using radio labeled microspheres dogs randomized receive either mg methoxamine single intravenous bolus repeated boluses mg kg epinephrine mg kg epinephrine normal saline solution placebo beginning three minutes following induction vf initiation closed chest cardiac massage cccm organ blood flow measurements determined normal sinus rhythm five minutes vf six dogs receiving methoxamine successfully resuscitated contrast one epinephrine treated groups none dogs receiving placebo p less although epinephrine associated significantly higher blood pressures placebo cardiopulmonary resuscitation cpr blood pressures achieved methoxamine significantly higher observed three treatment groups p less cerebral blood flow significantly higher methoxamine high dose epinephrine p less mean left right ventricular myocardial flows highest methoxamine achieve statistical significance contrast organ flows measured animals receiving lowest dose epinephrine significantly higher associated placebo cardiac output minutes cpr significantly lower high dose epinephrine methoxamine placebo p less results suggest methoxamine significantly improves regional cerebral blood flow survival cpr although high dose epinephrine associated comparable improvements regional cerebral blood flow treatment associated deterioration central hemodynamics prolonged vf enhance survival,C23,0.03725086,0.0013112902,0.0027582794,0.0008305739,0.0020584299,0.009053357,0.054508377,0.0013901734,0.001068716,0.0014524771,0.02462103,0.051795777,0.36264157,0.010747598,0.0012999444,0.009451537,0.113623254,0.0015226572,0.04889608,0.039471474,0.21483333,0.00052487635,0.008888335
unruptured intracranial aneurysms arteriovenous malformations frequency intracranial hemorrhage relationship lesions among patients unruptured intracranial arteriovenous malformations avm patients unruptured intracranial saccular aneurysms actuarial analysis showed risk intracranial hemorrhage among patients coexisting aneurysm avm per year years following diagnosis compared patients avm alone difference length survival free hemorrhage significant log rank p less several angiographic clinical parameters investigated better understand relationship lesions aneurysms occurred similar percentages patients small medium large avm twenty five aneurysms arteries feeding malformation system almost equally distributed proximally distally eleven aneurysms atypical location arose primary secondary branch feeders malformation enlarged feeding arteries eleven patients high flow avm associated aneurysms compared five patients low flow avm four low shunt malformations high shunt malformations associated aneurysms five aneurysms associated low shunt malformations direct arterial feeder malformation data suggest intracranial avm predispose aneurysm formation within avm feeding systems mechanism simply based upon high blood flow high arteriovenous shunt systems,C23,0.07589305,0.0017037969,0.0035839116,0.0010791884,0.021307657,0.002478822,0.19013336,0.0018236696,0.0013886134,0.0018872451,0.11366677,0.012641909,0.118682615,0.0044286153,0.010965626,0.002991,0.122686036,0.0019780493,0.002187051,0.20610261,0.099729694,0.00068198686,0.001978699
effects pill giving maintenance placebo response patients chronic mild depression fifty outpatients mild chronic mood reactive depression whose mood improved markedly day single blind placebo trial randomly assigned double blind design either placebo medication discontinued maintained additional weeks half patients condition relapsed within weeks indicating pill taking influence maintenance placebo response placebo response likely maintained patients currently married end months overall relapse rate authors raise questions utility initial day placebo washout antidepressant clinical trials discuss limits generalizability findings,C23,0.0027640613,0.0024518603,0.015997732,0.0015530133,0.0038488677,0.032863483,0.28257963,0.0025993567,0.0019982932,0.029455097,0.048453823,0.0057488093,0.05945705,0.006356614,0.0024306457,0.004304218,0.12090935,0.0028465248,0.13695998,0.046856012,0.185735,0.0009814177,0.0028491574
comparison ventricular arrhythmia induction use indwelling electrode catheter newly inserted catheter two methods serial electrophysiologic testing widespread use commonly electrode catheter removed study new catheter reinserted femoral vein every subsequent test alternative method employs electrode catheter remains place several days serial testing little known differences two methods respect likelihood induction arrhythmia frequency complications determine whether inducibility sustained arrhythmia altered frequency complications unacceptably high use indwelling catheter prospective randomized study conducted patients patient underwent baseline testing several days electropharmacologic testing indwelling catheter h drug elimination period placement new electrode catheter ventricular stimulation studies performed patient indwelling new electrode catheters differences found indwelling new catheter tests respect induction arrhythmia number extrastimuli required induce arrhythmia rate arrhythmia requirement cardioversion ventricular pacing thresholds higher effective refractory periods slightly longer measured indwelling catheter complications related catheter insertions included two may related indwelling catheter one episode staphylococcal sepsis one presumed pulmonary embolism four related invasive procedures pneumothorax long term adverse sequelae complications,C23,0.009492738,0.017213436,0.042486653,0.0009159527,0.0022700261,0.009985539,0.15210177,0.009417794,0.009067147,0.0016017844,0.23003255,0.0033917797,0.055057462,0.0038260613,0.0014335721,0.034101974,0.21394528,0.00946723,0.0018562424,0.10584129,0.08423648,0.000578831,0.0016784063
assessment biliary tract liver transplantation tube cholangiography iodida scanning biliary tract obstruction anastomotic leakage common problems following liver transplantation sequential study patients liver transplant investigated mtc iodida iodida scanning tube cholangiography ttc results compared clinical outcome seven patients extrahepatic biliary obstruction one patient biliary leak detection biliary complications ttc iodida scanning similar terms sensitivity per cent ttc better specificity per cent versus per cent accuracy per cent versus per cent iodida scanning liver function taken account diagnostic efficacy tests patients bilirubin levels less mumol l similar levels greater mumol l greater number false positive results iodida scanning per cent versus per cent significant biliary leak clearly detected ttc iodida scanning ttc remains effective way evaluating biliary tract transplantation iodida scanning limited value bilirubin levels elevated may provide additional information blood supply hepatocyte function intrahepatic cholestasis,C23,0.002496688,0.0022146867,0.028829876,0.001402787,0.0034765587,0.0032221058,0.24432074,0.014390321,0.0018049942,0.0024531425,0.117481105,0.0051555117,0.10854265,0.058726426,0.0021955243,0.026876407,0.19395573,0.0025982617,0.0028428463,0.05870087,0.11485569,0.0008864832,0.0025706158
minitracheotomy complications follow fibreoptic tracheoscopy complications changes tracheal mucosa minitracheotomy evaluated patients tracheal mucosa inspected fibreoptically insertion minitracheotomy cannula day intervals cannula removed thereafter assessments made every third day mucosa considered normal three significant complications occurred mediastinal puncture paratracheal entrance cannula subcutaneous emphysema difficulties insertion minitracheotomy cannula encountered patients air flow detected cannula one patient lack air flow another patient misleading signs position cannula passing suction catheter three patients normal end tidal carbon dioxide tracing one patient also found misleading correct position possible complications could verified fibreoptic tracheoscopy changes tracheal mucosa independent duration minitracheotomy therapy,C23,0.01806754,0.002745352,0.0057748067,0.0017389115,0.03427082,0.0039941603,0.1933506,0.002910504,0.0022374922,0.01801846,0.05447675,0.006365667,0.08948891,0.0076441024,0.002721598,0.0048318445,0.27714223,0.003190585,0.0035240261,0.08084068,0.18237473,0.001098895,0.0031913652
clinical significance white cell antibodies febrile nonhemolytic transfusion reactions febrile nonhemolytic transfusion reactions fnhtrs associated white cell wbc antibodies purposes study determine frequency wbc antibodies associate severity reactions antibody specificity distinguish fnhtrs infection postoperative fever using granulocyte indirect immunofluorescence test conjunction lymphocytotoxicity testing found percent fnhtrs patients involved wbc antibodies remaining percent apparent fnhtrs associated infections postoperative fever granulocyte specific antibodies prevalent hla antibodies associated severest reactions fnhtrs occur granulocyte specific antibodies hla antibodies possible monocyte specific antibodies untested studies reactions could grouped together wbc associated reactions,C23,0.0026962569,0.002387533,0.018028405,0.0015122682,0.0037478884,0.029523795,0.46347344,0.0025311597,0.028004799,0.002644599,0.04047533,0.018566135,0.033393808,0.18465243,0.002366875,0.004191292,0.09173084,0.0029209706,0.0030647176,0.023236096,0.037124984,0.0009556691,0.002770667
audiometric subjective assessment hearing handicap study compares self perceived assessment hearing handicap audiometrically derived measures hearing handicap sample elderly persons subjects evaluated traditional audiometric tests speech perception noise test hearing handicap inventory elderly self assessment questionnaire hearing handicap also calculated audiometrically derived american academy otolaryngology method results consistent studies indicate low correspondence audiometric measures hearing handicap self assessment hearing handicap furthermore hearing handicap inventory elderly considered true measure hearing handicap data indicate american academy otolaryngology method tends overestimate handicap among persons self perceived hearing handicap underestimates handicap among persons significant self perceived hearing handicap,C23,0.0036400033,0.0032288644,0.0067918682,0.0020451692,0.005198179,0.0047783633,0.30854028,0.0034285148,0.020160325,0.0035765169,0.13342595,0.0076076537,0.13053955,0.008392456,0.003200927,0.005668242,0.03496503,0.0038358746,0.039373,0.20333411,0.06320523,0.0012924329,0.0037714767
postinduction repression beta interferon gene mediated two positive regulatory domains virus induction human beta interferon beta ifn gene results increase rate beta ifn mrna synthesis followed rapid postinduction decrease paper show two beta ifn promoter elements positive regulatory domains ii prdi prdii required virus induction beta ifn gene also required postinduction turnoff although protein synthesis necessary activation necessary repression promoter elements examination nuclear extracts cells infected virus reveals presence virus inducible cycloheximide sensitive dna binding activities interact specifically prdi prdii propose postinduction repression beta ifn gene transcription involves virus inducible repressors either bind directly positive regulatory elements beta ifn promoter inactivate positive regulatory factors bound prdi prdii,C23,0.014736045,0.002241593,0.0155753335,0.0014198297,0.041599955,0.0032612514,0.1433624,0.0023764407,0.0018269232,0.002482946,0.07613508,0.005197598,0.019439971,0.047509715,0.002222198,0.02839652,0.067401506,0.12756333,0.0028773844,0.0672007,0.07771355,0.0008972531,0.24856251
nurse monitored cardiac recovery description first weeks health problems related patient management early recovery cardiac surgery well documented part larger study recovery cardiac surgery patient care giver pairs received telephone calls nurses weeks discharge purpose intervening facilitate early recovery home call nurses recorded detailed notes patients progress concerns content analysis detailed nurses recordings revealed following predominant nursing actions assessment provision support reinforcement predischarge teaching referrals teaching five nursing diagnoses occurred frequently across week recovery period altered comfort pain ineffective coping individual activity intolerance sleep pattern disturbance altered nutrition response problems patients managed prevented health related problems engaged health promotional normalizing activities anticipating common problems recovery patients care givers better prepared going home similarly nurses better prepared anticipate respond common recovery problems,C23,0.0020710875,0.011861436,0.0038777469,0.021205159,0.002890757,0.0026728462,0.33068258,0.0019476757,0.0014973041,0.002034965,0.020891577,0.02820383,0.015314243,0.00488474,0.0018212621,0.013247681,0.18921436,0.0021344053,0.042451333,0.1102439,0.1879817,0.0007353679,0.0021340873
nuclear pacemaker renewed interest warranted radioisotope powered nuclear pacemakers implanted patients newark beth israel medical center longevity first devices fixed rate voo pacemakers significantly better lithium chemistry demand vvi pacemakers used control devices p entire cohort nuclear pacemakers vvi devices voo units patients voo pacemakers needed reoperations often vvi pacemakers chiefly mode change p less power source failure observed case nuclear pacemakers removed reasons including component malfunction units mode change units high pacing thresholds units lead connector problems units actuarial survival years power sources entire pacing systems pulse generators plus leads frequency malignancy similar population large primary tumor sites randomly distributed deaths commonly due cardiac causes thus nuclear pacemakers safe reliable greater initial cost appears offset longevity resulting decrease frequency reoperations reasonable suggest use made long lasting nuclear power sources modern pacemakers implantable rhythm management devices,C23,0.0022791673,0.057147652,0.08142116,0.0012796385,0.014210441,0.002939242,0.33896312,0.0021417956,0.012660543,0.002237785,0.022072263,0.016047524,0.0959462,0.0163081,0.012804264,0.0145507045,0.13142009,0.0023488891,0.0025932773,0.06370865,0.08172957,0.0008086602,0.024381297
hemiparkinsonism hemiatrophy syndrome clinical neuroradiologic features evaluated patients hemiparkinson hemiatrophy syndrome body contralateral cerebral hemispheric hemiatrophy body hemiatrophy brain hemiatrophy mean age symptom onset years range mean sd years illness last follow visit presenting symptom unilateral tremor patients hand dystonia bradykinesia abnormal gait patient three patients good response levodopa moderate response patients poor response mean follow period years range months years hoehn yahr score changed patients gained points gained points years discuss association hemiparkinsonism body hemiatrophy contralateral hemispheric hemiatrophy raise possibility early childhood brain insult delayed onset parkinsonism,C23,0.044089444,0.016260384,0.005299602,0.0015958177,0.031230345,0.003700178,0.14629437,0.0026710005,0.0020533705,0.054982625,0.06398177,0.01836508,0.025562823,0.0065305997,0.04342301,0.018107986,0.29423812,0.0029249813,0.0032340365,0.09696334,0.1145607,0.0010084677,0.0029219391
hiccups breathing human fetuses serial recording low risk fetuses throughout second third trimesters showed hiccups predominant diaphragmatic movement weeks gestational age significant negative correlation gestational age pronounced reduction weeks result decrease number episodes hiccups rather change duration episodes contrast fetal breathing positively correlated gestational age greatest increase breathing occurring weeks gestation result increase number duration episodes time rest activity cycles behaviour could determined recordings breathing hiccups dependent behavioural state cycle occurring predominantly active episodes association quiet active behaviour breathing alter increasing gestational age variables fetal behavioural state became increasingly closely linked importance prolonged repeated recording also need take account variables fetal behaviour sinister conclusions drawn absence fetal breathing emphasised,C23,0.002203855,0.0019549294,0.025439031,0.0012382562,0.0030687982,0.0028441898,0.27782688,0.0020754186,0.07624168,0.034121506,0.015701838,0.0045329086,0.09258438,0.010769845,0.012602459,0.0034318606,0.07223958,0.0022711311,0.002509413,0.12691836,0.18370993,0.04343137,0.002282399
three year outcomes maintenance therapies recurrent depression conducted randomized year maintenance trial patients recurrent depression responded combined short term continuation treatment imipramine hydrochloride interpersonal psychotherapy five cell design used determine whether maintenance form interpersonal psychotherapy alone combination medication could play significant role prevention recurrence second question whether maintaining antidepressant medication dosage used treat acute episode rather decreasing maintenance dosage would provide prophylaxis superior observed earlier trials maintenance dosage strategy employed survival analysis demonstrated highly significant prophylactic effect active imipramine hydrochloride maintained average dose mg modest prophylactic effect monthly interpersonal psychotherapy conclude active imipramine hydrochloride maintained average dose mg effective means preventing recurrence monthly interpersonal psychotherapy serves lengthen time episodes patients receiving active medication,C23,0.0024092717,0.04878923,0.025867844,0.0013536715,0.0033551303,0.051672596,0.31740668,0.0022657083,0.0017417961,0.0023672509,0.025890525,0.0056830696,0.055323247,0.019876534,0.0021186527,0.003751737,0.12098547,0.0024896762,0.03773122,0.12610552,0.13947515,0.0008554449,0.0024846054
ethical principles geriatric nephrology seven principles suggested resolve ethical issues raised medical developments affecting aging society first must clear identification goals medical treatment second treatments must consider whole person third physiological concerns important chronological age fourth patient choice must respected choice result informed decision making process fifth access equitable respecting sixth principle requires allocation resources finally society must clearly identify appropriate principles guide care dying person,C23,0.003577285,0.0031732302,0.02398015,0.0020099306,0.004981256,0.03923475,0.30275977,0.003364122,0.0025862178,0.0035148924,0.028708532,0.024658587,0.02214405,0.009123519,0.0031457741,0.022885576,0.09311985,0.0036840104,0.09065006,0.19855028,0.109197825,0.0012701639,0.003680179
transsynaptic degeneration superficial dorsal horn sciatic nerve injury effects chronic constriction injury transection strychnine lumbar cervical spinal dorsal horns adult rats chronic days constriction injury sciatic nerve one side sham operation examined signs transsynaptic degeneration incidence neurons signs degeneration pyknosis hyperchromatosis dark neurons significantly increased lumbar dorsal horn sides ipsilateral lumbar increase significantly greater contralateral increase increase incidence dark neurons cervical dorsal horns rats distribution lumbar dark neurons similar bilaterally majority dark neurons found sciatic nerve territory laminae ii second group rats received surgery addition received series daily subconvulsive doses strychnine dark neurons found bilaterally ipsilateral predominance sciatic nerve territory lumbar laminae ii incidence significantly greater found group receive strychnine result obtained third group strychnine treated rats sham operation omitted thus appearance contralateral dark neurons dependent unintentional nerve damage created sham procedure additional group rats sacrificed days receiving unilateral sciatic nerve transection contralateral sham operation daily strychnine injections increase incidence dark neurons rats,C23,0.036133375,0.024599489,0.0043431544,0.0013078119,0.0032411797,0.0030039542,0.12915452,0.013450164,0.0016827878,0.02481956,0.016759116,0.11155703,0.056939315,0.017263558,0.002046877,0.003624636,0.09611646,0.0023970942,0.0026503725,0.124642216,0.32104623,0.00082646415,0.002394601
hypoxemia postanesthesia care unit observer study determine incidence duration hypoxemia postanesthesia care unit pacu patients investigated single blind observer study number unrecognized hypoxemic episodes well risk factors possible association hypoxemia postoperative morbidity studied oxygenation monitored continuously pulse oximeter one hypoxemic episodes spo less equal noted patients spo values less equal noted patients supplementary oxygen given hypoxemic episodes registered hypoxemic episodes unrecognized staff cases stepwise multiple logistic regression analyses risk factors associated higher incidence hypoxemia duration anesthesia p less age p less history smoking p less patients undergone regional anesthesia lower risk hypoxemia p less occurrence hypoxemia pacu could correlated postoperative morbidity conclude hypoxemic episodes pacu common routine use supplemental oxygen combined normal clinical surveillance prevent hypoxemic episodes,C23,0.0025905129,0.014836885,0.004864683,0.0014555035,0.003607207,0.0033431917,0.14841107,0.0024361496,0.014355729,0.002545331,0.04629036,0.0054423725,0.19187161,0.006081382,0.014817184,0.029107217,0.18159303,0.0026687265,0.015482907,0.2145954,0.09001193,0.000919797,0.002671817
behavioral modification colonic function constipation learned challenged two hypotheses first defecation suppressed extended time second effect upper colonic motility thus studied male volunteers conditions identical nutrition patterns physical activity two week period one week normal defecation one week voluntary prolonged suppression defecation followed randomized order frequencies defecation stool weights total segmental colonic transit times using radiopaque markers compared frequency defecations stool weights lower suppressed defecation vs mean se bowel movements per week p vs kg week p total transit times increased hr p segmental transit times increased rectosigmoid hr p right hemicolon hr hr p suppression defecation conclude defecation habits may induce changes colonic function seen constipation functional anorectal outlet obstruction may probably reflex mediation affect right colon,C23,0.002623616,0.0023272783,0.030287452,0.0014741028,0.0036533023,0.003385913,0.18172397,0.028270584,0.0018967576,0.0025778569,0.027329123,0.005957261,0.093525216,0.0063654426,0.00230726,0.01670545,0.07550867,0.028284883,0.027835365,0.08682306,0.36750686,0.00093155075,0.0026990795
prehospital prophylactic lidocaine favorably affect outcome patients chest pain study objectives purpose study determine morbidity mortality initially stable patients presenting paramedics chest pain examine possible beneficial effects use including reduction sudden death syndrome prehospital emergency department setting determine prophylactic lidocaine associated adverse effects patient population design setting randomized prospective study using prophylactic lidocaine patients complaining chest pain presented paramedic system january january type participants patients aged years older chest pain suspected cardiac origin presented paramedics study period included excluded patients presenting warning arrhythmias second third degree heart block bradycardias less hypotension less mm hg systolic known allergy lidocaine interventions patients randomized two groups lidocaine treated group control group initial bolus mg kg iv lidocaine administered lidocaine treated group simultaneous mg min iv drip established ten minutes first dose lidocaine second bolus mg kg administered measurements main results study period patients entered received lidocaine discharge diagnoses included acute myocardial infarction unstable angina cardiac problems noncardiac problems overall mortality rate equal distribution deaths lidocaine treated group control group six patients cardiac arrest prehospital setting cardiac arrest ed malignant ventricular arrhythmias precipitating arrest rhythm patients acute myocardial infarctions similar lidocaine treated control groups incidence adverse effects including hypotension bradycardias second third degree heart blocks tinnitus altered mental status similar groups conclusion benefits administration prehospital prophylactic lidocaine stable patients chest pain therefore routine use setting appears unwarranted,C23,0.0013220734,0.026536189,0.01439449,0.0007363649,0.0018249018,0.021469234,0.22187154,0.0012324587,0.00094747054,0.0012900899,0.018461827,0.0915492,0.12266403,0.0030446807,0.0011524662,0.002043253,0.21187828,0.001349651,0.0015542707,0.1370851,0.11577825,0.0004653293,0.0013488313
molecular biology circulatory shock part iii human hepatoblastoma hepg cells demonstrate two patterns shock induced gene expression independent exclusive prioritized shock resuscitation parenchymal cells solid organs exposed rapidly changing microenvironment may include reduced oxygen tension increased concentration certain cytokines including tumor necrosis factor alpha interleukin vivo experiments testedl iver biopsied pigs undergoing cardiogenic shock resuscitation demonstrated several patterns gene expression study independent additive influences hypoxia cytokines vitro human hepatoblastoma hepg cells perturbed hypoxia reoxygenation h r heat shock cytokines interleukin tumor necrosis factor alpha alone combination h r induces new patterns protein synthesis secretion indistinguishable induced heat shock independent acute phase response mediated cytokines h r heat shock response priority extinguish gene expression supported cytokines previously unrecognized hierarchy stress gene expression could well form molecular basis shock related cell organ failure,C23,0.0023813462,0.013639746,0.004445228,0.0013379812,0.02638682,0.003073251,0.23769648,0.0022394466,0.0017216073,0.0023398125,0.012601479,0.005647919,0.016109768,0.12459915,0.013619918,0.027474951,0.032496788,0.03120794,0.0027115128,0.05542008,0.23078273,0.023898745,0.12816732
assessment patient laboratory data acutely ill laboratory test results valuable source information nurses need assess laboratory test results part physical assessment patients comparison laboratory test results changes abnormal physical findings provides basis changes nursing care plan progressive monitoring laboratory results prompt interventions might lessen seriousness health problem acute care units initial group laboratory tests serves baseline assessing additional test results several reference values remembered particularly electrolytes potassium sodium calcium glucose bun creatinine albumin specific group profiles assist identifying monitoring patient health status incorporating laboratory test results plan evaluation care result safer effective patient care referring laboratory test findings comparing physical assessment findings required delivery professional nursing care,C23,0.0019172991,0.00170074,0.012949048,0.0010772521,0.011950072,0.021032955,0.5061427,0.0018030512,0.010663666,0.0018838589,0.09204119,0.022507528,0.057502653,0.014161138,0.0016860244,0.012264428,0.060889017,0.0019745003,0.020743394,0.114308365,0.028147431,0.0006807632,0.001972965
role calcium calcium channel initiation maintenance ventricular fibrillation cellular events initiation maintenance ventricular fibrillation vf poorly understood developed nonischemic isolated perfused rabbit langendorff preparation sustained vf could induced alternating current ac allowed changes perfusate composition also used na k pump inhibition microm ouabain k free perfusate induce vf ac stimulation na k pump inhibition always initiated vf calcium channel blockade verapamil nitrendipine uniformly inhibited initiation vf models na k pump inhibition vf prevented calcium channel blockade despite evidence ca overload abolition spontaneous sarcoplasmic reticulum generated cytosolic ca oscillations ryanodine na channel blockade tetrodotoxin prevent vf initiation lowering extracellular ca microm uniformly prevented initiation vf due na k pump inhibition due ac stimulation vf maintenance also studied using reduction perfusate ca blockade ca channels electrical defibrillation decreasing perfusate ca microm resulted defibrillation vf whether induced ac na k pump inhibition verapamil nitrendipine also resulted defibrillation regardless initiation method electrical defibrillation successful ac induced vf results demonstrate vf initiated maintained nonischemic rabbit langendorff preparation data suggest increases slow channel ca flux opposed increases cytosolic ca per se necessary initiation maintenance vf data however exclude important role cytosolic ca modulation vf,C23,0.0021437926,0.032992754,0.0039948816,0.021929769,0.0029814586,0.0027630704,0.2556655,0.0020134212,0.0015478468,0.002103657,0.023894357,0.06795652,0.01704329,0.13986969,0.0018827403,0.013695844,0.03514678,0.07570512,0.002437842,0.025405198,0.26586375,0.0007601909,0.0022025805
total perinatal wastage clarification priorities pregnancy outcome women carrying living fetuses weeks gestation studied well recording perinatal deaths losses weeks one year delivery recorded give total perinatal wastage rate per fetuses alive weeks compared perinatal mortality rate stillbirths plus early neonatal deaths per births deaths classified according pathological sub groups concept auditing perinatal care using perinatal mortality compared using total perinatal wastage,C23,0.0037054978,0.0032869615,0.0069140745,0.0020819681,0.0051597883,0.022706501,0.17471439,0.003484695,0.07437706,0.02157372,0.06490261,0.027579874,0.07240327,0.008520084,0.003258853,0.0057702307,0.06343282,0.0038160484,0.0042192545,0.32074594,0.10221855,0.0013156877,0.0038120796
influence high dose aprotinin treatment blood loss coagulation patterns patients undergoing myocardial revascularization intraoperative administration proteinase inhibitor aprotinin causes reduction blood loss homologous blood requirement patients undergoing cardiac surgery ascertain blood saving effect aprotinin obtain information mode action patients undergoing primary myocardial revascularization randomly assigned receive either aprotinin placebo treatment aprotinin given bolus x kallikrein inactivator units kiu surgery followed continuous infusion x kiu h surgery additionally x kiu added pump prime strict criteria used obtain homogeneous patient selection total blood loss reduced ml control group ml aprotinin group p less homologous blood requirement ml ml p less control group u homologous blood blood products given aprotinin group u given p less twenty five percent patients control group aprotinin group receive banked blood homologous blood products activated clotting time indicator inhibition contact phase coagulation significantly increased heparinization aprotinin group vs remained significantly increased heparin neutralized cardiopulmonary bypass cpb,C23,0.0018164724,0.0016111082,0.012175933,0.0010204791,0.0025290765,0.019920288,0.11025889,0.0017080274,0.001313071,0.0017845765,0.0276227,0.10922345,0.26611054,0.0041761296,0.010366594,0.011617528,0.1728542,0.011545896,0.010859092,0.027828135,0.18236725,0.0006448859,0.010645671
facial nerve injury hemifacial spasm studied evidence facial nerve damage patients hemifacial spasm three types evidence nerve damage analyzed objectively measured weakness eyelid protractor strength clinically evident weakness muscles innervated seventh nerve clinically evident aberrant seventh nerve regeneration patients study least one features seventh nerve damage objectively measured eyelid protractor weakness noted patients tested clinically apparent weakness least one four facial muscle groups noted patients aberrant seventh nerve regeneration documented patients findings indicate facial nerve damage common patients hemifacial spasm,C23,0.01954523,0.00296825,0.00624367,0.0018802186,0.004659483,0.0043184506,0.2220395,0.003146811,0.067213774,0.019477291,0.031247333,0.023082053,0.13442378,0.04066446,0.0029425675,0.005210736,0.17133297,0.0034460356,0.0038101457,0.023902254,0.20379508,0.0011881154,0.003461783
defective dystrophin duchenne becker dystrophy myotubes cell culture examined normal dystrophic human myotubes cell culture expression dystrophin protein product duchenne muscular dystrophy locus dystrophin levels developing myotubes detected western blotting increased hours reached maximum levels days fusion medium detect dystrophin myotubes cultured duchenne myoblasts cases myotubes becker muscular dystrophy patient biopsy produced lower molecular weight approximately kd dystrophin size whole muscle preparation biopsy kd dystrophin expected size becker patient whose dna deleted exons duchenne gene cell culture system allow detailed analysis effects potential pharmacologic agents steady state dystrophin levels,C23,0.0028792887,0.0025540728,0.033247445,0.029488945,0.0041479967,0.003715872,0.16621679,0.002707718,0.04389364,0.016760577,0.048196126,0.061617345,0.03646195,0.10416156,0.0025319739,0.0044836514,0.064767435,0.031160656,0.0032784936,0.036485147,0.2153831,0.0010223308,0.08483786
family recovery vascular surgery twenty one families observed month study assess family coping major vascular surgery recovery analysis family measures data family apgar family inventory resource management family crisis oriented personal evaluation scales combined grounded theory method assess family responses time recovery outcomes containment emerged major conceptual category grounded theory containment refers constellation constructed meanings events behavioral responses used families regulate impact surgical crisis reduce family disruption contained coping pattern manifested families avoidant behaviors narrow definitions problem defined situation terms surgical repair cure rather palliative intervention chronic progressive disease situational factors insidious development illness primary focus care providers hospital surgical care allowing families narrow definitions situation remain unchallenged also contributed containment containment resulted poor risk factor management major recovery outcome isolation family conflict evident throughout recovery period concerns generated continued evidence morbidity recovery contributed developing awareness underlying disease diminishing containment growing awareness openly shared within family significant findings family measures analysis compared grounded theory qualitative data corroborated key dimensions,C23,0.001545989,0.008839742,0.010326713,0.008348914,0.02459368,0.04686799,0.24850227,0.0014780505,0.023548733,0.008983179,0.03483142,0.010651881,0.033192534,0.162793,0.0013592526,0.017365357,0.12021628,0.0015918183,0.015470359,0.088028766,0.122232795,0.007632902,0.001598389
recombination two bp homologous sequences mechanism gene deletion factor ix seattle factor ixseattle kb intragenic deletion identified family hemophilia b sequencing across site deletion discovered deletion junction bp sequence tagaa gttcactt homologous two bp sequences kb apart introns f normal factor ix gene presence homologous sequences two different regions normal gene allows us propose genetic recombination occurred sequences resulting gene deletion precise recombination site able localized one bp agttc middle homologous sequences exact length deletion bp,C23,0.0037731356,0.0033469596,0.0070738965,0.020373235,0.0052539716,0.004869428,0.1813139,0.0035483025,0.0027278091,0.0037073272,0.02731077,0.007760619,0.028570777,0.097872585,0.0033180001,0.0058755567,0.03533088,0.027722899,0.0042962697,0.030522002,0.12618783,0.0013397033,0.3679042
urothelial grafts mice mouse bladder epithelium successfully transplanted bladders syngeneic mice survived least twenty weeks fate transplanted tissue followed using fluorescein label recipient bladders prepared stripping urothelium either surgical chemical method possibility adopting comparable technique treatment early bladder cancer man discussed,C23,0.005069222,0.0044966526,0.009458642,0.002848189,0.007058731,0.031072663,0.24664971,0.0047671576,0.0036648219,0.004980808,0.0685135,0.059500203,0.056744665,0.09379423,0.0044577457,0.007893832,0.20085397,0.005220458,0.0057720547,0.057069637,0.113098145,0.0017998965,0.0052150283
isolation novel tumor protein induces resistance natural killer cell lysis human metastatic tumor cell line cap produces soluble factor induces resistance nk lysis k susceptible leukemia cell line inhibit cytotoxic capacity effector cells use sequential hplc hydrophobic interaction chromatography reverse phase chromatography coupled cytotoxic assays resulted isolation separation homogeneity novel protein responsible biologic activity size estimation studies based tsk hplc columns showed protein mass kda amino acid composition analysis cap protein calculated hplc chromatograms shows protein contains around amino acids subsequent gas phase sequence analysis however hampered n terminus protein blocked therefore unsuitable sequencing edman degradation functional studies showed nk lysis resistance activity cap protein mediated interaction nonspecific binding nk target cells lymphokine activated killer macrophage mediated cytotoxicity mitogen induced proliferation affected unexpectedly cap protein appears mitogenic cell line thus induction nk lysis resistance mitogenic activity showed cap protein could contribute tumor growth metastatic establishment,C23,0.0019187093,0.0017019908,0.012864118,0.0010780444,0.035844218,0.04523792,0.198752,0.029643929,0.010656254,0.0018852445,0.047116414,0.003946418,0.012354213,0.17557321,0.010966243,0.04013918,0.018080357,0.12585601,0.020744858,0.02322291,0.11324106,0.0006812639,0.06849543
observer variability scoring colpophotographs colposcopy cervicography accepted tools assessing cervix atypical transformation zone studied validity colpophotograph measurement tool determining agreement experienced colposcopists using colpophotographs women interobserver agreement generally fair good kappa greater equal presence squamocolumnar junction area ectopia poor kappa less area border color characteristics atypical transformation zone intra observer agreement fair good color characteristics atypical transformation zone poor area border characteristics conclude observer agreement studies play role validation methods used visual diagnosis cervical intraepithelial neoplasia considerable lack agreement reporting cytologic findings well known problem lack agreement might even bigger problem reporting colposcopic findings,C23,0.002624093,0.0023277015,0.05569892,0.014164747,0.029037839,0.003386529,0.42047817,0.002467729,0.0018971025,0.027972098,0.04088267,0.005397258,0.096017376,0.0061470913,0.0023075612,0.004086259,0.13387758,0.015350752,0.0029879159,0.032739956,0.08381654,0.013632963,0.002701137
comparison parallel versus perpendicular placement retention sutures abdominal wound closure new technique placement retention sutures described twenty five rats underwent midline laparotomy incision control group closed traditional placement retention sutures placed perpendicular direction wound experimental group closed retention sutures placed parallel direction wound described wound bursting strength significantly p less greater one five days experimental group compared control animals addition inflammatory reaction pressure necrosis greater control group appears parallel placement sutures less tendency cut tissue subjected distracting forces midline wound,C23,0.064953394,0.0028302413,0.0059533706,0.0017926806,0.004442841,0.0041176644,0.109402835,0.018435799,0.017746745,0.034013484,0.020281482,0.072980404,0.1588647,0.0074946517,0.002805753,0.0049684625,0.15427145,0.0032858122,0.003632993,0.02219383,0.28111616,0.001132874,0.0032823947
circadian variation onset acute ischemic stroke circadian pattern onset myocardial cerebral infarction identified evaluate phenomenon analyzed prospectively collected data patients acute ischemic stroke number strokes per hour period following midnight noon noon pm pm midnight pattern affected previous use aspirin frequent time onset noon subgroups ischemic stroke small artery cardioembolic large artery atherothrombotic large artery atheroembolic unknown cause also investigated time awakening stroke onset patients found ischemic strokes occurred within first hour awakening data demonstrate early morning peak exists subtypes stroke data also suggest critical period first hour awakening,C23,0.05348648,0.002329825,0.004900752,0.014178703,0.0036592335,0.003440175,0.24655308,0.00246998,0.0018988331,0.0788302,0.08645967,0.0058295685,0.07862827,0.0062601776,0.0023096662,0.004089986,0.23822759,0.002704846,0.0029906416,0.038300253,0.11880622,0.00093257,0.00271328
biliary endoprostheses plastic versus metal stents plastic biliary endoprostheses relieved malignant obstructive jaundice patients comfort completely indwelling endoprosthesis offered palliatively treated tumor patients external internal catheters reserved minority patients return reoccluded endoprostheses patients bacterial flora rapidly contaminates endoprosthesis causes encrustations reocclusions thus second endoprosthesis also would reocclude quickly mechanism reocclusion plastic metal endoprostheses completely different plastic endoprostheses bacterial contamination causes decomposition bile subsequent encrustation metal endoprostheses tumor ingrowths struts stent cause reocclusion tumor ingrowths observed metal prostheses narrow woven mesh wallstent whereas prostheses large distances struts gianturco stent ingrowth rates fact shows tumor ingrowths reduced narrowing spaces metallic network therefore improvements design metal stents reduce occlusion rate plastic endoprostheses currently lower encrustation rate major advantages expandable metal prostheses relative ease minimal trauma implantation procedure wallstent endoprosthesis particular inserted f introducer sheath offers chance single step placement day mortality rate therefore significantly lower day mortality rate insertion plastic prostheses even simple external catheter drainage procedures higher reported day mortality rate expandable metal endoprostheses would useful device occlusion rate could kept large series increasing length endoprostheses cm expanded state could also improve long term patency rates,C23,0.03832293,0.010683187,0.020795722,0.0010482839,0.038834903,0.021165859,0.2612576,0.0017545656,0.019364696,0.0018332002,0.03424797,0.012852445,0.035087083,0.022471344,0.019653114,0.0029073418,0.11277226,0.0019599078,0.0021244208,0.15670487,0.18157342,0.0006624569,0.001922422
rapid percutaneous tracheostomy describe new method performing percutaneous tracheostomy rapidly safely using specialized instrument kit technique permits safe insertion full sized id mm id cuffed cannula trachea within min membranous second intercartilagenous space animal studies demonstrated superior healing process compared seen conventional tracheostomy techniques,C23,0.0047224606,0.004189058,0.0088224895,0.002653358,0.0066990606,0.0060945814,0.22890973,0.004441059,0.0034141287,0.004640095,0.20090556,0.009823356,0.065936,0.011198841,0.0041528125,0.0074249897,0.11848063,0.0048633516,0.005377216,0.12982266,0.16089348,0.0016767741,0.004858293
intraoperative air testing colorectal anastomoses prospective randomized trial total consecutive patients receiving colorectal anastomosis randomized test test anastomosis completed anastomotic testing performed pelvis filled saline rectum distended sigmoidoscopic insufflation air leaks demonstrated oversewn water soluble contrast enema performed tenth postoperative day seventy four patients randomized test test one patient withdrawn group leaving total analysis two groups well matched age sex diagnosis operative details eighteen per cent air leaks detected repaired test group operation three per cent clinical leaks test group ten per cent test group fisher exact test p eight per cent radiological leaks test group per cent test group p intraoperative air testing repair colorectal anastomoses significantly reduces risk postoperative clinical radiological leaks,C23,0.0024493083,0.049567927,0.01636534,0.0013755009,0.0034093834,0.0031594313,0.092151366,0.014151691,0.0017698845,0.0024054253,0.21276614,0.15214458,0.030919421,0.041274473,0.0021971907,0.0038122379,0.20202094,0.0025211617,0.017330024,0.06766596,0.077148795,0.0008692398,0.0025245394
evaluating hematuria children start proceed bleeding somewhere along urinary tract unusual children many causes systemic infection trauma among common history taking physical examination careful complete results obtained help direct laboratory evaluation diagnostic testing always begins urinalysis may progress intravenous urography voiding cystourethrography endoscopic procedures upper lower urinary tract sonography arteriography renal biopsy cases remain unexplained require follow assess renal function,C23,0.0035777695,0.00317366,0.058635574,0.0020102027,0.02230105,0.0055621485,0.30994242,0.003364997,0.002586568,0.0539026,0.10578574,0.024671702,0.039995495,0.00859033,0.020464951,0.02271065,0.1423453,0.0036845093,0.004349817,0.044805165,0.11258838,0.001270336,0.0036806774
mechanical myocardial actuation ventricular fibrillation improves tolerance ischemia compared cardiopulmonary bypass direct mechanical ventricular actuation dmva unique non blood contacting biventricular assist device provides circulatory support ventricular fibrillation without demonstrating adverse effects myocardium purpose study assess preservation myocardial energy stores myocardial responses ischemia circulatory support ventricular fibrillation direct mechanical ventricular actuation versus cardiopulmonary bypass twenty adult mongrel dogs randomized receive circulatory support either cardiopulmonary bypass direct mechanical ventricular actuation hours ventricular fibrillation hearts defibrillated left ventricular transmural biopsies obtained hearts excised subjected minutes normothermic total ischemia serial biopsies obtained minute intervals determine regional depletion high energy phosphates time peak ischemic contracture recorded using needle tipped millar catheters placed left ventricular endocardium epicardium septum right ventricle time peak ischemic contracture endocardium vs minutes p less septum vs minutes p less significantly prolonged direct mechanical ventricular actuation versus cardiopulmonary bypass respectively similar trends noted epicardium right ventricular regions however differences statistically significant left ventricular adenosine triphosphate atp levels better preserved direct mechanical ventricular actuation mumols g dry wt compared cardiopulmonary bypass mumols g dry wt depletion left ventricular endocardium atp normothermic ischemia significantly delayed direct mechanical ventricular actuation compared cardiopulmonary bypass,C23,0.036441397,0.0015450314,0.020110756,0.0009786261,0.0024256052,0.026883269,0.12558037,0.0016379758,0.0012592177,0.010140019,0.029877942,0.012812179,0.24861915,0.004102072,0.0015316807,0.0027297852,0.1430428,0.0017937279,0.0019832542,0.16879909,0.121545665,0.034345742,0.0018146329
premenstrual syndromes defined symptom sets analysis made pattern presenting premenstrual symptoms randomly selected general practice patients wellington region new zealand participants healthy women years old whose characteristics reasonably representative adult female population asked general obstetrical gynaecological health women menstruated within last month detailed questions asked last menstrual cycle woman assigned one seven premenstrual symptom sets three groups pure symptoms ie predominant single symptom breast tenderness bloating irritability three groups mixed symptom sets largest mixed groups formed women reported breast tenderness bloating irritability together tension depression women group likely rate symptomatology severe last group contains large number women miscellaneous symptoms characteristics groups outlined study highlights importance distinguishing among premenstrual syndromes foster effective clinical management,C23,0.0023286408,0.002064728,0.03812348,0.023833925,0.0032421374,0.08669697,0.31223288,0.0021889356,0.0016827761,0.020289756,0.02928146,0.07239962,0.026466709,0.005725004,0.013310561,0.003624611,0.0442113,0.0023970776,0.042219374,0.21452461,0.04980309,0.00082645845,0.0025258786
efficacy methylprednisolone reducing flap edema suggested systemic steroids reduce postoperative flap edema poorly documented several reports based subjective clinical observations effort provide quantitative data methylprednisolone edema flap edema model rat developed based inferior epigastric vessels significant edema developed hours differing intraoperative doses methylprednisolone studied producing dose response curve single low dose intraoperative steroid effective reducing flap edema previously recommended doses probably excessive,C23,0.0033472986,0.0029678917,0.022438336,0.0018798686,0.0046589207,0.0043179295,0.2707418,0.0031511758,0.0024188645,0.003287445,0.03247778,0.03927151,0.06550604,0.0076930276,0.0029422122,0.0052101067,0.11634519,0.0034456195,0.020000001,0.04667507,0.33658606,0.001187972,0.0034498917
postmortem chorionic villus sampling better method cytogenetic evaluation early fetal loss culture abortus material utero chorionic villus sampling time diagnosis intrauterine fetal death compared traditional use cultured fetal skin products conception amniocentesis total specimens early fetal losses evaluated success karyotyping chromosomal results found postmortem chorionic villus sampling technically possible offers highest likelihood getting cytogenetic result rapid reliable safe technique extraembryonic component intrauterine fetal deaths appears remain viable continues grow long embryo died samples obtained time diagnosis fetal death offer greatest changes successfully obtaining karyotype incidence chromosome abnormalities associated fetal loss particularly trisomies higher previous data suggested,C23,0.0023559066,0.0020898066,0.015830167,0.0013236878,0.026090136,0.014434972,0.26555908,0.002215523,0.10432419,0.0023148165,0.16659844,0.0048456495,0.031808127,0.028475545,0.002071805,0.0036686365,0.06356445,0.002426193,0.0026825462,0.19081335,0.051852737,0.0008364968,0.01381769
maternal serum screening aneuploid pregnancy alpha fetoprotein hcg unconjugated estriol number serum screening protocols either currently use proposed identify pregnant women years age increased risk syndrome fetus suggested screening methods applied gravidas years age identify women offered amniocentesis evaluate efficacy screening detection aneuploid pregnancy age group serum samples women underwent amniocentesis confirmed fetal aneuploidy assayed alpha fetoprotein afp hcg unconjugated estriol e concentrations compared women known euploid pregnancy underwent amniocentesis advanced maternal age mean multiple median mom three markers significantly different control values cases trisomy afp median mom unconjugated e median mom hcg median mom differences found aneuploidies considered likelihood ratios calculated cases controls examined ability predict need amniocentesis based currently recommended risk levels significant difference mean likelihood ratio cases trisomy compared controls mean likelihood ratio significant difference aneuploidies mean likelihood ratio cases trisomy analyzed four would diagnosed antenatally recommendation amniocentesis made based woman individual age specific risk modified likelihood ratio,C23,0.0016430964,0.0014575085,0.011607852,0.00092318887,0.0022879597,0.002129286,0.104577586,0.0015451878,0.017056545,0.0016144387,0.22652824,0.011922942,0.14239219,0.014410107,0.0014448975,0.0025586428,0.07268514,0.0016943237,0.009810088,0.26483628,0.10459499,0.00058340386,0.001696147
cytomegalovirus macerated second trimester fetus persistent viral inclusions light electron microscopy macerated stillborn fetus represents least one third perinatal deaths microscopic examination specimens often unrewarding reported clinically unsuspected cytomegalovirus infection second trimester macerated fetus cells suggestive cmv inclusions identified light microscopy electron microscopy confirmed presence viral infection proved valuable making diagnosis even though necrosis severe,C23,0.004741697,0.0041897804,0.008813141,0.0026538156,0.0065770107,0.028941594,0.26742333,0.0044557587,0.09483209,0.004640895,0.12207104,0.032280814,0.029237939,0.08876982,0.0041535287,0.0073551214,0.04752498,0.08486535,0.0053781434,0.08844425,0.056113727,0.0016770633,0.0048591313
effect outcome prolonged exposure patients nitrous oxide prolonged several days repeated exposure nitrous oxide n cause injury death assess whether relatively prolonged anesthesia n normal patients might similarly cause untoward effects investigated whether addition n isoflurane anesthesia caused injury patients surgical resection acoustic neuroma lasting approximately h twenty six patients undergoing surgical resection acoustic neuroma randomly assigned regimen included excluded n isoflurane anesthesia plus intravenous adjuvants average slightly less isoflurane used anesthesia n measured standard clinical variables blood pressure heart rate oxygen saturation neurologic status pain incidence type morbid outcomes exposure n increase incidence morbid outcomes including hepatic injury infection hypoxemia prolong hospitalization increase common postoperative complaints nausea vomiting coughing headache patients anesthetized either regimen equally satisfied anesthetic,C23,0.03614073,0.0020651624,0.0043440387,0.0013081304,0.01432224,0.003025435,0.25979403,0.0021893964,0.0016831303,0.013554128,0.02391982,0.016051503,0.07610384,0.0054321685,0.0020472938,0.082498826,0.20081191,0.0023988178,0.002650912,0.121609055,0.12482737,0.0008266324,0.0023954266
traction injury internal mammary artery report case review literature internal mammary artery ima used routinely along saphenous vein myocardial revascularization procedures documented particular form non perforating injury may reduce blood flow operation may lead early closure ima bypass graft traction injury intima well documented vessles previously reported ima present potentially disastrous example traction injury ima,C23,0.12777166,0.0036837521,0.007748718,0.002333296,0.00578266,0.005359421,0.28940913,0.0239389,0.0030022988,0.0040803826,0.04200603,0.008541542,0.0901681,0.009742315,0.0036518788,0.10320171,0.16082548,0.0042767087,0.0047285883,0.030911097,0.06308493,0.001474513,0.0042769266
cardiac arrhythmias critically ill patients epidemiologic study general prevalence cardiac arrhythmias consecutive patients ranging multiple trauma patients primary cardiovascular patients patients without recorded arrhythmias n used control subjects clinical group free cardiac arrhythmias atrial tachyarrhythmias highest prevalence population whole clinical groups except multiple trauma atrial fibrillation common atrial arrhythmia ventricular arrhythmias followed patients atrial tachyarrhythmias nodal rhythm ventricular bradyarrhythmias ventricular rapid rhythms significantly p less increased mortality rates respectively compared patients without arrhythmias relative risk dying rrd clinical groups increased respectively patients cardiorespiratory precipitating disease arrhythmia except atrial bradyarrhythmia mortality rate significantly p less different patients within clinical groups without arrhythmias rrd increased septic patients atrial tachyarrhythmia nodal rhythm neurologic patients nodal ventricular arrhythmias also significantly p less respectively increased mortality higher rrd data suggest severe illness may present clinical groups critically ill patients cardiac arrhythmias,C23,0.0018726584,0.0016546879,0.01253187,0.0010480827,0.002597487,0.011428585,0.1770472,0.001754229,0.001348589,0.0018328485,0.031647105,0.051596124,0.13262774,0.004296017,0.0016403708,0.0029047895,0.3651649,0.0019210353,0.0021240131,0.113928266,0.07645206,0.0006623298,0.0019190374
red cell autoantibodies multiple immunoglobulin classes autoimmune hemolysis effects interrelationships multiple immunoglobulin coating e increased red cell rbc bound igm iga addition igg investigated patients warm reactive rbc autoantibodies occasions multiple immunoglobulins detected enzyme linked direct antiglobulin tests samples agglutination methods differences populations examined chi square p less required significance multiple tests compared igg coating alone multiple immunoglobulins significantly associated larger quantities greater molecules rbc igg multiple igg subclasses igg c bound cells serum haptoglobin levels less g per l latter association still significant higher levels rbc bound igg subclass pattern taken account samples multiple immunoglobulin coating significant relationship p greater haptoglobins less g per l either c multiple igg subclasses concluded multiple immunoglobulin coating even undetected agglutination methods major cause hemolysis part generalized autoimmune response acts factors quantity bound igg igg subclass pattern complement also important hemolytic effect right,C23,0.0020505728,0.0018189603,0.003826156,0.0011521332,0.0028558995,0.0026463708,0.1992945,0.01185222,0.0014824728,0.044690553,0.17453825,0.014393174,0.09527078,0.041986886,0.011724763,0.0031931682,0.030874882,0.07151996,0.0023348788,0.057974037,0.22168072,0.0007280839,0.0021105527
exogenous opioids human breast milk acute neonatal neurobehavior preliminary study opioid analgesia requirements distribution breast milk influence neonatal neurobehavior evaluated ten parturient neonate pairs nursing elective cesarean section epidural anesthesia five patients received first loading dose intravenous meperidine umbilical cord clamping patient controlled analgesia pca intravenous meperidine finally meperidine tablets needed five patients received morphine manner treatment groups showed differences respect neonatal apgar scores visual analog scale vas pain satisfaction scores h postpartum breast milk specimens obtained h postpartum analyzed opioids metabolites showed persistently elevated normeperidine concentrations meperidine group blinded psychologist evaluated infant rd day life brazelton neonatal behavioral assessment scale nbas priori alertness three human orientation outcomes nbas chosen analysis best measures opioid induced effects four outcomes neonates morphine group scored significantly higher p less neonates meperidine group conclude post cesarean delivery pca morphine provides equivalent maternal analgesia overall satisfaction provided pca meperidine significantly less neurobehavioral depression among breast fed neonates rd day life,C23,0.0020928292,0.0018564438,0.044415537,0.0011758753,0.0029141982,0.033079583,0.11884645,0.012093962,0.0015130222,0.0020563274,0.031090047,0.13703085,0.07643418,0.0063215625,0.0018403811,0.00325897,0.13839743,0.002155267,0.022632847,0.1599089,0.18821463,0.010479517,0.0021911943
hepatic injury induced bile salts correlation biochemical morphological events continuous intravenous infusion taurochenodeoxycholate rate mumol min gm min rats caused threefold tenfold greater release proteins alkaline phosphatase lactate dehydrogenase albumin bile comparison animals infused tauroursodeoxycholate much higher rates mumol min gm hr simultaneous infusion tauroursodeoxycholate taurochenodeoxycholate mumol min gm respectively hr prevented marked biochemical changes bile induced taurochenodeoxycholate min exhibited significantly necrotic hepatocytes especially zone comparison animals infused tauroursodeoxycholate combination taurochenodeoxycholate tauroursodeoxycholate good correlation observed biochemical morphological indices bile acid induced hepatocyte injury data suggest primary events induced acute infusion toxic bile salts responsible cholestasis include zone hepatocellular necrosis b prevented simultaneous infusion tauroursodeoxycholate,C23,0.02515141,0.024884162,0.04255123,0.024096826,0.0032845854,0.014431531,0.16680697,0.0022142075,0.0017022042,0.002313442,0.011177283,0.017583033,0.26642105,0.071899526,0.0020704945,0.02512601,0.04492608,0.048010647,0.0026809534,0.020106118,0.179304,0.0008360001,0.0024222306
vivo nonthrombogenicity heparin immobilized polymer surfaces authors developed two different methods immobilize heparin polymer surfaces one method involves situ heparin immobilization segmented polyurethane urea biomer surface via hydrophilic poly ethylene oxide peo mn spacers method uses peo poly dimethylsiloxane pdms block co polymer heparin covalently linked block co polymer system peo pdms hep surfaces demonstrated high heparin bioactivity vitro excellent blood compatibility vitro ex vivo experiments report evaluates long term vivo blood compatibility heparin immobilized surfaces vascular grafts mm id cm length fabricated biomer heparin immobilized situ peo spacers b peo k coated luminal surfaces peo pdms hep biomer peo mn grafted biomer b peo k used controls grafts implanted abdominal aorta dogs retrieved months graft occlusion suspected retrieved grafts evaluated scanning electron microscopy sem transmission electron microscopy tem tem measured thickness adsorbed protein layer surface protein distribution albumin fibrinogen igg visualized immunogold method heparin immobilized grafts patent months whereas biomer b peo k grafts occluded within month sem pictures heparin immobilized surfaces months demonstrated minimal platelet adhesion activation without detectable fibrin formation heparin immobilized surfaces showed thin protein layer even months high concentrations albumin igg less fibrinogen,C23,0.012597261,0.0019144607,0.10487323,0.0012126233,0.0030057773,0.023677181,0.16021946,0.0020768463,0.032870356,0.002120591,0.09110854,0.0047905566,0.07677486,0.05045327,0.0018978959,0.0033631925,0.14179814,0.066555046,0.0024574662,0.029787248,0.18345939,0.00076631026,0.002220311
percutaneous biliary drainage high obstruction pbd preferred route palliative drainage patients high biliary obstruction frequency bifurcational obstruction setting requires familiarity drainages right left transhepatic approach preferred right transhepatic approach fluoroscopically guided left ultrasonography guidance choice large caliber drainage catheters required dilatation necessary transhepatic tracts extremely painful unless adequate inhalation anesthesia preferably epidural anesthesia provided long term biliary drainage requires choice internal external external drainage catheters endoprostheses made considering patient life expectancy adjustment stent extending outside feasibility corrective procedures internal external drainage catheter endoprosthesis becomes blocked needs considered definitive placement interventional radiologist becomes intimately involved follow care patients frequently direct appropriate patient evaluation familiarity antibiotic regimens important,C23,0.017783664,0.0027051151,0.005690169,0.0017134254,0.019039078,0.033454716,0.27454764,0.061920635,0.0022046987,0.0029963753,0.088144824,0.0062723695,0.023109201,0.0070738946,0.0026817091,0.06379459,0.25698984,0.0031405448,0.0034723766,0.07983502,0.03921006,0.0010827893,0.0031372786
simultaneous dual system rehabilitation treatment facial paralysis simultaneous dual system rehabilitation facial paralysis involves using two independent reanimation techniques optimize facial movement quantitative qualitative manner techniques involve use nerve grafting crossover procedures combined dynamic muscle transfer group patients underwent five different combinations reanimation analyzed techniques evaluated using standard rating scheme judging success reanimation procedures combination masseter muscle transfer lower region face cable graft upper facial nerve division appeared offer excellent results terms independent motion upper lower regions face good eye closure allowing spontaneous mimetic function cases advantages disadvantages techniques described clinical situations techniques advantage single reanimation techniques outlined,C23,0.0146571575,0.0022702338,0.029530635,0.013815092,0.0035913503,0.0033029201,0.24172066,0.0024070425,0.026630081,0.027280144,0.18119554,0.017653966,0.08788397,0.0062723383,0.0022505908,0.016871843,0.15389715,0.0026356627,0.0029141484,0.06221994,0.0974128,0.0009087172,0.0026780593
interdisciplinary nutrition assessment intervention protocol children disabilities multifactorial nature nutrition problems associated developmental disabilities well organized interdisciplinary effort necessary deal problems team composed professional support staff client family needs involved integrated approach service team members share knowledge expertise developing individual program plan meet identified needs article describes development implementation prototype interdisciplinary nutritional evaluation intervention outpatient setting regional nutrition feeding diagnosis evaluation clinic established contractual agreement university georgia university affiliated program st mary hospital athens ga purposes clinic twofold offer direct services developmentally disabled infants children require outpatient services provide unique community based interdisciplinary training experience graduate students nutrition health disciplines interdisciplinary treatment protocol based current knowledge treatment developmental disabilities,C23,0.0024381578,0.0021627676,0.016257005,0.0013699014,0.038786624,0.017281923,0.35524008,0.002292873,0.0017626795,0.049590793,0.06905564,0.0050148247,0.015092644,0.042627275,0.0021440543,0.015597218,0.10568055,0.0025108983,0.111229554,0.11139842,0.029092094,0.00086570124,0.0025082869
effect amiodarone erythrocyte shape membrane properties amiodarone potent anti arrhythmic drug lipophilic properties intercalation drug membrane erythrocytes may alter shape impact flow properties blood therefore studied influence amiodarone erythrocyte shape deformability vitro vivo incubation vitro increasing amiodarone concentrations led progressive stomatocytic shape transformation decreased deformability erythrocytes amiodarone treatment eight patients affect erythrocyte morphology deformability however increase membrane cholesterol phospholipid ratio found stomatocytic shape transformation erythrocytes vitro indicates amiodarone intercalates inner hemileaflet lipid bilayer leading membrane internalization results shed light interaction amiodarone biomembranes,C23,0.0032407173,0.002874678,0.14710523,0.0018208269,0.0045125964,0.01986472,0.27471408,0.0030513804,0.0023428944,0.0031841951,0.015129285,0.006665536,0.17074482,0.007990239,0.01853372,0.005046471,0.04299562,0.019017559,0.0040137228,0.023984555,0.20303497,0.001150661,0.01898149
porcelain resin veneers clinically evaluated year results clinical comparison two different types dental veneers baked porcelain veneer heat pressure processed urethane resin veneer made years although esthetic appearance gingival response equal systems resin veneers greater tendency chip fracture end years resin veneers failed whereas porcelain veneers remained,C23,0.0056206794,0.0049858233,0.010487605,0.003158327,0.007826618,0.0072537796,0.27468973,0.032489534,0.004063501,0.032710303,0.035853356,0.011560664,0.09411988,0.014791034,0.0049426835,0.008752567,0.198706,0.0057883677,0.0063999705,0.06456488,0.16345668,0.001995699,0.0057823476
early magnetic resonance imaging acute traumatic internuclear ophthalmoplegia adduction deficiency following acute head trauma may result orbital damage also internuclear ophthalmoplegia instances resolves weeks months date noninvasive imaging studies acute phase following injury definitive localizing pathology three cases adduction deficiency following head trauma caused internuclear ophthalmoplegia reported lesion brain stem found three cases magnetic resonance imaging subacute post traumatic period lesions visible routine x ray computed tomography obtained time injury,C23,0.06924812,0.003016388,0.006344927,0.0019105863,0.1364326,0.0043884856,0.23220101,0.019622942,0.0024583896,0.003341163,0.11196665,0.0069941203,0.040141832,0.007878381,0.002990289,0.038211387,0.11174136,0.003501922,0.003871937,0.025072858,0.16384119,0.0012073839,0.003616082
another way pumping blood rotary noncentrifugal pump artificial heart article describes alternative mode pumping blood inside body device non centrifugal valveless low speed rotary pump electrically powered based wankel engine principle authors developed implantable electrical actuator resulting compact sealed motor pump unit electrical magnetic components insulated fluids results flow curve pumping action show common points also basic differences compared classical pulsatile pumps centrifugal pumps blood coming atrium follows continuous movement without stop flow variations creating pulsatility ejection filling pump simultaneous always active filling hydraulic efficiency depends clearance pumping chamber outlet port pressure cc device allows flows liters implantable motor cyclindrical shape moderate weight grams presents good efficiency rotary speed rpm mean aortic pressure mm hg authors conclude device could proposed experimental studies lvad shortterm assistance good promise permanent application,C23,0.0024268823,0.04715438,0.0527756,0.0013083343,0.014499384,0.014189441,0.19494978,0.013451463,0.0016834599,0.002287967,0.051439654,0.11938504,0.21814576,0.005363852,0.0076639033,0.019045465,0.09461026,0.0023980516,0.0026514311,0.029699052,0.09039102,0.00082679425,0.0136530725
indications carbon dioxide laser tracheobronchial pathology infant young child cases fourteen children aged months years mean age years treated co broncholaser ent department trousseau hospital three groups diagnostic indication identified granulomas treated mucosal trauma tracheotomy foreign body granulomas due pulmonary lymph node tuberculosis adhesions stenosis secondary neonatal ventilation operative anesthetic technique described detail together possible adverse events co broncholaser appears technique choice age group narrowness airways makes endoscopic procedure difficult broncholaser allows early treatment obstructive tracheobronchial pathology risks severe ventilatory sequelae,C23,0.012606997,0.018252606,0.052274436,0.0017925317,0.019871017,0.056692757,0.18087843,0.0030002508,0.0023064865,0.034025084,0.07329929,0.037452452,0.02141522,0.0073356167,0.0028055198,0.00496805,0.2863393,0.003285539,0.0036326912,0.13208918,0.041261595,0.00113278,0.003282122
fibrillation chaos ventricular fibrillation examined determine whether instance deterministic chaos surface ecgs dogs fibrillation used generate state space representation fibrillation analysis failed identify low dimensional attractor could associated fibrillation results suggest fibrillation similar nonchaotic random signal note however random looking nonchaotic behavior also generated nonlinear deterministic system,C23,0.0054720715,0.004854,0.011679393,0.0030745335,0.007619686,0.0070619932,0.3683143,0.005146002,0.003956064,0.0053766314,0.10732799,0.011301705,0.04527669,0.07096648,0.0048120013,0.034997292,0.06663767,0.0056353263,0.006230758,0.051996227,0.16467164,0.0019429337,0.0056485687
effects inflammatory mediators responsiveness isolated human airways methacholine several studies suggested asthmatics quantities inflammatory mediators histamine thromboxane txa prostaglandin pgd prostaglandin f alpha pgf alpha leukotriene c ltc present airway lumen related degree bronchial responsiveness inhaled methacholine mch therefore studied effect mediators cholinergic responsiveness isolated human airway segments lung tissue collected thoracotomy patients studied dose response curves mch obtained bronchial segments incubation either subthreshold threshold concentration histamine stable txa analogue u pgd x x pgf alpha ltc exception ltc presence mediators either concentration increased sensitivity mch factor p less anova increase depend dose mediator p greater anova data indicate mediator induced muscle hypersensitivity explain small part leftward shift dose response curve inhaled mch observed asthma,C23,0.025732074,0.013743333,0.027908722,0.0013536594,0.0033548053,0.049761955,0.22316481,0.002265688,0.013404602,0.00236723,0.02536149,0.004955367,0.09191446,0.018726712,0.0021186338,0.027073957,0.03270527,0.0024888723,0.0027432858,0.0249222,0.31654423,0.070834704,0.01655396
serum acute phase proteins orthotopic liver transplantation acute phase proteins measured six patients liver transplantation h orthotopic liver transplantation ability donor liver mount acute phase response demonstrated although response less seen groups patients studied reduced response stress value measurements indicators liver function group patients limited,C23,0.0039940723,0.0035429415,0.026184445,0.0022441063,0.0055625243,0.0051545585,0.16371521,0.003756074,0.0028875365,0.003924411,0.019571079,0.046887573,0.11275362,0.009225195,0.022845794,0.10260865,0.13486266,0.062119365,0.004547839,0.045236334,0.2128489,0.0014181499,0.004108954
diclofenac day care arthroscopy surgery comparison standard opioid therapy sixty unpremedicated patients presenting day care arthroscopy surgery allocated randomly receive diclofenac mg kg fentanyl microgram kg v analgesic course anaesthesia patients receiving fentanyl slightly although significantly prolonged recovery times patients receiving diclofenac significantly improved postoperative visual analogue pain scores compared patients receiving placebo medication p less fentanyl pain scores reduced also effect statistically significant fentanyl diclofenac produced significant reduction postoperative analgesic requirements p less conclude diclofenac mg kg effective analgesic arthroscopic procedures knee useful alternative opioids day care patients,C23,0.016647978,0.002518791,0.005298239,0.0015954073,0.0039539337,0.017400786,0.125513,0.0026703137,0.0020528424,0.0027899896,0.014505018,0.14807959,0.09273567,0.006543544,0.0024969974,0.004421714,0.2659936,0.002924229,0.016978126,0.079329126,0.18162176,0.0010082084,0.0029211876
hormone implants tachyphylaxis serum oestradiol levels women treated hormone implants menopause clinic reviewed thirty eight found pmol l women supraphysiological oestradiol levels started therapy menopausal symptoms premenstrual syndrome pms women treated menopausal symptoms history psychiatric referral depression nine undergone surgical menopause nine women pms history psychiatric referral depressive symptoms conclude women attain supraphysiological levels oestradiol implant therapy high frequency psychopathology surgical menopause may require higher oestradiol levels adequate control symptoms,C23,0.0035771523,0.0031731126,0.006674595,0.002009856,0.004981071,0.05655907,0.22455354,0.0033639974,0.002586122,0.0035614192,0.016650988,0.007424055,0.02907061,0.061824266,0.03777977,0.0055703702,0.09193596,0.003683874,0.004073114,0.15578602,0.27021086,0.0012701168,0.0036800425
effect adjunctive arteriovenous fistula prosthetic graft patency controlled study canine model bilateral mm ptfe grafts placed external iliac artery femoral artery ligation intervening segment iliofemoral artery dogs arteriovenous fistula constructed distal anastomosis one randomly selected side animal contralateral graft served control graft follow ranged months animals serial arteriography performed confirm graft fistula patency demonstrated persistence antegrade flow arterial tree distal patent bypasses femoral intraarterial pressures distal patent grafts identical sides animal throughout study cumulative life table patency rates showed higher patency arteriovenous fistula bypasses control grafts time intervals vs months vs months vs months respectively first controlled study provides experimental evidence suggesting bypasses may produce increased patency prosthetic arterial grafts lends support use clinical prospective randomized study,C23,0.060837485,0.051829208,0.004775884,0.0014381156,0.0035644122,0.015667934,0.16154112,0.0024070467,0.026630487,0.0025149237,0.012328854,0.0054573403,0.07956546,0.0059084683,0.0022508176,0.003985776,0.21690704,0.0026413156,0.0029144422,0.021226201,0.2872893,0.025685191,0.002633187
intravenous fluid load recovery double blind comparison gynaecological patients day case laparoscopy effect intra operative fluid dextrose administration upon recovery tested randomised double blind trial three groups patients undergoing laparoscopic examination day cases studied two groups received fluid ml kg compound sodium lactate solution showed significant improvement p less variables reflected hydration fluid group also received dextrose g kg exhibited significant improvement intra operative fluid dextrose administration appears confer benefit upon recovery patients minor surgery,C23,0.0027273698,0.002419313,0.018282123,0.0015323978,0.003797776,0.04308613,0.12846883,0.0025648514,0.0019717668,0.0026798008,0.06581862,0.11236458,0.19036375,0.0062847347,0.00239838,0.004247082,0.12920013,0.016006118,0.055894457,0.033598967,0.17251857,0.0009683899,0.0028058174
background review current concepts reperfusion injury define concept reperfusion injury present background chronology experimental work supporting questioning concept identify several new influences current clinical interest thrombolytic therapy acute ischemia heart brain growing recognition endothelium regulator homeostasis propose influences encourage reexamination reperfusion injury factor ultimate outcome tissue exposed reversible ischemia briefly discuss major mechanisms presently implicated reperfusion injury loss calcium homeostasis free radical generation leukocyte mediated injury acute hypercholesterolemia,C23,0.10052214,0.0029675756,0.006266312,0.0018796683,0.0046584243,0.052893072,0.30694887,0.019333048,0.002418607,0.0032870949,0.01930637,0.0068809385,0.03292462,0.061242834,0.0029418988,0.053789638,0.032676008,0.0035228294,0.0038092798,0.1325311,0.14457017,0.0011878455,0.003441669
distribution enkephalins human carotid bodies showing cellular proliferation chronic glomitis human carotid bodies obtained necropsy showed prominence either sustentacular cell dark variant chief cell chronic carotid glomitis studied immunogold labeling technique peptides methionine leucine enkephalin similar distribution found normal human carotid body localized prominently predominantly dark progenitor variants chief type cells sustentacular type ii cells showed immunoreactivity enkephalins cell counts immunolabeled chief cells cases sustentacular cell hyperplasia chronic carotid glomitis found lower end normal range whereas dark cell prominence occurred nearer upper limit,C23,0.003190258,0.0028299182,0.0059526907,0.001792663,0.035320994,0.004117194,0.2117638,0.018439155,0.0023064145,0.003134616,0.1441586,0.0065814285,0.03998444,0.21496493,0.048584294,0.0049678953,0.051197875,0.0032883172,0.003632578,0.02311051,0.14910586,0.0011327447,0.020442886
effect screws pegs initial fixation stability uncemented unicondylar knee replacement two uncemented unicompartmental tibial components examined initial fixation stability conventional design employed single posteriorly angled peg compared new design held place cancellous bone screws components implanted medial condyles preserved human tibiae cyclic load first applied anteromedially posteromedially screwed implants failed significantly higher loads n mean standard error mean pegged implants n application n preload screwed implants moved significantly less pegged implants although differences micromotion subsidence always significant definite trends screwed implants much lower levels temporary permanent displacement compared pegged implants load levels initial load n including failure load motion resulted moving load anterior position posterior position examined screwed implant average total motion less microns compared almost microns pegged implant n load cycle cycle failure screwed implant average motion increased less microns whereas pegged implant average total motion almost microns information appears clear screws provide better initial fixation stability angled pegs uncemented unicondylar tibial components,C23,0.011626703,0.021045282,0.1645709,0.0011187874,0.031684473,0.022010857,0.08937439,0.001872571,0.0014395661,0.0019564943,0.0387561,0.0041150786,0.14230357,0.12226633,0.0017511146,0.012736131,0.15641643,0.0020506303,0.002267301,0.046866562,0.12100807,0.0007070112,0.002055659
histologic evaluation width soft tissue necrosis adjacent carbon dioxide laser incisions study evaluated width tissue necrosis lateral carbon dioxide laser incisions human intraoral excisional biopsy specimens measurements made specimens including epithelium muscle dense loose connective tissue salivary gland results showed mean width tissue necrosis microns epithelium microns muscle microns loose connective tissue microns dense connective tissue microns salivary gland range thermal necrosis different tissue types probably based water content within type cellular partially homogenized zone reversible thermal damage microns width visible adjacent zone thermal necrosis relatively narrow width tissue necrosis technique may account claimed superior properties laser induced wounds compared created electrosurgery,C23,0.0030948976,0.0027453287,0.050451405,0.0017391366,0.034271542,0.003994127,0.20280172,0.032859225,0.047179304,0.018019708,0.060438298,0.006365613,0.04559326,0.010744874,0.047663976,0.004819399,0.20791121,0.0031872315,0.0035239963,0.020631175,0.18765038,0.0010988857,0.0032152566
delayed facial palsy following uncomplicated stapedectomy report six cases partial lower motor neurone facial palsy occurring four ten days uncomplicated stapedectomy aetiology unclear recovery rapid complete patients,C23,0.00718445,0.006372966,0.013426749,0.0040366496,0.010004119,0.009271907,0.2585257,0.006756344,0.0051940377,0.041837446,0.067615,0.014777041,0.11367236,0.016519269,0.006317824,0.011187683,0.1826207,0.0073987925,0.008180553,0.052735366,0.14642298,0.0025509372,0.0073910975
comparison delphin biomedicus pumps increasing use centrifugal pump systems cardiopulmonary bypass cpb circulatory assistance biomedicus delphin centrifugal pump systems tested two side side identical vitro flow loops blood trauma flow probe accuracy blood parameters tested hemoglobin hematocrit lactate dehydrogenase free plasma hemoglobin platelet counts delphin pump demonstrated significant increases plasma hemoglobin levels three flow rates tested l min p less l min p less l min p less hr pumping drop platelet counts significantly greater biomedicus loop compared delphin loop p less l min l min flow rates however platelet levels remained within normal ranges systems l min statistical difference platelet counts noted flow probe readings found deviate much stopwatch timed flow rate comparisons low flow rates improved within better l min,C23,0.0022515734,0.023795381,0.0042012027,0.0012650673,0.0031355845,0.0029057728,0.13501222,0.0021174068,0.0016277874,0.0022123032,0.05713817,0.05963917,0.40879986,0.0054772613,0.001979977,0.0035213428,0.055544123,0.0023190842,0.0025637476,0.021552356,0.15626337,0.03348104,0.0131961955
accumulation p ras gtp response stimulation epidermal growth factor oncogene products tyrosine kinase activity ras gene product p gtp binding protein thought transduce signals regulating proliferation differentiation cells like gtp binding proteins p gtp active conformation transduce signals downstream whereas p gdp inactive one recently shown p gtp levels increased cells treated fetal bovine serum platelet derived growth factor initiate dna synthesis paper report epidermal growth factor also increase amounts p gtp cells effects epidermal growth factor platelet derived growth factor additive contrast mutant val p transforming activity responded neither platelet derived growth factor epidermal growth factor also found ratio p gtp p gdp increased fold transformants carrying activated erbb neu v src oncogenes results strongly suggest important role p transduction signals normal proliferation malignant transformation growth factor receptors tyrosine kinase activity related oncogene products,C23,0.014047362,0.002137012,0.004495173,0.0013535878,0.0033546272,0.0031090984,0.21884562,0.002266747,0.013391168,0.0023671046,0.015266115,0.004955105,0.02950202,0.15752462,0.0021185216,0.003769658,0.022959365,0.1210622,0.04938525,0.03502608,0.25233746,0.00085539196,0.039870758
percutaneous pedestal cochlear implantation direct electrical connection external sound processing device intracochlear electrodes accomplished via percutaneous pedestal patient pedestal complaints experience recorded pedestal problems classified six classes class indicating problems severity problem increasing classes class indicates pedestal trauma class problems encountered months experience patients class class pedestal experience detailed paper percutaneous pedestal found well tolerated efficient system information transfer cochlear implant patients,C23,0.03887769,0.020851426,0.024401814,0.037223272,0.0226466,0.0046986607,0.32462248,0.0034238661,0.002632147,0.003577314,0.055807147,0.042710636,0.025212076,0.026630385,0.1265808,0.0056695053,0.13111985,0.0037494353,0.0041456027,0.026390815,0.06399024,0.0012927209,0.0037455356
urinary tract functionalization long term diversion year experience patients previously diverted urinary tracts undiverted patients whose ages ranged years fifty six patients diverted years longer female male patients forty four patients one kidney two patients previous renal transplant one patient anephric time reconstruction two unsuccessful transplants diversions considered permanent types diversions reversed include ileal loop colon conduit loop ureterostomy pyelostomy end ureterostomy cystostomy vesicostomy long term nephrostomy ureterosigmoidostomy,C23,0.004237423,0.003758806,0.04893285,0.0023812375,0.026398726,0.0054686153,0.1193637,0.0039849244,0.0030634685,0.024670174,0.019487439,0.00871557,0.027019065,0.00989453,0.003726283,0.0065985494,0.3932403,0.0043638437,0.00482493,0.14962585,0.10359107,0.0015045551,0.025148083
identification patients greatest risk developing major complications cardiac surgery published erratum appears circulation jul part prospective program use risk adjusted outcome operative mortality morbidity measure quality care analyzed perioperative complication data patients representing patients undergoing cardiac surgery requiring cardiopulmonary bypass veterans administration medical centers april march one complications occurred patients undergoing coronary artery bypass grafting patients undergoing valve cardiac surgery patients experiencing one complications eightfold fold increase operative mortality compared patients perioperative complications frequent complication requirement mechanical ventilation least hours occurring patients undergoing coronary artery bypass patients undergoing valve cardiac surgery patients died within days surgery direct result surgical complication previous heart surgery strong predictor development one complications groups patients associated adjusted relative risk important predictors surgical groups surgical priority older age peripheral vascular disease higher serum creatinine although number preoperative risk factors could identified development renal failure low cardiac output requirement prolonged mechanical support risk factors could identified development mediastinitis reoperation bleeding observation suggests mediastinitis reoperation bleeding likely result technical factors rather patient related risk factors,C23,0.007885566,0.0077464115,0.009068658,0.0007599389,0.0018833737,0.01987362,0.165537,0.0012756505,0.0009778286,0.0013289532,0.009192796,0.015879244,0.038785234,0.003236257,0.0011893924,0.00228018,0.43215093,0.007754183,0.0016987196,0.20962168,0.060001247,0.000480239,0.0013928693
healing experimental intestinal anastomoses parameters repair anastomotic dehiscence remains major complication surgery large bowel studies healing sequence experimental anastomoses necessary define underlying mechanisms find ways improve surgical outcome particularly high risk situations quantitative description anastomotic repair mechanical biochemical parameters employed limitations mechanical parameters either bursting pressure breaking strength reflect growing anastomotic strength long disruption occurs within anastomotic area less one week surgery bursting pressure probably two weeks breaking strength biochemical description anastomotic repair limited behavior collagen represented rather unique constituent amino acid hydroxyproline conclusions based collagen concentrations per unit weight considered caution since may change consequence changes noncollagenous substances respect collagen content per unit length probably better parameter describe anastomotic collagen levels investigations addressed quality collagen e g crosslinking type since time distinct correlations demonstrated development mechanical strength occurrence leakage collagen levels healing anastomosis attention restricted description quantity collagen present quality anastomotic collagen investigated perhaps even,C23,0.0016970577,0.03435774,0.019592576,0.07257637,0.0023635847,0.0021901415,0.23165734,0.0015959336,0.0012268972,0.034522716,0.009288752,0.0034905234,0.06285786,0.023283524,0.0014923498,0.010850078,0.13470411,0.0017548242,0.025377663,0.105250865,0.20110138,0.00060256355,0.018165134
measuring crackles crackles heard auscultation represented graphically time amplitude plot associated waveform assess relative merits several measures might considered machine implementation diagnostic instruments compared reproducibility based initial voltage deflection begins crackle based largest deflection latter group showed less interobserver less intraobserver variability crackles measured twice two observers crackles teaching tape categorized fine coarse used study ability various measures tested distinguish fine coarse crackles individual basis assessed found favor measures based largest deflection showed average percent incorrectly classified crackles opposed percent two measures based initial deflection,C23,0.0032931487,0.0029211873,0.022084674,0.0018502859,0.0045875935,0.02018192,0.30555338,0.003096917,0.0023808,0.0032357122,0.08093299,0.022716071,0.21234724,0.0076083504,0.018767277,0.0051281173,0.11394684,0.0033913972,0.019673899,0.060901906,0.08084317,0.0011692775,0.00338787
lesions side branches arteries undergone percutaneous transluminal coronary angioplasty histopathologic study percutaneous transluminal coronary angioplasty ptca may cause occlusion side branches histologic studies however made side branches arteries ptca performed histologic study therefore made explain effect ptca side branches histologic specimens prepared serial step sectioning side branches autopsied cases undergone ptca results examination light microscope follows stenoses due ptca seen seven branches stenoses classified three types stenosis due blocking orifice side branch disrupted portion intima main artery one branch b stenosis due medial dissection main artery dissection occurring even side branches three branches c stenosis due fragmentation internal elastic lamina main artery accompanied proliferation smooth muscle cells even side branch three branches clear stenosis caused side branches long ptca extra care required major side branches exist portion procedure performed,C23,0.146654,0.024328532,0.0042953216,0.0012934655,0.0143487565,0.014107579,0.22433233,0.01323776,0.0016642546,0.0022618652,0.10295527,0.015862346,0.014994079,0.03922264,0.0020243342,0.0035847167,0.17765002,0.0023706942,0.0026211832,0.030033842,0.15897138,0.000817362,0.0023682285
meropenem pharmacokinetics penetration inflammatory exudate pharmacokinetics penetration cantharidine induced inflammatory exudate meropenem studied six volunteers following single g intravenous dose concentrations plasma urine inflammatory exudate determined microbiological assay mean elimination half life meropenem plasma h concentration plasma declining mean micrograms ml h micrograms ml h inflammatory fluid penetration rapid time maximum concentration drug serum h penetration recovery meropenem urine h administered dose,C23,0.0045150146,0.0040050433,0.008437728,0.0025368026,0.0062870146,0.0058268616,0.12626718,0.004245974,0.0032641545,0.004436267,0.024030285,0.078047484,0.15092625,0.03272193,0.0039703897,0.0070308167,0.058861032,0.0046497164,0.005141008,0.052319348,0.4062195,0.0016031176,0.004657067
differential regulation human immunodeficiency viruses hivs specific regulatory element hiv responds stimulation cell antigen receptor human immunodeficiency viruses hivs types similar genetic organization differ significantly nucleic acid sequence although infection either agent leads symptoms immunodeficiency recent studies suggest potential differences time course severity diseases report transcriptional regulation induction retroviruses analyzed report regulation hiv differs hiv distinct cell activation pathway triggering cd component cell receptor complex stimulates hiv hiv gene expression response cell receptor stimulation hiv mediated partly upstream regulatory element termed cd r recognized sequence specific dna binding protein nf cd r jurkat leukemia cell lines containing hiv provirus also showed increased viral replication stimulation cell receptor complex contrast hiv findings suggest transcriptional regulation induction hiv differ hiv raise possibility different cofactors contribute activation hiv hiv associated aids,C23,0.0019914599,0.0017665243,0.0249617,0.0011190003,0.0027730449,0.0025700827,0.25412568,0.001872793,0.0014397368,0.0019606438,0.0091970265,0.004145653,0.03422775,0.10593741,0.0017512395,0.060940232,0.018612701,0.09792491,0.00226757,0.05477961,0.1975162,0.000707095,0.11741191
cepod right retrospective study found long term greater months postoperative survival asa e e patients respectively supports confidential enquiry peri operative deaths recommendation life saving surgery withheld patients present serious condition unlikely survive surgery,C23,0.0051966407,0.00460968,0.009696392,0.0029197806,0.0072361575,0.006706536,0.20760947,0.030041873,0.00375694,0.030243363,0.024698166,0.0109070325,0.058317654,0.012080835,0.0045697945,0.033241857,0.31303632,0.0053516785,0.031060195,0.11804125,0.073487096,0.0018451383,0.0053461124
regulation lfa adhesion receptors c myc oncogene human b lymphoblastoid cells function c myc gene role tumorigenesis poorly understood order elucidate role c myc oncogene activation b cell malignancy phenotypic changes caused expression c myc oncogenes human b lymphoblastoid cells immortalized epstein barr virus analyzed c myc oncogenes caused regulation lymphocyte function associated antigen lfa adhesion molecules alpha l beta integrin loss homotypic b cell adhesion vitro regulation lfa occurred posttranscriptional modulation lfa alpha l chain rna soon acute c myc induction ii transcriptional modulation cells chronically express c myc oncogenes analogous reductions lfa expression detectable burkitt lymphoma cells carrying activated c myc oncogenes since lfa involved b cell adhesion cytotoxic cells natural killer cells vascular endothelium results imply functions c myc normal b cell development lymphomagenesis,C23,0.0029232537,0.002593072,0.005454488,0.001642457,0.004070538,0.0037726113,0.173111,0.002838517,0.0021133823,0.0028722684,0.013463297,0.0060125743,0.03259928,0.2428678,0.0025706354,0.06115276,0.03198076,0.048462164,0.0033285543,0.082843326,0.12146824,0.0010379412,0.15082109
obstructive jaundice use expandable metal endoprosthesis biliary drainage work progress expandable metal endoprostheses implanted transhepatically patients obstructive jaundice fifty three patients malignant eight benign obstructions small diameter compressed stent f primary implantation stent without previous catheter drainage preferred postprocedural complications occurred three patients biliary pleuritis peritonitis hepatic artery aneurysm day mortality rate reocclusions observed six patients malignant obstructions observation period months mean months two patients benign stenoses observation period months mean months higher reocclusion rate benign obstructions must interpreted care small number patients preliminary experience authors conclude expandable metal endoprostheses offer patency rates equal plastic stents implantation trauma reduced due small f introducing catheter system,C23,0.01745717,0.0025900907,0.005448217,0.0016405687,0.018162033,0.0037682739,0.12746052,0.0027459026,0.0021109525,0.0028689662,0.0416972,0.034259353,0.022357501,0.0215873,0.00256768,0.018669326,0.4446226,0.0030070057,0.0033247275,0.10648576,0.11312824,0.0010367478,0.003003878
rapid admixture blood warming technical advances technique rapid admixture blood warming cold erythrocyte units designed warm erythrocyte units rapidly less sec simultaneously providing saline dilution however questions raised recommended use standard ml bolus degrees c admixture saline uniformity speed blood unit warming difficulties inherent keeping saline bags degrees c safety methodology answer questions series tests performed modifications technique introduced mean weight successive units erythrocytes adult infusion g range maximum temperature degrees c using internal temperature probe cm temperature gradations sec recording intervals smallest unit admixed ml degrees c saline bolus largest unit minimum temperature degrees c plasma hgb osmotic fragility k minimum size erythrocyte unit showed significant deviation control thermographic photographs internal temperature recordings erythrocyte units demonstrated solely due fluid turbulence uniform mixing occurs within approximately sec beginning admixture process inverting blood units caused thermal layering fluids unacceptable maximum blood temperature degrees c difference mixing time efficacy presence standard large bore iv tubing additional line filters volumes ml saline bags admixture decreased markedly deviations electrolyte composition greater wk degrees c,C23,0.0016708638,0.009558842,0.15038799,0.00093821465,0.0023693964,0.0021557678,0.15294373,0.0015703372,0.0012072196,0.0016407153,0.06519663,0.020429092,0.37022796,0.013620518,0.009543357,0.0026007774,0.025352275,0.0017196578,0.026126167,0.023730397,0.11469908,0.00059289933,0.0017181078
effect indomethacin pain relief thoracotomy effect indomethacin postoperative pain studied adult patients undergoing thoracotomy prospective randomized double blind manner patients receiving indomethacin required significantly less opioid operation significantly lower pain scores compared control group pain movement coughing reduced also major adverse effects encountered,C23,0.025394548,0.066635475,0.008072317,0.0024307382,0.0060241534,0.0055832393,0.12937851,0.004068449,0.0031276795,0.004250786,0.020061444,0.06586772,0.1260386,0.009975382,0.003804387,0.0067368564,0.16560891,0.0044553108,0.025864331,0.054616388,0.256018,0.0015360909,0.004450677
retroviral promoter sufficient convert proto src transforming gene distinct src gene rous sarcoma virus src genes four natural isolates avian sarcoma viruses differ cellular proto src two genetic substitutions promoter cellular gene replaced retroviral counterpart least six codons terminus replaced retroviral heterologous cell derived elements since virus constructs complete proto src coding region failed transform avian cells acquired transforming function point mutations various codons proposed point mutation sufficient convert proto src transforming gene however promoter substitution sufficient convert two proto onc genes proto ras proto myc retroviral transforming genes view reexamined whether promoter substitution point mutation necessary convert proto src retroviral transforming gene found recombinant virus rpsv src gene rous sarcoma virus rsv replaced complete coding region proto src transformed quail chicken embryo cells oncogene rpsv differs src gene rsv three genetic properties weaker e g transformed cells flatter ii slower e g focus formation takes days compared days rsv iii host range narrower rsv e g subsets heterogeneous embryo cells transformed rpsv even weeks months replacement proto src terminus rpsv src rsv generates recombinant virus rpvsv equals rsv transforming function concluded retroviral promoter naturally substituted via illegitimate recombination retroviruses sufficient convert least three proto onc genes src myc ras retroviral transforming genes,C23,0.0018693327,0.0016581914,0.004807413,0.010829008,0.0026029865,0.101947926,0.1721562,0.06317073,0.0103727905,0.0018367291,0.01944493,0.0038448602,0.028441494,0.06007243,0.0016438441,0.0029109397,0.089415595,0.026081646,0.0021285103,0.040435098,0.10479742,0.0006637321,0.24886817
desmopressin antifibrinolytics desmopressin appears safe effective hemostatic agent use surgery patients mild moderate hemophilia von willebrand disease uremic patients also benefit substitution desmopressin cryoprecipitate control bleeding highly variable response desmopressin individual patients hemophilia von willebrand disease dictates patient receive trial administration prior surgery surgery proceed following verification therapeutically effective increase factor viii vwf desmopressin use desmopressin patients normal baseline hemostatic function clearly advantageous although certain patient subgroups might benefit prospective studies documented drug safety cases data lacking clarify role desmopressin surgery patients taking aspirin antifibrinolytic therapy appears decrease bleeding without increased risk cardiac surgery addition specific use urological surgery may beneficial absence upper urinary tract bleeding last ten years applications antifibrinolytic therapy found surgical intracranial aneurysms oral lacrimal surgery nonsurgical cancer patients gastrointestinal bleeding although anecdotal reports fueled fears increased thrombosis antifibrinolytics controlled studies indicate increased risk,C23,0.0020506044,0.011739999,0.013750758,0.001152151,0.002855402,0.0026609565,0.37265468,0.0019287452,0.0014824958,0.0020148393,0.045213714,0.022673476,0.043296617,0.005740484,0.0018032499,0.022960989,0.23757824,0.0021129157,0.012260577,0.054170247,0.13700795,0.0007280952,0.002162783
polyethylene cementless tibial component five nine year follow study polyethylene cementless tibial component used total knee arthroplasties one exception failures occur three years failure characterized medial subsidence tibial component abrasion polyethylene undersurface components failed survivorship seven nine years study demonstrated flexible cementless component function well used type bone however abrasion polyethylene occurs shearing forces concern polyethylene components need adequate provisions prevent shearing need surface treatment prevent abrasion,C23,0.0039919573,0.080844425,0.08417996,0.0022430492,0.0055597005,0.024467735,0.30782863,0.003754085,0.022205582,0.0039223325,0.045615774,0.0082106935,0.06182134,0.009873844,0.0035107017,0.0062163076,0.13947724,0.004111054,0.02381951,0.08087966,0.07192268,0.0014173989,0.0041263183
proliferation substrate effects endothelial cell thrombogenicity effects cellular differentiation status adhesive substrate endothelial cell function cell culture measured enzyme based assay surface thrombogenicity solid plastic microporous polymeric fibronectin fn treated microporous polymeric used substrates growth endothelial cells microporous fn treated synthetic substrates shown aid induction cellular differentiation mechanisms cells studied proliferative nonproliferative growth conditions thrombogenicity surface created endothelial cell monolayers various experimental conditions determined using enzyme based assay fibrin deposition actively proliferating cells solid plastic substrate produced thrombogenic surface confluent endothelial cell monolayers grown fn treated microporous substrate least thrombogenic surfaces data suggest endothelial cell surface thrombogenicity substrate control also related cellular differentiation status findings used design novel approach small diameter synthetic vascular graft problem,C23,0.0020452808,0.001814266,0.11243178,0.0011491597,0.0028479886,0.00264108,0.21192169,0.069114186,0.0014786469,0.0020096083,0.025381291,0.004239599,0.038957782,0.2138658,0.0017985682,0.022979813,0.07291392,0.0021063,0.002328853,0.037679005,0.13776724,0.00072620483,0.03180194
reconstruction patellar tendon rupture total knee arthroplasty extensor mechanism allograft although patellar tendon rupture total knee arthroplasty tka rare complication consistently poor outcome conventional tendon repair convinced abandon reconstruction favor prospective protocol using allograft distal extensor mechanism graft consists quadriceps tendon patella cemented prosthesis patellar tendon tibial tubercle since december knees patients reconstructed using method ten knees followed six months five knees followed months knee extension power improved function ultimately attained cases although minimal extensor lags present three cases preoperative motion returned one knee healing allograft host tissue attained primarily tibial junctions two graft complications occurred first three months surgery one quadriceps junction treated resuture failed one month mark graft revised extensor weakness rupture graft patella patellar tendon junction attributed surgical damage tendon completion healing host rehabilitation knee joint grafts series failed course normal daily activities one patient fractured allograft patella severe fall long term durability construct needs studied,C23,0.0025070554,0.0022152436,0.004659732,0.03766343,0.003477433,0.015301033,0.18346037,0.014433917,0.0018054481,0.02658269,0.07334313,0.0051368317,0.03889355,0.0060465094,0.014301637,0.016000409,0.340294,0.0025734988,0.014748698,0.044739716,0.14835984,0.00088670605,0.0025691462
review polyethylene tibial component total knee arthroplasty minimum seven year follow period retrospective analysis total knee arthroplasties performed minimum follow period seven years posterior cruciate condylar prosthesis used procedure patients followed clinically roentgenographically set statistical variables established based elevation joint line tibial component angular alignment overall limb alignment position tibial component anteroposterior lateral roentgenograms review study group found hospital special surgery knee scores improved preoperative score postoperative score good excellent results mean postoperative range motion degrees mean extension degrees radiolucencies developed knees knees progressive radiolucencies eight knees considered failures based clinical roentgenographic evaluations factors found significantly affect formation radiolucent lines included shift tibial component medially greater mm varus tilt tibial component greater degrees diagnosis rheumatoid arthritis variable associated aseptic loosening elevation joint line greater mm,C23,0.013440601,0.013183809,0.0043047788,0.0012932612,0.025731793,0.025217695,0.23646577,0.016512139,0.001664065,0.0022616077,0.031761266,0.048893902,0.14998879,0.00585033,0.0020242035,0.0035843083,0.26027283,0.002370424,0.0026542153,0.08474746,0.06458596,0.00081726885,0.0023735038
stress adaptation low frequency impedance rat lungs transpulmonary pressures ptp cmh pressure volume hysteresis isolated cat lungs found larger predicted amount stress adaptation j hildebrandt j appl physiol behavior inconsistent linear viscoelasticity interpreted terms plastoelasticity reinvestigated phenomenon isolated lungs wistar rats measuring changes ptp ml step volume changes initial ptp cmh response sinusoidal pressure forcing hz cmh peak peak mean ptp cmh stress adaptation curves found fit approximately hildebrandt logarithmic model delta ptp delta v b log delta v step volume change b coefficients time b averaged cmh ml respectively minor differences stress relaxation stress recovery curves response sinusoidal forcing characterized effective resistance elastance el decreased cmh ml hz cmh ml hz el increased cmh ml frequency range data analyzed frequency domain version model complemented newtonian resistance r account airway resistance r b f el b b log pi f f frequency,C23,0.0021575843,0.0019138849,0.0040258286,0.0012122586,0.023937928,0.086345404,0.12533271,0.0020290182,0.02244522,0.0021199533,0.017829044,0.015066445,0.30857563,0.038634475,0.05412246,0.013790194,0.028120015,0.002221954,0.002456727,0.043494653,0.16167653,0.00076607976,0.04172598
role membrane proteins monosodium urate crystal membrane interactions ii effect pretreatments erythrocyte membranes membrane permeable impermeable protein crosslinking agents intact human erythrocytes pretreated membrane permeable dimethyl adipimidate dma dimethyl suberimidate dms membrane impermeable dithiobis sulfosuccinimidylpropionate dtssp protein crosslinking agents incubated monosodium urate monohydrate msum crystals percent inhibition lysis values pretreated cells relative untreated cells determined agents caused concentration dependent inhibition msum induced hemolysis due decrease msum binding pretreated membranes proposed inhibition lysis due crosslinking integral cytoskeletal membrane proteins resulting reduced mobility proteins inhibition lateralization integral proteins aggregates decreased pore formation membrane,C23,0.0030650783,0.0027048665,0.16598636,0.0017132679,0.0042460305,0.003935259,0.19398652,0.0029141603,0.0022044962,0.0029960999,0.0147390915,0.006271793,0.07303453,0.055605263,0.0026814628,0.004748368,0.044128325,0.14309378,0.0034720576,0.035714656,0.2285269,0.0010826897,0.0031489905
en bloc transplantation kidneys donors weighing less kg adult recipients en bloc transplantation kidneys donors weighed less kg adult patients described intraperitonealization medial kidney allowed adequate renal positioning growth graft venous thrombosis occurred patient irreversible graft rejection occurred patients graft survival excellent function mean followup months en bloc transplantation pediatric cadaver kidney grafts adults acceptable procedure,C23,0.0042377836,0.0037591257,0.007907265,0.002381038,0.00590098,0.025975114,0.12216192,0.024493394,0.003063729,0.0041638715,0.020351937,0.00908871,0.11792287,0.030255895,0.0037266002,0.0065991106,0.33625197,0.04538904,0.00482534,0.0986981,0.11698183,0.001504683,0.0043596756
peripheral opioid receptors mediating antinociception inflammation evidence activation enkephalin like opioid peptides cold water swim stress study utilized inhibitors enzymatic degradation enkephalins investigate possibility class opioid peptides contributes stress induced antinociception seen inflamed peripheral tissues rats freund complete adjuvant initiated unilateral hind paw inflammation following min cold water swim stress rats previously injected hind paws vehicle showed transient elevation paw pressure threshold much greater inflamed noninflamed paws returned control levels within min preferential antinociception significantly pronounced prolonged rats previously injected bilaterally cocktail enkephalinase inhibitors thiorphan mg intraplantar bestatin mg intraplantar enhancement stress induced antinociception thiorphan bestatin dose dependently antagonized tertiary naloxone mg kg c evidence peripheral site action enkephalin like peptides model provided antagonism actions thiorphan bestatin quaternary naltrexone mg kg c systemic administration orally active enkephalinase inhibitor sch mg kg p also able dose dependently potentiate preferential stress induced antinociception naloxone mg kg c reversible manner,C23,0.023527507,0.012610365,0.01472864,0.0012383374,0.0030689994,0.002844376,0.13257568,0.0020726677,0.012189917,0.002165559,0.010814183,0.079585776,0.10214317,0.020192368,0.06595667,0.0034494153,0.06992819,0.030179651,0.0025095774,0.014999313,0.39016894,0.0007825601,0.0022681172
increased fatigue isovelocity vs isometric contractions canine diaphragm comparison fatigue loss force repeated contractions time performed canine respiratory muscle isometric nonshortening isovelocity shortening contractions situ diaphragm muscle strips attached linear ergometer electrically stimulated hz via left phrenic nerve produce either isometric n isovelocity n contractions optimal muscle length lo cm similar velocities shortening isovelocity experiments sd lo produced maximizing mean power output wmax mw cm could developed displacement approximately lo initial peak isometric tension kg cm whereas initial peak isovelocity tension kg mc p less initial isometric tension fatigue trials min conducted muscles contracting constant duty cycle end trials peak isovelocity tension fallen initial isometric tension p less whereas peak isometric tension fallen results indicate muscle shortening force production significant influence diaphragm muscle fatigue conclude effects shortening fatigue must considered models respiratory muscle function muscles typically shorten breathing,C23,0.00238138,0.002112403,0.01595988,0.0013380003,0.0033159964,0.0145878,0.103055716,0.0022394788,0.15159103,0.025392847,0.011599151,0.012432581,0.22613128,0.0101436805,0.0020941256,0.003712693,0.08721549,0.0024524266,0.025767755,0.019713113,0.27346745,0.00084554154,0.0024501523
lidocaine local anesthesia arthroscopic knee surgery forty five patients evaluated knee arthroscopy performed using local anesthesia produced lidocaine epinephrine determine dose response relationship operative analgesia serum lidocaine concentrations also measured patients randomized prospectively receive ml lidocaine epinephrine intraarticularly intraoperative discomfort measured verbal response point linear pain scale pain scores significantly higher patients receiving lidocaine first min surgery p min pain scores continued higher lidocaine group groups differences statistically significant ninety four percent patients lidocaine group willing repeat anesthetic technique surgery compared lidocaine group lidocaine group p greater duration postoperative analgesia similar groups serum lidocaine concentrations min instillation lidocaine highest lidocaine group peak concentration ng ml patient symptoms lidocaine toxicity recommend lidocaine concentrations used ml instilled intraarticularly knee arthroscopy based patient comfort absence lidocaine toxicity,C23,0.002203398,0.0019545238,0.004111312,0.0012379993,0.0030681617,0.0028435995,0.117668346,0.002072102,0.0015929586,0.002175766,0.062487982,0.16925748,0.16718754,0.005104129,0.0019376124,0.036546,0.20624872,0.0022691344,0.0025213663,0.019280922,0.18518178,0.0007823465,0.0022667744
insertion deletion polymorphism angiotensin converting enzyme gene accounting half variance serum enzyme levels polymorphism consisting presence absence bp dna fragment detected within angiotensin converting enzyme gene ace using endothelial ace cdna probe polymorphism used marker genotype study involving healthy subjects whose serum ace levels concomitantly measured allele frequencies shorter allele longer allele marked difference serum ace levels observed subjects three ace genotype classes serum immunoreactive ace concentrations respectively micrograms liter homozygotes longer allele n heterozygotes n homozygotes n shorter allele insertion deletion polymorphism accounted total phenotypic variance serum ace showing ace gene locus major locus determines serum ace concentration concomitant determination ace genotype improve discrimination normal abnormal serum ace values allowing comparison appropriate reference interval,C23,0.0022764618,0.0020193353,0.0152576165,0.0012790511,0.003169901,0.0029378927,0.16272429,0.013151121,0.0016457806,0.013249794,0.03246976,0.004723394,0.12543441,0.0053538308,0.0130291255,0.01456225,0.021250738,0.002344981,0.0025920868,0.05452107,0.27549005,0.0008082889,0.2297088
late onset adrenal hyperplasia mutation codon functional hydroxylase gene ubiquitous ten patients affected hydroxylase oh deficient late onset adrenal hyperplasia studied determine prevalence mutation codon functional oh gene cyp b results valine leucine amino acid shift mutation reported eight unrelated late onset adrenal hyperplasia patients ashkenazi jewish descent possessing human leukocyte antigen b dr haplotype normally two oh genes pseudogene cyp functional gene cyp b aberrant codon sequence normally present cyp late onset adrenal hyperplasia patients hybridization oligonucleotide probe specific mutation demonstrated cyp cyp b mutation codon cyp b appear ubiquitous genetic marker oh deficient late onset adrenal hyperplasia suggesting disorder may demonstrate molecular heterogeneity congenital adrenal hyperplasia,C23,0.00309547,0.0027458363,0.0057758256,0.0017392182,0.034343608,0.0039948653,0.26809537,0.06280934,0.002237887,0.003041481,0.014664622,0.00636679,0.020720294,0.04278991,0.002722078,0.0048202905,0.06988438,0.0031878208,0.0035246478,0.037673507,0.1634774,0.016073946,0.22621542
cytogenetic analysis spontaneous abortions direct preparation method chorionic villi implications studying genetic causes pregnancy wastage altogether cases spontaneous abortion fifth th week gestation analyzed cytogenetically direct preparation method using chorionic villi majority cases derived early abortions th week gestation frequency abnormal karyotypes trisomy predominant followed triploidy monosomy x tetraploidy structural chromosome anomalies among trisomies chromosomes prevalent frequency chromosomally abnormal abortions increased maternal age increase trisomy polyploidy monosomy x however decreased mean maternal age significantly increased trisomies highest trisomies results obtained within range variability reported earlier tissue culture type studies consistent feature study excess females chromosomally normal abortions male female sex ratio according methodology applied maternal cell contamination undetected xx molar samples cannot influenced sex ratio however bias introduced social status maternal age cannot excluded rapid convenient direct preparation chorionic villi reliable cytogenetic data causes spontaneous abortions obtained,C23,0.0018662512,0.001655458,0.0035402428,0.02903382,0.0025986957,0.0024084945,0.1943932,0.010883734,0.04616448,0.0018337014,0.11461668,0.0038385522,0.1455124,0.027655931,0.010654935,0.0029061413,0.034484927,0.0019360457,0.0021250015,0.2088771,0.1262908,0.000662638,0.026060754
feasibility cost savings outpatient electrophysiologic testing feasibility outpatient electrophysiologic testing examined reviewing consecutive outpatient tests performed patients seventy one patients underlying heart disease electrophysiologic tests performed evaluate supraventricular tachycardias n nonsustained ventricular tachycardia n unexplained syncope n palpitation n intermittent heart block n mean f electrode catheters inserted femoral vein electrode catheter inserted subclavian internal jugular vein tests f cannula inserted femoral artery monitor blood pressure tests results tests abnormal patients monitored mean h procedure discharged complications occurred cost analysis subgroup patients matched age gender heart disease indication electrophysiologic testing group patients underwent electrophysiologic testing inpatients physicians fees two groups similar however mean hospital charge inpatient group compared outpatient group p less thus outpatient electrophysiologic testing feasible safe results substantial cost savings patients without life threatening arrhythmias,C23,0.013008139,0.001975795,0.03833486,0.0012514726,0.0031015528,0.002874547,0.18596633,0.02365481,0.02317389,0.0021885294,0.24205887,0.060904767,0.09998917,0.0051318277,0.0019648888,0.0034684902,0.20450293,0.0022938296,0.002536197,0.027886383,0.050647397,0.00079086085,0.0022944952
fascinating rhythm primer chaos theory application cardiology nonlinear dynamics exciting new way looking peculiarities past ignored explained away attempted give general introduction basics mathematics applications cardiology brief review new tools needed use concepts nonlinear mathematics careful mathematical approach problems cardiac electrical dynamics blood flow opening window behaviors mechanisms previously inaccessible,C23,0.0050693597,0.0045216484,0.058531847,0.0028482664,0.0315751,0.055591144,0.37140566,0.004767287,0.0036649213,0.0049809436,0.024194084,0.010635665,0.08637422,0.036183376,0.004457867,0.05697413,0.06928713,0.0052206,0.0057722116,0.037731584,0.11319168,0.0017999454,0.0052213343
vertigo epidural morphine severe complications use epidural morphine analgesia caesarean section rare case reported extreme prostrating vertigo several hours epidural morphine injection time onset symptom coincided expected time arrival morphine within intra cerebral cerebro spinal fluid,C23,0.043057628,0.005958571,0.012533766,0.0037741712,0.0093536135,0.037363812,0.21339379,0.038832594,0.0048563015,0.046792302,0.06309781,0.046330847,0.10249698,0.015445123,0.005907015,0.0104602175,0.12813911,0.0069176946,0.0076486226,0.0790275,0.10931695,0.0023850654,0.0069105
effects iron chelator cellular injury induced vascular stasis caused hypothermia rewarming cooled rabbit leg associated generation oxygen derived free radicals shown instrumental tissue injury occurring rewarming present study used compound ability bind free iron remove hydroxyl radical oh tissue deferoxamine reduced tissue injury cooling rewarming evidenced ability decrease tissue release lactic acid dehydrogenase creatine kinase deferoxamine also reduced formation oh lipid peroxidation rewarming phase compound effect arterial blood flow pattern uniformly decreased cooling restored rewarming results study indicate efficacy deferoxamine reducing cellular injury associated cold rewarming suggest role oxygen derived free radicals pathophysiology cold rewarming injury,C23,0.07721924,0.0022996126,0.01738532,0.0014565793,0.0036098734,0.0033456627,0.2657341,0.0025015704,0.0018742097,0.0025472124,0.012808575,0.067938775,0.12577613,0.006311612,0.0022797154,0.016583879,0.02412817,0.037769735,0.0029518602,0.019028608,0.30285275,0.00092047686,0.0026762784
percutaneous transluminal coronary angioplasty gastroepiploic artery graft right gastroepiploic artery used third arterial conduit coronary artery bypass surgery presented case demonstrating successful percutaneous transluminal coronary angioplasty gastroepiploic artery graft successful accomplishment may avoid repeat surgical revascularization case failure gastroepiploic artery graft hence may encourage people use often,C23,0.1273312,0.02903644,0.009458519,0.0028481518,0.0070605027,0.0065420098,0.21615264,0.029304793,0.0036647741,0.0049807434,0.106434084,0.010426285,0.031624336,0.011655555,0.004457688,0.00789373,0.21272771,0.00522039,0.030298486,0.06190281,0.073964335,0.0017998731,0.005214961
anatomy physiology nerve injury nerves structure considerable complexity features special relevance nerve injury nerve regeneration include variations cross sectional areas devoted fascicular epineurial tissue fascicular redistribution mixing different branch fibers brought fascicular plexuses numbers nerve fibers representing individual branches elasticity tensile strength nerve trunks capacity resist traction deformation reside fascicular tissue epineurium provides protective cushion compression microstructure nerve trunks provides basis classification nerve injuries five degrees severity partial mixed types clearly defined pathology distinguishing clinical features following transection injury changes occur severed axons endoneurial tubes fasciculi nerve trunk type injury nature changes determine outcome axon regeneration,C23,0.111283824,0.0024849756,0.0052310326,0.0015741214,0.01743689,0.017166542,0.2907034,0.002634464,0.0020252825,0.029867131,0.06779016,0.0057619303,0.18118486,0.029520301,0.01601844,0.017918287,0.04232774,0.0028849705,0.0031897982,0.031850014,0.1037148,0.0009946729,0.016436433
improved biocompatibility postfixation treatment aldehyde fixed bovine pericardium long standing release locally cytotoxic aldehyde concentrations responsible lack spontaneous endothelialization increased calcification glutaraldehyde fixed bovine pericardium postfixation treatment amino acids made vitro endothelialization bioprosthetic heart valves possible treated pericardium calcified significantly less micrograms mg dry weight conventionally processed pericardium micrograms mg days subcutaneous implantation rats test ability spontaneous vivo endothelialization sheep mm grafts made postfixation treated pericardium ptp implanted carotid artery compared ptfe grafts contralateral side spontaneously endothelialize animal models pregnant animal grafts occluded remaining pericardial grafts remained patent one additional ptfe graft occluded another one stenosed area covered red thrombus significantly smaller ptp grafts ptfe grafts p tem sem showed endothelial cells growing directly ptp myofibroblasts ptfe grafts postfixation treatment glutaraldehyde fixed pericardium aids spontaneous endothelialization decreases tissue calcification,C23,0.002469288,0.014141529,0.028544854,0.0133249415,0.0034384052,0.014355283,0.18130825,0.01426599,0.013714694,0.0024262203,0.02416524,0.017140793,0.051458377,0.04490489,0.0021714296,0.0038451948,0.1269853,0.0025476015,0.0028116475,0.017603992,0.37911707,0.0008767544,0.0383822
development reversibility lymphocyte dysfunction experimental obstructive jaundice study evaluates effect experimental biliary obstruction bile duct ligation bdl biliary drainage cell mediated immunity wistar rats immune status assessed mitogen stimulation test lymphocytes phytohaemagglutinin animals followed days bdl regression analysis showed significant negative correlation lymphocyte function period jaundice correlation coefficient p less following bdl days groups animals internal biliary drainage days external drainage days compared obstructed animals days internal drainage required improve lymphocyte function p less animals days external drainage significantly lower lymphocyte stimulation internal drainage animals p less results demonstrate obstructive jaundice produces progressive reduction lymphocyte function reversed biliary drainage internal drainage effective external drainage,C23,0.0028791241,0.0025539268,0.005372147,0.0016176625,0.0040093698,0.01764748,0.10490648,0.0027075633,0.0020814787,0.0028289086,0.043380324,0.020617446,0.1278101,0.022486437,0.0025318293,0.0044833953,0.08522843,0.003005445,0.0032783065,0.068678886,0.44005337,0.0149489585,0.016892927
analysis base station morphine orders assessment supervising physician consistency paramedic contact base station gemerate consistent recommendations reflecting consensus base station physician care urban ems system paramedics must contact single base station provide morphine sulfate ms patient chest pain performed retrospective cohort analysis prehospital ms requests chest pain determine consistency circumstances paramedic team refused ms ms requests represented line physician consultations month study ms requests refused neither mean patient age sex distribution presenting vital signs correlated ms refusal maximum estimate transport time hospital less equal minutes noted medication refusals compared approvals documented estimated transport times p less equal simultaneous request nitroglycerin ntg noted medication refusals approvals p less found refusal ms administration uncommon supervising physicians tended refuse ms transport time short ntg requested concomitant administration also noted physician inconsistencies refusal scenarios findings guide physician consensus development avoid sending mixed messages paramedics,C23,0.00233205,0.0020686446,0.00470401,0.0013102837,0.003251643,0.0030096318,0.19758873,0.0134722255,0.0016859683,0.013532247,0.047510862,0.004796581,0.118773974,0.00539406,0.046849493,0.013499543,0.14952508,0.013669285,0.10420491,0.122095615,0.1274816,0.00082802615,0.0024155416
maximal uptake situ dog muscle acute hypoxemia constant perfusion investigated relationships among maximal uptake vo max effluent venous po pvo calculated mean capillary po pco isolated dog gastrocnemius situ arterial po pao progressively reduced muscle blood flow held constant hypothesis vo max determined part peripheral tissue diffusion predicts proportional declines vo max pco diffusing capacity muscle remains constant inspired fraction altered six dogs produce four different levels pao se torr muscle blood flow circulation isolated held constant ml g min muscle worked maximally isometric twitches hz four different values pao arterial venous samples taken measure lactate ph po pco muscle vo pco calculated using fick law diffusion bohr integration procedure vo max fell progressively p less decreasing pao decline vo max proportional r fall muscle pvo calculated pco calculated muscle diffusing capacity different among four conditions fatigue developed rapidly lower pao although lactate output muscle different among conditions results consistent hypothesis resistance diffusion peripheral tissue may principal determinant vo max,C23,0.012327689,0.0018563605,0.024061572,0.0011758225,0.0029140674,0.060120296,0.14310458,0.022223962,0.11295861,0.0020562352,0.021996735,0.0043043564,0.1942334,0.052925274,0.0018451508,0.023701664,0.030875847,0.0021551703,0.012429335,0.027342442,0.23237915,0.01085938,0.0021529286
influence calcium alginate haemostatic swabs upon operative blood loss adenotonsillectomy although adenotonsillectomy regarded minor procedure shown patients may experience operative blood loss total blood volume aim study determine whether calcium alginate haemostatic swabs reduce operative blood loss adenotonsillectomy seventy two patients ages years entered prospective trial operation performed either normal gauze swabs calcium alginate swabs thirty six children randomized group mean blood loss found ml total blood volume ml total blood volume respectively although significant reduction operative blood loss using calcium alginate groups blood loss much smaller stated majority previous workers,C23,0.0025276074,0.0022414776,0.004714915,0.0014197566,0.0035186145,0.0032610835,0.10537914,0.0023763182,0.0018268292,0.014715629,0.013933971,0.03699332,0.25983915,0.05904619,0.0022221936,0.0039348938,0.19668043,0.0026029116,0.020323452,0.16852093,0.09042446,0.0008972069,0.0025995714
hemorrhage mice produces alterations pulmonary b cell repertoires nosocomial pneumonia occurs frequently hemorrhage trauma contributes increased incidence morbidity mortality severe injury production secretory antibodies mucosally associated b cells important component pulmonary host defense mechanisms determine effects hemorrhage pulmonary b cell function examined hemorrhage induced alterations pulmonary b cell repertoires changes relative distribution b cells among intraparenchymal pulmonary lymphocytes blood loss hemorrhage induced decreases fold frequencies numbers pulmonary b cell clonal precursors specific bacterial ag levan pseudomonas aeruginosa polysaccharide decreases numbers frequencies bacterial ag specific pulmonary b cell clonal precursors present days blood loss similar decreases numbers frequencies found among pulmonary clonal precursors specific autoantigen mouse transferrin autoantigen dsdna external antigens ova keyhole limpet hemocyanin results demonstrate hemorrhage produces marked alterations pulmonary b cell repertoires may contribute postinjury abnormalities host defenses,C23,0.118010156,0.0019339224,0.06629404,0.0012249504,0.0030360918,0.003083438,0.20946403,0.0020502612,0.0015761682,0.0021421483,0.010204138,0.004491353,0.06831474,0.19926728,0.0019171893,0.025651716,0.021228068,0.0023679095,0.013033829,0.061956078,0.17973408,0.0007741003,0.0022443167
current trends suture fixation posterior chamber intraocular lenses corneal surgeons surveyed regard technique suture fixation posterior chamber intraocular lenses absence posterior capsular support fifty nine percent respondents stated perform procedure almost exclusively penetrating keratoplasty scleral fixation marginally favored iris fixation surgeons intraoperative problems reported related relative technical difficulty procedure although transient hemorrhage ciliary body also mentioned postoperative complications cited included mechanical problems involving lens iris cystoid macular edema glaucoma endophthalmitis,C23,0.02474958,0.0037591325,0.028420575,0.002381042,0.00590099,0.005469091,0.2942979,0.0039852704,0.0030637346,0.004163879,0.027488323,0.029192796,0.027666686,0.009768411,0.023858104,0.027112182,0.19447915,0.0043642228,0.025335917,0.17496316,0.07371552,0.0015046857,0.0043596835
adult height boys girls untreated short stature constitutional delay growth puberty accuracy five different methods height prediction determine accurately several methods height prediction estimate adult height compared height predictions calculated bayley pinneau roche wainer thissen rwt target height tanner whitehouse mark tw mi mark ii tw mii methods final adult height boys girls short stature constitutional delay growth puberty first seen chronologic age mean sd years boys years girls adult height years years cm boys cm girls respectively thus within lower range normal height predictions calculated total group patients parents normal group well short stature group boys rwt method gave accurate results underestimating adult height cm total group prediction errors methods cm tw mi cm tw mii cm bayley pinneau method cm target height girls method superior estimating adult height mean prediction error cm cm cm bayley pinneau tw mi tw mii methods respectively contrast adult height overpredicted cm cm rwt target height methods conclude patients short stature constitutional delay growth puberty reach adult height lower range normal height prediction methods differ respect accuracy tendency overestimate underestimate adult height,C23,0.0018995504,0.0016849961,0.0035443641,0.00106728,0.002645064,0.002482469,0.05969377,0.0017863602,0.0013732904,0.1398035,0.17889374,0.053974822,0.2198014,0.033555407,0.0016704744,0.002957995,0.0712561,0.030007517,0.0021629175,0.057742108,0.11097857,0.019064099,0.0019541874
intravenous intracolonic epidermal growth factor maintains colonocyte proliferation defunctioned rat colorectum role epidermal growth factor proliferation normal premalignant colonocytes vivo fully understood particular relative importance possible systemic intraluminal routes action fully clarified rats surgically defunctioned distal colorectums used mini osmotic pumps implanted study effects intraluminal iv administration epidermal growth factor colonocyte proliferation within weeks bypass colonocyte proliferation defunctioned colorectum decreased one third rate normal colorectum colorectum proximal defunctioning colostomy intraluminal epidermal growth factor infused time operation reverse hypoplasia whereas iv epidermal growth factor maintained colonocyte proliferation approximately normal rate bypassed colorectum model suitable testing putative colonic mitogens possible intraluminal systemic effects,C23,0.0028796454,0.0025543892,0.01935398,0.0016179553,0.004009815,0.017589998,0.12853423,0.0027080534,0.0020818554,0.0028294208,0.040007554,0.04771258,0.10768218,0.16463538,0.016468437,0.027335318,0.11006623,0.0029784057,0.0032789,0.03845451,0.23925447,0.0010224575,0.016944205
different tumor derived p mutants exhibit distinct biological activities wild type form protein p interfere neoplastic processes tumor derived cells often express mutant p full length mutant forms p isolated far transformed mouse cells exhibit three common properties vitro loss transformation suppressing activity gain pronounced transforming potential ability bind heat shock protein cognate hsc tumor derived mouse p variant described whose site mutation corresponds hot spot p human tumors absolutely nonsuppressing weakly transforming exhibits detectable hsc binding data suggest ability p mutant bind endogenous p sole determinant oncogenic potential data also support existence gain function p mutants,C23,0.00262327,0.0023269714,0.005852124,0.0014739446,0.06715011,0.041469403,0.19236724,0.00246777,0.0018965075,0.015269561,0.012478235,0.005395565,0.01763097,0.11974718,0.0023068376,0.016767703,0.03548835,0.25242293,0.0029869787,0.026125973,0.15723497,0.0009314279,0.017585969
muscle relaxation rates individuals susceptible malignant hyperthermia muscle relaxation rate following tetanic stimulus adductor pollicis muscle measured prospectively patients potentially susceptible malignant hyperthermia mh day muscle biopsy obtained mh vitro screening eleven subjects found mh susceptible mhs subjects mh negative mhn patients relaxation rate recorded three different temperatures skin overlying adductor pollicis degrees c achieved small surface heating unit placed thenar eminence mhs group exhibited slightly higher relaxation rate degrees c compared mhn group difference accentuated increasing temperature statistically different results present study suggest relaxation rates normal mhs individuals physiological conditions cannot used diagnostically mh screening,C23,0.0026569504,0.0023568475,0.08246825,0.001492832,0.016561126,0.0034289327,0.15497707,0.002498628,0.0533723,0.0026106096,0.075088896,0.031825874,0.15631393,0.00642526,0.002336455,0.0041374243,0.11204665,0.015682796,0.0030253287,0.042226307,0.22479074,0.0009433865,0.0027333724
mechanisms edema formation experimental autoimmune encephalomyelitis contribution inflammatory cells central nervous system cns endothelium regulates passage solutes functions blood brain barrier bbb experimental autoimmune encephalomyelitis eae inflammatory demyelinating disease cns loss bbb function occurs authors previously shown increase endothelial transcytotic activity associated decreased mitochondrial content evidence bbb dysfunction eae changes occurred capillary bed correlated cns edema clinical signs present report fixation procedure infusion intravascular tracer horseradish peroxidase hrp rats height clinical eae used animals tracer leakage noted inflamed venules diameters mu authors detected several mechanisms passive leakage increased junctional permeability increased interendothelial space leakage alongside migrating inflammatory cells small capillaries showed necrotic changes minimal tracer leakage report demonstrates bbb disruption also occurs via nonendocytic mechanisms may induced inflammatory cells,C23,0.002228018,0.012748297,0.0041572503,0.0012518323,0.0031026313,0.002875373,0.26431108,0.015590781,0.0016107578,0.012969718,0.038554184,0.004653778,0.06632229,0.08510899,0.0019592626,0.03626358,0.056391973,0.002294489,0.002536926,0.074433915,0.2859862,0.022352073,0.0022966044
metaplastic change mesenchymal stem cells induced activated ras oncogene murine mesenchymal stem cells potential differentiate variety different cell types even though show predilection undergo adipocyte differentiation vitro possibility activated c ha ras ejras oncogene might influence pathway differentiation stem cells investigated current study activated ras oncogene transfected stably expressed cells assays performed determine effect differentiation results show ejras transfected cell lines lose ability differentiate adipocytes instead differentiate cells express many characteristics macrophages cells contain numerous cytoplasmic granules extensive nonspecific esterase activity anchorage independent growth modulation differentiation pathway adipocyte lineage macrophagelike cell lineage result transforming effect ejras nontransformed cell clone expresses p ejras protein also exhibits modified differentiation pathway data suggest ejras oncogene specifically modulates differentiation pathway mesenchymal stem cells experimental system therefore provide excellent model evaluate mechanistic role ejras process metaplasia,C23,0.0020505444,0.0018189352,0.003826103,0.0011521569,0.002855318,0.012555223,0.1936561,0.031691305,0.0014824523,0.0020147802,0.011371988,0.0042175776,0.015925435,0.23925105,0.0018031969,0.013174375,0.04999326,0.05174304,0.0023348464,0.043386605,0.21437716,0.00072807376,0.09859043
recurrent cyanotic episodes severe arterial hypoxaemia intrapulmonary shunting mechanism sudden death pathophysiology recurrent cyanotic episodes investigated infants children episodes began median age weeks range day months less months characterised rapidity onset progression severe hypoxaemia early loss consciousness cerebral hypoxia common precipitating factor sudden naturally occurring stimulus pain fear anger uncontrolled trials cyanotic episodes reduced frequency severity tetrabenazine n additional inspired oxygen n eight patients died suddenly unexpectedly four cyanotic episodes twenty eight patients underwent physiological studies cyanotic episodes evidence seizure activity onset although prolonged absence inspiratory effort continued expiratory efforts common breathing sometimes continued episodes caused upper airway obstruction sometimes occurred positive airway pressure ventilation rapidity fall arterial oxygen pressure continued breathing suggested right left shunt sudden onset results contrast echocardiography lung imaging studies confirmed occurring within lungs cyanotic episodes included intrapulmonary shunting prolonged expiratory apnoea best explained interactions central sympathetic activity brainstem control respiration vasomotor activity reflexes arising around within respiratory tract matching ventilation perfusion lungs cause sudden unexpected death infancy early childhood,C23,0.036635097,0.0016400408,0.0034498014,0.0010388052,0.011521289,0.07312846,0.23229277,0.019637851,0.0013366514,0.07340685,0.017412318,0.004057509,0.06654368,0.005349931,0.012951986,0.0028790766,0.17856272,0.0019067479,0.028953044,0.09487402,0.12986283,0.00065646693,0.0019020503
biliary gut function following shock aim study characterize alterations gallbladder intestinal function hemorrhagic shock blood reperfusion opossums animals subjected shock mm hg arterial blood pressure minutes resuscitated blood reinfusion gallbladder epithelial ion transport gallbladder motility vitro vivo gastrointestinal motility flora stomach small bowel studied hours shock changes hours included decreased gallbladder contractility vitro decreased emptying vivo loss coordination intestinal motor activity decrease frequency intestinal electrical slow waves reduced duration intestinal migrating motor complex cycle hours gallbladder epithelial permeability increased vitro contractility remained reduced vivo functions showed partial recovery gastrointestinal flora affected changes data demonstrate hemorrhagic shock reperfusion affect digestive motility early timing alterations observed partial recovery hours post shock suggest ischemia hypoxia mechanism injury,C23,0.030811395,0.0019762076,0.015473898,0.022816403,0.0031024162,0.0028751472,0.252917,0.06594533,0.0016106311,0.0021889864,0.010382934,0.0045972406,0.2120618,0.016497782,0.012737631,0.0034846873,0.026999624,0.0023062609,0.0025367266,0.05999235,0.24559546,0.00079102605,0.002299095
molecular characterization inherited medium chain acyl coa dehydrogenase deficiency deficiency medium chain acyl coa dehydrogenase mcad common inherited defect energy metabolism characterization mrna encoding mcad dutch mcad deficient patient revealed g change nucleotide position mcad mrna coding region point mutation results substitution glutamic acid lysine amino acid position mature protein single base change found wild type mcad mrnas mutant allele specific oligonucleotide probe used hybridization analysis amplified genomic dna mcad deficient family members carrier normal individuals hybridization analysis specifically identified individuals heterozygotes homozygotes addition point mutation significant proportion index patient mcad mrna contained variety deletions insertions result exon skipping intron retention missplicing occurred multiple regions throughout mcad mrna analysis patient mcad gene regions missplicing occurred frequently reveal mutation splicing acceptor donor sites therefore molecular characterization family revealed crucial point mutation mcad gene unusual abnormality mcad pre mrna splicing,C23,0.0018832679,0.0016705525,0.0035139825,0.0010581313,0.05055304,0.0024304553,0.2560644,0.010860502,0.0013615189,0.0018504213,0.039997958,0.022080753,0.045951087,0.01501754,0.0016560982,0.012045916,0.04482589,0.18730398,0.0021443774,0.02814908,0.086869076,0.00066868,0.18204331
aplasia cutis congenita arteriovenous fistula case report review describe child congenital aplasia cutis congenita scalp occult giant posterior fossa arteriovenous fistula previous case reports central nervous system malformations associated aplasia cutis congenita reviewed exact incidence malformations unknown patients aplasia cutis congenita undergo neurologic evaluation families examined similar lesions early central nervous system imaging workup may required especially plastic surgery head region planned,C23,0.059768427,0.0034156214,0.0071847085,0.0021634614,0.079923816,0.0049693226,0.20459792,0.0222546,0.002783769,0.022424368,0.06845576,0.007959729,0.025579391,0.06476632,0.003386068,0.0059960918,0.10938474,0.003965418,0.0043844064,0.20728977,0.08393311,0.0013671869,0.0040460005
endoscopic control upper gastrointestinal bleeding estimated gastrointestinal gi bleeding occurs patients peptic ulcer disease year cases bleeding self limited major predictor persistent recurrent bleeding magnitude blood loss initial evaluation endoscopy important role evaluation patient suspected presumed upper gi bleeding active bleeding time endoscopy correlates likely probability persistent bleeding carries higher morbidity mortality addition continued interest finding visible vessel although controversy visible vessel actually closely observations agree recognition general agreement important endoscopic finding carries high likelihood rebleeding addition finding visible vessel many endoscopists feel ulcers found posterior inferior wall duodenal bulb high lesser curve stomach considered separate category owing proximity large vessels feel endoscopic management carries greater risk possibility inducing bleeding wide variety endoscopic approaches available therapy upper gi bleeding convenient divide therapies four categories topical b injection c mechanical thermal endoscopic therapy bleeding ulcers generally performed high degree safety,C23,0.01051529,0.019031262,0.0033646612,0.0010118834,0.019960979,0.0023242268,0.37086615,0.078800745,0.0013020106,0.0017695444,0.07114326,0.021625187,0.06396774,0.004349078,0.010293431,0.011501462,0.06042672,0.010469729,0.0020506526,0.16288212,0.069851674,0.0006394538,0.0018527566
gadolinium enhanced magnetic resonance imaging bell palsy inflammation facial nerve bell palsy demonstrated gadolinium enhanced magnetic resonance imaging studied series bell palsy patients gadolinium enhanced magnetic resonance imaging purpose paper report findings discuss significance acute bell palsy cases demonstrate facial nerve enhancement usually distal internal auditory canal labyrinthine geniculate segments segments demonstrate enhancement less often gadolinium enhancement occurs regardless severity paralysis persist clinical improvement paralysis findings study corroborate evidence segments facial nerve often involved bell palsy segments often enhanced gadolinium enhanced magnetic resonance imaging role gadolinium enhanced magnetic resonance imaging management bell palsy patients discussed,C23,0.019204345,0.0029201354,0.006142461,0.0018496197,0.1644577,0.0042484496,0.4541202,0.0030958017,0.0023799427,0.0032345469,0.034694575,0.0067709386,0.037406046,0.0076230927,0.018822964,0.005126271,0.058164816,0.003390176,0.003748384,0.021756666,0.13628739,0.0011688564,0.00338665
acellular matrix allograft small caliber vascular prostheses developed acellular matrix vascular prosthesis amvp made detergent enzymatic extraction natural arteries yielding tissue framework collagen elastin original vessel preservation natural basement membrane blood flow surface biografts excellent handling characteristics suturability well low thromboreactivity whole vessel static testing circumferential compliance sem x mmhg mmhg revealed behavior virtually identical paired natural vessel amvp derived nine canine carotid arteries implanted canine origin amvps nine dogs femoral three carotid arteries one infrarenal aorta antithrombotic drugs angiographic patency maintained one occlusion within days follow days years aneurysm formation three amvp years explant analysis revealed preservation amvp elastica collagen inflammation dystropic calcification amvp almost total thrombus free flow surfaces results suggest allograft amvps could achieve long term patency equivalent saphenous veins,C23,0.05024063,0.0141285295,0.024200292,0.08498893,0.0034522142,0.003184003,0.18633011,0.08004825,0.025627488,0.002424133,0.06255556,0.005074484,0.06969783,0.05531933,0.0021696547,0.0038418865,0.11526522,0.0025700484,0.0028092286,0.030206354,0.17243622,0.0008760001,0.0025536204
senior care study optimal use medications acutely ill older patients geriatric assessment units improved pharmacotherapy patients decreasing number medications prescribed senior care study randomized controlled trial compared multidisciplinary team approach patient care standard medical practice institution part trial effectiveness interdisciplinary team intervention improving use medications studied study goals decrease medications used decrease unnecessary medications improve medication choices acutely ill inpatient population pharmacist interviewed experimental patients patient records presented medication concerns recommendations team conference medications counted admission third day sixth week third month randomization medications paired patient problems medication problem pairs judged inappropriate choices potential side effects would affect patient function better alternatives available control experimental patients study similar age sex place origin number medications admission experimental patients took fewer medications controls third day versus p less experimental patients received fewer multiple unpaired medications versus p less fewer inappropriate medication choices versus p less results suggest team intervention effective improving pharmacotherapy acute care setting,C23,0.0015681055,0.016570965,0.018090025,0.008457399,0.0021835372,0.0020237218,0.17061102,0.0014746655,0.0011336704,0.031867452,0.021309722,0.014850335,0.044268608,0.003667325,0.0013880698,0.017609645,0.17524129,0.0016148887,0.030552542,0.29406542,0.13928163,0.0005567773,0.0016132091
pilot study nicardipine acute ischemic stroke author performed pilot study nicardipine nc ca channel blocker study dosing toxicity possible efficacy hemispheric cerebral infarction within hours mean hr onset determine advisability proceeding multi centered controlled trial nc administered iv mg hr x hours titrating dose mean arterial blood pressure mabp less baseline orally x days forty three patients entered mean age range male female ct evidence infarct entry results shown improvement point pt graded exam pts entry pts months patients completing months evaluation improved none worsened sixteen home minimal impairment mean barthel index mean maximal serum nc level ng ml mabp decreased entry hours larger controlled study warranted determine efficacy nc acute cerebral infarct,C23,0.05795267,0.0134755345,0.027194526,0.0013231963,0.026048733,0.0030392914,0.12850086,0.0022147004,0.013099385,0.013712366,0.044831447,0.010148096,0.17237884,0.016920539,0.0020709557,0.014939125,0.16680552,0.0024252925,0.0026815503,0.054599274,0.22237916,0.0008361863,0.00242277
prevalence prognostic significance exercise induced ventricular arrhythmias coronary artery bypass grafting exercise induced ventricular arrhythmias occur often coronary artery bypass grafting cabg prognostic significance unknown two hundred patients examined exercise electrocardiography cardiac catheterization including left ventriculography bypass graft native coronary artery angiography months cabg prospectively followed exercise induced ventricular arrhythmias occurred often patients patients cabg p less differences patients without ventricular arrhythmias prevalence graft patency vs postoperative ejection fraction vs ten cardiac deaths occurred mean follow time months witnessed sudden cardiac deaths cardiac deaths occurred patients exercise induced ventricular arrhythmias cabg postoperative ejection fraction lower cardiac death patients survivors p less clinical angiographic variable predicted occurrence cardiac death thus prevalence exercise induced ventricular arrhythmias increases cabg occurrence ventricular arrhythmias indicate increased risk cardiac death,C23,0.00238133,0.07128258,0.004443315,0.0013379722,0.0033159265,0.0030732304,0.121535584,0.013765509,0.0017215955,0.0023397966,0.05459712,0.004932807,0.04019617,0.005644206,0.0020940816,0.0037082261,0.36565143,0.0024523751,0.0027114945,0.16118799,0.12833187,0.0008455238,0.0024498245
acute hypervolaemic haemodilution avoid blood transfusion major surgery patients underwent acute hypervolaemic haemodilution dextran ringers lactate see whether procedure could avoid preoperative blood transfusion packed cell volume pcv oxygen extraction decreased cardiac index pulmonary wedge pressure increased although end systolic area unchanged pcv significantly different patients lost less greater initial blood volume preoperative manoeuvre reduces loss red blood cells allowed major surgery completed safely without blood transfusion,C23,0.019943016,0.0030164071,0.0063449675,0.0019105984,0.004735079,0.0044274107,0.14982623,0.0031978649,0.0024584052,0.0033411842,0.016580984,0.006994229,0.2373182,0.040746044,0.002990308,0.0052952752,0.22888958,0.0035019442,0.0038719617,0.105375975,0.14451793,0.0012073916,0.0035089988
evaluation c urea breath test detection helicobacter pylori monitoring effect tripotassium dicitratobismuthate non ulcer dyspepsia sixty nine patients non ulcer dyspepsia studied endoscopy biopsy quick urease clo test helicobacter pylori culture c urea breath test treatment tripotassium dicitratobismuthane denol two tablets twice daily four weeks symptoms non ulcer dyspepsia recorded using standard questionnaire using h pylori culture gold standard sensitivity c urea breath test specificity accuracy positive predictive value negative predictive value conversion rate h pylori positive negative status treatment tripotassium dicitratobismuthate symptoms non ulcer dyspepsia improved appreciably treatment irrespective h pylori status c urea breath test accurate research tool suitable serial testing population surveys,C23,0.003004984,0.0026655707,0.09598599,0.0016883779,0.03326742,0.0038780882,0.18823811,0.0028259233,0.0021724696,0.021318613,0.21012491,0.0061806776,0.0637493,0.036247335,0.002642507,0.004987741,0.047597367,0.003170339,0.017963788,0.142769,0.10536308,0.0010669606,0.0030914166
induction mixed erythroid megakaryocyte colonies bipotential blast cell colonies recombinant human erythropoietin serum free culture effects recombinant human erythropoietin rep murine hematopoietic progenitors studied using serum free culture high concentration rep stimulated formation mixed erythroid megakaryocyte colonies em colonies blast cell colonies well erythroid colonies erythroid bursts megakaryocyte colonies normal mouse bone marrow cells direct effects rep em colony megakaryocyte colony erythroid burst formation confirmed depletion accessory cells cells b cells macrophages crude bone marrow cells inhibition colonies addition rabbit anti rep antibody culture dose dependent fashion replating experiments performed confirm differentiating ability blast cell colonies grown presence rep blast cell colonies yielded secondary erythroid colonies also megakaryocyte colonies presence iu ml rep blast cell colonies produced secondary em colonies presence iu ml rep iu ml rep plus interleukin although granulocyte macrophage colonies found secondary culture results suggest ep acts late acting factor specific erythroid progenitors also bipotential em stimulating factor murine hematopoietic cells,C23,0.0019352663,0.0017166778,0.003611006,0.0010873472,0.002694797,0.002497562,0.100413986,0.022570971,0.0013991114,0.0019015127,0.021792598,0.014145083,0.044269823,0.43546763,0.011043395,0.012375699,0.0668729,0.028498393,0.0022035853,0.015079348,0.18651195,0.0006871427,0.02122421
chronic illness depressive symptoms elderly population based study cross sectional study distribution depressive symptoms association depressed mood chronic illness conducted geographically defined population southern california men women aged years older prevalence depressed mood total population women exhibited significantly higher mean depressive symptom score prevalence rate almost twice men depressive symptoms associated several risk factors sexes including age self perception current health status number reported chronic diseases medications amount exercise however relationship physical illness depressive symptoms appeared differ sex respect nature disease disability type medication currently used findings indicate risk depression diminish age among elderly studies suggested,C23,0.0022517303,0.012896057,0.004201495,0.0012652017,0.0031354632,0.013802364,0.27459884,0.0021175544,0.0016279008,0.0022197918,0.023874043,0.015131365,0.030371612,0.005242712,0.0019801545,0.014404362,0.022954663,0.013213573,0.02435598,0.3639585,0.16328065,0.00079950766,0.0023164973
stapling suturing anastomoses left side large intestine two hundred fifty patients undergoing elective surgical treatment involving anastomoses left side colon colon rectum studied randomized trial eea u surgical corp circular stapler compared single layer sutured anastomoses patients either technique feasible included analysis operative techniques largely standardized patients studied means limited barium enema ninth tenth postoperative day data analyzed leakage rate clinical roentgenologic complications degree experience surgeon eleven patients excluded analysis selected technique could carried eight stapled group possible perform sutured anastomosis instances possible staple possible suture remaining three exclusions patients either coloanal anastomosis hartmann procedure performed difference leakage rate roentgenologic clinical total two groups however analyzed surgeon clinical leakage rate surgeons training greater sutured anastomoses stapled anastomoses p thus appears benefits experience pronounced sutured anastomoses experienced hands neither technique superior,C23,0.0020720183,0.09211012,0.013960113,0.0011641826,0.0028857652,0.0026740476,0.21743935,0.022008752,0.0014979771,0.0020358798,0.05727182,0.024907725,0.027983047,0.0047714957,0.0018221345,0.013241931,0.2372004,0.0021338353,0.0023592976,0.16775395,0.0998176,0.00073569844,0.0021528893
effect chemodenervation cerebral vascular microvascular response hypoxia study evaluated effect bilateral carotid chemodenervation cerebrovascular response hypoxia conscious rats cerebral blood flow measured using iodo n methyl c antipyrine total perfused microvasculature studied injection fluorescein isothiocyanate dextran alkaline phosphatase staining maintain constant pco hypoxia achieved chemoreceptor intact rats use co n chemodenervated rats administration n blood gas hemodynamic parameters similar two groups rats chemodenervation significant effect either resting blood flow perfused microvasculature normoxia significant increase cerebral blood flow ml min g control ml min g chemodenervated rats percent cerebral arterioles capillaries perfused occurred hypoxic control chemodenervated rats chemoreceptor intact rats greatest increase blood flow perfused microvasculature occurred caudal structures medulla pons comparison rostral structures cortex thalamus hypothalamus chemodenervated rats similar increase blood flow perfused microvasculature occurred brain regions regional differences thus chemodenervation affect overall cerebral blood flow microvascular response hypoxia however rostral caudal regional differences hypoxic response lost chemodenervation,C23,0.07496318,0.0017495308,0.025904402,0.0011081564,0.0027463688,0.002545359,0.08657857,0.025240043,0.010954463,0.0019379031,0.026935292,0.02400912,0.30589017,0.0047679874,0.0017344155,0.0030756965,0.052569214,0.0020311447,0.0022457566,0.01763082,0.26441196,0.019789184,0.041181266
hypothermia safe efficient methods rewarming patient hypothermia relatively common problem winter months cause significant morbidity presents variety situations affects wide age range diagnosis requires high index suspicion symptoms primarily related central nervous system distinctive appropriate management requires accurate measurement core body temperature treatment centered rewarming patient safely efficiently providing supportive measures care taken avoid arrhythmias simple precautions greatly reduce risk hypothermia,C23,0.0031937829,0.0028314616,0.021404304,0.0017934536,0.01984873,0.019558756,0.30010927,0.0030017938,0.0023076725,0.019774003,0.06103148,0.00656533,0.12089694,0.022778466,0.015780564,0.03587166,0.13327803,0.0032872288,0.0036345595,0.13073388,0.06790149,0.0011333625,0.0032838099
myotonic dystrophy quantification muscle weakness myotonia effect amitriptyline exercise purpose study quantify degree muscle weakness myotonia patients myotonic dystrophy md quantitatively determine effects four six month therapeutic trial amitriptyline patients exercised weights one years shown initial improvement muscle strength reached plateau others improved study began muscle weakness quantified comparing five second maximum voluntary contraction mvc newtons n per kg body weight patients healthy subjects knee extensor elbow flexor first dorsal interosseous fdi muscles compared myotonia quantified measuring relaxation times rts end five second mvc produced fdi time taken mvc decrease referred rt results follows mean muscle strength three muscles patients significantly p less reduced compared healthy subjects rt means patients vs healthy subjects significantly prolonged p less eight patients participated therapeutic trial amitriptyline therapeutic effects quantified measuring muscle strength rt percent change evoked muscle action potential map fdi muscle ten second mvc determine change excitability mean muscle strength fdi improved n kg p less,C23,0.0019174991,0.020265,0.0035792445,0.019636203,0.0026700567,0.0024746323,0.103888564,0.0018032393,0.06636766,0.029676728,0.018226357,0.03239769,0.22535518,0.013677841,0.0016862003,0.040102527,0.17360447,0.001974706,0.020747991,0.043326426,0.17396829,0.00068083423,0.0019726523
facial muscle reanimation using trigeminal motor nerve experimental study rabbit surgical repair facial nerve deficits may marred lack muscle control donor region paresis using new zealand white rabbits study undertaken evaluate facial muscle reanimation donor source previously used motor division trigeminal nerve results compared severed facial nerve hypoglossal facial coaptation atrophy scale calibrated facial muscles rabbit clinical electromyographic histomorphometric findings confirmed trigeminal nerve suitable donor source neurorrhaphy produced exponential rate repair,C23,0.0035161548,0.0031190047,0.00656078,0.0019755838,0.004896134,0.004537781,0.18781647,0.0033066345,0.087654606,0.02046739,0.06402932,0.07629315,0.16735482,0.008767319,0.0030920177,0.005475384,0.12868512,0.05976311,0.0040036594,0.030862771,0.12289031,0.0012484587,0.003684019
addition clonidine enhances postoperative analgesia epidural morphine double blind study study undertaken evaluate analgesic effect combination epidural morphine clonidine versus epidural morphine alone patients postoperative pain randomized double blind design used patients scheduled post operative pain relief epidural morphine studied patients received either continuous epidural infusion morphine clonidine group n morphine alone group n h major abdominal surgery first h dose morphine mg per h second h decreased mg per h final h decreased mg per h groups group patients received clonidine micrograms h period additional epidural bolus injections mg morphine intravenous meperidine given demand pain score blood pressure heart rate respiratory rate relative forced vital capacity measured fixed times first h operation total consumption analgesics side effects recorded although total consumption analgesics significantly higher group p less pain scores lower group group entire observation period p less epidural clonidine produced significant decrease p less heart rate blood pressure whereas respiratory rate affected due better pain relief group forced vital capacity increased p less,C23,0.0018495185,0.0016397925,0.02179124,0.009984123,0.0025776192,0.002393502,0.123442456,0.010676534,0.01922998,0.019710569,0.0091870455,0.13044678,0.20852926,0.004269177,0.0016256572,0.0028795493,0.19068639,0.0019037422,0.02894549,0.018544354,0.18712911,0.0006563675,0.0019017622
excess deaths nine chronic diseases united states assess excess mortality chronic disease united states state age adjusted combined mortality rates nine chronic diseases compared three minimum rates two calculated rates actually achieved states third estimated mortality remaining elimination one risk factor disease hawaii lowest mortality rate combined diseases state excesses ranged sum lowest disease specific rates state per indicating excesses minimum mortality rate per estimated result elimination one risk factor nine diseases indicating state excesses us deaths reduction us mortality nine diseases risk factor eliminated rate estimated associated increased life expectancy birth years,C23,0.0023280524,0.0020650986,0.0043439046,0.0013080377,0.0032417392,0.014104668,0.2875542,0.0021893287,0.0016830784,0.0022874484,0.069786586,0.004788359,0.054734286,0.0058307825,0.0020472305,0.0036252618,0.04614093,0.0023975081,0.0026508302,0.4338139,0.049855724,0.0008266068,0.0023964266
thyroid antibodies risk factor syndrome trisomies test whether presence thyroid antibodies parent risk factor meiotic nondisjunction measured levels thyroid antibodies serum samples drawn early pregnancy gravidas delivered child trisomy gravidas trisomic child previous pregnancy husbands case mother three controls randomly selected population matched age race sex child hospital birth cases controls came two longitudinal populations child health development studies chds national collaborative perinatal project cpp together comprising live births cases definite diagnosis trisomy syndrome ds available serum included overall association presence thyroid antibodies mother trisomy offspring odds ratio confidence interval ci lack association seen three subgroups ds trisomies ds previous pregnancy ethnic groups age groups white mothers either less years age ci greater equal years age ci chds population case fathers compared control fathers higher prevalence thyroid antibodies,C23,0.0019914897,0.011404786,0.013332975,0.0011189368,0.002773086,0.002570121,0.07470885,0.0018728209,0.011078571,0.04052178,0.13089357,0.10246819,0.056500506,0.07529763,0.0017541051,0.0031011635,0.042070493,0.002050904,0.011904341,0.32447985,0.07571131,0.010345729,0.0020487711
bleeding time prolongation streptokinase reduction desamino arginine vasopressin mechanism treatment thrombolytic agents causes bleeding known recently frequency bleeding events shown correlate bleeding time particularly individuals treated aspirin examined effects streptokinase iu kg bleeding time rabbits pretreated aspirin model fibrinolytic therapy tested effects desamino arginine vasopressin ddavp microgram kg agent known reduce bleeding time variety bleeding disorders rabbits compared results control group rabbits receiving normal saline placebo aspirin increased bleeding time baseline mean sem value seconds control group seconds experimental group addition streptokinase increased bleeding time seconds control group seconds experimental group p ns subsequent infusion ddavp decreased bleeding time experimental group seconds p less versus streptokinase compared seconds p ns versus streptokinase control animals given saline placebo subset rabbits receiving aspirin streptokinase iu kg samples obtained platelet aggregation n von willebrand factor antigen concentration n von willebrand factor multimer distribution n maximal rates adp induced platelet aggregation affected ddavp infusion plasma concentration von willebrand factor antigen quantified immunoradiometric assay significantly affected ddavp infusion furthermore von willebrand factor multimer ratio decreased ddavp administration findings indicate aspirin streptokinase combined result marked increase bleeding time reduced ddavp effect ddavp accompanied increase platelet aggregation response plasma von willebrand factor antigen concentration von willebrand factor multimer ratio,C23,0.0013797509,0.001223771,0.0025741842,0.0007751391,0.0019352853,0.0017804414,0.24745136,0.0012973894,0.0076718125,0.0013555348,0.020788945,0.10405908,0.10847182,0.07339453,0.0012131825,0.008870185,0.026168894,0.0014209325,0.014927152,0.01448885,0.3568412,0.00048984465,0.0014207633
brachial plexus block new local anaesthetic per cent ropivacaine new local anaesthetic ropivacaine hydrochloride used concentration per cent patients receiving subclavian perivascular block upper extremity surgery one group n received per cent ropivacaine without epinephrine second group n received per cent ropivacaine epinephrine concentration anaesthesia achieved per cent patients groups c brachial plexus dermatomes motor block profound per cent patients groups developing paresis shoulder hand per cent developing paralysis shoulder rapid initial onset sensory block mean less four minutes analgesia prolonged duration mean greater hr analgesia addition epinephrine significantly affect quality onset sensory motor block duration sensory block reduced epinephrine analgesia c c anaesthesia duration sensory block remaining brachial plexus dermatomes well duration motor block effected epinephrine evidence cardiovascular central nervous system toxicity either group mean dose mg kg ropivacaine,C23,0.016666777,0.0025189135,0.019016203,0.0015954849,0.003954126,0.0036647196,0.21793786,0.0026704436,0.0020529423,0.030282691,0.014188957,0.13487409,0.19505632,0.020262497,0.002497119,0.0044219294,0.17383407,0.0029243713,0.0032570914,0.020027375,0.12436645,0.0010082574,0.0029213298
effect nontransmural necrosis epicardial potential fields correlation fiber direction effect nontransmural necrosis epicardial potential distributions studied dogs previous studies left ventricular epicardial pacing generated epicardial potential maps qrs onset negative central area two positive areas faced portions wavefront propagating along fibers subsequently positive areas expanded counterclockwise direction degrees degrees studies rotatory expansion positive areas tentatively attributed spread excitation deep myocardial layers fiber direction rotated counterclockwise epicardium endocardium test hypothesis tried interrupt counterclockwise expansion positive area creating localized nontransmural necrosis various depths left ventricular wall injection formalin application laser energy epicardial potential maps obtained grid x electrodes x mm area epicardial pacing selected sites generated epicardial maps positive areas missing compared controls direction straight line joining pacing site site missing positivity correlated well average fiber direction necrotic mass r p less angle epicardial fiber direction straight line described correlated well average depth necrosis expressed percent wall thickness r p less data support hypothesis counterclockwise expansion epicardial positivity occurring epicardial pacing results excitation spreading along deep fibers,C23,0.0018338312,0.0016266998,0.021312699,0.045396607,0.0025584174,0.0023666546,0.21653078,0.0017326057,0.0013257783,0.019549137,0.08179246,0.03085077,0.08700853,0.08890053,0.0016126249,0.011729053,0.15298846,0.0018986826,0.002117545,0.012786887,0.18463016,0.018404849,0.011046234
relation transcardiac transthoracic current defibrillation humans conceptually transthoracic defibrillation threshold current considered function least two quantities directly proportional transcardiac threshold current inversely proportional transcardiac current fraction fc ratio transcardiac transthoracic current although experimental theoretical estimates fc high previous measurements humans made study designed quantify fc humans intraoperative testing automatic implantable cardioverter defibrillator transthoracic rescue shocks j delivered device failed defibrillate simultaneous transthoracic voltage vt transcardiac voltage vc two implanted epicardial patch electrodes measured ratio vc vt mean sd patients dogs comparison made direct measurement fc vc vt fc determined specially designed electrode system calibrated account field distortion introduced electrodes significant difference fc vc vt approximately suggesting vc vt statistically equivalent fc results study therefore indicate transthoracic defibrillation humans approximately transthoracic current traverses heart relatively small percentage current results existence parallel pathways thoracic cage lungs shunt current around heart,C23,0.011833557,0.011631447,0.082241334,0.06990284,0.012630413,0.0126349395,0.17409432,0.0019102396,0.011293445,0.011825344,0.02879818,0.014191729,0.1514143,0.06338593,0.0017899892,0.10149384,0.06282291,0.002091881,0.0023628501,0.02967804,0.13913758,0.00072123343,0.002113625
evaluation antral mast cells nonulcer dyspepsia two hundred twenty five patients symptoms nonulcer dyspepsia underwent clinical endoscopic evaluation including histologic assessment endoscopic biopsies mast cells counted special staining low ph alcian blue patients found greater mast cells per high power field endoscopic routine histologic findings similar subset patients mast cells entire group patients increased antral mast cells failed treatment standard drug used peptic ulcer disease h antagonists improved symptoms majority patients adequate follow patients increased mast cells antral biopsy appear subset patients nonulcer dyspepsia amenable specific treatment h antagonists,C23,0.030760504,0.0025547529,0.033256296,0.0016181855,0.031894997,0.017649703,0.31273395,0.0027084388,0.0020821518,0.002843377,0.020169294,0.020016996,0.028247759,0.09789446,0.002532648,0.004484845,0.1652618,0.0029659795,0.0033758448,0.061597202,0.15136422,0.001022603,0.0029640032
diagnostic impact prehospital lead electrocardiography study hypothesis feasible apply prehospital lead electrocardiography stable prehospital chest pain patients prehospital diagnostic accuracy improved compared single lead telemetry population one hundred sixty six stable adult patients sought paramedic evaluation chief complaint nontraumatic chest pain methods one hundred fifty one prehospital lead ecgs diagnostic quality obtained paramedics adult patients presenting nontraumatic chest pain paramedics base station physicians blinded information acquired prehospital lead ecgs treated patients according current standard care clinical diagnosis single lead telemetry final hospital diagnoses classified three groups acute myocardial infarction suspected angina ischemia nonischemic chest pain paramedics base station physicians clinical diagnoses prehospital emergency department ecgs similarly classified compared prehospital ed lead ecgs read retrospectively two cardiologists results paramedics achieved high success rate obtaining diagnostic quality prehospital lead ecgs eligible prehospital patients patients acute myocardial infarction prehospital ecg alone significantly higher specificity paramedic clinical diagnosis vs p less significantly higher positive predictive value vs p less patients angina combining paramedic clinical diagnosis prehospital ecg significantly improved sensitivity vs p less increased negative predictive value vs p less compared paramedic clinical diagnosis alone high concordance prehospital ed ecg diagnosis acute myocardial infarction angina furthermore ten patients whose prehospital ecgs demonstrated ischemia final hospital diagnoses angina acute myocardial infarction mistriaged paramedics received base station physician directed therapy conclusion feasible apply prehospital lead electrocardiography stable prehospital chest pain patients prehospital lead ecgs potential significantly increase diagnostic accuracy chest pain patients approach congruity ed lead ecg diagnoses may allow consideration altering improving prehospital hospital based management patient population,C23,0.0015107661,0.001340125,0.012742191,0.0008488379,0.009885159,0.0019497224,0.27941442,0.0014207427,0.0010922167,0.008790484,0.16127588,0.0127801085,0.16195308,0.0035172985,0.0013285297,0.024192376,0.13903667,0.001562068,0.02389937,0.103205316,0.04616245,0.00053641817,0.0015558171
vitamin b treatment premenstrual syndrome review published erratum appears br j obstet gynaecol mar search literature yielded controlled trials vitamin b treatment premenstrual syndrome discussed emphasis methodological aspects major drawback trials limited number patients included existing evidence positive effects vitamin b weak well designed trials positive results would needed change view,C23,0.0044188593,0.0039197486,0.029593904,0.0024827768,0.0061531216,0.005742769,0.37409413,0.02554016,0.0031946385,0.004341789,0.08427496,0.009275854,0.04615259,0.010946446,0.0038858333,0.006881083,0.0671588,0.0045506926,0.09059928,0.11665077,0.09402681,0.0015689764,0.0045459596
electrotonic influences action potentials isolated ventricular cells work combines theoretical study electrical interactions two excitable heart cells using variable coupling resistance experimental studies isolated rabbit ventricular cells coupled variable coupling resistance passive resistance capacitance circuit theoretical results show response isolated cell increased frequency stimulation strongly altered presence coupling resistance another cell coupling resistance gradually decreased stimulated cell becomes able respond successfully rapid stimulation levels coupling resistance allow conduction two cells coupled pair cells exhibits arrhythmic interactions predicted intrinsic properties either cell experimental results show isolated rabbit ventricular cell extremely sensitive even small electrical load shortening action potential electrical coupling model cell similar input resistance capacitance ventricular cell high omega even though action potential amplitude current threshold insensitive electrical load,C23,0.0021355962,0.0018943805,0.05083422,0.0011999045,0.0029737502,0.09580265,0.22547106,0.0020083406,0.0015439411,0.002098349,0.030582946,0.004803458,0.041283198,0.17593876,0.0018779895,0.0136612775,0.06806191,0.012531734,0.0024316905,0.031853825,0.22805572,0.00075827265,0.0021970228
control total peripheral resistance hyperthermia rats elucidate effect blood volume circulatory adjustment heat stress studied alpha chloralose anesthetized rats three levels blood volume normovolemia nbv hypervolemia hbv plasma volume isotonic albumin solution infusion hypovolemia lbv plasma volume furosemide administration body surface heating performed infrared lamp raise arterial blood temperature tb rate approximately degree c min heating central venous pressure cvp significantly higher hbv mmhg lower lbv mmhg nbv mmhg tb cvp started decrease approximately degrees c hbv approximately degrees c nbv approximately degrees c lbv decreased mmhg degrees c tb hbv nbv lbv respectively stroke volume closely correlated cvp relationship affected tb heart rate responses raised tb similar among three groups mean arterial pressure map affected blood volume modification cvp maintained preheating tb degrees c level tb rose degrees c tb map increased tb reached degrees c mmhg three groups total peripheral resistance tpr inversely correlated cvp slope linear relationship tpr cvp lbv three fourfold steeper nbv hbv,C23,0.010106745,0.0017196154,0.017546814,0.001089208,0.0026994084,0.030654252,0.1134795,0.0018264047,0.0014015057,0.0019047668,0.0102802925,0.04249574,0.32466307,0.02305517,0.03807518,0.03130255,0.031568028,0.001996414,0.0022073563,0.06544477,0.2343286,0.0006883186,0.011466319
role tryptophan repeats flanking amino acids myb dna interactions c myb protooncogene codes sequence specific dna binding protein appears act transcriptional regulator highly conserved evolution dna binding domain myb shown contain three imperfectly conserved repeats amino acids constitute amino terminal end within repeat three tryptophans separated amino acids flanked basic amino acids determine role tryptophans flanking basic amino acids dna binding activity myb proteins selectively mutagenized individual tryptophans well amino acid residues flank tryptophans replacement tryptophans glycine proline arginine abolished dna binding activity whereas replacement aromatic amino acids leucine alanine appreciably affect activity hand replacement two amino acids asparagine lysine flank last tryptophan acidic amino acids completely abolished dna binding activity results consistent model present tryptophans form hydrophobic scaffold plays crucial role maintaining helix turn helix structure dna binding domain basic polar amino acids adjacent tryptophans seem participate directly dna binding,C23,0.00209577,0.0018590526,0.0039104894,0.0011775277,0.0029182932,0.0027194133,0.20419176,0.011420187,0.0015151484,0.012114298,0.09614278,0.004310598,0.029081352,0.0060369964,0.0018484629,0.0032635496,0.080738395,0.12388964,0.0023863425,0.035103977,0.14135541,0.0007441318,0.2311764
effect prolonged hypothermia cardiac function young patient accidental hypothermia year old man accidental prolonged severe hypothermia serial radionuclide ventriculography disclosed reduced myocardial contractility hypothermia resolved warming effects hypothermia cardiac function discussed,C23,0.0063320524,0.005594988,0.011768974,0.0035438768,0.008782869,0.038649052,0.1549715,0.0059315655,0.03506872,0.0061974013,0.02900708,0.012973138,0.089079395,0.014502685,0.0055465777,0.00982195,0.21377903,0.006495587,0.007181915,0.1313838,0.19465953,0.0022395323,0.0064888317
urgent care center pediatric telephone advice pediatric telephone advice sought frequently members community study undertaken evaluate quality accuracy pediatric telephone advice given free standing urgent care centers one hundred facilities telephoned advice requested research assistant case presented could represented pediatric medical emergency overall centers gave adequate advice data suggest circumstances free standing urgent care center pediatric telephone advice may inaccurate inappropriate workable policies protocols pediatric telephone advice instituted facilities,C23,0.0036406203,0.0032294118,0.0067930194,0.002045516,0.005069448,0.022313384,0.17392558,0.0034236833,0.0026320063,0.0035771232,0.079930805,0.007894744,0.024566948,0.008371061,0.0032014695,0.04091012,0.24717614,0.003749235,0.090673946,0.13847093,0.12336682,0.001292652,0.0037453359
isometric features orthostatic tremor electromyographic analysis patient described orthostatic tremor electromyography revealed tremor bursts hz lower extremities standing isometric activation muscles bursts disappeared isotonic activation muscles similar tremor recorded arms isometric isotonic activation review previously reported cases confirms findings clinical electrophysiologic features tremor distinguish recognized forms tremor,C23,0.0042384523,0.0037597187,0.028383307,0.0023814135,0.005929625,0.025978398,0.27745575,0.0039858916,0.044102475,0.004164528,0.04274988,0.008758605,0.08812599,0.010390346,0.0037271879,0.12965965,0.12822954,0.086819865,0.0048261015,0.033119764,0.057325058,0.0015049204,0.004383549
pancreatogastrostomy safe drainage procedure pancreatoduodenectomy purpose study evaluate role pancreaticogastrostomy alternative method restoring pancreaticointestinal continuity pancreaticoduodenectomy since patients undergone pancreaticogastrostomy pancreaticoduodenectomy institution pancreaticoduodenectomy performed pancreatic carcinoma patients ampullary carcinoma patients duodenal carcinoma patients common bile duct carcinoma patients pancreatic islet cell carcinoma patient trauma patient extensive colon carcinoma patient chronic pancreatitis patient gastroduodenal artery aneurysm patient one operative death overall operative mortality rate seven patients major postoperative complications overall morbidity rate pancreatic anastomotic leaks complications related pancreaticogastrostomy occurred twenty four patients died recurrent carcinoma mean survival months range months patients alive well mean follow months range months eight patients alive years operation four exocrine pancreatic insufficiency experience confirms pancreaticogastrostomy safe method pancreatic drainage pancreaticoduodenectomy suggests may technical advantages therefore merits widespread application,C23,0.013444112,0.0020420013,0.0042953193,0.0012934078,0.0032054815,0.002970869,0.18988827,0.0021648419,0.0016642537,0.0022618638,0.035874672,0.0047348025,0.01563643,0.02753597,0.002024333,0.014724724,0.53328097,0.0023724409,0.047183394,0.034027316,0.05618896,0.0008173615,0.002368227
postoperative hypoxemia nonabdominal surgery frequent event caused nitrous oxide tested whether anesthesia includes nitrous oxide n results development intraoperative postoperative pulmonary complications including hypoxemia also tested whether aging contributes development complications particularly anesthesia includes n randomly allocated patients total hip replacements carotid endarterectomies transsphenoidal hypophysectomies total n anesthetic regimen without n stratified within surgical group heat moisture exchanger included anesthetic circuit patients patients monitored perioperatively wk surgery using intermittent continuous pulse oximetry determine oxyhemoglobin saturation intraoperatively mean oxygen saturations lower patients given n particularly older patients hypoxemia saturation less developed five patients receiving n one receiving difference significant administration n decrease postoperative saturation alter incidence postoperative hypoxemia cough sputum production,C23,0.013401245,0.0023270557,0.004942725,0.0014739619,0.0036529528,0.021158844,0.2581387,0.0024670444,0.0018965763,0.0025776103,0.062354065,0.026896525,0.06838522,0.006213761,0.0023070157,0.054851234,0.3032302,0.002701631,0.002987087,0.071786195,0.08262008,0.00093146163,0.0026988212
surgical staples cesarean section randomized controlled trial randomized controlled trial compares use auto suture poly cs disposable surgical stapler n standard hysterectomy n low transverse cesarean sections subjective assessment blood loss surgeon resulted lower mean sem total blood loss estimates stapled group ml nonstapled group ml p however surgeon estimation blood loss result hysterotomy blood loss estimated hemoglobin deficit measured second postoperative day significantly differ two groups use stapling device tended lengthen total operating time averaged minutes group staples minutes group standard hysterotomy p risk febrile morbidity frequency endometritis length hospitalization similar two groups results support routine use auto suture poly cs disposable surgical stapler low transverse cesarean sections,C23,0.0026916896,0.01541451,0.0050224136,0.0015123506,0.0037480926,0.0034737657,0.15086043,0.041619986,0.0019459717,0.002644743,0.044651728,0.11049156,0.23112446,0.0061890255,0.015412676,0.0041915206,0.11632604,0.002771994,0.0031276601,0.12711921,0.09293143,0.013959605,0.002769111
effects nimodipine cerebral blood flow neuropsychological outcome cardiac surgery thirty five patients undergoing cardiac surgery requiring cardiopulmonary bypass cpb allocated randomly prospective double blind study receive either nimodipine micrograms kg min placebo cerebral blood flow cbf measured immediately cpb neuropsychological tests performed months surgery determine relationship ischaemic damage cbf administration nimodipine differences cbf nimodipine n placebo groups n significant changes neuropsychological tests found six patients tested months surgery conclusive signs ischaemic damage nimodipine treated group performed better tests verbal fluency visual retention suggesting memory functions preserved better group,C23,0.029130679,0.0024191907,0.01828024,0.0015323203,0.003797584,0.016683264,0.06915021,0.0025647217,0.0019716672,0.015877072,0.071960256,0.06692985,0.17940989,0.0063319216,0.0023982588,0.004254218,0.27096826,0.0028085967,0.042712376,0.034488946,0.15255643,0.00096834096,0.0028056756
measurement resistance versus flow assessing efficiency aortocoronary bypass grafts measurement flow saphenous bypass grafts electromagnetic flowmeter complicated poorly reproducible since coronary flow largely dependent variable factors stable value resistance seems appropriate comparison simple method developed intraoperative measurement resistance respective coronary bed pressure recorded saphenous graft electromanometer continuous flushing known amounts blood resistance calculated instantaneously procedure simple takes less one minute quality saphenous vein assessed simultaneously method resistances measured coronary surgery saphenous grafts results highly reproducible comparable excellent flows expected resistance peripheral resistance units pru pru flow poor,C23,0.0029200308,0.002590213,0.020289045,0.0016406463,0.0040660505,0.11430542,0.19047262,0.0027460323,0.0021110524,0.0028691017,0.044567354,0.006006664,0.25975016,0.007650414,0.0025678014,0.01868013,0.1558494,0.0030071477,0.003343431,0.079298824,0.07122389,0.0010367968,0.0030078064
marinesco sjogren syndrome examined computed tomography magnetic resonance f fluoro deoxy glucose positron emission tomography marinesco sjogren syndrome autosomal recessive degenerative disorder characterized congenital cataracts cerebellar ataxia spasticity mental deficiency skeletal abnormalities studied two adult siblings marinesco sjogren syndrome using anatomic metabolic brain imaging techniques characterize pattern nature abnormalities brain computed tomographic magnetic resonance imaging showed diffuse brain atrophy mild moderate degree involving primarily white matter cerebrum cerebellum brain stem cervical spinal cord pattern atrophy resembled seen diffuse leukoencephalopathies measurements local cerebral glucose metabolic rates positron emission tomography revealed statistically significant differences normal control subjects regions metabolic rate decreased thalamus one patient findings support diffuse white matter disorder marinesco sjogren syndrome,C23,0.058632325,0.0025539477,0.005378524,0.0016176756,0.09066735,0.01764245,0.25127497,0.0027075855,0.0020814957,0.030697644,0.09516452,0.0431301,0.09952104,0.006767927,0.00253185,0.032357816,0.05274172,0.0029695868,0.0032783332,0.031985894,0.16220956,0.0010222808,0.0030653605
clinical doppler echocardiographic evaluation bioprosthetic valve failure years four hundred thirteen consecutive patients underwent valve replacement bioprosthesis aortic valve replacement performed patients mitral valve replacement patients multiple valve replacement carpentier edwards porcine n angell shiley porcine n hancock porcine n ionescu shiley pericardial valves n inserted follow years postoperatively complete freedom structural valve deterioration respectively aortic mitral double valve replacement risk structural valve deterioration reoperation valve related complications significantly increased ionescu shiley pericardial prosthesis risk reoperation inversely related patient age postoperative doppler echocardiographic studies available patients revealed subgroup asymptomatic patients evidence structural valve deterioration patients n significantly reduced prosthetic valve areas aortic less cm mitral less cm elevated resting transvalvular gradients aortic greater mm hg moderate severe regurgitation summary postoperative doppler echocardiographic examination identified asymptomatic patients structural valve dysfunction patients must followed carefully determine optimal timing reoperation,C23,0.0020678139,0.021675253,0.0038267593,0.0011523148,0.024032047,0.0026467883,0.10499841,0.031705998,0.04117936,0.002015126,0.06329398,0.017270738,0.12366573,0.0047156434,0.041502602,0.0031936718,0.37789083,0.0021163155,0.002335247,0.066801354,0.05907595,0.0007281987,0.0021098864
long term effect dopaminergic drugs restless legs year follow thirty patients restless legs syndrome initially responded well treatment levodopa benserazide studied long term effect drugs least years year period two patients switched levodopa bromocriptine two patients longer needed levodopa one developed paraplegia symptoms restless legs syndrome disappeared completely remaining patients continued use levodopa eight patients maintained original dose nine use increased dose nine found decreased dose sufficient side effect transient nausea reported two patients study showed relief symptoms restless legs syndrome dopaminergic drugs wear passage time side effects minimal even long term use dose needed obtain relief may increase well decrease,C23,0.028007455,0.015023416,0.017549593,0.001473891,0.0036527773,0.0033854267,0.33201072,0.0024669257,0.0018964851,0.0025880074,0.013830079,0.0053955014,0.020403944,0.0060515157,0.014925661,0.004087576,0.19761962,0.0027659056,0.0029869436,0.092279896,0.22796857,0.0009314169,0.0026986916
induction rna stabilized dna conformers transcription immunoglobulin switch region deletion dna rearrangement associated immunoglobulin class switching igm igg iga ige recombination occurs immunoglobulin switch regions complex highly repetitive regions dna switch regions become transcriptionally active switch recombination analysis behaviour sequences transcription could elucidate mechanism switch recombination report transcription supercoiled plasmid containing murine iga switch region alpha leads loss superhelical turns resulting series less supercoiled plasmids stabilized rna dna hybrids formed nascent rna transcripts remain base paired dna templates,C23,0.0032467209,0.03429618,0.006263066,0.0018241999,0.004520956,0.004190062,0.26274598,0.0030532556,0.0023472346,0.018845348,0.01891499,0.006677884,0.03532243,0.040992122,0.018567542,0.020767061,0.03125967,0.050479382,0.0036968691,0.05819525,0.093505226,0.0011527926,0.27913576
systemic pattern free radical generation coronary bypass surgery diffuse impairment ventricular function cardiac surgery may related generation reperfusion myocardium free radicals derived oxygen fifteen patients undergoing elective coronary bypass surgery studied previously described assays peroxidised lipids isomerised lipids used indices free radical activity serial blood samples obtained systemic arterial mixed venous coronary sinus catheters ischaemic period patients underwent coronary artery surgery cardiopulmonary bypass membrane oxygenator relative hypothermia degrees c intermittent cross clamping aorta ischaemic periods significant changes indices free radical activity reperfusion phase significant increase free radical indices arterial mixed venous blood small rise free radical indices coronary venous blood statistically significant data indicate free radical activity increased patients shortly cessation cardiopulmonary bypass pattern distribution different sampling sites suggests much observed increase isomerised peroxidised lipids originates tissues myocardium,C23,0.0133489445,0.0018749826,0.034717556,0.0011876178,0.013126388,0.0027278767,0.12271668,0.03399685,0.011657865,0.0020768624,0.06508519,0.0044074133,0.17658386,0.017385878,0.03255392,0.013520919,0.21186605,0.0022217948,0.0024067906,0.017267825,0.21633317,0.00075050816,0.0021850185
balloon expandable stent implantation stenotic right heart valved conduits although valved conduits used successfully severe forms right ventricular pulmonary artery discontinuity progressive valved conduit stenosis important clinical problem determine feasibility reducing right heart valved conduit stenosis balloon expandable stent baboon model used pulmonary artery ligated right ventricular pulmonary artery mm bioprosthetic dacron valved conduit implanted five baboons average months valved conduit implantation fibrointimal stenosis valve site resulted narrowing mean transconduit pressure gradient mm hg range tubular slotted steel stent cm long deployed within valved conduit inflation mm diameter balloon catheter introduced femoral vein stent delivered valved conduits however two baboons balloon undersizing resulted stent dislodgment remaining three baboons transconduit gradient reduced mm hg right ventricular systolic pressure decreased acutely mm hg concluded stent deployment feasible right ventricular pulmonary artery stenotic valved conduits may result significant hemodynamic improvement however successful stent delivery critically dependent proper selection stent length balloon diameter,C23,0.16730955,0.0019760353,0.004156561,0.0120230215,0.00310193,0.031560022,0.1937563,0.03444492,0.033954833,0.0021887955,0.02343311,0.058477458,0.10549956,0.01654768,0.0019589378,0.0034689119,0.16710034,0.0022997968,0.0025365055,0.02563835,0.10548285,0.000790957,0.0022936102
reversibility canine vein graft arterialization assessed reversibility functional morphological changes arterialized vein segments returning venous circulation thirteen dogs underwent right carotid femoral veno arterial grafting weeks veno arterial grafts removed contractility norepinephrine ne hydroxytryptamine ht luminal prostacyclin pgi morphometric analyses remaining segments used left jugular femoral veno venous grafts another weeks veno venous grafts harvested ne veno arterial grafts ed log less sensitive control veins ed veno venous grafts ed sensitive control arteries ed maximum tension veno arterial grafts g greater veins less arteries g comparable veno venous grafts g ht veno arterial ed veno venous ed grafts sensitive arteries ed vein unresponsive maximum tension veno arterial grafts g less arteries g greater veno venous grafts g pgi production veins ng ml veno arterial grafts ng ml veno venous grafts ng ml comparable less arteries ng ml veno arterial graft intimal thickness microns intimal area x microns tended greater veno venous graft microns x microns also veno arterial graft medial area x microns greater veno venous graft x microns thereby resulting similar relative intimal area therefore changes associated arterialization example adrenergic sensitivity maximum tension ht medial thickening perhaps intimal hyperplasia reverted toward venous values replaced venous environment possibly due variations pressure flow shear stress graft preparation techniques luminal pgi unchanged grafts implying graft contractility modulated luminal pgi,C23,0.053153638,0.0018381724,0.05381082,0.02121517,0.0028855172,0.0026743223,0.12740004,0.11229781,0.021559509,0.0020360888,0.033747658,0.0042885775,0.20120601,0.0047930805,0.0018222678,0.003226895,0.11394369,0.0021340544,0.00235954,0.015891584,0.21483964,0.000735774,0.002140097
efficacy central venous pulmonary artery catheters therapy based upon reducing mortality morbidity purpose study evaluate relative cost effectiveness central venous pressure flow directed pulmonary artery catheters used maintain normal hemodynamic values therapeutic goals control groups vs supranormal values empirically observed critically ill postoperative survivors protocol groups evaluate tissue perfusion oxygenation relationship organ failure mortality two prospective clinical trials significant differences outcome central venous pressure pulmonary artery control groups used normal values therapeutic goals however marked significant reductions morbidity mortality protocol groups using supranormal cardiac index oxygen delivery oxygen consumption values goals cumulative oxygen debt less organ failures fewer less severe protocol groups control groups,C23,0.07923763,0.024059229,0.02628591,0.0012790024,0.0031697806,0.0035820631,0.1303826,0.0021407309,0.023660474,0.0022366724,0.053342037,0.109114304,0.22190523,0.0053946194,0.002001787,0.0035447897,0.085752316,0.0023454237,0.013610673,0.060382448,0.14342219,0.0008082582,0.0023418511
operative complication patient true posterior communicating artery aneurysm case report review literature intraoperative oculomotor nerve injury patient true posterior communicating artery aneurysm reported detail comparison internal carotid artery aneurysms posterior communicating artery junction true posterior communicating artery aneurysms deserves special attention vascular relationships aneurysm complex clip along internal carotid artery occlude blood flow aneurysm aneurysmal neck distal posterior communicating artery closer oculomotor nerve th reported case true posterior communicating artery aneurysm incidence true posterior communicating artery aneurysms ranges aneurysm patients aneurysms constitute called posterior communicating aneurysms two series difficulty associated preoperative diagnosis documented least cases awareness rare aneurysm stressed order avoid operative complications,C23,0.14636014,0.002627461,0.005758888,0.015990637,0.0041709505,0.018125951,0.10351226,0.055407103,0.07378476,0.0029103602,0.10957619,0.0060923123,0.0875885,0.0068106027,0.0026047272,0.0046124835,0.1991658,0.003050391,0.0033726974,0.09736692,0.04701194,0.0010517063,0.0030472185
tympanosclerosis middle ear late results surgical treatment late results one stage operation middle ear tymanosclerosis patients period january december presented mean observation time years range years follow rate per cent among patients stapes fixation removal tympanosclerotic masses stapes mobilization five cases underwent stapedectomy series divided six groups results analyzed best stable results occurred group stapes mobilization intact ossicular chain followed group stapes mobilization type ii tympanoplasty incus interposition poorest late results obtained ears lacking stapes crura stapes mobilization ears subjected stapedectomy case post operative sensorineural hearing loss occurred recommend care taken preserve intact ossicular chain stapes mobilization performed stage myringoplasty also ears defective ossicular chain intact stapes tympanosclerotic fixation recommend stapes mobilization one stage ears fixation stapes footplate defective crura recommend stapedectomy stapedotomy two stages,C23,0.0026261373,0.0022415041,0.048546094,0.0014198639,0.0035186564,0.0032611222,0.17779359,0.0023763464,0.0018268508,0.0024828475,0.08554286,0.05412841,0.044345852,0.010966923,0.0022221098,0.0039349403,0.36328378,0.0026023088,0.0028772703,0.046587415,0.07398331,0.00089721754,0.062534645
sincalide aided ultrasonography common bile duct predictor biliary obstruction determined ercp biliary manometry sonographically observed changes common bile duct caliber following intravenous sincalide injection correlated distal common duct pathology defined endoscopic retrograde cholangiopancreatography biliary manometry thirty two patients prior cholecystectomies studied post cholecystectomy patients mm greater diminution duct caliber within min represented normal response gallbladder contraction occurred normal patients intact gallbladder change diminution duct caliber observed gallbladder contraction observed normal response considered post cholecystectomy patients diminution duct caliber occurring using criteria two false negatives hypertensive sphincters oddi responded normally sincalide injection encountered technique valuable defining non obstructed post cholecystectomy dilated bile ducts demonstrated prompt diminution caliber following sincalide injection,C23,0.018988501,0.0022151957,0.01986542,0.0014031094,0.0034776845,0.0032228462,0.20728701,0.038543377,0.001805409,0.06286454,0.05853141,0.053490043,0.11875563,0.023792842,0.0021960288,0.0040568453,0.1390198,0.0025744417,0.0028434996,0.0481332,0.18347736,0.00088668684,0.0025690906
vagal modulation rate dependent properties atrioventricular node vagal effects atrioventricular av nodal conduction accentuated increases heart rate establish mechanism rate dependent negative dromotropic actions studied properties governing av nodal adaptation changes heart rate chloralose anesthetized dogs absence presence bilateral cervical vagal nerve stimulation hz msec stimulation protocols applied evaluate contributions changes av nodal recovery facilitation fatigue independently vagal stimulation slowed av nodal recovery voltage dependent way increasing time constant recovery tau r msec mean sem p less highest voltage studied facilitating effect premature beat manifested leftward shift recovery curve h versus h subsequent beat magnitude shift depended coupling interval reduced vagal stimulation intervals maximum shift control msec vagus msec p less recovery facilitation kept constant abrupt increases av nodal activation rate caused slow tau beats increase ah interval fatigue vagal stimulation increased magnitude process maximum control msec vagus msec p less without altering time course activation rates comparable sinus rhythm humans vagal stimulation intermediate voltage increased ah interval msec heart rate increased vagally induced changes dynamic processes amplified ah prolongation fivefold maximum rate role vagal changes individual functional properties depended heart rate slowing recovery single important factor constituting overall vagal action rapid rates conclude vagal stimulation alters ways av node responds changes activation rate rapid rates negative dromotropic action vagus due changes av nodal response tachycardia alterations rate dependent av nodal properties novel potentially important mechanism interventions may affect av nodal conduction,C23,0.0013895276,0.007934802,0.035492614,0.00078042323,0.0019341405,0.0017925786,0.25060126,0.00800276,0.0010041861,0.0013647755,0.038850375,0.0028654856,0.18898484,0.01835242,0.0012214527,0.002165944,0.034947634,0.021600025,0.0015815824,0.047014207,0.32347336,0.007212419,0.0014331501
cup containment orientation cemented total hip arthroplasties reviewed radiographs charnley sth zimmer cemented total hip arthroplasties mean follow seven years maximum years survivorship analysis used assess correlation radiographic performance bony containment coronal orientation acetabular cup cup orientation containment interrelated vertically oriented cups completely contained whereas horizontal cups partially contained completely contained cups significantly lower incidences complete cement bone radiolucency p wear p vertically oriented cups lower incidence continuous radiolucency neutrally oriented cups statistically significant p results confirm importance complete bony containment also indicate better accept vertical orientation obtain full bony coverage horizontal orientation partial containment,C23,0.0040702866,0.0036105474,0.0076845093,0.002286928,0.0056677456,0.0052529173,0.29616675,0.003827747,0.0029426361,0.0039992956,0.06564653,0.008645352,0.10793238,0.013125064,0.06263339,0.006338283,0.18587063,0.004256523,0.00463462,0.13306776,0.066376746,0.001445211,0.004518174
influence menstrual cycle systemic diseases physiological changes associated menstrual cycle influence clinical course diseases bronchial asthma allergies anaphylaxis epilepsy migraine dermatoses porphyria hormonal manipulation beneficial patients,C23,0.0077216914,0.0068495255,0.014407875,0.0043385033,0.01075221,0.009965245,0.31395614,0.0072615724,0.0055824392,0.007587015,0.0355112,0.015882043,0.088593446,0.017754553,0.006790261,0.01202428,0.1126126,0.007952062,0.008792282,0.10725329,0.18772626,0.0027416921,0.007943791
protocol investigation pregnancy loss protocol evaluation pregnancy loss include maternal history dysmorphic examination fetus abortus photographs autopsy chromosome studies cases radiographic xeroradiographic studies selected cases suspected ascending transplacental infection may require microbiologic investigation increasing specialized laboratory techniques may help diagnosis inborn errors metabolism storage disorders coordination studies requires interaction ob gyn pathology genetics cytogenetics nursing order assure delivery clinical service knowledge causes pregnancy loss typical time mode presentation facilitate focused evaluation high chance achieving accurate diagnosis goal investigations provide families recurrence risk data base future childbearing decisions well information potential prenatal monitoring,C23,0.0025907215,0.0022980992,0.0048340177,0.0014556207,0.028690612,0.02037398,0.30599645,0.014968903,0.026921004,0.0025511514,0.14707746,0.017853133,0.018972423,0.020466162,0.014818378,0.0040342924,0.047840845,0.0026770441,0.036143415,0.18362963,0.050546464,0.013458616,0.031801585
guidelines transfusion support patients undergoing coronary artery bypass grafting transfusion practices committee american association blood banks reviewed impact evolving issues coronary artery bypass grafting cabg transfusion support patients issues include increased awareness transfusion risks reappraisal traditional indicators triggering transfusion evolving alternatives homologous blood transfusion autologous blood pharmacologic therapy issues prompted programs national institutes health consensus conferences provide physicians guidelines appropriate use blood components however evidence suggests transfusion practice coronary artery bypass grafting procedures remains variable take account results recently published clinical studies therefore developed guidelines recommendations transfusion support patients undergoing coronary artery bypass grafting summary following institutions coronary artery bypass grafting programs establish multidisciplinary approach use combination interventions designed minimize homologous blood exposure prophylactic transfusion plasma platelets benefit therefore carry unnecessary risk patient special request products designated blood donation first degree relatives used risk transfusion associated graft versus host disease support intravascular volume crystalloids colloids used potential transmit infection,C23,0.0018997433,0.010875609,0.021582196,0.0010673882,0.002657546,0.011966811,0.35131255,0.0017865415,0.0105464235,0.0018666093,0.01940478,0.003907409,0.08229515,0.0043680966,0.0016705863,0.039733745,0.16508365,0.0019564207,0.13015105,0.07257466,0.06066409,0.0006745298,0.0019543858
effect continuous epidural analgesia postoperative pain rehabilitation duration hospitalization total knee arthroplasty efficacies three alternate methods postoperative analgesia studied patients total knee arthroplasty tka forty two patients received parenteral meperidine hydrochloride morphine group patients received periodic epidural injections morphine group patients received continuous epidural infusions bupivacaine hydrochloride duramorph group postoperative course patients documented terms incidence severity pain range joint motion duration hospitalization occurrence complications although epidural analgesia increased cost duration operation good excellent pain relief attained group group cases epidural analgesia compared patients group receiving conventional analgesia moreover patients group experienced frequent episodes moderate severe postoperative pain contrast patients group patients group result diminished pain greater joint motion obtained within first hours groups also shorter hospitalization days versus days group days group however use epidural analgesia reduce incidence complications including nausea continuous infusion epidural bupivacaine duramorph provided good excellent control postoperative pain tka however better analgesics needed reduce high incidence side effects associated various treatment methods,C23,0.0018330701,0.0016252747,0.0125411395,0.0010294523,0.002551315,0.0024010006,0.11321846,0.0017230462,0.0013246168,0.0018002683,0.058631893,0.1599073,0.0658169,0.013110647,0.0016112885,0.0028550983,0.33533013,0.0018868876,0.0020862573,0.103777185,0.112403296,0.0006505564,0.0018849252
problem solving implant dentistry dental implants become accepted form dental care reported functional year success rates higher impressive statistics include identify problems may created clinical ineptitude diagnostic acumen preventive measures stage implant treatment avoid many problems also appropriate measures timely recognition rescue repair often restore ailing implants prosthetic appliances full function,C23,0.0041522016,0.023759747,0.007747577,0.0023329526,0.005781809,0.005358632,0.36786968,0.023997497,0.0030018569,0.0040797815,0.04496215,0.008540285,0.07336494,0.094519235,0.0036513412,0.02656418,0.086572826,0.004276079,0.004727892,0.09231313,0.106677346,0.0014742959,0.004274577
myocyte cell loss myocyte cellular hyperplasia hypertrophied aging rat heart determine effects age myocardium functional structural characteristics heart studied rats months age mean arterial pressure left ventricular pressure first derivative dp dt heart rate comparable rat groups months interval months elevated left ventricular end diastolic pressure decreased dp dt indicated significant impairment ventricular function occurred senescence period months reduction nearly total number myocytes measured ventricles subsequent ages similar decreases myocyte cell number found left ventricle whereas right ventricle initial loss fully reversed months moreover months increase aggregate number myocytes occurred right ventricular myocardium left ventricle increment also seen small change statistically significant estimations myocyte cellular hyperplasia however complicated fact cell loss continued take place age volume fraction collagen tissue fact progressively increased months months left right ventricles respectively conclusion myocyte cellular hyperplasia tends regenerate ventricular mass lost age adult mammalian rat heart,C23,0.026222628,0.0014692151,0.011104045,0.016952211,0.0023063365,0.0021375332,0.15069366,0.04164676,0.0011974266,0.0016274058,0.0077620917,0.011956486,0.11697642,0.048910618,0.019128084,0.0025791938,0.20369965,0.0017057079,0.0018859339,0.11439416,0.19731553,0.016622791,0.001706151
inactivation human alpha globin gene expression de novo deletion located upstream alpha globin gene cluster synthesis normal human hemoglobin alpha beta based upon balanced expression genes alpha globin gene cluster chromosome beta globin gene cluster chromosome full levels erythroid specific activation beta globin cluster depend sequences located considerable distance beta globin gene referred locus activating dominant control region existence analogous element upstream alpha globin cluster suggested observations naturally occurring deletions experimental studies identified individual alpha thalassemia structurally normal alpha globin genes inactivated cis discrete de novo kilobase deletion located approximately kilobases alpha globin gene cluster conclude deletion inactivates expression alpha globin genes removing one previously identified upstream regulatory sequences critical expression alpha globin genes,C23,0.002437815,0.0021624635,0.00454871,0.0013697088,0.0033945802,0.0031461273,0.1419427,0.0022925509,0.0017624317,0.014184734,0.037940618,0.005074301,0.020987242,0.006125943,0.002143753,0.003796185,0.022945065,0.113109626,0.002775811,0.046941962,0.13466705,0.0126403645,0.41361025
possible mechanisms limiting n methyl aspartate receptor overactivation therapeutic efficacy n methyl aspartate antagonists cytotoxic overactivation neuronal n methyl aspartate receptors postulated contribute pathogenesis neuronal loss hypoxia ischemia however several events associated hypoxia ischemia may limit n methyl aspartate receptor mediated injury perhaps important events development extracellular acidosis limiting events may help explain n methyl aspartate receptors contribute injury focal ischemia hypoxia vitro global ischemia,C23,0.053680096,0.0030674725,0.023191288,0.0019429432,0.00481524,0.017031312,0.35501122,0.0032520022,0.019112995,0.0034307877,0.015903236,0.00711257,0.024438445,0.035378393,0.0030409312,0.0053849197,0.029533258,0.1020559,0.0042094006,0.2206114,0.06301082,0.0012278317,0.0035575253
effects micron nd yag laser brain thermal histological experimental data considering microns nd yag laser physicothermal properties close co laser series experiments conducted rat cortex n three laser wavelengths compared co laser microns microns nd yag microns nd yag lasers shot temperature measurements recorded infrared thermographic videocamera digitized signals figured thermal profiles temperature developments ninety five shots correctly studied analyzed co n microns nd yag n microns nd yag n histological lesions produced three lasers compared animals killed hours n days n days n laser impacts equivalent densities energy depth cortical necrosis comparable co laser microns microns nd yag laser microns whatever date death microns nd yag laser shots responsible much important damage microns important absorption water nervous tissue authors consider microns nd yag laser suitable neurosurgery particularly conducted optic fibers therefore easy handle neurosurgical procedures,C23,0.014409098,0.0021884523,0.051556468,0.013315268,0.015377933,0.0031839376,0.14231612,0.0023201029,0.0017836128,0.0024240834,0.04555824,0.037294902,0.08021636,0.026409382,0.026049625,0.0038418078,0.26847816,0.0025407171,0.0034578664,0.02651326,0.22734293,0.00087598216,0.002545721
kidney transplantation patients aged sixty years older outcomes renal transplantation reviewed transplants performed patients years age older three grafts family donors cadaver donors twenty one first transplants five retransplants cyclosporine used primary immunosuppression azathioprine prednisone administered patients overall patient graft actuarial survival rates respectively years patients n free diabetes cardiac disease low risk year patient graft survival rates respectively conversely high risk patients n patient graft survival rates years respectively early deaths less equal months caused sepsis two patients cardiac events three patients four five high risk patients irreversible rejections serious infectious complications common steroid induced diabetes occurred five patients experience suggests kidney transplantation done safely successfully patients older years age treatment choice low risk patients category,C23,0.0020112037,0.0017840381,0.0037526975,0.0011300134,0.0028005375,0.012321299,0.1443662,0.0018913604,0.0014540108,0.0019761259,0.009934167,0.004338065,0.04351145,0.01456702,0.011280494,0.012859776,0.384468,0.021536954,0.0022900514,0.2177107,0.101232655,0.0007141054,0.0020690523
outcome patients chronic affective disorder five year follow patients major depression mania schizo affective disorder present without remission years intake n followed prospectively years patients ill shorter periods intake despite substantial durations episode three quarters chronic patients recovered although recovery occurred much later follow period among nonchronic patients factors associated recovery less severe illness intake lack psychotic features good friendship patterns adolescence important relatively high maximum level functioning years preceding intake,C23,0.0031958395,0.0028299135,0.005952681,0.001792473,0.0044423263,0.034998186,0.24022178,0.0030001525,0.0023064108,0.018575042,0.0327598,0.0065617403,0.057003696,0.0077678636,0.0028054279,0.0049678874,0.24790186,0.0032854315,0.0036325722,0.21860538,0.092978805,0.0011327429,0.0032820145
predictors quitting smoking nhanes followup experience published prospective studies predictors spontaneously quitting cigarette smoking nationally representative u population paper describes study using cohort taken first national health nutrition examination survey nhanes traced nhanes epidemiologic followup survey successful quitting least year time followup ascertained among adults age years smokers time nhanes disabled followup independent predictors quitting proportional hazards multiple regression older age white race fewer cigarettes smoked day higher household income hospitalization followup period predictors relapse ex smokers nhanes smoking time followup younger age urban residence female gender findings implications intervention strategies public health projections research,C23,0.0031903498,0.0028299994,0.005952862,0.0017925275,0.0044424613,0.004117313,0.1275407,0.0030002436,0.017749332,0.003134706,0.078266054,0.0065631443,0.022329958,0.0074978303,0.002805513,0.020452952,0.15743288,0.0032855314,0.065393105,0.3952145,0.062593155,0.0011327773,0.0032821144
disability bicycle related injuries children bicycle crashes major cause injuries childhood goal study determine long term disabilities caused bicycle related injuries clarify long term treatment priorities injured children hospital records children ages yr median yr boys girls admitted bicycle related injuries provided clinical information social service visits hospital outpatient rehabilitative interventions physical status discharge complete evaluations made contacting parents telephone children personal interview physical examinations head injuries predominated twelve died major head injuries four suffered permanent severe impairment cervical spinal injuries head injuries remain institutionalized one third persistent disability noted time discharge medical record reported telephone interview confirmed physical examination still received physical therapy consultations hospitalization received social service assistance seen surgeon pediatrician discharge received outpatient physical therapy cognitive behavior changes noted many noting changes school performance worse behavior sleep particularly nightmares recurrent injuries occurred children ten required hospital admission bicycle related injuries cause significant short long term disabilities among children,C23,0.11377207,0.0014690588,0.0030901432,0.0009305048,0.018333139,0.0022668757,0.3106841,0.0015584533,0.0011972991,0.080218256,0.06275727,0.020092655,0.020294813,0.019828174,0.0014563479,0.0026899348,0.14829007,0.0017077863,0.025908295,0.13183695,0.029326001,0.0005880271,0.0017037524
conduction system injury aortic valve dilation dog single versus double balloon catheters range morbidity induced valvuloplasty fully known transient conduction disturbances common authors performed aortic valve balloon dilatation closed chest dogs normal aortic valves using femoral cutdown approach fluoroscopic guidance four done single mm balloon catheter two mm balloon catheters used balloons inflated atms pressure contrast solution several inflations dogs sacrificed hearts removed examined gross examinations revealed subendocardial hemorrhage outflow tract double balloons used microscopically aortic valve areas showed hemorrhage mostly loose connective tissues valve leaflets severity injury appeared greater two balloons used histologic examination showed definite injury myocytes left bundle branch double ballooned dogs none subjected single balloon procedure aortic valve dilation manifestation conduction system injury prolongation qrs complex dogs double balloon catheter used results suggest electrocardiographic conduction disturbances observed patients undergoing aortic valvuloplasty may result direct injury conduction tissue may likely occur larger balloons used,C23,0.06350057,0.001874715,0.015102588,0.0011874483,0.0029497123,0.0027274874,0.3453223,0.032675482,0.011755846,0.002076566,0.14686649,0.014570396,0.048063107,0.005122374,0.0018584941,0.003291045,0.154826,0.002192382,0.0024064472,0.015893085,0.12280685,0.00075040106,0.0021802087
balloon dilatation versus surgical revision infra inguinal autogenous vein graft stenoses long term follow although infra inguinal autogenous vein graft stenoses may treated balloon dilatation pta surgical revision optimal approach undefined last years pta procedures performed vein graft stenoses grafts graft stenoses diagnosed mean months implantation pta successfully completed procedures including primary secondary procedures recurrent vein graft stenosis graft thrombosis developed grafts mean months primary pta long term patency primary pta months secondary patency months period vein graft stenosis fem pop fem tib grafts surgically revised initial success rate complications four grafts occluded mean months repair yielding primary year patency although vein graft stenosis may safely effectively repeatedly treated pta long term durability appears superior surgical revision,C23,0.0027639442,0.0024517565,0.005157233,0.0015529474,0.0038487047,0.020560553,0.1589607,0.0025992466,0.0019982087,0.0027157376,0.052799765,0.019047393,0.01911387,0.0063551613,0.0024305428,0.004304036,0.58873665,0.0028464042,0.016506603,0.03632461,0.045101073,0.0009813762,0.0028434438
immune responses allogeneic xenogeneic implants collagen collagen derivatives whereas xenogeneic collagen provided safe effective biomaterial numerous medical applications instances data permit correlation immunologic profile well defined devices clinical sequelae major exception use injectable bovine dermal collagen soft tissue contour correction low incidence hypersensitivity studied context clinical efficacy safety several devices findings indicate immunity usually results manifestation local symptoms dermal inflammation sites treatment resolve implant resorbed host contrast immunogenic hemostatic agents may elicit frequent vigorous immune response clinically visible relevant application recent experiences collagen based devices repair regeneration bone also demonstrated presence immunity collagenous non collagenous components necessarily predict adverse clinical sequelae indeed numerous specific data indicate immunity exist epiphenomenon effect osteogenesis get true composite picture biocompatibility significant steps must taken characterize biomaterials properly ensure immunologic clinical histologic pertinent laboratory data viewed relation one another isolation,C23,0.0020306217,0.041117404,0.0136160515,0.050290573,0.014344911,0.014548549,0.37763083,0.041219663,0.009599487,0.0019979214,0.049750254,0.014002412,0.047739077,0.03822365,0.0017856775,0.03493111,0.040863782,0.0020936534,0.012122846,0.10725227,0.07171985,0.00072099996,0.01239842
reversal colchicine induced mitotic arrest chinese hamster cells colchicine specific monoclonal antibody ability high affinity colchicine binding monoclonal antibody reverse effects colchicine chinese hamster ovary cells investigated using flow cytometry complete mitotic blockade demonstrated hours x mol l molar colchicine colchicine induced changes reversible equimolar antibody added simultaneously hours colchicine delay addition antibody progressive irreversible increase mitotic blockade increase mean cell size observed prolonged colchicine exposure without antibody reversal led polyploidy structural chromosome breakage early antibody reversal restored cells diploid state whereas delayed reversal resulted time dependent increase polyploidy colchicine induced polyploidy chromosomal aberrations may basis colchicine toxicity time dependent increase irreversibility colchicine effects,C23,0.0025278544,0.002242333,0.0047167144,0.0014202984,0.0035677324,0.015493545,0.21251324,0.0023772249,0.0018275263,0.026956655,0.012444325,0.0051993136,0.057601776,0.1519514,0.014439783,0.003936395,0.06419149,0.06032362,0.0028783341,0.01999716,0.2558642,0.00089754927,0.07663151
laryngeal framework reconstruction miniplates defects laryngeal framework trauma cancer thyroplasty reconstructed mini reconstruction plates six patients miniplates used repair thyroid cartilage defect type thyroplasty prevent lateralization silastic implant three patients miniplates used hemilaryngectomy bridge thyroid cartilage remnants resulting better deglutition hemilaryngectomy three patients miniplates used repair laryngeal fractures plates tolerated well patients major complications rigid fixation using miniplates laryngeal reconstruction unique advantages use wires offers advantages rigid immediate stabilization ability bridge large defects alternative existing techniques laryngeal reconstruction,C23,0.0035774256,0.020490263,0.006675105,0.0020101252,0.056285378,0.03918268,0.27527836,0.0033642543,0.0025863193,0.0035150307,0.02729999,0.093941376,0.022723993,0.026695652,0.0031458978,0.0055707954,0.29224753,0.0036841552,0.004073425,0.040201157,0.06250056,0.0012702139,0.0036803235
channel specificity antiarrhythmic drug action mechanism potassium channel block role suppressing aggravating cardiac arrhythmias although work class iii antiarrhythmics remains early stage agents still appear possess greater efficacy less proarrhythmia conventional class agents experimental arrhythmia models considered representative clinical situation although prolongation repolarization carries tendency pause dependent arrhythmogenesis e torsade de pointes available data suggest may function nonspecificity potassium channel block rather general characteristic class iii activity availability new selective blockers specific cardiac potassium channels development class iii agents already helped clarify basic questions ionic mechanism repolarization heart one hopes growing clinical data base eventually determine relative safety efficacy agents preventing symptomatic life threatening arrhythmias,C23,0.0024407113,0.025795007,0.039991096,0.001371336,0.003398613,0.0032806816,0.29792792,0.0022952743,0.0017645255,0.018013753,0.024224555,0.0050200764,0.058874875,0.08364979,0.013956619,0.015608357,0.22261566,0.01904889,0.020577332,0.04879688,0.087969676,0.0008666078,0.0025117886
neurologic assessment neurologic nursing assessment requires knowledge anatomic physiologic principles well mastery complex assessment skills nurse often first consistent health team member interacting clients may provide key early recognition prevention treatment neurologic problems nurse dynamic member health team may first line defense initiating cost effective perhaps life saving measures neurologically impaired clients,C23,0.003916406,0.022431135,0.030409021,0.002200469,0.005460346,0.024002783,0.35097483,0.022634195,0.0028313873,0.041726314,0.074861504,0.0080552995,0.04105923,0.009005028,0.0034439887,0.006098659,0.04352555,0.041942045,0.10390993,0.09396024,0.06213198,0.0013905736,0.004029054
case porous coated hip implants femoral side series total hip arthroplasties thas using porous coated femoral components roentgenographically assessed implant fixation primary thas followed two years femoral revision rate ten year survivorship rate young patients fixation failure incidence mean follow period years revision thas femoral revision rate mean follow period months failures largely related inadequate femoral canal filling refinements implant design surgical techniques press fit implant currently achieved cases compared first five years porous coated femoral components yielded results equivalent cement primary thas excellent results observed relatively young patients patients revisions,C23,0.00272702,0.04202419,0.04468377,0.0015322013,0.003797289,0.0035270932,0.09506673,0.0025645227,0.081182465,0.015877241,0.07202086,0.005608959,0.023730548,0.059073005,0.0023980725,0.004246537,0.33646134,0.0028083785,0.0031051135,0.12442497,0.06936595,0.00096826575,0.0028054577
reduction postoperative morbidity following patient controlled morphine present study examined impact two methods pain management recovery women undergoing hysterectomy one group received iv morphine recovery room im morphine ward prn basis prn group group loading dose morphine mg iv given patient first complained pain patient controlled iv morphine pca initiated continued h pca group groups received similar amounts morphine overall differently distributed time pca patients received mg h recovery room approximately hrs less thereafter prn patients received approximately mg h entire hr period pain control better throughout convalescence less variable across time pca management minute ventilation also recovered faster day four per cent preoperative baseline pca group addition oral temperature became normal one day earlier ambulation recovered rapidly patients discharged hospital earlier data suggest early treatment relatively high self titrated morphine doses may alter course metabolic response surgery,C23,0.001953638,0.0017329743,0.013098378,0.0010976695,0.0027203788,0.011966751,0.22728585,0.0018372247,0.0014123932,0.011373172,0.019461937,0.14804871,0.08563289,0.0045238347,0.0017179798,0.021900956,0.1785607,0.0020125026,0.0024732111,0.029425744,0.22905922,0.0006936658,0.0020101888
effects menstrual phase amenorrhea exercise performance runners well controlled studies terms subject selection menstrual classification exercise protocol examined maximal submaximal exercise responses different phases menstrual cycle eumenorrheic runners compared runners amenorrheic runners thus purpose study measure selected physiological metabolic responses maximal submaximal exercise two phases menstrual cycle eumenorrheic runners amenorrheic runners eight eumenorrheic runners yr eight amenorrheic runners yr matched physical gynecological training characteristics studied eumenorrheic runners performed one maximal one submaximal min vo max treadmill run early follicular days midluteal lh surge phases amenorrheic runners performed one maximal one submaximal min vo max treadmill run cycle phases documented urinary luteinizing hormone progesterone assays plasma estradiol progesterone assays differences observed oxygen uptake minute ventilation heart rate respiratory exchange ratio rating perceived exertion time fatigue maximal plasma lactate following maximal submaximal exercise tests follicular luteal phases eumenorrheic runners amenorrheic runners conclude neither menstrual phase follicular vs luteal menstrual status eumenorrheic vs amenorrheic alters limits exercise performance female athletes,C23,0.0021803703,0.06526689,0.025172414,0.0012250611,0.0030360965,0.013357046,0.12134176,0.0020504466,0.064907715,0.01323816,0.024137551,0.00474098,0.11721368,0.026234165,0.014560052,0.11159568,0.06904829,0.00224542,0.0024826722,0.091217324,0.21119516,0.0007741702,0.012778888
patterns dyspepsia patients clinical evidence organic diseases studied dyspeptic patients obvious signs organic disease first examination order verify many diagnoses idiopathic dyspepsia really made exhaustive diagnostic procedures evaluate diagnostic power symptoms distinguishing organic idiopathic dyspepsia latter considered structural abnormalities found cases distinction made related associated organic dyspepsia according whether certain relationship abnormalities dyspeptic symptoms patients referred us follows spontaneously sent physicians collaborating us referred open access endoscopic service results show frequency idiopathic dyspepsia whereas associated structural abnormalities present obvious organic causes dyspepsia seen benign malignant diseases considered separately symptom alone allows correct diagnosis simultaneous evaluation symptoms linear discriminant analysis distinguishes idiopathic organic dyspeptic patients cases higher discrimination percentage cases higher discrimination percentage could probably obtained using wider range clinical parameters complex statistical analysis interrelationships exist clinical symptoms final diagnosis,C23,0.002050511,0.0018189056,0.0039524976,0.0011520985,0.012780484,0.022490377,0.42999285,0.0019283254,0.0014824282,0.013945537,0.16222842,0.004217509,0.06503129,0.004724629,0.02163918,0.013105082,0.10889539,0.0021116864,0.0122508295,0.06350739,0.047853023,0.00072806195,0.002113499
treatment idiopathic retroperitoneal fibrosis immunosuppression idiopathic retroperitoneal fibrosis exceedingly uncommon childhood etiology uncertain support immunological basis disease given report year old girl severe retroperitoneal fibrosis causing progressive azotemia azathioprine prednisolone used successfully case supports efficacy immunotherapy treatment idiopathic retroperitoneal fibrosis,C23,0.0056270743,0.004985897,0.037696943,0.0031580774,0.007826734,0.08887691,0.4438538,0.059692215,0.004063561,0.0055227294,0.056738347,0.011798089,0.035076004,0.012923869,0.004942757,0.008752696,0.04970149,0.005788454,0.0064000655,0.065833345,0.07296281,0.0019957286,0.0057824333
placement esophageal stethoscope acoustic criteria consistently yield optimal location monitoring core temperature esophageal stethoscope evolved device acoustic core temperature monitoring test whether routine placement according acoustic criteria results placement core temperature sensor region contiguity esophagus heart determined depth placement electrocardiographically patients undergoing nonthoracic elective operations requiring general anesthesia tracheal intubation first established different observers selected esophageal depth within cm electrocardiographically using criterion symmetric biphasic p wave maximal amplitude patients patients compared routine acoustic placements depths maximal amplitude biphasic p wave stethoscopes placed according acoustic criteria within cm p wave depths patients remaining patients measured discrepancies ranged cm conclude prevailing stethoscope design thermistor tip acoustic window ensure placement thermistor within optimal region monitoring core temperature modification design would take advantage reliability electrocardiographic positioning suggested,C23,0.06838493,0.0130370855,0.081381805,0.04535607,0.0031701797,0.002943577,0.18620664,0.0021410005,0.023686036,0.002236954,0.123463005,0.0046826582,0.12602544,0.005234749,0.002002039,0.003545236,0.1529212,0.0023445843,0.0025923145,0.028215423,0.117248155,0.00080835994,0.0023725368
alterations brain electrical activity may indicate onset malignant hyperthermia swine time course changes brain electrical activity halothane anesthesia examined malignant hyperthermia susceptible mhs normal nmhs swine power densities selected frequency bands calculated electroen cephalogram eeg eeg systemic variables determined period min starting halothane inspired malignant hyperthermia mh triggered susceptible pigs initial changes eeg development mh consisted decrease total power shift lower frequencies delta theta activity animals eeg alterations noted increase heart rate systemic variables still normal eeg changes mhs animals started arterial oxygen tension pao greater mmhg arterial carbon dioxide tension paco less mmhg mhs animals eeg became isoelectric pao mmhg paco mmhg mean arterial blood pressure time mmhg determine effects hypoxia eeg nmhs animals oxygen decreased period min inspired nmhs animals hypercarbia produced admixture carbon dioxide fresh gas supply achieve incremental increases paco mmhg significant eeg changes hypoxia comparable seen onset mh noted pao mmhg hypercarbia paco greater mmhg,C23,0.06887572,0.001856813,0.023689087,0.0011761092,0.0029147777,0.0030205748,0.16341953,0.0019685132,0.0116274245,0.02304325,0.019708617,0.004361028,0.235525,0.0049686986,0.022067573,0.014029496,0.0632645,0.0021564057,0.0023834677,0.01831963,0.29860517,0.00074323534,0.0122754155
pre discharge immunization among hospitalized filipino children identifying opportunities vaccinate eligible children one way boost rates immunization especially countries low immunization coverage convalescence infectious illness contraindication vaccination determine safety immunogenicity diphtheria tetanus toxoid pertussis oral polio immunization convalescing infants children community controls comparable image nutritional status studied using pertussis agglutination poliovirus neutralization tests quantitative serologic responses compared two study groups significant differences incidence rates febrile reactions controls convalescents local reactions controls convalescents seroconversion p greater noted two groups investigation suggests infants children convalescing infectious illnesses safely effectively vaccinated study suggests hospitalization provides opportunity vaccinate children,C23,0.0031912276,0.018273894,0.0059545,0.0017930206,0.019889226,0.0041184453,0.27798682,0.003001069,0.0023071156,0.08038336,0.055529743,0.058673345,0.108270206,0.0073376177,0.002806285,0.004969405,0.035213303,0.0032864353,0.019061755,0.13567494,0.14786212,0.001133089,0.0032830173
iron chelation deferoxamine inhibits lipid peroxidation cardiopulmonary bypass humans iron catalysis involved oxygen derived free radical generation subsequent lipid peroxidation reported occur cardiopulmonary bypass humans assessed effects iron chelator deferoxamine susceptibility circulating low density lipoproteins ldls induced peroxidation adult patients controls treated undergoing cardiopulmonary bypass coronary valve procedures deferoxamine given intravenously mg kg body wt starting minutes bypass extending next hours additive cardioplegic solution mg l blood samples taken atria immediately end cardiopulmonary bypass plasma lipid peroxidation assessed measuring spectrophotometrically thiobarbituric acid reactive substances tbars content selectively isolated ldls exposure peroxidizing agent cardiopulmonary bypass right left atrial blood values ldl tbars significantly different two groups cardiopulmonary bypass resulted lipid peroxidation significantly greater magnitude control treated patients postbypass right atrial values ldl tbars expressed mumol mmol ldl phospholipids mean sem control patients treated patients p less whereas left atrial blood ldl tbars yielded values respectively p less,C23,0.0021138361,0.0018750781,0.0039441986,0.0011876782,0.0029434497,0.012944736,0.16755788,0.03366611,0.0015282093,0.002076968,0.020235103,0.015579479,0.24254148,0.036513377,0.06323154,0.0032916823,0.1768998,0.002199895,0.0024069133,0.029209722,0.1750919,0.00075054634,0.0022104108
hemifacial spasm rochester olmsted county minnesota incidence hemifacial spasm residents olmsted county minnesota studied reviewing medical records patients residing community average annual incidence rate per men per women age adjusted us white population average prevalence rate per population men per women incidence prevalence rates highest years age,C23,0.004722385,0.004188991,0.00881148,0.0026533157,0.0065757716,0.006094484,0.09768314,0.0044409884,0.02627396,0.004640021,0.06780128,0.009713043,0.030849481,0.010858222,0.0041527464,0.0073537356,0.067214645,0.004863274,0.00537713,0.51090866,0.10828834,0.0016767473,0.004858216
lung sound nomenclature survey report terms used pulmonary physicians physicians specialties describe eight recorded examples lung sounds participants listened lung sounds american college chest physicians annual convention wrote free form answers pulmonary physicians used terms crackles rales equal frequency describe discontinuous adventitious lung sounds als describe continuous als physicians preferred term rales describing discontinuous als terms wheeze stridor used describing continuous als however term rhonchi frequently used describe continuous discontinuous als majority participants recognized normal breath sounds pleural friction rub use qualifying adjective describe als little agreement among lung sound terminology used physicians well standardized recommendations ats accp nomenclature subcommittee widely accepted,C23,0.022643812,0.0028301147,0.04103954,0.0017926004,0.004442642,0.10822465,0.24952364,0.0030003656,0.0023065747,0.0031348336,0.020578405,0.0065641147,0.027433155,0.0077280337,0.0028056272,0.035855833,0.19992594,0.0033112343,0.049959663,0.115141176,0.08733976,0.0011328234,0.0032854297
electroencephalographic activity related palatal myoclonus rem sleep polysomnography including electroencephalography electromyography electro oculography performed three patients palatal myoclonus pm amplitude myoclonus decreased sleep frequency change non rem sleep increased rem sleep two patients ocular myoclonus synchronized pm disappeared deep sleep stages two patients reappeared rem sleep one patient ocular myoclonus noted rem sleep absent even patient awake patients showed episodic eeg activities synchronous myoclonic jerks rem sleep episodes noted times throughout night episode lasting negative positive waves saw tooth appearance distributed predominantly central region episodes frequency myoclonic jerks increased two patients although known rem sleep influences pm ocular myoclonus first report demonstrating electroencephalographic activity associated pm,C23,0.0030778088,0.032370035,0.020598527,0.0017292951,0.0042857514,0.06704362,0.13010883,0.017787369,0.0022251187,0.0030241278,0.06952868,0.0063304645,0.053151965,0.018638521,0.0027065473,0.004856695,0.19695182,0.0031696327,0.003504538,0.15109283,0.20350668,0.0010928181,0.00321833
two discharge patterns carotid body chemoreceptors goat twenty nine single carotid body chemoreceptor units recorded normocapnic normoxia anesthetized goats classified two groups discharge pattern thirteen fibers interspike interval distributions prominent peak sd ms bin termed bursting fibers bf remaining fibers termed nonbursting fibers nbf notable peak interval distributions hypoxia hypercapnia chemoreceptor fibers continued discharge established patterns interval distribution nbf spike trains could described poisson process none bf could however except intervals range ms interval distribution bf could described exponential study suggests two distinct populations goat chemoreceptor fiber inherent discharge pattern chemoreceptor code information arterial po pco different patterns basic chemotransduction mechanism likely bf nbf difference discharge pattern likely reflect processes downstream transducer,C23,0.0027823364,0.002356993,0.030659584,0.0014931309,0.0036999474,0.0034291444,0.17158887,0.0024987825,0.0019209754,0.0026107708,0.11540865,0.018848838,0.05318383,0.09942303,0.027221313,0.0041376795,0.069138676,0.0027609083,0.0030255155,0.07650561,0.30362606,0.0009434447,0.0027359298
estrogen receptor level determines sex specific vitro transcription xenopus vitellogenin promoter female specific expression xenopus laevis vitellogenin gene reconstituted vitro addition recombinant vaccinia virus produced estrogen receptor nuclear extracts male livers gene silent transcription enhancement least times selectively restricted vitellogenin templates containing estrogen responsive unit thus male hepatocytes estrogen receptor limiting regulatory factor female liver controls efficient accurate sex specific expression vitellogenin gene furthermore xenopus liver factor b essential addition estrogen receptor activation gene successfully replaced xenopus extract purified human nuclear factor identifying factor b xenopus functional homolog well characterized human transcription factor,C23,0.0027639964,0.0024518026,0.01853263,0.0015529768,0.017180616,0.030311316,0.17000054,0.015967863,0.0019982464,0.0027157888,0.030741464,0.005757398,0.023037631,0.09152021,0.0024305887,0.04365643,0.025589855,0.056356646,0.0031472165,0.14644851,0.13133729,0.0009813947,0.17551963
endothelialization vascular prostheses transplantation venous tissue fragments method accelerate endothelialization vascular prostheses seeding venous tissue fragments developed piece peripheral vein obtained chopped small fragments stirred ml saline making tissue suspension suspension sieved wall highly porous vascular prosthesis water porosity prostheses mm id cm length seeded tissue fragments implanted thoracic descending aortae dogs removed days implantation ten prostheses preclotted fresh blood used controls seeded grafts infinite number endothelial cells migrated proliferated fragments produced numerous capillaries days implantation reached opened onto luminal surface prosthesis openings numerous endothelial cells spread formed colonies increase size colonies inner surface completely endothelialized within weeks quick neointimal formation seeding venous tissue fragments might applicable several artificial organs,C23,0.0023544957,0.0020885551,0.017221536,0.001322895,0.028559972,0.0030385994,0.1198197,0.1401467,0.013091906,0.0023134304,0.02747889,0.07243437,0.04665555,0.10889732,0.022058746,0.0036664396,0.037482727,0.0165958,0.0026809396,0.028396199,0.2890515,0.012219592,0.002424124
continuous epidural hydromorphone postthoracotomy pain relief forty four patients treated continuous infusion lumbar epidural hydromorphone thoracic operations postoperatively visual analog pain scores obtained postoperative day patients experienced either pain visual analog pain scale mild pain visual analog pain score rest incidence side effects hypoventilation pruritis nausea less reported epidurally administered opioids continuous infusion lumbar epidural hydromorphone produced safe predictable analgesia thoracotomy,C23,0.0043265563,0.024726616,0.07458969,0.0024309156,0.02694191,0.0055836462,0.1472197,0.0040687458,0.024064979,0.004251096,0.02868206,0.124856435,0.087454244,0.00994809,0.0038046646,0.006737348,0.18165894,0.004455636,0.06774476,0.05224627,0.10822052,0.001536203,0.0044510015
aggressive granulomatous lesions cementless total hip arthroplasty describe six patients aggressive granulomatous lesions around cementless total hip prostheses two patients previously cemented prosthesis hip lord prosthesis used five patients pca one prostheses made chrome cobalt alloy pain weight bearing occurred average years cementless arthroplasty time radiography revealed aggressive granulomatosis around proximal femoral stem acetabular component five patients one large solitary granuloma proximal femur revision performed average years cementless arthroplasty time granulomas grown large size waiting revision operation two femoral stem components fractured granulomas showed uniform histopathology included histiocytosis cause lesions thought plastic debris acetabular socket,C23,0.003843337,0.0034092318,0.044381097,0.020741312,0.07044452,0.0049600266,0.2036807,0.003614321,0.039988823,0.0037763044,0.02002568,0.00790501,0.024586977,0.027416922,0.0033797338,0.0059848754,0.2589474,0.0039650765,0.0043762047,0.041403584,0.19782358,0.0013646294,0.0039806385
nontraumatic coma glasgow coma score coma etiology predictors week outcome carried prospective study patients older years nontraumatic coma intensive care units columbia presbyterian medical center new york ny patients glasgow coma scale gcs determinations within hours dead persistent coma weeks onset age sex ethnicity influence outcome week outcome patients initial gcs awake dead persistent coma gcs group awake dead persistent coma hypoxic ischemic coma worst week outcome dead comatose coma caused metabolic disease sepsis focal cerebral lesions general cerebral diseases intermediate drug induced coma favorable outcome dead comatose independent predictors week outcome first gcs drug induced coma predicted probability waking weeks eight times better drug induced coma causes gcs held constant patients initial gcs score seven times likely waken score motor subscore alone significant independent predictor week outcome modification coma score include etiology may give accurate predictions week outcome nontraumatic coma,C23,0.02257336,0.0018746905,0.021025188,0.0011874328,0.013172968,0.0027274517,0.15697765,0.0019900708,0.0015278936,0.012305133,0.048306182,0.0677849,0.02812395,0.004936201,0.015450693,0.0032927433,0.15812863,0.0021764508,0.002406416,0.25076208,0.18034536,0.0007503913,0.0021741872
percutaneous puncture nondeflatable coronary artery angioplasty balloon report case balloon catheter became permanently inflated coronary artery saphenous vein bypass graft still inflated balloon forcibly withdrawn graft external iliac artery successfully deflated via percutaneous puncture using chiba needle,C23,0.041978005,0.006375114,0.013409957,0.0040380103,0.010007491,0.044057813,0.2178239,0.006758621,0.005195788,0.007180039,0.1163347,0.014782022,0.08017655,0.016524838,0.0063199536,0.011191454,0.20322116,0.007401286,0.008183311,0.047851294,0.121243335,0.002551797,0.007393589
usefulness combined propranolol verapamil evaluation surgical ablation accessory atrioventricular connections patients without structural heart disease successful surgical ablation atrioventricular av accessory connections may confirmed postoperative electrophysiologic testing absence accessory connection conduction anterograde retrograde directions whereas former may readily apparent examination surface electrocardiogram sinus rhythm atrial pacing assessment latter may complicated frequent presence enhanced retrograde av nodal conduction postoperative period consequently availability interventions selectively affect av nodal conduction refractoriness without concomitant effects accessory connections may helpful assessing success surgical procedure study effects combined propranolol verapamil administration electrophysiologic properties av node accessory av connection assessed pre postoperatively patients men women mean age years undergoing surgical ablation accessory connections preoperatively electrophysiologic characteristics accessory av connections unaffected propranolol verapamil administration postoperatively hand propranolol verapamil significantly prolonged retrograde av node effective refractory period baseline ms vs drugs ms p less shortest cycle length maintaining ventriculoatrial conduction baseline ms vs drugs ms p less late postoperative electrophysiologic evaluation weeks revealed evidence residual accessory av connection conduction patients remain asymptomatic months follow,C23,0.0018851497,0.0016722218,0.03963785,0.07395239,0.049556136,0.0024853414,0.21976672,0.0017728176,0.0013628793,0.0018522703,0.045261636,0.0038774486,0.08084637,0.0048844684,0.010763049,0.0029355702,0.2749027,0.0019451759,0.0021465202,0.057272285,0.09256141,0.00066934817,0.027990244
hypothalamic pituitary adrenal function patients premenstrual syndrome patients primary affective disorders melancholic depression anorexia nervosa frequently hyperactive hypothalamic pituitary adrenal hpa axis characterized hypersecretion crh blunted acth response exogenous crh premenstrual syndrome pms luteal phase dysphoric disorder characterized primarily affective behavioral disturbances hpa axis function compared pms patients control women respectively diagnosed dsm r criteria found current psychiatric disorders determined schedule affective disorders schizophrenia lifetime interview urinary free cortisol excretion pms normal women differences urinary free cortisol excretion follicular luteal phases occurred either group two hpa axis abnormalities however noted pms patients compared normal women first basal evening cortisol concentrations plasma significantly decreased time integrated response plasma cortisol ovine crh significantly increased second negative correlation time integrated plasma acth cortisol responses ocrh basal luteal progesterone concentrations present normal control women seen pms patients changes basal ocrh stimulated plasma cortisol levels association normal urinary free cortisol excretion suggest women pms might transient episodic disturbances hpa axis appear adequately corrected system servomechanisms probably explains maintenance regular menstrual cycles pms patients contrasts irregular menses observed patients depression anorexia nervosa women participate chronic strenuous exercise,C23,0.0015466113,0.008856893,0.04031696,0.008352479,0.0021536073,0.03193799,0.17961745,0.001454452,0.0011181312,0.0015196365,0.03615509,0.0111421775,0.042530607,0.00368072,0.001360051,0.024867732,0.10005352,0.0015938281,0.0017610445,0.07072854,0.4271022,0.0005491455,0.001601131
simplified technique isolating vascularized rib periosteal grafts modified technique obtaining vascularized rib periosteal segment utilizing posterolateral approach presented technique avoids inclusion large muscle cuff pleura around isolated rib segment therefore minimizes donor site morbidity chest complications previously associated approach,C23,0.005330999,0.004728862,0.00994709,0.0029952708,0.0074260174,0.006879932,0.28465167,0.005013336,0.029661935,0.0052380194,0.13928205,0.011849641,0.036562238,0.012272506,0.004687946,0.008301474,0.082018755,0.062092654,0.0060701263,0.10014984,0.1674588,0.001892844,0.005488028
mitral valve replacement first year life patients underwent mitral valve replacement first year life mitral stenosis mitral regurgitation patients mitral stenosis included two mitral arcade two supravalvular mitral stenosis hypoplastic mitral valve one parachute mitral valve included group patients mitral regurgitation atrioventricular canal defect six chordal leaflet defects one marfan syndrome one bacterial endocarditis prostheses included bjork shiley mm seven st jude medical mm four mm three five stent mounted dura mater valves mm mm one porcine xenograft mm four patients valves placed left atrium supraannular location nine operative atrioventricular canal defect seven mitral regurgitation two five late atrioventricular canal defect four mitral stenosis one deaths giving actuarial year survival rates respectively patients tissue valves died four supraannular mitral valve replacement survived since operative mortality reduced confidence limits nine patients required second mitral valve replacement prosthetic stenosis mean months original mitral valve replacement one operative death improvements repair atrioventricular canal defect infancy need mitral valve replacement atrioventricular canal defect repair decreased although valvuloplasty advocated repair congenital mitral valve disease applicable infants mitral regurgitation mitral valve replacement frequently unavoidable congenital mitral disease accomplished low operative risk even prosthesis positioned supraannularly,C23,0.0020954695,0.0018579598,0.013440411,0.0011768355,0.09413587,0.0027031105,0.11618604,0.0019697289,0.0015142577,0.0020580066,0.01917099,0.016045775,0.027610036,0.004989336,0.0018418839,0.013397731,0.4682749,0.002157027,0.0023849397,0.13306387,0.071027346,0.00074369437,0.0021547836
effect antiplatelet anticoagulant therapy patency femorotibial bypass grafts retrospective study autogenous femorotibial saphenous vein grafts inserted years followed mean period months seven patients eight grafts died hospital remaining grafts fell three groups sixty grafts patients received mg dipyridamole g acetylsalicylic acid daily starting second postoperative day continuing six months one hundred two grafts patients antithrombotic therapy forty grafts patients warfarin therapy maintain prothrombin time prothrombin proconvertin method within therapeutic range medication continued six months group included high risk patients two groups mean ages incidence risk factors vary significantly groups patency rates three groups five years ten years dipyridamole acetylsalicylic acid therapy warfarin groups respectively limb salvage rates dipyridamole acetylsalicylic acid therapy warfarin groups respectively thus best results seen aspirin dipyridamole group,C23,0.0024373727,0.0021620712,0.0045478847,0.0013694604,0.0033939644,0.0031455567,0.23065935,0.0022921348,0.001762112,0.002394862,0.023622312,0.112289675,0.07059641,0.0056132493,0.0021433642,0.0037954964,0.279058,0.00251009,0.0027753075,0.12627217,0.1137862,0.00086542254,0.0025074792
gastrointestinal bleeding month old male presentation munchausen syndrome proxy munchausen syndrome proxy well described entity may always immediately considered complicated case describe syndrome portrayed guise gastrointestinal bleeding month old male discuss difficulty involved solidifying diagnosis also consequences may occur diagnosis entertained failure diagnose munchausen syndrome proxy often results failure consider diagnosis cases frequently specific characteristics allow seasoned clinicians suspect diagnosis diagnosis considered crucial take steps protect index patient also siblings infrequently also recipients life threatening form child abuse,C23,0.0031904834,0.033721007,0.0059531108,0.0017926025,0.004442647,0.004117485,0.33559304,0.003000369,0.0023065775,0.018580297,0.13980395,0.0065622143,0.05071221,0.026132194,0.0028056304,0.035853453,0.094677866,0.0032856688,0.0036328346,0.14924002,0.07017703,0.0011328247,0.0032864956
l tyrosine potentiates anorexia induced mixed acting sympathomimetic drugs hyperphagic rats effects l tyrosine l tyr anorectic activity several mixed acting sympathomimetics determined dark cycle rats made hyperphagic food deprivation l tyr mg kg significantly potentiated anorectic activity phenylpropanolamine ephedrine amphetamine respectively dose l tyr varied mg kg significant dose dependent relationship noted observed potentiation positively correlated increases brain tyr concentrations blockade l tyr uptake brain coadministration l valine prevented potentiation various l amino acids well tyr failed mimic potentiating action l tyr determined alpha methyl p tyr pretreatment l tyr induced potentiation dependent upon increased catecholamine synthesis although various mixed acting sympathomimetic anorexiants similarly potentiated l tyr direct acting beta adrenoceptor anorexiants salbutamol methoxyphenamine results indicate l tyr specifically potentiates anorectic activity studied mixed acting sympathomimetics consistent requirement central conversion l tyr catecholamines via tyr hydroxylase response possibility effect mixed acting sympathomimetics normally limited availability l tyr suggested,C23,0.027329948,0.0146536855,0.05330852,0.0014375346,0.0035626744,0.01567784,0.30202305,0.0024060742,0.0018497045,0.0025139076,0.011785245,0.0052917325,0.06738905,0.0062509677,0.0022499082,0.016363995,0.025052974,0.02837467,0.0029132648,0.032093856,0.34889048,0.00090844167,0.027672492
preoperative piroxicam postoperative analgesia dental surgery fifty patients allocated randomly receive placebo piroxicam mg h surgical removal lower third molars general anaesthesia significantly greater number patients piroxicam group require opioid analgesia operation p less piroxicam group also required fewer doses paracetamol first h recovery anaesthesia p less time recovery first postoperative analgesia longer patients received piroxicam p less piroxicam significantly prolong duration recovery anaesthesia,C23,0.0037728504,0.0033467065,0.007039747,0.0021198108,0.0052535743,0.0048690597,0.08854994,0.003548034,0.0027276028,0.003707047,0.027290689,0.10150337,0.15443969,0.008959258,0.0033177494,0.0058751125,0.37334555,0.0038854103,0.022559421,0.040674854,0.12799355,0.001339602,0.0038813693
massive splenomegaly superior results combined endovascular operative approach splenectomy massive splenomegaly drained splenic weight greater g uncommonly high morbidity mortality technical challenges problems hemostasis group patients massive splenomegaly due myeloproliferative disorders average splenic weight g developed management algorithm based preoperative angiographic embolization splenic artery average operating time hours range hours average blood loss ml six patients blood loss less ml four minor complications one major complication gastric ulcer requiring reoperation deaths perioperative period patients required reoperation hemorrhage,C23,0.019925592,0.0029679388,0.006243015,0.0018798985,0.0046589947,0.004317998,0.24207285,0.003146481,0.002418903,0.0032874972,0.05060397,0.023079634,0.1463352,0.00769315,0.002942259,0.005210189,0.26923466,0.0034456742,0.0038097461,0.13968226,0.052413974,0.0011879909,0.0034420905
delta sleep ratio biological correlate early recurrence unipolar affective disorder slow wave sleep abnormalities long described depression considered nonspecific indicators psychopathology computerized techniques including amplitude frequency measures spectral analyses permitting new approaches examination delta sleep early studies suggested many depressed patients demonstrate lower delta wave intensity first non rapid eye movement period second one finding prominent middle aged depressed patients led examination ratio first second non rapid eye movement periods delta sleep measure seems robust predictor recurrence rapid eye movement latency analysis data patients long term maintenance treatment study minimum months demonstrates delta sleep ratio predict survival time following discontinuation drug treatment individuals high delta sleep ratio remain clinically remitted five times longer low delta sleep ratio,C23,0.0022275664,0.0019759627,0.004160635,0.011995862,0.0031024136,0.013654197,0.34257343,0.0020948306,0.0016104315,0.002188715,0.052404035,0.0045816787,0.17296816,0.0054174587,0.012737204,0.0035544797,0.16495743,0.0022940242,0.002536412,0.122035414,0.05627797,0.00079092797,0.013860767
primary abscess omentum yr old man presented upper abdominal pain fever due primary abscess omentum finding microscopic size foreign particles within abscess raised possibility antecedent clinically silent perforation bowel appendix surgical resection antibiotic therapy curative,C23,0.006521345,0.0057714507,0.01214016,0.03511295,0.009415637,0.008396774,0.33251682,0.038061876,0.004703796,0.0063928636,0.066049166,0.0133823035,0.041152734,0.01509862,0.0057215136,0.010131729,0.1340253,0.0067004543,0.03887635,0.077134915,0.09220399,0.002310166,0.038179066
distribution pulmonary capillary transit times recruited networks pulmonary blood flow elevated hypoxemia occur fastest moving erythrocytes transit times capillaries fall minimum time complete oxygenation desaturation likely occur distribution capillary transit times mean large increasing cardiac output known decrease mean pulmonary capillary transit time effect distribution transit times reported measured mean variance transit times single pulmonary capillary networks dependent lung anesthetized dogs vivo videofluorescence microscopy fluorescein dye bolus passing arteriole venule cardiac output increased l min mean capillary transit time decreased transit time variance decreased proportionately relative dispersion remained constant increasing cardiac output alter heterogeneity local capillary transit times lower lung capillary bed nearly fully recruited,C23,0.054243013,0.0023877458,0.01809646,0.001512403,0.0037496756,0.030101348,0.13626724,0.0025313853,0.054025616,0.0026448348,0.014789489,0.018563174,0.22766699,0.0061892406,0.002367086,0.017338289,0.09794755,0.002782935,0.003064991,0.023604253,0.19820704,0.079136126,0.00278307
blood conservation cardiac surgery reviewed current blood conservation techniques use cardiac surgery avoidance aspirin preoperatively important blood conservation measure patients scheduled elective operation participate autologous predonation programs careful monitoring patients major coronary artery disease safely donate blood preoperatively intraoperative processing blood withdrawn cardiopulmonary bypass provides autologous platelet rich plasma infusion reversal heparin sodium blood collected field operation blood remaining oxygenator bypass also processed yield washed concentrated red blood cells reinfusion randomized prospective studies document postoperative autotransfusion safe effective reducing homologous blood use aprotinin reduces plasma protein activation platelet damage bypass integration available blood conservation techniques comprehensive program combined careful consideration indications transfusion may allow patients avoid transfusion entirely,C23,0.0022540444,0.012903855,0.004204205,0.012170195,0.024881313,0.0029078494,0.16465853,0.0021189202,0.0016289507,0.0022138841,0.07189765,0.0048862034,0.16243514,0.01732912,0.0019813918,0.014460842,0.2148186,0.0241343,0.040441718,0.05127944,0.15239578,0.00080002326,0.013198023
interventional radiology biliary tract metallic stents biliary metallic stents placed patients bile duct obstruction six patients received gianturco stents wall stents results tests discussed,C23,0.008345585,0.0074029504,0.015571996,0.004689044,0.011620963,0.010770412,0.22031865,0.008155987,0.0060334867,0.008200027,0.07862557,0.022154398,0.0518216,0.019189078,0.007338897,0.012995811,0.27990356,0.008594569,0.009502676,0.05332728,0.14388861,0.002963214,0.00858563
neuroendocrine features reactive bile ductules cholestatic liver disease various cholestatic liver diseases accompanied striking increase number bile ductules called ductular reaction thought arise ductular metaplasia hepatocytes proliferation pre existing bile ductules previous studies shown reactive bile ductules differ normal counterpart enzyme immunohistochemical make using monoclonal antibodies directed neuroendocrine markers immunohistochemistry found reactive bile ductules cholestatic liver disease display neuroendocrine features cases primary biliary cirrhosis pbc primary sclerosing cholangitis psc extrahepatic obstruction acute hepatitis reactive bile ductules expressed neural cell adhesion molecule n cam reacted monoclonal antibody b n cam ganglioside recognized b restricted neuroendocrine cells tissues four cases bile ductules expressed chromogranin present matrix neuroendocrine granules furthermore three cases longstanding cholestasis scattered periportal hepatocytes expressed chromogranin n cam neuroendocrine markers neuron specific enolase synaptophysin myelin associated glycoprotein lacking bile ductules hepatocytes neuroendocrine phenotype bile ductules hepatocytes confirmed electronmicroscopy demonstrating various numbers dense cored neuroendocrine granules near peripheral cell membrane bile ductules well cells intermediate hepatocytes bile ductular cells cases normal liver tissue without ductular reaction bile ductules lacked neuroendocrine markers except two cases weak reactivity chromogranin observed findings illustrate presence new neuroendocrine cell type emerges liver cholestasis elucidation significance neuroendocrine substance produced dense cored granules reactive bile ductules awaits isolation characterization speculate molecule plays autocrine paracrine regulatory role process ductular metaplasia hepatocytes growth bile ductules,C23,0.010994921,0.0017012898,0.012861319,0.0010776218,0.0027414723,0.0024751744,0.3560599,0.011039824,0.00138657,0.001884468,0.07101492,0.0041307267,0.03516505,0.23478964,0.010949459,0.047749966,0.03249169,0.0020534194,0.011448886,0.041934803,0.103391536,0.00068098336,0.0019763373
low dose almitrine bismesylate enhances hypoxic pulmonary vasoconstriction closed chest dogs effect almitrine bismesylate hypoxic pulmonary vasoconstrictor response studied six closed chest dogs anesthetized pentobarbital paralyzed pancuronium right lung ventilated continuously left lung ventilated either hyperoxia hypoxic gas mixture hypoxia end tidal oxygen tension mm hg two consecutive days dog received either almitrine vectarion servier lab malic acid consecutive almitrine doses micrograms kg min equivalent volumes malic acid without almitrine administered intravenously constant peripheral infusion min percent blood flow lung calculated based variation traditional shunt equation change percent left lung blood flow delta ql va increased significantly hypoxia drug hypoxia almitrine micrograms kg min phase significant changes occurred almitrine doses respective malic acid control phases change arterial oxygen tension delta pao also increased significantly hypoxia drug hypoxia almitrine micrograms kg min phase significant changes occurred almitrine doses respective malic acid control phases concluded dogs low dose almitrine enhances hypoxic pulmonary vasoconstriction enhancement dose related,C23,0.046723988,0.001856238,0.003904569,0.0011757449,0.012853855,0.08793634,0.14386442,0.032358076,0.0116238175,0.0020560995,0.010603519,0.020218685,0.23402597,0.004864559,0.001840177,0.055678558,0.07722435,0.002155028,0.0023827294,0.027315587,0.19619069,0.00074300513,0.022403965
home treatment acute psychiatric illness objective determine factors influencing successful outcome community treatment severe acute psychiatric illnesses traditionally treated hospital design patients single electoral ward either admitted hospital treated home two year period october september included study case notes audited second year study reported setting electoral ward sparkbrook birmingham subjects patients aged severe acute psychiatric illness results patients managed home treatment alone required admission hospital location treatment significantly p less influenced social characteristics patients marital state age men ethnicity living alone characteristics referral occurring hours assessment taking place hospital police station dsm iii r diagnosis weakly associated outcome violence episode significantly related admission although deliberate self harm conclusions home treatment feasible patients acute psychiatric illness hour call assessment service increases likelihood success admission determined strongly social characteristics patient referral illness factors admission still required patients locally based mental health resource centre hour call service open referral system active follow policy increase effectiveness home treatment service,C23,0.0017424789,0.009960562,0.00856135,0.0009774246,0.0024223733,0.036275074,0.3036211,0.0016359647,0.0012576717,0.010760645,0.04138156,0.02041029,0.08659684,0.0042249067,0.0015297827,0.0027089585,0.19614185,0.0017915257,0.03840879,0.19071546,0.036464,0.00061767775,0.0017936822
tissue expansion head neck indications technique complications tissue expansion indicated reconstruction various defects head neck instances inadequate adjacent tissue allow either primary closure defect repair local flap may also indicated instances repair defect alternative method local regional distant flap result unacceptable donor recipient site deformity although tissue expansion simplistic concept require judgment indepth preoperative planning ensure optimal results complication rate high tissue expansion head neck particularly cheek neck area despite frequency complications vast majority cases intended reconstruction successful,C23,0.0030049873,0.0026655737,0.0056069945,0.05984659,0.04771843,0.018411055,0.18228419,0.017366726,0.002172472,0.0029525764,0.051679146,0.035271745,0.05721081,0.007839183,0.00264251,0.03376055,0.23110189,0.018828135,0.00342162,0.05864548,0.15341096,0.0010669618,0.00309142
comparison structure mechanical properties functions lumbar spinal ligaments organization collagen supraspinous interspinous longitudinal ligaments well ligamenta flava lumbar spines human cadavers investigated polarized light microscopy scanning electron microscopy x ray diffraction experiments performed ligaments situ bony attachments undisturbed excised ligaments range applied strains results related composition investigated standard histologic techniques gross structures investigated light microscopy ligaments importantly results related mechanical properties ligaments include stiffness failure conditions stress relaxation hysteresis necessary results supplemented compared obtained pig ligaments mechanical properties related postural changes ligament strains induced cadaveric specimens using results literature thus ligament structures could related physiologic functions,C23,0.002962143,0.016966747,0.049044,0.030323956,0.0041246903,0.0038227995,0.2132551,0.002785635,0.016471919,0.0029104792,0.055305317,0.007889455,0.06390351,0.028742315,0.016942468,0.0046440233,0.07396621,0.01737619,0.0033728355,0.15943462,0.17325146,0.0010517493,0.051452335
loss photosynthetic chlororespiratory genes plastid genome parasitic flowering plant photosynthesis hallmark plant life plastid metabolic process known controlled plastid genes complete loss photosynthetic ability however occurred several independent occasions parasitic flowering plants plants known lack chlorophyll certain photosynthetic enzymes known extent changes occurred genes encoding photosynthetic apparatus whether plants even maintain plastid genome report nonphotosynthetic root parasite epifagus virginiana plastid chromosome kilobases size far smaller previously characterized land plant plastid genome epifagus plastid genome lost chloroplast genes photosynthesis large family plastid genes ndh genes whose products may involved plastid respiratory chain extensive changes epifagus plastid gene content must occurred relatively short time x yr striga asiatica related photosynthetic parasite typical complement chloroplast genes photosynthesis chlororespiration plastid genome epifagus retained transcribed ribosomal rna ribosomal protein genes suggesting expresses one gene products plastid functions related photosynthesis,C23,0.0024964404,0.0022144672,0.004658099,0.001402648,0.0035587242,0.0032217863,0.25454062,0.014423795,0.0018048153,0.043775022,0.012854197,0.017751755,0.030406754,0.02403893,0.0021953066,0.023204064,0.04505082,0.0146555845,0.0028425646,0.09485494,0.13834874,0.0008863953,0.26081353
development small caliber biologic vascular graft evaluation antithrombogenicity early healing process authors previously showed small caliber xenograft using crosslinking technique applicable aortocoronary bypass grafting study graft antithrombogenicity healing process evaluated early stage implantation fresh sheep carotid artery mm id obtained cross linked polyepoxy compounds used small caliber vascular graft graft white soft six cm segments graft implanted carotid arteries bilaterally nine dogs sodium heparin given surgery anticoagulant used postoperatively fifteen grafts eight dogs removed hr days implantation grafts found patent two grafts one days days occluded anastomotic area occluded grafts felt hard touched outside one dog grafts shown angiographically patent days implantation dog kept long term observation macroscopically thrombus observed patent grafts microscopically inner surface near anastomotic lines covered endothelial cells infiltration fibroblasts observed outside days implantation foreign body reactions seen around graft days implantation thin layer plasma protein middle graft observed scanning electron microscopy sem observations concluded grafts exhibited satisfactory early antithrombogenicity healing implantation,C23,0.012097827,0.0018375566,0.027513986,0.01345176,0.023190426,0.0026734262,0.17827374,0.029995063,0.031574417,0.0020354067,0.055819992,0.07688981,0.02319672,0.034404803,0.0018216573,0.0032258136,0.19837177,0.024080517,0.0023587495,0.025063708,0.22924642,0.0007355275,0.0021409262
short term long term changes renal function donor nephrectomy retrospectively examined effect nephrectomy renal function living related donors renal function measured iodine orthoiodohippurate scans patients studied preoperatively week year postoperatively patients year followup available compensatory hypertrophy complete week postoperatively effective renal plasma flow remaining kidney higher preoperatively increase remained stable least year degree compensatory hypertrophy significantly greater male patients week female patients compensatory hypertrophy occurred age groups studied pronounced patients less years old patients followed years effective renal plasma flow decreased ml per minute week nephrectomy ml per minute years result similar decrease seen normal population according results renal donation living related persons lead long term decrease renal function,C23,0.0019721317,0.011293898,0.0036814588,0.0011080602,0.044664904,0.0025451386,0.12555315,0.0018546165,0.0014257634,0.021027336,0.0150901675,0.013643367,0.17335074,0.004552801,0.0017342428,0.003071019,0.16267234,0.02121676,0.002245562,0.11882344,0.26574403,0.0007002323,0.0020288562
management postoperative inflammation dexamethasone versus flurbiprofen quantitative study using new flare cell meter consecutive random prospective study conducted compare effect topical dexamethasone flurbiprofen drops postoperative inflammation patients undergoing extracapsular cataract extraction lens implantation objective quantitative measurements made postoperatively using kowa fc flare cell meter two treatments equally effective,C23,0.0046163592,0.004094941,0.008613647,0.024929691,0.028748494,0.005957652,0.31870386,0.00434128,0.0033374222,0.004535844,0.024908433,0.031848732,0.09679801,0.055312052,0.00405951,0.007188631,0.18275724,0.0047540846,0.005256404,0.055652358,0.1171971,0.0016391014,0.0047491402
pharmacokinetics paracetamol cardiac surgery plasma concentration measured rectal nasogastric administration paracetamol mg kg febrile children aged days years undergone cardiac surgery equivalent doses rectal administration neonates children first postoperative day found produce plasma concentrations therapeutic range higher concentrations nasogastric paracetamol second postoperative day less variance plasma paracetamol concentrations neonates plasma elimination half life area plasma concentration time curve significantly increased neonates suppository dosing compared older children difference antipyretic effect two routes administration much lower previously reported febrile children,C23,0.016124245,0.0024515393,0.005156776,0.0015528098,0.0038483636,0.003566698,0.07065797,0.0025990163,0.0019980315,0.05623448,0.012907738,0.019387612,0.11182047,0.006499317,0.0024303275,0.017659485,0.16494158,0.002846152,0.0031468782,0.10985486,0.3804912,0.0009812892,0.0028431918
development soft pliable slow heparin release venous graft prevent collapse certain amount stiffness generally required prosthetic venous grafts eptfe grafts used however native vein pliable without stiffness developed soft pliable graft maintain patency lumen compliance fresh porcine ureter incubated ficin solution remove cell components noncollagenous proteins one percent protamine sulfate solution injected ureter lumen impregnate inner surface ureter crosslinked glutaraldehyde solution dipped heparin solution hours rinsed distilled water procedure made ureter soft pliable also conferred antithrombogenicity graft heparinization grafts implanted posterior vena cavae dogs removed days implantation eighteen grafts patent two grafts occluded anastomotic site days respectively control experiment nonheparinized grafts implanted dogs occluded fresh thrombi patent grafts kept original elasticity allowed heave unison heartbeat similar appearance native vena cava heparinization effective preventing thrombus formation results indicate type graft ideal prosthesis venous graft physiologic properties compliance antithrombogenicity,C23,0.028004978,0.0531489,0.04711774,0.0014746508,0.0036545077,0.0033870304,0.26649493,0.06599115,0.0018973835,0.0025787074,0.012800386,0.11366117,0.03404039,0.057168044,0.002307903,0.0040868637,0.11859926,0.04282125,0.015581007,0.017150827,0.10440104,0.00093185814,0.00269997
differentiation delayed serologic delayed hemolytic transfusion reactions incidence long term serologic findings clinical significance delayed serologic transfusion reactions dstrs delayed hemolytic transfusion reactions dhtrs studied large tertiary care hospital dstr defined posttransfusion finding positive direct antiglobulin test dat newly developed alloantibody specificity dhtr defined dstr case showed clinical laboratory evidence hemolysis thirty four cases dstr percent due anti e jka documented prospectively month period retrospective review medical records found clinical evidence hemolysis thus incidence dstr recipients posttransfusion samples available testing whereas incidence dhtr patients tested fifteen patients followed days reaction twelve still demonstrated positive dat anti igg eluate studies indicated persistence positive dat dstr dhtr may involve several immunologic mechanisms including development posttransfusion autoantibodies study indicates dstrs frequent finding multiply transfused patients although cases benign fail meet rigid criteria dhtr persistence positive dat dstr dhtr common,C23,0.0021589801,0.022792242,0.0040256153,0.0012121944,0.0030047498,0.036143385,0.37606066,0.002028911,0.0015597548,0.049603187,0.16412678,0.0044375034,0.040905025,0.005033941,0.0018972247,0.0033596295,0.12591143,0.0022849673,0.002456597,0.05005876,0.08751702,0.00076603924,0.012655434
graft stenosis justification year surveillance femorodistal grafts femoropopliteal femorocrural performed prospectively studied weeks months operation intervals months thereafter duplex scanning intravenous digital subtraction angiography overall incidence stenoses per cent femorocrural per cent femoropopliteal per cent stenoses detected first year operation none occurred twenty four non haemodynamically significant stenoses treated followed intervals months forty two haemodynamically significant stenoses detected secondary procedures performed grafts mean months surgery thirteen percutaneous balloon dilatation six per cent remain patent mean follow months two grafts occluded within days three restenosed mean months tertiary procedures seventeen grafts surgically revised nine patch grafts eight bypass grafts eleven remain patent mean follow months one occluded immediately three occluded late two grafts restenosed mean months successful tertiary procedures total seven grafts tertiary procedures two balloon dilatation five surgery six remain patent mean follow months conclusion procedures performed grafts per cent remain patent mean follow months approximately one quarter femorodistal grafts develop graft related stenoses graft surveillance worthwhile first year operation,C23,0.001953813,0.0017331297,0.0036456126,0.0010977678,0.0121475,0.0025214977,0.07092941,0.0018373895,0.029731385,0.0019197362,0.05805851,0.0134694595,0.019347265,0.004529107,0.0017181925,0.0031530932,0.6484648,0.0020121036,0.0022247036,0.040465333,0.07632997,0.00069372804,0.0020164864
myocardial revascularization third time clinical characteristics follow twenty five patients presenting third revascularization procedure retrospectively reviewed loyola university medical center maywood il represents percent total revascularization cases five year period extending perioperative mortality none seven complications occurred six patients internal mammary arteries used revascularization percent group follow reveals one patient died secondary arrhythmia patients except one symptomatically improved patients remain angina free mean follow months therefore concluded patients clinically improved third revascularization procedure offered effective means treatment,C23,0.018349642,0.0027869472,0.0058623017,0.0017652579,0.0043993527,0.0040546767,0.20798048,0.0029546013,0.0022713928,0.0030870182,0.0825845,0.02167216,0.03888629,0.0072240043,0.0027629843,0.00489246,0.42894512,0.0032412892,0.003577419,0.06741752,0.0809368,0.0011155446,0.0032321839
aortic occlusion vascular isolation allowing avascular hepatic resection occlusion supraceliac abdominal aorta hepatic vascular isolation employed series patients definitive method allow avascular hepatic resection series compared earlier group patients treated conventionally avascular hepatic resection group mortality hypotension occur time hepatic vascular isolation rapid accurate excision hepatic lesions could achieved bloodless field resection midline lesions involving great veins possible segmentectomies resections crossing segmental boundaries could performed previously formal hepatic lobectomies required concomitantly greatest amount uninvolved hepatic parenchyma remained situ increased ease operative management reduced blood loss reduced operating time mean hours,C23,0.027797265,0.0022699318,0.0047782725,0.0014383302,0.053103153,0.0033024808,0.20017473,0.05222279,0.0018500196,0.0025143358,0.047577493,0.030040322,0.063658156,0.0058839857,0.0022502914,0.103082426,0.1357432,0.0026353123,0.04858801,0.09162763,0.115903124,0.0009085964,0.0026501792
radionuclide imaging asymptomatic versus symptomatic total knee arthroplasties ninety eight total knee prostheses evaluated roentgenograms bone scans fifty three asymptomatic symptomatic thirteen prostheses required revision surgery mean months asymptomatic knee replacements generally showed mild uptake one zones one knee uptake equal surrounding bone however symptomatic knee replacements showed significantly greater uptake patella femur medial lateral tibial plateau regions mann whitney two sample rank test bone scans symptomatic group obtained mean months excluding patients revision surgery differences remained significant furthermore symptomatic knee replacements normal roentgenograms also significantly greater uptake radiolucent lines noted asymptomatic patients whereas symptomatic knees radiolucencies radiolucencies generally associated significantly greater uptake lateral release effect patellar score,C23,0.002381311,0.0021123418,0.015957132,0.0013379616,0.018372323,0.0030732062,0.12135305,0.025293475,0.0017215819,0.002339778,0.17568724,0.031509347,0.13011873,0.0055392194,0.002094196,0.07287009,0.2641732,0.0024533842,0.002711473,0.027469216,0.08812416,0.0008455171,0.0024620185
muscle blood flow muscle metabolism exercise heat stress effect heat stress blood flow metabolism exercising leg studied seven subjects walking uphill km h treadmill min exhaustion first min exercise performed cool environment degrees c subjects moved adjacent room degrees c continued exercise speed inclination min exhaustion whichever occurred first rate consumption l min average cool hot conditions corresponded individual maximums cool environment steady state reached min subjects shifted hot room core temperature heart rate started rise reached values greater degrees c near maximal values respectively termination exercise leg blood flow thermodilution method femoral arteriovenous difference consequently leg consumption unchanged hot compared cool condition increase release lactate reduction glucose free net fatty acid uptake exercising leg heat furthermore rate glycogen utilization gastrocnemius muscle elevated hot environment tendency cardiac output increase heat mean l min may contributed increase skin circulation together possible reduction flow vascular beds muscle blood flow reduced,C23,0.011219589,0.057419688,0.031510253,0.0010777735,0.014097668,0.0024755718,0.12450097,0.0018294805,0.05710538,0.011147559,0.031342335,0.026264125,0.3480255,0.0044660084,0.020257682,0.022088118,0.030070487,0.0020013868,0.0021841836,0.023217702,0.17504406,0.00068109273,0.0019734013
scapegoat effect food aversions chemotherapy effects consuming novel food halva versus familiar food cookies gastrointestinal gi toxic chemotherapy patients preference familiar foods consumed chemotherapy treatment compared development aversions novel familiar foods also assessed patients history posttreatment nausea consumed either novel familiar food chemotherapy asked keep food record next breakfast rate preference foods patients consumed halva treatment significantly likely increase ratings foods consumed chemotherapy patients consumed familiar cookies aversions novel food significantly frequent aversions familiar food findings provide evidence novel familiar food consumed chemotherapy act scapegoat prevent items regular diet consumed chemotherapy decreasing preference providing patients novel food chemotherapy useful clinical intervention reduce likelihood forming aversions familiar foods consumed chemotherapy,C23,0.0024677813,0.014129079,0.1120532,0.001386079,0.003435151,0.01668122,0.24368967,0.0023199504,0.0017834957,0.0024239242,0.09791641,0.0050742994,0.05844554,0.005804752,0.014110327,0.0038415554,0.08384676,0.0025405504,0.0028089865,0.217765,0.10406046,0.0008759246,0.0025398456
modeling human performance running paper focuses characteristics model interpreting effect training athletic performance model theory presented mathematically graphically model systematically quantified impulse training produces dual responses fitness fatigue absence training decay exponentially time repetitive training responses satisfy individual recurrence equations fitness fatigue combined simple linear difference equation predict performance levels appropriate intensity training undertaken significant observed correlation model predicted performance measure actual performance training tapering provides validation model athletes nonathletes alike enables specific model parameters estimated used optimize future training regimens individual,C23,0.029790962,0.0024851584,0.01876519,0.0015741043,0.017424608,0.017173028,0.17020343,0.0026346578,0.0020254315,0.0027527357,0.058032792,0.005800025,0.042175822,0.007870778,0.01602106,0.08572598,0.04032453,0.002904124,0.003190033,0.20977424,0.25945106,0.0009947461,0.002905497
treatment desmopressin acetate routine coronary artery bypass surgery improve postoperative hemostasis desmopressin acetate ddavp shown decrease blood loss transfusions complex cardiac operations long extracorporeal times use routine cardiac valve operations shown beneficial role routine coronary artery bypass grafting operations defined examined effect ddavp prospective study patients undergoing uncomplicated primary coronary artery bypass grafting operations thirty consecutive patients received ddavp micrograms kg cardiopulmonary bypass compared consecutive patients receive ddavp significant differences seen hour mediastinal blood loss ml ddavp versus ml without ddavp hour mediastinal blood loss ml ddavp versus ml without ddavp transfusion blood products similar groups platelet aggregometry intraoperative postoperative time points using adp collagen ristocetin significantly different baseline values either group subgroup patients poor initial ristocetin induced platelet aggregometry significant increase p less ristocetin induced platelet aggregometry seen postoperatively patients received ddavp decrease blood loss transfusions however demonstrable patients aspirin nonsteroidal anti inflammatory drugs preoperatively ddavp improve mediastinal blood loss transfusion needs,C23,0.0017847401,0.0015831535,0.0033578891,0.00963702,0.028361162,0.0023033002,0.08578386,0.0016783912,0.0012902877,0.001753612,0.043209326,0.035598155,0.18671271,0.0041229,0.0015694554,0.0027792116,0.31824633,0.0018379864,0.0020321892,0.052547533,0.21134104,0.0006336964,0.0018360749
importance congenital hypertrophy retinal pigment epithelium familial adenomatous polyposis describe family familial adenomatous polyposis fap congenital hypertrophy retinal pigment epithelium rpe three five members fap showed flat well demarcated round oval pigmented patches congenital hypertrophy rpe stress importance congenital hypertrophy rpe clinical marker identifying patients fap since risk cancer,C23,0.0056207245,0.004985863,0.010487689,0.0031580557,0.14387064,0.0072538373,0.21540613,0.005285797,0.0040635336,0.0055226916,0.099294536,0.03877049,0.034793355,0.04012854,0.08657386,0.008752637,0.10142815,0.0057884143,0.033599865,0.06365868,0.07377836,0.001995715,0.0057823937
femoral arteriovenous fistula complication percutaneous transluminal coronary angioplasty report five cases arteriovenous fistula avf associated invasive diagnostic angiographic procedures rare incidence increased procedures percutaneous transluminal coronary angioplasty ptca still quite low report five cases avf within month period representing per cent cardiac catheterizations per cent ptcas five patients presented groin bruits two associated pseudoaneurysms one patient deep vein thrombosis patients underwent uneventful division fistula thorough understanding anatomy femoral triangle necessary order avoid complication fistulas superficial profunda femoris arteries emphasizes importance avoiding low groin puncture early angiography surgical intervention recommended optimal results,C23,0.018638156,0.0028307608,0.005954463,0.0017930096,0.035119202,0.00411842,0.16750644,0.033894796,0.03320307,0.023316925,0.13682793,0.006563705,0.04249839,0.023152353,0.018250786,0.0049693747,0.2327844,0.0032864152,0.0036336598,0.14800307,0.04923853,0.001133082,0.003282997
multiple pulse stimulation dantrolene malignant hyperthermia potentially fatal condition yet preventable malignant hyperthermia mh lacks satisfactory noninvasive diagnostic test studying effects intravenous dantrolene mg kg electrically stimulated skeletal muscle found approach conclusively distinguish normal humans susceptible malignant hyperthermia nonetheless yielded important information action dantrolene man mh supramaximal single multiple pulse stimulation common peroneal nerve produced stable torque responses dorsiflexor muscles monitored vivo dantrolene suppressed multiple pulse stimulation pulses torque suppression significantly less mh susceptible subjects control subjects distinction also observed mh swine confirms animal good model human mh dantrolene effect mh completely reversed high frequency stimulation intriguing presumably excitation contraction coupling differs mh normal muscle,C23,0.0026569823,0.002356876,0.018262394,0.00149285,0.0036997637,0.042007435,0.18777345,0.0024986584,0.040502783,0.0026106413,0.11849196,0.01873533,0.10536203,0.007595993,0.0023738544,0.004137474,0.032439917,0.036352616,0.0030253653,0.037594035,0.3093165,0.00094339787,0.019769657
color doppler diagnosis mechanical prosthetic mitral regurgitation usefulness flow convergence region proximal regurgitant orifice prosthetic paravalvular prosthetic mitral regurgitation transthoracic color doppler flow mapping sometimes fail detect regurgitant jet within left atrium shadowing prosthetic valve overcome limitation assessed utility color doppler visualization flow convergence region fcr proximal regurgitant orifice consecutive patients mechanical prosthetic mitral regurgitation documented surgery cardiac catheterization patients addition studied patients normally functioning mitral prostheses doppler studies performed apical subcostal parasternal long axis views fcr detected patients prosthetic mitral regurgitation jet area left atrium detected patients patients doppler detected fcr site leak correctly identified observing location fcr trivial jet area detected eight patients normally functioning mitral prosthesis none fcr identified thus color doppler visualization fcr proximal regurgitant orifice superior jet area diagnosis mechanical prosthetic mitral regurgitation moreover fcr permits localization site leak good accuracy,C23,0.002206156,0.0019569704,0.0041164584,0.011811695,0.0030720024,0.0028471593,0.16173534,0.034106575,0.022934886,0.002167678,0.18747464,0.004537641,0.05823013,0.029528053,0.0019400379,0.0034354436,0.19862112,0.0022851964,0.013179462,0.10284319,0.14789218,0.0007833259,0.0022946245
electrocardiographic abnormalities cerebrovascular accidents electrocardiographic abnormalities found patients acute cerebrovascular disease previously normal hearts described abnormalities often seen patients intracerebral subarachnoid hemorrhages common changes q tc prolongation st segment wave abnormalities mechanisms electrocardiographic abnormalities appear multiple,C23,0.0054718247,0.0048537813,0.0102098575,0.003074395,0.0076193423,0.0070616747,0.4224913,0.00514577,0.003955886,0.0053763893,0.053169057,0.011254498,0.078092285,0.013021598,0.0048117847,0.008520769,0.16486384,0.0056421286,0.0062304772,0.04315577,0.12839925,0.0019428461,0.0056354837
temporary cardiac pacing using new steerable balloon tipped pacing catheter new balloon tipped flow directed steerable pacing catheter unipolar temporary ventricular pacing presented successfully uneventfully tested patients acute myocardial infarction coronary care unit main advantage new catheter ease stable contact may achieved pacing electrode endocardium,C23,0.0053308522,0.004728732,0.035737284,0.0029951886,0.0074230433,0.084276505,0.3226727,0.005013198,0.003853969,0.0052378755,0.18016812,0.0109645445,0.059838932,0.012313898,0.004687817,0.008301246,0.12604927,0.005489894,0.0060699596,0.03407553,0.06739446,0.001892792,0.0054841843
chloroprocaine antagonism epidural opioid analgesia receptor specific phenomenon sixty healthy patients scheduled elective cesarean delivery epidural anesthesia randomized receive either lidocaine chloroprocaine primary local anesthetic agent patients first complained postoperative pain recovery room given either fentanyl micrograms butorphanol mg epidurally randomized blinded fashion postoperative analgesia quantitated visual analogue scale well time elapsed first request supplemental opioid differ patients receiving butorphanol either chloroprocaine lidocaine anesthesia contrast epidural fentanyl produced shorter lesser degree sensory analgesia chloroprocaine use whereas epidural fentanyl lidocaine anesthesia provided pain relief similar seen butorphanol groups side effects limited somnolence butorphanol pruritus fentanyl evidence respiratory depression seen patient conclude mg butorphanol epidurally provides approximately h effective analgesia cesarean delivery either lidocaine chloroprocaine anesthesia epidural fentanyl seems antagonized chloroprocaine lidocaine used primary local anesthetic agent suggest possible mu receptor specific etiology effect,C23,0.0025272162,0.0022417668,0.0047218767,0.013650841,0.0035190685,0.015491602,0.26191106,0.0023766246,0.0018270648,0.014712499,0.012442542,0.15473105,0.064529456,0.00629023,0.0022223701,0.040630996,0.12676568,0.027071025,0.016283805,0.043438274,0.17911369,0.00089732266,0.0026039204
low dose amitriptyline chronic pain gain modest double blind placebo controlled study presented effects investigated low dose amitriptyline mg patients chronic pain various origins active drug superior placebo reducing pain intensity reduction small second treatment week amitriptyline treated patients slept longer differences active drug placebo found respect daily activities use analgesics based data studies concluded amitriptyline antidepressants low doses positive effect intensity aspects chronic pain effect modest must kept mind chronic pain treatment resistant condition therefore even modest positive effects may worthwhile,C23,0.0027638287,0.002451315,0.0051563047,0.0015526679,0.0038480118,0.0035663717,0.30734822,0.0025987786,0.0019978487,0.0027152486,0.055946637,0.005740831,0.04555579,0.006792245,0.029182289,0.0043032607,0.057996094,0.0028458918,0.07003341,0.08327828,0.30050248,0.0009811994,0.0028429318
fatigue fatigue pervasive protective phenomenon affecting totality individual assessment management involve wide range activities address total human physical psychological cognitive spiritual dimensions elimination neutralization effect antecedent condition option redesigning one life style may primary avenue fatigue management protective mechanism fatigue may fact herald return quality purpose one life,C23,0.004948131,0.004389239,0.009232699,0.0027801527,0.0068901153,0.0063858205,0.4408485,0.004653282,0.0035772782,0.004861829,0.046670094,0.010177359,0.043062303,0.0198278,0.0043516443,0.0077052685,0.052331436,0.0050957543,0.04615449,0.115808174,0.15331548,0.0017569014,0.0051763044
effects screws sleeve initial fixation uncemented total knee tibial components aseptic loosening tibial components remains serious problem uncemented total knee arthroplasties achieving rigid initial fixation porous coated components one important factors promoting bone ingrowth results biomechanical study micromovement tibial component posteroanterior shear axial compressive loading presented forty anatomic specimen tibiae stress tested servohydraulic mechanical test machine evaluate effects screws sleeve initial fixation uncemented total knee tibial component twenty specimens used posteroanterior shear loading anterolateral axial compressive loading four cancellous screws inserted holes tibial tray pierce cortex proximal tibia methylmethacrylate sleeve applied central stem rigidity fixation significantly improved combination screws sleeve bone strength also important factor affecting quality fixation,C23,0.003345473,0.0029676016,0.094256066,0.0018796849,0.004669032,0.020501897,0.20296676,0.0031461234,0.0024186282,0.019473031,0.11072195,0.006881191,0.06615552,0.028644228,0.019242901,0.021397125,0.09690527,0.0034452826,0.003926417,0.07476175,0.20765585,0.001187856,0.0034503466
maintenance circulation ventricular fibrillation simultaneous use two counterpulsation devices two valveless single orifice counterpulsation devices pumping stroke volumes ml implanted ascending aorta pulmonary artery seven open chest anesthetized dogs completion preparation ventricular fibrillation induced devices synchronized pump simultaneously rate bpm combined use counterpulsation devices provided maximal aortic pressure mmhg ventricular fibrillation period min mean left ventricular pressure mmhg cardiac index ml kg min cardioversion ventricular fibrillation sinus rhythm restored normal hemodynamics counterpulsation device implanted ascending aorta able maintain circulation min induction ventricular fibrillation used alone conclusion use two counterpulsation devices implanted ascending aorta pulmonary artery able maintain circulation experimental animals ventricular fibrillation,C23,0.06218395,0.0914248,0.0056989063,0.016498195,0.004252941,0.0039556753,0.09995203,0.017647067,0.016989991,0.0030009763,0.022256857,0.03924074,0.3307353,0.067311324,0.002685827,0.0198707,0.042697087,0.0031461103,0.0034777084,0.022134246,0.10581449,0.015867788,0.0031573188
upper gi bleeding urban hospital etiology recurrence prognosis acute upper gastrointestinal bleeding ugib continues common cause hospital admission morbidity mortality study reviews patients admitted surgical service urban hospital total admissions patients readmitted times recurrence rate common causes bleeding endoscopically diagnosed included acute gastric mucosal lesion agml patients esophageal varices ev patients gastric ulcer patients duodenal ulcer patients mallory weiss tear patients esophagitis patients nonoperative therapy sufficient cases endoscopic treatment used cases operations performed cases including ulcers emergency operations control hemorrhage required cases rate major surgical complications mortality rate deaths deaths directly attributable ugib factors correlating death include shock admission systolic blood pressure less transfusion requirement five units presence ev p less cases ugib treated without operation including endoscopic treatment diagnostic endoscopy establishes source subsequent operation selected patients done low morbidity mortality rates,C23,0.0020105042,0.0017834177,0.013478807,0.0011296204,0.012531545,0.012317407,0.28981727,0.0018909645,0.0014535051,0.0019754386,0.103185005,0.0041609,0.102454215,0.005033971,0.0017680328,0.0031307733,0.29166442,0.002070486,0.01201159,0.104427814,0.028922087,0.00071385707,0.0020683326
progressive functional deterioration bioprostheses assessed doppler ultrasonography doppler echocardiography used study function bioprosthetic heart valves noninvasive means patients aged years various postoperative intervals ionescu shiley four hancock four carpentier edwards prostheses aortic mitral position initial studies performed mean years implantation repeated one two three years thereafter flow velocities mitral orifice left ventricular outflow tract ascending aorta well mitral pressure half time measured pulsed wave continuous wave doppler recordings mitral aortic valve areas aortic pressure gradients calculated aortic prostheses valve area decreased pressure gradient increased progressively relation time implantation mean value sd aortic valve area percent manufacturer nominal value first examination percent one year later percent two years later percent three years later overall differences p less mitral prostheses reduction valve area related time implantation mean mitral valve area percent nominal value rest increased percent exercise mean months implantation change values one year repeat study concluded population predominantly pericardial bioprostheses aortic tissue prostheses showed progressive functional deterioration demonstrable doppler echocardiography probably due degenerative changes mitral tissue prostheses significant reduction orifice area relation time implantation reduction mitral valve areas may extent reflect less full opening rest,C23,0.0015113811,0.0086519085,0.0028279184,0.0008488722,0.016709173,0.019704117,0.06607005,0.030668804,0.030330116,0.0014928232,0.038040962,0.05429403,0.17896754,0.003514387,0.0013285833,0.009661055,0.24357307,0.0015559015,0.001720299,0.055582087,0.223545,0.007847626,0.0015542833
analysis dna polymorphisms suggests de novo dup q chromosomes patients syndrome isochromosomes translocations syndrome rarely due de novo duplication chromosome dup q investigate origin dup q nature chromosome used dna polymorphisms families syndrome due de novo dup q origin extra chromosome q maternal six cases paternal four cases furthermore majority eight dup q chromosomes isochromosomes q four paternal origin four maternal origin however two families dup q chromosome appeared result robertsonian translocation q q maternal origin cases,C23,0.0035289405,0.0031205646,0.006564061,0.001976572,0.004928125,0.0045400504,0.12739755,0.0033082883,0.0025432946,0.02047417,0.11322833,0.007311815,0.022984901,0.049295712,0.0030935642,0.0054781227,0.052976716,0.0036228674,0.0040056617,0.29378873,0.082903184,0.0012490832,0.1816797
amenorrhea amenorrhea lack menstruation gynecologic disorder may arise variety causes logical orderly schema followed correct diagnosis appropriate management plan formulated,C23,0.0077217026,0.0068495353,0.0144078955,0.00433851,0.010752226,0.00996526,0.36039114,0.0072615827,0.005582447,0.0075870263,0.07289179,0.015882066,0.04832303,0.017754579,0.044151276,0.049403653,0.13212827,0.007952074,0.008792294,0.05001111,0.10716702,0.002741696,0.0079438025
simplified technique control femoral arterial bleeding coronary angioplasty method achieving arterial control inserting embolectomy catheter femoral introducer sheath patient femoral arterial bleeding ptca described herein approach allows quick control less dissection negligible blood loss,C23,0.08211072,0.0048539117,0.01021013,0.0030744774,0.0076195467,0.007061864,0.19713399,0.005145908,0.083427206,0.005376533,0.10495851,0.011670102,0.14883888,0.012581752,0.0048119132,0.008520997,0.13796832,0.005635223,0.006230644,0.05718857,0.08800855,0.0019428981,0.005629362
low dose aspirin versus anticoagulants prevention coronary graft occlusion prevention graft occlusion aspirin mg day heparin followed phenprocoumon investigated randomized trial patients aortocoronary bypass operation aspirin treatment started hours heparin hours phenprocoumon days surgery results vein graft angiography clinical outcome months postoperatively differ vein graft distal anastomoses aspirin group anticoagulant group occluded least occluded distal anastomosis present patients aspirin treated group anticoagulant group worst case analysis randomized patients showed graft occlusions cardiovascular complications lost follow aspirin treated patients compared patients treated anticoagulants grafts endarterectomy occlusion rate lower aspirin anticoagulant group p less equal increased perioperative blood loss aspirin group ml first hours vs ml anticoagulant group p less equal without higher reoperation rate indicates effective platelet inhibition low dose aspirin occlusion rates equal high patients advanced stage coronary artery disease combination low dose aspirin anticoagulation investigated reduce graft occlusion rates,C23,0.057293374,0.038466316,0.0035446642,0.0010673703,0.011915018,0.0024516764,0.11755398,0.0017865115,0.0013734067,0.0018665779,0.028845593,0.077460445,0.10617814,0.0043687825,0.0016705582,0.0029582456,0.25164366,0.001963742,0.0021843845,0.06303142,0.21973492,0.00067451847,0.0019667086
outcome renal transplantation urinary diversion enterocystoplasty retrospective controlled study total patients intestinal urinary diversion enterocystoplasty underwent renal transplantation patient age ranged years mean age years patients divided groups group patients required retransplantation ureter transplanted kidney implanted ileal colonic conduit enterocystoplasty group patients required second transplant diversion taken transplanted ureter implanted defunctionalized bladder living related cadaveric kidneys transplanted graft survival rates groups respectively rate kidneys statistical difference graft survival rate groups complications group included ureteroileal anastomotic leak patients ureteroileal stenosis calculus formation urosepsis hyperchloremic metabolic acidosis wound infection dehiscence complications group renal transplantation pre existing urinary intestinal conduit augmented bladder statistically adversely affect patient graft survival however complication rate much higher ureter implanted intestinal segment therefore preferable whenever possible implant ureter native bladder,C23,0.0021578935,0.0019141592,0.0458061,0.0012124323,0.0030047991,0.0131785665,0.1688727,0.002054515,0.011877927,0.012560682,0.009950247,0.0979243,0.026132768,0.058230836,0.0018976657,0.003360289,0.33233988,0.0022222726,0.002457079,0.104883835,0.09497492,0.00076618954,0.0022199613
case childhood cholesterol screening authorities proposed blood cholesterol screening children prevent coronary heart disease reviewed published studies estimate potential risks benefits screening childhood cholesterol levels poor predictor high cholesterol levels young adulthood even poorer predictor coronary heart disease later life evidence blood cholesterol levels lowered easily children adults seems unlikely cholesterol reduction childhood much effective preventing coronary heart disease cholesterol reduction begun middle age screening interventions lower blood cholesterol levels millions children would expensive could lead labeling family conflicts may cause malnutrition increased noncardiovascular mortality benefits cholesterol screening unlikely exceed risks conclude children screened high blood cholesterol levels,C14,0.002113354,0.022335257,0.0039499584,0.0011874074,0.0029427786,0.0027273935,0.17312232,0.0019874237,0.0015278609,0.06345873,0.09585607,0.0043467656,0.10771841,0.027689414,0.10416676,0.0032909317,0.05715588,0.0021764042,0.012614946,0.17455505,0.13215233,0.0007503752,0.0021741407
characteristics participants baseline treatment mild hypertension study tomhs treatment mild hypertension study tomhs randomized double blind clinical trial currently conducted compare effects nonpharmacologic therapy alone active drug regimens combined nonpharmacologic therapy long term management patients mild hypertension six classes drugs studied acebutolol beta blocker amlodipine calcium antagonist chlorthalidone diuretic doxazosin alpha antagonist enalapril angiotensin converting enzyme inhibitor placebo participants received nutritional hygienic advice reduce weight sodium alcohol intakes increase physical activity end points include blood pressure change side effects quality life indices incidence electrocardiographic echocardiographic abnormalities incidence cardiovascular clinical events including death among participants receiving drugs first step treatment well nonpharmacologic treatment compared incidence among participants randomized nonpharmacologic treatment initial step,C14,0.05597337,0.0019547273,0.046773214,0.0012381282,0.003068481,0.0028438957,0.3586852,0.0020723178,0.0015931244,0.0021651932,0.010187376,0.01712516,0.12215218,0.039424974,0.01260034,0.0034315058,0.05816381,0.0022693707,0.05439181,0.08256132,0.10760957,0.00078242796,0.012932539
comparison blood flow assessment laser doppler velocimetry hydrogen gas clearance method ischemic intestine dogs blood flow colon ileum measured intestinal devascularization laser doppler velocimetry hydrogen gas clearance technique dogs order evaluate clinical usefulness laser doppler velocimetry submucosal blood flow colon ileum measured hydrogen gas clearance method significantly decreased subserosal blood flow sites measured laser doppler velocimetry linear relationship flow values using two methods colon r p less ileum r p less data suggested laser doppler velocimetry may useful method assess degree intestinal ischemia noninvasiveness good correlation submucosal blood flow hydrogen gas clearance technique,C14,0.002624085,0.0023276943,0.004898384,0.0014743663,0.0036539552,0.0033865182,0.15390973,0.0024677212,0.0526977,0.0025783177,0.102811806,0.0053972723,0.28883812,0.0060335817,0.002307554,0.016775114,0.12012425,0.002712012,0.0029879068,0.048301905,0.1700607,0.0009317172,0.0026995619
glomerular hyperfiltration indicates early target organ damage essential hypertension patients essential hypertension world health organization stage ii examined relationship renal hemodynamics left ventricular hypertrophy left ventricular structure determined two dimensional guided mode echocardiography renal blood flow iodine aminohippuric acid clearance glomerular filtration rate creatinine clearance glomerular filtration rate correlated left ventricular mass r left ventricular cross sectional area r conversely similar age body mass index body surface area arterial pressure hypertensive patients left ventricular hypertrophy disclosed higher glomerular filtration rate filtration fraction without left ventricular hypertrophy whereas renal blood flow renal vascular resistance measurements significantly different thus similar levels arterial pressure renal blood flow glomerular hyperfiltration linked early cardiac structural changes essential hypertension conclude hypertensive patient normal renal function high glomerular filtration rate may indicator early target organ damage essential hypertension,C14,0.0021035222,0.0017332291,0.021148019,0.0105200615,0.002720779,0.0025216423,0.10172616,0.0018374949,0.02031063,0.0019198463,0.018423459,0.0040252763,0.19142763,0.007637554,0.027361149,0.0030426679,0.07624164,0.03171054,0.011679709,0.04827469,0.33526683,0.05744873,0.020918757
fibrinopeptide released coronary circulation coronary spasm examine whether acute myocardial ischemia activates coagulation system platelet activation coronary circulation measured plasma levels fibrinopeptide beta thromboglobulin coronary sinus aortic root simultaneously patients coronary spastic angina left coronary spasm induced intracoronary injection acetylcholine patients stable exertional angina acute myocardial ischemia induced rapid atrial pacing fifteen patients chest pain normal coronary arteries coronary spasm served controls coronary sinus arterial difference fibrinopeptide increased markedly p less ng ml anginal attacks coronary spastic angina group however fibrinopeptide levels remained unchanged attacks stable exertional angina group intracoronary injection acetylcholine control group plasma beta thromboglobulin levels remained unchanged attacks patient groups acetylcholine control group data indicate coronary spasm induces thrombin generation may lead thrombus formation coronary artery involved pacing induced ischemia activate coagulation system,C14,0.020527033,0.002137114,0.004498553,0.0013536524,0.0033547874,0.003109247,0.18700816,0.0139268655,0.0017417717,0.0023672176,0.011089899,0.11777738,0.08099176,0.0056126923,0.002118623,0.0037516844,0.07747462,0.037722833,0.0027432716,0.030568914,0.36346513,0.0008554328,0.025803383
improved cannulation method extracorporeal membrane oxygenation extracorporeal membrane oxygenation shown useful patients reversible cardiogenic shock effective arterial cannulation techniques infants developed simple use require minimal subsequent vascular repair reconstruction removal groin cannulation adults frequently requires bidirectional arterial cannulation ensure adequate distal perfusion well frequent complex arterial repairs discontinuation describe simple arterial cannulation technique using single right angle high flow arterial cannula technique adequate bidirectional arterial perfusion maintained single arterial cannula need vascular repairs reconstruction minimized,C14,0.0926302,0.0024227584,0.005238947,0.00153458,0.0038031843,0.032684304,0.14859347,0.02587771,0.028371204,0.0026836172,0.13286316,0.005617667,0.07055659,0.0062799957,0.0024017955,0.017547563,0.24919073,0.0028127385,0.003109934,0.08057435,0.08141977,0.0009697689,0.0028159632
effects low perfusate ca concentration newborn myocardial function ischemia greater dependence transsarcolemmal ca flux immaturity ca sequestration capacity may potentiate ca mediated reperfusion injury newborn myocardium effect serum ionized ca concentration left ventricular systolic diastolic function ischemia studied day old piglets undergoing minute period cold blood cardioplegic arrest control group ca maintained mm group n cardioplegic solution bypass perfusate modified achieve low ca concentration mm group b n left ventricular pressure volume loops acquired using high fidelity pressure sensor tipped volume conductance catheters ventricular function assessed slope end systolic ees end diastolic k pressure volume relations transient caval occlusion groups showed significant reduction ees ischemia p less intergroup comparison ees ischemia demonstrated better recovery systolic function low ca group versus normal ca group p significant increase chamber stiffness index group k ml p less versus significant change group b study shows feasibility acquiring continuous pressure volume data neonatal hearts using conductance catheter system better preservation systolic function diastolic compliance normal newborn myocardium low ca concentration peri ischemic period,C14,0.01903903,0.0087141255,0.010418131,0.00085513236,0.0021194834,0.0019641803,0.060326274,0.0014312782,0.001100316,0.001495424,0.025542945,0.07730466,0.29283804,0.09959422,0.0013383812,0.009731874,0.10207197,0.001577136,0.0017329857,0.09520592,0.16875821,0.0152744865,0.0015657457
bronchiolar morphology systemic arterial interruption assess ischemic lesions factor obliterative bronchiolitis lung transplantation authors severed left bronchial arteries dogs together left stem bronchus latter immediately reanostomosed examined bronchioles weekly interfals three half months week chosen dog anesthetized totally heparinized exsanguino perfused saline heart arrest thoracic aorta injected barium solution white medium appeared bronchial arteries heart lung blocs excised en bloc submitted soft tissue x ray fixed sliced cm corresponding right left mm thick samples slices prepared contact microradiography followed histologic micron thick stained correlated specimens two weeks left bronchial arteries remained empty necrosis edema two four weeks barium solution appeared bronchial arteries bronchiolar epithelium become multistratified later left bronchiangiogram became similar right folds mucosa little submucosal fibrosis studies provide proof significant ischemic lesions occurred repermeation bronchiolar vascular bed ischemia existent significant factor obliterative bronchiolitis,C14,0.05845122,0.0020887651,0.015769335,0.0013230281,0.04883466,0.025837036,0.14985994,0.07903637,0.013099747,0.002313663,0.042544372,0.057522766,0.10438715,0.010041501,0.0020706924,0.026304703,0.15156277,0.0025685357,0.0026812092,0.049210258,0.13916785,0.00083607994,0.01448838
light scattering detection microemboli extracorporeal lvad bovine model thromboembolization studies performed two calves supported extracorporeal left ventricular assist devices lvad using light scattering ne laser microemboli detector lsmd lsmd system placed outflow cannula lvad extracorporeal loop animal measurements included size number rate production circulating microemboli range microns less microemboli diameter less microns data compared independently concurrently obtained measurements emboli shear rate cpf platelet count red blood count rbc leukocyte count wbc plasma free hemoglobin factors xiii x v sorbitol dehydrogenase embolic number volume seen dynamic early phases acute thromboembolization minutes peak embolic response within first minutes dynamics reduced emboli volume rather number may implicated later stages thromboembolic passivation ventricles lsmd results generally showed inverse correlation microemboli volume rate cpf measurements ventricle lsmd cpf leukocyte platelet counts showed direct correlation reduced counts additional ventricle calves factor xii seen direct correlation time lsmd measurements ventricle parameters investigation study represents first time laser scattering filtration methods applied simultaneously hematologic assays order study dynamics device associated thrombogenesis,C14,0.0017401759,0.018385721,0.029885542,0.026223041,0.0024347978,0.00224536,0.14234437,0.0016361709,0.0012578302,0.0101233255,0.03375951,0.0035873926,0.15898837,0.026890814,0.0015299754,0.01112862,0.19246517,0.0017917515,0.001981069,0.05247378,0.25149322,0.017451901,0.010182087
finding increased myocardial ischemia carotid endarterectomy anesthesia nitrous oxide nitrous oxide n implicated cause myocardial ischemia investigated whether substitution n portion anesthesia supplied isoflurane increased myocardial ischemia patients risk ischemia seventy patients carotid endarterectomies patients carotid surgery seven patients prospectively randomly assigned anesthetic regimen included excluded n aspects anesthetic management similar except greater concentrations oxygen isoflurane patients given n perioperative monitoring myocardial ischemia infarction included lead electrocardiography transesophageal echocardiography creatine kinase isoenzyme levels transesophageal echocardiographic electrocardiographic criteria patients given oxygen given n myocardial ischemia intraoperatively p similarly myocardial infarction identified changes creatine kinase isoenzymes occurred one patient given n three given oxygen significantly different thus found trend indicating greater incidence myocardial ischemia infarction associated use n,C14,0.002839772,0.0025190194,0.0052987197,0.029065076,0.0039542927,0.0036648738,0.28999165,0.002670556,0.0020530287,0.0027902427,0.08062616,0.0062240288,0.038512215,0.006589129,0.002497224,0.059378996,0.14175577,0.0029244942,0.016967483,0.09384308,0.20175545,0.0010082999,0.00307043
prolongation ventricular refractoriness class ia antiarrhythmic drugs prevention ventricular tachycardia induction effects class la antiarrhythmic drugs procainamide quinidine right ventricular effective refractory period verp intraventricular conduction time assessed serial invasive electrophysiologic studies sustained monomorphic ventricular tachycardia vt patients remote myocardial infarction sustained vt inducible two extrastimuli basic drive one two basic cycle lengths right ventricular apex oral drug administration sustained vt longer inducible group patients remained inducible group ii protocol class la drugs prolonged verp groups greater lengthening drugs effective e g msec group vs msec group ii p less basic cycle length msec prolongation verp greater msec positive predictive value prevention sustained vt induction except one patient group drugs prolonged verp coupling intervals resulted sustained vt induction control conditions longer attainable contrast conduction time ventricle surface qrs duration sinus rhythm right ventricular pacing prolonged similarly regardless efficacy e g msec vs msec cycle length msec presence similar plasma levels drug imply equivalent prolongation verp two groups results suggest greater prolongation verp oral procainamide quinidine correlates drug efficacy vt induction better predictor drug effect achievement therapeutic plasma level,C14,0.03059702,0.020846546,0.04157834,0.0011083131,0.0027467574,0.0025457193,0.22075479,0.0018550396,0.010949574,0.0019381773,0.019155877,0.072825626,0.04850402,0.0049775834,0.030379372,0.041264668,0.20666634,0.002031432,0.0022460744,0.04697612,0.18732294,0.00070039206,0.0020293193
ventricular arrhythmias hypertensive left ventricular hypertrophy relationship coronary artery disease left ventricular dysfunction myocardial fibrosis ventricular arrhythmias occur increased frequency hypertensive patients left ventricular hypertrophy lvh relationships however ventricular arrhythmias coexistent coronary artery disease left ventricular dysfunction left ventricular fibrosis examined hypertensive lvh carried coronary arteriography fifteen hypertensive patients lvh nonsustained ventricular tachycardia greater equal consecutive ventricular complexes nine free significant greater stenosis coronary disease identify possible correlates left ventricular arrhythmias patients lvh comprising ventricular tachycardia without ventricular arrhythmias underwent quantitative assessment left ventricular function angiographic ejection fraction left ventricular mass echocardiography left ventricular fibrosis endomyocardial biopsy ejection fraction significantly different two groups v p ns however left ventricular mass significantly greater g v g p less percentage fibrosis significantly higher v p less patients ventricular tachycardia thus ventricular arrhythmias hypertensive patients lvh cannot entirely attributed coexistent coronary disease left ventricular dysfunction related degree cardiac hypertrophy subendocardial fibrosis,C14,0.0023542738,0.0020883584,0.04136507,0.0013227704,0.0032782517,0.003038313,0.19689463,0.0022139875,0.0017020352,0.0023132123,0.013725016,0.016240697,0.21290451,0.005421126,0.0020702889,0.0036660938,0.17339535,0.0024245116,0.002680687,0.041266836,0.12960546,0.1376065,0.00242199
effects nicardipine calcium antagonist myocardial salvage high energy phosphate stores reperfused myocardial injury current study determined effectiveness nicardipine dihydropyridine calcium antagonist preserving reperfused myocardium cat model temporary coronary occlusion ascertained replenishment myocardial phosphate stores reperfusion defined phosphorus nuclear magnetic resonance nmr spectroscopy indicative salvage twenty open chest anesthetized cats studied use snare ligature around proximal left anterior descending coronary artery coil sutured epicardial surface overlying distribution artery peak areas phosphocreatine inorganic phosphate adenosine triphosphate atp nmr signals measured h occlusion followed h reperfusion infarct size jeopardy area determined vitro simultaneous infusion phthalocyanine blue dye triphenyltetrazolium chloride aorta left anterior descending coronary artery respectively h myocardial reperfusion nicardipine treated control groups similar jeopardy area values versus left ventricle infarct area significantly reduced nicardipine treated group versus jeopardy area p less high energy phosphate compounds remained markedly altered reperfusion groups significant improvement phosphocreatine inorganic phosphate recovery observed animals pretreated nicardipine despite reduction infarct size myocardial atp greater reperfusion nicardipine treated compared control group average initial min reperfusion versus baseline values p less suggesting improved recovery atp however measured levels high energy phosphate compounds reperfusion ratios correlate infarct size thus predictive myocardial salvage,C14,0.08843746,0.010223316,0.014693249,0.0010031965,0.01112598,0.010905817,0.07618628,0.018965011,0.00983134,0.0017543532,0.011443856,0.08499933,0.28252038,0.033131305,0.0015701188,0.011480245,0.071784586,0.0018387632,0.002033048,0.013258267,0.2403433,0.0006339642,0.0018368509
improved morphologic characterization atrial septal aneurysm transesophageal echocardiography relation cerebrovascular events transthoracic transesophageal echocardiography performed consecutive adult patients atrial septal aneurysm three patients cerebrovascular event diagnosis established transesophageal approach interatrial shunting transthoracic imaging use echocardiographic contrast imaging doppler color mapping detected patients performing contrast imaging combination color flow mapping transesophageal echocardiography positive shunting demonstrated patients echocardiographic identification multiple fenestrations n thrombus within aneurysm n could achieved first time transesophageal ultrasound application cerebrovascular events occurred patients regarded definitely thromboembolic patients repeated cerebral events except mitral valve prolapse one patient potential cardiac source embolism could identified despite use transesophageal echocardiography thickening aneurysmal membrane greater equal mm found patients versus patients without cerebrovascular event p less proved significant difference two patient groups mechanism embolization may primary thrombus formation within aneurysm paradoxic embolization interatrial communication demonstrated findings two patients concluded atrial septal aneurysm cardiac abnormality thromboembolic potential patients lesion history embolic event long term anticoagulant therapy indicated,C14,0.011519352,0.0017498682,0.0132286325,0.08700899,0.0426122,0.0025458501,0.29944977,0.001855135,0.001426162,0.0019382768,0.07746989,0.014418092,0.02594889,0.0045816842,0.011282783,0.012617498,0.28553674,0.0020315363,0.0022461896,0.024898114,0.06335499,0.010248003,0.0020313624
new calcium antagonists relevance vasoselectivity calcium antagonists heterogeneous class drugs used treat number cardiovascular disorders new generation calcium antagonists development higher degree selectivity vascular smooth muscle coronary vasculature compared verapamil nifedipine diltiazem clinical relevance vasoselectivity impact drug selection discussed newer calcium antagonists important alternatives older agents may associated improved tolerance reduced incidence adverse effects place therapy yet defined comparative studies efficacy safety,C14,0.0037071332,0.003287401,0.0069330824,0.02000804,0.0051604784,0.0047827777,0.38989127,0.0035593035,0.0026792684,0.0036413562,0.03730785,0.0076225204,0.043262523,0.0088100685,0.021194896,0.0057710027,0.08192564,0.0038165587,0.018366843,0.14239132,0.18075219,0.0013158636,0.0038125894
transesophageal echocardiography critically ill patients feasibility safety clinical impact transesophageal echocardiography evaluated critically ill intensive care unit patients men women mean age years transthoracic echocardiography inadequate time transesophageal echocardiography patients mechanically ventilated transesophageal echocardiography performed without significant complications patients patients heart failure worsening hemodynamic respiratory difficulties insertion transesophageal probe frequent indication patients unexplained hemodynamic instability indications included evaluation mitral regurgitation severity prosthetic valvular dysfunction endocarditis aortic dissection potential donor heart patients transesophageal echocardiography identified cardiovascular problems could clearly diagnosed transthoracic echocardiography remaining patients transesophageal echocardiography permitted confident exclusion suspected abnormalities superior imaging qualities cardiac surgery prompted transesophageal echocardiographic findings patients findings confirmed operation therefore transesophageal echocardiography safely performed definite role diagnosis expeditious management critically ill cardiovascular patients,C14,0.0022767473,0.013035426,0.026260167,0.12249327,0.036173534,0.0029902412,0.1919731,0.013151779,0.0016459869,0.013253803,0.06462321,0.0046828343,0.031183071,0.0052350024,0.0020021142,0.003545369,0.30748934,0.013651076,0.01742244,0.088938296,0.034822542,0.00080839026,0.0023422337
stunned myocardium extracorporeal membrane oxygenation stunned myocardium syndrome reversible myocardial dysfunction may mediated oxygen derived free radicals phenomenon seen neonates undergoing extracorporeal membrane oxygenation performed echocardiograms measured creatine phosphokinase isoenzymes lipid peroxide levels neonates extracorporeal membrane oxygenation infants developed stunned myocardia echocardiography shortly initiation bypass exhibited concurrent elevations mb fraction creatine phosphokinase lipid peroxide levels simultaneously rise data suggest oxygen derived free radicals may cause stunned myocardium seen neonates undergoing extracorporeal membrane oxygenation,C14,0.0037920782,0.0033637625,0.0070756245,0.0021306141,0.005280349,0.0048938743,0.16650924,0.0035700817,0.07613107,0.0037259394,0.10117552,0.00779958,0.10094554,0.01089341,0.05658508,0.0059050545,0.12672675,0.061670266,0.0043178387,0.1253562,0.11688506,0.0013464292,0.0039206105
daylong pattern antianginal effect long term three times daily administered isosorbide dinitrate three times daily administration isosorbide dinitrate may avoid much tolerance seen frequent dosing determine daylong pattern antianginal effect three times daily isosorbide dinitrate eight men stable exertional angina positive exercise test studied subjects demonstrated increased exercise duration response oral isosorbide dinitrate therapy absence complete tolerance long term three times daily isosorbide dinitrate treadmill exercise onset angina performed days pm pm pm pm pm one day patient received isosorbide dinitrate pm pm previously titrated dose mean mg taken three times daily least weeks day hours patient received double blind placebo identical appearance isosorbide dinitrate one hour dose isosorbide dinitrate mean systolic blood pressure rest fallen mm hg mean exercise time angina increased however exercise time returned control level one hour pm dose isosorbide dinitrate exercise time increased mean control level h later,C14,0.001930882,0.04766644,0.003544522,0.0010673275,0.0026453233,0.024941025,0.09993174,0.010975499,0.0013733516,0.0110602025,0.036060188,0.0048268493,0.13802929,0.004469873,0.0016704912,0.0029581268,0.15887664,0.0019563092,0.020552665,0.05259407,0.37024018,0.0006744914,0.0019545355
role preoperative radionuclide ventriculography defining outcome revascularization extremity revascularization extremity performed upon patients preoperative radionuclide ventriculography rnvg mean ejection fraction ef per cent ventricular wall motion abnormalities present per cent revascularization included inflow procedures aortofemoral n extraanatomic bypass axillofemoral femorofemoral n infrainguinal reconstruction including femoropopliteal distal bypass n procedures improve perfusion limb correct complications previous vascular reconstruction upon extremity n perioperative days mortality rate per cent per cent patients discharged alive hospital myocardial infarction mi occurred per cent new ventricular arrhythmia per cent congestive heart failure per cent patients perioperative period follow study days per cent required major amputation ipsilateral reconstruction per cent required surgical angiographic revision hemodynamic failure reconstruction prior thrombosis per cent thrombosed part reconstruction revascularization failure appear related level cardiac function normal greater per cent ef greater survival life table analysis ef less equal per cent p mantel cox test ventricular wall motion abnormalities associated reduced survival p mantel cox test presence angina previous mi singularly combination adverse effect survival whereas diabetes p mantel cox test cigarette smoking p breslow test associated significantly diminished survival preoperative rnvg identify subgroups survival disadvantage revascularization extremity population presence angina previous mi predict survival,C14,0.0018653304,0.037768636,0.0034805129,0.001048053,0.0026055425,0.0024073059,0.20914115,0.0017615627,0.0013485508,0.0018327966,0.071720414,0.004086548,0.048426595,0.0046199476,0.0016403244,0.0029047073,0.397871,0.0019221638,0.002123953,0.11344973,0.085390694,0.00066231104,0.0019221505
use computed tomographic scanning aortography diagnosis acute dissection thoracic aorta introduction computed tomographic ct scanning aortography investigation choice acute aortic dissection patients referred brompton hospital suspected acute thoracic aortic dissection aortography diagnosis confirmed surgery n necropsy n supported clinical outcome n one patient aortography negative type b dissection necropsy another patient lost follow ct scanning became available unit used imaging investigation patients suspected acute dissection thoracic aorta patients aortography used alone results confirmed surgery n necropsy n supported clinical outcome n two patients lost follow additional patients aortography ct scanning performed concordant findings six results discordant aortography normal three subsequent ct scanning showed type b dissection ct scanning normal three patients aortography showed type dissection ct scanning aortography reliable techniques assessment suspected acute dissection thoracic aorta techniques misdiagnose occasionally frequency misdiagnosis minimised performing investigations patients level clinical suspicion high initial investigation negative ct scanning tends miss type dissection view success surgery condition failing serious clinical consequences,C14,0.002157863,0.012357833,0.0144671695,0.012398903,0.0134442225,0.0027848347,0.35556194,0.03336107,0.022444855,0.002120227,0.09249009,0.004438312,0.020364381,0.0052695093,0.0018975702,0.013798179,0.24070024,0.014026614,0.0024570443,0.05690812,0.073548414,0.00076617877,0.002236446
long term follow patients incessant ventricular tachycardia seventeen patients coronary artery disease idiopathic dilated cardiomyopathy organic heart disease presented incessant ventricular tachycardia vt studied followed mean period months patients incessant vt included greater equal episodes sustained vt rate greater equal beats min frequent episodes nonsustained vt hour period patient electrolyte disorder prolonged qt interval drug induced arrhythmia myocardial infarction less weeks old six patients died within months follow sudden death acute myocardial infarction three surviving patients remission vt within week diagnosis incessant vt patients antiarrhythmic drugs discontinued follow adverse effects drugs medical reasons found remission remaining alive patients deliberate attempts made discontinue antiarrhythmic drugs patients found remission drugs discontinued thus patients incessant vt remission mean follow months discontinuation antiarrhythmic drugs probability remission patients surviving incessant vt warrants trials discontinuation antiarrhythmic drugs patients,C14,0.0020925323,0.001873262,0.0039044486,0.0011757086,0.0029137852,0.015774747,0.28611675,0.001967843,0.0015128078,0.002056036,0.038125638,0.004303939,0.023165623,0.0048994194,0.0018401202,0.0032585082,0.43357447,0.0021549615,0.012511304,0.06916287,0.064460576,0.021001924,0.0021527202
tension pneumopericardium complication single lung transplantation tension pneumopericardium distinctly uncommon adult population present case tension pneumopericardium complication lung transplantation year old woman thromboembolic pulmonary hypertension underwent single lung transplantation,C14,0.059367314,0.005272789,0.011091233,0.0033397952,0.008277089,0.098129705,0.15929519,0.034356613,0.0042973813,0.005840511,0.12605464,0.012226053,0.038764887,0.013667517,0.0052271667,0.009256332,0.19463378,0.006121525,0.006768329,0.11304607,0.076705515,0.0021105641,0.0061500445
parallel group design crossover design group approach individual approach consequences heterogeneity response antihypertensive drugs clinical development programs new antihypertensive drugs care individual hypertensive patient previously sufficiently recognized play role inappropriate choice high daily doses antihypertensive drugs end extensive international development programs also implicated insufficient control blood pressure observed long term multicenter trials hypertension patients treated several years drugs appropriate disease adequately control blood pressure addition parallel group studies use double blind two period multiple period crossover designs provide valid data dose finding new antihypertensive drugs comparative evaluation end trial designs also offer patient opportunity treated right dose drug appropriate disease,C14,0.012466398,0.0018941873,0.045313954,0.01152171,0.013309528,0.0027741755,0.35152897,0.012342544,0.0015437836,0.0020981347,0.030127035,0.036896333,0.0764447,0.0049326797,0.001877798,0.034331895,0.09804953,0.0022054017,0.05362447,0.041166227,0.152268,0.011084946,0.0021975555
renal autotransplantation children successful treatment renovascular hypertension renovascular hypertension children common disease improved surgical technique incidence nephrectomy decreased renovascular reconstruction currently preferred method manage entity patients renovascular hypertension treated hospital patients years old underwent renal autotransplantation children unilateral bilateral disease requiring bilateral autotransplantation autotransplantation performed anastomosis renal artery end side common iliac artery renal veins anastomosed end side common iliac veins ureters left intact patient required bench operation patients unilateral procedure cured improved normal blood pressure small dose antihypertensive medication patients bilateral autotransplants cured results normalization blood pressure patients improvement blood pressure patency rate similar reported reconstructive modalities children,C14,0.0673567,0.034691714,0.0042924047,0.023062952,0.0031351212,0.0029056582,0.14818092,0.03481268,0.0016277232,0.04581209,0.042174585,0.004639456,0.10330834,0.0054231,0.001979899,0.00350603,0.24621277,0.0023196002,0.0025636465,0.06381752,0.13326544,0.022595415,0.0023162444
effect long term exercise regional myocardial function coronary collateral development gradual coronary artery occlusion pigs effect myocardial ischemia induced long term exercise regional myocardial function coronary collateral development examined pigs gradual occlusion left circumflex coronary artery lcx ameroid occluder thirty days surgery regional myocardial function blood flow assessed exercise pigs separated exercise n sedentary groups n exercise group trained treadmill days min day heart rates beats min weeks another exercise test performed exercise group training observed improvement systolic wall thickening expressed percentage rest collateral dependent lcx region p less moderate exercise levels beats min p less severe exercise levels beats min transmural myocardial blood flow lcx region expressed ratio flow nonoccluded region left ventricle also increased significantly p less severe exercise weeks sedentary group showed improvement systolic wall thickening lcx region moderate exercise compared initial exercise test p less significant change systolic wall thickening myocardial blood flow ratios severe exercise weeks conclude long term exercise gradual lcx coronary artery occlusion pigs improves myocardial function coronary collateral reserve collateral dependent myocardium exercise,C14,0.027711863,0.13351002,0.010746989,0.0009017455,0.0022348163,0.022574767,0.07302071,0.0015092969,0.001160294,0.0015769394,0.03822995,0.034380913,0.27748483,0.0194177,0.0014113362,0.0025008149,0.13764238,0.0016636644,0.0018274506,0.020416938,0.1877466,0.0005698528,0.0017601405
changes cerebral blood flow velocity release intraoperative tourniquets humans transcranial doppler study effect release intraoperative thigh tourniquets velocity blood flow middle cerebral artery examined five patients given general anesthesia controlled ventilation lower extremity orthopedic procedures using transcranial doppler sonography middle cerebral artery blood flow velocity increased significantly sem cm increase within min tourniquet release remained significantly elevated min positive linear correlation found middle cerebral artery blood flow velocity petco occasion greater equal r greater equal greater p greater tourniquet deflation assuming linear relationship flow velocity flow findings suggest significant increase cerebral blood flow occur intraoperative tourniquet release increase appears mostly co dependent,C14,0.0924796,0.002064929,0.015602389,0.0013079303,0.003241473,0.014261444,0.12862769,0.002189149,0.00168294,0.0022872605,0.022981271,0.0048719286,0.3516226,0.0224892,0.0020470624,0.026404727,0.08546935,0.0023973112,0.0026506125,0.017362095,0.17218669,0.02336407,0.0024082381
noninvasive assessment cardiac output children using impedance cardiography study evaluated effect intracardiac shunting accuracy thoracic bioimpedance derived cardiac output determinations twenty six patients ranging age months years underwent cardiac catheterization simultaneous fick impedance measurements cardiac output obtained subjects divided three groups children intracardiac shunts nine children predominant left right intracardiac shunts seven children predominant right left intracardiac shunts positive correlations impedance fick derived cardiac output determinations obtained non shunt group r lower correlations left right shunt group r right left shunt group impedance derived cardiac output correlated fick pulmonary flow r variability unacceptably large although study needed impedance cardiography appears validity methodology pediatric critical care cardiovascular health research,C14,0.14561366,0.002020492,0.004250075,0.0012797838,0.003172908,0.0029410855,0.11715934,0.10159488,0.012664962,0.0573711,0.11848166,0.05981893,0.10607008,0.0052531306,0.00200301,0.0036859433,0.13950926,0.0024533244,0.013616258,0.04446555,0.05339408,0.0008087519,0.0023717554
blood pressure response dietary calcium intervention humans epidemiological experimental studies suggested dietary calcium deficiency may lead development hypertension article reviews findings human trials calcium intervention special reference responses blood pressure biochemical variables calcium supplementation consistently resulted decreased blood pressure subset hypertensive normotensive subjects led increased blood pressure hypertensive patients variable blood pressure responses calcium supplementation could predicted basis routine biochemical parameters appeared due differences backgrounds subjects design size trials concluded studies required hypotensive effect calcium supplementation,C14,0.015012693,0.0022416604,0.016922604,0.0014198722,0.00359905,0.0032842255,0.29355347,0.0023765117,0.0018269779,0.0024830203,0.02866379,0.0052211597,0.19507857,0.09451656,0.0022222647,0.003935214,0.0428037,0.00260249,0.02734458,0.0606031,0.14168775,0.00089728,0.051703494
changing clinical spectrum thromboangiitis obliterans buerger disease patients diagnosed thromboangiitis obliterans tao age years mean sd range years women years old first diagnosed ischemic ulcerations present patients patients upper extremity patients lower extremity patients upper lower extremity lesions ninety one patients rest pain patients raynaud phenomenon patients superficial thrombophlebitis able follow patients months mean follow time months sixty five patients amputations one following amputations finger six patients toe patients transmetatarsal four patients knee patients knee two patients forty three patients stopped smoking mean months median months range months two patients amputations stopped smoking patients amputations continuing smoke p less spectrum patients tao changing male female ratio decreasing older patients diagnosed upper extremity involvement commonly present patients stopped smoking amputations continued disease activity uncommon,C14,0.0023276357,0.002064729,0.004343127,0.0013078036,0.02576127,0.003003935,0.13298696,0.013516989,0.024215406,0.0022870388,0.04777911,0.004787502,0.07383038,0.0056799133,0.0020468642,0.003624613,0.4500628,0.002397079,0.0026503557,0.14056306,0.051542375,0.0008264589,0.0023945859
combined alpha beta blockade versus beta selective blockade essential hypertension black white patients purpose multicenter investigation determine efficacy safety alpha beta blocker labetalol versus beta selective beta blocker atenolol white black patients essential hypertension equal numbers black white patients enlisted form four treatment groups white patients taking either labetalol atenolol black patients taking either labetalol atenolol two hundred ninety two patients white black patients essential hypertension characterized standing diastolic blood pressure mm hg inclusive recruited trial patients randomized either labetalol dosage titrated mg day atenolol dosage titrated mg day therapeutic goal achievement standing diastolic blood pressure mm hg less fall mm hg diastolic pressure baseline value end placebo run period end study significant differences blood pressure heart rate changes supine position labetalol atenolol groups contrast labetalol produced greater reduction standing systolic diastolic blood pressure mm hg respectively compared atenolol mm hg p less p less respectively greatest decrease blood pressure observed white patients receiving labetalol black patients decrease blood pressure greater treated labetalol compared atenolol particularly respect systolic blood pressure conclude alpha blocking property labetalol provides additional lowering blood pressure seen beta blockade alone especially standing position enhanced efficacy confined one radical group,C14,0.021594036,0.0014345077,0.018569855,0.0009086201,0.01790457,0.002087038,0.120460525,0.0015208033,0.032483865,0.0015889615,0.007555505,0.044562478,0.30762017,0.0040329164,0.0014220957,0.002518265,0.1657761,0.009470814,0.020589467,0.023614759,0.14833568,0.0005741972,0.045374777
time course hemodynamic responses sodium elderly hypertensive patients thirty one patients essential hypertension years old studied two different regimens sodium intake meq day weeks meq day weeks systemic hemodynamic data measured doppler echocardiography mitral flow velocity integral cardiac index total peripheral resistance calculated salt sensitive patients increase total peripheral resistance greater increase cardiac index salt loading termed sst salt sensitive patients termed ssc increase cardiac index greater increase total peripheral resistance increased sodium intake sst patients day high sodium diet remained sst group day nine patients ssc group day remained ssc group day remaining four patients ssc group day fell sst group day four eight non salt sensitive nss patients day high salt regimen remained nss group day whereas remaining four patients nss group day fell ssc group day data suggest changing pattern sodium loading initially high cardiac index followed persistently raised total peripheral resistance celiac superior mesenteric renal arteries vasoconstricted sodium repletion sst ssc patients salt loading terminal aortic vascular bed vasodilated ssc patients vasoconstricted sst patients,C14,0.009446805,0.0014349767,0.010839302,0.0009089171,0.0022525897,0.04065125,0.12195859,0.010441694,0.008975714,0.0015894809,0.00824827,0.06598076,0.13456938,0.0037195815,0.0014226424,0.002547329,0.22419326,0.0016659582,0.0018419843,0.093159854,0.24411106,0.0005743849,0.009466237
atenolol therapy exercise induced hypertension aortic coarctation repair successful repair coarctation aorta childhood exercise induced upper body systolic hypertension well documented beta blockade shown reduce arm leg gradient untreated coarctation aorta treatment coarctation repair decreased paradoxical hypertension repair ten patients successful surgical repair coarctation defined resting arm leg gradient less equal mm hg evaluated treadmill exercise beta blockade atenolol mean age years repair study baseline evaluation systolic blood pressures termination exercise ranged mm hg mean mm hg arm leg gradients exercise termination ranged mm hg mean follow treadmill exercise studies performed beta blockade upper extremity systolic pressures exercise termination normalized patients maximal systolic blood pressure recorded exercise termination ranged mm hg mean mm hg p less equal arm leg gradient termination exercise also decreased significantly mean mm hg p less patient symptoms atenolol exercise endurance times unchanged study results small series suggest cardioselective beta blockade used treat exercise induced upper body hypertension effectively surgical repair coarctation high incidence premature cardiovascular disease well documented satisfactory surgical repair findings importance group postoperative patients,C14,0.065289475,0.07290211,0.0027593179,0.00083088654,0.009216674,0.030354835,0.11222199,0.008650919,0.008223895,0.0014580153,0.02499631,0.0388101,0.15520442,0.003437525,0.028732732,0.0023028245,0.26293263,0.0015229356,0.008821547,0.02699074,0.13229367,0.0005250739,0.0015213516
normal angiograms carotid pathology nonstenotic ulcerated atherosclerotic plaques carotid arteries may associated symptoms transient ischemic attacks amaurosis fugax stroke preoperative evaluation patients symptoms traditionally included ultrasound arch aortography angiograms area carotid bifurcation recent evidence shown ultrasound accurate detection morphologic delineation nonstenotic lesions analyzed hospital records patients ultrasonographic evidence disease arteriograms negative patient group comprised men six women average years patients symptoms hemispheric transient ischemic attacks evaluated b mode ultrasound arteriography ultrasound positive arteriogram negative patients e described radiologist without hemodynamic significant disease ulceration normal ultrasound diagnosis confirmed operation findings per cent stenosis ulcerative plaques retrospective review arteriograms three ulcerations found patients conclude b mode ultrasound better defines nonstenotic ulcerative lesions decisions perform carotid endarterectomy may based either positive test ulcerative plaque b mode ultrasound appropriate symptoms therefore may require angiography operation,C14,0.011629363,0.0017664162,0.0037156304,0.0011188517,0.04128082,0.0025699255,0.24550259,0.0018726785,0.0014396488,0.0019734127,0.21258701,0.013736054,0.019167878,0.004843142,0.0017511325,0.012737883,0.2713343,0.0020576627,0.0022674315,0.051840752,0.061055247,0.00070705183,0.03304509
cardiac contractility conduction comparison antihypertensives four classes first line antihypertensive agents recommended report joint national committee detection evaluation treatment high blood pressure reviewed particular consideration given effects agents heart rate atrioventricular nodal conduction myocardial contractility patients cardiovascular diseases diuretics angiotensin converting enzyme inhibitors significant direct effects cardiac function beta blockers inhibit catecholamine stimulation heart may particularly beneficial treating patients history myocardial infarction calcium channel blockers reduce blood pressure dilating arterial resistance vessels structurally heterogeneous highly selective sites action consequence cardiac effects minimized selecting calcium channel blocker potent peripheral vasodilatory effects new calcium channel blocker isradipine currently undergoing clinical trials highly selective arterial smooth muscle appears safe effective antihypertensive agent,C14,0.016397078,0.0021371073,0.0044953735,0.0013536481,0.015105149,0.014770449,0.3295214,0.0022690496,0.0017417661,0.00236721,0.042293087,0.004995557,0.11984952,0.017284125,0.025442682,0.0037516723,0.11880735,0.014554616,0.014405138,0.019037372,0.22608672,0.0008554301,0.0024785271
pulse oximetry new non invasive assessment peripheral arterial occlusive disease peripheral skin perfusion reflects level vascularity viability limb may help planning site amputation bypass surgery patients vascular disease study used peripheral pulse oximetry healthy volunteers patients limb ischaemia pulse oximetry saturation levels psa compared ankle artery doppler pressures transcutaneous oxygen measurements ptc recordings taken two standard sites distally referenced finger forearm calculate index significant correlation found ptc psa patients ischaemia r p less group patients acute limb ischaemia similarly assessed revascularization revascularization mean ptc increased mmhg p greater mean psa increased per cent p less data suggest pulse oximetry sensitive index peripheral perfusion ptc ankle artery doppler pressure accuracy simplicity merits use,C14,0.040604524,0.0024191423,0.017636077,0.0015322895,0.03018613,0.022417517,0.22187395,0.0025982363,0.028356412,0.0026950764,0.037498657,0.018811945,0.2506629,0.006511813,0.0023982108,0.004246782,0.121848725,0.0028234425,0.0032163202,0.019558005,0.15832996,0.0009683215,0.0028056193
conservative management asymptomatic popliteal aneurysm historical review shows treatment popliteal aneurysm developed trial error disagreement proper management symptomless patient policy conservative management asymptomatic popliteal aneurysm adopted unit since time also managed nine patients thrombosed popliteal aneurysms arteriography low dose intra arterial streptokinase six patients treated within h occlusion achieved significant per cent lysis streptokinase ineffective treated days thrombosis six patients significant lysis three treated elective reconstruction two anticoagulation one patient significant lysis died vascular patency five successfully treated limbs maintained limb loss occurred presented late failed achieve significant lysis results reinforce view thrombolysis treatment choice thrombosed popliteal aneurysms low complication rate asymptomatic popliteal aneurysms advent safe effective thrombolysis indicate operation symptomless popliteal aneurysm longer required,C14,0.027937092,0.002451485,0.01853023,0.014919073,0.003848279,0.01693513,0.20869732,0.019047044,0.0019979875,0.002715437,0.053279355,0.005684276,0.047981728,0.0063693365,0.002430274,0.0043035597,0.34571925,0.0028460892,0.029900579,0.07561657,0.091589585,0.014357156,0.0028431292
synchronous reconstruction combined aortoiliac femoropopliteal occlusive lesions role proximal bypass january december patients underwent synchronous revascularization sr serious clinical condition lower limb presence arteriographically visible lesions average follow months operative mortality two patient populations identified group n patients underwent ilio femoral aorto femoral proximal revascularization pr group ii n patients axillo femoral pr group patients younger group ii yr versus yr p less association pre operative risk factors arterial hypertension coronary renal respiratory insufficiency twice frequent group ii group p less rate sr compared pr alone however statistically significant difference groups ii comparison actuarial survival curves patients ahd patency rates sr groups ii failed reveal statistically significant differences axillo femoral bypass used pr sr necessary high risk patients,C14,0.023376685,0.0020654239,0.0043445886,0.0013082437,0.025786016,0.0031650357,0.12471835,0.013424545,0.04677065,0.015243047,0.028288309,0.107243836,0.10295336,0.0057258545,0.013095568,0.024470173,0.2389999,0.0023978855,0.0139048295,0.11300797,0.08648757,0.000826737,0.0023953917
severe aortic regurgitation late complication temporal arteritis two patients remote history pathologically documented giant cell arteritis developed severe regurgitation first patient developed severe aortic regurgitation five years pathologic documentation giant cell arteritis temporal arteries giant cell arteritis involvement aortic root confirmed second patient developed aortic regurgitation seven years pathologic documentation giant cell arteries temporal arteries although pathologic confirmation aortic root process obtained case strengthens clinical association giant cell arteritis temporal arteries subsequent aortic root dilatation severe aortic regurgitation observation signs de novo severe aortic regurgitation indicated follow patients temporal arteritis,C14,0.1672322,0.0029674096,0.006241902,0.0018795633,0.004658164,0.06715717,0.15258606,0.0031459199,0.0024184717,0.019476363,0.04511435,0.0068805534,0.020750962,0.09914487,0.019134821,0.00520926,0.24179459,0.003452931,0.0038090667,0.048232578,0.07408355,0.0011877791,0.0034414767
insulin resistance blood pressure young black men insulin resistance independent obesity non insulin dependent diabetes mellitus demonstrated associated high blood pressure determine insulin resistance could antecedent hypertension high risk population studied normotensive mm hg borderline hypertensive mm hg lean young black men years old euglycemic hyperinsulinemic clamp technique subjects clinically normal oral glucose tolerance body mass index percent adipose mass groups fasting plasma insulin concentration significantly higher borderline hypertensive group p less insulin directed exogenous glucose metabolism degree steady state hyperinsulinemia significantly lower borderline hypertensive group versus mg kg min p less total population significant inverse correlation existed glucose infusion rate systolic blood pressure p less data indicate relation insulin mediated glucose uptake blood pressure furthermore high risk population insulin resistance may precede onset established essential hypertension,C14,0.027537948,0.0017007337,0.022175172,0.0010772481,0.0026816148,0.058140226,0.123031765,0.0018030446,0.0013861167,0.011163034,0.016190425,0.033124667,0.2232061,0.0046646534,0.0016860422,0.14722823,0.032388728,0.020979114,0.002183119,0.20145945,0.06353938,0.0006807607,0.0019724392
traumatic rupture aorta diagnosis doppler echocardiography traumatic rupture aorta serious complication accidents mainly road accidents high mortality unless immediate diagnosis surgical correction made case traumatic rupture aorta shown acute phase doppler echocardiography reported technique great value study patients thoracic trauma show clear signs aortic rupture require urgent aortography,C14,0.004515544,0.0040055127,0.008425537,0.0025370999,0.0062877517,0.027680628,0.22547664,0.026095895,0.13438536,0.026291955,0.11262121,0.009287611,0.08843303,0.01038263,0.0039708554,0.050747834,0.09686173,0.0046502617,0.005141611,0.06885905,0.07709351,0.0016033056,0.004645425
everted cervical vein carotid patch angioplasty theoretic benefits autologous vein undertook investigation evaluate cervical veins facial external jugular patch material carotid endarterectomy device stimulated circumferential fixation sutures radial tension exerted vivo patches constructed measure burst strength tissue mean bursting pressure groin saphenous vein n pounds per square inch psi psi ankle saphenous vein n psi everted double layer cervical vein n psi single layer cervical vein n significant differences saphenous vein level everted double layer cervical vein significantly different single layer cervical vein p less june november patients underwent carotid endarterectomies complemented adjunctive everted cervical vein patch angioplasty indications surgery asymptomatic stenosis transient ischemic attack cerebrovascular accident recovery patients studied surgery duplex scanning asymptomatic recurrent stenosis observed one patient transient hypoglossal nerve dysfunction occurred one patient one postoperative death occurred result massive aspiration results indicate everted cervical vein comparable saphenous vein resistance bursting yield similar results patch material carotid endarterectomy accordingly saphenous vein spared lower extremity incisions avoided,C14,0.0022518518,0.012894964,0.0042050714,0.0012652237,0.05761714,0.013805431,0.13904008,0.10022861,0.0016279886,0.013103921,0.08438305,0.015967721,0.1026624,0.005520339,0.0019802218,0.0035066018,0.26000705,0.002329834,0.0025640647,0.030816361,0.14110036,0.0007995508,0.0023221422
experience use coronary autoperfusion catheter complicated angioplasty february july patients underwent use stack autoperfusion catheter following acute occlusion obstructive dissection coronary angioplasty cases conventional balloon used attempt correct angiographic appearance followed use stack catheter results sub optimal patient required surgical revascularization although study prospective randomized observations suggest significant impact decreasing need emergency surgical revascularization complicated coronary angioplasty use approach,C14,0.02474224,0.044035237,0.007906522,0.002380814,0.02639798,0.0062059653,0.19261955,0.024491714,0.0030634408,0.00416348,0.13250236,0.008715492,0.03709256,0.009743057,0.0037262496,0.00659849,0.28473595,0.004363804,0.02241052,0.028992806,0.11924793,0.0015045415,0.004359266
assessment major venous anomalies computerized tomography congenital anomalies major venous structures common identification relative position particularly relation abdominal aortic aneurysm significant value planning conducting aortic operations computed tomography ct become common method preoperative evaluation aortic disease reliability providing accurate information regarding aneurysmal size configuration extension well presence intraluminal thrombus involvement renal iliac arteries demonstrated simultaneous visualization major adjacent venous structures use contrast enhancement obtained anatomic variants overlooked commonly subtle considered incidental preoperative diagnosis venous abnormalities significant vascular surgeon information accurately reliably acquired present ct techniques without need diagnostic studies,C14,0.015519923,0.0023572305,0.017820463,0.0014930746,0.06028658,0.016282612,0.31146103,0.12960331,0.001921169,0.002611034,0.09820537,0.0054657273,0.052377045,0.0062704966,0.0023368348,0.0041380967,0.1120007,0.002736663,0.0030258205,0.049011536,0.07567457,0.00094353984,0.028457206
accelerated arteriosclerosis heart transplant recipients associated lymphocyte mediated endothelialitis accelerated arteriosclerosis emerged major life threatening complication long term survivors heart transplantation proposed accelerated arteriosclerosis immune mediated complication rejection observed striking endothelialitis coronary arteries two explanted hearts obtained patients severe transplant related accelerated arteriosclerosis finding prompted us review pathologic changes coronary arteries autopsied patients received heart transplants infiltrate vessels characterized using immunohistochemical stains lymphocytes cd macrophages mac lymphocytes cd ro b lymphocytes l smooth muscle cells actin addition full panel monoclonal antibodies used fresh frozen tissue available one two explanted hearts ten eleven recipients accelerated arteriosclerosis moderate marked lymphocytic endothelialitis compared without transplant related arteriosclerosis p less immunohistochemical staining paraffin embedded material demonstrated lymphocytes subendothelial space vessels lymphocytes infiltrate associated accumulation macrophages proliferation smooth muscle cells intima explanted heart fresh frozen tissue available detailed cell typing cells marked predominantly cytotoxic lymphocytes cd cd results suggest accelerated arteriosclerosis may mediated part cytotoxic lymphocyte directed endothelialitis,C14,0.026850196,0.034323532,0.015057366,0.012020857,0.0031020178,0.010599436,0.21704178,0.038204055,0.0016103836,0.00218865,0.014093924,0.0049516317,0.08455786,0.07291416,0.012696116,0.0034686814,0.17923732,0.066765316,0.002536337,0.034728635,0.15996167,0.00079090445,0.0022991938
anatomic correlations long axis views biplane transesophageal echocardiography number views obtainable transesophageal echocardiography te limited fixed position transducer end probe confined standard te studies short axis tomography heart aorta recently biplane te probe become available capable long short axis imaging study prospectively assessed application long axis plane biplane probe providing complementary long axis views ambulatory patients six standard long axis views could obtained compared corresponding anatomic sections illustrate anatomic relations facilitate structure identification long axis views provide better appreciation dimensional nature cardiac anatomy function especially demonstrating relation vertically aligned structures,C14,0.0024673124,0.014130465,0.016501091,0.025249416,0.05125506,0.039008565,0.26079562,0.15759163,0.0136254355,0.0024242792,0.04048396,0.0050747897,0.04206129,0.005865916,0.0021696922,0.015782388,0.103984125,0.0025409227,0.002809398,0.070642404,0.098238856,0.00087605295,0.026421301
pharmacologic irreversible narrowing chronic cerebrovasospasm rabbits associated functional damage studied isolated basilar artery segments rabbit model chronic cerebrovasospasm autologous blood placed around basilar artery rabbits killed days later caused narrowing segments biphasic time course first immediate phase reversed intra arterial papaverine second phase exhibited increasing component narrowing papaverine insensitive based passive force length curves basilar artery segments became increasingly stiff days contrast segments contractility decreased responses basilar artery segments greater first days became less saline injected controls contractions response norepinephrine potassium reduced endothelium based acetylcholine induced vasodilation progressively diminished response sympathetic nerve stimulation negative correlation artery wall stiffness contractility papaverine insensitive component angiographic narrowing correlated directly loss contractility artery wall stiffness results consistent conclusion increased artery wall stiffness primary determining factor arterial narrowing chronic cerebrovasospasm,C14,0.04872416,0.0018747377,0.04483329,0.0011874627,0.0029429167,0.0027275204,0.18368633,0.0020029726,0.04243757,0.0020765911,0.015883813,0.050644863,0.09448676,0.009040091,0.0018585167,0.023751216,0.040496387,0.012401724,0.0024064763,0.028288975,0.38532302,0.00075041014,0.002174242
nisoldipine effects renin angiotensin aldosterone system catecholamines studies normotensive hypertensive subjects studied effects nisoldipine new calcium channel antagonist renin angiotensin aldosterone system plasma catecholamines healthy volunteers patients primary essential hypertension patients thirteen normal renin hypertension nrh sixteen low renin hypertension lrh eight healthy volunteers received placebo short term h effects measured subjects long term months effects mg nisoldipine daily monitored hypertensive patients plasma renin activity pra increased slightly although rise statistically significant h first dose nisoldipine normotensive subjects hypertensive patients h pra returned pre treatment level change pra observed administration placebo plasma angiotensin ii aii levels showed considerable variation nisoldipine administration plasma aldosterone levels decreased despite increase pra aii concentrations however concomitant reduction urinary aldosterone excretion observed plasma noradrenaline levels increased slightly h administration nisoldipine decreased thereafter changes plasma adrenaline levels seen nisoldipine long term effects renin angiotensin aldosterone system serum catecholamine levels,C14,0.032472294,0.0018558288,0.077011876,0.0011754858,0.002913233,0.0027000103,0.10906679,0.00196747,0.0015125211,0.0121715395,0.009999719,0.005090765,0.10797058,0.0048579117,0.0018397714,0.0032578905,0.11930391,0.0021549356,0.0226377,0.014085228,0.4630594,0.0007428414,0.002152312
ten year follow survival myocardial infarction randomized coronary artery surgery study coronary artery surgery study cass randomized patients initial strategy coronary surgery medical therapy medically randomized patients surgery within months total surgery years years difference cumulative survival medical vs surgical ns difference percentage free death nonfatal myocardial infarction medical vs surgical ns patients ejection fraction less exhibited better survival initial surgery treatment medical vs surgical p conversely patients ejection fraction greater equal exhibited higher proportion free death myocardial infarction initial medical therapy medical vs surgical p although long term survival remained unaffected medical vs surgical p significant differences either survival freedom nonfatal myocardial infarction whether stratified presence heart failure age hypertension number vessels diseased thus year follow results confirm earlier reports cass patients left ventricular dysfunction exhibit long term benefit initial strategy surgical treatment patients mild stable angina normal left ventricular function randomized initial medical treatment option later surgery symptoms progress survival equivalent patients randomized initial surgery,C14,0.00982435,0.0014929707,0.0031404418,0.00094565074,0.0023436274,0.0021720948,0.120797746,0.0015842686,0.0012167877,0.0016597431,0.007792983,0.004657379,0.057024065,0.004145846,0.009597634,0.0026208966,0.4487005,0.026925651,0.04155779,0.15303664,0.071991324,0.025040135,0.0017314847
nitrous oxide exacerbate pulmonary hypertension ventricular dysfunction patients mitral valvular disease using rapid response thermistor pulmonary artery catheter transoesophageal echocardiography study examined effects per cent oxygen per cent nitrous oxide per cent oxygen per cent nitrogen per cent oxygen pulmonary circulation ventricular function ten patients pulmonary hypertension comparison baseline measurements nitrous oxide administration resulted small statistically significant p less changes mean arterial pressure mean pulmonary arterial pressure mmhg cardiac output l min seventy per cent nitrogen resulted significant changes baseline repeat per cent oxygen measurements nearly identical nitrous oxide measurements concluded nitrous oxide exacerbate pulmonary hypertension ventricular dysfunction high dose fentanyl anaesthesia patients mitral valvular disease,C14,0.16702908,0.0023270992,0.0048986017,0.0014739895,0.003653021,0.0033962422,0.109073535,0.0024670905,0.0018966116,0.0025776585,0.026805278,0.019369453,0.26188207,0.0060633086,0.0023069642,0.068079315,0.15004644,0.0027016816,0.002987143,0.01915373,0.13818134,0.00093147904,0.0026988718
arterial vasodilator effects dihydropyridine calcium antagonist amlodipine alone combination verapamil systemic hypertension arterial vasodilator properties dihydropyridine calcium antagonist amlodipine compared effects vascular muscle cyclic guanosine monophosphate production sodium nitroprusside effects combined infusion amlodipine nondihydropyridine calcium antagonist verapamil untreated patients primary hypertension arterial vasodilation assessed measurement changes forearm blood flow mercury silastic strain gauge plethysmography brachial artery drug infusions forearm blood flow increased amlodipine infusions micrograms min ml forearm tissue maximum ml min ml sodium nitroprusside caused increase ml min ml attesting importance transmembrane calcium influx maintenance vascular tone addition verapamil micrograms min ml infusion amlodipine micrograms min ml resulted increase forearm blood flow ml min ml p less precise mechanisms finding yet elucidated may due interactions effects binding chemically pharmacologically different calcium antagonists distinct binding sites calcium channels clinical relevance observation treatment coronary artery disease systemic hypertension needs study,C14,0.09181377,0.0016546632,0.01709582,0.0010481655,0.0025974482,0.0024073382,0.17260359,0.0017993128,0.010378236,0.001832821,0.008671586,0.0038689654,0.3182278,0.07990948,0.010666012,0.0029191917,0.04306991,0.024846584,0.0021239812,0.012495968,0.187388,0.0006623199,0.0019190087
effect tachycardia regional function transmural myocardial perfusion graded coronary pressure reduction conscious dogs purpose present study examine subendocardial flow function graded coronary pressure reduction determine effect tachycardia lower autoregulatory pressure limit critical coronary pressure unanesthetized dogs atrial pacing rate beats min subendocardial flow measured radioactive microspheres averaged ml min g remained unchanged pressure reduced autoregulatory plateau mm hg reductions coronary pressure critical coronary pressure approximately mm hg associated concomitant reductions subendocardial flow endocardial epicardial flow ratio tachycardia although regional function remained constant autoregulatory plateau rightward shift coronary pressure function relation ischemia response steady state increase rate beats min reductions regional wall thickening began coronary pressures reached mm hg heart rate beats min mm hg heart rate beats min p less similar critical coronary pressure values obtained subendocardial segment shortening relations subendocardial flow myocardial function measured transmural wall thickening subendocardial segment shortening linear pacing heart rate beats min relative reductions wall thickening related reductions subendocardial flow nearly one one basis results study demonstrate shift lower limit subendocardial autoregulation tachycardia manifest onset subendocardial ischemia higher distal coronary artery pressure shift critical coronary pressure relates increase resting flow requirements due increased demand diminished subendocardial vasodilator reserve given coronary pressure secondary reduction time available diastolic subendocardial perfusion tachycardia,C14,0.018517235,0.009052916,0.010600442,0.00088825583,0.0022015038,0.009683268,0.079356365,0.0014867187,0.0011429365,0.009204066,0.016214827,0.019092692,0.349875,0.003635029,0.0013902234,0.017804507,0.04302636,0.0016280881,0.0018001128,0.08641891,0.3147927,0.00056132814,0.0016265019
evolution deep venous thrombosis prospective evaluation us forty six patients diagnosis acute deep venous thrombosis dvt established means duplex ultrasound us prospectively followed serial duplex us examinations month period assess persistence venous abnormalities patients asymptomatic isolated popliteal dvt found likely revert normal duplex compression us thrombosis involving femoral popliteal systems p less increased venous diameter sign acute clot p less clot echogenicity help enable distinction acute dvt chronic dvt compression us patients initially occlusive thrombosis persistent abnormalities mimicked findings consistent acute dvt chronic venous changes persisted months consisted either lumen recanalization resultant intimal thickening persistent venous occlusion conditions result incomplete compression major us indication acute dvt appearance confused acute dvt follow examinations establish baseline appearance obtained early months acute episode dvt,C14,0.013901499,0.0021125192,0.004443653,0.001338074,0.01484386,0.024597049,0.29563433,0.10754716,0.0132475365,0.015232577,0.120601706,0.004898979,0.06779183,0.0056688823,0.013614554,0.015216735,0.15654649,0.002454273,0.002771785,0.04192527,0.072315685,0.0008455881,0.002450011
retrograde recanalization occluded posterior tibial artery using posterior tibial cutdown two case reports recanalization two occluded posterior tibial arteries successfully achieved utilizing retrograde approach via posterior tibial artery cutdown level ankle cases previously unsuccessfully attempted using antegrade approach thus choice access vessel arterial entry site becomes crucial determinant angioplasty success,C14,0.17149533,0.0038622129,0.008079352,0.0024328567,0.006029404,0.04748356,0.21010377,0.0040855277,0.0031304054,0.0042544906,0.09726993,0.009812634,0.027491236,0.009986428,0.0038077028,0.006742728,0.20295548,0.004479522,0.0049303547,0.031073146,0.13449806,0.0015374298,0.004458446
production thrombi intact endothelium use antiheparin agents vivo suggested antithrombin activity surface intact endothelial cells may play role inhibiting platelet adhesion thrombus formation antithrombin activity may due thrombomodulin activation antithrombin iii glycosaminoglycans thrombomodulin possibly combination inhibitory activity shown affected antiheparin agents protamine hexadimethrine bromide polybrene aldrich chemical co milwaukee wis platelet factor well enzymes heparinase heparitinase used hamster cheek pouch preparation observe thrombus formation vivo normal vascular flow determine whether production thrombi thrombin enhanced antiheparin agents intra arterial injection topical application protamine hexadimethrine bromide platelet adhesion thrombus formation intact arteriolar endothelium produced dose thrombin injected alone effect thrombi found venules capillaries injection heparin antiheparin agents necessitated larger dose enhance action thrombin electron microscopy thrombi found consist primarily platelets adherent intact endothelium possible clinical implications observations discussed,C14,0.0026168115,0.0021622842,0.024783345,0.013166427,0.0033985905,0.0031458663,0.29735947,0.018083595,0.0017622856,0.0023950979,0.011987757,0.040408008,0.0285581,0.11562454,0.0021435753,0.027391057,0.02463955,0.029149659,0.0027755809,0.02943963,0.30384955,0.0126515,0.0025077262
delayed detection coarctation infancy implications timing newborn follow recent year period patients younger months age diagnosed coarctation aorta coarctation correctly diagnosed patients prior referral despite readily apparent femoral pulse abnormalities infants whose symptoms detected days age significantly ill infants outside age range high mortality rate number associated cardiac defects related severity clinical illness group suggesting closure ductus arteriosus primary determinate disease severity observations two patients suggested detectable pulse discrepancy occurs days postnatally upper extremity hypertension found commonly infants days age despite presence congestive heart failure earlier detection coarctation newborn requires diligent cardiovascular peripheral pulse examination days life upper extremity lower extremity blood pressure measurement high index suspicion,C14,0.012468637,0.022557214,0.014293525,0.0011999974,0.013233825,0.033581402,0.20611228,0.002008496,0.011880122,0.024385707,0.066141665,0.014733135,0.07182599,0.0053219134,0.0018781349,0.003325825,0.17920989,0.0022026172,0.0024318788,0.2177501,0.09049931,0.0007583313,0.0021999895
diurnal cardiovascular patterns spontaneously hypertensive wistar kyoto rats study designed determine whether diurnal patterns blood pressure heart rate locomotor activity differed among two substrains wistar kyoto rats derived originally charles river taconic farms stock spontaneously hypertensive rat cardiovascular parameters continuously monitored hours resting systolic diastolic blood pressure values statistically different among three groups lights rest lights active phases cycle blood pressure spontaneously hypertensive rats greater wistar kyoto rats taconic farms greater wistar kyoto rats charles river largest difference arterial pressure wistar kyoto taconic farms wistar kyoto charles river lights period heart rates rats decreased lights period wistar kyoto charles river largest decrease beats min wistar kyoto taconic farms least beats min spontaneously hypertensive rats decrease intermediate beats min pronounced diurnal variation pressure heart rate exhibited wistar kyoto charles river present either wistar kyoto taconic farms spontaneously hypertensive rats blood pressure magnitude correlated locomotor activity periods although groups showed minimal activity rest period observed differences wistar kyoto charles river wistar kyoto taconic farms due lack abnormality baroreceptor reflex function,C14,0.0021268104,0.0018370432,0.034559526,0.001163587,0.0028852436,0.0026784264,0.14675915,0.0019488758,0.0014972106,0.002034838,0.010291196,0.02475067,0.3092599,0.004852288,0.0018211483,0.013292651,0.027086867,0.015001112,0.0023580906,0.01909392,0.37182918,0.000735322,0.0021369644
mapping ataxia telangiectasia locus chromosome q region recently mapped gene ataxia telangiectasia group ata chromosome q linkage analysis using genetic markers thy pynb likely order cent thy present paper describes mapping locus means panel markers span approximately cm q region centered around thy location scores indicate three contiguous subsegments within thy segment well three contiguous segments telomeric thy unlikely contain locus centromeric stmy segment likely contain locus data together recent refinements linkage physical maps q place locus q,C14,0.0032923524,0.002920481,0.022058181,0.0018498385,0.0045845034,0.0042489525,0.38368353,0.0030961682,0.0023802242,0.019152978,0.016713422,0.038546167,0.046338633,0.007700559,0.0028952116,0.005126877,0.06734591,0.0033905772,0.0037488276,0.051481083,0.09825081,0.0011689947,0.21002576
estimation post test probability coronary disease following exercise testing using sequential application two bayesian methods recent studies revealed bayesian methods estimate post test probability following exercise testing differ sensitivity specificity across range post test probability take advantage relative strengths method combined two methods single method dual bayes compared two original methods patients underwent stress testing followed within months coronary arteriography patients post test probabilities determined using cadenza better sensitivity cadenza derived probabilities greater equal substituted post test probabilities determined diamond forrester original tabular method better specificity mean post test probabilities follows tabular cadenza dual bayes actual incidence comparison sensitivity specificity every fifth percentile post test probability revealed sensitivity dual bayes better tabular equal cadenza thresholds less equal specificity better cadenza equal tabular thresholds greater equal therefore using methods indicated better using either method alone,C14,0.0018486326,0.01953711,0.03029528,0.0010386712,0.002592454,0.0023857567,0.19192937,0.0017395872,0.0013364791,0.010755623,0.29491404,0.003802284,0.18425713,0.004251734,0.019519588,0.01182376,0.14191322,0.001944512,0.0021049401,0.021814067,0.029734122,0.018553743,0.0019079024
myocardial perfusion imaging technetium sestamibi spect evaluation coronary artery disease technetium tc sestamibi new myocardial perfusion imaging agent offers significant advantages thallium tl myocardial perfusion imaging results current clinical trials using acquisition processing parameters similar tl separate day injection protocol suggest tc sestamibi tl single photon emission computed tomography spect provide similar information respect detection myocardial perfusion defects assessment pattern defect reversibility overall detection coronary artery disease cad detection disease individual coronary arteries tc sestamibi spect appears superior tc sestamibi planar imaging former provides higher defect contrast accurate detection disease individual coronary arteries research currently way addressing optimization acquisition processing tc sestamibi studies development quantitative algorithms detection localization cad sizing transmural nontransmural myocardial perfusion defects expected implementation final results new developments significant improvement image quality attained turn increase confidence image interpretation development algorithms analysis end diastolic myocardial images may allow better evaluation small nontransmural myocardial defects furthermore gated studies may provide valuable information respect regional myocardial wall motion wall thickening implementation algorithms attenuation scatter correction overall specificity tc sestamibi spect improve significantly substantial decrease occurrence attenuation related image artifacts,C14,0.0227363,0.0015061407,0.019560382,0.009057246,0.13681433,0.0021912556,0.33717006,0.0015967455,0.0012275213,0.0016683071,0.13396655,0.012077544,0.07600964,0.003965098,0.0014931088,0.010860809,0.060713433,0.001766401,0.018365404,0.062347576,0.082554825,0.0006028701,0.0017484552
medical management congestive heart failure syndrome congestive heart failure result variety cardiac disorders left ventricular dysfunction common clinical presentation determined interaction cardiac dysfunction series compensatory mechanisms activated throughout body therapy disorder best approached understanding complex relationship appreciation influence preload afterload contractility cardiac performance recent important advances therapy include use combined diuretic therapy better understanding value digitalis glycosides evidence angiotensin converting enzyme ace inhibitors relieve symptoms prolong life intensive therapy earlier course congestive heart failure appears clinical benefit use ace inhibitors phase may delay progression underlying left ventricular dysfunction future therapy influenced results ongoing trials testing new agents expanded indications drugs currently available,C14,0.014687822,0.07563395,0.0048562237,0.0014198938,0.0035189549,0.0032613988,0.44667166,0.002376548,0.0018270058,0.0152059505,0.025834478,0.005197833,0.05647196,0.005931615,0.013376354,0.0161661,0.09340705,0.014829302,0.015110198,0.09808285,0.058169067,0.025363985,0.0025998228
prolonged cardiac preservation evaluation university wisconsin preservation solution comparison st thomas hospital cardioplegic solutions rat university wisconsin solution differs types solutions used organ preservation contains high energy phosphate precursors adenosine phosphate impermeants lactobionate raffinose oncotic agent pentafraction antioxidants allopurinol glutathione components potential enhance preservation atp reduce intracellular extracellular edema attenuate free radical mediated injury university wisconsin solution demonstrated enhance extend preservation liver pancreas kidney potential role heart remains unproven evaluated university wisconsin solution du pont comparing st thomas hospital cardioplegic solutions plegisol used europe united states routine cardiac surgery transplantation solution isolated working rat hearts arrested ml solution degrees c maintained immersed solution hours degrees c mean recovery functional indexes expressed percentage preischemic control values use university wisconsin solution follows peak aortic pressure dp dt aortic flow coronary flow cardiac output contrast mean recoveries st thomas hospital solution follows peak aortic pressure dp dt aortic flow coronary flow cardiac output contrast still mean recoveries st thomas hospital solution follows peak aortic pressure dp dt aortic flow coronary flow cardiac output recovery indexes significantly superior p less preservation university wisconsin solution compared either st thomas hospital solutions,C14,0.03230635,0.0014016405,0.025517583,0.0008878514,0.0098552,0.0020392202,0.120815426,0.05502302,0.0011423525,0.0015536515,0.024581121,0.12647654,0.28689942,0.02722026,0.009013243,0.009484361,0.12197732,0.0016560272,0.0017991929,0.02015385,0.117986456,0.0005610413,0.001648843
inferior vena caval filter thrombi evaluation intravascular us mhz intravascular ultrasound us transducer inside percutaneously inserted catheter used evaluate inferior vena caval ivc filters thrombi vitro vivo six different ivc filters studied intravascular us saline filled model filter characteristic recognizable us pattern experimental thrombi small cm easily detected intravascular us used clinically times evaluate ivc patients ivc filters positive contrast cavograms available comparison cases cases thrombi identified filter ivc either intravascular us cavography five cases thrombi intravascular us cavography demonstrated thrombi equally well six cases intravascular us superior cavography detection delineation thrombus ivc filter intravascular us considered superior external duplex us evaluation caval thrombi cases available comparison complications intravascular us noted,C14,0.0035165518,0.037165955,0.04055353,0.0019758071,0.038984884,0.0045382935,0.13855192,0.003307008,0.0025423104,0.0034552186,0.30597076,0.008686977,0.08147842,0.008110951,0.003092367,0.0054760026,0.12700127,0.0036214653,0.0040041115,0.028767599,0.14433053,0.0012485997,0.003619463
right coronary artery injury tricuspid valve annuloplasty unusual complication tricuspid valve annuloplasty described ring suture ligated right coronary artery precipitated myocardial infarct patient death need caution prevent complication surgery emphasized,C14,0.09226204,0.034054894,0.011093519,0.0033404834,0.0082787955,0.0076728617,0.18268159,0.063154966,0.004298267,0.005841715,0.02734228,0.012228573,0.06398758,0.04242602,0.005228244,0.00925824,0.2858918,0.006122787,0.006769724,0.04926698,0.07057121,0.002110999,0.0061164186
usefulness digital angiography assessment left ventricular ejection fraction modern digital cardiac systems image data digitized line real time allowing replay subsequent interpretation analysis directly cardiac catheterization procedure study evaluated advantages limitations manual tracing technique left ventricular digital angiograms phillips dci system thirty three patients catheterized suspected coronary artery disease studied manual tracings performed senior cardiologist experienced function analyst found short long term intraobserver variabilities assessment global ejection fraction small short term mean difference standard deviation correlation coefficient r global ef units long term r ef units interobserver variabilities r ef units slightly higher intraobserver variabilities decrease amount contrast medium administered significantly influence variabilities contour tracings would suggest use smaller doses average cardiologist function analyst required min analysis time left ventricular study respectively emphasizing need developments towards automated contour detection finally excellent correlation found standard line cinefilm analysis procedure thus may concluded quantitative digital left ventricular angiography based manual tracing outlines performed immediately following cardiac catheterization post processing feasible routine procedure assessment left ventricular function,C14,0.0018164135,0.0016112494,0.038556885,0.009801096,0.011448656,0.0023441762,0.25759792,0.0017081773,0.0013131861,0.0017847329,0.110734314,0.013666053,0.12299024,0.013869355,0.027962152,0.011656512,0.17414996,0.0018706047,0.002068254,0.045287747,0.10127437,0.04461168,0.001876275
white coat versus sustained borderline hypertension tecumseh michigan survey young subjects receiving treatment hypertension tecumseh michigan clinic self monitored blood pressures taken home readings days obtained subjects men women average age years hypertension clinic diagnosed clinic blood pressure exceeded mm hg systolic mm hg diastolic absence firm criteria constitutes hypertension home subjects whose average home blood pressure upper decile whole population considered hypertension home criteria whole population white coat hypertension e high clinic elevated home readings prevalence sustained hypertension e high readings clinic home subjects white coat sustained borderline hypertension tecumseh similar groups showed previous examinations ages years significantly higher blood pressure readings normotensive subjects young adults average age years parents hypertensive groups significantly higher blood pressure readings parents normotensive subjects hypertensive groups faster heart rates higher systemic vascular resistance higher minimal forearm vascular resistance hypertensive groups overweight higher plasma triglycerides insulin insulin glucose ratios normotensive subjects white coat hypertensive group also lower values high density lipoprotein normotensive group white coat hypertension frequent condition,C14,0.085682556,0.0014125082,0.002987319,0.00089468557,0.0022173193,0.002078842,0.06662885,0.0014976109,0.0011512098,0.009265711,0.065631256,0.05660307,0.23086852,0.0036700787,0.0014002866,0.033640042,0.03779495,0.0016398731,0.009516403,0.24930048,0.09538597,0.0005653913,0.040167026
prevalence aortic regurgitation color flow doppler relation aortic root size determine whether correlation aortic root size prevalence aortic regurgitation performed color flow doppler echocardiographic studies consecutive patients month period patients grouped according mode aortic root diameter measured left parasternal position measured groups ranged cm grouped cm intervals aortic root size enlarged prevalence aortic regurgitation increased linearly p less correlation coefficient r aortic root size small normal range cm prevalence aortic regurgitation intermediate top normal ranges cm prevalence aortic regurgitation increased linearly aortic root dilation prevalence aortic root regurgitation generally severity aortic regurgitation semiquantified aortic root size good indicator severity aortic regurgitation patients moderate severe aortic regurgitation variable aortic root sizes throughout range aortic root sizes mild aortic regurgitation predominated conclude aortic regurgitation common finding patients aortic roots dilated top normal size range prevalence aortic regurgitation increases linearly aortic root size aortic root size correlate severity aortic regurgitation,C14,0.0022040315,0.001955086,0.0041124937,0.0012383553,0.026891798,0.0028444172,0.13565747,0.012731355,0.022912774,0.0021655902,0.011945591,0.036543947,0.21417181,0.005186104,0.0019381696,0.003432135,0.27052727,0.0022715793,0.002509614,0.121306725,0.10374918,0.00078257144,0.01292196
alterations endocardial vascular resistance reperfusion low flow high demand model ischemia effects dipyridamole web platelet activating factor antagonist determine alterations regional coronary vascular resistance could occur type myocardial ischemia present severe angina pectoris regional perfusion function studied conscious sedated dogs stenosis producing severe hypokinesia perfused segment created h left anterior descending coronary artery episodes min high demand ischemia atrial pacing rate sufficient induce dyskinesia hypoperfused segment superimposed reperfusion dogs randomized three treatment groups control n dipyridamole n web n antagonist effects endogenous platelet activating factor stenosis residual endocardial blood flow ischemic nonnecrotic area averaged ml min per g control web dipyridamole groups respectively twenty four hours reperfusion endocardial blood flow ischemic area significantly lower control dogs ml min per g dogs treated web ml min per g p less dipyridamole ml min per g p less accordingly control dogs endocardial coronary vascular resistance ischemic area increased reperfusion mm hg ml min per g p less h contrast coronary vascular resistance ischemic area remained unchanged dogs receiving web mm hg ml min per g p ns decreased significantly dogs receiving dipyridamole mm hg ml min per g p less regional function h remained depressed three groups data indicate low flow high demand ischemia induces alterations subendocardial microvasculature alterations regional coronary vascular resistance might play role several forms ischemic heart disease severe angina appear susceptible improvement therapeutic interventions influence granulocyte platelet activation,C14,0.037371587,0.0013701007,0.0028819863,0.00086786103,0.0021507498,0.020453693,0.16415678,0.008927543,0.0011166472,0.0015176196,0.0071127336,0.052546866,0.32924905,0.0042863227,0.001358246,0.010671067,0.10460256,0.009063413,0.0017798988,0.07686088,0.15951587,0.0005484167,0.0015901071
placebo effect heart failure many patients enrolled controlled clinical trials new drugs treatment heart failure show favorable hemodynamic clinical responses placebo therapy placebo effect results creation supportive therapeutic environment spontaneous improvement commonly seen measurements symptoms cardiac function repeated frequently long intervals time three months treatment placebo produces reduction symptoms patients increase cardiac output decrease pulmonary wedge pressure increase exercise tolerance seconds physicians commonly seek maximize placebo effect since goal treatment clinical setting improve quality patient life hand clinical investigators seek minimize placebo effect since goal research study test hypothesis new drug superior placebo,C14,0.02601953,0.013960524,0.004548224,0.0013695626,0.0033942177,0.003157821,0.30634433,0.002292306,0.0017622436,0.002404888,0.024209041,0.04136928,0.03785261,0.005604691,0.0021435241,0.015592525,0.09524273,0.0025102773,0.13126867,0.042085133,0.23349467,0.0008654871,0.0025076664
effect intravenous streptokinase relation initial st predicted size final qrs estimated size acute myocardial infarcts thrombolytic therapy documented reduce acute myocardial infarct size previously established relation initial st segment elevation final electrocardiographic ecg myocardial infarct size patients without coronary reperfusion might therefore altered thrombolytic therapy effect intravenous streptokinase relation therefore studied patients initial acute myocardial infarction participated second international study infarct survival isis patients received streptokinase considered one group patients receive streptokinase control group final myocardial infarct size estimated qrs score predicted admission standard ecg previously developed formulas based st segment elevation control patients change st predicted final qrs estimated infarct size median versus p ns patients streptokinase group highly significant decrease predicted final myocardial infarct size median versus p less decrease found anterior median versus p less inferior median versus p infarct locations multiple regression analysis adjusting differences predicted infarct size confirmed significance streptokinase difference infarct size p based variability percent change predicted final infarct size control group threshold decrease greater equal required identification salvage,C14,0.09404774,0.0015304857,0.0032193537,0.00096941274,0.0024301335,0.0022266747,0.15855679,0.001622555,0.0012473628,0.0016952733,0.10143014,0.05810162,0.1809108,0.0039816587,0.0015172432,0.0026867536,0.19988623,0.0017791529,0.0019645828,0.06628574,0.10317125,0.008962855,0.001776161
bioenergetic recovery processes injured myocardium employed cervically transplanted nonworking myocardium simulate condition heart supported ventricular assist device investigate bioenergetic recovery processes injured myocardium p nuclear magnetic resonance nmr techniques heterotopic graft placed cervical portion recipient rat one week later control p nmr spectrum obtained graft day aorta graft clamped minutes room temperature procedure p nmr measurements graft performed week phosphocreatine pcr inorganic phosphate pi ratio beta phosphate adenosine triphosphate beta atp pi ratio first second day injury significantly lower control p less however ratios recovered significant extent third fourth day results suggest days required bioenergetic recovery reversibly injured myocardium even nonworking conditions,C14,0.017060723,0.016727325,0.005450038,0.0016411168,0.018203638,0.017866706,0.12554316,0.00274682,0.030347707,0.0028699248,0.05496685,0.0060487473,0.18823181,0.0071417117,0.002568538,0.01868322,0.11543216,0.0030080103,0.0033258384,0.04127903,0.28853613,0.0010370943,0.031283643
effects two types fish oil supplements serum lipids plasma phospholipid fatty acids coronary artery disease fish oil consistently shown lower triglyceride levels effects low density lipoprotein ldl cholesterol remain controversial current study compares long term effects different fish oil preparations ethyl ester triglyceride versus olive oil patients coronary artery disease eighty nine subjects randomly assigned receive capsules containing g day triglyceride group g day ethyl ester group n fatty acids capsules containing g day olive oil months mean triglyceride levels decreased ester triglyceride fish oil groups p less ldl cholesterol levels increased difference significant ester p less triglyceride fish oil groups hypertriglyceridemic subjects increase p less difference significant respectively plasma phospholipid fatty acid analysis showed fivefold increase eicosapentaenoic acid levels fish oil groups p less long term decrease arachidonic acid levels p less achieved eicosapentaenoic acid level correlated degree increase ldl cholesterol r p less data suggest fish oil administration associated increase ldl cholesterol levels diverse group patients coronary artery disease change appears correlated n fatty acid absorption impact increase ldl unknown considered potentially adverse,C14,0.0018825888,0.0016699502,0.0035141087,0.010504284,0.0026214453,0.002429579,0.14911613,0.010825993,0.001361028,0.010925479,0.008998971,0.06757979,0.19510144,0.0046058293,0.06540281,0.013331521,0.11546836,0.0019387543,0.0022128776,0.03677955,0.25991523,0.0006684389,0.033145793
sodium calcium interactions salt sensitive hypertension humans essential hypertension salt induced increases blood pressure reported correlate directly salt induced increases intracellular free calcium ca circulating mononuclear cells findings consistent hypothesis salt induced increases ca mediate phenomenon salt sensitivity circumstantial evidence suggests salt induced increases intracellular sodium plasma levels dihydroxy vitamin might mediate salt induced increases ca blood pressure however humans salt sensitive hypertension remains determined whether salt induced increases white blood cell ca reflect corresponding increases vascular smooth muscle ca whether salt induced increases ca cause consequence salt induced increases blood pressure whether salt induced increases dihydroxy vitamin intracellular sodium precede salt induced increases ca,C14,0.024045365,0.0019971612,0.015097264,0.0012650059,0.0031350928,0.002905632,0.16476524,0.002136662,0.012525137,0.002212196,0.010354233,0.0046308315,0.13495132,0.21969472,0.001979881,0.003505998,0.020694124,0.002337589,0.0025636232,0.015592761,0.35049048,0.00079941313,0.0023202843
clues electrocardiographic diagnosis subtle wolff parkinson white syndrome children electrocardiographic diagnosis wolff parkinson white syndrome wpw may missed delta waves subtle children examined electrocardiograms patients proven wpw questionable wpw subtle wpw consecutive electrocardiograms control patients identify additional clues wpw might present three features notable wpw q wave left chest leads pr interval less milliseconds left axis deviation subtle wpw findings similar respectively comparison control subjects q wave pr interval less milliseconds left axis deviation p less coexistence two features common wpw subtle wpw rare control subjects p less pr interval less milliseconds less specific year age patients wpw qrs duration greater milliseconds versus control subjects p less obvious wpw disappeared later patients however left axis deviation lack q wave persisted eight p less conclude diagnosis wpw children even subtle suggested presence four changes preexcitation may persist patients overt delta waves longer present,C14,0.0021576723,0.001913963,0.014426897,0.0012123081,0.0030044904,0.0027845884,0.22103034,0.085587546,0.022449587,0.033457294,0.08933326,0.0045133093,0.20672996,0.005322524,0.022781275,0.0033599446,0.0979484,0.0022220446,0.0024568273,0.06799588,0.08505385,0.000766111,0.0234919
left ventricular dilatation pulmonary thallium uptake single photon emission computer tomography using thallium adenosine induced coronary hyperemia study examined implications left ventricular lv dilatation increased pulmonary thallium uptake adenosine induced coronary hyperemia lung heart thallium ratio initial images significantly higher patients coronary artery disease cad normal subjects vessel disease n vessel disease n vessel disease n normal subjects n p less respectively significant correlation severity extent perfusion abnormality determined polar maps lung heart thallium ratio r respectively p less also significant correlation lung thallium washout lung heart thallium ratio r p peak heart rate r p less lv dilatation mostly due increase cavity dimension increase lesser extent increase due increase lv size cavity dimensions measured short axis slices midventricular level initial delayed images dilation seen patients cad normal subjects changes correlated extent severity thallium perfusion abnormality thus adenosine induced coronary hyperemia may cause lv dilation increased lung thallium uptake basis subendocardial ischemia,C14,0.015194639,0.0016546127,0.0034804533,0.001048035,0.022459961,0.052705366,0.1652316,0.012610941,0.0013485276,0.019871468,0.009297439,0.0038460535,0.33380967,0.0044747307,0.0016402963,0.057081677,0.08546332,0.0019217785,0.0021239165,0.037571806,0.14652403,0.018720705,0.0019189501
compensation overcompensation congestive heart failure compensatory mechanisms develop response heart failure well defined review argued compensatory mechanism leads overcompensation way distinguish beneficial aspects former harmful effects latter therapeutic agents maintain rather decrease blood pressure might perhaps beneficial crucial role hypotension initiating compensation overcompensation,C14,0.005069277,0.053563494,0.009458745,0.0028482198,0.0070588076,0.031072907,0.41667587,0.0047672093,0.0036648617,0.004980862,0.02351723,0.010426533,0.096481375,0.014161627,0.004457794,0.007893918,0.09029693,0.0052205147,0.030299857,0.033182748,0.13788623,0.001799916,0.005215085
role magnetic resonance contrast agents cardiac imaging improvements magnetic resonance imaging mri technology allow adequate spatial temporal resolution capture cardiac anatomy contractile function exceptional detail little risk however tissue characterization pathophysiologic state myocardium may require special indicators mr contrast agents must tailored detection mri process available agents effective low dose provide wide range indicator properties e g myocardial extracellular space blood pool capillary permeability membrane transport agent dynamic washin washout time intensity curve may reflect myocardial perfusion consequences ischemia combined use mri mr contrast agents may provide single diagnostic examination fully quantitatively assesses indexes cardiac performance information would global regional would well tolerated patients cost value cost effectiveness studies remain speculative,C14,0.0022276812,0.023537857,0.036414165,0.0012516433,0.046232786,0.01364943,0.34753618,0.0020949384,0.0016105144,0.012926409,0.059461363,0.015324013,0.08718611,0.005513906,0.023523062,0.014248409,0.09465713,0.0022941423,0.0025365427,0.07216146,0.12175618,0.011560614,0.0022954335
evaluation methods detecting venous reflux perspectives venous insufficiency using limbs nonobstructive venous reflux evaluated number techniques used assessment venous reflux venous doppler examination found reliable screening tool excellent sensitivity good specificity photoplethysmography sensitive patients ambulatory venous hypertension however milder forms reflux less sensitive major drawback photoplethysmography large number false positive results obtained ambulatory venous pressure measurement another pressure based technique valsalva induced foot venous pressure measurement defined overlapping different normal abnormal limbs descending venography performed described kistner et al found reliable tool assess reflux sensitivity horizontal technique performing descending venography nucleotide descending venographies unacceptably low sensitivity abandoned features venous reflux outlined modern technical tools described,C14,0.0139059825,0.0021127998,0.061898034,0.012856132,0.049554262,0.0030738725,0.16856128,0.1060136,0.03630226,0.0023402853,0.16346502,0.004898964,0.11168793,0.0068973755,0.002094519,0.0037090008,0.11722604,0.016637405,0.014088887,0.021776512,0.077599645,0.00084570044,0.0024544531
effects dopamine myocardial functional recovery reversible ischemic injury dopamine frequently used improve cardiac performance acute myocardial ischemia inotropic agents however increase myocardial oxygen demand could potentially delay recovery ischemic injury evaluate problem studied eight chronically instrumented dogs conscious state performed two minute coronary occlusions hours apart one occlusions either dopamine micrograms kg min saline placebo administered intravenously hours reperfusion alternative infusion given second study preload recruitable work area area beneath stroke work versus end diastolic length relationship used assess intrinsic myocardial performance ischemia decreased preload recruitable work area control occlusions reperfusion minute dopamine infusion acutely increased myocardial function nearly threefold compared placebo myocardial performance dopamine administration however significantly depressed compared placebo throughout remaining hours reperfusion p less data indicate dopamine may impair functional recovery ischemic myocardial injury suggest inotropic interventions used setting absolutely indicated,C14,0.065090604,0.001716812,0.0036112885,0.0010874323,0.0026950077,0.016108096,0.15518846,0.0018200902,0.0013992208,0.011267832,0.011261383,0.0041753836,0.21503851,0.0044514826,0.0017019574,0.012500421,0.086198516,0.011350268,0.035413686,0.10760703,0.24763824,0.0006871965,0.0019910864
prevalence symptoms raynaud phenomenon general practice objective investigate prevalence raynaud phenomenon populations five general practices design two populations studied questionnaire given new patients attending five general practices four weeks questionnaire sent post random sample adults two practices setting general practices inner london merseyside cheshire subjects patients completed questionnaires attended surgeries response rate unknown respondents postal survey response rate main outcome measures response questionnaire symptoms raynaud phenomenon patients regarded disease episodes blanching fingers precipitated cold accompanied sensory symptoms pins needles numbness subsequent interview clinical appraisal patients disease according responses questionnaire results prevalence raynaud phenomenon respectively men women completed postal questionnaire respectively completed questionnaire attending general practice thus overall rates slightly higher women effect age even adjustment rates practice method survey conclusion prevalence raynaud phenomenon high compared low number patients seek treatment disease,C14,0.0020105971,0.0017835001,0.013461718,0.0011296725,0.012497118,0.0026560726,0.24691914,0.00189079,0.0014535723,0.0019881732,0.038424112,0.014687079,0.08582803,0.004681022,0.0017680684,0.003130918,0.12659732,0.0020705818,0.10931485,0.21014436,0.11478099,0.00071389,0.0020684283
effects nitroprusside transmitral flow velocity patterns extreme heart failure combined hemodynamic doppler echocardiographic study varying loading conditions explore mechanisms change left ventricular diastolic filling associated preload afterload reduction influence nitroprusside transmitral flow velocity pattern pulmonary capillary wedge pressure left ventricular pressure interaction studied patients end stage heart failure pulsed doppler echocardiographic recordings mitral inflow obtained simultaneous high fidelity left ventricular phase corrected pulmonary capillary wedge pressure recordings levels nitroprusside infusion nitroprusside left ventricular systolic end diastolic pressures decreased p less p less respectively cardiac output increased p less pulmonary capillary wedge left ventricular crossover pressure decreased p less time constant isovolumetric left ventricular pressure decrease insignificantly changed isovolumetric relaxation time acceleration deceleration times early diastolic filling wave significantly prolonged nitroprusside infusion p less p less p less respectively peak early diastolic filling velocity maintained cm p ns spite decreased absolute crossover pressure changes peak early diastolic filling velocity correlated weakly changes crossover pressure r p less correlated better crossover left ventricular minimal pressure difference r p less peak early diastolic filling velocity appears affected early diastolic pulmonary capillary wedge left ventricular pressure difference rather absolute pulmonary capillary wedge pressure lack peak flow velocity change nitroprusside infusion could explained either associated decrease left ventricular minimal pressure downward shift left ventricular diastolic pressure amount decrease pulmonary capillary wedge pressure may reflect reduction external constraint ventricular distensibility produced reduction filling volume patients markedly dilated ventricle thus prolonged early diastolic filling period preserved peak early diastolic filling velocity spite decreased left ventricular filling pressure constant relaxation rate associated beneficial effects nitroprusside left ventricular function patients severe congestive heart failure,C14,0.00918035,0.013082445,0.0023124984,0.0006963402,0.0017257556,0.0067245094,0.15210636,0.0011654997,0.006870474,0.0012177342,0.0064033824,0.0025684491,0.37649032,0.0030270559,0.0010898531,0.007980653,0.115674905,0.001276325,0.0014111822,0.010832205,0.20445012,0.0724386,0.0012749976
echocardiographic definition left ventricular centroid ii determination optimal centroid systole normal infarcted hearts although two dimensional echocardiography widely used clinical experimental evaluations regional cardiac wall motion established clinical method quantitative analysis wall motion even normal radial motion observed short axis images measurement radial wall motion requires determination centroid radii emanate depending definition centroid variously affected throughout systole cardiac translation regional wall motion shift subject position transducer floating centroid defined relative ventricular walls frame frame whereas fixed centroid never moves respect transducer evaluation best approach definition centroid previously presented part issue next question use centroid study examines four centroid applications provides best reference quantifying regional wall motion systole method floating centroid defined separately every image frame method uses end diastolic centroid fixed reference image frames method uses end systolic centroid fixed reference method uses average fixed reference wall motion measured respect centroids determining radial wall motion end diastole end systole correlating radial motion throughout cardiac cycle normal control hearts,C14,0.013912832,0.0017010969,0.040688444,0.0010774782,0.08622188,0.011742061,0.2125387,0.013480622,0.010647946,0.0018842543,0.09658526,0.003957952,0.14813863,0.0044919727,0.0016863783,0.021543983,0.09419824,0.0019766195,0.02074296,0.08729652,0.1135477,0.009961892,0.00197661
flow patterns dilated cardiomyopathy pulsed wave color flow doppler study patients dilated cardiomyopathy pulsed wave color doppler examination performed addition normal patients served control subjects peak inflow velocity level mitral valve middle left ventricle apex outflow velocity level apex middle left ventricle subaortic area measured normal patients brisk propagation inflow velocity apex patients dilated cardiomyopathy demonstrated delayed propagation prolongation duration inflow compared control subjects p less continuous apical flow visualized dilated cardiomyopathies normal patients apical velocities significantly increased cardiomyopathies significant mitral regurgitation outflow velocities decreased dilated cardiomyopathy patients dilated cardiomyopathy apical dyskinesis flow directed toward base measured middle left ventricle isovolumic relaxation secondary dyskinetic rebound patterns abnormal flow dilated cardiomyopathies readily apparent color mode two dimensional color doppler,C14,0.0023865649,0.0021170022,0.0163792,0.0013409135,0.0033235545,0.01398061,0.09624726,0.0022443545,0.024813356,0.013895248,0.052021127,0.0049320017,0.27485618,0.0055968226,0.025073381,0.0037163778,0.18080631,0.0024591857,0.0027174552,0.038993634,0.21725862,0.0008473825,0.013993448
balloon rupture due lesion morphology coronary angioplasty report case coronary angioplasty left anterior descending artery lesion complicated rupture three successive balloon catheters rupture occurred pinhole jet contrast diagonal side branch causing subintimal staining case demonstrates balloon rupture may result lesion morphology,C14,0.062216032,0.031348214,0.010212174,0.0030750928,0.08729233,0.007063277,0.29164928,0.031641025,0.003956783,0.0053776093,0.10872246,0.0112570515,0.034735173,0.038853355,0.004812876,0.008522702,0.053079586,0.0056363507,0.006231891,0.037155125,0.09663077,0.001943287,0.058587555
long term outcome surgical repair isolated atrial septal defect follow years background atrial septal defects surgically correctable years long term survival rates among patients treated early era cardiac surgery poorly documented data critical importance future medical care employability insurability patients methods determine natural history surgically corrected atrial septal defects studied patients underwent repair isolated defect ostium secundum sinus venosus mayo clinic years procedure follow status patients determined written questionnaires telephone interviews hospital records death certificates obtained interim hospitalization death occurred results overall year actuarial survival rate among survivors perioperative period percent compared percent among controls matched age sex perioperative mortality percent four deaths actuarial year survival rates among patients younger two quartiles according age operation less equal years years different rates among controls percent percent respectively two older quartiles years greater years year survival rates significantly less p less percent percent respectively controls percent independent predictors long term survival according multivariate analysis age operation p less systolic pressure main pulmonary artery operation p less repair performed older patients late cardiac failure stroke atrial fibrillation significantly frequent conclusions among patients surgically repaired atrial septal defects operated age excellent prognosis older patients require careful regular supervision,C14,0.014346609,0.0076968228,0.0027384616,0.0007550751,0.034362286,0.0017739562,0.062381446,0.0012638073,0.0009715702,0.0013204475,0.03689712,0.01112987,0.12743999,0.0031496086,0.024538675,0.002093687,0.45050701,0.0013839804,0.0015302126,0.1804147,0.031444956,0.0004771653,0.001382541
exercise thallium scintigraphy diagnosis prognosis coronary artery disease objective determine discriminant accuracy exercise thallium myocardial perfusion scintigraphy diagnosis prognosis patients known suspected coronary artery disease data identification survey national library medicine medline database study selection key medical subject headings used coronary disease myocardial infarction radionuclide imaging thallium total retrieved studies considered relevant reviewed depth data extraction studies reporting sensitivity specificity thallium scintigraphy analyzed results discriminant accuracy diagnosis prognosis summarized terms pooled sensitivity specificity conclusions exercise thallium scintigraphy useful noninvasive diagnosis coronary artery disease especially patients abnormal resting electrocardiograms restricted exercise tolerance intermediate probability disease time testing well defining prognosis patients known suspected coronary artery disease especially previous myocardial infarction various shortcomings published record however marginal discriminant accuracy cost effectiveness thallium scintigraphy compared conventional clinical assessment exercise electrocardiography remain controversial,C14,0.0021808501,0.05472311,0.0040692403,0.022330083,0.01359077,0.0028145008,0.31409568,0.002050898,0.0015766576,0.012662543,0.15279652,0.0044855922,0.09293584,0.005014448,0.0019178479,0.0033960373,0.11216365,0.0022459142,0.023586746,0.07870876,0.089623466,0.00077434065,0.0022565378
hemodynamic effects new right ventricular assist device right ventricular assist device vad based principle counterpulsation developed institution device valveless pneumatically actuated cc sac type pump single inlet outlet port right ventricular support uniport pump anastamosed end side pulmonary artery previous experimental trials device shown impart minimal trauma blood components study biventricular failure induced eight holstein calves normothermic ischemia cardiopulmonary bypass pierce donachy left vad lvad used left ventricular support following ischemic insult hemodynamic measurements obtained throughout study animal served control significant increase post injury cardiac output obtained use uniport lvad compared use lvad alone p less equal hemodynamic parameters right heart failure including right atrial pressure rap pulmonary artery pressure pap left atrial pressure lap significantly affected data suggest uniport right ventricular assist device significantly improves cardiac output model moderate right ventricular failure additional studies required however optimize pump stroke volume define performance envelope device,C14,0.13562807,0.0685955,0.013226772,0.010901708,0.0027467585,0.0025481493,0.20116393,0.030502139,0.0014260892,0.001938178,0.020883415,0.033669718,0.13754314,0.0045682653,0.0017346392,0.0030743775,0.08718422,0.0020314327,0.011794009,0.051139794,0.16541879,0.010247072,0.0020338357
early late results isolated coronary artery bypass surgery patients aged years older studied patients years age older isolated coronary artery bypass grafting cabg since eighty seven percent surgery since two thirds patients male mean age years patients new york heart association nyha functional class iii iv unstable postinfarction angina pectoris rest pain almost half required preoperative admission coronary care unit required preoperative use intra aortic balloon pump operated emergently significant left main coronary artery disease greater equal stenosis present ten patients died within days surgery seven patients dying hospital admission soon transfer another institution resulted overall hospital mortality median hospital stay days univariate analysis significant predictors hospital mortality nyha iv angina rest preoperative admission coronary care unit emergency operation ejection fraction less presence mitral regurgitation multivariate analysis ejection fraction less significant risk factor p less hospital survivors followed mean months estimated year survival sem patients hospital survivors important predictor adverse survival ejection fraction less seventy nine percent angina free nyha classes ii majority patients felt improved surgery conclude cabg patients years older although associated increased operative risk gives excellent relief symptoms good year survival patients denied cabg age alone,C14,0.009284251,0.0014125969,0.0029713765,0.008502407,0.0022174586,0.0020551605,0.11463663,0.009195448,0.0011512821,0.0015731932,0.020882096,0.011579914,0.069272794,0.0039539877,0.016810015,0.002479801,0.4808954,0.001639976,0.001813257,0.17826252,0.049499884,0.008272259,0.0016382704
vitro vivo testing new valved intravascular catheter design long term intravascular catheterization carries finite risk catheter occlusion catheter tip valve design presented buchwald wigness strato medical corporation beverly incorporates features designed decrease risk thromboembolism reduce need maintenance procedures aspiration infusion controlled separate valves making possible engineer optimized inlet outlet parameters outlet valve elastic sleeve expanded around sidewall outlet ports opens injection pressure inlet valve tubular elastic element compressed inlet port within lumen opening aspiration pressure series valves prototyped outlet pressures ranging h inlet pressures ranging h flowrates h greater ml hr dog implants two prototypes outlet valve pressures h inlet pressures h demonstrated dormant periods weeks could achieved without detectable blood cell entry lumen significant hemolysis observed blood samples aspirated cc syringe scored slightly hemolyzed vs nonvalved controls indicating hemodialysis application likely,C14,0.024100808,0.0019977523,0.05867293,0.0012653804,0.0031364104,0.0029179314,0.15095142,0.0021179311,0.0016281903,0.0022128508,0.08666493,0.026766883,0.17972626,0.027006583,0.001980467,0.014446445,0.21722202,0.0023241532,0.0025643823,0.09140664,0.09777308,0.0007996498,0.0023169091
impact field transmitted electrocardiography time hospital thrombolytic therapy acute myocardial infarction assess impact field transmitted electrocardiogram ecg patients possible acute myocardial infarction randomized open trials performed portable electrocardiographic system coupled cellular phone programmed automatically transmit ecgs base hospital consecutive patients served units salt lake city emergency rescue system studied patients randomized field ecg n versus ecg n time scene minutes ecg group versus minutes non ecg group difference significant time transport averaged minutes respectively difference significant six patients field ecg showed acute myocardial infarction qualified received thrombolytic therapy minutes hospital arrival range compared minutes p less historical control patients minutes concurrent control patients without field ecg thus field ecg causes negligible delays paramedic time leads significant decreases time hospital thrombolysis may make field therapy feasible field ecg may important addition reperfusion strategies,C14,0.002180164,0.0019339141,0.014616747,0.0012249452,0.0030358091,0.0028136151,0.24648517,0.0020502526,0.0015761615,0.023234047,0.010639718,0.03526677,0.19645004,0.00501994,0.012464875,0.0036456704,0.19935592,0.0022452073,0.13904856,0.026944352,0.06675114,0.000774097,0.0022428723
dose dependent reduction myocardial infarct size perfluorochemical fluosol da perfluorochemical fluosol da shown reduce infarct size however dose response relationship agent unknown perfluorochemicals pfc potentially saturate reticuloendothelial system decrease carbon clearance well cause transient elevation liver enzymes present study conducted determine lowest effective dose new zealand white rabbits n randomly selected prior infarction receive ml kg pfc equivalent volume dextran control intravenously animals underwent minutes coronary artery occlusion pfc dextran infused minute period starting minutes occlusion animals put death hours infarct size determined histologically quantitated computerized planimetry neutrophil infiltration ischemic myocardium evaluated semiquantitatively hemodynamic differences noted within groups infarct size similar controls animals treated ml kg pfc significant infarct size reduction however noted animals treated ml kg pfc versus controls p respectively maximal infarct size reduction seen ml kg pfc neutrophil infiltration significantly decreased groups treated pfc results show intravenous fluosol da significantly reduces infarct size minimal dose ml kg,C14,0.07909892,0.0015698444,0.0033021444,0.0009943426,0.0024643017,0.0022839368,0.1399296,0.01878923,0.01841205,0.0017388698,0.008500607,0.05005511,0.19082956,0.0041423305,0.0015562614,0.013447198,0.07158021,0.010367518,0.002015105,0.0181532,0.35832068,0.00062836905,0.0018206395
substance p acetylcholinesterase beta endorphin levels plasma pericardial fluid patients without angina pectoris measured substance p like immunoreactivity spli beta endorphin like immunoreactivity beli acetylcholinesterase activity total protein content pericardial fluid plasma patients angina pectoris patients angina pectoris spli beli levels acetylcholinesterase activity total protein content determined radioimmunoassay colorimetric method method lowry et al j biol chem respectively pericardial fluid patients angina spli beli acetylcholinesterase total protein values fmol mg protein fmol mg protein units mg ml respectively patients angina spli beli acetylcholinesterase total protein values fmol mg protein fmol mg protein units mg ml respectively spli levels significantly higher p less acetylcholinesterase less total protein content less significantly lower pericardial fluid patients angina compared patients angina beli levels significantly different two groups plasma significant differences found spli beli acetylcholinesterase total protein values two groups patients patients angina spli beli acetylcholinesterase total protein values fmol mg protein fmol mg protein units mg ml respectively,C14,0.002180057,0.0019338195,0.035724856,0.0012248852,0.0030356606,0.0028134773,0.04483361,0.0020501523,0.0015760843,0.0021420342,0.032757834,0.026374668,0.3389802,0.00518286,0.0019172691,0.0033948023,0.117018305,0.1394498,0.0024823158,0.016056508,0.215854,0.0007740591,0.0022427624
cardioprotective effects carnitine extensive aortocoronary bypass grafting double blind randomized placebo controlled clinical trial cardioprotective effects carnitine tested patients undergoing multiple aortocoronary bypass grafting intermittent aortic cross clamping degrees c used mean total cross clamping time min patients randomized three groups control group receiving placebo group group pretreated g carnitine intravenously cardiopulmonary bypass cpb group group pretreated g carnitine intravenously group markers myocardial ischemia included levels adenosine triphosphate catabolites creatine phosphate transmural left ventricular biopsy specimens taken beginning end cpb well hemodynamic recovery weaning cpb next h intravenous infusion carnitine g hemodynamic effect end cpb myocardial tissue levels adenosine triphosphate creatine phosphate differ significantly among groups p greater recovery cardiac function weaning cpb following h similar three groups p greater concluded pretreatment carnitine neither facilitates weaning cardiopulmonary bypass patients undergoing aortocoronary bypass surgery favorably affects hemodynamic function next h,C14,0.0022521794,0.0019977957,0.004204244,0.0012654078,0.0031360886,0.02469806,0.11991441,0.013009735,0.0016282256,0.0022128986,0.03267883,0.1407313,0.22521771,0.0052338284,0.0019805478,0.0035123115,0.13443138,0.0023193716,0.054079466,0.028089177,0.18339011,0.01169996,0.0023169592
time delays diagnosis treatment acute myocardial infarction tale eight cities report pre hospital study group cincinnati heart project establish magnitude prehospital hospital delays initiating thrombolytic therapy acute myocardial infarction time telephone emergency medical system ems activation treatment components analyzed eight separate ongoing trials included estimates ambulance response time prehospital evaluation treatment time time admission hospital initiation thrombolytic therapy average time ems activation patient arrival hospital prospectively determined minutes patients eight centers time admission hospital initiation thrombolytic therapy retrospectively determined minutes separate group patients six centers prehospital hospital time delays much longer perceived paramedics emergency department directors shorter hospital time delays observed patients prehospital ecg obtained part protocol driven prehospital diagnostic strategy diagnosis acute infarction made arrival hospital minutes patients results show magnitude time required evaluate transport initiate thrombolytic therapy preclude initiation treatment patients within first hour symptoms implementation protocol driven prehospital diagnostic strategy may associated reduction time thrombolytic therapy,C14,0.0018996274,0.0016850643,0.012737447,0.0010673231,0.0118399095,0.002451568,0.22622164,0.0017864326,0.019744568,0.050449487,0.08719512,0.022300072,0.069349796,0.004393114,0.010860014,0.0029581147,0.2943761,0.020345317,0.011357742,0.04417962,0.10016807,0.00067448866,0.0019593798
intracoronary adenosine administration reperfusion following hours ischemia effects infarct size ventricular function regional myocardial blood flow previous studies demonstrated adenosine significantly enhances myocardial salvage minutes regional ischemia determine effect prolonged ischemia closed chest dogs underwent hours left anterior descending artery occlusion followed hours reperfusion intracoronary adenosine mg min ml min total volume ml n equivalent volume saline ml min total volume ml n infused left main coronary artery first minutes reperfusion regional myocardial blood flow assessed serially microspheres regional ventricular function assessed contrast ventriculography infarct size determined histologically light electron microscopy utilized assess neutrophil infiltration microvascular injury adenosine failed reduce infarct size expressed percentage area risk versus p ns improve regional ventricular function measured radial shortening method versus p ns hours reperfusion vasodilatory effects observed endo midmyocardial regions ischemic zone adenosine administration associated similar extent capillary endothelial changes neutrophil infiltration adenosine treated saline control groups results suggest severe functional abnormalities present vasculature hours ischemia adenosine therapy ineffective enhancing myocardial salvage,C14,0.056091994,0.0014348945,0.010834771,0.00090886507,0.0022526325,0.0025197829,0.07429629,0.040661193,0.008990535,0.0015893899,0.033860397,0.025752582,0.3086053,0.011741585,0.0014225077,0.011965567,0.10374316,0.009474315,0.0018418789,0.073221736,0.208698,0.008390404,0.0017022025
comparison standard one minute treadmill exercise strandness test absolute walking distance relation site lesion walking distance diastolic blood flow velocity doppler curves outpatients suffering occlusive arterial disease lower limbs authors compared decrease ratio ankle systolic pressure brachial systolic pressure according whether treadmill exercise limited one minute extended pain forced patient stop one minute walk pressure index always decreased significantly especially walking restricted decrease pressure index generally greater exercise continued absolute walking distance recovery time usually twice long fall pressure index significantly greater patients single multiple iliac stenoses stenoses lower levels patients diastolic blood flow velocity doppler curves rest modified walking maximum drop peripheral pressure recorded walking one minute instance intensification decrease peripheral pressure unlike patients without diastolic blood flow velocity rest one minute test maximal hemodynamic response sufficient appreciation ischemia exercise according different parameters measured,C14,0.0020030672,0.019365637,0.0034190859,0.0010295562,0.011421344,0.0023648199,0.09796945,0.00172322,0.036797725,0.0018004499,0.057954308,0.0037689353,0.4609028,0.004213275,0.0016113746,0.020550074,0.077060565,0.001894299,0.010938699,0.04107677,0.13959642,0.000650622,0.0018874966
cardioplegia induced damage ischemic immature myocardium independent oxygen availability known benefits hypothermic pharmacological cardioplegia protecting ischemic adult heart may extend children protection ischemic immature rabbit heart hypothermic krebs henseleit bicarbonate buffer better hypothermic st thomas ii cardioplegic solution investigated whether availability oxygen preischemic perfusate responsible increased tolerance ischemia immature day old hearts perfused krebs buffer comparison st thomas ii solution immediately ischemia obtaining preischemic control data working mode perfused hearts n per group minutes hypothermic degrees c krebs buffer hypothermic st thomas ii solution saturated oxygen followed hours global ischemia degrees c hearts reperfused minutes langendorff mode minutes working mode recovery function measured preischemic oxygen concentrations recovery aortic flow hearts protected hypothermia alone ischemia preischemic values respectively hearts protected hypothermia plus cardioplegia values respectively thus equal oxygen concentrations recovery postischemic function better hearts protected hypothermia alone compared hypothermia plus cardioplegia conclude factors oxygen availability responsible damaging effect st thomas ii solution ischemic immature rabbit heart,C14,0.0020920706,0.001855771,0.034372717,0.0011754491,0.002913142,0.0026999263,0.089863345,0.012084028,0.0015124739,0.012183307,0.010985821,0.06627194,0.27790803,0.0053753513,0.0018397141,0.0032611284,0.109396845,0.0021544858,0.0023821301,0.13023028,0.19511573,0.0007428183,0.033583503
percutaneous popliteal approach angioplasty superficial femoral artery occlusions angioplasty using percutaneous popliteal approach utilized patients pts recanalize occluded superficial femoral arteries unsuccessfully canalized using antegrade approach either flush origin occlusion inability maintain guide wire true lumen pts claudication rest pain non healing ulcers laser probe used cases rotablator cases occlusion length varied cm lesions less cm group cm group greater cm group angiographic success obtained lesions groups group three pts needed complementary common femoral endarterectomy one required percutaneous aspiration thromboembolus complications included arterial perforation dissection without clinical sequelae popliteal hematoma pt one patient severely ischemic leg underwent successful emergency vascular surgery another limb salvage patient required knee amputation worsening limb ischemia popliteal approach attempt discharge patients whose outcome would unsuccessful traditional antegrade approach clinically improved utilizing popliteal approach achieve successful angioplasty procedure,C14,0.06390148,0.022198524,0.003986657,0.0012004633,0.03485139,0.0031244152,0.16600369,0.002023391,0.04205788,0.012435204,0.052331325,0.0701346,0.097102374,0.0050450754,0.0018788641,0.0033946286,0.2831252,0.0022003343,0.002432823,0.072065674,0.055549346,0.0007586258,0.0021980458
prognostic value radionuclide angiography medically treated patients coronary artery disease comparison clinical catheterization variables evaluate usefulness multiple measures rest exercise radionuclide angiography rna predicting cardiovascular death cardiovascular events death nonfatal myocardial infarction assess prognostic usefulness rna relative clinical catheterization data studied stable patients symptomatic coronary artery disease upright rest exercise first pass rna within months catheterization medically treated median follow years patients died cardiovascular causes patients either died suffered nonfatal myocardial infarction using cox regression model preselected group rna variables important rna predictor mortality exercise ejection fraction chi p less neither rest ejection fraction change ejection fraction rest exercise contributed additional predictive information two rna study variables change heart rate rest exercise rest end diastolic volume index contribute additional prognostic information exercise ejection fraction chi p less compared noninvasive clinical data history physical examination electrocardiogram chest radiograph rna variables considerably predictive mortality chi clinical variables versus chi rna remarkably strength relation rna variables mortality equivalent set catheterization variables previously demonstrated large angiographic population prognostically important chi rna versus chi catheterization variables rna contained information provided clinical catheterization descriptors combined furthermore rna contributed significant additional prognostic information clinical catheterization data chi p cardiovascular events relative prognostic usefulness rna similar although relations outcome generally weaker descriptors rest exercise rna exhibit powerful relation long term outcomes useful defining risk even clinical catheterization data available,C14,0.0011102261,0.04383283,0.012774868,0.0006216727,0.0015477411,0.006739108,0.2571158,0.0010405249,0.0007999187,0.0064332797,0.033311862,0.007846362,0.11079579,0.0026415184,0.038455244,0.0445004,0.18136469,0.006489509,0.0012980768,0.12088424,0.03967124,0.00039286245,0.08033221
putative mechanism blood pressure reduction induced increases dietary calcium intake increase dietary calcium intake lowers blood pressure spontaneously hypertensive rats patients arterial hypertension mechanisms decrease come clear membrane stabilizing effect wrought increase extracellular calcium would appear unlikely since increases extracellular calcium concentration increased dietary intake minimal calcium regulatory hormones may mediators cybernetic framework suggested striking defects reported calcium handling hormonal household spontaneously hypertensive rat however clear cut relationship terms hormonal template yet identified prospective experiments data presented show increased calcium intake direct effect regulatory areas brain however mechanisms response would mediated entirely unknown increased calcium intake may induce natriuresis suggested increased calcium intake helps salt sensitive however prospective studies effect presented increased calcium intake may induce phosphaturia however evidence blood pressure lowering effects mediated phosphate depletion unconvincing evidence suggests increased calcium intake may influence local regulatory processes turn influences cell integrity growth point unifying hypothesis available however clues various possibilities intriguing,C14,0.020816468,0.01595871,0.010131791,0.00084894884,0.0027538633,0.020379607,0.16195762,0.0014209285,0.0010923594,0.009123138,0.02438471,0.018671775,0.074144326,0.13488963,0.0013287032,0.002354183,0.035258103,0.0015687593,0.0017359583,0.161373,0.29040745,0.007845596,0.0015544236
improved survival reduced myocardial necrosis cardiopulmonary bypass reperfusion canine model coronary occlusion cardiac arrest study question cardiopulmonary bypass cpb improve resuscitation rates limit infarct size cardiac arrest acute myocardial infarction design controlled randomized trial animals undergoing left anterior descending coronary artery occlusion subsequent ventricular fibrillation resuscitation animals supported four hours resuscitation intensive care setting intervention group eight resuscitated standard external cpr advanced life support group eight resuscitated cpb measurements main results group hemodynamic resuscitation variables number resuscitated number four hour survivors compared ischemic necrotic myocardial weights determined histochemical staining techniques four hour survivors infarct size measured ratio necrotic weight ischemic weight significantly fewer dogs resuscitated group four eight group eight eight p less group survivors required significantly less epinephrine lidocaine group survivors p less higher aortic diastolic coronary perfusion pressures cpb p less ratio myocardial necrotic weight ischemic weight four hours group group p less however collateral blood flow measured study conclusion pilot study substantiates improvement resuscitation rates obtainable cpb cpb may also limit infarct size postresuscitation period requires study,C14,0.044371355,0.0015564747,0.011731411,0.0009858742,0.0024433143,0.0027254797,0.1284519,0.018633574,0.0012685441,0.0017240606,0.009303014,0.08483989,0.31229293,0.0041745743,0.0015430074,0.002732377,0.16899088,0.0018070132,0.01854781,0.09209156,0.087356836,0.0006230175,0.0018051339
diagnostic value new myocardial perfusion agent teboroxime utilizing rapid planar imaging protocol preliminary results corrected republished original paging article originally printed j coll cardiol oct technetium labeled agents advantages thallium terms photon statistics cost clinical availability suggested alternative thallium myocardial perfusion imaging teboroxime new boronic acid adduct technetium dioxime bato compound demonstrates favorable characteristics preliminary studies use novel seated patient positioning technique rapid dynamic acquisition protocol patients underwent planar imaging teboroxoime rest maximal treadmill exercise postexercise scans completed average time mean sd min min views rest results compared coronary arteriography thallium scintigraphy treadmill exercise diagnostic agreement abnormal versus normal present patients p less regarding physiologic assessment compared thallium scintigraphy finding infarction ischemia concordant patients respectively report describes initial use teboroxime rapid dynamic planar imaging technique resulting high correlation exercise thallium scintigraphy delayed postexercise images obtained min exercise demonstrated rapid disappearance exercise induced defects noted initial min postexercise views rapid differential washout teboroxime previously described possible clinical significance discussed,C14,0.0018825402,0.029009536,0.04027678,0.0010577225,0.058287874,0.002429516,0.2969216,0.01999092,0.01047032,0.020055356,0.08445042,0.014632871,0.13499236,0.014167792,0.0016554582,0.012441173,0.13556938,0.011110026,0.0021435488,0.0392522,0.066596314,0.0006684216,0.0019378375
pathogenesis hyperadrenergic orthostatic hypotension evidence disordered venous innervation exclusively lower limbs pathogenesis hyperadrenergic orthostatic hypotension studied eight patients correction abnormal orthostatic changes inflated pressure suit mast confirmed previous evidence excessive gravitational pooling blood leg veins intravenous l norepinephrine infusion raised diastolic blood pressure relationship infusion induced increments plasma norepinephrine concentrations normal subjects indicating normal arteriolar responses contractile responses veins infused l norepinephrine measured linear variable differential transformer lvdt venous responses hand veins patients fell within confidence limits responses normal hand veins responses foot veins seven normal subjects however foot veins patients hyperadrenergic orthostatic hypotension hand foot veins patients diffuse autonomic failure supersensitive norepinephrine reflected steeper slope regression log norepinephrine infusion rate percentage reduction venous distensibility significantly lower ed e norepinephrine infusion rate induced reduction venous distensibility findings suggest anatomical functional postganglionic denervation lower limb veins causing excessive gravitational blood pooling consequent orthostatic hypotension patients,C14,0.0020106442,0.011516239,0.0037516535,0.0011296989,0.0027997585,0.0025948412,0.12436543,0.12842643,0.0014536063,0.0019755762,0.020696647,0.014392872,0.24054687,0.025545169,0.0017681099,0.027264118,0.085471705,0.0020788535,0.0022894142,0.05157777,0.24556218,0.0007139067,0.0020684768
functional significance myocardial perfusion defects induced dipyridamole using thallium single photon emission computed tomography two dimensional echocardiography mechanisms responsible inhomogeneous myocardial blood flow oral administration large dose mg dipyridamole assessed patients serial thallium single photon emission computed tomography spect simultaneous dimensional echocardiograms myocardial tomographic images obtained minutes hours administration dipyridamole two dimensional echocardiograms recorded baseline every minutes minutes dipyridamole caused mild reduction blood pressure mm hg mild increase heart rate beats min sixteen patients perfusion defects dipyridamole spect underwent partial total filling fourteen patients either new abnormality deterioration preexisting wall motion abnormality dimensional echocardiography thus considered developed transient ischemia dipyridamole administration ten patients normal perfusion fixed defects spect deterioration wall motion oral dipyridamole thus considered evidence myocardial ischemia conclusion patients transient thallium defects dipyridamole develop transient worsening resting wall motion dimensional echocardiography suggestive true myocardial ischemia myocardial oxygen demand indicated heart rate blood pressure product change significantly mechanism myocardial ischemia patients likely diminished regional blood flow related subendocardial steal induced dipyridamole,C14,0.001889232,0.0016401146,0.0034499567,0.0010388519,0.049016315,0.0023861716,0.22223274,0.0017387789,0.026528597,0.001816706,0.041611478,0.003802961,0.28854874,0.0043365504,0.0016259447,0.002879206,0.12631002,0.0019044046,0.0021053064,0.03397779,0.17860152,0.00065649644,0.0019021359
ischaemic left ventricular failure evidence sustained benefit months treatment xamoterol long term effects treatment xamoterol patients aged mild moderate heart failure result ischaemic heart disease reported months treatment xamoterol patients assessed randomised double blind crossover comparison xamoterol mg twice day placebo given one month compared placebo xamoterol significantly increased exercise duration work done bicycle ergometer reduced maximum exercise heart rate assessment symptoms activities months visual analogue likert scales showed trend towards relief symptoms breathlessness tiredness improvement activity improvement clinical signs heart failure haemodynamic deterioration month period assessed ejection fraction improvement exercise tolerance symptoms activities sustained months without side effects development tolerance,C14,0.014822229,0.051178258,0.0047153747,0.001419895,0.0035189579,0.0032614016,0.2907755,0.0023765499,0.0018270073,0.01740144,0.011661128,0.018005414,0.10474734,0.0062242993,0.0022223003,0.0039352775,0.17102145,0.0026025318,0.03957479,0.092589214,0.14039107,0.013128736,0.002599825
bradyarrhythmia heart transplantation incidence time course outcome june april adult recipients orthotopic heart transplantation developed prolonged greater hours bradyarrhythmias less beats min within days transplantation junctional bradycardia occurred recipients sinus bradycardia slow ventricular response atrial fibrillation four fifty five patients bradyarrhythmias less days duration less days patients days five patients fifty patients returned sinus rhythm greater beats min time discharge five patients expired within days seventeen patients bradyarrhythmia days symptomatic patients junctional bradycardia patients sinus bradycardia four patients received permanent pacemaker within days transplantation months mean months pacemaker implantation patients recovered sinus rhythm greater beats min five patients intrinsic rates beats min mean beats min months mean months follow donor ischemic time bradyarrhythmia patients minutes significantly longer p less minutes patients without bradyarrhythmia conclusively incidence posttransplantation bradyarrhythmia relatively high usually temporary however even patients prolonged duration bradyarrhythmia relation appears exist donor ischemic time incidence bradyarrhythmia,C14,0.0019539404,0.0017332425,0.0036458499,0.0010978393,0.012163955,0.011938719,0.099296704,0.0018375091,0.0014126119,0.011374932,0.008985953,0.014386429,0.15120788,0.004492712,0.0017182458,0.0030426914,0.47928503,0.020923525,0.0022248484,0.089646116,0.074927315,0.0006937732,0.0020101417
digitalis like activity human plasma relation blood pressure sodium balance purpose assumption renal tubular cells important target cells natriuretic factor blood cells used well characterized cultured renal tubular cell line madin darby canine kidney mdck cells monitor circulating digitalis like factor human plasma examine role regulation blood pressure sodium balance subjects methods investigated effects plasma binding radioactive ouabain monolayered mdck cells order determine level circulating digitalis like factor first measured specific h ouabain binding mdck cells presence plasma outpatients normotensive subjects hypertensive patients incubation hours second measured specific h ouabain binding incubation cells plasma hospitalized subjects eight normotensive subjects eight hypertensive patients receiving low high sodium diets results study ouabain binding lower plasma hypertensive patients plasma normotensive subjects p less significant negative correlation individual subject systolic mean blood pressure ouabain binding r p less r p less study ouabain binding also significantly reduced presence plasma hypertensive subjects compared plasma normotensive subjects irrespective sodium intake p less significant negative correlation also found subjects either systolic diastolic mean blood pressure ouabain binding r p less r p less r p less respectively changes low high sodium intake corresponding decrease ouabain binding p less increase sodium excretion p less significant negative correlation observed two parameters r p less conclusions findings suggest circulating digitalis like factor may act renal tubular cells ouabain displacing compound increased patients essential hypertension also demonstrate plasma levels may influenced changes dietary sodium intake,C14,0.0011959412,0.001060792,0.007982452,0.00067190785,0.0016664289,0.0015433262,0.1919814,0.001124606,0.0008645572,0.0011750077,0.030305017,0.011465977,0.28840643,0.11351356,0.0010516136,0.0076413173,0.036847547,0.01280652,0.0013616683,0.054604802,0.23106943,0.00042460827,0.0012350831
angioplasty occluded coronary arteries use thin shaft balloon wire system without pre dilatation retrospective review done consecutive patients underwent ptca totally occluded coronary arteries using recently released thin shaft balloon wire angioplasty system balloon size determined closest fit arterial size used without predilatation techniques technique initially successful patients clinically insignificant episodes distal embolization one probable early reclosure using thin shaft angioplasty systems balloon dilatation totally occluded coronary arteries done safely single balloon many cases resulting simplified procedures economic benefits,C14,0.07489337,0.0032873207,0.0069148303,0.0020821956,0.0052604675,0.004782661,0.27592713,0.003485076,0.002679203,0.0036412673,0.08862917,0.007622334,0.04569395,0.008521015,0.0032588774,0.0057708616,0.30986506,0.0038164656,0.0042197155,0.061248846,0.073263235,0.0013158314,0.0038210887
chronic calcium channel blockade prevents progression myocardial contractile electrical dysfunction cardiomyopathic syrian hamster programmed onset myocardial dysfunction progression congestive heart failure cardiomyopathic syrian hamster hallmarked alterations myocellular calcium regulation determine whether calcium channel blockade effective halting progressive depression myocardial contractile performance animal model congestive heart failure oral verapamil therapy instituted days age treatment continued various durations time study either days age left ventricular papillary muscle isometric isotonic performance well transmembrane electrical characteristics depressed diseased hamsters days age deteriorated days age changes evidenced prolongation contraction duration marked depression load velocity relation significant prolongation repolarization phase transmembrane action potential myocardial functional electrical alterations associated progression life myopathic hamsters completely halted verapamil therapy continuous days birth death diastolic arrest days age however premature termination verapamil treatment death resulted progressive renewal functional electrical alterations duration drug termination concluded pathological changes seen lifetime cardiomyopathic hamster prevented continuous calcium channel blockade intermediate prevention attained protracted verapamil therapy thus chronic verapamil therapy may useful adjunct prevention human congestive heart failure similar etiology,C14,0.001712449,0.09270364,0.0125370985,0.00096215523,0.002384531,0.03536679,0.21812488,0.0016104078,0.009527428,0.009970058,0.008390097,0.0035268073,0.12296762,0.0144502325,0.0015205519,0.019999778,0.0767136,0.034889307,0.0023436584,0.13801537,0.18161842,0.008895325,0.0017697985
hemodynamic status critically ill patients without acute heart disease physicians urged reduce use pulmonary artery catheter however guidelines help clinician make decision use withhold invasive monitoring individual patient study designed examine accuracy physician estimates cardiac function spectrum patients hemodynamic instability determine whether differences accuracy among subgroups would suggest subgroups patients could managed without invasive measurements physician estimates cardiac index found sufficiently accurate patients without acute heart disease initial management without invasive monitoring may appropriate selected cases however due general inaccuracy physician estimates efforts improve accuracy clinical judgments cardiac function hemodynamic status pursued vigor patients without acute cardiac dysfunction,C14,0.025651798,0.002064741,0.015838262,0.0013078111,0.0032411776,0.0032520166,0.25888768,0.0021889494,0.012945779,0.002298509,0.17818376,0.0051488774,0.07841051,0.005479502,0.002046876,0.037421107,0.18847468,0.0023970928,0.024848403,0.07726341,0.06942795,0.0008264636,0.0023945996
sensitivity set myocardial infarction screening criteria patients anatomically documented single multiple infarcts subset screening criteria q wave greater equal ms lead avf q r wave less equal ms less equal mv lead v r wave greater equal ms v proposed identify single nonacute myocardial infarcts cumulatively criteria achieved specificity sensitivities inferior anterior myocardial infarcts respectively among patients identified coronary angiography left ventriculography study establishes true sensitivities set screening criteria patients anatomically proven single myocardial infarcts patients multiple myocardial infarcts single inferior infarct group avf criterion sensitive v criterion q r wave less equal ms less equal mv sensitive single anterior infarct group single criterion proved sensitive identifying posterolateral infarct set screening criteria performed well multiple infarcts single infarcts cumulative sensitivity overall sensitivity screening set patients groups,C14,0.096521154,0.0017328253,0.07963077,0.0010975751,0.002761454,0.040285062,0.0715523,0.011291749,0.010814617,0.001919399,0.31124383,0.032836746,0.124911666,0.004503962,0.0017178322,0.0030419591,0.124806926,0.0020256524,0.0022833056,0.012879032,0.040521454,0.019606065,0.002014651
recanalization chronic totally occluded coronary arteries new angioplasty systems benefit safety new angioplasty equipment compared conventional guidewire approach evaluated consecutive patients chronic totally occluded coronary arteries protocol followed stepwise design first conventional guidewires low profile balloons used followed balloon wire systems probe ace shaft enforced tip deflecting catheter omniflex patients occlusions weeks duration recanalization achieved patients conventional approach patients new devices balloon wire n omniflex n thereby raising success rate occlusions greater weeks duration recanalization attempt successful mediated patients omniflex catheter patients balloon wire systems life threatening complications emergency bypass operation necessary new angioplasty devices therefore considerable value attempt improve results coronary angioplasty chronic total occlusions,C14,0.06002147,0.05952241,0.015939625,0.001338018,0.0033160402,0.0033298277,0.25768015,0.002239508,0.0017216544,0.013856247,0.08341875,0.004898108,0.048496462,0.0070052464,0.0020942604,0.003708353,0.3211616,0.0027106213,0.0027115874,0.023712898,0.07782167,0.0008455527,0.0024499083
discrepancies measurement isovolumic relaxation time study comparing mode doppler echocardiography mitral valve cusp separation mode echogram mitral valve opening artefact onset forward transmitral flow recorded doppler echocardiography taken mark end isovolumic relaxation onset taken either aortic closure sound recorded phonocardiographically aortic closure artefact determined doppler technique possible differences measurement isovolumic relaxation time studied landmarks used healthy people patients mitral stenosis patients left ventricular hypertrophy patients dilated cardiomyopathy recording mode echograms mitral valve pulsed continuous wave doppler spectra transmitral flow simultaneous electrocardiograms phonocardiograms effectively synchronous aortic artefact however onset doppler flow regarded end isovolumic relaxation interval significantly longer mitral cusp separation mode echograms used ms healthy individuals ms patients left ventricular hypertrophy ms patients dilated cardiomyopathy patients mitral stenosis interval ms longer mitral valve opening artefact consistently followed onset flow corresponded much closely e point mode echogram shows occurred rapid filling period well beyond isovolumic relaxation definition thus isovolumic relaxation time measured onset transmitral flow mitral valve opening artefact differs derived mitral valve cusp separation intervals cannot used interchangeably measure isovolumic relaxation time,C14,0.0019536915,0.0017330218,0.0036675544,0.0010976995,0.012165909,0.0025213405,0.20302838,0.031291645,0.048685174,0.049209163,0.025424238,0.0040347925,0.1770954,0.00462295,0.011154555,0.003042304,0.17955367,0.0020234736,0.021125093,0.037512094,0.10745227,0.019607965,0.05199761
circulating heart reactive antibodies patients myocarditis cardiomyopathy corrected republished original paging article originally printed j coll cardiol oct heart reactive antibodies commonly observed patients myocarditis cardiomyopathy antibodies may important pathogenesis disorders yet specific antigens recognized studied systematically report characterizes circulating heart autoantibodies patients myocarditis n idiopathic cardiomyopathy n healthy volunteers n indirect immunofluorescence demonstrated high titer greater equal immunoglobulin g igg antibody activity occurred myocarditis samples cardiomyopathy samples none normal samples samples tested western immunoblotting igg activity normal human heart extract number antigens recognized sample enumerated molecular weight antigen estimated prevalence reactivity antigens selected molecular weight classes determined difference mean number heart antigens recognized serum group weight classes prevalence either differ significantly among various groups subgroups greatest among samples healthy volunteers prevalence reactivity kilodalton kd antigens greatest p less among low titer serum samples patients myocarditis high titer cardiomyopathy serum differed normal serum increased p less prevalence antibodies kd antigens results suggest western immunostaining may ultimately contribute substantively identifying patients myocarditis cardiomyopathy,C14,0.001754977,0.0015567521,0.0032746051,0.00098605,0.0024439143,0.0022648892,0.19408083,0.0016504016,0.0012687703,0.001724368,0.10705792,0.02321308,0.12688704,0.16561157,0.018530942,0.011207489,0.07868629,0.0018330909,0.0019982995,0.06745075,0.15703107,0.009116724,0.02037018
subaortic obstruction intraoperative echocardiography adjunct operation fourteen patients undergoing operation subaortic obstruction membranous obstruction patients tunnel obstruction patients obstruction due reduplicated mitral valve tissue patient evaluated intraoperative epicardial echocardiography patients discrete obstruction underwent prebypass epicardial echocardiography septal lateral attachments lesion correctly demonstrated precise extent tunnel stenosis seen patients lateral attachment membrane patients multiple extensions another identified epicardial study missed precordial echocardiography discrete membrane enucleated patients partially resected one tunnel obstruction completely relieved partially relieved reduplicated mitral valve tissue remaining patient completely resected epicardial imaging bypass showed remnants membrane patients intraoperative doppler echocardiography color flow imaging confirmed absence clinically significant residual gradients less mm hg patient tunnel obstruction epicardial imaging provided excellent morphological information obstructive lesions left ventricular outflow tract enabled immediate assessment surgical repair,C14,0.025586741,0.0018387422,0.033971492,0.041235562,0.06321673,0.022156361,0.10327769,0.02201694,0.0014985952,0.0020367198,0.03595711,0.014261439,0.032540504,0.005107371,0.021836001,0.023285834,0.4574821,0.0021799363,0.0023602713,0.014362858,0.060890313,0.01076822,0.0021324959
clinical controversies surrounding thrombolytic therapy acute myocardial infarction treatment acute myocardial infarction changed tremendously past decade thrombolytic therapy become treatment choice patient acute myocardial infarction although many issues resolved several controversial issues remain unresolved article addresses thrombolytic agents terms superiority achieving infarct vessel patency mortality reduction well role thrombolysis patients present chest pain greater hours duration elderly inferior infarction,C14,0.025263065,0.0038374697,0.0080720605,0.002430661,0.006023962,0.005583062,0.38406754,0.0040866197,0.0031275803,0.025156388,0.019895269,0.008897969,0.055007044,0.0099470485,0.0038042662,0.0067366427,0.13255729,0.004455169,0.067747526,0.10337542,0.11394133,0.0015360422,0.004450536
selection patients acute myocardial infarction thrombolytic therapy purpose critically review current recommendations regarding eligibility patients myocardial infarction thrombolytic therapy data identification relevant studies published january january identified computerized search english language literature using medline manual search bibliographies identified articles study selection randomized controlled trials intravenous thrombolysis acute myocardial infarction unstable angina reviewed smaller observational studies previous review articles included relevant discussion data extraction key data extracted article including proportions patients eligible thrombolysis reasons exclusion thrombolytic therapy clinical outcomes patients treated excluded treatment validity certain exclusion criteria examined using subgroup analysis large randomized mortality trials intravenous thrombolysis observations smaller nonrandomized studies results data synthesis date relatively patients myocardial infarction considered eligible fibrinolytic therapy group early late mortality significantly reduced patients excluded thrombolysis however continue high early mortality data suggest potential benefits treatment might extended selected high risk subgroups particular risk benefit ratio may favor inclusion otherwise healthy elderly patients certain patients presenting hours onset symptoms patients history controlled systolic hypertension brief nontraumatic cardiopulmonary resuscitation data support use fibrinolytic therapy primary treatment patients unstable angina suspected myocardial infarction absence confirmatory electrocardiographic changes conclusions full potential thrombolytic therapy alter natural history acute myocardial infarction realized continued evaluation selection criteria identification treatment greatest possible number eligible patients,C14,0.007956209,0.0011998768,0.015561213,0.007295325,0.014967944,0.001745678,0.4106297,0.0012720576,0.0009779128,0.021485157,0.036549516,0.0428942,0.06933706,0.0031452654,0.014277046,0.015163684,0.11338921,0.014475081,0.031176731,0.12717114,0.040796146,0.00048028035,0.008053525
similar frequencies renin gene restriction fragment length polymorphisms hypertensive normotensive subjects prospective study conducted compare frequency renin gene polymorphisms normotensive hypertensive subjects hypertensive n blood pressure mm hg normotensive n blood pressure mm hg subjects white similar age sex distributions hypertensive group years old female normotensive group years old female similar body mass index hypertensive group normotensive group kg p familial susceptibility hypertension defined least one parent one sibling hypertensive age subjects normotensive group familial history hypertension renin gene polymorphisms located throughout renin gene identified using three restriction enzymes taq hinfi hindiii polymorphic restriction site allele frequencies similar hypertensive normotensive groups absence parental genotypes haplotype frequencies combining three restriction fragment length polymorphisms estimated using maximum likelihood techniques similar groups hypertensive group normotensive group three common haplotypes rare haplotype detected taq hind iii apparently frequent hypertensive normotensive group hypertensive group th th normotensive group th th difference statistically significant conclusion association renin gene polymorphisms essential hypertension demonstrated present study,C14,0.03488428,0.0015974053,0.004273041,0.0010117998,0.0025077648,0.0023513366,0.11601994,0.0104069,0.0100175645,0.0017693982,0.07330065,0.122417524,0.15788937,0.004148907,0.018095752,0.0028042302,0.02984657,0.011118918,0.0020504831,0.093197465,0.18194976,0.00063940097,0.11770154
caliber persistent artery stomach dieulafoy vascular malformation caliber persistent artery stomach also known cirsoid aneurysm dieulafoy lesion submucosal arterial malformation clinically manifested recurrent massive often fatal hematemesis lesion often seen endoscopically left gastric angiography one patient hematemesis showed convoluted ectatic artery gastric fundus proved caliber persistent artery stomach pathological examination tortuosity abnormal vessel condition attributed artefactual contraction stomach following excision formalin fixation first reported case pathologically proven lesion clearly visualized angiography demonstrates submucosal vessel truly artifactually sinuous proposed angiographic demonstration nontapering convoluted artery territory left gastric artery highly suggestive caliber persistent artery stomach,C14,0.111032665,0.00248666,0.005243467,0.0015750554,0.058253992,0.017182818,0.24252434,0.15472396,0.0020266552,0.0027543989,0.12982556,0.0057658358,0.017467255,0.006457645,0.0024651443,0.0043653087,0.061912507,0.0028869258,0.0031919603,0.078299366,0.08567634,0.0009953472,0.002886742
analysis randomized trials evaluating effect cholesterol reduction total mortality coronary heart disease incidence primary aim study estimate relation cholesterol reduction total mortality coronary heart disease chd incidence secondarily clinical issues whether efficacy cholesterol lowering dependent treatment modality presence chd baseline simultaneous introduction interventions explored randomized clinical intervention trials cholesterol reduction used overview analysis total mortality rate chd incidence analysis performed weighted linear regression trials include used primary secondary intervention diet drugs single multifactor design nineteen trials analyzed total mortality analyzed chd incidence rate net difference cholesterol change study groups used independent variable three previously mentioned dichotomous design characteristics used additional independent variables every reduction cholesterol estimated reduction chd incidence indicated cl regard chd drug trials tended toward better efficiency cholesterol lowering dietary trials regard total mortality efficiency higher secondary primary preventive trials efficiency also somewhat dependent baseline cholesterol level study shows cholesterol reduction effective lowering chd incidence cholesterol reduction must least effective lowering total mortality,C14,0.0014175639,0.00809463,0.030059097,0.0007964714,0.0019739128,0.0018354561,0.2701446,0.0013330943,0.0010248356,0.0013928398,0.045724303,0.010813653,0.059296098,0.010711101,0.07023623,0.0022090394,0.02907381,0.0014598558,0.06930245,0.2413128,0.139815,0.0005033254,0.0014698124
cardiac transplantation female emery dreifuss muscular dystrophy young woman humeroperoneal muscular dystrophy contractures received heart transplant severe dilated cardiomyopathy cardiac histopathology consisted myocyte hypertrophy interstitial fibrosis nuclear hyperchromaticity without mitochondrial abnormalities myopathy heart disease clinically evident family although three relatives unexplained shortened achilles tendons without weakness tendon contractures may partial expression myopathic disorder suggesting autosomal dominant inheritance variable penetrance muscular dystrophy clinically similar emery dreifuss edmd type thus occur women rather cardiac arrhythmias typical edmd dilated cardiomyopathy may occur present severe congestive heart failure first report cardiac transplantation case,C14,0.0031532312,0.033194136,0.021071725,0.0017655197,0.004375309,0.03446569,0.27823713,0.033359345,0.063110344,0.003087322,0.029256979,0.061926834,0.030615302,0.024984175,0.002763105,0.0048929416,0.20831586,0.0032358675,0.0035777711,0.08907986,0.04597434,0.0011156544,0.018441515
hemopump ventricular support patients undergoing high risk coronary angioplasty prophylactic implantation hemopump johnson johnson skillman nj evaluated nine patients selected high risk coronary angioplasty unstable patients refractory maximal pharmacology indications revascularization contraindications surgery low ejection fraction lack material bypass target lesion located last patent vessel pump inserted local anesthesia without graft specially designed occluder permitted avoidance retrograde bleeding implantation bypass flow ranged l min permitted rise cardiac index l min drop capillary wedge pressure mmhg balloon inflation electrocardiographic changes observed minor ventricular arrhythmias occurred significant hemolysis seen plasma free hemoglobin less mg dl hr pumping limitation technique appears difficulty time implantation narrow stenosed tortuous iliofemoral arteries patients experience strongly supports benefit temporary left ventricular hemopump support high risk situations clearly shows need smaller pump,C14,0.013009737,0.012753981,0.013914815,0.0012516263,0.013885188,0.015662022,0.15576011,0.0020985152,0.023166008,0.002188798,0.012514934,0.080058865,0.13150139,0.005122058,0.0019589402,0.025668403,0.23022524,0.01307253,0.0025365085,0.10001621,0.10822987,0.022348342,0.0130559085
magnitude time course beta adrenergic antagonism oral amiodarone therapy examine presence time course beta adrenergic antagonism produced amiodarone heart rate qt interval arrhythmia frequency response graded doses isoproterenol evaluated eight patients treated oral amiodarone sustained ventricular tachycardia measurements made every days beginning oral amiodarone therapy mg twice daily isoproterenol given doses ng kg body weight per min mean heart rate rest decreased beats min day beats min days amiodarone therapy significant linear decline heart rate rest observed day p less comparisons days isoproterenol produced progressive increase heart rate reached beats min day beats min day amiodarone blunted heart rate increase produced isoproterenol days p less versus day effect present day change significantly thereafter mean corrected qt qtc interval increased ms day ms day significant linear increase qtc interval observed day p less comparisons systematic effect isoproterenol qtc interval five eight patients significant number isoproterenol induced premature ventricular complexes ventricular ectopic activity response isoproterenol abolished days amiodarone therapy,C14,0.0017258904,0.0098646395,0.019714378,0.0093159545,0.0024032479,0.010576015,0.12361669,0.0016230483,0.001247742,0.0016957887,0.008118386,0.029651612,0.18058169,0.0043061175,0.0015177045,0.019520389,0.17951794,0.010706706,0.0019651803,0.028493714,0.35144883,0.000612801,0.0017755325
complement activation use cell saver cardiopulmonary bypass complement activation evaluated ten patients undergoing cardiopulmonary bypass cpb intraoperative blood salvage cell saver cs assess inflammatory response related cs washed red blood cell concentrate reinfused protamine injection plasma c measured radioimmunoassay preoperatively min cpb min cpb min protamine infusion end surgery hr addition clinical score based renal pulmonary neurologic myocardial postoperative evolution given every patient results compared c changes clinical scores obtained routine cs cardiac surgical patients results showed maximal c generation protamine activation cases cs concentrate reinfusion ranged ml ml difference clinical score observed cs control groups authors conclude cs enhance complement activation resulting extracorporeal circulation safely used blood saving strategy cardiac surgery,C14,0.013125401,0.001997595,0.0042019114,0.0012652808,0.013958945,0.0029322717,0.14803348,0.0021177642,0.0125258295,0.0022126765,0.058577135,0.099688284,0.23080765,0.038856205,0.001980311,0.003519681,0.1756986,0.045924585,0.0025641802,0.0296255,0.107270434,0.0007995868,0.0023167266
prospective evaluation protocol induction sustained ventricular tachycardia patients referred tertiary centre eight stages stimulation protocol used one two extrastimuli right ventricular apex sinus rhythm three ventricular drive rates beats min performed patients recurrent spontaneous sustained ventricular tachycardia despite drug treatment twenty two patients sustained previous myocardial infarct long term treatment amiodarone sustained greater ventricular tachycardia induced patients two extrastimuli significantly likely induce sustained ventricular tachycardia one extrastimulus overall individually three ventricular drive rates ventricular drive rate beats min significantly likely induce ventricular tachycardia ventricular drive rates beats min significantly effective sinus rhythm ventricular drive rate beats min one two extrastimuli induced ventricular tachycardia patients study full eight stage protocol progressive separately extrastimuli ventricular drive rate last two stages ventricular drive rate beats min one two extrastimuli effective entire protocol inducing ventricular tachycardia,C14,0.026654376,0.0022146446,0.004658472,0.0014027603,0.015561546,0.016179284,0.16594999,0.0023478707,0.09847703,0.0024530957,0.026736647,0.00513574,0.08586833,0.005891151,0.0021954824,0.01596766,0.31324643,0.0025711255,0.002842792,0.057952877,0.14223781,0.00088646624,0.0025684515
systolic hypertension elderly reasons treat isolated systolic hypertension elderly associated increased morbidity mortality accurate measurement blood pressure older patients difficult therapy associated various complications special problems elderly orthostatic hypotension hyperkalemia carefully considered drugs used low doses changes dosage made infrequently patients monitored frequently untoward effects therapy benefits blood pressure reduction optimal degree blood pressure reduction remain unknown,C14,0.035160758,0.0029201491,0.006176725,0.0018496284,0.0045839758,0.0042484696,0.28896695,0.0030958166,0.0023799539,0.0032345622,0.032822914,0.022702204,0.22648959,0.0075747655,0.0028948828,0.021059563,0.0997461,0.003390192,0.0037484018,0.12863016,0.093768686,0.001168862,0.003386666
efficacy acebutolol acute myocardial infarction apsi trial apsi investigators randomized placebo controlled trial carried determine effectiveness acebutolol preventing late death high risk patients surviving acute myocardial infarction mi average year mortality rate placebo groups trials beta blockers post mi patients compared nonselected cohort patients survived least days mi mandate trial based fact high risk patients whose mortality rate exceeds enrolled significant numbers previous trials remains proved whether beta blocking therapy patient population beneficial selection high risk patients inclusion trial based algorithm set essai de prevention secondaire de l infarctus du myocarde registry time second interim analysis mortality rate placebo group lower expected greater equal trial stopped time patients allocated placebo patients acebutolol therapy days deaths acebutolol treated group placebo group reduction total mortality p vascular deaths placebo group acebutolol group thus cardiovascular mortality acebutolol reduced p incidence cardiovascular related deaths lower acebutolol treated group total reduction mortality appear correlated secondary risk factors,C14,0.0016833667,0.0259328,0.011285209,0.000945575,0.0023434397,0.0021965497,0.12601615,0.0015940513,0.0012166903,0.009793197,0.018507952,0.062437065,0.037296124,0.0039043287,0.0014799883,0.0026206865,0.18000008,0.009858284,0.122159444,0.26261157,0.0971266,0.00874239,0.010248432
enhanced chemiluminescence measure oxygen derived free radical generation ischemia reperfusion suggested oxygen derived free radicals may contribute myocardial injury associated ischemia reperfusion presence enhanced free radical generation prerequisite damage several techniques used provide evidence increased oxygen free radical production reperfusion however techniques substantial limitations study used enhanced chemiluminescence evaluate oxygen free radical generation ischemia reperfusion isolated langendorff perfused rat heart chemiluminescent technique high sensitivity monitor radical generation continuously avoids limitations earlier methods chemiluminescence expressed counts per second decreased baseline ischemia markedly increased peak first minutes reperfusion followed slow decline minutes steady state level sequential change chemiluminescence highly significant p less superoxide dismutase units min significantly decreased peak reperfusion chemiluminescence p less hearts subjected second period ischemia reperfusion higher peak chemiluminescence also significantly attenuated units min superoxide dismutase p less,C14,0.012604635,0.0019142613,0.046352547,0.001212497,0.0030049584,0.0027850224,0.31415132,0.0020312583,0.0015601441,0.00212037,0.05626186,0.0044386564,0.2673766,0.017485997,0.0018976983,0.0033665414,0.03137283,0.0022505973,0.00245721,0.04397689,0.17835535,0.0007662304,0.0022565047
neuroendocrine activity congestive heart failure increased neuroendocrine activity patients congestive heart failure appears generalized attempt maintain blood pressure expense reduced cardiac performance salt water retention likely baroreceptor dysfunction contributes increased sympathetic nervous system activity patients congestive heart failure usual tonic inhibitory messages emanating baro mechanoreceptors great vessels heart fail adjust sympathetic traffic brain periphery leading uninhibited sympathetic tone arginine vasopressin plasma renin activity may increased secondarily however plasma renin activity activation could also induced low salt diet diuretic use preliminary baseline data indicate patients left ventricular dysfunction ejection fraction less equal mild symptoms heart failure increased plasma levels norepinephrine atrial natriuretic factor arginine vasopressin plasma renin activity normal suggesting neuroendocrine activity contributes pathogenesis congestive heart failure neurohormones angiotensin ii may alter gene expression leading changes shape size cell remodeling heart blood vessels associated heart failure hypertension angiotensin converting enzyme inhibitors demonstrated retard reverse remodeling process certain experimental conditions studies currently way test possibility patients,C14,0.01964986,0.08154762,0.0034246629,0.0010312354,0.0025755276,0.002405572,0.17535423,0.0017293735,0.0013269113,0.0018082567,0.017776508,0.012652011,0.1438849,0.041198876,0.001614003,0.011733157,0.08623355,0.018142067,0.002089871,0.043966413,0.29177988,0.009534214,0.02854129
hemodynamics internal carotid artery occlusion examined positron emission tomography using positron emission tomography nine patients minor strokes unilateral internal carotid artery occlusion good collateral circulation anterior portion circle willis analyzed regional cerebral blood flow cerebral metabolic rate oxygen oxygen extraction fraction cerebral blood volume studies allowed quantification regional hemodynamic status especially relation watershed areas compared eight normal controls patients significantly p less decreased regional cerebral blood flow middle cerebral artery territory surrounding watershed areas occluded hemisphere oxygen extraction fraction rose distance anterior portion circle willis attaining highest value superior parietal posterior temporo occipital watershed area concomitant decrease cerebral blood flow cerebral blood volume ratio suggested reduction mean blood flow velocity whereby elevated blood viscosity would liable reduce cerebral blood flow findings suggest hemodynamic vulnerability watershed areas internal carotid artery occlusion persons good collateral circulation anterior portion circle willis results also emphasize importance systemic hemodynamic factors blood pressure circulating blood volume genesis watershed infarction,C14,0.12538157,0.0016116843,0.0033901539,0.0010208441,0.0025299808,0.010919869,0.065782174,0.0017086383,0.0013135405,0.0017852146,0.049457476,0.0037427193,0.33505386,0.03175419,0.014204678,0.002829297,0.08269927,0.0018713446,0.0020688123,0.058201097,0.20015317,0.0006451165,0.0018753015
immunohistochemical study fibronectin experimental myocardial infarction light microscopic immunohistochemical studies performed evaluate distribution fibronectin paraffin sections p formaldehyde fixed normal rat hearts hearts rats undergone ligation left coronary artery peroxidase labeled antibody technique used together appropriate immunohistochemical control procedures localization fibronectin normal hearts hearts sham operated animals fibronectin localized interstitial space myocytes beneath arterial venous capillary endothelium hours coronary ligation fibronectin localized patchy fashion cytoplasm interstitial space myocytes area supplied ligated vessel hours intense homogeneous staining necrotic myocytes infarcted area capillary endothelium border zone hours intensity staining fibronectin maximal necrotic myocytes center infarct proliferating migrating capillaries fibroblasts border zone similar patterns localization observed days coronary ligation progressive decreases intensity staining two sources fibronectin appeared contributed changes plasma fibronectin diffusing damaged blood vessels would account early staining observed necrotic myocytes center infarct whereas de novo synthesis fibronectin connective tissue cells endothelial cells sprouting capillaries would responsible subsequent staining observed viable capillaries border zone infarct known properties fibronectin vitro combined vivo observations indicate fibronectin may influence thrombotic inflammatory angiogenic fibrotic processes involved infarct healing,C14,0.050149594,0.0015178315,0.051603533,0.0009613975,0.002382653,0.010485324,0.16395114,0.037277523,0.009516384,0.0016812566,0.026117384,0.012045204,0.06723794,0.051417008,0.02634544,0.010944781,0.09988329,0.010738376,0.0019483395,0.030733293,0.24747485,0.06686969,0.018717784
contribution calmodulin protein kinase c renin release spontaneously hypertensive rats study designed evaluate contribution calmodulin protein kinase c renin release isolated glomeruli spontaneously hypertensive rats shr okamoto aoki male week old shr age matched control wistar kyoto rats wky used study isolated glomeruli sealed superfusion chamber perfused krebs ringer solution constant flow ml min renin release increased calmodulin inhibitor w protein kinase c inhibitor h shr wky shr showed higher maximal levels renin release w lower maximal levels h compared wky results indicate calmodulin protein kinase c play inhibitory roles renin release juxtaglomerular cells calmodulin mediated suppression mechanism renin release appears augmented shr whereas protein kinase c mediated system attenuated,C14,0.0029617709,0.0026272386,0.0341834,0.0016640982,0.004124172,0.003835151,0.15215014,0.0027852852,0.030814964,0.002910114,0.01544993,0.02065214,0.080282226,0.025120711,0.0026045064,0.019397043,0.027116729,0.0031328937,0.0033724117,0.054955486,0.50576097,0.0010516172,0.0030469606
use technetium sestamibi determine size myocardial area perfused coronary artery value new radionuclide tracer technetium tc sestamibi demonstrate myocardial perfusion areas supplied specific coronary arteries evaluated patients injected agent cardiac catheterization tc sestamibi differs thallium physical characteristics photon energy kev half life hours lack significant redistribution allowing administration episode chest pain ischemia occurring outside nuclear medicine laboratory later imaging visualize distribution patients tc sestamibi administered intravenously balloon occlusion angioplasty patients defects single photon emission computed tomography images corresponded area made ischemic angioplasty remaining patients abundant collateral flow present defects seen second study patients tc sestamibi selectively injected coronary artery angiography later imaging identified area supplied artery injected tc sestamibi imaging detect perfusion defects associated short episodes ischemia area supplied different coronary arteries,C14,0.04488774,0.0019553402,0.0041130288,0.0012385164,0.081602134,0.0028447874,0.18444002,0.0020729674,0.0015936239,0.002165872,0.06833734,0.047205023,0.06822032,0.005359289,0.0019384217,0.013950247,0.18021803,0.0022700822,0.0025099404,0.08870144,0.19132052,0.00078267325,0.0022726685
isoflurane lead higher incidence myocardial infarction perioperative death enflurane coronary artery surgery clinical study patients examine choice volatile agents influences cardiac outcome coronary artery surgery patients undergoing elective coronary artery bypass grafting without additional operations received enflurane isoflurane primary anesthetics inspired concentration volatile agent administered nitrous oxide adjusted depending level blood pressure discretion anesthesiologist addition volatile agent assigned patient received small doses fentanyl induction sternotomy total mg kg groups differ preoperative surgical characteristics except frequent history renal dysfunction patients given isoflurane rates postoperative myocardial infarction administration positive inotropic agents time weaning cardiopulmonary bypass hospital deaths enflurane isoflurane groups p less p less p less respectively although mechanism adverse effects isoflurane could clarified study results demonstrate use isoflurane could inappropriate patients undergoing coronary artery bypass grafting,C14,0.0022274214,0.001975834,0.014895653,0.0012514972,0.0031019223,0.0031229316,0.20812942,0.002094694,0.0016103265,0.0021885724,0.021196732,0.06605451,0.095625214,0.0051216213,0.0127525255,0.03579107,0.27704525,0.0022938747,0.0025362468,0.08948909,0.14841321,0.0007908764,0.002291489
use variable length intraluminal sutureless graft august may treated patients acute ascending aortic dissections variable length intraluminal aortic prosthesis operation uses profound hypothermic circulatory arrest represents refinement existing techniques mortality morbidity minimal modifications technique used performing proximal aortic root reconstruction composite valved conduit use variable length intraluminal prosthesis hypothermic circulatory arrest illustrated safe useful technique select cases acute ascending aortic dissection,C14,0.0039306567,0.0034866885,0.026291724,0.0022084757,0.005473315,0.005072717,0.30309808,0.060775187,0.0028416899,0.003862101,0.10667298,0.008084609,0.09820522,0.009037794,0.0034565201,0.006129817,0.14609443,0.0040479247,0.004475631,0.047968738,0.14334632,0.0013956333,0.0040437146
intracoronary urokinase intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty acute ischemic syndromes intracoronary urokinase used treat flow limiting intracoronary thrombus accumulation complicated successful percutaneous transluminal coronary angioplasty ptca acute ischemic syndromes patients followed acute phase illness study group comprised patients unstable angina pectoris patients evolving acute myocardial infarction patients postinfarction angina initial mean percent coronary diameter stenosis entire population decreased initial ptca p less improved corresponding coronary flow thrombolysis myocardial infarction trial timi grade however thrombus accumulation resulted significant increase percent diameter stenosis p less corresponding significant reduction coronary flow also occurred timi grade administration intracoronary urokinase mean dose units range units average period minutes additional ptca mean percent diameter stenosis significantly decreased p less correspondingly significant improvement mean coronary flow timi grade occurred overall angiographic success rate ischemic events requiring repeat ptca procedure related myocardial infarctions deaths hospital discharge one patient referred urgent coronary artery bypass graft surgery successful ptca plasma fibrinogen levels obtained patients patient level normal laboratory,C14,0.0018322538,0.0016253005,0.021153884,0.0010294686,0.0025513554,0.002364619,0.11656264,0.0017230737,0.0013246379,0.001800297,0.019832402,0.012638956,0.15482883,0.004238481,0.0016112378,0.011719902,0.38245934,0.0018873332,0.010954853,0.048959393,0.19636622,0.00065056677,0.0018849551
clinical nuclear magnetic resonance spectroscopy insight metabolism nuclear magnetic resonance nmr spectroscopy nondestructively evaluate changes metabolites different disease states well therapeutic interventions animal studies provided basis understanding changes high energy phosphates myocardial ischemia studies graded ischemia due partial coronary stenosis shown sensitivity ratio phosphocreatinine inorganic phosphate small reductions myocardial blood flow relation myocardial function application nmr spectroscopy humans requires precise localization techniques avoid acquiring contaminating information structures around heart chest wall diaphragm localization techniques metabolic evidence ischemia demonstrated patients myocardial infarction patients known coronary disease although sensitivity technique diagnosis inducible ischemia unknown rest patients dilated hypertrophic cardiomyopathies often elevated phosphodiester resonance possibly signifying abnormal breakdown membrane phospholipids increasing oxygen demand patients usually alter high energy phosphates suggesting oxidative energy metabolism preserved conditions nmr spectroscopy powerful tool increase understanding metabolic changes variety pathologic conditions,C14,0.0019375406,0.0017176638,0.09712928,0.0010879717,0.030830218,0.0024989964,0.30710155,0.0018209933,0.010739827,0.001902605,0.047659185,0.013559801,0.11463494,0.030292036,0.0017028019,0.02174647,0.077104434,0.0020042318,0.002204851,0.08345263,0.13572283,0.0006875374,0.012461619
comparison thallium technetium hexakis methoxyisobutyl isonitrile single photon emission computed tomography estimating extent myocardial ischemia infarction coronary artery disease single photon emission computed tomography spect using thallium tl compared technetium hexakis methoxyisobutyl isonitrile tc mibi patients coronary artery diseaes patients exercised work load isotope studied normal hypoperfused left ventricular mass determined automated method estimated total left ventricular mass similar stress redistribution tl stress rest tc mibi images mean estimated defect size redistribution tl images vs g resting tc mibi studies difference significant individual determinations defect mass highly correlated r p less estimated defect size stress tl images g significantly larger exercise tc mibi estimates defect mass g p less linear correlation existed stress thallium technetium estimates defect size r tc mibi defects smaller tl defects partial redistribution tc mibi could explain discordance stress tc mibi spect defect size determined visual interpretation use isocount analysis may smaller seen stress tl spect,C14,0.002071271,0.021890314,0.07398082,0.041188505,0.14049879,0.002673083,0.14400847,0.0019478482,0.0014974367,0.0020351454,0.12290158,0.0042896965,0.15977074,0.0048275287,0.062081285,0.02327076,0.074264936,0.0021337941,0.0023584466,0.02860214,0.060783982,0.020788183,0.0021352265
transtelephonic defibrillation study objectives study undertaken assess safety reliability device transtelephonic defibrillation design transtelephonic system consists patient unit base station patient unit contains monitor defibrillator electrode pads microphone microprocessor dc defibrillator base station comprises control panel computer ecg display setting fifteen patients treated emergency department cardiac arrest placed patient units activated base station remote location within ed type participants thirteen patients treated ventricular fibrillation two patients treated ventricular tachycardia interventions thirty one shocks delivered transtelephonically measurements main results cases voice ecg transmission established without difficulty conclusions conclude system represents safe reliable method treatment ventricular fibrillation advocate additional use study prehospital applications transtelephonic defibrillation,C14,0.00314196,0.03320465,0.099317476,0.0017654125,0.0043750796,0.0047791186,0.3381326,0.002954737,0.017470596,0.0030871602,0.04678515,0.023049595,0.027488397,0.0076074847,0.0027629603,0.020099128,0.20616233,0.018439028,0.033274505,0.022571884,0.079146266,0.0011155958,0.0032689204
combined internal mammary artery graft coronary artery revascularization five patients multiple vessel coronary artery disease underwent isolated coronary artery bypass grafting technique involving internal mammary arteries small piece interposed saphenous vein combined internal mammary artery grafts used sequential grafting total anastomoses performed average number anastomoses per patient operative deaths postoperative complications included reoperation bleeding patient diaphragmatic dysfunction another postoperative coronary angiography days discharge mean time days postoperatively revealed sequential anastomoses combined ima graft patent exercise tolerance tests performed months postoperatively indicated excellent results ischemia based experience conclude method appears promising multivessel coronary artery bypass grafting,C14,0.041252535,0.05381124,0.0049586226,0.0014931419,0.03046611,0.0034296445,0.22551742,0.0025038724,0.0019212556,0.0026111517,0.08720413,0.0054659736,0.022248752,0.00622346,0.0023370846,0.016891196,0.3751647,0.0027402344,0.0030259567,0.057527445,0.049528595,0.00094358233,0.00273394
mental stress acute trigger ischemic left ventricular dysfunction blood pressure elevation coronary artery disease acute mental stress may frequent trigger transient myocardial ischemia myocardial infarction sudden cardiac death experimental setting effect mental stress hemodynamics left ventricular wall motion abnormalities detected radionuclide ventriculography measured patients exercise induced myocardial ischemia seventy five percent patients demonstrated mental stress induced wall motion abnormalities patients frequently exhibited greater increases peak systolic arterial pressure mental stress exercise personally relevant mental stress potent type mental stress terms frequency magnitude ischemia mental stress induced ischemic episodes clinically electrocardiographically silent occur heart rates significantly lower seen exercise systolic diastolic blood pressure increased mental stress induced ischemia suggesting increased myocardial oxygen demand plays role pathophysiology mental stress induced transient ischemia significant magnitude acute onset mental stress induced blood pressure elevation may manner contribute atherosclerotic plaque rupture findings may provide pathophysiologic link epidemiologic association mental stress acute ischemic coronary events new ambulatory radionuclide detector concurrently monitor left ventricular ejection fraction electrocardiographic st segment change may enhance detection evaluation transient myocardial ischemia ambulatory coronary patients,C14,0.0018823633,0.026809728,0.0032550134,0.0009775485,0.010848828,0.013327565,0.27230072,0.001636126,0.0012577956,0.010129327,0.028768366,0.0035784487,0.20228536,0.0041960967,0.0015299334,0.011127916,0.12494252,0.018869298,0.0020226908,0.08724383,0.1453332,0.025884006,0.0017933288
ace inhibition improves vagal reactivity patients heart failure deranged autonomic control heart rate studied patients heart failure new york heart association nyha functional class ii iii examining carotid sinus baroreflex carotid sinus baroreceptors stimulated graded suction slope regression line increases cycle length degree neck suction taken index baroreflex sensitivity reflex response mediated selective increase vagal efferent activity baroreflex sensitivity therefore represents measure vagal reactivity using multiple regression analysis baroreflex sensitivity bs correlated positively stroke volume index svi inversely plasma renin activity pra age bs svi pra age constant r p less addition digitalis diuretics angiotensin converting enzyme ace inhibitors captopril enalapril given patients mean days patients hemodynamic improvement group exhibited improved baroreflex sensitivity msec mm hg p less baroreflex sensitivity remained unchanged msec mm hg n patients without hemodynamic improvement group b increase reflex sensitivity correlate hemodynamic alterations baroreflex sensitivity ace inhibition bsd related baseline baroreflex sensitivity bsb bsd bsb r p less patients heart failure reflex bradycardia decreases age pra increases stroke volume chronic therapy ace inhibitors enhances vagal reactivity patients hemodynamic improvement,C14,0.0023602694,0.0019549178,0.014803526,0.001238249,0.0030735212,0.002844173,0.16223252,0.012734728,0.0015932798,0.0021654044,0.04245284,0.045837045,0.20256205,0.0055141426,0.012591102,0.025281213,0.12295961,0.022011785,0.0025093984,0.08345263,0.22677785,0.00078250427,0.0022672315
left main percutaneous transluminal coronary angioplasty autoperfusion catheter animal model left main coronary angioplasty associated high risk interruption blood flow much left ventricle balloon inflation autoperfusion balloon angioplasty catheter allows blood flow passively distal inflated balloon tested dogs compared inflations standard balloon catheters min occlusions left main coronary artery autoperfusion catheter regional myocardial blood flow preserved ml min g compared ml min g inflation standard balloon catheters p less similarly end min inflation left ventricular systolic pressure dp dt maintained autoperfusion catheter inflation severely depressed standard angioplasty balloon inflation seven dogs survived autoperfusion balloon inflation whereas five seven developed sustained ventricular tachycardia ventricular fibrillation standard balloon inflation thus distal blood flow hemodynamics survival preserved autoperfusion balloon inflation left main coronary artery,C14,0.015717048,0.002388225,0.005023596,0.0015127066,0.0037489748,0.0034745834,0.11035489,0.054667044,0.0019464298,0.0026453657,0.15873982,0.005537594,0.35603794,0.006312571,0.002367561,0.004206766,0.1494481,0.0027726465,0.0030656059,0.03697317,0.05630249,0.013987105,0.0027697629
dietary preference sweet foods patients dementia using telephone survey patients probable alzheimer disease n vascular dementia n compared elderly normal controls n preferences different foods patients alzheimer disease greater preference normal controls relatively high fat sweet foods high sugar low fat foods significantly differ preference foods including high complex carbohydrates protein vascular dementia patients showed similar pattern significantly different alzheimer patients results consistently support hypothesis increased sweet preference nonspecific form disinhibited behavior related declining mental status hypothesis relating sweet preference serotonin activity within brain consistently supported results provide preliminary evidence craving sweet food may significant part clinical syndrome dementia research needed delineate psychological biological mechanisms accounting,C14,0.013297052,0.01298567,0.0042905854,0.0012792053,0.0031702833,0.0029382468,0.30179203,0.0021997383,0.0016459791,0.013254851,0.011232244,0.004733777,0.1020494,0.019114047,0.0020021044,0.025569273,0.089022085,0.013558225,0.013608903,0.19998355,0.15912089,0.00080838636,0.002343492
components delay time suspected acute myocardial infarction particular emphasis patient delay two hundred thirty four patients admitted coronary care unit ccu interviewed days arrival hospital determine reasons patient delay various components total delay time onset symptoms arrival ccu three major components delay decision time time onset symptoms decision go hospital hospital procedure time time arrival hospital arrival ccu magnitude h min h min median whereas median time preparation transportation hospital somewhat shorter min decision time appeared similar patients confirmed non confirmed acute myocardial infarction ami associated intensity pain infarct size half patients hesitated go hospital resulted prolonged decision delay h concluded patient indecision seek medical help important reason delay hospital arrival patients suspected ami,C14,0.012940234,0.0019978115,0.036909435,0.012164598,0.0031361135,0.002969217,0.17587724,0.0021179935,0.0016282384,0.12102084,0.021237304,0.0046461495,0.07616773,0.0052187797,0.012893343,0.0035974646,0.3312129,0.0023241565,0.015878059,0.106883824,0.046061933,0.00079967343,0.0023169776
usefulness verapamil congestive heart failure associated abnormal left ventricular diastolic filling normal left ventricular systolic performance normal left ventricular systolic performance impaired left ventricular diastolic filling may present substantial number patients congestive heart failure chf evaluate effect oral verapamil subset men mean age years chf intact left ventricular function ejection fraction greater abnormal diastolic filling peak filling rate less end diastolic volumes per second edv studied placebo controlled double blind week crossover trial patients underwent echocardiography rule significant valvular disease thallium stress scintigraphy exclude major active ischemia compared baseline values verapamil significantly improved exercise capacity vs minutes baseline peak filling rate vs edv baseline p less placebo values minutes edv respectively difference significant improvement baseline objective clinico radiographic heart failure score scale significantly greater verapamil compared placebo median improvement score vs p less mean ejection fraction systolic blood pressure unchanged baseline diastolic blood pressure heart rate decreased small degree verapamil may therapeutic efficacy patients chf preserved systolic function impaired diastolic filling,C14,0.0017514299,0.042223606,0.018293906,0.0009456995,0.0023437485,0.002172207,0.14268753,0.001582865,0.0012168505,0.0016538046,0.009589811,0.028115049,0.37059796,0.005163828,0.009625832,0.010763263,0.084802926,0.018133556,0.04265549,0.08559354,0.07701674,0.041338805,0.001731574
kallikrein like enzyme blood vessels one kidney one clip hypertensive rats active inactive kallikrein kallikrein like enzyme found aorta vena cava tail artery veins rat studied concentration vascular kininogenase rats one kidney one clip renovascular hypertension unilaterally nephrectomized normotensive rats six weeks surgery active total vascular kininogenase activity active plus trypsin activated measured blood pressure mm hg hypertensive rats n mm hg normotensive rats n p less active kininogenase lower hypertensive rats although difference significant thoracic aorta versus highly significant abdominal aorta versus p less tail artery versus p less total vascular kininogenase activity active plus trypsin activated lower hypertensive rats arteries examined thoracic aorta versus p less abdominal aorta versus p less tail artery versus p less active kininogenase vena cava higher hypertensive rats versus however difference statistically significant whereas tail veins highly significant versus p less,C14,0.0809951,0.002420625,0.03095069,0.0015332288,0.0037998355,0.0035217213,0.17665666,0.06225171,0.0150807835,0.0026812542,0.012736418,0.0061558103,0.26800025,0.006534777,0.0023997827,0.004249385,0.057272818,0.029225703,0.0031071957,0.021461572,0.1920113,0.000968915,0.015984448
effects diltiazem functional recovery myocardium organ cellular level prolonged hypothermic ischemic cardiac arrest effectiveness diltiazem functional recovery heart calcium ca uptake binding ca atpase cardiac sarcoplasmic reticulum sr mb fraction creatine kinase mbck coronary sinus blood investigated one half hours reperfusion following three hours ischemic cardiac arrest dogs divided three groups group sham bypass group ii cold crystalloid cardioplegia group iii cold crystalloid cardioplegia diltiazem decrease aortic pressures left ventricular pressure development dp dt left ventricular work index lvwi total systemic vascular resistance tsvr left ventricular systolic pressure lvsp sham bypass group decrease cardiac index ci lvwi mean right atrial pressure mrap increase tsvr pulmonary vascular resistance pvr group ii compared group although tendency decrease indices myocardial contractility group ii significantly different group indices myocardial contractility ci lvwi group iii slightly higher group ii significantly different values calcium uptake sr groups ii iii similar significantly lower group calcium binding group iii significantly lower group calcium atpase sr three groups similar although mbck increased groups increases significantly different among three groups results study indicate cold crystalloid cardioplegia diltiazem better cold crystalloid alone preserving cardiac contractility cellular function prolonged ischemic cardiac arrest however cardiac function terms cardiac index better preserved diltiazem,C14,0.008804826,0.008649931,0.0028190487,0.0008488727,0.0021037804,0.0019672522,0.07253235,0.008723441,0.0010922615,0.008774903,0.006989369,0.20067307,0.26391563,0.05470218,0.0013309626,0.016975023,0.11566093,0.016181977,0.0017203002,0.02719828,0.1543041,0.0224772,0.0015542844
comparison coarctation resection subclavian flap angioplasty using ultrasonographically monitored postocclusive reactive hyperemia reported relatively high incidence early restenosis coarctation repair site subclavian flap angioplasty especially infants less months age prompted physiologically oriented analysis relief obstruction coarctation subclavian flap angioplasty versus resection end end anastomosis infancy twenty one patients undergone repair coarctation infancy either subclavian flap angioplasty nine patients median age years resection end end anastomosis patients median age years evaluated doppler spectrum analysis blood flow velocities femoral artery rest reactive hyperemia median resting right upper lower limb systolic pressure difference interquartile range similar angioplasty resection anastomosis control groups mm hg mm hg mm hg mm hg mm hg mm hg respectively also similar resting values maximum frequency advancing curve pulsatility resistance indices measured three groups reactive hyperemia leg however significant hemodynamic obstruction across repair site became clinically manifest angioplasty group documented lower pulsatility index comparison control group p mann whitney u test comparison hemodynamic results angioplasty resection anastomosis groups subdivisions infants operated age less greater months rest reactive hyperemia showed already rest significantly lower value pulsatility index former angioplasty subdivision p student test indicating significant resistance coarctation repair site angioplasty patients operated third month life disadvantage angioplasty compared resection anastomosis noted angioplasty performed third month life unequivocal lack advantage noted performed beyond period regarding relief obstruction coarctation addition definite potential adverse long term effects hemodynamics left upper limb subclavian flap angioplasty infancy documented reasons prefer perform resection end end anastomosis repair coarctation infancy,C14,0.020010605,0.034592696,0.0021638235,0.0006494939,0.0016096553,0.051714916,0.11055304,0.01235624,0.017615661,0.0067276815,0.04556516,0.031428672,0.2105205,0.0026631292,0.0010165332,0.0018000898,0.29023138,0.0011988337,0.001316245,0.11767213,0.036990006,0.0004104439,0.0011930782
detection quantitation ischemic left ventricular dysfunction using new video intensity technique regional wall motion evaluation eighty patients ischemic heart disease normal subjects evaluated left ventricular regional wall motion means new method wall motion analysis based video intensity technique uses temporally sliding analysis evaluate cardiac cycle msec intervals presence coronary artery disease defined measured diameter stenosis wall motion abnormalities regions perfused stenotic vessels common early diastole sensitivity method rest patients coronary artery disease p less overall accuracy p less abnormalities systole diastole common regions perfused severe lesions greater perfused moderately stenotic less vessels p less comparison new method phase amplitude analysis performed patients two frame analysis patients new method yielded higher sensitivity either two methods,C14,0.0022122029,0.0019547108,0.046772216,0.0012381177,0.024403526,0.013501212,0.20044552,0.0020837672,0.0015931109,0.0021651748,0.21434534,0.0045324014,0.1348381,0.005296435,0.023269301,0.014096018,0.18594544,0.0022703183,0.0025091325,0.028735485,0.048032966,0.022116544,0.017642977
valvular coronary surgery renal transplant patients authors report aortic valvular replacement avr coronary artery bypass graft surgery cabg successfully performed two renal transplant patients postoperative blood urea creatinine levels comparable preoperative values first patient underwent isolated avr second patient initial avr combined cabg followed two years later avr prosthetic dysfunction many reasons coronary artery cad valvular diseases uncommon renal transplant patients cardiac surgery feasible without impairment renal function provided precautions taken ie good mean perfusion pressure cardiopulmonary bypass cpb adequate volume replacement selected use mannitol dopamine,C14,0.002727156,0.0024191234,0.018282931,0.0015322777,0.0037974783,0.029915716,0.18815218,0.028960744,0.0019716125,0.0026795908,0.018828778,0.0056092385,0.12575905,0.0062764054,0.0023981922,0.004246749,0.41385818,0.0028085185,0.0031052683,0.01893865,0.11395825,0.000968314,0.0028055976
calcium contractile responses phorbol esters calcium channel agonist bay k arteries hypertensive rats study examined calcium dependency contractions arteries rats made hypertensive aortic coarctation rats genetic hypertensive stroke prone spontaneously hypertensive rats mesenteric artery aortic strips suspended tissue baths isometric force recording contractions two drugs characterized phorbol ester tpa tetrade canoylphorbol acetate calcium channel agonist bay k thoracic aortae mesenteric arteries hypertensive rats sensitive contractile properties protein kinase c activator tpa comparable arteries normotensive rats thoracic aortae coarcted rats contractile activity bay k potentiated compared normotensive values presence mmol l kcl responses bay k thoracic aortae normotensive rats potentiated differ coarcted values contrast contractions bay k tpa abdominal aortae obtained coarctation different normotensive values upon exposure mmol l kcl contractions bay k abdominal aortae potentiated aortae coarcted rats differ sham values contractile responses drugs blocked nifedipine verapamil responses attenuated calcium free solution conclude calcium channel function regulation protein kinase c contribute altered vascular reactivity hypertension abnormalities pressure dependency occur abdominal aortae coarcted rats,C14,0.071578026,0.0021131586,0.021431122,0.0013384789,0.0033171824,0.025939064,0.1638636,0.067940325,0.036314297,0.0023406828,0.012640305,0.016424645,0.084354855,0.07241593,0.0020948746,0.0152323125,0.022174118,0.002453304,0.0027125215,0.03110666,0.3387177,0.000845844,0.0026510425
percutaneous excimer laser coronary angioplasty determine efficacy percutaneous excimer laser coronary angioplasty adjunct alternative conventional balloon angioplasty patients studied multicenter trial patients underwent procedure using modification conventional balloon angioplasty technique first generation mm diameter catheter constructed individual silica fibers concentrically arranged around guidewire lumen used catheter tip energy density varied mj mm mean number pulses delivered hz acute success defined greater equal increase stenotic diameter lumen greater equal mm diameter laser treatment acute success achieved patients adjunctive balloon angioplasty performed patients percent diameter stenosis determined quantitative angiography decreased baseline laser treatment patients undergoing adjunctive balloon angioplasty mean minimal stenotic diameter increased baseline mm laser treatment mm balloon angioplasty deaths vascular perforations one patient required emergency coronary bypass surgery data suggest excimer laser energy delivered percutaneously specially constructed catheters safely ablate atheroma reduce coronary stenoses,C14,0.0021146913,0.0018752982,0.0141769815,0.0011878177,0.0029437954,0.0027283358,0.15617485,0.0019964932,0.0015283888,0.0020772119,0.08579172,0.045266,0.051906053,0.015595426,0.0018590724,0.003293245,0.443457,0.0021771563,0.002407196,0.03179256,0.10625753,0.021218253,0.002174892
effects xamoterol inotropic lusitropic properties human myocardium adenylate cyclase activity purpose present study characterize effects xamoterol human myocardium presence forskolin milrinone xamoterol increased isometric force contraction contraction velocity relaxation velocity isolated electrically driven preparations human myocardium effect alone difference effect xamoterol right atrial myocardium left ventricular myocardium nonfailing nf moderately failing nyha ii iii severely failing nyha iv human hearts positive inotropic lusitropic effects isoprenaline reduced depending severity heart failure left ventricular myocardium e nf greater nyha ii iii greater nyha iv presence norepinephrine xamoterol produced negative inotropic effects similar beta adrenoceptor antagonists pindolol propranolol xamoterol alone effects force contraction whereas pindolol propranolol markedly reduced contractile force nyha class iv isoprenaline stimulated adenylate cyclase twofold xamoterol like pindolol propranolol effect experiments beta beta selective antagonists cgp ici respectively showed positive inotropic lusitropic effects xamoterol mediated beta adrenoceptors consistently xamoterol selectivity beta adrenoceptors measured radioligand binding experiments concluded xamoterol acts beta adrenoceptor antagonist selectivity human ventricular myocardium compound intrinsic sympathomimetic activity produces beta adrenoceptor mediated positive inotropic lusitropic effects presence forskolin beneficial effects xamoterol patients heart failure could due prevention detrimental effects norepinephrine beta adrenoceptor downregulation increase gi inhibitory guanine nucleotide binding protein,C14,0.028685635,0.010401778,0.017852155,0.0098101115,0.0025293296,0.0023442053,0.15943706,0.0017081985,0.027684437,0.001784755,0.011349557,0.035272557,0.07667524,0.050316427,0.010385343,0.011611826,0.037878964,0.045972895,0.0020682795,0.012677919,0.3752823,0.018230243,0.050040778
short term effect hepatic arterial versus portal venous reperfusion energy levels liver tissue hepatic artery portal vein blood vary flow oxygenation hormonal content uncertain blood supply greater effect recuperative process hepatocytes ischemic liver initial reperfusion ability liver cells restore energy phosphates related viability liver study designed determine differences high energy phosphate liver predicated upon whether reflow first provided either hepatic artery portal vein followed subsequent reperfusion vessels recovery atp upon min hepatic arterial reperfusion min total ischemia much slower compared portal venous reperfusion may undesirable therefore reperfuse liver hepatic arterial blood first immediately warm liver ischemia,C14,0.059708554,0.0022417256,0.016923096,0.0014199136,0.0035190037,0.003284321,0.09923683,0.041475985,0.014003259,0.0024830927,0.012319062,0.030243855,0.1429637,0.038140237,0.0022223897,0.17969573,0.08046619,0.0026025658,0.0028775544,0.06162013,0.19905569,0.00089730613,0.002599859
surgical repair postinfarction ventricular septal defect thirty one patients underwent repair postinfarction ventricular septal defect vsd patients new york heart association functional class iv cardiogenic shock operated coronary arteriography performed patients surgery nine one vessel two vessel three vessel disease vsd anterior patients posterior operative technique evolved years fairly extensive infarctectomy reconstruction septum right left ventricular walls double dacron patch minimal infarctectomy closure vsd excluding infarcted muscle left ventricular cavity accomplished suturing single patch bovine pericardium healthy endocardium surrounding infarcted muscle right ventricle left intact overall mortality three operative deaths deaths occurred patients cardiogenic shock three vessel coronary artery disease thus mortality patients shock mortality patients three vessel disease operative mortality patients posterior vsd twice high patients anterior vsd however univariate analysis various clinical hemodynamic operative variables indicated three vessel disease predictive operative mortality number patients small overall operative mortality relatively low results analysis may valid,C14,0.058689073,0.0016257827,0.0034887122,0.0010297741,0.02026879,0.0023653205,0.15269284,0.035259087,0.019070346,0.010669414,0.030323818,0.0037697137,0.05588896,0.004417697,0.0104684625,0.0028551316,0.3952393,0.0018874774,0.010941019,0.10911839,0.03955941,0.018394472,0.011977
effects theophylline atenolol combination myocardial ischemia stable angina pectoris effects theophylline mg twice day atenolol mg twice day combination myocardial ischemia studied patients stable angina pectoris randomized single blind triple crossover trial placebo administered patients run run periods treadmill exercise test hour ambulatory electrocardiographic monitoring obtained end treatment period compared placebo theophylline significantly improved time onset myocardial ischemia mm st segment depression minutes p less exercise duration minutes p less atenolol combination treatment time onset ischemia exercise duration similar minutes minutes respectively longer theophylline administration p less ambulatory electrocardiographic monitoring showed theophylline administration heart rate higher placebo throughout hours p less atenolol combination treatment heart rate similar cases lower placebo p less compared placebo theophylline decreased total ischemic time minutes p less,C14,0.0021133348,0.022334917,0.0039432636,0.0011873967,0.0029559436,0.012953743,0.10465282,0.0019874058,0.001527847,0.022536408,0.037088882,0.004467881,0.27200225,0.0048592095,0.0018584405,0.003290902,0.093965285,0.0021763844,0.1046481,0.033924796,0.26259732,0.00075036846,0.0021771255
potential role tissue renin angiotensin system pathophysiology congestive heart failure circulating renin angiotensin system ras plays important role maintenance cardiovascular homeostasis recently demonstrated endogenous ras exist target tissues important cardiovascular regulation article reviews multiple effects angiotensin ii target tissues evidence presence functional tissue ras data suggest role tissue ras pathophysiology heart failure activation circulating neurohormones predictive worsened survival heart failure however cardiac renal tissue ras activities also increased compensated stage heart failure plasma renin angiotensin activity normal hypothesized plasma ras maintains circulatory homeostasis acute cardiac decompensation changes tissue ras contribute homeostatic responses chronic sustained cardiac impairment concept different functions circulating tissue ras pathophysiology heart failure may important pharmacologic implications,C14,0.0024965247,0.026370358,0.004658256,0.0014026953,0.0034765243,0.015293225,0.30201277,0.002347762,0.0018048761,0.0024529821,0.022970542,0.005134874,0.020526731,0.02903958,0.0021953809,0.028047418,0.09456103,0.039145723,0.0028426605,0.01723709,0.37252828,0.0008864252,0.0025683325
prehospital cardiac arrest impact witnessed collapse bystander cpr metropolitan ems system short response times objective numerous studies shown initiation bystander cpr significantly improve survival prehospital cardiac arrest however emergency medical services ems systems short response times bystander cpr shown impact outcome purpose study determine effect bystander cpr survival hospital cardiac arrest system design prehospital hospital death certificate data medium sized metropolitan area retrospectively analyzed adult nontraumatic cardiac arrest month period results total patients met study criteria one hundred ninety five arrests witnessed unwitnessed twenty five witnessed victims discharged alive whereas unwitnessed victims survived p less patients suffering witnessed episode ventricular fibrillation tachycardia vf vt likely survive patients p less among witnessed patients initiation bystander cpr associated significant improvement survival compared bystander cpr group p less bystander cpr also associated improved outcome witnessed patients successful prehospital resuscitation evaluated group bystander cpr survived compared patients bystander cpr p less conclusion data revealed improved survival rates bystander cpr initiated victims witnessed cardiac arrest ems system short response times,C14,0.011792733,0.0018010419,0.012774554,0.0011407835,0.002855989,0.013279612,0.17884319,0.0117289955,0.001467869,0.0019949605,0.020363541,0.023835832,0.122855514,0.004675234,0.0017854909,0.0031617125,0.24641095,0.0020936786,0.02567483,0.16979933,0.1388503,0.00072091154,0.0020929542
response spinal cord blood flow motor sensory evoked potentials aortic ligation produce spinal cord ischemia lamb ligation thoracic aorta performed minutes three animals spinal cord blood flow motor sensory evoked potentials measured aortic ligation ischemia blood flow zero ligation encountered thoracic lumbar cords followed hyperemia upon release ligature somatosensory motor evoked potentials obliterated aortic ligation gradually recovered following resumption flow motor sensory evoked potentials behaved similarly high aortic ligation,C14,0.021252405,0.0032289987,0.006792151,0.0020452545,0.0050688,0.022298094,0.075337335,0.07390606,0.020245656,0.0035766657,0.018800594,0.0075668576,0.33973372,0.00836984,0.0032010602,0.0056684776,0.07092703,0.0037487557,0.0041448516,0.061733894,0.131586,0.10702264,0.003744857
optimizing heparin utilization angiographic flush solutions various concentrations heparin angiographic flush solutions employed angiography effort determine whether differences outcome seen either high low concentrations heparin angiographic flush solutions utilized two groups patients evaluated difference outcome small systemic effect heparin seen groups use low concentration heparin suggested routine angiography,C14,0.02498661,0.0038385442,0.008074321,0.0024313417,0.006025649,0.0055846255,0.09788908,0.0040694596,0.0031284562,0.004251841,0.104823254,0.1363498,0.10713245,0.009949833,0.0038053317,0.0067385295,0.065444805,0.004456417,0.025869416,0.13188016,0.2372818,0.0015364724,0.004451782
effects phenylephrine right ventricular performance patients pulmonary hypertension pulmonary hypertension causes right ventricular ischemia failure result increased afterload combined reduced coronary blood flow increasing coronary driving pressure raising aortic pressure phenylephrine shown reverse right ventricular ischemia pulmonary hypertension animals since vasodilators often fail reduce afterload tested whether raising coronary driving pressure would improve right ventricular function man ten patients pulmonary hypertension hemodynamics right ventricular coronary driving pressure measured minutes steady state reached phenylephrine infusion titrated raise aortic pressure percent phenylephrine caused significant p less increase mean aortic pressure mm hg right ventricular coronary driving pressure mm hg response significant p less rise mean pulmonary artery pressure mm hg right ventricular end diastolic pressure mm hg wedge pressure mm hg insignificant fall cardiac output l min pulmonary artery saturation percent although phenylephrine increased right ventricular coronary driving pressure worsened right ventricular function manifest rise end diastolic pressure fall cardiac output benefit raising right ventricular coronary driving pressure may offset alpha vasoconstriction right ventricular coronary blood flow pulmonary arterial vasoconstriction phenylephrine appear useful therapy right ventricular failure pulmonary hypertension patients fail vasodilators,C14,0.2835755,0.016572315,0.0029257878,0.00088101404,0.0021834369,0.0020265067,0.13233653,0.024238864,0.0011336184,0.001540685,0.023330938,0.011113437,0.2730361,0.0036053932,0.0013788891,0.002443903,0.061983567,0.0016148145,0.0017854368,0.053198237,0.08174713,0.0005567517,0.016791105
high risk reparative surgery neglected alternative heart transplantation selection patients either high risk reparative operations heart transplantation become increasingly difficult result improved results modalities retrospective review done patients referred heart transplantation considered candidates conventional cardiac surgery yet instead underwent reparative procedures rather transplantation adult patients referred year period coronary artery disease five valvular heart disease new york heart association class iv symptoms preoperative left ventricular ejection fractions range mean ten patients coronary artery disease required insertion intra aortic balloon pump hemodynamic support perioperatively seven patients primary coronary artery bypass grafts reoperative coronary bypass procedures one patient left ventricular aneurysmectomy one endocardial stripping addition myocardial revascularization procedures patients valvular disease three aortic valve replacement two reoperations two others mitral valve replacements tricuspid annuloplasties mean follow months month actuarial survival rates respectively one patient underwent aortic valve replacement study successfully received heart transplantation months postoperatively results compare favorably current results patients undergoing first graft heart transplantation survivors enjoy new york heart association class ii functional capacity,C14,0.0016430671,0.0014574825,0.0030657928,0.00886864,0.010213493,0.010063933,0.12841953,0.017425293,0.0011878643,0.0016197866,0.03953381,0.01994331,0.053279854,0.004152135,0.040831834,0.018463138,0.5176648,0.0016920867,0.0018708736,0.06704664,0.03337626,0.01649003,0.0016903268
fish oil amplifies effect propranolol mild essential hypertension forty seven male patients mild essential hypertension randomly allocated three subgroups run period weeks first subgroup n received propranolol mg day weeks followed placebo period weeks second subgroup n run period weeks given supplement encapsulated fish oil g day weeks subsequent period weeks fish oil placebo given third subgroup n run period weeks given propranolol mg day weeks propranolol mg day plus fish oil capsules g day equivalent g day eicosapentaenoic acid g day docosahexaenoic acid weeks propranolol plus fish oil placebo doses weeks subsequent period weeks propranolol placebo administered results indicate blood pressure lowering effect fish oil comparable propranolol simultaneous intake fish oil plus propranolol effective propranolol fish oil alone propranolol treatment resulted decrease plasma norepinephrine plasma renin activity thromboxane b formation fish oil supplementation plasma norepinephrine thromboxane b formation likewise reduced whereas plasma renin activity appeared increased decrease serum triglycerides total low density lipoprotein cholesterol well rise high density lipoprotein cholesterol concomitant beneficial effects justify consideration fish oil alone combination antihypertensive drugs treatment mild hypertension,C14,0.010904388,0.0016547985,0.0034808442,0.0010481528,0.0025976605,0.002407535,0.15649183,0.018669378,0.0013486791,0.001832971,0.015537074,0.046731852,0.080074295,0.004332814,0.019706886,0.0029407723,0.054667905,0.0019211638,0.03824834,0.05814464,0.4566491,0.0006623741,0.01994659
cardioprotective effects amlodipine ischemia reperfusion two experimental models cardioprotective effect amlodipine long acting dihydropyridine derivative studied experimental models ischemia reperfusion isolated blood perfused feline hearts made globally ischemic minutes reperfused minutes alterations left ventricular developed pressure compliance monitored amlodipine treated hearts saline treated control animals changes perfusion pressure indicated amlodipine significantly reduced myocardial oxygen consumption coronary vascular resistance furthermore progressive increase resting left ventricular diastolic pressure indicated amlodipine administered onset global ischemia attenuated development ischemic contracture return contractile function minutes reperfusion maintenance tissue concentrations electrolytes significantly better amlodipine treated group control animals intact canine hearts regional myocardial ischemia induced minutes followed hours reperfusion although hemodynamic variables size region risk differ significantly treated animals control animals infarct size significantly smaller amlodipine treated group control animals gradual reduction coronary blood flow observed control group prevented amlodipine group comparison findings observed oxygen radical scavengers also discussed detailed report studies published american journal cardiology review included maintain continuity symposium convenience reader,C14,0.018055277,0.018863942,0.0036292137,0.009629958,0.0025397132,0.010938481,0.13083833,0.001678638,0.0012904773,0.0103926,0.008780463,0.050434608,0.25281006,0.004805701,0.010185726,0.002789297,0.0612862,0.0018382566,0.019297589,0.036633182,0.3235164,0.017914724,0.0018511723
haemostatic changes continuous oestradiol progestogen treatment postmenopausal women identify changes haemostatic balance continuous oestradiol progestogen treatment postmenopausal women climacteric complaints mean age years range randomly allocated receive one four hormone replacement regimens one year four formulations administered daily continuously contained mg beta oestradiol combination either norethisterone acetate mg group mg group b megestrol acetate mg group c mg group significant changes occurred treatment within groups platelet count fibrinogen antiplasmin activated partial thromboplastin time shortened p less group decline factor vii activity antigen p less atiii activity p less noted group protein c tended decline treatment groups statistically significant changes noted groups c two women developed crural thrombosis observation period,C14,0.002623095,0.002326816,0.0049999715,0.00147381,0.003657281,0.0033852407,0.16634718,0.0024667901,0.0018963809,0.002577345,0.014297077,0.142034,0.08732602,0.02960401,0.0023066835,0.0040847044,0.13360229,0.028095672,0.0029867794,0.06293128,0.28107974,0.0009313657,0.018966509
relation beta adrenergic blocker use various correlates left ventricular function chance developing congestive heart failure multicenter diltiazem post infarction research group study examined relations among beta adrenergic blocker use various correlates left ventricular function chance developing congestive heart failure patients myocardial infarction study performed placebo group multicenter diltiazem post infarction trial ejection fraction data available patients receiving beta blocker addition ejection fraction correlates left ventricular function included presence absence pulmonary rales chest x ray film evidence pulmonary congestion presence gallop beta blocker use less frequent patients ejection fraction less rales gallop pulmonary congestion chest x ray film twenty one percent patients ejection fraction less patients rales patients gallop patients pulmonary congestion receiving beta blocker therapy every correlate left ventricular function chance developing congestive heart failure greater patients diminished left ventricular function without level left ventricular function chance developing congestive heart failure requiring treatment greater patients taking beta blocker,C14,0.038560074,0.0959032,0.004025557,0.001212177,0.0030041654,0.059433352,0.19474658,0.0020288818,0.0015597324,0.0021198106,0.011233766,0.035761952,0.18648656,0.0051336517,0.0018971973,0.003359581,0.16094375,0.0022218043,0.023344398,0.032007754,0.06936399,0.063432604,0.0022194937
efficacy recombinant derived human superoxide dismutase porcine left ventricular contractility normothermic global myocardial ischemia hypothermic cardioplegic arrest porcine model normothermic global ischemia minutes followed systemic cooling degrees c degrees c crystalloid cardioplegic arrest minutes used assess efficacy recombinant derived human superoxide dismutase r hsod postreperfusion left ventricular function cardiopulmonary bypass isovolumic hemodynamic function monitored adenine nucleotide pool measured myocardial biopsy specimens coronary sinus effluent treatment group pigs n received mg kg r hsod immediately warm reperfusion left ventricular peak systolic pressure developed pressure significantly better r hsod group pigs p less vs placebo improvement persisted minutes reperfusion p less vs placebo myocardial atp total adenine nucleotides differ adenine nucleotide catabolites coronary sinus effluent differ treatment groups pigs exception nucleotide catabolite inosine significantly elevated coronary sinus effluent pigs treated r hsod minutes reperfusion p less vs placebo model global ischemia reperfusion recombinant derived human free radical scavenger provides significant protection systolic diastolic function values myocardial atp total adenine nucleotide content suggest improvement mechanical function reperfusion due enhanced preservation myocardial bioenergetics,C14,0.0020936306,0.0018557963,0.024670536,0.0011754652,0.0029131817,0.012785771,0.12881638,0.0019688257,0.0015124945,0.0020556103,0.010080119,0.043542154,0.33841616,0.005844266,0.011971393,0.0032578334,0.031799126,0.07192197,0.03276583,0.035201974,0.14998662,0.03112589,0.054239005
functional chiral asymmetry descending thoracic aorta determine whether rotational blood flow chiral asymmetry exists human descending thoracic aorta established ability color doppler ultrasound detect rotational flow tornado tube model vortex descending fluid column model human aortic arch pulse duplicator color doppler used demonstrate rotational flow occurs first transverse arch proximal descending thoracic aorta use color doppler esophageal echocardiography patients age range years mean age years prospectively examined rotational flow descending thoracic aorta cm superior retro left ventricular position patients revealed rotational flow obvious diastolic counterclockwise rotation less obvious systolic clockwise rotation cm superior retro left ventricular position patients revealed rotational flow tendency toward systolic clockwise diastolic counterclockwise rotation retro left ventricular position patients revealed rotational flow usually clockwise direction occurring systole data suggest aortic flow purely pulsatile axial rotational component rotational flow begins aortic arch carried descending thoracic aorta flow chirally asymmetric systolic clockwise diastolic counterclockwise components data demonstrate aortic rotational flow component may physiological implications organ perfusion,C14,0.0021364274,0.0018951178,0.03501199,0.0012003714,0.039590124,0.002757171,0.13304543,0.043371987,0.001544542,0.01241834,0.083349615,0.004394223,0.16191693,0.0068770354,0.0018787205,0.003326862,0.13217017,0.0022105055,0.002432637,0.11072217,0.18373092,0.03178545,0.0022332713
vascular flow capacity hindlimb skeletal muscles spontaneously hypertensive rats total regional skeletal muscle flows radiolabeled microspheres determined isolated maximally vasodilated hindquarters spontaneously hypertensive rats shr age matched mo normotensive wistar kyoto rats wky assess vascular flow capacity skeletal muscle vascular beds vascular flow capacity estimated measuring total hindquarters regional muscle blood flows conditions maximal vasodilation papaverine papaverine plus isoproterenol wide range perfusion pressures wky shr capillary exchange capacity estimated determining capillary filtration coefficient isogravimetric capillary pressures segmental vascular resistances determined hindquarter isogravimetric flows capillary pressures different wky shr however total precapillary vascular resistances significantly elevated shr postcapillary resistances different compared wky maximal capillary filtration coefficient values shr group averaged lower wky values suggesting hypertension associated reduction microvascular surface area available fluid exchange therefore capillary exchange capacity perfusion pressures studied total hindquarters flows averaged lower shr wky flows individual skeletal muscles averaged lower shr wky regardless muscle fiber type thus modifications exist hindlimb skeletal muscle vasculature shr reduces capillary exchange capacity limit capacity deliver flow given perfusion pressure gradient,C14,0.010016916,0.009797696,0.0037297388,0.01833074,0.0023824282,0.043618653,0.11064794,0.049678195,0.050934166,0.0016810979,0.03303977,0.029667383,0.29037663,0.020432303,0.0015046373,0.060640622,0.016369669,0.0017619833,0.0019481555,0.013857698,0.1361278,0.05857935,0.03487639
changes left ventricular diastolic performance aortic balloon valvuloplasty acute late effects evaluate acute follow changes left ventricular diastolic performance simultaneous digital left ventriculography micromanometry performed patients undergoing aortic balloon valvuloplasty patients improved symptomatically valvuloplasty returned months later follow catheterization immediately valvuloplasty aortic valve area increased versus cm p less cardiac output versus liters min ejection fraction versus change diastolic indexes worsened signified decrease peak filling rate versus ml p less increase time constant isovolumetric relaxation tau versus ms p less modulus chamber stiffness versus p less follow catheterization patients continued symptomatic improvement group recurrence symptoms group aortic valve area cardiac output ejection fraction follow catheterization groups similar unchanged values valvuloplasty,C14,0.028011035,0.00232704,0.004894894,0.0014739519,0.0036529282,0.0033855664,0.09185249,0.027857678,0.0018965633,0.0025979846,0.012823923,0.043725457,0.21842617,0.0060318857,0.0023069053,0.0040906323,0.25360775,0.002701613,0.0029870667,0.047639832,0.20868008,0.026329733,0.002698803
mitral stenosis evaluation mr imaging percutaneous balloon valvuloplasty evaluate pathoanatomic findings mitral valve stenosis changes percutaneous balloon valvuloplasty pbv magnetic resonance mr imaging performed patients patients imaged system within week days pbv angle interatrial septum measured transverse image facilitate successful transseptal puncture mr images mean transverse anteroposterior diameters left atrium level aortic root ventricular diastolic phase decreased significantly pbv areas flow related intraluminal signal intensity detected left atrial cavity patients procedure disappeared patients procedure mr imaging findings pbv disappearance intraluminal signal intensity pulmonary artery normal curvature interatrial interventricular septa pericardial effusion complication mr imaging thought provide useful information pbv patients mitral stenosis,C14,0.038850326,0.0027462505,0.020720117,0.0017394805,0.094210714,0.00400794,0.15605336,0.032885835,0.0022382245,0.0030419396,0.05639468,0.006367893,0.086153984,0.0072653643,0.0027224887,0.0347798,0.28814006,0.003190339,0.0035251793,0.0213224,0.129352,0.0010992547,0.0031923892
perioperative myocardial injury patients undergoing aortic valve replacement cases myocardial hypertrophy myocardial protection may insufficient order determine factors responsible myocardial injury assessed myocardial injury patients undergoing isolated aortic valve replacement cases hypothermic cardioplegic arrest induced different times measured serum level creatine kinase ck myocardial bound creatine kinase ckmb lactic dehydrogenase ldh alpha hydroxybutyrate dehydrogenase alpha hbdh glutamic oxaloacetic transferase got myoglobin mean duration ischemia minutes mean time extracorporeal circulation minutes performance multiple regression analysis significant correlation ischemia ldh alpha hbdh found ck got ldh alpha hbdh correlated duration extracorporeal circulation none patients low cardiac output syndrome observed results conclude study myocardial protection sufficient therefore detrimental effects extracorporeal circulation determining factors enzyme release,C14,0.051457543,0.0022415048,0.0047149723,0.0014197738,0.0035186573,0.003261123,0.10985969,0.002376347,0.0018268513,0.0024828482,0.060914688,0.0051973932,0.23200133,0.006858026,0.0022221105,0.0039349413,0.14022623,0.014832864,0.002877271,0.13036364,0.16498347,0.0008972178,0.05153148
prognostic value electrophysiology testing asymptomatic patients wolff parkinson white pattern published erratum appears circulation mar prognostic value electrophysiology testing studied asymptomatic patients wolff parkinson white electrocardiographic pattern patients underwent electrophysiology testing entry study followed annually total patient years median years male female patients age enrollment ranged years mean years median effective refractory period accessory pathway msec interquartile range msec median shortest rr interval preexcited beats atrial fibrillation srr corrected msec msec twenty three patients srr msec less eight patients median shortest srr interval msec less twelve patients inducible sustained reciprocating tachycardia patients inducible nonsustained reciprocating tachycardia patients inducible sustained atrial fibrillation twenty patients lacked retrograde conduction accessory pathway patient died suddenly median follow years six patients became symptomatic documented supraventricular tachycardia two underwent operative ablation accessory pathways patient absent retrograde accessory pathway conduction electrophysiology study became symptomatic inducible sustained nonsustained reciprocating tachycardia electrophysiology study predict development subsequent symptomatic supraventricular tachycardia nine patients lost preexcitation follow age enrollment relative risk decade confidence interval anterograde accessory pathway refractory period relative risk msec confidence interval independent predictors loss preexcitation,C14,0.0018487794,0.0016399596,0.021347571,0.0010387538,0.0025743668,0.0023859462,0.09408353,0.0017386145,0.01923539,0.0018165343,0.08070516,0.0038025859,0.089805245,0.050114613,0.019538617,0.002880715,0.3816021,0.0019039363,0.0021051073,0.16554835,0.05172057,0.0006564344,0.0019071108
ventilatory diffusion abnormalities potential heart transplant recipients data available concerning pulmonary function patients severe chronic congestive heart failure patients evaluated potential cardiac transplantation ucla underwent pulmonary function tests latter patients severe heart failure mean left ventricular ejection fraction percent mean cardiac index l min diffusion impairment either alone combined restrictive obstructive ventilatory defects occurred percent patients evaluated diffusion impairment occurred sole abnormality percent patients combination restrictive ventilatory defect percent reduction diffusing capacity previously described frequent finding patients chronic congestive heart failure contrast studies involving patients acute heart failure obstructive ventilatory defects uncommon none lung function abnormalities associated smoking status prior drug use chest roentgenographic changes hemodynamic findings clinical features including duration congestive heart failure mechanism diffusion impairment unclear could due chronic passive congestion pulmonary fibrosis recurrent pulmonary emboli recognition diffusion impairment common finding patients severe chronic congestive heart failure candidates heart transplantation important proper interpretation possible post transplant changes diffusing capacity due causes,C14,0.029326944,0.0702445,0.0029486814,0.008525294,0.040921103,0.05669594,0.31793797,0.016778732,0.0011424887,0.0015527405,0.037604507,0.003250381,0.06260717,0.04332933,0.0013896785,0.0024681366,0.19148384,0.00162745,0.0017994073,0.043590855,0.05493959,0.008208647,0.0016266342
prognostic importance serum magnesium concentration patients congestive heart failure magnesium abnormalities common patients congestive heart failure clinical prognostic significance abnormal serum magnesium concentration disorder investigated therefore relation serum magnesium concentration clinical characteristics long term outcome patients chronic heart failure evaluated serum magnesium concentration less meq liter patients within normal range patients greater meq liter patients patients hypomagnesemia frequent ventricular premature complexes episodes ventricular tachycardia patients normal serum magnesium concentration p less even though two groups similar respect severity heart failure neurohormonal variables patients low serum magnesium concentration significantly worse prognosis long term follow versus year survival p less patients hypermagnesemia severe symptoms greater neurohormonal activation worse renal function patients normal serum magnesium concentration tended fewer ventricular arrhythmias hypermagnesemic patients worse prognosis normal magnesium concentration versus year survival p less conclusion measurement serum magnesium concentration provides important clinical prognostic information patients chronic heart failure,C14,0.0021178934,0.05301443,0.0039914176,0.0011873797,0.00294271,0.019645587,0.23454824,0.0019873774,0.0015278253,0.0020812473,0.014356577,0.014638859,0.12121911,0.005130021,0.022315297,0.0032908549,0.25775692,0.012708346,0.0024063082,0.048216686,0.1719925,0.0007503577,0.00217409
mechanical factors large artery disease antihypertensive drugs hypertension may induce early alterations large arteries mechanical stresses one related intravascular pressure blood flow dynamics distending pressure force acts circumferential direction inducing decreased arterial distensibility arterial distensibility evaluated humans measurement arterial compliance pulse wave velocity well established chronic hypertension age elevated pressure act together increase arterial rigidity blood flow dynamics induce frictional forces endothelial surfaces arteries forces expressed shear stress proportional viscosity blood velocity gradient arterial wall measurement blood viscosity evaluation velocity profile brachial arteries hypertensive subjects shown reduction wall shear rate stress despite elevation blood viscosity several studies shown drug therapy successfully reduces blood pressure necessarily improve arterial compliance contrast data available effects antihypertensive medication arterial wall shear humans arterial compliance wall shear stress main therapeutic targets potential importance physiopharmacologic approach effects hypertension atherogenesis,C14,0.12053297,0.0338119,0.04073451,0.0009381344,0.010430868,0.03434448,0.20427886,0.018649505,0.025452293,0.001640575,0.010163211,0.011480249,0.18018551,0.028076245,0.025715759,0.002605392,0.015250413,0.009796701,0.0019011952,0.057950567,0.16372925,0.0005928486,0.0017385576
two year outcome angiographically documented myocardial reperfusion acute coronary occlusion thrombolysis angioplasty study group reperfusion therapy clearly shown decrease early mortality acute myocardial infarction impact therapy long term survival less extensively evaluated study reports extended follow large cohort patients treated intravenous thrombolytic therapy combined considered necessary maintain augment infarct vessel patency mechanical reperfusion therapies patient underwent coronary angiography within hours initiation thrombolytic infusion coronary angioplasty performed patients hospital discharge underwent coronary artery bypass graft surgery follow obtained mean months range months cause mortality period died cardiac causes nonfatal reinfarction occurred although low event rate limits validity statistical comparisons patients survived follow period tended younger vs years better predischarge left ventricular function left ventricular ejection fraction vs lower prevalence multivessel coronary artery disease vs excellent long term survival may part reflect exclusion high risk patients enrollment thrombolysis angioplasty myocardial infarction tami studies may also attributable however frequent use combined thrombolysis mechanical revascularization population,C14,0.01858133,0.0015435412,0.011609426,0.0009776821,0.002423344,0.0023091326,0.25530818,0.0016385284,0.0012580032,0.010114014,0.03352714,0.02096006,0.08659764,0.0040154853,0.0015301858,0.002711925,0.33604276,0.0017919978,0.0021506436,0.13095412,0.05470089,0.017463846,0.001790134
multivariate analysis prediction death hospital acute myocardial infarction prognostic factors patients acute myocardial infarction based clinical investigative data admission evaluated prospectively consecutive patients seventeen patients died hospital stay age previous infarct high killip class cardiomegaly high serum concentrations cardiac enzymes low ejection fraction high wall motion score index correlated significantly hospital mortality whereas sex risk factors pericardial effusion multivariate analysis showed age wall motion score index best predictors death hospital wall motion detected cross sectional echocardiography may reflect extent myocardial involvement age wall motion score index predicted hospital mortality sensitivity specificity predictive accuracy age wall motion score index determined admission useful identifying patients high risk cardiac death might benefit early intervention,C14,0.013437894,0.0020417215,0.0042947307,0.0012932306,0.0032050426,0.002970462,0.16972926,0.0021645452,0.0016640257,0.0022615541,0.08560923,0.047625087,0.13007826,0.005519727,0.024304759,0.014721456,0.18464053,0.002370368,0.0026208225,0.23248234,0.06377715,0.0008172496,0.0023705126
incidence perioperative myocardial ischemia detected different electrocardiographic systems determine extent different electrocardiographic systems account differences reported incidence perioperative myocardial ischemia authors simultaneously recorded patients undergoing coronary artery bypass grafting cabg v modified cm lead five ecg systems means specially constructed common v lead systems included spacelabs alpha model series ecg cardule bandwidths hz hz typical operating room monitor marquette electronics mac ii ecg hz hz standard ecg del mar holter recorder hz relative st segment position incidence new ischemia compared preoperative ecg determined sets preinduction traces sets intraoperative traces st segment position three recording systems conforming american heart association aha low frequency response recommendations hz similar compared standard ecg st segment position spacelabs hz consistently negative displacement holter consistently less negative less positive mv displacement criterion diagnosis myocardial ischemia one ecg system patients arrival patients intraoperatively suffered new myocardial ischemia based operating room monitor arrival intraoperative ischemia present patients respectively ischemia periods less frequent standard ecg system respectively least frequent holter recorder respectively,C14,0.0019261382,0.0017085806,0.013206237,0.0010822185,0.030651614,0.0031623004,0.30165035,0.011126463,0.0013925122,0.0018925439,0.09448791,0.004022152,0.13373585,0.004452567,0.0016937973,0.012318426,0.14288355,0.001983603,0.03892489,0.10668305,0.078857,0.0006839017,0.01147436
ultrasonic integrated backscatter two dimensional imaging evaluation mode guided acquisition immediate analysis consecutive patients shown previously cardiac cycle dependent integrated backscatter characterizes physical state myocardium patients ischemic heart disease cardiomyopathy present study clinical applicability mode guided two dimensional integrated backscatter imaging defined evaluation nonselected patients mean amplitude cyclic variation integrated backscatter normal segments long axis view follows basal septum db mean sd n mid septum db n basal posterior db n mid posterior decibels n respective mean delay values r wave nadir follows least one cardiac cycle could analyzed fully patients limitations included technically difficult two dimensional echocardiography inadequate line orientation technically remediable errors poor quality integrated backscatter images abnormal segments n cyclic variation reduced delay prolonged db respectively intraobserver interobserver variability amplitude measurements modest respective correlation coefficients r r findings demonstrate mode assisted integrated backscatter practical approach characterization regional myocardial properties promptly bedside large portion patients cardiac disease,C14,0.03961498,0.0017011071,0.06844042,0.0010774847,0.049671013,0.011747834,0.22871792,0.020357141,0.029221198,0.020449407,0.010004336,0.0039579594,0.11847643,0.004485391,0.0016863884,0.002986278,0.18851113,0.0019756248,0.0022015504,0.046461485,0.101479314,0.009961419,0.03681419
determinants ventricular rate atrial fibrillation determinants ventricular cycle length atrial fibrillation examined patients thirty three patients structural heart disease none accessory atrioventricular av connection av node effective functional refractory periods shortest atrial pacing cycle length associated conduction av node conduction time indexes concealed conduction av node measured baseline state patients modification sympathetic tone infusion isoproterenol propranolol patients atrial fibrillation induced rapid atrial pacing mean shortest longest ventricular cycle lengths measured variables correlated strongly mean rr interval atrial fibrillation av node effective refractory period r p less av node functional refractory period r p less shortest atrial pacing cycle length associated conduction r p less ah interval sinus rhythm r p less atrial pacing shortest cycle length conduction r p less weaker correlations measures concealed conduction improve prediction mean longest ventricular cycle length atrial fibrillation conclusion refractory periods conductivity av node best indicators potential node transmit atrial impulses ventricles atrial fibrillation degree concealed conduction av node less important determinant mean ventricular rate atrial fibrillation,C14,0.0025011224,0.0022186204,0.016825667,0.01334359,0.0034827336,0.0032278285,0.17758054,0.0023520857,0.0018082001,0.0024574995,0.024108093,0.0051617,0.2643998,0.005788502,0.014286855,0.0038963486,0.23824623,0.0025757414,0.0028478957,0.0888521,0.11010837,0.00088805764,0.013042409
interleukin attenuate hypertension spontaneously hypertensive rats recently reported interleukin administered single bolus injection units kg could prevent development hypertension young spontaneously hypertensive rats lower blood pressure normotensive levels spontaneously hypertensive rats established hypertension consequently efforts made duplicate finding male spontaneously hypertensive rats days old injected subcutaneously units kg units rat recombinant interleukin amgen systolic blood pressure measured twice weekly tail cuff technique systolic blood pressure interleukin treated group significantly different vehicle treated control group time point days follow second injection recombinant interleukin units kg administered days first injection reduction blood pressure observed interleukin treated group additional days mean arterial pressure sem measured via intra arterial cannula conscious rats age days days second treatment mm hg interleukin treated spontaneously hypertensive rats mm hg vehicle treated controls recombinant interleukin preparations conformed respective manufacturer indicated specific activity determined ability interleukin induce proliferation interleukin dependent cell line ht thus study demonstrated interleukin ineffective preventing attenuating hypertension spontaneously hypertensive rats,C14,0.0608617,0.017362524,0.03487435,0.008872363,0.0022908666,0.002120223,0.13762328,0.0015449846,0.0011877294,0.0016142265,0.023280075,0.056051992,0.14261651,0.02257315,0.0014447076,0.0025583066,0.0651976,0.0016918945,0.0177661,0.055568505,0.31564665,0.00058332714,0.026668943
biphasic effects doxorubicin calcium release channel sarcoplasmic reticulum cardiac muscle define mechanism doxorubicin cardiotoxicity effects doxorubicin caffeine examined calcium release channels cardiac sarcoplasmic reticulum found calcium release cardiac sarcoplasmic reticulum vesicles induced compounds sarcoplasmic reticulum vesicles incorporated planar lipid bilayers calcium permeable channels observed addition caffeine mm increased channel open probability less effect persisted mean minutes contrast doxorubicin microm biphasic effect initially doxorubicin activated channel whereas mean minutes channel became irreversibly inhibited although degree channel activation doxorubicin concentration dependent time needed inactivate channel concentration independent pretreatment dithiothreitol mm prevented doxorubicin induced channel inactivation channel activity persisted average minutes dithiothreitol alone alter channel open probability results support hypotheses integrity sulfhydryl groups important aspects calcium release channel function activation inactivation channel separable processes biphasic effect doxorubicin channel function may also correspond clinically observed adverse effects doxorubicin widely used chemotherapeutic agent prolonged usage causes dilated cardiomyopathy,C14,0.0018324106,0.010494214,0.0034213024,0.0010295567,0.0025515736,0.0023648213,0.16935223,0.001723221,0.010194924,0.001800451,0.028631995,0.021505414,0.08730655,0.20960231,0.028218575,0.0028559628,0.06000787,0.028495861,0.010943489,0.028118249,0.2870133,0.0006506224,0.0018851163
factors determining success energy requirements cardioversion atrial fibrillation factors thought affect success energy requirements cardioversion atrial fibrillation studied male female patients aged mean years transthoracic impedance measured advance countershock using khz low amplitude ac current passed self adhesive ecg defibrillator pads diameters cm applied chest antero posterior ap position patients anteroapical aa position patients mean transthoracic impedance patients sd ohms range ohms transthoracic impedance significantly greater aa ap position vs ohms p initial energy j delivered gradually increased maximum j required cardioversion successful per cent low energy shocks less equal j successful per cent patients using single factor analysis sex left atrial enlargement electrode pad positions aetiology atrial fibrillation presence left ventricular failure prior treatment verapamil beta adrenergic blockers significant determinants cardioversion success success low energy shocks prior treatment digoxin cardioversion success success low energies patients transthoracic impedance less equal ohms low energy shocks often successful per cent patients transthoracic impedance greater ohms per cent p using univariate analysis cardioversion success low energy shocks significantly associated prior treatment digoxin also duration atrial fibrillation hours one month one month three years shocks less equal j prior treatment amiodarone multifactorial linear regression analysis selected rank order duration atrial fibrillation hours less one month one month three years significant predictors cardioversion success irrespective shock strength success low energy shocks,C14,0.009368872,0.00919082,0.012035403,0.03966721,0.03330428,0.025364388,0.13920504,0.009275231,0.0011601228,0.009334958,0.015871657,0.08097733,0.17772305,0.0044661895,0.001411128,0.018019743,0.2354637,0.0016525694,0.0018271809,0.1320762,0.032602217,0.008335394,0.0016673849
novel mechanical cardiac assist device reversing left ventricular failure diastolic augmentation aortic pressure efficacious means improving coronary perfusion heart failure novel mechanical cardiac assist device mcad advantages conventional intraaortic balloon pump left ventricular assist devices developed consists high efficiency rotary solenoid coupled pair actuator plates clamp shunt aortic graft section operates diastolic counterpulsation mode system evaluated six anesthetized thoracotomized dogs myocardial ischemia mcad activated min coronary artery occlusion synchronized r wave illustrated representative sample data obtained one several trials preliminary experimental results demonstrated mcad worked effectively fulfill primary functions counterpulsation assist device e augmentation coronary perfusion reduction vascular impedance ventricular ejection,C14,0.0327936,0.03246216,0.0057311086,0.001725753,0.004277589,0.018790394,0.16163191,0.05809854,0.002220561,0.0030179333,0.0931178,0.02116973,0.104914576,0.0147710815,0.0027010033,0.0047995844,0.10886437,0.018025374,0.03322699,0.08219779,0.1317443,0.030828178,0.03288965
deleterious effects testicular venous occlusion young rats determine differences testicular arterial venous obstruction spermatic artery vein occluded varying periods time young rats two months later conclusion study testes examined histologic degeneration vascular obstruction graded modified johnsen tubular biopsy score tbs testicular concentrations enzymes lactic dehydrogenase sorbitol dehydrogenase known decrease testicular injury measured tbs seminiferous tubule diameter std found decrease significantly two hours vascular occlusion similar regardless whether obstruction produced occlusion arterial inflow venous drainage testicular concentration enzymes decreased significantly permanent ligation spermatic artery vein decreased minimally vascular obstruction lasted less minutes testicular injury produced venous occlusion equally severe occurred rapidly injury produced arterial combined arteriovenous occlusion significant injury noted contralateral testes group,C14,0.15894157,0.0019356833,0.01463207,0.0012260658,0.01358662,0.002990416,0.07636505,0.088313505,0.0015776034,0.0021440987,0.020476745,0.026099764,0.116273895,0.005052155,0.001918935,0.0033980743,0.13908735,0.0022472613,0.0024847083,0.04891117,0.23647527,0.011327258,0.024534712
hormones regulating cardiovascular function patients severe congestive heart failure relation mortality consensus trial study group varying hormonal activation heart failure able evaluate activation relate prognosis took blood samples baseline weeks patients severe heart failure new york heart association class iv randomized additional treatment enalapril placebo study consensus previously reported significant reduction mortality among patients treated enalapril present data show placebo group significant positive relation mortality levels angiotensin ii p less aldosterone p noradrenaline p less adrenaline p atrial natriuretic factor p similar relation observed among patients treated enalapril significant reductions mortality groups patients treated enalapril consistently found among patients baseline hormone levels median values significant reductions hormone levels baseline weeks group patients treated enalapril hormones except adrenaline correlations changes hormone levels summarily pronounced variable neurohormonal activation heart failure even patients similar clinical findings activation reduced enalapril therapy results suggest effect enalapril mortality related hormonal activation general renin angiotensin system particular,C14,0.0015861978,0.016688125,0.01041504,0.00088800996,0.002200775,0.01733512,0.15335022,0.0014863071,0.0011426202,0.0015529192,0.024934912,0.03665706,0.09827428,0.0038685359,0.016683469,0.0024611435,0.122582085,0.039881624,0.04512173,0.10376465,0.29693803,0.0005611727,0.0016259445
contribution transesophageal echocardiography patient diagnosis treatment prospective analysis capability transesophageal tee versus transthoracic tte echocardiography diagnostic tool clinical practice prospectively examined consecutive cases conclusive diagnosis possible tee whereas result achieved tte specifically tee provided conclusive diagnosis cases infective endocarditis tte gave result cases p less similarly tee allowed conclusive diagnosis instances aortic dissection tte gave indication two cases p less tee similarly effective eight eight cases atrial thrombi whereas tte gave diagnosis three eight cases p less five subjects intracardiac masses tee gave conclusive diagnosis five whereas tte able diagnose conclusively one subject p less seven patients mitral regurgitation tee gave conclusive diagnosis seven tte able provide information four p ns tee able provide conclusive diagnosis four patients aortic insufficiency tte gave information two four p ns patients prosthetic valve dysfunction tee gave diagnosis tte gave eight patients p ns methods gave conclusive diagnosis cases mitral stenosis p ns also tee provided conclusive diagnosis eight eight patients adult congenital heart disease tte gave information four p ns,C14,0.0024096624,0.0021374908,0.016157039,0.036307327,0.026669536,0.0031097948,0.29912093,0.025587704,0.0017420787,0.0023676348,0.19896777,0.0052331504,0.08640466,0.005548497,0.0021189963,0.015402358,0.17967153,0.0024815528,0.014405742,0.017181037,0.053636655,0.0008555836,0.0024832468
timing mechanism hospital late death primary coronary angioplasty acute myocardial infarction effect early myocardial reperfusion patterns death acute myocardial infarction ami unknown thus mechanism timing hospital late deaths among group patients treated coronary angioplasty without antecedent thrombolytic therapy ami determined death occurred patients hospital discharge four patients died catheterization laboratory death due cardiogenic shock patients acute vessel reclosure patients sudden patients followed elective coronary artery bypass surgery patients cardiac rupture observed patients failed infarct angioplasty occur among patients successful infarct reperfusion intracranial hemorrhage occur multivariate predictors hospital death included failed infarct angioplasty cardiogenic shock vessel coronary artery disease age greater equal years follow period months range patients died cause death cardiac patients including arrhythmic death patients due circulatory failure others one patient died reinfarction due late reclosure infarct artery actuarial survival curves demonstrated overall survival hospital discharge years respectively freedom cardiac death years multivariate predictors late death included vessel disease baseline ejection fraction less equal age greater years female gender,C14,0.042089675,0.0092638,0.0030179655,0.008730144,0.0022525387,0.0020873838,0.12251969,0.0015248414,0.0011693334,0.0015892247,0.025896022,0.011369896,0.05040798,0.00372616,0.009027262,0.0025186823,0.51871675,0.0016656896,0.0018416874,0.107285194,0.06323415,0.008402006,0.0016639573
transesophageal echocardiography diagnosis ostial left coronary artery stenosis diagnosis ostial stenosis left main coronary artery usually made use coronary angiography however positioning catheter across obstruction may obscure diagnosis contrast injection although damping arterial pressure catheter enters left coronary artery may suggest ostial stenosis may possible make diagnosis certainty cardiac catheterization report series four patients left coronary ostium proximal left coronary arteries visualized means transesophageal echocardiography ostial narrowing plaque abnormally fast flow velocities seen case echocardiographic findings contributed subsequent management patients,C14,0.029683052,0.0025541503,0.0053726174,0.029470805,0.01794323,0.003715985,0.2520765,0.07240519,0.0020816608,0.0028291564,0.17953509,0.019856494,0.06911031,0.006831597,0.0025320507,0.018413803,0.19330241,0.00296528,0.0032785933,0.018803533,0.063253924,0.0010223619,0.002962196
spectrum hemodynamic changes cardiac tamponade investigate pathophysiology cardiac tamponade hemodynamics consecutive patients greater ml pericardial effusion studied patients classified groups based equilibration intrapericardial right atrial pulmonary arterial wedge pressures mm hg group n intrapericardial pressure less right atrial pulmonary arterial wedge pressures group ii n intrapericardial pressure equilibrated right atrial pulmonary arterial wedge pressures group iii n intrapericardial pressure equilibrated right atrial pulmonary arterial wedge pressures pericardiocentesis produced following changes group significant p less decreases intrapericardial pressure mm hg right atrial pressure mm hg pulmonary arterial wedge pressure mm hg inspiratory decrease arterial systolic pressure mm hg significant change cardiac output group ii significant p less decreases intrapericardial pressure mm hg right atrial pressure mm hg pulmonary arterial wedge pressure mm hg inspiratory decrease arterial systolic pressure mm hg increase cardiac output liters min group iii significant p less decreases intrapericardial pressure mm hg right atrial pressure mm hg pulmonary arterial wedge pressure mm hg inspiratory decrease arterial systolic pressure mm hg increase cardiac output liters min changes pericardiocentesis parameters significantly p less greater group iii groups ii except change right atrial pressure significantly different groups ii versus iii changes pericardiocentesis indicate pericardial effusion caused greatest abnormalities group iii also caused significant abnormalities pressure flow group ii pressure alone group,C14,0.16670346,0.0012407687,0.0026099384,0.0007859054,0.001947727,0.0018086102,0.04526294,0.0013154096,0.00777719,0.021678124,0.01530304,0.10376225,0.38664335,0.0032225072,0.001230033,0.0021798976,0.06499029,0.0014404894,0.0015926925,0.009366727,0.15720305,0.00049664837,0.0014389913
simultaneous measurement myocardial perfusion ventricular function exercise single injection technetium sestamibi coronary artery disease new radiopharmaceuticals permit simultaneous assessment myocardial perfusion left ventricular function using single tracer injection purpose study quantitate relation myocardial perfusion function rest exercise patients documented coronary artery disease cad rest first pass radionuclide angiocardiogram rna recorded patients cad injection mci technetium tc sestamibi tomographic perfusion images obtained minutes later treadmill test performed attainment exercise end point second first pass rna recorded mci tc sestamibi tomographic images reflecting myocardial perfusion exercise obtained hour later tomographic perfusion defect size quantified using modifications cedars sinai program correlated directly end systolic volume inversely ejection fraction rest exercise however perfusion defect size often varied widely patients similar left ventricular function independence measurements perfusion function suggests simultaneous assessment physiologic variables could improve diagnostic prognostic information radionuclide tests,C14,0.001935439,0.04856488,0.0036113283,0.0010874443,0.045446035,0.0024977848,0.18480489,0.0018201103,0.0013992361,0.0019016825,0.07726204,0.032246422,0.22969125,0.0044714673,0.0017019762,0.031052671,0.15799549,0.011348247,0.01020286,0.035976633,0.07357663,0.019424753,0.021980738
early readmission elderly patients congestive heart failure repetitive hospitalizations major health problem elderly patients chronic disease accounting one fourth inpatient medicare expenditures congestive heart failure one common indications hospitalization elderly also associated high incidence early rehospitalization variables identifying patients increased risk analysis potentially remediable factors contributing readmission previously reported prospectively evaluated patients years older hospitalized documented congestive heart failure hospital mortality n among patients discharged alive readmitted within days recurrent heart failure common cause readmission occurring patients cardiac disorders accounted five readmissions noncardiac illness led readmission cases factors predictive increased probability readmission included prior history heart failure four admissions within preceding years heart failure precipitated acute myocardial infarction uncontrolled hypertension p less using subjective criteria first readmissions judged possibly preventable judged probably preventable factors contributing preventable readmissions included noncompliance medications diet inadequate discharge planning follow failed social support system failure seek medical attention promptly symptoms recurred thus early rehospitalization elderly patients congestive heart failure may preventable cases identification high risk patients possible shortly admission study nonpharmacologic interventions designed reduce readmission frequency justified,C14,0.00982689,0.07425043,0.007942503,0.0009385322,0.0023259853,0.037744213,0.3443324,0.0015708687,0.0012076282,0.0016432822,0.05562706,0.0034357028,0.021458462,0.0043632365,0.009553548,0.0026011672,0.13284643,0.0017202398,0.01806535,0.20041706,0.0658157,0.0005931,0.0017202004
transesophageal echocardiography diagnosis left atrial appendage aneurysm intrapericardial left atrial appendage aneurysm rare describe transthoracic transesophageal echocardiographic findings year old man atrial arrhythmia abnormal left atrial appendage chest roentgenogram presence intrapericardial left atrial appendage aneurysm confirmed surgery,C14,0.006120829,0.0054294807,0.011420831,0.09229336,0.00852306,0.007899248,0.19244148,0.15391721,0.0044250865,0.0060140737,0.06681522,0.012589375,0.037889052,0.015831664,0.0053825025,0.009531403,0.19558308,0.006335316,0.006969464,0.0734647,0.0726534,0.0021732838,0.006296883
developing improved observational methods evaluating therapeutic effectiveness therapeutic efficacy often studied observational surveys patients whose treatments selected nonexperimentally results surveys distrusted fear biased results occur absence experimental principles particularly randomization purpose current study develop validate improved observational study designs incorporating many design principles patient assembly procedures randomized trial specific topic investigated prophylactic effectiveness beta blocker therapy acute myocardial infarction accomplish research objective three sets data compared first developed restricted cohort based eligibility criteria randomized clinical trial second assembled expanded cohort using design principles except restricting patient eligibility third used data beta blocker heart attack trial bhat whose results served gold standard comparison research treatment difference death rates restricted cohort bhat trial nearly identical contrast expanded cohort larger treatment difference observed bhat trial also noted important largely neglected role eligibility criteria may play ensuring validity treatment comparisons study outcomes new methodologic strategies developed may improve quality observational studies may useful assessing efficacy many medical surgical therapies cannot tested randomized clinical trials,C14,0.0015800362,0.024345465,0.0411833,0.00088775787,0.0022003115,0.0020807276,0.4321314,0.0014858851,0.0011422959,0.024490777,0.04832156,0.0033832327,0.051110186,0.00369546,0.009001432,0.010106523,0.06802707,0.0016271754,0.08410428,0.11693557,0.06997266,0.00056101347,0.0016259149
ioxaglate iopamidol equally safe well tolerated cardiac angiography randomized double blind clinical study randomized double blind parallel group study performed patients undergoing left ventriculography coronary arteriography evaluate ecg changes effects left ventricular function low osmolar ionic contrast agent ioxaglate compared low osmolar nonionic contrast medium iopamidol twenty five patients received ioxaglate group patients received iopamidol group patients underwent hours continuous ecg recording beginning hours cardiac catheterization left ventricular systolic end diastolic pressure peak positive dp dt dp dt p ratio measured immediately left ventriculography minutes later left ventricular systolic pressure change injection either contrast medium left ventricular end diastolic pressure increased group p less group p less immediately left ventriculography increase group p less group p less observed minutes later differences observed values obtained two groups peak positive dp dt change immediately injection either contrast medium decreased significant group p less group three minutes left ventriculography significant differences two groups analysis continuous hour ecgs showed ioxaglate iopamidol induced slight increase respectively p less heart rate injection early complete recovery,C14,0.0016644105,0.0014574429,0.011473435,0.0009231473,0.0022878568,0.0021204061,0.091037855,0.03336039,0.0011878321,0.0016143661,0.051906683,0.1388681,0.307319,0.003833207,0.0014448324,0.0025585275,0.1495048,0.0017024829,0.03367898,0.012191195,0.11577072,0.03239854,0.0016957967
comparison direct indirect measures systemic arterial pressure weightlifting coronary artery disease based auscultation measurements exercise circuit weight training cardiac patients reported provoke minimal increases systolic pressure direct brachial artery catheter indirect sphygmomanometry measures blood pressure compared rest lifting legs approximately fourth ninth fourteenth repetition minutes recovery lifting arms legs subjects performed repetitions single arm curl single arm military press single double leg press exercises maximum load could lifted multistation weightlifting apparatus indirect measures systolic pressure rest less recorded directly vs torr p less diastolic pressures similar using either method pattern maintained lifting legs intensities exercise legs arms mean systolic pressure recorded indirectly immediately exercise torr torr less average peak intraarterial value recorded leg arm exercises respectively highest intraarterial pressures generated final repetitions set immediately last repetition systolic diastolic pressures rapidly decreased concluded indirect estimates systolic pressure significantly less true arterial values rest lifting moreover indirect measurements lifting allow accurate conclusions drawn arterial pressures generated lifting rapid decrease pressure occurs exercise,C14,0.032314032,0.05122001,0.011477798,0.0009614092,0.002418869,0.011021952,0.19904512,0.001609159,0.009471243,0.0016812771,0.07469613,0.011776017,0.40511954,0.003952992,0.009782786,0.002667989,0.052118607,0.001762171,0.0020021992,0.014026355,0.09850045,0.00060755695,0.0017663047
relationship sex hormones high density lipoprotein cholesterol levels healthy adult men objective study clarify complex uncertain relationship endogenous sex hormones high density lipoprotein hdl cholesterol levels healthy men fifty five healthy adult men consecutively recruited ongoing cross sectional study cardiovascular disease risk factors lipid research clinic university washington seattle subjects receiving medication excluded multiple linear regression analysis identified several factors correlated highly significantly hdl cholesterol levels including alcohol intake frequency strenuous exercise age levels total cholesterol low density lipoprotein cholesterol triglyceride carbohydrate intake nearly heterogeneity hdl cholesterol levels could accounted factors despite finding significant correlations factors known influence hdl cholesterol levels correlation estradiol level testosterone level ratio estradiol testosterone levels apparent conclusion endogenous sex hormones appear influence hdl cholesterol levels healthy adult men alternatively large proportion heterogeneity hdl levels group men accounted environmental factors disparity conclusion others may partially due differences accounting confounding variables,C14,0.0019009439,0.010880654,0.0035695361,0.010256355,0.0026460472,0.0024519204,0.19698583,0.010955783,0.0013735434,0.0018667637,0.042496614,0.020199928,0.13696398,0.004712475,0.047657818,0.021338228,0.02893638,0.0019565823,0.0021633161,0.24548888,0.18417789,0.019061668,0.0019588638
cis l cis diltiazem anti ischemic action isolated perfused working rat heart effect diltiazem cis diltiazem ischemic myocardium compared l cis diltiazem optical isomer less potent calcium channel blocking action isolated perfused working rat heart ischemia decreased mechanical function tissue levels atp creatine phosphate increased tissue levels nonesterified fatty acids nefa amp lactate reperfusion restore mechanical function restored incompletely levels metabolites except nefa altered ischemia ischemia induced changes nefa prevented cis diltiazem completely l cis diltiazem incompletely metabolic changes induced ischemia attenuated cis diltiazem l cis diltiazem heart pretreated cis l cis diltiazem mechanical function levels metabolites recovered reperfusion degree recovery drugs similar results indicate cis diltiazem also l cis diltiazem anti ischemic action probably due inhibition tissue nefa accumulation results also suggest mechanism protective effect cis diltiazem ischemic myocardium entirely due calcium channel blocking action treatment low ca mm cacl also attenuated ischemia induced changes interval reoxygenation start function reperfused heart treated low ca significantly longer cis l cis diltiazem effect isomers shorten interval may contribute common anti ischemic action,C14,0.0019187122,0.0109804645,0.022156747,0.0010772502,0.0026697735,0.00247437,0.09985105,0.0018030481,0.0013861194,0.0018838556,0.0088176085,0.0039462596,0.10153822,0.026275175,0.0017218179,0.002985628,0.08106905,0.021285504,0.0021831233,0.121958345,0.47936466,0.00068076205,0.0019724432
new single catheter technique simultaneous measurement action potential duration refractory period vivo vivo correlations action potential duration measured monophasic action potential catheter effective refractory period measured separate pacing catheter poor probably known variability action potential duration effective refractory period different ventricular sites study new quadripolar contact electrode catheter designed simultaneous pacing monophasic action potential recording closely adjacent sites mm separation recording electrodes pacing electrodes tested five closed chest dogs four patients dog studies pacing thresholds extremely low ranging mean sd n stable time less increase h continuous pacing close proximity pacing recording electrodes pacing artifact nearly coincided monophasic action potential upstroke low pacing threshold however pacing artifacts small monophasic action potential amplitude twice diastolic threshold strength affect duration configuration simultaneously recorded monophasic action potential short stimulus response time undisturbed monophasic action potential signal fidelity pacing allowed precise simultaneous measurements action potential duration effective refractory period endocardial site,C14,0.0022039663,0.001955028,0.06027633,0.0012383187,0.024260681,0.0028478326,0.2285497,0.002074491,0.0015933695,0.012825041,0.11875298,0.0045335786,0.23224984,0.0053062746,0.0019381123,0.0034320338,0.119181275,0.002309167,0.013160603,0.032528795,0.12572862,0.00078254833,0.0022714087
costs prevention prevention program cost effective yields health benefits alternative uses health care resources prevention programs meet standard either actually save health care resources utilize net costs per healthy year life gained lower alternatives curative palliative medicine prevention programs however less cost effective medical treatments disease one lesson public policy generalizations cost effectiveness prevention unwise another lesson prevention programs subjected higher standard health programs expected save money expected yield improved health reasonable price,C14,0.0031924148,0.09556164,0.021291858,0.017206945,0.0044453363,0.050462972,0.178131,0.0030021856,0.0023079738,0.003136735,0.065355815,0.007310376,0.08246023,0.0073403474,0.002807329,0.0049712537,0.08822982,0.0032876579,0.20324215,0.10982247,0.042015795,0.0011335105,0.0032842385
intermittent claudication heart disease risk factors mortality whitehall study whitehall study subjects aged years completed questionnaire intermittent claudication subjects deemed probable intermittent claudication possible intermittent claudication respectively within year follow period probable possible cases respectively died compared subjects without claudication probable cases suffered increased mortality rates due coronary heart disease cerebrovascular disease mortality rate due noncardiovascular causes increased possible cases demonstrated increased mortality rates due cardiovascular noncardiovascular causes difference mortality pattern may due chance possible probable cases still showed increased cardiovascular cause mortality rates adjusting coronary risk factors cardiac ischemia baseline systolic blood pressure plasma cholesterol concentration smoking behavior employment grade degree glucose intolerance intermittent claudication independently related increased mortality rates rare condition simple questionnaires exist detection latter usefully incorporated cardiovascular risk assessment screening programs,C14,0.0020152642,0.0017834287,0.0037534095,0.0011296273,0.0027998558,0.0123051135,0.15760261,0.011619385,0.0014535141,0.0019809587,0.072175436,0.0041639954,0.17546625,0.014341299,0.0114945285,0.01286088,0.0723105,0.002070499,0.0024273423,0.30452138,0.12894249,0.00071386143,0.0020683454
doppler assessment left ventricular filling pattern silent ischemia patients prinzmetal angina spontaneous angina ideal condition study left ventricular lv dysfunction induced acute myocardial ischemia patients prinzmetal angina lv diastolic function episodes spontaneous angina studied simultaneous recordings electrocardiographic ecg echocardiographic hemodynamic parameters particular pulsed doppler echocardiography measured peak velocity early e late transmitral flow e ratio indexes relative early versus late lv filling ischemic attacks time sequence pulsed doppler echocardiographic ecg changes showed distinct phases waxing phase transmitral flow changes minimal ecg modifications e steady phase maximal ecg changes e waning phase regression ecg changes e phase e ratio showed significant difference baseline value e result changes e suggesting myocardial ischemia affects mainly early phase diastole waxing phase lv diastolic dysfunction preceded systolic abnormalities documented significant reduction e ratio absence alterations lv ejection fraction well systemic arterial pulmonary wedge pressures finally recorded parameters consistent lv contractile rebound occurring waning phase affecting diastole systole,C14,0.018838795,0.0018202493,0.023689747,0.0011531464,0.0028573808,0.0026605683,0.2191313,0.0019297499,0.021339826,0.0020162358,0.010314478,0.0042352206,0.2201891,0.0047323103,0.0018044997,0.09459946,0.11625341,0.0021368242,0.002336533,0.024198271,0.19113488,0.020595009,0.01203298
coronary lesion morphology acute myocardial infarction demonstration early remodeling streptokinase treatment coronary lesion morphology analyzed patients days streptokinase treatment acute myocardial infarction compared lesion morphology control group patients stable angina streptokinase group infarct related artery patent patients compared stenoses stable angina group differences stenosis length severity calcification proportion located acute bend branch point however lesions streptokinase group often irregular p less eccentric p less shoulder p less globular filling defects p less linear filling defects p less contrast staining p less plaque ulceration index higher streptokinase stable angina group versus p less streptokinase treated patients maintained heparin infusion angioplasty days later repeat angiography angioplasty globular lesion filling defects seen eight patients disappeared whereas linear filling defects persisted cases fewer lesions irregular p less ulceration index decreased p less data show lesion infarct related artery streptokinase treatment irregular often associated filling defects perhaps corresponding plaque fissuring intraluminal thrombosis,C14,0.04788171,0.00168524,0.012697442,0.0010674344,0.11299469,0.0024518236,0.16558836,0.0017866188,0.0013734892,0.00186669,0.03738722,0.052183833,0.17024451,0.0043875705,0.01085898,0.021401249,0.18658365,0.0019565052,0.0021632307,0.025845738,0.09523939,0.000674559,0.041680045
clinical experience technetium teboroxime neutral lipophilic myocardial perfusion imaging agent technetium tc teboroxime new technetium based myocardial perfusion imaging agent investigational code sq cardiotec squibb diagnostics member class neutral lipophilic technetium containing complexes known boronic acid adducts technetium dioxime bato complexes agent chemically different cationic tracer thallium tl cationic technetium complex tc sestamibi cardiolite du pont imaging agents tc teboroxime high myocardial extraction rapid blood clearance little lung uptake rapid myocardial washout biexponential pattern myocardial washout demonstrated animals man effective half lives washout components man minutes hours represent approximately myocardial activity respectively first half life myocardium approximately minutes agent washes heart hepatic uptake occurs peaking minutes injection liver major organ excretion receives along large bowel largest radiation dose rapid imaging protocols using standard cameras achieved good myocardial counts planar views acquired minute period single photon emission computed tomography spect images acquired minute period entire stress rest procedure completed hour analysis data patients centers using planar spect imaging showed sensitivity specificity blinded readings respectively compared overall clinical impression,C14,0.001683316,0.0014931853,0.032165106,0.017191848,0.051409945,0.010319895,0.25598574,0.009724008,0.0012169626,0.026074253,0.021864496,0.015215512,0.17325051,0.0040343334,0.017775308,0.051296335,0.09278394,0.0017335364,0.018196255,0.04758677,0.1363442,0.00059768435,0.012056851
physiology pharmacology cardiovascular catecholamine receptors implications treatment chronic heart failure sympathetic nervous system physiologic effects endogenous catecholamines noradrenaline na adrenaline mediated alpha beta adrenoreceptors ars ar types subdivided two major subtypes alpha ars alpha predominant effect vasoconstriction alpha presynaptic inhibition na release postsynaptic vasoconstriction beta ars beta cardiac effects renal renin release lipolysis beta presynaptic facilitation na release postsynaptic vascular bronchial uterine smooth muscle relaxation glycogenolysis possibly part mediated cardiac effects last years growing evidence accumulated dopamine da third endogenous catecholamine immediate precursor na may also cause peripheral effects stimulation specific da receptors addition known action alpha beta ars well accepted least two different da receptors present many peripheral tissues da da including cardiovascular autonomic nervous system seem involved dilation certain vascular beds inhibition na release nerve stimulation natriuresis aldosterone release chronic heart failure cardiac beta ar function decreases presumably due endogenous regulation elevated catecholamines decrease related severity heart failure judged clinically new york heart association functional class human heart contains functional beta beta ars cardiac beta beta ars seem differentially affected different kinds heart failure end stage dilated cardiomyopathy beta ars selectively reduced whereas beta ars nearly normal,C14,0.0016183014,0.0014348236,0.01762538,0.00090885535,0.0022523496,0.0020911493,0.18354009,0.0015382217,0.0089728115,0.0015893113,0.018884184,0.0033269357,0.06092146,0.015206922,0.0014224089,0.03382832,0.082870245,0.047098693,0.0018417878,0.03560166,0.32653308,0.00057432364,0.15031867
characteristics biliary lipid metabolism liver transplantation biliary lipid metabolism studied liver transplantations continuous drainage bile within wk transplantation new liver produced bile concentrations biliary lipids agreement reported tube bile cholecystectolized nontransplanted subjects although changes biliary lipid composition occurred swiftly response various forms disturbed liver function provide substantially information standard serum tests simple measurements bile flow patients secretion rates phospholipids cholesterol found completely bile acid dependent micromole bile acids mumol phospholipids cholesterol secreted respectively bile flow related bile acid output linear relationship found r positive intercept indicating bile acid independent bile flow approximately microliters min analysis individual bile acids showed almost exclusively primary bile acids relative proportion chenodeoxycholic acid prominent first days transplantation different explanations discussed,C14,0.0020509658,0.0018193091,0.014600419,0.0011523541,0.002855905,0.012561739,0.2968305,0.0019287531,0.001482757,0.0020151944,0.040786047,0.0042360667,0.103377946,0.11212676,0.07129803,0.06373031,0.06617805,0.0021291326,0.0023353263,0.043057363,0.15060407,0.0007282235,0.002114733
relative risks left ventricular aneurysmectomy patients akinetic scars versus true dyskinetic aneurysms patients underwent left ventricular aneurysm resection analyzed preoperative procedure related variables ascertain risk factors surgery distinction made akinetic dyskinetic aneurysms assess potential relation postoperative outcome indications surgery arrhythmia patients congestive heart failure angina congestive heart failure angina combinations remaining patients left ventricular aneurysm dyskinetic patients akinetic risk factors surgical procedures similar groups left ventricular ejection fraction less equal patients coronary bypass grafting performed patients average grafts per patient mitral valve replacement common concomitant procedure performed patients intra aortic balloon assist required postoperatively patients overall operative mortality patients due low cardiac output patients arrhythmia patients univariate multivariate analyses related early mortality new york heart association functional classification heart failure predominant indications arrhythmia congestive heart failure left ventricular ejection fraction less equal need intra aortic balloon support excision akinetic rather dyskinetic left ventricular aneurysm follow period averaging nearly years actuarial survival years dyskinetic group akinetic group,C14,0.011418866,0.057919253,0.012977716,0.0010873993,0.032287627,0.0024976816,0.1065993,0.02054917,0.0014346916,0.0019016039,0.009682595,0.03257153,0.029450102,0.004498732,0.029743977,0.0030137564,0.41173553,0.0019930988,0.0022036908,0.12003298,0.047495667,0.05690283,0.0020021573
acebutolol effects lipid profile published erratum appears j cardiol dec relation lipid profile incidence coronary artery disease confirmed results epidemiologic intervention studies among antihypertensive agents beta blockers particularly without intrinsic sympathomimetic activity isa generally reported negative effects lipids may increase risk coronary artery disease ongoing treatment mild hypertension study third year evaluated patients date regard lipid profile additional end points measured multicenter randomized controlled double blind study include blood pressure reduction target organ deterioration trial patients received nutritional behavioral counselling modify diet exercise habits alcohol sodium consumption control hypertension nonpharmacologic means addition patients randomized receive low doses classes antihypertensive medication acebutolol beta blocker isa n amlodipine calcium channel blocker n chlorthalidone diuretic n doxazosin alpha blocker n enalapril angiotensin converting enzyme inhibitor n placebo n year acebutolol showed statistically significant p less decrease total cholesterol mg dl compared placebo mg dl chlorthalidone mg dl significant p less decrease low density lipoprotein cholesterol mg dl compared placebo mg dl chlorthalidone mg dl change high density lipoprotein cholesterol mg dl,C14,0.019061403,0.010221975,0.0033304652,0.0010028706,0.0024854369,0.002303525,0.18670872,0.0016785552,0.0012904138,0.0017537833,0.025418706,0.020054718,0.12311356,0.0041536866,0.13132018,0.002779483,0.090030685,0.010868754,0.052379787,0.1322039,0.16673094,0.00063375826,0.010474672
early late effects captopril treatment large myocardial infarction rats early days late months effects continuous treatment captopril left ventricular performance weight volumes studied rats myocardial infarction early effects examined rats subjected coronary ligation randomized either immediate treatment captopril g liter drinking water starting h surgery treatment days treated group showed reductions mean arterial left ventricular systolic left ventricular end diastolic pressures compared untreated rats right left ventricular weight left ventricular volumes decreased ejection fraction index increased captopril treatment study late effects captopril second group rats randomized immediate captopril treatment starting h surgery delayed captopril treatment starting days surgery treatment studied months treatment rats started captopril treatment h infarction showed differences compared rats started treatment days infarction treatment captopril months produced changes similar rats treated days captopril treatment improved hemodynamic function myocardial infarction rats examined either days months treatment extent benefit similar two treatment periods initiation captopril therapy immediately infarction appear produce greater effect treatment started days infarction rats studied drug administered months,C14,0.0015714021,0.0013599343,0.002874227,0.00086138514,0.0021350936,0.0019785427,0.20206904,0.008860332,0.0011083615,0.008924778,0.007108902,0.041872982,0.07848281,0.0035250655,0.0013481675,0.009803554,0.16515112,0.0015788366,0.0018044619,0.03217905,0.3787506,0.045074224,0.0015771945
collagen phenotypes development regression myocardial hypertrophy spontaneously hypertensive rats myocardium contains collagen matrix major determinant architecture structural integrity mechanical properties fibrillar matrix consists primarily type type iii collagens epimysial perimysial endomysial components present study shows alteration collagen phenotypes evolution hypertensive hypertrophy therapy captopril angiotensin converting enzyme inhibitor regresses cardiac hypertrophy reduces total amount collagen reverses altered distribution type type iii collagen normotensive rats captopril significantly reduce collagen content alter ratio type type iii collagen,C14,0.0030510933,0.01743812,0.035022236,0.14322501,0.0042463653,0.003935569,0.3346062,0.0323528,0.0022046699,0.0029963362,0.014107604,0.007955679,0.07841767,0.0076107397,0.017459704,0.01973809,0.039795868,0.0031405038,0.0034723312,0.03679963,0.16984095,0.0010827751,0.021500085
ventricular stroke work loss validation method quantifying severity aortic stenosis derivation orifice formula aortic stenosis results loss left ventricular stroke work due resistance flow valve turbulence aorta percentage stroke work lost may reflect severity stenosis index calculated pressure data alone relation percent stroke work loss anatomic aortic valve orifice area measured planimetry videotape investigated pulsatile flow model thirteen valves studied nine human aortic valves obtained necropsy four bioprosthetic valves stroke volumes ml giving data points valve area ranged cm mean systolic pressure gradient mm hg percent stroke work loss calculated mean systolic pressure gradient divided mean ventricular systolic pressure x ranged closely related anatomic orifice area inverse exponential relation significantly related flow r orifice formula derived predicted anatomic orifice area confidence interval cm orifice area cm x log percent stroke work loss r see results support clinical use percent stroke work loss easily obtained index severity aortic stenosis,C14,0.0019292819,0.0016853655,0.003545141,0.0010675138,0.0026456437,0.050121944,0.13983664,0.011413084,0.010468349,0.001866829,0.05467045,0.032949515,0.2355669,0.0051840534,0.0016707829,0.012139108,0.18836972,0.0019807515,0.0021633918,0.09956191,0.1293087,0.009869738,0.0019851755
technetium sestamibi myocardial imaging day rest stress studies dipyridamole unlike thallium technetium tc sestamibi redistribute myocardium injection thus separate injections rest stress dipyridamole required differentiate ischemia scar physical viewpoint hour interval injections preferable detection coronary artery disease cad tc sestamibi imaging however day studies convenient clinical practice results studies using different tc sestamibi injection protocols presented emphasis advantages rest stress injection sequence low dose rest mci followed hours later higher dose stress mci prospective study conducted patient population proven cad using day studies compare rest stress mci respectively stress rest mci tc sestamibi injection sequence agreement analyzed segments protocols however largest discordance type defect applied segments judged ischemic rest stress protocol called scars stress rest study showed rest stress sequence preferable using day protocol short time interval less hours tc sestamibi injections rest image performed initially represents true rest study necessarily case stress rest sequence preliminary studies performed evaluate dipyridamole tc sestamibi imaging normal subjects patients cad studies showed treadmill dipyridamole tc sestamibi imaging comparable results similar obtained thallium,C14,0.0015446253,0.0013701597,0.002917187,0.00086790114,0.054572713,0.016900932,0.15337308,0.0014525843,0.001125655,0.001517685,0.047704343,0.05613403,0.18127044,0.003586872,0.07613584,0.0024053028,0.092193894,0.0015909622,0.009232867,0.039923172,0.22026496,0.0005484403,0.033366412
impact public cholesterol screening program national cholesterol education program ncep endorsed physician case finding primary method detect individuals elevated cholesterol levels despite recommendation promotional profit public screening programs flourished surveyed participants mall based cholesterol screening program year screening sixty four percent screened previously known cholesterol levels newly screened less likely benefit testing general public since older mean age years likely female nonsmokers screenees excellent recall cholesterol level mean absolute reporting error mmol l mg dl good understanding cholesterol coronary heart disease risk elevated cholesterol levels reported high distress screening reduction overall psychosocial well actual decrease absenteeism advised seek follow elevated screening value done within year following screening program however values greater mmol l mg dl sought follow many participate public screening programs previously tested fall low benefit groups fail comply recommended follow therefore conclude cholesterol screening programs type commonly offered unlikely contribute greatly national efforts reduce coronary heart disease,C14,0.0015804417,0.0014016695,0.010585588,0.000887853,0.002200305,0.009675084,0.18914276,0.0014859895,0.0011423761,0.009181259,0.16718005,0.010899618,0.0689814,0.012034597,0.08553362,0.0024606178,0.103201695,0.0016272897,0.099233605,0.09387132,0.11785743,0.008207306,0.0016280704
bone mineral density spontaneous hypertension differential effects dietary calcium sodium dietary calcium sodium postulated modify bone mineral status blood pressure regulation humans animals spontaneously hypertensive rat shr manifests several defects calcium metabolism may contribute hypertension blood pressure bone mineral status measured shr normotensive wistar kyoto rats wky marker whole animal calcium metabolism addition effect alterations dietary calcium sodium bone status examined weeks age seven male shr seven male wky placed control diet age shr wky randomized four diets containing either calcium sodium four markers bone mineral status analyzed bone density measured direct photon absorptiometry total bone calcium phosphorus magnesium content measured atomic absorption spectrophotometry shr exhibited significantly lower levels p less bone density bone magnesium content wky whereas bone phosphorus calcium differ two strains calcium diets resulted increased bone density bone calcium content lower bone magnesium strains sodium diets associated decreased bone density shr wky findings identify another indicator disturbed calcium metabolism shr may related impaired renal calcium handling consistent previously reported reductions renal calcium reabsorption decreased intestinal calcium transport older shr,C14,0.016875451,0.0014017937,0.002948652,0.00088789896,0.002886285,0.002039443,0.19200464,0.0014861212,0.0011424774,0.001552725,0.09636111,0.010865473,0.09929291,0.1341383,0.0090388125,0.010214213,0.022010153,0.02383617,0.0020704076,0.1286152,0.23813494,0.0005611026,0.0016357686
two dimensional echocardiographic features double outlet left ventricle cyanotic newborn infant diagnosis double outlet left ventricle made two dimensional echocardiographic examination diagnosis later confirmed cardiac catheterization surgery parasternal subcostal views especially useful identification origin great arteries morphologic left ventricle review medical literature since revealed cases double outlet left ventricle diagnosed surgery postmortem examination anatomic features demonstrated two dimensional echocardiography case representative findings cited often cases reported medical literature,C14,0.0036403763,0.0032291955,0.006792565,0.002045379,0.005095252,0.022310205,0.26634812,0.021039188,0.055486415,0.0035768836,0.1879945,0.0074875583,0.023073228,0.008512492,0.003201255,0.005668823,0.11032956,0.003766904,0.004145104,0.18634257,0.064876765,0.0012925654,0.0037450849
endothelin family human plasma cerebrospinal fluid clarify whether endothelin may present human cerebrospinal fluid csf exists compare molecular forms endothelin human plasma analyzed pooled human csf plasma high performance liquid chromatography specific enzyme immunoassays endothelin peptide four human endothelin peptides hitherto identified big endothelin major molecular form endothelin present human csf addition small significant amount endothelin endothelin csf endothelin detectable similarly big endothelin endothelin endothelin identified human plasma although big endothelin abundant substantial amount endothelin endothelin found plasma resultant lower molar ratio big endothelin endothelin csf csf samples patients requiring diagnostic lumbar puncture lumbar anesthesia endothelin detectable preponderance big endothelin relative endothelin endothelin mean concentrations endothelin endothelin simultaneously collected plasma significantly p less higher csf significant difference mean big endothelin concentration plasma csf significant correlation among concentrations big endothelin endothelin endothelin paired sample results indicate endothelin present human csf differently processed endothelin vascular endothelial cells suggest possible role endothelin modulator neuronal functions,C14,0.002227251,0.0019756828,0.014935491,0.0012514015,0.024656067,0.0028743835,0.21360907,0.01573312,0.0016102033,0.0021884048,0.071391515,0.004608605,0.11402005,0.097616725,0.0019585884,0.01424083,0.038579524,0.0023003302,0.0025360528,0.017977446,0.35058144,0.0007908159,0.0023370583
left ventricular versus left atrial cannulation thoratec ventricular assist device retrospective study patients men women supported ventricular assist devices greater days effect lv cannulation versus la cannulation device performance compared patients ranged age years mean years supported days mean years fifteen patients supported left vads lv la patients supported bvads lv la mode operation time fill empty mode ten data points taken patient lv cannulation results higher vad flow index decreased preload lower vad systolic vacuum pressures shorter diastolic durations eleven patients survived although survival greater patients lv cannulation survival dependent upon reversibility myocardial damage eligibility transplantation development complications data indicate lv cannulation provides better vad performance la cannulation fill empty mode,C14,0.0022516712,0.034696728,0.0042013847,0.0012651222,0.0031353808,0.002905899,0.1500603,0.0021174988,0.001627858,0.0022123992,0.021345168,0.004631257,0.12979944,0.0051788515,0.0019800628,0.0035063203,0.3502891,0.002318848,0.0025638589,0.1375685,0.08964082,0.0116973175,0.035006177
clinical antecedents hospital cardiopulmonary arrest outcome hospital cardiopulmonary arrest studied extensively clinical antecedents arrest less well defined studied group consecutive general hospital ward patients developing cardiopulmonary arrest prospectively determined definitions underlying pathophysiology severity underlying disease patient complaints clinical observations used determine common clinical features sixty four patients arrested hours following hospital admission pathophysiologic alterations preceding arrest classified respiratory patients percent metabolic percent cardiac percent neurologic percent multiple percent unclassified percent patients multiple disturbances mainly respiratory percent metabolic percent disorders fifty four patients percent documented observations clinical deterioration new complaints within eight hours arrest seventy percent patients either deterioration respiratory mental function observed time routine laboratory tests obtained arrest showed consistent abnormalities vital signs showed mean respiratory rate breaths per minute prognoses patients underlying diseases classified ultimately fatal percent nonfatal percent rapidly fatal percent five patients percent survived hospital discharge patients developing arrest general hospital ward services predominantly respiratory metabolic derangements immediately preceding arrests underlying diseases generally rapidly fatal arrest frequently preceded clinical deterioration involving either respiratory mental function features high mortality associated arrest suggest efforts predict prevent arrest might prove beneficial,C14,0.0013526856,0.007746184,0.00905683,0.0007600189,0.008419365,0.021386202,0.27037883,0.001272082,0.0009779315,0.04061709,0.071565166,0.022419155,0.13974772,0.003110242,0.0011895177,0.015314977,0.26250657,0.0014021875,0.01462934,0.023694495,0.07406696,0.0004802895,0.007906162
effect intravenous streptokinase early mortality patients suspected acute myocardial infarction meta analysis anatomic location infarction published erratum appears ann intern med mar purpose determine effect intravenous streptokinase early mortality patients suspected acute anterior acute inferior myocardial infarctions data identification literature search english language studies use intravenous streptokinase treatment suspected acute myocardial infarction period using medlars ii bibliographies relevant articles number instances additional details early mortality location myocardial infarction provided authors study selection originally identified articles specifically met inclusion criteria selected randomized trials used intravenous streptokinase dose million units without additional agents compared group differed absence streptokinase trials selected review methods section without regard results data extraction data extracted independently two observers using specific methodologic criteria infarct location early mortality conferred observers agreed completely data results data synthesis among patients suspected acute anterior myocardial infarction mortality rate control group contrast patients treated streptokinase mortality mean risk difference ci summary risk ratio ci total patients suspected inferior infarction mortality rate control group corrected mortality streptokinase treated patients mean risk difference ci summary risk ratio ci conclusions intravenous streptokinase clearly confers protective effect early mortality patients suspected acute anterior myocardial infarction magnitude effect order absolute reduction risk death days patients need treated save additional life patients suspected acute inferior infarction benefit treatment reducing early mortality smaller magnitude less certain patients estimated absolute reduction early mortality approximately would require treating patients save additional life,C14,0.007086602,0.0010733902,0.008110117,0.0065248716,0.0016849807,0.01326794,0.29432562,0.006990086,0.01257109,0.0011889624,0.037871547,0.020992637,0.084649324,0.002844176,0.0010785734,0.0077267047,0.1623114,0.018787563,0.024762906,0.18410727,0.09444342,0.000429651,0.007171157
successful direct ptca lad first episode acute myocardial infarction improve cardiac function patients received direct percutaneous transluminal coronary angioplasty ptca acute mycardial infarction maintained potency unimproved cardiac function studied patients first episode acute myocardial infarction caused left anterior descending branch lesion ejection fraction left ventriculogram follow period improved group patients ejection fraction less unimproved group significant difference groups mean time onset infarction revascularization improved group min unimproved group min sigma q sum q wave depth v v v time admission improved group mm unimproved group mm maximum creatine kinase concentration significantly higher unimproved group improved group iu l unimproved group iu l p less time taken onset reach peak significantly shorter unimproved group improved group hr unimproved group hr p less results suggest probability sudden deterioration myocardium factors microcirculatory thromboembolism considered cause unimproved cardiac function successful direct ptca,C14,0.0124533875,0.0018940454,0.0039840965,0.021859862,0.013308984,0.0027556107,0.13473697,0.02268013,0.001543668,0.022769801,0.020189779,0.16009806,0.15350811,0.005505036,0.0018776574,0.003335531,0.16301437,0.002198921,0.0024312604,0.073945075,0.17295487,0.00075813854,0.0021966342
hematologist view contrast media clotting angiography syringes thrombosis coronary angiography ionic contrast media cm stronger anticoagulants antiplatelet agents nonionic ionic cm retard clotting fibrinopeptide generation platelet aggregation least born brien aggregometry thus nonionic cm cause clots thrombi rather driving force clot thrombus formation occurs blood contact activation foreign surface syringe catheter marked enhancement clotting glass syringes comparison plastic ones supports view blood syringe catheter therefore clot slowly presence nonionic ionic cm inhibitory effects latter profound respect models thrombosis sites vascular injury stenosis antithrombotic effects cm may either transient owing dynamic nature blood flow local endothelial cell denudation model case ionic cm actually enhance local platelet aggregation stenosis model situations preservation antithrombotic functions endothelium nonionic cm may quite critical,C14,0.015349034,0.0023310217,0.03778692,0.001476474,0.0036591785,0.0033913595,0.21493809,0.035849586,0.027330235,0.0025820034,0.075593285,0.03084422,0.16455907,0.034054972,0.0023108528,0.030875852,0.05785235,0.026505033,0.002992178,0.05730393,0.16877794,0.00093304913,0.0027034208
aspirin primary prevention angina pectoris randomized trial united states physicians purpose objective study examine effect low dose aspirin mg alternate days primary prevention angina pectoris united states physicians health study despite postulated role platelets atherogenesis myocardial ischemia effect chronic platelet inhibition development clinical angina pectoris unknown subjects methods physicians health study randomized double blind placebo controlled trial among male physicians aged years free previous myocardial infarction stroke transient cerebral ischemia entry followed average months physicians also free angina pectoris baseline constituted study population present analyses results person years follow patients confirmed angina pectoris diagnosed underwent coronary revascularization procedure coronary artery bypass graft surgery coronary angioplasty compared participants assigned placebo relative risk confirmed angina pectoris aspirin group confidence interval ci coronary revascularization relative risk ci simultaneous control coronary risk factors proportional hazards model relative risks remained near unity ci ci respectively risks angina pectoris examined according year randomization trial pattern increasing benefit longer duration treatment conclusion randomized trial data indicate chronic platelet inhibition low dose aspirin average duration months reduce incidence angina pectoris,C14,0.01035949,0.018701905,0.04612707,0.0009943086,0.0024642174,0.0022838586,0.20869663,0.0016642244,0.0012793967,0.0017427299,0.03483586,0.012483886,0.07923827,0.012634527,0.0015562081,0.002755753,0.12798542,0.012794652,0.04484813,0.15382811,0.22027642,0.0006283475,0.0018205771
recent changes treatment aortoiliac occlusive disease oxford regional vascular service four years january december patients treated aortoiliac occlusive disease oxford regional vascular service number patients treated percutaneous transluminal angioplasty increased two first year study third year study increase accompanied decrease proportion patients treated aortobifemoral bypass proportion patients treated extra anatomic bypass remained constant around per cent twice many patients treated fourth year first year study number surgical operations increased despite many patients treated exclusively percutaneous transluminal angioplasty number patients requiring mandatory treatment limb salvage increased per cent optional treatment intermittent claudication per cent introduction percutaneous transluminal angioplasty oxford coincided increase number patients presenting symptomatic aortoiliac occlusive disease allowed twice many people treated number aortobifemoral bypass operations remained unchanged concluded introduction percutaneous transluminal angioplasty generated workload also led increased demand surgical reconstruction aortoiliac occlusive disease,C14,0.0020710528,0.0018371271,0.0038643696,0.0011636401,0.0028838753,0.012687316,0.2273254,0.001963698,0.0014972789,0.002034931,0.011915051,0.014232971,0.01942107,0.0050799716,0.0018212316,0.00322506,0.441483,0.002132841,0.05247866,0.061612774,0.12640269,0.0007353556,0.0021306227
transient myocardial ischemia relation determinants myocardial oxygen demand conflicting data clear need establish relative role increase myocardial oxygen demand versus reduction coronary blood flow causation transient ischemia role heart rate blood pressure changes immediately preceding transient ischemic events observed daily life evaluated patients coronary artery disease elevations heart rate onset ischemia observed episodes similarly ischemic events preceded increase arterial pressure data provide evidence significant role increased myocardial oxygen demand genesis transient myocardial ischemia,C14,0.008420884,0.0025540323,0.019308526,0.0016177292,0.0040092547,0.01764706,0.27858344,0.002707675,0.0020815646,0.016765296,0.014249617,0.0059220525,0.24452522,0.006620269,0.0025319336,0.00448358,0.09791839,0.002965143,0.0032784417,0.113994285,0.14583129,0.0010223145,0.002962059
comparison antihypertensive efficiency nitrendipine metoprolol mepindolol enalapril using ambulatory hour blood pressure monitoring randomized month study patients antihypertensive efficiency calcium antagonist nitrendipine beta selective blocker metoprolol mepindolol beta blocker intrinsic activity angiotensin converting enzyme inhibitor enalapril compared monitored hour ambulatory blood pressure bp measurements study designed comparable decrease casual bp values obtained drugs normotension achieved monotherapy diuretic also administered pretreatment casual bp mean hour ambulatory bp values differ groups normotension assessed casual bp measurements observed groups months therapy significant differences groups however significantly diuretics required mepindolol n enalapril n groups compared nitrendipine n metoprolol n groups despite comparable casual bp control groups differed significantly mean hour measurements greatest systolic diastolic bp decreases seen metoprolol group metoprolol also effective drug decreasing frequency systolic pressure peaks greater mm hg beta blockers enalapril significantly decreased morning bp increase compared values treatment nitrendipine data show casual bp measurement good predictor hour bp patients taking hypertensive therapy despite equal degree office bp control different antihypertensive regimens confer degree nonoffice bp control,C14,0.014658601,0.0015434799,0.01180805,0.009388932,0.0024229153,0.002261022,0.16801265,0.0016363309,0.0012579531,0.0017096666,0.009244597,0.06603312,0.32556438,0.01274639,0.001530125,0.0027095648,0.08461272,0.0017919267,0.01029159,0.021710392,0.23823696,0.000617816,0.010210799
inflation pressure requirements coronary angioplasty examine balloon inflation pressures required successful percutaneous transluminal coronary angioplasty ptca maximal inflation pressure required coronary lesions consecutive patients determined retrospectively graded balloon inflations sufficient achieve full expansion used maximal inflation pressure used less equal atm stenoses less equal atm stenoses successful ptca achieved lesions major procedural complication rate second group patients studied prospectively inflation pressure required achieve full balloon expansion less equal atm stenoses less equal atm stenoses thus ptca coronary stenoses achieved high success rates low complication rates graded inflations pressures sufficient achieve full balloon expansion performed coronary stenoses respond pressures less equal atm,C14,0.0025269468,0.002241528,0.004715021,0.038085803,0.027984722,0.015484164,0.1545704,0.0023763713,0.02629039,0.0024828736,0.02754216,0.017430736,0.20691486,0.005824169,0.0022221333,0.0039349818,0.38464427,0.0026023362,0.0028773006,0.02235568,0.04339631,0.000897227,0.0025996296
early postoperative balloon coronary angioplasty failed coronary artery bypass grafting small number patients coronary artery bypass grafting cabg fails relieve anginal symptoms usefulness coronary angioplasty treatment early less equal days recurrent ischemia cabg examined forty five patients treated days cabg including patients studied emergently prolonged ischemic symptoms one vessel native disease found patients respectively time postoperative angiography major anatomic mechanism recurrent ischemia complete vein graft occlusion patients internal mammary artery occlusion vein graft stenoses internal mammary artery stenoses unbypassed disease disease distal graft insertion site angioplasty successful sites including lesions native arteries lesions vein grafts internal mammary artery lesions attempted complete revascularization achieved patients hospital deaths myocardial infarctions two additional patients underwent repeat cabg discharge uncomplicated unsuccessful angioplasty late follow survivors mean months deaths noncardiac repeat cabg required patients repeat angioplasty performed angina absent minimal patients patients employed full time thus percutaneous transluminal coronary angioplasty relieve myocardial ischemia unsuccessful cabg majority patients,C14,0.07288285,0.0016366044,0.0034236899,0.0010309425,0.029203221,0.02011593,0.19875851,0.010926785,0.0013265343,0.0018115318,0.008612633,0.0038171124,0.032953996,0.004282752,0.0016135444,0.0028581945,0.47924584,0.0018974151,0.0020892774,0.08330391,0.03566298,0.0006514981,0.0018942025
mortality years hypertensive participants multiple risk factor intervention trial multiple risk factor intervention trial mrfit randomized primary prevention trial tested effect multifactor intervention program coronary heart disease chd mortality high risk men aged years men randomly assigned either special intervention si program consisted dietary advice lowering blood cholesterol levels counseling aimed cessation cigarette smokers stepped care treatment hypertension elevated blood pressure usual sources health care within community uc among randomized men hypertensive baseline subgroup mortality rates years follow lower si uc group p chd p causes results reflected favorable outcomes si compared uc hypertensive men posttrial years march december preceding years february posttrial years death rates lower si uc men p chd p causes diastolic blood pressure equal mm hg posttrial trend continuation trend trial therefore years follow death rates markedly lower si uc p chd p causes similarly without baseline resting electrocardiographic abnormalities favorable posttrial outcome si group continuation trend trial contrast baseline diastolic blood pressure mm hg baseline resting electrocardiographic abnormalities favorable posttrial mortality findings si group reversal unfavorable trends recorded trial two factors appear contributed favorable mortality trend si group change diuretic treatment protocol si men years randomization involved replacement hydrochlorothiazide chlorthalidone daily maximum dose mg favorable effect intervention nonfatal cardiovascular events trial years addition delay full impact beneficial effects mortality end points smoking cessation cholesterol lowering could contributed abstract truncated words,C14,0.01568239,0.0070143724,0.008204181,0.00068833114,0.0017059066,0.0074047316,0.15932252,0.0011520946,0.00088568946,0.0072566792,0.023382079,0.031881988,0.121836826,0.01037061,0.012933416,0.048868787,0.047051586,0.0012616452,0.0689425,0.30962154,0.106934145,0.00043498687,0.0071630133
effects brief coronary occlusion reperfusion porcine coronary artery reactivity loss coronary vasodilator reserve ischemia reperfusion may due endothelial injury vascular dysfunction may contribute functional alterations observed ischemia determine whether endothelial dysfunction occurs relatively brief periods moderate low flow ischemia vivo open chest swine subjected minutes critical subtotal left anterior descending coronary artery occlusion followed minutes reperfusion serial measurements regional coronary flow made radiolabeled microsphere technique minutes reperfusion left anterior descending coronary artery excised together section normally perfused left circumflex coronary artery examine vitro relaxations endothelium dependent dilators adp bradykinin endothelial independent dilators sodium nitroprusside adenosine contractions serotonin quiescent rings also examined endocardial transmural blood flows recovered preocclusion levels within minutes reperfusion epicardial endocardial ratio vascular responses isolated reperfused left anterior descending coronary artery rings significantly different responses control left circumflex coronary artery rings endothelium dependent relaxations adenosine diphosphate bradykinin significantly depressed left anterior descending coronary artery rings compared left circumflex coronary artery rings p less serotonin induced contractions significantly greater occluded reperfused left anterior descending left circumflex coronary arteries p less relaxations adenosine sodium nitroprusside significantly different two groups,C14,0.037502907,0.010399931,0.020768981,0.0010210027,0.0025303736,0.002345173,0.1389734,0.09388223,0.0013137445,0.0105784945,0.010159031,0.012612672,0.22392514,0.0043979976,0.0015979874,0.0028467157,0.13177758,0.0018753865,0.0020691333,0.04688843,0.24001902,0.00064521667,0.0018694538
studies controlled reperfusion ischemia xviii reperfusion conditions attenuation regional ischemic effect temporary total vented bypass controlled reperfusion study tests hypothesis total vented bypass attenuate regional ischemic effect defined time interval controlled blood cardioplegic reperfusion thirty three dogs underwent hours occlusion left anterior descending coronary artery received regional blood cardioplegic reperfusate total vented bypass cardiopulmonary bypass reperfusion started hours ischemia eight dogs hours ischemia others among dogs seven total vented bypass started first hours hours regional ischemia segmental shortening ultrasonic crystals tissue water content wet dry weight histochemical damage triphenyltetrazolium chloride stain assessed hours reperfusion dogs reperfused hours ischemia recovered control systolic shortening sustained triphenyltetrazolium chloride nonstaining dogs undergoing hours regional ischemia total vented bypass hours reperfusion improved recovery systolic shortening versus p less limited epicardial edema versus water content p less reduced histochemical damage versus triphenyltetrazolium chloride nonstaining p less findings imply institution total vented bypass ischemia attenuates infarct process increases regional recovery contractility limits edema restricts histochemical damage may useful adjunct myocardial salvage controlled reperfusion provided,C14,0.031829476,0.0018192801,0.0038268287,0.011072411,0.0028558597,0.012533477,0.15211654,0.011855253,0.0014827334,0.0020151623,0.02194621,0.0048425775,0.28128457,0.0049797543,0.0018036759,0.0031937296,0.115306355,0.0021121213,0.0023352893,0.121127255,0.20682327,0.0007282119,0.0021099246
adenosine triphosphate derangement free radical mediated injury major cause ventricular dysfunction reperfusion role adenine nucleoside transport myocardial reperfusion injury aim study determine dual role atp energy substrate major source oxygen derived free radical mediated reperfusion injury using adenine nucleoside blocker p nitrobenzylthioinosine nbmpr adenosine deaminase inhibitor erythro hydroxy nonyl adenine ehna randomized study dogs instrumented minor axis ltz piezoelectric crystals intraventricular pressure transducers monitor bypass left ventricular performance using sensitive load independent index contractility slope stroke work end diastolic length relation hearts subjected minutes normothermic global ischemia minutes reperfusion normal saline without group n group n nbmpr ehna infused three boluses cardiopulmonary bypass reservoir ischemia reperfusion transmural serial biopsies obtained ischemia reperfusion analyzed myocardial adenine nucleotide pool intermediates using high performance liquid chromatography control group three hearts developed ischemic contracture another three hearts exhibited cardiogenic shock reperfusion ehna nbmpr treated group left ventricular performance recovered within minutes reperfusion p less vs control myocardial atp depleted normal groups end ischemia p less intramyocardial adenosine ehna nbmpr treated group fold greater nmol mg protein control group end ischemic period p less inosine fourfold higher control group nmol mg protein compared drug treated group p less reperfusion myocardial atp levels increased approximately normal ehna nbmpr group remaining depressed normal control group thus despite dramatic loss myocardial atp ischemia complete recovery ventricular performance significant repletion atp reperfusion observed adenosine transport deamination modulated ischemia reperfusion results suggest myocardium may atp needed basic cardiac functions washout atp diffusible catabolites detrimental ventricular performance reperfusion specific blockade nucleoside transport resulted complete functional recovery despite low critical atp levels abstract truncated words,C14,0.022719579,0.0011475718,0.034122147,0.0007268743,0.001801429,0.0016695805,0.13294373,0.0074974196,0.0009352837,0.0012711311,0.007268568,0.08982138,0.24277098,0.0032394393,0.019921295,0.009766003,0.10747794,0.053872924,0.0014812115,0.09052288,0.15470341,0.01298315,0.0013360195
humoral factors determining blood pressure response converting enzyme inhibition calcium channel blockade renin catecholamine levels determined patients mild moderate hypertension treatment sustained release diltiazem captopril correlated blood pressure response antihypertensives eight weeks treatment either agent led equal decreases systolic diastolic blood pressure pretreatment plasma renin activity pra plasma norepinephrine predict blood pressure response either agent diltiazem significantly increased pra supine norepinephrine levels however diltiazem treated patients correlation change plasma norepinephrine change systolic diastolic blood pressure contrast negative correlation p less reactive rise pra decrease systolic blood pressure thus antihypertensive response calcium channel blocker may determined part reactive response pressor systems,C14,0.015136543,0.0022996706,0.0048373225,0.001456616,0.0036099642,0.003345747,0.1679231,0.0024380116,0.0018742569,0.0025472764,0.031017255,0.00533229,0.2992496,0.011045408,0.002279773,0.0040370505,0.056441408,0.016171552,0.0029519345,0.025174849,0.33724278,0.0009205,0.002667061
pulmonary hypertension heparin protamine roles left sided infusion histamine platelet activating factor severe pulmonary hypertension protamine neutralization heparin infrequent life threatening event following cardiopulmonary bypass effect left ventricular infusion protamine pulmonary hypertension well possible role platelet activating factor paf histamine heparin protamine reaction investigated pigs four different groups general anesthesia group animals received iu kg heparin followed mg protamine intravenously min group protamine infused left ventricle group animals received histamine h h antagonists clemastine ranitidine min protamine infusion group paf receptor blocker web given min protamine platelet activating factor measured bioassay serum samples group group animals four groups protamine caused severe pulmonary hypertension thromboxane release transient decrease leukocyte counts paf release detected protamine infusion neither left ventricular infusion protamine histamine paf antagonists prevented attenuated reactions protamine infusion authors conclude left ventricular infusion protamine provides protection pulmonary hypertension histamine paf involved acute pulmonary vasoconstriction protamine neutralization heparin,C14,0.14897017,0.011628576,0.0037885844,0.0011408196,0.0028273189,0.0031238296,0.22524287,0.011736747,0.0014679154,0.0019950233,0.025192317,0.13051549,0.13513094,0.027829368,0.0017855149,0.0035531188,0.02835396,0.011919169,0.002311951,0.020370364,0.16881326,0.030208426,0.0020942516
clinical evaluation single versus multiple mammary artery bypass superior patency clinical advantages internal mammary artery ima grafting well established however relative benefits routine multiple ima grafting remain uncertain determine whether routine multiple compared single ima utilization improved survival patients undergoing coronary bypass procedures patients prospectively allocated beginning divergent management strategies single group n versus multiple ima grafting group n subsequent analysis anatomical extent disease preoperative baseline risk factors showed differences p ns two groups variables reflecting operative technique similar p ns two groups except group patients multivessel disease received single ima graft whereas group patients multivessel disease received multiple imas p less multivariate analysis impairment left ventricular ejection fraction acute evolving myocardial infarction advanced age unstable angina incremental risk factors mortality p less group assignment p ultimate therapy p survival probabilities expressed day group group year group group overall elective acute age less years age years older ejection fraction ejection fraction less nondiabetic diabetic differences survival significant p ns,C14,0.010246719,0.0015564502,0.011765575,0.0009858586,0.010936072,0.0022644498,0.18704003,0.010115898,0.0012685241,0.0017240334,0.14305314,0.11544429,0.073997974,0.012493988,0.018470969,0.062121958,0.15932865,0.0018069847,0.0019979118,0.12188131,0.040545326,0.009114547,0.0018393493
hypertension acculturation elderly mexican americans results hispanic hanes purpose study describe relationship acculturation hypertension elderly mexican americans two age groups examined data provided hispanic health nutrition examination survey hhanes prevalence hypertension among subgroups different acculturation ascertained based modified cuellar acculturation scale age group also stratified using hhanes poverty index index compared stepwise logistic regression performed among variables poverty gender age acculturation relation hypertension results indicate acculturation age stronger predictors hypertension poverty elderly mexican americans acculturation stronger predictor among age factors related acculturation may stronger influence prevalence hypertension older mexican americans differences related socioeconomic status,C14,0.08650322,0.0025538555,0.0053719967,0.0016176172,0.004008977,0.0037155559,0.1531454,0.0027074874,0.0020814205,0.0028288295,0.061924763,0.057648133,0.054585602,0.00678253,0.0025317583,0.0044978797,0.052454226,0.0029649376,0.017210672,0.3877308,0.08315019,0.0010222438,0.002961854
use pulmonary artery catheters patients acute myocardial infarction analysis experience patients sprint registry sprint study group study analyzes use pac registry comprising hospitalized patients ami total patients received pac hospital mortality higher patients chf received pac difference patients cardiogenic shock persistent hypotension mortality patients receiving pac higher irrespective presence absence pump failure separate analysis discharge summaries patients chf showed pac used frequently sicker patients severity chf assessed difference mortality found patients mild moderate chf conclude higher hospital mortality found patients receiving pac excess likely related difference severity chf assessed every individual unlikely pac increases mortality,C14,0.02836716,0.015218285,0.004957523,0.0014928108,0.0036996664,0.0034419927,0.16628069,0.002500054,0.0019208294,0.015452238,0.038358252,0.06305582,0.024588192,0.006171105,0.0023364956,0.016996088,0.26577342,0.0027361794,0.0030252857,0.23625897,0.09367102,0.0009433731,0.0027545788
clinical use berlin biventricular assist device bridge transplantation berlin artificial heart system biventricular assist device bvad used patients twenty eight patients awaiting cardiac transplantation tx age yrs patients contraindications allowing immediate tx five patients emergency cases tx list postcardiotomy cardiac failure acute myocarditis age five patients post tx patients graft failure age extracorporal circulation used implantation bvad group patients pts recovered subsequently transplanted hours days organ function restored pts mechanical circulation terminated days deterioration five transplanted pts died pts survived greater days pts transplanted satisfactory postoperative courses group pts two successfully weaned one patient allograft recovered days support,C14,0.04717146,0.03224574,0.0056926757,0.0017141801,0.0042482913,0.047818616,0.15965994,0.0028691099,0.0022056699,0.0029976952,0.03463527,0.050579756,0.081984304,0.0070149773,0.0026828905,0.0047508967,0.33216807,0.0031419282,0.0034739063,0.08166341,0.08705928,0.0010832662,0.0031386605
randomized trials study antihypertensive drugs heterogeneity response antihypertensive drugs addressed randomized trials individual subjects trial patient receives pairs treatment periods one period pair active drug one matched placebo random order patient clinician blinded allocation treatment targets monitored trials optimize antihypertensive therapy clinical practice facilitate investigation new drugs study pathophysiology trials also potential helping decide whether common nonspecific symptoms reported patients really drug related,C14,0.019576663,0.0030171422,0.0063763945,0.001911064,0.004736233,0.004389583,0.39228418,0.0031986444,0.0024590043,0.003349425,0.01591676,0.022176906,0.040320046,0.007832681,0.0030249928,0.021752806,0.10949687,0.019963313,0.15207039,0.06980069,0.075183794,0.01766327,0.0034991547
plaque morphology pathologic changes arteries patients dying coronary balloon angioplasty morphologic correlates pathologic success failure studied autopsy patients coronary arteries subjected balloon angioplasty presence following histologic features evaluated plaque concentricity eccentricity calcification fibrous fibropultaceous plaque medial disruption luminal thrombus inflammation angioplasty considered successful residual cross sectional luminal area greater pathologic examination arteries unsuccessful arteries eccentric plaques likely successfully dilated concentric lesions p less six fibropultaceous plaques successfully dilated compared fibrous plaques moderate severe calcification preclude morphologic success medial stretching dissection often associated successful result thus plaque morphology may important determinant pathologic outcome coronary angioplasty,C14,0.057867244,0.030027686,0.0053021074,0.0015965721,0.01771232,0.031171065,0.16238321,0.0026722632,0.0020543411,0.0027920266,0.04265583,0.0058446024,0.07448801,0.0069357557,0.0024988202,0.0044249427,0.33603966,0.0029263638,0.0032355653,0.045634355,0.13032767,0.0010089445,0.030400647
percutaneous valvuloplasty patient mitral stenosis following surgical annuloplasty case described patient carpentier edwards annuloplasty ring developed mitral stenosis treated percutaneous mitral valvuloplasty possible mechanisms development mitral stenosis briefly discussed,C14,0.007443107,0.0066024074,0.013888066,0.0041819783,0.010364291,0.009605718,0.31757662,0.006999588,0.005381035,0.0073132897,0.070062704,0.015309049,0.04627071,0.017114002,0.0065452806,0.011590466,0.27091515,0.007665166,0.008475073,0.049100876,0.09729542,0.0026427768,0.007657194
clinical significance simple heart rate adjusted st segment depression supine leg exercise diagnosis coronary artery disease evaluate clinical significance simple heart rate adjusted st segment depression delta st delta hr diagnosis coronary artery disease patients stable exertional angina underwent supine leg exercise testing cardiac catheterization exercise heart rate multilead electrocardiogram pulmonary artery wedge pressure recorded sensitivity accuracy delta st delta hr criteria greater equal microv beat min significantly greater conventional analysis st segment depression criteria greater equal mv detecting three vessel coronary artery disease matched specificity versus versus p less significant linear correlation found maximum pulmonary artery wedge pressure increments exercise delta pawp gensini score delta st delta hr delta pawp r p less gensini score r p less statistically significant differences delta pawp gensini score patients three vessel disease delta st delta hr greater equal microv beat min one two vessel disease delta st delta hr greater equal microv beat min delta pawp versus p ns gensini score versus p ns findings demonstrate delta st delta hr useful conventional analysis st segment depression identifying anatomically severe coronary artery disease also functionally severe coronary artery disease,C14,0.03287062,0.033806853,0.011193213,0.000937965,0.0023248354,0.051767986,0.16971572,0.0015854917,0.0012068982,0.0016402786,0.11239012,0.044240043,0.12962788,0.0038643852,0.0014729179,0.010926064,0.11953492,0.0017288586,0.0019008518,0.06160856,0.032715432,0.032918904,0.14002118
repair supravalvar aortic stenosis cardiovascular morphometric hemodynamic results supravalvar aortic stenosis associated normal systolic pressure aorta branches singular exception coronary arteries hypertensive uncommon lesion treated patch aortoplasty several types examined hemodynamics morphometrics patients underwent operation supravalvar aortic stenosis ranged age years mean age years standard error mean operative deaths preoperative postoperative years catheterization echocardiography combination done patients died late suddenly without postmortem examination lost follow yet restudied pressure gradients across stenosis patients treated single sinus patch n mm hg preoperatively mm hg postoperatively p less patients bisinus patch n mm hg preoperatively mm hg postoperatively p less two groups significantly different measurements diameters coronary arteries aortic annulus descending aorta made calculation ratio coronary artery annulus diameters descending aortic diameters preoperatively postoperatively possible patients left coronary artery larger normal operation preoperatively disproportionate increase left coronary artery annulus size systole left ventricular wall thickness decreased significantly postoperatively p less repair supravalvar aortic stenosis localized diffuse single sinus bisinus patch repair safe hemodynamic results good,C14,0.03163884,0.0015833736,0.003330603,0.0010029878,0.12205384,0.0023036203,0.10758931,0.044880573,0.01848725,0.0017538558,0.038020495,0.020937253,0.13551179,0.0041948915,0.0015696737,0.0027795979,0.32494074,0.0018395033,0.0020324718,0.05171496,0.060279224,0.009272265,0.012282906
hypertension racial differences racial differences prevalence course pathophysiologic characteristics hypertension black white populations reviewed accumulated epidemiologic data indicate prevalence hypertension among blacks greater among whites almost age sex matched groups hypertensive blacks higher incidence left ventricular dysfunction stroke renal damage lower incidence ischemic heart disease hypertensive whites significant pathophysiologic difference blacks whites salt sensitivity normotensive well hypertensive blacks tend salt sensitive blacks also tend lower renin levels whites dopamine response salt load diminished among blacks compared whites differences others lead recommendation hypertension among blacks managed initially salt restriction dietary control insufficient administration antihypertensive agent hour efficacy lowers vascular peripheral resistance promotes sodium excretion potentially improves renal hemodynamics recommended calcium channel blocker may satisfy requirements,C14,0.04687426,0.0020419597,0.059986576,0.01242879,0.003205416,0.02525377,0.19726054,0.0021898053,0.057384733,0.0022618177,0.015538724,0.019244304,0.0707489,0.00623568,0.0020362004,0.0035846413,0.047923796,0.0023706444,0.013750118,0.1498095,0.24554296,0.0119586745,0.0023681787
underestimation treatment effect crossover trials crossover trials subject serves control study cardiovascular diseases hypertension angina pectoria properly designed crossover studies preferred parallel studies considerable subject variability symptoms conditions bias due eliminated use crossover design however problem called treatment period interaction present study analyzes potential influences outcome trial physical carryover effect defined physical effect first treatment period carrying second tends minimize differences two consecutive treatment periods frustrating experience inactive agent first treatment period outside influences change seasons may affect lengthy crossover trials similar way author concludes treatment effect crossover trial tends underestimated current concept reports clinical trials generally biased toward exaggeration treatment effects seem apply crossover trials,C14,0.012357112,0.0018557783,0.02500522,0.0011754537,0.0029131533,0.013578036,0.44369152,0.0019674161,0.0015124799,0.012509489,0.017227136,0.00437877,0.040776953,0.0048929797,0.0018397212,0.013382829,0.06398978,0.0021544942,0.0732791,0.061030433,0.19757842,0.00074282114,0.0021609163
regression infundibular pulmonary stenosis successful balloon pulmonary valvuloplasty adults july march adult patients congenital pulmonary stenosis underwent balloon pulmonary valvuloplasty males females aged average years patients additional mild severe infundibular stenosis restudied mean months later repeat catheterization student test used comparison data right ventricular rv systolic pressure dilatation mean mm hg peak pulmonary gradient ppg mean mm hg immediately dilatation rv systolic pressure dropped mean p less ppg dropped mean p less infundibular gradient ranged mean mm hg infundibular diameter dilatation ranged mean mm hg repeat catheterization rv systolic pressure dropped mean mm hg ppg reduced mean mm hg p less infundibular gradient regressed mean mm hg p less infundibular diameter increased mean p less concluded moderate severe infundibular stenosis adults regress successful pulmonary valvuloplasty,C14,0.12398268,0.0019758402,0.0041561504,0.0012515011,0.013873228,0.0031426167,0.060027093,0.0020947007,0.0016103316,0.0021885792,0.027161537,0.036895413,0.3409847,0.005121546,0.0019587444,0.014235397,0.2958526,0.002293882,0.002536255,0.0189715,0.036603354,0.0007908789,0.0022914961
prevalence raynaud phenomenon adult population south carolina prevalence estimate raynaud phenomenon among adult residents south carolina based data obtained respondents statewide health survey followed face face interviews clinical screening raynaud phenomenon using screening procedure developed authors survey obtained personal interviews probability sample households survey subjects participated clinical screening prevalence estimates standard errors computed using survey case weights design based estimation logistic modelling techniques prevalence raynaud phenomenon among adult residents south carolina determined standard error prevalence higher females se males se figures much lower estimates existing literature raynaud phenomenon,C14,0.0027270748,0.0024190512,0.018262088,0.001532232,0.0037973651,0.0035441185,0.14025725,0.0025645741,0.0019715535,0.042272344,0.2593893,0.0056090713,0.039706584,0.0064885234,0.015590652,0.0042466223,0.079827055,0.002808435,0.069113344,0.24446437,0.036435723,0.014167156,0.0028055138
haemorheological changes patients retinal vein occlusion isovolaemic haemodilution patients central retinal vein occlusion branch vein occlusion measured haematocrit hct plasma viscosity pv red cell aggregation rca red cell filterability rcf apparent whole blood viscosity wbv control group n matched sex age cardiovascular risk factors measurements performed treatment isovolaemic haemodilution ihd found significant differences patients retinal vein occlusion rvo control subjects haematocrit plasma viscosity red cell aggregation red cell filterability increased whole blood viscosity patient group patients ischaemic retinal vein occlusion non ischaemic retinal vein occlusion show different haemorheological parameters either treatment haemodilution haematocrit whole blood viscosity significantly decreased changes plasma viscosity red cell aggregation red cell filterability,C14,0.08816541,0.0022418157,0.0047156257,0.0014199705,0.003519145,0.07648756,0.0739963,0.05131156,0.0018271045,0.0024831924,0.0128251165,0.036095206,0.14764252,0.08117404,0.0022291238,0.004036519,0.10354336,0.0026026703,0.0028776699,0.069646634,0.22766212,0.00089734216,0.0025999635
angiography angioscopy ultrasound imaging percutaneous balloon angioplasty report two patients undergoing peripheral percutaneous transluminal angioplasty angiography angioscopy ultrasound imaging performed balloon angioplasty first case smooth atheroma diagnosed angiography found unrecognized partially occlusive thrombus angioscopy angioplasty intimal tear identified angioscopy ultrasound seen angiography intravascular ultrasound image showed tear extend adventitia second case apparently smooth intimal surface imaged angiography found angioscopy ultrasound extensive damage including subintimal hemorrhage intimal flaps arterial dissection angioplasty site data suggest type information derived three imaging techniques quite different may specific role intravascular diagnosis,C14,0.011296429,0.0027459934,0.008746862,0.0017394255,0.07924051,0.003995094,0.22206946,0.0029139053,0.0022380152,0.0030416553,0.26983514,0.006367155,0.019360261,0.022458736,0.002722234,0.0048205666,0.16943783,0.0032407604,0.0035248497,0.022658877,0.13324614,0.0010991518,0.0032009028
dissecting aneurysm pulmonary artery pulmonary hypertension pulmonary artery dissection observed yr old female patient severe pulmonary hypertension probably primary pulmonary vascular resistance dyn cm normal range less equal dyn cm patient admitted hospital severe dyspnea exertion echocardiography demonstrated dissecting aneurysm pulmonary artery right heart catheterization revealed severe pulmonary hypertension mean pulmonary artery pressure mm hg normal range mm hg dissection pulmonary artery confirmed pulmonary arteriography one year follow uneventful literature patients dissecting aneurysm pulmonary artery reviewed dissection diagnosed life one patient echocardiography,C14,0.35424623,0.0025899347,0.005447889,0.00164047,0.0041119894,0.004377126,0.10198518,0.01687736,0.0021108256,0.0028687937,0.024936838,0.0060053,0.117102616,0.006902601,0.0025675257,0.004546607,0.18760405,0.0030285507,0.0033245275,0.077185236,0.066499986,0.0010366855,0.0030036974
progress cardioprotection role calcium antagonists calcium antagonists widely used treatment clinical hypertension angina pectoris efficacious treatment vasospastic fixed atherosclerotic mixed angina reduce incidence silent ischemia shown reduce postmyocardial infarct angina experimental data suggest may certain cardioprotective properties cases acute myocardial ischemia infarction stunned myocardium diastolic dysfunction left ventricular hypertrophy atherosclerosis moreover shown improve exercise performance well diastolic abnormalities patients hypertrophic cardiomyopathy animals may delay reduce extent myocardial necrosis coronary occlusion coronary occlusion followed reperfusion low doses alter hemodynamic profile shown enhance return ventricular function animals stunned myocardium however early first generation calcium antagonists nifedipine verapamil diltiazem shown reduce myocardial infarct size enhance survival patients acute myocardial infarction clinical studies suggest unlike beta blockers nitrates nifedipine may slow development atherosclerotic progression humans year period seems likely expansion use calcium antagonists angina hypertension also aspects cardioprotection calcium antagonists may delay prevent possibly regress atherosclerotic lesions exciting possibility,C14,0.061406404,0.021254873,0.013155315,0.010820493,0.012535537,0.002595487,0.30537775,0.011579794,0.0014539681,0.021445874,0.019686213,0.014152295,0.05792296,0.0054765977,0.0017685499,0.012862343,0.13201487,0.0020711457,0.012012315,0.045170784,0.22270817,0.0104474565,0.0020808212
clinical hemodynamic correlates sympathetic nerve activity normal humans patients heart failure evidence direct microneurographic recordings characterize neural excitatory state heart failure simultaneous measurements efferent sympathetic nerve activity muscle microneurography rest hemodynamics obtained normal subjects age years mean sem patients heart failure age years new york heart association functional class ii iv left ventricular ejection fraction cardiac index liters min per pulmonary capillary wedge pressure mm hg sympathetic nerve activity significantly higher patients heart failure bursts min normal subjects bursts min p less multiple linear regression analyses indicated sympathetic activity human subjects strongly inversely correlated left ventricular stroke work index r p less stroke volume index r p less strong positive correlation sympathetic nerve activity pulmonary artery diastolic r p less mean r p less pressures similar correlations seen patients heart failure analyzed separately significant correlation sympathetic nerve activity mean arterial pressure left ventricular ejection fraction radionuclide ventriculography cardiac chamber size echocardiography arterial oxygen tension patients heart failure direct measurements sympathetic nerve activity correlated closely plasma norepinephrine r p less patients heart failure thus sympathetic nerve activity rest parallels impairment cardiac performance patients heart failure,C14,0.040057916,0.0015832641,0.0033303725,0.0010028427,0.002502459,0.0023071019,0.10262035,0.0016793564,0.009930367,0.0017537344,0.04193752,0.0044346433,0.32797593,0.018979698,0.010194254,0.011723966,0.15157524,0.0018388506,0.002032331,0.06883267,0.16527379,0.026554573,0.0018787717
percutaneous transluminal angioplasty crural arteries authors dilated stenosed crural arteries patients primary success defined traversing reducing lesion residual stenosis less achieved cases complications included one vessel rupture one occluding intimal flap treated vascular surgeon bypass venous patch respectively one hematoma puncture site treated surgically size modern materials steerable guide wires low profile balloon catheters dilation crural arteries become safe indications percutaneous transluminal angioplasty pta crural arteries limited fontaine stages iii iv disease authors believe indications pta fontaine stage iib disease justified especially intervention improves outflow proximal recanalizing procedure performed,C14,0.06366969,0.0027459082,0.005775977,0.01662444,0.03624675,0.0039949697,0.19310886,0.023233663,0.0022379456,0.0030415605,0.069593504,0.006442525,0.049483586,0.0071176277,0.0027221492,0.0048204167,0.31277055,0.003198942,0.00352474,0.048690636,0.1366719,0.0010991177,0.0031845886
quality life among hypertensive patients diuretic background taking atenolol enalapril cardioselective beta blocker atenolol angiotensin converting enzyme inhibitor enalapril compared efficacy safety quality life factors patients hypertension whose hypertension inadequately controlled diuretic alone atenolol mg day enalapril mg day combined hydrochlorothiazide mg day similar levels efficacy safety comprehensive battery psychologic assessments quality life administered including measures anxiety depression psychiatric symptoms memory psychomotor function five conceptually based clusters first analyzed multivariate analysis variance procedures followed univariate analyses individual variables composing domain general neither atenolol enalapril associated major changes psychologic functioning data cluster statistically significant change memory function primarily result lower scores digit span backward test atenolol relative enalapril preliminary findings suggest atenolol enalapril comparable degrees efficacy safety major disparities quality life effects hypertensive patients history taking diuretics sort quality life assessment performed trials antihypertensive drugs,C14,0.025147576,0.0020886855,0.015855476,0.0013229777,0.026038596,0.014433407,0.2979169,0.0022143344,0.0017023019,0.014350588,0.024572918,0.018345557,0.052763987,0.006489619,0.013467848,0.0036666684,0.108923905,0.025214924,0.0140787065,0.04967773,0.27846053,0.0008360481,0.0024307047
prolonged extracorporeal life support pediatric adolescent cardiac transplant patients options mechanical support pediatric patients severe heart failure awaiting transplantation undergone transplantation limited report examines patients placed extracorporeal life support ecls awaiting transplantation patients underwent transplantation suffered subsequent heart failure due rejection postoperative myocardial dysfunction overall survival rate surviving patients failing transplanted heart survivors among patients placed ecls bridge transplantation case contraindication transplantation developed donor heart could obtained mean time ecls support hours range hours ecls circuit affect cyclosporin levels antirejection therapy extracorporeal life support used support pediatric cardiac transplant patients biventricular failure due acute rejection postoperative dysfunction although results discouraging ecls may still role bridge transplantation however complications develop ecls may preclude transplantation,C14,0.03366884,0.011755626,0.0038296294,0.0011531791,0.0028579496,0.030549146,0.22972193,0.001930134,0.0014838186,0.0020280052,0.025701266,0.004221465,0.05196671,0.0047192182,0.0018048589,0.003196067,0.44484025,0.012041095,0.0023369982,0.07985992,0.047493666,0.00072874484,0.0021114687
reduction mortality sudden death non fatal reinfarction beta adrenergic blockers survivors acute myocardial infarction new hypothesis regarding cardioprotective action beta adrenergic blockade beta adrenergic blockers shown definitely reduce incidence total mortality cardiovascular mortality sudden death nonfatal reinfarction survivors acute myocardial infarction mechanisms explain protective action beta blockers never elucidated conclusively include antiarrhythmic myocardial oxygen demand reducing effects drugs antithrombotic mechanism also suggested however beta blockers relatively weak antiplatelet activity suggesting antithrombotic effects may related prevention coronary artery plaque rupture subsequent propagation occlusive arterial thrombus rather direct anticoagulant action therapeutic ability beta blockers attenuate hemodynamic consequences catecholamine surges may protect vulnerable atherosclerotic plaque fracture thereby reducing risk coronary thrombosis myocardial infarction death,C14,0.0027988758,0.015226341,0.0049607884,0.0014937939,0.0037021032,0.016295971,0.24169667,0.0025002384,0.0019220946,0.015479135,0.012440513,0.0054683606,0.033267323,0.024146244,0.015071906,0.0041957987,0.16075024,0.015585631,0.0030272782,0.1294637,0.2868279,0.00094399444,0.0027351337
warm induction blood cardioplegia infant technique avoid rapid cooling myocardial contracture use profound hypothermia total circulatory arrest repair heart defects neonates usually involves period systemic myocardial bypass cooling rapid cooling muscle skeletal smooth myocardial result contracture elevation cytosolic calcium levels increased myocardial tone caused cooling might render heart vulnerable subsequent period cardioplegic ischemic arrest infants may susceptible contracture small body mass allows rapid myocardial temperature change prearrest bypass cooling used influence avoiding rapid myocardial cooling induced cardioplegic arrest analyzed group infants weighing less kg time open cardiac operation myocardial ischemic arrest warm degrees c induction blood cardioplegia used infants compared results infants treated standard blood cardioplegia multivariate logistic regression analysis revealed patient diagnosis weight age operation significant risk factors operative mortality use warm induction blood cardioplegia strongly positive independent effect survival p patient weight age diagnostic group recommend avoidance rapid myocardial cooling bypass patients induction cardioplegic ischemic arrest,C14,0.0017110615,0.0015177969,0.019948088,0.00096137566,0.0109448815,0.002208214,0.13517791,0.0016091029,0.0095197065,0.0016812184,0.051995084,0.020925857,0.24407497,0.0040622153,0.0015046818,0.03595376,0.19357213,0.010230618,0.0019482952,0.17430808,0.073770165,0.00060753577,0.001767252
additional salutary hemodynamic effects combined use paraaortic counterpulsation device intraaortic balloon pump versus paraaortic counterpulsation device alone hemodynamic effects combined use paraaortic counterpulsation device pacd stroke volume ml implanted ascending aorta ml intraaortic balloon pump iabp placed descending aorta compared pacd working alone dogs induction heart failure heart failure characterized left ventricular end diastolic pressure lvedp greater mmhg systolic aortic pressure sap stage mmhg greater equal sap greater mmhg stage b mmhg greater equal sap greater mmhg stage c sap less equal mmhg modalities mechanical assistance produced significant salutary hemodynamic effects stages b difference observed stage c conclusion combined use pacd iabp effective use either devices alone modality mechanical assistance may easily applied patients cannot weaned extracorporeal circulation iabp unsuccessfully applied,C14,0.00279457,0.055976942,0.005562402,0.0015530713,0.0038490116,0.0035672984,0.15815404,0.015969895,0.015277302,0.002715954,0.039459396,0.03294913,0.21788166,0.020180413,0.0024307366,0.017679418,0.15021175,0.0028466312,0.003147408,0.06962195,0.13418365,0.04112571,0.0028616667
liver transplantation atrioatrial anastomosis budd chiari syndrome report case young woman budd chiari syndrome mesentericoval shunt first performed followed transcaval liver resection hepatoatrial anatomosis years later liver transplantation became necessary years later deterioarating liver function portal hypertension bleeding successful transplantation performed atrioatrial anastomosis help cardiopulmonary bypass simplifying considerably technical procedure reducing dramatically blood loss,C14,0.025057608,0.044782627,0.007907807,0.0023812011,0.005901384,0.02519342,0.14015393,0.0039855363,0.003063939,0.0042026453,0.043219004,0.008716909,0.070497006,0.010213144,0.024212513,0.046987914,0.25147933,0.004364514,0.0051826253,0.1657821,0.100850105,0.0015047862,0.0043599745
calciotropic hormones human experimental hypertension although altered cellular calcium handling plays critical role pathophysiology hypertension little attention focused impact calcium regulating hormones process recent research provides evidence parathyroid hormone calcitonin dihydroxyvitamin well newly described factors calcitonin gene related peptide cgrp exert target organ specific actions cardiac peripheral vascular tissues linked renin aldosterone system thus control sodium metabolism may directly participate hypertensive process especially low renin salt sensitive forms hypertensive disease metabolic set point linked renin calcium hormone systems serve transduce environmental dietary mineral signals cellular level determines blood pressure consequences sodium calcium loading restriction helps explain heterogeneous seemingly inconsistent effects dietary maneuvers blood pressure measurement renin calcium factors hypertension thus provides physiological basis individualized therapeutic recommendations human hypertension,C14,0.039147746,0.0017054141,0.012709644,0.0010802128,0.0026771156,0.002738633,0.28655446,0.0018240398,0.0013899314,0.0018924257,0.032229908,0.003969062,0.071454436,0.11954009,0.0016906582,0.019114941,0.045318294,0.012151051,0.0346493,0.036449205,0.2690467,0.0006826342,0.0019841422
vitro vivo evaluation right ventricular assist device simple right ventricular assist device rvad developed device useful situations biventricular failure partially treated placement left ventricular assist device right ventricular failure occurs isolation pneumatically actuated r wave synchronized sac type pump contains valves connected graft pulmonary artery rvad tested circulation simulator verify hemodynamic efficacy implanted six calves weeks evaluate biocompatibility vitro testing rvad demonstrated restored normal hemodynamics presence severe simulated rvf six animal implantations small amount thrombus found one pump anticoagulants employed thrombus present connecting graft three animals two clearly related technical implant errors evidence significant hemolysis found simple rvad found hemodynamically effective simple use well tolerated refinements interconnection graft pulmonary artery device necessary,C14,0.12784263,0.052553397,0.029933508,0.014482206,0.01619078,0.0037051432,0.17821829,0.0024404263,0.0018761132,0.0025497994,0.048144106,0.045700476,0.035857577,0.06429676,0.0022820306,0.016595965,0.10229518,0.0026742006,0.0154981855,0.09119053,0.116935864,0.02604559,0.0026912475
coronary atherosclerosis associated left ventricular dysfunction dilatation aortic stenosis patients aortic stenosis develop widely variable patterns left ventricular hypertrophy dysfunction postulated coronary atherosclerosis cad may associated impaired left ventricular function chamber dilatation patients aortic stenosis left ventricular mass volumes quantified two dimensional echocardiography correlated coronary angiography patients severe aortic stenosis previous myocardial infarction regional wall motion abnormalities eighteen patients group smooth coronary arteries patients irregular coronary arteries less stenosis group patients obstructive cad group even though calculated valve area similar three study groups group patients higher values ejection fraction p systolic mass volume ratio p cardiac index l min min p patients groups respectively mean sd mean circumferential wall stress inversely related severity cad multivariate analysis showed cad independent predictor ejection fraction mass volume ratio group patients thus elderly population severe aortic stenosis patients obstructive nonobstructive cad increased incidence left ventricular enlargement systolic dysfunction,C14,0.023792583,0.0018373494,0.033943363,0.0011637808,0.022924198,0.02735693,0.13138355,0.02867666,0.011502634,0.002035177,0.02606366,0.07550903,0.24070399,0.00477204,0.011846268,0.013375134,0.1552117,0.012727939,0.0023584834,0.06590642,0.053906046,0.050872166,0.0021308805
optimizing exercise test pharmacological investigations exercise trials cardiology often hindered inconsistent approaches exercise testing inconsistencies include choice exercise protocol exercise end points points analysis absence misuse gas exchange data gas exchange techniques greatly enhance accuracy cardiopulmonary function assessed exercise commonly used protocols always appropriate patients studies cardiovascular disease exercise protocol important impact relation changes work rate oxygen uptake ramp protocols appear offer greatest promise assessing cardiopulmonary function analyzing hemodynamic gas exchange responses several points submaximally addition peak exercise add important information concerning efficacy drug great deal confusion continues hinder application gas exchange anaerobic threshold many commonly used testing end points reliable,C14,0.014298911,0.0989619,0.016751932,0.0014035205,0.0034783762,0.015303202,0.31416264,0.002349143,0.013887388,0.002454425,0.111221336,0.0051378943,0.07211367,0.0057824156,0.0021966721,0.051950376,0.041724883,0.0025725188,0.024341103,0.076303616,0.12012675,0.00088694657,0.0025903902
detection assessment unstable angina using myocardial perfusion imaging comparison technetium sestamibi spect lead electrocardiogram forty five studies using technetium tc sestamibi single photon emission computed tomography spect performed patients hospitalized spontaneous chest pain suggestive myocardial ischemia studies done injection episode chest pain repeated injection patients free pain patients hospitalized presumed diagnosis unstable angina none evidence previous myocardial infarction presence perfusion defect observed tc sestamibi injected chest pain sensitivity specificity detection significant coronary artery disease stenosis greater equal subsequent angiography criterion larger perfusion defect pain compared absence pain used sensitivity specificity contrast transient electrocardiographic ischemic changes pain sensitivity specificity electrocardiographic changes outside episodes chest pain sensitivity specificity diagnosis tc sestamibi spect represents reliable noninvasive diagnostic tool could aid diagnosis myocardial ischemia patients spontaneous chest pain provide additional information provided electrocardiogram,C14,0.0024094607,0.002137312,0.016157743,0.0013537777,0.050059337,0.0031095347,0.26646867,0.0022658862,0.013394769,0.0023674367,0.15560287,0.039941225,0.13230401,0.0057300366,0.002118819,0.0037520316,0.122540824,0.014042573,0.0027435257,0.043958806,0.102544904,0.012517657,0.0024787644
arterial blood oxygen desaturation infants children upper gastrointestinal endoscopy arterial blood oxygen desaturation abnormal electrocardiographic changes reported adults undergoing upper gastrointestinal endoscopy studied infants children less years age using pulse oximetry continuous electrocardiography upper gastrointestinal endoscopy performed intravenous sedation sinus tachycardia common electrocardiographic change clinically significant electrocardiographic abnormalities induced procedure desaturation less equal found patients commonly noted endoscopy procedure patients cardiopulmonary disease desaturation unpredictable correlation desaturation medication tolerance procedure weight age child patients subjectively appeared tolerate procedure well significant desaturation use pulse oximetry considered children undergoing upper gastrointestinal endoscopy,C14,0.02816463,0.002518988,0.005334796,0.0015955322,0.0039542434,0.003664828,0.16512878,0.0026717873,0.002053003,0.057781663,0.08812807,0.033279244,0.1233297,0.0066634146,0.0024971927,0.00442206,0.21694057,0.002924458,0.0032334577,0.16690937,0.06116057,0.0010082873,0.016635375
left ventricular filling impairment asymptomatic chronic alcoholics systolic left ventricular dysfunction relatively common even asymptomatic alcoholics whether diastolic function also altered much less well studied used mode doppler echocardiography study left ventricular size mass systolic function diastolic filling alcoholics free clinically detectable heart disease healthy control subjects left ventricular mass index posterior wall thickness higher alcoholics controls statistically significant difference either end diastolic size systolic ventricular function abnormalities found doppler indexes diastolic function however alcoholics prolonged relaxation time vs ms mean standard error p less decreased peak early diastolic velocity vs cm p less slower acceleration early flow vs cm p less higher atrial early peak velocity ratio vs p less pattern changes suggests primary abnormality relaxation left ventricle multivariate analyses abnormalities doppler indexes independent duration alcoholism quantity recent ethanol exposure increased mass left ventricle impaired early filling left ventricle due delayed relaxation common asymptomatic alcoholics may fact earliest functional sign preclinical alcoholic cardiomyopathy,C14,0.012679352,0.0015305321,0.01992107,0.00096944213,0.0024524804,0.0022267422,0.24655622,0.0016226042,0.026287014,0.026751144,0.037399106,0.0036776154,0.29619467,0.0043372503,0.0015172893,0.0027006862,0.085599355,0.010303864,0.0019646424,0.024269706,0.14690334,0.0340234,0.010112456
cardiac rhythm disturbances early orthotopic heart transplantation prevalence clinical importance observed abnormalities precisely define incidence type consequences cardiac arrhythmias early heart transplantation cardiac transplant recipients monitored continuously days day surgery discharge death subset patients sinus node function studies overdrive suppression performed weekly time endomyocardial biopsy results revealed sinus bradycardia patients junctional bradycardia supraventricular tachycardia form atrial tachycardia atrial fibrillation atrial flutter occurred patients ventricular tachycardia occurred patients nonsustained cardiac pacing h used nine patients pulse rate less beats min seven recovered permanent pacing instituted two subgroup sinus node function studies seven patients identified clinical bradyarrhythmia abnormal sinus node recovery time greater ms abnormal corrected sinus node recovery time greater ms least one study seven patients also significantly prolonged ischemic time versus min p less conclusion cardiac arrhythmias particularly ventricular tachycardia bradyarrhythmia occur commonly early orthotopic heart transplantation previously reported sinus node dysfunction due prolonged organ ischemic time antiarrhythmic drug use surgical trauma alone combination may contribute arrhythmias,C14,0.001817438,0.0016115317,0.021275995,0.0010207781,0.011506067,0.002344587,0.26948938,0.0017084766,0.0013134162,0.0017850456,0.019410454,0.0056147026,0.083436936,0.0043094726,0.010387852,0.002836173,0.41434428,0.0018723505,0.0020686162,0.035889313,0.10344216,0.00064505544,0.00186993
potential usefulness combined thromboxane serotonin receptor blockade preventing conversion chronic acute coronary artery disease syndromes evidence suggests unstable angina non q wave myocardial infarction q wave myocardial infarcts represent continuum transient reduction coronary blood flow associated platelet aggregation dynamic vasoconstriction sites coronary artery stenosis endothelial injury lead abrupt development unstable angina factors potentially responsible conversion chronic acute coronary artery disease include endothelial injury sites stenosis endothelial injury may result plaque fissuring ulceration hemodynamic factors including systemic arterial hypertension flow shear stress infection smoking coronary arteriography balloon angioplasty clinical experimental animal studies suggest interference thromboxane serotonin contributions platelet aggregation dynamic coronary artery constriction may prevent chronic coronary artery disease syndromes converting acute disease protect process may require thromboxane serotonin receptor antagonists combination thromboxane synthesis inhibitor receptor antagonist serotonin receptor antagonist studies needed test hypothesis,C14,0.06172694,0.02189314,0.03393057,0.0011639053,0.0028934984,0.0026734106,0.3680366,0.032025825,0.0014976203,0.0020353948,0.010891968,0.0146066435,0.10422443,0.007292625,0.0018216467,0.0032823968,0.11567024,0.03418128,0.0023587358,0.079470284,0.0954562,0.0007355232,0.0021311084
body surface mapping high frequency components terminal portion qrs complex prediction ventricular tachycardia patients previous myocardial infarction study clinical significance terminal qrs high frequency components prediction ventricular tachycardia lead body surface signal averaged mapping performed healthy subjects control patients previous myocardial infarction anterior inferior mapping data analyzed averaged beats seconds signal averaged beat filtered bidirectional bandwidth hz digital filter j point determined lead rms voltage nonfiltered qrs lead calculated sum absolute value filtered qrs msec ahead j point j point body surface distribution expressed map maxima maps mainly located upper sternal region healthy subjects left anterior chest patients previous anterior myocardial infarction central anterior chest patients previous inferior myocardial infarction patients group anterior myocardial infarction group inferior myocardial infarction value maximum significantly greater subjects control group respectively vs mv msec p less patients myocardial infarction n value maximum significantly greater ventricular tachycardia n without ventricular tachycardia n vs mv msec p less,C14,0.002113834,0.0018750762,0.056499492,0.0011876771,0.0029434469,0.012790978,0.20072512,0.012251951,0.0015282079,0.002076966,0.07922814,0.03589725,0.30060068,0.011682615,0.027455872,0.003291679,0.08902671,0.0021768985,0.002406911,0.02741771,0.07508766,0.00075054565,0.05098455
clinical significance plasminogen activator inhibitor activity patients exercise induced ischemia assess fibrinolytic system patients exercise induced ischemia relation ischemia severity coronary artery disease cad patients cad confirmed results coronary angiography underwent symptom limited multistage exercise thallium emission computed tomography patients cad exercise induced ischemia assessed thallium images pre peak exercise blood samples patient preexercise blood samples control subjects assayed several fibrinolytic components also assayed plasma adrenaline extent ischemia defined delta visual uptake score total visual uptake score delayed images minus total visual uptake score initial images severity cad number diseased vessels basal condition plasminogen activator inhibitor pai activity significantly higher patients exercise induced ischemia compared control subjects p less although significant differences fibrinolytic variables two groups moreover pai activity basal condition displayed significantly positive correlation extent ischemia r p less patients exercise induced ischemia divided two groups single vessel disease multivessel disease significant differences coronary risk factors hemodynamics plasma adrenaline levels exercise single vessel multivessel disease except delta visual uptake score significantly higher multivessel disease p less,C14,0.0014677377,0.058145896,0.038257692,0.0008246619,0.023357328,0.001894192,0.15555674,0.0013850926,0.001061109,0.009026821,0.043728136,0.0545533,0.14144193,0.021411717,0.0012907283,0.044914234,0.09968108,0.0015140041,0.0016712353,0.10792982,0.17382549,0.00052114035,0.0165399
contrast echocardiographic mapping collateralized myocardium humans coronary angioplasty conventional coronary arteriography able demonstrate presence coronary collateral vessels cannot delineate specific region myocardium supply blood test hypothesis contrast echocardiography specifically identify collateralized myocardium contrast echocardiographic perfusion maps compared patients n without n angiographic evidence coronary collateral flow coronary angioplasty contrast echocardiographic images mid left ventricle short axis view end diastole obtained separate injections sonicated contrast agent right left coronary arteries computer based contouring system used determine individual areas myocardium perfused two coronary arteries superimpose images two perfusion beds resulting area overlapping perfusion represented myocardium receiving blood flow coronary systems defined collateralized myocardium normalize heart size overlap area expressed percent total myocardial area area endocardium epicardium short axis view adjust differences vascular distribution overlap area expressed percent perfusion area recipient vessel patients angiographic collateral flow recipient vessel vessel receiving collateral flow patients without angiographic collateral flow right coronary artery considered recipient vessel overlap area total myocardial area recipient vessel area patients without angiographic evidence collateral flow compared respectively patients angiographic collateral flow p less four patients angiographic collateral flow abolished angioplasty overlap area decreased total myocardial area recipient vessel area p less thus contrast echocardiography able map specific myocardial territory perfused coronary collateral flow document immediate reduction perfusion territory collateral flow abolished angioplasty,C14,0.0138150165,0.0011473486,0.0024134305,0.0007267329,0.014815888,0.0016692557,0.14276691,0.05903799,0.00093510177,0.0012708838,0.020236772,0.019193232,0.2445188,0.023022186,0.007383056,0.00201416,0.19186449,0.013815706,0.0014727752,0.03771099,0.19834997,0.00045925463,0.001360026
blood rheology revert normal myocardial infarction myocardial infarction acute deterioration flow properties blood present study designed test whether abnormality persists blood plasma viscosity red cell aggregation deformability haematocrit erythrocyte sedimentation rate white cell count cholesterol triglycerides measured patients myocardial infarction mean years results patients controls compared matched pairs identical cardiovascular risk factors also selected blood viscosity red cell aggregation increased red cell deformability decreased patients abnormalities independent interval since infarction persisted years rheological abnormalities present myocardial infarction least partly independent acute event acute phase reactions contribute reduced perfusion microcirculation heart,C14,0.002692024,0.0023879595,0.024673127,0.0015125384,0.003748558,0.030711835,0.2217319,0.0025316118,0.01497652,0.0026450716,0.02467825,0.0057755117,0.18796276,0.078865655,0.04938269,0.017493244,0.08411065,0.002773118,0.0030652652,0.08540936,0.14914705,0.0009558399,0.0027694548
coronary artery surgery study cass comparability year survival randomized randomizable patients coronary artery surgery study cass includes patients mild moderate stable angina pectoris asymptomatic survivors myocardial infarction randomized either medical surgical therapy patients eligible randomization randomized randomizable patients substantial aggregate differences observed survival comparisons years follow study randomized randomizable patients assigned medical versus surgical versus groups patient subgroups stratified according coronary artery disease extent left ventricular ejection fraction cox regression analyses done independent variables known predictors survival including surgical versus medical therapy randomized versus randomizable group test null hypothesis mortality difference medical versus surgical assignment according group assignment randomized versus randomizable case initial group category enter significant predictor survival results randomizable group reinforce randomized group respect medical versus surgical comparison two subgroups identified significant surgical advantage patients proximal left anterior descending coronary artery stenosis greater equal ejection fraction less patients three vessel coronary artery disease ejection fraction less groups coronary bypass surgery statistically significant beneficial effect survival p less decade follow cass randomizable patients confirm conclusions reached basis cass randomized trial,C14,0.0016561493,0.0014690871,0.011063962,0.00093052274,0.0023061354,0.002137347,0.12727535,0.009876179,0.0011973222,0.001627264,0.037409008,0.14490594,0.0766137,0.003908841,0.0014563759,0.010639506,0.34853348,0.0017067469,0.0019563714,0.12465788,0.070346065,0.016621502,0.0017052386
left right ventricular flows doppler echocardiography serial measurements patients aortic regurgitation exercise cold pressor stimulation vasodilation test practicality doppler echocardiography measure serial change biventricular outputs measured patients aortic regurgitation control periods interventions bicycle exercise cold pressor stimulation vasodilation biventricular stroke volumes measured normal subjects validation methods differed reading errors signal quality improved first last observation p less velocity signals corrected intercept angles averaged degrees right heart flows degrees left side heart subjects negative correlations occurred intercept angles chronologic order patients studied left p right p flows mean flow areas varied left ventricle right ventricle total variability measuring flow determined control values twice variability used detectable level change exercise provoked real increases biventricular flows majority patients conclude serial measurements flow doppler echocardiographic methods exceed achieve significant change measuring intercept angle resolving flow area learning variables need greater emphasis,C14,0.045219596,0.036466025,0.0033616417,0.001011743,0.0025074254,0.011392967,0.06974654,0.045279708,0.027434912,0.001769299,0.063739404,0.021349527,0.33788982,0.004333333,0.001583513,0.002804073,0.08530273,0.0018615982,0.011118222,0.04054723,0.17407475,0.009353406,0.0018524996
planar imaging techniques used technetium sestamibi evaluate chronic myocardial ischemia results published unpublished studies comparing planar imaging performed radionuclides thallium technetium tc sestamibi reviewed average sensitivity detection coronary artery disease cad studies involving patients range average sensitivity individual vessels range average segmental concordance tc sestamibi end diastolic gated perfusion images improved concordance tc sestamibi angiography patients semiquantitative analysis increased concordance tc sestamibi ventricular function derived gated tc sestamibi perfusion images showed significant correlation echocardiography n r angiography n r equilibrium radionuclide ventriculography n r ratio lung left ventricle uptake ratio right ventricle left ventricle uptake assessed eight patients abnormally elevated lung index greater patients severe cad six patients abnormally elevated right ventricular index greater patients severe cad,C14,0.034495484,0.0023572484,0.030685326,0.0014930859,0.055156328,0.053324513,0.17688024,0.0025077788,0.0019211835,0.0026110536,0.078809425,0.0054657683,0.1677799,0.01895698,0.0023368525,0.029862288,0.19950059,0.002775666,0.01586835,0.023117224,0.09039642,0.000943547,0.002754729
increased rat cardiac angiotensin converting enzyme activity mrna expression pressure overload left ventricular hypertrophy effects coronary resistance contractility relaxation compared activity physiologic effects cardiac angiotensin converting enzyme ace using isovolumic hearts male wistar rats left ventricular hypertrophy due chronic experimental aortic stenosis control rats response infusion x angiotensin isolated buffer perfused beating hearts intracardiac fractional conversion angiotensin ii higher hypertrophied hearts compared controls vs p less ace activity also significantly increased free wall septum apex hypertrophied left ventricle whereas ace activity nonhypertrophied right ventricle aortic stenosis rats different control rats northern blot analyses poly purified rna demonstrated expression ace mrna increased fourfold left ventricular tissue obtained hearts left ventricular hypertrophy compared controls groups intracardiac conversion angiotensin angiotensin ii caused comparable dose dependent increase coronary resistance control hearts angiotensin ii activation significant effect systolic diastolic function however associated dose dependent depression left ventricular diastolic relaxation hypertrophied hearts novel observations suggest cardiac ace induced hearts left ventricular hypertrophy resultant intracardiac activation angiotensin ii may differential effects myocardial relaxation hypertrophied hearts relative controls,C14,0.014072568,0.0015847925,0.011979878,0.0010038108,0.0024878825,0.028250918,0.08774746,0.0016833709,0.0012916235,0.0017554275,0.019125018,0.012979407,0.14656252,0.004218429,0.0015710802,0.011305859,0.07858994,0.045079246,0.002034293,0.023431964,0.42293534,0.05252854,0.027780648
apical segmental dysfunction hypertrophic cardiomyopathy subgroup unique clinical features segmental wall motion abnormality unusual finding patients hypertrophic cardiomyopathy clarify clinical significance patients hypertrophic cardiomyopathy analyzed eight patients group apical segmental dysfunction group b normal wall motion patient either group coronary artery stenosis selective coronary arteriography patients group apical segmental dysfunction revealed left ventriculography however could detected echocardiography two patients group left ventricular hypertrophy electrocardiogram ecg common group b p less abnormal q waves frequently discovered group p less recognized predominantly lateral leads serial ecgs gradual development abnormal q waves noted six eight patients group malignant arrhythmias common group p less two patients group left ventricular dilation congestive heart failure developed follow period thus presence q wave lateral leads ecg patients hypertrophic cardiomyopathy may indicate presence apical segmental dysfunction left ventriculography performed examine presence abnormality h ambulatory ecg monitoring done detect malignant arrhythmias patients abnormal q waves lateral leads patients unique type hypertrophic cardiomyopathy need careful follow evaluation,C14,0.0019176245,0.020251578,0.0035885025,0.0010774618,0.0121251885,0.0024747942,0.34191325,0.04821966,0.0013863571,0.0018841786,0.021850262,0.10530479,0.06015476,0.0048497138,0.0016863105,0.012265746,0.22898436,0.0019824703,0.0021834974,0.013204843,0.09145879,0.019245936,0.0019899167
amiloride blocks onset acth induced hypertension sheep study investigated ability two diuretics amiloride frusemide prevent development acth induced hypertension conscious sheep infusion amiloride mg day frusemide mg day three days normotensive sheep significant effects blood pressure amiloride blocked acth induced hypertension sodium retention hypokalemia usually associated acth administration frusemide failed completely block hypertension potassium loss however blocked transient initial urinary sodium retention associated acth induced hypertension frusemide failed completely block hypertension unlikely amiloride effect due primarily effects urinary na excretion possible amiloride exerting antihypertensive effects blocking sodium channels,C14,0.15170465,0.014479387,0.041386656,0.03812533,0.003520305,0.0032626502,0.1784755,0.0023774598,0.0018277068,0.026952043,0.011648867,0.0052892314,0.05889021,0.018370783,0.026634738,0.0039446633,0.031765185,0.0026562756,0.0028786184,0.02358306,0.34872818,0.0008976379,0.0026008203
operative findings percutaneous pulmonary balloon dilatation right ventricular outflow tract tetralogy fallot since percutaneous balloon dilatation right ventricular outflow tract performed alternative surgical palliation selected cases tetralogy fallot royal liverpool children hospital december december patients underwent subsequent surgical correction age operation ranged months median years mean interval balloon dilatation correction months range months two patients systemic pulmonary shunt operation performed dilatation five required one afterwards overall patients anatomical alteration result balloon dilatation seven discernible change right ventricular outflow tract consistent relation ratio balloon size pulmonary annulus diameter morphological findings balloon dilatation may obviate need systemic pulmonary shunt expense structural damage particularly posterior cusp present data suggest dilatation bring growth annulus extent transannular patch longer needed intracardiac repair,C14,0.11504198,0.0020655931,0.0043449444,0.012552673,0.014994571,0.0030133459,0.1597466,0.002189853,0.0016834813,0.013560874,0.023315826,0.0047895056,0.06525399,0.016623229,0.013299961,0.015193872,0.3933449,0.002398082,0.025034003,0.05070686,0.057623494,0.0008268048,0.002395588
application time series analysis circadian rhythms effect beta adrenergic blockade upon heart rate transient myocardial ischemia circadian variations transient myocardial ischemia heart rate identified rhythms response beta blockade fully characterized time series analysis mathematical technique describe oscillatory activity occurring within continuous data set used address issues nine men coronary artery disease underwent hours ambulatory electrocardiographic monitoring therapy placebo metoprolol administration placebo ischemic time heart rate showed primary peak periodicity approximately hours tight coupling variables secondary peak periodicity hours metoprolol therapy heart rate ischemic variation reduced hour periodicity heart rate remained hour periodicity ischemia eliminated data hour periodicity became major component signal,C14,0.0023285744,0.0020650795,0.016260616,0.0013080256,0.0032417092,0.0031194491,0.23752517,0.0021893084,0.0016830626,0.024688128,0.05041131,0.004788722,0.1913256,0.00573147,0.0020472116,0.014891195,0.17496741,0.013644431,0.05888146,0.06791686,0.11774347,0.0008265992,0.002415119
reduction incidence inducible ventricular tachycardia myocardial infarction treatment streptokinase infarct evolution aim study determine whether intravenous streptokinase administered without oral aspirin patients evolving myocardial infarction reduces inducibility ventricular tachycardia electrophysiologic study thus risk sudden death infarct survivors patients randomized westmead hospital multicenter second international study infarct survival isis streptokinase aspirin acute myocardial infarction underwent electrophysiologic testing days infarction determine risk subsequent ventricular arrhythmias streptokinase patients aspirin patients streptokinase aspirin patients placebos patients patients underwent electrophysiologic testing similar clinical characteristics patients stimulation protocol comprised including four extrastimuli applied right ventricular apex twice diastolic threshold abnormal result defined ventricular tachycardia cycle length greater equal ms lasting greater equal ventricular tachycardia inducible electrophysiologic study patients received placebo streptokinase patient received active streptokinase versus p fischer exact test ventricular tachycardia inducible patients received aspirin therapy versus p ns mean follow period months spontaneous episodes ventricular tachycardia ventricular fibrillation witnessed sudden death streptokinase treated group compared three events placebo treated group p compared placebo therapy intravenous streptokinase substantially reduced incidence inducible ventricular tachycardia infarct survivors similar benefit attributable aspirin therapy,C14,0.04875338,0.0017008531,0.0036345671,0.0010773238,0.0026699558,0.0024830801,0.20666835,0.0018031712,0.0013862142,0.0018839843,0.043497577,0.0385999,0.031948972,0.0044135936,0.0016861367,0.002985832,0.26892987,0.0019746316,0.04538195,0.0675646,0.19973922,0.019244272,0.001972578
socioeconomic conditions childhood ischaemic heart disease middle age objective examine association socioeconomic conditions childhood ischaemic heart disease middle aged men including role physiological behavioural risk factors design prevalence study extensive examination testing recall childhood conditions setting population based study kuopio finland subjects representative sample men aged main outcome measures ischaemic findings progressive maximal exercise test results low socioeconomic style childhood associated significantly higher prevalence findings indicating ischaemias compared highest tertile childhood socioeconomic conditions age adjusted odds ratio subjects lowest tertile middle tertile adjustment years cigarette smoking times average number cigarettes smoked ratio high density lipoprotein low density lipoprotein cholesterol fibrinogen serum selenium concentrations adult height appreciably weaken association adjustment adult socioeconomic state resulted decline association association reduced non significance adjustment measures prevalent cardiovascular illness conclusions socioeconomic state childhood significantly associated ischaemic heart disease middle aged men levels risk factors measured middle age account association adult height childhood socioeconomic conditions precede development ischaemic heart disease substantial impact prevalent illness observed association suggests ischaemic heart disease develops earlier lower socioeconomic state childhood,C14,0.0016834235,0.009638689,0.018751495,0.0009456596,0.0023436495,0.019107498,0.31495762,0.0015827982,0.009360527,0.017899591,0.047557633,0.0034618413,0.15532227,0.003923735,0.0096037155,0.0026314135,0.017650383,0.0017389847,0.0020274296,0.25842068,0.09906191,0.0005976041,0.0017315008
relation intraventricular pressure volume diastole pressure volume curves patients various types heart disease studied throughout mid late diastole pressure volume increasing results used test currently held theory form relation exponential found patients examined hypothesis valid,C14,0.0047217035,0.0041883867,0.008810209,0.0026531555,0.0065748226,0.0060936045,0.25699475,0.004440347,0.0034135815,0.0046393513,0.075187065,0.009711642,0.27330282,0.011682833,0.004152147,0.0073526744,0.11458493,0.004862572,0.0053763543,0.10950043,0.075215705,0.0016765054,0.004864356
area risk determination technetium hexakis methoxyisobutyl isonitrile experimental reperfused myocardial infarction canine model reperfused myocardial infarction tested hypothesis reperfusion technetium hexakis methoxyisobutyl isonitrile tc mibi tomographic imaging still reflects occlusion blood flow tracer injected reperfusion nine anesthetized dogs underwent hours coronary occlusion followed hours reperfusion ending killed reference coronary blood flow determined radioactive microspheres injected occlusion reperfusion biopsies normal ischemic myocardium single photon emission computed tomography obtained occlusion reperfusion circumferential profiles applied axial slices divided degree sectors sectors divided groups selected occlusion acquisition normal mildly reduced severely reduced compared postreperfusion acquisition tissular tc mibi kinetics assessed tc mibi time activity curves normal ischemic tissue obtained biopsy relative gradient normal ischemic necrotic postmortem tissue samples biopsy samples tc mibi content remained unchanged occlusion reperfusion normal well ischemic tissue counts min mg vs counts min mg normal tissue ns counts min mg vs counts min mg ischemic tissue ns postmortem tissue samples good correlation occlusion microsphere blood flow tc mibi activity r necrotic samples mean normalized tc mibi activity slightly higher normalized microsphere blood flow p less markedly lower normalized microsphere reperfusion blood flow p less comparing single photon emission computed tomographic acquisitions reperfusion tc mibi activity remained unchanged normal well mildly reduced severely reduced segments thus data consistent hypothesis tc mibi traces blood flow redistribute significantly despite reperfusion used imaging area risk,C14,0.05205896,0.0013115354,0.05496608,0.0008307292,0.016368076,0.001908128,0.052295838,0.0013904334,0.0010689158,0.0014536482,0.06644384,0.060281448,0.3054579,0.0037876323,0.008433806,0.009417665,0.0772367,0.0015237629,0.001683531,0.026532622,0.2535027,0.0005249745,0.0015210635
diagnosis left atrial thrombi mitral valve disease coronary arteriography arteriographic findings neovascularity fistula formation coronary arteries left atrium occasionally described association left atrial thrombosis patients mitral valve disease validity coronary arteriographic findings diagnosis atrial thrombi evaluated patients mitral valve disease comparison made surgery study furnished diagnostic values sensitivity specificity positive predictive value even angiographic finding complementary diagnosis atrial thrombosis identification coronary arteriography patients mitral valve disease useful detection could improve diagnostic prediction thrombosis especially patients without previous embolic events echocardiography failed reveal thrombi,C14,0.019230714,0.0029207456,0.006143745,0.0018500063,0.020484084,0.0042493376,0.27474597,0.060801413,0.00238044,0.01915601,0.15422939,0.006772354,0.06791478,0.0076073604,0.0028954742,0.0051273424,0.19155478,0.019310355,0.0037491675,0.053455085,0.07086499,0.0011691008,0.0033873578
circadian rhythm heart rate variability acute myocardial infarction influence prognostic value heart rate variability study examined heart rate hr variability patients surviving acute myocardial infarction ami find optimum time duration recording ambulatory electrocardiogram prediction risk sudden cardiac death serious arrhythmic events twenty patients group initially survived ami later experienced serious events death symptomatic sustained ventricular tachycardia month follow compared patients group ii remained free complications greater months discharge groups ii matched regard age gender infarct site ejection fraction beta blocker treatment hr variability assessed hour electrocardiograms recorded first weeks ami various portions complete hour recording beginning length analyzed portion varied minutes total possibilities maximum reduction hr variability group patients systematically found assessing hr variability recordings starting approximately lasting approximately hours low risk patient diurnal rhythm hr variability marked high risk patient long term components hr variability due diurnal variation must included measurement hr variability using long term predictor risk arrhythmic events ami,C14,0.009830564,0.0014811248,0.011195414,0.0009381474,0.002325032,0.0021621396,0.15914197,0.0015702246,0.001207133,0.009561734,0.016893663,0.039337106,0.19772312,0.0038663375,0.0103208665,0.01875893,0.21706738,0.0017232198,0.0019012216,0.11310035,0.17758013,0.00059285684,0.0017213181
cardiac catheterisation french catheters beginning november end january coronary arteriograms left ventricular angiograms performed french coronary catheters patients diagnostic pictures obtained three standard types french catheters judkins left coronary right coronary pigtail catheters patients various french catheters required complete study nine patients french catheter used major complications causing cardiac arrest requiring urgent operation developed five patients sixty two patients minor complications required sublingual nitrates single bolus atropine developed haematoma need intervention mild reaction contrast material complications moderate severity developed patients severe chest pain arrhythmia requiring temporary pacemaker contrast reaction associated hypotension haematoma requiring blood transfusion transient ischaemic episode deaths french catheters used routine coronary angiography left ventriculography patients major complications related femoral artery puncture routine use french coronary catheters increase feasibility safe coronary angiography outpatients reduce cost investigation,C14,0.0132705765,0.01235051,0.004026041,0.0012123676,0.0030045265,0.023154205,0.26029032,0.03336482,0.012002185,0.0021200653,0.18872252,0.004437973,0.06574185,0.0049776156,0.0018974254,0.0033599848,0.2364419,0.0022220714,0.002456857,0.0654039,0.046112143,0.011209001,0.0022211694
circumferential quantitative analysis planar myocardial scintigraphy diagnosis coronary artery disease methodology computer analysis myocardial perfusion images developed several laboratories substantial evidence advantage approach visual inspection alone reported currently available computer analyses use different algorithms analyze kinetics myocardium authors evaluated compared two widely used software programs medical data system mds mean count profile cedars sinai cs maximal count profile planar scintigraphy ability detect coronary artery disease cad,C14,0.0037731528,0.003346975,0.025295455,0.0021199808,0.023516815,0.0048694503,0.39372048,0.0035483188,0.020990172,0.0037073444,0.08504805,0.007760654,0.063565314,0.008716101,0.0033180155,0.0058755837,0.090621635,0.0038857218,0.020844065,0.048537917,0.1716587,0.0013397095,0.003940424
hemodynamic effects nebivolol rest exertion patients heart failure nebivolol novel b adrenoceptor blocking drug unusual hemodynamic profile unlike classical b blockers dogs healthy volunteers decreases blood pressure heart rate improves left ventricular function authors studied male patients coronary artery disease heart failure ejection fraction mean swan ganz catheter placed pulmonary artery mean blood pressure heart rate pulmonary artery pressure pulmonary wedge pressure right atrial pressure cardiac output stroke volume measured rest exertion seven days treatment oral nebivolol mg day blood pressure heart rate decreased significantly pulmonary artery wedge pressures well right atrial pressure cardiac output change treatment stroke volume increased significantly maintained cardiac output cannot explained changes preload afterload instead positive inotropic mechanism must assumed unlike b blockers seems possible treat patients heart failure nebivolol without causing hemodynamic situation deteriorate,C14,0.111273125,0.0019977835,0.0042023077,0.0012654001,0.0031360695,0.0029144224,0.15776423,0.012966051,0.0016282157,0.0022128853,0.041289713,0.0046323165,0.32045028,0.016023548,0.0019804977,0.014401946,0.10335538,0.0023193574,0.002564422,0.034234177,0.14537106,0.011699889,0.0023169452
bronchial hyperreactivity patients mitral valve disease elicit mechanism bronchial hyperreactivity bhr chronic heart failure chf methacholine inhalation test pulmonary function test cardiac catheterization performed patients mitral valve disease mvd change severity bhr mitral valve replacement mvr also examined seven patients mvd sixteen patients mvd showed significant increase respiratory resistance methacholine inhalation test normal subjects maximal expiratory flow percent vital capacity vmax parameter small airway disease correlated significantly log cumulative dose producing percent decrease respiratory conductance pd grs r duration symptoms r significant correlation log pd grs mean pulmonary artery wedge pressure r mvr log pd grs significantly improved seven operated patients although six patients retained bhr conclude patients long term mvd marked bhr bhr long term mvd related peripheral airway narrowing organic remodeling ameliorated mvr procedure addition pulmonary congestion,C14,0.04696295,0.002241562,0.016937928,0.0014198099,0.003518747,0.06892346,0.16221859,0.0023764076,0.026280748,0.029710826,0.06806343,0.005197658,0.11928243,0.018475492,0.002222167,0.0039350414,0.2176074,0.002603314,0.0028773444,0.019771142,0.17587662,0.00089724065,0.0025996692
long term effect mexiletine left ventricular function relation suppression ventricular arrhythmia effects oral mexiletine left ventricular lv ejection fraction ef ventricular arrhythmias possible relation effects evaluated months therapy patients chronic ventricular premature complexes vpcs moderately reduced normal lvef hour holter monitoring radionuclide ventriculography rest maximum tolerable exercise testing average titration period days mean daily mexiletine dose mg maintained throughout treatment end titration months treatment patients baseline lvef less equal group responded median reduction hourly vpc rate respectively compared baseline lvef greater group couplets runs ventricular tachycardia almost completely suppressed nearly patients single patient proarrhythmic increase vpcs treatment compared baseline significant changes resting exercise lvef months treatment either groups patients correlation found treatment induced changes arrhythmia frequency resting ef symptoms congestive heart failure developed study confirms long term use mexiletine efficacious relatively free cardiac depressant effects even patients diminished lv function,C14,0.0018171628,0.045583267,0.021733535,0.0010208713,0.0025300484,0.0023448714,0.14776479,0.0017086838,0.0013135755,0.011362784,0.020361353,0.03036631,0.1804181,0.004223364,0.0016340953,0.0028293724,0.22406581,0.020101676,0.01062693,0.04072829,0.2073572,0.018235423,0.0018724713
evidence abnormal na h antiport activity detected phosphorus nuclear magnetic resonance spectroscopy exercising skeletal muscle patients essential hypertension exercise induced ph changes skeletal muscle studied group eight subjects essential hypertension using p n r spectroscopy leucocyte na h antiport activity measured vitro subjects using ph sensitive fluorescent dye resting skeletal muscle ph unstimulated leucocyte ph values similar control subjects increased na h antiport activity demonstrated leucocytes hypertensive subjects acid loading vitro decreased skeletal muscle acidification increased rate ph recovery also demonstrated vivo patients acid load induced isotonic exercise findings suggest increased cellular na h antiport activity demonstrated vitro essential hypertension also affects biochemical response skeletal muscle physiological levels exercise strengthens argument increased na h antiport activity hypertension generalized physiologically relevant cellular abnormality,C14,0.015125037,0.052461732,0.054930888,0.0014555093,0.01616966,0.0033432052,0.2287234,0.0024361594,0.001872833,0.0025453412,0.024661038,0.018103408,0.17353038,0.0064271535,0.0022780409,0.004033983,0.047829337,0.002674202,0.015399464,0.01868804,0.30371642,0.00091980066,0.0026749477
relevance intrinsic sympathomimetic activity beta blockers intrinsic sympathomimetic activity isa characterizes group beta blockers able stimulate beta adrenergic receptors agonist effect oppose stimulating effects catecholamines antagonist effect competitive way partial agonists ligands elicit submaximal response bound beta receptors maximal occupancy isolated rat atrium acebutolol produces maximal stimulatory effect maximal effect induced full beta agonist isoproterenol presence isa results less resting bradycardia less reduction cardiac output observed beta blockers without isa long term partial beta agonists may produce arterial vasodilation increase arterial compliance possibly leading additional beneficial effects treatment hypertension beta blockers isa adverse effects plasma lipoproteins long term treatment addition presence isa could counteract regulation beta adrenoceptors often observed beta blockers without isa finally presence isa conflicting issue use beta blockers secondary prevention myocardial infarction however impressive results acebutolol prevention secondary infarction trial high risk patients myocardial infarction show acebutolol beta blocker moderate partial agonist activity effective decreasing postinfarction mortality rate exhibiting strikingly different hemodynamic profile beta blockers without isa partial beta agonists form intriguing pharmacologic class drugs prospective clinical trials extensively pursued,C14,0.041232634,0.036164455,0.011964978,0.0010034274,0.0024868168,0.002304804,0.25951758,0.0016794872,0.027225757,0.001754757,0.016299104,0.012331543,0.03801017,0.0048059374,0.018851513,0.011416707,0.051445086,0.036420833,0.027967935,0.03956889,0.30881816,0.0006341102,0.0480953
experimental clinical percutaneous angioscopy experience dynamic angioplasty authors used ultrathin angioscopes high optical resolution assess effects dynamic angioplasty vitro vivo experimentally angioscopy used study effects f kensey catheter normal porcine coronary arteries npca postmortem human coronary arteries pmhca npca catheter keeps coaxial position intimal flaps ifs seen npcas occurred cam rotation speeds usually single small less lumen perforations patent arteries rare however catheter forced wall passing narrowing f diameter made band ligature perforations common higher cam speeds epicardium remained intact two thirds perforations angioscopy visualized perforations cases common sign large multiple intimal flaps often obstructive pmhcas angioscopy sensitive angiography detecting atheromatous lesions authors able give better assessment effect dynamic angioplasty treated lesions including demonstration intimal flaps visible angiography vivo performed percutaneous angioscopy dynamic angioplasty using french kensey catheters angioscopy revealed features shown angiographically,C14,0.04903638,0.0019140836,0.07201549,0.0012123844,0.046299573,0.002784764,0.21616143,0.027017727,0.022438379,0.012560828,0.16923675,0.004488454,0.027983187,0.006168846,0.01232557,0.0033601562,0.1531501,0.0022351777,0.0024569822,0.018021842,0.1461225,0.0007661593,0.0022432678
protein phosphorylation ischemia many investigations shown calcium adenosine triphosphate crucial central nervous system functions probable alterations substances central nervous system ischemia involved processes cause irreversible neural damage calcium regulates several protein kinases responsible phosphorylation proteins vital many central nervous system functions using rabbit spinal cord ischemia model found protein kinase c calcium calmodulin dependent kinase severely affected first hour ischemia protein kinase significantly affected time course lost protein kinase c enzyme activity closely corresponded irreversible loss neurologic function evidence protein kinase c inhibitor activity generated also drugs inhibit protein kinase c increased neurologic damage administered early phases ischemia results suggest protein phosphorylation particularly protein kinase c critical maintenance neurologic function,C14,0.002437559,0.0021622363,0.004548232,0.0013695649,0.0033942235,0.0031457967,0.31090927,0.0022938645,0.0017622466,0.0023950448,0.06434318,0.0054541263,0.050575227,0.12532237,0.0021435278,0.01575906,0.027204616,0.049712908,0.0027755194,0.104137115,0.21477576,0.0008654886,0.0025130855
comparison spect using technetium agents thallium pet assessment myocardial perfusion viability report reviews applications tomographic imaging current new tracers assessing myocardial perfusion viability multiple studies thallium ti single photon emission computed tomography spect imaging detection coronary artery disease cad demonstrated high sensitivity high rates normalcy high reproducibility assessing viability fixed defects frequently detected viable zones hour studies ti imaging redistribution imaging performed hours injection reinjection ti hour redistribution imaging shown improve accuracy viability assessment ti spect studies limited suboptimal physical properties ti result variable image quality new technetium tc labeled myocardial perfusion tracers offer ability inject much higher amounts radioactivity making possible assess ventricular function well myocardial perfusion injection radiotracer tc sestamibi slow myocardial clearance allows prolonged imaging time results image quality superior obtained ti tc teboroxime combination minimal redistribution tc sestamibi high count rates makes gated spect imaging feasible also permits assessment patients acute ischemic syndromes uncoupling time injection time imaging combination high image quality first pass exercise capabilities may lead choice agent ti assessment chronic cad,C14,0.0017397647,0.009963342,0.027988778,0.0009775028,0.08034467,0.002245257,0.31605166,0.0016360958,0.0012577724,0.0017094209,0.059454054,0.03726084,0.042494882,0.013577693,0.0015299051,0.044982776,0.11579211,0.0017916692,0.001980978,0.06624596,0.1685655,0.00061772723,0.0017916487
comparison coronary angiography early oral dipyridamole thallium scintigraphy patients receiving thrombolytic therapy acute myocardial infarction evaluated consecutive patients received thrombolytic therapy acute myocardial infarction using thallium single photon emission computed tomography combination oral dipyridamole mg assess frequency residual myocardial ischemia thallium studies performed early myocardial infarction mean days range patients time onset chest pain administration thrombolytic therapy hours range q wave myocardial infarction evident patients four patients non q wave infarction anterior infarction patients inferior infarction patients serum mean peak creatinine kinase iu l range coronary angiography performed patients mean days range revealed infarct related vessel patent patients ejection fraction range dipyridamole administration patients developed angina easily reversed administration intravenous aminophylline systolic blood pressure decreased mm hg p less heart rate increased beats min p less none patients significant hypotension arrhythmias evidence infarct extension perfusion abnormalities present initial thallium images patients redistribution suggestive ischemia present patients ischemia confined vascular distribution infarct vessel evident patients seven patients ischemia infarct zone well remote myocardial segment thus patients ischemia distribution infarct vessel ischemia infarct zone evident patients open infarct vessels patients occluded infarct vessels conclusion thallium single photon emission computed tomography using oral dipyridamole safely performed patients recent myocardial infarctions receive thrombolytic therapy,C14,0.061433855,0.0012749082,0.016583612,0.00080752943,0.009286125,0.0018548397,0.14593256,0.0013617552,0.021903602,0.00836731,0.031758796,0.012453522,0.12639621,0.00331649,0.0012638771,0.002271699,0.3424599,0.0014817521,0.001636515,0.06334092,0.1358749,0.00051031355,0.008428993
dissociation changes cardiovascular mass performance angiotensin converting enzyme inhibitors wistar kyoto spontaneously hypertensive rats effects angiotensin converting enzyme inhibitors cardiovascular mass function measured three groups week old male wistar kyoto normotensive spontaneously hypertensive rats treated cgs cilazapril quinapril left ventricular performance assessed electromagnetic flow meter rapid whole blood infusion arterial pressure increased abruptly aortic snare aortic distensibility also assessed vitro systemic hemodynamic effects three agents similar yet structural effects varied although left ventricular aortic masses diminished right ventricular mass remained unchanged three agents spontaneously hypertensive rats cgs cilazapril also reduced left ventricular mass normotensive wistar kyoto rats without changing aortic mass three agents improved aortic distensibility whether mass decreased left ventricular structural changes associated variable changes pumping ability data show reduced mass associated angiotensin converting enzyme inhibitor treatment consistent ventricles aorta dissociation exists structural functional changes reduction cardiac mass alone relate changes chamber mass function thus biologic pharmacodynamic differences exist among angiotensin converting enzyme inhibitors well classes antihypertensive agents,C14,0.01592896,0.0016700274,0.09491785,0.0010577987,0.0026215664,0.0024296911,0.175161,0.04733413,0.010372127,0.0018498395,0.00867622,0.03260627,0.109051906,0.0043408605,0.038100097,0.0029337527,0.0381878,0.0019388439,0.0021437034,0.066872105,0.30274406,0.037124556,0.0019368274
transesophageal doppler color flow mapping assessment atrial septal defect transesophageal doppler color flow imaging performed adult patients mean age years atrial septal defect demonstrated cardiac catheterization surgery transesophageal study correctly identified classified shunts contrast shunts identified transthoracic approach area atrial septal defect calculated assuming circular taking maximal doppler color flow jet width defect site diameter pulsed doppler sample volume placed parallel shunt flow direction defect site obtain mean velocity flow duration values shunt volume calculated product defect area mean velocity flow duration heart rate calculated shunt flow volume obtained transesophageal study showed good correlation shunt flow volume r p less pulmonary systemic blood flow ratio r p less obtained cardiac catheterization size defect transesophageal doppler color flow mapping correlated fairly well size estimated surgery r p concluded transesophageal doppler color flow imaging useful detection classification atrial septal defects assessment shunt volumes,C14,0.06140164,0.0013714344,0.002884792,0.09059514,0.08358693,0.0020450123,0.12954406,0.0014539358,0.008598071,0.001519097,0.121693574,0.0031799548,0.24889812,0.011212547,0.008837092,0.0024075406,0.13751896,0.0016005879,0.0017604195,0.021332575,0.05641903,0.0005489506,0.0015905319
surprising kidney fluid mechanism pressure control infinite gain short paper tried explain elation felt first realized kidney fluid mechanism controlling arterial pressure infinite feedback gain property pressure control mechanisms none ever shown similar infinite gain property must alter kidney fluid mechanism succeed causing long term changes arterial pressure able refute principle despite many experiments last decades reason first understanding infinite gain property kidney fluid mechanism like light end tunnel hope explain reader excitement seconds first recognized principle,C14,0.048004948,0.0030164062,0.04937833,0.0019105978,0.0047350777,0.0044149687,0.24016605,0.003197864,0.0024584045,0.0033411833,0.032280337,0.008361317,0.22642553,0.045829676,0.0029903068,0.0052952734,0.053257823,0.0035263225,0.0038719606,0.044666886,0.20816502,0.0012073911,0.003498301
evaluation abdominal aorta cardiac sonographers thorough evaluation abdominal aorta readily achieved use standard views echocardiographic examination ultrasound evaluation abdominal aorta represents logical extension standard echocardiographic examination adult patient article provides information needed carry complete ultrasound examination abdominal aorta including anatomy vascular disease steps involved accomplishing ultrasound examination abdominal aorta,C14,0.0042379242,0.0037592505,0.028393283,0.0023811169,0.10840093,0.005469262,0.29258844,0.037118673,0.0030638308,0.00416401,0.1715387,0.008716601,0.028178772,0.030241124,0.0037267238,0.00659933,0.13932073,0.0043643597,0.0048255003,0.05527272,0.051774163,0.001504733,0.0043598204
early late tamponade novacor left ventricular assist system cardiac tamponade major complication implantation novacor left ventricular assist system lvas patients received lvas bridge cardiac transplantation developed early tamponade hr postoperatively diagnosed late tamponade days postoperatively one patient early late tamponade early tamponade common increased perioperative blood loss ml vs ml patients p less early tamponade suggested reduction mean arterial pressure mmhg lvas output l min lvas stroke volume ml increase central venous pressure mmhg p less values late tamponade associated marked rise central venous pressure mmhg p less mild decrease lvas output l min stroke volume ml without significant change mean arterial pressure two five late episodes occurred patients anticoagulated heparin ptt sec one warfarin pt sec ptt sec two patients anticoagulants surgical drainage pericardial effusions especially clotted blood found frequently posterior left ventricle space created lvas decompressed left ventricle resulted immediate return hemodynamic measurements normal early late tamponade,C14,0.031440448,0.001894088,0.014310589,0.0011997191,0.023621552,0.033736065,0.16665561,0.0020080304,0.0015437027,0.0020980248,0.01864041,0.016754441,0.27082583,0.004961476,0.0018776995,0.013789982,0.25294814,0.0021994573,0.0024313151,0.03852304,0.074913174,0.02143055,0.0021966835
frequency dependent behavior cerebral autoregulation cerebral autoregulation complex physiological process composed fast slow components may respond differently different rates patterns blood pressure variation assess temporal nature autoregulation transcranial doppler velocity recordings middle cerebral artery obtained prolonged periods compared blood pressure recordings patients without cerebral disease patients intracranial pathological changes correlations velocity pressure wave forms various frequencies variation measured systems analysis techniques patients aneurysmal subarachnoid hemorrhage high correlations indicating pressure dependent flow impaired autoregulation patients without cerebral disease significantly lower correlations p less indicating intact autoregulation examples increasing correlations correlations new frequencies emerging clinical condition worsened given preliminary examples suggest application systems analysis techniques velocity pressure data allow measurement temporal nature cerebral autoregulation,C14,0.08041489,0.0018381438,0.01619692,0.001164284,0.012854189,0.0026742804,0.24901305,0.0019487209,0.011144511,0.002036057,0.06630186,0.004311488,0.3265163,0.017946305,0.0018222394,0.023284217,0.07627724,0.002138102,0.0023595032,0.01743328,0.07944722,0.0007357625,0.002141399
simultaneous transesophageal atrial pacing transesophageal two dimensional echocardiography new method stress echocardiography diagnostic use exercise echocardiography widely reported however transthoracic exercise echocardiography inadequate patients poor image quality related exercise attempt overcome limitations system developed transesophageal echocardiography combined simultaneous transesophageal atrial pacing means probe prospective study transesophageal echocardiography performed immediately maximal atrial pacing patients suspected coronary artery disease results transesophageal stress echocardiography considered abnormal new pacing induced regional wall motion abnormalities observed correlative routine bicycle exercise testing carried patients cardiac catheterization performed patients success rate obtaining high quality diagnostic images transesophageal echocardiography nine patients without angiographic evidence coronary artery disease normal result transesophageal stress echocardiogram specificity thirty eight patients coronary artery disease defined greater equal luminal diameter narrowing least one major vessel abnormal result transesophageal stress echocardiogram sensitivity sensitivity technique one two three vessel disease respectively compared respectively bicycle exercise testing lead electrocardiogram ecg rapid atrial pacing showed sensitivity respectively thus rapid atrial pacing combined simultaneous transesophageal echocardiography highly specific sensitive technique detection coronary artery disease ischemia induced wall motion abnormalities detected earlier observed ecg changes technique appears particularly suited patients unable perform active stress test poor quality transthoracic echocardiograms,C14,0.0013708043,0.040987324,0.029005982,0.08037627,0.008541132,0.0018125997,0.26589498,0.0012928705,0.020885715,0.0013468957,0.10583013,0.0028470855,0.0918374,0.0032893775,0.034385435,0.0021346272,0.17733872,0.009068658,0.0015852578,0.038101844,0.07353503,0.007120425,0.0014114705
diagnostic echocardiographic features sinus venosus defect establish diagnostic criteria sinus venosus atrial septal defect cross sectional echocardiograms cineangiograms surgical notes patients diagnosis seen children hospital pittsburgh reviewed seven patients identified extent atrial septum nature junction superior vena cava atria evaluated echocardiographically subcostal position overriding superior vena cava abnormally connected right pulmonary veins six patients undergone cardiac catheterisation cineangiography five patients underwent surgical repair operative findings consistent expected morphology five features additionally confirmed specimen cardiopathological museum therefore basic anatomical feature superior sinus venosus interatrial communication biatrial connection superior vena cava together anomalous drainage right sided pulmonary veins results interatrial communication outside confines true atrial septum overriding superior vena cava across upper rim oval fossa suggested pathognomonic diagnostic feature clearly demonstrated echocardiographically subcostal position essence lesion interatrial communication rather atrial septal defect,C14,0.036179543,0.0022703912,0.017142663,0.026145922,0.09038308,0.003321189,0.17075709,0.03966457,0.0018660516,0.014905459,0.15215059,0.0052643726,0.015922558,0.0060313987,0.0022507468,0.016370907,0.30950034,0.0026395598,0.0029143507,0.030751351,0.037676554,0.00090878026,0.014982548
geographical clustering risk factors lifestyle coronary heart disease scottish heart health study large cross sectional study scottish heart health study men women districts scotland undertaken try explain geographical variation coronary heart disease mortality analysis district showed classic risk factors cigarette smoking strongly associated heart disease mortality among men women mean diastolic blood pressure weakly associated rates among men high density lipoprotein cholesterol showed strong negative association among women total cholesterol showed weak negative association heart disease mortality serum concentrations cholesterol uniformly high districts strong association mortality would expected men women many dietary factors showed moderate strong associations mortality coronary heart disease district low consumption vitamin c notable factors associated heart disease included alcohol consumption serum triglycerides among men obesity physical activity serum triglycerides among women many factors associated heart disease showed strong intercorrelations clustering risk factors including smoking alcohol diet among men smoking diet obesity among women associated much regional variation heart disease mortality scotland,C14,0.0016695093,0.009553986,0.003115131,0.0009380292,0.0023251986,0.0021545887,0.16663557,0.0015700267,0.0012069809,0.001640391,0.02706553,0.0034338615,0.13429606,0.0043624532,0.025724374,0.019022863,0.038497567,0.009763208,0.018062003,0.40653434,0.120115735,0.0005927821,0.0017197987
randomized trial comparing direct current therapy bipolar diathermy outpatient treatment third degree hemorrhoids fifty patients third degree hemorrhoids randomized receive outpatient treatment either bipolar diathermy direct current therapy direct current therapy used treat patients bipolar diathermy used treat patients twenty patients group successfully treated judged resolution symptoms shrinkage hemorrhoidal tissue treatments effective outpatient management large prolapsing hemorrhoids bipolar diathermy less time consuming better tolerated,C14,0.0038434654,0.0034093456,0.026157897,0.0021594863,0.0053531537,0.023556486,0.33055753,0.0036144413,0.0027786545,0.003787811,0.104690105,0.02651221,0.08595807,0.0093813045,0.0033798465,0.06180402,0.15811805,0.003958132,0.004376351,0.05050589,0.08077904,0.0013646749,0.003954015
real impact mechanical bridge strategy patients severe acute infarction results obtained past years patients referred acute myocardial infarction ami cardiogenic shock mechanical bridge urgent transplantation permit one assess real impact present strategy clinical practice ten patients mean age admitted serious condition ci l min pcwp mmhg systolic aortic pressure mmhg urine output ml hr treated maximal sympathomimetic support v enoximone two implanted total artificial heart tah one left ventricular assist device lvad recurrent fibrillation despite hemodynamic improvement within hr two received transplants living well months seven initially improved markedly listed urgent transplant candidates two successfully transplanted three died suddenly days respectively one undergone successful coronary surgery one patient age diabetic secondarily rejected transplant died experience clearly shows despite initial spectacular hemodynamic improvement due optimized medical management death rate transplant sudden ventricular fibrillation remains unacceptably high prompt early mechanical support less invasive systems patients ami,C14,0.012112881,0.0018379892,0.0038661829,0.001164186,0.0028852285,0.06268273,0.19141252,0.011968127,0.01152466,0.012060593,0.035645247,0.014480531,0.096479416,0.014789161,0.001822132,0.023654923,0.2717069,0.0021338416,0.027546205,0.11693242,0.0703987,0.010763809,0.0021316225
ultrasound doppler diagnosis budd chiari syndrome report case apparently idiopathic budd chiari syndrome diagnosed ultrasound doppler sonography patient latent myeloproliferative disease case proves doppler sonography shows hepatic veins flow pattern suggestive partial thrombotic obstruction moreover suggest search latent myeloproliferative disorder means spontaneous erythroid colonies formation culture bone marrow blood mononuclear cells routinely included diagnostic evaluation case hepatic vein thrombosis without recognizable causes,C14,0.0037732255,0.0033470392,0.007040447,0.0021200215,0.023519475,0.004869544,0.22359177,0.05140101,0.02096976,0.0037074157,0.19411896,0.0077608037,0.07202985,0.06346667,0.0033180793,0.04239751,0.07511295,0.02214801,0.004296372,0.06582042,0.099969156,0.0013397352,0.0038817553
pharmacological reversibility experimental cerebral vasospasm using morphometric technique pharmacological reversibility luminal narrowing experimental subarachnoid hemorrhage sah investigated vasodilation cocktail consisting papaverine x sodium nitroprusside adenosine administered intra arterially forty two rabbits divided six groups control normal animals control plus cocktail normal animals perfused cocktail fixation sah animals sacrificed hours subsequent intracisternal injection ml kg arterial blood sah plus cocktail sah plus perfusion cocktail bacl animals sacrificed minutes intracisternal injection ml x bacl bacl plus cocktail bacl animals perfused cocktail diameter basilar arteries control control plus cocktail groups significantly different bacl reduced diameter sah reduced diameter significant differences diameter bacl plus cocktail group sah plus cocktail group compared control control plus cocktail group morphological examination light transmission electron microscopy showed luminal narrowing corrugation elastic lamina degenerative proliferative changes vessel wall animals sah results suggest cerebral vasospasm caused initially smooth muscle contraction rather proliferative vasculopathy irreversible process,C14,0.04105,0.0018944523,0.003984952,0.011510211,0.002973863,0.0027562026,0.07405409,0.0020156468,0.073803954,0.0020984283,0.030283364,0.11602465,0.13387363,0.0055542444,0.0018780606,0.023993807,0.08037233,0.002200258,0.0024317827,0.014184148,0.37010652,0.00075830135,0.002197106
functional status coronary artery bypass grafting percutaneous transluminal coronary angioplasty two cohorts consecutive patients comparable age similar preprocedure cardiac function underwent either coronary artery bypass grafting cabg n percutaneous transluminal coronary angioplasty ptca n entered prospective comparison study examining functional status return work first year recovery patients evaluated using standardized functional status instruments activities daily living work performance social activity mental health quality social interaction months procedure within cabg group statistically significant improvements functional status every subscale noted year follow patients undergoing ptca demonstrated significant improvement dimensions except quality interaction year compared baseline groups compared ptca group demonstrated greater participation cabg group routine daily physical social activities months apparent advantage disappeared year measures psychological functioning better cabg ptca reduction number employment occurred cabg ptca groups independent physical functional status measures improved groups procedures employment cabg group reported greatest improvement work performance,C14,0.001882371,0.0016697571,0.012580371,0.0010576275,0.0026215988,0.002429298,0.13073045,0.0017702045,0.0013608704,0.00184954,0.011889572,0.07060128,0.11171652,0.005413477,0.0016553096,0.0029327786,0.2154377,0.0019385301,0.0021816716,0.22515734,0.19051887,0.00066836155,0.0019365139
oral contraceptives lipoproteins atherosclerosis nonhuman primate model developed study effects oral contraceptives lipoproteins atherosclerosis cynomolgus macaques selected susceptibility diet induced atherosclerosis reproductive physiology menstrual cycle circulating sex hormone patterns similar human females first study compared vaginal ring containing levonorgestrel estradiol oral contraceptive containing norgestrel ethinyl estradiol second study compared two oral combinations norgestrel ethinyl estradiol ethynodiol diacetate ethinyl estradiol predicted use contraceptives led lowering high density lipoprotein cholesterol levels however contrary might expected use ethinyl estradiol containing oral contraceptives lead increase prevalence extent atherosclerosis concluded ethinyl estradiol neutralized atherogenic influence progestin component oral contraceptives,C14,0.0033456082,0.0029677215,0.022435924,0.0018797608,0.004665138,0.004317682,0.23366238,0.06789609,0.0024187258,0.0032872567,0.046312712,0.0068931943,0.02904978,0.016545674,0.051520474,0.021400925,0.033159126,0.0034454218,0.0038094672,0.10375129,0.33236438,0.0011879039,0.0036833738
multiple breakpoint method measuring effect antibiotics endocarditis strains streptococci activity penicillin alone combined aminoglycoside endocarditis strains streptococci examined good assay reproducibility obtained use logarithmic phase cultures standardised opacity careful inoculation well plates removal antibiotic membrane transfer incubating survival counts hydrogen plus carbon dioxide use fold intervals penicillin concentration simplified assay design without loss efficiency,C14,0.0049485466,0.004389608,0.057123475,0.0027803865,0.0068906946,0.006407793,0.19755487,0.004653673,0.003577579,0.0048622377,0.0827879,0.010178215,0.051124886,0.088599116,0.004351627,0.055234116,0.0814323,0.0054650777,0.0056346483,0.07517286,0.23998247,0.0017570491,0.0050908825
plasma epinephrine levels resuscitation cardiopulmonary bypass since highest plasma epinephrine levels recorded resuscitation evaluated isolated effect cardiac arrest upon adrenomedullary secretion determined plasma epinephrine dogs resuscitated cardiopulmonary bypass cpb cardiac arrest periods cpb n min cpb n h cpb following h critical care difference cpb cpb regarding cardiopulmonary functional variables plasma epinephrine markedly elevated immediately initiation cpb p less min cpb vs basal returned rapidly basal concentrations comparison plasma epinephrine levels cpb standard cpr groups showed responses cardiac arrest similar p greater min cpb vs min cpr conclude cardiac arrest main sole determinant plasma epinephrine elevation resuscitation,C14,0.0028396018,0.0025188685,0.0052984026,0.0015954565,0.0039540557,0.0036646542,0.12411178,0.0026703961,0.0020529057,0.0027900757,0.01592184,0.01983095,0.3396506,0.0065389206,0.0024970742,0.018539302,0.037465487,0.0029243191,0.0032333045,0.024359299,0.3736132,0.0010082395,0.0029212777
orthostatic hypotension following right ventricular myocardial infarction corrected mineralocorticoid therapy severe hypotension standing became problem patient discharge hospital following right ventricular myocardial infarction hemodynamic studies showed right ventricular systolic function maintain adequate left ventricular preload patient compensate cardiac dysfunction increasing blood volume volume expansion mineralocorticoid therapy corrected orthostatic hypotension ameliorated symptoms hypotension eventually resolved therapy stopped four months myocardial infarction,C14,0.06631234,0.0036108461,0.02725944,0.021948434,0.005668214,0.041517258,0.23027962,0.0038280636,0.0029428795,0.0040183864,0.018968012,0.008372494,0.15806416,0.0093596205,0.0035796035,0.0063388073,0.25668082,0.0041920673,0.0046350034,0.026974326,0.07011262,0.02114925,0.0041877073
polytetrafluoroethylene graft spontaneous coronary dissection year follow spontaneous coronary artery dissection remains exceedingly rare cause myocardial ischemia patients usually young female dissection frequently fatal use polytetrafluoroethylene aortocoronary conduit generally followed early occlusion report case spontaneous right coronary dissection polytetrafluoroethylene graft placed observed remain patent angiography least months operation,C14,0.026367478,0.004005578,0.0084256735,0.002537141,0.006287854,0.027682552,0.22169632,0.047965746,0.0032645904,0.0044368594,0.064243026,0.0092877615,0.028099123,0.0103827985,0.00397092,0.028889025,0.2563508,0.004650337,0.0051416946,0.08338102,0.14668494,0.0016033316,0.004645501
multiple arterial fenestrations multiple aneurysms arteriovenous malformation patient subarachnoid hemorrhage report case year old right handed man multiple vascular pathologies including fenestrated anterior communicating artery middle cerebral artery aneurysm anterior communicating artery multiple aneurysms middle cerebral artery arteriovenous malformation diagnoses made computed tomography cerebral angiography magnetic resonance imaging intraoperative dissection lesions managed surgically stages satisfactory results congenital hemodynamic factors may combined manifest anomalies present unique case believe similar combination vascular pathology reported previously,C14,0.095633656,0.002833456,0.0059601325,0.0017947168,0.086336784,0.0041223415,0.172227,0.05743605,0.017390847,0.0031385347,0.18097578,0.00659854,0.05706801,0.008149637,0.0028089397,0.004974106,0.111962914,0.0032895443,0.0036371194,0.10360241,0.06563706,0.0011341609,0.003288326
repair transposition great arteries intact ventricular septum left ventricular outflow tract obstruction repair transposition great arteries patients intact ventricular septum fixed left ventricular outflow tract obstruction restricted atrial baffle procedures without attempts relieve bypass left ventricular outflow obstruction however suboptimal results procedures coupled excellent functional results arterial switch operation patients without obstruction made anatomic correction goal repairing anomalies report technique anatomic correction transposition great arteries intact ventricular septum fixed left ventricular outflow tract obstruction consideration difficult cases advocated,C14,0.09775198,0.0026751652,0.0059901895,0.0016885322,0.004184727,0.047507506,0.12275268,0.01730978,0.002172668,0.002952843,0.031446118,0.020712664,0.018979559,0.0077815684,0.0026427484,0.0046798126,0.43304226,0.0030949179,0.0034219287,0.019818546,0.087039925,0.059262145,0.003091699
deferoxamine fails improve postischemic cardiac function hypertrophied hearts myocardial hypertrophy well recognized risk factor congenital cardiac surgery hypertrophied hearts demonstrated increased vulnerability ischemia reperfusion injury studied effects iron chelator hydroxyl radical scavenger deferoxamine given early reperfusion model isolated retroperfused rabbit hearts made hypertrophic aortic banding early life week age rabbits studied weeks age hearts subjected minutes degrees c ischemia followed minutes reperfusion postischemic recovery isovolumic developed pressure measured using intracavitary balloon untreated n deferoxamine treated n groups compared normal age matched controls deferoxamine mumol kg given one group hypertrophied hearts first minutes reperfusion left ventricular weight body weight ratio hypertrophied hearts x n versus x age matched controls p less postischemic peak developed pressure recovered preischemic value normal hearts minutes reperfusion compared untreated deferoxamine treated hearts p less vs control conclude chronic hypertrophy early life leads increased susceptibility ischemia iron chelator deferoxamine effective preventing injury reperfusion hypertrophied hearts,C14,0.021688271,0.011627916,0.0037897355,0.010960848,0.012653097,0.0026202358,0.17474091,0.011727013,0.0014678322,0.0019949102,0.009870678,0.048111275,0.26472506,0.0052363584,0.021425217,0.0031616332,0.080195524,0.0021034977,0.00231182,0.1325173,0.16443507,0.010547105,0.00208872
single photon emission computed tomography thallium adenosine induced coronary hyperemia correlation coronary arteriography exercise thallium imaging two dimensional echocardiography feasibility safety diagnostic accuracy single photon emission computed tomography spect thallium imaging adenosine induced coronary hyperemia evaluated patients without coronary artery disease proved coronary angiography adenosine infused intravenously dose mg kg body weight per min min thallium injected min adenosine caused increase heart rate baseline versus beats min peak effect p less change blood pressure sensitivity specificity confidence intervals confidence intervals respectively patients multivessel coronary artery disease also correctly identified patients predictive accuracy adenosine thallium imaging slightly higher exercise spect thallium imaging versus p ns confidence intervals respectively patients two dimensional echocardiography adenosine infusion disclosed new wall motion abnormality patients coronary artery disease patients reversible thallium defects p less side effects mild transient aminophylline used three patients thus adenosine spect thallium imaging provides high degree accuracy diagnosis coronary artery disease results comparable exercise spect thallium imaging reversible defects adenosine study associated transient wall motion abnormality,C14,0.0019915204,0.040329825,0.003717498,0.0107512,0.07988825,0.002570161,0.18851045,0.00187285,0.03034523,0.0019567858,0.071978554,0.014019426,0.23178482,0.0046455013,0.0017512928,0.015838115,0.14613725,0.002050936,0.0022676392,0.01695803,0.12787876,0.00070711656,0.0020488028
physiologic peripheral pulmonic stenosis infancy studied premature infants clinical diagnosis peripheral pulmonic stenosis pps normal full term neonates echocardiographic doppler examinations pps group average main pulmonary artery pa diameter similar control group vs cm difference significant smaller branch pa diameters right pa vs cm p less left pa vs cm p less pps group also greater peak velocities main pa vs cm p less right pa vs cm p less left pa vs cm p less similarly ratio peak velocity branch main pa greater pps group right main pa peak velocity vs p less left main pa peak velocity vs p less calculated right ventricular output pps group control group vs ml min kg p less hematocrits done control group pps group average hematocrit low concluded patients pps mild underdevelopment pa branches consequent increased flow velocity turbulent flow turbulent flow may contributed increased cardiac output mild anemia,C14,0.06315248,0.010383591,0.0033893695,0.0010206079,0.0025293955,0.020060625,0.082740515,0.05446568,0.010081834,0.0017848016,0.06338784,0.07940288,0.3911728,0.0042503257,0.0015973696,0.0028300944,0.06864988,0.010677667,0.0020683336,0.050639924,0.07320032,0.00064496725,0.0018687311
coarctation aorta coarctation aorta common cardiovascular disorder unknown etiology preductal type blood flows patent ductus distal aorta coarctation juxtaductal postductal blood flows lower extremities way subclavian arteries collaterals plain films may show reverse sign postductal coarctation arteriography gold standard making diagnosis however magnetic resonance imaging probably become increasingly important diagnostic tool treatment choice surgery complete resection stenosed segment,C14,0.023782304,0.0036119428,0.007597668,0.0022879455,0.064798266,0.044480477,0.31477398,0.0038292261,0.022554055,0.023707999,0.058670126,0.008375037,0.12010153,0.009411517,0.0035806906,0.0063407323,0.10445567,0.0041933404,0.004636411,0.048788104,0.09468288,0.0014457694,0.02389437
depression recovery right ventricular function cardiopulmonary bypass transient left ventricular dysfunction commonly described association cardiopulmonary bypass cpb evaluated changes right ventricular rv function elective cardiac surgery patients normal preoperative cardiac function irrespective distribution coronary artery disease use pharmacologic support transient depression rv systolic function respect preinduction initial postoperative postop values occurred min post cpb represented decrease rv stroke volume index vs ml postop rv ejection fraction vs postop increase rv end systolic end diastolic volume indices depression responded readily pharmacologic therapy within h resolved within h adverse consequences otherwise healthy patients studies needed identify cause phenomenon importance patients preexisting cardiac dysfunction,C14,0.03173612,0.0022979842,0.017344192,0.0014555479,0.003607317,0.04096443,0.17126283,0.002436224,0.0018728826,0.0025454087,0.014916927,0.0053283526,0.30683,0.0059864586,0.014814856,0.0040378966,0.21249938,0.002668517,0.0029497698,0.055562194,0.08275909,0.013458472,0.0026651055
interleukin induced lung permeability mediated leukotriene b interleukin il therapy leads respiratory dysfunction due increased vascular permeability study examines role chemoattractant immunomodulator permeability promoting agent leukotriene lt b setting sheep chronic lung lymph fistulae given il u kg iv bolus n within hours led significant increase ltb levels plasma lung lymph mean pulmonary artery pressure mpap rose pulmonary artery wedge pressure unchanged arterial oxygen tension pao fell lung lymph flow ql tripled p less hours coinciding increase lymph plasma l p protein ratio p less resulting increase lymph protein clearance p less data documenting increased microvascular permeability protein mild leukopenia thrombocytopenia p less occurred body temperature rose shaking chills common pretreatment lipoxygenase inhibitor diethylcarbamazine dec n reduced baseline plasma ltb levels prevented il induced increases ltb plasma lung lymph p less contrast il treatment alone dec blunted increase mpap prevented rises ql p less l p protein ratio p less lymph protein clearance p less dec also prevented il induced leukopenia fall platelet count rise body temperature p less respectively infusion il excipient control n affect plasma lymph ltb levels mild increases mpap p less ql also rose occurred l p protein ratio fell p less body temperature rose moderately pao leukocyte platelet counts unaffected data indicate il administration leads pulmonary dysfunction manifest pulmonary hypertension increased vascular permeability events associated ltb synthesis prevented dec leukotriene b appears therefore mediate il induced lung injury,C14,0.054448232,0.02586827,0.027109023,0.006884951,0.0017787428,0.059541717,0.15648836,0.007319283,0.0009235053,0.007433758,0.012008386,0.00317526,0.26311633,0.003371867,0.015127028,0.0019895912,0.0190739,0.053591106,0.0014579733,0.00944004,0.26808494,0.00045355927,0.0013141448
differentiation ventricular tachyarrhythmias implantable devices capable several modes therapy require differentiation various ventricular tachyarrhythmias three methods arrhythmia analysis magnitude squared coherence ventricular rate irregularity cycle length performed episodes induced ventricular tachyarrhythmia patients differentiation monomorphic ventricular tachycardia polymorphic ventricular tachycardia ventricular fibrillation possible mean magnitude squared coherence less possible rate possible beat beat irregularity faster monomorphic ventricular tachycardia overlapped rates polymorphic ventricular tachycardia ventricular fibrillation differentiation polymorphic ventricular tachycardia ventricular fibrillation possible rate irregularity progressive decrease mean magnitude squared coherence monomorphic ventricular tachycardia polymorphic ventricular tachycardia ventricular fibrillation strengthens previous observations coherence measure rhythm organization,C14,0.0032933406,0.018860973,0.022041483,0.0018503937,0.0045858724,0.020187395,0.2266092,0.0030970972,0.0023809385,0.0032359003,0.033957794,0.0067737717,0.114441976,0.0076148915,0.0028960805,0.0051284158,0.18772347,0.0033915946,0.0037499527,0.07066736,0.16754183,0.0011693456,0.08880089
novacor left ventricular assist filling ejection presence device complications order better understand relationship among certain device related complications novacor left ventricular assist system lvas pumping parameters mock circulatory loop utilized simulate following clinically realistic conditions inflow valve regurgitation inflow cannula obstruction outflow valve regurgitation outflow cannula obstruction various pumping parameters e g pump rate stroke volume pump output recorded baseline control simulation additionally pump volumes continuously recorded differentiated calculation rates pump filling fr ejection er results indicate perfusion pressures rates filling ejection change significantly presence device complications implications findings relates assessment pump operation lvas patients discussed,C14,0.0028797144,0.044375457,0.0053732484,0.001617994,0.004009911,0.017643522,0.21325041,0.0027081182,0.0020819053,0.0028294884,0.016550569,0.10492052,0.12769349,0.0073667257,0.002532348,0.004484314,0.2641985,0.0029656284,0.0032789784,0.057316247,0.08005729,0.028903054,0.0029625439
effects enalapril neuroendocrine activation prognosis severe congestive heart failure follow consensus trial consensus trial study group study enrolled patients severe heart failure new york heart association functional class iv centers scandinavia randomly assigned treatment placebo enalapril addition usual treatment heart failure initial titration period daily doses enalapril ranged mg end trial placebo treated patients enalapril treated patients alive p survival figures months completion trial respectively p respectively p year follow placebo group significant positive association mortality baseline levels norepinephrine epinephrine angiotensin ii aldosterone atrial natriuretic peptide association found enalapril treated patients results suggest effects enalapril mortality related counteraction neuroendocrine activation general renin angiotensin system particular,C14,0.0023107256,0.024320496,0.015258693,0.0012937295,0.003206279,0.025256291,0.1188064,0.0021653804,0.0016646676,0.0022624265,0.022163209,0.03965153,0.046722405,0.0054393667,0.01315599,0.003585606,0.22275385,0.024661986,0.102934144,0.08751434,0.23168607,0.00081756484,0.0023688162
experimental studies physiologic properties technetium isonitriles recently efforts directed development technetium tc labeled isonitrile compounds assessment regional perfusion viability experimental myocardial infarction ischemia one promising agents tc sestamibi undergone rather extensive laboratory investigation like thallium tl uptake tc sestamibi myocardial tissue proportional myocardial blood flow intravenous injection similar diffusible indicators tc sestamibi underestimates blood flow high flow rates low flow regions myocardial uptake agent higher relative nonischemic uptake microsphere determined blood flow attributed increased extraction low flows first pass myocardial extraction fraction tc sestamibi less tl however tc sestamibi higher parenchymal cell permeability higher volume distribution tc sestamibi shows minimal delayed redistribution initial intravenous administration uptake tc sestamibi altered myocardial stunning ischemic dysfunction produced sustained low coronary flow uptake isonitrile still proportional blood flow situations intact animal models myocardial uptake tc sestamibi coronary occlusion delineates vivo area risk tc sestamibi administered reperfusion following variable periods preceding coronary occlusion tc sestamibi uptake delineates area viable myocardium salvaged simply degree reflow suggests serial tc sestamibi imaging might useful assessing efficacy coronary reperfusion thrombolytic therapy,C14,0.019365916,0.0014574843,0.045271624,0.024750616,0.018175455,0.0021204662,0.1555834,0.001545162,0.0011878659,0.009742249,0.008811083,0.036541726,0.2659974,0.03658758,0.0014492702,0.06656595,0.063583806,0.010102819,0.009817746,0.037167925,0.18187875,0.00058339414,0.0017123024
left ventricular end systolic stress volume index ratio aortic mitral regurgitation normal ejection fraction evaluate left ventricular contractile state regurgitant valvular disease normal ejection fraction analyzed end systolic stress volume index relationship essvr means cineangiography normal subjects patients aortic regurgitation ar patients mitral regurgitation mr whose ejection fraction ef end systolic stress volume index ratio normal subjects kdyne cm mean standard deviation defined range including standard deviations ratio normal essvr range six patients ar five patients mr placed inside normal essvr range termed ar mr remaining five patients ar mr placed right normal range termed ar mr ef differ patients ar ar verus mr mr versus ef subdivided groups ar mr also differ normal subjects finding showed left ventricular contractile state depressed patients ar mr despite normal ef ar mr end systolic stress end systolic volume index differ end diastolic volume index larger ar versus ar ml mr versus mr ml p less regurgitant fraction higher ar versus ar mr versus mr p less addition linear inverse correlation end systolic stress volume index ratio end diastolic volume index subjects r n normal subjects linear inverse correlation end systolic stress ef r n relationship failed separate patients results present study suggest patients ar mr whose ef normal depressed contractile state patients large end diastolic volume index high regurgitant fraction abstract truncated words,C14,0.0014994189,0.0013113916,0.0027584927,0.0008306381,0.0020590746,0.0019079188,0.12565877,0.015698133,0.0010687987,0.015760105,0.007929265,0.010197578,0.40913302,0.003998926,0.058104984,0.016602414,0.18452373,0.0015242379,0.0016833463,0.031589184,0.08264079,0.021994319,0.0015254905
two cases spontaneous internal carotid artery occlusion due giant intracranial carotid artery aneurysm although spontaneous thrombosis giant intracranial aneurysm relatively common occlusion parent artery rare describe two recent patients parent artery spontaneously occluded one patient severe stenosis left internal carotid artery delayed appearance faint shadow vascular widening near posterior clinoid process one month later complete occlusion left internal carotid artery shown angiographically second patient dysarthria left hemiparesis resulting diagnosis left internal carotid artery giant aneurysm suffered episode visual disturbance right eye years angiography showed right cervical internal carotid artery occluded believe mechanism parent artery occlusion two patients due first stretching internal carotid artery enlarged aneurysm followed compression internal carotid artery aneurysm next anterior clinoid process optic nerve involved finally thrombosis aneurysmal cavity extends internal carotid artery,C14,0.22460826,0.0018943889,0.024650725,0.0011999097,0.0029737635,0.016508404,0.098778255,0.09283459,0.011857982,0.022772932,0.16518979,0.004392533,0.024204537,0.00510306,0.0018779978,0.0033255822,0.18186502,0.00219932,0.0024317014,0.03911781,0.06925811,0.00075827603,0.0021970326
effect hemodilution capillary arteriolovenous shunt flow organs cardiac arrest dogs purpose study observe changes capillary arteriolovenous shunting blood flow cardiac arrest subsequent resuscitation venous return occlusion produced inflation intra atrial balloon cross clamping ascending aorta determine hemodilution might modify changes organ capillary blood flow fractional distribution cardiac output measured microsphere microns diameter trapping method dogs simultaneously arteriolovenous shunt rate measured continuous collection venous blood drained ml min min brain kidney liver splanchnic organs skeletal muscle pelvic limb systemic circulatory organs capillary blood flow brain thyroid gland pancreas stomach decreased circulatory arrest five nonhemodiluted dogs group c arteriolovenous shunt rate unchanged circulatory arrest group however hemodilution induced either pre group n post group n circulatory arrest change occurred shunt rate organs exception increase systemic arteriolovenous shunt rate pre group capillary blood flow maintained almost level circulatory arrest pre group increased significantly several organs post group data indicated hemodilution might effective prevention organ ischemia cardiac arrest,C14,0.08024035,0.0103111835,0.01269163,0.0010116956,0.002507308,0.0023237956,0.07978491,0.03554258,0.001301769,0.0017692161,0.025628421,0.07349897,0.29933837,0.0041509396,0.0015834209,0.011201892,0.06255007,0.0018543414,0.0020502722,0.029021036,0.20685159,0.05293386,0.0018524127
noninvasive determination pulmonary artery wedge pressure comparative analysis pulsed doppler echocardiography right heart catheterization compare left ventricular filling variables derived transmitral pulsed doppler echocardiography tpde hemodynamic variables assessed right heart catheterization rhc icu patients male female aged yr mean without valvular heart disease examined simultaneously rhc transmitral flow velocity profiles obtained tpde ratio velocity time integrals late diastolic active wave early diastolic passive inflow left ventricle e wave calculated e ratio invasively determined pulmonary capillary wedge pressure wp ranged mm hg median mm hg linear regression analysis showed highly significant correlation e ratio wp r p less standard error estimate see e ratio also correlated hemodynamic variables cardiac output r p less see cardiac index r p less see stroke volume index r p less see interobserver agreement derived intraclass correlation analysis two examiners e ratio high r p less n conclude wp accurately determined noninvasively tpde assessment systolic ventricular function tpde limited diagnostic value,C14,0.039931085,0.0018760598,0.003946264,0.011411292,0.002944991,0.002773926,0.21176901,0.023514027,0.0015290095,0.0021008337,0.09217378,0.004350033,0.27951512,0.004870096,0.0018598274,0.013489358,0.15175654,0.002217469,0.0024081736,0.028802551,0.10357189,0.010986829,0.0022018345
angioplasty contralateral approach use guiding catheter coaxial angioplasty balloons f guiding catheter developed use coaxial angioplasty balloon catheters angioplasty femoral artery contralateral approach antegrade puncture ipsilateral femoral artery possible catheter may used angioplasty femoral artery bifurcation superficial femoral artery arterial stenoses patients renal transplants,C14,0.113423444,0.004008248,0.00843129,0.0025388324,0.0062920456,0.0058315243,0.19241351,0.004249372,0.09076782,0.004439817,0.117885835,0.009293953,0.028162736,0.01038972,0.003973567,0.007036443,0.24581991,0.004653437,0.005145122,0.05161787,0.07737253,0.0016044005,0.0046485974
blood pressure level trend variability dunedin children year study single birth cohort birth cohort children dunedin multidisciplinary health development study new zealand resting blood pressures recorded biennially five times age years using previously described methods examined level trend variability blood pressures children least three readings level trend variability height weight body mass index compared among six separate groups children two groups categorized basis high systolic pressure levels one low variability high variability thought resemble adult labile hypertension two additional groups categorized basis increasing decreasing blood pressure trends fifth group consistently low blood pressures sixth group consisted remaining children significant differences among groups level physical measurements trend body mass index significant differences found among groups gender socioeconomic status parental history high blood pressure stroke heart attack significantly common first two groups,C14,0.010419078,0.0015832853,0.003330417,0.0010028561,0.0024854008,0.0023034918,0.14333099,0.0016785308,0.001290395,0.053599123,0.035622027,0.073912725,0.3044975,0.004120021,0.010208474,0.0027794428,0.030275175,0.019045267,0.010668878,0.16453207,0.111795984,0.0006337491,0.010885091
beta blockers primary prevention nonfatal myocardial infarction patients high blood pressure population based case control study conducted determine whether beta blockers used treatment high blood pressure prevent first events coronary heart disease study subjects health maintenance organization enrollees pharmacologically treated hypertension patients presented new coronary heart disease control subjects probability sample eligible hypertensive enrollees free coronary heart disease investigators blind case control status subjects medical records reviewed coronary risk factors health maintenance organization computerized pharmacy database used ascertain use beta blockers larger proportion controls cases using beta blockers difference confined subgroup nonfatal myocardial infarctions current use estimated relative risk nonfatal myocardial infarction confidence interval among current users beta blockers higher doses conferred greater protection past use total lifetime intake beta blockers weakly associated case control status current use beta blockers may prevent first events nonfatal myocardial infarction patients high blood pressure,C14,0.012337674,0.032566287,0.014171483,0.0011874007,0.0029434073,0.002727378,0.18796586,0.0019874123,0.0015278521,0.0020764826,0.11556846,0.017345747,0.24662685,0.004859226,0.0018584495,0.033981767,0.0668321,0.002176392,0.043304298,0.13418882,0.07084212,0.00075037096,0.0021741283
blood liquid interface prolonged extracorporeal oxygenation excellent antithrombogenicity authors verified excellent antithrombogenicity blood liquid interface bli introduced oxygenator based principle gas exchange across direct bli newly developed oxygenator three layers liquid flowed horizontally contacting one another saturated silicone oil top saturated fluorcarbon bottom blood middle gas exchange carried across direct blis system provided excellent antithrombogenicity well good gas exchange results indicate method become promising modality prolonged extracorporeal oxygenation,C14,0.0046163416,0.0040949252,0.008613614,0.002593734,0.0064281095,0.07296407,0.30071548,0.0043412633,0.047986776,0.004535827,0.09122149,0.009494932,0.11796853,0.010710928,0.004059494,0.0071886037,0.17498854,0.0047540665,0.0052563837,0.05183507,0.05924364,0.0016390951,0.004749122
hemodynamic influence lvad right ventricular failure left ventricular assist device lvad pumping hemodynamic anatomic influences right ventricular performance total artificial heart tah model employed better understand hemodynamic influence lvad failing right ventricle biventricular failure simulated reducing ventricular drive pressures tah getting hemodynamic data lvad pumping case right ventricular failure simulated increasing left ventricular drive pressure lvad simulating condition cardiac output increased right atrial pressure decreased significantly p less compared biventricular failure condition whereas right ventricular function minute work two conditions even though changes accompanied adaptive increases pulmonary resistance substantially lower pulmonary artery left atrial pressures resulted lvad simulating condition hemodynamic perspective results indicate lvad increase right ventricular volume work decreasing right ventricular pressure work whereas right ventricular net pressure volume work unchanged right ventricular failure worsened,C14,0.15945575,0.05417099,0.014358958,0.0012129473,0.0030060746,0.034466818,0.11440733,0.012478964,0.02244152,0.0021211577,0.01990835,0.03552212,0.19472243,0.004965114,0.001898439,0.0033617162,0.044959497,0.0022232165,0.0024581228,0.11045058,0.13752215,0.021666871,0.0022209042
effects heparin versus saline solution intermittent infusion device irrigation purpose study compare effectiveness ml sodium chloride units heparin ml sodium chloride solution containing benzyl alcohol maintaining patency reducing incidence phlebitis patients intermittent infusion devices subjects n randomly assigned double blind experimental design repeated measures analysis variance revealed significant difference groups phlebitis patency variables results controlled study would suggest sodium chloride effective units heparin sodium chloride solution maintaining intermittent infusion device patency preventing phlebitis,C14,0.0034011835,0.085325435,0.05571737,0.0019105611,0.004774539,0.004398069,0.15478422,0.0031978025,0.0024583573,0.003341119,0.015688324,0.09020062,0.21692836,0.008892538,0.0029902495,0.0053048306,0.052121673,0.003511095,0.02032801,0.061384697,0.19853182,0.001207368,0.003601758
irrigation device neuroangiographic procedures simple irrigation device use diagnostic interventional neuroangiographic procedures described device used flush bubbles blood clots catheter hubs authors also describe technique device used prevent filling catheter air guide wire removed,C14,0.0056205634,0.14103647,0.010487388,0.0031579651,0.007826457,0.0072536296,0.16981237,0.005285646,0.004063417,0.0055225333,0.18864505,0.011560424,0.06309712,0.012994516,0.0049425815,0.008752386,0.16576806,0.0057882485,0.0063998383,0.09031399,0.07389347,0.0019956578,0.0057822284
acute changes dynamics cerebrospinal fluid system experimental subarachnoid hemorrhage early changes intracranial pressure icp icp volume index resistance absorption cerebrospinal fluid induced experimental subarachnoid hemorrhage studied cats sah icp slightly elevated decrease buffering capacity intracranial space sharp rise outflow resistance infusion blood cisterna magna constant infusion rate extensive increase icp could demonstrated contrast infusion saline caused slight elevation icp furthermore blood infusion icp level reach plateau phase pressure demonstrated infusion saline suggested marked increase icp blood infusion subarachnoid space caused intracranial volume loading simultaneous increase cerebrospinal fluid outflow resistance concluded reported relationship increased cerebrospinal fluid outflow resistance increased icp supports hypothesis strong increase icp subarachnoid hemorrhage human subjects,C14,0.0024099094,0.0021377099,0.016151775,0.0013540298,0.0034370294,0.049776174,0.1421554,0.0022663078,0.03644317,0.0023678774,0.04763777,0.024843952,0.3114215,0.0061780824,0.0021192133,0.029027443,0.022177974,0.002481807,0.0027440363,0.04258648,0.24693199,0.00085567124,0.002494668
pulmonary artery counterpulsation skeletal muscle power source evaluated feasibility using skeletal muscle sm provide pulmonary artery pa counterpulsation acute pulmonary hypertension pht model pa counterpulsation achieved six dogs dual chambered pump powered latissimus dorsi muscle rate responsive stimulator used make muscle contract counterpulsation graded pht induced infusing microns glass beads pa rv pa pressures monitored pa pressures ranging mmhg effective counterpulsation observed degree counterpulsation influenced extent pht induced amount rv tension time index tti unloading correlated level pa systole r therefore results divided two groups group pa systole less equal mmhg group pa systole greater mmhg group rv tti decreased mmhg sec pa diastole increased mmhg pa mean increased mmhg p less group rv tt decreased mmhg sec pa diastole increased mmhg pa mean increased mmhg p less,C14,0.08361498,0.002484646,0.019251715,0.0015737797,0.0039003338,0.017693946,0.14918299,0.0026341146,0.029145243,0.0027521683,0.015595993,0.10068066,0.22587475,0.0064927195,0.0024631477,0.023373447,0.084903754,0.0029028158,0.0031893752,0.022719339,0.195694,0.000994541,0.0028815877
elevated plasma noradrenaline concentrations patients low output cardiac failure dependence increased noradrenaline secretion rates plasma noradrenaline concentrations elevated patients congestive heart failure however pathogenesis elevated noradrenaline levels controversial possible mechanisms elevated noradrenaline concentrations patients congestive heart failure include increased noradrenaline secretion decreased clearance noradrenaline combination increased secretion decreased clearance present study plasma noradrenaline clearance apparent secretion rates determined using whole body steady state radionuclide tracer method six otherwise healthy patients moderate degrees low output cardiac failure six normal control subjects venous plasma noradrenaline level elevated patients congestive heart failure compared control subjects versus nmol l p less stimulation adrenal medulla evident normal plasma adrenaline levels groups versus nmol l significant apparent secretion rate noradrenaline elevated patients congestive heart failure versus nmol min p less whereas clearance rate noradrenaline similar two groups versus l min significant conclude high peripheral venous plasma noradrenaline concentrations patients mildly decompensated low output cardiac failure initially due increased secretion rather decreased metabolic clearance perhaps response diminished effective arterial blood volume,C14,0.0016003172,0.0924774,0.002926881,0.00088102976,0.0021847794,0.024785303,0.06704666,0.01665035,0.008712631,0.009093681,0.015676066,0.02643508,0.15330909,0.029192952,0.004729022,0.05650057,0.11000473,0.0016152769,0.0017854685,0.015029034,0.3571938,0.00055676163,0.0016131637
effectiveness daily calcium antagonist lacidipine controlling hour ambulatory blood pressure efficacy new daily dihydropyridine calcium antagonist lacidipine reducing ambulatory intraarterial blood pressure bp examined untreated hypertensive patients intraarterial recording commenced hours first mg dose continued hours thereafter dose titration chronic therapy second hour ambulatory bp recording made steady onset drug action maximal hours reflex tachycardia first dose chronic administration reduced bp throughout hour period without tachycardia mean daytime reduction bp mm hg systolic p less mm hg diastolic p less mean nighttime reduction mm hg systolic p less mm hg diastolic difference significant postural decrease bp degrees head tilting hypotensive action maintained isometric exercise reduction peak mm hg p less throughout dynamic exercise reduction peak mm hg p less lacidipine effective daily antihypertensive agent good control stress response,C14,0.079239294,0.03191825,0.02395051,0.0011637895,0.0028842457,0.0026731447,0.15180646,0.0019478933,0.011520731,0.012060063,0.009742286,0.0042814547,0.25010175,0.024807962,0.011846356,0.0032254742,0.04553212,0.002133115,0.002358501,0.02584865,0.29809162,0.00073545007,0.0021308963
persistent uptake indium antimyosin monoclonal antibody patients myocardial infarction indium antimyosin scintigraphy investigated patients myocardial infarction antimyosin fab administered intravenously planar single photon emission computed tomographic images obtained hours later uptake antimyosin present patients studied within days infarction second week positive scans seen patients including normal creatine kinase levels mechanism persistent positive antimyosin images subacute stage myocardial infarction remains clarified antimyosin scintigraphy may useful noninvasive method detection myocardial injury late early suspected acute myocardial infarction,C14,0.021263646,0.003229206,0.0067925868,0.0020453855,0.040990453,0.0046981103,0.20506577,0.0034411845,0.0026318387,0.0035768952,0.1508961,0.0074875825,0.05167409,0.00858787,0.0032012654,0.040910855,0.1840256,0.0042481953,0.0041451175,0.08147727,0.16457333,0.0012925696,0.003745097
analysis outcome following percutaneous transluminal coronary artery angioplasty autopsy series analyzed autopsy findings patients died following percutaneous transluminal coronary angioplasty ptca twenty one patients died within weeks undergoing ptca demonstrable cardiac complications found patients platelet fibrin thrombi patients coronary artery dissections patients thromboemboli patients atheroemboli seven patients myocardial infarcts patients increased incidence coronary platelet fibrin thrombi noted compared non ptca cardiac autopsy population five patients apparently increased incidence coronary atheroemboli thromboemboli patients coronary platelet fibrin thrombi eight patients compared patients platelet fibrin thrombi five patients although statistically significant evidence systemic hypercoagulable state disseminated intravascular coagulation pathogenesis unclear however vasospasm disruption endothelial surface induced ptca subsequent platelet activation possible causes although statistically significant proponderance female subjects seven patients increased incidence diabetes mellitus six patients hypertension patients compared control population patients undergoing ptca cleveland ohio clinic foundation suggesting diabetes mellitus hypertension female sex may clinical risk factors fatal complications following ptca,C14,0.029493969,0.010870922,0.004148758,0.0010676928,0.011801338,0.01164571,0.12219244,0.010976172,0.010300947,0.0018671419,0.010250861,0.00398535,0.056013137,0.022714209,0.001671063,0.0029839976,0.38071078,0.011151933,0.0021637543,0.14331754,0.14803341,0.00067472225,0.0019641398
transoesophageal echocardiography longitudinal axis correlation anatomy images clinical implications transoesophageal echocardiographic imaging longitudinal axis recent addition non invasive evaluation congenital acquired heart disease technique provides unique images intracardiac anatomy interpretation remains difficult heart specimen therefore cut according echocardiographic imaging planes elucidate morphological details results suggested longitudinal transoesophageal imaging complements transverse axis approach gave new imaging information right ventricular outflow tract pulmonary trunk atrioventricular valves interventricular septum cardiac apex thoracic aorta particular showed entire length right ventricular outflow tract longitudinal imaging used combination transverse imaging almost thoracic aorta could examined imaging longitudinal axis may also allow better assessment mechanisms atrioventricular valve regurgitation,C14,0.04321251,0.0020892038,0.004394609,0.01269649,0.15603642,0.0030455843,0.29331112,0.04780373,0.0017027243,0.0023141487,0.03560776,0.016813204,0.04425601,0.017341398,0.002071127,0.003667578,0.15433739,0.0024254932,0.0026817722,0.07474314,0.07618937,0.0008362555,0.0024229707
effect verapamil mortality major events acute myocardial infarction danish verapamil infarction trial ii davit ii effect verapamil death major events e death reinfarction acute myocardial infarction studied double blind randomized placebo controlled multicenter trial eight hundred seventy eight patients started treatment verapamil mg day patients placebo treatment started second week admission continued months mean months ninety five deaths major events occurred verapamil group deaths major events placebo group month mortality rates p hazard ratio confidence limits major event rates p hazard ratio confidence limits verapamil placebo groups respectively patients without heart failure coronary care unit mortality rates verapamil group placebo group p hazard ratio confidence limits major event rates p hazard ratio confidence limits patients heart failure mortality rates p hazard ratio confidence limits major event rates p hazard ratio confidence limits long term treatment verapamil acute myocardial infarction caused significant reduction major events positive effect found patients without heart failure,C14,0.0022513825,0.0019970885,0.004200846,0.0012649599,0.0031349787,0.0029055264,0.33410192,0.0021172273,0.0016276493,0.0022121156,0.021394592,0.0651969,0.023210127,0.005305163,0.001979809,0.0035058707,0.16682506,0.0023185506,0.08628051,0.145159,0.11989519,0.0007993841,0.0023161392
secondary prevention acute myocardial infarction beta blocking agents calcium antagonists discovery beta blockers possess clinically useful hypotensive antianginal antiarrhythmic properties attracted interest clinicians researchers pharmaceutical community alike addition minor differences variety ancillary properties led speculation specific classes drugs might advantages classes enthusiasm greeted reports first small trials showed beta blockers reduced postmyocardial infarction mortality rate attracted commercial support necessary evaluate different beta blockers clinical setting plethora beta blockers subsequently became available study led considerable improvement design implementation large clinical trials despite apparent discrepancies results various trials meta analysis indicates beta blockers reduce postinfarction mortality however meta analysis cannot recommend particular drug specific dose use individual patient clinical practice must based results individual trials conclusions meta analysis clinical utility beta blockers secondary prevention myocardial infarction coupled experimental evidence calcium antagonists reduce infarct size led series large studies designed establish whether calcium antagonists effect reducing mortality patients myocardial infarction lessons learned beta blocker trials permitted rapid evaluation efficacy calcium antagonists setting clear unlike beta blockers calcium antagonists effective secondary prevention myocardial infarction,C14,0.01049559,0.036472805,0.046502538,0.0010119423,0.011240579,0.016204352,0.38700745,0.0016937389,0.0013020864,0.010476349,0.02478654,0.0037343453,0.04793247,0.0044428236,0.01901767,0.02022827,0.07646234,0.0018547935,0.075786024,0.06795246,0.12404613,0.0006394911,0.010709189
coronary perfusion catheter effectiveness experimental model acute coronary occlusion effectiveness coronary perfusion catheter studied animal model acute coronary occlusion systemic hemodynamic variables regional myocardial blood flow rmbf subepicardium subendocardium regional systolic function systolic segmental shortening area perfused circumflex coronary artery cx measured eight anesthetized dogs baseline measurements cx coronary artery occluded silk snare measurements repeated minutes ischemia occlusion snare released hour later snare occlusion repeated placement perfusion catheter cx coronary artery minutes measurements repeated occlusion determine long term effectiveness catheter hemodynamic variables regional function measurements obtained every minutes total minutes occlusion rmbf decreased ml min gm p less subendocardial rmbf decreased ml min gm p less insertion perfusion catheter occlusion subepicardial rmbf maintained subendocardial rmbf maintained ml min gm occlusion subepicardial rmbf greater p less occlusion different baseline,C14,0.10660161,0.033246037,0.004025759,0.0012122378,0.0030043162,0.002784427,0.07444372,0.0020289836,0.0015598106,0.002119917,0.06932779,0.004437662,0.42098802,0.0049608676,0.001897315,0.003365491,0.09008663,0.0022219159,0.0024566848,0.028967207,0.13727792,0.00076606666,0.002219605
b mode imaging histomorphometric evaluation carotid atherosclerosis quantitative qualitative evaluation atherosclerotic lesions ultrasonography presented several problems determination accuracy reproducibility methodology humans present study aims evaluated results b mode imaging extracranial carotid arteries patients selected surgery compared histologic results observations samples obtained endarterectomy shrinkage effects histologic samples taken consideration several bidimensional images atherosclerotic lesions obtained ultrasound different incident angles used establish maximum thickness maximum degree vessel stenosis calculated ultrasound showed high correlation x se r p less compared one obtained histology imaging methodology provided however mean overestimation stenosis relationships among amount calcium p less necrotic core p less echogenic types ie soft mixed hard suggested statistical trend results suggested vascular lumen due advanced atherosclerotic lesions qualitative interpretation atherosclerosis b mode imaging ie morphologic characteristics seem present value investigations depth needed,C14,0.011568636,0.0017332857,0.022599118,0.010764643,0.097316675,0.002543487,0.23706828,0.015020625,0.0014126471,0.0019199089,0.1338914,0.004018982,0.11344204,0.01612961,0.0017182886,0.003042767,0.11751144,0.0020122847,0.0022249038,0.025906995,0.14367615,0.0006937905,0.033784017
increased endothelin experimental heart failure recent studies demonstrate endothelin potent endogenous vasoconstrictor peptide circulates plasma normal animals humans however role peptide pathophysiological states remains unclear present study designed test hypothesis circulating endothelin concentrations increased experimental congestive heart failure chf pathophysiological state characterized activation vasoconstrictor mechanisms anesthetized dogs chf produced days rapid ventricular pacing n circulating plasma endothelin increased compared values normal controls n versus pg ml respectively p less plasma endothelin level sensitive specific indicator significant chf moreover within group experimental chf right atrial pressure pulmonary capillary wedge pressure correlated independently circulating endothelin levels based recent studies demonstrating physiological actions twofold increases circulating endothelin observed present study possible role endothelin pathophysiology chf advanced,C14,0.0024093082,0.025448507,0.03807511,0.001353692,0.0033552302,0.0031164652,0.24338846,0.0022657425,0.0017418226,0.0023672867,0.011824625,0.029217705,0.09097312,0.0062224087,0.0021186848,0.015398658,0.03312182,0.027364666,0.0027433517,0.016504575,0.43763486,0.0008554578,0.0024984116
overview renal physiology pathophysiology aging cross sectional studies humans suggested progressive decline renal function age years decline various functions eg tubular maximums concentrating diluting abilities acidification tend parallel decreases glomerular filtration rate gfr renal blood plasma flow rpf recent observations baltimore longitudinal study aging suggest individuals follow pattern indeed many show decline even increase renal function time whether observed decreases renal function aging results intervening pathologic processes eg immunologic infectious toxic injury ischemia related hyperperfusion hyperfiltration resultant glomerulosclerosis relentless involutional process remains unclear purpose report review descriptive studies documenting changes renal morphology physiology age discuss known mechanisms involved losses renal substance function,C14,0.013298263,0.0020195947,0.015248497,0.0012792154,0.0031703084,0.013953835,0.20161772,0.0021410873,0.001645992,0.002237045,0.06248244,0.0046828487,0.075985104,0.019976882,0.0020021203,0.00354538,0.04092601,0.0023600727,0.0025924197,0.1415412,0.37208155,0.00080839277,0.014404053
effects bepridil diltiazem ventricular repolarization angina pectoris examine time course potential predictors prolongation ventricular repolarization calcium antagonist bepridil effects bepridil mg day n diltiazem mg day n qt qtc interval duration analyzed randomized double blind study patients angina pectoris electrocardiograms recorded days treatment begun days bepridil prolonged qt interval ms range ms qtc bazett formula ms range ms compared baseline p less qt qtc significantly increase thereafter however among patients less ms qtc prolongation day compared baseline exceeded limit least following visits diltiazem significantly alter qt qtc intervals absolute change qtc interval baseline observed days bepridil therapy inversely proportional baseline qtc interval r n p less degree bepridil induced qtc prolongation day correlated pretreatment rr interval r n p less conclusion chronic administration bepridil diltiazem prolongs ventricular repolarization patients angina pectoris overall effects bepridil therapy qt qtc intervals assessed electrocardiogram recorded days treatment subsequent measurements may required individual patients short baseline qtc interval slow initial heart rate may potentially useful predictors greater qtc prolongation bepridil,C14,0.0101656495,0.0015447722,0.011589175,0.0009784618,0.002424944,0.0022474597,0.17184776,0.001637701,0.0012590064,0.0017110981,0.01794588,0.0035819171,0.17546985,0.012502624,0.0015314062,0.011080543,0.29528964,0.001793427,0.018835025,0.05194912,0.20220123,0.0006183333,0.0017950162
determinants significance diltiazem plasma concentrations acute myocardial infarction multicenter diltiazem postinfarction trial research group total plasma diltiazem concentrations obtained patients enrolled multicenter secondary intervention study diltiazem acute myocardial infarction evaluate determinants significance diltiazem concentrations patient population related drug concentrations variety clinical variables recorded case history forms multiple linear regression analysis showed time last drug dose drug dose taken patient height index lean body weight patient age important determinants plasma concentration equivalent dose plasma diltiazem concentrations year old patient double year old patient total weight drug dose prescribed significantly affect plasma concentrations whereas drug concentrations higher p among patients left sided heart failure altered renal dysfunction hepatic disease beta blockers diltiazem concentrations significant determinant diastolic arterial pressure p less neither systolic pressure heart rate significantly related diltiazem concentration overall incidence adverse experiences related drug concentrations occurrence second third degree atrioventricular block coronary care unit need temporary pacemaker substantially higher among patients drug concentration greater ng ml respectively among patients lower concentrations atrioventricular block pacemaker p risk atrioventricular block particularly increased high diltiazem concentrations face acute inferior infarction results suggest diltiazem pharmacologic clinical effects large population concentration related consideration patient size age left ventricular function selecting diltiazem dose may allow effective drug therapy reduced likelihood adverse effects,C14,0.001334678,0.0011616823,0.0024446656,0.013406093,0.0018324489,0.008093405,0.26919916,0.007569091,0.0009467839,0.013955435,0.021849021,0.009099451,0.086027,0.0030308513,0.0074968254,0.0083658295,0.102897316,0.0013486729,0.007829426,0.111053005,0.3129078,0.006801987,0.0013493499
noncoordinate regulation alpha adrenoreceptor coupling reexpression alpha skeletal actin myocardial infarction induced left ventricular failure rats determine effects myocardial infarction induced left ventricular failure regulation surface alpha adrenoreceptors signal transduction large infarcts produced rats animals killed seven days later documentation impaired left ventricular pump performance radioligand binding studies alpha adrenoreceptor norepinephrine stimulated phosphoinositol turnover adp ribosylation kd substrate pertussis toxin examined hypertrophying unaffected myocardium moreover expression sarcomeric actin isoforms analyzed northern blots hybridization specific oligonucleotide probes alpha adrenoreceptor density found altered membranes obtained spared left ventricular tissue whereas phosphoinositol turnover increased fold viable myocytes infarcted hearts furthermore pertussis toxin substrate augmented fold membranes prepared surviving left ventricular myocardium finally upregulation skeletal actin isoform detected tissue failing left ventricle conclusion possibility raised presence severe myocardial dysfunction ongoing reactive hypertrophy effector pathways linked alpha adrenoreceptor may stimulate myocyte hypertrophic response would tend normalize cardiac hemodynamics reexpression alpha skeletal actin may molecular indicator persistance overload myocardium,C14,0.023550147,0.020650478,0.05817521,0.0010978006,0.013737914,0.009295278,0.19101104,0.0018374441,0.0014125619,0.0019197932,0.012355049,0.02577266,0.056837253,0.02517426,0.04898157,0.04784129,0.046277467,0.03356827,0.0022247697,0.040875763,0.20015395,0.047987856,0.08926219
intraoperative coronary excimer laser angioplasty preliminary clinical experience diffuse coronary artery atherosclerosis generally recognized deterrent successful revascularization cannot adequately treated mechanical endarterectomy useful optimal solution owing associated higher incidences perioperative infarction mortality use laser energy endarterectomy tool appears promising investigate application excimer laser radiation intraoperative coronary artery endarterectomy stenotic lesions patients treated excimer irradiation coronary artery bypass grafting eleven lesions enlarged excimer probe successes calcified lesions arteries enlarged excimer laser demonstrated calcified lesions perforations dissections heavily calcified arteries results phase safety efficacy study indicate excimer irradiation recanalize arteries including total subtotal occlusions calcified lesions evaluation better delivery systems needed determine whether perforation rate reduced,C14,0.057784405,0.002484973,0.005227104,0.001573987,0.098978,0.00361534,0.24209648,0.016148869,0.015582976,0.0027525304,0.031280104,0.032875516,0.054138992,0.00644301,0.0024635915,0.031483058,0.20726445,0.002901178,0.003189795,0.08693165,0.090907365,0.000994672,0.002881967
role angiotensin converting enzyme inhibitors congestive heart failure conventional therapy congestive heart failure chf includes sodium restricted diet diuretics digitalis vasodilators short term intravenous administration beta adrenergic agonists episodes decompensation specific class vasodilators angiotensin converting enzyme inhibitors recently gained predominance treatment congestive heart failure primary mechanism action reduce production angiotensin ii competitive inhibition enzyme converts angiotensin angiotensin ii reduced levels angiotensin ii turn promote vasodilation lower aldosterone production benefits angiotensin converting enzyme inhibitor therapy chronic congestive heart failure demonstrated improvement left ventricular performance exercise capacity functional status using new york heart association classification survival,C14,0.0031920339,0.14185981,0.021218756,0.001792966,0.004444062,0.00411832,0.27971256,0.003000978,0.0023070453,0.0031354732,0.032600682,0.02200462,0.051400583,0.009386533,0.049145743,0.020412026,0.05014406,0.0033149223,0.0036335716,0.10583945,0.16747108,0.016579088,0.0032856222
termination acute atrial fibrillation wolff parkinson white syndrome procainamide propafenone importance atrial fibrillatory cycle length effects intravenous procainamide n propafenone n evaluated patients acute atrial fibrillation wolff parkinson white syndrome patients received either procainamide mg kg body weight propafenone mg kg sustained greater min atrial fibrillation termination nonsustained atrial fibrillation termination atrial fibrillation attributed drug occurred less equal min infusion measurements included mean cycle length fibrillatory electrograms mean aa interval measured high right atrium shortest rr interval pre excited cycles atrial fibrillation atrial fibrillation terminated frequently procainamide administration propafenone although difference significant procainamide prolonged shortest pre excited rr interval ms p propafenone ms p magnitude increase greater propafenone p patients sustained atrial fibrillation shorter mean aa intervals counterparts nonsustained atrial fibrillation versus ms p termination sustained atrial fibrillation either drug accompanied prolongation mean aa interval necessarily shortest pre excited rr interval termination atrial fibrillation heralded increase mean aa interval procainamide administration compared increase arrhythmia persisted propafenone increases respectively,C14,0.00246715,0.002188485,0.016535157,0.013321109,0.0034354283,0.0031839856,0.13735892,0.0023201378,0.025669867,0.0024241197,0.011780943,0.02210771,0.2459657,0.00567274,0.014108684,0.016014455,0.14817391,0.0025407556,0.0028092132,0.08750788,0.23099956,0.0008759953,0.002538113
fish oil supplementation patients stable claudication increased blood viscosity occurs patients claudication increase viscosity mainly due elevated fibrinogen levels decreased red cell deformability adversely influences blood flow addition positive effect blood pressure blood lipids platelet responsiveness fish oil may improve blood flow due favorable influence hemorrheology prospective randomized double blind study evaluated effect six capsules fish oil g eicosapentaenoic acid g docosahexaenoic acid versus six capsules corn oil g linoleic acid administered months walking distances pressure indices rest exercise blood pressure red cell deformability fibrinogen lipid levels patients stable claudication significant changes walking distances pressure indices rest exercise occurred despite significant increase red cell deformability fish oil group fibrinogen levels change either group fish oil group favorable change blood lipids noted high density cholesterol increased triglycerides decreased mean arterial blood pressure declined similar extent groups thus short term supplementation fish oil lead clinically significant improvement symptoms patients stable claudication suggests red cell deformability minor importance arterial blood flow legs patients,C14,0.010383452,0.01854469,0.0032741616,0.0009859165,0.002443419,0.019054828,0.12968318,0.0016501782,0.0012685985,0.0017302242,0.014767429,0.038983095,0.2954393,0.040583637,0.044014692,0.019717341,0.0803443,0.0018070906,0.0104868775,0.025837693,0.20262393,0.0006230442,0.035752892
effects benazepril metoprolol oros alone combination myocardial ischemia patients chronic stable angina efficacy benazepril metoprolol oros combination evaluated patients years age chronic stable angina documented coronary artery disease placebo controlled double blind crossover trial using serial quantitated exercise testing ambulatory electrocardiographic ecg monitoring mean sem exercise time min placebo min confidence interval ci benazepril min ci metoprolol oros min ci combination benazepril metoprolol oros mean exercise time development mm st segment depression prolonged min placebo min ci benazepril min ci metoprolol oros min ci combination benazepril metoprolol oros benazepril alter rest maximal heart rate whereas metoprolol oros alone combination significantly lowered heart rate rest maximal exercise systolic blood pressure rest nonsignificantly reduced whereas diastolic blood pressure lowered significantly treatments comparison placebo maximal exercise metoprolol oros whether given alone combination benazepril able blunt significantly systolic blood pressure rate pressure product,C14,0.002135638,0.053579632,0.014524641,0.0011997275,0.0029937667,0.013088315,0.16420907,0.0020080444,0.032552633,0.0020980393,0.022298967,0.004452697,0.33249295,0.0049096714,0.0018777126,0.0033443924,0.09859854,0.0021989858,0.06445254,0.040595308,0.13343391,0.00075816084,0.0021966987
intraoperative assessment regional myocardial perfusion using quantitative myocardial contrast echocardiography experimental evaluation test hypothesis myocardial contrast echocardiography used quantitate regional myocardial flow arrested heart time delivery cardioplegic solution data acquired dogs cardiopulmonary bypass different degrees stenosis placed random order left anterior descending coronary artery stenosis myocardial contrast echocardiography performed injecting sonicated albumin microbubbles cross clamped aortic root time delivery cardioplegic solution resultant echocardiographic images analyzed line computer background subtracted time intensity plots generated exponential function f ce alpha de beta applied plot variables reflected total number microbubbles entering coronary artery bed area curve peak height curve correlated best radiolabeled microsphere measured myocardial flow r r respectively variables reflected appearance contrast microbubbles myocardium initial slope slope also good correlation myocardial flow r r respectively variables reflected washout contrast medium myocardium slope descending portion curve fair correlation myocardial flow r six dogs technique injecting contrast medium cross clamped aortic root also examined although continuous infusion contrast medium produced smaller perturbations mean aortic distal left anterior descending artery pressures compared bolus injection p less correlation variables time intensity curves flow equally close techniques concluded possible quantitate myocardial flow using myocardial contrast echocardiography time delivery cardioplegic solution dogs cardiopulmonary bypass implementation technique humans might useful guiding sequence graft placement thereby improving myocardial preservation coronary artery bypass operations,C14,0.015234127,0.0012661725,0.002719639,0.00080227025,0.015942466,0.022546183,0.16167238,0.028979173,0.021759592,0.008303725,0.015318066,0.030808624,0.29946685,0.003557053,0.02888211,0.0022227543,0.15911864,0.0014699824,0.0016253017,0.022547115,0.123033255,0.00050681684,0.032217722
muscle oxidative capacity work performance training local leg ischemia healthy young men executed supine one legged cycle training four times per week wk legs cycle ergometer inside pressure chamber opening sealed rubber membrane level crotch training session started training one leg ischemic conditions induced increased chamber pressure mmhg highest intensity tolerable min leg trained power profile normal atmospheric chamber pressure training period legs executed one legged exercise tests normal increased chamber pressure muscle biopsies taken vastus lateralis ischemic training increased performance normal training difference greater exercise executed ischemic conditions difference performance increase legs paralleled greater muscle citrate synthase activity ischemically normally trained leg,C14,0.0027639787,0.029211981,0.05867468,0.0015529669,0.0038487527,0.016931435,0.11011686,0.002599279,0.042141058,0.0027157713,0.02543459,0.019519974,0.17265403,0.006660692,0.015805846,0.017854214,0.072442286,0.0028492755,0.0031471963,0.21556844,0.17368181,0.0009813884,0.0028434792
regional blood flow supply demand heart failure heart failure results fall cardiac output also redistribution blood flow favoring regional beds brain heart expense others kidney working skeletal muscle chronic resting hypoperfusion striated muscle compromised exercise maladaptive vasoconstrictor control mechanisms prevent redirection blood flow nonworking muscle liver working muscle inappropriate preservation nonworking organ perfusion compromises functional capacity working muscle associated evidence metabolic deconditioning reduced oxygen extraction impaired oxidative phosphorylation becoming increasingly clear clinical response inotropic vasodilator therapy used heart failure part dependent differing regional blood flow profiles various agents studied ability angiotensin converting enzyme inhibitors redirect blood flow away nonworking regional beds exercising muscle thereby reestablish appropriate physiologic response changing metabolic needs may overriding reason long term efficacy certainly future comprehensive therapy heart failure take consideration central hemodynamic also regional blood flow supply demand issues,C14,0.023644885,0.033957828,0.014777564,0.011897444,0.0030684813,0.013504278,0.2699545,0.0020723178,0.054934315,0.0021651932,0.010467684,0.00454505,0.21631646,0.0050785653,0.0019378143,0.04579038,0.023262277,0.023594007,0.013167895,0.071905784,0.1509078,0.000782428,0.0022670105
hemodynamic efficacy rapid saline infusion dobutamine versus saline infusion alone model cardiac rupture despite recent reports describing survival cardiac rupture effectiveness circulatory support awaiting definitive surgical treatment controversial assess efficacy volume expansion pharmacologic support cardiac tamponade due cardiac rupture model hemorrhagic cardiac tamponade developed treatment rapid saline infusion dobutamine compared rapid saline infusion alone closed chest dogs right ventricular wound reproducible size produced deflating aortic valvuloplasty balloon previously passed way internal jugular vein pericardial space stab wound right ventricular free wall hemodynamic values compared baseline tamponade rapid infusion liter ml min either saline solution alone saline solution plus dobutamine micrograms kg per min atrial pericardial pressures increased significantly groups mean arterial pressure cardiac output stroke volume increased combined saline dobutamine infusion values similar baseline baseline respectively contrast saline infusion alone caused small increase cardiac output failed significantly increase mean arterial pressure stroke volume baseline respectively combined rapid infusion saline solution dobutamine infusion beneficial hemodynamic effect may effective rapid saline infusion alone resuscitating patients hemorrhagic cardiac tamponade due cardiac rupture,C14,0.058016032,0.009408774,0.019141559,0.008832909,0.002306806,0.065551266,0.17772543,0.020628987,0.0011880324,0.009531867,0.00765136,0.045899324,0.30308476,0.0037784532,0.0014450762,0.0025643199,0.13701741,0.0016923262,0.0018711383,0.011601975,0.10878742,0.000583476,0.0016912766
hemodynamic effects diltiazem vasoconstrictor pulmonary hypertension sheep calcium channel blockers effective pulmonary vasodilators patients pulmonary hypertension current study therefore compared effects prostaglandin e effective pulmonary vasodilator effects water soluble calcium channel blocker diltiazem pulmonary hypertension sheep pulmonary hypertension produced continuous intravenous administration u halothane anesthetized sheep prostaglandin e decreased pulmonary artery pressure decreased pulmonary vascular resistance rp affect ratio pulmonary systemic vascular resistance rp rs diltiazem decreased pulmonary artery pressure decreased rp affect rp rs ml kg polyethylene glycol ethanol vehicle vehicle used nifedipine administration prior study administered diltiazem infusion pulmonary artery pressure increased rp increased rp rs increased results indicate diltiazem effective pulmonary vasodilator suggest previously reported unfavorable results nifedipine may due vehicle used nifedipine administration,C14,0.25423223,0.0020646607,0.004411845,0.035099946,0.0032410515,0.0030146337,0.18228132,0.0021888642,0.0016827212,0.002286963,0.011785003,0.029182939,0.121297106,0.005352742,0.0020467963,0.014953667,0.08125634,0.0023969994,0.0026502677,0.015923074,0.21942991,0.00082643144,0.0023945065
beta adrenergic receptors lymphocyte subsets exercise alterations normal individuals patients congestive heart failure dynamic exercise increases number beta adrenergic receptors mixed lymphocytes mechanism incompletely understood set vivo studies investigated effects dynamic exercise subset distribution circulating lymphocytes number beta adrenergic receptors subsets two groups patients healthy subjects exercise increased plasma norepinephrine epinephrine caused lymphocytosis whereas number thelper cells increased modestly number tsuppressor cytotoxic natural killer cells tripled number beta adrenergic receptors varied among subsets significantly altered dynamic exercise subset except natural killer cells increase p group patients congestive heart failure dynamic exercise increased plasma norepinephrine alter plasma epinephrine cause significant lymphocytosis detect significant alterations circulating leukocyte subsets beta adrenergic receptors subsets exercise combined analysis healthy patients heart failure patients revealed significant correlation increases plasma epinephrine increases circulating lymphocytes conclude exercise induced increase beta adrenergic receptors mixed lymphocytes predominantly caused redistribution circulating cell subsets differ beta adrenergic receptor number appears mediated epinephrine rather norepinephrine,C14,0.0018160609,0.107109554,0.038581762,0.0010203705,0.0025392787,0.011065807,0.11056364,0.0017078456,0.0013129312,0.0017843865,0.013598391,0.021319913,0.08095771,0.085546754,0.0015969981,0.0028522732,0.07787674,0.07410741,0.002130562,0.020008564,0.3399747,0.00064481725,0.0018835319
prehospital thrombolysis acute myocardial infarction benefit risk prehospital thrombolysis acute myocardial infarction ami evaluated double blind randomized trial patients presenting less hours symptom onset received million units urokinase intravenous bolus either group n group b n hospital admission mean time interval onset symptoms thrombolytic therapy minutes group minutes group b p less patients thrombolytic therapy administered less hours symptom onset complication rates pre hospital period low differ groups three patients died group group b reinfarction days admission left sided cardiac catheterization discharge revealed patency rate infarct related artery group group b difference significant global left ventricular function regional wall motion infarct site differ significantly group b ejection fraction n vs n wall motion vs standard deviation respectively also peak creatine kinase differ significantly u liter group vs u liter group b prehospital thrombolysis using bolus injection urokinase low risk performed trained physician mobile care unit saving minutes early stage acute infarction prehospital thrombolysis appear important salvage myocardial function,C14,0.032472882,0.0018557975,0.014026088,0.0011754659,0.0029245652,0.0026999644,0.19531369,0.012093268,0.0015124955,0.04041878,0.022567663,0.14388452,0.21447244,0.0048183403,0.0018397403,0.0032578353,0.14877498,0.0021622789,0.012504281,0.04613596,0.08206855,0.010868131,0.0021522758
results percutaneous transluminal coronary angioplasty patients greater equal years age national heart lung blood institute coronary angioplasty registry national heart lung blood institute percutaneous transluminal coronary angioplasty ptca registry series initial procedures included patients age greater equal years elderly comparison younger patients greater proportion elderly patients women unstable angina elderly patients history hypertension history congestive heart failure although elderly extensive vessel disease numbers lesions vessels attempted ptca similar older younger cohorts angiographic success rates similar age groups although complication rates catheterization laboratory differ patients greater equal years much likely require emergency coronary artery bypass graft surgery cabg vs p less elective cabg vs p less hospital death rate considerably higher among elderly vs p less year follow symptomatic status cumulative rates myocardial infarction cabg repeat ptca similar elderly younger patients death rate years higher among elderly patients patients greater equal years vs patients less years p less relative risk death elderly adjusted factors prevalent among greater equal years history congestive heart failure multivessel disease unstable angina history hypertension female gender relative risk remained significant substantially reduced,C14,0.016271634,0.034301117,0.017443577,0.0008488157,0.009416052,0.020168958,0.06695062,0.001424699,0.0010921882,0.0014843777,0.032619193,0.010600791,0.08843758,0.0035614644,0.037891366,0.0023525157,0.24891518,0.001555798,0.0017201846,0.30636832,0.05791755,0.03710384,0.0015541799
epithelial abnormalities intestine kidney spontaneously hypertensive rat variety perturbations calcium metabolism reported occur spontaneously hypertensive rat shr compared genetic control wistar kyoto rat wky including significant dysfunction calcium handling proximal renal tubule shr resulting impaired active calcium transport gut apparent renal calcium leak explored intestinal renal epithelia week old shr wky using electron microscopy biochemical comparisons transport epithelia included measurements three vitamin dependent cellular proteins one structural protein alkaline phosphatase intestinal cabp k renal cabp k villin expression electron microscopy demonstrated patchy loss microvilli shr accounting approximately total microvillar surface kidney morphological abnormalities observed proximal renal tubule patchy loss microvilli brush border membrane shr duodenal alkaline phosphatase activity significantly reduced compared wky v integrated extinction min micron x brush border p less duodenal cabp k renal cabp k significantly reduced shr compared wky differences villin expression data consistent previously characterized disturbances active calcium transport intestine inappropriate renal calcium leak shr possible link disturbances hypertension remains determined study provides supportive evidence primary disturbance cell calcium handling transporting epithelia form genetic hypertension,C14,0.018520433,0.0015308481,0.0124183195,0.017664386,0.0024032078,0.0022272018,0.24738537,0.0016229392,0.0012476582,0.0016956748,0.00820098,0.0035784936,0.09444334,0.100173265,0.043336645,0.011151537,0.037165664,0.046751004,0.001965048,0.039089516,0.2740811,0.00061275985,0.032734606
efficacy propafenone preventing ventricular tachycardia inverse correlation rate related prolongation conduction time efficacy propafenone preventing induction ventricular tachycardia evaluated consecutive patients mean age years remote myocardial infarction underwent programmed electrical stimulation ventricular arrhythmia using three extra stimuli basic drive right ventricular apex nine patients group propafenone prevented induction sustained ventricular tachycardia noninducible four nonsustained less five patients group b sustained ventricular tachycardia still inducible tachycardia configuration unchanged cycle length significantly longer versus ms p less propafenone significantly affect either sinus cycle length ah hv intervals however prolonged qrs duration sinus rhythm equally groups patients ventricular pacing propafenone also prolonged right ventricular effective functional refractory periods surface qrs duration greater lengthening paced surface qrs duration drug therapy ineffective example ms group versus ms group b basic drive ms p less drug induced prolongation paced qrs complex greater ms positive predictive value drug failure prevent induction ventricular tachycardia drug induced percent prolongation ventricular tachycardia cycle length group b correlate well percent qrs prolongation,C14,0.0237686,0.055892702,0.05008871,0.0012515121,0.0031016504,0.0028746375,0.15703997,0.0020947189,0.023155734,0.0021941508,0.011171948,0.06929055,0.11738556,0.0059717814,0.0019587614,0.03581327,0.26778278,0.002293902,0.010635045,0.06488294,0.0882687,0.00079088577,0.0022915162
alcohol consumption blood pressure comparison native japanese american men compared cross sectional association alcohol consumption blood pressure japanese men jm living tokyo white men wm living new york mean systolic jm wm p less diastolic blood pressure jm p less wm p less associated alcohol consumption groups compared abstainers heaviest drinkers highest systolic jm p wm p less diastolic jm p less wm p less blood pressures relation blood pressure alcohol intake j shaped americans linear japanese exploratory analyses revealed j shape may due reporting heavy alcohol ingestion american abstainers abstainers excluded relationships similar american japanese positive association blood pressure alcohol consumption persisted adjustment age cigarette smoking use antihypertensive medications body mass index heart rate abdominal skinfold thickness hematocrit fasting blood glucose serum uric acid levels urinary sodium potassium ratio alcohol use also related prevalence hypertension findings confirm presence independent association alcohol intake blood pressure jm wm suggest despite differences metabolism alcohol relation alcohol consumption blood pressure similar nationalities,C14,0.011260715,0.0016858026,0.012743708,0.0010677908,0.0026580512,0.0024526422,0.14849393,0.01988053,0.010572058,0.020262945,0.02980484,0.013263811,0.3318495,0.004700171,0.020061571,0.03068694,0.018152123,0.013448291,0.038951296,0.19152635,0.0738428,0.0006747842,0.0019594
hypertension prevalence status awareness treatment control hispanic health nutrition examination survey hhanes prevalence rates hypertension among adult ages mexican americans cuban americans puerto ricans estimated using data hispanic health nutrition examination survey hhanes hypertension defined diastolic greater equal mm hg systolic greater equal mm hg currently taking antihypertensive medication among mexican americans southwestern united states percent males percent females found hypertensive among cuban americans dade county florida percent males percent females hypertensive among puerto ricans new york city area percent males percent females hypertensive age adjusted rates significantly lower comparable rates whites blacks measured second national health nutrition examination survey nhanes ii control hypertension hhanes populations fall short objectives nation established us public health service percent percent controlled mexican american hypertensives percent controlled cuban american hypertensives percent controlled puerto rican hypertensives,C14,0.06111349,0.0019342192,0.0040686014,0.0012251383,0.0030362878,0.013333756,0.1163805,0.0020505758,0.012130316,0.012661991,0.07338642,0.0046143546,0.10747498,0.0050377813,0.012457612,0.003395504,0.14719771,0.0022455615,0.09747588,0.22588612,0.068764955,0.021884985,0.002243226
financial impact rapid ck mb specific immunoassay diagnosis myocardial infarction purpose study twofold first evaluated financial impact rapid monoclonal antibody based ck mb mass assay stratus dade division baxter laboratories miami fla direct measurement ck mb serum samples patients admitted coronary care unit possible diagnosis acute myocardial infarction second evaluated retrospectively stratus assay activity assay electrophoresis ck mb following patient categories acute myocardial infarction treated without thrombolytic therapy angina congestive heart failure skeletal muscle trauma acutely ill without acute myocardial infarction advantageous features stratus mass assay follows first laboratory able perform assay frequently short assay time per specimen less minutes without additional personnel substantial impact clinician ability diagnose acute myocardial infarction move patients intensive care unit substantial financial savings patient hospital third party payer second stratus assay able detect low levels ck mb micrograms l presence low total creatine kinase activity less u l third stratus assay showed interference due high total creatine kinase activities greater u l ck bb macro creatine kinase mitochondrial creatine kinase,C14,0.0020934881,0.022095734,0.04463781,0.0011754661,0.0029131842,0.0026999651,0.20786157,0.001967437,0.0015124958,0.002055612,0.09991621,0.0043030516,0.098123685,0.112778716,0.0018398488,0.02350785,0.14626326,0.0022553136,0.02435074,0.05277791,0.14197324,0.000742829,0.0021545882
thoracic epidural anesthesia improves global regional left ventricular function stress induced myocardial ischemia patients coronary artery disease aim present investigation study effects high thoracic epidural anesthesia tea including cardiac sympathetic segments ischemic st segment changes left ventricular global regional wall motion abnormalities ten patients two three vessel coronary artery disease treated beta adrenergic blocker metoprolol severe stable angina pectoris performed two identical exercise stress tests first without tea control exercise second tea tea exercise stress test intravenous metoprolol given achieve maximal near maximal beta adrenoceptor blockade systolic diastolic arterial pressures radial artery cannula heart rate rate pressure product well global regional ejection fractions using equilibrium radionuclide angiography left anterior oblique projection measured rest maximal exercise st segment analysis v v performed regional wall motion score calculated control exercise tea exercise intravenous metoprolol intravenous metoprolol plus tea rest cause significant changes variables tea exercise systolic arterial pressure diastolic arterial pressure rate pressure product heart rate significantly lower compared control exercise global anterolateral ejection fractions significantly higher versus versus respectively p less regional wall motion score significantly lower versus p less tea exercise control exercise st segment depression significantly lower tea exercise versus mv p less,C14,0.03151961,0.08755252,0.0030174346,0.00090861076,0.0022518309,0.019576618,0.13455908,0.009810368,0.040309772,0.001588945,0.042821124,0.045624513,0.26536277,0.0046764985,0.0396461,0.0025182392,0.106933825,0.009470717,0.0018413634,0.024417223,0.10769496,0.016229881,0.0016679757
role endothelium response endothelin hypertension relation endothelin acetylcholine ach examined compared aortas wistar kyoto wky rats stroke prone spontaneously hypertensive rats shrsp relaxation produced ach endothelin induced contraction less aortas wky rats shrsp aortas wky rats shrsp contraction produced endothelin augmented intact aortic rings treated methylene blue augmentation also found preparations wky rat aortic rings endothelium removed augmentation present shrsp aortic rings similarly denuded treatment indomethacin x effect endothelin induced contraction either wky rat shrsp aortic rings findings indicate endothelin ach common ability release endothelium derived relaxing factor edrf wky rat aortic rings reduced endothelium dependent relaxation response ach wky rat probably reflects fact endothelin already released edrf rings strain rats release edrf endothelin less shrsp wky rats failure endothelin release edrf shrsp endothelin may contribute increase total peripheral resistance form hypertension,C14,0.030762011,0.013333487,0.0044737207,0.012573536,0.0032415024,0.014271638,0.19774413,0.060171556,0.035411485,0.0022872812,0.010793015,0.004788009,0.044511486,0.035738353,0.0020471397,0.0036249969,0.021805337,0.0024194932,0.0026506365,0.02493544,0.46918532,0.00082654646,0.0024038951
traumatic rupture thoracic aorta presenting transient paraplegia patient involved high speed motor vehicle accident presented paraplegic emergency department noted abnormal chest x ray subsequently underwent aortography revealed aortic transection patient paraplegia resolved spontaneously prior definitive aortic repair hours later aortic rupture presenting paraplegia rare association one emergency physician cognizant especially case blunt decelerating trauma,C14,0.0050690356,0.0044964873,0.009458294,0.0028480843,0.0070977733,0.0065418542,0.3375951,0.102921695,0.0036646868,0.004980625,0.05129027,0.010426037,0.04538457,0.011655278,0.004457582,0.007893542,0.18829907,0.0052294843,0.0057718423,0.07594243,0.101961575,0.0017998302,0.0052148364
use guiding catheter contralateral femoral artery angioplasty describe unique method employing transseptal sheath guiding catheter allows contralateral retrograde femoral artery access perform balloon angioplasty proximal superficial femoral artery lesions technique simplifies arterial access provides support crossing lesions allows angiographic visualization target lesions procedure,C14,0.09780425,0.0042875027,0.009018698,0.0027157129,0.076929376,0.0062378063,0.16226475,0.004545426,0.073691644,0.004749139,0.13296221,0.009941463,0.029919881,0.011113572,0.0042504054,0.007526672,0.18586934,0.02837148,0.005503583,0.054243,0.08136547,0.0017161791,0.0049724653
carotid endarterectomy ten year analysis outcome cost treatment patients average age years underwent carotid endarterectomies two hundred ten patients symptomatic asymptomatic six patients postoperative stroke immediate reoperation one patients died day mortality rate series two recovered completely whereas three mild permanent neurologic deficit two patients nonfatal myocardial infarction mean follow months range months achieved years actuarial survival rates stroke free survival rates observed actuarial stroke free rates years noted introducing observing guidelines required preoperative study clearly defined classes patients admission surgical treatment average length stay carotid endarterectomy lowered days first years study days second years p average hospital charges expressed constant dollars decreased first years second years p despite inflationary increase medical consumer price index experience shows length hospitalization patients carotid endarterectomy reduced cost admission lowered without untoward effect perioperative morbidity mortality rates,C14,0.0020925833,0.001855883,0.014021937,0.0011755201,0.013025818,0.002700089,0.10004194,0.0019675272,0.0015125652,0.0020557062,0.037766226,0.004303249,0.03993089,0.014899435,0.032147363,0.013368395,0.40993747,0.0021673709,0.002382274,0.12941174,0.17030191,0.0007428631,0.002191257
double peaking circadian variation occurrence sustained supraventricular tachyarrhythmias studied patients less equal years age admitted treatment symptomatic supraventricular tachyarrhythmia assess whether arrhythmias begin evenly throughout day manifest circadian variation occurrence arrhythmias included episodes atrial fibrillation episodes supraventricular reentry tachycardia episodes atrial flutter cases ectopic atrial tachycardia total patients could tell exact time symptoms started arrhythmia begun midnight noon noon pm pm midnight distribution differed significantly uniform occurrence chi square p less fifty patients using beta adrenoceptor blocking agents arrhythmia occurred compared patients morning surge arrhythmias versus episodes noon instead much higher incidence night versus episodes midnight chi square p less conclude frequency onset sustained supraventricular tachyarrhythmias varies time day showing nearly equal peaks morning evening trough night modifying effect beta adrenoceptor blockage suggests many morning arrhythmias adrenergic origin probably vagal arrhythmogenic mechanisms prevail night,C14,0.00216138,0.0019172517,0.004032911,0.032596365,0.003009653,0.0027893733,0.13213907,0.012441139,0.0015625814,0.036812816,0.032570787,0.004445594,0.118688375,0.00505927,0.0019006986,0.0033657178,0.26177388,0.0022258628,0.002461049,0.1792429,0.15581232,0.00076742744,0.0022235478
select drug long term treatment chronic heart failure first line drugs treatment chronic congestive heart failure produce immediate symptomatic benefit improve exercise tolerance thereby improve quality life preferentially active monotherapy least reduce need comedication drugs must safe well tolerated patients change end natural history disease sudden death prevented life expectancy improves none currently available drugs satisfies criteria diuretics digitalis converting enzyme inhibitors ibopamine come close described ideal,C14,0.003526654,0.071389176,0.0065781116,0.0019808027,0.0049141753,0.0045497683,0.38072726,0.0033153696,0.0025487386,0.0034639551,0.050339468,0.041354164,0.026085442,0.008106083,0.003100186,0.0054898486,0.1400906,0.003630622,0.004014236,0.073502064,0.15641466,0.0012517568,0.003626846
silent myocardial ischemia dilemma blessing developing optimal strategy evaluation management patients silent myocardial ischemia extremely difficult although otherwise healthy asymptomatic individuals may risk dying suddenly exercise neither exercise testing holter monitoring reliably identifies greatest risk patients underlying coronary artery disease silent ischemia increases risk adverse outcome,C14,0.0050692284,0.053577628,0.009458655,0.0028481928,0.03159845,0.0065421034,0.25318205,0.0047671637,0.0036648265,0.0049808146,0.09691163,0.010426435,0.038955517,0.011655722,0.0044577518,0.007893843,0.17805532,0.005220465,0.005772062,0.17970939,0.078237794,0.0017998988,0.0052150353
studies myocardial protection immature heart ii evidence importance amino acid metabolism tolerance ischemia study tests importance amino acid transamination determining tolerance immature hearts ischemic damage amino acid transamination inhibited metabolically pretreatment aminooxyacetic acid aminooxyacetic acid dose duration determined incubating vitro tissue homogenate showing mmol l aoa dose minutes blocked alanine aminotransferase aspartate aminotransferase activity control studies nonischemic hearts showed coronary perfusion aminooxyacetic acid minutes impair myocardial performance contrast pretreatment immature puppies aminooxyacetic acid severely impaired recovery minutes normothermic global ischemia versus recovery untreated hearts p less biochemical analyses hearts undergoing ischemia showed aminooxyacetic acid limit lactate production impair glutamate utilization prevent alanine production limit succinate accumulation p less data suggest amino acid transamination important adaptive process immature heart improves resistance ischemic damage,C14,0.002227487,0.012757348,0.00415626,0.0012515341,0.003101705,0.013656028,0.2133176,0.0020947556,0.001610374,0.0021886367,0.022927005,0.0045932294,0.21500158,0.018324655,0.023522275,0.0034686604,0.057753235,0.03761034,0.0025363215,0.092039146,0.2171374,0.0007908997,0.04793355
effects anxiety family members patients cardiac disease learning cardiopulmonary resuscitation effects anxiety learning cardiopulmonary resuscitation cpr family members patients cardiac disease examined family members hospitalized patients n family members nonhospitalized patients n control group n took one nine heart saver programs cpr taught performance evaluated subjects took state anxiety inventory three times immediately program immediately performance test months completion program family members hospitalized patients significantly higher program anxiety scores groups difference present immediately program months later family members hospitalized patients showed significant decline anxiety three testing times outcomes support benefit teaching cpr group,C14,0.003141752,0.0027868908,0.0058621834,0.0017652223,0.00437479,0.004054595,0.19545102,0.0029545417,0.002271347,0.003086956,0.047945872,0.07137584,0.085105166,0.007223858,0.0027627775,0.0048923614,0.22952111,0.0032354838,0.07695438,0.08448368,0.15640257,0.001115522,0.0032321187
studies salt intake hypertension epidemiology teach us suggested small changes population blood pressure major impact upon incidence cardiovascular disease caused blood pressure elevation early reports indicated close correlation intercultural differences salt intake blood pressure epidemiological associations translated population advice certain conditions met association validated scientifically persuasive evidence produced relationship causal reversible changes salt intake risk benefit analysis indicate net harm unlikely finally demonstrated population measures advocated produce adequate change dietary salt intake small individual effects upon blood pressure examined prevailing changes blood pressure cardiovascular mortality suggest data always fall short ideal therefore extrapolation always necessary nevertheless review present evidence indicates inadequacies available data basis population advice,C14,0.01300434,0.012756573,0.025658954,0.0012515255,0.003101981,0.024432838,0.23203923,0.0020947412,0.0016103628,0.012951216,0.010811327,0.0045935563,0.21692848,0.0053187804,0.012705267,0.0034686364,0.034480143,0.0022939264,0.0026252489,0.2259491,0.1488367,0.0007908942,0.002296168
regression intracardiac thrombus embolic stroke using two dimensional echocardiography studied pathophysiology intracardiac thrombus regression accompanied anticoagulant therapy consecutive patients acute cardiogenic cerebral embolism noted intracardiac thrombus patients nine started anticoagulant therapy warfarin potassium maintain prothrombin time international normalized ratio serial two dimensional echocardiograms obtained nine patients anticoagulation plasma levels fibrinopeptide fibrinopeptide b beta dimer measured time eight nine patients intracardiac thrombi gradually decreased size plasma level fibrinopeptide fell within normal range plasma levels fibrinopeptide b beta dimer remained normal ranges patient thrombus disappeared embolization right arm immediately starting anticoagulant therapy mobile small thrombi regressed earlier nonmobile large ones conclude regression intracardiac thrombi anticoagulation may based relative predominance plasma fibrinolytic activity anticoagulation inhibited thrombin activity,C14,0.014413274,0.0021893342,0.028479539,0.0013867287,0.003458571,0.015111216,0.16667764,0.014266285,0.025663063,0.0024250604,0.014513434,0.0050764247,0.06558752,0.019556535,0.014094877,0.039674457,0.2569637,0.0025436245,0.0028103031,0.015915483,0.24994224,0.0008763352,0.0383743
electrocardiographic signal averaging atrial pacing effect cycle length terminal qrs patients without inducible ventricular tachycardia electrocardiographic signal averaging sinus rhythm beats min atrial pacing beats min performed determine effect heart rate late potentials patients without group patients group inducible sustained ventricular tachycardia vt sinus rhythm vs beats min difference significant duration low amplitude signal less microv longer group group vs ms p patients late potentials vs p qrs duration vs ms terminal voltage vs ms significantly different atrial pacing group beats min patients developed simultaneous decrease terminal voltage increase terminal qrs duration consistent late potential mean total terminal durations unchanged terminal voltage increased significantly atrial pacing group beats min patients either late potential developed simultaneous decrease terminal voltage increase terminal qrs duration p vs group root mean square p vs group root mean square voltage decreased became significantly different group p mean qrs duration root mean square terminal voltage low amplitude terminal qrs duration however unchanged,C14,0.0023016701,0.0020416963,0.0042946776,0.0012932145,0.0032050028,0.0029704252,0.1327349,0.0021645185,0.001664005,0.002261526,0.04477452,0.10646493,0.25647905,0.006131807,0.0020240694,0.003584179,0.17539598,0.0023703387,0.00262079,0.01763852,0.112991735,0.0008172394,0.113775164
family doctors screen asymptomatic children high blood pressure whereas united states task forces blood pressure control children recommended annual blood pressure screening children working party british hypertension society formed opposite opinion relevant literature reviewed conclusion reached epidemiological ethical grounds screening children hypertension cannot present justified,C14,0.044351496,0.0036833202,0.0077478094,0.0023330224,0.005781982,0.025430745,0.13976331,0.0039048975,0.023097914,0.08448986,0.11808115,0.02912532,0.24919914,0.032827772,0.0036514506,0.006466035,0.035462566,0.004276207,0.044913083,0.07790884,0.05174943,0.0014743401,0.0042803288
pineal hyperactivity spontaneously hypertensive rats muscarinic regulation indole metabolism choline acetyltransferase activity h quinuclidinyl benzylate binding sites detected pineal gland normotensive wistar kyoto rats spontaneously hypertensive rats vitro muscarinic activation pilocarpine increased pineal metabolic production hydroxyindole derivatives hydroxytryptamine produced less marked stimulation melatonin biosynthesis electrical field stimulation pineal gland slices caused similar metabolic effects muscarinic blockade atropine inhibited effects hydroxyindole metabolism h quinuclidinyl benzylate binding sites indicative muscarinic receptors numerous basal hydroxytryptamine melatonin levels higher pineal gland spontaneously hypertensive rats compared wistar kyoto rats atropine sensitive metabolic effects pilocarpine electrical field stimulation pineal gland increased spontaneously hypertensive rats compared wistar kyoto rats,C14,0.0031416945,0.0027868398,0.043297417,0.0017651899,0.00437471,0.0040545203,0.07828198,0.086904734,0.0022713053,0.0030868994,0.026505288,0.006470399,0.04512901,0.024065237,0.0027627267,0.02009175,0.027370945,0.12121866,0.003646926,0.022121733,0.46628657,0.0011155015,0.0032500294
parental history independent risk factor coronary artery disease framingham study family history cad defined parental death cad found significant independent predictor cad logistic regression model controlling standard risk factors length follow among participants framingham study persons positive parental history increased risk cad strength association parental history cad similar found standard risk factors systolic blood pressure cholesterol level cigarette smoking evidence found persons family history cad decreased capacity cope deleterious effects known risk factors significant interaction found risk factors parental history cad among men low risk cad risk factor profile e nonsmoking thin nonhypertensive persons two thirds experience cad positive parental history study suggests cad among persons predicted low risk standard risk factors may substantial genetic component risk associated parental history may reduced modification factors nevertheless among persons positive family history favorable risk profile substantially less risk cad unfavorable risk profile,C14,0.0021355725,0.0018940015,0.02464996,0.0011996644,0.0029731554,0.002755547,0.17975679,0.002007939,0.0015436321,0.012424375,0.05102552,0.004418057,0.08865495,0.0059565348,0.07423416,0.013686222,0.041897204,0.00219887,0.002431204,0.3222528,0.15893996,0.00075812096,0.0022057279
myocardial amiodarone desethylamiodarone concentrations patients undergoing cardiac transplantation myocardial amiodarone desethylamiodarone concentrations measured multiple sites explanted heart four patients underwent cardiac transplantation patients taking amiodarone mg day mean days mean mean cumulative dose g plasma amiodarone concentration three subjects ng ml desethylamiodarone concentration ng ml respectively significant interindividual variability myocardial concentrations amiodarone desethylamiodarone observed p less mean myocardial amiodarone concentration ranged micrograms g p less mean desethylamiodarone concentration ranged micrograms g p less site save fat myocardial desethylamiodarone concentration higher amiodarone concentration greater intraindividual variability observed myocardial desethylamiodarone compared amiodarone concentration particularly septal scar tissue p ns significant relation found myocardial concentration duration treatment patients significant ventricular disease usefulness plasma amiodarone desethylamiodarone concentration estimate myocardial concentration limited intra interindividual variability,C14,0.0022034915,0.0019546067,0.0041114865,0.0012380519,0.003068292,0.0028437204,0.10950659,0.00207219,0.0015930262,0.0021650598,0.031282302,0.00453898,0.3040538,0.0051261624,0.0019376947,0.014076907,0.17410594,0.002286388,0.002508999,0.024437752,0.3018393,0.00078237976,0.0022668708
maximal oxygen uptake severe aortic regurgitation different view left ventricular function respiratory gas exchange used assess left ventricular lv function patients severe aortic regurgitation men three women aged years mean years anaerobic threshold symptom limited maximal oxygen consumption vo max measured treadmill exercise results compared conventional echocardiographic radionuclide indices lv systolic function results considered respect patients new york heart association functional class rest exercise lv ejection fractions variable mean results similar classes echocardiographic indices lv cavity dimensions fractional shortening radius thickness ratio systolic wall stress also showed wide range similar mean results class contrast vo max anaerobic threshold showed relationship functional class vo max ml kg min age matched control subjects patients class class ii combined class iii iv results patients classes ii similar groups significantly different control subjects p less patients class iii iv p less half patients moderate lv dysfunction judged reduced vo max asymptomatic lv function impaired patients class thus unlike conventional indices lv function vo max appeared capable distinguishing patients moderate severe lv dysfunction little lv dysfunction measurement respiratory gas exchange appears valid useful supplementary means assessing lv function severe aortic regurgitation long term evaluation required,C14,0.0016087919,0.016956743,0.0029943588,0.0009016621,0.010001921,0.03313998,0.1237057,0.011085319,0.016694771,0.020933094,0.043546136,0.015705243,0.29028177,0.0038868673,0.0633723,0.018104317,0.13072339,0.0016554042,0.0018272816,0.0689387,0.106179595,0.016105743,0.0016509417
value carvedilol congestive heart failure secondary coronary artery disease despite considerable interest use beta blocking agents congestive heart failure chf clinical application limited negative inotropic effects beta blockers vasodilating properties may advantage overcoming however carvedilol beta blocking agent vasodilating properties evaluated patients chronic chf secondary ischemic heart disease resting left ventricular ejection fraction less equal maintained diuretics exercise testing radionuclide ventriculography right sided cardiac catheterization performed intraarterial blood pressure measured weeks carvedilol therapy dosage mg twice day twelve patients completed study withdrew symptomatic hemodynamic improvement demonstrated patients heart rate intraarterial blood pressure reduced chronic therapy mean standard deviation exercise time improved minutes p less resting left ventricular ejection fraction p less pulmonary arterial wedge pressure fell mm hg mm hg p less total systemic vascular resistance dynes cm p less stroke volume index improved also ml ml p less hemodynamic changes mediated partly vasodilation diminished myocardial oxygen demand reduction sympathetic overactivity failing heart data suggest carvedilol may beneficial effects patients chronic chf secondary coronary artery disease,C14,0.013628769,0.053421766,0.020344729,0.001002901,0.002485718,0.002317395,0.17268303,0.001678606,0.0012904528,0.010382634,0.034132656,0.003671339,0.28241524,0.0047421437,0.0015696773,0.020050162,0.16013971,0.0018937482,0.010655003,0.013354914,0.15110843,0.017914383,0.019116621
electroencephalography laboratory diagnosis prolonged qt interval patients prolongation qt interval risk significant neurological morbidity mortality secondary ventricular tachyarrhythmias patients frequently undergo electroencephalographic eeg examination evaluate episodes loss consciousness may associated convulsions electrocardiogram recording part eeg simple common practice analysis possible qt prolongation routinely performed electroencephalographers part due fact calculation corrected qt interval straight forward calculator generally required nomogram presented simplifies determination corrected qt interval facilitating diagnosis prolongation qt interval eeg laboratory,C14,0.0033514244,0.0029702317,0.006247838,0.01808604,0.004662594,0.004321334,0.2686724,0.0031489118,0.0024207716,0.0032900372,0.09150052,0.0068870974,0.023320667,0.0076990933,0.002944532,0.02142082,0.34427625,0.0034483362,0.02001957,0.110958874,0.04571054,0.0011889087,0.00345318
transient left ventricular filling abnormalities diastolic stunning acute myocardial infarction variety experimental studies suggest diastolic left ventricular lv function changes acute myocardial infarction ami limited data exist changes humans assess diastolic filling ami patients underwent doppler echocardiographic examination within hours ami patients also underwent catheterization successfully reperfused subgroup patients underwent follow doppler examination days infarction whereas patients stable exertional angina served control subjects significant difference age gender incidence systemic hypertension diabetes mellitus heart rate mean arterial pressure severity coronary artery disease infarct control groups infarct group lower velocity time integral total cm vs cm p less lower velocity time integral e cm vs cm p less lower velocity time integral cm vs cm p less control group addition velocity time integral total significantly greater infarction group vs p less compared control group follow subgroup showed increase velocity time integral total p less velocity time integral e p less velocity time integral total p less first days infarction final recovery values days significantly different coronary artery disease group,C14,0.030561062,0.0013804389,0.002903733,0.00087437284,0.0021669779,0.009531358,0.12103906,0.0014634819,0.01617185,0.0015290711,0.033187777,0.062072538,0.37506709,0.003954588,0.0013685448,0.002423348,0.13898854,0.0016026418,0.0017719779,0.031907316,0.1428039,0.015618221,0.0016121273
apical hypertrophic cardiomyopathy non oriental man japanese investigators first described apical hcm patients diagnostic left ventricular catheterization suspected ischemic heart disease cardiomyopathy entity initially thought limited individuals asian origin uncommonly described patients western origin patients western origin differ several ways original description yamaguchi et al share classic criterion hypertrophy left ventricular apex major differences probably relate anatomic variation distribution left ventricular hypertrophy described maron et al known whether racial genetic environmental factors account variation disease expression asian western patients case illustrates diagnosis considered patients chest pain anginal atypical markedly abnormal findings electrocardiograms absence hypertension significant coronary artery disease,C14,0.017296595,0.0026276922,0.0055273115,0.0016643855,0.004124884,0.01815222,0.2365133,0.002785766,0.0021415981,0.0029106163,0.07514825,0.0061414447,0.06556764,0.0071795043,0.0026049563,0.0046698614,0.20819439,0.0030506596,0.003372994,0.15610203,0.108841,0.044073295,0.021309597
role beta blockade therapy ventricular tachycardia induced isoproterenol prospective analysis isoproterenol sometimes required ventricular tachycardia vt induction however role beta blockade treatment vt critically assessed use beta blockade evaluated prospectively consecutive patients required isoproterenol micrograms min induce sustained monomorphic vt greater seconds requiring termination due hemodynamic collapse negative baseline study vt mechanisms enhanced automaticity group six patients triggered automaticity group b three patients reentry group c five patients groups b serial intravenous electropharmacologic tests propranolol alone mg kg verapamil alone mg kg propranolol plus verapamil group c serial tests propranolol alone procainamide quinidine class ia drug alone propranolol plus class ia drug vt could longer induced six patients group responded propranolol alone group b one patient responded verapamil alone two patients responded propranolol plus verapamil group c three patients responded propranolol alone one patient responded class ia drug alone one patient responded propranolol plus class ia drug follow months vt recurred patient three patients treated initially propranolol alone required substitution amiodarone due refractory congestive heart failure patients requiring isoproterenol vt induction beta blockade alone appears effective preventing reinduction vt caused enhanced automaticity heterogeneous response occurs vt mechanisms triggered automaticity reentry,C14,0.018702103,0.02635754,0.0031926562,0.00096137356,0.0023825937,0.010449239,0.38536406,0.0016090994,0.0012370186,0.0016812148,0.038980864,0.07809668,0.030975403,0.004005992,0.034634903,0.020060444,0.2051423,0.0017621059,0.001948291,0.02054785,0.10950342,0.0006075344,0.0017973094
dietary ca prevents nacl sensitive hypertension spontaneously hypertensive rats sympatholytic mechanism current study tested hypothesis dietary ca supplementation reverses nacl sensitive component hypertension associated neurochemical abnormalities nacl sensitive spontaneously hypertensive rat shr male shr begun one four diets weeks age control nacl ca high nacl nacl ca high ca nacl ca high nacl high ca nacl ca high nacl shr x weeks higher mean arterial pressure map mm hg controls mm hg p less supplementation ca prevented rise map high nacl rats alter map controls nacl diet elevated plasma norepinephrine reduced anterior hypothalamic aha norepinephrine stores turnover concomitant ca supplementation restored plasma norepinephrine aha norepinephrine turnover normal clonidine microinjected aha rats maintained four diets weeks test hypothesis dietary ca supplementation prevents previously observed nacl induced upregulation alpha adrenoceptors aha clonidine caused dose dependent decreases map greater high nacl rats controls ca supplementation prevented exaggerated depressor response clonidine high nacl group controls ca supplementation effect pretreatment map map responses clonidine control nacl resistant shr shr r wistar kyoto wky rats thus dietary ca supplementation prevents nacl induced exacerbation hypertension augmented depressor response clonidine shr increasing noradrenergic input aha thereby preventing upregulation aha alpha adrenoceptors,C14,0.029126823,0.04589784,0.029992139,0.0008615125,0.0021351057,0.001978835,0.12004599,0.0014419568,0.0011085253,0.0015065813,0.014080659,0.018966435,0.09433831,0.116013885,0.0013483668,0.024630807,0.013714306,0.0015793017,0.0017459155,0.098977074,0.31140232,0.0005444278,0.06856286
prostaglandins kidney hypertension prostaglandins part family oxygenated metabolites arachidonic acid known collectively eicosanoids formed act inactivated locally rarely circulate plasma affect blood flow tissues might contribute control peripheral vascular resistance studies shown derangement total body prostaglandin synthesis metabolism hypertension increased renal synthesis one prostanoid thromboxane noted spontaneously hypertensive rats hypertensive humans potent vasoconstrictor may account increased renal vascular resistance suppressed plasma renin activity seen many patients hypertension increased renal vascular resistance could increase blood pressure directly component total peripheral resistance indirectly increasing glomerular filtration fraction tubular sodium reabsorption specific thromboxane synthesis inhibitors decrease renal thromboxane production also increase renal vasodilator prostaglandin synthesis prostaglandin synthesis stimulated redirection renal prostaglandin synthesis toward prostacyclin might benefit correcting fundamental renal defect patients hypertension,C14,0.100343086,0.0018014243,0.033115216,0.0011410258,0.010912497,0.012449999,0.19198234,0.0019097925,0.0014681808,0.011813419,0.009451964,0.01406707,0.07543773,0.040193383,0.011680731,0.003162384,0.042673033,0.085793376,0.002312369,0.014415222,0.33105573,0.0007210646,0.0020989673
design mediated thrombus reduction utah total artificial heart utah total artificial heart initially designed tested general design goals including improved fit human application improved reliability elimination thrombus formation identified improvements clinically used jarvik artificial heart previously developed institute biomedical engineering university utah specific design goals included elimination connector valve associated thrombus formation elimination gross mineralization thrombus formation creases blood pumping diaphragm device explant retrieval results calves sheep implanted jarvik artificial heart compared results calves sheep implanted utah artificial heart macroscopic thrombus formation found connectors jarvik artificial hearts compared p less equal animals utah artificial heart subvalvular supravalvular thrombi observed valves jarvik artificial heart p less equal valves utah artificial heart mineralization pumping diaphragm observed animals implanted jarvik artificial heart animals utah diaphragms thrombus formation diaphragm housing interface occurred jarvik ventricles utah ventricles identifiable diaphragm creases utah diaphragms incidence found jarvik devices results validate substantial progress toward improved design fabrication methods utah total artificial heart,C14,0.0020308164,0.021461187,0.058259413,0.04045147,0.0028278474,0.06605553,0.12368715,0.0019098043,0.040768757,0.0019953963,0.07173948,0.046303038,0.11146887,0.054133493,0.011617137,0.012989465,0.14854856,0.0021232087,0.0023123831,0.039748292,0.13675006,0.0007210691,0.0020975939
comparison medical surgical therapy uncomplicated descending aortic dissection guide choice medical versus surgical therapy patients descending type b aortic dissection tear descending aorta without involvement ascending aorta multivariate survival analysis applied patients admitted two medical centers acute n chronic n descending dissection group patients group patients without rupture pulse loss visceral organ compromise group patients group without major cardiac renal disease surgical medical group medical surgical subgroups well matched baseline characteristics potential candidates either mode therapy cox model analysis significant predictors mortality pleural rupture dissection complications increasing age cardiac disease p less surgical versus medical therapy independent determinant survival three groups acute chronic dissection survival probabilities group patients years medical surgical despite limitations retrospective study including possibility undefined treatment selection biases data suggest medical early surgical therapy associated equivalent outcome selected patients uncomplicated acute chronic descending aortic dissection,C14,0.001899838,0.001685251,0.0036244348,0.0010674729,0.0026454641,0.0024518399,0.2866249,0.029369993,0.01046763,0.0018667023,0.019759964,0.08416451,0.034000177,0.004412276,0.001673664,0.0029604996,0.23409928,0.001956518,0.0021632449,0.17253482,0.0880694,0.0006745634,0.011827568
balloon dilatation mitral valve single bifoil x mm trefoil x mm catheter efficacy balloon dilatation mitral valve bifoil x mm trefoil x mm catheter single catheter technique assessed patients mean age mitral stenosis women procedure unsuccessful three patients balloon dilatation left atrial pressure decreased mm hg mm hg mitral valve gradient mm hg mm hg mitral valve area increased cm cm exercise time standard bruce protocol increased minutes minutes patients mitral regurgitation developed grade regurgitation increased left right shunts pulmonary systemic flow ratios greater detected four patients transient cerebrovascular episodes developed two patients one patient died emergency valve replacement severe mitral regurgitation balloon dilatation mitral valve single catheter technique bifoil trefoil catheters effective treatment patients mitral stenosis mild mitral regurgitation frequent complication procedure,C14,0.07129264,0.014127376,0.016541922,0.0013859281,0.0034347768,0.004715586,0.10455684,0.038143042,0.0017833015,0.0024236601,0.14324829,0.016978007,0.16114822,0.0056831483,0.002169138,0.0038411373,0.25049803,0.0025402738,0.0028086805,0.052998684,0.09625908,0.00087582925,0.002546395
role echocardiography acute myocardial infarction interventional therapies thrombolytic agents angioplasty surgery emerged important options management patients myocardial infarction therapies aimed improving myocardial perfusion ultimate improvement restoration myocardial function two dimensional echocardiography digital storage display ideal technique temporally monitoring regional ventricular function effectiveness interventional therapy design dimensional echocardiography noninvasive performed conveniently bedside reasons echocardiography principal imaging technique indiana university hospital patients acute myocardial infarction computer retrieval echocardiograms achieved seconds nurses station coronary care unit availability examination physician better understanding site size function infarct area state noninfarcted myocardium also assessed may critical patient prognosis digital recordings serial studies displayed side side making easier physician follow natural history judge effect therapy echocardiography also useful identifying many complications occur myocardial infarction reasons echocardiography also show related cardiac problems indispensable management acute myocardial infarction,C14,0.012868708,0.0446256,0.025777811,0.0012384821,0.014443054,0.0028541016,0.3790323,0.0020729098,0.012242429,0.0021658118,0.064350605,0.015182396,0.029049959,0.015777813,0.001938368,0.0034324864,0.20333366,0.002272865,0.01309626,0.029308569,0.12188546,0.00078265154,0.0022676582
evidence decreased coronary flow reserve viable postischemic myocardium try unravel complexity heterogeneity reflow phenomenon underlying mechanisms studied tissue perfusion reperfused heart muscle using tracer microspheres anesthetized dog model minute coronary occlusion followed reperfusion hours hours week regional myocardial blood flow determined basal flow conditions reactive hyperemia effect intracoronary adenosine administration examined ultrastructure postischemic myocardium analyzed viable reperfused tissue delineated triphenyltetrazolium chloride staining reflow basal conditions unimpaired coronary flow reserve approximated peak reactive hyperemic flow intact start reperfusion decreases half hours recovers completely within week impairment coronary reserve relieved intracoronary adenosine administration ultrastructural examination capillaries patent hand irreversibly damaged myocardium basal reflow impairment decrease coronary flow reserve severe permanent coronary flow reserve already decreased start reperfusion pharmacological intervention beneficial effect ultrastructurally extracellular intracellular edema invariably present whereas vascular endothelium damaged capillaries packed red blood cells conclude reflow phenomenon e mechanical obstruction blood flow limited infarcted tissue viable myocardium however coronary flow reserve transiently diminished probably washout subsequent insufficient availability chemical mediator adenosine breakdown slow recovery precursor atp pool,C14,0.026891977,0.0016405914,0.02274449,0.001039154,0.011512845,0.008106202,0.15761934,0.0017504502,0.01923684,0.0018172342,0.018255487,0.003804051,0.19554827,0.026034664,0.010518247,0.011679712,0.043139007,0.0019501052,0.0021059185,0.023616303,0.372617,0.036464036,0.0019080321
two way factorial study alcohol salt restriction treated hypertensive men aim study determine whether moderate restriction dietary salt intake leads additional fall blood pressure treated hypertensive men asked simultaneously reduce usual alcohol intake sixty three subjects entered initial week familiarization period continued usual alcohol intake commenced low sodium diet less mmol day supplemented mmol sodium chloride per day enteric coated tablets subjects randomly assigned either drink low alcohol beer alone week period reducing self reported alcohol consumption ml week continue usual alcohol intake versus ml week within low normal alcohol intake groups subjects assigned either low normal sodium intake low sodium groups continued sodium restricted diet switched placebo sodium chloride tablets weeks resulted fall hour urinary sodium excretion mmol day normal sodium groups continued low sodium diet kept taking mmol day sodium chloride tablets urinary sodium excretion remained unchanged versus mmol day regular antihypertensive therapy continued throughout fifty nine subjects completed trial reduced alcohol intake fall systolic blood pressure mm hg supine p less diastolic blood pressure mm hg supine p less,C14,0.008496854,0.009401884,0.042792235,0.0009231104,0.0022877653,0.0021203214,0.24588901,0.0015450565,0.0011877846,0.0016143016,0.0076814373,0.035182,0.22299387,0.003814889,0.0014447748,0.0025707432,0.06032877,0.0016927572,0.01777707,0.12243428,0.2055475,0.00058335427,0.0016902135
antihypertensive efficacy hydrochlorothiazide prostacyclin dependent tested hypothesis vascular prostacyclin synthesis stimulated hydrochlorothiazide could account drug antihypertensive effect studied patients mild essential hypertension randomized double blind design assess effects indomethacin hydrochlorothiazide ability lower blood pressure alter body weight stimulate plasma renin activity modulate vascular prostacyclin biosynthesis assessed urinary excretion major enzymatically produced metabolite prostacyclin dinor keto prostaglandin f alpha pgf alpha measured gc ms administration hydrochlorothiazide mg daily weeks associated significant decrease systolic diastolic blood pressure supine systolic mm hg diastolic mm hg upright systolic mm hg diastolic mm hg positions hydrochlorothiazide administration resulted kg weight loss stimulation plasma renin activity ng angiotensin ml hr however urinary excretion dinor keto pgf alpha unchanged administration hydrochlorothiazide ng gm creatinine placebo ng gm week hydrochlorothiazide ng gm week drug administration indomethacin mg twice day resulted greater inhibition dinor keto pgf alpha excretion affect antihypertensive response hydrochlorothiazide indomethacin oppose diuretic effect hydrochlorothiazide assessed weight loss attenuate rise plasma renin activity data demonstrate blood pressure lowering effect thiazide diuretic require enhanced prostacyclin synthesis cyclooxygenase inhibitor indomethacin antagonize antihypertensive efficacy hydrochlorothiazide,C14,0.024583973,0.0016110379,0.04730241,0.009803778,0.011318757,0.0023469115,0.124020204,0.0017256266,0.0013130137,0.0017844987,0.008398534,0.0037422979,0.13913836,0.0044159624,0.0015970985,0.0028281622,0.03205697,0.020148885,0.0372295,0.021476189,0.4918548,0.00064485776,0.010658173
critical care transportation medicine new concepts pretransport stabilization critically ill patient regionalization health care trauma become commonplace concept critically ill medical surgical patients developing recent evidence suggests current stabilization measures used transport teams inadequate critically ill patient population trauma speed considered necessity get patient facility cannot carried field eg operating room acute medical illnesses critical care transport teams bring intensive care technology patient accumulating evidence supports premise speed transport important stabilization transport knowledge hemodynamics transport early use critical care monitoring systems reports identify need initial evaluation stabilization critically ill patients physicians critical care level expertise accordingly critical care transportation teams evolved creating new notions pretransport stabilization applicable previous transport systems,C14,0.0027274627,0.015608574,0.0050891624,0.00153245,0.017000439,0.029915126,0.34563187,0.002564939,0.001971834,0.042252406,0.01461607,0.0056098695,0.05563023,0.006271279,0.0816196,0.017448336,0.13244365,0.0028088342,0.025305524,0.1216833,0.06849471,0.00096842286,0.0028059129
plasma dehydroepiandrosterone dehydroepiandrosterone sulfate patients undergoing diagnostic coronary angiography corrected republished original paging article originally printed j coll cardiol oct serum levels dhea sulfate inversely associated cardiovascular death men urinary dehydroepiandrosterone dhea levels inversely associated clinical manifestations coronary artery disease observations may related antiproliferative effects dhea resulting inhibition atherosclerotic intimal hyperplasia examine relation steroids direct measure coronary atherosclerosis plasma dhea dhea sulfate levels determined middle aged patients men women undergoing elective coronary angiography plasma dhea sulfate levels lower men least one stenosis greater equal compared without stenosis greater equal versus nmol ml p levels dhea sulfate also inversely related number diseased coronary vessels r p continuous measure extent coronary atherosclerosis r p men association dhea sulfate levels extent coronary artery disease independent age conventional risk factors coronary disease women association plasma dhea dhea sulfate levels coronary disease data demonstrate consistent independent inverse dose response relation plasma dhea sulfate levels angiographically defined coronary atherosclerosis men plasma dhea sulfate may another important potentially modifiable risk factor development progression coronary atherosclerosis,C14,0.0018006823,0.0015972949,0.012470432,0.0010117299,0.0025075402,0.0023238743,0.17777438,0.046837635,0.001301813,0.001769276,0.044057935,0.003704062,0.04575004,0.0043679927,0.0015834745,0.037930086,0.105805404,0.011165491,0.0020503416,0.21742748,0.25683808,0.018072432,0.0018524755
distribution angiographic vasospasm subarachnoid hemorrhage implications diagnosis transcranial doppler ultrasonography study undertaken determine frequently angiographic vasospasm occurs outside normal access range transcranial doppler ultrasound patients suffered subarachnoid hemorrhage vasospasm located basal vessels readily identifiable using transcranial doppler ultrasound whereas spasm affecting distal vertically oriented arteries outside standard detection range therefore speculated sensitivity technique would adversely affected high incidence distal vasospasm total angiograms performed patients subarachnoid hemorrhage anterior circulation aneurysms reviewed determine typical distribution vasospasm cases showed greater equal vessel narrowing spasm restricted basal vessels spasm involving basal distal segments spasm distal segments none patients distal vasospasm alone developed delayed ischemic deficits concluded patients anterior circulation aneurysms develop vasospasm involvement basal vessels small number patients may develop vasospasm distal vessels,C14,0.011860608,0.0018015328,0.023437027,0.0011410946,0.002828001,0.002621016,0.1596415,0.014123835,0.11925571,0.01182406,0.09318176,0.004177227,0.07232672,0.004879385,0.0017859945,0.012990708,0.15558393,0.0020921838,0.0023125082,0.05452022,0.22516324,0.010550655,0.011901111
baroreflex control renal sympathetic nerve activity potentiated early phase two kidney one clip goldblatt hypertension conscious rabbits conscious normotensive two kidney one clip goldblatt hypertensive rabbits studied determine sensitivity arterial baroreflex control renal sympathetic nerve activity rsna heart rate relations mean arterial pressure rsna mean arterial pressure heart rate examined wide range blood pressures produced infusions phenylephrine nitroglycerin maximum slope obtained logistic function analysis considered represent baroreflex sensitivity early hypertensive group n mean arterial pressure sem mm hg day renal clip application maximum slope mean arterial pressure rsna relation significantly greater sham normotensive group p less maximum slope mean arterial pressure rsna relation late hypertensive group n mean arterial pressure mm hg day renal clipping significantly smaller another sham group p less contrast changes baroreflex control rsna control heart rate attenuated according magnitude mean arterial pressure elucidate mechanisms underlying potentiated baroreflex effects endogenous neuropeptides investigated first plasma concentrations angiotensin ii arginine vasopressin known affect baroreflex determined plasma concentrations vasopressin pg ml well angiotensin ii pg ml increased early hypertensive group plasma vasopressin returned similar level sham group late hypertensive group pg ml second study endogenous effects neuropeptides baroreflex maximum slopes baroreflex curves infusions antagonists peptides determined early hypertensive group maximum slope mean arterial pressure rsna intravertebral arterial sar ala angiotensin ii significantly greater p less whereas maximum slope intravertebral arterial infusion ch tyr arginine vasopressin significantly smaller p less vehicle infusion abstract truncated words,C14,0.08910693,0.0012320139,0.009311805,0.00078036013,0.001933984,0.0017924337,0.11143686,0.0013061281,0.001004105,0.0013646651,0.007197898,0.07283514,0.34035817,0.010751498,0.001221354,0.02918799,0.051674936,0.0014303254,0.0015814545,0.03733128,0.22523236,0.00049314403,0.001435147
calcium regulating hormones essential hypertension importance gender alterations calcium metabolism described human essential hypertension experimental hypertension investigated interrelationship parathyroid hormone pth oh vitamin oh patients untreated essential hypertension compared normotensive controls hypertensive subjects n men women mean blood pressure mm hg compared normotensive group n men women serum pth measured intact molecule immunochemiluminometric assay oh measured radioimmunoassay hplc separation hypertensive men pth levels higher normotensive men v pmol l p blood pressure analyzed continuous variable direct correlation serum pth men r p women contrast difference serum pth hypertensive normotensive subjects relationship blood pressure serum pth concentration blood pressure inversely correlated serum phosphorus levels sexes r p men elevated serum pth levels depressed serum phosphorus levels would predicted serum oh would higher hypertensive subjects however observed serum oh slightly lower hypertensive pg ml normotensive men p,C14,0.022650607,0.0018793653,0.016645467,0.0011903938,0.0029501799,0.012967005,0.08921549,0.0019924222,0.0015317035,0.002081717,0.026941556,0.014853383,0.21285333,0.063559026,0.012115137,0.022164932,0.05141407,0.002217062,0.0024124165,0.18318899,0.25223365,0.0007522625,0.0021898649
effects thoracic epidural anesthesia coronary arteries arterioles patients coronary artery disease effect cardiac sympathetic blockade high thoracic epidural anesthesia tea bupivacaine luminal diameter normal diseased portions epicardial coronary arteries determined quantitative coronary angiography patients n severe coronary artery disease cad separate group patients n severe cad effects tea coronary arterioles resistance vessels studied measuring total regional myocardial blood flow metabolism retrograde coronary sinus thermodilution technique stenotic segments tea induced increase luminal diameter mm p less change diameter nonstenotic segments mm second group patients tea induced changes coronary perfusion pressure total regional myocardial blood flow coronary venous oxygen content coronary blood flow distribution regional myocardial oxygen consumption lactate extraction uptake two patients chest pain control situation regional myocardial lactate production attenuated tea conclude tea may increase diameter stenotic epicardial coronary artery segments patients cad without causing dilation coronary arterioles effects may beneficial high tea used treat severe ischemic chest pain patients rest,C14,0.022379568,0.0017333316,0.0036460373,0.010544698,0.0027209406,0.038852535,0.09378761,0.011583599,0.020325221,0.0019199598,0.022214796,0.02312146,0.21273816,0.0045288177,0.001718388,0.021955818,0.21937382,0.013381875,0.0022249627,0.014623426,0.2539209,0.00069380883,0.002010245
surgical treatment endomyocardial fibrosis new approach endomyocardial fibrosis treated surgically many years complete removal fibrosis ventricles classic technique atrioventricular av valve removed replaced prosthesis relapse endomyocardial fibrosis observed surgical correction reoperations carried complications valve prostheses new surgical technique removal ventricular fibrous tissue preservation mitral tricuspid valves used nine consecutive patients endomyocardial fibrosis initial results show reduction pulmonary hypertension mean right left atrial pressures end diastolic pressures ventricles tricuspid annuloplasty performed seven patients mitral annuloplasty five valve prosthesis used death new york heart association functional class improved class iii iv preoperative period class ii postoperative period data suggest resection endocardial fibrous tissue indicated early clinical course performed preservation av valves,C14,0.028354438,0.0021921617,0.004611179,0.0013885197,0.0034411994,0.0032004644,0.16390175,0.026245477,0.001786636,0.0024281922,0.017056655,0.0050829807,0.06235748,0.0058838422,0.014121119,0.0038483196,0.4517401,0.0025450238,0.0028139325,0.051565632,0.13169126,0.0008774669,0.012866143
technetium sestamibi chronic coronary artery disease european experience since introduction technetium methoxy isobutyl isonitrile tc sestamibi europe growing interest use several european multicenter trials conducted evaluate new agent relation traditional perfusion marker thallium studies progress understand use perfusion marker diagnosis coronary disease use conjunction pharmacologic vasodilation use assessment ventricular function wall motion assessment interventions,C14,0.0047221184,0.0041887546,0.008810983,0.0026531657,0.0065754,0.0060941395,0.4095726,0.027268918,0.0034138814,0.0046397587,0.050471574,0.009712495,0.08550857,0.033692,0.0041525117,0.030192673,0.13010168,0.004862999,0.028236069,0.049106456,0.08948866,0.0016766526,0.004857941
buerger colour cyanosis hands feet buerger disease known buerger colour characteristic skin colour produced subpapillary venous plexus reactions subpapillary venous plexus patients buerger disease observed analysing fractional blood volume tissue using visible light reflective spectrophotometer capillary morphology investigated using intravital video microscopic system twenty seven subjects comprising normals patients buerger disease studied nailbeds patients buerger disease increase number loops cyanotic colour change dilatation observed condition incompetence venular tonus regurgitation venular valves buerger colour probably due excessive congestion venous blood subpapillary venous plexus produced mechanisms,C14,0.0033486502,0.0029679094,0.0062429532,0.0018798799,0.020855376,0.004317955,0.26359254,0.08412571,0.002418879,0.0032874648,0.017050771,0.0068817125,0.106491536,0.008349707,0.0029422299,0.005210138,0.12191203,0.0034471639,0.0038097084,0.04931248,0.24414866,0.017370902,0.020035615
differential light scattering cuvettes measurement thromboemboli high shear blood flow systems newly developed optical scattering cuvettes constructed modification existing mm mm internal diameter id cuvettes facilitate measurement platelet microemboli ranging microns microns diameter whole blood mm id flows ranging ml min perturbation solution one speed radiative transport equation used design calibration cuvettes series tests performed cuvettes extracorporeal left ventricular assist device bovine model recirculating closed loop flow system containing anticoagulated whole baboon blood determine extent affect platelet erythrocyte function ex vivo vitro serial hemolysis tests thromboxane radioimmunoassay measurements platelet counts activated partial thromboplastin times measured tests cuvettes extracorporeal vitro circuits statistically indistinguishable baseline measurements suggesting usefulness system measurement microemboli blood contacting materials extracorporeal circuits cardiac assist devices,C14,0.002496722,0.014297666,0.040883165,0.0014028063,0.0034766062,0.0032292341,0.17260507,0.002356974,0.0018050189,0.0024531758,0.057892166,0.01721441,0.26233318,0.006016048,0.014275803,0.028242623,0.11164162,0.014650743,0.0028428852,0.042416833,0.16545512,0.01297069,0.019041445
probe angioplasty total coronary occlusion using probing catheter technique coronary angioplasty ptca total coronary occlusion limited inability guidewires conventional dilating catheters cross lesions new technique therefore prospectively evaluated ptca lesions using ultra low profile probe balloon wire device intracoronary probing catheter used facilitate crossing stenosis guidewire deliver probe obstruction balloon dilatation technique utilized consecutive patients absolute coronary occlusions demonstrating angiographically detectable antegrade coronary flow successful dilatation achieved among occlusions less mo duration successfully dilated whereas chronic occlusions dilated p less chronic occlusions tapered morphology located cm branch point frequently dilatable serious complications including vessel perforations technique probing catheter technique offers safe effective method dilatation recent coronary occlusions using balloon wire technology,C14,0.09052779,0.0240773,0.0042519476,0.0012806396,0.025256338,0.013961978,0.23266827,0.0021486608,0.001647449,0.002239025,0.19319727,0.01663904,0.08416469,0.005239595,0.0020040777,0.025606753,0.14631894,0.0023499134,0.0025947143,0.017058315,0.07917353,0.00080910826,0.026784686
long term impact smoking cessation incidence coronary heart disease using simulation model us male population estimated long term impact future smoking cessation programs would distribution occurrence coronary heart disease males ages interventions reduce number smokers percent number men free coronary heart disease projected increase percent age standardized absolute incidence decline percent incidence rates absolute incidences projected fall men age absolute incidence would rise men age large part increased number men risk coronary heart disease reduction non coronary smoking related mortality trends marked greater smoking reductions generally unaffected variety analyses using alternative assumptions considered smoking risk factor elderly lag time benefits smoking cessation realized secular declines smoking prevalence subject assumptions model conclude smoking reductions markedly reduce coronary heart disease especially younger age groups benefit slightly offset small increase absolute incidence elderly men,C14,0.0017114927,0.0015177412,0.003192546,0.0009613404,0.0023831083,0.002208133,0.1323201,0.0016090439,0.0012369759,0.0016811567,0.018724771,0.011802246,0.06195248,0.022127053,0.009756465,0.0026706522,0.08709105,0.001762045,0.018771231,0.44171447,0.17243561,0.0006075135,0.0017627865
medical management chronic heart failure inotropic vasodilator inodilator drugs basis pathophysiologic mechanisms medical therapy today chronic heart failure reviewed advantages disadvantages vasodilator drugs inotropic drugs presented finally therapeutic value inodilator drugs combine central myocardial effects positive inotropic agents peripheral vasodilators discussed particular orally available dopaminergic agents ibopamine interact beta receptors heart mediating positive inotropic effect well dopaminergic receptors peripheral vessels mediating systemic vasodilator effect kidneys potentiating natriuretic effect diuresis seem advancement modern medical therapy chronic heart failure data shown long term treatment ibopamine sustained clinical benefit heart failure diminished despite decrease adrenergic receptors blood cells dopamine plasma concentration permanently normalized long term treatment discrepancy clinical improvement measured adrenergic downregulation may due interference inodilator neurohormonal systems multiple sites probably independent receptor activation suggested biosynthesis noradrenaline improved increasing intracellular dopamine transport,C14,0.0021588763,0.022796998,0.024889477,0.001212252,0.0030043514,0.0027844599,0.41852707,0.002033036,0.0015598289,0.0021199416,0.01777386,0.0044377143,0.10344711,0.030284308,0.022774689,0.0033675751,0.025845747,0.0608879,0.0024567137,0.049955204,0.18425491,0.0007660756,0.012661887
exercise test predictors ambulatory silent ischemia daily life stable angina pectoris predictive value several exercise test parameters identifying stable angina patients risk silent myocardial ischemia daily life examined total patients coronary artery disease stable angina ambulatory electrocardiographic data evaluated patients positive exercise test group greater equal episodes st segment depression group develop st changes ambulatory electrocardiographic monitoring comparison exercise test parameters groups revealed early onset ischemia exercise tests single significant p less predictor ambulatory silent ischemia exercise test parameters showing significant differences groups peak exercise heart rate vs beats min p less peak systolic blood pressure vs mm hg p less significantly lower group patients data used derive simple mathematical formulas calculating risk ambulatory silent ischemia results demonstrate stable angina patients risk silent ischemia daily life accurately identified evaluation selected exercise test parameters,C14,0.0020395552,0.078128375,0.00370058,0.0011080565,0.012784353,0.012902363,0.13065386,0.0018564925,0.0014257585,0.011482373,0.15069848,0.05247065,0.15787232,0.0045437035,0.0017342682,0.0030710085,0.09696073,0.0020639398,0.0022455542,0.15302506,0.106947914,0.010245102,0.0020394851
doppler diagnostics indications control surgical treatment patients carotid pathology major stroke relatively common cause death disabling invalidism patients atherosclerosis large percentage cases caused stenotic thrombotic processes carotid arteries emphasizes importance problem early diagnosis treatment carotid pathology recently doppler sonography become leading non invasive method early screening stenotic processes carotid arteries aim present study ascertain diagnostic abilities doppler sonography screening carotid pathology assessment extra cranial intracranial hemodynamics defining indications control vascular reconstructions carotids,C14,0.033562437,0.0027871155,0.005862656,0.0017653647,0.0043760226,0.0040549217,0.3010097,0.02661128,0.017457455,0.018294057,0.25783458,0.006662716,0.053444218,0.024637759,0.017969316,0.0048927558,0.10408769,0.0032357448,0.0035776354,0.02968594,0.0738426,0.001115612,0.0032323794
positron emission tomography interventional cardiology current noninvasive diagnostic techniques limited accuracy detection coronary artery disease cad symptomatic particularly asymptomatic patients silent disease furthermore standard noninvasive method provides reliable diagnostic information location coronary arteries involved severity stenosis presence collaterals myocardial viability based greater cardiac studies university texas cardiac positron emission tomography pet either generator produced rubidium cyclotron produced n ammonia f deoxyglucose suitable routine diagnostic purposes noninvasive diagnosis cad either symptomatic asymptomatic subjects sensitivity specificity accuracy sufficient schedule diagnostic catheterization multivessel angioplasty surgical backup basis pet scan university texas carry pet asymptomatic symptomatic patients direct mild disease cholesterol lowering reversal therapy severe disease percutaneous transluminal coronary angioplasty ptca assessment physiologic severity coronary artery stenosis compared automated quantitative coronary arteriographic analysis changes stenosis severity followed interventions including ptca bypass surgery vasodilator drugs cholesterol control regimens reversal coronary atherosclerosis imaging myocardial infarction ischemia viability zone risk sizing pathophysiologic processes,C14,0.011639136,0.0016113011,0.012168629,0.009810577,0.01265779,0.010105009,0.25475118,0.010454223,0.010095215,0.0017847902,0.18464912,0.003855139,0.08050906,0.004347493,0.019179514,0.02038157,0.20906632,0.0106497705,0.0020683203,0.06040393,0.049246803,0.0006449631,0.019920142
clinical cardiovascular magnetic resonance imaging magnetic resonance imaging mri powerful tool providing high resolution images heart great vessels without use ionizing radiation contrast agents mri systems currently use many hospitals used effectively routine clinical evaluation many forms cardiovascular disease including great vessel disease ischemic cardiac disease congenital cardiac disease moreover quantitative cine mri techniques available provide highly accurate measures chamber size wall motion wall thickening recent developments areas myocardial tagging high speed imaging mr assessments flow perfusion suggest potential increasing role mri clinical evaluation cardiovascular system,C14,0.0025904311,0.01483573,0.0048334757,0.0014554575,0.123647474,0.0033430862,0.3802103,0.0024493553,0.0018727663,0.0025452506,0.04498928,0.0053280215,0.10642239,0.0060112653,0.0022779596,0.016541233,0.122655876,0.0026677144,0.015468998,0.024494788,0.11177311,0.00091976795,0.0026663
abnormal hemodynamic response valsalva maneuver patients atrial septal defect evaluated doppler echocardiography hemodynamic responses valsalva maneuver studied eight healthy subjects group eight patients asd group using doppler echocardiography acute changes aortic blood flow profiles valsalva maneuver investigated basis beat beat estimation active strain phase phase group showed significant decrease systolic blood pressure sv co reflex tachycardia group significant decrease sv co reflex tachycardia systolic blood pressure percentage decreases sv co group significantly less group percent vs percent sv p less percent vs percent co p less release strain phase phase group showed significant reversed changes systolic blood pressure sv heart rate indicating overshoot effect however observed group thus patients asd presented abnormal valsalva response characterized absence phase overshoot less marked phase change findings suggest decremental effect impaired venous return stroke output active strain may attenuated increased pulmonary blood volume due left right shunt patients asd lesser decrement co phase may provoke sufficient sympathetic activity induce overshoot response phase,C14,0.016756672,0.0014018747,0.05634262,0.00088795024,0.008578748,0.010008077,0.14623651,0.02443295,0.0164233,0.0015528147,0.008699171,0.06445979,0.25710046,0.029592136,0.0090307575,0.0636662,0.09472204,0.009419969,0.0017994934,0.0107694855,0.16592604,0.000561135,0.0016318263
sequential gradient pneumatic compression enhances venous ulcer healing randomized trial treatment venous ulcers remained largely unchanged centuries application properly applied graduated compression bandages use graduated compression stockings surgery shown achieve healing however ulcers persist despite appropriate management randomized study undertaken compare two regimens treatment patients regimens included ulcer debridement cleaning nonadherent dressing graduated compression stockings one regimen sequential gradient intermittent pneumatic compression applied hours day one patients control group complete healing ulcers compared patients healed intermittent pneumatic compression group median rate ulcer healing control group area per week compared area per week intermittent pneumatic compression group results indicate sequential gradient intermittent pneumatic compression beneficial treatment venous ulcers,C14,0.002558415,0.002269442,0.004971491,0.0014374692,0.003562512,0.003301768,0.28097427,0.039557263,0.0018496203,0.002513793,0.011821104,0.10952276,0.03223024,0.0059083216,0.014626566,0.028752105,0.1795949,0.0026347435,0.0029402971,0.019952547,0.24548,0.0009084003,0.0026320033
new technique arterial switch operation difficult situations technique described modification aubert operation avoids coronary reimplantation also eliminates need use artificial material transfer coronary circulation,C14,0.03698676,0.0061592185,0.04654435,0.0039012614,0.009668584,0.00896093,0.22646788,0.006529738,0.005019831,0.0068223826,0.075993165,0.014281424,0.0765694,0.016047023,0.0061059264,0.044419445,0.21375081,0.0071506393,0.00790618,0.077954695,0.09315177,0.0024653794,0.0071432022
torsade de pointes critical care nurse dilemma torsade de pointes polymorphous ventricular tachycardia characterized gradual change direction qrs complex critical care nurses first recognize arrhythmias require knowledge skill intervene appropriately case report focuses identification characteristics contributing factors therapeutic modalities relevant nursing diagnoses patient torsade de pointes,C14,0.005621491,0.004986543,0.010997538,0.0031584864,0.007827749,0.034464195,0.25913194,0.032493744,0.0040640878,0.005523445,0.13470095,0.0115623325,0.08390223,0.01769443,0.0049433974,0.008753831,0.12316859,0.005853352,0.006421315,0.13288373,0.09401998,0.0019959873,0.005830639
clustering atherogenic behaviors coffee drinkers studied clustering coffee consumption selected atherogenic behaviors older adults living southern california community men somewhat likely drink caffeinated coffee women likely drink decaffeinated coffee men women caffeinated coffee drinking decreased age decaffeinated coffee drinking increased caffeinated coffee drinkers drank alcohol consumed dietary saturated fats cholesterol likely current smokers less likely current exercisers non coffee drinkers smoking exercise also showed dose response relationship amount caffeinated coffee consumed risk factor levels among drinkers decaffeinated coffee like caffeinated coffee non drinkers data illustrate clustering atherogenic behaviors coffee drinking highlight potential importance interpreting growing body literature coffee health,C14,0.0028796066,0.01649275,0.033214826,0.0016179334,0.004009761,0.0037162823,0.13401963,0.002708017,0.0020818273,0.01676384,0.027494198,0.0059228004,0.03523962,0.06689174,0.044191405,0.04966558,0.026379561,0.044779975,0.017215233,0.3280657,0.13266487,0.0010224436,0.002962433
videodensitometry versus digital calipers quantitative coronary angiography single plane left coronary angiograms patients prospectively analyzed using videodensitometry xr system handheld digital calipers compare arterial dimensions stenosis dimensions intraobserver variability interobserver variability methods total arterial segments measured yielding highly significant correlation videodensitometry caliper determined cross sectional area r p similarly highly significant linear relation observed videodensitometry caliper determined diameter r p data subsets small medium large arterial segments examined higher variability correlation videodensitometry caliper determined area observed large segments greater mm addition caliper estimated areas tended slightly smaller videodensitometry estimated areas segments diameter estimations correlations caliper videodensitometry data similar entire range arterial segment sizes intra interobserver variability low caliper videodensitometry determination diameter area thus wide range arterial dimensions results obtained caliper estimates luminal area diameter comparable obtained videodensitometry using xr system,C14,0.037085224,0.0017835842,0.0037517431,0.001129726,0.0028176615,0.002594903,0.170074,0.011622591,0.001453641,0.0019756232,0.13981895,0.0041392534,0.08724734,0.0046271025,0.01150222,0.0128502995,0.09820821,0.0020706796,0.002289469,0.02607093,0.37409773,0.0007139237,0.0020751492
early hour blood pressure elevation normotensive subjects parental hypertension subjects family history parental hypertension reported slightly higher office blood pressure prehypertensive stage whether reflects hyperreactivity blood pressure measurement permanent blood pressure elevation however known present study blood pressure measured normotensive subjects whose parents hypertensive fh normotensive subjects one hypertensive parent fh normotensive subjects whose parents hypertensive fh among three groups subjects matched age sex body mass index measurements made office variety laboratory stressors prolonged resting period hour period ambulatory blood pressure monitoring office blood pressure higher fh group fh group p less pressor responses laboratory stressors similar two groups fh group higher prolonged resting hour blood pressure fh group difference always significant p less systolic blood pressure fh group also greater left ventricular mass index echocardiographic examination fh group p less blood pressure values echocardiographic values fh group tended two groups thus higher blood pressure shown individuals prehypertensive stage family history parental hypertension reflect hyperreactivity stress early permanent blood pressure elevation,C14,0.02633675,0.001505241,0.0039271954,0.0009534227,0.018778196,0.0021899466,0.17912546,0.0015957917,0.001226788,0.018090788,0.016231019,0.09309436,0.4949613,0.0039130994,0.018396823,0.0026424367,0.054978155,0.009876797,0.001932178,0.013244176,0.026438247,0.008814563,0.0017472751
vena caval flow assessment cine mr velocity mapping authors used cine magnetic resonance mr velocity mapping study flow superior vena cava svc inferior vena cava ivc healthy control subjects patients right sided cardiac disease control subjects peaks flow systole diastole observed mean svc flow cardiac output respiratory gating used six control subjects acquire images end inspiration end expiration although systolic peak reduced end expiration total flow unchanged reduced systolic peak retrograde flow ivc observed patients tricuspid regurgitation reduced diastolic peak seen patients pulmonary hypertension pericardial constriction right ventricular dysplasia reflecting reduced diastolic compliance right ventricle patient obstruction svc absence flow confirmed retrograde flow seen azygos vein authors believe cine mr velocity mapping reliable method studying vena caval flow noninvasively important potential applications investigation disorders right side heart,C14,0.052350316,0.021683583,0.02340695,0.0011528276,0.02271998,0.0026515946,0.14729321,0.021791495,0.011404695,0.011943792,0.040833805,0.0042456505,0.33035195,0.004717742,0.001804334,0.013123785,0.16431753,0.002124184,0.0023362862,0.035109065,0.08179785,0.0007285228,0.0021108252
prostacyclin acetylcholine screening agents acute pulmonary vasodilator responsiveness primary pulmonary hypertension epoprostenol sodium prostacyclin administered intravenously considered standard assessing ability pulmonary circulation vasodilate present epoprostenol sodium investigational drug limited availability contrast acetylcholine also pulmonary vasodilator readily available therefore assessed feasibility using acetylcholine alternative prostacyclin testing capacity pulmonary vasculature vasodilate twenty three patients primary pulmonary hypertension mean pulmonary arterial pressure mm hg received incremental infusions prostacyclin acetylcholine predetermined maximal infusion rates part battery vasodilator agents administered according standard protocols mean agents patient range agents patient administration different agents timed avoid synergistic effects agents tested prostacyclin acetylcholine consistently effective evoking acute pulmonary vasodilation seemed distinguish patients capable manifesting acute pulmonary vasodilation however maximal doses set protocol prostacyclin generally elicited greater vasodilator response acetylcholine difference magnitude response may due use prescribed dosages acetylcholine submaximal respects two agents similar equally well tolerated side effects mild resolved rapidly vasodilator infusions stopped conclude majority patients primary pulmonary hypertension acetylcholine appears effective available substitute prostacyclin screening pulmonary vasodilator responsiveness,C14,0.119074814,0.016086813,0.017549364,0.00085528474,0.0021196716,0.017562715,0.28050736,0.0014315333,0.015835872,0.0014956906,0.052568443,0.024767797,0.094955646,0.003502683,0.008590633,0.0248129,0.09098652,0.0015676551,0.0017538893,0.048337,0.1735312,0.00054049224,0.0015660247
beta blocker duration action implications therapy two studies conducted measure effect serum half life beta blocker related heart rate reduction throughout hour period first study nadolol atenolol pindolol associated significant p less heart rate reduction even hours dose nadolol plasma half life hours pronounced heart rate lowering effect hours daily dose compared pindolol half life hours randomized double blind crossover study nadolol atenolol similar effects hours daily dose nadolol however produced greater suppression heart rate double product blood pressure x heart rate atenolol compared placebo hours ingestion daily dose ambulatory electrocardiography hours medication administration heart rate attenuating effect nadolol maintained versus atenolol effect statistically significant p less reductions heart rate produced nadolol atenolol furthermore nadolol remained peak blood level hours whereas atenolol data studies indicate significant differences duration action exist beta blockers,C14,0.0019534375,0.0017327965,0.013090409,0.0010975569,0.002753775,0.002521013,0.098885,0.0018370363,0.0014122484,0.0019193671,0.009029914,0.004369002,0.3038427,0.0046274853,0.0017178037,0.0030419086,0.058059108,0.0020117168,0.021131527,0.08293526,0.37932774,0.0006935947,0.0020096246
iliac artery stenosis occlusion preliminary results treatment gianturco expandable metallic stents ten patients atherosclerotic stenosis occlusion iliac artery treated gianturco expandable metallic stents five cases stenosis balloon dilation performed prior placement stents five patients occluded arteries given intraarterial infusions urokinase balloon dilation stent placement clinical symptoms improved patients technical failures complications occurred doppler ankle brachial index studies performed nine cases nine cases indexes improved stent placement follow months mean months arteries remained patent follow angiograms showed slight intimal thickening restenosis long term follow clinical experience necessary evaluate efficacy stent however preliminary results suggest gianturco expandable metallic stent value treatment arterial occlusive disease,C14,0.13106246,0.015218937,0.017818598,0.0014928748,0.0036998251,0.003429031,0.22147477,0.0024986998,0.01475888,0.0026188174,0.05791843,0.0056453226,0.07285772,0.0061323326,0.0023365219,0.004144462,0.3342119,0.0027362967,0.0030254154,0.023249237,0.069992624,0.0009434135,0.0027334508
cardiovascular response continuous variable rate alfentanil infusion abdominal aortic surgery prospective study undertaken determine cardiovascular response continuous alfentanil infusion abdominal aortic surgery aas subject n received beta blocking drug preoperatively premedicated oral lorazepam anaesthesia induced alfentanil micrograms kg thiopentone mg kg maintained variable rate infusion alfentanil per cent nitrous oxide oxygen infusion boluses alfentanil micrograms kg administered maintain heart rate blood pressure within per cent awake baseline values haemodynamic stability surgery achieved infusion rates varying micrograms kg resulted mean alfentanil serum concentrations ranging ng ml mean cumulative alfentanil dose mg patient surgery lasted average min throughout surgery patient required inhalational anaesthetic agents vasoactive drugs fifteen patients perioperative holter monitoring myocardial ischaemia detected intraoperative period however per cent incidence myocardial ischaemia first postoperative day myocardial infarcts deaths conclude beta blocked patients undergoing aortic reconstructive surgery variable rate alfentanil infusion administered per cent nitrous oxide provides anaesthesia characterized good haemodynamic control without need supplemental agents vasoactive drugs,C14,0.010697325,0.0016255436,0.0034429855,0.0010296226,0.011344245,0.020944534,0.15099202,0.054927744,0.0013248359,0.0018005661,0.011943577,0.00417857,0.20559607,0.004306592,0.0016114786,0.020987546,0.27221602,0.0018871997,0.0020866024,0.034477267,0.15797348,0.00065066403,0.02395552
rapid effective technique retrograde crossing valvular aortic stenosis using standard coronary catheters retrograde crossing valvular aortic stenosis challenging even experienced angiographers consecutive patients aortic stenosis catheterized past years technique using standard judkins right coronary catheter floppy straight tipped guide wire successful rapidly efficiently crossing pathologically distorted valves retrograde fashion valve crossed coronary catheter replaced pigtail catheter pressure ventriculography majority valves required less min cross using technique method valuable limiting time required catheterization thus helping reduce procedure related morbidity oftimes critically ill patients,C14,0.0030973915,0.0027454945,0.0057786666,0.0017417505,0.004309807,0.018445566,0.29561415,0.032872,0.0022376084,0.0030688783,0.13800253,0.021325668,0.07255334,0.007400935,0.0027217392,0.0048450665,0.27875,0.0031874238,0.0037424306,0.03975877,0.05342742,0.001098952,0.0032743453
health belief model predicting compliance dropout cardiac rehabilitation investigated health belief model health locus control constructs predictors group membership compliers dropouts cardiac rehabilitation whether added predictive utility routinely assessed patient demographics health behaviors questionnaires completed entry study patients coronary artery disease end month program compliers dropouts discriminant function analyses carried determine prediction group membership health belief model predicted group membership time explaining variance demographics health behaviors health belief model factors accounted variance compliers total dropouts group membership correctly predicted time avoidable unavoidable dropout correctly predicted time variance explained health locus control distinguish compliers dropouts addition health belief model provided additional information compliance cardiac rehabilitation beyond explained demographic health behavior variables alone particularly predicting avoidable unavoidable dropout,C14,0.0022764779,0.024057895,0.0042476715,0.00127906,0.003169923,0.01394783,0.16442384,0.0021408272,0.034701087,0.002236773,0.040216133,0.051326573,0.022379786,0.04554323,0.0020019622,0.0035449492,0.13777165,0.0023443946,0.13471888,0.049459737,0.23302655,0.0008082945,0.024376467
clinical performance st jude medtronic hall prostheses randomized comparative study newer improved models mechanical prostheses regularly added surgeons armamentarium study designed compare clinical performance two used current models mechanical prostheses august july white patients prospectively randomized implantation st jude medical patients medtronic hall patients prostheses mitral aortic double mitral aortic valve replacements differences two groups regard sex distribution age functional class emergency operation site implantation early mortality patients st jude valve medtronic hall p ns survivors followed years mean years cumulative follow patient years late mortality patient year st jude group patient year medtronic hall group p less however valve related mortality equal patient year groups noncardiac causes accounted difference st jude medtronic hall groups patient year patient year respectively cases thrombotic obstruction whereas serious systemic thromboembolism occurred rate patient year episodes st jude group patient year episodes medtronic hall group p significant another nine episodes systemic embolism left sequelae three patients st jude medtronic hall aortic valve replacement required reoperation patient year prosthetic endocarditis two deaths,C14,0.0017262271,0.0015312496,0.011558268,0.009310986,0.0024037166,0.0022434127,0.11104625,0.018331489,0.009602585,0.0016961194,0.025668347,0.10028545,0.046100777,0.003969129,0.0015180005,0.019396678,0.3166663,0.0017837435,0.001992715,0.24381678,0.066962965,0.0006129205,0.0017758787
alarm reaction serum k hypertensive patients effect serum k alarm reaction induced participation experimental noninvasive study evaluated subjects borderline hypertension essential hypertensives group inpatients undergoing routine blood sampling served control serum k blood pressure heart rate measured casual baseline min rest recumbent position baseline serum k values significantly higher casual values patients participating experimental protocol change observed inpatients undergoing routine blood sampling increase serum k induced relaxation significantly related heart rate decrease r relaxation patients increase serum k change greater patients subgroup patients repeated test three times alarm reaction still evident reproducible within patient data suggest potassium levels measured outpatients undergoing diagnostic experimental procedures falsely reduced levels found large proportion subjects,C14,0.011995219,0.0018188184,0.0038258575,0.0011520433,0.012805217,0.0026461645,0.113041066,0.001928233,0.011396568,0.002016777,0.10290886,0.01609059,0.25112134,0.0048066233,0.0018030812,0.0031958295,0.14902128,0.002111585,0.0023346965,0.022138705,0.27900407,0.0007280271,0.002109389
respiratory muscle strength congestive heart failure experimental animals conditions drastically decrease cardiac output may reduce strength endurance respiratory muscles leading hypercapnic respiratory failure patients chronic chf reduced cardiac output vital capacity fvc measured pimax pemax maximal handgrip force patients chf amns patients chf mean left ventricular ejection fraction percent maximal respiratory pressures significantly reduced group mean values sd pimax frc cm h chf cm h amn p less pimax values five patients chf low cm h patients pemax comparably reduced handgrip force less dramatically reduced suggesting selective respiratory muscle weakness possible explanations include reduction respiratory muscle blood flow generalized muscular atrophy weakness related cardiac cachexia,C14,0.02741237,0.038461097,0.0046580727,0.0014026401,0.0034761946,0.0032217682,0.13404164,0.0023476696,0.09848878,0.1232859,0.011595972,0.017546155,0.20689143,0.0057400553,0.0021952942,0.015956478,0.11285341,0.0025709053,0.0028425485,0.018528385,0.15094584,0.012969156,0.0025682314
circulating plasma platelet activating factor persistent pulmonary hypertension newborn platelet activating factor paf endogenous phospholipid mediator causes pulmonary hypertension thrombocytopenia experimental animal models investigate circulating paf persistent pulmonary hypertension newborn pphn studied paf degradative enzyme acetylhydrolase thirteen neonates pphn diagnosed routine clinical methods including echocardiography compared six age matched control patients respiratory distress overall plasma paf levels elevated patients pphn compared control patients versus ng ml p less addition plasma paf concentrations patients pphn correlated severity disease defined delta aapo r p three patients elevated paf levels clinical status improved plasma paf values decreased acetylhydrolase activity similar groups versus nmol ml min p ns conclude paf production increased pphn abnormal production paf may associated pulmonary hypertension,C14,0.09460134,0.0021124645,0.0044435374,0.0013380393,0.0033160928,0.0030839134,0.14134045,0.0022438967,0.0017216819,0.002339914,0.046826206,0.016918045,0.095436394,0.03776738,0.0020941866,0.015461274,0.08887691,0.002452498,0.01419054,0.13056369,0.26653537,0.012368962,0.013967197
right ventricular function metabolism right ventricular protection may limited current methods cardioplegic delivery sensitive measurements right left ventricular function metabolism made patients undergoing elective coronary artery bypass surgery cold cardioplegic arrest myocardial adenine nucleotide concentrations decreased cardioplegia reperfusion right left ventricles despite adequate levels precursors suggesting perioperative mitochondrial dysfunction postoperatively right left ventricular pressures measured micromanometer catheters volumes measured nuclear ventriculography right left ventricular systolic elastance calculated isochronic method end systolic method methods provided sensitive indexes end systolic elastance study demonstrated right ventricular function metabolism evaluated methods analogous methods used left ventricle results suggest right ventricular functional metabolic recovery delayed despite apparently adequate myocardial protection sensitive measurements may permit improved assessment alternative methods right ventricular protection,C14,0.053806316,0.0018943676,0.04462888,0.0011998963,0.013293577,0.025869995,0.14968446,0.053700496,0.011878247,0.012433561,0.11276839,0.014700063,0.18818769,0.004938274,0.0018779768,0.013661183,0.09729193,0.018272188,0.0024316742,0.02433318,0.11917777,0.03177287,0.0021970079
long term prognosis myocardial ischemia detected holter monitoring peripheral vascular disease assess long term prognostic significance myocardial ischemia measured ambulatory electrocardiographic monitoring patients occlusive peripheral arterial disease eligible patients scheduled elective peripheral arterial surgery brigham women hospital prospectively studied patients monitored preoperatively without alterations baseline medications prospective follow obtained routine medical care provided blinded independent physicians subsequent telephone contact patients thirty two patients total episodes myocardial ischemia asymptomatic mean follow period days cardiac deaths occurring hospital peripheral vascular surgery nonfatal myocardial infarctions occurring hospital peripheral vascular surgery cardiac events occurred patients ischemia including cardiac deaths patients without ischemia including cardiac deaths risk ratio confidence interval sensitivity ischemia specificity positive predictive value negative predictive value multivariate cox proportional hazards model controlling age gender coronary risk factors history angina myocardial infarction coronary artery disease antianginal medications presence ischemia independent predictor outcome patients peripheral arterial disease often unable perform adequate exercise testing ambulatory monitoring myocardial ischemia significant independent predictor year prognosis,C14,0.023415023,0.010048311,0.012246256,0.009476264,0.010858429,0.010748547,0.15980478,0.0016754247,0.0012684962,0.0017239955,0.06939468,0.0036300162,0.057771645,0.0042178608,0.010042601,0.0027415298,0.30473727,0.012835617,0.0019978678,0.18440689,0.10452861,0.000622994,0.0018069018
increase intraplatelet free calcium ion extracorporeal circulation hollow fiber oxygenator arterial filter dynamics platelet thrombosis oxygenator filter pig model intraplatelet free calcium ipfc ions provide common pathway platelet activation leading thrombosis embolization ipfc levels determined chlorotetracycline fluorometry extracorporeal circulation ecc systemic heparin eight yorkshire pigs weighing kg control ecc ratio slow phase organelle calcium sequestration fast phase platelet membrane binding index free calcium hr ecc hollow fiber oxygenator hfo bentley cm af bentley seven blood samples collected min ecc platelet deposition cpm microci hfo pdhfo simultaneously measured labeled autologous platelets microci geiger probe detector min ecc ipfc hfo thrombus increase significantly p less min respect control ipfc values suggesting direct participation calcium activated platelets thrombosis hfo decline ipfc due extrusion sequestration dense granules decline hfo thrombus due embolization hand embolus arterial filter trapped linear fashion consistent increase time ecc,C14,0.015190566,0.0021631015,0.02815433,0.0013701129,0.0033955816,0.0031470554,0.13594815,0.002293227,0.0017629516,0.0023960029,0.03509548,0.017344046,0.18765649,0.113603346,0.0021443854,0.05264752,0.03479748,0.03792385,0.0027766298,0.041053228,0.275762,0.0008658349,0.002508674
efficacy ibopamine treatment heart failure loss myocardial contractility reflexly enhanced vasoconstriction neuroendocrine excitation pathophysiologic hallmarks low output heart failure drugs counter consequences afford considerable therapeutic potential retarding perhaps even staying consequences syndrome ibopamine possesses potential unique ability stimulate dopaminergic beta adrenoreceptors heart circulatory system stimulation dopaminergic receptors beta adrenoreceptors results vasodilatation regional vascular territories beta adrenoreceptor agonist activity also affords mild positive inotropic activity heart whereas stimulation presynaptic dopaminergic receptors da attenuates increased sympathetic neural outflow drug also suppresses renin angiotensin aldosterone system addition direct natriuretic activity pharmacodynamic effects ibopamine exerted metabolite epinine translated measurable therapeutic benefits patients chronic heart failure increase peripheral blood flow induced regional vascular territories including kidneys associated increased cardiac output stroke volume reduction left ventricular pressure work wall stress myocardial oxygen consumption plasma norepinephrine angiotensin aldosterone also reduced renal sodium excretion enhanced hemodynamic neuroendocrine activities subject tolerance sustained administration drug accompanied clinically significant improvement symptoms exercise tolerance new york heart association classification disability important proarrhythmic effects observed sustained treatment minimal side effects observed long term treatment enhance safety profile drug,C14,0.010088939,0.018246597,0.036540378,0.00097016036,0.00240437,0.010573359,0.27461216,0.0016556283,0.0012483248,0.010417704,0.016284933,0.0035514848,0.10857736,0.0041925153,0.026589477,0.0026904864,0.031588577,0.03445291,0.001966098,0.063684806,0.30384237,0.008969361,0.026852014
effects adenosine human coronary arterial circulation adenosine potent vasodilator used extensively study coronary circulation animals use humans however hampered lack knowledge effects human coronary circulation concern safety investigated humans effects adenosine administered intracoronary bolus micrograms intracoronary infusion micrograms min intravenous infusion micrograms kg min coronary systemic hemodynamics electrocardiogram coronary blood flow velocity cbfv measured f coronary doppler catheter maximal cbfv determined intracoronary papaverine resting cbfv normal left coronary arteries n micrograms boluses adenosine caused coronary hyperemia similar caused papaverine resting cbfv right coronary artery n micrograms boluses caused maximal hyperemia resting cbfv intracoronary boluses caused small brief decrease arterial pressure similar caused papaverine changes heart rate electrocardiogram duration hyperemia much shorter adenosine papaverine administration intracoronary infusions micrograms min left coronary artery n also caused maximal hyperemia resting cbfv doses micrograms min caused minimal decrease arterial pressure mm hg significant change heart rate electrocardiographic variables intravenous infusions normal patients n micrograms kg min caused coronary vasodilation similar caused papaverine patients resting cbfv submaximal infusion rates however cbfv often fluctuated widely micrograms kg min infusion arterial pressure decreased mm hg heart rate increased beats min one patient developed cycle atrioventricular block otherwise electrocardiogram change eight patients microvascular vasodilator dysfunction delta cbfv less peak resting velocity maximally vasodilating dose intracoronary papaverine dose response characteristics intracoronary boluses intravenous infusions adenosine similar found normal patients abstract truncated words,C14,0.03802301,0.0074961134,0.008772215,0.0007358943,0.0018237834,0.027015131,0.089973025,0.020234507,0.026302846,0.0012869049,0.013041054,0.023371078,0.33766547,0.003880632,0.0011517599,0.0020480866,0.073113024,0.007718593,0.0014953805,0.035797186,0.26848912,0.00046504414,0.010100129
outlook acute myocardial infarction elderly compared patients aged years little known concerning late outcome prognostic factors acute myocardial infarction elderly greater years age accordingly study compared clinical course mortality rate year large multicenter data base included patients greater years age mean sd years less elderly subset patients years age mean years postdischarge year cardiac mortality rate greater years age compared patients years age p less differences prevalence several factors including female gender history angina pectoris history congestive heart failure smoking habits incidence congestive heart failure hospitalization multivariate analyses predictors cardiac death hospital survivors selected different factors important two age subgroups age selected year age group independent predictor elderly survival curves beginning day patients greater years old similar days diverged later elderly late cardiac deaths sudden due new myocardial infarction similar causes deaths younger age group,C14,0.0016435434,0.033254545,0.003065289,0.0009230207,0.0022881988,0.0021201153,0.115090035,0.0015449063,0.0011876692,0.0016153238,0.019385438,0.025700985,0.054168656,0.0039034202,0.02530117,0.010506021,0.19430764,0.0016918087,0.0018705662,0.4292525,0.06890496,0.0005832976,0.0016908582
ecmo assisted angioplasty cardiomyopathy patients unstable angina patients otherwise unsuitable candidates coronary bypass surgery standard coronary angioplasty ptca may successfully treated ptca ecmo five patients men women mean age years reported considered good candidates standard therapy poor left ventricular function mean ef range patients supported percutaneous femoral bypass using bard cps machine underwent successful ptca either two vessels three patients three vessels two patients addition one patient dilatation stenotic aortic valve patients supported ecmo mean minutes required transfusion mean units blood procedure complications included groin hematoma two patients discharged within days procedure follow patients completed mo hospitalizations unstable angina patients remain nyha class ii iii data suggest ecmo assisted angioplasty safe effective method palliation unstable angina associated cardiomyopathy,C14,0.0025582658,0.0022693095,0.017152753,0.0014373852,0.003562304,0.028039863,0.15817478,0.0024124186,0.014231044,0.0025136464,0.025592387,0.0052618636,0.053165324,0.005882243,0.0022496744,0.003983752,0.5362243,0.0026345896,0.0029129619,0.07098444,0.042834338,0.013290495,0.0026318494
quantification reversibility stress induced thallium myocardial perfusion defects multicenter trial using bull eye polar maps standard normal limits multicenter trial performed patients four centers determine accuracy quantitative analysis stress delayed thallium myocardial tomograms using normal limits assess relative amount reversibility stress induced defects patients found fixed reversible defects determined visual interpretation reversibility bull eye polar maps compared gender matched normal limits normals regions identified reversible normalized difference stress hr greater mean normal limits overall agreement experts multicenter sites reversibility maps reversible defects fixed defects sensitivity detecting reversibility highest left circumflex lowest right coronary results indicate reversibility polar maps normal limits offer objective accurate technique determining reversibility stress induced perfusion defects,C14,0.0022763778,0.0020192605,0.037303336,0.0012790038,0.06922104,0.002937784,0.24779102,0.01315776,0.0016457197,0.013253534,0.120220855,0.004829033,0.16861282,0.0056429366,0.064600766,0.0035447935,0.06659365,0.002352986,0.0025919909,0.017311636,0.14964332,0.000808259,0.0023621493
coronary artery disease octogenarian angiographic spectrum suitability revascularization angiographic findings consecutive octogenarians presenting symptoms coronary artery disease cad examined determine extent cad well suitability coronary artery bypass grafting cabg percutaneous transluminal coronary angioplasty ptca frequency vessel left main cad respectively based angiographic criteria patients significant cad suitable coronary anatomy cabg patients coronary anatomy amenable ptca cabg performed patients operative mortality major complication rate ptca performed patients clinical success rate mortality major complication rate concluded octogenarians cad cardiac catheterization often reveal coronary anatomy suitable cabg less suitable ptca morbidity mortality associated interventions high,C14,0.0029618472,0.0026273064,0.0055265,0.0016641412,0.048820037,0.0038224182,0.25818935,0.018512173,0.01647462,0.002918838,0.06203138,0.006125468,0.120582394,0.006810202,0.0026045737,0.018945424,0.25603643,0.0030537928,0.0033724988,0.10497698,0.049844958,0.0010516443,0.0030470393
heart failure prevented delayed reversed review clinical course chronic heart failure demonstrates current outcomes remain highly unsatisfactory mortality perhaps important morbidity extraordinary satisfactory functional responses seen patients undergo cardiac transplantation clearly identify primary cause status heart whatever pathophysiologic adjustments neuroendocrine system interventions wide variety drugs since donor hearts unlikely available even younger sufferers clinical syndromes prevention must hallmark protection viability myocytes acute myocarditis acute infarction essential myocardial collagen undergoes continual synthesis production greatly stimulated presence hypertrophy caused increased wall stress possible excess collagen intimately involved diastolic ventricular dysfunction may reversible process collagen producing stimulus removed thus reduction wall stress reversibility ventricular hypertrophy appear promising directions however limit catastrophic effects chronic heart failure early recognition precursors syndromes prevention progression surgical intervention valvular heart disease optimal point time essential,C14,0.0019913418,0.04032661,0.009011905,0.030036112,0.0027730567,0.0121964775,0.37651458,0.016389526,0.0014396515,0.021227052,0.02320709,0.0040958095,0.045024186,0.0050599654,0.021029916,0.012738263,0.12141381,0.021322818,0.0022674357,0.07867136,0.15050733,0.0007070531,0.002048619
timing triggers transient myocardial ischemia use exercise tolerance testing new techniques ambulatory electrocardiographic monitoring objectively measure myocardial ischemia enabled clinicians better recognize magnitude timing variable characteristics transient ischemic events commonly occurring events patients coronary artery disease diurnal pattern strikingly similar reported catastrophic cardiovascular events myocardial infarction sudden cardiac death stroke whether factors contribute reversible ischemic events similar causing infarction sudden death resolved however parallel increase morning activity related phenomena suggests better understanding triggers reversible myocardial ischemia may help improve understanding causes myocardial infarction sudden cardiac death,C14,0.0028019256,0.016047766,0.005247838,0.015126632,0.003901593,0.009067909,0.40234527,0.0026349649,0.0020256676,0.002783965,0.03541007,0.0057907985,0.03540355,0.055281788,0.0024639429,0.031478085,0.14760467,0.0028950605,0.0034603153,0.10323722,0.11111362,0.000994862,0.0028825179
hindbrain ischemia produced bilateral vertebral artery occlusion moderate hypotension spontaneously hypertensive rats hindbrain ischemia induced bilateral vertebral artery occlusion moderate hypotension spontaneously hypertensive rats shrs mean arterial blood pressure lowered mmhg shrs mmhg wistar kyoto rats wkys controlled hemorrhage vertebral artery bilaterally occluded alar foramina first cervical vertebra following vertebral occlusion blood flow cerebellum significantly decreased ml g min sem flow cerebrum remained shrs contrast cerebellar blood flow wkys preserved ml g min brain lactate pyruvate adenosine triphosphate atp determined shrs sixty minutes hypotension without vertebral occlusion although infratentorial metabolites actually unaltered rats hypotension alone infratentorial lactate lactate pyruvate ratio significantly increased mmol kg respectively concomitant decrease atp shrs hypotension vertebral occlusion bilateral vertebral artery occlusion together moderate hypotension shown produce marked reduction cerebellar blood flow induce ischemic metabolic changes infratentorial brain shrs,C14,0.14190146,0.034321364,0.036487542,0.0012515887,0.0031018404,0.0028748133,0.0766944,0.0020948472,0.0016104442,0.0021887321,0.0102865705,0.0046260403,0.2569904,0.005152531,0.0019588813,0.0034755575,0.12689534,0.0022940424,0.0025364321,0.039375402,0.20844996,0.033140194,0.0022916563
clinical electrophysiological characteristics ventricular tachycardia children normal hearts characteristics patients clinical ventricular tachycardia vt normal hearts documented physical examination echocardiography angiocardiography analyzed males females aged years mean sd years six patients hemodynamic instability vt patients hemodynamically stable two patients presented sustained vt episodes nonsustained vt varying intervals repetitive monomorphic vt among patients exercise tests performed seven exercise induced vt electrophysiologic studies vt induced patients morphology identical clinical vt vt induced programmed stimulation single double burst stimulation right atrium right ventricular apex sinus rhythm pacind eight beats patients isoproterenol vt aggravated spontaneously patients stimulation vt induced patients among patients whose vt induced programmed stimulation vt induced addition isoproterenol patients follow stable condition seven patients medication seven without medication pediatric patients normal hearts clinically detected vt usually vt induced programmed stimulation either without isoproterenol stimulation,C14,0.013566998,0.024601286,0.004343355,0.0013078722,0.0032413292,0.003004093,0.17665061,0.0021890518,0.0016828654,0.029046819,0.03505786,0.0047877533,0.024435714,0.005704487,0.0020469716,0.0036248034,0.2886627,0.002400299,0.034398083,0.06263467,0.26020566,0.0008265023,0.015580241
framingham disability study relationship various coronary heart disease manifestations disability older persons living community relation coronary heart disease disability examined community dwelling women men ages years framingham study participants originally recruited examination cardiovascular disease twenty seven years later remaining members cohort interviewed ascertain physical abilities score disability scale assigned multivariate logistic analyses examined disability relation uncomplicated angina pectoris ap complicated ap coronary heart disease ap controlling possible confounders younger older women men uncomplicated complicated ap associated disability coronary heart disease ap associated disability younger men congestive heart failure predicted disability women results suggest onset ap recognized critical point development disability ap better predictor disability myocardial infarction coronary insufficiency,C14,0.002276633,0.024046177,0.026264055,0.0012791472,0.0031701394,0.0029381134,0.32349846,0.0021409732,0.0016459043,0.024276448,0.07730893,0.026657494,0.07238844,0.0052346825,0.0020020136,0.0035451911,0.03594321,0.0023523918,0.013602318,0.26811552,0.078160286,0.00080834964,0.0023451438
central retinal vein obstruction axial length axial lengths consecutive adult eyes unilateral central retinal vein obstruction crvo compared contralateral unaffected eyes control population lengths two eyes persons unilateral crvo significantly different contrast eyes persons crvo averaged mm approximately diopters shorter control counterparts p anatomic difference may factor development crvo,C14,0.0047216904,0.004188375,0.008810185,0.0026529252,0.0065748044,0.028940685,0.16489072,0.050151914,0.003413572,0.0046393382,0.021714529,0.009992037,0.08080906,0.012390628,0.0041521355,0.007352654,0.109816425,0.004862558,0.005376339,0.12617378,0.3318408,0.0016765008,0.0048583453
value pulmonary artery central venous monitoring patients undergoing abdominal aortic reconstructive surgery comparative study two selected randomized groups one hundred two patients undergoing abdominal aortic reconstructive surgery prospectively randomly allocated two groups one monitored central venous catheter pulmonary artery catheter patients uncompensated cardiopulmonary renal disease excluded study general anesthesia administered surgical procedure patients followed hospital discharge statistically significant differences occurred two groups regard morbidity perioperative cardiac pulmonary renal sequelae mortality rate duration intensive care postoperative hospital stay cost hospitalization one statistically significant difference groups professional fee charged anesthetic care higher patients pulmonary artery catheters central venous catheters conclusion prospectively gathered data patients presented abdominal aortic reconstructive surgery data seem indicate choice central venous catheter pulmonary artery catheter monitoring makes little difference outcome abdominal aortic reconstructive surgery many patients pulmonary artery catheters necessary give appropriate adequate care size sample however declarations epidemiologic significance would unfounded therefore large scale multicenter studies addressing outcomes remain necessary,C14,0.09095912,0.009618346,0.011472063,0.0090778805,0.0023594012,0.010663674,0.18789643,0.099319845,0.0012167956,0.00165373,0.09710217,0.059942123,0.037785526,0.003905555,0.0014800626,0.018913247,0.18071453,0.0017332986,0.0100482525,0.11001401,0.051794805,0.0005976024,0.001731496
effect beta adrenergic blocking agents circadian occurrence ischemic cardiovascular events clinical observations suggest beta adrenergic blocking agents modify circadian occurrence variety ischemic events morning awakening associated rapid increase blood pressure pulse serum catecholamine content platelet activation time decreased blood thrombolytic activity beta adrenergic blocking agents potential modify many events current data indicate agents modify blood pressure pulse prevent early morning increase addition beta adrenergic blocking agents decrease ventricular ectopy circadian variation recent studies humans indicate however metoprolol affect circadian increase platelet activity serum catecholamines specific mechanism beta blockers affect circadian occurrence ischemic events remains uncertain,C14,0.0024670651,0.014129733,0.004605439,0.025263408,0.00343531,0.003183876,0.2847921,0.014235005,0.0017835782,0.05006853,0.0113648875,0.0050742812,0.12292741,0.0068182633,0.0021694747,0.015782181,0.07614212,0.014479573,0.0028091164,0.08114854,0.25388882,0.00087596517,0.0025553128
thromboxane development genetic hypertension lyon rat strain determine whether increased renal biosynthesis thromboxane observed young genetically hypertensive rats lyon strain could involved development hypertension lyon hypertensive female rats received either thromboxane synthetase inhibitors dazmegrel oky thromboxane receptor antagonist ah prehypertensive stage treatment weeks age dazmegrel failed reduce systolic blood pressure given weeks age dazmegrel oky induced similar progressive specific reduction urinary excretion thromboxane b associated transient decrease blood pressure level dazmegrel longer lasting blood pressure lowering effect oky ah given according schedule normalized blood pressure level effect persisted week cessation treatment interestingly active doses thromboxane synthetase inhibitors thromboxane receptor blocker required week delay exhibit antihypertensive properties concluded elevated production thromboxane observed young lyon hypertensive rats likely participate actively blood pressure regulation effect may independent direct vasoconstrictor properties,C14,0.022864554,0.01221338,0.024329338,0.011533465,0.0029733914,0.013370148,0.15281117,0.0020080984,0.0015437548,0.012432143,0.009924567,0.022260891,0.14879283,0.0057135005,0.022538926,0.013740665,0.0645913,0.022870947,0.002431397,0.11535665,0.31271836,0.00075818115,0.0022223243
responses cytosolic free calcium adp platelets spontaneously hypertensive rats abnormalities ca handling reported patients essential hypertension spontaneously hypertensive rats shr study responses cytosolic ca adp platelets shr examined four seven week old male shr age sex matched wistar kyoto rats wky used basal levels intracellular ca concentration platelets responses adp estimated using fluorescent indicator fura medium containing mmol l cacl ca free buffer mmol l egta basal levels platelet cytosolic ca shr significantly higher wky weeks age presence external ca however significant difference observed basal levels platelet cytosolic ca ca free egta containing buffer shr wky peak cytosolic ca concentration evoked adp significantly diminished shr compared wky absence external ca whereas responses platelet cytosolic ca adp similar shr wky presence external ca results suggest release intracellular ca store reduced shr regulation cytosolic ca shr dependent extracellular ca compared wky,C14,0.0021806085,0.0019341536,0.014582003,0.0012250968,0.003036185,0.0028139635,0.16234696,0.0020505064,0.0015763566,0.0021424042,0.02309064,0.004654603,0.053700175,0.19608648,0.0019500715,0.0139411045,0.029617984,0.0022454853,0.012947035,0.054110855,0.41073647,0.0007741928,0.0022566868
association type behavior change coronary risk factors among young adults association type b behavior pattern changes blood pressure total serum cholesterol serum triglyceride body mass smoking estimated cohort young black white men women rural county central kentucky type participants experienced significant increases systolic mmhg diastolic mmhg blood pressure cigarette smoking cigarettes per day eight year follow period type b participants experienced change type b individuals showed similar changes total serum cholesterol serum triglyceride body mass differences behavioral types blood pressure present women men blacks whites findings suggest possible significance type pattern development cardiovascular risk young adults,C14,0.0024376584,0.0021623245,0.028138869,0.001370051,0.003394362,0.003145925,0.2360184,0.0022924035,0.013561167,0.0023951423,0.02547036,0.0050384067,0.16289277,0.03344746,0.025787855,0.003795941,0.036931124,0.026038134,0.0027756325,0.19417518,0.18535756,0.0008655239,0.002507773
coronary angioplasty patients severe left ventricular dysfunction applications coronary angioplasty greatly expanded procedure increasingly used complex potentially high risk conditions report describes short long term effects coronary angioplasty patients severely depressed left ventricular function ejection fraction less equal unstable refractory anginal symptoms revascularization necessary despite increased risk retrospective analysis patients undergoing angioplasty january december ejection fraction less equal common clinical presentation unstable angina without recent myocardial infarction mean left ventricular ejection fraction forty five patients multivessel disease clinical success angioplasty achieved patients major complications death infarction emergency bypass surgery occurred five patients death two long term mean months follow study patients successful angioplasty died including noncardiac causes clinically symptomatic recurrence continued clinical success present patients event free patients clinical recurrence successful second angioplasty procedure performed restenosis thus patients depressed left ventricular function coronary angioplasty performed short term success rate comparable routine angioplasty surgical procedures however acute complications frequent late mortality rate higher patients less depressed function,C14,0.0017716051,0.0015695527,0.0033628172,0.0009941579,0.002463844,0.025705718,0.22447515,0.0016639722,0.0012792029,0.0017420485,0.013567028,0.003639333,0.07677273,0.00408187,0.0015559723,0.011316837,0.4228067,0.0018221963,0.0020147306,0.093994804,0.06668493,0.034890883,0.0018239113
response angiographically normal atherosclerotic left anterior descending coronary arteries acetylcholine acetylcholine induced constriction human coronary arteries vivo commonly attributed endothelial dysfunction examine effects important determinants vascular responses namely agonist concentration segment circulation study diameters proximal middle distal segments left anterior descending artery lad coronary sinus oxygen saturation measured patients angiographically normal coronary arteries group patients coronary atherosclerosis group intracoronary acetylcholine infused concentrations group acetylcholine caused minor less equal progressive dilatation lad constriction particularly distal segments tertiary branches occurred higher concentrations concentration range coronary sinus oxygen saturation rose progressively basal level maximum absence changes heart rate blood pressure suggesting marked progressive dilatation resistance vessels concentrations greater equal caused intense constriction distal epicardial vessels cases anginal pain objective signs ischemia conversely group acetylcholine infused ethical reasons failed cause significant changes lad diameter data suggest local acetylcholine concentration coronary vascular segment study may determine observed response least equivalent extent presence absence coronary atherosclerosis raising question whether constrictor response intracoronary acetylcholine reliably indicates presence coronary atherosclerosis,C14,0.0398366,0.0014020719,0.010591853,0.00088807516,0.0022009371,0.02499152,0.13749695,0.059166912,0.008720991,0.0091992505,0.014850593,0.04913779,0.09529145,0.003960015,0.0013899406,0.013877171,0.08872205,0.0016410103,0.017090742,0.03038176,0.3793213,0.008210603,0.0016303756
intracoronary infusion fluosol da prevent left ventricular diastolic dysfunction coronary balloon angioplasty distal intracoronary infusion perfluorochemical fluosol da shown prevent systolic dysfunction coronary artery balloon occlusion coronary angioplasty assess effect global diastolic dysfunction randomized single blind crossover protocol comparing intracoronary infusion fluosol infusion control performed balloon inflations patients mean age years undergoing coronary angioplasty assessment global systolic diastolic function obtained high fidelity micromanometer measurements left ventricular pressure eighteen pairs balloon inflations fluosol versus control analyzed patients reported significantly less severe chest pain inflations accompanied fluosol compared control however coronary balloon occlusion significant differences changes baseline values observed fluosol control regard ventricular relaxation including time constant early ventricular relaxation tau maximal rate fall left ventricular pressure maximal negative dp dt differences fluosol control observed terms increase end diastolic pressure minimal diastolic pressure balloon inflation mean systolic pressure decrease baseline values greater control fluosol inflations mm hg p significant difference observed change maximal rate rise left ventricular pressure maximal positive dp dt results suggest fluosol preserve global left ventricular diastolic function coronary balloon occlusion possibly limited oxygen delivery capability relative arterial blood,C14,0.050604343,0.017093249,0.018668551,0.0009087534,0.002252184,0.0026629712,0.09671996,0.0015210265,0.040317446,0.0015891945,0.029133288,0.011636744,0.36700356,0.0037550637,0.0014223044,0.0025221556,0.110384025,0.0016708797,0.0020512647,0.04144477,0.15524246,0.039723713,0.0016721152
prognostic value predischarge low level exercise thallium testing thrombolytic treatment acute myocardial infarction low level exercise thallium testing useful identifying high risk patient acute myocardial infarction ami determine whether use also applies patients thrombolytic treatment ami patients underwent early thrombolytic therapy ami patients without acute intervention evaluated ability electrocardiogram thallium tests predict future events compared groups mean follow days cardiac events groups respectively versus without acute intervention included death another ami coronary artery bypass grafting angioplasty events occurring months first infarction significant predictors outcome left ventricular cavity dilatation intervention group st segment depression increased lung uptake nonintervention group sensitivity exercise thallium intervention group nonintervention group p less therefore patients thrombolytic therapy ami nearly half events discharge predicted predischarge low level exercise thallium testing relatively weak correlation outcome unmasking ischemia laboratory discharge may due unstable coronary lesion rapid progression disease test tests considered useful prognostication ami may necessarily similar value acute intervention thrombolytic therapy,C14,0.001817119,0.036777794,0.013161526,0.0010203881,0.011319627,0.019925117,0.26357657,0.001707875,0.0013129538,0.010572126,0.101161495,0.05780979,0.08023855,0.0041801757,0.010381885,0.011613487,0.1398197,0.0018702738,0.0020678882,0.1113411,0.10702235,0.0094338935,0.0018683287
effects intravenous verapamil left ventricular relaxation filling stable angina pectoris left ventricular lv diastolic function often impaired coronary artery disease cad assess whether verapamil could improve lv diastolic properties patients cad undergoing right left sided cardiac catheterization well simultaneous radionuclide angiography studied intravenous administration verapamil mg kg bolus followed mg kg min heart rate kept constant atrial pacing studies lv pressure volume relations obtained verapamil decreased lv systolic pressure mm hg p less end systolic pressure volume ratio mm hg ml p less increased lv end diastolic mm hg p less pulmonary capillary pressures mm hg p less despite negative inotropic effects cardiac index increased liters min p less time constant isovolumic relaxation shortened ms p less peak filling rate increased ml p less end diastolic counts p less stroke counts p less,C14,0.055699363,0.0020196016,0.014990532,0.0012792199,0.0031703194,0.0029382803,0.09686708,0.013159984,0.0016459977,0.0022370527,0.04755162,0.026719732,0.38334858,0.005504704,0.0020021272,0.0035500757,0.09796189,0.013354355,0.0025924288,0.028165532,0.17004842,0.022850838,0.002342249
estrogen replacement coronary artery disease effect survival postmenopausal women relationship among postmenopausal estrogen use coronary stenosis survival examined retrospectively women undergoing coronary angiography patients selected study age years older time angiography previously undergone bilateral oophorectomy postmenopausal estrogen use patients coronary artery disease greater stenosis patients mild moderate coronary artery disease stenosis compared control subjects stenosis using life table analysis years follow significant difference survival among patients initially free coronary lesions arteriography either never used ever used estrogens among patients mild moderate coronary stenosis year survival never used estrogens among ever users survival among coronary stenosis never used estrogen among ever users never users group older vs years lower proportion cigarette smokers vs higher proportion subjects diabetes vs hyperlipidemia vs approximately equal numbers hypertensives vs cox proportional hazards model used estimate survival function multiple covariables estrogen use found significant independent effect survival women conclude estrogen replacement menopause prolongs survival coronary artery disease present less effect absence coronary artery disease,C14,0.001800333,0.0015969853,0.0033592347,0.0010115337,0.011221388,0.0023234235,0.22601537,0.001693055,0.0013015607,0.0017689329,0.055287026,0.012840546,0.066813424,0.0042265602,0.0015831675,0.002805783,0.35390922,0.0018540445,0.002049944,0.1397797,0.09555321,0.00934985,0.0018557288
blood pressure levels increasing denmark copenhagen city heart study prospective cardiovascular population study designed evaluate incidence risk factors cardiovascular disease random population sample comprising approximately individuals invited participate blood pressure measured information regarding use antihypertensive medication collected initial survey period attendance rate second survey period attendance rate significant increase systolic diastolic blood pressure survey survey found among men women greater years age using antihypertensive medication increase blood pressure follow survey could explained changes methods changes prescription antihypertensive medication selection bias factors associated changes systolic diastolic blood pressure examined multiple linear regression analysis increase body mass index increase alcohol consumption positively correlated changes systolic diastolic blood pressure use antihypertensive medication high value body mass index survey high level education negatively correlated changes systolic diastolic blood pressure female sex advanced age also negatively correlated changes diastolic blood pressure consumption tobacco alcohol income changes consumption tobacco significantly correlated changes systolic diastolic blood pressure,C14,0.0016695142,0.0014809425,0.011178398,0.00093803194,0.0023247458,0.0021697085,0.09353675,0.0015700314,0.0012069845,0.009685987,0.047091454,0.003434912,0.3418385,0.0039466093,0.0014681286,0.002599781,0.05190485,0.017809303,0.050391823,0.21797356,0.13346592,0.00059278385,0.0017212701
temporal relation left ventricular dysfunction chest pain coronary artery disease activities daily living forty three ambulatory patients angina increasing frequency underwent continuous monitoring left ventricular lv function average hours determine incidence temporal sequence lv dysfunction st segment depression chest pain indicators ischemia decrease ejection fraction greater lasting greater minute horizontal downsloping st segment depression greater equal mm onset patient typical chest pain complex combination monitoring interval subjects performed daily activities sitting walking climbing stairs eating patients episodes chest pain st segment depression observed eighteen episodes accompanied decrease ejection fraction patients chest pain accompanied decrease ejection fraction episodes whereas st segment changes occurred episodes decrease ejection fraction began earlier onset chest pain whereas patient ejection fraction decrease chest pain onset started time average interval decrease ejection fraction onset chest pain seconds range st changes occurred onset decrease ejection fraction episodes average interval onset ejection fraction decrease onset st change seconds data suggest lv dysfunction manifested decrease ejection fraction earlier indicator myocardial ischemia angina pectoris electrocardiographic evidence ischemia,C14,0.002030441,0.0018011025,0.0038687622,0.001140822,0.0028303836,0.03309595,0.16186893,0.011729513,0.0014679185,0.07080235,0.019874185,0.0041766386,0.112300895,0.004752385,0.0017855186,0.003161819,0.13749106,0.0020910176,0.002311956,0.12135129,0.2579522,0.030208584,0.011906275
five year experience triple drug immunosuppressive therapy cardiac transplantation although triple drug immunosuppression combination cyclosporine prednisone azathioprine shown improve short term survival cardiac transplantation long term effects still unknown december december patients n underwent orthotopic cardiac transplant institution received triple drug immunosuppressant therapy follow averaged months twenty one patients died survived days actuarial survival year years years twenty five episodes acute graft rejection diagnosed recipients episode per patient patients incidence infection episode infections viral due cytomegalovirus incidence coronary artery disease year years years coronary artery disease responsible late deaths arterial hypertension developed patients despite relatively well maintained renal function serum creatinine mg dl skeletal complications occurred lymphoma recipients complete long term rehabilitation achieved two surviving patients data support short long term effectiveness triple drug therapy regimen reduces incidence rejection infection lymphoma well degree renal failure however incidence posttransplant coronary artery disease reduced graft atherosclerosis represents major cause late graft failure death,C14,0.016003357,0.025326539,0.0030701896,0.0009234417,0.0022931653,0.0021210823,0.23701474,0.009454393,0.0011882109,0.010503581,0.010653087,0.0034759184,0.053882558,0.011814737,0.01726022,0.0025593436,0.33490768,0.0016925804,0.017620442,0.12090453,0.11505583,0.00058356364,0.00169082
adult open heart surgery new york state analysis risk factors hospital mortality rates study analyzes data new york state new cardiac surgery reporting system contains information cardiac preoperative risk factors postoperative complications hospital discharge purposes study determine set significant clinical risk factors identify cardiac surgical centers likely serious quality care problems significant risk factors hospital death age gender ejection fraction previous myocardial infarction number open heart operations previous admissions diabetes requiring medication dialysis dependence disasters acute structural defect renal failure cardiogenic shock gunshot unstable angina intractable congestive heart failure left main trunk narrowed type operation performed four hospitals significantly higher mortality rates expected given risk factors patients subsequent site visits medical record reviews confirmed facilities high percentages quality care problems among cases resulting mortality,C14,0.001816287,0.027979506,0.0033890032,0.0010205319,0.011255625,0.011050391,0.24099179,0.010498597,0.010077627,0.0017846087,0.05111957,0.012954424,0.075086355,0.004460969,0.027962076,0.011612598,0.20434982,0.0018753447,0.0022196528,0.24767177,0.038286515,0.0006448975,0.0018920441
transient myocardial ischaemia acute myocardial infarction prevalence characteristics transient myocardial ischaemia studied patients recent acute myocardial infarction early days late days ambulatory monitoring st segment transient st segment depression much commoner late patients early monitoring transient ischaemia greater episodes silent patients silent episodes late monitoring painful st depression accompanied greater st depression tended occur higher heart rate late transient ischaemia showed diurnal distribution occurred higher initial heart rate often accompanied increase heart rate early ischaemia thus first months myocardial infarction transient ischaemia became increasingly common closely associated increased myocardial oxygen demand transient ischaemic episodes early late ambulatory monitoring dissimilar characteristics may also different pathophysiologies prognostic implications,C14,0.0023276522,0.0020647435,0.0043689962,0.0013078128,0.0032411818,0.014267907,0.3921342,0.0021900318,0.001682789,0.002287055,0.010753741,0.004787536,0.11256145,0.005560618,0.013308356,0.0036246385,0.22513136,0.0023970958,0.0026503743,0.100397855,0.08973356,0.00082646473,0.0023946026
detection location myocardial infarction using technetium sestamibi imaging rest technetium tc sestamibi imaging rest used detect localize myocardial infarction largest study date cooperative study patients institutions normal subjects patients documented myocardial infarction based clinical enzymatic electrocardiographic criteria presence segmental myocardial perfusion defects compared presence q wave electrocardiogram wall motion abnormality gated blood pool scans performed within hours tc sestamibi study infarct patients showed perfusion abnormalities tc sestamibi imaging perfusion defect found patients q wave wall motion abnormality patients wall motion abnormality patients q wave normal subjects normal tc sestamibi images segments tc sestamibi defect regional wall motion abnormality gated blood scans present segments wall motion normal tc sestamibi imaging abnormal segments wall motion abnormal tc sestamibi images normal control subjects segments normal thirty eight patients coronary angiography close relation existed coronary anatomy myocardial tc sestamibi uptake territories supplied occluded vessel poor collaterals grade uptake scale markedly reduced normal,C14,0.012017351,0.0018190253,0.013700048,0.0011521743,0.105335794,0.0026464653,0.19657871,0.001931755,0.0014825257,0.00201488,0.10293936,0.014260304,0.19855025,0.005397973,0.0018032863,0.023042466,0.13840324,0.002115309,0.002334962,0.018465467,0.14107203,0.00072810985,0.012208515
primary varicose veins topographic hemodynamic correlations study conducted correlate clinical presentations uncomplicated primary varicose veins topographic anatomic source reflux escape points one hundred sixty three patients primary varicose veins females males unilateral bilateral involved limbs examined origin extent venous reflux traced doppler ultrasound three distinct groups recognized group typical saphenous varicosities junctional escapes occurred sapheno femoral junction sfj incompetence sapheno popliteal junction spj incompetence limbs group ii atypical saphenous varicosities non junctional escapes occurred limbs limbs escape detected twenty two limbs escapes localized main perforators mid thigh perforator upper calf distal ankle twenty four limbs escapes auxiliary perforators abdomino pelvic circumflex iliac external epigastric limbs group iii non saphenous lateral venous system varicosities occurred limbs based physical examination alone limbs would possibly undergone unnecessary ankle groin stripping limbs unnecessary sfj ligation doppler us essential diagnostic tool accurately map origin extent venous reflux obtained hemodynamic information permit selective multimodal therapy avoid indiscriminate often unnecessary stripping entire saphenous system cases primary varicose veins,C14,0.002114376,0.001875557,0.0039452063,0.03857997,0.013154256,0.07421552,0.28207538,0.09439787,0.032223117,0.0020774987,0.10183965,0.051070355,0.019091656,0.0050325943,0.001859329,0.027248077,0.04532446,0.0022165682,0.002407528,0.116797484,0.058889173,0.010975034,0.01258935
prevalence coronary heart disease scotland scottish heart health study data men women aged years districts scottish heart health study used describe prevalence rates coronary heart disease scotland relation geographical variation mortality districts prevalence measured previous history rose chest pain questionnaire minnesota code lead resting electrocardiogram prevalence coronary heart disease scotland high compared studies countries used standardised methods history angina common men women though response rose questionnaire women men reported chest pain history myocardial infarction three times common men women q qs pattern electrocardiogram significant correlations different measures coronary prevalence district measures angina correlated well mortality coronary heart disease correlations tended stronger women men significant correlation mortality coronary heart disease measures myocardial infarction study provides data prevalence coronary heart disease men women valuable planning cardiological services,C14,0.0020708623,0.0018369582,0.0038640143,0.0011635331,0.0028836103,0.0026725556,0.1977073,0.0019474641,0.0014971413,0.002037209,0.025353044,0.004259368,0.25180602,0.004761552,0.031896144,0.0032277005,0.033719603,0.0021326449,0.032429114,0.328981,0.06088741,0.00073528796,0.002130427
venous ulcers pathophysiology medical therapy venous ulcers may occur result lower extremity calf pump failure ensuing edema trapping white blood cells deposition pericapillary fibrin acute smaller lesions easily treated adequate compression occlusive dressings larger chronic wounds often benefit form external compression occlusive dressings local wound care effective used simultaneously compression sequential compression pumps merit study may prove therapeutic prophylactic value refractory cases long term use compression devices may required prevent ulcer recurrence,C14,0.0034008198,0.06887113,0.006345577,0.018347135,0.021223854,0.020842962,0.41588774,0.03611976,0.018920438,0.0033415053,0.053561766,0.05637458,0.05270906,0.024982177,0.0029905953,0.0052957837,0.0751341,0.0035022807,0.0038723338,0.050128575,0.05343959,0.0012075076,0.003500707
documentation effective length action antihypertensive treatment technique automated ambulatory blood pressure bp monitoring offers innovative means measuring bp throughout hour period recently available compact monitoring instruments shown accurate provide reproducible measurements circadian bp pattern monitoring procedure advantageous minimizes avoids placebo effects therapeutic trials moreover power makes possible draw statistically valid conclusions regarding efficacy fewer patients would required conventional methods used procedure also enhances diagnosis hypertension identifying patients office white coat hypertension thereby facilitates assessment treatment effects patients truly hypertensive automated monitoring measures bp critical times day including preawakening early morning hours enables peak trough antihypertensive drug effects carefully quantified since patient compliance appears enhanced twice daily dosing antihypertensive agents long durations action hours considerable interest report reviews recent studies monitoring technique used measure efficacy duration action differing antihypertensive drugs,C14,0.018900812,0.018703824,0.029353984,0.009550308,0.002464504,0.010767741,0.32090607,0.001664418,0.0012795456,0.018800322,0.07519547,0.0036403083,0.11384403,0.004104782,0.0015563892,0.045561966,0.10711703,0.0018226845,0.019150551,0.034740042,0.15842602,0.0006284206,0.001820789
subnormal parasympathetic activity cardiac transplantation heart period variability standard deviation consecutive rr pp intervals used assess baseline parasympathetic activity patients congestive heart failure orthotopic cardiac transplantation compared age matched control subjects mean heart period variability standard error mean significantly greater p less control subjects ms patients time transplantation heart period variability innervated recipient atria change significantly early weeks transplantation ms p increased significantly weeks transplantation ms p less versus transplantation stepwise regression model r p showed heart period variability directly related time transplantation inversely related systolic arterial pressure transplantation degree rejection heart period variability denervated donor atria change early late periods transplantation suggesting vagal reinnervation donor heart occurred data indicate baseline parasympathetic activity increase significantly first month transplantation increases significantly months,C14,0.002110022,0.020634314,0.0036466324,0.0010977803,0.0027206538,0.002521526,0.067950256,0.0018374104,0.0014125359,0.0019197579,0.009414809,0.0040320274,0.35280016,0.004697864,0.0017181534,0.0124848,0.308388,0.020922396,0.002224729,0.016066704,0.15869571,0.0006937359,0.0020100337
left ventricular asynchrony patients pulmonary hypertension left ventricular regional wall motion evaluated patients pulmonary hypertension control subjects patients secondary pulmonary hypertension less measured diameter stenosis vessel study utilizes video intensity based frame frame computerized technique pulmonary hypertensive patients showed early diastolic asynchrony anterior apical regions lasted ms size abnormal area varied ventricular silhouette four patients also showed systolic abnormalities abnormalities detected control group cause asynchrony detected pulmonary hypertension probably due interventricular interaction caused pressure gradients across septum,C14,0.13515915,0.0024193854,0.0050891414,0.0015324437,0.0038339004,0.0035531851,0.17482418,0.0025697658,0.001971826,0.0026798812,0.077077426,0.03909951,0.10158378,0.0067613074,0.015596883,0.004247209,0.16889003,0.0028088228,0.0031056046,0.046296705,0.1706824,0.027374692,0.002842826
brief angiotensin converting enzyme inhibitor treatment young spontaneously hypertensive rats reduces blood pressure long term study examines long term cardiovascular effects brief period angiotensin converting enzyme ace inhibitor treatment young spontaneously hypertensive rats shr shr treated perindopril mg kg day gavage weeks age systolic blood pressure measured tail weekly weeks age corresponding control groups received distilled water periods treatment group blood pressure reduced significantly treatment rose treatment stopped plateaued significantly control shr thereafter difference blood pressure weeks age due reduced total peripheral resistance determined microsphere methods plasma renin activity angiotensin ii concentrations different cardiac hypertrophy also reduced treated shr separate experiment perindopril treatment weeks age resulted significant reduction media lumen ratios mesenteric resistance vessels weeks age concomitant administration angiotensin ii perindopril weeks age prevented long term effects blood pressure seen perindopril treatment alone associated cardiovascular hypertrophy excess untreated control shr finally perindopril given shorter period weeks later life weeks significant long term effects blood pressure results demonstrate week period ace inhibitor treatment young shr sufficient prevent full expression genetic hypertension cardiovascular hypertrophy angiotensin ii might important development hypertension model role later life less important,C14,0.015226734,0.0148767335,0.009428258,0.00079092814,0.0019602529,0.015444519,0.14567107,0.0013246603,0.0010177031,0.001383146,0.013845272,0.03658749,0.16890238,0.0034105175,0.0012379065,0.0021920786,0.07091074,0.0014496957,0.0016028713,0.13229135,0.35077164,0.00049982243,0.00917418
origin significance diastolic doppler flow signals left ventricular outflow tract diastolic doppler flow signals greater equal left ventricular outflow tract well characterized origin significance remain controversial fifty nine patients years age technically good doppler echocardiographic studies studied prospectively normal subjects patients left ventricular hypertrophy dilated cardiomyopathy cardiac disease rhythm sinus atrial fibrillation two distinct doppler flow signals detected left ventricular outflow tract diastole termed e early active occurred ms higher velocity mitral inflow e passive filling atrial contraction signals among patients e signals present mean velocity patients normal sinus rhythm signals present mean velocity signals present four patients atrial fibrillation e velocities pulsed wave doppler ultrasound low left ventricular apex increased along basal septum left ventricular outflow tract prominent velocities greater equal seen patients left ventricular hypertrophy normal subjects patients dilated cardiomyopathy velocity higher patients left ventricular hypertrophy normal heart p less dilated cardiomyopathy p less major determinants diastolic outflow tract velocity mitral inflow e velocities left end diastolic dimension particularly combined r p less e r p less distinctive e doppler outflow tract signals result mitral inflow may detected patients normal heart size e velocities increase apex base prominent patients small normally contracting heart left ventricular hypertrophy,C14,0.0014819074,0.0013024118,0.0027396036,0.0008251402,0.002053528,0.0018948541,0.15111536,0.008486353,0.043691862,0.008512387,0.096906066,0.0030199112,0.21749893,0.004994621,0.0012911427,0.0022863718,0.22196297,0.0015367601,0.0016718195,0.044353075,0.10214743,0.07870979,0.0015177082
abnormal blood pressure response exercise hypertrophic cardiomyopathy investigate incidence abnormal exercise blood pressure responses hypertrophic cardiomyopathy hcm potential role hemodynamic instability mechanism sudden death consecutive patients hcm underwent maximal symptom limited treadmill exercise testing blood pressure recording four patterns blood pressure response observed forty three patients significant exercise hypotension either continuous fall systolic blood pressure n start exercise sudden fall systolic blood pressure mm hg mean mm hg peak value n patients normal response exercise abnormal blood pressure response recovery period remaining patients demonstrated normal blood pressure response patients exercise hypotension younger versus years family history hcm sudden death compared normal blood pressure response versus patients similarly patients abnormal recovery blood pressure responses younger versus years higher incidence family history sudden death versus patients left ventricular cavity dimensions smaller exercise hypotension clinical echocardiographic arrhythmic variables similar assess mechanism exercise hypotension patients demonstrated exercise hypotension symptomatic patients normal exercise blood pressure response underwent invasive hemodynamic exercise testing,C14,0.001576896,0.08362838,0.0028923654,0.0008678874,0.0021512387,0.0019934778,0.123182096,0.0014526269,0.008590326,0.0015226809,0.047093,0.0031796657,0.2778802,0.0035926993,0.0013583443,0.0024053734,0.22293438,0.0015916155,0.0017588347,0.04650668,0.15422858,0.008023488,0.0015891001
successful surgical treatment subaortic stenosis caused accessory mitral valve month old boy subaortic stenosis found relatively mature mitral valve tissue beneath aortic valve associated hypertrophic prominent interventricular septum tissue caused obstruction left ventricular outflow tract resulted pressure gradient mmhg aorta left ventricle surgical treatment successfully performed excise tissue part hypertrophic ventricular septum results microscopic examination resected specimen shown discussed,C14,0.0041099656,0.0035433923,0.007453473,0.002244392,0.005562327,0.06279348,0.22718321,0.003756552,0.022124033,0.042596668,0.019452281,0.046854924,0.044169657,0.010514572,0.0035127334,0.006220393,0.26735857,0.0041137557,0.0045484174,0.029537164,0.15748648,0.020754104,0.004109477
time course cellular enzyme release dog heart injury transport time enzyme heart plasma studied two experimental models first enzyme alanine aminotransferase slowly infused left ventricular wall open chest dogs half life washout alanine aminotransferase activity plasma minutes mean sem n different ischemic normally perfused tissue measurements arteriovenous differences alanine aminotransferase activity left ventricular blood flow concluded total enzyme washout ischemic tissue occurred direct entry bloodstream corresponding value vascular permeability surface area product ml kg hr second model studied myocardial enzyme release plasma abrupt heart injury induced minutes calcium free coronary perfusion followed reintroduction calcium calcium paradox mechanism half life release plasma hours mean sem n influenced sustained ischemia slower washout observed second model consistent increased interstitial protein space corresponds permeability surface area product ml kg hr results used calculate time course cellular enzyme leakage rate enzyme release plasma various forms heart injury significant shifts time curves evolving cellular injury enzyme release plasma observed hours ischemia followed coronary reperfusion permanent ischemia,C14,0.032701343,0.0014244127,0.013678445,0.0009022259,0.009993633,0.013755467,0.13023977,0.0015129802,0.0011609121,0.009304496,0.019357855,0.0033253606,0.18837863,0.04365095,0.009183263,0.0026281113,0.05556658,0.01026726,0.001828424,0.048742034,0.38462892,0.016115816,0.0016531443
prostaglandin modulation early afterdepolarizations ventricular tachyarrhythmias induced cesium chloride combined efferent cardiac sympathetic stimulation dogs prostaglandins inhibit efferent cardiac sympathetic nerve effects acting presynaptic sites may act suppress arrhythmias present study effects intravenous administration prostacyclin pgi prostaglandin e pge early afterdepolarizations ventricular tachycardia induced cesium chloride mmol liter per kg body weight intravenously combined stimulation bilateral ansae subclaviae anesthetized dogs examined right atrium paced constant cycle length ms left ventricular endocardial monophasic action potential catheter used detect early afterdepolarizations prostacyclin microgram kg per min reduced amplitude early afterdepolarizations monophasic action potential amplitude control study n p less well prevalence ventricular tachycardia dogs control study dogs p prostaglandin e microgram kg per min significantly reduce early afterdepolarization amplitude n p prevalence ventricular tachycardia versus dogs p alpha beta adrenoceptor blockade combined intravenous administration propranolol mg kg phentolamine mg kg decreased amplitude early afterdepolarizations induced cesium chloride bilateral ansae subclaviae stimulation n p additional administration pgi reduced early afterdepolarization amplitude n p,C14,0.046900216,0.00201951,0.004248009,0.0122918505,0.003170175,0.0029381467,0.3127269,0.0021409974,0.0016459229,0.002236951,0.028787227,0.028050233,0.07442137,0.029362703,0.0020020362,0.0035713757,0.06841772,0.02522401,0.0025923108,0.03865096,0.26075378,0.033870894,0.013976712
effects renin inhibition systemic hypertension effect direct renin inhibitor enalkiren abbott laboratories examined healthy patients essential hypertension unrestricted sodium diet plasma renin concentration inhibited within minutes intravenous enalkiren remained essentially undetectable greater equal hours ng angiotensin ml hour p less mean arterial blood pressure declined gradually mm hg p plasma aldosterone concentration ng dl p whereas plasma immunoreactive active renin concentration increased progressively pg ml p greater urinary excretion stable metabolite prostacyclin keto prostaglandin f alpha decreased slightly significantly ng g creatinine p addition diuretic decreased baseline blood pressure increased baseline plasma renin aldosterone values blood pressure responses enalkiren slightly though significantly greater observed diuretic administration conclude enalkiren effective decreasing blood pressure inhibiting renin system without significantly altering urinary prostacyclin excretion patients essential hypertension results suggest renin system contributes maintenance elevated blood pressure patients essential hypertension,C14,0.03637283,0.0017664614,0.051816113,0.0011188802,0.0027729461,0.012188029,0.13654438,0.0018727263,0.0014396856,0.0019566566,0.009186039,0.013729233,0.26738837,0.025224155,0.0017511772,0.0031010068,0.05130559,0.002055942,0.0022674892,0.013019387,0.341091,0.010345206,0.01168669
patient profiling individualization hypertension therapy although stepped care approach remains cornerstone antihypertensive therapy patient profile must also considered important issues include patient age race activity level potential hypertensive complications presence diseases cost medications probability adherence recommended drug regimen nonpharmacologic treatment based lifestyle changes useful adjunct drug therapy sufficient control hypertension patients selection pharmacologic therapy must based knowledge drug mode action side effects well characteristics special patient populations,C14,0.03209261,0.0026653796,0.005606586,0.0016882569,0.004184045,0.0038778102,0.4899586,0.0028257207,0.0021723139,0.0029523615,0.039115716,0.0062834453,0.02575334,0.024662962,0.0026423177,0.0046790494,0.113092236,0.0030944133,0.018519538,0.09378078,0.10166326,0.0010668841,0.01762236
transesophageal echocardiography detect atrial clots candidates percutaneous transseptal mitral balloon valvuloplasty left atrial thrombi common patients mitral stenosis percutaneous balloon mitral valvuloplasty performed patients potential risk thrombus dislodgment embolization study conventional transthoracic echocardiography transesophageal echocardiography performed percutaneous balloon mitral valvuloplasty consecutive candidates men women years old five patients transesophageal echocardiography revealed left atrial thrombus one suspicion left atrial thrombus transthoracic echocardiography balloon mitral valvuloplasty canceled four five patients three underwent mitral valve surgery confirmed echocardiographic findings transesophageal echocardiography better conventional transthoracic echocardiography detecting left atrial clots candidates balloon mitral valvuloplasty potential risk embolization transesophageal echocardiography recommended candidates balloon mitral valvuloplasty,C14,0.0030494197,0.0027049873,0.005689901,0.119775504,0.0042790566,0.003935435,0.14819045,0.06191809,0.0022045947,0.002996234,0.09931657,0.0062720734,0.019125376,0.007062619,0.0026815827,0.0047485805,0.34790665,0.0031523532,0.0034722127,0.109355725,0.037934475,0.0010827382,0.0031453548
preanaesthetic medication clonidine purpose study evaluate oral clonidine dose mg routine premedicant sixty nine normotensive female patients studied randomized double blind investigation clonidine compared inert treatment clonidine produced significant reduction anxiety p less sedation reduction sleep dose methohexitone p less tachycardia response intubation attenuated clonidine p less however magnitude increase arterial pressure intubation affected intraoperative postoperative hypotension common premedication clonidine mg caution urged use premedicant,C14,0.0046777586,0.0036839982,0.0077492357,0.002333452,0.0057830466,0.005359779,0.20704845,0.0039056162,0.0030024995,0.004080655,0.030808449,0.028519006,0.13611908,0.009549237,0.0036521228,0.006467225,0.13345401,0.004276994,0.044931747,0.08177572,0.2670748,0.0014746115,0.004272546
effect halothane isoflurane postischemic stunned myocardium dog short periods coronary artery occlusion known produce prolonged periods ventricular dysfunction effects halothane isoflurane contractility metabolism postischemic stunned myocardium studied open chest canine model left anterior descending artery lad occluded min reperfused regional function lad circumflex artery circ areas measured sonomicrometry metabolic data determined simultaneous arterial venous measurements oxygen lactate halothane isoflurane produced equivalent decreases systolic shortening normal circ stunned lad areas heart furthermore amount depression similar either halothane isoflurane halothane mac significantly decreased systolic shortening lad region circ region equivalent mac concentrations isoflurane values lad region circ area mac halothane systolic shortening lad region decreased circ area isoflurane mac produced significant decreases lad region circ area,C14,0.12366612,0.0022418946,0.0047157924,0.0014200207,0.00362319,0.015492487,0.07674421,0.02684342,0.001827169,0.00248328,0.018765984,0.0054797535,0.20287314,0.0058355117,0.0022224968,0.0039411634,0.08268919,0.002641755,0.0028777714,0.050441295,0.35521045,0.00089737383,0.0070665143
effects ketamine cardiac papillary muscle normal hamsters cardiomyopathy effect ketamine intrinsic contractility left ventricular papillary muscle normal hamsters cardiomyopathy bio month old investigated concentrations ketamine induced positive inotropic effect normal papillary muscle shown increase maximum unloaded shortening velocity p less active isometric force p less peak power output p less induced slight decrease sarcoplasmic reticulum function ketamine effect curvature total force velocity curve suggesting modify myothermal economy contractility papillary muscle hamsters cardiomyopathy less controls shown decrease isometric active force p less peak power output p less sarcoplasmic reticulum function positive inotropic effect ketamine papillary muscle hamsters cardiomyopathy less marked controls almost suppressed cases maximum unloaded shortening velocity significantly increased ketamine p less whereas significant changes observed active isometric force nonsignificant ns peak power output ns ketamine respectively,C14,0.014045211,0.0021626526,0.016341276,0.0013698286,0.003394877,0.038543344,0.102511495,0.0022927513,0.08438302,0.0023955058,0.023229975,0.0050406596,0.35951293,0.0056922375,0.0021439714,0.003796517,0.027605647,0.014437145,0.0027760537,0.016618777,0.25653228,0.012665697,0.0025081534
effect captopril injection patients moderate severe hypertension effect intravenous captopril studied white patients moderate severe hypertension patients received incremental doses mg delivered min intervals min blood pressure bp lowered within min initial dose administered continued decline reaching maximum response min mg time group mean bp fell mm hg p less additional dose increments average cumulative dose mg increase initial effect adverse side effects symptomatic hypotension occurred subject significant correlation diastolic bp decreases observed response intravenous captopril subsequent long term oral captopril therapy addition hydrochlorothiazide increased proportion patients reaching normotension conclude small intravenous bolus injections captopril appear effective rapidly well tolerated moderate severe essential hypertension short term intravenous administration seems predict response chronic oral captopril therapy,C14,0.023043718,0.0019139877,0.0040260446,0.0012123237,0.003004529,0.0027846245,0.1610452,0.0020291274,0.012003409,0.0021200671,0.017673302,0.13122378,0.15933214,0.004961219,0.012226232,0.0033809533,0.12888853,0.0022220735,0.002456859,0.021969367,0.29949662,0.0007661209,0.0022197624
relationship atherosclerosis young men serum lipoprotein cholesterol concentrations smoking preliminary report pathobiological determinants atherosclerosis youth pday research group investigators eight communities collected aortas right coronary arteries blood associated information males years age died violent causes pathologists central laboratories graded arteries atherosclerotic lesions serum lipoprotein cholesterol thiocyanate concentrations measured percentage intimal surface involved atherosclerotic lesions aorta right coronary artery positively associated serum low density lipoprotein low density lipoprotein cholesterol concentration negatively associated serum high density lipoprotein cholesterol concentration serum thiocyanate concentration marker smoking strongly associated prevalence raised lesions particularly abdominal aorta effect smoking explained lipoprotein levels blacks extensive total surface involvement aorta adjustment lipoprotein cholesterol levels smoking associations indicate serum lipoprotein cholesterol concentrations smoking important determinants early stages atherosclerosis adolescents young adults,C14,0.023052482,0.0019144001,0.020551411,0.0012125849,0.034348786,0.0027852245,0.15576644,0.054247193,0.0328238,0.002120524,0.03242341,0.014886843,0.043530814,0.009585211,0.054194346,0.0033607117,0.07419305,0.0022225522,0.0024573884,0.19882044,0.2325158,0.000766286,0.0022202407
current results elective aortic reconstruction aneurysmal occlusive disease decisions resect small aortic aneurysms employ non operative treatment aorto iliac occlusive disease must depend current rather historical surgical results assess current morbidity mortality reviewed consecutive aortic resections two groups patients treated undergoing elective aortofemoral bypass occlusive disease afb resection infrarenal abdominal aortic aneurysms aaa indications afb included claudication rest pain gangrene aaa size ranged cm mean cm presented abdominal back pain patients undergoing afb younger afb years vs aaa years higher incidence atherosclerotic risk factors diabetes mellitus vs tobacco use vs hyperlipidemia vs p less coronary artery disease cad prevalent aaa patients vs p less postoperative mortality different occlusive aneurysmal disease afb vs aaa occurrence serious complications myocardial infarction vs pulmonary embolism vs improvements patient selection perioperative care surgical technique lowered mortality elective aortic surgery given current standard care aggressive approach aaa even high risk patients appropriate low morbidity afb occlusive disease mandates critical appraisal less effective nonoperative therapies,C14,0.0019721137,0.0017493633,0.0036797598,0.0011080502,0.0027628897,0.0025451155,0.22258423,0.06867857,0.0014257504,0.0019377175,0.01003546,0.014164442,0.080885515,0.0046126805,0.0017342271,0.06261939,0.27163732,0.0020309503,0.0022455417,0.19596054,0.042901333,0.00070022594,0.002028838
coronary artery dissection case report coronary artery dissection spontaneous catheter induced associated significant morbidity mortality authors present case middle aged woman spontaneous right coronary artery dissection causing inferior wall myocardial infarction left coronary artery dissection time coronary arteriography suggested emergency aortocoronary bypass surgery performed preceded insertion intra aortic balloon acute evolving cases coronary anatomy favorable limit infarction avert loss life,C14,0.004326237,0.003837588,0.008072309,0.002430736,0.026942499,0.005583234,0.18765247,0.102725565,0.0031276767,0.004250782,0.10703085,0.008898242,0.03280091,0.010022465,0.0038043836,0.006736851,0.18128118,0.0044553066,0.004926057,0.11832797,0.16677992,0.0015360896,0.0044506732
possible triggering paroxysmal atrial fibrillation normal hearts psychological stressors report two cases paroxysmal atrial fibrillation triggered psychological stress two patients normal echocardiograms coronary angiography neither patient alcoholic ingested ethanol relation onset atrial fibrillation free metabolic derangements possible mechanisms involved triggering atrial fibrillation discussed,C14,0.0054730247,0.0048548463,0.010212096,0.0030750693,0.0076210136,0.0070632235,0.34713253,0.005146899,0.0039567533,0.031871106,0.07899804,0.011256966,0.06995813,0.013294003,0.031306397,0.008522638,0.13467391,0.005649793,0.006231844,0.05276254,0.15336543,0.0019432723,0.005630446
latissimus dorsi cardiomyoplasty treatment patients dilated cardiomyopathy stimulated skeletal muscle grafts proposed means reinforce ventricular wall treatment severe myocardial failure latissimus dorsi cardiomyoplasty performed patients advanced heart failure due cardiomyopathy new york heart association nyha class iii iv despite maximal medical therapy operative deaths eight patients followed mean months two patients remain muscle conditioning protocol one patient died latissimus dorsi ischemia congestive heart failure four eight patients long term follow nyha class three class ii one class iii months follow rest radioisotopic left ventricular ejection fraction increased p less doppler echocardiography demonstrated left ventricular segmental wall shortening improved p less left ventricular stroke volume ml p less cardiopulmonary exercise test showed maximal oxygen consumption treadmill test increased ml kg min p less months follow values remained essentially unchanged furthermore nonsustained ventricular tachycardia abolished without specific medical therapy four patients thus cardiomyoplasty improves left ventricular function reverses congestive heart failure may improve long term survival severe cardiomyopathies,C14,0.0020388463,0.06077202,0.0037974715,0.0011408582,0.0028672246,0.022271648,0.10542248,0.0019401353,0.040782176,0.0019950906,0.03187583,0.0043176035,0.1393093,0.005310612,0.021436572,0.0031671573,0.27899742,0.01187556,0.002312029,0.07752811,0.12856548,0.040039793,0.0122365765
endogenous vasopressin supports blood pressure prevents severe hypotension epidural anesthesia conscious dogs evaluate whether extent release endogenous vasopressin supports blood pressure efferent sympathetic drive blocked epidural anesthesia authors studied effects high epidural anesthesia alone vasopressin prevented acting vascular v receptor six awake trained unsedated dogs different days dose bupivacaine ml injected epidurally randomized fashion either presence absence v vasopressin receptor blockade effects evaluated cardiovascular arterial blood pressure heart rate respiratory blood gases oxygen consumption variables plasma concentrations vasopressin renin results also contrasted obtained epidural injection saline alone placebo dogs endogenous vasopressin prevented acting intravenous pretreatment specific v receptor antagonist beta mercapto beta beta cyclopenta methylene propionyl tyr arg vasopressin epidural anesthesia resulted rapid sustained decrease mean arterial blood pressure mmhg se mmhg contrast decrease mean blood pressure mmhg mm hg noted epidural anesthesia alone difference groups statistically significant p v receptor blockade alone detectable effect vasopressin plasma concentrations significantly increased pg ml pg ml epidural anesthesia change epidural saline,C14,0.025266636,0.028745288,0.0034822235,0.0010480836,0.0025974894,0.008444232,0.15161997,0.0017713987,0.019390952,0.010858084,0.02029925,0.0629823,0.2281406,0.0045844186,0.0016403723,0.048042655,0.044678345,0.04890744,0.0111528905,0.01404343,0.2319835,0.00066233036,0.029658128
dynamic positron tomographic imaging nitrogen glutamate patients coronary artery disease comparison nitrogen ammonia fluorine fluorodeoxyglucose imaging study designed test usefulness nitrogen n glutamate imaging positron emission tomography defining myocardial ischemia humans seventeen patients undergone coronary arteriography studied n glutamate peak supine exercise using bicycle ergometer well flow tracer n ammonia peak exercise second similar exercise test six patients also underwent imaging n glutamate rest exercise testing remaining patients imaging fluorine f fluorodeoxyglucose performed assess glucose metabolism second exercise test seven patients classic metabolism flow mismatches consistent ischemia decreased n ammonia uptake region relatively increased f fluorodeoxyglucose uptake evidence increased n glutamate uptake ischemic mismatched regions patients patients uptake n glutamate exercise paralleled uptake n ammonia exercise suggesting n glutamate behaves flow tracer rather metabolic marker ischemia humans,C14,0.002276423,0.079163045,0.026271496,0.0012790292,0.05826925,0.0029477053,0.16741686,0.0021407758,0.0016457525,0.013253027,0.077573776,0.0046909377,0.10462994,0.011153055,0.002001829,0.09167336,0.17628677,0.0023711547,0.0025920426,0.039795976,0.1293153,0.00080827513,0.00244426
development prospective application quantitative day stress rest tc methoxy isobutyl isonitrile spect diagnosis coronary artery disease clinical diagnostic accuracy day stress rest quantitative technetium tc methoxy isobutyl isonitrile tc sestamibi single photon emission computerized tomography spect assessed validation population patients two different sites using two different camera computer systems study population made catheterized patients cedars sinai medical center csmc university texas southwestern medical center utsmc eight utsmc patients less pre test likelihood coronary artery disease interpretation employed gender specific normal limits developed additional men women csmc less likelihood significant coronary artery disease results csmc compared utsmc different overall sensitivity detection patients coronary artery disease greater equal stenosis csmc utsmc overall specificity five patients normal coronary arteriograms csmc utsmc normalcy rate patients low likelihood coronary artery disease vessel sensitivity csmc utsmc vessel specificity csmc utsmc also significant difference sensitivities specificities male female populations addition agreement coronary angiography assessment disease extent normal coronary arteriogram single multivessel disease kappa study demonstrated tc sestamibi spect quantitative analysis accurate detection localization coronary artery disease furthermore csmc quantitative method shown provide similar diagnostic accuracy applied data acquired different site using different camera computer system,C14,0.0015923384,0.0014124836,0.027994905,0.00089466997,0.002237065,0.0020549956,0.28899932,0.0015014958,0.0011511898,0.0015645659,0.09868232,0.0033438737,0.11513478,0.0038735026,0.016815655,0.0332381,0.1783845,0.0016783889,0.0018131115,0.09233231,0.11538699,0.008271595,0.001641824
severe mitral insufficiency post balloon valvuloplasty late changes found disrupted mitral valve case yr old woman balloon valvuloplasty rheumatic mitral stenosis presented anterior mitral leaflet tear occurred complication procedure partial healing anterior mitral leaflet gradual dilatation left atrium occurred allowed damaged valve remain situ several months late changes occur complicated valvuloplasty illustrated patient eventually required surgery valve excision definitive repair,C14,0.004087707,0.0036119132,0.0075976057,0.0022877932,0.025366351,0.024949552,0.20637889,0.023539469,0.0029437493,0.0040008086,0.08332163,0.008374969,0.11052348,0.009438532,0.0035806613,0.0063406806,0.31087676,0.004193306,0.0046363734,0.046789553,0.10152548,0.0014457576,0.004188945
factors affecting survival total artificial heart recipients transplantation identify factors affecting successful bridge transplantation experience recipients jarvik artificial heart reviewed patients without successful bridge significant differences preoperative hepatorenal function postoperative hemodynamics significant differences body size recipients divided according body surface areas less greater smaller patients frequently developed respirator dependence vs p less renal failure vs p less hepatic failure sepsis resulting less frequent qualification transplantation vs p less successful bridge operations seven patients body surface areas less one success nine patients less cm height despite use smaller stroke volume model smaller patients poorer ventricular filling largely compensated drive controls set significantly longer diastole higher vacuum resulting similar hemodynamics groups results suggest device fitting manifested body size important factor affecting major organ recovery subsequent transplantation recipients jarvik artificial heart paracorporeal device may advisable patients body surface areas less less cm height even smaller model better fit thorax becomes available,C14,0.0016563811,0.04156208,0.0038072225,0.000930653,0.002331811,0.04922062,0.14397472,0.0015576809,0.009190134,0.017657507,0.009741868,0.028456515,0.20968089,0.04564657,0.038233012,0.018609012,0.22361086,0.001705798,0.0018933428,0.030290496,0.11795067,0.0005881208,0.0017040238
sex differences control cutaneous blood flow women far likely men suffer raynaud disease purpose study determine whether gender differences local central control cutaneous blood flow could account increased incidence raynaud disease women assess cutaneous blood flow hand blood flow hbf finger blood flow fbf skin perfusion sp measured fluid plethysmography mercury strain gauge plethysmography laser doppler spectroscopy respectively volunteers basal hbf men exceeded women versus ml ml min likewise fbf men surpassed women versus ml ml min similarly sp men greater women versus perfusion units however total body warming induce thermal sympatholysis hbf women exceeded men suggesting lower basal hbf women due increased sympathetic outflow extremities mental stress deep inspiration reduced hbf sp men paradoxically maneuvers increased hbf sp women determine whether paradoxical responses women due women elevated basal sympathetic tone experiments repeated total body cooling men increase sympathetic tone total body warming women reduce sympathetic tone total body cooling reduced hbf sp men conditions mental stress deep inspiration induced vasodilation women total body warming minutes increased hbf,C14,0.001699172,0.0015052303,0.019573674,0.00095341593,0.018775666,0.002189931,0.070620514,0.0015957804,0.009416404,0.0016672987,0.03388389,0.015345606,0.28862783,0.025698492,0.047156487,0.002645872,0.025844226,0.0017475203,0.0019321643,0.245641,0.18113163,0.0006025057,0.0017457028
hypertensive heart disease relationship silent ischemia coronary artery disease left ventricular hypertrophy ecg evidence silent ischemia occurs commonly patients systemic hypertension relationship left ventricular hypertrophy lvh large vessel coronary artery disease cad neurohumoral factors remains unclear accordingly validated results echocardiographic method used measure left ventricular lv mass soviet union comparison necropsy measurements patients examined relationships men essential hypertension among st segment depression ambulatory monitoring exercise stress transesophageal pacing n lv mass catheterization evidence cad n neurohumoral factors plasma catecholamines platelet aggregability echocardiographic measurements lv mass soviet penn methods closely correlated necropsy values r respectively p less ambulatory monitoring episodes greater equal mm st depression occurred patients hypertension ischemia also provoked exercise pacing stress patients respectively neither st depression occurrence additional episodes symptomatic angina related presence coronary obstruction catheterization patients without st depression differ age blood pressure lv mass,C14,0.023787951,0.023540199,0.04936149,0.012001904,0.0031022253,0.0136529775,0.20265661,0.0021009834,0.0016102878,0.0021885198,0.033941634,0.004611124,0.14721428,0.0063438513,0.034296963,0.003468475,0.17075583,0.0022938196,0.002536186,0.13626298,0.07805822,0.043922037,0.002291434
simplified method estimating true aortic valve mean gradient simultaneous left ventricular peripheral arterial pressure recordings estimation aortic valve gradient simultaneous recording left ventricular peripheral arterial pressures subject error due delay modulation arterial pressure contour propagates ascending aorta error corrected averaging mean gradients derived unaltered temporally aligned simultaneous left ventricular peripheral arterial pressure tracings patients aortic stenosis simultaneous recordings ascending aortic femoral arterial pressure compared method simplified approach peripheral arterial pressure partially aligned advancing left ventricular pressure time delay simultaneously recorded upstrokes gradients measured way predicted true aortic valve gradients left ventricular ascending aortic mean difference mm hg range mm hg recommend use simplified method correction predicts true aortic valve gradient equally well averaging technique r vs requires half time effort,C14,0.08927819,0.0020194524,0.004247888,0.0012791252,0.0031970022,0.0029380631,0.114682265,0.025261989,0.045697007,0.024276925,0.09523476,0.07190557,0.2238561,0.01620657,0.01301359,0.0035451301,0.081838116,0.0023853155,0.013606196,0.01514628,0.07007186,0.07795767,0.0023548896
mutation gene type iii procollagen col family aortic aneurysms experiments carried test hypothesis familial aortic aneurysms either thoracic abdominal caused mutations gene type iii procollagen col similar mutations gene shown cause rupture aorta disastrous consequences rare genetic disorder known ehlers danlos syndrome type iv family identified yr old female captain united states air force scrutinized many direct blood relatives died ruptured aortic aneurysms woman heterozygous single base mutation converted codon glycine alpha iii chain type iii procollagen codon arginine studies cultured skin fibroblasts demonstrated mutation caused synthesis type iii procollagen decreased temperature thermal unfolding protein mutation identified dna extracted pathologic specimens mother died age maternal aunt died age aortic aneurysms examination dna samples saliva revealed woman daughter son brother aunt also mutation results demonstrated mutations type iii procollagen gene cause familial aortic aneurysms dna tests mutations identify individuals risk aneurysms,C14,0.001865491,0.0016547836,0.021539625,0.0010483721,0.0118850265,0.0024075133,0.22157821,0.08302055,0.028411573,0.0018329545,0.101857044,0.016280806,0.023414312,0.030385138,0.010662619,0.0029049574,0.043714207,0.020419206,0.0021241358,0.122131154,0.053859275,0.0006623681,0.19634067
management asymptomatic chronic aortic regurgitation left ventricular dysfunction decision analysis study objective determine optimal strategy timing aortic valve replacement patients chronic severe aortic regurgitation left ventricular dysfunction design decision analysis comparing early surgery timed onset left ventricular dysfunction delayed surgery timed onset symptoms using data literature expert opinion variables representative case scenario year old man bicuspid aortic valve disease setting tertiary care center valve replacement surgery measurements main results early surgery approach preferred based quality adjusted life years sensitivity analysis showed result affected following variables within derived ranges rate symptom development onset left ventricular dysfunction delayed surgery approach perioperative mortality approaches occurrence major nonfatal stroke congestive heart failure approaches although decision sensitive yearly postoperative mortality rates delayed surgery operative mortality rate almost low early surgery rate change preference delayed surgery approach preference could also change survival much important patient first five years five years patient disliked living anticoagulants enough value year anticoagulants worth year anticoagulants conclusion decision analysis provides quantitative support impression patients similar case scenario better surgery timed onset ventricular dysfunction surgery delayed symptoms develop thus supports practice following patients noninvasively order time surgery,C14,0.0013291867,0.014003687,0.02774125,0.0007453113,0.0018471217,0.013020381,0.2836284,0.0012478473,0.00095900695,0.0716472,0.029403258,0.0027329654,0.055317346,0.0030744183,0.0011664985,0.0020656504,0.27789432,0.0013717179,0.011252144,0.13978994,0.03223297,0.026156824,0.0013725368
repair flail anterior leaflets tricuspid mitral valves cusp remodeling present alternative approach extensive rupture chordae tendineae leading flail anterior leaflets resection affected cusp segment suture cut edges extensive plication segment annulus devoid leaflets abolished massive regurgitation maintaining adequate valve orifice,C14,0.0063101742,0.0055974396,0.011774131,0.0035454296,0.0087867305,0.038682733,0.24807625,0.0059341644,0.004561975,0.006200117,0.02901979,0.012978823,0.117710255,0.01450904,0.005549008,0.009826254,0.24172382,0.037002537,0.007185062,0.04031748,0.1359766,0.0022405137,0.0064916746
single lung transplantation primary pulmonary hypertension single lung transplantation become therapeutic option end stage interstitial lung disease obstructive lung disease group recently extended treatment three patients primary pulmonary hypertension patients marked decreases pulmonary artery pressures pulmonary vascular resistance increases cardiac output following single lung transplantation spirometry lung volumes diffusion capacity different comparison preoperative studies quantitative ventilation perfusion scans revealed majority perfusion distributed transplanted lung ventilation approximately equally divided native transplanted lung despite ventilation perfusion imbalance resting hypoxemia arterial oxygen desaturation exercise one patient expired th postoperative day due cytomegalovirus infection lungs remaining two patients maximum exercise capacity following transplantation near normal one recipient reduced second recipient note evidence ventilatory limitation impaired oxygenation exercise two recipients although exaggerated exercise ventilatory response present limit exercise performance report supports use single lung transplantation treatment primary pulmonary hypertension,C14,0.09105911,0.043298706,0.0032197472,0.0009695312,0.011327706,0.11517619,0.18173961,0.0016227532,0.009542841,0.0016954804,0.03723411,0.020251144,0.11982351,0.012351573,0.0015174287,0.019389072,0.18035944,0.010391252,0.0019648229,0.039360743,0.0953034,0.0006126896,0.0017891572
pressor systems hypertension congestive heart failure role vasopressin clinical conference elevated peripheral vascular resistance characterizes hypertension congestive heart failure latter regardless absolute blood pressure level maintained large extent combined effects three major neurohormonal pressor mechanisms renin angiotensin system sympathoadrenal system arginine vasopressin blockade one mechanisms may lead compensatory stimulation others thus offsetting part hemodynamic benefits specific intervention combination therapy designed attack three systems use angiotensin converting enzyme inhibitor sympathetic blocker clonidine antagonist vasopressor action vasopressin may help treatment cases illustrate strategy two experimental studies one case malignant hypertension one case congestive heart failure presented,C14,0.06118672,0.089931466,0.018975938,0.016226081,0.0041951863,0.019080248,0.39453968,0.002825709,0.002172305,0.0029770753,0.057627656,0.006180209,0.053777963,0.0074339216,0.0026423067,0.019219978,0.025940437,0.017617611,0.0036354424,0.020408843,0.16923693,0.0010668797,0.003101397
doppler color flow images stenosed arterial model interpretation flow patterns capability recently introduced doppler color flow mapping devices accurately detect flow patterns region arterial stenosis evaluated use vitro flow model pulsatile flow simulating low resistance vessel induced straight acrylic tube alternatively contained axisymmetric stenoses diameter reduction doppler color flow mapper images taken realtime along tube midplane diameters downstream stenosis comparison doppler color flow mapping results similarly recorded flow visualization hydrogen bubble images showed close correspondence key features flow including detection high velocity centerline jet near wall separated flow zones distinctive flow patterns exist stenotic case considerable value diagnosing clinical disease conditions,C14,0.020874104,0.01396198,0.01633817,0.04839213,0.03880228,0.014947607,0.224131,0.0023198863,0.001762653,0.014186515,0.13389277,0.0050147492,0.20778178,0.005984359,0.0021440221,0.0037966615,0.087032564,0.0025108606,0.0027761594,0.01725921,0.13266261,0.0008656882,0.002562213
effects angiotensin converting enzyme inhibitors hydralazine endothelial function hypertensive rats function endothelium impaired hypertension spontaneously hypertensive rats shr acetylcholine induced relaxation decreased serotonin induced constriction increased goal study evaluate effect long term treatment cilazapril new angiotensin converting enzyme inhibitor hydralazine vasodilator endothelium dependent responses aorta shr wistar kyoto rats used normotensive reference isolated aortic rings without endothelium suspended organ chambers rings intact endothelium contracted norepinephrine acetylcholine induced relaxation markedly enhanced cilazapril treatment tension achieved maximal relaxation norepinephrine contraction cilazapril treated shr versus untreated shr p less hydralazine significant effect effect serotonin also markedly modified cilazapril untreated shr serotonin induced release vasoconstrictor substance endothelium assessed ratio maximal tension induced serotonin rings endothelium maximal tension rings without endothelium greater ratio reversed cilazapril treated shr hydralazine treated shr captopril effects similar cilazapril finally evaluation carotid arteries showed cilazapril also prevented morphological changes intima shr e infiltration mononuclear cells conclude angiotensin converting enzyme inhibitors prevent functional morphological alterations endothelium found hypertension speculate action might participate antihypertensive effect,C14,0.03631315,0.020454856,0.014272634,0.019803772,0.012063208,0.0024977964,0.122450426,0.03927902,0.038857136,0.0019016913,0.02133696,0.013364563,0.11964597,0.01629773,0.0017019841,0.0030261378,0.057348337,0.011350445,0.002203792,0.014112926,0.4196768,0.0006872072,0.011353479
regulation fibrillar collagen types iii basement membrane type iv collagen gene expression pressure overloaded rat myocardium left ventricular hypertrophy based cardiac myocyte growth hypertrophic process considered heterogeneous based whether also includes remodeling accumulation fibrillar types iii collagens responsible impaired myocardial stiffness heart messenger rna mrna fibrillar collagen types iii detected cardiac fibroblasts whereas mrna basement membrane collagen type iv present fibroblasts myocytes studied early long term expression collagenous proteins rat myocardium abdominal aortic banding renal ischemia complementary dna probes rat pro alpha mouse type iii mouse type iv collagens chicken beta actin used northern dot blot analysis total rna extracted left ventricular tissue indicated sixfold increase steady state levels mrna collagen type day abdominal aortic banding declined control levels day remained rather constant weeks type iii collagen showed similar pattern gene expression banding mrna levels type iv collagen hand elevated day banding returning control day remaining constant actin mrna levels also increased day banding followed rapid return control levels monospecific antibody types iii collagens immunofluorescent light microscopy frozen sections myocardium revealed week banding distribution density collagens similar control animals,C14,0.0014175269,0.001257417,0.0026460644,0.09751947,0.008934196,0.0018293922,0.20004421,0.035638038,0.0010248087,0.0013928034,0.008876939,0.028231053,0.042804196,0.041148007,0.042461466,0.009059626,0.052754592,0.048237387,0.0016140628,0.019739492,0.26280168,0.014226132,0.07634148
left ventricular mass regression aortic valve replacement measured ultrafast computed tomography left ventricular mass function measured using ultrafast computed tomography correlated clinical status patients aortic stenosis insufficiency undergoing aortic valve replacement balloon valvuloplasty wall mass gm initially decreased gm month p less decreased total gm months valve repair months mean wall mass within normal range three patients retained abnormal hypertrophy ejection fraction increased p clinical function improved patients three patients remaining outside new york heart association functional class months regression ventricular mass normal range correlated attainment class functional status p less despite lack increase ejection fraction single patient followed months valvuloplasty minor wall mass regression minor clinical improvement,C14,0.0023277742,0.0020648518,0.07195523,0.0013078814,0.025772654,0.003004114,0.11301096,0.0022427086,0.0016828772,0.0022871748,0.016124692,0.004787787,0.15020731,0.005424599,0.024602896,0.037417747,0.2534862,0.025304653,0.0026505133,0.07738781,0.1511844,0.023362875,0.002402352
biplane transesophageal echocardiography technique image orientation preliminary experience patients transesophageal echocardiography use uniplane phased array transducer transverse horizontal scanning plane become well established tool evaluating cardiovascular diseases recent introduction biplane probes enhanced diagnostic capability imaging technique article discusses technique biplane transesophageal echocardiographic examination image orientation diagnostic value advantages various biplane transesophageal images heart aorta aortic arch various esophageal positions described,C14,0.0035169935,0.0031197488,0.02354162,0.087084696,0.10705053,0.0045388634,0.24544235,0.02032255,0.019466475,0.0034556526,0.12573598,0.0072337836,0.10019716,0.008223371,0.0030927553,0.022499718,0.120071776,0.0036219202,0.0040046144,0.02334324,0.059569307,0.0012487567,0.0036181533
diet smoking alcohol influence coronary heart disease risk framingham study coronary heart disease chd shown life style particularly diet smoking alcohol consumption great impact incidence chd blood lipoproteins rather total blood cholesterol found accurate predictors chd risk blood triglyceride previously considered little bearing chd risk found negative impact many cases population subgroup high triglyceride greater equal mmol l greater equal mg dl low high density lipoprotein less equal mmol l less equal mg dl increased insulin resistance higher incidence diabetes mellitus found increased risk chd diet intervention trials shown reduction total cholesterol saturated fat consumption produced reduction chd incidence proportionate fall cholesterol cigarette smoking increased chd risk moderately smoked one pack per day twice risk nonsmokers alcohol consumption actually lowered chd incidence framingham study however alcohol consumption greater two drinks per day rise mortality cancer stroke observed,C14,0.001953573,0.0017329166,0.013069425,0.0010976329,0.0027202885,0.01197643,0.11395747,0.0018371636,0.0014123463,0.0019195001,0.043170124,0.017175904,0.12758593,0.0054934076,0.058551542,0.021953423,0.03586422,0.002011856,0.035465717,0.2880271,0.19140688,0.019607095,0.0020100318
changes myocardial ischemic threshold daily activities study assesses variations myocardial ischemic threshold heart rate onset ischemia daily activities patients ischemic episodes holter monitoring eighty patients known coronary artery disease positive treadmill stress test results greater equal ischemic episodes hour period holter monitoring studied lowest highest ischemic thresholds determined patient mean lowest ischemic threshold beats min mean highest ischemic threshold beats min highest ischemic threshold identical ischemic threshold values noted exercise ischemic episodes preceded moderate greater increase heart rate variability ischemic threshold difference percentage highest lowest ischemic thresholds increased number ischemic episodes range however different patients similar number ischemic episodes different variability observed differences ischemic thresholds probably indirect indicators vasomotor activity coronary arteries different patients,C14,0.010422704,0.018859081,0.003330185,0.0010027863,0.0024852278,0.0023033314,0.09195508,0.0016784141,0.0012903052,0.010391212,0.024874115,0.003689335,0.2912111,0.004515789,0.010207073,0.0027792493,0.24946572,0.0018380113,0.0020322169,0.10820143,0.14635776,0.00927151,0.0018383226
effects n fatty acids essential hypertension examined effects blood pressure plasma lipoproteins platelet function marine oil supplements rich n fatty acids vegetable oil supplements rich n fatty acids added usual diets patients mild essential hypertension randomized double blind parallel group study patients received g either marine oil n vegetable oil n daily weeks following baseline observation period diastolic blood pressure declined treatment fish oil mean sem v mm hg p change vegetable oil v mm hg systolic blood pressure change significantly either treatment serum triglycerides declined approximately patients receiving marine oil total cholesterol ldl hdl hdl hdl cholesterol subfractions apolipoproteins b unchanged treatment groups bleeding time increased treatment marine oil change vegetable oil supplements marine oil alter vitro platelet aggregation thresholds lack significant correlation blood pressure changes platelet membrane fluidity plasma renin activity aldosterone norepinephrine epinephrine suggests variables mediate antihypertensive effect marine oil conclude large doses marine oil reduce diastolic blood pressure lower triglycerides increase bleeding time patients mild hypertension,C14,0.016582798,0.0017174238,0.01280046,0.0010878197,0.0026967505,0.0024986474,0.12219687,0.0018207388,0.0013997194,0.0019023392,0.009051236,0.045714516,0.23613286,0.0046461225,0.048554353,0.0031931954,0.08284739,0.002021308,0.020941224,0.045244012,0.3342708,0.0006874414,0.0019919435
vitro vivo evaluation intraluminal ultrasound normal atherosclerotic arteries study evaluated dimensional morphologic precision arterial images obtained using intraluminal rotating scan ultrasound catheters f mhz f mhz dimensions vitro ultrasound images human arteries eight normal nine arteriosclerotic compared histologic sections vessels addition vivo ultrasound studies normal arteriosclerotic canine femoral arteries compared luminal dimensions obtained angiograms vessels correlation vitro ultrasound images luminal diameters n r adventitial diameters n r wall thickness n r normal human vessels significant p less vitro measurements images histologic specimens human atherosclerotic arteries also correlated significantly p less luminal diameters n r adventitial diameters n r wall thickness n r morphologically vitro images wall normal human arteries concentric laminated appearance atherosclerotic vessels patchy echodense echolucent areas vivo studies showed significant correlation diameters normal n r p less arteriosclerotic n r p less canine arteries compared luminal dimensions measured uniplanar angiograms conclude rotating scan intraluminal ultrasound accurately defines normal atherosclerotic arterial wall morphology dimensions technology may valuable intravascular guidance angioplasty devices identifying location consistency lesions,C14,0.067306995,0.018388614,0.019749478,0.0009779498,0.062585205,0.002246284,0.07307295,0.03908768,0.009681122,0.0017102028,0.13965388,0.0035800254,0.14373268,0.006388636,0.0015306049,0.0027104146,0.14329565,0.0018027086,0.001981884,0.011672679,0.23263265,0.00061800977,0.01559368
fate patients undergoing transluminal angioplasty lower limb ischemia prospective study patients underwent percutaneous transluminal angioplasties ptas lower limb ischemia year period performed follow rate achieved first pta successful patients failures failed attempts dilation occurred within month intervention patients failed pta underwent bypass surgery underwent amputation day mortality rate deaths attributed pta survival rate years successes double failures p less best results femoropopliteal stenoses two three patent calf vessels cumulative patency rate years worst femoropopliteal occlusions one patent calf vessels cumulative patency rate years log rank tests life table data used show factors favoring good outcome concluded pta treatment first choice suitable patients although failure intervention critical ischemia significant risk valuable addition therapeutic options patients little chance surgical treatment,C14,0.011968613,0.03764857,0.0038262294,0.020984443,0.0028554122,0.016435882,0.13219906,0.0019335881,0.0014825012,0.0020148468,0.023927968,0.0042178947,0.037428357,0.004848822,0.0018032565,0.013115429,0.42338225,0.0021117905,0.0023349235,0.20883138,0.043811116,0.0007280978,0.002109594
age related changes membrane fluidity erythrocytes essential hypertension present study age calcium related changes membrane fluidity erythrocytes examined patients essential hypertension use electron spin resonance method esr erythrocytes obtained patients essential hypertension examined esr spectra fatty acid spin label agent nitroxy stearate incorporated erythrocyte membranes values outer hyperfine splitting order parameter significantly higher subjects essential hypertension normotensive subjects finding indicates membrane fluidity erythrocytes lower essential hypertension calcium loading erythrocytes ca ionophore decreased membrane fluidity value increased strongly essential hypertension normotensive subjects furthermore ca induced change membrane fluidity significantly correlated age essential hypertension results demonstrate membrane fluidity erythrocytes markedly decreased calcium especially essential hypertension older patients suggests increased calcium sensitivity cell membranes aged hypertensive patient,C14,0.0025284016,0.0022428185,0.053160205,0.0014206058,0.0035548192,0.0032630342,0.10641424,0.0023777396,0.0018279218,0.0024843032,0.029737694,0.0052877576,0.196108,0.106680006,0.014442312,0.003937247,0.072582446,0.0026038345,0.0028789572,0.13638543,0.24658333,0.00089774356,0.0026011264
surgical treatment aneurysm dissection involving ascending aorta aortic arch utilizing circulatory arrest retrograde cerebral perfusion recently replaced ascending aorta aortic arch patients aneurysm dissection using profound hypothermic circulatory arrest retrograde cerebral perfusion operative deaths open aortic anastomosis facilitated repair aortic arch without clamping arch tributaries embolism due particulate debris clamping arch vessels eliminated retrograde cerebral perfusion profound hypothermic circulatory arrest simplified technique may protect brain method offers advantages previously described methods particularly obviating dissection arch tributaries clamping thereof protecting central nervous system,C14,0.061222874,0.01675008,0.033727355,0.00164432,0.004075155,0.04624381,0.1749156,0.07905705,0.0021157793,0.0028755262,0.06706146,0.0065979273,0.12343744,0.020883137,0.0025735514,0.004557277,0.2659426,0.0030138812,0.0033323297,0.02687008,0.04904858,0.0010391185,0.0030150518
erythrocyte fatty acids plasma lipids cardiovascular disease rural china cardiovascular disease cvd mortality coronary heart disease hypertensive heart disease stroke plasma lipids red blood cell fatty acid composition examined ecologic study rural counties people republic china means plasma total cholesterol triglyceride low density lipoprotein ldl cholesterol high density lipoprotein hdl cholesterol concentrations substantially lower ratio hdl cholesterol total cholesterol higher chinese population western populations mortality rates cvd china well western values within china neither plasma total cholesterol ldl cholesterol associated cvd strong inverse correlation red blood cell oleate concentrations cvd observed however red blood cell oleate concentrations associated plasma cholesterol strongly negatively associated arachidonate concentrations suggesting potential diminution cvd oleate reduced platelet aggregability results indicate geographical differences cvd mortality within china caused primarily factors dietary plasma cholesterol,C14,0.0023543763,0.0020882026,0.004392503,0.0013226718,0.003278007,0.0030380862,0.14970215,0.0022138224,0.0017019082,0.0023130397,0.010918165,0.0048595974,0.14580224,0.043224193,0.116376385,0.003672947,0.023287926,0.0024243307,0.014062516,0.17882197,0.28088728,0.00083585473,0.0024218094
hemodynamic metabolic effects dobutamine patients open heart surgery low cardiac output syndrome frequently follows cardiopulmonary bypass cpb surgery present study used dobutamine increase cardiac index ci oxygen delivery patients open heart surgery using increasing doses dobutamine micrograms kg min observed statistically significant p less increases mean ci l min mean heart rate hr beat min mean systemic vascular resistance index decreased significantly p less patients dyne sec cm pulmonary vascular resistance index change ten coronary artery bypass graft patients decreased significantly p less eight valve replacement patients dyne sec cm mean increased patients although concomitant increase oxygen consumption vo four patients observed significant p less increase mean vo remaining patients ml min spite significant decreases pao increases right left intrapulmonary shunting although increases hr ventricular arrhythmias may limit use dobutamine increases ci patients cpb present study dobutamine varying metabolic effect exemplifies need close monitoring hemodynamic metabolic variables using vasoactive drugs postoperative period,C14,0.019175347,0.0016252528,0.003418695,0.0010294385,0.0025512804,0.011586252,0.1156129,0.019460753,0.010190153,0.0018002441,0.009447151,0.013085421,0.3763214,0.0042127934,0.0016111904,0.011858465,0.2133959,0.0018868622,0.0020862292,0.023914851,0.15319395,0.0006505476,0.0018848998
effect ischemia induced middle cerebral artery occlusion superoxide dismutase activity rat brain acute cerebral ischemia increases generation free radicals causing cell damage theoretically may decrease activity scavenging enzyme superoxide dismutase investigate role superoxide dismutase cerebral ischemia used model middle cerebral artery occlusion rats model infarct produced pyriform frontoparietal cortices extending lateral basal ganglia measured superoxide dismutase activity using xanthine oxidase cytochrome c reduction assay areas rat brains tissue samples analyzed minutes hours days middle cerebral artery occlusion hours days sham operation n time significant change superoxide dismutase activity relative control values brain area time hours surgery however days middle cerebral artery occlusion significant decline superoxide dismutase activity p less unoperated controls observed brain areas results support important role changes activity endogenous superoxide dismutase acute phase cerebral ischemia however decrease superoxide dismutase activity days ischemia could indicate ongoing additional damage peri infarct tissue,C14,0.17859763,0.0015431443,0.020050041,0.0009774307,0.0024223886,0.0022450914,0.10916957,0.01005439,0.0012576798,0.001709295,0.01866006,0.0035957734,0.06416059,0.02357511,0.0015297924,0.01954325,0.037871294,0.0017915372,0.001980832,0.055929996,0.44092402,0.0006176817,0.0017934034
neuropsychological outcome survivors hospital cardiac arrest thirty patients resuscitated hospital cardiac arrest without postanoxic coma admission underwent clinical examination neuropsychological testing order assess quality life compared two matched control groups patients previous myocardial infarction healthy subjects none survivors showed severe neurologic impairment returned self sufficient physical activity however behavior rating scale scores significantly worse patients postanoxic coma processing ability linked memory significantly worse postanoxic coma group mood disorders also observed group pathological significance remarkably low incidence neurologic psychological sequelae resuscitated patients particularly early clinical evidence severe cerebral damage encouraging result supports therapeutic systems development efforts management hospital cardiac arrest,C14,0.01663106,0.002326977,0.004894762,0.001473912,0.0036528292,0.027472414,0.30336842,0.0024669608,0.0018965121,0.0025775232,0.089106224,0.06677955,0.08533471,0.020077562,0.002313549,0.004084987,0.16437063,0.002703524,0.015679343,0.06554883,0.113609575,0.00093143014,0.00269873
lower extremity percutaneous transluminal angioplasty multifactorial analysis morbidity mortality analyzed outcome percutaneous transluminal angioplasty pta procedures performed quantitate procedural risks define factors associated suboptimal results immediate clinical failure premorbid factors studied included age sex treatment single versus multiple lesions stenoses versus occlusions premorbid status limb claudication vs limb threat distal level pta adverse outcomes included complications hematoma acute occlusion thrombosis pta site distal embolization failure dilate cross arterial dissection rupture significant systemic derangement major amputations knee knee deaths complications amputations deaths series logistic regression analysis revealed major predictive variable occurrence complication p predictive variable outcomes amputation death p p respectively premorbid clinical status limb lower extremity pta intrinsically benign procedure associated significant risk complication amputation procedure associated death adverse outcomes cluster patients limb threat therefore may reasonable restrict use pta patients claudication strictly selected cases limb threat,C14,0.033906054,0.023544474,0.014898853,0.0012519372,0.0141649,0.0028749297,0.277101,0.002094932,0.0016105094,0.0021888209,0.041377634,0.0046319473,0.027942268,0.0053723436,0.0019868177,0.0034689521,0.18479598,0.013762623,0.0025365348,0.27620047,0.061177302,0.0007909662,0.0023197276
primary repair complete atrioventricular canal recommendation early primary repair forty patients complete atrioventricular canal cavc underwent primary repair fukuoka children hospital fukuoka japan august july age repair ranged months years mean months weight ranged kg surgical mortality justification early primary repair examined eleven patients underwent repair months age group patients months age group patients months age group degenerative changes atrioventricular valve increased significantly age repair increased p less group versus group incidence residual mitral regurgitation tended increase order group though degree ranged trivial mild study left atrium aorta ratio echocardiography revealed stable values around groups around group continued follow period years assessment diameter repaired mitral valve mean interval months groups revealed normal growth mitral valve annulus angle repaired mitral valve ventricular septum affected growth ventricular septum converged normal range mean interval months postoperative pulmonary vascular resistance groups higher respectively group p less versus group,C14,0.011419567,0.0014941342,0.003145167,0.0009463876,0.0023730006,0.0021892122,0.10789163,0.009735981,0.009268694,0.009809011,0.015549732,0.10578982,0.109645426,0.021108204,0.0014812063,0.0026229387,0.39958742,0.001742232,0.010056998,0.09444485,0.07736747,0.00059806416,0.0017328339
angioscopy intraoperative management thromboembolectomy experience angioscopy suggests direct visualization arterial lumen thromboembolectomy procedures would provide reliable method assessing luminal morphologic characteristics angiography alone inspected grafts seven aortobifemoral infrainguinal bypass seven dialysis access fistula grafts patients thirty one patients thrombotic events one patient acute embolus angioscopy following standard catheter thrombectomy revealed significant amounts retained thrombus neointima thrombectomies angioscopic information patients infrainguinal bypass graft led graft revision six cases placement new graft cases one graft limb replaced seven aortobifemoral grafts multiple repeated thrombectomies employed extract debris remaining six cases repeated graft thrombectomy also beneficial dialysis access fistulas angioscopy allowed us omit completion angiogram led improved technical result conclude angioscopy useful thromboembolectomy procedures,C14,0.0302878,0.0026660042,0.0056079,0.0016886524,0.004200317,0.003878719,0.2994621,0.017364014,0.016711144,0.0029530535,0.13123865,0.006181683,0.020977499,0.0069408235,0.0026429368,0.004680146,0.25756735,0.0030987405,0.0034221727,0.055296697,0.104436114,0.0010671341,0.017630372
conjugal temporal arteritis report simultaneous occurrence biopsy proven temporal arteritis husband wife serologic viral studies negative including viral culture wife temporal artery concurrent incidence giant cell arteritis married couple would suggest common exogenous exposure,C14,0.061719675,0.005125604,0.06672118,0.0032465681,0.008046043,0.007457144,0.23461092,0.0054339445,0.004177424,0.005677479,0.07630513,0.011884774,0.065034315,0.12516904,0.005081255,0.008997951,0.050392248,0.005950649,0.0065793977,0.15454878,0.07984441,0.0020516498,0.0059444597
pharmacology angiotensin converting enzyme inhibitors guide use congestive heart failure pharmacokinetics angiotensin converting enzyme ace inhibitors difficult assess several reasons first compounds exert influence inhibiting intermediary enzyme cascade enzymatic events whose rate limiting enzyme renin directly affected ace inhibition second renin angiotensin accumulate ace inhibition change dose ace inhibitor could produce sudden shifts angiotensin angiotensin ii third components circulating renin system require interaction several organ systems effector sites fourth kinetics ace inhibitors influenced organ systems responsible drug absorption metabolism excretion functional status systems affected heart failure process fifth least portion cardiovascular effects ace inhibitors influenced contributions systems whose physiologic effects may importance patients congestive heart failure sixth potential impact tissue bound ace yet fully understood finally appropriate drug dosing effects aging heart failure process extent renin system activity disposition ace inhibitors need considered complex pharmacokinetics treatment ace inhibitors guided pharmacodynamic clinical characteristics,C14,0.001991325,0.040313017,0.04340237,0.0011188444,0.0027728572,0.0025699087,0.32796904,0.0018726662,0.0014396394,0.021230806,0.012210317,0.013724725,0.014495618,0.017876185,0.011386643,0.022377541,0.045622524,0.026490206,0.010841291,0.06156091,0.31597787,0.0007070472,0.0020486019
regional myocardial metabolism high energy phosphates isometric exercise patients coronary artery disease background maintenance cellular levels high energy phosphates required myocardial function preservation animals severe myocardial ischemia characterized rapid loss phosphocreatine decrease ratio phosphocreatine atp methods determine whether ischemic metabolic changes detectable humans recorded spatially localized phosphorus nuclear magnetic resonance p nmr spectra anterior myocardium isometric hand grip exercise results mean sd ratio phosphocreatine atp left ventricular wall subjects rest normal subjects n patients nonischemic heart disease n ratio change hand grip exercise either group however patients coronary heart disease ischemia due severe stenosis greater equal percent left anterior descending left main coronary arteries n ratio decreased rest exercise p less recovered two minutes exercise three patients coronary heart disease clinical symptoms ischemia exercise repeat exercise testing five patients revascularization yielded values rest exercise p significant compared rest exercise revascularization p less conclusions decrease ratio phosphocreatine atp hand grip exercise patients myocardial ischemia reflects transient imbalance oxygen supply demand myocardium compromised blood flow exercise testing p nmr useful method assessing effect ischemia myocardial metabolism high energy phosphates monitoring response treatment,C14,0.010467023,0.08824251,0.0030510442,0.0009157713,0.010156007,0.01705279,0.18410382,0.011178523,0.0011783412,0.0016051035,0.057155598,0.0114265755,0.296001,0.0043565347,0.009302201,0.0025380848,0.11054578,0.0016930909,0.0018558748,0.04568356,0.11343486,0.016357966,0.001697971
determination aortic valve area gorlin formula cardiac sonographer know application gorlin formula cardiac catheterization laboratory standard reference determination aortic valve area continuity equation enables cardiac sonographer determine aortic valve area noninvasively echocardiography laboratory comparison results obtained two methods inevitable cardiac sonographer basic understanding theory pitfalls gorlin formula conflicting results obtained possible reasons clear,C14,0.0047222427,0.004188865,0.008811215,0.0026532356,0.0065755732,0.028948078,0.27425864,0.0044408543,0.0034139713,0.0046398807,0.14947039,0.009712751,0.07259288,0.033640828,0.004152621,0.07592244,0.11929745,0.004863127,0.005376968,0.03249627,0.14327902,0.0016766968,0.0048660277
vascular calcemic effects plasma spontaneously hypertensive rats circulating substances increase intracellular calcium circulating substances increase blood pressure described hypertensive animals humans study report existence factor plasma spontaneously hypertensive rats effects dose dependent time course effects correlated time course potentiation pressor agents plasma addition plasma spontaneously hypertensive rats found inhibit depressor effects parathyroid hormone results confirm presence circulating hypertensive factor plasma spontaneously hypertensive rats may act increasing calcium uptake vascular smooth muscle findings may also help explain secondary increase parathyroid hormone noted forms human experimental hypertension,C14,0.01475413,0.0022415982,0.0047151684,0.0014198328,0.0035188037,0.0035986395,0.21369307,0.0024114335,0.0018269273,0.0025004575,0.0117322765,0.0052080243,0.049769923,0.12034089,0.002222203,0.016162407,0.0649037,0.0026199406,0.0030071486,0.020173237,0.44967422,0.00089725514,0.002608683
post transplant hypertension post transplant hypertension remains important risk factor cardiovascular mortality graft function multiple mechanisms responsible post transplant hypertension details mechanisms poorly understood steroids acute chronic rejection recurrent renal disease native kidney disease renal artery stenosis implicated causing post transplant hypertension addition cyclosporine known hypertensive agent immunosuppressive armamentarium evaluation post transplantation hypertension become difficult presently medical therapy initially directed toward complications cyclosporine nephrotoxicity empirically converting enzyme inhibitors added antihypertensive regimen management aimed identification specific causes post transplant hypertension unfortunately multifactorial etiology post transplant hypertension lack detailed information mechanisms medical surgical therapy often unrewarding study needed clarify mechanisms involved post transplant hypertension thus direct therapy,C14,0.111563295,0.002220398,0.0046705743,0.013510118,0.01560198,0.003230415,0.44618124,0.0023539704,0.001809649,0.0024594688,0.018659044,0.0051484527,0.029408092,0.006426999,0.0022011863,0.0038978886,0.07725907,0.0025778052,0.0028501777,0.10483067,0.13967332,0.0008887693,0.002577423
clinical electrophysiologic characteristics patients antidromic circus movement tachycardia wolff parkinson white syndrome antidromic circus movement tachycardia documented consecutive patients wolff parkinson white syndrome undergoing detailed electrophysiologic evaluation twenty six patients men women mean age standard deviation years range multiple accessory pathways identified patients ten patients clinically documented antidromic tachycardia multiple accessory pathways dizziness syncope occurred patients antidromic circus movement tachycardia six patients clinical documentation atrial fibrillation patients resuscitated ventricular fibrillation patients distinct antidromic tachycardias recorded several different pathways observed orthodromic tachycardia frequently associated arrhythmia dual atrioventricular nodal pathways present patients however atrioventricular nodal tachycardia could initiated interruption accessory pathway successfully performed patients undergoing surgery,C14,0.0028792315,0.002554022,0.005372347,0.02100931,0.017946528,0.017643929,0.19653545,0.0027076642,0.029957797,0.0028290139,0.04120989,0.005922029,0.01921894,0.076302834,0.0025319234,0.018418597,0.34457287,0.003052505,0.0032784285,0.10705089,0.07502148,0.0010223105,0.002962047
changes plasma free fatty acids glycerols prolonged exercise trained hypertensive persons taking propranolol pindolol extent lipolysis attenuated prolonged submaximal exercise beta blockade determined normotensive endurance trained hypertensive sedentary men using nonselective drugs without intrinsic sympathomimetic activity isa initially subjects performed graded treadmill test determine maximal oxygen uptake vo max followed hour walks subject vo max treatments pindolol isa propranolol non isa placebo distribution medication randomized double blinded blood samples taken rest every minutes hour walks analyzed determine concentrations free fatty acids ffa glycerol basis respective changes ffa glycerols respiratory exchange ratio beta adrenergic blockade attenuate lipolysis untrained hypertensive subjects compared placebo administration however beta blockade demonstrate tendency attenuate lipolysis trained normotensive subjects compared results placebo administration particularly evident minutes exercise glycerol ffa concentrations increased resting values conditions beta blockade differences pindolol propranolol observed therefore beta blocking agent isa properties appears clear benefit respect lipid metabolism low moderate intensity exercise furthermore data demonstrate beta blockade inhibit exercise induced lipolysis low moderate intensities exercise formerly believed unlikely cause fatigue normally observed work patient populations taking beta blocking medication,C14,0.0017848848,0.070709124,0.009976146,0.001002854,0.0025098794,0.010936607,0.17149033,0.0016785273,0.018565545,0.027663141,0.018876621,0.0037461426,0.16883704,0.015266,0.027488329,0.021471059,0.06782333,0.011298538,0.036592778,0.095240586,0.1868431,0.0006337478,0.02956568
transesophageal echocardiography awake elderly patient role clinical decision making process assess impact management safety transesophageal echocardiography tee elderly population results limitations technique retrospectively analyzed patients tee indicated whenever transthoracic approach diagnostic inconsistent clinical setting frequent clinical indications investigate source emboli assess valvular regurgitation identify valvular vegetations patients tee significantly influenced management decisions selected patients tee avoided use invasive diagnostic procedures adverse effects included occasional premature atrial ventricular beats patients sinus bradycardia six patients protracted nausea one patient conclude elderly patients cardiovascular diseases tee plays significant role decision making process without adding significant risk,C14,0.0026236647,0.02771899,0.017490959,0.03953573,0.0036533698,0.0043579782,0.23472166,0.002467326,0.0018967927,0.0025779046,0.09480621,0.005396624,0.030609533,0.006458727,0.0023071845,0.0040855915,0.22684509,0.0027019395,0.026400398,0.13860099,0.12110448,0.000931568,0.0027073135
epidemiologic aspects heart failure prevalence heart failure northwest london lower figure quoted united states heart failure common reason medical admission hospital london area problem heart failure predominantly persons years coronary artery disease frequent cause hypertension relatively uncommon patients admitted hospital prognosis poor,C14,0.032826953,0.004986103,0.0104881935,0.0031582077,0.0078270575,0.0078901965,0.26785082,0.03248801,0.004063729,0.032731347,0.05240288,0.011561313,0.03987509,0.012924404,0.004942961,0.0087530585,0.16933557,0.0057886927,0.03359912,0.15211944,0.096608356,0.001995811,0.0057826727
intravascular ultrasound new potential modality angioplasty guidance current angioplasty devices limited significant rates arterial perforation dissection due inadequate techniques guidance restenosis may partly attributed inadequate debulking lesions paper describes authors initial experience vitro vivo intravascular ultrasound possible method enhancing three dimensional guidance devices atherosclerotic obstructions using vitro model correlated dimensions histologic morphology animal human arteries ultrasound images specimens additional vivo evaluations technology canine arteriosclerotic human atherosclerotic arteries preliminarily support hypothesis intravascular ultrasound defines transmural arterial morphology may enhance accuracy angioplasty procedures simultaneous imaging angioscopy intravascular ultrasound demonstrated potential method accurately defining intraluminal transmural arterial wall characteristics,C14,0.05954477,0.037589088,0.0045552514,0.0013706809,0.050677788,0.00314836,0.19465664,0.0023103165,0.0017636825,0.0023969964,0.17993002,0.005044646,0.0392453,0.0068737897,0.0021452743,0.015606093,0.13850491,0.002522991,0.0027777809,0.045900397,0.16680126,0.00086619385,0.035767794
comparison right ventricular biventricular circulatory support porcine model right heart failure effects right ventricular rvad biventricular assist devices bvad acute porcine model right heart ischemic failure produced occluding right coronary artery min rcao compared right left ventricular pressures measured millar transducers respective septal free wall dimensions rvsfwd lvsfwd ultrasonic crystals rcao alone resulted significant right heart failure marked reduction cardiac output pulmonary artery flow reduction rv stroke work isolated rvad significantly improved hemodynamic conditions restoring pulmonary blood flow left heart filling control levels rvad also resulted reduced rvsfwd control levels increased lvsfwd via rightward septal shift due right heart unloading biventricular support resulted hemodynamic improvement estimated lv peak systolic wall stress reduced compared control due concomitant lv unloading reductions lvsfwd therefore either right biventricular devices effective treating rv failure advantage biventricular support left ventricle also unloaded thus allowing improved circulatory support minimal lv wall stress,C14,0.11607234,0.038500693,0.021927154,0.001068193,0.0026473268,0.020422813,0.14346932,0.09241618,0.0013744653,0.0018680166,0.018505562,0.003939396,0.17907046,0.0043866974,0.02007758,0.0029663038,0.06011772,0.0019578955,0.002164768,0.02256602,0.23264922,0.0098760165,0.0019558594
intraoperative transesophageal color coded doppler echocardiography evaluation residual regurgitation mitral valve repair mitral valve competence mitral valve reconstruction awkward assess procedure evaluated respect transesophageal color coded doppler echocardiography patients undergoing mitral valve reconstruction severe mitral regurgitation transesophageal echocardiographic examinations performed induction anesthesia sternotomy baseline mitral valve repair decannulation sternal closure similar mean aortic pressure echocardiographic instrument settings degree mitral regurgitation transesophageal color doppler flow mapping visually quantified point scale pending left atrial extent regurgitant jet compared degree mitral regurgitation left ventricular cineangiography performed within several weeks operation also visually quantified point scale use right anterior oblique projection good correlation two methods r p less conclude residual mitral regurgitation assessed transesophageal color flow mapping operating room highly correlates ultimate mitral regurgitation cineangiography therefore transesophageal echocardiography helpful evaluation mitral valve competence mitral valve reconstruction hence case repair failure allow valve replacement surgical session thus avoiding reoperation,C14,0.0021401823,0.012236838,0.0039936625,0.052892197,0.02365942,0.023430958,0.123158485,0.033033587,0.022209445,0.0020991776,0.09539132,0.025307545,0.12040168,0.004939557,0.0018787313,0.055031944,0.29326925,0.0022001788,0.002432651,0.04500893,0.041987874,0.011098535,0.0021978905
alterations aldosterone secretion metabolism low renin hypertension low renin essential hypertensives lrh normal plasma aldosterone levels inappropriately high relation pra posture major determinant plasma aldosterone pra levels known whether postural increments delta plasma aldosterone delta pra also abnormal lrh evaluate lrh n normal renin hypertensives nrh n normotensive controls n subjects idiopathic hyperaldosteronism iha n studied metabolic unit controlled diet days overnight supine h upright pra plasma aldosterone h urinary tetrahydroaldosterone tha aldosterone secretion rates asr measured delta plasma aldosterone h upright posture different four groups ratio delta plasma aldosterone delta pra however elevated iha lrh compared nrh normals tha excretion also elevated iha lrh lrh normal asr resulted higher fractional tha excretion tha asr lrh compared three groups data support enhanced adrenal angiotensin ii sensitivity lrh aldosterone preferentially metabolized tha lrh since tha reduced biological activity may compensatory mechanism reduce mineralocorticoid activity lrh,C14,0.012644134,0.0019141891,0.12926556,0.0012124513,0.0030048452,0.0027849174,0.159271,0.0020293407,0.0015600852,0.0021202902,0.0111177815,0.025919406,0.084164254,0.017029982,0.0018976267,0.024782298,0.020213466,0.0022367095,0.0024571174,0.04580245,0.38108617,0.0007662015,0.06671971
long term amiodarone administration protects global myocardial ischemia reports effects amiodarone cardiac function variable study addresses effect long term amiodarone administration recovery cardiac function period global ischemia normotensive spontaneously hypertensive rats used normotensive rats n received mg kg amiodarone weeks total mg hypertensive rats n received mg kg amiodarone weeks total mg final myocardial concentrations amiodarone desethylamiodarone micrograms g wet weight normotensive rats micrograms g hypertensive rats p nonsignificant equal numbers controls received sterile saline solution weeks hearts excised perfused langendorff apparatus results indicate minutes normothermic ischemia hearts treated relatively low dose amiodarone recovered greater percentage preischemic work compared controls p less,C14,0.016168555,0.0024850576,0.0052272817,0.0015740405,0.00390098,0.0036154632,0.08908584,0.002634551,0.0020253493,0.016310917,0.013792641,0.053470243,0.16621725,0.0066299294,0.0024636595,0.0043624956,0.12928392,0.0028850657,0.016736262,0.09510055,0.36215317,0.0009947057,0.002882065
ultrasonic evaluation early carotid atherosclerosis investigated prevalence carotid atherosclerosis including mild early lesions association cervical bruits various risk factors age male sex hypertension hyperlipidemia diabetes mellitus obesity cigarette smoking consecutive japanese patients high resolution real time b mode ultrasonography performed determine extent atherosclerosis quantified using scoring system prevalence carotid atherosclerosis patients symptomatic patients asymptomatic patients respectively although carotid lesions detected frequently patients cervical bruits bruits noted examined patients carotid atherosclerosis independent risk factors carotid atherosclerosis patients found age male sex hyperlipidemia diabetes mellitus possible risk factor carotid atherosclerosis study show close association hypertension carotid atherosclerosis might caused high prevalence hypertension patients findings suggest increasing prevalence carotid atherosclerosis japanese though confirmed population based study study demonstrates clinical usefulness high resolution b mode ultrasonography evaluation early carotid atherosclerosis,C14,0.04259904,0.0018558195,0.0039036889,0.0011754798,0.043482527,0.0026999966,0.1725034,0.012048011,0.0015125135,0.002055636,0.07187736,0.004333825,0.048779093,0.004984099,0.0018397622,0.043915454,0.17533965,0.01249793,0.0023821923,0.26379845,0.06266002,0.00074283767,0.02301319
lvas pump performance following initiation left ventricular assistance prevention disturbed flow e g flow stasis consequent thrombosis heart pumps based upon design characteristics determined laboratory bench tests tests employ optimal filling emptying characteristics full fill complete empty mode novacor left ventricular assist system filling characteristics novacor lvas examined first hours implantation patients fill volume pump reduced pathologic states cardiac tamponade following initiation right ventricular mechanical circulatory support addition multiple regression analysis revealed right ventricular function measured amount inotropic support required right ventricular ejection fraction total pulmonary resistance significantly predicted left ventricular assist pump fill volume first hours support flow visualization simulating clinical conditions incomplete filling suggest inadequate valve washing particularly around inlet valve conduit may predispose thrombus formation,C14,0.04631375,0.013044673,0.0131583605,0.0012798071,0.0031814585,0.027326109,0.26931483,0.013129764,0.0016467533,0.0022380794,0.051749334,0.059807755,0.13670711,0.0052373824,0.0020030998,0.0035470198,0.1257815,0.002348048,0.0025936188,0.09435373,0.07799373,0.033889033,0.013355032
embolization giant renal arterial aneurysm year old man presented right flank pain angiography revealed giant right renal arterial aneurysm giant renal arterial aneurysms typically treated nephrectomy patient aneurysm embolized successfully multiple gianturco wallace coils polyvinyl alcohol case indicates embolization may reasonable alternative nephrectomy,C14,0.15355581,0.0046103904,0.009697887,0.0029202306,0.0073167267,0.03185889,0.18638308,0.0552093,0.0037575192,0.005106792,0.12316149,0.010690144,0.03217312,0.011956399,0.004570499,0.008093498,0.109769404,0.005370936,0.005918052,0.059645273,0.16104217,0.0018454228,0.0053469366
comparison intravenous amrinone dobutamine congestive heart failure due idiopathic dilated cardiomyopathy prospective randomized study performed consecutive patients refractory congestive heart failure chf due idiopathic dilated cardiomyopathy compare hemodynamic responses hour infusions amrinone dobutamine drugs substantially reduced pulmonary arterial wedge pressure right atrial pressure systemic vascular resistance increased cardiac index amrinone caused greater decrease right atrial pressure dobutamine p less positive chronotropic effect observed dobutamine p less increase heart rate produced amrinone correlated inversely changes right atrial pulmonary arterial wedge pressures suggesting baroreceptor response reduced preload dobutamine produced larger increase stroke volume index amrinone p less ninety one percent patients receiving amrinone receiving dobutamine reduction greater equal pulmonary arterial wedge pressure p less cardiac index increased greater equal similar numbers patients given amrinone dobutamine negative fluid balance recorded patients receiving amrinone patients receiving dobutamine p less target hemodynamic criteria achieved patients receiving micrograms kg min amrinone effective maintenance dose dobutamine extremely variable clinically important adverse effects observed either drug regimen amrinone dobutamine effective safe agents short term parenteral therapy patients dilated cardiomyopathy severe chf unresponsive oral medication,C14,0.026086276,0.04121702,0.0030659297,0.0009232136,0.0022884484,0.018209424,0.16865544,0.0015452292,0.0011879174,0.001614482,0.03825135,0.032591626,0.23360877,0.0039081215,0.0014449363,0.010512847,0.14999306,0.009640786,0.0018709572,0.028981365,0.20622136,0.016491083,0.0016904024
effect enoximone dobutamine hemodynamic performance open heart surgery clinical comparison prospective randomized study phosphodiesterase inhibitor enoximone compared dobutamine open heart surgery either group patients treated enoximone dobutamine respectively beginning immediately weaning cardiopulmonary bypass hours postoperatively drug administered continuous infusion micrograms min kg body weight enoximone significant increase cardiac output enoximone e dobutamine significant decrease pulmonary vascular resistance e total systemic vascular resistance e achieved systemic blood pressure heart rate different side effects observed enoximone proved safe superior dobutamine low cardiac output states open heart surgery,C14,0.04468059,0.016476473,0.0053725727,0.015548308,0.01792029,0.0037249343,0.14600033,0.0027077778,0.0020816436,0.0028291328,0.04127516,0.037290987,0.28770372,0.0066205203,0.0025320803,0.004488787,0.12117622,0.0029652554,0.0032785663,0.054824814,0.1765173,0.0010223534,0.0029621716
intraoperative peripheral nd yag laser assisted thermal balloon angioplasty short term intermediate term follow laser assisted thermal balloon angioplasty performed arteries iliac superficial femoral popliteal indications surgery limb salvage rest pain claudication patients categorized three groups lesions less cm greater cm greater cm length demographic characteristics risk factors outcome measures compared use fisher exact test student test time vascular patency failure compared use standard kaplan meier survival analysis three groups initial failure recanalize noted lesions less cm lesions greater cm lesions greater cm overall success rate mean follow year less cm lesion group significantly higher rate overall success p two groups combined greater cm lesion group significantly worse two groups combined p patients less cm group significantly longer patency two groups p less iliac lesions higher overall success rate superficial femoral popliteal artery lesions p conclusion widespread application laser assisted thermal balloon angioplasty cannot justified without long term clinical laboratory investigation conversely potential technique dismissed hand proper patient selection length nature lesion treated appropriate forms doses method delivery laser energy remain defined,C14,0.016183816,0.016013749,0.002827182,0.008173461,0.06812774,0.001955428,0.10528956,0.0014335371,0.030432973,0.0014887603,0.038571227,0.06913729,0.25097764,0.003554731,0.023331279,0.017026434,0.2204973,0.0015603915,0.0017252634,0.059626274,0.059963334,0.00053798786,0.0015646747
transesophageal echocardiography percutaneous balloon mitral valvuloplasty ascertain value transesophageal echocardiography percutaneous balloon mitral valvuloplasty present study undertaken anesthesized patients women men mean age years symptomatic rheumatic mitral valve stenosis one patient balloon dilation mitral valve successful doppler derived valve area increased cm transesophageal echocardiography provides continuous monitoring well guidance procedure crossing arterial septum well delivery sheath mitral valve orifice correct positioning balloon highly facilitated reduced x ray exposure time degree mitral regurgitation presence interatrial shunting end procedure could readily assessed making cineangiography necessary complications procedure pericardial effusion could detected hemodynamic deterioration occurred one patient advantages transesophageal echocardiography routine monitoring percutaneous mitral valvuloplasty however weighted added risk expense support,C14,0.013790899,0.0023271162,0.017991757,0.05904034,0.0036530476,0.0033856772,0.27001745,0.0024686987,0.027285619,0.0025776771,0.025024643,0.0053962143,0.06094583,0.006314858,0.002306981,0.004085231,0.28950462,0.0027256508,0.0029871645,0.09911792,0.095398515,0.00093148585,0.0027225567
calcitropic hormones platelet calcium blood pressure essential hypertension plasma ionized calcium platelet cytosolic calcium using fura method gel filtered platelets parathyroid hormone intact hormone midmolecule portion calcitriol calcidiol measured untreated male patients essential hypertension age matched normotensive male research subjects mean levels platelet cytosolic calcium parathyroid hormone calcitriol calcidiol significantly higher whereas plasma ionized calcium significantly lower hypertensive group compared normotensive group platelet cytosolic calcium intact parathyroid hormone positively correlated mean arterial pressure r p less r p less respectively whereas plasma ionized calcium inversely correlated mean arterial pressure r p less combined group study subjects three correlations significant hypertensive group alone normotensive group alone analyzed plasma ionized calcium body mass index serum calcitriol calcidiol multivariable regression model significance partial regressions platelet cytosolic calcium parathyroid hormone mean arterial pressure persisted intact parathyroid hormone positively correlated platelet cytosolic calcium r p less plasma ionized calcium inversely correlated platelet cytosolic calcium r p less results confirm previous reports disturbances calcium metabolism essential hypertension suggest elevated platelet cytosolic calcium observed essential hypertension may linked one alterations calcium metabolism,C14,0.027243596,0.0015434186,0.01056294,0.0009776045,0.0024228194,0.010647997,0.2217639,0.001636266,0.0012579033,0.0017095988,0.017334903,0.04599425,0.23207287,0.10773451,0.009944358,0.036869537,0.029469397,0.01676226,0.0019811841,0.035909068,0.18374571,0.0006177915,0.0017980994
molecular biology cardiology recent developments opportunities clinical applications revolution molecular biology taken place last decade provided powerful research methods changing understanding cardiovascular physiology disease editorial commentary highlight several areas current research activity within broad expanding field molecular cardiology special emphasis prospects clinical applications cardiovascular medicine,C14,0.0050694747,0.004496877,0.009459114,0.0028483311,0.03159017,0.0065935533,0.31788692,0.0047673956,0.0036650046,0.004981057,0.07232781,0.01042694,0.035269227,0.011944263,0.0044579683,0.10605501,0.07299349,0.0052207187,0.0059744758,0.033100378,0.24385655,0.0017999863,0.0052152886
mechanisms heart failure role angiotensin converting enzyme inhibition four major diagnostic criteria syndrome congestive heart failure left ventricular dysfunction exercise intolerance pulmonary congestion edema ventricular arrhythmias activation norepinephrine angiotensin ii vasopressin atrial natriuretic peptide may key factor vasoconstriction increased impedance left ventricular ejection heart failure interventions interfere vasoconstrictor mechanisms salutary effect left ventricular performance treatment angiotensin converting enzyme ace inhibitors alpha adrenoceptor blockers vasopressin antagonists resulted hemodynamic benefits difficult demonstrate long term clinical effectiveness reductions mortality demonstrated patients heart failure treated vasodilators ace inhibitors improvement quality life prolongation life two appropriate goals management heart failure understanding role angiotensin ii interference ace inhibition tissue processes heart failure needed,C14,0.032083564,0.060851403,0.020113515,0.0016884641,0.0041854316,0.0038931142,0.26164714,0.0028260676,0.0021725805,0.002952724,0.048790116,0.02071183,0.027194846,0.031017417,0.002642642,0.019224685,0.10539055,0.023476858,0.003421791,0.09333791,0.18457483,0.044710934,0.0030915744
enhanced alpha adrenergic responsiveness cardiomyopathic hamster cardiac myocytes relation expression pertussis toxin sensitive g protein alpha adrenergic receptors pathogenesis myopathy occurring heart cardiomyopathic strain syrian hamster well understood believed associated abnormal calcium handling myopathic cells purpose study determine whether cardiomyopathy occurring strain bio animals associated enhanced alpha adrenergic receptor mediated rise cytosolic calcium whether pertussis toxin sensitive g protein involved coupling alpha adrenergic receptor changes intracellular calcium whether enhanced alpha responsiveness associated increase level expression alpha adrenergic receptor pertussis toxin sensitive g protein proteins test hypothesis cardiomyopathic state associated greater alpha receptor mediated rise cytosolic calcium studied effect phenylephrine presence propranolol time averaged cytosolic calcium concentration ca isolated cardiac myocytes cardiomyopathic age matched control hamsters phenylephrine caused greater increase time averaged ca increase versus p less contractility versus p less cardiomyopathic normal cardiac myocytes exposure pertussis toxin ng ml hours attenuated alpha adrenergic receptor mediated increase contractility time averaged ca cardiomyopathic normal cells level pertussis toxin sensitive g protein determined pertussis toxin mediated p adp ribosylation fold higher cardiomyopathic versus normal hamster hearts density alpha adrenergic receptors measured antagonist radioligand h prazosin affinity receptor agonist antagonist similar myopathic normal heart membranes thus cardiac myocytes hamsters alpha adrenergic receptor mediated effects ca contractility appear mediated pertussis toxin sensitive g protein proteins myocytes cardiomyopathic hamsters alpha adrenergic effects increased magnitude level pertussis toxin sensitive g protein measurable alteration density ligand binding properties alpha adrenergic receptors,C14,0.016494825,0.0013701742,0.050666887,0.00086787116,0.0021508646,0.0094287805,0.12909222,0.0014525998,0.0011167072,0.0015177012,0.007577718,0.01081998,0.11150112,0.10007406,0.001358319,0.017917426,0.061636746,0.19056584,0.0017588018,0.028980706,0.22160327,0.00054844614,0.031498928
left ventricular asynchrony indicator regional myocardial dysfunction marked heterogeneity myocardial wall thickening within left ventricle among different individuals therefore difficult detect regional myocardial dysfunction absolute values systolic wall thickening tested whether extent left ventricular asynchrony ischemia reperfusion used quantify severity regional myocardial dysfunction nonischemic baseline function known six anesthetized open chest dogs regional myocardial wall thickness measured means sonomicrometry control conditions three degrees ischemic dysfunction mild moderate severe release minute occlusion left circumflex coronary artery degrees moderate mild reperfusion dysfunction similar preceding ischemic dysfunction present two indexes left ventricular asynchrony calculated postejection thickening pet phase difference first fourier harmonic posterior versus anterior myocardial wall motion pd systolic myocardial wall thickening decreased standard deviation control value mild ischemia moderate ischemia severe ischemia conversely pet increased mm control value mm mild ischemia mm moderate ischemia mm severe ischemia pd increased degrees control value degrees mild ischemia degrees moderate ischemia degrees severe ischemia release minute left circumflex coronary artery occlusion pet pd recovered mm degrees moderate dysfunction mm degrees mild dysfunction respectively inverse linear relationships systolic wall thickening pet r p less systolic wall thickening pd r p less inotropic stimulation postextrasystolic potentiation increased regional systolic myocardial posterior anterior wall thickening alter extent left ventricular asynchrony thus normal baseline function known severity regional myocardial dysfunction given inotropic state determined analysis left ventricular asynchrony significant correlation extent pet pd ischemia early reperfusion recovery contractile function late reperfusion thus pet provide prospective marker functional outcome reperfusion,C14,0.027231375,0.030716633,0.002286993,0.0006879316,0.0017049164,0.027253944,0.13301758,0.0011514258,0.0008851753,0.0012030294,0.017920226,0.0025582071,0.4041399,0.0028439348,0.006936941,0.037464093,0.05868129,0.0012610178,0.0013941416,0.084653676,0.11874325,0.035997268,0.0012670171
adaptation ischemia percutaneous transluminal coronary angioplasty clinical hemodynamic metabolic features clinical electrocardiographic coronary hemodynamic responses sequential second occlusions left anterior descending coronary artery patients undergoing elective percutaneous transluminal coronary angioplasty examined transmyocardial lactate metabolism examined additional group seven patients clinical hemodynamic features similar first group noted comparison initial balloon occlusion second occlusion characterized less subjective anginal discomfort less st segment shift versus mv p lower mean pulmonary artery pressure versus mm hg p addition heart rate blood pressure product cardiac vein flow second inflation significantly lower recorded first inflation versus ml min p finally significantly less myocardial lactate production second inflation lactate extraction ratio first inflation second inflation p conclude lessened clinical electrocardiographic hemodynamic metabolic evidence myocardial ischemia second two periods coronary artery occlusion percutaneous transluminal coronary angioplasty supports concept adaptation myocardial ischemia ischemic preconditioning,C14,0.07727655,0.0020192973,0.0152549585,0.012286567,0.0031698414,0.014068806,0.2569711,0.024177937,0.0016457496,0.0022367153,0.010468997,0.026850794,0.199765,0.0052568237,0.0020018255,0.003549409,0.15724972,0.0023526486,0.002592038,0.037485126,0.14016242,0.0008082737,0.002349384
possible mechanisms abnormal norepinephrine sensitivity reactivity resistance vessels development hypertension spontaneously hypertensive rats hypothesis study examined structural functional changes mesenteric resistance vessels early developing established stages hypertension development spontaneously hypertensive rats attempt identify possible mechanisms development maintenance hypertension results suggest development hypertension spontaneously hypertensive rats may caused genetic structural functional abnormalities resistance vessels abnormalities may caused hyperreactivity norepinephrine altered signal transduction process including regulation protein kinase c smooth muscle cells resistance vessels spontaneously hypertensive rats,C14,0.061186895,0.0026707782,0.02014981,0.0016882559,0.0041840426,0.07660391,0.34381467,0.002848774,0.0021723127,0.0029523598,0.01785452,0.006180231,0.023927068,0.030176798,0.031718023,0.01921562,0.046447147,0.0030944117,0.003421369,0.042817812,0.2525374,0.0010668836,0.0032709325
effects differential touch nervous system arousal patients recovering cardiac disease previous research suggests neural properties certain types touch well perceived significance disease state may related heightened activation nervous system study effects different types touch nervous system arousal examined adult patients receiving treatment coronary artery disease exposed standardized protocol systematically varied neural properties procedural nature touch received measures cardiovascular reactivity heart rate rhythm data well blood pressure measurements state anxiety used indexes arousal results indicated types touch evoked heart rate deceleration contrast baseline verbal conditions however differential effects related either neural properties procedural nature touch diastolic blood pressure state anxiety also lower result touch changes observed systolic blood pressure heart rhythm general findings suggested touch served reduce arousal rather produce negative psychophysiologic consequences recovery,C14,0.0020922245,0.0018556756,0.031654097,0.0011754867,0.0029129921,0.0026997873,0.33027482,0.0019673074,0.0015123961,0.0020554764,0.047549423,0.0072883866,0.18475085,0.02042278,0.0018396195,0.0032576215,0.09668503,0.012277298,0.0023820077,0.021892866,0.22055894,0.00074278004,0.0021521344
calcium blood pressure epidemiologic perspective reviewed research literature epidemiologic relationship blood pressure levels calcium emphasis dietary intake conceptual framework causal inference summarized designs results observational intervention studies presented reports observational studies relating intake calcium calcium rich foods blood pressure majority found evidence inverse association however many analyses support relationship two studies confirmed inverse association prospective design nineteen randomized controlled clinical trials calcium supplementation reported excluding exclusively pregnant women eleven showed significant effects blood pressure two trials systolic diastolic pressure significantly reduced remainder results equivocal pooled analyses yielded estimates small mm hg significant reduction systolic blood pressure effect diastolic pressure epidemiologic relationships serum urinary calcium possible mechanisms effects also discussed conclude evidence studies humans suggestive conclusive regarding role calcium hypertension recommendations epidemiologic studies presented,C14,0.017768227,0.001625456,0.030018924,0.0010295672,0.0025515994,0.0023753324,0.2239932,0.0017232385,0.0013247647,0.0018004692,0.02966288,0.003935407,0.15873456,0.073764816,0.0016113919,0.0028534732,0.03107248,0.001891807,0.03741279,0.18061933,0.18166755,0.000650629,0.01191214
inotropic effects angiotensin ii human cardiac muscle vitro direct effects angiotensin ii ang ii human cardiac muscle investigated using isolated trabecular muscles failing functionally normal hearts atrial ventricular trabeculae studied results demonstrated positive inotropic effect ang ii human cardiac muscle comparison effects ang ii among groups indicated responsiveness tended greater atrial normal muscle compared failing muscle results study also demonstrated heterogeneity responsiveness ang ii among human muscles correlated patient age sex diagnosis prior treatment angiotensin converting enzyme inhibitor heart function significant correlation response ang ii response isoproterenol demonstrated failing ventricular trabeculae may suggest defects beta adrenergic responsiveness failing human ventricle accompanied loss responsiveness ang ii studies extended syrian cardiomyopathic hamster control dose dependent inotropic response occurred normal hamster ventricular muscle significantly diminished cardiomyopathic muscle ang ii shorten timing contraction pretreatment adrenergic blocking agents shift dose response curve indicating response cyclic amp mediated study demonstrates first time ang ii exert inotropic effect directly human cardiac muscle confirms direct effect ang ii hamster cardiac muscle study suggests however inotropic response ang ii cardiac muscle heterogeneous may diminished heart failure,C14,0.0015680946,0.0013909782,0.01806067,0.00088104844,0.0096237715,0.0020237078,0.1631825,0.0014746552,0.092232086,0.001540745,0.016732082,0.010898574,0.065063015,0.0064579756,0.001388079,0.032802947,0.15744077,0.0016335302,0.0017855064,0.012269277,0.39177415,0.008137121,0.0016386678
frequency myocardial indium antimyosin uptake uncomplicated coronary artery bypass grafting reported incidence myocardial damage coronary artery bypass grafting cabg highly related methods used since indium monoclonal antimyosin antibody scintigraphy shown highly specific sensitive myocardial necrosis even small lesions uptake radiotracer evaluated cabg consecutive patients without previous myocardial infarction underwent cabg stable angina mbq indium antimyosin injected third postoperative day planar images obtained hours later analyzed myocardial uptake indium antimyosin scintigraphic results related creatine kinase mb levels duration aortic cross clamping cardiopulmonary bypass electrocardiographic changes patients surgical procedure postoperative course uncomplicated indium antimyosin uptake present patients diffused patients localized pathologic q waves occurred postoperatively fourteen patients exhibited st segment changes good relation found among indium antimyosin uptake creatine kinase mb levels duration cross clamping bypass st changes concluded degree myocardial damage though silent common cabg,C14,0.0022765265,0.0020193926,0.014397017,0.0012790874,0.036223713,0.002937976,0.18632643,0.013150504,0.0016458274,0.002236821,0.058222096,0.015686937,0.1324274,0.018773,0.00200192,0.058645576,0.24859591,0.013359155,0.0025921604,0.05538862,0.11657844,0.00080831186,0.014427217
increased erythrocyte sodium lithium countertransport activity essential hypertension due increased affinity extracellular sodium sodium lithium countertransport activity standard assay sodium affinity constant maximum velocity measured erythrocytes normal subjects essential hypertensive patients without family history hypertension normal subjects sodium concentration used standard assay similar sodium affinity constant activity measured assay less maximum velocity patients essential hypertension positive family history sodium lithium countertransport activity greater upper limit normal control range mmol li h l cells reason raised sodium lithium countertransport activity increased sodium affinity lower sodium affinity constant outside ion binding site patients essential hypertension positive family history sodium lithium countertransport activity within normal range standard assay also low sodium affinity constant low sodium affinity constant outside site sodium lithium countertransporter may specific indicator group patients inherited hypertension standard sodium lithium countertransport activity assay,C14,0.024490498,0.0019972704,0.0042012287,0.0012650752,0.0031352642,0.002905791,0.28606275,0.00211742,0.0016277975,0.002212317,0.022437856,0.015722387,0.23746593,0.14427385,0.0019799892,0.00350619,0.077221565,0.01435868,0.0025637636,0.015745917,0.13159211,0.0007994569,0.002316918
current status antitachycardia devices limitations currently available modalities treating clinically important tachycardias role implanted antitachycardia devices continue expand challenge future involve continued technological advances socioeconomic impact efficacious expensive mode therapy era increasing financial restraints studies definitively prove efficacy widespread use antitachycardia device therapy needed,C14,0.0053307014,0.08214743,0.035751447,0.0029951036,0.007422833,0.0068795476,0.3540185,0.005013056,0.0038538596,0.005237727,0.0766888,0.010964233,0.040879816,0.038058113,0.004687684,0.034105174,0.059865735,0.0054897387,0.02881113,0.06385892,0.09477195,0.0018927383,0.031275798
excretion thromboxane prostacyclin metabolites exercise testing patients without signs ischemic heart disease addressed hypothesis platelets activated association effort induced myocardial ischemia stable coronary disease seventy two patients undergoing diagnostic bicycle exercise test stratified according development chest pain yes exercise induced st segment depression least microv electrocardiogram yes noninvasive indexes platelet activation platelet vessel wall interaction urinary excretion dinor metabolites thromboxane tx prostacyclin pgi respectively analyzed samples collected basal state test basal tx pgi differ patients pg mg creatinine respectively without pg mg creatinine respectively chest pain pg mg respectively without pg mg respectively st segment depression test patients without chest pain without st segment depression moderately increased p less urinary tx respectively pgi respectively exercise significant increases observed developing chest pain st depression exercise data indicate effort induced myocardial ischemia associated increase platelet activation platelet vessel wall interaction patients stable coronary disease,C14,0.0020303014,0.05094531,0.04306092,0.0011407435,0.0028271303,0.03210375,0.15958883,0.0019272417,0.0014678175,0.011818243,0.087658145,0.0042692074,0.12354053,0.005506789,0.0017853957,0.0031616013,0.093197696,0.031573795,0.03179056,0.032500546,0.27528897,0.0007208862,0.0020955815
ten year follow quality life patients randomized receive medical therapy coronary artery bypass graft surgery coronary artery surgery study cass quality life indexes assessed patients years randomization medical therapy n coronary artery bypass graft surgery n coronary artery surgery study years mortality medical group surgical group p ns medical group undergone surgery increasing chest pain study entry medical surgical patients angina free years entry frequency asymptomatic patients surgical group medical group however years entry proportion patients free angina fallen surgical group medical group activity limitation use beta blockers long acting nitrates less surgical medical group years entry little different medical group years entry throughout follow recreational status employment status frequency heart failure use medications hospitalization frequency similar two groups thus indexes quality life angina relief increased activity reduction use antianginal medications initially appear superior patients stable manifestations ischemic heart disease assigned surgery years entry advantages much less apparent although observed similarities medically surgically assigned groups years reflect return symptoms surgical group extent important explanation performance late surgery large proportion medically assigned patients rendering asymptomatic,C14,0.00843675,0.0012838976,0.030694023,0.00081322336,0.0020158559,0.0018679183,0.1323,0.001361133,0.0010463907,0.0014261574,0.02794925,0.08751204,0.062305644,0.0034233837,0.015254741,0.023266776,0.2822724,0.0014928319,0.0016480541,0.16118965,0.15043697,0.0005139118,0.0014890104
florid pulmonary veno occlusive disease young woman presented rapidly progressive dyspnea clinical findings strongly suggestive primary pulmonary hypertension possible pulmonary embolism died acute right sided heart failure diagnosis pulmonary veno occlusive disease made autopsy approximately cases disease reported previously literature describe patient particularly florid progression unusual disease death occurred within six weeks onset symptoms,C14,0.081628494,0.0036104778,0.0075945864,0.002286884,0.005667636,0.026210262,0.40730733,0.0038276732,0.0029425793,0.02512311,0.0577917,0.00837164,0.025229657,0.009358666,0.0035792384,0.0063381605,0.10500012,0.0041916394,0.0046345307,0.12166433,0.08200488,0.0014451831,0.0041912403
coarctation aorta post stenotic aneurysm formation despite earlier angiography post stenotic aneurysm aorta unexpected finding operation two patients coarctation one aneurysm found intercostal artery year old man false aneurysm distal coarctation site year old boy aneurysms fragile apt rupture difficult diagnose preoperatively though local factors jet streams bacterial endocarditis may influence formation must underlying generalised weakness arterial wall coarctation regarded isolated arterial abnormality may feature generalised disease risk rupture may prevented antihypertensive treatment operation delayed age group,C14,0.05435037,0.02049553,0.0066768215,0.0020105264,0.022227636,0.056395743,0.3318098,0.022526372,0.019807871,0.038157787,0.028606376,0.04200491,0.057396833,0.009192235,0.0031467066,0.005572228,0.08630096,0.0036939527,0.0040744725,0.12375409,0.05684694,0.0012705404,0.00368127
lower extremity venography iohexol results complications frequency side effects nonionic contrast agent iohexol studied consecutive patients underwent venography clinically suspected deep vein thrombosis dvt compared frequency adverse reactions another series patients received either contrast material high osmolar ionic compound minor side effects including local pain discomfort nausea vomiting dizziness skin reactions superficial phlebitis edema occurred patients confidence interval ci serious adverse reaction bronchospasm seen two patients ci postvenographic thrombosis confirmed means repeat venography occurred one consecutive patients previous normal venogram incidence ci frequency side effects appears significantly less conventional high osmolar contrast agents used use iohexol venography associated minor side effects approximately one fifth patients serious adverse reactions necessitating therapy rare,C14,0.0027270457,0.0024190254,0.0050883843,0.0015322156,0.016998082,0.0035193944,0.3473349,0.028963998,0.0019715326,0.0026794823,0.045232072,0.037841823,0.083939165,0.0063731247,0.002398095,0.030643066,0.2067689,0.0028158277,0.0031051426,0.10221213,0.061662357,0.0009682748,0.0028060114
evolution continuity equation doppler echocardiographic assessment severity valvular aortic stenosis use doppler techniques greatly enhanced noninvasive ultrasound technique evaluation valvular aortic stenosis mode two dimensional echocardiography could reliably distinguish patients severe aortic stenosis milder obstructions hemodynamic information offered doppler complemented echocardiographic imaging provided alternative modality evaluation patients aortic stenosis application modified bernoulli equation pressure gradient across stenotic aortic valve could estimated doppler echocardiography though helpful widely used information provided pressure gradient across valve severity obstruction complete assessment valvular aortic stenosis therefore includes estimation valve area application continuity equation review examines maturation continuity equation doppler techniques discusses implications procedure,C14,0.0025304938,0.0022421563,0.0047163423,0.0014201864,0.040228654,0.039962493,0.2538142,0.0023770377,0.07523146,0.0024835698,0.098995626,0.041881826,0.04750719,0.0059524113,0.014449836,0.0773409,0.18243048,0.002603066,0.01496101,0.022781532,0.050370354,0.00089747855,0.0148216635
clinical hemodynamic assessment hepatojugular reflux hepatojugular reflux hjr test studied assess ability clinically predict response cardiac catheterization determine significance patients without heart failure correlate baseline hemodynamic parameters sixty five patients considered free heart failure undergoing routine cardiac catheterization enrolled hjr test defined venous pressure response sustained abdominal compression performed standardized manner bedside assessing change internal jugular venous pressure right sided cardiac catheterization measuring change right atrial pressure comparison sustained increase greater equal cm considered positive patients hjr test stabilized seconds results examination bedside agreed catheterization k p less hjr test result correlated best baseline mean right atrial pressure r right ventricular end diastolic pressure r bivariate regression analysis predicted right atrial f r p less right ventricular end diastolic f r p less pressures positive test high sensitivity specificity predicting right atrial pressure greater mm hg right ventricular end diastolic pressure greater mm hg concluded seconds adequate interpretation bedside observation predicts response right sided cardiac catheterization,C14,0.06336952,0.010963579,0.0035789597,0.0010776974,0.0026708816,0.011751068,0.094791956,0.029654225,0.0013866948,0.0018846375,0.18747683,0.0039451476,0.23878455,0.004424188,0.0016867212,0.0029868674,0.122413516,0.0019753163,0.0021840294,0.030651903,0.17040412,0.009964325,0.0019732618
efficacy safety low high dose sotalol versus propranolol prevention supraventricular tachyarrhythmias early coronary artery bypass operations supraventricular tachyarrhythmias reported patients early coronary artery bypass graft operations randomized study compared efficacy safety class iii antiarrhythmic beta blocking drug sotalol versus propranolol low high doses prevention supraventricular tachyarrhythmias consecutive patients coronary artery bypass graft operations patients severely depressed left ventricular function contraindications beta blockers excluded fourth hour sixth day coronary artery bypass patients received low dose sotalol mg every hours patients low dose propranolol mg every hours patients high dose sotalol mg every hours patients high dose propranolol mg every hours baseline characteristics comparable groups supraventricular tachyarrhythmia observed received low dose sotalol received low dose propranolol received high dose sotalol received high dose propranolol significant drug related adverse effects necessitating discontinuation drug occurred four receiving low doses receiving high doses p less conclusion medication found superior although supraventricular tachyarrhythmias tended less prevalent patients treated sotalol treated propranolol moreover significantly fewer adverse effects noted low dose groups therefore low dose beta blocking treatment especially low dose sotalol seems preferable,C14,0.0015333259,0.016203776,0.002861027,0.00086151325,0.0021351078,0.009348716,0.12804343,0.0014419582,0.0011085264,0.0015065827,0.015412144,0.07953714,0.15193444,0.0035382991,0.001348368,0.0023877071,0.24862918,0.0015790714,0.0017591165,0.05598795,0.2484569,0.007964537,0.01642119
increase calmodulin activator hypertension modulation dietary sodium calcium aim study investigate effects dietary calcium sodium blood pressure bp normotensive rats wistar wky spontaneously hypertensive rats shr dahl rats calmodulin cam activator newly discovered hydrophobic compound increases cam activity shr spontaneously hypertensive mice shm tissues j clin invest cam activator assessed capacity stimulate cam dependent phosphodiesterase cam pde wistar rats fed high sodium diet bp significantly increased p less mm hg parallel elevation cam activator u wky shr dahl salt sensitive ds jr salt resistant dr jr rats given low high ca diets sodium rats receiving high dietary ca progression hypertension diminished bp lower shr mm hg young ds jr rats mm hg receiving low dietary ca mm hg concomitant decrease cam activator animals levels indistinguishable wky dr jr rats activator also found heart kidneys erythrocytes shm presence exogenously added cam lipidic extracts shm heart showed augmented cam pde activity relative normotensive preparations difference eliminated trifluoperazine,C14,0.062441148,0.0019160813,0.014484831,0.011666768,0.0030078155,0.0027876704,0.13862981,0.0020313468,0.0015616275,0.0021223861,0.019598935,0.03540142,0.11790952,0.094557405,0.0018995025,0.01381471,0.023429466,0.002224504,0.0024595463,0.08770085,0.34691995,0.0007669589,0.01266773
left ventricular regional wall stress dilated cardiomyopathy left ventriculography simultaneous pressure micromanometry performed normal control subjects patients dilated cardiomyopathy dcm left ventricular silhouettes right anterior oblique projection divided eight areas regional wall stress computed janz method area excluding two basal areas wall stress higher dcm patients control subjects p less percent area changes end diastole end systole area lower dcm patients control subjects mean six areas versus respectively p less coefficient variation percent area changes six areas left ventricle dcm patients greater control subjects versus respectively p less indicating regional differences hypokinesis significant negative correlation end systolic regional wall stress percent area change r p less area thus excessive regional afterload may play important role causing regional hypokinesis dcm,C14,0.002327754,0.0020648339,0.004343347,0.0013078699,0.0032413234,0.014262151,0.07570085,0.028211873,0.0016828624,0.0022871548,0.05120704,0.016747205,0.3375983,0.0053796745,0.047121942,0.0036247969,0.1261584,0.0023975887,0.00265049,0.028676152,0.21725096,0.02336267,0.0023947074
nonuniform regional deformation pericardium cardiac cycle dogs hypothesized local contact forces pericardium heart cause regional variation pericardial deformation cardiac cycle reflecting volume changes underlying cardiac chambers test measured regional pericardial area right atrium ra right ventricle rv orthogonal pairs sonomicrometers six open chest dogs left ventricular end diastolic pressure mm hg rv pericardial area paralleled rv volume shrinkage ejection expansion filling ra pericardial area reciprocally related rv pericardial area average expansion ventricular ejection thus paralleling ra volume rv ejection volume loading rv pericardial shrinkage ejection increased ra pericardial area change longer reciprocal change rv ejection elimination contact forces cardiac tamponade resulted marked attenuation rv pericardial area changes synchronization rv ra pericardial area pattern shrank rv ejection two additional dogs measurement pericardial area left ventricle atrium showed similar results conclude dynamic pericardial contact forces cause regional variation pericardial deformation reflects volume changes underlying chambers findings imply influence pericardium filling ejection may complex previously recognized varying chamber dynamically course cardiac cycle,C14,0.06098668,0.001955532,0.059683494,0.022546723,0.0030697444,0.0028450666,0.14893912,0.0020731709,0.033606883,0.0021660845,0.04354628,0.015251898,0.19161421,0.01574062,0.001938612,0.0034329186,0.10412566,0.0022868803,0.0025101868,0.017660454,0.2502989,0.011452379,0.0022685009
effects calcium channel blockade calcium homeostasis mild moderate essential hypertension calcium channel blockers may alter parathyroid hormone secretion vitro would alter calcium homeostasis determine chronic effect calcium channel blockade vivo conducted randomized double blind week study comparing effects two pharmacologic antihypertensive agents calcium channel blocker diltiazem angiotensin converting enzyme inhibitor captopril parameters calcium homeostasis diltiazem captopril lowered blood pressure similar degree neither drug produced significant change blood levels total ionized calcium magnesium phosphorus affect regulation parathyroid hormone vitamin addition eight weeks following initiation neither drug altered serum levels parathyroid hormone pth oh vitamin chronic calcium channel blockade diltiazem alter serum parameters calcium homeostasis thus affect bone mineralization,C14,0.0028011505,0.0024847602,0.0052327216,0.0015738523,0.0039005135,0.0036150308,0.27073085,0.002634236,0.0020251072,0.002752295,0.027772686,0.0057686935,0.12436577,0.061791863,0.002463337,0.031475987,0.030341849,0.046111844,0.030302074,0.035308704,0.30267036,0.0009945867,0.0028817204
evidence hibernating myocardium new transesophageal echocardiographic technique reversal resting wall motion abnormalities successful coronary angioplasty documented patient use novel approach stress testing transesophageal stress echocardiography utilizes transesophageal atrial pacing provoke myocardial ischemia left ventricular contractility monitored means transesophageal echocardiography potential use technique illustrated report,C14,0.0050693406,0.004496758,0.009558722,0.10099274,0.007058896,0.006542248,0.2549331,0.0047672694,0.0036649075,0.0049809245,0.1419291,0.011209479,0.071231395,0.01165598,0.053539615,0.007894018,0.1394502,0.0052205804,0.0057721897,0.03318917,0.060775205,0.026338946,0.029729223
postinfarction ventricular septal defect repair retrospective thoughts historical perspectives evolution surgical techniques repair postinfarction ventricular septal rupture initially involved differentiation lesions prior experience surgical approaches congenital ventricular septal defects main applicable second understanding differing anatomical locations postinfarction ventricular septal defects required innovation terms location cardiotomy type repair necessary achieve successful result given patient gradual appreciation different clinical courses pursued patients postinfarction ventricular septal rupture terms location defect degree right ventricular functional impairment led increased urgency relative timing surgical repair incorporation specific anatomical concepts surgical repair better understanding time course physiological deterioration patients ultimately lead integrated approach aimed toward improved salvage patients suffering catastrophic complication acute myocardial infarction,C14,0.013572188,0.002065626,0.01579642,0.0013084279,0.0366965,0.014263816,0.23492089,0.0021898877,0.0016835079,0.0022880323,0.016757669,0.0048500034,0.019537501,0.031521127,0.0020477532,0.014878145,0.38641915,0.00239812,0.0026515068,0.066671744,0.11284638,0.0008268179,0.013808774
simulated left ventricular aneurysm aneurysm repair swine patch reconstruction left ventricular aneurysm may superior linear closure hypothesis tested experimentally accordingly six anesthetized domestic pigs instrumented measure regional left ventricular wall thickening stroke volume systolic left ventricular pressure myocardial oxygen consumption total bypass cardioplegia cm dacron patch inserted anteroapical left ventricle simulations follows left ventricular aneurysm patch open patch reconstruction patch plication standard repair ventriculotomy edges approximated global function stroke work stroke volume x integral left ventricular pressure left ventricular end diastolic pressure curves depressed three simulations compared control tendency stroke work greater standard repair left ventricular aneurysm patch reconstruction higher preloads statistically significant mechanical efficiency stroke work myocardial oxygen consumption joules per milliliter oxygen per beat mean standard error mean control standard repair patch reconstruction left ventricular aneurysm significant differences regional work calculated regional left ventricular wall thickening x integral left ventricular pressure slope regional work end diastolic wall thickness relation decreased posterior wall control versus left ventricular aneurysm patch reconstruction standard repair p less anterior wall contractility change significantly control left ventricular aneurysm patch reconstruction standard repair decreased end diastolic wall thinning anteriorly suggested tethering results normal left ventricle suggest patch ventriculoplasty greater benefit linear repair either repair may impede function adjacent myocardium restriction regional diastolic lengthening,C14,0.02486547,0.0014938834,0.010795524,0.0009462288,0.08385006,0.0022575895,0.07783494,0.0016309236,0.0012175315,0.009784042,0.031631425,0.0035404225,0.26115328,0.00392649,0.001480977,0.018914768,0.21102509,0.0017346467,0.001917599,0.048111938,0.09356674,0.10658788,0.0017325431
improvement early diastolic filling dynamics aortic valve replacement use ultrafast computed tomography patients undergoing aortic valve replacement aortic stenosis prospectively followed evaluate relation left ventricular mass diastolic function studies done intervention months later mass decreased g standard error mean baseline g g months respectively patients demonstrated significant greater mass regression operation one patient failed show significant changes mass diastolic function defined peak filling rate early diastole improved p less group mass regression baseline months respectively improvement time peak filling rate also noted heart rates unchanged whereas end diastolic volumes decreased ejection fractions increased slightly postoperative increase peak filling rate correlated regression ventricular mass within normal range standard deviations attainment new york heart association class status months p less thus improvement diastolic function seen aortic valve surgery associated improved functional class diastolic function improves later regression wall mass may imply delayed remodeling ventricle,C14,0.0017468942,0.0015432816,0.0706234,0.0009775177,0.010844883,0.0022452911,0.09765269,0.0016445282,0.0012577915,0.010128532,0.017944446,0.012124224,0.22644046,0.0047862106,0.026038893,0.03638536,0.23970158,0.001792012,0.001981008,0.06352864,0.15978512,0.009037405,0.001789833
predictive value lipoprotein serum lipoproteins angiographic diagnosis coronary artery disease determine relation among lipids predicting coronary artery disease cad patients undergoing diagnostic angiography suspected cad prospectively studied twenty one patients normal coronary arteries cad arteries arteriography measurements obtained digital calipers lipoproteins measured lipoprotein lp also assayed subset patients cad statistical analysis performed using uni multivariate techniques test association among age gender systemic hypertension diabetes mellitus cigarette smoking family history total cholesterol triglycerides high density lipoprotein hdl cholesterol low density lipoprotein ldl cholesterol low density lipoprotein cholesterol apolipoproteins apo apo b ratio apo apo b ratio hdl cholesterol total cholesterol lp cad factors except gender systemic hypertension diabetes mellitus cigarette smoking univariate predictors cad multivariate predictors decreasing order significance family history age hdl total cholesterol ratio apo b lp included multivariate predictors age family history apo b lp order lipid parameters alone showed hdl total cholesterol ratio lp provide best predictive tests detection cad referral population may ultimately become important screening tests cad,C14,0.03940813,0.0017166787,0.0036110082,0.0010873479,0.0026947986,0.0024975634,0.15142156,0.0018199489,0.0013991122,0.0019015139,0.16193429,0.003980475,0.12502092,0.015863582,0.16173618,0.012361088,0.086375035,0.0019937337,0.0022035865,0.15382805,0.06446459,0.0006871431,0.0019936657
natural history hypertrophic cardiomyopathy elderly prognosis patients diagnosed hypertrophic cardiomyopathy advanced age well defined study details follow information obtained patients initially diagnosed hypertrophic cardiomyopathy age greater equal years seventy five percent patients symptomatic defined presence chest pain dyspnea syncope mean ventricular septal thickness mm median duration follow study years survival rate years respectively significantly different age gender matched control group patients presenting new york heart association functional class ii dyspnea progressed class iii iv follow period however patients presenting class iii dyspnea year mortality rate significantly higher control subjects p less echocardiographic variables indexed left atrial size strongly associated reduced survival p less results suggest prognosis elderly patients hypertrophic cardiomyopathy generally favorable certain clinical echocardiographic variables appear use identifying patients less favorable prognosis,C14,0.0021353157,0.0018941317,0.0039842776,0.0011997469,0.0029906826,0.0027557362,0.20010872,0.012343126,0.0015437382,0.002098073,0.05192632,0.03227923,0.13092147,0.0050740405,0.014542578,0.0033251306,0.29096392,0.0021990212,0.002431371,0.16481291,0.057180654,0.011093102,0.002196734
effects calcium channel blockers coronary vasoconstriction induced endothelin closed chest pigs purpose study determine effects endothelin coronary vascular bed closed chest pigs endothelin pmol kg body weight selectively administered left anterior descending coronary artery coronary blood flow epicardial vessel diameter measured quantitative arteriography arterial pressure increased pmol kg dose heart rate changed coronary blood flow vessel diameter left anterior descending artery significantly decreased respectively p less versus control pmol kg dose whereas variables modestly decreased left circumflex artery endothelin doses pmol kg produced electrocardiographic st segment elevation associated decreased oxygen saturation coronary sinus venous blood endothelin induced coronary vasoconstriction significantly inhibited treatment intravenous diltiazem mg kg n nifedipine mg kg n vehicle administration n study demonstrates intracoronary administration endothelin causes significant myocardial ischemia coronary vasoconstriction inhibited calcium channel blocker data suggest calcium influx smooth muscle cells appears involved least part mechanism endothelin induced coronary vasoconstriction vivo,C14,0.031188915,0.001976094,0.0041579506,0.012027397,0.0031022201,0.0459941,0.1345565,0.04291626,0.0016105385,0.0021888604,0.0103339795,0.028614925,0.1827733,0.027113479,0.001958996,0.003469015,0.083246104,0.0022982068,0.002536581,0.018441752,0.35641205,0.0007909805,0.0022917907
dynamics platelet thrombus formation rate thrombus retention time rate embolization control heparin bonded polyurethane angio catheter dynamics platelet deposition embolization control heparin bonded polyurethane catheters cpc hbpc evaluated labeled autologous platelets plt computerized gamma camera cgc ten non heparinized dogs kg catheterized femoral arteries cm cpc hbpc fr cordis hr injection microci plt imaged hr computerized gamma camera regional platelet deposition curves rpdc indicated multiple peaks valleys curves analyzed early rate thrombus formation upswing thrombus retention time full width half maxima rpdc peak rate embolization downswing catheters four parameters mean sd thrombosis catheters integral radioactivity time curve hr duration imaging calculated normalized counts sec rate thrombus formation rate embolization higher control hbpc suggesting heparin bonding decreases early rate thrombosis embolization thrombus adhesivity retention time appear shorter control catheter indicating control thrombogenic catheter forms multiple thrombi emboli hbpc integral appears larger control catheter hbpc vivo dynamic studies vitro studies critical analyses radioactivity time curve essential complete evaluation thrombogenicity catheters cardiovascular prostheses,C14,0.011902419,0.0018078822,0.04332977,0.0011451163,0.032510288,0.0026547562,0.15025374,0.0019220772,0.01133662,0.0020025373,0.1300596,0.015005155,0.15754333,0.015250912,0.0017922396,0.0032277585,0.07199471,0.002103524,0.0023206584,0.08023374,0.25877053,0.0007236496,0.002109022
note measurement hypertension hhanes using data hhanes found rates elevated blood pressure readings clinical examination extremely low sample mexican american puerto rican women prevalence rates one fourth one fifth rates found comparable sample white women nhanesii findings discrepant little known hypertension prevalence among hispanics estimates hypertension prevalence mexican americans puerto ricans drawn nhanesii hhanes samples women much lower rates clinical high blood pressure whites reported hypertension histories excess whites rates medicine usage among hispanics insufficiently large effective treatment explain disparity prevalence estimates increased relative discrepancies remained altered sample specifications clinical high blood pressure measure possible explanation discrepancies physicians performed majority blood pressure readings hhanes sample may statistically inefficient discrepancies noted suggest hhanes may reliable source information hypertension among hispanic women,C14,0.05326597,0.0018747001,0.02439272,0.0011874388,0.0029435167,0.0027274657,0.18248175,0.0019874764,0.042450633,0.0020765495,0.12179141,0.0043468806,0.15506598,0.005151518,0.012087837,0.023743805,0.044838063,0.0021764617,0.012619677,0.19487587,0.08454458,0.00075039506,0.022619344
regeneration myocardial phosphocreatine pigs despite continued moderate ischemia effects hour mild moderate reductions coronary blood flow myocardial high energy phosphate levels evaluated thirty anesthetized pigs instrumented left anterior descending arterial venous catheters crystals instantaneous wall thickness fluid filled occluder measurement myocardial blood flow performed microspheres series myocardial biopsies also performed pigs overall coronary blood flow lowered fall subendocardial subepicardial flow ratio wall thickening subendocardial flow fell coronary blood flow thickening constant hour ischemia phosphocreatine mumol g wet wt subendocardial third ischemic zone fell minutes ischemia p less versus control returned normal minutes p ns despite ongoing ischemia subendocardial atp mumol g wet wt fell slowly leveled minutes ischemia p less versus control similar regeneration phosphocreatine found seven additional pigs transmural reduction coronary blood flow reduction subendocardial flow significant changes atp phosphocreatine noted two different control groups n pigs regeneration phosphocreatine despite ongoing ischemia low atp levels related changes myocardial oxygen demand consumption regional function period ischemia may reflect successful downregulation energy needs ischemic myocardium maintain cell viability metabolic abnormality ability cells produce atp primarily use phosphocreatine,C14,0.0018960879,0.010305194,0.020785572,0.0010117105,0.0025073448,0.0023238296,0.09269589,0.019123552,0.001301788,0.001769242,0.03299606,0.03041006,0.38594437,0.022173168,0.0015834441,0.0028039827,0.07970703,0.0018545814,0.0020503022,0.094762966,0.18950206,0.00063934457,0.0018524398
dental implants used periodontal patients performing implant treatment continued research reports long term successful results essential evaluating validity implants especially variables design surface treatment introduced dental profession enthusiastically embraced clinical results implant treatment benefits patient however patients undergo periodontal restorative treatment must continue regular long term routine maintenance therapy ensure dental health must patients receive dental implants periodontist places implants dentist fabricates prosthetic replacement must work cooperatively deliver healthy restoration function many years,C07,0.0031420798,0.017932324,0.023599906,0.0017654065,0.004375247,0.0040791044,0.33985046,0.00295485,0.0022715838,0.0182791,0.027389938,0.026091073,0.03859283,0.11114642,0.0027630657,0.0048928717,0.24014911,0.0032358214,0.01878481,0.044698443,0.05965744,0.0011156384,0.0032324558
needle aspiration biopsy salivary gland lesions value needle aspiration biopsy evaluation management salivary gland pathology controversial major reasons controversy difficulty cytologic evaluation fact extent surgery easily defined based clinical judgement however preoperative diagnosis helpful discussions patients regarding extent type surgery apart fact needle biopsy distinguish benign malignant conditions also useful distinguishing salivary nonsalivary pathology past years performed needle aspirations parotid submandibular submucosal lesions adequate specimens cytologic evaluation obtained patients total parotid lesions submandibular lumps submucosal abnormalities detected cytologic diagnosis benign pathology made patients twelve patients lymphoma diagnosis suspected based needle aspiration patients tuberculosis patients hyperplastic lymph nodes benign lymphoepithelial disease parotid three false positive two false negative reports complications hematoma nerve injury infection developed major difficulty distinguishing malignancy obstructive sialadenitis submandibular region needle aspiration helpful evaluating lesions tail parotid submandibular area cytologic distinction salivary nonsalivary pathology useful planning appropriate surgery extent surgical resection clinical standpoint distinction benign malignant salivary nonsalivary pathology helpful preoperative diagnosis warthin tumor lymphoma benign lymphoepithelial disease essential correct management patients,C07,0.01185857,0.0018009649,0.033272006,0.0011407706,0.1011128,0.041927554,0.2879787,0.0019093055,0.0014678063,0.011785663,0.1197718,0.0041759103,0.032180823,0.004708637,0.0017854978,0.042473514,0.21760438,0.0020908578,0.0023117792,0.015362102,0.060456317,0.00072088075,0.0021033834
maintaining periodontal treatment dental maintenance supportive periodontal treatment spt keep periodontium peri implant tissues healthy active therapy patients comply suggested spt fare better periodontally keep teeth longer data gathered examinations talking patients reviewing personal oral hygiene sub supra gingival deposits removed average spt visit last hour scheduled every months supportive periodontal treatment patients advanced periodontal peri implant destruction responsibility periodontist,C07,0.004721678,0.004188364,0.008810161,0.025507867,0.0065747867,0.0061989054,0.3453523,0.004440323,0.003413563,0.027479723,0.06741441,0.009711589,0.07236668,0.062289614,0.0041521243,0.0073526343,0.1763688,0.004862545,0.0053763245,0.034628317,0.11225531,0.0016764962,0.004857488
using periodontal plastic surgery techniques mucogingival surgery evolved periodontal plastic surgery various techniques designed produce root coverage areas marginal tissue recession augment deficient ridges lengthen crowns cases excessive gingival display periodontal plastic surgery enables dentist reconstruct also regenerate lost tissues,C07,0.005621787,0.0049868054,0.037651286,0.0031586527,0.00782816,0.0073061013,0.15686685,0.0052867965,0.004064302,0.0055237357,0.10172303,0.011562942,0.062750585,0.0137930615,0.0049436577,0.0359498,0.2043907,0.0057895086,0.0064012315,0.086125866,0.18902718,0.0019960923,0.0372519
prevalence periodontitis military treatment population group males females age range military dental clinic given oral examinations full mouth circumferential periodontal probing diagnoses made individual quadrants entire mouth using clearly defined diagnostic criteria results showed subjects gingivitis early periodontitis moderate periodontitis advanced periodontitis juvenile periodontitis necrotizing gingivitis prevalence periodontitis increased age peak year age group proportion periodontitis affected quadrants although initially lagging behind overall case diagnoses also increased age,C07,0.0035161905,0.020132447,0.0065608467,0.001975604,0.004896184,0.004537827,0.30508512,0.0033066683,0.0025420492,0.0034548638,0.14132611,0.043599915,0.070179164,0.008100607,0.020083519,0.00547544,0.059487723,0.0036210932,0.0040037003,0.20001945,0.08322965,0.0012484716,0.0036173272
sialolithiasis case studies review three cases sialolithiasis presented representative acute chronic presentations problem evaluation treatment salivary gland duct stones outlined primary axiom treat gland stone essential aspects emergency medical management antibiotics sialogogues warm compresses mechanical stimulation appropriate referral otolaryngologist,C07,0.005471949,0.0048538917,0.010210089,0.029552622,0.034108914,0.0070618354,0.39001858,0.031625025,0.0039559756,0.0053765113,0.07820895,0.011254753,0.0342944,0.0125817,0.0048118937,0.035008594,0.06297106,0.0056352,0.032707825,0.08720929,0.10550869,0.0019428903,0.0056293393
long term fate vascularized iliac crest bone graft mandibular reconstruction vascularized bone grafts iliac crest become major tool mandibular reconstruction due growing trend toward immediate bone replacement followed implant osseointegration dental rehabilitation understanding long term characteristics grafts essential early postoperative bone scans demonstrate increased activity within vascularized graft relative surrounding bone study addressed use bone spect single photon emission computed tomography scintigraphy long term method evaluating integrity vascularized bone grafts,C07,0.0041581425,0.0036833163,0.027847309,0.00233302,0.02616828,0.0053587873,0.20556073,0.0039048933,0.0030019435,0.0040798998,0.21923262,0.008540532,0.028582659,0.054839548,0.0036514467,0.006466028,0.20627812,0.0042762025,0.024814228,0.02816757,0.123308636,0.0014743385,0.004271755
primary repair bilateral cleft lip nose year review new treatment plan years forked flap used columella reconstruction primary repair bilateral cleft lip nose adolescent growth spurt three unfavorable features become apparent columella may grow long nostrils large often nasal tip remains broad drift columellar base lip columellar angle transgressed scar procedure therefore discontinued new treatment plan presented columella reconstructed tissues splayed nasal tip,C07,0.0041522137,0.0036832208,0.0077476003,0.0023329596,0.0057829367,0.005358648,0.44113165,0.003904792,0.0030018657,0.004079794,0.021231972,0.00854031,0.025841158,0.055242006,0.003651352,0.00646586,0.17877734,0.044471893,0.004727906,0.03470204,0.08922656,0.04167427,0.0042716446
periodontics general practice professional plaque control traditionally primary emphasis preventive periodontics daily patient performed plaque control recent studies indicate frequent professional subgingival toothcleaning mandatory treatment prevention recurrent periodontitis pathogenic subgingival bacterial complexes disrupted frequent cleaning require time reestablish disease progression prevented recall interval exceed time required reestablishment pathogenic plaque legally patients acquired duty comply prescribed recall interval patient practitioner benefit preventive program includes frequent professional subgingival toothcleaning,C07,0.0036403134,0.07371311,0.006959777,0.019653931,0.005069021,0.005106659,0.22649781,0.0034233949,0.037862636,0.0035768219,0.091480285,0.0077067264,0.03333866,0.008372693,0.0032011997,0.0056687254,0.20770188,0.0037489193,0.056803707,0.025820855,0.16561534,0.001292543,0.0037450204
reviewing nonsurgical periodontal therapy selection appropriate case clinical competency treatment modalities results success nonsurgical periodontal therapy patient early periodontitis significant local factors form professionally accessible plaque calculus receptive nonsurgical periodontal treatment clinician must make decisions centering around important question patient moreover therapist delivering debridement gain access microbial subgingival plaque frequent basis host defense threshold respective patient answer yes nonsurgical periodontal therapy rewarding answer modalities periodontal surgery must instituted,C07,0.0041522626,0.0036832641,0.007747691,0.002332987,0.005781894,0.0055863033,0.38714325,0.0039048379,0.0030019009,0.0040798415,0.05886613,0.048727557,0.054325785,0.013104793,0.0036513947,0.046663884,0.19284326,0.004276142,0.024819938,0.06686061,0.052696813,0.0014743175,0.0042751296
whole organ sectioning mixed parotid tumors pathologic study involving standard formal parotidectomy specimens carried using whole organ sectioning technique histopathologic characteristics noted included presence exposed capsule breaks capsule capsular incompleteness tumor ingrowth thickness cellularity lymphocytic infiltration tracings histopathology slides used reconstruct three dimensional configuration tumor viewed different angles tumor smooth surface extreme two tumor lumps connected narrow waist separated tumors seen one specimen lymph node contain additional tumor form adenolymphoma tumors showed exposed capsule bare area degree affected mainly position tumor capsular damage occasionally seen usually minor capsular incompleteness tumor ingrowth make global capsular dissection unsafe concluded formal parotidectomy remains operation choice pleomorphic adenoma parotid gland although capsular dissection otherwise termed enucleation cannot entirely avoided procedure,C07,0.002559008,0.002269968,0.028455522,0.0014378022,0.13984005,0.015631234,0.20815732,0.03956418,0.014210371,0.0025143758,0.05583815,0.0052633905,0.048291855,0.008016057,0.0022503273,0.0039849076,0.065228045,0.015003008,0.002913807,0.09553622,0.19389565,0.0009086108,0.04823016
esthetic approach vertical root extrusion patient anterior open bite report case previous attempt locate root canal system maxillary left central incisor bur created perforating root defect level alveolar crest patient received root canal therapy next vertical root extrusion chosen expose sound tooth structure apical defect crown could constructed anterior open bite natural crown left intact possible position anchor bar incisal lingual position maintaining esthetics patient extrusive stabilization phases treatment,C07,0.00417721,0.0035609927,0.010069462,0.021561172,0.082513526,0.04377801,0.28261402,0.023080261,0.0028863293,0.00392277,0.03754864,0.011246015,0.09681356,0.02603302,0.0035108181,0.025541626,0.11347321,0.0041115126,0.0045459378,0.028670762,0.12617202,0.0014175571,0.042751588
parotid gland plain gadolinium enhanced mr imaging purpose study show typical appearance lesions parotid gland plain mr imaging mr imaging enhanced gadopentetate dimeglumine seventeen patients inflammatory changes benign malignant tumors studied examinations carried plain weighted sequences repetition time tr msec echo time te msec tr te weighted sequences gadolinium enhanced weighted sequences axial coronal sagittal orientations identifying normal anatomic structures facial nerve main duct administration gadopentetate dimeglumine helpful inflammatory changes gadolinium enhanced images showed diagnostic advantages gadopentetate dimeglumine proved helpful delineating tumorous lesions differentiating benign malignant lesions however exact differentiation different histologic types possible post operative fibrosis could differentiated recurrent tumors administration gadolinium question regarding infiltration definition boundaries lesion cannot answered non enhanced mr imaging gadopentetate dimeglumine administration advised however routine imaging parotid gland use recommended,C07,0.0024974751,0.002215385,0.0046600294,0.0014033424,0.14854626,0.0153020825,0.14154375,0.07488598,0.0018055633,0.014495998,0.08737957,0.005136829,0.07055555,0.0059172017,0.0021962165,0.003988203,0.08092485,0.0025731493,0.014924375,0.06924152,0.18590441,0.00088676263,0.063015535
basis defective proliferation peripheral blood cells anti cd antibodies primary sjogren syndrome anti cd induced cell proliferation analyzed peripheral blood samples primary secondary untreated sjogren syndrome patients anti cd stimulated pbmc proliferation low one third primary sjogren syndrome samples despite number cd cells similar primary secondary sjogren syndrome normal pbmc samples depressed response anti cd mainly found anti ro la patients experiments purified cells demonstrated defect cell level responsible anti cd unresponsiveness cell proliferation failure associated poor il il receptor mrna expression consequently il il receptor synthesis since defective anti cd induced mitogenesis could reversed phorbol myristate acetate calcium ionophore probably correlated impaired protein kinase c activation comparison anti cd triggered pbmc proliferation treated untreated patients long term study nine patients showed defect stable characteristic primary sjogren syndrome patients reversed pharmacological immunosuppression,C07,0.0020302904,0.011628779,0.0037883115,0.0011407374,0.01493236,0.0026201955,0.15084976,0.0019093098,0.0014678097,0.0019948797,0.048786055,0.0042509255,0.05403266,0.1687542,0.0017853862,0.0031615845,0.12724465,0.05814739,0.0023117843,0.017072823,0.2795663,0.0007208824,0.041802894
role herpes simplex virus development oral mucositis bone marrow transplant recipients herpes simplex virus hsv implicated major etiologic factor development ulcerative mucositis bone marrow transplant bmt recipients study patients received bmts evaluated least days post transplant ulcerative mucositis presence culturable hsv fifty nine patients received prophylactic acyclovir forty six patients developed ulcerative lesions culture negative hsv neither source transplant autologous versus allogenic hsv antibody status patient affected frequency mucositis conditioning regimen appeared significant factor contributing severity ulcerative mucositis majority ulcers occurred movable nonkeratinized mucosa bmt recipients usual sites reactivation intraoral hsv nonmovable keratinized mucosa conclude hsv probably major etiologic agent mucositis bmt recipients acyclovir effective agent preventing hsv reactivation,C07,0.0030489925,0.032222766,0.0056891036,0.0017131044,0.019005232,0.0039348835,0.39183822,0.0028673094,0.0022042857,0.0029958142,0.01874139,0.00903839,0.07886029,0.064231925,0.002681207,0.004747915,0.17206392,0.033945408,0.0034717263,0.06100043,0.051959325,0.0010825865,0.032655723
epithelial rests function replantation splinting necessary replantation problem resorption replantation relationship epithelial rests lack splinting studied ten mongrel dogs used two dogs served control subjects eight mandibular incisors intentionally replanted studied histologically observed rests malassez present see resorption lack splinting result resorption loss teeth appears stain epithelial rests malassez immunofluorescent antibodies use technique study tissue,C07,0.004418618,0.003919535,0.025681539,0.066651925,0.006152786,0.005702457,0.3126175,0.004155322,0.0031944641,0.004341552,0.04077292,0.0091543235,0.16950168,0.037555676,0.0038856212,0.006880707,0.06587753,0.029872078,0.0050312467,0.053384796,0.13513313,0.0015688908,0.0045457114
diagnosing periodontal diseases present diagnosis periodontal disease requires clinical evaluation patient including visual findings use periodontal probe radiographs test available evaluate disease activity specific cases adjunctive procedures may also useful identification pathogenic microorganisms may aid evaluating periodontal status special patients however required adequate diagnosis common adult form chronic periodontitis,C07,0.0037729053,0.021609353,0.043564145,0.0021198415,0.023517478,0.023124538,0.44103897,0.0035480857,0.020973358,0.0037071009,0.13080177,0.007760145,0.024487942,0.010036537,0.0033177976,0.005875198,0.10159102,0.0038854668,0.0042960076,0.04789823,0.06784812,0.0013396216,0.003886344
premolarization fractured maxillary first molar multidisciplinary treatment diagnosis treatment fractured maxillary first molar described case report year old male successful treatment retained palatal root fractured molar referred premolarization ensued integration endodontic orthodontic periodontic fixed prosthodontic care,C07,0.006944342,0.039593443,0.012957422,0.0039017426,0.009669776,0.008962035,0.22278072,0.040142097,0.0050204503,0.006823224,0.099161215,0.014283184,0.04298675,0.015967187,0.0061066793,0.010813785,0.17615017,0.007151521,0.007907155,0.12626874,0.1267986,0.0024656835,0.007144083
histopathologic grading salivary gland neoplasms iii adenoid cystic carcinomas histopathologic grading adenoid cystic carcinomas provide valuable prognostic information particularly presence absence solid growth architecture noted growth patterns exemplified tubuloductal cribriform cylindromatous differentiation associated protracted biologic course less rapid mortality three tiered grading system based three growth patterns carcinoma presented,C07,0.005472253,0.031316523,0.010219692,0.0030746358,0.0076199393,0.007062228,0.38438237,0.0051461733,0.0039561954,0.058329504,0.03278884,0.013179881,0.060779642,0.09205621,0.0048121614,0.008521437,0.067667834,0.0056355135,0.0062309653,0.07331165,0.084379934,0.0019429983,0.03211346
surgical pocket reduction possible within scope paper describe detail aforementioned procedures found various textbooks journals clinical periodontology instead objectives treatment spectrum techniques available rationale use described periodontal surgery performed certain conditions patient must physically mentally competent undergo type surgery understand agree procedure postoperative management finally periodontal surgery considered nonsurgical therapy accomplish desired result periodontal surgery pocket elimination performed selected defects properly evaluated debridement healing period executed technical competence proper postoperative care preserve dentition affected periodontal disease,C07,0.01920833,0.018858258,0.022071011,0.018320909,0.036396153,0.00424933,0.28180173,0.018981956,0.018315265,0.0032352172,0.04119543,0.0067723417,0.037222378,0.007695442,0.002895469,0.005127333,0.34693143,0.0033908787,0.0037491608,0.041643325,0.0573822,0.0011690987,0.003387352
detection human intracisternal type retroviral particle antigenically related hiv sjogren syndrome autoimmune disease characterized dryness mouth eyes loss salivary lacrimal gland function accompanied lymphocytic infiltration similar symptoms glandular pathology observed certain persons infected human immunodeficiency virus hiv search initiated possible retroviral etiology syndrome human intracisternal type retroviral particle antigenically related hiv detected lymphoblastoid cells exposed homogenates salivary tissue patients sjogren syndrome comparison retroviral particle hiv indicates distinguishable several ultrastructural physical enzymatic criteria,C07,0.0037732362,0.0033470488,0.025254013,0.0021202376,0.02351756,0.004869558,0.3293854,0.040072467,0.020976983,0.0037184265,0.06416428,0.007787014,0.030925767,0.05334942,0.0033180888,0.0058757137,0.04994535,0.0038858077,0.0042963843,0.091084465,0.13160066,0.0013397391,0.09539237
mapping epitopes la ss b autoantigen primary sjogren syndrome identification cross reactive epitope autoepitopes ribonucleoprotein la ss b identified using recombinant la ss b polypeptides sera patients antinuclear autoantibody anti la ss b la ss b polypeptides encoded polymerase chain reaction derived overlapping nonoverlapping fragments la ss b gene encodes protein amino acids aa sera tested reacted fusion protein comprising first n terminal aa laa reacted fusion protein comprising aa lac reacted fusion protein comprising aa lal c terminus la ss b order immunodominance assessed number sera reacting epitope strength reactivity laa aa greater lac aa much greater lal aa cross reactivity observed antibodies eluted lac aa lal aa significant primary sequence homology two regions lac region contained least two epitopes one encompassing putative rna binding motif aa recognized patient sera serial serum samples three patients showed antibody response la ss b initially directed n terminus laa aa period time three major epitopes including encompassing putative rna binding motif recognized result suggests primary immune response la ss b restricted immunodominant epitope specificity autoantibody response broadens includes rna binding motif may important implications expression disease,C07,0.0019182817,0.0017016116,0.0035793146,0.0010779776,0.030066134,0.0024756424,0.24050376,0.0018041545,0.0013868322,0.011161249,0.033178244,0.022442533,0.016277233,0.029306017,0.0016868885,0.0029871634,0.09240843,0.13945027,0.0021842457,0.042105522,0.16163664,0.0006811121,0.15998077
histologic study eustachian tube cartilage without congenital anomalies preliminary study investigated histopathologically development eustachian tube et cartilage cellular level individuals without congenital anomalies fourteen specimens obtained individuals ranging age weeks gestation years cleft palate trisomy syndrome specimens nonanomaly control group individuals ranging weeks gestation years age temporal bone specimens included et accessory structures processed stained hematoxylin eosin histologic study routine manner number cartilage cells midcartilaginous portion et determined light microscopy groups cartilage cell density et decreased increasing age however cell density tended higher ages individuals cleft palate microtia versus controls tended lower ages individuals syndrome,C07,0.0027279297,0.0024198098,0.005090034,0.0015327125,0.0037985558,0.0035205355,0.19370851,0.0025653783,0.02826847,0.0026803513,0.117633455,0.09067265,0.03762586,0.05145442,0.0023988725,0.004247954,0.047063045,0.0028093155,0.0031061494,0.24602923,0.13367294,0.00096858875,0.016005198
repair salivary fistulae laryngectomy new surgical technique described repair salivary fistulae used three patients fistulae occurred laryngectomy unsuccessfully treated local regional flaps principle technique use bipedicled jejunal patch free microvascular transfer one patch used reconstruction pharynx excising mucosa skin defect closed patch mucosa excised expose muscle create recipient site split skin graft,C07,0.0049479757,0.004389101,0.009232409,0.0027800656,0.15058208,0.00638562,0.17338249,0.028542176,0.027530698,0.0048616766,0.065011084,0.03412664,0.056089383,0.01139722,0.004351125,0.0077050272,0.2465346,0.0051286854,0.005633998,0.031614006,0.112926796,0.0017568463,0.005090295
secondary correction unilateral cleft lip nose using conchal composite graft secondary deformity unilateral cleft lip nose many components one dorsal dislocation lateral crus alar cartilage used conchal composite graft positioned piriform aperture lateral crus upper lateral cartilage correct dislocation nine patients believe graft effective elevates lateral crus alar cartilage depressed piriform aperture technique simple perform easy achieve nasal symmetry results quite satisfactory recurrence dorsal dislocation donor site covered subcutaneous pedicled flap cephaloauricular sulcus leaving inconspicuous deformity,C07,0.0039920486,0.0035411462,0.046089865,0.002242969,0.024879377,0.0051519466,0.15621927,0.10135532,0.0028860734,0.003922422,0.06388886,0.06617653,0.025146782,0.028487211,0.0035105066,0.0062164497,0.1944541,0.047638323,0.0045455345,0.08346318,0.120667785,0.0014174314,0.0041068722
balancing dental service requirements supplies epidemiologic demographic evidence counterpoint negative interpretations recent trends article presents positive picture dentistry st century reported trends show large increases older dentate adults retaining natural dentition new diagnosis treatment technologies increased incidence dental caries older adults increased awareness periodontal diseases greater interest esthetic dentistry generally higher expectations health fitness society factors point greater need adult dental services therefore next years dental profession prepared provide increased amounts diagnostic preventive adult operative fixed prosthodontic endodontic orthodontic services declines need expected children operative dentistry extractions complete dentures,C07,0.0026233897,0.027710726,0.0048949732,0.0268655,0.0036537715,0.041468598,0.24116947,0.0024670674,0.014587096,0.015277628,0.08830787,0.01807923,0.02491274,0.006296698,0.0023069428,0.016763851,0.06980265,0.0027016564,0.06647952,0.20451795,0.11548234,0.00093147036,0.0026988466
activation cell subsets peripheral blood patients sjogren syndrome multicolor flow cytometric analysis using color flow cytometry determined proportions activated cells dr including cd cells cd cells subsets peripheral blood patients sjogren syndrome ss activated cells significantly increased cd cells cd cells suppressor inducer cd leu helper cd leu cytotoxic cd cd subsets suppressor natural killer subset cd cd patients ss compared controls furthermore proportions activated cells cd leu subset cd subset cd cd subset showed positive correlation serum gamma globulin levels ss patients findings suggest certain immunoregulatory balance helper suppressor activities maintained ss patients although balance seems occur highly activated levels quantitative changes lymphocyte subsets important factors maintaining balance discuss possibility cd leu cells recirculate peripheral lymph nodes cd leu cells migrate inflammatory tissues salivary glands since leu antigen reported homing receptor peripheral lymph nodes process might accelerated ss cell subset may participate immunologic activation lymph nodes target tissues,C07,0.0021576735,0.001913964,0.004025995,0.0012123088,0.0030738127,0.00278459,0.18328553,0.012462775,0.0015599019,0.0021200408,0.016670931,0.017082015,0.09710118,0.16298568,0.0018974036,0.0033599464,0.0830845,0.085784584,0.0024568287,0.043988377,0.26799905,0.0007661115,0.0022267501
improved primary surgical dental treatment clefts improved combination surgical dental teamwork primary treatment clefts presented consistent principles fact staged design correction classic clefts lip palate based biological principles facilitates continuance failed embryonic migrations toward normal end point positioning alveolar segments dissection mucoperiosteum cleft union mucoperiosteum across alveolar anterior hard palate cleft make possible create periosteal tunnel across bony gap set condition conducive bone formation eventual tooth eruption cleft area lip closure adhesion reduces tension primary lip closure allows gentle molding solidification arch occurs thus complete cleft rendered incomplete cleft balanced stabilized maxillary platform definitive lip nose corrections carried completion early years age planned actions bypass persistent cleft fistulas raw areas malposition alveolar segments probably necessity later bone grafting question totally answered effect approach final growth although reports seem indicate growth proceed within normal limits another years careful follow indicated fact progress,C07,0.002528299,0.014456129,0.01489736,0.0014202574,0.0035266762,0.027254568,0.27560288,0.019355223,0.0018274735,0.0024836939,0.038683657,0.0051991637,0.04923433,0.032527916,0.0022228672,0.015991751,0.21978378,0.002605748,0.01758197,0.06684124,0.18247704,0.00089752336,0.0026004885
salivary gland cancer case control investigation risk factors unlike upper aerodigestive tract cancers salivary gland cancers relatively infrequent characterized diversity histologic subtypes never etiologically associated tobacco exposure present results case control study risk factors cancers risk estimates derived self administered comprehensive risk factor questionnaires distributed patients university texas anderson cancer center houston cases patients histologically confirmed salivary gland cancer control subjects randomly selected patient population excluding patients cancer head neck nonmelanoma skin cancer frequency matched cases age sex ethnicity achieve control subjects cases ratio multivariate analysis prior radiotherapy significant risk factor men odds ratio women among women higher educational attainment alcohol use hairdye use also significantly associated risk significant differences cases control subjects respect tobacco exposure specific occupational leisure time exposures biological plausibility associations hairdye use alcohol exposure,C07,0.0022272158,0.0019756516,0.01489541,0.0012513817,0.013882264,0.002874338,0.123691805,0.0020962937,0.0016101779,0.012966451,0.10092872,0.1210954,0.13395455,0.00600669,0.0019903106,0.0034682383,0.10936029,0.017525744,0.0025360128,0.2807596,0.041794088,0.0007908034,0.0023185296
asian osteomalacia determined dietary factors exposure ultraviolet radiation restricted risk factor model twenty seven previously osteomalacic normal asian women participated seven day survey dietary intake daylight outdoor exposure individual levels daylight outdoor exposure discriminated poorly normal osteomalacic women presence osteomalacia strongly related varying degrees vegetarianism lactovegetarianism meat fish egg consumption associated significantly greater osteomalacic risk ovolactovegetarianism meat fish consumption unlike asian rickets high extraction wheat cereal chapatti significant risk factor osteomalacia asian women dietary fibre less important risk factor absent dietary meat fish egg exposure ultraviolet radiation limited asian osteomalacia asian rickets determined dietary factors,C18,0.0031908958,0.002830484,0.005962456,0.017227652,0.0044432213,0.0041180174,0.098407574,0.0030007572,0.0023068758,0.0031352425,0.014738957,0.0065631913,0.09653981,0.011178487,0.0028059932,0.0049688886,0.062043533,0.0032902064,0.019075532,0.5015622,0.12819065,0.0011329711,0.0032863829
absence brown product ffi nondiabetic diabetic rat collagen accumulation brown products long lived proteins might important factor determining long term diabetic complications fluorescent chromophore furoyl furanyl h imidazole ffi isolated hydrolyzed brown products synthesized vitro proposed specific brown product responsible functional structural changes long lived proteins study attempt made demonstrate means collision spectroscopy presence ffi collagen samples taken diabetic rats diabetic rat collagen samples showed mean values absorbance per milligram hydroxy l proline significantly higher observed nondiabetic rats suggesting higher ffi levels surprisingly collagen samples diabetic nondiabetic rats gave collision spectra peak diagnostic ffi presence observed data suggest absorbance level observed diabetic rats due presence ffi structurally related compounds investigated means mass spectrometry,C18,0.002160494,0.001939442,0.04429736,0.043019388,0.0030066457,0.013206166,0.24404176,0.012828904,0.0015609165,0.012567575,0.044253368,0.01527194,0.078024775,0.014106104,0.054143194,0.0660714,0.04631713,0.023970557,0.012819318,0.02271544,0.24068905,0.0007666098,0.0022224935
biochemical studies rt alloantigens bb wor normal rats evidence intact unexpressed rt structural gene diabetes prone bb rats lymphocytes bearing lymphocyte differentiation antigen rt play important immunoregulatory role development autoimmune diabetes bb rats immunofluorescence studies suggest diabetes prone dp diabetes resistant dr bb rat lymphocytes fail express rt antigen ontogeny two alloantigenic forms molecule exist e rt rt linked cell membranes phosphatidylinositol pi linkage studies pi phospholipase c plc treatment lymphocytes bb normal rats followed immunoabsorption sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis released proteins anti rt allotype specific monoclonal antibodies performed rt several nondiabetic rat strains found consist family nonglycosylated variably glycosylated molecules n glycanase resistant mr peptide four n glycanase sensitive peptides mr contrast rt found mr nonglycosylated polypeptide electrophoretic pattern rt observed antigen extracted w cd versus w lymphocytes resting versus mitogen activated cells pattern bands characteristic rt antigen found normal rat strains detected plc treatment detergent solubilization lymphocytes obtained dr rats contrast evidence either rt species found plc detergent treatment comparable numbers lymphocytes dp bb rats interestingly lymphocytes wistar furth rt x dp rt f crosses observed coexpress rt rt molecules electrophoretic pattern rt similar obtained dr rat strains study provides biochemical evidence dp rats may intact rt structural gene,C18,0.0017625007,0.0015564056,0.028658142,0.0009859344,0.0024432058,0.0022643849,0.29069114,0.0016500341,0.0012684878,0.001723984,0.061437827,0.0036127362,0.020002017,0.12882519,0.04399485,0.0027322557,0.023145892,0.029545331,0.0019978546,0.02205587,0.25808266,0.00062298984,0.07094032
famine southern ethiopia population structure nutritional state incidence death among children objective assess effects drought mortality children design prospective epidemiological study forming part nutritional monitoring famine relief work setting food distribution sites arero borana provinces southern ethiopia patients monthly average children examined respectively altogether child months available analysis intervention families children supplied food month basic medical care also provided main outcome measure mortality children results increase crude mortality observed among children living traditional stable societies severe consequences observed mainly among children living relief shelters threefold fourfold increase crude mortality recorded among children increased childhood mortality also associated high prevalence malnutrition living arid areas dry season long period food aid needed normalise nutritional state especially children living relief shelters conclusions severe consequences widespread famine occurred arero borana provinces southern ethiopia seen among children living relief shelters early food intervention may decrease scale migration thus also reduce severe consequences famine,C18,0.036206316,0.009562174,0.017725008,0.00093820586,0.0023251767,0.04143595,0.23183206,0.009619215,0.0012072083,0.13098441,0.009448278,0.011789968,0.021046972,0.012341345,0.017612906,0.010526532,0.054608963,0.0017222242,0.010585543,0.18399078,0.17369129,0.00059289375,0.010206589
effects moderate exercise training nutrient intake mildly obese women relationship moderate exercise training five minute sessions per week brisk walking vo max weeks changes nutrient intake investigated group sedentary mildly obese women study conducted using x factorial design two groups subjects exercise nonexercise groups three periods baseline week week testing sessions data analyzed using repeated measures anova pattern change caloric intake time tended different groups f p exercise group experienced significant decrease caloric intake weeks significant group x time interactions found intakes carbohydrate dietary fiber thiamin niacin vitamin b folate intake tended decrease exercise group increase nonexercise group change intake nutrients significantly correlated change bread cereal consumption pattern change bread cereal intake time significantly different groups pillais trace f p exercise group significant decreases intake weeks vs baseline values data suggest mildly obese women reduce energy intake subsequent initiating exercise program concomitantly decrease quality nutrient intake diets compared sedentary controls,C18,0.0018162789,0.0807388,0.010509739,0.0010204001,0.0025288805,0.021581585,0.08726608,0.0017078951,0.0013129691,0.001784438,0.021965763,0.101342276,0.16735323,0.015558829,0.0015970443,0.0028280662,0.02219178,0.0018702957,0.0023832505,0.17401712,0.27610812,0.0006448359,0.0018723226
changes basal stimulated growth hormone secretion aging rhesus monkey comparison chair restraint tether vest sampling studied basal serum gh gh responses iv clonidine insulin induced hypoglycemia group four young yr old four older yr old adult male rhesus monkeys two restraint conditions chair adaptation tether vest system determine changes gh secretion occur aging serum gh response iv administration gh releasing hormone ghrh also studied groups tether vest restraint serum samples collected every min assayed gh using human gh ria cortisol using enzyme linked immunosorbant assay gh cortisol concentrations young older groups analyzed analysis variance anova chaired studies older animals lower mean h basal gh concentration younger animals vs micrograms l p prestimulation gh lower clonidine insulin older chaired group micrograms l respectively compared younger group micrograms l respectively p less poststimulation gh lower clonidine insulin older chaired group micrograms l respectively compared younger chaired group micrograms l respectively p less differences gh increments statistically significant tether vest studies older animals lower mean h basal gh concentration younger animals vs micrograms l p less prestimulation gh concentrations also lower older tethered animals clonidine micrograms l ghrh micrograms l compared levels younger animals micrograms l p p respectively younger tethered animals greater poststimulation responses clonidine micrograms l insulin micrograms l ghrh micrograms l older animals micrograms l p less p p less respectively abstract truncated words,C18,0.0015002328,0.0013307814,0.0027992788,0.00084291963,0.0020890268,0.0019361286,0.06437755,0.0014108372,0.0010846016,0.0014740669,0.039995722,0.06658551,0.14442375,0.020223914,0.008545087,0.03897474,0.015702082,0.0015449912,0.0017082358,0.18225518,0.39128107,0.00053267815,0.009381662
efficient method removing bilirubin bilirubin tightly bound albumin making hemoperfusion ineffective treatment hyperbilirubinemia adding safe unbinding agent blood solutizer adsorbed hemoperfusion become efficient practical canines made hyperbilirubinemic intravenous infusion mg ml solution na co hour peak concentrations mg dl reached adult dogs kg hemoperfusion initiated without control solutizer sodium benzoate bilirubin unbinding effect sodium benzoate rapid effective simultaneous adsorption sodium benzoate small activated carbon section presaturated solutizer located proximal main hemoperfusion column addition continuous infusion reach mm blood comparison normalized bilirubin concentration benzoate augmented hemoperfusion average control dogs shows benzoate results threefold decrease normalized bilirubin concentration hr hemoperfusion sodium benzoate may also advantage protecting platelets hemoperfusion,C18,0.0026575294,0.0023573614,0.017843304,0.0014931575,0.029386763,0.01628962,0.32356763,0.0153589025,0.0019212755,0.002611179,0.03087578,0.076174885,0.12908217,0.0061172917,0.028047843,0.0041414946,0.025227692,0.028463809,0.0030259883,0.03189086,0.20694254,0.00094359217,0.015579339
immunological evidence accumulation lipoprotein atherosclerotic lesion hypoascorbemic guinea pig lipoprotein lp extremely atherogenic lipoprotein lp found plasma humans primates species mechanism exerts atherogenicity still poorly understood observed lp found plasma several species unable synthesize ascorbate species detected apoprotein plasma guinea pig induced atherosclerosis animal dietary ascorbate depletion using sds page subsequent immunoblotting identified lp accumulating atherosclerotic plaque importantly adequate amounts ascorbate mg per kg body weight per day prevent development atherosclerotic lesions animal model accumulation lp arterial wall suggest analogous mechanism humans similarity guinea pigs humans respect lack endogenous ascorbate production role lp human atherosclerosis,C18,0.0031097683,0.016998664,0.017254213,0.016026724,0.03286825,0.01818833,0.17529829,0.03537792,0.0021456566,0.0029612489,0.05302086,0.006152687,0.032914605,0.018064946,0.04569892,0.018972807,0.08691444,0.02002943,0.003379386,0.063680544,0.32676136,0.001053792,0.0031271374
lack predictive value islet cell antibodies insulin antibodies hla dr phenotype remission cyclosporin treated iddm patients canadian european randomized control trial group effect immunosuppression humoral immune response islet autoantigens exogenously administered insulin predictive value islet cell cytoplasmic antibodies icas insulin antibodies ias hla dr phenotype remission immunosuppression studied prospective randomized double blind trial cyclosporin administration newly diagnosed insulin dependent diabetes mellitus iddm patients hla dr phenotype glycosylated hemoglobin determined study entry insulin requirement glucagon stimulated c peptide icas ias measured entry mo follow cyclosporin therapy caused significant suppression prevalence serum concentrations icas ias cyclosporin treated iddm patients ica study entry higher levels stimulated c peptide mo study increased beta cell function associated higher frequency insulin free remission mo ica ia status entry predict cyclosporin insulin free remission assessed prevalence insulin free remission beta cell function mo study significant decrements titers total disappearance icas associated increased prevalence duration non insulin requiring remission higher stimulated c peptide values correlation serum levels icas ias entry beta cell function mo follow,C18,0.0018002847,0.0015969423,0.01206318,0.0010115065,0.0025068393,0.011028369,0.10940404,0.0016930095,0.0013015257,0.0017688854,0.014148541,0.012747548,0.06352373,0.09084311,0.0015831564,0.10346805,0.06811399,0.0018539948,0.02819409,0.08710792,0.35560557,0.0006392157,0.027996501
management hypercholesterolemia family practice setting study undertaken assess physician adherence patient compliance national cholesterol education program guidelines management newly detected hypercholesterolemia study site department family medicine medical university south carolina charleston university based family medicine residency program serum cholesterol levels measured july september reviewed patients classified normal borderline hypercholesterolemic based serum cholesterol levels coronary heart disease risk factors patients previously recognized hypercholesterolemic excluded six months later medical record reviews performed hypercholesterolemic borderline hypercholesterolemic patients hypercholesterolemic patients received appropriate dietary therapy follow patient compliance physician recommendations excellent minimal unnecessary testing treatment borderline hypercholesterolemia low rates appropriate management hypercholesterolemia may related inadequate physician knowledge low physician perceived self efficacy regarding dietary counseling time constraints,C18,0.002180254,0.023040846,0.014620794,0.0012249958,0.0030359346,0.0029240528,0.21571197,0.0020503371,0.0015762266,0.0021422275,0.059992276,0.0047698817,0.033570886,0.040461797,0.033577316,0.035222493,0.2143335,0.0022630105,0.054134093,0.15486155,0.09528475,0.00077412894,0.0022466616
hla antigens nailfold capillary microscopy studies patients insulin dependent noninsulin dependent diabetes mellitus limited joint mobility investigated hla status patients diabetes associated limited joint mobility microvascular complications increased frequency hla b dr dr patients insulin dependent diabetes mellitus iddm compared controls patients noninsulin dependent diabetes mellitus niddm confirmed hla antigen dqw detected less frequently patients iddm negatively associated limited joint mobility retinopathy limited joint mobility significantly correlated disease duration iddm associated neuropathy iddm niddm retinopathy iddm correlation found dr dr limited joint mobility diabetic complications also investigated usefulness nailfold capillary microscopy large group patients iddm niddm although capillary enlargement avascular areas noted patients nailfold capillary microscopy felt useful tool evaluation diabetes,C18,0.0028794312,0.0025541992,0.0053727203,0.001617835,0.031955663,0.0037160562,0.2079893,0.016582103,0.043894153,0.0028292104,0.025072977,0.02023114,0.13154717,0.03662771,0.0025320994,0.06023249,0.1792065,0.0029728534,0.0032786562,0.054042578,0.10511877,0.05677236,0.0029739966
health homeless children housed poor children homeless children families increasing numbers across country noted frequent health problems health status homeless children assessed multiple dimensions parental report survey conducted homeless families shelters los angeles housed poor families march january month survey homeless housed poor children experienced high rates illness symptoms disability bed days homeless housed poor children frequently rated parents fair poor health vs p homeless children however reported behavior problems school failure vs p housed poor children homeless children also high rates health problems developmental delay overweight diets homeless children frequently imbalanced dependent food fast food restaurants characterized repeated periods deprivation family problems common among homeless families especially among single parent homeless families compared single parent housed families spousal abuse vs p less parental drug alcohol abuse vs p less concluded homeless children significant child behavior developmental problems disorders nutrition growth associated multiple risk factors environment,C18,0.0018996318,0.010880321,0.003544516,0.0010673257,0.0026451773,0.0025056694,0.17766203,0.0017864368,0.0013733492,0.13606094,0.044744715,0.0039071795,0.040149767,0.121443614,0.0016704883,0.03054256,0.14883772,0.001956306,0.06653563,0.09115226,0.10699247,0.00067449023,0.0019674078
late onset ornithine transcarbamylase deficiency male patients published erratum appears j pediatr feb report male patients presented days age ornithine transcarbamylase otc deficiency define late onset otc deficiency patients appeared normal birth irritability vomiting lethargy often episodic later developed age presentation ranged months years biochemical testing revealed hyperammonemia hyperglutaminemia hypocitrullinemia increased urinary orotate excretion decreased liver otc activity measured vitro ranged normal male patients older presentation somewhat different pattern presenting symptoms likely die data illustrate phenotypic variability otc deficiency unexplained episodes repetitive protracted vomiting association progressive alterations behavior neurologic findings suggest diagnosis urea cycle defect another symptomatic inborn error metabolism regardless age medical history patient,C18,0.0023544258,0.0020884932,0.049963035,0.0013228558,0.014349222,0.014430105,0.25221607,0.0022141307,0.0017021451,0.0023189099,0.047963347,0.004842604,0.036883812,0.01940393,0.013466609,0.013936872,0.14421809,0.0024390724,0.0026808602,0.18277262,0.1736608,0.012230737,0.0025412536
effects childbearing glucose tolerance niddm prevalence published erratum appears diabetes care nov goal study estimate effects childbearing subsequent glucose tolerance non insulin dependent diabetes mellitus niddm prevalence sample subjects different locations united states recruited inclusion second national health nutrition examination survey complex survey design used select probability sample subjects location total women recruited underwent clinical laboratory evaluation presence diabetes mellitus women classified glucose tolerance based results oral glucose tolerance test previous physician diagnosis diabetes mellitus combined current use hypoglycemic medication childbearing defined number live births experienced woman time interview fasting plasma glucose increased linearly increasing number live births coefficient confidence interval ci h value coefficient ci adjustment age body mass index bmi education income substantially reduced magnitude association childbearing either plasma glucose measurement prevalence niddm relation childbearing examined logistic regression analysis significant linear increase diabetes prevalence seen increasing number live births relative prevalence niddm birth vs ci adjustment age bmi education income greatly reduced magnitude association relative prevalence niddm birth vs ci,C18,0.0016182842,0.0014349938,0.02670263,0.000908928,0.0100825345,0.026194867,0.17797242,0.0015213187,0.0011695358,0.0015894999,0.12159879,0.011141193,0.07207115,0.00394768,0.0014226009,0.082776465,0.04785275,0.017282223,0.017500455,0.24434912,0.12862207,0.00057439174,0.0016660802
daily pattern vo max heart rates normal undernourished school children pattern usage vo max expressed vo max ordinary school days minute minute heart rate recording studied boys girls yr age divided three age groups yr living economically deprived conditions colombia classified nutritionally normal marginally malnourished h period groups children spent average h less vo max h vo max accumulated time min vo max latter occurred short bursts rather sustained periods statistically significant small decrease approximately average h vo max age effects sex nutritional status overall average vo max groups data may suggest existence regulation physical activity level easily sustainable long periods expressing data min averages h school h free time activity allows possibility seeing group differences shorter periods time may prove useful exercise training programs studies effort workplace,C18,0.0021363497,0.012235117,0.003986207,0.0012003278,0.0029747994,0.0027570706,0.1483451,0.0020090493,0.0015444858,0.07573595,0.05769818,0.06183341,0.112350576,0.034380283,0.001878652,0.023392616,0.09012861,0.002201318,0.020951401,0.13421303,0.20506893,0.0007585402,0.002220032
uncoupling biliary lipid bile acid secretion organic anions rat number organic anions shown inhibit biliary phospholipid cholesterol secretion without affecting bile acid secretion however mechanism uncoupling phenomenon still unclear study shows comparison effects ampicillin mumol g body wt sulfated taurolithocholic acid mumol g body wt indocyanine green mumol g body wt control groningen yellow wistar rats chronic days biliary drainage groningen yellow rats hereditary defect hepatobiliary transport various organic anions bile secretion hepatic uptake three organic anions strongly impaired groningen yellow rats compared controls ampicillin sulfated taurolithocholic acid caused strong uncoupling control rats effect much smaller effect lipid secretion groningen yellow rats indocyanine green affect lipid secretion either control groningen yellow rats gel filtration chromatography bile showed specific coelution ampicillin sulfated taurolithocholic acid bile acid fraction whereas indocyanine green coeluted phospholipid cholesterol fraction study concludes uncoupling ampicillin sulfated taurolithocholic acid occurs secretion bile caused interaction compounds bile acids hypothesized interaction inhibits capacity bile acids induce secretion phospholipids cholesterol bile,C18,0.0020921275,0.0018558213,0.0039036926,0.011266804,0.0040681283,0.012807538,0.20528364,0.001967462,0.001512515,0.0020663003,0.009732173,0.015329454,0.057112027,0.17060111,0.07776671,0.12151595,0.021533301,0.012270335,0.0023821949,0.018358694,0.24367835,0.0007428384,0.0021527985
natural history beta cell dysfunction niddm non insulin dependent diabetes mellitus niddm characterized insulin resistance beta cell dysfunction review focuses beta cell defects occur two major anatomic observations made niddm beta cell mass mildly reduced especially obesity taken account also amyloid deposits frequently observed islets unclear whether changes genetically mediated result secondary loss glucose homeostasis many studies looked aspect insulin secretion niddm two types distinct abnormalities described early marked disruption pulsatile insulin delivery potentially important contributor insulin resistance unclear whether loss pulsatile delivery acquired genetically induced later glucose intolerance started several secretory abnormalities develop coincident loss beta cell glucorecognition net result deterioration timing insulin delivery postprandial hyperglycemia second important consequence glucose blindness inherent compensatory beta cell mechanisms guard hyperglycemia bypassed propose loss glucose responsiveness direct result elevated glucose concentration called glucotoxicity generated substantial data rat models support idea logical conclusion beta cell function niddm maximized achieving best metabolic control possible,C18,0.0016698067,0.025715936,0.019341819,0.00093822926,0.00689047,0.034481682,0.24010645,0.0015701071,0.025452338,0.0016404748,0.007871851,0.011691934,0.025153326,0.07120272,0.0014681994,0.14632735,0.06300066,0.0017491892,0.009969855,0.044636033,0.19759446,0.0005928124,0.060934294
assessment vitamin status disk applicator conjunctival impression cytology conjunctival impression cytology performed indonesian preschool children half mild xerophthalmia half age matched controls devised applicator applies paper disk fixed area conjunctiva even pressure disk applicator used collect impression cytology specimens temporal bulbar conjunctiva one eye original strip technique used eye mean sd serum retinol values children normal abnormal discs micrograms dl micrograms dl p less mean serum values normal abnormal strips micrograms dl micrograms dl p less specimens obtained new disk applicator corresponded closely serum vitamin levels therefore vitamin status obtained traditional strip technique,C18,0.017787276,0.0027049435,0.053744562,0.0017133168,0.0042461515,0.003935371,0.11820432,0.0028770904,0.0022045588,0.03252143,0.16809602,0.0062998096,0.13806698,0.008435102,0.061714668,0.0047485037,0.047755104,0.0031424565,0.0034721566,0.052199166,0.26191124,0.0010827206,0.0031370795
quantitative histologic study sural nerve lesch nyhan syndrome sural nerve year old man lesch nyhan syndrome obtained autopsy studied histologically large myelinated nerve fibers reduced number myelinated nerve fibers larger microns seen diameter distribution myelinated nerve fibers demonstrate bimodal pattern density myelinated nerve fibers mm decreased compared controls electron microscopic examination lipid like inclusions observed cytoplasm schwann cells role inclusions could elucidated reduction larger myelinated nerve fibers suggests peripheral nervous disorder patients syndrome therefore patients lesch nyhan syndrome must reappraised disorders peripheral nervous system,C18,0.0035169302,0.0031190251,0.006560823,0.0019755969,0.004900452,0.0045378106,0.26957846,0.0033066561,0.00254204,0.0034548512,0.04446532,0.0073005976,0.02969387,0.045665607,0.020109542,0.00547542,0.10305693,0.054670773,0.0040036854,0.12513386,0.25206596,0.001248467,0.003617314
primary hypertriglyceridemia borderline high cholesterol elevated apolipoprotein b concentrations comparison gemfibrozil vs lovastatin therapy common pattern dyslipidemia elevated levels plasma triglyceride borderline high total cholesterol reduced high density lipoprotein increased apolipoprotein b pattern dyslipidemia frequently associated premature coronary heart disease nicotinic acid drug first choice pattern study gemfibrozil lovastatin compared effects overall lipoprotein profile men type dyslipidemia drugs significantly reduced low density lipoprotein intermediate density lipoprotein cholesterol levels modestly raised high density lipoprotein cholesterol levels gemfibrozil therapy however failed reduce total cholesterol total apolipoprotein b levels whereas lovastatin therapy lowered levels total cholesterol low density lipoprotein cholesterol total apolipoprotein b moreover lovastatin therapy caused greater declines lipoprotein cholesterol ratios gemfibrozil therapy lovastatin thus seems certain advantages gemfibrozil treatment elevated plasma triglyceride levels accompanied borderline high total cholesterol raised apolipoprotein b levels therefore lovastatin therapy considered one approach management condition,C18,0.0019000856,0.010859445,0.0035443683,0.0010673115,0.002645067,0.0024514718,0.2976479,0.0017863624,0.0013732921,0.0018664221,0.012237128,0.0039070565,0.09799711,0.004381919,0.15921849,0.012150115,0.029957661,0.0019562244,0.00216292,0.055266373,0.2929946,0.0006744621,0.0019541897
change hexose distribution volume fractional utilization f deoxy fluoro glucose brain acute hypoglycemia humans used positron emission tomography pet study effects mild hypoglycemia cerebral glucose uptake metabolism nine healthy men studied basal saline infusion conditions euglycemic hypoglycemic clamp studies insulin infused rate mu kg min clamp studies euglycemic clamp studies glucose infused rate sufficient maintain basal plasma glucose concentration whereas hypoglycemic clamp studies glucose infusion rate reduced maintain plasma glucose mm study lasted h included min baseline period subsequent min period insulin glucose administered blood samples measurement insulin glucose cortisol growth hormone glucagon obtained min intervals bolus injection mci f deoxy fluoro glucose dfg administered min initiation study plasma radioactivity dynamic pet scans obtained frequent intervals remaining min study cerebral regions interest defined concentrations radioactivity calculated used three compartment model dfg distribution described sokoloff glucose levels similar saline infusion mm euglycemic clamp mm studies whereas desired degree mild hypoglycemia achieved hypoglycemic clamp study mm p less insulin level saline infusion pm,C18,0.023846852,0.001360023,0.0102847,0.0008614413,0.002142476,0.112543486,0.08288107,0.0014418379,0.0011084338,0.001506457,0.036751907,0.0032003166,0.16617404,0.003671436,0.023585955,0.14853753,0.03956126,0.0015911398,0.0017457713,0.025873167,0.3091952,0.00054438284,0.0015910637
conjugated catecholamines human plasma coming origins conjugated catecholamines remain poorly known aim present study see whether major contribution comes sympathetic nervous system assumed kind parallelism activity sympathetic nervous system amount catecholamines released taken amount conjugated catecholamines circulating plasma accordingly increase sympathetic activity followed increase plasma level conjugated catecholamines plasma levels sulfoconjugated glucuroconjugated catecholamines measured patients mental disease resistant drug treatment electroconvulsive therapy expected blood pressure norepinephrine concentration epinephrine concentration plasma transiently increased neither sulfoconjugated glucuroconjugated catecholamines significantly changed conjugated catecholamines measured volunteers nadir insulin induced hypoglycemia expected plasma levels norepinephrine epinephrine drastically increased plasma levels sulfoconjugates decreased glucuroconjugates increased narrow statistically significant variations data reported present article support major role activity sympathetic system fixing level conjugated catecholamines human plasma negative nonetheless important observation human subjects currently available information suggests important role intestinal wall renal function determining level circulating sulfoconjugates,C18,0.0020119806,0.0017847272,0.0129701495,0.0011304498,0.0028016192,0.0025965658,0.26464772,0.0018961582,0.0111665325,0.001976889,0.012013283,0.0044003935,0.0986568,0.024235876,0.011472684,0.012869854,0.052421153,0.0020720065,0.002290936,0.04521203,0.42857137,0.0007143812,0.0020864897
increased preproinsulin mrna pancreatic islets incubated islet cell stimulating antibodies serums type diabetic patients recently described autoantibodies stimulate release insulin pancreatic beta cells vitro vivo aim study establish whether islet cell stimulating antibodies icstas also increase islet cell preproinsulin mrna content wistar rat islets isolated collagenase digestion exposed mm glucose insulin release increased fold response higher glucose concentration dot blot analysis islet mrna rat preproinsulin cdna probe showed concomitant increase mrna levels globulin fractions four test serums three patients type insulin dependent diabetes one patient insulin autoimmune syndrome showed clear fold stimulation insulin release nonglobulin fractions serums fractions three control serums failed stimulate secretion insulin insulin mrna content islets incubated icsta globulin fractions greatly increased compared levels observed islets treated control serum globulin fractions conclude icstas stimulate release insulin also increase preproinsulin mrna content islet cells,C18,0.0017255102,0.0015306136,0.011502598,0.0009695786,0.0024027182,0.018924193,0.141364,0.0016226907,0.001247467,0.0016954151,0.01780569,0.029363176,0.013710381,0.12000386,0.0015242754,0.109932154,0.052817795,0.061591577,0.018654373,0.021744873,0.34946936,0.00061266596,0.019785058
practical nutritional advice elderly part evaluation supplements rdas geriatrics panel discussion time someone reaches old age thinks know everything want need know nutrition yet malnutrition many effects rising danger first two installments panel discussion nutritional experts review practical concerns treating physician including assessment interpretation weight loss use supplements relevance rdas elderly,C18,0.00494803,0.0043891496,0.009232511,0.0027800964,0.07872739,0.006385691,0.23411863,0.0046531875,0.0035772056,0.00486173,0.04667913,0.034117866,0.039141957,0.01137705,0.004351173,0.00780284,0.06710084,0.005095651,0.00563406,0.2903727,0.12779263,0.0017568658,0.0051036454
serum lipoproteins apolipoproteins low density lipoprotein subfractions month fibrate treatment primary hypertriglyceridaemia serum lipoproteins apolipoproteins studied hypertriglyceridaemic htg patients week period treatment gemfibrozil week washout period marked decrease low density lipoprotein vldl cholesterol triglyceride observed increase high density lipoprotein hdl cholesterol particularly hdl component slight increase low density lipoprotein ldl cholesterol observed weeks almost disappeared weeks treatment resulted increase serum apolipoprotein ii levels reduction serum apo c iii apo e vldl subfractionation density gradient centrifugation four subfractions decreasing size b c showed predominant reduction large subfractions b c decrease vldl less marked percentage changes baseline level vldl vldl cholesterol found inversely correlated percentage changes hdl ldl cholesterol respectively might reflect transfer cholesterol vldl hdl vldl ldl data suggest fibrate induced stimulation lipoprotein lipase indicate enhanced transfer cholesterol vldl ldl induced fibrates htg patients less pronounced prolonged period treatment,C18,0.002010908,0.0017837757,0.03293922,0.0011298471,0.0028224057,0.0025951816,0.13368832,0.0018910823,0.001453797,0.011663925,0.009478404,0.013966575,0.11079947,0.0046976395,0.19644167,0.012804578,0.082741134,0.002070902,0.0022897145,0.015016536,0.3549322,0.0007140004,0.002068748
contribution impaired muscle glucose clearance reduced postabsorptive systemic glucose clearance niddm reduced postabsorptive rates systemic glucose clearance non insulin dependent diabetes mellitus niddm thought consequence insulin resistance peripheral tissues although peripheral tissues involved identified generally assumed primarily muscle major site insulin mediated glucose disposal test hypothesis measured postabsorptive systemic forearm glucose utilization clearance volunteers niddm age weight matched nondiabetic volunteers although systemic glucose utilization increased niddm subjects vs mumol kg min p less systemic glucose clearance reduced vs ml kg min p less although forearm glucose utilization increased niddm subjects vs mumol dl min p less forearm glucose dl clearance reduced vs ml l min p less however extrapolation forearm data total body muscle indicated impaired clearance reduced muscle glucose disposal mumol min whereas impaired systemic clearance reduced systemic glucose disposal mumol min thus impaired muscle glucose clearance accounted less reduced systemic glucose clearance niddm subjects therefore conclude muscle insulin resistance plays minor role reduced systemic glucose clearance found niddm postabsorptive state propose reduced brain glucose clearance largely responsible,C18,0.00942182,0.0014124406,0.002973914,0.0008946427,0.0022172132,0.01747007,0.12522028,0.0014974087,0.047402784,0.0015645183,0.008672388,0.011736688,0.25563964,0.012272027,0.025472768,0.11178623,0.014180033,0.024008261,0.0018130563,0.044124044,0.2780163,0.00056536426,0.0016380891
development iddm donating kidney diabetic sibling goal study describe patient developed insulin dependent diabetes mellitus iddm donating kidney sibling suggest possible solution prevent occurrence yr old man found islet cell autoantibodies icas part screening program first degree relatives iddm two years previously donated kidney hla identical sibling long standing iddm oral intravenous glucose tolerance tests demonstrated gradual loss insulin secretion increasing glucose intolerance patient developed iddm yr nephrectomy whether presence ica absolute contraindication kidney donor could debated nonetheless ica used screening test identify individuals risk subsequent iddm found positive counseling provided,C18,0.0031417725,0.01799469,0.0058622216,0.0017652338,0.004375369,0.004054621,0.30767146,0.0029545608,0.0022713616,0.0030910538,0.11113991,0.052081484,0.02161148,0.025777591,0.0027627954,0.11134042,0.08732755,0.018436758,0.013419533,0.122536965,0.07603367,0.0011155292,0.003233928
experimental diabetes increases insulinlike growth factor ii receptor concentration gene expression kidney insulinlike growth factor igf mitogenic hormone important regulatory roles growth development one target organs igf action kidney synthesizes abundant igf receptors igf study involvement igf igf receptor development nephropathy one major complications diabetes mellitus measured expression genes kidney tissues streptozocin induced diabetic rat binding labeled igf crude membranes measured tissues observed fold increase steady state level igf receptor mrna diabetic kidney accompanied fold increase igf binding addition increase igf binding igf receptor also binding lower molecular weight material may represent igf binding protein change detected level igf peptide mrna similarly igf ii receptor mrna levels igf ii binding significantly increased diabetic kidney igf igf ii receptor mrna levels igf igf ii binding returned control values insulin treatment igf receptor able transduce mitogenic signals activation tyrosine kinase domain hypothesize among factors high levels receptor diabetic kidney may also involved development diabetic nephropathy increased igf ii receptor expression diabetic kidney may important intracellular transport packaging lysosomal enzymes although role receptor signal transduction cannot excluded finally possible role igf binding proteins requires study,C18,0.0013796989,0.0012238617,0.015925664,0.00077519653,0.00857873,0.0017805733,0.16288456,0.014614576,0.0009974609,0.0013556351,0.02020325,0.0028471,0.059546992,0.042158283,0.014557408,0.050071854,0.020440934,0.19395043,0.121780254,0.010753012,0.21727595,0.0004898809,0.036408655
treatment severe reactive hypoglycemia somatostatin analogue sms reactive postprandial hypoglycemia sometimes represent severe disorder refractory conventional therapeutic measures present first individual trial knowledge administration somatostatin analogue sms may alleviate severity complaints appear diabetogenic effects somatostatin analogue documented hour oral glucose tolerance test glucose induced c peptide rise clearly attenuated also blood glucose concentration fall low enough induce hypoglycemic symptoms,C18,0.0037865497,0.0033470276,0.007040423,0.002120014,0.0052540787,0.041388467,0.27971318,0.0035483746,0.0027278645,0.0037204565,0.053612098,0.0077607767,0.10250022,0.008780645,0.039820757,0.060647685,0.08265605,0.003885783,0.024628285,0.045893945,0.21194586,0.0013397306,0.0038817418
incidence iddm population aged less yr residents turin italy goal study measure incidence insulin dependent diabetes mellitus iddm residents turin italy aged less yr primary data source list subjects diagnosed iddm attended diabetes clinics turin data sources general register death certificates list hospital discharges computerized data base insulin prescriptions eighty incident cases iddm identified study person yr less yr age age adjusted world standard incidence rates age groups yr respectively estimated completeness primary data source compared data sources whereas estimated completeness ascertainment registry incidence rates iddm northern italy compare european countries low medium incidence population based register established province turin inhabitants aged yr collection incident cases since,C18,0.0026234607,0.0023271407,0.0048951055,0.0014740155,0.003653086,0.0033857126,0.14611049,0.0024671343,0.0018966453,0.0025960717,0.11168523,0.031234926,0.13467827,0.0060321465,0.0023070052,0.10565822,0.07535162,0.0027017295,0.002987196,0.30043256,0.039178587,0.013624744,0.0026989197
molecular mapping mouse db mutation diabetes db autosomal recessive mutation located midportion mouse chromosome results profound obesity hyperphagia increased metabolic efficiency insulin resistance clone gene generate molecular map region around mutation two genetic crosses established intraspecific backcross c bl j db db females c bl j db db x dba j f b db f male mice interspecific intercross b db f males c bl j db db x mus spretus f b spretus db f females progeny crosses characterized genotype db locus map series restriction fragment length polymorphisms relative db locus measurements body weight body length plasma concentrations glucose insulin animals allowed assignment genotype db db vs db total progeny intraspecific cross db db progeny interspecific cross typed individual restriction fragment length polymorphisms generate gene order centromere brown mt p lambda mm ifa inta cjun db rp glut mtv lck several genes linked db cjun glucose transporter glut lck map human chromosome p suggesting db may part syntenic group human p distal portion mouse chromosome addition phenotyping progeny crosses revealed wide range plasma concentrations glucose insulin among obese progeny animals developing overt diabetes remaining euglycemic distributions age controlled plasma glucose insulin among intraspecific cross obese progeny bimodal suggesting role polygenic differences progenitor strains c bl j dba j development overt diabetes,C18,0.0017698932,0.0015699837,0.020403003,0.012772932,0.020032296,0.01935713,0.2415579,0.0016644291,0.0012795541,0.0017390241,0.028397249,0.022542533,0.025871245,0.042131763,0.009677276,0.07129737,0.015920077,0.0018252908,0.0020152838,0.072295055,0.17954257,0.0006284248,0.20570968
delta delta gap approach mixed acid base disorders anion gap ag helpful yet underused clinical tool presence high ag suggest certain differential knowledge relationship rise ag delta ag fall bicarbonate delta hco important understanding mixed acid based disorders simple arithmetic converts relationship numerical value delta gap delta gap delta gap delta ag delta hco delta gap significantly positive greater metabolic alkalosis usually present rise ag fall hco conversely delta gap significantly negative less hyperchloremic acidosis usually present rise ag less fall hco familarity relationship changes ag hco useful unmasking occult metabolic disorders,C18,0.0030956755,0.0027460186,0.0057762093,0.0017393338,0.019271504,0.0039951303,0.30834255,0.0029112108,0.017096443,0.003041683,0.043496594,0.006367341,0.19421315,0.024612593,0.002722259,0.0048206104,0.04238623,0.0031880324,0.0035364535,0.07122886,0.1562026,0.0010991619,0.07811034
changing epidemiology diabetes mellitus among navajo indians although early descriptions diabetes mellitus among navajo indians characterized disease infrequent benign chemical abnormality prevalence diabetes complications among navajos appears increased substantially century reviewed recent indian health service inpatient ambulatory care data compared data previous reports estimated navajo population aged years older ambulatory care visit diabetes october september diabetes coded hospital admissions persons aged older lower extremity amputations done diabetes involved age adjusted mortality rate diabetes per approximately twice general us population explanation increased prevalence diabetes mellitus among navajos probably relates increasing prevalence obesity,C18,0.0029621192,0.0026275476,0.005527007,0.0016642939,0.0041246573,0.003822769,0.3220761,0.0027856128,0.0021414803,0.0029161063,0.05660994,0.006092513,0.031109393,0.006841439,0.0026048128,0.033266895,0.07109245,0.0030504917,0.046384383,0.2974144,0.09077591,0.001051741,0.0030579874
devices insulin administration significant need revised safe effective insulin delivery methods subcutaneous injections treatment type insulin dependent type ii non insulin dependent diabetes aim review describe rationale methods better use injection infusion devices intensive insulin therapy describe results animal human research lead implantable artificial pancreas injection devices e g jet injectors insulin pens access ports cannot considered major breakthrough quest improved control although may improve patient comfort external pumps benefits multiple injections conventional insulin therapy specific subgroups patients e g recurrent severe hypoglycemia used experienced personnel external artificial pancreas biostator also used experienced personnel limited clinical research applications e g surgery diabetic patient development implantable version artificial pancreas linked progress field reliable long duration glucose sensors finally programmable implantable insulin pumps used open loop delivery system promising alternative intensive subcutaneous insulin strategies short term although clear evidence improved safety efficacy remains documented,C18,0.0018036433,0.027743606,0.09048372,0.0010116838,0.0025071253,0.019749139,0.2618047,0.0016932026,0.027446125,0.0017690872,0.050819986,0.06806781,0.05769084,0.005626081,0.010262794,0.11597187,0.14507346,0.0018552836,0.002118542,0.018850276,0.08513457,0.00063928857,0.0018771846
mild hypoglycemia impairment brain stem cortical evoked potentials healthy subjects evaluate impact mild hypoglycemia cns function healthy adults measured brain stem auditory evoked potentials p potentials elicited cognitive processing auditory stimuli hypoglycemic euglycemic insulin clamps mu min hypoglycemic clamp study n plasma glucose allowed fall mm hourly approximately mm steps subsequently returned euglycemic baseline levels euglycemic clamp study n plasma glucose maintained baseline levels throughout neither brain stem p responses changed euglycemic control study symptoms counterregulatory hormones also unaffected hypoglycemia study epinephrine growth hormone rose plasma glucose reached mm brain stem p potentials remained unchanged mm glucose step neurophysiological changes suddenly developed conjunction reported symptoms glucose level wave v component brain stem potential selectively altered subjects furthermore p latency significantly increased amplitude diminished changes brain stem cortical p responses reversed euglycemia restored conclude modest reductions plasma glucose mm produce marked alterations brain stem cortical responses auditory stimuli changes neural function appear time symptoms follow rather precede rise counterregulatory hormones hypoglycemia data suggest adverse effects mild hypoglycemia brain function limited higher centers also involve brain stem,C18,0.009023698,0.001370634,0.017837068,0.0008681623,0.002209087,0.054275572,0.18678696,0.0014530871,0.0011170818,0.0015280712,0.023695156,0.021792755,0.19002776,0.030905647,0.038732607,0.055941857,0.03128037,0.0015912584,0.011736437,0.019474424,0.28873023,0.00054863014,0.009073409
polymorphisms hepg erythrocyte glucose transporter gene linkage relationships implications genetic analysis niddm assess contribution hepg erythrocyte glucose transporter hepg gt gene inherited susceptibility non insulin dependent diabetes mellitus niddm cdna genomic probes used search restriction endonuclease polymorphisms locus analysis dna unrelated black american individuals enzymes many six different probes defined four polymorphisms kilobase region nucleotide diversity pi low relative loci average base pairs different two chromosomes locus observed combined heterozygosity four sites indicates markers locus could useful linkage analysis families linkage disequilibrium values four polymorphisms evaluated pairwise analysis extended haplotypes calculating pairwise associations disequilibrium statistic delta another measure disequilibrium maximum likelihood disequilibrium less dependent frequency significant linkage disequilibrium could demonstrated however frequencies observed extended haplotypes shown differ chi df p less predicted frequencies sites linkage equilibrium blacks frequencies four polymorphisms determined black nondiabetic n niddm n subjects neither allelic genotypic frequencies polymorphisms differed two groups,C18,0.0020925112,0.0018561617,0.014031765,0.0011756966,0.002913983,0.002815762,0.30875528,0.0019678227,0.0015127924,0.002056015,0.036498386,0.014433955,0.117187604,0.017494101,0.011944227,0.03741549,0.02718561,0.012964691,0.012494703,0.06016616,0.13075274,0.0007429747,0.18154159
physical growth development children type glycogen storage disease comparison effects long term use dextrose uncooked cornstarch thirteen patients type glycogen storage disease gsd studied compare effects biochemical control growth therapy intermittent feedings uncooked cornstarch ucs fasting glucose production rate therapy continuous overnight glucose cog dextrose feedings day mean biochemical abnormalities groups minimized normalized either cog ucs growth progressed normally cog started age normal growth rate maintained ucs weight increased ideal body weight onset cog cog first year ucs therapy increase second year growth failure occurred onset cog sd score chronological age sdsca partial correction sdsca genetic potential height occurred intermittent feeding ucs provides effective alternative cog treatment gsd,C18,0.0024092905,0.013799822,0.004540373,0.013517944,0.0033548607,0.026390119,0.30837348,0.002265726,0.0017418099,0.04902037,0.011184951,0.0290837,0.04270952,0.0677285,0.013758402,0.03873889,0.12850407,0.0024824312,0.0027433317,0.09485746,0.13942382,0.00085545157,0.0025157128
beta cell cytoadherent lymphocytes subjects risk type insulin dependent diabetes progression diabetes within years increased binding vitro cd cd lymphocytes type insulin dependent diabetic patients beta cell membrane antigens compared lymphocytes control subjects previously shown marker cell mediated immunity called diabetic rosettes present study diabetic rosettes detected subjects risk type diabetes first degree relatives type diabetic patients nondiabetic subjects previous transient hyperglycaemia mean number lymphocytes adherent beta cells beta cl significantly higher subjects risk type diabetes age sex matched control blood bank donors p less number beta cl higher type diabetic patients subjects risk p less one way analysis variance rank kruskal wallis revealed three populations controls diabetics risk subjects different terms beta cl values p less percentage subjects risk positive test arbitrarily defined beta cl value higher th percentile controls difference observed two subgroups subjects risk terms either mean sem beta cl percentages individuals positive test diabetic rosettes slightly associated acute insulin response iv glucose lower th percentile controls immunoreactive insulin min pmol l chi p hla dr heterozygosity chi p associated islet cell antibodies regardless threshold positivity expressed juvenile diabetes foundation units insulin autoantibodies activated hla dr lymphocytes sex statistical association detected hla dr heterozygosity low acute insulin response iv glucose chi p less preliminary yr longitudinal follow revealed five islet cell antibody positive subjects progressed type diabetes three displayed beta cl values higher th percentile controls diabetic rosettes could thus detected individuals risk type diabetes marker cell mediated immunity,C18,0.0011623375,0.0010310514,0.017465828,0.00065321574,0.0016261949,0.007102866,0.16107735,0.0010930763,0.0008403183,0.0011425549,0.07315483,0.0027282697,0.1970275,0.08277154,0.010413522,0.120536864,0.0387021,0.023781661,0.0013234923,0.13611576,0.06407009,0.0004127038,0.055766903
calcitonin gene related peptide induction hyperglycemia conscious rats vivo effect calcitonin gene related peptide cgrp glucose metabolism investigated conscious unrestrained rats vivo intravenous injection rat cgrp nmol kg caused significant dose dependent increase plasma glucose concentration simultaneous dose dependent increase plasma insulin level contrast plasma glucagon level changed hand intravenous infusion cgrp pmol kg min decreased tolerance intragastric administration glucose iggtt plasma insulin response iggtt however affected cgrp infusion moreover although intravenous injection cgrp nmol kg elicited significant increase plasma epinephrine norepinephrine concentrations concomitant administration epinephrine norepinephrine inducing prominent rise plasma catecholamines induced cgrp affected neither plasma glucose insulin levels finally plasma insulin levels obtained simulating cgrp induced changes plasma glucose glucose plus catecholamine levels infusion glucose glucose plus catecholamines different induced cgrp injection results suggest cgrp hyperglycemic action mediated sympathetic outflow conscious rats inhibition insulin secretion play major role hyperglycemic action cgrp demonstrated specific cgrp receptors linked adenylate cyclase activation rat liver plasma membranes hyperglycemic effect cgrp vivo may partly due direct action liver,C18,0.0015567801,0.0013804772,0.017998185,0.00087439705,0.00216711,0.009518344,0.13547206,0.0014635226,0.0011251043,0.0015291135,0.0074430346,0.05526878,0.041998733,0.0038382455,0.0013685328,0.15233707,0.013807293,0.024404991,0.001772027,0.020148048,0.5023733,0.00055257016,0.001602363
reduced beta cell glucose transporter new onset diabetic bb rats previous studies laboratories suggested defect glucose transport islets isolated bb rats first day overt diabetes quantitate immunostaining glucose transporter beta cells glut onset autoimmune diabetes employed antibody cooh terminal octapeptide first day overt diabetes defined day daily blood glucose first reached mg dl volume density ratio glut positive insulin positive beta cells compared age matched nondiabetic diabetes resistant controls p less age matched nondiabetic diabetes prone rats would become diabetic ratio also less controls p less protein gold labeling glut beta cells day diabetic rats revealed gold particles per micrometer length microvillar plasma membranes compared controls p less nondiabetic diabetes prone rats p less reduction glut correlates temporally may contribute loss glucose stimulated insulin secretion precedes profound beta cell depletion autoimmune diabetes,C18,0.00181673,0.0016113233,0.020941487,0.0010206155,0.007183524,0.0023442837,0.17302938,0.0017082556,0.0013132463,0.019370588,0.07930375,0.012884836,0.12923457,0.08878403,0.045553662,0.08197155,0.01909127,0.0109104235,0.002068349,0.042027563,0.19376428,0.000644972,0.063421346
nature nurture nutrition interdisciplinary programs address prevention malnutrition dehydration malnutrition dehydration common problems nursing home patients one explanation may large number patients requiring feeding assistance dysphagia team department veterans affairs medical center miami florida served primary source expansion nutritionally supportive environment assist prevention malnutrition dehydration patients feeding swallowing disorders silver spoons program volunteers provide supervised feeding happy hour time day atmosphere provided encourages socialization hydration second seating lunch provided patients require modification eating style food texture timing described analysis program outcomes show timely pleasing patients cost effective,C18,0.0036405507,0.038476374,0.00679289,0.019624636,0.005070649,0.0046983203,0.29232064,0.003423618,0.002631956,0.021152934,0.017620897,0.007487917,0.046790045,0.0086142495,0.0032014083,0.0232772,0.25048184,0.0037491636,0.09072048,0.08350871,0.06166482,0.0012926273,0.0037580498
folate status adolescents effects folic acid supplementation study designed determine folate status adolescent population demonstrate effect folic acid supplementation subjects low folate status phase one folate status evaluated biracial sample adolescents years old socioeconomic demographic anthropometric day food record data collected serum erythrocyte folate levels determined thirty five adolescents considered low folate status months earlier participated phase two month supplementation period reevaluation racial differences observed folate status indicated amount folate blood diet boys significantly p less higher folate levels serum erythrocytes girls thirteen percent boys girls folate deficient judged amount erythrocyte folate less nmol l ng ml folate deficient subjects significantly p less lower values hemoglobin normal subjects seventeen percent boys girls folate intakes recommended dietary allowance folate supplementation micrograms folic acid daily months resulted significant p less increases serum folate erythrocyte folate hemoglobin values decrease mean corpuscular volume evidence high prevalence low folate status positive relationship erythrocyte folate hemoglobin responses hemoglobin mean corpuscular volume supplement indicated folate consumption may optimal groups adolescents especially girls,C18,0.0017696004,0.001569724,0.011848789,0.0009942664,0.0024642812,0.002299781,0.11836469,0.0016641538,0.009836381,0.010296357,0.043997154,0.012206826,0.24211876,0.0041336133,0.001556142,0.020638118,0.08225063,0.0018226686,0.0020149504,0.1053548,0.2347472,0.03487766,0.053173423
changes phosphoinositide turnover ca mobilization protein phosphorylation platelets niddm patients enhanced platelet functions demonstrated patients non insulin dependent diabetes mellitus niddm study evaluated abnormalities platelet signal transduction diabetic patients including turnover phosphoinositides mobilization intracellular ca phosphorylation mr proteins p p washed platelets obtained patients niddm whose platelet aggregation rates abnormally elevated dm group niddm patients normal platelet aggregation rates dm b group age matched healthy control subjects mass specific radioactivity phosphatidylinositol bisphosphate pip phosphatidylinositol phosphate pip phosphatidylinositol pi phosphatidic acid pa p labeled platelets different among three groups hydrolysis pip pip pi accumulation pa phosphorylation p platelets stimulated u ml thrombin significantly increased dm group compared control dm b group difference p phosphorylation among three groups contrary p p phosphorylation induced nm tetradecanoylphorbol acetate activator protein kinase c significantly decreased dm group additionally intracellular free ca concentration ca measured fluorescent ca indicator fura although basal ca value similar three groups rise ca induced u ml thrombin presence absence extracellular ca significantly higher dm group groups,C18,0.002071143,0.0018372071,0.013886522,0.0011636907,0.002884239,0.002672918,0.082316205,0.0019477279,0.0014973441,0.012054043,0.011228755,0.10891495,0.17097442,0.13292463,0.0018213108,0.050772917,0.07719039,0.022276577,0.01229345,0.020895822,0.26550886,0.0007353876,0.0021314556
absence angiogenesis inhibitory activity aqueous humor diabetic rabbits studied inhibitory activity angiogenesis eye explore formation new blood vessels diabetic microvascular diseases examined effects extracts various ocular tissues nondiabetic rabbits proliferation bovine aortic endothelial cells potent inhibitory activity found lens aqueous humor aqueous humor inhibited angiogenesis chorioallantoic membrane vivo promotion endothelial cell growth vitro induced retinal extracts however diabetic rabbits aqueous humor lost ability inhibit growth endothelial cells loss activity became evident mo alloxan injection lasted animals hyperglycemic addition diabetic aqueous humor failed suppress retinal extract induced angiogenesis promotion endothelial cell growth absence inhibitory activity angiogenesis diabetic aqueous humor might involved promotion neovascularization diabetic ocular disease,C18,0.0023814237,0.0021124417,0.018700242,0.0013380247,0.003316057,0.003087127,0.1504671,0.094723575,0.013238405,0.0023398886,0.011346683,0.025672106,0.040143203,0.17037673,0.013597018,0.11899205,0.021924812,0.02745385,0.002711601,0.027273413,0.19302481,0.000845557,0.054933902
role two types glucose transporters enlarged adipocytes aged obese rats mechanism insulin resistant glucose transport activity enlarged aged adipocytes examined glucose transport activity assessed measuring methylglucose transport concentration hepg erythrocyte glucose transporter glut muscle adipose tissue transporter glut estimated immunoblotting basal glucose transport activity increased fold cell remained constant per unit cellular surface area due cell enlargement maximal insulin stimulated transport activity remained constant per cell decreased per unit cellular surface area per protein basis glut glut aged rats decreased approximately young rats respectively however protein content fraction recoveries marker enzymes used estimating amount transporters intact adipocytes amount glut per cell remained relatively constant whereas glut decreased basal cells young rats total glut per cell located plasma membrane whereas aged rats located plasma membrane thus comparing basal adipocytes aged rats young rats glut per cell plasma membrane increased fold increase less transport activity fold basal cells young rats total glut located plasma membrane fold increase observed insulin treatment amount glut fraction aged rats markedly decreased,C18,0.0015484366,0.0013701764,0.05634225,0.0008679204,0.002150868,0.0019934438,0.09710844,0.0014526021,0.02349661,0.00899125,0.023321405,0.0031897828,0.039798133,0.098719396,0.050370697,0.06882755,0.015762199,0.032374006,0.0017588045,0.043192472,0.3953153,0.000548447,0.03149984
lack beta hydroxy delta c steroid dehydrogenase isomerase fibroblasts child urinary excretion beta hydroxy delta bile acids new inborn error metabolism cultured fibroblasts shown capable catalyzing conversion alpha hydroxy cholesterol alpha hydroxy cholesten one important reaction bile acid synthesis apparent km approximately mumol liter vmax varied nmol mg protein per h assay conditions used assay used investigate fibroblasts patient presented familial giant cell hepatitis found excrete monosulfates beta alpha dihydroxy cholenoic acid beta alpha alpha trihydroxy cholenoic acid urine clayton p j v leonard lawson k r setchell andersson b egestad j sjovall j clin invest addition alpha hydroxy cholesterol found accumulate circulation cultured fibroblasts boy completely devoid beta hydroxy delta c steroid dehydrogenase isomerase activity fibroblasts parents reduced activity compatible heterozygous genotype results provide strong evidence suggestion patient liver disease caused primary defect beta hydroxy delta c steroid dehydrogenase isomerase involved bile acid biosynthesis,C18,0.012779491,0.0019343222,0.004068818,0.0012252035,0.009087495,0.0028142086,0.27945474,0.002050685,0.001576494,0.012699026,0.023483602,0.015030629,0.024534043,0.09217649,0.030357143,0.013264806,0.039330542,0.028398074,0.002482961,0.035605647,0.16343144,0.0113276,0.19288658
effect central obesity regulation carbohydrate metabolism obese patients varying degrees glucose tolerance proposed central obesity virtue enhanced lipolytic activity abdominal adipose tissue leads higher plasma ffa concentrations turn decrease hepatic removal insulin insulin stimulated glucose uptake peripheral tissues short predicted consequences abdominal obesity elevations circulating ffa insulin levels well insulin resistance goal study evaluate relationships predicted overall hypothesis study carried obese females defined normal glucose tolerance n impaired glucose tolerance n noninsulin dependent diabetes mellitus n abdominal obesity estimated determining ratio waist hip girth fasting postprandial plasma ffa insulin concentrations measured hourly intervals h insulin stimulated glucose disposal quantified euglycemic hyperinsulinemic clamp technique first step postulated sequence events tested greater whr higher total integrated plasma ffa response correlation coefficient two variables indicating results support prediction furthermore could demonstrate relationship magnitude plasma ffa insulin responses r p ns however modest inverse relationship height circulating plasma insulin concentration decrease insulin stimulated glucose uptake r p less group whole hand three groups analyzed individually significant inverse relationship seen control group r direct relationship actually seen patients impaired glucose tolerance r furthermore mean responses variables three groups compared apparent postulated relationships abdominal obesity plasma ffa concentration insulin secretion action present thus data presented support hypothesis differences degree central obesity play important role regulation plasma concentrations either ffa insulin modulation insulin stimulated glucose uptake patients studied,C18,0.0011965253,0.0010613777,0.002235852,0.0006722788,0.0016923178,0.018868262,0.10865608,0.02428691,0.006453379,0.006959157,0.03876713,0.03624344,0.059154745,0.017651131,0.00105221,0.19879666,0.034611806,0.026533239,0.0069156727,0.053788733,0.34673184,0.00042484267,0.0072463974
importance context choosing nutritional indicators nutritional indicators used screen diagnose evaluate interventions individuals also used populations ascertain place surveillance magnitude nutritional problems location causes evaluate impact programs policies nutritional indicators also used research make inferences biological social mechanisms affecting affected nutrition activities include measurements nutritional indicators choice indicators measurements analyses need data different inferences research patient management making public policy planning evaluating programs best indicator best measure indicator best analysis indicator generic sense definition best depends ultimately appropriate decision must made paper gives examples,C18,0.015495625,0.0023569406,0.0049577896,0.001492891,0.016550532,0.0034290683,0.49606913,0.002498727,0.0019209328,0.002610713,0.05572732,0.005510868,0.057616897,0.0064443587,0.015195073,0.02985284,0.07772231,0.0027363265,0.06568396,0.06573777,0.06670529,0.00094342383,0.002741209
hyponatremia rats induces downregulation vasopressin synthesis hyponatremia due inappropriate secretion vasopressin common disorder human pathophysiology vasopressin synthesis hypoosmolality investigated used new method quantitate synthesis vasopressin rats hyponatremia induced administering ddavp vasopressin agonist liquid diet vasopressin synthesis completely turned vasopressin mrna levels hypothalamus paralleled reduction synthesis reduced levels content control rats hyponatremia corrected withdrawal ddavp vasopressin mrna slowly returned normal observation vasopressin synthesis completely turned leads several conclusions normal physiological conditions neurohypophysis chronically upregulated must osmotic threshold initiation vasopressin synthesis release large store hormone posterior pituitary essential vasopressin available times decreased synthesis finally nonosmolar stimulus synthesis must present clinical disorders vasopressin secreted synthesized despite hypoosmolality,C18,0.014993928,0.014472898,0.01693627,0.0014198693,0.0035196042,0.015449017,0.23872498,0.0023765068,0.0018269742,0.0024830152,0.025753146,0.005262136,0.035090547,0.0062817466,0.0022344296,0.028392736,0.02645935,0.16441442,0.0028774648,0.01632825,0.37119436,0.00089727814,0.002611077
nutritional assessment requirements nutrition plays important role health disease prevention treatment increasing emphasis placed upon nutrition therapeutic tool decrease morbidity mortality associated obesity hypertension coronary artery disease cancer adequate nutrition concern health care workers impact overall health patients health care professionals familiar essentials nutritional assessment basic nutritional requirements able improve patients care face nutritional deficiencies excesses,C18,0.02244419,0.02201363,0.0071716146,0.0021595187,0.023933452,0.060773853,0.2604085,0.0036144953,0.002778696,0.022366662,0.019752478,0.026511172,0.027527327,0.008837446,0.0033798967,0.024552835,0.12780331,0.0039581913,0.09709076,0.12044557,0.107038684,0.0013646953,0.0040730177
mechanism increased gluconeogenesis noninsulin dependent diabetes mellitus role alterations systemic hepatic muscle lactate alanine metabolism assess mechanisms responsible increased gluconeogenesis noninsulin dependent diabetes mellitus niddm infused c lactate c alanine h glucose postabsorptive niddm subjects age weight matched nondiabetic volunteers measured systemic appearance alanine lactate release forearm tissues conversion plasma glucose corrected krebs cycle carbon exchange systemic appearance lactate alanine significantly greater diabetic subjects mumol kg min respectively nondiabetic volunteers mumol kg min respectively p less p less conversions lactate alanine glucose also significantly greater niddm subjects mumole kg min respectively nondiabetic volunteers mumol kg min respectively p less p less proportion systemic alanine appearance converted glucose increased niddm subjects vs nondiabetic volunteers whereas proportion systemic lactate appearance converted glucose increased niddm subjects vs nondiabetic volunteers p less latter increased hepatic efficiency accounted approximately increased lactate conversion glucose neither forearm total body muscle lactate alanine release significantly different niddm nondiabetic volunteers therefore conclude increased substrate delivery liver increased efficiency intrahepatic substrate conversion glucose important factors increased gluconeogenesis niddm tissues muscle responsible increased delivery gluconeogenic precursors liver,C18,0.0018322731,0.0016253177,0.038587254,0.0010294796,0.0025513822,0.0023646438,0.115663126,0.046064008,0.045675594,0.0018003159,0.00842642,0.003985195,0.3035938,0.005098212,0.0016923592,0.12120219,0.01893632,0.00189928,0.0020863125,0.04204137,0.22243823,0.00065057364,0.01075634
use cholesterol measurements childhood prediction adult hypercholesterolemia muscatine study article describes validity utility screening tests total cholesterol levels school age children predict adults cholesterol levels national cholesterol education program suggests need continuing surveillance intervention two thousand three hundred sixty seven children aged years examined several occasions followed ages years children cholesterol concentrations exceeding th percentile two occasions girls boys would qualify intervention adults national cholesterol education program criteria children cholesterol levels exceeding th percentile two occasions girls boys would qualify intervention adults efficacy safety acceptability cost treatment high cholesterol concentrations childhood evolving need universal screening childhood cholesterol levels must considered carefully view number children high levels cholesterol adults meet criteria intervention suggested national cholesterol education program,C18,0.0021802434,0.0019339847,0.0040681083,0.0012249899,0.00303592,0.013358344,0.1636729,0.012597105,0.001576219,0.10127454,0.10376966,0.0044843443,0.028767806,0.0050824666,0.11821593,0.0033950924,0.0428049,0.0022452893,0.039257593,0.22089384,0.1231436,0.0007741252,0.002242954
sulfonylureas although controversies remain usefulness sulfonylureas evidence favor use many patients non insulin dependent diabetes mellitus used properly sulfonylureas improve insulin secretion action effects may maintained years combined hypocaloric dietary regulation rapid short acting sulfonylureas may help patients reach maintain euglycemia without provoking chronic hyperinsulinemia weight increase evidence sulfonylurea treatment causes beta cell exhaustion instead antihyperglycemic effect helps improve beta cell function sulfonylurea failures often dietary failures may due late introduction drugs e beta cell function already attenuated desensitization insulinotropic effect sulfonylureas may occur might avoided discontinuous less h day sulfonylurea exposure e daily administration short acting sulfonylurea moderate dose important adverse effect sulfonylureas long lasting hypoglycemia may lead permanent neurological damage even death mainly seen elderly subjects exposed intercurrent event e g acute energy deprivation drug interaction e aspirin long acting sulfonylureas may likely promote long lasting hypoglycemia dose response relationships sulfonylureas poorly investigated sulfonylurea therapy always initiated maintained lowest possible dose,C18,0.0018015489,0.027746605,0.0033610293,0.009723189,0.011208491,0.014974826,0.31738436,0.010355551,0.0013018034,0.0017844724,0.008551656,0.02112466,0.038931802,0.041486774,0.018986689,0.03966635,0.05695833,0.0018543904,0.002170806,0.12642816,0.2155567,0.0006393521,0.028002478
morbidly obese patients perceptions social discrimination surgery obesity morbidly obese patients perceptions obesity related prejudice discrimination assessed months operation obesity preoperatively consecutive patients perceived overwhelming prejudice discrimination work within family public places weight loss kg lb patients perceived little prejudice discrimination examine factors contributing change patients perceptions comment upon patients perceptions negative attitudes held health professionals toward obese patients,C18,0.0043264893,0.003837812,0.00807278,0.0024308779,0.026891535,0.0055835596,0.1149702,0.004068683,0.0031278592,0.025168577,0.034979403,0.009113179,0.03709648,0.047835868,0.0038046055,0.09049217,0.30262116,0.004455567,0.025867516,0.1370744,0.1021942,0.0015361791,0.0044509326
limited duration remission insulin dependency children recent overt type diabetes treated low dose cyclosporin preliminary data group indicated cyclosporin induced frequent remissions insulin dependency group insulin dependent type diabetic children given onset clinical manifestations diabetes report yr analysis response cyclosporin group patients included initial study observed remission could obtained patients association shorter duration symptoms less severe hyperglycemia lower incidence ketoacidosis higher plasma c peptide concentrations remissions ended follow period mean se duration days range days two parameters linked duration remissions mean circulating level cyclosporin first mo duration prediagnostic polyuria unable relate end remission variations cyclosporin regimen titer autoantibodies progression beta cell failure euglycemic clamp technique revealed insulin sensitivity decreases time patients taking insulin mo patients remission insulin dependency better glycemic control lower insulin dosages c peptide levels two threefold higher nonremission patients four sixfold higher historical control subjects cyclosporin regimen well tolerated observed period specifically serum creatinine remained unchanged kidney biopsies performed mo treatment within normal limits,C18,0.0016577559,0.009485671,0.03451358,0.0009306009,0.0023129021,0.029980192,0.19927512,0.0015574794,0.001197335,0.027166545,0.03922442,0.037003867,0.100978926,0.0123678,0.0014563914,0.0747346,0.15257685,0.010729345,0.0018857897,0.06513155,0.18508649,0.0005880447,0.010158774
monomeric insulins experimental clinical implications due inherent pharmacokinetic properties available insulins normoglycemia rarely ever achieved insulin dependent diabetic patients without compromising quality life subcutaneous insulin absorption influenced many factors among associated state insulin hexameric pharmaceutical formulation may importance review describes development series human insulin analogues reduced tendency self association rapid absorption better suited meal related therapy dna technology made possible prepare insulins remain dimeric even monomeric high concentration introducing one amino acid substitutions human insulin analogues characterized used elucidating mechanisms involved subcutaneous absorption investigated preliminary clinical studies relative receptor binding vitro potency free fat cell assay ranging relative human insulin strongly correlated r vivo analogues exhibited approximately activity explainable dominating receptor mediated clearance confirmed clamp studies correlation receptor binding clearance observed thus analogue reduced binding clearance gives higher circulating concentrations counterbalancing reduced potency cellular level absorption studies pigs revealed strong inverse correlation r rate subcutaneous absorption mean association state insulin analogues studies also demonstrated monomeric insulins absorbed three times faster human insulin healthy subjects rates disappearance subcutis two three times faster dimeric monomeric analogues human insulin concomitantly rapid rise plasma insulin concentration earlier hypoglycemic response analogues observed monomeric insulin lag phase followed monoexponential course throughout absorption process contrast two phases rate absorption identified dimer three normal hexameric human insulin initial lag phase subsequent accelerated absorption soluble insulin explained associated state native insulin pharmaceutical formulation progressive dissociation smaller units absorption process light results effects insulin concentration injected volume temperature massage absorption process also understood abstract truncated words,C18,0.001162923,0.0122771505,0.029343452,0.01189074,0.0016214031,0.012731091,0.20077813,0.0010930406,0.00084029086,0.012379696,0.0068537523,0.013862022,0.046272445,0.041746933,0.017884674,0.14483649,0.05812278,0.0484105,0.0013234491,0.05091403,0.26325732,0.00041269034,0.021985043
l arginine augments endothelium dependent vasodilation cholesterol fed rabbits evidence exists endothelium derived relaxing factor nitric oxide l arginine precursor synthesis nitric oxide vitro whether exogenous l arginine contributes modulation vascular smooth muscle tone vivo still controversial hypercholesterolemia resistance vessels relax normally response pharmacological stimuli release endothelium derived relaxing factor bioassay experiments suggested impaired synthesis release endothelium derived relaxing factor accounts part blunted relaxation hypothesized hypercholesterolemia reduces arginine metabolism thereby impairs endothelium derived relaxing factor synthesis accordingly designed study determine whether exogenous l arginine could augment endothelium dependent vasodilation hind limb resistance vessels anesthetized cholesterol fed rabbits femoral blood flow recorded electromagnetic flow probe cholesterol fed control rabbits hind limb vasodilator responses incremental intra arterial infusions acetylcholine micrograms kg min nitroprusside micrograms kg min studied intravenous administration l arginine mg kg min arginine mg kg min saline vasodilator response acetylcholine impaired cholesterol fed rabbits compared control rabbits l arginine augmented vasodilation acetylcholine cholesterol fed control rabbits l arginine alter effect nitroprusside either group neither saline arginine changed response either acetylcholine nitroprusside data demonstrate exogenous l arginine normalizes endothelium dependent vasodilation hind limb resistance vessels cholesterol fed rabbits,C18,0.0016002988,0.0013709926,0.039598994,0.0008683895,0.0094469655,0.02480996,0.1738475,0.0014753636,0.008596115,0.009325917,0.091902986,0.07608264,0.11722116,0.06395007,0.06120189,0.0024225498,0.014358297,0.0647395,0.0017598522,0.0127966795,0.22047937,0.0005487737,0.0015957016
metabolic control complications years patients insulin dependent diabetes iddm stockholm diabetes intervention study sdis planned year study patients insulin dependent diabetes mellitus iddm non proliferative retinopathy unsatisfactory blood glucose control monitored years patients randomized intensified conventional treatment ict n regular treatment rt n group hba c normal range reduced mean value sem ict group p rt group p nerve conduction velocities sural peroneal nerves p impaired rt group ict group retinopathy increased groups condition ict patients confidence interval rt patients deteriorated regard least one microvascular complication retinopathy nephropathy neuropathy p lower hba c levels study significantly reduced risk deterioration p total ict patients least one episode serious hypoglycaemia compared rt group p patients ict group also gained weight p improved blood glucose control slowed progression microangiopathy year period patients non proliferative retinopathy price increased frequency serious hypoglycaemic episodes gain body weight,C18,0.00211471,0.0018748856,0.003964862,0.011410919,0.0029431477,0.0027277356,0.14292084,0.01215425,0.0015280526,0.002076755,0.041200045,0.10017022,0.18976408,0.004898933,0.0018586983,0.09466361,0.16318947,0.012464407,0.0024267384,0.11093684,0.09178591,0.0007504694,0.0021744135
reduced membrane fluidity platelets diabetic patients platelets diabetic patients hypersensitive agonists vitro membrane fluidity modulates cell function reduced membrane fluidity cholesterol enriched platelets associated platelet hypersensitivity agonists including thrombin decreased membrane fluidity platelets attributed increased cholesterol phospholipid molar ratio platelet membranes examined response platelets diabetic subjects thrombin platelet membrane fluidity platelet cholesterol phospholipid molar ratio twelve poorly controlled diabetic subjects compared age sex matched control subjects response low concentration thrombin mean values release c serotonin washed prelabeled platelets significantly different diabetic control subjects diabetic subjects release response greater paired control subjects mean steady state fluorescence polarization values diphenyl hexatriene labeled platelets prepared diabetic subjects significantly greater control subjects indicates decreased membrane fluidity platelets diabetic subjects total low density vldl low density ldl high density hdl hdl lipoprotein cholesterol concentrations plasma significantly different groups however ratio vldl ldl hdl hdl significantly greater diabetic control subjects difference total platelet cholesterol phospholipid molar ratio groups,C18,0.001769729,0.0015696185,0.013033691,0.0009941995,0.002463947,0.002283608,0.055517703,0.0016640419,0.0012792564,0.0017386195,0.008175528,0.03173146,0.3091877,0.021202138,0.08161012,0.07984763,0.03420958,0.0018222727,0.002014815,0.014486843,0.33094883,0.0006282786,0.0018203774
characteristics learning memory streptozocin induced diabetic mice demonstrated mice streptozocin induced diabetes mellitus normal acquisition relatively simple tasks show problems learning complex tasks shuttle box avoidance enhanced learning previously reported simple passive avoidance tasks appears due increased foot shock sensitivity diabetic mice show marked memory retention deficit learning active avoidance maze task retention deficit reversed single injection insulin suggesting may related hyperglycemia per se diabetic mice shift left inverted u shaped dose response curve memory retention produced acetylcholine agonist arecoline based preliminary screening responses several pharmacological memory enhancers probably altered diabetic mice studies suggest mouse model diabetes mellitus demonstrates deficit memory retention retrieval similar seen humans diabetes mellitus,C18,0.0026935742,0.0023877036,0.0320268,0.0015123764,0.0037486576,0.0034738248,0.19734961,0.015560182,0.0019460048,0.015671747,0.03179538,0.018636774,0.03425477,0.08195158,0.002367044,0.08237335,0.023721643,0.0027728654,0.0030649367,0.049538065,0.37525925,0.0009557374,0.016938116
metabolic effects combination glipizide human proinsulin treatment niddm effects mo treatment combination glipizide human proinsulin studied small group closely monitored patients patients non insulin dependent diabetes mellitus niddm poor glucose regulation despite maximal sulfonylurea therapy randomized double blind placebo controlled trial three treatment groups received either mg glipizide given min breakfast dinner human proinsulin given subcutaneously bedtime n glipizide human proinsulin placebo n glipizide placebo human proinsulin n glycemic regulation assessed measurements h plasma glucose profiles glycosylated hemoglobin observations demonstrate combination glipizide plus human proinsulin effective either agent alone controlling overall glycemia patients niddm data support concept use agent day major effects postprandially another agent bedtime relatively hepatospecific,C18,0.0026914962,0.0023874913,0.00505288,0.0015122419,0.0037636322,0.016488766,0.23263621,0.002532991,0.014971557,0.015670354,0.013552265,0.043623526,0.043969315,0.048079107,0.0023668339,0.08412699,0.12571903,0.0027717948,0.042150527,0.019461492,0.272686,0.0009556525,0.0028298348
nt polymorphism g pd g pd mediterranean mutation may originated independently europe asia polymorphic site exists exon g pd wild type enzyme nucleotide nt c individuals diverse populations present instead nine x chromosomes europeans mixed origins nine x chromosomes ashkenazi jewish subjects three x chromosomes sicilians five african x chromosomes nine asian indian x chromosomes mutant genotype contrast mutation found three oriental x chromosomes three central south american x chromosomes mutation absent four samples chimpanzee dna twenty one male subjects mediterranean countries g pd mediterranean genotype investigated present study reported previously nt one normal c nt contrast g pd mediterranean males indian subcontinent normal c nt findings suggest mutation nucleotide giving rise g pd mediterranean may arisen independently europe asia,C18,0.0029200627,0.0025902414,0.005448534,0.0016406641,0.0040660948,0.003768493,0.21933645,0.059257492,0.0021110752,0.0028691331,0.028348519,0.0060998886,0.06312815,0.0071835006,0.0025678293,0.0045471448,0.024989594,0.08081299,0.017443448,0.09004859,0.14233232,0.0010368081,0.22745295
biometry crystalline lens early onset diabetes lenticular biometry non cataractous lenses studied means scheimpflug photography digital image analysis patients early onset insulin dependent diabetes non diabetic controls anteroposterior axial lens thickness cortical thickness nuclear thickness anterior posterior lenticular curvatures anterior chamber depth assessed highly significant differences lenses diabetic subjects non diabetic controls found effect age accounted within diabetic subgroup diabetic duration found highly significant determinant lens dimensions age related dimensional changes various biometric parameters accelerated onset diabetes diabetic duration early onset diabetic subjects studied work accurately known report first precise assessment effect true diabetic duration lens biometry possible,C18,0.014940875,0.0022695994,0.0047740685,0.013809549,0.018068828,0.003301997,0.26579565,0.0024061315,0.012099402,0.052059095,0.041157935,0.0067260778,0.1602316,0.0059320643,0.0022499617,0.13694005,0.04356458,0.014998247,0.0029133342,0.10421398,0.087998316,0.00090846326,0.002640184
definitive prenatal diagnosis type iii glycogen storage disease prenatal diagnosis type iii glycogen storage disease performed using immunoblot analysis polyclonal antibody prepared purified porcine muscle debranching enzyme qualitative assay debranching enzyme activity cultured amniotic fluid cells three pregnancies three families proband absence debrancher protein subjected immunoblot analysis two unaffected one affected fetus predicted addition cultured amniotic fluid cells nine pregnancies eight families screened qualitative assay based persistence polysaccharide structure approaching phosphorylase limit dextrin cells exposed glucose free medium qualitative assay predicted six unaffected three affected fetuses predictions either method confirmed postnatally except one spontaneously aborted fetus data indicate definitive diagnosis type iii glycogen storage disease made prenatally methods,C18,0.0027288194,0.0024205989,0.0446859,0.0015333998,0.0037997945,0.016705783,0.25481904,0.0025662147,0.05476876,0.0026812253,0.19453856,0.018806498,0.031898253,0.15340808,0.0023996548,0.017456945,0.0304092,0.018810067,0.0031071622,0.055252787,0.07022393,0.0009689046,0.016010417
depletion alcohol hexanol dehydrogenase activity epidermis jejunal mucosa sjogren larsson syndrome using histochemical technique demonstrated consistent deficiency alcohol hexanol dehydrogenase activity within epidermis jejunal mucosa patients sjogren larsson syndrome biochemical assay fatty alcohol nad oxidoreductase activity cultured fibroblasts leukocytes patients showed deficient activities compared controls histochemical biochemical results complementary simpler histochemical method used reliably initial screening patients ichthyosis diagnosis sjogren larsson syndrome suspected,C18,0.004418926,0.0039198077,0.008245257,0.002482814,0.027537568,0.0057028537,0.17152666,0.004155611,0.0031946865,0.0043418542,0.12714283,0.00921946,0.0394206,0.07276898,0.0038858918,0.0068811863,0.15439506,0.0045507606,0.005031597,0.11866483,0.18735668,0.001569,0.033587065
brain glucose metabolism noninsulin dependent diabetes mellitus study pima indians using positron emission tomography hyperinsulinemia euglycemic glucose clamp determine whether insulin noninsulin dependent diabetes mellitus affects brain glucose metabolism brain glucose utilization studied basal state hyperinsulinemic euglycemic glucose clamps nondiabetic diabetic pima indians positron emission tomography f fluoro deoxy glucose fdg glucose utilization brain areas determined analysis single scans least squares estimation rate parameters fdg model data compared results normal caucasian volunteers effect ethnicity diabetic status brain glucose utilization observed hyperinsulinemic clamps mean insulin pmol l clearance fdg blood accelerated accumulation brain radioactivity reduced however glucose utilization brain identical results sham glucose clamps mean insulin pmol l performed patients studies hyperinsulinemia k representing loss tissue radioactivity increased brain areas mean increase min p less possible mechanisms effect multiple physiological significance unknown studies effects insulin brain glucose metabolism needed,C18,0.08738676,0.0017329053,0.0036451404,0.0010976257,0.0027313759,0.07813076,0.18215825,0.0018371515,0.001412337,0.0019194875,0.041259687,0.0040180995,0.097338654,0.0045626247,0.020617815,0.12787813,0.039511003,0.015230721,0.0022244155,0.036080226,0.24651586,0.00069363817,0.0020173735
impact glucose self monitoring non insulin treated patients type ii diabetes mellitus randomized controlled trial comparing blood urine testing goal study compare relative efficacy cost self monitoring blood glucose smbg routine urine testing management patients type ii non insulin dependent diabetes mellitus treated insulin fifty four patients type ii diabetes mellitus treated insulin inadequate glucose control diet alone diet oral hypoglycemic agents studied patients performed smbg urine glucose testing part standardized treatment program also included diet exercise counseling mo study urine testing smbg groups showed similar improvement glycemic control within group significant improvements fasting plasma glucose reduction mm p less glycosylated hemoglobin reduction p less levels seventeen patients actually normalized glycosylated hemoglobin values urine testing group smbg group comparisons urine testing smbg groups showed significant differences mean fasting plasma glucose p greater glycosylated hemoglobin p greater weight p greater patients type ii diabetes mellitus treated insulin smbg effective times expensive urine testing facilitating improved glycemic control results support widespread use smbg diabetic patients treated insulin,C18,0.001579972,0.009047993,0.018813131,0.0008878485,0.002200061,0.0020390362,0.1978272,0.0014858248,0.0011422494,0.0015524153,0.07147889,0.11283818,0.12160261,0.003684238,0.009014093,0.12910688,0.11220086,0.0016271092,0.013485203,0.04024501,0.1459548,0.00056099065,0.0016254169
obesity iron status menstruating women relationship iron stores obesity menstruating women studied obese nonobese women matched age contraception although difference observed serum iron total iron binding capacity obese group showed significantly higher hemoglobin vs g l mean sd p less hematocrit vs p less serum ferritin concentrations vs micrograms l p less difference obese nonobese women either menstrual cycle interval duration menstrual flow iron intake significantly higher obese group vs mg p less results suggest obese menstruating women low risk depleting iron stores possibly high iron intake iron fortification programs might thus undesirable subjects,C18,0.0031418318,0.0027869616,0.0058623324,0.0017652672,0.0043749013,0.0040546977,0.1114954,0.0029546167,0.0022714045,0.0030870344,0.014558846,0.04500574,0.18951142,0.007288192,0.0027725713,0.05049769,0.028562073,0.018443085,0.004264909,0.2563915,0.22137862,0.016298737,0.0032322009
defective free fatty acid oxidative glucose metabolism iddm hypoglycemia influence glycemic control examine impact diabetes treatment plasma free fatty acid ffa oxidative fuel metabolism hypoglycemia combined indirect calorimetry h glucose h low dose insulin infusion plasma insulin approximately fold basal six poorly controlled nine well controlled insulin dependent diabetes mellitus iddm patients six healthy subjects diabetic subjects received insulin overnight maintain euglycemia study although free insulin levels counterregulatory hormone responses similar plasma glucose fall pronounced well controlled diabetic subjects well controlled diabetic healthy subjects small increment insulin rapidly suppressed plasma ffa fat oxidation approximately stimulated carbohydrate oxidation approximately contrast plasma ffa levels fall poorly controlled diabetic subjects glucose oxidation stimulated determine whether resistance antilipolytic effect insulin occurs absence hypoglycemic counterregulation used sequential low dose euglycemic insulin clamp mu kg min healthy subjects plasma ffa nearly maximally suppressed lowest insulin dose contrast plasma ffa remained persistently elevated poorly controlled diabetic subjects insulin dose however insulin dose response curve suppression plasma ffa near normal well controlled subjects conclude poorly controlled iddm diabetic patients resistant antilipolytic effects insulin show impaired stimulation glucose oxidation insulin induced hypoglycemia amelioration defects well controlled patients may another factor contributing higher risk hypoglycemia intensified insulin therapy,C18,0.0013437957,0.0011920137,0.009001411,0.00075502397,0.008277993,0.02119726,0.14028034,0.0012637217,0.0009715044,0.0013203581,0.013285265,0.0038806184,0.17259987,0.0045472826,0.027175035,0.20398368,0.03884641,0.026253626,0.0015686468,0.02353435,0.29685724,0.000477133,0.0013874198
electroretinogram minimal diabetic retinopathy pattern diffuse flash electroretinograms measured normal subjects diabetic patients either normal fundi microaneurysms amplitudes pattern electroretinogram found similar normals diabetics case flash electroretinogram diabetic patients showed division two main groups one group dissimilar group normal subjects second group showed hypernormal amplitudes explanation could given data collected subdivision though suggested might reflect degree metabolic disturbance,C18,0.0037729098,0.0033467591,0.0070474437,0.002119844,0.0052536572,0.0048691365,0.1657662,0.0035480899,0.0027276457,0.0037071053,0.12681033,0.08659592,0.14553693,0.009113375,0.0033178015,0.079731114,0.08996966,0.0038925658,0.0042960127,0.027513362,0.21584307,0.0013396231,0.0038814305
recent progress understanding apolipoprotein b past years investigators many different laboratories contributed greatly increased understanding two important lipid carrying proteins plasma apo b apo b apo b extremely large protein composed amino acids synthesized liver crucial assembly triglyceride rich vldl particles apo b virtually protein ldl cholesteryl ester enriched class lipoproteins metabolic products vldl apo b ldl serves ligand ldl receptor mediated uptake ldl particles liver extrahepatic tissues ldl receptor binding region apo b located carboxyterminal portion molecule whereas lipid binding regions appear broadly dispersed throughout length apo b contains amino terminal amino acids apo b produced intestine result editing single nucleotide apo b mrna changes codon specifying apo b amino acid premature stop codon apo b obligatory structural role formation chylomicrons therefore synthesis essential absorption dietary fats fat soluble vitamins apo b apo b encoded chromosome single gene contains exons introns elevated level apo b plasma potent risk factor developing premature atherosclerotic disease past years many different apo b gene mutations affect concentrations apo b cholesterol plasma characterized missense mutation codon apo b amino aid associated hypercholesterolemia mutation results poor binding apo b ldl receptor thereby causing cholesteryl ester enriched ldl particles accumulate plasma disorder called familial defective apo b probably cause premature atherosclerotic disease familial hypobetalipoproteinemia condition associated abnormally low levels apo b cholesterol affected individuals may actually reduced risk atherosclerotic disease abstract truncated words,C18,0.0013360041,0.020568877,0.008956836,0.0007505602,0.00827104,0.0081770895,0.2171865,0.023449332,0.00096576085,0.0013125521,0.02951952,0.0027475902,0.009534478,0.012786413,0.09816218,0.03400942,0.049155883,0.10398942,0.0015210629,0.056544248,0.17713872,0.00047431217,0.13344216
vitamin status preschool age indonesian children assessed modified relative dose response assay modified relative dose response mrdr assay validated rats function vitamin status tested group american children study mrdr assay applied west javan children risk vitamin deficient children enrolled tested time course study involving children aged blood samples taken different times doses mumol didehydroretinyl acetate kg body wt generally ratio dehydroretinol retinol dr r ratio peaked h thereafter survey children aged single blood samples drawn h dehydroretinyl acetate dose dr r ratio ranged dr r ratio cutoff value children judged marginal vitamin status,C18,0.0028397064,0.0025189614,0.035198808,0.0015955152,0.0039542015,0.003664789,0.0977313,0.0026704944,0.0020529814,0.09902459,0.061863463,0.019954344,0.18116765,0.04776606,0.0024971662,0.0044220136,0.03558417,0.002924427,0.030718347,0.106023364,0.23769408,0.0010082766,0.017125309
chylomicron remnant clearance plasma normal familial hypercholesterolemic homozygotes defined receptor defects retinyl palmitate fat tolerance test used measure chylomicron remnant clearance normal subjects apolipoprotein e apo e isotypes normolipidemic apo e homozygotes familial hypercholesterolemic homozygotes skin fibroblasts fully upregulated ldl receptors latter subjects degraded rabbit beta vldl vitro rates ranging less normal experiments vivo revealed significant differences normal homozygous familial hypercholesterolemic fhh subjects chylomicron remnant clearance assessed basis areas curves retinyl palmitate levels present post prandial serum chylomicron remnants sf less chylomicrons sf greater remnant clearance greatly decreased times apo e homozygotes indicative important degree flux control exerted receptor mediated step involving apo e ligand absence excess remnant accumulation fhh subjects varying impairment ldl receptor mediated degradation apo e containing lipoproteins permits conclusion chylomicron remnants initially cleared plasma apo e recognizing receptors genetically distinct ldl receptors,C18,0.0021355455,0.012214566,0.003987742,0.0011999251,0.023353988,0.023423577,0.13095722,0.0020082928,0.0015439043,0.0020982989,0.055247862,0.0060805357,0.19440565,0.05583236,0.05354265,0.01364215,0.035691757,0.106346354,0.0024316327,0.051079404,0.19570568,0.0007582546,0.02631263
amniotic fluid insulin concentration predictor obesity longitudinal correlations obtained amniotic fluid insulin concentration weeks gestation anthropometric characteristics age years children diabetic mothers prospective studies indicated age years birth greatest increase weight relation height relative obesity seen children experienced greatest exposures insulin uterus judged amniotic fluid insulin concentration significant correlations amniotic fluid insulin relative obesity age years found adjustment maternal obesity macrosomia birth highest amniotic fluid insulin values clustered subgroup children obviously obese age years findings consistent hypothesis association anthropometric development intrauterine metabolism suggest premature excessive exposure insulin gestation may predispose obesity childhood amniotic fluid insulin concentration may predict eventuality,C18,0.0021137698,0.012086565,0.024407808,0.0011876409,0.0029433572,0.00272793,0.13151552,0.0019878147,0.011620997,0.043008156,0.14507477,0.004494967,0.032961078,0.0049494766,0.0018587958,0.14654383,0.03463622,0.013958155,0.0024068377,0.2779061,0.098685145,0.0007505228,0.0021745684
pseudohypophosphatasia aberrant localization substrate specificity alkaline phosphatase cultured skin fibroblasts explored biochemical basis disorder pseudohypophosphatasia pshypt one patient examining substrate specificity localization alkaline phosphatase alp cultured dermal fibroblasts despite substantial alp activity cell homogenates toward artificial substrate methyl umbelliferyl phosphate mup marked deficiency alp activity toward natural substrates pyridoxal phosphate plp phosphoethanolamine pea indicating altered substrate specificity furthermore although mup phosphatase mup p tase activity predominantly localized ecto enzyme small amount plp phosphatase plp p tase activity intracellular differential localization apparent intact cells since brief acidification medium degrees c inactivated majority mup p tase activity plp p tase activity contrast greater inactivation homogenates greater mup p tase activity plp p tase activity released phosphatidylinositol specific phospholipase c pi plc digestion degradation extracellular plp less disrupted cells mup plp p tase activities predominantly lipid anchored form could converted soluble lipid free form pi plc digestion findings suggest clinical biochemical presentation pshpt patient results production two aberrant alp species one form alp appropriate ectoorientation preferentially deficient activity toward natural substrates alp species appropriate substrate specificity sequestered substrates intracellular location,C18,0.0020741355,0.0018372653,0.118365966,0.021209862,0.015948813,0.0026730024,0.22118512,0.0019477896,0.0014973915,0.002035084,0.009525363,0.004462107,0.08335506,0.17695165,0.021871421,0.023276484,0.039074883,0.0022665996,0.0023583756,0.03279005,0.1651548,0.0007354109,0.0494034
diabetes myo inositol paradox test general applicability hypothesis diabetes mellitus causes increased polyol pathway activity decreased tissue free myo inositol resultant pathological changes tissues susceptible ravages diabetes measured glucose sorbitol myo inositol quantitative histochemical techniques layers cornea aortic myointima cardiac left ventricle atrioventricular node avn retina kidney days mo mildly diabetic non insulin treated md severely diabetic insulin treated sd groups alloxan induced diabetes model aqueous humor glucose rose linearly increased serum glucose sorbitol markedly increased md sd groups myo inositol change diabetic group change glucose sorbitol aortic myointima group myoinositol decreased day diabetic rabbits unchanged md rabbits paradoxically increased sd rabbits glucose sorbitol myo inositol increased three corneal layers sd rabbits epithelium stroma day md rabbits avn glucose sorbitol change day diabetic md sd diabetic rabbits avn myo inositol three times higher ventricular myo inositol appear change sd rabbits retinal pigmented epithelium myo inositol decreased sd rabbits glomerular myo inositol also decreased significantly sd rabbits conclude paradoxical increase corneal aortal myo inositol raises fundamental questions general applicability myo inositol depletion hypothesis,C18,0.0019914056,0.0017664762,0.0037157563,0.0011188897,0.0027729692,0.0025700128,0.11228413,0.021144554,0.0014396977,0.001956673,0.035692234,0.14472626,0.10460778,0.023439782,0.0017511919,0.14700289,0.047124226,0.0020508177,0.011898099,0.016083213,0.31210715,0.0007070758,0.0020486847
need accurate nutrition survey methodology south carolina experience assessment two nutrition related risk factors obesity fat intake completed representative sample south carolina adults obesity estimates determined self reported heights weights less prevalences determined direct measurements white males vs white females vs black males vs black females vs total vs nine fat intake habits identified dietary mannerisms involving consumption red meat fat meat fried fish chicken butter eggs whole milk bacon sausage cheese use solid fats cooking vegetables mean number nine habits exhibited four total number habits correlate well serum cholesterol individuals none nine fat intake habits blood cholesterol values greater mmol l mg ml individuals seven habits high level cholesterol nine habits explained less variability serum cholesterol values,C18,0.0024377625,0.002162417,0.0045486116,0.0013696792,0.0033945069,0.0031460593,0.14248377,0.0022925013,0.025364073,0.014187961,0.06643686,0.005014011,0.15838319,0.0058514853,0.04944229,0.050975684,0.039909367,0.014305793,0.014571832,0.27946824,0.11088046,0.00086556084,0.00250788
growth obese children treated obesity study assesses growth patterns year period children aged years treated obesity using behavioral family based treatment procedures previous studies suggested decrease height velocity weight reduction results consider either height parent greater height obese nonobese children results show entry obese children taller nonobese peers th percentile even years remain taller norm th percentile child weight level physical maturity accounted variance predicting baseline height percentile entrance height parental height accounted variance changes height percentile adjusted parental height weight change correlate growth adjusted parental height results suggest negative effects height long term side effect child weight control,C18,0.0023276692,0.013330289,0.0043431893,0.0013078224,0.0032412056,0.0030039784,0.2075368,0.0021889682,0.0016828012,0.1905179,0.028791357,0.004814529,0.06506376,0.050422583,0.0020468936,0.02612489,0.07371669,0.0023971132,0.0026503936,0.11833216,0.19293794,0.0008264707,0.0023946203
effect beta cell distribution performance bioartificial pancreas insulin response available prototype hollow fiber bioartificial pancreas devices remains unacceptably slow although previous experimental theoretical investigations provide insight factors governing performance devices currently results effects beta cell distribution insulin response authors developed detailed theoretical model insulin response hollow fiber bioartificial pancreas model predictions shown good agreement literature data insulin release vitro hollow fiber device study model simulations used evaluate effects axial radial variations beta cell density insulin response device convective recirculation e diffusion controlled device radical distribution cells matrix shell plays critical role determining device response insulin response essentially independent axial beta cell distribution contrast device substantial recirculation strong dependence axial beta cell distribution weaker dependence upon radial distribution results clearly demonstrate potential importance beta cell distribution analysis vivo vitro experimental data design effective clinical devices,C18,0.0017547385,0.07801006,0.054267514,0.009466437,0.0024435453,0.0022670175,0.18183888,0.010096338,0.0012685978,0.0017241336,0.018681845,0.020884959,0.021849837,0.08139283,0.01003321,0.055622485,0.020767651,0.0018099886,0.0019980278,0.06380326,0.30401236,0.00062304386,0.05538322
effects lovastatin diabetic patients treated chlorpropamide patients non insulin dependent diabetes mellitus niddm higher risk atherosclerotic cardiovascular disease nondiabetic subjects seven patients hypercholesterolemia niddm controlled chlorpropamide lovastatin mg b weeks lowered low density lipoprotein cholesterol total cholesterol apolipoprotein b lovastatin levels hour period measured hydroxy methylglutaryl coenzyme reductase inhibitory activity similar measured previously nondiabetic patients lovastatin alter chlorpropamide kinetics glycemic profiles patient elevation serum transaminases creatinine phosphokinase patient laboratory clinical drug related adverse experience study lovastatin effective reducing low density lipoprotein cholesterol patients niddm nondiabetic subjects diabetic control unaltered evidence alteration lovastatin chlorpropamide blood levels noted,C18,0.0027275684,0.0024190827,0.0050885044,0.001532252,0.0037974145,0.0035194778,0.16715822,0.0025646074,0.0019715792,0.002679546,0.012571444,0.0056647193,0.1417371,0.0063756537,0.094940424,0.065100364,0.1719374,0.0028084712,0.003105216,0.07243577,0.2260905,0.0009682977,0.0028063478
hypoglycemia alters striatal amino acid efflux perinatal rats vivo microdialysis study adult brain insulin induced hypoglycemia striatal extracellular fluid concentrations excitatory amino acids glutamate aspartate rise markedly fourfold tenfold study used vivo microdialysis determine insulin induced hypoglycemia altered striatal amino acid efflux similar fashion immature brain microdialysis probes inserted right striatum rats postnatal day hour recovery period animal minute baseline sample obtained insulin mu kg intraperitoneal injection administered n dialysate sampling continued next minutes terminal blood glucose level less mg dl untreated control rats n sampled time interval pre column derivatization phthaldialdehyde dialysate samples assayed high pressure liquid chromatography electrochemical detection measure amino acid content eight amino acids glutamate aspartate taurine glutamine alanine serine glycine asparagine consistently detected controls amino acid efflux change hours hypoglycemic animals glutamate efflux increased peak baseline p repeated measures analysis variance anova glutamine efflux declined baseline p anova taurine efflux increased baseline p less anova contrast fold increases aspartate efflux reported adult striatum aspartate efflux increased slightly baseline significant,C18,0.019231806,0.0015970996,0.003361454,0.0010116061,0.0025070861,0.011023161,0.1032542,0.010406153,0.0013016538,0.0017690596,0.06597363,0.032003548,0.25227046,0.013053128,0.03642587,0.055043213,0.017566053,0.001890356,0.0020500908,0.014064514,0.29793924,0.0006392786,0.05561736
insulinomimetic properties trace elements characterization vivo mode action lithium vanadate insulinomimetic actions vitro study examined vivo effects lithium vanadate glucose metabolism diabetic partial pancreatectomy rats four groups chronically catheterized rats studied control diabetic diabetic treated lithium plasma concn meq l vanadate mg ml drinking water diabetic treated lithium vanadate zinc magnesium postmeal plasma glucose increased diabetic versus control rats vs mm p less normalized addition lithium vanadate mm lithium vanadate zinc magnesium mm euglycemic insulin clamp studies performed wk posttreatment insulin mediated glucose uptake reduced diabetic compared control rats vs mumol kg min p less returned normal lithium vanadate mumol kg min increased supranormal levels lithium vanadate zinc magnesium mumol kg min insulin clamp muscle glycogenic rate severely impaired diabetic versus control rats vs mumol kg min normalized lithium vanadate mumol kg min lithium vanadate zinc magnesium mumol kg min,C18,0.002328145,0.0020649729,0.0153414775,0.001307958,0.003241542,0.03674852,0.06856478,0.0021891955,0.012952009,0.002287309,0.012349925,0.02845092,0.16638927,0.005811015,0.013292851,0.17242076,0.039487615,0.026617425,0.0026506688,0.04406572,0.3269622,0.0008265565,0.013649144
ten year follow behavioral family based treatment obese children using prospective randomized controlled design examined effects behavioral family based treatment percent overweight growth years obese year old children obese children parents randomized three groups provided similar diet exercise behavior management training differed reinforcement weight loss behavior change child parent group reinforced parent child behavior change weight loss child group reinforced child behavior change weight loss nonspecific control group reinforced families attendance children child parent group showed significantly greater decreases percent overweight years respectively children nonspecific control group respectively children child group showed increases percent overweight years respectively midway child parent nonspecific groups significantly different either years child height related strongly height parent sex r children cm taller parents differences height groups,C18,0.0019351069,0.01108233,0.012957374,0.0010872576,0.002694575,0.0025148739,0.13308395,0.001819798,0.0013989962,0.16116273,0.010610872,0.10915473,0.10848697,0.07938592,0.0017016842,0.003013364,0.06527844,0.0019928394,0.002218622,0.16737011,0.11837158,0.00068708614,0.0019907667
role insulin management surgical patients diabetes mellitus surgery likely event lifetime patients diabetes health care team members need aware metabolic problems may occur perioperative period surgery especially presence general anesthesia produce diabetogenic response generally due elevation counterregulatory hormones although endogenous insulin also suppressed excessive lipolysis ketogenesis occur surgery particularly deleterious effects patients diabetes thus sufficient insulin must provided period suppress catabolic processes major controversy regarding surgery diabetes concerns route insulin administration article reviews various treatment options patients insulin dependent non insulin dependent diabetes mellitus particular emphasis role insulin special situations e g outpatient surgery coronary artery bypass emergency surgery also discussed,C18,0.0023295179,0.0020650702,0.0043438445,0.0013080196,0.0032416945,0.0030044315,0.31116018,0.0021892984,0.001683055,0.013508779,0.03735493,0.0047882926,0.03813501,0.0057958444,0.0020472023,0.12398386,0.19710147,0.024933122,0.025180478,0.06282382,0.12980051,0.0008265954,0.0023949814
multigenic basis type diabetes association hras polymorphism hla dr dqw dr dqw analyzed extended haplotypes composed dna loci short arm chromosome segregation insulin dependent type diabetes mellitus markers loci tyrosine hydroxylase insulin c ha ras proto oncogene hras report study families specific haplotype h containing kilobase kb hras taq dna polymorphism segregated differentially diabetic nondiabetic siblings p parallel population study showed kb hras taq polymorphism increased frequency type patients two strong hla susceptibility haplotypes compared type patients healthy control blood donors p less p less respectively polymorphic variable enhancer promoter regions flanking human insulin gene h haplotype associated type diabetes results indicate hras locus genes linkage disequilibrium locus involved pathogenesis hla dr type diabetes mellitus,C18,0.002559497,0.0022704017,0.004775756,0.0014384475,0.015891973,0.0033031642,0.25736335,0.002406982,0.0018504024,0.0025148562,0.050629113,0.005326975,0.10545155,0.04027682,0.0146157285,0.067507684,0.046478465,0.015018133,0.002914364,0.10834784,0.08210491,0.0009087844,0.16604477
promoting adherence low fat low cholesterol diets review recommendations evidence lowering blood cholesterol levels reduces risk coronary heart disease prompted widespread recommendations hyperlipidemic individuals undergo dietary therapy however extent people adopt maintain diets lower lipids unclear article review currently known regarding adherence low fat diets present approach dietary counseling lowering cholesterol incorporates elements behavioral self management social learning theory discuss specific recommendations counseling hyperlipidemic patients based dietary alternatives study recommendations include providing patients adequate knowledge base make dietary changes using goal setting self monitoring help patients initiate dietary changes enlisting support patient family enhancing self efficacy promote long term dietary maintenance,C18,0.0020310679,0.0018011386,0.0136162415,0.0011408449,0.0028273815,0.030429276,0.3220574,0.0019094896,0.0014679478,0.0019969137,0.010038636,0.013988518,0.050247334,0.023039594,0.041100953,0.03263701,0.08511716,0.0020910595,0.06346822,0.19759877,0.09858337,0.0007209503,0.0020906932
exogenous fructose metabolism truly insulin independent although fructose widely regarded insulin independent fuel source vivo conversion glucose represents theoretical limitation clinical usefulness diabetics particularly given large doses determine whether small amounts fructose well utilized setting insulinopenia administered low dose fructose infusion g hr fasting type diabetic patient receiving continuous subcutaneous insulin dose previously maintained stable euglycemia hr plasma glucose mg dl despite low infusion rate less calorie requirement fructose caused immediate marked rise plasma glucose mg dl hr glucose loss urine accumulation plasma could account fully half administered hexose load thus utilization even small quantities exogenous fructose profoundly impaired hypoinsulinemic conditions misleading regard fructose truly insulin independent fuel source,C18,0.0023020008,0.0020419897,0.06464808,0.0012934587,0.003206097,0.025218667,0.22876401,0.0021648295,0.0016642441,0.002261851,0.011686908,0.05684829,0.0720173,0.005654839,0.024306893,0.13382587,0.054835875,0.002415188,0.0026545045,0.07462353,0.2243794,0.00081735686,0.0023687778
urinary organic acid excretion feeding medium chain long chain triglyceride diets patients non insulin dependent diabetes mellitus medium chain triglycerides mcts absorbed metabolized differently long chain triglycerides lcts recent data indicate mcts may useful dietary substitute variety clinical disorders current studies undertaken characterize urinary organic acid excretion patients non insulin dependent diabetes mellitus lct mct diet urinary excretion dicarboxylic acids adipic suberic hydroxysebacic omega hydroxylation products hydroxyhexanoic acid hydroxyoctanoic acid increased mct feeding compared lct feeding urinary suberic hydroxyoctanoic acid excretions increased fold respectively mct substituted diet urinary organic acid profiles provide information fate lipids mct feeding may also useful assessing complicance clinical trials employing mct substituted diets,C18,0.00255837,0.002269402,0.091449685,0.0014374438,0.0035624492,0.0033017097,0.4318626,0.0024059222,0.0018495875,0.0025137488,0.012708399,0.005336262,0.029925441,0.005902564,0.014630232,0.06651922,0.061328437,0.0026835105,0.015296984,0.06179135,0.12508504,0.0009083842,0.054673232
coupling beta cell desensitization hyperglycemia excessive stimulation circulating insulin glucose infused rats nondiabetic rats infused glucose h maintain moderate marked hyperglycemia mean blood glucose mm respectively two levels hyperglycemia increased plasma insulin levels severalfold decreased insulin response mm glucose respectively versus saline infusion diazoxide mg kg h continuously infused hyperglycemia protocols completely inhibited glucose induced rise plasma insulin levels diazoxide transformed beta cell insensitivity stimulation glucose induced insulin release thus increased moderate hyperglycemia marked hyperglycemia stimulatory effects diazoxide reversed exogenous insulin infusion u h dose dependent manner concluded excessive beta cell stimulation rather glucotoxicity underlies hyperglycemia induced beta cell insensitivity effects hyperinsulinemia form part mechanisms whereby excessive stimulation affects beta cell secretion,C18,0.0020108544,0.021245807,0.023209933,0.0011298171,0.0028000511,0.021961551,0.07812234,0.0018910317,0.0014537582,0.0019757824,0.009247695,0.0042166715,0.06308151,0.077663,0.021200432,0.22827387,0.020105556,0.0020905477,0.0022896535,0.04280234,0.3105493,0.00071398134,0.061964527
menarche associated diabetic retinopathy goal study evaluate association menarchal status diabetic retinopathy diabetic retinopathy present females premenarchal postmenarchal range severity retinopathy greater postmenarchal group multivariate analyses duration diabetes menarchal status diastolic blood pressure associated prevalence diabetic retinopathy partitioning duration diabetes years years menarche significant number years diabetes menarche strongly associated yr follow examination postmenarchal premenarchal females progression retinopathy p data suggest stage sexual development reflected menarchal status associated presence possibly risk progression diabetic retinopathy,C18,0.0034577358,0.0030671842,0.0064517763,0.0019427608,0.004814788,0.0044623883,0.21498682,0.0032516967,0.002499789,0.0034346776,0.054557107,0.040582642,0.09001945,0.008519343,0.0030406457,0.022066813,0.095699504,0.0035608946,0.003937141,0.33338255,0.09147941,0.0012277163,0.0035571912
complement fixing antibodies sympathetic parasympathetic tissues iddm autonomic brake index heart rate variation describe herein complement fixing anti adrenal medullary cf adm anti sympathetic ganglia cf sg antibodies insulin dependent diabetes mellitus iddm study describes complement fixing anti vagus cf v nerve antibodies relationship cardiovascular autonomic brake index measure transient decrease heart rate st min tilt r r interval variation deep breathing cf v detectable subjects iddm aged yr mean se yr duration diabetes yr yr seventy six nondiabetic subjects aged yr negative cf v scores cf v scores correlated cf adm yr iddm r p less cf sg r p less seventy iddm subjects aged yr duration diabetes yr without proteinuria proliferative retinopathy screened cf adm cf sg cf v antibodies five cf sg negative cf adm cf v brake indices ranged three cf adm brake indices four cf v antibodies brake indices subjects cf sg cf adm anti sympathetic higher brake indices subjects cf v anti parasympathetic antibodies p less,C18,0.0020309214,0.0018015285,0.0037894885,0.0011410918,0.0028279936,0.0026210097,0.07487061,0.001909903,0.0014682657,0.0020106505,0.046468254,0.052985795,0.29037437,0.06493859,0.011591888,0.10204378,0.044861645,0.0020997394,0.0023125026,0.016191285,0.26885027,0.00072110636,0.002089337
differences lipoprotein subfraction composition distribution type diabetic men control subjects subfractions low density low density lipoproteins examined male normolipidemic type insulin dependent diabetic patients improvement metabolic control compared subfractions male control subjects matched diabetic patients entry age body mass index plasma cholesterol plasma triglycerides two consistent differences subfraction composition noted diabetic patients entry control subjects first subfractions diabetic patients tended cholesterol ester poor triglyceride rich particularly marked low density lipoprotein subfractions second subfractions pretreatment diabetic patients contained higher proportions non apolipoprotein b apolipoproteins compositional anomaly lipid modifications responded completely normalized improved glycemic control also accompanied reductions plasma concentrations subfractions treatment modified subfraction distribution lipoprotein profile posttreatment diabetic patients closely resembled profile observed control subjects changes achieved without significant modification daily insulin dose context blood lipid risk factors results argue need maintain optimal insulinization even apparently normolipidemic diabetic patients avoid modifications lipoprotein pattern toward potentially atherogenic profile,C18,0.001683264,0.0014931392,0.009739334,0.0009458523,0.002343892,0.00217234,0.1507623,0.009869061,0.001216925,0.0016539058,0.007928367,0.0035714959,0.119320534,0.004297329,0.13772134,0.08821144,0.10877316,0.01158047,0.0019166438,0.08920339,0.24324279,0.0005976659,0.0017553924
relationship content lysyl oxidase dependent cross links skin collagen nonenzymatic glycosylation long term complications type diabetes mellitus many abnormalities collagen reported insulin dependent diabetes mellitus attributed increased cross linking although recent work focused role glucose derived collagen cross links pathogenesis diabetic complications relatively studies investigated role lysyl oxidase dependent lox cross links present study lox cross links nonenzymatic glycosylation quantified skin collagen diabetic subjects increase difunctional cross link dihydroxylysinonorleucine dhlnl well one trifunctional maturation products hydroxypyridinium lox crosslinks normal nonenzymatic glycosylation increased diabetic skin collagen increase correlated increases dhlnl p less biochemical results examined correlations clinical data subjects increases dhlnl content associated duration diabetes p less glycohemoglobin levels p less hand contractures p less skin changes p less microalbuminuria p less nondiabetic subjects age correlated collagen cross link content exception hlnl increased age r p less diabetic subjects pa levels decreased age r p less increased duration diabetes dhlnl content increased r p less ohp increased r p less whereas pa levels decreased r p less nonenzymatic glycosylation collagen also increased increased duration diabetes hex lys r p less hex hyl r p less conclude lysyl oxidase dependent cross linking increased skin collagen diabetes b changes skin collagen correlated duration diabetes glycemic control long term complications,C18,0.0014472358,0.0012837703,0.002700392,0.09347941,0.04405272,0.008868266,0.2620092,0.0013614916,0.001046287,0.008423957,0.0067341933,0.0029766874,0.24288991,0.010468487,0.0082527725,0.051289737,0.044895817,0.0015023551,0.0016478908,0.04830993,0.15434639,0.00051386084,0.0014992764
developmental adaptations cytosolic phosphate content ph regulation sheep heart vivo study examines adaptations myocardial cytosolic phosphate content buffering capacity occur vivo function development phosphate metabolites monitored open chest sheep preparation using p magnetic resonance surface coil left ventricle newborn lambs aged n underwent exchange transfusion adult blood reduce blood borne diphosphoglycerate contamination heart monophosphate phosphomonoester resonances thus allowing determination phosphate concentrations blood exchanged newborns mature controls aged n infused n hydrochloric acid decrease ph greater less simultaneously intracellular extracellular ph determined chemical shifts respective phosphate peaks compared arterial blood ph findings follows diphosphoglycerate contribution cardiac spectrum found negligible b significant decreases cytosolic phosphate p less phosphomonoester p less content occurred maturation c large decreases extracellular ph greater u groups similarly associated small changes intracellular ph less u change cytosolic phosphate content implies alterations occur phosphorylation potential resulting effects regulation myocardial respiration cardiac energetics,C18,0.0020942735,0.0017510947,0.026776265,0.029770454,0.012316958,0.0025476345,0.22259268,0.0018564352,0.010978348,0.0019396354,0.021869184,0.023339093,0.23570463,0.038988944,0.0017359435,0.03758846,0.044303823,0.0020447369,0.002247764,0.06171775,0.19600764,0.00070091896,0.021127356
regulation parathyroid hormone gene expression hypocalcemia hypercalcemia vitamin rat vivo rat oh decreases low calcium increases pth mrna levels report effect wk changes dietary vitamin calcium pth mrna levels pth mrna levels increased wk calcium deficiency five times vitamin deficient diet two times combined deficiency times changed high calcium vitamin deficient diet rats pth mrna decrease single large dose oh decrease partially repeated daily doses oh rats vitamin calcium deficient ca diet respond changes serum calcium h flow cytometry isolated cells parathyroid thyroid tissue separated smaller parathyroid larger thyroid cells allowed analysis parathyroid cell number normal vitamin normal calcium ndnca rats parathyroid cells n total cell number whereas ca rats n p less ca rats times number cells whereas times amount pth mrna indicating major contribution times increased pth gene expression per cell moreover calcium deficient vitamin deficient diet amplifies expression pth gene vitamin necessary intact response pth mrna oh calcium,C18,0.0017877494,0.0015834207,0.012090599,0.0010029419,0.002487223,0.0023036888,0.09442177,0.0016786744,0.0012905054,0.0017539079,0.00939003,0.029582683,0.030281028,0.21475077,0.0015697601,0.011411175,0.02152265,0.0018410479,0.0020325321,0.0259608,0.41628376,0.0006338033,0.114339456
insulin use niddm rationale based pathophysiology disease basal hyperglycemia major feature non insulin dependent diabetes mellitus diabetes control monitored fasting blood glucose concentration hierarchical sequence therapies proposed major aim maintain near normal fasting blood glucose concentrations expectation help prevent development long term complications diet tablet therapy longer effective keeping fasting blood glucose level less mm basal insulin supplement long acting insulin ultralente added monitored fasting blood glucose concentration little risk hypoglycemia patient continue normal life style without restrictions concerning exercise size individual meals basal insulin supplement induce marked weight gain dose insulin required predicted level fasting blood glucose degree obesity provides index accompanying insulin resistance based current evidence insulin therapy equally appropriate patients insulin deficiency insulin resistance benefit maintaining near normal glucose concentrations probably outweighs putative risk hyperinsulinemia severely affected patients additional regular insulin cover meals needed lowering fasting blood glucose normal basal insulin supplement reduces endogenous insulin production may advantageous accompanying production islet amyloid polypeptide islet amyloid formation also reduced,C18,0.0014477108,0.0152964275,0.00996107,0.00081324193,0.0020353296,0.022819823,0.23891406,0.0013687811,0.0010464147,0.0014257893,0.010508071,0.009991459,0.10500331,0.0034375489,0.008242912,0.24769036,0.0487037,0.0014918677,0.0016721874,0.05569019,0.19482197,0.0005139235,0.017103873
association fasting glucose levels delayed secretion insulin oral glucose subjects glucose intolerance two hundred nineteen second generation japanese american men classified g oral glucose tolerance test normal glucose tolerance impaired glucose tolerance igt noninsulin dependent diabetes mellitus niddm peak insulin response oral glucose load progressively delayed glucose tolerance categories similar finding observed peak c peptide response oral glucose except absence distinction igt niddm variables measuring initial rate insulin c peptide secretion min oral glucose also demonstrated progressive diminution increasing glucose intolerance relative incremental insulin response min relative incremental c peptide response min highly correlated fasting glucose levels r r p less respectively variables measuring min secretory response high variances whereas variance fasting glucose low twelve men initially classified igt subsequently developed niddm men significantly higher fasting glucose levels baseline remaining men develop diabetes min secretory parameters oral glucose although lower subsequently developed diabetes significantly different baseline however fasting glucose used surrogate measure secretory response men appear impairment oral glucose stimulated insulin secretion antedating development niddm inability secretory parameters detect abnormality may due type ii statistical error may resolved larger sample size,C18,0.0013896305,0.0012320991,0.029241355,0.00078043615,0.001956325,0.008510159,0.21822365,0.0013062184,0.0010041745,0.014810449,0.050368838,0.002864586,0.144451,0.003278019,0.014569827,0.21116468,0.015742209,0.008413694,0.008287627,0.061846383,0.19191429,0.007213958,0.0014303924
hypokalemic ecg sequelae combined beta agonist diuretic therapy protection conventional doses spironolactone triamterene salbutamol albuterol diuretics commonly prescribed together patients airflow obstruction associated electrocardiographic effects investigated whether use potassium sparing drugs might prevent ecg sequelae combined therapy ten healthy subjects received seven days randomized treatments placebo bendrofluazide mg bendrofluazide plus triamterene mg conventional dose triamterene mg high dose bendrofluazide plus spironolactone mg potassium ecg responses inhaled salbutamol mg measured treatment period wave flattening response bendrofluazide salbutamol ci mv attenuated addition triamterene mg ci mv p less spironolactone mg ci mv p less triamterene mg ci mv spironolactone high dose triamterene also diminished frequency u waves st depression ecg effects mirrored hypokalemic responses also blunted high dose p less low dose triamterene well spironolactone p less thus use high dose triamterene spironolactone protected hypokalemic ecg sequelae combined beta agonist diuretic therapy whereas conventional dose triamterene effect findings may important prevention potentially dangerous interaction susceptible patients taking combination drugs,C18,0.0022515403,0.0346905,0.015077199,0.012150127,0.0031382586,0.00290573,0.27810585,0.0021173758,0.0016277634,0.0022122706,0.043041598,0.028539978,0.12166562,0.0053508356,0.0019799478,0.0035061166,0.059743933,0.002318713,0.01868915,0.019677155,0.3162967,0.00079944014,0.024114234
self reported weight height error self reported weight height compared measured weight height evaluated nationally representative sample adults aged second national health nutrition examination survey although weight height reported average small errors self reported weight height unreliable important population subgroups errors self reporting weight directly related person overweight status bias unreliability self report increased directly magnitude overweight errors self reported weight greater overweight females overweight males race age end digit preference ancillary predictors reporting error weight errors self reporting height related person age bias unreliability self reporting increased directly age age overweight status also predictor reporting error height,C18,0.0024666423,0.0021880348,0.0046024984,0.0013859057,0.0034347211,0.0031833302,0.18918166,0.0023196603,0.0017832725,0.0860085,0.06437724,0.005619836,0.04270448,0.005684058,0.002169103,0.0038410749,0.031626873,0.0025402326,0.01474453,0.38857463,0.054560646,0.08446544,0.0025375907
impact intensive educational approach dietary change niddm aim study compare effects intensive educational approach incorporating longer time greater simplicity repetition cognitive motivational techniques conventional one subjects established non insulin dependent diabetes mellitus niddm whose weight glycemic control diet optimal subjects randomly allocated intensive conventional education subjects met study criteria included established niddm greater equal mo suboptimal recent glycemic control dietary fat intake greater equal total energy intake body mass index greater equal kg intensive approach associated significantly greater improvements dietary compliance dietary intake complex carbohydrate p legumes p less fiber p less total fat p less saturated fat p less total cholesterol level p transient improvement glycemic control similar groups intensive education program improve dietary compliance established niddm subjects conventional one recommended dietary improvements achieve better improvement total cholesterol necessarily improve glycemic control,C18,0.0020712677,0.0218889,0.0039118924,0.0011637608,0.0028841745,0.012690119,0.17117573,0.0019478451,0.0014974343,0.01205477,0.075997025,0.025392491,0.21475545,0.0147813475,0.021934005,0.0241743,0.04013375,0.012074835,0.0077833454,0.20385735,0.09488314,0.030816238,0.0021308437
slow glucose removal rate hyperinsulinemia precede development type ii diabetes offspring diabetic parents objective determine whether insulin resistance insulin deficiency primary pathogenesis type ii diabetes design cohort analytic study persons normal glucose tolerance high risk developing type ii diabetes average follow time years setting outpatients intravenous glucose tolerance test contacted periodically ascertain diagnoses diabetes participants one hundred fifty five normal offspring ranging age years two parents type ii diabetes normal control subjects age range family history diabetes measurements main results two phenotypic characteristics distinguished offspring diabetic parents control subjects slower glucose removal rates kg p less higher insulin levels fasting second phase insulin response intravenous glucose p less control subjects even adjustment differences obesity sixteen percent offspring developed type ii diabetes mean kg baseline min among offspring subsequently developed diabetes min among offspring remained nondiabetic min among control subjects corresponding means first phase insulin pm respectively whereas second phase insulin means pm respectively multivariate analysis low kg high serum insulin levels independently increased risk developing diabetes among offspring diabetic parents conclusions one two decades type ii diabetes diagnosed reduced glucose clearance already present reduced clearance accompanied compensatory hyperinsulinemia hypoinsulinemia suggesting primary defect peripheral tissue response insulin glucose pancreatic beta cell,C18,0.001246988,0.0011059304,0.013168169,0.0007006103,0.0070647174,0.03256111,0.20433587,0.0011724598,0.0009013456,0.0012250062,0.06648626,0.016041111,0.1539221,0.017361673,0.00710585,0.14344826,0.033624943,0.0012845338,0.0078773685,0.109905645,0.17100342,0.000442676,0.008013981
acylation stimulatory activity hyperapobetalipoproteinemic fibroblasts enhanced cholesterol esterification another serum basic protein bp ii cultured fibroblasts patients familial hyperapobetalipoproteinemia hyperapob used determine defect lipid metabolism present three basic proteins bp bp ii bp iii isolated normal human serum preparative isoelectric focusing preparative sds page reversed phase hplc mr pi values proteins bp bp ii bp iii proteins differed significantly content arginine cysteine proline histidine serine methionine bp appears protein acylation stimulating protein bp ii bp iii appeared different acylation stimulating protein lipid carrier proteins bp bp ii bp iii stimulated incorporation c oleate lipid esters normal fibroblasts effect time concentration dependent hyperapob cells bp ii markedly increased fold incorporation c oleate cholesteryl ester compared normal cells addition decrease stimulation triglyceride acylation cholesterol esterification bp difference normal hyperapob cells observed bp iii summary identification another serum basic protein bp ii led elucidation another cellular defect hyperapob fibroblasts enhanced cholesterol esterification may related precocious atherosclerosis abnormal lipoprotein metabolism seen hyperapob,C18,0.002277333,0.002020108,0.0042492673,0.0012795406,0.022917869,0.013958304,0.17275782,0.023878578,0.012647451,0.0022376135,0.039123345,0.0047318423,0.053998064,0.057296377,0.079173,0.014897968,0.03097895,0.13069254,0.0025930789,0.03000962,0.283474,0.00080859824,0.013998766
randomized crossover study effect resistance training glycemic control muscular strength cholesterol type diabetic men goal study evaluate program resistance weight training cardiovascular risk factors blood glucose management overall strength diabetic subjects randomized crossover design performed eight male type insulin dependent diabetic subjects mean sd age yr height cm body wt kg duration diabetes yr insulin dose u nph day u regular day program consisted heavy resistance weight training days wk wk concentrating strengthening major muscle groups progressive resistance blood tests included total cholesterol triglycerides low density lipoprotein high density lipoprotein cholesterol hba c tests repeated three time points program field strength testing performed training improvement seen squat increase p less bench press increase p less hba c triglyceride levels showed change resting portion experiment showed significant change training program hba c vs p triglyceride vs mm p self monitored glucose taken pre postexercise showed decrease mm p low density lipoprotein cholesterol triglycerides change training analysis variance showed significant differences time three time points regard reductions cardiovascular risk factors hba c,C18,0.0015562782,0.0013804964,0.0067845536,0.00087450177,0.0021670682,0.04341884,0.13239275,0.0014635428,0.016188601,0.03368417,0.06562018,0.030914925,0.12304587,0.003861998,0.05414202,0.06819869,0.02827957,0.0016027085,0.043472342,0.13440013,0.20439713,0.00055257784,0.0016010416
temporary amelioration hyperlipidemia low density lipoprotein receptor deficient rabbits transplanted genetically modified hepatocytes familial hypercholesterolemia inherited disease humans associated coronary artery disease caused deficiency receptor mediates internalization low density lipoprotein ldl used animal model familial hypercholesterolemia watanabe heritable hyperlipidemic whhl rabbit design therapeutic approach disease attempts correct hepatic defect ldl receptor expression hepatocytes harvested whhl rabbits plated primary cultures exposed recombinant retroviruses capable efficiently transferring functional human ldl receptor gene genetically modified cells harvested infused portal vein whhl recipients analyzed metabolic consequences human ldl receptor expression animal exhibited statistically significant decrease total serum cholesterol days transplantation eventual return pretreatment levels proviral dna sequences virus directed transcripts detected liver tissue hr transplantation situ hybridization demonstrated provirus expression small population hepatocytes distributed periportal sections liver study illustrates potential somatic gene therapy ameliorating hyperlipidemia associated familial hypercholesterolemia,C18,0.0018826008,0.022513274,0.010206227,0.0010577566,0.006337059,0.029522693,0.13466887,0.010878484,0.0013610367,0.0018497659,0.043530792,0.0060789157,0.028929561,0.10239658,0.07469403,0.03835973,0.08181429,0.06188672,0.002143618,0.046984002,0.17335732,0.00066844316,0.1188782
overview hemochromatosis hemochromatosis autosomal recessive genetic disorder occurs high prevalence populations european origin gene abnormal hemochromatosis found short arm chromosome close proximity approximately centimorgan hla product coded gene unknown pathogenetic mechanism hemochromatosis continued excessive absorption dietary iron loss normal control mechanisms leading gradual vast expansion storage iron ferritin especially hemosiderin mechanisms probably include peroxidation lipid membranes excess iron injures hepatocytes islet b cells gonadotropes anterior pituitary myocardium synovial cells chondrocytes probably cells tissues well patients hemochromatosis remain undiagnosed throughout life removal excess iron phlebotomy prevent complications hemochromatosis begun early significantly improve survival virtually patients important therefore diagnosis hemochromatosis considered much frequently clinical medicine order effective therapy utilized,C18,0.0024669354,0.014128991,0.016543677,0.013283267,0.0034351295,0.0031837088,0.2785222,0.002319936,0.0017834846,0.002423909,0.045220636,0.022343436,0.04537151,0.08054668,0.014107167,0.015780516,0.08322487,0.002541927,0.002808969,0.19640137,0.10946135,0.0008759192,0.04322445
effect acarbose carbohydrate lipid metabolism niddm patients poorly controlled sulfonylureas ability acarbose lower plasma glucose concentration studied patients non insulin dependent diabetes mellitus niddm poorly controlled diet plus sulfonylurea drugs patients studied mo addition acarbose treatment program significant improvement glycemic control noted although decrease fasting plasma glucose concentration modest mm average postprandial plasma glucose concentration decreased mm acarbose therapy discontinued patients plasma glucose levels rapidly returned toward pretreatment levels addition improvement glycemia acarbose treatment also led significant reduction hba c p less triglyceride mm p less concentrations neither plasma insulin response meals insulin stimulated glucose uptake improved acarbose therapy consistent view acarbose improves glycemic control delaying glucose absorption considerable individual variation noted response acarbose results patients dramatic striking reductions fasting postprandial glucose concentrations addition acarbose patients niddm well controlled sulfonylureas appears significant clinical benefit,C18,0.0020503625,0.0018187739,0.003825764,0.0011520151,0.002855065,0.0026460998,0.20985882,0.01184617,0.0014823208,0.011928257,0.009455466,0.004230839,0.06458831,0.004772063,0.011724087,0.1413815,0.09528511,0.002119826,0.011752417,0.016480856,0.38590857,0.00072800927,0.0021093374
alkaline phosphatase tissue nonspecific isoenzyme phosphoethanolamine pyridoxal phosphate ectophosphatase normal hypophosphatasia fibroblast study clarify physiologic role alkaline phosphatase alp examined normal skin fibroblasts shown tissue nonspecific tns isoenzyme type evidenced heat inhibition profiles active toward millimolar concentrations putative natural substrates phosphoethanolamine pea pyridoxal phosphate plp fibroblast alp low affinity activity distinctly alkaline ph optimum toward methylumbelliferyl phosphate mup pea plp physiologic ph optimum toward physiologic concentrations micromolar pea plp normal fibroblast alp linked outside plasma membrane since intact cell monolayers dephosphorylation rates membrane impermeable substrates pea plp medium physiologic ph similar observed disrupted cell monolayers brief exposure acidic medium resulted greater inactivation total alp activity digestion phosphatidylinositol specific phospholipase c pi plc released alp activity hypophosphatasia fibroblasts markedly deficient control values alkaline physiologic alp activity mup plp pea used substrate majority detectable alp activity however appeared properly lipid anchored ecto orientation thus findings genetic deficiency pea plp phosphatase activity hypophosphatasia fibroblasts well biochemical findings indicate tns alp acts physiologically lipid anchored pea plp ectophosphatase,C18,0.0022342624,0.0019759599,0.07183881,0.012281329,0.013884431,0.0028747867,0.24664676,0.0020948276,0.0016104291,0.002188712,0.010975586,0.015602099,0.042914346,0.08522324,0.023561608,0.0034687794,0.020380361,0.06676802,0.0025364086,0.07427579,0.26209256,0.00079092686,0.033779934
impaired growth hormone gh response pyridostigmine type diabetic patients exaggerated gh releasing hormone stimulated gh secretion present study investigated effects acetylcholinesterase inhibitor pyridostigmine pd hypothesized decrease hypothalamic somatostatin tone alone association gh releasing hormone ghrh gh secretion type diabetic patients normal subjects using randomized double blind placebo controlled protocol subjects received either mg oral pd placebo min iv injection either human ghrh nh micrograms sterile water ml normal subjects pd alone ghrh alone caused significant increase gh pd ghrh acted synergistic fashion combined diabetic patients gh response ghrh variable segregate responses ratio gh increase ghrh plus pd ghrh alone calculated subject diabetic patients group ratio lower sd p less mean response normal subjects patients showed exaggerated gh increase ghrh lower gh increase pd respect normal subjects eight diabetic patients group b showed ratio similar normal subjects similar gh responses stimuli significant differences found groups b respect age body mass index blood glucose levels duration diabetes longer basal gh levels higher group hemoglobin c higher group borderline statistical significance p data demonstrate diabetic patients exaggerated gh responses ghrh increase cholinergic tone affect gh secretion data suggest type diabetic patients altered somatostatinergic control gh secretion may contribute abnormal gh response ghrh,C18,0.0014691916,0.0013032462,0.0027413592,0.0008255794,0.0020459061,0.001960007,0.15890282,0.0013816456,0.0010621601,0.0014435671,0.030701213,0.07418356,0.22063,0.014257888,0.00129197,0.059512075,0.07418175,0.01593719,0.022998799,0.0499061,0.25414103,0.00760697,0.0015159595
therapy hypercholesterolemia patients hypercholesterolemia effectively lowered drug therapy several issues considered first drug therapy never considered without adequate dietary intervention dietary therapy may effective many patients mild moderate elevations cholesterol none drugs used treat lipid disorders benign agents still debate interpretations recent studies ability generalize studies whole population cost effectiveness drug treatment within framework aha ncep guidelines individualized approach therapy prudent initiated maximal patient education drug therapy maintained long term life ldl hdl levels age sex chd risk factors cost treatment patient awareness motivation must assessed making treatment decisions drug therapy considered patients isolated hypercholesterolemia bile acid sequestrants drugs choice,C18,0.0023282263,0.0020652527,0.0046062637,0.0013081353,0.0032419814,0.025526555,0.4450088,0.002189492,0.012950231,0.0023081994,0.03339892,0.0047887163,0.03956053,0.016495936,0.058095645,0.014878639,0.09445685,0.002397687,0.025180344,0.13680096,0.06919071,0.0008266685,0.0023951933
transfer diabetes mice prevented blockade adhesion promoting receptor macrophages insulin dependent diabetes mellitus iddm disease autoimmune aetiology non obese diabetic mouse good spontaneous animal model human disease iddm developing female mice age months disease transferred splenic cells diabetic donors prevented cell depletion mechanism beta cell specifically destroyed known cells macrophages implicated based presence macrophages infiltrated islet ability chronic silica treatment prevent disease monoclonal antibody c specific myelomonocytic adhesion promoting type complement receptor cr cd b cd bind cells show blockade macrophage cr vivo prevents intra islet infiltration macrophages cells inhibits development iddm conclude cells macrophages essential role onset iddm,C18,0.0024667913,0.049956024,0.004605145,0.0013860385,0.0034349286,0.0031835225,0.25575846,0.085913196,0.0017833803,0.014363239,0.024499511,0.017004402,0.015269897,0.18585224,0.002169234,0.04547421,0.04167955,0.092653476,0.0028088046,0.048736487,0.084777586,0.00087586796,0.015347976
high frequency aspartic acid position hla dq beta chain japanese iddm patients nondiabetic subjects hla dq beta chain dqb genes japanese patients insulin dependent diabetes mellitus iddm control subjects studied polymerase chain reaction pcr amplification allele specific oligonucleotide hybridization dqw dqbblank dqw dqb increased iddm patients compared control subjects dqb dqb dqw dqb decreased thirty five iddm patients alleles carrying aspartic acid position dq beta chain asp asp non asp heterozygous non asp alleles control subjects respective values three genotypes respectively high frequency asp alleles iddm control subjects contrasts data whites therefore asp hypothesis presence aspartic acid position dq beta chain provides protection developing iddm tenable japanese iddm patients drb gene particularly position dr beta chain may contribute iddm susceptibility japanese,C18,0.0024669382,0.0021882972,0.0046030506,0.001386072,0.051202424,0.0031837123,0.2034462,0.0023199385,0.013724087,0.0024239116,0.011431568,0.005165182,0.21338288,0.006434954,0.014086225,0.020137506,0.09117925,0.0025405374,0.002808972,0.07270612,0.06296849,0.0008759201,0.20933774
family glucose transporter genes implications glucose homeostasis diabetes glucose transport facilitated diffusion mediated family tissue specific membrane glycoproteins least four members gene family identified cdna cloning hepg type transporter widely distributed proteins provides many cells basal glucose requirement atp production biosynthesis sugar containing macromolecules liver type transporter expressed tissues net release glucose occur beta cells pancreatic islets genetic defect resulting reduced activity transporter could hypothetically lead two principal features non insulin dependent diabetes mellitus insulin resistance relative hypoinsulinemia adipocyte muscle transporter expressed exclusively tissues insulin sensitive respect glucose uptake protein excellent candidate highly specific genetic defect predisposing insulin resistance,C18,0.0023555295,0.01343232,0.048817363,0.0013231251,0.019002097,0.03723369,0.2018971,0.002214394,0.013101103,0.002313637,0.012322126,0.00484318,0.014811755,0.16106461,0.013463375,0.13758744,0.04528433,0.02861378,0.03684746,0.049637318,0.10387695,0.00083607057,0.049121253
beneficial effects fetal liver tissue fetal pancreatic transplantation recently composite grafts hepatocytes islets shown improve survival hepatocytes possibility reciprocal effect hepatocytes islet function investigated diabetic lewis rats isografted fetal pancreas fetal liver fp fl fetal pancreas alone fp fetal pancreas fetal spleen fp fs grafts transplanted small bowel subserosa fp fl recipients cured glucose less mg dl greater days whereas fp alone fp fs recipients cured amount time normoglycemia fp fs recipients less days compared fp days fp fs recipients days mean glucose levels weeks mg dl mg dl mg dl cured fp fl fp fp fs recipients respectively glucose tolerance test results significantly different nondiabetic control rats contrast fp alone fp fl recipients well granulated hyperplastic islets hepatocytes histologic examination new isograft recipients treated cyclosporine fp recipients remained hyperglycemic however fp fl recipients cured conclusion fl composite graft fp resulted better engraftment earlier isograft function protection cyclosporine islet toxicity,C18,0.0020506121,0.0018189953,0.013685124,0.040860552,0.0028554124,0.0026464218,0.15601939,0.0019284205,0.07096559,0.0020148468,0.029789457,0.004237503,0.19788796,0.045483503,0.051432293,0.062507614,0.061760843,0.0021117905,0.012242585,0.013772714,0.22109066,0.00072809786,0.0021095942
leucine metabolism iddm role insulin substrate availability effect insulin plasma amino acid concentrations leucine metabolism examined healthy nondiabetic young volunteers subjects insulin dependent diabetes mellitus iddm euglycemic insulin clamp technique mu min combination c leucine diabetic subjects studied poor metabolic control fasting glucose mm hba c mo intensified insulin therapy fasting glucose mm hba c insulin mediated total body glucose uptake poorly controlled diabetic subjects mg kg min significantly reduced compared control subjects mg kg min p less improved slightly insulin therapy mg kg min p less although still remained significantly lower control subjects p less insulin clamp study performed subjects poorly controlled iddm endogenous leucine flux elf leucine oxidation lo nonoxidative leucine disposal nold decreased mumol min respectively extent control subjects mo intensified insulin therapy effect acute hyperinsulinemia elf lo nold comparable control subjects whereas insulin stimulated glucose metabolism still impaired examine effect substrate availability leucine turnover well regulated iddm control subjects underwent repeat insulin clamp study combined balanced amino acid infusion designed increase circulating plasma amino acid levels approximately twofold conditions nold equally enhanced baseline control iddm subjects p less whereas elf inhibited greater extent p less insulin clamp performed without amino acid infusion control vs diabetic subjects ns conclusion insulin mediated glucose metabolism severely impaired subjects poorly controlled well controlled iddm whereas effect acute insulin infusion leucine turnover normal combined hyperaminoacidemia hyperinsulinemia stimulated nold similar extent iddm control subjects,C18,0.0012243836,0.0010860083,0.031417146,0.0006878798,0.0017062502,0.031647354,0.09302616,0.0011513392,0.0008851087,0.0012042299,0.010062943,0.0025633418,0.29208466,0.010074888,0.010825236,0.19368128,0.040207654,0.039137017,0.0013940367,0.015300771,0.19519024,0.00043470165,0.025007337
hydroquinone induced localized exogenous ochronosis treated dermabrasion co laser exogenous localized ochronosis result repeated use hydroquinone containing creams many available counter report case managed dermabrasion co laser incidence proposed etiologies hydroquinone induced exogenous ochronosis reviewed,C18,0.005779364,0.033103045,0.09684779,0.003247189,0.008047582,0.0074585704,0.22806856,0.005434984,0.004178223,0.005678565,0.059943236,0.011887047,0.035775326,0.01613836,0.005082227,0.008999672,0.17275366,0.005951787,0.0065806564,0.105493955,0.16535306,0.0020520422,0.0061451085
use doppler flow velocity waveform analysis detection initial diabetic microangiopathy doppler flow velocity waveform analysis fvwfa recorded dorsalis pedis artery dpa radial artery ra performed women attempting detect initial diabetic microangiopathy dm study comprised two groups women affected non insulin dependent diabetes mellitus patients pts reproductive age pts menopause ii two groups age matched healthy controls c iii iv clinical signs initial dm present group examined pts nonsmokers normotensive without cardiopathy signs diabetic macroangiopathy collagen vascular disease raynaud phenomenon renal failure four waveform dimensions capable separating different degrees peripheral obstructive arteriolar disease determined velocity tracing results used single best discriminant equation resultant discriminant score ds derived fvwfa dpa showed highly accurate rate separating young pts dm c pts menopause without dm furthermore resultant ds statistically different groups ii iii iv conclusion fvwfa dpa experience proved accurate sensitive method detection initial dm,C18,0.022809729,0.022224823,0.024504917,0.032161605,0.014119577,0.0030939619,0.173392,0.0020360984,0.02219905,0.022769615,0.12434678,0.060242314,0.09579297,0.004938304,0.0018778528,0.059370466,0.08800273,0.0022243103,0.0024315135,0.08142995,0.13705644,0.0007582175,0.0022168006
combined insulin sulfonylurea therapy treatment niddm past years interest focused combination insulin sulfonylurea search effective treatments non insulin dependent diabetes mellitus niddm patients fail oral hypoglycemic agents although several studies demonstrated beneficial effects therapy niddm patients average effect small observed half patients however several problems previous studies including small sample size selection patients simultaneous use several end points first residual beta cell function considered prerequisite beneficial effect combination therapy therefore studies failed demonstrate improved glycemic control adding sulfonylurea insulin therapy patients insulin dependent diabetes mellitus inclusion patients impaired beta cell function therefore attenuate effect combination therapy second studies used glycemic control end point nevertheless insulin dose reduced avoid hypoglycemia adding sulfonylurea insulin thus comparison made treatments smaller insulin dose sulfonylurea larger insulin dose without sulfonylurea patient likely benefit combination therapy slightly obese niddm relatively short period preserved beta cell function patient combined insulin sulfonylurea therapy predominantly stimulates basal insulin secretion resulting effective suppression hepatic glucose production lower fasting plasma glucose side effects notably frequent mild hypoglycemic reactions,C18,0.0015001124,0.0013305459,0.01718937,0.0008427705,0.002109884,0.0121052675,0.3081248,0.0014105875,0.0010844097,0.00873106,0.019635955,0.0030851462,0.031750865,0.026313754,0.008543568,0.13147971,0.11260695,0.016052805,0.0017079335,0.039532132,0.23100406,0.0005325839,0.023325777
controlled study diabetic children comparing insulin dosage adjustment manual computer algorithms controlled trial new microprocessor device insulin dosage adjustment undertaken two matched groups priori well controlled diabetic children prospective study design three equal wk periods used first period groups used manual methods insulin dosage adjustment manual criteria second period one group children adjusted insulin dosage computer algorithms whereas continued use manual methods third period groups adjusted insulin traditional methods mean premeal glycemia glycosylated hemoglobin levels change either group throughout study second period episodes hypoglycemia frequent children without computer used device keeping latter outcome group used microprocessor device given less insulin second period first vs u kg day p less comparison control group patients concurrently given increased insulin dose second period compared first study showed insulin treatment specific computer mediated dosage adjusting algorithms safe minimized hypoglycemia effectively accommodating seasonally changing insulin requirements recommend device help diabetic children families care insulin dependent diabetes,C18,0.0016694596,0.033806738,0.010018288,0.0009380013,0.0023246696,0.016088624,0.16225828,0.00156998,0.001206945,0.044871382,0.07330582,0.07220731,0.07392271,0.016166333,0.052965768,0.10766478,0.09626799,0.0017600688,0.01165371,0.09143537,0.12558644,0.00059276447,0.0017185604
insulinlike activity new antidiabetic agent cp l adipocytes examined vitro effects cp novel antidiabetic agent l adipocytes cp stimulated deoxyglucose uptake absence insulin least min incubation required stimulation uptake effect increased h sustained h stimulation deoxyglucose uptake cp could inhibited approximately inhibition protein synthesis cycloheximide half maximal maximal responses cp h incubation observed microm drug respectively threefold stimulation uptake microm approximating maximal response cells acute insulin stimulation cp able overcome insulin resistance induced dexamethasone l cells effect drug like insulin primarily increase vmax deoxyglucose uptake stimulation uptake cp insulin could prevented incubating cells degrees c temperature impedes translocation glucose transporters plasma membrane therefore appears cp like insulin stimulates glucose uptake mechanism involves translocation intracellular glucose transporters plasma membrane de novo protein synthesis compared effect cp sulfonylureas primary drugs used treatment non insulin dependent diabetes mellitus niddm cp potent effective stimulator deoxyglucose uptake l cells either first second generation sulfonylureas,C18,0.0018489986,0.010589235,0.030456265,0.001038877,0.002574672,0.011335196,0.25661764,0.0017388207,0.02818773,0.0018167497,0.0371013,0.0038283463,0.037396234,0.06522164,0.0016259628,0.17695177,0.018061975,0.049628966,0.002105357,0.013048933,0.2462665,0.0006565122,0.0019023292
cholesterol lowering effect skim milk immunized cows hypercholesterolemic patients effect skim milk cows immunized variety human intestinal bacteria serum cholesterol concentrations examined patients primary hypercholesterolemia wk randomized double blind placebo controlled crossover study wk baseline period patients treated wk either skim milk immunized cows active control skim milk placebo followed wk period treatment order reversed eight weeks active treatment skim milk immunized cows reduced serum total cholesterol concentrations mmol l mean sd p less ldl cholesterol mmol l ns atherogenic index total cholesterol hdl cholesterol p less compared placebo treatment reversal favorable development occurred upon cessation active treatment conclude daily supplementation normal diet skim milk immunized cows result significant reduction elevated blood cholesterol concentrations,C18,0.0025585478,0.0022692755,0.004773387,0.0014373637,0.0035622509,0.003301526,0.23916125,0.0024057883,0.0018494846,0.002513609,0.011798334,0.0053012376,0.12453273,0.0062455027,0.064361975,0.0039836923,0.10443901,0.002635291,0.0400632,0.035547942,0.29236832,0.00090833363,0.04398189
time course sprouting muscle reinnervation vitamin e deficient rats typical aspect motoneuron plasticity sprouting occurs muscle reinnervation resulting transitory multiple innervation muscle cells order verify effect decreased protection free radical attack sprouting multiple innervation extensor digitorum longus muscle following sciatic nerve crush regeneration studied vitamin e deficient rats thus innervated end plates end plates multiple innervation studied histochemical electrophysiological techniques percentage innervated end plates similar groups well days nerve crush nevertheless multiple innervation found larger part muscle lasted longer deficient rats finding discussed relation major hypotheses sprouting may relevant treatment lesions peripheral nerve,C18,0.002919874,0.002590074,0.005448182,0.0016405581,0.018233502,0.0037897518,0.22591835,0.016871972,0.072789915,0.0028689476,0.08103253,0.020255102,0.11653626,0.02326325,0.0025676636,0.004546851,0.071880735,0.003006986,0.01744649,0.07175172,0.18822996,0.0010367412,0.045374583
implanted peritoneal oxygen tonometer calibrated situ oxygen tension peritoneum continuously measured silastic tonometer integral oxygen electrode inlet outlet tubes gasequilibrated electrolyte solution remote kinetic calibration system periodically performed tonometers implanted six rabbits peritoneal oxygen tension measured awake anesthetized rabbits various oxygen breathing conditions,C18,0.0069434834,0.006159216,0.046553563,0.00390126,0.00966858,0.008960927,0.19623062,0.0065297354,0.005019829,0.00682238,0.075891994,0.096567646,0.14103931,0.10174281,0.006105924,0.010812447,0.11610754,0.0071506365,0.007906177,0.044363867,0.08591344,0.0024653785,0.0071431994
long term maternal fetal exposure high low insulin concentrations alter liver brain insulin receptors investigated effects long term days vivo exposure hyperinsulinemia hypoinsulinemia maternal fetal rat days gestation term approximately days brain liver insulin receptors studied vitro effects long term insulin exposure cultured rabbit neuronal cell insulin receptors long term glucose infusions maternal rats resulted maternal fetal hyperglycemia mild hyperinsulinemia decreases liver insulin receptor abundance mother increased fetus streptozotocin induced maternal diabetes resulted maternal fetal hyperglycemia hypoinsulinemia near normal insulin levels increased maternal fetal liver insulin receptors maternal fetal brain insulin receptor abundance failed change high low insulin concentrations similarly long term insulin micrograms ml exposure failed alter cultured neuronal cell insulin receptors well conclude perturbations maternal fetal circulating insulin concentrations fail affect brain insulin receptors protective phenomenon may critical maintaining normal neuronal energy balance functioning certain disease states diabetes mellitus hyperinsulinism,C18,0.036043912,0.0015700448,0.0033033232,0.0009944696,0.0024646164,0.0022842286,0.15284643,0.0016644939,0.026910208,0.0017390918,0.016581157,0.018426321,0.054330025,0.025146179,0.0015564602,0.18420878,0.05576021,0.07428294,0.0020153623,0.08284771,0.2525746,0.00062844926,0.0018210195
tumor necrosis factor increased hepatic low density lipoprotein production increased serum triglyceride levels diabetic rats previous studies demonstrated administration tumor necrosis factor tnf diabetic rats rapidly increases serum triglyceride levels stimulates hepatic lipogenesis without affecting activity adipose tissue lipoprotein lipase serum insulin levels purpose study determine mechanism tnf increases serum triglyceride levels stimulates hepatic fatty acid synthesis diabetic animals maximal increase approximately fold serum triglyceride levels diabetic rats seen dose micrograms tnf g body wt half maximal effect observed micrograms tnf g body wt clearance labeled triglyceride rich lipoproteins circulation affected tnf administration triglyceride diabetic vs tnf administered diabetic vs min respectively ns production triglyceride measured triton wr technique increased twofold diabetic animals tnf administration results indicate rapid increase serum triglyceride levels tnf treatment accounted increased hepatic lipoprotein secretion tnf administration alter either amount activation state hepatic acetyl coa carboxylase key regulatory enzyme fatty acid synthesis also change hepatic levels fatty acyl coa allosteric inhibitor acetyl coa carboxylase however increase hepatic citrate concentrations citrate allosteric activator acetyl coa carboxylase changes hepatic citrate concentrations shown mediate changes rates fatty acid synthesis,C18,0.0015107479,0.0013401088,0.0028213835,0.00084882765,0.0021037508,0.0019496989,0.094266996,0.0014207256,0.02297886,0.0014843986,0.012940545,0.0031392367,0.041588105,0.024496712,0.07444589,0.13395457,0.015548319,0.037235856,0.0017202088,0.0171369,0.4245328,0.080981046,0.0015542768
evidence secular change obesity height weight among navajo indian schoolchildren survey measuring heights weights schoolchildren residing navajo indian reservation conducted findings compared national center health statistics nchs reference data surveys navajo children approximately twice many children exceeded th percentile weight age girls boys would expected nchs reference population mean weight height z scores exceeded nchs reference population ages sexes compared data mean heights increased among boys among girls whereas mean weights increased among boys among girls across age groups data suggest secular change height weight obesity navajo indian children past,C18,0.0028402433,0.0025194376,0.018871821,0.0015958168,0.003954949,0.003665482,0.103875004,0.0026709992,0.0020533695,0.1540402,0.040870056,0.032982923,0.16695732,0.0065305964,0.0024976383,0.031886164,0.04238043,0.0029249797,0.05822844,0.23182847,0.08289437,0.0010084672,0.0029227773
lowering plasma glucose concentrations bezafibrate patients moderately controlled niddm goal study investigate whether treatment bezafibrate improves glucose tolerance non insulin dependent diabetes mellitus niddm study included niddm patients hba concentrations greater normal kidney liver function treated diet alone diet together sulfonylurea drug one patient withdrew constipation randomization mo treatment patients given standard mixed test meal tolerance test mtt cal overnight fast plasma glucose insulin c peptide metabolite nonesterified fatty acid nefa triglyceride concentrations measured min intervals serum lipid hba fructosamine concentrations measured monthly intervals glucose nefa triglyceride concentrations significantly lower throughout second mtt bezafibrate patients p less placebo group fasting serum insulin c peptide levels postprandial concentrations reduced bezafibrate patients p less mo mean fasting serum triglyceride concentrations fell mm p less total serum cholesterol concentrations mm p less low density lipoprotein cholesterol concentrations mm p less bezafibrate patients changes serum lipid concentrations placebo group treatment patients moderately controlled niddm bezafibrate improves glucose tolerance serum lipid profile bezafibrate treatment may useful adjunct hypoglycemic therapy patients niddm,C18,0.0016562527,0.0014690794,0.035131846,0.0009305179,0.0023061235,0.010076706,0.108874924,0.0015574547,0.001197316,0.0016272555,0.025139064,0.028668389,0.12242109,0.00384633,0.041575924,0.10664622,0.10772937,0.0017058252,0.017919699,0.022972815,0.35425603,0.0005880354,0.0017037764
diabetic patients abnormal cerebral autoregulation cardiopulmonary bypass tested hypothesis insulin dependent diabetic patients coronary artery bypass graft surgery experience altered coupling cerebral blood flow oxygen consumption study patients diabetics age matched controls cerebral blood flow measured using xe clearance nonpulsatile alpha stat blood gas managed cardiopulmonary bypass conditions hypothermia normothermia diabetic patients cerebral blood flow degrees c ml g min degrees c ml g min p ns control patients increased cerebral blood flow ml g min degrees c ml g min degrees c p less equal oxygen consumption calculated jugular bulb effluent increased hypothermic values ml g min diabetics ml g min p normothermia rose ml g min p controls thus despite temperature mediated changes oxygen consumption diabetic patients increase cerebral blood flow metabolism increased arteriovenous oxygen saturation gradients oxygen extraction across brain calculated arterial jugular bulb blood samples increase arteriovenous oxygen difference temperature conditions diabetic patients controls significantly different p data reveal diabetic patients lose cerebral autoregulation cardiopulmonary bypass compensate imbalance adequate oxygen delivery increasing oxygen extraction,C18,0.07246036,0.0014464152,0.026810737,0.00091616233,0.0022893203,0.013562259,0.07496892,0.0015334272,0.016956873,0.001602151,0.057686944,0.011454196,0.41824192,0.0046618027,0.0014339002,0.0753101,0.12366171,0.0018946779,0.0018566672,0.019015105,0.060392305,0.0005789635,0.011265097
familial hypercatabolic hypoproteinemia disorder endogenous catabolism albumin immunoglobulin metabolism albumin igg investigated two siblings products first cousin marriage female aged yr male aged marked reduction respective serum concentrations igg mg ml albumin mg ml metabolism radioiodinated igg albumin studied two patients total circulating body pools igg less normal igg synthetic rates within normal range however igg survival short respective fractional catabolic rates increased fivefold intravenous pool per day normal furthermore patients reduced total body pools normal synthetic rates increased fractional catabolic rates albumin proteinuria abnormality renal liver function addition patients circulating antibodies directed toward igg iga albumin furthermore patients normal fecal cr labeled albumin tests thus excluding excessive gastrointestinal protein loss propose siblings previously unrecognized familial disorder characterized reduced serum concentrations igg albumin caused defect endogenous catabolism leading short survival proteins associated family chemical diabetes skeletal deformity,C18,0.0017253582,0.0015303596,0.011595565,0.0009693329,0.01034827,0.06903998,0.14177999,0.0016224213,0.00124726,0.001699164,0.03558398,0.0127498945,0.057073094,0.03413216,0.017296439,0.035917047,0.078994215,0.02336296,0.001964421,0.12805632,0.33091682,0.00061256427,0.0017823656
accuracy self reports physical activity investigation determined accuracy self reports physical activity compared observations obtained surreptitiously subjects adults engaged h preferred physical activity actual activity levels surreptitiously obtained compared immediate self reported estimates physical activity results indicated subjects moderately accurate recalling physical activity levels r underestimated sedentary activities overestimated aerobic activities males overestimated activity relative females obese subjects underestimated activity levels compared normal weight subjects finally number two way interactions moderated accuracy subjects engaging high chronic levels physical activity observed,C18,0.0027635645,0.015821131,0.04527821,0.0015527342,0.003848176,0.0035665238,0.22818746,0.0025988894,0.001997934,0.0027153643,0.09403381,0.005684124,0.12018479,0.009121484,0.0024302087,0.0043034446,0.025422111,0.0028468259,0.0031467245,0.096031696,0.32464054,0.0009812413,0.002843053
continuous glucose treatment patients type glycogen storage disease comparison effects dextrose uncooked cornstarch biochemical variables responses uncooked cornstarch ucs dextrose dex mixture ucs dex determined seven children type glycogen storage disease gsd ucs maintained blood glucose bg serum insulin concentrations mmol l mean sem pmol l respectively six seven patients h four seven patients completed h test ucs dex bg mmol l dex tests stopped patients min initiation bg mmol l two methods providing dietary glucose overnight continuous intragastric glucose infusion cog intermittent ucs compared monitoring metabolites glucoregulatory hormones use ucs amounts equal calculated glucose production rate effective method providing continuous dietary source glucose overnight patients gsd,C18,0.0028012723,0.0024848683,0.021336248,0.0015740817,0.003900683,0.05779814,0.24634054,0.0026343504,0.0020251952,0.01631359,0.066863306,0.005865907,0.089904666,0.006532995,0.0024633682,0.10274258,0.16237028,0.002884846,0.0031896606,0.05439263,0.14170432,0.00099463,0.0028818457
insulin administration via liposomes liposomes used insulin therapy means selectively target insulin liver enhance oral absorption insulin prolong insulin action liposomes effective means delivering insulin specifically hepatocytes usefulness hepatically targeted liposomes treatment diabetes restricted due requirement given intravenously dilute concentration insulin present liposomal preparations cost associated liposome production encapsulating insulin liposomes results enhanced oral absorption insulin high doses liposome entrapped insulin required perorally coupled extreme variability glycemic response peroral liposomes limits value peroral liposomal insulin viable diabetic therapy insulin action sustained via encapsulation insulin liposomes given subcutaneously insulin appears remain injection site presence lipid matrix subcutaneous insulin delivery raises concerns enhanced antigenicity liposomal insulin given subcutaneously viewed light limitations outlined contribution liposomal insulin understanding treatment diabetes mellitus probably via use hepatically targeted liposomes pharmacological probe decipher role liver metabolic complications associated diabetes mellitus,C18,0.0020319805,0.0018012152,0.0037888293,0.020794844,0.0028275016,0.012440436,0.3101926,0.021545896,0.011293923,0.0019951523,0.009803323,0.036735594,0.044915393,0.026719471,0.011610849,0.19963044,0.04992024,0.03263266,0.0023121005,0.02775401,0.16644292,0.0007209809,0.002089648
reduced insulinotropic effects glucagonlike peptide amide gastric inhibitory polypeptide isolated perfused diabetic rat pancreas pathophysiological role incretin diabetes mellitus established therefore examined effects glucagonlike peptide amide truncated glp gastric inhibitory polypeptide gip insulin glucagon release isolated perfused pancreases diabetic rats wk age mean se fasting plasma glucose mm n injection mg kg streptozocin nd day birth compared results nondiabetic control rats diabetic rats infusion nm glp gip perfusates varying glucose concentrations mm caused nearly equal degree insulin stimulation similar basal insulin level meanwhile basal glp gip stimulated insulin release increased correlation ambient glucose concentration nondiabetic rats degree stimulation insulin release glucose concentrations mm diabetic rats approximately nondiabetic rats stimulation potency glp gip insulin treatment diabetic rats u kg nph insulin days brought slight improvement glucose dependency glp stimulated insulin release effects glp gip glucagon release completely opposite glp suppressed release gip stimulated diabetic rats degree suppression glp stimulation gip almost similar basal glucagon levels perfusate varying glucose concentrations,C18,0.0016301495,0.0014459481,0.026890572,0.008787441,0.0022698126,0.0021036826,0.099675536,0.0015329319,0.0011784638,0.0016016336,0.00821881,0.011826,0.041891146,0.003833246,0.032174096,0.20980884,0.016472764,0.010371296,0.0018560677,0.026822781,0.471581,0.0005787765,0.017449014
removal inorganic acid load subjects ketoacidosis chronic fasting large inorganic acid load ingested normals proton load eliminated rate excretion ammonium rise mmol day subjects ketoacidosis chronic fasting large increase rate excretion ammonium might possible atp balance considerations proximal cells subjects ketoacidosis chronic fasting excreted less net acid defined conventional way consumed large inorganic acid load vs mmol day control fasted subjects nevertheless vast majority inorganic acid load eliminated steady state slightly lower concentration bicarbonate vs mmol liter ketoacid anions vs mmol liter blood using definition net acid excretion component bicarbonate loss expanded include potential bicarbonate ketoacid anions urine rate excretion net acid higher subjects ingested inorganic acid load owing much lower rate excretion ketoacid anions vs mmol day lower rate excretion due lower filtered load also higher fractional reabsorption ketoacid anions acidosis vs higher fractional reabsorption could explained lower filtered load ketoacid anions restricted intake sodium,C18,0.0019011104,0.001685313,0.17826456,0.0010674807,0.011861964,0.0024519297,0.31154978,0.0017866961,0.010442273,0.0018667709,0.018757049,0.01323011,0.14418441,0.016156534,0.0016707309,0.03974162,0.02912651,0.001957115,0.0021633243,0.07128908,0.13621649,0.0006745882,0.001954555
altered steady state mrna levels basement membrane proteins diabetic mouse kidneys thromboxane synthase inhibition examined steady state levels mrna encoding type iv collagen b chain laminin basement membrane heparan sulfate proteoglycan kidney cortex mouse model kkay non insulin dependent diabetes mrnas encoding laminin b proteoglycan unchanged kidneys taken diabetic mice demonstrable basement membrane thickening mrna levels type iv collagen contrast significantly elevated fold diabetic mice concurrent preceding morphologically thickened basement membranes negative correlation ratio proteoglycan type iv collagen levels albuminuria diabetic mice correlation noted laminin also examined effects inhibiting synthesis thromboxane potent vasoconstrictor steady state levels type iv collagen diabetic mice inhibition thromboxane stopped progression albuminuria prevented increase type iv collagen mrna levels conclude basement membrane thickening diabetes hallmark diabetic nephropathy partly consequence unbalanced increase production type iv collagen relative decrease proteoglycan production may contribute chronic albuminuria,C18,0.0022517608,0.012896396,0.015099881,0.05836158,0.013992393,0.0029060144,0.15414363,0.002117583,0.0016279228,0.0022124872,0.046886533,0.004631536,0.05449817,0.09599423,0.0019801415,0.091921,0.021828877,0.12121733,0.0025639609,0.016663386,0.24041736,0.0007995184,0.034988325
increased hepatic mitochondrial capacity rats hydroxy cobalamin c lactam induced methylmalonic aciduria treatment rats vitamin b analogue hydroxy cobalamin c lactam hccl impairs methylmalonyl coa mutase function leads methylmalonic aciduria due intracellular accumulation propionyl methylmalonyl coa since accumulation acyl coas disrupts normal cellular regulation present investigation characterized metabolism hepatocytes liver mitochondria rats treated subcutaneously hccl saline control osmotic minipump consistent decreased methylmalonyl coa mutase activity co production c propionate mm decreased wk wk hccl treatment respectively contrast wk hccl treatment co production c pyruvate mm c palmitate mm increased respectively isolated liver mitochondria state oxidation rates unchanged decreased activities mitochondrial enzymes citrate synthetase succinate dehydrogenase carnitine palmitoyltransferase glutamate dehydrogenase expressed per milligram mitochondrial protein unaffected hccl treatment contrast activities enzymes significantly increased liver homogenate expressed per gram liver isolated hepatocytes expressed per cells hccl treated rats mitochondrial protein per gram liver calculated basis recovery mitochondrial enzymes increased wk hccl treated rats activities lactate dehydrogenase catalase cyanide insensitive palmitoyl coa oxidation arylsulfatase liver affected hccl treatment hepatic levels mitochondrial mrnas elevated fold hccl treated animals assessed northern blot analysis thus hccl treatment associated enhanced mitochondrial oxidative capacity increased mitochondrial protein content per gram liver increased mitochondrial oxidative capacity may compensatory mechanism response metabolic insult induced hccl administration,C18,0.0017262892,0.0015306555,0.028250398,0.0009695203,0.002402784,0.01040985,0.19932659,0.001622735,0.0012475011,0.0016954615,0.016889427,0.0044642156,0.03724017,0.06978585,0.0015174116,0.13190472,0.02184828,0.050919425,0.001964801,0.013781601,0.39809507,0.0006126827,0.0017945333
effects exercise insulin induced hypoglycemia purpose study determine effect exercise rate onset hypoglycemia induced infusion excess insulin mu min g rats either fasted overnight fs fed ad libitum fd fs rats killed min infusion rest running treadmill min grade fd rats killed min infusion rest exercise rats also killed min postexercise fs min postexercise fd continued insulin infusion progressive decline blood glucose altered exercise fs rats fd rats showed significant difference due exercise min rest mm exercise mm significant postexercise repletion glycogen observed red vastus soleus muscles fd rats despite decreasing blood glucose values data indicate exercise accelerates rate development hypoglycemia fd rats fs rats rate decline blood glucose greater exercise effect time course development hypoglycemia,C18,0.0020516685,0.08123146,0.011916843,0.0011520649,0.0028551882,0.012566174,0.083382875,0.001928269,0.011408155,0.011938533,0.0094847465,0.0042704367,0.29449275,0.0047419243,0.041480992,0.07645258,0.021991245,0.013848441,0.0023347402,0.03370808,0.2739254,0.0007280407,0.0021094284
glucose gluconeogenic substrate exchange forearm skeletal muscle hyperglycemic insulin treated type ii diabetic patients determine contribution skeletal muscle fasting hyperglycemia noninsulin dependent type ii diabetes niddm forearm balance glucose lactate alanine quantified control subjects hyperglycemic blood glucose mmol l insulin treated patients niddm blood glucose mmol l forearm glucose uptake similar controls mumol l min hyperglycemic diabetic patients mumol l min spite diabetic patients lactate mumol l min alanine release forearm fold higher control group lactate p less alanine p less respectively ratio lactate release glucose uptake diabetic control subjects respectively insulin administration affect either glucose uptake release gluconeogenic substrates forearm concluded fasting patients niddm glucose taken skeletal muscle normal amounts preferentially used nonoxidatively lactate formation suggests although muscle contribute directly fasting hyperglycemia may play indirect role increased delivery glucose precursors insulin induced normoglycemia maintained mechanisms involve exchange glucose gluconeogenic substrates skeletal muscle,C18,0.0019352507,0.001716664,0.040587388,0.0010874388,0.0026947754,0.0024975417,0.18816572,0.0018377843,0.020134922,0.0019014975,0.01909075,0.014117522,0.18838067,0.0046132454,0.0017018106,0.2713566,0.07628146,0.0019993656,0.0022035677,0.013179513,0.12311774,0.0006871372,0.020711595
low dose lovastatin safely lowers cholesterol cardiac transplantation hypercholesterolemia occurs many cardiac transplant patients may aggravate graft coronary arteriopathy well contributing peripheral vascular disease lovastatin inhibits hydroxy methylglutaryl coenzyme reductase doses mg day effectively lowers cholesterol general cardiac population associated rhabdomyolysis cardiac transplant recipients determine whether lower doses lovastatin would effective safe lowering cholesterol cardiac transplantation patients blood cholesterol greater mg dl least months cardiac transplantation received mg lovastatin daily addition lovastatin enzyme inhibitor level assayed six patients determine whether metabolism drug abnormal lovastatin decreased total cholesterol mg dl p less primarily reduction low density lipoprotein fractions well tolerated without symptoms abnormal creatine phosphokinase levels patients one patient developed rhabdomyolysis reversible renal failure lovastatin increased mg daily enzyme inhibitor levels six transplant patients times higher measured normal volunteers low dose lovastatin effectively lowers cholesterol patients transplantation metabolism altered perhaps cyclosporine monitoring enzyme inhibitor levels may required allow safe administration drug cardiac transplant recipients,C18,0.0016830647,0.009639752,0.0031404241,0.00094564544,0.0023436144,0.0021720827,0.22902077,0.0015898915,0.0012167809,0.0016568092,0.008552482,0.022248462,0.06367553,0.023687487,0.08929445,0.002620882,0.21284597,0.0017440139,0.018193545,0.05136119,0.2500381,0.0005975951,0.001731475
approaching protein sparing modified fast protein sparing modified fast safe effective method losing large amount weight relatively quickly diet used combination exercise program behavior modification patient education caloric intake range per day candidates diet generally healthy least lb lose percent ideal body weight,C18,0.0043268525,0.024783073,0.0080734575,0.0233694,0.0060519027,0.026429823,0.17363946,0.004069024,0.0031281216,0.025194438,0.04585284,0.008899508,0.057889618,0.030881401,0.0038049247,0.04862366,0.11828546,0.046349876,0.019276569,0.1554203,0.1596391,0.0015363081,0.004474835
hyperglycemia induced b cell toxicity fate pancreatic islets transplanted diabetic mice dependent genetic background role pancreatic b cell dysfunction phase preceding clinical onset insulin dependent non insulin dependent diabetes mellitus much debated investigation impact prolonged diabetic environment pancreatic islet b cells transplanted syngeneically kidney capsule c bl b c bl ks bks mice studied alloxan diabetic mice bearing subcapsular islet graft insufficient normalize blood glucose level rendered normoglycemic second intrasplenic islet graft various period hyperglycemia examine reversibility hyperglycemia induced b cell dysfunction using perfusion technique graft bearing found strains mice exhibited diminished glucose induced insulin secretion wk hyperglycemia compared normoglycemic mice carrying islet grafts normoglycemia restituted splenic graft wk normalization glucose stimulated insulin secretion renal islet grafts b mice whereas insulin secretion grafted bks islets remained impaired morphometric measurements islet grafts demonstrated reduction graft volume diabetic bks mice wk compared normoglycemic animals whereas decrease observed b mice islet grafts removed hyperglycemic mice strains exhibited diminished insulin mrna contents bks mice also reduced glucose oxidation rate islet grafts vitro metabolic dysfunction partly explained reduced graft size present findings emphasize genetic constitution decisive factor survival function period sustained stress limited b cell mass,C18,0.0015924254,0.0014123828,0.016303487,0.0008946061,0.002238475,0.002054849,0.12156241,0.0014973474,0.0011511076,0.0092698885,0.010722734,0.0032854707,0.0930732,0.14007197,0.016805278,0.18560332,0.074379705,0.02953794,0.03102825,0.0637027,0.17785214,0.00056534115,0.015394962
biguanides sulfonylureas combination therapy niddm oral combination therapy biguanides metformin sulfonylureas discussed rationale use combination based different sites action two kinds drugs possibility obtaining additive potentiating effects reduced side effects clinical usefulness chlorpropamide glyburide combination metformin demonstrated clinical trials combination may provide satisfactory glycemic control several years possibly insulin therapy postponed even avoided special safety problems encountered use combination attributed use metformin sulfonylurea alone e lactic acidosis hypoglycemia respectively lethality risks associated conditions comparable concluded data needed evaluate full clinical potential mechanism action oral combination therapy,C18,0.01663292,0.01625951,0.0052983547,0.0015954421,0.0039958116,0.0036646212,0.47027263,0.002670372,0.0020528873,0.0027900506,0.01618715,0.0059132734,0.022320272,0.006529063,0.01620717,0.01816523,0.030196687,0.002928016,0.01697858,0.06418932,0.2712232,0.0010082304,0.0029212513
effect isocaloric substitution chocolate cake potato type diabetic patients traditional dietary advice given people diabetes includes eliminating simple sugars primarily sucrose diet many people difficulty following recommendation patients type insulin dependent diabetes need overall calorie restriction caloric reason restrict sucrose study looked effect isocaloric substitution piece chocolate cake baked potato mixed meal determine whether would increase blood glucose patients type diabetes glucose response cake added meal significantly greater standard meal glucose response different cake substitution meal standard meal reproducibility studies showed difference repeated standard meals urinary glucose excretion significantly greater cake added meal different pairs significant differences counterregulatory hormone responses baseline paired studies conclusion patients type diabetes may substitute sucrose containing dessert another carbohydrate diet without compromising postprandial glucose response data suggest dessert exchange may helpful harmful management diabetic patients inherent variability least insulin requiring patient response meal making self monitoring blood glucose adjustment insulin doses necessary achieve near euglycemia,C18,0.0017851928,0.01016985,0.029604629,0.0010031465,0.0024858243,0.0023038841,0.26671574,0.0016788169,0.0012906148,0.0017540567,0.027960991,0.0037408755,0.08525697,0.004260134,0.0015698534,0.09784373,0.12502868,0.0018384525,0.027947737,0.04940261,0.22226003,0.0006338571,0.033464316
renal concentrating defect associated potassium depletion independent prostaglandin e prostaglandin e pge impairs hydrosmotic effect vasopressin toad bladder mammalian kidney studies animals suggested potassium depletion enhances renal pge production present study examined whether renal concentrating defect potassium depletion humans mediated pge five normal volunteers studied moderate potassium depletion achieved days dietary potassium restriction administration polystyrene sulfonate potassium exchange resin kayexalate maximal urinary osmolality umax decreased mean sem mmol kg mosm kg p less following potassium depletion urinary pge excretion change ng respectively indomethacin suppressed pge excretion significantly failed increase umax either normal potassium depleted state mmol kg respectively concluded renal concentrating defect produced moderate potassium restriction humans mediated pge,C18,0.028379716,0.02807636,0.056329817,0.014324744,0.04214239,0.0034291218,0.12037707,0.002498766,0.01478015,0.0026107538,0.012312404,0.005588808,0.07816145,0.008422282,0.0023365838,0.0041527683,0.045163933,0.043295346,0.0030254957,0.04983492,0.4155563,0.00094343856,0.018257331
sulfonylurea treatment impaired glucose tolerance delay development complications niddm chronic hyperglycemia non insulin dependent diabetes mellitus niddm evolves gradually usually preceded transient hyperglycemia classified impaired glucose tolerance igt already phase increased risk cardiovascular complications many igt subjects like niddm patients often display several metabolic circulatory disturbances associated hyperglycemia e g insulin resistance hyperinsulinemia hyperproinsulinemia delayed insulin release dyslipidemia hypertension therefore untreated hyperglycemia self perpetuating condition early detection early intervention may necessary prevent progression complications niddm turn would necessitate screening procedures therapeutic goal include euglycemia normalization plasma insulin plasma lipids blood pressure study german democratic republic indicated mortality screening detected niddm patients differ patients detected routine care swedish study screening detected niddm subjects igt rather manifest niddm could maintain fasting blood glucose less equal mm yr hypocaloric dietary regulation alone screening detected niddm delayed acute insulin release net postprandial hyperglycemia improved addition glipizide managed attain maintain fasting blood glucose less equal mm approximately yr addition however yr increase blood glucose suggesting preventive intervention either may possible may start igt phase,C18,0.008507558,0.015394727,0.009655892,0.0008189922,0.0020297267,0.015983397,0.23873548,0.0013707886,0.0010538136,0.023420846,0.08692073,0.010037021,0.093326405,0.0035219484,0.008333351,0.16893885,0.10709657,0.009343029,0.0016597451,0.06437732,0.12745258,0.0005175574,0.0015036366
pursuing mild elevations liver enzyme values exclude hemochromatosis determine whether physicians academic medical center excluded hemochromatosis diagnosis population patients mildly elevated liver enzyme values reviewed charts patients aspartate aminotransferase alkaline phosphatase levels less twice upper limit normal analyzed chart determine hemochromatosis would excluded subsequent workup patients complete workup assigned one three categories mention made abnormal liver enzyme values liver enzyme values ascribed condition hemochromatosis definitive workup done condition patient poor assessment seem indicated ninety patients given workup exclude hemochromatosis physicians often ignore mild elevations liver enzyme values,C18,0.0030494668,0.0027050292,0.020409355,0.0017133709,0.0042462857,0.0039354954,0.25731364,0.0028677555,0.03170456,0.00299628,0.04575462,0.00637456,0.1986879,0.007072206,0.0026816241,0.0773828,0.15471259,0.003141682,0.018216683,0.054644473,0.096150115,0.0010827548,0.0031567852
hepatic extrahepatic responses insulin niddm nondiabetic humans assessment absence artifact introduced tritiated nonglucose contaminants well established patients non insulin dependent diabetes mellitus niddm resistant insulin however contribution hepatic extrahepatic tissues insulin resistance remains controversial uncertainty may least part due errors introduced unknowing use previous studies impure isotopes measure glucose turnover determine hepatic extrahepatic responses insulin absence errors steady state glucose turnover measured simultaneously h c glucose sequential h infusions insulin rates mu kg min diabetic nondiabetic subjects low insulin concentrations h c glucose gave similar estimates glucose turnover hepatic glucose release equal zero nondiabetic subjects persistent glucose release p less decreased glucose uptake p less observed diabetic patients high insulin concentrations isotopes underestimated glucose turnover st h initiation high dose insulin infusion time p less required reachieve steady state niddm nondiabetic subjects steady state h c glucose systematically underestimated p less glucose turnover groups due presence tritiated nonglucose contaminant percentage radioactivity plasma due tritiated contaminants linearly related turnover,C18,0.0017295268,0.0015310806,0.027943164,0.0009697896,0.0105978735,0.010581212,0.15618514,0.0016287056,0.0012478476,0.010013725,0.016859798,0.012612938,0.16580819,0.004710991,0.034921937,0.29005378,0.04432613,0.001781228,0.0019653465,0.03001886,0.15540214,0.017322423,0.0017881758
management brittle diabetes preprogrammable implanted insulin pump delivering intraperitoneal insulin objective glycaemic control young woman brittle diabetes design use preprogrammable fully implanted pump infusaid deliver insulin intraperitoneally variable rates giving total dose units h setting endocrinology department teaching hospital patient thirty year old woman years history brittle diabetes main outcome measures glycated haemoglobin concentration plasma glucose concentration results implantation pump immediate sustained improvement diabetic control patient glycated haemoglobin concentration decreased seven months daily glucose concentrations range mmol l admitted hospital since implantation pump eight months time writing conclusion implanted programmable intraperitoneal insulin pump may value management patients brittle diabetes attempts glycaemic control failed,C18,0.0023281008,0.0020760335,0.025947778,0.0013080649,0.0032418068,0.02642977,0.16850045,0.0021893743,0.0016831133,0.0022874959,0.028033935,0.14178081,0.08355362,0.039159615,0.0133325495,0.08251862,0.14389433,0.002397558,0.0026830577,0.07321799,0.15021427,0.00082662405,0.0023950643
haplotype analysis human apolipoprotein b mutation associated familial defective apolipoprotein b haplotype analysis conducted mutant allele unrelated subjects heterozygous mutation codon amino acid human apolipoprotein b mutation associated defective binding low density lipoprotein low density lipoprotein receptor moderate hypercholesterolemia ten markers used haplotyping eight diallelic markers within structural gene two hypervariable loci flanking gene seven eight unequivocally deduced haplotypes identical one revealed minor difference one hypervariable loci genotypes six affected subjects consistent assigned haplotype data consistent common ancestral chromosome provide evidence recurrent mutation potentially hypermutable cg dinucleotide despite fact mutation rare,C18,0.002880217,0.01648936,0.019274147,0.0016182765,0.0040259645,0.0037170702,0.24617204,0.030569661,0.0020822687,0.0028299824,0.04559366,0.0060149976,0.057735473,0.0070028016,0.11406564,0.004485097,0.02481392,0.046257988,0.0032795507,0.048878238,0.05703166,0.0010226604,0.25415933
behavioral covariates waist hip ratio rancho bernardo examined lifestyle dietary habits men women mean age years completed interview examination food frequency questionnaire waist hip ratio increased age body mass index men women multiple regression waist hip ratio independently associated smoking alcohol consumption exercise men smoking alcohol consumption women data suggest waist hip ratio affected least part behavioral potentially modifiable factors,C18,0.003773402,0.021612717,0.0070407763,0.0021201207,0.0052543427,0.0048697717,0.20199701,0.0035485527,0.0027280017,0.0037075889,0.06500008,0.0077611664,0.14958167,0.0089536905,0.0033182343,0.024127368,0.05455476,0.022068711,0.0042965733,0.34527448,0.0531893,0.0013397979,0.0038819367
glucagon catecholamine pancreatic polypeptide secretion type diabetic recipients pancreas allografts successful pancreas transplantation type diabetic patients restores normal fasting glucose levels biphasic insulin responses glucose however virtually data pancreas recipients available relative islet hormonal responses hormonal counterregulation hypoglycemia consequently glucose glucagon catecholamine pancreatic polypeptide responses insulin induced hypoglycemia stimulation arginine secretin examined diabetic pancreas recipients type diabetic nonrecipients nondiabetic normal control subjects glucose recovery insulin induced hypoglycemia pancreas recipients significantly improved basal glucagon levels significantly higher recipients compared nonrecipients normal subjects glucagon responses insulin induced hypoglycemia significantly greater pancreas recipients compared nonrecipients similar observed control subjects glucagon responses intravenous arginine significantly greater pancreas recipients observed nonrecipients normal subjects differences observed epinephrine responses insulin induced hypoglycemia differences pancreatic polypeptide responses hypoglycemia observed comparing recipient nonrecipient groups less observed control subjects data demonstrate significant improvement glucose recovery hypoglycemia associated improved glucagon secretion type diabetic recipients pancreas transplantation,C18,0.0014578826,0.008348102,0.073257014,0.000819457,0.0020301933,0.0018814735,0.066413015,0.0013710104,0.0010539843,0.0014324553,0.020834448,0.017743587,0.24571371,0.0035600122,0.057718985,0.1716304,0.04128586,0.0015048492,0.022817066,0.013496461,0.22246803,0.00051764114,0.022644302
origin spread glucose phosphate dehydrogenase variant g pd mediterranean middle east common glucose phosphate dehydrogenase g pd variant characterized severe enzyme deficiency b like electrophoretic mobility called g pd mediterranean found different populations around mediterranean sea sequence analysis italian subjects revealed molecular basis g pd mediterranean single c transition nucleotide position causing serine phenylalanine replacement amino acid position g pd mediterranean subjects also silent c transition without amino acid replacement nucleotide position twenty one unrelated individuals saudi arabia iraq iran jordan lebanon israel severe g pd deficiency b like electrophoretic mobility tested mutations using amplification followed digestion appropriate restriction enzymes one mutation one mutation another unrelated middle eastern individuals normal g pd activity known g pd deficient similarly tested four silent mutation position absence deficiency mutation position conclude large majority middle eastern subjects g pd mediterranean phenotype mutation found italy silent mutation independent polymorphism middle east frequency mutation leading g pd mediterranean deficiency probably arisen chromosome already carried silent mutation,C18,0.0021652733,0.0019139403,0.004025945,0.0012122936,0.089335635,0.023666358,0.19988501,0.0020290771,0.0015598825,0.0021200145,0.03718293,0.0044378666,0.054441962,0.02105825,0.03322166,0.035132512,0.051530827,0.023954166,0.002456798,0.069601364,0.08391822,0.00076610193,0.2543839
mechanisms impaired growth hormone secretion genetically obese zucker rats roles growth hormone releasing factor somatostatin gh secretion markedly blunted obesity however mechanism mediating response remains elucidated present study examined involvement two hypothalamic gh regulatory hormones gh releasing factor grf somatostatin srif using genetically obese male zucker rat spontaneous gh insulin glucose secretory profiles obtained free moving chronically cannulated rats revealed marked suppression amplitude duration gh pulses obese zucker rats compared lean littermates mean h plasma gh level vs ng ml p less obese rats also exhibited significant hyperinsulinemia presence normoglycemia plasma gh response iv bolus microgram rat grf nh administered peak trough periods gh rhythm significantly attenuated obese rats peak vs ng ml p less although trough times passive immunization obese rats specific antiserum srif failed restore amplitude gh pulses normal values mean h plasma gh level obese rats given srif antiserum significantly different obese rats administered normal sheep serum pituitary wet weight pituitary gh content concentration reduced obese group measurement hypothalamic grf immunoreactivity revealed significant p less reduction mediobasal hypothalamic grf content obese rats pg fragment compared lean controls pg fragment although significant difference observed hypothalamic srif concentration peripheral srif immunoreactive levels significantly p less elevated pancreas stomach obese rats results demonstrate genetically obese zucker rat exhibits marked impairment spontaneous grf induced gh release cannot reversed srif immunoneutralization significant reduction pituitary gh concentration depressed hypothalamic grf content elevated gastric pancreatic hypothalamic srif levels findings suggest defect pituitary gh secretion observed genetically obese zucker rat due least partially insufficient stimulation hypothalamic grf srif play significant role,C18,0.0013018682,0.026343374,0.015019224,0.0070151226,0.0077297115,0.0016796461,0.09838974,0.0012405504,0.00094092236,0.0012787945,0.006391362,0.009354793,0.1407853,0.02137233,0.0011445011,0.027217971,0.013355074,0.024031263,0.020363143,0.016320722,0.55053455,0.0004621133,0.00772798
southern blood club symposium update selected aspects hemochromatosis genetic epidemiology studies indicated hereditary hemochromatosis hh occurs caucasians frequency per thousand clinical recognition however occurs far less frequently disparity best resolved defining hh homozygosity hla linked hemochromatosis allele regardless total body iron burden variability clinical expression explained part physiologic iron loss women variability males may due environmental factors gene gene interactions polymorphisms mutated hemochromatosis alleles although clinical variability great laboratory phenotype hh fairly constant marked elevation transferrin saturation elevated transferrin saturation occurs early life organ iron loading occurs used screening tool detect hh organ damage occurs cloning characterizing hh gene located within centimorgan hla locus resolve issues concerning clinical variability,C18,0.002498807,0.0022146886,0.01673473,0.0014027882,0.015537534,0.0032221084,0.3268719,0.014425787,0.0018049957,0.0024531444,0.028911147,0.005135214,0.11252397,0.0059466134,0.011925653,0.02803644,0.025572754,0.01482663,0.027006641,0.08345007,0.1357828,0.0008864839,0.13282908
induction insulin resistance vivo amylin calcitonin gene related peptide hyperinsulinemic glucose clamp studies intravenous infusion calcitonin gene related peptide cgrp rats antagonized ability insulin stimulate peripheral glucose disposal vs mumol kg min p less inhibit hepatic glucose output p less cgrp also inhibited vitro effects insulin stimulate hexose uptake cultured bc h myocytes insulin concentrations studied amylin peptide isolated amyloid deposits pancreatic islets type ii non insulin dependent diabetic subjects present normal beta cells bears striking homology cgrp synthetic human amylin infused clamp studies inhibited ability insulin stimulate glucose disposal vs mumol kg min p less suppress hepatic glucose output therefore amylin cgrp cause insulin resistance vivo may implicated insulin resistant states type ii diabetes mellitus,C18,0.0023813196,0.0021123495,0.004447626,0.0013381193,0.0033159123,0.0722281,0.16689312,0.002239422,0.0017215882,0.0023397864,0.011040428,0.016829873,0.09349144,0.07579935,0.0020940725,0.21818407,0.020892749,0.015885897,0.014220213,0.03478909,0.2222902,0.0008455201,0.014619727
assessment cardiac function patients morbidly obese cardiac function patients morbidly obese studied bariatric surgery twelve patients studied months surgery patients mean age years body mass index kg cardiac function measured echocardiography radionuclide angiography scanning right heart catheterization determine degree cardiac dysfunction patients studied exercise intravenous fluid challenges ultrasonography produced evidence myocardial thickening increased interventricular septum eight patients increased left ventricular mass patients radionuclide scan suggested morbid obesity associated significantly p less increased end diastolic volume decreased left ventricular ejection fraction compared patients normal weight exercise patient normal weight increase end diastolic volume stroke volume heart rate patient morbidly obese increased heart rate produce necessary increase cardiac output right heart catheterization indicated relationship pulmonary wedge pressure left ventricular stroke work index abnormal patients depressed six patients exercise one liter fluid caused abnormal relationship pulmonary wedge pressure left ventricular stroke work index patients depressed response patients cardiac studies repeated patients kg weight loss echocardiography indicated decrease dilatation significant p less decrease hypertrophy weight loss radionuclide right heart catheterization studies indicated improved cardiac function reduced filling pressures increased left ventricular work fluid exercise challenges results support presence obesity related cardiomyopathy ventricular dysfunction appears caused noncompliant ventricle significant weight loss achieved gastroplasty results increased ventricular compliance improved cardiac function,C18,0.023908969,0.030905489,0.008264465,0.0006920449,0.0017255219,0.0015955478,0.0835054,0.019044481,0.000890468,0.0012102227,0.034240346,0.008662986,0.20276509,0.0029969232,0.0010831305,0.013806388,0.2598548,0.0071808146,0.0014024775,0.07688966,0.18785729,0.030250363,0.0012671328
serial evaluation lipid profiles risk factors development hyperlipidemia cardiac transplantation determine prevalence time course factors responsible hyperlipidemia heart transplantation consecutive year survivors studied year patients serum total cholesterol levels greater mmol liter mg dl patients serum total cholesterol higher age sex matched ninety fifth percentile end year follow serum total cholesterol correlated recipient age p less preoperative cholesterol level p less actual dose maintenance prednisone year p less cumulative year steroid dose p less similarly serum triglyceride level year correlated pretransplant level serum triglycerides p less recipient age p less cumulative year steroid dose p less patients pretransplant diagnosis coronary artery disease significantly higher level serum total cholesterol triglyceride levels year p less p less respectively heart transplant recipients body mass index greater equal kg also presented significantly elevated serum total cholesterol triglyceride levels year compared nonobese patients p less p less respectively hyperlipidemia occurs frequently detected within first month heart transplantation optimal management problem requires study,C18,0.0015446162,0.0013701515,0.0029469135,0.0008678568,0.009626855,0.0019934075,0.10329325,0.0014525757,0.0011166887,0.001517676,0.020433914,0.0032349154,0.21851632,0.003836617,0.08885406,0.009879051,0.19433205,0.008982624,0.0017587726,0.09148931,0.22333491,0.008023613,0.001593848
cholesterol lowering effects soluble fiber cereals part prudent diet patients mild moderate hypercholesterolemia soluble fiber breakfast cereals examined cholesterol lowering ability male patients mild moderate hypercholesterolemia randomized double blind placebo controlled study patients followed step diet minimum wk randomly assigned groups incorporating either corn flakes one two soluble fiber cereals pectin enriched psyllium enriched diet additional wk diet phase total cholesterol dropped cereal plus diet phase total ldl cholesterol values pectin enriched cereal group dropped additional p p respectively dropped p p respectively psyllium enriched cereal group cereal plus diet phase significant effects hdl cholesterol triglyceride body weight found within cereal groups results support use soluble fiber cereals effective well tolerated part prudent diet treatment mild moderate hypercholesterolemia,C18,0.0028013273,0.0024849172,0.005226986,0.015126727,0.0039007596,0.003615259,0.1658368,0.0026344021,0.002025235,0.0027524687,0.013198421,0.077191874,0.13504763,0.075629726,0.043276023,0.045044918,0.08173681,0.0028849028,0.016737906,0.058440614,0.24052976,0.0009946496,0.0028819023
increased overnight growth hormone concentrations diabetic compared normal adolescents determine extent spontaneous plasma gh concentrations abnormal adolescents insulin dependent diabetes mellitus performed h overnight plasma gh profiles diabetic adolescents males females aged yr median yr healthy adolescent controls males females aged yr median yr data analyzed using pulse detection program pulsar time series analysis presented respect age puberty stage mean maximum gh concentrations sum peak amplitudes mean calculated baseline concentrations normal children higher puberty highest levels seen girls puberty stages boys stages similar pattern observed diabetic adolescents measures pulse height mean calculated baseline concentrations significantly greater normal subjects multivariate analysis p less pulse frequency change puberty normal diabetic subjects dominant pulse periodicity groups min conclude predominant change gh release puberty pulse amplitude increased diabetes whereas pulse frequency remains constant normal diabetic adolescents,C18,0.002071348,0.001837389,0.0038649205,0.001163806,0.0028842865,0.022574462,0.095423646,0.0019479207,0.0014974923,0.035668846,0.037351605,0.0144167645,0.27204463,0.004847077,0.0018214912,0.11066105,0.09378989,0.0021348917,0.010621139,0.04499698,0.23549716,0.0007354604,0.0021477132
increased testosterone type diabetic subjects severe retinopathy diabetic retinopathy rarely occurs puberty suggesting changes sex hormones may influence development condition authors measured serum testosterone estradiol dhea sex hormone binding globulin levels men women type diabetes wisconsin epidemiologic study diabetic retinopathy wesdr population based study diabetic complications mean age years mean duration diabetes years subjects proliferative preproliferative retinopathy greater equal retinopathy level matched duration diabetes years sex subjects minimal retinopathy less equal retinopathy level seven stereoscopic retinal photographs eye obtained photographs read university wisconsin reading center serum testosterone concentrations significantly higher male diabetic subjects proliferative retinopathy ng dl male diabetic subjects minimal retinopathy ng dl p statistically significant differences sex hormones subjects without proliferative retinopathy observed although results regarded preliminary small number subjects support hypothesis testosterone concentrations may associated development retinopathy type diabetic patients,C18,0.0020792424,0.0018372262,0.003864578,0.0011639221,0.0028840308,0.012689602,0.14925069,0.0019477481,0.0014973597,0.012048475,0.057304572,0.004615541,0.15723571,0.004954838,0.025849938,0.084480375,0.10099078,0.002132956,0.022344269,0.16751498,0.17042269,0.0107597485,0.0021307375
diet induced hypercholesterolemia mice prevention overexpression ldl receptors current studies designed determine whether chronic overexpression low density lipoprotein ldl receptors liver would protect mice increase plasma ldl cholesterol induced high fat diets line transgenic mice studied express human ldl receptor gene liver control transferrin promoter fed diet containing cholesterol saturated fat bile acids weeks transgenic mice contrast normal mice develop detectable increase plasma ldl current data indicate unregulated overexpression ldl receptors protect diet induced hypercholesterolemia mice,C18,0.0031418786,0.01799437,0.021040503,0.0017652934,0.00438632,0.0040831994,0.14120522,0.0029546607,0.0022714383,0.0030870803,0.0147961145,0.00651161,0.02581506,0.087909885,0.10918019,0.08068873,0.02708132,0.06911149,0.0035774908,0.046507925,0.30131975,0.0011155669,0.02445496
continuous subcutaneous insulin infusion csii multiple injections mi conventional insulin therapy ct self selecting insulin dependent diabetic patients comparison metabolic control acute complications patient preferences continuous subcutaneous insulin infusion csii multiple injections mi shown metabolic advantages highly selected insulin dependent diabetics idds comparative studies self selected idds mi optimal insulin preparation overnight insulin delivery defined compared conventional injection therapy ct csii mi human isophane insulin mi human isophane human ultralente insulin mi human ultralente respectively bedtime self selected idds idds invited participate individuals entered study indices glycaemic control showed better values csii also mi compared ct differences small fasting blood glucose higher mi human ultralente mi human isophane one subcutaneous abscess one case ketoacidosis requiring hospitalization occurred csii serious hypoglycaemic episodes non significantly increased intensified therapy patients clearly preferred intensified insulin therapy approximately one half csii,C18,0.00199118,0.0017662761,0.003774906,0.020390188,0.0027726553,0.0025697215,0.2364006,0.0018725299,0.011074758,0.0019564515,0.05819029,0.036874734,0.12482051,0.045892097,0.0017509935,0.15685429,0.13339655,0.0020505853,0.0022672515,0.044875823,0.1056519,0.0007069957,0.0020986767
autoxidative glycosylation possible involvement peroxides free radicals ldl modification glucose postulated etiology complications diabetes involves oxidative stress perhaps result hyperglycemia consistent hypothesis shown glucose physiological conditions produces oxidants possess reactivity similar hydroxyl free radical oxidants hydroxylate benzoic acid fragment protein induce peroxidation phosphatidylcholine liposomes low density lipoprotein ldl ldl incubated hyperglycemic levels glucose vitro reactions accelerated transition metals inhibited metal chelating agent atherosclerotic potential ldl diabetes mellitus often discussed terms protein glycosylation may affect cellular interactions studies demonstrate however peroxidative reactions also accompany ldl glycosylation vitro peroxidative modification ldl also implicated ldl atherogenicity studies indicate glycosylation peroxidation occur concomitantly ldl modified glucose vitro may contribute behavioral changes lipoprotein,C18,0.0025277785,0.0022422657,0.016887072,0.0014202556,0.0035201535,0.0032622297,0.37517563,0.0024071424,0.0018274713,0.0024836909,0.024355019,0.0052104257,0.024254933,0.02510376,0.14903168,0.065120175,0.04737045,0.051539257,0.0028782475,0.059022315,0.13086207,0.00089752226,0.0026004852
multinational project childhood diabetes diamond project group insulin dependent diabetes mellitus iddm one important chronic diseases children worldwide iddm leads fold excess risk mortality developed countries whereas developing countries cases die within years fold international gradient iddm incidence reported epidemic periods identified new world health organization program multinational project childhood diabetes diabetes mondiale diamond developed investigate characterize global incidence mortality health care yr study collect population based data concerning iddm greater centers countries worldwide goals diamond collect standard information incidence risk factors mortality associated iddm evaluate efficiency effectiveness health care economics diabetes establish national international training programs diabetes epidemiology hoped diamond project instrumental prevention serious disease sequelae,C18,0.0025588016,0.027042156,0.0047744582,0.0014376863,0.0035630502,0.0033022668,0.286693,0.002406328,0.0018498997,0.015562062,0.09790242,0.042408388,0.045284074,0.0059091137,0.0022501454,0.06510638,0.055278897,0.002771126,0.06205669,0.2223693,0.04592431,0.0009085375,0.0026408832
association elevated fasting c peptide level increased intra abdominal fat distribution development niddm japanese american men japanese american population king county washington known high prevalence non insulin dependent diabetes mellitus niddm part community based study reexamined second generation japanese american men initially classified nondiabetic mean follow period mo men developed niddm remained nondiabetic variables measured initial visit distinguished diabetic men nondiabetic men older age higher serum glucose level h g oral glucose higher fasting plasma c peptide level increased cross sectional intra abdominal fat area determined computed tomography older age higher h glucose levels variables associated development niddm association higher fasting c peptide level greater intra abdominal fat area subsequent development niddm new observations elevated fasting c peptide level persisted adjustment fasting serum glucose elevated c peptide level represents hypersecretion insulin interpreted reflect compensatory response underlying insulin resistant state antedates development niddm fasting c peptide level correlated intra abdominal fat area suggesting intra abdominal fat area may associated insulin resistance thus individuals develop niddm insulin resistance increased insulin secretion increased intra abdominal fat present diabetic glucose tolerance demonstrated,C18,0.001407927,0.0012489016,0.0026270458,0.0007910568,0.01557647,0.015447032,0.17586723,0.0013240316,0.0010178686,0.0013833711,0.043040954,0.002895837,0.024837052,0.010113168,0.028485324,0.18318556,0.021240834,0.0014499314,0.02203597,0.15144862,0.2926267,0.00049990375,0.0014492049
antigen identification human cell lymphocyte proliferation sites immune responses normal retinal proteins including antigen demonstrated patients variety retinal disorders well received panretinal laser photocoagulation cell lymphocytes cells implicated pathogenesis several ocular inflammatory diseases possible autoimmune etiology used synthetic peptides correspond amino acid sequence antigen lymphocyte proliferation assays identify specific sites molecule recognized human cells ten patients type ii diabetes studied initial panretinal laser photocoagulation proliferative diabetic retinopathy cell responses expressed stimulation index antigen peptides negative patients treatment three weeks panretinal laser photocoagulation eight assays positive stimulation index greater p less lymphocytes stimulated peptide bsa six nine positive p less peptide bsa six six positive p less peptide bsa study identifies several specific sites antigen elicit human immune responses implications findings regard pathogenesis treatment autoimmune uveitis discussed,C18,0.001991165,0.0017662628,0.0037153077,0.0011187829,0.0027728383,0.0025697025,0.2766089,0.0018725159,0.0014395238,0.0019564368,0.04011912,0.004687264,0.066184476,0.23819588,0.0017509804,0.012729004,0.100494504,0.013914281,0.0022672345,0.047679182,0.15233186,0.0007069904,0.023127766
physiological pharmacological stimulation pancreatic islet hormone secretion type diabetic pancreas allograft recipients successful heterotopic denervated pancreas allograft transplantation pat often results normoglycemia peripheral hyperinsulinemia insulin dependent type diabetic recipients contribution altered hepatic insulin extraction hie resulting hyperinsulinemia patients remains uncertain furthermore whether denervated pancreas allografts exhibit beta cell hyperresponsiveness physiological pharmacological stimulation controversial evaluated beta cell function hie successful whole cadaveric pat systemic venous drainage type diabetic patients mixed meal intravenous glucose glucagon administration results compared nondiabetic patients kidney transplantation native innervated pancreases portal insulin delivery receiving equivalent triple immunosuppressive therapy cyclosporin azathioprine prednisone healthy control subjects family history diabetes pat fasting poststimulation serum glucose concentrations normalized pat associated marked basal hyperinsulinemia fold assessed immunoreactive insulin iri levels type diabetic patients mean se pm compared control subjects pm nondiabetic kidney transplantation patients pm mixed meal ingestion mean incremental integrated insulin area similar pat patients nm min compared kidney transplantation patients nm min healthy control subjects nm min basal serum c peptide levels significantly greater pat nm kidney transplantation nm patients healthy control subjects nm p less,C18,0.001533436,0.0013602342,0.0250852,0.009827859,0.00221504,0.01681338,0.10006749,0.016273605,0.008527752,0.008892024,0.0072340034,0.01697658,0.18100655,0.019979723,0.031005273,0.13035133,0.15168358,0.0098512,0.009149876,0.015162917,0.22003615,0.0005444674,0.016422369
insulin mimetic effects vanadate possible implications future treatment diabetes vanadate ions low molecular weight phosphate analogues mimic rapid actions insulin various cell types administered orally diabetic hyperglycemic rats vanadate reaches circulation mimics insulin stimulation glucose uptake metabolism leads normoglycemic partial anabolic states addition vanadate restores tissue responsiveness insulin hepatic glycogen levels activates new synthesis key enzymes carbohydrate metabolism suggests correcting hyperglycemia sufficient correct typical metabolic alterations found streptozocin induced diabetic rats several weeks oral administration vanadate diabetic rats produced detectable liver kidney toxicity mechanism vanadate mimics actions insulin still obscure unlike insulin vanadate seem stimulate autophosphorylation endogenous tyrosine phosphorylation insulin receptor kinase intracellular proteins either directly virtue known inhibitory effect protein phosphotyrosine phosphatase results many studies support model vanadate activates glucose metabolism either utilizing alternative insulin independent cascade bypassing early events insulin dependent cascade either possibilities clinical importance early insulin events may become defective result severe hyperinsulinemia may contribute insulin resistance alternative pathways vanadate may stimulate glucose metabolism e g increasing intracellular ca levels regulating intracellular intravesicular ph discussed clinical perspective studies continued evaluating level vanadate toxicity prolonged treatment searching agents potentiate insulin mimetic actions vitro vivo,C18,0.0014298019,0.008161149,0.0026639411,0.0008019584,0.0019874736,0.015657231,0.31077334,0.008242332,0.0010318762,0.0014091892,0.008510142,0.015582741,0.04147955,0.067896925,0.008160053,0.17842339,0.05535651,0.051374473,0.0016251939,0.010658613,0.20679055,0.00050678325,0.001476803
fasting postprandial concentrations somatostatin somatostatin type ii diabetes men recent evidence suggests somatostatin srif cleaved prosomatostatin cells upper intestine acts nutrient stimulated inhibitor insulin secretion healthy men role srif pathophysiology diabetes previously explored although several groups measured circulating somatostatinlike immunoreactivity sli diabetic subjects investigate possible mediation abnormal insulin secretion diabetes srif plasma levels measured non insulin dependent diabetic men age weight matched control subjects concentrations srif sli also obtained subjects admitted study overnight fast blood collected min intervals h fat meal plasma samples analyzed srif srif specific methods basal glucose levels diabetic men significantly higher control subjects vs mm insulin levels similar vs pm diabetic men significantly lower basal srif levels control subjects vs pm p fat intake srif levels throughout h study indistinguishable two groups vs basal basal srif sli levels significantly different two groups srif sli concentrations rose similarly meal correlations basal srif glucose insulin levels,C18,0.001725321,0.0015304459,0.0032192701,0.0009694513,0.0024024548,0.01891897,0.11560722,0.0016226621,0.0012473303,0.0016952293,0.06762109,0.03193634,0.14352919,0.015370362,0.0015197081,0.14313197,0.01511922,0.0017767947,0.02699912,0.078565925,0.32309797,0.00061259884,0.0017813077
cytomegalovirus rasmussen encephalitis situ hybridisation biotinylated cytomegalovirus cmv dna probe done brain biopsy specimens patients rasmussen encephalitis age matched control patients neurological diseases patients intractable epilepsy focal neurological deficits perivascular cuffing microglial nodules astrogliosis neuronal loss cmv genomic material demonstrated patients neurons astrocytes oligodendrocytes endothelial cells control patients probes herpes simplex virus hepatitis b virus negative patients fibroblast controls results suggest cmv likely cause rasmussen encephalitis,C02,0.025808878,0.0039196056,0.008244832,0.045262136,0.006154268,0.0057025603,0.25356793,0.025536949,0.003194522,0.0043416303,0.031822752,0.009603639,0.06310172,0.052929904,0.0038856918,0.006880832,0.16730355,0.0045505264,0.005031338,0.10973221,0.093136124,0.0015689192,0.068719484
impact cytomegalovirus infection organ transplant recipients cytomegalovirus cmv single important infectious agent affecting recipients organ transplants least two thirds patients cmv infection months transplantation latently infected allografts major exogenous source cmv infection transplant recipients although leukocyte containing blood products also transmit virus three patterns cmv infection recognized primary infection reactivation infection superinfection primary infection greatest clinical impact clinical effects cmv infection include infectious disease syndromes pneumonia chorioretinitis immunosuppressed state predisposes potentially lethal opportunistic infection initiation process result allograft injury progress made controlling cmv infection hyperimmune anti cmv globulin certain antiviral drugs appear promising prophylaxis combination hyperimmunoglobulin ganciclovir appears promising therapy,C02,0.016588097,0.0025191838,0.019033743,0.015336751,0.018032447,0.003665113,0.44783637,0.0026707302,0.0020531628,0.0027904247,0.019997671,0.019993063,0.061345845,0.0072136046,0.0024973867,0.004422404,0.10040186,0.0029334654,0.025595441,0.049376097,0.1539854,0.0010083657,0.02070335
cd monocyte counts persons hiv infection early increase followed progressive decline study asked whether difference number cd cd peripheral blood monocytes cd cells decrease hiv mediated immunodeficiency monocytes cells hiv positive hiv negative persons analyzed flow cytometry hiv positive patients represented entire spectrum cd cell counts report cd cells decrease number cd monocytes decrease parallel moreover significantly higher cd monocyte counts observed persons early stage hiv disease e greater cd cells mm hiv negative persons greater cd cells mm potential implications findings discussed,C02,0.0030947106,0.0027451627,0.005774409,0.0017387916,0.0043092864,0.018969426,0.25315166,0.0029103032,0.017213907,0.003040735,0.057760704,0.006435283,0.083055526,0.1429413,0.0027214102,0.0048191077,0.09237072,0.0032144953,0.0035237833,0.033851393,0.25205785,0.0010988193,0.0032011862
occurrence groups b respiratory syncytial virus years associated epidemiologic clinical characteristics hospitalized ambulatory children years respiratory syncytial virus rsv isolates hospitalized ambulatory children examined strain group subset subgroup determine associated epidemiologic clinical characteristics three patterns yearly outbreaks existed strong predominance group strains years strains relatively equal proportions group b strains years strong predominance group b strains years separated decade first pattern highly dominant strains occurred cycles consecutive years single intervening year b strains greater equal isolates subgroups predominated b occurred almost equally greater clinical severity group strains suggested children group infections requiring intensive care significantly often vs p strongly dominant strain years associated higher proportions rsv admissions requiring intensive care vs p less strains subgroups b frequently found hospitalized patients outpatients years highest rates intensive care admissions subgroup dominated,C02,0.0021578383,0.0019141104,0.014460537,0.0012124014,0.0030047216,0.0027848028,0.2550163,0.0020292574,0.0015600211,0.064798206,0.04423948,0.11279096,0.035597622,0.004982302,0.0018975487,0.013999654,0.07828959,0.0022222158,0.0024570164,0.2422989,0.076782785,0.011210138,0.024293557
measles update incidence measles united states dramatically increased low cases cases family physicians help reverse trend following revised immunization schedule includes measles mumps rubella mmr booster preschool age children new guidelines also recommend either two dose mmr schedule serologic evidence immunity required persons entering college employed medical field immunization policies physician offices ensure office staff acquired measles immunity triage policy separating patients rash illnesses utilized mild upper respiratory illness history seizures nonanaphylactic egg allergy asymptomatic human immunodeficiency virus infection contraindications measles vaccine cases measles reported local health department,C02,0.003142441,0.0027875018,0.0058634686,0.03218921,0.0043757493,0.004152538,0.19312477,0.0029554442,0.0022718448,0.035747405,0.13099779,0.024357598,0.04098285,0.029061625,0.017974582,0.03528785,0.109660156,0.0032361932,0.057722457,0.12548228,0.09828979,0.0011157666,0.03922063
measles antibody reevaluation protective titers school blood drive measles outbreak permitted correlation preexposure measles antibody titers clinical protection using plaque reduction neutralization prn test eia donors detectable preexposure prn titer less equal met clinical criteria measles seroconfirmed compared none preexposure prn titers greater p less seven donors preexposure prn titers greater equal fold rise antibody titer mean fold compared none preexposure prn titer greater equal p less noncases preexposure prn titer less reported one symptoms compared donors preexposure prn titers greater equal p less eia case detectable preexposure antibody preexposure geometric mean titer asymptomatic donors significantly higher symptomatic donors meet clinical criteria measles p study suggests prn titers less equal protective measles disease illness without rash due measles may occur persons prn titers level,C02,0.0026600424,0.0023570706,0.0049580624,0.0014929732,0.0037000692,0.029148242,0.20451073,0.0024988647,0.014759018,0.016648237,0.11072691,0.0054654013,0.21028963,0.044700626,0.002336676,0.004193734,0.07748156,0.10008431,0.003025615,0.03575384,0.08094043,0.03953432,0.002733631
situ hybridisation digoxigenin labelled dna probes detection viral genomes applicability recently developed non radioactive dna labelling detection method uses digoxigenin dig enzyme linked immunosorbent assay elisa system detection viral infections pathology specimens situ hybridisation examined efficacy compared biotin radioisotope labelling methods three cases progressive multifocal leucoencephalopathy two verruca vulgaris seven cases laryngeal papilloma studied sensitivity dig labelled probe almost labelled probe dot blot hybridisation test using situ hybridisation labelled dig labelled probes levels hybridised signals detected similar biotin labelled probe less sensitive particularly cases laryngeal papilloma dig labelling detection method highly sensitive applicable detection viral infection ish preferable radiolabelled probe especially situ hybridisation done pathology laboratory,C02,0.002727227,0.0024191865,0.05583443,0.0015323177,0.0037975775,0.029898977,0.2960294,0.0025647175,0.001971664,0.002679661,0.2211132,0.005626034,0.0393781,0.13041118,0.0023982548,0.0045870226,0.023981545,0.0028085918,0.0031053494,0.032678615,0.09058091,0.0009683393,0.042907704
immunocytochemical analysis lymph node aspirates patients human immunodeficiency virus infection thirty four patients positive human immunodeficiency virus hiv lymphadenopathy investigated using fine needle aspiration cytological analysis included immunocytochemical investigation alkaline phosphatase antialkaline phosphatase apaap method patients confirmation cytological diagnosis lymph node biopsy fifteen aspirates follicular hyperplasia evaluated eleven patients showed b cell predominance b cell population show light chain restriction ten patients b cell non hodgkin lymphoma five burkitt lymphoma five b cell immunoblastic lymphoma investigated nine cases monoclonal respect light chain determinants one case burkitt lymphoma partial lymph node metastasis show light chain restriction cytological diagnosis included two mycobacterial infections four cystic lesions histological investigation necessary diagnose extent lymph node disease caused kaposi sarcoma findings indicate immunocytological investigation lymph node aspirates useful evaluating lymphadenopathy hiv positive patients,C02,0.0030047512,0.0026653642,0.020149361,0.0016882471,0.018729443,0.0038777879,0.22081694,0.017366605,0.0021723013,0.01746128,0.17789929,0.006180199,0.018849831,0.08987549,0.0026423023,0.019219946,0.13194682,0.0030943954,0.003421351,0.05240535,0.16362686,0.001066878,0.021839237
hiv hiv cross reactive cytotoxic cell epitope hla b restricted hiv gag cytotoxic lymphocyte ctl epitope highly conserved amongst hiv isolates one hiv eli single amino acid substitution region hiv differs five amino acids broadly cross protective aids vaccine protect infection isolates hiv hiv tested ctl specific hiv epitope peptide analogues hiv eli hiv two simian immunodeficiency virus siv isolates recombinant vaccinia viruses expressing respective gag genes determine whether cross reactivity ctl epitope ctl hiv infected donor could recognize hiv eli peptide hiv peptide recombinant vaccinia virus infected target one two siv peptide treated targets epitopes exhibit cross reactivity may valuable vaccine design,C02,0.0032407618,0.0028747173,0.037408333,0.0018216487,0.020198239,0.00419641,0.22322567,0.0030476516,0.0023429266,0.003184239,0.036350515,0.006665628,0.020110888,0.028772011,0.002849844,0.00504654,0.03242574,0.15498602,0.003690084,0.036258955,0.13861021,0.0011506767,0.23154227
treatment adult chickenpox oral acyclovir thirty one late adolescents adults varicella studied patients identified within hours varicella exanthem offered open treatment acyclovir g patients identified hours exanthem followed treated twenty two patients treated acyclovir nine patients treated severe complications occurred patients minor complications including prolonged fever localized secondary infections persistent cough prolonged fatigue frequent untreated group acyclovir therapy begun within first hours varicella exanthem rash clinical illness dramatically lessened treatment oral acyclovir considered varicella adults identified within first hours exanthem,C02,0.0031499017,0.002787051,0.00586252,0.0017653237,0.0043750415,0.025996672,0.28361848,0.0029598102,0.0022714774,0.0030871332,0.036661185,0.02167297,0.03735224,0.0072242734,0.0027629363,0.004892642,0.33012405,0.0032356696,0.0035775523,0.10009636,0.09698461,0.001115586,0.018426571
measles israel west bank gaza continuing incidence case new eradication strategy measles continues occur epidemic waves israel gaza west bank causing morbidity mortality israel immunization infants measles began immunized mid gaza west bank immunization infants measles began respectively immunization rate reached late increased greater measles epidemics previously occurred year cycles occurred every years affected individuals older affected previous years israel commitment eradicating measles require substantially expanded immunization program comparison traditional program requires immunization infants alone benefits several alternative immunization strategies considerably exceed costs new two dose immunization needed minimal strategy campaign administering booster doses school aged children may required well achieve control eradication measles measles serious preventable public health problem appropriate strategies must devised national international public health officials control disease developing developed countries,C02,0.002437925,0.002162561,0.016339138,0.0013697706,0.0033947334,0.014928297,0.3322696,0.0022926542,0.0017625112,0.025981389,0.03530553,0.034873806,0.034589417,0.0056055426,0.013914312,0.027637504,0.087544434,0.0025106585,0.046856575,0.19493468,0.109914586,0.0008656186,0.0025087239
use single fiber emg macro emg study reinnervation use single fiber emg macro emg studies reinnervation discussed sfemg gives information changes topography motor unit function transmission terminal nerve motor endplate muscle fiber dynamics reinnervation may studied technique amount reinnervation obtained macro emg studies capacity reinnervation discussed conditions well factors limit reinnervation process,C02,0.004418605,0.0039195227,0.029624524,0.0024826338,0.006152767,0.0057024397,0.29241332,0.0041553094,0.024585146,0.0043415385,0.103983924,0.00926881,0.099524155,0.102788016,0.0038856096,0.028266035,0.040046785,0.0045504305,0.026417851,0.033348355,0.14043128,0.001568886,0.028124064
increasing incidence varicella hospitalizations united states army navy personnel today teenagers susceptible recruits vaccinated hospital records united states army navy adult varicella chickenpox admissions reviewed annual hospital admission rates varicella increased fourfold active duty army fold among active duty navy enlisted personnel fifty seven percent varicella admissions occurred junior military members aged half total varicella admissions occurred personnel less year military service multivariate analysis navy data confirmed increasing time related trends risk suggesting national temporal trend increased varicella susceptibility us teenagers young adults administering safe effective varicella vaccine army navy recruits could prevent hospital bed days first year use,C02,0.0033457289,0.01916302,0.006242783,0.0018798285,0.0046588215,0.020484757,0.19374211,0.003146364,0.002418813,0.003287375,0.031566568,0.007097341,0.04931298,0.007692978,0.0029422583,0.037284065,0.21117185,0.003685809,0.036194727,0.22197096,0.12808098,0.0011879468,0.0034419624
effect vaccination serotype specific antibody responses infants administered wc bovine rotavirus natural rotavirus infection evaluation wc bovine rotavirus serotype vaccine infants subjects experienced natural serotype rotavirus infection vaccination others therefore effects wc natural rotavirus strains either primary boosting immunogens serotype specific neutralizing antibody responses could determined primary natural infection symptomatic asymptomatic neutralizing antibody titers highest serotype consistently high serotype low titers greater equal serotypes often detected previous vaccination wc little effect magnitude responses contrast subjects infected serotype strains vaccination experienced large average fold rises neutralizing antibody human serotypes vaccinated wc thus although wc natural strains distinct serotypes epitopes sufficiently similar reinfection wc could boost neutralizing antibody titers human serotypes subjects primed previous natural infection,C02,0.0026232398,0.0023269446,0.0048946934,0.09641058,0.029097442,0.0033854276,0.28103933,0.0024669266,0.0018964856,0.0025774871,0.030902596,0.005499418,0.078582555,0.070266396,0.0023068108,0.019148521,0.046147164,0.028753703,0.0029869443,0.06799527,0.17189895,0.013628532,0.035164572
suppression herpes simplex virus type reactivation latency z hydroxymethyl cyclohexyl methyl guanine l vitro latent herpes simplex virus type hsv infection induced human embryonic lung cells vitro using combination viral replication inhibitors elevated temperature reactivating conditions superinfection human cytomegalovirus temperature manipulation nonantiviral thymidine kinase inhibitor l found suppress delay reactivation hsv latently infected human embryonic lung cells l alone combination interferon ineffective primary acute viral replication inhibitor unable induce latent hsv infection cell culture data suggest initial acute virus replication replication resulting reactivation latency separate events,C02,0.003049735,0.0027052672,0.07948194,0.0017136887,0.049747158,0.06293899,0.2414164,0.0028744822,0.0022048226,0.017757457,0.016749265,0.006272722,0.048817366,0.13792787,0.00268186,0.004749072,0.036108475,0.032645263,0.003472572,0.036096238,0.15450537,0.00108285,0.055001114
routine tool detection assessment epidemics influenza like syndromes france regression model nonepidemic level influenza like syndrome estimated cases collected october august using french communicable diseases computer network start major epidemic detected early size epidemic entire country estimated approximately million cases excess cost sick leave among working age estimated million,C02,0.004238607,0.0037598559,0.007908801,0.0023815003,0.030881314,0.005470143,0.2450481,0.024503741,0.023495829,0.0041646804,0.24051157,0.008718004,0.02634576,0.009765801,0.0037273238,0.027104,0.040401526,0.0043650623,0.0048262775,0.13879232,0.117219605,0.022005167,0.004364971
american blood donors seropositive human lymphotropic virus types ii exhibit normal lymphocyte subsets recent reports demonstrated lymphocyte subsets abnormal japanese blood donors seropositive human lymphotropic virus type htlv determine similar changes characterize american blood donors seropositive htlv ii lymphocyte subsets measured htlv seropositive htlv seronegative blood donors seronegative individuals matched age race gender seropositive individuals peripheral blood mononuclear cells treated panel monoclonal antibody pairs analyzed two color flow cytometry significant differences observed seropositive seronegative groups respect absolute number circulating lymphocytes percentages lymphocytes belonging subsets assessed subsets included b cd cd cells subpopulations cd cd cells defined coexpression markers appear cd hla dr cd disappear leu cd ra activation findings indicate htlv seropositive persons american blood donor pool exhibit lymphocyte subset alterations reported htlv seropositive blood donors japan,C02,0.0024965545,0.0022145684,0.016699884,0.0014028297,0.0034766952,0.0032219337,0.24769476,0.0023477902,0.0018048978,0.0024530115,0.025500672,0.021241305,0.1658005,0.069478065,0.002205122,0.0038975396,0.02709003,0.12333397,0.03908665,0.0556937,0.17936318,0.0008864358,0.0026098813
measles incidence vaccine efficacy mortality two urban african areas high vaccination coverage measles incidence vaccine efficacy mortality examined prospectively two districts bissau vaccine coverage children aged months bandim bandim little difference cumulative measles incidence months age respectively months years age however contracted measles bandim bandim even adjusting vaccination status incidence significantly higher bandim relative risk p even though children measles antibodies vaccination vaccine efficacy confidence interval ci unrelated age vaccination unvaccinated children mortality hazard ratio compared vaccinated children p indicating protective efficacy death ci measles vaccination data suggest necessary vaccinate age months control measles hyperendemic urban african areas,C02,0.0032918213,0.0029200097,0.08582296,0.00184954,0.004583757,0.0042482666,0.081073046,0.0030956685,0.0023798402,0.066980556,0.031063264,0.006936384,0.06250226,0.02444103,0.0028947445,0.021057319,0.11216105,0.00339003,0.0037482227,0.35662982,0.11437513,0.0011688061,0.0033865042
isolation human cell lymphotropic virus type guaymi indians panama human lymphotropic virus type htlv associated adult cell leukemia lymphoma chronic degenerative myelopathy however another major type htlv htlv ii isolated sporadically little known disease associations transmission routes risk factors htlv ii infection recent studies indicate high percentage certain groups v drug users blood donors infected htlv ii seroepidemiologic studies found elevated rate seroreactivity htlv among guaymi indians bocas del toro province panama identify cause seroreactivity among unique population used htlv ii specific polymerase chain reaction techniques detect htlv genetic sequences blood leukocytes three seropositive guaymi indians htlv ii primer amplified polymerase chain reaction products two subjects partially sequenced matched published htlv ii nucleotide sequences p gag bases pol bases regions cd lymphocyte line established one subjects produced htlv ii specific proteins tested antigen capture immunoblot assays well mature htlv particles demonstration htlv ii infection geographically culturally isolated central american indian population without typical risk factors htlv infection suggests htlv ii infection endemic population provides important clue potential natural reservoir virus,C02,0.001991294,0.0017663771,0.0037155482,0.01120107,0.012463986,0.0025698687,0.3629652,0.021137115,0.0014396169,0.0019565634,0.054329775,0.029194558,0.0663029,0.060399562,0.0017591363,0.022367889,0.018039523,0.030958064,0.040815223,0.09845271,0.07933612,0.0007070362,0.07613088
chronic encephalitis caused leukoencephalopathy mentioned previously ms pml demyelinating conditions cns pose diagnostic difficulties differentiation similarities clinical findings however certain features unique diseases helpful clinical diagnosis ms unlike pml disease unknown cause polygenetic influences combination exposure environmental agent immune mediated factors may operative pathogenesis ms age onset peaks third fourth decades predominance women contrasted pml peaks fifth sixth decades non aids associated cases slight predominance men ms prevalent areas farther equator north america europe australia new zealand common initial symptoms seen ms include bilateral limb weakness legs affected twice often arms hyperreflexia spasticity optic neuritis diplopia incoordination paresthesias paresthesias typically found lower limbs symmetric pattern may follow obvious anatomic distribution often correspond distribution sensory symptoms vibration position sense frequently disturbed pain temperature intellectual impairment mental deterioration uncommon early ms whereas frequent initial presentation pml addition presence speech impairment monoparesis hemiparesis homonymous hemianopsia suggestive pml brain stem involvement infrequent,C02,0.0022276465,0.0019760337,0.025722038,0.0012516237,0.014141503,0.01536576,0.39701578,0.023645164,0.0016104893,0.013874724,0.07363696,0.0045818435,0.038190145,0.039299306,0.0019589362,0.015276535,0.06314779,0.0023423722,0.013302213,0.10607348,0.12064035,0.011570327,0.013148976
human immunodeficiency virus primary care physician scope size human immunodeficiency virus hiv epidemic grows primary care physician need assume greater role knowledge hiv risk factors ability perform pretest posttest counseling hiv testing essential counseling patients hiv risk reduction part hiv risk interview understanding benefits contraindications testing well respect impact testing important hiv seropositive individuals undergo complete history review symptoms soon test results known judicious use laboratory testing including monitoring cd cell counts recommended pneumocystis carinii prophylaxis zidovudine therapy offered patients appropriately low cd counts,C02,0.0029619993,0.0026274412,0.0055267834,0.0016642265,0.0041849813,0.018055806,0.2958505,0.0027855,0.0021413937,0.0029178443,0.12120602,0.0060922666,0.023633633,0.08577227,0.016942335,0.004612449,0.109840915,0.0030503683,0.016246,0.14552154,0.107105486,0.0010516983,0.020208614
immunological studies basis apathogenicity simian immunodeficiency virus african green monkeys potential reasons lack pathogenicity simian immunodeficiency virus sivagm natural host african green monkey agm cercopithecus aethiops investigated respect immunological mechanisms functional immune response monkeys infection similar though identical humans infection human immunodeficiency virus type hiv sera infected animals neutralizing antibodies found low absent particular neutralization various isolates homologous sera detectable antibody complement cytotoxicity though agm sera able initiate antibody dependent cellular cytolysis infected cells presence healthy effector peripheral blood lymphocytes human hiv system macrophages agms readily infected sivagm two possibly important differences agm sivagm system human hiv system low immune response agms core protein sivagm ii significantly lower inhibitory effect sivagm proteins proliferation agm lymphocytes,C02,0.0024092442,0.0021371199,0.016127843,0.0132168,0.026678909,0.0031092553,0.35522076,0.013925946,0.0017417764,0.002367224,0.011175183,0.01739648,0.08852316,0.101223014,0.0021186287,0.015404924,0.020616224,0.026367702,0.002743279,0.070303686,0.15470621,0.0008554351,0.051631212
stressful life events risk factors herpes zoster determine psychologically stressful life events risk factors herpes zoster conducted case control study zoster self reported recent negative life events major changes spousal relationships subjects healthy community dwelling cases zoster healthy controls matched age sex race generated random digit dialing geriatric scale recent life events administered case control subjects additional questions asked regarding perception life event results showed case subjects experienced negative life events significantly often subjects control groups months zoster onset analysis discordant pairs versus odds ratio confidence interval ci p months versus odds ratio ci p months versus odds ratio ci p mean number total life events significantly higher cases months zoster case means control means p significant differences months significant differences case subjects control subjects spousal events given single life event conclusion found whereas patients herpes zoster experienced kinds life events year preceding illness control subjects recent events perceived stressful significantly common among patients zoster,C02,0.0017847932,0.0015832006,0.011932692,0.0010028025,0.002485268,0.0023033686,0.25036135,0.0016784411,0.001290326,0.01039138,0.112403706,0.0348834,0.2415483,0.0041710157,0.001600135,0.0027792943,0.09457146,0.001838041,0.010662564,0.15590782,0.052347004,0.0006337152,0.0018398776
hiv seroconversion two homosexual men receptive oral intercourse ejaculation implications counseling concerning safe sexual practices seroconversion hiv antibody occurred two homosexual men reported anal intercourse greater equal years multiple episodes receptive oral intercourse ejaculation neither man reported intravenous drug use receipt blood products last antibody negative specimen also negative polymerase chain reaction p antigen assays sexually active persons clearly counselled receptive oral intercourse ejaculation carries potential risk hiv transmission,C02,0.003773291,0.0033470974,0.0070405696,0.0021200583,0.005254188,0.048278373,0.30561414,0.0035484484,0.0027279214,0.00370748,0.05203231,0.026020434,0.04171386,0.091914676,0.0033181368,0.005875799,0.05381594,0.003885864,0.040827624,0.1985772,0.07312015,0.01960461,0.0038818226
infection mice lactate dehydrogenase elevating virus destroys subpopulation kupffer cells involved receptor mediated endocytosis lactate dehydrogenase enzymes previous experiments rats shown rapid plasma clearance number clinically important enzymes due receptor mediated endocytosis kupffer cells resident macrophages others shown infection mice lactate dehydrogenase elevating virus virus proliferates macrophages leads reduced plasma elimination enzymes paper integrates two sets experiments plasma elimination intravenously injected radioactively labeled lactate dehydrogenase mitochondrial malate dehydrogenase mice shown caused part uptake liver spleen bone uptake lactate dehydrogenase tissues large extent saturable two dehydrogenases competitively inhibited clearance results suggest also mice enzymes partly cleared plasma endocytosis way common receptor cells probably macrophages liver spleen bone marrow morphometrical data showed normal mouse liver contains x kupffer cells cm number reduced controls hr infection mice lactate dehydrogenase elevating virus returned normal within next days saturable component uptake lactate dehydrogenase liver spleen bone disappeared hr infection virus return kupffer cell population recovered findings suggest lactate dehydrogenase large extent removed circulation way receptor subpopulation macrophages permissive replication lactate dehydrogenase elevating virus,C02,0.00974011,0.0014574474,0.018988285,0.008868427,0.010250295,0.025959102,0.22476354,0.02540528,0.0011878357,0.0016143711,0.04022741,0.012473408,0.03317612,0.17713821,0.001444837,0.073690794,0.016640276,0.045104504,0.0018858201,0.041709077,0.17596221,0.00058337935,0.051729254
breast cancer military experience wilford hall usaf medical center reviewed experience breast cancer wilford hall usaf medical center years total cases identified wilford hall tumor registry overall year year survivals respectively infiltrating ductal carcinoma represented principal histologic category predominant variants included invasive lobular carcinoma lobular carcinoma situ ductal carcinoma situ recently patients modified radical mastectomy definitive surgical therapy chemotherapy reserved primarily patients advanced disease,C04,0.0045160265,0.0040059406,0.008426437,0.002537371,0.050009172,0.0058281673,0.26791957,0.004246926,0.003264886,0.0044372613,0.08148803,0.009454235,0.057351857,0.010383739,0.0039715953,0.007032392,0.27402526,0.0046507586,0.026921047,0.08093966,0.08234026,0.0016034768,0.0046459213
association selected cancers service us military vietnam ii soft tissue sarcomas selected cancers cooperative study group part series investigations health vietnam veterans conducted population based case control study soft tissue sarcomas men born diagnosed area covered eight cancer registries considered eligible controls selected random digit dialing analyses men pathologically confirmed sarcoma controls showed vietnam veterans relative risk sarcoma comparison men serve vietnam confidence interval restriction analysis men soft tissue sarcoma yielded relative risk confidence interval several attributes military service vietnam eg branch duration service military region characteristics may associated use agent orange examined none associated increased risk development sarcoma furthermore morphologic type sarcoma overrepresented among vietnam veterans results unchanged vietnam veterans compared veterans men never served military study power detect relative risk sarcomas provides evidence risk development soft tissue sarcomas increased among veterans years following service vietnam,C04,0.012325904,0.001874686,0.044862255,0.0011874725,0.045335025,0.0027274452,0.26311067,0.0019874615,0.0015278899,0.0020765339,0.07293553,0.05111496,0.02880134,0.004890058,0.0018584655,0.003290994,0.045971457,0.0021810785,0.053556092,0.23463474,0.120800294,0.0007503895,0.002199237
justification surgical treatment metastatic melanoma gastrointestinal tract fifty six patients symptomatic metastatic melanoma gastrointestinal tract git treated surgically sydney melanoma unit reviewed majority patients presented abdominal pain symptoms anemia small intestine site metastasis per cent mean survival time months range one months surgical treatment first metastasis git months range zero months postoperatively second git metastasis forty four patients reported complete relief symptoms postoperatively results suggest aggressive approach symptomatic git metastases malignant melanoma justified relieve distressing symptoms prolong life,C04,0.037556365,0.0031218797,0.023599243,0.001977405,0.03895094,0.004541964,0.25051472,0.020336676,0.0025443665,0.0034977905,0.016185509,0.0072387247,0.023786712,0.008092178,0.0030948678,0.005480431,0.40385872,0.0036357483,0.0040073497,0.06163978,0.07146838,0.0012496096,0.0036206245
enhanced expression c myc h ras oncogenes letterer siwe disease sequential study using colorimetric situ hybridization tissues two patients disseminated histiocytosis x letterer siwe disease histiocytosis x cells exhibited histologic cytologic features malignancy evaluated situ hybridization use biotinylated nucleic acid probes c myc h ras oncogenes enhanced expression oncogenes observed mononucleated multinucleated cells histiocytosis x terminal proliferative phase early quiescent phase letterer siwe disease patients findings indicate deregulation c myc h ras histiocytosis x late events likely confer selective growth advantage histiocytosis x cells,C04,0.0039176187,0.0034751233,0.00730987,0.0022011502,0.00545516,0.02397977,0.36816305,0.0036841761,0.002832264,0.0038492905,0.02070634,0.008057793,0.024967385,0.095004365,0.003445055,0.06299376,0.098562784,0.022994237,0.023314312,0.029439053,0.10465039,0.0013910041,0.079606004
premalignant lesions cancers skin general population evaluation role human papillomaviruses evaluate role human papillomaviruses hpv development premalignant lesions cancers skin general population biopsies obtained patients benign neoplasms premalignant lesions cancers skin patients squamous cell carcinoma lip analyzed southern blot hybridization dna probes specific various cutaneous genital hpv types used hybridizations conducted nonstringent stringent conditions hpv dna sequences detected eight specimens obtained six patients hpv one case periungual bowen disease hpv yet uncharacterized hpv two cases actinic keratosis hpv one case basal cell carcinoma yet unrecognized hpv one case squamous cell carcinoma hpv one case squamous cell carcinoma lip none specimens cutaneous horn keratoacanthoma contained detectable hpv dna contrast hpv dna sequences mostly hpv detected cases anogenital bowen disease invasive bowen carcinoma hpv dna sequences detected cutaneous samples analyzed polymerase chain reaction technique using amplification primers contain conserved sequences among genomes hpv results strongly suggest known hpv types play minor role skin carcinogenesis general population,C04,0.0024090535,0.0021369506,0.0161539,0.0013536598,0.096656546,0.003109009,0.25768325,0.0022655032,0.0017416384,0.0023670364,0.22234571,0.03994193,0.026839362,0.024952527,0.0021184608,0.0037513974,0.05786787,0.0024841086,0.0027430616,0.029476488,0.06640352,0.00085536734,0.13434362
multisurface method pattern separation medical diagnosis applied breast cytology multisurface pattern separation mathematical method distinguishing elements two pattern sets element pattern sets comprised various scalar observations paper use diagnosis breast cytology demonstrate applicability method medical diagnosis decision making cytological characteristics breast fine needle aspirates reported differ benign malignant samples graded time sample collection nine characteristics found differ significantly benign malignant samples mathematically values sample represented point nine dimensional space real variables benign points separated malignant ones planes determined linear programming correct separation accomplished samples benign malignant one misclassified malignant case fine needle aspirate cytology definitely benign cytology excised cancer definitely malignant believe tumor missed aspiration mathematical method applicable medical diagnostic decision making problems,C04,0.016119378,0.0024516617,0.0053169117,0.0015528876,0.017239785,0.04364719,0.17104998,0.0025991462,0.0019981314,0.0027156328,0.30662614,0.019065242,0.05244405,0.0063790423,0.002430449,0.017669326,0.049423162,0.0028462943,0.0032008328,0.13936089,0.11866631,0.0143541945,0.002843334
purification characterization inhibitor soluble tumor necrosis factor receptor tumor necrosis factor lymphotoxin obtained serum ultrafiltrates human cancer patients serum ultrafiltrates suf human patients different types cancer contain blocking factor bf inhibits cytolytic activity human tumor necrosis factor alpha tnf alpha vitro bf protein molecular mass kda reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page active material purified homogeneity combination affinity chromatography page high pressure liquid chromatography amino acid sequence analysis revealed bf derived membrane tnf receptor purified bf blocks lytic activity recombinant human mouse tnf alpha recombinant human lymphotoxin murine l cells vitro however bf inhibits lytic activity tnf alpha effectively lymphotoxin bf also inhibits necrotizing activity recombinant human tnf alpha coinjected established cutaneous meth tumors balb c mice bf may important role regulation control tnf alpha lymphotoxin activity cancer patients ii interaction tumor host antitumor mechanisms iii use systemically administered tnf alpha clinical trials human cancer patients,C04,0.0020923328,0.0018556115,0.034263734,0.0011753981,0.03506471,0.002699694,0.15486045,0.001975258,0.0015123439,0.0020554054,0.012068866,0.0565509,0.027637735,0.21642907,0.0018395559,0.013374559,0.056740735,0.059677925,0.022626348,0.01620543,0.15000142,0.041246902,0.0880456
posterior mediastinal teratoma abdominal extension posterior mediastinal benign teratomas uncommon neoplasms infancy nine cases reported far one month old baby found benign posterior mediastinal teratoma infiltrating lower oesophagus level carina oesophageal hiatus upper abdomen partial oesophagectomy provided successful outcome,C04,0.007184967,0.006373424,0.013406402,0.0040369397,0.010004839,0.0092725735,0.26247647,0.07704491,0.005194411,0.007059652,0.105605125,0.014778104,0.052977465,0.016698191,0.0063182786,0.0111884875,0.096494034,0.0073993243,0.008181142,0.13842334,0.12993917,0.0025511207,0.007391629
use molecular probes distinguish new primary tumors recurrent tumors gynecologic malignancies first report using dna molecular probe technology distinguish recurrent tumor second primary malignancy patient tumor dna extracted squamous cell carcinoma cervix time radical hysterectomy eighteen months later squamous cell cancer found vaginal apex biopsy dna extracted tumor dna lesions subjected restriction enzyme digestion dna molecular hybridization human papillomavirus hpv probes although lesions positive hpv respective restriction enzyme patterns different hpv genetic arrangements thereby demonstrating distinctness,C04,0.003141961,0.017982977,0.021069653,0.0017653398,0.15671183,0.034467023,0.25546828,0.0029547382,0.0022714979,0.003087161,0.036790594,0.021671727,0.037205953,0.007690496,0.0027629612,0.004892687,0.090432785,0.003235699,0.0035775846,0.022687234,0.11679938,0.0011155962,0.15221682
abnormal vitamin b status childhood leukemia vitamin b involved many biological processes potential relevance carcinogenesis tumor growth including dna synthesis maintenance immunocompetence yet little information exists b nutritional status childhood leukemia using radioenzymatic assay authors measured plasma pyridoxal phosphate plp biologically active form b newly diagnosed untreated children leukemia age matched controls children leukemia significantly lower plp levels controls additional leukemia patients additional controls high performance liquid chromatography assay also demonstrated lower plasma plp levels childhood leukemia compared controls differences significant acute lymphoblastic leukemia acute nonlymphoblastic leukemia anll plp values correlate indices leukemia cell burden correlate reported b intake suggesting illness related diet changes least partially responsible low plp levels chemotherapy overall nutritional status suboptimal cases anll cases newly diagnosed children leukemia suboptimal overall nutrition well suboptimal vitamin b status,C04,0.002527666,0.002242166,0.004716363,0.0014201925,0.01576531,0.003262085,0.28295052,0.002377048,0.00182739,0.039194573,0.08205693,0.0053003808,0.18137246,0.061000306,0.0022227657,0.016167866,0.04112404,0.002603077,0.0028781197,0.06966038,0.17583099,0.0008974824,0.0026018256
papillary cystic neoplasm pancreas increasingly recognized clinicopathologic entity clinical course papillary cystic neoplasm pancreas contrasted pancreatic ductal adenocarcinoma former occurs predominantly young women low malignant potential highly curable surgical treatment three cases reported illustrate typical clinical features indolent nature tumor one case discovered blunt abdominal trauma resulted rupture tumor hemoperitoneum cases treated pancreatic resection preservation spleen important consideration younger patients patients free disease long term follow increasing awareness tumor resulted reclassification several tumors lead better recognition surgeons caring patients pancreatic diseases,C04,0.0031419117,0.0027870324,0.0058624814,0.001765312,0.06521783,0.019229025,0.33805156,0.033368204,0.0022714622,0.033475906,0.05962592,0.006462312,0.023381071,0.0072242254,0.002762918,0.00489261,0.1480299,0.0032500897,0.049193263,0.11204547,0.073613696,0.0011155787,0.003232283
magnetic resonance imaging vertebral osteoblastoma report two cases two patients vertebral osteoblastoma evaluated computed tomography magnetic resonance imaging presented literature review revealed cases osteoblastoma originating within vertebral body exceedingly rare,C04,0.0063069714,0.005594598,0.011768154,0.00354363,0.20478591,0.008139475,0.2272021,0.03646025,0.0045596594,0.0061969697,0.10483908,0.012972235,0.04023639,0.014501675,0.035527755,0.009821266,0.08935181,0.006507854,0.0071814144,0.07895361,0.07682147,0.0022393763,0.0064883796
breast cancer screening included recommendations u preventive services task force reviewed regard screening breast cancer contradistinction issued national organizations screening breast cancer using mammography ages recommended concluded scientific evidence insufficient present recommend mammography screening women aged recommendations task force women age receive annual breast examination women mammography every one two years beginning age concluding approximately age unless disease detected may prudent begin mammography earlier age women high risk breast cancer recommendations appropriate light available evidence though present evidence clinical examination breasts age reduces breast cancer mortality upper age beyond breast cancer screening longer significant effect reducing breast cancer mortality unknown evidence women high risk breast cancer benefit different degree screening women high risk,C04,0.0023031873,0.013182765,0.0043039476,0.0012933279,0.0032052835,0.014083911,0.18475324,0.0021648179,0.0016641509,0.0022617243,0.15948245,0.010532241,0.03735485,0.005301445,0.002024208,0.014724836,0.029746078,0.0023705463,0.047185406,0.33878174,0.12009266,0.00081731105,0.0023698402
elevated insulin receptor content human breast cancer growth breast cancer cells regulation hormones growth factors receptors present study employed new sensitive specific radioimmunoassay direct measurement insulin receptors surgical specimens breast cancers specimens insulin receptor content ng mg protein value sixfold higher mean value found normal breast tissues obtained total mastectomy p less six normal specimens obtained reduction mammoplasty p less insulin receptor content breast cancer tissues also higher normal tissue investigated including liver pezzino v v papa v trischitta brunetti p goodman k treutelaar j williams b maddux r vigneri goldfine j physiol e insulin receptor breast cancer retained ability bind insulin undergo insulin induced tyrosine kinase activation immunostaining specimens revealed insulin receptor present malignant epithelial cells detected stromal inflammatory cells univariant analysis revealed insulin receptor content tumors correlated positively tumor size p histological grading p estrogen receptor content p significant correlations insulin receptor content age body weight menopausal status nodal involvement patients studies indicate therefore insulin receptor content increased breast cancers raise possibility insulin receptor may role biology tumors,C04,0.0016692759,0.0014807311,0.0087486375,0.017093703,0.030248418,0.0021542876,0.12059462,0.0015698073,0.0012068122,0.0016401616,0.066910304,0.019594457,0.090003885,0.073713705,0.0014679513,0.11569767,0.042755876,0.12320848,0.0019007162,0.07517596,0.2008454,0.0005926992,0.0017264419
adult cell leukemia derived factor thioredoxin produced human lymphotropic virus type epstein barr virus transformed lymphocytes acts autocrine growth factor synergizes interleukin interleukin interleukin il obtained epstein barr virus infected b lymphoblastoid cell line b shown involved autocrine growth b b cells independently adult cell leukemia derived factor adf purified human lymphotropic virus infected leukemic cell line atl reported interleukin il receptor inducing factor previously reported molecular mass pi nh terminal amino acid sequence b derived il adf cdna cloning adf demonstrated high homology prokaryotic disulfide reducing enzyme thioredoxin show adf b derived il identical rna blot b atl cells shown contain high levels kilobase mrna corresponding adf message detected resting peripheral blood lymphocytes could weakly induced lymphocyte activation antibodies raised synthetic peptides corresponding nh terminus cooh terminus adf immunoblotting sequential immunoprecipitation antibodies revealed kda protein b atl cells recombinant adf could sustain growth b atl cells low cellular concentration without fetal calf serum adf thus appears involved autocrine growth similarly recombinant adf could enhance growth b cell lines including epstein barr virus negative burkitt lymphoma line bl lymphoblastoid cell lines crag crb g finally recombinant adf exhibits marked synergism cytokines il il allowing virally infected lymphocytes respond suboptimal amounts variety growth factors,C04,0.0016700998,0.0014812615,0.019275535,0.009124012,0.03615711,0.010220993,0.24398355,0.0015712244,0.00927778,0.001640749,0.012862831,0.0034346113,0.033049036,0.18048981,0.0014684449,0.0026003409,0.014436412,0.06476189,0.009972628,0.029813025,0.18353423,0.0005929115,0.12858146
demonstration lipiodol paraffin sections using modified silver impregnation technique demonstrate postangiographic lipiodol lip hepatocellular carcinoma hcc paraffin sections direct impregnation formalin fixed tissue blocks silver nitrate agno followed routine processing lip appeared black globules sinusoids ninety four tissue blocks postangiographic lip hccs non lip hccs fatty livers studied seventy two negative controls positive blocks seen soft tissue radiographs strs correctly coded specificity sensitivity twenty six lip negative areas strs lip cases contained scanty globules less microns diameter fatty change gave positive readings thus modified agno impregnation simple accurate means detecting lip high quality paraffin sections suitable tumor diagnosis applied postangiographic lip ultrasonographically guided liver biopsy verify biopsy reached suspected tumor focus,C04,0.002879566,0.0025543189,0.052261688,0.0016179107,0.045881297,0.017651109,0.1116127,0.044525363,0.0020817982,0.0028293428,0.19618645,0.021624407,0.12730125,0.0075856866,0.0025322177,0.036800195,0.08391385,0.0029961332,0.0033176811,0.06431127,0.14372575,0.0010224293,0.024787543
uneventful delivery following series successive treatments virilized cushing syndrome due adrenocortical carcinoma twenty one year old virilized woman cushing syndrome due huge adrenocortical carcinoma successively treated trilostane beta hydroxysteroid dehydrogenase inhibitor subsequent adrenalectomy postoperative cis platinum clinical biochemical abnormalities peculiar cushing syndrome gradually subsided three one half years adrenal surgery patient delivered normal female infant study points clinical biochemical responses treatment,C04,0.0040881657,0.0036189163,0.007612337,0.002292229,0.005680883,0.024993472,0.25303334,0.0038366192,0.022695936,0.0040085656,0.043712877,0.028112072,0.028869813,0.030198958,0.003587604,0.0063529746,0.15327981,0.004204648,0.004645363,0.09960632,0.24017553,0.0014485609,0.023945017
compound blue nevus variant blue nevus additional junctional dendritic component clinical histopathologic immunohistochemical study six cases studied six cases heavily pigmented melanocytic lesions features blue nevi within dermis additional junctional dendritic component compound variant blue nevus uncommon lesion previously identified distinct histologic entity immunoperoxidase staining protein counterstaining azure b distinguished presence melanocytes among numerous melanophages within dermis compound variant blue nevus distinguished histologically combined blue nevus pigmented spindle cell nevus malignant melanoma melanosis due regressed malignant melanoma six lesions three men three women whose ages ranged years mean years three lesions located trunk two extremities one head mean follow period months range months evidence recurrence,C04,0.01948234,0.002874425,0.037418462,0.0018209771,0.11432207,0.019858671,0.20790158,0.034414016,0.0023426882,0.018863827,0.054145463,0.053717136,0.03168611,0.025865838,0.0028495542,0.005046027,0.15305941,0.047731943,0.0036897087,0.084889576,0.057565473,0.0011505598,0.01930417
active specific immunotherapy patients melanoma clinical trial mouse antiidiotypic monoclonal antibodies elicited syngeneic anti high molecular weight melanoma associated antigen monoclonal antibodies published erratum appears j clin invest feb two clinical trials mouse antiidiotypic monoclonal antibody mab mf bears internal image human high molecular weight melanoma associated antigen hmw maa administered subcutaneous route without adjuvants patients stage iv malignant melanoma day additional injections administered anti antiidiotypic antibodies found titer decreased first phase trial patients initial dose mg per injection escalated mg per injection neither toxicity allergic reactions observed despite development anti mouse ig antibodies minor responses observed three patients second clinical trial mab mf administered patients dose mg per injection since dose shown initial study effective inducing anti antiidiotypic antibodies two patients inevaluable remaining patients average duration treatment wk trial well neither toxicity allergic reactions observed immunized patients increased levels anti mouse ig antibodies developed antibodies inhibit binding antiidiotypic mab mf immunizing anti hmw maa mab one patient increased level anti hmw maa antibodies one patient achieved complete remission disappearance multiple abdominal lymph nodes duration wk minor responses observed three patients results suggest mouse antiidiotypic mab bear internal image hmw maa may useful reagents implement active specific immunotherapy patients melanoma,C04,0.0016298619,0.0014457689,0.0030411533,0.0009157529,0.018047001,0.0021034216,0.19575116,0.009411901,0.0011783176,0.001601435,0.012419914,0.037753884,0.011910753,0.13161902,0.0014332595,0.026190925,0.15845649,0.013917958,0.041307427,0.074557625,0.25304908,0.00057870476,0.0016791786
oncogene amplification squamous cell carcinoma head neck cellular oncogenes appear involved control normal cell growth differentiation abnormal activation genes naturally occurring experimentally induced cancers may important role expression malignant phenotype cancer cells mechanisms activation genes include chromosomal translocation point mutation dna amplification amplification specific oncogenes correlates clinical prognosis several human malignancies including breast cancer neuroblastoma examined fresh frozen human squamous cell carcinomas aerodigestive tract amplification known cellular oncogenes c myc n myc l myc n ras h ras k ras erb b erb b raf int using southern blotting techniques eleven tumors demonstrated two fold fold amplification int oncogene one member family genes related basic fibroblast growth factor amplification c myc gene codes dna binding protein involved regulation cell growth seen two tumors none eight genes studied amplified tumor specimens,C04,0.0145620275,0.002214701,0.00465859,0.001402796,0.039777618,0.0032221263,0.33365703,0.0023479306,0.0018050057,0.0024531581,0.06878944,0.031167854,0.027595896,0.117621966,0.0021955383,0.017255273,0.023168618,0.08735863,0.014918332,0.018786838,0.06017547,0.00088648876,0.12397867
immunophenotypic aberrancy adult acute lymphoblastic leukemia recent reports indicate high frequency immunophenotypic aberrancy acute lymphoblastic leukemia investigate issue regard adult authors reviewed immunophenotyping data cases analyzed clinical laboratory flow cytometric analysis peripheral blood bone marrow performed use panel b cell cell myeloid monoclonal antibodies moabs surface antigen profiles leukemic cells compared normal bone marrow thymic counterparts defined current models twenty six cases b precursor b burkitt leukemia two cases coexpressed lymphoid myeloid antigens contrast intralineage aberrancy quite common immunophenotypes b precursor cases deviated normal b lineage marrow cells defined recent classification cases also immunophenotypically heterogeneous high incidence aberrant antigen expression adult suggests leukemogenesis also involves aberrant differentiation rather purely process maturational arrest,C04,0.0025904353,0.0022978454,0.02897314,0.0014554599,0.003607099,0.0033430916,0.29145047,0.0024360768,0.0018727693,0.0025452548,0.10619839,0.0053280303,0.075383045,0.15889826,0.014811619,0.016571566,0.027228141,0.028256567,0.015480993,0.067621216,0.109466076,0.00091976946,0.033264697
benign lymphangioendothelioma studied eight cases acquired lymphatic endothelial lesion propose name benign lymphangioendothelioma lesions developed solitary slowly extending erythematous macules plaques usually occurring extremities shoulders adolescents adults characteristic histopathologic feature permeation dermal collagen flattened endothelium lined channels spaces hemorrhage iron deposition inflammation part lesion ulex europaeus agglutinin labeled lesional endothelial cells consistently factor viii related antigen labeling negative histologic pattern special studies suggested lymphatic lesion surgical excision performed six patients followed recurrence,C04,0.0036405688,0.0032293661,0.006826875,0.037282933,0.094303675,0.0046983436,0.32998592,0.038664494,0.002631969,0.0035770726,0.06257283,0.007487954,0.023750165,0.11250228,0.0032014244,0.0056691226,0.11699449,0.0037491822,0.004145323,0.029978544,0.082478486,0.0012926337,0.021336375
effects fudr primary cultured colon carcinomas metastatic liver hepatic arterial infusion fluorodeoxyuridine fudr demonstrated efficacy treatment metastatic colorectal carcinoma liver study direct cytotoxic effect fudr measured ten metastatic two primary site colorectal carcinomas primary culture assay system overall clinically achievable concentrations fudr microm induced partial cell kill tumors including greater reduction viable tumor cell number two tumors less remaining seven total cell kill observed tumor three tumors resistant fudr concentrations tumor sensitivity correlated size tumor growth fraction increasing exposure time fudr days approximately doubled magnitude response flurouracil cisplatin clinically achievable concentrations toxic metastatic tumor cells fudr limited chemosensitivity metastatic colorectal tumor cells fudr vitro postulate mechanisms besides direct cytotoxicity contribute clinical efficacy fudr vivo,C04,0.0025307154,0.0021123837,0.050193783,0.0013379881,0.114257075,0.003073267,0.2280903,0.0022394583,0.001721616,0.0023398243,0.01382126,0.004941696,0.09766328,0.12791099,0.0020966267,0.03787011,0.04379472,0.01599165,0.0027115266,0.019535856,0.22247021,0.0008455338,0.0024501274
epidermal growth factor regulates vitro sensitivity human ovarian carcinoma cells cisplatin cisplatin ddp effective drug treatment human ovarian cancer mechanisms determine sensitivity cytotoxic action ddp well understood treatment two human ovarian carcinoma cell lines epidermal growth factor egf simultaneously increased sensitivity ddp caused persistent change morphology absence mitogenic effect sensitization ddp shown dependent egf concentration egf receptor number c mouse fibroblasts expressing human egf receptor transfection pbpv plasmid construct containing human egf receptor gene control transferrin receptor inducible regulator sensitization human ovarian carcinoma cells ddp blocked inhibition protein synthesis egf enhance sensitivity ddp alter morphology ddp resistant human ovarian carcinoma cells despite presence functional egf receptors cells results showed elements signal transduction pathway activated egf determined cellular sensitivity ddp ddp resistant phenotype associated defect signal transduction pathway,C04,0.002381419,0.0021124375,0.07278665,0.0013380222,0.004218298,0.0030733454,0.23391926,0.015800953,0.0017216599,0.002339884,0.011030093,0.016948884,0.024525514,0.21765833,0.0020941598,0.0037083647,0.021388702,0.10212773,0.0027115957,0.04612339,0.14627825,0.0008455554,0.06486751
melanocyte melanoma paper reviewed interesting biological aspects melanocytes relationship nevus melanoma also proposed rationale adequate surgery management melanoma according level depth margins trends treatment propositions derived analysis cases melanoma head neck,C04,0.0368192,0.005595074,0.011833983,0.034065634,0.008783004,0.038666382,0.27522066,0.005940987,0.0045600473,0.006197497,0.07464063,0.012973337,0.069566995,0.014552293,0.005546663,0.009822101,0.08666805,0.0066485433,0.03770444,0.09063849,0.15474465,0.0022395668,0.00657179
localization surgical treatment occult insulinomas management patients biochemical evidence insulinoma negative preoperative imaging studies occult tumors controversial varying primarily medical management aggressive blind nearly total pancreatectomy extirpate tumor since consecutive patients occult insulinoma underwent preoperative portal venous sampling pvs insulin followed surgical exploration intraoperative ultrasound ious eleven twelve patients insulinoma removed cured portal venous sampling correctly predicted location insulinoma patients tumor would found another patient fourfold insulin gradient pancreatic tail one patient correctly predicted distal pancreatectomy would remove insulinoma despite fact neither palpation ious identified tumor intraoperative ultrasound single best method identify occult tumors correctly identified insulinomas found including five pancreatic head tumors palpable palpation identified five insulinomas tumors identified operation palpation ultrasound ious identified significantly versus p guided successful enucleation results support strategy preoperative pvs operation ious localize remove insulinoma patients occult tumors tumors correctly localized specific pancreatic region preoperative pvs identified ious allowing simple enucleation biochemical correction hypoglycemia morbid blind pancreatic resections longer indicated long term medical management hypoglycemia reserved occasional patient fails preoperative pvs operation guided ious,C04,0.009517721,0.0014463416,0.010829388,0.008807123,0.081206694,0.002104255,0.2193968,0.017313717,0.0011787844,0.009457367,0.106888294,0.0112120155,0.01707604,0.0039585293,0.017224165,0.041931115,0.25554737,0.0016791525,0.049206007,0.07049169,0.042731717,0.000578934,0.020216778
neonatal intracranial teratomas two neonates intracranial teratomas presented cranial enlargements weeks birth cases underwent surgery one died intraoperatively longest known survivor alive years months subtotal excision mature teratoma left sylvian fissure previous operations relatively nearly unsuccessful size favorable location may important prognostic features regardless histologic classification mature immature one cases demonstrates even subtotal excision mature teratoma result long term survival,C04,0.0039162776,0.0034739333,0.0073073674,0.0022003965,0.047476415,0.00505416,0.23418632,0.022640128,0.0028312942,0.022803307,0.098657094,0.064893745,0.024242476,0.009004731,0.04135723,0.006098458,0.2386447,0.004033116,0.0044592577,0.0835345,0.06775993,0.0013905278,0.0040346384
prospective study alcohol intake large bowel cancer alcohol intake cohort japanese men hawaii directly significantly related risk developing rectal cancer whether assessed basis amount consumed percent total calories wine whiskey directly related rectal cancer beer alcoholic beverage displays statistically significant dose response p colon cancer risk also related directly alcohol intake association statistically significant measured percent energy intake suggests alcohol might displace cancer inhibitors diet calcium vitamin c dietary fiber inversely related colon cancer risk cohort micronutrients displays statistically significant negative correlation alcohol intake possible positive association alcohol lung cancer ruled adjusting cigarette smoking cancers prostate stomach unrelated alcohol intake risk acquiring cancer sites combined strongly related alcohol intake,C04,0.002381995,0.0021129486,0.027392779,0.0013383459,0.0033176574,0.014604089,0.19705856,0.0107556805,0.0017220764,0.0023404502,0.029644975,0.121495955,0.08921928,0.029927714,0.0020947133,0.003709262,0.0680976,0.002459476,0.01421269,0.2671736,0.105643936,0.00084575993,0.0024505088
laparoscopic management ovarian cysts one hundred two women ovarian cysts managed laparoscopically year period thirteen treated laparoscopic inspection followed laparotomy laparoscopic fine needle aspiration followed laparotomy laparoscopic fenestration biopsy without coagulation removal cyst lining satisfactory results noted patients treated completely laparoscopy functional simple paraovarian cysts recurred study period two ovarian endometriomas treated fenestration coagulation removal lining recurred whereas lesions recurred treated fenestration alone surgical complications,C04,0.0048318873,0.004286125,0.03240432,0.0027148402,0.030791355,0.006235802,0.18341807,0.004543965,0.0034932394,0.004747613,0.022335036,0.009938268,0.032078814,0.011110001,0.027503636,0.0075242533,0.34213692,0.005097478,0.005501814,0.094409965,0.15821005,0.0017156276,0.004970867
potent toxicity chlorodeoxyadenosine toward human monocytes vitro vivo novel approach immunosuppressive therapy lymphoid cells thought uniquely susceptible excess deoxyadenosine dado exposed inhibitors adenosine deaminase ada however find human monocytes sensitive lymphocytes dado ada resistant congener chloro deoxyadenosine cldado monocytes exposed vitro cldado dado plus deoxycoformycin rapidly developed dna strand breaks dna damage toxicity cldado dado toward monocytes blocked deoxycytidine inhibitors poly adp ribose polymerase partial decrease rna synthesis gradual decline cellular nad early biochemical events associated monocyte dna damage low cldado concentrations nm inhibited monocyte phagocytosis reduced release interleukin higher cldado concentrations led dose time dependent loss monocyte viability circulating monocytes disappeared within wk patients cutaneous cell lymphoma rheumatoid arthritis continuous cldado infusion marked sensitivity human monocyte function survival cldado vitro together monocyte depletion patients receiving cldado chemotherapy suggests cldado dado analogues offer novel therapeutic strategy chronic inflammatory autoimmune diseases characterized inappropriate monocyte deployment function,C04,0.0020924886,0.0018558893,0.057514317,0.0011755241,0.002913328,0.0027000983,0.37895238,0.0019717193,0.0015125704,0.0020557134,0.030083792,0.006185096,0.029039921,0.04670273,0.0018398315,0.013627881,0.06485397,0.022403248,0.002382282,0.0337008,0.2299938,0.0007428656,0.06569973
cholangiocarcinoma diagnosis cholangiocarcinoma made greater rapidity accuracy clinical setting obstructive jaundice ct scan sonogram may suggest cholangiocarcinoma dilated intrahepatic ducts seen nondilated extrahepatic biliary tree diagnosis confirmed cholangiography tumor staged combination cholangiography angiography tumor extensively involves lobes liver involves main portal vein hepatic artery lesion considered unresectable patients best palliated nonoperatively still attempt tissue diagnosis various lesions masquerade cholangiocarcinoma comparison tumor confined distal hepatic duct bifurcation extends one lobe liver involves right left portal vein hepatic artery lesion may resectable exploration indicated many half patients explored curative intent successful resection various surgical options appropriate patients undergoing tumor resection depending site extent lesion similarly several surgical options possible palliation patients unresectable cholangiocarcinoma role radiotherapy management cholangiocarcinoma uncertain results like many retrospective analyses suggest radiotherapy prolongs survival curative resection well palliative stenting however data randomized studies necessary support refute impression studies adjuvant chemotherapy hormonal therapy also necessary improve patient survival,C04,0.019408697,0.0016218253,0.012149254,0.009775575,0.076250136,0.018196164,0.27156168,0.045676265,0.0013136603,0.021878595,0.0711855,0.0047115264,0.046564158,0.0043132743,0.0015978849,0.06404935,0.1796802,0.0018769694,0.011608295,0.05178685,0.08227688,0.0006451753,0.0018720872
buschke loewenstein tumor verrucous carcinoma penis buschke loewenstein tumor anogenital tumor characteristic clinical histologic pattern best considered low grade well differentiated squamous cell carcinoma remarkable neoplasm features reviewed detail stressing salient advances understanding,C04,0.0074437787,0.0066030035,0.013889319,0.004182356,0.11847689,0.009606584,0.30258852,0.00700022,0.005381521,0.00731395,0.039197676,0.015310431,0.0582527,0.053074736,0.04258043,0.011591512,0.0743773,0.007665858,0.008475837,0.09135236,0.10533411,0.0026430155,0.007657885
anesthesia craniotomy double blind comparison alfentanil fentanyl sufentanil using prospective randomized double blind study design alfentanil n fentanyl n sufentanil n combination n administered patients undergoing craniotomy supratentorial tumor resection physicians given two syringes one labeled load initial loading dose maintenance continuous infusion concentration drug syringe adjusted permit administration milliliter per kilogram basis target loading doses alfentanil fentanyl sufentanil microgram kg respectively initial infusion rates microgram kg h respectively additional supplementary boluses changes maintenance infusion rate made according predetermined guidelines isoflurane increasing inspired increments used maximum allowed opioid dose given e supplementary bolus doses equal calculated loading dose supplementary bolus doses equal calculated loading dose combined increase maintenance infusion rate opioid infusions stopped time bone flap replacement antihypertensive medications naloxone subsequently given discretion anesthesiologist group demographics different total volumes drug similar among groups indicating equipotent preparations administration isoflurane antihypertensive medications naloxone different among groups although decreases blood pressure seen induction similar among groups alfentanil treated patients received ephedrine frequently intubation thirty minutes entry postanesthesia recovery area respiratory rate ph lowest sufentanil treated patients,C04,0.0016695822,0.009546443,0.01926326,0.009016637,0.01047688,0.0023396192,0.110147305,0.0015700953,0.009279852,0.009717758,0.037244275,0.1230646,0.1731803,0.01190986,0.0014682102,0.03526895,0.10205843,0.009796031,0.01806127,0.05741875,0.24519147,0.00059280795,0.0017176046
clinical problems follow patients conservative surgery radiotherapy patients treated conservative surgery radiotherapy early stage breast carcinoma risk developing ipsilateral breast recurrence long period fortunately patients present inoperable recurrence simultaneous distant metastases salvage rates high may improved early detection although usually unambiguous physical examination treated breast may reveal changes attributable surgery radiotherapy mimic recurrent cancer also substantial overlap radiologic appearance benign malignant lesions may necessary perform biopsy question recurrence careful life long follow patients thus critical part care,C04,0.0030949102,0.0027453396,0.020754075,0.0017389037,0.019826142,0.0039941426,0.29011753,0.017886244,0.0022374822,0.003040931,0.030078921,0.021347165,0.044494547,0.007182586,0.0027215858,0.004819419,0.28462905,0.0031910357,0.018497013,0.1598155,0.05350465,0.0010988901,0.0031839292
selection therapy stage iii breast cancer locally advanced breast cancer heterogenous group including operable inoperable lesions local surgery radiation alone produces poor survival rates indicating micrometastases diagnosis systemic chemotherapy part multimodality regimens increased length rate disease free survival,C04,0.0051964414,0.004609503,0.009696021,0.0029196683,0.032391917,0.0067062783,0.29376027,0.004886796,0.0037567958,0.005105809,0.049052853,0.061000377,0.056186616,0.011952555,0.0045696194,0.00809194,0.20025018,0.005351473,0.0059169126,0.049647093,0.17175993,0.0018450675,0.005345907
cancer families children soft tissue sarcoma cancer experience among first degree relatives mothers fathers siblings population based series children soft tissue sarcoma reported current study represents extension earlier work authors found excess breast cancer mothers children cancers among first degree relatives compared expected relative risk rr p excess fathers excess borderline significance seen mothers rr p significant excess siblings rr p mainly due carcinoma breast pediatric tumors results step forward cox multivariate analysis identified three variables index child independently associated high cancer risk relatives follows age younger months diagnosis histologic type embryonal rhabdomyosarcoma unspecified soft tissue sarcoma male sex possible therefore identify subgroup children whose relatives high risk early onset cancer rr group pattern cancers consistent li fraumeni syndrome authors conclude marked proportion childhood soft tissue sarcoma genetic basis,C04,0.002072753,0.0018370303,0.04396348,0.001163636,0.05300812,0.0026726606,0.1831402,0.0019475404,0.0014972,0.07221551,0.053693682,0.08200568,0.030108448,0.025407277,0.0018211355,0.013247596,0.06071606,0.0021327285,0.0023580738,0.32719713,0.034921076,0.00073531683,0.0021376954
survival patients large bowel cancer population based investigation melbourne colorectal cancer study five year survival data obtained percent new patients histologically confirmed colorectal adenocarcinoma month period part large comprehensive population based study colorectal cancer incidence etiology survival melbourne colorectal cancer study fifteen percent patients dukes stage percent dukes b percent dukes c percent dukes five years diagnosis observed survival rate percent adjusted rate percent dukes staging highly discriminating factor survival p less survival rates better women men better patients colon cancer patients rectal cancer survival dukes staging affected colon subsite tumor first single tumor metachronous tumor synchronous tumor survival younger patients better dukes stages b c worse dukes survival worse presence bowel perforation dukes c stages within dukes incurable cases survival best absence hepatic metastases slightly worse hepatic metastases present poorest presence hepatic extrahepatic metastases statistical modeling survival determinants staging indicated cell differentiation largest effect survival decreasing poor cell differentiation followed site survival worse rectal cancer colon cancer age survival better younger patients bowel perforation smallest effect survival,C04,0.001643023,0.0014574435,0.0030657107,0.0009231476,0.034310002,0.0021204068,0.16087422,0.0015451188,0.0011878326,0.0016143667,0.037706234,0.027240628,0.03544028,0.025577141,0.001444833,0.026409093,0.3739052,0.0101699885,0.02570696,0.13516136,0.07354823,0.0005833778,0.018365365
interplay local distant control cure cervical cancer women cervical cancer received definitive radiation therapy extraperitoneal surgical staging relapse free rates strong functions pelvic lymph node metastases cervical size recurrence distribution consisted isolated local isolated distant combined local distant failures assumption independent local distant failure probabilities suit et al method extended assess potential improvement cure attainable perfect local distant control yielding local lsa distant dsa survival advantages various subsets clinical stage cervical size pelvic node metastases periaortic metastases peritoneal metastases lsa dsa prognostic group lsa never exceeded dsa showing effective systemic therapy would greater impact improving survival would advances local regional tumor control therapeutic implications limitations extended lsa dsa model discussed form analysis used guide intensity local distant treatment maximize cure patient cancer,C04,0.002496701,0.02638799,0.004658585,0.037662454,0.01841665,0.0032221228,0.2412866,0.0023479278,0.0018050037,0.0024531553,0.0549304,0.106668904,0.08012273,0.020305136,0.026364328,0.003910768,0.120185174,0.0025711881,0.0035137746,0.091872685,0.14535497,0.00088648783,0.0025762394
race nutritional status survival breast cancer effects nutritional status differences survival black white women breast cancer studied cohort georgia women diagnosed data adjusted stage disease socioeconomic status prognostic factors poorer survival rates shown black women within stage classification lower levels serum albumin hemoglobin higher relative body weight common among blacks independently associated poorer survival among women stage disease adjustment variables substantially reduced excess mortality rate among blacks suggesting racial differences survival may partly explained differences nutritional status extent disease within stage,C04,0.0029649902,0.002629277,0.019877471,0.016006045,0.004127372,0.0038252852,0.21093401,0.0027874461,0.00214289,0.0029123717,0.01847669,0.006182156,0.023673734,0.0070387507,0.031300038,0.018959638,0.18991113,0.0030524994,0.0033750285,0.26464358,0.14675525,0.015375005,0.0030493247
prognostic implication ecto nucleotidase activity acute lymphoblastic leukemia ecto nucleotidase n activity determined patients children adults acute leukemia elevated values n registered common acute lymphoblastic leukemia blast cells cell common antigen negative non low enzyme activity comparable values acute non lymphocytic leukemia dependence remission duration n activity analyzed adults treated similarly prospective multicenter trial remission curves patients n activity lower nmol h x cells substantially significantly better patients high activity greater nmol h x cells difference also evident immunologic subclass common statistical evaluation showed interaction immunologic subtype blast cells n activity prognostic significance remission duration addition independent factor initial age interaction also prognostic survival,C04,0.002558242,0.0022692883,0.004773414,0.0014373718,0.015945558,0.0033015446,0.15814368,0.0024058018,0.014222271,0.014898217,0.018121086,0.017939687,0.10928539,0.15583898,0.027013721,0.0040992657,0.1332115,0.002634565,0.0029129349,0.12554705,0.1798915,0.0009083388,0.0026406483
direct interaction ligand erbb oncogene product egf receptor p erbb erbb oncogene encodes kilodalton transmembrane protein whose sequence similar epidermal growth factor receptor egfr kilodalton factor gp secreted mda mb human breast cancer cells shown ligand p erbb antibody egfr abolished tyrosine phosphorylation induced egf transforming growth factor alpha tgf alpha partially blocked produced gp sk br breast cancer cells two cell lines overexpress erbb expresss egfr mda mb breast cancer cells chinese hamster ovary cell line transfected erbb phosphorylation p erbb induced gp gp specifically inhibited growth cells overexpressed p erbb antibody egfr effect inhibition sk br cell colony formation obtained gp thus appeared gp interacted directly egfr erbb direct binding gp p erbb confirmed binding competition experiments gp found displace p erbb binding specific antibody p erbb evidence described suggests gp ligand p erbb,C04,0.0029641632,0.0026293606,0.005530821,0.0016654425,0.004133334,0.0038254072,0.23797114,0.002787535,0.002142958,0.017254878,0.03569266,0.0062090373,0.019571101,0.27577394,0.0026066103,0.0046158186,0.042785633,0.124789916,0.0033751358,0.021218712,0.117917754,0.0010524667,0.06348618
invasive migration epidemic kaposi sarcoma cells vitro kaposi sarcoma ks low grade malignant neoplasm shows invasive growth often occurs immunosuppressed patients acquired immune deficiency syndrome aids epidemic ks also found elderly men usually limited skin classic ks present study investigated chemotaxis invasive migration epidemic ks cells vitro compared cells grown classic ks lesions fibroblasts epidemic ks cells demonstrated invasive migration reconstituted basement membrane matrigel well interstitial connective tissue collagen early passages whereas fibroblasts invade either barrier epidemic ks cells late passages show invasive migration following pretreatment tumour necrosis factor alpha tnf alpha enhanced migration matrigel collagen epidemic ks cells whereas classic ks cells showed increased migration type collagen barrier,C04,0.0026916605,0.002387637,0.025977327,0.05573182,0.029835058,0.003473728,0.1906784,0.098818615,0.0019459507,0.0026447144,0.08234365,0.005536231,0.023183571,0.13036141,0.0023669782,0.004191475,0.061964545,0.002771964,0.0030648513,0.065003425,0.18827392,0.0009557108,0.015797324
hepatic tumors signal enhancement doppler us intravenous injection contrast agent experiments carried detect establish origin doppler echo signal enhancement small vessels systemic circulation tumors intravenous injection contrast agent eight woodchucks marmota monax studied woodchuck naturally occurring hepatocellular carcinoma injections ml air filled human serum albumin microspheres administered hind limb jugular vein ultrasound us examination included transabdominal duplex scanning color doppler imaging placement doppler transducer exposed tumor surgical implantation pulsed doppler cuffs doppler signals assessed recording color doppler images results spectral analysis subjective echo level unaffected within tumors dramatic doppler signal enhancement recorded normal tumor vessels optimum dose levels signal gain approximately db recorded tumor analysis showed echo enhancement due presence contrast agent branches hepatic artery results suggest tumor detection may enhanced intravenous administration us contrast agent,C04,0.031892844,0.001786243,0.013458503,0.010840226,0.09054198,0.012304966,0.23485984,0.0019008948,0.050180897,0.0019785683,0.10528616,0.084877096,0.04065175,0.008555374,0.0017707878,0.022620648,0.043334827,0.0020747005,0.0022928817,0.06468686,0.17129423,0.000714988,0.0020947338
paraneoplastic cerebellar degeneration clinical comparison patients without purkinje cell cytoplasmic antibodies review patients paraneoplastic cerebellar degeneration pcd women purkinje cell cytoplasmic antibodies pcab women patients seropositive seronegative patients active cancer time neurologic diagnosis gynecologic breast cancers found seropositive seronegative female patients lung cancer diagnosed seronegative patients seropositive patient seropositive patients onset syndrome often abrupt abnormalities affect mentation ocular motility cerebrospinal fluid igg index common seronegative patients additional paraneoplastic neurologic syndromes present five seronegative patients seropositive patient clinical impairment equivalent groups approximately patients confined wheelchair bed last follow four seropositive patients died months onset pcd seronegative patients died months onset pcd thus pcab seem marker clinical subset female patients gynecologic breast cancer high frequency autoimmune paraneoplastic syndromes patients seronegative pcd suggests pcd seropositive seronegative patients may common pathogenic basis involves yet unidentified antineuronal autoimmune mechanism,C04,0.0021352395,0.0018940639,0.003984135,0.0011997039,0.0029732534,0.014254846,0.28849563,0.002008005,0.011860901,0.03310746,0.04985065,0.045739576,0.041344475,0.0469518,0.0018776756,0.0033250118,0.25183856,0.0021989427,0.0024312842,0.10951604,0.08005759,0.00075814594,0.0021969848
antitumor activity liposome encapsulated doxorubicin advanced breast cancer phase ii study previous studies animals demonstrated liposome encapsulated doxorubicin led substantially less cardiac toxicity free doxorubicin retains antitumor activity phase clinical study led maximum tolerated dose mg dose limiting toxicity considered reached granulocytopenia produced used led treat patients advanced measurable breast cancer led given doses mg every weeks intravenous infusion regression disease objectively measured nine patients five patients complete regression index lesion occurred mean duration responses months hematologic toxicity consisted grade leukopenia patients gastrointestinal toxicity mucositis generally mild tolerable alopecia occurred patients usually complete twelve patients received cumulative doses led greater mg evaluated radionuclide ventriculograms eight patients cumulative dose greater mg five endomyocardial biopsies four biopsy results billingham grade one cumulative led dose mg showed grade changes mild myofibrillar loss dilatation sarcoplasmic reticulum involving less cardiac myocytes two patients decreases left ventricular ejection fraction one patients received total dose led mg decline left ventricular ejection fraction clinical evidence congestive heart failure billingham grade endomyocardial biopsy,C04,0.0017698745,0.01868991,0.029003922,0.0009944203,0.011036057,0.0022841152,0.272986,0.0016644114,0.0012795405,0.0017390057,0.008663697,0.0506681,0.10627165,0.00414431,0.0015564167,0.037190914,0.17729583,0.0018226773,0.0020152624,0.02959929,0.21974093,0.017762873,0.0018207816
expression aminopeptidase n cd mesenchymal tumors long time cd molecules considered restricted myeloid cells related neoplasms meanwhile however expression cd also detected hepatocellular gallbladder renal lung carcinomas even fibrosarcomas malignant melanomas study expression cd antigen immunohistochemically examined non neoplastic mesenchymal cells along benign malignant mesenchymal tumors met using cd monoclonal antibodies mab u wm mou non neoplastic mesenchymal cells expression cd restricted perivascular fibrocytes blasts tissue histiocytes osteoclasts perineurium peripheral nerve trunks neoplastic conditions cd detectable tumors smooth muscle fibrous fibrohistiocytic synovial osteogenic peripheral nerve sheath origin even tumors adipose tissue tumors striated muscle origin autonomic ganglia cartilage forming tissues cd negative throughout thus tumors studied pattern expression cd mirrors situation found cells origin findings enrich data expression leukocyte differentiation antigens extra hematopoietic tissues expression cd meanwhile known identical aminopeptidase n important peptide cleaving enzyme met might reflect special functional state neoplasms,C04,0.002276795,0.0020196307,0.0042482633,0.0012792383,0.06930532,0.03599946,0.23646167,0.013072441,0.023606762,0.0022370848,0.019619416,0.015690941,0.054822687,0.10312208,0.002002156,0.017845526,0.023052081,0.0023478225,0.002592466,0.08001217,0.18927602,0.00080840715,0.09830159
hepatic vein reconstruction preserving remnant liver function hepatic malignancies often infiltrate major hepatic vein recently performed hepatic resection combined hepatic vein reconstruction preserving remnant liver function three patients one patient saphenous vein graft postoperative liver function patients underwent hepatic vein reconstruction compared eight patients underwent hepatic resection segments vii viii right hepatic vein four resected remaining four preserved skeletalization using ultrasonic aspirator although four patients right hepatic vein resection showed severe lowering liver function surgery postoperative course patients preservation reconstruction right hepatic vein maintained good liver function liver regeneration three patients hepatic vein reconstruction good computed tomography besides report knowledge report hepatic vein reconstruction preserving remnant liver function problems hepatic resection combined hepatic vein reconstruction discussed conclude hepatic vein reconstruction one means extending indication malignant tumor resection liver,C04,0.012747515,0.0017661966,0.0037151682,0.0011187125,0.022047333,0.011076037,0.15913577,0.12718013,0.0014394698,0.0019563634,0.009771959,0.0040952927,0.041411605,0.004578132,0.0017509147,0.22455288,0.28774875,0.0020504931,0.0022835056,0.023620348,0.053198062,0.0007069639,0.0020483604
histopathologic spectrum clinically atypical melanocytic nevi ii studies nonfamilial melanoma published erratum appears arch dermatol dec studied clinically atypical pigmented lesion removed patients newly diagnosed sporadic melanoma specimens categorized type nevus ie junctional compound presence congenital features degree nuclear atypicality presence nuclear enlargement nuclear pleomorphism hyperchromatism prominent nucleoli intraepidermal nevomelanocytes frequency nuclear abnormality graded rare cells cells greater cells nuclear parameter among lesions junctional nevi compound nevi dermal nevi eighteen percent total either dysplastic nevi cases malignant melanoma situ three cases fourteen nevi congenital features junctional compound nevi one dermal nevus exhibited nuclear abnormality four junctional nevi compared compound nevi sufficient atypia designation dysplastic nevus two nevi congenital features demonstrated nuclear abnormality clearly nondysplastic thus among nevi surgically removed clinically atypical lesion study compound nevi much likely demonstrate nuclear atypia dysplasia nevi ie junctional dermal nevi nevi congenital features,C04,0.0030049502,0.002665541,0.0056191757,0.0016884266,0.10627369,0.003878045,0.31633356,0.017368913,0.016714454,0.00295254,0.065464854,0.07890843,0.058844645,0.071975015,0.0026426744,0.0046793325,0.09169128,0.017635832,0.0034215779,0.02696319,0.0971156,0.0010669486,0.003091382
treatment planning internal radionuclide therapy three dimensional dosimetry nonuniformly distributed radionuclides calculational approach described provides spatially varying radiation absorbed dose presented isodose contours superimposed ct images nonuniform irregular cumulated activity distributions ct images read magnetic tape displayed high resolution color graphics display monitor source tissue geometries defined series contiguous ct images automatically edge detection algorithm manually using trackball thereby obtaining three dimensional representation various source volumes activity dose calculations performed using radionuclide specific absorbed dose point kernel form lookup table method described yields spatially varying dose delivered tumor normal tissue volumes patient specific cumulated activity distribution clinically implementable manner level accuracy determining normal tissue tumor doses may prove valuable evaluation implementation radionuclides radiolabeled compounds therapeutic purposes,C04,0.0025588651,0.002269841,0.0047997567,0.001437722,0.07789007,0.0033023488,0.24690418,0.0024063878,0.0018499456,0.0025142352,0.14606602,0.04241191,0.06828557,0.007675859,0.0022502015,0.003984685,0.105309285,0.0026371987,0.0029136443,0.017608589,0.25137666,0.00090856006,0.0026384946
actin architecture cultured human thyroid cancer cells predictor differentiation actin cytoskeleton important cell structure motility disordered actin architecture correlated high metastatic potential melanoma fibrosarcoma colon cancer models thyrotropin known induce growth differentiation cultured thyroid cells whereas carcinogenic phorbol ester tetradecanoylphorbol acetate tpa causes dedifferentiation malignant transformation many cell lines therefore assessed effect thyrotropin tpa actin architecture ftc human follicular thyroid cancer cells continuous culture staining filamentous actin rhodamine phalloidin showed mu ml mu ml thyrotropin induced actin polymerization detectable hour notable hours similarly tpa mumol l caused rapid actin fiber disruption redistribution cell periphery secondary antibody staining alpha actinin protein binds crosslinks actin prominent treatment thyrotropin decreased tpa findings indicate actin cytoskeleton dynamic response trophic factors thyrotropin promoted actin polymerization tpa caused depolymerization effects may correlate cellular alpha actinin levels actin architecture may therefore reflect state differentiation thyroid tumor cells,C04,0.0019174227,0.048093412,0.014738443,0.0010773216,0.011951845,0.0024745339,0.2392522,0.0018031676,0.0013862113,0.0018839805,0.008840614,0.059733648,0.04321621,0.13153213,0.10376179,0.002985826,0.027853979,0.021064194,0.0021832678,0.024798319,0.17629988,0.00068080716,0.072470814
clinical management port wine stain infants young children using flashlamp pulsed dye laser flashlamp pulsed dye laser flpdl nm wavelength well absorbed oxyhemoglobin causes highly selective vascular injury addition microsecond pulse duration produced laser approximates thermal relaxation time dermal blood vessels thereby confining energy target new laser effects excellent lightening port wine stain pws infants young children without adverse complications hypertrophic scarring permanent pigmentation abnormality textural changes complications often seen conventional laser systems flpdl permits treatment patient population expected gain benefit early laser therapy much safer manner psychological complications marked person develop purpose report describe theoretical considerations behind achieving selective removal pws understood used nonsurgically oriented practitioner describe practical application device used clinical management infants young children,C04,0.012871835,0.012619431,0.004111972,0.0012381983,0.01372123,0.0028440566,0.3268068,0.0020921514,0.0015932145,0.034171823,0.024052814,0.01518752,0.028818222,0.0051152464,0.012597705,0.014095993,0.21168917,0.012932214,0.0025092957,0.12528728,0.13259418,0.0007824722,0.0022671386
survey alabama physicians use mammography early surveyed questionnaire alabama primary care physicians n concerning attitudes toward use mammography respondents majority recommend mammograms patients according american cancer society guidelines obtain baseline studies asymptomatic women ages years appears cost mammograms decreasing alabama screening study available less responding physicians almost one half physician respondents believe patients least one mammogram,C04,0.004152394,0.023783198,0.0077479365,0.0023330608,0.005782077,0.005358881,0.20795509,0.0039049615,0.003001996,0.024154661,0.09353165,0.028641798,0.09509033,0.009547636,0.0036515105,0.026550652,0.112839684,0.0042762775,0.0851282,0.15158388,0.09523789,0.0014743642,0.00427183
changes clearance total unbound etoposide patients liver dysfunction disposition total non protein bound etoposide investigated cancer patients receiving etoposide cisplatin combination chemotherapy etoposide plasma concentrations determined using specific high performance liquid chromatography hplc method etoposide plasma protein binding determined equilibrium dialysis patients wide range renal function creatinine clearance ml min hepatic function total bilirubin range mg dl aspartate aminotransferase ast range iu l serum albumin range g dl mean etoposide total systemic clearance different patients total bilirubin less mg dl versus six patients total bilirubin mg dl ml min v ml min test p trend toward higher total clearance patients abnormal bilirubin values however mean clearance unbound etoposide significantly lower patients increased total bilirubin ml min v ml min test p fraction etoposide unbound fu plasma significantly higher patients increased bilirubin v test p explaining trend toward higher total clearance patients etoposide clearance total unbound patients measurable hepatic metastases different clearance seven patients without hepatic metastases study provides explanation patients increased bilirubin lower total systemic clearance etoposide indicates patients higher exposure unbound etoposide results ongoing pharmacodynamic studies total unbound etoposide patients increased bilirubin determine clinical relevance altered etoposide protein binding,C04,0.0015560822,0.0013803225,0.0029034878,0.0008742991,0.0021686964,0.002008205,0.07316799,0.0014633585,0.0011249781,0.001528942,0.0416352,0.012551945,0.31226176,0.0046375436,0.031108618,0.046373963,0.14894973,0.04679797,0.0017718284,0.020934982,0.24264432,0.0005525082,0.0016032895
association disease free survival percent ideal dose adjuvant breast chemotherapy relationship percent ideal dose disease free survival examined stage ii iii patients participated year breast adjuvant chemotherapy trial consisting cyclophosphamide methotrexate fluorouracil cmf given postoperatively analyzed analogously previous work results confirmed dose response relationship appeared improved disease free survival patients receiving higher doses adjuvant chemotherapy major criticism analysis bias bias addressed considering patients still receiving therapy months dose response relationship longer seen although causality cannot inferred apparent differences disease free survival among dose groups attributed recurrences first years among patients receiving lower doses chemotherapy,C04,0.0024375287,0.0021622095,0.0045481753,0.0013695479,0.015166034,0.0031457576,0.17612882,0.0022922815,0.0017622247,0.0024094987,0.011772373,0.049154345,0.05811293,0.005604631,0.002143501,0.003795739,0.23211049,0.0025136452,0.026368879,0.15915889,0.23445612,0.00086547784,0.002520876
systemic therapy metastatic colorectal cancer fluorouracil based chemotherapy regimens utilized metastatic colorectal cancer years early attempts defining optimal treatment schedule use combination drugs failed significantly improve results contrast clinical effectiveness fluorouracil improved continuous infusion administration modulation folinic acid approaches increased response rate compared results achieved traditional bolus schedules effect survival less significant unfortunately expense instances toxicity also increased detracts overall usefulness clinical studies evaluate fluorouracil chemotherapy combination biological response modifiers ongoing areas intense research next years,C04,0.0030495448,0.021399384,0.005690134,0.031237539,0.004261504,0.029516686,0.3002,0.0028678288,0.002204685,0.0029963567,0.023810279,0.031098368,0.09509804,0.021799453,0.0026816926,0.019496666,0.114701934,0.0031405254,0.0034723552,0.036513656,0.24054337,0.0010827825,0.003137259
oncogenes suppressor genes involvement colon cancer editorial abnormalities oncogenes broadly classified viral cellular oncogenes suppressor genes appear critical development colon cancer cellular oncogenes contribute malignant transformation become activated point mutation translocation amplification loss regulator sequences properties oncoproteins proteins encoded oncogenes essential carcinogenesis unclear suppressor genes normally suppress tumorigenic phenotype keeping growth cells check inactivation contributes malignant transformation development colon cancer appears take place stepwise accumulation multiple genetic alterations progression normal colon adenoma carcinoma activation ras early event sequence found colon cancers overexpression c myc found approximately inactivation suppressor genes occurs later stages noted greater tumors current model colonic tumorigenesis presented,C04,0.0029624277,0.0026278212,0.029884072,0.0016644673,0.018466154,0.0038231674,0.3449192,0.002785903,0.0021417034,0.0029107593,0.057356033,0.020433288,0.025249267,0.06770996,0.002605084,0.019173378,0.07658333,0.07610465,0.0033731598,0.04138204,0.13859408,0.0010518505,0.058198247
improving diagnostic accuracy cervical metastases computed tomography magnetic resonance imaging elective neck dissection patients head neck cancer continues controversial management patients would greatly facilitated improvements predicting cervical metastases recent investigations suggested computed tomography magnetic resonance imaging sensitive detecting cervical metastases physical examination department otolaryngology ohio state university hospitals columbus undertook prospective study compare preoperative sensitivities physical examination computed tomography magnetic resonance imaging pathologic findings patients undergoing neck dissections head neck cancer results indicate computed tomography magnetic resonance imaging sensitive respectively physical examination although results achieve statistical significance sensitivity combined computed tomography magnetic resonance imaging,C04,0.002840128,0.0025193351,0.060018763,0.0015957521,0.21019758,0.01740113,0.19874218,0.016413555,0.0020532862,0.016502148,0.034247916,0.03522391,0.037695307,0.006617588,0.0024975368,0.018006405,0.22882591,0.002924861,0.0032339036,0.04098886,0.05751414,0.0010084263,0.0029313473
overall mortality cancer mortality around french nuclear sites higher expected mortality leukaemia observed population age living around sellafield dounreay nuclear reprocessing plants united kingdom report results similar study population residing around nuclear sites france number leukaemia deaths comparable control areas slightly less expected national mortality statistics twelve deaths due hodgkin disease observed around nuclear sites twice number hodgkin deaths observed control areas twice number expected national mortality statistics observation must however interpreted light fact several causes deaths studied increasing play chance,C04,0.0028816771,0.002554095,0.019284876,0.0016177689,0.017909067,0.01763249,0.20644784,0.0027077415,0.0020816156,0.016762136,0.06578724,0.020949962,0.0434793,0.0069104806,0.0025319958,0.0044836905,0.033385195,0.0030135761,0.017199172,0.30875668,0.19963893,0.0010223397,0.0029621318
medroxyprogesterone acetate lowers plasma corticotropin cortisol suppress anterior pituitary responsiveness human corticotropin releasing factor endocrine action medroxyprogesterone acetate mpa claimed glucocorticoid like nature upon clinical observation mpa shown improve life quality overall well patients advanced breast cancer renal carcinoma prostatic carcinoma uterine adenocarcinoma authors evaluated mpa endocrine action administration human corticotropin releasing factor hcrf minute assay patients advanced breast cancer renal cell carcinoma initiation oral high dose mpa treatment mg mpa well least days therapy curves corticotropin beta endorphin cortisol responses hcrf tumor patients tested initiation mpa treatment parallel curves healthy control group probands tested equal conditions although significantly higher respective hormone levels patients malignant disorders assayed mpa administration basal peak hormone levels found comparable values obtained healthy controls conclusion mpa appeared act suprapituitary level since pituitary responsiveness hcrf preserved mpa treatment moreover appeared mpa brought hormonal stress state found patients malignant tumors back normal,C04,0.0019721617,0.0017494058,0.013212369,0.0011080771,0.02184095,0.0025451772,0.20344523,0.0018546446,0.001425785,0.0019377646,0.047394022,0.013826433,0.12835819,0.062007185,0.01127911,0.022161167,0.07927966,0.011612191,0.0022630473,0.030639227,0.33735147,0.00070024293,0.002036492
recognition elam sialyl lex determinant myeloid tumor cells endothelial leukocyte adhesion molecule elam endothelial cell adhesion molecule allows myeloid cells attach walls blood vessels adjacent sites inflammation elam recognizes sialyl lewis x sialyl lex determinant neuac alpha gal beta fuc alpha glcnac granulocyte carbohydrate also found surface tumor cell lines binding myeloid cells soluble elam inhibited monoclonal antibody recognizing sialyl lex proteins bearing sialyl lex may participate humoral regulation myeloid cell adhesion stimulated granulocytes also release inhibitor elam binding selectively adsorbed monoclonal antibody sialyl lex,C04,0.003705477,0.003286943,0.007126881,0.0020819565,0.041037504,0.0047821114,0.14972423,0.07584595,0.002678895,0.003640849,0.018193372,0.0076214583,0.04087521,0.15181983,0.003258503,0.023699129,0.05210379,0.12637578,0.0042192307,0.04244521,0.15859672,0.0013156803,0.07556527
therapeutic dilemmas associated antenatally detected ovarian cysts fifteen instances ovarian cysts detected antenatally reported seven cysts centimeters diameter treated surgically clinical signs palpable abdominal mass vomiting abdominal distension seven cysts less centimeters diameter one cyst centimeters diameter began regress spontaneously within six months birth pathophysiologic nature neonatal ovarian cysts elucidated borderline physiologic pathologic factors still unclear propose conservative approach management neonatal ovarian cysts avoid unnecessary operations,C04,0.0041544465,0.0036852015,0.028587442,0.002334214,0.0057849353,0.00536153,0.1849442,0.04412278,0.00300348,0.0302077,0.061566696,0.008544903,0.057190225,0.037742477,0.0036533156,0.08646079,0.19980763,0.0243764,0.0047304486,0.13678707,0.061180677,0.0014750931,0.004298335
breast cancer pregnancy lactation breast cancer frequently seen cancer pregnancy lactation incidence low disease seen approximately pregnancies breast cancer overall diagnosed pregnancy lactation evidence implicate pregnancy lactation either etiology progression breast cancer careful breast examination early pregnancy important find solid masses require biopsy breast engorgement hides therapeutic options vary depending stage disease stage pregnancy operable disease first months pregnancy treated mastectomy irradiation contraindicated late pregnancy lumpectomy axillary dissection done irradiation delayed delivery general anesthesia safe usual precautions taken compensate physiologic changes induced pregnancy unfortunately delay diagnosis common patients operable primary lesions positive axillary lymph nodes late stage appears reason generally worse prognosis patients stage stage course similar nonpregnant patients adjuvant chemotherapy considered late pregnancy usually delayed delivery patients locally advanced metastatic cancer diagnosed early pregnancy chemotherapy radiation therapy would normally recommended consideration must given termination pregnancy evidence termination pregnancy improves outlook patients permit standard aggressive therapy advanced disease,C04,0.0017850155,0.0015833977,0.029239278,0.0010029274,0.011125903,0.0023036555,0.30001768,0.0016786502,0.018570136,0.027676102,0.19232836,0.021752933,0.013691366,0.0041455645,0.0015696975,0.011417247,0.17188102,0.0104650855,0.0020325028,0.091925845,0.081337266,0.0006337941,0.0018365826
endosonography pararectal lymph nodes vitro vivo evaluation one hundred thirteen patients carcinoma rectum evaluated lymph node metastases endorectal ultrasound use mhz based different echo patterns two main groups lymph nodes differentiated hypoechoic hyperechoic lymph nodes compared pathologic findings hypoechoic lymph nodes represent metastases whereas hyperechoic lymph nodes visualized due unspecific inflammation lymph node metastases predicted sensitivity percent inflammatory lymph nodes specificity percent physical basis differentiation lymph nodes assessed vitro determination ultrasound parameters speed sound acoustic impedance attenuation backscattered amplitude attenuation coefficient benign lymph nodes db mhz x cm significantly higher mean value lymph node metastases db mhz x cm results demonstrate involved nodes principally differentiated involved nodes micrometastases mixed lymph nodes changing echo patterns within inflammatory nodes explain accuracy rate percent,C04,0.003405056,0.0030170914,0.039243437,0.0019110319,0.021221984,0.02084478,0.17328992,0.0031985906,0.002458963,0.0033419423,0.18180293,0.023462933,0.15169232,0.007820558,0.0029909865,0.0052964767,0.1786643,0.0035386116,0.0038728402,0.027030855,0.12073012,0.0012076655,0.019956602
mediastinal hibernoma rare tumor hibernoma uncommon soft tissue tumor derived remnants fetal brown fat review world medical literature revealed cases intrathoracic present seventh case intrathoracic hibernoma case hibernoma within mediastinum without direct invasion structures,C04,0.005944784,0.00527332,0.01109235,0.0033401314,0.10149784,0.007672053,0.23905106,0.06611493,0.03306457,0.005841099,0.113159135,0.012227284,0.06548889,0.013766467,0.005227693,0.038015757,0.050770894,0.00625656,0.006769011,0.09736992,0.07056376,0.0021107767,0.039381716
extraadrenal retroperitoneal paragangliomas natural history response treatment extraadrenal retroperitoneal paragangliomas rp uncommon tumors rarity little known natural history response treatment reviewed patients rp seen center distribution male female patients nearly equal mean age patients admitted pain mass eight tumors functional significant difference noted duration symptoms size tumor survival functional nonfunctional tumors eleven rp metastasized therefore classified malignant five year year disease free survival rates tumors resected completely resected metastases occurred year survival rate patient survived beyond months predictors survival included complete resection tumor size functional status although patients received chemotherapy radiotherapy clinical responses survival benefit could shown rp high rate malignant behavior treated aggressively operation late metastases uncommon prolonged follow necessary metastases occurred patients may prolonged survival,C04,0.0021352565,0.001894079,0.014316543,0.0011997134,0.06967342,0.0027556596,0.15145695,0.022673292,0.0015436953,0.002105752,0.020697186,0.02855985,0.01802993,0.015336214,0.012146027,0.013657028,0.38773108,0.0022513927,0.0024313035,0.09788266,0.12856582,0.000758152,0.0021989776
sialosyl tn novel mucin antigen associated prognosis colorectal cancer patients colon cancers typically produce mucin however known whether tumor mucin plays biological role cancer cell behavior address issue expression mucin associated antigen sialosyl tn examined immunohistochemical study primary colorectal carcinoma specimens patients underwent curative surgical resection antigen expression correlated disease free overall year survival sialosyl tn antigen expression occurred tumors independent age gender tumor location dukes stage depth invasion degree differentiation ploidy status survival years patients sialosyl tn negative versus sialosyl tn positive tumors versus p less disease free survival versus respectively p although advanced dukes stage deeper invasion aneuploidy associated poorer overall year survival antigen negative tumors within groups much better prognoses antigen positive tumors multivariate regression analysis revealed tumor ploidy p less sialosyl tn expression p less two variables importance predicting disease free overall survival authors conclude sialosyl tn expression independent predictor poor prognosis colon cancer therefore suggest qualitative mucin alterations may reflect important differences biological behavior neoplasms,C04,0.0017112936,0.0015180027,0.011484992,0.009204035,0.062054604,0.0022085134,0.18837601,0.0016093212,0.001237189,0.0016814464,0.08698648,0.029707974,0.055713706,0.08546393,0.009784674,0.002673599,0.1763724,0.0017638205,0.018506655,0.06977511,0.12911335,0.00060761813,0.052445255
gamma detecting probe autoradiographic studies radiolabeled antibody b cx colon xenografts nude mice bearing cx colon tumors injected microci labeled monoclonal antibody mab b radioactivity tumors studied gamma detecting probe gdp days mab injection day two mice sacrificed sections examined autoradiography arg immunoperoxidase methods imp routine stains mean probe counts showed increasing tumor background ratios arg demonstrated progressive increase radionuclide tumors distribution primarily around vascular spaces day day progressively appeared tumor gland lumina necrotic areas regional correlation shown radionuclide vascular spaces sequestration tumor elements,C04,0.0030498556,0.002705374,0.005690714,0.0017135894,0.092923366,0.018694382,0.20639591,0.051386327,0.0022049097,0.0029966622,0.0736245,0.035792302,0.05579369,0.05285196,0.002681966,0.0047492594,0.050754253,0.0034311854,0.003472709,0.055983223,0.26887324,0.0010828929,0.00314776
primary malignant melanoma lower respiratory tract report case literature review authors report case primary bronchial malignant melanoma occurring year old woman presenting persistent cough bronchoscopic examination polypoid mass found occlude left mainstem bronchus biopsies showed malignant epithelioid tumor resembling atypical carcinoid histochemistry electron microscopic study immunohistochemistry confirmed diagnosis melanoma physical examination additional clinical history exclude possible primary sites negative patient underwent thoracotomy left pneumonectomy nineteen months resection found histologically similar tumor involving left adrenal gland review literature shows melanoma lower respiratory tract reported adults tendency present central polypoid growth may responsive surgical resection,C04,0.0027276522,0.015567301,0.031495813,0.0015325565,0.030208046,0.016696105,0.3290831,0.044646163,0.0019719712,0.042286433,0.10070756,0.0056273607,0.031578254,0.01984086,0.015601711,0.004247522,0.11992279,0.017589059,0.0031058332,0.08428223,0.07750708,0.0009684902,0.002806108
erythrocyte stearic acid desaturation patients colorectal carcinoma erythrocyte stearic oleic acid ratio saturation index investigated means differentiating control subjects n patients benign n malignant n colorectal disease patients undergoing postoperative follow curative resection n erythrocyte fatty acid profiles determined gas liquid chromatography neither age sex dukes stage degree differentiation tumors significant effect erythrocyte saturation index erythrocyte saturation index lower patients primary recurrent colorectal cancer compared control subjects patients inflammatory bowel disease benign colonic polyps p less erythrocyte saturation index found useful postoperative follow patients using saturation index age means differentiating patients primary colorectal cancer control subjects gave sensitivity percent specificity percent,C04,0.0027270273,0.002419009,0.018313482,0.0015322054,0.016998723,0.0035193707,0.16310444,0.0025645294,0.015153976,0.0026794644,0.014591401,0.005781187,0.35976347,0.0063189953,0.0023980788,0.0042465483,0.24494095,0.0028174522,0.0031051217,0.03347977,0.076577745,0.00096826826,0.015998775
phase trial cisplatin hypertonic saline escalating doses fluorouracil continuous intravenous infusion patients advanced malignancies thirty four patients incurable solid tumors treated phase trial fixed dose high dose cisplatin cddp administered hypertonic saline escalating doses infusional fluorouracil fu five treatment levels fu ranging mg day days studied leukopenia thrombocytopenia oral mucositis dose limiting toxicities encountered nephrotoxicity minimal ototoxicity peripheral neuropathies rare mild patient group patients received small number treatment cycles diarrhea dose limiting two complete responses one non small cell lung cancer one sweat gland carcinoma observed major responses noted dose cddp set mg day consecutive days maximum tolerated dose mtd concurrent day fu infusion found mg day recommended dosages phase ii trials mg day cddp mg day fu consecutive days cancers lung breast gastrointestinal tract genitourinary tract would reasonable targets phase ii studies,C04,0.011966603,0.0018188766,0.014092902,0.0011520801,0.012781279,0.028753253,0.10180532,0.021774823,0.0014824045,0.0020147152,0.016032917,0.07228589,0.068561904,0.015771298,0.0018031389,0.048293103,0.15239155,0.012032324,0.03578524,0.05807686,0.318486,0.00072805036,0.0021094563
liver fatty acid binding protein marker studying cellular differentiation gut epithelial neoplasms human liver fatty acid binding protein residue cytoplasmic protein synthesized liver intestinal epithelium previous studies normal transgenic mice indicated liver fatty acid binding protein gene sensitive marker enterocytic differentiation study shows use immunohistochemical methods examine liver fatty acid binding protein gene expression normal human colonic epithelium colonic villoglandular adenomas nonmucinous mucinous adenocarcinomas several types noncolonic epithelial neoplasms cells containing liver fatty acid binding protein found normal colonic epithelium two thirds colorectal villoglandular adenomas nonmucinous adenocarcinomas one third mucinous adenocarcinomas noncolonic nonhepatic carcinomas liver fatty acid binding protein positive colonic adenomas adenocarcinomas contained patches immunoreactive cells distributed among histologically identical patches cells without liver fatty acid binding protein immunoreactivity mosaicism also found metastases liver fatty acid binding protein positive colonic adenocarcinomas immunostaining liver fatty acid binding protein positive tissues carcinoembryonic antigen show mosaic cellular pattern expression data suggest within given neoplasm differences exist differentiation programs monoclonally derived malignant colonic epithelial cells liver fatty acid binding protein useful marker operationally defining subpopulations liver fatty acid binding protein also potentially useful diagnostic marker colorectal hepatic carcinomas,C04,0.0016699617,0.0014813393,0.03477976,0.025734194,0.018465366,0.0021551726,0.2425964,0.0015705671,0.0012073079,0.0016408354,0.0634403,0.0035602332,0.016661787,0.07382328,0.0014685221,0.10668226,0.014394465,0.20899001,0.009466059,0.015939757,0.08069803,0.0005929427,0.072981454
autologous bone marrow transplantation high risk remission lineage acute lymphoblastic leukemia using immunotoxins plus hydroperoxycyclophosphamide marrow purging fourteen patients high risk lineage acute lymphoblastic leukemia complete remission underwent autologous bone marrow transplantation bmt attempt eradicate residual disease burden combined immunochemotherapy protocol using cocktail two immunotoxins directed cd tp cd tp lineage differentiation antigens combination vitro active cyclophosphamide congener hydroperoxy cyclophosphamide hc used purge autografts despite high dose pretransplant radiochemotherapy effective purging autografts patients relapsed median months range months post bmt two patients remain alive disease free months post bmt used novel quantitative minimal residual disease mrd detection assay combines fluorescence activated multiparameter flow cytometry cell sorting leukemic progenitor cell lpc assays analyze remission bone marrow bm samples lineage patients presence residual lpcs notably high numbers residual lpc detected remission bm bmt constituted poor prognostic indicator providing first evidence biologic significance clinical value vitro lineage lpc assays median value residual leukemia burden bmt approximately x lpc mononuclear cells mnc approximately lpc patients residual leukemia burden less median value appeared better outlook remaining free relapse autologous bmt patients greater leukemia burden v p mantel cox comparison log kill efficacy purging remaining numbers lpc purged autografts estimated numbers reinfused lpc correlate probability disease free survival dfs results indicate primary reason recurrence leukemia inefficient pretransplant radiochemotherapy rather inefficient purging autografts,C04,0.0017108654,0.0015368285,0.019729048,0.00096126547,0.0023891423,0.01046282,0.22485821,0.0016184149,0.0012368795,0.0016810257,0.076486275,0.0035189232,0.09783621,0.07722307,0.009779914,0.0026653328,0.28551847,0.034888368,0.0019480719,0.047388107,0.08520186,0.00060746615,0.010753439
equal parental origin chromosome losses human sporadic meningioma evidence genomic imprinting inactivation tumor suppressor genes occur either mutation gene locus loss part chromosome region containing gene latter frequently detected dna markers loss heterozygosity tumor tissue several reports paternal homologue preferentially retained embryonal tumors associated loss particular chromosomal regions suggesting genomic imprinting corresponding tumor suppressor loci explore generality findings possible role genomic imprinting adult tumors nervous system determined parental origin chromosome loss sporadic meningioma nine cases studied five tumors retained maternally derived chromosome homologue four retained paternally derived chromosome thus contrast embryonal tumors meningioma locus chromosome inactivated random mutation sporadic adult meningiomas,C04,0.0027644555,0.00245221,0.0051581874,0.0015532348,0.097533345,0.003567674,0.26499885,0.0026010538,0.0019985782,0.00271624,0.029669467,0.0056859567,0.01901397,0.0070850924,0.0024309924,0.017684205,0.030882545,0.002866735,0.0031477392,0.15179609,0.092323065,0.0009815578,0.25108877
use flow cytometry prognosis stage ii adjuvant treated breast cancer patients characterization breast cancer cells histology flow cytometry steroid receptors performed stage ii breast node positive cancer patients given adjuvant chemotherapy plus tamoxifen patients positive hormone receptors histologic steroid receptor assays performed using standard techniques flow cytometric analysis performed paraffin embedded blocks obtained primary tumor quality control studies reproducibility tissue heterogeneity analysis procedures included patients studied aneuploidy found median value range results demonstrated number positive nodes receptor status grade prognostic value cell cycle kinetic data independent prognostic value series however ploidy could differentiate prognosis receptor negative subgroup patients receptor negative tumors significantly better overall survival tumor diploid nature cell kinetics significantly prognostic either receptor subgroup although patients higher tended better relapse free overall survival disagreement studies may demonstrate treatment confounded results diminished ability flow cytometry data help predict outcome,C04,0.0018486732,0.0016398655,0.0123868985,0.001038694,0.029466253,0.0028962411,0.14072554,0.0017385148,0.0013365084,0.0018361046,0.14116877,0.01629309,0.06461051,0.057381567,0.028469566,0.0028828348,0.20866527,0.06455215,0.0023598506,0.0584,0.14879987,0.009595115,0.001908108
bactericidal effect doxycycline associated lysosomotropic agents coxiella burnetii p cells consistently reliable treatment endocarditis resulting chronic coxiella burnetii infection causative agent q fever although certain antibiotics recommended basis vitro bactericidal activities results therapy antibiotics often disappointing evaluate whether currently recommended antibiotic susceptibility tests c burnetii give misleading results continued division uninfected cells thereby resulting dilution infected cells hence false picture antibiotic efficacy blocked cell division antibiotic susceptibility testing cycloheximide using new method found currently recommended antibiotics treatment q fever doxycycline pefloxacin rifampin reduce ratio infected noninfected cells either l p days postinfection test hypothesis lack antibacterial activity due antibiotic inactivation low ph phagolysosomes c burnetii found used alkalinizing lysosomotropic agents chloroquine amantadine concurrently doxycycline resulted sterilization c burnetii infection p cells finding seems confirm suspicion acidic conditions phagolysosomes c burnetii located inhibit antibiotic activity inhibition reversed vitro lysosomotropic alkalinizing agents used,C04,0.0023842377,0.0021124904,0.027488537,0.0013380556,0.014841666,0.003073422,0.426577,0.0022395712,0.013239067,0.0023399424,0.11554292,0.016791886,0.043713417,0.10354537,0.002094212,0.0037084573,0.03007171,0.0025012747,0.0027116635,0.050448958,0.10689409,0.00084557646,0.02549647
unique aspects acute promyelocytic leukemia acute promyelocytic leukemia apl accounts approximately cases acute myeloid leukemia aml distinctive features disorder time diagnosis include leukopenia coexisting marrow replaced granulated dysplastic promyelocytes disseminated intravascular coagulopathy lack ia hla dr antigen expression translocation long arms chromosomes heparin widely universally used interfere coagulopathy initial phases treatment serial bone marrow examinations induction period demonstrate achievement remission despite persistence malignant appearing promyelocytes patients apl generally younger subtypes aml likelihood entering remission thought favorable prognosis individuals aml remission may achieved conventional anthracycline cytarabine combination anthracycline alone apparently trans retinoic acid genes potentially important myeloid differentiation granulocyte colony stimulating factor g csf myeloperoxidase located close breakpoint conclusively shown rearranged translocation better understanding unique aspects apl may well shed light pathogenetic processes aml,C04,0.0028400337,0.0025192518,0.0052992087,0.0015956991,0.00396793,0.017387738,0.35815346,0.016407492,0.002053218,0.0027905,0.110629454,0.005841407,0.018373424,0.029025102,0.0024974542,0.031916287,0.085383676,0.016669119,0.030720033,0.058008533,0.12495251,0.0010083928,0.07196013
endoscopic screening early esophageal cancer lugol dye method patients head neck cancers poor prognosis esophageal cancer could improved lesions detected early stage detect early esophageal cancer endoscopic screening esophagus lugol dye method performed patients head neck cancers asymptomatic regarded high risk synchronous metachronous esophageal cancer patients screened esophageal cancer eight patients early stages lymph node metastasis lesions lesions detectable barium studies ordinary endoscopic study epidemiologic statistical analysis patients confirmed significantly high observed expected number e ratio p less results demonstrate value endoscopic screening esophagus lugol dye method patients head neck cancers imply endoscopic screening lugol dye method may useful detecting early esophageal cancer individuals risk causes,C04,0.002381311,0.0021123416,0.004443279,0.0013379615,0.037942503,0.0030732057,0.18288834,0.0022394136,0.0017215818,0.0023397778,0.1860175,0.108659,0.13929263,0.0056203734,0.0020940648,0.0037081963,0.1450093,0.0024620825,0.0027114728,0.10526425,0.05537835,0.000845517,0.002457603
technicon h analyzer discriminates chronic lymphocytic leukemia b cell leukemias automatic assessment large unstained cells separation chronic lymphocytic leukemia b cell origin chronic b cell leukemias subjective largely based morphologic features lymphoid cells peripheral blood percentage large unstained cells determined technicon h analyzer automated blood cell differential analyzer technicon instruments corp tarrytown ny used cell volume variable investigation cases chronic lymphocytic leukemia b cell origin chronic b cell leukemias significant degree correlation percentage large unstained cells morphoimmunophenotypic diagnosis although obtained relatively small number cases suggests method cell volume analysis used improve diagnostic reproducibility chronic b cell leukemia,C04,0.0028793088,0.0025540907,0.005377643,0.0016177662,0.0040119304,0.0037158981,0.26480332,0.0027077368,0.0020816121,0.01676415,0.12105809,0.005922188,0.14493248,0.22415067,0.0025319916,0.018351631,0.043904968,0.0029652107,0.0032785167,0.02711755,0.09528259,0.0010223379,0.0029683614
complications associated limb salvage extremity sarcomas management retrospective clinical review consecutive patients extremity sarcomas managed limb salvage operations performed evaluate local tumor control morbidity mean follow period months overall survival local recurrences patients complications patients wound necrosis frequent complication failure allogeneic bone graft operations occurred patients complications salvageable without loss limb limb salvage acceptable surgical treatment extremity sarcomas based adequate local control minimal morbidity,C04,0.00363989,0.020849118,0.0067916573,0.0020451057,0.022689292,0.028214492,0.15674323,0.0034229967,0.0026314785,0.0035764058,0.057788745,0.06965671,0.040132478,0.008369232,0.0032008276,0.0056720413,0.4217339,0.0037484833,0.0041445503,0.07190142,0.058010995,0.0012923927,0.0037445847
pediatric osteosarcoma therapeutic strategies results prognostic factors derived year experience ninety eight pediatric patients treated three separate protocols treatment investigation osteosarcoma tios ii iii developed recurrent disease metastases local recurrence actuarial overall disease free survival hereafter designated survival patients treated initially preoperative intraarterial cisplatin cdp postoperative chemotherapeutic regimens comprised high dose methotrexate leucovorin rescue mtx cf adriamycin adr doxorubicin adria laboratories columbus oh cyclophosphamide primary definitive treatment comprised amputation limb salvage tios tios iii patients treated preoperative cdp surgery tios iii survival patients tios ii refused surgical extirpation treated exclusively chemotherapy survival survival patients treated amputation limb salvage prognostic factors considered significant relation development pulmonary metastases comprised tumor burden p percentage tumor necrosis induced preoperative chemotherapy p histopathologic subtype marginally significant chondroblastic favorable opposed osteoblastic p findings compared results prognostic factors published literature,C04,0.014043094,0.0021372305,0.004495633,0.0013537261,0.015018517,0.0031372427,0.21953851,0.002267455,0.0017418666,0.0023673465,0.012375631,0.0068106023,0.0341928,0.007922323,0.037106108,0.0037518886,0.35333872,0.0025063157,0.014385114,0.10358342,0.14292529,0.012514405,0.0024867405
detection duodenal gastrinomas operative endoscopic transillumination prospective study ability operative endoscopic transillumination bowel wall detect duodenal gastrinoma evaluated prospectively patients zollinger ellison syndrome results assessed exploratory laparotomy compared results localization techniques twelve duodenal gastrinomas resected patients operative endoscopic transillumination detected gastrinomas sensitivity significantly greater p less either preoperative imaging intraoperative ultrasonography palpation sensitivity operative endoscopic transillumination result ability detect focal areas transilluminate serosal side duodenum mucosal appearances seen endoscope helpful operative endoscopic transillumination detected gastrinomas less cm diameter throughout duodenum patients study duodenal gastrinomas greater frequency previously reported results indicate operative endoscopic transillumination sensitive technique yet described detecting duodenal gastrinomas performed routinely patients zollinger ellison syndrome undergo exploratory laparotomy cure,C04,0.0026241012,0.015028354,0.042896457,0.014175663,0.016350647,0.0033865394,0.10822118,0.048311032,0.0018971084,0.0025783335,0.14246042,0.0053977817,0.084539205,0.0065691858,0.0023075684,0.0040862714,0.30935577,0.0027023891,0.015660487,0.060358208,0.10745127,0.000931723,0.0027103291
diet female sex hormone concentrations intervention study type fat consumed possible mechanism dietary fat may influence development breast cancer influencing concentration female sex hormones study investigated effect alteration type fat consumed concentrations female sex hormones serum female volunteers randomly assigned continue usual meat eating diet change vegetarian diet change diet predominantly vegetarian fish consumed least three times per week change vegetarian fish diet little effect diet total hormone concentrations however amount estradiol significantly decreased vegetarian group nutrient consumption correlated hormone concentrations prolactin directly associate fat consumption sex hormone binding globulin inversely associated fat consumption particularly cholesterol consumption proportion nonprotein bound estradiol directly associated complex carbohydrate consumption,C04,0.002437564,0.0021622411,0.0409776,0.0013697126,0.003394231,0.0031458035,0.20757899,0.0022923148,0.0017622503,0.00239505,0.011244542,0.01681516,0.052073345,0.005667228,0.013951205,0.088106535,0.021595906,0.014308239,0.0027755254,0.12240213,0.3801713,0.00086549047,0.0025076761
dna ploidy prognostic significance stage cutaneous melanoma recent studies suggested presence dna aneuploidy stage cutaneous melanoma carries poor prognosis see experience correlated reports used dna analysis flow cytometry propidium iodide stained nuclei disaggregated formalin fixed paraffin embedded tissue biopsy specimens retrospectively study patients cutaneous stage melanomas patients treated mean follow years thirty nine histograms diploid histograms aneuploid dna content significantly associated conventional prognostic factors including growth pattern ulceration pathologic stage tumor thickness clark level dna aneuploidy significantly related disease free survival predicted poorer prognosis p less stratified tumor thickness lost significance multivariate discriminant function analysis factors melanoma showed six factors independently significant determining prognosis dna content p ranked fifth importance behind growth pattern p less ulceration p less thickness p pathologic stage p less dna content although significantly associated conventional prognostic factors disease free survival best indicator biologic behavior melanomas study investigation usefulness necessary dna content become routine diagnostic modality work stage cutaneous melanomas,C04,0.0020709678,0.0018370518,0.0038642113,0.0011635923,0.022935234,0.0026726918,0.20303765,0.0019475633,0.0014972176,0.0020348476,0.08565342,0.0042597363,0.10863046,0.06728408,0.03189425,0.013218872,0.19196533,0.0021327536,0.0023581015,0.09012152,0.11033678,0.00073532545,0.048348323
cutaneous melanoma bilateral retinoblastoma report case otherwise healthy year old man bilateral enucleation early childhood bilateral retinoblastomas addition two cutaneous melanomas first appearing age years also dysplastic melanocytic nevi history cutaneous melanoma mother retinoblastoma may aggregate families associated dna abnormalities chromosome recent reports emphasized appearance second malignancies retinoblastoma survivors second malignancies include osteosarcoma soft tissue sarcoma cutaneous melanoma cutaneous melanoma also may aggregate families usually setting dysplastic melanocytic nevi features case similar reported cases suggest may greater expected association retinoblastoma cutaneous melanoma,C04,0.0033459761,0.0029680477,0.0062432443,0.0018799675,0.020849919,0.020394048,0.3383232,0.019337837,0.0024189916,0.003287618,0.06311765,0.006904249,0.023920761,0.056872252,0.019138938,0.0052103805,0.054791383,0.0034458006,0.003925578,0.14902505,0.108985096,0.04978068,0.03583332
selective nonoperative management patients referred abnormal mammograms screening mammography provides means detecting clinically occult breast carcinoma question whether abnormal mammograms require biopsy remains unanswered retrospectively reviewed records women referred year period abnormal mammograms selectively assigned biopsy mammographic follow based specific mammographic criteria women initially observed mammographically later found biopsy carcinoma initial assignment mammographic observation delayed recommendation biopsy months respectively patients effect outcome documented benign lesions clinical mammographic criteria women spared biopsy continue monitored closely believe data support use selective approach biopsy based specific mammographic criteria,C04,0.0026917167,0.0023876869,0.09870525,0.0015123658,0.01677806,0.0034738006,0.24414659,0.0025331886,0.0019459913,0.015672408,0.13188544,0.0056237252,0.02763349,0.0071386285,0.0023670278,0.0041915625,0.17513575,0.0027720218,0.042100236,0.10126997,0.10630343,0.0009557308,0.0027759282
ogura memorial lecture moral dilemmas head neck cancer neither morality dilemma defined meaningfully concept practical management head neck cancer although important implications particularly regard ethnic social factors play relatively minor role determining management policy little knowledge intrinsic causes cancer treatment strategy limited radiotherapy surgery desire cure must tempered concern avoid increase patient privations philosophy based upon care patients almost years reflects difficulties applying concept nothing may cause harm offering patient opportunity long term cure,C04,0.0033457258,0.0029678259,0.006471968,0.034272842,0.0046588173,0.03669943,0.3093897,0.003146361,0.002418811,0.019480495,0.016068717,0.055472594,0.02549585,0.008345174,0.002942147,0.021402229,0.12625025,0.0034455429,0.020330042,0.18851079,0.10425474,0.0011879457,0.0034419594
potential deoxy f fluoro glucose fdg detection tumor involvement lymph nodes assess potential fdg pet imaging nodal tumor metastases evaluated uptake normal lymph nodes tumor involved lymph nodes subcutaneous tumor xenografts rodents normal lymph nodes mice rats accumulate fdg moderately developing node blood ratios hr following v injection contrast fdg given subcutaneously healthy sprague dawley rats developed high normal draining lymph node blood ratios versus v injection nude mice subcutaneous human ovarian cancer xenografts fold uptake relative blood normal popliteal lymph nodes subcutaneous tumor xenografts rat breast cancer developed tumor normal node uptake ratios tumor blood ratios hr postinjection mouse nodes involved c murine b cell lymphoma mean node blood ratios tumored node normal lymph node uptake thus fdg given intravenously subcutaneusly due high normal nodal uptake potential agent detection metastatic tumors regional lymph nodes using pet scanning,C04,0.002205978,0.0019552163,0.025437115,0.011865826,0.109778576,0.0028446072,0.18022366,0.002072836,0.001593523,0.0021657348,0.035864502,0.040099133,0.22186095,0.062935196,0.0019382989,0.07809081,0.06497019,0.0023037032,0.0025097814,0.015428013,0.13079935,0.0007826237,0.002274346
distinct characteristics lymphokine activated killer lak cells derived patients b cell chronic lymphocytic leukemia b cll factor b cll serum promotes natural killer cell like lak cell growth show lymphokine activated killer lak cell precursors derived patients b cell chronic lymphocytic leukemia b cll cultured presence recombinant interleukin normal human serum nhs develop primarily nk cell like cd lak cells whereas identically prepared lak cell precursors normal subjects develop mainly cell like cd cd lak cells b cll lak cells exhibited greater proliferative capacity normal lak cells normal lak cells grown b cll serum instead nhs proliferation increased nk cell levels also increased found b cll lak cells suggesting b cll serum contains factor promotes nk cell like growth lak cells derived normal b cll patients demonstrated similar lytic activity toward k raji cells growth b cll serum reduce lytic potential thus altered phenotype growth exhibited b cll lak cells normal lak cells grown b cll serum lead abnormalities cytolytic functions propose instead predominance nk like cells b cll lak cell populations presence nk cell like growth factor b cll serum reflect abnormalities related nk cell mediated b cell regulation ie either inhibition normal b cell growth growth stimulation leukemic clone b cll,C04,0.0016048944,0.0014234248,0.025211697,0.0009016589,0.0022346168,0.0020709138,0.1716533,0.017512338,0.001160107,0.0015766852,0.007705821,0.011101079,0.03164289,0.40680757,0.0014111086,0.025796225,0.03640643,0.038580697,0.009582729,0.020794958,0.17373958,0.000569761,0.010511487
expression murine renin genes subcutaneous connective tissue renin promoter large tumor antigen antigen fusion gene constructed provide reporter function renin expression transgenic mice transgenic mice gave rise tumors subcutaneous soft tissue attributed transgene expression site immunohistochemical analysis transgenic fetuses several independent lines revealed scattered antigen containing mesenchymal cells fibroblasts subcutaneous layer skin panniculus carnosus muscle skin skeletal muscle body wall localization consistent location overt tumorigenesis adult mice pattern specific renin antigen fusion gene immunohistochemical staining observed transgenic fetuses containing heterologous promoter antigen fusion gene northern blot analysis tumor rna indicated tumors expressed antigen endogenous renin gene ren c addition multiple renin genes introduced crossing transgenic mice nontransgenic dba j mice contain another allele ren locus well duplicated locus ren resultant tumors expressed ren gene northern blots used analyze renin expression subcutaneous tissue normal mice fully processed renin mrna detected eviscerated day postcoitus fetal newborn carcasses newborn skin data indicate renin expressing cell population fetal newborn subcutaneous tissue,C04,0.0017400876,0.0015435446,0.0032468229,0.0009777565,0.081530124,0.0022456737,0.17150475,0.0016436013,0.043349903,0.0017097383,0.030247929,0.0036126932,0.012971187,0.16183077,0.009761655,0.011165042,0.02405644,0.010867897,0.0019813457,0.05837151,0.18518029,0.0006178419,0.1798434
prognostic significance nondiploid dna determined flow cytometry sporadic familial medullary thyroid carcinoma clarify role dna measurements predicting outcome surgical treatment medullary thyroid carcinoma mtc performed flow cytometric analysis nuclear suspensions mtc tumors patients patients sporadic tumors patients familial tumors survivors followed mean years dna content normal patients abnormal nondiploid patients ten year cause specific mortality rates diploid tetraploid polyploid aneuploid tumors p greater nondiploid tumors sporadic p multiple endocrine neoplasia familial cases p none patients tnm stage disease died mtc patients tnm stages ii iii iv disease dna nondiploid tumors associated increased deaths mtc cox proportional hazards model involving patients adjusted disease stage inheritance pattern nondiploid dna independently associated increased deaths mtc p identical cox model restricted dna diploid tumors phase fraction remained significant variable p adjustment stage inheritance pattern therefore conclude dna measurements role play predicting outcome surgical treatment mtc,C04,0.0019913525,0.001766429,0.0037156572,0.01065786,0.07989474,0.0025699441,0.20305976,0.001872692,0.0014396592,0.0019566207,0.10187339,0.023358425,0.056195226,0.016266234,0.0017698623,0.012737895,0.24097036,0.002052047,0.0022674478,0.09974283,0.069994025,0.0007070569,0.06314052
rhabdomyosarcomas head neck mr imaging evaluation determine typical magnetic resonance mr signal intensity characteristics rhabdomyosarcomas short repetition time tr short echo time te weighted long tr proton density weighted images patients rhabdomyosarcomas head neck retrospectively reviewed seven patients received gadopentetate dimeglumine injections common mr appearance homogeneous mass hyperintense muscle fat long tr long te images isointense minimally hyperintense muscle short tr short te images lesions patients received gadopentetate dimeglumine enhanced markedly two lesions intratumoral hemorrhage six markedly heterogeneous signal intensity similar mr signal intensity patterns described lymphomas nasopharyngeal carcinomas forte mr imaging lies ability delineate precisely extent rhabdomyosarcoma,C04,0.0034574282,0.0030669111,0.023184609,0.0019425878,0.12198059,0.004461991,0.15132947,0.03672067,0.0359755,0.0033971262,0.016944207,0.042668264,0.024882887,0.008018555,0.019750064,0.038847618,0.1541142,0.0035605778,0.0039367904,0.120416604,0.17655885,0.0012276071,0.0035568746
localization peptide content endocrine pancreatic tumors endocrine pancreatic tumors contain frequently secret neurohormonal peptides phenomenon used diagnostic classifying tool study analyzes patients operated endocrine pancreatic tumor including diagnostic procedures localization methods insulinoma cases patients positive arteriography selective pancreatic vein samplings positive immunoreactivity showed besides insulin tumors also contained peptides four gastrinoma cases arteriography positive three selective vein sampling localized tumor tumor content peptides showed mixed patterns four glucagonomas arteriography positive venous sampling performed three cases also positive five pancreatic polypeptide containing tumors pp omas arteriography positive four sampling performed two positive pp omas peptide pattern showed tumors frequently contain several peptides used selective pancreatic vein sampling cases positive result cases arteriography negative sampling results helped surgeon find tumor peptide pattern tumors varied greatly tumors multihormonal,C04,0.0018996799,0.0016851109,0.0035446056,0.0010673526,0.11300547,0.013029926,0.13221632,0.03856783,0.0013733839,0.0018686384,0.24374238,0.003907278,0.01187491,0.006038513,0.0016705305,0.030545194,0.05059239,0.0019563553,0.06508853,0.022740783,0.21515203,0.0006745073,0.03775828
unusual epidural vascular spinal lipoma year old child case report review literature epidural lipomas usually benign tumors affecting spinal cord report unusual presentation cervicothoracic spinal lipoma associated cervical dysraphism young boy diagnostic options using magnetic resonance imaging gadolinium diethylenetriaminepentaacetic acid discussed pathway early diagnosis occult spinal lesions,C04,0.0051966114,0.0046096537,0.009696337,0.002919764,0.10786695,0.0067064976,0.35439223,0.050974842,0.0037569187,0.05541821,0.08048034,0.010688436,0.03239373,0.037090413,0.004569769,0.008092204,0.047608517,0.005351648,0.0059171063,0.0942034,0.06487516,0.0018451279,0.005346082
primary non hodgkin cell lymphoma esophagus case peculiar endoscopic ultrasonographic pattern report case primary esophageal non hodgkin cell lymphoma young white female admission endoscopy revealed large irregularly shaped esophageal ulcerations super imposed candidiasis endoscopic ultrasonography assess submucosal alterations periesophageal involvement revealed diffuse hypoechogenic thickening mm esophageal wall pattern consistent lymphomatous infiltration definitive diagnosis made aid histology immunohistochemistry,C04,0.004419132,0.0039199907,0.029636998,0.0024829302,0.006232128,0.0057031205,0.27139094,0.033813816,0.024586586,0.0043420573,0.14646651,0.009089311,0.09142651,0.052948903,0.0038860734,0.006910372,0.045917694,0.0045686327,0.005031832,0.07297373,0.1681374,0.0015690733,0.0045462404
immunocytochemical estrogen progestin receptor assays breast cancer monoclonal antibodies histopathologic demographic biochemical correlations relationship endocrine response survival breast cancer specimens women assayed estrogen receptors er using immunocytochemical assay ica employing monoclonal antiestrophilin antibody h sp gamma results showed significant correlation biochemical er determinations well tumor grade menopausal status cases results progesterone receptor assay ica using monoclonal anti pgr antibody kd also correlated significantly biochemical pgr measurements erica pgrica positivity significantly frequent postmenopausal white women colloid carcinomas likely erica positive pgrica positive whereas medullary carcinomas often negative patients advanced mammary carcinoma results erica pgrica closely related endocrine response er pgr dextran coated charcoal assay dcc women stage stage ii breast cancer erica significantly associated disease free survival analysis cox proportional hazard model however showed pgrica best predictor survival disease free survival women stages disease data indicate ica predictive prognosis biochemical er pgr ease ica performance coupled results indicate method acceptable substitute dcc analyzing breast cancers er pgr,C04,0.0019353112,0.0017167176,0.0036110901,0.0010873724,0.012063355,0.002520382,0.26164055,0.0018208345,0.020132642,0.001901557,0.09929712,0.013350243,0.06472007,0.07614764,0.0017018638,0.003013682,0.11218275,0.039420146,0.0022036366,0.12982607,0.1470206,0.0006871587,0.0019992138
decrease cerebral metabolic rate glucose high dose methotrexate childhood acute lymphocytic leukemia measured changes regional cerebral metabolic rate glucose rcmrglu using f fluorodeoxyglucose positron emission tomography assessment neurotoxicity childhood acute lymphocytic leukemia treated high dose methotrexate hd mtx therapy studied children acute lymphocytic leukemia mean age years treated hd mtx mg kg mg therapy cmrglu hd mtx therapy reduced patient central nervous system leukemia treated largest total doses intrathecal mtx mtx hd mtx cmrglu whole brain hd mtx therapy reduced average p less reductions cmrglu patients correlated total doses mtx r p less systemic hd mtx r p less cmrglu cerebral cortex especially frontal occipital cortex reduced noticeably basal ganglia white matter suggest measurement changes rcmrglu hd mtx therapy useful detecting accumulated mtx neurotoxicity,C04,0.029052021,0.00238745,0.0050219656,0.0015122157,0.0037486292,0.0034734558,0.22448531,0.002531072,0.0019457983,0.015673999,0.022587463,0.031589825,0.1682707,0.019786635,0.0023669058,0.03024813,0.08100932,0.0027717468,0.0030646112,0.05327456,0.29146245,0.000955636,0.0027801043
validation intermediate end points cancer research investigations using intermediate end points cancer surrogates quicker smaller less expensive studies use malignancy end point present strategy determining whether given biomarker valid intermediate end point exposure incidence cancer candidate intermediate end points may selected case series ecologic studies animal experiments prospective cohort sometimes case control studies may used quantify intermediate end point cancer association appropriate measure association attributable proportion intermediate end point valid cancer surrogate attributable proportion close close usually attributable proportion close neither case valid surrogacy requires intermediate end point mediate established exposure cancer relation would turn imply exposure effect would vanish adjusted intermediate end point discuss relative advantages intervention observational studies validation intermediate end points validation strategy also may applied intermediate end points adverse reproductive outcomes chronic diseases cancer,C04,0.002251598,0.0019972797,0.016405558,0.001265081,0.0031352788,0.0029058044,0.22206134,0.00211743,0.0016278051,0.0022123272,0.2128947,0.102014765,0.040451743,0.0067159156,0.0019799983,0.025297394,0.05169787,0.0025251217,0.0025637755,0.21192369,0.08283973,0.0007994606,0.002316361
metabolism human gliomas assessment h mr spectroscopy f fluorodeoxyglucose pet localized hydrogen magnetic resonance mr spectroscopy fluorine fluorodeoxyglucose fdg positron emission tomography pet employed obtain metabolic information intracranial gliomas advantages difficulties associated comparison results two modalities realized forty patients studied h mr spectroscopy mr signal intensities lactate n acetylaspartate naa choline creatine volume interest containing tumor contralateral volume obtained evaluated naa signal intensities generally decreased tumor spectra choline signal intensities elevated h mr spectroscopy unsuccessful eight patients fdg pet scans obtained four patients successful mr spectroscopic examinations lactate signal intensity detected patients successful h mr spectroscopic fdg pet studies lactate signal intensities observed lesions shown fdg pet hypermetabolic well lesions found hypometabolic,C04,0.0030048862,0.002665484,0.020126635,0.001688323,0.07777984,0.0038779622,0.20214692,0.0028258313,0.0021723988,0.0029524772,0.2033685,0.0061804764,0.060864072,0.038630806,0.075372934,0.019204875,0.12125352,0.003135103,0.003421505,0.04031903,0.08227602,0.0010669259,0.025665512
loss expression blood group antigen h associated cellular invasion spread oral squamous cell carcinomas membrane bound carbohydrates may influence metastatic behavior cancer cells forty two squamous cell carcinomas scc buccal maxillary alveolar mucosa studied retrospectively using monoclonal antibody reacts blood group h type chain structure immunoperoxidase avidin biotin peroxidase complex staining technique h antigen staining within entire tumor correlate stage tumor e tumor spread however loss staining within invasive sites tumors correlated significantly stage tumor development histologic grade malignancy findings support view features regarding cells deeper parts carcinomas important clinical behavior tumors loss h antigen expression related stage tumor invasion carcinoma cells,C04,0.002527513,0.00224203,0.018765723,0.0014201555,0.089173645,0.0032618872,0.28870824,0.014604921,0.0018272793,0.0024834299,0.048209146,0.041910943,0.069919474,0.12962201,0.0022226311,0.0039358633,0.061834782,0.022906328,0.0028779453,0.074897386,0.06421029,0.000897428,0.051540922
drug induced dna damage tumor chemosensitivity cytotoxic drugs act principally damaging tumor cell dna quantitative analysis interaction provides basis understanding biology therapeutic cell kill well rational strategy optimizing predicting tumor response recent advances made possible correlate assayed dna lesions cytotoxicity tumor cell lines animal models patients malignant disease addition many complex interrelationships dna damage dna repair alterations gene expression response dna damage defined techniques modulating dna damage cytotoxicity using schedule specific cytotoxic combinations dna repair inhibitors cell cycle manipulations adjunctive noncytotoxic drug therapy developed critical therapeutic targets identified within tumor cell subpopulations genomic dna alike importantly methods predicting clinical response cytotoxic therapy using vitro markers tumor cell sensitivity vivo measurements drug induced dna damage becoming reality advances expected provide strong foundation development innovative cytotoxic drug strategies next decade,C04,0.01060861,0.0016556093,0.022509472,0.010080466,0.066717625,0.011359739,0.31549352,0.0017552057,0.0013493398,0.001833869,0.047340985,0.003838873,0.03369871,0.06676311,0.0016412842,0.012477421,0.043938283,0.0115520265,0.0021251957,0.032078654,0.18605737,0.0006626986,0.114461884
molecular structure major insulin mitogen activated kda protein kinase molecular structure rat hepatoma kda insulin mitogen stimulated protein kinase obtained molecular cloning compared rat homolog kda xenopus protein kinase alpha kinases cloned h hepatoma cdna libraries kda kinase calculated molecular mass da exhibits single catalytic domain closely related amino acid sequence identity amino terminal kinase c like domain rat p kinase calculated molecular mass da strong similarity extends residues carboxyl terminal catalytic domain identity corresponding region also conserved among kinase c family outside segment approximately amino acids structures p p kinases diverge substantially p kinase known activated serine threonine phosphorylation unidentified insulin mitogen activated protein kinases model regulation p protein kinase activity proposed wherein low activity unphosphorylated enzyme results binding basic inhibitory pseudosubstrate site located carboxyl terminal extended catalytic domain acidic substrate binding region located amino terminal catalytic domain substrate binding thereby prevented kinase activation requires displacement inhibitory segment proposed occur consequent multiple phosphorylation putative autoinhibitory segment contains several serine threonine residues followed directly proline residue motif may prevent autophosphorylation permit transphosphorylation two serine residues reside maturation promoting factor mpf cdc consensus motif thus hormonal regulation kinase may involve action mpf cdc protein kinases related substrate specificity,C04,0.0015118999,0.015978107,0.039871577,0.00084947486,0.08985468,0.040862758,0.1575546,0.016578544,0.0010930363,0.0014855304,0.033534817,0.01035157,0.011320685,0.026328461,0.0013295265,0.0554341,0.021195322,0.11460879,0.0089633195,0.041043244,0.19070137,0.0005368207,0.119011745
signet ring cell carcinoma ampulla vater describe variant carcinoma ampulla vater knowledge previously described classic signet ring cells represented predominant cell type admixed poorly differentiated tumor cells chromogranin positive findings raise possibility amphicrine tumor ampulla,C04,0.0067171655,0.005958461,0.012533534,0.0037745535,0.10690851,0.008668852,0.21710305,0.006316904,0.0048562116,0.0066000097,0.05327529,0.013815926,0.041580487,0.16159612,0.005906906,0.010460024,0.12240013,0.006917567,0.0076966826,0.08891767,0.09869125,0.0023850214,0.0069196997
tissue preparation simultaneous flow cytometric quantitation tumour associated antigens dna solid tumours multiparameter flow cytometric assay simultaneous study tumour associated antigens taa dna fresh solid tumours devised cell suspensions prepared disaggregating unfixed solid tumour samples mechanically stainless steel mesh indirect immunofluorescence used identify taa dna stained propidium iodide cell morphology well preserved cell clumping negligible high quality indirect immunofluorescence quality indirect immunofluorescence dna staining obtained technique simple rapid reproducible multiparameter assays developed study prognostic indicators membrane oncoproteins receptors multidrug resistance solid tumours suitable panel antibodies technique might become aid differential diagnosis biochemical diagnosis solid tumours,C04,0.0029625033,0.0026278882,0.03429921,0.016002493,0.01843774,0.018163038,0.28098997,0.002785974,0.002141758,0.0029108333,0.09579452,0.020418484,0.101402074,0.12986879,0.016940137,0.0046132337,0.026885383,0.01739145,0.0034944948,0.0463241,0.065405965,0.0010518773,0.08908804
growth group rotaviruses human liver cell line recent observations children rotavirus gastroenteritis infant mice given rotavirus vaccine oral administration suggest well known gastrointestinal pathogen may infect liver examine possibility susceptibility hep g cells infection variety rotavirus strains tested cells used considered well differentiated exhibit many liver specific functions hep g cells supported growth simian strain rhesus rotavirus mmu strain currently used vaccine trails support growth human strain ds price st rhesus rotavirus infection cytopathic resulted release lactate dehydrogenase rhesus rotavirus growth hep g cells displayed trypsin enhanced infectivity inhibited pretreatment cells arthrobacter ureafaciens neuraminidase neuraminidase clostridium perfringens hep g cells also permissive another simian strain sa bovine strain uk single gene substitution reassortants containing vp major outer capsid neutralization protein human rotavirus strain remaining genes either rhesus rotavirus uk general uk reassortants produced lower levels antigen rhesus rotavirus reassortants hep g cells hepatic cell lines may prove useful tools explore hepatotropic potential wild type rotaviruses candidate vaccine strains,C04,0.002135302,0.0018941193,0.003984252,0.001199739,0.023783471,0.0027557183,0.33153173,0.0020080637,0.0015437283,0.012435078,0.03941532,0.015118598,0.015441148,0.19863285,0.0018777306,0.043515597,0.027969386,0.033191483,0.0024313554,0.052272078,0.12223657,0.0007581681,0.0638685
short term tamoxifen plus chemotherapy superior results node positive breast cancer three hundred eleven patients node positive breast cancer randomized one three adjuvant treatments cyclophosphamide cytoxan methotrexate fluorouracil tamoxifen citrate tamoxifen bacillus calmette guerin vaccination local therapy patients modified radical mastectomy estrogen receptors measured primary tumors patients stratified number positive nodes one three nodes three nodes estrogen receptor value less femtomole mg greater equal femtomole mg follow available mean maximum years study efficacy short term tamoxifen apparent chemoimmunotherapy alone continues significant prolonged follow addition tamoxifen chemoimmunotherapy significantly prolonged disease free survival among patients estrogen receptor positive tumors postmenopausal larger tumors greater cm extensive axillary node involvement three nodes tamoxifen improved overall survival patients estrogen receptor positive tumors larger cm addition bacillus calmette guerin cytoxan methotrexate fluorouracil tamoxifen significantly alter disease free overall survival,C04,0.0025582097,0.014651156,0.017155815,0.0014373537,0.05336217,0.003301503,0.20239653,0.0024057713,0.0018494717,0.0025135912,0.0966017,0.02988587,0.18358372,0.0062172078,0.002249625,0.0039836643,0.22964968,0.015017791,0.0030514547,0.025276601,0.08692868,0.01329061,0.0026317919
effect somatostatin analogue octreotide blood flow endocrine tumors metastatic liver angiographic evaluation effect octapeptide analogue somatostatin octreotide tumor blood flow evaluated angiography eight patients hepatic endocrine tumors one patient primary intrahepatic gastrinoma two patients hepatic metastases gastrinomas two patients vipomas vasoactive intestinal polypeptide secreting tumor three patients carcinoid tumors octreotide caused marked decrease tumor blood flow two patients gastrinomas two vipomas one patient could evaluated due lack tumor blush control angiogram patients carcinoid tumors octreotide caused slight reduction blood flow tumors two patients change one patient octreotide markedly decreased gastrin gastric acid secretion two three patients gastrinomas lowered vip stopped diarrhea patients vipomas controlled symptoms two three patients carcinoid tumors vasoactive effect octreotide hepatic endocrine tumors may direct action tumor blood supply secondary inhibition endocrine tumor cell secretion consequent decreased blood flow,C04,0.0020519057,0.0018190817,0.013743447,0.00115221,0.1418478,0.0026465475,0.14895898,0.021748036,0.0014825717,0.0020221882,0.021084514,0.0042445017,0.15370175,0.014789464,0.0018033423,0.062641405,0.16887173,0.0021216723,0.012235301,0.0139969345,0.19430606,0.00072813244,0.012002417
effective ultraviolet irradiation platelet concentrates teflon bags several plastic materials used blood storage evaluated ability transmit ultraviolet b uvb light plastic bag manufactured sheets transparent teflon efficiently transmitted uvb light employed subsequent functional studies lymphocytes platelets exposed uvb light contained bags vitro experiments showed uvb dose dependent abrogation lymphocyte responder stimulator functions concurrent preservation platelet aggregation responses phase pilot study uvb treated platelet concentrates administered four bone marrow transplant recipients adverse effects attributable transfusions observed patients showed clinically effective transfusion responses patient developed lymphocytotoxic hla platelet antibodies studies suggest platelets effectively irradiated uvb light closed system however numerous variables including container material volume composition contents steady exposure versus agitation exact uv wavelength must considered,C04,0.0030490628,0.002704671,0.005689235,0.001713144,0.0042457236,0.0039349743,0.26903817,0.017618783,0.0022043367,0.0029958833,0.015597097,0.0074897534,0.052332643,0.04003275,0.0026812688,0.019505661,0.06315734,0.017896356,0.018211612,0.030379781,0.41527215,0.0010826114,0.0031670143
increased expression multidrug resistance gene undifferentiated sarcoma analyzed multidrug resistance gene mdr gene expression patient undifferentiated sarcoma liver using cloned cdna mdr gene tissue samples available time initial diagnosis two intracranial relapses chemotherapy regimen including doxorubicin teniposide level mdr gene expression increased sevenfold intracranial tumor time first relapse fold second relapse case may example acquired multidrug resistance associated overexpression mdr gene,C04,0.004070322,0.02331306,0.0075947987,0.0022869478,0.025372501,0.06436754,0.16196546,0.00382778,0.0029426615,0.0039993306,0.12698793,0.008371875,0.028498072,0.009511866,0.0035793385,0.045045845,0.096991,0.004499896,0.00463466,0.034344446,0.2226935,0.0014452235,0.11365592
constitutional symptoms patients germ cell neoplasms patient mediastinal germ cell neoplasm evidenced fever weight loss pruritus painful adenopathy ingestion alcohol retrospective review revealed percent patients advanced germ cell neoplasm evidence constitutional symptoms presentation,C04,0.0067170835,0.005958388,0.012533381,0.0037740553,0.009427351,0.008668746,0.3220354,0.0063168267,0.0048561525,0.006693979,0.030891119,0.013815757,0.04157998,0.11300203,0.005906834,0.010459896,0.18459502,0.006934748,0.0076483875,0.09799415,0.09089544,0.0023849923,0.006910288
induction donor type chimerism murine recipients bone marrow allografts different radiation regimens currently used treatment leukemia patients three radiation protocols currently used treatment leukemia patients bone marrow transplantation bmt investigated murine model c bl c h hej bm allograft rejection include single dose total body irradiation gy tbi delivered dose rate gy min b fractionated tbi gy administered six fractions gy twice day days delivered dose rate gy min c hyperfractionated tbi gy administered fractions gy three times day days delivered dose rate gy min donor type chimerism weeks bmt hematologic reconstitution day bmt found groups compared results obtained mice conditioned gy tbi delivered dose rate gy min routinely used murine model results parameters showed marked advantage single dose gy tbi treatments advantage found equivalent three fourfold increment bm inoculum compared hyperfractionated radiation afforded least favorable conditions development donor type chimerism fractionated radiation protocol equivalent efficacy results obtained mice irradiated single dose gy tbi afforded smaller significant advantage hyperfractionated protocol model also used test effect radiation dose rate development donor type chimerism significant enhancement found increase dose rate gy min enhancement could achieved dose rate increased gy min survival high dose rate reduced results demonstrated indirectly dose rate affects expression host type pluripotent stem cells progeny appear weeks treatment gy tbi delivered dose rate gy min eradicated radiation delivered dose rate gy min,C04,0.0013097206,0.0011617227,0.015117806,0.0007359302,0.0018237049,0.0016901684,0.21465805,0.0012316084,0.00094681693,0.0012868056,0.021667315,0.05508991,0.10798818,0.05680649,0.0059115402,0.015781509,0.07554386,0.039384864,0.00781259,0.026617363,0.3387968,0.00046500828,0.008172259
fine needle aspiration biopsy diagnosis management fibroadenoma breast cytological histological biopsies obtained breast lumps clinically diagnosed fibroadenomas per cent lesions benign per cent confirmed fibroadenomas histologically cytology benign per cent inadequate diagnosis per cent remaining lesions included three breast cancers one lymph node hodgkin disease group cytology inadequate diagnosis per cent including one breast cancer lesion benign cytology subsequently shown malignant study supports view clinical diagnosis cytology accurate diagnosis benign breast disease type breast cancer may rarely present clinical features fibroadenoma lesions studied assess fully performance cytological biopsy detecting small mobile lesions non excisional policy therefore include prolonged follow repeat biopsy,C04,0.002879154,0.002553953,0.061123606,0.0016177515,0.073701955,0.0037156981,0.2882545,0.0027075913,0.0020815001,0.016754111,0.13699672,0.0337984,0.018186994,0.0066623692,0.0025318554,0.0045386967,0.10017258,0.017811546,0.017206986,0.15193436,0.050782885,0.001022283,0.0029644687
endoscopic radiographic evaluation murine colon endoscopic radiographic techniques widely applicable evaluation chemically induced murine colon cancer authors investigated methods cleansing rat colon refined endoscopic radiographic techniques compared total colonoscopy tc air contrast acbe single contrast barium enema scbe findings obtained necropsy rats dimethylhydrazine dmh induced colon cancer gastrograffin enemas bisacodyl suppositiories showed complete evacuation solid feces sprague dawley rats treated dmh colons cleansed underwent tc mm olympus bronchoscope either scbe acbe colonoscopy acbe equally sensitive respectively although scbe significantly insensitive identifying lesions p less study demonstrates mechanical cleansing rat colon feasible tc barium radiology done routinely mechanical cleansing tc double contrast sensitive identifying colon lesions techniques provide means manipulation murine tumors vivo surveillance,C04,0.0028397825,0.0025190287,0.045551218,0.0015955579,0.07274891,0.003664887,0.14993191,0.0026705659,0.0020530364,0.002790253,0.12909009,0.0058776774,0.06695788,0.049326573,0.002497321,0.004422132,0.053022932,0.002931643,0.00323351,0.06441261,0.32793027,0.0010083036,0.0029239298
survival discriminants differentiated thyroid cancer since american cancer society illinois division published end results major cancer sites drawn patient data contributed voluntarily hospital cancer registries throughout state current study undertaken part apprehend information regarding contested areas management patients differentiated papillary follicular thyroid cancer total patients either papillary follicular carcinoma thyroid different illinois hospitals providing years follow information life table analysis retrospectively analyzed demographic disease treatment related predictors survival multivariate analysis using cox proportional hazards method made stage age race sex morphology history radiation exposure presence positive lymph nodes initial surgical treatment postoperative iodine therapy replacement suppressive thyroid hormone treatment statistically significant p less equal predictors favorable survival thyroid cancer low stage ii young age less years white race female sex administration postoperatively either thyroid hormone radioactive iodine factors influence survival lymph node status choice initial surgical treatment history prior irradiation suggest prospective clinical trial impracticable retrospective analysis large detailed database available cooperating hospital based tumor registries may yet provide useful insights solutions cancer management problems,C04,0.0015333185,0.008780224,0.010253457,0.0082700625,0.016986314,0.0019788274,0.24915841,0.0014419514,0.015949687,0.0015065755,0.03675314,0.1100138,0.033214122,0.003820808,0.016211182,0.009807601,0.20951067,0.0015811747,0.031424407,0.15842216,0.06302916,0.0005444257,0.009808495
time recurrence varies inversely thickness clinical stage cutaneous melanoma thickness tumor identified principal prognostic factor cutaneous malignant melanoma however time recurrence conclusively related thickness retrospective study patients primary cutaneous malignant melanoma recurred conducted clarify relationship investigate possible independent relationships age diagnosis sex patients time recurrence results analysis linear regression revealed inverse linear relationship thickness time recurrence p less patients years age time diagnosis shown relapse sooner less years age p sex significant factor predicting time recurrence p greater results suggest thickness tumor provides indication time recurrence patients destined recur stress need long term surveillance patients history malignant melanoma possibility late relapse even thin lesions,C04,0.0025904775,0.0022978827,0.0052206586,0.0014554836,0.042997696,0.003343146,0.18635426,0.0024361163,0.0018727998,0.0025452962,0.05610872,0.005328117,0.04768026,0.006699029,0.05204853,0.029267585,0.219047,0.002671458,0.015405936,0.16792417,0.14311406,0.0009197844,0.0026715412
comparative study cutaneous cell lymphoma adult cell leukemia lymphoma clinical histopathologic immunohistochemical analyses important disease entity distinct cutaneous cell lymphoma ctcl japan adult cell leukemia lymphoma atl usually shows phenotype ctcl e helper inducer cell phenotype cd cd usually involves skin clinically ctcl atl heterogeneous nature study demonstrated differences ctcl atl terms clinical immunopathologic cell surface features patients atl predominant clinical findings peripheral lymph node involvement skin lesions hepatosplenomegaly leukemic manifestations aggressive course patients ctcl contrast skin lesions predominated onset disease relatively good prognosis demonstrated phenotypic heterogeneity atl skin e cd cd cd cd cd cd demonstrated expression leu cd leu cd ra h high skin infiltrating atl cells peripheral blood lymph node atl cells compared skin infiltrating ctcl cells expression cd il r cd okt hla dr hla dq higher skin infiltrating atl cells ctcl cells expression cd b high cd ra h low skin infiltrating atl ctcl cells compared peripheral blood lymph node atl cells expression cd ro uchl significantly high skin infiltrating ctcl cells compared atl cells significant phenotypic difference atl cells ctcl cells expression leu lymph node homing receptor cd cd antigens cell surface main phenotypic difference skin infiltrating atl ctcl cells peripheral blood lymph node atl cells expression cd cd ra findings confirm difference antigen expression cell surface might reflect clinical features atl ctcl suggest predominant phenotype peripheral blood lymph node atl cells naive relatively immature activated cells ctcl cells previously activated memory cells words ctcl cells share origin atl cells observations support concept atl disease distinct ctcl,C04,0.001370504,0.0012157055,0.0026138963,0.00801397,0.081683524,0.008388599,0.21711943,0.0012888386,0.0009908134,0.021248292,0.007649659,0.0028662863,0.09618007,0.22014278,0.0012051867,0.00213416,0.029321138,0.030225502,0.0015605205,0.058787324,0.15076186,0.0071103633,0.04812159
bcr abl recombinant dna analysis versus karyotype diagnosis therapeutic monitoring chronic myeloid leukemia karyotype bcr abl recombinant dna analyses two means detecting chromosomal aberration chronic myeloid leukemia authors compared two methods retrospective study patients cml found bcr abl dna recombinant event patients philadelphia chromosome achieve sensitivity battery two bcr probes three restriction enzymes necessary authors propose sequential algorithm efficient use probes enzymes patients bcr abl rearrangement detected bgl ii digest commercial probe additional patients detected second assay membrane rehybridized combination bcr probe one patient required additional restriction enzyme digest bamh detect recombinant event probe karyotype analysis used determine cytogenetic remission patients cml therapy authors studied use dna analysis southern blot technique detect decrease relative number leukemic cells dilution studies densitometric scanning autoradiographs authors able detect decrease relative number cells bcr abl recombinant event authors report preliminary results three patients compared karyotype recombinant dna analysis multiple time points clinical course conclusion bcr abl recombinant dna analysis superior karyotype diagnosis cml used monitoring treated patients,C04,0.0016835028,0.0014933511,0.044140145,0.009052461,0.010637114,0.0021726482,0.27275762,0.0015831864,0.02546408,0.0016541404,0.16675259,0.0034626436,0.020436581,0.034572244,0.0014804299,0.002621564,0.1391697,0.0017337288,0.0019169156,0.025025794,0.093577094,0.0005977507,0.13801473
community lifestyle characteristics risk acute lymphoblastic leukaemia children high rates leukaemia children young people associated features community isolation population growth incidence data collected two specialist registries used compare incidence rates ward level relevant ward characteristics derived routine census ordnance survey data england wales excess risk childhood acute lymphoblastic leukaemia found wards farthest large urban centres excess greatest wards higher socioeconomic status children aged years childhood peak two fold excess seen findings general support hypothesis childhood leukaemia infectious aetiology,C04,0.0031904785,0.0028301135,0.005953102,0.0017925997,0.0044440003,0.0041174786,0.20971736,0.0030025195,0.0023065738,0.05250492,0.07872319,0.068332694,0.06846286,0.023070652,0.0028056263,0.005237238,0.046154987,0.0230716,0.049959335,0.27488077,0.06501635,0.001132823,0.003292753
extended neck dissection time crile described radical neck dissection surgical procedure became popular management metastatic cancer neck past two decades modified neck dissection effectively utilized conservation function cosmesis achieving oncologic goals however several instances standard procedures adequate resection malignant tumors although definite trend toward conservation procedures extended neck dissection often necessary especially patients n n disease apart standard structures removed radical neck dissection structures removed extended neck dissection include skin digastric muscle hypoglossal nerve vagus nerve sympathetic chain ramus mandibularis carotid artery tracheo esophageal nodes etc past seven years performed extended neck dissections patients n n disease neck nine patients unknown primaries thirteen patients primary tumors oral cavity laryngopharynx five patients primary tumor salivary glands two patients metastatic melanoma patients underwent extensive skin excision pectoralis myocutaneous flap reconstruction patients received postoperative radiation therapy one patient died cardiac problems weeks operation local control achieved difficult region local control disease behind mastoid process difficult problems patients involvement subdermal lymphatics data suggests definite situations extended neck dissection indicated satisfactory local control nodal disease,C04,0.0018997433,0.0016851671,0.0035447238,0.0010673882,0.05782533,0.0116385585,0.23326337,0.038568556,0.019756913,0.0018666093,0.012678514,0.06916468,0.056589294,0.004889666,0.0016705863,0.048896004,0.3059082,0.0019564207,0.01133869,0.017322628,0.06114129,0.0006745298,0.036653157
lewis system alterations gastric carcinogenesis alterations expression type blood group related antigens lewis b examined immunohistochemically consecutives gastric biopsy surgical specimens patients gastric carcinoma abh lewis phenotype secretor status patients correlated histologic findings anomalous expression lewis antigen found gastric biopsy specimens lewis b phenotype patients prevalence anomaly increased evolution premalignant process agreement commonly accepted model gastric carcinogenesis thus anomalous lewis antigen appeared gastric dysplasia cases intestinal metaplasia atrophic gastritis superficial gastritis alterations found subjects normal gastric mucosa forty seven lewis b phenotype gastric carcinoma patients showed antigenic alterations tumor cells anomalous lewis antigen loss lewis antigens gastric specimens anomalous lewis antigen present areas intestinal metaplasia dysplasia away area neoplastic transformation expression lewis antigen lewis b phenotype patients frequent phenomenon gastric neoplastic cells could result blocked synthesis lewis b antigen accumulation precursors findings suggest gastric carcinogenesis antigenic alterations may precede neoplastic transformation anomalous lewis antigen could constitute significant index severity histologic lesion contribute identifying high risk individuals,C04,0.0017703146,0.0015703575,0.018479677,0.0009946855,0.019605232,0.0023028448,0.40395352,0.0101694465,0.0012798586,0.0017394382,0.10309293,0.012211412,0.054065812,0.11142223,0.0015567701,0.0027719396,0.06471034,0.027733602,0.0020157637,0.05248423,0.07791046,0.0006285744,0.027530596
human macrophage colony stimulating factor induces macrophage colonies l phenylalanine methylester treatment human marrow macrophage colony stimulating factor csf well known effects murine bone marrow colony stimulating activity human bone marrow controversial treatment human bone marrow l phenylalanine methylester pme macrophage colonies cfu induced csf dose dependent fashion optimal concentration recombinant human macrophage colony stimulating factor rhm csf u ml purified human urine csf colony stimulating activity similar rhm csf studies performed determine factors responsible enhanced cfu formation pme treated marrow compared nylon wool carbonyl iron monocyte depletion methods pme eliminated significantly monocytes myeloid cells observation suggested cells may release hematopoietic inhibitory factors cfu low concentrations normal concentrations blood monocytes inhibitory mean inhibition cfu high concentrations monocytes augmented cfu colonies hl conditioned media used simulate secretory products early myeloid cells hl conditioned media inhibited cfu formation granulocyte macrophage granulocyte colonies conclude csf colony stimulating activity human marrow recognized removal inhibitory cells pme treatment,C04,0.0021576302,0.0019139256,0.0040259142,0.0012122843,0.0030044317,0.013187605,0.21974586,0.03387258,0.0015598706,0.01252731,0.025424276,0.025433725,0.07116201,0.1973671,0.0018973656,0.034687288,0.032080714,0.040089317,0.0024567794,0.016687617,0.24370012,0.00076609605,0.015040203
radioimmunoscintigraphy using iodine anti cea monoclonal antibodies thallium scintigraphy medullary thyroid carcinoma case report case report demonstrates use thallium tl scans versus iodine l anti cea f ab scans patient high serum cea levels due metastases medullary thyroid carcinoma suprarenal region sacroiliacal region scintigraphy using monoclonal antibodies directed cea showed higher tumor uptake dose dose respectively thallium scan believed promising future radiotherapeutic applications,C04,0.00433257,0.0038380288,0.008073236,0.02326227,0.028614506,0.0055838753,0.12816213,0.04595587,0.003128036,0.00425127,0.13614066,0.053330842,0.040364362,0.010088799,0.0038048204,0.048626207,0.08259944,0.0044558183,0.004926623,0.09129412,0.26309243,0.001536266,0.004537808
intraoperative radiation canine carotid artery internal jugular vein vagus nerve therapeutic applications management advanced head neck cancers step application intraoperative radiotherapy iort treating advanced head neck cancers preliminary information obtained radiation tolerance canine common carotid artery internal jugular vein vagus nerve single high dose electron beam sides neck eight mongrel dogs operated expose cm segment common carotid artery internal jugular vein vagus nerve one side neck irradiated using escalating doses cgy contralateral side neck served unirradiated control months iort one dog dose level killed none dogs developed carotid bleeding time iort light microscopic investigations using hematoxylin eosin staining common carotid artery internal jugular vein showed consistent changes suggested radiation damage however masson trichrome stain hydroxyproline concentration irradiated common carotid artery indicated increase collagen content tunica media marked changes irradiated vagus nerve seen indicating severe demyelination loss nerve fibers appeared radiation dose dependent four patients advanced recurrent head neck cancer treated surgical resection iort without acute subacute complications role iort supplement surgery external beam irradiation chemotherapy selected patients advanced head neck cancer needs exploration,C04,0.001980077,0.030393485,0.0036802648,0.010650894,0.002746483,0.012084283,0.2768979,0.068691246,0.049151525,0.0019379836,0.041861463,0.052879356,0.042186376,0.014073169,0.0017344651,0.02469603,0.11288739,0.002031229,0.00224585,0.03726807,0.20719019,0.00070032204,0.002031949
hla class class ii antigen expression squamous cell carcinoma head neck compared human major histocompatibility hla class class ii antigen expression squamous cell carcinoma head neck normal mucosa frozen sections consecutive series squamous cell carcinomas stained monoclonal antibodies w class anti dr class ii using immunoperoxidase technique normal mucosa showed class class ii expression basal layers class expression tumors diffuse patchy scattered class ii expression tumors diffuse patchy scattered absent patterns expression correlate significantly clinical parameters including survival except class ii diffuse patchy patterns found correlate poorly differentiated tumors,C04,0.0035160428,0.0031189055,0.006560571,0.001975521,0.055961713,0.0045376364,0.15393776,0.020322584,0.0025419425,0.0034547185,0.13350233,0.0072320052,0.0902344,0.052810173,0.088198245,0.00547521,0.06790966,0.0036253408,0.0040035318,0.0263295,0.1336789,0.001248419,0.12982489
final report french multicenter phase ii study nitrosourea fotemustine evaluable patients disseminated malignant melanoma including patients cerebral metastases one hundred sixty nine patients histologic evidence disseminated malignant melanoma including patients cerebral metastases entered phase ii study nitrosourea fotemustine treatment regimen consisted mg hour iv infusion every week consecutive weeks followed week rest period induction therapy responding stabilized patients maintenance therapy consisted mg every weeks disease progressed one hundred fifty three patients evaluable response three complete responses partial responses observed according world health organization criteria leading objective response rate confidence interval responses also documented cerebral visceral nonvisceral metastatic sites median duration response weeks range weeks objective response rate previously untreated patients patients main toxicity hematologic delayed reversible leukopenia thrombopenia objective response rate observed especially untreated patients activity cerebral metastases small amount extra hematologic toxicity encountered suggest fotemustine effective drug disseminated malignant melanoma,C04,0.04788113,0.010858344,0.0035446822,0.0010673756,0.0026453012,0.0024516887,0.24288511,0.0017865206,0.0013734136,0.011059939,0.020481534,0.010272366,0.078793526,0.0044041425,0.0016705666,0.030768286,0.21172097,0.0019594808,0.011355569,0.01608854,0.28430223,0.00067452184,0.0019547278
trends conserving treatment invasive carcinoma breast females population based study presents trends treatment node negative invasive carcinoma breast females detroit metropolitan area done determine whether significant shift toward conservation breast trend analyses surgical treatment tumor size node status year diagnosis age race performed patients drawn metropolitan detroit cancer surveillance system significant increase use conserving breast observed younger women receiving treatment option often older women implications continuing shift biologic findings treatment carcinoma breast discussed,C04,0.002839822,0.002519064,0.0052988133,0.0015955801,0.019496353,0.0036649383,0.22848451,0.002670603,0.002053065,0.002790292,0.0790456,0.026702533,0.039720137,0.006683025,0.002497268,0.0044221934,0.100896604,0.002924546,0.003233555,0.32013404,0.13839768,0.0010083176,0.0029215042
multimodal therapy locally advanced breast carcinoma among patients treated breast cancer advanced disease found subgroup presented untreated locally advanced disease without demonstrable distant metastases time diagnosis stage iiib abed nx mo first years patients treated primarily sequential radiotherapy chemotherapy group group b management consisted four courses induction multi drug chemotherapy followed primarily mastectomy additional chemotherapy mean follow recent group group b months follow complete local disease control rate groups survival remarkably different group patients experienced median survival months one survived years group b median survival months nine patients alive months seven year survivors overall mortality patients inflammatory breast cancer greater groups compared group noninflammatory disease survival patients group b better group inflammatory noninflammatory cancers p less estrogen receptor nodal menopausal status influence survival data suggest neoadjuvant chemotherapy improves survival patients stage iiib breast carcinoma delays establishment progression distant metastases mastectomy important component treatment disease,C04,0.0018997447,0.0016851684,0.012738236,0.001067389,0.011797968,0.0024517195,0.22029014,0.0017865429,0.001373431,0.011060079,0.019141989,0.13664216,0.023861334,0.0043849843,0.0016705876,0.012148415,0.37911728,0.001956422,0.002163139,0.08476444,0.056242075,0.00067453034,0.011082224
interferon alpha fluorouracil advanced colorectal carcinoma assessment activity toxicity preclinical data showed cytotoxic effects fluorouracil fu augmented interferon ifn small study patients advanced colorectal cancer responded regimen fu ifn using dose schedule pilot study previously untreated patients metastatic colorectal carcinoma treated continuous intravenous iv infusion fu mg daily days followed weekly bolus fu mg subcutaneous ifn million units three times per week evaluable patients nine partial response confidence limit median response duration months range greater months seven patients minor response ten stable disease common toxicities observed stomatitis diarrhea neurotoxicity seen patients consisted gait disturbance dizziness confusion memory loss dementia toxicity patients required reduction ifn dose least required reduction fu dose least although combination fu ifn patients advanced colorectal carcinoma activity regimen toxic observed response rate substantially superior alternative fu programs,C04,0.0022038806,0.001954952,0.02599199,0.0119038075,0.0030719426,0.0028442226,0.25639033,0.002072556,0.0015933075,0.002165442,0.021997359,0.026938658,0.041643687,0.005152337,0.0019380369,0.0034392073,0.22308794,0.0022765575,0.01168652,0.039333906,0.2985478,0.0007825179,0.012983012
role attitudes beliefs personal characteristics italian physicians surgical treatment early breast cancer influence italian physicians attitudes beliefs personal characteristics medical decision making examined case surgical treatment early breast cancer responses mail survey physicians different specialties analyzed comparing doctors recommending radical procedure preferring conservative procedure younger patients considering conservative surgery treatment choice regardless patients age findings suggest likelihood physicians preferring conservative procedure influenced specialty extent feel patient role treatment decision differences beliefs treatment outcomes preferences small group indicating radical surgery sole admissible treatment accounted ignorance distrust results recent trials findings suggest scientific factors guide many doctors decision making may help explain diffusion research results clinical practice often disappointingly slow,C04,0.0025272314,0.0022417803,0.004715551,0.0014199482,0.0035190894,0.0033248554,0.35280654,0.0023766388,0.0018270757,0.054603733,0.029552437,0.018024689,0.019621642,0.020843256,0.0022223834,0.016164528,0.17860788,0.0026026291,0.048146624,0.12871586,0.102629416,0.000897328,0.0026088904
colorectal tumors vitro study high resolution mr imaging study potential utility magnetic resonance mr imaging staging colorectal tumors resected colonic segments containing elevated lesions examined superconductive mr system whole intestinal wall apparent three five layers images obtained short repetition time tr short echo time te six eight distinct layers including intestinal wall proper well adherent mucus layer outer layer pericolonic fat long tr te images cases colonic carcinoma mr images correlated well pathologic findings including macroscopic growth pattern depth mural invasion presence foci calcific tumor necrosis pools extracellular mucin colloid features suggest mr imaging may valuable clinical evaluation colorectal tumors,C04,0.0029201629,0.00259033,0.005448721,0.03383702,0.13129187,0.0037686222,0.33935156,0.002781977,0.0021111476,0.0028692314,0.033710353,0.0060062166,0.024356695,0.024768997,0.0025679176,0.018662568,0.046828434,0.0030369652,0.017449202,0.055674423,0.22176825,0.015168675,0.0030306424
treatment advanced squamous cell carcinoma skin cisplatin fluorouracil bleomycin authors treated patients advanced squamous cell carcinoma scc skin lip one four cycles combination chemotherapy consisting cisplatin bolus injection fluorouracil fu bleomycin continuous day infusion objective responses seen evaluable patients four patients complete remission seven patients partial remission local control definitive complementary radiation surgical treatment achieved seven patients toxic side effects acceptable consisted nausea vomiting patients transient skin changes hematologic grade abnormalities four patients pulmonary fibrosis one elderly patient results show chemotherapy combination could play role reducing tumor mass facilitating definitive treatment obtain better functional cosmetic results advanced scc skin,C04,0.01762282,0.0026653258,0.035665337,0.0016882228,0.09599793,0.003912097,0.28899893,0.0028256637,0.0021722699,0.0029523019,0.027125517,0.023324434,0.044440977,0.0069088126,0.0026422641,0.004692811,0.23553525,0.003094351,0.0034213017,0.033942506,0.15621288,0.0010668626,0.0030911325
early gastric cancer endoscopic diagnosis depth invasion order decide treatment strategy gastric cancers accurate preoperative evaluation depth cancer invasion essential preoperative endoscopic diagnosis depth invasion compared pathological results resected specimen early gastric cancers early like advanced gastric cancers endoscopic distinction early early like advanced cancers correctly made cases among early gastric cancers mucosal submucosal invasion correctly presumed cases tumor elevated type located antrum endoscopic diagnosis tended deeper true depth size tumor contributed little depth diagnosis pathomorphological changes tips converging folds important clue diagnosing depth,C04,0.002764339,0.0024521067,0.00515797,0.05668081,0.06300705,0.0035675236,0.32446903,0.002599618,0.0020267537,0.0027161255,0.14856274,0.09936469,0.029118026,0.0065555894,0.00243089,0.020592168,0.09136011,0.026646253,0.0031476065,0.032910753,0.056682043,0.0009815163,0.016206322
modified van nes rotationplasty osteosarcoma proximal tibia children knee amputation traditional treatment osteosarcoma proximal tibia recent advances chemotherapy encouraged development limb salvage techniques van nes rotationplasty malignant lesions distal femur increased popularity reconstructive technique similar procedure described lesions proximal tibia developed modified rotationplasty lesion performed four children surgical technique postoperative management results procedure described two patients delayed wound healing complications developed patients disease free follow appearance leg well accepted patients parents procedure useful addition armamentarium tumour surgeon treatment malignant lesions proximal tibia,C04,0.0033454078,0.0029675437,0.006242184,0.0018796482,0.06944146,0.004317423,0.21575032,0.019334553,0.002418581,0.051873956,0.033612613,0.006902345,0.028748296,0.0076921256,0.002941867,0.005209496,0.30189282,0.0034452153,0.0038092388,0.06752254,0.1560229,0.0011878328,0.0034416323
correlation hyperthermoradiosensitivity clinical effect carcinoma esophagus correlation hyperthermoradiosensitivity evaluated vitro succinate dehydrogenase inhibition sdi test histopathologic effects hyperthermochemoradiotherapy hcr therapy investigated patients carcinoma esophagus succinate dehydrogenase sd activity tissue fragments taken biopsy assayed exposure heat degrees c radiation grays done sensitivity radiation plus heat treatment estimated percentage sd activity treated cells compared control cells patients divided three groups according degree sd activity exposure radiation plus heat treatment sd activity less per cent group highly sensitive per cent group moderately sensitive per cent group less sensitive eighteen group group two six group classified histopathologically effective hcr therapy two year survival rate groups zero per cent respectively statistical differences regard prognostic factors data suggest vitro activities sd correlate well clinical effectiveness hcr therapy therefore recommended sd inhibition test included among guidelines clinical management,C04,0.0022272144,0.012753643,0.0684546,0.001251381,0.0031013256,0.0028743364,0.24599378,0.0020944995,0.001610177,0.0021883692,0.07012176,0.10679128,0.13098572,0.04675644,0.012733784,0.01423231,0.069138184,0.0023218663,0.0025360114,0.032692842,0.16605845,0.00079080294,0.0022912761
clinical application ras gene mutation diagnosis pancreatic adenocarcinoma pancreatic adenocarcinomas known ras gene oncogene mutations site mutations localized codon k ras gene high incidence localization ras gene mutations observed human malignancies polymerase chain reaction direct sequencing method enabled us analyze dna sequence around codon k ras gene small quantities specimens obtained needle biopsies aspirate samples pathological diagnosis materials obtained patients pancreatic adenocarcinoma showed mutations whereas obtained patients chronic pancreatitis showed mutations several cases using mutations k ras gene marker analysis supplemented conventional pathology cytology making diagnosis pancreatic adenocarcinoma analysis ras gene mutations useful clinical diagnosis pancreatic adenocarcinoma,C04,0.0025273543,0.0022418892,0.016947366,0.0014200172,0.0035192606,0.003261682,0.21024935,0.026798427,0.0018271646,0.0024832739,0.17828986,0.0051982845,0.01679358,0.0061343163,0.0022224914,0.031747956,0.049621873,0.0026096741,0.051803734,0.04614255,0.061922707,0.0008973716,0.2753398
antigen related cell proliferation malignant gliomas recognized human monoclonal antibody human monoclonal antibody cln igg produced human human hybridoma derived lymphocytes patient cervical carcinoma reactivities antibody various human glioma tissues cultured glioma cells characterization antigen recognized cln igg malignant glioma cells analyzed reported cln igg reacted various human glioma cells glioma tissues especially glioblastoma react normal brain tissues fetal brain tissues large amount antigen recognized cln igg expressed cell membranes undifferentiated glioma cells glioma cells g tumor growth phase cycling cells antigen recognized cln igg detected one seven samples cyst fluid detected serum samples samples cerebrospinal fluid glioma patients cln igg exhibited antibody dependent cell cytotoxicity u mg glioma cells primary cultured cells glioblastomas anaplastic astrocytomas data suggest antigen recognized cln igg might related cell proliferation malignant gliomas thus cln igg might useful immunotherapy immunoimaging malignant gliomas,C04,0.024585903,0.002041688,0.00429466,0.0012932093,0.014372977,0.002970413,0.18273687,0.002165121,0.0127932215,0.0022615169,0.060373757,0.004734076,0.037974313,0.39215463,0.0020240224,0.014723404,0.045615718,0.070033,0.0026207792,0.01892834,0.09807404,0.0008172361,0.0024110503
natural history cardiac rhabdomyoma infancy childhood although spontaneous regression cardiac rhabdomyoma reported prognosis still considered poor surgery continues indicated experience rhabdomyoma diagnosed live infants year period reviewed diagnosis angiography echocardiography accepted multiple tumors present tuberous sclerosis also diagnosed nine patients diagnosed prenatally remaining age less months identified total tumors measurements planes demonstrated least evidence regression patients complete resolution one patient required delayed surgery excision subaortic ridge appeared site resolved tumor findings suggest pediatric cardiac rhabdomyoma often benign condition spontaneous regression rule surgery recommended patients refractory dysrhythmias severe hemodynamic compromise,C04,0.002563673,0.0022700783,0.004775076,0.0014378723,0.053182293,0.027785616,0.23329626,0.0024066393,0.001850139,0.031727344,0.10384455,0.017630383,0.050819688,0.0058966065,0.0022505429,0.041138247,0.26413035,0.0026418476,0.002913949,0.074274875,0.06962254,0.00090865506,0.0026327414
impact microinvasion axillary node metastases survival patients intraductal breast cancer rational approach local treatment intraductal breast cancer continues generate considerable debate however finding invasive component intraductal breast cancer widely regarded appropriate indication axillary node dissection part local treatment staging disease despite view natural history patients intraductal breast cancer foci microinvasion poorly defined patients pathologic finding intraductal carcinoma foci microinvasion seen ucla medical center twenty three patients presented mammographic abnormalities patients presented palpable mass one patient presented paget disease nipple thirty three patients underwent axillary node dissection part local treatment lymph node metastases identified median follow patients months local recurrences deaths recurrent breast cancer intraductal breast cancer associated microinvasion appears extremely favorable lesion minimal risk nodal metastases,C04,0.0028014889,0.0024850604,0.03234869,0.0015740423,0.017462354,0.0036154673,0.34525555,0.016188974,0.0020253516,0.016302727,0.04781098,0.073567845,0.018959206,0.0064930245,0.0024635585,0.031576082,0.2568586,0.002885069,0.015406933,0.061657026,0.038385257,0.0009947069,0.0028820683
activation inducer subset phenotype lymphocytic infiltrate around epidermally derived tumors situ analysis mononuclear cell infiltrate found association range benign premalignant malignant epidermal tumors described predominant cell phenotype recently described immunoregulatory helper inducer lymphocyte large number lymphocytes expressed antigens associated cellular activation suggesting ongoing immunologic response host tumor although evidence situ proliferation cells lacking findings suggest infiltrate found association cutaneous tumors represent passive accumulation lymphocytes circulation rather active antitumor response,C04,0.0037053549,0.0032868346,0.0069138077,0.0020818878,0.07708783,0.0047819535,0.3261792,0.0034845606,0.0026788067,0.0036407288,0.018195279,0.007621207,0.043174792,0.14516091,0.0032583955,0.005770008,0.08971507,0.039689034,0.0042190915,0.072901726,0.13130663,0.0013156369,0.0038312126
neuropeptide neuron specific enolase levels benign malignant pheochromocytomas neuron specific enolase nse isoform enolase glycolytic enzyme found neuroendocrine system neuropeptide npy peptide recently discovered peripheral central nervous systems serum nse plasma npy levels reported increased patients pheochromocytoma authors evaluated whether measurement molecules could help discriminate benign malignant forms pheochromocytoma nse levels normal patients benign pheochromocytoma n elevated one half malignant pheochromocytoma n plasma npy levels average significantly higher malignant pmol l n benign forms disease pmol l n however difference percentage patients elevated npy levels results show determination serum nse may useful distinguishing malignant benign pheochromocytoma measurement plasma npy useful differentiating two kinds tumors,C04,0.0030946555,0.0027451138,0.0057743057,0.0017387606,0.01929043,0.062001903,0.24050769,0.0029102513,0.002237298,0.0030458407,0.05520046,0.006426888,0.09958536,0.08070264,0.0027213618,0.004819022,0.07435559,0.003188008,0.003557439,0.023244558,0.29856524,0.0010987996,0.0031884029
giant eccrine acrospiroma four cases large eccrine acrospiroma three benign one malignant reported benign tumors involved lower extremities two women one man years age duration lesions ranged years malignant tumor involved left side chest year old man occurrence lesion present years suggested malignant transformation pre existing benign eccrine acrospiroma tumor showed little cellular atypia mitotic rates mitotic figures per high power fields varied within lesions average mitotic rates differentiate benign malignant tumors important distinguishing features large benign eccrine acrospiromas relative circumscription lack cellular atypia absence stromal perineurial angiolymphatic invasion,C04,0.019546425,0.019178418,0.022456462,0.0018814304,0.11873832,0.0043215165,0.27736622,0.019357866,0.002420874,0.0032901762,0.03113161,0.0068873884,0.029122101,0.05533406,0.0029446564,0.021420488,0.052890558,0.003448482,0.0041382774,0.21423395,0.08525688,0.001188959,0.0034448954
transfer secretory proteins endoplasmic reticulum golgi apparatus discrimination homologous heterologous transfer intact heterokaryons examine aspects transfer secretory proteins endoplasmic reticulum golgi apparatus situ heterokaryons formed hep g human hepatoma cells wi human fibroblasts cells appropriately treated cycloheximide fusion emptied respective secretory proteins serum albumin hep g cells procollagen wi cells fusion complete cycloheximide washed protein synthesis resumed rates reappearance serum albumin procollagen two separated golgi apparatuses within heterokaryon followed immunofluorescence microscopy serum albumin found always reappear first golgi apparatus contributed hep g half heterokaryon procollagen golgi apparatus wi half results suggest endoplasmic reticulum golgi apparatus transfer situ simply stochastic process either spatially restricted exhibits cell type specificity,C04,0.004365174,0.0038582631,0.008239471,0.002444047,0.006056603,0.005613314,0.15745205,0.0040903646,0.024191795,0.004273683,0.021160055,0.008946182,0.048968747,0.23516734,0.0038248796,0.0067731454,0.115901664,0.14984697,0.025995879,0.039059836,0.11773046,0.0015443652,0.004495711
chondrolipoangioma cartilage containing benign mesenchymoma soft tissue clinical pathologic features four cases benign mesenchymoma mature cartilage represented predominant component reported distinctive histologic feature four cases lobular proliferation cartilaginous tissue exhibiting spectrum hyaline cartilage fibrocartilage myxoid cartilage cartilage ossification even bone marrow formation intimately associated mature adipose tissue vascular elements localization tumors proximity bone attached periosteum continuity joint lesions may mistaken cartilaginous neoplasms soft tissue recognition entity potentially important diagnostic therapeutic implications mutilating surgery may avoided,C04,0.0035165458,0.0031193516,0.023582434,0.0019758036,0.07299107,0.0045382855,0.29299307,0.042069416,0.03650519,0.0034552126,0.08406571,0.12638348,0.021768063,0.044248726,0.0030923616,0.005475993,0.061455894,0.03766558,0.0040041045,0.06547412,0.056716315,0.0012485976,0.003654639
ability circular extrachromosomal dna molecules carry amplified mycn proto oncogenes human neuroblastomas vivo amplification proto oncogene mycn also known n myc neuroblastomas shown correlate disease stage prognosis yet little known dna structures carry amplified mycn genes neuroblastomas vivo used dna irradiation pulsed field gel electrophoresis analyze mycn amplification structures eight neuroblastomas separate patients four primary tumors four metastatic lesions exhibiting mycn amplification six eight neuroblastomas three primary tumors three metastatic lesions exhibited mycn dna irradiation profiles consistent presence circular extrachromosomal dna amplification structures five neuroblastomas possessed amplification structures within size range double minute chromosomes one contained smaller dna circles two neuroblastomas exhibited mycn dna irradiation patterns consistent larger presumably chromosomal amplification structures multiple sizes dna circles observed neuroblastomas four different patients implying vivo multimerization amplification structures presence circular mycn amplification structures six eight neuroblastomas examined suggests circular dna molecules important structures vivo gene amplification,C04,0.0025905706,0.0022979653,0.0048426413,0.001455536,0.063987955,0.0033432662,0.20490317,0.0024362039,0.014387165,0.0025453877,0.028799746,0.005328309,0.036526028,0.0067810514,0.0022780823,0.01657036,0.09105484,0.05656683,0.0030089123,0.046857037,0.18953973,0.0009198175,0.21297936
screening neuroblastoma weeks age methods preliminary results quebec neuroblastoma screening project large neuroblastoma screening study recently started province quebec canada project collaboration quebec network genetic medicine university minnesota studying impact screening infants preclinical detection neuroblastoma population based mortality caused tumor infants born quebec year period screened twice weeks months urinary homovanillic acid vanillylmandelic acid determination dried filter paper samples used screening initial qualitative screening done means thin layer chromatography confirmatory quantitative screening gas chromatography mass spectrometry gc ms initial months week screening neonates compliance rate screened tested also gc ms nine neonates positive results two gc ms tests referred evaluation rule presence neuroblastoma four tumor calcified adrenal gland tumor detected three additional neonates clinical diagnosis neuroblastoma reached screening age weeks neuroblastoma secrete homovanillic acid vanillylmandelic acid diagnosed clinically additional patient tested negative screening,C04,0.002050558,0.011742068,0.03359265,0.001152125,0.04264431,0.0026463522,0.19584927,0.0118434625,0.02129149,0.0020147937,0.27208242,0.014130721,0.015539726,0.004889597,0.0018032091,0.0031931454,0.103626855,0.0021117348,0.021688499,0.14601138,0.087240845,0.00072807865,0.0021266823
function amputation arthrodesis arthroplasty tumors knee studied function twenty two patients malignant skeletal tumor adjacent knee knee amputation done seven resection arthrodesis nine replacement arthroplasty six patients walked similar speed sixty one sixty six meters per minute slower normal eighty meters per minute walked comparable efficiency three velocities mean consumption oxygen milliliter per kilogram body weight per meter free velocity milliliter per kilogram body weight per meter walked per cent faster milliliter per kilogram body weight per meter walked per cent faster three groups patients normal control group consumed oxygen similar rates patients amputation active least worried damaging affected limb difficulty walking steep rough slippery surfaces patients arthrodesis stable limb performed demanding physical work recreational activities difficulty sitting patients arthroplasty led sedentary lives protective limb least self conscious limb,C04,0.003345367,0.0029675076,0.037127677,0.050460234,0.037049264,0.0043173702,0.21986575,0.0031460237,0.0024185514,0.0032870197,0.016115712,0.040738367,0.16923077,0.0099027585,0.0029418312,0.021395452,0.17554745,0.0034483888,0.0038091925,0.06985543,0.11840049,0.0011878182,0.0034415904
effect dietary omega fatty acids fish oil azoxymethanol induced focal areas dysplasia colon tumor incidence maxepa fish oil high omega fatty acids combined various levels corn oil co rich omega fatty acids fed female cf mice three fish oil blends co two co levels diets studied follows co diet co diet co diet co diet co diet diets provided weeks weekly subcutaneous injection saline azoxymethanol aom studies epithelial cell proliferation incidence focal areas dysplasia fad involved six weekly aom injections one week last aom injection hour killing mice injected tritiated thymidine htdr differences proliferative parameters found among five groups saline treated mice among aom treated animals fed diet showed significantly fewer cells per crypt significantly fewer labeled cells gland co diets additionally distribution phase cells crypts aom treated mice fed diet closely resembled saline controls greatest alteration distribution proliferative cells observed high co diet diet lowest level diet mice fed diets significantly fewer fad microns distal colonic serial sections fed high co diet diet mice involved chronic tumor incidence studies received three weekly injections dose aom regardless diet approximately tumors arose distal colon significantly larger tumor bearing population observed high co diet lowest maxepa diet diet compared incidence diets low co diet diet ratio omega omega fatty acids approximately apparently prevented development adenoma type proliferative pattern thereby reducing fad numbers subsequent tumor incidence,C04,0.0013099402,0.0075009116,0.034128398,0.0072606592,0.033613734,0.0016926547,0.09177113,0.014066151,0.0009469765,0.0012870226,0.006240497,0.060790032,0.07391832,0.11533673,0.007470965,0.028067777,0.051153872,0.0013489472,0.0014914778,0.1052458,0.35354525,0.00046508666,0.001347674
transthyretin receptors human astrocytoma cells transthyretin ttr transport protein retinol binding protein principal binding protein cerebrospinal fluid function regard delivery ligands respects unclear binding ttr cultured human astrocytoma cells studied determine whether cells carry receptors ttr scatchard analysis consistent single class binding sites kd nm significant cross reactivity transferrin serum albumin observed internalization ttr temperature dependent proportional receptor occupancy dilutions cerebrospinal fluid displaced ttr proportion content radioimmunoassayable ttr parallel purified ttr uptake internalization ttr increased presence high concentrations results demonstrate ttr binds specific high affinity receptors human astrocytoma cells receptor binding ttr provides potential mechanism delivery ligands within central nervous system,C04,0.002763822,0.002451648,0.045253616,0.0015535785,0.0038489788,0.0035668563,0.18482779,0.0025991318,0.028755149,0.0027156174,0.01750561,0.0056846538,0.024200475,0.12166564,0.029185794,0.01767755,0.02498032,0.19787268,0.016442569,0.07546086,0.18709755,0.0009813327,0.00290878
single breath nitrogen test mortality cancer relationship indices single breath nitrogen test mortality overall cancer incidence respiratory cancer incidence examined cohort men yr age examined followed june closing volume closing capacity slope phase iii related mortality cancer contrast fev related mortality estimated relative mortality risk confidence interval per liter expected fev given height age smoking fev related cancer inability perform acceptable single breath nitrogen test tracings related mortality relative mortality risk cancer conclude indices single breath nitrogen test predictive value concerning overall mortality cancer incidence,C04,0.0026567949,0.0023567097,0.030678922,0.0014927447,0.0036995027,0.0034287323,0.0654882,0.0024984821,0.0019207444,0.07223391,0.15465106,0.10315755,0.042826626,0.006108792,0.0023363184,0.03739755,0.047000308,0.0027360583,0.0030251518,0.34847522,0.06214372,0.00094333134,0.0027436384
estimation pr er immunocytochemistry breast cancer comparison radioligand binding methods immunocytochemical assays progesterone receptor pr using monoclonal antirabbit pr antibodies pr ica estrogen receptor er er ica compared radioligand binding dextran coated charcoal dcc methods receptor determination patients breast cancer immunocytochemical staining pr exclusively nuclear localization regard pr staining similar previous findings er pr ica showed sensitivity specificity er ica also sensitive similarly specific good correlation degree intensity staining quantitative binding radioligand receptor positive tumors however show considerable variation immunocytochemical staining suggesting heterogeneity cellular pr content availability immunocytochemical assay pr increases discriminatory potential methods receptor determination,C04,0.0029617734,0.0026272407,0.03326613,0.0016640996,0.018462073,0.003822323,0.3109163,0.0027852876,0.0021412303,0.017236205,0.11180053,0.0061065317,0.09503316,0.059844404,0.031275265,0.004612097,0.043373942,0.10341699,0.0033724147,0.022130731,0.10472365,0.01537921,0.0030484174
intraatrial extension thyroid cancer technique results radical surgical approach occlusion superior vena cava tumor thrombus extending right atrium diagnosed three patients follicular thyroid cancer patients showed typical clinical picture superior vena cava syndrome right parasternal thoracotomy performed preparation major vessels superior vena cava opened entire intravascular tumor thrombus removed cavotomy closed directly two patients third patient left brachiocephalic trunk resected reconstructed vascular polytetrafluoroethylene graft patient bone brain metastases occlusion graft months surgery anticoagulation stopped two patients clinically symptom free without local recurrence months surgery aggressive surgical approach justified grossly invasive thyroid cancer decrease local recurrence death rates correct disturbing clinical symptoms superior vena caval occlusion prevent tumor embolism development distant metastases reducing tumor mass even better basis radioiodine treatment prepared,C04,0.050996624,0.026049517,0.016541617,0.013325214,0.051208284,0.003183793,0.24758102,0.048320174,0.0017835317,0.0024365878,0.06499792,0.08866731,0.01777608,0.0056723966,0.0021694181,0.0038416332,0.23377976,0.0025406017,0.0028090433,0.04076807,0.07213748,0.00087594235,0.0025379595
multicentric endobronchial granular cell myoblastoma granular cell myoblastoma gcm rare benign neoplasm involving tracheobronchial tree believed arise schwann cell four cases tracheobronchial gcm multicentric presented conservative therapeutic approach suggested,C04,0.0074434355,0.006602699,0.0138886785,0.0041821627,0.010364749,0.009606142,0.30966446,0.043030962,0.0053812726,0.0073136124,0.07007302,0.015309724,0.04607623,0.1252216,0.042559393,0.011590977,0.10155109,0.0076655047,0.008475446,0.047769874,0.095928565,0.0026428935,0.007657532
internists practices health promotion disease prevention survey objective estimate internists use disease prevention health promotion activities explore demographic professional behavioral psychological cognitive organizational factors associated use practices design mail survey setting subjects sample members fellows american college physicians acp participated study engaged patient care activities hours per week stratified gender region lived four geographic areas united states northeast southeast central west comprising acp regions measurements questionnaire requesting background information well information personal health record keeping use immunizations pneumococcal influenza tetanus hepatitis b use screening tests procedures detecting cancer breast examination papanicolaou smear stool occult blood test diseases electrocardiograms cholesterol level tests chest radiographs behavioral counseling promote health areas smoking exercise alcohol seat belt use main results internists used effective preventive interventions less frequently ineffective practices frequently experts recommend internists use health promotion disease prevention activities associated habit attitude lack adequate knowledge younger physician age general internal medicine practice personal health promotion disease prevention practices strongly associated appropriate use recommended practices p less conclusions internists use disease prevention health promotion activities falls short expert recommendations programs improve delivery preventive services might aimed improving physicians personal health practices might directed toward patients might include development effective systems remind physicians,C04,0.0014575003,0.050681185,0.009107031,0.00081890996,0.002029523,0.010202359,0.23370272,0.0013706508,0.015159878,0.036698416,0.106895916,0.010052144,0.057644527,0.0043957406,0.008330896,0.023434497,0.041704483,0.0015009836,0.1653332,0.11117384,0.10627414,0.0005175054,0.0015140077
concomitant cisplatin chemotherapy radiotherapy advanced mucosal squamous cell carcinoma head neck long term results radiation therapy oncology group study one hundred twenty four eligible patients advanced mucosal squamous cell carcinoma head neck entered pilot study concomitant cisplatin mg given every weeks three doses standard irradiation initial complete response cr additional two cases salvaged surgery overall cr keratin identified histologic specimen patients cr nasopharynx showed best cr among sites years treatment estimated locoregional tumor control rate survival keratin present specimen estimated locoregional control tumor superior versus keratin identified p estimated survival also superior versus p acute treatment related toxicities included one death due renal damage two patients life threatening renal damage delivery radiotherapy altered late toxicity included necrosis fibrosis one fistula results study justify randomized trial comparison combination cisplatin radiotherapy versus radiotherapy alone advanced mucosal carcinomas head neck,C04,0.0025597431,0.002269181,0.0047731884,0.0014373038,0.02882675,0.0033013884,0.3238836,0.002405688,0.014229363,0.0025135041,0.106283434,0.033310656,0.025134062,0.0058885333,0.002249547,0.0039835265,0.22440478,0.00263887,0.002912797,0.027147565,0.17630655,0.0009082958,0.0026317006
infiltration dendritic cells relation tumor invasion lymph node metastasis human gastric cancer infiltration dendritic cells determined patients gastric carcinoma investigated standpoint tumor invasion lymph node metastasis prognosis dendritic cell infiltration graded slight marked frequency marked infiltration group mucosal stage change proportion invasion deeper layers year survival rate patients marked infiltration slight infiltration statistically different p less difference survival rates statistically significant cancer emerging serosa p less similar incidence lymph node metastasis marked slight infiltration groups grade tumor invasion however marked infiltration dendritic cells prevented widespread nodal involvement beyond primary node cases advanced carcinoma p less findings indicate infiltrating dendritic cells prevent spread tumor invasion prevent nodal involvement therefore patients gastric cancer emerging serosa prognosis good,C04,0.002409276,0.037127152,0.027805667,0.0013536739,0.05001005,0.003109296,0.17740403,0.095568225,0.0017417993,0.002367255,0.034346752,0.070636086,0.075361475,0.08482549,0.0021186564,0.0037517438,0.12812513,0.0024811549,0.0027433152,0.06174322,0.13163021,0.0008554464,0.002484914
management local regional recurrence mastectomy breast conserving treatment locoregional failures primary treatment breast cancer include diverse group lesions represent different categories failures various prognoses although patients chest wall recurrences regional nodal failures traditional radical surgery poor prognosis many patients still achieve significant degree palliation even long term survival cure carefully orchestrated multimodal treatment patients breast failures breast conservation surgery radiation long term salvage cure achieved majority prompt detection appropriate treatment like treatment primary breast cancer includes consideration local control also risk subsequent systemic failure need treatment,C04,0.0028794429,0.072254196,0.005381954,0.029496036,0.017948302,0.0037160711,0.26010677,0.016589683,0.0020817092,0.0028428792,0.027176674,0.049399693,0.083843924,0.006633552,0.0025321094,0.018420428,0.22119445,0.0029653488,0.0032786694,0.10942295,0.05785053,0.0010223855,0.0029622647
germ line p mutations familial syndrome breast cancer sarcomas neoplasms familial cancer syndromes helped define role tumor suppressor genes development cancer dominantly inherited li fraumeni syndrome lfs particular interest diversity childhood adult tumors occur affected individuals rarity high mortality lfs precluded formal linkage analysis alternative approach select plausible candidate gene tumor suppressor gene p studied previous indications gene inactivated sporadic nonfamilial forms cancers associated lfs germ line p mutations detected five lfs families analyzed mutations produce amounts mutant p protein expected exert trans dominant loss function effect wild type p protein frequency germ line p mutations examined additional families lfs cancer patients families clinical features might attributed mutation,C04,0.0024668013,0.002188176,0.0046027955,0.0013859951,0.040271495,0.0071103675,0.30626765,0.0023198097,0.0017833876,0.0024526718,0.041780543,0.052841935,0.018360209,0.051187173,0.0021692428,0.015761914,0.054965433,0.050293956,0.0030895711,0.14385496,0.07946171,0.0008758715,0.11450835
impaired production tumor necrosis factor breast cancer spontaneous lipopolysaccharide lps induced production tumor necrosis factor tnf peripheral blood macrophages investigated breast cancer whereas spontaneous tnf production macrophages derived patients breast cancer comparable one found healthy controls p greater lps stimulated macrophages derived patients disease free interval well metastatic breast cancer found produce significantly lower amounts tnf compared macrophages derived healthy control individuals p less however production tnf significantly differ two patient populations p greater impairment lps induced tnf production depend upon characteristics primary tumor size axillary lymph node estrogen receptor status upon fact administration adjuvant chemotherapy patients metastatic disease hormone treatment investigate cytokine production macrophages spontaneous lps induced interleukin il production investigated also however difference found patients controls concerning il generation authors thus conclude lps induced tnf production impaired breast cancer independent presence detectable metastatic disease whereas il production remained unimpaired,C04,0.001972079,0.0017493326,0.003679695,0.0011080308,0.013044545,0.0025450708,0.22161452,0.051607426,0.0014257254,0.0019376836,0.016087044,0.0041150106,0.10158597,0.0067742774,0.0017341967,0.0030755952,0.078933746,0.033171292,0.002245502,0.083688624,0.2887963,0.07707078,0.0020375352
prognostic value c myc proto oncogene overexpression early invasive carcinoma cervix prognostic effect c myc oncogene overexpression assessed multivariate analysis patients invasive carcinoma cervix stage ib iia iib proximal treatment based association brachytherapy colpohysterectomy lymphadenectomy analysis c myc gene expression done using northern slot blot hybridization techniques overexpression c myc ie levels least three times mean observed normal tissues present tumors proportion carcinomas c myc overexpression significantly increased size primary tumor p relationship found c myc overexpression clinical histologic parameters including nodal status relative risk relapse overall pelvic failure distant metastases analyzed cox proportional hazards model three factors significantly related risk overall relapse multivariate analysis performed namely tumor size nodal status c myc expression combination c myc expression nodal status provided accurate indication risk relapse indeed patients negative nodes year disease free survival rate confidence interval cl c myc expressed normal level whereas rate cl c myc overexpressed log rank test p addition subgroup patients positive nodes rate cl cl c myc gene expressed normal level overexpressed respectively finally c myc gene overexpression multivariate analysis first factor selected model regarding risk distant metastases,C04,0.0018655036,0.010684824,0.030563774,0.0010481504,0.033853386,0.0024075296,0.15252899,0.0017543421,0.001348676,0.0018329668,0.12217325,0.014271702,0.051953733,0.008123316,0.019697038,0.002904977,0.11749823,0.0019273163,0.0021241503,0.1651062,0.17812243,0.00066237256,0.07754718
autologous antibodies eluted membrane fragments human ovarian epithelial neoplastic effusions iii cytotoxic potential vitro characterization antigen cyst ascites fluids patients ovarian epithelial neoplasms contain immunoglobulins antitumor activity autologous antibodies bound cellular membrane fragments obtained human ovarian neoplastic effusions react cell surface antigens different human ovarian cell lines surgical specimens human ovarian adenocarcinoma human ovarian tumors grown athymic balb c mice antibodies react tissue preparations normal human ovaries nonovarian normal neoplastic tissues nonovarian human cell lines studies indicate antibodies capable complement mediated lysis human ovarian tumor cell lines vitro preliminary characterization autologous ovarian tumor associated antigen indicates may composed three large molecular weight proteins,C04,0.0027272396,0.0024191975,0.0328663,0.041137177,0.05682995,0.0035196447,0.12764479,0.002564729,0.0019716728,0.002679673,0.03164052,0.018801007,0.033105984,0.2955676,0.0023982655,0.004246879,0.07619464,0.032485824,0.0031053633,0.01997577,0.15162751,0.00096834364,0.0555219
identical splicing aberrant epidermal growth factor receptor transcripts amplified rearranged genes human glioblastomas epidermal growth factor receptor gene found amplified rearranged human glioblastomas vivo present sequence across splice junction aberrant epidermal growth factor receptor transcripts derived corresponding uniquely rearranged genes coamplified coexpressed non rearranged epidermal growth factor receptor genes six primary human glioblastomas six tumors contains aberrant transcripts derived identical splicing exon exon consequence deletion rearrangement amplified gene extent variable among tumors spite intertumoral variability intragenic rearrangement results loss coding bases exons creation new codon novel splice site corresponding transcripts rearrangements however affect mrna sequence signal peptide first five codons reading frame downstream rearrangement,C04,0.002558952,0.002269918,0.0047762725,0.013812778,0.028339682,0.0033024608,0.15843955,0.0650283,0.0018500084,0.0025143207,0.046882614,0.005263275,0.02072682,0.12125084,0.002250278,0.018682301,0.025321456,0.15858491,0.0029137433,0.06394819,0.12266096,0.00090859085,0.1277138
autologous bone marrow transplantation multiple myeloma identification prognostic factors multiple myeloma remains universally fatal malignancy median survival time exceeding years clinical trial undertaken determine feasibility efficacy marrow ablative chemoradiotherapy supported unpurged autologous bone marrow abmt define prognostic variables total body irradiation either melphalan thiotepa administered patients median age years range years group patients resistance standard melphalan prednisone continuous infusions vincristine adriamycin high dose dexamethasone vad included primary unresponsive disease resistant relapse among patients achieving remission vad regimen first subsequent remission marked cytoreduction greater equal observed among patients refractory myeloma whereas cytoreduction magnitude noted patients already remission vad five early deaths among patients occurred patients resistant relapse none achieved complete remission group median durations relapse free overall survival months respectively among remaining patients one early death achieved complete remission including incidence among patients treated first remission projected year survival rate regardless disease status first later remission primary resistance information sensitivity prior therapy unavailable presence abmt high beta microglobulin levels greater mg l non igg isotype helped identify among patients poor prognosis responders relapsed within months patients died within months contrast year projected survival rate patients series justifies investigation novel treatment approach comparison standard dose regimens results indicate marrow ablative therapy cannot recommended myeloma patients resistant relapse combination risk factors advanced tumor burden absence igg isotype apparent lack adverse effect even marked plasmacytosis autografts emphasizes need better cytoreduction rather bone marrow purging,C04,0.0013096065,0.0011616864,0.0152472425,0.0007358145,0.008256093,0.025763666,0.21381293,0.0012315698,0.00094678724,0.0012888008,0.039532058,0.017091619,0.04117975,0.01128181,0.019976987,0.0020588518,0.34612715,0.020364968,0.008912102,0.10091027,0.114660524,0.0068024197,0.0013472749
bilateral familial carotid body paragangliomas report case dna flow cytometric cytogenetic analyses case study bilateral familial carotid body paragangliomas dna flow cytometric cytogenetic analyses presented analysis tumor cell nuclear dna content flow cytometry revealed aneuploid cell populations tumors standard cytogenetic analysis giemsa banding technique used right carotid body paraganglioma showed evidence numerical structural abnormalities describe parameters currently used predict biological behavior tumors,C04,0.0035768703,0.0031728623,0.0066740685,0.0020096975,0.059533432,0.004616137,0.24263306,0.02067683,0.002585918,0.003514485,0.24555379,0.0073569384,0.023416467,0.06016883,0.072214946,0.0055699307,0.0507332,0.0036890113,0.004072793,0.0443193,0.051802333,0.03589917,0.046209916
limbal autograft reconstruction conjunctival squamous cell carcinoma two patients squamous cell carcinoma extensive limbal corneal involvement treated surgery cryotherapy rarely large areas cornea involved tumor visual prognosis patients poor two patients autologous limbal transplants effective restoring excellent corneal surface good visual function technique may useful reconstruction eyes extensive neoplastic involvement corneoscleral limbus cornea,C04,0.0049477387,0.004388891,0.08011864,0.0027799325,0.030947631,0.0063853147,0.21709281,0.004652913,0.0035769949,0.028801305,0.03243757,0.058043927,0.034228653,0.012339146,0.0043509165,0.007704658,0.32695612,0.0050953506,0.005633728,0.031612493,0.09105843,0.0017567623,0.0050900513
soft tissue sarcomas head neck adults reviewed clinical records pathologic material adults primary soft tissue sarcomas treated memorial sloan kettering cancer center seventy two patients low grade sarcomas high grade sarcomas patients underwent form excision initial therapy adjuvant radiotherapy chemotherapy combined surgical excision showed significant effect significantly increased risk treatment failure associated large tumor size positive surgical margins bone involvement local recurrence metastatic spread high histologic grade except recurrence p value univariate analysis log rank test comparison survival according clinical pathologic characteristics p less although overall survival years years years patients high grade sarcomas alive years treatment patients rhabdomyosarcoma high grade peripheral nerve tumor high grade fibrous histiocytoma patients high grade angiosarcoma died disease less years diagnosis new therapeutic strategies needed improve survival adult patients high grade soft tissue sarcomas head neck,C04,0.0021801325,0.0124871265,0.004067901,0.0012249275,0.0807177,0.0028135746,0.2165087,0.002050223,0.0015761388,0.0021421083,0.05677019,0.01503742,0.13726853,0.016383972,0.0019171535,0.0033949197,0.2489369,0.002245175,0.0024824014,0.1213352,0.065441094,0.0007740858,0.0022444623
comparison lymphangiography computed tomography scanning evaluating abdominal disease stages iii iv hodgkin disease southwest oncology group study authors reviewed records patients laparotomy plus computed tomography ct lymphangiograms lag part staging workup hodgkin disease accordance southwest oncology group swog protocol evaluated relative ability ct lag detect disease abdomen two regions abdomen designated upper lower examine capabilities ct lag lower abdomen ct upper abdomen lag sensitive p less ct detecting positive lower abdominal nodes upper abdomen ct scan low sensitivity detecting positive nodes liver spleen study suggests lag lower abdomen provided information ct therefore abandoned valid method detecting nodal disease,C04,0.0029199137,0.0025901091,0.04764291,0.029853852,0.03260017,0.0037683006,0.22752771,0.03114821,0.0021109676,0.0028689867,0.23891957,0.03427761,0.09067343,0.006795543,0.0732239,0.017506786,0.03986703,0.0030070269,0.0033247513,0.03155622,0.07375583,0.0010367553,0.0030244302
molecular phenotype pediatric small round cell tumor molecular probes used characterize unusual small round cell abdominal tumor arising fallopian tube year old girl dna rna extracted tumor adjacent normal tissue subjected southern northern blot analysis using variety different probes n myc oncogene rna greatly expressed tumor expressed normal tissue amplified chromosomal dna insulin like growth factor ii rna similarly overexpressed neoplasm normal tissue histopathologic studies could distinguish neuroectodermal neoplasm wilms tumor electron microscopy pattern gene expression consistent wilms tumor,C04,0.002962225,0.0026276412,0.0055272044,0.0016643533,0.118849605,0.03249342,0.22663529,0.031450663,0.0021415567,0.0029105598,0.017053006,0.0060927304,0.043870952,0.06925499,0.016923644,0.018949997,0.045550894,0.017973935,0.017700847,0.019603398,0.15132481,0.0010517784,0.14738645
decollateralization silicone rubber sheeting advanced hepatocellular carcinoma preliminary report new treatment method interception collaterals silicone rubber sheet applied three patients advanced hepatocellular carcinoma arterial chemoembolization assessed ineffective developed collateral feeding arteries procedure followed arterial chemoembolization intraportal infusion chemotherapy follow celiac angiography confirmed long term decollateralization achieved shielding liver silicone rubber sheeting technique resulted partial responses without serious complications patients including two responses chemoembolization procedure response durations months respectively one patient died gastrointestinal bleeding months decollateralization two patients still alive survivals procedure months respectively therapy considered promising may worth choosing adjuvant treatment advanced hepatic malignancies uncontrolled arterial chemotherapy chemoembolization,C04,0.05773832,0.0026273862,0.0058281957,0.0016641918,0.004124404,0.0038225346,0.21132503,0.0027854417,0.0021413488,0.0029271569,0.04870703,0.006303072,0.0732708,0.006810409,0.002604653,0.047912568,0.36555287,0.0030544824,0.0033726015,0.040986847,0.1023419,0.0010516763,0.003047132
trends primary breast cancer management going treatment cancer period based whim clinician therapeutic consequences dominant biologic model disease dominant model breast cancer disease spread centrifugally along anatomic pathways time determinant prognosis alternative model biologic determinism posits outcomes treatment determined extent microscopic dissemination occurred tumor became detectable model flaws author suggests time kuhnian paradigm shift breast cancer exhibits heterogeneity phenotypes resulting one perhaps two mutations multiple prognostic variables may epiphenomena expressing different degrees amplification limited domain genome,C04,0.0032923005,0.0029204348,0.0061589996,0.0018498093,0.03645191,0.02017585,0.30566984,0.0030961193,0.0023801867,0.0032348784,0.045364756,0.022708783,0.028474646,0.05172731,0.018826801,0.036997017,0.06813698,0.01987707,0.0037487682,0.057716798,0.20522176,0.017096754,0.038872246
adjuvant cyclophosphamide methotrexate fluorouracil patients axillary node positive breast cancer update guy manchester trial patients premenopausal postmenopausal operable breast cancer positive axillary lymph nodes randomized total mastectomy axillary clearance receive cyclophosphamide methotrexate fluorouracil cmf n adjuvant therapy n median follow years relapse free survival rfs survival significantly prolonged premenopausal patients receiving cmf rfs p less p treatment cmf resulted significant improvement rfs premenopausal patients steroid receptor positive steroid receptor negative tumors also subgroups premenopausal patients defined number axillary nodes involved premenopausal patients developed permanent amenorrhea following cmf significantly better rfs continued menstruate induction amenorrhea following cmf related age almost patients years becoming amenorrheic patients less equal years development amenorrhea following cmf influence outcome difference detected control cmf groups rfs p p postmenopausal patients subgroup patients results trial efficacy cmf improving rfs strengthened longer follow,C04,0.002251523,0.0019972133,0.015098809,0.001265039,0.024927756,0.0029057078,0.15558478,0.0021173595,0.0016277509,0.0022122536,0.0734583,0.04263359,0.07549353,0.0053731594,0.0019799927,0.025279427,0.3146075,0.024117686,0.029922659,0.08056928,0.11345807,0.000799434,0.002319206
vivo selection characterization murine mammary tumor subline high potential spontaneous lymph node metastasis transplantable mammary adenocarcinoma grown balb c mice marked enhancement draining lymph node metastatic ability mm ln obtained vivo procedure variant tumor moderately metastatic lymph nodes mm mm mm ln presented similar latency tumor growth rate reached tumor mean diameter death mm ln tumor bearing mice exhibited larger mean survival time new variant showed fold higher incidence tumor draining lymph node metastases mm line differences incidence lung metastases morphology well cytogenetic vitro adhesion properties studied order characterize new subline murine tumor model potential application study metastatic process lymphoid tissue,C04,0.0024968735,0.0022148513,0.023547783,0.0014028914,0.114420585,0.015308505,0.1621689,0.00234809,0.0018051284,0.0024533249,0.04667543,0.017755711,0.05350578,0.09389253,0.0021956875,0.018107807,0.08270831,0.028619597,0.0028430577,0.10343613,0.20526785,0.00088654907,0.01593866
cryoprobe handle resection metastatic liver tumors resection metastatic liver tumors difficult risky procedure using cryoprobe handle greatly facilitate resection providing taut surface transection improving visualization ductal vascular structures addition technique may decrease risk contaminating surrounding tissues cancer cells may inhibit tumor recurrence within margins resection,C04,0.0050691897,0.004496624,0.010274538,0.002848171,0.08068212,0.031069458,0.21391572,0.004936466,0.0036647983,0.0049807765,0.04396691,0.034965947,0.0337483,0.091316946,0.0044577173,0.055973973,0.09489555,0.005220425,0.005772018,0.08955429,0.14664164,0.0017998851,0.029748559
generation human monoclonal antibodies colon cancer lymphocytes regional lymph nodes patients colon cancer fused human lymphoblastoid cell line without vitro immunization efficacy two protocols generation human monoclonal antibodies colon cancer investigated hyperplastic lymph nodes adjacent tumor best source b lymphocytes fusion frequency number tumor reactive clones markedly increased vitro immunization protocol applied prior fusion stimulant vitro immunization supernatant pokeweed mitogen stimulated lymphocytes superior supernatant mixed lymphocytes culture carcinoembryonic antigen micrograms l seemed optimal dose vitro immunization reactivities human monoclonal antibodies thus generated measured enzyme linked immunosorbent assay confirmed immunoperoxidase staining combining vitro immunization lymphocytes cancer patients may lead successful production clinically useful human monoclonal antibodies,C04,0.003516172,0.00311902,0.026440961,0.0019755936,0.03939985,0.004537803,0.29362702,0.0033066508,0.002542036,0.0034548456,0.035634138,0.024253072,0.06110038,0.1523147,0.003092033,0.005475411,0.10913433,0.0036413842,0.004003679,0.026975362,0.18754807,0.0012484649,0.0036590474
selenium nutritional toxicologic clinical aspects despite recent findings environmental contamination selenium toxicosis humans exceedingly rare united states known cases resulting industrial accidents episode involving ingestion superpotent selenium supplements chronic selenosis essentially unheard country typical diversity american diet nonetheless growing public interest selenium dietary supplement occurrence environmental selenium contamination medical practitioners familiar nutritional toxicologic clinical aspects trace element,C04,0.0040707826,0.0036109872,0.007595658,0.0022872067,0.0056684357,0.005253557,0.24609978,0.04323755,0.0029429945,0.10251859,0.07745099,0.008372822,0.02519889,0.0440833,0.0035797434,0.028159248,0.035619017,0.004192231,0.06374545,0.20642482,0.07420757,0.0014453869,0.004234988
laser therapy vaginal intraepithelial neoplasia hysterectomy recent years marked increase number reported cases vaginal intraepithelial neoplasia vain hysterectomy years ago radiation surgery therapeutic modality mostly used disease recently topical drugs bleomycin fluorouracil cream used often ineffective poorly tolerated last years used co laser treatment vain treated total patients use combination wire sutures vaginal mucosa introduction fluids underlying submucosal areas allows retraction ballooning recesses scars permits us place vaginal mucosa right angles laser beam allow complete treatment,C04,0.0035165686,0.0031193718,0.006561552,0.0019758164,0.004916016,0.0045856833,0.30343372,0.020328183,0.0025423225,0.0034552352,0.06427546,0.007232909,0.045314796,0.0082673095,0.0030925353,0.0054760287,0.23333855,0.0036214825,0.0040041306,0.13622205,0.12985395,0.0012486057,0.003617716
mucinous adenocarcinoma submandibular gland rare tumor easily classifiable among published histologic categories salivary gland tumors reported neoplasm developed within submandibular gland year old woman invasion mandible metastasis regional lymph nodes histopathologically cuboidal cells possessing clear cytoplasm displaced round nuclei proliferated exhibited adenomatous pattern many cystic spaces surrounded tumor cell strands seen mucus substance filled cystic spaces tumor cells seemed mucus secreting neither epidermoid cells papillary appearance could observed electromicroscopically numerous mucous droplets low electron density prominent cytoplasm tumor cells sparse irregular microvilli luminal surface mucin histochemistry including paradoxical concanavalin staining revealed tumor cells contained neutral acid mucins identified class ii iii mucosubstances neoplastic lesion except recurrent metastatic neck nodes detected years first examination seems tumor rare primary mucinous adenocarcinoma submandibular gland,C04,0.002880406,0.002555064,0.005374539,0.0016183828,0.11957808,0.01765419,0.22524989,0.114260934,0.0020824054,0.030686893,0.047103446,0.025369806,0.051623676,0.106542006,0.0025329564,0.0044853915,0.033212263,0.01724855,0.017201914,0.050326306,0.10184354,0.0010227276,0.01954668
implementation cancer prevention guidelines clinical practice data several sources including consumer surveys physician surveys medical record audits indicate consumers receive cancer screening tests recommended national cancer institute american cancer society u preventive services task force performance rates consistently published standards tests except pap tests major reasons physicians perform recommended tests include physician forgetfulness disagreement recommendations lack time patient refusal physicians also tend overestimate performance rates barriers screening test performance categorized patient factors physician factors test factors health care delivery system factors interventions computerized reminder systems physician audits feedback patient education reminders effective promoting performance screening interventions target physician patient may particularly effective,C04,0.0023814503,0.013638374,0.004443539,0.0013380398,0.003316094,0.0030733857,0.28681445,0.0022395446,0.01324632,0.0023399147,0.15330501,0.05989651,0.01573207,0.01004574,0.0020941873,0.015219194,0.0850402,0.013975507,0.094934575,0.16727154,0.046358857,0.00084556645,0.002449948
fallopian tube cancer roswell park experience sixty four patients primary fallopian tube cancer treated roswell park memorial institute underwent retrospective clinicopathologic review patients fallopian tube cancer primary patients primary fallopian tube cancer part multifocal upper genital tract malignancy patients unifocal fallopian disease median survival months patients alive disease free follow ranging months median months survival associated stage disease tumor histology grade depth invasion series fourteen patients received cisplatin based chemotherapy evaluable response three patients responded two complete one partial twelve patients without clinical evidence disease underwent second look procedures ten laparotomy two laparoscopy four ten second look laparotomies negative secondary debulking done three four patients gross disease one negative third look laparotomy negative laparotomy second look third look associated improved survival p one two laparoscopies negative patient recurred remaining patients cancer fallopian tube part multifocal upper genital tract malignancy patients tubal disease invasive situ separate primaries occurred ovaries n uterus n cervix n represents ovarian malignancies treated roswell park memorial institute study period fallopian tube cancer seems virulent ovarian cancer long term survivors frequently associated sites upper genital tract malignancy second look laparotomy important predictor survival second look laparoscopy may useful positive,C04,0.0019172244,0.0017006737,0.0035773418,0.0010772102,0.011950606,0.002474278,0.2763118,0.0018032665,0.0013860678,0.0018837856,0.12760694,0.073522225,0.021566205,0.00441859,0.0016859587,0.012263187,0.36115402,0.001977421,0.002183042,0.029822892,0.057064172,0.00068073673,0.0019723698
apocrine mammary carcinoma clinicopathologic study cases apocrine carcinoma ac uncommon poorly characterized type breast tumor review patients intraductal id ac patients infiltrating ac analyzed retrospectively define histologic features clinical course neoplasm recurrences breast occurred id ac patients treated biopsy alone patients received local radiation therapy biopsy one patient id ac axillary metastases time treatment mastectomy died disease five years later remaining patients id ac treated mastectomy remained disease free one three patients ac treated biopsy alone died disease one two patients ac treated biopsy radiotherapy alive carcinoma twelve patients ac treated mastectomy ten recurrence free time last observation one third cases id ac ac detected mammography alone survival analysis ac cases compared nonapocrine duct carcinoma cases matched stage revealed statistical difference estimated recurrence free survival estimated survival probability ac distinct morphologic entity natural history similar nonapocrine ductal carcinoma,C04,0.002071083,0.001837154,0.0439674,0.0011640495,0.013239983,0.0026908314,0.20988482,0.011963385,0.0014973008,0.012012694,0.09970367,0.03481103,0.017234473,0.004815886,0.0018278266,0.003225107,0.3037614,0.002178439,0.0023582326,0.11247848,0.114392556,0.0007353663,0.0021488504
years potential life lost another indicator impact cutaneous malignant melanoma society years potential life lost ypll indicator premature mortality complements traditional incidence mortality rates facilitates comparisons among different cancers calculated ypll cutaneous melanoma cancers routinely recorded tracked surveillance epidemiology end results seer ypll cutaneous melanoma ranked eighth persons younger years age fourth years age average ypll per death due melanoma one highest rates adult onset cancers results study first apply ypll cutaneous melanoma emphasize disproportionate impact cancer young middle aged adults reemphasize importance cancer public health priority,C04,0.0030987489,0.017707538,0.0059315786,0.0017389638,0.004309713,0.0045157727,0.18252806,0.0029105914,0.0022375595,0.018021934,0.028795239,0.09626569,0.02827469,0.022072311,0.017700506,0.01977133,0.048475936,0.0031873542,0.06254036,0.36036667,0.06526159,0.001098928,0.0031888934
e dependent expression adenovirus genes otf embryonal carcinoma cells role e induced differentiation undifferentiated f embryonal carcinoma cells allow adenovirus genes expressed independently e oncogene normally required activation attributed cellular equivalent e f cells however transcription early genes low undifferentiated otf embryonic carcinoma cells first hr infection adenovirus type ad transcription increased level seen hr infection cells induced differentiate retinoic acid ra referred ra df cells increase occur cells infected e deletion mutant dl addition e trans ra immediate effect viral transcription otf cells viral transcription increased hr additions ad induced transcription several differentiation specific genes otf cells kinetics induction ra genes superinduced ra df cells camp infection adenovirus suggest small amount e produced early infection otf cells activates cellular genes differentiation specific required efficient transcription viral genes e induces induced differentiation simple hypothesis cellular equivalent e adequately explain complex interactions viral cellular genes otf embryonic carcinoma cells,C04,0.001832536,0.0016255508,0.0034530612,0.0010296546,0.02027086,0.019992804,0.24967968,0.001723339,0.0013248419,0.0018005741,0.017865337,0.003769176,0.013526596,0.18736777,0.010460016,0.011718378,0.019523205,0.081719495,0.0020866117,0.024121966,0.19514206,0.00065066695,0.12931578
soft tissue tumor abnormal amianthoid collagen fibers electron microscopic examination solitary soft tissue tumor face demonstrated large areas abnormal amianthoid collagen fibers neoplasm lesion classified benign neoplasm myofibroblasts tentatively named myofibroblastoma significance amianthoid collagen fibers unknown normal native collagen fibers found parts neoplasm,C04,0.0048322114,0.0042864126,0.009016405,0.11967854,0.124472976,0.0062362207,0.24061355,0.00454427,0.0034934739,0.028124677,0.092425436,0.009938936,0.033850733,0.11731933,0.0042493246,0.007524758,0.041501835,0.004982042,0.0055021835,0.03139532,0.0993244,0.0017157428,0.004971201
computed tomography bronchoscopy chest radiographically occult main stem neoplasm diagnosis nd yag laser treatment patients studied adult patients variable symptoms cough dyspnea stridor wheezing hemoptysis fiberoptic bronchoscopy showed complete nearly complete endobronchial obstruction main stem bronchus neoplasm mean bronchial diameter mm mm mean standard deviation patients lobar bronchus also completely obstructed mass visible chest radiographs patient however computed tomography showed main stem endobronchial obstruction lobar obstruction instances patients patients hypoperfusion involved lung computed tomographic scan showed additional abnormalities unsuspected viewing chest radiographs bronchoscopy including mediastinal adenopathy patients extraluminal tumor component therapy nd yag laser main stem airway diameter increased mean mm mm p less pulmonary functions improved results suggest complementary role computed tomography fiberoptic bronchoscopy detection laser treatment planning chest radiographically occult severe neoplastic obstruction main stem bronchus,C04,0.008547369,0.0020418118,0.026578048,0.0012932877,0.060084287,0.041294347,0.19444121,0.024432072,0.0016640993,0.0022685982,0.0864837,0.0047343634,0.032640863,0.0053000855,0.013094768,0.0147122,0.27743486,0.0024269146,0.0026209385,0.017687293,0.1770088,0.0008172857,0.0023927907
phosphatase activity present peripheral blood myeloid cells chronic myelogenous leukemia patients normal individuals alters nuclear protein binding transcriptional enhancers interferon inducible genes cytoplasmic protein peripheral blood myeloid cells chronic myelogenous leukemia cml patients altered electrophoretic mobility complexes formed nuclear proteins interferon inducible transcriptional enhancers immature myeloid marrow cells blasts promyelocytes higher level activity mature myeloid marrow cells bands polys activity detectable peripheral blood cells normal individuals least fold higher cml marrow blasts promyelocytes found marrow blasts promyelocytes normal individuals activity inhibited vivo incubation immature myeloid cells phosphatase inhibitor sodium orthovanadate mm adding orthovanadate mm directly cytoplasmic proteins myeloid cells interferon alpha u ml reduced effects cml myeloid cell cytoplasmic protein electrophoretic mobility nuclear protein dna complexes data suggest unique phosphatase may involved abnormalities cml modulated interferon alpha,C04,0.0024969422,0.0022145614,0.0047749644,0.0014027077,0.003476362,0.0032219233,0.2031579,0.0023477825,0.001804892,0.0024530035,0.0116227465,0.017179858,0.09768898,0.14690486,0.014263394,0.0039091078,0.043564495,0.110895455,0.0028426854,0.020585276,0.22620136,0.00088643294,0.076104335
mapping site interaction murine ige high affinity receptor chimeric ig investigated interaction mouse ige fc epsilon ri rat basophilic leukemia cells using set chimeric ig constructed exchanging homologous h chain c domains human hu igg mige binding affinities examined equilibrium kinetic measurements found epsilon c gamma mige c epsilon replaced c gamma indistinguishable mige huigg chimeric ig contain c epsilon c epsilon bind detectably rat basophilic leukemia cells ka less ability chimeric ig stimulate cellular response degranulation presence multivalent ag also tested epsilon c gamma indistinguishable mige eliciting high level degranulation whereas chimeric ig stimulated response even preaggregated enhance binding avidity results demonstrate c epsilon may replaced c gamma without affecting binding cell activating properties mige lack binding chimeric ig indicates c epsilon c epsilon necessary binding interaction,C04,0.0029202772,0.0025904316,0.02545081,0.0016407846,0.018196391,0.017797308,0.24354759,0.031011052,0.0021112303,0.0028693439,0.030089954,0.006006452,0.053628173,0.16529699,0.002568018,0.0045474786,0.029902115,0.1069546,0.0034272687,0.024516474,0.1884129,0.0010368843,0.035477497
cancer antigen carcinoembryonic antigen carbohydrate determinant ovarian tumors authors studied data combination assays tumor markers simultaneous elevation different types tumor markers serum puzzling interpreted phenomena regarding cancer antigen carcinoembryonic antigen carbohydrate determinant ovarian tumors tissue expression antigens compared preoperative serum levels several different factors found cause simultaneous elevation two three markers serum furthermore even levels tumor markers raised serum ovarian tumor always produce marker study indicates immunohistochemical identification marker tumor tissue prerequisite use marker serum monitor disease status,C04,0.0027643463,0.0024521132,0.01863782,0.0015532386,0.10785697,0.0035675329,0.26277235,0.0025996247,0.0019984993,0.0027161327,0.024960717,0.034152173,0.081720956,0.113146715,0.0024308965,0.0043046623,0.03890562,0.0028468184,0.003147615,0.04591971,0.22434005,0.0009815189,0.016223935
male breast cancer male breast cancer uncommon important diagnosis easily made breast biopsy patients presenting earlier course disease past despite patients often first seen tumors metastasized axillary nodes markedly decreases survival rate therapy localized disease includes simple excision modified radical mastectomy radical mastectomy consensus operation appropriate radiation therapy strongly considered patients metastases axillary nodes role adjuvant hormonal therapy chemotherapy unclear treatment disseminated disease tamoxifen seems replacing orchiectomy favorable response rate especially patients estrogen receptor positive tumors lack side effects high level patient acceptability make attractive therapeutic choice,C04,0.002961877,0.0026273327,0.019861799,0.001664158,0.0471368,0.0038224568,0.3231491,0.031453732,0.0021413052,0.0029102182,0.04337245,0.006092015,0.039145343,0.006894986,0.0026046,0.018947883,0.15480381,0.0030502423,0.017634455,0.1334193,0.11788483,0.0010516549,0.01736963
squamous cell carcinoma antigen detection squamous cell mucoepidermoid carcinoma primary treatment preliminary report study evaluated efficacy using periodic measurement serum level squamous cell carcinoma antigen scc antigen determining local recurrence metastasis squamous cell mucoepidermoid carcinomas primary treatment found time clinical recognition recurrence scc antigen level normal metastasis regional lymph nodes remote organs generally accompanied increase scc antigen changes scc antigen level mucoepidermoid carcinoma seemed less sensitive squamous cell carcinoma,C04,0.004070185,0.003610457,0.044888753,0.002286871,0.0056676036,0.0052527855,0.2753419,0.0235233,0.0029425626,0.0039991955,0.04767141,0.0083715925,0.12148804,0.13844484,0.003579218,0.006338124,0.04726864,0.0041934135,0.004634504,0.027827034,0.21296719,0.0014451748,0.004187256
use mohs micrographic surgery establish quantitative proof heightened tumor spread basal cell carcinoma recurrent following radiotherapy compared basal cell carcinomas bccs recurrent following radiotherapy subsequently excised mohs micrographic surgery control group bccs recurrent following treatment modalities similarly excised mohs technique permitted precise quantitative tumor assessment obtained via novel method utilizing three parameters number surgical stages required complete excision percentage increase clinical preoperative tumor area final postoperative defect area presence deep subcutaneous tissue invasion figures postradiation group larger three categories latter two revealing statistically significant differences versus nonradiation group study gives strong direct quantitative support clinical impression bcc recurrent following radiotherapy uniquely aggressive invasive subset recurrent bcc,C04,0.0024092824,0.0021371536,0.016121393,0.0013536775,0.06309686,0.0031093045,0.2846994,0.0022657183,0.001741804,0.0023672616,0.0994894,0.05415253,0.04104022,0.049804546,0.0021186622,0.003783818,0.17259707,0.0024832396,0.0027433224,0.046826012,0.14232528,0.00085544866,0.002478581
effect tamoxifen serum insulinlike growth factor levels stage breast cancer patients insulinlike growth factor igf shown potent mitogen breast cancer cells vitro igf receptors demonstrated human primary breast neoplasms randomized placebo controlled study document administration antiestrogen tamoxifen patients breast cancer associated statistically significant p reduction serum level igf mean igf level u ml placebo treated group u ml tamoxifen treated group serum igf level growth hormone gh dependent data suggest pubertal surge gh igf levels sex steroid dependent speculate mechanism underlying observation may involve blockade tamoxifen estrogen action hypothalamic pituitary axis conclude tamoxifen treatment reduces igf levels reduction may contribute therapeutic effect drug,C04,0.0024967815,0.0022145086,0.008024603,0.0014026742,0.0034765275,0.0032218467,0.19611733,0.023105238,0.001804849,0.002452945,0.011623932,0.034123324,0.048111577,0.023177385,0.0021953478,0.0038875497,0.10411251,0.03881997,0.12207286,0.044913117,0.31918058,0.0008864119,0.0025781735
human immunodeficiency virus type vpr gene essential productive infection human macrophages human immunodeficiency virus hiv genetic determinant responsible tropism human cells macrophages well defined studied role hiv type hiv nef vpr genes viral tropism hiv mutants lacking either vpr nef genes vpr nef obtained site specific mutagenesis biologically active hiv proviral clone hiv sbl isy infectious human cells macrophages viral progeny carrying mutations nef vpr nef vpr genes replicated efficiently parental virus primary human peripheral blood cells human hut cell line contrast hiv nef mutant infected human macrophages efficiently parental virus whereas viruses lacking vpr gene either alone conjunction lack nef gene replicate macrophages thus lack nef hiv enhances viral replication cells interfere viral replication primary macrophages whereas vpr essential replication hiv human macrophages parental hiv sbl isy cloned virus also infects rhesus macaques use animal studies hiv mutants differences cell tropism rates replication highly useful understanding mechanism viral infectivity possibly pathogenicity vivo,C04,0.0020302243,0.0018009103,0.0037906,0.0011407596,0.032534603,0.0026201103,0.298078,0.07070878,0.0014677618,0.0019948147,0.012020667,0.0042801583,0.02949434,0.16374739,0.0017853281,0.0031614816,0.019677086,0.036336217,0.002311709,0.032281097,0.10302212,0.0007208589,0.17499496
dietary fat risk breast cancer relationship dietary fat subsequent risk breast cancer studied initially cancer free finnish women aged follow period breast cancer cases diagnosed risk breast cancer significantly inversely related energy intake nonsignificantly inversely related absolute fat intake positive association energy adjusted total fat intake occurrence breast cancer also observed relative risk highest tertile compared lowest tertile confidence limits corresponding relative risks saturated fatty acids monounsaturated fatty acids polyunsaturated fatty acids cholesterol intake adjustment different potential confounding factors alter results present data suggest breast cancer associated inversely energy intake weakly positively energy adjusted fat intake,C04,0.0029203966,0.0025905375,0.033723123,0.0016408517,0.0040665595,0.003768924,0.14012097,0.0027463762,0.0021113167,0.0028694612,0.04908291,0.076694615,0.08021794,0.006976374,0.016714778,0.04693073,0.039742414,0.0030075242,0.003325301,0.34846997,0.1282376,0.0010369266,0.0030043963
human colorectal cancers display abnormal fourier transform infrared spectra fourier transform infrared spectroscopy ft ir applied study tissue sections human colorectal cancer pairs tissue samples colorectal cancer histologically normal mucosa cm away tumor obtained patients underwent partial colectomy cancer specimens displayed abnormal spectra compared corresponding normal tissues changes involved phosphate c stretching bands ch stretch region pressure dependence ch bending c stretching modes findings indicate colonic malignant tissue changes degree hydrogen bonding oxygen atoms backbone nucleic acids increased ii oh groups serine tyrosine threonine residues cell proteins decreased iii c groups acyl chains membrane lipids increased addition indicate changes structure proteins membrane lipids judged changes ratio methyl methylene groups packing conformational structure methylene chains membrane lipids cell malignant colon tissues responsible spectral abnormalities unknown cultured colon adenocarcinoma cell lines displayed similarly abnormal ft ir spectra diagnostic potential observed changes discussed,C04,0.002050822,0.0018191814,0.0567713,0.011040863,0.012783422,0.02248724,0.15306567,0.011851089,0.001482653,0.0020150528,0.05601384,0.06378518,0.0884116,0.034623347,0.07129285,0.003193556,0.03692721,0.032344867,0.0023351624,0.013552054,0.23466712,0.0007281723,0.086757734
glucocorticoids locally disrupt array positioned nucleosomes rat tyrosine aminotransferase promoter hepatoma cells transcriptional activation steroid hormones often associated appearance dnase hypersensitive site resulting local alteration nucleoprotein structure promoter mouse mammary tumor virus long terminal repeat viral promoter glucocorticoid control model proposed appearance hormonodependent dnase hypersensitive site reflects displacement single precisely positioned nucleosome associated glucocorticoid responsive elements determine mechanism general relevance transcriptional activation steroid hormones investigated nucleosomal organization rat tyrosine aminotransferase promoter kilobase region contains glucocorticoid regulatory target region displays hormonodependent dnase hypersensitive site absence hormone micrococcal nuclease digestion nuclei demonstrates presence positioned nucleosomes cutting sites centered around positions treatment cells dexamethasone induces disruption chromatin structure relatively short stretch dna approximately positions overlaps two nucleosomes observations suggest strong similarity role chromatin structure glucocorticoid dependent transcriptional activation mouse mammary tumor virus tyrosine aminotransferase promoters,C04,0.0021358994,0.012220608,0.05610716,0.0012000748,0.06506587,0.013067525,0.1964798,0.022683041,0.0015441602,0.012434638,0.02430548,0.015026324,0.028257554,0.06327051,0.0018782561,0.003352269,0.032595944,0.053545203,0.0024320357,0.06626385,0.2132292,0.0007583803,0.11214619
delayed reconstruction following mohs chemosurgery skin cancers head neck case records patients cutaneous neoplasms treated mohs chemosurgery subsequently reconstructed plastic surgeons reviewed determine delay resection reconstruction adversely affected outcome reconstruction reconstruction performed days mohs chemosurgery basal cell carcinomas cutaneous neoplasms complications interval resection reconstruction following reconstruction minor wound complications occurred patients major complications microscopic examination excised wound revealed residual disease cases basal cell carcinoma cutaneous malignancies patients residual basal cell carcinomas e false negative margins mohs surgery presented mohs surgeon recurrent tumors follow period months years complete resection recurrent tumor developed cases basal cell carcinoma cases squamous cell carcinoma delayed reconstruction usually days mohs chemosurgery performed without significant morbidity excision mohs chemosurgical wound pathologic examination detect residual disease may especially indicated large recurrent wounds,C04,0.0022273152,0.0019757398,0.0041559394,0.0012514376,0.047742292,0.0028744664,0.23118335,0.0020945943,0.0016102497,0.034534596,0.07608537,0.015362406,0.015617046,0.048792154,0.001958645,0.003468393,0.32196862,0.0022959847,0.0025361262,0.06306539,0.116115175,0.00079083873,0.0022938945
embryonic stem cell virus recombinant murine retrovirus expression embryonic stem cells expression moloney murine leukemia virus vectors derived restricted undifferentiated mouse embryonal carcinoma embryonal stem es cells developed retroviral vector murine embryonic stem cell virus mesv active embryonal carcinoma es cells mesv derived retroviral mutant pcc cell passaged myeloproliferative sarcoma virus pcmv expressed embryonal carcinoma cells es cells enhancer region pcmv shown functional cell types sequences within untranslated region pcmv found restrict viral expression es cells replacement region related sequences obtained dl rev retrovirus results mesv modified pcmv virus confers g resistance fibroblasts es cells similar efficiencies expression mesv es cells mediated transcriptional regulatory elements within long terminal repeat viral genome,C04,0.0025587813,0.0022697668,0.0047744205,0.0014377573,0.0035630218,0.052770823,0.12430902,0.002407496,0.001849885,0.0025141528,0.017138714,0.0052851117,0.019066634,0.2571479,0.014614669,0.0039845547,0.04488027,0.019544162,0.015188097,0.045329295,0.08831814,0.00090853026,0.27013883
brain stem spinal metastases supratentorial glioblastoma multiforme clinical series although spread supratentorial glioblastoma multiforme brain stem spine extensively described published autopsy series information diagnosis treatment subsequent clinical course patients manifesting symptoms glioblastomatous dissemination ante mortem remains scant report series patients signs symptoms neuraxis dissemination supratentorial glioblastoma multiforme patients radiographic documentation metastases either contrast enhanced myelograms enhanced magnetic resonance imaging scans ten presented spinal involvement whereas one presented lower cranial neuropathies secondary diffuse involvement basal cisterns mean age patients years mean time interval diagnosis intracranial disease diagnosis metastases months diagnosis tumor spread subsequent mean survival time months patients received additional radiotherapy areas metastasis clinical response radiotherapy quite poor study confirms previous reports literature suggesting metastases occur younger patients patients extended survival findings suggest relatively infrequent clinical incidence symptomatic spread glioblastoma multiforme compared frequent incidental discovery spread autopsy may result limited survival affected patients due biology tumor,C04,0.0020316578,0.0018012149,0.0037888288,0.0011408932,0.022761296,0.013301562,0.2648676,0.0019095705,0.0014680101,0.012360716,0.11490988,0.0043520457,0.035039693,0.04396884,0.00178563,0.0031620164,0.28712192,0.002093476,0.012119884,0.06760511,0.09960023,0.0007209808,0.0020889733
patterns care outcome study cancer uterine cervix results second national practice survey report summarizes outcome results patterns care study pcs cancer uterine cervix patients treated year survival evidence disease stage stage ii stage iii year local field failure rate stage stage ii stage iii extent parametrial involvement unilateral versus bilateral may important determining survival local failure four year actuarial survival unilateral involvement versus bilateral p local failure rate unilateral versus bilateral p less analyzed stage patients stage iib disease unilateral parametrial involvement showed trend toward improved survival decreased local failure compared bilateral stage iib cancers p use intracavitary irradiation significantly improved survival reduced local failures furthermore number intracavitary applications important two intracavitary applications used compared one application local field failure significantly reduced versus years p less four year survival improved versus p four year actuarial rate major complications depended stage stage stage ii stage iii statistically significant increase major complications patients undergoing laparotomy staging versus laparotomy versus years p less equal trend toward increased major complications patients thin prior abdominal surgery study confirmed stage dependent outcome treatment cancer uterine cervix radiation indicated division stage iib indicate prognostic significance unilateral bilateral parametrial involvement may warranted study also confirmed importance intracavitary radiation optimizing control established pcs suggests possible two intracavitary insertions may yield better results one insertion,C04,0.007454308,0.03946497,0.0024600003,0.000740756,0.0018447987,0.0017014657,0.1872054,0.0076111197,0.0009531455,0.0012954068,0.029220179,0.07178571,0.048512626,0.0030620934,0.013827305,0.027579535,0.29497272,0.0013595952,0.01966589,0.08033696,0.13159427,0.02599543,0.0013563228
treatment fallopian tube carcinoma cisplatin doxorubicin cyclophosphamide primary carcinoma fallopian tube uncommon often treated using regimens active ovarian carcinoma evidence scant therapies benefit patients fallopian tube carcinoma december july treated patients adenocarcinoma fallopian tube combination cisplatin mg doxorubicin mg cyclophosphamide mg administered intravenously day every days histologic confirmation fallopian tube carcinoma obtained entry study three patients stage disease five stage ii nine stage iii one stage iv sixteen patients received combination therapy first line treatment cytoreductive surgery two patients received recurrent carcinoma seven patients clinically measurable disease start therapy two patients complete clinical response two stable disease three progressive disease eight patients stages ii iv disease underwent second look laparotomy four complete response therapy four partial response making overall response rate toxicity regimen moderate median survival months patients stages ii iv disease median survival months progression free survival months regimen appears active fallopian tube carcinoma result response rates comparable reported epithelial ovarian cancer,C04,0.0019001511,0.010875187,0.003545485,0.010258715,0.0026558102,0.011644557,0.3363278,0.010975104,0.0013737247,0.0018670101,0.010790303,0.026849652,0.012251022,0.0043690344,0.001670945,0.0029589306,0.33788118,0.0019568407,0.011177222,0.025053063,0.17098878,0.00067467464,0.0019548053
thyroid carcinoma mixed tall cell columnar cell features tall cell columnar cell carcinomas regarded aggressive variants papillary thyroid carcinoma present case report authors describe composite tumor forms differentiation coexisted transitional changes occurring within single follicular structures finding indicates two variants closely related local recurrences one feature appeared separate lesions lung metastases developed patient died years diagnosis primary treatment,C04,0.0038431436,0.00340906,0.007170907,0.0021593056,0.07976866,0.023563623,0.29001316,0.022711404,0.0027784216,0.0037761142,0.08129625,0.063707866,0.029850923,0.09854608,0.0033795633,0.0059845736,0.12442998,0.0039578006,0.004375984,0.033941973,0.065565504,0.0013645606,0.04440512
human tumor fluorouracil trapping clinical correlations vivo f nuclear magnetic resonance spectroscopy pharmacokinetics previously reported fluorouracil fu accumulation metabolism human livers tumors studied vivo nuclear magnetic resonance spectroscopy nmrs extended observations evaluating pharmacokinetics fu tumors patients carcinoma breast colon endometrium cervix kidney using f nmrs magnetom siemens medical systems cerrito ca magnetic resonance imaging unit mri nmrs measurements detected long lived tumor pool fu six tumors patients including carcinomas pelvis breast lung liver half life tumor pool trapped fu hours minutes much longer fu blood minutes neither anabolites fu fluorinated nucleosides nucleotides fu rna fu thymidylate synthase catabolites eg fluorobetaalanine fbal detectable f nmrs patient response chemotherapy appeared correlate extent trapping free fu human tumors seven patients receiving fu fu fudr plus leucovorin four four patients whose tumors trapped fu responded fluorinated pyrimidine chemotherapy whereas three patients failure detect tumor trapping resistant fu conclude nmrs clinically feasible enables investigators study fu pharmacokinetics metabolism tumors vivo f nmrs fu allows vivo evaluation fu metabolic modulation might able guide therapeutic decisions,C04,0.002071136,0.011862755,0.034234267,0.0011636867,0.15328674,0.012697947,0.16776413,0.0019477214,0.0014973391,0.02208262,0.026779989,0.0048468676,0.07542373,0.04453809,0.0018213047,0.042941652,0.109899834,0.024267554,0.002358293,0.06585117,0.17460759,0.0007353851,0.017320236
expression mdr gene human gastric colorectal carcinomas measured expression mdr gene also known pgy gene human gastrointestinal tract mdr messenger rna mrna levels elevated colorectal carcinoma specimens six gastric carcinoma specimens well differentiated colorectal carcinomas contained significantly higher concentrations mdr mrna moderately differentiated colorectal carcinomas similarly moderately differentiated gastric carcinomas contained higher concentrations mdr mrna poorly differentiated gastric carcinomas mdr gene expression normal colorectal gastric tissues adjacent carcinomas similar carcinomas mdr gene expression xenografts colorectal gastric carcinomas nude mice also investigated elevated expression mdr gene seen four xenografts colorectal carcinoma seen xenografts gastric carcinoma p glycoprotein distributed luminal surface colorectal carcinoma results imply higher levels mdr mrna found well differentiated carcinomas derived colorectal tissues results increased expression mdr gene luminal surface cells level expression mdr gene colorectal gastric carcinomas appears correlate degree differentiation also appears affected transplantation nude mice,C04,0.002410046,0.0021378312,0.027945437,0.0013541066,0.0033559129,0.00311029,0.2539333,0.002266902,0.0017423561,0.002368012,0.036212914,0.0283076,0.058153816,0.039655212,0.0021193337,0.0037529431,0.0698323,0.053650856,0.002744192,0.020292679,0.23939992,0.00085571985,0.1443983
left superior vena cava pitfall computed tomographic diagnosis surgical implications report cases computed tomography mediastinum demonstrated abnormality originally misinterpreted lymphadenopathy subsequently shown represent left superior vena cava misinterpretation may result errors optimum treatment may complicate surgical exploration mediastinum cases presented remind radiologists surgeons possibility unusual anatomy,C04,0.005069119,0.0044965614,0.00945845,0.0028481311,0.05621571,0.006541962,0.39351648,0.05384694,0.0036647473,0.004980707,0.10100516,0.010426208,0.031698648,0.012089244,0.0044576554,0.007893672,0.120996736,0.005220352,0.0057719373,0.058086343,0.07016301,0.026337268,0.0052149226
immunohistochemical study pi class glutathione transferase expression normal human tissue glutathione transferases gsts family isoenzymes play important role protecting cells cytotoxic carcinogenic agents separated biochemical immunologic characteristics three distinct classes named alpha mu pi previous studies indicated marked heterogeneity expression different gst isoenzymes different normal malignant tissues better understand regulation human pi class glutathione transferase isoenzyme gst pi tissue distribution protein wa studied immunohistochemical technique using anti gst pi polyclonal antibody normal paraffin embedded human tissues studies indicate broad distribution gst pi normal human tissues establish precise localization within different organs studied gst pi expressed predominantly normal epithelial cells urinary digestive respiratory tracts suggesting possible role gst pi detoxication elimination toxic substances previous studies indicated gst pi putative drug efflux pump p glycoprotein overexpressed multidrug resistant human breast cancer cells xenobiotic resistant preneoplastic rat hyperplastic liver nodules results study indicate also similarities normal tissue distribution gst pi previously reported mammalian p glycoprotein particularly secretory epithelia finding suggests two gene products implicated development resistance cytotoxic drugs may coregulated normal malignant cells,C04,0.0018328078,0.0016257919,0.021159293,0.019813295,0.0025521268,0.011235916,0.24915992,0.0017235946,0.0013250384,0.010668362,0.028844355,0.030096365,0.014230116,0.12259096,0.054838337,0.020007696,0.016830517,0.012260944,0.0020869211,0.01370519,0.30932072,0.009512672,0.044579033
biopsy breast mammographically detected lesions prospectively studied women underwent biopsy breast suspicious mammographically detected mammary lesions attempt identify key clinical risk factors well roentgenographic characteristics associated appearance early carcinoma breast patients benign outcome average age years versus years patients carcinoma breast seventy six per cent patients previous history mammary problems per cent positive family history carcinoma breast per cent premenopausal per cent used birth control pills except age p less distribution clinical risk factors equal among patients benign malignant outcomes suspicious mammographic findings included mass lesions per cent calcifications per cent association per cent predominant wolfe pattern mammography p per cent relationship observed wolfe pattern malignant conditions group patients mammography poorly specific however positive predictive value increased age related age specific prevalence carcinoma breast eight hundred twenty five lesions removed twenty five per cent n specimens taken biopsy contained carcinoma stellate mass lesions highly suggestive malignant growth p less relationship size suspicious mammographic mass malignant lesion observed marked correlation chi square test yate correction observed malignant tumor lesions linear branching pattern calcifications small sized calcifications presence mass calcifications associated carcinoma per cent incidence invasive carcinoma much higher mass lesions per cent suspicious calcifications per cent p less,C04,0.0098934015,0.0015243412,0.07710082,0.0009534556,0.08024034,0.010377744,0.19856507,0.009803718,0.0012268304,0.0016673681,0.089929566,0.011966996,0.041238762,0.019413002,0.009705494,0.010842907,0.107675396,0.0017475929,0.0019322446,0.23108144,0.08074628,0.0006025307,0.0017647257
cutaneous manifestations postthymic cell malignancies description five clinicopathologic subtypes study undertaken identify cutaneous manifestations among different prognostic subgroups postthymic cell malignancies cutaneous involvement demonstrated cases recognized five clinicopathologic subtypes type classical cutaneous cell lymphoma ctcl mycosis fungoides six cases type ii primary large cell type ctcl ki antigen ki ki seven cases type iii primary angioinvasive cell lymphoma three cases type iv human lymphotropic virus type htlv adult cell leukemia lymphoma atl eight cases type v secondary cutaneous involvement peripheral cell lymphoma ptl cases primary ctcl atl tend involve papillary dermis without epidermotropism whereas ptl angioinvasive cell lymphoma predominantly affect skin adnexae vessels subcutis cutaneous lesions type v ptl heterogeneous may confused panniculitis vasculitis eczematous eruption classic ctcl ki lymphoma angioinvasive cell lymphoma chronic course whereas atl ki large cell lymphoma ptl clinically aggressive,C04,0.0025583638,0.0022693966,0.0047736415,0.001437779,0.02842494,0.003301702,0.33841035,0.0024112477,0.0018495832,0.0025137428,0.10462442,0.019954959,0.01678136,0.16531599,0.014628184,0.0039839046,0.046057746,0.0026441754,0.0029130736,0.044799328,0.18680209,0.00090838206,0.0026357067
segregation analysis breast cancer cancer steroid hormone study histologic subtypes segregation pattern breast cancer white families cancer steroid hormone study investigated families categorized four groups based histologic type breast cancer probands ductal cancer lobular cancer adenocarcinoma medullary cancer ductal cancer sample split premenopausal proband postmenopausal proband subset results six complex segregation analyses presented findings suggest heterogeneity transmission breast cancer analyses evidence multifactorial component mixed model ie major locus plus transmission genetic cultural interpretation medullary cancer adenocarcinoma lobular cancer analyses permit discrimination among major locus models segregation breast cancer entire ductal sample consistent autosomal recessive transmission ductal subanalyses recessive gene sufficient explain breast cancer distribution proband postmenopausal breast cancer contrast proband premenopausal breast cancer transmission model consistent dominant major gene sporadic cases disease,C04,0.002657014,0.0023569039,0.01852167,0.0014929472,0.0036998077,0.003429015,0.21728295,0.002498688,0.014781716,0.0026106723,0.07653237,0.13409208,0.016656391,0.0323032,0.002336511,0.004137523,0.023092773,0.0027362837,0.054474585,0.049640678,0.24871217,0.013795563,0.07215844
antigen induced cross linking ige receptor leads association detergent insoluble membrane skeleton rat basophilic leukemia rbl h cells cross linking ige receptor surface rat basophilic leukemia cells multivalent ag dnp bsa causes rapid conversion detergent insoluble form concurrent increase amount filamentous actin associated plasma membrane degree receptor detergent insolubility rise f actin content rapid half maximal response less min rapidly reversed addition monovalent ag dnp lysine two early steps triggering rat basophilic leukemia cells dissociated pretreatment cells either cytochalasin sodium azide reagents block increase f actin effect receptor detergent insolubility indicates microfilaments responsible detergent insolubility receptor may membrane skeleton interacting complex confirmed finding cross linking ige receptors surface purified plasma membranes also leads detergent insolubility receptor therefore components necessary detergent insolubility receptor present plasma membrane cytoplasmic components needed results suggest detergent insolubility immobility cross linked receptors caused multivalent interaction membrane skeleton actin filaments may interact receptor membrane skeletal complexes order produce large scale clustering capping membrane skeleton may therefore acting intermediate structure cell surface receptors microfilaments,C04,0.0019354338,0.0017168263,0.08036582,0.0010876252,0.002695393,0.0024977783,0.28432584,0.0018201054,0.010764633,0.0019016773,0.008968805,0.01334029,0.039350636,0.10117709,0.03914499,0.0030325216,0.021432796,0.123537965,0.002203776,0.035724435,0.19987462,0.0006872022,0.022413703
clinical significance colonic fermentation recent evidence potential benefits short chain fatty acids prompted renewed interest area human colonic fermentation paper reviews clinical metabolic consequences colonic fermentation,C04,0.03797924,0.0057712337,0.012139704,0.0036555112,0.009059535,0.008396459,0.36932275,0.0061184135,0.0047036195,0.0063926238,0.029920822,0.013381801,0.040273942,0.018465485,0.0057212985,0.04160756,0.05593266,0.0067002024,0.00740815,0.076327056,0.18734679,0.002310079,0.051065076
ultrastructural evidence differentiation human glioblastoma cell line treated inhibitors eicosanoid metabolism human glioblastoma cells incubated presence inhibitors eicosanoid biosynthesis show decreased cellular proliferation without cytotoxicity studied ultrastructural morphology human glioblastoma cell line cultured nordihydroguaiaretic acid ndga lipoxygenase inhibitor eicosatetraynoic acid cyclooxygenase lipoxygenase inhibitor glioblastoma cells treated days antiproliferative concentrations either agent shared many morphological characteristics including evidence increased astrocytic differentiation limited signs toxicity inhibited glioma cells demonstrated increase number length astrocytic processes containing greater numbers glial filaments ndga treated cells also demonstrated extensive lateral pseudopod formation along processes glioblastoma cell shape also became elongated losing usual nuclear lobularity nuclear inclusions especially ndga treated cells many cytoplasmic organelles packed cytosol inhibited glioma cells including prominent golgi apparatus dilated smooth endoplasmic reticulum evolving dilated vesicles cytoplasmic vacuoles numerous concentric laminations limited evidence toxicity however mitochondria pleomorphic mitochondrial distention disruption cristae along increase cytoplasmic vacuolization conclude inhibitors eicosanoid biosynthesis ndga eicosatetraynoic acid suppress glioblastoma cell proliferation also induce increased astrocytic differentiation,C04,0.0019001602,0.010870205,0.003545502,0.010237657,0.002650152,0.0024522557,0.28483394,0.023476273,0.019756842,0.011060321,0.009135526,0.0039082663,0.014061782,0.20932822,0.001670953,0.0029589445,0.024760816,0.021541584,0.0021636118,0.030403906,0.26034164,0.00067467784,0.04826676
suppression serum insulin level diazoxide alter serum testosterone sex hormone binding globulin levels healthy nonobese women suppression serum insulin levels diazoxide associated decrease serum testosterone increase serum sex hormone binding globulin obese women polycystic ovary syndrome determine whether physiologic insulin levels play regulatory role androgen status nonobese women normal menses androgen status five nonobese normal women assessed two occasions control study days oral diazoxide mg three times daily administration insulin release response gm oral glucose administration decreased nmol min l p diazoxide administration however despite suppression insulin release diazoxide administration affect serum total testosterone diazoxide control nmol l p ns sex hormone binding globulin diazoxide control nmol l p ns concentrations observations suggest physiologic insulin levels nonobese healthy women regulate testosterone metabolism diazoxide exert direct independent effect serum testosterone sex hormone binding globulin levels,C04,0.0023275402,0.0020646444,0.03813667,0.00130775,0.003241026,0.003003812,0.11680974,0.0021888472,0.001682708,0.002286945,0.0108193075,0.004832111,0.06941785,0.005551109,0.0020468223,0.085364014,0.02080452,0.029096963,0.002650247,0.1271953,0.46595114,0.000826425,0.0023944876
aromatase activity human granulosa cells patients polycystic ovaries treated dexamethasone effect dexamethasone dex alpha fluro alpha methyl prednisolone secretion steroids human granulosa luteinized cells studied culturing cells mature follicles women polycystic ovarian disease treated infertility vitro fertilization program patients treated dex mg day human chorionic gonadotropin administration cells cultured hours presence androstenedione incubating hours medium replaced cells incubated additional hours medium harvested assayed estradiol e progesterone p results compared control group treated dex estradiol production cells significantly lower study group treated dex progesterone production influenced dex follicular fluid levels e androgens vary dex treatment whereas cortisol levels markedly decreased p levels increased treatment findings suggest glucocorticosteroids directly influence granulosa luteinized cell function,C04,0.0024379508,0.002162584,0.016276686,0.0013697852,0.0033947695,0.0031463027,0.1898384,0.014082755,0.00176253,0.0141231315,0.011254659,0.041107167,0.064198405,0.13827483,0.0021438724,0.015591809,0.07770262,0.0025106852,0.012549372,0.051947948,0.30536315,0.0008656278,0.027894963
mutagen sensitivity patients head neck cancers biologic marker risk multiple primary malignancies eighty four patients head neck cancers evaluated vitro sensitivity mutagens followed longitudinally development multiple primary malignancies assessed mutagen sensitivity exposing lymphocytes bleomycin vitro quantitating bleomycin induced chromosomal breaks per cell mutagen hypersensitive patients ie expressed greater break per cell significantly likely develop multiple primary cancers patients less sensitive less equal break per cell relative risk confidence limits relationship independent age sex site treatment first primary cancer tobacco alcohol exposures sensitivity bleomycin induced chromosomal damage serves indicator genetic susceptibility multiple primary malignancies patients head neck cancers,C04,0.0027274985,0.0024194273,0.110437036,0.0015324702,0.0037979553,0.003519979,0.22431737,0.002568557,0.0019718602,0.0026799275,0.059448577,0.071640246,0.0557289,0.06528347,0.0024022285,0.004252468,0.16126692,0.002816323,0.0031056583,0.11474374,0.09951595,0.00096843566,0.0028549999
use levator scapulae muscle flap head neck reconstruction numerous techniques available reconstruction defects following composite resection oral cavity oropharyngeal tumors single technique applicable situations levator scapulae muscle flap well known application carotid protection little attention paid usefulness aspects head neck reconstruction using levator scapulae muscle flap variety reconstructive problems flap useful buttressing intraoral suture lines closing intraoral defects providing soft tissue fill dead spaces bulk lateral anterior oral defects levator flap found easy elevate safe reliable minimum wound complications review patients representative case studies discussion surgical technique relevant anatomy blood supply presented,C04,0.003049329,0.017464457,0.0056897313,0.0017132936,0.10870478,0.003935318,0.25227973,0.03238709,0.061252344,0.0029961448,0.105556354,0.006271887,0.07987708,0.022330778,0.0026815028,0.049030814,0.13910475,0.0031403033,0.018220628,0.02103754,0.05904781,0.0010827059,0.0031456628
kda membrane bound protease associated expression invasiveness human malignant melanoma cells malignant spreading cancer cells requires cell surface proteases cleave crosslinked collagenous matrix connective tissues correlating morphologically defined invasiveness tumor cells presence specific membrane associated proteases identified malignant human melanoma cell line lox invades crosslinked gelatin films vitro contains uniquely neutral kda gelatinase cell membrane similar gelatinase found membranes recovered culture media conditioned lox kda gelatinase wheat germ agglutinin binding protein proteolytic activity maximal neutral ph enhanced edta dithiothreitol inhibited cysteine protease inhibitors n ethylmaleimide hgcl phenylmethylsulfonyl fluoride bind organomercurial adsorbent suggesting neutral sulfhydryl sensitive protease kda gelatinase lox cells found control melanoma cell line sk mel tumor cell lines show extracellular gelatin degradation thus identified large membrane bound protease may specific marker molecule melanoma cell invasiveness,C04,0.002466735,0.002188117,0.0783861,0.0013859578,0.027853006,0.015083022,0.27348262,0.014212997,0.013720929,0.002423712,0.014995863,0.018160028,0.026943916,0.25082427,0.0021691846,0.0038412195,0.022297371,0.11001559,0.0028087406,0.019457674,0.06673749,0.000875848,0.029669601
cytobrush evaluating routine cervicovaginal endocervical smears conventional wooden spatula cotton tipped applicator remained method obtaining papanicolaou smears clinicians university california los angeles student health service shs adopted zelsmyr cytobrush sole method obtaining cervical samples late study done define changes adequacy sampling detection rate squamous glandular epithelial abnormalities cytobrush accomplish goal cytobrush conventionally obtained smears analyzed prospectively shs samples obtained prior change method reviewed retrospectively compared cervical samples obtained conventional methods cytobrush smears contained significantly endocervical cells fewer drying artifacts methods obtained equivalent squamous samples similar final class distributions case endocervical adenocarcinoma carcinoma situ invasive adenocarcinoma detected shs patients initial endocervical cells samples whose repeat sample contain endocervical cells retained class cases study confirmed cytobrush technique produces papanicolaou smears improved sampling squamocolumnar junction questioned whether results increased detection rate cervical pathology,C04,0.0022519692,0.001997609,0.0042019407,0.023061298,0.013876728,0.0029062836,0.13445579,0.002117779,0.0016280735,0.013107152,0.34651834,0.01563393,0.042204686,0.050233297,0.023780154,0.014398647,0.1004542,0.002327597,0.035264075,0.029842064,0.13656077,0.0007995924,0.0023780565
diagnosis metastatic lesions stomach salvage cytology report three cases secondary neoplasms stomach rare often clinical diagnostic problems three patients bleeding volcano like ulcers diagnosed combined endoscopic salvage cytology surgical biopsy metastatic submucosal lesions hematologic spread combination endoscopic appearance clinical findings tissue cytologic examination lead correct diagnosis results cases support utility cytologic technique combination biopsy clinical setting,C04,0.0038432756,0.003409177,0.04438003,0.0021593797,0.046553712,0.0049599474,0.30979893,0.07697855,0.002778517,0.003776244,0.16421793,0.0079048835,0.024279451,0.029747985,0.0033796795,0.005984779,0.10211568,0.0039579365,0.022969387,0.025129959,0.10635614,0.0013646075,0.00395382
colorectal cancer identified effective screening strategy three currently used screening methods aimed detecting colorectal cancer asymptomatic curable detecting polyps removed progress cancer digital rectal examinations relatively cheap easy detect small fraction large bowel cancers sigmoidoscopy sensitive low acceptability patients partially mitigated introduction cm flexible instrument fecal occult blood testing limited sensitivity blood cancers polyps neither continuously shed uniformly distributed feces specificity positive predictive value also low sources blood stool prudent judgment suggests screening tests may prevent death colorectal cancer patients however none proven effective general use well controlled studies case control studies provide timely valuable new evidence regard authors investigations progress described current lack strong evidence support screening tests interpreted evidence use,C04,0.0022767028,0.013039273,0.025736988,0.0012791865,0.014167469,0.0029382037,0.301372,0.002141039,0.0016459548,0.013254657,0.21682778,0.039541803,0.110316925,0.016592138,0.0020273952,0.015341587,0.09587996,0.015636986,0.013583042,0.038405158,0.054842185,0.0008083745,0.0023451727
concept locally advanced gastric cancer effect treatment outcome gastrointestinal tumor study group previous gastrointestinal tumor study group gitsg reports gastric cancer patients locally unresectable disease treated combined radiation chemotherapy shorter median survival weeks remained alive years compared randomized receive chemotherapy alone weeks respectively test concept combined modality therapy might increase number long term survivors second protocol designed three major modifications course chemotherapy would precede fluorouracil potentiated radiation therapy doxorubicin would added fluorouracil plus methyl ccnu combination radiation therapy would given single course cgy fluorouracil given daily days beginning end course median survival patients treated chemotherapy alone weeks alive years following combined modality therapy median survival weeks lived years although problem early deaths combined modality group resolved long term survival combination therapy demonstrated study,C04,0.0019721428,0.0017493892,0.021941768,0.0011080666,0.022530455,0.022420885,0.28475326,0.001854627,0.0014257715,0.011478896,0.054132447,0.057221152,0.018021872,0.004599471,0.0017342527,0.0030710367,0.22156386,0.0020309803,0.0022455747,0.104779765,0.15663244,0.0007002363,0.002031648
developmental regulation granulocytic cell binding hemonectin hemonectin hn component bone marrow bm extracellular matrix promotes adhesion cells granulocytic lineage purified near homogeneity tested ability mediate attachment normal leukemic cells granulocytic lineage purified hn immobilized plastic substrates promoted serum free attachment normal granulocyte macrophage progenitor cells cfc gm using situ attachment assay cell attachment inhibited specific polyclonal antisera unfractionated bm cells allowed attach purified hn stained situ hn preferentially bound cells earlier stages granulocytic differentiation observations confirmed using cells hl progranulocytic cell line mirrored differentiation stage specific binding hn hn promoted attachment uninduced hl cells arrested progranulocyte stage whereas uninduced hl cells attached uncoated plastic attached plastic coated equal microgram quantities bovine serum albumin bsa hl cells induced differentiate along granulocytic pathway incubation dimethylsulfoxide dmso attachment hemonectin reduced thus primary bm granulocytic cells granulocytic cell line show preferential attachment cells earlier stages differentiation developmentally regulated binding suggests mechanism release maturing bm peripheral circulation,C04,0.0021583,0.0019140913,0.024909718,0.07430566,0.0030139396,0.002784775,0.16039038,0.002029237,0.0015600056,0.002120182,0.024241358,0.014843235,0.038569253,0.2730473,0.0018975297,0.013796389,0.076954566,0.07574025,0.002456992,0.014220174,0.143872,0.00076616235,0.044408485
increasing incidence cecal sigmoid carcinoma data connecticut tumor registry studied distribution incidence colorectal cancer using connecticut tumor registry oldest tumor registry united states time period left sided colon cancers accounted cancers right sided cancers cancers unspecified sites indeed pattern distribution remained constant years period calculated sex specific age adjusted normalized u census incidence age adjusted incidence rectal cancer remained stable years men cases year women cases year years age adjusted incidence cecal carcinoma men increased cases year women increased cases year sigmoid carcinoma men increased cases year women increased cases year incidence colon cancer site continues increasing constant rate age adjusted incidence colorectal cancers increased cases year men cases year women thus distribution colorectal cancers site connecticut remained stable years importantly however age adjusted incidence colon cancer continued increase years whereas rectal cancer remained relatively stable,C04,0.0017252672,0.001530398,0.0032191696,0.00096935726,0.027459124,0.00225024,0.16492546,0.009972347,0.0012472913,0.010043173,0.097346984,0.0703669,0.036234222,0.00413482,0.0098452885,0.0026865997,0.026107466,0.0017887995,0.0019644704,0.40482855,0.11896525,0.0006125797,0.0017762488
neoadjuvant cis ddp esophageal cancers experience regional cancer centre india analysing results patients underwent surgery esophageal cancer forty patients received pre operative single agent cis ddp grouped patients went surgery directly grouped b twenty two patients group showed tumor necrosis groups underwent resection hand sewn anastamosis esophagus post operative deaths among resected cases anastomatic leak cis ddp induced negligible side effects comparatively high survival rate early years patients responded cis ddp suggests neoadjuvant chemotherapy might value,C04,0.0034575518,0.0030670208,0.0064514326,0.0019426573,0.004814531,0.0044621504,0.19330446,0.0032515235,0.002499656,0.0033972475,0.045998245,0.13588943,0.11827176,0.025486318,0.0030404837,0.005384127,0.29665986,0.003560705,0.003936931,0.037401423,0.07619084,0.017961146,0.0035704812
carcinoma male breast review cases reviewed cases consecutive men treated breast carcinoma vanderbilt university affiliated hospitals examine controversies methods therapy disease twenty two patients stage ii lesions potentially curable operative therapy overall year survival rates stage stage ii stage iii stage iv radical mastectomy offered advantage modified radical mastectomy terms survival rate recurrence diagnosis early clinical stage finding disease axillary lymph nodes important factors survival series patients tumors evaluated hormone receptors positive although experience limited encouraging results obtained use tamoxifen citrate adjuvant well palliative roles exception predominance centrally located lesions uniquely high frequency positive hormone receptor status carcinoma male breast appears biologically similar disease women treatment guided similar principles,C04,0.002251885,0.0019975342,0.0042017833,0.0012652422,0.03584062,0.0029061746,0.25831693,0.0021176997,0.0016280125,0.0022126092,0.09646193,0.014565542,0.033593483,0.0054136827,0.0019802507,0.003506653,0.24612513,0.024121562,0.0025641022,0.18220636,0.06272509,0.0007995625,0.013198162
newly established human osteosarcoma cell line osteoblastic properties human osteosarcoma cell line huo established tumor heterotransplanted athymic nude mice antiserum nude mouse spleen cells added early passage cultures eliminate host fibroblastic cells cell line retained high activity liver bone kidney type alkaline phosphatase alp secreted osteocalcin e bone gamma carboxyglutamic acid containing protein bgp medium addition dihydroxyvitamin oh increased alp activity well level bgp secreted medium alp oh treated cells inhibition characteristics heat amino acids untreated cells synthetic human parathyroid hormone stimulated production intracellular adenosine cyclic monophosphate camp approximately fold within five minutes however stimulation observed synthetic human thyrocalcitonin huo cells transplanted back nude mouse tumor abundant osteoid formation mineralization produced results indicate huo cell line expresses well differentiated osteoblastic phenotypes huo first established human cell line produce bgp provides useful model studies osteoblasts regulatory mechanisms bgp production,C04,0.0021356775,0.0018944525,0.016771905,0.0011999817,0.02453833,0.002756203,0.28894117,0.002022279,0.0015439998,0.0020984286,0.057539888,0.0043926807,0.02559176,0.23702171,0.001878061,0.01417888,0.033101466,0.022949966,0.0024317831,0.01531475,0.22634068,0.00075830147,0.014597619
synthetic analogues fumagillin inhibit angiogenesis suppress tumour growth neovascularization critical growth tumours dominant feature variety angiogenic diseases diabetic retinopathy haemangiomas arthritis psoriasis recognition potential therapeutic benefit controlling unabated capillary growth led search safe effective angiogenesis inhibitors report synthesis family novel inhibitors analogues fumagillin naturally secreted antibiotic aspergillus fumigatus fresenius first isolated fungus contaminated culture capillary endothelial cells purified fumagillin inhibited endothelial cell proliferation vitro tumour induced angiogenesis vivo also inhibited tumour growth mice prolonged administration limited caused severe weight loss synthesis fumagillin analogues yielded potent angiogenesis inhibitors angioinhibins suppress growth wide variety tumours relatively side effects,C04,0.0028508592,0.0025190301,0.005301306,0.0015955587,0.003954309,0.017399661,0.2538682,0.04390679,0.0020530373,0.01653396,0.040518377,0.005911309,0.020300025,0.2034652,0.0024972344,0.0044221343,0.040275928,0.07769195,0.0032335117,0.05522178,0.16506559,0.028492782,0.0029214649
distribution immunoglobulins secretory component gastric cancer aged secretory immune system plays important role local humoral immunity gastrointestinal tract order evaluate humoral immunity gastric cancer distribution immunoglobulins ig secretory component immunohistochemically studied early advanced primary gastric cancers non cancerous gastric mucosa iga igm secretory component mainly identified cytoplasm intestinal metaplasia early gastric cancer well differentiated type localization iga igm secretory component similar intestinal metaplasia advanced gastric cancer faintly observed showed low positivity number ig containing cells infiltrating cancerous stroma enumerated immunoglobulin containing cells dominant stroma early gastric cancer hand ig containing cells stroma advanced gastric cancer number iga containing igm containing cells also decreased results suggest local humoral immunity suppressed gastric cancer especially advanced gastric cancer,C04,0.0024374127,0.0021621068,0.05174532,0.0013695143,0.00339402,0.0031456081,0.44274065,0.0022921725,0.0017621409,0.0023949011,0.012824159,0.13598575,0.018186135,0.09699196,0.0021433993,0.0038963659,0.024160754,0.014303975,0.002775353,0.06525152,0.10660814,0.0008654367,0.0025631937
effect metoclopramide ovarian responsiveness gonadotropin administration patients severe polycystic ovarian syndrome six patients poor ovarian response menotropin pretreatment gonadotropin releasing hormone analog exhibited improved ovarian responsiveness metoclopramide added days cycle evidenced higher number leading follicles versus higher mean maximal serum beta estradiol levels versus pg ml shorter duration menotropin treatment versus days fewer ampules menotropin used versus ampules cycle metoclopramide treated cycles compared control cycles respectively serum prolactin levels reached maximum ng ml within hour metoclopramide administration declined normal range within hours results suggest intermittent increased prolactin secretion may augment ovarian response gonadotropins,C04,0.002777612,0.0024543086,0.05873067,0.0015545641,0.003852711,0.016952552,0.12796266,0.0026019523,0.015390687,0.0160385,0.027042368,0.019674709,0.07887333,0.006684873,0.0024330728,0.04448763,0.12429452,0.01634081,0.016521903,0.064307794,0.3338022,0.0009823977,0.016238214
performing screening flexible sigmoidoscopy using colonoscopes experience subjects still controversy regarding optimal length flexible sigmoidoscopes performed screening distal colon examinations using cm colonoscopes asymptomatic subjects unsedated sigmoidoscopy cleansing preparation mean depth penetration cm similar persons examination discontinued poor preparation versus discomfort polyps detected patients subjects polyps detected cm conclude group unsedated subjects scheduled flexible sigmoidoscopy sigmoidoscopy prep use instruments longer cm gives little additional yield,C04,0.0035165239,0.0031193323,0.006561469,0.070068724,0.004896648,0.004538257,0.14966185,0.0033069816,0.0025422904,0.0034641812,0.18637645,0.026591247,0.18101771,0.008121692,0.0030923425,0.02249508,0.16856676,0.0036214367,0.00400408,0.046433605,0.09313123,0.0012485898,0.0036234998
colorectal cancer evidence distinct genetic categories based proximal distal tumor location purpose examine studies normal colon colorectal cancer evidence location primary tumor proximal distal splenic flexure colon may determine distinct genetic categories disease data identification studies identified manual search journals medline review bibliographies identified articles study selection approximately articles examined articles excluded tumor location reported reported way permit correlation results conclusions data extraction articles selected either presentation data permitted correlation results anatomic regions colon relevant inherited colorectal cancer results analysis differences noted biologic properties proximal distal segments normal fetal adult colonic epithelium epidemiologic pathologic cytogenetic molecular features proximal distal colorectal cancer differences correlated features inherited colorectal cancer proximal nonpolyposis distal polyposis forms conclusions developmental biologic differences proximal distal colon may reflect differing susceptibilities neoplastic transformation differences proximal distal colorectal cancer suggest may arise different pathogenetic mechanisms proximal tumors appear represent genetically stable form disease may arise mechanisms underlie inherited nonpolyposis colon cancer distal tumors show evidence greater genetic instability may develop mechanisms underlie polyposis associated colorectal cancer syndromes,C04,0.0016563021,0.0094692735,0.0091899065,0.010914784,0.050415903,0.010144118,0.46853113,0.0015576066,0.009202263,0.0016274141,0.011401741,0.0034762244,0.06836858,0.0146016,0.025494816,0.0025792068,0.025182739,0.0017401406,0.0018859437,0.108650945,0.16153161,0.0005880927,0.0017896575
hepatic metastases colorectal carcinoma impact surgical resection natural history patients colorectal liver metastases recorded followed january cases diagnosis based external imaging whereas patients operative confirmation staging liver disease three groups patients analysed group involved cases deemed non resectable whereas could unequivocally classified patients lived longer years seven survived years year survivors group comprised highly selected patients laparotomy demonstrated resectable metastatic spread confined liver treated mainly formerly different therapeutic approach patients significantly longer median survival time versus months also failed achieve year survival patients forming group underwent hepatic resection intent cure nine minimal macroscopic disease left gross tumour removed positive margins survival patients eventually non radical resections followed identical course group median survival months maximum months patients potentially curative resection ten died surgery per cent actuarial year survival rates remaining patients per cent seven patients alive respective periods time january patients remained free recurrent disease years three patients tumour status death unclear patients developed definite cancer relapse nevertheless demonstrated prolongation survival time median year compared non radically resected patients untreated patients resectable liver metastases accomplished maximum survival time years radical excision colorectal secondaries liver therefore offers effective palliation small number chance cure,C04,0.0014078575,0.0012488399,0.0026269162,0.014420459,0.015605792,0.008609664,0.17753538,0.008137177,0.0010178183,0.008192575,0.036018956,0.05060842,0.03276585,0.01072783,0.0012380343,0.061734613,0.44334343,0.0014498598,0.004726809,0.04408939,0.07254524,0.00049987907,0.001449181
comparison dna content gastric cancer cells primary lesions lymph node metastases cytophotomtric dna contents tumor cells primary lesions corresponding metastatic lymph nodes compared cases gastric cancer determine whether dna content remains stable lymph node metastasis dna distribution patterns grouped three types according proportion aneuploid cell population changes dna patterns primary metastatic lesions evident patients remaining dna distribution patterns noted lesions dna pattern primary carcinoma transformed narrowly scattered one metastatic lesion lymph node mean modal values frequency cells tetraploid c hexaploid c significantly higher primary lesion compared findings metastatic lesions reduction dna content metastatic lesions frequent occurrence differentiated undifferentiated adenocarcinoma p less therefore primary lesions widely scattered dna ploidy tumor cells smaller dna ploidy frequently metastasized lymph nodes particularly cases differentiated carcinoma observations may pertinent future designing treatment protocols,C04,0.0021802606,0.0019339999,0.0040681404,0.0012250461,0.119142786,0.028097749,0.24049994,0.0020503434,0.012119078,0.0021422342,0.048496183,0.03615084,0.09469453,0.058478713,0.0019172662,0.013946226,0.053696778,0.002245307,0.0024825474,0.04620552,0.15132526,0.00077413133,0.07612716
genotypic characterization centrocytic lymphoma frequent rearrangement chromosome bcl locus centrocytic lymphomas defined kiel classification b cell lymphomas composed exclusively cells resembling cleaved follicular center cells fcc lymphomas shown histologically immunophenotypically clinically distinct cleaved fcc lymphomas dna centrocytic lymphomas patients analyzed using southern blotting probes immunoglobulin heavy jh kappa light chain jk joining gene cell receptor beta chain constant gene cb bcl bcl c myc gene rearrangements lymphomas jh jk rearrangements confirming b cell origin none specimens detectable cb bcl c myc rearrangements however patients rearrangement chromosome bcl locus therefore centrocytic lymphomas genotypically distinguishable majority small cleaved fcc lymphomas lack demonstrable bcl rearrangements supports distinct nature centrocytic lymphomas suggests lack importance putative oncogene bcl cases furthermore frequent rearrangement bcl suggests possible role locus pathogenesis least centrocytic lymphomas,C04,0.002590654,0.0022980392,0.0048338915,0.0014558518,0.033457622,0.003463985,0.21636048,0.0024362823,0.0018729274,0.0025454697,0.08023027,0.019531097,0.01620631,0.08847212,0.027357027,0.0040341867,0.06886288,0.049319405,0.0029498406,0.0440544,0.17778723,0.00091984705,0.14896023
flow cytometric evaluation chemosensitive chemoresistant head neck tumors patients head neck squamous carcinoma clinical response induction chemotherapy correlated survival advantage similarly patients diploid tumors displayed survival advantage compared patients aneuploid tumors study examined dna content patients undergone induction chemotherapy part two clinical protocols determine correlation patients diploid tumors patients clinical response chemotherapy although patients stage iii tumors longer disease free survival stage iv patients p less addition dna content information improve ability predict response specifically correlation dna content response chemotherapy addition group patients diploid dna content correlated survival advantage conclude dna content information add significantly prediction clinical outcome patients received induction chemotherapy,C04,0.0025581636,0.0022692187,0.0047732675,0.0014373277,0.077870086,0.0033014433,0.22431336,0.002405728,0.0018494383,0.0025135458,0.025897061,0.020422917,0.0877416,0.005882008,0.0022495845,0.041131537,0.264291,0.0026344843,0.0029128455,0.04454314,0.17546074,0.00090831093,0.002633244
insulin like growth factor binding protein secretion breast carcinoma cell lines correlation estrogen receptor status breast tumor cell lines shown secrete several distinct polypeptide growth factors although conflicting results exist insulin like growth factors igfs contrast limited number breast tumor cell lines definitely shown secrete high affinity igf binding proteins igfbps modify igf actions characterize types igfbps secreted breast tumor cell lines conditioned medium collected seven separate tumor cell lines three estrogen receptor er negative four er positive three er negative cell lines mda mda hs secreted binding proteins mr igfbp well igfbp mr contrast four er positive cell lines secreted igfbp mr forms none secreted mr forms bt cell line positive er messenger rna mrna negative er protein secreted predominantly mr protein amount total igfbp activity released h ranged nm equivalents igfbp significant difference er positive negative cell lines mcf cells produced predominantly mr forms showed fold increase igfbp secretion estrogen stimulation immunoblotting specific ria igfbp showed er negative lines mda mda hs secreted form northern blotting analysis mrna encoding protein showed mda mda contained single kilobase mrna species hybridized igfbp complementary dna cdna probe immunoblotting analysis cell lines showed mr form secreted er positive cell lines reacted igfbp antisera exposure conditioned media three er negative cell lines n glycanase revealed mr forms igfbp glycosylated therefore probably represent igfbp conclude er negative cell lines secrete three forms igfbps igfbp igfbp mr form contrast er positive cell lines secrete predominantly igfbp mr form secrete igfbp abstract truncated words,C04,0.0013181464,0.0011692615,0.0024595242,0.0007406505,0.034516927,0.0017011365,0.2877208,0.0012396007,0.0009529611,0.0012951562,0.11597556,0.0027339358,0.014837591,0.053341873,0.007507543,0.028223734,0.016985344,0.09000523,0.020624852,0.07648851,0.11404361,0.00046802586,0.12565
late development squamous carcinoma reconstructed pharynx report case squamous cell carcinoma found arisen delto pectoral skin flap used pharyngeal reconstruction flap forming neo pharynx years signs recurrent disease developed period raises possibility tumour induction heterotopic skin used oropharyngeal reconstruction,C04,0.005471955,0.0048538973,0.010210101,0.0030744683,0.060600646,0.0070618433,0.37361518,0.005145893,0.00395598,0.03186196,0.06248458,0.011254766,0.035031017,0.012944555,0.031281106,0.035005253,0.17082934,0.0056352066,0.006230626,0.046705484,0.069167584,0.0019428924,0.005635625
intraperitoneal yttrium labeled monoclonal antibody ovarian cancer march march phase ii study carried patients ovarian cancer received escalating doses intraperitoneally ip administered yttrium labeled monoclonal antibody hmfg tumor cell surface antigen myelosuppression prevented escalation administered activity mci labeled antibody absorbed peritoneal cavity circulation maximum blood activity observed hours ip injection mean injected activity range circulation radiation dose bone marrow received circulating labeled antibody blood radiation dose calculated applying medical internal radiation dose mird formulation measured activity patients blood myelosuppression occurred following calculated blood radiation doses bone marrow cgy excessive myelosuppression following modest radiation doses circulating labeled antibody could explained uptake bone attempt reduce bone absorption seven patients received intravenous iv infusion edta sinclair pharmaceuticals ltd godalming united kingdom increased urinary excretion mean injected activity p fourteen patients assessable tumor laparoscopy tumor regression observed one patient palliation ascites patient,C04,0.0019727086,0.0131725725,0.0038230303,0.0011082264,0.03139301,0.0247944,0.048411354,0.0018548944,0.0014259771,0.0019380256,0.032751217,0.13310741,0.11801743,0.12645774,0.0017345027,0.03182911,0.14624178,0.03922799,0.0022458986,0.042253315,0.19350995,0.00070033723,0.0020291605
prospective randomized evaluation treatment colorectal cancer metastatic liver year period patients solitary multiple metastases colorectal cancer stratified based findings laparotomy one three groups prospectively randomized one two treatment arms within group group patients solitary resectable metastases group b patients multiple resectable metastases group c patients multiple unresectable metastases patients randomized one two treatment arms within group group arm resection arm resection continuous hepatic artery infusion chai fluorodeoxyuridine fudr group b arm b resection chai arm b chai group c arm c chai arm c systemic fluorouracil followed chai median time failure ttf months groups b c respectively arm improved ttf compared arm p median survival correlated extent disease months groups b c respectively survival changed treatment variation arms within group two year cumulative survivals groups b c respectively patients multiple metastases groups b c patients whose original tumor dukes b significantly improved ttf survival patients whose tumor dukes c p less equal,C04,0.01300696,0.023532316,0.004172338,0.022795836,0.035447374,0.0028742861,0.09340765,0.002094463,0.0016101488,0.023746189,0.06762948,0.18947358,0.112552285,0.0051209647,0.001958522,0.035808038,0.282818,0.0022936217,0.0025590942,0.025451077,0.04856572,0.00079078914,0.0022912363
basic studies new material inducing antitumor immune cells recently adoptive immunotherapy cancer lymphokine activated killer lak cells widely used experimentally therapy several problems including difficulty handling sterilization time consumption solve problems new materials able induce antitumor immune cells investigated pokeweed mitogen pwm pwm conjugated materials cmc could induce strong killer cells short term stimulation human peripheral blood lymphocytes pbl induced killer cells showed wide killing spectrum vitro human tumor cell lines mkk prmi nbt zr h hela kb hmv pc c human pbl stimulated short time cmc also showed tumoricidal effect tumor bearing mkn mkn nude mice results suggest cmc may solve problems currently used lak therapy may provide easily applicable extracorporeal immunotherapy cancer,C04,0.016339676,0.0024846494,0.0052264235,0.0015737821,0.031020658,0.0036148694,0.33975416,0.0026341185,0.0155797675,0.0027521723,0.014331006,0.03288051,0.062469583,0.11651236,0.0024631512,0.00438356,0.02744892,0.002884592,0.0031893798,0.087620385,0.20516354,0.0009945424,0.018678157
intraoperative pathologic diagnosis thyroid neoplasms report experience specimens intraoperative pathologic examination frozen section fs performed specimens thyroid tissue obtained patients period years examination permanent sections ps malignant neoplasm diagnosed specimens primary thyroid carcinoma four metastatic carcinoma three malignant lymphoma fs diagnosis benign malignant deferred sensitivity fs diagnosis malignancy specificity positive predictive value negative predictive value overall accuracy ps disclosed malignant neoplasm specimens fs diagnosis deferred sixty eight percent papillary carcinomas undifferentiated carcinomas single case medullary carcinoma diagnosed fs examination fs diagnosis malignancy made ten specimens containing follicular carcinoma ten neoplasms well differentiated eight encapsulated minimally invasive inability diagnose follicular carcinoma intraoperatively fs significant factor accounting relatively low sensitivity fs diagnosis malignant thyroid neoplasms,C04,0.0029617944,0.0026272596,0.034200594,0.0016641115,0.018446716,0.0038223502,0.115950845,0.017118074,0.016452665,0.017244535,0.37016198,0.063428886,0.05459409,0.019333526,0.0026045274,0.00461213,0.13394515,0.0031397506,0.0033724387,0.038509253,0.0716338,0.0010516256,0.0031238566
melanoma soft tissue sarcoma seven patients seven patients melanoma sarcoma seen dana farber cancer institute boston year period three additional malignant neoplasms one patients also hereditary cutaneous malignant melanoma dysplastic nevus syndrome observations suggest possibility biologic relationship melanoma sarcoma nature remains unknown,C04,0.006717213,0.005958503,0.012533623,0.0037741282,0.041865457,0.0086689135,0.23402977,0.0063169487,0.004856246,0.0066000563,0.032121375,0.04633418,0.042230565,0.015505277,0.005906948,0.010460097,0.2045967,0.006917616,0.007648535,0.1098967,0.17776568,0.0023850384,0.006910421
persistence mucosal gastric carcinomas years two patients small gastric carcinoma detected man refused surgery eight years later readmitted check partial gastrectomy performed pathologic examination revealed well differentiated adenocarcinoma restricted within mucosa another man irregularly shaped grossly depressed lesion indicating malignancy present gastric angle years later agreed partial gastrectomy lesion proved well differentiated adenocarcinoma confined mucosa retrospective examination original biopsy specimen revealed small area adenocarcinoma presumably overlooked initial examination thus gastric carcinomas well differentiated type grow extremely slow rate without extensive spread invasion findings cases contribute knowledge biological behavior gastric carcinomas,C04,0.0032921608,0.002920311,0.0061428305,0.0018498157,0.03895247,0.020160142,0.3057651,0.003095988,0.018291034,0.0032347415,0.13056223,0.0067713456,0.022372877,0.062218037,0.0028950432,0.005126579,0.15192546,0.0033982217,0.0037554114,0.13003804,0.07267306,0.0011689267,0.0033901657
surgical treatment cardiac myxomas long term results patients underwent operations cardiac myxomas two patients complex myxoma syndrome mitral valve replacement required initial operation patients one patient died perioperatively others died subsequently surviving patients recently underwent evaluation mean duration years operation ten asymptomatic new york heart association class ii symptoms nine patients continue employed eleven sinus rhythm permanent pacemakers chronic atrial arrhythmias echocardiography showed atrioventricular valve insufficiency patients reduced contractility new tumor recurrences long term prognosis relatively large group patients cardiac myxomas good patients without complex myxoma syndrome recurrence whereas patients require reoperation mitral valve replacement long term disability chronic arrhythmias infrequent functional status employability patients good,C04,0.0023554205,0.0020884492,0.0046133557,0.0127119655,0.03756654,0.0030384453,0.1702679,0.0022140841,0.0017021094,0.014856139,0.023081996,0.016240327,0.016708434,0.005413438,0.013452264,0.0036662535,0.49645016,0.0024246173,0.0026808039,0.0829838,0.08222547,0.0008359535,0.0024220955
extrahepatic metabolism morphine occurs humans pharmacokinetics morphine studied six patients radiologic localization insulinoma performed general anesthesia sampling done peripheral artery mesenteric vein five six patients hepatic vein peripheral vein well urine hepatic blood flow estimated indocyanine green infusion technique end radiologic procedure morphine terminal half life minutes total body clearance ml min hepatic extraction ratio concentration gradient observed artery superior mesenteric vein showing gut wall metabolism morphine occurred total body clearance exceeded hepatic clearance concluded extrahepatic extraintestinal clearance morphine probably occurred kidney,C04,0.030795721,0.002557376,0.005379402,0.015564101,0.004014503,0.0037206777,0.17259483,0.051174764,0.0020842897,0.002832729,0.05433407,0.034693476,0.14216703,0.00783214,0.028097386,0.061666332,0.121186905,0.0030117999,0.0032827337,0.019621346,0.21276034,0.001023653,0.019604355
anti idiotype monoclonal antibody carrying internal image ganglioside gm murine anti idiotype monoclonal antibodies generated human igm monoclonal antibody l recognizes ganglioside gm human melanoma hybridomas secreting antibodies bound specifically l selected enzyme linked immunosorbent assay using l three negative control human igms including monoclonal anti gm anti gd antibodies well purified serum igm antigen sources gm binding inhibition cell binding inhibition assays used identify seven anti idiotype monoclonal antibodies recognized determinants located within antigen combining sites l determine whether anti idiotype monoclonal antibodies possessed internal image original antigen immunized syngeneic balb c mice one anti idiotype monoclonal antibodies c coupled keyhole limpet hemocyanin sera immunized mice reacted strongly antigen positive melanoma cell line purified gm l detects kills melanoma tumor cells vitro vivo presence complement without affecting normal tissues anti idiotype monoclonal antibodies carrying internal image gm may effective tool active specific immunotherapy patients melanoma,C04,0.0024092924,0.0021371625,0.016088976,0.0013536831,0.06228163,0.0031093173,0.26338553,0.0022657276,0.001741811,0.002367271,0.041440297,0.01726299,0.033649445,0.23081827,0.0021186708,0.0037517692,0.032004546,0.1322175,0.0027433336,0.039639466,0.09057872,0.00085545215,0.015779125
phase ii study fluorouracil recombinant interferon alfa previously untreated advanced colorectal carcinoma conducted phase ii clinical trial fluorouracil fu recombinant interferon alfa rifn alpha previously untreated patients bidimensionally measurable metastatic colorectal cancer week fu administered continuous intravenous infusion mg consecutive days intravenous bolus administration fu mg given weekly weeks starting day rifn alpha roferon hoffman laroche nutley nj x u administered subcutaneously three times weekly weeks patients evaluated response week patients enrolled study assessable toxicity assessable response fifteen patients experienced partial response one patient achieved clinical complete response overall response rate confidence interval ci median duration response months range months seventy percent patients entered study alive median follow duration months twenty five percent patients developed grade toxicity developed grade toxicity one drug related death presence sepsis reported two treatment related seizures occurred experience schedule produced lower response rate greater toxicity previously reported current randomized trials comparing schedule fu rifn alpha fu plus folinic acid leucovorin single agent fu may determine role treatment advanced colorectal carcinomas,C04,0.0017846324,0.001583058,0.0033401167,0.018279217,0.0024850443,0.0023031612,0.23201445,0.00167829,0.0012902098,0.0017535063,0.009267456,0.0143187875,0.027527012,0.0041997675,0.0015693607,0.02924184,0.29632977,0.0018378756,0.019310214,0.021578252,0.26038012,0.00063365814,0.047294203
immunoscintigraphy ovarian cancer indium labeled ov tl f ab monoclonal antibody safety diagnostic accuracy immunoscintigraphy indium labeled monoclonal antibody ov tl f ab ov tl f ab diagnosis follow ovarian cancer prospectively studied patients planar spect scintigraphy performed days v injection mbq ov tl f ab surgical evaluation possible patients imaging results compared x ray computed tomography ultrasound ca serum level using histologically confirmed surgical findings gold standard apart transient rash observed two patients immediate delayed adverse reactions observed within surgically evaluated group ovarian cancer lesions detected patients distinct tumor deposits found operation detected localized immunoscintigraphy x ray computed tomography ultrasound visualized respectively,C04,0.0027643037,0.015828323,0.005157904,0.05901553,0.0841424,0.003567478,0.12633684,0.0025995846,0.0019984685,0.016095147,0.12644126,0.076361045,0.030108018,0.04917559,0.002430859,0.017521206,0.17057915,0.049561583,0.0031475665,0.01979578,0.119598456,0.0009815039,0.016791977
diffuse sclerosing variant papillary carcinoma thyroid clinical importance surgical treatment follow study diffuse sclerosing variant rare among papillary carcinomas thyroid patients female younger years age variant characterized diffuse involvement one thyroid lobes dense sclerosis patchy lymphocytic infiltration abundant psammoma bodies controversy still exists concerning prognosis reviewed experience patients treated patients young females age years mean hashimoto thyroiditis suspected nine patients came clinic nowadays diagnosis cancer possible entity mind detect abundant psammoma bodies either ultrasonography soft tissue roentgenography neck total thyroidectomy modified neck dissection carried eight patients subtotal thyroidectomy neck dissection five lobectomy neck dissection one alive well without distant metastasis mean follow years patients variant papillary carcinoma young women prognosis favorable complete resection without causing later recurrence also cosmetic complication free surgery considered,C04,0.0024094987,0.0021373457,0.004495875,0.0013537991,0.06167063,0.0031095836,0.13607678,0.04891812,0.0017419604,0.0023930091,0.08050322,0.051601805,0.03529474,0.005625022,0.036837194,0.0037520907,0.22960119,0.0024813842,0.0027435687,0.20836699,0.075532146,0.0008555255,0.0024985508
results conservative surgery radiation therapy breast cancer stage ii breast cancer conservative surgery radiation therapy effective modified radical radical mastectomy cases cosmetic considerations availability therapy primary concerns extent surgical resection less mastectomy subject randomized trial controversial appears removal quadrant breast small lesions safe excessive using histologic findings biopsy guide may possible limit breast resection gross tumor removal patients using wider resections patients extensive intraductal component invasive lobular carcinoma also appears excluding patients breast conservation basis positive margins first attempt tumor excision may unnecessarily restrictive although patients extensive intraductal component invasive lobular carcinoma negative margins appears patient predominantly invasive ductal carcinoma treated without excision gross tumor resected reason suspect extensive microscopic disease patients indeterminate margins excision axillary dissection provides prognostic information prevents progression disease within axilla axillary dissections limited level accurately identify substantial number patients pathologically positive clinically negative nodes combined radiation therapy axilla level dissection results limited number patients progressive axillary disease patients pathologically positive axillas patients particularly high risk systemic disease extent axillary node involvement identified dissections levels ii radiation therapy avoided safely patients pathologically negative axillas level ii dissection appears advantage routine dissection level iii lymph nodes lymphedema arm breast increases extensive dissections radiation therapy,C04,0.0016560552,0.0107602775,0.03514978,0.00093046983,0.05842151,0.02490182,0.3272608,0.0015573744,0.0011972542,0.009606156,0.10397893,0.00356371,0.021443173,0.00393622,0.0014562932,0.018608106,0.16179277,0.0017054622,0.0018856624,0.11582808,0.0920684,0.000588005,0.0017036885
familial occurrence gastric cancer year experience population based registry authors studied familial occurrence tumors individuals gastric cancer reviewing clinical data genealogical tree patients registered local health care district modena italy cancer stomach crude age adjusted world population incidence rates gastric cancer new cases year respectively men women respectively among first degree relatives registered patients cases gastric carcinoma versus cases control group matched age sex mantel haenszel odds ratio h p less excess gastric neoplasms observed siblings versus h p less parents versus significant besides gastric cancer significant excess type tumors case families familial occurrence gastric cancer tended frequent patients diffuse carcinoma subjects intestinal cancer although difference statistically significant conclusion current investigation suggests family history gastric neoplasms usually observed approximately registered cases already described common malignancies therefore familial occurrence gastric carcinoma suggests existence genetic susceptibility cancer stomach least fraction patients,C04,0.0018322894,0.001625332,0.003418862,0.0010295216,0.020291857,0.0023813737,0.25087774,0.018270709,0.0013246636,0.0018003319,0.11911473,0.11322831,0.078699335,0.019106176,0.014251845,0.011720566,0.0737558,0.0018869543,0.010942796,0.19858515,0.053310394,0.0006505794,0.001894695
combined tensor fasciae latae musculocutaneous flap sartorius musculocutaneous flap repair wide defects lower leg tensor fasciae latae musculocutaneous flap great advantages reconstruction abdominal wall medial border territory limited thigh order expand territory combined tensor fasciae latae musculocutaneous flap sartorius musculocutaneous flap devised flap successfully used resurface large defect lower leg distally based musculocutaneous flap advantages flap extremely large territory fact total necrosis flap cannot occur proximally distally pedicled flap suitable large defects abdominal wall lower leg gluteal region,C04,0.004238268,0.003759555,0.007908168,0.0023813099,0.067942746,0.025977364,0.27604967,0.0759789,0.003064079,0.004164347,0.063554645,0.008717307,0.17123722,0.009854493,0.0037272058,0.0065998645,0.08889877,0.004364713,0.0048258915,0.061410803,0.09937221,0.0015048549,0.0044676564
prospective evaluation clinical pathologic detection axillary metastases patients carcinoma breast complete axillary dissection performed patients undergoing modified radical mastectomy identify patterns axillary node metastases well discontinuous axillary node skip metastases positive pathologic findings compared preoperative clinical examinations patients showed cases clinically suspicious tumor contrast pathologically confirmed positive lymph nodes axillary contents classified level ii iii based relationship pectoralis minor muscle average nodes resected per patient level level ii level iii tumors ranged size cm mean cm increasing tumor size associated increased likelihood positive nodes data patients complete clinical pathologic data show patients negative level nodes limited axillary dissection level would fail identify positive level ii positive level iii nodes whereas patients positive level nodes limited axillary dissection would fail identify positive level ii nodes positive level iii nodes positive levels ii iii nodes complete axillary dissection levels ii iii performed stage patients accurately well remove tumor involved nodes diminish local axillary recurrences clinical examination axilla appears poor means identifying axillary metastatic cancer,C04,0.001769373,0.0015695221,0.0033014663,0.0009941385,0.04875726,0.002283468,0.18139441,0.0016639398,0.009844166,0.0017385129,0.1827019,0.03570544,0.03005167,0.004124372,0.001555942,0.0027552817,0.20935178,0.0018244805,0.0020146915,0.06947361,0.20467608,0.00062824006,0.0018202657
excision repair pyrimidine dimers induced simulated solar radiation skin patients basal cell carcinoma one prominent lesion induced dna ultraviolet uv radiation cyclobutyl pyrimidine dimer formed adjacent pyrimidines dna strand investigated whether people developed basal cell carcinoma sun exposed skin altered ability repair uv induced pyrimidine dimers dna twenty two patients least one basal cell carcinoma aged years healthy volunteers aged years took part study groups given one minimal erythema dose med simulated solar radiation lower back dna extracted irradiated skin h later number uv induced pyrimidine dimers determined using dimer specific endonuclease time average number dimers per unit dna similar two groups h average dimers removed group basal cell carcinoma compared cancer free group basal cell carcinoma group patients repaired dimers h compared cancer free subjects p less conclude patients develop basal cell carcinoma sun exposed skin may decreased ability repair pyrimidine dimers induced skin exposed simulated solar radiation,C04,0.0020105988,0.0017835015,0.0134794405,0.0011296734,0.07093371,0.0025947825,0.13324748,0.0018907915,0.0014535735,0.0020245116,0.0096896,0.07489393,0.04844292,0.08676119,0.0017680699,0.003132599,0.117918596,0.0020705834,0.012008398,0.03975673,0.30006635,0.0007138906,0.0722291
chondrosarcoma head neck chondrosarcoma malignancy rarely encountered head neck attempt define tumor characteristics response therapy cases chondrosarcoma treated university michigan past years retrospectively studied fourteen cases originating nose paranasal sinuses mandible temporal bone larynx reviewed aggressive surgical resection mainstay treatment resulted overall survival average follow years survival highest primary temporal bone lesions lowest paranasal sinus lesions unresectable lesions cured modalities study therefore continued support crucial role wide surgical resection treatment head neck chondrosarcoma conservative resection needed preserve important structures resulted long term survival,C04,0.018916989,0.002910716,0.0060461476,0.017505324,0.08293974,0.019824216,0.2946026,0.0030472595,0.002342625,0.018857643,0.10087919,0.00666477,0.027724434,0.0074505536,0.0028494776,0.005045891,0.24488445,0.003337018,0.0036896092,0.039900523,0.070417166,0.0011505287,0.019013109
fine needle aspiration cytology flow cytometry intracystic papillary carcinoma breast define criteria cytologic diagnosis intracystic papillary carcinoma icpc authors retrospectively reviewed fine needle aspiration fna cytologic specimens eight cases histologically proven icpc breast patients five black three white women years age fna specimen cyst fluid four cases bloody three clear one aspirates showed cellular smears small large clusters cells papillary cribriform configurations numerous single epithelial cells cells cuboidal columnar minimal atypia icpc suggested fna case patients underwent surgical excision mastectomy flow cytometry performed fresh fna specimen one case paraffin embedded surgical tissue eight cases showed seven tumors aneuploid one diploid authors contend icpcs breast distinct cytomorphologic features recognized fna icpc may present cyst fluid either bloody clear breast cyst fluids postmenopausal women examined cytologically flow cytometric demonstration aneuploid population may assist confirming malignancy lesion,C04,0.0028010022,0.0024846287,0.0052263797,0.016346183,0.044700585,0.030728493,0.180544,0.016184563,0.015582904,0.0027521492,0.20211975,0.005761126,0.030933917,0.051359665,0.0024631307,0.004368019,0.12907386,0.047959797,0.003189353,0.13030125,0.071240984,0.0009945341,0.0028837519
immunocytochemical localization progesterone receptors endocrine cells human pancreas progesterone receptors pgr immunocytochemically localized nuclei several endocrine cells human pancreas variable number neoplastic cells endocrine pancreatic tumors conversely exocrine epithelial cells pancreas exhibit pgr immunoreactivity normal well different pathologic conditions including pancreatic adenocarcinomas estrogen receptors detected pancreatic samples investigated double immunocytochemical experiments documented pgr immunoreactivity normal langerhans islets consistent feature glucagon producing cells approximately insulin producing b cells variable percentage pancreatic polypeptide pp producing cells ranging figures affected sex age underlying disease patients reported findings corroborate previous clinical experimental evidence indicating sex steroid hormones may regulatory effects functional activity endocrine pancreas,C04,0.002354656,0.0020886974,0.015724456,0.012714481,0.014677452,0.0030388064,0.25132996,0.002214347,0.0017023116,0.0023135878,0.027032461,0.004959547,0.029316086,0.13932638,0.002070625,0.026402008,0.05309733,0.048849072,0.036862828,0.060482573,0.2341005,0.0008360528,0.028505785
pedunculated giant lipoma esophagus patient giant lipoma esophagus presented progressive dysphagia odynophagia fever recurrent melena two years previously symptoms less pronounced misdiagnosed achalasia surgical removal lipoma patient became symptom free,C04,0.06736738,0.005594968,0.0117689315,0.003543864,0.008782838,0.03866911,0.27204388,0.005931544,0.0045599607,0.0062800706,0.029006975,0.012973092,0.06629386,0.014502632,0.0055465577,0.009821915,0.16919994,0.006495564,0.007181889,0.053220857,0.1924803,0.0022395242,0.0064943954
endoscopic ultrasonography staging rectal cancer endoscopic ultrasonography eus used stage rectal cancer assessing depth invasion bowel wall layers involvement lymph nodes eus findings correlated histopathologic findings discern usefulness modality predicting patients could candidates sphinctersaving procedures avoidance abdominoperineal resection olympus eu endoscopic ultrasound system used assess depth penetration rectal wall layers identify lymph nodes comparison eus findings histopathologic findings possible patients eus agreed histopathology cases p kappa statistic eus agreed histopathology presence absence lymph nodes cases p however presence lymph nodes could necessarily predict metastatic involvement nodes one patient invasion vaginal cuff correctly predicted nine cases computed tomographic analysis ct available comparison eus detection penetration beyond bowel wall ct agreed histopathology whereas eus agreed histopathology,C04,0.00334576,0.019162517,0.006242841,0.018062761,0.004658865,0.0043178773,0.2731149,0.037466303,0.0024188356,0.0032874057,0.21397784,0.03927536,0.10083542,0.0079930145,0.002942177,0.0052100443,0.13150904,0.003445578,0.036177274,0.022972856,0.05894699,0.0011879578,0.00344842
human recombinant gm csf allogeneic bone marrow transplantation leukaemia double blind placebo controlled trial randomised double blind trial patients leukaemia received human recombinant granulocyte macrophage colony stimulating factor gm csf received placebo days allogeneic matched sibling bone marrow transplantation neutrophil count recovered x l days earlier gm csf group placebo group significant median neutrophil count days significantly higher gm csf group vs x l lymphocyte count significantly higher gm csf placebo group days transplantation difference associated higher incidence graft versus host disease evidence gm csf associated greater incidence leukaemic relapse gm csf group lower haemoglobin concentrations platelet counts higher plasma urea creatinine bilirubin placebo group duration hospital stay patient groups studies indicated assess overall effect gm csf outcome allogeneic bone marrow transplantation,C04,0.0024376074,0.0021622793,0.016340872,0.0013695922,0.003394291,0.0031458593,0.087681554,0.0022923555,0.0017622816,0.0023950925,0.011948555,0.11770816,0.07370401,0.007328472,0.0021466527,0.0037958617,0.14334829,0.037909567,0.1089824,0.12466818,0.21042603,0.00086550583,0.03418647
chemical shift imaging human brain axial sagittal coronal p metabolite images multivoxel magnetic resonance mr spectroscopy novel data analysis techniques developed obtain high quality phosphorus metabolite images human brain overlay metabolite distribution directly onto corresponding hydrogen mr images p mr spectroscopic data acquired means three dimensional chemical shift imaging phase encoding three spatial dimensions clinical instrument equipped specially designed quadrature p birdcage coil constructed authors laboratory axial sagittal coronal metabolite images based area one five peak regions phosphodiester phosphocreatine gamma alpha beta adenosine triphosphate generated x x x x csi arrays voxel sizes cm cm respectively positions images aligned anatomic features means voxel shifting capability fourier transform direct overlays metabolite images corresponding proton images demonstrated excellent correlation anatomy factors indicating utility technique viewing p metabolite levels areas brain simultaneously,C04,0.03613811,0.0020650653,0.06011808,0.0013080166,0.14631838,0.037339658,0.177121,0.013451478,0.0016830511,0.0022874114,0.09026042,0.004812612,0.09000605,0.013006799,0.0020471974,0.0148920305,0.03777097,0.0023974692,0.016309006,0.027779423,0.16640598,0.0008265935,0.055655193
reliability colposcopy directed punch biopsy group women underwent laser cone biopsy data collected routinely proforma case notes entered computerized database histology cone biopsies compared previous colposcopically directed punch biopsies cytology smears taken clinic colposcopic diagnosis punch biopsy false negative rate neither two microinvasive carcinomas biopsied way detected biopsy ten women negative punch biopsies cin iii cone punch biopsy showed cin ii worse cone biopsy confirmed presence cin evidence false negative cone biopsies data suggest management based solely upon punch biopsy result include consideration cytology colposcopy findings excisional methods treatment likely reveal early invasion adenocarcinoma situ,C04,0.003095316,0.0027456996,0.17061026,0.0017391318,0.004324701,0.0039946665,0.3317374,0.0029108727,0.0022377756,0.0030413298,0.102954835,0.026057964,0.042499658,0.0073929904,0.0027219427,0.0048200507,0.099268064,0.0032025299,0.0035244725,0.114558235,0.062274966,0.0010990342,0.0031880827
chance cut chance cure fifty seven patients underwent local excision invasive distal rectal cancer initial operative procedure curative intent five year survival rectal cancer specific mortality rate level wall invasion vascular permeation tumor ulceration mobility differentiation criteria studied prognosis poor prognostic factors included mucinous cell differentiation full thickness invasion cases abdominoperineal resection recommended none patients without adverse prognostic factors died rectal cancer factors appear influence outcome local excision distal rectal cancer would treatment choice selected patients,C04,0.0028401176,0.002519326,0.0052993647,0.029077094,0.045194205,0.03114409,0.11566115,0.0027872797,0.0020532785,0.0027905824,0.08095199,0.08833774,0.07480198,0.041852772,0.02999088,0.0044226535,0.1993205,0.0029248502,0.0032338917,0.13182548,0.07083238,0.0010084226,0.031129975
immunocytochemical profile benign carcinomatous effusions practical approach difficult diagnosis one great challenges cytodiagnosis effusions distinction reactive mesothelium histiocytes cancer cells notably true patients undergone radiation chemotherapy establish whether monoclonal antibodies moabs could used reliable diagnostic adjuvants authors retrospectively blindly studied cases diagnosed standard cytologic criteria malignant benign equivocal panel seven readily available moabs cytokeratins vimentin ema b alpha cea hmfg leu lectin ulex europaeus malignant cases showed reactivity ema hmfg whereas reacted b alpha cea respectively combinations ema b ema alpha cea ema alpha cea b displayed positivity malignant cases respectively benign cases reacted hmfg ema b one case reacted ema b based results equivocal cases regrouped malignant benign cases follow effusions obtained within ensuing three months patients allowed authors unequivocally confirm diagnosis five combination ema b moabs detected malignant cells cases incidence false positive cases study panel ema b alpha cea moabs prove useful simple approach correct diagnosis questionable effusions potential pitfalls discussed,C04,0.002466718,0.014127061,0.016513336,0.0013859482,0.0034906424,0.003183428,0.1673405,0.0023197315,0.025634881,0.0024236953,0.30397257,0.018529143,0.03603323,0.029751591,0.0021691695,0.003841193,0.17366104,0.002546053,0.0028087213,0.0470336,0.07708171,0.00087584194,0.06281017
parosteal osteosarcoma treatment wide resection prosthetic replacement reviewed cases parosteal osteosarcoma treated wide local resection prosthetic replacement followed six years limb function excellent one patient grade iii histological disease developed pulmonary metastases four patients local recurrences related repeated preliminary biopsies inappropriate siting biopsy vascular encroachment tumour mode treatment outcome related medullary invasion tumour,C04,0.0281661,0.004286176,0.055797663,0.0027148728,0.00672833,0.00629168,0.23432477,0.0046200296,0.003493281,0.0047476697,0.045305792,0.056719135,0.033885468,0.0111101335,0.0042490903,0.030900769,0.2818108,0.004976102,0.00550188,0.07222937,0.07207722,0.0017156481,0.028348057
receptor imaging application mr imaging liver cancer new contrast agent magnetic resonance mr imaging directed asialoglycoprotein asg receptors hepatocytes used detection liver cancer rats ultrasmall superparamagnetic mean size nm particles iron oxide uspios targeted asg receptors coating particles arabinogalactan ag liver relaxation times decreased effectively single intravenous administration ag uspio equal dose conventional superparamagnetic liver mr contrast agent ami mean size nm receptor affinity studies demonstrated receptor mediated attachment subsequent cellular endocytosis occur primary malignant hepatocellular carcinoma metastatic adenocarcinoma tumors surface asg receptors lost malignant dedifferentiation vitro relaxation vivo mr imaging experiments liver tumors show targeting uspio hepatocytes rather mononuclear phagocytic system allows considerable dose reduction increases tumor liver contrast potentially allows distinction asg positive benign hepatocellular asg negative malignant hepatocellular tumors,C04,0.0022518572,0.0019975097,0.004466454,0.012120379,0.07944321,0.002906139,0.19137418,0.0021176736,0.0016279925,0.013101737,0.06929956,0.04279924,0.026846264,0.051463414,0.0019802263,0.07907286,0.050867118,0.105632335,0.013444328,0.020516759,0.19579314,0.00079955265,0.030078055
insulin like growth factor ii possible local growth factor pheochromocytoma pheochromocytomas neural crest tumors express abundance insulin like growth factor ii igf ii assess potential igf ii play autocrine role tumors measured igf ii content rra pheochromocytomas peripheral blood patients igf ii receptors western analysis characterized tumor binding proteins ligand blot studies igf ii levels tumors varied micrograms g chromatography revealed peptide eluted large mol wt form igf ii kda remainder coeluted mature peptide kda contrast igf ii levels normal adrenal tissue micrograms g another neural crest derived tumor medullary carcinoma thyroid micrograms g serum igf ii levels patients pheochromocytoma ng ml similar normal controls ng ml radiolabeled igf ii igf bound specifically pheochromocytoma membranes western analysis membranes using specific antiserum directed type ii receptor demonstrated band kda affinity cross linking studies igf demonstrated specific band kda ligand blot analysis performed void volume pools sephadex g column demonstrated bands kda conclusion data confirm pheochromocytomas increased levels igf ii demonstrate despite high igf ii concentrations tumors peripheral levels elevated suggesting little tumoral igf ii released circulation unlike catecholamines demonstrate presence igf ii igf receptors describe binding protein species similar present tissues thus presence high levels igf ii type type ii receptors suggests igf ii may act receptors alter tumor growth,C04,0.0014890633,0.0013208734,0.009984901,0.00083671045,0.05353014,0.0019217137,0.23904058,0.0014004853,0.008182115,0.001463092,0.027520632,0.025146602,0.05015978,0.038348045,0.022921307,0.023941766,0.0399215,0.123574205,0.044931933,0.011564308,0.27072337,0.00052871223,0.0015481727
parental age sporadic hereditary retinoblastoma children sporadic hereditary retinoblastoma born studied age parents birth compared age mean age parents birth children period netherlands mean age fathers birth children sporadic hereditary retinoblastoma years significantly higher mean age fathers birth children general population years p less one sided similarly mean age mothers birth children sporadic hereditary retinoblastoma years significantly higher mean age mothers birth children general population years p less one sided analyzed parental age factor measuring relative risk age groups comparing incidence sporadic hereditary retinoblastoma various parental age groups incidence sporadic hereditary retinoblastoma total population mothers years age older relative risk child sporadic hereditary retinoblastoma compared mothers population general p one sided similarly fathers years age older relative risk child sporadic hereditary retinoblastoma compared fathers population general p one sided parental age effect found children nonhereditary retinoblastoma conclude high paternal high maternal age significant risk factors sporadic hereditary retinoblastoma,C04,0.0018322633,0.019363426,0.030027393,0.0010294741,0.0025513687,0.0023646313,0.0661281,0.0017230826,0.0013246448,0.08163449,0.008512544,0.02151059,0.13819969,0.0042683673,0.0016112629,0.002853215,0.023366578,0.0018869274,0.0020863013,0.5347057,0.05048203,0.00065057015,0.0018873997
introduction nerve growth factor ngf receptors medulloblastoma cell line results expression high low affinity ngf receptors ngf mediated differentiation expression cloned human nerve growth factor receptor ngfr cdna cell lines generate high low affinity binding sites since inability respond appropriately differentiation factors ngf may contribute determining malignant phenotype neuroblastomas sought determine whether true medulloblastomas generate human central nervous system neuronal cell line would respond ngf infected medulloblastoma cell line med defective retrovirus carrying cdna coding human ngfr resultant cells med ngfr expressed abundant low high affinity ngfrs ngf treatment induced rapid transient increase c fos mrna ngfr expressing cells parent line cells infected virus lacking cdna insert however med ngfr cells internalize ngfr high efficiency differentiate response ngf three important conclusions emerge study internalization ngfrs necessary early rapid transcriptional effects ngf ii unknown factor cooperates cloned ngfr allowing high affinity ngf binding found primitive central nervous system cell line iii ngfrs introduced expressed med e med ngfr cells partially functional unable induce differentiation primitive neuron like tumor cells implying high efficiency receptor mediated endocytosis ngf receptor may necessary step cascade events leading ngf mediated differentiation,C04,0.0016300498,0.0014459355,0.0030437005,0.0009158584,0.026729306,0.002103664,0.26834536,0.0015329185,0.0012066488,0.0016016196,0.016085003,0.0035433972,0.051772602,0.19811973,0.0014334247,0.0025383264,0.01684024,0.08788641,0.02551784,0.05196431,0.15728828,0.00057877146,0.07787661
bilateral breast cancer second primary breast cancer opposite breast either synchronous metachronous majority metachronous woman breast cancer fivefold increase risk second breast cancer additional risk factors include multifocal cancer lobular carcinoma situ original cancer early age long survival lobular carcinoma situ predominantly marker subsequent development second primary breast cancer incidence synchronous bilateral cancer approximately metachronous cancer cancer invasive noninvasive mammography increased number synchronous cancers found overall incidence incidence invasive cancer detected random biopsy opposite breast high enough justify routine adoption procedure remaining breast must followed remainder patient life physical examination annual mammography treatment secondary primary breast cancer appropriate stage disease prognosis woman second primary breast cancer quite favorable dependent stage first second cancer,C04,0.0024666158,0.0021880113,0.016539982,0.0013858908,0.0034346844,0.015094107,0.2262037,0.0023196354,0.0017832534,0.0024235947,0.06708138,0.10060437,0.017419353,0.005785142,0.0021690796,0.01577895,0.19690794,0.0025402051,0.0028086049,0.22797987,0.059789073,0.024754828,0.0025417705
cancer mortality higher income black population new york state comparison rates united states whole census median family income among blacks suffolk county new york e much higher american blacks whole e american whites e proportion poverty level still higher suffolk county blacks american whites observed numbers deaths total cancers cancer sites suffolk county black men women lower expected basis age specific gender specific death rates blacks us although numbers deaths cervical cancer prostate cancer slightly lower expected suffolk county blacks versus american blacks numbers still significantly greater expected basis death rates among american whites age specific death rates age groups years years tended lower suffolk county lung cancers black men breast cancer black women specific cancer sites differ direction association incidence socioeconomic status age gender must considered comparisons cancer mortality race socioeconomic level implications comparisons discussed regard goal reducing racial differences cancer death rates,C04,0.0018659133,0.0016546763,0.003480587,0.0010480754,0.0025974687,0.011436222,0.15103264,0.0017542166,0.028438943,0.0018490977,0.026604941,0.094148904,0.05983256,0.03499748,0.019702915,0.002904769,0.042357076,0.0019313833,0.047262814,0.37319267,0.089320764,0.0006623251,0.0019235534
insulin like growth factor supports proliferation autocrine thymic lymphoma cells pre cell phenotype studied phenotypic characteristics growth properties murine lymphoma cell lines derived primary x ray induced thymic lymphomas earliest stage detected well spreading organs occurred cell lines serve model systems earliest events cell lymphoma induction tumor cell progression spreading organs find primary x ray induced cell lymphoma lines phenotypic characteristics thymic pre cells show proliferative response il tested hematopoietic growth factors however proliferate response insulin like growth factor igf small autocrine peptide distinct igf term lymphoma growth factor one earliest lesions cell lymphoma induction may therefore inhibition differentiation one several specific points early stages lymphoma cell growth may restricted environment local concentrations specific growth factors igf lymphoma growth factor sufficiently high,C04,0.0018823256,0.0016697168,0.0037282004,0.0010577375,0.021002686,0.0024292392,0.24462123,0.0017709048,0.0013608376,0.0018494955,0.031104697,0.012979448,0.031550433,0.19585511,0.0016552696,0.048489626,0.04010829,0.0019750637,0.065917075,0.024104869,0.23200154,0.0006683454,0.03221788
expression pancreatic secretory trypsin inhibitor gene human colorectal tumor expression pancreatic secretory trypsin inhibitor psti gene examined northern blotting analyses human colorectal tumors included two benign adenomas adenocarcinomas among total cases proved adequate mrna analyses one showed expression psti various levels contrast psti expression detected two malignant lymphomas rectum level psti expression correlated patient age sex tumor location size stage differentiation lymph node metastasis progression stage colorectal adenocarcinomas also shown express genes hybridize human trypsinogen cdna probe looks though tumors protease inhibitor produced simultaneously part cellular self defense mechanism,C04,0.002920148,0.002590317,0.033661794,0.001640712,0.06612499,0.017895546,0.17644688,0.0027461424,0.002111137,0.002869217,0.048950873,0.0060061864,0.043346815,0.007992054,0.002585059,0.004547278,0.07171564,0.017133413,0.031581867,0.024302773,0.250116,0.0010368384,0.18167827
role elective lymph node dissection management patients thick cutaneous melanoma retrospective search patients seen duke melanoma clinic identified clinically stage patients mm cutaneous melanomas five year ten year survival respectively elective lymph node dissection elnd done patients difference disease free interval dfi survival patients versus patients treated wide excision p thirty two patients pathologically positive nodes elnd patients shorter dfi p survival p compared patients negative node dissections divided breslow thickness difference persisted patients mm lesions p however thicker lesions greater mm difference survival node negative node positive groups p mean follow years elective lymph node dissection done patients recurred first regional nodes patients compared patients pathologically positive nodes elnd see patient survival improved early removal nodal disease difference dfi p survival p two groups concluded elnd may provide prognostic information patients thick cutaneous melanomas however change dfi ultimate survival patients followed nodes removed clinically positive authors recommend elnd patients thick melanomas risk distant metastases outweighs benefit regional node dissection,C04,0.002050343,0.0018187565,0.0038257272,0.001152004,0.03262818,0.0026460744,0.16422103,0.0019281673,0.0014823066,0.0020145823,0.09264042,0.03940528,0.051964972,0.004782442,0.011720044,0.0031928103,0.37873518,0.0021115132,0.002334617,0.08830254,0.108205706,0.0007280023,0.002109317
procarbazine chemotherapy treatment recurrent malignant astrocytomas radiation nitrosourea failure brain tumor study group shown procarbazine pcb effective adjuvant treatment bis chloroethyl nitrosourea bcnu treated patients recurrent malignant astrocytomas radiation nitrosourea failure successive courses pcb mg days every weeks courses patients complete responses partial responses stable disease progression significantly patients receiving pcb complete partial responses stable disease similar group patients previous trial received intra arterial ia cisplatin ddp significant advantage time disease progression receiving pcb compared receiving ia diaziquone azq results suggest pcb effective nd agent ia ddp azq following radiation nitrosourea failure,C04,0.028715087,0.04564854,0.005527094,0.0016643201,0.018464522,0.0038228293,0.33555514,0.0027856566,0.002141514,0.002910502,0.013701278,0.0608446,0.03838172,0.020922702,0.0026048538,0.0046127085,0.19265917,0.0030505396,0.01771166,0.021440359,0.17273605,0.0010517575,0.003047367
multimodality preoperative treatment advanced stage iv mo cancer head neck sixty three patients advanced unresectable squamous cell carcinoma head neck treated combination chemotherapy radiation surgery observed response neoadjuvant chemotherapy year survival rate patients patients alive years year survival rate patients completed treatment plan received chemotherapy radiation surgery compared chemotherapy radiation refused surgery development second primary cancer cause death patients survived months,C04,0.003991478,0.0035406402,0.007447684,0.0022426487,0.0055855853,0.0051512104,0.1600637,0.0037536344,0.002885661,0.0039218618,0.018356364,0.052891437,0.030187905,0.009177641,0.003510005,0.0062155616,0.5021356,0.0041105608,0.004544885,0.045339055,0.11942336,0.0014172288,0.0041062855
lipiodol computerized tomography sensitive specific technique diagnosis hepatocellular carcinoma computerized tomography ct following intra arterial injection lipiodol lipiodol ct performed patients suspected hepatocellular carcinoma hcc four main patterns uptake lipiodol within liver seen ct well circumscribed lesions dense homogeneous uptake lipiodol confirmed hccs lesions dense patchy uptake lipiodol periphery centre confirmed hccs patients ill defined faint patchy uptake lipiodol present liver hepatic uptake present one patient found later hcc three hypodense lesions liver lipiodol uptake one found necrotic hcc one cholangiocarcinoma one regenerative nodule diagnosis hcc lipiodol ct overall sensitivity accuracy specificity patients hcc solitary diagnosis size hccs ranged cm cm diameter median size cm eleven hccs resectable conclude part screening programme high risk patients lipiodol ct useful early detection hccs technique also plays important role determining whether tumour resected managed chemotherapy detecting hccs still small resectability rate also improved,C04,0.010815814,0.00201962,0.02601202,0.012276884,0.040489256,0.002938307,0.1968427,0.0021411143,0.0016460126,0.0022472052,0.14882654,0.015699737,0.07021022,0.0055962354,0.012995899,0.113500595,0.23009276,0.0023902138,0.0025924523,0.04112826,0.05638398,0.0008084029,0.002345735
bronchogenic carcinoma situ carina eradicated endobronchial biopsy squamous cell carcinoma situ bronchus rare disorder isolated clinical setting present case carcinoma situ located carina excisional biopsy via fiberoptic bronchoscope recurrence five years knowledge represents case carcinoma situ treated solely excisional biopsy case emphasizes importance securing biopsy specimens mucosal abnormalities raises possibility limited excision sole therapy carcinoma situ,C04,0.0050702062,0.004497526,0.08309561,0.002848742,0.03159005,0.030872336,0.32199124,0.02930963,0.0036655334,0.0049817753,0.09654029,0.010428445,0.056590077,0.03627329,0.028999925,0.007895365,0.066162996,0.0052214717,0.006027187,0.07249453,0.06390158,0.0018002461,0.029742002
oral contraceptives breast cancer among women general risk breast cancer years age appear affected appreciably use oral contraceptives nonetheless concern continues expressed effects early age first use long term duration use formulation variety factors thought influence breast cancer risk presence oral contraception number recent studies restricted young women suggest long term use may increase risk disease occurring early present lack consistent findings well conducted epidemiologic studies prevents certain conclusion regard cause effect however increased risk indeed present plausible interpretation long term oral contraception promotes earlier clinical manifestation breast cancer women net impact lifetime risk disease,C04,0.0025908793,0.014838984,0.01725706,0.0014557093,0.0036077173,0.0033436646,0.41613507,0.0024364942,0.0018730904,0.01499789,0.037140578,0.0053289435,0.021013007,0.026247751,0.0022783538,0.004034538,0.041693263,0.002668176,0.013880366,0.26429865,0.099271335,0.0009199271,0.0026885828
oral zidovudine continuous infusion fluorouracil oral leucovorin calcium phase study phase clinical pharmacologic biochemical evaluation escalating oral zidovudine azt given days fixed dose continuous infusion fluorouracil mg per day x days oral leucovorin calcium performed eighteen patients treated doses azt ranging g per day nausea vomiting dose limiting maximally tolerated dose g per day rash mucositis occurred dose limiting dose related increase peak plasma levels azt observed alpha half life azt plasma min unaffected high doses doses g per day trough levels significantly increased perhaps reflecting prolonged absorption gut responses observed however significant increase dna single strand breaks observed peripheral blood cells threshold dose g per day confirming biological effect azt regimen trials intravenous formulation capable maintaining plasma levels circumventing dose limiting toxicity warranted,C04,0.00213544,0.0018942419,0.0039845095,0.0011998166,0.01330991,0.0027558967,0.1673418,0.0020081936,0.001543828,0.0020981953,0.011151195,0.068111226,0.09146946,0.035917763,0.001877852,0.024417995,0.07434682,0.002210171,0.012767889,0.01608909,0.4284241,0.0007582172,0.034186423
technetium v dimercaptosuccinic acid planar scintigraphy head neck cancer clinical scintigraphic radiological study technetium tc v dimercaptosuccinic acid dmsa imaging agent proposed scintigraphic marker head neck squamous cell carcinoma fifty four patients studied head neck tumour patients examined imaged using tc v dmsa scintigraphy computerized tomography scintigraphy less sensitive clinical examination detection patients cancer patients primary tumours patients metastatic neck disease ct sensitive accurate clinical examination sensitive tc v dmsa detecting patients cancer primary tumours ct sensitive accurate clinical examination tc v dmsa scintigraphy predicting patients metastatic neck disease although tc v dmsa accumulated squamous cell carcinoma inability detect low volume disease apparent low specificity means role play management patients head neck squamous cell carcinoma,C04,0.0028396077,0.0025188737,0.060119808,0.0015954596,0.031445004,0.0036646614,0.3222428,0.030158877,0.00205291,0.0027900813,0.1492239,0.047080815,0.08595927,0.006606489,0.0024970793,0.0044218595,0.14742793,0.002970846,0.003233311,0.022009991,0.06520649,0.0010082414,0.002925734
predictive value tumor estrogen progesterone receptor levels postmenopausal women advanced breast cancer treated toremifene predictive value estrogen receptor er concentrations evaluated group postmenopausal patients estrogen receptor positive er greater fmol mg protein advanced breast cancer patients tumors also sampled progesterone receptor pgr determination patients treated toremifene novel antiestrogen mg daily median er responders fmol mg protein nonresponders fmol mg protein median pgr levels fmol mg protein respectively response rate patients er less fmol mg protein group er greater fmol mg protein significant ns response rate patients pgr less fmol mg protein patients greater fmol mg protein duration response patients er greater fmol mg protein significantly longer lower er levels p pgr associated duration response cox multiple regression analysis er independent prognostic factor p response duration thus er concentration tumor tissue predicts duration response response rate toremifene patients advanced breast cancer pgr status predict response rate duration response,C04,0.0021133556,0.0018746518,0.003943302,0.0011874082,0.03363607,0.0027273954,0.06877344,0.0019874251,0.0015278619,0.002076496,0.08093623,0.025160832,0.09276401,0.0052848035,0.012082432,0.0032944442,0.17710876,0.114720315,0.0024063662,0.12668718,0.23678268,0.00075037574,0.0021741423
role mastectomy breast cancer surgical management breast cancer continues evolve attempt define ideal line therapeutic efficacy morbidity clear breast cancer biologically heterogeneous group diseases single hypothesis explains behavior surgical options proposed individual patient must draw experience retrospective clinical studies prospective randomized trials attempt optimize treatment plan patients without distant disease eligible consider mastectomy accomplish excellent local control significantly improve survival earlier stages disease however breast conservation remains appropriate alternative carefully defined subset patients today early stage disease patient need leave operating room without breast recent advances reconstructive surgery make mastectomy immediate reconstruction limited resection plus axillary dissection postoperative radiation therapy two principal treatment choices available future studies focus integration treatment modalities clinical research use preoperative chemotherapy downstage disease permit less extensive surgery interest recent application molecular biologic techniques oncogene analysis cytogenetic studies proliferative indices highly sensitive detection distant micrometastases using monoclonal antibodies may assist design innovative approaches surgery radiation therapy systemic drug treatment advances show great promise improving quality life cure rate patients breast cancer today surgical treatment options evolved fulfill objectives outlined dr james ewing memorial hospital years ago concerns breast cancer remain relevant today half century ago drawn impression dealing mammary cancer surgery meets peculiar difficulties uncertainties almost form disease anatomical types numerous variations clinical course wide paths dissemination free diverse difficulties determining actual conditions complex sacrifice tissues great render impossible majority cases reasonably accurate adjustment means end,C04,0.0073579676,0.01601794,0.028544689,0.013592485,0.008182298,0.03824242,0.32040918,0.02656098,0.0009472103,0.0012873403,0.036366664,0.022070292,0.07685487,0.010413895,0.0011521495,0.027402863,0.18452422,0.0013492802,0.014139254,0.08976217,0.07300493,0.00046520148,0.0013517434
teniposide vm continuous infusion cytosine arabinoside initial induction failure childhood acute lymphoblastic leukemia pediatric oncology group pilot study twenty six evaluable children newly diagnosed acute lymphoblastic leukemia failed achieve initial remission receiving two seven drugs least week period given teniposide vm continuous infusion cytosine arabinoside ara c twenty two received mg vm days mg ara c continuous infusion days second shortened course given day eight patients evidence antileukemic effect clinically judged able tolerate second course last four patients received three daily doses vm day infusion ara c daily dosages twelve achieved complete remission cr trend toward decreasing response rates increasing number drugs used initial induction regimen e five cr among seven patients prior two drug induction attempt six cr among patients prior three four drug induction attempt one cr among four patients prior five seven drug induction attempt p ten non cell patients two nine cell patients achieved remission p median time required achieve complete remission initiation treatment days range days period shorter required one course compared required two induction courses e days median vs days median toxicity significant due mainly marrow aplasia infection one patient severe prolonged vm induced hypotension patients entering remission two removed marrow transplant one removed due parental request remaining nine patients median remission duration months range months nine patients relapsed marrow among entire group patients one patient alive long term event free survivor allogeneic marrow transplant due current use aggressive initial induction regimens extremely poor prognosis children fail achieve initial remission intensive regimens continuation therapy alternative therapies bone marrow transplant considered,C04,0.0013302614,0.010817027,0.0024775874,0.00074605184,0.001848957,0.02516726,0.19631271,0.0012487046,0.0009599598,0.014160938,0.012853369,0.055268757,0.012741481,0.0164675,0.0011676576,0.05884511,0.41418114,0.0077907457,0.007853371,0.0272093,0.12871462,0.0004714631,0.0013660195
expression ki antigen cd mesenchymal tumors expression cd ki antigen long considered restricted activated lymphocytes related tumors however expression antigen also detected embryonal carcinomas nonembryonal carcinomas malignant melanomas even myeloid cell lines macrophages late stages differentiation study using monoclonal antibody ki expression cd antigen immunohistochemically examined frozen sections benign malignant mesenchymal tumors authors found cd expressed two four leiomyomas seven leiomysarcomas one six rhabdomyosarcomas two two aggressive fibromatoses one three fibrosarcomas two four synovial sarcomas one giant cell tumors tendon sheaths five malignant fibrous histiocytomas three osteosarcomas one three ewing sarcomas tumor cell subpopulation two ten malignant schwannomas schwann cell compartment one two ganglioneuromas tested furthermore cd consistently expressed myoepithelial compartment fibroadenomas however five lipomas seven liposarcomas three neuroblastomas ganglioneuroblastomas chondrosarcomas tumors disputed origin tested consistently cd negative findings indicate outside lymphatic system cd antigen restricted epithelial neoplasms may also present tumors mesenchymal origin authors conclude cd antigen although limited utility differential diagnosis tumors questionable histogenesis may eventually define relevant subgroups within main tumor categories,C04,0.014569282,0.0022145398,0.004658251,0.013481006,0.12209694,0.0032218918,0.266238,0.026516318,0.0018048744,0.0024529796,0.094892085,0.0055744904,0.02852999,0.15858296,0.0021953785,0.0038876042,0.054856323,0.021757228,0.014915843,0.03397638,0.04169982,0.00088642427,0.08099141
reconstruction mastectomy advances materials techniques especially involving transposition muscle skin flaps made breast reconstruction possible women undergo mastectomy breast cancer availability option alleviate breast chest wall deformity results virtually local treatment breast cancer essential reconstruction surgeon part breast cancer management team beginning treatment planning surgeon work closely general surgeon medical oncologist radiation therapist well adjunctive treatment team members patient clinical status type local treatment significant determinants reconstructive options women stage breast cancer decisions may based largely oncologist local adjunctive therapy procedures woman desire proceed delay women systemic disease members breast management team may need agree advisability timing reconstruction central numerous decisions described paper regarding timing type extent breast reconstruction primary goal entire team best possible management breast cancer promise attractive symmetric natural appearing breasts complete symmetric nipple areolar complex eased somewhat diminishment self esteem threat femininity accompany loss breast lowering fear widely recognized availability breast reconstruction may encourage women monitor breasts seek diagnosis changes may influence selection type local treatment cancer detected psychological cultural significance breast reconstructive surgeon must particularly sensitive psychological aesthetic expectations patient even patients metastases limited life expectancy breast reconstruction enhance quality life,C04,0.008256079,0.0012575666,0.024126286,0.007917663,0.008835906,0.0018296099,0.32155055,0.008288529,0.007887347,0.03567827,0.019690968,0.044090286,0.012399445,0.0033761463,0.0012466856,0.01584664,0.15221207,0.0014630109,0.022192566,0.24834648,0.05154329,0.00050337217,0.0014612149
basement membrane cervical adenocarcinoma immunoperoxidase study laminin type iv collagen basement membrane components type iv collagen laminin examined immunohistochemically cases adenocarcinoma cervix patterns staining adenocarcinoma situ invasive adenocarcinoma early invasive adenocarcinoma compared see whether characteristic patterns could delineated adenocarcinoma situ uniform intact basement membrane whereas basement membrane invasive adenocarcinoma fragmented irregular cases early stromal invasion showed early gland buds outpouchings defective basement membrane staining degree histologic differentiation tumor clearly related amount basement membrane component staining concept early stromal invasion cervical adenocarcinoma supported immunohistochemical studies discussed relates possible pathogenic mechanism early invasion infiltration adenocarcinoma cervix,C04,0.003142035,0.002745314,0.05033598,0.09717593,0.019291835,0.018962273,0.34907836,0.032866288,0.017200632,0.0030409023,0.10266485,0.006365579,0.029882573,0.008128964,0.0027215604,0.0048193736,0.031936552,0.0031872143,0.0035239772,0.024356265,0.16444378,0.0010988798,0.023030903
correlation free phenytoin serum albumin cancer patients objectives study compare total free phenytoin serum concentrations cancer patients hypoalbuminemia cancer patients normal serum albumin correlate percentage free phenytoin albumin concentration total patients studied normal albumin concentration low albumin mean free phenytoin normal albumin group percent percent low albumin group groups combined mean free phenytoin percent range albumin range g l significant negative correlation r p less percentage free phenytoin measured serum albumin cancer patients serum albumin concentration appears key factor determines percentage free phenytoin cancer patients low serum albumin concentration total free phenytoin concentration measured adequate assessment phenytoin therapy,C04,0.0025580337,0.0022691037,0.0047730254,0.0014372548,0.003561981,0.08998503,0.10565032,0.002405606,0.0018493445,0.0025134184,0.020156201,0.10433358,0.2938733,0.009753167,0.0022495934,0.0039833905,0.15661974,0.0026360676,0.0029126976,0.030213205,0.15272602,0.00090826483,0.0026316107
prospective study estrogen replacement therapy risk breast cancer postmenopausal women published erratum appears jama apr prospectively examined use estrogen replacement therapy relation breast cancer incidence cohort women years age person years follow among postmenopausal women incident cases breast cancer documented overall past users replacement estrogen increased risk relative risk confidence interval including even years since last corrected use relative risk adjustment established risk factors confidence interval however risk breast cancer significantly elevated among current users relative risk confidence interval among current users stronger relationship observed increasing age increasing duration use data suggest long term past use estrogen replacement therapy related risk breast cancer current use may modestly increase risk,C04,0.002527037,0.0022416078,0.041414574,0.001419839,0.0035188189,0.0032866518,0.21483296,0.002376456,0.0018269352,0.002482962,0.039741006,0.0051986463,0.028035522,0.005810438,0.0022222125,0.04095807,0.14999412,0.0026024291,0.0028774033,0.32110542,0.12202992,0.000897259,0.0025997225
retroviral recombination reverse transcription recombination occurs high rate retroviral replication observation requires virion containing two different rna molecules heterodimeric particles analysis retroviral recombinants formed single round replication revealed nonselected markers changed frequently expected rate recombination selected markers ii transfer initially synthesized minus strand strong stop dna either intramolecular intermolecular iii transfer first synthesized plus strand strong stop dna always intramolecular iv strong correlation type transfer minus strand strong stop dna number template switches observed data suggest retroviral recombination ordered occurs synthesis minus plus strand dna,C04,0.0033455654,0.0029676836,0.0062424783,0.0018798742,0.038671385,0.0043176264,0.2082352,0.0031462102,0.002418695,0.0032872146,0.02039808,0.0068811886,0.042495184,0.008149569,0.0029420059,0.022567924,0.04233647,0.037197188,0.0038094185,0.20997243,0.105822995,0.0011878888,0.22172773
embryologic fusion planes spread cutaneous carcinoma review reassessment long held embryologic fusion planes influence spread skin cancer embryologic fusion planes implicated depth invasion horizontal spread recurrence cutaneous carcinoma however structures never studied detail review surgical literature reveals considerable confusion regarding exact nature location tumor interactions fusion planes review gross microscopic development sites embryologic fusion examine histologic sections fusion sites normally developed adult fetal fresh cadaver specimens studies supported review developmental anatomy indicate fusion planes persist identifiable anatomic structures would influence tumor spread,C04,0.0034575236,0.003066996,0.0064513804,0.0019426416,0.0739743,0.021188978,0.35784715,0.019984242,0.019224765,0.020123392,0.032922458,0.02384851,0.022433605,0.09869152,0.019770086,0.0053840834,0.04858728,0.0035797213,0.0039368994,0.1170261,0.05830292,0.001227641,0.03702781
conservative surgery radiation therapy soft tissue sarcoma wrist hand ankle foot seventy eight patients soft tissue sarcoma sts arising distal extremities wrist hand finger ankle foot toe treated conservation surgery radiation therapy studied retrospectively respect survival local recurrence functional limb preservation complications distant metastasis median follow years actuarial year year survival rates respectively disease free rates times actuarial local control rates years respectively fifteen patients local recurrence salvaged ultimately patients retained normal fairly normal extremity six needed amputation complications needed amputation control recurrent disease functional outcome significantly better patients upper extremity lesions lower extremity tumors even latter treatment strategy preferable amputation incidence hematogenous metastases distal extremity sarcomas depends size primary tumor concluded conservation surgery radiation therapy xrt acceptable treatment strategy sts arising distal extremities yielded high rate disease control functional limb preservation,C04,0.0023815297,0.0021125355,0.0044436874,0.0013380843,0.07575185,0.014549902,0.17899837,0.0022396194,0.0017217399,0.0023399927,0.02280945,0.018092392,0.07744085,0.0055886153,0.025134493,0.015216519,0.2902677,0.0024548986,0.0027117217,0.09838722,0.15272324,0.0008455946,0.0024500298
reduction membrane fluidity human breast cancer cells tamoxifen beta estradiol intracellular steady state levels methotrexate previously shown reduced estrogen receptor er negative human breast cancer mda mb cells er positive human breast cancer mcf cells following treatment pharmacologically relevant concentrations beta estradiol e report e tamoxifen tmx significantly decreased fluidity mcf mda mb cellular membranes e tmx concentrations greater microm perturbations membrane fluidity accompanied apparently non er mediated cytotoxicity alterations membrane structure may contributed cytotoxicity high dose endocrine therapy ability e inhibit methotrexate transport cytotoxicity human breast cancer cells,C04,0.0034003844,0.0030163107,0.039266814,0.0019105374,0.004734928,0.0043883733,0.19420254,0.0031977626,0.0024583265,0.0033410774,0.035324614,0.0069941403,0.061814778,0.18254559,0.019445367,0.0055272416,0.039632995,0.003529395,0.0038718379,0.068116985,0.24898498,0.001207353,0.06308769
lymph node metastasis papillary follicular thyroid carcinoma young patients total patients years age papillary follicular thyroid cancer presented anderson cancer center common presenting symptom cervical mass twenty percent patients history prior irradiation sixty percent initially palpable lymph nodes clinically negative examinations pathologically positive lymph nodes recurrence highest regional lymph nodes recurrence rate primary site recurrence rate distant sites deaths due thyroid cancer maintain low rate recurrence near total thyroidectomy neck dissection followed iodine treatment considered young patients,C04,0.003403934,0.0030161922,0.02280111,0.0019104624,0.004734742,0.004388201,0.21654996,0.0031976372,0.0024582301,0.003354758,0.060478155,0.10575313,0.035583436,0.007895364,0.01951485,0.005294898,0.20808819,0.003526978,0.003871686,0.23236604,0.047106676,0.0012073056,0.003498053
association extent colonic mucosal sialomucin change subsequent local recurrence curative excision primary colorectal cancer two interrelated studies carried determine whether extent sialomucin change adjacent primary colorectal carcinoma predicted local tumour invasiveness risk local recurrence first depth tumour penetration correlated length sialomucin band adjacent primary colorectal cancers significant p less increase sialomucin band length adjacent tumours invading adjacent structures compared mann whitney u test although overall correlation depth penetration duke classification degree differentiation kruskal wallis test sialomucin band greater cm associated per cent probability adjacent structure invasion observations tested prospectively second study involving patients determine whether presence greater cm sialomucin band could predict local recurrence presence greater cm sialomucin band significant x f p less independent predictor local distant recurrence addition interval local recurrence survival significantly shorter greater cm sialomucin band present however accuracy greater cm sialomucin band predictive test local recurrence per cent extent sialomucin adjacent primary colorectal cancer provide crude assessment tumour invasiveness risk local recurrence,C04,0.0022273203,0.0019757443,0.004158087,0.033582423,0.013868072,0.002874473,0.20599766,0.0020945992,0.0016102535,0.002188473,0.12415157,0.026144654,0.20468602,0.0055032047,0.023509854,0.035812255,0.062249456,0.0022937707,0.002536132,0.07678462,0.13032678,0.00079084054,0.034633767
motility factor produced malignant glioma cells role tumor invasion better understand cellular mechanism tumor invasion production cell motility stimulating factor malignant glioma cells studied vitro serum free conditioned media cultures rat c human g cell lines contained factor stimulated locomotion producer cells factor termed glioma derived motility factor glioma derived motility factor heat labile protein molecular weight greater kd relative stability acid factor showed chemotactic activity also chemokinetic stimulated random locomotion activity two types glioma cells studied although glioma derived motility factors conditioned media obtained two different cell origins likely chemokinetic migration g cells conditioned medium much stronger c cells coincubation cells cytochalasin b disrupts assembly cellular actin microfilaments almost completely inhibited cell migration stimulated glioma derived motility factor cytochalasin b also induced marked alterations cell morphology including cell retraction arborization drug affect cell attachment culture dishes results indicate glioma cells produce motility factor may play role particularly tumor cells detached migrate away original tumor mass thus promoting tumor invasion also glioma cell migration stimulated motility factor requires normal organization cytoskeletons actin microfilaments,C04,0.0017415273,0.0015448217,0.028537098,0.009487378,0.044580426,0.002247532,0.23688148,0.028210167,0.0012590467,0.001711153,0.019251384,0.011202205,0.02206445,0.33007792,0.024371745,0.0027364627,0.01671828,0.021158444,0.001982985,0.03964109,0.13125125,0.0006183531,0.022724798
carcinoma external auditory canal update review continuation series cases carcinoma external auditory canal originally reported senior author colleagues eighteen additional cases evaluated treated since preoperative high resolution computed tomographic scanning replaced polytomography improved surgical skull base approaches allowed extended resections advanced lesions revised classification local extensive lesions presented prognosis localized tumors treated en bloc resection remains excellent whereas prognosis extensive lesions might dependent histologic type grade tumor,C04,0.0039164457,0.0034740826,0.0073076813,0.021842726,0.10025569,0.005054377,0.30026355,0.022631016,0.0028314157,0.0038481378,0.095169365,0.027011031,0.027205419,0.009050862,0.0223973,0.04395799,0.16040407,0.0040332894,0.0044594496,0.04102314,0.069499314,0.0013905875,0.022973035
oncocytic glomus tumor trachea oncocytic variant glomus tumor trachea occurred year old woman experienced intermittent cough hemoptysis three years bronchoscopy chest ct scan showed small reddish polypoid tumor lower end trachea bronchoscopic biopsy carefully done diagnosed oncocytoma wedge resection tumor done tumor cells characterized strongly eosinophilic granular cytoplasm light microscopy numerous closely packed round ovoid mitochondria prominent tubular cristae electron microscopy arranged sheet around small vessels result biopsy diagnosis oncocytoma changed oncocytic glomus tumor knowledge first report oncocytic glomus tumor arising trachea,C04,0.0035780207,0.003173883,0.041316744,0.0020103438,0.14904195,0.004617622,0.17285043,0.023044541,0.0025867498,0.0035156156,0.061276764,0.007359305,0.029880377,0.032052834,0.020446438,0.0055717225,0.09836123,0.020960448,0.0040869243,0.085547835,0.22374143,0.0012704252,0.0037083838
tumor atrioventricular nodal region clinical immunohistochemical study autopsy specimens tumors atrioventricular nodal region studied sudden death occurred children adults seven patients history atrioventricular block syncope three tumors incidental findings infants congenital anomalies diaphragmatic agenesis pulmonary hypoplasia meckel diverticulum one patient mitral atresia one congenital hydrocephalus ventricular septal defect patent ductus arteriosus coarctation aorta patent omphalovitelline duct third immunohistochemical stains demonstrated strong positivity carcinoembryonic antigen cases b antigen cases cytokeratin cases twenty control cases mesothelioma mesothelial hyperplasia negative b one showed focal carcinoembryonic antigen staining ultrastructural analysis one case demonstrated short rudimentary microvilli characteristic mesothelial cells conclude called mesotheliomas atrioventricular nodal region mesothelial origin strong carcinoembryonic antigen positivity occasional positivity b antibodies react glycoproteins found endodermally derived tissue generally mesothelial tissue conduction system tumors likely congenital rests endodermal origin associated congenital anomalies often cause symptoms heart block sudden death,C04,0.011922232,0.0020001952,0.01501738,0.0012669277,0.06878736,0.015013235,0.22297181,0.024158811,0.012528431,0.025691692,0.13542563,0.0046974747,0.036493115,0.088681564,0.012897165,0.0035282932,0.10963033,0.0023425284,0.0025675178,0.14012226,0.06107576,0.0008006276,0.0023796787
nm treatment port wine stains although flashlamp pulsed dye laser successfully used treatment port wine stains pws nm number adult patients incomplete clearance birthmarks treatment modality residual vessels lying beyond mm penetration depth nm irradiation fifteen adult patients nine previously treated limited success nm group six untreated patients group b included study group patients treatment nm produced successful clearance birthmark six patients group b parallel treatment different sites lesion coupled skin biopsies histologic examination revealed change wavelength nm allowed laser light penetrate midreticular dermis subcutaneous fat explained clearance achieved nm nm,C04,0.0030491373,0.002704737,0.020447068,0.016460055,0.03511455,0.018685771,0.23396857,0.0028719215,0.0022043905,0.0029959565,0.047904078,0.06531813,0.02274729,0.0072676702,0.0026813345,0.019487817,0.22722492,0.0031531292,0.0034718914,0.029951286,0.2280697,0.0010826379,0.003137977
immediate versus delayed shoulder exercises axillary lymph node dissection total evaluable patients breast cancer enrolled multicenter randomized prospective study establish role delayed shoulder exercises wound drainage shoulder function axillary lymph node dissection patients group n started active shoulder exercises day postoperatively patients group n started eight postoperative day following week immobilization arm patients group less wound drainage volume group ml versus ml difference however significant also differences could established two groups duration volume wound drainage number volume seroma aspirations wound complication rates shoulder function compared months surgery,C04,0.00309467,0.04768957,0.005774333,0.0017387688,0.019262541,0.0039938325,0.16398048,0.002910265,0.0022373085,0.033001825,0.015592776,0.10057437,0.20149796,0.007412696,0.0027214559,0.0048190444,0.22380203,0.0031869968,0.0035684647,0.027303768,0.12155442,0.0010988049,0.0031836822
regional chemotherapy colorectal liver metastases phase ii evaluation targeted hepatic arterial fluorouracil colorectal liver metastases results systemic chemotherapy patients liver metastases colorectal cancer remain dismal regional chemotherapy advocated method improving delivery cytotoxic drugs tumour minimizing systemic toxicity use vasoactive agents redistribute arterial blood flow towards tumour biodegradable microspheres slow tumour blood flow also suggested methods improving tumour exposure drug present patients received intrahepatic arterial chemotherapy colorectal liver metastases combined treatment angiotensin ii albumin microspheres fluorouracil administered weekly bolus fluorouracil given intervening weeks toxicity minimal responses seen seven patients fewer half deaths liver metastases quarter patients died non cancer related causes survival prolonged treated group compared historical controls results suggest regimen activity patients colorectal liver metastases,C04,0.032430805,0.0021371169,0.0044953935,0.0013536542,0.01501672,0.014767148,0.24633712,0.013884718,0.013400956,0.0023672206,0.035192512,0.038849905,0.10836576,0.005662568,0.0021186257,0.10628308,0.16951452,0.014138669,0.0027432751,0.03123081,0.13637547,0.0008554339,0.002478538
effect intraarterial versus intravenous cisplatin addition systemic doxorubicin high dose methotrexate ifosfamide histologic tumor response osteosarcoma study coss osteosarcoma intraarterial ia administration systemic treatment advocated improve local tumor response preparing even obviating definitive surgery data literature unequivocally support local superiority ia infusion comparative study started preoperative chemotherapy consisted mg doxorubicin days g high dose methotrexate days g ifosfamide days followed days intravenous iv versus ia tourniquet infusion cisplatin ddp strict randomization patients feasible balanced distribution risk factors strived stratifying allocating appropriate patients centrally infusion time prolonged hours iv group ddp dose reduced mg arms intolerable ototoxicity became apparent multivariate analysis performed exclude bias response rates risk factor distribution modifications ddp infusion time dosage overall fraction histologic good responders greater necrosis found different ia versus iv treatment vs intraarterial instead iv use ddp within aggressive systemic treatment seem improve local tumor response,C04,0.0021137055,0.0018747824,0.003943577,0.01140351,0.03363841,0.0027275854,0.13273528,0.012164318,0.0015279683,0.0020766405,0.011671562,0.11701041,0.100500934,0.018207284,0.001876986,0.013720014,0.12761126,0.0021765574,0.0024065338,0.07576862,0.32191935,0.000750428,0.0021742936
clinical evaluation side entry access port novel dual lumen venous access device initial clinical experience low profile side entry access sea dual lumen implantable venous access port cancer chemotherapy administration summarized report catheter material polyurethane overall experience patients study total patient days mean days per patient variety chemotherapeutic agents biologic response modifiers antibiotics administered patients device chambers simultaneous use treatment period incidence clinical subclavian vein thrombosis noted infectious complications inconsistencies blood withdrawal temporary catheter dysfunction comparable access ports clinical use novel design side entry port catheter material low thrombogenicity make device good option patients requiring low profile system dual access nursing staff made aware side entry design service training accessing septum required centers devices routinely used,C04,0.0021570767,0.08472408,0.034496866,0.0012016115,0.013329825,0.013610383,0.19595642,0.033065826,0.0015461376,0.002101334,0.06798851,0.015421206,0.05837288,0.0049173813,0.0018807219,0.012259102,0.20680086,0.0022024391,0.012777804,0.07294666,0.15928333,0.0007593514,0.0022001483
intraoperative decision making thyroid surgery based results preoperative needle biopsy frozen section prognostic factors well differentiated thyroid cancer age patient grade size distant metastasis extracapsular spread disease however surgeon often sure pathologic diagnosis thyroid nodules accuracy preoperative studies ultrasonography thyroid scanning limited cost effective test fine needle aspiration accuracy exceeds series however large group nodules exist aspiration cytologic studies considered either suspicious indeterminate decision extent thyroidectomy may difficult patients intraoperative frozen section may help surgeon distinguish benign malignant lesions fine needle aspiration major problem distinction follicular adenoma follicular carcinoma frozen section diagnosis follicular adenoma changed follicular carcinoma one third cases cases decision extent thyroidectomy patients follicular adenomas based prognostic factors age sex patient size nodule accuracy frozen section diagnosis experience suggests decisions regarding extent thyroidectomy best made preoperative fine needle aspiration confirmation frozen section diagnosis equivocal cases,C04,0.0021805326,0.0019342413,0.054310706,0.011738061,0.015466149,0.019184483,0.21404146,0.0020505993,0.0015764281,0.0021487668,0.18017131,0.06781176,0.017241001,0.021375448,0.025517074,0.035059858,0.15404207,0.002245587,0.017024428,0.114111245,0.0377513,0.0007742279,0.0022432515
cholecystokinin stimulates growth human pancreatic adenocarcinoma sw effect synthetic analogue cck thr nle cck growth sw human pancreatic cancer examined two experimental models nude mice bearing sw pancreatic cancer xenografts injected cck micrograms kg vehicle twice daily days animals sacrificed tumor volume weight protein deoxyribonucleic acid dna content evaluated sw cells grown vitro effects cck secretin vasoactive intestinal peptide vip proglumide cck receptor antagonist cell number dna synthesis determined highest dose cck micrograms kg significantly increased tumor weight protein content dna content p less vitro cck caused significant increases cell counts six days days compared control graded concentrations cck biphasic effect dna synthesis significant increases p less cck induced cell proliferation inhibited proglumide secretin slightly increased cancer cell growth although potently cck vip secretin combination cck show potentiation results indicate growth human pancreatic cancers may influenced gastrointestinal peptides cck potent,C04,0.0021579093,0.0019141731,0.004026435,0.0012124412,0.024059799,0.013192207,0.09148702,0.002029324,0.0015600723,0.0021202725,0.010447862,0.057879873,0.074963905,0.16650842,0.001897611,0.0033603136,0.04519125,0.033560194,0.044228695,0.033790953,0.3814183,0.0007661952,0.0022268149
detection primary colorectal cancer indium monoclonal antibody b b murine monoclonal antibody immunoglobulin subclass igg directed tag cell surface antigen present colorectal carcinoma cells investigated utility scanning indium labeled b patients high clinical suspicion biopsy proven primary colorectal cancer patient received mg b monoclonal antibody labeled mbq indium patients underwent scanning days days infusion planar emission computed tomography nineteen lesions confirmed patients three patients benign polyps true negative monoclonal antibody scans indium labeled imaging b detected nine lesions unsuspected tumor sites identified monoclonal antibody scan three patients detection additional abdominal disease extra abdominal spread indium labeled scanning b directly affected treatment patients,C04,0.002623292,0.0023269907,0.019050451,0.039541006,0.06971006,0.003385495,0.18105863,0.027857298,0.0019214167,0.0025775384,0.103198916,0.0063432422,0.032171074,0.13455084,0.0023068567,0.0041020773,0.17125775,0.06663904,0.015673922,0.020379893,0.08969151,0.0009314356,0.0027012955
needle localized mammographic lesions results evolving treatment strategy january december needle localization breast biopsies performed institution mammographically detected abnormalities reviewed needle localization breast biopsy procedures performed two periods january june n january august n compare results treatment patterns determine prevalence missed lesions mammographic abnormalities detected routine screening accounted larger proportion needle localization breast biopsies later series vs however rate carcinoma identified remained constant percentage cancers invasive vs overall rate malignant diagnoses needle localization breast biopsy lowest asymptomatic women undergoing routine screening mammography significantly higher women undergoing mammographic follow contralateral breast treatment breast cancer seven missed lesions needle localization breast biopsies necessitating second procedure six interval mammograms one,C04,0.0024093227,0.0021371895,0.062812835,0.0013537002,0.03841319,0.0031093564,0.2573667,0.0022657563,0.001741833,0.0023673011,0.1444011,0.016619455,0.052072342,0.0064671035,0.0021186976,0.0037518165,0.1443156,0.002481203,0.0027433683,0.192944,0.05477067,0.000855463,0.002481969
multiple intracranial tumors different cell types multiple intracranial tumors different cell types rare report nine patients multiple intracranial tumors history trauma irradiation phacomatosis clinical radiological histopathological findings well indications operations patients asymptomatic second tumors discussed,C04,0.00461586,0.004094498,0.008612716,0.0025938384,0.095813505,0.0059570074,0.27678984,0.02668273,0.0033370613,0.0045353533,0.17673175,0.009493941,0.02857302,0.057614204,0.026403524,0.0071878536,0.10780696,0.0047535705,0.0052558356,0.031232748,0.10552661,0.0016389241,0.0047486266
immunophenotypes classical b cell chronic lymphocytic leukemia correlation normal cellular counterpart clinical findings study evaluates expression series membrane antigens normally expressed b lymphocytes lymphocytic mantle marginal zone selected cases classical mouse red blood cell receptor cd cd surface immunoglobulin b chronic lymphocytic leukemia b cll aim contributing toward identifying normal counterpart b cll correlations surface antigen pattern certain clinical characteristics clustered cd c w unclustered nub f kib monoclonal antibodies moab tested almost cases showed high reactivity cd w nub expression cd c low f kib cd variable reactivity f kib strictly correlated correlated individually cd results show frequent b cll phenotype cd nub kib f cd corresponds one cellular subsets mantle zone correlation found moab expression surface immunoglobulin sig class type clinical stage disease activity age diagnosis difference statistically borderline expression f kib young versus old patients suggests modulations expression surface antigens affect clinical behavior disease,C04,0.002157497,0.0019138074,0.05940046,0.0012122422,0.0030042462,0.0028140962,0.3121662,0.0020289363,0.0015597742,0.0021198674,0.09571689,0.004471949,0.08407186,0.14728525,0.012336442,0.0033596714,0.040364664,0.02347915,0.0024566276,0.05708431,0.084434085,0.00076604873,0.055795908
prospective clinical evaluation autogenous vein grafts used nerve conduit distal sensory nerve defects cm less purpose study determine efficacy autogenous vein grafts nerve grafts avnc bridging small peripheral sensory nerve gaps compared direct repair conventional nerve grafting techniques ang patients painful neuroma segmental nerve injury cm chosen test group amenable direct repair classified controls total patients enrolled study total nerves repaired venous nerve conduit sural nerve graft direct repair significant symptom relief satisfactory sensory function return uniformly observed two point discrimination measurements indicated superiority direct repair probably conventional nerve grafting however universally favorable patient acceptance return measurable two point discrimination indicates effectiveness autogenous vein grafts nerve conduits selectively applied bridge small nerve gap less equal cm nonessential peripheral sensory nerves,C04,0.023533693,0.012619291,0.01637105,0.0012382033,0.024372583,0.024109028,0.13757269,0.044742372,0.001593221,0.0021744685,0.085869215,0.015319927,0.27471653,0.0051960866,0.0019379985,0.003431714,0.15774775,0.012899928,0.002509306,0.015241574,0.13375379,0.0007824754,0.0022671479
carotid body tumors surgical management carotid body tumors requires identification preservation neural vascular structures without compromising resection neoplasm fifteen patients examined treated carotid body tumors cleveland ohio clinic foundation benchmark diagnosis bilateral carotid angiography neural structures free tumor meticulous dissection facilitates preservation large tumor size increases risk arterial resection necessitating reconstruction use vascular shunt minimizes risk cerebral ischemia postoperative intravenous digital subtraction angiography allows evaluation arterial repair retrospective review carotid body tumor resections performed patients revealed evidence tumor recurrence mortality associated surgical intervention postoperative cerebrovascular accident limited morbidity associated unavoidable sacrifice neural elements,C04,0.05300682,0.0023568505,0.0049576,0.0014928338,0.11889462,0.0034289372,0.11818537,0.0025721204,0.0019208592,0.0026106131,0.16700494,0.018319806,0.017722176,0.006109157,0.053591713,0.0041374294,0.18044694,0.0027402537,0.0030253325,0.12786403,0.0673578,0.013801165,0.028452618
cholecystectomy right colon cancer puerto rico case control study undertaken evaluate possible relationship cholecystectomy right colon cancer two hundred patients adenocarcinoma cecum ascending colon diagnosed compared matched neighborhood controls cholecystectomy history obtained interviews using structured questionnaires subsequently validated hospital records statistically significant association odds ratio found right colon cancer history prior cholecystectomy altered bile metabolism occurs removal gallbladder may carcinogenic effect right colon dietary habits colon cancer patients study consistent prior reports literature showing group lower intake vegetables cereal fiber control population,C04,0.0030494945,0.002705054,0.0056900405,0.0017133866,0.0042463243,0.0039355317,0.22772385,0.076668575,0.0022046487,0.0029963073,0.07731139,0.031217959,0.044666328,0.036970273,0.037710823,0.004748697,0.10436013,0.0031576536,0.0034722982,0.1502328,0.17099842,0.0010827647,0.0031372076
epidemiology ophthalmic malignancies new york state epidemiologic characteristics primary eye cancers icd site diagnosed among new york state nys residents described among nys male residents average annual age adjusted incidence rate per among nys female residents rate per male female rate ratio majority ophthalmic malignancies included within three histologic groupings melanomas retinoblastomas squamous cell carcinomas average annual incidence retinoblastoma among persons nys less years age per boys per girls male female rate ratio average annual incidence age adjusted ocular melanomas per among men per among women nys male female rate ratio expanded knowledge epidemiology ophthalmic cancers help develop foundation monitor disease patterns serve stimulate etiologic research involving rare malignancies,C04,0.0030047996,0.002665407,0.005647132,0.0016882743,0.004184088,0.010721486,0.20539182,0.017368043,0.0021723362,0.024378039,0.018897915,0.03527269,0.08198277,0.008962917,0.031722568,0.004679098,0.046520863,0.0031045852,0.0036990498,0.4306269,0.053151045,0.0010668951,0.0030912268
comparison methods checking surgical margins surgical margins cutaneous neoplasm evaluated various combinations three major types sections vertical perpendicular horizontal parallel oblique mohs method vertical sections may run transversely tumor breadloaf method longitudinally tumor breadloaf cross method peripheral tumor peripheral perimeter sectioning methods methods evaluate almost margin disadvantage showing relationship tumor margin seen clearly vertical transverse sections seven methods checking surgical margins compared contrasted none judged perfect best,C04,0.003915944,0.0034736379,0.0073067457,0.0022019886,0.08317486,0.00505373,0.1735525,0.060552225,0.0028310535,0.0038476451,0.19982034,0.008054349,0.0641782,0.0090890275,0.0034435824,0.00609794,0.10535667,0.0040327734,0.0044588787,0.027803922,0.21628821,0.0013904095,0.004075359
increase beta branched oligosaccharides human esophageal carcinomas invasive surrounding tissue vivo vitro glcnac beta man beta branched n glycosidic oligosaccharides expressed tumor cells found contribute malignant metastatic potential experimental tumor models phaseolus vulgaris leukoagglutinin l pha requires beta linked lactosamine antenna high affinity binding used histochemically characterize distribution sugar structures human esophageal squamous cell carcinomas patients leukoagglutinin reactive carcinoma cells invasive tumors distributed predominantly outer surface tumor adjacent surrounding tissue furthermore te cells human esophageal squamous cell carcinoma line cultured collagen gel matrix obtain colonies three dimensional form colonies exhibited high affinity l pha binding outer cell layer facing collagen matrix unrelated cell growth cycle findings suggest increase beta branched oligosaccharides esophageal carcinomas important trait tumor invasion surrounding tissue,C04,0.014056358,0.013746991,0.017107558,0.024680324,0.0708887,0.014754471,0.13919903,0.02555522,0.0017420601,0.014015864,0.05855731,0.005054939,0.07790908,0.1794897,0.0021189738,0.0037523054,0.03493119,0.043018494,0.002743726,0.038823828,0.12783422,0.00085557444,0.08916412
alternating cisplatinum vac ineffective end stage squamous cell carcinoma head neck sixteen patients end stage squamous cell carcinoma head neck admitted phase ii study alternating courses cisplatinum mg vac vincristine mg adriamycin mg cyclophosphamide mg given three weekly intervals two patients achieved response per cent median survival time days much similar group patients received chemotherapy previous trial days,C04,0.0046162647,0.0040948573,0.008613471,0.0025936908,0.0064280024,0.0059575303,0.11930763,0.004341191,0.003337354,0.0045357514,0.021343205,0.04378737,0.032860406,0.057234958,0.004059427,0.029533414,0.34679702,0.0047539873,0.027603075,0.06513585,0.19667742,0.0016390679,0.004749043
standard dose radiation microscopic disease appropriate elective irradiation sites potential occult tumor spread often part patient radiation therapy program required radiation dose depends probability occult disease exists p occ number sites risk number tumor clonogens present ni radiation sensitivity desired control rate exponential model cell survival used quantify importance factors control probability pocc x e ni x sf sf surviving fraction gy implications clinical radiation therapy include since number clonogens occult site may vary degrees ni major determinant required dose intrinsic radiation sensitivity clonogens sf also extremely important determining dose factors less influential since vary less variability ni logs larger variation cell number seen gross disease cm versus cm logs ni approximately required dose approaches needed small volume gross disease cells cm dose prescribed elective sites reflect risk occult disease based primary tumor site stage grade regions clinicoradiologic evaluation difficult e g pelvis obese neck require higher doses macroscopic tumor deposits may exist relatively low doses gy often thought inadequate microscopic tumor however similar doses reported sterilize microscopic tumor ovarian rectal bladder breast head neck carcinomas relatively low doses discounted since may useful select cases normal tissue tolerances previous irradiation treatment limit radiation dose,C04,0.0014372219,0.0012748875,0.016636714,0.0077502076,0.050750393,0.0018548096,0.34005532,0.008302345,0.0010390474,0.015324227,0.041458987,0.03166804,0.102669105,0.06201602,0.008677396,0.016143965,0.063682705,0.0014872057,0.004377541,0.082606636,0.1387866,0.0005103052,0.0014903537
quality control practices centralized tumor registries north america survey quality control practices mailed central registries u canada response rate respondents representing wide range registry characteristics reporting strategies registries expressed different priorities data use respondents felt quality control data important identification problems common method quality control acceptance sampling used respondents took form visual review recoding edit checking computer based edit checks almost universally used process control methods sort used respondents less registries reporting formal quantitative criteria sixty one percent respondents reported conducting one designed studies e g reabstracting casefinding studies made results public greater emphasis placed development quantitative process controls experimental design quality control studies formal analyses reporting study results,C04,0.002496718,0.0022147135,0.040899858,0.001402804,0.015563032,0.0032364347,0.32008088,0.0023479438,0.001805016,0.002453172,0.084667444,0.0053142314,0.12622364,0.021239989,0.0021955508,0.0038879092,0.063188516,0.0025712056,0.070917696,0.059196778,0.16460651,0.0008864939,0.0026034988
carcinoma thyroglossal duct review instances excision cyst thyroglossal duct performed st paul medical center dallas texas revealed two patients carcinoma thyroglossal duct review english literature yielded instances uncommon tumor eighty four per cent papillary adenocarcinoma thyroid type per cent squamous cell carcinoma patients six years old female male ratio metastatic disease lymph nodes noted per cent invasion overlying strap muscles found per cent carcinoma thyroid gland occurred per cent preoperative diagnosis rare sistrunk procedure recommended initial surgical therapy surgical adjuvant therapy dependent associated clinical findings prognosis carcinoma thyroglossal duct thyroid type parallels carcinoma thyroid gland,C04,0.003095037,0.0027454523,0.005775018,0.0017391698,0.035566363,0.0039943065,0.24943304,0.06283842,0.01722049,0.062937416,0.05953016,0.0662832,0.03419257,0.007228848,0.0027216976,0.034772698,0.18075758,0.0031915822,0.003524155,0.104290895,0.053878926,0.0010989353,0.00318406
surgical treatment brain metastases malignant melanoma authors report results retrospective review patients underwent craniotomies resection metastatic malignant melanoma university colorado denver co preoperative evidence extracranial disease patients eight patients one intracranial metastasis operation intraoperative ultrasound used craniotomies minimize surgical trauma brain day mortality zero day morbidity minimal patient acquired new neurologic deficit result surgery patients regained least preoperative level functioning six patients living time review followed months median months seven patients dead time review survived months median months results compare favorably survival untreated patients metastatic melanoma brain median month patients treated radiation therapy alone median months treated chemotherapy alone median months excision metastatic melanoma brain although curative may increase survival patients problem little morbidity mortality even presence metastases,C04,0.043483343,0.001894086,0.0143106,0.011494874,0.013294213,0.0027556699,0.22000657,0.0020080286,0.001543701,0.012428894,0.03758093,0.004391831,0.017601877,0.0050577456,0.0018776977,0.013683017,0.4844151,0.0021989683,0.0024313126,0.030496467,0.07409026,0.0007581548,0.0021966812
hyperthermia alone treatment recurrences malignant tumors experience lesions localized hyperthermia alone used treatment cancer recurrences previous conventional therapies failed since patients lesions heated means microwave radiofrequency system treatment protocol provided minutes heating intratumor temperature least degrees c twice week total number six eight ten heating sessions invasive intratumor thermometry performed lesions complete response cr obtained ten cases partial response pr higher rates cr observed chest wall compared head neck area trunk limbs none adenocarcinoma responsive histologic type squamous cells carcinoma cr case undifferentiated carcinoma showed cr none five sarcomas long term local control months approximately multivariate analysis showed statistical significance histologic variety adenocarcinoma versus others p less side effects complications treatment minimal,C04,0.0026232284,0.0023269344,0.017669031,0.014520193,0.054450843,0.028764019,0.26748314,0.0024669156,0.0018964773,0.002577476,0.10774154,0.031509243,0.088453434,0.02100283,0.0023069,0.00408884,0.1456568,0.0027014902,0.015667785,0.02824331,0.14149028,0.0009314131,0.015427835
diagnostic expert system colonic lesions diagnostic expert system colonic lesions descl designed discriminate colonic adenoma adenocarcinoma normal colonic tissue although originally developed use conjunction machine vision analytic system descl evolved teaching tool model conceptual machine learning expert system table driven consists shell knowledge base latter comprises series architectural cytologic observations quantitative estimate diagnostic importance relating observations diagnostic outcome validation study colonic lesions expert system achieved success rate flexibility allow individual pathologists customize knowledge base suit diagnostic criteria,C04,0.0036402356,0.0032290707,0.041984096,0.0020452999,0.07555597,0.004713699,0.28796163,0.0034233218,0.020228928,0.0035767453,0.171692,0.007487269,0.026419438,0.00877752,0.020819528,0.005668604,0.051951375,0.0037527592,0.00416775,0.09926551,0.14860182,0.0012925154,0.0037449403
head neck cancer ageing retrospective study patients evaluate whether age years represents prognostic factor head neck cancer reviewed cases observed four hundred thirty eight patients considered relation three age groups less equal greater equal years defined non elderly mid elderly elderly respectively main parameters analyzed included histological diagnosis difference emerged among three age groups anatomical site hypopharyngeal carcinoma frequent non elderly patients tnm stage higher incidence early stages seen elderly performance status better non elderly previous illnesses life style related diseases frequent non elderly contraindications surgery frequent elderly surgical treatment en bloc resections often employed non elderly post operative complications local control difference three groups multiple primary malignancies head neck oesophagus lung frequent non elderly patients survival difference although age affects several features head neck cancer patients appear present study independent prognostic factor local control survival regard survival stage appeared important prognostic factor,C04,0.0016427232,0.0014571775,0.0030651512,0.0009229792,0.00228744,0.015803432,0.15284696,0.0015448368,0.0011876158,0.0016140721,0.07224215,0.07499554,0.037918713,0.003936045,0.025297265,0.002601701,0.17147279,0.0016957463,0.0018704821,0.37583032,0.03954124,0.008533413,0.0016921769
tyrosine kinase control cell proliferation usefulness phosphotyrosine antibodies detection physiologically regulated deregulated tyrosine kinases discussed report rather rare enzymatic activity shared receptors polypeptide growth factors products class oncogenes antibodies able detect proteins phosphorylated tyrosine fibroblasts stimulated growth factors egf pdgf major phosphorylated protein species receptors undergo phosphorylation addition exogenous factor transiently phosphotyrosine antibodies able detect products retroviral class oncogenes endowed deregulated tyrosine kinase activity fact cases constitutive phosphorylation relevant proteins observed occurred continuously independently presence lack exogenous ligands tyrosine kinase constitutively activated human gastric carcinoma cells detected p tyr antibodies molecule characterized molecular level mechanisms responsible enzymatic activation investigated question whether tyrosine kinase identified responsible induction maintenance transformed phenotype gastric carcinomas remains answered reasonable suggest might case analogy situations class oncogenes activated transduction retroviruses abnormal expression egf receptors deregulated activity c abl encoded proteins chronic myelogenous leukemia acute lymphoblastic leukemia thus search deregulated kinases means phosphotyrosine antibodies seems useful identifying new activated oncogenes clinical oncology,C04,0.0019727312,0.0017499109,0.041850623,0.0011083971,0.012285734,0.012078081,0.256258,0.011400919,0.0014261968,0.0019383242,0.07324009,0.004096467,0.04390031,0.18379252,0.030381672,0.022165744,0.031203348,0.116627134,0.011786426,0.023932159,0.080577254,0.00070044515,0.035527546
regulation gene expression double stranded phosphorothioate oligonucleotides alteration gene transcription inhibition specific transcriptional regulatory proteins necessary determining factors participate cellular differentiation functions proteins antagonized several methods specific limitations inhibition sequence specific dna binding proteins achieved double stranded ds phosphorothioate oligonucleotides contained octamer kappa b consensus sequences phosphorothioate oligonucleotides specifically bound either octamer transcription factor nuclear factor nf kappa b modified oligonucleotides accumulated cells effectively standard ds oligonucleotides modulated gene expression specific manner octamer dependent activation reporter plasmid nf kappa b dependent activation human immunodeficiency virus hiv enhancer inhibited appropriate phosphorothioate oligonucleotide added transiently transfected b cell line addition phosphorothioate oligonucleotides contained octamer consensus jurkat leukemia cells inhibited interleukin il secretion degree similar observed mutated octamer site il enhancer ds phosphorothioate oligonucleotides probably compete binding specific transcription factors may provide anti viral immunosuppressive therapeutic effects,C04,0.0021578951,0.0019141607,0.0044061258,0.0012124332,0.0030080106,0.0027848762,0.22708319,0.0020293107,0.0015600622,0.0021202588,0.020368768,0.004448997,0.024683548,0.15725966,0.0018975985,0.03525951,0.046675064,0.14813495,0.03374785,0.022341667,0.11760237,0.0007661902,0.13853747
shear stress induces platelet aggregation also platelet tumor cell interaction investigate interaction platelets tumor cells well defined flow conditions effect tumor cells platelet aggregation induced shear stress studied using cone plate viscometer adapted measuring transmitted light intensity aggregation markedly enhanced hmv cells cell number dependent fashion shear stress dyne cm enhancement observed high shear stress dyne cm monoclonal antibody gpiib iiia e completely abolished enhancement aggregation hmv apyrase similar inhibitory effects scanning electronmicroscopy showed direct contacts platelets hmv cells could demonstrated platelet platelet interaction inhibited e apyrase results may indicate shear stress dyne cm direct contacts platelets hmv cells may trigger enhancement platelet aggregation,C04,0.0026917239,0.0023876934,0.0050224774,0.014500171,0.04287321,0.00347381,0.23856439,0.0025313296,0.0019459965,0.0026447768,0.013221476,0.01862334,0.08652221,0.1554253,0.023194242,0.017212376,0.024186471,0.030193951,0.0030649235,0.019446013,0.28854924,0.00095573335,0.0027691463
effect gastric mucus uptake carcinogen mnng gastric mucosal dna prostaglandin e pge pirenzepine indomethacin administered rats incorporation n methyl h n nitro n nitrosoguanidine methyl h mnng gastric mucosal dna measured quantitatively liquid scintillation counting intragastric instillation methyl h mnng amount incorporation pmol mg dna control rats pmol mg dna pge administered rats pmol mg dna pirenzepine administered rats pmol mg dna indomethacin administered rats pge pirenzepine significantly decreased incorporation compared control group contrast indomethacin increased incorporation addition gastric mucosa drug treated rats studied histochemically pge pirenzepine increased secretion gastric mucus whereas indomethacin decreased possible gastric mucus protective effect ulcerogenic agents also carcinogens considered gastric mucus plays important role defense mechanism carcinogenesis,C04,0.014755874,0.0022416636,0.041346613,0.0014198744,0.0035189064,0.06440898,0.18382277,0.0023765154,0.0018269807,0.002483024,0.011640864,0.019430302,0.032559436,0.0058162706,0.002222268,0.028397411,0.028259592,0.0026024939,0.002877475,0.024636049,0.44645578,0.00089728134,0.07600358
polypoid melanoma virulent variant nodular melanoma report three cases literature review report cases three patients polypoid melanoma case microscopic evidence melanoma cell invasion papillary dermis polypoid variant nodular melanoma melanoma cells accumulate large volume skin surface increase tumor volume encourages dislodgment melanoma cells carried superficial lymphatic vessels without invading reticular dermis feature differentiates polypoid melanoma nonpolypoid nodular variant although polypoid melanoma considered malignant form melanoma findings albeit limited three cases suggest early diagnosis prompt surgical excision may provide favorable year survival rate,C04,0.0036401523,0.0032289966,0.007224708,0.002045253,0.11109481,0.004697806,0.27681303,0.0034395962,0.002631668,0.0035766633,0.10481383,0.0074870973,0.06655799,0.0823481,0.003201058,0.005668474,0.11170341,0.0037487533,0.004144849,0.099415466,0.08747804,0.0012924857,0.0037477834
epidemiology cancer among hispanic women experience florida explore cancer incidence among hispanic women living dade county florida data analyzed statewide cancer registry three sites hispanics lower rates prevalent cancers non hispanics however higher rates cancer among hispanics noted cancers gallbladder liver heart soft tissue subgroups women significantly higher rates cervical cancer thyroid cancer lower rates among hispanics observed cancers esophagus vagina breast colon buccal cavity pharynx malignant melanoma data suggest cancer sites traditionally higher among us latino women higher among dade hispanics sites common among non hispanics yet shown increased incidence among hispanic women dade county,C04,0.003049415,0.0027049833,0.0056898925,0.001713342,0.019001225,0.0039354293,0.1497233,0.017539727,0.0022045914,0.017752785,0.014454435,0.18311161,0.057183,0.007011547,0.0026815787,0.020043239,0.035910238,0.003184066,0.0034722078,0.3235161,0.121887766,0.0010827365,0.0031467234
preoperative cell mediated immune function prognosis patients gastric carcinoma cell mediated immune function patients gastric carcinoma assessed preoperatively results compared patients benign lesions data subjected analysis order evaluate prognostic significance abilities induce allogeneic cytotoxicity produce interleukin il patients stage iv carcinoma significantly depressed compared patients benign lesions whereas natural killer nk cell activity significantly impaired significant correlation among immune functions patients stratified two groups high greater mean value patients benign lesions low less value values immune reactivities survival patients high nk activity greater equal significantly better compared patients low cytotoxicity less however correlation survival allogeneic cytotoxicity patients high ability produce il greater equal u ml correlated better survival patients group patients underwent curative resection,C04,0.0021351157,0.0018939541,0.003983904,0.0011996344,0.04430165,0.002755478,0.09451217,0.0020078886,0.0015435936,0.0020978765,0.011303141,0.025066085,0.24969803,0.048701834,0.0018775668,0.003324819,0.24029252,0.021386297,0.0024311433,0.08904101,0.12680984,0.02142936,0.0022071023
von willebrand factor head neck cancer laboratory abnormalities blood coagulation factors common patients cancer significance unknown twenty eight patients head neck cancer studied time diagnosis twenty five advanced stage iii iv patients levels clotting factors antithrombin iii plasminogen normal levels von willebrand factor vwf antigenic functional ristocetin cofactor elevated group patients followed minimum months median months fifteen patients died within follow period von willebrand factor levels significantly higher survivors extreme elevation ristocetin cofactor greater u dl seen six patients died none survivors plasma vwf elevated head neck cancer level measured time diagnosis may prognostic potentially therapeutic implications,C04,0.0026236936,0.0023273472,0.00489554,0.014074756,0.0036534101,0.0033860132,0.15673159,0.0024673531,0.0018968136,0.002577933,0.05174302,0.068909846,0.09943954,0.07756259,0.027698202,0.0040856367,0.26685405,0.015423289,0.0029874612,0.029384244,0.15764697,0.0009315783,0.0026991593
coexpression patterns vimentin glial filament protein cytokeratins normal hyperplastic neoplastic breast authors studied immunohistochemistry intermediate filament protein profile frozen samples breast tissue including normal parenchyma variants fibrocystic disease fcd fibroadenomas cystosarcoma phylloides ductal lobular carcinomas monoclonal antibodies mabs cytokeratins included mab ka binds polypeptide complex polypeptide recognizes preferentially myoepithelial cells mab ka binds polypeptides individual mabs polypeptides mab mixture ae ae authors also applied three mabs vimentin vim three mabs glial filament protein gfp selected samples studied double label immunofluorescence microscopy staining sequential sections said mabs mab alpha smooth muscle actin well characterized polyclonal antibodies possible coexpression diverse types cytoskeletal proteins gel electrophoresis immunoblot analysis also performed samples reacted cytokeratins mabs ae ae although reaction involve cells monoclonal antibody ka stained preferentially luminal secretory cells normal breast fcd whereas stained vast majority cells carcinomas monoclonal antibody ka stained preferentially basal myoepithelial cells normal breast fcd staining tumor cell subpopulations carcinomas vimentin positive cells found normal breasts fcd cases vim reactive cells appeared myoepithelial occasional luminal cells also stained variable subpopulations vim positive cells noted ductal lobular carcinomas glial filament protein reactive cells found normal breast lobules ducts cases fcd rare exceptions gfp reactivity restricted basally located myoepithelial appearing cells occasional gfp reactive cells found carcinomas evaluation sequential sections double label immunofluorescence microscopy showed coexpression certain cytokeratins possibly including polypeptides vimentin alpha smooth muscle actin together gfp myoepithelial cells presence gfp myoepithelial cells confirmed gel electrophoresis immunoblotting results indicate coexpression cytokeratin vimentin gfp comparatively frequent normal basal myoepithelial cells breast abstract truncated words,C04,0.0014083068,0.0012492384,0.025919033,0.0007912855,0.02921908,0.0018317547,0.2680199,0.028581295,0.014645631,0.008152676,0.08301011,0.0028966179,0.01992333,0.17308545,0.0148343835,0.0021930265,0.016371112,0.07131929,0.0016035644,0.06994947,0.1066857,0.00050003856,0.05780968
cell lineage markers human pancreatic cancer normal pancreas consists three major cell types lineages share common embryologic origin pluripotent endodermal precursors type cell undergoes neoplastic transformation form pancreatic carcinoma controversial may influence phenotype biologic behavior tumor study immunohistologic techniques used determine cell lineage differentiation expressed primary exocrine pancreatic adenocarcinomas five metastatic exocrine pancreatic adenocarcinomas five islet cell neoplasma specimens normal pancreas chronic pancreatitis used comparison cell lineage markers consisted monoclonal polyclonal antibodies trypsin lipase acinar cells secretory component carbonic anhydrase ii pancreatic cancer mucin span ductal cells chromogranin somatostatin islet cells expression carcinoembryonic antigen cea lysozyme also determined collection markers allowed differentiation acinar ductal islet cells normal pancreas chronic pancreatitis specimens expression cell lineage markers islet cell tumors homogeneous restricted chromogranin contrast expression markers primary metastatic exocrine pancreatic adenocarcinomas variable reactivity monoclonal anti cea absent normal pancreas present chronic pancreatitis specimens well exocrine pancreatic adenocarcinomas addition lysozyme reactivity absent normal pancreas however lysozyme expressed one case chronic pancreatitis cases primary carcinoma three cases metastatic carcinoma findings support concept original transformed cell type many pancreatic exocrine carcinomas resemble endodermal stem cells retain capability differentiation along one cell lineage pathway,C04,0.0017255987,0.0015306922,0.018248677,0.00096959807,0.019110253,0.01892001,0.3387291,0.0016227739,0.001247531,0.010011175,0.07222185,0.020255653,0.016220056,0.22818084,0.009842714,0.0026871162,0.01606077,0.0017799481,0.04371771,0.03158701,0.06492977,0.008959119,0.07144199
premorphological metabolic changes human breast carcinogenesis malignant breast tissue characterized morphological metabolic changes compared normal breast tissue study cytochemical measurement glucose phosphate dehydrogenase g pd activity used detect abnormal metabolism breast tissue determine whether abnormal metabolic activity precedes morphological change human breast carcinogenesis normal benign breast tissue morphologically normal tissue cancer containing breasts malignant breast tissue studied malignant tissue mean e g pd activity significantly increased compared normal benign tissue versus mean integrated extinction mie x p less g pd activity increased morphologically normal tissue cancer containing breasts compared normal benign breast tissue breasts known cancer versus mie x p less findings suggest metabolic abnormalities precede morphological changes breast carcinogenesis abnormal metabolism detected widely within cancer containing breast detection abnormality may prove helpful identifying patients high risk developing breast cancer,C04,0.0018823148,0.0016697071,0.0035122042,0.028373828,0.0026210637,0.0024292252,0.1976581,0.0017701515,0.0013608298,0.0018494847,0.058178157,0.04032246,0.1237116,0.034308255,0.0016552601,0.012040579,0.036222667,0.0019560608,0.0021432922,0.1541918,0.28946117,0.0006683416,0.0020134086
prognostic significance ca half life patients ovarian cancer received primary chemotherapy surgical cytoreduction fifty four patients advanced epithelial ovarian cancer monitored serial serum ca levels surgical cytoreduction multi agent chemotherapy cisplatin containing regimens ca half life less days associated prolonged overall survival p less patients eventually found disease free surgical surveillance procedures normalization serum ca levels less u ml within days primary operation also suggested improved survival p less,C04,0.003515944,0.0031188177,0.006619452,0.018989116,0.004895841,0.004537509,0.19209823,0.0033064364,0.002541871,0.0034546214,0.017200418,0.048603863,0.08626814,0.09234209,0.0030918324,0.005475056,0.28107437,0.0036208394,0.0040034195,0.025775848,0.18456972,0.001248384,0.0036481363
malignant rhabdoid tumor liver distinct clinicopathologic entity malignant rhabdoid tumor occurring primary hepatic neoplasm six month old white infant reported treated attempt total resection involving right hepatic lobectomy chemotherapy cis platinum vp adriamycin despite recurrence tumor resulted girl death within three months neoplasm showed typical light microscopic features malignant rhabdoid tumor well filamentous cytoplasmic inclusions electron microscopic examination staining cytokeratin vimentin immunohistochemistry classic clinicopathologic features tumor support concept malignant rhabdoid tumors similar kidney may occur extrarenal sites,C04,0.0039916295,0.0035603042,0.0074479664,0.0022432844,0.12150522,0.04377038,0.32063553,0.04239724,0.022207852,0.0039220103,0.037998393,0.008249955,0.031852797,0.009177988,0.0035105464,0.06368903,0.081224136,0.04022562,0.004545057,0.06995638,0.07236496,0.0014172826,0.004106441
giant cell tumor bone clinicopathologic dna flow cytometric analysis flow cytometric dna analysis performed cases giant cell tumor bone results correlated clinicopathologic features tumors studied men women whose ages ranged years median years common sites distal end femur proximal end tibia accounting lesions treatment consisted resection patients curettage bone chip packing patients curettage cement packing patients ten patients local relapse within years two lung metastases forty two patients exhibited tumors diploid dna content aneuploid two tetraploid six aneuploid patients relapses one treated resection tumor five curettage remaining ten unrelapsed aneuploid patients nine treated resection tumor one curettage four diploid patients relapses treated curettage tumor two tetraploid tumors treated resection none relapsed histologic parameters correlate relapse rate dna pattern although relapse common among aneuploid tumors study shows appears influenced treatment modality rather ploidy status based study dna analysis giant cell tumor bone limited utility predicting tumor biologic behavior,C04,0.03213776,0.0018370337,0.003864173,0.0011635809,0.12319558,0.012696791,0.17597438,0.001947544,0.0014972028,0.012052907,0.121898316,0.014280582,0.02567771,0.047516968,0.0018211389,0.0032248958,0.21683212,0.012759952,0.012370919,0.071935505,0.0566986,0.0007353182,0.047880996
clear cell adenocarcinoma lower genital tract correlation mother recall diethylstilbestrol history obstetrical records written obstetric records maternal exposure diethylstilbestrol des used criterion standard compared des exposure history recalled mothers women vaginal cervical indeterminable vaginal exocervical clear cell adenocarcinoma among cervical cases sensitivity maternal recall n specificity among vaginal vaginal exocervical cases sensitivity specificity majority mothers said take des des positive written records thus investigators avoid using maternal recall alone measure des exposure among subjects written maternal obstetric records available vaginal cases cervical cases des positive authors conclude cases vaginal clear cell adenocarcinoma occur young women cohort women exposed utero des continues age whereas cases cervical origin may continue occur,C04,0.0025914824,0.014841752,0.017377833,0.0014560482,0.0036085572,0.040975776,0.22069615,0.0024370614,0.0018735264,0.0025462836,0.14132124,0.005330184,0.08813361,0.045857143,0.027369164,0.004035477,0.051993117,0.0027060264,0.0029507838,0.2703241,0.04798851,0.00092014123,0.0026660215
upper gastrointestinal pathology familial adenomatous polyposis results prospective study patients multiple gastric duodenal biopsy specimens asymptomatic patients familial adenomatous polyposis taken prospective endoscopic screening programme examined one hundred patients microscopic gastroduodenal pathology often absence macroscopic lesions adenomas found patients duodenum second third parts hyperplasia villous crypt epithelium also seen sometimes absence adenomas may precursor neoplastic change stomach fundic gland polyps commonest abnormality seen microscopically patients chronic antral gastritis common patients without fundic polyps gastric adenomas present six patients also duodenal adenomas duodenal adenomas familial adenomatous polyposis similar malignant potential colorectum sequential endoscopy biopsy necessary detect cancer patients,C04,0.002729814,0.002421481,0.09705883,0.001533771,0.017015548,0.003522967,0.33398187,0.04194095,0.001973534,0.0026822025,0.13922247,0.019060109,0.022356324,0.01949833,0.0024005296,0.004250888,0.20244892,0.0028112556,0.0031082947,0.01915274,0.05704939,0.00096925773,0.002810491
ampullary carcinoma patients years age poor prognosis clinicopathologic features japanese patients ampullary carcinoma compared among three age groups patients divided three groups patient age time operation patients group younger aged less equal years group ii ordinary aged group iii elderly aged greater equal three groups showed significant difference sex icterus duration icterus size tumor year operation macroscopic type histopathologic type tumor margin lymphatic permeation venous invasion pancreatic invasion survival curve group worse groups ii iii multivariate regression analysis using prognostic variables failed reveal age patient time operation independent factor younger patients aged less equal fared worse elderly patients aged greater equal group tumors included significantly greater number advanced ampullary carcinoma frequent perineural invasion group iii tumors,C04,0.0023276242,0.0020647189,0.0043431055,0.0013080409,0.05131355,0.0032135202,0.11468257,0.013449383,0.0016827688,0.0022870277,0.024051221,0.13093999,0.07950201,0.0057368,0.013308196,0.0036269154,0.23852584,0.0023970671,0.013899114,0.22906528,0.036518984,0.023361692,0.002394574
internal mammary chain treatment decrease risk death patients medial breast cancers positive axillary lymph nodes effect internal mammary chain treatment type malignant death related event analyzed patients operable breast cancer histologically involved axillary lymph nodes group patients internal mammary chain treatment compared control group patients treated surgery postoperative radiation therapy multivariate analysis taking account age clinical size tumor histoprognostic grading number positive axillary lymph nodes quantitative interaction tests used determine whether effects internal mammary chain treatment type malignant event significantly different patients lateral tumor compared medial tumor authors found effects treatment risks distant metastases secondary breast cancer patients medial tumor lateral tumor untreated patients medial tumor risks distant metastases second breast cancer respectively p p compared treated patients conversely women lateral tumor difference two treatment groups observed thus internal mammary chain treatment may improve long term survival rate patients medial tumor positive axillary lymph nodes essentially decreasing risk development distant metastases mainly brain distant lymph nodes multiple simultaneous metastases secondary breast cancer,C04,0.010246207,0.001556282,0.003273616,0.0009858237,0.07333714,0.0022642054,0.21612203,0.027128236,0.0012683871,0.0017238472,0.060713764,0.04011394,0.050260678,0.004352787,0.0015428164,0.002732039,0.18487199,0.010277752,0.001997696,0.11406502,0.14411934,0.0006229404,0.046423458
squamous cell carcinoma antigen ta penile carcinoma ta antigen originally isolated women squamous cell carcinoma cervix elevated sera patients squamous cell carcinomas several sites including esophagus lungs head neck study compared serum levels ta normal volunteers patients resected penile squamous cell carcinoma patients metastatic penile squamous cell carcinoma ta values elevated patients metastatic disease ta normal first time metastasis clinically detected rose disease progressed moreover patients serial determinations made serum ta values correlated well disease progression response treatment conclude ta values elevated patients metastatic squamous cell carcinoma penis may become useful marker monitoring response therapy,C04,0.0030489701,0.0027045887,0.0056890617,0.001713092,0.004245594,0.018693876,0.32030284,0.0028672884,0.0022042696,0.002995792,0.043323785,0.0062711486,0.11686744,0.040196314,0.0026811874,0.0047478806,0.14685252,0.0031486421,0.003471701,0.037197445,0.22654983,0.0010825786,0.003144125
cisplatin fluorouracil interaction squamous cell carcinoma xenograft patients squamous cell carcinoma head neck treated cisplatin fluorouracil according schedule based findings clinical studies similar schedule showed supra additive effect treatment xenografted human squamous cell carcinoma head neck sought ascertain whether schedule optimal single intraperitoneal injection cisplatin mg kg combined three injections fluorouracil given hour period total dose mg kg cisplatin administration combined effect cisplatin fluorouracil tumor growth toxic effects schedule dependent consideration toxic effects tumor growth inhibition assessed reduction area growth curve optimal administration interval found fluorouracil given days cisplatin administration,C04,0.0168016,0.0025544008,0.005373144,0.057379995,0.031891525,0.0037163494,0.23665443,0.0027080658,0.002081865,0.0028294337,0.016010012,0.051650807,0.05955662,0.062205765,0.0025324072,0.0044842274,0.0838219,0.0029774474,0.017201325,0.020062422,0.31350613,0.0010224622,0.0029777116
rectal carcinoma ct staging water contrast medium computed tomography ct used study patients rectal carcinoma water used contrast medium studying local extent tumor patients scans read prospectively without knowledge histologic staging compared pathologic specimens ct depicted tumor patients comparison ct histologic results following dukes classification showed disease correctly staged three four patients b eight c nine nine overall carcinoma correctly staged ct patients diagnostic accuracy accuracy assessment local invasion detection lymph node involvement accuracy sensitivity specificity ct recommended preoperative staging rectal carcinoma aid choosing appropriate therapy use water enema complete distention rectum reliable techniques improving accuracy ct assessment local invasion cancer,C04,0.0029622864,0.002627696,0.01986565,0.0016643879,0.047755864,0.0038229849,0.1584303,0.00278577,0.016470844,0.0029106203,0.16718534,0.106475875,0.10092754,0.0068112114,0.016938861,0.047583327,0.18562663,0.003050664,0.003392184,0.042603105,0.056009598,0.0010518003,0.003047491
mammographic measurements augmentation mammaplasty thirty five augmented women underwent mammography using standard implant compression technique possible implant displacement technique preaugmentation film screen mammography available evaluation area mammographically visualized breast tissue augmentation mammaplasty measured using transparent grid patients subglandular implants mean decrease percent measurable tissue area compression mammography percent decrease displacement mammography patients submuscular implants percent decrease measurable tissue area compression mammography percent decrease displacement mammography anterior breast tissue seen better displacement mammography posterior breast tissue compression mammography patients degree parenchymal scarring lower image quality augmentation state art mammography possible patients augmented silicone gel filled implants,C04,0.017052593,0.01672423,0.005454919,0.0016406891,0.03232128,0.017884621,0.14553733,0.002746104,0.0021111073,0.0028691767,0.070577346,0.006006102,0.09581537,0.09374779,0.0025678684,0.004547214,0.19312403,0.0030072262,0.0033249713,0.0821731,0.19672598,0.001036824,0.0030040985
interventional radiology biliary tract intraductal radiation one palliative method treating patients high duct cholangiocarcinoma use ir wire placed tumor previously intubated delivers high local dose radiation mean survival time patients treated intraductal radiation months improvement compared surgical bypass endoscopic radiologic drainage procedures,C04,0.005197567,0.004610501,0.009698121,0.002920301,0.032399476,0.006707731,0.11244494,0.004887855,0.0037576095,0.030221269,0.049063824,0.060998835,0.0835853,0.011950812,0.0045706094,0.008093693,0.35495967,0.005352632,0.0059181945,0.058202647,0.13726102,0.0018454673,0.0053519537
recombinant immunotoxin anti tac fv pseudomonas exotoxin cytotoxic toward peripheral blood malignant cells patients adult cell leukemia anti tac fv pe recombinant single chain immunotoxin containing heavy light variable regions anti tac monoclonal antibody fused mutant form pseudomonas exotoxin pe anti tac binds p subunit human interleukin il receptor anti tac fv pe kills human monkey cell lines contain either intact il receptor p subunit alone assess usefulness anti tac fv pe treatment il receptor positive leukemia tested peripheral blood mononuclear cells six patients adult cell leukemia six patients anti tac fv pe extremely cytotoxic malignant cells metabolic activity sensitivity fresh cells improved small amount il units per ml present incubation toxin concentration necessary inhibit protein synthesis hr incubation cells immunotoxin varied ng ml x every case binding means tac antigen anti tac fv pe cytotoxicity prevented adding excess anti tac antibody moreover anti tac alone inactive mutant anti tac fv pe without adp ribosylation activity little cytotoxic activity peripheral blood mononuclear cells normal controls patient tac negative leukemia adult cell leukemia patients without significant peripheral blood involvement sensitive anti tac fv pe results indicate anti tac fv pe potent cytotoxin adult cell leukemia cells vitro warrants clinical testing,C04,0.0018683203,0.010682441,0.029895259,0.0010480189,0.002597329,0.0024072276,0.13894188,0.0017541222,0.0013485069,0.001832737,0.066171154,0.0038512344,0.10563675,0.19322525,0.001640271,0.011929514,0.07339735,0.10129481,0.002123884,0.031390745,0.16368495,0.0006622895,0.052615978
head neck paragangliomas clinicopathologic study dna flow cytometric analysis total head neck paragangliomas subject pathologic study including histologic immunohistochemical dna flow cytometric analyses cannot absolutely predict aggressive clinical behavior using histologic parameters alone use parameters segregate patients low risk high risk groups several trends observed current study tumors higher phase fractions g fractions aneuploid cell populations tended behave aggressively presence sustentacular cells primary tumors cannot used absolute indicator tumor metastatic potential two metastatic paragangliomas study contained sustentacular cells primary metastatic lesions dna ploidy status cannot used absolute prognostic parameter two metastatic tumors composed diploid primary metastatic lesions three tumors aneuploid cell populations showed aggressive histologic clinical features length follow period cases limited draw conclusions although absolute criteria used present gauge aggressiveness close follow patients essential especially pathologic findings suggest aggressive course ie malignant histology higher phase fractions g fractions aneuploid cell populations decreased sustentacular cell density,C04,0.001917265,0.0017007097,0.0035774175,0.001077233,0.076918446,0.0024743304,0.2699767,0.0018030192,0.0013860973,0.0018838254,0.051869478,0.01322509,0.109875225,0.094583325,0.012120312,0.030828366,0.059704546,0.001974465,0.002183088,0.10850338,0.116881415,0.0006807511,0.03485553
endoscopic ultrasonography evaluation smooth muscle tumors upper gastrointestinal tract experience cases surgery patients suspected leiomyoma patients suspected leiomyosarcoma studied endoscopic ultrasonography eus computed tomography ct endoscopy barium swallow results correlated surgery histology ten leiomyomas one benign gastric ulcer one carcinoid metastasis eight leiomyosarcomas two leiomyoblastomas one mucus secreting adenocarcinoma one bronchial carcinoma diagnosed eighteen additional patients suspected benign submucosal lesions endoscopy barium meal treated non surgically studied eus ct eus superior imaging techniques detection staging follow submucosal smooth muscle tumors clear imaging intramural abnormality adjacent lymph nodes,C04,0.0039164103,0.0034740516,0.0073076156,0.0022004712,0.13817376,0.024006825,0.19606969,0.0036833498,0.0028313904,0.0038481033,0.16693047,0.008055308,0.0355303,0.009005037,0.0034439925,0.0065982947,0.18751979,0.0040332535,0.0044594095,0.04627677,0.118289575,0.0013905751,0.022955604
left ventricular fibroma echocardiographic diagnosis successful surgical excision three cases management three patients left ventricular fibromas outlined asymptomatic children routine chest radiography suggested cardiac masses mode two dimensional echocardiography valuable adjuncts conventional angiography assessing children electrocardiographic changes present cases shown regress postoperatively stress importance noninvasive aids initial investigation outline operative methods reconstruction,C04,0.0039162613,0.0034739194,0.045222986,0.04010913,0.04335197,0.0050541395,0.170038,0.0036828998,0.02176854,0.041766945,0.19084437,0.0080550015,0.031512752,0.009004694,0.041359946,0.0060984334,0.17046092,0.0040331,0.0044592395,0.025680868,0.0678254,0.03930755,0.02297291
cutaneous surgery pregnant patient cutaneous surgery pregnant women described main indication surgery diagnosis treatment malignancy surgery period organogenesis days avoided possible patients positioned left side procedure avoid supine hypotensive syndrome monitoring fetal heartbeat desirable local anesthetics penicillin erythromycin safe used carefully acetaminophen analgesic choice exposure sun avoided perioperative period,C04,0.0045217224,0.02589859,0.008559791,0.0025405714,0.028181244,0.026948905,0.17800125,0.026140634,0.025146265,0.004442858,0.09205918,0.031186298,0.029820975,0.010396836,0.0039762887,0.007041262,0.26895657,0.0046566245,0.005148646,0.14351115,0.06660707,0.0016054993,0.004651781
adjuvant antiestrogen therapy breast cancer past present future laboratory investigations using animal models breast cancer growth indicated antiestrogenic compound tamoxifen tumoristatic agent therefore effective suppressing rather destroying breast tumor use adjuvant breast cancer management successful proportion women benefiting long periods tamoxifen treatment initial studies recruited postmenopausal women tamoxifen proposed treatment premenopausal women extended time naturally many aspects toxicology tamoxifen consider however careful monitoring clinical trials determine safety drug general patient population,C04,0.003640111,0.020845259,0.00686702,0.00204523,0.022690669,0.004697753,0.41309342,0.0034232046,0.0026316382,0.0035766228,0.01938699,0.025098259,0.025594305,0.030469447,0.0032010218,0.00566841,0.12607707,0.003748711,0.039383322,0.1308042,0.10202007,0.0012924712,0.003744812
successful fontan type operation nonresectable right ventricular tumor large intracavitary right ventricular tumor year old patient considered nonresectable involved interventricular septum free ventricular walls tricuspid valve surgical palliation consisted closure tricuspid pulmonary valves right atrium anastomosed pulmonary artery bifurcation patient asymptomatic years operation neoplasm rhabdomyoma increased size,C04,0.1510855,0.004006224,0.008427033,0.0025379132,0.054365497,0.0058405106,0.14865054,0.004348776,0.0032651173,0.004437575,0.04348368,0.009289261,0.030118303,0.0105200615,0.003971561,0.0070328903,0.33910728,0.004651088,0.0051425244,0.034242656,0.11922611,0.0016035904,0.0046462505
reasons mastectomy patients breast reconstruction breast reconstruction mastectomy valuable yet small percentage eligible patients ever reconstruction little done determine patients proceed reconstructive surgery homogeneous population mastectomy patients underwent breast reconstruction others surveyed regarding attitudes breast reconstruction total women surveyed one hundred fifty eight percent responded reconstructed comparison responses two groups suggests factors play role determining whether mastectomy patient accept decline option breast reconstruction considerations made less likely woman would pursue reconstruction included advanced age time mastectomy concern complications surgery uncertainty outcome fear effect reconstruction future problems breast cancer marital status receiving chemotherapy knowing patient bad result reconstruction affect decision awareness understanding factors may helpful physicians counseling patients increasing number women enjoy benefits breast reconstruction,C04,0.0020513176,0.0018196212,0.003827546,0.011074489,0.002856395,0.02244422,0.19965585,0.0117152855,0.0014830114,0.011918155,0.009433872,0.01591419,0.03905157,0.016756369,0.01171606,0.022968672,0.27151427,0.0021125171,0.022192575,0.25858837,0.05806575,0.0007283484,0.0021115919
prognostic factors hepatocellular carcinoma west multivariate analysis patients investigate prognostic factors western patients hepatocellular carcinoma patients confirmed diagnoses hepatocellular carcinoma studied terms survival patients diagnosed multivariate survival analysis cox regression model using clinical biochemical ultrasonographical pathological data obtained diagnosis disclosed bilirubin p ascites p toxic syndrome defined presence weight loss greater premorbid weight malaise anorexia p blood urea nitrogen p tumor size p gamma glutamyltranspeptidase p age p serum sodium p presence metastases p independent predictors survival according contribution factors final model prognostic index constructed allowing division patients different groups according relative risk death rrd exp age x ascites x bun x serum sodium x gamma glutamyltranspeptidase x bilirubin x tumor size x toxic syndrome x metastases x results facilitate stratification hepatocellular carcinoma patients design evaluate future controlled trials,C04,0.0024091676,0.002137052,0.03947377,0.001353613,0.030939069,0.003115987,0.17026675,0.0022656103,0.013377669,0.0023671486,0.081293896,0.016960328,0.073028855,0.007927492,0.037103,0.0037542277,0.157768,0.0024848746,0.014404762,0.21434492,0.119884945,0.00085540785,0.0024834704
effect somatostatin hydroxytryptamine release carcinoid tumor one major manifestations carcinoid syndrome secretory diarrhea thought due overproduction hydroxytryptamine ht synthetic somatostatin analogues proved clinically effective controlling diarrhea established continuous cell line human pancreatic carcinoid tumor secretes ht examined ability somatostatin analogue sms inhibit ht release vitro tumor cells exposed sms mol l pentagastrin mol l acetylcholine mol l isoproterenol mol l alone combination ht release assayed high pressure liquid chromatography found pentagastrin ng ml isoproterenol ng ml acetylcholine ng ml stimulated release ht compared control values ng ml sms significantly reduced release ht response isoproterenol acetylcholine inhibit effect pentagastin data suggest different agents act pathway stimulate ht release human pancreatic carcinoid cells,C04,0.002659032,0.0023570664,0.005204981,0.0014929706,0.0428013,0.003429251,0.23046713,0.0024988602,0.0019210351,0.002610852,0.026928866,0.0055212234,0.06538171,0.12864718,0.002336672,0.0041378085,0.03615541,0.0027364723,0.054462727,0.04958101,0.32498255,0.0009434741,0.0027424616
ige receptor mediated phosphatidylinositol hydrolysis exocytosis rat basophilic leukemia cells independent extracellular ca hypotonic buffer containing high concentration k isotonic buffer ige receptor mediated exocytosis rat basophilic leukemia cells dependent extracellular ca half maximal degranulation requiring mm ca significant exocytosis occurs absence extracellular ca absolute requirement ca eliminated suspending cells hypotonic buffer containing mm k na cannot substitute k optimal ca independent exocytosis occurs buffer containing mm dipotassium pipes ph mm kcl mm glucose mm mg acetate bsa mm egta cells maintain ca independent exocytosis even preincubated mm egta min degrees c triggering exocytosis eliminated isotonicity approached adding sucrose nacl kcl potassium glutamate buffer quin fluorescence measurements reveal small rise ca cells triggered hypotonic buffer absence extracellular ca presence mm egta isotonic buffer degranulation occur conditions lead small rise ca sustained ige receptor mediated phosphatidylinositol hydrolysis also ca dependent isotonic buffer becomes independent ca hypotonic buffer fact rate phosphatidylinositol hydrolysis hypotonic buffer absence ca presence mm egta twice observed isotonic buffer presence mm ca data show hypotonic buffer requirement ige receptor mediated pi hydrolysis extracellular ca eliminated degranulation proceeds ca microm baseline level ca found resting cells results consistent hypothesis isotonic buffer ca requirement mast cell degranulation generation second messengers via hydrolysis membrane phosphatidylinositols,C04,0.0016832786,0.0014931521,0.011308382,0.0009457656,0.002349245,0.026610706,0.23638667,0.0015829756,0.009361577,0.0016539202,0.007800963,0.0034621824,0.14369667,0.26135033,0.0014802328,0.019366844,0.02172841,0.04545966,0.010046899,0.01769532,0.17219868,0.0005976711,0.0017404762
trends basal cell carcinoma squamous cell carcinoma melanoma skin major increases occurred incidence basal cell carcinoma squamous cell carcinoma skin well cutaneous malignant melanoma period british columbia greatest increases basal squamous cell carcinomas head neck indicates exposure sunlight major causative factor greatest increase melanoma trunk men lower limbs women dramatic increases nonmelanoma skin cancers british columbia relatively low sunlight area suggest major prevention programs needed areas considered sunspots,C04,0.003843027,0.022010794,0.0071706898,0.0021592402,0.06116543,0.0049596266,0.20093116,0.0036140291,0.0027783373,0.022376707,0.017673653,0.026507752,0.040522754,0.051764525,0.003379461,0.0059843925,0.04268428,0.0039576804,0.012086333,0.2161121,0.24299993,0.0013645192,0.0039535644
anionic complex carbohydrate units human thyroglobulin human thyroglobulin htg contains sulfate chondroitin sulfate chains complex carbohydrates study sulfate containing complex carbohydrates characterized number sulfate sialic acid residues contain samples normal nodular thyroid tissue incubated h sulfate containing medium htg purified tissues media complex carbohydrates enzymatically removed htg subsequent analysis hplc anion exchange column ph separated carbohydrate units according number negative charges sulfate containing peaks monitored radioactivity sialic acid containing peaks identified shift lower charge treatment neuraminidase peaks corresponding sialic acid free carbohydrate units one four sulfates identified also carbohydrate units two three negative charges containing sulfate sialic acid present nodular tissue one patient sulfated units higher charge especially units containing sialic acid patient proportion sulfated polyvalent units sialic acid normal nodular tissue difference composition charged units tissues corresponding media seen making unlikely sulfate containing carbohydrates play role htg release concluded htg contains complex carbohydrate units four sulfate groups units sulfate sialic acid patients sulfate containing anionic carbohydrate units htg normal nodular thyroid tissue different,C04,0.0018003574,0.0015970068,0.10784355,0.0010115474,0.0025069406,0.002323455,0.18003546,0.0016930779,0.0013015782,0.010463743,0.041042075,0.030683875,0.065290116,0.025761692,0.0015831889,0.0028035308,0.04903827,0.108843915,0.0020499716,0.022940988,0.22878553,0.0006392415,0.10996089
cerebral tumor staging patients bronchial carcinoma computed tomography computerized tomographic ct scans patients histologically proven bronchial carcinoma accomplished initial tumor staging retrospectively evaluated signs cerebral metastasis results histologic subtypes quite different patients small cell carcinoma limited disease authors found signs brain metastasis however routine cerebral staging patients seem useful lack therapeutic consequences hand patient non small cell carcinoma n scc tumor stage ii brain metastases patients brain metastasis n scc classified tumor stage iii cerebral imaging among patients however authors found brain metastasis without known distant metastatic disease iii especially large cell carcinoma adenocarcinoma stage iii patients undergo routine cerebral imaging tumor surgically resectable thoracotomy planned,C04,0.11127954,0.01424428,0.00465858,0.0014027929,0.102505825,0.003222119,0.2043613,0.0023479252,0.0018050016,0.026622476,0.086953335,0.005837971,0.029026438,0.043328196,0.0021955334,0.004045365,0.20415317,0.014635646,0.0028428582,0.047502525,0.08357135,0.00088648684,0.0025712838
local recurrence curative resection colorectal adenocarcinoma total patients colorectal adenocarcinomas operated institution complete follow information obtained six patients available histologic slides reviewed determine pathologic stage characteristics six hundred fifty one patients underwent potentially curative procedure operative mortality rate patients available analysis local recurrence median time local recurrence months local recurrences diagnosed years original resection median survival patients local recurrence years original resection patients survived years longer multivariate logistic regression analysis conducted examine influence several clinical pathologic characteristics local recurrence among dukes stages b c adenocarcinomas n exclusion patients synchronous tumors n postoperative deaths n loss follow n incomplete data n analysis revealed local recurrence rate significantly related depth invasion b c b c p less site origin right plus transverse colon left plus rectosigmoid colon rectum p less lymphatic capillary microinvasion absent present p less analysis attempts identify patients high risk development local recurrent disease select candidates postoperative adjuvant therapy,C04,0.0020306027,0.03113309,0.013558035,0.010929356,0.012959949,0.0027746074,0.21902572,0.021568384,0.0014680353,0.0019951863,0.027578728,0.023835178,0.052232802,0.004714661,0.0017857058,0.0031620706,0.30969062,0.0020976209,0.0023121398,0.17438485,0.06811663,0.010536514,0.0021095467
physical state human papillomavirus dna cervical carcinoma cervical intraepithelial neoplasia cervical carcinomas cervical intraepithelial neoplasias cin analyzed presence human papillomavirus hpv dna using southern blot hybridization five hpv types examined hpv types hpv dna detected frequently hpv positive carcinomas examined hpv dna present integrated state cellular dna without coexistence episomal species one case however episomal species detected among seven cases hpv positive cin four contained hpv dna episomal state rest contained hpv dna integrated state coexistence states found results suggest integration hpv dna necessary cells become malignant although frequently associated malignant cells,C04,0.0036403448,0.0032291675,0.0067925057,0.0020455208,0.005069065,0.0046980544,0.390855,0.0034234244,0.0026318072,0.0035768526,0.116048984,0.0074874936,0.03979644,0.096200995,0.0032012274,0.040912803,0.042342767,0.0037489515,0.004145068,0.028149426,0.10956664,0.0012925542,0.08114491
decreased expression integrin adhesive protein receptors adenocarcinoma breast integrin superfamily represents major class receptors mediating cell substrate adhesion recent study tissue distribution alpha beta integrin cell surface collagen receptor revealed high levels receptor expression associated orderly regulated epithelial cell proliferation observations prompted present investigation alpha beta integrins adenocarcinoma breast alpha beta integrin highly expressed epithelium ducts ductules normal breast tissue normal nearly normal levels receptor expressed fibroadenomas contrast markedly decreased undetectable alpha beta expression typical poorly differentiated adenocarcinomas well differentiated lesions exhibited intermediate levels expression similar less extensive decreases expression observed alpha beta fibronectin receptor alpha v beta vitronectin receptor significant expression beta subunit even poorly differentiated tumors suggests expression undefined members beta family reduced low level alpha beta alpha beta expression alpha beta integrin highly correlated estrogen receptor expression decreased expression alpha beta integrin adhesive protein receptors probably contributes altered adhesive properties tumor cells characteristic malignant phenotype,C04,0.001643104,0.0014573205,0.016275974,0.016824597,0.026785284,0.002120228,0.14231089,0.009488769,0.0011877324,0.009518863,0.007590331,0.0033837717,0.04224971,0.08272147,0.009392512,0.0025583128,0.014308797,0.10797525,0.009812524,0.043706883,0.18265994,0.0005833286,0.26544443
total pelvic exenteration simultaneous bowel urinary reconstruction technique total pelvic exenteration simultaneous bowel urinary reconstruction described surgical option management pelvic sarcoma adults highly selected patients types advanced pelvic malignancy surgical technique presented detail performed year old man presented extensive primitive pelvic sarcoma believe approach may provide benefits exenterative operation without undesirable psychosocial sequelae permanent colostomy external urinary diversion,C04,0.00415246,0.0036834395,0.06805495,0.0023332578,0.025869085,0.005358966,0.2750756,0.003905024,0.0030020438,0.004080036,0.03271522,0.008540818,0.08697032,0.009606567,0.003652036,0.0064662443,0.26389548,0.0042763455,0.04490681,0.08443998,0.053269036,0.0014743877,0.004271898
relation meat fat fiber intake risk colon cancer prospective study among women background rates colon cancer various countries strongly correlated per capita consumption red meat animal fat lesser degree inversely associated consumption fiber methods conducted prospective study among women years old without history cancer inflammatory bowel disease familial polyposis completed dietary questionnaire person years follow incident cases colon cancer documented results adjustment total energy intake animal fat positively associated risk colon cancer p trend relative risk highest compared lowest quintile percent confidence interval association found vegetable fat relative risk colon cancer women ate beef pork lamb main dish every day percent confidence interval compared reporting consumption less month processed meats liver also significantly associated increased risk whereas fish chicken without skin related decreased risk ratio intake red meat intake chicken fish particularly strongly associated increased incidence colon cancer p trend relative risk women highest quintile ratio compared lowest quintile percent confidence interval low intake fiber fruits appeared contribute risk colon cancer relation statistically independent meat intake conclusions prospective data provide evidence hypothesis high intake animal fat increases risk colon cancer support existing recommendations substitute fish chicken meats high fat,C04,0.001533167,0.0013599956,0.03264411,0.00086142396,0.009555728,0.0019786318,0.12217526,0.0014418088,0.0011084115,0.0015064266,0.037137866,0.019355815,0.11093408,0.03135059,0.0087721795,0.06179791,0.09481495,0.0015789077,0.009152712,0.3620201,0.08679824,0.0005443719,0.0015772657
insulinoma streptozotocin therapy metastatic gastrinoma natural history iatrogenic complication islet cell carcinoma frequently produces one chemical product although clinical expression usually restricted single hormone describe unusual patient presented full blown metastasizing gastrinoma treated cimetidine five years streptozotocin therapy resulted regression hepatomegaly fall serum gastrin levels following one year therapy streptozotocin admitted hyperinsulinemic hypoglycemic stupor appears first reported case shift clinical gastrinoma insulinoma possibly related prolonged streptozotocin therapy,C04,0.0037731237,0.003346949,0.0070402576,0.0021199642,0.0052539553,0.0048694126,0.38059905,0.0035482913,0.0027278005,0.0037073155,0.044569727,0.026004681,0.041767105,0.027365707,0.0033179899,0.042399306,0.17649105,0.0038856918,0.004296256,0.034615137,0.15342566,0.0013396991,0.023535876
debulking pelvic para aortic lymph node metastases ovarian cancer cavitron ultrasonic surgical aspirator six patients metastatic ovarian cancer extensive involvement pelvic para aortic lymph nodes underwent surgical debulking cavitron ultrasonic surgical aspirator intraoperative postoperative morbidity minimal suggested technique may used cytoreductive surgery combination standard surgical techniques,C04,0.056932013,0.0047285906,0.0099465195,0.002995099,0.0074815033,0.006879537,0.17949235,0.056617852,0.0038538536,0.0052377186,0.06724196,0.06257726,0.033885166,0.012256909,0.0046876767,0.008311298,0.31816554,0.00548973,0.006069778,0.034114663,0.10565817,0.0018927354,0.0054840203
long survival prognostic factors hepatocellular carcinoma studied survival prognostic factors cases hepatocellular carcinoma seen midwestern teaching hospital cases diagnosed life autopsy males females age diagnosis ranging median survival patients diagnosed life days patients lived longer one year two patients long survivors presumed cured one living years diagnosis surgical treatment years cox regression model showed young age diagnosis low stage disease diagnosis significant predictors long survival white patients survived nearly twice long black patients difference significant gender year diagnosis appear important determinants survival pathologic material still available one two long survivors histology fibrolamellar carcinoma young adults,C04,0.002466834,0.014127725,0.004602856,0.013325923,0.0034349882,0.0031835777,0.10021694,0.0023198405,0.0137235075,0.017989662,0.13384734,0.0051114094,0.033317585,0.006177346,0.026048275,0.0038413734,0.3386196,0.014379438,0.0028088533,0.18466069,0.07238261,0.0008758831,0.002537788
lack relationship perioperative blood transfusion survival time curative resection gastric cancer better comprehend relationship perioperative blood transfusion survival time curative gastrectomy advanced gastric cancer authors reviewed retrospectively data patients treated clinics required blood transfusion required transfusions within perioperative period univariate analysis indicated survival time transfusion recipients significantly less patients transfusions p less subgroups authors patients stratified adjust stage disease however significant difference survival rates subsequently multivariate analysis using cox regression analysis adjusted sex age covariates indicated perioperative blood transfusion useful factor predicting survival time multivariate analysis suggested tumor size p less degree invasion gastric wall p less status lymph node metastasis p less important covariates curative gastrectomy advanced gastric cancer authors findings revealed lack relationship perioperative blood transfusion survival time patients underwent curative resection advanced gastric cancer,C04,0.002030296,0.0018009738,0.0037906768,0.020764764,0.013568317,0.0026202027,0.2604267,0.0019436307,0.0014678136,0.001994885,0.046455342,0.05091668,0.16444421,0.0049062017,0.001785391,0.003161593,0.22730005,0.002092687,0.0023117906,0.12329169,0.06011302,0.0007208843,0.002092243
immunohistochemical differentiation basal cell epithelioma cutaneous appendages using monoclonal anti glycoprotein antibody tnkh application mohs micrographic surgery tnkh primarily developed detect differentiated melanocytic tumor cells found recognize basal keratinocytes hair follicle basal keratinocytes human epidermis thus tnkh decorated basal cells following structures epidermis part specimen opes upper hair follicle one opes lower hair follicle high rate specimen vhes sebaceous duct vhes sebaceous gland ten germinative cells near duct eccrine duct three opes epithelial tumors considered derived differentiating toward hair follicle trichilemmoma one one vhes basal cell epithelioma bce vhes labeled peripheral cells entirety hand epidermal tumors seborrheic keratosis ten opes actinic keratosis two three opes squamous cell carcinoma one two opes showed irregular peripheral basal cell staining normal epidermis apocrine sweat apparatus eccrine secretory portion negative eccrine ductal tumors syringoma two tested eccrine acrospiroma one eccrine carcinoma two tnkh negative taking advantage total labeling bce versus peripheral labeling hair follicle authors could distinguish bce tissue structures clearly among confusing structures upper hair follicle eccrine duct excluded easily negative staining tnkh lower hair follicle tnkh positive outer basal layer whereas bce tnkh positive entire basaloid cells result indicated tnkh useful antibody mohs micrographic surgery,C04,0.0021353425,0.0018941554,0.0039843274,0.011529493,0.044323843,0.013082406,0.18161008,0.01256146,0.0015437576,0.043409742,0.13326144,0.0043919915,0.021335531,0.13685583,0.0018778574,0.013658277,0.061789494,0.0022292482,0.0024314015,0.028877987,0.22746609,0.00075818255,0.04899208
malignant melanoma pigmented lesions diagnostic management dilemma document two cases malignancy occurring site partially removed benign nevi difficulty clinical diagnosis uncertainty behavior propose recurring melanocytic nevus expanding beyond original surgical scar excised specimen carefully analyzed ensure complete removal,C04,0.0065058116,0.00577098,0.012195899,0.0036553503,0.040554214,0.008396089,0.26866463,0.0061181444,0.0047034123,0.006392342,0.1397061,0.013381211,0.040385723,0.046440553,0.0057210466,0.010130902,0.17489384,0.0067367605,0.0074078236,0.046298098,0.13684922,0.0023099773,0.0067818696
inhibition tumor growth glioma model treated boron neutron capture therapy investigation attempts determine whether increased survival time seen f glioma model treated boron neutron capture therapy bnct result inhibition tumor growth caused radiation induced alterations endothelial cells normal tissue components indirect effect radiation called tumor bed effect series tumor bearing rats studied using standardized investigational bnct protocol consisting mg kg na b h sh injected intravenously hours neutron irradiation x n cm ten rats serving controls received treatment either tumor implantation second group rats treated bnct days tumor implantation animals received treatment remaining group rats received pretreatment treated bnct days implantation histological ultrastructural analyses performed animals group days implantation survival times untreated control animals mean days differ statistically survival times rats pretreated group mean days rats treated bnct implantation survived significantly longer p less mean days controls preirradiated animals tumor size indices calculated measurements taken time death similar groups results indicate tumor model bnct cause tumor bed effect cerebral tissue therapeutic gains observed bnct result direct effects tumor cells peritumoral neovascularity,C04,0.0085699875,0.00131082,0.016936209,0.00082467834,0.07565286,0.013761305,0.15564556,0.008475466,0.008148674,0.0014421671,0.011343157,0.10466085,0.070742376,0.03334656,0.0012907172,0.0022910435,0.10356817,0.0015171616,0.0016712685,0.020668365,0.3560975,0.00052115065,0.0015140119
breast cancer dietary plasma concentrations carotenoids vitamin case control study breast cancer conducted buffalo participants completed food frequency questionnaire donated fasting blood sample definitive workup breast masses dietary plasma concentrations carotenoids retinol women found breast cancer compared women found free breast cancer control subjects case control differences dietary estimates vitamin intake plasma alpha carotene lycopene however subjects breast cancer lower concentrations plasma beta carotene control subjects p overall association plasma retinol breast cancer positive relationship observed retinol breast cancer subgroup low beta carotene values results suggest low plasma beta carotene associated increased risk breast cancer studies need determine whether low carotene concentrations subtle effect disease might causally related breast cancer,C04,0.0024089578,0.0021368659,0.02781117,0.0013534952,0.0033543976,0.0031088856,0.10133469,0.002265413,0.0017415693,0.0023669426,0.09626094,0.0053799776,0.14033884,0.0056096814,0.0021183768,0.015403818,0.03816813,0.0024808273,0.002742953,0.19358127,0.30005187,0.0008553334,0.04912556
downstream initiation element required efficient tata box binding vitro function tfiid gfa gene encodes glial fibrillary acidic protein intermediate filament protein expressed glial cells vitro transcription analysis shown human gfa promoter contains two initiation elements independently specify transcription startpoint one elements tata box base pairs bp upstream transcription startpoint located bp downstream transcription initiation site shown transfection elements required efficient transcription cultured cells partially purified natural human tata box binding factor tfiid hela cells gave footprints extended upstream tata box downstream initiator deletion downstream initiator inhibited tfiid binding tata box transcription vitro contrast natural human tfiid clone human yeast tfiids expressed bacteria gave footprints covering tata box region although hypersensitive sites observed downstream region cloned tfiids also showed less dependence natural human tfiid downstream initiator tata box binding vitro transcription results suggest natural human tfiid contains additional component contribute stable tfiid binding effective transcription interacting downstream initiator,C04,0.0023278168,0.0020648898,0.026870482,0.046378754,0.025735142,0.0030041689,0.1959944,0.0021891072,0.0016829079,0.0022872167,0.011583676,0.017535819,0.02785541,0.13013709,0.0020470235,0.003624895,0.024541767,0.1838682,0.002650562,0.06268129,0.109791145,0.0008265232,0.114321716
occurrence beta hexachlorocyclohexane breast cancer patients residues polycyclic aromatic hydrocarbon pah neutral organochlorine compounds breast fat breast cancer patients women free cancer determined statistically significant differences appeared two comparison groups regard occurrence pah compounds neutral organochlorine compounds residues beta hexachlorocyclohexane hch found frequently breast cancer patients adjusting age parity stepwise logistic regression beta hch remained significant risk factor breast cancer using cutoff point residue level beta hch breast adipose tissue mg kg fat odds ratio ci,C04,0.020879956,0.0031737287,0.006675891,0.0020102463,0.0049820384,0.0046173977,0.16210833,0.0033646505,0.01970655,0.0035154447,0.038436804,0.10707096,0.038528338,0.00866316,0.0031462682,0.057520907,0.10014963,0.003684589,0.004073905,0.2432896,0.090167485,0.0012703633,0.07296373
adjuvant chemotherapy breast cancer many women cured breast cancer even best early detection surgical techniques micrometastases present diagnosis adjuvant therapy extended disease free interval patients lengthens overall survival many combination chemotherapy become standard form adjuvant treatment premenopausal women breast cancer positive lymph nodes primary therapy minimal toxicity disease free overall survival improved results less impressive less clear cut postmenopausal women woman negative lymph nodes long term toxicities adjuvant chemotherapy may include second malignancies cardiac dysfunction although complications probably rare must considered seriously weighing chemotherapy patients benefits may slight innovations likely become standard adjuvant therapy decision making include risk assessment new prognostic indicators growth fraction oncogene expression investigation dose intensification using bone marrow growth factors autologous stem cell support,C04,0.0021803551,0.0019340838,0.0040683164,0.011778034,0.0030452218,0.013361575,0.38715765,0.012601341,0.0015762997,0.002142327,0.06350602,0.004484574,0.035711873,0.05415673,0.0137382345,0.003398009,0.16836415,0.012796055,0.002482655,0.0835752,0.10343486,0.00077416486,0.013732214
dioxin inducible ah receptor dependent transcription vitro developed homologous vitro transcription system requires tetrachlorodibenzo p dioxin called tcdd dioxin ii ah receptor iii dioxin responsive enhancer activity unfractionated nuclear extracts mouse hepatoma cells contain inhibitor fail direct transcription vitro however following phosphocellulose chromatography reconstitution fractionated nuclear extract directs accurate transcription vitro using template promoter enhancer region mouse cytochrome p gene cyp linked g free cassette generates transcript guanosine residues extracts tcdd treated cells exhibit higher activity extracts untreated cells transcribing template containing promoter enhancer transcribing template containing promoter alone extracts ah receptor defective cells fail direct vitro transcription tcdd inducible fashion regulatory element contains two binding sites liganded ah receptor plus truncated cyp promoter suffices direct tcdd inducible ah receptor dependent transcription vitro inducible receptor dependent enhancer dependent properties system make appropriate analyzing vitro mechanism dioxin action function ah receptor,C04,0.002252578,0.001998149,0.020545505,0.0012656318,0.0031366437,0.013782987,0.2809279,0.0021183516,0.0016285137,0.0022132902,0.022900479,0.018519107,0.015944052,0.0992667,0.0019808603,0.014409429,0.03724354,0.17343774,0.0025648915,0.06342368,0.10941119,0.00079980865,0.110228956
effects tamoxifen somatostatin analogue growth human medullary follicular papillary thyroid carcinoma cell lines tissue culture nude mouse xenograft studies knowledge normal thyroid contains somatostatin polypeptide growth factors influence thyroid cell function thyroid cells contain steroid hormone receptors prompted us add somatostatin analogue sms ng ml tamoxifen citrate tam mumol l day monolayer cultures cells well three separate human thyroid carcinoma cell lines dr medullary wr follicular npa papillary results tabulated cell numbers well x day revealed tam inhibited growth medullary follicular cells tam plus sms inhibited growth papillary cells vivo studies subcutaneous tumor cell xenografts nude mice documented tam mg subcutaneous pellet significantly inhibits growth medullary implants flow cytometric dna studies medullary cell cultures demonstrated reduced g phase tam treatment papillary cell implants tam plus sms micrograms subcutaneously twice daily suppress tumor growth three cell lines negative estrogen receptor addition estradiol ng ml medullary cell cultures neither stimulated replication reversed inhibitory effects tam vitro conclude tam slowed growth cell line human medullary carcinoma vitro vivo effect reversed estradiol tam plus sms inhibited replication papillary carcinoma cell line vitro vivo tam alone tam plus sms inhibited replication cultures human follicular thyroid carcinoma cell line tam sms may useful treatment human thyroid carcinomas,C04,0.0016972914,0.0015055821,0.011330429,0.00095363875,0.04660874,0.002190443,0.15217622,0.0015961534,0.0012270662,0.0016676885,0.012667011,0.061002214,0.015136409,0.32653642,0.0014925551,0.019070432,0.044425275,0.019884015,0.010704724,0.030654738,0.17814936,0.0006026465,0.05872094
variations sensitivity sectioning intercostobrachial nerve authors present prospective study variations sensitivity appear armpit arm intercostobrachial nerve sectioned modified radical mastectomy total patients studied intercostobrachial nerve sectioned patients whereas remained intact patients peripheral branches nerve sectioned patients examined regular postoperative intervals order evaluate sensitivity touch pain axilla arm four hundred thirty three examinations carried operative groups assessed accordingly nerve sectioned increasing anesthesia armpit hypoesthesia posterointernal face arm patients intercostobrachial nerve remained intact alterations less intense long lasting significant statistical differences two groups also exist absence axillary lymphatic ganglia infiltrated tumor conservation intercostobrachial nerve recommended,C04,0.025066854,0.0024846855,0.06350609,0.0015738049,0.017460264,0.0036149218,0.164932,0.05687232,0.0020250462,0.01629551,0.05170953,0.033460435,0.21699932,0.007259369,0.0024632504,0.018335791,0.16258423,0.0028846338,0.003189426,0.057748146,0.08565821,0.0009945568,0.0028816336
time recovery hypothalamic pituitary adrenal axis curative resection adrenal tumors patients cushing syndrome recovery time hypothalamic pituitary adrenal hpa axis curative resection adrenal tumors patients cushing syndrome poorly documented eight consecutive patients treated standardized hydrocortisone replacement strategy curative resection cortisol secreting tumor time recovery hpa axis determined hypercortisolism documented elevated hour urinary free cortisol levels cure documented undetectable postoperative morning serum cortisol levels patient received replacement hydrocortisone surgery reevaluated every months adrenocorticotrophic hormone acth stimulation test patient also monitored carefully symptoms signs adrenal insufficiency defined symptoms consistent diagnosis responded increases hydrocortisone levels surgical resection patient cured hypercortisolism subsequently despite replacement hydrocortisone patient symptoms hypocortisolism four eight patients dose hydrocortisone increased relieve symptoms patients required median time months range months recover normal acth stimulation test months range months allow discontinuation replacement doses hydrocortisone results suggest surgical resection cortisol secreting adrenal tumor result rapid cure hypercortisolism complete recovery hpa axis discontinuation replacement steroids require years normal adrenal function assessed cortisol response acth returns despite replacement doses hydrocortisone replacement doses hydrocortisone tapered rapidly discontinued normal acth stimulation test,C04,0.008322361,0.0012750878,0.009857565,0.028640188,0.029837206,0.0018551011,0.14392683,0.0082852775,0.0010392107,0.01104115,0.035551958,0.0030357377,0.011351593,0.003352637,0.0012640553,0.002238405,0.3085356,0.001481212,0.0016367456,0.009486546,0.37599632,0.00051038543,0.0014787932
multiple spinal metastases paraganglioma isolated vertebral body metastases paraganglioma exceedingly rare reported occur presence active primary tumor neck local recurrence widespread metastases unique case carotid body tumor paraganglioma reported following features multiple vertebral body metastases c l presenting spinal cord compression evidence local recurrence metastatic disease absence mitoses original specimen metastatic deposit prolonged interval years development symptomatic metastases,C04,0.004615879,0.004094515,0.008612752,0.0025934742,0.051120248,0.0059570326,0.36442268,0.049029253,0.0033370752,0.0045353724,0.10920595,0.0094939815,0.029472364,0.0110534355,0.07077108,0.007187884,0.13106394,0.00475359,0.0052558575,0.0385634,0.078472644,0.001638931,0.004748646
liver transplant metastatic neuroendocrine tumor generally results liver transplantation metastatic liver disease favorable one exception unique group neuroendocrine tumors slow growth allows liver transplantation effectively palliate control symptoms report two cases year old man underwent orthotopic liver transplantation resection pancreatic primary tumor nonfunctioning malignant neuroendocrine tumor features carcinoid islet cell glucagonoma remains symptom free without evidence tumor recurrence months follow b year old man underwent orthotopic liver transplantation whipple resection metastatic islet cell tumor head pancreas fully recovered months follow,C04,0.020532887,0.003119085,0.0065609487,0.0019756346,0.10703443,0.0045378977,0.24212526,0.0033067195,0.0025420887,0.0034818184,0.0339697,0.025608577,0.048212305,0.05915248,0.0030920974,0.038360484,0.22338769,0.0036211496,0.038031645,0.05943515,0.06704605,0.0012484909,0.0036173833
dacron fabric enveloped hydroxyapatite prosthesis sternal tumor defect autopsy report year old housewife solitary plasmacytoma manubrium underwent subtotal sternectomy treated resection lesion reported followed replacement dacron fabric enveloped hydroxyapatite prosthesis dacron fabric sutured surrounding tissues clavicle passed cylindrical shaped dacron fabric form sternoclavicular joint capsule patient returned daily life months operation trouble daily living without dislocation sternoclavicular joints displacement artificial sternum autopsy examination year operation showed dacron fabric enveloping artificial sternum became stronger time sternoclavicular joint also stably fixed dacron fabric fulfilled function artificial articular capsule biologic fixation surrounding supporting tissues,C04,0.0039918288,0.003540951,0.06539916,0.021543644,0.06349041,0.005151663,0.19061995,0.0037539639,0.0028859144,0.003922206,0.038007103,0.008210429,0.02705396,0.01002636,0.0035103133,0.0062722294,0.24511412,0.0041109216,0.004545284,0.07401292,0.1690775,0.0014173533,0.04434179
characterization vitro human tumor necrosis factor binding protein soluble form tumor necrosis factor receptor tumor necrosis factor tnf pleiotropic mediator inflammatory responses cysteine rich highly glycosylated kd tnf binding protein tnf bp purified urine may role regulation protects vitro biological effects tnf cytotoxic effect tnf fibrosarcoma cell line wehi inhibited fold excess tnf bp binding tnf receptor partially reversed addition tnf bp results biosynthetic labeling cells cysteine followed immunoprecipitation anti tnf bp indicated tnf bp formed released cell surface cleavage corresponding cellular polypeptide observed cellular kd polypeptide immunoprecipitated anti tnf bp may correspond transmembrane tnf receptor molecule precursor tnf bp thus tnf bp appears soluble form transmembrane tnf receptor moreover results demonstrate production tnf bp increased tnf receptor downregulated cells treatment tnf activation protein kinase c phorbol esters tnf bp may important agent blocks harmful effects tnf therefore useful clinical applications,C04,0.00213536,0.0018941708,0.017634634,0.0011997717,0.002976498,0.002755793,0.25140062,0.0020081182,0.0015437701,0.0020981166,0.0102911685,0.014718391,0.013726066,0.11057022,0.0018777816,0.024584716,0.024506463,0.13229683,0.0024314213,0.027229272,0.17085159,0.14548044,0.03578879
results stereotactic brachytherapy used initial management patients glioblastoma recent studies shown survival benefit patients recurrent glioblastomas treated stereotactic brachytherapy basis encouraging results began prospective study evaluate use brachytherapy patients newly diagnosed glioblastoma patients considered eligible study met following criteria karnofsky performance status greater tumor size greater cm dimension radiographically well delineated supratentorial lesion involving ependymal surfaces pathologically confirmed glioblastoma treated patients stereotactic brachytherapy part initial therapy treatment protocol involved surgery partial brain external beam radiotherapy gy fractions stereotactic brachytherapy temporary high activity iodine sources giving additional gy tumor bed chemotherapy used initial management patients compare results obtained matched control group identified patients glioblastoma treated surgery external radiotherapy without chemotherapy institution patients clinical radiographic characteristics would made eligible brachytherapy protocol survival rates years diagnosis respectively patients receiving brachytherapy versus respectively controls p less conclude stereotactic brachytherapy improves survival patients glioblastoma incorporated initial treatment approach unfortunately one four patients glioblastoma suitable candidates brachytherapy time initial presentation,C04,0.010513967,0.0015969436,0.006683861,0.0010115074,0.02970279,0.01973068,0.27018952,0.0016930109,0.0013015268,0.0017688868,0.03829769,0.021908991,0.07961405,0.0103060035,0.001592234,0.00280342,0.34124252,0.0018554911,0.0020498906,0.094796315,0.05884943,0.0006392162,0.001852068
selection breast preservation therapy primary invasive breast carcinoma breast preservation treatment primary breast cancer used women women frequently excluded consideration treatment choose may elderly concerned cosmetic appearance live distance weeks daily trips radiotherapy would inconvenient even impossible also radiotherapeutic expertise facilities available breast preservation program difficult massachusetts full course cgy cgy whole breast cgy local boost costs roughly thus breast preservation expensive mastectomy even reconstruction patients still frequently require hospital admission general anesthesia axillary dissection although insurance policies cover expenses patients insurance inadequate coverage may find extra expense breast preservation technique burdensome impossible women small breast proportionately large cancer may unsatisfactory cosmetic outcome appropriate lumpectomy cosmetic result patients frequently cannot predicted beforehand fact adds emphasis need two step process lumpectomy evaluation cosmetic outcome well pathologic features decisions regarding breast preservation finally women may strikingly different attitudes toward breast preservation expected surgeon women urge preserve breast strong accept virtually risk achieve option whereas women constant anxiety recurrence undergoing radiation therapy traumatic enough readily accept mastectomy referral surgical oncology practice roughly patients currently treated breast preservation techniques remainder undergo mastectomy immediate reconstruction approximately three fourths cases proportion patients elect breast preservation depends greatly local medical customs attitudes radiotherapeutic skills available women attitudes frequently dependent local press publicity surgeon interest enthusiasm program appropriate proportion patients treated breast preservation techniques clearly proportion patients treated increases experience acceptability publicity availability thus selection breast preserving therapy individual patients result extraordinary array factors need considered patient abstract truncated words,C04,0.0012465044,0.013172385,0.02644149,0.00070036,0.0077746487,0.0076292264,0.22664991,0.007199279,0.00090116716,0.028661355,0.034597393,0.02669843,0.02337448,0.010134166,0.0010961446,0.044393137,0.16709775,0.0012836929,0.02163222,0.27691832,0.07067287,0.0004425884,0.0012824768
van nes tibial rotationplasty functionally viable reconstructive procedure children tumor distal end femur twelve patients malignant tumor distal end femur treated van nes tibial rotationplasty survival rates comparable knee amputees patients endoprosthetic replacement results functional testing showed patients performed well endoprosthetic replacement better knee amputation rotationplasty therefore favorable alternative amputation endoprosthetic replacement either primary salvage procedure,C04,0.00483185,0.0042860922,0.009015731,0.0027148195,0.053512137,0.006235754,0.19463262,0.0045439303,0.0034932126,0.028139368,0.04769757,0.009938193,0.0322402,0.011109916,0.004249007,0.0075241956,0.4225297,0.0049760044,0.0055017723,0.033646666,0.1024948,0.0017156143,0.004970829
computed tomography metastatic cervical lymph nodes clinical computed tomographic pathologic correlative study retrospective comparative study neck dissections undertaken evaluate accuracy high resolution computed tomography ct detection nodal metastases previous studies indicated trend toward superiority ct scanning palpation respective values neck examination ct scanning histopathologic examination assessed patients head neck cancer underwent total neck dissections overall agreement clinical examination findings histopathologic findings vs ct scanning retrospective analysis ct findings failed reveal greater accuracy found nodes measuring mm central low density always malignant ct scanning seems offer little advantage palpation nonirradiated neck regarded essential tool staging nodal disease radiation therapy neck dissection performed clinical radiologic suspicion ct scanning utmost importance,C04,0.0028792622,0.0025540492,0.0053724046,0.015541056,0.04581465,0.003715838,0.31088644,0.058459267,0.0020815786,0.0028290444,0.13031761,0.019859605,0.074975766,0.0066473326,0.030473512,0.018417556,0.1088521,0.0029651627,0.0032784636,0.07396222,0.07612749,0.0010223214,0.002967302
serologic determinants survival patients squamous cell carcinoma head neck specific circulating serum proteins may reflect unique properties governing growth progression head neck cancers one hundred three previously untreated patients squamous cell carcinoma head neck prospectively evaluated serum iga igg igm c q binding macromolecules immunoglobulins assessed immunoturbidimetric technique c q binding macromolecules c qbm measured utilizing iodine assay zubler et al j immunol neither level serum immunoglobulins c qbm values correlated primary site ajc american joint committee cancer stage disease size primary lesion likewise comparison serum iga c qbm values demonstrated laboratory parameters independent variables r pearson linear regression univariate statistical analysis utilizing cox proportional hazard model showed serum iga c qbm values contribute significantly ability predict survival patients advanced squamous cell carcinoma head neck p respectively furthermore multivariate analysis reveals c qbm serum iga levels contribute significantly hazards model beyond staging predicting survival p less predictive results apparent patients stage iv disease related probability regional distant metastatic recurrences conversely serologic analysis provided information patients staged early results support pretreatment multiparametric serologic analysis patients squamous cell carcinoma head neck,C04,0.0019722732,0.0017495048,0.006804239,0.0011081399,0.014713427,0.0025453214,0.23974481,0.0018547496,0.0014258658,0.0019378742,0.08537215,0.04468286,0.098415144,0.042466737,0.0017343673,0.0030783394,0.1447739,0.032660715,0.011775682,0.038353726,0.22008902,0.0007002826,0.0020408484
invasive papillary carcinoma breast mammographic appearance mammographic findings patients invasive papillary carcinoma studied retrospectively mammograms patients showed multinodular pattern seven patients solitary nodules one patient irregular ill defined mass retroareolar region two patients found carcinoma contralateral breast two patients intraductal carcinoma adjacent invasive papillary carcinoma varied mammographic features may occur rare breast malignancy discussed,C04,0.004721665,0.0041883523,0.031664096,0.025487104,0.006574769,0.0060935547,0.26786837,0.050152853,0.0034135536,0.004639313,0.1279732,0.009711563,0.029666062,0.01093137,0.004152113,0.0073526143,0.18296358,0.004862532,0.00537631,0.10377682,0.10182779,0.0016764917,0.0049259006
regional systemic distribution anti tumor x anti cd heteroaggregate antibodies cultured human peripheral blood lymphocytes human colon cancer xenograft anti tumor antibody g covalently coupled anti cd antibody okt produces heteroaggregate ha antibody target pbl lyse tumor cells expressing appropriate tumor ag v p distribution radiolabeled ha antibody g x okt radiolabeled cultured human pbl studied athymic nude mice bearing solid intraperitoneal tumor established human colon tumor line ls mice injected labeled ha antibody labeled anti tumor mab labeled pbl designated timepoints tissues harvested measured radioactivity g x okt localized specifically tumor sites tumor radioactivity levels percent injected dose gram lower g x okt ha antibody g anti tumor mab similar levels reported anti tumor mab major difference radioactivity levels observed v p administration g x okt increase hepatic radioactivity v ha antibody administration ha antibodies produced f ab fragments exhibit decreased w decreased fc receptor mediated binding demonstrated improved tumor tissue ratios compared intact antibody ha g f ab x okt f ab antibody levels equivalent intact ha antibody levels tumor lower intact ha antibody levels blood bowel liver tumor bowel ratios h highest g f ab x okt f ab injected p autoradiography confirmed anti tumor x anti cd ha antibodies localized specifically intraperitoneal tumor p administered ha antibodies penetrated tumor directly v administered ha antibodies distributed along tumor vasculature cultured human pbl distributed moderate concentrations intraperitoneal tumor administered p administered v poor localization v injected pbl tumor may reflect species disparity homing receptors endothelial ligands problem may overcome syngeneic model results suggest regional therapy ha antibodies pbl may offer advantages systemic therapy initial clinical trials,C04,0.0012143883,0.0069224536,0.0022916961,0.00067991874,0.120025836,0.0015617268,0.12874104,0.0069858395,0.00087486504,0.0011890169,0.011760299,0.041455396,0.05957034,0.19492997,0.0010641516,0.019255864,0.034729283,0.036365513,0.018935073,0.022634871,0.27404475,0.0004296707,0.014338015
contamination peripheral blood stem cell harvests circulating neuroblastoma cells peripheral blood stem cells pbsc used one alternative autologous marrow rescue patients neuroblastoma solid malignancies physicians prefer use pbsc less risk tumor contamination believed exist hypothesis evaluated immunocytologic analysis blood samples concurrently drawn bone marrow bm samples pbsc harvests obtained patients disseminated neuroblastoma found circulating neoplastic cells specimens analyzed diagnosis therapy pbsc harvests tumor cells blood obtained therapy appear months time diagnosis clearance circulating neuroblastoma cells documented two courses induction chemotherapy six patients minimal bm disease positive blood specimens conclude substantial risk tumor contamination pb harvests exists recommend induction chemotherapy administered hematopoietic progenitor cells collected blood,C04,0.0024375657,0.0021622423,0.0045482446,0.0013695688,0.03879631,0.0031458056,0.13144092,0.0022923162,0.0017622515,0.0023950515,0.15690567,0.00509715,0.11823363,0.09518087,0.0021435337,0.027548049,0.13300334,0.014306173,0.002775527,0.0858074,0.16524781,0.000865491,0.0025350626
characteristics duodenal wall gastrinomas fifteen patients duodenal wall gastrinomas dwgs zollinger ellison syndrome treated since patients dwgs recognized operation totally excised four patients tumor subsequently found proximal duodenum surgical specimens patients dwgs single lymph node metastases present three patients dwgs multiple lymph node metastases present two dwgs submucosal located first second portions duodenum except one found fourth portion tumor size ranged mm nine less mm patients single dwgs remained eugastrinemic resection mean follow years none patients multiple dwgs became eugastrinemic surgery dwgs characteristically single small microscopic submucosal located proximal duodenum rarely metastasize liver usually curable surgical resection,C04,0.003049214,0.002704805,0.0056895167,0.0017132289,0.03559893,0.0039351694,0.19146313,0.002921428,0.002204446,0.017744519,0.10882064,0.00627165,0.031366773,0.007090574,0.0026814018,0.018529275,0.306601,0.0031649836,0.0034719785,0.039477013,0.16864309,0.001082665,0.035774637
significance positive margins oral cavity squamous carcinoma three hundred ninety eight consecutive previously untreated patients undergoing surgery epidermoid carcinoma oral cavity reviewed one hundred twenty nine patients classified positive surgical margins patients tumor within mm surgical margin premalignant changes margin situ carcinoma margin invasive cancer margin remaining patients uninvolved margins significance positive margins relating survival subsequent clinical course local recurrence patterns treatment failure examined along impact adjuvant postoperative radiotherapy positive margins percentage patients positive margins progressively increased increasing stage versus primary cancer overall year survival patients negative margins patients positive margins year survival difference statistically significant incidence local recurrence patients positive surgical margins twice much negative margins versus metastasis rates neck distant sites significantly influenced status surgical margin patients positive margins received postoperative radiotherapy patients treated trend toward lower recurrence rates noted differences statistically significant retrospective review confirms importance adequate resection primary tumor well relative ineffectiveness adjuvant postoperative radiotherapy improvement local control patients positive surgical margins,C04,0.0019352178,0.011084169,0.012976768,0.0010873199,0.021431793,0.011856083,0.13891879,0.011181618,0.0013990763,0.0019014651,0.07751306,0.03998298,0.066099316,0.004524451,0.011065672,0.0030135366,0.4010798,0.0020005263,0.018497083,0.06632975,0.093442716,0.0006871255,0.0019916706
human basophils express interleukin receptors interleukin il multipotential lymphokine reputed play important role regulation immune responses interacts variety hemopoietic target cells specific cell surface membrane receptors present study designed investigate whether human basophils express il binding sites purpose basophils enriched homogeneity purity respectively peripheral blood two chronic granulocytic leukemia cgl donors using cocktail monoclonal antibodies moabs complement purified basophils bound radiolabeled recombinant human rh il specific manner quantitative binding studies scatchard plot analysis revealed presence single class high affinity il binding sites sites per cell donor sites per cell donor apparent dissociation constant kd x x x mol l respectively ku f human basophil precursor cell line found express single class high affinity il binding sites kd x mol l change numbers binding constants il receptors found exposure ku f cells rhil potent activator basophils minutes effect rhil h thymidine uptake release synthesis histamine expression basophil differentiation antigens bsp cd b cd cd cd primary human cgl basophils ku f cells observed,C04,0.0019535287,0.0017328775,0.03276622,0.0010976081,0.002728305,0.0025265198,0.23048687,0.0018371221,0.0014123144,0.0019194568,0.013894662,0.014034548,0.05615357,0.1926273,0.030068018,0.021949189,0.017577637,0.17038035,0.00222438,0.032880224,0.12186695,0.0006936271,0.04718873
doxorubicin unresectable hepatocellular carcinoma prospective study addition verapamil prospective study conducted assess safety efficacy addition oral verapamil intravenous adriamycin doxorubicin management patients unresectable hepatocellular carcinoma hcc patients studied histologically verified disease cirrhosis present patients adequate tissue sampling overall median survival days chemotherapy terminated seven patients one course treatment partial response complete response noted four patients one patient respectively among patients evaluated side effects related chemotherapy present patients studied death fulminating sepsis occurred three patients leukopenia symptomatic myocardial dysfunction developed one patient addition verapamil apparently potentiate tumoricidal effect systemic adriamycin hcc probably increase complications,C04,0.0027635552,0.0024514112,0.0051565072,0.0015527289,0.003848163,0.01693534,0.25601274,0.0025988808,0.0019979274,0.0027153553,0.028552156,0.019582555,0.054901175,0.0064353817,0.0024302006,0.00430343,0.35097593,0.01620241,0.003146714,0.023305347,0.19030781,0.000981238,0.0028430435
long term follow patients undergoing radical resection ampullary carcinoma potentially curative radical pancreaticoduodenectomy ampullary adenocarcinoma performed patients year period overall operative mortality actuarial survival rate years standard error mean sem subsequently remained unchanged time period patients underwent potentially curative radical pancreaticoduodenectomy periampullary tumors pancreatic origin similar analysis showed overall operative mortality survival rate years sem results radical pancreaticoduodenectomy ampullary carcinoma recent years compared former years statistically significant differences year survival rate however operative mortality decreased former period recent period survival dependent nodal status year survival rate sem absence nodal metastasis versus sem presence regional nodal metastasis findings support concept radical pancreaticoduodenectomy offers realistic probability cure selected group patients carcinomas ampulla vater,C04,0.0023284866,0.0020654837,0.0043447143,0.035104744,0.014514317,0.014262835,0.24615473,0.002189737,0.0016833921,0.0022878747,0.024980608,0.029491534,0.024418565,0.005596772,0.013095956,0.0036259377,0.3609438,0.0023979552,0.01390427,0.14454956,0.048831362,0.00082676095,0.002400633
granular cell tumor esophagus endoscopic ultrasonographic demonstration endoscopic removal yr old japanese man granular cell tumor esophagus removed endoscopic polypectomy presented radiography endoscopy showed x mm sessile protrusion distal esophagus endoscopic ultrasonography demonstrated hypoechoic mass submucosa without continuity muscularis propria lesion successfully treated endoscopic polypectomy without complications cross sections resected specimen quite agreement ultrasonographic findings endoscopic ultrasonography valuable assess exact location extent tumor determine indication endoscopic polypectomy,C04,0.0047217705,0.004188446,0.031664804,0.0026542004,0.09818075,0.028942136,0.30819768,0.027293757,0.0034136297,0.0046394165,0.070126675,0.00971178,0.031902805,0.05657508,0.004152206,0.030206313,0.0823127,0.0048626405,0.00537643,0.05458443,0.12972127,0.0016765291,0.0048945406
comparison conventional method lymph node staging comprehensive fat clearing method gastric adenocarcinoma discrepant results long term survival united states japanese patients resectable gastric adenocarcinoma may result accurate staging japanese series authors compared comprehensive fat clearing method conventional pathology method lymph node sampling patients undergoing curative gastrectomy extended lymphadenectomy institution comprehensive fat clearing doubled total lymph node counts p less identified smaller lymph nodes p less identified histologically involved nodes significantly smaller size p less comprehensive fat clearing pathologically upstaged authors eligible specimens accurate pathologic staging necessary comparing japanese united states survival data resectable gastric adenocarcinomas,C04,0.0028794084,0.002554179,0.0053726775,0.015515688,0.004047945,0.0037160264,0.18495014,0.0027078304,0.002081684,0.0028291878,0.21536952,0.005922497,0.10753544,0.006671816,0.0025321785,0.07415365,0.18152744,0.016882608,0.00327863,0.08932738,0.06615945,0.0010223733,0.002962229
carboplatin childhood brain tumors children cancer study group phase ii trial october march children cancer study group institutions entered patients recurrent brain tumors phase ii trial carboplatin mg every weeks complete partial responses observed one evaluable children brainstem glioma two ependymoma six medulloblastoma central nervous system primitive neuroectodermal tumor pnet none high grade astrocytoma children medulloblastoma ependymoma central nervous system pnet five prior cisplatin exposure responses two prior cisplatin exposure responses p thirty four percent patients absolute neutrophil count nadirs less microliters platelet count nadirs less microliters sixteen percent moderate severe otoxicity nausea vomiting none nephrotoxicity,C04,0.032116618,0.002667016,0.03421403,0.0016892933,0.047853455,0.003880191,0.17428407,0.0028274553,0.0021736475,0.061177224,0.05802039,0.064406484,0.04859925,0.036010366,0.0026439396,0.033790156,0.14727986,0.003096313,0.03253354,0.0363661,0.17020994,0.0010675391,0.0030930927
haemangiosarcoma maxillary antrum angiosarcomas extremely rare head neck histological diagnosis often difficult present case haemangiosarcoma maxillary antrum year old male histological diagnosis subsequent management discussed,C04,0.007443398,0.0066026654,0.013888608,0.0041821417,0.010364695,0.009606092,0.34280363,0.043030743,0.005381245,0.0073135756,0.17824242,0.015309647,0.046075996,0.017114671,0.006545536,0.0115909185,0.07213955,0.0076654656,0.008475403,0.083680995,0.09224221,0.0026428802,0.007657493
cytomegalovirus brain vitro infection human brain derived cells models human cytomegalovirus hcmv brain infection developed variety brain derived cells factors governing virus infectivity might studied vitro studies initiated brain endothelial cells likely portal entry virus central nervous system primary explant cultures brain endothelial cells derived homogenates healthy human brain supported complete viral gene expression cytopathic effect cpe endothelial cells appear barrier hcmv passage central nervous system astroglial lines primary explant tumor derived varied ability support hcmv replication g supported incomplete immediate early gene expression others support detectable gene expression astroglial lines hs supported extensive virus replication minimal viral cpe neuronal cell lines sk n mc fully permissive differentiated glial lines astrocytoma fully permissive hcmv infection however less differentiated glial lines glioblastoma partly nonpermissive,C04,0.07226831,0.001837455,0.003865059,0.011183117,0.033907015,0.0026732783,0.30902612,0.033224784,0.0014975461,0.002035294,0.00954575,0.0042605195,0.032581825,0.13073234,0.0018215565,0.013219818,0.05564665,0.00216671,0.002358619,0.014928813,0.118922226,0.0007354868,0.1415617
posttranslational gastrin processing depends tumor morphology extracellular matrices recently demonstrated alter cell morphology culture altered cell morphology associated changes gene transcription translation known whether also affects posttranslational processing using tyrosine sulfation marker processing studied effects various substrates biologically active gastrin irg production sulfation gastrin containing tumor cells gt cells dispersed gt cells plated onto different substrates incubated culture media days assayed specific antibodies recognize total irg nonsulfated irg cells cultured plastic dried films laminin collagen matrigel collaborative research inc lexington mass flattened formed monolayers gt cells cells cultured porous membrane hydrated gels collagen matrigel flatten formed spheroids gt cells monolayer cultures showed increase sulfation time decrease irg production spheroid cultures maintained constant level sulfation time exception matrigel gel also showed decrease irg production results indicate level sulfation unchanged original tumor cells grown spheroids increased cultured monolayers appears alteration cellular milieu alters colony morphology turn alters gastrin processing,C04,0.00193566,0.001717027,0.041086487,0.019824695,0.030829487,0.02122113,0.25520787,0.0111424,0.0013993961,0.0019018997,0.049512193,0.003981283,0.061747678,0.24294466,0.0017022463,0.0030199464,0.01903148,0.01213044,0.0022040338,0.014007714,0.14968313,0.00068728253,0.053081863
prognostic indicators invasive breast cancer tumor size axillary lymph node involvement primary determinants clinical course patients receptors estrogen progesterone important additional prognostic factors disease free survival overall survival survival time initial disease recurrence likelihood response hormonal therapy histologic grading merit prognostic factor although poor reproducibility limits broad application promising data emerging use flow cytometry analyze dna content proliferative rate patients aneuploid tumors likely shorter survival time patients diploid tumors high phase fraction also identifies subset patients increased risk early relapse combined index ploidy phase may useful guide together diploidy low phase identify subgroup node negative patients low risk disease recurrence number oncogenes identified breast cancer amplification neu gene overexpression gene product may important prognostic indicator node positive patients,C04,0.0021575193,0.0019138274,0.014446578,0.0012122222,0.03643835,0.0027843912,0.2670973,0.0020289575,0.0015597905,0.0021198895,0.07094418,0.0047891657,0.033679433,0.0071633267,0.053309344,0.055580664,0.1946623,0.012665287,0.0024566532,0.115120105,0.09246283,0.00076605676,0.024641827
leiomyoma digital artery benign soft tissue masses hand common vascular leiomyoma unusual tumor smooth muscle origin year old man tumor arose within digital artery persistent symptoms prompted excisional biopsy requiring resection portion artery adequate collateral circulation preempted need vascular graft vascular repair grafting may necessary collateral circulation adequate,C04,0.068605766,0.0039203283,0.051034242,0.002483144,0.07033952,0.04848654,0.1891351,0.047801744,0.0031951112,0.004369953,0.020324847,0.009090093,0.07011422,0.010856331,0.025260378,0.006882101,0.16040273,0.0045513655,0.0050322656,0.088082775,0.10391559,0.0015692085,0.004546632
node negative breast cancer prognostic subgroups defined tumor size flow cytometry adjuvant systemic therapy women node negative breast cancer easily justified patients highest risk relapse examined impact tumor size histologic grade estrogen receptor er status tumor ploidy phase fraction spf relapse free survival rfs patients node negative breast cancer order identify groups patients high low risk relapse patients small tumors less equal cm significantly better rfs larger tumors p remaining relapse free years patients tumors less equal cm thus excluded analysis attempting define group poor prognosis within group patients tumors greater cm tumor ploidy p er status p progesterone receptor pgr status p predict rfs patients grade infiltrating ductal tumors significantly better prognosis grade tumors p prognostic factor gave widest separation subgroups however spf patients whose tumors greater cm spf less equal year rfs compared year rfs spf greater p combined tumor size spf identify three prognostic groups tumor less equal cm year rfs tumor greater cm plus spf less equal year rfs tumor greater cm plus spf greater year rfs prognostic groupings may help identify patients suitable adjuvant therapy,C04,0.0015679464,0.001399169,0.0029256253,0.00088096515,0.12832202,0.01615882,0.112846114,0.0014745158,0.0011335554,0.010023748,0.062994465,0.044619452,0.18970303,0.0042714155,0.03893909,0.010028729,0.19109051,0.009203829,0.0018912003,0.118366644,0.049986146,0.0005567208,0.0016162292
trabecular merkel cell carcinoma two cases trabecular cell carcinoma skin presented clinical presentation behavior histologic findings tumor described surgical excision primary lesion regional lymph node dissection indicated treatment choice distant metastasis treated local irradiation,C04,0.005943945,0.005272576,0.011090785,0.0033396604,0.12337772,0.0076709706,0.29871532,0.005589758,0.0042972076,0.005840275,0.055946678,0.040996946,0.03679411,0.100164935,0.0052269553,0.009255959,0.14173676,0.006121278,0.0067680557,0.03808569,0.07953901,0.002110479,0.0061149118
immunohistochemical demonstration placental form glutathione transferase detoxifying enzyme human gliomas expression human placental form glutathion transferase gst pi human gliomas investigated immunohistochemical methods result compared normal human glial cells gliomas study composed five benign astrocytomas grade ten anaplastic astrocytomas grade glioblastomas grade normal human glial cells showed weak immunostaining response gst pi cytoplasm nuclear membranes benign astrocytomas diffusely weak gst pi immunostaining resembling normal glial cells increasing grade gliomas showed strongly positive reaction gst pi positive reactions remarkable especially gemistocytes giant cells high grade gliomas results suggest cells gliomas detoxifying function expression detoxifying enzyme gst pi related degree malignancy gliomas,C04,0.019851785,0.003016729,0.022968365,0.0019108023,0.021136941,0.004388982,0.21713968,0.0031982062,0.035336375,0.0033415407,0.055982206,0.006994911,0.054056495,0.1963577,0.019429222,0.00529584,0.031208385,0.0035065396,0.0038723748,0.028358387,0.21508811,0.0012075204,0.046352923
endothelin like immunoreactivity human breast cyst fluid immunoreactive endothelin detected samples breast cyst fluid cases pmol l mean sem cases detectable less pmol l fast protein liquid chromatographic analysis immunoreactive endothelin pooled breast cyst fluid showed two immunoreactive peaks one void volume position endothelin probable endothelin produced epithelial cells lining breast cysts significance presence endothelin breast cyst fluid remains elucidated,C04,0.004152836,0.0036837724,0.0077487607,0.02243035,0.026384491,0.06564696,0.17970659,0.003905377,0.0030023153,0.004080405,0.10498761,0.00854159,0.08560406,0.07442943,0.0036518988,0.02656206,0.038842708,0.025936214,0.0047286144,0.13065831,0.16952318,0.0014745211,0.004317944
low dose preoperative radiation postpones recurrences operable rectal cancer results randomized multicenter trial western norway randomized multicenter clinical trial conducted western norway study effectiveness preoperative radiation therapy operable rectal cancer given dosage cgy fractions weeks radical surgery three hundred nine patients entered trial may december radiation tumor seen patients increased morbidity mortality surgery year survival evaluable patients control group radiotherapy group patients operated cure year survival control group radiotherapy group respectively radiation significantly delayed local distant recurrences patients radiation group curative resection months controls months local recurrence rate corresponding groups respectively conclude higher preoperative radiation doses used new trials higher dosage may transform observed positive effects survival benefit,C04,0.0023542924,0.01348159,0.0043928656,0.012717844,0.014675185,0.014417771,0.12914447,0.002214005,0.0017020486,0.013707299,0.024333468,0.13882974,0.10263862,0.017586088,0.0020955114,0.003666123,0.25550637,0.002424531,0.056857035,0.030633148,0.15336406,0.0008359237,0.0024220091
role ultrasound guided fine needle aspiration biopsy diagnosis hepatocellular carcinoma cases hepatocellular carcinoma ultrasound showed high sensitivity identifying focal liver lesions fine needle aspiration biopsy guided ultrasound yielded pathological diagnosis majority cases advantages technique high diagnostic yield low cost render older technique blind percutaneous biopsy using coarse needle obsolete laparoscopy retains essential role selected cases complementary use fine needle aspiration biopsy ultrasound guidance laparoscopy assures highest rate diagnostic accuracy hepatocellular carcinoma confirm poor sensitivity alpha fetoprotein,C04,0.0034007686,0.0030166516,0.10512639,0.0019107532,0.037643936,0.0043888693,0.1744063,0.003198124,0.0024586043,0.003341455,0.29100585,0.0069947313,0.027829755,0.007819418,0.0029905501,0.037736416,0.06083191,0.0035181004,0.020328201,0.14659706,0.05075008,0.0012074894,0.0034985854
expression placental alkaline phosphatase gastric colorectal cancers immunohistochemical study using prepared monoclonal antibody authors developed monoclonal antibodies moab human placental alkaline phosphatase plap four specific moab reacting plap two nonspecific moab reacting equally isozymes alkaline phosphatase hepatic intestinal placental obtained immunohistochemical staining specific moab showed cell membrane cytoplasm cancer cells stained gastric colorectal carcinoma incidence plap positivity gastric carcinomas among gastric carcinomas positivity highly differentiated carcinoma papillary adenocarcinoma well differentiated tubular adenocarcinoma significantly higher rate found poorly differentiated carcinoma poorly differentiated adenocarcinoma signet ring cell carcinoma five incidence plap positivity four colorectal carcinoma contrast gastric adenoma intestinal metaplasia noncancerous tissue adjacent cancer show staining results indicated expression plap apt occur highly differentiated gastric carcinoma highly specific carcinoma gastrointestinal tract although incidence high,C04,0.002919966,0.0025901555,0.03368265,0.0016406098,0.00406596,0.0037683682,0.4213291,0.0027459713,0.044471785,0.0028690381,0.038221557,0.0625605,0.033446353,0.08027031,0.0025677443,0.018669793,0.027552234,0.00309558,0.0033248106,0.108706445,0.06572378,0.0010367738,0.034740485
hbv dna sequences tumor nontumor tissue patient fibrolamellar variant hepatocellular carcinoma one patient fibrolamellar variant hepatocellular carcinoma found seropositive hbsag anti hbe dna tumor nontumor areas liver examined molecular hybridization hepatitis b virus dna sequences undigested dna tumor gave high molecular weight smear restriction enzyme analysis indicated single instance integration nontumor liver tissue analyzed three separate areas hepatitis b virus dna detected two restriction enzyme digestion suggested contained different sites viral integration typical hepatitis b virus related hepatocellular carcinoma analysis hepatitis b virus dna nontumorous liver yielded different pattern high molecular weight bands indicating virus genome integrated different chromosomal locations seen tumor finding integrated hepatitis b virus dna especially tumorous also nontumorous liver would consistent oncogenic role hepatitis b virus certain instances fibrolamellar tumors typical hepatitis b virus related hepatocellular carcinoma,C04,0.0020513185,0.001819622,0.0038275477,0.0011525523,0.08230024,0.0026473335,0.11789561,0.021782579,0.0014830121,0.002015541,0.028898064,0.0042697466,0.01321805,0.016098784,0.011716373,0.062421083,0.037408795,0.0021197023,0.002335728,0.12614228,0.22554034,0.00072834874,0.23212734
primary leiomyoma liver yr old woman right upper quadrant abdominal pain found hepatic leiomyoma youngest patient rare tumor found diagnostic approach toward gastrointestinal leiomyomata emphasized including role immunohistochemistry,C04,0.0063071284,0.005594738,0.011768447,0.0035437183,0.039316215,0.008139678,0.2720929,0.09848763,0.004559773,0.0061971243,0.09596218,0.012972558,0.039042283,0.047489293,0.0055463295,0.070254125,0.093474664,0.0064952965,0.0071815937,0.07654993,0.080296375,0.0022394322,0.006488541
treatment advanced neuroblastoma emphasis intensive induction chemotherapy report study group japan one hundred nine newly treated patients advanced neuroblastoma entered study january may eligible patients included infants younger months age stage iva disease bone cortex distant lymph node remote organ metastases patients aged months older stage iii iv disease iva plus ivb tumor crossing mid line metastases confined bone marrow liver skin patients first received six cyclic course intensive chemotherapy regimen consisting cyclophosphamide mg vincristine mg tetrahydropyranyl adriamycin pyrarubicin mg cisplatin mg original tumors regional lymph node metastases removed time first six cycles chemotherapy patients divided three groups patients course received alternating treatment regimen b cyclophosphamide acnu intensified regimen course treated alternating administration regimen c cyclophosphamide dtic intensified patients course treated bone marrow transplantation bmt preceded high dose preconditioning chemotherapy survival rates stage iii stage iv years stage iii stage iv years major toxicities encountered bone marrow suppression leukocyte counts mm mild cystitis hearing impairment year survival rate patients underwent bmt complete remission achieved concluded intensive induction chemotherapy significant value increasing rate complete response widening indications achieving improved results treatment bmt,C04,0.009663386,0.0014691148,0.027115569,0.01014646,0.026587274,0.0021373872,0.1999262,0.0015574922,0.0011973447,0.0016272946,0.016236728,0.049764384,0.030790485,0.019805653,0.0014564033,0.026320742,0.33387187,0.02575548,0.0018858052,0.0758645,0.13452291,0.00058804953,0.0017094773
vaccination tumor cells expressing breast cancer epithelial tumor antigen ninety one percent breast tumors aberrantly express epithelial tumor antigen eta identified monoclonal antibody h vaccinia virus recombinants expressing tumor antigens considerable promise active immunotherapy cancer evaluated potential vaccinia recombinants expressing secreted cell associated transmembrane forms h eta elicit immunity tumor cells expressing eta tumorigenic ras transformed fischer rat fibroblast lines fr fr expressing form h eta respectively constructed use challenge experiments expression h eta lines confirmed western blotting immunofluorescence challenged subcutaneous seeding tumor cells fr fr syngeneic fischer rats rapidly developed tumors failed regress vaccination recombinant vaccinia virus expressing eta prior challenge prevented tumor development animals seeded fr cells animals seeded fr vaccinia recombinant expressing form less effective immunogen vaccination protected animals developing tumors upon challenge either fr cells increased immunogenicity recombinant expressing eta reflected elevated levels eta reactive antibody vaccinated animals confirming secreted antigens expressed vaccinia virus less effective immunogens membrane associated counterparts,C04,0.001991564,0.011405898,0.013355269,0.020395854,0.101206526,0.012193561,0.21346381,0.0018728907,0.001439812,0.0115858205,0.022870347,0.016034117,0.04090788,0.21268182,0.001751331,0.003101279,0.045065373,0.0022058014,0.0022676885,0.033894476,0.12119596,0.000707132,0.10840581
characterization significance sulfonylurea receptors study describes characterizes putative sulfonylurea receptor radioligand used h glipizide ci mmol beta cell plasma membranes derived transplantable rat insulinoma generated subcutaneous injection rinm f cells purified ultracentrifugation sucrose gradient specific binding h glipizide purified beta cell plasma membranes determined maximal temperatures degrees c ph incubation h scatchard analysis indicated single binding site kd nm sulfonylurea binding pmol mg membrane protein displacement h glipizide purified beta cell plasma membranes various sulfonylureas analogues correlated well known hypoglycemic insulin releasing activities various agents including nutrients agents affecting ca flux gastrointestinal hormones pancreatic hormones effect h glipizide binding beta cell plasma membranes putative sulfonylurea receptors beta cell brain cell plasma membranes reported several groups investigators sulfonylurea binding beta cell hypothesized close atp sensitive k channel leads depolarization membrane activation voltage dependent ca channel,C04,0.011858045,0.0018010532,0.07248144,0.0011407908,0.0028272474,0.012425658,0.20871529,0.0019096758,0.011292969,0.001994973,0.0110734645,0.053285703,0.045823086,0.1446394,0.0017854697,0.012987618,0.027603336,0.11053928,0.012121628,0.013840835,0.16304843,0.0007209161,0.07608367
photodynamic therapy treatment squamous cell carcinoma head neck photodynamic therapy experimental modality tumor treatment based combined action tumor localizing agent ie hematoporphyrin derivative red light patients treated using hematoporphyrin derived drugs nm light delivered tunable dye laser patients biopsy proved squamous cell carcinoma head neck either failed traditional treatment modalities refused conventional therapies histological complete responses achieved patients partial responses patients periods months minimal toxic reaction noted group guide treatment planning patient group large tumors used optical dosimetry model based tissue optics rate complete responses treatment data indicate photodynamic therapy capable inducing significant clinical histological responses majority treated patients prolonged response produced certain select head neck malignancies photodynamic therapy important role treatment modality,C04,0.0023812589,0.0021122952,0.015967477,0.0013379322,0.03796233,0.0030731384,0.26661998,0.0022406077,0.0017215441,0.0023397265,0.08116284,0.039472666,0.016352221,0.0055428776,0.002094019,0.003710078,0.23718216,0.0024709208,0.0027114134,0.03242379,0.22560242,0.00084549846,0.014672774
growth cultured human cerebral meningiomas inhibited dopaminergic agents presence high affinity dopamine receptors found microm concentrations dopamine agonist bromocriptine significantly decrease proliferation rate human meningioma cells culture inhibition effect also seen direct application dopamine well dopamine agonist skf applied microm concentrations meningioma cell cultures receptor studies dopamine ligand sch dopamine antagonist indicated dopamine binding sites present membranes meningioma tissue mean dissociation constant kd sem pm receptor density bmax sem fmol mg pellet protein human meningiomas pharmacological specificity proven skf skf butaclamol inactive isomers skf butaclamol fold excess results provide evidence human meningiomas possess high affinity dopamine receptors dopamine agonists antiproliferative effect tumors culture conclude proliferation cerebral meningiomas may dopaminergic control dopamine agonists may role medical treatment patients meningiomas,C04,0.038288813,0.002188086,0.017808342,0.0013859381,0.015375906,0.015110901,0.23808025,0.0023197145,0.0017833143,0.0024236776,0.02409707,0.0051102014,0.04325135,0.16944312,0.0021691537,0.016256547,0.040528532,0.107421815,0.0028087008,0.054910645,0.1958106,0.00087583554,0.0025514693
impact u preventive services task force guidelines cancer screening perspective national cancer institute u preventive services task force evaluated medical literature utilizing strict criteria judge merits experimental trials designed show benefit screening cancer individuals normal risk task force able make recommendations screening colorectal prostate skin oral testicular cancers one physical examination cancer screening procedure ever tested randomized trial past years national cancer institute nci funded six randomized screening trials thus far one shown decrease mortality recognizing limitations trials nci published working guidelines early cancer detection designed practicing physician guidelines based upon best available evidence judgment representatives medical professional organizations,C04,0.002692171,0.015418532,0.031062705,0.001512621,0.016780682,0.0034980483,0.18607268,0.0025317501,0.0019463197,0.002645216,0.16995557,0.108398244,0.037021596,0.006333822,0.002367427,0.04327608,0.06270063,0.0027950844,0.10173537,0.10510818,0.0924218,0.000955892,0.0027696062
rapid inactivation phosphorylation pyroglutamyl peptidase ii human retinoblastoma cells exposure phorbol ester pyroglutamyl peptidase ii ec membrane bound metalloproteinase highly specific trh degrading enzyme exposure human retinoblastoma cells tetradecanoyl phorbol acetate tpa decreased activity enzyme time concentration dependent manner ic x min tpa treatment pyroglutamyl peptidase ii activity remained tpa treatment affect activity cytosolic enzyme pyroglutamyl peptidase ec membrane bound enzyme dipeptidyl peptidase iv ec pretreatment cells protein kinase c inhibitors h sphingosine prevented inactivation pyroglutamyl peptidase ii tpa time course tpa mediated effect paralleled time course translocation activation protein kinase c cell line immunoblot analysis demonstrated inactivation pyroglutamyl peptidase ii due dissociation internalization enzyme molecule incubation tpa activated cell membranes gamma p atp followed immunoprecipitation revealed time dependent phosphorylation kilodalton subunit pyroglutamyl peptidase ii studies indicate phorbol ester effect mediated protein kinase c reveal mechanism potentiation action trh target sites,C04,0.002694841,0.0154227195,0.04424344,0.0015129646,0.00377325,0.003475176,0.31417936,0.0025323252,0.0019467619,0.002645817,0.025529392,0.005538539,0.033790514,0.11333084,0.002367965,0.0042395457,0.045746017,0.09212553,0.0030661288,0.020667303,0.2574336,0.0009561092,0.0027818976
cancer prevention reminder system cancer prevention reminder system computer based system designed increase delivery periodic health maintenance procedures program provides printed reminders identify patients overdue procedures prints summary reports percentage patients eligible overdue procedure prints mailing labels patients performed randomized controlled trial effects computer based reminders compared two interventions among residents university based group practice,C04,0.0039917273,0.04218818,0.026732914,0.002242789,0.005558354,0.005187667,0.25065956,0.0037538689,0.04152403,0.0039221067,0.031020597,0.073656976,0.059544787,0.028486924,0.0035102244,0.0062159495,0.18876825,0.0041108173,0.07392448,0.05551089,0.08396502,0.0014173173,0.004106542
alterations opioid parameters hypothalamus rats estradiol induced polycystic ovarian disease distribution density selectively labeled mu delta kappa opioid binding sites examined vitro radioautography hypothalamus normal estradiol valerate ev injected estradiol e implanted female rats hypothalamic beta endorphin concentration also examined ria three groups animals quantitative analysis film radioautographs demonstrated selective increase mu opioid binding medial preoptic area ev treated e implanted rats however estrogenized groups exhibited reduction density delta opioid binding suprachiasmatic nucleus statistically significant changes either estrogenized groups observed kappa opioid binding results hypothalamic concentration beta endorphin indicated marked reduction ev injected animals respect controls contrast e implanted animals exhibited beta endorphin concentrations similar controls present results confirm increase opioid receptor binding previously reported hypothalamus ev treated rats demonstrate increase confined medial preoptic area exclusively concerns mu opioid receptors concomitant reduction beta endorphin levels observed group animals suggests observed increase mu opioid binding could reflect chronic regulation receptor response compromised beta endorphin input given restriction effect site origin lhrh neurons demonstrated inhibitory role opioids lhrh release tempting postulate regulation could lead suppression plasma lh pattern characterizes polycystic ovarian disease ev treated rat,C04,0.0015921951,0.0014123565,0.022121651,0.00089458947,0.0022173163,0.0020548108,0.14282763,0.0014973196,0.0011510862,0.0015644252,0.007816647,0.059622284,0.011513528,0.046877418,0.0014001362,0.026082,0.0180033,0.1114256,0.0018129484,0.041532613,0.4762863,0.0005653306,0.01972852
lymphokine activated killer lak cells v mercaptoguanosine il sparing agent lak generation guanine ribonucleosides substituted c position either bromine thiol group recently shown regulate several immunologic responses previously shown mercaptoguanosine mg replace requirement cytokines generation mhc restricted ctl paper examined ability mg induce mhc nonrestricted killer cells found mg induce significant lytic activity normal resting lymphocytes however mg able synergize minimal amounts il inducing lytic activity similar lymphokine activated killers lak nk sensitive nk resistant tumor cells killed precursors effectors mg lak activity similar nk cells cd cd asialo gm nk similar il induced lak mg lak b mg appeared stage precursor lymphocytes become responsive il optimal induction mg lak required preincubation mg addition il staging appeared due release second signal since readily inhibited cyclosporine anti ifn alpha beta efficient cyclosporine inhibiting mg lak generation whereas anti ifn gamma anti il exhibit significant inhibition findings suggest mg possible utility il sparing agent lak generation nk cells,C04,0.013004836,0.0019548086,0.044691395,0.0012381797,0.035058346,0.024163472,0.25177833,0.012728488,0.0015931906,0.002165283,0.011777922,0.015358151,0.031169958,0.08915504,0.0019378947,0.014146878,0.034096148,0.013686229,0.013164887,0.015174672,0.3474695,0.0007824605,0.023703927
pharmacokinetics plasminogen activator inhibitor rabbit pharmacokinetics activated latent forms plasminogen activator inhibitor pai isolated ht fibrosarcoma cells ht pai nonglycosylated form human pai isolated yeast expression system rpai followed rabbit assessed immunologic assay specific human pai guanidine hci activated ht pai rpai entered total plasma volume following intravenous bolus administration exhibited biphasic clearance pattern ht pai initial beta phases equalled minutes respectively rpai initial beta phases equalled minutes respectively similar results obtained measuring pai activity plasma trace amounts rpai suggesting pharmacokinetic behavior could also apply endogenous pai liver main site rpai clearance unactivated latent pai exhibited different pharmacokinetic profile latent rpai cleared circulation within minutes minutes difference clearance behavior activated latent pai may related ability activated pai latent pai rapidly form high molecular weight complexes plasma binding factors observed vitro vivo pai could potentially tilt fibrinolytic balance toward prothrombotic state rapid clearance may represent important control mechanism governing circulating levels key component fibrinolytic pathway,C04,0.0018653467,0.0016546556,0.023209943,0.0010480622,0.002597436,0.011429988,0.2101547,0.0017541946,0.0013485625,0.0018328127,0.010706387,0.004597167,0.108884856,0.102386616,0.0016403754,0.038781244,0.055754516,0.06758921,0.0021239715,0.014794818,0.30278414,0.0006623168,0.032398663
campylobacter pylori interactions gastric cell tissue culture many investigators reported gastric mucosal biopsies patients chronic gastritis peptic ulcer disease show presence campylobacter pylori large majority cases histologic examinations tissues indicate close approximation c pylori gastric surface epithelial cells recent report described adherence cell invasion gastric cells c pylori using transmission electron microscope examined interaction c pylori c jejuni e coli vitro gastric cancer cell line kato iii results indicate marked toxicity e coli moderate toxicity c jejuni kato iii cells c pylori minor effect tissue culture viability c pylori found strong association kato iii cell membranes evidence occasional cell invasion c jejuni e coli showed attachment association kato iii cells interpret findings indicating c pylori may specific adhesion gastric cells,C04,0.002382243,0.013636785,0.053214636,0.02438241,0.014896454,0.003074409,0.39122197,0.0022402904,0.013138979,0.0023406937,0.035883635,0.026879633,0.014809007,0.20581158,0.0020948844,0.0037275115,0.04232282,0.0024533155,0.0027125343,0.077025406,0.062453743,0.000845848,0.0024512138
interaction trimethoprim sulfamethoxazole methotrexate children leukemia trimethoprim sulfamethoxazole tmp smx causes neutropenia children leukemia investigated possibility pharmacokinetic interaction methotrexate mtx tmp smx causes accumulation antileukemia agent studied pharmacokinetics mtx given intravenously orally nine children acute lymphoblastic leukemia without tmp smx increase free mtx fraction tmp smx therapy patients mean sd without tmp smx tmp smx p less plasma clearance total mtx change significantly whereas clearance free mtx decreased significantly ml kg min p less consistent decrease renal clearance free mtx ml kg min p less elimination half life mtx affected significantly tmp smx significant correlation serum concentrations tmp smx percentage decrease renal clearance free mtx r p less changes protein binding tubular clearance mtx caused competition tmp smx result mean increase systemic exposure mtx may explain myelotoxicity often observed coadministration two drugs,C04,0.0024374404,0.013947601,0.004548011,0.0013694983,0.0033940584,0.0031456437,0.18647256,0.0022921984,0.0017621609,0.0377955,0.011397912,0.0050751693,0.23957275,0.022291863,0.0021629778,0.0038043077,0.03313585,0.026108969,0.0027753843,0.032463815,0.36067328,0.0008654465,0.0025075488
importance calcium regulation toxic cell injury studies utilizing technology digital imaging fluorescence microscopy regulation ions within cell critical importance acute chronic toxicology recently new methods developed measuring changes living cells correlating studies structure function biochemistry major revolution occurred linkage computer light microscope resulted use digital imaging fluorescence microscopy video intensification microscopy coupled image analysis methods already yielded much additional information anticipated application pathologists toxicologists continue uncover important role ion deregulation toxic cell injury,C04,0.033060342,0.017713197,0.0057746973,0.0017388784,0.04925525,0.003994085,0.2996824,0.0029104487,0.047178835,0.018017476,0.08362001,0.006854906,0.05438888,0.12341596,0.032683495,0.049760997,0.0321217,0.003187198,0.0035239593,0.022695284,0.08832677,0.0010988741,0.018996304
oral contraceptives breast cancer review meta analysis evaluate relation use oral contraceptives incidence breast cancer authors reviewed epidemiologic literature used quantitative methods summarize data study results use oral contraceptives pooled using model accounted interstudy intrastudy variability authors also explored interstudy variability modeled duration effect relation oral contraceptive use breast cancer case control follow studies considered separately overall authors observed increase risk breast cancer women ever used oral contraceptives even long duration use results consistent across study design however data combined case control studies revealed statistically significant positive trend p risk premenopausal breast cancer women exposed oral contraceptives longer duration risk predominant among women used oral contraceptives least years first term pregnancy relative risk confidence interval additional study required determine whether finding subgroup exposed women confirmed whether risk remains increased advancing age,C04,0.0021133067,0.0018746085,0.024392758,0.0011873809,0.0029533016,0.0027364867,0.20981915,0.0019873793,0.0015278267,0.002076448,0.13965861,0.0048560076,0.03307088,0.004889407,0.0018583885,0.0032908581,0.066159874,0.0021823845,0.0024063105,0.296694,0.19134018,0.00075035845,0.002174092
photopheresis treatment cutaneous cell lymphoma investigated use extracorporeal chemotherapy photopheresis eight patients cutaneous cell lymphoma initially described edelson et al treatment erythrodermic cutaneous cell lymphoma expanded treatment include patients extensive patch plaque disease well tumor stage disease four five patients erythrodermic stage disease either complete partial clinical remission photopheresis alone one patient extensive patch plaque disease continued partial clinical remission months duration photopheresis alone two patients tumor stage disease one remained without evidence clinical disease months photopheresis alone whereas second patient partial clinical remission months combination local radiation therapy followed monthly photopheresis skin biopsy specimen obtained patient tumor stage disease complete clinical remission show cutaneous cell lymphoma conclude photopheresis effective modality alone combination adjunctive therapy erythroderma extensive patch plaque disease tumor stage disease,C04,0.0021575692,0.0019138716,0.0040258006,0.0012122502,0.088808574,0.013151516,0.3768258,0.0020290043,0.0015598265,0.0021199386,0.024445713,0.014878108,0.014206277,0.046741933,0.001897312,0.0033597841,0.27871296,0.0022219387,0.00245671,0.014766798,0.09952257,0.00076607446,0.0022196276
growth factor dependent differentiation along myeloid lymphoid lineages immature acute lymphocytic leukemia bone marrow cells child immature cd cd cd acute lymphocytic leukemia cultured presence absence human ril il granulocyte macrophage gm csf cells cultured without growth factors failed divide initiated presence il gm csf underwent maturation terminal lymphoid myelomonocytic differentiation respectively contrast permanent growth factor dependent cell line designated tall established upon culture il tall cells gradually lost cell specific markers acquired myeloid phenotype cd cd switching il dependent cells early passage medium containing human ril resulted establishment subline named tall lymphoid phenotype cd cd tcr gamma delta cd tall cells strictly require il growth irreversibly committed lymphoid lineage cannot survive presence hemopoietic growth factor tested far contrast il dependent tall cells could adapted grow synthetic serum free medium also presence either gm csf il retain myeloid phenotype interestingly mo culture il tall cells still phenotypically converted lymphoid lineage upon addition il thus maintaining bipotentiality despite marked phenotypic differences tall tall cell lines show karyotypes multiple abnormalities present primary malignant clone identical rearrangements tcr gamma delta loci thus confirming derivation common precursor cell together findings indicate phenotype immature cells drastically modified presence specific hemopoietic growth factors environment leading either lymphoid myeloid lineage commitment leaving karyotype genotype intact,C04,0.0016857486,0.0014935081,0.027144836,0.0009459911,0.010521081,0.010301187,0.33810115,0.009731902,0.009107221,0.010759645,0.024828719,0.012215811,0.05548827,0.2368395,0.0014805857,0.00262184,0.03053509,0.011438211,0.026359476,0.019994369,0.079160824,0.0005978136,0.07864722
new type bcr abl junction philadelphia chromosome positive chronic myelogenous leukemia new rare type bcr abl junction exon c portion bcr gene abl exon identified leukemic cells two ph positive chronic myelogenous leukemia patients chronic phase fourth type bcr abl junction far identified ph positive hematologic malignancies consequence unusual breakpoint position chromosome falls approximately kb downstream major breakpoint cluster region bcr bcr gene new hybrid mrna base pairs bp longer expressed k cell line could codify bcr abl protein carrying additional aminoacids respect larger p protein far identified hematologic phenotype expressed two patients carrying unusual type bcr abl rearrangement significantly differ commonly seen chronic myelogenous leukemia,C04,0.0028051217,0.002488283,0.0052340664,0.047732543,0.017630426,0.0036201559,0.3127768,0.016213562,0.0020279782,0.0027561968,0.08202761,0.005769839,0.04164225,0.055946257,0.0024667534,0.017944803,0.049300432,0.08436279,0.0031940436,0.07404981,0.09267209,0.0009959968,0.07634217
use molecular cloning methods map distribution epitopes topoisomerase scl recognized sera scleroderma patients report initial molecular characterization autoimmune response dna topoisomerase topo scl sera patients scleroderma healthy control subjects studied using subcloned portions topo twenty three sera recognized least independent epitopes molecule therefore anti topo like non organ specific autoantibodies characterized date polyclonal multifocal cloned protein prove suitable sensitive early detection anti topo clinical setting,C17,0.0034574512,0.0030669319,0.022266354,0.0019426008,0.038280625,0.004462021,0.309176,0.003251429,0.0024995834,0.0033971488,0.08792882,0.0071680085,0.08081386,0.0089716315,0.0030403954,0.0056805955,0.07303852,0.06577803,0.003936817,0.05697825,0.1913569,0.0012276153,0.022280453
spinal synovial cyst case report using magnetic resonance imaging case year old woman developed spinal synovial cyst l disk space reported clinical signs symptoms presented comparison among preoperative myelogram computed tomography scan magnetic resonance imaging showed magnetic resonance imaging accurate detailing intraoperative pathological findings,C17,0.00562068,0.0049858238,0.010487606,0.0031580308,0.17715824,0.0072537805,0.29380667,0.032489054,0.0040635015,0.0055226483,0.11267205,0.0115606645,0.042479623,0.012923679,0.004942684,0.008752568,0.103336886,0.0057883686,0.006399971,0.06616203,0.072657414,0.0019956992,0.005782348
cicatricial pemphigoid identification two distinct sets epidermal antigens iga igg class circulating autoantibodies patient severe cicatricial pemphigoid demonstrated vivo bound circulating anti basement membrane zone antibodies iga igg classes complement component c also deposited basement membrane zone lesional skin well normal appearing buccal mucosa patient however c q absent granular deposits two factors alternative complement activating pathway properdin properdin factor b present basement membrane zone lesional skin normal buccal mucosa deposition alternative complement pathway reactants lesion suggests complement activation iga associated lesion development western blot analysis patient serum electrophoresed cultured keratinocyte antigens identified two distinct sets epidermal antigens igg bound antigens kd patient iga antibodies bound distinct set antigens kd potential pathogenic role iga cicatricial pemphigoid discussed,C17,0.0024111918,0.002137081,0.051242918,0.04184092,0.026706662,0.04970524,0.18964201,0.0022656412,0.013385302,0.0023671808,0.013898166,0.051598273,0.016365344,0.14311993,0.025440827,0.003751626,0.08889558,0.078112,0.0027945426,0.03324288,0.15769805,0.0008554195,0.0025232204
temporomandibular joint rheumatoid arthritis correlations clinical computed tomography features clinical computed tomography ct examination temporomandibular joint tmj performed patients rheumatoid arthritis ra control subjects examination scored group ra physical signs stomatognathic system compared control group ns group ra erosive cystic lesions tmj compared control subjects p less clinical dysfunction score correlate ct tmj score ra correlated number slow acting antirheumatic drugs used rheumatoid factor titer radiographic scores hands cervical spine agreement others believe specific ct lesions ra erosions cysts mandibular condyle correlation clinical ct findings tmj ra intensity destructive lesions tmj ct ra well correlated severity disease,C17,0.0029616146,0.0026271,0.005526066,0.015992979,0.075810514,0.003822118,0.29823127,0.0027851383,0.0021411155,0.031566944,0.054114293,0.11213238,0.19854547,0.018927088,0.016936457,0.00461185,0.07096402,0.003049972,0.003372234,0.032116562,0.039664447,0.0010515618,0.0030488118
marfan syndrome china collective review cases among families collective review patients marfan syndrome among pedigrees reported provinces cities china year period positive family history marfan syndrome found patients mode inheritance dominant recessive sporadic cases occurred screening children found five children marfan syndrome giving prevalence per population gene frequency per genes penetrance pleiotropy clear cases arachnodactyly ectopia lentis dilated aortic root chromosome examination showed regular aberrations except family five giant satellited chromosome found three afflicted members two unaffected relatives high prevalence aortic root dilation marfan syndrome makes echocardiography useful practical means diagnosis close follow regular echocardiographic evaluation indicated patients marfan syndrome also families diagnostic therapeutic purposes,C17,0.017541884,0.0026659523,0.020154784,0.0016886196,0.018733121,0.018420722,0.2604284,0.002826328,0.0021727807,0.046592716,0.1450526,0.006288347,0.026239963,0.053756874,0.0026428855,0.004680055,0.109773844,0.0030950783,0.017960405,0.09560089,0.0667818,0.0010671134,0.07583481
contact allergy due colophony vi sensitizing capacity minor resin acids commercial modified colophony products minor resin acids commercial modified colophony products different origins studied experimental sensitization means modified fca method resin acids almost negative commercial products gave different results maleic modified product greek origin showed strong sensitizing power fumaric modified terpene phenol modified disproportioned rosin moderate remarkable difference obtained swedish finnish tall oil rosins contrast previously studied french product exhibited weak sensitizing capacity,C17,0.0036440017,0.020842506,0.0067921337,0.002045249,0.005068787,0.0046977974,0.30109188,0.0034232368,0.002631663,0.0035766566,0.05568774,0.007662537,0.051415663,0.008594804,0.0032010518,0.04150612,0.037275627,0.02136515,0.004144841,0.2392021,0.17109202,0.0012924833,0.003745959
autologous mixed lymphocyte reaction reduced patients psoriasis autologous mixed lymphocyte reaction auto mlr studied test interactions immunocompetent cells patients psoriasis auto mlr patients psoriasis significantly lower normal controls lower values found untreated psoriatic patients remission following treatment values latter group significantly lower controls six patients atopic dermatitis remission tendency increase auto mlr decrease disease activity confirmed five patients studied treatment contrast allogeneic lymphocyte reaction allo mlr psoriatics similar normal controls,C17,0.0036407344,0.003228759,0.0067916466,0.0020451024,0.0050684237,0.00469746,0.21822773,0.0034229911,0.0026314743,0.021174338,0.035446506,0.026397906,0.19972248,0.034435224,0.0032008223,0.0056680567,0.17337386,0.0037648147,0.004144544,0.031392183,0.206488,0.0012923906,0.0037445787
aging skin recognizing managing common disorders senescent changes structure function skin chronic solar radiation damage predispose skin elderly certain inflammatory infectious diseases context diagnosis treatment senile xerosis pruritus discussed common types dermatitides infections infestations,C17,0.0056208367,0.004985963,0.010487898,0.0031583407,0.089461654,0.007253983,0.36336273,0.005285903,0.004063615,0.0055228025,0.053059224,0.011560988,0.050258838,0.013005685,0.0049428223,0.008752812,0.070582755,0.0058328602,0.00640015,0.1250733,0.11634436,0.001995755,0.032986768
role epidermal cytokines inflammatory skin diseases cytokines hormone like polypeptide mediators play major role inflammatory immunoregulatory responses skin particularly keratinocytes skin represent potent source many cytokines including interleukins hemopoietic colony stimulating factors cytokines initiate biologic action interacting target cells bearing cytokine receptors initiating cascade cellular interactions certain inflammatory skin diseases associated overproduction cytokines alteration cytokine receptors dysregulation cytokines data still quite preliminary likely cytokines contribute pathogenesis many inflammatory skin diseases,C17,0.0037054538,0.0032869224,0.006913992,0.0020819432,0.09485415,0.004782081,0.41452447,0.0034846535,0.0026788781,0.0036944535,0.01704097,0.0076214103,0.04264786,0.06633947,0.0032584826,0.005783129,0.031868447,0.07556883,0.004219204,0.0636889,0.100991316,0.019248975,0.02171601
natural history peyronie disease natural history peyronie disease evaluated men means questionnaire disease duration ranged months years questions addressed pain bending ability intercourse effect disease psychological effects treatments received degree disease progression approximately patients found pain bending ability intercourse effects unchanged course disease bending ability relations worsened patients interval worsening pain patients reported psychological effects due peyronie disease improved change worsened patients believed disease one gradual resolution believed little change believed disease pattern one gradual progression found statistically significant association disease duration spontaneous improvement penile bending similar lack statistical significance found improvement variety categories compared patients received therapy versus received variety conventional medical therapies,C17,0.002382568,0.0021123013,0.0044499612,0.0013379359,0.0033158367,0.0030731473,0.3107638,0.002239371,0.001721549,0.0023397333,0.02528818,0.047911063,0.042415023,0.005528801,0.0020940248,0.015231119,0.21763745,0.0024523085,0.025756272,0.07813598,0.20051803,0.00084550085,0.0024500147
pruritus scroti pruritus scroti common clinical disorder caused various inflammatory disorders infections infestations neoplasms laboratory evaluation including bacterial fungal cultures microscopic examination skin biopsies measurement blood glucose levels useful establishing diagnosis management pruritus scroti includes avoidance irritants allergens restrictive clothing use topical systemic agents provide symptomatic relief specific treatment underlying cause,C17,0.024734136,0.003758776,0.028416907,0.0023808163,0.046927657,0.025959048,0.42238197,0.0039848923,0.003063444,0.004163484,0.04366374,0.0087155,0.10128928,0.033060256,0.0037262535,0.02710954,0.058419574,0.004363809,0.025335869,0.0493633,0.07331512,0.001504543,0.0043620807
severe phototoxic burn following celery ingestion year old woman developed severe generalized phototoxic reaction following visit suntan parlor history taking revealed consumed large quantity celery root apium graveolens hour earlier use thin layer chromatography methoxsalen methoxypsoralen methoxypsoralen identified extract similar celery root biologic activity extract evaluated semiquantitative candida albicans inhibition technique indicated total psoralen dose approximately mg substantial amounts psoralen may absorbed vegetables celery unusual circumstances may constitute health hazard,C17,0.0040852614,0.0036110664,0.027262805,0.0022872568,0.0057006194,0.044653673,0.28118318,0.0038282971,0.0029430592,0.0039998707,0.094414525,0.008394673,0.034826066,0.009542745,0.023352992,0.0063391943,0.07365363,0.004231309,0.024338938,0.050026886,0.24610814,0.0014454187,0.043770406
dermatitis herpetiformis bodies ultrastructural study skin patients using direct preembedding immunogold labeling skin samples three adult patients dermatitis herpetiformis dh granular iga deposits papillary tips studied using ultrastructural immunogold technique iga positive called dh bodies identified amorphous clumps probably immunocomplex aggregates scattered throughout upper papillary dermis dermatitis herpetiformis bodies seen underneath basement membrane sometimes along microfibrillar bundles well adjacent papillary collagen fibers within surface microfibrillar region elastic tissue dh bodies however related fibrillar components collagen elastic fibers microfibrillar bundles anchoring fibrils elastic microfibrils unlabeled dermatitis herpetiformis bodies found normal human skin results ultrastructural study indicate dh bodies either bound nonfibrillar component dermal connective tissue represent deposits immune complexes trapped dh skin,C17,0.00304929,0.0027048725,0.040298637,0.04599439,0.06329457,0.0039352677,0.22961406,0.0028678703,0.046477582,0.0029961066,0.112690754,0.006271807,0.023217121,0.08705475,0.09099193,0.004748379,0.07560733,0.01817326,0.0034720653,0.025836183,0.10644269,0.0010826922,0.0031784151
persistent melanocytic lesions associated cosmetic tanning bed use sunbed lentigines patient persistent melanocytic lesions tanning bed use described review literature provides two additional examples similar clinical histologic presentations uva exposure without psoralen knowledge first reported case sunbed lentigines united states,C17,0.006120231,0.0054289503,0.011419716,0.0034387081,0.067780524,0.007898477,0.33262718,0.005777733,0.0044246544,0.0060134865,0.057008673,0.012670192,0.041499216,0.014072301,0.0053819767,0.009530473,0.12236105,0.0063028233,0.0069864066,0.17818397,0.08660398,0.0021730717,0.0062962677
cutaneous phototoxic occurrences patients receiving photofrin incidence cutaneous phototoxic reactions induced intravenous injection photofrin polyporphyrin assessed series patients injections undergoing photodynamic therapy pdt roswell park cancer institute period addition usual verbal questions regarding phototoxic reactions solicited follow forty two patients group also responded written questionnaire designed solicit answers specific questions photofrin doses ranged mg kg overall patients reported type phototoxic response,C17,0.0041519958,0.0036830273,0.027806412,0.002333,0.0057815225,0.005395952,0.26989427,0.0039045871,0.003001708,0.0040795794,0.022930052,0.14455992,0.02663659,0.0104383845,0.0036511603,0.0064655207,0.21710868,0.0042758672,0.04492049,0.07741074,0.10582008,0.0014742228,0.0042762295
expression retrovirus like particles psoriasis retrovirus like particles isolated patients psoriasis antigens crossreacting major internal protein pso p particles demonstrated wall dermal vessels subfraction cells psoriatic lesions antigen also observed blood lymphocytes psoriatic patients pso p antigen anti pso p antibodies present complement activating immune complexes psoriatic scale blood patients psoriasis psoriatic arthritis potential contribution circulating immune complexes inflammatory process psoriasis discussed,C17,0.0044184737,0.0039194063,0.008475781,0.00248256,0.0061537065,0.00570227,0.2125239,0.0042254087,0.0031943596,0.0043414095,0.021904139,0.05185918,0.070131235,0.13274612,0.003885494,0.006880482,0.10474274,0.04732852,0.005031082,0.029418001,0.17896578,0.0015688394,0.090101086
anaesthetic management systemic mastocytosis systemic mastocytosis uncommon disorder mast cell proliferation connective tissues mast cell degranulation may occur exposure various stimuli drugs release histamine heparin vasoactive substances prostaglandin may cause severe hypotension anaphylactoid manifestations anaesthetic management include perioperative stabilization mast cells avoidance use histamine releasing drugs intradermal skin testing useful predicting sensitivity drugs may used anaesthesia present patient systemic mastocytosis underwent uneventful cholecystectomy,C17,0.023745686,0.00328681,0.024848603,0.0020818722,0.023096455,0.020611355,0.42546424,0.02141214,0.0026787864,0.0036407013,0.054225706,0.0076211495,0.07177091,0.087079644,0.003258371,0.005769965,0.08703418,0.0038158724,0.00421906,0.02630106,0.09290992,0.001315627,0.0038119038
health status reports care patients rheumatoid arthritis examined use formal health status reports every months year clinical care patients rheumatoid arthritis ra reports consisted single page computer generated summaries scores derived either aims arthritis impact measurement scales mhaq modified health assessment questionnaire health status questionnaires total subjects community practice sites randomly assigned three study groups practice intervention attention placebo control results showed physicians found reports least moderately useful aid patient management primarily improving doctor patient relationship however detectable differences among three groups seen terms medication compliance number physician visits number referrals frequency major medication changes attitudes towards physician patient satisfaction change health status year failure demonstrate objective benefits health status reports study may due physician unfamiliarity health status scores failure link report office visit relative stability clinical status subjects year relatively short time frame study,C17,0.0017407616,0.02680802,0.028500155,0.0009774505,0.002422654,0.002245137,0.2972785,0.0016366373,0.0096557345,0.0185395,0.0450721,0.04723153,0.06360159,0.004091174,0.001529856,0.0027090306,0.07826509,0.001805783,0.094198294,0.22857969,0.040697195,0.0006176942,0.001796461
experimental models psoriasis evidence suggests inherent skin psoriatic subjects cells architectural structures mediators minimum responsible hyperproliferative epidermis objective laboratory establish vitro definition inherent aberration fibroblasts important epidermal proliferation differentiation unconfirmed report fibroblasts psoriatic subjects might drive abnormal epidermal proliferation psoriasis caused focus fibroblast data show fibroblasts patients psoriasis involved uninvolved presence human serum either normal psoriatic increased rate proliferation fibroblasts uninvolved psoriatic sites responsive determine fibroblasts psoriatics could induce psoriasiform phenotype normal keratinocytes interactive skin equivalent system developed system fibroblasts uninvolved involved sites cause normal keratinocytes enhanced outgrowth uninvolved fibroblasts cause greatest changes nature skin equivalent system calls occur via message distance conclude fibroblasts psoriatic subjects induce psoriasiform phenotype via soluble message,C17,0.002527757,0.0022422466,0.0047165323,0.0014202435,0.052466314,0.027721347,0.35492906,0.0023771334,0.014038746,0.0024836697,0.012229319,0.005199113,0.10637625,0.07337435,0.0022228458,0.0039362432,0.03619051,0.0026134537,0.002878223,0.021227483,0.22706705,0.01312923,0.028632855
prevention occupational contact dermatitis contact dermatitis frequent type occupational skin disease although prevention contact dermatitis workplace ideally accomplished total elimination cutaneous exposure hazardous substances often feasible therefore eight basic elements multidimensional approach prevention identified elements include recognition potential cutaneous irritants allergens engineering controls chemical substitution prevent skin exposure personal protection appropriate clothing barrier creams personal environmental hygiene regulation potential allergens irritants within workplace educational efforts promote awareness potential allergens irritants motivational techniques promote safe work conditions practices preemployment periodic health screening comprehensive prevention program based multidimensional approach requires cooperative efforts employees employers engineers chemists industrial hygienists safety supervisory personnel union representatives governmental agencies occupational health practitioners,C17,0.002920527,0.087422445,0.0054494003,0.0016409889,0.032343447,0.02026685,0.33434883,0.016876297,0.002111411,0.031131541,0.09102563,0.0061414717,0.026874548,0.009312529,0.0025684393,0.032819506,0.044250652,0.0030076585,0.08764005,0.09993336,0.05774298,0.001036973,0.0031344183
comparative efficacy toxicity second line drugs rheumatoid arthritis results two metaanalyses performed metaanalyses placebo controlled comparative clinical trials examine relative efficacy toxicity methotrexate mtx injectable gold penicillamine dp sulfasalazine ssz auranofin aur antimalarial drugs second line drugs commonly used treat rheumatoid arthritis ra efficacy study applied set inclusion criteria focused trials provided information tender joint count erythrocyte sedimentation rate grip strength found clinical trials contained treatment groups interest drug combined treatment groups outcome results showed aur tended weaker second line drugs results outcome measures synthesized composite measure outcomes aur significantly weaker mtx p injectable gold p less dp p less ssz p slightly significantly weaker antimalarial agents p also found heterogeneity among antimalarial agents patients treated chloroquine better treated hydroxychloroquine found little difference efficacy mtx injectable gold dp ssz power analysis showed trial contain least patients per treatment group successfully differentiate effective less effective e g aur second line drugs none reported interdrug comparative trials reviewed large toxicity study inclusion criteria captured ra trials reported proportion patients discontinued therapy drug toxicity total proportion dropped found clinical trials contained treatment groups average proportion dropped average proportion dropped drug toxicity computed drug overall patients trials dropped drug toxicity injectable gold higher toxicity rates p less higher total dropout rates p less drug gold treated patients dropped side effects versus trial patients antimalarial drugs aur relatively low rates toxicity rate mtx imprecise discrepancies trials thus commonly used second line drugs aur weakest injectable gold toxic agents introduced future compared drugs abstract truncated words,C17,0.0011493779,0.0010195556,0.032776978,0.017326921,0.0016027148,0.014188693,0.4705262,0.0010808889,0.0008309491,0.012251708,0.03338319,0.024921684,0.116902344,0.002759889,0.0010107697,0.012905914,0.06758984,0.012292898,0.06649618,0.06890563,0.032922633,0.005961306,0.0011937396
localized hyperhidrosis pretibial myxedema two cases spontaneous hyperhidrosis limited pretibial myxedema lesions studied quantitative measurements stimulated eccrine sweat made intradermal injection methacholine sweat rate two four times greater lesional skin perilesional skin eccrine secretory glands excisional biopsy specimens pretibial lesions significantly larger perilesional skin knowledge hyperhidrosis localized areas pretibial myxedema reported,C17,0.0054719006,0.004853849,0.010209998,0.0030744376,0.11415166,0.0070617725,0.21601675,0.03162475,0.0039559403,0.0053764633,0.05201284,0.037743792,0.108019605,0.013562928,0.0048118513,0.008520887,0.05735111,0.0056351502,0.0062613552,0.08848603,0.18175031,0.001942873,0.032103702
growth factor proto oncogene expression psoriasis expression several proto oncogenes growth factors analyzed normal skin psoriatic lesions rna blot hybridization isolation intact rna frozen biopsy samples required immediate exposure denaturants tissue homogenization lipocortin ii cyclophilin transcripts used internal controls transcripts abundant slightly significantly elevated psoriatic lesions results normalized according reference transcripts increase expression c myc c ha ras c erbb egf receptor c jun transforming growth factor beta tgf beta transcripts psoriatic lesions lesional c fos transcripts decreased relative normal skin contrast expression tgf alpha mrna transcripts markedly increased psoriatic lesions even normalization placement normal psoriatic tissue organ culture h resulted strong induction c fos c jun c myc transcripts genes studied thus overexpression proto oncogenes may characteristic epidermal response acute injury steady state hyperplasia characteristic psoriasis interferon gamma ifn gamma increased tgf alpha mrna levels cultured human kc long time intervals h however various cytokines tested egf tgf alpha induced tgf alpha mrna short time intervals h results well selective overabundance tgf alpha mrna psoriatic lesions among various cytokines tested suggest activation egf receptor tyrosine kinase tgf alpha important pathogenesis psoriatic epidermal hyperplasia,C17,0.023346182,0.0017663292,0.024459913,0.0011187964,0.022051547,0.0025697988,0.16978443,0.02114774,0.0014395778,0.0019565101,0.040137026,0.004111081,0.079635635,0.07645899,0.011366846,0.013250066,0.022256408,0.0709111,0.021532865,0.042858496,0.25992396,0.0007070169,0.08720968
psoriasis application genetic technology mapping recent progress molecular genetics led creation map human genome utilizing rflp given sufficient family structure genetic diseases placed map genetic studies psoriasis help resolve confounded problems disease heterogeneity environmental effects disease expression lack clear model inheritance,C17,0.004237779,0.024260236,0.007907256,0.0023810351,0.026405556,0.044881556,0.31346115,0.0039852588,0.0030637255,0.004179953,0.05879347,0.011093022,0.026558738,0.035522133,0.0037265958,0.027110733,0.077530384,0.0043642097,0.004935531,0.032793272,0.10205013,0.02200982,0.15874845
prolonged remission cyclosporine therapy pemphigus vulgaris report two young siblings report clinical evolution two young siblings severe pemphigus vulgaris treated cyclosporine months respectively one resistant treatment high dose corticosteroids azathioprine good clinical response achieved cases major side effects observed patients remained disease free months stopping cyclosporine therapy,C17,0.0046338122,0.0040944535,0.008612622,0.002593435,0.0064273686,0.028283047,0.34767538,0.004340763,0.0033370247,0.004535304,0.04331235,0.009673813,0.043881543,0.010613171,0.0040590265,0.0071877753,0.1942517,0.0047535184,0.005255778,0.09259137,0.16349924,0.0016389062,0.0047485745
dermal mast cell degranulation systemic sclerosis paired biopsy samples involved uninvolved skin obtained patients generalized scleroderma early progressive disease late improving disease skin biopsy samples double stained mast cell granules mast cell membrane number mast cells increased patients systemic sclerosis ssc involved uninvolved skin early late disease increase number degranulated mast cells involved skin patients early late disease yet involved skin patients early disease however increase number degranulated mast cells areas previously involved normal skin patients late disease increases mast cell number degranulation precede clinically apparent dermal fibrosis ssc observations absence mast cell degranulation regressing skin suggest participatory role mast cell clinical progression skin changes ssc,C17,0.002354046,0.0020881563,0.038578857,0.0013226426,0.09444946,0.014427776,0.30268058,0.0022137736,0.0017018706,0.0023129885,0.03917773,0.004841823,0.03681827,0.14228147,0.0020700889,0.0036657394,0.14150742,0.0024252643,0.0026804279,0.022373324,0.1367696,0.0008358363,0.0024228767
linear porokeratosis successful treatment diamond fraise dermabrasion patient linear porokeratosis successfully treated diamond fraise dermabrasion follow evaluation revealed excellent cosmetic result adequate repigmentation scarring recurrence lesions long term follow necessary determine whether dermabrasion treatment linear porokeratosis provides adequate prophylaxis subsequent development malignancy,C17,0.005196541,0.0046095913,0.009696206,0.0029197244,0.06137351,0.08217107,0.23589697,0.0048868903,0.0037568677,0.0051059066,0.026403474,0.010688292,0.032356597,0.012061718,0.004569707,0.083552256,0.2704814,0.0053636516,0.005917026,0.033645418,0.092156105,0.0018451029,0.00534601
piroxicam induced photosensitivity contact sensitivity thiosalicylic acid photocontact dermatitis developed three patients application gel containing piroxicam patch tests positive thiomersal thiosalicylic acid photopatch tests piroxicam several concentrations positive three patients negative normal volunteer subjects patch tests performed patients proved systemic photosensitivity piroxicam positive thiomersal thiosalicylic acid nine patients previously sensitized thiosalicylic acid history exposure piroxicam showed positive photopatch test reactions chemical results support relation piroxicam induced photosensitivity contact sensitivity thiosalicylic acid contact allergic sensitivity latter marker patients high risk developing photosensitivity reactions piroxicam reactions may due photoproducts drug rather metabolites,C17,0.002803719,0.0024847055,0.059459426,0.0015738176,0.030992737,0.017154817,0.3360236,0.002634178,0.0020250625,0.0027522342,0.15442383,0.0057613044,0.06328315,0.007924519,0.01602182,0.01791806,0.11250948,0.0028867684,0.0031894518,0.0533699,0.10090044,0.0009945648,0.0029123803
transdermal viprostol treatment male pattern baldness fifty seven men randomly assigned treatment androgenetic alopecia viprostol vehicle placebo twice daily weeks nonvellus hair growth assessed subjectively patient investigator objectively hair counts macrophotographs target area nonvellus target area hair counts declined three treatment groups end month study viprostol effective hair growth promoter androgenetic alopecia,C17,0.004947549,0.004388723,0.009231614,0.002779826,0.0068893055,0.0063850703,0.20000471,0.0046527353,0.003576858,0.0048612575,0.02436099,0.03412829,0.032743935,0.059276495,0.00435075,0.007704363,0.15560466,0.052994717,0.02958405,0.081506394,0.26318112,0.001756695,0.005089856
spontaneous rheumatoid like arthritis line mice sensitive collagen induced arthritis twenty eight percent month old male mice high antibody responder line biozzi selection hi spontaneously developed long lasting inflammatory arthritis disease clinically histologically similar human rheumatoid arthritis synovium joints tendons hypertrophied thickening synovial cell layer infiltration polymorphonuclear mononuclear leukocytes cases synovial pannus formation led destructive damage articular cartilage bone rheumatoid factor antinuclear anti dna anti type ii collagen cii antibodies often found sera arthritic mice clinically normal littermates presence cii autoantibodies line mice suggests potentially harmful anti cii cell autoimmunity also develop spontaneously lead joint damage moreover hi mice also susceptible collagen induced arthritis closely related mouse line hii resistant diseases data support hypothesis collagen induced arthritis pathogenetically related spontaneous arthritis rheumatoid arthritis,C17,0.0026569888,0.0023568817,0.011147576,0.054243825,0.003713899,0.0034289826,0.31539688,0.018899905,0.0019208847,0.0026106476,0.03832134,0.0054759113,0.01852173,0.20002328,0.002336489,0.0041374844,0.050798934,0.015689464,0.0030253727,0.039137933,0.18924063,0.0009434002,0.0159716
il regulation transin stromelysin transcription rheumatoid synovial fibroblasts appears involve two antagonistic transduction pathways inhibitory prostaglandin dependent pathway mediated camp stimulatory protein kinase c dependent pathway il like agents shown capacity induce protein kinase c potent transcriptional activator metalloproteinase stromelysin synovial fibroblasts camp shown inhibit stromelysin transcription fibroblasts nonsynovial origin regarded important second messenger il addition stimulating metalloproteinase transcription il also induces pge production synoviocytes determined ril alpha led time dependent accumulation intracellular camp serum starved rheumatoid synovial fibroblasts effect blocked indomethacin camp agonists forskolin isobutyl methylxanthine pge suppressed il induction stromelysin conversely indomethacin superinduced il elicited stromelysin mrna results recapitulated transcriptional level cells transfected rat transin stromelysin promoter reporter cat construct dideoxyadenosine inhibitor adenylate cyclase also augmented il induction stromeylsin mrna h specific inhibitor camp dependent protein kinase staurosporine h inhibitors protein kinase c blocked il induction stromelysin mrna conclude il appears stimulate least two transduction pathways synovial fibroblasts patients rheumatoid arthritis antagonistic effects regulation stromelysin transcription,C17,0.014403082,0.0021880895,0.004602614,0.0013859404,0.0034348073,0.00318341,0.26677322,0.0023197182,0.0017833172,0.0024236816,0.011401512,0.005073539,0.01604095,0.11669856,0.0021691574,0.08742787,0.03464207,0.118141055,0.0028087054,0.019263295,0.26839432,0.000875837,0.014565208
clinical laboratory effects prolonged therapy sulfasalazine gold penicillamine effects disease duration treatment response serial observations years clinical score subjective global assessment serum c reactive protein crp erythrocyte sedimentation rate esr analyzed groups patients active rheumatoid arthritis ra requiring treatment second line drug groups comprised patients women men sulfasalazine sas patients women men sodium aurothiomalate gold patients women men penicillamine groups matched respects gold group smaller proportion women shorter median disease duration higher median crp remaining groups penicillamine group contained higher proportion seropositive patients group significant improvements clinical score crp esr time points months improvements maintained longer months sas sas gold groups differences drugs months probably consequence falling number patients differing drug potencies mean esr crp levels fell mm h mg l respectively response defined treatment duration greater months clinical score improvement greater months esr fall less mm h months criteria patients responded response rates sas gold penicillamine,C17,0.0016829165,0.0014928309,0.0031401475,0.009073014,0.0023452395,0.0021718915,0.24034649,0.0015826351,0.0012166738,0.0016535643,0.024300773,0.10048061,0.08509799,0.0040673777,0.001481709,0.002620651,0.21192521,0.009879283,0.001916248,0.14320321,0.14797458,0.0005975425,0.0017493822
quantitative estimation hair growth androgenetic alopecia women effect minoxidil quantitative growth hair week period reported eight women androgenetic alopecia using random double blind protocol women given either minoxidil solution placebo vehicle hair permanently marked site fronto parietal scalp pulled cm square clear plastic template outline template drawn scalp hair carefully hand clipped collected five eight week intervals one untreated four treated using great care collect hairs within marked area subsequent measurements included total weight hair grown marked area total number hairs randomized hair subsample weight lengths optical diameters calculated quantities included average weight per hair average length average optical width average total hair weight minoxidil treated subjects increased week test period compared placebo treated subjects average p changes average number count respectively average p increases observed using unusually small number subjects clearly distinguished treated subjects untreated test period averaged quantities weight diameter length hair subsample showed insignificant change p usually greater addition showing larger percentage increase total number total weight easier obtain less prone error sampling measurement therefore recommend total weight defined area considered primary quantitative estimator hair growth,C17,0.0015563584,0.0013805676,0.017962823,0.00839597,0.0021676475,0.019111006,0.13072999,0.0014636182,0.0011251778,0.0015292135,0.07021659,0.012411391,0.13730876,0.047933668,0.00891938,0.0024235735,0.07625902,0.0016064086,0.030604014,0.14625002,0.27096,0.00808369,0.0016011241
immunosuppressive effects clonidine induction contact sensitization balb c mouse clonidine transdermal therapeutic system clonidine tts associated significant incidence allergic contact sensitization incidence predicted premarket skin sensitization testing animals humans one possible explanation lies recent findings guinea pigs clonidine exposure could inhibit elicitation skin reactions unrelated strong contact sensitizers however studies also showed clonidine pretreatment appear affect induction contact sensitization basis sought specifically evaluate induction phase sensitization clonidine alternative means assessing sensitization properties method selected assay situ lymphocyte proliferation lymph nodes draining sites clonidine exposure method recently promoted alternative means assess contact allergenic potential utilizing various induction application techniques regimens consistently unable demonstrate clonidine allergenic potential assessment lymphocyte proliferation also unable demonstrate sensitization vivo ear swelling vitro lymphocyte blastogenesis assay techniques however subsequent assessment effect clonidine exposure induction sensitization unrelated strong contact allergens demonstrated consistent inhibition proliferative response contact allergens oxazolone trinitrochlorobenzene similar degree suppression produced corticosteroids fluocinonide hydrocortisone tested times lower concentrations addition observed comparable inhibition ear swelling response oxazolone data extend knowledge immunomodulatory effects clonidine offer additional mechanistic insights failure short term predictive patch test methods detect chemical potential induce allergic contact sensitization,C17,0.001580143,0.00905018,0.023534123,0.0008878179,0.02517215,0.0020392567,0.31890282,0.0014859856,0.0011423731,0.0015525833,0.102304734,0.003354143,0.047888737,0.06291466,0.0013895378,0.07491142,0.039361224,0.021673378,0.009668574,0.060050864,0.1889443,0.00056105136,0.0016299477
cytotoxic immunologic effects methotrexate psoriasis based recent experience cyclosporin immunosuppressive drug produces marked improvement psoriasis possible immunomodulatory activities methotrexate mtx reviewed look alternate mechanisms mtx action psoriasis generally considered therapeutic results mtx psoriasis related direct effect epidermal cell hyperplasia inhibition dna synthesis several studies literature suggest possible effects mtx immune system psoriatics well animal models may pathogenic similarities psoriasis psoriatics receiving mtx neutrophil chemotaxis suppressed resulting possible alteration potential pathologic activity neutrophils commonly found lesional skin mtx improve psoriatic rheumatoid arthritis animal studies latter using adjuvant arthritis graft vs host disease gvhd indicated several possible mechanisms mtx affect processes gvhd mtx selectively destroys cycling cd cells adjuvant arthritis activation macrophages prevented inhibition cell function mtx generally clinically utilized immunomodulatory drug immunologically related diseases may nonetheless selective actions could specific diseases mtx cyclosporin could work mechanistically similar ways different steps activation cells macrophages may major direct effect mtx epidermal cell proliferation complemented even mediated subtle immunoregulatory effects melange cells affected skin systemic immune response,C17,0.0017847458,0.010221173,0.011959571,0.0010027759,0.011124011,0.0023033076,0.434408,0.027596194,0.009910651,0.0017536177,0.010191555,0.027449634,0.013420132,0.0997497,0.0015694605,0.002782046,0.018535316,0.036560744,0.0020321957,0.0653379,0.20783716,0.0006336984,0.0018364225
olive oil cause contact allergy patients venous eczema occupationally cases contact allergy olive oil identified departments dermatology kristianstad ostersund hospitals known components olive oil could proved cause allergy high number patients contact allergy olive oil possible explanations discussed,C17,0.0063072043,0.005594805,0.042299923,0.0035437609,0.008782582,0.008139775,0.29770634,0.036458205,0.004559828,0.0061971988,0.08987623,0.012972713,0.04375541,0.015540995,0.005546396,0.040339887,0.19150726,0.0064953747,0.00718168,0.076220445,0.082233466,0.002239459,0.0065010404
aspirin hydroxychloroquine hepatic enzyme abnormalities methotrexate rheumatoid arthritis levels serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvic transaminase sgpt patients rheumatoid arthritis centers involved arthritis rheumatism aging medical information system correlated use specific antirheumatic medications elevated levels sgot sgpt frequent patients taking salicylates methotrexate mtx least frequent patients taking hydroxychloroquine combination mtx salicylates greatly increased frequency abnormal liver enzyme values contrast addition hydroxychloroquine regimen either mtx aspirin essentially eliminated sgot sgpt abnormalities results centers consistent remained adjustment age sex disease duration knowledge important drug interactions may permit continuation mtx therapy patients drug might otherwise discontinued,C17,0.0029617203,0.0026271937,0.019813078,0.0016640698,0.004135813,0.05545676,0.41731018,0.0027852377,0.0021411919,0.002910064,0.021410653,0.0060916925,0.047037702,0.007286934,0.0026415046,0.03230036,0.11821603,0.003050081,0.003380098,0.09412348,0.14855608,0.0010515993,0.0030484833
diminished incidence severe rheumatoid arthritis associated oral contraceptive use suggested negative association rheumatoid arthritis ra oral contraceptive oc use might limited severe forms ra investigate studied consecutive female patients definite ra female patients probable ra female controls patients ra symptoms recent onset mean followup period years patients definite ra classified either severe disease course n mild disease course n negative association oc use prior onset ra symptoms development ra limited patients definite ra severe disease course therefore conclude oc use prior onset ra symptoms associated reduction incidence severe ra may explain divergent results previous studies,C17,0.0028488142,0.0025187111,0.0052980715,0.0015953567,0.0039538085,0.072385386,0.32334808,0.0026702292,0.0020527774,0.053043798,0.023128437,0.0059040072,0.042424537,0.0066073625,0.0024969182,0.0044215745,0.15220626,0.0029241364,0.0032331024,0.16458385,0.11842359,0.0010081765,0.0029230253
specificity anti scl antibodies scleroderma increased sensitivity detection using purified dna topoisomerase calf thymus large scale purification dna topoisomerase calf thymus obtained using combinations ammonium sulfate precipitation biorex hydroxylapatite phenylagarose chromatography silver staining preparation separated sodium dodecyl sulfate polyacrylamide gel electrophoresis revealed bands apparent molecular weight kda immunoblotting serum anti scl specificity also recognized proteins anti scl antibodies detected patients diffuse scleroderma elisa ability neutralize topoisomerase activity sera anticentromere antibodies react dna topoisomerase assays presence anti scl antibodies remained disease specific despite increase sensitivity assays,C17,0.00300485,0.0026654517,0.03469782,0.04531498,0.0042115496,0.0038779152,0.19809632,0.002825797,0.0021723728,0.0029524413,0.077059515,0.020717254,0.021806002,0.119243346,0.01717125,0.004679176,0.04190974,0.10104458,0.0034214635,0.01971244,0.20825848,0.001066913,0.06409031
identification isolation phospholipase activating protein human rheumatoid arthritis synovial fluid induction eicosanoid synthesis inflammatory response joints injected vivo eicosanoids important mediators destructive arthropathy observed rheumatoid arthritis rate limiting step eicosanoid synthesis pathway availability free arachidonic acid phospholipase enzymes release arachidonic acid membrane phospholipids thus play important role regulation eicosanoid production previously demonstrated enhanced phospholipase c enzyme activities cells patients rheumatoid arthritis also described phospholipase activating protein plap mammalian cell lines attempt determine biochemical basis enhanced phospholipase activity found patients inflammatory joint disease examined synovial fluid patients rheumatoid arthritis plap determine whether plap specific rheumatoid disease assayed specimens patients arthropathies histologic examination rheumatoid joint tissue use immunohistochemical techniques demonstrated high concentration plap monocytes macrophages chondrocytes vascular smooth muscle endothelial cells human plap could biochemically isolated synovial fluid patients rheumatoid arthritis found similar plap previously isolated murine bovine sources determine whether plap could directly mediate aspect inflammatory disease purified plap injected rabbit knee joints resulted acute inflammatory arthritis synovial cell proliferation synovial fluid leukocytosis purified plap also induced eicosanoid formation vivo vitro enzyme linked immunosorbent assays found plap synovial fluid specimens patients rheumatoid arthritis compared samples patients inflammatory arthropathies well osteoarthritis noninflammatory arthropathy data suggest plap may responsible least part aspects destructive inflammatory arthropathy observed patients rheumatoid arthritis,C17,0.0016830572,0.0015118468,0.019463595,0.00906177,0.0023438456,0.010292619,0.25054446,0.024747571,0.0012167755,0.0016537026,0.050147887,0.022433627,0.013029577,0.11523394,0.001480038,0.018908989,0.09486565,0.05975866,0.026347088,0.014958555,0.23221417,0.00873986,0.019362714
autoantibodies patients localized generalized bullous pemphigoid immunoprecipitate kd keratinocyte antigen two patients demonstrating typical clinical histologic immunopathologic features nonscarring localized bullous pemphigoid described patients possess circulating igg autoantibodies bind epidermal side mol l sodium chloride split human skin indirect immunofluorescence microscopy immunnoprecipitation studies demonstrate patients circulating autoantibodies immunoprecipitate kd bullous pemphigoid antigen precipitated autoantibodies patients generalized bullous pemphigoid findings indicate localized bullous pemphigoid true clinical variant generalized pemphigoid rather separate nosologic entity,C17,0.0041523217,0.023782533,0.0077478015,0.00233302,0.048595563,0.0053587873,0.24148197,0.023997644,0.040727176,0.0040798998,0.02281963,0.008540533,0.026007202,0.067038454,0.003651447,0.0064660283,0.16642551,0.024375804,0.004728029,0.027050376,0.16796829,0.0014743386,0.071197614
molecular identification major minor bullous pemphigoid antigens skin antigens defined basement membrane zone antibodies patients bullous pemphigoid analyzed western immunoblot thirty four patients antibodies major bullous pemphigoid antigen molecular weight approximately kd twelve patients antibodies minor bullous pemphigoid antigen molecular weight approximately kd included four patients antibodies kd antigen depending epidermal extract used variable number patients also antibodies minor bullous pemphigoid antigens molecular weights approximately kd results study confirm bullous pemphigoid antigens heterogeneous molecular level approximately patients antibodies directed solely minor bullous pemphigoid antigen,C17,0.0030953751,0.002745752,0.020746516,0.016712112,0.049259543,0.003994743,0.24506204,0.002910928,0.0022378184,0.0030413878,0.015191742,0.0063665947,0.034646958,0.23019364,0.0027219946,0.004820143,0.1380342,0.0031970537,0.0035245398,0.103263296,0.0866281,0.0010990552,0.020506432
increased expression platelet derived growth factor type b receptors skin patients systemic sclerosis expression b type receptors platelet derived growth factor pdgf investigated skin biopsy samples patients systemic sclerosis ssc immunohistochemical staining using monoclonal antibodies specific receptor whereas skin healthy individuals lacked expression pdgf b receptors receptor expression seen sclerodermatous skin lesions patients increased receptor expression observed dermal vessels well many stromal fibroblast like cells close vessels pdgf b receptor expression pronounced within around dermal vessels perivascular infiltrates leu positive lymphocytes hla dr positive rfd positive activated macrophages present perivascular inflammatory cell infiltrates pdgf b receptor expression generally also seen macroscopically normal areas skin ssc patients indicating observed phenotypic alterations may precede macroscopically observable features scleroderma skin observed induction pdgf b receptors together indirect indications increased synthesis release pdgf would compatible altered pdgf mediated control connective tissue cell growth part molecular basis development skin lesions ssc,C17,0.0018995969,0.0016850373,0.026478149,0.0010673797,0.09460787,0.0024515288,0.23146453,0.012904003,0.0013733241,0.0018664656,0.04597581,0.00393135,0.039273173,0.0508087,0.0016704577,0.012283122,0.055224176,0.12869996,0.020544307,0.022256412,0.17370966,0.00067447784,0.06915053
extracellular collagenase proteoglycanase products activity released organ culture intact dermal inflammatory lesions produced sulfur mustard peak healing inflammatory lesions produced rabbits topical application military vesicant bis chloroethyl sulfide commonly called sulfur mustard sm sm produces acute sterile dermal inflammatory reaction little necrosis except epidermis dies first day animal killed lesions excised intact full thickness cm explants organ cultured order maintain viability local infiltrating cells extracellular fluid lesion equilibrated culture fluid collected daily analyzed collagenase proteoglycanase activities metalloproteinase activities measured destroyed alpha macroglobulin inhibitors kscn ii destroyed tissue inhibitor metalloproteinases timp reduction alkylation iii activated latent proteinase activity aminophenylmercuric acetate apma hydroxyproline containing peptides glycosaminoglycans gag released culture fluids also measured indicators local collagenase proteoglycanase activity within inflammatory lesions general levels metalloproteinases products activity higher second third day culture fluids first day culture fluids higher fluids sm lesions normal skin activated fibroblast apparently major cell type producing collagenase proteoglycanase hydrolysis collagen ground substance occurs pericellularly excess inhibitors exists outside pericellular region daily change culture fluids apparently decreased inhibitors second third day culture could detect changes pericellular enzyme activity detectable first day culture inflammatory lesions healed extracellular enzyme products hydroxyproline gag increased enzymes produced products healing decrease occurs extravasation serum components especially large ones alpha macroglobulin inhibitors propose healing decrease inhibitors allows metalloproteinases begin remodeling process peak phase inflammation inhibitors protect extracellular matrix hydrolysis proteinases,C17,0.0013583646,0.0011997356,0.009746808,0.0074217096,0.05434443,0.0017454725,0.17739417,0.0012719079,0.0009777978,0.0013289113,0.024570828,0.017722556,0.109887704,0.1143729,0.0011893549,0.021745423,0.021549948,0.014877488,0.0015400209,0.04706469,0.34951106,0.00048022383,0.018698476
clinical laboratory radiographic features early rheumatoid arthritis evaluated disease status relation age sex disease duration using short term indices disease activity laboratory tests radiological features patients rheumatoid arthritis duration varying months mean months differences observed among various age groups disease duration female male ratio incidence radiologic lesions indices disease process clinical markers disease process involvement flexor tendons hands ritchie index score greater significantly frequent women p less p less respectively patients disease recent onset women slightly numerous men however disease duration months significantly women p less suggesting greater tendency chronic disease sex radiological lesions small joints hands feet wrists found cases disease duration months months p less lesions associated significantly frequently ritchie index p less laboratory indices inflammatory activity erythrocyte sedimentation rate greater equal mm h p less immune response latex test greater equal p less logistic regression analysis showed duration illness important factor correlating radiologic lesions,C17,0.0016967156,0.0015050714,0.011344237,0.0009533153,0.03521851,0.0022211513,0.24078146,0.00979988,0.0012266499,0.018084,0.05774139,0.019643968,0.23106529,0.0048826425,0.0015132626,0.01085226,0.08793908,0.0017473358,0.0019319602,0.16952045,0.07155464,0.017028853,0.0017478617
ionizing radiation induced pemphigus case presentations literature review reports pemphigus following ionizing radiation exposure rare report two cases review literature regarding association characteristics common cases include prodromal persistent nonspecific dermatitic eruption often interpreted radiation dermatitis latency variable duration onset vesiculobullous eruption begins portal irradiation direct immunofluorescence positive intercellular igg indirect immunofluorescence commonly positive low titers hla correlations studied documentation clinical course laboratory confirmation diagnosis including hematoxylin eosin direct indirect immunofluorescence hla determinations available recorded enable clarification entity,C17,0.0032923818,0.018856747,0.0061432426,0.001849855,0.020484077,0.00424899,0.37868935,0.019677663,0.0023802454,0.019171357,0.13659175,0.0067717996,0.052766826,0.0077706687,0.0028952374,0.036934115,0.04542381,0.0033906072,0.003748861,0.14587153,0.078484826,0.0011690051,0.003387081
lymphocyte adhesion psoriatic dermal endothelium mechanism modulation psoriasis characterized hyperproliferation keratinocytes epidermis accumulation activated cd lymphocytes upper dermis recently tested hypothesis abnormal endothelial proliferation dermal papillae psoriatic lesions may mechanistically linked expression endothelial ligands capable promoting lymphocytes binding extravasation results indicated specialized endothelial cells lining post capillary venules psoriatic lesions capable promoting selective adherence human cd cells memory subset contrast b cells cd cells cd ra cells deficient capacities bind adhesion process energy calcium dependent involves tissue specific lymphocyte receptors lfa molecules playing accessory role concluded transformation dermal endothelium lymphocyte receptive phenotype defined growth factors cytokines may represent positive feedback mechanism promoting lymphocyte migration diseased sites,C17,0.0026918114,0.002387771,0.005022641,0.001512419,0.0037520926,0.0034739228,0.29580694,0.055080675,0.0019460598,0.0026448627,0.05063497,0.01855422,0.03066121,0.22570734,0.002367111,0.017217126,0.024847375,0.058540095,0.003065023,0.017925568,0.13063397,0.0139724165,0.031554427
itraconazole treatment tinea capitis fifty patients tinea capitis treated itraconazole mg day days six countries forty seven patients responded clinically healed markedly improved therapy patients completely healed patients markedly improved three patients failed therapy forty two patients assessable mycologic examination patients converted mycologically negative patients remained positive organisms one group patients treated days patients clinically mycologically healed week follow visit additional patients healed weeks treatment patients clinically mycologically healed primary organisms reported microsporum canis trichophyton tonsurans one patient reported possible side effect tired legs laboratory values within normal limits except one patient transient slight increase serum transaminase level low dose itraconazole appears safe effective treatment tinea capitis,C17,0.002763489,0.015826816,0.005156384,0.0015526918,0.003848071,0.0035664267,0.25969365,0.0025988186,0.0019978797,0.0027152903,0.06562204,0.01906243,0.036288887,0.0064936318,0.015723731,0.0043033273,0.29311568,0.0029162993,0.0031466389,0.02132219,0.22846147,0.0009812146,0.0028429758
treatment idiopathic guttate hypomelanosis liquid nitrogen light electron microscopic studies idiopathic guttate hypomelanosis common skin disorder unknown cause studies shown significantly fewer dopa positive melanocytes white macules idiopathic guttate hypomelanosis normal skin electron microscopy observed melanocytes lesional skin round less dendritic fewer melanosomes normal pigment cells lesions gently frozen liquid nitrogen repigmented weeks number dopa positive melanocytes significantly greater repigmented areas untreated lesions less normal skin,C17,0.003917575,0.0034750842,0.022545338,0.0022011255,0.10028429,0.042945813,0.23272981,0.0036841347,0.021795794,0.0038492472,0.054415815,0.026725696,0.12895946,0.04335947,0.0034450165,0.0061004786,0.0829492,0.027649704,0.0044607352,0.031017106,0.14806786,0.0013909885,0.0040302565
lymphocyte chemoattractants psoriasis normal skin local production lymphocyte attractants may influence physiologic lymphocyte trafficking skin well infiltration cells pathologic states recent evidence production acidic lipid lymphocyte chemoattractants particularly r hydroxyeicosatetraenoic acid psoriatic lesions reviewed water extractable lymphocyte attractant activity may also recovered normal skin samples psoriatic lesional stratum corneum may important pathophysiology lymphocyte trafficking less kd activity normal skin undergone detailed characterization led isolation novel yet unidentified compound normal skin termed plasma associated lymphocyte chemoattractant palc,C17,0.0037054722,0.0032869389,0.006914027,0.020006614,0.09485464,0.004782105,0.28633067,0.021411674,0.0026788914,0.003640844,0.053736605,0.061430942,0.06500963,0.03967562,0.021192437,0.005770191,0.050076906,0.023074491,0.02213843,0.0559981,0.14915703,0.0013156786,0.0038120532
treatment hirsutism pure antiandrogen flutamide effectiveness antiandrogen flutamide combination oral contraceptive studied patients moderate severe hirsutism eight patients previous therapy whereas failed respond oral contraceptives spironolactone dexamethasone therapy treatment antiandrogen flutamide mg twice daily oral contraceptive ortho resulted particularly rapid marked decrease total hirsutism score reached normal range months seborrhea acne hair loss score also rapidly corrected treatment associated decrease plasma luteinizing hormone progesterone estradiol levels plasma sex hormone binding globulin levels initially low patients increased significantly therapy clinically significant side effects observed,C17,0.0034002713,0.019473322,0.02285509,0.0019104737,0.0047419285,0.004388227,0.2921413,0.0031976562,0.0024582448,0.0033409663,0.01582118,0.056257114,0.055523176,0.007907131,0.0029902547,0.0052949297,0.13574104,0.0035033608,0.003871709,0.03851614,0.3119611,0.0012073128,0.0034980737
pentoxifylline inhibits proliferation human fibroblasts derived keloid scleroderma morphoea skin production collagen glycosaminoglycans fibronectin pentoxifylline analogue methylxanthine theobromine inhibits proliferation certain biosynthetic activities fibroblasts derived normal human skin fibroblasts skin patients keloids scleroderma morphoea cultured vitro presence absence pentoxifylline micrograms ml determine whether inhibits fibroblast proliferation production collagen glycosaminoglycans gag fibronectin collagenase activity exposure subconfluent fibroblast cultures pentoxifylline resulted non lethal dose dependent reductions serum driven fibroblast proliferation micrograms ml pentoxifylline virtually negating proliferative effect serum cells fibroblasts assayed confluent cultures produced reduced amounts collagen gag dependent concentration pentoxifylline presence absence serum pentoxifylline similarly inhibited fibronectin production keloid scleroderma fibroblasts effect collagenase activity,C17,0.0031903863,0.0028300318,0.00595293,0.063569985,0.050777785,0.00411736,0.14471456,0.0030094015,0.017725827,0.003134742,0.0149661675,0.006562015,0.020471662,0.25288326,0.0028055452,0.024679298,0.04287951,0.0034674297,0.003632724,0.05445666,0.26970258,0.0011327902,0.0033373465
substitution non glycine position triple helical domain pro alpha collagen chains present individual variant marfan syndrome substitution highly conserved non glycine residue triple helical domain pro alpha collagen molecule found individual variant marfan syndrome single base change resulted substitution arginine glutamine position gly x repeat responsible decreased migration sds polyacrylamide gels pro alpha chains type collagen synthesized dermal fibroblasts individual family studies suggest substitution inherited individual father also produces abnormally migrating pro alpha collagen chains shares abnormal skeletal features single base change creates new bsu sau mst ii restriction site detectable genomic dna southern blot analysis probed col fragment analysis control individuals chromosomes negative new bsu site suggesting substitution common polymorphism,C17,0.0023025281,0.0020424572,0.0042962786,0.04696071,0.070077844,0.014097694,0.3362677,0.013277388,0.0016646252,0.002262369,0.041362807,0.0047871694,0.020924581,0.016720418,0.0020247851,0.003740024,0.021543447,0.0023805262,0.0026217669,0.078698546,0.13590032,0.00081754406,0.17522843
treatment molluscum contagiosum using lidocaine prilocaine cream emla analgesia eighty three year old children scheduled curettage least five molluscum contagiosum lesions participated double blind study children randomly allocated receive lidocaine prilocaine emla cream n placebo cream n applied minutes treatment pain assessed children physician none slight moderate severe addition children rated pain visual analog scale emla cream effectively prevented pain three application times p less significant difference pain observed among minute emla treated groups proportion children reporting pain verbal scale increased minute group minute group placebo group one children reported pain transient local redness skin reaction noted conclusion application time emla cream less minutes satisfactory curettage molluscum contagiosum children,C17,0.0027271262,0.015619455,0.02083675,0.014730989,0.030201623,0.0035194985,0.18984869,0.0025646226,0.001971591,0.09509874,0.027615998,0.11248728,0.15245816,0.0062705055,0.002398166,0.030647906,0.066129506,0.002808488,0.06911013,0.026242042,0.12293883,0.0009683035,0.002805567
correcting stairstep deformity secondary lower abdominal scars use decorticated hypogastric flap author describes decorticated hypogastric flap used correction prevention retracted scars suprapubic stairsteps deformities common cesarean sections patients undergo liposuction followed retrieval excess skin surgical technique described author also analyzes advantages results occur without increase either time surgery complications,C17,0.0044184816,0.025307197,0.008244428,0.0024825644,0.02754209,0.0057022804,0.15794493,0.046929903,0.0031943654,0.0043414175,0.06365387,0.009087972,0.036307517,0.010202529,0.003885501,0.0068804948,0.36680323,0.0045503033,0.005031091,0.11332436,0.088030055,0.0015688422,0.004566558
management onychomycosis oral terbinafine safety efficacy oral terbinafine treatment finger onychomycosis caused trichophyton rubrum evaluated open study including patients treatment consisted mg terbinafine given twice daily months infection cleared end treatment period patients clinically mycologically normal drug acting fungal barrier prevent distal fungal invasion nailplate mild gastric discomfort one patient side effect reported study laboratory abnormalities detected,C17,0.003991813,0.04218948,0.0074483086,0.0022428366,0.02484772,0.024469182,0.42719996,0.003753949,0.002885903,0.0039221905,0.030702705,0.008316857,0.059603833,0.009480599,0.0035102994,0.0062160827,0.15125085,0.0041147606,0.004545266,0.02794597,0.14582083,0.0014173477,0.0041232156
submammary median sternotomy vertical skin incision used routine approach sternotomy resulting scar often disappointing top visible unpleasant especially young women women ranging years mean years median sternotomy performed via submammary skin incision cases open heart surgical procedure performed adequate exposure heart achieved every case technical problems related approach hospital mortality major complications cosmetic result excellent approach certainly justified open heart surgery young women,C17,0.003400403,0.0030163273,0.0063447994,0.0019105477,0.0376581,0.020840405,0.2178401,0.019622544,0.00245834,0.0033410958,0.064555384,0.006993979,0.041948106,0.007818577,0.0029902286,0.0052951346,0.3201347,0.0035018513,0.003871859,0.16293909,0.058812838,0.0012073596,0.0034982092
prevalence sources sensitization emulsifiers clinical study patients suspected cosmetic medicament related contact dermatitis patch tested emulsifier agents triethanolamine cetyl stearyl alcohol sorbitan sesquioleate polyoxyethylene sorbitan monopalmitate polyoxyethylene sorbitan monooleate amerchol l patients gave positive patch tests emulsifiers total positive reactions found clinically relevant triethanolamine frequent sensitizer patients emulsifier sensitivity generally give high prevalence positive patch tests common ingredients topical preparations preservatives active ingredients cosmetics topical medicaments detected source sensitization equal number patients patch tests patients causative preparations frequently negative avoid overlooking emulsifier sensitivity advisable test compounds patients contact dermatitis possibly due topical preparations regardless whether clinically relevant positive reactions whether patch tests products negative,C17,0.0027668027,0.0024514692,0.031911984,0.0416879,0.07071789,0.0035889612,0.2253414,0.002598942,0.0019979745,0.0027154193,0.20105079,0.021442454,0.051191345,0.0065996186,0.0024303757,0.017678859,0.12442921,0.0028460708,0.003146788,0.13758661,0.04199313,0.0009812611,0.002844725
cyclosporin combination photochemotherapy puva treatment psoriasis forty patients relapsing plaque psoriasis involving body surface treated either cyclosporin cya plus puva retinoid etretinate plus puva repuva initially received either cya weeks etretinate week alone puva given concomitantly complete remission patients monitored period months relapse recorded combined treatment regimen cya plus puva repuva patients cleared within comparable periods time mean treatment period vs weeks initiation therapy vs weeks initiation puva however cumulative uva dose required clearance j cm vs j cm p less incidence severe early relapses significantly higher cya cohort within months severe relapses occurred cya plus puva repuva treated patients p less suggests cya plus puva regimen performed study less effective repuva,C17,0.0028855025,0.0025538157,0.015366418,0.0016175921,0.004018478,0.04551948,0.2523763,0.0027074455,0.0020813881,0.0028287857,0.013570041,0.0064466656,0.12141388,0.010818939,0.01392912,0.0044832,0.2628295,0.0029648917,0.003278164,0.054014254,0.1703121,0.0010222279,0.0029618081
uroporphyrinogen decarboxylase splice site mutation causes deletion exon multiple families porphyria cutanea tarda uroporphyrinogen decarboxylase uro cytosolic heme biosynthetic enzyme converts uroporphyrinogen coproporphyrinogen defects uroporphyrinogen decarboxylase locus cause human genetic disease familial porphyria cutanea tarda splice site mutation found pedigree familial porphyria cutanea tarda causes exon deleted mrna intron exon junctions either side exon fall codons resulting protein shorter normal protein missing amino acids coded exon shortened protein lacks catalytic activity rapidly degraded exposed human lymphocyte lysates detectable western blot analysis lymphocyte lysates derived affected individuals mutation detected five unrelated familial porphyria cutanea tarda pedigrees tested appears common first splice site mutation found uro locus first mutation causes familial porphyria cutanea tarda found one pedigree,C17,0.0025908677,0.014837979,0.00483429,0.013985223,0.015024434,0.015742341,0.26230392,0.014973795,0.0018730819,0.0025456795,0.116565116,0.0053289193,0.031345725,0.029133411,0.0022783435,0.0040345197,0.025880013,0.16011302,0.002950084,0.037921146,0.07817564,0.00091992295,0.15664257
arthritis mast cell activation significance mast cell pathogenesis rheumatic diseases continues receive attention increased numbers mast cells found synovial tissue fluid patients inflammatory arthritides mast cells activated many substances found inflammatory synovial fluid activation results release mediators capable amplifying inflammatory process within joint space recent research shown mast cells also produce variety cytokines hematopoietic growth factors may paracrine autocrine functions important development inflammatory cell infiltrate increased numbers mast cells also found many fibrotic conditions including scleroderma mast cells directly mediator generation affect function endothelial cells fibroblasts growth factors important proliferation function cells clearer understanding mast cell involvement inflammatory arthritides fibrotic processes lead new therapeutic strategies,C17,0.0024963391,0.0022143773,0.0046579097,0.0014025911,0.003476073,0.015299146,0.35111532,0.02650187,0.001804742,0.0024527998,0.012321734,0.009606848,0.038234264,0.27088934,0.0021952176,0.0038873192,0.041544452,0.038822412,0.0028424494,0.018506302,0.12210767,0.02505272,0.0025681416
subacute cutaneous lupus erythematosus lesions progressing morphea women annular lesions subacute cutaneous lupus erythematosus slowly resolved replaced plaques morphea immunologic implications unique transitional case subacute cutaneous lupus erythematosus morphea discussed,C17,0.008022137,0.007116036,0.014968476,0.0045073116,0.088844225,0.010352986,0.18873528,0.046369027,0.0057996484,0.007882222,0.07538489,0.016500004,0.049658503,0.019181529,0.0070544654,0.012492136,0.18423392,0.008261471,0.009134384,0.09040087,0.13399923,0.0028483695,0.00825288
inhibition nk cell function azathioprine treatment patients rheumatoid arthritis treatment azathioprine patients rheumatoid arthritis leads dramatic reduction h nk cytotoxicity k cells h cytotoxicity k u cells however remains intact generation cell free supernatant cytotoxic factor incubating non adherent mononuclear cells u cells h similar azathioprine patients controls large part supernatant cytotoxicity due tumour necrosis factor alpha inhibited specific monoclonal antibody mechanism reduced h nk cytotoxicity remains unknown probably related anti inflammatory properties azathioprine,C17,0.0038628913,0.003409051,0.00848884,0.0021592998,0.0053527784,0.004959764,0.30930623,0.0036141293,0.0027784144,0.0037761042,0.017716805,0.008029276,0.03253684,0.20375371,0.0033795545,0.006401571,0.09866231,0.004305876,0.004375973,0.049364164,0.19970012,0.0013645571,0.022701707
induction ornithine decarboxylase following sellotape stripping normal psoriatic skin ornithine decarboxylase odc measured epidermis healthy volunteers uninvolved skin psoriatic patients various times sellotape stripping basal levels less pmol min mg protein activity peaked maximum pmol min mg protein h followed abrupt decline lower level remained relatively constant least h difference seen response controls psoriatic patients pretreatment topical corticosteroids reduced peak odc levels one half oral indomethacin effect,C17,0.0034578447,0.003066831,0.006451033,0.0019425369,0.03828865,0.037915796,0.1133818,0.003251322,0.0024995012,0.020130508,0.016155992,0.007180105,0.19853486,0.008093916,0.0030402953,0.022601152,0.096224464,0.03729112,0.0039366875,0.041379794,0.33039144,0.001227575,0.0035567814
mechanisms involved allergic contact dermatitis allergic contact dermatitis common inflammatory skin disease caused agents plants chemical compounds topical medications histologic features typically include edema within epidermis dermis lymphohistiocytic infiltrate admixture basophils langerhans cells keratinocytes play pivotal roles allergic contact dermatitis reactions langerhans cells synthesize express class ii molecules allow presentation exogenous antigens lymphocytes additionally keratinocytes langerhans cells produce interleukin thought second signal activates cells mast cells basophils also may play proinflammatory role treatment primarily consists removal offending agent times systemic corticosteroids may required especially acute phase chronic cases topical corticosteroids may beneficial antihistamines may useful soporific effects usefulness limited,C17,0.0030491038,0.0027047072,0.020436533,0.001713167,0.019005718,0.003935027,0.5244781,0.002867414,0.0022043663,0.0029959234,0.03726452,0.021021415,0.022938434,0.07415672,0.002681305,0.019505925,0.02934372,0.017893856,0.003471853,0.06534259,0.11876076,0.0010826259,0.003146294
speculations immunopathogenesis psoriasis cell violation keratinocyte sphere influence thesis advanced differences antigen processing presentation described fresh cultured langerhans cells vitro reflect similar differences intraepidermal intranodal langerhans cells vivo functional properties langerhans cells dependent upon microenvironment reside thus intraepidermal langerhans cells influence cytokines secreted keratinocytes whereas intranodal langerhans cells come influence lymphokines lymphocytes speculated genetic lesion psoriasis robs keratinocytes capacity create appropriate epidermal microenvironment consequence intraepidermal langerhans cells adopt functional program intranodal cells uninvolved psoriatic skin receives cutaneous challenge antigen langerhans cells activating naive cells situ unwittingly engender microenvironment appropriate lymph node skin becomes involved gradually acquires features associated lymph nodes high endothelial venules derangement complicated abnormalities proliferation differentiation among keratinocytes dermal fibroblasts respond inappropriate cell derived lymphokines giving rising typical active psoriatic lesion,C17,0.0029622968,0.002627705,0.006778364,0.0016643937,0.06148888,0.018141538,0.22951087,0.032060422,0.0021416086,0.0029106305,0.056464262,0.015459907,0.039302852,0.12103513,0.002604969,0.061971426,0.046073113,0.023270052,0.014711343,0.07477348,0.15738133,0.0010518039,0.0256136
phenotypic characteristics dissociated mononuclear cells rheumatoid synovial membrane phenotypic characteristics enzymatically dissociated synovial membrane mononuclear cells patients samples rheumatoid arthritis ra assessed fluorescence activated flow cytometry compared peripheral blood pb mononuclear cells patients ra normal controls significant difference percentage cd cd lymphocytes synovial membrane compared ra normal pb double labelling experiments revealed similar percentages cd cdw helper inducer cd cd r suppressor inducer cells ra normal pb contrast sm cd cdw cells present significantly higher proportions ra normal pb p less conversely synovial membrane cd cd r cells present significantly lower proportions ra normal pb p less similar pattern cdw cd r antigen expression noted cd lymphocytes reflecting increased killer effector p less decreased suppressor effector p less cells respectively experiments revealed significant increase percentage synovial membrane cd cells b lymphocytes hla dr cells compared ra pb p less p less normal pb p less p less similar proportions cd cells monocytes macrophages results suggest ra synovial membrane contains populations b lymphocytes differ quantitatively qualitatively pb may account abnormalities intraarticular humoral cellular immune responses patients ra,C17,0.0019534829,0.0017328367,0.060386874,0.0010975823,0.0027424104,0.0025210714,0.17131051,0.011290864,0.0014122811,0.0019194116,0.01949489,0.004223433,0.30396464,0.14300062,0.0017178435,0.003041979,0.051983662,0.012290756,0.0022243275,0.054012675,0.13476855,0.00069361075,0.012215678
condylomata acuminata children frequent association human papillomaviruses responsible cutaneous warts identify papillomavirus types associated condylomata acuminata children evaluate mode transmission studied children anogenital warts external condylomata found mothers fathers ten mothers including two without external lesions cervical condylomata blot hybridization studies disclosed genital human papillomavirus hpv children hpv hpv two patients hpv hpv found another child polymerase chain reaction technique infection occurred likely birth nonsexual contact sexual abuse could excluded one year old girl cutaneous hpv found seven children yet uncharacterized papillomaviruses found two children three mothers hpv infected children common hand warts two children subungual warts study shows frequent nonsexual transmission genital papillomaviruses children unexpectedly high association children condylomata papillomaviruses responsible skin warts possibly transmitted heteroinoculation autoinoculation,C17,0.0028791889,0.002553984,0.0053722677,0.0016177644,0.031885725,0.003874977,0.31545085,0.002707624,0.01599302,0.15615736,0.07487796,0.0059219413,0.018933363,0.014548303,0.002531886,0.004483496,0.04107839,0.002965087,0.031151773,0.1786662,0.054691784,0.0010222953,0.030634752
fibrin deposition occurs early late intervals ige dependent contact sensitivity reactions elicited mouse skin mast cell dependent augmentation fibrin deposition early intervals combined ige dependent contact sensitivity reactions elicited skin mice either ige dependent immediate hypersensitivity reactions cell dependent contact sensitivity cs reactions result local extravasation fibrinogen deposition fibrin however two types reaction differ kinetics requirement ige mast cells cells present study investigated kinetics magnitude fibrin deposition combined ige dependent cs reactions elicited simultaneously site compared results obtained two reactions elicited separate sites found fibrin deposition pure ige dependent reactions greater h challenge h significant fibrin deposition persisted sites h challenge cs reactions fibrin deposition detected early h challenge indicating fibrin deposition accompanies early component cs detected van loveren et al use measurements tissue swelling much fibrin deposition present cs reactions h h ag challenge ige dependent cs reactions elicited site fibrin deposition early intervals h challenge increased three fold compared seen isolated cs reactions h results combined reactions virtually identical cs responses studies genetically mast cell deficient congenic normal mice indicated mast cells required expression ige dependent augmentation fibrin deposition observed early intervals combined ige dependent cs reactions fibrin deposition associated pure cs reactions findings indicate net effect ige dependent mast cell activation cs responses increase fibrin deposition associated responses effect appreciated early intervals elicitation reaction,C17,0.0016047556,0.009173995,0.04181412,0.00090166024,0.017771212,0.009829409,0.44659445,0.0015091316,0.0011601669,0.0015767667,0.012357334,0.01106474,0.029360453,0.09475331,0.009170978,0.002565852,0.036682907,0.01854471,0.0018272504,0.011732667,0.22081248,0.0005697904,0.018621838
familial occurrence bullous mastocytosis diffuse cutaneous mastocytosis studied four patients mother two daughters son bullous mastocytosis diffuse cutaneous mastocytosis whose genetic inheritance suggested autosomal dominant pattern clinical characteristics included extensive bullae numerous urticaria pruritus flushing pseudolichenified skin body surfaces without systemic organ involvement histopathologic findings disclosed pronounced accumulation mast cells dermis electron microscopic studies lesional skin obtained infancy showed round spindle shaped mast cells numerous fingerlike villous protrusions cytoplasmic granules varied size shape appearance degranulation markedly noted adult mast cells markedly decreased numbers granules cytoplasmic villi cells displayed degenerative necrotic appearances findings correlated well clinical course cases improved spontaneously time,C17,0.00300614,0.0026665963,0.0058747777,0.0016890274,0.020929322,0.0038795804,0.20865999,0.07558388,0.030974848,0.017499343,0.08928818,0.0061830557,0.05931448,0.08560562,0.016082171,0.0046811854,0.058042113,0.003095826,0.0034229327,0.10404031,0.19526686,0.0010673711,0.0031463937
treatment chromoblastomycosis treatment chromoblastomycosis frequently difficult unsatisfactory representative case presented chronic subcutaneous fungal infection characterized warty cauliflower like lesions usually extremities chromoblastomycosis treatment reviewed attention itraconazole new triazole compound possible drug choice,C17,0.006306937,0.005594568,0.01176809,0.0035436105,0.03931448,0.008139431,0.50762177,0.00593112,0.0045596347,0.0061969357,0.060661305,0.04349436,0.039041094,0.014590644,0.005546161,0.040350795,0.057978064,0.006495099,0.0071813753,0.04177733,0.07514993,0.0022393642,0.0065178946
method determination uva protection normal skin although uvb portion electromagnetic spectrum nm responsible harmful effects sunlight skin wavelengths uva region also contribute photodamage simple rapid clinical test sun protection factor determination available assess sunburn protective effect sunscreen primarily uvb effect however practical test proposed measure sunscreen uva protection described method calculation uva protection normal subjects determination uva protection involves three steps uv absorbance spectrum sunscreen skin determined spectrophotometrically convolution spectrum calculated multiplying solar spectrum commission internationale de l eclairage uv hazard spectrum sunscreen transmission spectrum incorporated convolution spectrum obtain uva effectiveness ratio expressed uva protection percentage uva protection percentage value based normal erythemic risk standard sunlight protection product easily measured procedure simple values generated reproduced laboratories,C17,0.002623283,0.040418737,0.0049068155,0.0014739158,0.041751575,0.0034205003,0.17618604,0.002466967,0.090792716,0.0025775295,0.15199119,0.0053955917,0.15622038,0.04464418,0.002306849,0.0040849973,0.05057876,0.0027043251,0.015681919,0.07444468,0.1216695,0.00093143247,0.002728078
role antihistamines atopic dermatitis although several lines evidence support role histamine pathogenesis atopic dermatitis antihistamines generally offered marginal therapeutic benefit efficacy classic antihistamines severely limited sedative effects demonstrating need improved nonsedating agents multifunctional antihistamines third generation antiallergic drugs appear offer variety advantages beyond ability inhibit histamine release inhibition mediator release interference eosinophil migration double blind studies high dose regimens needed help clarify therapeutic efficacy antiallergic drugs,C17,0.0035163867,0.0031192105,0.057617556,0.0019757142,0.004900426,0.0048038834,0.48458132,0.02029567,0.002542191,0.0034711778,0.025610376,0.0072325356,0.04277271,0.044630345,0.0030922217,0.0054757455,0.031614475,0.0036594707,0.03524903,0.036904868,0.15505062,0.018266514,0.003617529
surgical management palmar hyperhidrosis hyperhidrosis idiopathic pathologic condition characterized excessive sweating beyond required cool body disturbance central nervous system endocrine system obesity associated condition patients history several years occupational social embarrassment individuals japanese ancestry jews northern african yemeni balkan descent predisposed condition nonoperative therapy merely temporizing unacceptable lack efficacy side effects surgical intervention provides effective permanent control key surgical correction appears division sympathetic chain ganglion ganglion involved side removal entire segment corresponding spinal nerves paper presents experience dorsal thoracic approach interruption sympathetic innervation severe palmar hyperhidrosis also review surgical efficacy various approaches sympathetic chain well possible side effects operative intervention,C17,0.016379591,0.014656706,0.02955261,0.0014379226,0.015937211,0.014238111,0.41930506,0.0024067236,0.014231059,0.002514586,0.024104565,0.005315492,0.06068514,0.018438414,0.02654969,0.016335113,0.12533167,0.0026355744,0.0029140508,0.072485454,0.08489014,0.00090868684,0.028746443
psoriasis vulgaris genetic approach evidence genetic contribution psoriasis comes direct examination large segment population isolated island environment epidemiologic questionnaire studies presented psoriatic patients twin studies collected literature twin registries splitsibship analysis concordance psoriasis monozygotic twins whereas psoriasis dizygotic twins determination concordance older twin pairs national twin registry denmark revealed nearly heritability order link psoriasis known markers within human genome serologic studies carried variety blood group polymorphic protein antigens weak association mns lewis blood groups systems relative risk identified stronger associations class b locus class ii locus genes relative risk also determined studies human lymphocyte antigen system finally strong association hla cw determined marker thought linkage disequilibrium b locus genes previously associated psoriasis relative risk developing psoriasis hla cw positive individuals large kindred reported dermatology literature support hypothesis autosomal dominant inheritance penetrance approximately cooperation national psoriasis foundation identified families psoriasis three generations begun process ascertainment construction family trees collection leukocyte dna linkage analysis established restriction fragment polymorphisms rflp initial assessment directed four rflp span approximately centimorgans short arm human chromosome although karyotyping uncommonly done patients psoriasis seek evidence translocations chromosome association psoriasis,C17,0.0016832697,0.0014931442,0.035732187,0.00094576064,0.0023487257,0.0021723474,0.31942827,0.009697005,0.001216929,0.0016539114,0.080728255,0.01976017,0.029332148,0.04916771,0.009623542,0.0026278342,0.032224055,0.010083219,0.010046938,0.19466498,0.061105363,0.008739162,0.1155251
epidermal growth factor transforming growth factor alpha receptors psoriasis abnormal growth differentiation psoriasis reflected abnormal regulation epidermal growth factor transforming growth factor alpha egf tgf alpha receptor metabolism psoriasis hyperproliferative skin conditions receptors persistently expressed throughout interfollicular epidermis long growth stimulatory signal persists one first biochemical signs effective therapy psoriasis return egf tgf alpha receptor pattern toward primarily basilar distribution seen normal human adult skin whether abnormal expression tgf alpha involved skin induces persistent expression egf receptors known signal causes increased production tgf alpha studies determine factors regulate egf receptor expression tgf alpha induction may yield important new insights pathogenesis therapy psoriasis,C17,0.0026570435,0.0023569302,0.017790576,0.0014928845,0.04228892,0.0034290531,0.28415743,0.0025070151,0.0019209243,0.015468304,0.0464514,0.005465031,0.021868793,0.14483508,0.0151907895,0.029856406,0.029109254,0.08647663,0.003025435,0.047218144,0.10790265,0.00094341964,0.08758784
abnormal essential fatty acid metabolism darier disease fatty acid levels plasma erythrocyte cell membranes determined danish patients darier disease danish controls concentrations main dietary essential fatty acids linoleic acid n alpha linolenic acid n consistently modestly normal concentrations delta desaturase metabolites linoleic alpha linolenic acids however consistently often significantly normal results suggest capacity enzyme delta desaturase activity inadequate patients darier disease,C17,0.003773196,0.0033470131,0.04355716,0.002120005,0.005254056,0.004869506,0.33455554,0.0035483593,0.0027278527,0.0037073868,0.025448916,0.00782606,0.08356264,0.030696105,0.0033180534,0.024136377,0.066815965,0.003908363,0.0042963387,0.0641138,0.20013337,0.0013397248,0.076944195
epidemiology natural history pressure ulcers elderly nursing home residents analyzed prospective data elderly residents nursing homes determine prevalence incidence natural history pressure ulcers among residents admitted nursing homes possessed stage ii stage iv pressure ulcer residents admitted nursing home without pressure ulcers study period year incidence increased years nursing home stay people already residing nursing home start study year incidence increased years pressure ulcers associated increased rate mortality hospitalization longitudinal follow residents pressure ulcers demonstrated majority lesions healed year improvement occurred early person nursing home stay although nursing home residents pressure ulcers higher mortality good medical care pressure ulcers expected heal,C17,0.0023815488,0.0021125525,0.004443723,0.001338095,0.0148632815,0.0030735126,0.19287111,0.0022396373,0.0017217537,0.0023400115,0.023253342,0.037772775,0.1428775,0.005475916,0.002094274,0.0037085665,0.08918085,0.0024526003,0.014226669,0.39998814,0.04828358,0.00084560143,0.0024549942
activation pathways synovial lymphocytes expression function um cdw antigen accumulating evidence implicates central role synovial cells pathogenesis rheumatoid arthritis activation pathways drive proliferation effector function cells known recently generated novel monoclonal antibody rheumatoid synovial cell line recognizes antigen termed um cdw antigen expressed minority peripheral blood cells represents surface component distinct pathway human cell activation current studies performed examine expression function um cells obtained synovial fluid synovial membranes patients rheumatoid arthritis forms inflammatory joint disease um antigen expressed high surface density three fourths synovial fluid cells small subset synovial fluid natural killer cells synovial tissue present cells lymphoid aggregates approximately cells stromal infiltrates addition um expressed synovial tissue previously undescribed population hla dr dp negative non cells dendritic morphology anti um co mitogenic ra non ra synovial fluid mononuclear cells induced il receptor expression um cdw antigen may represent functional activation pathway synovial compartment cells could play important role pathogenesis inflammatory arthritis,C17,0.0019174216,0.0017008486,0.0334309,0.0010773782,0.0026733612,0.0024745325,0.16948988,0.011037514,0.010642646,0.0018839793,0.031642247,0.0039437697,0.02632973,0.30562907,0.0016861322,0.01576707,0.0320395,0.06805763,0.0021832664,0.055120006,0.17765243,0.0006808067,0.042939845
digital imaging techniques dermatology digital imaging versatile technique infrequently used dermatology record visual images used technology patients follow cutaneous lesions including alopecia mucinosa psoriasis dysplastic nevi setup included personal computer digitizer board monitor video camera lights introduction electronic digital imaging given many possible applications dermatology discussed,C17,0.005069151,0.02902265,0.03501961,0.0028481493,0.12976055,0.0065420037,0.34175447,0.004767091,0.0036647706,0.029503372,0.07126046,0.010661269,0.032749213,0.011655544,0.004457684,0.032430276,0.105204284,0.0052203853,0.005771974,0.033517737,0.09210454,0.0017998714,0.0052149557
cultured epidermal autografts allografts study differentiation allograft survival cultured epidermal sheets examined various times grafting skin ulcer beds grafting sheet consisted four five layers keratinocytes incomplete differentiation ten days grafting graft recipient sites showed compact hyperkeratosis normal appearing epidermis flat dermoepidermal junction months stratum corneum basket weave appearance dermoepidermal junction remained flat monoclonal antibodies keratins showed normal basal suprabasal localization respectively electron microscopy showed normal basement membrane anchoring fibrils lh monoclonal antibody binds type vii collagen molecule stained dermoepidermal junction biopsy specimens ae antibody stains suprabasal cells hyperproliferative skin expressed suprabasally weeks healing weeks grafting expression confined basal layer weeks healing months grafting anti involucrin staining found deeper layers epidermis weeks healing weeks grafting receded normal distribution upper spinous granular layers weeks months grafting overall histologic patterns observed recipient sites first months grafting resembled observed days newly healed epidermis hyperproliferative states psoriasis four sex mismatched graft sites specimens reacted biotinylated probe chromosome situ hybridization lack chromosome positive cells suggested host keratinocytes replaced allografts multilocus dna analysis one patient confirmed observation data suggest altered state epithelial maturation persists several months culture grafting restoration normal pattern months differences detected autografted allografted sites,C17,0.0017849212,0.010157772,0.0050953133,0.054210696,0.019766556,0.0023035337,0.21541075,0.019027775,0.0012904186,0.00175379,0.05750682,0.0037203361,0.05902429,0.065666385,0.01020165,0.0027794936,0.12045966,0.043173127,0.0020323955,0.023992483,0.22008246,0.00063376065,0.059925593
functional studies soluble low affinity interleukin receptors rheumatoid synovial fluid since abnormal regulation interleukin il demonstrated rheumatoid arthritis ra functional role low affinity soluble il receptors sil r purified ra synovial fluids sf studied picomolar levels sil r detected ra sf using enzyme linked immunosorbent assay levels higher serum sf ra patients controls p less higher ra sf paired ra serum p less soluble il r ra sf estimated molecular weights kd kd gel filtration analysis kd peak likely dimer kd peak since single kd peak found elution sodium dodecyl sulfate polyacrylamide gels since inhibitory activity lymphocyte proliferation found kd range sil r purified anti cd affinity column analyzed purified fractions interfere proliferation mitogen stimulated lymphocytes binding radiolabeled il ctll cells although direct binding il demonstrated affinity sil r ra sf binding il range nm similar affinity sil r purified human cell clone indicating sil r low affinity receptors il conclude concentration binding affinity low affinity sil r purified ra sf render unable interfere il related activities,C17,0.002381424,0.002112442,0.0044434904,0.01282995,0.0033165829,0.026112577,0.16774036,0.00223952,0.0017216636,0.002339889,0.04626727,0.004920441,0.14757669,0.08535272,0.0020979296,0.026756838,0.044014234,0.106204815,0.0027116016,0.031276233,0.25785807,0.00084555714,0.018879743
comparative histopathologic study photodistributed nonphotodistributed lichenoid drug eruptions study compares histopathologic characteristics photodistributed nonphotodistributed lichenoid drug eruptions patients types said unknown proportion different idiopathic lichen planus involve deep well superficial plexus contain eosinophils parakeratotic scale found features often present nonphotodistributed lichenoid drug eruptions seldom present photodistributed eruptions thus biopsy specimen shows classic features lichen planus used evidence drug eruption especially lesions photodistributed,C17,0.004418534,0.0039194603,0.008244527,0.024374492,0.027542625,0.0057023484,0.5282698,0.004155243,0.0031944034,0.004341469,0.045066036,0.03046902,0.036299363,0.010711227,0.0038855474,0.0068805767,0.057329323,0.0045503573,0.005031151,0.040980246,0.13847359,0.001568861,0.0045917165
basophil histamine release airway response mite allergen atopic dermatitis twelve patients atopic dermatitis ad subjected vitro histamine release peripheral blood leukocytes basophils vivo bronchial inhalation challenge using house dust mite dermatophagoides farinae allergen seven patients asthmatic history also five patients without asthma responded vitro vivo challenges significant correlation observed hr mite concentration producing release total cellular histamine pc allergen mite concentration producing fall fev also significant correlation mhr maximal histamine release maximal fall fev relationship held ad patients asthma without asthma results suggest histamine release induced house dust mite allergen good vitro test predicting bronchial response allergen also suggest tests disease specific valuable evaluating degree atopic state subject,C17,0.003004876,0.0026654748,0.020183956,0.0016883172,0.0041841944,0.03296735,0.2157649,0.0028258217,0.031263497,0.032038257,0.06527844,0.0061804554,0.13354607,0.0073635937,0.017208679,0.0046792165,0.09672056,0.0031036409,0.003421493,0.021290464,0.29045933,0.0010669222,0.0030944576
cyclosporine treatment psoriasis clinical mechanistic perspective cyclosporine unique immunomodulatory agent used increasingly last years management severe psoriasis remarkable efficacy drug coupled known immunosuppressive properties enabled appreciation role immune system induction maintenance psoriatic plaques although acting primarily lymphocytes also evidence effect cyclosporine constitutive cell types within skin future use systemically administered cyclosporine treatment psoriasis cutaneous diseases dependent successful balance efficacy side effect profile namely dose related problems hypertension nephrotoxicity result toxicity encountered systemically administered cyclosporine attempts formulate successful topical preparation use cutaneous disease made advent cyclosporine provides dermatologist new therapeutic strategem management psoriasis although long term safety interventional therapy remains discerned,C17,0.03168143,0.03607644,0.04510875,0.01537401,0.017461518,0.024400728,0.44593534,0.0026344594,0.002025279,0.0027525285,0.013357095,0.02268647,0.017409017,0.02124528,0.0024634702,0.031473674,0.08459211,0.0028849654,0.0031897926,0.055191282,0.11817807,0.0009946711,0.0028836115
immunologic mechanisms psoriasis demonstration activated lymphocytes hla dr cam gamma ip keratinocytes increased levels lymphokines active plaques suggests immunologic mechanisms may play role pathogenesis psoriasis epidermal hyperplasia inflammation psoriasis may linked cytokines many produced keratinocytes leukocytes epidermal acanthosis keratinocyte mitoses observed delayed type hypersensitivity reactions intradermal injection gamma interferon gamma interferon induced proteins demonstrated active psoriatic plaques increased levels keratinocyte autocrine cytokines transforming growth factor tgf alpha interleukin il detected active plaques apparent overexpression il hyperplastic psoriatic tissue may explain features psoriasis link keratinocyte proliferation immune activation tissue inflammation il gamma interferon increased tgf alpha expression normal cultured keratinocytes cytokines produced immune activation inflammatory processes may lead epidermal hyperplasia,C17,0.0030492228,0.002704813,0.0056895334,0.001713304,0.0042462987,0.003935181,0.31735116,0.032386698,0.0022044524,0.017754473,0.020989839,0.021028114,0.021346882,0.061191555,0.0026814097,0.004748274,0.07025451,0.06568753,0.0034719887,0.054592654,0.26268375,0.0010826682,0.019205682
anti u small nuclear rna antibodies anti small nuclear ribonucleoprotein sera patients connective tissue diseases small nuclear ribonucleoprotein snrnp particles class rna containing particles nucleus eukaryotic cells sera patients connective tissue diseases often contain antibodies proteins present snrnps antibodies rna components snrnps u snrnas thought rare tested anti snrnp sera presence anti snrna antibodies found sera sera antibodies igg f ab fragments thereof exclusively directed u snrna anti u rna antibodies always accompanied anti u rnp antibodies found sera contain antibodies sm serotype directed nucleoplasmic u snrnp particles like anti rnp antibodies anti u rna activity confined sera patients sle sle overlap syndromes rarely found patients connective tissue diseases analyzing binding subfragments u snrna made vitro demonstrated anti u rna antibodies recognize epitopes distributed throughout u rna molecule sera however either second fourth hairpin loop main target antibody possible mechanisms could lead production new type autoantibody discussed,C17,0.0020104728,0.0017833897,0.013480911,0.0011296311,0.0027997016,0.00259462,0.311088,0.011619131,0.0014534824,0.011695014,0.024046477,0.0041351584,0.012519476,0.14630266,0.011495366,0.0031307244,0.059929352,0.043631226,0.002289219,0.024173576,0.18754992,0.00071384583,0.12042868
multiple keratoacanthomas treated oral retinoids multiple eruptive keratoacanthoma witten zak rare disorder characterized numerous small eruptive tumors larger typical keratoacanthomas affected patients features grzybowski type keratoacanthomas ferguson smith type two patients multiple keratoacanthomas treated oral retinoids patients hundreds follicular papules trunk extremities less common lesions included nodules central horn filled craters characteristic classic keratoacanthomas retinoid therapy resulted regression larger typical keratoacanthomas patients small follicular keratoacanthomas remained unaffected thus oral retinoids partially beneficial treatment grzybowski type witten zak type multiple eruptive keratoacanthomas,C17,0.003516018,0.0031188834,0.006560525,0.0019757955,0.039052162,0.0045376043,0.430543,0.07138783,0.0025419244,0.003454694,0.08309494,0.007231777,0.036182452,0.008240947,0.0030918973,0.022480486,0.15191615,0.0036209156,0.004003504,0.024518363,0.084053904,0.0012484102,0.0036277834
lymphocyte trafficking psoriasis new perspective emphasizing dermal dendrocyte active dermal recruitment mediated via endothelial cells followed intra epidermal cell activation prominent within inflammatory infiltrate psoriasis hla dr positive lymphocytes factor xiiia positive dermal dendrocytes many investigators studying psoriasis assumed hla dr positive cells activated thereby capable producing lymphokines gamma interferon however immunohistochemical analysis greater dermal cells psoriatic lesions ki negative suggests resting non cycling go state contrast dermal cell population epidermal cell population contains greater population ki positive lymphocytes entry cells epidermis therefore apparently associated important activation event likelihood involves interaction keratinocyte presence activated intraepidermal cells substantiated ability detect gamma interferon mrna polymerase chain reaction epidermal sheets psoriatic lesions pathophysiologic implication psoriasis distinctions compartmentalization involving dermal epidermal cells placed context cascade cellular trafficking events dissected specific network molecular mediators inflammation report suggests attention placed microenvironment skin specific emphasis mechanism cells accumulate dermis epidermis elucidation selective inductive recruitment capabilities endothelial cells perivascular dermal dendrocytes keratinocytes,C17,0.0022276482,0.001976035,0.0041565606,0.0012516247,0.024665127,0.0028748962,0.2683852,0.023655023,0.012305805,0.0021887952,0.055124354,0.0045818468,0.028885696,0.23078673,0.0019589376,0.0035415455,0.05419454,0.06069519,0.0025365052,0.073108956,0.12702407,0.011569754,0.0023052124
effects haem arginate variegate porphyria four patients variegate porphyria vp treated repeated haem arginate infusions daily days weekly weeks initial four daily doses haem arginate haem mg kg excretion faecal protoporphyrin mean nmol g dry wt fell almost normal level mean nmol g dry wt coproporphyrin mean nmol g dry wt normal level mean nmol g dry wt patients however period four weekly infusions haem excretion porphyrins increased almost pretreatment level phototesting showed changes photoreactivity skin improvement skin lesions seen treatment except one case thrombophlebitis side effects occurred child homozygous vp four daily infusions haem arginate mg kg normalized faecal protoporphyrin content effect increased erythrocyte protoporphyrin concentration,C17,0.017533416,0.0026655323,0.034558564,0.0016883535,0.047826227,0.0038780323,0.10295151,0.0028258825,0.0021724382,0.017499723,0.028977932,0.02198209,0.17718247,0.006984009,0.017165955,0.0046894955,0.10846609,0.0030961612,0.003421567,0.019833257,0.35596308,0.0010669453,0.017571257
protective effect oral contraceptive pill rheumatoid arthritis overview analytic epidemiological studies using meta analysis oral contraceptive pill ocp implicated protective effect development rheumatoid arthritis ra results studies reported produced differing results conclusions discrepancy results importance issue undertook review studies performed meta analysis independent studies satisfied criteria selection case control design longitudinal using standard meta analysis techniques overall pooled odds ratio studies crude results ci adjusted results ci graphical odd man method produced interval pooled odds ratio case control studies lower longitudinal studies however subdividing studies type case source produced pooled odds ratio studies using hospital based cases ci considerably less studies using population based cases difference unlikely explained bias due selection controls suggest ocp use may protective effect development ra may prevent progression severe disease modifying disease process,C17,0.0020592313,0.011745086,0.012902936,0.0011522805,0.0028556404,0.013413359,0.3133357,0.0019285745,0.0014826197,0.0119221555,0.13310863,0.0043203533,0.041375868,0.015808731,0.031571,0.0031972746,0.048743743,0.002111959,0.012253851,0.10600862,0.2258645,0.000728156,0.0021097625
contact dermatitis acrylate methacrylate compounds lowicryl embedding media electron microscopy report occupational contact dermatitis found workers chemistry laboratory using lowicryl embedding media contain meth acrylate monomer mixtures known composition notation meth acrylates used refer acrylates methacrylates meth acrylate monomers polymerize absence oxygen induced metal ions peroxides heat ultraviolet light monomers low viscosity remain liquid state temperatures far degree c volatile compounds exhibit pungent odour tendency penetrate tissue permeate finest fissures property makes suitable sealants glues embedding material etc toxicity may represent danger health individuals need work especially precautions taken show patch testing one patient reacted strongly compound hydroxyethyl acrylate dilutions tested v v meth acrylates test volunteer controls negative hydroxyethyl acrylate demonstrate maximum working concentration hydroxyethyl acrylate penetrates latex vinyl gloves elicits irritant allergic reactions patient irritant reactions control finally discuss necessary protective measures,C17,0.0027276713,0.0024195805,0.05742575,0.0015325672,0.016983163,0.029810367,0.32838982,0.002565135,0.0019719847,0.01586169,0.0848585,0.047427397,0.10341606,0.0263035,0.0023986453,0.0042475513,0.06337868,0.029196614,0.016306669,0.034208428,0.12476998,0.00096849696,0.002831736
effect long term puva treatment psoriasis collagen elastin gene expression growth skin fibroblasts vitro proliferation rate collagen metabolism collagen elastin messenger rna levels studied fibroblasts derived patients received many courses either systemic methoxypsoralen topical trioxsalen puva treatment proliferation rate fibroblasts measured incorporation h thymidine cellular division decreased obtained patients puva treatment compared controls collagen synthesis slightly increased cells puva treated patients relative collagen synthesis ratio types iii collagen unchanged levels collagen elastin mrnas increased fibroblasts derived puva treated patients significant differences histology immunochemistry could found biopsies taken topical systemic puva treated patients,C17,0.0025271238,0.0022416848,0.029180948,0.090315536,0.015751816,0.0032613848,0.18782619,0.0023780782,0.001826998,0.0024830475,0.029241338,0.008230709,0.10661596,0.068980604,0.0022222889,0.003935257,0.15651678,0.05798831,0.002877502,0.055096973,0.14049512,0.0008972898,0.02910909
sodium lauryl sulphate irritant patch testing dose response study using bioengineering methods determination skin irritation dose response relationship patch testing sodium lauryl sulphate sls studied irritant skin response quantified visual scoring well following noninvasive methods measurement transepidermal water loss tewl evaporimeter measurement skin color colorimeter measurement superficial blood flow laser doppler flowmetry measurement edema skin ultrasound scan twelve volunteers patch tested sls skin response evaluated h respectively found statistically significant linear dose response relationship dose sls skin response evaluated measurement tewl skin color superficial blood flow edema statistical evaluation regression analysis proved measurement tewl method best suited overall quantification relation patch testing sls whereas colorimetry found least sensitive applied methods ultrasound scan found promising method quantification inflammatory response consistently sensitive measurement skin color,C17,0.0020715059,0.001837529,0.036237534,0.0011638947,0.13535999,0.0026733861,0.08640686,0.0019480692,0.01150086,0.0020353762,0.19825235,0.016043913,0.14697526,0.004852447,0.0018216299,0.023267837,0.07901766,0.012106352,0.0023587141,0.04608043,0.1851218,0.0007355164,0.0021310889
contact dermatoses disposable glove use review contact dermatoses disposable gloves reported greater frequency variety eruptions occur become increasingly relevant dermatologists procedures use disposable gloves article represents review relevant issues use disposable gloves dermatologists methods management prevention morbidity associated disposable glove use also discussed,C17,0.005944193,0.034047004,0.011091247,0.0033397996,0.0082771005,0.0076712905,0.46684018,0.0055899913,0.004297387,0.005840519,0.056112114,0.012226069,0.12187905,0.01369946,0.005227173,0.009256344,0.053829335,0.0061215335,0.03553633,0.0488475,0.0761007,0.002110567,0.0061151665
alteration cellular fatty acid profile production eicosanoids human monocytes gamma linolenic acid administered borage seed oil capsules day weeks normal controls patients active rheumatoid arthritis therapy provided gm day gamma linolenic acid gla gla administration resulted increased proportions first metabolite dihomo gamma linolenic acid dgla circulating mononuclear cells ratios dgla arachidonic acid dgla stearic acid increased significantly cells significant reductions prostaglandin e leukotriene b leukotriene c produced stimulated monocytes seen weeks gla supplementation antiinflammatory effects gla administration observed animal models apparent clinical improvement experienced rheumatoid arthritis patients given borage seed oil open uncontrolled study may due part reduced generation arachidonic acid oxygenation products,C17,0.016173033,0.0024192533,0.018258914,0.00153236,0.0037976822,0.0035197258,0.33762527,0.0025647883,0.015116883,0.0026797347,0.012694575,0.005729341,0.0538008,0.039274137,0.002398321,0.004255576,0.059276707,0.0028095518,0.003105435,0.020626148,0.3601579,0.000968366,0.031215517
arthropathy syndrome juvenile rheumatoid arthritis like arthropathy previously documented patients syndrome additional patients described literature reviewed unknown whether patients juvenile rheumatoid arthritis unique arthropathy light genetic immunologic abnormalities associated syndrome patients progressive course polyarticular disease complicated subluxations long lag time diagnosis purpose reporting children increase awareness association facilitate appropriate timely diagnosis arthritis syndrome patients,C17,0.0041522244,0.0036832304,0.0077476203,0.0023329656,0.0057818415,0.045543198,0.19718932,0.0039048023,0.0030018736,0.024181332,0.059296887,0.008540332,0.028508363,0.009547247,0.023722108,0.02656433,0.21685332,0.004276103,0.0047279187,0.21916549,0.095485106,0.0014743041,0.0043200557
interleukin human skin dysregulation psoriasis cytokine dysregulation attractive concept explain many observed abnormalities psoriasis il particular potentiate immune cellular activation activate fibroblasts increase endothelial cell adhesiveness leukocytes review il regulation normal psoriatic skin vivo relation normal skin cultured keratinocytes contrary expectations il functional activity psoriatic lesions reduced increased relative normal skin reduction attributable presence il inhibitors reduced il alpha levels il beta lacked function cell assays il beta protein actually significantly increased psoriatic lesions mechanism non functionality remains unclear unlike cultured keratinocytes accumulate large inactive il beta precursors normal psoriatic skin process il beta mature form novel mechanisms post translational processing epidermis vivo may generate novel form il beta unknown functions marked abnormalities il regulation psoriatic skin suggest molecule may important normal skin homeostasis,C17,0.0022524332,0.0019975007,0.034166552,0.001265221,0.079621546,0.01379289,0.20209497,0.013008806,0.0016279852,0.002212572,0.04551579,0.015492867,0.05229396,0.06362604,0.0019802174,0.029817589,0.019424343,0.04339626,0.002564059,0.041009832,0.25848484,0.00079954905,0.07355417
role immune system pathogenesis psoriasis psoriatic involved skin contains increased number activated cells mechanism cells achieve maintain activated state unknown antigen dependent independent mechanisms may contribute recently novel pathway antigen independent cell activation described pathway identified monoclonal antibody binds cell membrane surface molecule termed um molecule expressed minority psoriatic peripheral blood cells majority cells lesional skin thus um could play role antigen independent cell activation psoriasis indeed monoclonal antibody anti um consistently induces proliferation psoriatic um cell clones activity antigen dependent pathways also enhanced psoriatic epidermis much involved skin relative uninvolved skin contains increased number function antigen presenting cells upon activation lesional cells release lymphokines central immune hypothesis psoriasis cell lymphokines act keratinocytes induce changes characteristic psoriasis indeed lymphokines lesional psoriatic cell clones directly alter vitro keratinocyte phenotype induction intercellular adhesion molecule icam hla dr cell surface expression furthermore lymphokines also enhance keratinocyte growth data suggest critical role immune system pathogenesis psoriasis,C17,0.0016968648,0.0015052038,0.020613601,0.00095339917,0.029391821,0.0021898926,0.22064693,0.0015957523,0.0012267578,0.0016672694,0.035400815,0.0035431518,0.027896151,0.32244605,0.0014921802,0.010931516,0.032524213,0.06528045,0.0019321303,0.07230902,0.13354485,0.00060249504,0.010609498
neutrophil zinc levels psoriasis seborrhoeic dermatitis median zinc content neutrophils significantly reduced patients psoriasis comparison normal controls six patients seborrhoeic dermatitis p less reduction unrelated extent skin involvement plasma erythrocyte zinc levels unchanged,C17,0.006308907,0.0055945423,0.0117680365,0.0035435944,0.03931409,0.008139393,0.123285,0.005931093,0.0045596138,0.0061969077,0.029065596,0.013072124,0.18980773,0.014687551,0.005546136,0.040348835,0.14548665,0.0064989575,0.0071813427,0.04088024,0.284056,0.002239354,0.0064883144
dna content ks binding psoriatic lesion treatment vitamin analogue mc betamethasone twenty patients psoriasis treated vitamin analogue mc betamethasone ointment double blind trial left right comparison addition clinical severity scores ks binding detects keratin expression dna synthesis quantified using flow cytometry markers decreased significantly treatment remained normal range even total clearance lesions treatment mc regard ks binding significantly better betamethasone,C17,0.004070263,0.0036105262,0.0075946883,0.0022869147,0.04507702,0.0052528866,0.2892375,0.043235693,0.002942619,0.0039992724,0.032716613,0.027574373,0.10769747,0.009628394,0.003579528,0.026025837,0.10638503,0.06456418,0.044041578,0.031520072,0.11148031,0.0014452025,0.026034068
variations urethral bladder pressure stress episodes healthy women pressure variations urethra bladder stress episodes time separations investigated healthy female volunteers pressure measured means double microtip transducer catheter distal sensor bladder proximal sensor bladder neck mid urethra distal urethra advance pressure spike cough pressure rise demonstrated bladder sites measurement urethra urethral pressure increments preceding following pressure spike statistically significantly higher mid urethra corresponding bladder pressures active urethral pressure generation mid urethra distal urethra initiated ms bladder pressure began rise pressure urethral high pressure zone higher bladder pressure cases passive pressure transmission urethral high pressure zone take place insignificantly due continuous higher pressure inside urethra bladder due location high pressure zone demarcation abdominal cavity concluded urethral pressure rise high pressure zone stress episodes mainly generated actively intra peri urethral structures,C08,0.0020951845,0.0018558466,0.08958744,0.0011754971,0.002913714,0.0027000362,0.12732138,0.022216862,0.0015125355,0.002055666,0.030370029,0.004303734,0.38099107,0.0048105125,0.03222357,0.0032579217,0.06102251,0.0021622737,0.012505805,0.11940987,0.08249255,0.0007428485,0.012273157
cytomegalovirus infections allogeneic bone marrow transplantation cytomegalovirus cmv infection occurs approximately recipients allogeneic bone marrow transplants seen frequently cmv seropositive patients cmv seronegative patients sources infection include reactivation latent endogenous virus blood products cmv seropositive blood donors use marrow cmv seropositive donor cmv seronegative recipient common severe clinical syndrome associated cmv infection allogeneic transplant recipients interstitial pneumonia occurs approximately patients risk factors cmv pneumonia include old age conditioning total body irradiation severe graft vs host disease rapid diagnosis cmv pneumonia facilitated immunochemical staining bronchoalveolar lavage fluid centrifugation cell cultures cmv monoclonal antibodies treatment cmv pneumonia remains problematic therapy combination intravenous immune globulin ivig plus ganciclovir resulted survival rates substantially better achieved previous trials antiviral therapy cmv seronegative patients cmv infection pneumonia prevented modified use cmv seronegative blood products ivig ivig may also additional benefits preventing infectious complications graft vs host disease patients receiving cmv seronegative blood products cmv seropositive patients effective prophylaxis cmv reactivation pneumonia yet established clinical trial prophylactic ganciclovir way,C08,0.0020577498,0.03159694,0.0038272631,0.0011520933,0.0028716323,0.022491021,0.3634723,0.0019283167,0.0014824215,0.0020147383,0.020115742,0.028517898,0.09602086,0.02464405,0.009706453,0.023037126,0.14794496,0.04181421,0.022187242,0.08646067,0.05382885,0.0007280587,0.012099388
determination serum concentrations type iii procollagen peptide mechanically ventilated patients pronounced augmented concentrations adult respiratory distress syndrome type iii procollagen peptide pcp byproduct type iii collagen synthesis potential marker collagen secretion chronic diffuse interstitial lung diseases elevated pcp concentrations found serum well bronchoalveolar lavage fluid proposed pcp marker early active stages fibrosis severe fibrosis frequent complication adult respiratory distress syndrome ards investigated pcp patients ards compared results patients requiring mechanical ventilation heart failure neurosurgical surgical interventions spontaneously breathing patients including healthy volunteers patients pneumonia liver cirrhosis renal failure pcp concentrations patients ards extremely elevated compared control subjects p less correlated positively fio r p less results support pathophysiologic concept early fibrogenesis ards preventing pulmonary fibrosis ards essential improving survival rate believe pcp valuable diagnostic tool ards,C08,0.0061890543,0.022339653,0.003949864,0.023425085,0.023301251,0.044446535,0.26621348,0.0019877749,0.0015281308,0.0020768612,0.058866564,0.004717175,0.08034829,0.004946798,0.0018587585,0.023126056,0.1480424,0.012397842,0.02282828,0.04923937,0.19524574,0.0007505078,0.0021745248
atypical presentation pulmonary embolism today discussed interesting patient atypical presentation pulmonary embolism outlined suggested algorithm aid diagnosis management disease references reference section suggested readings offer insight diagnosis management entity,C08,0.00594481,0.005273343,0.06863726,0.03210757,0.008277959,0.007672087,0.36281896,0.03436503,0.004297833,0.005841125,0.08489764,0.012227338,0.094268754,0.013668953,0.0052277157,0.009257305,0.077170424,0.0061221686,0.0067690406,0.038517933,0.079650104,0.002110786,0.034875877
six month isoniazid rifampin treatment pulmonary tuberculosis children one hundred seventeen children pulmonary tuberculosis underwent treatment month daily regimen rifampin mg kg day isoniazid mg kg day criteria diagnosis pulmonary tuberculosis clinical symptoms signs children history direct contact adult tuberculosis children tuberculin reaction mm without previous bacillus calmette guerin bcg children suggestive radiologic alterations patients positive bacteriology histology four patients treatment completed children mean weight gain therapy g excellent clinicoradiologic response treatment improvement chest roentgenograms observed patients end therapy relapses occurred among patients followed average months study indicates treatment primary pulmonary tuberculosis children combination rifampin isoniazid daily months efficacious result relapse,C08,0.06781716,0.0023874454,0.005021956,0.0015122127,0.0037575162,0.0034930878,0.28811303,0.0025310668,0.0019457943,0.11233123,0.05552611,0.0055357865,0.020454463,0.006257658,0.015394578,0.004200996,0.22772743,0.0027717412,0.0030646052,0.020018507,0.14641318,0.00095563405,0.0027688586
search nonsearch protocols radiographic consultation six radiologists acting radiograph reviewers used two different consultation protocols differentiate among ambiguous chest radiographic findings simulated nodules normal findings previous readers false positive reports nodules nonsearch protocol identified finding film location reviewers rated likelihood finding pulmonary nodule search protocol asked reviewers report rate locations regarded possible nodules radiograph assigned default negative rating unreported finding nodule normal structure receiver operating characteristic analyses demonstrated significantly higher accuracy reviewer search protocol discriminations nodules ambiguous normal findings superiority search result suggests radiologists second opinions suspected lesions might accurate consultants follow search protocol independently reviewing radiographs without prior knowledge specific findings concerned primary radiograph readers,C08,0.018597428,0.0028302146,0.021355925,0.0017926637,0.019901244,0.0041544745,0.45920536,0.0030004717,0.0023066562,0.0031349445,0.087543525,0.0065626,0.0823465,0.008108598,0.0028057264,0.004968416,0.042566232,0.0032928397,0.03670925,0.057403114,0.11074456,0.0011328635,0.019536423
inhibition exercise induced bronchoconstriction mk potent leukotriene receptor antagonist background exercise common stimulus bronchoconstriction subjects asthma also bronchoconstriction inhaling sulfidopeptide leukotriene ltd purpose study investigate importance ltd mediator exercise induced bronchoconstriction methods double blind randomized crossover study subjects stable asthma treated intravenously mk mg selective potent ltd receptor antagonist placebo minutes two challenges involving exercise level previously demonstrated cause fall least percent forced expiratory volume one second fev two exercise challenges separated one week results challenges expressed maximal fall fev exercise time recovery bronchoconstriction results treatment mk attenuated exercise induced bronchoconstriction subjects mean sem maximal percent decrease fev exercise percent subjects taking placebo percent subjects taking mk p less mean percent inhibition entire group percent mean time recovery exercise minutes placebo group minutes mk group p less conclusions study demonstrates pretreatment potent selective ltd antagonist markedly attenuates exercise induced bronchoconstriction suggests ltd major mediator type bronchoconstriction,C08,0.01041852,0.087986656,0.00333018,0.0010028257,0.0024855402,0.0023033277,0.19288316,0.0016784114,0.018567547,0.027666524,0.018146727,0.032336805,0.15565924,0.013173621,0.0102049615,0.002779245,0.08518799,0.032051466,0.04248685,0.01194239,0.22793637,0.017910153,0.0018614677
placebo controlled trial immunotherapy two extracts dermatophagoides pteronyssinus allergic rhinitis comparing clinical outcome changes antigen specific ige igg igg subclasses double blind placebo controlled trial immunotherapy conducted patients dermatophagoides pteronyssinus rhinitis thirty patients received extract high content der p pharmalgen received conventional mite extract allpyral patients received histamine chloride placebo specific igg subclasses measured months treatment ria elisa specific ige rast clinical outcome assessed skin prick tests nasal challenge visual analogue diary card symptom drug scores findings clinical index derived igg response occurred pharmalgen treated group pter igg igg increased months p less plateaued months p less igg levels increased throughout treatment p less p less igg ige ratio subclass switch igg igg occurred pter ige rose months p less clinical improvement occurred months pharmalgen treated group pretreatment levels ige igg igg predict clinical outcome findings compatible hypothesis igg subclasses may modulate antigen ige interactions although antibody response potent extract need causally related improvement,C08,0.0018160659,0.001610941,0.0033885906,0.0010203733,0.011319254,0.0023437275,0.24565746,0.0017083538,0.0013129348,0.0017877567,0.032501977,0.047212016,0.11237096,0.04368798,0.0015970025,0.0028279922,0.118514955,0.021516513,0.054814897,0.034119416,0.21861209,0.000644819,0.03961393
midfacial hypoplasia associated long term intubation bronchopulmonary dysplasia six preterm infants bronchopulmonary dysplasia nasotracheally intubated days gestational age birth ranged weeks endotracheal tube size changed account growth varied mm infants developed features midfacial hypoplasia namely depressed nasal bridge small tipped nose long philtrum underdeveloped malar areas carplike mouth features associated long term intubation premature infants suggest features prolonged nasotracheal intubation direct compression tube method tube fixation decreased air flow developing nares sinuses reduced faciomuscular activity resulting observed midfacial hypoplasia degree growth corrects deformations unknown,C08,0.018327782,0.017982833,0.018419674,0.0017659656,0.0044354107,0.06486166,0.20944351,0.0029557857,0.0022723032,0.0030882556,0.061352383,0.021527583,0.050570298,0.04007928,0.0027639407,0.0048944214,0.1170491,0.02121954,0.003578853,0.11242055,0.20146632,0.016291099,0.0032334796
neutrophilia bronchoalveolar lavage fluid diffuse panbronchiolitis clinical pathologic features diffuse panbronchiolitis dpb well reported date although pathogenesis remains unknown present study performed bronchoalveolar lavage bal three patients biopsy specimen proven dpb eight patients highly probable dpb six women five men one smoker ten nonsmokers nine patients chronic bronchitis men five smokers four nonsmokers nine normal control subjects six women three men nonsmokers clarify cell populations lower respiratory tract neutrophils comprised percent recovered cells bal dpb patients percent chronic bronchitis patients percent normal control subjects p less comparisons dpb patients also exhibited decreased percentage alveolar macrophages percent compared chronic bronchitis patients normal control subjects p less comparisons percentage lymphocytes recovered lavage cells dpb patients differ chronic bronchitis patients normal control subjects results indicate neutrophils play important role pathogenesis dpb also suggest neutrophilia bal recovered fluid common finding diseases associated bronchiolar inflammation despite clinical pathophysiologic differences,C08,0.0022763025,0.002019194,0.0042473446,0.0012789615,0.0031696793,0.002937687,0.22666383,0.0021406626,0.0016456655,0.013251213,0.05708129,0.0047529,0.24898306,0.06551961,0.002001723,0.0035446766,0.17359309,0.01360016,0.0025919054,0.09542004,0.07013099,0.00080823235,0.0023417762
permeability pulmonary edema following lung resection etiology edema associated pulmonary resection investigated five patients immediate postoperative period three patients received pneumonectomy two patients one lobe resected patients suffered severe respiratory distress x ray evidence diffuse interstitial pulmonary edema within hours surgery hemodynamic data obtained radial pulmonary artery catheters edema fluid obtained along blood samples simultaneous determination protein albumin content patients studied normal high cardiac output normal cardiac filling pressures edema fluid protein serum protein ratio greater suggestive permeability changes contributing edema fluid accumulation calculated shunt fraction exceeded percent patients pulmonary edema noted patients following pulmonary resection early postoperative period patients reviewed two factors appeared significant first increase pulmonary capillary pressure associated passage normal high cardiac output reduced volume pulmonary vascular bed second factor demonstrated protein content edema fluid injury alveolar capillary membrane,C08,0.11041195,0.0016399228,0.012397309,0.0010387305,0.0025745803,0.031952463,0.07274832,0.012549116,0.0013365553,0.0018164937,0.061797053,0.004026139,0.16172065,0.020724129,0.0016370123,0.0028788697,0.19614246,0.038411226,0.01100488,0.0907545,0.15094428,0.009591474,0.0019019136
mortality pulmonary embolism united states examine effect advances prevention therapy pe reviewed mortality pe united states age adjusted pe mortality increased percent white non white men women rates declined percent non white pe mortality greater white pe mortality men greater risk pe death women age specific patterns years age pe mortality followed age adjusted death rates increases noted groups declines period patterns might reflect improved ascertainment cases better prevention disease magnitude rates suggests list indications prophylactic anticoagulation examined possible expansion,C08,0.0025903292,0.039915673,0.0048332857,0.013949998,0.0036069513,0.0033429547,0.17789601,0.0024359769,0.052032858,0.0025451505,0.026753562,0.017867954,0.020422718,0.006308022,0.0022778702,0.004065724,0.07924831,0.0026676096,0.002949471,0.40626848,0.1244337,0.0009197318,0.0026676797
peak flow nasal patency indices self assessment septoplasty present study evaluates results septoplasty monitored objective peak flow nasal patency indices subjective patient self assessment scores nasal obstruction mini wright peak flow meters used peak flow nasal patency index defined ratio nasal oral peak flow rates uni bi lateral well ex spiratory indices calculated peak ex spiratory flow nasal patency indices significantly increased months post operatively indicating improved nasal patency marked post operative increase nasal patency indices seen preoperatively worst airway total airway weak significant positive correlation found peak flow nasal patency indices patient mean self assessment scores uni bi lateral nasal obstruction change peak flow nasal patency indices measured months post operatively correlated well patient overall assessment operative changes total nasal patency method found quick easy handle monitoring effect functional septoplasty recommended alternative rhinomanometry,C08,0.0018824721,0.0016698467,0.0035324013,0.0010576843,0.011655597,0.024319327,0.20237784,0.019994307,0.0013609435,0.0018496393,0.05167804,0.021094345,0.3933423,0.0043926816,0.0016554364,0.0029314004,0.1240928,0.029271405,0.0021434713,0.020122688,0.07697033,0.00066839746,0.0019366179
pneumonia syndromes clinical approach elderly important pathogenesis pneumonia elderly patient chronic diseases including diabetes mellitus coronary artery disease congestive heart failure chronic obstructive pulmonary disease cerebrovascular disease also vital changes take place immune system mucociliary clearance mechanisms lung clinician aware risk factors especially since mortality rate lower respiratory infections approaches elderly patients treatment guidelines included,C08,0.01923502,0.038456913,0.006791932,0.0020451886,0.005068637,0.024342943,0.35393417,0.0034231353,0.002631585,0.021193417,0.016740127,0.007486861,0.029844638,0.02609808,0.003200957,0.04089964,0.107760414,0.003748635,0.004144718,0.18315172,0.094764054,0.001292445,0.0037447363
late pulmonary sequelae bronchopulmonary dysplasia background bronchopulmonary dysplasia chronic lung disease often develops mechanical ventilation prematurely born infants respiratory failure become common form chronic lung disease infants united states long term outcome infants bronchopulmonary dysplasia determined methods studied pulmonary function adolescents young adults born bronchopulmonary dysplasia infancy compared results two control groups age matched adolescents young adults similar birth weight gestational age undergone mechanical ventilation age matched normal subjects results sixty eight percent subjects bronchopulmonary dysplasia infancy tested airway obstruction including decreases forced expiratory volume one second forced expiratory flow percent vital capacity maximal expiratory flow velocity percent vital capacity compared control groups p less comparisons twenty four percent subjects bronchopulmonary dysplasia infancy fixed airway obstruction percent reactive airway disease indicated responses administration methacholine bronchodilator hyperinflation increased ratio residual volume total lung capacity frequent subjects history bronchopulmonary dysplasia either matched cohort p less normal controls p less six subjects bronchopulmonary dysplasia infancy severe pulmonary dysfunction current symptoms respiratory difficulty conclusions adolescents young adults bronchopulmonary dysplasia infancy degree pulmonary dysfunction consisting airway obstruction airway hyperreactivity hyperinflation clinical consequences dysfunction known,C08,0.028874004,0.0177806,0.0031417904,0.0009457346,0.0023438353,0.06276342,0.19593295,0.0015829237,0.00936127,0.019012986,0.02539871,0.023849767,0.24442813,0.0039484506,0.011096852,0.018914487,0.0849162,0.001734076,0.0019165975,0.13201794,0.091433786,0.016871624,0.00173384
acute pulmonary effects aerosolized pentamidine randomized controlled study toronto aerosolized pentamidine study taps group june february enrolled patients human immunodeficiency virus randomized double blind placebo controlled trial assessing efficacy toxicity aerosolized pentamidine ap secondary prophylaxis pneumocystis carinii pneumonia patient underwent spirometric evaluations aerosolized treatment significant difference results baseline pulmonary function tests two groups eleven patients percent ap group developed cough four demonstrated significant reduction forced expiratory flow rates ap four patients percent placebo group developed cough significant change expiratory flow rates noted bronchospastic episodes self limited symptomatically responded remedial inhaled albuterol salbutamol treatment conclude ap treatment frequently associated coughing attacks percent actual incidence bronchospasm spirometry much lower percent generally quite mild,C08,0.02835269,0.0023567476,0.017817333,0.0014927686,0.016576298,0.0034554398,0.213894,0.0024985222,0.0019207754,0.002610499,0.025229778,0.067315094,0.1279317,0.0073070945,0.0023363559,0.016995609,0.2185976,0.0027361023,0.03414482,0.07435121,0.11148936,0.00094334653,0.01964683
bilious pleural effusion following liver biopsy pleural effusions patients chronic liver disease common usually little consequence bilious pleural effusion occur following percutaneous biopsy cholangiography procedures pleura traversed report emphasizes role biliary tract obstruction development bilious effusion importance biliary tract decompression treatment discuss laboratory evidence supporting diagnosis bilious effusion review reported experience complication,C08,0.003773525,0.0033473049,0.04357452,0.0021201898,0.005254514,0.0048699304,0.33789203,0.0035486685,0.0027280906,0.00370771,0.03562026,0.0077614198,0.02349059,0.026917312,0.021582032,0.05963138,0.25355384,0.003886105,0.004296713,0.02619432,0.121027604,0.0013398416,0.0038820633
treatment atelectasis upper lung lobes selective bronchial suctioning j shaped catheter tip guide mark developed technique blind bronchial suction using curved tip catheter guide mark treatment atelectasis lower middle lobes lung suction upper lobe bronchi could performed combination peculiar anatomy upper lobe bronchi catheter design treated successfully two cases atelectasis right upper lobes using rusch metras bronchography catheter guide mark readily available therefore devised j shape tipped catheter guide mark successfully treated episodes atelectasis right upper lobe patients one episode left upper lobe one patient new catheter,C08,0.0029201417,0.016724428,0.03134972,0.0016407085,0.01854395,0.062667176,0.14154151,0.13133864,0.0021111325,0.0028692107,0.24574897,0.0060061733,0.020625137,0.0067144195,0.002567899,0.0045472677,0.07774244,0.0030072618,0.017454073,0.051714398,0.14812434,0.0010368362,0.0030041342
results patients undergoing bronchoplastic procedures bronchial lesions bronchoplastic procedures used patients various bronchial disorders ten benign lesions malignant tumors principal operative procedures sleeve lobectomy sleeve pneumonectomy bronchogenic carcinoma limited bronchial resections performed patients benign lesions minute bronchogenic carcinomas low grade malignant tumors patients malignant tumors underwent bronchoplastic procedure without carinal resection sleeve lobectomy limited bronchial resection one operative death overall year survival rate patients bronchogenic carcinoma group patients undergoing curative resection survival patients stages ii iiia respectively bronchoplastic procedure carinal resection performed patients twelve group underwent sleeve pneumonectomy two operative deaths patient survived longer years two patients low grade malignant tumors underwent carinal resection without lung resection still alive believe bronchoplasty safe valuable procedure limited bronchial resection appears procedure choice localized bronchial lesions,C08,0.0025584488,0.0022694718,0.0047738,0.001437488,0.102651075,0.015686076,0.13049309,0.0024059962,0.0018496446,0.002523876,0.015216301,0.030765995,0.088391736,0.0058826637,0.0022498353,0.003984037,0.49301964,0.0026347782,0.0152143985,0.026959332,0.0331224,0.0009084122,0.015001466
glucocorticoids inhibit neurogenic plasma extravasation prevent virus potentiated extravasation rat trachea capsaicin increases permeability blood vessels rat tracheal mucosa mechanism involving release tachykinins sensory nerves capsaicin induced increase vascular permeability potentiated viral infections respiratory tract present study done determine whether neurogenic plasma extravasation inhibited glucocorticoids learn time course inhibition determine whether glucocorticoids prevent potentiating effect viral respiratory infections neurogenic plasma extravasation groups pathogen free f rats treated dexamethasone h mg kg p h mg kg per p another group rats treated dexamethasone h following intranasal inoculation sendai virus magnitude plasma extravasation produced capsaicin substance p assessed treatment using monastral blue pigment evans blue dye intravascular tracers found dexamethasone reduced dose dependent fashion magnitude plasma extravasation produced rat trachea capsaicin substance p significant inhibition produced dose dexamethasone small mg kg p effect dexamethasone latency several hours reached maximum treatment furthermore dexamethasone prevented potentiation neurogenic plasma extravasation usually present sendai virus respiratory infection,C08,0.011523261,0.030403873,0.0323225,0.0011085531,0.002796443,0.012044119,0.20996013,0.0018569403,0.0014263975,0.03058964,0.009602186,0.048089113,0.053619403,0.033643078,0.001735014,0.012470099,0.02619998,0.0020401378,0.0022465605,0.026373593,0.41856587,0.0007005437,0.030682534
ultrastructural localization proteinase target antigen anti cytoplasmic antibodies circulating wegener granulomatosis investigate distribution proteinase target antigen anti cytoplasmic antibodies acpa c anca within organelles resting normal human polymorphonuclear leukocytes monocytes authors used immunocytochemical techniques thin frozen sections obtain valuable tools immunolabeling two murine monoclonal antibodies mabs directed acpa antigen produced neutrophils authors observed immunogold label acpa antigen predominantly myeloperoxidase positive azurophil granules smaller amounts plasma membrane monocytes acpa antigen could detected small granules occasionally also contained myeloperoxidase rare labeling found monocyte membrane finding acpa antigen expressed plasma membrane neutrophils monocytes thereby becoming accessible circulating autoantibodies supports supposition acpa markers disease activity also involved pathogenesis wegener granulomatosis,C08,0.0026233648,0.0023270554,0.042993918,0.0014739617,0.016327202,0.003385589,0.21920836,0.027863236,0.014578763,0.00257761,0.08023855,0.0053957603,0.02799167,0.20922315,0.002306921,0.0040851245,0.025246415,0.041110784,0.0029870868,0.01714396,0.2472637,0.0009314616,0.0027163425
changes self concept pulmonary rehabilitation part purpose two part study describe changes self concept formal pulmonary rehabilitation program item semantic meaning differential scale administered patients severe chronic obstructive pulmonary disease participating multidisciplinary pulmonary rehabilitation program patients asked evaluate past present future selves program admission program discharge months home discharge mean total self concept score present self significantly increased program admission home discharge weeks later mean change p less significant declines self concept found months home discharge p men showed significantly higher change total self concept score women week program p however men change score dropped significantly home discharge p suggesting need intensive follow care women self concept tool study provided easy way monitor subjective changes psychologic status,C08,0.052611485,0.0019973104,0.0042223735,0.0012651006,0.014009889,0.007045344,0.18558435,0.0021174625,0.0016278301,0.0022123612,0.01112641,0.05079105,0.16025576,0.005198612,0.0019801012,0.0035062602,0.116508506,0.0023188083,0.039786067,0.18525517,0.14746387,0.0007994729,0.0023163967
additive effect albuterol ipratropium bromide treatment bronchospasm children inhaled albuterol salbutamol alone albuterol plus ipratropium bromide ib administered asthmatic children following administration alone combination ib significant increase fev fef significant statistical difference favor association plus ib observed minutes fev period minutes fef additive effect present large small airways short lived additive effect plus ib suggests opportunity increase frequency drug administration patients severe bronchial obstruction,C08,0.003922901,0.003473726,0.02623246,0.0022002652,0.005455104,0.042961642,0.19873989,0.0036826949,0.0028311252,0.09863665,0.018077774,0.008287004,0.11527565,0.009004193,0.00344367,0.0060980944,0.10431674,0.0040593515,0.004458992,0.0949751,0.23844782,0.0013904448,0.004028681
ventilator dependency united kingdom children currently long term ventilator dependent uk nine cared entirely home additional children long term ventilator dependent since march prevalence children appears increasing financial manpower resources needed children whether home hospital considerable reasons suppose apparent increase prevalence continue,C08,0.0050694123,0.0044968217,0.009458997,0.002848296,0.007058996,0.031050513,0.31317535,0.0047673364,0.0036649595,0.12769105,0.023313662,0.010426812,0.03769853,0.011656145,0.0044579133,0.007894129,0.13582872,0.005220654,0.0057722717,0.14048132,0.10095294,0.0017999641,0.0052152243
effect oral omeprazole intragastric ph volume women undergoing elective caesarean section studied obstetric patients efficacy omeprazole increasing intragastric ph reducing volume less ml omeprazole mg given orally night morning surgery asian women scheduled undergo elective caesarean section induction anaesthesia gastric tube inserted intragastric contents aspirated volume ph recorded measurements repeated completion surgery median range volume ml surgery ml end surgery insufficient volume measure ph patients median range ph surgery patients end surgery patients adverse drug reactions noted mothers neonates omeprazole mg orally twice elective caesarean section appeared effective reducing intragastric volume acidity acceptable values,C08,0.0026584046,0.028070267,0.017818129,0.02721222,0.0036997278,0.003428941,0.14789183,0.02821951,0.0019208613,0.002610616,0.025349297,0.005575374,0.21214285,0.0061091636,0.0023364606,0.016993446,0.26128042,0.0027362248,0.0030253357,0.084414095,0.112830125,0.00094338873,0.002733379
tracheal reconstruction polytetrafluoroethylene graft dogs use prosthetic materials long segment tracheal reconstruction limited owing infection graft migration ingrowth fibrous tissue stenosis polytetrafluoroethylene ptfe flexible porous may resist infection previously used materials evaluated ptfe use long segment tracheal reconstruction cm segment trachea resected dogs replaced mm reinforced ptfe graft using vicryl sutures control dogs one tracheal arch resected primary anastomosis performed animals followed weekly bronchoscopy endoscopic photography euthanasia performed weeks signs respiratory distress developed postmorten examination anastomoses examined grossly light scanning electron microscopy dogs underwent tracheal replacement ptfe granulation tissue developed anastomoses resulting airway obstruction weeks epithelial growth occurred graft anastomoses control animals well conclude granulation tissue formation anastomosis lack respiratory epithelial ingrowth across graft makes ptfe unsuitable long segment tracheal reconstruction,C08,0.0024093958,0.060448986,0.0044956827,0.024676317,0.0033550088,0.003109451,0.2044111,0.031622913,0.013396286,0.025691513,0.032718245,0.0050409483,0.03086524,0.018143658,0.002118762,0.0037519303,0.18957448,0.0024812783,0.01435766,0.016146384,0.30784997,0.00085548894,0.002479244
tumor necrosis factor alpha mediates acid aspiration induced systemic organ injury acid aspiration induced systemic organ injury mediated sequestration activated neutrophils pmn settings cytokines shown increase neutrophil endothelial adhesion requisite injury study tests whether systemic leukosequestration permeability following localized aspiration mediated tumor necrosis factor tnf alpha induced synthesis adhesion protein anesthetized rats underwent tracheostomy insertion fine bore cannula anterior segment left lung followed instillation either ml n hci n ml saline control rats n localized aspiration induced generalized pulmonary leukosequestration pmn high power fields hpf aspirated lung pmn hpf nonaspirated lung higher control values pmn hpf pmn hpf saline nonsaline aspirated sides respectively p less leukosequestration associated permeability edema shown increased protein concentrations bronchoalveolar lavage bal micrograms ml aspirated micrograms ml nonaspirated side higher saline micrograms ml micrograms ml respectively p less generalized pulmonary edema following aspiration measured increase wet dry weight ratios w aspirated nonaspirated lung higher control values respectively p less localized aspiration led systemic leukosequestration documented increases myeloperoxidase activity units g tissue heart kidney higher control values respectively p less event associated edema organs w ratios relative control values p less treatment animals n minutes aspiration anti tnf alpha antiserum rabbit anti murine normal rabbit serum n reduced lung leukosequestration aspirated nonaspirated segments pmn hpf bal protein concentration micrograms ml w ratio p less heart kidney reductions myeloperoxidase activity w ratio p less treatment rabbits n protein synthesis inhibitor cycloheximide mg kg hr effective tnf alpha antiserum modifying aspiration injury abstract truncated words,C08,0.041098014,0.01477796,0.016145289,0.00078572036,0.008525989,0.03666103,0.0832346,0.01484972,0.0010110021,0.0013740389,0.012123286,0.017030355,0.30036205,0.034997854,0.0012297435,0.0021776452,0.036917757,0.062804416,0.0016038509,0.020421105,0.26286557,0.014032567,0.014970432
flow volume dependence respiratory system mechanics constant flow ventilation normal subjects adult respiratory distress syndrome seven control subjects seven patients adult respiratory distress syndrome ards artificially ventilated flow volume tracheal pressure monitored respiratory system resistance rrs max partitioned homogeneous rrs min uneven rrs u components respiratory system elastance ers also measured groups ers vary different inspiratory flows volumes significantly higher ards increasing volume isoflow maneuvers rrs max rrs u increased rrs min remained unaltered ards control patients however resistances vary rrs max rrs u smaller rrs min equaled corresponding values ards hence stress relaxation seems increased ards isovolume maneuvers rrs max rrs u decreased increasing flows groups although significantly higher ards rrs min modified different flows similar groups thus pendelluft also increased ards conclusion mechanical profile ards characterized increased ers rrs max latter secondary augmented mechanical unevenness within system,C08,0.0020304457,0.0018011067,0.013818586,0.0011408246,0.0028273314,0.03210513,0.13479225,0.0019094558,0.0014679219,0.041308686,0.009365264,0.044247214,0.33827108,0.02541769,0.02143185,0.0031703103,0.048318677,0.0020913235,0.021927064,0.06505362,0.18468341,0.0007209375,0.0020998549
selective igg subclass deficiencies antibody responses pneumococcal capsular polysaccharide antigen adult community acquired pneumonia measured serum concentrations igg subclasses healthy subjects n patients community acquired pneumonia cap admission n recovery n months admission n control subjects patients measured igg subclasses mean serum antibody concentrations pneumococcal capsular polysaccharides wk immunization pneumococcal vaccine compared control subjects serum concentration igg subclass lower admission patients cap bacterial unknown cause p less concentrations igg subclasses patients differ admission recovery admission months later vaccination control subjects patients increase concentrations igg subclasses p antipneumococcal antibodies p less show serum igg concentration patients cap bacterial unknown cause lower healthy subjects remains lower several months immunization pneumococcal vaccine increase serum concentrations igg subclasses antipneumococcal antibodies patients differ control subjects,C08,0.0025267522,0.0022413554,0.0047146576,0.001419679,0.0035184224,0.0032609054,0.09219512,0.0023761883,0.0018267294,0.0024826825,0.0116564585,0.0052460455,0.25135782,0.069079004,0.0022219622,0.0039346786,0.15999334,0.0026021358,0.027339472,0.01974651,0.3267635,0.00089715794,0.0025994296
pulmonary lipid peroxidation cigarette smokers lung cancer patients lipid peroxidation lpo studied lung tissues patients lung cancer lc n nonlung cancer nlc n relationships smoking habits degree airway obstruction investigated specimens peripheral lung parenchyma free tumor tissue taken malondialdehyde mda content measured fractions airway obstruction assessed flow volume curves data expressed percentage predicted values cigarettes smoked expressed pack years patients lc nlc differ mda content age number pack years contrary fef mef significantly lower lc nlc patients p less mda content inversely correlated number days patients refrained smoking r p less mda content higher recent smokers ie people smoking last days surgery patients vs mumol g tissue p less considering recent smokers mda content higher lc patients mumol g tissue nlc patients mmol g tissue p patients divided high mda low mda groups mef much lower high mda group percent low mda group percent p less results suggest following enhanced level prooxidant state lungs associated recent cigarette smoking lc patients may prone respective nlc patients oxidative stress mda level degree small airway obstruction associated differed lc nlc patients even though groups differ percentage recent smokers common free radical mediated pathway may active lc small airway obstruction,C08,0.0016701121,0.0013600371,0.0028633855,0.00086145033,0.009556779,0.04758342,0.13053003,0.0014418529,0.0011084453,0.0015064726,0.019128706,0.06253489,0.1316306,0.0531281,0.009390027,0.009747968,0.16537082,0.001591727,0.009153648,0.110028766,0.22768457,0.00054438855,0.0015838395
bronchial cartilage alterations lung transplantation changes hyaline cartilage proximal bronchial tree investigated group combined heart lung double lung recipients without ob ossification calcification fibrovascular ingrowth normally avascular hyaline bronchial cartilage observed almost patients independent small large airway inflammation alterations integrity hyaline cartilage produced others animals ligation blood supply finding similar changes airway cartilage transplanted lungs argues relatively poor perfusion proximal air conducting passage mechanism may contribute development ob bronchiectasis predilection infections following pulmonary transplantation,C08,0.0031991727,0.0026273811,0.005526657,0.01599469,0.004125557,0.10395692,0.20784251,0.0027854363,0.0021413446,0.017245332,0.013841216,0.09451432,0.09460708,0.0075150244,0.0026046478,0.004667269,0.119132966,0.0030502984,0.0033725947,0.04878858,0.22403467,0.015379258,0.0030471259
treatment small cell lung cancer alternating chemotherapy regimen given weekly intervals southwest oncology group pilot study designed intensive weekly treatment regimen patients small cell lung cancer sclc using six active chemotherapeutic agents disease doxorubicin dox cyclophosphamide ctx vincristine vcr etoposide vp cisplatin cddp methotrexate mtx goal program gain rapid repetitive exposure multiple active drugs treatment administered weekly total weeks seventy six sclc patients limited disease extensive disease treated overall complete plus partial response rate complete response rates observed patients limited ld extensive disease ed respectively median survivals patients ld ed months respectively toxicities tolerable primarily hematologic twenty six patients one transient life threatening toxicities one patient developed fatal toxicity eighty four percent patients received greater intended protocol dosages entire week treatment period conclude intensive short duration treatment regimen least good standard regimens encouraged aged complete response rate median survival patients ed sclc,C08,0.001953735,0.0017330605,0.010315096,0.001097724,0.002720514,0.03369173,0.32944584,0.0018373161,0.0014124635,0.0019196594,0.016422678,0.05454214,0.026933309,0.03285476,0.0017181309,0.0030423717,0.27959415,0.0020120232,0.009330659,0.05693704,0.12778197,0.00069370033,0.0020099306
bombesin stimulation mitogenesis specific receptors signal transduction early events quiescent cultures swiss cells stimulated recommence dna synthesis polypeptide growth factors neuropeptides various pharmacologic agents act via multiple signal transduction pathways neuropeptides bombesin family provide potent mitogens elucidate pathways peptides bind specific receptors characterized radioligand binding sensitivity antagonists identified glycoproteins mr chemical cross linking binding bombesin elicits cascade early molecular events including stimulation phosphorylation acidic mr cellular protein major substrate protein kinase c ca mobilization mediated ins p na k fluxes transmodulation egf receptor enhancement camp accumulation expression proto oncogenes c fos c myc studies using membrane preparations permeabilized cells indicate g proteins play role transduction mitogenic signal triggered binding bombesin receptor pertussis toxin insensitive g protein couples bombesin receptor generation signal activates protein kinase c whereas pertussis toxin sensitive g protein mediates cross talk transmembrane signaling pathways bombesin mediated mitogenesis blocked different antagonists interrupting signal transduction process various postreceptor levels thus prolonged treatment vasopressin causes heterologous desensitization mitogenic action bombesin mitogenic block mediated uncoupling receptor signaling system loss responsiveness bombesin stimulated dna synthesis also induced regulation protein kinase c,C08,0.020288527,0.0016851918,0.04851003,0.011407226,0.011830917,0.0024517537,0.24087323,0.029338757,0.0013734499,0.0018666367,0.028080434,0.0039074663,0.030733975,0.17621227,0.0016706109,0.021345388,0.02656266,0.17625102,0.002163169,0.017396346,0.12217387,0.0006745397,0.02320251
exercise induced biphasic responses methacholine reactivity asthma biphasic early late asthmatic responses exercise occurred seven children reproducible exercise induced asthma biphasic allergen induced asthma associated prolonged increase nonspecific bronchial hyperreactivity effect sought asthmatic children significant change methacholine pd fev exercise challenge either children early early late exercise responses late reactions allergen exposure likely considerable clinical significance relation enhancement bronchial responsiveness reassuring case exercise challenge would major implications relation recommendations asthmatics participate normal activities even training programs furthermore suggests differences pathophysiology asthma induced exercise produced allergens,C08,0.0029616046,0.10299098,0.005526047,0.0016640049,0.0041721305,0.003822105,0.19067927,0.0027851288,0.0021411083,0.07459588,0.027462559,0.0062877815,0.027889514,0.0073026572,0.0026043605,0.0046118344,0.109298736,0.0030517492,0.04496973,0.13291857,0.23816593,0.0010515582,0.0030467897
plasma cross linked fibrin degradation products pulmonary embolism plasma concentrations cross linked fibrin degradation products marker intravascular thrombosis fibrinolysis measured patients suspected pulmonary embolism referred ventilation perfusion lung scanning determine whether concentrations increased pulmonary embolism potential use diagnosis lung scans described normal n showing low n indeterminate n high probability n pulmonary embolism difference mean levels cross linked fibrin degradation products scan category normal scans ng ml low probability scans ng ml indeterminate probability scans ng ml high probability scans ng ml p less patients high probability scans raised concentrations explanations discrepant low results include incorrect scan diagnosis delay blood sampling anticoagulation patients low indeterminate probability pulmonary embolism increased concentrations cross linked fibrin degradation products could attributed cases another illness owing wide range values lung scan diagnostic category raised concentrations fibrin degradation products cannot used without reference patient clinical state discriminatory test pulmonary embolism evaluation significance normal concentrations excluding diagnosis pulmonary embolism appears warranted,C08,0.0016833615,0.0014932257,0.003140978,0.017407069,0.010900125,0.03476706,0.23039897,0.0015830536,0.0012169954,0.009799893,0.22752492,0.0034773713,0.14536032,0.046764836,0.0014803057,0.010754052,0.09868948,0.0017390543,0.0019167548,0.0142656965,0.13328841,0.00059770053,0.0017503889
relative value conventional staging procedures developing prognostic models extensive stage small cell lung cancer published prognostic models small cell lung cancer sclc either combined limited extensive stage patients included standard anatomic staging information assess relative value knowledge specific sites number sites metastases predicting survival extensive stage disease studied extensive stage patients traditional staging procedures performed previously demonstrated significant pretreatment variables determined using cox proportional hazards model data included three variables significant performance status ps p number sites metastases p age p prognostic algorithm developed using variables divided patients three distinct groups anatomic staging data omitted serum albumin p variable addition ps p age p significant alternative algorithm using three variables nearly predictive original therefore extensive stage patients reasonable pretreatment prognostic information obtained without using number specific sites metastases variables presence distant metastases demonstrated,C08,0.0019721612,0.0017494055,0.022772448,0.0011083835,0.0027465962,0.04073038,0.30349696,0.0018546444,0.0014257849,0.0019377643,0.043269195,0.042243674,0.04120697,0.033717513,0.030371685,0.0030710653,0.19047259,0.0020832596,0.011980708,0.10406045,0.114997074,0.0007002428,0.0020310213
effect rifampicin rhinoscleroma electron microscopic study twenty five cases suffering rhinoscleroma divided two groups first group consisted patients treated rifampicin systemically group consisted patients treated locally rifampicin form ointment electron microscopic study pathological changes lesions showed rifampicin highly effective systemically locally treatment rhinoscleroma,C08,0.005330493,0.0047284137,0.009946148,0.0029949867,0.033227567,0.0068792794,0.31967294,0.0050128605,0.0038537094,0.005237523,0.051180694,0.11418647,0.041055568,0.012549208,0.0046875016,0.008300687,0.1444826,0.0054895245,0.0060695508,0.066574305,0.14115651,0.0018926646,0.0054908125
pentoxifylline attenuates edema formation proteolytic enzyme induced lung injury ex vivo canine lung lobes exposed pancreatic proteolytic enzyme chymotrypsin alone chymotrypsin pretreatment continuous infusion pentoxifylline lobes exposed chymotrypsin gained g pentoxifylline treated lobes gained g p less h experimental period results suggest pentoxifylline significantly attenuates lung weight gain associated chymotrypsin,C08,0.031138767,0.0047288276,0.009947019,0.002995249,0.0074231927,0.08430436,0.16936007,0.103771955,0.0038540468,0.005237981,0.024517257,0.03672543,0.08291562,0.012332434,0.004687912,0.008301414,0.06915165,0.005490005,0.031859018,0.043518547,0.25036216,0.0018928301,0.005484295
intact epithelial barrier function critical resolution alveolar edema humans within min endotracheal intubation resolution pulmonary edema studied next h mechanically ventilated patients serial measurements alveolar arterial oxygen difference extent edema initial follow chest radiograph initial final measurement total protein albumin concentration sequential samples pulmonary edema fluid based oxygenation chest radiographic data patients clinically improved patients improve patients clinically improve hydrostatic edema permeability edema change final edema fluid protein concentration g ml compared initial edema fluid protein concentration g ml p ns however patients clinically improved hydrostatic edema permeability edema increase every patient final edema protein concentration g ml compared initial edema protein concentration g ml p less patients final edema fluid concentration g ml exceeded final plasma protein concentration g ml mean value g ml protein data provide first evidence humans support hypothesis active ion transport across alveolar epithelial barrier primary mechanism clearance edema fluid air spaces lung,C08,0.03131566,0.0016550599,0.0035819435,0.019107498,0.011420061,0.030990366,0.096065976,0.0017546233,0.010323121,0.0018332605,0.019225586,0.0038490514,0.22176677,0.021605931,0.010672419,0.011993394,0.15072176,0.06515064,0.0021244907,0.029957967,0.25228915,0.0006624787,0.0019327893
cigarette smoke causes physiologic morphologic changes emphysema guinea pig investigate long term effect cigarette smoke pulmonary structure function exposed groups guinea pigs smoke cigarettes day days per week months found guinea pigs developed progressive lung destruction emphysema alterations pulmonary function tests similar seen humans cigarette smoke induced chronic obstructive lung disease method smoke induced lung destruction provide good model study early changes emphysema,C08,0.028194575,0.0029675984,0.006242299,0.0018796829,0.0046584606,0.076641664,0.17383868,0.00314612,0.0024186256,0.0032871203,0.050292052,0.023223005,0.029091982,0.008519636,0.0029419216,0.0052356585,0.1320184,0.01962676,0.0038093093,0.10997881,0.28842038,0.0011878547,0.022379411
lung overexpansion increases pulmonary microvascular protein permeability young lambs study effects inflation pressure tidal volume vt protein permeability neonatal pulmonary microcirculation measured lung vascular pressures blood flow lymph flow ql concentrations protein lymph l plasma p chronically catheterized lambs received mechanical ventilation various peak inflation pressures pip vt nine lambs ventilated initially pip cmh vt ml kg h base line overexpanded lungs pip cmh vt ml kg h ql increased ml h l p change ratio albumin globulin lymph relative ratio plasma decreased indicating altered protein sieving pulmonary microcirculation seven lambs mechanically ventilated h pip cmh vt ml kg base line chest abdomen bound pip increased cmh h without change vt ql decreased average ml h p l p unchanged,C08,0.03717521,0.0024521477,0.018538153,0.0015531953,0.017782323,0.06283437,0.10937284,0.02183894,0.0019985274,0.0027161709,0.015420984,0.030754238,0.29612213,0.0063578524,0.0024309307,0.004304723,0.041368898,0.069761455,0.0031476594,0.031923067,0.21832082,0.0009815327,0.0028438976
hospitalization decision patients community acquired pneumonia prospective cohort study purpose identify low risk subset patients community acquired pneumonia could safely treated ambulatory setting assess clinicians make hospitalization decision patients methods performed prospective observational study ambulatory hospitalized adults clinical radiographic evidence pneumonia patients followed assess potential morbid complications week mortality physicians responsible managing patients surveyed assess reasons treating hospital ambulatory setting therapies dictate hospitalization results sixty one percent patients indication admission presentation using modified appropriateness evaluation protocol criteria severe vital sign abnormality alteration mental status suppurative complication arterial hypoxemia severe laboratory abnormality acute coexistent medical problem requiring admission independent pneumonia among patients complicated course defined death within weeks development new suppurative medical complication due pneumonia intensive care unit admission persistent fever use intravenous fluids oxygen beyond days hospitalization lasting days subsequent hospitalization patients initially treated ambulatory setting five predisposing factors complicated course identified logistic regression models odds ratio age years comorbid illness temperature degrees c degrees f immunosuppression high risk etiology risk complicated course increased linearly number risk factors none four factors p less physicians often relied general clinical appearance patient making triage decision commonly cited intravenous antibiotics chest physical therapy treatments requiring hospitalization conclusions validated findings could improve physicians assessment prognosis may identify low risk subset patients community acquired pneumonia could safely managed ambulatory setting,C08,0.0015433698,0.0011843148,0.015583177,0.00075014745,0.008320884,0.03214826,0.30106974,0.0077802762,0.0009652297,0.0077695823,0.032752007,0.015672022,0.042095434,0.0032200816,0.007600296,0.00860145,0.20458138,0.0013749485,0.00986433,0.21563867,0.07963679,0.0004740513,0.0013735185
respiratory response pharmacokinetics intravenous salbutamol infants bronchopulmonary dysplasia effects iv salbutamol respiratory mechanics studied six infants bronchopulmonary dysplasia salbutamol infused dose micrograms kg min five infants sixth infant received micrograms kg min salbutamol caused improvement total respiratory system compliance airflow resistance correlation salbutamol serum concentration pulmonary function elimination half time appears dictated infants distribution volume vd clearance cl area concentration time curve salbutamol correlated inversely change heart rate hr significant positive correlation vd percent hr change data provide evidence preterm infants measurable activity bronchiolar beta receptor responsive salbutamol,C08,0.0032408703,0.016261896,0.0052983733,0.0015954477,0.003954034,0.07197563,0.11955946,0.0026703812,0.0020528943,0.044027172,0.028404944,0.029644825,0.19629094,0.0067853574,0.0024971152,0.02490907,0.04870942,0.016669787,0.0032332866,0.12450758,0.23003796,0.0010082339,0.016665349
systems architecture quantification dynamic myoelectric kinematic activity human vocal tract paper describes systems architecture useful scientific investigations require acquisition analysis multiple time synchronous signals large volume architecture recently developed group enhance capability research quantify central nervous system function production normal pathologic speech architecture utilizes modern advances desktop microcomputers designed vocal motor control laboratories similar settings modest funding fully participate comprehensive investigations speech production research experiments organized architecture may involve many subjects measures previously possible without significant increases time personnel resources paper demonstrate technique practicality architecture used successfully guide research map hierarchic central nervous system regions involvement two speech disorders spasmodic dysphonia stuttering architecture broad usefulness many areas otolaryngology health science,C08,0.0149207935,0.08895627,0.041245177,0.0014376001,0.0035638441,0.028725527,0.26965407,0.0024061839,0.0018497888,0.0025140222,0.06994235,0.02662148,0.10124696,0.05675147,0.0022500106,0.016353708,0.0750403,0.002636024,0.01529592,0.03231856,0.14268248,0.00090848305,0.0026789752
bronchoalveolar lavage liquid paraffin pneumonitis evaluated cells lipids recovered bronchoalveolar lavage fluid seven patients liquid paraffin pneumonitis patient balf whitish oil droplets surface alveolar macrophages contained numerous large vacuoles react may grunwald giemsa papanicolaou periodic acid schiff stained black sudan b orange sudan iii red oil red liquid paraffin identified thin layer chromatography balf extracted lipids hydrophobic compound migrating solvent front control liquid paraffin abnormal spot definitely identified liquid paraffin infrared spectroscopy gas liquid chromatography first patient number percentage ams largely decreased balf patient whereas number neutrophils eosinophils lymphocytes increased findings suggest cell mediated inflammatory response plays role development interstitial fibrosis late stages liquid paraffin pneumonitis,C08,0.0036423756,0.003230969,0.02831333,0.0020465022,0.0050732773,0.0047006756,0.26929727,0.021049153,0.020247245,0.003578848,0.057713117,0.025989098,0.0790602,0.09769689,0.038466025,0.005671936,0.16465864,0.0038193548,0.0041473806,0.029175993,0.106769845,0.0012932753,0.024358625
local global function right ventricle canine model pulmonary microembolism oleic acid edema influence ventilation peep right ventricular rv dysfunction may occur due increased rv afterload hence might also contribute decrease cardiac output following institution peep patients adult respiratory distress syndrome ards test hypothesis authors examined influence peep local global rv function anesthetized dogs experimental ards eards induced pulmonary microembolization glass beads oleic acid local rv function analyzed rv inflow tract rvit rv outflow tract rvot assessing diastolic segment length systolic segment shortening segment work sonomicrometry global rv contractility quantified measuring maximum rate pressure rise drvp dtmax maximum velocity contractile element shortening vmax eards despite fivefold increase pulmonary vascular resistance change cardiac index ci global rv contractility rvit rvot work rvit shortening whereas rvot shortening decreased p less diastolic segment length increased rvit p less rvot peep cmh alter global rv contractility rvit rvot shortening rvit work reduced rvot work p less ci p less cardiac index decreased peep cmh p less global rv contractility remained intact despite decreased rvit rvot shortening p less work p less presence reduced fiber preload regions findings concluded decreased ci mechanical ventilation peep constant right ventricular end diastolic pressure rvedp caused depressed global rv contractility dogs eards normal myocardium prior insult decreased diastolic segment length segment shortening peep suggest peep reduces stroke volume starling mechanism rather ischemia rv free wall finally regionally incongruent changes fiber preload indicate local differences rv wall compliance likely occur subsequent eards peep,C08,0.06625559,0.0089119105,0.0108594205,0.0008745318,0.0021673727,0.009737558,0.08867746,0.001470306,0.0011252776,0.001529349,0.012062153,0.041248687,0.19279307,0.027352724,0.0013687436,0.009941397,0.09098256,0.0016031371,0.009257246,0.09738178,0.32223186,0.0005526553,0.0016151906
altered function pulmonary surfactant fatty acid lung injury determine whether acute fatty acid lung injury impairs pulmonary surfactant function studied anesthetized ventilated rabbits given oleic acid mg kg iv n equivalent volume saline n measurements pulmonary mechanics indicated decrease dynamic compliance within min injury decrease lung volume disproportionately large low pressures consistent diminished surfactant activity vivo bronchoalveolar lavage fluid obtained h injury significantly increased erythrocytes total leukocytes largely polymorphonuclear cells phospholipid content composition cell free fraction minor changes controls protein content increased fold measurements lavage surface activity vitro showed increase average minimum surface tension se dyn cm controls dyn cm injured animals alterations static pressure volume curves decrease lavage surface activity suggest severe alteration surfactant function form lung injury occurs despite presence normal amounts surfactant phospholipids,C08,0.08133213,0.0117415,0.01943029,0.0011520694,0.002856235,0.05241089,0.1049132,0.0019282766,0.0014823907,0.0020146966,0.010528846,0.011581691,0.25343418,0.084345624,0.0018059473,0.0032887247,0.018480528,0.03350453,0.0023347493,0.02424513,0.27434912,0.00072804355,0.0021111912
penetration aminoglycosides alveolar lining fluid rats effect airway inflammation concentration time profile gentamicin tobramycin alveolar lining fluid alf rats determined intravenous bolus injection using bronchoalveolar lavage bal bal used evaluating penetration aminoglycosides alf highly sensitive detection methods used endogenous marker urea applied avoid unpredictable dilutional effect lavage procedure concentration gentamicin tobramycin alf reached peak min respectively remained high plasma concentrations declining suggesting accumulation reservoir lung acini ratio auc concentration time profile alf plasma gentamicin tobramycin respectively penetration aminoglycosides alf significantly higher induction airway inflammation inhalation endotoxin ratio auc alf plasma endotoxin exposed animals gentamicin tobramycin respectively ratio auc concentration time profile gentamicin alf tobramycin without inflammation endotoxin exposure thus without inflammation gentamicin penetrates better alf tobramycin,C08,0.002590306,0.0022977309,0.031246202,0.0014553873,0.0036199214,0.053500768,0.16557646,0.0024359552,0.0018726761,0.0025451279,0.048316456,0.031682957,0.17016175,0.005983743,0.00227785,0.029430868,0.04219784,0.0026675859,0.0029494446,0.03806428,0.35554212,0.0009197236,0.0026648114
platelet derived growth factor idiopathic pulmonary fibrosis fibrosis complex process involving inflammatory reaction fibroblast proliferation abnormal accumulation interstitial collagens mononuclear cells usually present lung fibrosis activated monocytes macrophages culture shown produce several growth factors including platelet derived growth factor pdgf pdgf potent mitogen chemoattractant fibroblasts smooth muscle cells stimulator collagen synthesis studied expression c sis pdgf mrna lung tissues derived five patients idiopathic pulmonary fibrosis ipf four control individuals without ipf northern blot analysis specimens obtained four patients ipf revealed expression c sis pdgf protooncogene control lung tissue without ipf express c sis protooncogene situ hybridization extended studies demonstrating expression c sis mrna five specimens ipf four control specimens without ipf expression c sis mrna localized primarily epithelial cells invading alveolar macrophages also expressed c sis mrna expression c sis mrna accompanied expression pdgf like proteins lung specimens ipf control lung specimens findings demonstrate vivo expression c sis pdgf protooncogene production pdgf like proteins epithelial cells macrophages fibrotic tissue localized sustained production pdgf like mitogen may constitute important contributing factor abnormal fibroblast proliferation collagen production events associated pulmonary fibrosis,C08,0.022603644,0.0015563172,0.0033189717,0.043450624,0.002448587,0.049362972,0.22252324,0.01887343,0.0012684157,0.0017238861,0.077389665,0.0037212004,0.030143829,0.11481009,0.0015428512,0.0027321004,0.03024366,0.109029874,0.01897403,0.013692201,0.14054441,0.00062295445,0.089423046
prediction postoperative clinical course autologous tumor killing activity lung cancer patients fifty patients primary localized lung cancer tested time surgery ability lymphocytes kill autologous freshly isolated tumor cells assay evaluated prognostic significance peripheral blood lymphocytes patients demonstrated significant autologous tumor killing activity hour cr release assays twenty three patients autologous tumor killing activity remained tumor free survived years curative surgery negative autologous tumor killing activity relapsed months surgery died within months surgery differences survival curves two groups highly significant p less autologous tumor killing activity correlated natural killer nk cell activity k human myeloid leukemia cells proliferation lymphocytes stimulated autologous freshly isolated tumor cells mixed culture differences total survival patients positive results negative results tests nk cell activity autologous mixed lymphocyte tumor culture reaction results indicate autologous tumor killing activity meaningful prognostic indicator provide evidence immunological control tumor growth metastasis according preliminary data unlikely lung cancer patients remain tumor free months follow develop recurrence die disease conducting study determine whether induction autologous tumor killing activity surgery treatment biological response modifiers improve clinical outcome patients naturally potential,C08,0.0014077973,0.0012487865,0.0026268037,0.0075641507,0.09062577,0.022261802,0.13485228,0.0013239096,0.0010177748,0.008177508,0.03702845,0.03137221,0.13102591,0.110918336,0.008051314,0.009000682,0.20534843,0.0014497979,0.0016029844,0.016155278,0.1680169,0.0004998577,0.00842331
potential usefulness artificial neural network differential diagnosis interstitial lung diseases pilot study artificial neural network approach applied differential diagnosis interstitial lung diseases neural network designed distinguish nine types interstitial lung diseases basis items clinical radiographic information data base training testing neural network created hypothetical cases nine diseases performance neural network evaluated means receiver operating characteristic analysis decision performance neural network high comparable chest radiologists superior senior radiology residents preliminary results strongly suggest neural network approach potential utility computer aided differential diagnosis interstitial lung diseases,C08,0.00364013,0.0032289769,0.0858878,0.0020453362,0.0050687655,0.09438111,0.3492729,0.0034232223,0.002631652,0.0035766414,0.088386744,0.0074870517,0.032163948,0.008404812,0.0032010383,0.0056684394,0.06834108,0.0037487303,0.021754583,0.1365694,0.06607206,0.0012924778,0.0037530994
breathing exercises medical patient art science art breathing exercises traced late past years increased demand treatment respiratory muscle failure dysfunction resulted numerous studies evaluating methods treatment training article provides overview research practice focused treating medical patient experiencing dyspnea loss respiratory muscle strength endurance,C08,0.0044188974,0.068097465,0.008245205,0.0024827984,0.006153175,0.027090067,0.19670904,0.025538793,0.024586776,0.0684994,0.04650953,0.009088828,0.040328436,0.031481702,0.003885867,0.0068811425,0.18377769,0.0045507317,0.026420858,0.13165647,0.07748214,0.00156899,0.0045459988
intraluminal irradiation palliation lung cancer high dose rate micro selectron fifty patients inoperable symptomatic endobronchial carcinoma treated single exposure intraluminal radiotherapy high dose rate afterloading system micro selectron hdr used minimise radiation exposure staff haemoptysis relieved patients breathlessness patients cough nine patients radiological collapse resolved patients treatment given outpatient basis well tolerated intraluminal radiotherapy appears offer effective alternative conventional fractionated external beam radiotherapy,C08,0.044300232,0.0036836474,0.007748497,0.0023332296,0.0057824957,0.025461745,0.24164224,0.0039052444,0.0030022133,0.004080266,0.080503434,0.052292112,0.031194517,0.009548328,0.003651775,0.006466609,0.2589929,0.004276587,0.0047284537,0.08738767,0.1132602,0.001474471,0.0042830682
measurement histamine nasal lavage fluid comparison glass fiber based fluorometric method two radioimmunoassays determination histamine nasal secretions nasal lavage fluid may importance monitor activation histamine containing cells nasal cavity however studies besieged controversy specifically findings changes histamine levels relation allergenic stimulation controversy may due specificity accuracy various methods used determine histamine nasal fluid therefore applied compared three new methods determine histamine nasal lavage fluids obtained allergen challenge normal subjects patients allergic rhinitis used fluorometric glass fiber based histamine method fhr two rias ii fhr detection limit nmol ria ii detection limit nmol specific histamine whereas ria detection limit nmol measures mainly methylhistamine cross reacts extent histamine histamine levels nasal lavage fluids nasal challenges demonstrated histamine values nmol l histamine significantly higher levels postallergen challenges allergic subjects compared normal control subjects fhr correlated well ria ria ii methods correlation coefficients p less respectively however ria methylhistamine antibody always demonstrated absolute histamine values values measured ria ii level cross reactivity histamine,C08,0.0017261545,0.0015302418,0.0033416948,0.00096955936,0.0024024288,0.010566699,0.32684857,0.0016222964,0.001247164,0.0016950032,0.11679964,0.0035617836,0.23909278,0.043074414,0.009863605,0.019383369,0.021707436,0.08159656,0.00196427,0.014789149,0.09381179,0.0006125171,0.0017929049
effects prostaglandin e platelet attenuation oxidant induced edema isolated rabbit lungs numerous studies suggest platelets may contribute preservation normal endothelial cell permeability models lung injury previously shown washed human platelets prevent xanthine oxidase induced edema isolated perfused lung protective mechanisms depend platelet glutathione redox cycle uncertain however whether platelets preserve endothelial function reducing toxic oxygen metabolites aggregating releasing endothelial cell supportive factors activity may require glutathione redox cycle study present data demonstrating platelet prevention oxidant lung injury occurs independent platelet aggregation release isolated rabbit lungs perfused cell free medium instilled purine mmol l xanthine oxidase u ml generate oxidant lung edema infusion washed human platelets x cells prevented lung edema formation measured lung weight gain wet dry lung weight ratios lung histology incubation platelets prostaglandin e pge potent inhibitor platelet aggregation release inhibit platelet attenuation lung edema additionally instillation pge perfusate inhibit platelet aggregation prevention lung protection pge treated platelets seen results compared studies lungs infused xanthine oxidase pge aggregometry studies documented inhibitory effect pge platelet aggregation persisted minutes duration isolated lung protocol conclude platelet aggregation release platelet factors required platelet attenuation oxidant lung edema,C08,0.031050488,0.030819604,0.024924899,0.000855096,0.0021192036,0.11248219,0.12847534,0.04359889,0.0011002691,0.0014953604,0.007093024,0.0035839207,0.058926597,0.09873572,0.023425616,0.014662103,0.028141389,0.008952461,0.001732912,0.014354186,0.36136124,0.000540373,0.001569139
chronic obstructive pulmonary disease chronic obstructive pulmonary disease indeed multifaceted illness obstructive picture result multiple pathologic processes common cause cigarette smoking key decreasing incidence disease education prevent people starting smoke educate smoke stop therapeutic management involves numerous medications oxygen physiotherapy unfortunately pharmacologic management remains largely empiric sympathomimetics anticholinergics methylxanthines corticosteroids agents especially methylxanthines corticosteroids without considerable toxicity therefore embarking pharmacologic plan requires weighing risk benefit ratio carefully comprehensive plan assess subjectively objectively efficacy toxicity chosen therapy,C08,0.036899127,0.019803999,0.02318836,0.0019426979,0.021537106,0.0044969297,0.41359115,0.01998097,0.0024997084,0.02012398,0.054140538,0.007111672,0.041132238,0.008582282,0.0030405475,0.00538424,0.03347767,0.0035607796,0.020661572,0.16566563,0.08839408,0.0012276768,0.0035570762
surgical treatment secondary retracted nose surgical technique presented correct nasal tip retraction frequently associated surgical sequelae corrected simultaneously based use shield anchor half anchor otocartilage one two posterior supports sutured together forming small l fixed bed project nasal tip necessary correct unilateral bilateral alar collapse,C08,0.05548538,0.02974696,0.034832545,0.0029199342,0.007236539,0.006706889,0.2313492,0.0048872414,0.0037571378,0.0051062736,0.033858944,0.01068906,0.032169856,0.01247547,0.0045700357,0.03324831,0.27992386,0.055663176,0.005917452,0.03837655,0.10387826,0.0018452356,0.0053556883
appropriate inappropriate neuroendocrine products pulmonary tumourlets pulmonary tumourlets focal aggregates neuroendocrine cells occur periphery lung may associated chronic inflammation scarring six lesions seen five lungs series pairs lungs studied necropsy immunoreactive neurone specific enolase protein gene product range neuroendocrine products peptides found neuroendocrine cells normal human lungs gastrin releasing peptide present tumourlets calcitonin one none contained leucineenkephalin series peptide protein hormones present neuroendocrine cells healthy human lungs growth hormone present six tumourlets adrenocorticotrophin two identical patterns peptide expression displayed neuroendocrine cells airway associated tumourlets two cases cells increased number abnormally clustered aberrant expression peptides might accompany morphological changes pulmonary neuroendocrine cells seen diseased lungs florid focal proliferation occasionally resulting formation tumourlet,C08,0.027005773,0.002041926,0.0042951605,0.012408509,0.014348218,0.08970581,0.2430725,0.0021841933,0.0016641922,0.0022617804,0.043116916,0.004734628,0.033933915,0.12990811,0.0020242583,0.025863715,0.028504398,0.04737748,0.0026210847,0.047657784,0.19251755,0.00081733137,0.0419348
trends lung cancer chronic obstructive lung disease emphysema death rates england wales relation trends cigarette smoking trends smoking associated respiratory diseases england wales studied careful attention problems caused changes classification cause death three diseases selected analysis lung cancer emphysema chronic obstructive lung disease deaths would previously certified chronic bronchitis increasingly tended classified chronic airways obstruction definition chronic obstructive lung disease used includes terms avoid artificial decline caused consideration chronic bronchitis isolation age specific rates three diseases show pronounced cohort period birth pattern rates men rising rates born shortly turn century declining rates women peaking cohort born years later chronic obstructive lung disease lung cancer emphysema cohort peak superimposed sharply declining downward trend sexes cohort patterns cumulative cigarette consumption peak time broadly similar seen three diseases trends cigarette consumption however cannot explain underlying steeply declining rate chronic obstructive lung disease fully explain declining trends lung cancer emphysema rates younger men women,C08,0.0017109917,0.001517735,0.011448694,0.0009613364,0.01065297,0.08504043,0.17791654,0.0016090373,0.0012369709,0.009958921,0.019603504,0.036835745,0.06587859,0.0040795845,0.009780601,0.00266437,0.039913934,0.0017620377,0.010211462,0.34484488,0.15999994,0.00060751097,0.0017642414
dyspnea multidimensional model dyspnea includes sensation perception distress response reporting components presented assessment tools currently available evaluated recent research findings pharmacologic oxygen physical psychologic treatments article concludes suggesting role nurse dyspnea amelioration,C08,0.0063071167,0.005594727,0.042299334,0.0035437117,0.039291058,0.008139662,0.45551354,0.005931289,0.0045597646,0.0061971126,0.032643873,0.012972534,0.03976219,0.014502009,0.0055463193,0.009821492,0.06732121,0.0064952844,0.00718158,0.04180321,0.17584506,0.002239428,0.006488529
predicting risk bronchopulmonary dysplasia selection criteria clinical trials early identification neonates bronchopulmonary dysplasia likely develop permits appropriate enrollment clinical trials testing early intervention therapies prevention treatment bronchopulmonary dysplasia analysis neonatal intensive care unit survivors days revealed supplemental oxygen requirement days could predicted logistic regression including birth weight gestational age minute apgar score peak inspiratory pressure hours hour old neonates birth weight gestational age peak inspiratory pressure hours mean airway pressure days day old neonates two regression analyses applied prospectively three new data sets totaling neonates test predictive ability neonates classified low moderate high risk groups basis predicted probability requiring oxygen supplementation days low probability less moderate probability high probability greater although populations demographically distinct original group regression analyses performed well regression analysis hours age classified neonates low risk required supplemental oxygen days regression analysis days classified neonates low risk required supplemental oxygen hour regression analysis classified neonates moderate risk required supplemental oxygen days day regression analysis classified neonates moderate risk required supplemental oxygen,C08,0.0014373536,0.03606174,0.010092423,0.00080778217,0.0020081403,0.02086251,0.15334056,0.0013517047,0.0010391426,0.015317372,0.13005151,0.023014572,0.10292998,0.0033049458,0.0012639895,0.0231028,0.0746349,0.0015055711,0.017414467,0.23926781,0.09706466,0.035233736,0.008892356
rising mortality cryptogenic fibrosing alveolitis objective determine pattern mortality ascribed cryptogenic fibrosing alveolitis identify factors might important aetiology disease assess validity death certification disease design retrospective examination mortality ascribed cryptogenic fibrosing alveolitis england wales analysis multiple logistic regression independent effects age sex region residence social class indicated occupation data also retrospective review hospital records patients certified died cryptogenic fibrosing alveolitis nottingham certified cause death patients known disease main outcome measures time trends mortality nationally effects mortality age sex region residence validity death certification nottingham results annual number deaths ascribed cryptogenic fibrosing alveolitis doubled increase occurring mainly ages mortality standardised age sexes likewise increased steadily period deaths due cryptogenic fibrosing alveolitis commoner men odds ratio confidence interval increased substantially age times higher subjects aged much greater aged odds ratios death due cryptogenic fibrosing alveolitis adjusted age sex increased traditionally industrialised central areas england wales p less maximum odds ratio regions significant increase odds death found manual occupations people whose deaths registered nottingham due cryptogenic fibrosing alveolitis ascertained clinical records disease patients known cryptogenic fibrosing alveolitis life recorded died disease conclusions diagnostic accuracy death certification cryptogenic fibrosing alveolitis high number deaths recorded due disease may underestimate number patients dying disease half mortality due disease increasing male predominance regional differences mortality suggest environmental factors important aetiology,C08,0.0014401942,0.0012750119,0.019886838,0.00080759515,0.0020014811,0.008993559,0.20314886,0.0013517127,0.0010391488,0.022275094,0.035819538,0.002962826,0.06675438,0.0034752367,0.025585288,0.009042888,0.10097331,0.0014802447,0.0085804565,0.34788617,0.13318437,0.00051035505,0.0015254894
inhaler spacer use obstructive airway diseases role inhaled aerosols treatment obstructive airway diseases increasing immediate bronchodilation prophylactic anti inflammatory effects inhaled aerosol agents available metered dose inhaler nebulizer forms maximum therapeutic benefit metered dose inhalers assured correct inhaler technique used spacer devices may helpful patients,C08,0.004831931,0.074460626,0.009015882,0.002714865,0.053498384,0.053018045,0.31103763,0.0045440067,0.003493271,0.004747656,0.03771738,0.009938359,0.048938766,0.011355626,0.004249078,0.007524322,0.118882276,0.0049760877,0.0055018645,0.031972144,0.19088937,0.0017156432,0.004976805
lactate levels predictors relationship oxygen delivery consumption ards reviewed changes vo patients ards interventions included fluid loading blood transfusion peep significant change patients lactic acidosis lactate level greater mmol l exhibited significant corresponding changes vo p less however change vo observed patients without lactic acidosis beta greater conclude biphasic pattern oxygen utilization patients ards emerges subsets patients without lactic acidosis compared lactic acidosis marker anaerobic metabolism may characteristic patients ards exhibit changes vo dependent changes,C08,0.0035769255,0.0031729115,0.015306763,0.0020097285,0.0049807555,0.004616209,0.2313496,0.003363784,0.019898253,0.0035145395,0.017394003,0.007357052,0.20655565,0.008224457,0.003145458,0.005570017,0.14933474,0.05265158,0.0040728557,0.056676764,0.17496432,0.0012700363,0.020993575
confluence pulmonary veins simulating pulmonary mass confluence pulmonary veins commonly appears frontal view chest generally easily recognized plain film tomography computerized tomography pulmonary angiography anatomy convergence pulmonary veins prior common entry left atrium clearly displayed report attention called occasional appearance confluence pulmonary veins lateral view chest clearly circumscribed round opacity mimicking lung mediastinal mass,C08,0.12825495,0.003839263,0.07089993,0.0024317969,0.026954267,0.02833074,0.22510588,0.19264834,0.0031290418,0.0042526373,0.061416525,0.008902126,0.026791887,0.009951696,0.0038060439,0.006739791,0.05351298,0.004501065,0.004928207,0.02961699,0.09799643,0.0015367599,0.0044526155
effects famotidine cimetidine plasma levels epidurally administered lignocaine effects two h receptor antagonists famotidine cimetidine plasma levels epidurally administered lignocaine studied group n received famotidine mg orally night surgery mg intramuscularly minutes induction anaesthesia group b n received cimetidine mg orally night surgery mg orally minutes anaesthetic induction group c n received neither famotidine cimetidine served controls twelve millilitres lignocaine adrenaline injected epidural space patients establishment general anaesthesia nitrous oxide oxygen enflurane patients received cimetidine showed significantly higher plasma concentrations lignocaine compared either group group c investigation times p less mean peak plasma concentrations sem sem sem micrograms ml group b c respectively study suggests famotidine preferable cimetidine control gastric acidity use lignocaine epidural anaesthetic,C08,0.002879988,0.04437114,0.0053737587,0.0016181477,0.004010292,0.017606441,0.1252956,0.0027083755,0.002082103,0.0028297573,0.013366438,0.1723846,0.13515513,0.0066219815,0.0025325888,0.046287954,0.09281912,0.0029659101,0.00327929,0.020320645,0.27763167,0.001022579,0.016836511
mechanical disruption pulmonary emboli dogs flexible rotating tip catheter kensey catheter pulmonary embolism induced dogs injection three four day old allogeneic blood clots clots made radiopaque soaking contrast material resulting clots firm cm long cm diameter injection clots external jugular vein consistently produced occlusion least one lobar pulmonary arteries every instance tip catheter could positioned clot embolus six dogs clots readily fragmented number french mm od flexible rotating tip catheter kensey catheter activated rpm overall perfusion shown posttreatment angiograms markedly improved studies show catheter tip fragmentation pulmonary emboli kensey catheter excellent potential therapeutic application patients pulmonary embolism,C08,0.07684444,0.017453449,0.020421498,0.00171333,0.019003082,0.003951992,0.18550259,0.002867687,0.002204576,0.0029962086,0.12835608,0.035792343,0.07872155,0.007356382,0.00268156,0.034264904,0.13029344,0.017895559,0.0034721834,0.06082909,0.16315822,0.001082729,0.003137104
pulmonary edema induced phagocytosing neutrophils protective effect monoclonal antibody phagocyte cd integrin studied changes pulmonary hemodynamics lung wet weight induced opsonized zymosan oz isolated guinea pig lungs perfused ringer albumin solution containing neutrophils pmns addition oz pmn perfused lungs caused pulmonary vasoconstriction weight gain neither oz pmns added individually perfusate altered pulmonary vasomotor tone wet weight steady gain lung weight mg minute study period associated pulmonary capillary hypertension increase capillary filtration coefficient indicative increased lung vascular permeability responses may due generation oxygen radicals alterations pulmonary hemodynamics lung weight reduced addition superoxide dismutase catalase superoxide dismutase plus catalase examined basis pmn mediated effects layering pmns bovine pulmonary artery endothelial monolayers challenge oz resulted increased endothelial permeability albumin monoclonal antibody ib directed cd common beta subunit structurally related adhesion receptors phagocytes lfa mac p prevented oz mediated increase pmn adherence endothelial cells increase endothelial permeability albumin ib also inhibited lung weight gain mediated oz stimulated pmns intact lungs protective effect ib could ascribed neither inhibition uptake oz pmns inhibition release oxygen radicals myeloperoxidase elastase,C08,0.07960057,0.011404254,0.003757083,0.01072188,0.0027727894,0.13584036,0.16710636,0.04042541,0.0014396042,0.001956546,0.0091895275,0.01372779,0.028189925,0.0452636,0.0017510783,0.012942829,0.018796988,0.050873846,0.0022673612,0.026763117,0.30048868,0.010332161,0.02438826
serologic evidence subclinical pertussis immunized children incidental vaccine study involving immunized children conducted two study sites inner city children significantly higher geometric mean pertussis agglutinin titers compared suburban children fourth dose diphtheria tetanus whole cell pertussis vaccine vs p less higher titers inner city correlated residence census tracts cases pertussis reported three hundred thirty two children placebo arm study clinically observed paired serum samples taken month period analyzed evidence natural bordetella infection twelve inner city children three suburban children spontaneous fold greater rises least two different pertussis antibodies measured agglutinin antitoxin enzyme linked immunosorbent assay igg pertussis toxin igg iga filamentous hemagglutinin eighty percent children iga filamentous hemagglutinin nine inner city children serologic evidence pertussis lived within blocks case pertussis reported within month observed antibody rise study subjects none household member pertussis none symptomatic disease,C08,0.0026231515,0.0023268664,0.004894529,0.014162872,0.0036526555,0.0033853138,0.22155376,0.0024668435,0.0018964219,0.12957084,0.06372094,0.005395393,0.11587669,0.044530403,0.0023067333,0.0043868674,0.085207105,0.015792584,0.028379582,0.025081849,0.21914412,0.00093138585,0.0027130684
family study variability pulmonary function alpha antitrypsin deficiency quantitative phenotypes group alpha antitrypsin deficient individuals phenotype pi z relatives underwent protocol including pulmonary function testing completion questionnaire blood donation population permitted minimum frequency estimate x pi null alleles five quantitative phenotypes measured including fev fef total serum alpha oxidized serum alpha total serum ige found total alpha levels higher pi z subjects lung function impairment fev less equal predicted pi z subjects impaired pi z subjects lung function impairment elevated serum levels oxidized alpha ige levels relatively elevated first degree pi mz relatives impaired pi z subjects moreover fev tended relatively reduced heterozygous parents impaired pi z subjects suggesting subset pi mz individuals risk development lung disease familial factors results represent initial step toward development intermediate phenotypes predictive severe course alpha deficiency suggest addition cigarette smoking atopic predisposition undetermined familial factors may important codeterminants lung disease progression,C08,0.0138376085,0.0015302923,0.019966537,0.00096929027,0.0024022139,0.048619565,0.26465988,0.00162235,0.0012472052,0.043448266,0.048479997,0.011899848,0.13758095,0.03051146,0.0015171439,0.0026864142,0.03443616,0.026821712,0.0019643346,0.056210518,0.16943808,0.0006125373,0.07953764
effect fasting lung glutathione redox cycle air oxygen exposed mice beneficial effects sugar fasting increases susceptibility hyperoxic lung damage mice least part decreasing lung glutathione level determine whether fasting alters components glutathione redox cycle whether diet sugar alone reverses fasting effects normally fed sugar fed fasted mice exposed room air oxygen days air exposed mice fasting decreased glutathione peroxidase gp glutathione reductase gr activities days p less glutathione level days p less corrected protein concentration gp gr values similar fed mice glutathione levels remained lower days p less oxidized glutathione gssg unchanged ratio gssg total glutathione reduced glutathione plus gssg increased day p less oxygen exposed fed mice gp increased gr increased day p less time lung injury severe glutathione increased days p less gssg increased threefold eightfold days p less oxygen exposed fasted mice dead day versus deaths fed mice failed increase gr total glutathione response oxidant stress increased gp gssg day extent fed mice day,C08,0.009825102,0.025477052,0.027134856,0.0009305272,0.0023061465,0.042087596,0.066687316,0.0015574704,0.001197328,0.0016272718,0.0077160727,0.003408914,0.1161299,0.06901791,0.105871335,0.058696248,0.019828983,0.009722178,0.0018857787,0.054287422,0.36430252,0.00058804126,0.009714021
viral pneumonias diagnostic therapeutic challenge viral pneumonias diagnostic therapeutic challenge primary care physicians illness suspected upper respiratory tract infection progresses include dyspnea cyanosis rapid diagnostic tests available detect viruses cause pneumonias fortunately viral pneumonias usually resolve without specific antiviral therapy however ribavirin indicated respiratory syncytial virus pneumonia children ganciclovir sodium cytovene cytomegalovirus pneumonia immunocompromised patients acyclovir zovirax indicated pneumonias due herpes simplex virus varicella zoster virus infections high index suspicion bacterial superinfections essential reduce risk death complication,C08,0.0035846378,0.020487126,0.0066789435,0.002009769,0.0049808556,0.0046163015,0.31834656,0.0033642317,0.00258601,0.05546318,0.1157106,0.0073571997,0.04639314,0.06647954,0.0031455213,0.0055701286,0.09276826,0.0036837142,0.0040729376,0.08407292,0.07117513,0.0012700618,0.076183215
randomized controlled trial glucocorticoid prophylaxis experimental rhinovirus infection effects combined intranasal systemic glucocorticoid steroids local inflammatory response symptoms due experimental rhinovirus infection studied adults randomized prophylaxis either placebo steroids intranasal beclomethasone micrograms twice day begun days viral challenge continued days challenge oral prednisone mg twice daily given days beginning day challenge first h viral inoculation nasal obstruction nasal mucus weights kinin concentrations nasal lavages lower steroid recipients subsequent increases variables steroid group resulted significant cumulative differences treatment groups data suggest steroid prophylaxis may suppress nasal inflammation cold symptoms first days experimental rhinovirus colds,C08,0.0025287247,0.0022417272,0.029170144,0.0014199147,0.0035190063,0.0032614465,0.18004842,0.0023765827,0.0018270325,0.0025016936,0.011642628,0.09083675,0.04960825,0.03025411,0.002222331,0.003935332,0.04302712,0.06376923,0.020362861,0.081151456,0.37079802,0.00089730683,0.002599861
pleuropulmonary morbidity internal thoracic artery versus saphenous vein graft although use internal thoracic artery ita coronary artery bypass grafting results superior graft patency improved patient survival initial clinical observations suggested increased incidence pleuropulmonary morbidity use one hundred consecutive patients left ita grafts studied prospectively compared consecutive retrospective group patients undergoing coronary artery bypass grafting saphenous vein grafts preoperative postoperative day pod pod postoperative week chest roentgenograms analyzed atelectasis effusion postoperative left lower lobe atelectasis common groups pod saphenous vein versus ita significant pod saphenous vein versus ita significant significantly higher incidence pleural effusion pod ita group versus p less small chest tube drainage versus ml p less greater need secondary thoracostomy thoracentesis versus ita group left pleural space opened ita patients pleurotomy appear influence postoperative morbidity conclude use internal thoracic artery coronary artery bypass grafting results small significant increase pleuropulmonary morbidity,C08,0.03613191,0.0020647396,0.004343149,0.0013078102,0.0032411756,0.0030039505,0.100143366,0.047259387,0.03548206,0.0022870505,0.044692487,0.049865153,0.103998035,0.0053519807,0.0020468745,0.0036246313,0.3136188,0.0023970911,0.0026503692,0.075185366,0.15807742,0.0008264631,0.0024006884
corticosteroids primary tuberculosis bronchial obstruction usefulness prednisolone combination modern potent antituberculous drugs studied children primary lung tuberculosis hilar adenopathy causing bronchial obstruction children divided random two groups patients groups treated similarly except one group received prednisolone groups similar onset treatment variables tuberculous infection healed groups group steroids improved earlier significantly fewer complications radiography bronchoscopy two patients steroids still progressive lesions young baby probably developed two severe viral infections consecutively another infant months whose treatment unreliable parents compliant patients initially treated prednisolone improved given prednisolone treatment recommended reliability treatment cannot guaranteed hazard harm would exceed expected benefit,C08,0.002730233,0.0024191365,0.0050886176,0.0015322859,0.017422607,0.0431223,0.2612324,0.0025646642,0.001971623,0.06183617,0.018006904,0.11369591,0.06445691,0.0062706075,0.002398205,0.004246772,0.17006607,0.01600245,0.0031052849,0.08495525,0.11310166,0.0009683192,0.0028056125
selection evaluation recipients heart lung lung transplantation heart lung lung transplantation successfully performed increasing frequency patients end stage cardiopulmonary pulmonary disease transplantation must considered therapeutic option selected patients physicians required understand principles involved determining suitable candidates operative procedures choice indications contraindications choice operation respect underlying disease discussed herein methods evaluation appropriate timing transplantation special considerations regarding specific patient populations also addressed properly selected patients heart lung lung transplantation provide viable therapeutic option end stage disease unresponsive conventional management,C08,0.0027249116,0.0022693607,0.0047735665,0.0014374177,0.0283318,0.10221431,0.27091786,0.0024058784,0.001849554,0.0025137032,0.037480112,0.005261983,0.0731676,0.0061078942,0.0022497252,0.016365742,0.28696093,0.0026346492,0.015282159,0.09485418,0.036654525,0.00090836774,0.0026337244
adherent subline unique small cell lung cancer cell line downregulates antigens neural cell adhesion molecule small cell lung cancer sclc lines distinguished non small cell lung cancer nsclc lines growth floating aggregates contrast adherent monolayers formed nsclc cells culture well characterized sclc lines recently described national cancer institute nci navy medical oncology branch four variant cell lines sclc v grew adherent monolayers one line nci h unique growing long term coexisting floating surface adherent subpopulations physically segregated two populations many passages vitro enrich relatively pure cultures floating adherent cells differences c myc expression keratin pattern cytogenetic appearance found adherent floating sublines however expression neuroendocrine marker neuron specific enolase floating cells three times found adherent cells floating subline also much greater surface expression neuroendocrine tumor antigens detected monoclonal antibodies uj hnk recently shown detect neural cell adhesion molecule ncam sclc cells two adherent sclc v lines also found unreactive uj hnk generalizing association ncam expression growth sclc cultures floating aggregates conclusion interesting model study expression ncam related adhesive properties sclc cells,C08,0.010878619,0.001654905,0.009677652,0.0010482202,0.021707365,0.038532216,0.22651857,0.015107457,0.0013487659,0.010860614,0.047957197,0.041888677,0.014975038,0.2756584,0.0016405861,0.002967432,0.040425245,0.0019212874,0.0021242918,0.060001884,0.11037074,0.0006624167,0.06207242
bronchodilator response ipratropium bromide infants bronchopulmonary dysplasia although muscarinic antagonist ipratropium bromide used clinically bronchodilator infants ventilated bronchopulmonary dysplasia bpd studies compared response efficacy different dosages effectiveness combination beta adrenergic agonists measured response respiratory system mechanics ventilated infants days age micrograms ipratropium bromide ib micrograms ib plus mg salbutamol sal micrograms ib plus mg sal saline vehicle delivered via nebulizer ventilator circuit respiratory system resistance rrs compliance crs measured passive flow volume technique rrs crs measured h h delivery five drug dosages saline six studies completed within h period saline significant effect mechanics significant responses ipratropium alone seen micrograms rrs decreased sem p less h p less h micrograms ib sal micrograms ib sal rrs significantly decreased h h crs significantly increased respectively h greatest decrease rrs seen h micrograms ib salbutamol,C08,0.014937378,0.027037187,0.01715686,0.0014374411,0.0035660686,0.015684923,0.11766336,0.0024059177,0.014230723,0.027280422,0.0209994,0.025193136,0.21527344,0.0058824723,0.002249762,0.003983907,0.05849337,0.0026346922,0.0029130753,0.07254169,0.34489444,0.0009083826,0.002631952
external detection pulmonary accumulation indium labelled transferrin guinea pig accumulation radioisotope labelled transferrin lungs guinea pigs determined external detection system method based intravascular extravascular distribution indium labelled transferrin compared intravascular distribution technetium labelled red blood cells guinea pigs given iloprost prostacyclin analogue potent pulmonary vasodilator noradrenaline pulmonary vasoconstrictor attempt increase decrease respectively blood volume lungs neither agent altered transferrin accumulation lung comparison saline infusion iloprost infused oleic acid infusion reduced macro molecular leakage compared oleic acid alone data suggest double isotope method distinguish hydrostatic injury induced pulmonary oedema,C08,0.07262319,0.0027931887,0.020552522,0.0017664797,0.019587113,0.10247875,0.14146803,0.0029566463,0.002272965,0.0030891548,0.08139352,0.006670131,0.1796911,0.084660426,0.0027647454,0.005575756,0.027890451,0.01844966,0.003579895,0.036940593,0.17844488,0.0011163166,0.003234421
selection factors resulting improved survival surgical resection tumors metastatic lungs total patients underwent operations removal metastatic tumors lungs number lesions removed ranged form one patients solitary lesions overall year survival year survival primary tumors except melanoma breast cancer year survival greater year survival greater rare exceptions operation choice unilateral lesions ipsilateral thoracotomy bilateral lesions median sternotomy adequate conservative resection rule three pneumonectomies lobectomies single wedge resections multiple unilateral wedge resections bilateral wedge resections postoperative hospital deaths cox covariate analysis demonstrated improved survival patients whose largest lesion less cm diameter disease free interval longer year survival related number lesions age patient aggressive surgical approach justified patients primary tumors limited number lung metastases less cm diameter resection metastases melanoma breast cancer accomplished sites metastatic disease ruled stringent criteria,C08,0.0019913455,0.011349356,0.0037156441,0.010734603,0.09960893,0.041129176,0.14384922,0.011508541,0.0014396542,0.011589315,0.036672156,0.004095817,0.066234834,0.0053231083,0.0017511882,0.003100939,0.34910658,0.0020569307,0.0022674396,0.09219633,0.07823311,0.019984227,0.002061544
changes self concept pulmonary rehabilitation part two part study describes changes self concept pulmonary rehabilitation item semantic meaning differential scale administered patients severe chronic obstructive pulmonary disease participating multidisciplinary pulmonary rehabilitation program patients asked evaluate past present future self concepts program admission program discharge months home discharge part study item level quantitative data well qualitative data counseling session program discharge reported quantitative data documented detailed changes self concept various stages pulmonary rehabilitation counseling session results indicated patient involvement item level analysis greatly facilitates psychosocial intervention findings study establish clinical indications use self concept evaluation tool adult patients chronic obstructive pulmonary disease use tool recommended early rehabilitation process,C08,0.07034843,0.0022145896,0.016704505,0.013474738,0.03972024,0.06831085,0.32452354,0.0023478128,0.0018049151,0.002453035,0.022398686,0.01844524,0.043668564,0.0061416524,0.0021954281,0.003887692,0.14978364,0.002571062,0.03756412,0.048546623,0.11943429,0.0008864443,0.0025738934
trends lung cancer incidence mortality united states published erratum appears mmwr morb mortal wkly rep dec lung cancer common fatal malignant neoplasm united states based current smoking patterns substantial public health burden smoking related lung cancer continue next several decades report describes trends lung cancer incidence lung cancer mortality,C08,0.00451531,0.004005305,0.0084251,0.0025369683,0.0062874258,0.1369845,0.25879273,0.004246252,0.0032643678,0.004436557,0.024896866,0.11858494,0.027950596,0.010382092,0.0039706496,0.028887885,0.0385626,0.0046500205,0.02693426,0.21689089,0.058546305,0.0016032225,0.004645184
real pseudo late asthmatic reactions submaximal exercise challenge patients bronchial asthma new definition late asthmatic responses exercise challenge late asthmatic reaction exercise challenge remains controversial issue study patients recorded peak expiratory flow rate pefr two control days without performing exercise difference control days pefr h compared baseline pefr pefr hours compared baseline pefr analyzing variation coefficients baseline pefr control day exercise day pefr allowed differ percent patient comparing exercise day control day late fall pefr study patients late asthmatic reaction exercise challenge present pefr fall greater equal percent compared baseline pefr value eight patients real late asthmatic reaction exercise challenge present pefr fall greater equal percent least three successive time points pefr fall greater equal percent compared corresponding clocktime control day late asthmatic reaction exercise challenge characterized nonspecific epiphenomenon fall pefr greater equal percent compared baseline pefr value corresponding clocktime control day least three successive time points graphic illustration airway responses following exercises may facilitate detection late asthmatic response,C08,0.0017699045,0.0872542,0.0033024582,0.0009944371,0.011020219,0.019414578,0.16092584,0.0016644396,0.0012795621,0.01026921,0.037260365,0.0036977166,0.2364605,0.02131832,0.0015564093,0.0027561095,0.1658475,0.0018227082,0.0105742505,0.023161476,0.16091491,0.03490097,0.0018339265
recessive oncogenes lung cancer observation carcinogen exposure strongly associated probability developing pulmonary neoplasms suggested many years acquired somatic mutations play key role genesis environmentally induced cancers advent new techniques cytogenetics molecular analysis dna extracted lung tumors become possible test hypothesis search candidate genes may targeted chronic exposure environmental insults early work field studying lung tumors different histologic types appears implicate several distinct chromosomal loci chromosomes p q p others suggesting sequential genetic events occur initiation progression pathways pulmonary tumorigenesis identifying candidate gene products understanding chronology stringency mutational events loci essential goal understanding cellular basis lung tumors developing strategies next generation diagnostic therapeutic studies,C08,0.018542008,0.0021126724,0.0044439747,0.016401587,0.04943492,0.0676106,0.40484834,0.0022397642,0.0017218514,0.0023401442,0.06252913,0.05100478,0.014918416,0.017434254,0.0020943927,0.003708777,0.042147953,0.0025046489,0.0028327692,0.055325586,0.09101657,0.0008456494,0.08394124
heterogenous amplification myc family oncogenes small cell lung carcinoma one hundred forty two foci small cell lung carcinoma sclc patients examined amplification myc family oncogenes c myc n myc l myc dot blot hybridization using formalin fixed paraffin embedded materials resected surgically obtained autopsy selected patients also examined situ hybridization amplification myc family genes detected patients c myc one n myc five l myc five two patients one n myc one l myc heterogenously amplified clones patient n myc amplification amplification detected metastatic tumors pancreas lung pleura liver lymph node metastases primary tumor areas without n myc amplification seen patient l myc amplification although amplification detected surgically resected primary lesion mediastinal lymph node metastatic lesions obtained autopsy showed l myc gene amplification two cases together previously reported evidence suggest myc gene amplification plays important role malignant progression rather development sclc stage iii iv groups patients ten fold myc gene amplification suggested survive shorter time patients without amplification p,C08,0.0026572426,0.002357107,0.017798344,0.014256039,0.055157006,0.04202106,0.1847402,0.015335452,0.0019210681,0.002610897,0.07589335,0.018329531,0.016728723,0.07862267,0.002336712,0.029229356,0.20379639,0.0029178476,0.0030256617,0.032049,0.13750777,0.0009434903,0.05976512
avoiding wrapped endotracheal tube laser laryngeal surgery experiences apneic anesthesia metal laser flex endotracheal tubes ninety one laser laryngeal procedures using apneic technique anesthesia performed patients months years age seventy two procedures performed children adults complications eight laser laryngoscopies performed using new metal laser flex endotracheal tube obstruction endotracheal tube mucous plug occurred one case apneic technique described paper provides laser operative field free endotracheal tube virtually eliminating danger laser fire relatively safe effective means performing laser laryngeal surgery addition laser flex endotracheal tube appears acceptable alternative metallic tape wrapped endotracheal tube,C08,0.018328523,0.002787136,0.005862699,0.0017653776,0.004375175,0.0040549515,0.1277903,0.0029548015,0.0022715467,0.033507943,0.077567145,0.006462552,0.021544855,0.0072244937,0.0027630206,0.03530615,0.48003593,0.0032357683,0.0038122337,0.062506124,0.09149521,0.0011156201,0.003232403
diagnostic value nonfluoroscopic percutaneous lung needle aspiration patients pneumonia forty one patients mean sd age years range years seven female male clinical signs symptoms pneumonia performed nonfluoroscopic percutaneous lung needle gauges aspiration plna investigate diagnostic yield technique patients receiving antibiotics time study plna performed either lack response empiric antibiotic treatment severity pneumonia underlying condition patient eight patients mechanically ventilated mv due acute respiratory failure plna performed bedside without fluoroscopic guidance twenty two microorganisms identified means stains cultures plna samples sensitivity plna percent detected three false positive cultures probably due contamination skin area punctured eight mv patients studied sensitivity plna percent microbiologic findings turned crucial outcome patients pneumothorax developed three patients percent plna none three patients developed pleural infection two required thoracostomy drainage none mv patients presented complications results showed nonfluoroscopic plna technique moderately good sensitivity low rate false positive cultures percent diagnose pulmonary infections patients unresponsiveness empiric antibiotic treatment severe pneumonia evaluation diagnostic value complications mv patients needed although preliminary results suggest plna alternative technique methods diagnosing pulmonary infections patients receiving artificial ventilatory support,C08,0.01646454,0.009718594,0.04422666,0.0009533787,0.026944071,0.028920395,0.21305463,0.001595718,0.0012267315,0.009876437,0.15503822,0.0037479731,0.02140603,0.028975692,0.001492148,0.0026423146,0.29629937,0.001747452,0.0019320888,0.06414517,0.06724349,0.0006024821,0.0017463985
use fenestrated silicone drain stent malignant tracheobronchial stenosis innovative use fenestrated silicone drainage tube endobronchial stent reported patient respiratory obstruction due carinal tumour laser photoresection failed restore airway patency,C08,0.0074632713,0.0066033658,0.013890082,0.0041825855,0.010365795,0.08164643,0.18909855,0.007000604,0.0053818165,0.04334826,0.10622032,0.015311272,0.04719594,0.017116487,0.006546231,0.011592149,0.24939981,0.007666279,0.008476303,0.05135484,0.09983814,0.0026431605,0.007658306
trimming inferior turbinates prospective long term study aim study determine whether initial benefits radical trimming anterior trimming inferior turbinates nasal airflow persisted long term radical trimming significantly reduced nasal resistance months following operation n p less significant change nasal resistance next months symptom scores nasal obstruction also showed significant reduction n p less months change significantly next months radical trimming inferior turbinates highly effective operation patients hypertrophy inferior turbinates initial complications however analysis data revealed patients lose initial subjective benefit relief nasal obstruction within years follow late onset crusting occurs patients though directly attributable increase nasal airflow study also concludes anterior trimming inferior turbinates cannot recommended form treatment,C08,0.014143115,0.0021370598,0.0044952733,0.001353618,0.0033652245,0.038093276,0.22918743,0.0022656189,0.0017417273,0.0023671575,0.018433088,0.0049556834,0.15700646,0.0056393086,0.013772819,0.0037515888,0.2834924,0.07456149,0.0027432018,0.03328688,0.09984435,0.00085541105,0.0025078217
differential roles opioid receptors respiration respiratory disease opiate induced respiratory depression summary findings indicate importance designing future experiments delineate opioid nonopioid forms respiratory disease dysfunction need identify means diagnosing order achieve successful recovery apparently great diversity animal species terms contributions endogenous opioids tonic control ventilation future work strive identify species appropriate model human ventilatory control disease certain opioid receptor types appear linked independent respiratory functions instance mu receptors brain stem produce strong inhibitory actions respiratory parameters including rr vt co sensitivity effects observed vivo electrophysiologic recordings vitro delta receptors may also exert inhibitory effect respiration especially nts cns ventral surfaces medulla pons especially nts na seem important sites opioid induced inhibition respiration whereas spinal cord probably involved opioid mediated ventilatory depression kappa receptors appear devoid respiratory depressant activity whereas sigma receptors may stimulate ventilatory parameters morphine similar pure mu agonists fentanyl oxymorphine probably produce analgesic respiratory depressant effects stimulation mu receptors mixed agonists antagonists mu antagonist partial agonist activity plus kappa agonist sigma agonist activity show ceiling effect respiratory depression future tests need determine opioid receptor may responsible ceiling effect addition effects mu delta kappa sigma selective agonists hypoxic drive also determined drug stimulates hypoxic sensitivity face hypercapnic depression may produce less overall respiratory depression due counteractive effects future clinically optimal opiates specificity action available may achieved creating drugs selective single receptors creating drugs desirable combinations receptor selectivities combinations mixed agonists antagonists pure mu agonists currently use today promising provide analgesia reduced respiratory depression early days opiate research development combination drug regimens thoroughly tested determine ideal ratios would retain analgesic properties undesirable effects respiratory depression abstract truncated words,C08,0.017343577,0.0063344017,0.03166103,0.0006216272,0.0015427327,0.04488186,0.21169482,0.0010404252,0.011490951,0.06535588,0.028981466,0.009822463,0.039509512,0.017311322,0.006323989,0.029577203,0.0320831,0.06847407,0.0012597424,0.041614223,0.32004398,0.00039282476,0.0126387775
inspiratory flow dynamics mechanical ventilation patients respiratory failure studied effect inspiratory flow rate respiratory resistance mechanical ventilation patients acute respiratory failure arf resistance measured constant flow inflation occlusion methods inspiratory flow rates increased l endotracheal tube resistance subtracted total resistance obtain respiratory resistance contrast flow dependent increase endotracheal tube resistance respiratory resistance decreased continuously flow rate airway pressure increased except four six patients asthma respiratory resistance increased flow increased mechanical airway dilatation tissue resistance stress relaxation time constant inequalities may contribute decrease respiratory resistance status asthmaticus however effects turbulence noncompliant airways reflex bronchoconstriction may sufficient cause flow dependent increase resistance,C08,0.013586371,0.024600266,0.015599461,0.0013077629,0.0032410582,0.16075921,0.11749293,0.0021888688,0.0016827247,0.11496475,0.025868084,0.004787353,0.19855608,0.005553209,0.013323131,0.0036245002,0.060764182,0.0023970043,0.0026502733,0.05396573,0.16986609,0.0008264332,0.0023945114
community acquired pneumonia evidence functional inactivation alpha proteinase inhibitor quantitative qualitative elastase inhibitory capacity eic alpha proteinase inhibitor alpha pi measured pulmonary arterial systemic arterial blood patients community acquired pneumonia cap eleven patients uncomplicated cap compared patients fulminating pneumonia requiring intensive care management appropriate increase quantitative alpha pi demonstrated patients significant functional inactivation alpha pi demonstrated icu treated patients apparent uncomplicated cap patients p less low eic returned normal wk hospital discharge survivors significant p less difference eic pulmonary arterial systemic arterial blood found nonsurvivors admission suggests alpha pi inactivated lungs patients fulminating cap present data demonstrate alpha pi functionally inactivated patients fulminating cap low serum functional alpha pi may result proteolytic lung damage unfavorable outcome,C08,0.06806531,0.0021621531,0.016308013,0.0013695122,0.0033951285,0.027474856,0.17268136,0.0022922216,0.0017621786,0.0023949526,0.011781595,0.0050409413,0.15586337,0.0056886715,0.0021434452,0.039190736,0.15382566,0.0025109234,0.0027754123,0.029158682,0.19634034,0.00086545525,0.09690909
cytomegalovirus pneumonia allogeneic bone marrow transplantation immunopathologic process recent literature suggests cmv pneumonia immunopathologic process case report summarizes clinical course patient supports hypothesis patient recipient allogeneic bmt recovered episode cmv pneumonia occurred two months transplant despite recovery viral infection follow bals revealed persistent lymphocytosis apparent asymptomatic patient subsequently developed boop four months initial cmv infection observations suggest viral infection may resulted activation host cell mediated response provides evidence support hypothesis cmv pneumonia immune mediated process,C08,0.0032920672,0.0029202278,0.006142656,0.0018496782,0.0046003717,0.004248584,0.30329823,0.020118916,0.0023800181,0.0032346493,0.038548607,0.006771153,0.040014785,0.104952276,0.0028949608,0.0051264334,0.18126321,0.054622754,0.0037485028,0.089755505,0.115660764,0.0011688934,0.0033867573
developmental expression plasminogen activator inhibitor type human alveolar macrophages possible role lung injury urokinase activity regulated specific endogenous plasminogen activator inhibitors type pai type pai one inhibitors pai directly implicated connective tissue metabolism virtue ability bind extracellular matrix proteins normal lung relatively rich urokinase abnormalities urokinase activity associated fibrotic lung diseases explored possibility local production pai pai human lung reverse transcription subsequent amplification polymerase chain reaction total lung rna revealed pai mrna three normal samples two specimens patients adult respiratory distress syndrome ards situ hybridizations lung biopsy specimens patient ards crna probes pai pai indicated alveolar macrophages express pai mrna acute injury phase subsequent reverse transcription pcr amplification normal human monocyte alveolar macrophage mrna revealed neither cell type expressed mrna urokinase inhibitors however h stimulation endotoxin vitro monocytes strongly positive pai negative pai mrna whereas conditions alveolar macrophages exhibited mrna pai pai metabolic labeling endotoxin stimulated alveolar macrophages methionine followed immunoprecipitation pai pai antibodies revealed macrophages synthesized pai pai judged immunoprecipitation functional studies pai found major intracellular pa inhibitor whereas pai found predominate outside cell thus mononuclear phagocytes exhibit developmental potential pai expression release pai stimulated macrophages observed setting ards may one mechanism cells promote connective tissue accumulation,C08,0.017146006,0.0014238204,0.010587003,0.0009019374,0.0022468339,0.056053635,0.25822622,0.024819046,0.0011604293,0.009343445,0.033161543,0.011067244,0.012204459,0.1289424,0.0014115656,0.018031295,0.03365794,0.10632027,0.009962632,0.031180145,0.18530197,0.00056991936,0.046280265
surfactant replacement improves lung recoil rabbit lungs acid aspiration tested hypothesis surfactant replacement would beneficial acid aspiration model acute lung injury hcl n ml kg injected trachea excised rabbit lungs n control lungs n intervention perfused tyrode solution mixed autologous whole blood ml min kg min degassed modified natural surfactant survanta ross laboratories injected trachea four lungs injured hcl mg kg mg ml two quasi static pressure volume curves determined mean alveolar pressures tlc greater hcl group control group p less however difference observed control lungs received hcl survanta anesthetized paralyzed ventilated rabbits deflation pressure volume curves determined tlc frc measured helium dilution n hcl ml kg injected trachea seven survanta instilled min later mean alveolar pressures tlc higher min hcl group compared pre hcl time point p less hcl survanta group differences seen min slight increased seen min effect surfactant replacement arterial blood gases observed hcl aspiration increased recoil excised vivo lungs surfactant replacement survanta returned recoil normal,C08,0.01642102,0.0015978293,0.01207789,0.00972218,0.011037658,0.07208735,0.08413333,0.0016939498,0.010002869,0.010272695,0.02588297,0.1154037,0.34826174,0.004291391,0.0015840043,0.002814709,0.060473014,0.0018606257,0.0020510275,0.028337544,0.17749986,0.0006395707,0.0018530951
rise tuberculosis america bills mortality newspaper gazette articles journals records specific references consumption phthisis terms tuberculosis reviewed determine occurrence importance tuberculosis american colonies review sources indicates marked increase proportional mortality tuberculosis united states th century consumption may leading cause death adult american colonists,C08,0.005197147,0.0046101287,0.05996108,0.0029200648,0.0072368626,0.006707189,0.28682247,0.00488746,0.003757306,0.005106502,0.023901101,0.010689538,0.09062951,0.04321385,0.029726116,0.008093039,0.04528574,0.0053521995,0.05622327,0.19720982,0.095272064,0.0018453181,0.0053522266
prototype volume controlled resuscitator neonates infants twenty five infants receiving assisted ventilation icu manually ventilated min periods using either new prototype volume controlled resuscitator vcr standard self inflating resuscitator sir variables monitored min periods included heart rate respiratory rate mean arterial pressure mean airway pressure paw end tidal co petco pulse oximetry oxygen saturation pao paco significant differences posttrial values following variables petco vs torr p less b paco vs torr p less c ph vs p less comparable paw vs ns eighty four percent infants vcr group normal paco values torr sir group achieved normocarbia p less measurements highest pmax lowest pmin inspiratory pressure cm h patients demonstrated marked variation pmax sir differences pmax sir minus vcr significant p less pmin ns study demonstrates ventilation vcr resulted less hyperventilation minimal pressure variability compared sir studies neonate warranted,C08,0.010573708,0.0020192561,0.04924484,0.001279001,0.0031711685,0.035991047,0.11665928,0.0021407285,0.0016457161,0.02426929,0.012179217,0.0342842,0.40672383,0.005252463,0.0020017847,0.0035542303,0.105667174,0.0023446793,0.002591985,0.11436637,0.06088994,0.0008082572,0.0023418483
respiratory health effects indoor environment population dutch children effect indoor exposure nitrogen dioxide respiratory health studied period yr population nonsmoking dutch children yr age lung function measured schools information respiratory symptoms collected self administered questionnaire completed parents children nitrogen dioxide measured homes children palmes diffusion tubes addition information smoking dampness home collected questionnaire relationship exposure nitrogen dioxide home respiratory symptoms respiratory symptoms found associated exposure tobacco smoke home dampness weak negative association maximal midexpiratory flow mmef exposure nitrogen dioxide fev peak expiratory flow mmef negatively associated exposure tobacco smoke home dampness associated pulmonary function lung function growth measured period yr consistently associated indoor exposure variables development respiratory symptoms time associated indoor exposure nitrogen dioxide significant association exposure environmental tobacco smoke home development wheeze also significant association home dampness development cough,C08,0.00867419,0.0017008637,0.0035777416,0.0010773306,0.0026699726,0.023561722,0.13480215,0.0018031825,0.010664503,0.16702718,0.059419714,0.0040532383,0.08508168,0.02326385,0.0016861472,0.0032225442,0.031245723,0.001974644,0.020744905,0.3293411,0.08175424,0.0006808128,0.00197259
effect different rates infusion propofol induction anaesthesia elderly patients effect changing rate infusion propofol induction anaesthesia studied elderly patients propofol administered ml h loss consciousness judged loss verbal contact patient achieved duration induction significantly longer p less slower infusion rates total dose used significantly less p less patients mg kg respectively decrease systolic diastolic arterial pressure significantly less ml h group end induction immediately induction p less incidence apnoea also significantly less slower infusion group,C08,0.0034260664,0.002553848,0.0053719813,0.0016176126,0.0040089656,0.0037155452,0.09742611,0.0027074798,0.0020814145,0.0028288213,0.014187734,0.038153738,0.3310381,0.006638046,0.0025317932,0.07497527,0.11310114,0.0029649292,0.0032782054,0.12248879,0.16092034,0.0010222408,0.0029618456
pulmonary blood volume edema postpneumonectomy lung growth rats pneumonectomy young animals contralateral lung undergoes compensatory growth generally attains weight air space volume lungs age matched controls study determined contribution lung edema increased blood volume weight gain rats three weeks pneumonectomy n sham pneumonectomy n pulmonary blood volume extravascular water albumin evaluated use cr labeled erythrocytes labeled albumin air space volume blood free lung weights dna protein content also compared data show total pulmonary blood volumes blood volume per gram blood free dry lung similar pneumonectomized age matched sham controls total extravascular albumin extravascular albumin per gram blood free dry lung also similar well extravascular lung water wet dry weight ratios dna protein content air space volumes data indicate increased weight postpneumonectomy lung due cellular stromal proliferation blood volume interstitial fluid increased proportion increase lung parenchyma neither vascular congestion increased extravascular protein water contributed observed weight gain,C08,0.014933581,0.001625227,0.003418641,0.0010294222,0.00255124,0.1313861,0.07757595,0.0017411876,0.0013245781,0.0018002156,0.008864414,0.03133134,0.2700519,0.051271074,0.0016112046,0.002853071,0.027276594,0.028495928,0.002086196,0.08642569,0.2320739,0.0006505373,0.019622
causes cryptogenic fibrosing alveolitis case control study environmental exposure dust objective investigate role occupational domestic exposure dust aetiology cryptogenic fibrosing alveolitis design matched case control study subjects patients cryptogenic fibrosing alveolitis community controls matched age sex responded questionnaire main outcome measure responses self administered questionnaire asking lifetime exposure dust animals smoke home work results patients cryptogenic fibrosing alveolitis likely report occupational exposure metal dust matched odds ratio confidence interval p less wood dust p worked cattle p lived house heated wood fire p history smoking social class based occupation significantly related disease state conclusion environmental exposure dust may important factor aetiology cryptogenic fibrosing alveolitis,C08,0.0028394747,0.0025187558,0.022562642,0.001595385,0.003953879,0.0036845952,0.22933438,0.0026702764,0.0020528138,0.016530119,0.09790634,0.0072779097,0.10278449,0.006768218,0.06949988,0.0044216528,0.05128964,0.0029241883,0.0032331597,0.22888277,0.1333401,0.0010081943,0.0029211468
current epidemiology pertussis japan since introduction whole cell pertussis vaccine general use part routine immunization preventive immunization law steady decrease reported cases pertussis noted time number reported cases reached time low deaths caused pertussis reported vaccine diphtheria tetanus whole cell pertussis vaccine given infants weeks old older ml dose deep subcutaneous injection three doses given intervals weeks fourth dose booster given months third dose immunization completed four doses whole cell vaccine appeared associated severe neurologic illnesses temporarily suspended vaccine resumed soon thereafter age administration raised months circumstances acceptance rates pertussis occurred reaching peak although whole cell vaccine used even temporary suspension considered unacceptable public result acellular pertussis vaccine developed totally replaced whole cell vaccine since steady decrease reported cases pertussis well number deaths noted since accordance increase vaccine acceptance rates national surveillance system begun demonstrated also steady decrease incidence pertussis past years,C08,0.0019758076,0.011272677,0.003680201,0.0011081832,0.012270723,0.021619039,0.18914776,0.011390776,0.0014259215,0.0019379499,0.08032469,0.056871846,0.03717572,0.056945626,0.001734435,0.012616746,0.06975142,0.0020311938,0.0022458108,0.17000411,0.25173998,0.00070030993,0.002029081
pulmonary denervation humans effects dyspnea ventilatory pattern exercise role pulmonary autonomic nerves mediation respiratory sensation unclear pulmonary neurogenic mechanisms may contribute dyspnea either directly indirectly via influence pattern ventilation using human heart lung transplantation model pulmonary denervation studied ventilatory response respiratory drive p sensation breathlessness modified borg scale maximal incremental bicycle exercise subjects four female heart lung transplant recipients months post transplant age matched control subjects ventilatory response increasing co output vco higher p less transplant recipients control subjects ventilation peak exercise similar two groups despite lower peak vco transplant recipients ratio tidal volume inspiratory capacity increased increasing ventilation similar fashion groups although respiratory rate increased quickly transplant recipients similar peak ventilation two groups ventilatory timing duty cycle half peak peak ventilation similar transplant recipients control subjects dyspnea ratings different two groups similar levels ventilation dyspnea function p also similar transplant control groups results indicate pulmonary neurogenic mechanisms play role determining level pattern ventilation exercise furthermore pathways appear contribute significantly perception breathlessness normal humans,C08,0.03157913,0.03275341,0.018666826,0.00090873917,0.002272415,0.097392134,0.09246142,0.0015210026,0.01681673,0.03290371,0.008618384,0.07432583,0.25690714,0.021657633,0.009134948,0.010342355,0.03999064,0.0016658561,0.0018416237,0.036714844,0.20926993,0.0005742725,0.001681051
virologic pathogenetic aspects cytomegalovirus infection cytomegalovirus cmv ubiquitous agent rarely causes disease immunocompetent humans important cause morbidity mortality immunocompromised number host viral factors associated pathology following cmv infection cmv found many sites body causes disease certain patient populations situations mechanism underlying disease direct viral replication others particularly cmv pneumonitis allogeneic transplant recipients immunopathologic basis strongly implicated important factor pathogenesis infection expression symptomatic disease source cmv infection whether arises exogenous source due reactivation latent endogenous virus exogenous infection occur previously seronegative individuals prior exposure virus renal transplant recipients types exogenous infection associated disease another factor affects interaction cmv host modulating effect virus host immune response mechanism remains unknown,C08,0.0025926146,0.0022977972,0.042441946,0.014205858,0.0036070235,0.0033430215,0.4064457,0.0024360255,0.0018727301,0.015072331,0.011993637,0.0053279186,0.016388742,0.07000225,0.027253762,0.029103221,0.061527617,0.002671358,0.015476132,0.104115635,0.1037031,0.0009197502,0.05720176
prostaglandin f alpha enhancement capsaicin induced cough man modulation beta adrenergic anticholinergic drugs effect inhaled prostaglandin pg f alpha response inhaled tussive agent capsaicin investigated normal subjects seven subjects inhaled three breaths four doses capsaicin nmol immediately inhaling pgf alpha mumol placebo nacl separate days numbers capsaicin induced coughs greater pgf alpha mean coughs sodium chloride visual analogue scores cm continuous scale showed capsaicin irritant pgf alpha saline total respiratory resistance rrs measured forced oscillation technique unaltered throughout study double blind placebo controlled study effects inhaled salbutamol micrograms mumol ipratropium bromide micrograms mumol cough induced capsaicin nmol pgf alpha mumol pgf alpha augmented capsaicin induced coughing performed seven subjects neither drug effect capsaicin induced coughing salbutamol reduced coughing due pgf alpha mean coughs salbutamol placebo ipratropium bromide mean coughs ipratropium bromide placebo salbutamol also inhibited augmentation capsaicin induced cough followed inhalation pgf alpha mean augmentation coughs salbutamol placebo whereas ipratropium bromide augmentation coughs ipratropium bromide placebo changes rrs seen pgf alpha either drug thus salbutamol reduces pgf alpha induced cough augmentation capsaicin induced cough follows pgf alpha,C08,0.025398154,0.0020647498,0.0044115772,0.0013078167,0.0032411916,0.025536682,0.115986414,0.002188959,0.012944993,0.013550307,0.018309439,0.043394666,0.13914256,0.03419339,0.002046931,0.0036246495,0.08174764,0.002397624,0.081528924,0.03142729,0.32979977,0.0008264672,0.024929838
contributions john b murphy thoracic surgery john b murphy prominent surgeon lived chicago death career associated rush presbyterian northwestern medical schools responsible popularizing use artificial pneumothorax effective adjunct treatment pulmonary tuberculosis modality however original concept addition fields general surgery murphy undertook management empyema lesions chest wall also performed thoracoplasty procedures although done several thoracotomy procedures laboratory rarely undertook operation clinical setting drop ether anesthesia used surgical procedures murphy use closed water seal drainage chest oration thoracic surgery given annual meeting ama excellent monograph subject undoubtedly contributed increased interest progress field surgery murphy wise surgeon able technician scholarly teacher high regard held contemporaries best expressed remark william mayo surgical genius generation,C08,0.009845996,0.01599224,0.018765235,0.001574235,0.017464492,0.050437782,0.2617351,0.0026348766,0.029146953,0.029873123,0.028836591,0.020175545,0.036924526,0.023922645,0.0024638602,0.03147693,0.23671846,0.0028854222,0.0075309817,0.069619484,0.098066576,0.0009948286,0.002914085
amiodarone postmarketing evaluation monitoring drug induced toxicity amiodarone antiarrhythmic drug predominantly class iii effects demonstrated serious adverse drug reactions interactions departments pharmacy cardiology retrospectively evaluated monitoring parameters institution criteria based current literature developed twenty six patients administered amiodarone qualifying entry audit patients seven excluded medical records unavailable incomplete eligible patients hospitalized initiation therapy followed outpatient cardiology clinic collected data extracted medical charts compared following elements criteria selected baseline evaluation prior start therapy monitoring signs pulmonary hepatic thyroid cardiac ophthalmologic neurologic dermatologic toxicity evaluation potential drug interactions digoxin warfarin type anticoagulants percentage criteria elements appropriately monitored patient ranged percent average percent frequently overlooked parameters warning patient possible photosensitivity reaction decreasing digoxin dose patient concurrently taking amiodarone performing slit lamp examination every six months frequent examination patient total organ system laboratory tests addition patient education essential safe monitoring amiodarone therapy,C08,0.010586564,0.0016113888,0.0034100618,0.0010206825,0.028928615,0.0023835236,0.32234564,0.001708325,0.010075765,0.010573506,0.11623008,0.013223146,0.036908064,0.004396899,0.0015975011,0.03800017,0.19326767,0.0018707665,0.0020684327,0.07948362,0.10901313,0.0006449982,0.010651418
methacholine responsiveness among working populations relationship smoking airway caliber suggested development bronchial hyperresponsiveness bhr smokers may intermediate event progression chronic obstructive pulmonary disease group true prevalence data bhr general population show independent association bhr smoking status test analyzed bhr inhaled methacholine white men without known asthma relation smoking skin test reactivity type work office versus industrial indicators baseline airway caliber fev predicted fev fvc bhr measured traditional way pc slope fev versus methacholine concentration linear scale pc less mg ml considered responsive analyses outcome found although positive skin test smoking industrial worker appeared significant predictors increased bhr p less fev predicted fev fvc taken account none variables alone remained significantly associated bhr strongest predictors bhr prechallenge fev fev fvc p less combination smoking atopy work groups identified small subgroup atopic smokers office workers also remained significantly associated increased bhr also used regression model allowed comparison predictors bhr responsive subset population n remainder study population,C08,0.0019853257,0.0015431741,0.003246044,0.0009774835,0.020762576,0.044094384,0.22448477,0.0016360069,0.017037282,0.06065678,0.08022175,0.0323831,0.09159739,0.0040645753,0.001529822,0.028234184,0.01767742,0.0017915717,0.0019808703,0.26314905,0.0985321,0.00061769364,0.0017966299
neuropeptides nasal secretion recent research disclosed neurotransmitters neuropeptides released within autonomic nervous system exert homeostatic control nasal secretion although cholinergic adrenergic influences long thought predominant mechanisms nonadrenergic noncholinergic responses may suitable longer lasting effects peptides sensory nerves calcitonin gene related peptide substance p neurokinin may participate axon response mediated vasodilation plasma extravasation substance p gastrin releasing peptide may induce glandular secretion defensive responses local mucosal injury may amplified axon response initiates vascular glandular reactions cholinergic effects primarily responsible mediating parasympathetic reflexes vasoactive intestinal peptide may regulate acetylcholine release augment glandular secretory responses vasodilatory effect sympathetic nervous system neuropeptide probably functions long acting vasoconstrictor integration sympathetic parasympathetic influence may regulate normal nasal cycle sensory parasympathetic defensive reflexes may respond epithelial mast cell stimulation possible pathophysiology vasomotor rhinitis involves exaggeration neural influences,C08,0.013910996,0.002112643,0.015961694,0.012860338,0.0033163736,0.0030804777,0.25763837,0.016840037,0.01322456,0.0023401119,0.022496415,0.016626375,0.055724416,0.018601721,0.0020943638,0.03829272,0.034289967,0.05122888,0.00271186,0.033113606,0.3802383,0.0008456377,0.0024501546
foam cuffed tracheal tubes clinical laboratory assessment efficiency foam cuffed tracheal tube studied protecting pulmonary tree aspiration oropharyngeal gastric contents following instillation methylene blue dye cuff subsequent fibreoptic bronchoscopy revealed instance dye staining tracheal mucosa bench study undertaken subsequently estimate likely pressure cuff would exert tracheal mucosa result elastic recoil properties foam results suggested normal clinical conditions pressure likely exceed value impairment mucosal blood supply would occur,C08,0.021993833,0.003347009,0.024831323,0.0021200022,0.0052738856,0.0049130768,0.36419317,0.0035483548,0.0027278494,0.0037073821,0.07472445,0.0077607334,0.106945775,0.00926774,0.0033180492,0.024126945,0.07041703,0.0038927703,0.004296333,0.07801803,0.17535478,0.0013397231,0.0038817201
effects albuterol procaterol exercise induced asthma procaterol albuterol beta agonists studied using placebo controlled repeated exercise challenge design order assess duration effectiveness bronchodilation modifying exercise induced asthma eia fifty three subjects aged years least drop fev screening exercise tolerance test entered subjects took two inhalations procaterol micrograms inhalation albuterol micrograms inhalation placebo thirty minutes later exercised treadmill workload sufficient induce greater equal aerobic consumption six minutes pulmonary function measured serially minutes exercise exercise challenge repeated three six nine hours drug administration procaterol albuterol bronchodilated modified eia minutes three hours mean drops fev respectively minutes three hours compared placebo falls six hours subjects response similar procaterol albuterol fewer subjects fall fev placebo although protection afforded beta agonists substantially less three hours drugs tolerated well,C08,0.0064959507,0.086383164,0.010842898,0.0012251297,0.0030362664,0.044492543,0.10560843,0.0020505614,0.0015763988,0.038188107,0.03267265,0.0044972803,0.2773842,0.0050698174,0.0019174699,0.0033954799,0.05454591,0.0022455454,0.044704147,0.07262191,0.16636512,0.011327853,0.023353212
utility fiberoptic bronchoscopy nonresolving pneumonia although fiberoptic bronchoscopy fob traditionally used evaluate nonresolving pneumonia efficacy unknown therefore reviewed fob consecutive patients roentgenographic infiltrate cough either temperature greater degrees c leukocytosis sputum production symptoms present least ten days antibiotic therapy least one week known lung cancer aids excluded fiberoptic bronchoscopy diagnostic percent specific cause found patient endobronchial cancer two patients nondiagnostic fob persistent systemic symptoms open lung biopsy specimens showing wegener granulomatosis bronchiolitis obliterans organizing pneumonia boop twenty one patients nondiagnostic fob final diagnoses community acquired pneumonia conclude fob extremely useful finding specific diagnosis nonresolving pneumonia specific diagnosis made fiberoptic bronchoscopy likely yield specific diagnosis nonsmoking patients multilobar infiltrates long duration could avoided older smoking otherwise compromised patients lobar segmental infiltrates decrease diagnostic yield series,C08,0.002526984,0.002241561,0.04194428,0.0014198093,0.0035187453,0.05216737,0.3346604,0.0023804298,0.001826897,0.0024925785,0.15092494,0.029663429,0.039213594,0.006709059,0.002222166,0.0039350395,0.14999698,0.0026023746,0.015098005,0.08191791,0.069033094,0.00089724024,0.002607151
platelet activating factor leukotriene b induced release lactoferrin blood neutrophils atopic nonatopic individuals found increased accumulation neutrophils components lactoferrin lf elastase well platelet activating factor paf leukotriene b ltb sites ongoing human allergic reactions determine whether paf ltb could stimulus vivo lf release blood neutrophils subjects incubated paf ltb phorbol ester phorbol myristate acetate pma released lf elisa assay compared spontaneous release significantly increased lf release induced paf mol l p less ltb mol l p less pma micrograms ml dose dependent reaction cytochalasin required lf secretion enhance responses paf induced lf secretion inhibited specific paf antagonist bn lf released neutrophils atopic nonatopic subjects response paf mol l micrograms ml versus micrograms ml p less ltb pma buffer p significant conclude paf ltb released vivo could stimulate local neutrophils release lf possible pathogenic effects neutrophils atopic subjects responsive paf neutrophils nonatopic subjects regard,C08,0.014937547,0.0022694236,0.017200662,0.0014374574,0.0035624832,0.01565823,0.22561778,0.002405945,0.014215462,0.0025137728,0.012006002,0.017643549,0.1563198,0.070939995,0.0022497876,0.02874885,0.02435526,0.0026515906,0.0029131083,0.02137838,0.35742745,0.0009083929,0.0026390334
mr imaging bird nest filter appearance bird nest inferior vena cava filter magnetic resonance mr images patients described complication symptomatic filter displacement encountered result mr imaging performed filters created significant local artifact distortion mr images however diagnostic mr images pelvis spine brain may still obtained,C08,0.056975238,0.0047315187,0.035199977,0.0029969534,0.16228901,0.006883797,0.15723436,0.030831998,0.00385624,0.005304497,0.07501996,0.036789432,0.07322462,0.0122644985,0.0046905796,0.008306137,0.18568636,0.005493129,0.0060735364,0.0346433,0.0841235,0.0018939073,0.005487416
use biological glue control pulmonary air leaks biological glue natural adhesive generated interaction fibrinogen pre glue thrombin produce fibrin pre glue prepared single donor avoid problems pooled plasma stored cryoprecipitate used thawed dissolved saline activated adhesive addition topical thrombin biological glue used prophylactically prevent air leaks bronchial suture lines raw lung surfaces pulmonary resections six patients addition two new methods using biological glue developed control persisting air leaks selective intrabronchial tamponade glue instilled bronchial tree flexible bronchoscope therapeutic pleurodesis instilled pleural cavity chest drainage tube air leaks resolved cases seven procedures using selective intrabronchial tamponade carried six patients four immediately successful three required interventions therapeutic pleurodesis alone successfully carried one patient adjunct selective intrabronchial tamponade two occasions thoracotomy eventually needed one seven patients,C08,0.02777336,0.030409921,0.0094892355,0.015548181,0.004015047,0.03457727,0.24293219,0.0027079538,0.0020817788,0.0028293165,0.084013864,0.0071004373,0.075427935,0.018123427,0.016463619,0.0044840416,0.1457693,0.030839454,0.0032787793,0.080167755,0.15797795,0.0010224199,0.0029667981
identification somatostatin receptors human small cell lung carcinoma biopsy specimens obtained eight patients lung cancer tested content somatostatin receptors autoradiography somatostatin receptors detected two three patients small cell lung cancer sclc none five patients non small cell lung cancer nsclc including adenocarcinoma two squamous cell carcinoma two bronchoalveolar carcinoma one sclc specific somatostatin receptor binding evidenced tumor foci surrounding stroma normal lung parenchyma tissue characterization immunoperoxidase staining pancytokeratin monoclonal antibody mab lu revealed labeling nsclc none sclc specimen selective immunoreactivity detected sclc nsclc specimen chromogranin neuron specific enolase nse whereas none specimen detectable immunostaining somatostatin bombesin serotonin adrenocorticotropic hormone neurofilament calcitonin synaptophysin identification somatostatin receptors primary human lung cancer may bearing biology disease perhaps clinical application somatostatin analogues patients sclc,C08,0.0025904297,0.0022978405,0.0048334734,0.0014554568,0.016634345,0.06604654,0.1582202,0.0024360716,0.0018727655,0.0025452494,0.10656122,0.055490304,0.030515997,0.09529668,0.0022779587,0.020435927,0.09194027,0.099094264,0.090714164,0.039731458,0.1054039,0.0009197675,0.0026856898
tracheostomy children guillain barre syndrome yr period beginning january infants children guillain barre syndrome gbs admitted hospital tracheostomies performed patients records reviewed fourteen patients recalled assessment pulmonary function respiratory muscle strength rms median duration assisted ventilation including endotracheal et intubation days median duration tracheostomy days two patients discharged tracheostomy situ patients successfully decannulated first attempt tracheostomy related complications symptoms reported apart croup two patients review lung volumes maximal inspiratory expiratory flows normal evidence tracheal stenosis significant tracheomalacia rms tests normal hospital tracheostomy safe well tolerated procedure management infants children gbs need long term ventilation deaths patients returned normal school gainfully employed illness although patients mild persistent weakness least foot dorsiflexion,C08,0.0026637337,0.0021406508,0.0044952673,0.0013536162,0.0033546975,0.0728213,0.16667058,0.0022677637,0.013400641,0.11369991,0.023117706,0.016575981,0.092727266,0.00577377,0.0021185663,0.0039182045,0.2626746,0.00248564,0.0027431983,0.13451593,0.06714711,0.0008554099,0.0024784687
hydraulic conductivity canine parietal pleura vivo hydraulic conductivity lp parietal pleura measured vivo spontaneously breathing anesthetized dogs either supine n prone n position excised portion chest wall pleura adjacent tissue intact n capsule glued exposed parietal pleura intercostal muscles removed capsule filled either autologous plasma isotonic saline transpleural fluid flow v measured several transpleural hydrostatic pressures delta p rate meniscus movement within graduated pipette connected capsule delta p defined measured difference capsule pleural liquid pressures lp parietal pleura calculated slope line relating v delta p use linear regression analysis lp vivo averaged x x sd ml h cmh cm regardless whether capsule filled plasma saline irrespective body position value significantly different measured excised chest wall preparation x x ml h cmh cm parietal pleura offers little resistance transpleural protein movement observed difference plasma saline conclude lp intact parietal pleura extrapleural interstitium approximately times smaller previously measured isolated stripped pleural preparations removal parietal pleural results damaged preparation,C08,0.002340173,0.0020193744,0.004892993,0.03433942,0.025648369,0.034413394,0.12884676,0.0021408538,0.0126659805,0.002236801,0.012631052,0.005176499,0.25845477,0.038573895,0.0021672547,0.014560814,0.022783961,0.015584592,0.002592137,0.019272573,0.26019433,0.0008083046,0.09765566
high frequency oscillation simulated altitude exposure ventilatory requirements using high frequency oscillation hfo simulated altitude exposure investigated control dogs animals oleic acid induced lung injury fio values supplied bias flow normal injured dogs respectively control period animals exposed simulated altitude ft barometric pressure torr followed second control period ground level experimental groups similar values paco ground level exposure reduced barometric pressure tidal volume necessary maintain eucapnia higher oleic acid injured animals compared control group cardiac output functional residual capacity lower alveolar arterial oxygen difference substantially larger oleic acid group adequate gas exchange maintained hfo exposure altitude provided ventilation inspired po reduced normobaric levels,C08,0.039175514,0.0023874603,0.005021987,0.0015122222,0.0037494446,0.055586386,0.11395089,0.0025310826,0.0019458066,0.0026445186,0.013316136,0.049823694,0.26114413,0.0063712993,0.002366803,0.017214885,0.066117965,0.0027723277,0.0030646243,0.063915774,0.28166246,0.00095564005,0.002768876
pulmonary masses contrast enhancement radiographic studies discriminate benign malignant pulmonary masses previously focused morphologic recently computed tomographic ct attenuation characteristics lung mass experience use intravenously administered iodinated contrast medium examining enhancement properties lung masses reviewed distinctive differences vascularity pathophysiologic features pharmacodynamics malignant versus benign pulmonary masses identified forty five patients peripheral pulmonary masses examined enhancement evaluated means optical density values measured trispiral tomograms lung masses bolus injection contrast medium results suggest contrast enhancement pulmonary masses measured sectional images may become feasible diagnostic method detection lung cancer ct offers simplified technique explored authors,C08,0.06728353,0.0026271285,0.13453206,0.0016640285,0.018458074,0.08287773,0.23625368,0.0027851684,0.0021411388,0.002909992,0.101389624,0.023161838,0.08588579,0.006842245,0.0026043975,0.0046119,0.0710242,0.003050005,0.0033722704,0.025195673,0.11722902,0.0010515732,0.0030488884
adult respiratory distress syndrome adult respiratory distress syndrome remains enigmatic disorder high mortality rate although sometimes managed effectively recognizing conditions associated first step preventing occurrence decreasing risk factors developing ards remains fundamental goal initial management syndrome developed particular patient clinician goals management stabilize patient avoid insults maximize support therapies available cognizant avoid potential adverse effects supportive therapies,C08,0.0033454676,0.051548738,0.0062422953,0.0018796817,0.0046584574,0.0043175,0.30262366,0.0031461183,0.002418624,0.0032871184,0.015385432,0.039256006,0.024129324,0.023868406,0.0029419197,0.02139542,0.11739645,0.0034637216,0.052363724,0.23611027,0.07559213,0.001187854,0.0034416935
multifocal posterior uveitis clinical pathological findings pathological study performed necropsy eyes year old woman suffered nine years multifocal posterior uveitis disease controlled steroid therapy good preservation visual function extensive investigation reveal aetiology macroscopic examination numerous focal lesions various degrees pigmentation observed scattered across fundi lesions studied light electron microscopy immunohistochemistry ongoing chorioretinal inflammation foci producing destruction bruch membrane retinal pigment epithelium rpe outer retina focal scars showed migration rpe glial cells neovascularisation capillary venule endothelial cells swollen inflammatory sites attempts establish cause condition unsuccessful,C11,0.03757056,0.0031599505,0.04100296,0.001976266,0.040619995,0.021519385,0.24990577,0.0543783,0.019561347,0.0034560212,0.040202137,0.024774501,0.064668044,0.04214407,0.0030930853,0.005477275,0.075933546,0.0036389749,0.0040050414,0.110636584,0.13039534,0.018262336,0.0036185393
use symblepharon ring treatment filtration leaking blebs glaucoma filtration surgery report use symblepharon ring treatment seven cases flat anterior chamber six cases total iridocorneal touch one corneallens touch secondary overfiltration bleb leak cases anterior chamber reformed within hours symblepharon ring used advantages using ring permits testing visual acuity tonometry intraocular examination without removing b require suturing conjunctiva c disturb corneal epithelium may available institutions lacking shells e cost effective,C11,0.0046182084,0.026451543,0.0086170975,0.047280747,0.006430709,0.0059600384,0.2880011,0.004343019,0.0033387588,0.0045376606,0.15248533,0.031816985,0.045862854,0.05524282,0.004061621,0.0071915104,0.1355884,0.0047559887,0.027579553,0.059674248,0.06977103,0.0016397579,0.0047510425
caspar stromayr sixteenth century ophthalmologist caspar stromayr ophthalmologist hernia surgeon credited writing first german ophthalmic work known authorship written appendix practica copiosa larger work hernia surgery ophthalmic chapters describe stromayr thoughts etiology treatment cataract stromayr master craftsman also expresses hostility shams ignorance charlatan eye surgeons day interesting historical article provides biographical sketch stromayr description book translation two chapters cataract eye take beginning whence come recognize cataract ripe recline taken away,C11,0.005777934,0.005125316,0.0107810255,0.0032463854,0.008048321,0.007456725,0.352267,0.005433639,0.004177189,0.0056771594,0.026659315,0.011884106,0.03576647,0.041459434,0.0050809695,0.008997445,0.12520982,0.0059993183,0.006579028,0.22154166,0.09473169,0.0020515344,0.006048479
whitnall sling poor function ptosis severe unilateral ptosis poor levator function previously treated maximal levator muscle resection bilateral unilateral frontalis suspension one us r l developed technique called whitnall sling levator aponeurosis resected preserving whitnall ligament attachments whitnall ligament underlying resected levator muscle sutured superior portion tarsal plate surgery preserves levator muscle muller muscle whitnall ligament without altering structures produce three layer tear film eyelids operated july july minimum year follow one use obtained results satisfactory directly related levator function believe technique anatomically physiologically superior maximal levator resection similar long term results recent results shown addition mm superior tarsectomy provides additional elevation mm whitnall sling best suited cases opposite fissure height mm less levator function ptotic eyelid mm,C11,0.0028508818,0.00251905,0.005298784,0.015297238,0.017672867,0.0173998,0.1823398,0.0026705882,0.08454133,0.016529415,0.09729688,0.0058519295,0.08351375,0.0065295915,0.002497254,0.0044221687,0.1800283,0.0029245296,0.003233537,0.022410223,0.21263935,0.014751334,0.016781392
immunohistologic study epiretinal membranes proliferative vitreoretinopathy performed immunohistologic study specimens epiretinal membranes surgically obtained patients rhegmatogenous retinal detachment proliferative vitreoretinopathy immunostaining procedures used identify immunoglobulin complement deposits visualize class ii antigen expression proliferating cells determine eventual infiltration cells immune system diffuse deposits igg iga ige c q c c c found epiretinal membranes whereas numerous cells including glial pigmented epithelial cells expressed hla dr hla dq antigens macrophages b lymphocytes identified results suggest activation immune system course proliferative vitreoretinopathy class ii antigen expression could dependent upon growth promoting factors interferon gamma could play crucial role immune reaction resulted immunoglobulin deposition activation complement however eventual role immune phenomena extension proliferative processes remains determined,C11,0.0025584067,0.0022694345,0.041929267,0.013815379,0.0035625002,0.0033017572,0.29935038,0.039556816,0.0018496142,0.002513785,0.08856526,0.030022465,0.0172407,0.14607796,0.0022497983,0.053517587,0.058988765,0.027402436,0.0029131223,0.07446793,0.058765557,0.00090839725,0.028172657
serous retinal detachment following glaucoma filtering surgery report occurrence serous retinal detachment association choroidal effusion hypotony six eyes undergone glaucoma filtering surgery hypotony choroidal effusion documented five patients onset serous retinal detachment one patient underwent vitrectomy treatment conservative patients serous retinal detachment choroidal effusions resolved spontaneously intraocular pressure normalized although one patient regained preoperative visual acuity patients lost least one line snellen acuity,C11,0.0051967627,0.004609788,0.0096966205,0.0029198492,0.007260639,0.006706693,0.18368733,0.004887099,0.0037570284,0.030262198,0.023899334,0.010688748,0.032228105,0.011948963,0.029704766,0.008092441,0.43094555,0.005351804,0.005917279,0.11296215,0.062060744,0.0018451817,0.0053708935
aqueous humour serum zinc copper concentrations patients glaucoma cataract serum aqueous humour zinc copper concentrations patients glaucoma cataract determined serum values found within normal ranges highest mean copper concentration seen glaucoma group addition significant negative correlation aqueous humour levels zinc copper patients glaucoma concluded increased copper value together low zinc value might importance patients glaucoma,C11,0.0043258495,0.0038372444,0.0289901,0.0024305184,0.0060236086,0.005582734,0.122224994,0.0040680813,0.0031273966,0.004250401,0.041610938,0.029839745,0.1898697,0.010239028,0.024741702,0.0067362473,0.14861119,0.0044566025,0.004925616,0.032288432,0.31583366,0.001535952,0.0044502746
posterior horizontal vertical tightening treat combined punctal ectropion medial canthal tendon laxity classical operations treat either medial canthal tendon laxity punctal aversion occurring alone possess drawbacks used treat conditions occur simultaneously simplified procedure described whereby tissue removed via posterior eyelid approach eyelid may tightened horizontally vertically thus inverting punctum fixating lacrimal lake procedure quite easy perform done local anesthesia office,C11,0.055510107,0.0046097273,0.009696493,0.0029198108,0.0072362325,0.006706605,0.35295004,0.0048870347,0.0037569788,0.0051060575,0.025076944,0.03584233,0.033960428,0.012483124,0.004569842,0.033240877,0.22462615,0.005351734,0.0059172013,0.033203144,0.12515779,0.0018451575,0.005346168
influence prior therapy success trabeculectomy role early surgery management primary open angle glaucoma debate determine whether previous medical therapy influences outcome subsequent trabeculectomy retrospectively reviewed results surgery two groups patients first group underwent primary trabeculectomy average weeks preoperative medical therapy group compared group patients received least year topical glaucoma therapy undergoing trabeculectomy multiple treatment group two groups similar terms number variables including race age sex presenting intraocular pressures presenting visual fields differed known duration disease success rate trabeculectomy significantly higher primary trabeculectomy group compared multiple treatment group p less discuss possible reasons difference implications future management primary open angle glaucoma,C11,0.0022762709,0.0020191658,0.026261326,0.0012789437,0.003169635,0.0029376461,0.35116795,0.0021406326,0.0016456424,0.0022365698,0.023906762,0.104304686,0.07299313,0.0053798934,0.0020149327,0.0035446272,0.15630202,0.0023441815,0.002725407,0.15152943,0.076670036,0.00080822106,0.0023429461
assessing acquired ocular diseases assessing patient ocular complaint one must listen carefully description symptoms decrease vision frequently symptom prompts person seek attention pain around eye next frequent symptom complained discomfort often tolerated long periods professional attention obtained visual acuity must checked vital sign exacerbation improvement many conditions measured take eyes granted suddenly cannot see world takes completely different complexity loss vision may mean loss livelihood independence,C11,0.004070633,0.0036108547,0.0075953794,0.0022871227,0.0056682276,0.005516439,0.37583882,0.0038280727,0.0029428867,0.029361743,0.05168976,0.0083725145,0.13672316,0.009359643,0.023169681,0.026041789,0.073134474,0.0042925724,0.024323335,0.08498884,0.111551024,0.0014453339,0.004187717
glaucoma screening little late screening glaucoma usually measuring intraocular pressure popular repeated analysis indicates poor sensitivity specificity extensive testing required testing focused high risk groups including blacks elderly regular comprehensive eye examinations schedule adjusted risk factors probably cost efficient means identifying patients glaucoma primary care provider pivotal role encourage patients undergo examinations warranted encourage intraocular pressure lowering medications comply medication use,C11,0.003640378,0.0032291969,0.006792567,0.01966543,0.022643875,0.039914835,0.19080977,0.0034234554,0.0026318312,0.003576885,0.14217071,0.025111292,0.06670781,0.008374448,0.0032012565,0.023287563,0.16353078,0.0037489857,0.004145106,0.2004167,0.057930246,0.001292566,0.003754321
hemihang back recession description technique review literature describe modification hang back loop techniques call hemihang back recession muscle reattached sclera posterior original insertion single absorbable suture recommend difficult strabismus cases specifically recessions mm required,C11,0.043474726,0.0066027017,0.013888684,0.0041821646,0.010364752,0.009606145,0.21867312,0.0069998996,0.041416068,0.0073136156,0.19831951,0.015309731,0.04607625,0.017114764,0.006545572,0.011590982,0.15291123,0.0076655075,0.00847545,0.047598053,0.11554033,0.0026428946,0.0076878355
early intraocular pressure rise trabeculectomy intraocular pressure iop measured hours surgery first postoperative day eyes consecutive patients undergoing initial trabeculectomy eyes anterior chamber formed completion surgery balanced salt solution eight eyes reformed hyaluronate sodium total six eyes iop mm hg greater hours surgery patients received hyaluronate maintain depth anterior chamber significantly greater chance experiencing marked postoperative iop rise hours p first postoperative day p correlation postoperative iop rise patient age sex glaucoma diagnosis preoperative iop use fluorouracil number sutures used close scleral flap hyaluronate may contribute early increase iop could result visual field loss eyes severe glaucomatous damage recommend early monitoring iop trabeculectomy avoiding routine use hyaluronate,C11,0.0028027678,0.0024515002,0.01895237,0.014917542,0.0038483024,0.030309275,0.16648418,0.0025989749,0.0019979998,0.0027154535,0.05156931,0.021663237,0.15234053,0.0068885344,0.002463614,0.004303586,0.33318526,0.0028461067,0.0031468282,0.055374444,0.11531221,0.0009812736,0.0028467488
possible significance cilioretinal arteries low tension glaucoma cilioretinal arteries arise short posterior ciliary artery circulation directly choroidal circulation presence cilioretinal artery may compromised discs steal flow peripapillary circulation account worsening glaucoma damage reviewed records patients unilateral cilioretinal arteries admitted investigation low tension glaucoma looked absolute difference affected unaffected eyes well percent difference relative mean value two eyes value unaffected eye following variables mean defect corrected loss variance corrected pattern standard deviation adjusted neuroretinal rim area statistically significant differences found mean disc area eyes cilioretinal arteries significantly larger previously reported normal eyes results suggest vascular steal exists presence artery major clinical importance,C11,0.10693598,0.0023875856,0.018049985,0.0015123016,0.016675312,0.003473653,0.27843755,0.0025709814,0.0019459086,0.0026446574,0.013293976,0.005834663,0.2001781,0.0068135457,0.028416865,0.0041913847,0.11178375,0.0027728088,0.0030647852,0.06520899,0.120082535,0.0009556902,0.0027690213
unusual exudative retinal detachment months scleral buckling surgery year old man developed exudative retinal detachment months uncomplicated scleral buckling surgery left eye subretinal exudates strictly localized along buckle showed remarkable response steroid cause would noninfectious inflammation like posterior scleritis triggered buckle associated factors important note subretinal exudates long scleral buckling occur consequence steroid responsive inflammation well insidious bacterial fungal infection described previously,C11,0.026371583,0.004005447,0.008425398,0.0025370582,0.006287649,0.027658848,0.284491,0.026104484,0.0032644835,0.004436714,0.020885888,0.009287458,0.028002625,0.011915533,0.00397079,0.0070315255,0.17788339,0.0046501854,0.026998773,0.118597,0.16883203,0.0016032793,0.026758881
pupillary responses amblyopia relative afferent pupillary defects rapd detected patients amblyopia modification swinging flashlight test synoptophore consideration various clinical investigations significant factors identified patients showing rapd anisometropia early age onset strabismus present level visual acuity following treatment longer period occlusion therapy points bear similarities results pattern electroretinograms perg amblyopes possibility causative defect ganglion cell level discussed effect occlusion treatment cannot predicted presence absence rapd,C11,0.03957378,0.003286784,0.024849037,0.0020818557,0.03979546,0.00478188,0.27961698,0.0034845069,0.0026787654,0.02157612,0.10174271,0.0076210895,0.08848244,0.036593623,0.0032583454,0.005769919,0.10603826,0.0038158423,0.004219027,0.075260304,0.14034027,0.0013156167,0.0038173741
surgical techniques reattachment rates retinal detachment due macular hole evaluated reattachment rates transvitreal transscleral techniques treating eyes retinal detachment due macular hole initial success rate transvitreal approach difference results gas tamponade alone vitrectomy gas tamponade initial success rate transscleral approach macular diathermy macular buckling showed higher reattachment rate macular diathermy alone final success rates regardless approach selected initial technique patients whose initial transvitreal reattachment failed underwent additional transvitreal procedures including macular laser photocoagulation showed success rate believe gas tamponade possibility better visual prognosis selected initial technique final success rate found regardless initial surgical techniques,C11,0.0030090006,0.002665282,0.020141,0.001688195,0.0041838917,0.0038776682,0.23255983,0.002825617,0.045795836,0.017490713,0.040638246,0.0062970086,0.030482367,0.006949638,0.0026422208,0.004678878,0.44326577,0.0030943,0.0034212456,0.069164276,0.05097108,0.001066845,0.0030910817
increase neuroretinal rim area surgical intraocular pressure reduction optic nerve head analyzer used measure optic disc structure eyes adult glaucoma patients surgical intraocular pressure reduction neuroretinal rim area markedly increased mm mm eight eyes changed either little less mm remaining eyes mean increase mm mm increased neuroretinal rim area found time remained eyes reexamined years surgery data support previous findings glaucomatous disc cupping may reversed even adult eyes perhaps result adequate pressure reduction,C11,0.038188975,0.003172911,0.006674171,0.0020097282,0.0049807546,0.021922814,0.2101167,0.0033637837,0.0025859575,0.003514539,0.017699283,0.007357051,0.11904347,0.008276022,0.0031454577,0.02288156,0.14628395,0.0036836397,0.004072855,0.050200984,0.28124848,0.0012700361,0.03830685
histopathologic study molteno glaucoma implant three patients three eyes molteno glaucoma implant one eye epithelial downgrowth one eye iridocorneal endothelial syndrome one eye aphakia glaucoma enucleated two six years implantation histopathologic examinations disclosed evidence erosion sclera conjunctiva eye glaucoma implant device outer layers bleb wall mostly degenerated inflammatory cells present represented minimal inflammatory reaction scanning electron microscopy tubes three patients showed tube intact patent without signs degradation tube entering anterior chamber caused appreciable inflammation maintained patency even downgrowth epithelial cells lined anterior chamber molteno plate induced little inflammatory reaction therefore molteno glaucoma implant useful device patients high risk failure surgery glaucoma,C11,0.0032055506,0.04916872,0.0060720393,0.03268027,0.0044497647,0.0041177548,0.23616001,0.026966898,0.0331851,0.018576201,0.08316327,0.021991162,0.024441808,0.13525952,0.0028058144,0.020581346,0.13916743,0.0032858842,0.0036330726,0.07251863,0.07415437,0.001132899,0.0032824667
vision screening primary care setting missed opportunity determine effectiveness vision screening primary care setting administered questionnaire vision test patients general medical clinic subjects referred complete ophthalmologic evaluation failed vision test met high risk criteria based information contained questionnaire patient initiated requests eye examinations also honored total patients scheduled eye examinations actually underwent ophthalmologic evaluation one hundred one examined referred basis study criteria serious eye disease cataract glaucoma diabetic retinopathy age related macular degeneration diagnosed patients prompt surgical intervention recommended medical treatment begun serious eye disease met criteria failing vision test met high risk criteria determined questionnaire subjects received ophthalmologic evaluations requested serious eye disease diagnosed patients none individuals required immediate surgery medical treatment glaucoma begun eight data suggest screening serious eye disease primary care setting efficient mechanism use identification patients undetected ocular disorders require follow treatment,C11,0.0018322673,0.010491247,0.0034188207,0.009895924,0.038021415,0.051305827,0.2250427,0.0017230863,0.0013246477,0.0018003102,0.1747791,0.004438105,0.036238063,0.0043962477,0.0016112973,0.038327318,0.15753181,0.0018869315,0.02404114,0.16991448,0.039425116,0.00065057154,0.0019035528
cytopathology adenovirus keratitis replica technique corneal replicas made severely affected eyes patients presenting typical signs symptoms epidemic keratoconjunctivitis adenovirus isolated eyes histopathological study replicas cytology diseased cells removed replica showed diffuse mild oedema epithelium scattered moderately swollen deformed cells clinically observed punctate lesions histologically consisted markedly swollen cells become oval rounded fusion cells led small syncytial formations development pseudopodia like processes occasionally observed loss cell contents resulted formation plicae surface many cells two types inclusion bodies detected epithelial cells first type intranuclear vacuolar inclusions contained homogeneous material second type inclusions round dense bodies developed homogeneous material intranuclear vacuolar inclusions dense bodies contained replicating maturing virus particles cell degeneration dense bodies become extracellular making corneal replica beneficial effect clinical course adenovirus keratitis,C11,0.0023543688,0.0020884427,0.024467373,0.01339161,0.014675114,0.0030384355,0.32109666,0.01987396,0.0017021039,0.0023133056,0.03937327,0.038997065,0.038012777,0.13058288,0.0701042,0.003666242,0.039051976,0.07533983,0.0026807953,0.022524988,0.103050515,0.00083595084,0.030778175
lateral wall advancement orbital decompression treatment dysthyroid orbitopathy enhanced modified craniofacial approach using lateral wall osteotomy anterolateral advancement osteosynthesis conjunction medial inferior wall orbital decompression technique lateral wall advancement described results discussed authors advocate orbital decompression dysthyroid optic neuropathy advancement lateral orbital wall easily performed adjunct two three wall decompression procedure advancement appears increase overall decompressive effect providing potential space lateral expansion occur enlarging bony orbital volume also appears lessen lid retraction facilitates cases obviates need lid retraction surgery,C11,0.003843275,0.0034091766,0.007171152,0.02072001,0.0053516384,0.0049599465,0.27081415,0.19559824,0.0027785166,0.0037762434,0.08613169,0.007904882,0.07879977,0.008965671,0.003379679,0.0059847785,0.13573277,0.003957936,0.004376134,0.03273035,0.10829557,0.0013646072,0.0039538196
magnetic resonance imaging evaluation vitreoretinal disease eyes intraocular silicone oil media opacification eyes filled silicone oil makes evaluation recurrent retinal detachment difficult ultrasonography silicone oil subject significant imaging artifacts performed magnetic resonance imaging six patients unilateral intravitreal silicone oil determine technique would detect detached retina subretinal oil patients undergone pars plana vitrectomy silicone oil injection proliferative vitreoretinopathy five patients encircling solid silicone scleral buckles five patients media clear ophthalmoscopic findings correlated magnetic resonance findings four patients recurrence inferior retinal detachment magnetic resonance imaging demonstrated subretinal oil three patients one patient concentric shallow anterior retinal detachment magnetic resonance scanning demonstrated globular hyperintensity suggestive subretinal oil sixth patient opaque cornea magnetic resonance imaging suggested retina attached preoperatively confirmed subsequent surgery chemical shift artifact helpful defining contour retinal detachments presence subretinal oil outlining silicone oil within eye,C11,0.0027641915,0.0024519756,0.005157694,0.028294416,0.21856467,0.016941577,0.23752564,0.002599479,0.0019983873,0.0027159804,0.047856305,0.019061936,0.046589166,0.0066371392,0.00243076,0.017675234,0.20249146,0.0028531943,0.0031474384,0.03339174,0.095020086,0.0009814639,0.002850022
clinical morphometric results penetrating keratoplasty one piece anterior chamber suture fixated posterior chamber lenses absence lens capsule clinical records serial corneal endothelial images acapsular pseudophakic eyes kelman style one piece anterior chamber intraocular lenses acapsular pseudophakic eyes suture fixated posterior chamber intraocular lenses following penetrating keratoplasty reviewed determine clinical success endothelial survival year twenty two grafts anterior chamber intraocular lens group grafts sutured posterior chamber intraocular lens group clear year best corrected visual acuity better noted eyes anterior chamber intraocular lens group eyes sutured posterior chamber intraocular lens group mean intraocular pressure anterior chamber intraocular lens group significantly lower sutured posterior chamber intraocular lens group months vs mm hg months vs mm hg differ year mean percent endothelial cell loss year differ anterior chamber intraocular lens group sutured posterior chamber intraocular lens group clinical endothelial morphometric advantages noted year suture fixated posterior chamber intraocular lens kelman style one piece anterior chamber intraocular lens following pseudophakic penetrating keratoplasty however long term prospective randomized study two intraocular lens types recommended,C11,0.0028556723,0.015813708,0.005156692,0.001552865,0.017223833,0.016938284,0.23618276,0.056108993,0.001997999,0.0027154526,0.018807832,0.12612252,0.0365781,0.019977022,0.0024302877,0.0043035843,0.2730893,0.0028461055,0.0031468268,0.053167656,0.08578981,0.0009812731,0.016213385
survey initial referral children ophthalmology department report survey referral children making first visit ophthalmology department information gathered interviewing parents reviewing case notes parents relatives initiated referrals cases health visitors initiated cases general practitioners rarely first notice condition though played major part subsequent referral process reasons referral squint important cases followed poor vision cases confirmed cases amblyopia detected child aged years overall accuracy referral reasons referral confirmed cases child found normal parents relatives first noticed cases confirmed squint cases poor vision health professionals especially health visitors great importance first detecting poor vision,C11,0.0025902963,0.002297722,0.029910965,0.0014553817,0.0036069055,0.0033429123,0.2464546,0.002435946,0.0018726689,0.075639404,0.21643765,0.0053277444,0.021505011,0.0063221245,0.014813164,0.00403363,0.20373523,0.00268935,0.06564708,0.026605608,0.0596895,0.00091972004,0.0026674285
extraorbital use disinserted superior oblique sling third nerve palsy new single stage surgical technique management third cranial nerve palsy surgical usual technique correct alignment eyes first stage followed ptosis correction sling operation second stage new single stage surgical technique involved disinsertion superior oblique muscle bring eye midline position simultaneously used extraorbitally sling raise ptotic upper eyelid postoperatively fairly good cosmetic effect achieved upper eyelid showed paradoxic aberrant elevation eso depression,C11,0.003640791,0.0032295634,0.0067933383,0.0020456119,0.040305868,0.022319881,0.19007617,0.0034243343,0.020257201,0.003577291,0.18093403,0.0074884114,0.076052554,0.025801789,0.0032016197,0.0056694685,0.29219595,0.003749411,0.004145576,0.025545068,0.07449953,0.0012927126,0.0037538628
learning curve radial keratotomy prospectively evaluated learning curve radial keratotomy rk comparing results achieved two groups consecutive eyes performed rk without previous experience procedure group eyes matched age sex preoperative refractive error performed rk performed procedure times group although nine microperforations group none group postoperative refractions uncorrected visual acuities similar groups since microperforations adverse effect visual results reasonable conclude effect learning curve involved experience rk,C11,0.0037729125,0.0033467617,0.06181044,0.0021198457,0.0052536614,0.00486914,0.12231934,0.0035480927,0.0027276478,0.003707108,0.06565424,0.13472009,0.09789274,0.008675091,0.0033403104,0.0058752093,0.27359766,0.0038854745,0.004296016,0.049959026,0.115146086,0.019601708,0.0038814333
contact transscleral laser cyclocoagulation glaucoma new way treat glaucoma laser coagulation ciliary body developed laser beam channeled eye fiberoptic system tip fiberoptic probe placed direct contact surface eye treated technical equipment developed contact transscleral laser cyclocoagulation simple practical easy use method investigated experimentally animals human eyes enucleated tried clinical practice patients facing glaucoma surgery methods conservative therapy failed selected kind treatment immediate hypotensive effect approximately mmhg first hours gradual elevation tension reducing initial effect average method definite advantages surgical cyclocoagulation far safety simplicity concerned use contact fiberoptic systems may open new possibilities fields laser treatment glaucoma including techniques channel laser beam structures anterior chamber angle,C11,0.016007842,0.015616688,0.00547788,0.0015323916,0.0037977607,0.0035197986,0.29963237,0.0025648412,0.001971759,0.015866244,0.061553366,0.005649605,0.035255715,0.053972572,0.014990003,0.0042470647,0.22754376,0.0028087273,0.021450091,0.045343276,0.14288726,0.000968386,0.017342618
graves ophthalmopathy correlation saccadic eye movements age presence optic neuropathy extraocular muscle volume quantitative infrared oculography used record saccadic eye movements patients graves ophthalmopathy peak saccadic velocities decreased patients developed presented optic neuropathy effect pronounced larger eye movements peak saccadic velocity also decreased total extraocular muscle volume limitation ocular motility increased given extraocular muscle volume peak saccadic velocity degrees slower patients years older younger patients relationship velocity motility limitation pronounced intermediate muscle volumes total orbital volume saccadic velocities patients optic nerve compression often improved following treatment study demonstrated eye movement recording useful adjunct evaluation patients graves ophthalmopathy furthermore age related lowering peak saccadic velocities implicated changes extraocular muscle structure factor development optic neuropathy,C11,0.013253964,0.0020193532,0.004249376,0.0012790625,0.015256313,0.0029379188,0.25183848,0.0021408314,0.05675054,0.0022367775,0.011653709,0.0048200293,0.28289104,0.0057790563,0.0020019433,0.0035449562,0.098087735,0.0023443992,0.0025921098,0.11400576,0.10615322,0.0008082961,0.013355167
glaucomatous optic nerve atrophy small discs low cup disc ratios glaucomatous optic nerve damage generally associated high cup disc ratios fifteen eyes nine patients increased intraocular pressure glaucomatous visual field loss low cup disc ratios reported optic disc area significantly p less smaller normal subjects glaucoma patients high cup disc ratios parapapillary chorioretinal atrophy significantly larger retinal nerve fiber bundles significantly less visible normal group latter two parameters significantly different glaucoma groups low high cup disc ratios groups matched mean perimetric loss authors conclude eyes small optic discs glaucomatous optic nerve damage may indicated sensitively parapapillary changes cup disc ratios glaucomatous eyes small optic nerve heads misleadingly low cup disc ratios,C11,0.06963166,0.0024514531,0.0051565953,0.0015527554,0.003850078,0.0035665727,0.11188885,0.01594069,0.0019979614,0.029465333,0.013104408,0.052715875,0.33047667,0.020177128,0.0024371722,0.0043035033,0.059974685,0.0028471667,0.0031467676,0.05154605,0.20994426,0.0009812547,0.002843092
epiphora treatment means dacryocystoplasty balloon dilation nasolacrimal drainage apparatus new interventional radiologic procedure developed treatment epiphora small bore soft tipped guide wire introduced superior canaliculus guided fluoroscopic control nasolacrimal drainage system retrieval nasal aperture small bore angioplasty catheter introduced retrograde direction nasolacrimal drainage apparatus dilated fluoroscopic control procedure attempted eyes patients moderate severe epiphora technically completed cases demonstrated improvement patients showing complete resolution symptoms three patients whose epiphora improve worsening symptoms occurred results preliminary follow ranged weeks months authors believe technique may hold promise treatment epiphora may obviate use invasive procedures,C11,0.0033456602,0.0030053172,0.0062426548,0.00187979,0.0046593216,0.020468814,0.25226837,0.0031462994,0.0024187635,0.022987513,0.10905868,0.0070905453,0.037794016,0.007692706,0.0029420892,0.005209889,0.32986116,0.019633258,0.0038095263,0.023538157,0.12831761,0.0011879223,0.0034418919
experimental endoretinal biopsy performed transvitreal endoretinal biopsy rabbit eyes develop reliable safe technique obtain retinal specimens attached retina pars plana vitrectomy without lensectomy followed injection ringer solution subretinal space produce focal retinal detachment apex focal detachment excised intraocular scissors removed eye pneumohydraulic expulsion fluid air exchange reattached retina biopsy sites evaluated clinically light electron microscopy regular intervals weeks postoperatively initial five procedures performed without heparin infusion fluid complicated severe fibrin reaction early retinal detachment remaining eyes without intraoperative complication maintained attached retinas biopsy site developed early ring hyperpigmentation along border biopsy bed became increasingly hyperpigmented cytoplasmic hyperplasia hypertrophy pigment epithelium epiretinal membranes subretinal neovascularization observed histologically retinal biopsy specimens reproducible suitable diagnostic studies,C11,0.0029317392,0.0025904959,0.09027503,0.0016408253,0.018175859,0.017893363,0.2123796,0.016878618,0.03037849,0.0028694149,0.073206656,0.065245286,0.08116389,0.0068731466,0.0025680817,0.0045535685,0.1512704,0.019271463,0.0033252477,0.06249697,0.115852304,0.00103691,0.017122645
visual results complications transsclerally sutured intraocular lenses penetrating keratoplasty retrospectively reviewed charts consecutive patients undergone penetrating keratoplasty transscleral fixation posterior chamber intraocular lens follow ranged months mean months postoperative visual acuity improved patients remained eight worsened two patients least months follow best corrected visual acuity measured pinhole hard contact lens better worse problems lens decentration tilt scleral suture related infections minimal glaucoma msot common cause decreased vision patients months follow three patients developed rhegmatogenous retinal detachments early postoperative course,C11,0.0038431205,0.0034090397,0.025764741,0.0021592926,0.0053514238,0.004959747,0.25305644,0.0036141172,0.021352164,0.0037760916,0.017693812,0.007904564,0.046925336,0.008836521,0.0033795433,0.0059885224,0.45514777,0.003957777,0.004375958,0.030169597,0.08301618,0.0013645524,0.003953661
miniaturized vitrectomy system vitreous retinal biopsy author developed miniaturized vitrectomy system accessories size gauge needle hand piece inserted inside eye ziegler knife track instrument used atraumatic removal vitreous biopsy specimens removal small pieces retina system also seems application vitreous surgery premature infants eyes,C11,0.006307301,0.036108766,0.042300213,0.0035438153,0.009071868,0.008139901,0.2805415,0.0059314626,0.004559898,0.0061972938,0.06460225,0.012972913,0.07041395,0.0145488065,0.0055464813,0.04035259,0.11589169,0.0064954744,0.00718179,0.0715067,0.17905708,0.0022394934,0.006488719
ocular movements essential blepharospasm essential blepharospasm histopathologic electrophysiologic evidence supports existence lesions proximity brainstem nuclei controlling ocular movements studied horizontal ocular movements eight patients treated previously surgery botulinum toxin injection control essential blepharospasm mean age years compared seven control subjects blepharospasm mean age years examined fixation stability saccades vestibulo ocular reflex visual enhancement suppression vestibulo ocular reflex optokinetic nystagmus pursuit using digitally sampled direct current electro oculography patients blepharospasm exhibited ocular movement abnormalities since quantitative aspects ocular movements sensitive nonspecific brainstem lesions absence abnormal ocular movements suggests lesion blepharospasm specifically limited neurons regulating facial muscles,C11,0.0033454383,0.0029675707,0.05441266,0.0018796653,0.053245835,0.0043174624,0.29742098,0.0031460908,0.018613784,0.0032870898,0.035823926,0.025034277,0.114528805,0.024214324,0.002941894,0.021402458,0.113151826,0.019634884,0.019991353,0.10726301,0.068742864,0.0011878436,0.0034459326
viscous fluid pump describe device useful injection viscoelastic material vitreous cavity internal tamponade instrument proven reliable user friendly clinical setting,C11,0.008345501,0.047801517,0.015571839,0.0046889964,0.011620846,0.010770303,0.22155552,0.00784821,0.04642452,0.008199945,0.09393299,0.097959556,0.092057176,0.019188885,0.007338823,0.012995681,0.11167219,0.008594482,0.00950258,0.053321753,0.09905995,0.0029631841,0.008585543
assessment tear drainage canalicular obstruction using fluorescein dye disappearance assessment tear drainage impairment monocanalicular obstruction difficult authors used fluorescein dye disappearance evaluate tear drainage experimental obstruction upper lower neither canaliculi subjects marked impairment noted subjects canaliculi occluded p less monocanalicular obstruction either upper lower generally resulted minimal impairment though subjects showed marked impairment fluorescein dye disappearance proved reliable rapid method assessing tear drainage detecting lacrimal obstruction,C11,0.0035773506,0.0031732884,0.024050793,0.0020099673,0.0049813474,0.0046167574,0.26072598,0.0033648016,0.019893229,0.0035149571,0.14047624,0.0073579266,0.106414735,0.0082492735,0.0031458319,0.057979695,0.18373458,0.003684078,0.00407334,0.02814811,0.1218734,0.0012701872,0.0036840988
multicenter trial cryotherapy retinopathy prematurity one year outcome structure function cryotherapy retinopathy prematurity cooperative group study safety efficacy cryotherapy treating severe retinopathy prematurity registered infants birth weights less g study centers two hundred ninety one infants developed defined threshold retinopathy prematurity cryotherapy performed approximately half eyes randomization protocol twelve months randomization results masked grading fundus photographs posterior pole similar results obtained months randomization indicated unfavorable outcome eyes received cryotherapy compared control eyes p less first time masked teller acuity card assessment grating acuity performed study group indicated unfavorable functional outcome treated eyes compared control eyes p less results indicate cryotherapy reduces risk unfavorable retinal functional outcome threshold retinopathy prematurity,C11,0.01908514,0.002627194,0.0055262633,0.0016640701,0.004124102,0.016460203,0.16735363,0.002785238,0.002141192,0.0029100645,0.01858113,0.0446933,0.14194609,0.0068152067,0.0026044624,0.004612015,0.15463847,0.0030500812,0.01763431,0.16857792,0.1936873,0.0010515994,0.017431017
use conchal cartilage graft involutional entropion simple stable technique repairing involutional entropion described transconjunctival incision lower border tarsus lower lid retractor eyelid divided tarsus orbicularis oculi muscle external internal layers internal layer moved upward eyelashes turn outward sutures placed fix corrected state resultant defect lower end tarsus retractor filled conchal cartilage graft raw surface cartilage epithelialized surrounding mucosa within weeks without shrinkage technique stable technique performed,C11,0.005069157,0.0044965954,0.02277324,0.0028481528,0.030978492,0.0065420116,0.17237014,0.004767097,0.028204981,0.004980745,0.070171185,0.10857775,0.063533634,0.02348717,0.004457689,0.007893732,0.21627751,0.005220392,0.005771981,0.08295881,0.12160472,0.0017998735,0.005214962
unilateral mydriasis caused transdermal scopolamine contamination eye handling transdermal scopolamine patch may cause accidental mydriasis simple office test discussed identify pharmacologic blockade thereby avoid extensive neurologic workup,C11,0.0067181964,0.0059593758,0.0125354575,0.0037746807,0.041847896,0.008670183,0.32016277,0.0063178735,0.004856957,0.0066010226,0.114024475,0.013818046,0.04170696,0.015447209,0.0059078126,0.010461629,0.057376157,0.039419893,0.007649655,0.14658137,0.12086553,0.0023853874,0.006911433
topical timolol serum lipoproteins oral timolol taken treatment systemic hypertension shown affect adversely serum lipoprotein levels week study patients topical timolol therapy raised intraocular pressure found significant adverse effect serum lipoprotein levels reassuring view large number patients form long term therapy selection type beta blocker use influenced lipid changes associated oral form drug,C11,0.020886824,0.0031728975,0.006674143,0.002009808,0.004981711,0.0046161884,0.36477754,0.020672241,0.0025859466,0.003514524,0.016747598,0.00735702,0.03671804,0.009128781,0.072399914,0.0055699926,0.08105485,0.003683624,0.004072838,0.103346474,0.22107378,0.0012700307,0.0036852446
evaluation visual fields ophthalmologists octosmart program introduction goldmann perimetry standardized measuring conditions much possible spite possible perimetrist influence results perimeter measurements introduction computer controlled perimetry however largely eliminated influence investigator perimetry results nevertheless interpretation perimetric result everyday clinical situation still extensively subjectively coloured liable vary depending doctor carrying octopus program g introduced years ago used glaucoma program greatly simplified visual field assessment thanks visual field indices indices make possible compare visual field results normal population present introduction octosmart program represents step forward program analyses measured visual fields aid standardized statistical criteria based large normal value study analysis standardizes thereby simplifies interpretation visual field results study compares outcome octosmart program visual field interpretations eye doctors,C11,0.0024380556,0.002162677,0.03995066,0.001369844,0.015212506,0.014935672,0.33129296,0.002292777,0.0017626057,0.0024015242,0.06962334,0.0050407033,0.13024943,0.021957101,0.0021439646,0.015591367,0.033175074,0.0025129302,0.09072211,0.12849155,0.083291255,0.000865665,0.0025162622
effect local anesthesia ocular massage central corneal curvature using standard javal keratometer obtained central corneal curvature measurements patients administration local anesthesia noted flattening mean average keratometry approached statistical significance along increase overall astigmatism decreased intraocular pressure found factor,C11,0.005330645,0.004728548,0.009946431,0.002995072,0.0074227545,0.006879475,0.16727643,0.005013003,0.003853819,0.005237672,0.05004929,0.114170946,0.084773846,0.021977376,0.0046876348,0.059905782,0.12830004,0.0054896805,0.0060697235,0.05434019,0.24417494,0.0018927184,0.005483971
hydrogen peroxide localization experimental optic neuritis association reactive oxygen species altered permeability blood brain barrier acute experimental encephalomyelitis investigated ultrastructural cytochemical localization hydrogen peroxide h sites optic nerve previously identified extravasation intravascular horseradish peroxidase using modified cerium method found electron dense cerium derived h reaction product localized perivascular space lamina retinalis lamina choroidalis lamina scleralis optic nerve head electron dense reaction product observed presence intravascular leukocytes although adjacent perivascular interstitial inflammatory cells site scant myelinated retrobulbar optic nerve cerium derived h reaction product seen intravascular space blood vessels surrounding perivascular interstitial foci inflammatory cells reaction product also observed extracellular space adjacent plasmalemma axons glial cells optic nerve head retrobulbar nerve perivascular intravascular distribution cerium derived reaction product suggests h may play role pathogenesis altered vascular permeability experimental optic neuritis supports previous observations suppression blood brain barrier permeability detoxification h exogenous administration antioxidant enzymes,C11,0.07323011,0.0021625832,0.028141953,0.0013697846,0.0033947679,0.014895136,0.37921435,0.0022997872,0.013547059,0.002395429,0.026921563,0.0050143967,0.07383274,0.06172361,0.0021438715,0.003796395,0.021469282,0.002566597,0.0027759646,0.03586471,0.22622615,0.0008656274,0.016148146
new ophthalmic microtrephine present new instrument designed facilitate microtrephination tissues required various ophthalmic procedures microtrephine gauge stainless steel tube mm diameter mm long sharpened cutting end plastic finger grip area facilitate micro rotation standard plastic luer hub allows trephine used syringe either standard type one spring assisted plunger scar tissue biopsy specimens abnormal inflammatory fluids suctioned syringe subsequent pathologic examination,C11,0.004947803,0.004388948,0.033136845,0.0027801718,0.03080722,0.006430187,0.3077964,0.0046529737,0.0035770412,0.004861507,0.09363235,0.010176685,0.08702638,0.012147841,0.004350973,0.007704758,0.16242883,0.0050954167,0.005633801,0.031823747,0.16975322,0.0017567851,0.005090117
glaucoma secondary epithelial downgrowth fluorouracil since epithelial downgrowth involves actively proliferating intraocular tissue possible antimetabolite fluorouracil may inhibit report case secondary glaucoma caused epithelial downgrowth filtration surgery performed adjunctive use subconjunctival fluorouracil cessation injections retrocorneal membrane grew rapidly involve entire posterior cornea eye eventually became blind painful enucleated use fluorouracil given usual manner appears failure,C11,0.0269606,0.026442364,0.03095992,0.09197794,0.0064280606,0.005957584,0.31844154,0.0043412307,0.0033373842,0.0045357924,0.04735992,0.033896003,0.028611364,0.062059987,0.0040594633,0.0071885493,0.13927265,0.00475403,0.027597062,0.030952908,0.08847751,0.0016390827,0.0047490858
recession superior oblique tendon pattern strabismus performed mm recession superior oblique tendon pattern strabismus patients average preoperative pattern measured prism dioptres pd average pattern correction pd patients residual pattern pd less average pd patient experienced significant underaction superior oblique surgical complications ptosis brown syndrome laceration vortex vein superior rectus occur procedure corrected pd pattern amount pattern corrected correlated size preoperative pattern total amount recession done significant shift esodeviation primary position noted patients underwent superior oblique recession procedure appears particular value patients moderate superior oblique overaction advantages recession superior oblique tendon include potential reversibility reoperation low risk induced superior oblique palsy allowance asymmetric surgery potential adjustable suture technique,C11,0.0028011235,0.016036285,0.005226606,0.0015738371,0.018155942,0.0036149959,0.18041655,0.016187645,0.0020250876,0.0027522685,0.06970006,0.005761376,0.08559295,0.0064740046,0.0024633256,0.004361932,0.36078766,0.002884693,0.0031894913,0.052346006,0.15377188,0.0009945772,0.0028816927
topical use cyclosporine treatment vernal keratoconjunctivitis treated patients vernal keratoconjunctivitis four nine months topical cyclosporine dilution castor oil significant side effects occurred except mild transient burning upon administration within first days symptoms signs condition improved significantly results maintained throughout entire treatment relapses disease occurred two four months end therapy double masked clinical trial nine patients cyclosporine castor oil vs castor oil alone confirmed results treated eyes improved significantly signs symptoms compared control eyes topical cyclosporine may therefore considered effective substitute corticosteroids excellent anti inflammatory activity patients corticosteroid dependent corticosteroid resistant vernal keratoconjunctivitis,C11,0.0029198513,0.0025900537,0.019557953,0.0016405453,0.0040658005,0.0037682203,0.38827422,0.0027458635,0.0021109225,0.017759448,0.01342831,0.0060497764,0.09108774,0.0068961703,0.0025676435,0.0045468155,0.19136064,0.0030136702,0.017458621,0.08530419,0.12881298,0.0010367332,0.0030038354
role communities decision making eye care programs concept primary health care involves educating people live lives ways beneficial health communities whole must participate decision making involved education promotive preventive curative rehabilitative refer participation participatory communication based two fundamental tenets everyone community special knowledge contribute development health community person superior another subsequent sociological anthropological studies communities southern sudan norwegian church aid norwegian association blind partially sighted conducted village workshops based concept,C11,0.0037058797,0.021203035,0.024853073,0.01998133,0.00516032,0.04065146,0.26950094,0.003485054,0.002679186,0.039518017,0.15826383,0.007622286,0.024370313,0.008932203,0.003258857,0.0057708253,0.05476065,0.0038164416,0.11621227,0.09423398,0.08689177,0.0013158232,0.0038124723
effects lesions anterolateral columns dorsolateral funiculi self mutilation behavior rats possible role anterolateral columns alcs dorsolateral funiculi dlf pain mechanisms examined effects lesions tracts alone combined tests chronic deafferentation pain autotomy rats spinal lesions alone e without denervation either alc dlf combined dlf alc lead form self mutilation behavior cervical surgery without spinal lesion followed limb denervation sham resulted similar autotomy characteristics observed following limb denervation alone control results considered one set controls alc lesions simultaneous weeks prior limb denervation ipsilaterally contralaterally produced significant delay onset autotomy decrease percentage rats showing behavior dlf lesions followed limb denervation produced significant acceleration onset autotomy increase percentage rats showing behavior combined dlf alc lesions limb denervation produced intermediate effects observed following either alc dlf lesions alone results give support concept autotomy related rostral transmission nociceptive information spino bulbo spinal inhibitory loop involving dlf alc triggered chronic deafferentation pain,C21,0.002157531,0.0019138376,0.004025729,0.0012122287,0.086564906,0.021321345,0.31799796,0.0020289682,0.0015597988,0.033452913,0.02079866,0.004515404,0.07342335,0.048032865,0.0018972782,0.013794331,0.069427975,0.002221899,0.015240648,0.023459554,0.25196618,0.00076606084,0.0022205792
continuous suprascapular nerve block analgesia scapular fracture fracture scapular uncommon painful case described comminuted scapular fracture treated continuous suprascapular nerve block patient lying supine epidural needle directed towards scapular notch via superior approach epidural catheter placed notch believed identified repeat injections ml bupivacaine per cent epinephrine provided analgesia within minutes duration hr injection ml radio opaque dye demonstrated catheter lateral scapular notch however dye dispersed throughout supraspinous fossa including scapular notch thus blocking suprascapular nerve case demonstrates continuous suprascapular nerve block performed five days location scapular notch less important previously thought,C21,0.003639944,0.003228812,0.0069830874,0.002045136,0.0050701825,0.0046975375,0.21175823,0.038660765,0.0026315174,0.0035764587,0.13080958,0.042778477,0.17760476,0.008431294,0.003200875,0.00566815,0.21667351,0.0037485387,0.004144612,0.02721085,0.09239674,0.0012924118,0.0037485617
overcoming potential pitfalls use medicare data epidemiologic research used medicare data bases us census data address two questions critical use medicare files epidemiologic research first examined degree population enrolled medicare program similar elderly resident population united states estimated us census found small differences total population estimates substantial differences age race second found among medicare enrollees physician claims identify small proportion hip fracture cases documented hospital discharge files proportion varies age region state within united states calculation rates based medicare hospital discharge data probably hospital discharge data sets well must take limitations account use available medicare data files overcome limitations,C21,0.0028011047,0.016042544,0.005242838,0.0015738265,0.0039004497,0.0038083044,0.2784602,0.0026341928,0.002025074,0.0027522498,0.083528005,0.0058514597,0.03257536,0.0064859744,0.0024632995,0.004361903,0.11172404,0.0028846734,0.055160373,0.27287883,0.09893608,0.0009945706,0.002914622
agreement two dietary methods measurement alcohol consumption study compares estimates alcohol consumption two dietary methods self reported diet diary quantitative food frequency questionnaire university michigan food frequency study black white male female respondents ages years kept diet diaries covering days year period end year respondents completed dietary quantity frequency questionnaire included alcoholic beverages two methods showed excellent agreement estimated group mean ethanol consumption good agreement ranking individual respondents respondents described alcohol consumption abstract terms questionnaire way consistent consumption recorded diary however two methods showed poor moderate agreement classifying individuals infrequent moderate heavier drinkers suggesting classifications used cautiously results suggest general population studies dietary quantity frequency questionnaire diet diary covering several weeks measure moderate levels alcohol consumption similarly degree consistency suggests moderate levels intake measures alcohol consumption derived two methods equally valid,C21,0.0021354435,0.043239888,0.024755837,0.0011998186,0.0029735372,0.0027559008,0.26184455,0.0020092793,0.0015438305,0.0020981985,0.10904504,0.014730108,0.08024514,0.004910044,0.012208754,0.013631424,0.12187922,0.0022153438,0.0024315163,0.15351628,0.1376705,0.00075821835,0.0022021264
identification driver two rider motorcycle accidents inguinal contusion laceration indication driver motorcycle accidents involving two riders medicolegal identification driver necessary one riders die particularly important latter case survivor almost always insists driving one characteristic injury distinguishes driver passenger inguinal contusion laceration accompanied internally pelvic fracture injury caused collision pelvis fuel tank identifies driver,C21,0.07176117,0.005958903,0.012534464,0.0037743815,0.009354134,0.0411806,0.31244624,0.0063173724,0.037352696,0.006600499,0.06323077,0.013816951,0.04164499,0.015810212,0.005907344,0.0104608,0.15454431,0.00691808,0.0076490487,0.043876387,0.11956457,0.0023851984,0.0069108848
ten year review treatment delayed union nonunion implanted bone growth stimulator ten year clinical roentgenographic review conducted patients original australian multicenter trial evaluated use implantable bone growth stimulator delayed union nonunion original patients patients located seven patients died unrelated causes unlocatable patients located patients representing fractures participated detailed clinical review roentgenographic assessment fractures remained united normal bone remodeling occurred adverse effects generator cathode wire six patients initially reported failures healed surgical intervention thus normal osteogenesis occurs association electrical stimulation using implantable bone growth stimulator ten year review supports long term safety effectiveness technique treating nonuniting fractures,C21,0.0027636157,0.042586446,0.031869274,0.014917589,0.0038482475,0.0035665901,0.25442508,0.0025989378,0.0019979712,0.02947108,0.08338916,0.0056842295,0.021788217,0.06937271,0.002430254,0.0043035243,0.24019165,0.0028512387,0.003146783,0.06732782,0.08090425,0.0009812595,0.02958407
children riding back pickup trucks neglected safety issue motor vehicle related trauma leading cause death children united states states pediatric restraint requirements passenger vehicles help prevent deaths injuries states however possess safety laws restrictions passengers ride back pickup trucks retrospective review medical records month period revealed patients whose injuries direct result passenger cargo area bed pickup truck injuries pertinent data discussed representatives highway safety commission state surveyed specific highway safety laws responses revealed states district columbia child restraint requirements passenger automobiles states adult restraint laws states type restriction passengers riding back pickup trucks seventy one percent states pickup truck regulations include preschool age child data national highway traffic safety administration concerning pickup trucks passenger fatality presented discussed,C21,0.04124568,0.07953128,0.0049576294,0.0014928946,0.0037207073,0.048817914,0.34187135,0.0024986463,0.0019208707,0.06957997,0.025064882,0.0054648784,0.017357925,0.0063581043,0.002336472,0.016990228,0.10159667,0.0027411536,0.032106582,0.088632,0.102035835,0.00094339333,0.002734942
critical care clonidine poisoning toddlers clonidine may source serious toxicity ingested toddlers describe cases clonidine ingestion toddlers mean dose mg kg range source clonidine grand parent six cases symptoms included altered level consciousness n miosis n bradycardia n hypotension n apnea respiratory depression n hypothermia n hypertension n therapeutic interventions included naloxone n atropine n dopamine n fluid resuscitation n endotracheal intubation n deaths symptoms clonidine ingestion typically mild dose ingested less mg kg bradycardia hypotension occurred usually doses greater mg kg apnea respiratory depression common dose exceeded mg kg effective measures needed prevent potentially serious intoxications,C21,0.055515975,0.020487722,0.006674278,0.0020097606,0.0049808347,0.03924627,0.28862453,0.0033638375,0.002585999,0.045093026,0.050861504,0.0073571694,0.11520282,0.008224587,0.003145508,0.04019619,0.121379234,0.0036836988,0.004072921,0.03807621,0.13426805,0.0012700565,0.0036798676
controlling severity injuries emergency medicine research injury severity score iss age used retrospectively control trauma severity control variables revised trauma score rts triss method estimates probability survival patient additionally require values blood pressure glasgow coma scale respiratory rate recorded emergency department authors question rts iss iss age probability survival calculated using triss method used control severity injuries trauma research relations predictor variables survival hospital discharge hospital length stay survivors length icu stay compared cause injury penetrating motor vehicle accident low fall blunt data collected months consecutive adult patients died stayed five nontrauma three trauma centers hours survival false negative rates probability survival calculated using triss method approximately half iss age variable adequately explained survival among low falls combinations iss rts age explained variation lengths hospital stay among survivors iss explained variation lengths intensive care unit icu stay researchers consider iss rts age control severity lengths hospital icu stay studied triss method used studies survival cases rts requires data collection emergency department must calculated,C21,0.035433963,0.001543438,0.011664261,0.0009776168,0.0024280432,0.012012108,0.18457077,0.0016362864,0.001257919,0.010127672,0.13861391,0.029068906,0.1269116,0.0040007224,0.0015300834,0.0027094912,0.1842643,0.0017918779,0.010394508,0.10583215,0.11399163,0.009033783,0.010204957
organ injury scaling ii pancreas duodenum small bowel colon rectum organ injury scaling committee american association surgery trauma charged devise injury severity scores individual organs facilitate clinical research first report addressed spleen liver kidney following proposed pancreas table duodenum table ii small bowel table iii colon table iv rectum table v grading scheme fundamentally anatomic description scaled representing least severe injury emphasize represent initial classification system must undergo continued refinement clinical experience dictates,C21,0.07521047,0.0031196102,0.05853267,0.0019759675,0.0048970846,0.03499337,0.26655486,0.0033072764,0.002542517,0.0034554992,0.017089622,0.075278744,0.021869415,0.025084391,0.02011127,0.021127053,0.107523456,0.0036217594,0.038041037,0.044263672,0.16653357,0.0012487011,0.0036179926
elliptical incised wound breast misinterpreted bite injury bite injuries upon homicide victims often initially identified forensic pathologist course autopsy examination following recognition injury photographs traumatized site referred forensic odontologist examination characterization subsequent comparison suspect dentition however pathologist misidentifies injury caused another mechanism human bite mistake potentially perpetuated dental consultant since relatively dentists regularly examine traumatic injuries arising bites illustrate event case presented involving incised wound breast originally identified avulsive bite wound detailed examination two odontologic consultants confirmed wound caused human teeth related bite injury specific individual bite injury interpretation represented scientific evidence implicating suspect subsequent trial capital murder later examination tissues photographs forensic pathologist another dental consultant revealed injury due human dentition rather resulted sharp edged instrument consultants conducted unique experiment reduplicate injury prove causation information presented jury suspect trial resulted acquittal charges,C21,0.11721673,0.0022694203,0.0171488,0.013808721,0.0035722991,0.0033017364,0.3349814,0.014782524,0.0018496027,0.014895167,0.12981984,0.0055926377,0.017647306,0.066552825,0.014613422,0.0039839465,0.05110574,0.0026586622,0.052423976,0.05260519,0.0755974,0.0009083916,0.002664237
geriatric injury analysis prehospital demographics mechanisms patterns study objective evaluate emergency medical services ems system use injury mechanisms prehospital assessments among elderly victims trauma design analyzed prehospital data injuries among patients years old older ems dispatch requested medium sized metropolitan area month period results total cases occurred women represented dispatches involving elderly patients injury mechanisms fall motor vehicle accident mva fight accidental poisoning choking persons lower frequency mvas younger patients p less frequent injuries determined prehospital assessment head face upper extremity hip lower extremity back chest abdomen frequency serious neurologic injuries less falls mvas mechanisms p less suspected hip p less pelvic p less injuries occurred frequently falls mechanisms injury whereas back injuries occurred frequently mvas p less seventy one fall victims suspected medical causes fall twelve patients cardiac arrest conclusion report injury patterns mechanisms among elderly victims trauma presenting ems system knowledge patterns useful emergency physicians ems administrators,C21,0.10499302,0.0017166424,0.01295667,0.0010873248,0.0026947416,0.0025673036,0.30139726,0.0018199104,0.010757969,0.011252952,0.050140783,0.0039803907,0.14857042,0.0044496832,0.0017018245,0.031115264,0.10172587,0.0019929623,0.021237187,0.13511968,0.046034086,0.0006871286,0.002000894
knee function complex femoral fractures treated interlocking nails twenty three complex femoral fractures treated interlocking nails fracture healing knee function analyzed including alignment quadriceps hamstring strength thigh atrophy range motion rom similar previous studies preinterlocking nail era knee function impaired comparison contralateral limb seventy three percent patients decreased quadriceps strength decreased hamstring strength sixty five percent thigh atrophy rom alignment satisfactory despite advantages early rom femoral fractures treated interlocking nails knee function often unsatisfactory fracture union occurred therefore formal knee rehabilitation program recommended achieve optimal result,C21,0.003516623,0.00311942,0.0068920148,0.0019758472,0.004896786,0.004538385,0.23183797,0.003307075,0.05361436,0.12261119,0.025408933,0.007252438,0.08509429,0.008085802,0.0030924296,0.0054761134,0.2078442,0.003673567,0.0040041925,0.05410629,0.1547663,0.0012486251,0.003637158
childhood injuries paper present leading causes fatal childhood injury united states examine three types explanations injury rates high united states compared could actually number industrialized european countries conclusions based learn look specific injury problems apply knowledge field childhood injury prevention whole decrease number fatal injuries children recognize injuries major public health problem injuries perceived problems solved accidents determined fate understandable consequently preventable addition injuries addressed multidisciplinary fashion typifies successful public health approach problems address intentional injury part problem intentional injury treated separate field entirely addressed scientifically public health problem one consequence injuries due firearms addressed frequently problem unintentional injury result firearm injuries ie intentional studied addressed adequately situation like studying motor vehicle injuries excluding drunk driving speeding contributing factors like studying acquired immunodeficiency syndrome ignoring anal intercourse intravenous drug use develop support organizations plan coordinate effectively national approach injury control,C21,0.1657158,0.01118818,0.0037535096,0.0010977439,0.0027204917,0.030887071,0.32900771,0.001837301,0.0014124518,0.0113775665,0.02205601,0.023648145,0.035987422,0.0058125444,0.0017180511,0.031408865,0.0354396,0.0020176517,0.106405914,0.074245214,0.09955826,0.00069369463,0.0020107767
scroto abdominal impalement injury skateboard rider injuries sustained skateboard riders vary minor cuts abrasions fractures report describes unique injury sustained young skateboard rider impaled metal rod literature review skateboard injuries reveal instances penetrating abdominal trauma,C21,0.15158662,0.006602726,0.013888736,0.00418218,0.01052627,0.009606181,0.19821851,0.043024592,0.005381295,0.0073136427,0.034231674,0.015309787,0.04607642,0.017114827,0.0065455963,0.047611333,0.06357025,0.007701996,0.0084754815,0.16835329,0.12437814,0.0026429044,0.007657564
asymptomatic patient suspected myocardial contusion diagnostic criteria guidelines hospital admission suspected myocardial contusion mcc remain unclear study defines examines clinical sequelae patients admitted suspicion mcc criteria observation following isolated minor blunt chest trauma suggested hospital trauma registry records patients admitted month period suspected mcc reviewed conventional evaluation criteria cardiac related complications associated injuries analyzed patients twenty eight cardiac related complications occurred patients complications included dysrhythmias infarctions pericardial effusions patients abnormal admission electrocardiograms normal ones latter one patient developed dysrhythmia hours admission three major multi system injuries requiring admission intensive care unit overall incidence cardiac related complications minimally injured patients complications patients isolated chest wall contusions normal admission electrocardiogram normal rhythm hours significant association creatine phosphokinase isoenzymes echocardiogram cardiac related complications complete absence significant cardiac sequelae patients isolated chest wall contusion normal admission hour electrocardiograms associated major injuries suggests patients need admitted,C21,0.030909352,0.01138298,0.013348893,0.0011187375,0.012410346,0.0025696633,0.2597395,0.0018724875,0.001439502,0.001956407,0.073796205,0.0040953844,0.045370545,0.0049359314,0.0017509538,0.012721745,0.38012737,0.0020568843,0.0022672,0.06585367,0.06751624,0.0007069797,0.0020530685
spectrum emergency care agricultural trauma central wisconsin agriculture among dangerous occupations united states injuries occur emergency department ed primary source care year period emergency medicine section marshfield clinic st joseph hospital cared victims agricultural trauma although initially admitted later treated remainder received care solely ed unlike occupational injuries people age may involved agricultural injuries series less years age years older half injuries mechanical devices including tractor farm machinery remainder animals falls exposure although several different types injuries occurred common diagnoses soft tissue injuries fractures common procedure diagnostic radiography followed wound fracture care ed rural setting prepared deal agricultural trauma,C21,0.08533088,0.016263327,0.0052988995,0.0015956889,0.017694956,0.004342698,0.24637629,0.016413132,0.015795896,0.0027903372,0.044197876,0.0070465417,0.059884187,0.006560065,0.0024973084,0.0044222656,0.12538119,0.0029245934,0.030039081,0.20706213,0.09415275,0.001008334,0.0029215517
foreign body removal appendicostomy removal button cell batteries small coins impacted terminal ileum right colon appendicostomy described technique used effectively three patients,C21,0.0071849115,0.006373375,0.0134063,0.0040369085,0.010004762,0.009272503,0.15102221,0.04153748,0.005194371,0.0070595974,0.06510897,0.01477799,0.046623062,0.051303938,0.0063182297,0.011188402,0.1593895,0.0073992675,0.07635896,0.046232652,0.21550901,0.002551101,0.04214651
controlled tissue expansion groin flap upper extremity reconstruction large upper extremity defect year old girl resurfaced expanded groin flap tissue expansion allowed complete coverage defect minimizing donor deformity pretransfer expansion pedicled flaps offers alternative free flap reconstruction complex upper extremity defects especially valuable pediatric patient donor site morbidity significant,C21,0.0048323204,0.0042865095,0.009247993,0.072864234,0.07713096,0.0062363613,0.19413532,0.0045443727,0.0034935526,0.0047480385,0.0232599,0.0100914305,0.041373372,0.011793766,0.004249421,0.007524928,0.1916882,0.05741954,0.005502308,0.05816772,0.20072266,0.0017157814,0.0049713133
whole bowel irrigation cocaine body packer new approach common problem gastrointestinal drug smuggling common problem many major cities though majority cases never require medical attention body packer frequently presents life threatening symptoms intoxication including seizures cardiorespiratory collapse well mechanical obstruction ingested drug packets risk asymptomatic smugglers may vary packaging materials remains unknown lack controlled studies variations packaging materials clinical outcomes prevented formulation consistent management strategy current recommendations asymptomatic body packers vary immediate surgical removal use laxatives observation authors present first reported case asymptomatic cocaine body packer treated whole bowel irrigation polyethylene glycol electrolyte lavage solution strategy safe well tolerated resulted rapid elimination drug packets gastrointestinal tract facilitated assessment contrast radiography potential benefits limitations use whole bowel irrigation difficult problem discussed,C21,0.014342958,0.014129031,0.004604624,0.0013860743,0.0034351393,0.0031837178,0.45523497,0.0023199427,0.0017834896,0.014789906,0.09562943,0.03021405,0.032353863,0.0056722625,0.04950147,0.02772439,0.05698102,0.0025405418,0.014736668,0.0739361,0.092086524,0.0008759216,0.0025378994
paradoxes history anterior cruciate ligament historic review anterior cruciate ligament acl investigation reveals two important paradoxes ideas concepts recently proposed first put forth much earlier controversy regarding ligament continues despite increased amount information available much recent acl literature although regarded newly discovered roots far older apparently forgotten overlooked work examples include acl intactness best tested full extension hemarthrosis acl rupture closely associated acl rupture sometimes masquerades minor injury additionally early investigators achieved notable advances surgical techniques contributions disappeared literature two major reasons first early investigators observed patients typical practitioners rarely seeing acl injuries consequently little data existed support observations second observations could confirmed advent widespread successful surgery undoubtedly orthopedists know much acl yet many issues remain controversial acl perform vital function efficacy operative versus nonoperative treatment relative merits direct repair intraarticular substitutes extraarticular nonanatomic procedures origins continued existence controversy stem several sources including less rigorous study design scarcity natural history long term follow studies basic science studies perception acl simple structural unit also perpetuated controversy,C21,0.020674117,0.01108341,0.050922655,0.0010874148,0.002700742,0.011988583,0.3229213,0.011319488,0.0013991984,0.020618496,0.024337696,0.013327689,0.0203092,0.004744831,0.020431379,0.012378159,0.20703137,0.0019970618,0.011563827,0.111339785,0.11513908,0.0006871855,0.0019972913
subtle injuries lisfranc joint fifteen patients subtle injury lisfranc joint tarsometatarsal articulation found lesion defined diastasis two five millimeters bases first second metatarsals seen anteroposterior radiographs often long delay injury diagnosis eight patients treated knee cast three treatment cast tarsometatarsal arthrodesis two initial treatment later arthrodesis two open reduction internal fixation duration follow ranged two thirteen years diagnosis correlation severity diastasis patient functional result marked disability pain persisted seven patients six flattening longitudinal arch maintenance longitudinal arch usually associated better functional outcome patient subtle injury lisfranc joint weight bearing lateral radiographs feet needed identify flattening longitudinal arch radiographs made routinely evaluation injuries foot may involve lisfranc joint,C21,0.068741746,0.0024191437,0.01828067,0.0015322905,0.03020209,0.0035195663,0.263638,0.015764073,0.001971629,0.015878936,0.058433946,0.0056092856,0.025151208,0.006297485,0.015592011,0.0042467844,0.2507934,0.002808542,0.0031052942,0.114570916,0.08766901,0.0009683221,0.002805621
profile alcohol prescription drug abuse high risk community based elderly population substance abuse among elderly relatively common often remains undetected ignored health social workers psychosocial health factors related aging process major contributors alcoholism drug abuse estimated two ten percent individuals age suffer alcoholism article profiles alcohol prescription drug abuse among geriatric clientele elderly services spokane ess division spokane washington community mental health center addition traditional channels ess uses unique gatekeeper network identify high risk community based elderly elderly persons referred gatekeepers regarded hidden elderly highest risk notably percent ess clients referred via mechanism case management records ess clients reviewed history alcoholism total persons percent diagnosed either primary secondary alcohol abuse fifty subjects five percent average active ess caseload referred prescription drug abuse misused prescription drug classes sedative hypnotics antianxiety agents analgesics diazepam codeine meprobamate flurazepam top four agents percent subjects found duration prescription drug abuse excess five years percent correlation prescription drug abuse previous active alcoholism found additional characteristics geriatric study population discussed detail including specific psychosocial factors source referral age gender living situation marital status psychiatric history presence polypharmacy,C21,0.0017398678,0.0015433496,0.0032464128,0.0009775608,0.0024227109,0.00224539,0.3238092,0.0016361928,0.009591496,0.0185511,0.13737889,0.0035785758,0.03427338,0.016543899,0.026828678,0.011124,0.09099895,0.0017917755,0.027244905,0.25585222,0.026213167,0.00061776384,0.001790549
alterations splanchnic blood flow following chronic ethanol exposure purpose experiments determine whether tolerance develops effect g kg ethanol total regional splanchnic blood flow male wistar rats animals given lieber decarli liquid diet containing ethanol days ethanol fed animals withdrawn hr prior experiments regional blood flow cardiac output co measured reference microsphere technique intraperitoneal injection g kg ethanol acute ethanol administration produced early nonsustained increases portal vein blood flow animals fed ethanol days withdrawn hr control animals however chronic exposure ethanol pattern increase blood flow response ethanol splanchnic organs different ethanol fed control groups increases portal vein flow control groups due concomitant increases small intestinal colonic cecal blood flow increase ethanol fed group due rise small intestinal stomach blood flow increase stomach blood flow occurred animals treated chronically ethanol may viewed conditioned response ethanol since found control group results demonstrate pattern increase blood flow splanchnic organs produced acute dose ethanol depends animal previous exposure ethanol,C21,0.009980958,0.001493034,0.011278141,0.0009456907,0.0023438283,0.010273965,0.1962239,0.0068937833,0.0012168392,0.0016537892,0.014799092,0.07566574,0.22874683,0.004324029,0.0014801334,0.0026266505,0.022109237,0.0017333607,0.0019165087,0.040748388,0.36119893,0.00059762376,0.0017495097
portrayals alcohol prime time television alcohol portrayals analyzed week composite sample prime time fictional television programs aired fall approximately episodes contained one appearances alcohol alcohol ingested programs overall alcohol drinking acts per hour movies made television highest rate drinking acts per hour followed situation comedies theatrical movies dramas within category dramas evening soap operas stand acts per hour drinking nondrinking characters compared number attributes relevant role modeling regularly appearing characters likely drink nonregular characters drinking characters also tended high status largely white upper class professionals time trend analysis showed regular increase alcohol television reaching acts trend appears reverse,C21,0.0031419406,0.002787058,0.005862535,0.0017653282,0.0043750526,0.004054838,0.25576234,0.0029553818,0.01747997,0.003087141,0.054851156,0.02165922,0.109110326,0.008088835,0.01796813,0.020095186,0.072385885,0.0032356777,0.025966113,0.21345934,0.12310974,0.0011155889,0.027683163
acute intoxication acute alcohol intoxication commonly encountered clinical presentation emergency medicine role considered many emergency department presentations specifically major minor trauma gastrointestinal metabolic neurologic psychiatric disorders differential diagnosis change mental status must considered intoxicated patients management intoxicated patients generally supportive although complications chronic alcoholism considered management consist correction complications resultant intoxication well observation provision safe environment patient recovery phase acute intoxication,C21,0.022030123,0.0033471016,0.0070405784,0.0021200608,0.0052541946,0.0048696348,0.45572105,0.0035484529,0.0027279248,0.0037074846,0.035596386,0.007760948,0.028090607,0.008675972,0.003318141,0.02413967,0.15916742,0.003885869,0.0225119,0.07832965,0.11293362,0.0013397601,0.00388342
familial values factors influencing long term psychological adjustment children severe burn injury study replicates earlier findings children survive severe burn injury make positive psychological adjustment family support family value autonomy predicted critical variables promotion psychological adjustment addition study presents hypothesis length time burn injury level intelligence contributing factors psychological adjustment forty four adolescents mean total body surface area tbsa full thickness burns studied half subjects scored within normal range measure psychological adjustment familial value patterns critical prediction psychological adjustment positive psychological adjustment predicted greater family cohesion independence open expressiveness within family level intelligence contribute adjustment length time injury important psychological healing appears factor initial years burn injury,C21,0.070340194,0.0021880863,0.0047262716,0.0013859384,0.0034348022,0.018901078,0.20580633,0.002319715,0.0017833146,0.02630718,0.08819443,0.015253534,0.12421786,0.11389871,0.011456294,0.0038411655,0.09381609,0.0025410214,0.0028087012,0.037383948,0.16598189,0.0008758357,0.0025376505
ethanol inducible cytochrome p assessment substrates specific chemical probes rat liver microsomes capacity liver microsomes oxidize various substrates known specific alcohol inducible cytochrome p studied rats treated different xenobiotics methylcholanthrene phenobarbital acetone ethanol analysis results showed significantly marked increase following ethanol acetone treatments p nitrophenol hydroxylation n nitrosodimethylamine ndma demethylation benzene hydroxylation butanol oxidation aniline hydroxylation ether de ethylation significant increase n nitrosodiethylamine ndea de ethylation rat microsomes respectively versus control animals mean sd values expressed nmol min nmole p activities significantly decreased mc treatment except p nitrophenol hydroxylation pb treatment markedly enhanced ndea de ethylation p nitrophenol benzene hydroxylations respectively versus controls results suggest ndma especially butanol specific useful probes alcohol inducible cytochrome p crude liver microsomes,C21,0.003049263,0.0027048485,0.09421948,0.0017132565,0.004246002,0.018655056,0.28165334,0.0028675639,0.0022044815,0.00299608,0.015634788,0.0064092074,0.15183721,0.031798024,0.017416278,0.034776554,0.04060131,0.0031402353,0.0034720346,0.021025682,0.25531176,0.0010826825,0.0031848715
pediatric penetrating head neck trauma penetrating head neck trauma children causes uncommon potentially life threatening injuries reviewed charts patients sustained penetrating injuries face upper neck seventeen males females aged weeks gestation years mean years comprised study population gun shot wounds shotgun injury stab wounds significant problems included vascular injuries central nervous system injuries ocular injuries airway compromises facial nerve injuries cervical esophageal penetration cases pneumothorax three deaths occurred majority patients survived sustained minimal permanent disability included review unique case intrauterine gunshot wound face approximately weeks gestation treatment protocol differences adult patients management highlights reviewed,C21,0.09774561,0.0024851908,0.0052275616,0.0015741249,0.01744832,0.017175466,0.25988483,0.03853873,0.042634193,0.043433532,0.066931754,0.0058203856,0.06750069,0.019991035,0.002463688,0.0043688337,0.1404168,0.0028852203,0.0031900746,0.094242476,0.062163867,0.000994759,0.0028828986
comorbidity mental disorders alcohol drug abuse results epidemiologic catchment area eca study prevalence comorbid alcohol drug mental disorders us total community institutional population determined persons interviewed national institute mental health epidemiologic catchment area program estimated us population lifetime prevalence rates non substance abuse mental disorder alcohol dependence abuse drug dependence abuse among mental disorder odds ratio addictive disorder lifetime prevalence including overlapping alcohol another drug disorder either alcohol drug disorder odds addictive disorder seven times greater rest population among alcohol disorder comorbid mental disorder highest mental addictive disorder comorbidity rate found drug alcohol disorders among half found mental disorder odds ratio individuals treated specialty mental health addictive disorder clinical settings significantly higher odds comorbid disorders among institutional settings comorbidity addictive severe mental disorders highest prison population notably antisocial personality schizophrenia bipolar disorders,C21,0.0027019894,0.002387488,0.0050220457,0.0015122398,0.0037478178,0.016490938,0.44163415,0.002531112,0.0019458293,0.0026445494,0.065988004,0.01854393,0.055804007,0.0062203915,0.0023669072,0.0042202417,0.03206249,0.0027717908,0.0035443606,0.24388526,0.08024986,0.00095565116,0.0027689082
arterial proximity valid indication arteriography penetrating extremity trauma prospective analysis three hundred seventy three patients penetrating extremity injury studied assess yield arteriography patients underwent arteriography following present bruit history hemorrhage hypotension fracture hematoma decreased capillary refill major soft tissue injury nerve pulse deficit absence findings arteriography performed injury proximity major neurovascular bundle patients arteriography performed abnormal finding noted sixty five injuries identified requiring intervention proximity indication arteriography patients seventeen injuries identified one required repair penetrating extremity trauma need arteriography based clinical findings use arteriography screen arterial injury proximity alone indication rarely identifies significant injury abandoned,C21,0.13166265,0.0026271385,0.005526147,0.0016640349,0.018454166,0.0038221742,0.31888708,0.002785179,0.002141147,0.017234607,0.10066696,0.0060922992,0.044082604,0.0068097664,0.016940383,0.004611918,0.2185135,0.0030500167,0.0033722834,0.021431891,0.05119628,0.015374644,0.0030531066
ureteric substitution boari bladder flap patients underwent ureteric substitution boari bladder flap institute indications ureteric injury following hysterectomy difficult forceps delivery difficult ureterolithotomy ureteric strictures caused dormia basket previous ureteric surgery tuberculosis retroperitoneal fibrosis post ureteric reimplantation fistula patients solitary kidney acute renal failure double j stenting carried patients stent removed weeks post operatively good results morbidity mortality achieved patient simple silastic stent migrated pelvis required open surgery remove attribute success tension free anastomosis wide based posterior flap preservation vascular supply use double j stent vicryl suture material,C21,0.03888603,0.038470514,0.0067925337,0.019644585,0.0050690854,0.004698074,0.27402434,0.0034638206,0.020251216,0.0035768673,0.017518405,0.0074875243,0.06091085,0.008370311,0.0032012404,0.005668797,0.26851535,0.0037489668,0.004145085,0.075346,0.10301242,0.0012925594,0.025905434
liberty tardive dyskinesia informed consent antipsychotic medication forensic psychiatric hospital paper addresses informed consent antipsychotic medication incarcerated forensic psychiatric hospital ways unique setting forensic psychiatric hospital impinge upon three components informed consent information voluntariness competency explored special attention given risk benefit ratio receiving antipsychotic medication terms liberty interests stake freedom movement effects tardive dyskinesia freedom space release forensic psychiatric facility,C21,0.031940002,0.004854134,0.036699537,0.003074618,0.0076198955,0.008206402,0.19161738,0.0051461435,0.0039561726,0.005376779,0.027416196,0.018512739,0.060398474,0.012582327,0.0048121335,0.034992248,0.14703976,0.005635481,0.058057263,0.19790998,0.12657975,0.0019429871,0.00562962
long term prognosis soft tissue injuries neck reviewed patients sustained soft tissue injuries neck mean years recovered completely residual symptoms intrusive severe pain neck lower back commonest complaint older patients worse prognosis two years symptoms alter passage time,C21,0.062630475,0.004609773,0.009696589,0.0029198397,0.057546806,0.024746602,0.19192536,0.08035803,0.003757016,0.0051859715,0.023899255,0.010688714,0.057130076,0.011948924,0.029584652,0.008092415,0.20647268,0.005479477,0.00591726,0.09321425,0.09700445,0.0018451756,0.0053462205
locked intramedullary nailing displaced tibial shaft fractures published erratum appears j bone joint surg br jan analysed results tibial shaft fractures treated grosse kempf locked nail twenty six fractures comminuted open grade ii located outside middle third tibia deep infection rate two poor results use method recommended discussed,C21,0.006505854,0.005771017,0.012139249,0.003655374,0.009059195,0.008396143,0.29916465,0.006118184,0.004703443,0.0063923835,0.18049538,0.013381299,0.046238534,0.014958967,0.005721084,0.010130968,0.1296862,0.006699951,0.0074078715,0.05929424,0.1236006,0.0023099924,0.038169403
morphine pharmacokinetics anesthesia surgery patients burns plasma clearance plasma half life apparent volume distribution morphine anesthesia surgery determined seven patients burns compared seven age matched control subjects burn group significantly lower clearance longer terminal half life smaller volume distribution control group clearance ml min kg half life minutes volume distribution l kg subjects burns compared ml min kg minutes l kg control subjects p less less less respectively data contrast theory patients burns tolerance narcotics suggest need study pharmacologic effects burn injury surgery,C21,0.016360827,0.002484671,0.0052264687,0.0015737957,0.0039003734,0.0036149009,0.069491304,0.0026341414,0.0020250345,0.002752196,0.012911871,0.036632497,0.32193968,0.006440479,0.0024631727,0.03187776,0.11667811,0.002884617,0.0031894075,0.051577963,0.28593346,0.0009945511,0.016412687
pneumatic firearm injuries trivial trauma perilous pitfalls report describes injury due pneumatic firearm though powder firearm injuries generally considered serious pneumatic weapon injuries often viewed minor insignificant trauma children adolescents primarily wield weapons contributing harmless aura however dramatic increases muzzle impact velocities transformed newer generation pneumatic firearms formidable weapons consequently literature replete increasing incidences serious injury due pneumatic weapons,C21,0.1274311,0.0040947516,0.008613248,0.002593624,0.0064278366,0.028287198,0.29100353,0.026680814,0.0033372678,0.026883135,0.021684015,0.009494529,0.080901824,0.011103902,0.0040593217,0.051876184,0.04550724,0.0047538644,0.019675387,0.12637454,0.09282877,0.0016390255,0.0047489204
effect gender subtype platelet mao alcoholism decreased platelet mao activity identified male alcoholics suggestions primarily true type alcoholics defined criteria stockholm adoption study little information available regarding platelet mao activity female alcoholics study evaluated group alcoholics receiving inpatient treatment including female alcoholics platelet mao activity compared controls female alcoholic platelet mao significantly lower controls different activity levels male alcoholics among male alcoholics type type subgroups lower controls type levels differ type levels thus unable replicate gender subgroup low platelet mao specificity among alcoholics find significant differences alcoholics controls,C21,0.0028010844,0.016042428,0.005226533,0.0015742681,0.003959645,0.0036149453,0.2198374,0.0026341737,0.015513066,0.00275223,0.087766744,0.05006777,0.099839486,0.0070900605,0.002463203,0.017917337,0.02700984,0.020220026,0.0031894466,0.15542988,0.2511742,0.0009945633,0.0028816524
role medical schools prevention alcohol related problems agreement physicians play major role prevention alcohol problems among patients medical schools prepare physicians role teaching three major subject areas knowledge attitudes clinical skills despite agreement acknowledged high prevalence alcohol problems clinical populations medical school coverage problems proportional importance barriers adequate coverage alcohol problems traditional attitudes confusion whether problems medical lack adequate faculty role models problems could remedied encouragement training interested faculty members establishment substance abuse centres university medical schools integration alcohol related material relevant topics departments inclusion alcohol related questions medical qualifying exams,C21,0.0030500211,0.03223469,0.020347882,0.0017136824,0.0042470577,0.033458896,0.38309866,0.0028682768,0.0022050296,0.047267105,0.014026708,0.021022193,0.034852896,0.0070129912,0.017443104,0.0047495174,0.0704922,0.01788467,0.03378171,0.14575501,0.08357009,0.0010829517,0.01783465
mac scale normal population meaning false positives mac scale successful identifying alcoholics studies clinical populations often considered test predisposition alcoholism macandrew however holds mac scale assesses general personality trait characterized sociability boldness rebelliousness pleasure seeking present study examines distribution mac scale scores normal population tests correlates high mac scores alcohol related problems e g arrest history sample consisted men participants normative aging study mean age expected heavier drinkers problem drinkers reported significantly higher mac scale scores lighter nonproblem drinkers however arrestees without drinking problems mac scale scores nearly identical problem drinkers without arrest histories respectively sample without problem drinking arrest histories mac scale scores clinical indicator alcoholism scores entire sample men mac scores problems either arrest drinking results interpreted supporting macandrew interpretation meaning mac scale general personality measure rather specific alcoholism instrument,C21,0.0022274726,0.0019758793,0.014927341,0.001251526,0.013845581,0.0028746694,0.31204376,0.0020947421,0.0016103635,0.0021886225,0.09432644,0.0792505,0.14516287,0.0067637106,0.03430845,0.003468638,0.045275208,0.002295701,0.013301263,0.14834192,0.06937588,0.00079089456,0.002298608
simultaneous reconstruction cervical soft tissue esophagus gastro omental free flap microvascular transfer gastric tube omentum used simultaneously reconstruct cervical soft tissue esophageal defects five patients patients previous high dose radiation multiple flap reconstructions largest esophageal soft tissue defects cm cm respectively wounds healed primarily except one orocutaneous fistula one death intraoperative stroke gastro omental flap useful cases reconstructive surgeon faced esophageal soft tissue defects particularly heavily irradiated patients reconstructive options,C21,0.0039166394,0.0034742546,0.0073080426,0.0022006,0.13875708,0.005054627,0.17786701,0.022579119,0.002831556,0.022792486,0.08852652,0.008104373,0.14474328,0.009046778,0.0034441939,0.006099022,0.15220656,0.004033489,0.00445967,0.09805714,0.08907763,0.0013906563,0.004029294
alcohol consumption college undergraduates current use year trends carefully executed study high response rate random sample undergraduate student body rural new england university surveyed subjects use alcohol surveyed students returned questionnaires results compared similar studies conducted campus daily almost daily use alcohol registered respondents represents continuing decrease daily consumption earlier studies one fourth sample indicated drinking one drink fewer per week contrary common perception campus nevertheless recorded hangover recorded vomiting drinking much recorded blackout last week compared u population alcohol consumption appears evenly distributed college sample still drinking done one fifth groups,C21,0.0031419566,0.0027870722,0.0058625652,0.0017653372,0.004375075,0.0040728226,0.24136925,0.002954734,0.0022714948,0.003106515,0.046485513,0.021791002,0.07247472,0.007486151,0.016576866,0.020100478,0.089272745,0.0032356943,0.033994637,0.15489627,0.25763115,0.0011155946,0.0032323292
corneoscleral limbus human corneal epithelial wound healing studied epithelialization ocular surface human eyes patients large corneal conjunctival abrasions focused healing limbal region epithelialization cell movement found occur circumferentially along corneoscleral limbus centripetally corneoscleral limbus patient central corneal defect close corneoscleral limbus first epithelialized completely normal limbal healing observed occur circumferentially migrating tongue shaped corneal limbal epithelium tongue shaped projections developed either side remaining intact epithelium advanced along corneoscleral limbus met centripetal movement cells corneoscleral limbus completed healing process three patients however advancing conjunctival epithelium extended across corneoscleral limbus tongue shaped projections corneal limbal epithelium met surface cornea covered conjunctival epithelium thin irregular later showed peripheral scarring vascularization recurrent erosions,C21,0.0034153468,0.019477759,0.031221,0.018367166,0.014623924,0.053774364,0.17615125,0.0031981873,0.002458653,0.0033415211,0.021973439,0.08927792,0.02392697,0.13712485,0.0193547,0.005295809,0.190098,0.003588572,0.003872352,0.023488112,0.15113696,0.0012075133,0.0036256518
effect early feeding postburn hypermetabolic response rats effect early enteral feeding hypermetabolic response following burn injury rat burn model investigated rates heat production partitioned heat loss determined fourteenth postburn day five treatment groups burn fed rat chow ad libitum starting hours postburn ii burn fed gastrostomy beginning hours postburn iii burn fed gastrostomy delayed hours postburn iv controls fed gastrostomy hours post anesthesia v controls fed rat chow ad libitum hours post anesthesia gastrostomy feedings delivered kcal kg day mean rates heat production heat loss three burn groups differ significantly whether rats fed chow ad libitum gastrostomy early late contrary previous studies using guinea pig model method timing feeding burned rat model significant effect postburn increment rate heat loss corresponding increment rate heat production,C21,0.015518678,0.0023567837,0.0049574594,0.0014927916,0.0036996189,0.0034288398,0.10928225,0.0024985606,0.0019208047,0.015469515,0.02711757,0.06927494,0.12059229,0.006108984,0.0023363917,0.029853156,0.0649898,0.0027361442,0.0030252468,0.108914524,0.40074903,0.00094336097,0.0027332983
cartilage begets bone versus endochondral myelopoiesis observations cellular events involved embryonic long bone formation ectopic osteogenesis fracture repair analysis mesenchymal stem cell potential provide evidence intimate direct relationship osteogenesis angiogenesis vasculature sequence cellular events cartilage replaced bone rather target vascularization myelopoiesis mind may necessary replace term endochondral bone formation endochondral myelopoiesis,C21,0.004073199,0.0036131307,0.007600167,0.0022885643,0.0056718006,0.024849273,0.31271458,0.06733179,0.0029447414,0.004002157,0.12326382,0.047802437,0.025213849,0.040112223,0.0035818683,0.0063428176,0.08834242,0.023907997,0.004637936,0.05412923,0.11798845,0.0014462449,0.028141316
chilblains perniosis unfamiliarity physicians chilblains perniosis gives rise unnecessary hospital admissions expensive laboratory radiologic evaluations times hazardous therapy seven cases chilblains seen san francisco november january patients presented pruritic times painful purple acral patches plaques fingers toes nose exposure cool cold damp environment histologic examination two cases revealed perivascular lymphocytic infiltrate endothelial swelling subcutaneous fat upper lower dermal plexus,C21,0.0053309584,0.004728826,0.009947015,0.002995248,0.090457566,0.0068798796,0.23894845,0.030940084,0.0038540456,0.00523798,0.1337668,0.03980007,0.043171316,0.01225752,0.0046879104,0.03408817,0.12316517,0.005501513,0.00607008,0.049773235,0.14102106,0.0018928297,0.005484293
latissimus dorsi musculocutaneous flap extremity reconstruction orthopedic surgery latissimus dorsi transferred pedicle flap ten patients free vascular flap ten others extremity reconstruction group comprised ten patients transfer used solely cover skin soft tissue defect although partial necrosis transferred skin one patient remaining nine patients obtained complete coverage without reconstructive surgery group ii comprised five patients transfer latissimus dorsi performed active flexion extension elbow abduction shoulder postoperatively muscle strength obtained classified grades according muscle testing method three patients obtained muscle strength grade two obtained grade group iii comprised five patients brachial plexus palsy high dose irradiation coverage skin soft tissue performed neurolysis brachial plexus palsy free tissue bed scarred tissue postoperatively sensory motor disturbances alleviated four five patients,C21,0.0028799104,0.002554624,0.0192946,0.015551518,0.115531504,0.0037166744,0.08912679,0.02021983,0.01602347,0.030655118,0.107731976,0.047750477,0.064671405,0.0068339435,0.0025325206,0.0044846195,0.24564369,0.0029658303,0.0032792017,0.020276817,0.17429024,0.0010225516,0.0029627457
sensory nerve evoked responses spinal cord injury previous studies documented presence fibrillations positive waves decreased motor evoked response amplitudes spinal cord injury sci subjects purpose study evaluate sensory nerve status population twenty eight subjects sci least five months evidence spasticity included sural sensory tibial motor evoked response amplitudes measured mean sural sensory amplitude microv normal microv mean tibial motor amplitude mv normal mv six subjects significantly reduced sural sensory amplitudes extensive electrodiagnostic testing performed studies showed diffusely decreased lower extremity sensory motor evoked response amplitudes diffuse positive waves fibrillations particular distribution thus subjects sci may sensory well motor nerve abnormalities intact connection second order primary sensory neuron may necessary maintenance axonal integrity primary neuron,C21,0.02968579,0.0022147775,0.004728495,0.013320182,0.0034767014,0.003222238,0.19338654,0.0023480118,0.0018050682,0.0024532431,0.06508145,0.005135454,0.24294607,0.1059376,0.0021956144,0.0038880217,0.07680907,0.0025723283,0.002842963,0.059195973,0.17329925,0.00088651956,0.0025686058
antibiotics postburn hypermetabolic response severe burn injury documented significantly increase resting metabolic energy expenditure increase metabolic rate appears possibly correlated degree burn wound colonization infection bacteria prevention colonization infection use topical antimicrobial agents appears decrease metabolic alterations resulting burn injury findings indicate appropriate use topical antibacterial agents may decrease metabolic demands seen burned patients burn induced translocation intestinal bacteria also hypothesized contribute postburn hypermetabolic response attempts preventing entity burned guinea pig model use selective decontamination digestive tract administration enteral antibiotics failed demonstrate measurable effect,C21,0.035894677,0.041229717,0.0058708848,0.0017657293,0.004376388,0.024141612,0.27984306,0.0029553901,0.0022719991,0.0030878424,0.03028029,0.0064639784,0.07133051,0.024425248,0.002763571,0.020414062,0.06371095,0.0032364128,0.0035783742,0.041988343,0.32602203,0.0011158424,0.0032330467
injury disability matched men women intercollegiate sports eight matched men women intercollegiate varsity teams studied prospectively one academic year determine incidence athletic injury resulting disability sports men women participated comparable manner chosen basketball fencing gymnastics swimming tennis indoor track outdoor track volleyball men women injured comparable rates percent versus percent adjusted exposure time seven eight sports continued show similar injury rates women gymnasts however experienced injuries per person hours exposure compared injuries men p disability greater women gymnasts days per person hours versus days men p percent season lost injury also greater women gymnasts types sites injury similar men women sprains strains accounting half injuries found evidence gender differences matched sports except gymnastics technically diverse events may accounted differences observed,C21,0.0894636,0.00199745,0.0042016064,0.0012652512,0.003135546,0.0029060522,0.20544663,0.012960672,0.0016279438,0.013064815,0.03276112,0.0071247844,0.029036654,0.005224501,0.0020138784,0.0035065052,0.08761061,0.002324285,0.0025639941,0.31064546,0.17800105,0.0007995288,0.0023180374
carbon monoxide poisoning five years experience defined population review presented cases east denmark manner death fatal carbon monoxide co poisoning incidence far frequent single substance poisoning yet decreased years despite preventive measures number fatal co poisoning cases may diminish result natural gas project progress purpose survey therefore contribute evaluation actual causes fatal poisonings east denmark discuss existing measures prevent gas poisonings expectation decline gas suicides accidental gas poisonings within next years,C21,0.0033456772,0.035350557,0.038626797,0.018066803,0.02085424,0.07879524,0.26223475,0.0031463152,0.06719314,0.0032873242,0.066968285,0.006881418,0.055315044,0.008317352,0.0029421041,0.005209915,0.069984905,0.0034454928,0.020001115,0.12674113,0.09865414,0.0011879284,0.0034502964
influence prophylactic orthoses abdominal strength low back injury workplace study designed determine effect multimodal intervention prevention back injury evaluate adverse side effects using lumbosacral corset workplace subjects male warehouse workers randomly selected employees grocery distribution center subjects assigned three groups true controls back school brace orthoses back school back school plus wearing custom molded lumbosacral orthosis comparisons pre testing month follow post testing abdominal strength cognitive data work injury incidence productivity use health care services evaluated controls training group showed changes strength productivity lost time orthoses training group showed changes strength productivity accident rate however showed substantially less lost time study supports concept using education prophylactic bracing prevent back injury reduce time loss appears use intermittent prophylactic bracing adverse affects abdominal muscle strength may contribute decreased lost time work injuries,C21,0.049497064,0.049018838,0.022172876,0.0010976541,0.002761653,0.012329283,0.12661484,0.030201744,0.010815399,0.077559814,0.038129922,0.033279687,0.12442644,0.0046090037,0.0017179559,0.003042178,0.057041664,0.0020118952,0.021129217,0.17290545,0.15692785,0.00069365615,0.0020159325
blunt traumatic pericardial rupture ten year experience blunt traumatic pericardial rupture rarely diagnosed preoperatively associated high mortality ten year period patients admitted major trauma center found blunt traumatic pericardial rupture sixteen injured vehicle accidents motorcycle crashes falls crushed eighteen diagnosed intraoperatively resuscitation surgery associated injuries four diagnosed preoperatively pericardial window eighteen males four females median age years range tears found following sites left pleuropericardial diaphragmatic right pleuropericardial superior mediastinal associated cardiac injuries found patients died overall mortality rate high index suspicion alert trauma surgeon make diagnosis intraoperatively emergency surgical resuscitation hemodynamically unstable patient pericardial window stable patient,C21,0.032572318,0.002704776,0.005689456,0.0017132106,0.033697184,0.003935127,0.16713996,0.032388743,0.0022044224,0.017744329,0.0890654,0.006271583,0.053580083,0.007134242,0.0026813732,0.0047482094,0.25356296,0.0031531795,0.0034719415,0.23183706,0.04048489,0.0010826535,0.0031368854
alcoholism society problems alcohol abuse rampant society permeate emergency department experience cost society measured social medical occupational legal effects exceedingly high probably underestimated emergency physicians opportunity intervene vicious cycle must learn role process,C21,0.006506031,0.005771174,0.043624803,0.0036554735,0.009059442,0.008396372,0.29089996,0.00611835,0.0047035706,0.0063925576,0.03876995,0.013381663,0.07244195,0.017601373,0.0057212394,0.010131244,0.06552889,0.0067001334,0.101878785,0.12674496,0.14696887,0.0023100553,0.006693165
lead article reviews historical current uses lead sources absorbed lead water lead based paint cookware bullet wounds means absorption collection specimens quantification methods effects lead toxicity discussed,C21,0.006717202,0.0059584933,0.012533602,0.0037741216,0.009353491,0.008668899,0.3783325,0.006316938,0.004856238,0.006600045,0.103224024,0.04632727,0.06241848,0.015444921,0.0059069376,0.042976707,0.069065645,0.0069176042,0.0076485225,0.04291809,0.11223251,0.034897346,0.00691041
studies b lymphocyte dysfunctions severely burned patients studied vitro functional parameters peripheral blood b lymphocytes severely burned patients n burn injuries ranging tbsa number b cells remained unchanged b cell proliferation induced staphylococcus aureus strain cowan sac normal even enhanced early late phases postburn showed marked suppression second fourth week similar pattern observed pokeweed mitogen pwm sac stimulated synthesis immunoglobulin igm whereas igg production decreased whole postburn period monitored cytokine interleukin induced b cell activation indicated expression cd surface antigen impaired throughout second fifth week parallel release proteolytic cleavage product scd represents b cell growth differentiation factor reduced data provide evidence activation proliferation differentiation processes b lymphocytes impaired severely burned patients may contribute enhanced susceptibility infection sepsis,C21,0.013483087,0.002042032,0.029450877,0.0012934273,0.00320553,0.014073174,0.1652062,0.0021648745,0.0016642788,0.0022618982,0.01144779,0.015896995,0.039403528,0.14572616,0.0020243637,0.014725889,0.10211778,0.058516447,0.0026212211,0.062167488,0.27389255,0.00081737386,0.035797063
public support policy initiatives regulating alcohol use minnesota multi community survey public support policies control alcohol sales consumption surveyed seven minnesota communities total women men asked indicate level support opposition nine different proposals designed regulate alcohol general support policies strongly related characteristics respondents type policy proposed women significantly supportive items men marriage older age low alcohol consumption also associated support education voter status generally policies activities serve primarily protect youth received strongest support restrictions prohibitions limiting advertisements less popular least support expressed increases taxes alcohol measures would eliminate existing practice prohibiting wine cooler sales convenience stores majority respondents also indicated felt individual opposed manufacturer retailer responsible problems associated alcohol focus intervention strategies shifting focus individual environmental regulatory control discussed,C21,0.0024375173,0.0021621995,0.0142556075,0.0013695844,0.0033941655,0.028949166,0.34362215,0.0022922708,0.0017622164,0.0023950038,0.049355756,0.012813903,0.067272425,0.01855483,0.0021435542,0.003802889,0.024769176,0.0025102387,0.08537402,0.19036253,0.13699521,0.00086547376,0.0025401248
cranial electrostimulation ces use detoxification opiate dependent patients paper reviews scientific literature cranial electrostimulation ces non chemical means alleviate opiate withdrawal symptoms ces involves applying small amounts electrical stimulation electrodes applied skin surface cranium paper summarizes major theories gate endorphin chinese acupuncture attempt explain ces may help alleviate drug withdrawal craving two studies reviewed show ces patients experienced severe withdrawal early part treatment comparison groups methadone patients studies show ces patients better methadone patients findings studies reviewed however limited low participation rates high dropout rates difficulties blinding subjects evaluators absence standardized procedures equipment evidence reviewed suggests ces promising line inquiry continued efforts develop nonchemical ways detoxify opiate dependent individuals improved research designs larger sample sizes integrity data collection improved data analysis needed future,C21,0.023830475,0.0019219137,0.040125504,0.0012122513,0.014552006,0.029378345,0.38973826,0.0020290061,0.001559828,0.0021266243,0.021536125,0.014882746,0.03672055,0.0053568175,0.0018973136,0.0034076734,0.11454624,0.0022219406,0.027825184,0.09963695,0.15206756,0.011203809,0.0022229045
excess injury mortality among children united states comparison recent international statistics using data national center health statistics world health organization child injury death rates us compared canada england wales france netherlands norway except canadian figure overall us childhood injury mortality greater childhood injury mortality rates countries studied year injury mortality steadily declined countries whereas us rate appears increasing attention specific causes reveals much difference explained motor vehicle injuries homicide every childhood age group us death rates due drowning firearms homicide poisoning fire among highest excess us injury mortality largely attributable deaths among children younger older years age vulnerable groups countries especially high rates among us minorities account little observed differences many injuries mortality rate us nonblacks several times reported comparison nations behavioral strategies inadequate deal excess death rates magnitude limiting exposure regulation handguns greater use public transportation affordable accessible day care among measures implemented,C21,0.0821921,0.0018010464,0.01359757,0.0011407865,0.0028391827,0.0026203084,0.17111462,0.001909392,0.0014678728,0.03148341,0.023754904,0.024362661,0.07839392,0.005106093,0.0017854631,0.022813598,0.056628786,0.0021076805,0.021967048,0.35473332,0.09536876,0.0007209134,0.002090587
motor unit numbers contractile properties spinal cord injury number motor units thenar muscle group estimated patients cervical spinal cord injuries surface electromyogram twitch force response maximal stimulation median nerve divided average surface electromyogram twitch single units average single unit size obtained intramuscular microstimulation motor nerve branches graded whole nerve stimulation provided three independent estimates two based electromyogram one based force motor unit estimates patients covered wide range essentially normal motor units numbers contractile properties others varying reductions numbers units patients showed large reduction motor unit numbers also greatly enlarged units produced average sixfold normal force enlarged units summed produce maximal compound action potentials twitches sometimes indistinguishable normal magnetic resonance imaging scans cervical spine obtained patients provided independent evidence patients low motor unit counts sustained direct injury anterior aspect spinal cord relevant segmental levels patients showed normal number motor units long injury evidence transneuronal degeneration could demonstrated thenar group patients current techniques,C21,0.046593577,0.0016398209,0.09100637,0.009979294,0.022015223,0.0113213435,0.1287836,0.0017384675,0.05503103,0.0018163807,0.08589996,0.03959519,0.084108405,0.014696665,0.0016256324,0.012121517,0.13610998,0.0019060341,0.011040439,0.049504388,0.19090521,0.00065637886,0.0019050977
discharge videotaping means augmenting occupational physical therapy regional burn centers commonly receive patients medical facilities geographically distant logistic problems may hamper follow care burn center lead decrease function result contractures hypertrophic scar formation inexperience part therapists community facilities serves intensify problem discharge videotaping respect physical occupational therapy programs means documenting range motion time discharge providing visual documentation therapy program followed outpatient basis video tapes forwarded outlying community hospital therapy department order accomplish goals,C21,0.0032408638,0.002874808,0.02172528,0.0018209092,0.0045128004,0.0041825036,0.36434078,0.0030733268,0.0023430004,0.003184339,0.061942,0.027071731,0.033168137,0.007451747,0.002849934,0.005046699,0.2383828,0.0033375525,0.030932928,0.116329946,0.057703126,0.001150713,0.0033340813
leakage fluid administered epidurally rats subcutaneous tissue epidural catheters implanted rats halothane nitrous oxide anaesthesia contrast medium iopamidol injected via catheter fluoroscopic control h implantation rats contrast could seen leaking epidural space usually microliters administered leakage associated diminished antinociceptive response morphine administered via catheter leakage decreased response morphine could largely prevented applying drop supa glue site entry catheter epidural space time catheter implantation investigators using epidurally cannulated rats document leakage occur discard results rats showing evidence leakage,C21,0.0031912585,0.018278161,0.006048044,0.001793038,0.0044437265,0.0041184854,0.16706723,0.003001098,0.0023071377,0.0031355987,0.10081807,0.060601253,0.056748625,0.039106596,0.0028063122,0.02035028,0.04829697,0.0032986822,0.003633717,0.10730582,0.33923376,0.0011330999,0.003283049
comparison familial nonfamilial male alcoholic patients without coexisting psychiatric disorder family history alcoholism presence additional psychiatric disorder male alcoholic patients associated earlier onset problem drinking greater alcoholism severity poorer clinical outcomes assess relative contribution family history alone sample male alcoholics positive psychiatric disorder selected divided family history alcoholism fh family history alcoholism fh among first degree relatives although fh alcoholics reported younger age onset problem drinking greater severity alcohol related sequelae differences extensive pronounced found previous study sample psychiatrically heterogeneous patients penick et al bi dimensional typology alcoholism incorporating additional psychiatric diagnoses positive family history alcoholism suggested,C21,0.003190521,0.0028301512,0.021396328,0.0017926235,0.0044426993,0.0041175336,0.35775504,0.0030004045,0.0023066045,0.034024753,0.12503915,0.022664923,0.029177958,0.007638823,0.0028056635,0.0049683047,0.10219014,0.0032857077,0.0036328775,0.1963967,0.06292799,0.0011328381,0.0032822902
alcohol trauma endemic syndrome injuries pervasive costly problem alcohol use appears important risk factor injury examined blood alcohol levels selected demographic epidemiologic variables recorded trauma patients trauma center month period total trauma patients admitted trauma center period male injured vehicle related incidents blood alcohol levels patients measured alcohol present blood patients blood alcohol level done level higher mg per dl conclude level alcohol involvement trauma high involvement must addressed medical community health care system,C21,0.03257142,0.0027047014,0.005689299,0.0017131633,0.004245771,0.0039350186,0.27079976,0.0028674079,0.016955847,0.002995917,0.028762657,0.0062714103,0.10582884,0.0074592116,0.017440658,0.0047480785,0.13965075,0.0031400644,0.032981366,0.1514614,0.1535578,0.0010826236,0.0031367987
screening psychiatric substance abuse disorders clinical practice psychiatric disorders particularly depression alcohol abuse represent large burden illness society many individuals disorders receive care health care providers mental health specialists evidence non psychiatric physicians frequently recognize disorders patients screening questionnaires introduced improve detection patients several studies found screening questionnaires increase detection rates important impact patient outcomes demonstrated review article outlines several reasons difficult discern improvement patient outcomes inadequate study design insufficient physician education interdependence psychiatric medical conditions vague treatment guidelines practical use current psychiatric screening questionnaires key areas investigation considered,C21,0.0027271155,0.0024190876,0.015785247,0.0147217885,0.0037983484,0.032398622,0.37971097,0.0025646125,0.001971583,0.0026795513,0.095667616,0.0071001216,0.019665536,0.006289748,0.0023981566,0.046929687,0.0931215,0.0028180636,0.055619415,0.14322872,0.064610675,0.0009682997,0.002805556
analysis potential risks associated sodium chloride resuscitation traumatic shock published erratum appears arch surg jan evaluated potential side effects rapidly infusing ml either sodium chloride sodium chloride per dextran using lactated ringer control critically injured patients two prospective double blinded emergency department trials eight patients significant hyperchloremic acidemia association infusion hypertonic solutions eight moribund infusion many factors hyperchloremia could contributed acidemia blood chemistry changes might associated hypertonic solutions hyperosmolality hypernatremia made insignificant factors high blood alcohol levels concomitant administration sodium bicarbonate cases central pontine myelinolysis bleeding potentiated difficulty crossmatching blood anaphylactoid reactions occurred setting limited volume resuscitation solutions likely favorable risk benefit ratio,C21,0.0028793921,0.0025541645,0.005372647,0.001617813,0.0040094624,0.0040027485,0.31114933,0.0027078153,0.0020816724,0.002829172,0.03142341,0.0507336,0.18608415,0.008047691,0.0025320647,0.0049992683,0.08685315,0.0029652966,0.04480423,0.13469428,0.10366744,0.0010223675,0.002968835
age effect prognosis functional recovery acute traumatic central cord syndrome purpose study determine age significant functional recovery acute traumatic central cord syndrome ccs recovery ambulation adl status bowel bladder function evaluated retrospective study tested hypothesis functional recovery consecutive ccs patients better younger patients older patients four patients years died ability ambulate independently discharge compared patients younger years patients years older results showed younger patients ambulatory compared seven older patients p less younger patients also able achieve independence self care bowel bladder function significantly greater proportion prognosis functional recovery acute traumatic ccs consider patient age prognosis less optimistic older patients considerably favorable younger patients previously reported,C21,0.0022515578,0.001997244,0.0042011733,0.0012650584,0.0031352227,0.0029057525,0.079921596,0.0021173921,0.001627776,0.0022122876,0.022072293,0.0046310984,0.06906611,0.005256485,0.012848151,0.0035061436,0.22041303,0.002318731,0.024336591,0.27451217,0.2562884,0.0007994463,0.0023163196
early detection myocardial contusion complications patients blunt trauma myocardial contusion remains elusive clinical entity consumes disproportionate amount scarce expensive critical care resources purpose cardiac monitoring study attempts define group patients high risk identified available data present time admission patients admitted suspicion myocardial contusion year period retrospectively studied records examined history physical findings electrocardiographic ecg results creatine kinase levels injury severity score iss echocardiographic findings diagnosis myocardial contusion made patients ecg consistent acute injury increased creatine kinase mb abnormal echocardiogram consistent acute injury patients stratified two groups group patients satisfied criteria myocardial contusion group patients lacked sufficient evidence substantiate diagnosis records examined presence factors available emergency room might predictive myocardial contusion complications total patients evaluated found myocardial contusion group patients placed group myocardial contusion group patients abnormal admission ecg p less iss greater equal p less multivariate analysis identified two factors predictive myocardial contusion abnormal ecg iss greater two predictors absent probability myocardial contusion predictors complication myocardial contusion identified data suggest combination easily obtained variables emergency department used select patient population high risk myocardial contusion prospective evaluation variables necessary,C21,0.026126204,0.02172194,0.01124679,0.00094561983,0.010760873,0.01450865,0.31031713,0.0015827317,0.001216748,0.0016536652,0.07997015,0.06847286,0.029846122,0.00439232,0.009636978,0.0026208109,0.20568278,0.0017332308,0.001916365,0.11776067,0.06740929,0.0087428065,0.0017352308
extensor indicis proprius transfer rupture extensor pollicis longus tendon reviewed patients ruptures extensor pollicis longus mean years transfer extensor indicis proprius tendon transfers described result good two fair mean deficit extension operated unoperated thumbs cm mean flexion deficit cm pressure gauge measurements showed strength transfer uninjured extensor two fair results extensor lag cm independent extension index maintained patients none discernible lag strength index extension reduced normal finger evidence functional loss extensor indicis proprius transfer rupture extensor pollicis longus tendon simple reliable procedure complications gives satisfactory long term extension thumb,C21,0.0037072387,0.0032870884,0.0069143414,0.0020820484,0.023063768,0.004782323,0.14717993,0.0034848296,0.020607073,0.03951204,0.035593033,0.007861701,0.2205766,0.008897463,0.039111868,0.0057875426,0.23287895,0.0038178961,0.0042194175,0.08526345,0.096243456,0.0013157384,0.0038122267
trend toward nonoperative management splenic injuries treatment splenic injuries evolved past decade reflect effort conserve function spleen records patients admitted year period identified documenting treatment splenic injuries collected data regarding patient age gender degree hemodynamic stability number units blood required severity splenic injury injury severity score results treatment adults age greater years pediatric patients age less years mean age groups years respectively males comprised group blunt injury occurred patients adults splenectomy splenorrhaphy laparotomy without operative treatment spleen nonoperative management observed time pediatric group time respectively using operative splenic repair techniques increased use nonoperative management splenic salvage rate increased last years without increase morbidity mortality incidence spleen salvage correlated severity spleen overall injury cardiovascular stability,C21,0.07606645,0.0019340003,0.025270788,0.0012249997,0.0030359444,0.0028429087,0.15014297,0.002050344,0.0015762317,0.0021422345,0.045634765,0.047980495,0.10924592,0.00506918,0.0019172665,0.0033951197,0.243048,0.0022523098,0.0130301295,0.17817724,0.08094562,0.00077413145,0.0022429721
tricyclic antidepressant overdose conservative management community hospital cost saving implications reports late onset cardiovascular complications following tricyclic antidepressant tca overdose led conservative approach patients many patients hospitalized continuous cardiac monitoring regardless clinical presentation management algorithms based clinical predictors outcome recently proposed used algorithm developed tokarski young retrospectively evaluate care tca overdose patients admitted hospital year period identified patients could treated outpatient basis algorithm employed ten admitted monitored unit spent mean hours unit none patients developed complications hospital stay use algorithm would resulted estimated cost savings hospital days,C21,0.002879527,0.002554284,0.03448984,0.0016178887,0.00400965,0.0037161794,0.3275369,0.002707942,0.0020817698,0.0028293042,0.113125235,0.0059230016,0.021693572,0.006671565,0.0025321832,0.004484022,0.29107115,0.0029654354,0.003278765,0.10842426,0.051422734,0.0010224154,0.002962351
methylene chloride report five exposures two deaths five patients presented emergency department ed following exposure enclosed space methylene chloride dichloromethane used removing paint two workers three rescuers involved two rescuers complained dizziness mild nausea subsequently discharged ed one rescuer asymptomatic worker arrived cardiac arrest eventually died ed despite resuscitation efforts worker also presented ed cardiac arrest successfully resuscitated pulse blood pressure however never regained consciousness spontaneous respirations died fourth day interest worker carboxyhemoglobin level increased hours following admission despite administration oxygen endotracheal tube among conclusions drawn cause death patients carbon monoxide poisoning solvent induced narcosis carboxyhemoglobin levels may continue rise following cessation exposure despite administration high flow oxygen rescuers easily become victims proper protective clothing respirators worn,C21,0.0031906255,0.002830244,0.005953376,0.017226163,0.004442845,0.019553356,0.32027313,0.003000503,0.0023066802,0.0031349768,0.031618625,0.006562507,0.13164084,0.007382624,0.0028057555,0.020393338,0.14416903,0.0032858152,0.019072063,0.06167198,0.1850702,0.0011328752,0.0032823978
pathologic synovial plica knee results conservative treatment observations cases pathologic synovial plica knee analyzed regard etiology symptoms results conservative treatment results obtained conservative treatment good cases average poor opinion results justify treatment condition physical therapy proceeding surgical correction objective physical therapy decrease compressive forces anterior compartment knee increasing structural flexibility flexor extensor muscles increase flexibility obtained instituting stretching exercises hamstrings gastrocnemius quadriceps,C21,0.0039929086,0.022870127,0.0074503534,0.0022434525,0.005559999,0.0051530567,0.36919174,0.0037549797,0.041545115,0.024707576,0.08363491,0.00821265,0.07992111,0.00918093,0.022820944,0.025367122,0.07766079,0.0041120336,0.004546514,0.056112956,0.1363947,0.0014177368,0.004148322
skiing snowboarding injuries schussing pain downhill cross country skiing snowboarding growing rapidly popularity ever increasing number participants physicians must prepared deal injuries specific sports important physicians need use epidemiologic data advise patients methods minimize risk injury participate healthy vigorous winter sports,C21,0.08725843,0.004986081,0.037688263,0.00316027,0.007827023,0.0072541544,0.2622654,0.005286028,0.004063711,0.0055229333,0.05306083,0.038756955,0.0713881,0.055281054,0.004942939,0.008753019,0.113440365,0.005788667,0.006400301,0.12297196,0.08605442,0.0019958022,0.0058532543
alcohol use depressive symptoms among mexican americans non hispanic whites alcohol use associated depressive symptoms several studies using data community survey study examined whether relationship accounted ethnic sociodemographic differences among persons engage various levels alcohol use b differs mexican americans n non hispanic whites n using large quantities alcohol among men daily drinking associated depressed mood associations similar mexican americans non hispanic whites associations quantity frequency depression independent among women cultural demographic characteristics high quantity drinkers abstainers tended mexican americans accounted association alcohol use depression among men suggestion unemployment unmarried status mediated association alcohol quantity depression people drank greater quantities alcohol per occasion reported somatic depressive symptoms frequent male drinkers reported types depressive symptoms,C21,0.0027638031,0.0024516312,0.0051569697,0.0015529573,0.0038494794,0.06680103,0.21712047,0.0025991139,0.05551619,0.0027155988,0.034481652,0.005725826,0.04126762,0.0071807164,0.0024304187,0.0043808515,0.024208711,0.002975244,0.029898547,0.31039026,0.17270833,0.0009813261,0.0028432987
flumazenil benzodiazepine antagonist although benzodiazepines proven safe effective induction maintenance sedation instances require reversal events prior natural process metabolism elimination flumazenil imidazobenzodiazepine antagonist reduce terminate benzodiazepine effects dose dependent manner antagonist acts competitive inhibition benzodiazepines central nervous system receptor sites administered intravenously incremental doses flumazenil allows optimal patient response individual basis despite short elimination half life small doses flumazenil usually effective producing benzodiazepine reversal flumazenil short duration activity due rapid hepatic metabolism elimination intravenous antagonist doses mg followed mg min total dose mg produced significant results reversing benzodiazepine sedation much mg flumazenil necessary treating benzodiazepine mixed agent intoxications situations response rarely exceeds duration one hour resedation occurs additional doses infusion antagonist may provide desired response flumazenil well tolerated locally well systemically nausea vomiting occurring anesthesia documented adverse effect placebo treatment populations however significant difference occurrence vomiting placebo compared flumazenil treated subjects careful observation slow reversal central nervous system depression crucial avoidance benzodiazepine withdrawal patients dependent upon agents flumazenil appears provide mechanism safe effective reversal benzodiazepine induced sedation,C21,0.040528376,0.0014018794,0.0029498688,0.008528614,0.0022006345,0.009685766,0.26689923,0.0014862121,0.0011425472,0.009190227,0.032319,0.07608979,0.05154531,0.023161113,0.008931781,0.04198821,0.08075832,0.011337545,0.017099917,0.0752357,0.19709696,0.0005611369,0.03986183
pulsed carbon dioxide laser ablation burned skin vitro vivo analysis pulsed lasers produce efficient precise tissue ablation limited residual thermal damage study efficiency pulsed co laser ablation burned normal swine skin studied vitro mass loss technique heats ablation normal burned skin j cm tissue ablated respectively mean threshold radiant exposures ablating normal skin eschar j cm j cm respectively radiant exposures greater j cm produced plasma decreased efficiency laser ablation thus radiant exposures efficient ablation range j cm within radiant exposure range microns tissue ablated per pulse also examined gross histopathologic basis vivo burn eschar excision pulsed co laser laser allowed bloodless excisions full thickness burns backs male hairless rats zone thermal damage approximately microns subjacent fascia pulsed co laser ablate burn eschar efficiently precisely bloodlessly may prove valuable excision burned necrotic tissue,C21,0.0023821038,0.002113045,0.038970523,0.0013384069,0.1070944,0.003074229,0.15713921,0.0022401593,0.001722155,0.0023405568,0.030535523,0.0049330695,0.13519761,0.005827329,0.025151765,0.003709431,0.16838756,0.0024623773,0.0027123755,0.06472429,0.23463868,0.00084579847,0.0024594257
hippocampus parahippocampus schizophrenia suicide control brains published erratum appears arch gen psychiatry may recent postmortem studies schizophrenia shown abnormalities medial temporal lobe structures including hippocampus parahippocampus tried replicate previous studies explore specificity finding schizophrenia anterior hippocampus parahippocampal cortex evaluated area shape postmortem tissue schizophrenic nonschizophrenic suicide nonpsychiatric control brains significant differences found hippocampal area parahippocampal cortex significantly smaller schizophrenic group control group parahippocampi right left sides analyzed separately suicide schizophrenic groups smaller parahippocampi right side controls corrected suicide group exhibited greater parahippocampal areas left right tissue samples within group difference exist schizophrenic control groups study demonstrated changes temporal lobe structures schizophrenic nonschizophrenic suicide groups,C21,0.029921612,0.029604074,0.0052266326,0.001573845,0.003900891,0.0036150143,0.18450746,0.056876022,0.0020250978,0.0027522824,0.030909752,0.11458128,0.15384266,0.006666352,0.00246325,0.004361954,0.056918792,0.018938994,0.0031895074,0.02649373,0.22696573,0.0009945823,0.03367053
fatal high cervical spinal cord injury automobile accident complicating os odontoideum report case spinal instability incomplete fusion dens c os odontoideum allowed anterior displacement skull first cervical vertebra following right frontal impact pillar automobile accident resultant crushing laceration spinal cord occurred level c c without either radiographic investigation detailed examination spine fatal injury might overlooked death attributed acute alcoholic poisoning blood alcohol level,C21,0.055512726,0.0046096803,0.009696393,0.028063675,0.0072361585,0.05701753,0.23600282,0.030041877,0.0037569404,0.0051060054,0.07800661,0.010688498,0.10297486,0.011948683,0.004569795,0.008092252,0.115721755,0.005351679,0.020566868,0.06569108,0.13215287,0.0018451385,0.005346113
submersion netherlands prognostic indicators results resuscitation study objectives analyze prognostic indicators outcome resuscitation submersion victims drowning near drowning design retrospective study setting intensive respiratory care unit january december submersion victims admitted files victims available statistical analysis male victims female victims average age years ten salt water fresh water submersions measurements main results predictors better survival potentials young age submersion less ten minutes signs aspiration central body temperature less c admission detect factors accelerated decrease core body temperature admission assume lethal hypoxia preceded protective hypothermia submersion victims orlowski score predictive value time found nonindependent indicators score neurologic outcome patients treated according brain protection protocol worse outcome published authors used protocol thirty three percent victims cardioventilatory arrest victims ventilatory arrest survived resuscitation discharged five nonarrest victims died due late complications conclusion study shows indicator rescue site hospital absolutely reliable respect death survival,C21,0.012936461,0.012488034,0.035722196,0.01177409,0.003036406,0.0033377165,0.1935373,0.0020506554,0.012121282,0.023251288,0.042731643,0.046316426,0.091854975,0.01740559,0.043439064,0.0033956359,0.1607644,0.013387862,0.023068052,0.17278817,0.07155948,0.00077424914,0.0022590614
endotracheal tube cuff pressure assessment pitfalls finger estimation need objective measurement estimation endotracheal et cuff pressure finger palpation one methods currently used clinical setting compared accuracy method instrumental intracuff pressure measurement tracheal model tests members icu team four different et tubes three different pressure levels examined accuracy estimated method finger palpation high pressures normal pressures low pressures observed differences terms sensitivity specificity positive predictive power different tubes reflecting differences tube characteristics interobserver variability conclude precise intracuff pressure measurement mandatory prevent complications underinflation,C21,0.0029200339,0.016724495,0.0054484806,0.001640648,0.046443835,0.003768456,0.13788809,0.0027460353,0.0021110545,0.016956659,0.14809881,0.006052667,0.28882426,0.0067481953,0.030832667,0.0045471,0.043898188,0.0030078779,0.017449833,0.038144562,0.17170721,0.001036798,0.0030040233
penetrating injuries abdominal aorta charts consecutive patients penetrating injuries abdominal aorta reviewed attempt identify prognostic factors mechanism injury gunshot wound gsw per cent cal greater cal shotgun wound sgw per cent stab wound sw per cent overall mortality per cent gsw per cent cal greater cal per cent sgw per cent sw average initial systolic blood pressure isbp survivors nonsurvivors ns eighteen patients isbp one survivor thirty patients isbp less three survivors six emergency department ed thoracotomies performed five patients surviving reach operating room none surviving long term ten patients died ed surgical intervention six within hr seven greater hr postop average time injury minutes minutes survivors minutes nonsurvivors p less minutes dying minutes surviving dying postop ns surgery six patients thoracotomy celiotomy control thoracic aorta three surviving two surviving long term survivors associated injuries nonsurvivors ns significant difference noted number location associated injuries survivors nonsurvivors,C21,0.07324871,0.037343632,0.0045486237,0.001369683,0.003394516,0.0033345781,0.08994192,0.0022925073,0.013532323,0.002395251,0.030268362,0.017339908,0.15089503,0.0061084535,0.013938298,0.0037961132,0.3933408,0.0025104978,0.0027757585,0.1096871,0.034564473,0.00086556317,0.0025078868
toxicological screening three year experience poisonings kuwait results toxicological screening body fluids urine blood gastric lavage pediatric patients analyzed period january december cases approximately one half positive least one foreign substance one fifth cases multiple substances detected commonly implicated drugs acting central nervous system including barbiturates tricyclic antidepressants phenothiazines benzodiazepines carbamazepine,C21,0.0048319343,0.0042861667,0.009015888,0.0027148668,0.0067283153,0.0062358626,0.2923434,0.0045440095,0.0034932734,0.004747659,0.18293893,0.0333197,0.07985819,0.03627165,0.026188266,0.0075243264,0.15621954,0.004976091,0.0055018677,0.048129648,0.07337681,0.0017156443,0.0050379885
whole bowel irrigation treatment zinc sulfate overdose year old boy ingested approximately zinc sulfate tablets znso mg tablets spontaneous emesis ipecac induced emesis orogastric lavage abdominal radiograph performed four hours ingestion still demonstrated approximately znso tablets within stomach three pills within colon whole bowel irrigation begun polyethylene glycol lavage solution peg golytely administered nasogastric tube within one hour patient began producing rectal effluent contained pills patient remained asymptomatic throughout whole bowel irrigation stool guaiac tests negative serum chloride however increased meq l follow kidney ureter bladder studies demonstrated clearance zinc tablets gastrointestinal tract next hours,C21,0.0035785304,0.003174335,0.0066771666,0.0020106302,0.004983993,0.02192607,0.19114736,0.034824483,0.0025871182,0.024144795,0.0735224,0.025657717,0.07473451,0.009226885,0.0031468694,0.005572516,0.102161735,0.038315058,0.0040746834,0.05945032,0.30404103,0.0012706061,0.0037711873
pulmonary functional impairment associated pleural asbestos disease circumscribed diffuse thickening define pulmonary functional impairment associated pleural asbestos signs pas compared men circumscribed plaques diffuse pleural thickening chest roentgenograms irregular opacities ilo pneumoconiosis criteria age matched asbestos exposed men without roentgenographic signs men unexposed asbestos men white spirometry total thoracic gas volumes tgv measured expressed percentage predicted white michigan men modeled spirometric values thereby adjusting height age current ex smokers duration smoking asbestos exposed men never smoked reduced fef p less increased tgv p less compared unexposed men men pas never smoked reduced flows p less fvc p less tgv p less compared age matched asbestos exposed men asbestos exposed current smokers normal chest roentgenograms compared unexposed smokers reduced expiratory airflows p less reduced fev p less increased tgv p less current smokers pas additional air trapping reduced vital capacity thus pas associated significant pulmonary dysfunction men never smoked current ex smokers additional dysfunction even adjustment duration smoking,C21,0.03013897,0.0017009607,0.0035779455,0.001077392,0.0026701249,0.0024927196,0.11024826,0.0018032853,0.03851339,0.04828441,0.04421001,0.0039440296,0.19999887,0.01386703,0.0016862648,0.04011663,0.03980561,0.0019751668,0.0021834103,0.24802518,0.16099916,0.00068085163,0.0020003193
case report severe ethylene glycol intoxication normal osmolal gap chilling thought case year old male presenting altered sensorium vomiting right flank pain despite normal osmolal gap found suffering ethylene glycol intoxication little described presentation result clinician failing consider ethylene glycol causative agent,C21,0.0061459206,0.0054305573,0.011423096,0.003439726,0.00852475,0.037513163,0.24711551,0.06502938,0.0044259643,0.0060152663,0.091858156,0.012591871,0.06407863,0.015596748,0.0053835697,0.06880303,0.09398457,0.0063269488,0.006970846,0.12325705,0.10761345,0.0021737148,0.006298132
frostbite methods minimize tissue loss frostbite treated successfully direct indirect effects injury must understood rapid rewarming helps preserve tissue limiting amount direct cellular injury selective management blisters helps protect subdermal plexus application aloe vera cream eg dermaide aloe cream combats local vasoconstrictive effects thromboxane oral administration ibuprofen decreases systemic levels thromboxane,C21,0.0493103,0.0040946486,0.008621339,0.0025935587,0.0064276746,0.07254705,0.30042788,0.00434097,0.0033371837,0.004559024,0.043574,0.031836838,0.043561105,0.011317976,0.0040592197,0.029530974,0.04498335,0.004753745,0.0054245135,0.038627047,0.2796838,0.0016389843,0.004748801
alcohol protects diaphragm dietary restriction recently reported alcoholic rat diaphragm develops greater contractile force diaphragm pair fed control animals present experiment examines whether alcohol dietary restriction likely cause surprising finding conditioned rats using liquid diet containing ethanol calories ten pair fed control animals received equal amount isocaloric ethanol free liquid diet ten ad libitum control animals unrestricted access lab chow water rats killed weeks left costal diaphragm strips studied vitro optimal length using direct stimulation supramaximal voltage isometric force measured divided muscle cross section compute stress maximal tetanic stresses developed muscle pair fed controls systematically less alcoholic ad libitum control values p less depend temperature degrees vs degrees p greater pair feeding increased twitch half relaxation times p less shifted tetanic stress stimulation frequency relationship leftward hz p less diaphragm pair fed rats continued generate lower stresses fatigue caused repeated contractions p less conclude dietary restriction associated pair feeding compromises diaphragm performance rats chronic alcohol consumption prevents reverses changes since diaphragm function alcoholic ad libitum control animals different,C21,0.0017111612,0.0097996555,0.019738123,0.0009616652,0.0023827378,0.018734317,0.18040133,0.018173845,0.09234675,0.0016813164,0.017638404,0.029376607,0.14011724,0.004471094,0.03463931,0.002664634,0.018230429,0.0017622124,0.0019484088,0.05863301,0.33045575,0.0006075712,0.01352438
treatment digitalis intoxication emphasis clinical use digoxin immune fab many studies cases digitalis intoxication reported since time william withering first publication recognition management digitalis toxicity challenging digoxin immune fab commercially available treatment consisted managing signs symptoms toxicity digitalis eliminated digoxin immune fab offers safe effective specific method quickly reversing digitalis toxicity factors must considered clinical use agent include dosage calculation administration technique postdose monitoring pharmacokinetics mechanism action interference commercially available digoxin assays partial neutralizing dosing rebound free digoxin indications use severe life threatening toxicity digoxin immune fab treatment choice,C21,0.003523028,0.0031196307,0.023545792,0.0019759806,0.004897117,0.038537525,0.43269718,0.020324131,0.0025425337,0.003455522,0.06480395,0.0072335103,0.02251683,0.033111297,0.0030926384,0.005476483,0.0538364,0.0036217833,0.004004463,0.11575708,0.12983496,0.0012487094,0.020843435
extending intramedullary rods congenital pseudarthrosis tibia five patients boyd type ii congenital pseudarthrosis tibia underwent excision pseudarthrosis double onlay bone grafting stability maintained extending intramedullary rods clinical union achieved cases mean months range six rods extended range growth occurred one rod removed infection vascularised free fibular graft subsequently performed extending rods provided stability union occurred require revision legs grew rods removed easily jeopardized surgical options,C21,0.0045152586,0.00400526,0.008425004,0.0025370927,0.07185439,0.0058271764,0.3252873,0.0042462037,0.0032643308,0.004436507,0.07558231,0.009287024,0.03955776,0.05500089,0.0039706044,0.0070311967,0.23259254,0.0046499674,0.005141286,0.050769296,0.07577023,0.0016032043,0.0046451315
dyskinetic movements cognitive impairment negative symptoms elderly neuropsychiatric patients presence absence tardive dyskinesia cognitive status psychopathology assessed group elderly male psychiatric patients n nursing home setting twenty five patients found tardive dyskinesia associated greater degree cognitive impairment negative symptoms finding related obvious macroscopic organic pathologies less prevalent dyskinetic patients fact patients frontal lesions primarily lobotomies significantly lower prevalence tardive dyskinesia,C21,0.0043259445,0.0038373286,0.008089789,0.0024305717,0.026965447,0.026369017,0.31384516,0.0040681707,0.0031274653,0.0042817285,0.04478668,0.029843124,0.10079712,0.010066768,0.0038041265,0.0067363954,0.14749864,0.0044550058,0.005075473,0.18132052,0.062289197,0.0015359857,0.0044503724
subxiphoid pericardiotomy versus echocardiography prospective evaluation diagnosis occult penetrating cardiac injury diagnostic subxiphoid pericardiotomy sp presently advocated diagnosis occult cardiac injuries patients stable vital signs juxta cardiac penetrating chest wounds approach however results reported negative pericardial exploration rate investigate reliability bedside two dimension echocardiography echo predicting cardiac injury compared sp prospective study undertaken patients stable vital signs admitted penetrating chest wounds located within space bounded manubrium nipples subcostal line initial evaluation patients bedside echo found accuracy specificity sensitivity predicting cardiac injury false negative findings patient consented sp hours bedside echo performed reliability bedside echo compared sp significantly different according kappa measure reliability data suggest bedside echo expeditious reliable method diagnose occult cardiac injuries initial assessment patient stable vital signs penetrating chest trauma approach may allow selective use sp patients positive bedside echo could eliminate unnecessary surgical procedures,C21,0.061439484,0.0021621669,0.016344912,0.0013695209,0.02726113,0.0031456957,0.24131401,0.0022922363,0.013550678,0.0023949677,0.13481914,0.005014301,0.08676658,0.0056438074,0.002143459,0.003795664,0.27649385,0.0025433192,0.0027754302,0.018731551,0.07484505,0.0008654608,0.01428763
reappraisal pancreatic duodenal injury management based injury severity evaluated effectiveness treatment protocols pancreatic duodenal injuries according severity injury patients survived initial injury pancreatic injuries without ductal involvement occurred patients treated drainage late deaths occurred pancreatic injuries ductal disruption occurred patients treated pancreatic resection abscesses developed seven patients late deaths occurred nineteen patients duodenal injuries without pancreatic injury duodenal complications occurred simple closure sufficed injuries affecting duodenal circumference wounds affecting duodenal circumference treated suture closure alone adjunctive duodenal tube decompression reserved wounds affecting greater duodenal circumference closure tension associated injuries head pancreas pyloric exclusion rarely necessary patients,C21,0.18604612,0.026704963,0.016889907,0.0014200163,0.0035192582,0.00326168,0.2126627,0.002376753,0.0018271634,0.01470526,0.012538267,0.0051982813,0.031162731,0.0058344644,0.00222249,0.0039356137,0.29927316,0.0026027542,0.07627534,0.04299008,0.045055583,0.00089737104,0.002600047
medical education alcohol drug abuse united states initiatives individuals private foundations government led improvements united states medical education dealing alcohol drug related problems progress made particularly past years developing new medical school curricula faculty development greater activity national professional organizations helped raise priority training alcohol drug related areas undergraduate postgraduate medical education example project adept alcohol drug education physician training primary care brown university providence rhode island described importance positive motivated faculty role models skills training emphasized,C21,0.0037060215,0.003287426,0.0069150515,0.0020822622,0.0051605175,0.0074755214,0.3849351,0.0034851874,0.0026792884,0.03147146,0.052622873,0.0076225777,0.047089126,0.036523286,0.021195868,0.005771046,0.097377114,0.0038165876,0.004627509,0.17273417,0.09429349,0.0013158736,0.003812618
long term therapeutic use benzodiazepines ii effects gradual taper compared effect withdrawal severity acute outcome per week taper short half life vs long half life benzodiazepines benzodiazepine dependent patients patients unable tolerate taper permitted slow taper rate ninety percent patients experienced withdrawal reaction rarely mild moderate nonetheless long half life short half life benzodiazepine treated patients unable achieve drug free state difficulty experienced last half taper baseline personality high eysenck neuroticism female sex mild moderate alcohol use found significant predictors withdrawal severity daily benzodiazepine dose benzodiazepine half life findings suggest personality factors contribute significantly patient difficulties gradual benzodiazepine discontinuation therapeutic doses benzodiazepines,C21,0.0028396687,0.0025189277,0.005298527,0.001595494,0.003954149,0.003682089,0.26850024,0.0026704588,0.002052954,0.016524153,0.013180902,0.005840813,0.052922335,0.007173939,0.0024971329,0.0044219545,0.17499012,0.030375717,0.0032333804,0.17326745,0.21852994,0.0010082632,0.0029213463
scapular manipulation technique reduction acute anterior shoulder dislocations anterior shoulder dislocations common occurrence busy emergency departments numerous techniques treating problem reported majority techniques use traction leverage humerus often requiring considerable force causing significant patient discomfort report simple relatively painless atraumatic method shoulder reduction involving manipulation scapula well humerus technique used emergency department considerable success complications,C21,0.0043268567,0.003838138,0.008073466,0.0024310844,0.006025011,0.005584034,0.25877148,0.025006635,0.02406905,0.06708583,0.11999859,0.008899517,0.08107646,0.00994878,0.0038049286,0.0067378157,0.1419971,0.004455945,0.004926763,0.098077536,0.1088774,0.0015363096,0.0044513107
brief intervention strategies harmful drinkers new directions medical education recent advances technology behavioural interventions harmful drinkers created new role clinical practice new challenges medical education several reports expert committees recommended new initiatives secondary prevention alcohol problems physician based interventions primary care level conceptual scientific bases recommendations discussed terms recent studies harmful hazardous drinkers behavioural principles thought account effectiveness brief interventions explained despite promising developments difficulties inherent introduction new technologies especially behavioural technologies medical practice major challenge medical education development academic programs teach skills competencies secondary prevention also deal socialization physicians behavioural practitioners,C21,0.003400399,0.10178287,0.006344792,0.0019105455,0.004734948,0.004388392,0.47689292,0.0031977764,0.002458337,0.0033410918,0.024073523,0.006993971,0.02118698,0.007828087,0.002990225,0.0052951286,0.047346696,0.0035018472,0.06905019,0.086254105,0.11232161,0.0012073581,0.003498205
effects methylpyrazole methanol ethylene glycol antidote healthy humans methylpyrazole mp inhibitor alcohol dehydrogenase may useful treatment methanol ethylene glycol intoxications placebo controlled double blind multiple dose sequential ascending dose study performed determine tolerance mp healthy volunteers oral loading doses mp followed supplemental doses every h days producing plasma levels therapeutic range slight transient elevation one serum transaminase values observed subjects treated mp effect dose related apparently mediated hypersensitivity reaction serum triglyceride levels increased mp treated subjects also placebo subjects mp treatment produce significant changes objective clinical parameters subjective side effects results suggest mild transient increase liver function tests might observed subjects treated multiple doses mp nevertheless slower elimination rate lesser degree toxicity mp would make preferable ethanol therapy poisonings,C21,0.00213543,0.0018942329,0.024695717,0.001199811,0.0029735186,0.01304082,0.25857654,0.002008184,0.0015438207,0.0020981852,0.059122674,0.035400763,0.15813145,0.0056096883,0.012178048,0.012303794,0.04672167,0.0022565967,0.033439755,0.042430498,0.27927306,0.0007582136,0.0022075346
assessing nutritional needs burned patient assessment nutritional needs following thermal injury remains important adjunct providing dietary therapy designed minimize detrimental effects hypermetabolism subsequent catabolism anthropometric measurements frequently utilized nonburned patients relatively little usefulness assessing burned individuals energy expenditure adequately estimated patients direct calorimetry indirect calorimetry formulae direct calorimetry expensive complicated method use formula inexpensive least complicated yield good results clinical setting differences estimated energy expenditure multiple formulae may statistically significant rarely clinically significant therefore selection formula based simplicity estimations formula require readjustment intervals weeks general enteral feedings remain superior parenteral delivery nutrients finally current animal research suggests significant differences metabolic immunologic effects diet depending qualitative make dietary fat sources,C21,0.014072017,0.0021370954,0.039178304,0.0013536407,0.003354758,0.014974793,0.34066236,0.0022656566,0.013400822,0.025686717,0.094994776,0.0056787133,0.06272606,0.0055609173,0.025437782,0.050398614,0.10894272,0.0024810939,0.0028238252,0.04646882,0.13406658,0.0008554254,0.0024785134
outcome nonoperatively treated complete tears anterior cruciate ligament active young adults results nonoperative treatment patients complete anterior cruciate ligament acl tears documented examination anesthesia arthroscopy evaluated patients acute injury hemarthrosis previously normal knee patients meniscal repair excluded collateral posterior cruciate ligament tears associated fractures treatment cases consisted standard protocol early rehabilitation bracing detailed rating symptoms function performed average months postinjury range eight months overall results excellent good fair poor thirty five percent acl reconstruction follow period results indicate young adults return vocation requiring strenuous physical activity frequently expect unsatisfactory results nonoperative treatment acute complete tear acl,C21,0.029920494,0.00248471,0.00522655,0.015120088,0.0039004344,0.0036149574,0.24830085,0.0026341826,0.0020250662,0.0027602783,0.046659954,0.0057613146,0.04010541,0.0069255345,0.002463211,0.03147695,0.40970653,0.0028878278,0.0031894573,0.050397273,0.08056057,0.0009945666,0.0028837656
efficacy tetracaine adrenaline cocaine topical anesthetic without tetracaine facial laceration repair children published erratum appears pediatrics feb determine whether tetracaine component traditionally used tetracaine adrenaline cocaine tac necessary obtain effective topical anesthesia prospective study performed compare tac adrenaline cocaine preparations repair facial lacerations children physicians blind preparation used patients studied received tac sutures placed received adrenaline cocaine sutures placed anesthetic efficacy preparation approximately adverse reactions related administration either medication complications wound healing noted either group tetracaine component tac superfluous obtaining topical anesthesia minor dermal lacerations face children tac formulation simplified omitting tetracaine without compromising anesthetic efficacy,C21,0.0032403897,0.0028743874,0.084481694,0.048880316,0.00451214,0.0041818917,0.12445371,0.0030473017,0.0023426574,0.06593063,0.04707689,0.033688,0.02443669,0.0074980985,0.002849517,0.03641171,0.24557334,0.003337064,0.019369144,0.12426942,0.10705989,0.0011505446,0.0033345658
new orthosis central cord syndrome brachial plexus injuries proximal upper extremity weakness may develop secondary central cord syndrome due spinal cord injury brachial plexus injury functional deficits pain decreased upper extremity arm swing gait shoulder subluxation common sequelae injuries report describes new orthotic design easily fabricated two four hours readily available materials compensate deficits orthosis allows early participation activities daily living patients greater proximal distal upper extremity weakness orthosis consists figure eight shoulder harness unilateral bilateral forearm cuffs orthoplast connected harness flexible rubber tubing length tubing adjustable clamps connected forearm cuff allow variable arm positioning three patients aged two central cord syndrome one injury upper portion brachial plexus erb palsy described shoulder girdle musculature less biceps less triceps less hands less patients benefits use orthosis may include improved arm swing balance ambulation reduced shoulder pain subluxation increased independence tasks carrying lightweight objects lower extremity dressing bathing light homemaking leisure activities gardening,C21,0.07152755,0.029208617,0.044950288,0.0015532619,0.017227145,0.017243084,0.21254972,0.0026004142,0.0019986131,0.0027162873,0.044447117,0.005686056,0.084454015,0.0065302514,0.0024310348,0.0043049073,0.11012986,0.0028469807,0.0031477942,0.09306975,0.23755172,0.0009815749,0.0028440196
inadequate granulopoiesis major torso trauma hematopoietic regulatory paradox late postinjury sepsis largely result defective host defense including failure maintain adequate number functioning phagocytic cells study used stem cell culture techniques measure colony stimulating activity quantitated number circulating myeloid stem cells see defects granulopoiesis occur major torso trauma forty two acutely injured patients blunt penetrating injuries mean age years undergoing laparotomy abdominal trauma index studied prospectively blood samples obtained days patients segregated injury severity abdominal trauma index less n versus abdominal trauma index greater equal n severely injured abdominal trauma index greater equal patients fewer circulating granulocytes monocytes colony stimulating activity normal control levels patients decreased increased injury severity severely injured patients blunted bone marrow response significantly fewer circulating myeloid stem cells suffered major septic complications vs conclusion major trauma torso causes paradoxic depression granulopoiesis worsens increased injury severity may contribute late septic morbidity colony stimulating activity deficiency state similar seen major burns may amenable future modulation,C21,0.037314426,0.0104946485,0.0034188905,0.0010294972,0.0074362066,0.02009919,0.22250104,0.0017231216,0.0013246748,0.001800347,0.037273254,0.0037839767,0.14301346,0.08009873,0.0016112826,0.0028532795,0.15183562,0.01079515,0.0020863484,0.05817206,0.18102011,0.018389847,0.0019248362
improved trauma care rural hospital establishing level ii trauma center study motor vehicle accident deaths occurring napa county california showed preventable death rate deaths related central nervous system injuries developing level ii trauma center hospital preventable death rate decreased statistically significant total chi square less p less significant increase average injury severity score versus p less well significant improvements surgeon response time minutes versus minutes p less time hospital arrival start surgery hours versus hours less p less conclude changes indicative improved trauma care reflect favorably upon effectiveness rural trauma center meets level ii trauma center guidelines established american college surgeons committee trauma,C21,0.027670903,0.014833855,0.0048333392,0.0014554164,0.0036069914,0.04094986,0.19797276,0.0024360039,0.0018727134,0.0025451789,0.012879353,0.01933105,0.20684674,0.018482376,0.0022779412,0.016555898,0.1211669,0.0026676392,0.015471819,0.13638546,0.14617322,0.000919742,0.0026648648
genucom knee analysis system reproducibility database development genucom relatively new computerized system performs multidimensional analysis knee laxity therefore purposes present investigation twofold estimate reproducibility testing system ability obtain similar test values test subject within back back two test protocol develop database normal values standard values suspected ligament injury compared reliably determine whether fact ligament injury occurred reproducibility phase study subjects tested two trials eight tests yielding separate test values per trial accounting angle flexion plane force tested legs tested providing n test retest correlations two trials dependent tests indicated genucom provided generally stable reproducible results normal value database phase study different subjects given one trial eight tests testing legs provided n greater means standard deviations calculated test,C21,0.024588695,0.0020418395,0.004294979,0.0012933053,0.0032052274,0.0029856316,0.31486365,0.0021646703,0.012801279,0.013401003,0.26225868,0.0047944025,0.1396076,0.00538358,0.0020241726,0.025868563,0.03645972,0.0023723675,0.047194712,0.015796078,0.07340941,0.00081729674,0.0023731117
examination cloninger type type ii alcoholism sample men alcoholics treatment cloninger clinical method classifying alcoholics two groups types ii examined data obtained va hospitalized male alcoholic patients operational criteria cloninger clinical method subtyping alcoholics employs age onset problem drinking symptom clusters supposedly associated subtype marked overlap found symptom clusters used define two subtypes ninety one percent entire sample satisfied criteria symptom clusters dividing sample early onset type ii less equal years late onset type greater years alcoholism substantially reduce overlap symptom clusters e early onset late onset subgroups positive symptom clusters men could classified age onset type appropriate symptom cluster used separate patients hospital settings least findings suggest two group clinical alcoholism typology proposed cloninger basically reflects age onset problem drinking,C21,0.0021144238,0.0018746243,0.014255104,0.0011876123,0.0029427374,0.0027273553,0.30309525,0.001987396,0.0015278396,0.07159821,0.16764778,0.0379345,0.02601778,0.0049671796,0.0018584043,0.013518414,0.07660003,0.06355548,0.0024063308,0.14094086,0.058318175,0.00075036474,0.0021741104
effort rupture diaphragm effort rupture diaphragm rare accounts diaphragmatic injuries year old patient bilateral rupture followed sudden movement described,C21,0.045103867,0.006849546,0.014407919,0.0043385164,0.010752243,0.009965275,0.17934464,0.04463989,0.08031997,0.007587038,0.035511307,0.015882092,0.048134744,0.017754607,0.006790281,0.012024315,0.17527033,0.007952086,0.08355165,0.049340524,0.09641582,0.040119514,0.007943816
effects fluoxetine overdose patient fluoxetine prozac new antidepressant first marketed united states january limited toxicologic information fluoxetine overdose available goal prospective multi center study develop toxicity profile initial signs symptoms observed fluoxetine overdose standardized data collection form used patients ingesting fluoxetine reported four poison centers information obtained included age dose co ingested drugs presenting symptoms vital signs ekg abnormalities lab values cases acute fluoxetine overdose collected cases met criteria study ingested drugs including ethanol ingested fluoxetine alone latter group amounts ingested ranged mg observed remained asymptomatic sleepy sinus tachycardia beats per minute greater diastolic pressure mm hg data collection ongoing based upon initial experience fluoxetine overdose appears relatively benign,C21,0.0027271223,0.015618745,0.031476688,0.0015322587,0.0037974312,0.016711732,0.33225802,0.0025646188,0.001971588,0.016655153,0.108922,0.032025486,0.061615296,0.006340863,0.0023981624,0.0042466964,0.14747036,0.0028172894,0.0031052297,0.03911339,0.13645676,0.027367825,0.0028072929
shielding patient gonads intramedullary interlocking femoral nailing levels exposure radiation recorded sixty sites fifteen patients intramedullary interlocking femoral nailing radiation film dosimeters placed four gonadal sites subject standard male gonad cup pelvic drape millimeter thick lead equivalent put place shield gonads second set four dosimeters placed external shield approximate unprotected exposure total duration fluoroscopy averaged five minutes range thirty seconds fourteen minutes total exposure radiation external shield millirems male gonadal sites millirems female gonadal sites use gonadal shield exposure radiation measurable thirteen fifteen patients differences exposures shielded unshielded sites radiation statistically significant p less highest level gonadal exposure found treatment proximal femoral fractures use statically locked nails regardless conditions types fractures locations results demonstrated gonadal shielding justified,C21,0.0031417506,0.0027868894,0.0058621806,0.0017652988,0.0043753204,0.019148929,0.32140946,0.0029545403,0.047898736,0.0030869544,0.014794541,0.006693724,0.09369732,0.0072830375,0.002762971,0.004892359,0.16642809,0.0032713911,0.0036858753,0.15242374,0.12728928,0.0011155215,0.003232117
rapid visual colorimetry peritoneal lavage fluid study hypothesis visual colorimetry used rapidly precisely estimate erythrocyte count dilutions simulated peritoneal lavage fluid population fifty four normal adult human subjects methods automated chamber rbc count often used fluid obtained peritoneal lavage patients abdominal trauma help determine need surgery unfortunately method sometimes results excessive delay designed built simple colorimeter facilitated rapid direct visual comparison unknown samples known color standards radiograph view box used light source standards prepared mm glass tubes simulate peritoneal lavage fluid rbc counts ranging cell microl increments dilutions water used throughout reduce opacity thimerosal added unknowns standards stabilize color samples kept refrigerated c use double blind vitro study subject matched randomly distributed unknowns ranging erythrocytes microl nearest standard results mean absolute error determinations rbc microl ci sd df p less method correctly predicted rbc count within cells microl time conclusion visual comparison dilutions simulated peritoneal lavage fluid known color standards used rapidly precisely estimate erythrocyte count,C21,0.0018168594,0.01038188,0.07407396,0.0010206427,0.0025294817,0.0024195684,0.1742966,0.010494302,0.0013132814,0.05038338,0.11465654,0.034790277,0.17581615,0.029656772,0.0016021306,0.011551333,0.10273899,0.0018711522,0.013906318,0.044826772,0.12853767,0.009435716,0.0018802384
late versus early onset problem drinking older men age onset problem drinking studied older men age years older admitted va geriatric alcoholism outpatient treatment program demographics alcohol history self reported psychological status special treatment treatment compliance variables tested association onset age late onset defined onset first alcohol problem age uncommon occurring sample patients age older compared earlier onset cases late onset alcohol problems milder circumscribed associated less family alcoholism greater psychological stability late onset patients also compliant outpatient treatment requirements however treatment program variables better predictors compliance onset age,C21,0.0026570775,0.0280807,0.004957831,0.0014929035,0.0036998964,0.01628211,0.24097103,0.015351447,0.014774543,0.07979046,0.077828184,0.0054651005,0.034754287,0.019067116,0.015197979,0.004137622,0.08778488,0.0027363494,0.035765942,0.26818648,0.037341144,0.0009434317,0.0027335035
evaluation surgical treatment burst fractures authors instituted prospective randomized study patients presenting acute burst fractures thoracolumbar lumbar spine patients alternately treated posterior distraction using pedicle instrumentation ao fixateur interne anterior decompression instrumentation kostuik harrington device forty patients presented mean follow months preoperatively significant canal compromise patients measured patients undergoing posterior surgery patients undergoing anterior surgery postoperatively reduced respectively statistically significant difference two groups p less mean preoperative kyphotic deformity degrees patients treated anterior surgery degrees group treated posterior surgery last follow mean improvement kyphotic deformity degrees anterior group degrees posterior group statistically significant difference two groups two implant failures anterior kostuik harrington construct two implant failures ao fixateur interne blood loss significantly higher patients undergoing anterior surgery complications thoracotomy anterior decompression dural sac study supports hypothesis posterior distraction instrumentation effectively decompress canal correct kyphosis patients sustaining burst type injuries anterior surgery however results complete reliable decompression canal,C21,0.05322497,0.04401591,0.0032793228,0.0009859016,0.027893962,0.002300606,0.10768205,0.001650037,0.009750883,0.001723987,0.010286044,0.05015649,0.21866874,0.02282356,0.0015429416,0.0027322604,0.33086506,0.0018069361,0.010470669,0.051270414,0.04444121,0.0006229909,0.0018050568
coding external causes injury e codes maryland hospital discharges statewide study explore uncoded population examined trends hospital discharge e coding maryland year period overall proportion e coded discharges increased percent percent e coding lower severely injured elderly patients long hospital stays findings demonstrate e code reporting varies limited number data fields available coding discharge diagnoses universal systematic reporting e codes hospital discharge data essential data provide critically needed information nonfatal injuries hospital discharge data formats contain separate fields e codes use codes believe mandated,C21,0.035739012,0.019161697,0.02240236,0.0018797655,0.004659271,0.0043176925,0.18820229,0.0031462584,0.002418732,0.0032872648,0.1421746,0.0068812943,0.041185547,0.008759017,0.002942051,0.0052098213,0.18859835,0.0034454307,0.004173665,0.16020605,0.14650238,0.001187907,0.0035195323
laboratory tests follow treated alcoholics often testing repeated study group consisted male female alcohol dependent employed patients participated inpatient treatment alcoholism followed bimonthly eight months treatment period results ggt asat alat mcv combination ggt mcv studied respect effect taking tests eight months twice every four months four times bimonthly according definition treatment outcome good laboratory test values within normal range whole follow period differences observed outcome eight months treatment small whether one took tests end follow period four e bimonthly times nevertheless differences laboratory markers get accurate picture drinking follow period one repeat test bimonthly asat alat every four months ggt combined ggt mcv eight months mcv time course relapses important study frequent test taking also indicated,C21,0.0022515804,0.001997264,0.004201215,0.0012650712,0.014300079,0.0029329727,0.2534034,0.0021174133,0.0016277924,0.00221231,0.11275864,0.016406946,0.05362331,0.005251405,0.001979983,0.003506179,0.30291626,0.0023201334,0.0134453345,0.082018785,0.11634818,0.0007994544,0.002316343
serum urinary beta hexosaminidase markers heavy drinking serum urinary beta hexosaminidase shex uhex determined alcoholic men admitted inpatient detoxification treatment seven days teetotallers admission shex increased uhex seven days abstinence corresponding percentages shex uhex treatment shex decreased significantly uhex admission treatment uhex correlated positively shex r p less results suggest uhex may sensitive marker heavy drinking shex furthermore uhex stays longer elevated shex,C21,0.004615883,0.0040945187,0.07541405,0.0025934763,0.0066011823,0.0059570377,0.24883871,0.004340832,0.003337078,0.004535376,0.02122838,0.009951776,0.12439416,0.010734053,0.004059091,0.00718789,0.045582816,0.0047535943,0.0052558617,0.09923769,0.25620803,0.0016389324,0.04943953
detection alcoholism hospitalized schizophrenics comparison mast mac michigan alcoholism screening test mast macandrew alcoholism scale mac administered forty one schizophrenic inpatients also meeting dsm iii criteria either alcohol abuse alcohol dependence schizophrenic inpatients qualify additional substance abuse diagnosis marijuana abuse dependence mac failed differentiate alcoholic nonalcoholic groups groups scored recommended cutting score mast significantly differentiated alcoholic nonalcoholic schizophrenic patients sensitive history alcohol abuse alcohol dependence neither mast mac sensitive recent versus remote drinking overall classificatory accuracy mast found mac logistic regression analysis revealed use four mast items yield group classificatory rate concluded mast exhibited sufficient sensitivity specificity used initial screening instrument alcoholism schizophrenic patients,C21,0.0036402154,0.0032290528,0.041543093,0.0020452884,0.005108377,0.022310697,0.16671437,0.0034233027,0.0026317136,0.0035767253,0.21563284,0.14227474,0.06930891,0.008526905,0.020822186,0.005668572,0.13851155,0.022444839,0.0041449205,0.05000817,0.06338695,0.0012925082,0.0037540765
monoscleral fixation posterior chamber intraocular lenses cases posterior capsule rupture method monoscleral fixation posterior chamber intraocular lenses posterior capsule rupture described five lenses fixated technique reviewed,C21,0.089144826,0.0074026533,0.015571371,0.0046888557,0.011620496,0.01076998,0.19123836,0.007847974,0.006033244,0.008199698,0.15417887,0.017164584,0.05165863,0.019188307,0.007338602,0.01299529,0.11697953,0.008594224,0.0095022945,0.058481447,0.099056974,0.002963095,0.08938069
interaction whole bowel irrigation solution activated charcoal implications treatment toxic ingestions study objectives purpose study address issues safety efficacy combining whole bowel irrigation activated charcoal administration treatment toxic ingestions study design two vitro studies performed first serial ratios polyethylene glycol peg activated charcoal ac powders added water solutions analyzed peg concentration osmolality second serial ratios pharmaceutical bowel irrigation solution ac preparation combined constant amount salicylic acid solution osmolalities peg salicylic acid concentrations quantified results adsorption peg powder ac demonstrated however changes solution osmolality negligible thus concurrent administration therapies appears safe however combining bowel irrigation solution ac resulted decreased salicylic acid adsorption especially smaller amounts ac would pertain smaller doses ac used multiple dose charcoal therapy conclusion vitro data applicable overdose patients administration routine initial charcoal dose treated whole bowel irrigation would appropriate however unlikely addition multiple dose charcoal therapy whole bowel irrigation would provide additional benefit patient,C21,0.0020303405,0.0018010132,0.013595262,0.010965871,0.0028273393,0.0026386396,0.29248133,0.0019093567,0.0014678458,0.011803142,0.036717273,0.08280391,0.039894227,0.004892042,0.0017854301,0.022810504,0.09005654,0.03157276,0.021959143,0.05361413,0.2695578,0.00072090013,0.0020952162
loads lumbar spine work assembly line risks fatigue injuries vertebral bodies study performed attempt determine total spinal compressive load assembly line work find possible association many complaints back pain flexion analyzer used register trunk movements analysis postures lifted weights done video recordings load spine l level calculated biomechanical model meant analysis static sagittally symmetric postures lifting tasks maximum lift tests performed full work day peak load l l level lifting corresponded average load lift test mean load work cycle n concluded many complaints back pain could attributed high peak loads repetitivity lifts large load doses monotony stress low job satisfaction likely factors greater importance,C21,0.015928438,0.0024424759,0.12389895,0.0015322054,0.0038088069,0.019826818,0.2230376,0.0025645294,0.0019715193,0.0026794644,0.07680637,0.0056089736,0.10281555,0.006614625,0.041537505,0.0042465483,0.04301981,0.0028083858,0.0031051217,0.16823836,0.14372194,0.00096826826,0.002817726
chronic alcohol ingestion increases aortic lipid levels rats evaluated effects alcohol ingestion aortic lipid concentrations pair fed sprague dawley rats divided three groups five animals control rats fed liquid diet energy provided maltose dextrin days remaining two groups rats fed equivalent proportion energy alcohol days months alcohol fed rats exhaled significantly greater quantities ethane controls days months serum cholesterol levels increased triglyceride levels increased phospholipid levels remained unchanged alcohol fed rats compared controls aortic concentrations cholesterol phospholipids increased twofold threefold respectively alcohol fed rats corresponding alteration cholesterol phospholipid ratio time intervals tissue triglyceride levels elevated days differences aortic lipid peroxide levels detected alcohol fed rats controls results study indicate alcohol ingestion increases aortic cholesterol phospholipid triglyceride levels days cholesterol phospholipid triglyceride levels months mechanisms underlying accumulation lipids aortic tissue need elucidation,C21,0.002070971,0.0018370546,0.003864217,0.0011635942,0.0028837614,0.012652103,0.08916444,0.06209543,0.0014972199,0.0020348507,0.018019872,0.07124221,0.050652888,0.004872198,0.10206871,0.0032446634,0.060503464,0.0021327569,0.002358105,0.01523258,0.48753223,0.00073532655,0.002141375
diagnostic peritoneal lavage accuracy predicting necessary laparotomy following blunt penetrating trauma purpose study evaluate ability diagnostic peritoneal lavage dpl predict intra abdominal injuries required surgical repair retrospectively reviewed patients blunt penetrating abdominal trauma underwent dpls initial dpl patients sustaining blunt trauma sensitivity specificity accuracy positive predictive value ppv negative predictive value npv initial dpl patients penetrating trauma sensitivity specificity accuracy ppv npv utilizing final lavage results patients dpl sensitivity specificity accuracy ppv npv predicting intra abdominal injury requiring surgical repair,C21,0.040305704,0.0033469333,0.0070402245,0.0021199544,0.0052539306,0.00486939,0.15098706,0.0035482747,0.0027277877,0.0037072983,0.24607053,0.007971123,0.09157801,0.008727698,0.0033179743,0.0058755106,0.30214947,0.0038856736,0.004296236,0.024328785,0.072671115,0.0013396929,0.0038816324
salvage posterior urethroplasty failed initial repair pelvic fracture membranous urethral defects experience salvage urethroplasties patients pelvic fracture membranous urethral defects failed previous delayed urethroplasty presented total patients successfully managed stage procedures bulboprostatic reanastomosis tubed pedicled island skin substitution urethroplasty staged perineoscrotal skin tube inlay performed patients anastomosis could achieved either due excessively long urethral defect inelasticity anterior urethra precluding elongation anastomosis free tension successful result achieved patients rationale procedure selection discussed,C21,0.021737631,0.038464546,0.0067924554,0.0020453462,0.093129866,0.022310812,0.19648235,0.003423399,0.0026317877,0.021196928,0.05352699,0.007487438,0.046155207,0.008425156,0.0032014605,0.005668732,0.35405707,0.0037489238,0.0041450374,0.029163377,0.07051375,0.0012925446,0.0043992084
preventing alcohol problems survey canadian medical schools preparation national conference medical education prevention alcohol problems survey conference participants conducted participants undergraduate postgraduate representatives canadian medical school representatives provincial territorial alcohol drug agencies agreement physicians medical schools important roles prevention treatment alcohol problems traditional medical roles seen important current training variable seen inadequate time devoted treatment prevention correct situation renewed priorities faculty leadership needed respondents felt uniform standards assessing undergraduate students skills dealing alcohol problems provincial alcohol drug agencies underused medical education prevention treatment alcohol problems,C21,0.003516486,0.08823844,0.040597714,0.018995749,0.004896595,0.0045382082,0.40492836,0.0033069458,0.0025422627,0.020435546,0.035343133,0.007232739,0.02264587,0.0080854865,0.003092309,0.039519,0.053746857,0.0036213973,0.038047507,0.084263995,0.1075392,0.0012485763,0.003617631
toxic psychosis due chloroquine uncommon children toxic psychosis due chloroquine relatively uncommon occurrence childhood entity must kept differential diagnosis case unexplained psychosis resorting sophisticated array detailed investigations purpose familiarize pediatricians relatively uncommon entity authors encountered four cases psychosis wide variety symptomatology period past months,C21,0.039062466,0.0052729556,0.011091583,0.032103807,0.008277351,0.0076715234,0.215952,0.09191647,0.0042975172,0.092173345,0.11126533,0.012226439,0.03963612,0.0136679495,0.0052273315,0.009256626,0.11435484,0.006121719,0.0067685433,0.07802611,0.087404005,0.002110631,0.006115352
application tridimensional personality questionnaire population alcoholics substance abusers assess construct validity application cloninger tridimensional personality questionnaire tpq administered inpatient substance abusers one hundred seventy two patients alcoholic abused stimulants abused drugs primarily benzodiazepines marijuana polysubstance abusers sample female analyses conducted determine whether tpq scores could used classify alcoholics either cloninger type type ii examine intercorrelations tpq scales identify differences patterns due drug choice replicate previously obtained gender differences tpq results indicate tpq scores classify alcoholics expected frequencies type type ii scales independent give rise differences among drug user groups confirm previously reported gender differences results indicate cloninger model tpq must subjected careful empirical study prior widespread acceptance,C21,0.002842211,0.0025188231,0.005298307,0.0015956698,0.0039539845,0.003664588,0.33477703,0.002670348,0.0020528687,0.0165172,0.12008799,0.09433579,0.058767535,0.0067388653,0.0024970293,0.032238126,0.044941083,0.0029386603,0.003233246,0.117574185,0.13682118,0.0010082213,0.0029270987
major trauma outcome study establishing national norms trauma care major trauma outcome study mtos retrospective descriptive study injury severity outcome coordinated american college surgeons committee trauma north american hospitals submitted demographic etiologic injury severity outcome data trauma patients motor vehicle related injuries frequent twenty one per cent patients penetrating injuries overall mortality rate mortality rate direct admissions strongly related presence serious head injury head injuries less equal ais abbreviated injury scale greater equal ais respectively survival probability norms use revised trauma score injury severity score patient age injury mechanism patients unexpected outcomes identified statistical comparisons actual expected numbers survivors made institution results provide description injury outcome support evaluation quality assurance activities,C21,0.12618093,0.0018940548,0.003984116,0.0011996982,0.013308595,0.0028164128,0.2821983,0.0020079953,0.011870839,0.002097988,0.050302975,0.036063515,0.03645462,0.0055615567,0.0018776667,0.013653355,0.12641847,0.002198932,0.029444508,0.19601445,0.0411617,0.011092652,0.0021966451
arterial abnormalities shoulder athletes vascular lesions shoulder may misinterpreted one familiar shoulder abnormalities treating physician reporting athletes found symptoms related compression subclavian axillary artery tributaries nine amateur professional baseball pitchers severe arm fatigue finger ischemia secondary embolization presenting symptoms arm fatigue noted pitchers complete history physical examination including auscultation bruits functional positions athletes evaluated noninvasive tests doppler duplex scanning arteriography performed positional testing recreating overhead activity complete radiographic visualization dye digital arteries two patients found subclavian artery aneurysm remaining athletes found compression subclavian artery beneath anterior scalene muscle five patients axillary artery beneath pectoralis minor two patients arterial segments two patients one found arterial compromise level humeral head branch artery compression also noted one pitcher occluded posterior circumflex humeral artery embolization digit two patients subclavian aneurysms underwent saphenous vein bypass cervical rib resection athletes except one underwent resection cm segment anterior scalene muscle pectoralis minor muscles returned previous level activity except one patient developed impingement type symptoms required acromioplasty currently undergoing rehabilitation proper recognition vascular compromise upper extremity athletes essential avoid catastropic complications arterial thrombosis,C21,0.14688829,0.0017835422,0.0037516544,0.01111517,0.031989183,0.0027420116,0.2141886,0.016976966,0.04038457,0.0019902524,0.04750587,0.004135512,0.04280639,0.0049502873,0.011499949,0.003130992,0.23131904,0.0020706307,0.0022894146,0.0626497,0.113049604,0.0007139069,0.0020684772
bilateral simultaneous fractures femoral neck case report case bilateral fractures femoral neck resulting high voltage electric injury reported surgeons caring patients electrical injuries must aware possibility injury well skeletal injuries may result muscle contraction falls related electric shock without vigilance injuries diagnosis may delayed,C21,0.12180331,0.0042864536,0.0090164915,0.0027150484,0.0067287656,0.0062362803,0.25770596,0.027930615,0.026886815,0.028138615,0.068749964,0.00993903,0.082447335,0.0111108525,0.0042493655,0.00752483,0.06786227,0.004976424,0.005502236,0.1027149,0.09000289,0.048500314,0.0049712486
open versus closed diagnostic peritoneal lavage evaluation abdominal trauma two hundred forty two patients underwent diagnostic peritoneal lavage dpl month period one hundred sixteen patients randomized open lavage technique percutaneous closed guide wire procedure closed procedure required average minutes complete one operator whereas open method required two operators average time minutes p less technical complications occurred patients undergoing closed lavage patients undergoing open lavage p less fifty eight percent closed lavage complications related fluid return guide wire placement open lavage complications caused inadequate fluid return data support initial use percutaneous lavage open technique favored certainly used closed method fails direct visualization peritoneal cavity indicated physicians involved management abdominal trauma must familiar methods dpl,C21,0.01633256,0.002484755,0.005226645,0.0015738488,0.017459754,0.0036150229,0.23595932,0.00263423,0.0020251027,0.002752289,0.1008271,0.009151766,0.1307035,0.0064639477,0.0024632558,0.0043619643,0.34210575,0.0028847144,0.013348409,0.053254295,0.04049549,0.0009945846,0.0028817141
inhalation injury tracheal epithelium ovine model cotton smoke exposure early phase minutes purpose study evaluate lung cell injury acute phase smoke inhalation injury group sheep anesthetized halothane pancuronium followed endotracheal intubation first experiment sheep given air sham group insufflated cooled cotton smoke modified bee smoker second part study experiment animals insufflated following number smoke breaths x n x n x n x n sham control n min animals killed kcl trachea prepared scanning transmission electron light microscopy initial observation scanning electron microscopy revealed large amount mucus surface epithelia numerous ciliated cells sloughed epithelium observed surface remaining ciliated cells sloughed cells intact cilia remained apical cell surface light transmission electron microscopy revealed goblet cells process extruding mucus cytoplasm goblet basal cells appeared normal ciliated cells slightly vesiculated cytoplasm many process sloughed epithelial surface cells desmosomal attachment separated light microscope evaluation tracheal epithelium showed dose dependent effect four treatment groups,C21,0.040743828,0.001685392,0.0037991435,0.047040526,0.022706646,0.030041814,0.14988971,0.010975196,0.028933054,0.0018668586,0.0101190265,0.04890614,0.04617505,0.16566363,0.0016708093,0.022028811,0.042845897,0.0019624124,0.002163426,0.077692054,0.2404613,0.00067461986,0.0019546468
incidence lingual nerve trauma postinjection complications conventional mandibular block anesthesia trauma lingual nerve potential risk factor patients receiving mandibular block anesthesia paper describes results patient survey conventional mandibular blocks received adults incidence lingual nerve trauma postinjection complications reported along associated analysis duration complications procedures time incident side occurrence right left gender ratios addition recommendations patient evaluation treatment follow care discussed,C21,0.0034572375,0.01980085,0.006450847,0.0019424808,0.02154968,0.0044617453,0.22160353,0.03672352,0.0024994288,0.003396939,0.069950484,0.010096961,0.098876394,0.008527793,0.0030402075,0.038849045,0.20156446,0.0035603815,0.037402082,0.15386648,0.047584858,0.0012275395,0.0035670614
calcium carbonate gel therapy hydrofluoric acid burns hand hydrofluoric acid used extensively industrial cleaning agent metals glass many workers injured cutaneous contact acid exposed skin surfaces particularly hands hydrofluoric acid burns characterized delayed onset symptomatology skin ulceration severe pain may extended duration treatment hydrofluoric acid burns traditionally consisted local infiltration intraarterial injections calcium solutions injections painful frequently require retreatment new treatment utilizing topical gel calcium carbonate described nine patients treated hydrofluoric acid burns hand calcium carbonate gel applied topically covered occlusive glove dressings gel slurry compounded calcium carbonate tablets k jelly fingernails affected fingers removed subungual burn obvious gel put surgeon glove placed burned hand patient replaces glove slurry every hours hours first day glove discontinued unless resumption painful symptoms full range motion encouraged interval calcium carbonate gel technique successfully utilized nine patients need injection therapy patients pain relief obtained within hours treatment progression skin ulceration reconstructive procedures required patient one patient return full duty work within week long term sequelae burns treated topical therapy except one patient presenting hours burn developed digital tip neuroma excised,C21,0.0019182413,0.0017008946,0.020688057,0.0010773501,0.03979312,0.07672357,0.3112453,0.020358449,0.0013862479,0.021331199,0.016051186,0.076396756,0.018445319,0.017435422,0.0016861777,0.01226478,0.20932606,0.0019746798,0.0021833256,0.05321616,0.09213997,0.00068082515,0.0019769026
tardive dyskinesia managing common neuroleptic side effect neuroleptics useful medications treatment psychosis severe behavioral disturbances elderly unfortunately older patients high risk developing deleterious side effects medications especially persistent tardive dyskinesia td diagnosis risk factors cause treatment td discussed important careful assessment indications neuroleptic use monitor closely development td side effects work closely patient family making decisions neuroleptic use,C21,0.0039313505,0.022429237,0.0073527033,0.0022002836,0.0054530124,0.023995126,0.348591,0.0036948647,0.002831149,0.003847775,0.0393595,0.008054621,0.02535961,0.0358944,0.0034436989,0.0060981456,0.13549824,0.0040329094,0.004459029,0.22031495,0.087739214,0.0013904565,0.004028715
ao dynamic hip screw pugh sliding nail femoral head fixation compared laboratory conditions resistance cutting ao dynamic hip screw pugh sliding nail mean load cut adjusted bone strength greater pugh sliding nail reasons difference discussed,C21,0.03471621,0.0052729384,0.097415544,0.0033398897,0.008277324,0.036447287,0.22712867,0.005590142,0.033072095,0.034608584,0.05611236,0.012446164,0.11008939,0.013667905,0.0052273143,0.009256595,0.12456316,0.0061216988,0.006768521,0.08308312,0.078569084,0.002110624,0.006115332
stress surgeons sample members association surgeons great britain ireland circulated postal questionnaire relating occupational stressors type coronary prone behaviour mental health six hundred seventy two per cent useable forms returned anonymously major individual stressors interference job personal life general administration number patients clinics type behaviour similar professional groups surgeons showed mean scores significantly higher general population two subscales mental health index free floating anxiety hysterical anxiety findings female surgeons per cent similar men exhibit raised free floating anxiety levels,C21,0.0034008066,0.0030166851,0.022767384,0.0019110505,0.0047355155,0.0043889177,0.20830101,0.0031981596,0.0024586318,0.052694358,0.03258563,0.040391356,0.07616673,0.028339768,0.019451918,0.005295763,0.056328602,0.019959958,0.020324834,0.22257492,0.16699792,0.0012075028,0.0035026085
recovery morphine controlled release preparation source opioid abuse ms contin purdue fredrick norwalk ct controlled release preparation morphine sulfate demonstrated efficacy management chronic cancer pain problems recently come attention authors ms contin represents potential source opioid abuse extraction intravenous injection morphine preparation authors describe simple aqueous extraction method used quantitatively determine extent morphine could obtained ms contin tablets,C21,0.0044185943,0.0039195134,0.029633772,0.1094354,0.006153734,0.005702426,0.26124194,0.0041552996,0.003194447,0.0043415283,0.09215795,0.08144733,0.045374546,0.010159861,0.0038856003,0.028266435,0.0615773,0.025919765,0.0050312197,0.051712316,0.15615642,0.0015688823,0.0045456868
long term therapeutic use benzodiazepines effects abrupt discontinuation published erratum appears arch gen psychiatry jan compared effect abrupt discontinuation therapeutic doses short half life long half life benzodiazepines benzodiazepine dependent patients daily use greater year despite use mean daily dose mg diazepam equivalents notable residual symptoms anxiety depression present intake hamilton rating scale anxiety score hamilton rating scale depression score benzodiazepine intake stabilized weeks double blind assignment placebo n continued benzodiazepine use n clinical assessments performed daily including benzodiazepine plasma levels depending outcome criteria used anywhere patients judged experienced withdrawal reaction peak severity days short half life days long half life benzodiazepines relapse onto benzodiazepines occurred patients receiving long half life benzodiazepines patients receiving short half life benzodiazepines baseline predictors relapse nonpanic diagnoses higher benzodiazepine dose higher eysenck neuroticism score short half life higher daily doses associated greater withdrawal severity personality traits dependency neuroticism less education higher baseline levels anxious depressive symptoms patients able remain free benzodiazepines least weeks obtained lower levels anxiety benzodiazepine discontinuation results provide detailed picture symptoms time course multidimensional determinants benzodiazepine withdrawal syndrome,C21,0.001725229,0.009858783,0.0032190983,0.00930699,0.0024023266,0.018926717,0.24804565,0.0016224262,0.0012472637,0.0017011994,0.029424997,0.056214925,0.062294822,0.003966834,0.0015171227,0.0026865401,0.13426997,0.0017766998,0.018665375,0.14531514,0.24342448,0.00061256613,0.0017748519
lateral arm fascial free flap anatomy use reconstruction free fascial transfer used reconstruction gliding surfaces upper lower extremities thin pliable coverage required hand heel nose ear experience lateral arm fasciocutaneous flap found fascia alone excellent source tissue free flap transfer thorough investigation microscopic gross radiographic anatomy lateral arm fascia undertaken study fresh cadavers vascular pathways mapped locations analyzed correlated elevation design transfer flap lateral arm large fascial component located anterior posterior lateral intermuscular septum lies triceps brachialis brachioradialis muscles perfused posterior radial collateral artery prca one terminal branches profunda brachii vessel prca provides least four fascial branches cm proximal lateral epicondyle largest located average cm superior lateral epicondyle fascia x cm may used good axial perfusion histologic cross sections demonstrate complex anatomy fascia well relation nutrient vessels applied lateral arm fascial flap five cases upper extremity reconstruction also found flap valuable preservation underlying anatomic detail total reconstruction ear nose local tissue conventional flaps available,C21,0.060684085,0.012105786,0.03723335,0.0011879654,0.043975208,0.013183451,0.20637555,0.112826325,0.011760996,0.0020769949,0.059178416,0.01457662,0.08639617,0.019838894,0.0018589458,0.0032917247,0.123015456,0.0021769286,0.0024069443,0.023368884,0.13401072,0.000750556,0.02772003
subtrochanteric fractures retrospective analysis retrospective review patients treated eight year period subtrochanteric fractures average follow period months range six months comparisons fracture patterns fixation devices complications osteosynthesis made attempt identify fixation devices best suited treatment difficult orthopedic problem seinsheimer system classification used fracture risk identified long spiral fractures associated butterfly fragments osteopenic bone elderly patients occurred frequently complications osteosynthesis inherent instability despite theoretic biomechanical advantages offered intramedullary systems follow observations showed better results patients treatment extramedullary devices,C21,0.003190269,0.064438835,0.005952711,0.0017924821,0.0044423486,0.0042823562,0.29128975,0.0030001677,0.0023064225,0.0031346267,0.051666733,0.006561774,0.022964345,0.0073354137,0.018243076,0.020408772,0.31229827,0.003285448,0.0036325906,0.08544007,0.07991028,0.0011327487,0.0032905638
tertiary trauma care rural state trauma patients rural areas usually access regional trauma systems designated trauma centers efforts provide quality trauma care small hospitals may seriously overextend local capabilities urban trauma center retains important role trauma care even initial care must provided local level twenty five trauma patients transferred university hospital definitive care initiated community hospitals time period total trauma patients transferred trauma service information available total incidence trauma medical records reviewed determine reasons transfer major reasons included need complex surgery better critical care support inadequate blood banks trauma centers serving rural areas provide valuable resource well beyond initial hours,C21,0.002301958,0.013183258,0.0043790643,0.0012933763,0.0032054035,0.014080676,0.41470754,0.0021647892,0.012735006,0.0022618088,0.022277348,0.027018605,0.04114645,0.0052929125,0.0020244431,0.0035846273,0.1915401,0.002370635,0.031588323,0.116512336,0.0831458,0.0008173416,0.0023681694
relative biological effectiveness fractionated doses fast neutrons mevd normal tissues pig ii late effects cutaneous subcutaneous tissues late effects irradiation single fractionated doses x rays kv fast neutrons mevd bc cutaneous subcutaneous tissues pig evaluated measurements changes relative field length determined intervals weeks irradiation fractionated irradiation x rays average fractions exponent n obtained log log plot iso effect dose ed fraction number independent period assessment significant indication time factor however exponent n vary level effect range greatest greater equal reduction relative field length assuming validity linear quadratic model cell survival alpha beta ratio gy however model fitted data less well least severe levels damage alpha beta ratios significantly different zero irradiation fast neutrons showed small effect fractionation doses given greater equal fractions compared single dose significant increase iso effect dose dose given fractions compared fractions relative biological effectiveness late cutaneous subcutaneous damage energy fast neutrons used vary period assessment e weeks compared weeks significantly different previously obtained ischaemic dermal necrosis seen higher doses weeks irradiation,C21,0.001675919,0.01764107,0.035440344,0.00093797233,0.002324598,0.010227661,0.075724036,0.0015699316,0.0012069078,0.009702406,0.010576217,0.037471782,0.08729099,0.07882001,0.01290602,0.010782731,0.06508718,0.0017194437,0.0019195118,0.01736422,0.46713236,0.01675475,0.035723954
comparison resting energy expenditures caloric intake children severe burns nutritional support provided children severe burn injuries amounts derived empirical formulas measurements resting energy expenditure scrutinize methods indirect calorimetry measurements performed survivors burns greater equal total body surface area compared actual caloric intake percent weight change optimal caloric requirements formulated curreri shriners equations parameters showed spite initial deficit actual caloric intake compared formulated goals weight maintained whereas resting energy expenditures ranged actual caloric intake furthermore subgroup patients n met formulated needs stratified extent burn illustrated significant weight gain severely burned children conclusion nutritional formulas popular use overestimate caloric requirements severe burns whereas resting energy expenditure measurements require additional factor maintain body weight,C21,0.01673468,0.0024515437,0.0068485006,0.014923442,0.003907735,0.083248585,0.17015733,0.0026018682,0.0019980352,0.042854685,0.033547617,0.06317613,0.2136296,0.024065211,0.010734426,0.031047666,0.10979389,0.0028903328,0.003146884,0.05210776,0.092918485,0.014358435,0.002857166
alcohols methanol ethylene glycol isopropanol alcoholic patient attempt maintain altered mental status may ingest ethanol substitutes containing methanol ethylene glycol isopropanol subsequent clinical presentation emergency department highly variable depends ethanol substitute ingested time since ingestion concomitant ethanol abuse article describes clinical features intoxication ethanol substitutes early diagnosis therapeutic intervention may prevent irreversible sequelae rationale treatment interventions discussed,C21,0.004418657,0.06772042,0.008244756,0.0024826631,0.00615284,0.006066133,0.56163937,0.0041553588,0.0031944923,0.00434159,0.04171043,0.009088333,0.031982455,0.010568025,0.0038856554,0.006880768,0.0955652,0.004550484,0.005031291,0.05637122,0.059791952,0.0015689046,0.004589019
unusual type foreign body maxillary sinus broken end spear presenting foreign body nasopharynx right maxillary sinus year old papua new guinean described types foreign bodies mechanisms introduction site summarized,C21,0.008021335,0.0071153245,0.01496698,0.0045075794,0.011169455,0.010351951,0.4595003,0.007543361,0.005799068,0.007881433,0.037764087,0.016498353,0.05460575,0.018713288,0.00705376,0.012490887,0.13634837,0.008293455,0.00913347,0.051250566,0.0998911,0.0028480848,0.0082520535
subxiphoid pericardial windows helpful selected cases small group patients sustain multiple penetrating injuries present haemodynamic changes making difficult clinically exclude prove presence penetrating cardiac injury select group patients found subxiphoid pericardial windows extremely useful prove disprove existence cardiac injury thereby prevent delay diagnosing injuries,C21,0.08998531,0.02530896,0.008244702,0.0024826468,0.0061528,0.00570247,0.25291175,0.0041553313,0.0031944716,0.025729695,0.17349388,0.051871605,0.035775673,0.010850047,0.00388563,0.006880723,0.17978035,0.0045504547,0.0050312583,0.029473057,0.06842452,0.0015688944,0.0045457217
path bullet injuries determined radiography radiography commonly used find bullet pathways forensic pathology case presented man sustained multiple gunshot wounds one bullet could traced radiograph used find bullet showed interesting bullet pathway observing bullet pathway radiograph sometimes surmise victim body posture time incident,C21,0.03375001,0.0051253666,0.010781133,0.0032464177,0.00804567,0.007456799,0.28839225,0.005433693,0.0041772304,0.0056772158,0.10717292,0.011884224,0.04313199,0.102277055,0.0324202,0.008997534,0.08984594,0.005950373,0.006579093,0.07214336,0.1395158,0.0020515549,0.0059441845
relationship oxygen dose angiogenesis induction irradiated tissue study accomplished irradiated rabbit model assess angiogenic properties normobaric oxygen hyperbaric oxygen compared air breathing controls results indicated normobaric oxygen angiogenic properties normal revascularization irradiated tissue air breathing controls p hyperbaric oxygen demonstrated eight ninefold increased vascular density normobaric oxygen air breathing controls p irradiated tissue develops hypovascular hypocellular hypoxic tissue revascularize spontaneously results failed demonstrate angiogenic effect normobaric oxygen suggested oxygen sense drug requiring hyperbaric pressures generate therapeutic effects chronically hypovascular irradiated tissue,C21,0.0037729533,0.0033467978,0.04272888,0.0021198685,0.0052546235,0.004869193,0.21807571,0.0035923894,0.0027276773,0.0037071481,0.017754328,0.025632884,0.06521259,0.0120679615,0.00331784,0.024134168,0.04294771,0.0038870575,0.0042960625,0.08646678,0.41886628,0.0013396386,0.0038814752
anterior cruciate ligament injury evaluation intraarticular reconstruction acute tears without repair two seven year followup athletes evaluate effectiveness treatment regimen retrospectively studied surgically treated knees athletes aged years sustained acute acl tears treated ligament excision intraarticular bone patellar tendon bone reconstruction followed early motion emphasis full extension follow period ranged years patients available final followup minimum years reconstruction patients evaluated objective measures kt cybex lachman test range motion postoperative competition level subjective assessment scores pain swelling stability activity level walking stair climbing running jumping twisting subjective scores tabulated stability level total score activity level patients achieved full range motion kt measurements pound force revealed average difference mm injured noninjured knees patients firm endpoint lachman test cybex tests showed mean hamstring strength mean quadriceps strength sixty varsity athletes eligible play returned preinjury competition level following season one reconstruction failure eight chose continue competition academic reasons questionnaire score average maximum points normal athletic knee score concluded surgical procedure emphasis early full extension postoperatively achieved excellent results provided stable knee,C21,0.011303159,0.029820757,0.0036108869,0.0010873113,0.0317567,0.0024974796,0.19591051,0.0018198878,0.010761259,0.03731946,0.07136238,0.051018797,0.07303441,0.004662557,0.0017018217,0.0030135126,0.31819165,0.001995843,0.0022035125,0.017544594,0.1267055,0.0006871201,0.0019908648
effects acute chronic ethanol administration withdrawal level binding somatostatin rat brain acute ethanol administration resulted increase total number specific somatostatin receptors rat frontoparietal cortex hippocampus decrease level somatostatin like immunoreactivity hippocampus frontoparietal cortex chronic administration ethanol caused decrease number somatostatin receptors frontoparietal cortex hippocampus although level somatostatin like immunoreactivity unchanged brain areas week suppressing ethanol value specific binding tracer somatostatin receptors frontoparietal cortex significantly different control rats although actual number receptors slightly lower results suggest possible role somatostatin nervous system alcoholism post withdrawal reaction,C21,0.030334933,0.0025190702,0.005298827,0.0015955842,0.0039543724,0.0036649476,0.17715298,0.0026706099,0.00205307,0.002790299,0.013294137,0.0058685113,0.07084285,0.026197141,0.0024973634,0.018016856,0.033009414,0.09916139,0.09945006,0.043651827,0.35204056,0.0010083201,0.0029268921
osteogenic response distant skeletal injury tested hypothesis one bone skeleton injured others experience osteogenic response although similar related phenomena observed previously purposes study determine response reproducible characterize terms magnitude duration show related type injury sustained obtain information model used intramedullary nail implanted femur standard closed fracture subsequently produced osteogenic response measured histomorphometry eight four nine week old male sprague dawley rats divided seven groups twelve animals groups ii consisted control animals injury produced group iii rats cortical drilling intercondylar notch piriformis fossa right femur performed without intramedullary nailing groups iv vii half group received intramedullary nails half intramedullary nailing done closed transverse diaphyseal fracture produced two different fluorochrome labels rates mineral apposition measured left right tibiae animals labeling periods differed group designed determine peak response occurred long lasted whether aging course experiment affected response,C21,0.033846434,0.001934064,0.014599714,0.012100154,0.0030360443,0.0028413052,0.19245225,0.023158558,0.0015762836,0.002142305,0.043968767,0.110509105,0.070351005,0.043318518,0.0019173296,0.0033952317,0.041146412,0.0022453812,0.0024826296,0.090665,0.2992873,0.00077415694,0.0022520588
acute effects alcohol blood pressure young normotensive men alcohol acute effects arterial blood pressure bp examined separate effects alcohol bp fluid volume expectancy normotensive men divided three groups alcohol group received ml absolute alcohol kg body weight expectancy group expected alcohol received tonic control group expected received tonic age covariate significant changes systolic bp found alcohol group indicating changes systolic bp attributable subject expectancy volume fluid consumed expectancy control groups differ significant quadratic trend found systolic bp alcohol group suggesting alcohol may acute biphasic effect systolic bp initial decrease alcohol ingested followed increase toward basal level detoxication significant effects found diastolic bp,C21,0.0026419214,0.0022415365,0.016907321,0.013644254,0.003518707,0.003261169,0.09630468,0.0023763804,0.001826877,0.0024828832,0.012723573,0.14317133,0.23866144,0.005919988,0.0022221417,0.0039349967,0.03670995,0.0026023462,0.0028773115,0.11218795,0.2902864,0.0008972304,0.0025996396
traumatic disruptions thoracic aorta treatment outcome patients admitted level trauma center acute disruption thoracic aorta two patients died exsanguination aortic repair one patient massive leakage aneurysm aortography died surgery patients suffered multiple injuries eighty three percent patients major operations addition aortic repair clamp sew technique used patients two multiple tears aortic arch heparin coated shunts used five patients cardiopulmonary bypass performed one patient multiple tears three postoperative deaths related polytrauma cardiogenic shock sepsis paraplegia developed three patients two multiple aortic lesions necessitating longer ischemia time repair one patient complete neurologic deficit year follow series neither surgical procedure proved superior conclude clamp sew technique repair disrupted thoracic aorta may allow favorable outcome,C21,0.025432665,0.025165347,0.0044447375,0.0013384005,0.014847937,0.026099384,0.12187507,0.04836036,0.0017221468,0.0023405456,0.12758476,0.004899509,0.01644061,0.0054771663,0.002094752,0.0037094133,0.39874145,0.013741814,0.0027123627,0.101209834,0.048465356,0.00084579445,0.0024506089
hair dryer burns children three children burn injuries caused home hair dryers described one patient injury believed accidental two cases injuries deliberately caused caretaker lack prior experience hair dryer burns initially led suspicion causes characteristics case aided final determination accidental vs nonaccidental injury cases prompted testing home hair dryers determine heat output highest heat settings dryers rapidly generated temperatures excess degrees c dryers turned protective grills maintained sufficient temperatures cause full thickness burns minutes cases results testing demonstrate hair dryers must added list known causes accidental nonaccidental burns children,C21,0.06812805,0.0029675015,0.0554493,0.0018796215,0.0046589104,0.020498808,0.30142638,0.0031460174,0.0024185467,0.051874094,0.13156222,0.006880767,0.062586814,0.0076920167,0.0029418257,0.0052094217,0.08466556,0.0034451666,0.003809185,0.09225252,0.08187462,0.0011878159,0.003444833
pulmonary circulation burns trauma lung critical organ victims thermal injury multiple trauma since blood drains injured organs circulates pulmonary circulation passing organ lung therefore receive first volley cytotoxins released postinjury addition target injury lung may also contribute injury systemic organs injury may result reduced delivery oxygenated blood direct release cytotoxins systemic circulation injury lung may pulmonary microvasculature airway bronchial circulation responds injury marked elevation blood flow microvascular permeability latter effects may important mediating changes occur lung parenchyma,C21,0.11510588,0.002328566,0.017109731,0.0014749186,0.0036553238,0.06882584,0.21953672,0.015111398,0.014601873,0.0025792832,0.036302626,0.009875083,0.1665626,0.0062052486,0.015007922,0.0040877764,0.047590137,0.015405818,0.0029890258,0.03265035,0.19936123,0.0009320662,0.002700573
plasma noradrenaline platelet alpha adrenoceptors functional scores ethanol withdrawal plasma noradrenaline platelet alpha adrenoceptor density sites cell using h rauwolscine without phentolamine correlated withdrawal score hospitalized patients undergoing ethanol withdrawal control groups plasma noradrenaline patients admitted hospital elective gastroscopy laboratory workers accustomed venipuncture controls platelet alpha adrenoceptor measurements separate group normal subjects mean age close patients withdrawing ethanol plasma noradrenaline significantly higher patients undergoing ethanol withdrawal patients admitted hospital elective endoscopy twelve laboratory controls plasma noradrenaline levels significantly lower either patient group significant though poor statistical correlation existed ethanol withdrawal score simultaneously determined plasma noradrenaline level platelet alpha adrenoceptor sites cell reduced ethanol withdrawal compared normal controls platelet alpha adrenoceptor sites cell increased first hr ethanol withdrawal remained significantly lower control values change platelet adrenoceptors accompanied fall mean plasma noradrenaline thus stress hospital admission associated increase plasma noradrenaline ethanol withdrawal enhances increase accompanied probably causes reduction platelet alpha adrenoceptor numbers changes begin return towards normal within hr withdrawal reaction subsides,C21,0.0019912801,0.0017662044,0.0037151848,0.0011187175,0.0027725426,0.0025696172,0.15124223,0.0018724538,0.0014394762,0.001956372,0.010113522,0.064602144,0.2108176,0.037906315,0.011387445,0.0031005556,0.13492133,0.00206752,0.0022671595,0.0425425,0.29743788,0.000706967,0.0116849905
conventional radiographic computed tomographic findings cases fracture mandibular condylar process total patients fractures mandibular condylar process examined average months injury conventional radiologic examination consisted panoramic radiography lateral transcranial view fracture mouth open mouth closed positions sixteen patients fractures condylar process examined additionally computed tomography ct temporomandibular joint problems sagittal coronal projection computed tomography revealed bony changes fractured mandibular condyle position mandibular fossa exactly conventional radiographic examinations furthermore results showed disturbances position function articular disc may common earlier anticipated suggesting frequent use ct examinations evaluate temporomandibular joint changes condylar process fractures,C21,0.020537337,0.0031189097,0.0065605803,0.0019755238,0.10832819,0.0045709037,0.26078936,0.03734573,0.002541946,0.0034547234,0.22085546,0.007401652,0.048684314,0.00897862,0.0030922054,0.0054752175,0.10303439,0.003625277,0.0040035374,0.028738026,0.11202248,0.0012484208,0.00361718
use diazepam chloroquine poisoning year old patient found unconscious taken g chloroquine treatment consisted mainly gastric lavage diazepam experimental clinical evidence presented show diazepam varying doses significantly decreases mortality rate,C21,0.006306955,0.005594584,0.011768124,0.003543621,0.008782235,0.008139454,0.37373176,0.005931137,0.0045596478,0.006196954,0.029745022,0.043507516,0.07022811,0.014613421,0.0055461773,0.009821241,0.09058963,0.006495118,0.0071813962,0.09058346,0.18840669,0.0022393707,0.006488363
case management addictions treatment need case management addictions treatment systems recognized least years attention paid developing treatment component data available concerning implementation case management addictions becoming apparent lack consensus concerning provide case management defined paper reviews sources variability case management services identified mental health field discusses implications development case management addictions programs,C21,0.020870583,0.02048835,0.02398933,0.002009889,0.0049811536,0.0046165776,0.45967835,0.0033640529,0.0025861645,0.0035148202,0.13016772,0.00735764,0.034557972,0.008746281,0.0031457094,0.005570462,0.05572607,0.003697614,0.07082889,0.07744202,0.05171007,0.0012701378,0.0036801032
bilateral sacroiliac joint fracture dislocation case report bilateral sacroiliac joint fracture dislocation sacrum displacement rare injury found four injuries previously reported literature nonoperative management case led complete functional return acceptable alignment,C21,0.07674852,0.0063730367,0.013405588,0.0040366943,0.010004231,0.00927201,0.19133167,0.076315664,0.0051940954,0.007059223,0.070964925,0.014777206,0.044899784,0.016768198,0.0063178944,0.011187808,0.11465224,0.007398875,0.008180644,0.08423292,0.14137599,0.07211161,0.00739118
estimation amount alcohol ingested single blood alcohol concentration capillary blood alcohol concentrations bal measured young adult male volunteers received three different treatments alcohol total n related quantitatively dose alcohol ingested linear regression reasonably homogeneous variances found bal hr divided person body weight plotted versus g kg w dose error analysis indicated least error predicted dose w obtained bal measured hr post dosing latter case mean absolute error errors within errors within,C21,0.0035769779,0.003172958,0.0066742697,0.019317698,0.0049808286,0.0046162764,0.14034511,0.0033638333,0.002585996,0.003514591,0.07742491,0.040434092,0.15332474,0.008287429,0.055167343,0.0055700988,0.035769314,0.0036836942,0.0040729158,0.07763529,0.2376099,0.10516938,0.0037023744
nicotine dependence preventable risk factor diseases nicotine meets critical criteria addictive drug furthermore evidence would widespread compulsive use tobacco without nicotine findings led consideration cigarette contaminated vehicle addictive drug nicotine nevertheless nicotine may also used therapeutically reduce exposure carcinogens tobacco toxins nicotine replacement useful adjunct treating tobacco dependence example nicotine replacement form polacrilex resin chewing gum alleviate physically based signs symptoms tobacco abstinence fact form nicotine replacement attractive non users tobacco opened door use nicotine therapeutic modality permitting hope eliminating tobacco dependence,C21,0.0037763112,0.0033471372,0.0070406534,0.0021200834,0.0052542505,0.041391175,0.3981441,0.0035484908,0.002727954,0.0037075242,0.06322476,0.06254092,0.025058523,0.0097954245,0.0033181764,0.0059716585,0.11817748,0.0038859104,0.004296498,0.15466054,0.07278528,0.0013397745,0.0038874203
health locus control beliefs alcohol related factors may influence treatment outcomes treatment programs based treatment approach premise alcoholics exert internal control situations events affect since chronic alcohol use affects health individual walston walston multidimensional health locus control scale administered alcoholics treatment program population reflected higher belief health status control control chance powerful others however results indicated recovering alcoholics powerful health orientation tended maintain membership longer alcoholics anonymous would seek help sooner would begin heavy drinking later age would attempt formal treatment often,C21,0.00276362,0.0024634358,0.0051566283,0.0149231795,0.0038482533,0.03335052,0.3162183,0.0025989418,0.0019979742,0.0027175911,0.013073902,0.026283555,0.070198014,0.0066479915,0.0024302576,0.04441888,0.029651146,0.0028460703,0.11907044,0.19731495,0.0714507,0.000981261,0.02959442
asbestos content lung tissue lymph nodes pleural plaques former shipyard workers autopsy samples eight former shipyard workers collected lung parenchyma tracheal lymph nodes pleural plaques tissue respective area prepared modified bleach digestion technique residue collected micron pore polycarbonate micron mixed cellulose ester filter quantitation ferruginous bodies uncoated fibers done light transmission electron microscopy respectively differences asbestos burden noted site ferruginous bodies observed parenchyma nodes plaques three subjects found ferruginous bodies per gram dry weight lymph nodes lung parenchyma likewise subjects found uncoated fibers per gram nodes parenchyma amphibole chrysotile fibers noted lung extrapulmonary sites chrysotile predominant asbestiform plaques majority uncoated fibers nodes plaques less equal microns length however fibers dimensions conforming stanton hypothesis reached areas residual patterns likely reflect impact clearance lung burden opposed eventual accumulation stasis extrapulmonary areas,C21,0.002590925,0.0022982797,0.004834397,0.001455735,0.028649738,0.04097228,0.11725184,0.002436537,0.026907185,0.0025457358,0.064650185,0.03171447,0.09913552,0.080994,0.038329788,0.0040346086,0.095025234,0.0026914836,0.003389425,0.05692766,0.26453364,0.00091994327,0.027711375
mineralogic parameters related amosite asbestos induced fibrosis humans previously shown lungs group chrysotile miners millers grade interstitial fibrosis asbestosis directly proportional tremolite fiber chrysotile fiber concentration inversely proportional mean fiber length length related parameters compare effects commercial amphibole asbestos amosite parenchymal fibrosis histologically graded fibrosis four different sites lungs shipyard insulation workers heavy amosite exposure measured analytic electron microscopy fiber concentration size corresponding portions lung tissue fibrosis grade found strongly positively correlated amosite concentration negatively correlated mean fiber size parameters including fiber length width surface area mass comparison present results data chrysotile miners millers showed regression lines fibrosis grade versus concentration amosite chrysotile tremolite statistically different findings indicate amosite concentration like chrysotile tremolite concentration closely directly related fibrosis local lung level furthermore observations raise possibility short fibers may important commonly believed genesis fibrosis man last concentration comparison data indicate fiber fiber amosite fibrogenic chrysotile tremolite indirectly suggest tremolite fibrogenic chrysotile,C21,0.0019724143,0.00174963,0.04483543,0.0011082191,0.015873728,0.0417166,0.19618662,0.0018559,0.0014259678,0.0019380129,0.009671832,0.035157036,0.051700145,0.1147824,0.0017344914,0.022132473,0.037800957,0.022039948,0.002245884,0.061332617,0.33000734,0.0007003327,0.0020320322
porta hepatis disruption blunt trauma extrahepatic porta hepatis injuries blunt abdominal trauma exceedingly rare recently reported cases involve disruption common bile duct intrapancreatic portion herein report patient lacerations proper hepatic artery bile duct occurring deceleration torsion porta hepatis high speed vehicular collision,C21,0.06538179,0.06467962,0.011420322,0.033057105,0.00852268,0.007898896,0.32174614,0.035382446,0.004424889,0.006013805,0.057544924,0.012588813,0.043071333,0.014073047,0.005382262,0.03914886,0.08353593,0.006303157,0.0069691525,0.053609576,0.1107755,0.0021731867,0.0062966016
effects alcohol import aldehyde dehydrogenase precursor rat liver mitochondria previously showed incubation rat liver mitochondria alcohols resulted inhibition import aldehyde dehydrogenase precursor ornithine transcarbamylase precursor wang tty farres j weiner h arch biochem biophys time required inhibition import occur measured ethanol mm butanol mm degree degrees c required approximately min achieve inhibition butanol min ethanol substantiate membrane perturbing effects alcohols also examined effect oleic acid import found incubation mitochondria oleic acid microm resulted inhibition aldehyde dehydrogenase precursor import dose response fashion addition vitro effects alcohols import conducted preliminary study import protein liver mitochondria isolated rats fed ethanol found rate aldehyde dehydrogenase precursor import liver mitochondria isolated ethanol fed rats identical control results consistent finding activity amount aldehyde dehydrogenase mitochondria isolated alcohol fed control animals,C21,0.002558323,0.0022693602,0.07793475,0.0014374173,0.0035623838,0.0033016491,0.20813374,0.002405878,0.0018495537,0.0025137027,0.012040079,0.018172767,0.06464659,0.0060101477,0.0022497247,0.056042247,0.065818794,0.018830063,0.002913027,0.019505216,0.42426366,0.00090836757,0.002632551
treatment juxtaarticular nonunion fractures knee long stem total knee arthroplasty retrospective study ten patients juxtaarticular nonunions knee treated long stem total knee arthroplasty performed average age patients years old average follow months nonunions present average months six patients series prior total knee arthroplasty clinical union achieved ten patients patients improved ambulatory status range motion improved average preoperative range degrees average postoperative range degrees complications occurred three ten patients one postoperative infection surgical techniques described aid treatment difficult juxtaarticular nonunion fragments,C21,0.0031416973,0.0027868424,0.021449232,0.0017651916,0.004374714,0.004054524,0.1703435,0.0029544902,0.0022713074,0.0030869022,0.0188234,0.006461871,0.048199065,0.0072237323,0.002763057,0.004892276,0.43544388,0.0032354274,0.0035772845,0.120749414,0.12802865,0.0011155026,0.003258044
cyclosporine prolonging allograft survival patients massive burns cyclosporine csa immunosuppression used three patients massive burns prolong skin allograft survival cyclosporine kinetic studies patients burns revealed markedly accelerated blood clearance high variability drug absorption compared studies renal transplantation patients doses required maintain therapeutic levels varied widely patients receiving adequate maintenance therapy csa immunosuppression allograft tightly adherent without gross microscopic rejection indistinguishable autograft ultimately patients wounds permanently covered sequential autografts recropping limited donor sites unusual septic complications although prophylaxis opportunistic infections used disadvantage allograft use early rejection obligatory replacement permanent coverage autograft accomplished cyclosporine prolong allograft survival allow autograft coverage limited donor sites sequential fashion may lead increased survival patients massive burns,C21,0.002763715,0.0024515532,0.01851525,0.0015528188,0.03139478,0.016936319,0.30874947,0.0025990312,0.001998043,0.0027155124,0.013932548,0.037332118,0.057796523,0.0063546347,0.0024303412,0.017661953,0.27776498,0.03316787,0.0031468961,0.02062672,0.13628447,0.0009812948,0.0028432081
puffer fish poisoning regarded many delicacy puffer fish source lethal food poisoning humans syndrome caused tetrodotoxin one potent poisons known intoxication produces constellation symptoms paresthesias generalized muscle weakness common complaints treatment symptomatic often needs aggressive life support may required series mortality rate approached percent,C21,0.0049475934,0.004388762,0.009231696,0.02672466,0.0068893675,0.006385127,0.39222193,0.0046527768,0.027528573,0.004877256,0.024636146,0.010176254,0.03137774,0.021731155,0.004350789,0.007704432,0.10812312,0.029038876,0.0056335633,0.16097187,0.10144185,0.0017567107,0.0052097086
deranged vitamin metabolism normal bone mineral density finnish noncirrhotic male alcoholics study effect prolonged ethanol consumption calcium metabolism prevalence osteoporosis examined finnish noncirrhotic male alcoholics years age dietary interviews biochemical measurements measuring bone mineral content forearm using single photon absorptiometry spa bone mineral density spine humerus proximal femur using nonquantified computer tomography ct dual energy x ray absorptiometry dexa comparison two groups healthy controls studied mean daily dietary intake calcium g patients g controls dietary intake vitamin equal study groups serum levels calcium phosphate parathyroid hormone show difference patients controls alcoholics urinary excretion calcium reduced p less compared controls serum levels hydroxyvitamin dihydroxyvitamin dihydroxyvitamin reduced alcoholics p less p less p less respectively compared controls alcoholic men normal levels serum testosterone hypercortisolism bone mineral content dominant forearm measured spa similar study groups bone mineral densities bmd lumbar humeral areas measured ct bmd lumbar femoral neck ward triangle trochanter sites measured dexa differ either,C21,0.0022275497,0.001975724,0.004155906,0.0012514276,0.0031014413,0.0028744435,0.1207643,0.0020945775,0.0016102369,0.0021884507,0.024319999,0.0627872,0.22792795,0.05054125,0.0019586291,0.0034683654,0.06041411,0.0023428027,0.002536106,0.1574819,0.2608955,0.0007908324,0.0022913616
dealing geographic variations use hospitals experience maine medical assessment foundation orthopaedic study group orthopaedists physicians maine organized maine medical assessment foundation deal problem variations rates hospitalization orthopaedic conditions five musculoskeletal injuries five orthopaedic procedures selected study variation decision making orthopaedists least fractures ankle fractures hip greatest fractures forearm derangement knee lumbosacral sprain rates area tended consistently high low treatments major reasons variations appeared related lack agreement optimum treatment feedback data physicians variations patterns practice reduced variations,C21,0.02089329,0.0031729643,0.0066742836,0.0020097622,0.004980839,0.0046162857,0.39218023,0.0033638403,0.002586001,0.0035145981,0.017533377,0.024674006,0.16658634,0.0082245935,0.0031455106,0.00557011,0.103442565,0.0036837019,0.02138627,0.12546413,0.07134736,0.0012700575,0.0036798706
bronchial blood flow reduction positive end expiratory pressure acute lung injury sheep smoke inhalation increases bronchial blood flow qbr produces edema airway system study investigates whether increased qbr seen h inhalation injury affected mechanical ventilation peep cm h sheep n previously prepared cardiopulmonary catheters ultrasonic transit time flow probes mounted around bronchial arteries insufflated four sets breaths cotton smoke different levels peep added mechanical ventilation h injury peep level applied min significant increases qbr lung lymph flow ql associated marked decrease bronchial vascular resistance bvr h injury however change observed mean arterial pressure map cardiac index ci substantial reduction pao fio p f indicated deterioration arterial oxygenation application varying levels peep decreased qbr p less bvr increased p less ql p f ci map recorded removal peep none cardiopulmonary variables significantly different postsmoke control values findings suggest mechanical ventilation peep markedly decreases smoke induced hyperemia edema frequently seen inhalation injury without significant alterations map ci,C21,0.08050055,0.0016405197,0.02207787,0.018932292,0.0025752462,0.06504986,0.14618826,0.0017392084,0.010231912,0.010697314,0.03666264,0.0128200175,0.21065353,0.0042981654,0.0016263253,0.021350777,0.024340278,0.0019045866,0.0021126114,0.047268946,0.27476948,0.0006566586,0.0019029338
gasoline burns preventable cause thermal injury gasoline related burns significant cause thermal injuries year united states retrospective review admissions regional burn center persons gasoline related injuries natural gas distillates excluded victims male mean age years mean burn size total body surface area skin grafts performed patients deaths mean length stay decreased days p less first second year time periods even though significant change age mean burn size majority gasoline related burns result inappropriate unsupervised use gasoline general public largely unaware dangers gasoline education area needed,C21,0.048044167,0.002745337,0.015049203,0.016711848,0.022612667,0.018956842,0.15180649,0.0029104883,0.01720097,0.0030409282,0.016103745,0.0063656326,0.09025176,0.012814293,0.04728897,0.01978627,0.21426693,0.0031872413,0.003524007,0.18068238,0.10236699,0.0010988892,0.0031839265
two cases fatal atlantoaxial distraction injury without fracture rotation atlantoaxial injuries regardless mechanism typically result bony injury present two unusual cases fatal traumatic c c distraction without associated fracture rotation ligamentous anatomy common underlying structural medical predispositions possible mechanism injury discussed,C21,0.11766874,0.005125358,0.010781114,0.0032464121,0.035992417,0.06339667,0.35029203,0.0054336837,0.0041772234,0.005677206,0.08217196,0.011884204,0.035766765,0.013285364,0.033032842,0.008997519,0.050587118,0.005950363,0.006579082,0.064920574,0.07703764,0.0020515514,0.0059441742
murine model ethanol induced immunosuppression alcohol abuse associated increased susceptibility infectious diseases certain tumors basis observations effect ethanol immune system suggested used mouse model system male c bl mice fed either lieber decarli liquid diet containing ethanol sufficient supply total calories isocaloric control diet pair feeding design examine effect ethanol immune system group consuming ethanol containing diet maintained relatively stable levels blood ethanol days feeding consumption ethanol days resulted profound loss thymus spleen cells recovery thymus cellularity delayed relative recovery spleen cell numbers ethanol feeding discontinued proliferation spleen lymphocytes cell stimuli concanavalin alloantigens diminished however b cell proliferation lipopolysaccharide relatively unchanged mice fed ethanol containing diet also ethanol fed mice significant decrease primary antibody response sheep red blood cells independent antigen trinitrophenol ficoll occurred data establish murine model system means define effect ethanol immune system host defense mechanisms,C21,0.0020107378,0.0017836249,0.05222158,0.010847306,0.012533548,0.012426296,0.2025388,0.0018909222,0.0014536739,0.031175824,0.009890825,0.014048324,0.056333855,0.1870337,0.00176824,0.003133397,0.033506904,0.0020707266,0.0022895208,0.08408154,0.27416086,0.00071393995,0.0020858655
acute opioid physical dependence humans effect varying morphine naloxone interval ii previous studies demonstrated antagonist precipitated withdrawal min hr acute opioid administration nondependent human subjects purpose study examine longer postagonist intervals determine maximum interval agonist administration antagonist challenge precipitated withdrawal observed study nondependent male volunteers reported using opiates average times per week received naloxone challenges mg kg hr single injections morphine mg kg mg kg interval tested independently random order naloxone reliably precipitated withdrawal signs symptoms hr postmorphine withdrawal symptoms greatly diminished intensity hr postmorphine elicited postmorphine intervals longer hr withdrawal precipitation persisted somewhat longer pupillary constriction pupils returned predrug diameters hr postmorphine generally appeared correspondence offset agonist effects dissipation precipitated withdrawal study extends observations time course acute physical dependence effects begin within minutes acute morphine exposure dissipate within hr associated onset offset agonist effects require chronic opioid administration,C21,0.023536643,0.0019549052,0.014759858,0.0012382409,0.00306892,0.013499416,0.20265171,0.0020725064,0.0015932693,0.013670993,0.023963055,0.044999573,0.067996226,0.0056078197,0.023270192,0.0034451329,0.055601735,0.0022844772,0.002509382,0.08918177,0.4000253,0.00078249915,0.0022863694
scapular dislocation locked scapula report case year old woman presented emergency department pain inability move right shoulder falling backwards striking cart radiographs shoulder revealed dislocated scapula closed reduction ed successful rare case scapular dislocation serves emphasize heightened awareness injury necessary recognized treated appropriately treatment prognosis reviewed,C21,0.033751573,0.005125604,0.010781632,0.0032465681,0.008104441,0.03539493,0.300317,0.061378784,0.004177424,0.005677479,0.08215811,0.011884774,0.06440956,0.04381858,0.005081255,0.008997951,0.12463288,0.006029704,0.0065793977,0.07015605,0.100300215,0.0020516498,0.0059444597
identification driver automobile collision report three occupant automobile collision one two survivors claimed deceased operated vehicle attempted identify driver left face neck deceased appeared struck vehicle interior survivors slightly injured right side faces japan passenger side left case right side vehicle damaged comparing injuries deceased survivors relation vehicle damages concluded deceased occupant probably passenger driver,C21,0.02696325,0.09323777,0.008613224,0.0025936163,0.006427818,0.006201072,0.15971152,0.11607812,0.003337258,0.049216535,0.05569448,0.009494501,0.03586393,0.010613914,0.00405931,0.007188278,0.21311839,0.004753851,0.0052561453,0.05247309,0.12271602,0.0016390207,0.0047489065
selective monitoring patients suspected blunt cardiac injury blunt chest trauma result cardiac injury consequent dysrhythmias valve malfunction frank rupture typically patients blunt chest trauma suspected cardiac injury required cardiac monitoring hours predicting patients blunt chest trauma risk cardiac complications would obviate many patient hours monitoring intensive care unit series examines sensitivity two dimensional surface echocardiography predicting cardiac complications month period patients admitted blunt chest trauma prospectively evaluated cardiac injury admission electrocardiograms serial creatine kinase isoenzyme studies two dimensional echocardiography thirty one patients abnormal two dimensional echocardiograms patients cardiac complications requiring treatment developed eighty four patients normal two dimensional echocardiograms cardiac complication requiring treatment developed patients required treatment cardiac complications normal admission electrocardiograms elevated levels myocardial specific isoenzymes creatine kinase believe two dimensional echocardiography sensitive test evaluating cardiac injury resulting blunt chest trauma helpful selecting patients require monitoring intensive care unit,C21,0.047447797,0.0016697798,0.051793512,0.0010576419,0.0026211778,0.002429331,0.22683123,0.010843571,0.046910018,0.0018495653,0.05092178,0.0038717303,0.032161634,0.004945989,0.0016553322,0.002931283,0.3964043,0.0019417364,0.0021433856,0.032222267,0.074740894,0.0006683707,0.0019377084
unexpected geographic variation rates hospitalization patients fracture hip medicare enrollees united states use data hospitals fiscal year calculated rates hospitalization fracture hip state residence enrollees medicare sixty five years old older adjusted age race rate fracture hip highest south lowest northeast especially women cause difference known,C21,0.0049477452,0.0043888967,0.009231979,0.0027799362,0.0068895784,0.007295645,0.16711405,0.0046529192,0.0035769993,0.0048614503,0.045779962,0.0102647785,0.07103539,0.011376394,0.004350922,0.0077046677,0.2147505,0.005095357,0.0056337356,0.3134326,0.08798185,0.0017567645,0.0050978633
field performance intoxilyzer comparison blood breath alcohol results wisconsin drivers intoxilyzer blood alcohol results drivers arrested operating motor vehicle intoxicated related offenses compared two year period three hundred ninety five pairs results studied breath blood alcohol specimens study collected within h mean blood alcohol concentration obtained g dl range zero g dl comparison mean intoxilyzer result g l range zero g l compared blood alcohol result intoxilyzer results lower g l time within g l time higher g l time,C21,0.0039159087,0.0034736067,0.0073066796,0.0022001895,0.005452779,0.0050536846,0.17870633,0.0036825682,0.0028310278,0.0038476104,0.06819623,0.008054276,0.31247032,0.009003884,0.02237842,0.0060978844,0.11550347,0.0040327366,0.0046418123,0.070947126,0.15678453,0.001390397,0.0040285424
use intestinal antibiotics delay prevent infections patients burns bacterial colonization infection wounds seriously burned patients often comes patient indigenous bowel flora prospective randomized clinical trial involved patients greater total body surface area burns undertaken evaluate use standard antibiotic bowel preparation delay prevention bacterial colonization burn wound sepsis certain enteric bacteria seen less frequently treated group enterobacter organisms bacteria appeared often treated group proteus organisms enterococci average time colonization burn wounds days treated group days control group blood cultures positive enteric organisms earlier treatment group pseudomonads appeared earlier wound blood cultures treated group control group effect antibiotic bowel suppression patients burns varied unpredictable bowel preparation may select certain organisms lead earlier colonization wounds overall outcome survival improved use antibiotic bowel preparation patients,C21,0.002276339,0.02405755,0.019299947,0.034336902,0.0031697298,0.0029377341,0.228779,0.0021406969,0.0016456918,0.024274208,0.022034196,0.086181484,0.069368936,0.036218774,0.0116558885,0.014560984,0.21008028,0.0023442518,0.06869274,0.024613267,0.10818136,0.00080824527,0.0023418136
inpatient treatment employed alcoholics randomized clinical trial hazelden type traditional treatment first randomized clinical trial hazelden type treatment showed aa oriented treatment alcoholism result significant improvement drinking behavior compared traditional form treatment one hundred forty one employed alcoholics randomized either hazelden type treatment n traditional type treatment n treatment groups highly comparable bimonthly follow lasted one year according copes questionnaire short form treatment hazelden type institute significantly involving supportive encouraging spontaneity oriented personal problems traditional type institute accordance treatment drop rate hazelden type institute traditional type institute p less participation outpatient treatment significantly better hazelden type treatment proportion abstinent admitted ethanol consumption g day gammaglutamyl transferase mean cell volume normal higher hazelden type institute last months follow period vs p fourteen percent hazeldon type institute patients traditional type institute patients stayed abstinent whole year follow period p less differences corresponding rates controlled drinking admitted ethanol consumption less g day ggt mcv normal direction reach statistical significance thus hazelden type treatment obtained better results year abstinence rate traditional type treatment,C21,0.0019911458,0.0017662456,0.0037152714,0.0011189271,0.0027726074,0.0026026238,0.31711638,0.0018724975,0.0014395097,0.011577389,0.022347964,0.03431554,0.1505628,0.027620163,0.0017509633,0.003100628,0.18370321,0.002051699,0.040521406,0.06733932,0.1179565,0.0007069835,0.0020502158
hypophosphatemia incidence etiology prevention trauma patient hypophosphatemia associated number undesirable physiologic consequences reported occur frequently trauma patients studied patients immediate posttraumatic period document decrease serum p b renal p excretion c response prophylactic po administration group n group n patients measured serum p creatinine ionized ca urinary p excretion creatinine clearance daily first days postinjury patients group also received mmol kg day po first h admission group patients exhibited significant p less decrease serum p first h mmol l contrast group patients demonstrate decrease serum p urinary p excretion group accounts observed decrease serum p results study show immediate posttraumatic period associated decrease serum p massive urinary p excretion also showed prophylactic administration mmol po kg day prevents serum p decrease,C21,0.002203445,0.044620782,0.014619206,0.0012380258,0.0030684038,0.0028436605,0.15968005,0.0020721464,0.0015929926,0.0021650142,0.010274236,0.077069886,0.032245543,0.01743413,0.0019376539,0.014094571,0.14787285,0.023594761,0.0025089462,0.052809533,0.383005,0.00078236323,0.0022668228
alcohol trauma countermeasures alcohol related trauma essential public perception low risk detection punishment alcohol precipitated violence addressed current legislation aimed decreasing availability alcohol e g adjusting legal drinking age decreasing serum alcohol intoxication limit restricting sale alcoholic beverages public events increasing detection e g greater driver surveillance increased number dedicated personnel strengthening legal penalties alcohol related offenses mandating rehabilitative therapy physicians intervene alcohol trauma cycle unfortunately notably poor detecting patient alcohol related injury moreover physicians infrequently refer patients facilities personnel expert alcohol detoxification rehabilitation recidivism positively impacted physicians sensitive versed medical social patterns alcohol abuse,C21,0.020894494,0.0031731469,0.058386073,0.0020098777,0.004981125,0.004616551,0.24310108,0.0033640335,0.0025861498,0.0035148002,0.08975858,0.007357598,0.038643505,0.00854753,0.0031456915,0.022885326,0.12325928,0.0036839135,0.037352905,0.18931748,0.12446463,0.0012701305,0.0036860872
reporting occupational injury illness semiconductor manufacturing industry united states occupational illness injury cases meeting specific reporting criteria recorded company occupational safety health administration osha logs case description data submitted participating state agencies coding entry national supplementary data system sds evaluated completeness reporting percentage reportable cases recorded company osha log semiconductor manufacturing industry reviewing company health clinic records manufacturing sites member companies national semiconductor manufacturing industry trade association randomly selected work related cases met osha reporting criteria reporting completeness percent lowest occupational illnesses percent case description data reported cases submitted twice state coding personnel evaluate coding reliability reliability high kappa nature affected body part source type variables coding sds appears reliable reporting completeness may improved use stepwise approach company personnel responsible reporting decisions,C21,0.026040202,0.013957461,0.004548509,0.0013696935,0.0033944305,0.026739698,0.32972276,0.0022924496,0.013551941,0.0023951908,0.19045216,0.0050138985,0.030930791,0.0057797143,0.013410496,0.0037960175,0.09572125,0.0025145074,0.049973913,0.11195126,0.06306891,0.00086554134,0.0025091758
alcohol consumption problem drinking vietnam era veterans nonveterans relationship vietnam era veteran status indicators alcohol consumption problem drinking examined using data national health interview surveys conducted national center health statistics compared group nonveterans frequency matched age greater proportion vietnam era veterans currently heavy drinkers smaller proportion abstainers simultaneous adjustment seven demographic factors age region u urbanization ethnicity marital status education income white veterans white nonveterans demonstrate effect increasing abstention increasing age across interview years race veteran groups proportion lifetime abstainers ranked increasing order follows white veterans white nonveterans non white veterans non white nonveterans ranking reversed lifetime heavy drinking nearly half white veterans report drinking heavily point lives among whites non whites significantly greater proportion veterans nonveterans report alcohol related motor vehicle crashes violations,C21,0.00246681,0.0021881834,0.0046028113,0.0013859998,0.0034354245,0.0031835467,0.115839206,0.002319818,0.12120639,0.014359769,0.08787095,0.03553308,0.05963282,0.005806533,0.0021784827,0.030593654,0.04657452,0.0025404051,0.03863215,0.29681838,0.11939462,0.00087587454,0.002560603
foley catheter balloon puncture risk free fragment formation incidence free fragment formation following balloon puncture spontaneous bursting examined foley catheters immersed h urine catheters divided groups inflated manufacturer recommended volume twice volume times recommended volume catheter balloons punctured pricking hypodermic needle overall incidence free fragment formation types catheter examined increasing balloon volume associated increased risk free fragment formation following puncture however increasing volume associated increased free fragment formation balloon burst spontaneously view high risk free fragment formation cystoscopy performed cases spontaneous catheter balloon rupture percutaneous balloon puncture,C21,0.0027270874,0.0024190627,0.005088462,0.0015324722,0.0037973828,0.0035194482,0.08461497,0.08656308,0.0019715629,0.0026795235,0.14911465,0.045209162,0.09687531,0.006531067,0.0023981319,0.004246642,0.062333748,0.0028084477,0.0031051901,0.1104712,0.31821954,0.0009682896,0.0028055268
alcohol withdrawal syndromes current studies begun elucidate pathophysiology alcoholism withdrawal syndrome newer benzodiazepines beta blockers alpha agonists butyrophenones calcium channel blocking agents alone combination studied recently alcohol withdrawal article discusses evaluation therapy delirium tremens major alcohol withdrawal mild alcohol withdrawal adjunct therapy admission criteria,C21,0.0054724575,0.004854343,0.0102110375,0.0030747505,0.03411208,0.007062491,0.34061807,0.005146365,0.003956343,0.005377011,0.05379195,0.011255799,0.062033653,0.03901453,0.0048123407,0.035012197,0.046996105,0.0056357235,0.0062311976,0.0644636,0.21680409,0.0019430708,0.032120764
prospective evaluation gastric emptying self poisoned patient authors prospectively studied effect gastric emptying ge activated charcoal ac upon clinical outcome acutely self poisoned patients presumed overdose patients n treated using alternate day protocol based question cognitive function examination presenting vital sign parameters asymptomatic patients n receive ge ac administered asymptomatic patients even days ge remaining symptomatic patients n performed even days emptying days alert patients ipecac induced emesis obtunded patients received gastric lavage ac therapy followed gastric emptying nonemptying days symptomatic patients treated ac clinical deterioration occurred asymptomatic patients treated without ge ac use alter outcome measures asymptomatic patients ge procedures symptomatic patients significantly alter length stay emergency department mean length time intubated mean length stay intensive care unit gastric lavage associated higher prevalence medical intensive care unit admissions p aspiration pneumonia p data support management selected acute overdose patients without ge fail show benefit ac asymptomatic overdose patients,C21,0.0018997684,0.0016851893,0.021933574,0.0010674023,0.011840789,0.00245175,0.24277589,0.0017865652,0.001373448,0.011058038,0.09147128,0.0043118754,0.03441198,0.013695375,0.0016706083,0.0029583345,0.33035642,0.020302344,0.011350112,0.07535143,0.11361891,0.0006745387,0.0019544116
isolated avulsion biceps femoris insertion case report clinical roentgenographic operative findings isolated biceps femoris avulsion year old man demonstrated significance static stabilizers knee menisci articular cartilage examination dynamic structures knee however may present diagnostic problem systematic examination musculature hamstrings quadriceps patellofemoral mechanism included evaluation every acute knee injury special attention given surface anatomy well function knee,C21,0.025271166,0.003837782,0.070045285,0.0024308588,0.047968384,0.0055835163,0.3611067,0.02500621,0.0031278348,0.067046136,0.08503505,0.009057048,0.030036774,0.010802322,0.0038045757,0.0067371908,0.05953916,0.004455532,0.0049263057,0.049178082,0.09807931,0.0015361671,0.025388658
hymenoptera venom study iii safety venom immunotherapy one thousand four hundred ten subjects hymenoptera venom study accepted venom immunotherapy vit time maintenance averaged days largest number achieved maintenance subjects day ninety two percent treated subjects achieved maintenance continued therapy subjects study terminated one hundred seventy one subjects experienced treatment systemic reactions srs incidence pruritus angioedema urticaria similar mild moderate severe srs sr severity correlate severity recent sting entry hymenoptera venom study severe historical sting sr severe sr venom skin tests total dose venom degree skin test reactivity lowest concentration yielding positive skin test srs occurred micrograms maintenance honeybee wasp venoms likely produce sr study largest kind use standardized extracts demonstrates good compliance various historical diagnostic criteria predict srs vit srs vit likely occur micrograms maintenance honeybee wasp venoms likely produce sr vit relatively safe,C21,0.0023894135,0.025164798,0.0044464665,0.0013379537,0.03805791,0.03764864,0.2539464,0.0022394005,0.0017215718,0.013863798,0.106090814,0.005378305,0.13567163,0.005721978,0.0020941086,0.003708175,0.09224519,0.0024523411,0.002711457,0.055334017,0.19296373,0.0008455121,0.013966411
femoral neck fracture fixation comparison sliding screw lag screws rigidity sliding compression screw three cannulated lag screws treatment subcapital fractures compared five pairs female cadaver femora significant differences compressive strength bone density cortical thickness singh index bones pair subcapital fracture standardised using perpendicular saw cut across femoral neck uniaxial load test system force length measurement facilities used mimic cyclical stressing applied vivo frequency hz times body weight significant difference fixation afforded sliding compression screw three lag screws bone quality single important factor stability bone implant unit,C21,0.0038432346,0.0034091407,0.051997114,0.02075633,0.0053515825,0.0049598943,0.14589573,0.0036142243,0.02137805,0.022371933,0.14706707,0.008015339,0.19014719,0.03527553,0.077785246,0.0059847157,0.038649987,0.00399898,0.004421928,0.08613717,0.11361586,0.0013645929,0.0039591664
orthotic stabilization thoracolumbar injuries biomechanical analysis jewett hyperextension orthosis spinal orthoses traditionally used management thoracolumbar injuries treated without surgical stabilization however orthotic treatment modality management spinal fractures remains subjective since objective data available effectiveness orthoses stabilizing injured segments study used finite element model spine evaluate effectiveness hyperextension orthosis controlling progression deformities injury site gravitational flexion loads two types injuries simulated single level injury l two level injury l segments injury increasing severity simulated progressively reducing bending stiffness affected segments relative normal values flexion extension mode interaction three point hyperextension orthosis spine simulated using experimentally measured stiffness properties orthosis authors results suggest single level injuries cause loss segmental stiffness orthosis restore normal resistance deformity injured segments gravitational well large flexion loads loss stiffness normal severe two column disruptions orthosis restore resistance deformity restricted patient activity level brace low flexion moment beyond loss segmental stiffness three column injuries orthosis alone appears ineffective preventing progression deformity,C21,0.10373288,0.0607691,0.043033484,0.0011407759,0.0028275822,0.0291194,0.22895734,0.0019092986,0.001467801,0.001994868,0.065588124,0.004197028,0.04340357,0.0051226537,0.0017853758,0.003161566,0.043955814,0.0020969799,0.0023117708,0.10764463,0.23219384,0.00072087813,0.012865267
mortality following hip fracture implementation prospective payment system recent studies patients hip fractures two hospitals suggested marked reduction length stay occurred following implementation medicare prospective payment system pps resulted decreased quality care patients assess whether change influenced mortality studied patients hip fractures aged years older sample michigan medicare enrollees patients years preceding october september years following october september implementation pps although demographic characteristics patients hip fractures change pps mean length stay confidence interval decreased days however mortality year following fracture change pps pps rate difference finding consistently present within subgroups defined patient demographic characteristics furthermore analysis restricted patients treated hospitals greatest reduction average length stay following pps days significant change year mortality patients enrolled medicaid nursing home time fracture increase rate nursing home residence year fracture thus findings population based study suggest key outcomes postfracture mortality nursing home residence affected implementation pps,C21,0.0019911216,0.0017662242,0.013343777,0.0011187299,0.0027878198,0.002569646,0.2200597,0.0018724748,0.020710219,0.0019606045,0.030395968,0.0053157588,0.058230266,0.004599097,0.001750942,0.0031005903,0.31089678,0.002050525,0.002310184,0.18095954,0.1294509,0.0007069749,0.0020521525
relative biological effectiveness fractionated doses fast neutrons mevd normal tissues iii effects lung function effect single fractionated doses fast neutrons mevd early late radiation responses pig lung assessed measurement changes lung function using xe washout technique results obtained irradiation schedules fast neutrons compared photon irradiation statistically significant difference values relative biological effectiveness rbe early late radiation response lung rbe neutron beam increased decreasing size dose fraction upper limit value infinitely small x ray doses per fraction,C21,0.0033453743,0.035355423,0.03863097,0.01807148,0.0047178967,0.06909942,0.112681404,0.0031460305,0.0024185567,0.019435832,0.04340507,0.040677648,0.11835675,0.04215512,0.0029783784,0.0052094436,0.104475185,0.003446391,0.0038092008,0.022743046,0.30120528,0.0011878208,0.0034482887
replantation distal part leg successfully replanted five amputated legs five patients followed patients two years average six years three months although patients found impossible squat run joint contractures muscle weakness deformities foot patients could perform activities without difficulty none important pain intolerance cold satisfied results replantation,C21,0.0057779895,0.005125365,0.010781129,0.0032464166,0.008045668,0.035418734,0.22714134,0.005433691,0.0321491,0.005677214,0.05982618,0.039826024,0.03587558,0.014579695,0.0050810184,0.008997532,0.28961295,0.0059503713,0.006579091,0.08329547,0.103583746,0.0020515542,0.0059441826
removal blunt foreign bodies esophagus historically removal blunt foreign bodies esophagus esophagoscopy general anesthesia considered relatively safe effective recent years alternative techniques blind removal balloon catheters bougies advocated paper reports esophagoscopies performed year period remove blunt esophageal foreign bodies eighty one percent foreign bodies coins children years age deaths perforations instances mediastinitis complications encountered due esophageal erosion respiratory problems secondary long standing foreign bodies author opinion esophagoscopy best method removal esophageal foreign bodies simply seem need alternative methods involving blind removal,C21,0.03789553,0.003067099,0.006451597,0.0019427068,0.004814654,0.0044622645,0.16474983,0.0032516064,0.0024997196,0.053612676,0.09477689,0.0071117044,0.09028904,0.007950182,0.0030405612,0.022107879,0.23694932,0.0035607957,0.037408616,0.075679064,0.1335935,0.0012276822,0.0035570923
role spinal flexibility back pain complaints within industry prospective study commonly used clinical measurements spinal flexibility sagittal frontal planes examined predictors future back pain reports within industry study sample consisted aircraft manufacturing employees examined tracked years reports back pain modified schober sit reach lateral bending measurements significantly associated risk future back pain reporting trends present statistically significant relationship decreased flexibility reports current previous back problems however differences flexibility subjects without history back problems small practical significance,C21,0.0038431233,0.003409042,0.0071708695,0.0021592942,0.0053514275,0.004959751,0.35679573,0.022216143,0.002778407,0.0037760944,0.03877763,0.03224603,0.11391498,0.008836527,0.021982953,0.024586897,0.07583632,0.0039577796,0.004375961,0.1623341,0.09537273,0.0013645535,0.0039536636
injuries elderly inner city population even though injuries leading cause morbidity mortality among elderly united states comprehensive population based study nonfatal fatal injuries carried elderly minority inner city population study injuries population developed active surveillance system part large injury prevention program poor urban black community report cases nonfatal fatal injuries community persons years age older resulted emergency room treatment death march february nearly elderly population treated emergency room died result injury study period overall injury rate injuries per persons injury rates older women exceeded older men increased advancing age sexes fall injuries accounted injuries hospitalizations injury motor vehicle incidents violence second third common injuries accounting injuries respectively given predominance falls relative injuries prevention falls receive major emphasis injury prevention efforts inner city minority populations,C21,0.16747898,0.030981107,0.013481796,0.001129626,0.0028001138,0.022055699,0.21192576,0.001890712,0.0014535122,0.0019754483,0.04695315,0.0052923975,0.05341078,0.0046227933,0.0017679954,0.0031307887,0.07982631,0.0020704963,0.017658465,0.29368904,0.03362284,0.00071386056,0.0020683429
situational riskiness alcoholic beverages using face face interview data sample young adults study investigates perceived risk alcohol consumption drinking driving interactions police probability intoxication results show beer perceived less risky liquor two risk situations men drinkers particular ranking beer lower risk beverage intoxication considered drinkers rank preferred beverage less risky alternative finally analysis relative riskiness beer comparison liquor reveals beer perceived less risky liquor consensus vary significantly sex respondent characteristics,C21,0.0039165416,0.0034741678,0.045222096,0.002200545,0.005490784,0.005054501,0.21434802,0.003683163,0.02176638,0.041755278,0.08847644,0.008055745,0.1228218,0.009702854,0.003444108,0.06296005,0.05840124,0.0040420718,0.02334349,0.16427815,0.10213011,0.0013906216,0.004041843
radial forearm flap reconstruction upper extremity radial forearm flap owing good caliber arteries long length equally well distributed venous system proved reliable earned place recognition reconstructive hand surgery also emerged workhorse microvascular surgeon used radial forearm flaps upper extremity reconstruction present herein experience technique extracorporeal tissue transfer published elsewhere used two patients detailed four representative patients presented,C21,0.028223444,0.004286367,0.00901631,0.0027149937,0.00672863,0.006236154,0.2476462,0.07470311,0.026875334,0.004747881,0.07077335,0.00993883,0.030381415,0.011637957,0.00424928,0.007524678,0.2464959,0.004976324,0.02887339,0.055987556,0.111296035,0.0017157245,0.004971148
biomechanical strength non vascularised vascularised diaphyseal bone transplants experimental study studied healing torsional strength non vascularised vascularised sections tibial diaphyses cats types graft achieved fracture union period time weeks non vascularised grafts strong vascularised grafts,C21,0.006307053,0.005594671,0.011768307,0.00354431,0.008782371,0.0081395805,0.16844752,0.03645941,0.0045597185,0.0672565,0.060554177,0.012972402,0.042327434,0.014741096,0.005546263,0.010801457,0.14939076,0.0064952187,0.0071815075,0.18585663,0.17454575,0.0022394054,0.0064884634
comparison support provided semirigid orthosis adhesive ankle taping exercise purpose study compare relative effectiveness athletic taping semirigid orthosis providing inversion eversion range restriction hour volleyball practice effect support method subjects vertical jumping ability also assessed fourteen ankles treated methods support passive inversion eversion range motion measured ankle stability test instrument five testing sessions support exercise minutes exercise minutes exercise exercise two way analysis variance posthoc comparisons revealed maximal losses taping restriction inversion eversion minutes exercise orthosis demonstrated mechanical restrictive failure exercise comparisons made eversion range motion compromised neither support system affected subjects vertical jumping ability results suggest semirigid orthosis may effective taping providing initial ankle protection guarding ligamentous reinjury,C21,0.0026569641,0.11812299,0.01781766,0.0014928398,0.0037116944,0.029136647,0.30710647,0.0024986411,0.014779411,0.0026106234,0.06452173,0.005464867,0.1551179,0.006117088,0.0023364672,0.0041374457,0.059482433,0.0027389687,0.015884593,0.03860288,0.14198495,0.0009433914,0.0027333866
ethanol inducible cytochrome p activity increase acetaldehyde bound microsomes chronic administration acetaldehyde ethanol chronic ethanol consumption results acetaldehyde adduct formation proteins haemoglobin liver proteins vivo purpose study binding acetaldehyde liver microsomal proteins site ethanol oxidation via cytochrome p especially p ii e chronic administration ethanol acetaldehyde days rats liver microsomal oxidation butanol ethanol inducible p also examined acetaldehyde bound liver microsomal proteins higher ethanol fed rats compared acetaldehyde treated rats vs nmol mg protein respectively biotransformation n butanol butyraldehyde liver microsomes increased ethanol fed rats vs controls whereas acetaldehyde treated rats increase much lower however last group significant negative relationship quantity acetaldehyde bound microsomal proteins monooxygenase catalyzed transformation butanol liver microsomes demonstrated r p less results suggest proteins liver microsomes target acetaldehyde binding ethanol oxidation adduct formation could impair oxidative properties alcohol inducible cytochrome p,C21,0.0024375042,0.0021621878,0.051661775,0.0013695342,0.00339438,0.0031535185,0.15506653,0.0023730153,0.001762207,0.002394991,0.016611667,0.01739065,0.050034963,0.0061521856,0.0021434797,0.08599607,0.04103861,0.17996146,0.0027754572,0.018622322,0.35012445,0.00086546916,0.0025076144
corticocancellous grafting ao asif lag screw nonunion scaphoid retrospective analysis report experience patients using corticocancellous bone grafts lag screw fixation un united scaphoid fractures using grading system analysed suitability method three types nonunion recommend operation treatment scaphoid nonunion except avascular necrosis proximal pole,C21,0.006120566,0.0054292474,0.011420341,0.0034392353,0.008522694,0.007898909,0.2859152,0.0057558543,0.0044248966,0.0060138153,0.15023565,0.012588834,0.038434602,0.014198668,0.06461835,0.009530994,0.13311341,0.006303168,0.0069691646,0.07630043,0.1342714,0.0021731905,0.006321346
fatal big cat attacks two cases fatal attacks large cats presented first case year old female zoo worker attacked jaguar escaped cage second case year old girl fatally injured father pet leopard pattern injuries cases nearly identical cats prey wild,C21,0.038006246,0.005771713,0.012140712,0.0036558146,0.00906541,0.10282839,0.23153692,0.006118921,0.0047040097,0.006393154,0.17434746,0.013382911,0.04215637,0.01523201,0.0057217735,0.010132189,0.06533272,0.0067007584,0.0074087647,0.116395265,0.11396444,0.0023102707,0.0066937893
neuroleptic malignant syndrome unique association tricyclic antidepressant report lst case neuroleptic malignant syndrome occurring patient receiving desipramine tricyclic antidepressant exposure neuroleptics case suggests syndrome may caused central imbalance norepinephrine dopamine dopamine depletion alone,C21,0.0067170877,0.005958392,0.012533389,0.0037740576,0.009353332,0.008668751,0.27564868,0.0063168304,0.0048561553,0.0065999334,0.094899,0.027259791,0.04279501,0.015444659,0.0059068375,0.010459903,0.113039486,0.0069174864,0.0076483926,0.20276342,0.12314411,0.0023849937,0.006910292
physician role injury prevention beyond u preventive services task force report injuries prevention received little attention medical community despite fact injuries leading cause premature death however much done reduce number severity injuries practicing physician important role play process report outlines u preventive services task force report recommendations prevention strategies reduce injuries seeks define broader role physician prevention injuries extends beyond confines office based practice screening counseling proven effectiveness certain situations interventions passive automatic action air bags proven effective long term solutions reduce number severity injuries author outlines provides examples seven areas physicians major impact either directly implementing effective injury control strategies treatment education screening hazard identification research advocacy policy making using approaches physicians play truly effective role reducing burden injuries patients,C21,0.098712504,0.06391164,0.003984064,0.021863127,0.0029731998,0.0027555882,0.3442109,0.002007969,0.0015436553,0.0020979603,0.08355631,0.022040313,0.0161914,0.005926999,0.0018776419,0.023992663,0.054577116,0.0021989031,0.0642886,0.07156574,0.106768966,0.0007581323,0.002196616
carburetor burns preventable injuries associated high morbidity frequent litigation identified carburetor burns significant cause preventable morbidity long term functional cosmetic standpoints epidemiology carburetor burns experience described patients male mean age years average burn size anatomic distribution burns often dominant hand face contributes morbidity burns injury associated increasingly frequent litigation believe active education campaign addition warning labels car engine compartments would make impact decreasing incidence carburetor burns,C21,0.041833375,0.0034737869,0.007307059,0.0022003036,0.0055510257,0.093179815,0.19940203,0.0036827594,0.0028311748,0.022789415,0.030888569,0.008054694,0.049860753,0.031775136,0.0034437303,0.006098201,0.15308593,0.004032946,0.018939026,0.18303552,0.1231155,0.0013904691,0.004028752
living artificial grass knowledge update part epidemiology part study evaluated effect artificial grass athletes play section reviewed epidemiological studies evaluated influence artificial grass frequency site injury american football players review concluded play practice artificial surface probably responsible increase relative risk injury lower extremity participants however evident well controlled studies necessary completely clarify issue,C21,0.038213775,0.0031732258,0.12759922,0.0020099278,0.004981249,0.004616666,0.30275562,0.020676639,0.019892478,0.020826995,0.020244641,0.0074680625,0.03383842,0.008822539,0.020357687,0.02283843,0.05970425,0.0037849413,0.059232727,0.073474914,0.14053726,0.0012701622,0.0036801738
facial trauma women resulting violence men year period women facial injuries treated injury related form violence exerted man cases individual known usually husband boyfriend almost assault consisted beating hands cases fracture mandible common injury also cases home accidents,C21,0.078688875,0.004496407,0.009458126,0.0028480336,0.0070583457,0.006541738,0.31116503,0.0047668973,0.0036646219,0.004980536,0.095724456,0.010425852,0.031923417,0.011962144,0.0044575026,0.007893402,0.06972727,0.005220173,0.00577174,0.21674237,0.099455684,0.0017997982,0.005227558
endoscopic extraction entrapped nasogastric tube inadvertent entrapment nasogastric tube within stapled gastrointestinal anastomosis preventable infrequent surgical complication report experience complication describe successful endoscopic approach management,C21,0.007443495,0.04262472,0.013888789,0.040205214,0.0103648305,0.045621913,0.2444239,0.0069999527,0.0053813155,0.007313671,0.034231804,0.015309847,0.0460766,0.017114894,0.0065456214,0.011591069,0.27916142,0.0076655657,0.008475514,0.05090606,0.08835326,0.0026429147,0.007657593
secondary total hip replacement fractures femoral neck studied rate revision consecutive total hip replacements performed failed osteosynthesis femoral neck fractures compared primary arthroplasty osteoarthritis age sex adjusted risk prosthetic failure times higher failure fixation excess risk patients years age radiographic signs loosening femoral component five years secondary arthroplasty six survivors general results secondary replacement worse obtained primary arthroplasty femoral neck fracture consider internal fixation primary procedure total hip replacement safe secondary procedure osteosynthesis fails,C21,0.0035770994,0.0378074,0.04128032,0.0020098262,0.0049809976,0.0046164333,0.12441332,0.0033639476,0.019900093,0.020826584,0.024689587,0.0073574097,0.02780246,0.008224856,0.0031664118,0.005570288,0.4151046,0.0036838192,0.004073054,0.1557636,0.05955397,0.001270098,0.0209638
pediatrician knowledge practices regarding parental use alcohol problems alcohol common united states frequently ignored physicians particularly working children explored pediatricians knowledge practices regarding parental use alcohol compared attributes family practitioners child health care providers attending three continuing medical education courses general pediatrics surveyed using closed item questionnaire one hundred ninety participants responded including pediatricians family practitioners forty six percent responding pediatricians compared family practitioners stated ask problems alcohol taking routine family history thirty eight percent pediatricians knew frequency alcoholism compared indicated include taking routine family history forty six percent pediatricians experienced problem alcohol family compared pediatricians without personal experience routinely address issue alcohol use parents children similar analyses among family practitioners revealed significant differences conclude fewer half pediatricians ask problems alcohol taking family history likelihood asking problems influenced health care provider knowledge alcoholism influenced provider personal family history problems alcohol important morbidity associated alcohol use families intervention improve functioning adaptation child training continuing medical education courses address issue,C21,0.0020303652,0.0018010351,0.0136052985,0.0011407793,0.002832995,0.032053173,0.35474104,0.0019093798,0.0014678636,0.06096721,0.012788337,0.004213801,0.04683118,0.063675806,0.0017854518,0.012987118,0.092752084,0.0020923049,0.09538727,0.14706957,0.04505422,0.00072090887,0.0020927829
development medical education alcohol drug related problems university toronto medical education alcohol drug related problems university toronto covers undergraduate residency graduate programs result collaboration since university addiction research foundation ontario undergraduate core curriculum developed early offered year supplemented electives selectives comprehensive clinics undergraduate program rated highly students since completed core program residency training started available electives lasting months internal medicine psychiatry family community medicine date residents completed one electives completed graduate programs theses concerned alcohol drug related topics additional research postdoctoral fellows despite progress still need improve expand undergraduate residency programs develop effective program continuing medical education goals ensure far possible medical graduates university toronto knowledge attitudes skills behaviours needed contribute effectively prevention treatment alcohol drug related problems chosen field practice avoid problems personal use alcohol drugs,C21,0.0023544843,0.024883222,0.01577044,0.0013228887,0.0032785446,0.0030710332,0.33550137,0.0022141854,0.0017021874,0.045069117,0.033595435,0.016223535,0.01781822,0.017794367,0.002070474,0.0036888507,0.14012054,0.0024247284,0.102849565,0.13984002,0.08514857,0.0008359918,0.0024222066
basophil releasability severely burned patients thermal injury known induce dysregulation immune system however precise mechanisms clarified investigated histamine release basophil granulocytes severely burned patients n stimulation anti ige ca ionophore respectively anti ige induced basophil histamine release patients reduced comparison healthy donors beginning day one postburn p b vs ca ionophore induced release decreased day two p b basophils patients finally succumbed injuries showed poor responsiveness zero levels total time contrast basophil releasability surviving patients returned nearly normal levels fifth seventh week p b already second week p b significant difference histamine release survivors nonsurvivors e g days p b vs p less ca ionophore stimulation altered basophil histamine release neither due diminished dose delayed time response stimuli due differences basophil counts cellular histamine content data indicate decrease basophil releasability may secondary altered signal transduction pathways severely burned patients correlates clinical outcome,C21,0.024722263,0.0019972296,0.0150881,0.0012650493,0.0031352004,0.0029057318,0.13630007,0.002117377,0.0016277643,0.013108893,0.01038499,0.0047053676,0.08950705,0.050341345,0.012881828,0.014400618,0.14463459,0.013264165,0.0025637113,0.05812579,0.39380395,0.0007994406,0.0023194477
fatal ethanol intoxication household products intended ingestion fatal acute ethanol intoxication frequently encountered medicolegal practice although vast majority acute ethanol toxicity deaths follow ingestion conventional alcoholic beverages ethanol obtained variety commercial products often contain high levels ethyl alcohol manufactured designed consumption products may easily purchased locales statutory limitations restrict liquor availability sundays early morning hours several acute ethanol fatalities encountered new mexico directly related consumption non beverage ethanol containing products occurring times alcoholic beverage sales restricted despite fact manufacturers deliberately include compounds products discourage ingestion policy apparently little deter individuals searching source ethanol conventional beverages available products consumed fatalities also contained compounds would toxic much greater concentrations inconsequential effects comparison direct toxic effect ethanol investigation scene awareness alcohol containing products fatally abused essential detecting unconventional ethanol sources,C21,0.02698629,0.014472839,0.04038633,0.013641593,0.0035188799,0.040957168,0.4326612,0.0023764973,0.0018269669,0.0024830052,0.052165397,0.029654866,0.024707265,0.0075127203,0.0022222511,0.032534122,0.053200338,0.0026024743,0.027339851,0.05964353,0.12551303,0.0008972746,0.0026961202
blunt trauma heart pathophysiology injury blunt injuries heart common potentially lethal injuries often go undetected obvious problems treated cardiac injury suspected patient sustains severe chest trauma spectrum cardiac trauma ranges injuries actual cellular damage myocardial concussion cardiac chamber rupture pathophysiology diagnosis treatment injuries discussed,C21,0.15631168,0.004005188,0.008424854,0.02438825,0.0062872423,0.0070423954,0.30287206,0.004246128,0.025117753,0.0044364273,0.0426216,0.009286858,0.07665295,0.010381789,0.0039705336,0.007031071,0.18438832,0.0046498845,0.0051411944,0.028876996,0.07761863,0.0016031757,0.0046450486
survey wound monitoring topical antimicrobial therapy practices treatment burn injury survey done determine burn wound microbial monitoring performed topical antimicrobial agents employed survey sent burn care facilities comprised major burn centers united states survey contained questions concerning frequency techniques wound monitoring personnel involved monitoring well questions decisions made initiate topical antimicrobial therapy agents selected administered sixty facilities responded survey although areas unanimous agreement several trends emerge facilities monitored burn wounds microbes wound monitoring typically done least twice weekly either surface swab quantitative biopsy nursing staff played significant role specimen collection facilities solely responsible obtaining biopsy specimens facilities used biopsies exclusively responding facilities used topical antimicrobial agents silver sulfadiazine popular facilities surveyed laboratory microbial monitoring rapid techniques early diagnosis wound sepsis used units topical antimicrobial testing used facilities surveyed,C21,0.011745389,0.0017837773,0.04586043,0.0011298482,0.0028001282,0.002595184,0.4144237,0.0018910839,0.0014537983,0.001975837,0.063082404,0.004312211,0.029380998,0.005019542,0.0017683433,0.0031314048,0.07086111,0.0020709038,0.109372914,0.1535744,0.0592442,0.010441701,0.002080659
spectrum drinkers intervention opportunities adults north america either light drinkers abstainers alcohol cause problems however small often highly visible minority approximately adult population show major symptoms alcohol dependence extremes sizable group population particularly young men drinking risk levels encountered problems related alcohol use traditionally physicians efforts focused diagnosing treating patients substantial history alcohol dependence relatively little attention given early intervention nondependent problem drinkers identifying patients present primary care settings alcohol related morbidity accidental injury recent evidence indicates early intervention primary care physicians effective strategy reducing alcohol problems among patients,C21,0.03026664,0.0024846997,0.0052265287,0.0015738138,0.0039004183,0.017169856,0.41032648,0.01615739,0.01558008,0.01696945,0.020996563,0.019914724,0.018180707,0.006441693,0.016021779,0.017917318,0.07905971,0.0028846501,0.016742613,0.18183643,0.09647187,0.0009945625,0.002882067
low bone density etiologic factor stress fractures athletes objective determine whether low bone density risk factors osteoporosis associated stress fractures athletes design case control study setting institutional sports injury clinic primary secondary care participants twenty five athletes nineteen women scintigraphically confirmed stress fractures matched sex age weight height exercise history control athletes history bone injury measurements main results bone mineral density measured dual energy x ray absorptiometry significantly lower athletes fractures control athletes spine bone mineral density g cm athletes fractures g cm control athletes p femoral neck g cm athletes fractures g cm control athletes p also significantly lower ward triangle p greater trochanter p eight athletes fractures control athletes less predicted age related spine density p three athletes fractures bone mineral densities sds predicted level athletes fractures control athletes current menstrual irregularity amenorrhea oligomenorrhea p less fewer athletes fractures using oral contraceptives p less seven day diet records indicated similar energy nutrient intakes except athletes fractures lower calcium intakes mg compared mg p dairy product intake lower athletes fractures since leaving high school p less incidence family history osteoporosis similar groups conclusions athletes similar training habits stress fractures likely lower bone density lower dietary calcium intake current menstrual irregularity lower oral contraceptive use,C21,0.018741554,0.010047627,0.01992883,0.0009857699,0.0024430556,0.011017326,0.08400224,0.010141238,0.0012684098,0.01868855,0.07021624,0.043519028,0.23120673,0.022423564,0.056712456,0.019716835,0.033395406,0.0018102649,0.002056006,0.23177281,0.10747821,0.00062295154,0.0018049427
separation ruptured angioplasty balloon successful percutaneous retrieval case report case ruptured angioplasty balloon complete separation catheter presented successful percutaneous retrieval balloon endoscopic biopsy forceps performed,C21,0.0077218832,0.0068496955,0.051788084,0.004338611,0.010752478,0.009965492,0.18166402,0.044637628,0.0055825775,0.0075872038,0.11841833,0.015882438,0.047799874,0.017754994,0.0067904294,0.012024578,0.28193906,0.007952259,0.0087925,0.049414404,0.09165769,0.00274176,0.007943989
relationship ethanol intake dsm iii r alcohol dependence purpose investigation quantify relationship ethanol consumption dsm iii r alcohol dependence using mathematical modeling techniques allowed control confounding assessment interaction although sex education ethnicity marital status identified actual confounders logistic regression model ethanol intake dependence association stronger among younger opposed older respondents year olds average log odds dependence increased additional ounce ethanol consumed daily corresponding increase risk among year olds implications results discussed terms age differences drinking patterns differential social control drinking behavior separate analyses aggregates alcohol dependence criteria served outcome measures helped qualify interpretation overall ethanol intake dependence relationship need examine components global classifications alcohol dependence using better operationalizations highlighted,C21,0.0024669946,0.0021883473,0.028468104,0.0013861037,0.003435212,0.011917128,0.18001223,0.0023199916,0.0017835273,0.0024475418,0.08857379,0.044166066,0.032683346,0.026941637,0.014105455,0.015855918,0.03817491,0.0025405954,0.0029995153,0.34641713,0.14769828,0.00087594014,0.002542226
natural history alcohol abuse implications definitions alcohol use disorders dsm iii r category alcohol abuse validly differentiated dsm iii r category alcohol dependence abuse primarily mild prodromal condition typically deteriorates dependence year longitudinal epidemiologic study male drinkers provided data answer question study used identical questions baseline follow follow subjects initially classified alcohol abusers still abusers classified remitted contrasted significantly outcome subjects initially reported alcohol dependence although additional research needed results indicate alcohol abuse often course distinct alcohol dependence,C21,0.0037732353,0.0033470478,0.0070404653,0.0021215363,0.023508562,0.0048695565,0.31715176,0.003548396,0.002727881,0.003720637,0.05790908,0.04427518,0.14482898,0.009036506,0.003318088,0.005875712,0.1011716,0.004123548,0.040821828,0.12101628,0.09059259,0.0013397387,0.0038817653
anomie alcohol abuse alcohol consumption prospective analysis cross sectional month prospective analyses relationships among anomie alcohol abuse alcohol consumption patterns provided little support anomie directly associated ethanol ingestion patterns sample male air traffic controllers lack association observed self reported alcohol consumption interview established alcohol abuse biochemical markers alcohol intake addition anomie predictive change alcohol use abuse months controlling baseline levels alcohol use abuse relevant demographic factors measurement anomie alcohol use abuse relative importance anomie various socioeconomic groups issues related prospective research topic discussed,C21,0.0034573937,0.0030668806,0.023186296,0.0019425685,0.004814311,0.0044619464,0.27249223,0.003251375,0.019227719,0.0033970922,0.0901971,0.024509838,0.1113638,0.008620492,0.019773547,0.022116736,0.11425322,0.0035605421,0.02066537,0.13692306,0.10391642,0.0012275949,0.003574463
injury patterns scottish heavy athletics interest participation athletics scottish american highland games increased throughout united states aim study define injury patterns risk factors field events modern track field evolved part seven events heavy athletics retrospective prospective study athletes least years experience carried years injuries involved upper extremities back incidence injury injury exposure rate per hours competition training appropriate instruction consistent weight program exercise injuries serious,C21,0.11133588,0.021222746,0.006913751,0.0020818706,0.005159547,0.0047819144,0.26036504,0.0034857797,0.0026787845,0.003640699,0.0436474,0.007625241,0.032704484,0.008519685,0.003258369,0.059575114,0.06808471,0.0038158698,0.06731014,0.18895914,0.089706354,0.0013156261,0.0038119012
early identification alcohol problems high proportion patients seen clinical practice underlying alcohol problem often difficult detect failure make diagnosis may result unnecessary investigations inappropriate treatment furthermore good evidence effectiveness brief intervention problem drinking still early stage several questionnaires procedures based clinical examination findings laboratory tests available help early diagnosis incorporated standard medical assessment form basis screening programs health risk factors,C21,0.0031903596,0.04916389,0.0059528803,0.001792533,0.0045123724,0.0042261076,0.4215281,0.0030002529,0.002306488,0.0031891845,0.11269406,0.006743918,0.037303347,0.007508046,0.0028055217,0.020397026,0.089054085,0.0032855414,0.06436068,0.10936257,0.04320272,0.0011327808,0.0032875366
evaluation management patients inhalation injury inhalation injury present approximately one third burned patients treated burn centers increases mortality maximum relation age extent burn development animal models inhalation injury made possible identification airway vascular responses evoked smoke inhalation inflammatory occlusion terminal bronchioles necrosis endobronchial mucosa render airway pulmonary parenchyma susceptible infection resulting pneumonitis increases mortality early diagnosis best achieved endoscopic bronchoscopy xeon ventilation perfusion scan permits timely application high frequency ventilation appears reduce incidence pneumonia decrease mortality pharmacologic agents give promise ameliorating deleterious changes vasculature recent advances understanding inhalation injury identified research needed improve patient salvage,C21,0.07503182,0.0022416746,0.004715329,0.0014198812,0.028822782,0.11490066,0.20091717,0.0024115853,0.0018269896,0.0024830361,0.059126183,0.005274022,0.05538154,0.018030863,0.0022222786,0.0283992,0.102261804,0.0026025064,0.002877489,0.1421882,0.13111556,0.0008972857,0.014852116
wounding effects ak rifle used patrick purdy stockton california schoolyard shooting january limited disruption produced tissue simulant rifle bullets used stockton california schoolyard shooting entirely consistent autopsy reports five children died wounds also entirely consistent well documented battlefield studies previous tissue simulant studies many laboratories inconsistent many exaggerated accounts assault rifle wounding effects described media aftermath incident information documented historical record however critical reason correcting misconceptions produced media reaction incident prevent inappropriate gunshot wound treatment,C21,0.003991678,0.042183284,0.0074480562,0.002242761,0.005558285,0.005151468,0.42242467,0.003753822,0.0028858052,0.023246331,0.020863425,0.008210118,0.025506455,0.009513024,0.0035101806,0.025524288,0.12959783,0.004110766,0.004545112,0.029688763,0.2145201,0.0014172997,0.004106491
nonosmotic stimuli alter osmoregulation patients spinal cord injury studies two quadriplegic patients developed severe hyponatremia episodes acute respiratory distress performed determine whether differences osmoregulation vasopressin release could identified patients compared quadriplegic subjects previously studied similar manner patients clinically stable normonatremic signs symptoms respiratory distress studies performed however exhibited evidence hemodynamic instability sitting posture linear regression analysis plasma vasopressin plasma osmolality pavp posm relationship infusions sodium chloride showed significant differences either slope sensitivity abscissal intercept osmotic threshold relationship compared quadriplegic subjects patients supine contrast patients studied sitting posture marked shift relationship pavp posm indicative increased sensitivity reduced osmotic threshold vasopressin release slopes pavp posm relationships two patients respectively compared sd previously studied quadriplegic subjects oral water loading studies performed one patient revealed marked impairment urine diluting ability free water clearance sitting posture compared observations similar studies performed patient supine impairment renal water excretion could attributed effect vasopressin reduced unquantifiable levels water loading studies shown hemodynamic stress related autonomic dysfunction quadriplegic patients may result marked alteration osmoregulation vasopressin release severely affected individuals altered osmoregulation may also associated vasopressin independent impairment renal water excretion sitting posture may predisposing factor development hyponatremia especially presence potent nonosmotic stimuli,C21,0.009581119,0.0013207608,0.053199165,0.00083657255,0.0020779585,0.0082754865,0.22831102,0.0014002137,0.0010764346,0.0014629674,0.008911158,0.049160216,0.120752685,0.0039159427,0.008514736,0.002327273,0.12398513,0.01622488,0.016067203,0.05977416,0.2807614,0.0005286672,0.0015348966
management tracheobronchial foreign bodies children update tracheobronchial foreign bodies continue source morbidity mortality pediatric population technical advances anesthesia equipment made removal troublesome objects feasible diligence must still exercised coordinated team effort must employed order achieve satisfactory safe outcome patient appropriate use diagnostic studies management techniques discussed,C21,0.004721732,0.027045079,0.008810262,0.0026529487,0.006574862,0.0060936413,0.2882687,0.004440374,0.003413602,0.065476485,0.06075297,0.0097117005,0.03746092,0.010856721,0.004152172,0.075910866,0.11836955,0.004862601,0.02822801,0.14286551,0.08279725,0.0016765154,0.004857544
effects nonparticipation trauma center system emergency department utilization university illinois hospital uih serves inner city urban population one highest crime rate districts chicago may city level trauma ordinance took effect university illinois hospital declining participate measure impact ordinance nonparticipating hospital undertook retrospective analysis trauma patient utilization statistics consecutive monthly patient census data months compiled emphasis patient presenting complaints related subspecialty evaluation observed significant decreases patients presenting head injuries fractures animal bites well major trauma minor trauma general surgery hospital admission final disposition patients arriving ambulance consistent observed decrease major traumatic conditions minor traumatic conditions however mean number patient presentations per day ppd admitted regular medical surgical beds decreased ppd ppd mean number ppd sent home increased ppd ppd data suggest loss trauma center status designation profound effect utilization emergency departments participating trauma system nonparticipation appears associated significant decrease utilization rates major minor trauma patients significant increase number patients discharged arrived chicago fire department paramedic system cfd effect emergency department extends utilization inpatient services,C21,0.019572318,0.001625498,0.012218458,0.0010295938,0.011421307,0.0111580165,0.26499042,0.001723283,0.0013247989,0.010635071,0.008600741,0.003782934,0.032110874,0.004350273,0.0016114335,0.0028535468,0.26638418,0.0018871468,0.018628497,0.14139132,0.18016128,0.00065064576,0.0018883942
pathophysiologic events related thermal injury skin acute thermal injury skin equivalent second degree injury involving approximately total body surface results series pathophysiologic events lead local distant tissue organ injury distant effects involve intravascular hemolysis acute lung injury attributed complement activation intravascular stimulation neutrophils resulting oxygen radical production results injury red cells pulmonary vascular endothelial cells local site thermal injury progressive increase vascular permeability linked complement activation histamine release outcome interaction histamine xanthine oxidase resulting enhanced catalytic activity enzyme toxic oxygen products xanthine oxidase including h conversion product hydroxyl radical appear linked damage dermal vascular endothelial cells resulting progressive vascular permeability increased vascular permeability greatly attenuated use inhibitors xanthine oxidase inhibitor histamine release cromolyn catalase iron chelator deferoxamine scavengers hydroxyl radical interestingly neutrophils appear play little role dermal vascular injury animal model thermal trauma studies suggest pathophysiologic events following local thermal trauma complex involve variety mediator pathways,C21,0.08090748,0.001625294,0.003630069,0.0010294645,0.020290686,0.08292157,0.3272513,0.037584506,0.0013246326,0.0018002896,0.008737337,0.039242085,0.015162129,0.05411435,0.054972906,0.0117182145,0.02257685,0.02064102,0.002086282,0.017178817,0.18380454,0.009515101,0.0018851067
effects individually motivating smoking cessation male blue collar workers adverse demonstrable health effects linked individual smoking shown american workers motivate cessation routine examinations detect asbestosis intervention evaluated six months later mailed questionnaire telephone non responders results compared yearly quit rates percent percent workers ex smokers initial examination men responded mail percent quit smoking percent cut mean cigarettes per day percent smoking subsequent follow one year showed percent remained quit percent cut quit overall quit rate percent non responders contacted telephone percent quit percent reduced smoking samples quit likely lower alveolar carbon monoxide coa levels older asbestosis responders mail age non responders smoked longer higher prevalences asbestosis emphysema chronic bronchitis higher coa demonstration adverse personal effects smoking appear contributed quit rates reduced smoking rates percent responding workers,C21,0.0022292256,0.0019763173,0.004157154,0.0012518032,0.013844062,0.0028753064,0.14691536,0.0020952064,0.0016107203,0.012956609,0.062136102,0.0045825006,0.019982964,0.005410924,0.0019592172,0.003514205,0.23357874,0.0022974464,0.024099087,0.32822996,0.1212106,0.0007910698,0.0022954352
poly l lactide implants repair defects orbital floor animal study life long presence alloplastic nonresorbable orbital floor implants complications use mentioned literature use resorbable material appears preferable repair orbital floor defects high molecular weight polymerized poly l lactide plla used repair orbital floor defects blowout type goats artificial defect created bony floor orbits reconstruction orbital floor carried using concave plla implant mm thickness weeks postoperatively one goat killed microscopic examination showed full encapsulation implant connective tissue weeks weeks resorption remodeling bone points support implant could detected differentiation sinus orbital sides connective tissue capsule observed orbital side showed significantly dense capsule antral side loose appearance weeks bony plate progressively formed weeks new bone fully covered plate antral orbital side inflammation rejection plla implant seen,C21,0.0026572547,0.053812575,0.030663583,0.0014930925,0.06490512,0.016240641,0.17132013,0.015355843,0.0019210768,0.0026109086,0.07435599,0.0054951343,0.04054366,0.101355456,0.0023367226,0.004137898,0.116234064,0.0027365317,0.0030256752,0.06335695,0.18102223,0.00094349455,0.04347604
unintended injuries children french situation french situation respect mortality unintentional injuries children far satisfactory international comparison made difficult statistical bias although excess injury mortality decreasing france rates higher advanced european countries many regulations enacted past years reduce economic social burden injuries political insufficient establish consolidated national program enforcement existing legislation inadequate evaluation preventive educational programs less optimal many attempts met basic methodologic requirements situation improving partly growing social concern new regulations preparation solution major public health problem also demands behavioral change much difficult effect measures greater commitment research proper evaluation sound programs enforcement existing law doubtless would reduce excess morbidity mortality resulting unintended injuries children,C21,0.06188877,0.015632933,0.0044956096,0.024675302,0.026681986,0.036241222,0.2315776,0.0022657881,0.0017418576,0.03736002,0.023878274,0.016611755,0.053733252,0.020342886,0.0021187274,0.062065523,0.034414653,0.0024812378,0.044850636,0.18321702,0.11039086,0.00085547497,0.0024786573
role buspirone management alcohol withdrawal preliminary investigation one hundred eighteen patients men women ranging age years age admitted inpatient facility central new york administered buspirone hcl treatment alcohol withdrawal syndrome although one patient unwitnessed seizure none subjects required discontinuance buspirone hcl symptoms dizziness nausea headache nervousness lightheadedness typical side effects described manufacturer one individuals given buspirone hcl alcohol detoxification completed phase treatment within six days manner effectively controlled withdrawal symptoms findings suggestive important role buspirone hcl detoxification alcohol dependent patient using pharmacologic agent traditional medications benzodiazepines phenobarbital beta blockers magnesium sulphate clonidine,C21,0.003516217,0.00311906,0.006560896,0.001975619,0.0048962208,0.0045378613,0.3113987,0.020319864,0.0025420685,0.003475416,0.035156894,0.0076445797,0.046414055,0.008084869,0.020098813,0.022494748,0.15254018,0.0036211205,0.021005189,0.1568183,0.15891351,0.0012484809,0.0036173544
physician role physicians play important role society response alcohol problems diagnosis alcohol problems among patients frequently overlooked physicians routinely ask patients alcohol intake light evidence effectiveness brief interventions especially heavy drinking nondependent patients physicians treatment efforts focused direction patients alcohol dependent might best treated nonphysicians research contributions physicians concentrated topics physician input needed longitudinal studies health consequences factors contributing mortality health service costs biochemical markers alcohol use basic pharmacology strong evidence links population alcohol consumption levels overall harm therefore prevention efforts aimed population well people may risk physicians contribute efforts influencing public policy setting healthy examples alcohol use,C21,0.0028395501,0.030009568,0.005298306,0.0015954274,0.0039539835,0.019961633,0.32553858,0.0026703472,0.0020528683,0.0027900247,0.030370655,0.005840412,0.034019914,0.0075015086,0.0024970288,0.018452462,0.098224565,0.0029264328,0.13814043,0.14594132,0.11544555,0.0010082211,0.0029212243
aid management pediatric trauma peripheral centers proposal pediatric trauma board children age living queensland accounted australia pediatric population year pediatric deaths queensland resulting road traffic incidents another injured children admitted hospital less children treated accident emergency e department staffed qualified pediatrician e departments staffed qualified emergency physician pediatric trauma board proposed lead improvement care injured critically ill pediatric patients board made pre marked whiteboard includes normal pediatric values replacement fluid flow charts approximately three feet height six feet width board aimed primarily nonpediatric clinicians may may specifically trained interested emergency medicine provides quick easy access normal values vital signs children different ages sizes enables accurate calculation fluid requirements resuscitation provides means following response therapy drug doses per weight provided copy board made size photostats inclusion hospital chart part admission notes,C21,0.002157689,0.0019139779,0.014630717,0.0012123175,0.003047172,0.013219925,0.26443294,0.002029117,0.02242508,0.06479365,0.022840267,0.014877748,0.10816977,0.0050486764,0.0018974174,0.02423698,0.23065807,0.0128489295,0.0024568464,0.07427728,0.10983834,0.000766117,0.0022209634
characteristics correlates asthma university clinic population contribute comprehensive information characteristics asthma article analyzed patients served university alabama birmingham comprehensive asthma program physicians rated one fifth patients severe asthma remainder equally divided moderate mild one two first received diagnosis asthma ten years previously common comorbidities hypertension obesity rhinitis bronchitis sinusitis arthritis one half visited emergency room hospitalized asthma past year inhaled bronchodilators continuous theophylline commonly prescribed medications side effects especially tachycardia insomnia common almost exclusively associated theophylline corticosteroid therapy spirometric assessment showed chronic airflow obstruction severe asthma prevalence respiratory symptoms intensity medication regimen incidence side effects health care utilization increased asthma severity increased,C20,0.01728802,0.0156139545,0.0051490795,0.014721274,0.003797815,0.028563276,0.30713433,0.002564878,0.001971787,0.01672116,0.040694475,0.024576869,0.04256474,0.0064448984,0.015596577,0.017411202,0.124674514,0.0028087676,0.026670469,0.17642714,0.104819484,0.00096839987,0.0028168734
amyloidosis saphenous vein aortocoronary bypass grafts patient idiopathic amyloidosis aortocoronary saphenous vein grafts found autopsy two years myocardial revascularization due coronary atherosclerosis reported idiopathic generalized immunocyte derived amyloidosis extensively studied autopsy obviously present time surgery although remained unnoticed macroscopically inserted graft appears simultaneously arterialization deposition also significant redistribution amyloid within walls vein grafts additionally took place insertion seems interesting spite amyloidosis grafts functioned well found patent two years surgery,C20,0.004521552,0.0040062326,0.008427051,0.002537556,0.006288882,0.005828592,0.3750638,0.038248222,0.003265124,0.0044375844,0.021460887,0.0092892805,0.09388367,0.010532237,0.0039715692,0.007032905,0.22334331,0.0047006435,0.005142535,0.040352155,0.12140043,0.0016035938,0.004662183
activation complement system human immunodeficiency virus infection relevance classical pathway pathogenesis disease severity vitro studies implicate classical alternative complement pathway activation pathogenesis human immunodeficiency virus hiv infection ascertain importance vivo activation fragments classical c alternative ba common c pathways measured fragment parent molecule ratios derived hiv infected individuals related circulating immune complex cic levels centers disease control cdc stage beta microglobulin neopterin cd positive cd lymphocyte levels fragments ratios significantly higher patients p less controls c conversion indices c c c increased linearly increasing cdc stage p less cd lymphocytes decreased linearly p less c c c c c c correlated increasing cic beta microglobulin c c c correlated decreasing cd lymphocytes p less relationship classical complement pathway activation disease progression cd lymphocytes suggests involvement pathogenesis hiv infection,C20,0.0024964078,0.0022144385,0.004728453,0.0014026298,0.003476169,0.0032217444,0.18017685,0.0023484093,0.0018047919,0.0024528673,0.01728242,0.042356446,0.21828564,0.11474239,0.014276059,0.0038874263,0.09578896,0.06264567,0.0028425276,0.022263141,0.18409772,0.00088638376,0.016322408
dust mite assays clinical allergy practice mite antigen exposures among skin test positive patients kansas attempted determine whether sensitive monoclonal antibody assays dermatophagoides mite antigens der p der f carried private clinical allergy practice laboratory ascertain incidence significant home mite exposure dust samples patient homes kansas consider whether information impacts patient management analyzed dust samples patient homes patients skin prick test positive one common mite species available skin testing potentially relevant histories der p der f antigen levels added together levels micrograms g dust considered positive definition elevated levels found least one sample homes tested however mattress samples tested carpet samples furniture samples levels considered likely cause symptoms samples yielded der p levels micrograms g conclude monoclonal antibody assays der p der f antigens performed well equipped office laboratory staffed trained medical technologists der f predominant mite species kansas data derived mite assays may important treatment planning patients suspected mite related allergy symptoms,C20,0.0018654017,0.013095214,0.020226073,0.0010480932,0.03871738,0.01801681,0.2350122,0.0017550654,0.0013486025,0.0018403865,0.16662984,0.003836775,0.023322737,0.079643816,0.010669063,0.0029048186,0.086587064,0.009178028,0.028679824,0.12728415,0.12574735,0.0006623364,0.0019289296
relapse safer sex next challenge aids prevention efforts prevention campaigns reduce sexual transmission human immunodeficiency virus hiv typically emphasize initial adoption safer sex techniques present data year prospective study show vast majority resident gay men san francisco made initial risk reductions rather relapse safer sex techniques predominant predominant kind high risk sex accounting approximately two thirds prevalent high risk sex wave data collection predictors relapse safer sex identified discussed terms implications preventing relapse exclusive practice safe sex communities already manifested widespread behavioral risk reductions hiv infection highly prevalent finding ways prevent relapse behavioral risk reductions next important challenge fight acquired immune deficiency syndrome,C20,0.0024975783,0.050559025,0.016742095,0.0014027288,0.0034764146,0.015291705,0.27387485,0.002347818,0.0018049193,0.0024530406,0.061269425,0.0051366254,0.016678274,0.03346318,0.0021954332,0.0038877008,0.073800564,0.0025710678,0.039098028,0.28021562,0.095683366,0.012965447,0.0025850846
bronchoconstriction induced spirometric maneuvers patients bronchial asthma analyzed forced expiration maneuver induced bronchoconstriction asthmatic patients seven normal subjects breaking forced expiration maneuver spirometry fvc maneuver two phases slow deep inspiration total lung capacity tlc di maneuver forced expiration residual volume rv pfv maneuver specific airway conductance sgaw measured functional residual capacity frc three maneuvers maneuvers caused greatest bronchoconstriction immediately completion maneuver mean decreases sgaw immediately fvc di pfv maneuvers sd p less p less p less respectively decrease sgaw fvc maneuver close combined algebraic sum di maneuver pfv maneuver normal subjects show changes sgaw maneuvers inhalation albuterol almost abolished response bronchoconstriction three maneuvers inhalation anticholinergic agent ipratropium bromide blunt response study suggests forced expiration maneuver induced bronchoconstriction asthmatics caused deep inspiration tlc also forced expiration rv bronchoconstriction may brought mainly increase parasympathetic activity,C20,0.002252223,0.001997834,0.0042024143,0.0012654322,0.0031361491,0.046516385,0.114417665,0.0021180178,0.056141544,0.012899429,0.032514635,0.004647138,0.1418253,0.21840243,0.0019806009,0.036213096,0.07085381,0.013276158,0.0025644873,0.015849605,0.21379659,0.0007996826,0.002329416
functional assessment scales study persons multiple sclerosis purpose study investigate disability persons multiple sclerosis ms using combinations functional assessment scales subscales predict burden care measured minutes assistance provided per day another person home subject level satisfaction life general functional independence measure fim incapacity status scale environmental status scale barthel index high intercorrelations although predictive ms subject physical care needs fim useful change total fim score one point equivalent average minutes help another person per day brief symptom inventory environmental status scale fim contributed predicting patient general satisfaction well propose burden care subjective satisfaction life standards functional assessment instruments compared reflect pragmatic terms impact disability lives individuals human economic resources community,C20,0.002437607,0.002162279,0.0045551863,0.0013695919,0.0034000375,0.02495324,0.25073993,0.002292355,0.0017622813,0.016670203,0.090285584,0.07552388,0.115264684,0.0066659916,0.0021436217,0.003795861,0.03506043,0.002510331,0.0032690244,0.15141873,0.20032656,0.00086550566,0.0025270483
immunoblot analysis sera patients allergic bronchopulmonary aspergillosis correlation disease activity immunoblot analysis used evaluate igg ige iga responses aspergillus fumigatus antigen sera five patients allergic bronchopulmonary aspergillosis abpa suspected exacerbation disease results revealed heterogenous antibody response unique patient specific aspergillus fumigatus antigens correlated molecular weights previously well characterized antigens importance immunopathogenesis abpa rating scale devised measuring band intensity allowed patient antibody responses reproducibly semiquantitated immunoblot analysis demonstrated qualitative semiquantitative information available vitro assays used study patients abpa elisa initial results emphasize need additional evaluation technique assess potential clinical application disease,C20,0.002961827,0.016963216,0.019825058,0.0016641297,0.018895095,0.0038223919,0.33935875,0.0027853379,0.002141269,0.0029101688,0.031291977,0.006091912,0.048787594,0.12153216,0.04561374,0.018946543,0.1300848,0.0030531834,0.0033724755,0.020696945,0.15509155,0.0010516371,0.0030582123
protection allergen induced asthma salmeterol effects long acting beta agonist salmeterol early late phase airways events provoked inhaled allergen assessed group atopic asthmatic patients placebo controlled study salmeterol micrograms inhaled allergen challenge ablated early late phase allergen induced bronchoconstriction h time period salmeterol also completely inhibited allergen induced rise non specific bronchial responsiveness time period effects shown unrelated prolonged bronchodilatation functional antagonism data suggest novel actions topically active long acting beta agonists asthma extend beyond protective action airways smooth muscle,C20,0.0036402384,0.003229073,0.006792307,0.0020453015,0.0050689164,0.039941438,0.17291524,0.0034233243,0.0026317302,0.003576748,0.034653246,0.025110332,0.025443293,0.031672433,0.020718528,0.052170314,0.14493357,0.0038383324,0.021754121,0.03358772,0.32151538,0.0012925164,0.04004586
failure cell receptor anti cd monoclonal antibody interaction cells marrow recipients induce increases intracellular ionized calcium multiple immune defects cells recipients bone marrow transplantation bmt study examines recipient cells increases intracellular ionized calcium concentration ca binding cell receptor cd complex anti cd mab pbl short term recipients less yr bmt responded poorly less control anti cd stimulation pbl blunted calcium flux responses control purified cd cd cells seven additional short term recipients including three autologous marrow recipients closely examined sizable proportion cd cells six seven recipients increase ca anti cd stimulation decreased magnitude responses due decreased numbers responding cells decrease mean cd fluorescent intensity calcium flux responses single cell basis five seven long term recipients greater yr bmt pbl responded normally two seven pbl blunted calcium flux responses data show signal transduction response mediated cd antigen receptor measured calcium flux defective early autologus allogeneic bmt,C20,0.0018669143,0.010686794,0.0035092798,0.0010483437,0.0030854864,0.0024079736,0.15266299,0.0017552021,0.0013489248,0.0018520901,0.018146187,0.0038563842,0.17143509,0.20331788,0.010667927,0.020933868,0.045758042,0.05888033,0.011065731,0.030359827,0.24275798,0.00066249474,0.001934242
selective induction toxicity human cells expressing human immunodeficiency virus type tat conditionally cytotoxic adenovirus vector human immunodeficiency viruses hivs primarily infect cd lymphocytes leading eventually development systemic immune dysfunction termed acquired immunodeficiency syndrome aids attractive strategy combat hiv mediated pathogenesis would eliminate initial pool infected cells thus prevent disease progression engineered replication defective conditionally cytotoxic adenovirus vector ad tk whose action dependent targeted expression herpes simplex virus type thymidine kinase gene tk cloned downstream hiv long terminal repeat human cells expressing hiv transcriptional activator tat infection tat expressing human hela jurkat cells ad tk resulted high level tk expression deleterious viability cells however presence antiherpetic nucleoside analog ganciclovir ad tk infection resulted massive reduction viability tat expressing cell lines adenoviruses natural passengers human lymphoid system results suggest adenovirus vector based strategies targeted expression control cis responsive hiv regulatory elements cytotoxic agents hiv infected cells therapy hiv mediated pathogenesis,C20,0.0021135074,0.012104433,0.014172724,0.011806616,0.023399388,0.012930218,0.2631633,0.0019875679,0.0015279717,0.012300769,0.009975133,0.004388725,0.030831883,0.1930591,0.001858565,0.013516177,0.029511271,0.027939951,0.0126150865,0.07190396,0.11888815,0.00075042964,0.1292551
immune complexes pediatric human immunodeficiency virus infection circulating immune complexes cic analyzed cohort children infected human immunodeficiency virus elevated cic detected c q assay patients raji cell assay patients less one third patients elevated cic free serum antibodies epstein barr virus detectable antibodies epstein barr virus associated cic enriched cic human immunodeficiency virus infected children contained low levels complement findings document expression humoral immunodeficiency cic human immunodeficiency virus infected children deficient complement thus underestimated complement precipitating methods used detection,C20,0.0030490302,0.002704642,0.005811604,0.0017131257,0.048525922,0.0039349324,0.12427851,0.002867345,0.0022043132,0.04727907,0.06762875,0.050543413,0.037364528,0.114459775,0.0026812402,0.004747974,0.10313633,0.0031510848,0.0034717694,0.050848275,0.14387077,0.0010825999,0.17464505
incubation period aids lengthening data cohort study homosexual men los angeles used estimate distribution times hiv infection aids detect changes distribution find weak statistically significant evidence incubation period lengthening incubation period distribution assumed changed estimate proportion developing aids within years hiv infection confidence interval however assume incubation period distribution began change july estimate individuals infected first half develop aids within years infected first half develop aids years four different hypotheses suggested lengthening incubation period treatment hypothesis cofactor hypothesis better health care hypothesis changing virus disease hypothesis statistical method used semiparametric modeling joint distribution date infection incubation period participants study methods although computationally intensive attractive way analyzing data prevalent cohort minimal parametric assumptions made,C20,0.0020108388,0.0017837144,0.062158003,0.0011298084,0.02226655,0.0025950922,0.26826355,0.0018910172,0.0014537469,0.0019757673,0.082929544,0.004235289,0.028730962,0.0480403,0.0017682809,0.003133693,0.12019309,0.0020708307,0.012010517,0.15714602,0.16089086,0.0007139758,0.012608569
immunology hiv infection biology interferons interferons ifn prototypic biologic response modifiers comprise multigene family regulatory proteins glycoproteins affect variety cellular functions including normal neoplastic cell growth immune reactivity host parasite interactions importance basic cell biology cellular immune defense interactions human immunodeficiency viruses hiv molecular cellular levels form basis review,C20,0.004832059,0.0042862776,0.009016121,0.0027149369,0.030110177,0.006236024,0.3142479,0.004544127,0.0034933637,0.004747782,0.022282759,0.009938622,0.036480986,0.16917656,0.027637564,0.007524521,0.042378653,0.02880313,0.00550201,0.081893474,0.15202788,0.0017156886,0.030409383
hodgkin disease cd positive anaplastic large cell lymphomas continuous spectrum malignant disorders quantitative morphometric immunohistologic study authors examined cellular areas lymphoma tissue cases hodgkin disease hd anaplastic large cell lymphoma alcl ki cell lymphoma evaluate boundaries two entities methods applied included conventional histology test point analysis semiautomated morphometry nuclear profile features reed sternberg atypical large cells rsalcs immunohistochemistry elements paraffin sections cases frozen sections mean nuclear profile morphotypes rsalcs per case varied independently immunophenotype histologic diagnosis conversely immunohistochemistry demonstrated significant although consistent preferential positivities cd elements cd hd epithelial membrane antigen ema cd alcls latter rsalcs also exhibited tendency cd cd ro positivity expression cell associated antigens however considerable overlaps continuous spectrum rsalc nuclear profile morphotypes immunophenotypes ranging hd questionable cases intermediate hd alcl alcls paralleled differences reactive component lymphomas lymphocytes granulocytes significantly deficient alcls,C20,0.0023026103,0.0020425303,0.034698416,0.012433269,0.0032085236,0.0029716385,0.20875527,0.024455287,0.023955002,0.024541717,0.14712472,0.00479071,0.036793526,0.08659565,0.0020248573,0.0035856431,0.05189453,0.0135122975,0.0026218605,0.061535213,0.22374183,0.0008175733,0.025597291
transfusion induced graft versus host disease patients malignant lymphoma case report review literature case transfusion induced graft versus host disease gvhd occurring year old female hodgkin disease complete remission reported clinical features similar reported cases transfusion induced gvhd associated malignant lymphoma lack relationship underlying histology disease stage nearly uniformly fatal outcome underscores importance prophylactic irradiation blood products given patients malignant lymphoma undergoing therapy,C20,0.0039917864,0.022859573,0.007448259,0.002242822,0.005558436,0.024470495,0.3139762,0.023071246,0.0028858837,0.0039221644,0.05658684,0.008352574,0.04604828,0.009326222,0.022830635,0.0062160413,0.11309741,0.02339783,0.004545236,0.07646383,0.21718429,0.0014173383,0.0041066026
immunoproliferative small intestinal disease portrait potentially preventable cancer third world purpose review recent progress understanding clinical laboratory characterization well management immunoproliferative small intestinal disease ipsid data identification literature search conducted using index medicus medline bibliographies identified relevant articles study selection international comprehensive reviews reported epidemiologic immunologic studies prospective clinical trials published abstracted english selected results data synthesis high incidence lymphoma primarily gastro intestinal tract third world countries stimulated enormous epidemiologic pathogenetic interests globally ipsid distinctive biologic marker alpha heavy chain para protein affects young underprivileged population countries initially benign appearing antibiotic responsive immunoproliferative lesions often evolve fatal high grade lymphomas roles environmental host factors evolutionary course emerging recently demonstrated malignant potentials form early onset pathogenesis given new dimension traditional management strategy ipsid conclusions epidemiologic immunologic pathogenetic data emerged last year study ipsid improved understanding complexity infection immunity cancer interrelationships comparable arisen study acquired immunodeficiency syndrome early detection institution antimicrobial based treatment regimens judicious consistent follow save lives many young patients whose manpower badly needed third world countries,C20,0.0016696528,0.0014810653,0.0031153988,0.00093810976,0.010411214,0.028210303,0.40218464,0.0015701617,0.0012070846,0.025885496,0.035794906,0.020037469,0.055709288,0.014585516,0.009529195,0.010661314,0.076563045,0.017880112,0.0180567,0.15843078,0.08747785,0.00059283304,0.018007865
dideoxycytidine alone alternating schedule zidovudine children symptomatic human immunodeficiency virus infection objective determine whether short course dideoxycytidine ddc could provide safe antiretroviral activity children symptomatic human immunodeficiency virus infection whether could used azidothymidine azt zidovudine goal maintain uninterrupted antiretroviral therapy sparing azt related myelosuppression ddc related neuropathy methods pilot study evaluated four dosage levels ddc mg kg given orally every hours children months years age centers disease control p e symptomatic human immunodeficiency virus infection thirteen patients prior antiretroviral therapy two patients received benefited azt dose limiting neutropenia developed dosage level ddc given consecutive weeks stopped day rest schedule ddc week followed weeks azt therapy mg every hours alternating schedule repeated long tolerated age appropriate psychometric testing performed start ddc therapy weeks results weeks therapy ddc alone neutropenia anemia observed patients decreases p antigen levels increased cd cell count mg kg level rash developed three patients mild mouth sores developed patients alternating ddc azt schedule neuropathy observed conclusions dideoxycytidine antiretroviral activity children appears safe short intervals longer courses ddc lower dosage levels schedules integrating ddc combination regimens deserve explored,C20,0.016361292,0.008767601,0.010266157,0.037971064,0.0021368745,0.001978636,0.27029946,0.0014418119,0.0011084138,0.031196028,0.024546944,0.0131007265,0.057704423,0.053906996,0.0013482312,0.009806293,0.14474209,0.001589277,0.0017457398,0.0561056,0.22606611,0.00054437306,0.027265843
predicting need hospitalization children acute asthma attempt identify factors influence decision physicians admit patients acute asthma hospital studied prospectively children age years mean sd presenting emergency room acute asthma children assessed arrival disposition emergency room one investigators obtaining historic data clinical score assigned oxygen saturation pulmonary function measured percent children discharged home emergency room five returned within seven days one subsequently admitted clinical score disposition sole variable found best predict decision hospitalization sensitivity percent specificity percent variables obtained presentation resulting decision tree found clinical score predict decision hospitalization sensitivity percent specificity percent individual components clinical score analyzed degree dyspnea assessed investigator chosen rule predict hospitalization decision sensitivity percent specificity percent conclude decision respect need hospitalization acute childhood asthma practice based mainly careful clinical evaluation pulmonary function sao measurements although helpful adjuncts assessment acute asthma appear contribute identification patients need hospital admission,C20,0.019411717,0.0017040429,0.049819395,0.0010673043,0.011839703,0.012499452,0.28374097,0.001786401,0.0013733219,0.03865191,0.072467536,0.039265435,0.0761646,0.0046724044,0.0016704549,0.0029580628,0.18131879,0.0020374777,0.011355559,0.14098568,0.042575683,0.0006744768,0.001959617
differences knowledge risk factors aids hispanic non hispanic women attending urban family planning clinic risk factors aids contraceptive use seroprevalence hiv level knowledge aids education session assessed clients attending family planning clinic los angeles usa history partner bisexual intravenous drug user blood transfusion recipient common risk factors spanish speakers reported fewer traditional risk factors english speakers also less likely report history drug alcohol use sexually transmitted diseases fewer sexual partners less one third women identified risk exposure using condoms none consecutive patients tested hiv antibodies positive english speakers scored higher pre post tests knowledge aids cultural factors may lower personal risk hiv exposure spanish speaking women lack knowledge aids partner behavior may increase risk,C20,0.0023813418,0.0021123688,0.06208436,0.0013379788,0.0033159428,0.014585153,0.16631205,0.0022394427,0.001721604,0.01384985,0.07049413,0.027649634,0.09333287,0.05586528,0.025149673,0.0037249012,0.06918149,0.0024523872,0.0027169304,0.32701373,0.04918353,0.0008455279,0.0024498366
effect inhaled methacholine inspiratory flow one hundred consecutive outpatients symptoms suggestive asthma came pulmonary function laboratory methacholine challenge test studied addition forced expiratory maneuvers forced inspiratory maneuvers performed maximal response methacholine patients methacholine challenge suggested asthma forced expiratory volume fev decrease greater equal percent six patients also decrease maximal forced inspiratory flow fifmax greater equal percent nine decrease forced inspiratory flow percent vital capacity fif greater equal percent suggesting bronchoconstriction cause decreased inspiratory well expiratory flows patients methacholine challenges negative fev decrease less equal percent suggesting asthma nevertheless patients fifmax decrease greater equal percent patients fif decrease greater equal percent suggesting intermittent central airway obstruction responsible patients symptoms,C20,0.013879486,0.0021123362,0.004443268,0.001337958,0.0033158916,0.0031007004,0.12691702,0.002239408,0.05936011,0.10882439,0.044352878,0.004897889,0.10590961,0.028649867,0.0020940595,0.0037081868,0.20247062,0.0024523493,0.0027114658,0.01561923,0.2006669,0.058486555,0.0024497986
modulation interleukin beta rna monocytic cells infected human immunodeficiency virus effect hiv infection cytokine levels studied monocytic cells using northern blotting analysis monoblasts thp u express il beta rna even cells infected hiv exposure lps micrograms ml tetradecanoylphorbol acetate tpa nm h hiv infected monoblasts accumulated fold greater levels il beta rna compared hiv uninfected counterparts similarly stimulated contrast levels rnas coding monocyte colony stimulating factor csf tumor necrosis factor alpha tnf alpha elevated less twofold hiv infected cells compared hiv uninfected cells stimulation lps tpa inhibition new protein synthesis block marked accumulation il beta rna produced exposure lps tpa hiv infected cells time course experiments showed maximal levels il beta rna occurred h lps tpa stimulation hiv infected uninfected u cells respectively studies stability rna using actinomycin showed il beta rna equally stable infected uninfected u cells stimulation tpa lps taken together data show hiv infection markedly augments il beta rna accumulation stimulated monocytic cells probably increasing rate transcription il beta,C20,0.0019173175,0.0017007564,0.0035775157,0.0010772625,0.021230794,0.0024743981,0.1626103,0.0018030687,0.01066383,0.0018838771,0.021497834,0.004045536,0.037117183,0.14184564,0.0016860407,0.003022418,0.020194452,0.041440334,0.002183148,0.02806065,0.28847986,0.009957524,0.19153029
computer assisted selection assessment antibodies diagnosis lymphomas increasing numbers reagents problem selecting appropriate antibodies solve problems diagnosis lymphoma becoming complex one approach use computer program optimise selection process program devised incorporating data extensive literature search presented differential diagnosis selects appropriate antibody panel given results evaluates relative likelihood possible diagnosis retrospective study tests used non discriminatory using results remaining tests computer able select correct diagnosis high degree certainty development use system illustrated several problems application computer assisted diagnostic techniques histopathology problems include incomplete data lack understanding process histopathological diagnosis,C20,0.0026234158,0.0023271006,0.018976795,0.0014739903,0.0036530232,0.0033856547,0.36866125,0.002467092,0.0018966128,0.00257766,0.15803392,0.0054489677,0.024074536,0.06908871,0.0023069656,0.04607225,0.0370237,0.0027016832,0.024843473,0.09917432,0.11955855,0.0009314796,0.0026988734
rapid specific diagnosis hiv hiv infections evaluation testing strategies identify cost effective testing strategies hiv hiv infections evaluated different combinations tests serum specimens consecutive patients attending tuberculosis treatment centers abidjan cote lvoire virus specific whole virus enzyme linked immunosorbent assay wve western blot wb synthetic peptide enzyme linked immunosorbent assay spe used sequential fashion determine true prevalence infection reactive hiv hiv viruses specimens positive wb hiv hiv spe diagnosed hiv reactive hiv reactive remained reactive viruses using wve one two rapid min mixed hiv hiv antigen tests rmats screening test followed spe supplemental test gave results sensitivity specificity positive predictive value diagnosing hiv infection important savings time reagent costs spe allows specific distinction hiv hiv infections wb could replace supplemental test many settings wb may required specimens reactive screening tests negative spe sensitivity spe evaluated mixed antigen screening test followed spe seems efficient testing strategy diagnosing hiv hiv infections,C20,0.0020921973,0.0018558834,0.014074253,0.0011755202,0.029497929,0.0027000895,0.28880554,0.0120837,0.0060317726,0.0020557067,0.27393714,0.014844468,0.05573218,0.03168318,0.0018398254,0.0032728522,0.075349316,0.0021546162,0.012473927,0.02407146,0.09939837,0.0007428632,0.04412722
diagnosis mold allergy rast skin prick testing sera patients mold allergy proven bronchial provocation analyzed specific ige six mold species comparing improved phadebas rast four techniques new method sensitive gave significantly higher ige antibody concentrations tested molds except cladosporium herbarum,C20,0.005944001,0.0052726255,0.03811441,0.0033396918,0.03705181,0.0076710433,0.1980584,0.0055898107,0.004297248,0.0058403304,0.20746084,0.012680944,0.087865554,0.054701526,0.0052270046,0.009256046,0.09046624,0.0061213356,0.0067681195,0.05602135,0.14392504,0.002110499,0.0062161563
tracking spread hiv infection epidemic among young adults united states results first four years screening among civilian applicants u military service period infection clinically apparent disease long variable changing new therapies developed applied aids data inadequate tracking current values critical parameters hiv infection epidemics prevalence infection rate acquisition new infections incidence rate direction rate change infection incidence time acceleration vital signs infection epidemics tracked using serial cross sectional seroprevalence data however october september million applicants u military service screened antibody hiv overall seroprevalence per seroprevalences highest near urban centers aids epidemic independently associated age race ethnicity gender based age seroprevalence trends crudely estimated least one young men one young women infected hiv annually u infection incidence rates estimated age temporal trends estimated highest among black males year lowest among white females year poisson regression analysis seroprevalence trends suggested infection incidence rates accelerated among black females first years screening since selection factors undoubtedly changed period estimates based data probably underestimate actual values general population particularly near urban aids epicenters nonetheless even crude estimates critical values particularly among adolescents young adults useful guide policy development allocate resources monitor program effects,C20,0.0015922859,0.0014124371,0.036185548,0.0008946405,0.009922024,0.009729012,0.24969229,0.001497405,0.008857302,0.0015645145,0.116951846,0.003275028,0.043770056,0.019782124,0.00908129,0.010184905,0.031931423,0.009324879,0.030394675,0.33711192,0.064640954,0.00056536286,0.0016380851
anaphylaxis induction general anesthesia subsequent evaluation management twenty seven patients referred evaluation anaphylaxis induction general anesthesia ga thiobarbiturates muscle relaxants antibiotics administered intravenously skin testing prick intracutaneous methods performed dilutions thiobarbiturates muscle relaxants beta lactam reagents used patients also received drugs skin test reactivity noted normal subjects skin tests positive patients thiobarbiturates five muscle relaxants six antibiotics two patients two patients dermatographic yielded indeterminate skin test results eleven patients subsequently ga patients received premedication regimen prednisone diphenhydramine three patients negative skin tests one experienced arrhythmia signs attributable anaphylaxis noted one patient dermatographism ga without reaction positive skin tests implicated agent avoided seven patients one patients experienced delayed urticaria angioedema completion ga thus patients developed anaphylaxis subsequent ga agents producing positive skin tests avoided premedication regimen used,C20,0.0022765307,0.0020193965,0.015243042,0.0012790898,0.10236063,0.0029379816,0.18863347,0.002140877,0.034709025,0.024275303,0.19300927,0.005355844,0.03013021,0.0054319217,0.0020019237,0.025581066,0.24382731,0.0023472481,0.0025921653,0.049927533,0.0497517,0.0008083134,0.01336018
breakdown blood brain barrier precedes symptoms mri signs new lesions multiple sclerosis pathogenetic clinical implications extensive serial magnetic resonance imaging mri study multiple sclerosis ms identified cases disruption blood brain barrier detected gadolinium dtpa enhancement preceded mri abnormalities case clinical evidence new lesion supports view defect blood brain barrier therefore inflammation early possibly crucial event pathogenesis new lesion ms cases showed marked discrepancy mri abnormality symptoms mechanisms contributing disparity discussed concluded far surprising expected,C20,0.0035771634,0.02047671,0.023981698,0.0020098623,0.09136885,0.0046165157,0.41896832,0.003364008,0.00258613,0.023118835,0.096259676,0.0073575415,0.07888878,0.032558817,0.0031456673,0.0055703875,0.04974272,0.0036838853,0.0040731267,0.0411628,0.07853326,0.0012701207,0.0036851172
surgery juvenile chronic arthritis overview surgery well established place management childhood arthritis however satisfactory results achieved team medical experts composed pediatric rheumatologist orthopedic surgeon anesthetist physiotherapist others knowledgeable particular problems juvenile chronic arthritis aggressive team approach offers best available help,C20,0.004948478,0.028343443,0.009233346,0.026728341,0.03078469,0.007498909,0.35808197,0.0046536084,0.0035775292,0.07168302,0.023521816,0.010178073,0.030952666,0.038815424,0.0043515665,0.0077058095,0.18535642,0.005096112,0.005981715,0.07336142,0.06229782,0.0017570248,0.0050908118
effect repetitive exercise airway temperatures determine relationship exists intra airway thermal events reduction pulmonary mechanics occur asthmatics perform repetitive exercise recorded intrathoracic airstream temperatures seven subjects two identical bouts cycle ergometry performed min apart data global regional thermal energy exchanges calculated inspired air conditions work loads minute ventilations held constant trials pulmonary mechanics measured prior serially challenge expected second provocation produced smaller response first association mechanical changes second challenge also produced less airway cooling slower rewarming central airways hence repetitive exercise trials performed short intervals attenuate essential thermal gradients necessary produce obstruction extent differences intra airway temperature reflect changes perfusion data raise possibility responsivity bronchial microcirculation asthmatics may altered repetitive exercise,C20,0.01365988,0.043249432,0.055673975,0.0011999315,0.0029738173,0.083641425,0.15697263,0.002008386,0.0015439759,0.0020983962,0.012876551,0.025468469,0.11879721,0.0050071464,0.03288835,0.013811884,0.07700389,0.0021993597,0.023108592,0.09873302,0.21380906,0.00075828977,0.012516344
value multiantigen radioallergosorbent test diagnosing atopic disease young children purpose study investigate value new multiantigen radioallergosorbent test phadiatop paediatric diagnosis atopy children less years age diagnosis atopic disease established history physical examination total serum ige concentration results prick skin tests radioallergosorbent tests compared result phadiatop paediatric test patient one hundred two patients boys ages months years enrolled median age years history physical examination patients believed atopic nonatopic diagnosis uncertain skin prick test reactions variety foods inhalants positive children tested results radioallergosorbent tests positive children overall atopy diagnosed children found nonatopic clinical diagnosis used gold standard phadiatop test resulted correct diagnosis atopy cases atopy cases sensitivity specificity efficiency although phadiatop paediatric test indicate specific sensitivities provides clinician useful screening test atopic disease children years age less researcher means validating atopic populations,C20,0.001953515,0.0017328653,0.013098861,0.0010976004,0.021633742,0.002521113,0.1640191,0.0112657705,0.0014123045,0.06812069,0.2661989,0.0040180073,0.06434899,0.0047776885,0.030128263,0.01248898,0.1480507,0.0020117967,0.0022243643,0.1088218,0.0673699,0.0006936222,0.0020114542
seroprevalence hiv infection general population cote ivoire west africa seroepidemiological survey determine prevalence human immunodeficiency virus hiv infection general population ivory coast carried february sera collected subjects years old urban areas including abidjan rural areas using cluster sample technique total people tested urban areas hiv positive rate varied significantly age sex maximum rate observed among men years old rural areas total people tested positive hiv highest rate noted men aged years high seroprevalence recorded general population urban rural areas compatible incidences acquired immune deficiency syndrome aids cases reported hospitals country,C20,0.0030489773,0.002704595,0.035184737,0.0017130959,0.0042456044,0.003934864,0.12468345,0.0028672952,0.0022042748,0.0030022291,0.13926251,0.0062713083,0.073362954,0.008410496,0.0026990813,0.004747892,0.053351004,0.017890694,0.047744565,0.27788308,0.18053456,0.0010825811,0.0031701652
penicillamine induced lupus erythematosus describe patient presented polyarthritis pleurisy rash positive antinuclear antibody result years penicillamine therapy penicillamine induced antinuclear antibodies mainly high titer igg directed h h b dna complex weak igm activity h h b also observed withdrawal penicillamine therapy resulted improvement clinical symptoms gradual resolution serologic abnormalities,C20,0.004721502,0.004188208,0.009003073,0.0026528193,0.006574542,0.006093344,0.34205908,0.0044401577,0.0034134358,0.004655888,0.04027737,0.009711227,0.034379337,0.06859232,0.0041519697,0.0073523605,0.12915377,0.004862364,0.0053761243,0.04427921,0.23467335,0.0016764337,0.027712058
prevalence antibody htlv ii united states plasma donors united states french hemophiliacs antibody htlv ii detected plasma donors five regions united states us seroprevalence rate approximately times whole blood donors regional distribution infection follows southwest percent southeast percent midwest percent northwest percent northeast percent rates htlv ii infection blacks hispanics higher p less whites infected units donated subjects aged older even though percent donations came persons less years old equal rates htlv ii infection found men women htlv ii antibody detected french us hemophiliacs transfused regularly noninactivated plasma derivatives suggests transfusion htlv ii seropositive plasma products transmit viral infection,C20,0.003004662,0.0026652853,0.020146823,0.001688197,0.004183897,0.003877673,0.19959229,0.0028256206,0.016716119,0.002952257,0.041107476,0.006180016,0.08282573,0.06965213,0.002642224,0.0046788836,0.16329455,0.046726104,0.0034212498,0.1537119,0.16387169,0.0010668463,0.0031684025
mathematical models hiv infection threshold conditions transmission host survival second series papers modeling human immunodeficiency virus hiv infections four levels transmission interaction immune system gene regulation selection mutants previous paper described presented theory hiv cytopathic effect based upon models review literature article give mathematical equations threshold conditions connect infectivity length host survival frequency acts conducive transmission formula derived homogeneous populations also populations arbitrary number subgroups varying frequencies risk behavior varying rates infection latency periods varying frequencies interaction groups,C20,0.030314183,0.002519012,0.0052987044,0.0015955473,0.003954281,0.0036648628,0.29458973,0.0026718392,0.0020530226,0.0027902345,0.017292917,0.031997316,0.07404493,0.036205456,0.016216567,0.03190048,0.07741742,0.019184306,0.044473443,0.10013835,0.1813783,0.0010082969,0.019290756
suppressive effects morphine pellet implants vivo parameters immune function chronic morphine treatment elicits variety immunosuppressive effects mice work describing immuno suppressive activity opioid based vitro assessments performance certain components immune system morphine treated animals relatively little done way tracking effects chronic morphine treatment immunologic parameters intact animal therefore study used several classic vivo determinations immune function mice treated chronically morphine morphine pellet mg implantation led significant inhibition paw swelling picryl chloride induced delayed type hypersensitivity response uptake iododeoxyuridine vivo lymphocyte proliferation assay splenomegaly graft vs host reaction also significantly suppressed morphine pellet implantation respectively coimplantation naltrexone pellet mg completely reversed suppressive responses morphine assay naltrexone alone significant effect assays suppressive effects morphine less pronounced adrenalectomized mice graft vs host assay vs reduction morphine pelleted shams relative morphine pelleted adrenalectomized mice findings indicate pathophysiologic significance previously reported suppression vitro correlates immune function morphine pelleted mice results demonstrate immunosuppressive effects observed morphine pellet implantation naltrexone reversible suggest activation adrenal one potential mechanism effect,C20,0.0018538749,0.0016399575,0.032152347,0.0010387821,0.0025744922,0.002385943,0.25682425,0.0017386123,0.0013365835,0.019713864,0.019537088,0.03172121,0.05608626,0.10489397,0.0016432103,0.020774143,0.030339561,0.03474763,0.0021051045,0.067373544,0.29801843,0.0006564336,0.010844713
identification human immunodeficiency virus hybridizing sequences peripheral blood patient systemic lupus erythematosus systemic lupus erythematosus multisystemic disorder considered prototype autoimmune diseases although cause remains unknown viral etiology proposed report rapid sensitive messenger rna situ hybridization technique detected hybridizing sequences human immunodeficiency virus type peripheral blood cells woman systemic lupus erythematosus presence acquired immuno deficiency syndrome reasonably excluded,C20,0.0043262765,0.0038376234,0.049908705,0.0024309342,0.0060242033,0.0055832854,0.25029823,0.004068483,0.0031277055,0.0042508207,0.05636671,0.008898324,0.07435255,0.082191706,0.0038044185,0.0067369128,0.06552396,0.0044553475,0.0049261022,0.11270971,0.11178799,0.0015361037,0.13285388
comparison aerosolized glycopyrrolate metaproterenol acute asthma efficacy nebulized glycopyrrolate compared metaproterenol evaluated patients acute asthma double blinded randomized fashion patients received sole therapy either mg glycopyrrolate mg metaproterenol every h h study period patients completing study analysis variance demonstrated difference percentage change fev glycopyrrolate metaproterenol two hours initial dose percent increase fev glycopyrrolate compared percent increase metaproterenol p greater ns contrast comparable bronchodilator activity side effects profile two agents markedly dissimilar subjective complaints tremor palpitations paresthesias increased metaproterenol heart rate response significantly elevated p less compared glycopyrrolate based data administration aerosolized anticholinergic agent glycopyrrolate reasonable therapeutic alternative acute asthma,C20,0.0028397052,0.0025189603,0.019043861,0.0015955146,0.0039545717,0.0036647876,0.2128921,0.0026704932,0.0020529805,0.030276686,0.0145051405,0.024933485,0.16218787,0.020931087,0.0024971652,0.018104533,0.1777829,0.0029244255,0.016973069,0.02490823,0.24881278,0.0010082761,0.002921384
search epitope specific antibody responses human immunodeficiency virus hiv envelope glycoproteins signifying resistance disease development essential development strategies prevention therapy human immunodeficiency virus hiv infections define host factors playing dominant role determining clinical outcome infection antibodies directed restricted regions hiv glycoproteins gp gp likely represent important factors involved host defense hiv definition qualitative quantitative differences spectrum anti gp anti gp antibodies two vastly different groups hiv infected individuals long term asymptomatic carriers individuals acquired immunodeficiency syndrome aids died might reveal epitope specificity antibodies contributing prevention clinical disease accomplish goal sera groups assayed antibodies recognizing synthetic peptides gp gp shown earlier experiments mimic epitopes two hiv glycoproteins none sera recognized distinct peptides gp gp spectrum antibodies distinct sera groups hiv infected individuals nevertheless antibody responses distinguishing two groups discerned particular possible predict unfavorable outcome disease comparative measurements levels antibodies peptide corresponding entire v hypervariable loop gp providing evidence declining levels antibodies course infection antibodies recognizing additional peptides significantly less prevalent aids patients asymptomatic carriers appears possible maintenance high levels respective antibodies would contribute preventing aids hiv infected individuals active immunization antigens containing epitopes defined respective peptides administration corresponding antibodies may considered modality therapy hiv infections,C20,0.0013613981,0.020977885,0.028892152,0.007813223,0.008546963,0.0149325505,0.37215737,0.0012802753,0.014161177,0.0013376536,0.041257918,0.038374517,0.031217655,0.13613375,0.0011971792,0.00211998,0.027816614,0.04720252,0.001550152,0.06498228,0.13478635,0.00048338302,0.0014170556
determinants vivo histamine release cutaneous allergic reactions humans determine host factors influencing magnitude mediator release ongoing cutaneous allergic reactions humans compared subjects first hour second fifth hour total hours skin chamber histamine release vitro reactivity sensitivity basophils antigen histamine release skin test sensitivity reactivity antigen histamine codeine significant correlation first hour second fifth hour histamine release combination basophil antigen histamine codeine skin sensitivity reactivity magnitude first hour second fifth hour total hours skin chamber histamine release could accounted conclude antigen induced vivo allergic responses complex phenomenon dependent part antigen sensitivity basophil mast cell reactivity end organ responsiveness mediators,C20,0.002691549,0.0023875383,0.059793442,0.0015122717,0.05655413,0.0034735843,0.17120247,0.0025311655,0.0019458702,0.002644605,0.025737733,0.005536002,0.14209116,0.11576592,0.0023670164,0.017216012,0.040006705,0.002786691,0.0030647246,0.02409535,0.28680468,0.02701217,0.0027791783
enhanced percutaneous absorption novel topical cyclosporin formulation assessment immunosuppressive activity clinically successful topical cyclosporin cya formulation produced mainly due apparent lack drug penetration study produced first vitro kinetic data cya penetration across human cadaver stratum corneum shown addition penetration enhancers pe azone propylene glycol cya vehicle significantly enhanced drug permeation across skin barrier using flow permeability cells w v cya sandimmun alone cya pe cya pe olive oil donor chamber penetration rate mean sd microgram cm h receptor fluid n cya n cya pe vivo efficacy formulation assessed guinea pigs undergoing delayed type hypersensitivity dth reactions dinitrofluorobenzene dnfb cya applied topically time challenge twice daily thereafter h skin reactions revealed compared appropriate drug vehicles concentrations cya pe significant inhibitory effect upon erythema response corresponded significant reductions cell infiltrates cya statistically significant reductions erythema demonstrated cya pe reduction number infiltrating lymphocytes sites receiving cya pe compared vehicle treated sites p less suggests pe permitted penetration otherwise non immunosuppressive concentration cya skin,C20,0.0021364526,0.0018942185,0.014908679,0.001199858,0.035090405,0.013033746,0.19659609,0.002008169,0.0015438091,0.01243258,0.021379875,0.005244062,0.08370078,0.03312147,0.001877829,0.026631625,0.11467208,0.027200399,0.0024314828,0.07013975,0.32979554,0.0007582078,0.0022029236
azt demonstrates anti hiv activity persistently infected cell lines implications combination chemotherapy immunotherapy sensitive quantitative focal immunoassay used measure effects three different therapeutic agents tissue culture cells infected human immunodeficiency virus hiv effects drugs studied acutely persistently infected cd cell lines three agents azidothymidine azt interferon alpha ifn alpha anti hiv envelope antibody coupled ricin chain tested alone combination azt found greatest effect early stages infection also action persistently infected cell lines effect azt persistently infected cells seen within h increased extended exposure drug persisted removal ifn alpha variable effects acutely infected cells suppressed chronic infection combinations therapeutic agents studied using model allowed treatment acute persistent stages infection effective combination suppressing hiv infection continual use azt ifn alpha highest tolerable doses knowledge efficacy azt persistently infected cells allow effective design clinical protocols,C20,0.0019538929,0.0017332005,0.031137664,0.0010978128,0.07147426,0.002527324,0.28885716,0.0018397153,0.0014125776,0.0019198145,0.021463472,0.013471938,0.018853659,0.07601823,0.011168284,0.012420076,0.042725034,0.020925311,0.0022284107,0.08558512,0.21949881,0.0006937564,0.07099447
effect education use universal precautions university hospital emergency department study objectives determine educational program would improve knowledge practice universal precautions nursing personnel design participants given question test observed practice universal precautions routine iv catheter placement phlebotomy trauma care six months education service setting university hospital emergency department type participants nursing personnel interventions one hour lecture addressing occupational risk human immunodeficiency virus hiv infection recommended use universal precautions measurements main results mean overall correct response rates questionnaire service respectively p ns pattern incorrect responses suggested perceived risks hiv transmission underestimated particularly among healthy appearing patients care critical trauma patients significant increases frequency rates service glove protective eyewear use vs p less vs p less respectively frequency rates glove use iv placement phlebotomy noncritical patients gown use trauma patient care also increased vs vs respectively however changes statistically significant conclusion intensive educational program associated modest increase compliance ed nursing personnel universal precautions long term effect general knowledge hiv risk practice universal precautions still far universal ed,C20,0.019206038,0.010308614,0.038207177,0.0010115764,0.002506888,0.0023600394,0.16249955,0.0016930423,0.0013015509,0.0017723757,0.039261952,0.0038463,0.12155542,0.004848277,0.0015831556,0.0028034719,0.16575314,0.0018568535,0.108104065,0.18825588,0.118755504,0.00063922803,0.001869934
naturally occurring hiv isolates differences replicative capacity distinguished situ hybridization infected cells replication human immunodeficiency virus type hiv isolates peripheral blood mononuclear cells pbmc studied situ hybridization using riboprobe bh r htlv iiib two series isolates tested isolates individuals varying severity hiv infection b sequential isolates subjects showing signs clinical progression month observation period results show hiv isolates distinct replicative capacity distinguished intensity radioactive labeling single infected cells situ hybridization sequential isolates patients clinically progressive hiv infection show gradual increase replicative capacity time pbmc cultures infected sequential isolates intensity radioactive label single infected cells increases strongest isolates obtained time low cd counts blood results suggest restriction virus replication operates early stages hiv infection gradually lost progression disease,C20,0.002251583,0.0019972664,0.0042012203,0.0012653741,0.04673008,0.024693433,0.33807915,0.002117416,0.0016277942,0.013106959,0.03953386,0.004675552,0.0669715,0.079096705,0.023776004,0.03839357,0.065490626,0.002351067,0.0025637585,0.037392795,0.17112005,0.00079945533,0.03176479
random double blind trial combination nebulized atropine methylnitrate albuterol nocturnal asthma combination nebulized atropine methylnitrate amn beta agonist shown produce greater longer lasting bronchodilation either drug alone examined efficacy combination diminishing morning dipping pefr eight hospitalized stable asthmatics patients received nebulized albuterol along either amn amn alb placebo alb random double blind cross fashion pm four nights pefr fev recorded pm pm administration bronchodilators statistically significant difference alb amn alb reducing morning dipping patients,C20,0.004238482,0.0037587732,0.028418375,0.05431511,0.0059429896,0.027385222,0.1820713,0.0039848895,0.003063442,0.02466741,0.019591674,0.05592435,0.037824627,0.00974306,0.0037262507,0.006598492,0.097022876,0.0043638055,0.0868791,0.05860049,0.25327042,0.001504542,0.02710433
effect facial cooling mucosal blood flow mouth humans determine effects facial cooling intraoral thermal events placed thermal conductivity sensor buccal surface left cheek six normal six asthmatic subjects room temperature cold stimuli applied integument surface sides face mucosal surface temperature thermal conductivity index blood flow recorded room temperature challenge effect application cold stimulus exterior left cheek caused monotonic decrease temperature mouth subjects associated change thermal conductivity blood flow increased fell baseline despite continued drop temperature responses purely local cooling right side face change temperature blood flow left side differences noted asthmatic normal subjects data indicate lowering temperature skin face produces significant alterations thermal environment within mouth facial cooling buccal temperature falls mucosal blood supply transiently rises effect appears purely local thermally mediated event facial pressure cutaneous reflexes play role changes may contribute conditioning inspired air oral breathing,C20,0.002010557,0.030981766,0.10548128,0.00112965,0.012531665,0.0025947287,0.1419292,0.0408232,0.0014535432,0.031162031,0.009257724,0.0435242,0.2749479,0.008306866,0.05042928,0.013111423,0.03011256,0.0021321287,0.002289315,0.031116126,0.16187768,0.00071387575,0.0020833171
epidemiology acquired immune deficiency syndrome persons aged years older acquired immune deficiency syndrome aids afflicted persons ages yet recently attention devoted aids older persons examine epidemiology aids persons greater equal years old united states analyzed cases reported centers disease control number reported annually persons greater equal years old increased december reported representing cases although male homosexual contact accounted cases persons aged blood transfusion became common means exposure increasing age accounting cases persons aged cases individuals aged greater equal proportion women increased persons aids aged aged greater equal proportion aids diagnoses made month death increased persons aged aged greater equal suggesting either rapid progression disease increasing delay diagnosis incidence older persons continues increase clinicians caring older patients must become familiar aids,C20,0.0021577955,0.0019140722,0.066909865,0.0012123772,0.0030046618,0.0027847474,0.20712976,0.0020292168,0.00155999,0.01290355,0.08150937,0.00447743,0.048862386,0.005003157,0.0018975108,0.013796074,0.05673917,0.0022221715,0.0127181355,0.35701707,0.058930174,0.052996818,0.0022244768
total hip knee arthroplasty juvenile rheumatoid arthritis total hip knee arthroplasty indicated patients juvenile rheumatoid arthritis marked functional impairment severe disabling pain advanced structural hip knee joint involvement relief pain dramatic improvement function achieved patients hip knee involved hip arthroplasty probably done first regional anesthesia preferable careful preoperative planning essential custom prostheses often required small bone size osteoporosis soft tissue contractures make surgery technically demanding skeletal immaturity absolute contraindication surgery component loosening frequent late complication hip arthroplasty less common condylar metal plastic knee arthroplasty patellar complications predominate cementless arthroplasty evolving role patient juvenile rheumatoid arthritis date often used hip knee,C20,0.020130262,0.0029682112,0.022439625,0.001880071,0.022142103,0.04349033,0.28758538,0.0031467697,0.0024191248,0.003287799,0.060698375,0.0068824124,0.038346317,0.0076960544,0.01912108,0.021400195,0.29403093,0.0034459904,0.0038100956,0.03839314,0.092055224,0.0011881,0.0034424064
ultraviolet cross linking helical oligonucleotides two monoclonal mrl pr pr anti dna autoantibodies variations h l chain binding dna experiments performed determine whether h l chains different anti native dna autoantibodies uniformly involved binding dna two purified monoclonal mouse mrl pr pr igg autoantibodies h c tested bound synthetic helical oligonucleotides base pairs gel electrophoresis retardation assay differed preferences given base sequences exposure antibody radiolabeled oligonucleotide mixtures uv light nm min led specific covalent cross linking oligonucleotide h l chains h h chain c single labeling events detected without higher aggregation oligonucleotides cross linked unrelated igg even h irradiation cross linked radioactively labeled h l chains h c isolated denaturing electrophoresis gels digested lysyl endopeptidase staphylococcal v protease h c h chains yielded major labeled peptide fragment peptides two antibodies different experiments measured antibody dna interactions probably bases major groove dna indicated two mrl pr pr igg anti native dna antibodies differ h l chain contacts dna provide approach identifying affinity labeled binding sites antibodies,C20,0.0020711506,0.001837214,0.0038645524,0.0011638801,0.0028840117,0.012678913,0.22930112,0.0019477352,0.0014973497,0.0020350271,0.053750023,0.0045001633,0.041913915,0.13795501,0.0018213176,0.0032452915,0.020948472,0.056710295,0.0023583097,0.015921507,0.21479876,0.00073539035,0.1860606
molecular targets aids therapy development antiretroviral therapy acquired immunodeficiency syndrome aids intense research effort since discovery causative agent human immunodeficiency virus hiv large array drugs biologic substances inhibit hiv replication vitro nucleoside analogs particularly belonging dideoxynucleoside family inhibit reverse transcriptase anabolic phosphorylation azido dideoxythymidine azt first drug tested individuals aids considerable knowledge structure activity relations emerged class drugs however virtually every step replication hiv could serve target new therapeutic intervention future non nucleoside type drugs likely become important experimental therapy aids antiretroviral therapy exert major effects morbidity mortality caused hiv,C20,0.0028791763,0.002553973,0.061125133,0.0016177418,0.045879215,0.003715727,0.39260674,0.0027076122,0.0020815162,0.01675517,0.027537968,0.005921915,0.017981986,0.0785292,0.016464937,0.0045713014,0.026265666,0.030837426,0.032169994,0.10023711,0.09331955,0.0010222909,0.033218626
full length recombinant cd recombinant gp inhibit fusion hiv infected macrophages uninfected cd expressing lymphoblastoid cells human immunodeficiency virus hiv infected monocyte macrophages may contribute pathogenesis hiv associated immune deficiency dysfunction acting target potential reservoir virus vivo functioning abnormally following infection shown hiv infected macrophages fuse uninfected cd expressing lymphoid cells vitro may provide additional mechanism cd lymphocyte depletion vivo report inhibition syncytium formation hiv infected macrophages uninfected cd expressing lymphoid cells monoclonal antibody directed epitope cd involved binding hiv gp recombinant protein comprises full length extracellular domain cd molecule recombinant full length hiv envelope glycoprotein gp results indicate molecules gp cd critical fusion process suggest gp expressed surface hiv infected monocyte macrophages,C20,0.0027271472,0.0024191157,0.0058828355,0.0015322728,0.030191423,0.0035195255,0.29196098,0.06289342,0.001971606,0.0026795822,0.012956877,0.005609221,0.028890269,0.15632148,0.0023981845,0.0042467355,0.03689732,0.087823674,0.0031052583,0.019530842,0.1546685,0.00096831087,0.08080541
sle nephritis ultrastructural immunogold study evaluate relationship immune complexes basement membrane components type iv collagen fibronectin heparan sulphate proteoglycans nature immune complexes relationship normal glomerular basement membrane gbm components type iv collagen fibronectin heparan sulphate proteoglycans hspg examined glomeruli cases systemic lupus erythematosus sle glomerulonephritis using ultrastructural immunogold technique paraformaldehyde fixed lowicryl resin embedded tissue electron dense deposits contained igg igm iga c whether subepithelial intramembranous subendothelial mesangial particular relationship class immunoglobulin site immune complex localization within glomerulus normal gbm components type iv collagen fibronectin hspg found within glomeruli distribution type iv collagen fibronectin found predominantly inner aspect gbm diffusely throughout central regions mesangial matrix contrast hspg seen mainly outer aspect gbm periphery mesangial matrix none cases gbm antigens localized within electron dense deposits results suggest autoantibodies gbm components may play role development glomerulonephritis,C20,0.0029618547,0.002627313,0.06593211,0.0352475,0.004124289,0.003822428,0.2619367,0.031421483,0.030804379,0.0029101963,0.093686745,0.006091969,0.021034744,0.031226682,0.016937915,0.0046122237,0.027484545,0.0030606885,0.032038286,0.0429472,0.25343913,0.001051647,0.024599964
rescue interleukin activity leucovorin following inhibition methotrexate murine vitro system recently shown methotrexate mtx inhibits interleukin il activity vitro effect may play important role rapid antiinflammatory action mtx rheumatoid arthritis present study showed inhibition il activity vitro mtx dependent folate pathways since addition leucovorin inhibitory effect mtx abolished findings may shed light mechanism action mtx rheumatoid arthritis also point fact il activities may dependent intracellular folate pathways,C20,0.0038431934,0.0034091042,0.0071760924,0.0021593336,0.0053515253,0.0049598413,0.34658143,0.0036141856,0.0027784577,0.003776163,0.03674047,0.007904714,0.024623372,0.12123327,0.0033796073,0.02458008,0.04286121,0.028354937,0.004376041,0.02484552,0.29213312,0.0013645784,0.003953736
circadian basis late asthmatic response late asthmatic response lar allergen challenge marked impact lung function patient asthma virtually studies lar done daytime study evaluated lar function time day inhaled allergen challenge performed allergen challenge given morning produced lar subjects challenge evening caused lar p less time onset lar following morning evening challenges h versus h respectively p less maximal decrease fev lar morning challenge versus evening p less additionally bronchial responsiveness methacholine significantly greater h following evening allergen challenge morning p less challenge thus important take account time day patient exposed allergen regard development lar,C20,0.0031419124,0.002787033,0.021062376,0.06259965,0.0043750135,0.019263783,0.20002817,0.0029546926,0.017477788,0.048671648,0.01624693,0.00657856,0.18139465,0.007235413,0.0027629186,0.004892611,0.123705,0.0032356489,0.0038391966,0.02375644,0.23964274,0.0011155789,0.0032322838
antidepressant pharmacotherapy depression associated multiple sclerosis double blind clinical trial involving patients multiple sclerosis major depressive disorder patients randomly assigned week trial desipramine individual psychotherapy placebo plus psychotherapy clinical judgments indicated patients treated desipramine improved significantly placebo group confirmed scores hamilton rating scale depression beck depression inventory scores side effects limited desipramine dosage half treated patients authors conclude desipramine modest beneficial effect serious depression associated multiple sclerosis side effects may limiting factor patients without medical neurologic disease,C20,0.0035160324,0.0031188962,0.0065605515,0.0019755152,0.0048959637,0.07262194,0.31135812,0.0033065195,0.0025419348,0.0034547083,0.03352421,0.057953916,0.036156207,0.0096997805,0.0030919102,0.022488449,0.15374441,0.0036331518,0.08911184,0.07477419,0.09760619,0.0012484153,0.0036171644
influence human immunodeficiency virus infection reproductive decisions article discusses role practitioner pregnancy decision making process hiv infected woman literature women decisions reviewed variables influence decisions discussed author concludes hiv infection significant impact pregnancy decisions cultural psychosocial variables may importance,C20,0.0047215433,0.0041882447,0.00880991,0.0026528428,0.0065745995,0.0060933977,0.26728195,0.004440197,0.0034134658,0.004639194,0.10463632,0.009711312,0.03888784,0.01625712,0.027005337,0.0073524253,0.04874154,0.0048624068,0.025240274,0.2599033,0.10500819,0.0016764485,0.037902124
effects deep inhalation early late asthmatic reactions allergen published erratum appears rev respir dis feb eighteen asthmatic patients biphasic asthmatic reaction house dust mite studied effect deep inhalation di quantitated comparing maximal expiratory flow mef vital capacity partial p maximal flow volume curves specific airway conductance sgaw di sgawdi baseline ratio mef p significantly larger unity sd whereas ratio sgawdi sgaw significantly different unity early phase reaction mef p sgawdi sgaw significantly increased respectively late phase reaction fev values similar observed early phase reaction mef p sgawdi sgaw respectively significantly higher values baseline significantly lower early phase reaction similar results obtained subgroup nine patients sgaw values late phase reaction similar early phase reaction conclude di different effect early late asthmatic reactions suggesting different ratio airway parenchymal hysteresis may result increased parenchymal hysteresis peripherally located bronchial obstruction decreased airway hysteresis prominent airway inflammation late phase reaction,C20,0.0019353521,0.0017167538,0.012960953,0.0010873954,0.021425813,0.058710776,0.25688177,0.0018200285,0.020134524,0.011260653,0.04196505,0.0046130344,0.21644586,0.01538969,0.0017018998,0.06859759,0.08201717,0.0020061766,0.002203683,0.01421257,0.15077655,0.0006871732,0.011449507
aberrant regulation il expression macrophages young autoimmune prone mice il multifunctional immunoregulatory polypeptide produced many cell types activated macrophages major source il also implicated pathogenesis autoimmune disease investigated regulation il expression several autoimmune prone strains mice peritoneal macrophages derived autoimmune prone strains mrl lpr mrl nzb nzb w f well nzw displayed transient expression il contrast stable expression characteristic control normal strains including thy j b b b c bl balb c c h hen regulation il macrophages autoimmune prone mice attributable inherently defective signal transduction macrophages normal autoimmune prone strains displayed substantial initial levels cell associated secreted il however first days culture macrophages autoimmune prone mice became progressively refractory induction maintenance il pattern correlated changes levels il alpha beta mrna progressive reduction il expression macrophages autoimmune prone strains due reduction general metabolism viability expression cell surface antigens including mhc class ii ag lfa comparable control macrophages il plays critical role homeostasis variety cell lineages defective expression maintenance il perhaps cytokines macrophages autoimmune prone strains may contribute immune dysregulation develops mice alternatively cytokine dysregulation might contribute directly disease rather reflect basic defect related specific signal transducing gene regulatory pathways,C20,0.0017408169,0.0015431655,0.0032826995,0.0009774657,0.002904637,0.01066045,0.2983919,0.07803145,0.001257697,0.0017093185,0.008675001,0.0036300817,0.021461107,0.17833446,0.0015298134,0.036389157,0.019775538,0.021221412,0.0019808593,0.034019563,0.16153216,0.0006176902,0.110333554
annual summary vital statistics us infant mortality continued decline slowly provisional rate per live births lowest ever recorded final data showed change cause death distribution wide discrepancy white black infant mortality state rates varied vermont georgia worldwide us rate bettered countries japan lowest births increased number rate higher fertility rate women childbearing years birth rate mothers years age younger increased proportion women inadequate prenatal care essentially unchanged deaths crude death rate age adjusted death rate decreased excess births deaths added almost million persons us population highest rate natural increase since marriage rate essentially unchanged whereas divorce rate decreased slightly lowest level since exception human immunodeficiency virus infection homicide pulmonary malignancies rates causes death declined comparison declines substantial led pneumonia perinatal conditions large scale increases among major causes half century two diseases related cigarette smoking chronic obstructive pulmonary disease eightfold respiratory cancer almost sixfold death rates cancers group decreased cardiovascular diseases,C20,0.018085884,0.0015699342,0.0033023332,0.0095522655,0.0024650677,0.01164264,0.13478561,0.0016643766,0.018404895,0.010301631,0.00818251,0.03790982,0.032141037,0.0043780515,0.0100970175,0.0027560052,0.027537245,0.0018226391,0.0020152202,0.44963565,0.19960998,0.000628405,0.0115118
profile bronchospastic disease puerto rican patients new york city possible relationship alpha antitrypsin variants high prevalence asthmalike symptoms noted among patients puerto rican descent attending beth israel north central bronx medical centers new york city compared ethnic groups evaluation family medical histories pulmonary function data alpha antitrypsin phenotypes undertaken puerto rican patients control subjects without asthma patients showed higher proportion ms mv phenotypes patients mm variant phenotype groups exception four mm patients features indicative asthma labile airway obstruction elevated serum immunoglobulin e eosinophil levels latter significantly higher patients variant phenotypes mm patients patients alpha antitrypsin variants also much shorter smoking histories compared mm group reported histories asthma first degree relatives compared among mm patients conclude increased incidence asthma among puerto ricans new york city antitrypsin variant phenotypes specifically v play role incidence expression,C20,0.012070963,0.001837153,0.003864424,0.0011636565,0.063035056,0.002696759,0.17520128,0.0019476705,0.0014973,0.034594066,0.009556501,0.0350133,0.06807731,0.01536633,0.061974317,0.0032251053,0.18032907,0.002132871,0.0023582315,0.1442962,0.16673326,0.00073536596,0.012293773
tartrazine sensitivity tartrazine fd c yellow approved azo dye present many drugs food products many cases tartrazine sensitivity reported led new regulations required listing azo dyes package inserts drugs packages food products tartrazine sensitivity frequently manifested urticaria asthma although azo dyes implicated accentuating hyperkinetic syndromes tartrazine considered offender vasculitis purpura contact dermatitis infrequently occur manifestations tartrazine sensitivity cross sensitivity aspirin sensitive nsaid sensitive patients may also occur mechanism sensitivity obscure called pseudoallergic management consists mainly avoidance drugs food products contain tartrazine,C20,0.003640014,0.003228874,0.14745437,0.002045647,0.005068604,0.0046976274,0.4669438,0.0034231131,0.0026315681,0.0035765276,0.052422896,0.0074868132,0.022583986,0.008736141,0.0032009364,0.04090617,0.054446973,0.0037486108,0.0041446914,0.109310456,0.045214187,0.0012924367,0.0037955458
effect digitalis clinical symptoms conduction variables patients multiple sclerosis digitalis shown reverse conduction block demyelinated nerve fibers experimental animals search symptomatic treatment multiple sclerosis digoxin mg per kilogram body weight given intravenously patients probable clinically definite multiple sclerosis patients temperature dependent symptoms patients improvement clinical deficits observed concurrent significant changes evoked potential findings digitalis derivatives may useful ameliorating symptoms selected patients multiple sclerosis,C20,0.0042372746,0.0037586738,0.028415177,0.022885393,0.0059002703,0.0054684235,0.4100629,0.0039847842,0.003063361,0.004197646,0.020486841,0.008928495,0.041860312,0.030242505,0.0037261522,0.0065983175,0.1677092,0.00436369,0.0048247604,0.027951052,0.16496485,0.0015045023,0.024865365
stereotactic biopsy active multiple sclerosis lesion immunocytochemical analysis neuropathologic correlation magnetic resonance imaging stereotactic biopsy active multiple sclerosis lesion year old patient unilateral symptoms isolated high signal intensity magnetic resonance abnormality yielded serial tissue cores x cm spanning mm within around lesion performed semiquantitative analysis lymphocyte phenotype using antisera cd cd cd cd molecules separate perivascular cuffs three tissue sections lesion edge total cells cuffs varied ratios cd cd cells individual cuffs varied although intense parenchymal infiltrates bordered least cellular cuffs parenchymal perivascular cell phenotypes indistinguishable arguing selective trafficking lymphocytes tissue individual microfoci cells displaying cd ra cd tq antigens present remarkable phenotypic heterogeneity lymphocytes multiple sclerosis lesion border consistent exposure situ diversity differentiating stimuli histologic demyelination correlated closely signal intensity abnormality observed magnetic resonance imaging studies provide unusual insight histologic immunocytochemical morphologic appearance active multiple sclerosis plaque,C20,0.0024377196,0.002162379,0.039941236,0.0013696551,0.14500709,0.0031460042,0.3004647,0.0265373,0.0017623627,0.0024001733,0.035977326,0.005013923,0.06558487,0.07924704,0.0021437716,0.0037960364,0.07190416,0.002510447,0.0027757024,0.020698892,0.16994421,0.012656024,0.0025190287
response patterns hairy cell leukemia b cell mitogens growth factors effect mitogens recombinant b cell growth factors gfs vitro growth hairy cells examined tumor cells isolated spleens four patients hairy cell leukemia hcl ficoll hypaque sedimentation e rosetting enrichment tumor cells confirmed intracytoplasmic immunoglobulin ig staining tartrate resistant acid phosphatase trap staining staining using monoclonal antibodies moabs directed b myeloid monocytoid antigens ags indirect immunofluorescence assays tumor cells b cd b cd b cd il r cd pca trap hcls neither synthesized dna secreted ig response culture granulocyte macrophage colony stimulating factor gm csf interleukin alpha il alpha il beta il il il il il however proliferative response stimulation index greater equal without ig secretion triggered hcls mitogens combinations gfs specifically dna synthesis induced days three four hcl samples cultured staphylococcus aureus cowan sac combination phorbol ester tpa calcium ionophore ca dna synthesis triggered later day tumor necrosis factor tnf il il contrast fourth patient nonresponder sac tpa ca demonstrated increased dna synthesis day cocultured il il autoradiography staining antibromodeoxyuridine brdu moab conjugated fluorescein confirmed dna synthesis minority tumor cells within patient dual staining confirmed responsive cells brdu trap dna synthesis induced tpa ca blocked specifically anti il ab contrast hcl proliferative response sac tnf il il inhibited anti il ab alpha interferon inhibited response tpa ca tnf il il without effect response sac finally peroxidase antiperoxidase staining demonstrated hcls induced tpa ca sac produce intracytoplasmic il data demonstrate il il il mediated dna synthesis hcls vitro suggest possible vivo role growth factors pathophysiology hcl,C20,0.0015804974,0.0014019801,0.010600285,0.000888017,0.033453133,0.009661842,0.16974118,0.0014863189,0.0011426293,0.0015529315,0.025079822,0.003250781,0.018421482,0.24802968,0.0013898495,0.025406836,0.053808704,0.0016523728,0.0017996287,0.068527676,0.2335974,0.03881184,0.04871515
comparative airway response inhaled bradykinin kallidin des arg bradykinin normal asthmatic subjects bradykinin kallidin lys bradykinin des arg bradykinin oligopeptides may contribute mediators pathogenesis asthma interacting specific receptors designated b b study investigated airway response inhaled bradykinin kallidin des arg bradykinin normal asthmatic subjects changes airway caliber followed maximum expiratory flow vital capacity vp forced expiratory volume fev one six normal subjects responded bradykinin maximum cumulative concentration mg ml neither kallidin des arg bradykinin measurable bronchoconstrictor effect normal subjects whether airway caliber measured vp fev subjects asthma bradykinin kallidin des arg bradykinin produced concentration related fall fev geometric mean provocation concentrations inhaled agonist reducing fev baseline mg ml bradykinin kallidin histamine respectively bronchoconstriction produced bradykinin kallidin maximal within min recovery occurring min bradykinin kallidin agonists b receptors des arg bradykinin agonist b receptors vivo structure activity studies suggest asthmatic normal airways hyperresponsive kinins compared histamine potent bronchoconstrictor action specific pharmacologic effect compatible stimulation b receptors variant,C20,0.0023278885,0.0020647198,0.0043444396,0.012560456,0.014497582,0.059344288,0.13235363,0.002188927,0.012946888,0.047353327,0.010779685,0.0047964538,0.2579583,0.02745634,0.002046855,0.0036319431,0.025168683,0.063388966,0.0026503438,0.016958576,0.26894754,0.012089272,0.014144891
epidemiology cytomegalovirus infections determinants cytomegalovirus cmv infection disease understood studies newborns recipients organ bone marrow transplants subjects infected human immunodeficiency virus recipients blood transfusions cmv transmitted neonate transplacentally passage contaminated birth canal ingestion infected breast milk adult heterosexual homosexual sex infected partner transplant recipient infected organs major unsolved problem study cmv nature viral latency knowledge regarding requirements activation latent infection molecular cellular host level incomplete viral host factors may contribute successful transmission cmv latently infected cells transplanted organs transfused blood,C20,0.003094994,0.0027454142,0.0057749376,0.0017389508,0.079223745,0.018967355,0.22032148,0.0029105698,0.0022375428,0.0030410134,0.014315622,0.006365811,0.13434161,0.07553853,0.0027216596,0.004819549,0.086791284,0.033150494,0.018894332,0.13888341,0.123534255,0.0010989199,0.019488469
bronchial responsiveness histamine infants older children normal infants shown respond relatively low concentration inhaled histamine however studies used partial maximal expiratory flow volume pmefv curves assess lung function order directly compare responsiveness infants older children compared bronchial responsiveness histamine group normal infants median age wk range wk group nonasthmatic older children median age yr range yr using pmefv curves groups assess lung function infant group pmefv curves generated using forced expiratory flow volume technique older children pmefv curves generated voluntary effort provocative concentration histamine produced fall pc maximum flow functional residual capacity vmaxfrc calculated pmefv curves geometric mean pc infants g l lower geometric mean older children g l p less however results corrected dilution aerosol due air entrainment ae corrected values pc significantly different infants older children results demonstrate importance accounting ae evaluation histamine responsiveness suggest bronchial responsiveness may similar normal infants older children,C20,0.0017261056,0.0015302815,0.011544699,0.00096928346,0.010759764,0.02492365,0.17359751,0.0016223387,0.009594481,0.07545886,0.01693863,0.037114494,0.20343143,0.004020013,0.009863861,0.037487205,0.07318926,0.0017777195,0.010308502,0.18112874,0.11062588,0.00061253307,0.0017747561
fcr mediated enhancement hiv infection antibody although cd major receptor human immunodeficiency virus hiv infection cells studied others clearly show fc receptor fcr also plays role infection perhaps conjunction surface receptors igg antibodies hiv enhance infectivity cells monocyte macrophages surface fc receptors f ab fragments antibodies enhance blocking fcr inhibited enhancement high affinity fcr igg fc gamma ri appeared functional sera hiv infected patients neutralizing activity high concentrations enhanced infection low concentrations e high dilutions studies show cd receptor required antibody mediated enhancement infection enhancement blocked recombinant soluble cd leu antibody although enhancement demonstrated vitro vivo importance enhancing antibodies remains defined hiv infection,C20,0.0028009957,0.002484623,0.03713421,0.015125128,0.0039006385,0.003614831,0.2558083,0.0026340904,0.0020249954,0.002752143,0.013259845,0.005761113,0.02358901,0.18536542,0.016018508,0.004361733,0.043279618,0.0848229,0.0031893458,0.028316556,0.24589422,0.0009945318,0.016867263
serum soluble interleukin receptor associated clinical pathologic disease status hairy cell leukemia hairy cell leukemia chronic lymphoproliferative disorder b cell lineage whose malignant cells express interleukin il receptor soluble form il receptor released cells culture sera patients hairy cell leukemia contain elevated levels soluble receptor four hundred twenty seven serum samples patients analyzed soluble il receptor sil r clinical status patients appeared associated serum level sil r hairy cell index measure tumor cell burden correlated square root serum sil r level r improved clinical status associated decreasing serum sil r levels whereas disease relapse associated increasing levels notably every patient responded therapy decline serum sil r level every patient disease progression increase serum sil r level phenomenon observed several different treatments including standard dose interferon low dose interferon deoxycoformycin predictive reliability test currently prospectively evaluated,C20,0.0020918294,0.0018555571,0.0039031368,0.0011753136,0.013039053,0.002699615,0.25733218,0.0019671817,0.0015122996,0.012174519,0.04205858,0.0043024933,0.038365047,0.1204655,0.001839502,0.0032574136,0.0716522,0.052788563,0.0023818556,0.06667959,0.2955456,0.00074273266,0.0021702517
characteristics patients food related complaints forty five patients classic food allergic symptoms subjective food related complaints traditionally associated food allergy underwent evaluation basis comprehensive clinical history skin testing placebo controlled double blind food challenges patients assigned one two groups patients reactions highly suggestive ige mediated food hypersensitivity group n patients atypical adverse food reactions could confirmed double blind food challenge group b n patients groups female patients group b respectively group b onset symptoms occurred older age group years versus p respectively involved foods versus p foods causing prominent symptoms among patients group included legumes tree nuts crustaceans fish group b milk white sugar wheat egg smoked cured meat yeast among troublesome foods one patient group gave positive skin test response food four patients group b positive response conclude subset patients food related complaints accurately predicted negative double blind challenge suspected foods basis information obtained history skin testing,C20,0.0018163773,0.010348492,0.01213866,0.009811406,0.03770217,0.0023441296,0.18027335,0.0017081432,0.010104203,0.012881707,0.080544494,0.11118234,0.014324065,0.005337871,0.019182542,0.0028284772,0.12657201,0.0020149418,0.03723567,0.24291912,0.07621627,0.0006449296,0.001868622
cytomegalovirus update primary care physicians cytomegalovirus infection spread various ways mother fetus baby small children day care centers caregivers parents blood transfusions sexual contact although illness usually inconsequential congenital infection severe consequences including mental retardation hearing loss dr bean describes different aspects virus discusses promising vaccine may prevent congenital disease,C20,0.0045336094,0.025866715,0.008426379,0.002537354,0.050003868,0.0276714,0.2460813,0.004246897,0.025045019,0.02629988,0.020768562,0.00928854,0.07167274,0.032225087,0.0039712526,0.028844917,0.102661006,0.004650727,0.026991254,0.12170224,0.12840216,0.001603466,0.026505644
cytomegalovirus setting infection human immunodeficiency virus human cytomegalovirus cmv several possible roles pathogenesis aids cmv causes number clinical syndromes including retinitis pneumonitis gastroenteritis patients infected human immunodeficiency virus type hiv addition cmv may potentiate cellular immunodeficiency observed patients hiv infection either directly enhancement hiv replication finally cmv may predispose host bacterial fungal infection compromising integrity mucosal barriers infection therapy ganciclovir cmv infection may result decrease morbidity related virus problems drug toxicity resistance agent mandate development additional therapeutic approaches,C20,0.0031419182,0.0027870382,0.051481303,0.0017653682,0.034789108,0.031060472,0.4584382,0.002954698,0.0022714671,0.0030871192,0.014449471,0.0064623253,0.02072773,0.047830924,0.0027629237,0.0048926203,0.058599517,0.00324229,0.022197727,0.06124039,0.09654341,0.001115581,0.06815847
histopathologic immunophenotypic genotypic analysis ki anaplastic large cell lymphomas express histiocyte associated antigens cd ki antigen expression cases malignant lymphomas examined using ber h monoclonal antibody among cases categorized ki anaplastic large cell lymphoma two cases histiocyte associated markers also expressed cases histopathologic extensive situ immunophenotypic analyses used genotypic studies determination cell lineage sinusoid histologic pattern involvement partial lymph node infiltration pleomorphic neoplastic cells noticed nodes patients solid areas node replacement resembling metastatic carcinoma seen patient immunohistologically tumor cells cases positive cd cd cd ln hla dr ema cd cd vimentin alpha antichymotrypsin cd patient also cd ro cd whereas patient positive alpha antitrypsin cd tumor cells genotypic studies revealed tcr beta tcr gamma chain genes clonally rearranged patient whereas rearrangements detected patient study supports view ki anaplastic large cell lymphomas may express multiple histiocyte associated antigens confirms group neoplasms immunophenotypic heterogeneity results genotypic analyses used immunophenotyping exclude tumor cells cases may true histiocytic origin despite ki positive phenotype,C20,0.0021137022,0.0018749593,0.013998427,0.001187603,0.045256723,0.0027278427,0.24783131,0.012208486,0.0015555513,0.0020768365,0.17199421,0.014580134,0.013455697,0.15768966,0.0018587364,0.003291474,0.10044907,0.002273801,0.0024067608,0.021392565,0.1044098,0.010972306,0.06439434
basophil histamine release platelet activating factor aspirin sensitive subjects asthma histamine release induced platelet activating factor paf leukocytes aspirin sensitive subjects asthma higher normal control subjects despite similarity anti ige induced histamine release moreover basophils aspirin sensitive subjects asthma released histamine paf stimulation absence cytochalasin b affects histamine release required paf induced histamine release leukocytes atopic subjects asthma normal control subjects addition temperature dependency inhibition ethylenediaminetetraacetic acid reported previously paf induced histamine release enhanced cytochalasin b indomethacin inhibited dexamethasone features common ige mediated histamine release suggest existence common pathway paf induced histamine release ige mediated histamine release results present study indicate pathophysiologic significance paf induced histamine release activation basophils paf may relevant pathogenesis aspirin sensitive subjects asthma,C20,0.002839423,0.0025187097,0.07151283,0.0015953559,0.0039538066,0.0036644232,0.24838057,0.0026702278,0.0020527763,0.0027898997,0.013106984,0.0058824047,0.16435637,0.096105985,0.0024969168,0.004421572,0.026333515,0.027878804,0.0032331008,0.022712158,0.28756407,0.0010081759,0.0029218965
disease control priorities developing countries health policy responses epidemiological change health systems developing countries facing major challenges beyond growing epidemiological diversity consequence rapid economic development declining fertility infectious parasitic diseases childhood must remain priority time chronic diseases among adults emerging serious problem health policymakers must engage undertaking epidemiological economic analysis major disease problems evaluating cost effectiveness alternative intervention strategies designing health care delivery systems choosing governments persuasion taxation regulation provision services world bank commissioned studies two dozen diseases developing countries confirmed priority child survival interventions revealed interventions many neglected emerging adult health problems comparable cost effectiveness developing countries lack information major diseases among adults reflecting lack national capacities epidemiological economic analyses health technology assessment environmental monitoring control critical need national international investment capacity building essential national health research build base health policies,C20,0.0020304841,0.011616019,0.013609875,0.0011408462,0.0028317638,0.0026387991,0.46824256,0.0019094918,0.011293456,0.021647513,0.056413148,0.004259424,0.040096268,0.01447195,0.0017855566,0.04247527,0.06481813,0.002103048,0.120265245,0.020847509,0.09268895,0.0007209511,0.0020937591
rearrangement immunoglobulin cell receptor bcl genes malignant lymphomas hong kong pattern malignant lymphomas hong kong chinese population characterized low incidence hodgkin disease follicular lymphomas authors studied immunoglobulin ig cell receptor tcr bcl gene rearrangement cases malignant lymphoma population southern blot hybridization two cases hodgkin disease showed rearrangement ig tcr genes cases b cell lymphoma ig heavy chain jh rearrangement without additional rearrangement light chains c kappa c lambda one case diffuse b cell lymphoma additional cell receptor beta chain c beta rearrangement sixteen cases cell lymphoma c beta rearrangement one case lymphoblastic lymphoma additional jh rearrangement two eight cases follicular lymphoma one cases diffuse b cell lymphoma bcl rearrangement detected pfl probe none cases showed bcl rearrangement using pfl probe conclusion ig tcr gene rearrangement pattern lymphomas found hong kong correlates well cell b cell lineage similar reports white population however incidence bcl gene rearrangement follicular b cell lymphoma lower reported us comparable japan,C20,0.0021573838,0.0019137072,0.0040254546,0.001212146,0.0030040888,0.0027842163,0.18942113,0.00202883,0.0120016495,0.0021197565,0.17380685,0.004444646,0.019325968,0.11195477,0.001897149,0.0033594954,0.019517064,0.033553816,0.002456499,0.0800341,0.21474624,0.0007660086,0.113469
randomized comparison methotrexate dose addition bleomycin chop therapy diffuse large cell lymphoma non hodgkin lymphomas cancer leukemia group b study cancer leukemia group b initiated randomized study determine usefulness addition bleomycin high dose methotrexate standard therapy treatment certain adult non hodgkin lymphomas patients diffuse large cell lymphoma dlcl patients intermediate grade non hodgkin lymphoma randomized receive therapy three courses cyclophosphamide adriamycin vincristine prednisone chop every weeks without low dose bleomycin continuous iv infusion responders three courses randomized weeks therapy either high dose methotrexate gm week intravenously leucovorin rescue standard dose methotrexate mg week orally without rescue therapy concluded three additional courses chop neither addition low dose infusion bleomycin use high dose rather low dose methotrexate significant effects response patients dlcl complete response rates four treatment programs ranged median failure free survival ffs entire group dlcl patients months year ffs significant effect ffs addition either low dose bleomycin chop year ffs chop chop b p use different doses methotrexate year ffs high dose standard dose p patients follicular large cell lymphoma without diffuse areas better ffs year ffs patients dlcl year ffs patients histopathologic subtypes diffuse lymphomas poorest ffs year ffs,C20,0.0015679859,0.016566016,0.0029371928,0.00088098727,0.0021844283,0.0020235674,0.18123503,0.0014745529,0.001133584,0.0015406382,0.03804942,0.081794865,0.04494244,0.027724342,0.0013788472,0.002446494,0.20337005,0.0016147655,0.011098829,0.05205376,0.32181242,0.0005567348,0.001613086
allogeneic marrow transplantation patients acute myeloid leukemia first remission randomized trial two irradiation regimens randomized trial gy versus gy total body irradiation tbi performed patients acute myeloid leukemia undergoing allogeneic marrow transplantation first complete remission patients received mg kg cyclophosphamide followed tbi marrow hla identical siblings cyclosporine methotrexate used prophylaxis acute graft versus host disease gvhd thirty four patients received gy fractions irradiation daily days received gy fractions daily days year actuarial probabilities relapse free survival patients received gy received gy year probabilities relapse gy group gy group p year probabilities transplant related mortality respectively p probability moderate severe acute gvhd gy group gy group p patients exposed higher irradiation dose received less immunoprophylaxis higher incidence acute gvhd increased dose tbi significantly reduced probability relapse improve survival increased mortality causes relapse,C20,0.0024967357,0.0022143759,0.004657907,0.0014025902,0.003476071,0.0032216536,0.117588416,0.002347586,0.0018047409,0.0024527982,0.0788819,0.10640013,0.047874335,0.012462479,0.03160461,0.0038873167,0.23387423,0.0025708138,0.0028424475,0.098558806,0.23592556,0.0008863587,0.00256814
use antihistamines prevention treatment anaphylaxis anaphylactoid reactions pathophysiologic effects histamine anaphylaxis shown mediated h h receptors individually combination h receptors mediate coronary artery vasoconstriction wheezing cutaneous vascular permeability possibly increase pulse rate h receptors stimulate ventricular atrial inotropy arterial chronotropy coronary vasodilation rises basophil cyclic adenosine monophosphate cyclic amp neither receptor mediates increases cyclic amp mast cells h h receptors combination seem potent mediating flush headache increases pulse pressure decreases diastolic blood pressure clinical trials conducted determine efficacy h h antagonists preventing anaphylactic reactions plasma expanders anesthesia inducing agents morphine radiocontrast material concurrently retrospective observations prevention anaphylactic reactions chymopapain recorded despite conflicting inconclusive data sum studies indicates pretreatment combination h h antagonists effective h antagonists alone preventing reactions agents results added available knowledge physiology histamine release support preferential use h h antagonist combinations prevention treatment anaphylaxis anaphylactoid reactions,C20,0.0534797,0.06528211,0.046254832,0.0012253526,0.0030523639,0.013318841,0.23656836,0.0020509344,0.0015766857,0.0021428515,0.020593436,0.004485672,0.07273516,0.017746868,0.0019178188,0.013944183,0.054351952,0.091199905,0.013720908,0.04279495,0.23853914,0.00077435444,0.0022436182
transforming growth factor beta noncytopathic mechanisms immunodeficiency human immunodeficiency virus infection study examines contribution transforming growth factor beta tgf beta one potent endogenous immunosuppressive factors development immunodeficiency human immunodeficiency virus hiv infection increased titers tgf beta found supernatants peripheral blood mononuclear cells pbmcs hiv infected donors compared uninfected controls p less correlated closely defective responses cd lymphocytes recall antigens tuberculin purified protein derivative tetanus toxoid addition tgf beta neutralizing antibody pbmcs partially restored defective cell responses furthermore purified tgf beta hiv pbmc culture supernatants preferentially inhibited proliferation cd lymphocytes compared cd cells increased expression tgf beta protein associated increased tgf beta mrna determined polymerase chain reaction assay increase tgf beta protein mrna due selective upregulation tgf beta isoform results indicate overexpression tgf beta occurs hiv infected individuals cytokine contribute impaired immune functions depletion cd lymphocytes,C20,0.0026255634,0.0023268291,0.0048944503,0.0014738183,0.0037420704,0.0033852598,0.18694031,0.0024680987,0.0018963915,0.0025773593,0.0122142965,0.0056658094,0.097220086,0.18069157,0.0023066965,0.016766677,0.025762716,0.10428959,0.0029867962,0.061140668,0.204024,0.00093137095,0.073669575
biology retroviruses detection molecular biology treatment retroviral infection although human retrovirology trace roots early part century within last decade field seen greatest advances including description first human retroviruses htlv subsequent discovery htlv ii aids retroviruses hiv hiv growth field undergone recent years would possible key advances fields cell biology immunology biochemistry molecular biology nowhere evident description hiv etiologic agent aids relatively short time since disease initially described agent responsible isolated much complex biology defined drug helps combat licensed use rapidity events transpired largely unprecedented remain many unanswered questions regarding hiv aids still effective vaccine cure significant questions regarding immune response hiv hiv response immune chemotherapeutic challenge establishment maintenance hiv latency important mechanisms hiv cytopathicity remain unanswered clear hiv offers easy answers significant work remains done death aids halted,C20,0.0023544256,0.002088493,0.052868992,0.012718565,0.0032784631,0.017107245,0.3302337,0.0022141305,0.013088181,0.016437896,0.022854134,0.0048426036,0.047873966,0.04559903,0.0020704225,0.0036663304,0.08045556,0.002424668,0.08404949,0.11327088,0.12338622,0.00083597103,0.016280646
vivo immune selection moloney murine leukemia virus induced tumor results loss viral tumor associated antigens protocol vivo immune selection used isolate variant moloney murine leukemia virus mulv induced tumor mbl characterization tumor variant indicated selection resulted isolation cell incapable producing infectious virus longer capable synthesizing viral proteins although failure express viral ag rendered variant tumor cells resistant lysis ctl specific mulv viral ag variant tumor cells retained susceptibility lysis ctl appear directed mulv induced tumor associated ag data indicate expression nonviral tumor associated ag mbl dependent upon continued viral gene expression,C20,0.0025902928,0.014836663,0.004841716,0.0014553799,0.1540872,0.0033429076,0.23271109,0.0024359426,0.0018726663,0.0025451148,0.012497364,0.005327737,0.016301643,0.1736763,0.002277838,0.0040336247,0.0229668,0.019401746,0.015469672,0.10142577,0.12452646,0.0009197188,0.08045634
non hodgkin lymphoma elderly pathologic features presentation pathologic findings patients aged years older non hodgkin lymphoma nhl reported patients formed consecutive cases nhl seen single institution year period thirty one nhl cases histologically classified whereas remaining could classified according international working formulation wf nhl clinical usage immunophenotypic analyses carried nhl cases group nhl elderly patients elderly nhl could classified histologic categories wf cases low grade intermediate grade high grade categories eighty one cases diffuse histologic types follicular nodular histologic types thirty five cases g diffuse large cell h large cell immunoblastic categories significant differences prevalence different subtypes observed among patients younger older years immunohistologically nhl cases elderly expressed b cell phenotype sixty two nhl elderly extranodal presentation results study indicate elderly patients form relevant proportion patients developing nhl thereby present difficult management problem pathologic features nhl elderly differ significantly younger counterparts although increase diffuse versus follicular histologic patterns extranodal versus nodal disease observed advancing age,C20,0.001899626,0.001685063,0.003544505,0.0010673834,0.0026458572,0.0024515663,0.28345186,0.0017864313,0.001373345,0.0018697106,0.14341065,0.013289438,0.047204796,0.04432819,0.0016704832,0.0029581126,0.10365818,0.011130124,0.0021630037,0.21406929,0.1117043,0.0006744882,0.0019635824
clearance mtc dtpa pigeon fancier hypersensitivity pneumonitis rate clearance inhaled mtc dtpa measured nonsmoking pigeon fanciers control subjects degree avian contact pigeon related symptoms noted humoral immune response form igg antibody pigeon gamma globulin quantified diffusing capacity total lung capacity measured thirteen fanciers high level antibody increased rates clearance mtc dtpa mean half time clearance sem min p even asymptomatic even diffusing capacity total lung capacity normal seven control subjects without exposure pigeon derived antigens normal clearance mean min seven fanciers antigen exposure without antibody response intermediate rates clearance mean min clearance directly related indices intensity duration antigen exposure measurement rate clearance mtc dtpa pigeon fanciers identify alteration pulmonary integrity subtle found conventional pulmonary function tests may therefore useful test studying pulmonary response inhaled antigen detecting earliest stages evolution hypersensitivity pneumonitis,C20,0.028975293,0.0017664314,0.0037172073,0.0011188613,0.0027728989,0.023785627,0.1799183,0.0018740746,0.0014396611,0.001962226,0.06507722,0.013838078,0.20746937,0.07882483,0.011399925,0.03338422,0.03765236,0.0020724537,0.0022674508,0.07954867,0.21836878,0.0007070578,0.0020589686
genetic aspects juvenile chronic arthritis immunogenetic studies past decade confirmed theory association one immunogenetic background manifestation several forms juvenile chronic arthritis jca particular pauciarticular onset jca considerable work done serologic level demonstrate disease association major histocompatibility class ii antigens pauciarticular onset jca polygenic nature jca best illustrated findings particularly well defined clinical subgroup evidence emerging analysis dna sequence derived protein sequence structure class ii molecules yield significant insight genetic predisposition jca,C20,0.0035771627,0.003173122,0.023962053,0.0020098619,0.0049817576,0.004616515,0.3958852,0.0033651572,0.0025861294,0.055463858,0.052864946,0.009378545,0.028319035,0.026262635,0.0031456666,0.0055703865,0.044079848,0.02697208,0.021377059,0.09726322,0.07169857,0.0012701205,0.1121771
bacterial lipopolysaccharide transforms mesangial proliferative lupus nephritis without interfering processing pathogenic immune complexes nzb w mice systemic lupus erythematosus multifactorial systemic disease genetic immunologic hormonal environmental factors may contribute disease pathogenesis bacterial products eg bacterial lipopolysaccharide lps induce lupuslike disease normal mice trigger early accelerated form lupus nephritis nzb w mice investigate whether mechanism lps accelerates nephritis nzb w mice involves interference processing immune complexes ic administered lps nzb w mice weeks probed kinetics removal liver uptake organ localization subsaturating dose radiolabeled ic mg bovine serum albumin antibovine serum albumin control nzb w mice received vehicle saline alone nzb w exposed lps features polyclonal b cell activation pba enhanced anti dna antibodies raised proliferative glomerulonephritis developed associated renal insufficiency substantial proteinuria lps accelerated nephritis could attributed altered complement concentration altered blood cell carrier function delayed removal pathogenic large sized ics circulation impaired liver uptake ics enhanced localization ics kidney findings indicate transformation nephritis probably result lps induced pba defective processing pathogenic ic contributory factor nephritis mechanisms passive renal localization circulating ics must operative,C20,0.0018327533,0.0016257436,0.012249994,0.0010297493,0.0025523913,0.011219751,0.26892203,0.0017235434,0.027927803,0.010669929,0.035025444,0.02574798,0.04661468,0.12811744,0.001611677,0.05567755,0.0364135,0.046553507,0.019829547,0.02529175,0.20837437,0.00065074407,0.030338133
relationships among shrimp specific igg subclass antibodies immediate adverse reactions shrimp challenge high levels shrimp specific ige association positive prick test always predictive positive immediate response double blind placebo controlled food challenge dbpcfc shrimp observation shrimp sensitive individuals general increased levels circulating shrimp specific igg interest antigen allergen specific igg subclasses associated adverse reactions foods therefore current study measured shrimp specific igg subclass ige antibodies individuals histories immediate adverse reactions shrimp immediately dbpcfc shrimp tolerant subjects individuals history shrimp sensitivity significantly raised shrimp specific igg igg compared shrimp tolerant individuals challenge positive subjects distinguished subjects negative equivocal responses increased igg p less equal specific igg raised p less equal studies indicate shrimp specific igg subclass levels increased shrimp sensitive subjects however none subclass responses significantly predictive positive response dbpcfc therefore diagnostic shrimp intolerance,C20,0.0021802753,0.0019340129,0.033864185,0.0012250077,0.0030359642,0.013357928,0.21962516,0.0020503572,0.0015762419,0.0021422484,0.08847114,0.004484501,0.119023874,0.085646175,0.023026016,0.024493983,0.023148036,0.002245322,0.023584055,0.060856216,0.26100564,0.0007741365,0.0022495536
high hiv risk taking among young gay men previous research shown younger age correlated greater hiv sexual risk taking among gay men purpose study identify variables associated hiv risk taking among younger gay men ninety nine gay men aged three medium sized west coast communities completed self report questionnaires regarding hiv related behaviors attitudes respondents reported engaged unprotected anal intercourse previous months men engaged unprotected anal intercourse reported greater enjoyment unprotected anal intercourse perceived less risk unprotected anal intercourse labeled risk aids reported poorer communication skills sexual partners likely boyfriend lover men engaged high risk sex addition respondents perceived likelihood acquiring hiv unprotected anal intercourse young gay men significantly lower older gay men findings highlight need hiv risk reduction interventions designed specifically young gay men identify critical areas targeted interventions,C20,0.002496489,0.0022145105,0.02881634,0.0014026754,0.003476282,0.0032326635,0.21884853,0.0023477287,0.0018048505,0.014510801,0.029766712,0.0051349523,0.048994966,0.029896695,0.0021953497,0.0038875528,0.06388199,0.014650916,0.0028426202,0.43745175,0.078689404,0.0008864126,0.0025697593
platelet activating factor induced clinical histopathologic responses atopic skin modification platelet activating factor antagonist bn clinical histopathologic responses intradermal platelet activating factor paf acether atopic subjects without evidence atopic dermatitis documented immediate acute wheal flare reaction observed volunteers histopathologically reaction characterized predominantly neutrophilic response seen minutes maximal hours eosinophils observed infiltrate early minutes injection maximal hours specific paf acether antagonist bn antagonized acute flare response intradermal paf acether little effect cellular recruitment site injection,C20,0.040298596,0.0033467666,0.025272489,0.0021198487,0.023517804,0.004869147,0.2752716,0.0035480978,0.039255396,0.0037071137,0.017708136,0.04428608,0.11671969,0.061836503,0.003317809,0.024135621,0.054073576,0.0039239405,0.0042960225,0.034543402,0.20871025,0.0013396261,0.0039024584
cytotoxic activity hiv infected monocytes recombinant interleukin activated natural killer cells natural killer nk cells long known aid control viral infections killing virus infected cells including infected human immunodeficiency virus hiv among possible nk susceptible target cells infected individual monocyte macrophages special significance since may serve reservoir hiv aid dissemination virus throughout body new technique enrichment cultivation large numbers recombinant interleukin ril stimulated nk cells developed provides cells high cytotoxic activity il activated nk cells adherent lymphokine activated killer cells lak kill monocytes infected hiv h days optimal target sensitivity days recognition killing infected monocytes appear restricted major histocompatibility complex mhc antigens could cold target inhibited tumor cell lines lak cells may useful newer therapeutic approaches treatment hiv infection,C20,0.002327683,0.002064771,0.04244305,0.0013078301,0.059665408,0.003003996,0.34433284,0.013448635,0.0016828112,0.0022870852,0.020760063,0.016504884,0.060843006,0.17254555,0.012124555,0.0036246865,0.026581937,0.058736496,0.0026504095,0.018997198,0.07153843,0.0008264757,0.061702136
therapeutic approaches neoplasms aids multifactorial etiology kaposi sarcoma ks seen primarily men includes genetic predisposition immunosuppression recently ks seen association human immunodeficiency virus hiv infection shown mediated production certain growth factors hiv per se may also play etiologic role via tat gene therapeutic options include irradiation local cosmetic control interferon alpha combinations antiretroviral agents interferon alpha chemotherapy use antineoplastic agents either individually combination cases advanced disease somewhat successful resultant immunosuppression neutropenia may predispose patients infection thereby adversely affecting survival aids related lymphoma late manifestation hiv infection often presents widespread extranodal disease median survival time series approximately months two thirds patients may central nervous system involvement time course illness intensive chemotherapeutic regimens associated increased likelihood opportunistic infection prolong survival combinations antineoplastic agents given low doses short periods may associated long term remissions,C20,0.0021133504,0.0018746472,0.024403097,0.0011874054,0.0029654282,0.0027273889,0.42067352,0.0019874203,0.0015278583,0.0020764908,0.02105684,0.02644047,0.016732993,0.040101312,0.0018584271,0.003290926,0.15338178,0.0022185706,0.0024063603,0.10966984,0.11889561,0.00075037393,0.0416599
genomic divergence hiv german aids patient probably infected mali complete nucleotide sequence hiv isolate derived german aids patient predominantly neurological symptoms reported hiv ben sequence highly divergent previously described hiv siv strains evolutionary tree analysis eight hiv sequences reveals existence three hiv groups hiv ben belongs group two isolates ghana gambia based comparison hiv ben six hiv isolates sivsmm sivmac variability structural env gag proteins similar within hiv sivsmm mac hiv groups contrast regulatory hiv proteins highly conserved hiv strains multiple sequence alignments reveal domains envelope regulatory proteins well conserved among hiv hiv sivsmm mac sivagm sivmnd identification conserved domains within external glycoprotein could help develop broadly active vaccines,C20,0.0031909873,0.002830565,0.036848165,0.017235305,0.053598423,0.018964512,0.32980612,0.0030016082,0.0023069417,0.0031729995,0.027707417,0.053701993,0.035930578,0.007633246,0.01823338,0.0049690306,0.08709602,0.07582827,0.003906322,0.0824537,0.057808116,0.0011330036,0.07264326
effect procaterol arterial blood gas asthmatic children determined changes arterial blood gas inhalation procaterol highly beta selective long acting adrenergic agonist asthmatic children seven patients maximum fall mmhg showed decrease pao mean sd mmhg poorer pulmonary function lower initial pao four subjects increase pao inhalation statistically significant correlation values pao inhalation p less,C20,0.06066401,0.0037586244,0.007906211,0.0023807203,0.005900193,0.068965256,0.11952933,0.0039847316,0.04407394,0.045190006,0.020295866,0.009234531,0.2739937,0.009742674,0.0037261033,0.006598231,0.1159576,0.0043636328,0.004824697,0.02838087,0.13415504,0.0015044825,0.024869537
cytomegalovirus infection children aids data children perinatally exposed human immunodeficiency virus hiv evaluated determine impact cytomegalovirus cmv infection course perinatally acquired hiv infection thirteen children belonged p indeterminate group one p asymptomatic group p symptomatic group per classification centers disease control children p group died mean follow time months children died months children p group serial cultures urine performed patients cmv isolated seven children died four children survived p less one p children culture positive cmv compared p children p less cmv infected children continued demonstrate cmv viruria serial cultures mean age time first culture positive cmv months microcephaly present p children none p p children p less eight cmv infected children microcephalic seven children infected cmv microcephalic p greater data suggest prevalence active cmv infection significantly higher p children p p children addition significant association cmv infection mortality among p children,C20,0.002030289,0.0018009676,0.013614565,0.0011407365,0.01266426,0.0026201936,0.14205626,0.0019093083,0.0014678085,0.1789203,0.06301844,0.064366065,0.10802533,0.05367759,0.0116072,0.0031615822,0.17617816,0.002090861,0.002495772,0.07025074,0.08408671,0.00072088186,0.0020959761
normal responsiveness superficial hand veins alpha beta adrenergic stimuli allergic asthma effects terbutaline prednisolone beta adrenergic responsiveness impaired function adrenergic receptor system postulated contribute pathogenesis bronchial asthma using dorsal hand vein compliance technique compared changes diameter superficial hand veins response phenylephrine alpha adrenoceptor agonist isoproterenol beta adrenoceptor agonist untreated patients allergic asthma nonatopic control subjects significant differences median effective dose phenylephrine produced maximal venoconstriction ed maximal response emax two groups bronchial hyperreactivity assessed methacholine challenge tests patients asthma uncorrelated ed emax isoproterenol results demonstrate evidence generalized change alpha beta adrenergic responsiveness smooth muscle cells asthma hand vein responsiveness isoproterenol unchanged treatment days oral terbutaline mg three times per day thus unlike leukocytes smooth muscle appears readily susceptible beta adrenoceptor desensitization vivo local infusions prednisolone dexamethasone hours systemic administration dexamethasone hours caused significant fall emax isoproterenol mechanism attenuation beta adrenoceptor responsiveness corticosteroids remains determined,C20,0.0023277176,0.013329735,0.01560191,0.0013078495,0.0032415208,0.0030040408,0.16012101,0.047259513,0.0242173,0.0022871192,0.030437712,0.028834928,0.14081618,0.030429158,0.0020469362,0.06026788,0.086156175,0.0294089,0.0026504488,0.01569131,0.27480572,0.00082648796,0.024930468
monitoring glucocorticoid therapy pharmacokinetic approach although glucocorticoid therapy essential treatment severe inflammatory disorders systematic approach patient variables may affect availability steroid dose development data base pharmacokinetic parameters examined glucocorticoid pharmacokinetics patients years age using pharmacokinetic studies administration intravenous methylprednisolone n oral methylprednisolone n intravenous prednisolone n oral prednisone n eleven patients unusually rapid methylprednisolone elimination clearance ml min population mean sd ml min without identifiable cause incomplete absorption methylprednisolone prednisone observed three patients one patient respectively evaluation glucocorticoid pharmacokinetics children aged year months years demonstrated significant inverse correlation r p less prednisolone clearance age therefore important consider age interpretation pharmacokinetic data simplify measurement prednisolone clearance single dose single point method developed based highly significant relationship hour postdose prednisolone concentration prednisolone clearance log prednisolone clearance hour postdose concentration r p less evaluation glucocorticoid pharmacokinetics clinical setting used identify abnormalities absorption elimination patient compliance technique used individualize glucocorticoid dosing regimens,C20,0.0018231516,0.010398831,0.07495174,0.0010203749,0.020121729,0.011126389,0.26994106,0.0017078529,0.0013129368,0.010575912,0.09396366,0.021571273,0.10308548,0.0041757026,0.001597005,0.0028395024,0.1115406,0.0018702496,0.0020678614,0.07552781,0.17626473,0.00064482,0.0018713623
laboratory methods diagnosis prognostic staging infection human immunodeficiency virus type laboratory evaluation infection human immunodeficiency virus type hiv may involve detection antibodies hiv direct detection hiv measurement individual immunologic status time presentation elisa currently preferred initial screening test although variety rapid immunoassays also developed methods defining antigenic specificity antibody response western blot become standard confirmatory tests setting cd cell enumeration hiv antigen capture assay useful predicting course hiv infection monitoring antiretroviral therapies newer techniques hiv co cultivation permit characterization viral isolates stratification patients facilitate monitoring effects antiretroviral agents polymerase chain reaction value identifying hiv infection individuals inconclusive serologic results judicious use laboratory tests including surrogate markers beta microglobulin also provides prognostic information potentially useful clinical management hiv infected patients,C20,0.0022516295,0.0019973076,0.015405757,0.0012651505,0.014034207,0.013720624,0.46219903,0.0021174597,0.0016278279,0.0022123582,0.1376319,0.0046311715,0.03976261,0.08994514,0.012873455,0.0035062553,0.051524285,0.018688563,0.002642544,0.03709951,0.056993376,0.0007994718,0.027070375
reduced cerebral blood flow early stages human immunodeficiency virus infection order determine brain perfusion abnormalities known patients acquiredimmunodeficiency syndrome dementia occur early stages human immunodeficiency virus infection technetium hexamethyl propyleneamine oxime single photon emission computed tomography studies performed patients infected human immunodeficiency virus belonged walter reed stages iv none patients demonstrated signs dementia severe neurological dysfunction pathological patterns hexamethyl propyleneamine oxime uptake seen patients seven normal results neurological examination four patients signs cerebral atrophy cranial computed tomographic scan data suggest subtle changes cerebral perfusion seem arise early course human immunodeficiency virus infection may indicate human immunodeficiency virus encephalopathy neurological symptoms noticeable structural damage occurs,C20,0.058806006,0.0021369522,0.004495047,0.036337707,0.015433527,0.005617992,0.2215676,0.0022655046,0.0017416397,0.04007258,0.054560777,0.0049549663,0.10683745,0.0077692647,0.025425669,0.015407569,0.14789309,0.0024821544,0.0027430637,0.042641416,0.08982925,0.000855368,0.11012543
monocytoid b cell lymphoma patient human immunodeficiency virus infection demonstration human immunodeficiency virus sequences paraffin embedded lymph node sections polymerase chain reaction amplification significantly increased incidence malignant lymphoma patients acquired immunodeficiency syndrome aids lymphomas usually high grade b cell phenotype frequent presence reactive monocytoid b lymphocytes patients aids related lymphadenopathy recently documented several studies knowledge reported cases monocytoid b cell lymphoma neoplastic counterpart monocytoid b lymphocytes patients aids describe human immunodeficiency virus hiv positive patient hiv related lymphadenopathy monocytoid b cell lymphoma developed course disease morphologic immunologic features lymphoma characteristic monocytoid b cell lymphoma involved lymph node exhibited reversed cd cd ratio moreover using polymerase chain reaction able demonstrate hiv genome dna extracted lymph node tissue knowledge first report case monocytoid b cell lymphoma occurring hiv positive patient able using sensitive molecular biologic technique demonstrate hiv sequence paraffin embedded fixed lymph node sections,C20,0.002113333,0.0018746317,0.044123203,0.0011873955,0.013176868,0.0027653764,0.24191234,0.022444595,0.0015278456,0.0020764738,0.0738535,0.0043468596,0.032324474,0.09321765,0.0018584116,0.0032908989,0.12436317,0.012401022,0.0024167432,0.07161006,0.16293736,0.00075036776,0.083427384
zidovudine retrovir update zidovudine azt first antiretroviral agent licensed treatment human immunodeficiency virus hiv infection since initial placebo controlled trial showing improved survival among patients acquired immunodeficiency syndrome aids symptomatic hiv infection aids related complex arc zidovudine evaluated stages hiv infection review offers physicians treat patients hiv infection comprehensive analysis current data clinical efficacy zidovudine various stages hiv infection zidovudine adverse effects search medline pertinent articles published since controlled studies studies long term zidovudine therapy zidovudine therapy hiv related conditions incidence management adverse reactions evaluated addition abstracts international meetings reviewed significant difference clinical outcome found high dose low dose zidovudine therapy significantly fewer toxic effects low dose group two studies zidovudine found delay disease progression patients asymptomatic mildly symptomatic hiv infection absolute cd count less x l low incidence adverse reactions may due either early stage infection low dose used demonstration zidovudine resistant isolates least months therapy yet correlated clinical deterioration begin zidovudine therapy among asymptomatic patients cd count less x l remains unclear zidovudine used safely delay progression aids arc certain patients asymptomatic mildly symptomatic hiv infection prolong survival severe infection studies necessary identify indicators could better define start treatment alleviate toxic effects combination therapy agents interferon alpha may become preferred choice therapy prevent toxic effects zidovudine resistance zidovudine prophylaxis used hiv exposure although studies animal models encouraging results infection occurred despite immediate prophylaxis thus investigation required,C20,0.0013544462,0.0077448967,0.029657505,0.0007598927,0.0018855953,0.021373337,0.3700262,0.0012718707,0.0009777691,0.0144209135,0.032907486,0.009583207,0.055641215,0.003358755,0.0011893201,0.015175889,0.15781061,0.0013928106,0.021171827,0.09249604,0.1503211,0.00048020977,0.008999092
effect paf acether inhalation nonspecific bronchial reactivity adrenergic response normal asthmatic subjects bronchial hyperreactivity although recognized hallmark asthma totally understood mast cell derived mediators including histamine shown cause immediate bronchoconstriction recently single mediator shown induce prolonged changes airway reactivity recent reports indicate paf acether paf induce increased nonspecific bronchial reactivity normal subjects asthmatics sought elucidate role paf airway hyperreactivity comparing effect inhaled paf methacholine isoproterenol airway responsiveness six nonasthmatic six asthmatic subjects neither nonspecific airway reactivity isoproterenol responsiveness changed following paf inhalation nonasthmatic subjects six days following paf asthmatics increased airway responsiveness methacholine two hours post paf persist responsiveness isoproterenol change asthmatic subjects additional evaluation role paf causing changes airway reactivity warranted,C20,0.0027637521,0.002451586,0.0051568747,0.0015528395,0.017226657,0.083843015,0.21777004,0.0026012708,0.0019980697,0.0027155487,0.015142384,0.00568451,0.17322572,0.03518946,0.015801236,0.031058485,0.05730615,0.002902311,0.016508207,0.062157962,0.21634428,0.027736919,0.0028627117
evaluation active control trials aids settings effective standard treatment exists active control trials provide ethically appealing approach evaluating experimental therapies allowing patients randomized either promising new regimen standard would routinely delivered clinical practice paper describes appropriate statistical approach analyzing clinical efficacy new treatments studies confidence intervals relative efficacy new treatment vis vis standard therapy used provide information required determine whether experimental treatment improved therapeutic index desirable properties approach include ability implement standard group sequential guidelines early trial termination ability use valid surrogates hard clinical outcomes availability straightforward formulas sample size calculations,C20,0.002409276,0.002137148,0.074431136,0.0013536739,0.016994061,0.003109296,0.44932222,0.0022657122,0.0017417993,0.002367255,0.044452246,0.033286512,0.034813777,0.00557978,0.0021186564,0.027069338,0.04323647,0.0024811549,0.058139663,0.039101154,0.15023878,0.0008554464,0.002495488
aids related experiences practices primary care physicians los angeles telephone interviews random samples los angeles primary care physicians obtained information aids related practice experiences sexual history taking data mid reveal almost percent worked least one patient aids hiv infection past six months percent caring least one patient aids aids related complex self reported use appropriate sexual history questions improved substantially five year period,C20,0.003400407,0.0030163308,0.09460736,0.00191055,0.0047676987,0.0043884027,0.18211366,0.003197784,0.002458343,0.0033410997,0.06423966,0.0069939876,0.021394737,0.007818586,0.035913,0.02175382,0.16038516,0.00350951,0.053253777,0.2286456,0.08818493,0.001207361,0.0034982134
amyloid deposition intrahepatic large bile ducts peribiliary glands systemic amyloidosis amyloid deposition hepatic parenchyma portal tracts liver well known systemic amyloidosis recently experienced autopsy case systemic amyloidosis presenting amyloid deposits intrahepatic biliary tree experience prompted us survey autopsy cases systemic amyloidosis amyloid deposition found lining epithelium intrahepatic large bile duct cases around peribiliary glandular acini cases respectively amyloid deposition intrahepatic large bile duct peribiliary glands positively correlated degree amyloid deposition liver type amyloid protein double staining amyloid vascular endothelium disclosed amyloid deposition closely related inner part peribiliary vascular plexus vascular plexus encircling peribiliary glands lining biliary epithelium peribiliary glandular acinar cells exact pathogenesis amyloid deposition anatomical components however remains unclear although cases failed show overt clinical symptomatologies related amyloid deposition biliary components seems conceivable massive amyloid deposition anatomical components could give rise clinical symptoms,C20,0.0025274234,0.0022419507,0.04169053,0.0014200988,0.015934989,0.0032617718,0.3618537,0.1280525,0.014035684,0.01528112,0.08716976,0.00529213,0.09439839,0.04824275,0.0022225524,0.052012533,0.032958306,0.014837491,0.015108001,0.019075762,0.038883366,0.0008973963,0.0026018352
large volume spacer devices reduce systemic effects high dose inhaled corticosteroids used high doses inhaled corticosteroids may cause suppression hypothalamo pituitary adrenal axis influence mode drug inhalation degree suppression clear hypothalamo pituitary adrenal function assessed measurement h serum cortisol concentrations short tetracosactrin test hour urine free cortisol excretion adults asthma taking micrograms beclomethasone dipropionate daily via metered dose aerosol twelve patients hypothalamo pituitary adrenal suppression judged subnormal results least two three tests one patient abnormal insulin stress test response patients changed inhaling dose beclomethasone dipropionate ml spacer device volumatic endocrine tests repeated nine days eight weeks later patients comparison initial values showed adding spacing device caused increase median h cortisol concentration nmol l nmol l post tetracosactrin cortisol concentration nmol l nmol l hour urine free cortisol excretion nmol nmol rise serum cortisol concentration response tetracosactrin change evidence persisting hypothalamo pituitary adrenal axis suppression present four patients pronounced improvements function tended occur never required long term oral corticosteroids results uncontrolled study suggest asthmatic patients taking high dose beclomethasone dipropionate may minimise adverse effects using large volume spacer device,C20,0.0015801643,0.03199615,0.033610195,0.0008877699,0.0022007918,0.017330667,0.21336077,0.016762786,0.0011423113,0.0015524994,0.042511363,0.02618881,0.1081082,0.003640908,0.016683236,0.010106193,0.09338034,0.0016271974,0.001799128,0.027288407,0.33842194,0.00056102104,0.0092591755
asthmatic airways disproportionate hyperresponsiveness lte compared normal airways ltc ltd methacholine histamine airways responsiveness leukotriene lt c ltd lte histamine methacholine studied eight asthmatic six normal subjects airways responsiveness bronchoconstrictor agonist assessed constructing cumulative dose response curves dose produced decrease specific airways conductance pd obtained linear interpolation airways subjects asthma approximately fold responsive histamine methacholine ltc ltd lte respectively normal subjects thus substantially augmented level hyperresponsiveness lte bronchial asthma observed bronchoconstrictor agents compared normal subjects contrast ltc ltd histamine methacholine responsiveness increase dose ratio histamine lte pd histamine pd lte dose ratio methacholine lte also tended increase suggests nonspecific airways responsiveness increases relative potency lte also increases whereas potency ltc ltd decrease results suggest mechanism bronchoconstriction induced lte may distinct produced ltc ltd subjects asthma may reflect leukotriene subtype receptor heterogeneity asthmatic airways,C20,0.0021135397,0.0018748153,0.014172808,0.02294439,0.0029430373,0.09481245,0.220735,0.0019875984,0.0015279952,0.002076677,0.010580911,0.0043584444,0.15353377,0.0175783,0.0018585935,0.06068812,0.018602576,0.018753165,0.002406576,0.035447743,0.2978562,0.010971463,0.0021758357
soluble mediators articular cartilage degradation juvenile rheumatoid arthritis juvenile rheumatoid arthritis jra involves wide range joint tissues tissue changes include proliferation synovial cells alterations synovial fluid degradation articular cartilage synovial cell proliferation results increased numbers fibroblasts lymphocytes changes synovial fluid include increased content antibodies altered complement ratios increased levels factors stimulating cartilage mediated proteoglycan degradation decreased levels insulinlike growth factor levels cytokine interleukin interleukin vary cell culture assay technique cartilage degradation apparent increased quantities proteoglycan glycosaminoglycan serum synovial fluid type ii collagen peptide antibodies also prevalent jra patients cartilage degradation appears linked factors jra synovial fluid conditioned medium peripheral blood mononuclear cells patients jra also stimulates increased release cartilage proteoglycan thus outcome jra likely reflects activities interacting soluble factors directly influence cartilage homeostasis,C20,0.0022272677,0.0019756975,0.0041558505,0.012275137,0.0031013996,0.002874405,0.20546272,0.0020945494,0.0016102154,0.0021884213,0.016452067,0.069264345,0.05330351,0.24916604,0.001958603,0.003477828,0.045658182,0.0023047205,0.013305826,0.03050406,0.26278004,0.011567776,0.0022913308
frequency indeterminate western blot tests healthy adults low risk human immunodeficiency virus infection niaid aids vaccine clinical trails network part phase trial candidate aids vaccine blood specimens collected healthy adult volunteers minimal risk becoming infected human immunodeficiency virus type hiv specimens screened evidence hiv infection enzyme immunoassay eia biotech du pont western blot n culture n polymerase chain reaction assay n none subjects positive test result assays indeterminate western blot tests demonstrated single band low intensity common bands p p p envelope bands unusual gp gp serum specimen collected months individuals indeterminate western blot results positive eia western blot agreement test results first second serum samples lot western blot kit used agreement different lots used biotech du pont western blot kit thus frequently yields indeterminate test results absence hiv infection reproducibility subject lot lot variability,C20,0.0021577252,0.0019140099,0.024915555,0.0012123787,0.0030047875,0.0027846568,0.27041817,0.002029151,0.011916711,0.0021200918,0.23238398,0.004438028,0.0980459,0.052903928,0.04366995,0.02455285,0.04666991,0.0022220993,0.0129011525,0.049073666,0.08227992,0.0007661298,0.027619192
hiv disease review family physician part evaluation conventional therapy family physicians challenged caring increasing numbers patients infected human immunodeficiency virus confirming presence infection physician must follow logical sequence evaluation counseling treatment current centers disease control classification series evaluation treatment protocols form basis prescribing zidovudine delay mitigate involvement lymphocytes neuronal cells,C20,0.003991637,0.0035407813,0.007447981,0.021552198,0.08285481,0.0051514157,0.30243418,0.0037537839,0.0028857759,0.023242962,0.041596353,0.008413248,0.03823488,0.10402063,0.02282745,0.025537163,0.11303101,0.0041327514,0.004545066,0.05965913,0.07235716,0.0014172853,0.04737234
small proportion cationic antibodies immune complexes sufficient mediate deposition glomeruli positively charged antibodies mediate enhanced deposition circulating immune complexes glomerular basement membrane presented experiments demonstrate soluble immune complexes prepared mixture antibodies containing cationic antibodies noncationic antibodies complexes deposited mouse glomeruli one two cationic antibodies immune complex sufficed deposition complexes proof obtained two kinds experiments first injected immune complexes prepared ag excess mixtures radiolabeled noncationic rabbit antibodies human serum albumin hsa unlabeled cationized rabbit antibodies hsa thus permitting specific quantitation deposition noncationic antibodies glomeruli presence cationized antibodies within complexes control experiment immune complexes prepared noncationic antibodies resulted little deposition kidneys time period second detection localization noncationic antibody deposits glomeruli immunofluorescence microscopy accomplished using immune complexes prepared mixtures noncationic goat antibodies hsa cationized rabbit antibodies hsa thus synthesis small population cationic antibodies immune response may lead formation circulating immune complexes enhanced propensity deposition glomeruli patients sle immune complex diseases,C20,0.00211372,0.0018749749,0.019258557,0.011408051,0.0029435304,0.0027278655,0.2094613,0.0020068628,0.011751064,0.0020768538,0.024694392,0.037199568,0.014634997,0.28430885,0.0018587519,0.013519226,0.0364798,0.01419943,0.0024067808,0.10533224,0.18591419,0.00075050513,0.013078461
racial social environmental risks childhood asthma unlike number childhood problems clear racial socioeconomic disparities prevalence childhood asthma analyzed data child health supplement national health interview survey population based survey information concerning children address following questions racial socioeconomic differences rates childhood asthma yes contribution social environmental characteristics observed differences sample black children likely asthma white children vs racial disparities prevalence emerged early childhood ages due higher black rates onset ages years poverty status maternal cigarette smoking large family size smaller size home low birth weight maternal age younger years child birth associated increased rates childhood asthma available social environmental characteristics controlled using multivariate analyses increased risk asthma among black poor children reduced statistical insignificance conclude black poor children united states higher rates asthma social environmental factors exert substantial influences rates asthma much racial economic disparity prevalence accounted variety social environmental characteristics,C20,0.0019193229,0.010979506,0.0035773863,0.0010772236,0.0027423063,0.0117482385,0.1263693,0.0018030034,0.0106654735,0.076138735,0.09320423,0.004012557,0.017773602,0.014749168,0.0016859797,0.002990666,0.08030879,0.0019744476,0.05786827,0.39023456,0.076255575,0.009943364,0.0019783215
proton magnetic resonance spectroscopy multiple sclerosis regional vivo proton magnetic resonance spectroscopy provides quantitative data selected chemical constituents brain imaged volunteers clinically definite multiple sclerosis tesla magnetic resonance scanner define plaque containing volumes interest obtained localized water suppressed proton spectra using stimulated echo sequence twenty five plaque containing regions provided spectra adequate quality spectra subjects consistent presence cholesterol fatty acids remainder similar obtained white matter normal volunteers early experience regional proton spectroscopy suggests individual plaques distinct differences likely reflect dynamic stages evolution demyelinative process previously accessible vivo investigation,C20,0.017055362,0.0025903098,0.062459882,0.0016409681,0.060611404,0.017895494,0.24175793,0.0027461348,0.002111131,0.0028692088,0.03751291,0.020813497,0.12198719,0.0098555265,0.059102528,0.01866262,0.08075142,0.032612354,0.0033669816,0.028794724,0.13432811,0.0010368355,0.039437454
reactive airway dysfunction syndrome three police officers following roadside chemical spill reactive airway dysfunction syndrome rads recently described syndrome bronchial hyperreactivity asthmatic symptoms develop previously healthy individuals single large exposure irritating gas fume vapor report cluster three philadelphia police officers developed rads common exposure toxic fumes roadside truck accident results initial pulmonary function testing normal three methacholine challenge required diagnosis two three syndrome needs recognized physicians dealing environmental industrial medicine potential cause loss work inability perform job also potential multiple individuals develop syndrome single incident,C20,0.014446317,0.0028299452,0.0059527475,0.001792493,0.004443174,0.03919043,0.35553405,0.003000186,0.017731702,0.0031418637,0.110472776,0.006561814,0.07379269,0.007504217,0.0028054593,0.004967943,0.093749054,0.020716308,0.0036326128,0.16764519,0.05566187,0.0011327555,0.0032943916
buddy volunteer commitment aids care buddy volunteers provide crucial assistance people hiv related illnesses based volunteers self administered questionnaires study describes nature buddy work volunteers indicated satisfaction personal performance buddy program administration several factors associated volunteer satisfaction report first attempt describe special relationship created response human immunodeficiency virus hiv epidemic,C20,0.004326203,0.00388611,0.0290137,0.0024307168,0.0060241004,0.026470361,0.22401686,0.0040684133,0.003127652,0.025176518,0.021303987,0.009190959,0.13333187,0.017578186,0.0038043535,0.0067367973,0.08494782,0.0044552716,0.043830995,0.18121378,0.15901409,0.0015360774,0.004515206
serologic biologic western blot analysis suppressor factor specificity hapten hydroxy nitrophenyl acetyl derived serum free medium cell hybridoma producing suppressor factor tsf specificity hapten nitrophenyl converted long term growth serum free medium product tested serology bioactivity western blot analysis results indicated ag specific suppressive activity present serum free medium tsf could exhibit characteristics ascribed various groups could bind nominal ag specificity bound anti tsf mab could mediate ag specific suppression vivo vitro western blot sds page analysis purified tsf revealed kda single chain protein,C20,0.0032402917,0.0028743003,0.0217487,0.0018205878,0.004525021,0.0041817655,0.29543,0.0030477596,0.0023425866,0.003183777,0.043267637,0.02235146,0.039246548,0.09084765,0.0028494308,0.005045808,0.03404068,0.16276646,0.0036895487,0.024553083,0.20210457,0.0011505098,0.025691818
aids related knowledge sexual behavior condom use among men women kinshasa zaire study conducted among random sample men women reproductive age administrative zones kinshasa capital city zaire determine existing levels knowledge regarding aids acquired immunodeficiency syndrome sexual behavior knowledge use condoms marital extramarital relations perceived risk aids attitudes toward testing human immunodeficiency virus hiv awareness aids almost universal vast majority know four main modes transmission almost half believed transmission mosquitoes vaccine cure aids majority male respondents knew condoms negative attitudes toward condom use widespread respondents perceived play central role combatting aids,C20,0.0030494055,0.002704975,0.109026894,0.01647365,0.0042462004,0.018661784,0.1267885,0.002867698,0.0022045844,0.04725953,0.051003125,0.0062720445,0.020095607,0.044767015,0.0026815704,0.0047485586,0.041070662,0.0031403822,0.03413196,0.30670515,0.13015676,0.0010827332,0.02086121
evaluation efficacy cost effectiveness health education methods increase medication adherence among adults asthma randomized adult asthma patients control group patients experimental group received special health education intervention four adherence measures documented baseline month follow correct inhaler use inhaler adherence medication adherence total adherence rating costs routinely deliver intervention patient experimental group patients exhibited significantly higher level improvement adherence percent control group patients percent,C20,0.003292076,0.0029202357,0.022077996,0.0018496832,0.020520102,0.004248596,0.11500899,0.003095908,0.0023800244,0.003234658,0.03107564,0.113994494,0.13875578,0.0075694993,0.0028950612,0.005126447,0.20583537,0.019321587,0.040896166,0.1418377,0.10950831,0.0011688966,0.0033867664
cell membrane expression functional role p subunit interleukin receptor lymphoproliferative disease granular lymphocytes cell membrane expression functional role interleukin receptor il r analyzed nine patients lymphoproliferative disease granular lymphocytes ldgl using monoclonal antibodies moabs specific p tu p anti tac subunits il r four patients characterized proliferation cd cd granular lymphocytes gl expressing alpha beta cell receptor alpha beta one case proliferation cd cd cd gl expressing gamma delta cell receptor gamma delta four additional cases proliferating cells cd negative gl consistent data observed normal gl phenotypic analysis demonstrated patients gl lack expression p il r whereas p subunit constitutionally expressed expanding gl cell either alpha beta gamma delta natural killer nk origin variable proportions cells analysis cytotoxic proliferative activity demonstrated anti p moab failed inhibit il mediated activation whereas marked inhibition cytotoxicity proliferation obtained using anti p chain specific moab data indicate p chain il r responsible il signal transduction cd cd ldgl patients gl,C20,0.002203406,0.001954531,0.025443532,0.001238004,0.0030687742,0.0028436102,0.17962359,0.0020721098,0.0015929645,0.0021649757,0.056676906,0.004531985,0.014874085,0.18399163,0.0019376196,0.014087034,0.06546887,0.067136124,0.002508902,0.025139617,0.1495171,0.00078234944,0.19114226
salsalate cross sensitivity aspirin sensitive patients asthma ten aspirin asa sensitive patients asthma underwent double blind placebo controlled oral challenges salsalate followed asa sensitive confirmatory challenges patients sustained asthmatic reactions asa two developed respiratory reactions gm salsalate two patients repeat confirmatory challenges gm salsalate reproduced asthmatic reactions patients desensitized asa cross desensitization gm salsalate achieved conclude salsalate weak inhibitor cyclooxygenase vitro less likely asa induce asthma known asa sensitive patients asthma may occasionally cross react patients reactions mild easily treated beta agonists,C20,0.003705405,0.003286879,0.09596308,0.0020838473,0.005159659,0.004782018,0.29030615,0.0034846077,0.0026788427,0.021574108,0.017040744,0.0076213097,0.0559397,0.008680224,0.0032584395,0.005770086,0.25296786,0.021733703,0.040087856,0.027707597,0.09089305,0.0013156546,0.03395915
anaphylaxis following ingestion psyllium containing cereal recently psyllium hydrophilic mucilloid bulk forming laxative added breakfast cereals cholesterol lowering effects report case year old woman prior history psyllium ingestion developed anaphylactic symptoms eating psyllium containing cereal previous exposure dispensing psyllium containing laxative nurse immunoglobulin e mediated sensitization documented skin testing basophil histamine release literature reviewed regarding allergic reactions psyllium health care workers pharmaceutical workers handling psyllium may increased risk due sensitization inhalation physicians consumers aware potential serious reactions eating psyllium containing cereals even without prior history ingestion psyllium,C20,0.0037776448,0.0033468795,0.0070401113,0.0021199202,0.023518598,0.023127245,0.37144345,0.0035482175,0.002727744,0.0037169403,0.053521708,0.007760433,0.02515777,0.032913677,0.058114022,0.024132952,0.06746091,0.0040710913,0.022548463,0.1316033,0.122934565,0.0013396713,0.0040746806
cytomegalovirus going nearly years elapsed since rowe weller colleagues discovered human cytomegalovirus cmv complex structure long replicative cycle low yield vitro highly species specific cell substrate requirement cellular molecular biologic analyses human cmv slow recombinant dna monoclonal antibody technologies bringing rapid changes long period latency wide range disease presentations epidemiologic medical insights also come slowly however clinical events occur iatrogenic immunosuppression transplantation cancer therapy result immunocompromise due human immunodeficiency virus infection currently promoting understanding epidemiology cmv disease definition clinical spectrum rapid diagnostic methods antiviral drugs vaccines cmv becoming available may yet understand completely impact agent nonimmunosuppressed aspects pathogenesis e g immune functions controlling recrudescence possibility increased disease severity detectable immune defect availability new approaches issues clarified functions host virus involved mechanism persistence,C20,0.0020727916,0.021883888,0.04726064,0.0011637219,0.032407787,0.02271045,0.39764982,0.00194778,0.011518817,0.002035074,0.040014416,0.014688953,0.046177514,0.045150973,0.0018888789,0.0032252865,0.03793626,0.016400585,0.031314984,0.0709383,0.08509312,0.0007354073,0.065784544
selective regulation activity different hematopoietic regulatory proteins transforming growth factor beta normal leukemic myeloid cells viability normal bone marrow myeloid precursor cells induced interleukin il il alpha ability il il alpha induce formation colonies granulocytes macrophages megakaryocytes densely seeded bone marrow cultures suppressed transforming growth factor beta tgf beta induction normal bone marrow colony formation il much less sensitive tgf beta little effect tgf beta colony formation induced macrophage colony stimulating factor csf granulocyte macrophage csf gm csf different clones myeloid leukemic cells tgf beta suppressed differentiation induced il il alpha lipopolysaccharide lps suppress differentiation induced il gm csf effect tgf beta differentiation leukemic cells dissociated effect cell growth tgf beta suppressed production il normal bone marrow cells cultured il alpha production il gm csf leukemic cells cultured il alpha lps suppression il production explain suppression tgf beta effects il alpha lps mediated il tgf beta also suppressed differentiation clones myeloid leukemic cells induced differentiation factor leukemia inhibitory factor tumor necrosis factor different leukemic clones tgf beta suppressed enhanced induction differentiation dexamethasone results show tgf beta selectively control activity different molecular regulators normal leukemic hematopoiesis,C20,0.0019172013,0.0017006532,0.039210673,0.0010771973,0.011939572,0.011713304,0.043947887,0.01793137,0.0013860512,0.0018837629,0.008874646,0.003962961,0.025233528,0.21665764,0.0016859384,0.049386833,0.017771132,0.11250798,0.0021830157,0.013186812,0.27397272,0.009956919,0.13191219
multiple sclerosis prevalent zoroastrians parsis india using schumacher classification determined prevalence rate clinically definite multiple sclerosis ms distinct tiny zoroastrian largely parsi community adjacent cities bombay latitude degrees poona pune prevalence day clinically definite cases ms counted bombay poona total zoroastrian population respectively crude prevalence ratio per bombay per poona age adjusted prevalence ratio bombay per confidence limits much higher low rates believed prevalent india comparable found parts europe united states,C20,0.0040709213,0.0036111102,0.007606784,0.0022883592,0.005668629,0.005253736,0.17974058,0.023503836,0.0029430948,0.023671659,0.06508868,0.008425627,0.12880532,0.009928227,0.043053094,0.0063392706,0.085511826,0.0043381187,0.0046353424,0.23627092,0.14361143,0.0014454362,0.0041880137
effect exercise complement activity complement measurements c c q c c c c anaphylatoxins c c c total hemolytic activity classical alternative pathways made experienced adult runners shortterm aerobic exercise baseline results compared nonexercising age matched controls subjects tested running resulted nanogram increases c c corresponding decreases hemolytic activity c c h baseline values c c h decreased significantly runners compared nonexercising controls preliminary studies measuring effect exercise c levels also done three asthmatic runners mean resting postexercise levels exercise induced increases c anaphylatoxin asthmatic subjects significantly higher nonasthmatic subjects findings indicate short term exercise results activation c c subsequent generation c c anaphylatoxins suggest activation classical pathway complement selective downregulation c production may occur persons regularly engaged aerobic exercise exaggerated generation c asthmatic subjects exercise raises possibility anaphylatoxins play etiologic role exercise induced asthma,C20,0.0023541213,0.093262084,0.004392546,0.0013226847,0.0032780394,0.003038116,0.22551788,0.002213844,0.0017019248,0.0023130623,0.021285083,0.039768465,0.24569087,0.031989407,0.0020701943,0.0036658563,0.035732348,0.025214046,0.0026805133,0.017012259,0.232239,0.00083586294,0.002421833
tachyphylaxis inhaled methacholine normal asthmatic subjects methacholine inhalation tests measure airway responsiveness asthmatic normal subjects tachyphylaxis occurs repeated methacholine inhalations normal subjects purpose study examine time course mechanisms methacholine tachyphylaxis normal subjects determine whether occurs mildly asthmatic subjects fifteen normal nine asthmatic subjects studied study days least h apart day two inhalation tests carried one day subjects performed two methacholine inhalation tests h later methacholine test results expressed provocation concentration causing fall forced expiratory volume fev pc normal subjects developed methacholine tachyphylaxis mean pc increased mg ml se se p less h interval increase lasted greater equal h p asthmatic subjects develop methacholine tachyphylaxis mean methacholine pc mg ml se se p h later two series experiments normal subjects pretreated cyclooxygenase inhibitors indomethacin mg day flurbiprofen mg day placebo days two methacholine tests h apart indomethacin flurbiprofen significantly inhibited development methacholine tachyphylaxis results confirm methacholine tachyphylaxis occurs normal subjects lasts greater equal h may occur release inhibitory prostaglandins contrast methacholine tachyphylaxis occur asthmatic subjects,C20,0.011090319,0.0016850192,0.0035444128,0.0010672946,0.0026451002,0.04128375,0.15070091,0.0017863847,0.0013733093,0.011052301,0.063957065,0.004307918,0.24827543,0.034183815,0.0016704397,0.012143803,0.05269845,0.001969594,0.011357355,0.024864066,0.29731563,0.019065099,0.001962555
hiv tropism mononuclear phagocytes determined regions gp outside cd binding domain cells mononuclear phagocyte system predominant cell producing hiv tissues including central nervous system cns spinal cord lung skin infection associated dementia neuropathy pneumonitis dermatitis respectively different hiv isolates vary markedly ability infect mononuclear phagocytes productively describe molecular clones cns derived isolate hiv jr fl replicate efficiently mononuclear phagocytes analysis polymerase chain reaction early events infection indicates early phase viral replication reverse transcription determines tropism genetic mapping macrophage tropic phenotype construction recombinant viruses indicates mononuclear phagocyte infectivity determined amino acid region gp glycoprotein hiv jr fl significantly region upstream previously defined cd binding domain propose least one determinant mononuclear phagocyte tropism involves target cell interactions regions gp distinct cd binding domain,C20,0.002558297,0.002269337,0.00478441,0.0014374938,0.040713564,0.015685143,0.29700476,0.014865602,0.0018495348,0.002513677,0.013919452,0.005308504,0.049660314,0.08893719,0.0022497019,0.016365493,0.035376858,0.07883085,0.0029129975,0.019469135,0.18848282,0.0009083583,0.11389648
polyclonal b cell activation lupus prone mice precedes predicts development autoimmune disease polyclonal b cell activation early feature autoimmune disease humans mice systemic lupus erythematosus contribution polyclonal activation progression autoimmunity unclear however since precedes development end organ damage months years examine issue autoimmune prone nzb x nzw f x nzb backcross mice hemi splenectomized wk number antigenic specificity ig secreting b cells quantitated elisa spot assay mice polyclonally increased numbers ig secreting cells spleen died mo contrast backcross mice normal numbers ig secreting b cells wk died period p less polyclonally activated mice also developed proteinuria earlier frequently littermates normal numbers ig secreting cells p less adults backcross mice proteinuria expressed repertoires skewed towards production anti dna antibodies wk mice expressed repertoires marked polyclonal activation rather preferential anti dna production findings indicate autoimmune disease sle accompanied autoantigen driven production autoantibodies preceded predicted polyclonal b cell activation,C20,0.0021134815,0.0018747636,0.014164472,0.0011874791,0.002942956,0.0027275581,0.30474502,0.0019875437,0.011733588,0.0020766198,0.023052562,0.0043470277,0.043180473,0.25319958,0.0018585423,0.013518941,0.07763862,0.08377374,0.012628828,0.022459108,0.094306834,0.0007504205,0.02373188
putative tyrosine kinases expressed k human leukemia cells tyrosine phosphorylation important transmission growth differentiation signals known tyrosine kinases include several oncoproteins growth factor receptors interestingly differentiated cell types erythrocytes platelets contain high amounts phosphotyrosine analyzed tyrosine kinases expressed k chronic myelogenous leukemia cell line bipotential erythroid megakaryoblastoid differentiation capacity analysis polymerase chain reaction amplified cdna clones led identification different tyrosine kinase related sequences jtk two clones jtk jtk represent unusual members fibroblast growth factor receptor gene family clones jtk jtk jtk may also belong family receptor tyrosine kinases lack close relationship known tyrosine kinase different genes characteristic expression pattern k cells several human tumor cell lines addition jtk jtk mrnas induced megakaryoblastoid differentiation k cells tyrosine kinases may role differentiation megakaryoblasts physiology platelets,C20,0.0024094887,0.0021373366,0.004495856,0.0013538395,0.015128209,0.0031095706,0.26891094,0.0022659122,0.0017419531,0.0023674641,0.026914082,0.016543398,0.015677616,0.15724635,0.0021188436,0.015410679,0.021151358,0.04913814,0.037730105,0.02160231,0.19746451,0.0008555219,0.13422647
immune deficiency family members patients hodgkin disease indirect data supporting preexisting immunologic impairment patients hodgkin disease hd presented recent years immunologic defects supposed related genetic environmental factors study first degree relatives spouses consecutive patients hd studied immunologically furthermore seven twin pairs one partner hd four additional nonmatched healthy co twins also included study decreased lymphocyte dna synthesis induced concanavalin high spontaneous dna synthesis low cd ratio found consanguineous two nonconsanguineous relatives five healthy co twins corresponding figures untreated patients hd control series respectively total lymphocyte counts lymphocyte subpopulations differ hd relatives controls increased frequency blood lymphocyte defects among consanguineous first degree relatives favors existence genetically determined immune deficiency least proportion apparently healthy relatives patients hd however nongenetic factors age environment may add defect,C20,0.0024964146,0.014281764,0.065081455,0.0014026335,0.042624965,0.003221753,0.25317425,0.0023476586,0.0018047966,0.0024528739,0.012418735,0.0052660177,0.13757572,0.0062373015,0.0021953348,0.0038874368,0.10598411,0.0025708931,0.0028425353,0.13047719,0.19817355,0.00088638614,0.0025962242
myelin basic protein specific lymphocyte lines ms patients healthy individuals derived total lymphocyte lines specific human myelin basic protein mbp peripheral blood ms patients control group healthy donors determined reactivities cell lines h thymidine incorporation exposure mbp mbp peptides defined hla restriction lines using monoclonal antibodies monomorphic determinants human hla dr hla dq hla dp molecules mbp specific cell lines could isolated comparable efficiency ms patients healthy individuals groups mbp specific lymphocytes recognized least different epitopes mbp molecule specificities showed comparable patterns different mbp peptides mbp specific cell lines derived ms patients controls restricted dr products human major histocompatibility class ii locus notable phenotypic differences cell lines existed groups lines isolated ms patients expressed predominantly cd cd cd phenotype control lines composed cd cd cd lymphocytes findings illustrate presence mbp specific cells ms patients controls similarly sensitized mbp restricted hla dr products,C20,0.002251646,0.0019973225,0.004201338,0.0012651081,0.014349382,0.0029058666,0.3482479,0.0021182997,0.0016278399,0.0022123745,0.01106242,0.04143213,0.10658533,0.08385351,0.0019801105,0.0035062812,0.085184455,0.06581727,0.0025638302,0.016997432,0.15019779,0.00079947774,0.04884289
ability anti hiv agents inhibit hiv replication monocyte macrophages u monocytoid cells conditions enhancement gm csf anti hiv antibody monocyte macrophages important target cell human immunodeficiency virus hiv infection body study hiv infection cells however rather complicated represent variable population hiv entry replication may markedly influenced number factors must considered therapeutic approaches hiv infection present set experiments studied interaction certain agents increase infection monocyte macrophages hiv two groups anti hiv agents dideoxynucleosides specific inhibitors gp cd binding found cytokine granulocyte macrophage colony stimulating factor gm csf markedly enhances hiv replication affect activity recombinant soluble cd scd okt two agents block gp cd binding however varying effects different dideoxynucleosides gm csf increased net anti hiv activity azido dideoxythymidine azt time reduced activity dideoxycytidine ddc dideoxyinosine ddi effects probably represent interplay varying effects gm csf drug entry phosphorylation additional experiments showed low concentrations anti hiv antibodies could enhance hiv infection u monocytoid cell line interestingly effect hypothesized occur cd independent mechanism found anti hiv activities scd okt unchanged conditions enhancement,C20,0.0018825992,0.0016698149,0.012505178,0.0010576642,0.030149052,0.011470439,0.2955228,0.001770266,0.0013609177,0.0018496043,0.0087824445,0.014266633,0.013174194,0.16865022,0.01057815,0.0029344861,0.017647017,0.02927542,0.0022085132,0.029452827,0.3318438,0.0006683848,0.011279552
hiv testing policies us hospitals determine human immunodeficiency virus testing policies adopted us hospitals surveyed stratified random sample nonfederal general acute care hospitals drawn american hospital association database interviews completed chief administrator hospitals response rate two thirds hospitals admitted least one patient acquired immunodeficiency syndrome formal written policies human immunodeficiency virus testing contain provisions protecting patients rights eg require pretest informed consent require special human immunodeficiency virus testing consent form require patients test seropositive informed many policies also contain provisions protect providers eg require test results appear patients records require review treatment plans patient tests seropositive require transferring patients hospital characteristics strongly associated adoption testing policies,C20,0.0024379308,0.0021625662,0.004548926,0.0013697739,0.0033947413,0.014885254,0.23067375,0.014091813,0.0017625154,0.00239541,0.117374405,0.0050143576,0.029366737,0.007963511,0.0021438547,0.003796365,0.24318585,0.0025106645,0.09718063,0.0766745,0.050255857,0.0008656206,0.085945
regular inhaled beta agonist treatment bronchial asthma subjects stable asthma took part double blind placebo controlled randomized crossover study effects regular versus demand inhaled bronchodilator therapy subjects inhaled fenoterol placebo dry powder delivery system weeks control asthma judged daily morning evening peak expiratory flow rates symptom diaries use additional inhaled bronchodilator requirement short courses prednisone subjects completed trial showed clear difference degree control asthma fenoterol placebo periods confidence interval asthma better controlled regular inhaled bronchodilator treatment whereas control better placebo treatment bronchodilator symptom relief mean airway responsiveness methacholine increased slightly fenoterol period adverse effect regular bronchodilator inhalation occurred among subjects used bronchodilator sole treatment better worse regular bronchodilator treatment also among took inhaled corticosteroids better worse thus regular inhalation beta sympathomimetic agent associated deterioration asthma control majority subjects trends use regular higher doses longer acting inhaled beta sympathomimetic treatment may important causal factor worldwide increase morbidity asthma,C20,0.012454484,0.0018940199,0.003986518,0.011524134,0.0029731842,0.044096176,0.35448238,0.0020079582,0.011876065,0.002104415,0.010137732,0.015823053,0.16337448,0.0052777976,0.001877632,0.0033249345,0.04515538,0.0021988915,0.064449765,0.10242964,0.10458805,0.0007581283,0.03320516
evaluation aids dementia complex clinical trials aids dementia complex adc one common important causes morbidity associated infection human immunodeficiency virus type hiv evaluation adc clinical trials significant clinical impact syndrome also value measuring cardinal features index drug efficacy emerging role major clinical end point objectives therapy include prevention adc presymptomatic patient alleviation established disease present pathogenesis adc incompletely understood several critical aspects particularly processes underlying clinical manifestations central nervous system cns hiv infection processes related systemic disease consequently yet clear extent patients necessary achieve therapeutic drug levels within cns nevertheless assessment adc prevention treatment relies principally complementary approach neurological examination diagnosis neuropsychological testing quantitative serial measurement treatment effects additionally surrogate markers cerebrospinal fluid csf may hold promise objective rapid assessment treatment response dose adjustment measurements including routine csf analysis neuroimaging neurophysiological assessments used principally differential diagnosis rather monitoring adc status accumulating experience available antiviral agents suggests adc effectively prevented treated least period time assessment condition indeed valuable approach measuring antiviral therapy,C20,0.0015922376,0.03224387,0.029678699,0.008671909,0.025329089,0.009755321,0.45049962,0.0014973596,0.0011511169,0.001564467,0.052953377,0.0032749285,0.06820577,0.05314837,0.0014001736,0.01018196,0.058395736,0.0016397408,0.03936998,0.034510054,0.10437068,0.00056534575,0.010000195
new antiretroviral agents clinic since first controlled clinical trial zidovudine act terminated fall much learned concerning use agent treatment human immunodeficiency virus hiv infection recent report hiv resistance associated long term azt therapy accelerated sense urgency development additional agents use either alone combination azt infection several new agents various stages preclinical clinical evaluation dideoxycytidine dideoxyinosine dideoxydidehydrothymidine azidouridine foscarnet inhibit viral dna synthesis inhibition reverse transcriptase potentially useful agents presumably act different stages infection soluble cd example soluble form receptor hiv must bind infect cells castanospermine represents new class compounds block maturation process viral glycoprotein apparently potent less toxic analogue latter agent n butyl deoxynojirimycin currently phase testing,C20,0.0025584071,0.0022694347,0.0047737225,0.0014374646,0.028331814,0.015685182,0.43498635,0.002405957,0.014208199,0.0025137854,0.0278648,0.01822489,0.060113765,0.08404587,0.014629921,0.016366199,0.06308759,0.06086433,0.015297207,0.04546596,0.06792715,0.00090839743,0.016033622
analysis lymphocytes monocytes neutrophils human immunodeficiency virus hiv infected persons hiv dna human immunodeficiency virus hiv infects depletes alters function cells involved immune responsiveness helper lymphocytes monocyte macrophages infected via cell surface cd vitro previous studies showed blood cells express hiv rna vivo study used dna amplification determine levels hiv dna purified lymphocytes monocytes neutrophils hiv infected asymptomatic individuals persons aids average numbers hiv dna copies lymphocytes aids patients asymptomatic individuals similar approximately copies cells however expressed basis numbers cd cells aids patients cells contained approximately times hiv dna hiv dna present lymphocytes subjects little hiv dna observed monocytes neutrophils asymptomatic person contained levels hiv dna monocytes proviral copies cells comparable levels expressed lymphocytes expression monocyte hiv dna person persistent least months observed neutrophils suggesting monocyte hiv dna originate myeloid precursors study shows aids asymptomatic hiv infection lymphocytes predominant infected cell found blood,C20,0.001953501,0.001732853,0.053658873,0.0010975926,0.031075401,0.0025210949,0.24860209,0.0018421331,0.0014122943,0.0019194296,0.051456474,0.0040246435,0.05118821,0.13618934,0.0017178596,0.021951644,0.049549837,0.0020195167,0.0022243485,0.040992387,0.14399359,0.0006936173,0.14818326
rapid oral desensitization isoniazid rifampin year old black woman sputum positive acid fast bacilli developed hypersensitivity isoniazid rifampin admitted hospital desensitized medications using modified penicillin protocols skin testing negative drugs desensitization isoniazid complicated drug fever controlled prednisone patient able maintain day dosing without incident even steroid taper knowledge first reported case dual isoniazid rifampin hypersensitivity rapid oral desensitization,C20,0.004616277,0.004094868,0.008628386,0.0025936977,0.028775103,0.028234435,0.33378786,0.004341203,0.0033373628,0.004535763,0.112531856,0.009647083,0.04929237,0.010687236,0.0040594377,0.029527396,0.06747295,0.004754,0.005270039,0.13051742,0.14690712,0.0016390722,0.0047490555
bronchodilator cardiovascular hypokalaemic effects fenoterol salbutamol terbutaline asthma airway response cardiovascular hypokalaemic effects fenoterol salbutamol terbutaline given multiples standard doses metered dose inhalers studied ten patients mild asthma double blind crossover placebo controlled study subjects received puffs drug intervals min forced expiratory volume heart rate qtc interval plasma potassium concentration tremor bronchial reactivity histamine measured three drugs produced similar bronchodilatation however rises heart rate qtc interval tremor fall plasma potassium greater fenoterol salbutamol terbutaline maximum mean sd increases heart rate fenoterol salbutamol terbutaline bpm bpm bpm respectively falls plasma potassium mmol l mmol l mmol l respectively fenoterol afforded additional protection histamine compared salbutamol findings suggest doses based used clinical practice fenoterol causes adverse effects salbutamol terbutaline likely explanation effects fenoterol marketed higher dose beta agonists fenoterol may addition less selective beta receptors,C20,0.0021580851,0.0019143292,0.004026763,0.0012125401,0.0030050653,0.01322931,0.23164882,0.0020294895,0.0015601995,0.0021204455,0.020132268,0.034390118,0.20440505,0.0049621044,0.0018977657,0.034945805,0.06507294,0.012668609,0.033794053,0.03642205,0.2645247,0.00076625764,0.023113204
macrophage tropism hiv vivo vitro studies clearly demonstrate cells mononuclear phagocyte lineage major hosts human immunodeficiency virus type hiv replication presumably cells play key role pathogenesis acquired immunodeficiency syndrome aids delineate interactions hiv host cells susceptibility permissivity normal human peripheral blood derived monocyte macrophages lymphocytes neoplastic monocytoid lymphoid cell lines various hiv isolates assessed results suggest fresh isolates recovered patients propagated normal host cells exhibit dual tropism cells regardless tissue origin cell type isolated repeated passage hiv isolate normal generally result loss ability infect normal cells vice versa majority fresh hiv isolates infect neoplastic cells either origin show preference monocytoid lymphoid targets regardless cell origin,C20,0.0025904265,0.0022978378,0.017411526,0.0014555588,0.041264765,0.0033430804,0.2580152,0.015125723,0.014386363,0.0025452462,0.012182328,0.0053280126,0.05081849,0.22242509,0.0022779559,0.004033833,0.041608263,0.03676803,0.0029495817,0.07802134,0.1536975,0.0009197664,0.030534135
hiv infection among quebec women giving birth live infants first anonymous unlinked seroprevalence study canada use serum samples newborns determine seroprevalence rate human immunodeficiency virus hiv infection among childbearing women samples tested confirmed positive overall crude seroprevalence rate per live births confidence interval ci woman women lived montreal island overall rate per live births ci woman observed significant association revenue index seroprevalence rates high per live births ci woman montreal island postal code areas revenue indexes provincial median extrapolation data suggested women hiv infection gave birth live infant quebec even though attempts generalize data childbearing women women childbearing age inherent conservative bias results study suggest women ci aged years quebec hiv infection actual number likely substantially higher need well designed creative interventions prevent hiv transmission women evident planning provision medical psychosocial services sensitive specific needs women already infected start immediately,C20,0.002157852,0.02246766,0.024697527,0.0012124091,0.01344763,0.003131507,0.12643811,0.0020292704,0.011994391,0.03460602,0.061407622,0.004586109,0.041513972,0.0069918702,0.012316749,0.0033602247,0.09368378,0.0022251268,0.033777885,0.35113996,0.14380492,0.0007661749,0.002243207
defective expression p interleukin receptor cells patients systemic lupus erythematosus possible defect process increased intracellular calcium leading p expression phytohemagglutinin pha stimulated cells patients systemic lupus erythematosus sle showed hyporesponsiveness interleukin il expressed less p il r healthy controls ionomycine im calcium ionophore selectively upregulated p expression induced less p patients sle healthy controls however intracellular calcium levels cells patients sle increased much healthy controls cells stimulated im pha results suggest impaired expression p il r cells patients sle due defective calcium influx events rise calcium levels,C20,0.0028822022,0.0025540823,0.005372474,0.0016177609,0.0054566474,0.0037158858,0.122191906,0.002707728,0.0020816054,0.0028290807,0.013593587,0.0060082027,0.14683233,0.24061197,0.0025319832,0.032256953,0.10463611,0.018898193,0.0032785058,0.019276239,0.18095191,0.0010223346,0.078692265
use inhaled corticosteroids patients mild asthma double blind parallel group study carried investigate effect inhaled budesonide moderate micrograms low micrograms twice daily dosage compared effect placebo adults mild symptomatic asthma subjects recorded peak expiratory flow pef asthma symptoms beta agonist consumption home period seven weeks one week run six weeks treatment morning baseline pef around predicted normal increased non significantly micrograms budesonide daily p less micrograms compared placebo evening pef around predicted normal change significantly active placebo treatment comparison placebo significant decrease nocturnal asthma symptoms beta agonist consumption changes day less pronounced significant micrograms budesonide daily significant differences two active treatments detected concluded low doses inhaled budesonide effective patients mild symptomatic asthma particularly night time symptoms early morning lung function early introduction inhaled corticosteroids patients mild asthma night time symptoms may improve quality life night early morning,C20,0.0018652927,0.010675505,0.0034804426,0.028129665,0.0025973609,0.011435749,0.2171483,0.0017541439,0.0013485235,0.0018494976,0.02708898,0.0221368,0.20722151,0.004345314,0.0016402913,0.0029833848,0.07786252,0.0019215883,0.04727366,0.049088888,0.2564378,0.00066229765,0.02105246
hepatocyte plasma membrane glycosphingolipid reactive sera patients autoimmune chronic active hepatitis identification sulfatide sera patients autoimmune chronic active hepatitis found contain igg class antibody acidic glycosphingolipid fraction rabbit hepatocyte plasma membrane solid phase enzyme linked immunosorbent assay using serum positive antibody probe isolated target antigen iatrobeads column chromatography analysis thin layer chromatography negative ion fast atom bombardment mass spectrometry revealed antigen sulfatide presence antisulfatide antibody also confirmed immunoblotting reactivity serum sulfatide diminished preincubation serum galactosylceramide sulfate sulfatide indicating antibody reacted sulfated galactosylceramide regardless position sulfate residue antibody found respectively patients autoimmune chronic active hepatitis primary biliary cirrhosis cirrhosis systemic lupus erythematosus chronic active hepatitis chronic persistent hepatitis thus antisulfatide antibody characteristic autoimmune type chronic liver diseases antisulfatide antibody absorbed rabbit hepatocyte plasma membrane preincubation sera sulfatide immobilized sepharose decreased reactivities sulfatide also rabbit plasma membrane rat hepatocytes therefore sulfatide may target antigen antibody hepatocyte surface membrane,C20,0.0017548546,0.0015566436,0.056242175,0.000986,0.0110652475,0.0022647313,0.34191567,0.001652602,0.0012686817,0.0017242477,0.012982802,0.004016381,0.014242887,0.21851988,0.010219332,0.027694147,0.04059391,0.04838601,0.00199816,0.067681156,0.1217968,0.0006230851,0.010814586
effect thromboxane antagonists ozone induced airway responses dogs airway hyperresponsiveness inhaled ozone dogs may occur result thromboxane release airway study two thromboxane receptor antagonists l l used doses inhibit response inhaled thromboxane mimetic u determine role thromboxane ozone induced airway hyperresponsiveness dogs studied days separated wk day dogs inhaled ozone ppm min one randomly assigned day dogs received infusion l mg kg h dogs received infusion l mg kg h day dogs received control infusion airway responses doubling doses acetylcholine measured inhalation ozone expressed concentration acetylcholine giving rise resistance cmh l baseline acetylcholine provocation concentration development airway hyperresponsiveness ozone inhibited thromboxane antagonists mean log difference acetylcholine provocative concentration ozone l treatment day se control day p l treatment day mean log difference se control day p results support important role thromboxane causing ozone induced airway hyperresponsiveness,C20,0.02458108,0.002041632,0.0042945426,0.0012931739,0.003204902,0.10325119,0.17637298,0.0021644502,0.0016639527,0.002261455,0.011437695,0.06991744,0.1349674,0.039363366,0.002023967,0.0035980856,0.029136525,0.002370264,0.0026207075,0.016025562,0.36421385,0.00081721373,0.0023785282
care infant born exposed human immunodeficiency virus expanding epidemic hiv infection reproductive age women availability antiretroviral therapy children recommendations increased case identification activities augur time pediatricians going called care hiv exposed infants article outlines comprehensive medical framework care children labor delivery setting nursery outpatient clinic emergency room includes issues infection control medical developmental psychosocial care laboratory evaluations finally address need long term follow children born exposed hiv,C20,0.003345632,0.0029677425,0.038615618,0.018063743,0.020853957,0.0045396704,0.15767218,0.0031462729,0.018611275,0.051878303,0.047105856,0.0069730408,0.02579821,0.033211417,0.0029420643,0.005209845,0.061498027,0.0034454463,0.0683641,0.25829613,0.14383897,0.0011879124,0.022434562
monoclonal antibodies immunogenic lymphoma cell variants displaying impaired neoplastic properties characterization applications immunogenic nontumorigenic cell variants derived highly tumorigenic mouse lymphoma cell line used raise monoclonal antibodies mabs syngeneic balb c mice mabs following specifications derived mabs interacted preferentially immunogenic variants b mabs interacted immunogenic variants parental tumorigenic cells c mab interacted immunogenic tumorigenic cells normal balb c splenocytes six mabs raised way found recognize least five different cell surface epitopes functional analysis different mabs suggested potential usefulness passive immunization parental tumorigenic cells well enrichment immunogenic cells mixed population containing preponderance tumorigenic cells,C20,0.003516047,0.0031189092,0.0073876977,0.0019755233,0.07391385,0.0045376415,0.29216626,0.0033099568,0.0025419453,0.0034547227,0.018135842,0.0072318367,0.023411123,0.25489476,0.003091923,0.022492727,0.042100023,0.037174113,0.0040035364,0.04085397,0.14577827,0.0012484206,0.0036608868
coordinate secretion interleukin beta granulocyte macrophage colony stimulating factor blast cells acute myeloblastic leukemia role interleukin endogenous inducer acute myeloblastic leukemia aml blasts shown produce variety cytokines culture interleukin il il granulocyte macrophage granulocyte macrophage colony stimulating factor gm csf tumor necrosis factor alpha tnf alpha using two sensitive specific enzyme linked immunosorbent assays il beta gm csf document present study production two cytokines aml blasts culture coordinated first observe striking correlation levels gm csf il beta released cells thus high production il beta always concordant high production gm csf conversely low production il beta concordant low levels gm csf second neutralization intrinsic il using antibodies specific il alpha beta suppresses release gm csf cells third neutralization endogenous source il also results abrogation gm csf mrna fourth production il beta gm csf regulated exposing aml blasts exogenous source il suggesting positive regulation autocrine growth factor production taken together results indicate gm csf production aml blasts mediated endogenously produced il il beta alpha produced aml blasts although il beta appears abundant spontaneous colony formation aml blasts abrogated addition neutralizing antibodies il beta gm csf whereas antibody alone little effect blast proliferation taken together results consistent view production il beta aml blasts supports autocrine growth culture induction csfs cytokines stimulate blast proliferation,C20,0.0018825082,0.0016698787,0.019329939,0.0010577046,0.002621333,0.0024294748,0.19820419,0.010875682,0.0013609696,0.0018496749,0.025027985,0.0038719596,0.02237493,0.17951575,0.0016554302,0.057604413,0.027848125,0.02197537,0.011244175,0.02142673,0.24542676,0.009776641,0.13097034
pediatric acquired immunodeficiency syndrome unusually high incidence twinning surveillance data incidence twins among reported cases pediatric aids new york city presented pairs concordant hiv infection three discordant pairs described elsewhere possible reasons association discussed including likely explanation twins show symptoms early overrepresented early years surveillance pediatric aids,C20,0.00461746,0.0040959176,0.05332176,0.0025943625,0.006429667,0.005959073,0.30157346,0.0043423157,0.0033382182,0.029364422,0.06591862,0.009497234,0.030123841,0.010616967,0.026398698,0.029527994,0.14348534,0.0047552185,0.0052576577,0.19180709,0.060584914,0.0016394923,0.0047502727
effect continuous infusion zidovudine therapy neuropsychologic functioning children symptomatic human immunodeficiency virus infection neuropsychologic function assessed children symptomatic human immunodeficiency virus disease centers disease control class p ranging age months years initiation treatment eight patients classified encephalopathy psychologic tests administered months continuous infusion azidothymidine azt zidovudine treatment months treatment significant increase iq points demonstrated general cognitive functioning p less follow patients indicated months azt therapy maintained gains iq points improvements adaptive behavior months therapy assessed standardized interview paralleled findings iq data significant differences amount change observed different subgroups magnitude improvements could explained practice effects environmental changes general improvement physical state conclude neuropsychologic function significantly improved continuous infusion azt treatment,C20,0.0021133854,0.0018746783,0.003943358,0.001187425,0.0029430187,0.0027274338,0.26467893,0.0019874533,0.0015278836,0.022539025,0.07694295,0.04372531,0.09695885,0.020080378,0.012084096,0.0032909806,0.1684242,0.0021764366,0.012634021,0.030422147,0.19939229,0.0007503864,0.027595406
allergens proteases aspergillus fumigatus proteinase directly induces human epithelial cell detachment allergic bronchopulmonary aspergillosis abpa characterized pulmonary systemic allergic inflammatory processes triggered fungal antigens airway damage feature disorder although aspergillus derived proteinases described capacity aspergillus however directly induce damage human epithelium previously studied therefore cultured aspergillus fumigatus two patients abpa extracted mycelial products sonication filtration evaluated capacity induce epithelial cell ec desquamation basement membrane using vitro model uses intact human amniotic ec native basement membrane fumigatus extracts induced detachment ec dose dependent fashion producing detachment p less compared medium alone enzyme analysis fumigatus extract using synthetic substrates revealed presence number different enzymes therefore studies specific proteinase inhibitors undertaken identify proteinase responsible detachment fumigatus induced desquamation partially inhibited phenylmethylsulfonylfluoride substantially inhibited glutathione n acetylcysteine alpha antitrypsin phenanthroline ethylenediaminetetraacetic acid aprotinin soybean trypsin inhibitor concentrations inhibit serine metalloproteinases gel filtration extract sepharose b column revealed major epithelium detaching activity appeared kd fraction comparison proteinase standards suggested role chymotrypsin like proteinase thus fumigatus releases proteinase directly able induce ec detachment,C20,0.009339161,0.0016851492,0.013259501,0.05623621,0.0026567788,0.023063138,0.31742376,0.0017870796,0.0013734152,0.0018665894,0.011566264,0.013079877,0.03118137,0.12538168,0.011230522,0.02134644,0.047625426,0.0019674287,0.002163114,0.01357316,0.24195854,0.0006745226,0.049560864
effect long term treatment inhaled corticosteroid budesonide airway hyperresponsiveness clinical asthma nonsteroid dependent asthmatics several short term studies shown inhaled steroids reduce airway hyper responsiveness asthma evaluate whether prolonged treatment bring full recovery double blind randomized controlled trial examined effect budesonide micrograms daily yr airway hyperresponsiveness time course characteristics improvements associated changes clinical asthma severity also evaluated thirty two stable adult asthmatics requiring bronchodilators alone selected monthly throughout study airway responsiveness methacholine measured clinical asthma severity assessed questionnaire daily bronchodilator use number asthma exacerbations patients receiving budesonide showed fourfold mean improvement airway responsiveness compared receiving placebo p less whose responsiveness remained stable fifteen budesonide subjects improved returned normal range largest improvements occurred first months still progressing slowly yr improvements responsiveness accompanied significant improvements asthma symptoms bronchodilator use number asthma exacerbations results show regular prolonged use inhaled steroid produce marked improvements airway hyperresponsiveness sometimes full resolution improvements accompanied clinically significant improvements clinical asthma,C20,0.0017399585,0.0015432177,0.011657568,0.0009774773,0.0024227363,0.04434176,0.36088705,0.001636053,0.0012577395,0.011941031,0.00849964,0.00474767,0.11079309,0.0043001785,0.0015298652,0.052320503,0.16166815,0.0017920993,0.026885474,0.015571541,0.17107975,0.00061771105,0.0017897589
formoterol treatment nocturnal asthma formoterol fumarate new beta adrenergic agonist long lasting effect bronchospasmolytic effect micrograms formoterol compared micrograms albuterol salbutamol single center double blind randomized within patient study drugs given aerosols mdi patients nocturnal asthma stable phase inhalations given pm fev values parameter measured hours afterwards fev hours administration formoterol significantly higher albuterol ancova p still case hours test dose following morning ancova p fev fell basic starting value albuterol whereas remained least percent formoterol inhalation five patients required rescue therapy albuterol two formoterol conclude formoterol dose micrograms via mdi confers good protection nocturnal asthma insufficient patients severe asthma studies higher dosages patients clearly indicated,C20,0.0026937653,0.0023875332,0.0050221407,0.0145302145,0.0037478886,0.055586226,0.16349635,0.00253116,0.0019458659,0.04481593,0.048574157,0.006056597,0.1265767,0.00618992,0.0023668753,0.017218072,0.17072788,0.0027718432,0.04177275,0.020003341,0.25725576,0.0009556692,0.0027733955
seroprevalence hiv infection greece crete seroprevalence hiv evaluated consecutive normal blood donors homo bisexuals heterosexuals presenting hiv test using eia test sixty seven sera revealed repeatedly positive analysis western blot confirmed infection four cases indeterminate antibodies gag encoded proteins pattern revealed cases whereas sera negative three four hiv positive sera also reacted two distinct close synthetic peptides homologous viral gp fourth serum display antibodies gp western blot react gp derived synthetic peptides none sera reacted native hiv antigens synthetic peptides homologous gp sera indeterminate hiv western blot react gp derived synthetic peptides although also displayed indeterminate hiv western blot serum sample reacted two gp derived synthetic peptides proved positive tested p antigen one bisexual one heterosexual hiv positive subject reported sexual contacts west africans whereas two heterosexuals multiple sexual partners different countries,C20,0.0030048748,0.0026654738,0.005606785,0.0016884736,0.0042159543,0.0038779476,0.24364325,0.0028275675,0.0021723907,0.002952466,0.29865646,0.006180453,0.036260374,0.09161263,0.002642411,0.004679215,0.045020815,0.07565143,0.003421492,0.05275543,0.09023285,0.0010669219,0.019164361
serial studies evoked potentials circulating lymphocyte subsets multiple sclerosis attempts monitor progress concurrent change evoked potential measurements quantitation circulating suppressor cd lymphocyte subpopulations might indicate increased subclinical disease activity eight untreated patients clinically definite multiple sclerosis monitored monthly changes numbers cells positive cd markers hence ratio cd cd positive cells changes found associated changes evoked potentials clinical status,C20,0.0039163935,0.003493215,0.007416255,0.0022004617,0.005453454,0.0429166,0.24169615,0.0036830239,0.002831378,0.0038480866,0.050000194,0.0080552725,0.16207005,0.090224035,0.0034439776,0.006098639,0.07392057,0.004033236,0.00445939,0.058063336,0.1978437,0.001390569,0.022941994
effects glq hiv replication human monocyte macrophages chronically infected vitro hiv glq formulated version tricosanthin single chain ribosome inactivating protein shown earlier studies inhibit human immunodeficiency virus hiv replication lymphoblastoid cells decrease hiv p levels hiv infected monocyte derived macrophages measured flow cytometry current studies performed test selectivity observed inhibitory effects hiv replication chronically infected macrophages infected vitro peripheral blood derived monocyte macrophages infected vitro cultivated suspension least two weeks prior glq treatment anti hiv effects quantitated measurement cytoplasmic hiv p enzyme linked immunosorbent assay elisa flow cytometry hiv rna levels measured slot blot analysis incorporation h leucine trichloroacetic acid tca precipitable protein also evaluated index nonspecific inhibitory effects mediated compound infected uninfected cultures five days single h treatment glq concentration dependent decrease measurable hiv parameters within infected cultures anti hiv effects persisted least days without evidence increasing hiv expression glq treatment parallel uninfected macrophage cultures showed significant inhibition tritiated leucine uptake experiments demonstrate single pulsed exposure glq macrophages infected hiv vitro caused sustained concentration dependent decrease hiv p antigen levels well hiv rna without causing measurable toxicity uninfected cultures,C20,0.0017109513,0.0015176992,0.003499276,0.0009613138,0.08525067,0.0022080718,0.21312399,0.043610223,0.0012369417,0.0016811102,0.029057592,0.012843942,0.063741714,0.08060168,0.00977849,0.035790063,0.020343222,0.027553894,0.0019481698,0.021793474,0.2970273,0.00060749665,0.0441127
effect interleukin bsf infection peripheral blood monocyte derived macrophages hiv effects various cytokines examined vitro model human immunodeficiency virus type hiv infection human peripheral blood monocyte derived macrophages mdm monocytes obtained blood normal donors ficoll hypaque gradient centrifugation adherence cells allowed mature presence varying concentrations cytokines five days culture cells harvested counted inoculated g htlv iiib subclone cells replated presence concentrations cytokines culture supernatants sampled days p antigen ag measured ag capture assay repeat experiments following observations made mdm donors could infected presence tumor necrosis factor alpha tnf alpha granulocyte macrophage colony stimulating factor gm csf interleukin il effect gm csf variable tnf alpha also enhanced hiv replication controls il potent enhancer hiv replication mdm cytokines tested inducing p ag levels times seen control cultures run simultaneously effect dose dependent ag production observed day postinfection experiments multinucleated giant cell formation observed presence il,C20,0.012206178,0.0018556844,0.0039034046,0.0011754439,0.03328762,0.0026998,0.16645335,0.028424738,0.0015124034,0.0020554864,0.03433801,0.028069388,0.07206842,0.18643531,0.0018396283,0.0032576371,0.02426197,0.04269474,0.002382019,0.014404578,0.3004607,0.010865098,0.025348378
morphometric analysis follicular center cell lymphomas lukes collins classification non hodgkin lymphomas subdivides follicular center cell fcc lymphomas four categories based nuclear size shape state transformation well recognized difficulty making subdivisions routine histologic sections morphometric analysis typical small cleaved sc large cleaved lc small noncleaved snc large noncleaved lnc fccs performed describe compare four categories using objective parameters following features previously tested normal follicles measured calculated nuclear area na nuclear contour index ellipticity ncie nuclear contour index nuclear irregularity ncini relative chromatin dispersal index cdi presence nucleoli also recorded mean values na ncie ncini cdi significantly different among four fcc lymphoma subtypes except cdi reflects transformation similar sc lc cell groups comparison using proportion cells nucleoli case revealed significant differences snc lnc groups lc group highest mean nuclear ellipticity nuclear irregularity values mean nuclear area smallest sc group followed lc snc lnc groups despite many differences parameters showed broad spectrum values either mean values individual cases fcc subtype distribution curves cells within certain subtype compared morphometric data demonstrates four histologically recognized types fcc lymphomas distinctive using analytic technique study also provides insight differences among evidence nuclear transformation nuclear size chromatin dispersal frequent nucleoli important criterion nuclear contours distinguishing lnc lc lymphomas although lc lymphomas features intermediate sc noncleaved fcc lymphomas closely resemble sc lymphomas finally morphometric analyses provide objective morphologic foundation future prospective investigations transformation related phenomena studies may facilitate comparison morphologic data immunophenotype genotype non hodgkin lymphomas comparison various b cell neoplasms follicular center cell neoplasms,C20,0.0014079986,0.001248965,0.02306165,0.00079111604,0.0019916813,0.010145926,0.24325672,0.015156085,0.007828604,0.008124565,0.08222506,0.038387515,0.17228565,0.0573183,0.008047274,0.0021925468,0.10310182,0.009363761,0.0016032136,0.047239166,0.15587331,0.0004999292,0.008849171
multiple alterations insulin responses glucose islets h glucose infused nondiabetic rats examine biochemical mechanisms hyperglycemia produces insulin secretory abnormalities studied isolated islets control rats rats infused h glucose solution preserve effects vivo hyperglycemia vitro handling islet isolation standard isolation procedure utilized buffers containing mm glucose islets infused rats released similar amounts insulin low high glucose first incubations degrees c ng islets min mm ng islets min mm contrast control uninfused islets ng islets min mm ng islets min mm glucose p less secretion islets glucose infused rats lower min second incubations mm glucose first incubations islets low glucose p less phenomenon comparable paradoxical hypersecretion observed first min exposure glucose infused pancreas low glucose perfusions paradoxical secretion low glucose waned rapidly second incubations degrees c little immunoreactive insulin release occurred mm glucose despite persistence two additional lesions glucose insulin dose response curves second incubations showed leftward shift glucose infused islets two threefold higher secretion mm glucose control islets termed sensitization glucose,C20,0.0015221122,0.0013501894,0.01018097,0.00085521274,0.009487026,0.009306358,0.13816723,0.0014314126,0.0011004193,0.0014955646,0.016255999,0.015156237,0.122491084,0.0037048585,0.008681122,0.26703393,0.026603827,0.0015696213,0.016453175,0.027573796,0.31745228,0.0005404467,0.0015871087
quantitation mast cells eosinophils bronchial mucosa symptomatic atopic asthmatics healthy control subjects using immunohistochemistry used fiberoptic bronchoscopy obtain endobronchial biopsies mast cells eosinophils enumerated using monoclonal antibodies directed mast cell tryptase aa eosinophil cationic protein eg eleven symptomatic atopic asthmatics treated beta agonists alone six normal subjects studied period wk prior bronchoscopy patients recorded asthma symptom scores bronchodilator usage twice daily peak expiratory flow five days bronchoscopy methacholine responsiveness assessed two biopsies taken subcarinae one processed araldite immunostaining streptavidin biotin immunoperoxidase method spurr resin electron microscopy number aa staining mast cells present bronchial mucosa significantly different epithelium submucosa asthmatic normal subjects however biopsies asthmatics significantly greater numbers eg staining eosinophils epithelium median mm versus zero p less submucosa median mm versus mm p less electron microscopy showed morphologic features mast cell eosinophil degranulation asthmatics correlation could established mast cell eosinophil numbers indices disease activity pc methacholine points complexity mechanisms responsible symptoms airway hyperresponsiveness asthma,C20,0.0023276897,0.0020647768,0.038146384,0.0013078338,0.003241234,0.014269298,0.25354105,0.0021889876,0.001682816,0.0022924838,0.053354308,0.0048059607,0.17463493,0.111388005,0.0020469115,0.014887852,0.12575631,0.03666115,0.002650417,0.018694328,0.10832033,0.000826478,0.024910435
identification activated lymphocytes eosinophils bronchial biopsies stable atopic asthma used immunohistochemistry monoclonal antibodies analyze phenotypic composition activation status cellular infiltrate bronchial biopsies obtained fiber optic bronchoscopy atopic asthmatic subjects fev predicted range atopic nonasthmatic control subjects normal healthy subjects examination mucosal biopsies obtained central level subsegmental level ii bronchi showed highest number cd dc dc cd positive cells found group asthma significant increase number interleukin receptor cd positive cells marker lymphocyte activation airway level asthmatic group compared nonasthmatic atopic p less normal control subjects p less eosinophil numbers significantly increased asthma airway levels airway level ii nonasthmatic atopic group compared normal healthy control subjects p less eg positive cells index secretion eosinophil cationic protein following activation found airway levels asthmatic group level nonasthmatic atopic control group p less asthmatic subjects compared normal healthy subjects reduction number neutrophil elastase positive cells asthmatic subjects percentage leukocytes significant p,C20,0.0019171361,0.0017005954,0.031417504,0.0010771606,0.0026695514,0.039596595,0.074636884,0.001802898,0.001386004,0.011154566,0.07990777,0.05187663,0.29690042,0.0877783,0.0016858812,0.012259367,0.026125716,0.058558807,0.0021829414,0.035170645,0.17753127,0.00068070536,0.0019826586
angiotropic intravascular large cell lymphoma clinicopathologic study seven cases unique clinical presentations authors recently reported antigenic phenotypes three cases called malignant angioendotheliomatosis suggested angiotropic large cell lymphoma alcl appropriate designation disease authors report additional seven cases alcl unique clinical presentations one patient presented prostate enlargement second lytic bone lesions thickened nasal sinus mucosa third diffuse myalgia fourth dyspnea pulmonary infiltrates fifth gangrene lower extremities total body skin involvement pancytopenia sixth lesion foreskin mimicking squamous cell carcinoma seventh mediastinal mass cases histologic features characteristic alcl two cases extravascular spread soft tissue immunohistologic studies showed b cell phenotype five cases cell phenotype one case two patients received combination chemotherapy using established treatment protocol large cell lymphoma remain complete clinical remission two patients responding clinically combination chemotherapy two patients died shortly receiving combination chemotherapy one patient recently diagnosed alcl long term follow available data indicate although alcl affects predominantly central nervous system skin unusual clinical presentations may occur patients alcl may respond combination chemotherapy large cell lymphoma,C20,0.010678356,0.010492334,0.012283899,0.0010294396,0.05130989,0.0023857136,0.3853497,0.0017230251,0.0013246007,0.0018002463,0.1287517,0.0048433263,0.014712984,0.075201094,0.010283919,0.0117196515,0.124513395,0.019582598,0.0020862317,0.015030178,0.11236226,0.00065054843,0.001884902
anaphylaxis grand keyhole limpet abalone like shellfish abalone report five patients developed moderate severe anaphylactic reactions induced ingestion grand keyhole limpet gkl abalone specific ige mediated hypersensitivity shellfish demonstrated history prick skin test rast rast inhibition technique revealed cross antigenicity gkl abalone keyhole limpet hemocyanin,C20,0.0067171245,0.0059584244,0.012533457,0.0037764069,0.044077754,0.008668799,0.33285767,0.0063168653,0.004856182,0.006599969,0.0937081,0.013815841,0.04165974,0.019508254,0.03842416,0.0104599595,0.09342712,0.04338172,0.007648434,0.043985717,0.15224095,0.0023850068,0.006992326
anaphylactic shock associated chymopapain skin test case report review literature allergic response chymopapain intradiscal therapy well documented serious reactions anaphylactic shock may result death various screening methods including skin tests proposed identify susceptible patients anaphylactic shock occurred year old woman application screening skin test appropriate therapeutic intervention readily accessible test performed,C20,0.0041521373,0.003683153,0.028111484,0.0023329167,0.06608534,0.0053585498,0.2583839,0.02399835,0.0030018105,0.0040797186,0.20195,0.008540153,0.046019632,0.009547046,0.0036512848,0.066765584,0.09328,0.004276013,0.004727819,0.0784671,0.07784216,0.0014742732,0.004271566
isolation human immunodeficiency virus hiv autopsy one six days postmortem blood tissue studied potential infectivity autopsy ten patients human immunodeficiency virus hiv infection special attention paid possibility detecting hiv bone craniotomy postmortem intervals one six days specimens hiv isolation included skull bone brain blood bone marrow spleen lymph node cerebrospinal fluid one case hiv grew culture least one specimen eight autopsies one performed six days postmortem hiv recovered blood five patients tissue five patients including three negative blood cultures skull bone contained hiv two cases hiv also grew native spleen specimens stored days postmortem degrees c recommended precautions including bone indicated autopsy hiv infected patients even long postmortem intervals,C20,0.017807852,0.002704582,0.00569675,0.0017130877,0.004245584,0.003934845,0.20806754,0.0028672812,0.0022042643,0.0029957849,0.18150662,0.006271133,0.08907854,0.109416276,0.0026811808,0.004747869,0.11146898,0.017895766,0.032975633,0.021324562,0.16613673,0.0010825758,0.0031765264
low level atmospheric sulfur dioxide pollution childhood asthma quarterly analysis childhood asthma hong kong hospitalization episodes relation levels pollutants tsp rsp revealed seasonal pattern attack rates correlates inversely exposure sulfur dioxide r p less cannot found pollutants many factors may contribute seasonal variation asthma attacks speculate prolonged exposure terms months low level one factor might induce airway inflammation bronchial hyperreactivity predispose episodes asthma,C20,0.0042376327,0.0037589918,0.007906984,0.0023809532,0.005943849,0.025980784,0.21596627,0.0039851214,0.00306362,0.0041637234,0.022688283,0.008716001,0.15432625,0.012207458,0.0037264675,0.02705263,0.07929456,0.004374125,0.0048251683,0.24451792,0.15500194,0.0015046295,0.0043766135
impact hiv related illness employment used structured telephone interviews determine extent work loss following onset symptoms interval onset symptoms cessation work risk factors work loss among persons symptoms human immunodeficiency virus hiv related illness attending aids clinic university california san francisco october september estimates duration time onset hiv related symptoms work loss derive life table method kaplan meier cox proportional hazards model used estimate effect risk factors probability withdrawing work time interval eighty six percent respondents worked prior onset first symptom hiv related illness percent working time recent interview mean days later total number hours worked declined percent time kaplan meier analysis indicates percent worked prior onset hiv related illness stopped working within two years stopped within years onset first symptom,C20,0.0022035798,0.0019546852,0.014776859,0.0012381016,0.0030684152,0.0028438345,0.13546115,0.0020745462,0.0015930901,0.10403928,0.08660443,0.004532343,0.024564205,0.006012769,0.0019378165,0.014093641,0.14590058,0.0023045936,0.011046613,0.2909326,0.13972776,0.00078241114,0.0023067023
differentiating agents facilitate infection myeloid leukemia cell lines monocytotropic hiv strains published erratum appears blood apr monocytotropic human immunodeficiency virus type hiv isolates patients acquired immunodeficiency syndrome aids infect mononuclear phagocytes well activated cells usually infect immature human myeloid cell lines vitro hl promyelocytic myeloblastic cell line promonocytic line u susceptible productive infection monocytotropic hiv isolates hiv jr fl htlv iiiba l treatment retinoic acid dimethyl sulfoxide dibutyryl camp dihydroxyvitamin oh tetradecanoyl phorbol acetate tpa virus production detected compounds added virus infection virus replication correlate cd receptor expression undifferentiated hl cells express cd level cd expression increase differentiation presence retinoic acid oh tpa mature monocytic cell line thp capable infection without pretreatment treatment differentiating agents enhanced virus production chronically infected cell line j hl isolated hiv jr fl infection hl cells treated retinoic acid virus production cell line enhanced fold differentiation presence oh tpa majority virus production oh treated j hl cells associated mature adherent population molecular analysis cloned line j hl showed integration single dna provirus results suggest cellular factors associated precursor cell differentiation along myelomonocytic pathway required optimal replication monocytotropic hiv strains vitro,C20,0.0018823184,0.0016697104,0.020041673,0.0010576212,0.04999405,0.00242923,0.3392633,0.001770155,0.0013608325,0.0018494884,0.010180133,0.03117898,0.025150811,0.13434352,0.0016552634,0.002984837,0.031130087,0.029216433,0.0021432964,0.045219947,0.09979695,0.00066834287,0.16501302
htlv sequences detected peripheral blood genomic dna brain cdna multiple sclerosis patients human cell lymphotropic virus htlv recently reported etiologically associated multiple sclerosis ms genomic dna peripheral blood lymphocytes brain plaques patients ms analyzed presence sequences homologous htlv pol gene using polymerase chain reaction dot blot techniques comparison dna amplification patterns patients ms control subjects autoimmune conditions healthy control subjects htlv infected cell line indicates htlv pol sequence present peripheral blood patients ms virus active ms brain plaques,C20,0.049528945,0.0028302313,0.0059533496,0.0017926743,0.00444904,0.00411765,0.2585108,0.0030004894,0.00230667,0.0031349629,0.032106053,0.0066348813,0.1507612,0.04763175,0.002805743,0.0049684453,0.1125408,0.0032858006,0.0036329802,0.024309928,0.15412053,0.0011328701,0.120444246
late pulmonary allergic responses actively passively ige sensitized rats previous studies suggested although rats passively sensitized monoclonal murine immunoglobulin e ige would respond pulmonary antigen challenge immediate increase resistance exhibited late increases resistance unlike late changes rats actively sensitized preferentially produce ige antibody hypothesized passively sensitized rats also would develop antigen induced pulmonary inflammation blinded protocol compared immediate responses pulmonary resistance inflammation h challenge placebo antigen dinitrophenol bovine serum albumin dnp bsa elicit passively sensitized response ovalbumin oa elicit actively sensitized response despite similar immediate responses oa dnp bsa rats challenged oa marked inflammatory changes significant incidence late elevations resistance inflammation scores lung resistance significantly correlated oa group also observed anesthesia fentanyl droperidol significantly attenuated immediate late responses antigen challenge compared rats anesthetized ketamine conclude ige mediated immediate responses pulmonary antigen challenge insufficient may unnecessary initiate antigen induced late inflammatory changes,C20,0.04690471,0.0018748301,0.014164974,0.0011875211,0.0029430604,0.070488006,0.09443208,0.0019876142,0.0015280072,0.0020766933,0.009775791,0.035147205,0.068504296,0.10428806,0.0018586082,0.013513353,0.11476342,0.013945423,0.022866733,0.05190875,0.3127146,0.0007504471,0.012375831
gallium imaging predictor residual tumor viability clinical outcome patients diffuse large cell lymphoma durable complete remissions crs achieved patients diffuse large cell lymphoma dlcl multidrug chemotherapy length time reach cr may predictive treatment outcome however defining cr chest radiograph computed tomography ct often difficult since residual abnormalities always indicate residual disease prospectively evaluated ability gallium citrate ga imaging define residual disease predict outcome consecutive patients dlcl patients received megabecquerels mbq ga imaged prior following cycles completion intensive chemotherapy ga scan results correlated radiographic studies seventeen patients showed persistent abnormal ga uptake halfway chemotherapy four cr partial remission pr two showed change tumor size follow died three scored cr seven pr halfway therapy two alive active tumor one relapsed survives following bone marrow transplant four three pr one cr therapeutic halfway point without disease median months presentation patients ga negative halfway therapy cr nine pr five patients died three radiographic cr died months two radiographic pr died months one patient alive active tumor patients alive without disease median months presentation ga imaging proved excellent indicator residual viable tumor positive scan halfway therapy predicted poor outcome may well justify change treatment,C20,0.0016045246,0.0014232934,0.010749341,0.0009015169,0.08463752,0.0020707224,0.30915946,0.0015115868,0.0011599999,0.0015765396,0.09542255,0.019717328,0.015475404,0.01938719,0.0014109784,0.010259768,0.29149932,0.0094152745,0.0018269873,0.04986156,0.0687087,0.00056970835,0.0016506757
medical treatment juvenile arthritis range medications available treat juvenile arthritis markedly expanded past years multiple new nonsteroidal antiinflammatory drugs nsaids available united states although approved use children none proven significantly better aspirin suppressing inflammation average time significant improvement noticed days children respond nsaid within three months percentage responders progressively increases length therapy treatment continued one reasonably certain improvement occur changing medication severely involved child gold disease modifying medications used however difficult prove value medications controlled studies high rate significant improvement control group treated nsaids preliminary studies methotrexate appears significant benefit children failed treatments newer therapies intravenous gammaglobulin used small number patients yet proven beneficial,C20,0.0023541478,0.02487977,0.004392596,0.0013226997,0.0032780764,0.0030381505,0.295808,0.0022138692,0.0017019442,0.04790105,0.07619912,0.028528962,0.13813925,0.0055403626,0.0020701783,0.0036658978,0.11288669,0.013815114,0.0026805436,0.10516196,0.12116395,0.0008358724,0.0024218606
novel x linked combined immunodeficiency disease novel x linked combined immunodeficiency disease found five living males extended family united states age affected males ranged yr prominent clinical abnormalities paucity lymphoid tissue recurrent sinusitis otitis media bronchitis pneumonia severe varicella chronic papillomavirus infections principal immunologic features disorder normal concentrations serum immunoglobulins restricted formation igg antibodies immunogens normal numbers b cells nk cells decreased numbers cd cd lymphocytes particularly cd ra subpopulations diminished proliferative responses blood cells allogeneic cells mitogens antigens decreased production il mitogen stimulated blood lymphocytes thus affected males family carry abnormal gene x chromosome results combined immunodeficiency distinct previously reported disorders,C20,0.0026008126,0.0022980878,0.0048339935,0.0014559835,0.0036074799,0.01587334,0.3313357,0.0024541623,0.001872967,0.016959924,0.039165135,0.0053285924,0.059684988,0.1529604,0.0022782038,0.027226841,0.02991664,0.00272041,0.015407318,0.08935462,0.16400126,0.0009198665,0.027743286
myelin autoreactivity multiple sclerosis recognition myelin basic protein context hla dr products lymphocytes multiple sclerosis patients healthy donors panel human myelin basic protein hmbp specific lymphocyte lines generated peripheral blood eight multiple sclerosis ms patients two healthy donors expressing hla dr haplotype associated increased susceptibility ms using hla dr gene transfected mouse l cell lines antigen presenting cells established hmbp specific lymphocyte lines restricted dr gene products dr dw haplotype four cell lines recognized hmbp context dr b products dr dw haplotype dr b restricted cell responses demonstrable cell lines derived ms patients hmbp epitopes presented dr heterodimer mapped peptides covering amino acid residues region spanning thrombin cleaved bond arg ala dr b restricted cell lines recognized epitopes within amino acids peptide also presented context hla dr molecules data show ms patients dr dr b products dr dw haplotype function restriction elements myelin autoantigen hmbp ii dr molecule presents least five different epitopes hmbp specific lymphocytes iii anti hmbp cell lines derived individual donors differ antigen fine specificity well hla restriction,C20,0.0022274205,0.0019758332,0.014918193,0.0012514967,0.014011789,0.002874602,0.29425424,0.012960961,0.0016103259,0.0021885715,0.011001474,0.0045813783,0.053717583,0.08303433,0.0019587374,0.0034685568,0.059418906,0.1214138,0.0025362459,0.041171912,0.14356777,0.0007908761,0.12506503
recognition b cell lymphoma anti idiotypic cells idiotypic igm derived b cell lymphoma act tumor associated ag immunization purified protein generates anti idiotypic immune response specifically suppresses tumor development spleens immune mice contain cells proliferate response idiotypic igm however idiotypic ag presented cells efficiently natural form surface lymphoma cells soluble igm plus presenting cells variant tumors display either little idiotypic igm cell surface otherwise indistinguishable parental tumor induce weak response fail stimulate cells respectively anti idiotypic lines clones derived splenic cells growth presence irradiated tumor cells phenotypic analysis revealed cells lines clones express cd cd ag cd recognition tumor id required added presenting cells inhibited antibody mhc class ii ag variably anti cd proliferative responses inhibited anti idiotypic antibodies also antibodies constant region mu h chain indicating perturbation surface igm abrogates availability idiotypic determinants cells,C20,0.0020304725,0.0018011304,0.014907816,0.010960522,0.07579655,0.012390245,0.17704809,0.021876272,0.0014679412,0.0019950585,0.010268964,0.0042240056,0.015100267,0.28508934,0.0017855462,0.022814162,0.01940993,0.025847811,0.0023119915,0.047319945,0.2261008,0.000720947,0.018732164
effects lipoxygenase inhibitor asthma induced cold dry air background enzyme lipoxygenase catalyzes metabolism arachidonic acid form products implicated airway obstruction asthma hypothesized products lipoxygenase pathway important mediating obstruction prevention formation decrease severity induced asthmatic response methods randomized double blind placebo controlled crossover study examined effect lipoxygenase inhibitor bronchoconstriction induced hyperventilation cold dry air patients asthma completeness lipoxygenase inhibition confirmed examining profile eicosanoids produced whole blood ex vivo activation calcium ionophore results decreased mean sem ionophore induced synthesis leukotriene b lipoxygenase product percent ng per milliliter p less affect ionophore induced synthesis thromboxane b cyclooxygenase metabolite arachidonic acid ng per milliliter vs ng per milliliter concert selective inhibition lipoxygenase amount cold dry air expressed respiratory heat exchange required reduce forced expiratory volume one second percent increased percent kj per minute placebo vs kj per minute p less similar results obtained minute ventilation used indicator outcome liters per minute placebo vs liters per minute p less conclusions selective inhibition lipoxygenase associated significant amelioration asthmatic response cold dry air suggesting lipoxygenase products involved response approach may useful treatment asthma,C20,0.0018005668,0.0103098955,0.0033593525,0.0010115692,0.0025069946,0.011027094,0.24712762,0.0017046112,0.0013016063,0.0104796,0.020310925,0.03909705,0.11763195,0.042244855,0.001583223,0.0028035913,0.06990349,0.046185326,0.028193649,0.0603543,0.26911741,0.0006392553,0.011306087
virologic immunologic aspects acquired immunodeficiency syndrome initial clinical descriptions acquired immunodeficiency syndrome aids present time much discovered concerning epidemiologic factors pathogenesis treatment prevention disease recent advances epidemiology included better understanding occupational risk human immunodeficiency virus hiv infection percutaneous exposure responsible approximately per cent instances appreciation potential variability time interval infection seroconversion generally order three months occasionally longer establishment need intimate contact transmit infection following discovery hiv etiologic agent aids many rapid advances possible including development screening tests elucidation hiv genome discovery cd lymphocyte predominant cell destroyed hiv progressive destruction cd cells results progressive decline immunologic function may take variety clinical forms ranging symptoms severe opportunistic infections delineation life cycle hiv helped development antiretroviral therapies including agents interfere reverse transcription nucleoside analogues zidovudine dideoxycytidine dideoxyinosine azidodideoxyuridine agents interfere viral assembly protease inhibitors interferon alpha precise understanding nature immune response elicited hiv infection resulted development several candidate hiv vaccines including recombinant vaccinia viruses expressing hiv envelope recombinant envelope proteins,C20,0.001919116,0.010980088,0.031467713,0.0010773045,0.0026699079,0.036738027,0.37832266,0.0018031389,0.0013861893,0.0018890621,0.027405696,0.003943709,0.017676141,0.074084654,0.0016861063,0.012252549,0.094530344,0.029809842,0.012837492,0.10184476,0.08111899,0.0006807963,0.0738757
silk induced asthma children report cases total children less years age asthma caused silk studied diagnosis based history wheezing positive skin tests silk positive conjunctival nasal provocation tests serum ige sw silk waste average age onset years months sex ratio f positive skin test essential diagnosis conjunctival provocation tests performed cases reliability safety convenience first symptom appeared average months initial exposure silk patients asthma accompanied allergic rhinitis cases conjunctivitis cases asthma occurred winter due seasonal use bed quilts clothes filled silk silk highly potent allergen average mean wheal diameter elicited silk prick testing larger two histamine equivalent prick tests cross reactivity exists among mulberry silk silkworm cocoons batryticated silkworms silkworm chrysalis,C20,0.0027663873,0.015823781,0.005156425,0.0015532722,0.030667188,0.003566455,0.22605582,0.0025988393,0.0019978955,0.04629336,0.2302075,0.0056840144,0.054435395,0.0065066125,0.01583719,0.0043033613,0.1307449,0.029595697,0.003146664,0.092492305,0.08672572,0.0009812224,0.0028599626
method pharmacoepidemiologic analysis uses computerized medicaid method pharmacoepidemiologic data analysis utilizes computerized medicaid data presented cohort design medicaid enrollees receiving drugs normally used treat similar underlying conditions described period time medicaid service transactions evident required individual eligible selection cohort selection study subjects descriptions cohorts based medicaid service histories occurring preliminary prerequisite period time risk considered begin prescription study drug dispensed continues either refill dispensed prescription alternative drug within therapeutic class dispensed predetermined number days passed subjects followed forward time relevant health care transactions suggestive suspected adverse drug reactions noted incidence densities associated sequentially ranked prescriptions within sequential courses therapy compared methods increase accuracy case ascertainment briefly discussed separate validation studies may used evaluate validity computerized case ascertainment methods compensate misclassification outcome proposed method intended provide timely estimates risk selected outcomes outcomes cannot accurately ascertained computerized data method may useful determining feasibility customized studies,C20,0.0018655797,0.0016548623,0.030472077,0.0010481931,0.0025977606,0.0024129367,0.3085381,0.0017544137,0.010368105,0.01084489,0.14194117,0.0044470346,0.082642525,0.0043440107,0.01970067,0.01190468,0.11291274,0.0019212378,0.029209321,0.16973124,0.04710289,0.0006623996,0.0019231153
aids minority patients doctors risk talking asked physicians providing primary care mostly minority patient population respond questionnaire concerning attitudes behavior toward aids risk assessment preventive counseling indicate beliefs concerning patients knowledge behavior physicians responded agreed physicians must educate patients aids also reported patients engage risk taking behavior may know much aids transmission prevention despite beliefs doctors reported gave advice male patients female patients one third physicians reported feeling uncomfortable talking patients sexual preferences practices identify patients risk help prevent aids methods must found make physicians comfortable discussing sexual issues patients especially minority patients,C20,0.0025582851,0.03941699,0.06669769,0.001437396,0.003562331,0.0033747647,0.2832063,0.0024058423,0.0018495263,0.015613921,0.030170301,0.0053364807,0.01583848,0.04693347,0.0022496914,0.003983782,0.16972679,0.0026346096,0.051186845,0.20052567,0.047748916,0.00090835406,0.00263357
endorphin derivatives hydrocortisone prevent eeg limbic seizures induced corticotropin releasing factor rabbits corticotropin releasing factor crf injected cerebral ventricles small mammals induces eeg limbic seizures behavioral excitability stereotyped behavior tardive enhancement hippocampal theta voltage frequency addressed phenomenon explained pathogenesis infantile spasms children wished study interference exerted gamma endorphin fragments eeg epileptiform behavioral symptoms induced crf rabbit animals implanted intracerebroventricularly c v semichronic cortical hippocampal electrodes together cannula left lateral ventricle gamma endorphin derivatives dt gamma e de gamma e injected intravenously v days hydrocortisone prevented eeg ictal seizures induced hippocampus rabbits crf injected c v hydrocortisone de gamma e also prevented appearance scattered spiking partially prevented tardive enhancement theta voltage hippocampal eeg finally de gamma e also prevented stereotyped behavior excitability induced crf results confirm regulatory role exerted crf limbic structure excitability suggest peptides may involved regulatory feedback mechanism crf metabolism activity possibility peptides may also interesting antiepileptogenic properties considered,C10,0.015130293,0.06501175,0.06482995,0.001455697,0.0036076866,0.0033436362,0.21108189,0.040061925,0.0018730744,0.01620627,0.011943776,0.06786174,0.018792568,0.10568038,0.0022783345,0.0040345034,0.070528194,0.0026986676,0.01547671,0.025398467,0.236584,0.0009199192,0.015200571
auditory brain stem implant effect tumor size preoperative hearing level function auditory brain stem implant investigational device designed provide hearing sensations patients without functioning auditory nerves analyzed results implants patients determine tumor size preoperative hearing level might related proper device function found significant correlation preoperative hearing level tumor size device function also found significant correlation preoperative hearing level tumor size patients,C10,0.003345181,0.051548727,0.022402255,0.018061254,0.09429165,0.0043474124,0.14944974,0.0031458489,0.002418417,0.003286837,0.018409746,0.006880398,0.11364768,0.05967215,0.0029416678,0.0052091423,0.19318123,0.0034449818,0.0038089806,0.025951771,0.20990801,0.0011877522,0.0034591693
rapid eye movement sleep deprivation probe elderly subjects effects night rapid eye movement rem sleep deprivation rsd procedure electroencephalographic sleep mood examined healthy elderly control subjects elderly patients endogenous depression patients primary degenerative dementia compared control subjects patient groups maintained higher amount rem sleep time rem activity rsd unexpectedly depressed patients showed little rebound visually scored automated rem sleep measures following rsd showed stability rem activity temporal distribution baseline recovery conditions contrasted rebound rem sleep activity seen control subjects modest increase demented patients rsd fairly specific impact delta sleep procedure recovery sleep mood ratings unaffected rsd findings demonstrated greater plasticity rem sleep regulation healthy elderly control subjects suggested higher rem pressure ceiling effect depressed patients patients dementia appeared impaired capacity respond challenge rsd,C10,0.0023018655,0.0020418696,0.004299555,0.0012933243,0.0032055534,0.014109784,0.16573416,0.0021647022,0.0016641462,0.002261718,0.010955445,0.027915582,0.2484526,0.005844674,0.0020242024,0.059284557,0.13824269,0.0023772325,0.0027021712,0.06814496,0.23179142,0.0008173088,0.0023704767
failure nine month phenobarbital administration reverse amygdaloid kindled seizure susceptibility cats upon completion left amygdaloid kindling cats underwent long term phenobarbital administration subsequent month rest period plasma phenobarbital levels maintained micrograms ml restimulated following plasma phenobarbital washout three cats served nonmedicated controls cats subjected repeated hour sleep monitoring observation interictal discharges observed often immediate postictal period frequency decreased gradually throughout experiment medicated control animals never completely disappeared except contralateral amygdala medicated animal upon primary site restimulation medicated animals responded generalized convulsion afterdischarge induced animals underwent secondary site amygdaloid kindling showed positive transfer effect findings suggest although phenobarbital potent anticonvulsant little effect acquired seizure susceptibility previously amygdaloid kindled cats,C10,0.0028399304,0.016266674,0.019003008,0.0015956411,0.003954513,0.017391201,0.17964129,0.016417004,0.0020531432,0.016492138,0.02652879,0.016984921,0.07304191,0.010633294,0.0025449682,0.01816589,0.13999885,0.034787342,0.0032336786,0.049968824,0.330713,0.0010083561,0.016735611
synaptic transmission human neocortex removed treatment intractable epilepsy children synaptic transmission pyramidal cells studied slices neocortex resected infants children n age months years undergoing surgical treatment intractable epilepsy specimens least abnormal area resection stable intracellular recordings could obtained hours recorded neurons electrophysiological characteristics similar regular firing pyramidal cells layers iii v confirmed intracellular staining lucifer yellow local extracellular stimulation evoked sequence excitatory inhibitory postsynaptic potentials application gamma aminobutyric acid antagonist bicuculline microm extracellular stimulation induced large excitatory postsynaptic potentials epileptiform bursts spontaneous bursts occasionally occurred bicuculline effect bicuculline observed tissue samples even infant patients n age months kynurenic acid depressed abolished spontaneous stimulation induced bursts competitive antagonist n methyl aspartate receptors dl amino phosphonopentanoic acid decreased duration bicuculline induced bursts data provide evidence similar rat cat neocortex excitatory inhibitory amino acids important transmitters pyramidal cells immature human neocortex,C10,0.021474369,0.0017836605,0.0068938453,0.0011297741,0.0028003675,0.0025950137,0.26291043,0.00189096,0.001453703,0.021444706,0.030096173,0.016652882,0.015644496,0.10152904,0.0114796925,0.03232755,0.11676812,0.039788377,0.021754494,0.07861278,0.17637004,0.0007139542,0.033885576
aaem minimonograph clinical experience transcranial magnetic stimulation elicited motor evoked potentials meps using transcortical magnetic stimulation control subjects aged years patients variety diseases significant side effects cortex target muscle latencies measured ms thenar ms extensor digitorum communis ms biceps ms tibialis anterior central motor delay cortex c l measured ms ms respectively mean spinal cord motor conduction velocity measured mep amplitude expressed percentage maximum wave never less wave value less considered abnormal mep latency increases linearly age central motor delay longer older subjects compound muscle action potentials absolute mep amplitudes decreased linearly age multiple sclerosis ms mep latency central delay often prolonged mep sensitive sep ms amyotrophic lateral sclerosis mep latencies modestly prolonged characteristic abnormality reduced amplitude pseudobulbar features predominated meps often absent mep normal latency parkinson disease age related amplitude often increased mep latency amplitude normal huntington disease abnormal meps persisted several months stroke despite good functional recovery mep could used advantage demonstrate proximal conduction slowing block demyelinating neuropathies plexopathy ability elicit mep several days onset paresis good evidence neuronal continuity motor fibers,C10,0.0017697783,0.0015696691,0.010667374,0.0009942317,0.0024642162,0.0022836819,0.23878364,0.0016640957,0.01841211,0.039156064,0.009374133,0.01230683,0.3100791,0.022135716,0.010113651,0.0027555397,0.06942569,0.010440351,0.00201488,0.09124872,0.13987383,0.0006282989,0.001838393
circulatory thermal adjustments prolonged exercise paraplegic women circulatory thermal responses min wheelchair ergometer exercise examined five wheelchair dependent wd women low level spinal dysfunction five able bodied ab women served comparison group metabolic rate exercise w wd w ab p greater oral temperature tor mean skin temperature tsk oxygen uptake vo heart rate hr cardiac output qc assessed periodically throughout exercise period ambient conditions degrees c relative humidity significant group x time interaction found tor p less tsk p less tor wd group steadily increased exercise whereas ab group showed stable tor tsk wd increased rapidly first min exercise continued rise slower rate throughout exercise contrast tsk ab rose peak first min showed decreasing trend vo hr remained stable groups throughout exercise period following initial increase qc minute minute groups values wd continually decreased qc min lower min findings suggest wd women greater thermoregulatory strain ab women indicated higher tor tsk inability maintain qc due paralysis lower limbs perhaps increase cutaneous blood volume,C10,0.0107256,0.07194568,0.029804816,0.0010203725,0.011319244,0.0023437256,0.19188085,0.001707849,0.0013129337,0.00178439,0.008503581,0.05648747,0.28211197,0.004346397,0.019173272,0.011844709,0.05552256,0.0018702452,0.0020678565,0.10219963,0.12951376,0.0006448185,0.0018683001
anteromedial tibial tubercle transfer without bone graft followed patients years anteromedial tibial tubercle transfer persistent patellofemoral pain associated patellar articular degeneration twelve patients followed years report good excellent results subjectively good excellent results objectively quality improvement sustained patients evaluated years surgery examined separately patients advanced patellar arthrosis achieved good result none patients achieved excellent result postoperative continuous passive motion markedly reduced incidence stiffness serious complications compartment syndrome infection skin slough avoided completely consecutive cases patellofemoral contact pressure studies five cadaver knees shown anteromedial tibial tubercle transfer provide substantial reduction patellofemoral contact stress helping balance medial lateral facet pressures surgical procedure mechanically clinically successful alleviating intractable pain related patellar malalignment articular degeneration procedure enables majority appropriately selected patients malalignment patellar articular degeneration resume increased levels activity substantially diminished pain,C10,0.002409724,0.0021370193,0.004509856,0.0013535924,0.015016279,0.0035372062,0.14186083,0.014421373,0.0017416944,0.0023864142,0.048386097,0.004955329,0.053869847,0.005852319,0.025413165,0.027063925,0.3753081,0.0025045916,0.017743234,0.10210417,0.14409141,0.0008553948,0.002478425
acth therapy infantile spasms relationship dose acth initial effect long term prognosis relationship dose acth initial effect investigated children infantile spasms mg iu kg day acth needed good initial response seizures electroencephalographic abnormalities relationship dose acth long term prognosis investigated patients relationship daily total acth dosage provided dose greater mg iu kg day outcome seizures electroencephalographic abnormalities however acth mg iu kg day total acth dose mg iu kg resulted better mental development smaller doses acth side effects acth increased dosage small large dose acth lead better mental development proper dose acth used careful attention potential side effects,C10,0.0023812694,0.0021123048,0.0044432017,0.012853064,0.003316469,0.0030731524,0.23233783,0.0022393747,0.0017215519,0.013867555,0.011398276,0.00492998,0.017421426,0.005475274,0.0020941452,0.0037081318,0.09948524,0.0024523127,0.0027114255,0.026654152,0.5420286,0.00084550225,0.0024497623
schindler disease molecular lesion alpha n acetylgalactosaminidase gene causes infantile neuroaxonal dystrophy schindler disease recently recognized infantile neuroaxonal dystrophy resulting deficient activity lysosomal hydrolase alpha n acetylgalctosaminidase alpha galnac recent isolation expression full length cdna encoding alpha galnac facilitated identification molecular lesions affected brothers family first cases described autosomal recessive disease southern northern hybridization analyses dna rna affected homozygotes revealed grossly normal alpha galnac gene structure normal transcript sizes amounts therefore alpha galnac transcript affected homozygote reverse transcribed amplified polymerase chain reaction pcr sequenced single g transition nucleotide detected multiple subclones containing pcr products point mutation resulted glutamic acid lysine substitution residue e k alpha galnac polypeptide base substitution confirmed dot blot hybridization analyses pcr amplified genomic dna family members allele specific oligonucleotides furthermore transient expression alpha galnac construct containing e k mutation resulted expression immunoreactive polypeptide detectable alpha galnac activity,C10,0.0020717627,0.001837757,0.0038656944,0.001164039,0.054892052,0.0026737177,0.2968597,0.021984112,0.0014977922,0.0020356285,0.036025316,0.037047703,0.014703784,0.019124722,0.0118388515,0.0032261654,0.036852345,0.030524926,0.012368871,0.016786765,0.15979014,0.0007356077,0.23209256
spectral electroretinography thioridazine toxicity three patients thioridazine toxicity electroretinogram erg red light found average normal range significant increase amplitude appeared cessation therapy two cases deterioration erg amplitude stimulus conditions white blue red lights occurred dose medication increased third patient,C10,0.005471919,0.0048538656,0.0102100335,0.02952593,0.007619474,0.0070617967,0.27170116,0.005145859,0.030444557,0.005376482,0.071026295,0.011254692,0.0574512,0.012960093,0.0048118676,0.008520916,0.13056916,0.005640669,0.006230585,0.076704994,0.22984627,0.0019428796,0.0056293085
quantifying language development birth years using early language milestone scale point scoring technique early language milestone scale described normative data based original cross sectional sample validation data based separate longitudinal sample presented mean early language milestone scale point scores standard deviations percentile equivalents raw point scores presented ages birth months correlations point scores early language milestone scale scores standardized developmental tests stanford binet intelligence scale peabody picture vocabulary test illinois test psycholinguistic abilities presented clinical research advantages point scoring technique presented compared original pass fail scoring method,C10,0.0026920107,0.0023879479,0.005023013,0.0015125311,0.0037485398,0.0034741801,0.22639856,0.0025315995,0.001946204,0.0026450588,0.24009435,0.120716006,0.02892971,0.019140055,0.0023672862,0.017207034,0.09482622,0.04182423,0.0030652503,0.10988446,0.06586049,0.0009558352,0.0027694413
cerebrovascular metabolic effects rat brain focal nd yag laser irradiation investigate effects focal neodymium yttrium aluminum garnet nd yag laser irradiation lambda nm regional cerebral blood flow cerebral protein synthesis blood brain barrier permeability parietal brain surface rats irradiated focused laser beam constant output energy j survival times ranged minutes hours laser irradiation immediately caused well defined cortical coagulation necrosis within minutes unilateral irradiation c iodoantipyrine autoradiographs demonstrated severely reduced blood flow irradiation site perilesional neocortex distinct reactive hyperemia areas forebrain apart persistent ischemic focus vicinity cortical coagulation necrosis blood flow alterations remote areas brain subsided within hours irradiation autoradiographic assessment h tyrosine incorporation brain proteins revealed rapid onset prolonged duration protein synthesis inhibition perifocal morphologically intact cortical subcortical structures impairment amino acid incorporation proved completely reversible within hours immunoautoradiographic visualization extravasated plasma proteins using h labeled rabbit anti rat immunoglobulins showed hour irradiation immunoreactive proteins confined neocortex irradiation site hours vasogenic edema present vicinity irradiation site subcortical white matter later stages hours also extended contralateral hemisphere although followed gradual decrease labeling intensity resolution edema still complete hours analysis sequential functional changes conjunction morphological alterations indicates evolution morphological damage laser irradiation correlate time course spatial distribution protein synthesis inhibition vasogenic edema although central coagulation necrosis represents direct effect radiation final size laser induced lesion determined delayed colliquation necrosis due persistent perifocal ischemia extent severity ischemia zone initial preservation neuroglial cells explained optical properties nd yag laser extensive scattering light within brain parenchyma associated high blood brain absorption ratio selectively affects blood vessels outside irradiation focus,C10,0.048721068,0.0011260936,0.017089454,0.0132424785,0.014923747,0.020068407,0.13825127,0.0011975513,0.00091777876,0.013969937,0.013192073,0.012111432,0.14403364,0.0243144,0.008015325,0.008323846,0.123256244,0.08079185,0.0014454917,0.057700776,0.24257818,0.00045074683,0.014278158
prevalence characteristics multiple analgesic drug use elderly study group exceptions use multiple analgesic drugs achieves dubious increases analgesia placing elders increased risk many potential adverse effects analgesic drugs potential duplication analgesic therapy among elderly great due prevalent painful chronic conditions variety prescription nonprescription analgesic remedies available prevalence multiple analgesic product use patterns concurrent use different analgesic categories investigated geographically defined population persons years age older demographic characteristics users multiple analgesic drug products examined smoking status alcohol use lifetime history rates major illnesses physical functioning pain experiences memory performance depressive symptoms substantial proportion analgesic users reported taking multiple products preceding weeks female male analgesic users men reported pain preceding year likely use multiple analgesic products women experienced pain limited physical functioning higher depressive symptom scores life time history ulcers likely use multiple analgesic products thus although users multiple analgesic products reported significant pain several factors shown related phenomenon multiple use,C10,0.0018663137,0.010682129,0.0034805215,0.0010480556,0.0025974198,0.002407312,0.37191272,0.0017541836,0.010369074,0.0018328012,0.06622641,0.012866871,0.029358512,0.004372,0.01969963,0.0029047146,0.04369073,0.0019209858,0.0021239582,0.28501335,0.12129099,0.00066231267,0.0019189878
feasibility safety vagal stimulation monkey model feasibility safety preliminary effects chronic vagal stimulation studied aluminagel monkey model pilot studies perfect equipment determine stimulation thresholds insure comfort safety animals preceded study four monkeys equipped indwelling electrode cuff titanium bands spaced mm apart silicone encased cm total length contact around right vagus nerve avoidance cardiac branch confirmed electrocardiograms postsurgical recovery intact awake animals received constant current stimulation hz hz hz randomly ms pulse width onset every spontaneous seizure duration seizure every h stimulation occurred preceding hour stimulation periods weeks differing levels stimulation preceded followed least week baseline period stimulation stimulation periods seizure rate decreased zero two monkeys interseizure intervals became invariable remaining two monkeys effects carried temporarily poststimulation baseline periods vagal stimulation consistent effects seizure severity eeg interictal spikes histological studies six vagus nerves unable separate electrode cuff damage direct effects stimulation may nerves although appears chronic vagal stimulation feasible epileptogenic processes influenced safety efficacy procedure still question,C10,0.016163824,0.032239877,0.029882805,0.0011756129,0.002913548,0.012760058,0.17191006,0.012093834,0.0015126846,0.012884981,0.010303133,0.019588185,0.11284967,0.005392792,0.011960474,0.013384641,0.08287392,0.013145544,0.0125018135,0.03591581,0.38565126,0.0007429217,0.002152545
ubiquitin immunoreactivity kuru plaques creutzfeldt jakob disease cerebellar kuru plaques cases creutzfeldt jakob disease studied immunohistochemically similar cerebellar senile plaques alzheimer disease many kuru plaques contained ubiquitin positive tau negative small granular elements presumably representing dystrophic neurites results suggest similar mechanisms involved neuritic changes cerebellar plaques creutzfeldt jakob alzheimer diseases despite differences amyloid proteins plaques,C10,0.0048322435,0.004286441,0.009016464,0.0027150405,0.006728746,0.0062362617,0.37603632,0.0045443,0.02686054,0.004747963,0.08525982,0.010253379,0.060072195,0.01204624,0.004249353,0.007524808,0.15084746,0.028369378,0.00550222,0.068706214,0.11439827,0.001715754,0.005050582
embolic stroke smoking crack cocaine year old woman embolic upper division middle cerebral artery branch occlusion hours smoking free base cocaine crack radionuclide ventriculography demonstrated cardiomyopathy echocardiography documented left atrial thrombus case demonstrates embolism one mechanism ischemic stroke cocaine use cardiomyopathy possibly cocaine induced may source embolus cardiac source embolus sought patients cocaine associated cerebral infarction,C10,0.116363235,0.004095286,0.008614373,0.0025939625,0.006431264,0.005958154,0.18466638,0.02681534,0.0033377034,0.004536226,0.1042168,0.009495769,0.033339553,0.0107197445,0.0040598516,0.007189237,0.1809459,0.004754485,0.02758909,0.10813807,0.13975081,0.0016392395,0.0047495402
limited selective posterior rhizotomy treatment spasticity secondary infantile cerebral palsy preliminary report limited selective posterior rhizotomy performed children suffering spasticity secondary infantile cerebral palsy opposed standard techniques stimulate divide dorsal rootlets l dissected l l dorsal roots l laminectomy eight rootlets root electrically stimulated two unipolar electrodes pulse width microseconds v muscle responses observed visually registered electromyography rootlets associated abnormal motor response evidenced sustained muscular contraction prolonged electromyographic response divided spasticity scored muscular groups assessed involved flexion shoulder elbow wrist upper limbs involved flexion adduction hip flexion leg plantar flexion lower limbs patients assessed week months operation reduction spasticity observed muscular groups patients presented functional improvement motor abilities preliminary results indicate limited procedure reduces extension laminectomy length operation could effective treating spasticity secondary infantile cerebral palsy,C10,0.027775308,0.0022978021,0.017356351,0.0014554326,0.0036070314,0.003343029,0.20532922,0.0024368207,0.05202912,0.015085424,0.033060223,0.06791422,0.051205106,0.0062229848,0.0022779207,0.004033771,0.1908159,0.0026676687,0.0029495363,0.03365204,0.2709005,0.0009197522,0.0026648943
putative neuroexcitation cerebral ischemia brain injury involvement neuroexcitatory mechanisms cerebral ischemia brain injury explored experimental models repetitive forebrain ischemia temporary occlusion carotid arteries gerbils cryogenic injury cerebral cortex rats gerbils observations models revealed pattern injury involved anatomic structures outside areas direct ischemic traumatic insult foci injury revealed conspicuously abnormal uptake ca associated slight moderate neuronal alteration whereas severely injured areas showed ca uptake electron microscopic observations revealed characteristic presence calcium swollen dendrites closely resembling pictures obtained neuroexcitatory conditions epileptic seizures abnormal uptake ca associated apparent blood brain barrier changes characterized intracytoplasmic uptake extravasated albumin neurons protein synthesis assayed vivo h leucine incorporation reduced regions showing calcium accumulation observations suggest neuroexcitation may play important role development secondary chronic changes ischemic traumatic brain insults,C10,0.12364487,0.011976018,0.003905684,0.0011755909,0.0029400396,0.033071216,0.23975775,0.0019689903,0.0015126565,0.0020558303,0.029458107,0.0143554965,0.037847094,0.08940339,0.0018399361,0.044438854,0.044761572,0.025756067,0.0023824174,0.061443746,0.20980859,0.00074290787,0.015753185
serious migraine study epidemiological aspects data scant concerning epidemiological aspects severe headaches cause serious personal economic morbidity purpose study incidence epidemiological features patients suffering severe migraine exacerbations unselected population patients suffered severe migraine bouts represented new walk neurological consultations area covered study patients years old although females clearly predominated ages fifteen age slight male predominance calculated incidence serious migraine exacerbations per people per year corrected incidence females males highest incidence females year olds males year olds data seem confirm periodic nature condition since patients migraine bouts ie groups attacks lasted two nine months also support reported existence genetic hormonal factors susceptibility migraine exacerbations results may help planning public health aspect migraine add light natural history common condition,C10,0.0022082997,0.001954804,0.014759187,0.011900905,0.0030686015,0.053518903,0.17639886,0.002072399,0.0015931869,0.013035373,0.011205741,0.025858765,0.025202258,0.0051837075,0.0019378902,0.035429943,0.10254422,0.002272421,0.072004884,0.34630376,0.08848864,0.00078245864,0.002274788
dementia depression grief differential diagnosis depression grief dementia conditions frequently encountered among community living elderly review offers primary care perspective distinguishing features discusses special issues managing elderly major depression elderly usually responds antidepressant medication whether depression occurs alone endogenous response another condition reactive,C10,0.026364433,0.004005301,0.00842509,0.0025369655,0.006287419,0.09326263,0.35871407,0.0042462475,0.0032643643,0.026289927,0.042603992,0.009287119,0.028364494,0.01038208,0.003970645,0.050741047,0.05680724,0.0046500154,0.026991637,0.15064807,0.07590879,0.0016032207,0.004645179
facial bone fracture associated carotid cavernous sinus fistula cases facial bone fracture ten patients carotid cavernous sinus fistulas ages ranged years seven male three female two ten patients lower third three patients middle third three patients upper third two patients combined middle lower third facial bone fractures signs symptoms fistula appeared first postinjury day days injury mean days four patients symptoms operation facial bone fracture fistulae identified arteriography treatment followup ranged year months years months mean years months one patient malocclusion nine patients complete resolution bruits complications included unilateral complete visual loss two csf rhinorrhea two stroke one two csf rhinorrhea patients one patient expired due severe head injury one death unrelated cause,C10,0.04919645,0.0023874363,0.018040137,0.001512207,0.0037477368,0.010097407,0.11883599,0.0025312023,0.001945787,0.0026606927,0.16540796,0.0055357656,0.024282256,0.0061884383,0.0023667791,0.0041911225,0.3748958,0.0027717308,0.0030645935,0.1320017,0.06461429,0.00095563044,0.002768848
transient hyperprolactinemia associated midcycle luteinizing hormone surge study demonstrates lh surge cycles ivf patients associated significantly higher serum prl concentrations cycles spontaneous lh surge occur findings support hypothesis concomitant lh prl release time midcycle gonadotropin surge well estrogen sensitization pituitary lactotropes suggest possible mechanism transient midcycle hyperprolactinemia,C10,0.0051965886,0.0046096332,0.060000625,0.002919751,0.007237046,0.006706468,0.36393273,0.0048869345,0.0037569022,0.005105953,0.024335627,0.010688897,0.05770011,0.0120037,0.004569749,0.008092169,0.0755019,0.0053516245,0.00591708,0.052382555,0.27191275,0.0018451198,0.0053460584
lateralized effects subclinical epileptiform eeg discharges scholastic performance children interaction lateralization subclinical epileptiform discharges cognitive tasks investigated children girls boys mean age years seventeen diagnosis epilepsy partial secondarily generalized testing reading arithmetic intelligence subtests continuous telemetric eeg video monitoring children left sided discharges significantly lower reading performance children right sided discharges reading epileptiform discharges occurred relatively less frequently shorter total duration left hemisphere right supports view cognitive tasks suppress epileptiform discharges activate region brain within epileptogenic zone discharges epileptogenic zones directly activated tasks increased however,C10,0.021642026,0.0032868339,0.04843551,0.002081887,0.005159588,0.004781952,0.16296798,0.057298213,0.002678806,0.1112707,0.064766124,0.007623912,0.09523589,0.009387813,0.0032585503,0.023704546,0.057931762,0.05762584,0.0042190906,0.13614717,0.115295835,0.0013156366,0.0038843427
racial differences anterior circulation cerebrovascular disease much explained risk factors entry characteristics patients enrolled extracranial intracranial bypass study examined determine site differences intracranial extracranial arterial lesions among racial groups could explained differences risk factors blacks often hypertensive diabetic cigarette smokers whites higher systolic blood pressure hemoglobin values orientals lowest prevalence vascular risk factors despite differences risk factors multivariate analysis showed race independent strong predictor location cerebrovascular lesions knowledge study unique documenting risk factors prospectively systematically three racial groups simultaneously although generalization limited possible biases related patient selection results affirm previous tentative conclusions role race determining location cerebrovascular disease,C10,0.012707634,0.0023877611,0.00502262,0.0015124127,0.029810477,0.0034739084,0.26265422,0.00258816,0.014975276,0.0026448518,0.052867938,0.033113163,0.1448663,0.006415365,0.0023671011,0.017463526,0.09833367,0.0027783676,0.0030676546,0.21586047,0.068359725,0.013960182,0.0027692248
molecular biology atherothrombotic brain infarction reduced high density lipoproteins may contribute atherothrombotic brain infarction performed molecular biologic metabolic studies characterize high density lipoprotein metabolism respect role reverse cholesterol transport clone high density lipoprotein receptor determine gene polymorphism apolipoprotein major protein high density lipoprotein altered structure may impair reverse cholesterol transport high density lipoprotein metabolism measurements high density lipoprotein isolated purified labeled iodine radiolabeled high density lipoprotein reinjected daily blood samples taken days synthesis rates fractional catabolic rates determined specific activities daily decrements preliminary data indicate stroke prone individuals fractional catabolic rates high density lipoprotein twice normal individuals also conversion high density lipoprotein high density lipoprotein reduced individuals suggesting high density lipoprotein may abnormally processed individuals prone atherothrombic brain infarctions surveyed patients carotid stenosis using kb probe apolipoprotein gene subset patients displays polymorphism restriction enzymes saci psti preliminary findings suggest gene polymorphism apolipoprotein may provide molecular clue atherothrombic brain infarction,C10,0.038003396,0.0016399983,0.003449712,0.0010387782,0.020464951,0.0023860023,0.2215945,0.0017386555,0.0013366167,0.0018165772,0.032272637,0.0038026755,0.05689448,0.041793097,0.07321835,0.002879002,0.051858258,0.0435748,0.019995483,0.118734054,0.1734761,0.0006564499,0.08737543
effect flumazenil midazolam induced amnesia studied effect v flumazenil mg kg amnesia sedation caused midazolam mg mg v volunteers order determine relationship actions antagonist two effects midazolam caused dose dependent central neural depression assessed critical flicker fusion frequency dose dependent amnesia word cards subjects given flumazenil min administration midazolam fusion frequency readings memory restored levels comparable midazolam administration two effects flumazenil similar time course extent suggesting share mechanism action flumazenil given alone effect memory study demonstrated anterograde amnesia following benzodiazepine administration antagonism flumazenil neither retrograde amnesia retrograde antagonism amnesia,C10,0.017551713,0.002666406,0.005608746,0.001688907,0.004185933,0.01842698,0.15987313,0.002826809,0.0021731504,0.0029534986,0.028798267,0.021974305,0.08582961,0.0069237407,0.0026433354,0.019665735,0.070800856,0.0030956052,0.0034226887,0.05301883,0.46718013,0.001067295,0.017624324
patellar resurfacing total knee arthroplasty technical errors patellar resurfacing time total knee arthroplasty tka responsible many complications affect patellofemoral joint instability patellar fracture wear metal backed patellar implants significantly affected errors patellar resurfacing review tkas using condylar prosthesis standardized technique patellar resurfacing performed evaluate accuracy technique patients evaluated mean years range two five years surgery hospital special surgery knee score improved preoperative mean last evaluation hospital special surgery knee scores excellent good knee society knee score improved preoperative mean pain function last evaluation mean pain function none patients symptoms referable patellofemoral joint patellar fractures dislocations instances implant loosening patella roentgenograms revealed nine asymmetrically resurfaced patellae five tilted patellae patellar subluxations patellar thickness maintained preoperative level mm joint line height elevated mm patellar height decreased mm preoperative height using standard technique satisfactory clinical results achieved minor errors resurfacing alignment still occur,C10,0.002135373,0.0018941824,0.0039843842,0.001199779,0.024556736,0.0027896282,0.16960919,0.0020081305,0.0015437796,0.03997742,0.054600555,0.03436226,0.061184883,0.02557937,0.0018779174,0.013647308,0.33193877,0.002202028,0.012743293,0.04656051,0.13163836,0.031769373,0.002196793
neurodevelopmental outcome children evidence periventricular leukomalacia late mri fifteen children months age older neonatal follow program underwent magnetic resonance imaging neurologic cognitive language evaluations magnetic resonance imaging findings children included increased white matter signal weighted images ventricular enlargement adjacent regions abnormal white matter extent degree abnormal white matter signal degree sulcal prominence variable twelve children cerebral palsy children cerebral palsy manifested significant sensory impairments median score cognitive testing children exhibited severe profound cognitive disability cognitive scores stable retesting degree motor disability correlated extent white matter signal abnormality however cognitive outcome related extent degree white matter signal abnormality degree sulcal prominence despite association major handicapping condition periventricular leukomalacia cognitive language functioning may relatively spared,C10,0.002447251,0.0021624004,0.016634686,0.0013696688,0.07420164,0.01493598,0.23341967,0.0022924836,0.0017623801,0.085007064,0.12361555,0.026113173,0.10967194,0.0059518544,0.0021436904,0.03919609,0.0927468,0.014305684,0.010419806,0.09485136,0.043357905,0.0008655542,0.0025273361
continuous removal middle molecules hemofiltration patients acute liver failure patients acute liver failure hepatic coma increase abnormal middle molecules seen chromatograms sera suspected playing etiologic role coma pilot study continuous hemofiltration using high performance membrane conducted patients attempt decrease serum levels middle molecules procedure used alternately plasma exchange high performance liquid chromatography showed notable removal substances filtrates sequential removal serum hemofiltration eight patients amelioration level consciousness weaned successfully hemofiltration although three patients survived acute illness others lived average days five patients survived greater wk continuous removal middle molecules serum may reverse liver failure procedure used conjunction plasma exchange may provide means life support e g patients awaiting liver transplant,C10,0.013867236,0.044235133,0.01724758,0.0130101275,0.0033552344,0.019327966,0.19901475,0.0022659784,0.0017420037,0.014026347,0.013820937,0.0049570594,0.020178761,0.005577508,0.0021189053,0.061346915,0.216718,0.0024814461,0.0027436372,0.048173644,0.25547358,0.0008555468,0.037461687
woolley roe case reassessment two patients cecil roe albert woolley sued anaesthetist alleged negligence developed painful spastic paraparesis spinal anaesthesia court found phenol used sterilise outside ampoules local anaesthetic percolated glass invisible cracks contaminating solution anaesthetist could aware risk case important despite fact judgement favour anaesthetist fears generated incidence paralysis spinal anaesthesia invisible crack theory subject much scepticism new information obtained case examined objectively probable source contamination led paralysis two patients third received spinal anaesthesia day identified similar explanation may lie behind number episodes paralysis associated spinal anaesthesia,C10,0.0041523045,0.0036833014,0.0077477694,0.0023330105,0.0057819528,0.0053587654,0.27719143,0.0039048775,0.0030019314,0.004079883,0.1447247,0.064492814,0.027378064,0.01035432,0.0036514318,0.026551679,0.1095676,0.0042761853,0.0047280095,0.17397474,0.107319154,0.0014743324,0.0042717378
structure expression function schwannoma derived growth factor development nervous system cells require growth factors regulate division survival identify new growth factors serum free growth conditioned media many clonal cell lines screened presence mitogens central nervous system glial cells cell line secreting potent glial mitogen established tumour schwannoma derived sheath sciatic nerve cells tumour named js cells adapted clonal culture identified schwann cells schwann cells secrete autocrine mitogen human schwannoma extracts mitogenic activity glial cells neither mitogen purified report purification characterization mitogenic molecule designated schwannoma derived growth factor sdgf growth conditioned medium js schwann cell line sdgf belongs epidermal growth factor family autocrine growth factor well mitogen astrocytes schwann cells fibroblasts,C10,0.002801184,0.00248479,0.005226719,0.0015738711,0.00390922,0.003615074,0.28524375,0.0309066,0.0020251314,0.002752328,0.053996153,0.0057615004,0.019087086,0.31643504,0.0024632907,0.004362026,0.04050617,0.02440919,0.043862432,0.019171806,0.06077376,0.0009945987,0.067638345
replication patterns fragile x heterozygous carriers analysis brdurd antibody method replication status fragile x chromosomes studied short term cultures lymphocytes six female heterozygous carriers fragile x induced adding microm fluorodeoxyuridine last h culturing replication status x chromosomes studied using bromodeoxyuridine brdurd antibody method brdurd added final concentration micrograms ml early phase chromosome replication h harvest microgram ml late phase last h culturing micrograms ml early phase micrograms ml late phase brdurd incorporated replicating chromosomes detected using nuclease brdurd monoclonal antibody frequency fragile x reduced brdurd treatment degree reduction severe micrograms ml microgram ml series severe late early treatment early late replicating fragile x chromosomes actively replicating brdurd treatment reduced others thus average rate early late treatment microgram brdurd ml assumed closest reflection situation vivo correlation average rate early replicating active fragile x intelligence heterozygous carriers studied,C10,0.0020994467,0.0018557919,0.0039100493,0.01129481,0.043415446,0.025019307,0.19591416,0.0019674306,0.0015124909,0.0020556054,0.05104112,0.0043030377,0.066346996,0.056867726,0.0018397347,0.05389576,0.09748544,0.0022788516,0.002382157,0.1021582,0.18208952,0.0007428266,0.089524105
antinociception cardiovascular responses produced electrical stimulation nucleus tractus solitarius nucleus reticularis ventralis caudal medulla experiment quantitative regional comparisons antinociceptive cardiovascular responses produced electrical stimulation caudal medulla including regions nucleus tractus solitarius nts nucleus reticularis ventralis nrv nucleus reticularis gigantocellularis nrgc nucleus reticularis paragigantocellularis nrpgc nucleus raphe obscurus nro medial portions lateral reticular nucleus lrn made rat electrical stimulation regions resulted inhibition nociceptive tail flick reflex although threshold intensity inhibition greater sites nts compared many sites ventral nts antinociception generally accompanied increase mean arterial blood pressure exception sites nro depressor responses evoked stimulation detailed comparisons nts nrv revealed greater intensities electrical stimulation required produce antinociception sites nts compared nrv significant differences threshold intensities antinociception function rostrocaudal subdivisions nts lateral subdivision nts significantly efficacious medial subdivision mediolateral difference within nts primarily due stimulation medial sites producing overt movements animals probably due stimulation adjacent midline nuclei pathways within nrv thresholds inhibition tail flick reflex greater sites dorsal subdivision compared ventral subdivision contains spinopetal projections nrm slopes lines recruitment inhibition tail flick reflex stimulation sites either nts nrv steep similar forms antinociception experiment pulse duration electrical stimulation varied sites stimulation lateral nts nrv generate strength duration curves experiment confirmed stimulation sites lateral nts required greater current intensities inhibit tail flick reflex sites nrv however chronaxies derived strength duration functions nts nrv approximately microseconds indicating antinociceptive effects regions may exclusively due stimulation fibers passage results discussed terms role nts nrv caudal medulla modulation nociceptive responses cardiovascular function,C10,0.0015663577,0.0013600098,0.0028607603,0.008269329,0.0021414042,0.0019786523,0.23835202,0.031625114,0.001108423,0.01634243,0.017330445,0.003595153,0.16477622,0.06787138,0.031033844,0.009806732,0.023744088,0.0016470139,0.0017457543,0.024438864,0.34624305,0.00054437754,0.0016185808
quantitative assessment extradural bupivacaine analgesia bupivacaine ml administered extradurally six healthy volunteers found simultaneous application needles skin could evoke pain analgesia obtained one needle stimulation addition laser beam used quantitative technique activate simultaneously many cutaneous nociceptors h thresholds sensory pain pain evoked brain potentials amplitude latency laser stimulation monitored used quantitative assessment onset efficacy duration analgesia various dermatomes c l l onset time analgesia shortest conduction delay longest dermatome related site injection l full analgesia obtained l l although peak efficacy delayed min injection minor effect found dermatome c approximately min injection,C10,0.017053833,0.0025900775,0.034405187,0.0016405603,0.018200155,0.0037682548,0.28414622,0.0027458887,0.0021109418,0.05941013,0.046306673,0.052422483,0.14814915,0.035951026,0.002567667,0.019146955,0.067714795,0.017872404,0.0033247108,0.054106567,0.12232518,0.0010367426,0.003004401
disturbance daily sleep wake patterns patients cognitive impairment decreased daily activity sleep wake patterns chronically ill mentally physically handicapped patients visually monitored hourly consecutive days four types sleep wake patterns found order investigate cognitive physical functions correlated sleep disorders patients classified based scale mental function grading daily activity percent total sleep hours sleep rating showing disturbances sleep wake pattern evaluated found high degree individuality sleep wake patterns sleep disturbance associated daily activity well cognitive impairment monitoring system provides medical personnel valuable information clinical management,C10,0.0028018532,0.0024853835,0.005257083,0.0015743047,0.0039014919,0.0036159377,0.34149122,0.0026348967,0.0020256152,0.0027529853,0.04024498,0.019316956,0.063090436,0.0067595956,0.002463973,0.0043630684,0.14955224,0.0028854443,0.01651766,0.04964985,0.2727377,0.0009948363,0.0028824434
phenotypic heterogeneity spinal muscular atrophy mapping chromosome q sma q made phenotypic analysis families spinal muscular atrophy sma linking chromosome q sma q may map locus assess clinical symptoms among sma families known result mutation identical gene locus although current number families still small correlation clinical phenotype molecular genotype supports observations first sma mutations q locus present broad continuum clinical abnormalities nd single clearly unlinked family presents unusual phenotype characterized relatively late onset early death thus yet unambiguous cases typical sma families clearly unlinked locus q ie clear cases nonallelic heterogeneity analysis sma q families supports view certain exceptions little phenotypic intrafamilial variability families ranked severity disease strong correlation age onset onset within st months associated early death cases rare exception onset year age associated less severe disease greater longevity,C10,0.0019207618,0.0017008329,0.0035776766,0.001077311,0.011940835,0.021031845,0.28889912,0.020362193,0.019941894,0.06454993,0.047150403,0.003943733,0.071716525,0.0754327,0.0016861164,0.031532448,0.04800603,0.0019757145,0.0021832462,0.08426219,0.067233846,0.01923736,0.11063729
spatial dispersion magnetic stimulation peripheral nerves assess longitudinal dispersion stimulus induced magnetic coil collision experiments performed seven normal ulnar nerves supramaximal electrical stimulus delivered wrist followed supramaximal stimulus upper arm either electrical electrical collision studies magnetic magnetic collision studies interstimulus interval varied msec increments time complete cancellation evoked motor response onwards include entire span recovery compound motor action potential collision curves obtained magnetic electrical stimuli plotting amplitude motor response elicited function interstimulus interval seven normal ulnar nerves comparison collision curves showed evoked motor response restored significantly slowly magnetic stimulation used finding best explained longitudinal dispersion stimulus induced magnetic coil relative conventional electrical stimulation large fibers stimulated away coil small ones interpretation confirmed findings obtained method two cases ulnar neuropathy comparison different intensities magnetic stimulation,C10,0.00246683,0.0021882013,0.016542394,0.0013860111,0.0034361763,0.0031835726,0.12662947,0.0023200423,0.0017834082,0.0024238052,0.10005557,0.033958286,0.19184996,0.053964257,0.026021222,0.003841367,0.05959039,0.00255595,0.0028088486,0.046394717,0.31318587,0.00087588164,0.0025377837
brainstem auditory evoked response subcortical abnormalities autism previous studies neurobiology autism used brainstem auditory evoked response given contradictory results authors study considered two supplementary aspects added ipsilateral masking procedure compared results every subject values corrected age sex large number normal children twenty autistic according dsm iii r criteria mentally retarded nonverbal iq less subjects assessed eighty percent autistic subjects abnormal interpeak latencies compared mentally retarded subjects v iii v prolonged interpeak latency values seen autistic subjects ipsilateral masking procedure doubled rate detection higher brainstem abnormalities autistic children,C10,0.0031419669,0.0027870813,0.021019567,0.001765343,0.0043765507,0.004054872,0.18664193,0.0029547436,0.002271502,0.03350899,0.072950475,0.0065907356,0.23261583,0.041811634,0.0028024702,0.0048926957,0.13685736,0.0032367334,0.018774599,0.08768191,0.12491512,0.0011155983,0.0032323396
routine quantitative eeg analysis gilles de la tourette syndrome gilles de la tourette syndrome gdlt neurobehavioral disorder reportedly high frequency eeg abnormalities performed eegs consecutive patients gdlt frequency analysis patients males compared results age sex matched normal controls routine channel eeg revealed minimal diffuse nonspecific slowing patients controls frequency analysis eeg gdlt patients normal controls showed similar brain activity conclude significant differences exist eeg activity gdlt patients compared sex age matched controls routine well quantitative eeg,C10,0.017809339,0.0027048073,0.020396197,0.0017132305,0.004265165,0.003935173,0.24589747,0.0028675203,0.002204448,0.0029960345,0.06818332,0.007640559,0.15042557,0.026237763,0.0027501434,0.0047536367,0.14511232,0.003147342,0.0034719817,0.13837828,0.1408664,0.0010826661,0.0031606236
randomized comparison manipulation fractured nose local general anaesthesia reduction simple nasal fractures may performed local general anaesthesia latter far popular method britain though hard define attempted compare approaches means randomized prospective trial fifty consecutive adult patients radiologically proved fractures nasal bones randomized local general anaesthesia group underwent manipulation asch walsham forceps days post injury analysis results h weeks post operatively showed significant benefit conferred fracture reduction general anaesthesia opposed local anaesthesia respect post operative airway patency cosmesis suggested significant benefits obtained terms patient convenience cost effectiveness nasal fractures reduced local anaesthesia outpatient procedure,C10,0.01717293,0.0026043826,0.005448234,0.0016405736,0.004065871,0.032020543,0.16530666,0.002745911,0.002110959,0.0028689748,0.09689277,0.11786555,0.11207662,0.006713756,0.0025676878,0.004546894,0.13215399,0.0454073,0.04702629,0.07060319,0.124111496,0.001036751,0.003012622
influence warning signal timing cognitive preparation aversiveness electric shock many medical dental procedures noxious finding optimal way warning patients concerning aversive procedures could help cope better model effective use warning signal coping pain posited person needs enough time able react possess skills necessary utilize time effectively felt short warning period e g sec could long enough sec warning period would become aversive reactions electric shock obtained paid volunteer subjects tested within subject counterbalanced order different warning periods sec subjects divided groups experimental group provided pretested self instructional booklet learn variety pain control techniques placebo group provided self instructional booklet citizenship control group waited quietly min significant results obtained different pain coping conditions significant differences however obtained various warning periods maximum skin resistance changes higher ratings pain anxiety obtained compared sec warning periods maximum heart rate obtained sec warning results discussed terms psychological meaning various measures well clinical implications,C10,0.0019534647,0.0017328208,0.0036449626,0.010550499,0.012175765,0.01555709,0.22739227,0.001837062,0.001412268,0.001923784,0.08522311,0.05811151,0.19070847,0.004825214,0.0017178276,0.0030454504,0.12819646,0.0020117448,0.026951022,0.11287731,0.10544864,0.00069360435,0.0020096526
epilepsies clinical implications international classification earliest days neurology classification epileptic seizures generalized beginning definable localization cortex onset added knowledge function nervous system elaboration classification seizures localized six layered isocortex whose elaboration involves regions brain involved consciousness memory provided basic focus burgeoning subspecialty epilepsy surgery increasingly apparent etiology seizure disorder least equal greater significance nature seizures spawns product localization nervous system also causative factors implications reaching areas genetics higher cortical function intelligence prognosis concerning outcome epilepsy consideration based facets pathophysiological substratum seizure presenting symptom constitutes epilepsy epileptic syndrome formulation rational treatment plan based,C10,0.018639738,0.0028309105,0.0059547783,0.0017931045,0.0044438913,0.019563088,0.3385454,0.0030012096,0.0023072234,0.03623777,0.03679417,0.02200024,0.026379108,0.0094221905,0.049151547,0.020220261,0.09503197,0.0032865892,0.0036391513,0.15490831,0.112386174,0.001133142,0.032330036
delirium masquerades misdiagnosis elderly inpatients delirium organic mental disorder defined transient fluctuating global dysfunction cognition common elderly medical inpatients yet varied presentation often missed misdiagnosed,C10,0.007722019,0.006849816,0.014408487,0.0043386878,0.010752667,0.0099656675,0.3689703,0.00726188,0.0055826763,0.0075873374,0.03606447,0.015882717,0.08056006,0.017755307,0.0067905486,0.01202479,0.074330464,0.0079524,0.008792655,0.15673406,0.12898709,0.0027418083,0.0079441285
infarction territory medial branch posterior inferior cerebellar artery report cases cerebellar infarction territory medial branch posterior inferior cerebellar artery mpica axial sections mri middle medulla cerebellum showed infarction triangular area dorsal base ventral apex directed towards fourth ventricle infarct also involved lateral dorsal medulla mpica supplied part regions three clinical patterns observed pseudolabyrinthine signs without dysmetria ataxia medulla spared marked axial lateropulsion present cases complete incomplete wallenberg syndrome medulla involved silent infarction syndromes precisely previously attributed pica occlusion without distinction branch involved alteration consciousness recorded spontaneous recovery rule cerebellar infarction distribution mpica regarded benign condition good prognosis,C10,0.15672667,0.0031192764,0.02355507,0.001975756,0.0048965607,0.004538176,0.31552935,0.037351098,0.0025422447,0.020473434,0.06811797,0.007232688,0.022250602,0.008123588,0.003092287,0.005491313,0.07257047,0.0036451565,0.004004008,0.0659388,0.16390115,0.0012485675,0.0036757432
case control study alzheimer disease australia conducted case control study clinically diagnosed alzheimer disease ad cases aged years controls matched age sex possible general practice origin trained lay interviewers naive hypotheses clinical status elderly person carried risk factor interviews informants significant odds ratios found variables history either dementia probable ad syndrome st degree relative underactivity behavioral trait recent distant past previously reported suggested associations confirmed study include head injury starvation thyroid disease analgesic abuse antacid use aluminum exposure alcohol abuse smoking left handed,C10,0.034079947,0.002830168,0.030317634,0.0017926341,0.0044427253,0.004117558,0.2224242,0.0030004221,0.0023066183,0.0031424093,0.09031881,0.028922582,0.10874166,0.007907892,0.031078441,0.004968334,0.031321734,0.0032965245,0.019075347,0.26150435,0.09999486,0.0011328447,0.0032823097
auras subclinical seizures characteristics prognostic significance characteristics prognostic significance subclinical seizures independent auras studied patients partial epilepsy long term electroencephalographic eeg monitoring intracranial electrodes focal restricted subclinical seizures noted patients patients experienced auras accompanied ictal eeg discharges auras subclinical seizures usually identical eeg appearance distributed differently among patients subclinical seizures auras usually origin complex partial seizures always reliably indicate complex partial seizure origin subclinical seizures auras favorable prognostic significance patients undergoing temporal lobectomy majority greater individuals subclinical seizures auras free complex partial seizures surgery whereas minority patients without subclinical seizures auras became free complex partial seizures,C10,0.0035163697,0.0031191956,0.03278788,0.0019757047,0.0048964336,0.0045380583,0.32564417,0.020323006,0.0025421788,0.0034550398,0.033290897,0.0072325007,0.023961691,0.008717249,0.0030922068,0.0054844194,0.22285737,0.0036212779,0.0040039043,0.14409176,0.13598263,0.0012485351,0.0036175116
primary fibromyalgia exist twenty one consecutive primary fibromyalgia fibrositis patients identified year period tertiary care day ward pain syndromes examined fifteen fulfilled criteria fibromyalgia unexpectedly cases either psychiatric disturbance thyroid dysfunction four patients seen follow two developed neurological diseases another rheumatoid arthritis one hypothyroidism thus years patient fulfilled criteria primary fibromyalgia women occupied manual workers represented patients reported beneficial effects physiotherapy none patients able return full time work,C10,0.0037053148,0.0032867992,0.006913733,0.020014303,0.0051595336,0.004781902,0.22932336,0.003484523,0.0026787776,0.0036406894,0.10353377,0.04348187,0.027084269,0.008542948,0.02117667,0.0057699457,0.2999616,0.00381586,0.004219046,0.09888354,0.09541404,0.0013156227,0.0038118912
review techniques employed estimate number motor units muscle smallest functional units neural control motor units play integral role muscle physiology however present time exist widely accepted technique quantifying estimating number motor units muscle specifically existing techniques increment counting technique technique based spike triggered averaging macro emg based technique vary invasiveness noninvasive highly invasive respectively discuss techniques along associated shortcomings detail,C10,0.003577165,0.003173124,0.023986712,0.0020098633,0.004981089,0.004616518,0.2953978,0.0033640093,0.054539565,0.0035147748,0.2548386,0.007598072,0.042072732,0.00955012,0.0031456687,0.02287073,0.05148101,0.003683887,0.0040731286,0.07644599,0.12012708,0.0012701213,0.0036822862
physical features prader willi syndrome neonates retrospective study patients undertaken identify physical features may typify neonates prader willi syndrome several features known typical prader willi syndrome early infancy confirmed including hypotonia genital hypoplasia number features previously emphasized characterizing prader willi syndrome also identified notably abnormal cry males signs genital hypoplasia apparently normal phallus features included disproportionately large head circumference disproportionately large anterior fontanelle mild micrognathia mild anomalies gingivae alveolar ridges changes appearance skin appreciation features may assist pediatrician recognizing child prader willi syndrome neonatal period appearance better known findings later onset obesity acromicria,C10,0.027288588,0.0022697367,0.0047743577,0.0014376559,0.015981873,0.028016133,0.3647992,0.05193861,0.0018498607,0.039674405,0.014499351,0.005262855,0.07098655,0.020281157,0.0022500982,0.016332077,0.07656627,0.002652954,0.0029135107,0.19031273,0.056360744,0.0009085183,0.0026427705
excitatory amino acids developing brain ontogeny plasticity excitotoxicity besides role neurotransmitters excitatory amino acids eaas developing brain crucially involved plasticity excitotoxicity modified distinct ontogeny along incomplete neuritogenesis synaptogenesis presynaptic markers eaa system immature developing brain however postsynaptic eaa system activities particularly n methyl aspartate quisqualate receptors transiently enhanced early life transient enhancement presumably beneficial immature brain physiologic activation eaa system plays critical role plasticity early learning morphogenesis time transient hypersensitivity renders immature brain vulnerable pathologic excitation eaa system excitotoxicity observed neonatal hypoxia ischemia,C10,0.09340217,0.0032870092,0.006914175,0.0020822405,0.0051598633,0.0047822073,0.43006638,0.0034847457,0.020591274,0.003640922,0.017041419,0.0076216115,0.026543308,0.0089454595,0.0032585687,0.0057703145,0.056343637,0.07153844,0.0042193155,0.10023844,0.11994066,0.0013157068,0.003812135
characterization descending inhibition facilitation nuclei reticularis gigantocellularis gigantocellularis pars alpha rat descending influences spinal nociceptive tail flick tf reflex produced focal electrical stimulation glutamate microinjection nuclei reticularis gigantocellularis ngc gigantocellularis pars alpha ngc alpha examined characterized rats lightly anesthetized pentobarbital inhibition facilitation tf reflex produced electrical stimulation identical sites ngc ngc alpha glutamate microinjection inhibited tf reflex chronaxie stimulation inhibition tf reflex microseconds inhibition tf reflex stimulation produced throughout ngc ngc alpha intensities stimulation inhibition least ventral ngc ngc alpha threshold intensities stimulation inhibition tf reflex outlast period stimulation facilitation tf reflex produced many sites stimulation inhibited tf reflex always lesser intensities stimulation mean microa vs microa inhibition n stimulation ngc ngc alpha threshold intensities facilitation inhibition tf reflex significantly affect blood pressure strength duration characterization electrical stimulation microinjection glutamate identical sites ngc ngc alpha suggest descending inhibition tf reflex results activation cell bodies ngc ngc alpha,C10,0.0026568573,0.0023567649,0.00495742,0.0014927797,0.0036995895,0.0034288126,0.12680872,0.0024985406,0.0019207895,0.015462622,0.012218788,0.005464713,0.11558414,0.04620809,0.04032307,0.004137279,0.026961058,0.06223536,0.0030252228,0.034570474,0.36920372,0.00094335346,0.11384182
safety stability effectiveness immunoadsorption membrane plasmapheresis treatment myasthenia gravis nine patients five women four men average age years refractory myasthenia gravis mg underwent thymectomy treated immunoadsorption membrane plasmaphersis iap thymic histology showed hyperplasia nine patients immunoadsorption column asahi med co made tryptophan plasouto asahi med co used machine plasma separator first filter asahi med co immunoadsorption columns used plasma perfusion iap treatment performed three times weekly total six times iap done every weeks removal rate anti ach r titer igg iga igm levels improved nine nine patients iap treatment improvement gait disturbances seen two two muscle strength improved nine patients whereas speech disturbances improved two three eye ptosis improved nine nine patients subjective improvement reported nine nine patients none severe side effects iap conclusion iap safe stable effective clinically useful treatment mg,C10,0.0026336126,0.027723378,0.068390496,0.0014739708,0.0036529752,0.016073557,0.2636514,0.01516163,0.0018965878,0.015209716,0.034937218,0.005395794,0.038652834,0.0060319635,0.0023070257,0.00408515,0.18557225,0.0027016476,0.0029871054,0.0842879,0.21354349,0.00093146734,0.0026988378
misdiagnosis patients amyotrophic lateral sclerosis confirm impression high percentage patients amyotrophic lateral sclerosis initially misdiagnosed reviewed records patients definitive diagnosis amyotrophic lateral sclerosis seen years fourteen patients initially misdiagnosed mean time correct diagnosis significantly greater misdiagnosed group months rest patients months two three patients initial symptom dyspnea misdiagnosed three patients underwent laminectomies misdiagnosis age stage disease unusual presenting symptoms identified causes misdiagnosis likely causes physicians failure consider diagnosis lack familiarity common clinical presentations amyotrophic lateral sclerosis earlier diagnosis amyotrophic lateral sclerosis may help prevent medical mismanagement may benefit patients medically psychologically,C10,0.0030048436,0.03175842,0.020115986,0.001688299,0.004184149,0.017883627,0.2935721,0.0028257912,0.002172368,0.0029971448,0.08219959,0.020729197,0.07080166,0.00717052,0.017152054,0.0046791662,0.28955817,0.0030995845,0.0036550735,0.07140576,0.045188278,0.0010669108,0.0030912722
characterization periventricular edema normal pressure hydrocephalus measurement water proton relaxation times magnetic resonance longitudinal relaxation time transverse relaxation time water proton periventricular white cortical gray matter measured control patients patients suspected normal pressure hydrocephalus nph latter group showed good response shunting true nph group seven showed response false nph group true nph group periventricular white matter significantly prolonged compared control values slowly shortened cerebrospinal fluid csf shunting true nph group showed significantly longer white matter false nph group white matter longer gray matter group reverse relationship observed control patients white matter false nph group significant prolongation difference seen compared control values change either region csf shunting false nph group showed significant difference either white gray matter difference either gray matter false nph control groups preshunt postshunt measurements patient group suggested distinction true false nph cannot made radiographic appearance alone may possible measurement relaxation times mechanism varied relaxation behavior two entities may explained difference properties biological water environment,C10,0.020081183,0.0016697822,0.010592361,0.0010576434,0.012377714,0.0024293344,0.087789826,0.010875846,0.05538565,0.001849568,0.009529299,0.14327902,0.2248662,0.015750527,0.0016553346,0.0029312875,0.08813784,0.0019391902,0.0021433886,0.045291085,0.2464229,0.0006683716,0.013276692
resistance atracurium induced neuromuscular blockade patients intractable seizure disorders treated anticonvulsants previous studies demonstrated exception atracurium resistance neuromuscular blocking effects various muscle relaxants develops patients receiving anticonvulsant therapy studied effects mg kg iv atracurium neurosurgical patients nonepileptic patients receiving anticonvulsant therapy med epileptic patients treated carbamazepine years med epileptic patients treated carbamazepine plus either phenytoin valproic acid years med evoked compound electromyogram adductor pollicis brevis recorded results analyzed using analysis covariance weight age covariables onset time significantly different among three groups times recovery baseline train four responses stimuli significantly shorter med med groups control patients med recovery index time recovery baseline electromyogram values progressively shorter three groups med min med min med min p less study demonstrates atracurium used epileptic patients requiring long term years anticonvulsant therapy shorter duration action used nonepileptic patients,C10,0.012452959,0.0018940279,0.0039840597,0.0011996812,0.002973748,0.023427483,0.17586675,0.0020079669,0.011879711,0.012432092,0.0121896705,0.05823165,0.16486153,0.015363879,0.00187764,0.0033397186,0.20964237,0.012512279,0.002431238,0.0875487,0.18091546,0.00075813156,0.0022092173
fatal severely disabling cerebral infarction hospitalization stroke transient ischemic attack six patients admitted cerebral infarction transient ischemic attack tia suffered fatal severely disabling hospital cerebral infarction following period stabilization improvement lasting day infarctions characterized sudden onset stupor coma subsequent development transtentorial herniation due carotid middle cerebral artery territory infarction widespread brain stem infarction due basilar occlusion one patient survived four patients large vessel disease documented doppler angiography autopsy six infarcts occurred morning hours days initial event days initiation intravenous heparin within h intravenous heparin discontinued coagulation abnormalities documented believe cases indicate among patients admitted cerebral infarction tia fatal severely disabling hospital cerebral infarction period stabilization improvement may occur patients initially mild moderate clinical deficit suffering large artery disease may greater risk may relationship heparin withdrawal cerebral infarction patients,C10,0.12378667,0.001954815,0.004111924,0.01189445,0.0030697375,0.03804914,0.24268556,0.002076122,0.012236575,0.012831183,0.042234536,0.025862332,0.06470209,0.005090653,0.001937901,0.0034316597,0.25778005,0.0022694725,0.0025092661,0.056637585,0.08179127,0.00078246306,0.0022745493
adjuvant chemotherapy primary lymphoma central nervous system ten immunocompetent patients primary non hodgkin lymphoma central nervous system treated neuro oncology service university california san francisco ucsf undergoing surgery biopsy removal tumors patients group received irradiation hydroxyurea followed adjuvant chemotherapy combination procarbazine lomustine ccnu vincristine outcome treatment group compared three groups patients primary cns lymphoma patients treated ucsf cancer research institute underwent surgery radiation therapy rt group patients described literature surgery rt group patients described literature surgery rt chemotherapy group median quartile survival times greater patients received adjuvant chemotherapy group months group months patients receive chemotherapy rt group months group months results suggest adjuvant chemotherapy useful treatment primary cns lymphoma,C10,0.0023812368,0.002112276,0.01596733,0.0013379198,0.015160248,0.00307311,0.12548164,0.002239344,0.0017215282,0.002339705,0.011923118,0.1544881,0.017627796,0.05156697,0.0020939996,0.0037080809,0.40138748,0.002452279,0.014228558,0.05115879,0.1142553,0.00084549066,0.0024497285
antinociceptive interaction opioids medetomidine systemic additivity spinal synergy antinociceptive interaction tail flick tf hot plate hp tests opioid analgesics medetomidine intravenous iv intrathecal administration examined isobolographic analysis male sprague dawley rats received fixed ratios medetomidine morphine fentanyl meperidine respectively iv administration intrathecal administration respectively data expressed percentage maximal possible effect mpe dose producing mpe drug drug combination determined dose response curve isobolographic analysis revealed effect medetomidine combined fentanyl morphine meperidine additive iv administration intrathecal administration combinations medetomidine opioids produced synergistic antinociceptive effect tf hp test data confirmed interaction medetomidine opioids producing antinociception may additive synergistic depending route administration drug ratio administered level processing nociceptive input e spinal vs supraspinal moreover results consistent spinal role alpha adrenoceptors mediating antinociception authors suggest interaction opioid alpha adrenergic receptors occurs within spinal cord,C10,0.002466631,0.0021880248,0.0046024774,0.0013858994,0.0034539243,0.0031833157,0.24397331,0.0023196496,0.01372035,0.0024236098,0.053672034,0.07958078,0.09616663,0.028962312,0.0021690931,0.015758678,0.02735107,0.023378046,0.0028086223,0.038585294,0.3325004,0.00087581103,0.018474024
substantia nigra site action muscle relaxant drugs sites action centrally active muscle relaxant drugs well defined clinical experience drugs suggests spinal cord may one important regions pathologically increased muscle tone may relieved supraspinal centers may also involved expression muscle relaxant action yet defined report microinjections therapeutically relevant muscle relaxants midbrain tegmentum genetically spastic rats decrease muscle tone substantia nigra region midazolam baclofen tizanidine drugs used clinically treatment spasticity gamma vinyl gaba amino phosphonoheptanoate pro phe trp substance p experimental drugs active animal models spasticity reduce muscle tone genetically spastic rats hoffmann reflexes normal rats effects muscle relaxant drugs topographically restricted substantia nigra pars reticulata receptor specific observations disclose previously unknown function substantia nigra mediating muscle relaxation,C10,0.002623541,0.02771031,0.0048946156,0.001473868,0.0036527202,0.0033853739,0.34504452,0.0024668872,0.12889037,0.0025774462,0.014363577,0.005395417,0.03348895,0.0064821267,0.0023067743,0.004084865,0.03971928,0.021671383,0.002986897,0.018000226,0.30317727,0.0009314023,0.0246722
neonatal facial cry responses invasive non invasive procedures evaluation pain neonates difficult due limited means communication aim determine whether behavioural reactions cry facial activity provoked invasive procedure could discriminated responses non invasive tactile events thirty six healthy full term infants mean age h received procedures counterbalanced order intramuscular injection application triple dye umbilical stub rubbing thigh alcohol significant effects procedure found total face activity latency face movement cluster facial actions comprised brow bulging eyes squeezed shut deepening naso labial furrow open mouth associated frequently invasive procedure comparisons non invasive procedures showed facial activity thigh swabbing least application triple dye umbilical cord acoustic analysis cry showed statistically significant differences across procedures latency cry cry duration group whole however babies cried two procedures showed higher pitch greater intensity injection significant differences melody dysphonation jitter methodological difficulties investigators area examined including criteria selection cries analysis logical statistical challenges contrasting cries induced different conditions babies always cry concluded facial expression combination short latency onset cry long duration first cry cycle typifies reaction acute invasive procedures,C10,0.0018832472,0.001669728,0.012612698,0.0010576091,0.011833478,0.0024292558,0.1911591,0.0017701738,0.0013608468,0.02917783,0.061391033,0.03950485,0.10375766,0.0044897315,0.010770416,0.03026588,0.15558976,0.011041181,0.002143319,0.09709273,0.21643281,0.00066834997,0.011898289
maxillofacial surgery nasal cpap comparison treatment obstructive sleep apnea syndrome nasal continuous positive airway pressure cpap primary therapy obstructive sleep apnea syndrome osas recent reports indicated however small significant number failures related patient compliance primary surgical treatment uvulopalatopharyngoplasty uppp declined poor results reviewed uppp failures shown uppp eliminated palatal obstruction failed eliminate base tongue obstruction maxillofacial surgery reported treatment osas correcting base tongue obstruction thirty patients severe osas evaluated compare nasal cpap maxillofacial surgery goal determine surgical protocol effective nasal cpap patients initially underwent baseline diagnostic polysomnography document osas nasal cpap study performed determine appropriate positive end expiratory pressure patients study using nasal cpap found unacceptable long term treatment elected surgery maxillofacial surgery consisted maxillary mandibular hyoid advancement polysomnography performed six months following surgery compared night cpap results parameters included investigation respiratory disturbance index rdi lowest sao number sao falls percent total sleep time tst rem sleep percent stage sleep percent wake sleep onset mean rdi treatment sd completing therapy rdi surgery cpap sd sd respectively mean low sao prior treatment sd cpap results postsurgical results sd sd respectively analysis variance used examine results statistical difference nasal cpap surgery respiratory variables,C10,0.0015589393,0.031478148,0.0029100436,0.00087437325,0.01721954,0.017071044,0.24438858,0.0014634826,0.0011250735,0.031647705,0.039965943,0.011065829,0.12238993,0.0037262852,0.001368523,0.00995374,0.36111802,0.009127155,0.0017719787,0.039170794,0.048451338,0.0005525551,0.0016009758
metoprolol aggressive behavior persons mental retardation persons mental retardation sometimes exhibit behaviors difficult control use neuroleptic medications may limited side effects ineffectiveness beta blockers propranolol metoprolol shown decrease aggressive impulsive behaviors patients mental retardation,C10,0.0069432845,0.0061590397,0.012955449,0.0039011484,0.009668304,0.008960671,0.2724995,0.006529549,0.0050196857,0.0068221847,0.03225766,0.01461249,0.069017395,0.11679304,0.0061057494,0.010812138,0.13355713,0.040758338,0.007905951,0.07902566,0.14008729,0.0024653082,0.007142995
aids visual impairment article provides flavour type range aids available visually impaired person many aids leisure learning daily living illustrated rnib equipment games catalogue,C10,0.007443651,0.042636655,0.15803169,0.0041827383,0.010365048,0.009606419,0.31679276,0.0070000994,0.005381428,0.0073138243,0.034232523,0.015310167,0.09128182,0.017284013,0.006545759,0.0115913125,0.089714535,0.007958598,0.008475692,0.047559578,0.090990975,0.00264297,0.007657754
opposite pupil herniation serially examined pupil opposite one already enlarged transtentorial herniation patients main abnormalities stereotyped patients initially diminished light reaction mm diameter pupil followed slight reduction size reenlargement greater original size preserved roundness subsequent deterioration varied among patients transitional oval shape infrequent oculomotor function preserved pupils enlarged fixed pupil side mass enlarges heralding herniation subsequent deterioration appreciated changes reactivity size opposite pupil,C10,0.004947883,0.02833978,0.033181384,0.0027800135,0.0071702506,0.0063855005,0.1887329,0.004653049,0.0035770992,0.0048615853,0.03113425,0.01017685,0.043561332,0.011376711,0.0043510436,0.007704883,0.23559178,0.005095499,0.0056338925,0.034093257,0.31980407,0.0017568135,0.0050901994
massive increases extracellular potassium indiscriminate release glutamate following concussive brain injury increase extracellular k concentration k c rat hippocampus following fluid percussion concussive brain injury demonstrated microdialysis role neuronal discharge examined situ administration mm tetrodotoxin potent depressant neuronal discharges mm cobalt blocker ca channels small short lasting k c increase fold observed mild insult pronounced longer lasting increase fold induced without overt morphological damage severity injury rose certain threshold unconscious seconds small short lasting increase reduced prior administration tetrodotoxin cobalt indicating neuronal discharges source increase contrast larger longer lasting increase resistant tetrodotoxin partially dependent ca suggesting neurotransmitter release involved order test hypothesis release excitatory amino acid neurotransmitter glutamate mediates increase k c extracellular concentration glutamate glu c measured along k c results indicate relatively specific increase glu c compared amino acids induced concomitantly increase k c furthermore situ administration mm kynurenic acid excitatory amino acid antagonist effectively attenuated increase k c dose response curve suggested maximum effect kynurenic acid obtained concentration substantially blocks receptor subtypes excitatory amino acids data suggest concussive brain injury causes massive k flux likely related indiscriminate release excitatory amino acids occurring immediately brain injury,C10,0.08134754,0.0014575452,0.004373621,0.008848904,0.0023109522,0.0021265568,0.18312168,0.0015452267,0.0011879154,0.009564863,0.016510718,0.011921566,0.06438511,0.03105003,0.0014449339,0.0026094855,0.02019866,0.04424089,0.00980419,0.08073138,0.41091824,0.0005834185,0.009716614
cerebral blood flow progressive aphasia without dementia case report using xenon inhalation technetium hexamethylpropyleneamine oxime single photon emission computerized tomography report case progressive aphasia without clinical signs intellectual behavioral impairment satisfying mesulam clinical criteria primary progressive aphasia yrs extensive psychometric testing radiological imaging comprising ct mri failed detect evidence relevant involvement outside left perisylvian regions cranial ct normal mri showed multiple bilateral lesions deep white matter cerebral blood flow cbf studies single photon emission computerized tomography however showed initial frontotemporal focus hypoperfusion progressively extended include ipsilateral hemisphere contralateral frontal lobe suggests cbf imaging may yet sensitive technique revealing subclinical injury degenerative brain diseases focal onset,C10,0.06119548,0.002665596,0.019324416,0.001688394,0.04942671,0.03296785,0.28444242,0.046462987,0.0021724903,0.032045,0.13445805,0.0061807367,0.10292691,0.0070791743,0.0026425323,0.0046794293,0.038338535,0.0030999798,0.0034216489,0.05165357,0.09439864,0.015609806,0.003119636
study verbal description neuropathic pain aim paper study quality verbal description diagnostic value neuropathic pain verbal description pain assessed french adjective list questionnaire qdsa compared group patients neuropathic pain mixed group chronic benign cancer non neuropathic pain patients seventeen descriptors qdsa descriptors significant intergroup frequency difference principal component analysis varimax rotation intercorrelation matrix descriptors neuropathic group factors accounting total variance derived six factors reflect purely sensory affective aspects pain experience seven descriptors discriminant analysis function correctly assign neuropathic pain patients non neuropathic pain patients second neuropathic pain group patients discriminant function coefficient permits correct diagnostic categorization cases implications clinical practice trials discussed,C10,0.017529018,0.0026657255,0.03468184,0.001688476,0.004184588,0.018415907,0.21584868,0.017781343,0.0021725958,0.0029527445,0.066194,0.081147574,0.101561226,0.008827452,0.0026427668,0.0048544663,0.16813497,0.0031339698,0.07000255,0.11569224,0.05569894,0.0010670226,0.0031219467
intraoperative dexamethasone irrigation lumbar microdiskectomy lumbar hemilaminectomy microdiskectomy patients control group patients standard operative procedure remaining patients treated intraoperative irrigation long acting dexamethasone incision closure age weight gender ratio mean postoperative hospital stay mean hospital narcotics usage incidence perioperative complications among two groups compared age gender ratios comparable although control group significantly heavier body weight steroid irrigated group steroid irrigated group significant reduction hospitalization marked reduction narcotics usage compared control group postoperative fever occurred one patient steroid group control group three postoperative complications preliminary observations suggest dexamethasone irrigation lumbar diskectomy safe effective adjunct surgical management,C10,0.0028395457,0.0025188187,0.019034337,0.015333224,0.0039539775,0.0036645816,0.080763295,0.002670343,0.002052865,0.0027900203,0.040517677,0.12532912,0.12311964,0.006528992,0.0024970248,0.004421763,0.31192386,0.0029242611,0.0032332405,0.07105086,0.16890313,0.0010082194,0.00292122
multiple muscle enzyme release psychiatric illness associations p less serum concentrations lactate dehydrogenase ldh glutamic oxaloacetic transaminase sgot observed physically well patients mania n r depression n r chronic schizophrenia n r schizoaffective atypical psychosis n r discharged contrast negligible association enzymes nonpsychiatric inpatient control subjects patients mania iu l showed significantly p less two tailed higher lactate dehydrogenase ldh levels control subjects iu l incidence abnormally high serum ldh levels vs among control subjects results unchanged patients taking neuroleptics excluded results indicate psychiatric illness especially mania induces release ldh sgot occasionally unusually high levels similar previous reports muscle creatine phosphokinase release psychiatric patients presumably enzymes released skeletal muscle association agitation muscle tension blood stasis local tissue hypoxia consequent hypoactivity,C10,0.00283979,0.0025190352,0.0052987533,0.0015955621,0.0039543174,0.01740826,0.16870366,0.01637904,0.057040174,0.0027902604,0.023097262,0.020356044,0.14729664,0.006629589,0.0024972395,0.0044221436,0.08091118,0.016651526,0.0032335185,0.10354576,0.30890054,0.0010083062,0.0029214711
glucocorticoid induced muscle atrophy prevention exercise fast twitch fibers exercise shown effective preventing glucocorticoid induced atrophy muscles containing high proportions type ii fast twitch fibers investigation undertaken evaluate response type iia iib fibers determined histochemical staining myofibrillar adenosinetriphosphatase alkaline acid preincubation steroid cortisol acetate ca mg kg body wt exercise running min day min treatments initiated simultaneously consecutive days female rats fiber distribution area measurements performed deep superficial region plantaris muscle exercise regimen spared approximately ca induced plantaris muscle atrophy deep region fiber population contained approximately type slow twitch type iia iib fibers affected either treatment superficial section consisted solely type ii fibers proportion type iia fibers higher vs p less steroid vehicle treated groups within region type iia fibers less susceptible atrophy type iib fibers within fiber type deep region less atrophy superficial region type fibers unchanged steroid treatment type iia fibers exercise prevented atrophy deep region superficial region type iib fibers activity spared atrophy regions respectively results show glucocorticoids capable changing myosin phenotype,C10,0.0087414775,0.05941676,0.024566984,0.0008429483,0.0020884478,0.0019355922,0.21204707,0.008665337,0.030127684,0.052292988,0.075251766,0.010472064,0.066082634,0.15148377,0.0013189013,0.017432904,0.04424524,0.001544563,0.0017077625,0.03288128,0.19001718,0.0005325306,0.006304084
fetal homotransplants ventral mesencephalon adrenal tissue striatum parkinsonian subjects fetal ventral mesencephalon fetal adrenal tissue grafted caudate nucleus four three parkinsonian patients respectively shown alternative treatment amelioration signs disease ventral mesencephalon patients significant amelioration rigidity bradykinesia postural imbalance gait disturbance facial expression three four patients returned work fatal adrenal group showed amelioration rigidity bradykinesia though patients able perform basic daily living activities one renewed household tasks two yet able return work differences observed ventral mesencephalon fetal adrenal transplanted patients may related heterogeneity disease type graft implanted however encouraging results may experimental procedure obviously requires studies practiced outside highly qualified clinical research centers,C10,0.002920023,0.002590206,0.00544846,0.0016407458,0.0040660393,0.017898595,0.20379584,0.0027460249,0.058647208,0.016999861,0.0139497705,0.021463688,0.04966663,0.02348086,0.0025677944,0.004547083,0.21690853,0.0030071395,0.01745767,0.075285815,0.22261202,0.015162258,0.017137768
anatomical physiological theoretical basis antiepileptic effect vagus nerve stimulation vagus mixed nerve carrying somatic visceral afferents efferents majority vagal nerve fibers visceral afferents wide distribution throughout central nervous system cns either monosynaptically via nucleus solitary tract besides activation well defined reflexes vagal stimulation produces evoked potentials recorded cerebral cortex hippocampus thalamus cerebellum activation vagal afferents depress monosynaptic reflexes decrease activity spinothalamic neurons increase pain threshold depending stimulation parameters vagal afferent stimulation experimental animals produce electroencephalographic eeg synchronization desynchronization shown affect sleep states desychronization eeg appears depend activation afferent fibers conduction velocities less equal vagal afferent stimulation also influence activity interictal cortical spikes produced topical strychnine application either attenuate stop seizures produced pentylenetetrazol mercaptoproprionic acid maximal electroshock topical alumina gel mechanisms antiepileptic effects vagal stimulation fully understood probably relate effects reticular activating system vagus provides easily accessible peripheral route modulate cns function,C10,0.0024378852,0.002162526,0.004548841,0.013147357,0.003394678,0.026706098,0.22853407,0.0022926168,0.013560402,0.0023953654,0.011473559,0.0050270082,0.07940996,0.06804087,0.0021438147,0.02738782,0.036086522,0.04971607,0.002775891,0.07165982,0.3437252,0.0008656045,0.0025080065
rehabilitation chronic stroke patients changes functional performance forty stroke patients least one year post onset completed one month intensive rehabilitation program month program served control period program patients received individual sessions occupational physical therapy four days week participated group activities fifth day therapy emphasized instruction motor planning balance weight shift use adaptive equipment motor abilities practiced within real life situations patients demonstrated significant improvement outcome measures weight shift balance adl scores one month rehabilitation program weight shift f p balance f p adl f p retained new skills three month follow period,C10,0.0028792396,0.0025540292,0.0053723627,0.0016177273,0.0040097306,0.017638205,0.17764334,0.0027076718,0.002081562,0.016765278,0.013789096,0.040774785,0.10008238,0.021419328,0.0025319308,0.01841429,0.22295766,0.0029651395,0.042872753,0.1019894,0.1949497,0.0010223134,0.0029620556
transcranial electrical stimulation high frequency intermittent current limoge potentiates opiate induced analgesia blind studies transcutaneous cranial electrical stimulation tces high frequency khz intermittent current hz limoge current used several years cardiac thoracic abdominal urological micro surgery main benefits reduced requirement analgesic drugs especially opiates long lasting postoperative analgesia confirmed clinical observations rats using tail flick latency tfl test measure pain threshold tces found modify pain threshold drug free rats potentiated morphine induced analgesia systemic injection obtain maximal effect stimulation must initiated h drug injection maintained throughout duration pharmacological action tces potentitation found depend dose drug intensity current polarity electrodes findings confirmed blind tests efficiency tces several opiate analgesic drugs currently used human surgery morphine fentanyl alfentanil dextromoramide analgesic effect opiates tfl baseline without tces respectively results obtained systemic opiate treatment also intracerebroventricular injection morphine micrograms analgesic effect tces suggesting tces potentiation opiate induced analgesia centrally mediated,C10,0.0019724683,0.0017495003,0.0132104885,0.0011081371,0.002746321,0.012082949,0.25987124,0.011391602,0.020516772,0.0019378694,0.045967747,0.04273369,0.119084165,0.0051959422,0.011276725,0.04126151,0.0835759,0.0020853558,0.021335054,0.022241626,0.27591643,0.00070028077,0.0020382155
total knee arthroplasty fixation comparison early results paired cemented versus uncemented porous coated anatomic knee prostheses results matched pairs porous coated anatomic knee prostheses studied compare early clinical functional performance cemented versus uncemented fixation average five year follow period knee score improved preoperative average points postoperative average points cemented group points points uncemented group particular individual pain scores range motion values well matched three six month follow visits showed steady improvement subjectively patients pleased results surgery one third preferred cemented side one third preferred uncemented side one third found difference performance either knee clinical functional performance knee prostheses patients one cemented knee one uncemented knee comparable possibly unrelated type fixation method,C10,0.0028009824,0.029602434,0.005226343,0.001573842,0.0039002793,0.030724624,0.23549657,0.0026340778,0.0020249856,0.0027521297,0.13303058,0.083224736,0.053117346,0.006499487,0.002476509,0.0043617124,0.18280016,0.0028845475,0.0031893305,0.10291332,0.10488993,0.0009945271,0.0028815474
long term evaluation hemiparkinsonian monkeys adrenal autografting cavitation alone autografts adrenal medulla implanted preformed cavities caudate nuclei four rhesus monkeys hemiparkinsonism induced methyl phenyl tetrahydropyridine mptp five hemiparkinsonian monkeys underwent caudate cavitation received tissue implant animals marked bradykinesia affected arm stable apomorphine induced turning cavitation implantation moderate behavioral recovery seen five monkeys cavitation two three monkey long term adrenal autografts fourth adrenal recipient sacrificed days grafting improvement occurred months procedure early complete seen fetal dopaminergic grafts surviving adrenal tissue found animal showed behavioral recovery two adrenal autograft recipients surviving adrenal medulla animals cavitation ingrowth dopaminergic fibers area olfactoria nucleus accumbens caudate oriented toward cavity findings show mechanism improvement adrenal medullary implants parkinsonism dopamine secretion chromaffin cells may related sprouted host fibers results also indicate limited recovery adrenal implants parkinsonian patients may result cavitation necessarily result tissue implantation,C10,0.002327897,0.01332547,0.015538513,0.0013079504,0.014509642,0.0030042722,0.2324062,0.0021891824,0.012939206,0.0022872954,0.011031616,0.03418923,0.043390807,0.09169222,0.0020470938,0.014887624,0.13537298,0.002397348,0.002650653,0.015832273,0.34345108,0.00082655164,0.0023948546
pharmacology recovery stroke laboratory research past decade begun provide insights neurobiologic basis functional recovery brain injury clear drugs influencing specific neurotransmitters also influence recovery process drugs may beneficial others may detrimental difficulties interpreting results behavioral studies reviewed potential mechanisms drug effects discussed types studies leading increased awareness potentially harmful effects drugs often given stroke patients pharmacotherapy designed enhance functional recovery stroke may possible future,C10,0.034615368,0.002874465,0.036103353,0.017830025,0.02016051,0.03684049,0.4426529,0.003047384,0.0023427207,0.0031839593,0.01630563,0.006723902,0.02160927,0.008218443,0.002849594,0.005046097,0.041203886,0.0033371544,0.00368976,0.04684401,0.24003503,0.0011505757,0.003335459
osseointegration titanium implants total hip arthroplasty osseointegration defined direct contact light microscopic level living bone tissue implant using titanium screw dental implants jaw lasting interface loaded conditions extending year follow period demonstrated demonstration brings question whether similar interface achieved total hip arthroplasty tha living bone titanium alloy implant necessitated conditions immediate loading two series cases reported first series used femoral press fit titanium alloy component second used press fit titanium acetabular component redesigned femoral press fit titanium alloy component demonstrated high percentage good excellent results roentgenograms showed geometrical changes redesigned femoral component gave early indications better fixation loading valgus less subsidence less evidence distal stress transfer two one half year postoperative anatomic specimen study confirmed osseointegration press fit titanium alloy femoral component multiple areas contact bone metal without fibrous interposition seen examination electron microscopy supported light microscopic findings findings support use smooth press fit titanium components thas without need porous coating mesh surface modifications,C10,0.0022516053,0.0019972862,0.099081695,0.0012650852,0.0031358306,0.014726148,0.273663,0.0021174368,0.045227606,0.024007967,0.10561923,0.00469198,0.057348758,0.055003054,0.012877715,0.0035062176,0.12988375,0.013920772,0.013454082,0.023406195,0.109698735,0.0007994632,0.0023163685
auditory hallucinations smaller superior temporal gyral volume schizophrenia recent neuropathologic investigations schizophrenia report smaller volume medial temporal lobe structures findings confirmed preliminary magnetic resonance imaging mri studies direct stimulation lateral temporal lobe structures region superior temporal gyrus provokes hallucinations authors mri study young schizophrenic patients demonstrates smaller volume superior temporal gyrus auditory association area left amygdala smaller size left superior temporal gyrus left amygdala accounted smaller size overall brain temporal lobe shrinkage left superior temporal gyrus strongly selectively correlated severity auditory hallucinations,C10,0.020192843,0.003066763,0.00645089,0.001942494,0.026466137,0.0044617755,0.18031098,0.08693701,0.0024994458,0.0033969618,0.14572422,0.007110925,0.08609381,0.007992261,0.003040228,0.0053836745,0.10178352,0.003577572,0.0039366,0.066387855,0.18970059,0.0012275478,0.042315893
effects mk recovery sensorimotor cortex lesions histologic evidence suggests drugs acting noncompetitive antagonists n methyl aspartate receptor beneficial pathologic effects central nervous system neurons present experiments examined effects mk recovery behavioral function unilateral lesions rat somatic sensorimotor cortex first experiment rats unilateral sensorimotor cortex lesions given either mk mg kg saline hours surgery additional injections given postoperative days behavioral tests measured somatosensory asymmetries e bilateral tactile stimulation tests forelimb placing creation sensorimotor cortex lesions rats showed ipsilateral somatosensory bias impairment placing contralateral forelimb rats treated mk recovered slightly faster saline treated animals measured bilateral tactile stimulation test p less contrast significant difference groups recovery forelimb placing second experiment rats sensorimotor cortex lesions treated single injection mk behavioral recovery twenty hours mk injection rats sensorimotor cortex lesions showed reinstatement placing deficits impairment endured least days injection behavioral data support idea mk either beneficial detrimental effects administered brain damage,C10,0.028694527,0.0016400815,0.0034498873,0.001038831,0.05628016,0.011258615,0.1806369,0.0017387439,0.0013366847,0.0018166695,0.03828345,0.09573534,0.045843307,0.027251782,0.0016258908,0.011820384,0.09141185,0.010853442,0.002105264,0.033819105,0.33290052,0.01855458,0.00190402
codeine increases pain thresholds copper vapor laser stimuli extensive poor metabolizers sparteine analgesic efficacy kinetics single oral dose mg codeine investigated extensive metabolizers poor metabolizers sparteine double blind placebo controlled crossover study cosegregation demethylation codeine morphine sparteine oxidation polymorphism confirmed hence morphine could detected plasma poor metabolizers whereas detectable morphine plasma levels found extensive metabolizers pain thresholds laser stimuli determined drug intake minutes drug intake codeine significantly increased pricking pain thresholds extensive metabolizers p less whereas significant changes poor metabolizers change pain thresholds occurred placebo two phenotypes extensive metabolizers significant positive correlation increase pain threshold plasma concentration codeine study supports hypothesis morphine formation essential achievement analgesia codeine treatment,C10,0.002763714,0.002451552,0.01853417,0.0015528181,0.0038483841,0.0035667168,0.22627866,0.0026300491,0.0019980422,0.0027155112,0.04397615,0.005684478,0.20677623,0.006651869,0.0024303403,0.01766917,0.122724526,0.002860846,0.043280274,0.05322002,0.20974343,0.0009812944,0.01766172
disease delirium managing declining elderly patient many geriatric patients concurrent physical psychiatric illnesses times may difficult determine primary delirium transient syndrome presents psychiatric symptoms usually manifestation organic disorder undetected untreated fatal clinicians therefore must learn recognize syndrome search diligently underlying etiology treat accordingly,C10,0.00472156,0.004188259,0.008809941,0.0026528519,0.006574623,0.028945364,0.44294664,0.004440212,0.0034134777,0.004651981,0.02171393,0.009711347,0.032820754,0.010856325,0.0041520204,0.03020038,0.11579138,0.0048874803,0.0053761904,0.12591736,0.12069413,0.0016764544,0.004857367
platelet activating factor putative mediator central nervous system injury platelet activating factor hexadecyl acetyl sn glycero phosphorylcholine potent lipid autacoid produced many cell types platelet activating factor produced cerebellar granule cells culture extracted brain tissue multiple platelet activating factor receptors demonstrated brain tissue activation platelet activating factor receptors transformed neuronal cell lines involved increases intracellular calcium platelet activating factor potent actions cerebral vessels cerebral metabolism administered vivo may direct effects brain microvessels excessive platelet activating factor production pathological states nervous system neurotrauma stroke shown models e g spinal cord ischemia reperfusion focal repercussion brain injury multiple studies using highly specific potent platelet activating factor antagonists reversal prevention key consequences brain injury hypoperfusion following ischemia reperfusion edema inflammatory cell accumulation neurologic motor deficits neuronal salvage demonstrated review provides analyzes evidence support role platelet activating factor might modulation brain function pathophysiological processes brain ischemia trauma,C10,0.124910764,0.011188015,0.003646623,0.0010977361,0.002720879,0.011961323,0.20268759,0.0018408127,0.0014124309,0.0019196152,0.03886848,0.0139142675,0.02381112,0.17821324,0.011171055,0.0030423016,0.02280577,0.06656152,0.0022245634,0.060000315,0.17242905,0.010146166,0.033426363
ph adjustment discomfort caused intradermal injection lignocaine published erratum appears anaesthesia mar one hundred adult day case patients required intravenous access cannulae inserted using local anaesthesia lignocaine lignocaine adrenaline corresponding ph adjusted solutions local anaesthetic solutions modified addition ml sodium bicarbonate ml lignocaine pain scores different stages cannulation noted showed significant reduction use ph adjusted solutions p less plain lignocaine less lignocaine adrenaline modification ph lignocaine solutions addition sodium bicarbonate simple method significantly reduce discomfort caused infiltration local anaesthetic,C10,0.0034586051,0.0030671,0.0064515993,0.0019427073,0.0048146555,0.004462266,0.19595684,0.019978778,0.0024997205,0.0033973353,0.053650886,0.17441855,0.12726991,0.007950184,0.0030405622,0.005384266,0.10257802,0.0035607968,0.003937033,0.09567092,0.1717245,0.0012276827,0.0035570934
dementia dementia syndrome acquired intellectual deterioration interferes personal social functioning diagnosis requires historical information family mental status evaluation orientation recent memory comprehension calculation abstraction dementias create permanent even progressive cognitive deterioration yet presentations remission exists common reversible conditions include depression drug toxicity normal pressure hydrocephalus hypothyroidism subdural hematoma neoplasm screening laboratory studies consist urinalysis chemistry profile blood count thyroid survey vitamin b folate measurements serology chest roentgenogram computerized tomographic scan head electroencephalogram electrocardiogram treatment focuses potential reversibility psychosocial issues restoring deficits specific symptoms,C10,0.020888483,0.003173085,0.006674537,0.0020098384,0.0410683,0.056564942,0.37919673,0.003363968,0.0025860993,0.02199052,0.07053401,0.024656411,0.093062386,0.029286364,0.00314563,0.0055703213,0.033324864,0.0036868455,0.038701963,0.08005901,0.075503364,0.0012701057,0.003682237
cemented ingrowth fixation miller galante prosthesis clinical roentgenographic comparison three six year follow studies one hundred thirty nine cemented cementless miller galante total knee prostheses followed three six years average months fixation technique based patient age bone quality ability delay full weight bearing clinical follow studies possible cemented knees fifteen knees lost death three year follow study eight knees required component removal one hundred twenty three cementless knees available clinical follow studies three deaths six failures required component removal cemented failure due fixation three cementless failures due lack tibial ingrowth two pain undetermined etiology one preoperative knee scores slightly significant cemented knees averaging points cementless knees averaging points similar significant difference maintained final follow study significant differences noted pain limp support scores average range motion similar two groups radiolucent lines femoral component rare cementless tibial radiolucencies partial examined zones complete tibial tray radiolucency seen three patients correlation radiolucency knee scores seen,C10,0.002182943,0.044152994,0.04628242,0.0012249822,0.0030396283,0.0028137001,0.20042768,0.012600617,0.012127554,0.012693583,0.057253357,0.048701722,0.08337018,0.0050130216,0.0019172897,0.003395071,0.21106611,0.002245275,0.0025171284,0.12783702,0.11611724,0.0007741204,0.0022464031
cerebrospinal fluid reflector central cholinergic amino acid neurotransmitter activity cerebellar ataxia cerebrospinal fluid csf amino acid neurotransmitters related compounds precursors choline levels acetylcholinesterase activity measured csf patients cerebellar ataxia randomized double blind crossover placebo controlled clinical trial physostigmine salicylate csf gamma aminobutyric acid methionine choline levels adjusted age significantly lower patients cerebellar ataxia compared controls physostigmine selectively reduced level csf isoleucine elevated levels phosphoethanolamine change occurred csf acetylcholinesterase activity levels plasma amino compounds patients cerebellar ataxia compared controls median ataxia scores statistically differ placebo physostigmine functional improvement occur patients,C10,0.003240836,0.0028743814,0.036718257,0.001820639,0.0045121307,0.0041818833,0.13168061,0.0030472954,0.0023426528,0.0031838666,0.014956674,0.055752154,0.0864979,0.007699462,0.002849511,0.0050459504,0.119092524,0.0033370573,0.0664335,0.063294075,0.34559348,0.0011505423,0.034694623
improving outcomes analgesic treatment education enough frequent undertreatment analgesic responsive acute pain chronic cancer pain persists despite intensive efforts provide clinicians information analgesics set background factors must addressed interventions improve pain treatment traditional patterns clinician patient interaction ward quality assurance drug regulatory practices support prompt recognition treatment pain possible interventions modify patterns daily practice include monitoring displaying patient pain ratings routinely making available educational tools assist optimal drug ordering encouraging patients communicate unrelieved pain reviewing quality assurance pain treatment regimens increasing behavioral research analgesic prescribing selectively modifying narcotics regulatory practices,C10,0.0027274145,0.01562042,0.0050890725,0.014721365,0.016975828,0.030803356,0.37258783,0.015759774,0.0019717992,0.0026798449,0.018860433,0.032010376,0.0400404,0.006978939,0.01559336,0.030645648,0.061646253,0.0028087848,0.09996881,0.12083237,0.08790361,0.0009684058,0.0028058635
indications thymectomy myasthenia gravis fifty six board certified neurologists interest expertise myasthenia completed survey indications thymectomy myasthenia gravis thymectomy advocated virtually patients thymoma variable subset patients generalized myasthenia without thymoma occasionally selected patients disabling ocular myasthenia,C10,0.007722225,0.006849999,0.014408871,0.0043388032,0.010752954,0.009965934,0.19967224,0.007262074,0.005582825,0.0075875395,0.035513654,0.01588314,0.04780199,0.01775578,0.0067907297,0.04938901,0.23124868,0.045317158,0.046172656,0.052936167,0.16636138,0.0027418816,0.007944341
quantitative evaluation sway indicator functional balance post traumatic brain injury test sway using different conditions stance measurements average radial deviation center pressure path length sway per unit time shown useful clinical tool determining balance problems traumatic brain injury tbi patients normative values established determine individual patient sway values fell within normal range mean sd tests shown good test retest reliability tbi patients addition shown sensitivity test sufficient identify changes patients performances clinical conditions change demonstrated different stance conditions battery tests become progressively difficult perform comfortable stance eyes open eyes closed narrow stance eyes open eyes closed tandem stance right left foot forward eyes open eyes closed using subtests easy distinguish performances able bodied patients tbi patients mild balance problems validity measure documented correlating sway performance clinical functional performance tests test performance also correlates patient assessment gait difficulties limited data available suggest test sway relates difficulties static balance frequency falls finally subtests permit identification specific problems maintaining balance basis therapeutic intervention,C10,0.035730373,0.010047483,0.028749166,0.0009858069,0.019429825,0.010747401,0.3043518,0.010140671,0.009734071,0.010198232,0.086993314,0.0036087625,0.15999947,0.00414804,0.0015429021,0.0027321905,0.11293366,0.0018073417,0.0019978068,0.07169268,0.11000027,0.00062297494,0.0018057685
prospective double blind study metoclopramide hydrochloride control migraine emergency department study objective determine effectiveness iv metoclopramide sole therapy relieving pain acute migraine emergency department design prospective study fifty patients divided randomly subjects placebo controls blinding treating physician patient participants patients presenting ed migraine requiring parenteral treatment interventions subjects received mg iv metoclopramide controls received iv normal saline patient assessment relief followed means numerical scale measurements main results sixty seven percent subjects compared controls effective pain relief within one hour p less subjects achieved mean relief scores compared controls p less significant side effects observed conclusion iv metoclopramide single agent effective safe therapy migraine ed,C10,0.037367377,0.013795234,0.027802126,0.0013535444,0.0033545196,0.0031194363,0.22919677,0.0022654955,0.0017416327,0.0023670287,0.015720066,0.10294776,0.24264309,0.005570617,0.0021184538,0.0037513848,0.15912157,0.002481587,0.037727006,0.017601488,0.08460741,0.00085536455,0.0024910467
cerebral blood flow velocities anterior cerebral arteries basilar artery hydrocephalus treatment studied pourcelot index pi shows cerebral vascular resistance anterior cerebral arteries basilar artery pi ratio pourcelot index anterior cerebral artery pourcelot index basilar artery measurements hydrocephalus mean values pi anterior cerebral artery basilar artery pi ratio treatment significantly higher treatment normal infants treatment mean pi anterior cerebral arteries significantly higher mean pi basilar artery pi ratios increased treatment normal infants mean pi anterior cerebral arteries significantly lower mean pi basilar artery pi ratios decreased less believe pi ratio useful evaluate need effect treatment hydrocephalus,C10,0.17813976,0.002297551,0.0048328643,0.0014552735,0.003606637,0.0033426634,0.15635549,0.0024357645,0.0018725295,0.0025449288,0.013952991,0.005327408,0.45104173,0.005999308,0.0022776716,0.00403333,0.046949375,0.0026683062,0.0029492138,0.046441086,0.057891823,0.0009196516,0.0026646028
confusion term confusion describes plethora possible cognitive deficits behavioral manifestations subjective assessment confusion must followed objective systematic evaluation develop cognitive behavior profile age associated physiologic pathologic changes elderly patients high risk developing acute confusion management confusion presents challenge nursing nursing play significant role prevention early detection acute confusion preventing identifying confusion early decrease physical psychological stress patient well decrease cost hospitalization shortening length stay additional research needed determine efficacy present nursing activities identify new approaches management,C10,0.0028791858,0.03042942,0.033230815,0.0016176971,0.017946243,0.0037157391,0.4502022,0.002707621,0.0020815232,0.0028289692,0.032919783,0.0059219347,0.033883393,0.022480987,0.016467895,0.004483491,0.082623556,0.016889136,0.0032783765,0.13782938,0.09159838,0.0010222943,0.0029620002
geographic patterns parkinsonism dementia complex guam average annual age adjusted incidence rates parkinsonism dementia complex obtained election districts guam highest rates found southern central districts lowest rates found northern western districts geographic temporal patterns incidence associated socioeconomic status geochemical factors risk parkinsonism dementia complex susceptible sibships much higher general population even districts highest incidence rates especially districts lowest incidence rates evidence tends support hypothesis multiple factors linked cycad use play important role cause pdc hypotheses related metal exposure simple genetic factors unsatisfactory explanations epidemiologic patterns observed,C10,0.0031419676,0.002787082,0.0060327807,0.0017653434,0.0043750904,0.004054873,0.19032656,0.0029547443,0.0022715027,0.0030871676,0.03420077,0.006462427,0.02292491,0.009028148,0.002762967,0.020086998,0.043584045,0.0032403457,0.0035775923,0.4711615,0.15781371,0.0011155985,0.0032438466
selective spatial attention patients visual extinction present study designed verify attentional performance patients parietal lesions experimental condition pay attention spatial positions located left right directly fixation stimulus experiment spatial positions time experiment twelve patients subjects right parietal lesions subjects without neurological deficits participated experiment results experiment showed patients right parietal lesions speed accuracy response horizontally aligned stimuli increased gradually right left whereas control group showed effect due different retinal eccentricities stimuli responses central stimuli faster accurate responses left right stimuli results experiment showed neurological control groups faster respond central left right stimuli neurological group faster respond right left stimuli whereas difference rts two visual fields obtained control group furthermore patients respond spatial locations aligned horizontally experiment speed accuracy response right stimulus focus attention experiment results showed focus attention patients visual extinction rightmost stimulus increased attention right accompanied decreased attention left,C10,0.0019185469,0.0017006953,0.040125947,0.028918441,0.052038252,0.030879973,0.14673127,0.14102991,0.0013860854,0.0018838095,0.041514777,0.12041805,0.045140896,0.0051742485,0.0016859801,0.002985555,0.08908186,0.0019744483,0.0022115817,0.024455639,0.20682949,0.00068074535,0.011233813
primary progressive aphasia longitudinal course neuropsychological profile language features four patients clinical syndrome primary progressive aphasia nonfluent aphasia profile followed period years extensive neuropsychological data three patients revealed progressive quantitative decline language relative stability memory visuospatial skills reasoning comportment activities daily living preserved even speech unintelligible although several aphasia types may associated primary progressive aphasia nonfluent aphasia profile phonemic paraphasic errors useful differentiating much common clinical syndrome probable alzheimer disease clinicopathological correlates probable alzheimer disease differ associated primary progressive aphasia therefore clinical distinction two syndromes may important predicting underlying pathophysiologic changes life patient,C10,0.0031902504,0.0028299112,0.021394512,0.0017925258,0.004453189,0.019555261,0.46840233,0.00300015,0.002306409,0.0031346083,0.02166099,0.006561735,0.029038316,0.007877993,0.0028054256,0.004967883,0.13228033,0.0032879955,0.0036325692,0.14030091,0.097670764,0.016573986,0.0032820117
late juvenile onset krabbe disease krabbe disease autosomal recessive leukodystrophy characterized lack galactocerebroside beta galactosidase activity contrast classic early infantile onset form krabbe disease less recognized late onset variants exist authors present case late juvenile onset krabbe disease including associated magnetic resonance imaging mri findings patients late onset krabbe disease present visual loss due optic atrophy associated gait abnormalities parental consanguinity increase clinician suspicion child may late onset krabbe disease prolonged survival late onset krabbe disease recent development bone marrow transplantation patient makes diagnosis disorder particularly important,C10,0.0029226013,0.0025900775,0.01957236,0.0016405603,0.03233015,0.0037682548,0.4455741,0.0027458887,0.0021109418,0.07354568,0.05328632,0.020088626,0.033366635,0.0072098216,0.002567667,0.018672276,0.13253227,0.018162718,0.0033247108,0.037268005,0.06758363,0.0010367426,0.018099984
decline prevalence childhood deafness jewish population jerusalem ethnic genetic aspects longitudinal study performed jewish children bilaterally sensorineural hearing loss moderately severe profound degree born jerusalem eighteen years prevalence rate children declined years time rate consanguinity parents decreased decline evident genetic group among children non ashkenazi ethnic origin decline found among ashkenazi children consanguinity among parents children recorded study supports assumption restriction consanguineous matings may affect prevalence genetic deafness children well defined population tried remain unbiased concede certain shortcomings present study,C10,0.003016811,0.0026656657,0.0350838,0.001688438,0.004184494,0.018412655,0.18658535,0.0028260238,0.01670866,0.09024329,0.01657095,0.020729022,0.025999682,0.022103319,0.0026426013,0.004707998,0.04877354,0.0030947456,0.017956087,0.3083247,0.16347085,0.0010669986,0.003144349
gilles de la tourette syndrome linked dopamine receptor gilles de la tourette syndrome important genetic component pathophysiology disorder may involve dopamine system tested dopamine receptor locus drd recognized probe hd g genetic linkage gilles de la tourette syndrome using genetic linkage map region drd long arm chromosome restriction fragment length polymorphism data total four markers drd pbgd able exclude linkage candidate gene gilles de la tourette syndrome two extended kindreds segregating gilles de la tourette syndrome rules causation gilles de la tourette syndrome mutation drd kindreds studied genetic assumptions employed use map multipoint linkage analyses also allowed us exclude gilles de la tourette syndrome susceptibility locus larger genetic region,C10,0.002879676,0.0025544164,0.019310826,0.0016179725,0.004010494,0.003716372,0.3685644,0.0027080823,0.0020818776,0.0028294509,0.034279365,0.0059229434,0.019449467,0.02055229,0.002532446,0.018343903,0.029812181,0.03389088,0.0032789349,0.19808806,0.053810682,0.0010224683,0.16874282
symptomatic carotid endarterectomy trials possible benefit carotid endarterectomy stroke prevention evaluated three major clinical trials date european carotid surgery trial randomized patients carotid stenosis greater appropriate symptoms north american symptomatic carotid endarterectomy trial randomized patients half severity appropriate stenosis quality control evaluation outcome events trial achieved three tier review including review medical surgical adjudicators blinded treatment arm patient baseline characteristics patients eligible randomized similar patients randomized two percent patients randomized surgical arm declined surgery crossed medical arm elected surgery randomization medical arm studies well veterans administration trial continuing randomize patients,C10,0.002526906,0.014471595,0.0047149444,0.001420196,0.015750214,0.0032611038,0.24802384,0.0023763329,0.0018268406,0.0024893556,0.05088514,0.0057200706,0.04166208,0.0058101374,0.0022220972,0.028398426,0.2579865,0.0026022943,0.1725727,0.06422019,0.06754945,0.0008972125,0.002612389
sensitivity detecting fibrillation potentials comparison concentric monopolar needle electrodes sensitivity monopolar concentric electrodes detecting fibrillation potentials fp never formally compared studied muscles fp sampling sites concentric monopolar needles concentric needle identified mean standard deviation sites spontaneous activity although statistically significant wilcoxon signed rank test p less difference sensitivity appreciably affect diagnostic interpretation subjects described concentric needles painful needle insertions muscles demonstrated needle movement generated majority fp suggest increased tissue injury caused concentric needles may account increased sensitivity discomfort,C10,0.02019502,0.0030669258,0.106874235,0.0019425971,0.004814993,0.0044620126,0.22553347,0.003251423,0.035975672,0.036832117,0.12889707,0.00791606,0.1136814,0.008432208,0.0030403896,0.022090355,0.06691903,0.003584619,0.0039368095,0.044693902,0.14906722,0.001227613,0.0035648472
white matter hyperintensities dementia alzheimer type healthy subjects without cerebrovascular risk factors magnetic resonance imaging study weighted magnetic resonance images used study prevalence subcortical white matter hyperintensities wmhis patients dementia alzheimer type dat age matched older healthy control subjects younger healthy control subjects exclusionary criteria groups included cerebrovascular risk factors subjects hachinski ischemic index scores less computed tomographic scans showing infarct wmhis classified periventricular wmhis deep wmhis graded indicated absent severe group dat older control subjects periventricular wmhis deep wmhis graded fewer subjects respectively whereas younger control subjects ratings grade less serum cholesterol systolic blood pressure values although within normal range elevated significantly older control subjects compared younger control subjects significant differences wmhi ratings blood pressure cholesterol triglyceride levels found patients dat age matched control subjects systolic blood pressure levels correlated severity periventricular wmhis older control subjects age correlated periventricular wmhis deep wmhis within older control subjects patients dat significant correlation wmhis severity dementia group dat results suggest subjects screened cerebrovascular risk factors wmhis rare occur identical frequency patients dat age matched healthy control subjects,C10,0.010198828,0.0014123062,0.002970765,0.00089468015,0.033633955,0.008855527,0.103130385,0.009200442,0.0011510452,0.0015643694,0.06668963,0.03591492,0.4246696,0.012342294,0.024509996,0.0024792906,0.06646476,0.0016398216,0.0018128838,0.13548088,0.052777465,0.0005653105,0.001640866
magnetic resonance imaging demonstrates electric stimulation cerebellar fastigial nucleus reduces cerebral infarction rats sought determine whether high spatial resolution magnetic resonance imaging useful noninvasive quantitation ischemic infarct produced occlusion middle cerebral artery detection reduced infarct volume elicited electric stimulation cerebellar fastigial nucleus male rats spontaneously hypertensive strain anesthetized middle cerebral artery occluded fastigial nucleus stimulated hour twenty four hours later rats reanesthetized weighted images obtained rats killed volume distribution lesion established histopathology magnetic resonance imaging estimates lesion volume mm middle cerebral artery n mm middle cerebral artery fastigial nucleus stimulation n reduction p less histopathological analysis revealed lesion mm involving somatosensory cortex lateral caudate putamen lateral hippocampus fastigial nucleus stimulation resulted reduction infarct volume mm retrieved zone largely cortex dorsal ventral lesion mostly posterior lesion estimates lesion volume magnetic resonance imaging histopathology differ highly correlated r p less study confirms previous finding fastigial nucleus stimulation reduces volume focal ischemic infarct demonstrates magnetic resonance imaging accurately estimates volume lesion also detect changes small mm,C10,0.12601396,0.0015052694,0.011366895,0.00095344067,0.15547624,0.0021899878,0.08099413,0.018023388,0.0012268112,0.001667342,0.07801668,0.0034902787,0.119355746,0.003989003,0.0014922451,0.0026424867,0.06410058,0.0017559611,0.01012868,0.03639405,0.26797056,0.0006025213,0.010643705
systems analysis cerebrovascular pressure transmission observational study head injured patients observational study head injured patients cerebrovascular pressure transmission investigated using systems analysis approach whereby blood pressure bp waveform used measure input stimulus cerebrovascular bed cvb intracranial pressure icp waveform response stimulus transfer function measure much pressure transmitted cvb given frequency calculated using fourier analysis pressure waveforms transfer function allows quantification pressure transmission performance cvb thus providing basis comparison normal abnormal function fifteen hundred samples icp bp waveforms collected head injured patients via microcomputer line spectral analysis waveform database revealed four main classes transfer function overall flat transfer function curve type elevated low frequency response curve type elevated high frequency response curve type exhibiting elevated low high frequency response curve type curve types often associated raised icp greater mm hg whereas curve types often affiliated icp less mm hg studies type may provide insight pathophysiology cvb ultimately aid prediction treatment raised icp,C10,0.042354528,0.0015696469,0.020418802,0.010576474,0.0024701543,0.0023267888,0.32962006,0.001664072,0.0012792796,0.0017386511,0.059704076,0.0036655734,0.2579146,0.004295559,0.010116914,0.011300503,0.055213843,0.01054193,0.027710631,0.024994198,0.118065104,0.00062829,0.0018302997
effects vagal stimulation experimentally induced seizures rats repetitive stimulation vagus nerve inhibits chemically induced seizures dogs report results conclusions studies designed answer immediate questions raised finding maximal stimulation vagal c fibers frequencies greater hz prevents reduces chemically electrically induced seizures young male rats antiepileptic potency directly related fraction vagal c fibers stimulated vagal stimulation shortens shut chemical seizure begun rats optimal stimulus frequency approximately hz duration stimulus ms stimulus strength mm nerve cross section results taken together similar results obtained dogs monkeys humans strongly suggest periodic stimulation vagus nerve using appropriate stimulation parameters powerful method preventing seizures data literature suggest antiepileptic actions vagal stimulation largely mediated widespread release gaba glycine brainstem cerebral cortex probable pathway via projections nucleus solitary tract reticular formation thence diffuse projections cortex areas intermittent vagal stimulation potentiality reducing number intensity seizures patients intractable epilepsy results indicate feasibility studies humans continued expanded,C10,0.012768218,0.023043977,0.014600426,0.026311016,0.0030361468,0.0028336658,0.20559047,0.015883725,0.012127723,0.012687831,0.03722402,0.004489632,0.034537636,0.08584912,0.0132383695,0.024489786,0.033113867,0.0022619343,0.013028316,0.07936557,0.34048605,0.0007741831,0.0022583057
semantic deterioration alzheimer patterns expect differentiating language changes normal aged early stages dementia never simple knowing differences expect aid making diagnosis,C10,0.0071844966,0.0063730073,0.04818483,0.0040366757,0.010004184,0.009271967,0.24200639,0.0067563877,0.005194071,0.00705919,0.07936698,0.015025008,0.097240545,0.017086519,0.006317865,0.0111877555,0.09987218,0.0074101393,0.008180606,0.17717007,0.12511241,0.0025509538,0.0074077332
early cerebral infarction gadopentetate dimeglumine enhancement gadopentetate dimeglumine administered prospectively patients presented magnetic resonance mr imaging within weeks cortical cerebral infarction twenty two patients imaged within days clinical ictus abnormalities detected gadopentetate dimeglumine enhancement observed patients classic parenchymal enhancement late finding observed patients imaged days infarction time three additional phases contrast material related abnormalities observed enhancement vessels supplying infarct intravascular enhancement sign earliest finding seen infarcts aged days day day abnormal enhancement meninges adjacent infarct frequently noted meningeal enhancement sign finally transition phase combined intravascular meningeal enhancement early parenchymal enhancement seen day day gadopentetate dimeglumine enhanced mr imaging early stroke reveals evidence vascular engorgement sluggish flow precede development classic parenchymal enhancement,C10,0.06369125,0.0022415433,0.02916461,0.001419798,0.10420825,0.0032611787,0.267817,0.0024043727,0.0018268825,0.026945267,0.036043957,0.005267753,0.029280093,0.00590408,0.014442921,0.04063273,0.13053524,0.0026127656,0.0028773202,0.01760565,0.20831393,0.0008972331,0.00260614
motor unit discharge characteristics short term synchrony paraplegic humans frequency firing regularity discharge human motor units short term synchrony pairs motor units assessed extensor digitorum communis edc tibialis anterior ta muscles control subjects clinically complete paraplegic subjects discharge pattern ta motor units paraplegia ranged extremely regular irregular different motor units whereas control population edc groups narrow intermediate range regularity little difference incidence degree short term synchrony sts edc paraplegic normal subjects contrast virtually sts motor units observed ta muscles paraplegic group whereas control subjects exhibited approximately amount sts ta edc muscles concluded extra burden placed arm muscles paraplegia change amount synchronisation motor units furthermore section spinal cord increase sts predicted lesions reticulospinal tract cats may reflect coincidental removal supraspinal synchronising inputs motoneurons reorganisation synaptic inputs chronic paraplegia,C10,0.002763765,0.0024515975,0.0051595788,0.0015528469,0.019463189,0.0035667827,0.11845208,0.015973127,0.06889408,0.0027155615,0.03925135,0.0380714,0.22087272,0.007928405,0.0024303852,0.017678548,0.06477142,0.016291648,0.003146953,0.054802958,0.28990144,0.0009813126,0.002878852
influence amphetamine treatment somatosensory function normal infarcted rat brain consequences acute amphetamine administration metabolic responsiveness cerebral cortex physiologic activation studied normal infarcted rats treated rats received mg kg intravenous injection amphetamine hour unilateral vibrissae stimulation deoxyglucose study nontreated normal rats metabolic activation restricted major relay stations vibrissae barrel circuit amphetamine treated rats stimulation induced increased glucose utilization widespread including ipsilateral contralateral cortical regions outside barrel field circuit example increase glucose utilization control seen cortical areas anterior barrel field region increased glucose utilization induced stimulation severely depressed nontreated rats undergone infarction left cortical barrel field weeks previously vibrissae stimulation failed increase glucose utilization significantly cortical areas remote infarct contrast bilateral increases glucose utilization observed within cortical regions treated infarcted rats example increase glucose utilization detected cortical areas bordering infarct thus normal infarcted rat amphetamine appears promote alternate circuit activation pharmacologic property may advantageous recovery injury,C10,0.079109155,0.0017663778,0.00933147,0.0011188273,0.0027728148,0.0025698696,0.09164037,0.011510441,0.0014396175,0.0019565641,0.01858549,0.032153305,0.04769041,0.027265757,0.0017510944,0.012735427,0.022934074,0.041342914,0.0023018338,0.024963751,0.552627,0.010342157,0.0020913032
brain imaging abnormalities mental disorders late life psychiatric inpatients dementia n depression n late life times likely manifest magnetic resonance imaging abnormalities brain elderly controls n controlling effects age gender demented patients distinguishable controls increased prevalence cortical atrophy infarction depressed patients exhibited increased prevalence cortical infarctions leukoencephalopathy patients dementia distinguishable major depression increased prevalence cortical atrophy results indicate major depression late life like dementia associated remarkable increase overt pathologic changes brain,C10,0.05030273,0.0028744463,0.0060463552,0.0018206801,0.05157245,0.051241662,0.16256212,0.0030473643,0.0023427056,0.03455105,0.0618963,0.006863592,0.061323598,0.007453321,0.0028495754,0.005046064,0.13168429,0.019018522,0.0036897361,0.1833047,0.1460245,0.0011505682,0.0033336617
innervation territories touch pain afferents single fascicles human ulnar nerve mapping intraneural microrecording microstimulation peripheral distribution fibre content individual ulnar nerve fascicles supplying skin muscles hand human volunteers indirectly mapped tracing fields projected sensation evoked intraneural electrical microstimulation inms tracing receptive fields delineated intraneural recording afferent impulse activity elicited natural stimulation end organs moderate intensity suprathreshold inms delivered cutaneous fascicles induced nonpainful sensations projecting stereotyped coherent areas skin fascicular projected fields fpfs fascicular receptive fields frfs mapped microneurographic recording determining area skin activated light tactile stimuli elicited afferent neural discharges recorded intraneurally found given electrode position skin nerve fascicle moderate intensity inms induced nonpainful sensations projecting cutaneous field fpf coincides frf high intensity inms induced painful sensations projecting within cutaneous field nonpainful sensations pain induced inms muscle nerve fascicles projected muscles innervated fascicle instances areas beyond muscular receptive field study demonstrates individual ulnar nerve fascicles wrist levels subserve well defined cutaneous territories hand area skin covered sum ulnar fascicular receptive projected fields matches maximal possible cutaneous distribution ulnar nerve insights practical relevance regarding clinical expression fascicular nerve injuries also brought study,C10,0.011631376,0.02104009,0.032616016,0.0107493615,0.060650073,0.0025699944,0.19484022,0.0018727286,0.04964128,0.0019566591,0.021318888,0.025607826,0.10407554,0.018818742,0.033215284,0.012726035,0.018970637,0.011683877,0.0025012386,0.015185547,0.3339965,0.00070707075,0.0136250295
growth factor expression stroke fibroblast growth factors polypeptides potent trophic effects central nervous system cells acidic basic forms fibroblast growth factor found mammalian brain examined expression factors focal brain injury stroke infarction lateral cerebral cortex mature rat brain found twofold threefold increase first weeks stroke levels fibroblast growth factors tissue surrounding infarcts increase persisted least months appeared mainly due increased levels basic acidic fibroblast growth factor gliotrophic angiogenic neuronotrophic properties basic fibroblast growth factor may play important role cascade cellular reactions contributes wound healing functional recovery stroke,C10,0.084163256,0.0028745227,0.0070160488,0.017477239,0.0045123524,0.0041820887,0.20663968,0.018732192,0.0023427678,0.003184023,0.0152619155,0.02231209,0.022365987,0.16362688,0.018528802,0.005046198,0.047620106,0.01901653,0.019365178,0.055695854,0.2236293,0.0011505989,0.03525639
dissociation pain autonomic disturbances cluster headache relationship pain autonomic disturbances cluster headache studied patients whose attack always recurred side others whose attack affected either side different occasions one seven patients facial flushing ocular sympathetic deficit observed original side headaches patients orbital region warmer painful side three cases region cooler attacks lacrimation rhinorrhoea common severe attacks temperature difference orbits increased increasing severity pain findings support view certain autonomic disturbances cluster headache provoked pain residual autonomic dysfunction could influence autonomic activity cluster headache residual dysfunction pain free side could explain dissociation autonomic disturbances pain observed cases,C10,0.0029313345,0.07326902,0.029275334,0.015767839,0.0040659327,0.017890893,0.15393035,0.016873863,0.0021109914,0.031134697,0.056381024,0.0060489457,0.1470026,0.0068389233,0.0025677271,0.0045469636,0.1514846,0.06398456,0.0033247885,0.024260884,0.18218005,0.0010367669,0.0030919437
clinical characteristics migraine episodic tension type headache relation old new diagnostic criteria eighty one patients diagnosed migraine tension headache according previously used criteria performed standardized interview determine frequency severity headache characteristics used new operational diagnostic criteria international headache society ihs every patient original diagnosis fulfilled also ihs criteria patients criteria fulfilled half less attacks applying ihs criteria also achieved additional diagnosis one patient attacks fulfill pain criteria migraine tension headache fulfill criteria accompanying symptoms overall ihs criteria sensitive specific may possibly improved regard accompanying symptoms present study suggests recording frequency graded severity characteristics using headache diary may improve distinction different types headache,C10,0.0025581883,0.0022692406,0.018803665,0.001437422,0.003562196,0.0033014752,0.40700153,0.002405751,0.0018494562,0.0025216641,0.23966861,0.0052617043,0.04651507,0.006111802,0.0022496062,0.003983631,0.08919868,0.0026345097,0.015271731,0.054577813,0.0852733,0.00090831966,0.0026346012
deteriorating ischemic stroke risk factors prognosis determine risk profile deterioration cerebral infarction less hours duration studied prospectively series clinical radiologic data patients evaluated canadian neurological scale score barthel index follow period months deterioration st hours patients high systolic blood pressure elevated blood sugar concentration admission carotid territory involvement independently related deterioration logistic regression analysis death occurred patients deteriorating infarcts stable infarcts end study functional capacity lower deteriorating infarcts groups improved parallel th day onward,C10,0.06031397,0.016910467,0.005526544,0.015997354,0.0041243117,0.0038224487,0.13145687,0.0027853793,0.0021413008,0.0029102121,0.057728022,0.04875485,0.15575784,0.0068102563,0.0026045947,0.018945107,0.15292655,0.003050236,0.0033725258,0.123619206,0.17633203,0.0010516527,0.0030583127
responses intercostal muscle biopsies normal subjects patients myasthenia gravis order evaluate mechanisms weakness muscles patients myasthenia gravis mg intercostal muscle biopsies obtained normal subjects mg patients compound muscle action potential ap tension responses nerve muscle stimulation contracture responses exposure caffeine monitored vitro normal muscle stimulation nerve muscle hz ap responses showed decrement amplitude one third attributable failure neuromuscular transmission two thirds failure muscle membrane excitation stimulation hz ap responses showed little decrement contractile responses showed significant fade tension due failure e c coupling contractility muscle patients generalized mg stimulation nerve frequencies hz caused much greater decrement aps fade tension responses normal muscle due mainly failure neuromuscular transmission however hz decrement aps due failure muscle membrane excitation hz fade tension due failure e c coupling contractility normal muscle direct stimulation contraction half relaxation times slower tetanic tension smaller normal muscle especially mg patient thymoma caffeine induced contractures smaller mg muscle normal muscle results indicate weakness mg muscle due mainly failure neuromuscular transmission also partly due reduced e c coupling contractility,C10,0.0018211995,0.06315439,0.04897495,0.0010203706,0.0025288076,0.0023437215,0.08661318,0.0017115568,0.14198542,0.0017843867,0.012451763,0.012515731,0.09550573,0.0044518784,0.0015969983,0.011614653,0.084179044,0.0018728056,0.028439684,0.042492762,0.35042784,0.0006448173,0.0018682968
effects physostigmine spatial attention patients progressive supranuclear palsy tested patients progressive supranuclear palsy control subjects task visuopatial attention targets preceded cues side termed validly cued opposite side invalidly cued subjects validly cued targets responded faster invalidly cued difference reaction times invalidly validly cued targets hypothesized measure attentional movement significantly increased patients performance controls certain neuropsychological tests correlated attentional ability correlations altered progressive supranuclear palsy physostigmine treatment patients induced speeding responses invalidly cued targets function duration disease studies show defects cognition attention patients progressive supranuclear palsy demonstrate physostigmine reduces abnormal visual attentional performance,C10,0.0030955852,0.032708235,0.020745756,0.0017388554,0.018528124,0.063919894,0.16768312,0.00291041,0.00223742,0.0030408464,0.051528912,0.0064633605,0.17530674,0.023152452,0.0027215101,0.0048192847,0.1112139,0.06311379,0.0035239125,0.072839126,0.16442609,0.0010988596,0.003183841
fractures clivus classification clinical features fractures clival complex diagnosed series patients admitted maryland institute emergency medical services system university maryland medical system month period fractures divided pathologically three types based upon appearance computed tomography longitudinal transverse oblique mechanisms injury similar groups glasgow coma scale scores admission comparable regardless fracture type survivors nonsurvivors longitudinal fractures associated severe injury central nervous system brain stem infarction patients died transverse fractures clival complex found patients died patients fractures petrous ridge survivors multiple cranial nerve deficits one patient developed carotid cavernous fistula patients oblique clival fractures survived multiple cranial nerve palsies addition one patients developed carotid cavernous fistula using present generation computed tomographic scanners fractures clival complex reliably diagnosed probably common previously believed separated three groups based characteristics computed tomographic scans clinical findings,C10,0.027748035,0.002041844,0.0046714656,0.0012933983,0.014511579,0.010952797,0.2911173,0.013300916,0.0016641255,0.0022616896,0.11131605,0.060661066,0.03863261,0.016843867,0.013160638,0.0035844382,0.21108162,0.00237051,0.013753748,0.08185192,0.073993795,0.00081729854,0.0023692357
vasoactive peptide release extracerebral circulation humans migraine headache innervation cranial vessels trigeminal nerve trigeminovascular system recently subject study view possible role mediation aspects migraine since stimulation trigeminal ganglion humans leads facial pain flushing associated release powerful neuropeptide vasodilator substances local release extracerebral circulation humans determined patients either common classic migraine venous blood sampled external jugular cubital fossa ipsilateral side headache plasma levels neuropeptide vasoactive intestinal polypeptide substance p calcitonin gene related peptide determined using sensitive radioimmunoassays peptide values cubital fossa external jugular control population compared substantial elevation calcitonin gene related peptide level external jugular cubital fossa blood seen classic common migraine increase seen classic migraine greater seen common migraine peptides measured unaltered finding may importance pathophysiology migraine,C10,0.0026917628,0.015415942,0.017284418,0.0015123916,0.0037481943,0.00347386,0.24711473,0.029999964,0.0019460246,0.002644815,0.028528273,0.018763712,0.1483212,0.0082716765,0.01539362,0.01718961,0.036135904,0.0027720693,0.016082391,0.053801164,0.30544457,0.00095574715,0.022507945
long term potentiation electrotonic coupling mixed synapses long term potentiation chemical synapses closely related memory learning studies process concentrated chemically mediated excitatory synapses contrast activity dependent modification gap junctions also widely exist higher structures hippocampus neocortex described report mixed synapses sensory afferents identified reticulospinal neuron electrotonic coupling potential potentiated well chemically mediated excitatory postsynaptic potential prolonged time period using stimulation paradigm like produces long term potentiation hippocampus effect coupling due increase gap junctional conductance data indicate potentiation synaptic components requires increase intracellular calcium involves activation nmda n methyl aspartate receptors specific tetanized pathway,C10,0.003007659,0.0026656452,0.020151852,0.016223224,0.004184462,0.0038781967,0.37141532,0.0028276094,0.0021725304,0.0029526558,0.01664726,0.0061808503,0.022805393,0.12253183,0.002642581,0.004679516,0.11306086,0.04530404,0.003421712,0.048564,0.16587484,0.0010669904,0.01774096
correlation clinical computed tomographic findings stroke patients evaluated correlation clinical features computed tomographic findings prospective study consecutive patients acute cerebrovascular disease seen year patients symptoms signs initially suggested cerebrovascular disorder computed tomography revealed relevant lesion hemorrhagic ischemic significant nonstroke abnormality among remaining patients symptoms signs suggesting central nervous system disorder stroke computed tomography revealed cerebrovascular lesion lesions ischemic computed tomographic findings compatible final clinical diagnosis patients lesions entire sample patients cerebrovascular disorder would missed without computed tomography hand computed tomography failed visualize cerebrovascular lesion patients lesion clinically obvious results emphasize careful neurologic assessment policy early computed tomography crucial importance diagnosis stroke therapeutic considerations,C10,0.0024091653,0.0021370498,0.0044952524,0.0013536116,0.13695672,0.0031091531,0.36706161,0.0022656082,0.0017417192,0.028179022,0.088927664,0.004955777,0.042628683,0.02884485,0.013776971,0.003751571,0.18149091,0.0024839411,0.014396472,0.030082995,0.0356174,0.00085540704,0.0024784603
childhood stroke minor neck trauma case report cerebral infarction minor trauma neck rarely reported case presented child trauma vertebrobasilar artery resulting stroke computerized tomography scan angiography results presented despite two subsequent separate transient episodes vertigo child good functional recovery complete restoration language cognitive function months residual impairments identified mild right sided ataxia hemiparesis,C10,0.042643357,0.022801768,0.0074488726,0.0022430066,0.005577659,0.0051520322,0.28662625,0.061729018,0.0028861214,0.06189935,0.099825606,0.008211018,0.053551093,0.009179105,0.0035105653,0.006216553,0.11593679,0.0041112164,0.00454561,0.08578818,0.10459244,0.001417455,0.0041069407
slow release carbamazepine treatment poorly controlled seizures thirty three children poorly controlled epilepsy six new patients treated slow release carbamazepine twelve former reduction number seizures half fewer side effects three new patients stopped seizures variations plasma concentrations doses significantly less patients took slow release preparation compared standard preparation slow release carbamazepine may improve conditions children whose seizures poorly controlled,C10,0.003991627,0.0035407727,0.0074479626,0.040888432,0.0055582146,0.005151403,0.2998224,0.0037537748,0.002885769,0.06189335,0.019031651,0.008210226,0.0882407,0.009880056,0.0035101364,0.006215794,0.14271744,0.0041107144,0.004545055,0.032640886,0.24043992,0.0014172818,0.004106439
ionic channels cholinergic mechanisms recovery sensorimotor function neocortical infarcts rats unilateral photochemical infarcts produced hind limb sensorimotor neocortex rats intravenous injection fluorescein derivative rose bengal focal illumination intact skull surface facial contact stimuli governed degree recovery rate contralateral tactile proprioceptive forelimb placing reactions contralateral forelimb placing recovered whereas hind limb placing resistant recovery infarcted rats displayed marked recovery spontaneous limb usage beam traversing however deficits isolated tactile proprioceptive hind limb placing reactions endured posttreatment class iv calcium antagonist flunarizine neocortical infarction protected sensorimotor function dose dependent manner protective effect may due peculiar ionic channel blocking profile flunarizine scopolamine hydrobromide reinstated contralateral placing errors infarcted rats dosage affect neurologically intact rats cognitive enhancer sabeluzole novel benzothiazol derivative dose dependently blocked anticholinergic induced deterioration sensorimotor deficit rats,C10,0.0906068,0.002554101,0.025934633,0.0016177727,0.004009363,0.003715913,0.15091138,0.0027077477,0.0020816205,0.0028291014,0.027137727,0.033794593,0.02519025,0.06822683,0.016465763,0.0044837007,0.102583185,0.0029652228,0.00327853,0.03687509,0.37411025,0.01495828,0.0029621387
pharmacologic treatment noncognitive behavioral disturbances elderly demented patients fifty nine elderly residents long term care facilities dsm iii diagnoses dementia studied week randomized double blind comparison trial haloperidol oxazepam diphenhydramine test efficacy agents treatment clinically significant behavioral disturbances patients dementia three agents demonstrated modest significant efficacy measured clinician ratings agitated behavior activities daily living absolute magnitude improvement greater haloperidol diphenhydramine oxazepam differences among groups approach statistical significance frequencies acute adverse events trial similar across drug treatment groups although drugs may differ terms long term safety efficacy appear equivalent short term management agitated behavior severely demented patients,C10,0.0026916363,0.0023876159,0.0310818,0.0015123207,0.003748444,0.003473697,0.30942938,0.0025312474,0.0019459333,0.0026446907,0.03899505,0.032509178,0.12212157,0.035099432,0.002366957,0.017211866,0.11363755,0.0027719392,0.055183385,0.12116826,0.09376325,0.0009557023,0.0027690562
foci increased signal intensity mr images healthy elderly subjects follow study month follow study conducted healthy elderly subjects without foci increased signal intensity mr imaging subjects differ respect health status cognitive performance measured cognitive subscale cambridge mental disorders elderly examination mini mental state examination follow significant decline performance digit symbol substitution test subjects evidence foci compared performance subjects without foci may indicate presence foci correlated subtle difficulties learning memory,C10,0.0035774654,0.0031733904,0.0066751796,0.0020100318,0.022205722,0.0046169055,0.19588439,0.003364292,0.0025863482,0.0035150698,0.06862601,0.0073581627,0.22909436,0.008736272,0.003145933,0.005570858,0.08999798,0.0036841964,0.021388393,0.17615989,0.13300873,0.0012702281,0.0043502175
igm deposits nodes ranvier patient amyotrophic lateral sclerosis anti gm antibodies multifocal motor conduction block studied patient amyotrophic lateral sclerosis multifocal motor conduction block igm anti gm antibodies sural nerve biopsy demonstrated deposits igm nodes ranvier direct immunofluorescence deposits granular located nodal gap adjacent myelin internodes instances extended along surface paranodal myelin sheath injected rat sciatic nerve serum igm bound nodes ranvier binding activity removed preincubation gm observations suggest anti gm antibodies may caused motor dysfunction binding nodal paranodal regions peripheral nerve,C10,0.0040703774,0.0036106277,0.032585125,0.002286979,0.005668691,0.005253034,0.15746146,0.0038278322,0.0029427016,0.0039993846,0.020907486,0.028061168,0.12394219,0.09023869,0.0035793872,0.026028503,0.07587217,0.08300424,0.0046347235,0.026814418,0.26160094,0.0014452431,0.03216463
differential effect oncotic pressure cerebral extracerebral water content cardiopulmonary bypass rabbits study effect oncotic pressure brain water content cardiopulmonary bypass cpb anesthetized new zealand white rabbits underwent min nonpulsatile cpb normothermia animals grouped according composition circuit priming fluid group animals n received priming fluid hydroxyethyl starch n nacl mosm kg mean sd maintained normal colloid oncotic pressure cop cpb mmhg group animals n received priming fluid n nacl mosm kg led hypooncotic state cop mmhg blood chemistries hemodynamics recorded every min cpb animals given additional priming fluid sodium bicarbonate cpb maintain circuit flow ml kg min arterial ph greater significant differences groups respect temperature central venous pressure mean arterial pressure pao paco plasma sodium concentration osmolality time cpb although osmolality increased groups min bypass animals killed organ water contents determined wet dry weight ratios separate group nine similarly prepared anesthetized animals undergo cannulation cpb also underwent measurement plasma chemistries tissue water contents served nonbypass controls group brain kidney water contents unaffected oncotic pressure whereas duodenum skeletal muscle significantly greater water content p p respectively hypooncotic cpb,C10,0.04114714,0.0015432278,0.011663659,0.0009774837,0.0024225197,0.002245213,0.10141738,0.0016360637,0.009677721,0.0017093875,0.0083372565,0.1464101,0.3586018,0.0040916717,0.0015298752,0.00271497,0.06251613,0.0017918424,0.0019809392,0.022623662,0.21255447,0.0006177151,0.0017897707
efficacy methylphenidate among mentally retarded children attention deficit hyperactivity disorder twelve children iq scores educable mental retardation met rigorous diagnostic criteria attention deficit hyperactivity disorder participated double blind crossover study efficacy two doses methylphenidate compared placebo dependent measures included behavioral ratings classroom work output laboratory measures attention learning direct observations social behavior improvement medication conners hyperactivity index observed subjects significant increases work output task behavior attentional skills associated methylphenidate however gains measures attention associated improvement learning measured paired associate learning task additionally significant increases appropriate social interactions free play associated methylphenidate results suggest mentally retarded children attention deficit hyperactivity disorder respond methylphenidate similar rates similar domains nonretarded population,C10,0.0025583676,0.0022693996,0.029542744,0.0014374424,0.015926331,0.04044758,0.26641876,0.0024059198,0.0018495858,0.039670646,0.03697511,0.03007541,0.16834421,0.03373659,0.0022497638,0.016366024,0.03671562,0.0026346943,0.027680967,0.13456148,0.10459304,0.00090838334,0.0026319542
anencephaly clinical determination brain death neuropathologic studies twelve liveborn anencephalic infants serially examined determine would meet clinical criteria whole brain death within day period protocol infants received intensive care including intubation birth protocol infants received intensive care period death imminent brain death determined absence brainstem function including loss cranial nerve responses sustained apnea pco greater torr hours confirmation findings outside consulting child neurologist initial examinations infants revealed spontaneous movements startle myoclonus suck root gag responses increased tone deep tendon reflexes absent pupillary responses absent oculocephalic corneal responses absent auditory moro responses nonvisualization optic nerve mild depression neurologic function occurred first several days life subsequently infants responses easier elicit sustained infants met clinical criteria brain death neuropathologic findings indicated observed complex motor responses based upon cortical activity infant normally formed cerebrum brainstem neuronal activity may accounted motor responses patients even level neurons scanty absent findings suggest although rare clinical brain death determined liveborn anencephalic infants ophthalmologic otologic developmental abnormalities may confound examination cranial nerve function absence cortical neurons supports widely held opinion infants experience sensation,C10,0.047471266,0.001401626,0.0108031435,0.0008877928,0.0022054638,0.024980733,0.23640949,0.009130829,0.0011423408,0.009201657,0.062701955,0.021835081,0.07968409,0.028863218,0.0013894986,0.0024605417,0.037534326,0.0016389136,0.0017991744,0.22065264,0.19561173,0.00056103553,0.0016334216
limited diagnostic investigation obstructive sleep apnea syndrome oximetry static charge sensitive bed simplified sleep apnea investigation consisting combined oximetry respiration movement monitoring compared conventional polysomnography two types recordings performed simultaneously one night patients suspected obstructive sleep apnea syndrome osas static charge sensitive bed scsb used simplified recording provides comfortable reliable means recording respiration movements periods obstructive apneas gave diamond shaped periodic respiration movement pattern scsb usually accompanied repetitive oxygen desaturations average number desaturations greater equal percent per sleeping hour termed oxygen desaturation index odi compared apnea index ai whole population well correlated p less r individual cases considerable discrepancies patients periodic respiration movements less percent total sleeping time odi less never ai greater equal whereas patients periodic respiration greater percent odi greater always ai greater equal fifty one patients fulfilled criteria bradycardia response apneas absent percent patients ai greater equal combination respiration movement oximetry recording thus seems give sufficient information confirm negate diagnosis osas majority patients clinical symptoms borderline patients investigations performed,C10,0.0022516025,0.0019972837,0.047520883,0.0012651474,0.036925796,0.0029058103,0.200492,0.0021174343,0.012516403,0.013986962,0.08090277,0.004771717,0.13736232,0.005326247,0.0019800505,0.0035062132,0.19892225,0.0023224466,0.0025637806,0.10119361,0.09244463,0.044400163,0.0023244896
brain protection physiological pharmacological considerations part physiology brain injury ischaemia whether focal global nature produces sequence intracellular events leading increased cell permeability water ions including ca loss cellular integrity function increased production prostaglandins free radicals acidosis lactate accumulation events may exacerbated glucose administration pharmacological agents aimed alleviating ischaemic injury could directed decreasing cerebral metabolic requirements oxygen improving flow ischaemic areas preventing ca induced injury inhibition free radical formation lactate removal inhibition prostaglandin synthesis prevention complement mediated leukocyte aggregation part paper describes pathophysiological events leading ischaemic brain injury part paper consider current agents available brain protection,C10,0.140766,0.03670739,0.004444689,0.001338386,0.0033169521,0.014595777,0.23861212,0.0022614005,0.013125405,0.0023405203,0.02236892,0.02795384,0.029245967,0.06792461,0.002094729,0.02677076,0.023007333,0.020436749,0.002712333,0.043970495,0.26118946,0.00084578525,0.013970346
neonatal monosodium glutamate abolishes corticotropin releasing factor induced epileptogenic activity rats intracerebroventricular c v injection rat corticotropin releasing factor rcrf doses micrograms rats induces epileptogenic activity characterized pacemaker like spikes localized hippocampal leads effect still present rats neonatally treated saline absent neonatally treated monosodium glutamate msg treatment caused marked changes concentration several brain neurotransmitters neuropeptides hypothalamic nuclei crf highly concentrated believed induce endocrinologic behavioral effects present results suggest rcrf induced spiking activity mediated activation neuronal pathways sensitive msg neurotoxic effect,C10,0.01892717,0.00287456,0.019568745,0.0018207522,0.004512411,0.004182143,0.20444103,0.0030474847,0.0023427983,0.0032221745,0.014903296,0.032525945,0.043730322,0.061022226,0.002849688,0.005046264,0.072111264,0.041584883,0.0036898819,0.03677018,0.3916683,0.0011506138,0.028007861
familial trigeminal neuralgia charcot marie tooth neuropathy report two families review typical trigeminal neuralgia occasionally occurred multiple members family several generations clinical features cases including increased incidence females absence apparent hereditary neurologic metabolic structural abnormalities identical sporadic cases rarely familial trigeminal neuralgia described setting hereditary peripheral neuropathy especially charcot marie tooth disease describe patients two different families charcot marie tooth disease medically intractable trigeminal neuralgia patients successfully treated percutaneous retrogasserian glycerol rhizolysis occurrence cranial nerve symptoms patients demyelinating peripheral neuropathies discussed light current hypotheses regarding etiology trigeminal neuralgia,C10,0.002839825,0.0025190664,0.005298819,0.0015955819,0.0039543663,0.028066399,0.25862786,0.01640915,0.002053067,0.017617509,0.094031714,0.005840977,0.08723589,0.052717358,0.029968858,0.018167289,0.103352316,0.016651735,0.02005946,0.09216019,0.13690273,0.0010083186,0.0029215072
electroencephalography routine evaluation syncope adults reviewed reports electroencephalograms obtained nashville tenn veterans administration hospital september august seventy three patients referred evaluation syncope near syncope patients abnormal findings twenty six patients referred complaints similar syncope ie blackouts loss consciousness falling passing fainting patients five abnormal findings reviewed medical records patients abnormal findings found final diagnosis treatment syncope affected electroencephalogram one patient findings suggest routine electroencephalography significant value evaluation syncope adults,C10,0.0037055272,0.0032869873,0.006914129,0.0020819844,0.05897672,0.0047821756,0.33675122,0.0034847225,0.0026789312,0.003640898,0.14581916,0.007648485,0.072876714,0.008559977,0.003258547,0.0057702763,0.17964779,0.0038160784,0.0042192875,0.056839794,0.08011277,0.001315698,0.0038121096
onset phase spinal bupivacaine analgesia assessed quantitatively laser stimulation analgesia assessed quantitatively various dermatomes c l l first min subarachnoid administration bupivacaine ml stimulation needles laser stimulation could evoke pain dermatomes adequate analgesia single needle stimulation analgesia assessed thresholds sensory pain pain related brain potentials amplitude latency laser stimulation little analgesia found increased gradually towards caudal segments dermatome related site injection l blocked greater extent surrounding dermatomes conduction time latency evoked brain potential increased relatively dermatome compared l,C10,0.036323197,0.003016318,0.00634478,0.0019105419,0.00473494,0.037297927,0.19065745,0.0031977703,0.0024583326,0.036262397,0.019040227,0.023450522,0.15115584,0.04155477,0.0029902195,0.05564647,0.09749876,0.0035147283,0.0038718472,0.027558753,0.24679776,0.0012073559,0.0035091192
platelet monoamine oxidase activity female migraine patients platelet monoamine oxidase activity mao group n white female migraineurs acute migraine attack similar values obtained group patients two three weeks headache episode pain free period results obtained group n sex race matched age comparable drug free healthy volunteers blind study substrate p tyramine p methoxybenzylamine nmole hr platelets sd respectively patient serving control mao activity migraine episode pain free failed show significant trend neither number medical conditions use several medications appeared significantly influence results present work dealing small well defined patient population argues possible usefulness platelet mao activity biological marker migraine headaches,C10,0.0026568468,0.0023567555,0.017803563,0.0014927738,0.0036995749,0.003428799,0.2131096,0.0024985308,0.014780786,0.002610508,0.016170505,0.052040122,0.049642634,0.006506149,0.002341646,0.004137263,0.09156329,0.0027361116,0.01587958,0.19159932,0.299269,0.00094334973,0.002733266
study seasonal variation migraine available evidence supports contention migraine involves disturbance serotonin function several parameters serotonin function humans found vary seasonally may underlie seasonal fluctuations observed many clinical neuropsychiatric phenomena thought involve serotonin dysfunction therefore postulated migraine headaches might also vary seasonally examined admissions hospital year period primary diagnosis migraine peak admissions found occur frequently spring females comparison males p less equal chi square implications findings discussed,C10,0.003345501,0.019161034,0.0062423577,0.0018797006,0.0046585044,0.0043175435,0.34667462,0.0031461497,0.0024186482,0.0032871512,0.034447964,0.0068810564,0.16072853,0.010581032,0.002941949,0.021402026,0.114339575,0.019595891,0.003809345,0.06821054,0.15725692,0.0011878659,0.0034861162
signs distinguishing spasmus nutans without central nervous system lesions infantile nystagmus clinical findings well eye head movement recordings analyzed patients spasmus nutans without central nervous system cns changes patients spasmus nutans like disease head nodding intermittent nystagmus associated intracranial anomalies visual pathway disorders patients infantile nystagmus ten diagnostic signs established differentiate patient groups although helpful separating patients infantile nystagmus spasmus nutans difference found patients spasmus nutans without cns lesions study indicates eye head movement recordings allow differentiation benign spasmus nutans spasmus nutans like disease differentiation must made basis neuroimaging,C10,0.049526613,0.0028303124,0.021388838,0.0017927256,0.03533585,0.019553732,0.31036887,0.018381996,0.0023067358,0.034024134,0.05877673,0.023935217,0.032165688,0.08596602,0.0028058232,0.0049685873,0.139916,0.0032858946,0.0036330842,0.028576035,0.07981095,0.0011329026,0.03951727
syncope presyncope associated probable adverse drug reactions purpose study determine whether syncope presyncope associated drug therapy patients referred tertiary care ambulatory clinic drug use information obtained validated classified potential cause syncope presyncope utilizing standardized adverse drug reaction algorithm nine patients rated probable drug induced syncope presyncope events overall medications implicated patients probable adverse drug reactions older taking medications taking antihypertensive seven nine patients probable adverse drug reactions previously classified syncope unknown origin initial clinic evaluation syncope presyncope commonly associated adverse drug reactions especially elderly taking multiple medications,C10,0.002801129,0.0024847412,0.005226616,0.00157384,0.017459655,0.0036150026,0.36906266,0.0026342154,0.0020250916,0.0027522736,0.088108785,0.0061300127,0.017339502,0.0065558,0.015987027,0.00436194,0.093539156,0.0028846983,0.0031894972,0.24401353,0.10437776,0.000994579,0.0028824904
untying gordian knot genetics tourette syndrome review current status genetics tourette syndrome presented course years since gilles de la tourette described syndrome bears name body carefully collected described analyzed data produced model genetics implicates single dominant gene variably penetrant males females moreover locus action gene likely dopaminergic system midbrain systematic search gene using recombinant dna techniques way,C10,0.0041524675,0.0036834457,0.027814128,0.002333102,0.005782179,0.0053589754,0.2068302,0.0039050304,0.003002049,0.0040800427,0.068732895,0.0085408315,0.026649406,0.0095478045,0.023386994,0.026566235,0.09617984,0.004276353,0.004728195,0.15024985,0.116794616,0.0014743903,0.19593099
loss consciousness emergence anaesthesia case suspected micturition syncope case postanaesthesia micturition syncope respiratory arrest described syncope occurs temporary myocardial ischaemia cerebral hypoperfusion may increase anaesthetic risk marginally compensated patient loss airway protection syncopal period also cause concern recommend use indwelling bladder catheter prolonged surgical procedure,C10,0.028899098,0.0043891277,0.0331443,0.0027800824,0.0068899407,0.05427428,0.16979429,0.004653164,0.0035771877,0.028810842,0.11595107,0.010177102,0.087565765,0.01142921,0.004351151,0.0077050733,0.18713899,0.0050956253,0.005634032,0.13627945,0.08461301,0.0017568569,0.0050903256
triiodothyronine brain excitability investigated mechanisms involved thyroid hormone action brain excitability effect acute exposure triiodothyronine rat hippocampal slices vitro studied significant changes could detected prevolley field excitatory postsynaptic potentials fepsp population spike amplitude minor nonsignificant trend toward shortening population spike latency time effect penicillin induced epileptiform activity however active accumulation radioactively labeled slices rat cervaux isole preparation used determine focal seizure thresholds visual cortex acute h effects demonstrated significant acute effects brain excitability hippocampus visual cortex observed despite active accumulation thus effect brain excitability likely due delayed effects,C10,0.07191963,0.0024847747,0.04588093,0.015130768,0.003900806,0.0036150517,0.18818106,0.0026443696,0.0020251188,0.016309831,0.022891076,0.019303767,0.06021479,0.021306297,0.0024632753,0.004361999,0.025811307,0.0028847374,0.003221351,0.09278678,0.38877296,0.0009945926,0.0028946798
survey adolescents severe intellectual handicap diagnostic survey undertaken children aged years tameside severe learning difficulties intelligence quotient less equal eighty two children identified medical records reviewed specific diagnosis retardation documented children syndrome probable aetiology disorder unknown aetiology identified children confirm existing diagnosis identify new diagnoses offer genetic counselling parents children offered detailed reassessment child fifty three children reviewed specific disorder identified previously undiagnosed children frequent diagnoses made fragile x syndrome rett syndrome completion survey children specific diagnosis probable aetiology identified associated disorders cerebral palsy nine children clues cause retardation,C10,0.002971249,0.0026271525,0.005526176,0.015987733,0.004124037,0.034864753,0.2555341,0.002785194,0.0021411583,0.1559295,0.18218116,0.0060915975,0.031243734,0.008066263,0.0026044215,0.0046119425,0.07532009,0.0030623977,0.046382286,0.11230749,0.041479733,0.0010515829,0.00310618
temporoparietal cortex aphasia evidence positron emission tomography forty four aphasic patients examined f fluorodeoxyglucose positron emission tomography resting state determine whether consistent glucose metabolic abnormalities present ninety seven percent subjects showed metabolic abnormalities angular gyrus supramarginal gyrus lateral transverse superior temporal gyrus pearson product moment correlations calculated regional metabolic measures performance western aphasia battery significant correlations found western aphasia battery scores right hemisphere metabolic measures left hemisphere regions correlated one score western aphasia battery temporal frontal regions significant correlations comprehension score left temporoparietal region consistently affected subjects suggesting common features aphasias caused left temporoparietal dysfunction behavioral differences resulted extent temporoparietal changes dysfunction elsewhere brain particularly left frontal subcortical areas,C10,0.016140636,0.002451401,0.0051564854,0.0015527224,0.0038481469,0.00365085,0.25981435,0.08287123,0.001997919,0.0027153438,0.07720034,0.045233425,0.19526903,0.0063817105,0.0024301906,0.031057252,0.053112,0.0028459916,0.0031467008,0.033673245,0.16552493,0.0009812339,0.0029448539
discriminant validity study negative symptoms special focus depression antipsychotic medication construct validity negative symptom syndrome established conceptual operational overlap negative symptoms syndromes depression effects medication must explained author assessed patients schizophrenia patients without schizophrenia depression end average week drug washout period approximately months psychotropic medication administration negative symptoms remarkably consistent patients schizophrenia despite pharmacological intervention contrast patients without schizophrenia manifested significant decreases negative symptoms,C10,0.0032404982,0.0028744836,0.0060464335,0.0018207037,0.0045122914,0.066930376,0.23611529,0.0030474039,0.0023427359,0.07976004,0.115178585,0.0066650854,0.024883294,0.007450906,0.0028496124,0.0050461297,0.13716196,0.0033371758,0.0036897839,0.115045,0.16751733,0.0011505831,0.0033342924
auditory evoked responses benign intracranial hypertension syndrome study auditory brainstem evoked responses conducted patients otologic symptoms pulsatile tinnitus hearing loss aural fullness secondary benign intracranial hypertension syndrome abnormalities consisting mainly prolonged interpeak latencies detected one third patients speculated pathophysiologic mechanisms responsible auditory brainstem evoked abnormalities stretching compression cochlear nerve brainstem caused intracranial hypertension primary edema structures due benign intracranial hypertension syndrome normalization improvement noticed majority patients management since number patients study small felt diagnostic prognostic value test needs evaluation,C10,0.06686666,0.0028300225,0.0059529105,0.001792542,0.019886127,0.0041173464,0.21920098,0.003000268,0.0023064998,0.0031466975,0.13761131,0.006561993,0.07238074,0.04162475,0.018243723,0.004968079,0.14228861,0.0032855582,0.0036327122,0.10019367,0.11991495,0.0011327865,0.01906107
myasthenia gravis myasthenia gravis disorder neuromuscular function resulting immunologically based premature destruction acetylcholine receptors disease characterized clinically variable weakness accentuated repetitive muscular activity usually responding administration acetylcholinesterase inhibitors myasthenia gravis complex disease requires understanding many facets natural history immunological basis ensure optimal individual patient management long term goal control immunological imbalance treatment regimens include thymectomy corticosteroids azathioprine plasmapheresis common use acetylcholinesterase inhibitors provides symptomatic relief variable daily muscular activity disability due myasthenia gravis large extent reversible death preventable early recognition myasthenia gravis appropriate treatment often rewarded remission may permanent,C10,0.016849924,0.016246032,0.0053898185,0.0015956146,0.017702993,0.017393062,0.44847563,0.016410036,0.029540807,0.0027903523,0.013345555,0.034621622,0.020684866,0.0068080015,0.0024973217,0.031915165,0.08705493,0.016671533,0.003233625,0.028830066,0.17800653,0.0010083395,0.0029281776
frequency three hex mutant alleles among jewish non jewish carriers identified tay sachs screening program mutations hex gene encoding alpha subunit beta hexosaminidase hex cause tay sachs disease well juvenile chronic adult gm gangliosidoses examined distribution three mutations nucleotide insertion exon g c transversion splice site intron gly ser amino acid substitution exon among individuals enzymatically diagnosed carriers hex deficiency mutation analysis included polymerase chain reaction pcr amplification relevant regions genomic dna followed allele specific oligonucleotide hybridization another test heterozygosity exon insertion based formation heteroduplex pcr fragments low electrophoretic mobility percentage distribution exon intron exon unidentified mutant alleles among jewish carriers hex deficiency among non jewish carriers regardless mutation ancestral origin jewish carriers primarily eastern somewhat less often central europe whereas non jewish carriers western europe twelfth jewish carriers four fifths non jewish carriers hex deficiency mutant alleles three common ones tested enzyme based tests cannot replaced dna based tests present time however dna based tests two carrier couples could identify risk chronic adult gm gangliosidoses rather infantile tay sachs disease,C10,0.0018826418,0.0016699972,0.0035128144,0.0010577796,0.0026215191,0.0024296474,0.23266295,0.03377621,0.0013610662,0.0018498062,0.09744167,0.0038722346,0.06887162,0.0056964676,0.0016555478,0.0030757596,0.03268691,0.10555379,0.005349388,0.11195028,0.09471363,0.0006684577,0.18563981
mechanism stroke patients taking aspirin year period prospectively studied mechanism severity stroke patients sustaining cerebral infarction taking aspirin mechanism stroke undetermined patients remaining patients identified potential mechanisms large artery atherosclerosis patients cardioembolism patients small vessel occlusive disease patients patients carotid atherosclerosis stroke greater carotid stenosis occlusion patients stroke undetermined mechanism previous stroke also undetermined mechanisms disability stroke moderate severe patients data suggest stroke patients taking aspirin variety etiologies frequently causes moderate severe disability patients carotid disease failing aspirin often high grade carotid stenosis occlusion stroke undetermined mechanism may recur frequently stroke subtypes patients taking aspirin,C10,0.053418193,0.002326974,0.004894755,0.0014739101,0.003653324,0.0033854702,0.38626838,0.016156439,0.0018965096,0.0025775197,0.06838436,0.005395571,0.018739462,0.0060392017,0.00230684,0.029481122,0.2685187,0.002701536,0.002986982,0.06495822,0.050806385,0.00093142886,0.0026987265
beneficial effect butanediol cerebral energy metabolism edema following brain embolization rats assessed effect butanediol cerebral energy metabolism edema inducing multifocal brain infarcts rats intracarotid injection microns carbonized microspheres ethanol dimer induces systemic ketosis mmol kg p butanediol injected every hours produce sustained increase plasma level beta hydroxybutyrate treatment significantly attenuated ischemia induced metabolic changes increasing concentrations phosphocreatine adenosine triphosphate glycogen reducing concentrations pyruvate lactate lactate concentration hours embolization decreased respectively brain water content increased six unembolized rats saline treated seven butanediol treated rats hours embolization p less decrease water content associated significant decreases concentrations sodium chloride antiedema effect butanediol could explained osmotic mechanism since equimolar doses urea ethanol ineffective results support hypothesis beneficial effect butanediol mediated cerebral utilization ketone bodies arising butanediol metabolism reducing rate glycolysis deleterious accumulation lactic acid ischemia,C10,0.078925624,0.0019973267,0.015093623,0.0012651108,0.0031353526,0.0029058729,0.13115759,0.00211748,0.0016278434,0.0022123794,0.010355213,0.06874593,0.0703853,0.00535127,0.023203788,0.0035062889,0.04548675,0.002410289,0.0025638358,0.056515172,0.4570244,0.0007994794,0.013214135
neurologic complications cocaine abuse neurologic complications cocaine toxicity responsible major portion morbidity mortality associated cocaine complications appear related hyperadrenergic state induced cocaine may treated symptomatically diazepam effective drug cocaine induced seizures,C10,0.0057781,0.005125463,0.010781335,0.0032464787,0.008045821,0.0074569387,0.3646922,0.005433795,0.004177309,0.0056773224,0.08249089,0.011884447,0.035769667,0.013566621,0.0050811153,0.008997703,0.16283847,0.005950485,0.0065792166,0.07056529,0.16786547,0.0020515933,0.0059442963
lack change neurochemical markers postepileptic phase intrahippocampal tetanus toxin syndrome rats chronic epileptic syndrome induced injecting tetanus toxin rat hippocampus causes functional changes essentially permanent outlasting period active seizures least year long term changes characterized impaired performance range behavioral tasks turn associated physiologic depression hippocampal evoked responses discernible histopathology present study examined hippocampi rats postseizure phase tetanus toxin model observed significant changes concentration neurochemical markers six neurotransmitters therefore long term reduction hippocampal excitability cannot attributed major loss afferents hippocampal neurons using aspartate acetylcholine gamma aminobutyric acid gaba glutamate norepinephrine ne serotonin transmitters,C10,0.0029199808,0.0025901687,0.005448381,0.0016406181,0.018186057,0.017899977,0.29174542,0.0027459853,0.002111016,0.0028690526,0.013977824,0.02012557,0.114436686,0.035835,0.0025677574,0.032816432,0.056158956,0.019783184,0.0033248276,0.09414019,0.25462565,0.001036779,0.0030144863
resistance tubocurarine lower motor neuron injury related increased acetylcholine receptors neuromuscular junction hypothesis lower motor neuron injury associated proliferation acetylcholine receptors achr induces resistance neuromuscular effects tubocurarine dtc tested rat left gastrocnemius denervated lesion sciatic nerve effective dose twitch depression ed studied denervated gastrocnemius compared contralateral undenervated sham injured control gastrocnemius muscles approximately weeks injury achr number quantitated specific ligand alpha bungarotoxin alpha bt plasma dtc concentrations measured high performance liquid chromatography hplc correlated twitch tension spontaneous recovery neuromuscular blockade denervated animal ed mean se dtc denervated leg significantly p less higher mg kg contralateral sham operated left legs twitch tension recovered control twitch height significantly p less higher plasma dtc concentrations denervated micrograms ml compared contralateral micrograms ml limb achr number significantly increased denervated limb fmol mg protein compared contralateral right control left limb significant p less positive correlation r ed achr number variability ed could explained changes achr study therefore confirms hypothesis proliferation achr nerve denervation results resistance neuromuscular effects dtc,C10,0.040939074,0.0017833886,0.0037513312,0.010849237,0.01253134,0.041525003,0.0831681,0.040821467,0.011185698,0.011699475,0.025804507,0.0041730995,0.22990061,0.07832303,0.0017679579,0.0031307223,0.022293111,0.046254363,0.0022892174,0.04143132,0.2638124,0.00071384537,0.021851713
unusual blink reflex four components patient periodic ataxia characteristic findings blink reflex reported year old female periodic ataxia blink reflexes side ipsilateral stimulation consisted four components latencies ms instead usual two components seen normal subjects contralateral side last three components also present second component different normal r response latency shorter normal habituate stimulation rate hz addition affected diazepam third fourth components considered r may consisted three components shorter latency second component could explained facilitation,C10,0.0032921578,0.03479398,0.13364567,0.0018497292,0.0045842254,0.004274,0.2535253,0.018979138,0.0023800835,0.0032347385,0.018265154,0.0067713396,0.10852766,0.007828645,0.0028950404,0.0051265745,0.048806474,0.0033952666,0.003748606,0.1255254,0.20399508,0.0011689257,0.0033868507
increased serotoninergic noradrenergic activity hepatic encephalopathy rats thioacetamide induced acute liver failure functional changes various neurotransmitter systems implicated pathogenesis hepatic encephalopathy study role brain monoaminergic neurotransmitter systems hepatic encephalopathy investigated rats thioacetamide induced acute liver failure concentrations serotonin dopamine noradrenaline metabolites hydroxyindoleacetic acid dihydroxyphenylalanine following inhibition dihydroxyphenylalanine decarboxylase dihydroxyphenylacetic acid homovanillic acid methoxy hydroxyphenyl glycol measured cerebral cortex striatum hippocampus high performance liquid chromatography electrochemical detection hepatic encephalopathy concentrations hydroxyindoleacetic acid increased three brain areas saline treated controls p less concentrations serotonin increased frontal cortex p less frontal cortex hippocampus encephalopathic rats dopamine levels increased p less levels noradrenaline p less decreased associated increased methoxy hydroxyphenylglycol levels p less extent changes correlated stage hepatic encephalopathy hepatic encephalopathy dihydroxyphenylalanine accumulation increased hippocampus unchanged cerebral cortex dopamine noradrenaline dihydroxyphenylacetic acid homovanillic acid concentrations unchanged striatum results study indicate hepatic encephalopathy thioacetamide induced acute liver failure rats associated neurochemical changes suggesting increased activity noradrenergic serotoninergic neurotransmitter systems,C10,0.023046479,0.03324874,0.014437461,0.0012122418,0.0030043263,0.0027844366,0.16749406,0.0020289903,0.0015598158,0.002119924,0.020439005,0.0046344805,0.16365482,0.016023453,0.001897299,0.04456061,0.035651207,0.002226621,0.0024566932,0.018101044,0.43643263,0.0007660692,0.0022196125
health locus control gender differences adjustment persistent pain locus control loc beliefs long thought important adjustment persistent pain studied among subjects males females referred comprehensive pain rehabilitation program subscale structure multidimensional health locus control mhlc factorially replicated sample three unique mhlc profile clusters identified males females among men cluster assignment related age younger male patients reported stronger internal attributional style older male patients relied heavily chance powerful factors among women cluster assignment related use coping strategies example patients high internal scores reflecting strong internal orientation towards self management health care needs likely utilize information seeking self blame threat minimization coping strategies patients high scores internal powerful factors appears presence internal powerful health attributional styles associated less frequent use cognitive self management techniques understanding loc scores important rely pattern analysis scores implications clinical treatment discussed,C10,0.0021353057,0.0018941227,0.003984259,0.0011997411,0.0029733453,0.014522456,0.2314835,0.002009802,0.001543731,0.0020980632,0.079594545,0.05615713,0.059049863,0.0055345274,0.0018777339,0.034893557,0.07582887,0.033203326,0.054111775,0.25561044,0.03446258,0.00075816945,0.04507315
myelopathy associated human cell lymphotropic virus type htlv natal south africa clinical investigative study patients unexplained spastic myelopathy black zulu patients similar seen tropics previously described natal south africa following reports linking human cell lymphotropic virus type htlv spastic myelopathy undertook prospective retrospective search htlv antibodies patients labelled unexplained myelopathy positive htlv isolated patients whose peripheral blood lymphocytes cultured eighteen gave short history less months female preponderance spinothalamic dysfunction common many half severely disabled wheelchair bound routine laboratory studies showed specific trends apart hypergammaglobulinaemia csf pleocytosis greater cells microliter patients total csf protein raised greater g l patients igg index greater patients conventional myelography show specific abnormalities computer assisted myelography undertaken patients showed arachnoiditis spinal cord atrophy periventricular lucencies seen patients computed tomography head nerve conduction studies demonstrated abnormalities patients indicating subclinical peripheral nerve dysfunction common visual evoked responses abnormal patient brainstem auditory evoked response studies showed abnormality patients finding htlv antibodies significant number isolation htlv blood black patients noncompressive myelopathy represents substantial clinical advance future studies define clearly role virus disorder,C10,0.0096667735,0.0014689765,0.011095422,0.00093049835,0.002306113,0.002137186,0.26803315,0.0015573456,0.001197232,0.017653806,0.028821569,0.0034360453,0.10499569,0.10587724,0.009478842,0.0025787747,0.18895696,0.017957948,0.00988276,0.061691575,0.13926189,0.0005879942,0.010426222
practicing physicians north carolina rate challenging geriatric medicine concerns recently surveyed random sample physicians family practice general practice internal medicine north carolina discover challenging geriatric concerns using three stage survey technique respondents asked answer two open ended questions challenging geriatric problems face specific geriatric content areas would attract participation educational program asked rank topics would like information total responses received response rate undeliverable responses indicated physicians concerned management diagnosis revealed considerable evidence empathy concern top three topics management dementia multiple problems depression approximately physicians consider problems financing health care among challenging problems,C10,0.003240419,0.0028744135,0.006046286,0.0018206594,0.0045308336,0.019864859,0.2852577,0.0030473294,0.0023426788,0.034546383,0.06227915,0.011408655,0.023508327,0.025571648,0.0028497,0.020701697,0.06437121,0.0033414834,0.12859333,0.15240836,0.1369077,0.0011505551,0.0033366177
pain children assessment management children pain topic received great deal attention since late nurse researchers played dominant role areas pediatric pain relief likely continue currently number pediatric pain assessment instruments developed used selected practice settings use extended document existence pediatric pain relief pharmacologic interventions pediatric pain relief hampered incorrect beliefs analgesic risks prescribing administrating habits virtual explosion information area analgesics although nurses traditionally used nonpharmacologic interventions pain relief methods well researched continued research efforts important area result improved diagnosis management pediatric pain,C10,0.0035162321,0.0031190733,0.0065609245,0.018983496,0.0048962417,0.004537881,0.36673224,0.0033067074,0.0025420792,0.03750058,0.058713723,0.008201659,0.023957502,0.008330249,0.0030920857,0.005475505,0.19059834,0.003621136,0.038044803,0.09813569,0.10526797,0.0012484862,0.00361737
spatiotemporal contrast sensitivity differs normal aging parkinson disease measured contrast sensitivity static laterally drifting vertical gratings young adults normal elderly adults patients parkinson disease pd compared static motion contrast sensitivity spatial frequencies cycles per degree cpd temporal frequencies hz results show normal aging leads reduction motion sensitivity spatial frequency cpd compared elderly controls pd patients present specific abnormalities domain however spatial frequencies cpd temporal frequencies hz motion sensitivity worse static sensitivity pd patients elderly controls findings suggest specific deficit motion perception pd possible dopaminergic involvement control visuospatial behavior,C10,0.003094629,0.0027450903,0.11110201,0.0017387457,0.019269286,0.00399378,0.30864102,0.0029102264,0.002237279,0.0030406546,0.014352769,0.0064595067,0.18159138,0.029262764,0.0027213385,0.0048189806,0.069756,0.0031907312,0.0035236902,0.106187746,0.11507592,0.0010987902,0.0031875977
fluctuation timing upper airway chest wall inspiratory muscle activity obstructive sleep apnea imbalance amplitude electrical activity upper airway chest wall inspiratory muscles associated collapse reopening upper airway obstructive sleep apnea osa purpose study examine whether timing phasic activity inspiratory muscles also associated changes upper airway caliber osa hypothesized activation upper airway muscle phasic electrical activity activation chest wall pump muscles would help preserve upper airway patency contrast anticipated reversal pattern delayed activation upper airway inspiratory muscles would associated upper airway narrowing collapse therefore timing amplitude midline transmandibular costal margin moving time average mta electromyogram emg signals analyzed apnea cycles stage sleep six osa patients postapnea breaths analyzed upper airway mta peak activity preceded chest wall peak activity obstructed respiratory efforts upper airway mta peak activity followed chest wall peak activity onset phasic electrical activity followed pattern inspiratory efforts phasic inspiratory emg amplitude change preapnea apnea timing changes noted occurred even within breaths relative timing upper airway chest wall electrical activities closely associated changes pressure flow relationship conclude relative timing inspiratory activity upper airway chest wall inspiratory muscles fluctuates sleep osa,C10,0.02081332,0.001733148,0.032016907,0.0010977795,0.021623213,0.0025598598,0.08130995,0.0018389961,0.07708183,0.11155802,0.01360764,0.013459883,0.089036115,0.03377826,0.0017181521,0.0030425254,0.07491775,0.030385265,0.024337359,0.11127927,0.23938623,0.0006937354,0.012724777
rett syndrome findings suggesting axonopathy mitochondrial abnormalities report histopathologic findings sural nerve biopsies muscle biopsy patients rett syndrome sural nerve biopsies demonstrated ultrastructural abnormalities including presence many pi granules mitochondrial changes cytoplasm schwann cells occasional bands bungner onion bulb formations mitochondrial alterations myelinated axons morphometric analysis disclosed reduction number large myelinated fibers normal densities comparison age matched normal control light microscopic examination biopsied muscle year old patient rett syndrome revealed existence many small dark angulated fibers nadh tr staining ultrastructural investigation muscle confirmed presence dumbbell shaped mitochondria peripheral nerve involvement possibility mitochondrial abnormalities rett syndrome suggested results,C10,0.0029616384,0.002627121,0.06285054,0.0016640237,0.004137565,0.0038221485,0.35606533,0.002806975,0.0881617,0.0029099835,0.029791383,0.0061514163,0.06700414,0.06973332,0.016924052,0.004621512,0.0673126,0.0030714232,0.0033722608,0.09543403,0.10447181,0.0010515702,0.003053451
local anesthesia neonatal circumcisions family practice residents likely use dorsal penile nerve block lidocaine dpnb local anesthetic technique neonatal circumcision effective consistent ethical concerns infant welfare included training programs prepare residents care newborns assess current level dpnb use residents family practice training program identify attitudes factors relate use survey sent residents department family practice community health university minnesota respondents used dpnb could characterized high users employing technique one half circumcisions performed residents comprehensive understanding newborn capacity feel pain likely using dpnb less well informed counterparts four factors identified predicting use cooperation nursery staff procedure accessibility instruction pnb technique belief pnb effective reducing infant pain likelihood parents giving consent pnb results suggest strategies may implemented family practice educators wish promote principles techniques dpnb,C10,0.002303157,0.0020418232,0.004294945,0.0012932951,0.0032052023,0.00297061,0.17192389,0.002164653,0.0016641086,0.013377023,0.094873235,0.040517613,0.03761879,0.06776196,0.0020241565,0.037009537,0.111306556,0.002370486,0.1012509,0.23991826,0.05691423,0.0008172903,0.0023782374
quantitative evaluation hypnotically suggested hyperaesthesia analgesia painful laser stimulation ability reduce clinically experimentally induced pain hypnotic suggestion analgesia well known however nature hypnotic analgesia still remains uncertain attempts demonstrate identify specific psychophysiological mechanisms far unsatisfactory methodological problems inducing pain monitoring physiological responses may reason lack success present study attempted eliminate methodological problems sensory pain thresholds laser stimulation determined laser evoked brain potentials measured highly hypnotically susceptible subjects conditions waking state suggestion hyperaesthesia suggestion analgesia thresholds reduced induced hyperaesthesia increased analgesia hyperaesthesia sensations could evoked laser intensities intensities could perceived awake state amplitude evoked brain potentials increased hyperaesthesia decreased analgesia latency potential remained constant perception pain hypnosis change fast indicating slow endogenous mechanisms may play minor role suggested hyperaesthesia analgesia,C10,0.03565621,0.0020427096,0.004247708,0.001279071,0.014195766,0.024949042,0.39046192,0.013133183,0.0016458062,0.0022439605,0.011298288,0.0046823197,0.09637243,0.041845128,0.02403915,0.025574587,0.06703223,0.0023444148,0.002592127,0.02686046,0.20435114,0.0008083015,0.0023440493
vagus nerve stimulation humans neurophysiological studies electrophysiological monitoring evidence studies experimental animals indicates electrical stimulation vagus nerve alters behavioral electrographic seizure activity report effects electrical stimulation vagus nerve five patients medically intractable seizures part clinical trial chronic vagal stimulation control epilepsy mechanism action vagal antiepileptic effect unknown hoped analysis electrophysiological effects vagal nerve stimulation help elucidate brain areas affected stimulation left vagus nerve neck accomplished programmable implanted stimulator effects stimulus amplitude duration rate studied noncephalic reference recording vagus nerve evoked potential showed unusual properties scalp negative component occurred latency ms high amplitude microv widespread scalp distribution field distribution studies indicate potential generated neck region stimulating electrodes muscle paralysis confirms observation stimulation various frequencies noticeable effect electroencephalographic eeg activity regardless whether patient general anesthesia awake asleep,C10,0.014070774,0.002137075,0.024866618,0.0013536277,0.003354726,0.0032479197,0.26800048,0.037251756,0.013404287,0.002376062,0.017065616,0.004987116,0.09073439,0.054938808,0.013744479,0.0037516155,0.058377225,0.0024981375,0.026273489,0.023053754,0.33113903,0.0008554171,0.0025176245
steroids induce acetylcholine receptors cultured human muscle implications myasthenia gravis antibodies acetylcholine receptor achr diagnostic human autoimmune disease myasthenia gravis block achr function increase rate achr degradation leading impaired neuromuscular transmission steroids frequently used alleviate symptoms muscle fatigue weakness patients myasthenia gravis well documented immunosuppressive effects show steroid dexamethasone significantly increases total surface achrs cultured human muscle exposed myasthenia gravis sera results suggest clinical improvement observed myasthenic patients treated steroids due effect immune system also direct effect muscle propose identification development pharmacologic agents augment receptors proteins reduced human genetic autoimmune disease broad therapeutic applications,C10,0.0023830892,0.0021123677,0.004607012,0.0013379779,0.003315941,0.0030732437,0.26643372,0.0022394413,0.04783582,0.0023451718,0.024263972,0.0048981183,0.024811376,0.086803295,0.0020941752,0.026761595,0.07121495,0.060093027,0.014235113,0.047240287,0.29848394,0.0008455274,0.0025708796
acute long term changes serum lipids acute stroke studied serum lipid profiles patients less equal hours onset acute stroke months later patients suffering cerebral infarction significantly higher serum concentrations total cholesterol low density lipoprotein cholesterol apolipoprotein b significantly lower serum concentrations triglycerides lipoprotein less equal hours ictus months later lipid profiles patients suffering lacunar infarction similar occasions significant differences higher total cholesterol low density lipoprotein cholesterol concentrations less equal hours ictus significant changes observed among patients suffering cerebral hemorrhage apart significantly higher concentration high density lipoprotein cholesterol less equal hours ictus study many patients classified according stroke subtype gives results different previous studies much fewer patients conclude studies serum lipid lipoprotein concentrations risk factors cerebral infarction comparing values obtained less equal hours admission control values may incorrectly identify certain lipid fractions risk factors,C10,0.027001807,0.0015430856,0.0032458575,0.0009773935,0.0024222964,0.002245006,0.077423,0.0016359128,0.0012576318,0.010128007,0.022663554,0.003635892,0.20194332,0.0041902494,0.11949054,0.0027088725,0.15902744,0.0017914688,0.0019807566,0.09052573,0.26175493,0.00061765814,0.0017896056
cerebral hemodynamics patients normal pressure hydrocephalus correlation cerebral circulation time dementia regional cerebral blood flow regional cerebral circulation time measured demented patients chronic hydrocephalus mostly normal pressure hydrocephalus average hemispheric frontal temporal cerebral blood flows significantly reduced average regional cerebral circulation time values significantly prolonged frontal temporal thalamic regions markedly frontal white matter periventricular lucency observed computed tomography clinical improvement obtained patients operation postoperative regional cerebral blood flow values change compared preoperative ones postoperative regional cerebral circulation time values significantly reduced regions measured markedly frontal white matter present results suggest microcirculation frontal lobe closely correlated dementia association pressure exerted nerve fibers frontal white matter patients normal pressure hydrocephalus,C10,0.040439654,0.0022979467,0.004833697,0.0014555241,0.028574375,0.0033432392,0.1000001,0.015265035,0.001872852,0.002545367,0.027404517,0.005328332,0.4008615,0.0061802324,0.002278064,0.004034024,0.17258844,0.0026692525,0.0029497216,0.041321166,0.13004258,0.00091981003,0.002794605
controlling stability complex movement system human movement systems frequently treated one dimensional single axis rigid bodies order simplify gathering analysis interpretation data problem approach results assumptions often lead conclusions production control movement relate control demands placed central nervous system order truly understand central nervous system plans produces movements match environmental demands must take account many variations available within body purpose article examine two movement systems potential act multiple spatial dimensions variable muscle action patterns performing stabilizing task methods analyzing systems operate differing task constraints results experiments presented hypothetical models proposed explain complex movement systems operate also discussed,C10,0.00246683,0.026061885,0.0047461106,0.0013860111,0.0034349824,0.0031835726,0.38285735,0.014236933,0.013724988,0.0024238052,0.09573749,0.00599564,0.039525557,0.062007345,0.03068418,0.015779844,0.059132375,0.0025404259,0.0028088486,0.05086078,0.17696191,0.00087588164,0.0025672568
phenotypic functional characterization cells patients myasthenia gravis study cell surface phenotypes pbl myasthenia gravis mg patients showed cells significantly higher percentage b cells helper inducer subset age sex matched controls pbl mg patients proliferated significantly higher normal subjects ns response purified alpha chain acetylcholine receptor achr anti achr antibody present sera mg none ns pbl b cells mg cultured autologous cells stimulated either pokeweed mitogen achr alpha chain secreted antibody achr alpha chain whereas b cells alone secreted antibody cells pbl mg patients readily cloned cells ns limiting dilution presence recombinant il absence achr alpha chain cell clones mg patients compared none ns proliferated achr alpha chain response hla dr restricted mg cell clones display significant cytotoxic activity compared control cell clones results indicate mg b regulatory cells play role pathogenesis mg cytotoxicity likely ability stimulate specific antibody production b cells,C10,0.0019721384,0.0017493853,0.03364104,0.0011080642,0.0027461404,0.0025451474,0.14583941,0.0018546229,0.0014257684,0.0019377419,0.028377986,0.0042680237,0.08155042,0.22780104,0.0017474791,0.0030710297,0.06514118,0.011617812,0.0022455698,0.017288234,0.2537614,0.0007002347,0.10761015
deja vu experience remembrance things past deja vu experience common phenomenon occurring pathological well nonpathological conditions defined subjectively inappropriate impression familiarity present experience undefined past authors discuss epidemiologic data clinical features etiology phenomenon deja vu also review different hypotheses psychopathogenesis deja vu experience introduce explanation based hologram mnestic model,C10,0.0049478514,0.004388991,0.03314828,0.0027799958,0.006889726,0.00638546,0.42262346,0.0046530194,0.0035770761,0.0048615546,0.046399344,0.010176784,0.035345424,0.012257451,0.0043510157,0.05559721,0.07773306,0.0050954665,0.0056338566,0.13617586,0.1101322,0.0017568022,0.005090167
apneic oxygenation apnea tests brain death controlled trial performed prospective controlled study apneic oxygenation patients undergoing apnea tests brain death patients preoxygenated oxygen existing respirator settings minute apnea tests nine patients given continuous apneic oxygenation tracheal cannula six patients tracheal tubes open room air patients given apneic oxygenation little hypoxia end test patients given room air test became hypoxic many neurologists perform apnea tests oxygenation preoxygenation alone first prospective controlled study knowledge apneic oxygenation shows preoxygenation alone prevent hypoxia apnea tests brain death recommend apnea tests performed apneic oxygenation,C10,0.045976806,0.016963707,0.0055631865,0.0016641109,0.0041242037,0.0038223488,0.19109766,0.0027853064,0.016421689,0.002910136,0.17466876,0.0067135673,0.05565334,0.006810078,0.0026045265,0.018945634,0.23174801,0.0030501562,0.0033798146,0.09840974,0.1025886,0.0010516252,0.0030469839
volume conduction parietal n potential prerolandic frontal area somatosensory evoked potentials recorded frontal parietal areas patients various lesions central nervous system stimulation median nerve five representative cases showed selective loss positive potential frontal area reported case parietal n potential relatively well preserved midposition frontal central areas fc area showed negative potential following p peak negative potential synchronous parietal n potential negativity fc area considered volume conducted potential parietal n prerolandic frontal area anterior volume conduction parietal n would explained concept tangentially oriented dipole generated posterior bank central sulcus instead generator parietal n potential radically oriented dipole generated mainly parietal area postulated,C10,0.017548665,0.0026656135,0.0056070783,0.001688405,0.018731195,0.01841133,0.25415954,0.017319022,0.0021725046,0.017496344,0.07988897,0.006180777,0.13493282,0.021792453,0.0026425496,0.00467946,0.06024194,0.017596915,0.0034216712,0.05128394,0.2573804,0.0010669777,0.0030914664
changes thermal mechanical pain thresholds hand amputees clinical physiological long term follow previous study allodynia cold vibratory stimuli found finger stumps patients amputations control values obtained fingers intact contralateral hand treated regional intravenous guanethidine block rgb patients short lasting relief symptoms whereas others experienced long lasting beneficial effect present long term follow study patients examined years rgb treatment aim investigate whether earlier symptoms signs persisted whether differences respects patients long lasting group short lasting relief symptoms rgb group patients asked answer questionnaire concerning clinical symptoms addition visited laboratory determination thermal vibration induced pain thresholds comparisons made values obtained first examination rgb treatment values healthy subjects tested similar way occasions interval years twenty patients reported cold exposure still evoked stump pain however threshold measurements showed time patients become tolerant thermal stimuli injured also uninjured hand rise pain threshold also observed vibration induced pain tested injured hand significant difference groups similar changes pain thresholds time observed group healthy control subjects,C10,0.021901255,0.0014458301,0.012352096,0.008797663,0.018018007,0.0021200466,0.21070984,0.0015328068,0.0011783675,0.012128602,0.05798589,0.0616066,0.18251087,0.014000006,0.032989863,0.0025381416,0.12661754,0.0016877671,0.0018559162,0.07367494,0.1520924,0.00057872926,0.0016768129
rat soleus muscle ultrastructure hindlimb suspension aim present investigation determine quantitative electron microscopy effects wk tail suspension period rat soleus muscle ultrastructure marked decline muscle mass occurred mean fiber cross sectional area decreased greater extent capillary fiber ratio leading higher capillary density hypokinesia total mitochondrial volume density remained unchanged whereas volume density myofibrils slightly significantly reduced shift subsarcolemmal interfibrillar mitochondria occurred interfibrillar mitochondrial volume density highest near fiber border decreased toward fiber center increase volume density satellite cells suggested muscle regenerative events soleus atrophy tail suspension greatly decreases muscular volume leaves ultrastructural composition muscle fibers relatively unaffected,C10,0.0026241634,0.0023273467,0.017592585,0.0014741461,0.041733015,0.016073978,0.15516995,0.015166783,0.09080751,0.027975649,0.024731837,0.018045725,0.17829105,0.08223752,0.0023072734,0.01678174,0.044244543,0.015357353,0.0029874605,0.02085374,0.19419369,0.026323728,0.0026991586
neuromuscular diseases evaluation high frequency sonography forty four patients clinically suspected neuromuscular disease healthy volunteers underwent high frequency ultrasound examination rectus femoris vastus medialis vastus lateralis biceps brachii muscles number perimysial septa determined numbers muscle soft tissue ratios lower extremity compared findings correlated results muscle biopsy patients suspected disease using number perimysial septa lower extremity authors found significant differences muscles healthy volunteers patients duchenne muscular dystrophies muscular dystrophies spinal muscular atrophies receiver operating characteristic curve showed average perimysial septa within cm muscle ideal cutoff value differentiate subjects without morphologic changes pathologic findings authors conclude measurement useful differentiation neuromuscular diseases may noninvasive reproducible means evaluate disease progression,C10,0.002727346,0.002419292,0.01828875,0.0015323845,0.030200884,0.0035197823,0.2301951,0.0025648293,0.10759905,0.029062988,0.08019613,0.03254213,0.19742683,0.007508349,0.0023983594,0.004247045,0.12516806,0.0028087143,0.0031054846,0.04237286,0.05714662,0.00096838153,0.016000649
infantile cns spongy degeneration cases clinical update studied arab infants infantile spongy degeneration products consanguineous marriages presented infancy macrocephaly poor visual behavior blindness axial hypotonia appendicular spasticity brain ct mri showed diffuse symmetric leukoencephalopathy even neurologic symptoms relatively normal eegs visual evoked responses p either absent delayed early course brainstem auditory evoked responses showed milder abnormalities loss later components earlier ones deficient aspartoacylase activity cultured fibroblasts brain biopsy confirmed diagnosis patients,C10,0.036940493,0.003067576,0.0734133,0.0019430089,0.0048154024,0.0044629583,0.22287625,0.003252112,0.0025001084,0.040647656,0.08523065,0.0071128104,0.024782857,0.1050837,0.003041034,0.022076337,0.0928191,0.0035801171,0.020525938,0.1011446,0.1170223,0.0012278731,0.022433797
dominantly inherited apathy central hypoventilation parkinson syndrome clinical biochemical neuropathologic studies new cases describe new patients family persons successive generations dominant neuropsychiatric disorder characterized apathy central hypoventilation parkinsonism neuropathologically patients showed severe neuronal loss reactive gliosis substantia nigra neurochemical studies showed marked depletion dopamine substantia nigra putamen caudate nucleus well reduction serotonin content substantia nigra glutamate contents low frontal cortex thalamus gamma aminobutyric acid gaba contents low thalamus substantia nigra patients addition phosphoethanolamine contents reduced brain regions patients especially substantia nigra one patient severe symptoms low levels homovanillic acid hydroxyindoleacetic acid gaba csf repeatedly years death aged nd patient died aged unrelated cause developing symptoms familial disorder brain deficiencies multiple neurotransmitters appear involved disorder unlikely respond treatment however neurochemical studies csf may make presymptomatic diagnosis feasible,C10,0.02972728,0.0022147447,0.016735157,0.0014028238,0.0034766498,0.024476195,0.33548412,0.002347977,0.0018050415,0.015893891,0.06813948,0.0051353443,0.037290584,0.030124977,0.0021955818,0.0038879642,0.12757125,0.002571242,0.0028429208,0.061912365,0.22125614,0.00088650634,0.002621788
depression dementia alzheimer type multi infarct dementia authors used hamilton rating scale depression rating depressed mood investigate prevalence depression patients alzheimer disease patients multi infarct dementia nondemented comparison subjects prevalence depressed mood depended severity dementia measured mini mental state examination significantly lower among patients severe stages alzheimer disease among patients severe multi infarct dementia,C10,0.071226604,0.0039194296,0.008244461,0.0024827947,0.0061526205,0.11001521,0.22841889,0.00415521,0.0031943785,0.004341435,0.06510382,0.009088223,0.12530504,0.010240824,0.003885517,0.0068805227,0.1475397,0.004550322,0.0050311117,0.08829563,0.085813805,0.0015688486,0.0045455894
surgical technique implantation neurocybernetic prosthesis surgical technique implantation neurocybernetic prosthesis described detail procedure straightforward easily carried surgeons familiar carotid surgery,C10,0.0074434252,0.0066026896,0.01388866,0.004182157,0.010364734,0.009606129,0.13906233,0.0069998875,0.005381265,0.0073136026,0.117618,0.087363064,0.046076167,0.017114734,0.0065455604,0.011590961,0.26844823,0.007665494,0.008475435,0.11960465,0.088352434,0.00264289,0.0076575214
cerebral effects sevoflurane dog comparison isoflurane enflurane cerebral effects sevoflurane compared dogs enflurane isoflurane initially minimum alveolar concentrations mac sevoflurane enflurane determined electroencephalographic eeg responses increasing doses sevoflurane mac enflurane mac unparalysed animals examined administration sevoflurane associated seizure activity concentration either normocapnia paco kpa hypocapnia paco kpa even presence intense auditory stimuli dogs anaesthetized enflurane demonstrated sustained eeg motor evidence seizure activity induced auditory stimuli concentrations enflurane greater mac particularly hypocapnia separate group dogs effects increasing concentrations sevoflurane isoflurane mac compared directly arterial pressure cardiac output heart rate cerebral blood flow cerebral metabolic rate oxygen cmro using venous outflow technique sevoflurane common isoflurane minimal effects cerebral blood flow concentrations studied significantly reduced cmro end tidal concentrations sufficient produce burst suppression pattern eeg approximately mac sevoflurane isoflurane significantly decreased arterial pressure dose dependent manner neither drug significantly altered cardiac output,C10,0.09695952,0.0019757708,0.0149276005,0.0012514573,0.003101702,0.0028745115,0.14351739,0.012869626,0.0016102751,0.0021885026,0.020053858,0.026352018,0.22259675,0.0057342076,0.0019586757,0.003470704,0.040476736,0.0022938014,0.002536166,0.01982326,0.37034503,0.00079085113,0.0022915925
alkalinisation prilocaine intravenous regional anaesthesia suitability clinical use eighty unpremedicated patients undergoing day case hand surgery intravenous regional anaesthesia randomly allocated receive double blind study either ml prilocaine hydrochloride ml sodium bicarbonate ml saline alkalinised group significantly less pain injection p surgery p minutes tourniquet deflated p time elapsed insertion block commencement surgery affected,C10,0.0050688586,0.004496331,0.009457964,0.0028479851,0.0070582256,0.0065416265,0.18062367,0.0047668163,0.0036645592,0.0049804514,0.04814793,0.1439178,0.19538963,0.0116548715,0.0044574267,0.007893267,0.19908804,0.005220084,0.03030515,0.033493064,0.08391184,0.0017997676,0.005214655
plasticity aging brain reversibility anatomic metabolic cognitive deficits normal pressure hydrocephalus following shunt surgery course idiopathic normal pressure hydrocephalus studied year old woman year history progressive dementia underwent neuropsychologic testing quantitative x ray computed tomography magnetic resonance imaging positron emission tomography fludeoxyglucose f measure rates regional cerebral glucose utilization preshunt cognitive testing demonstrated progressive deterioration years positron emission tomography showed significant reductions regional cerebral glucose utilization compared age sex matched control subjects frontal temporal parietal whole brain regions periodic testing carried year period shunt surgery showed steady improvement clinical status parallel clinical changes significant reversal neuropsychologic test scores increased brain volume increased regional cerebral glucose utilization several brain regions results documented considerable potential recovery compromised brain function older subjects even years progressive brain disease,C10,0.086616695,0.0019340368,0.0048173717,0.001225023,0.034729615,0.04502867,0.15750086,0.0020503826,0.0015762615,0.012685009,0.0715346,0.015749797,0.15223156,0.0050757243,0.026077913,0.003395184,0.08701841,0.0022466595,0.002482595,0.11355367,0.15403329,0.0007741461,0.017662555
ethyl chloride venepuncture pain comparison intradermal lidocaine one hundred twenty unpremedicated patients undergoing gynaecological surgery randomly allocated one three equal treatment groups assess effectiveness ethyl chloride producing instant skin anaesthesia prevent pain venepuncture g cannula received either anaesthetic ml one per cent lidocaine plain intradermally ten second spray ethyl chloride cannulation site ethyl chloride produced skin anaesthesia significantly reduced pain venepuncture however effective intradermal lidocaine effect vein visualisation ease cannulation ethyl chloride recommended method producing instant skin anaesthesia,C10,0.0042391466,0.044787653,0.007907065,0.0023809774,0.06744681,0.005468942,0.28419903,0.0039851624,0.0030636513,0.004163766,0.040002283,0.038893405,0.07462299,0.009743727,0.0037265057,0.0065989434,0.1758827,0.0043782033,0.004825218,0.027521865,0.18029776,0.0015046449,0.004359565
fibrillation potential amplitude muscle atrophy following peripheral nerve injury maximum peak peak fibrillation potential amplitude measured subjects days years post complete partial peripheral nerve injury mean amplitude first months muv third fourth months muv fifth sixth months muv first year population fibrillation potentials greater muv recorded sciatic nerve sectioned guinea pigs animals studied weeks fibrillation potential amplitude gastrocnemius muscles declined paralleling humans end study type fibers lost almost half initial diameter type ii fibers atrophied twice amount fibrillation potential amplitude may useful estimating time post nerve injury appears correlate surface area fiber diameter type muscle fiber,C10,0.03654603,0.0020883218,0.0045782235,0.0013229364,0.0032781945,0.00303826,0.20134339,0.0136053255,0.035893735,0.025099339,0.029991437,0.0048679435,0.16313156,0.07377603,0.0020702528,0.0036660298,0.15661584,0.0024244692,0.014059195,0.05670718,0.16262193,0.00083590247,0.0024384223
one mutant allele causes infantile tay sachs disease french canadians two tay sachs disease tsd patients french canadian origin shown myerowitz hogikyan homozygous kb deletion mutation end hexosaminidase alpha subunit gene order determine whether french canadian tsd patients homozygotes deletion allele assess geographic origins tsd population ascertained tsd families french canadian origin screened occurrence mutations associated infantile tsd dna samples obtained french canadian tsd families samples analyzed using polymerase chain reaction pcr amplification followed hybridization allele specific oligonucleotides aso restriction analysis pcr products cases southern analysis genomic dna performed eighteen independently segregating mutant chromosomes sample carried kb deletion mutation end gene one chromosome carried nucleotide insertion exon jewish mutation population individuals detected substitution splice junction exon previously identified ashkenazi jews one chromosome carried undescribed b mutation allele came parent non french canadian origin patients three families carried tsd alleles different mutations deletion mutation clusters persons originating southeastern quebec gaspe adjacent counties northern new brunswick,C10,0.0020305745,0.0018012208,0.0037888412,0.010957857,0.012608016,0.0026205622,0.13706344,0.0019095768,0.0014680149,0.0019951586,0.09884739,0.0041765035,0.013846922,0.042441357,0.001785636,0.0031873453,0.080401964,0.06105945,0.0023121077,0.1602768,0.07839127,0.0007209832,0.27630904
ucla university utah epidemiologic survey autism etiologic role rare diseases twelve rare diseases known cause cns pathology found autistic probands identified recent epidemiologic survey utah probands significantly lower mean iqs remaining patients versus similar sex distribution prevalence abnormal eegs seizures rarity diversity diseases make highly unlikely randomly occurred autism presence epidemiologic survey compelling evidence date support hypothesis different diseases producing different types cns pathology play etiologic role autism,C10,0.003400723,0.0030166109,0.0063453964,0.0019108035,0.004735399,0.00438881,0.37196428,0.036121685,0.0024585712,0.019784117,0.03859155,0.023591917,0.049621623,0.04486258,0.0029905098,0.005295633,0.07223682,0.0035021808,0.053258903,0.122506954,0.12470625,0.0012074731,0.0035012122
community hospital carotid endarterectomy patients age compared prevalence stroke death patients aged older carotid endarterectomies performed patients less age carotid endarterectomies performed three strokes patients aged older nine strokes younger patients p deaths patients aged older deaths younger patients p controlling possible confounding effects diabetes prior stroke history angina prior carotid artery disease previous vascular surgery history myocardial infarction preoperative hypertension requiring medication female gender logistic regression model showed patients aged older likely stroke death patients age conclude age alone contraindication safe performance carotid endarterectomy community hospital,C10,0.014936961,0.0022693623,0.0047735698,0.0014374187,0.003562387,0.0033016524,0.123137675,0.0024289219,0.014210128,0.002513705,0.079272866,0.0053277058,0.033423766,0.0058823805,0.027018964,0.003983845,0.24240424,0.002634651,0.0029130299,0.3529736,0.068052866,0.00090836844,0.0026319108
large striatocapsular infarct clinical pathophysiological entity examined patients strictly subcortical large striatocapsular infarctions eight aphasia neglect patients underwent transcranial doppler ultrasonography selective carotid angiography magnetic resonance imaging single photon emission tomography assessment cerebral blood flow blood volume cerebral perfusion reserve signs compatible cortical territorial infarctions rather lacunes magnetic resonance imaging computed tomographic scans lesions corresponded territories medial lateral group lenticulostriate arteries heubner artery anterior choroidal artery infarctions either due cerebral embolization segment middle cerebral artery due stenosis site ie lesions acutely simultaneously occluded orifices lenticulostriate neighboring arteries persistent occlusion middle cerebral arteries decrease cortical regional cerebral blood flow found patients aphasia neglect patients without aphasia neglect showed rapid recanalization middle cerebral artery occlusion stenosis segment cortical regional cerebral blood flow decrease large striatocapsular infarctions occur due occlusive disease middle cerebral artery large vessel disease due disseminated situ occlusion long penetrating arteries small vessel disease lacunes neuropsychological deficits explained decreased cortical blood flow due persistent occlusive lesion middle cerebral artery,C10,0.22032312,0.0016852423,0.003546783,0.001067436,0.06968249,0.002451827,0.16411401,0.0145449275,0.0013734911,0.0110583855,0.045159016,0.013104808,0.13924219,0.004563123,0.0016706609,0.0029584274,0.12246612,0.0019612787,0.0021632337,0.041751593,0.13248278,0.0006745599,0.001954473
etiologic importance intimal flap external carotid artery development postcarotid endarterectomy stroke technically unsatisfactory end point transition removed diseased plaque normal distal intima leading intimal flap external carotid artery identified source perioperative stroke mechanism involves thrombus formation retrograde propagation thrombus subsequent embolization internal carotid artery report describes three cases illustrating mechanism methods identification correction mechanism postoperative stroke adds justification routine use intraoperative surveillance studies document technical result endarterectomy involving internal external carotid arteries unsatisfactory end point identified external carotid artery corrected sense concern similar finding internal carotid artery,C10,0.056518026,0.0032296225,0.006793463,0.0020456496,0.005069779,0.0046987166,0.26769117,0.02097883,0.055491827,0.0035773567,0.14746957,0.0075201187,0.028942198,0.0086310925,0.05603418,0.005669573,0.16222066,0.0037546956,0.004145652,0.044388194,0.100091286,0.0012927364,0.0037455803
nmda antagonists potentiate antiparkinsonian actions l dopa monoamine depleted rats systemically administered n methyl aspartate nmda antagonists mk methyl dihydro h dibenzo cyclohepten imine maleate cpp carboxypiperazin yl propyl phosphonate potentiate ability l dopa l dihydroxyphenylalanine reverse akinesia alleviate muscular rigidity monoamine depleted rats basis findings proposed nmda antagonists may beneficial adjunctive treatment therapy parkinson disease cpp locally injected subthalamic nucleus entopeduncular nucleus rat homologue internal pallidal segment substantia nigra pars reticulata monoamine depleted rats stimulates locomotor activity alleviates rigidity whereas local microinjection cpp neostriatum ineffective results make unlikely neostriatum site antiparkinsonian action nmda antagonists monoamine depleted rats whereas subthalamic nucleus internal pallidal segment substantia nigra pars reticulata appear important effects nmda antagonists,C10,0.095116176,0.0033474609,0.025419509,0.0021202886,0.0052547604,0.004870157,0.25734517,0.0035488338,0.020986248,0.021956302,0.017865865,0.046222363,0.02336098,0.009032555,0.0033184972,0.005876437,0.033285707,0.0038979405,0.0042969133,0.062295165,0.3270986,0.001339904,0.022144152
relief injection pain adults emla cream minutes venepuncture effectiveness skin anaesthesia minutes topical application lignocaine prilocaine cream evaluated one hundred twenty patients estimated pain antecubital venepuncture linear scale verbally use cream either minutes placebo cream treatment reported pain significantly less minutes lignocaine prilocaine cream p cream used relieve pain routine injections,C10,0.054111674,0.029033136,0.009458472,0.0028481379,0.031598084,0.006541977,0.16010144,0.004767072,0.003664756,0.0049807187,0.08740218,0.08404838,0.19402182,0.011655497,0.0044576656,0.05696671,0.07546897,0.0052203643,0.0303111,0.07331146,0.0630156,0.0017998641,0.0052149347
progressing cerebral infarction relation plasma glucose gerbils studied neurologic morbidity evolution hyperglycemia induced immediately permanent unilateral common carotid artery ligation mongolian gerbils total animals divided five groups one experiencing severe hyperglycemia hour onset ischemia brief hyperglycemia group n normoglycemic control group brief hyperglycemia group n group severe hyperglycemia hours onset ischemia prolonged hyperglycemia group n normoglycemic control group prolonged hyperglycemia group n hyperosmolar normoglycemic control group prolonged hyperglycemia group n neurologic morbidity mortality higher two hyperglycemic groups three normoglycemic control groups neurologic deficit progressed according duration severe hyperglycemia three normoglycemic control groups neurologic status stabilized minutes onset ischemia brief hyperglycemia group stabilization occurred minutes prolonged hyperglycemia group neurologic deficit progressed approximately minutes coinciding death one gerbil neurologic deficit remained stable death hours ischemia suggest hyperglycemia another cause progressing cerebral infarction,C10,0.02302626,0.011167387,0.0036453456,0.0010976875,0.01216227,0.028735211,0.07992883,0.001837255,0.010845635,0.030291963,0.03750358,0.17207772,0.1030709,0.0045175864,0.0017180502,0.12598978,0.12651287,0.0020119562,0.0022245408,0.111216344,0.09826862,0.010139944,0.0020102798
cognitive function testing comprehensive geriatric assessment comparison cognitive test performance residential clinic settings tests cognitive function frequently used geriatric assessment effect test setting rarely explored determine effect testing site performance elderly patients undergoing comprehensive geriatric assessment administered mini mental state exam geriatric patients clinic residence cognitive abilities varied normal severely impaired patients scores mean sd higher residence clinical importance difference score clear reason second analysis performed difference scores five points greater settings considered clinically meaningful twenty five percent differed five points patients tested better residential setting differences statistically significant p conclude testing site may affect test performance home assessment may reveal optimal cognitive function geriatric patients,C10,0.0022515666,0.001997252,0.00420119,0.0012650635,0.003145536,0.035557922,0.23995762,0.0021174005,0.0016277825,0.013099116,0.1354664,0.044027887,0.06304672,0.005235045,0.012875401,0.014402479,0.12276129,0.014825588,0.0026064566,0.15374158,0.122671604,0.0007994495,0.002319652
parathyroid hormone related peptide lactation umbilical cord blood parathyroid hormone related peptide pthrp expressed lactating rat mammary glands suckling result increases prolactin rather suckling per se addition pthrp produced fetal parathyroid glands placenta may responsible stimulation placental calcium transport current study used radioimmunoassay human pthrp measure levels peptide human breast milk cow milk two infant formulas sequential plasma samples prepartum postpartum lactating women women pathologic hyperprolactinemia human umbilical cord blood normal subjects plasma pthrp levels ranged less pmol liter contrast human breast milk contained substantially increased levels immunoreactive pthrp similar elevations found cow milk one infant formula column chromatography breast milk demonstrated pthrp immunoreactivity included region adenylate cyclase stimulating activity consistent presence biologically active pthrp plasma prepartum pthrp values differ corresponding postpartum values lactating women women hyperprolactinemia mean plasma pthrp value high normal range umbilical cord blood considerably suppressed parathyroid hormone values pthrp levels indistinguishable normal human plasma thus pthrp present high concentrations breast milk apparently gain access maternal circulation significant amounts addition women pathologic hyperprolactinemia seem increased levels circulating pthrp,C10,0.0018162978,0.0016111467,0.0033890232,0.0010205036,0.0025292626,0.011112892,0.1342484,0.019283902,0.018868016,0.0017846192,0.020295894,0.0037383623,0.17437951,0.06553982,0.019166764,0.0116182435,0.02160198,0.010743175,0.0020681222,0.10192952,0.37069443,0.00064490136,0.0019152198
skin conductance arousal newborn measured skin conductance continuously sole foot babies different conceptional ages minutes heel prick carried routine blood sampling studied healthy babies whose gestational postnatal ages ranged weeks days median skin conductance level preheel prick babies weeks conceptional age micros microsiemens differed significantly awake babies micros asleep micros contrast babies less weeks significantly lower median skin conductive level micros identical awake asleep babies response heel prick babies became aroused skin conductance rose sharply immediately babies weeks conceptional age seven babies weeks median rise one minute babies weeks significantly higher weeks micros compared micros babies less weeks change skin conductance heel prick results consistent notion emotional sweating function maturity develop weeks conceptional age,C10,0.0026915001,0.002387495,0.00502206,0.0015122441,0.08192839,0.0034735212,0.08844685,0.0025311194,0.0019458348,0.015666923,0.0149210775,0.005536038,0.18998763,0.07220543,0.0023668373,0.0041912254,0.07006899,0.002771799,0.0030646687,0.11583026,0.30972555,0.0009556539,0.002768916
electrocorticographic confirmation focal positron emission tomographic abnormalities children intractable epilepsy relationship focal disturbances glucose utilization demonstrated positron emission tomography pet electrophysiologic abnormalities defined intraoperative electrocorticography ecog studied eight children aged months years underwent cortical resection intractable seizures none children pure temporal lobe epilepsy computed tomography ct magnetic resonance imaging mri normal four eight children scalp electroencephalogram eeg showed lateralized interictal epileptiform abnormalities eight lateralized ictal onset five eight seven children interictal pet showed focal hypometabolism eighth child focal ictal hypermetabolism ecog time surgery showed epileptiform spiking slowing suppression normal background activity every case corresponded focus pet scan ecog findings support notion children epilepsy focal metabolic abnormalities pet correspond electrophysiologically abnormal areas cortex presumably also epileptogenic regions areas appear normal anatomic imaging studies ct mri ictal scalp eeg data ambiguous contradictory pet provides less invasive means chronic grid depth electrode recording evaluating whether localized epileptogenic area exists,C10,0.002381416,0.002112435,0.027487386,0.012852232,0.038828295,0.026123425,0.25856513,0.0022395125,0.013223363,0.09457217,0.07392667,0.004898118,0.042203695,0.0057587246,0.0020941573,0.00370836,0.0956679,0.0024561305,0.0027115925,0.09149067,0.19338304,0.00084555434,0.0024700349
use obstetric analgesia sweden use obstetric analgesia investigated swedish population based prospective study births represents almost women vaginal deliveries sweden lumbar epidural analgesia eda used paracervical block pcb pethidine morphine pudendal block four types analgesia much commonly used nulliparae multiparae variables maternal age smoking nationality relationship infant father gestational age moderate influence rates different types analgesia eda pcb frequently used larger smaller hospitals daytime night differences found pethidine morphine pudendal block administered routinely midwives,C10,0.0038436987,0.022008533,0.007171943,0.0021599128,0.0053538606,0.004960493,0.25509557,0.0036146608,0.021382645,0.0037766597,0.024366222,0.008230436,0.026988426,0.009261639,0.0033800516,0.024589747,0.14052045,0.0039583724,0.0043766163,0.2460323,0.15504162,0.019931868,0.0039542555
anti gm igm antibodies motor neuron disease neuropathy found anti gm igm antibodies patients motor neuron disease mnd patients neuropathy controls neurologic nonneurologic diseases patients anti gm igm antibody titers less slightly higher antibody titers found patients mnd neuropathy high titers patient mnd igm kappa protein reacted gm gd b asialo gm six patients anti gm igm also bound gd b reactivity gd b correlate anti gm titers present patients mnd neuropathy anti gm igm antibodies may normal constituent human antibody repertoire frequency cases levels higher patients mnd neuropathy origin pathogenetic role antibodies neural impairment remain established,C10,0.002656862,0.002356769,0.0049574287,0.0014927823,0.003699596,0.0034288187,0.18154149,0.002498545,0.0019207929,0.0026105228,0.055153962,0.0054863114,0.17609093,0.124299616,0.0023363773,0.0041372865,0.1291816,0.10638295,0.0030252282,0.025574928,0.15748519,0.00094335515,0.0027386546
implantable neurocybernetic prosthesis system neurocybernetic prosthesis cyberonics inc implantable multiprogrammable pulse generator delivers constant current electrical signals vagus nerve purpose reducing frequency severity epileptic seizures device implanted subcutaneous chest pocket clavicle similar cardiac pacemaker placement stimulation signal transmitted prosthesis vagus nerve stimulation lead prosthesis programmed using ibm compatible personal computer programming software programming wand electrodes used first group patients found break unacceptable rate design modifications appear resolved problem,C10,0.02551151,0.024778524,0.091816455,0.0024308101,0.0060243313,0.0055925157,0.28232694,0.0040685693,0.003127772,0.025177483,0.0629754,0.05152629,0.03563858,0.041519437,0.0038044995,0.027678944,0.09500878,0.0044554425,0.024582386,0.040057417,0.13591094,0.0015361363,0.0044508087
compliance reliability validity self monitoring physical disturbances parkinson disease parkinson symptom diary previous clinical research parkinson disease recognized value self monitoring procedures patients observe record frequency severity symptoms occur within patient social work environment discuss issues methodology report study compliance test retest reliability validity new self monitoring instrument parkinson symptom diary two recordings frequency loss balance hesitation freezing two ratings severity tremor difficulty walking made four times daily one week patients n without apparent loss cognitive memory functions total diaries received requested met strict compliance criteria independent sampling days could assumed test retest stability one month demonstrated score spearman rho greater representative subsample patients criterion validity demonstrated score expected pattern correlations independently obtained observer ratings related indices disease comparison hoehn yahr disability stages simplicity self assessment device invaluable complement traditional methods clinical laboratory assessment care evaluation parkinson patients,C10,0.0019177331,0.03883494,0.0035981243,0.001077496,0.0119654955,0.011748665,0.34999302,0.0018034595,0.0013864357,0.033580158,0.049958035,0.03675637,0.09025631,0.014047935,0.0016864506,0.012276116,0.114659585,0.00198005,0.020709448,0.110917665,0.08819267,0.00068091735,0.001972893
double blind comparison topical lignocaine prilocaine cream emla lignocaine infiltration arterial cannulation adults double blind double dummy study efficacy topical emla cream compared lignocaine infiltration alleviating pain arterial cannulation forty unpremedicated adults allocated randomly four groups receive emla cream alone emla saline infiltration emla lignocaine infiltration placebo cream lignocaine infiltration following arterial cannulation pain assessed patient using visual analogue score independent observer using four category verbal rating score significantly lower pain scores observed patients receiving emla compared receiving placebo cream lignocaine infiltration patient p less observer p less assessments significant differences three emla groups,C10,0.0426533,0.0025540616,0.01930927,0.0016177478,0.004009301,0.0037158558,0.122878306,0.08633454,0.0020815884,0.0028290579,0.015603453,0.13549186,0.19616772,0.0067976913,0.0025319627,0.004494545,0.14469399,0.002965177,0.05903263,0.07925229,0.061001245,0.0010223263,0.002962093
clarifying confusion confusion assessment method new method detection delirium objective develop validate new standardized confusion assessment method cam enables nonpsychiatric clinicians detect delirium quickly high risk settings design prospective validation study setting conducted general medicine wards outpatient geriatric assessment center yale university site general medicine wards university chicago site patients study included subjects ranging age years site patients without delirium participated site patients without delirium participated measurements main results expert panel developed cam consensus building process cam instrument completed less minutes consists nine operationalized criteria diagnostic statistical manual mental disorders dsm iii r priori hypothesis established diagnostic value four criteria acute onset fluctuating course inattention disorganized thinking altered level consciousness cam algorithm diagnosis delirium required presence first second criteria either third fourth criterion sites diagnoses made cam concurrently validated diagnoses made psychiatrists sites values sensitivity respectively values specificity values positive predictive accuracy values negative predictive accuracy cam algorithm highest predictive accuracy possible combinations nine features delirium cam shown convergent agreement four mental status tests including mini mental state examination interobserver reliability cam high kappa conclusions cam sensitive specific reliable easy use identification delirium,C10,0.0016173563,0.0014346758,0.02583681,0.00090872654,0.00226057,0.016377168,0.32131028,0.0015209814,0.0089872815,0.0094162505,0.20171978,0.019227328,0.09870678,0.0040226053,0.024886755,0.018163733,0.11448436,0.001689866,0.011304411,0.051401854,0.062483117,0.00057426444,0.0016650184
cholinergic deficiency frontal dysfunction parkinson disease investigate influence central cholinergic deficit cognitive function parkinson disease pd compared neuropsychological performance group patients treated anticholinergic drugs mean daily dose mg group patients received anticholinergics two groups matched variables parkinsonism levodopa therapy dose used significant difference two groups patients intellectual visuospatial instrumental memory function contrast group received anticholinergics severe impairment observed tests believed assess frontal lobe function results suggest lesion ascending cholinergic neurons demonstrated post mortem pd may play role subcorticofrontal behavioral impairment disease,C10,0.0028507786,0.0025189586,0.019020505,0.0015955135,0.01771116,0.017399168,0.24450955,0.016402183,0.0020529793,0.0027901754,0.028343894,0.10990353,0.07730296,0.020249262,0.0025012325,0.004422009,0.107509606,0.0029436226,0.0032334202,0.039182853,0.27360588,0.0010082755,0.002942476
gross motor patterns children cerebral palsy spastic diplegia rolling sitting crawling patterns motoscopically analyzed children cerebral palsy spastic diplegia relation patterns severity locomotive disability studied rolling trunk rotation elbow support difficult severely diplegic children sitting patients heel sitting pattern thighs adducted knees flexed crawling reciprocal thigh movements insufficient accompanied lateral bending trunk many patients impaired patients thighs supported weight flexion move reciprocally creeping elbows without reciprocal leg movements demonstrated severely affected children years age,C10,0.004237689,0.003759042,0.007907089,0.0023809848,0.0059017627,0.005468959,0.31032875,0.024497407,0.0030636608,0.08622682,0.027753806,0.008716117,0.088888295,0.009743757,0.003726517,0.0065989634,0.1143264,0.024867263,0.0048252326,0.09872036,0.15216564,0.0015046495,0.004390801
effect normal msafp screening maternal age genetic amniocentesis routine maternal serum alpha fetoprotein msafp screening neural tube defects considered many standard obstetrical care recently many encouraged test screen trisomy syndrome questioned whether normal msafp screen risk trisomy decreases enough warrant modifying recommended age genetic amniocentesis syndrome logistic regression developed using reported values sensitivity specificity msafp detection trisomy assuming constant threshold risk opting amniocentesis indicates genetic amniocentesis trisomy may deferred women normal msafp screening sensitivity analysis varying thresholds normal msafp demonstrates year old woman median msafp level risk trisomy unscreened women years younger abnormal msafp useful screening neural tube defects possibly trisomy normal msafp may allow delaying potentially risky amniocentesis otherwise low risk pregnancies,C10,0.0020922713,0.0018559492,0.014029526,0.001175562,0.02260092,0.012769196,0.16087379,0.0019675975,0.0015126191,0.012181326,0.20640516,0.0043034027,0.08625274,0.018041842,0.0018398907,0.0032581019,0.030025775,0.0021594055,0.012501273,0.30075583,0.10047474,0.0007428896,0.00218021
efficacy safety vagus nerve stimulation patients complex partial seizures clinical trial chronic intermittent vagal stimulation five patients suggests procedure may safe effective adjunctive treatment medically intractable seizures partial onset patients tolerated well implantation neurocybernetic prosthesis vagal stimulation without serious physiological lifestyle changes stimulation vagus nerve either reduced seizure frequency decreased duration intensity seizures adverse side effects limited tingling sensation throat hoarseness stimulation major complication mechanical interruption wire electrode circuitry consequent cessation stimulation small number patients relatively short follow period make pilot study results promising,C10,0.0031916548,0.0028305042,0.022465605,0.0017928471,0.0044432534,0.0041180467,0.25938356,0.0184092,0.0023068923,0.034028333,0.014674861,0.021992723,0.028156795,0.0075406493,0.03368366,0.020408208,0.18443482,0.0032861172,0.019079588,0.09764499,0.21171199,0.0011329793,0.0032826995
ultrasonography magnetic resonance imaging leigh disease infant leigh disease younger sister similarly affected infant examined onset disease ultrasonography revealed hyperechoic lesions putamen caudate nucleus preclinical stage onset changes extended cerebral cortex medulla lesions also detected weighted magnetic resonance imaging mri areas increased signal intensity brother demonstrated ultrasonographic results cranial computed tomography disclosed low density areas basal ganglia detected hyperechoic lesions ultrasonography findings suggest ultrasonography useful detecting early intracranial lesions leigh disease,C10,0.0034573367,0.00306683,0.0064510317,0.0019425364,0.14388697,0.004461873,0.2656064,0.0032513214,0.019210016,0.03687038,0.15724826,0.007111081,0.025533617,0.008025344,0.019753702,0.0053837923,0.048288208,0.0035642756,0.0039366866,0.07953268,0.14862359,0.0012275747,0.0035665042
protocol butalbital aspirin caffeine bac detoxification headache patients abuse combination drug containing butalbital mg aspirin mg caffeine mg bac commonly recognized headache specialists causing headaches despite widespread problem published treatment regimen bac detoxification patients describe protocol used four times three patients patients fulfilled diagnostic criteria ihs headache classification headaches induced chronic substance abuse analgesics abuse headache patients took bac month years two patients previously undergone inpatient detoxification one patient unsuccessfully tried detoxification twice outpatient patients required psychological support prior hospitalization protocol bac discontinued pentobarbital challenge test corroborated butalbital dosage patients given phenobarbital caffeine tapered several days dihydroergotamine dhe metoclopramide used raskin propranolol mg bid started narcotics permitted hospital discharge patients allowed continue subcutaneous dhe needed one patient restarted bac use months without two patients still bac free months detoxification,C10,0.0028011124,0.0024847265,0.005226585,0.0015738307,0.003910404,0.0036149814,0.30446082,0.0026342,0.0020250794,0.0027943123,0.075148374,0.005827245,0.03147492,0.0067903525,0.016016833,0.0043619145,0.30030242,0.0028974197,0.03029292,0.035877578,0.15557383,0.0009945732,0.002915503
efficacy brainstem auditory evoked potentials acoustic tumor surgery identification patients small acoustic neuromas salvageable hearing increases intraoperative auditory nerve monitoring used increasingly attempt improve hearing preservation rate far field recordings obtained brainstem auditory evoked potentials baep times enhanced electrocochleography become standard method intraoperative auditory nerve assessment evaluate usefulness monitoring technique hearing preservation results series unmonitored acoustic tumor removals compared series patients monitored via standard brainstem auditory evoked potentials comparable average tumor sizes unmonitored patients hearing preserved preoperative levels compared monitored patients neither preoperative baep assessments absolute tumor size predictive hearing preservation report brings question effectiveness far field intraoperative baep monitoring acoustic tumor resection suggests direct auditory nerve monitoring may appropriate,C10,0.002527025,0.026299585,0.017791778,0.0014198323,0.07284336,0.0036620675,0.2772161,0.002376445,0.0018269267,0.0024829505,0.048316304,0.0051976074,0.12492723,0.0058642845,0.002222202,0.01616548,0.20402423,0.0026024168,0.027052613,0.01915224,0.13253236,0.0008972548,0.0025997101
involvement central nervous system chronic inflammatory demyelinating polyneuropathy clinical electrophysiological magnetic resonance imaging study consecutive series patients chronic inflammatory demyelinating polyneuropathy cidp minor clinical evidence cns involvement found five cranial magnetic resonance imaging mri performed revealed abnormalities consistent demyelination nine patients aged less years abnormalities five aged years measurements central motor conduction time cmct obtained showed unilateral bilateral abnormalities six concluded subclinical evidence central nervous system cns involvement common least patients cidp united kingdom clinically evident signs cns disease infrequent association multiple sclerosis like syndrome cidp rare,C10,0.003345344,0.002967487,0.0062420648,0.0018796123,0.05491442,0.0043173404,0.33824384,0.019336972,0.018601922,0.022764364,0.02704458,0.006880733,0.07219259,0.089982696,0.002941811,0.005209396,0.13545966,0.0034486873,0.0038091661,0.095171556,0.08061642,0.0011878101,0.0034415664
screening early dementia using memory complaints patients relatives study examined whether subjective impression memory function might differentiate healthy elderly subjects patients memory complaints whether memory complaints differed patients without dementing illness self assessment relatives responses new memory questionnaire differentiated patient groups control subjects relatives form measuring deterioration memory function time identified dementing individuals non dementing causes memory complaints factor analysis indicated patients memory complaints correlated depression rather objective memory performance relatives ratings correlated objective memory scores depression stepwise discriminant function analyses showed objective memory testing greatly improved specificity sensitivity subjective memory questionnaire alone,C10,0.0028009543,0.0024845863,0.08657916,0.001573742,0.0039002402,0.0442885,0.27396658,0.0026340515,0.0020249654,0.0027521022,0.055598628,0.03292721,0.18344893,0.008077724,0.0024630886,0.0044476693,0.11286738,0.0029039504,0.0031892986,0.09691428,0.07026524,0.0009945171,0.0028972577
epidural hematoma unusual presentation authors present patient traumatic epidural hematoma complained headache presented emergency department hours fall mental status neurological examination normal delayed presentation commonly seen subdural hematoma present may result epidural bleeding delayed formation traumatic epidural hematoma may occur following present elevated intracranial pressure hypovolemic shock concomitant mass lesion coagulopathy bleeding dural diploic veins dural sinus laceration traumatic pseudoaneurysm arteriovenous fistula although criteria computed tomography patients head injuries remain variable literature delayed presentation epidural bleeding must considered differential diagnosis posttraumatic headache irregardless time interval neurological presentation,C10,0.03407846,0.0028300446,0.021393605,0.032678902,0.035329405,0.004117378,0.36337224,0.022498228,0.0023065177,0.049468614,0.07787626,0.0065620444,0.06921584,0.0074717575,0.0028055578,0.0049681175,0.09709859,0.0032883934,0.0036327404,0.060337145,0.09425522,0.0011327954,0.0032821666
fructose induced aberration metabolism familial gout identified p magnetic resonance spectroscopy hyperuricemia responsible development gouty arthritis results wide range environmental factors underlying genetically determined aberrations metabolism p magnetic resonance spectroscopy studies children hereditary fructose intolerance revealed readily detectable rise phosphomonoesters marked fall inorganic phosphate liver vivo rise serum urate response low doses oral fructose parents family members heterozygous enzyme deficiency showed similar pattern given substantially larger dose fructose three nine heterozygotes thus identified also clinical gout suggesting possibility defect fairly common cause gout present study noninvasive technology used identify spectral pattern families studied hereditary gout one family index patient three brothers mother showed fructose induced abnormality metabolism agreement maternal inheritance gout family group test dose fructose used produced significantly larger increment concentration serum urate patients showing changes p magnetic resonance spectra patients familial gout nonaffected members thus suggesting simpler method initial screening defect,C05,0.0018999357,0.020067075,0.040387373,0.010225582,0.049332805,0.002451966,0.29028648,0.0017867226,0.0013735689,0.01106434,0.09220198,0.02294294,0.05154072,0.03360153,0.010847033,0.010617403,0.046955395,0.0019805208,0.011349679,0.043926854,0.23219241,0.00067459815,0.012293111
prerandomization alternative classic randomization effects recruitment controlled trial arthroscopy osteoarthrosis knee possibly greatest threat success randomized clinical trial inability recruit adequate number subjects concern randomized clinical trial adversely affect physician patient relationship common reason physicians reluctance enroll patients trials report modification prerandomized design first described zelen implemented randomized clinical trial arthroscopy patients osteoarthrosis knee method associated sixfold increase rate accrual patients compared use classic randomization trial propose design potential solution problem recruitment subjects particularly clinical studies,C05,0.003400302,0.0030162376,0.03873402,0.001910491,0.004734813,0.022162646,0.28657305,0.0031976851,0.002458267,0.0033409966,0.035706133,0.028166128,0.078473374,0.008110183,0.0029901399,0.005294977,0.1519002,0.0035017473,0.13084553,0.08019614,0.10058149,0.0012073237,0.0034981053
radiographic appearances lumbar disc prolapse pre operative lumbar spine radiographs consecutive patients undergone discectomy prolapsed intervertebral disc reviewed prolapse recognized bulging sequestration disc consequent root compromise measurement lumbar level interiliac line shown correlate level disc prolapse incidence transitional vertebrae lumbosacral junction significantly higher normal pathological value lumbosacral angle could identified,C05,0.0053308522,0.004728732,0.0099468175,0.028789865,0.007443117,0.0068797427,0.23074238,0.056609225,0.003853969,0.0052378755,0.032711808,0.010964765,0.17094555,0.012434064,0.004687817,0.008301246,0.14807609,0.0055596284,0.0060699596,0.064211,0.16909848,0.001892792,0.0054841843
inwardly pointing knee unrecognized problem external rotational malalignment twelve patients inwardly pointing knees chronic knee pain disability suggestive patellofemoral subluxation none responded well conservative measures surgical correction level soft tissues pattern limb alignment studied roentgenographically found differ significantly control group healthy young adults deformities primarily related tibia external tibial torsion excess varus angulation tibial plateau varus knees angulation femoral condyles normal femoral anteversion appear contribute significantly deformity surgery seven cases nine knees derotation valgus maquet osteotomy tibia lateral release realignment patellae outcome assessments three year follow period five knees excellent early results remaining cases satisfactory,C05,0.0033453815,0.0029675204,0.006242135,0.0018796334,0.0046583377,0.0043173893,0.28223842,0.019338343,0.034807324,0.0032870339,0.10496259,0.023556452,0.12677455,0.008297645,0.002941844,0.005209455,0.11527659,0.0034470572,0.003809209,0.10931147,0.12870221,0.0011878235,0.0034416053
volvo award experimental studies anulus tears intervertebral disc degeneration experimental study using animal model animal model developed test hypothesis discrete peripheral tears within anulus lead secondary degenerative changes disc components adult sheep cut made left anterolateral anulus three randomly selected lumbar discs cut parallel adjacent inferior end plate controlled depth mm left inner third anulus nucleus pulposus intact closely reproduced rim lear lesion described schmorl animals randomly allocated different groups relation length time interval operation death varying months death lumbar spine cut individual joint units disc sectioned six parasagittal slabs observation slabs dissecting microscope two six slabs one containing anulus lesion contralateral processed histology results study suggest despite great care taken operation ensure inner anulus left intact progressive failure inner anulus seen sheep occurred majority discs months operation although outermost anulus showed ability heal defect induced cut led initially deformation bulging collagen bundles eventually inner extension tear complete failure findings suggest discrete tears outer anulus may role formation concentric clefts accelerating development radiating clefts peripheral tears anulus fibrosus therefore may play important role degeneration intervertebral joint complex,C05,0.019832944,0.021673804,0.03541961,0.040853936,0.032591507,0.012567632,0.21757105,0.04920975,0.0014825567,0.0020149222,0.012696061,0.024790723,0.016639613,0.007187167,0.011705647,0.0031933489,0.12829447,0.012016248,0.0023350108,0.07615729,0.26890543,0.00072812504,0.0021331462
gallium nitrate advanced paget disease bone effectiveness dose response analysis objective evaluate whether brief course treatment gallium nitrate reduce biochemical parameters accelerated bone turnover patients advanced paget disease design unblinded trial decreasing dose schedules gallium nitrate setting university hospital primary orthopedic metabolic bone disease specialty patients ten patients advanced paget disease previously received conventional therapy consisting calcitonin etidronate mithramycin interventions five patients entered three dose schedules mg kg body weight per day continuous intravenous infusion days mg kg per day days subcutaneous injection mg kg per day days subcutaneous injection several patients treated different dose schedules patients followed relapse results fifteen courses treatment administered ten patients reductions serum alkaline phosphatase urinary hydroxyproline excretion observed treatment dose schedule treatment high intermediate low doses median maximum decreases serum alkaline phosphatase activity respectively median maximum decreases urinary hydroxyproline excretion respectively maximum decrease urinary hydroxyproline excretion occurred within median weeks start treatment whereas maximum decrease serum alkaline phosphatase activity occurred substantially later median weeks treatment schedules well tolerated response duration highly variable range weeks conclusions short term treatment gallium nitrate reduce biochemical parameters disease activity patients advanced paget disease bone larger trials using low dose intermittent treatment schedules required evaluate safety effectiveness therapy,C05,0.013591347,0.019558443,0.04611889,0.043728773,0.0017678025,0.0017650448,0.21993086,0.0011937659,0.00091772486,0.0012472671,0.04213517,0.039327975,0.05746978,0.002971599,0.0011162846,0.008115577,0.17110306,0.0074291956,0.01975152,0.009997351,0.2890039,0.00045072037,0.0013079572
incidence cervical spinal stenosis professional rookie football players sagittal canal vertebral body ratios measured cervical spine lateral radiographs professional football players rookie football players total levels measured players thirty two percent professional football players rookies ratio less one levels c c ratio considered indicative cervical spinal stenosis first time incidence spinal stenosis determined torg ratio demonstrated population professional rookie football players one third population cervical spinal stenosis determined torg ratio factors considered evaluation player transient quadriplegic episode making continued play decisions,C05,0.003843098,0.0034090197,0.007170822,0.00215928,0.023997545,0.004959718,0.15400983,0.022215994,0.0027783888,0.0037760695,0.020322656,0.007904517,0.22021806,0.009323058,0.017186105,0.005984503,0.15366082,0.0039577535,0.0043759323,0.21668938,0.106739275,0.0013645444,0.0039536376
studies porcine intestinal calcitriol receptor pseudo vitamin deficiency rickets type calcitriol dihydroxyvitamin concentrations plasma humans pigs pseudo vitamin deficiency rickets type pvdri reported significantly lower normal subjects animals sometimes however calcitriol concentrations relatively high subjects animals pmol l nevertheless clinical symptoms rickets develop studied whether development rachitic lesions piglets pvdri due altered binding properties intestinal calcitriol receptor addition defective renal production calcitriol pvdri piglets clinical biochemical symptoms rickets hypocalcaemia increased activity alkaline phosphatase calcitriol concentrations plasma pmol l n used compared unaffected piglets normal calcitriol concentrations pmol l n equilibrium dissociation constant kd receptor pvdri piglets nmol l control piglets nmol l maximum binding capacity bmax fmol mg protein respectively different n association rate constant kass degrees c x x mol l min dissociation rate constant kdiss x x min half life dissociation h respectively also different diseased control piglets,C05,0.0023828135,0.0021124254,0.015605527,0.0013381342,0.014843654,0.037639238,0.23860337,0.0022395025,0.0017216501,0.015676364,0.011392321,0.0049833953,0.16633296,0.0065766526,0.0020941477,0.015503461,0.035020698,0.07249821,0.0027115804,0.038750622,0.30862042,0.00084555056,0.0025073271
controlled trial intravenous immunoglobulin g chronic fatigue syndrome purpose currently established therapy chronic fatigue syndrome cfs recently defined illness associated variety immunologic abnormalities based hypothesis chronic viral infection immunoregulatory defect involved pathogenesis cfs therapeutic benefit intravenous immunoglobulin g iv igg evaluated group patients cfs additionally serum immunoglobulin concentrations peripheral blood lymphocyte subset numbers measured outset study effect iv igg therapy igg subclass levels determined patients methods thirty patients cfs enrolled double blind placebo controlled trial iv igg treatment regimen consisted iv igg g kg intravenous placebo albumin solution administered every days months participants completed self assessment form prior six treatments used measure severity symptoms functional status health perceptions patients also asked report adverse experiences defined worsening symptoms occurring within hours treatment results twenty eight patients completed trial baseline patients complained moderate severe fatigue measures social functioning health perceptions showed marked impairment low levels igg found low levels igg end study significant therapeutic benefit could detected terms symptom amelioration improvement functional status despite restoration igg levels normal range major adverse experiences observed iv igg placebo groups conclusion results study indicate iv igg unlikely clinical benefit cfs addition ongoing need placebo controlled trials candidate therapies cfs expanded research effort needed define etiology pathogenesis disorder,C05,0.0012243057,0.0069462145,0.014127286,0.0006878874,0.0065174713,0.007501296,0.35342896,0.0011513518,0.0008851185,0.007571023,0.015408784,0.06312623,0.053056028,0.025430918,0.0010766234,0.0019064986,0.09211029,0.0012611039,0.066588946,0.07965672,0.19864036,0.00043470645,0.0012618887
sagittal plane analysis idiopathic scoliosis patients treated cotrel dubousset instrumentation one hundred sixty patients idiopathic scoliosis treated cotrel dubousset instrumentation cdi underwent preoperative postoperative sagittal plane analysis thoracic spine thoracolumbar junction lumbar spine data suggest mild moderate improvements thoracic hypokyphosis possible crossing thoracolumbar junction reversal rod bend reversal hooks derotation rod appear provide physiologic sagittal contour cotrel dubousset instrumentation mid distal lumbar spine preserve times enhance lumbar lordosis,C05,0.0050693806,0.0044967937,0.009458939,0.06143142,0.0070589525,0.0065423,0.28003332,0.004767307,0.05274205,0.0049809646,0.029768923,0.010426748,0.035235744,0.011873926,0.0044578854,0.00789408,0.1972774,0.029748123,0.005772236,0.066263914,0.08897531,0.0017999529,0.073924325
multicenter analysis percutaneous discectomy study performed evaluate group patients undergoing percutaneous discectomy patients single level unilateral l l disc herniation documented either computer tomographic ct scan myelogram magnetic resonance imaging mri average follow percutaneous discectomy months range months average hospitalization time days range days patients able return work procedure thirteen patients ultimately underwent surgical discectomy continued symptoms procedure additional patients undergo surgical discectomy never returned work percutaneous discectomy patients undergo surgical discectomy significantly pain residual weakness numbness compared patients undergoing surgical discectomy results study clearly indicate percutaneous discectomy appear predictable successful treatment modality surgical discectomy,C05,0.0028394575,0.0025187405,0.005298133,0.0015953754,0.018237496,0.0036644677,0.13834874,0.0026702601,0.0020528014,0.0028052956,0.05758481,0.019589571,0.032828253,0.0065312157,0.0024969473,0.018146595,0.5125611,0.0029241703,0.00323314,0.051420532,0.10870513,0.0010081882,0.0029395549
arthrometric evaluation knees torn anterior cruciate ligament used kt arthrometer test knees patients acute tear anterior cruciate ligament patients chronic tear control subjects total individuals three testing parameters extent anterior translation eighty nine newtons force maximum manual force compliance index differences involved uninvolved knees calculated eighty nine newtons one control subjects anterior translation ten millimeters less compared per cent patients chronic tear maximum manual force two control subjects translation ten millimeters less compared per cent patients acute chronic tear analysis variance showed clinical diagnosis correlated well results tests p less however uninjured knees patients acute chronic tear compared knees control subjects significant differences noted p less patients chronic tear relationship time injury operation extent anterior translation arthrometric test maximum manual force strongest discriminant differentiated normal abnormal knees p less high sensitivity per cent high specificity per cent high positive predictive accuracy cut point eleven millimeters less,C05,0.012095853,0.011858639,0.013886237,0.0011635586,0.012907633,0.0027048958,0.18859534,0.0019475068,0.041595515,0.0020347885,0.10407505,0.0043152235,0.34700462,0.004779277,0.031905685,0.02478407,0.10205721,0.0021384594,0.002358033,0.03233464,0.052591957,0.00073530414,0.0021304735
use liposuction contour cherubism yet another application suction lipectomy equipment presented remove pathologic tissue cherubism owing variations consistency material condition technique may successful patients certainly recommended indicated,C05,0.007443393,0.006602661,0.013888599,0.004182139,0.010364689,0.009606087,0.3151118,0.0069998573,0.005381242,0.007313571,0.08864571,0.015309637,0.082095854,0.018120682,0.006545532,0.047621883,0.14398946,0.007665461,0.008475398,0.04755793,0.13677804,0.0026428786,0.0076574883
relationship glucocorticoid dosage serum bone gla protein concentration patients rheumatologic disorders serum bone gla protein bgp measurements rheumatic disease patients receiving long term prednisone therapy revealed inverse relationship r p less serum bgp levels prednisone dosage multiple regression analysis demonstrated significant relationships r p less serum bgp prednisone dosage dosage serum creatinine age age creatinine interaction model predicts suppression serum bgp low dosages steroids suppression dosages mg day,C05,0.003640008,0.0032288686,0.059646588,0.002045172,0.005106709,0.00469762,0.16106397,0.0034231073,0.0026315637,0.0035765215,0.08472305,0.010687677,0.086916424,0.009455056,0.003200931,0.005668249,0.09833366,0.041332927,0.0041446844,0.10204465,0.2993954,0.0012924345,0.0037447058
effect local deep microwave hyperthermia experimental zymosan induced arthritis rabbits effect local deep microwave hyperthermia ldmwh normal zymosan induced arthritis evaluated rabbits joints ldmwh four treatments joint twice weekly period wk generated antenna operating mhz min reaching intraarticular temperature degrees c surface cooling system used microwave apparatus two weeks last treatment animals sacrificed application ldmwh normal joints induced limited proliferation synovial lining cells minimal perivascular infiltration mononuclear neutrophil cells however histologic damage skin muscles bone cartilage bone marrow adjacent heated joints could noted induction zymosan arthritis wk ldmwh characterized pannus formation granulomatous reaction accompanied fibrinoid deposits disseminated necrotic foci synovial intima ldmwh treatment examined arthritic joints brought reduction degree granulomatous reaction concomitant appearance fibrocytes fine collagen fibrils findings suggest ldmwh safely applied even repeatedly without morphologic evidence damage normal mesenchymal tissue moreover reduces inflammatory process experimentally induced synovitis,C05,0.013768822,0.002088989,0.019542322,0.012718143,0.014678744,0.0030475461,0.2057037,0.043327715,0.013102654,0.0023139108,0.053356856,0.06808591,0.037688132,0.066622026,0.002070914,0.027923336,0.057520162,0.014069872,0.0026814963,0.02922649,0.3071943,0.00083616946,0.0024317985
arachnoid granulation cerebrospinal fluid otorrhea case report review temporal bone tb collection department otolaryngology suny health science center syracuse demonstrated occurrence arachnoid granulations ags posterior fossa surface tb role cerebrospinal fluid csf otorrhea large ag responsible csf otorrhea year old man excised soft tissue repair dural defect sixteen tbs collection contained ags ranging size mm nine ags small less mm demonstrate enlargement twelve intermediate size mm three large mm intermediate large ags associated bone erosion high incidence communication pneumatized mastoid complex serous otitis media meningitis findings suggest ags sufficient size produce bone erosion primary responsible lesions adult onset spontaneous csf otorrhea,C05,0.018348403,0.002787061,0.012274627,0.0017653301,0.066563025,0.004054842,0.25404596,0.018157693,0.0022714855,0.018295228,0.06591007,0.006462378,0.0361729,0.01889874,0.002762946,0.00489266,0.12656373,0.0032356812,0.018783998,0.09428785,0.18865834,0.03153166,0.0032753833
limited precision lumbar spine dual photon absorptiometry variations soft tissue background estimation error due variations soft tissue baseline lumbar bone mineral content bmc measured dual photon absorptiometry dpa calculated new method automatic baseline subtraction water phantom measurements soft tissue st baseline matched closely r random error calculated using kev kev count rates directly determined baseline variations volunteers patients osteoporosis st variations larger expected random error revealing source error related inhomogeneity soft tissue estimation error bmc caused st variations healthy subjects mean bmc gha patients mean bmc gha results indicate st related errors important limit precision lumbar dpa measurements,C05,0.0029230707,0.0025900772,0.005448189,0.0016405602,0.063394435,0.0041139256,0.19273685,0.002751202,0.0021109416,0.0028689513,0.060899965,0.023624625,0.2911351,0.007227814,0.038238883,0.004546857,0.07559826,0.0030112898,0.0033247103,0.042227868,0.0807325,0.08585009,0.0030038627
quantitative evaluation digital dental radiograph imaging systems two digital imaging systems video camera analog digital converter charge coupled device linear photodiode array slide scanner tested suitability quantitative studies periodontal disease information content original films estimated digital systems assessed according requirements radiometric geometric performance criteria digital systems estimated measurements observations scanner based image acquisition digitization system detectable noise modulation transfer function curve superior video based system scanner based system equivalent video based system recording radiographic film densities geometric distortion video based system comparison demonstrated superiority charge coupled device linear array system quantification periodontal disease extent activity,C05,0.0029200446,0.030860007,0.047836214,0.001640654,0.06066498,0.017894588,0.38840613,0.0027460454,0.0021110624,0.0028691154,0.10668558,0.006005974,0.07126826,0.022590447,0.0025678135,0.046946447,0.025585087,0.0030102478,0.017438179,0.034356102,0.1015562,0.0010368017,0.0030040343
arthritis roles radiography imaging techniques evaluation imaging studies performed patients arthritis variety reasons determine whether arthritic condition present establish specific diagnosis determine extent disease assess activity disease detect complications disease evaluate progression disease judge efficacy drug treatment help selection surgical candidates aid choice surgical procedures size design fabricate prostheses identify complications surgery conventional radiography still mainstay examinations arthritic patients arthrography best applied evaluate complications disease surgery although may useful disease detection determining specific diagnosis nuclear medicine studies best used identify complications surgery may also useful assess disease activity extent ultrasound useful detect dissecting synovial cysts deep venous thrombosis valuable role computed tomography design fabrication prostheses evaluating complex anatomy involved joints magnetic resonance imaging may useful early detection articular cartilage damage may assist determination specific diagnosis enhancement contrast material may aid assessment disease activity,C05,0.0018002542,0.0015969153,0.055226892,0.0010114894,0.06651481,0.010823892,0.36694217,0.010400276,0.0013015036,0.0018109715,0.17645343,0.0037027788,0.022117862,0.0053793616,0.0015830981,0.020228876,0.1491003,0.0018539634,0.002173225,0.012995291,0.0844879,0.00063920487,0.0018555099
making core decompression work meaningful assessment treatment modality osteonecrosis must take account number factors accurate diagnosis consistent staging disease process understanding variability disease consistent application treatment modality surgical technique clear understanding goal treatment used article reviews important steps diagnostic algorithm used accurately diagnose stage disease process consistent surgical technique clearly defined goals also outlined results two clinical studies based diagnostic therapeutic philosophies assess role core decompression treatment reviewed first study compared core decompression conservative management prospective randomized study hips decompression provided predictable pain relief changed indications surgical intervention consistently conservative management second study represents preliminary review ten year study decompression procedure showed core decompression particularly useful stage stage ii roentgenographic stabilization predictable stage hips core decompression safe effective predictable procedure treatment stage stage ii,C05,0.0020920832,0.011966692,0.0039036104,0.011290592,0.0029131598,0.012820305,0.41602468,0.0019674203,0.0015124831,0.0020555947,0.122908816,0.02454199,0.029097613,0.05225662,0.0018397252,0.013381481,0.20105387,0.0021544988,0.0023821446,0.036293484,0.044648044,0.00074282277,0.002152258
electrophysiological spectrum inclusion body myositis present electrodiagnostic data patients inclusion body myositis ibm order better delineate electrophysiological features comprehensive electromyography emg nerve conduction studies ncs performed cases twelve patients single fiber electromyography sfemg emg showed abundant short small motor unit potentials mup fibrillations positive sharp waves patients mixed pattern large small mup neurogenic features seen ncs slow sfemg revealed mildly abnormal jitter slightly increased fiber density ibm demonstrates heterogeneous emg profile pattern large small mup highly suggestive ibm seen one third cases,C05,0.0033455577,0.0029676768,0.006242464,0.0018797325,0.0046786023,0.0043176166,0.30466917,0.003146203,0.018609684,0.003287207,0.1276957,0.0068811732,0.0403517,0.04058756,0.034750745,0.0052097295,0.11424876,0.03688215,0.0038094097,0.08394104,0.14786406,0.001187886,0.003446158
determinants vertebral mineral density patients receiving long term glucocorticoid therapy study addresses impact clinical biochemical factors bone density patients receiving glucocorticoid therapy vertebral mineral density measured quantitative computed tomography patients aged years received therapeutic glucocorticoid drugs years mean sem vertebral mineral density z score subjects z score unrelated underlying diagnosis sex age significantly related duration previous steroid therapy r total cumulative glucocorticoid dose r rate change bone density subjects followed period months significantly greater subjects taking mg prednisone per day bone loss influenced sex age duration previous steroid treatment diagnosis predictable biochemical measures calcium metabolism,C05,0.002466594,0.002187992,0.05235387,0.0013858787,0.01536794,0.0031832682,0.21200566,0.002319615,0.0017832378,0.002430817,0.072007604,0.051978614,0.13541593,0.019484468,0.0021691127,0.0038410001,0.12473389,0.0025521596,0.022051895,0.16378663,0.10308051,0.00087579794,0.002537541
bone loss distal anterior femur total knee arthroplasty bone loss distal anterior femur asymptomatic total knee arthroplasty tka patients noted roentgenographically revision surgery retrospective roentgenographic review tka cases carried document bone loss influence mode fixation porous coated cemented implant design bone loss examined time onset progression bone loss studied bone loss occurred distal anterior femur majority cases reviewed prevalence bone loss independent mode fixation implant design qualitative observation roentgenographically detectable bone loss occurred within first postoperative year progress previously three dimensional finite element analysis demonstrated replacement bearing surface femur stiff metallic implant reduces stress distal anterior femur least one order magnitude therefore speculated observed bone loss results stress shielding apparent lack progression may reflect development new remodeling equilibrium altered stress conditions bone loss distal anterior femur described implicated source failure however since bone strength femoral region compromised becomes osteopenic bone failure may occur longer periods cyclic loading furthermore result bone loss revision arthroplasty may difficult,C05,0.0016836735,0.017787483,0.04935959,0.00094560964,0.0023527467,0.0021769747,0.21124643,0.0015827145,0.009360848,0.01794355,0.16049188,0.0034848244,0.06514835,0.031449985,0.025976036,0.0026219839,0.10241815,0.0017369613,0.0019163443,0.2164863,0.053066276,0.00059757254,0.02016571
effect early fronto orbital advancement frontal sinus development forehead aesthetics frontal sinuses make important contribution normal forehead glabellar contour study designed test clinical impression early fronto orbital frontal bone advancement could adverse effect frontal sinus development consequently forehead aesthetics retrospective study conducted patients undergone fronto orbital advancement also long period follow institute reconstructive plastic surgery new york university longitudinal cephalometric data compared unoperated controls one exception patient underwent bilateral fronto orbital advancement developed frontal sinus patients flattened brow contour compared unoperated patients percent developed least one frontal sinus three patients underwent unilateral fronto orbital advancement plagiocephaly flattened forehead two developed frontal sinus unoperated side one developed bilateral frontal sinuses two patients unilateral frontal sinus development particularly obvious deformity resulting normal glabellar projection unoperated side flattened contour operated side fronto orbital advancement affects forehead aesthetics performed infant patients moderate severe deformities patients plagiocephaly whose deformity sufficiently severe warrant surgery preferably undergo bilateral fronto orbital advancement technique described rather unilateral advancement order avoid brow asymmetry results unilateral frontal sinus development,C05,0.0021432345,0.032903794,0.024239743,0.0011997243,0.0029733037,0.01348147,0.24496622,0.002008039,0.0015437092,0.012427543,0.03548951,0.00442473,0.041639138,0.0051519354,0.012198853,0.0033250682,0.25647947,0.0022014845,0.0024313254,0.12504315,0.13976513,0.031766742,0.0021966929
biomechanical comparison single double pin fixation acute slipped capital femoral epiphysis biomechanics pin fixation acute slipped capital femoral epiphysis scfe studied vitro immature canine model acute scfe created paired femurs paired specimens pinned either one two pins loaded failure strength stiffness paired limbs expressed percentages loads necessary create initial scfe intact specimen strength stiffness equivalent statistically intact physis fractured physis fixed two pins single pinning strong stiff intact physeal plate double pin fixation recommended single pin fixation acute scfe data however extrapolated clinical situation fixation chronic scfe,C05,0.0040691826,0.022865774,0.103236474,0.0022429079,0.005558649,0.0051518055,0.26984742,0.003754068,0.04153511,0.042565454,0.10019146,0.008210656,0.053487528,0.05284831,0.0035104107,0.027467215,0.06490789,0.0041110357,0.00454541,0.050114676,0.124202505,0.0014173926,0.0041586477
lumbar discography followed computed tomography refining diagnosis low back pain two hundred fifty patients low back pain underwent lumbar discography followed computed tomography ct subject prospective study patients combined imaging techniques provided additional useful diagnostic information affected patient management selection treatment alternatives lumbar discography followed ct proved valuable determining significance equivocal multiple level abnormalities determining type disc herniation defining surgical options evaluating previously operated spine patients surgery ct discography correctly predicted type disc herniation protruded extruded sequestrated internally disrupted computed tomography discography may sensitive magnetic resonance imaging mri early stages disc degeneration discs normal weighted image discographically abnormal ct discogram revealed annular tears radial fissuring radiographic morphology normal herniated degenerative lumbar discs shown ct discography gives unique insight pathogenesis disc degeneration complications followed discograms one case urticaria one disc space infection even availability high resolution ct mri lumbar discography remains pain provocation challenge lumbar disc,C05,0.002381427,0.0021124445,0.038612705,0.0013381159,0.074241064,0.0030733556,0.31484514,0.0022395228,0.0017216657,0.0023398919,0.10525823,0.004952053,0.038503982,0.019240186,0.0020941668,0.003708377,0.2223539,0.0024583356,0.0027116048,0.05643419,0.08444328,0.0008455582,0.014090818
radical osteoclastic craniectomy sagittal synostosis report experience surgical treatment sagittal synostosis using radical osteoclastic craniectomy consecutive patients surgery children aged months younger group reossification usually started weeks postoperatively complete within months resulting optimal skull contour children aged months group ii reossification prolonged lasted months longer skull contour normalized biparietal width improved sagittal diameter remaining however slightly abnormal children older months group iii skull contour partly improved biparietal diameter change sagittal direction reossification incomplete persistent pseudosutures enlarged frontal subarachnoid spaces reversible improved patients independent age time surgery encountered complications series opinion radical osteoclastic craniectomy simplest efficient physiologically sound method treatment sagittal synostosis patients months age procedure allows rapidly growing brain form skull vault thus providing optimal cosmetic results older children osteoplastic morcellation procedures treatment choice,C05,0.025144864,0.0020884213,0.004392963,0.0013228102,0.026038408,0.0030384043,0.22875185,0.002216005,0.0017020863,0.047905054,0.027759494,0.045687243,0.017198155,0.018032208,0.0134440735,0.0036699632,0.29788622,0.0024245847,0.0026807676,0.14100254,0.08435408,0.0008359422,0.0024238504
mother daughter pairs spinal femoral bone densities dietary intakes bone mineral density bmd lumbar spine l l femur femoral neck ward triangle trochanter measured healthy white mother daughter pairs dual photon absorptiometry mothers daughters aged mean sd respectively three day dietary intakes evaluated significant correlations mother daughter pairs bmd lumbar femoral areas except l r p indicated familial resemblances bone mineralization total calcium intake significantly correlated three bmd values daughters l femoral neck trochanter mothers mothers classified pre n postmenopausal n correlation coefficients bmd higher premenopausal mothers daughters lower postmenopausal mothers daughters except trochanter results suggest nature inheritance bone mass women may least two components one influencing level peak bone mass one related bone loss menopause,C05,0.0028394982,0.0025187766,0.046534322,0.0015953983,0.0039539114,0.0174001,0.107738145,0.0026702986,0.04329067,0.0027899737,0.12788925,0.019792195,0.15901197,0.020288542,0.0024970355,0.0044216895,0.02729446,0.0029242125,0.0032331864,0.29044777,0.10693918,0.0010082027,0.002921171
computer assisted tomography scoliosis operated without harrington rod biomechanics aspects fusion forty eight cases posterior vertebral arthrodesis scoliosis performed without instrumentation examined using computed tomography ct scanning study evolving fusion mass authors observed fusion mass area voluminous cases performed without instrumentation ones performed instrumentation years fusion bone mass shows already considerable increase cases operated harrington technique increase fusion mass slow becomes considerable years operation series section fusion masses apex curve asymmetric prevalence concave side area central resorption shows structure long bone box section,C05,0.020190714,0.019801421,0.090136155,0.0019425369,0.021544013,0.0044618743,0.13546564,0.036721963,0.0024995012,0.036861923,0.19003311,0.007111083,0.04263709,0.007949486,0.0030402953,0.0053837937,0.09458017,0.0035604844,0.020660508,0.059902616,0.1740012,0.001227575,0.020286873
factors influencing result posterior spinal fusion treatment adolescent idiopathic scoliosis sixty six consecutive patients adolescent idiopathic scoliosis treated posterior spinal fusion using harrington distraction compression instrumentation followed minimum years initial surgical correction satisfactory follow period mean years years loss correction several factors age sex number vertebrae fusions use cross wires important influences correction method assessing balance posterior spinal fusion described useful assessing radiographs,C05,0.061968323,0.0035411527,0.0267109,0.0022443333,0.005558811,0.005151956,0.20104006,0.0037541776,0.0028860786,0.0039224294,0.04599385,0.008210896,0.07058036,0.011963263,0.0035604213,0.0062164613,0.31074497,0.0041111554,0.004545543,0.15063304,0.06109617,0.001417434,0.004148222
healing non vascularised diaphyseal bone transplants experimental study four different experiments performed study healing large non vascularised diaphyseal bone segment adult cats first experiment cm segment tibia periosteum excised replaced bed experiments similar except second periosteum segment removed third medullary canal blocked silastic rod last group segment isolated muscle bed silastic sheet reparative processes quantified estimating resorption index cortical new bone formation index callus encasement index osteocyte count bone resorption apposition occurred segment even periosteum absent medullary canal blocked osseous union ends eight weeks provided segment isolated muscle bed thus muscle bed played significant role reparative processes,C05,0.0029198641,0.0025900654,0.005448164,0.0016405527,0.004066907,0.0037823832,0.2066354,0.022458123,0.04451782,0.002868938,0.105622694,0.060132377,0.078535326,0.010280899,0.002567655,0.02520732,0.059478484,0.003006976,0.003324695,0.0703731,0.28048065,0.0010367377,0.0030248156
dermatomyositis correlative mr imaging p mr spectroscopy quantitative characterization inflammatory disease magnetic resonance mr imaging phosphorus mr spectroscopy used examine four patients dermatomyositis five control subjects weighted images thigh muscles patients showed increased signal intensity focal inhomogeneous involvement predominantly vastus lateralis secondarily vastus intermedius vastus medialis values vastus lateralis patients significantly higher control subjects values rectus femoris biceps femoris generalized inflammation moderately elevated still significantly higher control subjects p mr spectra quadriceps muscles obtained rest exercise two graded levels recovery concentrations adenosine triphosphate phosphocreatine pcr diseased muscles normal values inorganic phosphate pcr ratios increased patients muscles rest throughout exercise values well p metabolite data correlated symptoms clinical assessment,C05,0.0028792217,0.030430056,0.019278,0.0016177172,0.031883623,0.0037157855,0.15883057,0.0027076548,0.05783731,0.051384408,0.018979963,0.0059738336,0.3052229,0.020822039,0.016449256,0.0044835466,0.07965129,0.0029658456,0.0032784173,0.05195818,0.12566602,0.001022307,0.002962037
treatment psoriatic arthritis oral dihydroxyvitamin pilot study conducted month open label trial patients active psoriatic arthritis received micrograms oral dihydroxyvitamin daily statistically significant improvement noted tender joint count physician global impression patients substantial greater equal improvement moderate greater equal improvement tender joint count two patients unable receive therapeutic doses hypercalciuria high dose vitamin may useful therapeutic agent psoriatic arthritis,C05,0.003991988,0.022857988,0.026737042,0.0022429354,0.005558717,0.005151869,0.30848297,0.003754114,0.0028860297,0.003922363,0.019438552,0.057488225,0.03663919,0.028488785,0.0035104535,0.0062163556,0.15296037,0.023387412,0.023869937,0.029910937,0.18832898,0.040067986,0.0041068103
capacitive coupling adjunctive treatment avascular necrosis purpose study determine effectiveness capacitive coupling noninvasive method applying electrical stimulation biologic tissues used adjunct decompression grafting treatment avascular necrosis avn femoral head also compared results core decompression grafting nonoperative management forty patients stages iii avn femoral head treated core decompression grafting wore capacitive coupling units electrodes placed femoral head continuously six months one half units active one half inactive patients followed two four years results determined preoperative postoperative harris ratings quantitative roentgenographic measurements number hips required total hip arthroplasty tha evaluations completed patients divided stimulated nonstimulated groups patients groups similar regarding gender etiology roentgenographic stage involvement results also compared hips previously treated symptomatically without surgery electrical stimulation fractures infections significant complications hips operated hips treated decompression grafting without electrical stimulation satisfactory hips treated symptomatically regard roentgenographic progression need tha however indication addition capacitive coupling gave better results decompression grafting alone,C05,0.03420215,0.012618074,0.040107735,0.0012380839,0.013734482,0.0028437937,0.20245872,0.0020722435,0.03359413,0.0021651157,0.044215906,0.04546018,0.059674866,0.005575896,0.0019377448,0.0034313828,0.33900928,0.0022692895,0.0025090638,0.038556278,0.109275155,0.0007823999,0.0022680152
american college rheumatology criteria classification reporting osteoarthritis hand clinical criteria classification symptomatic idiopathic primary osteoarthritis oa hands developed data collected multicenter study patients oa compared group patients hand symptoms causes rheumatoid arthritis spondylarthropathies variables medical history physical examination laboratory tests radiographs analyzed patients pain aching stiffness hands patients classified clinical oa examination hard tissue enlargement involving least selected joints swelling fewer metacarpophalangeal joints hard tissue enlargement least distal interphalangeal dip joints patient fewer enlarged dip joints deformity least selected joints necessary order classify symptoms due oa selected joints second third dip second third proximal interphalangeal trapeziometacarpal base thumb joints hands criteria derived using classification tree method sensitive specific traditional format classification method required least criteria present classify patient oa hand latter sensitivity specificity radiography less value clinical examination classification symptomatic oa hands,C05,0.0022288954,0.0019757496,0.013987691,0.0012514438,0.0031014814,0.0028744806,0.32676163,0.0020955452,0.0016102578,0.0021961427,0.17194393,0.015363924,0.047703292,0.0057529807,0.06665239,0.00346841,0.18371798,0.0023077643,0.013300896,0.056593005,0.07201408,0.00079084263,0.0023071633
evaluation electrogoniometric instrument measurement laxity knee eight lower extremities cadavera tested anterior posterior laxity two positions transection anterior cruciate ligament critical points tests electrogoniometric radiographic measurements tibiofemoral translation compared direct measurement determined accuracy radiographic method millimeter per cent measuring anterior posterior translations tibia respect femur electrogoniometer estimated displacement tibia respect femur anterior drawer test millimeters degrees flexion knee millimeters degrees flexion direct comparison measurements obtained means radiographic technique showed electrogoniometer tended average overestimate tibial translation amount overestimation millimeter intact knees millimeters sacrifice anterior cruciate ligament despite small average error measurement tibial translation difference individual electrogoniometric radiographic measurements varied greatly per cent confidence limit millimeters error electrogoniometric measurements varied angle flexion knee testing accuracy reliability electrogoniometric measurements greatly diminished degrees flexion electrogoniometric method also tended overestimate tibial internal rotation average degrees external rotation average degrees reliability measurements degrees,C05,0.040444706,0.0023570668,0.005209422,0.0014929709,0.029424904,0.029144982,0.13315463,0.0024988607,0.0019210355,0.0026108525,0.16521549,0.005483415,0.30472124,0.0067710006,0.028007785,0.004137809,0.024854776,0.0027364728,0.0030256102,0.05009208,0.12729219,0.026669094,0.0027336269
monosodium urate crystals stimulate phospholipase enzyme activities synthesis phospholipase activating protein eicosanoids important mediators inflammatory response monosodium urate crystals msuc results gout phospholipase enzymes cleave fatty acids membrane phospholipids thought rate limiting step eicosanoid production understand better mechanism eicosanoid production disease stimulated human peripheral blood neutrophils monocytes msuc measured phospholipase enzyme activities msuc stimulated intracellular secretory phospholipase enzyme activities time concentration dependent manner specificity observed phospholipase c activities affected pretreatment colchicine aspirin indomethacin allopurinol islet activating protein abrogated enhanced phospholipase activities recently isolated characterized phospholipase activating protein termed plap synovial fluid patients rheumatoid arthritis murine bovine cell lines plap detected gouty synovial fluid immunodot blotting elisa assays expressed characteristics plap identified sources examine role plap msuc induced phospholipase stimulation treated cells msuc observed increase immunoreactive plap response also could blunted colchicine drugs phospholipase plap induced production human monocytes pge leukotriene b neutrophils findings suggest phospholipase activation response msuc requires intact microtubule structure phospholipase plap may important modulators least portion gouty inflammatory response,C05,0.0021641806,0.0019137855,0.02051331,0.0012121956,0.0030042117,0.0027843302,0.25427148,0.002028913,0.0015597563,0.0021198431,0.01352588,0.004437508,0.033734135,0.12083472,0.0018972266,0.0033596328,0.0404599,0.10064007,0.0024565994,0.028901191,0.3046523,0.011205095,0.04232371
quantitative electromyography polymyositis reappraisal manual analysis motor unit action potentials muaps performed patients polymyositis studied acute stage chronic stage contrary common description myopathic potentials low amplitude short duration polyphasic shape quantitated study revealed difference amplitude short duration muaps patients normal subjects though short duration muap short duration polyphasic potentials times respectively common patients controls although mean duration muaps usually significantly shorter polymyositis controls average scatter muaps duration groups average incidence polyphasic muaps times higher patients controls incidence long duration avoid misinterpretation emg findings due excess polyphasic muaps greater number individual potentials usually recommended collected allowing valid estimate mean duration muaps simple configuration,C05,0.0024982202,0.0022144408,0.0046580434,0.0014026313,0.0034884834,0.0032217482,0.25382364,0.002347655,0.0018047938,0.0024528701,0.06427921,0.018288659,0.18500918,0.005864915,0.01426087,0.0038874305,0.14834842,0.0025747593,0.0028425308,0.21539918,0.057873048,0.00088638475,0.0025728378
clinical epidemiological study low back pain description two clinical syndromes patients mainly chronic low back pain lbp signs symptoms evaluated prospectively without preconceived expectation particular findings two clinical syndromes distinguished characterized typical local tenderness associated specific clinical features syndromes described previously literature receiving scant attention named greater trochanteric pain syndrome trochanteric bursitis iliac crest pain syndrome iliolumbar syndrome occurred patients respectively recognition syndromes may enable us study aetiology prognosis therapy lbp homogeneous groups patients,C05,0.0034574156,0.0030669002,0.0064511793,0.0019425809,0.0048143417,0.021189185,0.33564258,0.0367198,0.0024995576,0.0033971139,0.035999995,0.054992743,0.039457068,0.008315964,0.019749993,0.022100968,0.10969335,0.003560565,0.0039367764,0.22495003,0.05325972,0.0012276027,0.0035746002
influence joint line position knee stability condylar knee arthroplasty using special knee testing device ten knees obtained autopsy subjected varus valgus anterior posterior flexion rotation analysis intact state total knee arthroplasty ten knees showed significant change stability knee replacement joint line maintained natural position femoral component repositioned mm proximally mm anteriorly significant increase laxity occurred midflexion joint line shifted mm distal mm posterior anatomic location significant tightening occurred midrange motion coupled rotation tibia knee flexion decreased surgery knees specific relationship joint line position coupled rotation varus valgus testing however remained within normal range first degrees flexion joint line restored normal anatomic position stability condylar knee arthroplasty part dependent position joint line surgical techniques rely restoring flexion extension gap without regard joint line position may result alteration varus valgus anterior posterior displacement midrange flexion,C05,0.052266438,0.015413972,0.020277988,0.014532687,0.08192747,0.02952431,0.24276191,0.0025312095,0.014972925,0.002644651,0.0621584,0.0055360985,0.12583058,0.0070334864,0.0023670045,0.004203137,0.102809735,0.002774011,0.003064778,0.025322545,0.1783125,0.00095568795,0.0027785117
histologic biochemical ion analysis tissue fluids retrieved total hip arthroplasty large amounts metal polyethylene debris high ion readings found capsule fibrous membranes loose titanium cobalt chromium stems prostaglandin e interleukin collagenase levels elevated compared control values collagenase highest consistent elevations synovial fluid blood ion readings elevated loose cemented cementless stems made materials blood ion readings elevated fixed stems fixed stems much less particulate debris soft tissues data showed failure metal hip stems initially due mechanical cause high debris ion counts occurring secondarily capsule fibrous membranes particulate debris high ion readings primarily focal problem contained periprosthetic fibrous connective tissue encapsulation within femoral canal joint capsules systemic problems manifest patients examined followed study,C05,0.014482676,0.0139623275,0.0281488,0.0013696213,0.003395315,0.0031459262,0.17016469,0.0022924042,0.013559957,0.0023951433,0.024558105,0.005033885,0.13492796,0.13202336,0.0021436159,0.0037959423,0.060193468,0.002510385,0.0027756335,0.06228343,0.19699213,0.0008655242,0.118979715
flurbiprofen versus diclofenac treatment osteoarthritis knee seventy four patients enrolled double blind randomized single center study evaluate therapeutic effectiveness mg tid regimens flurbiprofen diclofenac sodium patients osteoarthritis knee chance flurbiprofen patients significantly advanced disease status baseline diclofenac treated counterparts however subsequent follow evaluations treatment groups experienced significant reduction disease severity regardless baseline differences serious safety problems associated either investigational therapy frequency reported medical events distributed equally flurbiprofen diclofenac groups although imbalance disease severity treatment groups made rigorous statistical interpretation results difficult data clinical trial tend support equiefficacy mg tid regimens flurbiprofen versus diclofenac treating osteoarthritis knee,C05,0.0027635738,0.029205164,0.0051565417,0.0015527393,0.017225547,0.016922783,0.43678293,0.0025988983,0.0019979407,0.0027153734,0.038198303,0.054608773,0.079110235,0.0063543096,0.002430217,0.01767383,0.12979627,0.0028460228,0.036554806,0.050934758,0.06073626,0.0009812446,0.0028534841
little women loja growth hormone receptor deficiency inbred population southern ecuador background methods laron type dwarfism characterized clinical appearance isolated growth hormone deficiency elevated serum levels growth hormone decreased serum levels insulin like growth factor igf described approximately patients condition caused deficiency cellular receptor growth hormone transmitted autosomal recessive trait indicated equal sex distribution high rate consanguinity affected families studied patients females male years age inbred spanish population southern ecuador clinical features laron type dwarfism results seventeen patients members two large pedigrees among affected sibships affected unaffected female siblings affected unaffected male siblings patients heights ranged sd normal mean height age united states addition previously described features patients limited elbow extensibility blue scleras affected adults relatively short extremities four affected women years age hip degeneration basal serum concentrations growth hormone elevated affected children micrograms per liter normal moderately elevated adults serum level growth hormone binding protein ranged percent normal igf concentrations low less equal micrograms per liter children less equal micrograms per liter adults normal ecuadorean women serum levels igf ii growth hormone dependent igf binding protein also low conclusions describe inbred population high incidence growth hormone receptor deficiency resulting clinical picture resembling laron type dwarfism differing principally showing marked predominance affected females population mediterranean origin may genetically related reported populations laron type dwarfism genetic defect linked trait resulting early fetal death affected males,C05,0.0012390274,0.007078959,0.014287182,0.0006962194,0.00698962,0.0015990294,0.24845153,0.0071560484,0.0068804272,0.031206008,0.011802447,0.008493736,0.02842557,0.017997857,0.0010895694,0.013922076,0.10429626,0.044958383,0.03138445,0.1947246,0.2155769,0.0004399336,0.0013042028
magnetic resonance imaging nonoperative treatment spinal epidural abscess report describes three patients spinal epidural abscess diagnosed magnetic resonance imaging treated nonoperatively prior treatment one patient neurologically intact one patient demonstrated moderate neurological deficit one patient severely paraparetic loss bladder bowel control following identification pathogenic organism antibiotic therapy continued patients demonstrated clinical improvement radiological resolution abscess patients remained stable improved neurologically analysis previously reported patients treated antibiotics suggests nonoperative treatment may reasonable alternative therapy certain clinical conditions include identification pathogenic organism stable neurological condition access magnetic resonance imaging computed tomography potentially rapid reevaluation appropriate neurosurgical consultation nursing care nonoperative treatment may also considered reasonable alternative patients severe concurrent medical illness,C05,0.002697445,0.014646273,0.006527542,0.026205117,0.090488285,0.015672823,0.35244218,0.0024060158,0.026605431,0.0025138466,0.022092804,0.0053560347,0.03794713,0.016423361,0.0022498537,0.016366677,0.20947762,0.0026347996,0.027633728,0.07367356,0.042393748,0.0009084196,0.0026372704
bipolar versus total hip arthroplasty avascular necrosis femoral head comparison relatively small series cases results bipolar prostheses avascular necrosis inferior total hip arthroplasty tha femoral loosening rates reduced using bipolar prostheses tha produced inferior results avascular necrosis degenerative joint disease early results noncemented tha avascular necrosis good also must withstand test time fixed noncemented acetabular component preferable bipolar prosthesis avascular necrosis femoral head,C05,0.052185766,0.004286238,0.032405537,0.0027149117,0.006728427,0.029576221,0.28187412,0.004544085,0.0736699,0.028136432,0.08539132,0.00993853,0.04160869,0.0111369025,0.0042491513,0.0075244512,0.08515918,0.004976174,0.005501959,0.04144708,0.18025829,0.0017156728,0.004970998
effects rib elongation spine distortion vertebral alignment rabbit elongation one rib right side cm achieved two groups adult rabbits different age osteotomy application metallic expander procedure resulted immediate deviation spine frontal sagittal planes moderate scoliosis convex left significant decrease normal cervicothoracic lordosis thoracolumbar kyphosis moreover computed tomography ct scanning demonstrated rotation vertebra longitudinal axis relative anterior midline body deviation spinous process toward convex left side scoliotic deformity rib hump developed right side elongated rib changes occurred simultaneously three planes less pronounced group older animals two weeks operation distorted configuration spine remained unchanged observed changes alignment vertebrae changes except direction horizontal plane resembled associated idiopathic scoliosis man support earlier proposed link early stage development condition asymmetry rib growth,C05,0.0029199633,0.0591318,0.034198053,0.0016406083,0.0040659565,0.003768365,0.18229258,0.07342192,0.0021110035,0.0028690356,0.015647622,0.07579989,0.12766996,0.028551342,0.014019366,0.018678682,0.09129992,0.003022004,0.0033248079,0.10526346,0.14626294,0.001036773,0.0030039507
effect pulsing electromagnetic field metabolically derived osteoporosis rats pilot study literature suggests pulsating electromagnetic field pemf effective bone loss disuse osteoporosis study conducted evaluate effects pemf metabolically derived osteoporosis rats sixteen month old female sprague dawley rats divided three groups g g given normal diet exposure pemf g oophrectomized fed low calcium diet months g also exposed hr day pemf generated applying hz peak peak square wave helmholtz coils cm turns coil rats sacrificed months skeletal changes analyzed measurements acid extracted bone calcium bone mineral content bmc using single photon absorptiometry spa although animals started approximately weight mean g g showed progressive increase mean weight months g g g g g g calcium content femur g g months lower g significant differences among three groups,C05,0.0026231543,0.002326869,0.0049492572,0.0014738435,0.0036526595,0.016077911,0.12211757,0.0024726975,0.0018964239,0.0025774033,0.04325338,0.04656459,0.09898261,0.045047216,0.0023067358,0.004084797,0.088089354,0.0028096766,0.0030428516,0.08102224,0.40201044,0.00093138684,0.021686945
restorative surgical technique full maxillary subperiosteal implant edentulous atrophic maxilla represents one challenging implant restorative opportunities prescribed within appropriate diagnostic range performed highly skilled experienced practitioner full maxillary subperiosteal implant predictable solution patient edentulous atrophic maxilla,C05,0.0065058605,0.005771023,0.012139261,0.035137016,0.009059205,0.008396152,0.24821353,0.00611819,0.0047034477,0.00639239,0.09111804,0.044869922,0.042059224,0.109442875,0.00572109,0.04162408,0.18054445,0.006699958,0.0074078795,0.041567773,0.07750563,0.0023099948,0.0066929897
effects lignocaine somatosensory evoked potentials recorded extradural space studied effects extradural administration lignocaine l interspace somatosensory evoked potentials recorded cervical extradural space corrective surgery idiopathic adolescent scoliosis eight patients equivalent volume sodium chloride solution administered lumbar extradural space acted control group lignocaine resulted decrease overall amplitude main effect significant decrease amplitude second third peaks suggesting action dorsal columns spinal cord significant increase latency found lignocaine sodium chloride groups conclude use extradural lignocaine patients undergoing scoliosis surgery may interfere intraoperative monitoring somatosensory evoked potentials,C05,0.0035161893,0.0031190352,0.0065608444,0.0019756032,0.004896182,0.0045378255,0.20303354,0.0033066669,0.0025420482,0.0034548624,0.041338712,0.06221862,0.16674289,0.008240163,0.003092048,0.0054754377,0.16064616,0.0036210918,0.0040036985,0.027320568,0.275492,0.001248471,0.0036173258
sequential three step lateral release correcting fixed valgus knee deformities total knee arthroplasty approach mild moderate severe fixed valgus deformities knee described sequential approach soft tissue releases fixed valgus knee allows surgeon regain neutral alignment valgus deformities degrees additional benefit approach spontaneous correction fixed external tibial rotation deformities using approach early late stability allows use unconstrained knee implants including mobile bearing elements,C05,0.0039315266,0.0034739114,0.0073288223,0.0022003825,0.024404895,0.023996206,0.2986718,0.022638956,0.0028312763,0.0038479483,0.020017497,0.008054983,0.03351483,0.046910636,0.0034440397,0.00609842,0.12051638,0.004033091,0.0044592298,0.14925231,0.20495346,0.0013905191,0.0040288963
analysis effect zielke operation shaped curves idiopathic scoliosis follow study revealing skeletal soft tissue factors involved curve progression article analyzes fate shaped idiopathic spinal curves follow patients zielke vds operation spinal radiographs evaluated cobb angle end vertebra angles evas vertebral rotation new method using tilt surgically fused spinal block frontal plane spinal growth measured using conventional criterion cobb angle progression lower curves upper curves progress use evas shows progression occurs mainly middle thoracolumbar segment spine curve progression occurs frontal plane without significant change vertebral rotation progression upper curve cobb angle related progression cobb angle lower curve related tilt spinal block growth spine block overall linear spinal growth progression upper eva upper curve associated skeletal immaturity key features leading curve progression zielke operation appear spinal asymmetry frontal plane linear spinal growth concave lumbar muscle tether myostatic contracture surgical implications findings outlined,C05,0.0025269613,0.0022415407,0.0047150473,0.013640317,0.01618738,0.003261175,0.2350666,0.0023770542,0.014059574,0.0024828878,0.12770747,0.005197476,0.20180273,0.06751919,0.002222146,0.028388344,0.16549204,0.0026054906,0.002877317,0.02704172,0.06906913,0.0008972321,0.0026211343
pediatric spondyloarthropathies seronegative spondyloarthropathies childhood often misdiagnosed juvenile rheumatoid arthritis recognition distinct clinical manifestations unique underlying pathophysiologies aid making proper diagnosis ankylosing spondylitis reiter syndrome psoriatic arthritis arthritis associated inflammatory bowel disease arthritides often found young adults may also present children extraarticular manifestations include inflammation eyes skin gastrointestinal tract genitourinary tract associated inflammation entheses proper diagnosis allow treatment regimens differ usually used juvenile rheumatoid arthritis early diagnosis treatment often lead early recovery return normal daily activities,C05,0.0035769586,0.0031729408,0.023988375,0.044442587,0.022296239,0.004616251,0.4695399,0.020671602,0.0025859817,0.020831069,0.07471355,0.00735712,0.025871115,0.008761378,0.003145487,0.0055700685,0.056926813,0.003744242,0.0040728934,0.046444472,0.14272106,0.001270048,0.0036798432
cross sectional radiography implant site assessment accurate tomographic technique described acquisition optimal cross sectional images implant sites implant surgery described technique applicable tomographic systems equipped cephalometric head positioner cross sectional tomographic technique performed series patients images first patients subsequently evaluated cross sectional images allowed characterization alveolar crest visualization anatomic structures buccolingual dimension providing accurate estimation available vertical space crest,C05,0.022034386,0.021611577,0.025259012,0.0021200597,0.06005334,0.0413678,0.22070031,0.0035484508,0.002727923,0.0037074822,0.21476181,0.0077609434,0.02348099,0.06347237,0.021575743,0.0058758026,0.15612534,0.00391735,0.0042964495,0.024984334,0.047137205,0.0013397593,0.022141553
biomechanics mammalian terrestrial locomotion mammalian skeletons experience peak locomotor stresses force per area failure strength indicating safety factor two four mechanism animals achieve constant safety factor varies depending size animal much size kilograms larger mammals maintain uniform skeletal stress primarily upright posture decreases mass specific muscle force increasing muscle mechanical advantage greater sizes increased skeletal allometry decreased locomotor performance likely maintain stresses constant smaller sizes skeletal stiffness may critical strength decrease mass specific muscle force mammals weighing kilogram indicates peak muscle stresses also constant correlates decrease mass specific energy cost locomotion consistent pattern locomotor stresses developed long bones different speeds gaits within species may important implications bones adaptively remodel changes stress,C05,0.0021804476,0.03359875,0.03573221,0.022311369,0.0031915898,0.0028139811,0.2127017,0.0020505192,0.07546705,0.023245608,0.03496434,0.015365913,0.06790766,0.018317668,0.06525221,0.0033954103,0.078643784,0.0022454993,0.0024827602,0.07408045,0.22102934,0.0007741977,0.0022475466
evaluation anterior maxillary alveolar ridge resorption opposed transmandibular implant fifteen edentulous patients complaints regarding denture comfort function treated transmandibular implant patients restored conventional maxillary dentures opposed implant supported removable prostheses two years surgery patients evaluated vertical horizontal maxillary bone loss radiographic analysis developed authors technique attention focused vertical alveolar ridge resorption anterior maxilla although sample size small findings study indicate vertical bone loss anterior maxilla occur maxillary denture opposed implant supported overdenture comparison results previous study evaluated anterior maxillary resorption complete maxillary denture opposed natural mandibular anterior teeth distal extension removable partial denture demonstrated statistically significant difference,C05,0.0031902352,0.002829898,0.005952648,0.017226925,0.021525843,0.019556087,0.23898257,0.0030001358,0.002306398,0.0031345934,0.12847264,0.006779725,0.13257594,0.06918959,0.0028054123,0.0049678595,0.19005017,0.0032854134,0.003632552,0.07158797,0.0645251,0.0011327366,0.0032895892
open transpedicular biopsy vertebral body describe method obtaining biopsy body vertebra open transpedicular route minimises danger contamination tissue planes spaces,C05,0.0074436935,0.0066029276,0.085959405,0.0041823075,0.010365107,0.009606474,0.19749357,0.0070001394,0.005381459,0.007313866,0.09635357,0.015310255,0.061230134,0.018152142,0.07782293,0.04760469,0.10010895,0.00766577,0.0084757395,0.08356277,0.1320633,0.002642985,0.0076577975
high lumbar disc degeneration incidence etiology three hundred seventy nine consecutive magnetic resonance images mris dual echo images entire lumbar spine reviewed authors patients presented back pain leg pain interviewed examined pain drawings completed patients disc pathologies involving l l l levels six patients isolated disc degeneration herniations limited high lumbar segments remaining patients degenerative changes higher discs variable involvement lower lumbar discs spondylolistheses l high disc pathologies one levels presenting skipped lesions severe high disc lesions noted grade ii slips isolated high disc degeneration often associated pre existing abnormalities end plate defects scheuermann disease limbus vertebra forth stressful cumulative work activities construction workers airplane mechanics forth high disc degeneration noted previous fractures high disc involvement diffuse changes lower lumbar spine commonly found ascending fashion older age groups patients previous lower lumbar spine surgeries prior fusions particular findings suggest altered mechanics associated high lumbar disc pathologies,C05,0.002418409,0.0021369155,0.0044949697,0.0013535266,0.073317416,0.014759925,0.27495235,0.0022654657,0.0017416098,0.0023669975,0.04406917,0.02826798,0.03543403,0.0057135494,0.002118426,0.0037513354,0.14183219,0.0024808848,0.0027430167,0.23383455,0.1166136,0.00085535325,0.0024783046
estrogen therapy menopause treatment osteoporosis estrogen remains single effective agent treatment menopausal symptoms prevention bone loss article focuses use estrogen therapy menopause pharmacotherapy osteoporosis risks benefits hormonal therapy regimen selection menopausal women discussed second section article focuses current treatment strategies osteoporosis,C05,0.0045151045,0.025860686,0.008424717,0.002536853,0.00628714,0.049539465,0.51388466,0.026098872,0.0032642195,0.004446352,0.0604928,0.009286707,0.027949326,0.010381619,0.003970469,0.028886572,0.042273205,0.004649809,0.0051411106,0.09318308,0.06265937,0.0016031496,0.0046647517
molecular basis hereditary dihydroxyvitamin resistant rickets seven related families hereditary dihydroxyvitamin oh resistant rickets hvdrr autosomal recessive disease caused target organ resistance action oh active form hormone defect target cells heterogenous commonly appears mutation gene encoding vitamin receptor vdr studied cultured skin fibroblasts epstein barr virus transformed lymphoblasts seven family branches extended kindred eight children affected hvdrr previously shown cells three affected children group contain ochre nonsense mutation coding premature stop codon exon within steroid binding domain vdr gene current studies found cells affected children failed bind h oh undetectable levels vdr determined immunoblots using anti vdr monoclonal antibody measurement vdr mrna hybridization human vdr cdna probe showed undetectable decreased abundance steady state vdr mrna parents expected obligate heterozygotes showed approximately half normal levels h oh binding vdr protein mrna mutation nucleotide counting mrna cap site results conversion gtac gtaa eliminates rsa restriction enzyme site facilitates identification mutation found polymerase chain reaction pcr amplification exons family members subsequent rsa digestion allows detection specific genotype individuals rsa digests pcr amplified dna subjected polyacrylamide gel electrophoresis children hvdrr exhibit homozygous banding pattern loss rsa site parents exhibit heterozygotic dna pattern detection normal mutant alleles summary data show genetic abnormality point mutation within steroid binding domain vdr seven related families hvdrr analysis restriction fragment length polymorphism locus pcr amplified dna fragments used diagnose mutation affected children parents carrying disease,C05,0.008149611,0.007988868,0.0026093435,0.00078572624,0.02158724,0.015335737,0.21952848,0.021594724,0.0144983,0.03522483,0.041374523,0.016390322,0.024664117,0.053651698,0.0012297526,0.008944577,0.012784964,0.14802296,0.0015923292,0.033412658,0.17219518,0.0004965351,0.13793753
intertrochanteric corrective osteotomy slipped capital femoral epiphysis long term follow study patients results intertrochanteric corrective osteotomy series hips moderate severe chronic slipped capital femoral epiphysis reported follow studies hips slippage less degrees ten hips arthrosis present one hip remaining cases slippage exceeded degrees osteoarthrosis present even though correction adequate observations concluded intertrochanteric corrective osteotomy prevent degeneration cases severe slip basis present observations treated untreated cases authors advocate treatment fixation without realignment accepting deformity moderate severe chronic slips rotational osteotomy may considered event hip joint contracture,C05,0.0035222534,0.020138942,0.006591591,0.0019755508,0.0048960517,0.038570657,0.28349596,0.0033065788,0.036583696,0.0034547704,0.08875177,0.007231937,0.060065214,0.00808459,0.0030919658,0.005475292,0.24261409,0.0036209954,0.004003592,0.0426609,0.1269979,0.0012484378,0.0036172294
soft tissue rheumatism upper extremities diagnosis management upper extremity tendinitis bursitis usually result repetitive microtrauma probably resulting disruption fibers focus inflammation often occurs producing pain spasm disability careful history physical exam diagnosis made distinguishing soft tissue rheumatism arthritis treatment consists rest heat ice frequently use non steroidal anti inflammatory drugs injections control inflammatory response protection repeated trauma may beneficial preventing recurrence,C05,0.0039163837,0.04138745,0.0073075653,0.002200456,0.0433667,0.04296725,0.34534004,0.003683759,0.002831371,0.0038480768,0.07488569,0.028029708,0.048169807,0.027956616,0.022402054,0.03466419,0.040135864,0.0040332256,0.004459379,0.034599397,0.17839539,0.0013905655,0.004029031
eosinophilic granuloma cervical spine case report review literature report case eosinophilic granuloma involving second cervical vertebra year old woman case reports literature describing eosinophilic granuloma presenting cervical spine disease due intimate relation central nervous system opportunity neurological sequelae neurosurgical intervention common cervical eosinophilic granuloma report brief history eosinophilic granuloma reviewed case histories literature cervical spine involvement summarized therapeutic options described recommended protocol management outlined,C05,0.004425785,0.0039194333,0.00824447,0.045257248,0.0061526266,0.0057023093,0.34664658,0.025538405,0.0031943815,0.0043414393,0.10081339,0.009088018,0.027774686,0.031536493,0.04666609,0.006880529,0.08660844,0.004550326,0.005031117,0.16338663,0.0581272,0.0015688501,0.0045455936
psoriatic arthropathy temporomandibular joint case psoriatic arthritis temporomandibular joints described brief review literature discussion management condition date psoriatic arthritis successfully treated conservative means case reported surgical replacement condyles became necessary eliminate pain restore function,C05,0.006505986,0.0057711345,0.012139495,0.0036554483,0.040512193,0.03988271,0.25658447,0.0061183083,0.0047035385,0.0063925134,0.12425283,0.01338157,0.057427965,0.015168375,0.0057212,0.010131174,0.23654899,0.006700087,0.0074080224,0.042945575,0.089045264,0.0023100392,0.0066931187
type xi collagen degrading activity human osteoarthritic cartilage homogenates samples human osteoarthritic cartilage shown degrade exogenous type xi collagen sodium dodecyl sulfate polyacrylamide gel electrophoresis cleavage products generated homogenate similar identical obtained cleavage substrate purified gelatinase enzyme activity inhibited edta greater extracts fibrillated osteoarthritic cartilage extracts grossly normal cartilage joint extracts cartilage joints osteonecrosis activation apma enhanced digestion breakdown apparent extracts fibrillated osteoarthritic cartilage even without apma enzymatic degradation type xi collagen could play significant role turnover articular cartilage health disease states,C05,0.0032407371,0.0028746957,0.0530879,0.05520994,0.004512624,0.019829165,0.25325674,0.0030476286,0.0023429086,0.0031842147,0.039244078,0.10211231,0.03956769,0.07223416,0.0028498224,0.020693894,0.029813945,0.03533538,0.019374777,0.024112618,0.11821887,0.001150668,0.09470522
joint inflammation provoked local synovial allergic reaction homocytotropic antibody stimulated animals administering protein antigens vaccine b pertussis adjuvant titers allergic antibody responses judged passive cutaneous anaphylaxis reactions sera globulin fractions containing high titers antibody activity injected knee joints experimental animals sufficient delay unfixed proteins cleared knee joints animals challenged intravenously corresponding antigen resultant local reaction swelling warmth passive synovial anaphylaxis judged visually scanning procedures histological studies showed evidence mast cell degranulation concurrent synovial reaction,C05,0.0039161528,0.0034738232,0.007307135,0.0022003266,0.005512103,0.024005247,0.226001,0.0036827978,0.0028312043,0.022803351,0.037339482,0.09648143,0.029620916,0.1740062,0.003448683,0.006098265,0.052549817,0.041950285,0.004459116,0.029196067,0.21767457,0.0013904836,0.0040515536
diastrophic dysplasia gene maps distal long arm chromosome used polymorphic dna markers map gene clinically well characterized form osteochondrodysplasia diastrophic dysplasia dd autosomal recessive disorder unknown pathogenesis linkage analyzed families two three affected sibs comprising total individuals positive two point logarithm odds lod scores obtained dd locus three polymorphic markers chromosome highest pairwise lod score estimate zero recombination locus suggests tight linkage evidence heterogeneity multipoint linkage analysis published order three loci gave result centromere dd terminus four point lod score present findings place dd locus distal gene adenomatous polyposis coli distal part long arm chromosome results provide basis refining map position dd locus followed physical localization isolation characterization gene,C05,0.0025275594,0.0022420713,0.004716164,0.0014201326,0.015750086,0.003261947,0.37157688,0.0023769476,0.001827313,0.0024834757,0.07438695,0.054983556,0.01955027,0.033213627,0.0022228921,0.003935936,0.050424524,0.0026029672,0.027332217,0.03855733,0.08631099,0.013122868,0.18517332
effect stem stiffness femoral bone resorption canine porous coated total hip arthroplasty bilateral noncemented total hip arthroplasty tha produced dogs determine effect stem stiffness stress related bone resorption two porous coated femoral implants substantially different stiffnesses designed direct comparison one manufactured cobalt chromium cocr alloy titanium alloy titanium stem hollowed wall thickness mm reduce stiffness cumulative stiffness differences fold axially fold bending torsion staged bilateral tha performed eight dogs dog received stiff cocr stem one side flexible titanium stem death femora removed processed undecalcified thin section histology bone ingrowth remodeling quantified computer aided image analysis compared stem designs femoral specimens showed bone ingrowth fixation stiff flexible stems along implant length tetracycline labeling indicated active bone turnover femoral cortex regions ingrowth however gross differences femoral bone remodeling observed roentgenographically histologically femora flexible stems consistently showed much less bone resorption stiff stems quantitative analysis paired cross sections indicated average cortical bone area femora flexible stems severe resorption cortex midstem region occurred three femora stiff stems none flexible stems stem stiffness strongly influences bone remodeling flexible stem results uniform load transfer less stress shielding,C05,0.0018726257,0.010682821,0.039257597,0.0010485979,0.011624949,0.011773326,0.13073123,0.01981186,0.046502948,0.0018329631,0.108327955,0.0044684145,0.04586707,0.02465145,0.019700775,0.026643494,0.104248606,0.023302969,0.0021241459,0.021781394,0.3230207,0.018721033,0.002003079
high levels inflammatory phospholipase activity lumbar disc herniations inflammation neural elements frequently mentioned clinically association lumbar radiculopathy mechanical embarrassment neural elements definable structural abnormalities inadequate sole explanation nerve injury condition purpose study demonstrate whether enzymatic marker inflammation phospholipase could identified human disc samples removed surgery radiculopathy due lumbar disc disease samples assayed phospholipase activity level activity disc samples compared values obtained human tissues using assay specific activity percent hydrolysis radiolabelled substrate ranged nmol min mg mean activity human disc material nmol min mg compared nmol min mg human pmn nmol min mg inflammatory human synovial effusion ph cation related activity identical demonstrated phospholipase inflammatory conditions human lumbar disc phospholipase activity fold active phospholipase described enzyme responsible liberation arachidonic acid cell membranes phospholipase rate limiting step production prostaglandins leukotrienes data establish biochemical evidence inflammation site lumbar disc herniations,C05,0.022983583,0.0018747668,0.034616236,0.0011874811,0.0029434208,0.0027275628,0.2037411,0.0019875471,0.0015279558,0.0020766233,0.0830845,0.004347035,0.10727033,0.1360875,0.012069292,0.03611382,0.07374935,0.0022527182,0.0024065138,0.08660326,0.17740515,0.0007504218,0.0021938125
effects parathyroid hormone pth pth related peptide osteoclast resorption bone slices vitro analysis pit size resorption focus mechanism whereby pth potent stimulator bone resorption may certain circumstances exert anabolic effects bone known possible involves reduction size osteoclast resorption lacunae therefore made detailed vitro study effects pth pth related peptide pthrp resorption neonatal rat osteoclasts paying particular attention plan area resorption pits order distinguish increased resorption particular site increased numbers sites used eyepiece graticule define focus resorption namely area occupying th bone slice may contain either one several pits addition studied relationship number pits resorption focus total area bone resorbed focus found pth pthrp doses x x exerting significant stimulatory effects bone resorption caused reduction median plan area pits increase number resorption foci primary stimulatory effect pth pthrp occurring within h case pth however plan area bone resorbed focus showed significant increase despite increase number pits per focus pits formed focus pits smaller thus partially dissipating stimulatory effect pth resorption results consistent activation new remodeling sites pth vivo furthermore formation smaller pits resorptive influence pth may together maintenance coupling formation resorption play role preservation cancellous bone recorded cases primary hyperparathyroidism anabolic effect exogenous pth,C05,0.0017111099,0.0015178398,0.028045163,0.009230702,0.0024520056,0.068474576,0.30137014,0.0016334435,0.0012370563,0.001681266,0.083116814,0.012521265,0.013151996,0.005035062,0.0015047485,0.002664554,0.05089673,0.020647408,0.0019483503,0.06398234,0.3247937,0.00060755294,0.001776188
focal fibrocartilaginous dysplasia associated tibia vara focal fibrocartilaginous dysplasia tibia insertion pes anserinus expanded tendinous insertion gracilis sartorius semitendinous muscles rare unilateral lesion characteristic deformity proximal tibial metadiaphysis associated unilateral tibia vara toddlers three cases entity described radiologic features presented recognition disease important response conservative therapy excellent,C05,0.005471979,0.004853918,0.010210145,0.0030744819,0.03410955,0.007061874,0.28155392,0.058122706,0.03044638,0.0053765406,0.05103622,0.011254814,0.033872552,0.012581769,0.00481192,0.008521009,0.099729136,0.0056352313,0.006230653,0.14423215,0.17424075,0.0019429009,0.00562937
macrophage colony stimulating factor restores vivo bone resorption op op osteopetrotic mouse op op variant murine osteopetrosis recessive mutation characterized impaired bone resorption due lack osteoclasts cultured osteoblasts fibroblasts mutant secrete csf activity resident macrophages absent bone marrow failure related mutation within csf coding region report administration recombinant human csf rhm csf corrects vivo impaired bone resorption animal treatment restores bone marrow cavity virtually absent op op animal induces appearance resorbing osteoclasts resident bone marrow macrophages proves deficiency csf cause op op bone disorder cytokine directly indirectly necessary physiological osteoclastogenesis resulting bone resorption establishment bone marrow hemopoiesis,C05,0.0030991104,0.017729687,0.0057801893,0.0017391393,0.019283287,0.0039946837,0.18725474,0.047862988,0.0022377854,0.0030413428,0.061286278,0.02213457,0.021660835,0.04925841,0.0027219546,0.0048200716,0.04985086,0.12230363,0.0035244878,0.07060577,0.17864221,0.001099039,0.120068945
polymyositis case history approach differential diagnosis treatment wide range conditions mimic polymyositis thus diagnosing condition challenge although single criterion diagnostic polymyositis following criteria proposed widely used symmetric proximal muscle weakness characteristic violaceous rash hands elbows knees increased muscle enzymes serum characteristic electromyographic findings insertional activity fibrillation potentials motor unit potentials increased frequency decreased duration normal conduction velocity nerves muscle biopsy specimen characteristic inflammatory myopathic changes although polymyositis primarily involves muscle patients may extramuscular problems main treatment polymyositis high dose corticosteroids corticosteroid resistant patients methotrexate often effective report case histories presented highlight usefulness limitations common diagnostic criteria polymyositis,C05,0.0027269686,0.0024189572,0.0050965897,0.0015321724,0.0037972175,0.003519295,0.398724,0.0025644742,0.054778844,0.002679407,0.1519701,0.0056088534,0.08151538,0.0065180557,0.028800169,0.0042464575,0.06127954,0.0028097564,0.0031050548,0.020421041,0.15211162,0.0009682475,0.0028078614
spondyloepiphyseal dysplasia maroteaux cases four patients unusual clinical entity disproportionately short stature referred spondyloepiphyseal dysplasia maroteaux described patients syndrome abnormalities confined musculoskeletal system patients corneal opacities increased excretion keratosulphate mode transmission appears autosomal dominant platyspondylysis present anterior tongue like deformities vertebral bodies presence spondyloepiphyseal dysplasia normal intelligence lack abnormalities birth entity seems mimic morquio syndrome however unlike morquio syndrome disorder involves biochemical abnormalities thus entity may classified new,C05,0.0037733072,0.0033471119,0.025276996,0.0021200674,0.005254211,0.0048696497,0.3732131,0.021781176,0.0027279332,0.003707496,0.073813245,0.02598869,0.08514345,0.009217481,0.019956136,0.005875824,0.101978235,0.0038899835,0.022559004,0.11937043,0.062662944,0.0013397643,0.022133755
operative treatment progressive early onset scoliosis preliminary report thirteen patients progressive early onset scoliosis managed operatively attempt achieve correction without bracing allow spine grow posterior segmental spinal instrumentation ssi without fusion anterior apical growth arrest separate additional procedure year follow curve correction averaged patients anterior apical growth arrest ssi without fusion less curve deterioration ssi alone new methods described measuring growth instrumented segment spine calculating predicted growth instrumented segment eight predicted growth three predicted growth two less predicted growth operative treatment successful short term malignant form infantile idiopathic scoliosis,C05,0.016359517,0.0024925878,0.0052272268,0.0015740241,0.0039009429,0.050010826,0.15007368,0.0026345234,0.0020253283,0.02987532,0.10154253,0.00576206,0.15464523,0.12108847,0.00246353,0.00436245,0.22247136,0.0028850355,0.0031898702,0.020233689,0.093302794,0.0009946954,0.0028843137
intra osseous pressure oxygen tension avascular necrosis osteoarthritis hip intra osseous pressure po pco measured hips patients painful showed severe degenerative changes pre operative scintigraphy radiography performed patients thirteen hips showed early osteoarthritis eight early osteonecrosis changes core biopsies performed bone examined histologically graded necrosis histologically necrosis present specimens scintigraphic findings correlate histological results closely related radiographic findings intra osseous pressure hips histological necrosis mean mmhg significantly higher hips without necrosis mean mmhg po lower bone histological necrosis mean mmhg bone without mean mmhg po increased intra osseous pressure decreased decompression results confirm ischaemia plays central role development necrotic changes bone histological necrosis found hips radiographic signs osteonecrosis osteoarthritis radiography scintigraphy shown insensitive methods differentiating disorders,C05,0.0026334743,0.0023269479,0.030256005,0.0014738934,0.0036527833,0.016072713,0.22489075,0.0024684046,0.0018964881,0.015271456,0.098806895,0.0053955535,0.21265005,0.006189017,0.002306814,0.0040849354,0.2101471,0.02945753,0.0029869485,0.021049343,0.10235276,0.0009314184,0.002698696
influence growth hormone reversibility articular cartilage degeneration rabbits growth hormone chondrogenic affects normal well damaged articular cartilage study influence growth hormone investigated early degenerative changes articular cartilage new zealand white rabbits cartilage lesions created femoral condyles using immobilization model cartilage damage assessed using biochemical histologic biomechanical criteria growth hormone influence prevention immobilization abnormalities significant affect healing established lesions,C05,0.0044184313,0.025306912,0.008244335,0.0024825362,0.048933003,0.0057022157,0.28237456,0.0041551464,0.0459735,0.004341368,0.052458126,0.094070084,0.04294369,0.010924014,0.003885457,0.0068804165,0.041356467,0.004553764,0.005031034,0.044878658,0.25497195,0.0015688244,0.004545519
effects rib elongation spine ii correction scoliosis rabbit three intercostal nerves right side growing rabbits resected partially months later moderate left convex thoracic scoliosis rotation vertebrae developed sagittal curvatures spine diminished one group animals mechanically produced increase cm length one rib side convexity resulted immediate correction scoliotic deformity improvement still evident weeks operation two groups rabbits resection three intercostal nerves time left convex side months first operation resulted regression scoliosis halted progression results support new concept precipitating factor development scoliosis ascribed asymmetric longitudinal growth ribs also suggest regulation rib length could promising approach effective correction progressive scoliosis early stage man,C05,0.0026916338,0.05450762,0.0050223093,0.0015123192,0.0037480146,0.0295257,0.1968052,0.041621752,0.027998885,0.0026573455,0.0126060685,0.06408142,0.07897715,0.048433572,0.0023669547,0.030240642,0.16449985,0.0027719364,0.0030648208,0.06555469,0.15758733,0.00095570134,0.0027690534
estrogen prophylaxis u preventive services task force recommendation although routine postmenopausal estrogen replacement recommended estrogen therapy considered asymptomatic women increased risk osteoporosis lack known contraindications received adequate counseling potential benefits risks,C05,0.00562133,0.0049864003,0.010488818,0.003158396,0.007827524,0.061630875,0.32375672,0.0052863667,0.0040639713,0.0055232868,0.090876125,0.022102376,0.038737316,0.012925174,0.004943256,0.00875358,0.097963415,0.005789038,0.033599824,0.160026,0.08415323,0.00199593,0.0057910564
giant cell reparative granuloma hand foot bones giant cell reparative granuloma gcrg uncommon benign reactive intraosseous lesion occurs skull jaw hand foot facial bones rarely skeletal sites solitary lytic expanded lesion infrequently may extend surrounding soft tissue histologically composed fibrous stroma spindle shaped fibroblasts multinucleated giant cells inflammatory mononuclear cells areas hemorrhage uniformly present may difficult distinguish entity aneurysmal bone cyst giant cell tumor brown tumor hyperparathyroidism roentgenographic histologic similarities accurate diagnosis essential appropriate treatment serum calcium phosphorus parathyroid hormone levels measured curettage bone graft effective treatments primary lesions recurrences second recurrences rare,C05,0.065983124,0.0028745239,0.006046518,0.01748429,0.11432173,0.019859357,0.25009736,0.03441744,0.0023427687,0.018858802,0.10902625,0.006665179,0.03257912,0.104261,0.0028496522,0.020730933,0.033065222,0.036879227,0.0036898355,0.020836398,0.09264693,0.0011505993,0.0033337518
long scoliosis fusion sacrum adults nonparalytic scoliosis improved method first adults nonparalytic scoliosis long fusion sacrum treated luque galveston technique reviewed men women average age time surgery years mean follow period months neurologic complications patient developed significant loss lumbar lordosis fusion occurred patients two patients developed pseudarthrosis neither anterior fusion level pseudarthrosis best results occurred patients two stage procedures initial anterior lumbar fusion sacrum without instrumentation followed posterior segmental instrumentation galveston technique fixation pelvis,C05,0.020532975,0.0031188058,0.0065603615,0.0019754579,0.0048958217,0.0045374916,0.14858754,0.0033064235,0.0025418613,0.0034546081,0.063821085,0.0072315973,0.071924366,0.00808421,0.0030918205,0.005475035,0.4133394,0.0036208255,0.004003404,0.14112422,0.07390726,0.0012483791,0.0036170597
musculoskeletal impairments physical disablement among aged article summarizes results longitudinal investigation progression sight hearing musculoskeletal impairments association change physical disability adls among members massachusetts health care panel study findings confirm widely held clinical beliefs specific types musculoskeletal decrement important cause physical disability among older persons decrement hand function significant musculoskeletal impairment influencing limitations basic adl progression instrumental adl dysfunction influenced progression lower extremity impairments progression sight hearing impairments associated change physical disability musculoskeletal impairments one prevalent symptomatic chronic complaints middle old age deserve increased attention epidemiologists disability researchers clinicians seeking ways prevent disablement among aged,C05,0.0031903845,0.018273154,0.0059529264,0.001792597,0.0044425093,0.0041173575,0.5073742,0.0030002762,0.002306506,0.00313474,0.014702906,0.0065620113,0.06538473,0.007527599,0.0028055436,0.020403119,0.053990275,0.0033001595,0.049956717,0.14708264,0.07028318,0.0011327897,0.0032836536
mechanism pivot shift mechanism pivot shift investigated analysing movements valgus torque fresh cadaveric knees movements measured three dimensions using biplanar photography ligaments intact ligaments sequentially divided anterior cruciate ligament sectioned pivot shift occurred seven knees examined though pivot shift observed abnormal internal rotation occurred degrees degrees flexion division iliotibial tract addition division anterior cruciate ligament stopped pivot shift tibia remained internally rotated throughout range flexion axis rotation pivot shift located medial collateral ligament kept tight applied valgus torque sudden movement pivot shift caused complex interaction geometry knee valgus torque applied,C05,0.0047734687,0.0040953057,0.02151993,0.002593975,0.006428707,0.0059581827,0.23040214,0.049030274,0.0033377195,0.0045362483,0.079470836,0.03183516,0.07356136,0.029186768,0.0040598717,0.007189272,0.09350668,0.0047545084,0.005256872,0.032715548,0.27706763,0.0016392475,0.027080286
arthrodesis ankle cancellous bone screws fibular strut graft biomechanical analysis stability arthrodesis two cancellous bone screws across ankle joint evaluated eighteen ankles fresh frozen cadavera tibiotalar motion recorded response following loading modes medial lateral moment plantar flexion dorsiflexion moment internal external tibial torque series loading tests performed two cancellous bone screws tibia talus lateral fibular strut graft fixed proximal distal screw tests repeated strut graft removed reapplied amount motion site arthrodesis greatest tibial torque least medial lateral bending true specimens without fibular strut graft removal strut graft allowed increased tibiotalar motion modes loading increases motion far greater specimens poor bone quality,C05,0.0039917897,0.0035409164,0.026762854,0.0022428236,0.00564283,0.005151612,0.17348664,0.06172715,0.022113316,0.0039221677,0.23294711,0.008210348,0.06904571,0.009178357,0.0035102789,0.0062160464,0.09170964,0.0041311556,0.004714551,0.02975185,0.18537128,0.0014173394,0.045214288
ethical issues geriatric nephrology overview developments medical care past five six decades provided remarkable life sustaining technologies lst contributed prolongation life span patients well general increase health well end stage renal disease esrd treatment prototype lst treatments issues surrounding provision chronic catastrophic care remarkable progress accompanied ethical dilemmas include allocation scarce resources initiation termination care lst consideration ethical dilemmas especially poignant elderly raise hard choices easy answers ethical dilemmas,C12,0.0034584748,0.019796088,0.02310071,0.0019431759,0.0048158164,0.021172356,0.30786487,0.0032523917,0.0025003233,0.0033981546,0.01590514,0.007113422,0.024706904,0.026897918,0.0030412956,0.0053855646,0.11390041,0.0035616558,0.13787025,0.14414786,0.12138127,0.0012279787,0.0035579514
tissue developmental tumor specific expression divergent transcripts wilms tumor wilms tumor locus chromosome p mapped region defined overlapping tumor specific deletions complementary dna clones representing transcripts wit kb wit mapping region isolated kidney complementary dna library expression wit wit restricted kidney spleen rnase protection revealed divergent transcription wit wit originating dna region less bp transcripts present high concentrations fetal kidney much reduced amounts year old adult kidneys eleven wilms tumors classified histopathologically heterogeneous exhibited absent reduced expression wit whereas histopathologically homogeneous tumors showed reduced expression data demonstrate molecular basis pathogenetic heterogeneity wilms tumorigenesis,C12,0.0028404305,0.0025196036,0.0052999486,0.0015959219,0.14625071,0.0036657234,0.21470524,0.0026711752,0.015791085,0.0027908897,0.029893804,0.0058422224,0.033882555,0.03348272,0.016220381,0.004423141,0.0331131,0.031128462,0.003234248,0.08379178,0.118669555,0.014748665,0.1934387
basic evaluation female urinary incontinence urinary incontinence common disorder frequently underreported social implications although several types urinary incontinence recognized generally classified failure bladder store failure urethral mechanism systematic approach evaluation incontinence includes history physical examination basic laboratory tests often urodynamic evaluation offers comprehensive assessment etiology incontinence,C12,0.004721949,0.04990803,0.0316338,0.002653219,0.07515444,0.006093921,0.38004625,0.004440578,0.003413759,0.0046395925,0.044483703,0.009712147,0.029320773,0.011485116,0.027010424,0.030209238,0.08720554,0.004892372,0.0053766337,0.12332865,0.057735488,0.0016765925,0.004857767
analysis sperm function globozoospermia implications mechanism sperm zona interaction globozoospermic condition provided unique opportunity determine abnormal mitochondrial organization acrosomal loss associated syndrome influence sperm function despite abnormal midpiece architecture movement characteristics spermatozoa terms curvilinear path progressive velocities amplitude head displacement hyperactivation within normal range similarly behavior spermatozoa percoll gradients normal although capacity isolated fractions generate reactive oxygen species negligible particular significance fact globozoospermic spermatozoa incapable sperm oocyte fusion binding human zona pellucida even intracellular calcium signal generated ionophore sudden induction sperm zona interaction could however achieved use ferrous ion promoter system induce limited lipoperoxidation result demonstrates enhancing effect peroxidation sperm zona adhesion involves direct action properties sperm plasma membrane rather indirect consequence acrosomal damage acrosin leakage findings emphasize value specific teratozoospermic conditions globozoospermia dissecting mechanisms regulate human sperm function,C12,0.0139056,0.013612481,0.020199103,0.0013381739,0.0033166932,0.014597279,0.33236435,0.002239769,0.001721855,0.0023401491,0.013639843,0.016391706,0.07309271,0.16373444,0.002096287,0.026763333,0.044670667,0.014147978,0.002711903,0.069935896,0.16387157,0.0008456512,0.002462547
comparative study renal scintigraphy clearance technetium mag iodine hippurate patients renal disorders aim study compare kit prepared technetium mercaptoacetyltriglycine mtc mag routine radiopharmaceutical iodine hippurate routine radiopharmaceutical iodine hippurate oih renal dynamic scintigraphy seventeen patients different nephrologic disorders hypertension first studied oih reinvestigated mag days later renal mag gamma camera images almost identical oih except higher p less liver background ratios min postinjection irrespective kidney function urinary peristalsis visible longer clearly mag studies mag oih renograms showed identical relative kidney uptake r elimination mag kidneys slower p less plasma clearance mag lower oih correlated r significantly plasma distribution volume content blood cells lower p less binding mag plasma proteins higher compared oih p less urinary excretion expressed percent given dose min injection two substances thus significant differences renal handling plasma distribution cell penetration mag oih mag however seems particular qualifications radionuclide dynamic renal scintigraphy especially patients require acute investigations low renal function,C12,0.011193528,0.0017008918,0.04070277,0.010344309,0.01194892,0.002474595,0.111677065,0.011048516,0.0013862456,0.001884027,0.02713489,0.023446038,0.17251365,0.032860402,0.0016861749,0.021641232,0.066645876,0.020538831,0.0021833219,0.07764681,0.3466795,0.000680824,0.0019815392
economics screening carcinoma prostate proposition whether adopt system mass screening carcinoma prostate u well suited clinical decision analysis approach authors demonstrate using available data suggest offering screening program men ages would prohibitively expensive method also permits calculation eventual morbidity screening costs analysis demonstrates importance attempting predict ultimate patient outcomes implementing health care strategy standard,C12,0.0042372756,0.044026945,0.0284152,0.0023807522,0.005902213,0.006219241,0.28047484,0.003984785,0.0030633616,0.004163372,0.20240866,0.008715265,0.026742432,0.009769014,0.024234995,0.006598319,0.058307037,0.004363691,0.043128785,0.16517252,0.061808642,0.0015045026,0.004378154
treatment testicular cancer new improved model testicular cancer become model curable neoplasm prior advent cisplatin combination chemotherapy standard chemotherapy consisted dactinomycin alone combination chlorambucil methotrexate disseminated germ cell tumors chemosensitive older regimens objective response rate complete remission rate however cure rate began initial cisplatin plus vinblastine plus bleomycin pvb chemotherapy thirty three patients disseminated germ cell tumors treated achieved complete remission cr additional five rendered disease free post pvb resection teratoma carcinoma twenty seven patients continuously disease free minimal follow years thus cisplatin based chemotherapy produced one log increase cure rate compared dactinomycin subsequent phase iii study performed demonstrated vinblastine dosage could reduced mg kg mg kg reduction toxicity without decrement therapeutic efficacy third generation pvb study documented optimal cure rates achieved weeks induction therapy pvb long term maintenance therapy vinblastine unnecessary initiated salvage therapy cisplatin plus etoposide vp patients cured pvb patients subsequently cured regimen represented first time adult solid tumor cured second line regimen began studies third line therapy cisplatin plus ifosfamide combination chemotherapy even refractory setting approximately patients curable compared cisplatin plus vp plus bleomycin pvp b pvb first line chemotherapy significant reduction neuromuscular toxicity favoring vp arm furthermore patients continuously disease free compared pvb approximately patients disseminated germ cell tumors cured pvp b additional curable salvage chemotherapy represents highest cure rate adult malignancy,C12,0.0015219317,0.0013498573,0.0102039995,0.059790447,0.034510773,0.0019638818,0.33231676,0.0014310606,0.0011001487,0.0014951967,0.008912909,0.018423593,0.02890597,0.025658332,0.0013381778,0.017152054,0.1585871,0.0015671375,0.0017327223,0.113635115,0.1762968,0.0005403138,0.001565722
applications prostate ultrasonography transrectal ultrasonography relatively new imaging modality may useful evaluation management patients prostate cancer although cancer may characteristic appearance cannot always reliably differentiated benign conditions technique clinical applications staging monitoring tumor response therapy assisting biopsy unclear whether useful information obtained evaluation patients palpable disease role transrectal ultrasonography patients nonpalpable disease screening tool yet determined diagnostic tests conjunction ultrasound may future prove useful carefully performed prospective investigations state art equipment still needed define role diagnostic modality,C12,0.0029200434,0.0025902241,0.019923517,0.0016406532,0.07474331,0.003768468,0.3217061,0.016875215,0.0021110615,0.019616392,0.20836371,0.020157438,0.06313483,0.006714082,0.0025678126,0.032816254,0.10309967,0.0030071605,0.003324899,0.034101617,0.0527767,0.0010368014,0.0030040331
double blind placebo controlled cross study flavoxate treatment idiopathic detrusor instability detrusor instability occurs approximately adult population producing troublesome symptoms pharmacotherapy currently available usually partially effective cannot adequately evaluated except blind conditions significant component attributable placebo effects results present study revealed advantage resulting treatment flavoxate assessed subjectively objectively suggest therapy appear beneficial medical management detrusor instability,C12,0.003705399,0.003286874,0.024849107,0.0020823935,0.005174212,0.0047820103,0.4744837,0.003484602,0.0026788386,0.0036480366,0.018218944,0.0076212976,0.07261669,0.008519856,0.0032584344,0.005770077,0.104469135,0.003819383,0.07596835,0.060369205,0.106050864,0.0013156525,0.003826913
evaluation plasma sodium concentration hemodialysis computerization dialysate conductivity kinetics modeling based sodium mass balance changes conductivity dialysate outlet compared dialysate inlet led predicting plasma water conductivity blood inlet conductivity transducers temperature compensation located dialysate inlet outlet ports dialyzer connected conductimeter interfaced portable computer data acquisition dialysis sessions close relationship found estimated plasma water conductivity cdbi measured plasma sodium concentration na bi according formula cdbi na bi n r study shows plasma sodium concentration dialyzer inlet could evaluated standard error meq l continuous measurement conductivity gradient dialysate inlet outlet,C12,0.0033458844,0.0029679665,0.074932,0.001879916,0.020855533,0.020499613,0.20553227,0.0031465103,0.0024189255,0.003287528,0.054828744,0.055489056,0.10358666,0.007739188,0.0029422864,0.005210238,0.12755471,0.0034457063,0.0038097817,0.026385931,0.24933347,0.0011880021,0.019620055
alpha reductase deficiency without hypospadias boy aged penoscrotal hypospadias brother aged micropenis typical changes homozygous alpha reductase deficiency three injections chorionic gonadotrophin trivial rise plasma dihydrotestosterone normal increase plasma testosterone urine steroid chromatography showed abnormally high beta alpha ratios alpha reductase activity appreciably reduced genital skin fibroblasts results indicate alpha reductase deficiency invariably associated genital ambiguity,C12,0.0048330612,0.0042862445,0.009016052,0.0027149161,0.030120006,0.0062359762,0.1238065,0.027927486,0.003493337,0.051490743,0.022391692,0.056716472,0.08199585,0.011444399,0.0042491583,0.0075244633,0.042644836,0.004979045,0.005501968,0.041280653,0.34059227,0.0017156755,0.11503924
kinetics cellular proliferation rat urinary bladder treated n butyl n hydroxybutyl nitrosamine cellular proliferation bladder epithelium determined sequentially rats treated n butyl n hydroxybutyl nitrosamine bbn incorporation bromodeoxyuridine brdurd dna synthesis phase determined vitro labeling technique percentage labeled cells expressed labeling index li average li values normal subjects cancer bearing subjects respectively transition bladder epithelium simple hyperplasia cancer li values bladder epithelium increased cases papillary nodular pn hyperplasia divided two types according localization brdurd labeled cells li pn hyperplasia difference cancer significant another experiment effect partial cystectomy bladder tumors examined group partial cystectomy showed increases grade stage cancer li cancer group without partial cystectomy results indicate partial cystectomy may play role promotor bladder tumors current study may practical value conventional one investigating histogenesis progression human bladder cancer,C12,0.0025269277,0.002241511,0.016945548,0.0014198624,0.02798501,0.0032611317,0.15684314,0.039072197,0.0018268563,0.0024828548,0.04813926,0.1261723,0.17173588,0.11865778,0.014442713,0.0283988,0.048260383,0.0026029903,0.002877279,0.03166282,0.14893892,0.0008972202,0.0026086273
nutritional causes renal impairment old age occurrence renal insufficiency tends increase late adulthood common complication old age associated increased physical dependency morbidity mortality lowered quality life review authors develop thesis dietary practices early middle adulthood importantly influence risk renal insufficiency elderly,C12,0.004418743,0.003919645,0.008244916,0.0024827113,0.0061529595,0.005702618,0.23128478,0.0041554393,0.0031945545,0.0043416745,0.037946045,0.00908851,0.02930223,0.010160054,0.0038857309,0.0068809018,0.08737816,0.0045505725,0.026419934,0.28466132,0.21971369,0.001568935,0.00454584
laboratory studies detection carcinoma prostate acid phosphatase prostate specific antigen extremely useful markers management patients prostatic carcinoma prostatic acid phosphatase relatively low sensitivity specificity well analyte instability diurnal variability unsuitable prostate cancer screening improved performance characteristics stability lesser diurnal variation association elevated prostate specific antigen prostatic intraepithelial neoplasia make prostate specific antigen possibly better candidate early detection common malignancy investigations area clearly indicated recommend screening prostate specific antigen,C12,0.0034574105,0.0030668955,0.006451169,0.0019425779,0.0048143347,0.0044619683,0.3265464,0.0032513905,0.0024995538,0.020130932,0.12098403,0.0071112323,0.09458863,0.12563084,0.0030403594,0.005383907,0.097655796,0.0035605596,0.0039367704,0.07146642,0.08522877,0.0012276008,0.0035624302
hypophosphatemia infants continuous ambulatory peritoneal dialysis three infants irreversible renal failure treated continuous ambulatory peritoneal dialysis capd developed hypophosphatemia one rachitic lesions observed x ray bone biopsy showed osteomalacic osteodystrophy different mechanisms may origin hypophosphatemia high doses phosphate binders low phosphorus intake phosphate loss dialysate possibly nutritional repletion dietary phosphorus restriction use phosphate binders applied caution serum phosphate monitored regularly infants treated capd,C12,0.004418926,0.025311701,0.043477263,0.002482814,0.027545068,0.0057028537,0.21279061,0.004155611,0.0031946865,0.0043418542,0.042039286,0.030528784,0.03141884,0.010403416,0.0038858918,0.0068811863,0.09443226,0.0045507606,0.005031597,0.2074742,0.2238174,0.001569,0.0045460276
suppression immunoglobulin interleukin production peripheral blood mononuclear cells dialysis membranes influence dialysis membranes immunoglobulin interleukin production estimated vitro peripheral blood mononuclear cells patients undergoing hemodialysis incubated days cuprophan hemophan polyacrylonitrile flat sheet membranes igg iga igm il assayed supernatants aid enzyme linked immunosorbent assay elisa techniques pokeweed mitogen stimulated igg production declined significantly ng ml polystyrole ng ml cuprophan ng ml hemophan ng ml polyacrylonitrile similar pattern observed iga igm production il production significantly reduced presence cuprophan pg ml hemophan pg ml polyacrylonitrile pg ml compared polystyrole pg ml concluded long term exposure mononuclear cells artificial surfaces dialysis may contribute impaired humoral response observed dialysis patients effect may due decline b cell stimulation monocytes possibility suggested reduction monocytic il production,C12,0.0030976299,0.002745236,0.07229661,0.0017388382,0.004309402,0.003993992,0.18229698,0.0029103812,0.0022373977,0.0030408162,0.04081785,0.006375023,0.1030828,0.111630075,0.0027214831,0.0048192367,0.093582004,0.0032188464,0.0035238774,0.025482312,0.3217966,0.0010988486,0.0031838093
comparison pathological lesions repeated renal biopsies patients primary iga glomerulonephritis value quantitative scoring approach final prognosis order improve possibility establishing long term prognosis iga nephritis patients cohort followed mean period years institution iga nephritis prospective second renal biopsy years later biopsies rb rb developed quantitative scoring elementary lesions glomerular interstitial tubular vascular index sum indexes gave global optical score gos pathological improvement light microscopy delta gos less equal noticed patients stability less delta gos less patients mild deterioration less equal gos less patients major progression delta gos greater equal patients observed pathological remission even patients complete clinical remission pathological progression characterized increase elementary lesions mainly tubulo interstitial vascular ones immunofluorescence mesangial iga deposits remained stable disappearance however number intensity vascular c deposits significantly greater rb chronic renal failure serum creatinine greater mg dl correlated best major pathological progression mainly progression extraglomerular lesions iga nephritis slowly progressive disease pathological remission evolution characterized progression extraglomerular lesions mainly vascular might play major role ultimate development chronic renal failure,C12,0.0017848951,0.018864462,0.029250104,0.0010028598,0.04569011,0.010937824,0.24134618,0.0017238365,0.0012903997,0.0017537642,0.008495911,0.021505425,0.13062784,0.004222118,0.018846052,0.011386184,0.22413324,0.010423575,0.0020323656,0.040180136,0.13398741,0.00927219,0.031243129
mechanical properties urethra healthy stress incontinent females dynamic measurements resting urethra relationship pressure cross sectional area resting urethra inflation deflation examined healthy females patients genuine stress incontinence gsi measurements performed bladder neck high pressure zone distally urethra mechanical properties urethra found vary significantly function time induction cross sectional area stress episode groups women pattern response urethra showed significant differences normals gsi particularly dynamic conditions results indicate mechanical laxity urethra bladder neck midurethrally especially dynamic events stress episodes pathophysiological importance gsi,C12,0.0028791316,0.0025539333,0.0888918,0.0016176666,0.0040090997,0.0037156693,0.12756053,0.03057874,0.002081484,0.0028289158,0.05236061,0.020124866,0.1850657,0.0068152975,0.058283918,0.018415036,0.05063602,0.002965998,0.0032783148,0.15542631,0.17592679,0.001022275,0.0029619443
shortening hemodialysis procedure mortality healthy dialysis patients influence shortening chronic hemodialysis mortality studied following cumulative survival ideal nondiabetic dialysis patients diseases besides renal disease beginning dialysis hoped thereby problems shortening dialysis could separated problems inherent patient otherwise healthy dialysis patients n divided age groups less greater years studied four periods dialysis time shortened hr per treatment time kt v maintained generally first four year cumulative survival improved dialysis shortened four year cumulative survival best age groups dialysis shortest time four year cumulative survival different age matched total u population shortening dialysis time increasing efficiency keeping least stable weekly kt v harmful healthy patients dialysis led continued improvement cumulative survival,C12,0.0027270594,0.0024190377,0.00508841,0.0015322234,0.0037973437,0.0035194121,0.23390742,0.0025645597,0.0019715426,0.0026794958,0.014274277,0.045212343,0.08400614,0.006270415,0.0155916,0.0042465986,0.28563407,0.002808419,0.0031051582,0.16368224,0.11118847,0.00096827967,0.002805498
diagnostic use angiotensin converting enzyme ace inhibited renal scintigraphy identification selective renal artery stenosis presence multiple renal arteries case report patients renovascular hypertension unknown whether angiotensin converting enzyme ace inhibited renal scan identify stenosis segmental branch single renal artery accessory artery multiple renal arteries present since multiple renal arteries may present approximately individuals important establish whether ace inhibited renal scan useful population report case stenosis involving renal artery patient multiple renal arteries successfully identified ace inhibited renal scintigraphy,C12,0.14633542,0.0026270486,0.0055259573,0.0016639779,0.0041349092,0.01814874,0.19059972,0.017114747,0.0021410736,0.0029099034,0.17585692,0.0060913563,0.018332578,0.039611448,0.0026043183,0.0046117594,0.096141934,0.0030499124,0.003372168,0.036659673,0.2183653,0.0010515412,0.003049587
vitro evaluation pollen extract cernitin regulation prostate cell growth nine human derived cancer non cancer continuous cell lines employed evaluate relative vitro activity pollen extract cernitin responses cell lines drug assessed measuring growth cell survival determined cell count results demonstrated continuous cell lines tested derived human prostate growth inhibited pollen extract whereas non prostate derived cells exhibited variable degrees resistance selectivity drug prostate cell lines even pronounced hormone independent models suggesting might place pollen extract control abnormal growth hormone insensitive cells,C12,0.0029201112,0.0025902842,0.03956969,0.0016406913,0.018217932,0.017903095,0.18321207,0.0027499862,0.0021111104,0.0028691806,0.033516888,0.03546567,0.042959634,0.16888447,0.002567872,0.025952177,0.083978854,0.03096713,0.003324976,0.066400535,0.17117012,0.0010368254,0.05999073
patient acceptance satisfaction external negative pressure device impotence patient acceptance satisfaction external negative pressure device treatment impotence retrospectively analyzed among men satisfaction rate reasons dissatisfaction discontinuing use device included premature loss penile tumescence rigidity pain discomfort either application suction intercourse inconvenience negative pressure therapy effective treatment impotence various etiologies among treatment options offered impotent patient,C12,0.004515135,0.09143453,0.008424774,0.0025368703,0.006287183,0.0058270176,0.29457536,0.004246088,0.0032642419,0.004436386,0.06481313,0.009286771,0.11867398,0.01038169,0.003970496,0.028885402,0.12094713,0.0046498408,0.005141146,0.14342317,0.057994604,0.0016031605,0.004681905
prognostic implications disappearance rate biologic markers following radical prostatectomy six patients localized prostatic carcinoma undergoing radical prostatectomy studied serial sample collection time surgical removal prostate one week postoperative period three markers studied pap psa lasa half life specific prostatic markers calculated half life pap found hours se hours psa half life could obtained patients found hours se hours patients psa fall regular fashion half life could obtained patients metastatic disease developed within six months surgery lasa demonstrated progressive increase following surgery likely due associated inflammatory reaction studies confirm previous observations psa sensitive marker pap presence elevated psa radical prostatectomy denotes presence residual disease,C12,0.0026250796,0.0023270675,0.016198633,0.0014739693,0.0036533168,0.020604841,0.29011592,0.0024670567,0.0018965858,0.0025776234,0.04848026,0.018071767,0.04783428,0.026028614,0.0150001105,0.016751291,0.26730588,0.002706156,0.0029871021,0.030409431,0.15131041,0.013624318,0.015550258
validity creatinine clearance estimates assessment renal function clinical practice estimations renal function commonly used calculate appropriate dose drugs renally cleared continuous infusion inulin clearance clin hour creatinine clearance clcr hour creatinine clearance clcr measured subjects men women varying degrees stable renal function clin ml min compared clcr values predicted five equations basis plasma creatinine concentrations age weight height clcr positively correlated clin r p less exceeded clin range ml min clin similarly clcr correlated well clcr r p less clin r p less relative role tubular secretion overall clearance creatinine increased declining clin exceeded clin ml min clcr estimated cockcroft gault mawer methods significantly differ either clcr clcr whereas equations generally underestimated clcr among numerous mathematical equations clcr estimated method proposed either mawer cockcroft gault best predictor clin clin clrcr clin clcr respectively r p less present data support use estimator equations proposed cockcroft gault mawer rapid estimation renal function clinical setting,C12,0.0020505576,0.0018189469,0.013922711,0.0011521247,0.0028553365,0.013966149,0.18726248,0.011845699,0.0014824619,0.021856785,0.096275486,0.014171758,0.24057691,0.0047148652,0.021649277,0.064080626,0.024845636,0.0021117344,0.012258315,0.06197578,0.19628875,0.00072807854,0.002109538
preliminary binephrectomy necessary patients autosomal dominant polycystic kidney disease undergoing renal transplantation patients end stage chronic renal failure due autosomal dominant polycystic kidney disease underwent renal transplantation without preliminary binephrectomy retrospectively studied determine effect binephrectomy outcome nineteen patients identified thirteen patients surgery prior transplantation six underwent preliminary binephrectomy one patient died result nephrectomy twenty one renal allografts performed patients seven died sepsis functioning grafts one returned dialysis patients undergoing preliminary binephrectomy statistically significant p less increase mortality morbidity due septic complications related polycystic kidney disease indications bilateral nephrectomy reconsidered,C12,0.0030988387,0.017726053,0.0057743797,0.0017387829,0.004309265,0.003993865,0.18582658,0.03284461,0.0022373267,0.0030407195,0.020585533,0.006428996,0.03660002,0.007140456,0.0027213967,0.0048190835,0.41993734,0.0031870226,0.0035237654,0.060716376,0.15449007,0.016075829,0.003183708
fate residual fragments extracorporeal shock wave lithotripsy monotherapy infection stones reviewed patients infection stones treated extracorporeal shock wave lithotripsy eswl monotherapy determine long term rate free stones stone recurrence rate correlated pre treatment stone burden radiological presence sand fragments procedure long term followup mean months available patients representing kidneys although kidneys free stones immediately eswl without stones months stone free followup kidneys fragments mm final treatment residual fragments months experienced stone progression kidneys sand remaining kidneys appeared free stones eswl without stones followup month plain film kidneys ureters bladder reliable indicator eventual outcome kidneys free stones months remained without stones kidneys residual stone particles months showed disease progression stable disease passed residual sand patients free stones stable stone disease positive urine culture followup patients infection stone fragments months eswl monotherapy high rate stone progression undergo treatment eswl monotherapy infection stones requires close patient followup assure residual fragments passed urine remains sterile,C12,0.0022272898,0.012755532,0.004155892,0.0012514233,0.0031014306,0.0028744335,0.24793233,0.0020945703,0.012381121,0.002188443,0.020093022,0.02613559,0.03635236,0.018083205,0.0019586224,0.0034683535,0.36258835,0.0022937392,0.002536097,0.029568264,0.19210842,0.0007908297,0.013060658
natural history low stage prostatic cancer impact early detection expanding increasingly older population rising incidence prostate cancer uncertainties regarding treatment effectiveness made disease target special concern natural history cancer must consequence host tumor interactions little known sure subject growth rate tumor determined many factors including genetic instability present tumor grade volume ploidy useful techniques judging growth rate metastatic potential stage tumors generally indolent whereas stage tumors aggressive natural history stage b lesions well documented author asks two questions cure necessary may possible cure possible may necessary reviews problems inherent screening prostate cancer time,C12,0.0024666793,0.01412538,0.0046025678,0.0252675,0.075085364,0.0031833781,0.293439,0.0023196952,0.0017832994,0.0024236573,0.055310965,0.06476896,0.044169415,0.03901414,0.0021691355,0.015777642,0.14010964,0.014475898,0.02504429,0.11930284,0.051714905,0.0008758282,0.002569867
peritoneal transport capd patients permanent loss ultrafiltration capacity year period patients undergoing continuous ambulatory peritoneal dialysis capd developed permanent loss ultrafiltration capacity ufc risk ufc loss increased one year six years treatment six hour single dwell study glucose dialysis fluid carried nine ufc loss patients capd patients normal ufc intraperitoneal dialysate volumes calculated using tagged albumin risa volume marker correction applied elimination peritoneal cavity risa elimination coefficient ke serve estimation upper limit lymphatic flow also calculated diffusive mass transport coefficients kbd investigated solutes glucose creatinine urea potassium total protein albumin beta microglobulin calculated period dialysate isovolemia two patterns ufc loss observed seven patients high kbd values small solutes resulting rapid uptake glucose whereas kbd values proteins normal b two patients normal kbd values threefold increase fluid reabsorption rate ke conclude loss osmotic driving force due increased diffusive mass transport small solutes increased fluid reabsorption possibly due increased lymphatic reabsorption two major causes permanent loss ufc capd patients,C12,0.0018344261,0.0016253357,0.033172607,0.0010294908,0.029148744,0.055239394,0.114485845,0.0017231108,0.01905216,0.0018003358,0.047282968,0.012610277,0.14814322,0.004291753,0.037122276,0.056072805,0.15251084,0.020002957,0.0020863356,0.12414779,0.13407898,0.0006505808,0.0018877791
digital rectal examination early detection prostate cancer screening using digital rectal examination improves clinical stage distribution prostate cancer prolongs survival unfortunately digital rectal examination may sensitive enough detect small volume tumors amenable cure several studies approximately per cent cancers detected screening already spread beyond prostate regardless key demonstrating overall benefit screening diminished disease specific mortality rate date shown lower mortality rates prostate cancer demonstrated randomized study comparing screened unscreened populations study recently approved funded national institutes health require years complete time value screening prostate cancer digital rectal examination method unknown beyond lack proved benefit screening prostate cancer may harmful variable natural history disease morbidity mortality rates associated treatment exists large population patients pathologically detectable prostate cancer never clinical disease detection tumors may expose patients risks unnecessary treatment large scale prostate cancer screening studies may ultimately shown advantageous sooner occurs earlier aggressive screening advocated similar screening breast cancer however temptation embark screening programs without first demonstrating clear benefit resisted,C12,0.0017847384,0.001583152,0.010786594,0.009640455,0.019823039,0.010935708,0.32245305,0.0016783896,0.0012902864,0.0017536102,0.22195043,0.029807588,0.03314698,0.013761446,0.0015694539,0.01139792,0.098648086,0.0018393643,0.017467916,0.11461468,0.07159526,0.00063369574,0.0018381713
effects calcium antagonists renal hemodynamics recent attention focused effects calcium antagonists renal function administered vitro isolated perfused kidney calcium antagonists exhibit consistent actions permitting characterization actions permitting characterization renal effects calcium antagonists affect vasodilated isolated perfused kidney markedly alter response kidney vasoconstrictor agents presence norepinephrine calcium antagonists markedly augment glomerular filtration rate produce modest improvement renal perfusion studies using isolated perfused hydronephrotic rat kidney model permits direct visualization afferent efferent arterioles demonstrated augmentation glomerular filtration rate attributable preferential vasodilation preglomerular vessels although clinical implications observations fully delineated preliminary studies experimental animal models indicate calcium antagonists might exert salutary effects renal function clinical settings characterized acute impairment renal hemodynamics apparent however renal hemodynamic effects calcium antagonists commend use management essential hypertension,C12,0.0026572228,0.0023570892,0.017753385,0.0014929851,0.0037002936,0.016287733,0.26396573,0.002533325,0.0019210537,0.0026108774,0.012776999,0.0054987785,0.038165223,0.006708034,0.0023366946,0.0041378485,0.053422667,0.015594277,0.003025639,0.070396714,0.4689703,0.00094348326,0.0027436283
percutaneous operative gastrostomy gastric decompression major urological surgery postoperative gastric decompression necessary percutaneous gastrostomy tube alternative nasogastric intubation percutaneous insertion suprapubic bladder catheter easy procedure without notable complications increases comfort patient immediate postoperative period advocate use major urological abdominal operations,C12,0.005778024,0.0051253955,0.010781193,0.0032464361,0.008045715,0.007456841,0.2198264,0.033395454,0.004177254,0.005677248,0.08250848,0.011884292,0.039773025,0.0133916065,0.0050810487,0.008997585,0.35322207,0.0059504067,0.0065791304,0.039145086,0.12196149,0.0020515665,0.005944218
effect post pubertal varicocele testicular volume paediatric varicocele well known entity effect adult infertility adequately clarified since measurement testicular volume currently best method estimating male reproductive potential boys aged years examined regard testicular volume incidence varicocele average volumes right left testes ml respectively incidence varicocele incidence increased ages increased differences volume testes boys varicocele statistically significant compared normal group significance failed become pronounced slight varicocele group grade included normal group compared severe varicocele group grades ii iii may significant differences volumes testes boys varicocele careful measurement strict statistical analyses applied however boys varicocele group found testicular volumes confidence interval mean se sd testicular volumes differed certain age groups group requires follow results study added contradictory findings issue paediatric varicocele terms testicular atrophy estimation potential fertility indications immediate surgery need prospective controlled trials,C12,0.0019429303,0.0017167804,0.0036919722,0.0010874121,0.0026949581,0.011857534,0.2125267,0.011186222,0.0013991949,0.05221888,0.02924362,0.086086035,0.22215372,0.0045075626,0.011061623,0.0030137922,0.061669152,0.0019939886,0.020938056,0.121643275,0.114643015,0.0006871838,0.022036415
rapid methods estimating kt v three formulas compared three rapid formulas kt v compared kt v pru pru kt v pruopt pru ktv ln r uf w accuracy compared database week modeling sessions patients standard comparison kt v obtained point variable volume single pool modeling using k values estimated koa qb qd uf rate accurate formula kt v ln correlated kt v high degree error sd correlation error modeled kt v least accurate formula kt v pru although correlation kt v pru modeled kt v high error error correlated significantly modeled kt v kt v pruopt showed high correlation modeled kt v error latter minimal correlation modeled kt v relative accuracies three formulae kt v ln vs kt v pru kt v ln vs kt v pruopt results suggest kt v ln accurate estimate kt v formula based pru alone,C12,0.0028394333,0.002518719,0.019186893,0.0015953617,0.003953821,0.017394114,0.14491495,0.0026702376,0.002052784,0.00278991,0.21270178,0.0058402177,0.22741409,0.006528734,0.002496926,0.004427999,0.045651276,0.0029241457,0.0032331126,0.026473539,0.18973064,0.06973825,0.0029230213
fertility prognosis infertile men results follow study semen analysis infertile men two different populations evaluated cox regression model using cox proportional hazard regression model one material group identified four variables semen analysis significant prognostic information fertility four variables combined model establishing probability individual male achieve pregnancy function time model tested first another material group ii goodness fit test indicates excellent agreement expectations model observed number pregnancies group ii second two groups pooled three variables give significant prognostic information time pregnancy man age semen analysis years percentage morphologically normal spermatozoa ln degree motility good poor three important variables enter new better prognostic model,C12,0.0025269696,0.0022415482,0.017019464,0.0014198011,0.0035187253,0.003261186,0.21180384,0.002376393,0.0018268866,0.0024828962,0.12653439,0.056343086,0.049292605,0.0059915395,0.014448588,0.016152022,0.1356987,0.0026206558,0.0028773267,0.13784227,0.20020987,0.0008972351,0.0026139352
ionic strength affects diffusive permeability inorganic phosphate ion negatively charged dialysis membranes electrolytes undergo electrostatic resistances reaching membrane surfaces passing membrane pores weakly charged dialysis membranes used hemodialysis treatments diffusive permeability electrolyte weakly charged dialysis membranes depends upon effective charge density membranes varies ionic strength authors carried dialysis experiments temperature k p na hpo aqueous nacl bovine serum obtain diffusive permeability inorganic phosphate ion regenerated cellulose polymethylmethacrylate membranes various fixed charge densities varying ionic strengths ranging mol diffusive permeability inorganic phosphate ion increased ionic strength bovine serum ionic strength approximately mol gave higher diffusive permeability inorganic phosphate ion internal structure dialysis membranes pore size surface porosity tortuosity also affects diffusive permeability electrolyte diffusion theory gives effective charge density mol cellulosic membrane conclusion ionic strength enhances diffusive permeability inorganic phosphate ion aqueous nacl bovine serum inorganic phosphate ion transport negatively charged dialysis membranes depends upon degree dissociation inorganic phosphate molecular size valence hydrated inorganic phosphate ion effective charge density internal structure membrane ionic strength,C12,0.0023544373,0.0020885034,0.19232132,0.0013228623,0.018477524,0.014434471,0.21464813,0.0022141414,0.0017021534,0.013701366,0.026813217,0.019116338,0.037376817,0.120854765,0.0134618385,0.0036663485,0.06375391,0.0024246802,0.0026808733,0.029600747,0.15651956,0.00083597517,0.059630033
extracorporeal removal anti hla antibodies transplant candidates report results clinical trial transplant candidates treated extracorporeal immunoadsorption system using protein selectively removes immunoglobulin plasma also assessed dynamics anti hla antibody model igg removal equilibration well clinical safety procedure end treatment course plasma igg levels reduced control values p less contrast albumin levels reduced p less specific cytotoxic anti hla antibody titers reduced approximately fold panel reactivity measured proportion member cell donor panel killed patients serum presence complement nine patients significant reduction parameter range week follow period anti hla antibody titers returned baseline levels remarkable changes observed blood chemistries unanticipated adverse reactions seen patients treated conclude selective extracorporeal immunoadsorption safe effective way removing igg type antibodies potential application reduction hla antibodies transplant candidates,C12,0.001935664,0.011078891,0.012967762,0.0010873562,0.0026946974,0.011860365,0.17473911,0.0018198806,0.0013990597,0.0019014425,0.009460285,0.013458096,0.08993163,0.061142385,0.0017017615,0.013596383,0.1701601,0.028874386,0.020935075,0.014228737,0.352348,0.00068711734,0.001991847
epidemiology prostate cancer available epidemiologic data allow targeting specific populations prostate cancer screening early detection programs although certain strong factors identified age race location none sufficiently defines high risk groups recommendations differ age matched patients certainly strong familial tendency identified relative contribution genetic environmental factors patients remains unclear hypotheses pathogenesis prostate cancer possible based available data genetic factors appear permissive hormonal influences partially regulated genetics environmental factors appear promotional genetically susceptible men dietary fat may also important promotional factor genetically susceptible men dietary factors appear exert influence modulating sex hormone concentration several factors demand investigation understanding epidemiology prostate cancer relative frequency disease increasing death rate prostate cancer concern similarities incidence latent prostate cancer among various groups strong differences rate clinically apparent disease raise significant issues regarding potential lifestyle environmental promotional factors understanding pathogenesis prostate cancer may allow refinement definition programs prevention early detection disease,C12,0.0019173411,0.048105486,0.022139357,0.0010772758,0.011939308,0.0024744286,0.25046065,0.0018030908,0.0013861523,0.011142401,0.08026086,0.022816336,0.02912494,0.036537882,0.0016860614,0.012419506,0.035540763,0.011250657,0.034490686,0.32415706,0.05659633,0.0006807782,0.0019926196
phenomenological interpretation variation dialysate volume dwell time capd intraperitoneal fluid volume ipv changes versus time followed patients undergoing continuous ambulatory peritoneal dialysis capd using simple volume recovery method patient dialysates containing percent glucose osmotic agent investigated patients ipv versus time data fitted function determined four arbitrary coefficients initial ultrafiltration uf rate immediately following intraperitoneal p fluid instillation final peritoneal blood fluid absorption rate could assessed peritoneal osmotic conductance glucose peritoneal ultrafiltration coefficient kf times peritoneal osmotic reflection coefficient glucose sigma g kf sigma g determined using two related approaches kf sigma g major determinant transperitoneal volume exchange calculated se microliters min mm hg respectively depending assumption employed kf sigma g analysed according three pore model membrane permeability determine possible range kf sigma g compatible peritoneal small solute sieving coefficient phi ranging according calculations kf sigma g ranged ml min mm hg dimensionless respectively maximal peritoneal lymph flow l realistic according analysis compatible measured total peritoneal blood fluid absorption rate ml min ml min plausible values however falling ml min,C12,0.0019019655,0.001625527,0.012552641,0.0010296121,0.002551711,0.043857127,0.11978437,0.0017233138,0.010191934,0.0018005478,0.03423649,0.021665843,0.36654672,0.024406834,0.0016114801,0.030049713,0.16199073,0.0018871806,0.0020865812,0.040980093,0.10274446,0.0006506574,0.014124474
cell injury associated calcium oxalate crystalluria renal tubular cell damage resulting membranuria induced administration subcutaneous gentamicin male sprague dawley rats one group rats received gentamicin second group given gentamicin plus ethylene glycol drinking water concentration increased urine oxalate alone cause calcium oxalate crystalluria crystalluria occurred early combined treatment groups persisted duration experiment crystalluria present animals receiving gentamicin ethylene glycol results suggest cellular fragments serve heterogeneous foci nucleation calcium oxalate crystals,C12,0.020892825,0.0031728933,0.006674134,0.002009717,0.004980727,0.0046161823,0.27895916,0.0033637648,0.0025859433,0.0035145194,0.016450284,0.14646256,0.027459566,0.10228342,0.020453028,0.005569985,0.03985837,0.0036836192,0.004072833,0.05012254,0.24786413,0.0012700291,0.0036797882
studies requirements trackpoints cellsoft automated semen analysis cellsoft cryo resources ltd new york ny system computer assisted sperm analysis evaluated appropriate settings trackpoints fifty eight human spermatozoa exhibiting complex swimming modes chosen analysis room temperature accumulated measures curvilinear velocity linearity mean maximum amplitude lateral head displacement beat cross frequency determined range trackpoints stable measures within confidence interval frames observed frames curvilinear velocity frames linearity corresponding figure mean amplitude lateral head displacement beat cross frequency frames conclude frame requirements concerning measures curvilinear velocity linearity mean amplitude lateral head displacement beat cross frequency respectively thus consecutive frames analyze suffice,C12,0.04532756,0.002590374,0.005560259,0.0016419978,0.004066303,0.04616516,0.14398743,0.04515596,0.0021111835,0.00286928,0.016478369,0.0060233353,0.22476128,0.0072001033,0.016689243,0.032787282,0.058044225,0.017138323,0.0033250912,0.14089245,0.10152111,0.0010368612,0.074626796
interaction parameters male female fertility couples previously unexplained infertility prospective study undertaken relationship semen variables serial endocrine follicular ultrasound measurements one complete menstrual cycle treatment independent chance conception couples referred unexplained infertility couples studied mean length infertility months follow rate achieved stepwise analysis performed examining semen variables ultrasonographic endocrine variables mean ratio salivary progesterone plasma estradiol days respect luteinizing hormone surge grade motile sperm density variables achieved level significance highly significant relationship product two variables chance conception study clearly demonstrates interaction parameters male female fertility,C12,0.0029200327,0.0025902148,0.0054484783,0.0016406473,0.004066439,0.032021016,0.20797576,0.0027460342,0.0021110536,0.0028691036,0.051107068,0.0060068816,0.0653945,0.0077561066,0.002567803,0.0045518717,0.1689034,0.0030071496,0.0033248868,0.17750052,0.24144161,0.0010367975,0.0030126292
flutamide hormone resistant prostatic cancer flutamide mg orally times daily yielded subjective response fully evaluable patients hormone resistant prostatic cancer four additional patients early progression greater decrease pre treatment prostate specific antigen level observed patients finding correlated improved survival toxicity mainly gastrointestinal resulted permanent discontinuation flutamide patients flutamide similar antiandrogens may role management hormone resistant prostatic cancer relief subjective symptoms important treatment goal together improvement survival however drug used routinely management hormone resistant prostatic cancer phase studies must confirm effectiveness especially comparison less expensive drugs,C12,0.015912684,0.028817264,0.031471126,0.0015323093,0.016984379,0.0035196096,0.32628587,0.0025647036,0.0019716532,0.0026853806,0.027299056,0.07214534,0.07196732,0.021213036,0.0023982418,0.0174463,0.14467451,0.0028269538,0.0031053324,0.019313818,0.18208954,0.00096833403,0.0028071923
continence level following radical prostatectomy relationship urethral anastomosis postoperative continence following radical prostatectomy uncertain objective study determine radiographically functional level continence following radical prostatectomy relative site intraoperative urethral anastomosis patients radical prostatectomy intraoperative hemoclip placed site urethral anastomosis postoperative functional level continence determined using standing lateral cystogram functional level continence mm sd distal site urethral anastomosis level urethra continence occurs may function intrinsic continence parameters individual patient,C12,0.0036400526,0.07370776,0.024411425,0.0020451972,0.005068658,0.0046976777,0.2020139,0.03865423,0.002631596,0.0035765655,0.018257663,0.0074868924,0.02994224,0.008369605,0.0032009704,0.005668319,0.21533056,0.003791219,0.004144735,0.026307968,0.31201556,0.0012924505,0.003744752
non heparin hemodialysis oral administration newly developed antiplatelet agent non heparin hemodialysis hd successfully done anuric dogs oral administration newly developed antiplatelet agent cyano bis methoxyphenyl pentenoic acid e eisai pharmaceutical co japan current study antithrombotic effect e hd investigated eleven mongrel dogs bilateral ureteral ligation given mg kg e orally hr undergoing hr hd using hollow fiber dialyzers pmma regenerated cellulose without heparin general anesthesia blood samples taken administration e hr starting hd blood counts hematocrits blood chemistries plasma thromboxane levels txb examined platelet aggregation activated clotting times act activated partial thrombin times aptt also measured sequential plasma e concentrations determined anuric dogs non heparin hd successfully done minimal clotting dialyzer drip chambers maximum aggregation rate depressed less initial value throughout hd plasma txb concentration depressed act aptt mildly significantly prolonged neither hemorrhagic complications side effects e observed,C12,0.0026569644,0.015205119,0.017809752,0.0014928399,0.0036997388,0.029145168,0.26219147,0.0024986414,0.0019208669,0.0026106236,0.012817791,0.005515954,0.12538762,0.006205157,0.0023364674,0.03344724,0.08329113,0.028455645,0.0030253448,0.044856,0.28603417,0.026662847,0.002733387
management posterior urethral valves initial vesicostomy delayed valve ablation managed neonates infants temporary vesicostomy delayed valve ablation criterion successful management gauged estimated creatinine clearance renal failure death occurred patients required transplantation apparent difference patients managed initially vesicostomy series managed initially valve ablation preventing complications posterior urethral valves,C12,0.049308732,0.048789684,0.008613318,0.002593645,0.0064278883,0.028263463,0.1766901,0.0043411143,0.0033372948,0.049228985,0.07658993,0.00970755,0.03458445,0.01061403,0.004059355,0.007188357,0.2704714,0.004753903,0.0052562035,0.10611191,0.086680725,0.0016390388,0.0047489586
treatment mesangial iga nephropathy cyclophosphamide dipyridamole warfarin two year prospective trial patients mesangial iga nephropathy allocated treatment cyclophosphamide months dipyridamole warfarin years treatment randomized prospective year study entry treated untreated groups patients differ mean serum creatinines urinary protein excretions quantitative urinary erythrocyte counts blood pressure readings end trial mean sem serum creatinine values gone mmol l p less untreated patients mmol l p less treated patients mean sem log values urinary erythrocyte rbc counts changed significantly log rbc ml untreated patients log rbc ml treated patients however treated patients mean sem urinary protein excretions decreased g h p less whereas untreated patients urinary protein unchanged initial values follow g h significant changes blood pressure occurred either group study supports observation treatment iga nephropathy cyclophosphamide dipyridamole warfarin associated reduction urinary protein excretion significant effect preservation renal function least determined serum creatinine values could confirmed two year study,C12,0.0017846813,0.0015831013,0.08106147,0.0010027396,0.0024851123,0.0023032243,0.13119169,0.001678336,0.0012902451,0.027666343,0.00838175,0.024277426,0.19094457,0.00412879,0.0015694037,0.0027791199,0.22057573,0.03762264,0.024636183,0.015928635,0.20601967,0.0006336755,0.010455488
elderly dialysis considerations compliance compliance scheduled treatments dietary fluid restrictions multiple medications important component care well end stage renal disease esrd patients given rigorus complex demands dialysis important examine issue compliance focusing large ever increasing segment patient population elderly esrd literature reflects efforts define measure levels compliance identify factors influence predict compliance develop intervention strategies improve adherence treatment regimens limited attention focused specifically elderly studies suggesting age may factor associated improved adherence social support may significant contributor compliance patient group effort examine current status needs dialysis elderly research progress chromalloy american kidney center washington university replicates study years ago eighty four patients age dialysis minimum months identified sociodemographic treatment compliance functional capacity data collected additional mental psychological testing completed patients willing able participate preliminary data suggest current elderly population larger significantly older years ago sociodemographic data indicate population increasingly female black socioeconomically disadvantaged regard compliance vast majority elderly demonstrate good compliance measured serum potassium fair good compliance phosphorus fair poor compliance fluid restrictions,C12,0.0014678534,0.07946819,0.010105075,0.007926937,0.002044644,0.016101541,0.2120505,0.0013803871,0.0010611927,0.0014422522,0.044338178,0.010389708,0.05795698,0.0035119173,0.0012907933,0.023600662,0.1482424,0.0015116456,0.030087497,0.23619358,0.10779625,0.00052118144,0.0015105895
long term experience swan neck missouri catheters swan neck missouri catheters designed reduce major complications including exit tunnel infections downward directed exit hole pericatheter leaks placement deep cuff rectus muscle catheter tip migration caudal direction intraperitoneal segment outer cuff extrusion permanent bend cm cm spaced cuffs sn sn catheters respectively april april swan neck catheters implanted comparison prospective data swan neck catheters retrospective data standard tenckhoff toronto western hospital catheters implanted january june showed reduced complication rates swan neck catheters overall survival months swan neck catheters significantly better standard catheters,C12,0.018433133,0.0027456193,0.020728014,0.0017390809,0.01927857,0.0040225685,0.15808153,0.017860603,0.017221536,0.0030412406,0.18980817,0.021772172,0.10225319,0.05293994,0.002721863,0.0048199096,0.21406092,0.0031875689,0.0035243693,0.052488115,0.08498858,0.0010990021,0.0031842536
experimental treatment benign prostatic hyperplasia transurethral balloon dilation prostate preliminary study humans prospective noncontrolled study safety potential efficacy transurethral balloon catheter dilation prostate tudp treatment benign prostatic hyperplasia bph performed subjects moderate severe symptoms signs prostatism selected basis quantitative symptom score ss uroflowmetry measurements residual urine volume seven patients urinary retention mean age years range years tudp successfully accomplished patients significant complications mean follow months range months forty six patients showed improved ss recent follow patients ss unimproved necessitating prostatectomy subjects reduction mean residual urine volume statistically significant patients median lobe enlargement showed improvement ss compared others authors conclude tudp safe shows promising effectiveness ultimate demonstration effectiveness requires controlled clinical trial,C12,0.0023813553,0.03669459,0.027498301,0.012857737,0.003315962,0.01459102,0.21264024,0.03681823,0.0017216139,0.01592526,0.023752471,0.041788742,0.122876614,0.007255885,0.0020941037,0.0037082655,0.28601635,0.0024524012,0.014238448,0.03104015,0.09700016,0.00084553275,0.0024865791
stress incontinence new endoscopic approach describe experience using new endoscopic technique suspending bladder neck urethra patients stress incontinence procedure started dissecting retropubic space first sound foley catheter passing absorbable suture abdominal fascia bladder neck using elbowed needle introduced bladder neck exteriorized urethra dissection retropubic space helped form postoperative adherences fixed bladder neck urethra firmly pubic symphysis technique simple require vaginal surgery incidence complications minimal,C12,0.0045151752,0.004005186,0.008424848,0.002536893,0.0062872386,0.026843084,0.20160303,0.11353613,0.0032642707,0.004477233,0.090938985,0.009286853,0.02836336,0.011195985,0.0039705313,0.0070392657,0.2853481,0.0046498817,0.0054932423,0.07659403,0.09537049,0.0016031747,0.0046530846
morbidity mortality hemodialysis patients increase mortality hemodialysis patients united states rising concern study annual mortality rate determined morbidity mortality patients dialyzed analyzed patients followed urea kinetics uk patients divided according ncds mapping bun protein catabolic rate pcr group inadequate protein intake n group adequate dialysis n group excessive dialysis n group undefined domain n group transitional domain n uk parameters measured midweek predialysis bun pcr kt v group definition lowest pcr g kg day vs greater groups patients group significantly lower bun creatinine hematocrit serum albumin results laboratory tests significantly different numbers hospitalizations days hospital higher group causes hospitalization similar groups mortality rate group vs group dialysis prescription using uk maintained annual mortality rate past nine years,C12,0.002327714,0.0020647987,0.015603795,0.0013078477,0.037031822,0.036790445,0.10277686,0.0021890106,0.0016828338,0.002287116,0.024930496,0.15715559,0.10648681,0.005419054,0.0020469332,0.0036247352,0.14087883,0.024934273,0.002650445,0.21588863,0.10869455,0.00082648674,0.0024008658
pressure effects roller pump blood flow hemodialysis accurate measurement blood flow hemodialysis essential avoid underdialysis blood roller pumps pushed high flow rates demanded high performance dialyzers flow may overestimated study examined effect inflow pa outflow pv pressures induced hemodialysis roller pumps flow vitro vivo blood flow measured volumetrically ultrasonic flow probe whereas pa adjusted torr pv torr pa influenced flow torr true flow measured volumetrically averaged less blood pump revolutions per minute rpm meter reading torr difference visible indication flow reduced less pump meter readings pv hematocrit source pump tubing significant effect flow measured ultrasonic transit time probe routine hemodialysis patients less pump meter readings pa varied torr blood pump meter readings greater ml min usually inaccurate low pa prepump monitoring arterial inflow pressure prevent hidden reductions blood flow decrease dialysis efficiency,C12,0.031026818,0.011864349,0.014039741,0.0011639453,0.0029284388,0.0026735025,0.096101545,0.011939645,0.011469406,0.0020354646,0.035721246,0.08513196,0.41622174,0.004787281,0.0018217092,0.0032276823,0.0503792,0.0021334004,0.0023588168,0.06356615,0.11647094,0.00073554844,0.032201476
development hypertension unilateral renal artery stenosis conscious dogs renal systemic changes stenosis left renal artery n sham stenosis n conscious dogs studied sequentially days stenosis produced prompt rise arterial pressure times due reduced peripheral vascular conductance increase cardiac output despite initial evidence mild fluid retention decrease peripheral conductance attributable stenotic kidney total due mechanical effect stenosis nonstenotic kidney total caused angiotensin ii nonrenal vasculature decrease conductance nonrenal vasculature due partly angiotensin ii also gradually developing non angiotensin ii component acute administration captopril caused significantly greater changes arterial pressure peripheral conductance throughout period stenosis stenosis greater sham stenosis dogs indicating angiotensin ii constricting peripheral vasculature even plasma renin levels longer elevated stenotic kidneys captopril produced fall renal vascular resistance renal blood flow rise approximately equal rise resistance stenosis evidence role autonomic nervous system hypertension ganglion blockade pentolinium similar hemodynamic effects stenosis thus hypertension due times reduced peripheral conductance two kidneys responsible reduced conductance,C12,0.06564746,0.0014574922,0.011016722,0.00092317857,0.002287934,0.018018166,0.08215063,0.010650079,0.0011878723,0.0016144207,0.03138679,0.0033818288,0.13180803,0.0518047,0.0014449231,0.020719336,0.12238515,0.0096229445,0.0018708861,0.047142196,0.3812054,0.00058339734,0.0016904365
kt v hemodialysis morbidity revisited analysis national cooperative dialysis study ncds showed dialysis morbidity related kt v recently various formulae shown accurate easier calculation kt v calculated kt v outpatient unit utilizing kt v r uf w patients kt v less patients group group b greater group c difference hematocrit hct bun creatinine serum phosphorus albumin ratio men women mean age years mean body weight lb groups b c respectively dialysis related hospital admissions similar p greater data suggest patients higher body weights men frequently kt v less kt v influence biochemical parameters hospitalizations population indicates kt v may good predictor morbidity heavier patients may fairly well even kt v less search better index dialysis adequacy continued,C12,0.0026569585,0.002356855,0.017814705,0.014346675,0.0036997306,0.019293949,0.19326548,0.002498636,0.0019208628,0.0026106178,0.076054126,0.06678314,0.15586448,0.006150966,0.01175354,0.016996382,0.11981676,0.002736227,0.0030253383,0.17642851,0.1002431,0.0009433895,0.0027395529
radiation therapy localized prostate cancer justification long term follow series presented survival patterns years radiotherapy patients clinical stage carcinoma prostate deviate significantly age matched peer group patients clinical stage b disease nodular disease exceed involvement one lateral lobe survival less years age matched group california men spite fact lymph node status true incidence capsular penetration unknown moreover patients stratified histopathologic grade either acid phosphatase prostate specific antigen values one restrict patients intermediate low gleason scores normal acid phosphatase low prostate specific antigen values likely would difference survival prostatic cancer age matched peers one deviates conservative selection criteria includes patients advanced stages likelihood achieving year survival diminishes radiation treatment however patients whose disease clinical examination extends beyond prostate seem advanced radical prostatectomy still may per cent per cent chance year survival,C12,0.0023018164,0.0020418258,0.0042949505,0.0012932967,0.0032538776,0.014091332,0.28933412,0.024443597,0.012745552,0.0143174,0.039108794,0.05027609,0.10529595,0.033500634,0.002024159,0.0035844066,0.2389874,0.0023717245,0.0026209564,0.09421747,0.04533711,0.0008172913,0.013740238
use prostaglandin f alpha prophylaxis cyclophosphamide induced cystitis rats well established cystitis significant cause morbidity cyclophosphamide administration clinical populations induced hemorrhagic cystitis rats using cyclophosphamide compared controls pretreated prostaglandin f alpha rats evaluated differences bladder weights gross edema gross bleeding histologic changes weights bladders treated cyclophosphamide greater controls weights bladders pretreated prostaglandin f alpha cyclophosphamide greater controls significant differences found cyclophosphamide controls prostaglandin f alpha pretreated groups gross weight p less gross edema p less histology less p less conclude prostaglandin f alpha may helpful preventing cyclophosphamide induced cystitis,C12,0.07573307,0.01720944,0.0056064418,0.0016882133,0.0041839373,0.0038777103,0.16018361,0.0028256478,0.002172258,0.0029522856,0.01696042,0.022417966,0.19316027,0.007019408,0.0026422495,0.0046789288,0.05275107,0.0030943337,0.0034212829,0.07528545,0.26524743,0.0010668567,0.075821705
hemodialysis elderly patient potential advantages quality life urea generation serum creatinine less interdialytic weight gain total patients treated maintenance hemodialysis continuous ambulatory peritoneal dialysis capd studied ascertain advancing age influences adaptation uremia therapy difference karnofsky score noted among patients years age two groups patients years age respectively subset hemodialysis patients studied midweek noted increasing age associated lower serum creatinine concentration lower interdialytic weight gain lower urea generation rate three findings contribute relative ease treating older uremia patients hemodialysis capd tend stable compliant relative younger patients,C12,0.0030046145,0.0026652429,0.065912336,0.0016881702,0.00418383,0.0038776114,0.19764802,0.0028255759,0.0021722026,0.0029522101,0.013966144,0.037069023,0.06072834,0.007294765,0.0026422623,0.0046788095,0.20307669,0.0030942548,0.0034211955,0.23481745,0.13812344,0.0010668294,0.0030910366
triamterene nephrolithiasis renewed attention warranted although triamterene known contribute urinary calculus formation presumed rare phenomenon review stone analyses performed last decade single laboratory reveals increasing incidence triamterene stones awareness calculogenic potential triamterene containing medications emphasized,C12,0.005778683,0.00512598,0.038755696,0.003246806,0.008100229,0.04123604,0.3085863,0.04700414,0.0041777305,0.005677895,0.061322607,0.011885646,0.04128314,0.058805145,0.0050816275,0.008998611,0.06605206,0.03527956,0.00657988,0.10764686,0.121203266,0.0020518003,0.0061203074
treatment outflow tract obstruction due benign prostatic hyperplasia pollen extract cernilton double blind placebo controlled study whilst prostatectomy remains gold standard treatment outflow tract obstruction due benign prostatic hyperplasia medical treatment symptomatic relief appears attractive alternative pharmacological agents use block hormonal sympathetic neurological pathways influence prostate growth function drugs known side effects sixty patients outflow obstruction due benign prostatic hyperplasia bph entered double blind placebo controlled study evaluate effect month course pollen extract cernilton statistically significant subjective improvement cernilton patients compared placebo significant decrease residual urine patients treated cernilton antero posterior p diameter prostate ultrasound however differences respect flow rate voided volume statistically significant concluded cernilton beneficial effect bph may place treatment patients mild moderate symptoms outflow obstruction,C12,0.026706146,0.0021124687,0.0044435463,0.012861268,0.0033160995,0.0030733908,0.20710383,0.036822554,0.0017216854,0.0023468887,0.023460286,0.017425882,0.061482288,0.028523631,0.0020941908,0.0037084194,0.33587778,0.002452503,0.060351044,0.049077604,0.11174053,0.00084556785,0.0024524287
angiotensin ii receptor regulation anti glomerular basement membrane nephritis expression glomerular receptor angiotensin ii ang ii r examined longitudinally following induction anti glomerular basement membrane gbm nephritis rat specific aim project determine whether immunologically induced glomerular injury led significant abnormalities relationship glomerular ang ii r circulating ligand ang ii scatchard analysis used measure ang ii r purified glomeruli selected time intervals two months following single dose sheep anti rat gbm antibody corresponding values plasma ang ii determined receptor density fell approximately hours following injection antibody control x nephritic x receptors glomerulus p less corresponding threefold increase plasma ang ii control nephritic pg ml p less however reduction receptor binding could explained rise plasma ang ii concentration effective blockade ras enalapril alter receptor expression x receptors glomerulus subsequently rise receptor density corresponding fall plasma ang ii observed three days antibody administration receptor concentration increased significantly control values x plasma ang ii undetectable less pg ml ang ii r remained elevated next two weeks returned normal four eight weeks administration nephrotoxic antibody,C12,0.010160948,0.0015431665,0.0032460277,0.026233267,0.0024224233,0.0106503405,0.10718756,0.0016359986,0.0012576977,0.0017093195,0.009462664,0.012221047,0.117810845,0.042352203,0.0015298143,0.01954521,0.03996598,0.09479613,0.0019808605,0.011699827,0.4605896,0.00061769056,0.021381399
biocompatibility dialysis membranes importance objective subjective symptoms hemodialysis clinical importance biocompatibility hemodialysis membranes matter controversy authors studied relationship biocompatibility acute symptoms hemodialysis hd twenty three patients underwent different bicarbonate hd using cuprophan hemophan polyamide membranes short hr long hr treatments small large membrane areas subjective objective symptoms registered hd hours thereafter type membrane membrane area kt v importance occurrence subjective objective symptoms patients registered fewer symptoms hr hd high blood flow hr hd slow blood flow p headache particularly frequent hr hd blood pressure extent subjective symptoms influenced ultrafiltration volume type membrane biocompatibility determinant acute side effects hemodialysis,C12,0.00287925,0.0025540385,0.08900571,0.0016178584,0.004009961,0.0038743713,0.33264172,0.0027076816,0.0020815695,0.002873854,0.040756706,0.005922067,0.1442568,0.006666466,0.04434568,0.018416923,0.093048595,0.0029651502,0.0032784496,0.06416125,0.12795149,0.0010223171,0.0029620663
enhancing effect partial cystectomy rat urinary bladder carcinogenesis effects partial cystectomies bladder tumorigenesis initiated n butyl n hydroxybutyl nitrosamine bbn investigated wistar rats examining histological findings cell proliferative activity incorporation bromodeoxyuridine brdurd dna synthesis phase determined vitro labeling technique eight weeks treatment drinking water containing bbn partial cystectomy performed end week resected bladder sutured dexon silk difference incidence papillary nodular pn hyperplasia control partial cystectomy groups however incidence cancer group given partial cystectomy much higher control cancers control group grade superficial tumors whereas grade invasive tumor observed six animals partial cystectomy group labeling index cancer partial cystectomy group greater control group also significant difference number brdurd labeled cells pn hyperplasia control partial cystectomy groups findings indicate partial cystectomy enhances bbn initiated bladder carcinogenesis increase dna synthesis found pn hyperplasia cancer may associated induction bladder tumors,C12,0.0023275577,0.0020646597,0.015608337,0.0013077598,0.037045382,0.0030038345,0.16203147,0.03598908,0.0016827206,0.0022869622,0.035490807,0.16785727,0.07245415,0.0611403,0.0020467956,0.03742283,0.04448953,0.0023969985,0.0026502667,0.058655053,0.24880879,0.00082643115,0.0024129993
confronting cisternae presenting intracytoplasmic inclusions monocytes small gray blue intracytoplasmic inclusions noted peripheral monocytes neutrophils patient renal failure ultrastructural analysis revealed confronting cisternae within cytoplasm authors submit case report introduce previously undescribed morphologic feature leukocytes may mistaken light microscopic level dohle bodies inclusions,C12,0.0053309496,0.030536084,0.009946998,0.002995243,0.0074734213,0.006879868,0.24208169,0.030813916,0.02964455,0.005237971,0.05009374,0.010964744,0.033826016,0.0122575,0.030032914,0.008301397,0.12468575,0.08780268,0.00607007,0.039161175,0.21845093,0.0018928264,0.005519573
overlooked retained double j stent series patients long overlooked retained ureteral stents presented illustrate variable unpredictable times hazardous course patients cases cited emphasize need careful documentation observation follow patients stents placed,C12,0.0063080485,0.0055955537,0.011770164,0.0035442351,0.008783758,0.008140865,0.25996795,0.0059321653,0.0045604385,0.006198028,0.06972067,0.01297445,0.04000881,0.04501549,0.0055471384,0.009822943,0.28438434,0.006496244,0.007182641,0.076628126,0.112688705,0.0022397588,0.006489488
angiotensin thromboxane enhanced renal adrenergic nerve sensitivity acute renal failure roles intrarenal angiotensin thromboxane tx vascular hypersensitivity renal nerve stimulation rns paradoxical vasoconstriction renal perfusion pressure rpp reduction autoregulatory range wk norepinephrine ne induced acute renal failure arf rats investigated renal blood flow rbf responses determined intrarenal infusion aii txa antagonist saralasin sq alone partially corrected slopes rbf rns rpp reduction ne arf rats p less saralasin sq normalized rbf response rns combined saralasin sq eliminated vasoconstriction rpp reduction similar effect renal denervation appropriate vasodilatation restored renal vein norepinephrine efflux rns disproportionately increased ne arf p less suppressed saralasin sq infusion p less concluded enhanced sensitivity rns paradoxical vasoconstriction rpp reduction wk ne arf kidneys result intrarenal tx aii acceleration neurotransmitter release adrenergic nerve activity,C12,0.016579311,0.03001078,0.032787766,0.0015953743,0.003953852,0.0036644654,0.0784532,0.020183917,0.0020528,0.002789932,0.013058584,0.0059007816,0.2203177,0.0066279187,0.01621926,0.018275358,0.032798063,0.016664425,0.003233138,0.018333526,0.4525705,0.0010081875,0.0029211272
ethical legal issues geriatric nephrology ethical legal issues affecting geriatric nephrology conditioned individuals status elderly sick people distinctive characteristics kidney disease failure key ethical issues obligation respect persons particular recognizing competent persons autonomy medical choice affording due protection dependent vulnerable individuals beneficence good acting justice treating like cases alike avoiding unjust discrimination law reinforces ethical obligations legal concepts informed consent duty maintain appropriate confidentiality special applications concerning medication management elderly additional legal issues concern advanced care directives terminal care decisions,C12,0.003350286,0.019163439,0.00624258,0.0018797674,0.020806735,0.020499773,0.3003485,0.0031462617,0.0024187344,0.003287268,0.030794317,0.006881301,0.023336329,0.0076926136,0.0029420538,0.03760013,0.04484481,0.0034640334,0.14957179,0.2308052,0.043949816,0.017364845,0.019609382
determination norepinephrine levels adult human prostate tissue levels norepinephrine measured prostate tissue men ranging age years prostatic tissue obtained men subtle palpable prostate nodules undergoing transperineal needle biopsy none patients shown histologic evidence adenocarcinoma severity symptoms prostatism evaluated prospectively using standardized micturition symptom score questionnaire norepinephrine levels quantified using sensitive radioenzymatic assay rea overall prostates contained relatively high levels norepinephrine ng gm inverse correlations observed tissue norepinephrine levels severity symptoms prostatism r p age r p prostate size r p norepinephrine levels also measured tissue specimens obtained men undergoing enucleation prostatectomy transurethral resection prostate turp level norepinephrine prostatectomy specimens ng gm level prostate biopsy specimens relatively low level norepinephrine specimens obtained patients symptoms necessitating prostatectomy provides evidence norepinephrine levels inversely related degree symptomatic bladder outlet obstruction,C12,0.0023019144,0.0020419129,0.026185507,0.0012933518,0.0032303173,0.0029707404,0.15777504,0.002164748,0.0016641816,0.037294224,0.1343744,0.0131265875,0.060584042,0.02752165,0.0020242454,0.014710987,0.112368986,0.024642112,0.0026210682,0.102918394,0.2649616,0.00081732613,0.0024066889
pathophysiology prolonged penile erection associated trazodone use treatment antidepressant trazodone associated occurrence prolonged penile erection priapism evaluate effect trazodone erection monitored periodic physiological sleep related erections healthy volunteers double blind crossover study comparing effect trazodone trimipramine tricyclic antidepressant placebo addition determine effects trazodone neurovascular control penile smooth muscle performed vitro studies corpus cavernosum tissue obtained patients undergoing penile prosthesis implantation trazodone significantly increased total interval nocturnal erectile activity trimipramine effect high dose treatment nights average duration erectile activity per night placebo minutes mean standard deviation night minutes night trazodone treatment erectile activity per night significantly prolonged minutes night night p less analysis erectile activity relation rapid eye movement sleep period erectile activity usually occurs revealed detumescence phase erection sympathetic control significantly prolonged average times trazodone compared placebo p less vitro trazodone concentrations comparable reached plasma significantly impaired corporeal smooth muscle contractions elicited electrical stimulation adrenergic nerves antagonized contractions induced exogenous norepinephrine conclude trazodone enhance penile erection man propose mechanism related alpha adrenoceptor blocking properties trazodone interference sympathetic control penile detumescence,C12,0.0019911851,0.0017662806,0.033520736,0.0011187658,0.0027855798,0.0025697283,0.15123855,0.0018725347,0.0014395383,0.0019564563,0.011515761,0.023947408,0.16702268,0.004865806,0.0017510259,0.012736825,0.11072519,0.012024311,0.040824298,0.063275754,0.34828922,0.0007069975,0.0020553588
reverse antibody capture enzyme linked immunosorbent assay detection antisperm antibodies sera genital tract secretions reverse antibody capture enzyme linked immunosorbent assay elisa detection antisperm antibodies developed assay enables detection immunoglobulin ig igg iga igm igg iga antisperm antibodies serum cervical mucus seminal plasma samples reverse elisa specific sensitive conventional elisa detecting human antisperm antibodies different isotypes using assay statistically significant differences levels antibodies infertile fertile individuals demonstrated sera genital tract secretions studies infertile couples revealed presence antibodies sera necessarily reflected individual genital tract secretion vice versa data emphasize importance detecting antisperm antibodies sera well genital tract secretions correct evaluation sperm immunity,C12,0.00283956,0.0025188313,0.012055166,0.0015954329,0.01819894,0.0036646,0.27125278,0.0026703565,0.0020528755,0.0027900343,0.10918675,0.006881266,0.026259279,0.21445034,0.016239122,0.07314831,0.04677372,0.0029277126,0.0032332567,0.0246157,0.10756814,0.0010082246,0.04806956
cancer urinary bladder blacks whites case control study racial differences risk cancer urinary bladder associated cigarette smoking alcohol consumption examined study cases whites blacks controls matched sex race age cases significant increases cancer risk associated cigarette smoking observed whites blacks however dose response patterns appeared differ race whites statistically significant elevations threefold higher observed odds ratios smoking levels pack years whereas blacks corresponding point estimates increase significantly greater pack years smoking although risk patterns compatible higher incidence bladder cancer white men sample blacks small tests significance suggestive higher risks whites specific amounts smoking p less effects alcohol consumption inconsistent detectable synergism smoking drinking additional study race specific risk factors tobacco metabolism needed determine true nature apparent racial differences risk urinary bladder cancer associated cigarette smoking,C12,0.0020709103,0.0018370008,0.05398382,0.0011635601,0.002888048,0.0026726176,0.14858022,0.0019475091,0.07167088,0.002034791,0.08705504,0.07155765,0.07850014,0.0053932373,0.0018244764,0.003224838,0.022778109,0.0021548613,0.002358036,0.25850073,0.1749334,0.000735305,0.0021348288
time course alterations bladder function following acetone induced cystitis although chemical cystitis known clinically cause decreased bladder function experimental studies progression recovery chemical cystitis mature male rabbits underwent intravesical instillation acetone solution urethral catheter micturition profiles showed marked decrease mean maximal micturition volume increase number micturitions early one day treatment micturition profile gradually normalized four eight weeks instillation vivo cystometry showed small bladder capacity low compliance first week following instillation gradually recovered control levels four weeks functional studies using vitro whole bladder model showed significant decrease ability bladder generate pressure empty three days instillation parameters recovered partially two weeks completely four weeks chemical cystitis induced intravesical acetone instillation resulted severe decrease bladder function e contracted bladder low compliance poor ability generate pressure empty however changes reversible within two month period study,C12,0.0021376282,0.022564957,0.014323235,0.0011996984,0.0029732396,0.033750992,0.1561694,0.0020079957,0.01187635,0.0020979885,0.021802982,0.035584584,0.0843159,0.005366709,0.022513555,0.01391338,0.09746622,0.0022232109,0.002431273,0.03343857,0.42888466,0.0007581425,0.0021993357
flow cytometry carcinoma prostate flow cytometry quantitative cytologic technique demonstrated utility assessment prostate cancer well tumors authors summarize current data use disease detection diagnosis prognostic evaluation monitoring response therapy also project future developments,C12,0.0057779797,0.0051253564,0.010884714,0.0032464112,0.06410121,0.0074567837,0.34048057,0.005433682,0.004177222,0.0056772046,0.13942449,0.0118842,0.036630012,0.013323265,0.033046585,0.036967084,0.08126001,0.005950361,0.034538858,0.03772272,0.1088956,0.0020515507,0.0059441724
endourological experience cystine calculi treatment algorithm may january patients pyeloureteral units documented symptomatic cystine stones treated stone size ranged mm largest diameter average mm pyeloureteral units treated initially endourological methods including ureteroscopy percutaneous ultrasonic lithotripsy extracorporeal shock wave lithotripsy eswl chemolysis patients required combination technologies required open operation units free stones patient discharged hospital patients retained stones fragments greater mm diameter based experience algorithm developed urological management cystine stones ureteral calculi may removed ureteroscopic techniques manipulated renal pelvis managed renal stones cystine renal calculi less cm may treated eswl monotherapy stones cm may treated eswl dissolution percutaneous ultrasonic lithotripsy plus dissolution staghorn calculi may treated percutaneous ultrasonic lithotripsy plus eswl dissolution retained fragments,C12,0.04596257,0.016949823,0.04853423,0.0016640043,0.004164461,0.0038221038,0.24062924,0.0027851278,0.0021411076,0.0029099495,0.03446725,0.0060914527,0.06728186,0.0068096416,0.0026043595,0.004611833,0.3184712,0.0030499608,0.0033722215,0.020210039,0.15936923,0.0010515578,0.0030467887
serum levels sex hormone binding globulin oestradiol patients testicular cancer serum testosterone oestradiol e sex hormone binding globulin shbg measured orchiectomised testicular cancer patients treatment months therapy patients divided groups according treatment group cisplatin based chemotherapy patients group abdominal radiotherapy patients group antiproliferative treatment chemotherapy radiotherapy patients months antiproliferative treatment particularly chemotherapy reversible significant increase e shbg observed patients without antiproliferative treatment showed significant changes comparable hormone levels normal values associated elevated levels shbg e although aetiology hormonal changes remains unknown may related clinical symptoms hypogonadism displayed patients undergoing treatment testicular cancer,C12,0.003004543,0.0026651795,0.020124953,0.0016881302,0.004183731,0.0038775194,0.2466988,0.017359937,0.0021721509,0.002961478,0.014683187,0.12254436,0.09501525,0.007027359,0.0026421193,0.0046786983,0.21085687,0.0031160195,0.0034211143,0.022018082,0.20510276,0.001066804,0.003090963
prostatic carcinoma histological immunohistological factors affecting prognosis neuro endocrine paracrine cells human prostate urethra identified various methods predominantly silver stains immunocytochemistry incidence neuro endocrine differentiation prostatic carcinoma varied considerably studied previously independent factor affecting prognosis nucleolar organiser regions nors loops ribosomal rna occurring nucleoli cells ultimately process rna genes nors demonstrated silver ag staining techniques studied numerous malignant tumours pilot study laboratory shown distinct significant difference agnor staining prostatic carcinoma benign prostatic epithelial hyperplasia retrospective study performed least years follow confirmed presence neuro endocrine cells half patients investigation significant correlation survival absence neuro endocrine cells demonstrated agnor staining shown prognostic value,C12,0.0026570843,0.0023569663,0.0049578436,0.016560264,0.0037006417,0.0034291057,0.24123819,0.028219266,0.0019209536,0.0026107414,0.05961112,0.005513515,0.07073907,0.10121971,0.028047038,0.017100831,0.09031983,0.0027871428,0.0030254812,0.08330604,0.16392669,0.0009434341,0.06580902
chronic nightly tidal peritoneal dialysis nightly tidal peritoneal dialysis ntpd technique initial fill peritoneal cavity portion dialysate rapidly cycled five anuric stable pd patients entered month study determine ntpd session length necessary clinically adequate dialysis creatinine clearance similar four daily l capd exchanges ntpd performed using modified pac x cycler drain phase regulated target volume one patient completed months study one months three months one patient continued ntpd months mean ntpd session time hr min range hr min hr min end months patients clinically adequate dialysis three patients preferred ntpd capd particularly empty abdomen daytime one patient required increase ntpd time addition one daytime exchange low creatinine clearance conclusion ntpd provides weekly creatinine clearances comparable capd acceptable duration nightly dialysis sessions anuric patients new pd machine providing inexpensive dialysis solution large quantities well safe false alarm free dialysis sessions needed practical ntpd implementation,C12,0.0023546084,0.002088655,0.015780317,0.0013229584,0.003279432,0.07142238,0.21570693,0.0022143023,0.001702277,0.002313541,0.027915804,0.016326595,0.10948017,0.0054339743,0.0020705832,0.015697997,0.30179724,0.025162512,0.002681068,0.018987821,0.13022129,0.0008360359,0.025203494
treatment renal calculi elderly management renal calculi geriatric patient population poses unique problems include anesthetic risks underlying medical disease general risk benefit concerns variety relatively noninvasive procedures available including extracorporeal shock wave lithotripsy eswl percutaneous nephrostolithotomy pcnl practical management plan presented based primarily stone size takes consideration problems unique elderly patient,C12,0.0043260753,0.024778103,0.008072008,0.0024306453,0.006185957,0.005583026,0.40964392,0.0040682936,0.00312756,0.025189914,0.04425716,0.008897911,0.0267792,0.009946983,0.0038042418,0.0067365994,0.11517495,0.0044551403,0.004925873,0.17719685,0.09843308,0.0015360322,0.004450507
role ifosfamide plus cisplatin based chemotherapy salvage therapy patients refractory germ cell tumors prospective study four cycles etoposide ifosfamide cisplatin vip chemotherapy conducted germ cell tumor gct patients refractory cisplatin etoposide vinblastine based therapy forty patients evaluable response ten patients complete response seven chemotherapy alone additional three patients surgical resection viable gct median follow months four complete responders relapsed six patients remain remission hematologic nephrotoxicity moderately severe durable complete responses vip second salvage achieved suggests ifosfamide adds efficacy standard first salvage therapy observed nephrotoxicity myelotoxicity considerations design ifosfamide cisplatin based regimens hematopoietic growth factors may useful ameliorating myelotoxicity early use ifosfamide based chemotherapy may reduce nephrotoxicity exacerbated prior cisplatin trial vip first salvage relapse complete response platinum based induction therapy warranted modest proportion patients achieve durable remission vip second salvage emphasizes need efficacious salvage therapy patients achieve durable complete response,C12,0.002310929,0.002041644,0.048646636,0.0012931814,0.02548962,0.014308404,0.3040923,0.002164463,0.0016639625,0.0022614682,0.01275721,0.004734302,0.014672342,0.05973988,0.0020239789,0.014719764,0.2918201,0.002370278,0.013761582,0.019715447,0.15622748,0.0008172185,0.0023678127
immunotherapy murine bladder cancer irradiated tumor vaccine investigation explored efficacy irradiated autologous mouse bladder tumor ir mbt active specific immunotherapeutic agent adjuvant therapy bacillus calmette guerin bcg subcutaneously transplanted murine bladder tumor tumor incidence significantly reduced groups receiving bcg p less ir mbt bcg p less compared control survival significantly improved groups treated bcg p less ir mbt bcg p less ir mbt bcg p less compared control surprisingly ir mbt consistently reduced efficacy bcg alone ir mbt alone appeared enhance tumor growth autologous irradiated bladder tumor vaccine alone combination bcg displayed immunotherapeutic advantage use irradiated tumor cell vaccine bladder cancer therapy may reduce results achievable bcg alone,C12,0.0030077512,0.0026652464,0.034696262,0.0016881726,0.106006645,0.0038776165,0.24746414,0.0028255796,0.0021722054,0.002952214,0.013818119,0.07964323,0.18270075,0.08929107,0.0026421857,0.0046788156,0.069493786,0.0030942587,0.0034212,0.038322497,0.10137898,0.0010668308,0.0030924804
nephrotoxicity associated concomitant ace inhibitor nsaid therapy angiotensin converting enzyme ace inhibitors nonsteroidal anti inflammatory drugs nsaids nephrotoxic may synergistically compromise renal function computer assisted study done asses prevalence compromised renal function clinical importance drug interaction search records patients seen university nebraska medical center internal medicine clinic conducted identify cases involving renal insufficiency therapy ace inhibitors therapy nsaids records cases meeting criteria reviewed clinical correlation revealed patients treated nsaids ace inhibitors nephrotoxicity found conjunction monotherapy three cases reversible renal failure found conjunction combination therapy significant nephrotoxicity concomitant use ace inhibitors nsaids uncommon attention drawn potentially important interaction,C12,0.0029620049,0.01696596,0.0055267937,0.0016642297,0.0041435794,0.0038226214,0.3908618,0.017114453,0.0021413977,0.0029103437,0.0889699,0.006092278,0.04853405,0.0072925882,0.01693959,0.0046124575,0.09143442,0.0030530372,0.003372678,0.054085627,0.22340126,0.0010517003,0.0030472013
long term urinary continence renal function neonates posterior urethral valves posterior urethral valves known associated considerable morbidity mortality especially neonate recently role bladder dysfunction pathophysiology renal function impairment urinary incontinence valve ablation questioned treated male newborns posterior urethral valves institution initial treatment cases consisted bladder drainage urethral catheter correction existing fluid electrolyte abnormalities subsequent treatment dictated degree upper tract abnormalities included valve ablation alone patients vesicostomy later valve ablation valve ablation later upper tract reconstruction cutaneous ureterostomy followup ranges years mean long term renal functional impairment related serum creatinine age year serum creatinine mg patients normal values long term followup greater mg patients normal values followup urinary continence assessed patients normal etiology incontinence remaining patients bladder dysfunction sphincter incompetence patients urinary incontinence also high incidence upper tract abnormalities compared continent valve patients,C12,0.032145884,0.0018370686,0.023996225,0.0011636029,0.0028837833,0.0026727163,0.19209054,0.0019483081,0.0014972312,0.01204837,0.061353166,0.004259624,0.11178156,0.004911217,0.0018211735,0.003224957,0.25126025,0.002134943,0.01237399,0.12367231,0.14805552,0.00073533214,0.002132248
placebo response subfertile couples attending tertiary referral centre objective study determine whether placebo response clinic attendance couples prolonged greater years subfertility years subfertility observed treatment independent cumulative conception rate independent length subfertility twenty seven women conceived years subfertility conceived greater years subfertility fecundity latter group significantly greater women years subfertility similar normal subjects stopped contraception study demonstrates subgroup apparently normal women greater years subfertility responded positively clinic attendance independent investigation therapy,C12,0.0035162752,0.0031191115,0.006561005,0.0019756516,0.0048970417,0.0045379363,0.14068584,0.0033067479,0.019492041,0.003454947,0.020360343,0.03856775,0.10096989,0.008486058,0.0030921237,0.0054873303,0.064209506,0.0036249976,0.03804864,0.31187966,0.20886122,0.0012485016,0.0036174143
glance urodynamic database three hundred sixty four patients urinary incontinence presenting complaint evaluated urogynecology laboratory department obstetrics gynecology university rochester rochester new york found genuine stress urinary incontinence gsi subset demonstrably incontinent patients characterized symptoms stress urge incontinence incidence nulliparity occurrence incontinence intercourse influence weight bladder pressure using clusters symptoms accurately distinguish gsi types urinary incontinence four percent gsi patients nulliparous reasonable explanation incontinence anatomic relaxation twenty three percent sexually active gsi patients acknowledged incontinence intercourse none anatomic urodynamic parameters evaluated distinguished group gsi counterparts lose urine intercourse increasing weight expressed body mass index correlated increase vesical pressure supine standing positions,C12,0.003190724,0.0028303314,0.00595356,0.001792868,0.019884104,0.050449174,0.19482984,0.0030005954,0.0023067514,0.0031628206,0.042354677,0.037451252,0.08935795,0.024044862,0.04914147,0.020398967,0.18096218,0.034138445,0.0036331087,0.10481709,0.12180363,0.0011329101,0.0033627201
one year rhuepo therapy prolongs rbc survival may stabilize rbc membranes despite natural progression chronic renal failure uremia need dialysis rhuepo administered eight patients chronic renal failure crf uremia u year creatinine clearance gfr averaged ml min hct baseline rbc survival cr highly correlated gfr r p less average days repeat cr months gfr ml min hct prolonged days p less year remained increased days p less hct despite decreased gfr less ml min need dialysis reticulocytes varied weeks months year bone marrow cellularity increased months year e ratio decreased months year marrow iron decreased months year doses rhuepo reduced avoid polycythemia rhuepo stimulates erythropoiesis pts progressive crf u year initial increase hematocrit due early peak reticulocytes months rhuepo maintains increased hematocrit three mechanisms increased reticulocytosis trend increased bone marrow erythroid cellularity lengthened rbc survival year rhuepo therapy trend increased marrow cellularity persists however maintenance target hematocrit via lengthened rbc survival despite progression crf u rhuepo produced rbcs longer survival expected rbc membranes may stabilized rhuepo,C12,0.0018013306,0.03644954,0.020788005,0.009716736,0.0025068286,0.011032143,0.1194869,0.0016930022,0.00130152,0.054055523,0.008279273,0.012851018,0.16875681,0.004235689,0.010289495,0.0028135772,0.2586645,0.027996376,0.00204988,0.07121172,0.17152886,0.0006392129,0.0018520585
treating impotence urology sex therapy complementary urologists mental health professionals neither competitors adversaries principles sex therapy represent thoughtful sensitive way approach patients almost clinical problem comfortable recommended tests treatments sex therapy may helpful adjunct treating organic well primarily emotional erectile dysfunction believe information help build bridge urologists mental health professionals,C12,0.004616507,0.004095072,0.02983279,0.002593827,0.028736819,0.05028959,0.3855339,0.004341419,0.003337529,0.0045541227,0.061547577,0.009495272,0.037332132,0.010876583,0.0040596398,0.0071888613,0.15535372,0.0047542364,0.005387943,0.09733788,0.08234615,0.0016391538,0.004749292
strategies enhancing compliance dialysis elderly noncompliance must viewed symptom another problem problems treatment plans developed based individualized assessment patient physiologic functioning psychosocial situation must determined whether patient intentionally unintentionally complying staff must also aware impact compliance staff responsibility maximize individual efforts comply must realized ultimate decision responsibility rests patient,C12,0.0044189286,0.046702825,0.008245262,0.0024828156,0.006153218,0.0057028574,0.37390724,0.02554056,0.0031946886,0.004355176,0.02112105,0.009088892,0.055378933,0.0103180185,0.0038858943,0.028266018,0.14642812,0.025929213,0.045838904,0.072536506,0.09438987,0.001569001,0.004546031
protein differences normal oligospermic human sperm demonstrated two dimensional gel electrophoresis protein expression sperm obtained men normal semen analysis men oligospermia evaluated two dimensional gel electrophoresis proteins solubilized urea nonidet p lkb bromma sweden lysis buffer underwent second dimension separation polyacrylamide gradient gels set invariant proteins identified normospermic samples whereas evaluable oligospermic samples lacked invariant proteins proteins absent oligospermic samples may critical normal sperm function may serve markers infertility,C12,0.0037731673,0.0033469878,0.02529875,0.002119989,0.0052548707,0.041335996,0.19591382,0.0035483323,0.039242968,0.0037073586,0.12160169,0.027088586,0.05218727,0.011487096,0.003318028,0.005875606,0.055180285,0.12234937,0.004350955,0.11306591,0.12259459,0.0013397146,0.036018655
extracorporeal shock wave lithotripsy patients bleeding diatheses five patients known bleeding diatheses treated extracorporeal shock wave lithotripsy specific therapy administered extracorporeal shock wave lithotripsy reverse bleeding disorder treatment patient monitored serial hemoglobin determinations renal ultrasonography course lithotripsy uneventful patients conclude extracorporeal shock wave lithotripsy viable option patients significant bleeding diatheses provided specific therapy reverse coagulopathic condition available used treatment,C12,0.004152394,0.023783196,0.007794839,0.0023330606,0.0057820766,0.0053588804,0.38029465,0.0039049613,0.0030019959,0.0040799705,0.062890716,0.008874672,0.030531676,0.010426631,0.0036515102,0.0064661405,0.17873925,0.004276277,0.004728111,0.048457213,0.13157521,0.021550046,0.047346517
spontaneous resolution congenital nephrotic syndrome neonate infant congenital nephrotic syndrome recovered spontaneously completely age days remained well age year reinforces view reversible congenital nephrotic syndrome occur single disease universally dismal prognosis,C12,0.005620885,0.004986006,0.010487989,0.0031581463,0.08945327,0.0072540455,0.18783993,0.032489937,0.00406365,0.00552285,0.040076386,0.011561087,0.034924053,0.0129241515,0.031998713,0.008752887,0.103020504,0.0059285723,0.0064002047,0.2543848,0.13133775,0.0019957721,0.005818452
transrectal sonographic cystourethrography studies stress urinary incontinence transrectal ultrasonic sagittal transducer excellent modality image bladder urethra dynamic change female patients found also helpful diagnosis urinary stress incontinence posterior urethrovesical puv angle measured transrectal sonoprobe strain non strain conditions compared results sonographic cystourethrogram radiographic chain cystourethrogram sonographic cystourethrography superior radiography former may estimate puv angle accurately differentiate patients without stress urinary incontinence furthermore also use transrectal sagittal probe intraoperatively adjust suspension force well puv angle patients underwent vesical neck suspension stress urinary incontinence sui,C12,0.039575208,0.0032869393,0.060711898,0.002081954,0.06654095,0.004782106,0.20788799,0.021416735,0.020611508,0.0036408447,0.09199372,0.0077858972,0.060632996,0.0086333165,0.057073895,0.0059314184,0.14416127,0.0038160225,0.0042192256,0.095119335,0.06704037,0.0013156787,0.021740757
pooled sequential ejaculates way increase total number motile sperm oligozoospermic men investigated yield total number motile spermatozoa oligozoospermic men pooling two closely spaced sequential ejaculates semen characteristics compared sequential ejaculates within period hours oligozoospermic males sperm concentration less x ml total sperm count less x ejaculate control group normozoospermic men whereas median total number motile sperm normozoospermic males significantly decreased x first ejaculate x second sequential ejaculate decrease detected oligozoospermic males x x respectively percent normozoospermic oligozoospermic men demonstrated decreased less comparable increased greater total motile sperm count second ejaculate comparison first ejaculate versus respectively consequently pooling two sequential ejaculates significantly increased median total number motile sperm normozoospermic males oligozoospermic males x suggest pooling two sequential ejaculates oligozoospermic males simple cost effective method increase significantly total number motile sperm intrauterine insemination vitro fertilization gamete intrafallopian transfer semen cryopreservation,C12,0.002203664,0.00195476,0.0041118083,0.0012381489,0.0030687805,0.0028439432,0.14413808,0.0020750305,0.0015931509,0.0021652293,0.052148946,0.015540863,0.1924947,0.0058419365,0.0019380401,0.003431563,0.08322617,0.0022694084,0.013140501,0.22811362,0.23340824,0.000782441,0.002270981
effect calcium entry blocker nitrendipine renal function renal vascular occlusion ability ca entry blocker nitrendipine improve postischemic renal function studied nine groups n rats anesthesia nitrendipine administered min femoral vein dose administered depended group group n control received nacl group n mg kg group n mg kg group n mg kg group n mg kg group n mg kg group n mg kg group n mg kg group n mg kg administration nitrendipine kidneys rendered ischemic one hour cross clamping renal vessels comparison h creatinine clearances h reversal ischemia demonstrated nitrendipine capable providing degree protection renal ischemia protective effect dose dependent p less,C12,0.01680901,0.0025540483,0.0053776787,0.0016177393,0.0040096114,0.0037158364,0.10514052,0.022083933,0.016017143,0.0028290432,0.013393017,0.18462808,0.07499166,0.03449079,0.0025319494,0.01887654,0.04236287,0.0029651616,0.0032784622,0.04882861,0.37560278,0.0010223209,0.016873185
anti alpha reductase autoantibodies serum patients prostatic cancer human sera tested ability inhibit alpha reductase binding potent inhibitor enzyme thirty one serum samples patients diagnosed suspected prostatic cancer significant inhibitory activity whereas serum samples patients inactive majority inhibitory activity igg fraction purified chromatography protein sepharose affinity column anti human igg agarose column igg fractions non inhibitory sera inactive inhibitory igg also inhibited enzymatic activity microsomal alpha reductase liver ventral prostate preputial gland rat liver prostate facial skin human inhibitory igg effect nadh menadione reductase beta hydroxysteroid dehydrogenase results suggest alpha reductase autoantibodies present blood prostatic cancer patients,C12,0.002763647,0.0024514927,0.018482376,0.0015527804,0.017226247,0.0035666302,0.10657857,0.01596635,0.0019979936,0.0027154454,0.065591484,0.04582133,0.03306066,0.095470786,0.0024394754,0.108356826,0.07929423,0.042981192,0.0031468184,0.034814112,0.29623055,0.0009812706,0.018509679
stress incontinence low urethral closure pressure correlation preoperative urethral hypermobility successful suburethral sling procedures forty eight women genuine stress incontinence low urethral closure pressure treated suburethral sling procedure using polytetrafluoroethylene patients underwent preoperative clinical evaluation multichannel urodynamic testing clinical examination included q tip test determine presence absence urethral hypermobility urethral hypermobility defined maximal angle change greater equal degrees horizontal measured straining coughing lithotomy position thirty four patients underwent repeat multichannel urodynamic testing three months postoperatively determine objective surgical success ninety three percent patients positive preoperative q tip test cured patients negative preoperative q tip test cured preoperative urethral hypermobility good prognostic indicator operative success suburethral sling procedure used treat genuine stress incontinence low urethral closure pressure,C12,0.0026914978,0.002387493,0.0050264746,0.027570643,0.04282782,0.003473518,0.12376516,0.002531117,0.014971566,0.0026445547,0.12810361,0.0055358964,0.16072465,0.006209149,0.0153898,0.0041912217,0.3551139,0.0027717964,0.0030646662,0.035591662,0.038661715,0.0139832245,0.0027689137
familial testicular cancer five members cancer prone kindred family siblings four brothers developed testicular neoplasms one embryonal cell carcinoma three testicular seminomas first cousin removed mother side family fourth degree relative developed embryonal carcinoma treatment alive well mother dizygous twin one ten siblings multiple cancers diagnosed among siblings offspring including breast carcinoma age years monozygous twin nieces associated urogenital abnormalities concordance age discordance pathology five males testicular cancer discussed identification reporting risk factor encouraged,C12,0.0039917943,0.022862975,0.02728839,0.0022428264,0.005558447,0.0051516183,0.24803391,0.0037539315,0.0028858895,0.0039221724,0.06427428,0.08551028,0.03920845,0.09465789,0.003510283,0.006216054,0.0385897,0.0041108862,0.023858923,0.25482735,0.05401998,0.0014173411,0.0041066105
transrectal ultrasonography early detection staging prostate cancer relatively recent changes improvements equipment vastly increased image resolution transrectal ultrasonography prostate expanded use transrectal ultrasonography greatly furthered knowledge prostate zonal anatomy permitted clinical evaluation internal prostate architecture technique operator dependent quality results related directly person knowledge experience significant majority prostate cancers originate peripheral zone palpable stage b nodules characteristically hypoechoic appearance disagreement tumor characteristics cause hypoechogenicity large tumors may obscure normal prostate anatomy appear isoechoic lack contrast surrounding prostate tissue transition zone prostate origin benign prostatic hyperplasia almost per cent prostate cancers tumors probably correspond stage lesions transrectal ultrasonography less accurate identifying transition zone tumors mixed echogenicity transition zone interference prostatic calculi calcified corpora amylacea poorer image resolution area studies evaluating use transrectal ultrasonography early detection prostate cancer generally shown twofold increase detection rate compared digital rectal examination however decreased morbidity expense transrectal prostate biopsy using automatic gun device increased frequency biopsy ultrasound examined patients compared historically evaluated digital rectal examination increased detection rate may part function increased use biopsies independent factors transrectal ultrasonography rarely detects cancer patient normal digital rectal examination normal serum prostate specific antigen level transrectal ultrasonography may capable identifying early capsular penetration seminal vesicle invasion patients known prostate cancer however superiority digital rectal examination purpose demonstrated unequivocally ultrasonography allow directed biopsies seminal vesicles suspect areas may helpful staging disease use transrectal ultrasonography prostate cancer evolved rapidly changes technology antiquate reports within years abstract truncated words,C12,0.0013437166,0.020694213,0.061042808,0.0007549796,0.073537685,0.00822532,0.24556625,0.014268392,0.0009714473,0.01432299,0.10964606,0.022277921,0.054922853,0.013909546,0.020686993,0.002094513,0.08759329,0.0013849392,0.0015537444,0.08172236,0.16161866,0.00047710497,0.0013841481
bidirectional incompatibility conspecific populations drosophila simulans cytoplasmic incompatibility ci describes phenomenon whereby eggs fertilized sperm insects infected rickettsial endosymbiont fail hatch unidirectional ci conspecific populations insects well documented phenomenon bidirectional ci however described mosquito populations recently closely related species parasitic wasps interest unusual form reproductive isolation potential means insect population suppression report first known example bidirectional ci conspecific populations drosophila simulans show defects early first cleavage division associated ci observation suggests cellular basis ci involves disruption processes zygote formation ci arises defects structure function sperm fertilization,C12,0.0034578252,0.019793097,0.023180656,0.0019428108,0.054932944,0.0044625034,0.34196216,0.003287732,0.0024998535,0.0033975162,0.04087061,0.0071120854,0.02825023,0.009851198,0.019758834,0.022103028,0.13084173,0.0035609866,0.020657506,0.152639,0.08328968,0.001227748,0.020920249
treatment desmopressin severe nocturnal enuresis childhood series patients severe nocturnal enuresis treated desmopressin randomised double blind cross study treatment micrograms highly effective compared placebo difference dry nights found dosages desmopressin proved safe effective treatment,C12,0.005799275,0.0051261266,0.010782731,0.0032485873,0.008046863,0.06338949,0.33705592,0.0054344987,0.0041778497,0.0056780577,0.06422969,0.0121300975,0.10541308,0.013395018,0.0050817733,0.008998868,0.09999255,0.005951255,0.06252972,0.04392998,0.121560685,0.002051859,0.0059960694
current options management clinical stage c prostatic carcinoma evaluation clinical stage c prostatic cancer enhanced advances staging modalities past years better staging local lesion possible transrectal ultrasound guided multiple biopsies prostate vicinity biopsies suspect pelvic lymph nodes guided ct lymphangiography may obviate pelvic lymphadenectomy particularly patients high grade stage c lesions advances understanding serum markers supplemented staging information single therapeutic modality appropriate cases clinical stage c cancer c lesions radical prostatectomy adjunctive radiation hormonal therapy seems produce best year survival rates external beam radiation alone combination interstitial radiation may equivalent success clinical stage c disease external beam radiotherapy seems present best therapeutic modality interstitial radiation sole method management stage c disease carries high local recurrence rate significant risk metastatic progression transurethral prostatectomy hormonal treatment continue place management selected poor risk patients current results surgery radiation therapy alone less ideal recommended aggressive combination treatment compared monotherapy randomized clinical trials monitored jointly radiation urologic oncologists,C12,0.001991142,0.0017662423,0.023307804,0.0011187415,0.042716604,0.0025696724,0.3270016,0.0018724941,0.001439507,0.001956414,0.094434015,0.03952853,0.055557612,0.0046409047,0.00175096,0.03355814,0.176119,0.0020505462,0.015026331,0.09395581,0.074880295,0.0007069822,0.0020506245
sterile versus non sterile dialysis fluid chronic hemodialysis treatment quality water dialysis fluid varies considerably view fact endotoxin active derivatives cause acute side effects patients dialysis fluid must sterile therefore introduced ultrafiltration dialysis fluid entering dialyzer fifteen patients ten women five men treated weeks nonsterile sterile dialysis fluid bacterial loading dialysis fluid hemodialysis x ml hemodialysis x ml endotoxin concentration high varied less eu ml greater eu ml hemodialysis ultrafiltration dialysis fluid polyamide hollow fiber membrane samples free bacteria concentration endotoxin lower detectable limit less less eu ml ultrafiltration dialysis fluid obtain sterile dialysate endotoxin free interleukin tumor necrosis factor patients ultrafiltration significantly lower without ultrafiltration,C12,0.0028396638,0.0025189235,0.01904364,0.0015954913,0.003954142,0.003664734,0.19493388,0.016409691,0.0020529507,0.0027901365,0.03212333,0.019579943,0.28651267,0.0072638867,0.01621256,0.0045182197,0.08944649,0.0029303243,0.01807518,0.09018534,0.16567707,0.014750373,0.0029213415
burkitt lymphoma testicle report cases occurring elderly patients burkitt lymphoma rare patients older years almost never presents testicular tumor report cases primary burkitt lymphoma testicle men years old man extragonadal tumor rapid lasting response combination chemotherapy cases interest unusual presentation disease possibility control burkitt lymphoma older patients without undue toxicity management testicular lymphoma requires radical orchiectomy prophylactic irradiation contralateral testis chemotherapy indicated advanced disease may prevent relapses patients early disease role central nervous system prophylaxis controversial,C12,0.0031905165,0.033718623,0.005956503,0.001792621,0.036388088,0.004155974,0.3633916,0.018441806,0.0023066013,0.01854279,0.06036505,0.0066630533,0.023484241,0.022780327,0.0028056595,0.020392641,0.11066793,0.003285703,0.0036328724,0.10768564,0.13051508,0.0011328364,0.018703882
hyperfiltration induced renal injury normal man myth reality current knowledge fails support notion adaptive hyperfiltration remnant kidney donor nephrectomy deleterious rather maladaptive hyperfiltration appropriately compensates loss functional renal mass accordingly kidney donors expected maintain stable level renal function without proteinuria hypertension essential proper selection donors nephrectomy exclusion high risk potential donors bearing mind fact apparently healthy asymptomatic relatives end stage renal disease patients prone disease processes inflict general population higher risk underlying renal disease,C12,0.033059157,0.0027454204,0.06568336,0.016709486,0.004309691,0.00399426,0.20620002,0.0029105765,0.002237548,0.0030410204,0.031866793,0.0063658254,0.054532938,0.032538682,0.002721666,0.019800035,0.080497526,0.06398826,0.0035294457,0.14504918,0.21393615,0.0010989225,0.0031840228
urinary incontinence symptoms urinary incontinence distressing disruptive everyday life also indicative serious underlying disorders many methods symptom management available matching affected person effective appropriate treatment method significant challenge nursing pressing need develop test cogent conceptual model symptom management includes primary prevention,C12,0.004947728,0.052292857,0.009231946,0.0027799264,0.006889554,0.0063853003,0.41811353,0.004652903,0.003576987,0.0049077454,0.09455421,0.015272645,0.039233964,0.011399186,0.0044280286,0.055605534,0.04926007,0.0050953394,0.005633716,0.083935834,0.11495622,0.0017567584,0.00509004
magnetic resonance imaging cystic partially differentiated nephroblastoma magnetic resonance imaging mri appearance cystic partially differentiated nephroblastoma described together pathologic correlation difficulty reaching correct preoperative diagnosis even multimodal imaging techniques emphasized mri adjunct ultrasonography may superior computerized tomography ct scan evaluation child multiloculated cystic renal mass,C12,0.0049479376,0.0043890676,0.057126984,0.0027800442,0.1296794,0.0063855713,0.13110055,0.02859993,0.0035771388,0.1006562,0.15431505,0.03411723,0.036298275,0.0353034,0.0043510916,0.007704968,0.113963515,0.0050955554,0.005633955,0.03437866,0.09274841,0.0017568328,0.0050902558
modulation peritoneal macrophage antimicrobial activity peritoneal dialysis fluid ca oh capd patients previous vitro studies showed ca oh modulate peritoneal macrophage pm antimicrobial activity capd patients twenty four capd patients evaluated vivo never peritonitis overall peritonitis incidence one episode per patient months effects different peritoneal dialysis fluids pdf ca concentrations mmol l pm cytoplasmic ca concentration superoxide generation leukotriene b ltb release bacterial killing staphylococcus epidermidis parameters also evaluated adding oh microgram l pdf results showed direct correlation pdf ca concentration pm ca levels superoxide ltb generation bacterial killing mmol l ca values significantly higher seen mmol l addition oh potentiated ca induced effects hand pdf ca levels mmol l inhibition aforementioned parameters seen however effect reversed addition oh vivo results confirm importance ca oh pm antibacterial function capd patients may useful determining prophylaxis therapy peritonitis,C12,0.0020302867,0.0018009656,0.0037906251,0.0011407352,0.0028271098,0.041924514,0.18499692,0.021564608,0.0014678069,0.001994876,0.013818543,0.0041759615,0.08469334,0.119680725,0.011609531,0.0031615787,0.10196059,0.0021110387,0.021967102,0.03742849,0.3232236,0.00072088104,0.01191019
absence nephrotoxicity differential nephrotoxicity tobramycin gentamicin conducted prospective double blind randomized trial gentamicin tobramycin evaluate differences nephrotoxicity evaluated levels creatinine creatinine clearance beta microglobulin n acetyl beta glucosaminidase nag indicators nephrotoxicity attempted correlate forty patients met criteria evaluation given tobramycin remaining received gentamicin significant nephrotoxicity defined increase creatinine mg dl occur either group increases beta microglobulin values seen patients tobramycin group gentamicin group elevations nag levels occurred tobramycin group gentamicin group elevation nag beta microglobulin levels congruent cases conclude significant difference nephrotoxicity gentamicin tobramycin elevations nag beta microglobulin occurred rates similar reported literature correlate significant nephrotoxicity,C12,0.0030947481,0.0027603374,0.005774479,0.0017388127,0.019290008,0.033935197,0.16429545,0.0029103386,0.002237365,0.0030407717,0.054723054,0.10381802,0.1886185,0.0071157813,0.017696185,0.0048191664,0.11744473,0.0031870774,0.018500065,0.043586016,0.18215184,0.0010988326,0.018163167
use distal thiersch duplay urethroplasty proximal hypospadias repairs conjunction short island pedicle flap experience boys proximal hypospadias severe chordee foreshortened dorsal hooded foreskin presented use distal thiersch duplay tube incorporated addition island pedicle flap achieve correct meatal location glans one boy perineal hypospadias required proximal distal thiersch tube island flap interposition follow nine months years demonstrated excellent cosmetic functional results recurrent chordee urethral stenosis fistula noted developed proximal thiersch tube island flap anastomosis boy perineal hypospadias advantages aforementioned procedure include decreasing risk chordee basis foreshortened island pedicle flap use vascularized flaps completing procedure one stage satisfactory result,C12,0.0035913219,0.020478107,0.006675,0.0020099778,0.00498212,0.021919545,0.199044,0.0033642014,0.0025862788,0.055464346,0.07024181,0.0073579648,0.023190724,0.008225476,0.020439375,0.005570708,0.29442373,0.0036840972,0.004073361,0.08342026,0.15430714,0.0012701938,0.0036802655
intrauterine spermatic cord torsion newborn sonographic pathologic correlation five newborn patients spermatic cord torsion sonography demonstrated enlarged globular testis hydrocele skin thickening four patients testicular parenchyma heterogeneous peripheral hypoechoic areas seen two four patients two central hypoechoic region peripheral echogenic rim testis fifth patient diffusely hyperechoic duplex doppler sonography performed two patients failed demonstrate signal spermatic cord either abnormal contralateral hemiscrotum scintigraphic findings positive testicular torsion two patients equivocal three patients surgery performed days sonography established diagnosis spermatic cord torsion pathologic examination demonstrated hemorrhagic infarction entire testis well scattered calcifications authors conclude solid globular testicular mass seen neonatal period suggestive intrauterine spermatic cord torsion,C12,0.0034006455,0.0030165422,0.022803755,0.0019106839,0.037762303,0.00438871,0.16788375,0.003198008,0.0024585153,0.003341334,0.19082922,0.006994478,0.02393195,0.007939172,0.0029904419,0.0052955123,0.23034003,0.003502101,0.003872135,0.0560839,0.15798561,0.0012074456,0.05886373
adult minimal change glomerulopathy acute renal failure oliguric acute renal failure occurs adult patients minimal change glomerulopathy look clinical pathologic factors increase risk developing acute renal failure adults minimal change glomerulopathy serum creatinine greater mumol l mean mumol l range mumol l greater mg dl mean mg dl range mg dl compared adults minimal change glomerulopathy serum creatinine less mumol l mean mumol l range mumol l less mg dl mean mg dl range mg dl minimal change glomerulopathy patients acute renal failure older v years p less higher systolic blood pressure v mm hg p proteinuria v g h p arteriosclerosis renal biopsy specimen v scale p tubular epithelial simplification identical observed ischemic acute renal failure acute tubular necrosis observed patients serum creatinine greater mumol l greater mg dl less mumol l less mg dl patients renal failure follow data available recovery function mean creatinine mumol l mg dl time biopsy mumol l mg dl last follow sometimes weeks dialysis support,C12,0.001844001,0.06315309,0.020961255,0.009804188,0.002528763,0.0023500794,0.101574324,0.0017078158,0.0013129083,0.0017843553,0.008351715,0.012516621,0.22183459,0.004683716,0.07192636,0.0028347017,0.16782181,0.0018760718,0.0020678162,0.05922744,0.23732534,0.00064480596,0.0018682638
rationing health care end stage renal disease program potential impact rationing health care end stage renal disease esrd program considered possible implications recommendations emanating study conducted institute medicine national academy sciences also mentioned particular emphasis given potential consequences rationing health care elderly certain socioeconomic groups esrd,C12,0.0046160426,0.00409466,0.0086130565,0.002593566,0.0064276927,0.005957243,0.26038042,0.004340982,0.0033371933,0.0045355326,0.043819908,0.033871345,0.032393735,0.010901713,0.0040592314,0.007188138,0.1589782,0.004753758,0.16088483,0.065961346,0.16590358,0.001638989,0.0047488143
gastric mucosal pge levels gastric non ulcer ulcer patients chronic renal failure without renal diseases healthy subjects pge like immunoactivity mucosal specimens gastric corpus antrum measured individuals chronic uremia without renal diseases absence presence gastric ulcerations healthy subjects regardless group patients compared normal mucosa significant decrease pge like immunoactivity found mucosa atrophic superficial gastritis whenever patients control group patients renal diseases suffered ulcers pge like immunoactivity compared nonulcer subjects revealed decrease nonulcerated mucosa compared nonulcerated mucosa tissue ulcer rim patients gastric ulcer showed relative increase pge like immunoactivity eg pge like immunoactivity twice high tissue ulcer rim output pge like immunoactivity gastric juice subjects without renal diseases comparable found patients chronic uremia basal pentagastrin stimulated conditions therefore conclude gastric mucosal formation probably influenced chronic uremia,C12,0.002276363,0.013038367,0.015264898,0.0012789955,0.003176896,0.013943848,0.36343673,0.0021531228,0.0016457092,0.0022366603,0.021974081,0.027052538,0.14382398,0.005661707,0.0020017764,0.0036790867,0.08663605,0.002346591,0.013593536,0.04562457,0.2260044,0.0008082538,0.0023418383
screening prostatic carcinoma routine testing prostatic carcinoma digital rectal examination transrectal ultrasonography prostate specific antigen determination proposed reduce deaths earlier diagnosis questionable reliability results cost screening inability establish balance benefits treatment adverse effects quality life men screened make screening experimental controlled studies prove value,C12,0.004618016,0.004094534,0.008629861,0.002593486,0.0064274953,0.00595706,0.2530332,0.0043408484,0.0033370906,0.0045353933,0.28054205,0.009644484,0.04952799,0.038376976,0.004059106,0.007187917,0.04419225,0.004753612,0.0052558817,0.098403364,0.15409674,0.0016389386,0.004753662
mohan urethral valvotome new instrument electrothermic fulguration posterior urethral valves resectoscope difficult newborns especially small gestation date premature newborns small caliber urethra difficulty prompted innovation valvotome described outer diameter valvotome mm easily introduced without stretching urethra instrument used successfully patients date patient age ranged days years varying degrees hydronephrosis hydroureter patients good urinary stream regression hydronephrosis hydroureter,C12,0.026962258,0.02642371,0.031398967,0.0025938735,0.006428455,0.02829718,0.11935462,0.004341497,0.0033375889,0.004536071,0.1057973,0.009495443,0.039870754,0.010614966,0.0040597124,0.029522538,0.26623115,0.004754322,0.005256667,0.10558141,0.15875293,0.0016391834,0.0047493773
urodynamic tests female geriatric urinary incontinence urodynamic tests currently use evaluation female urinary incontinence applied community based sample determine specificity study random sample noninstitutionalized elderly self reported continent self reported incontinent women sixty years older participated household survey underwent clinic evaluation history physical examination urinalysis continent incontinent female respondents underwent urodynamic testing uroflowmetry cystometry supine static urethral pressure profilometry upp findings differ significantly continent incontinent subjects whether based self report clinician diagnosis urinary continence status standing static dynamic upp lateral cystography showed significant differences self reported continent incontinent respondents provocative stress test significantly distinguishes continence incontinence stress incontinence types sensitivity provocative stress test percent whereas specificity percent urodynamic testing including uroflow study static upp lateral cystography used screening test rather selectively confirmatory test determine therapeutic approach assess outcome therapy,C12,0.0023814416,0.0021124575,0.04341931,0.0013381129,0.026372826,0.014591454,0.1846307,0.025294863,0.0017216763,0.0023399063,0.17058349,0.0049230433,0.108920254,0.0058213263,0.0366797,0.015227078,0.112172745,0.002504522,0.014235036,0.15995501,0.06147952,0.0008455634,0.0024499393
x linked hypophosphataemia treatment height gain nephrocalcinosis clinical data patients x linked hypophosphataemia analysed retrospectively height data expressed sd scores difference final height patients treated vitamin dihydroxyvitamin phosphate least two years n hypophosphataemic family members never treated mean final sd score treated patients however significantly higher value treatment indicated average absolute height gain cm compared expected height values six treated patients developed ultrasonographically detectable nephrocalcinosis normal renal function daily phosphate intake excretion patients nephrocalcinosis significantly higher patients normal renal morphology difference doses vitamin two groups average urinary calcium creatinine ratio two groups similar hypercalciuric mmol mmol limit group nephrocalcinosis however higher incidence hypercalciuric episodes group without nephrocalcinosis observations compared six observations respectively benefits risks treatment patients x linked hypophosphataemia must evaluated high dose phosphate seems important factor development nephrocalcinosis group patients,C12,0.0019911395,0.0017662401,0.0229608,0.0011187401,0.0027725988,0.0025696694,0.22989592,0.0018724918,0.0014395053,0.05014748,0.009625503,0.074741654,0.1617573,0.02640482,0.0017509579,0.0031006183,0.13524778,0.0020586515,0.0022672052,0.10496505,0.14782125,0.0007069813,0.0130176535
prolonged neuromuscular blockade vecuronium neonate renal failure day old neonate renal failure caused dysplastic kidneys anaesthetised thiopentone vecuronium nitrous oxide oxygen insertion long term peritoneal dialysis catheter complete neuromuscular block minutes duration ensued initial dose vecuronium micrograms kg partial block persisted minutes prolonged neuromuscular block case may proportionately greater dependence renal clearance vecuronium neonates,C12,0.00441922,0.046708304,0.008245806,0.0024829796,0.006153624,0.027058437,0.13518995,0.004155888,0.0031948993,0.004342143,0.06279296,0.030460343,0.08461177,0.010161151,0.025271649,0.028207602,0.15464295,0.025922185,0.005031932,0.12820663,0.19662414,0.0015691045,0.004546331
treatment idiopathic testicular failure high dose testosterone undecanoate double blind pilot study effect high dose mg intake testosterone undecanoate studied sperm characteristics function accessory sex glands hormonal parameters men idiopathic oligozoospermia asthenozoospermia teratozoospermia using two phase protocol including month double blind period followed month open phase increased sperm viability semen content adenosine triphosphate either reproducible patients placebo switched undecanoate reach statistical significance whereas changes detected sperm characteristics accessory sex glands intake undecanoate significantly increased concentration alpha dihydrotestosterone dht ratio dht peripheral blood suppressed luteinizing hormone concentration tended decrease serum follicle stimulating hormone concentration concluded high dose undecanoate effective treatment men infertility idiopathic testicular failure,C12,0.0025272083,0.026710441,0.004715509,0.0014199353,0.0035190575,0.003261494,0.18829978,0.026835917,0.0018270592,0.014642974,0.018514112,0.017419688,0.06934601,0.0060004373,0.0022223634,0.028401747,0.07636316,0.014831178,0.039578263,0.1258211,0.29701343,0.0008973199,0.029831868
minimizing urinary incontinence nursing home nursing home urinary incontinence common problem often treated irremediable problem aging physicians nurses patients etiologies numerous approaches treatment setting however thoughtful approach diagnosis care primary care physician may able determine patients forms urinary incontinence benefit specific therapies,C12,0.005196374,0.004609443,0.009695895,0.0029196306,0.007235786,0.006706191,0.46223295,0.030033946,0.003756747,0.0051057427,0.049052216,0.010687948,0.035042536,0.012709875,0.0045695603,0.008091835,0.116153434,0.0053514037,0.005916836,0.13788661,0.06984518,0.0018450436,0.005354808
activity type erythrocyte complement receptors uremia renal transplantation effect uremia activity erythrocyte complement receptors type cr changes occurring renal transplantation studied complement receptor activity measured immune adherence utilizing rosette technique patients terminal kidney failure hemodialysis program exhibited significantly lower values erythrocyte cr activity comparison healthy controls circulating immune complexes affect erythrocyte cr activity successful renal transplantation irrespective immunosuppressive program used significant increase erythrocyte cr activity appeared similar control group values however activity erythrocyte cr graft recipients cyclosporin treatment significantly higher patients receiving azathioprine prednisone therefore possible cyclosporin transported erythrocytes modifies complement receptor function,C12,0.0023542256,0.013484391,0.0044413097,0.0013229378,0.0032781847,0.0030382508,0.1455746,0.0022139424,0.0017020004,0.002313165,0.017142076,0.08333023,0.23810689,0.0060987035,0.013460628,0.003666019,0.10486596,0.059409685,0.024493098,0.031550057,0.22352794,0.0008359,0.013789771
effects basic fibroblast growth factor suramin cell motility growth rat prostate cancer cells suramin new type cancer chemotherapeutic agent growth factor antagonist properties reported affect growth prostate cancer metastatic lesions partin et al previously reported prostate cancer cell motility essential tumor cell metastasis studied effects suramin cell motility cell growth prostate cancer cell model demonstrated suramin differential effects rat prostate cancer cells vitro effects suramin cell growth biphasic low concentrations mm mm suramin stimulated growth inhibitory higher concentration mm mm suramin resulted cell death cell motility inhibited suramin concentration mm inhibition cell motility suramin may blockage growth factor effects reducing serum growth factor concentration reduced cell motility motility restored addition basic fibroblast growth factor bfgf media motility restored bfgf could blocked presence suramin inhibition cell motility suramin reversible washout drug suramin inhibits cell motility human prostate cancer cells lncap rat mll,C12,0.01335815,0.0020192352,0.004430116,0.0012790377,0.025225641,0.002937747,0.16247784,0.0021407062,0.0016456989,0.0132098505,0.010776874,0.015700646,0.016071254,0.32252774,0.0020017638,0.014554588,0.02130914,0.0023600701,0.03564218,0.029717019,0.29746306,0.0008082488,0.002343357
prevalence subfertility review current confusion report two new studies difficulties inherent measuring prevalence subfertility discussed four subtypes subfertility defined enabling comparisons made widely different approaches previously reported detailed assessment made prevalence subfertility two different samples british women aged years using interviews postal questionnaires medical record searches data collected women general practice hospital patients combined data showed women attempting conceive experience episode subfertility stage reproductive life thirteen percent experience attempting conceive first child attempting conceive subsequent child three percent women involuntarily childless parous women able many children would wish,C12,0.0027635698,0.0024800834,0.0051565347,0.014917341,0.0038481834,0.04366796,0.28942135,0.0025988945,0.001997938,0.045373995,0.05813778,0.005684135,0.032709643,0.0063543003,0.0024302136,0.031050365,0.10935753,0.0028460186,0.016522087,0.24933858,0.06951915,0.0009812432,0.0028430587
palmar keratoses family members individuals bladder cancer total bladder cancer cases first degree relatives spouses bladder cancer cases hospital controls studied evaluate association palmar keratoses bladder cancer environmental genetic factors crude prevalences keratoses groups respectively logistic regression models showed bladder cancer patients raised risk palmar keratoses relative hospital controls odds ratio ci whereas blood relatives spouses significantly increased odds ratios case family blood relative possessed keratoses among several environmental behaviour factors cigarette smoking significantly associated increased risk odds ratio ci data suggest genetic component may influence occurrence palmar keratoses unknown environmental agent appears causing association spouses,C12,0.002763699,0.0024515388,0.05867316,0.0015528097,0.0038483634,0.0035666975,0.1526973,0.002599016,0.0019980313,0.016032217,0.10077806,0.09139504,0.12760305,0.023483472,0.01579784,0.004303654,0.06896372,0.0028461518,0.0031468777,0.23019533,0.0814407,0.0009812891,0.0028819642
sedoanalgesia urology safe cost effective alternative general anaesthesia review cases sedoanalgesia technique developed provide safe satisfactory operating conditions wide range patients independent age overall level fitness although use children remains established suitable endoscopic open procedures day cases patients used day case surgery significantly improves overall efficiency recognised day case surgery important cost effective element surgical care increasing restraints imposed upon hospital finances patient beds staffing levels strategies designed improve efficiency sphere surgical activity welcomed patients prefer sedoanalgesia conventional general anaesthesia attests high degree acceptability technique sedoanalgesia applications potential impact urology detailed,C12,0.0029198015,0.0025900097,0.019680245,0.0016405174,0.004065731,0.0037943353,0.19534664,0.0027458167,0.0021108866,0.017003886,0.12680195,0.0060056373,0.062396966,0.007032688,0.0025675998,0.018877657,0.22919959,0.0030069116,0.04420102,0.09757759,0.14639404,0.0010367155,0.0030037842
effects intracavernosal trazodone hydrochloride animal human studies trazodone hydrochloride oral antidepressant agent associated improvement erections impotent men development prolonged erections priapism potent men vivo study animal human subjects performed gain experience effect intracavernosal trazodone anesthetized new zealand white rabbit intracavernosal trazodone major metabolite chlorophenylpiperazine cpp produced full penile erection animals studied respectively doses ranging one mg hand intracavernosal administration five mg papaverine resulted prolonged erection animals studied selected volunteer patients intracavernosal trazodone caused tumescence full penile erection corporal body pressures mm hg intracavernosal papaverine papaverine phentolamine subjects resulted significantly higher corporal body pressures mm hg p less intracavernosal administration alpha adrenoceptor agonists normal saline resulted complete detumescence trazodone cpp induced prolonged erection animal studies intracavernosal trazodone results erectile activity appears part based local alpha blocking activity like intracavernosal alpha blocking agents effective initiating penile erections intracavernosal agents directly induce smooth muscle relaxation,C12,0.0022273054,0.001975731,0.014923747,0.001251432,0.0031014523,0.0028744536,0.2525329,0.002094585,0.01239071,0.0021884583,0.011158678,0.03174905,0.12361334,0.0063705593,0.02137709,0.0034683777,0.10436502,0.0136401,0.0025361148,0.04403241,0.31253973,0.00079083524,0.02879791
vivo human testicular function assessed p mr spectroscopy clinical feasibility assessing testicular metabolic integrity phosphorus magnetic resonance mr spectroscopy investigated six healthy volunteers patients azoospermia mr spectroscopic findings compared sperm count motility patients findings testicular biopsy patients significant differences p less found p spectra normal azoospermic testicles following peak area ratios phosphomonoester pm beta adenosine triphosphate pm phosphodiester inorganic phosphate pm patients azoospermia significant differences peak area ratios patients primary testicular failure chronic tubular obstruction although differences two groups statistically significant large overlap numbers therefore study larger patient population required p mr spectroscopy sensitive tool assessment testicular metabolic integrity differentiation normal testicles markedly decreased spermatogenesis,C12,0.0026232107,0.015025228,0.030092075,0.001473875,0.029179653,0.04147184,0.18655361,0.0024668989,0.0018964645,0.0025774585,0.012339939,0.02049669,0.15388341,0.007048667,0.014984689,0.004084884,0.16731822,0.002711932,0.0029869112,0.038349163,0.22952402,0.00093140674,0.031979777
sodium loading treatment amphotericin b induced nephrotoxicity increased frequency duration antifungal treatment amphotericin b immunocompromised patients stimulated great deal research mechanisms nephrotoxic effects treatment modalities designed attenuate effects review amphotericin b induced nephrotoxicity underlying pathophysiologic mechanisms role salt loading means minimizing renal impairment described animal human studies regarding efficacy sodium loading presented well case report describing use salt supplementation prolonged course therapy,C12,0.0038432735,0.0034091754,0.044364005,0.0021593787,0.0053516366,0.004976593,0.34529275,0.022212585,0.0027785157,0.003776242,0.0364041,0.007951539,0.045039304,0.010702743,0.003379678,0.005984776,0.14444208,0.0039579347,0.0043761325,0.031122187,0.24043705,0.0013646068,0.026673714
psychological assessment follow vitro fertilization assessing impact failure present study conducted assess immediate psychological impact failed vitro fertilization ivf emotional status marital functioning also examined pre ivf demographic information psychological test scores evaluated predictors reaction treatment failure failed first cycle males females showed significant increases anxiety depressive symptoms although group means clinically elevated participants coping adequately prevalence mild moderate depression increased substantially particularly among women addition women without children subgroup particularly vulnerable stress failure predisposition towards anxiety pre ivf depressive symptoms fertility history important predictors emotional response treatment implications findings discussed,C12,0.002727323,0.0420294,0.031484183,0.0015323716,0.0037977109,0.01671863,0.27419236,0.0025648077,0.015165409,0.01588292,0.03356746,0.04122369,0.07026631,0.006504075,0.028803617,0.0042470093,0.06739791,0.0028086905,0.023479953,0.12165675,0.19017525,0.0009683733,0.0028057694
comparison two methods estimation urea kinetics introduction third simplified method claimed computed urea kinetic uk modelling hemodialysed patients estimation protein intake leads overestimation protein catabolic rate pcr present study three different methods kinetic modelling determination pcr kt v compared patients first method direct quantification method ddq based collection urea eliminated body first computed method icmi urea kinetic modelling method described sargent dialyzer clearances measured directly estimated theoretical extrapolation second computed method icmii based indirect calculation urea distribution volume vu according watson dialyzer clearances vu pre post dialysis urea concentrations three methods resulted pcr significantly different ddq icmi icmii mg kg bw hrs p greater results correlated following results obtained icmi vs icmii r p less icmi vs ddq r p less ddq vs icmii r p less intermutual comparison kt v values resulted virtually identical results especially comparing icmi icmii regression line equalled identity line conclusion methods seem equally reliable determining mean pcr kt v data obtained directly measured dialyzer urea clearances confirm earlier held opinion computed modelling results overestimation pcr,C12,0.0018654324,0.0016547316,0.066690266,0.0010481103,0.0026030843,0.0024074377,0.19780622,0.0017542752,0.010367646,0.0018328968,0.17831878,0.0038368618,0.18584417,0.004314808,0.027776098,0.01191915,0.08046506,0.021554077,0.0021240693,0.02886075,0.15535125,0.009685746,0.0019190881
difference beta microglobulin removal cellulosic synthetic polymer membrane dialyzers several kinds dialyzers highly permeable membranes hpm designed specifically remove beta microglobulin bmg clarify solute transport characteristics nine types hpm dialyzers evaluated vivo vitro studies using human plasma aqueous solutions bmg membrane adsorption plugging seen cellulosic membrane dialyzers vitro experiments using human plasma hand synthetic polymer membrane dialyzers adsorptive properties dialyzer polymethylmethacrylate membrane large amount bmg removed adsorption alone dialyzers cellulose triacetate polyacrylonitril membranes showed higher values bmg diffusive dialysance greater ml min sieving coefficient greater vitro experiments using aqueous solution containing several solutes relatively small middle molecular weights hpm dialyzers higher overall mass transfer coefficient conventional membrane dialyzer,C12,0.002801119,0.0024847323,0.15437582,0.0015739135,0.0039013436,0.030922186,0.24466754,0.002634206,0.0020250843,0.01630878,0.050770994,0.05445198,0.0960783,0.028242694,0.016017163,0.004377002,0.032347772,0.0028947918,0.003189486,0.024146607,0.22184472,0.0009945756,0.0029491659
phenotypic characterization monocytes macrophages capd patients purpose study phenotypically characterize compare peripheral blood monocytes capd patients peritoneal macrophages isolated peritoneal dialysis effluents monocytes macrophages labeled fluorescent ligands monoclonal antibodies specific receptors c formyl met leu phe fmlp fc region igg c b cr c bi cr class ii histocompatibility antigens hla dr hla dq monocyte macrophage surface antigen cd cells analyzed using flow cytometry results indicated differences monocytes peritoneal macrophages receptor expression fmlp cr cr however paired testing indicated peritoneal macrophages significantly increased expression fc c receptors well enhanced antigen expression hla dr hla dq cd results suggest peritoneal macrophages capd patients activated increased expression receptors antigens important host defense,C12,0.0029618046,0.0026272684,0.0056980513,0.0016641172,0.004124219,0.018150773,0.18819936,0.1031552,0.0021412529,0.002910147,0.031559672,0.0061783474,0.07038693,0.12038528,0.0026045362,0.0046121455,0.07494542,0.074742526,0.017619804,0.021740794,0.15572403,0.0010516292,0.08681665
prospective comparison plain abdominal radiography conventional digital renal tomography assessing renal extracorporeal shock wave lithotripsy patients publications citing effectiveness renal extracorporeal shock wave lithotripsy used plain abdominal radiography assess residual calculi treatment compared radiologist sensitivity specificity detection calculi plain abdominal radiographs versus conventional film screen digital renal tomograms extracorporeal shock wave lithotripsy patients patients imaged within hours lithotripsy six radiologists evaluated resultant studies presence location calculi mean sensitivity digital tomograms pre lithotripsy post lithotripsy studies significantly higher plain abdominal radiography conventional tomography lithotripsy however significantly false positive stone diagnoses associated digital tomogram interpretation signal detection analysis verified superiority digital tomography post extracorporeal shock wave lithotripsy imaging calculus detection conventional digital tomography superior detection plain abdominal radiography however perform delayed imaging possible say impact digital tomography might management extracorporeal shock wave lithotripsy patients,C12,0.0027272888,0.015618244,0.018288711,0.0015323523,0.04340381,0.003519708,0.19075446,0.0025647753,0.0019717084,0.015879573,0.23160106,0.0056107547,0.16179432,0.006639724,0.0023983088,0.0042469557,0.12387078,0.0028086551,0.0033216653,0.039270647,0.11839773,0.0009683611,0.002810383
whole bladder photodynamic therapy critical review present day technology rationale development intravesical laser catheter monitoring system present day whole bladder photodynamic therapy wbpdt cumbersome time consuming cystoscopic ultrasonic manipulations necessary position light emitter within bladder important wbpdt inherently unsafe often ineffective since neither uniform photoirradiation accurate light dosimetry achieved techniques employed photoirradiate bladder wall intravesical laser catheter ivlc eliminates need cystoscopy ultrasonography passage treatment fiber catheter central lumen automatically positions light diffusing tip within center bladder use ivlc delivery system also assures accurate photoirradiation bladder wall since inflation catheter balloon transforms asymmetric bladder sphere known diameter light sensor incorporated balloon wall provides method monitor light fluence measure total light dose provided parameters bladder volume laser energy output desired light dose computerized control system calculates treatment time automatically adjusts period photoirradiation compensate variations laser light production energy losses transmission variations light intensity resulting integrating sphere effect bladder wall delivery system also increases safety wbpdt since monitor automatically discontinues treatment unsafe situation respect light fluence develops photoirradiation,C12,0.009979889,0.01807721,0.02904288,0.0009614452,0.018945826,0.020599443,0.2171345,0.0016281938,0.017801894,0.00168134,0.09720198,0.020334413,0.04808267,0.012533689,0.009791875,0.010940473,0.09847601,0.0017622372,0.010227621,0.06416855,0.2882587,0.0006075797,0.001761576
polyarteritis nodosa masquerading primary testicular neoplasm case report review literature report case polyarteritis nodosa presenting mass testis mimicking neoplasm diagnosis confirmed radical orchiectomy unusual presentation systemic disease discuss physical findings ultrasonographic features pathological findings well review literature previous similar cases,C12,0.0054718885,0.004853838,0.036695994,0.0030744309,0.0076194312,0.0070617567,0.47045392,0.03162878,0.0039559314,0.0053764516,0.10443063,0.011314083,0.048289068,0.012581561,0.0048118406,0.008520868,0.06908533,0.0057098316,0.0062305494,0.046890445,0.07190475,0.0019428687,0.032095794
geriatric pharmacokinetics kidney general population aging result drugs increasingly prescribed variety medical conditions group patients multiple physiologic pharmacokinetic abnormalities present report summarizes principles prescribing elderly especially related decline renal function frequently occurs,C12,0.0053306473,0.00472855,0.009946435,0.054597113,0.0074227573,0.0068794778,0.32131788,0.0050130053,0.0038538205,0.005237674,0.04288219,0.03677094,0.03729645,0.012256804,0.0046876366,0.034104,0.07651083,0.03128206,0.006069726,0.1289074,0.15752791,0.0018927191,0.0054839733
urethral plug new treatment modality genuine urinary stress incontinence women new modality urethral plug used treat women genuine urinary stress incontinence plug made thermoplastic elastomer kraton g consists meatal plate soft stalk spheres along stalk spheres located according result urethral pressure profile midpoint proximal sphere placed bladder neck distal sphere placed maximum urethral pressure point voiding plug removed afterwards new plug inserted plug spheres tested week period plug distal sphere tested week period total patients completed period eight patients complete period mostly due either unchanged incontinence period repeated loss plug sphere periods patients subjectively objectively continent improved total patients completed periods eight patients preferred plug spheres preferred plug preference side effects preliminary study shows urethral plug seems promising alternative treatment female genuine urinary stress incontinence,C12,0.0027656571,0.002451501,0.04529278,0.0015527857,0.003848304,0.0035666425,0.20306493,0.015971417,0.0019980005,0.0027154547,0.087199755,0.005684313,0.101366974,0.0063544996,0.0024304502,0.0043035876,0.28120694,0.0028461078,0.0031468293,0.09639145,0.10865799,0.000981274,0.016202314
treatment primary nocturnal enuresis oral androgen mesterolone clinical cystometric study double blind clinical study boys six ten years age primary nocturnal enuresis undertaken assess role androgens treating enuresis oral synthetic androgen mesterolone selected minimal potential toxic effects twenty boys treated mesterolone received placebo fourteen boys became dry treatment mg daily days remained dry follow period four months increased cystometric bladder capacity disappearance uninhibited detrusor contractions noticed significant number cases treatment side effects recorded mesterolone probably modulated autonomic innervation vesical musculature correction defective neural mechanism believed implicated pathogenesis nocturnal enuresis,C12,0.0029618766,0.0026273322,0.0055265543,0.0016641576,0.004124319,0.0038224559,0.29002118,0.0027853844,0.0021413048,0.04592024,0.042479053,0.006657201,0.038124718,0.022869896,0.0026045993,0.033435304,0.2135372,0.0030502416,0.03204743,0.042604133,0.19685957,0.0010516547,0.0030841224
intrarenal de novo production angiotensin subjects renal artery stenosis estimate renal extraction de novo production angiotensin assess contribution blood borne renin renal angiotensin production aortic renal venous plasma levels renin intact angiotensin endogenous angiotensin continuous systemic intravenous infusion monoiodinated angiotensin measured subjects unilateral renal artery stenosis n treated captopril mg b results demonstrated angiotensin delivered renal artery extracted affected unaffected kidney sides major part angiotensin renal vein derived intrarenal de novo production production plasma angiotensin excess extraction p less affected side whereas extraction excess production p less contralateral side plasma level de novo intrarenally produced angiotensin renal vein seven times higher affected side contralateral side difference far big explained difference transit time blood two kidneys augmented production angiotensin circulating blood passing affected kidney due higher level venous plasma renin activity kidney combination,C12,0.04418543,0.054142497,0.0042450093,0.03254089,0.0030074527,0.0027846708,0.12336368,0.05619064,0.0015599472,0.0021201025,0.020568985,0.026778314,0.13448009,0.005299861,0.0018974587,0.013838867,0.07172775,0.0022483878,0.0024569,0.05036311,0.33175534,0.00076613366,0.013678478
intracavernous injection prostaglandin e combination papaverine enhanced effectiveness comparison papaverine plus phentolamine prostaglandin e alone compared erectile response intracavernous injection combination papaverine prostaglandin e combination papaverine phentolamine patients prostaglandin e alone degree erection achieved significantly better papaverine plus prostaglandin e papaverine plus phentolamine duration erection less although incidence prolonged erections greater hours similar combinations papaverine prostaglandin e likewise resulted significantly better degree erection prostaglandin e alone prolonged erections occurred drug combination erections subsided spontaneously none required medical intervention throughout study pain noted injection prostaglandin e incidence clearly lower versus injection micrograms prostaglandin e combination papaverine although difference statistically significant subjectively side effects caused drug combination described much less dramatic patients prostaglandin e alone combination papaverine prostaglandin e shows clearly synergistic effect might suitably replace papaverine plus phentolamine prostaglandin e alone patients respond well suffer side effects high single doses,C12,0.122379534,0.01185852,0.003869675,0.0011635837,0.002913782,0.002672672,0.20316648,0.011960868,0.0014972065,0.0020348325,0.02284892,0.05892525,0.11351057,0.00484211,0.0018211433,0.0032249037,0.15578978,0.0021327378,0.002358084,0.06888713,0.19927216,0.00073532,0.0021347534
influence high energy shock waves cisplatin antitumor effect murine bladder cancer potential application high energy shock waves hesw control experimental bladder cancer investigated subcutaneous murine bladder cancer mbt c h mice exposed hesw alone shocks combination cisplatin mg kg p although hesw alone showed influence tumor growth hesw cisplatin combination therapy suppressed tumor growth cisplatin alone subsequent studies revealed air fluid interface relative tumor location played pivotal role chemosensitizing effect hesw hesw treatment able enhance cisplatin cytotoxicity tumors placed adjacent air fluid interface,C12,0.0032403353,0.002874339,0.021730442,0.0018206121,0.07289986,0.0041818214,0.23460653,0.0030472504,0.002342618,0.0031838196,0.015002686,0.08742287,0.067025475,0.08756533,0.002849469,0.020728583,0.045705944,0.01949964,0.0036895983,0.07947919,0.21661952,0.0011505253,0.0033335374
clinical effects polyethylene glycol grafted cellulose membrane thrombogenicity biocompatibility hemodialysis biocompatibility thrombogenicity polyethylene glycol peg grafted cellulose hemodialysis hd membranes pegc investigated cross hd five hd patients ordinary cellulose oc pegc significantly suppressed transient leukocyte thrombocytopenia release c beta thromboglobulin platelet factor corresponding quantity grafted peg hd pegc resulted lower granulocyte elastase production protein blood cells adsorption membrane surface oc minimum heparin hd pegc three times lower oc thrombin antithrombin iii complex elevation lower hd oc results indicate grafted peg effectively suppresses blood membrane interaction thus improving biocompatibility reducing thrombogenicity clinical hd,C12,0.0037060603,0.0032867899,0.09665864,0.0020828608,0.005159519,0.0047818883,0.18131506,0.0034845131,0.00267877,0.0036406792,0.017040987,0.0076212105,0.15668827,0.053771615,0.0032583512,0.0057699294,0.05378347,0.057627283,0.022135928,0.03294041,0.25536332,0.001315619,0.02588879
pharmacokinetics enoxacin oxometabolite following intravenous administration patients different degrees renal impairment enoxacin fluorinated quinolone potential clinical use treatment serious infections twenty three patients age years different degrees renal function including group undergoing chronic hemodialysis received enoxacin mg intravenous infusion h blood samples collected infusion end infusion min h infusion enoxacin oxoenoxacin concentrations measured high pressure liquid chromatography pharmacokinetic parameters mean standard deviation calculated using noncompartmental pk model according creatinine clearances milliliters per minute total clearance enoxacin decreased ml min per kg group normal creatinine clearance ml min per kg patients severe renal failure creatinine clearance less ml min whereas elimination half life increased h respectively elimination oxoenoxacin main metabolite enoxacin urine markedly decreased creatinine clearance less ml min hemodialysis removed insignificant amount enoxacin oxoenoxacin data indicate creatinine clearance falls ml min daily enoxacin dose reduced half prolonged administration enoxacin patients creatinine clearances less ml min accumulation oxoenoxacin might lead unexpected side effects,C12,0.001837909,0.010494258,0.012279961,0.001029459,0.0025513314,0.013417481,0.13447899,0.0017230575,0.0013246255,0.0018002801,0.04960968,0.058820892,0.307865,0.0042248853,0.0016112413,0.012085404,0.08943494,0.0018871437,0.0020862708,0.0362552,0.25264654,0.0006505606,0.0018849374
hyaluronic acid sperm select improves retention sperm motility velocity normospermic oligospermic specimens effects sperm select pharmacia ab uppsala sweden hyaluronic acid medium motility membrane integrity properties sperm studied normospermic specimens overnight incubation motility parameters control versus sperm select group follows mean sem motility versus velocity versus microns linearity versus lateral head displacement versus microns tail beat cross frequency versus hz density motile sperm versus x sperm ml finally velocity coefficient multiple sperm motility linear velocity versus however found sperm select related differences testing sperm membrane integrity hypoosmotic swelling supravital staining thus sperm select improves retention sperm motility prominently velocity apparently due direct action hyaluronic acid sperm metabolism contractility rather preservation sperm membrane integrity oligospermic specimens sperm select caused similar improvements sperm motility duration motility could predicted degree enhancement sperm velocity short term sperm select exposure modified sperm select protocol described increases motile sperm yield without centrifugation step,C12,0.014451801,0.002162455,0.06321671,0.0013701437,0.0033945667,0.014936972,0.22606343,0.014091002,0.0017624247,0.002395287,0.09708135,0.017312784,0.18363231,0.021820925,0.0021437446,0.0155831985,0.07727507,0.0025214686,0.0027758,0.026586441,0.20603545,0.0008655761,0.0025210318
evaluation new rapid office test microalbuminuria comparison fully quantitative radioimmunoassay novel enzyme linked immunosorbent assay elisa dialbumin rapid office measurement microalbuminuria evaluated performance compared commercially available radioimmunoassay double antibody albumin urine samples containing micrograms ml albumin obtained diabetic patients assayed methods comparison paired values obtained two methods gave correlation coefficient greater dialbumin assay used detachable eight well strips strip sample min incubation tap water wash min color development step read elisa reader hand held analytical device acc u dial designed specifically test findings study indicate dialbumin assay used conjunction acc u dial device affords rapid convenient sensitive method quantitative determination broad range micrograms ml urinary albumin levels office setting,C12,0.0024670416,0.02607193,0.038818352,0.0013861301,0.015377036,0.040010016,0.30004606,0.0023200358,0.0017835613,0.0024240133,0.16298811,0.030138165,0.10138731,0.07142632,0.0021694542,0.01627415,0.06803642,0.0025406438,0.0028090898,0.030009324,0.07808795,0.00087595684,0.0025529664
case initial treatment localized prostate cancer contribution summarizes evidence natural history pathology disease given high incidence latent cancer policy radical treatment diagnosis represent treatment majority cases yet neither radical prostatectomy radical radiotherapy shown effective managing poorly differentiated tumor patient localized disease patient well differentiated disease little evidence early treatment mandatory majority patients die prostatic cancer adoption policy diagnosis followed active surveillance would spare many patients hazard discomfort major operation course radiotherapy would minimize expenditure would ensure treatment given patients progression demonstrated approach almost certain effective treatment diagnosis confirmation view likely obtained existing studies immediate versus delayed orchiectomy lhrh therapy currently undertaken urological working party medical research council united kingdom urological group eortc within europe,C12,0.0024375087,0.0021621918,0.004548138,0.0013695366,0.015204895,0.0031457318,0.3554906,0.025875654,0.0017622103,0.014191939,0.081827566,0.05629081,0.015665684,0.005604585,0.0021434836,0.015590992,0.16008827,0.0025102298,0.026367767,0.13047004,0.050292417,0.00086547073,0.026094291
ionized calcium parathormone mortality critically ill surgical patients prospective study measured ionized calcium parathormone sequentially hour intervals surgical intensive care unit patients twelve patients died mean day median day levels ionized calcium parathormone blood urea nitrogen creatinine albumin magnesium phosphate patients lived compared levels patients died incidence hypotension renal failure creatinine greater equal bacteremia well amount red cell crystalloid colloid administration two groups compared hypotension bacteremia red cells crystalloid colloid different days ionized calcium levels significantly lower parathormone levels significantly higher nonsurviving patients difference persisted days blood urea nitrogen creatinine levels increased early nonsurviving patients renal failure occurred nine nonsurviving patients develop mean day median day phosphate level slightly higher still within normal range nonsurviving patients days ionized calcium parathormone levels different nonsurviving patients despite improvement renal function magnesium albumin levels different groups ionized calcium levels lower parathormone levels higher early nonsurviving patients difference readily explained associated clinical conditions including renal dysfunction although etiology remains unclear low ionized calcium elevated parathormone early predictors mortality critically ill surgical patients,C12,0.001592188,0.016827619,0.033790812,0.0008945855,0.0022170714,0.017465888,0.1497876,0.0014973129,0.001151081,0.0096718175,0.0073361355,0.019210035,0.11166748,0.019299014,0.009099082,0.002479368,0.22787182,0.0016399819,0.0018129402,0.06718496,0.28759444,0.008270815,0.0016379843
toxicity comparison neoadjuvant versus adjuvant methotrexate vinblastine doxorubicin cisplatin vac radical cystectomy patients reduction toxicity vac chemotherapy postulated patients receive drugs prior radical cystectomy muscle invasive bladder carcinoma review toxicity patient dropout rates group patients received neoadjuvant vac little different patients treated vac radical cystectomy similarity suggests preoperative vac favored basis reduced patient morbidity,C12,0.004618862,0.0040949127,0.008613588,0.002593726,0.0064280895,0.005957611,0.27446795,0.0043412503,0.025685325,0.004535813,0.04357286,0.05324699,0.036400072,0.010614363,0.004059482,0.029532185,0.24679658,0.027057223,0.005256368,0.06506588,0.1306727,0.0016390901,0.004749107
influence phosphatidylcholine ultrafiltration solute transfer capd patients fifteen patients mean age years treated capd mean months underwent peritoneal clearances days intraperitoneal phosphatidylcholine pc treatment mg l difference observed urea creatinine uric acid reverse dextrose clearances statistically significant increase phosphate clearances hr dwell times reduction drainage volume hr dwell time observed treatment urine output percent dextrose reabsorption unchanged ultrafiltration uf showed tendency increase lasted days discontinuation treatment tendency allowed patients reduce period amount hypertonic solution l vs l required tendency increase uf time deserves study,C12,0.0030053167,0.0026654252,0.034683943,0.0016882857,0.0041841166,0.047484867,0.13635848,0.002825769,0.0021723509,0.046574246,0.014359722,0.05511512,0.055151977,0.0069090086,0.0026423628,0.0046791295,0.23481771,0.0031041682,0.0034214293,0.045099013,0.27435994,0.0010669023,0.017630767
uremic platelets functional defect affecting interaction von willebrand factor glycoprotein iib iiia uremic patients impaired platelet function related membrane glycoprotein gp abnormalities using perfusion system studied interaction normal uremic platelets vessel subendothelium se flow conditions reconstituted blood containing washed platelets purified von willebrand factor vwf u ml normal washed red blood cells exposed de endothelialized rabbit segments minutes two different shear rates seconds experiments monoclonal antibody gpiib iiia complex edu added perfusates normal platelets percentage vessel covered platelets cs seconds seconds platelets observed contact forming monolayers vessel se edu inhibited spreading normal platelets cs statistically decreased p less platelets observed contact vessel surface data indicate flow conditions interaction vwf gpiib iiia support spreading normal platelets absence exogenous fibrinogen experimental conditions interaction uremic platelets se markedly impaired shear rates studied p less v normal platelets presence edu modify interaction uremic platelets results confirm impairment platelet adhesion observed uremic patients furthermore indicate presence functional defect interaction vwf gpiib iiia fact perfusions normal uremic platelets presence antibody gpiib iiia complex show differences gives indirect evidence functionally normal interaction vwf gpib uremic patients,C12,0.0015218931,0.0013499951,0.04270819,0.00085508963,0.012587217,0.0019640822,0.17938901,0.001435398,0.001100261,0.0014953493,0.0072393767,0.0034459461,0.13151795,0.15937313,0.0013383144,0.002369904,0.04319097,0.017220937,0.0017328991,0.037668593,0.34838516,0.00054036896,0.0015699198
patient selection results impact tumor resection potency sparing radical prostatectomy results show using nerve sparing radical retropubic prostatectomy potency preserved majority appropriately selected patients without compromising adequacy tumor excision however proper patient selection important patients focal well differentiated tumors especially young patients stage b tumors ideal candidates patients extensive less well differentiated tumors higher risk incomplete tumor excision although suspect adequacy tumor excision determined extent tumor technique radical prostatectomy used believe nerve sparing surgery used great caution patients extensive high grade tumors patients microscopic extracapsular tumor extension extremely common impossible detect time operation less likely adequately encompassed nerve sparing techniques hand current data provide little evidence excision neurovascular bundles beneficial possible extensive resections materially alter incidence positive margins cure rates finally might argued forms radical prostatectomy inappropriate patients poorly differentiated clinical stage b prostate cancer really effective treatment options continue recommend radical prostatectomy patients based finding patients clinical stage b disease organ confined tumors expected excellent long term disease free survival rates similar clinical stage b patients remaining patients clinically understaged prospects minimal microscopic tumor remaining controlled adjunctive radiation therapy may better controlling bulky primary tumor radiation therapy alone hypothesis need tested randomized clinical trial,C12,0.0014371239,0.0012748006,0.009625624,0.02862723,0.12027534,0.0018546833,0.29135832,0.0013514886,0.0010389766,0.0014120586,0.041087583,0.003195066,0.074550435,0.0034083792,0.0012637705,0.030167215,0.22543499,0.0014799993,0.020574776,0.08763764,0.050953515,0.0005102705,0.0014807438
income survival chronic dialysis patients relationship income survival rates chronic dialysis patients michigan examined evaluate relative risk rr dying income cox survival regression model used adjust age race black versus white gender dialytic treatment modality year first end stage renal disease esrd therapy primary cause esrd average household income reported census data zip code residence patient analyzed socioeconomic indicator treatment modality day esrd classified either center hemodialysis hd capd new patients aged registered michigan kidney registry included study patients followed day esrd death censoring transplant adjusted relative risk dying decreased black patients per increase income p less trend income white patients negligible p greater difference trends two groups statistically significant p less surprising result since white patients higher death rates overall black patients particularly among subgroups diabetes hypertension whose rr respectively poor socioeconomic status area residence strongly negative effect survival black patients white patients reasons relationship death rates income especially black patients need examined greater detail,C12,0.010241139,0.0015562637,0.020257937,0.0009857406,0.002442983,0.0022641784,0.16401863,0.0016498837,0.035241146,0.010209528,0.062245235,0.015421453,0.037477486,0.004033968,0.0015427981,0.011208872,0.3305485,0.0018067681,0.0019976723,0.17355363,0.108865544,0.00062293303,0.0018077006
dose titration study evaluating terazosin selective day alpha blocker treatment symptomatic benign prostatic hyperplasia efficacy safety terazosin selective long acting alpha adrenergic blocker evaluated normotensive patients symptomatic benign prostatic hyperplasia ranging years old patients underwent complete urodynamic evaluation transrectal prostatic ultrasonography enrollment study dose terazosin titrated mg per day month interval provided adverse drug reactions observed patients completed dose titration study parameters used assess effectiveness terazosin included peak mean urinary flow rates micturition symptom scores global assessment patient symptomatic improvement mean systolic diastolic blood pressures changed less peak mean urinary flow rates increased respectively obstructive irritative symptom scores improved respectively participants indicated voiding symptoms markedly improved terazosin five patients complete dose titration study due development adverse drug reactions including erectile dysfunction tiredness light headedness palpitations nasal congestion asymptomatic hypotension patients followed terazosin months mean months improvements urinary flow rates symptom scores maintained interval although preliminary experience terazosin encouraging ultimate role terazosin long term treatment benign prostatic hyperplasia needs evaluation,C12,0.0017257628,0.0098771965,0.03661991,0.00096924783,0.027450664,0.0022262959,0.17591332,0.026672075,0.0012471506,0.0016992628,0.028315373,0.0035643906,0.15204996,0.003967044,0.0015169851,0.0026862964,0.2591522,0.010118546,0.0019642487,0.045097657,0.19643049,0.00061251054,0.010123395
comparison albumin excretion rate obtained different times collection study undertaken assess usefulness different techniques determination albumin excretion rate aer ninety patients type insulin dependent diabetes mellitus type ii non insulin dependent diabetes mellitus aer h less micrograms min included patients free major systemic complications diabetes overt kidney disease mean serum creatinine mg dl range mg dl compared timed day night h specimens well timed spot specimens water induced diuresis patients type type ii diabetes aer less micrograms min showed significant differences aer dependent collection time differences diminished absent aer less micrograms min sensitivity specificity prediction rates aer different specimens evaluated h aer use albumin concentrations albumin creatinine ratios improve test performance comparison aer sampling time overall rate aer influenced measurement urinary albumin excretion day h aer useful determine presence abnormal aer aer albumin concentration spot samples limited use initial screening frequently require day h specimens aer confirmation day h aer used long term follow diabetic patient,C12,0.0016298572,0.0014457647,0.03454156,0.0009159304,0.0022695246,0.049442057,0.14908326,0.0015327374,0.0011783142,0.0016014305,0.12778294,0.011479959,0.15272582,0.0039788685,0.017207734,0.0386008,0.13903935,0.0016784826,0.0018558322,0.048224278,0.19574565,0.016353857,0.0016860107
portable digital data recorder long term monitoring scrotal temperatures application new miniaturized portable digital data recorder thermoport institute reproductive medicine munster west germany continuous determination scrotal temperatures revealed great variations scrotal temperature hours normal men maximum temperatures approached body core temperatures mean scrotal temperatures normal men rose sauna degrees c degrees c treadmill running scrotal temperatures increased degrees c minimal scrotal temperatures increased men varicocele compared normal fertile men indicating impaired cooling mechanisms continuous temperature measurements facilitate assessment temperature dynamics miniaturized design thermoport makes suitable routine use outpatients infertility clinics occupational medicine evaluation heat hazards investigations body temperatures various experimental conditions,C12,0.0026569753,0.0023568696,0.19705784,0.0014928461,0.017301107,0.0034304287,0.15653169,0.0024986519,0.0019208749,0.0026106343,0.046123527,0.00546616,0.23780882,0.0062276013,0.023807319,0.017193507,0.04427422,0.002753482,0.0030253571,0.11812907,0.103656195,0.00094339537,0.0027333982
myxoid malignant fibrous histiocytoma bladder although common soft tissue sarcoma adulthood malignant fibrous histiocytoma mfh extremely rare tumor urinary bladder three well documented cases reported world literature patient presented report represents first case myxoid variant develop urinary bladder whereas previous patients mfh bladder intermittent hematuria patient chief complaint bladder outlet obstruction due extension tumor prostate managed radical cystoprostatectomy postoperative radiation therapy tumor bed adjuvant chemotherapy using doxorubicin patient tolerated therapy well disease free year follow visit histogenesis clinical features pathologic characteristics treatment considerations rare bladder tumor discussed detail,C12,0.0031452936,0.0027872922,0.036284734,0.0017654765,0.095645905,0.0040551787,0.34693506,0.033375446,0.002271674,0.0030874005,0.07878343,0.0064629144,0.03524645,0.007224899,0.0027631754,0.004893066,0.18677822,0.0032359497,0.0035778622,0.06499835,0.072333895,0.0011156827,0.003232584
various methods calculation kt v clinical comparison analysis national cooperative dialysis study ncds showed dialysis morbidity mortality related kt v urea various formulas derived make calculation kt v simpler compared kinetically measured kt v estimated kt v derived approximate total body water body weight uniform dialyzer clearance b kt v pru pru reduction bun c kt v r uf w r post pre bun uf ultrafiltration l hd w postdialysis weight patients correlation coefficient r p less vs b p less vs c p less vs c vs additional patients kt v calculated using formulas b c r c vs b vs b vs c b greater patients could misclassified using ncds criteria adequacy dialysis study suggests use formulas c b appropriate accurate kt v calculation formula c may simpler easier uf w required serial kt v could easily accurately calculated using c quality assurance quantitation dialysis,C12,0.0029618456,0.002627305,0.019857047,0.015994033,0.0041242763,0.003926767,0.2445755,0.0027894292,0.0021412827,0.0029101872,0.14018197,0.020422379,0.20100062,0.006810341,0.012372343,0.018947683,0.079142325,0.003115125,0.0033975663,0.06625378,0.12434866,0.0010516437,0.02104785
efficacy tolerability topical terbinafine treatment tinea cruris thirty men clinical mycologic evidence tinea cruris enrolled controlled randomized double blind trial comparing terbinafine cream cream vehicle placebo patients applied test medications affected area twice daily weeks therapeutic response evaluable patients week treatment follow visit weeks therapy ended visit terbinafine found effective cream vehicle reduction signs symptoms infection conversion culture microscopy findings negative normal end treatment therapy effective nine terbinafine treated patients compared nine placebo treated patients follow examination efficacy rates terbinafine treatment group placebo group difference borderline statistical significance p possible reasons result may include higher incidence chronic disease terbinafine group large number patients classified delayed exclusions negative initial culture dermatophytes side effects significant alterations laboratory hematologic tests observed either treatment group,C01,0.0019910994,0.0017662045,0.03524196,0.0011187176,0.0027729124,0.0025696175,0.293414,0.001872454,0.011068771,0.011592114,0.08259427,0.045516,0.030367011,0.026356656,0.0017509225,0.0031058071,0.16667856,0.0020515674,0.060100004,0.07579818,0.13951786,0.0007069671,0.0020483697
intraocular pressure changes postural changes intraocular pressure experimentally induced hansen disease rhesus mangabey african green monkeys long term evaluation patients hansen disease frequently found reduction intraocular pressure furthermore noted changes intraocular pressure change posture determine changes significance measured intraocular pressures experimentally infected control monkeys sitting reclining positions found significant reduction intraocular pressure compared controls sitting position significant increase intraocular pressure checked first sitting reclining position offer possible pathophysiological explanation changes occur,C01,0.03886982,0.0032292216,0.0067926194,0.0020453956,0.105080225,0.004698133,0.21086422,0.0034234817,0.0026318512,0.0035769125,0.017333273,0.007716544,0.21620709,0.008546764,0.003201281,0.040907532,0.07998362,0.0037490143,0.0041451375,0.058623478,0.17333671,0.0012925758,0.0037451151
patterns bacterial infection calves implanted artificial hearts device related infection one serious potential consequences total artificial heart tah implantation complication must addressed full potential benefit devices especially fully implantable devices realized review research reports clinical data conducted ascertain similarities existed patterns infection reported human tah recipients seen experimental animal models infection reported approximately human tah recipients approximately implanted animals implant periods ranged days humans days animals spectrum organisms isolated groups similar high proportion infections caused pseudomonas aeruginosa staphylococcus epidermidis addition numerous isolates enterobacter enterococci obtained animals positive blood cultures often observed animals within weeks following implantation devices similarities noted review suggest calf may appropriate animal model study pathogenesis tah related infection,C01,0.0019538025,0.039565314,0.022527032,0.01999268,0.0027206081,0.011891258,0.30562124,0.011286287,0.010865596,0.0019197258,0.017704815,0.033950992,0.058253054,0.07323452,0.0017181806,0.021954414,0.061820064,0.0020120926,0.021133665,0.020410324,0.25674883,0.0006937243,0.002021834
absence significant bacteremia urinary catheter manipulation patients chronic indwelling catheters objective study quantify microorganisms present blood urinary catheter removal reinsertion patients chronic indwelling urinary catheters prospective study month period university affiliated geriatric medical center subjects patients chronic indwelling urinary catheters positive urinary cultures urinary catheter usually changed month peripheral vein line used blood withdrawal urinary cultures quantitative blood cultures isolator performed shortly urinary catheter removal insertion patients significant bacteriuria greater cfu ml average microorganisms among sequential quantitative blood cultures performed two patients bacteremia urinary source low concentration one patient cfu ml str faecalis blood minutes removal urinary catheter cfu ml proteus mirabilis minutes reinsertion new urinary catheter none patients subjective objective clinical problem hours urinary manipulation clinical symptoms bacteremia rare events prophylactic antibiotics appear necessary urinary catheter removal reinsertion elderly institutionalized patients studies necessary identify risk factors rare instances patients bacteremia,C01,0.0017251052,0.009875218,0.11178856,0.0009692663,0.0024044705,0.0022263383,0.20064722,0.026672766,0.0012471743,0.0016987523,0.12675889,0.0035485304,0.15263343,0.038837727,0.001517014,0.019373992,0.16944878,0.0017765724,0.0019642862,0.031082647,0.09141604,0.0006125222,0.0017747247
individualizing treatment vaginal candidiasis clinicians vast array effective antimycotics treatment vaginal candidiasis multiple topical formulations available yet little evidence suggest formulation per se influences outcome growing number highly effective oral systemic antimycotic agents provide practitioner additional options treatment regimens also changed introduction shorter often single day single dose courses therapy therapeutic agents activity vaginal fungal pathogens topical azoles tend active nystatin differences patient characteristics however important differences antimycotic agents therapeutic regimens determining selection appropriate antimycotic patients vaginal candidiasis vary regard duration severity symptoms past frequency attacks distribution inflammation pregnancy status clinician consider variables selecting appropriate antimycotic agent route administration planning duration therapy individualized therapy offers additional benefits patients may enjoy maximum advantages antimycotics available,C01,0.0021133348,0.022334468,0.0039432636,0.0011873967,0.0029427519,0.0027273688,0.49352533,0.0019874058,0.001527847,0.0020787176,0.03992,0.0044166446,0.044590604,0.016961306,0.0018584133,0.064669885,0.059031397,0.0021763844,0.0024063427,0.112054676,0.11461289,0.00075036846,0.0021832061
mycoplasmal pneumonia thinking atypical presentations presentations mycoplasmal pneumonia varied sometimes complicated atypical nature illness opposed clear pattern findings classic bacterial pneumonias leads physician diagnosis appropriate therapy allows quick improvement rule sequelae,C01,0.0069432827,0.0061590383,0.012955446,0.0039011473,0.009668302,0.04256719,0.37262392,0.0065295473,0.0050196843,0.0068221833,0.07753161,0.014281006,0.047088742,0.015964752,0.0061057475,0.04442293,0.09417627,0.00715043,0.04151696,0.044362586,0.124600925,0.0024653075,0.007142993
early postoperative care cardiac transplantation patient routine considerations immunosuppressive therapy authors attempted outline current state art respect early postoperative management cardiac transplant recipient special attention immunosuppressive therapies commonly used agents well successful combination regimens described along current levels expectation regarding rates rejection infection much learned regarding management problems much remains learned decrease incidence postoperative infection rejection equally importantly studies investigate etiology transplant coronary artery disease need undertaken measures delay prevent occurrence arrest progression instituted,C01,0.0028011058,0.029135376,0.005226573,0.015121571,0.003918558,0.004077864,0.31203914,0.002634194,0.0020250748,0.016309476,0.025254212,0.0057613393,0.06245626,0.0065715224,0.0024632218,0.03148071,0.25861138,0.0028846746,0.003189471,0.11513444,0.08902765,0.0009945709,0.0028816746
ceftazidime clindamycin versus tobramycin clindamycin treatment intra abdominal infections order assess efficacy toxicity ceftazidime substitute aminoglycosides treatment intra abdominal sepsis prospective randomized trial conducted ninety four patients trauma randomized receive ceftazidime clindamycin caz c n tobramycin clindamycin c n caz gm c gm administered intravenously every hours dosage adjusted maintain peak mg l trough less mg l concentrations age sex baseline serum creatinine etiology infection comparable two groups clinical cure similar culture positive culture negative patients received caz c vs clinical cure rate however significantly lower c culture positive culture negative patients p pathogenic organisms eradicated caz c c patients respectively p nephrotoxicity nephrotoxicity ototoxicity observed none caz c patients one two c patients respectively caz c effectively eradicated bacteria isolated patients significant difference clinical response observed culture positive patients findings plus lack toxicity suggest caz c effective alternative treatment iai,C01,0.0022765435,0.013023352,0.015266627,0.023319663,0.0031700148,0.0029379982,0.25017327,0.0021408892,0.01264716,0.0022368378,0.06725883,0.020589067,0.112431675,0.06466456,0.002001935,0.003545052,0.15323797,0.013346538,0.024624523,0.069123425,0.13883376,0.0008083179,0.0023420241
restriction endonuclease analysis total cellular dna aspergillus fumigatus isolates geographically epidemiologically diverse origin typing system exists aspergillus fumigatus though isolates distinguishable phenotypic characteristics dna prepared lysis protoplasts followed deproteination phenolchloroform extraction dialysis dna prepared uniform size exceeded kb digestion sali xhoi endonucleases dna electrophoresed stained photographed differences mobilities kb bands distinguished isolates reproducibility shown repeated preparations animal passage use proposed notation system describing restriction fragment length polymorphism patterns epidemiologically characterized isolates three continents revealed patterns dna types three dna types represented isolates dna type isolates types unique two groups isolates dna type stanford university hospital one patient isolate stanford dna type sewage isolate new jersey another stanford isolate german isolate observations indicate widespread dispersal clones restricted locales others paired isolates airway fluids three patients two dna types restriction endonuclease typing shows promise investigating epidemiology ecology fumigatus,C01,0.0021578479,0.0019141188,0.004034957,0.037773214,0.0030486751,0.02367158,0.37256426,0.012417511,0.001560028,0.0021202122,0.011384106,0.038390685,0.029997278,0.0056110406,0.012350672,0.003360218,0.08889764,0.002223702,0.01282702,0.027131883,0.16942815,0.00076617335,0.13636905
protection mice lyme disease agent immunizing recombinant ospa lyme borreliosis tick borne illness caused borrelia burgdorferi gene outer surface protein ospa b burgdorferi strain n cloned expression vector expressed escherichia coli c h hej mice actively immunized live transformed e coli purified recombinant ospa protein produced antibodies ospa protected challenge several strains b burgdorferi recombinant ospa candidate vaccine lyme borreliosis,C01,0.005472318,0.004854219,0.011026591,0.0030746723,0.007620029,0.033537153,0.19651857,0.005146234,0.0039562425,0.031863436,0.02516658,0.011255512,0.03392902,0.10784765,0.0048122182,0.008521537,0.09444753,0.058620576,0.006231039,0.06952336,0.12665634,0.0019430213,0.14797617
comparison species distribution antimicrobial susceptibility aerobic actinomycetes clinical specimens compare species distribution antimicrobial susceptibility aerobic actinomycetes evaluated isolates referred centers disease control october february used conventional biochemical tests identify various species four species accounted aerobic actinomycete isolates nocardia asteroides isolates actinomadura madurae isolates streptomyces griseus isolates nocardia brasiliensis isolates sputum wounds common sources isolate resistant amikacin n brasiliensis isolate resistant sulfamethoxazole trimethoprim sulfamethoxazole madurae isolate resistant ceftriaxone imipenem summary findings show unusual species aerobic actinomycetes cause infection colonization antimicrobial resistance varies markedly species,C01,0.0036403893,0.003229207,0.006792589,0.0020453862,0.005069127,0.03991265,0.43127325,0.003423466,0.020231916,0.0035768964,0.12906764,0.0075727166,0.06484188,0.008410986,0.0032012665,0.005668843,0.050897114,0.0037489973,0.004145119,0.062171996,0.13604088,0.00129257,0.0037450984
ringer acetate dextran without hypertonic saline endotoxin induced shock pigs effects ringer acetate dextran nacl combination nacl dextran tested resuscitation endotoxin shock induced continuous iv infusion escherichia coli endotoxin pigs h reproducible shock state achieved treatment started governed left atrial pressure hypertonic solutions nacl nacl dextran show overall advantages isotonic solutions ringer acetate dextran transient beneficial hemodynamic effects lasting less min infusion seen dextran administered cardiovascular function markedly improved oxygen delivery survival significantly higher compared crystalloid groups ringer acetate nacl administration large amounts ringer acetate resulted immediate deterioration pulmonary function difficult elevate left atrial pressure even keep baseline level cardiac index transiently increased overall result deterioration poor survival compared dextran treated pigs conclude dextran superior ringer acetate resuscitation endotoxin induced shock pigs furthermore found role use hypertonic saline alone combination dextran treatment type prolonged endotoxin shock,C01,0.012193219,0.0018557891,0.0039311796,0.0011755364,0.0029670626,0.0027303698,0.14399724,0.022221986,0.0116362525,0.0020556024,0.03494656,0.06688814,0.14913437,0.015535638,0.001839732,0.00326653,0.15443662,0.002154507,0.0023821534,0.017169511,0.34458688,0.0007428255,0.002152266
impetigo current etiology comparison penicillin erythromycin cephalexin therapies attempted determine causative bacterial pathogens impetigo children area compare effectiveness three frequently used oral antimicrobial treatment regimens correlate antimicrobial sensitivity bacterial isolates clinical responses treatment seventy three children impetigo randomly assigned receive penicillin v potassium cephalexin monohydrate administered dosages mg kg per day erythromycin estolate administered dosage mg kg per day drugs given three divided doses days treatment failure defined persistence lesions days initiation drug therapy determined examiners blinded treatment therapies forty five cultures showed staphylococcus aureus showed aureus group beta hemolytic streptococci six showed group beta hemolytic streptococci eight showed growth organisms treatment failure occurred six patients treated penicillin v one patients treated erythromycin estolate patients treated cephalexin conclude aureus common cause impetigo children study population cephalexin effective treatment erythromycin estolate nearly equally effective may preferred cost effectiveness basis penicillin v inadequate treatment infection,C01,0.002180188,0.040027384,0.0146192,0.0012249587,0.013589312,0.017472446,0.3949179,0.0020502752,0.0015761788,0.033806432,0.010427311,0.06260844,0.022460677,0.026147095,0.0019172023,0.02450133,0.082731724,0.0022452322,0.023587111,0.04898812,0.14879738,0.00077410555,0.023349956
national immunization program netherlands brief explanation immunization policy netherlands national immunization program described special attention given coupling municipal population records computerized database individual immunization records provincial level dutch program achieves coverage rates greater routine immunizations participation program free charge every child living country age years obligation requirement immunized financing program also discussed,C01,0.0046160636,0.004094679,0.030950043,0.0025935778,0.0064277225,0.028294353,0.20239559,0.004341002,0.0033372086,0.049227856,0.079737134,0.009774734,0.033193756,0.010649288,0.00405925,0.029519059,0.09908719,0.00475378,0.13587251,0.13277209,0.11791528,0.0016389965,0.004748836
superficial cultures neonatal sepsis evaluations impact antibiotic decision making authors performed retrospective analysis neonatal superficial cultures effect antimicrobial decision making nine month period nashville general hospital obtained reviewed charts infants n paired superficial skin gastric aspirate deep blood cerebrospinal fluid cultures evaluation early onset sepsis superficial cultures positive pathogens streptococcus enteric gram negative cases antimicrobial decision making affected one cases seemingly inappropriate manner summary evidence review superficial cultures used sepsis evaluation influenced physician antimicrobial decision making one case may led unnecessary antibiotic exposure,C01,0.0032404063,0.002874402,0.006046262,0.0018206522,0.06726153,0.004181913,0.23184446,0.0030473173,0.033694677,0.018868659,0.14009309,0.0066648964,0.039984006,0.08692677,0.0028495316,0.02071725,0.16377322,0.0033370813,0.015842693,0.081056565,0.061382852,0.0011505506,0.003341209
inactivation antithrombin iii serum elastase patients surgical infections relationship serum elastase antithrombin iii determined septic surgical patients possible mechanism intravascular thrombosis hypercoagulability sepsis eighteen patients surgical infections elevated white blood cell counts blood assayed daily white blood cell count serum elastase antithrombin iii patient white blood cell count returned normal antithrombin iii significantly lower elastase normal range greater micrograms ml elastase significantly higher micrograms ml antithrombin iii less normal data indicate elevated serum elastase associated significant reduction circulating antithrombin iii stimuli increase serum elastase e surgery trauma sepsis may promote intravascular thrombosis inhibition antithrombin iii blood endothelial cell interface,C01,0.0026230535,0.0023267793,0.0048943455,0.0014737868,0.0036525188,0.0033851871,0.13425544,0.015155021,0.039991207,0.0025773041,0.012090546,0.005395213,0.17599118,0.08752832,0.0023066471,0.0040846397,0.16673717,0.0027133424,0.0029867322,0.024390945,0.30181077,0.000931351,0.0026985006
oral terbinafine versus griseofulvin treatment moccasin type tinea pedis safety effectiveness oral terbinafine mg twice daily griseofulvin mg twice daily patients moccasin type tinea pedis examined double blind randomized trial end week treatment period clinical mycologic cure mycologic cure minimal signs infection noted terbinafine treated patients compared patients treated griseofulvin overall response rate weeks completion treatment terbinafine treated group griseofulvin treated group contacted months completion study terbinafine treated patients reported sustained clearing tinea pedis nail involvement time treatment reported improvement contrast tinea pedis remained cured patients received griseofulvin onychomycosis improved,C01,0.002961689,0.03129917,0.005526204,0.048502807,0.004124058,0.0038222137,0.24031131,0.0027852082,0.0021411693,0.017242517,0.014168149,0.040202122,0.04325279,0.0068691736,0.0026044345,0.004614826,0.2850401,0.0030500486,0.017704375,0.02413773,0.19554138,0.0010515881,0.0030468763
giant basilar aneurysm course subacute bacterial endocarditis describe man aged years mitral valve regurgitation suffered subacute bacterial endocarditis caused streptococcus morbillorum clinical picture began toxic syndrome five months later patient embolic episode right rostral pontine stroke followed days later adversive focal seizure right despite antibiotic treatment suffered complete third nerve palsy arteriography magnetic resonance imaging computed tomography brain showed giant aneurysm rostral end basilar artery aneurysm clipped discuss clinical features radiology characteristics aneurysm unique case giant bacterial aneurysm vertebrobasilar system,C01,0.07412276,0.003228961,0.0067920713,0.0020452305,0.0579323,0.004697754,0.22201227,0.038665786,0.002631639,0.0035906364,0.03884636,0.007487015,0.043484446,0.008369742,0.0032010227,0.0056684115,0.20023453,0.003748712,0.021764182,0.18721195,0.059226934,0.0012924715,0.0037448131
platelet activating factor platelet activating factor antagonist decreases tumor necrosis factor alpha plasma mice treated endotoxin l platelet activating factor paf alprazolam paf antagonist administered lipopolysaccharide lps treated mice level plasma tumor necrosis factor tnf alpha determined either elisa cytotoxic assay using wehi cells significantly lowered inactive stereoisomer paf effective lowering plasma tnf alpha levels lps treated mice decrease plasma tnf alpha induced l paf alprazolam partly reversed indomethacin despite decrease plasma tnf alpha l paf alprazolam caused increase amount tnf alpha mrna present kidneys livers lps treated mice suggesting posttranscriptional event leading synthesis release tnf alpha inhibited agents,C01,0.03163096,0.0026270328,0.0055259243,0.0016639679,0.004123849,0.0038220203,0.15212016,0.002785067,0.0021410608,0.002909886,0.0145048015,0.0061421245,0.026128689,0.17667955,0.0026043025,0.018177027,0.036955394,0.031715047,0.0033721477,0.024649596,0.3882814,0.029722517,0.031717435
antimicrobial resistance shigella isolates usa importance international travelers nationwide sample shigella isolates collected tested resistance antimicrobial agents assess prevalence epidemiologic correlates antimicrobial resistance shigella isolates resistant ampicillin trimethoprim sulfamethoxazole nalidixic acid fifty isolates associated foreign travel best predictor clinically important resistance history foreign travel isolates foreign travelers showed trimethoprim sulfamethoxazole resistance compared isolates without history quinolone resistance identified travel related isolates quinolones may appropriate initial therapy travel related shigellosis trimethoprim sulfamethoxazole,C01,0.0039158436,0.0034735487,0.007306558,0.002200153,0.0054526883,0.118797824,0.39195606,0.0036825067,0.0028309808,0.0038475464,0.08455329,0.008054142,0.043287363,0.009044076,0.060314097,0.025051845,0.05252885,0.0040326696,0.004458764,0.10372148,0.056070853,0.0013903738,0.004028476
vitro evaluation nicotinamide riboside analogs haemophilus influenzae exogenous nad nicotinamide mononucleotide nicotinamide riboside required growth haemophilus influenzae compounds defined v factor growth requirement previously shown internalization nicotinamide riboside energy dependent carrier mediated saturation kinetics thionicotinamide riboside pyridinealdehyde riboside acetylpyridine riboside aminopyridine riboside prepared corresponding nad analogs compounds several nicotinamide riboside analogs evaluated ability support growth h influenzae ability block uptake carbonyl c nicotinamide riboside h influenzae aminopyridine riboside blocked uptake carbonyl c nicotinamide riboside inhibited growth h influenzae nad nicotinamide mononucleotide nicotinamide riboside served v factor antibacterial activity aminopyridine riboside found specific h influenzae effect growth staphylococcus aureus escherichia coli additional experiments reversed phase high performance liquid chromatography determined whole cells h influenzae degrade aminopyridine adenine dinucleotide aminopyridine riboside internalized inside cell aminopyridine riboside ability interfere growth h influenzae undetermined mechanism,C01,0.0032404768,0.0028744645,0.021720115,0.0018206917,0.020198444,0.019859437,0.20926929,0.0030473836,0.0023427205,0.0031839586,0.017018376,0.057390217,0.023095364,0.20915037,0.0028495935,0.05210508,0.033379313,0.003360603,0.05073397,0.04870818,0.19421557,0.0011505756,0.01928577
effects method hemostasis wound infection rate adequate hemostasis important preventing postoperative wound infection study compared four methods hemostasis specific pinpoint vessel electrocautery spc specific vessel ligation vicryl svl nonspecific electrocautery vessel plus excessive surrounding tissue nsc nonspecific ligation vessel excessive surrounding tissue vicryl nsl rate wound infection rabbits contaminated staphylococcus aureus statistical significant increase rate wound sepsis electrocautery used fashion producing minimal nonviable tissue compared specific vessel ligation electrocautery use specific vessel hemostasis result higher wound infection rate contaminated wounds,C01,0.0031418905,0.017995367,0.005862442,0.0017653002,0.0043749833,0.01925524,0.20806107,0.002989273,0.002271447,0.003087092,0.04830427,0.0343084,0.031509712,0.022174839,0.0027628993,0.004897643,0.09012445,0.0032356265,0.0035775045,0.18093446,0.25938222,0.04673924,0.0032446003
reduction contamination total hip replacement special working clothes assessed wound air operative field contamination total hip operations performed zonal ventilation system theatre staff wore either specially designed polypropylene non woven coverall conventional cotton shirt trousers surgeons wore partially impermeable operating gowns polypropylene coverall associated significantly lower air wound counts coverall warmer cotton judged acceptable combined use zonal ventilation coverall achieved ultra clean air conditions,C01,0.0047217067,0.0041883895,0.027328582,0.0026529345,0.0065748272,0.056138135,0.1718868,0.0044403505,0.0034135839,0.0046393545,0.047728922,0.009712201,0.04974343,0.010856663,0.00415215,0.0074446565,0.18144603,0.0048625753,0.005721341,0.24579659,0.14001672,0.0016765066,0.004857518
activity compound g isolated alfalfa roots experimental dermatophyte infection compound g isolated alfalfa roots applied topically skin lesions guinea pigs experimentally infected dermatophyte trichophyton mentagrophytes var granulare applications infected lesions cured judged clinical microbial criteria compared untreated lesions healed spontaneously p less,C01,0.031941555,0.0048539066,0.010887446,0.029563116,0.14007467,0.007061857,0.23462945,0.0051459027,0.0039559877,0.0053765276,0.051650897,0.06422609,0.07371124,0.013111559,0.0048119086,0.035007685,0.047853548,0.0056352173,0.006230638,0.037651602,0.17904696,0.0019428962,0.0056293565
general model sexually transmitted disease epidemiology implications control achieving control stds may possible integrating activities discussed previously research provide additional empiric data sex behavior develop innovative strategies access communicate risk std e core group members foster biologic study std pathogens goal vaccine development new strategies identify core group members aside currently used std repeater status would immense help targeting educational efforts laboratory screening vaccines achieving complete control stds may possible recent advances understanding epidemiology transmission dynamics translated effective new interventional strategies,C01,0.0030951384,0.0027455422,0.020747753,0.001739032,0.004309882,0.022073394,0.3446226,0.0029107055,0.0022376473,0.003045654,0.03617099,0.058471918,0.029231241,0.025843384,0.0027217865,0.004819774,0.086144984,0.018165668,0.07485306,0.09828472,0.15348072,0.0010989711,0.0031854417
antimicrobial prophylaxis open heart operations adults undergoing coronary artery bypass cardiac valve replacement enrolled prospective randomized comparative trial cephalothin versus cefamandole perioperative prophylaxis assessed hospitalization weeks months discharge postoperative infectious complications eleven patients major postoperative infections including sternal wound infections three bacteremic bacteremia prosthetic valve endocarditis severe venous donor graft site infections eight major infections occurred patients receiving cephalothin prophylaxis three patients receiving cefamandole five sternal wound infections occurring cephalothin group postoperative pathogens responsible major infections included gram negative aerobes patients staphylococcus aureus staphylococcus epidermidis preoperative colonizing staphylococcal isolates predictive postoperative staphylococcal pathogens although statistically significant difference rate major postoperative infectious complications using either cephalothin cefamandole prophylaxis trend favor cefamandole gram negative aerobes becoming increasingly important pathogens setting,C01,0.0025956081,0.014821372,0.00483346,0.013980399,0.0036070815,0.025600638,0.3739696,0.014968811,0.0018727602,0.0025452424,0.012244276,0.026503166,0.022772774,0.005956182,0.0022779524,0.0040338268,0.33670834,0.015648926,0.018304143,0.05497498,0.038195744,0.000919765,0.0026649314
safety evaluation prp haemophilus influenzae type b conjugate vaccine children immunized months age older follow study children evaluated safety prp conjugate hib vaccine prohibit connaught children vaccinated months age southern california kaiser permanente medical clinics period april july surveillance potential reactions involved postcard questionnaires telephone surveys reports kaiser staff review hospitalizations covered two periods following immunization first hours days surveillance invasive hib disease involved methods addition systematic reviews laboratory hospital records january rates local systemic reactions within hours vaccination prp alone low less equal fever greater degrees f local redness swelling similar previously reported vaccination prp hospitalization seizures vaccinated children respectively occurring within month immunization appeared unrelated vaccination one month old child onset fatal episode hib sepsis meningitis within hours vaccination also month old child developed hib meningitis months prp vaccination conclude prp safe given alone combination childhood vaccines months age,C01,0.002227306,0.023536164,0.02584166,0.0012514762,0.01388258,0.013650954,0.28332937,0.0020945854,0.001610243,0.07766894,0.033416364,0.028055603,0.08480227,0.005144564,0.0019586366,0.0034683784,0.21015728,0.0022937558,0.013313311,0.11850653,0.050707873,0.0007908354,0.0022913702
chancroid results outbreak houston texas recent continuing epidemic chancroid houston included morphologic variation disease including called dwarf classic giant transient follicular phagedenic pseudogranuloma inguinale types cases clearly acquired unprotected sexual encounters local prostitutes strain haemophilus ducreyi responsible outbreak relatively easily cultured routine media unexpected sensitivity strain vancomycin rendered recommended selective growth medium much less optimal isolation therapeutic success uniformly followed use intramuscular ceftriaxone sodium one case responded oral ciprofloxacin hydrochloride,C01,0.042636506,0.0035412929,0.02677281,0.0022431626,0.0055590314,0.00515216,0.39304206,0.0037543264,0.0028861929,0.02324555,0.087738104,0.02753369,0.06388554,0.03153677,0.003510652,0.006216707,0.106288426,0.023400338,0.023853142,0.049315352,0.06236364,0.0014174901,0.004107042
seven day administration recombinant human granulocyte colony stimulating factor newborn rats modulation neonatal neutrophilia myelopoiesis group b streptococcus sepsis single pulse administration rhg colony stimulating factor csf neonatal rats previously demonstrated induce peripheral neutrophilia modulate bone marrow bm neutrophil storage proliferative pools nsp npp study investigated prolonged effects days rhg csf therapy micrograms kg per day sprague dawley newborn rats less equal hours injected intraperitoneally ip daily days rhg csf phosphate buffered saline human serum albumin pbs hsa rhg csf induced significant early late peripheral neutrophilia day microl day v microl p less equal addition days rhg csf resulted significant increase bm nsp microl v microl p less equal however depletion significant change bm npp seven days rhg csf also induced mild increase bm cfu gm colony formation p less equal however significant change liver spleen cfu gm colonies cfu gm proliferative rate either bm liver spleen cultures finally days prophylactic rhg csf therapy resulted synergistic response antibiotic therapy significantly modulated mortality rate experimental group b streptococcal sepsis gbs v gvsc p less equal pulse rhg csf administered hours hours gbs inoculation however failed act synergistically antibiotics improve survival prevent peripheral neutropenia study suggests days prophylactic rhg csf therapy induces peripheral neutrophilia myeloid maturation increases neutrophil bm reserves also may provide immunologic enhancement neonatal host defense experimental gbs term neonatal rats,C01,0.0015108014,0.023278488,0.010119794,0.0008488577,0.0021038207,0.009224171,0.09946123,0.0014207759,0.0010922422,0.0014844511,0.007287615,0.02870228,0.08658841,0.040454056,0.0013285606,0.031376347,0.120179474,0.008865013,0.0017202696,0.061236784,0.45160887,0.0005364307,0.00957123
selection antibiotic coverage vascular patients undergoing cystoscopy bacteremic seeding prosthetic vascular grafts represents cause graft infection transurethral procedures account one source bacteremia therefore prospective study patients undergoing cystoscopy conducted identify incidence bacteruria factors associated organisms involved antibiotic sensitivities positive cultures found incidence patients patients positive cultures found patients received antibiotics four percent showed signs bacteremia cultures identified gram positive negative organisms multiple organisms grew gram negative organisms common patients candida grew gram positive organisms sensitive ampicillin sulfatrimethoprim cefazolin gram negative aminoglycosides cefazolin view unpredictable multiple organisms recommended pre cystoscopy cultures performed specific antibiotic coverage based sensitivities,C01,0.0029197496,0.0025899636,0.046642024,0.0016404882,0.004065659,0.003768089,0.22078848,0.0301604,0.002110849,0.016998269,0.15867098,0.006550694,0.032589357,0.12099806,0.0025675541,0.004546657,0.21505094,0.003006858,0.0033245643,0.0583372,0.05863156,0.001036697,0.003004931
clostridium difficile invasion toxin circulation fatal pediatric pseudomembranous colitis direct involvement clostridium difficile lesional tissue pseudomembranous colitis demonstrated organism effects assumed strictly toxin mediated c difficile cytotoxin may found incidentally intestinal lumina asymptomatic infants role organism variety pediatric intestinal diseases uncertain authors studied seven cases fatal pediatric pseudomembranous colitis presence c difficile uniformly demonstrable lesional tissues use intestinal spore stain specific immunostain patients either underlying hirschsprung disease hematologic malignancy striking pathologic features peculiar patients altered mucosal mucin immunologic barriers former group neutropenia latter two patients demonstrable circulating cytotoxin serum ascitic fluid c difficile identified invading colonic mucosa submucosa phenomena occur control pediatric patients multiple intestinal lesions altered host factors may responsible intestinal invasion c difficile systemic toxin circulation cases fatal pediatric pseudomembranous colitis,C01,0.0026573753,0.0023572245,0.0049583865,0.0014930709,0.0423043,0.042019133,0.32525834,0.015335336,0.0019211641,0.0026110273,0.08372759,0.01879495,0.061105274,0.04381986,0.0023368287,0.004138086,0.14106768,0.02090429,0.0030258128,0.035432007,0.14105363,0.00094353745,0.002735055
use latex agglutination technique detecting legionella pneumophila serogroup antibodies following outbreak legionnaires disease stafford serum samples submitted indirect immunofluorescence antibody test latex agglutination latex agglutination using ultrasonically disrupted legionella pneumophila antigens coupled latex particles proved rapid simple method detecting circulating antibodies l pneumophila one minute slide latex agglutination test good correlation indirect immunofluorescence antibody test ifat specificity sensitivity respect diagnostic result respectively using series well characterised sera latex agglutination test seems well suited screening test presumptive cases legionnaires disease latex reagent easy prepare seems remain stable degrees c six months,C01,0.0030492805,0.002704864,0.020601109,0.0017132664,0.0042460267,0.0039352556,0.22715321,0.0028675804,0.002204494,0.0029960973,0.2723835,0.021402985,0.11426648,0.08375158,0.0026814605,0.004748364,0.0663288,0.0031806622,0.0034720544,0.050563846,0.08646092,0.0010826887,0.018205486
prevalence diagnosis legionella pneumonia year prospective study emphasis application urinary antigen detection year period frequency legionellosis hospitalized patients community acquired nosocomial pneumonias cases respectively diagnostic tests evaluated detection legionella pneumophila serogroup antigen urine highest sensitivity culture proven cases positive sensitivities serologic tests examination respiratory secretions culture direct immunofluorescence respectively diagnostic value serology examination respiratory secretions low specimens obtained processed typical conditions hospitalization urinary antigen detection represents important diagnostic addition examination postmortem lung tissue fatal cases pneumonia important adjunct estimating prevalence legionellosis assessing effectiveness premortem diagnostic tests,C01,0.0025581503,0.014649359,0.054309014,0.0014373203,0.003562143,0.028067077,0.13921952,0.014780585,0.0018494288,0.027278127,0.31032407,0.018739592,0.058215663,0.07843699,0.0022495727,0.04113185,0.064633995,0.0026344706,0.0029128303,0.077759616,0.05171054,0.0009083062,0.0026317306
treatment oral candidosis itraconazole review oral candidosis common infection infants elderly persons patients receiving immunosuppressive therapy patients acquired immunodeficiency syndrome aids orally active antifungal agent itraconazole evaluated number different patient populations oral oropharyngeal candidosis initial studies shown itraconazole mg day days active placebo treating oral candidosis comparative study itraconazole capsules mg daily clotrimazole troches mg five times daily showed equivalent results end therapy significantly faster response itraconazole faster relapse rate clotrimazole study aids patients oropharyngeal candidosis demonstrated itraconazole mg day ketoconazole mg day weeks give equivalent clinical cure rates similar relapse rates pilot study oral solution itraconazole given impressive clinical mycological response rate within week treatment conclusion itraconazole capsule solution form may constitute major addition armamentarium drugs oropharyngeal candidosis,C01,0.0021353457,0.0122170895,0.02465711,0.021867743,0.002973572,0.0027557749,0.3104916,0.002008105,0.0015437598,0.0020981026,0.02143961,0.032528784,0.020236304,0.0050752973,0.0018777691,0.023991542,0.1163858,0.0021990521,0.01276724,0.089043625,0.26780316,0.00075818365,0.023145447
parents vs physicians utilities values clinical outcomes potentially bacteremic children previous analyses decision strategies children months acute onset fever greater equal degrees c evident bacterial focus infection indicated risks routine blood cultures unnecessary hospitalization treatment children clear bacteremia spontaneously outweigh benefits prevention cases major infectious sequelae analyses based parents values beneficial adverse clinical outcomes wished examine whether values differed physicians whether differences sufficient change results decision analysis using pre tested linear analog utility value scale evaluated eight potential clinical outcomes potentially bacteremic children surveying parents healthy month old children attending private pediatric group practice attending physicians tertiary care children hospital emergency room utilities based normalization utility worst outcome meningitis major bacterial infection plus venipuncture utility best outcome complete recovery without venipuncture hospitalization analyzed using recently developed statistical model utility majority parents physicians combined imputed components outcomes disease pain venipuncture stress hospitalization nonlinear fashion parents assigned substantially lower utility e greater disutility venipuncture minor infection hospitalization physicians utilities even lower parents children home,C01,0.0016968763,0.017924057,0.019643558,0.0009534056,0.0023628464,0.018613698,0.26783964,0.001595763,0.009429392,0.06738713,0.03790096,0.028532153,0.100062884,0.01211912,0.009704294,0.010842337,0.05634108,0.0017475012,0.10871907,0.15051055,0.06550272,0.008814812,0.0017561729
hemofiltration reverses left ventricular dysfunction sepsis dogs depressed left ventricular lv contractility sepsis ascribed presence circulating cardiodepressant substance filterable cardiodepressant factor sepsis fcs however finding controversial authors hypothesized decrease lv contractility indeed occurred due circulating depressant substance removal substance hemofiltration would reverse dysfunction study lv mechanics examined hemofiltration anesthetized dogs continuous intravenous infusion live escherichia coli left ventricular anterior posterior apex base dimensions measured subendocardial ultrasonic crystal transducers implanted weeks experiments left ventricular contractility determined end systolic pressure dimension relationship slope relationship emax index contractility h sepsis emax reduced one half hemofiltration resulted return emax control values fcs activity plasma also assessed percent reduction isometric contraction electrically stimulated isolated right ventricular trabeculae obtained nonseptic dogs fcs activity reached peak h sepsis reduced h hemofiltration results show experimental sepsis circulating substance less produces decrease lv contractility lv dysfunction may improved hemofiltration,C01,0.03418869,0.001913966,0.014862838,0.0012123099,0.003004495,0.0027845928,0.08976741,0.0020291044,0.0015599035,0.02299235,0.03562313,0.03039201,0.15387559,0.051840577,0.0018974056,0.0033618885,0.13665138,0.0022220484,0.0024568313,0.030541113,0.31116986,0.04254762,0.023104856
bioaerosols prevalence health effects indoor environment assessing role bioaerosols residence related symptoms involves determining symptoms related residence medical examination careful questioning connecting reported symptoms known hypothesized effects bioaerosols examining residence bioaerosol risk factors overcrowding poor ventilation inappropriate outdoor air intrusion dampness standing water finally obvious risk factors present air sampling air sampling always last resort use reliable volumetric method particulate samplers burkard personal spore trap inexpensive alternatives viable particle samplers provide data organisms implicated hypersensitivity diseases interpretation residential bioaerosol sample data requires qualitative quantitative comparison adjacent outdoor air examination aerosol changes related domestic activities recommendations lead decrease indoor bioaerosols include use air conditioning allow limitation outdoor aerosols prevention dampness moisture intrusion discouraging use humidifying devices steam bioaerosol assessment workplace often complex residences symptomatic subjects charge environment situations often lead difficult employee management relations occasionally litigation essential step workplace bioaerosol assessment defensible best possible methods used approach similar approach used residences larger scale symptom assessment must include stress ergonomic factors air sampling necessary must usually extensive controls ventilation rates occupancy spatial variation,C01,0.0017398362,0.018386073,0.030068344,0.0009775431,0.0024228878,0.020686498,0.37897375,0.0016361631,0.0096687935,0.0113583,0.089931294,0.021118693,0.043061275,0.02576726,0.009950053,0.01954362,0.056306105,0.010193502,0.018818192,0.14360487,0.07489674,0.0006177526,0.010272448
percutaneous central venous catheterization three years experience neonatal intensive care unit prolonged venous access desirable low birth weight infants infants feedings contraindicated prospectively evaluated small diameter venous catheters placed percutaneously patients years catheters placed infants weighing kg less mean catheter stay days range less days almost half central thoracic catheters placements removed nonelectively due problems leaking clotting suspicion sepsis venous occlusion episodes possible sepsis catheter stays six confirmed catheter related sepsis confirmed alternate locus sepsis three factors specific percutaneous central venous catheter related sepsis prolonged catheter stay weeks staphylococcus epidermidis weight less equal kg four factors specific alternate locus sepsis presence alternate infection site earlier infection weeks extremely low birth weight prolonged clinical instability percutaneous central venous catheterizations reduced need stress repeated venipuncture resulting lower complication rates reported surgically placed central venous catheters leading identification risk factors specific catheter sepsis alternate locus sepsis,C01,0.01863695,0.001517673,0.011469447,0.0009612972,0.0023824044,0.0022080338,0.13800447,0.026451375,0.009510889,0.0016810811,0.1102019,0.003587298,0.039426632,0.07347904,0.009784643,0.002664261,0.29229686,0.0017697173,0.0019481361,0.11364284,0.09381858,0.017158395,0.027398044
protective effects polyclonal sera monoclonal antibodies active salmonella minnesota lipopolysaccharide experimental endotoxemia mice passively immunized sera blood donors active rough lipopolysaccharides lps j rc chemotype mutant escherichia coli b chemotype mutant salmonella minnesota protected mice lethal challenge smooth e coli wf lps e coli salmonella rough mutant lps free lipid epitopes recognized monoclonal antibodies mabs reacting lps minnesota lipid localized keto deoxy manno octulosonic acid kdo region lipid core reactive mabs reacted homologous lps free lipid one gl cross reacted kdo alone mabs gl gl l l l protected actinomycin sensitized mice lethal effects lps e coli wf salmonella enteritidis e coli j minnesota free lipid gl antibody also protective injected lps challenge results indicate antibodies directed core glycolipid minnesota lps may useful additive form therapy may enable decreased mortality gram negative bacterial sepsis,C01,0.0031418563,0.0027869833,0.005862378,0.038159993,0.0043749353,0.0040547294,0.28013912,0.0029546397,0.0022714222,0.0030870584,0.01807537,0.0216561,0.03626846,0.08826451,0.07881188,0.02008184,0.042712387,0.086240344,0.01878464,0.03528254,0.20254095,0.001115559,0.0033322647
infection control nursing home physician role infection control nursing home long term care facility increasingly complex activity high rates approximately special risks group activities crowding nosocomial infection demand special attention attending physicians specific responsibilities include recognition infection knowledge use basic infection control principles appropriate antibiotic use review immunizations facilitation communications among office hospital long term care facility involvement infection control program,C01,0.004070252,0.003610517,0.0077409586,0.0022869087,0.005667697,0.0052528726,0.32812142,0.02352369,0.0029426112,0.0039992617,0.018718638,0.03293681,0.05868574,0.010724245,0.003579277,0.026039826,0.08063833,0.004191685,0.014999571,0.20708407,0.14954846,0.0014451987,0.004191949
evidence gonococcal transmission within correctional system study examine sexually transmissible disease occurring within large correctional system sexual activity prohibited male inmates acquired culture proven gonorrhea jail sexual activity three month period results provide evidence encourage inmate education acquired immunodeficiency syndrome aids support condom distribution programs correctional facilities,C01,0.0047214194,0.004188135,0.031664494,0.0026527732,0.006576358,0.006093238,0.3267972,0.00444008,0.0034133762,0.004639072,0.044964056,0.009711058,0.030090421,0.041619837,0.004151897,0.007352232,0.07519205,0.004862279,0.047885295,0.1949255,0.13752557,0.0016764045,0.0048572225
cefuroxime treatment failure nontypable haemophilus influenzae meningitis associated alteration penicillin binding proteins year old boy presented nuchal rigidity cerebrospinal fluid csf leukocytosis initially day intravenous cefuroxime therapy mg kg day csf specimens yielded nontypable beta lactamase negative haemophilus influenzae susceptible disk tests relatively resistant cefuroxime mic fold greater control isolates define mechanism resistance cefuroxime resistance marker transformed susceptible h influenzae recipient inactivation permeability beta lactam substrate tested penicillin binding protein pbp profiles examined inactivation beta lactam substrate detected reduced permeability found however reduced beta lactam binding pbps observed fold penicillin fold cefuroxime required saturate block binding sites pbps respectively thus reduced affinity pbps beta lactam substrate appears mechanism cefuroxime resistance strain reduced affinity targets appears contributed bacteriologic clinical failure patient,C01,0.0024984407,0.026384797,0.040899664,0.0014026248,0.0034761564,0.051559288,0.26186365,0.0023476437,0.0018047853,0.026618332,0.07996444,0.01809767,0.049419973,0.0059616296,0.0021952703,0.00395489,0.036815424,0.12798984,0.0028425173,0.019496579,0.18108916,0.00088638056,0.05243082
epidemiologic differences chlamydia gonorrhea assess prevalence demographics transmission patterns genital chlamydia infection screened patients compared identified cases n gonorrhea cases n diagnosed setting chlamydia cases younger likely white gonorrhea counterparts chlamydia cases distributed diffusely geographic overlap two diseases percent gonococcal coinfection noted less percent patients chlamydia nearly half men chlamydia four fifths women asymptomatic cases identified screening contact tracing populations high risk chlamydia seemingly different gonorrhea differences may due control interventions active gonorrhea passive chlamydia chlamydia case reporting control initiatives recommended,C01,0.0032959094,0.0029200043,0.0061421855,0.0018495366,0.004583748,0.0049992763,0.16024235,0.0030956627,0.034247804,0.0032344016,0.22518803,0.0070238416,0.07858107,0.0075688995,0.0028947392,0.0051260404,0.109382756,0.0033900237,0.034860857,0.21719424,0.079623304,0.0011688039,0.003386498
nasal carriage staphylococcus aureus correlation hormonal status women view recent observations hormone microorganism interactions study staphylococcus aureus nasal carriage relation sex hormone status undertaken prospectively women attending colpocytologic clinic hormonal status assessed determining karyopyknotic index ki smears stained papanicolaou method rates aureus nasal carriage premenopausal women postmenopausal women p significant carriage rates significantly higher p chi women high kis intermediate low kis respectively aureus nasal carriage also correlated independently significantly previous antibiotic use presence insulin treated diabetes mellitus preliminary observation confirms association levels sex hormones reflected ki aureus nasal carriage rates,C01,0.003094892,0.0027453236,0.0057747476,0.0017388936,0.004309539,0.0039941194,0.16904525,0.017885348,0.0022374692,0.0030409133,0.046475798,0.0063932827,0.14053574,0.008404086,0.00272157,0.034740586,0.05665779,0.08246565,0.0035239898,0.26926446,0.13066779,0.0010988837,0.0031839109
monoclonal antibody mouse lipopolysaccharide receptor protects mice lethal effects endotoxin specific endotoxic lipopolysaccharide lps binding sites cell membranes murine lymphocytes macrophages may serve functional receptors lps recently identified using photoactivatable cross linking lps derivatives monoclonal antibody mab specificity kda protein also generated characterized capacity mab protect mice lethal effects endotoxin investigated pretreatment cf mice little micrograms mab provided virtually complete protection dose endotoxin fold greater required kill mice untreated control group using galactosamine sensitization model significant protection also afforded normal mice given mab relative saline several lines evidence suggest mab mediated protection due agonist properties antibody rather receptor blockade mechanism,C01,0.0024986267,0.0022144974,0.0359864,0.025568476,0.0034805893,0.0032218304,0.22648081,0.014430286,0.0018048399,0.0024529328,0.014695729,0.025754489,0.043914575,0.13423325,0.0021953366,0.028778313,0.039686278,0.14759013,0.0028426035,0.01644199,0.222264,0.0008864074,0.0025775635
initial evaluation human monoclonal anti lipid antibody ha patients sepsis syndrome ha human monoclonal immunoglobulin antibody binds specifically lipid domain endotoxin administered septic patients evaluate safety pharmacokinetics immunogenicity antibody thirty four patients received single infusion either mg mg mg followed clinically days treatment ha serum levels measured infusion frequently infusion radiometric assay one compartment pharmacokinetic model fit measured serum levels accurately described changes ha level time dose group r mean sem apparent volume distribution ha ml kg mean serum clearance ml kg h mean serum half life ha h mean serum level one hour mg dose micrograms ml mean concentration h later micrograms ml dose administered presence gram negative bacterial infection significantly influence volume distribution serum clearance adverse reactions ha observed antibodies ha detected patient data indicate pharmacokinetics ha well described one compartment pharmacokinetic model ha safe nonimmunogenic patients sepsis,C01,0.0019351401,0.011078578,0.011241756,0.0010872763,0.021420803,0.0024973992,0.09201368,0.0018198292,0.0013990202,0.0019013889,0.015413734,0.018342543,0.13783833,0.0715603,0.020434272,0.012498218,0.15239872,0.013089819,0.011568544,0.024478579,0.37328485,0.00068709796,0.002010102
lack association medication use presence absence bacteriuria elderly women study undertaken determine association medication use presence absence bacteriuria elderly ambulatory women women participated three urine culture surveys every months month study period bacteriuria least one survey univariate multivariate analyses demographics age place residence medication use drug class revealed place residence significant association presence absence bacteriuria regard bacteriuric subjects commonly resided nursing home less commonly lived apartment house complex compared nonbacteriuric subjects p less therefore study demonstrates elderly ambulatory women medication use appear associated presence absence bacteriuria,C01,0.0030049612,0.0026655504,0.0056959223,0.0016883651,0.0042073512,0.003878059,0.20534274,0.0028259018,0.01671026,0.017493889,0.029468222,0.02071701,0.10002634,0.021454433,0.017184513,0.0046793497,0.12327232,0.003099828,0.03251218,0.30835992,0.0715546,0.0010669526,0.0030913933
accuracy early prediction prognosis patients septic shock analysis simple indices prospective study consecutive septic shock patients analyzed clinical hemodynamic metabolic data volume infusion test circulatory reserve response fluid repletion patients investigated identify early variables could predict outcome survivors group nonsurvivors group b mean group patients hemodynamically evaluated h onset sepsis syndrome whereas group b patients underwent cardiac catheterization h interval initial evaluation groups demonstrated similarly decreased mean arterial pressure mean heart rate mean cardiac filling pressure group patients evidenced elevated cardiac index ci greater l min associated low systemic vascular resistance index less dyne sec cm generally recognized hyperdynamic cardiac state however none initial cardiovascular variables could serve predictor survival fluid challenge increased left ventricular preload mm hg group group b respectively increases associated significant increases ci l min however end fluid challenge group patients exhibited normal cardiac response evidenced change left ventricular stroke work index lvswi given increase pulmonary capillary wedge pressure wp referred left cardiac preload,C01,0.0017721192,0.0014123906,0.0029709425,0.00089461106,0.009929304,0.0020548603,0.16515833,0.009203185,0.001151114,0.00926994,0.06222996,0.07629706,0.21959834,0.011460121,0.0014001699,0.002484152,0.20750916,0.010210089,0.001812992,0.059879493,0.12567686,0.015979776,0.0016450546
large outbreak antibiotic resistant shigellosis mass gathering july large outbreak shigellosis occurred among attendees mass gathering national forest annual rainbow family gathering sanitation campsite poor allowing widespread transmission disease probably food water person person spread attack rate may greater among estimated attendees outbreak caused shigella sonnei resistant ampicillin tetracycline trimethoprim sulfamethoxazole organism colicin type contained kilobase plasmid found non outbreak related strains dispersal group resulted nationwide dissemination organism outbreaks three states linked transmission attendees gathering outbreak demonstrates potential rapid dissemination disease setting necessity careful planning mass gatherings,C01,0.0039163544,0.0034740018,0.06437196,0.0022005325,0.00545639,0.03504779,0.40354523,0.003682987,0.0028313498,0.0038480482,0.060343947,0.04597109,0.02544808,0.05389051,0.003443943,0.006260839,0.05808242,0.004036531,0.05028238,0.10479155,0.05362056,0.0013905552,0.0040629706
prevention infection porous tracheal prosthesis omental wrapping ideal tracheal prosthesis permit complete incorporation epithelialization luminal surface possible currently available impermeable solid silicone tube authors developed reinforced porous polyurethane tubular prosthesis potential complete incorporation however prostheses implanted contamined area airway become infected order prevent infection authors evaluated effect omental wrapping guinea pigs authors tubular prosthesis implanted subcutaneously abdominal area ends open air ten prostheses wrapped omentum prostheses weeks control prostheses infected marsupialized wrapped prostheses remained place macroscopically infected microscopically wrapped prostheses well vascularized incorporated granulation tissue occur prostheses control group results authors conclude omental wrapping would effective way prevent infection porous tracheal prostheses open air situation allow rapid tissue ingrowth incorporation host,C01,0.0028793656,0.04437141,0.005375817,0.001617798,0.031885535,0.017652093,0.30326852,0.016636193,0.002081653,0.0028291456,0.07132228,0.036199678,0.027096389,0.037323587,0.0025320414,0.018415095,0.09314598,0.0029652691,0.0032785812,0.08997008,0.18516898,0.0010223581,0.002962185
group b streptococcus endocarditis following second trimester abortion year old woman underwent elective second trimester abortion developed streptococcus agalactiae group b streptococcus endocarditis characterized large pedunculated vegetation involving previously normal tricuspid valve polyarthritic symptoms well multiple pulmonary emboli experienced cure followed course treatment using intravenous penicillin g potassium combined gentamicin sulfate endocarditis caused pathogen usually occurs among individuals compromised underlying chronic disorders today rare sequela pregnancy abortion planning therapy consideration given possibility tolerance among clinical isolates need operative intervention selected patients,C01,0.035671204,0.0029676575,0.0062424233,0.018073687,0.004659231,0.004334124,0.46629778,0.019338084,0.0024186736,0.0032931971,0.048056014,0.05768428,0.026569292,0.008045956,0.00294198,0.0052096955,0.12773418,0.020334562,0.003809385,0.07019481,0.06148204,0.0011878783,0.0034538582
botulism among alaska natives role changing food preparation consumption practices alaska natives one highest rates food borne botulism worldwide outbreaks associated consumption native foods recent years outbreaks occurred previously unaffected areas involved new food items five botulism outbreaks occurred area southwestern alaska without previous confirmed outbreaks among one ethnic group yupik eskimo outbreaks associated fermented beaver tail nontraditional native food recently introduced region preparation techniques vary widely within villages among ethnic groups traditional fermentation techniques changed past years current preparation methods used families ethnic groups may favorable clostridium botulinum growth prevention efforts targeted high risk subgroups alaska natives appear modified traditional practices increased risk food borne botulism,C01,0.002691538,0.015414666,0.005022131,0.040600486,0.0037478816,0.00347357,0.20586868,0.002531155,0.0019458623,0.0026445943,0.070205614,0.05223007,0.025879914,0.032243982,0.0023668706,0.017218474,0.03016062,0.016505113,0.04215186,0.31522536,0.10811215,0.0009556674,0.002803731
effects epinephrine hemodynamics oxygen metabolism dopamine resistant septic shock hemodynamic effects epinephrine prospectively studied patients septic shock remained hypotensive fluid loading dopamine hemodynamic measurements performed one hour start epinephrine infusion systolic diastolic mean arterial pressure increased patients p less cardiac index systemic vascular resistance increased percent respectively p less heart rate pulmonary vascular resistance remained unchanged concomitant increase oxygen delivery p less oxygen consumption p less magnitude latter related baseline lactacidemia p less view generally recognized physiologic goals septic shock management conclude epinephrine could appropriate alternative fluid loading dopamine failed,C01,0.031536832,0.0027870662,0.005862552,0.0017653333,0.004375065,0.0040716385,0.17512418,0.018157423,0.017477937,0.0030871502,0.03145302,0.037657563,0.30805674,0.007224424,0.0027629512,0.020146588,0.15427797,0.025315356,0.0035775718,0.024695346,0.11623942,0.0011155922,0.003232322
detection interleukin serum mice infected mycobacterium lepraemurium infection mice mycobacterium lepraemurium accompanied ablation erythropoiesis bone marrow gross enlargement spleen together increased monocytopoiesis earlier demonstration macrophage colony stimulating factor serum infected mice suggested activity additional cytokines eight weeks infection mice lepraemurium interleukin il activity demonstrated serum titer serum titer il activity maximal weeks greater slightly reduced weeks il activity detected serum lepraemurium infected mice reflected presence il confirmed neutralization assay using anti murine il antibodies il activity serum mice weeks infection completely abolished anti il antibodies finally kb signal il rna detected spleens lepraemurium infected mice weeks infection,C01,0.0027640758,0.0024515295,0.03189809,0.0015528037,0.0172336,0.0035666837,0.23181723,0.0025990058,0.015373252,0.002715486,0.049703404,0.0056843786,0.020506145,0.18021123,0.0024569824,0.0043036374,0.029965,0.051069494,0.0031468656,0.020191774,0.30249766,0.0009812852,0.017310338
occurrence secondary attenuating mutations avirulent salmonella typhimurium vaccine strains attenuating delta aroa mutation salmonella typhimurium strain sl complemented vitro selecting aroa recombinant dna clones sl containing cloned aroa genes require exogenous phenylalanine tryptophan tryosine p aminobenzoic acid dihydroxybenzoic acid growth defined media cloned aroa genes restore wild type virulence sl however murine typhoid model delta aroa mutation transduced typhimurium strain sr mouse virulent strain recently passaged mice sr delta aroa mutant highly attenuated mice challenged parenterally cloned aroa genes isolated sl restored virulence sr delta aroa mutant wild type sr results suggest delta aroa allele remains effective reducing typhimurium virulence laboratory passage attenuated vaccine strains may lead accumulation additional attenuating defects,C01,0.002920711,0.0025901385,0.019570252,0.001640599,0.014382295,0.0037683435,0.29060283,0.0027459534,0.0021109916,0.002869019,0.013526144,0.020130327,0.018377487,0.0833079,0.0025677276,0.0045469645,0.03510241,0.059520528,0.003324789,0.032933082,0.17123765,0.001036767,0.21118711
day care characteristics associated haemophilus influenzae disease haemophilus influenzae study group identify characteristics day care facilities associated h influenzae disease compared licensed facilities case h influenzae disease occurred randomly selected facilities cases occurred matched univariate analysis showed personnel facilities h influenzae disease occurred likely control facilities use towels handkerchiefs wipe children noses admit children toilet trained diarrhea liberal fecal policy narrower age range likely control facilities profit less likely use volunteers multivariate model adjusted age range profit status liberal fecal policy towel handkerchief use ci variable independently associated case facilities first association specific day care practice h influenzae disease,C01,0.0027270843,0.0024190599,0.0050884564,0.0015322374,0.0037973786,0.0035194443,0.21538262,0.0025645832,0.015145602,0.02908421,0.056934554,0.026784366,0.06844949,0.006585973,0.002413078,0.004246637,0.07348808,0.0028084447,0.042706102,0.32716396,0.10338218,0.0009682886,0.0028081243
calcitonin gene related peptide levels elevated patients sepsis calcitonin gene related peptide cgrp endogenous vasoactive peptide encoded calcitonin gene nerve cells distributed throughout cardiovascular system potent vasodilator plasma levels cgrp elevated animal models sepsis study designed determine whether plasma cgrp levels elevated patients sepsis perhaps contribute hyperdynamic cardiovascular state sepsis plasma cgrp levels obtained normal healthy volunteers patients sepsis volunteers afebrile normal pulse blood pressure patients sepsis selected according following criteria temperature higher degrees c white blood count greater ml positive blood culture bacterial organisms hemodynamic parameters consistent hyperdynamic sepsis negative history thyroid endocrine abnormalities cgrp extracted assayed radioimmunoassay iodine labeled human cgrp patients sepsis cardiac index l min normal systemic vascular resistance mm hg l min normal oxygen delivery ml min normal plasma cgrp levels significantly elevated patients sepsis pg ml compared plasma cgrp levels control volunteers pg ml p less elevated levels cgrp may contribute decreased vascular resistance increased cardiac output hyperdynamic septic state,C01,0.012481893,0.0014929973,0.019453567,0.00094566756,0.002343669,0.0021794115,0.0877372,0.0015828115,0.017510569,0.0016537486,0.032333497,0.01165683,0.21332921,0.06774466,0.009626199,0.010908866,0.16769472,0.0100011565,0.010061383,0.024129728,0.27585405,0.0005976091,0.018680569
seroprevalence helicobacter pylori seventh day adventists groups maryland lack association diet evaluate possible role diet transmission helicobacter pylori compared h pylori seroprevalence among seventh day adventists vegetarian abstain alcohol caffeine meat n two non seventh day adventist control groups n use enzyme linked immunosorbent assay h pylori antigen prepared french pressure cell found difference seroprevalence among groups however seropositivity strongly correlated age black race,C01,0.0047214604,0.004188171,0.008809756,0.002652796,0.006574484,0.0060932906,0.23470655,0.0044401186,0.0034134057,0.004639112,0.024838762,0.10870163,0.10532035,0.0578728,0.004151933,0.0075786794,0.048422482,0.0048623215,0.02822891,0.11186184,0.21138747,0.001676419,0.0048572645
treatment tinea cruris topical terbinafine twenty three patients enrolled randomized double blind trial terbinafine cream versus vehicle placebo treatment tinea cruris one patient negative initial culture excluded two patients dropouts one poor study compliance terbinafine one adverse event placebo twenty patients examined efficacy treatment terbinafine treated placebo treated groups similar age sex duration disease prior therapy size location lesion infecting organism predisposing factors terbinafine cream effective vehicle cream reduction signs symptoms tinea cruris addition higher conversion rate negative culture normal microscopy findings terbinafine treated group clinical results combined evaluation mycologic tests end therapy showed terbinafine rapid significantly effective treatment tinea cruris placebo vs cure rate respectively follow cure rates confirmed findings respectively significant adverse events occurred terbinafine treatment,C01,0.002135146,0.012226617,0.024682784,0.021871123,0.03628564,0.0027555171,0.30045873,0.002007917,0.011870285,0.0020979063,0.03187552,0.026565494,0.064416274,0.030793883,0.001889978,0.0033248663,0.19006903,0.0022037202,0.074785486,0.09450848,0.060220964,0.00075811276,0.0021965594
itraconazole treatment phaeohyphomycosis nineteen patients phaeohyphomycosis treated itraconazole assessable clinical outcome two received prior therapy five failed amphotericin b therapy four failed ketoconazole miconazole therapy five failed amphotericin b azole therapy one patient received prior surgical intervention fungi seven different genera caused disease skin nine patients soft tissue nine sinuses eight bone five joints two lungs two itraconazole given dosages ranging mg day months clinical improvement remission occurred nine patients two patients stabilization disease six patients failed treatment one relapse initially successful treatment itraconazole appears highly effective patients phaeohyphomycosis including patients refractory antifungal agents,C01,0.0031416041,0.0027867595,0.0058619073,0.0017651392,0.034788933,0.019261893,0.4195028,0.0029544025,0.0022712399,0.0030868105,0.02965388,0.0076822066,0.02046248,0.007223518,0.0027626473,0.004892131,0.30744913,0.0032353313,0.0035771783,0.030175958,0.08311663,0.0011154695,0.0032319664
leprotic involvement peripheral nerves absence skin lesions case report literature review absence clinically apparent cutaneous lesions primarily neural leprosy uncommon primarily neural leprosy presents clinically peripheral neuropathy frequently affects motor nerves occasionally involves sensory nerves well long incubation period leprosy occurrence outside endemic areas often lead delayed diagnosis present case glove stocking hypoesthesia weakness flexor muscle right great toe palpable thickening right popliteal nerve hypoesthetic normal appearing areas back developed trinidadian immigrant lived canada years skin biopsy specimen obtained visibly normal hypoesthetic area back demonstrated acid fast bacteria small dermal nerves arrector pili smooth muscle rare perivascular histiocytes associated sparse mixed inflammatory cell infiltrate patient responded well therapy dapsone rifampin clofazamine classification review primarily neural leprosy presented patient represents first reported case primarily neural borderline lepromatous leprosy canada,C01,0.0021803463,0.001934076,0.0040683,0.0012250476,0.0452913,0.0028138505,0.3256364,0.054823946,0.0121309245,0.023249205,0.09338775,0.0044845557,0.11157336,0.016249042,0.02301455,0.02450003,0.052566275,0.012969151,0.002482645,0.065846324,0.11655571,0.0007741618,0.00224306
lung function children following empyema spirometry performed response exercise measured children following recovery empyema evaluate impact pleural infection subsequent lung function seven children underwent chest tube drainage eight two groups similar age mean sd years sex distribution bacterial pathogen producing empyema age follow evaluation years one child reported recurrent respiratory symptoms child restrictive spirometric changes total lung capacity less vital capacity less predicted seven reduced forced expiratory volume second less predicted forced expiratory flow middle half vital capacity less predicted suggesting mild airway obstruction child demonstrated reduced exercise tolerance due restrictive ventilatory limitations mild obstructive abnormalities lung function identified equal frequency children treated without chest tube drainage,C01,0.0022537736,0.023796234,0.004201236,0.0012650774,0.024951922,0.06830157,0.14235426,0.0021174238,0.0016278004,0.09548514,0.07798533,0.015600973,0.18171495,0.005177104,0.0019800342,0.014400373,0.10114634,0.0023187657,0.0026786474,0.08928626,0.13824095,0.0007994583,0.0023163543
comparison cilofungin amphotericin b therapy murine candidiasis compared efficacies cilofungin amphotericin b treatment murine model disseminated candidiasis three different dosages drug plus controls evaluated statistically improved survival noted among mice treated mg amphotericin b per kg body weight p less amphotericin b regimens two lower dosage cilofungin regimens significantly reduced yeast cell counts kidneys compared controls amphotericin b treated mice significantly higher percentage sterile kidneys following therapy compared treated cilofungin p,C01,0.003844013,0.0034089596,0.044367503,0.020755226,0.005351298,0.004959631,0.19493072,0.0036140322,0.00277834,0.003776003,0.018859541,0.008066214,0.2104432,0.10185515,0.003379464,0.005984397,0.124103494,0.003957684,0.0043758554,0.02919208,0.1966791,0.0013645204,0.0039535677
possible role bacterial siderophores inflammation iron bound pseudomonas siderophore pyochelin function hydroxyl radical catalyst tissue injury linked neutrophil associated hydroxyl radical oh generation process requires exogenous transition metal catalyst iron vivo iron bound noncatalytic form obtain iron required growth many bacteria secrete iron chelators siderophores since pseudomonas aeruginosa infections associated considerable tissue destruction examined whether iron bound pseudomonas siderophores pyochelin pch pyoverdin pvd could act oh catalysts purified pch pvd iron loaded fe pch fe pvd added hypoxanthine xanthine oxidase superoxide hydrogen peroxide h generating system evidence oh generation sought using two different spin trapping agents dimethyl pyrroline oxide n butyl alpha phenylnitrone well deoxyribose oxidation assay regardless methodology oh generation detected presence fe pch fe pvd inhibition process catalase sod suggested oh formation fe pch occurred via haber weiss reaction similar results obtained stimulated neutrophils used source h addition fe pch fe pvd stimulated neutrophils yielded oh detected assay systems since pch pvd bind ferric fe ferrous fe iron oh catalysis fe pch would likely involve mediated reduction fe fe subsequent release free fe confirmed measuring formation fe ferrozine complex exposure fe pch fe pvd enzymatically generated data show fe pch fe pvd capable catalyzing generation oh process could represent yet another mechanism tissue injury sites infection p aeruginosa,C01,0.02086923,0.0017329861,0.023515133,0.0010976769,0.0027203972,0.0025212886,0.4191963,0.0018532695,0.0014124028,0.01136502,0.04766188,0.004023417,0.01773187,0.06078974,0.0111631695,0.012485957,0.032022424,0.060780898,0.021130953,0.03082211,0.20231092,0.00069367053,0.0120992465
bird attack milk bottles possible mode transmission campylobacter jejuni man case control study carried test hypothesis rise rate campylobacter jejuni infection brigend area south wales may due consumption handling milk bottles attacked birds cases meeting case definition interviewed along controls per case matched age sex area residence strong associations campylobacter infection doorstep delivery milk bottles history milk bottle attack birds milk bottle attack birds week illness consumption milk attacked bottles week illness strong dose response relation frequency bird attack illness controls history milk bottle attack birds likely cases taken preventive measures bird attack consumption contaminated milk although people witnessed attacks likely culprits magpies pica pica jackdaws corvus monedula,C01,0.0033492777,0.019138642,0.0068458193,0.0018797002,0.020842152,0.0043175425,0.16383213,0.003146149,0.018610545,0.0032871505,0.11219301,0.027886035,0.06754862,0.0076923384,0.058862176,0.005237941,0.030715585,0.0034453108,0.036193542,0.18619595,0.19797002,0.0011878656,0.019622488
thoracic empyema causes diagnosis treatment thoracic empyema disease recognized centuries principles management stated hippocrates remain less unchanged diagnosis masked underlying cause preemptive antibiotic treatment frequently associated debilitating diseases specific investigation main diagnostic test remains diagnostic thoracentesis empyema encountered objectives save life eliminate empyema complications chronicity return pulmonary mechanics normal reduce duration hospital stay introduction antibiotics dramatically influenced spectrum disease encountered original infection adequately treated empyema rarely occurs penicillin removed major cause empyema developments antibiotics mean majority empyemas occur patients disabled disease processes malnutrition remains delay medical attention patients often less able withstand prolongation infective processes sometimes encountered staged approach treatment developments operative postoperative care meant patients best treated aggressive definitive surgical management,C01,0.04802483,0.002064805,0.0043432866,0.0013078518,0.0032412782,0.0030092672,0.35216287,0.0021890174,0.035484042,0.02481789,0.094582215,0.004787678,0.052484542,0.0061177397,0.0020469395,0.014889756,0.19691905,0.0024066868,0.0026504532,0.07439817,0.06884935,0.0008264893,0.0023958234
treatment fungal skin infections state art number cases mycotic infections increasing presenting physicians today unprecedented challenge handling treatment prophylactic control disorders increase mycotic disorders due many factors longer life span organ transplantation acquired immunodeficiency syndrome pharmaceutical industry providing physicians newer potent drugs manage mycoses overview current practice use topical oral agents especially ketoconazole given following specific mycoses tinea capitis pityriasis versicolor seborrheic dermatitis trichophyton rubrum infections vaginal candidiasis moist intertriginous tineas efficacy ketoconazole various vehicles dosage schedules traditional agents griseofulvin discussed relation mycoses,C01,0.0032954966,0.018852152,0.022078894,0.017784223,0.020521179,0.004248768,0.38039574,0.0030960338,0.002380121,0.0032347895,0.030968351,0.006946697,0.04997158,0.03346255,0.002895086,0.021061873,0.09455411,0.019319877,0.019683326,0.12994523,0.11074623,0.001168944,0.0033887248
tuberculous meningitis short course chemotherapy march began month short course trial therapy tuberculous meningitis patients analyzed diagnosis based following cerebrospinal fluid test results cases mycobacterium tuberculosis identified direct smear culture lowenstein jensen medium positive detection anti bacille calmette guerin bcg antibodies enzyme linked immunosorbent assay positive dosification adenosine deaminase activity positive addition cases diagnosis established means autopsy findings moreover diagnosis supported bacteriological analyses another tissue body fluids despite administration antituberculous therapy patients died decreased reached last stage disease beginning treatment sixteen percent patients survived months follow therapy ended suffered neurological sequelae month therapeutic regimen morbidity mortality similar found longer course therapies latter regimen therefore thought good acceptable therapeutic option treatment tuberculous meningitis,C01,0.0022035788,0.012599943,0.0041116495,0.011900177,0.0030684136,0.0028648856,0.2909712,0.0020722721,0.0015930893,0.0021651455,0.13094282,0.015289121,0.029913178,0.030943941,0.012079673,0.0034314303,0.21154411,0.0022693207,0.013175354,0.10242111,0.11138347,0.00078241073,0.0022736934
enterobacter bacteremia pediatric patients enterobacter emerged important human pathogen particularly sick hospitalized patients previous reports nonepidemic enterobacter bacteremia focused adult patients report epidemiologic factors clinical characteristics treatment outcome patients enterobacter bacteremia large children hospital year period reviewed ratio males females patients ages ranged days years patients less months old twenty two cases nosocomially acquired six polymicrobial nature significantly underlying conditions present patients biliary tract central venous catheters common sources bacteremia two thirds patients preceding antibiotic therapy overall mortality mortality attributable enterobacter bacteremia statistically significant differences mortality associated age less months p thrombocytopenia p presence fever borderline significance p enterobacter bacteremia important cause morbidity mortality pediatric patients,C01,0.0026914256,0.0023874287,0.005021921,0.0015122022,0.0037484027,0.0034734248,0.3022983,0.002531049,0.0019457808,0.015673859,0.03994025,0.005651893,0.07052404,0.017467007,0.0023667717,0.0041911094,0.26778698,0.002771722,0.0030645838,0.18662032,0.041548666,0.013965385,0.002817448
drug therapy helicobacter pylori infection problems pitfalls antibacterial chemotherapy helicobacter pylori currently assessed open randomized controlled clinical studies efficacy eradicating bacterium stomach patients gastritis gastroduodenal ulcer whereas presently optimal agent treatment scheme combination antibiotics metronidazole tinidazole amoxicillin bismuth salts proves definitely superior vivo either agents administered alone several reasons proposed explain clinical failure treatment insufficient concentration active drugs gastric mucus instability agents acidic ph inappropriate formulation drug insufficient duration treatment variable compliance patients recently appeared several clinical trials h pylori may rapidly acquire resistance antibiotics event might also account clinical failure critical review literature h pylori treatment indicates association bismuth antibiotics antibiotics alone may efficiently reduce risk emergence resistance improve therapeutic outcome guidelines treatment suggested order avoid future misuse antibiotics would increase selection antibiotic resistant h pylori negatively affect ecology gastric microflora likewise accurate definition subset patients h pylori really require treatment needs rapidly established,C01,0.001953981,0.030104697,0.013227544,0.0010976426,0.012331537,0.021434665,0.5164018,0.0064408383,0.0014123587,0.001919517,0.039690673,0.0045866002,0.015549889,0.0044951127,0.0017179378,0.021941485,0.05772626,0.0020197406,0.020700457,0.078576334,0.14396746,0.0006936489,0.0020097815
postneonatal mortality norway study recent trends comparison mortality rates norwegian children postneonatal mortality norway decreased rapidly subsequently remained stable recent years postneonatal death rate appears increasing primarily due greater numbers deaths attributed sudden infant death syndrome period mortality among older children also decreased decline evident leading causes among people aged years recent trends less encouraging number fatal traffic accidents particular remaining stable increasing although room continued improvement widely held belief health status norwegian children good supported trends mortality,C01,0.0027658509,0.0024513805,0.0051564425,0.0015527094,0.0038481147,0.016938945,0.31478694,0.002598848,0.015364495,0.044784255,0.012786957,0.0056840335,0.05066344,0.0065201884,0.00243017,0.004303376,0.038059697,0.002845968,0.029896019,0.3355071,0.09723086,0.0009812257,0.002843008
air contamination open heart surgery disposable coveralls gowns drapes effect polypropylene coverall replacing shirt trousers combined sterile laminated gowns drapes compared cotton system studied regard dispersion bacteria particles conventionally ventilated operating theater operations carried open heart procedures adult patients blood agar sedimentation plates placed operative anesthesia perfusion areas mean sedimentation values hour start operation follows laminate group colony forming units cfu operative area cfu anesthesia area cfu perfusion area corresponding figures cotton group cfu cfu cfu respectively p less beginning operation mean values noted colony forming units air operative site cfu laminate group cfu cotton group one hour later values cfu cfu respectively p less end operation number particles microns larger air operative site laminate group cotton group concluded use polypropylene coverall laminated gowns drapes significantly reduces particle bacterial contamination air bacterial sedimentation cardiac operations,C01,0.0020714765,0.0018371132,0.023911472,0.0011636312,0.0028848955,0.0026727812,0.114772364,0.011961357,0.0014972676,0.0020349156,0.009707056,0.065595955,0.19825386,0.02937983,0.0018212177,0.023268411,0.22930127,0.0021494802,0.012381201,0.11422349,0.114327714,0.00073535,0.03404792
effect blood transfusion oxygen consumption pediatric septic shock treatment plans pediatric septic shock advocate increasing oxygen consumption vo recent studies septic shock indicate improving oxygen delivery increasing blood flow increase vo prospectively examined effect vo improving increasing oxygen content co blood transfusion eight hemodynamically stable septic shock patients transfusion consisted ml kg packed rbc h hemodynamic oxygen transport measurements obtained blood transfusion transfusion significantly p less increased hgb hct g dl g dl respectively mean sd significantly p less increased transfusion ml min vo change ml min ns pediatric septic shock patients increasing co blood transfusion may increase vo,C01,0.0030489946,0.0027046103,0.035200555,0.0017131056,0.004245628,0.0039348863,0.13881315,0.0028673112,0.016960708,0.017747644,0.033880427,0.0063283024,0.3309015,0.0070124427,0.032190334,0.0047577485,0.10258561,0.0031399587,0.0034717286,0.022672897,0.22160318,0.0010825872,0.003136693
dependence oxygen consumption oxygen delivery children hyperdynamic septic shock low oxygen extraction studied effect increasing systemic oxygen delivery packed rbc prbc transfusion oxygen consumption vo children hyperdynamic septic shock routine resuscitation volume loading pharmacologic support patients studied significant derangements oxygen transport variables defined baseline vo less ml min oxygen extraction extr less eight studies performed prbc transfusion increased ml min p less without increasing cardiac index vs l min vo increased ml min p less extr unchanged vs despite initial low extr vo increased pediatric septic shock increase since vo correlates survival one consider enhancing despite initial low extr high effects morbidity mortality require study,C01,0.002919847,0.00259005,0.019573105,0.0016405429,0.0040657944,0.0037682145,0.11351778,0.0027458593,0.030378675,0.04527351,0.022173356,0.020117432,0.3547683,0.0067835767,0.016696367,0.0045636864,0.14644848,0.0030069582,0.0033246751,0.053350203,0.12415125,0.0010367315,0.017105633
clinical trial topical terbinafine new allylamine antifungal treatment tinea pedis twenty three patients enrolled randomized double blind trial terbinafine cream compared placebo vehicle treatment tinea pedis patients evaluated efficacy received terbinafine received placebo except terbinafine treated patients average years older patients receiving placebo median duration disease weeks longer placebo group two groups demographically clinically similar results mycologic tests clinical findings showed terbinafine significantly effective placebo treatment tinea pedis significantly terbinafine treated patients placebo treated patients showed conversion negative culture microscopy end therapy significant reduction scored signs symptoms overall efficacy follow combined mycologic clinical findings also significantly greater terbinafine group placebo group zero p less unexplained elevation liver function test results noted three placebo treated patients one terbinafine treated patient changes considered clinically relevant drug related,C01,0.0019910226,0.0017661365,0.022990773,0.0011186744,0.002772436,0.0025695185,0.21818385,0.0018723819,0.011068344,0.0019562966,0.038224977,0.06922284,0.1105601,0.014271758,0.0017508551,0.011596062,0.25308353,0.0020504233,0.11793368,0.05300196,0.059259158,0.00070693984,0.0020482908
limited efficacy haemophilus influenzae type b conjugate vaccine alaska native infants alaska h influenzae vaccine study group background prevention invasive haemophilus influenzae type b disease requires vaccine effective administered first six months life infants alaska natives particularly high risk invasive h influenzae type b disease methods evaluate protective efficacy h influenzae type b polysaccharide diphtheria toxoid conjugate vaccine polyribosylribitol phosphate diphtheria toxoid prp enrolled alaska native infants randomized double blind placebo controlled trial either vaccine saline placebo administered approximately two four six months age results subject years follow episodes h influenzae type b disease overall incidence invasive disease reduced significantly vaccinated subjects cases per patient years compared placebo controls alaska native infants one two three doses significant protective efficacy vaccine three doses efficacy percent percent confidence interval lack efficacy related age onset disease age immunization type disease degree alaska native heritage time immunization year study levels h influenzae type b anticapsular antibody recipients vaccine became significantly higher levels received placebo second third doses even third dose percent vaccinated infants antibody levels microgram per milliliter geometric mean titer antibody responses vary level maternally acquired antibody degree alaska native ancestry age time first second immunizations increased increasing age time third dose p less conclusions found evidence prp vaccine provides significant protection least alaska native infants invasive diseases caused h influenzae type b ineffectiveness vaccine paralleled limited immunogenicity,C01,0.001521881,0.0087134335,0.03994363,0.0008550673,0.002118921,0.0019638347,0.19468632,0.0014310264,0.0011001223,0.008859171,0.06699266,0.045474004,0.07868513,0.034273922,0.0013381457,0.0023696055,0.09704924,0.0015671001,0.031196516,0.19456811,0.18318632,0.00054030085,0.0015655933
development potential use antibody directed lipopolysaccharide treatment gram negative bacterial sepsis gram negative bacterial sepsis remains major cause lethality hospitalized patients despite routine therapy consisting antimicrobial agents hemodynamic monitoring fluid resuscitation metabolic support large body evidence supports concept gram negative bacterial lipopolysaccharide endotoxin lps responsible many direct host mediator induced deleterious effects recent work centered development use anti lps antibody preparations order ameliorate lethality polyclonal monoclonal antibody preparations directed common deep core lipid region lps cross reactive vitro cross protective vivo wide range challenge organisms lps preliminary clinical trials indicate reduction lethality may possible precise endotoxin epitope antibody directed order maximize protection however established modality probably become standard form adjunctive therapy within next several years treatment gram negative bacterial sepsis,C01,0.0022763791,0.002019262,0.004263068,0.02852451,0.0031701173,0.02496446,0.4357791,0.0021407346,0.0016457208,0.0022366762,0.04759688,0.004682077,0.02587764,0.04064979,0.023857052,0.0035447958,0.0833353,0.020538794,0.057692446,0.057470463,0.11352478,0.011822979,0.0023870007
quinolone antibiotics treatment salmonella infections fluoroquinolones new class antimicrobial agents possess broad vitro antibacterial activity including efficacy enteric pathogens salmonella shigella campylobacter yersinia vibrio species drugs clinically effective drug sensitive multiresistant strains salmonella typhi salmonella paratyphi cause enteric fever salmonella enterocolitis quinolones unlike older antimicrobial agents may little impact duration symptomatic illness fact prolong fecal carriage salmonellae actually shorten course clinical disease terminate excretion organisms stool similarly chronic carriers typhoidal nontyphoidal salmonella strains quinolones effective eradicating biliary fecal reservoirs infection immunosuppressed persons salmonellosis aids may benefit short term treatment prolonged prophylaxis quinolone antibiotic optimal agent dose duration quinolone therapy salmonella syndromes remain determined larger controlled trials,C01,0.003240438,0.00287443,0.06847942,0.0018206699,0.0045128614,0.004181954,0.4525895,0.003047347,0.0023426923,0.0031839206,0.015063841,0.0067425626,0.056026865,0.007723655,0.0185316,0.020728542,0.0934439,0.003337114,0.032989323,0.07843025,0.11622492,0.0011505617,0.003333643
beta lactamase production susceptibilities amoxicillin amoxicillin clavulanate ticarcillin ticarcillin clavulanate cefoxitin imipenem metronidazole non bacteroides fragilis bacteroides isolates fusobacteria u centers beta lactamase production nitrocefin disk method agar dilution susceptibility amoxicillin amoxicillin clavulanate ticarcillin ticarcillin clavulanate cefoxitin imipenem metronidazole determined bacteroides species bacteroides fragilis group fusobacteria u centers overall bacteroides species fusobacteria beta lactamase positive among bacteroides species positivity rates highest b bivius followed b splanchnicus b eggerthii b oralis black pigmented bacteroides species beta lactamase positive among fusobacteria fusobacterium mortiferum showed highest rate beta lactamase positivity mics amoxicillin micrograms ml ticarcillin micrograms ml beta lactamase positive strains reduced micrograms ml respectively addition clavulanate mics amoxicillin ticarcillin beta lactamase negative strains micrograms ml respectively greater equal strains susceptible beta lactams tested beta lactamase producing strains susceptible amoxicillin less equal micrograms ml susceptible ticarcillin less equal micrograms ml addition clavulanate raised rates respectively strains susceptible cefoxitin imipenem metronidazole activity amoxicillin beta lactamase producing strains bacteroides species fusobacteria enhanced addition clavulanate however strains susceptible amoxicillin susceptible ticarcillin,C01,0.003640819,0.003228856,0.024388127,0.002045164,0.005068576,0.0046976013,0.13969588,0.003423094,0.0026315534,0.0035765076,0.13201003,0.026456477,0.12809978,0.008739456,0.0032009184,0.005810599,0.12377986,0.00374859,0.004144668,0.10221759,0.22912009,0.018911948,0.02136379
history antifungals two three decades ago drugs available treatment fungal infections status antifungal therapy changed dramatically late introduction newer broader spectrum agents iodinated trichlorophenols imidazoles acted disruption fungal cell membrane recently developed broad spectrum antifungal drugs include triazoles terconazole itraconazole fluconazole dimethylmorpholine amorolfine allylamines represent one newest classes compounds shown effective management fungal disorders two members unique chemical class studied clinically naftifine terbinafine effective wide spectrum fungal organisms terbinafine added advantage topical oral activity,C01,0.0034574587,0.036536485,0.023187308,0.001942605,0.0048144017,0.0044620307,0.43875492,0.0032514362,0.052710664,0.0033971563,0.016337758,0.0238383,0.024141764,0.026871609,0.053252287,0.0053839823,0.04783649,0.0035606092,0.020663615,0.056860253,0.1439543,0.001227618,0.003556906
cerebrospinal fluid changes hours effective therapy hemophilus influenzae type b meningitis interval cerebrospinal fluid csf analysis often performed assess efficacy treatment bacterial meningitis authors reviewed cases pediatric bacterial meningitis resulting hemophilus influenzae type b analysis csf occurred admission hours initiation parenteral antibiotic therapy one patient positive repeat csf culture cases sterile csf repeat culture instance recrudescence infection hospitalization following characterized interval changes csf profile group persistence pleocytosis differential cell count conversion polymorphonuclear neutrophil leukocyte pmn predominance relative lymphocytosis initial positive gram stained smear negative results organisms normalization initial hypoglycorrhachia normalization initial abnormally elevated protein levels differences mean values csf total white blood cell counts percentage pmns glucose protein concentrations presentation hours therapy highly significant p less hours effective antibiotic therapy h influenzae type b meningitis csf pleocytosis abnormally elevated protein concentration usually preserved whereas hypoglycorrhachia usually resolves uncommon differential cell count convert pmn predominance relative lymphocytosis significant alteration csf parameters associated h influenzae type b meningitis occur hours effective parenteral antibiotic therapy,C01,0.001882309,0.001669702,0.030847797,0.0010575927,0.0026210556,0.011515055,0.2754057,0.010871945,0.010471064,0.0018494792,0.06802286,0.01318659,0.13341182,0.061420485,0.0016552939,0.021382216,0.089583315,0.029275762,0.0203658,0.013694461,0.19719407,0.00066833955,0.001947271
intraamniotic infection early phase second trimester total consecutive patients studied effort examine prospectively incidence asymptomatic intraamniotic infection early phase second trimester patients referred amniotic fluid karyotyping addition amniotic fluids examined gram stain directly cultured blood agar macconkey agar well thioglycollate broth found positive amniotic fluid cultures eight cases however results gram stain examinations negative amniotic fluid samples data indicate correlation white blood cells amniotic fluid positive amniotic fluid culture results one pregnancy positive amniotic fluid culture resulted septic abortion therefore suggest intraamniotic infection exist early pregnancy even intact membranes cases without clinical symptoms,C01,0.0025750767,0.0022691789,0.01912848,0.0014373024,0.003562099,0.0033013853,0.35548654,0.0024056856,0.014231439,0.002518113,0.25719962,0.005261561,0.06701566,0.06753707,0.0022496972,0.028749175,0.061929345,0.002634438,0.0152897015,0.036592446,0.04508601,0.0009082949,0.002631698
survival depend amount autotransplanted splenic tissue susceptibility streptococcus pneumoniae infection studied groups rats allocated sham operation splenectomy splenic autotransplantation removed spleen three months later rats exposed intravenously type streptococcus pneumoniae median lethal dose ld control group survivors killed days bacterial challenge autopsy showed splenic tissue recovered rats received less splenic tissue compared received survivors found among sham operated rats confidence intervals rats splenic tissue implanted confidence interval found regenerated splenic tissue conclude spleen autotransplanted protect rat optimally infection splenectomy,C01,0.0034004345,0.003016355,0.006344858,0.019257864,0.004734997,0.0043884376,0.18092737,0.0031978097,0.0024583628,0.0033411265,0.016183447,0.062489014,0.07142041,0.028836679,0.0029902563,0.0052951835,0.15875617,0.0035018837,0.003871895,0.041363608,0.36951822,0.0012073707,0.0034982415
buccal cellulitis buccal cellulitis bc innocuous appearing infection cheek found children high incidence concomitant bacteremia typically child younger months hour prodrome coryza fever developing cellulitis cheek purplish hue cellulitic region highly suggestive hemophilus influenzae bacteremia differential diagnosis reviewed complete blood count blood culture cellulitis aspirate culture obtained patients bc meningitis may present despite lack meningeal signs lumbar puncture performed children risk bacteremic bc vast majority children bacteremic require parenteral antibiotics typical case bc presented management reviewed,C01,0.003915898,0.0034735966,0.007306659,0.0022001832,0.0054527638,0.00505367,0.30261552,0.022630706,0.0028310197,0.09863624,0.072651275,0.008054254,0.09862069,0.04771251,0.0034435417,0.006097867,0.113465846,0.0040327255,0.0044588256,0.100421734,0.08142208,0.001390393,0.0041119778
tetanus immunization status immunologic response booster emergency department geriatric population study objectives although effective procedures prevention tetanus long available serosurveys done since demonstrate elderly population lacks protective antitoxin level iu ml study undertaken assess tetanus immunization status patients presenting emergency department evaluate immunologic response tetanus booster setting study conducted tertiary care ed type participants patients enrolled years old breaks skin barriers design patient initial presentation pertinent demographic data tetanus immunization history recorded patient followed days interventions patient antitoxin titer determined serum sample elisa required advisory committee immunization practices criteria booster administered first visit measurements main results serum antitoxin assays repeated days initial visit seroconversion titer iu ml forty four patients protective levels initial presentation levels protective age sex predictive protection past military service definite history three previous immunizations good predictors protection patients followed serially inadequate initial titers seroconverted day patients seroconvert likely older p less conclusions study demonstrated significant number elderly patients lacked initial protective level tetanus antitoxin failed seroconvert within days carried potential risk developing tetanus,C01,0.0017396788,0.018384954,0.02484391,0.0009774915,0.010853752,0.01605867,0.2030669,0.001636015,0.009669889,0.0017093366,0.04476872,0.0036170222,0.04134802,0.01302721,0.021620648,0.0027090418,0.23403482,0.0017915807,0.022236768,0.147034,0.17646414,0.0006176967,0.0017897175
denatured muscle grafts nerve repair experimental model nerve damage leprosy patients leprosy develop localised granulomatous lesions peripheral nerves report experiments guinea pigs freeze thawed autogenous muscle grafts used treatment mycobacterial granulomas granulomas induced guinea pig tibial nerves animals left days order assess maximal damage local area nerve damage excised gap filled denatured muscle grafts clinical assessment periods days showed good sensory motor recovery correlated well histological findings muscle graft technique may value treatment chronic nerve lesions selected cases leprosy,C01,0.003048957,0.002704577,0.0056890375,0.0017130846,0.03376601,0.003934838,0.24218959,0.017625535,0.076007344,0.0029957793,0.042020503,0.03537239,0.1558004,0.008067101,0.002681176,0.00474786,0.08649909,0.0031399203,0.003471686,0.036333676,0.22797225,0.0010825739,0.0031366546
altered ca homeostasis functional correlates hepatocytes adipocytes endotoxemia sepsis decreased cytosolic ca impaired ca release response ip challenge among perturbations hepatocyte ca homeostasis associated endotoxemia sepsis changes consistent accompanying alterations appropriate physiologic functions e g activation glycogen phosphorylase gluconeogenesis mediated ca c defective phosphorylation relevant enzymes attenuation ip binding subcellular fractions imputed targets ip decrease size ip sensitive pool releasable ca underlying components mechanism reduced ca release upon ip stimulation metabolic sequelae et treatment leads significant increase ca associated cell surface compartment adipocytes reduction ca uptake endoplasmic reticulum higher cytosolic ca basal conditions upon acth stimulation observed cells control rats reduced ca uptake also manifest adipocytes septic rats alterations adipocyte metabolism induced et include increased oxidation glucose co insulin like effect increased lipolysis upon ne acth stimulation,C01,0.0021805959,0.0019339534,0.036361557,0.00122497,0.003065347,0.0028136722,0.14266105,0.002050294,0.0015761935,0.0021421826,0.010121177,0.004501708,0.04593437,0.16801053,0.0019187562,0.07021888,0.043808106,0.065123975,0.0024824876,0.017701725,0.3711414,0.0007741127,0.0022529683
positive lyme serology subacute bacterial endocarditis study four patients lyme borreliosis multisystem inflammatory disorder caused tick borne spirochete borrelia burgdorferi clinical manifestations protean involving skin joints peripheral central nervous systems heart however presentation lyme disease often overlaps conditions describe four patients region endemic lyme disease elevated levels antibodies reactive b burgdorferi whose signs symptoms initially attributed lyme borreliosis whose subsequent blood cultures established diagnosis nonspirochetal subacute bacterial endocarditis although immunoblots serum samples three four patients consistent prior infection b burgdorferi positive immunoblot establish active infection similarly seropositivity b burgdorferi indicates possible exposure organism occurrence positive serologies b burgdorferi presence diseases lead diagnostic confusion,C01,0.0030046618,0.002665285,0.0056063873,0.0016881969,0.018728675,0.0038776726,0.43438566,0.0028256204,0.0021722368,0.032038197,0.11574867,0.006180015,0.042722415,0.057075765,0.0026422238,0.004678883,0.088906296,0.0030943034,0.0034212493,0.054882675,0.109468944,0.0010668462,0.003119101
tumor necrosis factor alpha plays role host defense histoplasma capsulatum tumor necrosis factor alpha detected supernatants collected balb c mouse peritoneal macrophages incubated continuously histoplasma capsulatum levels tnf alpha measured actinomycin bioassay peaked within hours exposure greatly declined h tnf alpha also measured bronchoalveolar lavage fluid balb c mice challenged intranasally h capsulatum lavage fluid tnf alpha levels exhibited pattern vitro supernatants peaked within hours challenge lower levels detected h treatment mice anti tnf alpha antibody accelerated mortality response systemic infection significantly increased tissue colony counts liver spleen murine model tnf alpha produced response h capsulatum appears play role host defense infection,C01,0.0029617148,0.0026271888,0.0055262526,0.0016640667,0.004124094,0.018146686,0.19229665,0.01712017,0.002141188,0.0029100587,0.047482964,0.0060917567,0.14034957,0.12678699,0.0026044573,0.017963877,0.026308382,0.0317139,0.003372348,0.04466896,0.23853102,0.029724283,0.03488343
resurgence acute rheumatic fever mid south children hospital resurgence acute rheumatic fever arf reported many areas united states recent years retrospectively reviewed medical records inpatients new diagnosis arf children hospital serves six state referral area mid south thirty patients identified seen rate new cases arf per hospital discharges significantly greater patients recently diagnosed arf predominantly nonurban areas polyarthritis common recent major manifestation reasons resurgence arf us including mid south unclear experience serves support recently published guidelines diagnosis management streptococcal pharyngitis light resurgence arf,C01,0.0032920882,0.0029202465,0.006142695,0.0018496901,0.0045841285,0.004248611,0.39349735,0.0030959197,0.0023800333,0.035110053,0.09011363,0.006771563,0.03542432,0.0075695277,0.0028949792,0.02104595,0.1338758,0.003390305,0.01966377,0.09974322,0.11783048,0.0011689009,0.003386779
epidemiology lyme disease virginia prior january one case lyme disease reported virginia however virginia department health observed increase reports suspected lyme disease physicians despite fact ixodes dammini highly prevalent virginia tick population twenty eight cases lyme disease identified virginia eight cases occurred lyme disease appears increasing frequency virginia moving southward along eastern atlantic seaboard,C01,0.0050690575,0.004496507,0.009458336,0.0028480967,0.007058502,0.006541883,0.45873985,0.004767003,0.003664703,0.004980647,0.108160876,0.010426083,0.0405375,0.011655329,0.0044576013,0.007893577,0.06970431,0.005220289,0.030308034,0.06800249,0.12899463,0.0017998382,0.0052148597
itraconazole common dermatophyte infections skin fixed treatment schedules itraconazole effective medication common dermatophytoses shown active griseofulvin ketoconazole ease use affinity keratinized tissues lack toxicity continued activity discontinuation possibility using fixed schedules advantages itraconazole fixed schedules indicated pharmacokinetics clinical studies one mg capsule daily days cases tinea corporis tinea cruris dosage days cases tinea pedis tinea manuum fixed treatments limitations recommended treating tinea capitis tinea unguium drug well tolerated,C01,0.0036401316,0.0032289785,0.006792108,0.05491092,0.022690041,0.0046977797,0.40099895,0.003423224,0.002631653,0.003576643,0.06791289,0.025067382,0.022778237,0.008628769,0.00320104,0.0056684418,0.03807708,0.0037487322,0.0041448255,0.041588318,0.24994303,0.0012924785,0.021358375
immunogenicity haemophilus b conjugate vaccine meningococcal protein conjugate children prior invasive haemophilus influenzae type b disease children younger years age previous invasive haemophilus influenzae hib type b disease may develop protective antibodies antigens hib may risk developing second episode hib disease twenty three children prior hib disease immunized haemophilus b conjugate vaccine meningococcal protein conjugate children months age given one dose vaccine children younger months age given doses months apart antibody polysaccharide capsule hib prp measured radioimmunoassay eighteen children preimmunization serum antibody concentrations less micrograms ml children responded greater micrograms ml antibody single dose vaccine children preimmunization serum antibody concentration greater micrograms ml seventeen children ultimately responded greater micrograms ml antibody p less concentrations antibody thought correlate protection haemophilus b conjugate vaccine meningococcal protein conjugate immunogenic children invasive hib disease children younger years age invasive hib disease subsequently immunized hib conjugate vaccine,C01,0.0021801516,0.0019339033,0.004067937,0.0012250306,0.0030357921,0.0028135993,0.23134857,0.002050241,0.0015761526,0.118243866,0.05905691,0.0045895246,0.05894186,0.09415192,0.0019171704,0.0139279915,0.057954933,0.033908315,0.0024824233,0.16068737,0.12996177,0.0007740926,0.013170503
pseudomonas aeruginosa compared escherichia coli produces less endotoxemia cardiovascular dysfunction mortality canine model septic shock investigated effects two different gram negative bacteria radiation induced leukopenia endotoxemia cardiovascular abnormalities mortality canine model septic shock serial hemodynamics measured conscious dogs using radionuclide heart scans thermodilution cardiac output catheters plasma endotoxin concentrations determined chromogenic limulus amebocyte lysate assay viable pseudomonas aeruginosa escherichia coli implanted intraperitoneally produced concordant hemodynamic patterns septic shock p less endotoxin concentrations tenfold lower dogs infected p aeruginosa compared e coli p less despite lower endotoxin levels p aeruginosa infected dogs higher mortality p less severe hypotension p less greater depression left ventricular ejection fraction p less dogs e coli sepsis nonlethal e coli challenge combined leukopenia induced nonlethal dose radiation resulted mortality percent p less without greater cardiovascular dysfunction higher endotoxin concentrations findings suggest bacterial products endotoxin host related factors may important contributors toxicity cardiovascular instability mortality gram negative septic shock quantitative determinations plasma endotoxin unlikely correlate clinical severity septicemia heterogeneous patient populations infected different gram negative organisms,C01,0.01255474,0.0018371646,0.0038644485,0.0011636638,0.03417457,0.022252025,0.16598679,0.0019476828,0.0014973095,0.012040494,0.04197727,0.0042598466,0.18064171,0.028633403,0.0018212687,0.01321782,0.08001978,0.0021328845,0.012381547,0.101679474,0.26302645,0.01075898,0.0021306663
streptococcus mitis sepsis bone marrow transplant patients receiving oral antimicrobial prophylaxis purpose streptococcal infection increasingly become problem neutropenic patients report outbreak streptococcus mitis sepsis six bone marrow transplant patients receiving oral antimicrobial prophylaxis patients methods performed epidemiologic study patients bone marrow transplant program hospital microbiology records patients reviewed bone marrow patients treated according specified protocols including oral prophylactic antimicrobial regimen changed late vancomycin polymyxin tobramycin norfloxacin identification susceptibility testing whole cell protein analysis streptococcal isolates performed reference antimicrobial investigations laboratories centers disease control results detected six cases mitis sepsis among patients undergoing bone marrow transplantation concurrent pathogen isolated patient time mitis bacteremia bacteremia developed within hours transplant five six patients associated severe mucositis four patients environmental study failed reveal common source outbreak whole cell protein analysis six mitis isolates revealed distinct patients receiving oral vancomycin polymyxin tobramycin one developed mitis bacteremia versus five nine patients receiving norfloxacin p less conclusion believe mitis bacteremia potential complication bone marrow transplantation associated antimicrobial prophylaxis norfloxacin especially setting mucositis,C01,0.0018038191,0.010305867,0.0033591425,0.0010115596,0.0025114752,0.018052733,0.29354602,0.0016930085,0.0013015249,0.0017688844,0.055135865,0.004452314,0.04988787,0.021862257,0.0015831239,0.002803416,0.33426026,0.08069184,0.01136652,0.036455408,0.063648075,0.0006392153,0.0018598026
risk factors staphylococcus aureus nosocomial pneumonia critically ill patients staphylococcus aureus nosocomial pneumonia become important infection apparently increasing incidence also high mortality rate total episodes nosocomial pneumonia critically ill patients etiologic diagnosis well established prospectively followed medical surgical intensive care unit icu aureus isolated total episodes univariate analysis variables significantly associated aureus nosocomial pneumonia yr age coma nonuse corticosteroids antecedent trauma step forward logistic regression analysis defined coma significantly influencing risk developing aureus nosocomial pneumonia suggest antimicrobial drugs active aureus must included initial empirical antimicrobial regimen treating nosocomial pneumonia patients coma identification factors influencing etiology possibility earlier effective antimicrobial treatment may represent step control nosocomial pneumonia critically ill patients improving prognosis,C01,0.0026232195,0.0023269267,0.017588409,0.00147388,0.00365275,0.0033854013,0.3644969,0.0024669073,0.0018964709,0.0026057186,0.03977038,0.005451549,0.05406917,0.03414007,0.0023069335,0.016736118,0.118931405,0.002701481,0.0029869212,0.24328642,0.07346872,0.00093140994,0.0027028916
infectious diseases canadian subspecialty projections year infectious diseases relatively new subspecialty canada past decade however important advances made include formation canadian infectious diseases society development first royal college physicians surgeons examinations subspecialty infectious diseases majority canadians training practice field infectious diseases enrolled programs canada despite predictions united states excess physicians specialize infectious diseases situation occurred canada physicians training infectious diseases required canada next decade fill positions patient care microbiology individuals clinical laboratory training research epidemiology infection control programs related human immunodeficiency virus infections geographic international medicine pharmaceutical industry education administration canada extent infectious diseases physicians involved areas varies united states review suggests continued need physicians appropriate training infectious diseases,C01,0.0031903319,0.0028299836,0.005952828,0.0017925174,0.019881658,0.019545684,0.3620253,0.0030252119,0.0023064679,0.018575503,0.030591218,0.0066678245,0.023435146,0.008771,0.0028054973,0.05129843,0.05131946,0.0032855128,0.07526979,0.16751875,0.11457249,0.0011327709,0.024206623
immunogenicity animals polysaccharide protein conjugate vaccine type iii group b streptococcus native capsular polysaccharide type iii group b streptococcus elicits specific antibody response nonimmune human subjects enhance immunogenicity polysaccharide coupled type iii polysaccharide tetanus toxoid prior coupling aldehyde groups introduced polysaccharide controlled periodate oxidation resulting conversion sialic acid residues polysaccharide residues carbon analogue sialic acid acetamido dideoxy galactosyloctulosonic acid tetanus toxoid conjugated polysaccharide reductive amination via free aldehyde groups present partially oxidized sialic acid residues rabbits vaccinated conjugate vaccine produced igg antibodies reacted native type iii group b streptococcal polysaccharide rabbits rabbits immunized unconjugated type iii polysaccharide failed respond rabbits sera animals receiving conjugate vaccine opsonized type iii group b streptococci phagocytic killing human peripheral blood leukocytes protected mice lethal challenge live type iii group b streptococci results suggest method conjugation carrier protein may useful strategy improve immunogenicity type iii group b streptococcus polysaccharide human subjects,C01,0.0025582847,0.002269326,0.004773494,0.01662026,0.0035623303,0.0033015995,0.30595145,0.0024058418,0.001849526,0.014892506,0.025323663,0.17872816,0.07014599,0.09453286,0.002249691,0.016354723,0.023676079,0.02740424,0.0029129833,0.030738678,0.16618805,0.0009083539,0.002651905
changing epidemiology group streptococcal infection usa see whether changes epidemiology group streptococcal disease usa accompanied corresponding change serotype distribution epidemiological typing typing data strains sent centers disease control atlanta analysed proportions types increased significantly study period types likely invasive cause fatal infection occur cluster infections types contrast proportions types decreased less invasive less likely found clusters types data suggest changes epidemiology group streptococcal disease may related changes distribution types causing infection,C01,0.003004628,0.002665255,0.0056063244,0.0016885317,0.0041838493,0.018417383,0.38429737,0.0028255887,0.0021722123,0.0029522236,0.044515617,0.050833765,0.11237631,0.0070691374,0.002642194,0.004678831,0.046438348,0.03217785,0.0034212111,0.053418133,0.21045731,0.0010668343,0.0030910505
emergence ciprofloxacin resistance nosocomial methicillin resistant staphylococcus aureus isolates resistance ciprofloxacin plus rifampin therapy methicillin resistant aureus colonization initiated randomized single blinded trial ciprofloxacin plus rifampin vs sulfamethoxazole trimethoprim plus rifampin therapy patients underwent colonization methicillin resistant staphylococcus aureus mrsa patients colonized mrsa received weeks either regimen study terminated enrollment subjects due recognition ciprofloxacin resistance new mrsa isolates last months study five patients ciprofloxacin resistant mrsa isolates never received ciprofloxacin long term month eradication achieved three ciprofloxacin plus rifampin four sulfamethoxazole trimethoprim plus rifampin recipients use new fluoroquinolone eradication mrsa colonization usually effective may risk development ciprofloxacin resistance mrsa within hospital environment,C01,0.003776829,0.0033467058,0.007039746,0.0021198103,0.0052535734,0.08721838,0.3430253,0.02180419,0.0027276021,0.0037070462,0.028863726,0.010482569,0.062265627,0.008693209,0.0033177487,0.005875111,0.23922752,0.0038854096,0.022559498,0.045021918,0.084544204,0.0013396018,0.0039046844
congenital insensitivity pain neuroparalytic keratitis congenital insensitivity pain well defined entity group sensory deficiency syndromes best knowledge unilateral neuroparalytic keratitis associated congenital insensitivity pain reported report case alert clinicians potentially blinding problem,C01,0.0059443633,0.005272947,0.011091566,0.0033398953,0.09460187,0.0076715103,0.3069706,0.005590151,0.0042975103,0.005840686,0.057353847,0.041004412,0.0367967,0.013667927,0.005227323,0.03802451,0.0641146,0.0061217085,0.037490875,0.11167836,0.12939535,0.0021106275,0.0063927085
itraconazole tinea versicolor review itraconazole new orally active triazole antifungal tested patients pityriasis versicolor number studies shown itraconazole effective mild fungal skin disease total dose required effective treatment mg given mg days days organisms disappear slowly skin even dead results assessed clinically mycologically around weeks treatment numerous studies shown itraconazole superior placebo effective selenium sulfide clotrimazole ciclopirox olamine also better tolerated patients selenium sulfide,C01,0.0035164373,0.020128503,0.023540538,0.0019757426,0.038943183,0.0045381454,0.34011772,0.020321013,0.0025422275,0.037481017,0.052125257,0.007319903,0.043707646,0.008641565,0.0030924613,0.005475824,0.08540016,0.0036213472,0.021026088,0.057465196,0.21415387,0.0012485591,0.003617581
catheter related sepsis prospective randomized study three methods long term catheter maintenance studied infectious risk different methods managing vascular catheters long term use consecutive surgical icu patients requiring triple lumen catheters pulmonary artery catheters arterial catheters greater days prospectively randomized one three management groups percutaneous perc puncture every day catheter change new site b weekly change nwc new site changed c guidewire exchange gwx every day catheter change site groups catheter change mandatory positive blood culture skin site infection sepsis without likely source cultures obtained clinically indicated time every catheter change catheter related sepsis crs defined positive blood culture catheter culture organism total patients met evaluation criteria intergroup differences age primary diagnosis severity injury illness number study days number protocol violations route catheterization number catheters present patient day catheter sepsis rate bacteremia rate nwc group demonstrated increased number days catheter fewer catheter subcutaneous tract segment cultures patient reduced incidence catheter tip colonization results occurred setting number crs episodes patient gwx perc nwc conclude difference infectious risk three methods long term catheter management method least complications expense used,C01,0.027820053,0.0012572696,0.002644648,0.00079635717,0.0157034,0.015828868,0.16940846,0.0013399858,0.0010246887,0.0013926402,0.21258062,0.03156151,0.05717619,0.045323048,0.0012464195,0.00904486,0.2011275,0.0014702468,0.0016701268,0.0825817,0.110198215,0.0005032533,0.008299942
recombinant capsular antigen fraction yersinia pestis induces protective antibody response balb c mice yersinia pestis produces glycoprotein capsule biosynthesis appears temperature dependent fraction f component capsule specific pestis detection f antibodies basis several serological tests report cloning f gene expression escherichia coli using phagemid vector lambda zapii f specific monoclonal antibody recombinant f antigen molecular weight kda proved identical f antigen produced pestis recombinant cells produced f antigen degrees c minimal amounts degrees c suggesting genetic features affected temperature pestis may operating e coli clone known similar molecular weights reflect glycosylated nature proteins f antigen purified e coli recombinant induced protective immune response balb c mice challenged virulent pestis resistance immunized mice plague infection correlated high titers f antibody cloned gene expresses immunogenically competent f antigen suitable use plague serodiagnostics vaccine development,C01,0.0023278054,0.0020648795,0.03863132,0.0013078989,0.014461795,0.014271167,0.19385721,0.0021890965,0.0016828998,0.0022872055,0.047103804,0.00479603,0.05065377,0.1929857,0.014057625,0.0036295298,0.02112423,0.033675555,0.002650549,0.030882308,0.20337035,0.00082651916,0.121162765
interleukin receptor antagonist reduces mortality endotoxin shock five patients admitted hospital develop bacterial sepsis leading shock mortality rate high despite antibiotic therapy infection results hypotension poor tissue perfusion eventually leads failure several organ systems bacterial endotoxin thought direct cause shock gram negative sepsis cause shock animals antibodies endotoxin prevent gram negative shock animals humans symptoms septic shock result actions host cytokines induced endotoxin cytokine interleukin implicated important mediator septic shock induce tachycardia hypotension act synergistically tumour necrosis factor cause tissue damage death report specific interleukin receptor antagonist reduces lethality endotoxin induced shock rabbits indicating interleukin indeed play important part endotoxin shock,C01,0.0030504023,0.03222722,0.005689485,0.0017132192,0.00424591,0.003935147,0.31542188,0.0028675015,0.0022044335,0.003003465,0.028729178,0.008762056,0.036813445,0.053649448,0.0026813867,0.0047482336,0.12627412,0.003140167,0.032992963,0.0756345,0.23322633,0.015838822,0.0031507483
postneonatal infectious disease mortality french situation mortality caused infectious parasitic diseases represents limited part postneonatal deaths france stable past decade component worthy careful analysis least partially preventable statistics presented interpreted discussion disorders included assessing impact infection morbidity mortality figures international rankings change according inclusiveness definition chosen need epidemiologic statistical research make comparisons mortality clear morbidity also important high incidence frequent hospitalization heavy social cost policy services france relate control treatment infection described shortcomings call efforts,C01,0.003190374,0.0028300209,0.021394737,0.001792541,0.050750066,0.04764005,0.40838814,0.0030002664,0.0023064984,0.0031347298,0.017942104,0.00665398,0.061908685,0.0073462785,0.0028055343,0.02040509,0.046847917,0.003285556,0.06430406,0.17161873,0.048033193,0.0011327858,0.0032887016
mycobacterium leprae specific cells tuberculoid leprosy patient suppress hla dr restricted cell responses immunodominant epitope kda hsp mycobacteria polar tuberculoid type tt leprosy characterized high cell reactivity mycobacterium leprae associated hla dr surprisingly dr restricted low cell responsiveness leprae found hla dr positive tt leprosy patients low responsiveness specifically induced leprae tuberculosis seen patients healthy controls studied patient specific leprae induced dr restricted low cell responsiveness depth one representative hla dr positive tt leprosy patient using cell clones patient two types cell clones obtained one type cross reactive tuberculosis recognized immunodominant epitope amino acids kda heat shock protein hsp type leprae specific reacted protein kda one examine whether leprae specific cell clones responsible dr restricted low responsiveness leprae tested ability suppress proliferation dr restricted kda hsp reactive clones dr restricted leprae specific cells completely suppressed proliferative responses dr restricted cross reactive cell clones kda hsp patient well individuals also dr restricted responses irrelevant ag suppressed leprae specific cell clones however suppression non dr restricted cell responses seen although mechanism must still elucidated leprae induced dr restricted immunosuppression may least partly explain observed dr associated low cell responsiveness tt leprosy patients,C01,0.0016693141,0.001480765,0.013691414,0.01384813,0.002324467,0.0021543368,0.1766918,0.0015698433,0.0012068398,0.0016484781,0.02965083,0.003448302,0.04670234,0.18403335,0.0014713409,0.057114612,0.07808374,0.12586954,0.0019007596,0.022398105,0.2200454,0.0005927128,0.01240357
syphilis adults article reviews clinical manifestations syphilis diagnostic tests might help diagnose accurately disease current recommendations therapy association syphilis human immunodeficiency virus infection raises additional questions related transmission diagnosis therapy diseases,C01,0.0051964247,0.004609488,0.00969599,0.0029196593,0.007235857,0.0068796086,0.3806715,0.004886781,0.003756784,0.005117638,0.12318601,0.0106880525,0.03335419,0.016614016,0.004569605,0.033246007,0.045501985,0.005351456,0.10611713,0.07518541,0.06826262,0.0018450617,0.04510877
low gastric acid risk factor cholera transmission application new non invasive gastric acid field test although gastric acid thought important host defense certain enteric infections field studies role gastric acid preventing enteric infections hampered lack suitable non invasive test low gastric acid output gao established risk factor cholera assessed validation whether new non invasive test estimates gao measuring breath hydrogen excess ingestion magnesium stimulant gastric acid secretion could discriminate persons high low risk developing cholera fifteen age matched pairs participants field trial two oral cholera vaccines rural bangladesh tested pair case person recovered severe cholera least months testing control person resided home cholera patient remained uninfected stimulated breath hydrogen higher controls median hydrogen excess mumol min cases median hydrogen excess mumol min p less higher controls pairs results consistent past invasive assessments association hypochlorhydria cholera suggest non invasive test may useful evaluating gao epidemiological field studies,C01,0.0020745376,0.01186042,0.013877242,0.0011635598,0.0028836767,0.022713102,0.35501596,0.0019475089,0.0014971758,0.0020347908,0.134584,0.0043416284,0.09863053,0.00519826,0.0018211061,0.024014832,0.061515376,0.002132694,0.058315717,0.15127957,0.04023251,0.0007353049,0.0021304758
use prophylactic furazolidone control nosocomial epidemic multiply resistant salmonella typhimurium pediatric wards nosocomial spread enteric pathogens often difficult control overcrowded pediatric wards despite cohorting patients enforced hand washing cases nosocomial multiply resistant salmonella typhimurium phage type r observed two adjacent pediatric wards cases occurred summer months new cases detected early summer oral administration furazolidone throughout entire hospital stay mg kg twice daily recommended subsequently hospitalized infants among infants appropriately treated one additional case detected contrast cases occurred among infants inappropriately treated treated treatment furazolidone delayed greater hours p less appropriately inappropriately treated groups pediatric wards infection control measures cannot optimally applied prophylactic furazolidone administration may helpful preventing spread enteric pathogens,C01,0.002496496,0.062636,0.0048158397,0.0014027448,0.0034762917,0.0032218583,0.23276363,0.0023477352,0.0018048555,0.014535473,0.10552292,0.07036556,0.09375804,0.030782664,0.0021953557,0.0038875637,0.1650999,0.002570977,0.002842628,0.0700237,0.11999021,0.0008864151,0.0025731232
randomized prospective field trial conjugate vaccine protection infants young children invasive haemophilus influenzae type b disease background haemophilus influenzae type b leading cause invasive bacterial disease young children capsular polysaccharide vaccine protect children greatest risk age months polysaccharide protein conjugate vaccine proved immunogenic age group methods enrolled infants finland open prospective randomized trial h influenzae type b capsular polysaccharide diphtheria toxoid conjugate vaccine polyribosylribitol phosphate diphtheria toxoid prp children born odd numbered days vaccinated ages months born even numbered days formed control group received vaccine age months results three doses vaccine cases verified bacteremic h influenzae type b disease group receiving early vaccination compared cases control group ages approximately months protective efficacy vaccine thus percent percent confidence interval serious adverse effects reported immune response conjugate vaccine characteristic cell dependent response studied cohort infants primary immunization series resulted geometric mean concentration anticapsular antibody micrograms per milliliter age seven months fourth dose evoked anamnestic response mean antibody concentration micrograms per milliliter conclusions new conjugate vaccine consisting capsular polysaccharide h influenzae type b covalently linked protein carrier prp administered infants beginning age months highly effective protecting young finnish children months old invasive h influenzae type b infections,C01,0.001629787,0.009318481,0.010928707,0.0009157709,0.0022694268,0.002103325,0.21157208,0.0015326715,0.0011782635,0.041052233,0.06679422,0.054693405,0.015856432,0.03731913,0.0014331936,0.010419274,0.115609504,0.017727604,0.033571698,0.21386322,0.14795524,0.00057867815,0.0016776547
tampon absorbency composition oxygen content risk toxic shock syndrome tampon use identified major risk factor toxic shock syndrome although etiologic role tampons clearly understood two epidemiologic studies conducted date reported association tampon absorbency risk toxic shock syndrome finding corroborated laboratory studies however suggested absorbency may marker characteristics create environment conductive elaboration toxic shock syndrome toxin used data previously reported tri state study estimate simultaneously effects tampon oxygen content absorbency chemical composition although data sparse oxygen content strongly associated risk toxic shock syndrome either absorbency chemical composition results suggest may possible develop highly absorbent tampon associated high risk toxic shock syndrome,C01,0.0030946264,0.002745088,0.0057742517,0.0017387443,0.004309169,0.0039937766,0.375778,0.002910224,0.002237277,0.0030406523,0.052320402,0.006365055,0.020205708,0.007351459,0.0027213364,0.004818977,0.029485807,0.003186952,0.0035236874,0.30322027,0.1568961,0.0010987894,0.0031836375
amoxycillin plus probenecid versus doxycycline treatment erythema migrans borreliosis adults erythema migrans early lyme borreliosis enrolled randomised prospective trial comparing amoxycillin mg plus probenecid mg three times day doxycycline mg twice day days antibiotic regimens chosen known vitro sensitivity borrelia burgdorferi antibiotic tissue penetration pharmacokinetics drugs organism disseminate early course infection patients evaluable doxycycline group amoxycillin probenecid group two regimens equally effective treatment erythema migrans mild fatigue arthralgia post treatment complaints resolved within months none patients needed antibiotic treatment lyme borreliosis,C01,0.004152006,0.0036830367,0.027844567,0.002332843,0.005781537,0.0053583803,0.34401053,0.003904597,0.0030017158,0.00407959,0.03918606,0.048781276,0.082913555,0.009799204,0.0036511694,0.006465537,0.17300916,0.004275878,0.044920553,0.030165328,0.1469329,0.0014742266,0.004276312
vitro susceptibility xanthomonas pseudomonas maltophilia newer antimicrobial agents susceptibilities clinical environmental isolates xanthomonas maltophilia antimicrobial agents determined broth microdilution newer quinolones pd pd pd amifloxacin fleroxacin active agents tested isolates susceptible agents isolates resistant trospectomycin new aminoglycosides sch sch active isolates respectively,C01,,,,,,,,,,,,,,,,,,,,,,,
